PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	D2	EA	PG	WC	WE	SC	GA	UT	PM	OA	HC	HP	DA	WOS
J	Morrison, LJ; Rizoli, SB; Schwartz, B; Rhind, SG; Simitciu, M; Perreira, T; MacDonald, R; Trompeo, A; Stuss, DT; Black, SE; Kiss, A; Baker, AJ				Morrison, Laurie J.; Rizoli, Sandro B.; Schwartz, Brian; Rhind, Shawn G.; Simitciu, Merita; Perreira, Tyrone; MacDonald, Russell; Trompeo, Anna; Stuss, Donald T.; Black, Sandra E.; Kiss, Alex; Baker, Andrew J.			The Toronto prehospital hypertonic resuscitation-head injury and multi organ dysfunction trial (TOPHR HIT) - Methods and data collection tools	TRIALS			English	Article							DISABILITY RATING-SCALE; GLASGOW OUTCOME SCALE; TRAUMATIC BRAIN-INJURY; HEMORRHAGIC-SHOCK; CRITICAL-CARE; REACTION-TIME; SALINE; SYSTEM; RECOMMENDATIONS; HYPOTENSION	Background: Clinical trials evaluating the use of hypertonic saline in the treatment of hypovolemia and head trauma suggest no survival superiority over normal saline; however subgroup analyses suggest there may be a reduction in the inflammatory response and multiorgan failure which may lead to better survival and enhanced neurocognitive function. We describe a feasibility study of randomizing head injured patients to hypertonic saline and dextran vs. normal saline administration in the out of hospital setting. Methods/Design: This feasibility study employs a randomized, placebo-controlled design evaluating normal saline compared with a single dose of 250 ml of 7.5% hypertonic saline in 6% dextran 70 in the management of traumatic brain injuries. The primary feasibility endpoints of the trial were: 1) baseline survival rates for the treatment and control group to aid in the design of a definitive multicentre trial, 2) randomization compliance rate, 3) ease of protocol implementation in the out-of-hospital setting, and 4) adverse event rate of HSD infusion. The secondary objectives include measuring the effect of HSD in modulating the immuno-inflammatory response to severe head injury and its effect on modulating the release of neurobiomarkers into serum; evaluating the role of serum neuro-biomarkers in predicting patient outcome and clinical response to HSD intervention; evaluating effects of HSD on brain atrophy post-injury and neurocognitive and neuropsychological outcomes. Discussion: We anticipate three aspects of the trial will present challenges to trial success; ethical demands associated with a waiver of consent trial, challenging follow up and comprehensive accurate timely data collection of patient identifiers and clinical or laboratory values. In addition all the data collection tools had to be derived de novo as none existed in the literature.	[Morrison, Laurie J.; Perreira, Tyrone; Baker, Andrew J.] St Michaels Hosp, Li Ka Shing Knowledge Inst, Keenan Res Ctr, Toronto, ON M5B 1W8, Canada; [Morrison, Laurie J.; MacDonald, Russell; Black, Sandra E.] Univ Toronto, Dept Med, Toronto, ON M5S 1A1, Canada; [Rizoli, Sandro B.; Schwartz, Brian; MacDonald, Russell; Black, Sandra E.; Kiss, Alex] Sunnybrook Hlth Sci Ctr, Toronto, ON M4N 3M5, Canada; [Rizoli, Sandro B.] Univ Toronto, Dept Surg, Toronto, ON M5S 1A1, Canada; [Schwartz, Brian] Sunnybrook Osler Ctr Prehosp Care, Etobicoke, ON M9W 7K6, Canada; [Schwartz, Brian] Univ Toronto, Dept Family & Community Med, Toronto, ON M5S 1A1, Canada; [Rhind, Shawn G.] Def Res & Dev Canada, Toronto, ON M3M 3B9, Canada; [Simitciu, Merita; Baker, Andrew J.] Univ Toronto, Dept Anaesthesia, Toronto, ON M5S 1A1, Canada; [MacDonald, Russell] Ornge Transport Med, Toronto, ON, Canada; [Trompeo, Anna] Univ Turin, I-10124 Turin, Italy; [Stuss, Donald T.] Rotman Res Inst, Toronto, ON M6A 2E1, Canada; [Kiss, Alex] Inst Clin & Evaluat Sci, Toronto, ON M9W 7K6, Canada		Morrison, LJ (corresponding author), St Michaels Hosp, Li Ka Shing Knowledge Inst, Keenan Res Ctr, 30 Bond St, Toronto, ON M5B 1W8, Canada.	morrisonl@smh.toronto.on.ca; sandro.rizoli@sunnybrook.ca; bschwartz@socpc.ca; shawn.rhind@drdc-rddc.goc.ca; singhs@smh.toronto.on.ca; perreirat@smh.toronto.on.ca; rmacdonald@ornge.ca; singhs@smh.toronto.on.ca; dstuss@rotman-baycrest.on.ca; sandra.black@sw.ca; alex.kiss@ices.on.ca; bakera@smh.toronto.on.ca	Black, Sandra E./C-7294-2011; morrison, laurie J/A-6325-2012	morrison, laurie J/0000-0001-8369-9774; Black, Sandra/0000-0001-7093-8289; Rhind, Shawn/0000-0003-2300-0620	Defense Research and Development Canada (DRDC) [w7711-027801/001/TOR]	Funding for this study was provided in part from the Defense Research and Development Canada (DRDC). Grant no. w7711-027801/001/TOR (Government of Canada). The investigators would like to acknowledge the assistance of Sandy Malhi, Vincenza Notarangelo, Jennifer Long, Pang Shek (DRDC), Boris Bojilov, Amanda White-McFarlan, Jane Topolovec-Vranic, Jennifer Shield, Josh Sullovoy, Mark Etherington, Dean Popov, Ori Rotstein, Rory O'Neil and Welson Ryan for their contribution to the preparation of this protocol.	Basser PJ, 1996, J MAGN RESON SER B, V111, P209, DOI 10.1016/j.jmr.2011.09.022; Beck A., 1996, BECK DEPRESSION INVE, V78, P490; Benton A.L., 1983, CONTRIBUTIONS NEUROP; Cuschieri J, 2002, J IMMUNOL, V168, P1389, DOI 10.4049/jimmunol.168.3.1389; Dade LA, 2004, NEUROIMAGE, V22, P1492, DOI 10.1016/j.neuroimage.2004.03.023; Delis DC, 1987, CALIFORNIA VERBAL LE; Dick WF, 2000, BRIT J ANAESTH, V84, P818, DOI 10.1093/oxfordjournals.bja.a013601; DODDS TA, 1993, ARCH PHYS MED REHAB, V74, P531, DOI 10.1016/0003-9993(93)90119-U; Ferreira FL, 2001, JAMA-J AM MED ASSOC, V286, P1754, DOI 10.1001/jama.286.14.1754; Freedman M, 1998, CEREB CORTEX, V8, P18, DOI 10.1093/cercor/8.1.18; Gao FQ, 2003, NEUROBIOL AGING, V24, P49, DOI 10.1016/S0197-4580(02)00013-1; Golden CJ., 1978, STROOP COLOUR WORD T; GOUVIER WD, 1987, ARCH PHYS MED REHAB, V68, P94; HALL K, 1985, ARCH PHYS MED REHAB, V66, P35; Heaton R.K., 1981, WISCONSIN CARD SORTI; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; Kaplan E.F., 1978, BOSTON NAMING TEST; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Kovacevic N, 2002, NEUROIMAGE, V17, P1087, DOI 10.1006/nimg.2002.1221; Kreimeier U, 2002, ACTA ANAESTH SCAND, V46, P625, DOI 10.1034/j.1399-6576.2002.460601.x; Lancaster GA, 2004, J EVAL CLIN PRACT, V10, P307, DOI 10.1111/j..2002.384.doc.x; LAWRENCE M, 1991, J NEUROSURG, V75, pS14; LEZACK MD, 1983, NEUROPSYCHOLOGICAL A; Loomis WH, 2001, AM J PHYSIOL-CELL PH, V281, pC840, DOI 10.1152/ajpcell.2001.281.3.C840; MARSHALL JC, 1995, CRIT CARE MED, V23, P1638, DOI 10.1097/00003246-199510000-00007; MATTOX KL, 1991, ANN SURG, V213, P482, DOI 10.1097/00000658-199105000-00014; Morganti-Kossmann MC, 2007, INJURY, V38, P1392, DOI 10.1016/j.injury.2007.10.005; Pelinka LE, 2003, SHOCK, V19, P195, DOI 10.1097/00024382-200303000-00001; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Rey A, 1941, ARCH PSYCHOLOGIE, V28, P286; Rizoli SB, 1999, J SURG RES, V83, P130, DOI 10.1006/jsre.1999.5581; Rizoli SB, 2000, AM J PHYSIOL-CELL PH, V279, pC619, DOI 10.1152/ajpcell.2000.279.3.C619; Rizoli SB, 1998, J IMMUNOL, V161, P6288; Rizoli SB, 1999, J BIOL CHEM, V274, P22072, DOI 10.1074/jbc.274.31.22072; ROUMEN RMH, 1993, ANN SURG, V218, P769, DOI 10.1097/00000658-199312000-00011; Rudkin TM, 1999, ARCH NEUROL-CHICAGO, V56, P919, DOI 10.1001/archneur.56.8.919; Safar PBN, 1988, CARDIOPULMONARY CERE; Simma B, 1998, CRIT CARE MED, V26, P1265, DOI 10.1097/00003246-199807000-00032; Soriano SG, 2008, EUR J ANAESTH, V25, P154, DOI 10.1017/S0265021507003390; Stuss DT, 2002, NEUROPSYCHOLOGY, V16, P500, DOI 10.1037//0894-4105.16.4.500; STUSS DT, 1989, J NEUROL NEUROSUR PS, V52, P742, DOI 10.1136/jnnp.52.6.742; Swartz RE, 1999, CAN J NEUROL SCI, V26, P77; Swartz RH, 2002, PSYCHIAT RES-NEUROIM, V116, P83, DOI 10.1016/S0925-4927(02)00068-9; Tan TS, 2002, ANAESTHESIA, V57, P644, DOI 10.1046/j.1365-2044.2002.02603.x; Thiel M, 2001, J LEUKOCYTE BIOL, V70, P261; Togashi H, 2009, CELL ADH MIGR, V3; Wade CE, 1997, J TRAUMA, V42, pS61, DOI 10.1097/00005373-199705001-00011; Walker PM, 1999, J SURG RES, V84, P193, DOI 10.1006/jsre.1999.5641; Ward T, 2008, BRIT J CANCER, V99, P841, DOI 10.1038/sj.bjc.6604519; Wechsler D, 1987, MEMORY SCALE REVISED; Wechsler D., 1997, MANUAL WECHSLER ADUL; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; WONG DT, 1991, CAN J ANAESTH, V38, P374, DOI 10.1007/BF03007629; 2000, PROVINCIAL ADV LIFE	54	8	9	0	2	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1745-6215			TRIALS	Trials	NOV 20	2009	10								105	10.1186/1745-6215-10-105			9	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	532KH	WOS:000272746200001	19930566	Green Published, gold			2022-02-06	
J	Hart, T; Whyte, J; Ellis, C; Chervoneva, I				Hart, Tessa; Whyte, John; Ellis, Colin; Chervoneva, Inna			Construct Validity of an Attention Rating Scale for Traumatic Brain Injury	NEUROPSYCHOLOGY			English	Article						traumatic brain injury; attention; observational rating scale; methylphenidate	METHYLPHENIDATE; REHABILITATION; CONSCIOUSNESS; IMPAIRMENTS; DISABILITY; BATTERY; TASK; COMA	Attention deficits are nearly ubiquitous after traumatic brain injury (TBI). In the subacute phase of moderate to severe TBI, these deficits may be difficult to measure with the precision needed to predict outcomes, assess degree of recovery, and monitor treatment response. This article reports the findings of four studies, three observational and one a randomized, controlled treatment trial of methylphenidate (MP), designed to provide construct validation of the Moss Attention Rating Scale (MARS), an observational measure of attention dysfunction following TBI. One hundred seven participants with moderate to severe TBI were enrolled during treatment on an inpatient rehabilitation unit. MARS scores were provided independently by four rehabilitation disciplines (Physical, Occupational and Speech Therapies and Nursing). Results indicated that the MARS: (1) is more strongly related to concurrent measures of cognitive versus physical disability, supporting its validity as a measure of cognition, (2) is more strongly related to concurrent psychometric measures of attention versus measures thought to rely less on attention, supporting its validity as a measure of attention; and (3) predicts 1-year outcomes of TBI better than psychometric measures of attention. However, the MARS (4) was not differentially affected by MP versus placebo treatment. Results support the construct validity and utility of the MARS, with further research needed to clarify its role in treatment outcome assessment.	[Hart, Tessa; Whyte, John; Ellis, Colin] Moss Rehabil Res Inst, Elkins Pk, PA 19027 USA; [Chervoneva, Inna] Thomas Jefferson Univ, Div Biostat, Dept Pharmacol & Expt Therapeut, Philadelphia, PA 19107 USA		Hart, T (corresponding author), Moss Rehabil Res Inst, 60 E Township Line Rd, Elkins Pk, PA 19027 USA.	thart@einstein.edu		Whyte, John/0000-0002-4381-1474	National Institute on Disability and Rehabilitation Research [H133A020505]	This research was supported by the National Institute on Disability and Rehabilitation Research (grant number H133A020505). We thank Jason McLaughlin, Caron Morita, and Kelly Bognar for data collection and Gemma Baldon for database management. We also gratefully acknowledge the physicians and other clinicians of the Drucker Brain Injury Center, MossRehab Hospital for their assistance in patient enrollment and data collection.	Benton A, 2000, MULTILINGUAL APHASIA; Brown AW, 2005, J NEUROTRAUM, V22, P1040, DOI 10.1089/neu.2005.22.1040; Burgess PW, 2006, J INT NEUROPSYCH SOC, V12, P194, DOI 10.1017/S1355617706060310; Cicerone KD, 2005, ARCH PHYS MED REHAB, V86, P1681, DOI 10.1016/j.apmr.2005.03.024; DIKMEN SS, 1994, ARCH NEUROL-CHICAGO, V51, P177, DOI 10.1001/archneur.1994.00540140087018; Hamilton BB, 1987, REHABILITATION OUTCO, P137; Hanks RA, 2008, ARCH PHYS MED REHAB, V89, P950, DOI 10.1016/j.apmr.2008.01.011; Hart T, 2006, ARCH PHYS MED REHAB, V87, P647, DOI 10.1016/j.apmr.2006.01.016; HART T, 2008, MOSS ATTENTION RATIN; HEINEMANN AW, 1993, ARCH PHYS MED REHAB, V74, P566, DOI 10.1016/0003-9993(93)90153-2; Kalmar K, 2008, ARCH PHYS MED REHAB, V89, P942, DOI 10.1016/j.apmr.2008.01.008; Martin RT, 2007, AM J PHYS MED REHAB, V86, P613, DOI 10.1097/PHM.0b013e3181154a84; McDowell S, 1997, NEUROPSYCHOLOGIA, V35, P1341, DOI 10.1016/S0028-3932(97)00082-1; Park NW, 1999, NEUROPSYCHOLOGIA, V37, P1119, DOI 10.1016/S0028-3932(99)00034-2; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Reitan R, 1985, HALSTEAD REITAN NEUR; Robertson I H, 1996, J Int Neuropsychol Soc, V2, P525; Sherer M, 2002, ARCH PHYS MED REHAB, V83, P183, DOI 10.1053/apmr.2002.28802; Smith A., 1982, SYMBOL DIGIT MODALIT; Smith GT, 2003, PSYCHOL ASSESSMENT, V15, P467, DOI 10.1037/1040-3590.15.4.467; TEASDALE G, 1974, LANCET, V2, P81; Warden DL, 2006, J NEUROTRAUM, V23, P1468, DOI 10.1089/neu.2006.23.1468; Wechsler D., 1997, WECHSLER MEMORY SCAL; Whyte J, 2004, AM J PHYS MED REHAB, V83, P401, DOI 10.1097/01.PHM.0000128789.75375.D3; Whyte J, 2003, ARCH PHYS MED REHAB, V84, P268, DOI 10.1053/apmr.2003.50108; Whyte J, 2000, J INT NEUROPSYCH SOC, V6, P1, DOI 10.1017/S1355617700611013; Whyte J, 2008, ARCH PHYS MED REHAB, V89, P966, DOI 10.1016/j.apmr.2007.12.031; Willmott C, 2009, J NEUROL NEUROSUR PS, V80, P552, DOI 10.1136/jnnp.2008.159632	28	8	8	0	6	AMER PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA	0894-4105	1931-1559		NEUROPSYCHOLOGY	Neuropsychology	NOV	2009	23	6					729	735		10.1037/a0016153			7	Psychology, Clinical; Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	518KD	WOS:000271689300005	19899831				2022-02-06	
J	Murphy, J; Nyland, J; Lantry, J; Roberts, C				Murphy, Joshua; Nyland, John; Lantry, Jacab; Roberts, Craig			Motorcyclist "biker couples": A descriptive analysis of orthopaedic and non-orthopaedic injuries	INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED			English	Article						Scapula; Fractures; Motor vehicle trauma; Closed head injuries	SCAPULAR FRACTURES; TRAUMA; PATTERNS; ACCIDENTS; DRIVER	The term "biker couple" is becoming all increasingly common site in emergency departments The purpose of this Study Was to identify orthopaedic and non-orthopaedic injury patterns among this unique patient group A 14-year (1993-2006) retrospective review of a Level 1 Trauma Institute Registry was performed Patient demographic and Injury data were obtained from 2 1 confirmed biker couples (n = 42). Nineteen of 21 biker couple pairs (90 5%) included a male driver and a female passenger Drivers were more likely to have a positive blood alcohol concentration/toxicology teat. Drivers had a greater incidence of scapular and rib fractures than passengers Both drivers and passengers Who Sustained scapular fractures had a greater incidence of clavicle, rib. pelvis, and fibula fractures Drivers with scapular fractures had a greater incidence of thoracic spine fractures. While passengers with scapular fractures had a greater incidence of arm-forearm-wrist-hand. femur, tibia, and foot-ankle fractures. Overall, biker couple drivers and passengers did not differ for head Injury, pulmonary system, road rash, aortic injury or visceral injury. Both drivers and passengers with scapular fractures had a greater incidence of head injuries, and passengers had a greater incidence of pulmonary system, visceral Injury and road rash Both drivers and passengers who were not wearing a helmet had a greater incidence of head Injuries Unhelmeted drivers were more likely to sustain head injury thin passengers. When a scapular fracture was present both drivers and passengers had a greater incidence of head injuries Prospective investigations are needed to better delineate the precise mechanisms for these Injury patterns (C) 2009 Elsevier Ltd All rights reserved	[Murphy, Joshua; Nyland, John; Lantry, Jacab; Roberts, Craig] Univ Louisville, Dept Orthopaed Surg, Louisville, KY 40202 USA		Nyland, J (corresponding author), Univ Louisville, Dept Orthopaed Surg, 210 E Gray St,Suite 1003, Louisville, KY 40202 USA.						ARMSTRONG CP, 1984, INJURY, V15, P324, DOI 10.1016/0020-1383(84)90056-1; Baldwin KD, 2008, J TRAUMA, V65, P430, DOI 10.1097/TA.0b013e31817fd928; BRIED JM, 1987, CLIN ORTHOP RELAT R, P252; Brown CVR, 2005, AM SURGEON, V71, P54; CRAIG GR, 1983, INJURY, V15, P163, DOI 10.1016/0020-1383(83)90005-0; DEPERETTI F, 1994, INJURY, V25, P223, DOI 10.1016/0020-1383(94)90066-3; DRYSDALE WF, 1975, J TRAUMA, V15, P99, DOI 10.1097/00005373-197502000-00003; Grange JT, 2004, J TRAUMA, V57, P591, DOI 10.1097/01.TA.0000144065.56090.2A; IDEBERG R, 1995, ACTA ORTHOP SCAND, V66, P395, DOI 10.3109/17453679508995571; Ihama Yoko, 2007, Legal Medicine, V9, P274, DOI 10.1016/j.legalmed.2007.03.003; IMATANI RJ, 1975, J TRAUMA, V15, P473, DOI 10.1097/00005373-197506000-00002; Jeffers RF, 2004, J ORTHOP TRAUMA, V18, P87, DOI 10.1097/00005131-200402000-00005; Lowenstein S, 1996, ANN EMERG MED, V27, P389; Markogiannakis H, 2006, EMERG MED J, V23, P27, DOI 10.1136/emj.2004.022392; MCGAHAN JP, 1980, J TRAUMA, V20, P880, DOI 10.1097/00005373-198010000-00011; MCGINNIS M, 1989, J TRAUMA, V29, P1488, DOI 10.1097/00005373-198911000-00006; MCLENNAN JG, 1982, J BONE JOINT SURG AM, V64, P598, DOI 10.2106/00004623-198264040-00017; PEEK C, 1994, J TRAUMA, V37, P358; Price N, 1996, INJURY, V27, P441, DOI 10.1016/0020-1383(96)00036-8; Scavenius M, 1996, Acta Orthop Belg, V62, P129; SHIONO H, 1990, AM J FOREN MED PATH, V11, P190, DOI 10.1097/00000433-199009000-00002; STEPHANS NC, 1995, ANN EMERG MED, V25, P439; Tadros AMA, 2008, INJURY, V39, P314, DOI 10.1016/j.injury.2007.10.014; Tadros AMA, 2007, J TRAUMA, V63, P889, DOI 10.1097/01.ta.0000235876.32569.db; Tham KY, 2004, EMERG MED J, V21, P478, DOI 10.1136/emj.2002.002261; THOMPSON DA, 1985, J TRAUMA, V25, P974, DOI 10.1097/00005373-198510000-00008; VARLEY GW, 1993, INJURY, V24, P443, DOI 10.1016/0020-1383(93)90145-V; Veysi VT, 2003, J TRAUMA, V55, P1145, DOI 10.1097/01.TA.0000044499.76736.9D; Weening B, 2005, J TRAUMA, V59, P1477, DOI 10.1097/01.ta.0000199191.14780.75; Zargar M., 2006, Eastern Mediterranean Health Journal, V12, P81; ZETTAS JP, 1979, J TRAUMA, V19, P833, DOI 10.1097/00005373-197911000-00007	31	8	8	1	2	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0020-1383	1879-0267		INJURY	Injury-Int. J. Care Inj.	NOV	2009	40	11					1195	1199		10.1016/j.injury.2009.03.015			5	Critical Care Medicine; Emergency Medicine; Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Emergency Medicine; Orthopedics; Surgery	512LU	WOS:000271251700015	19524908				2022-02-06	
J	Rutherford, GW; Wlodarczyk, RC				Rutherford, George W.; Wlodarczyk, Renee C.			Distant Sequelae of Traumatic Brain Injury: Premature Mortality and Intracranial Neoplasms	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						mortality; posttraumatic neoplasm; traumatic brain injury	LOS-ANGELES-COUNTY; SEVERE HEAD-INJURY; LONG-TERM SURVIVAL; OF-THE-LITERATURE; RISK-FACTORS; LIFE EXPECTANCY; POPULATION; TUMORS; GLIOMA; ADULTS	Objective: Determine the relationship between traumatic brain injury (TBI.) and premature mortality and intracranial neoplasms occurring 6 months or more after TBI. Participants: Not applicable. Design: Systematic review of the published, peer-reveiwed literature. Primary Measures: Not applicable. Results: We identified 23 studies that examined premature mortality following TBI and 16 that addressed intracranial neoplasms. There was clear evidence of an association between penetrating brain injury and premature mortality among patients surviving at least 6 months; and similarly compelling evidence of an association between moderate or severe TBI and premature mortality among patients injured severely enough to require acute rehabilitation. There was inadequate evidence to reach a conclusion about whether other closed head injuries were associated with premature mortality. For intracranial neoplasms, there was an apparent association between TBI and intracranial neoplasms diagnosed within 1 year following TBI; however, these tumors were likely incidentally found during evaluation for the TBI. For tumors diagnosed more than I year post injury, the evidence was inadequate to conclude that there was an association, although at least 1 very large registry-based study found a borderline association. Conclusion: More severe TBI (ie, penetrating and moderate and severe TBI requiring rehabilitation) is associated with premature mortality among patients surviving at least 6 months. There is no clear evidence for an association between TBI and intracranial neoplasms presenting more than 1 year following TBI.	[Rutherford, George W.] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94105 USA; [Rutherford, George W.] Univ Calif San Francisco, Program Global Hlth Sci, San Francisco, CA 94105 USA; [Wlodarczyk, Renee C.] Natl Acad Sci, Inst Med, Washington, DC 20418 USA		Rutherford, GW (corresponding author), Univ Calif San Francisco, Dept Epidemiol & Biostat, Global Hlth Sci 50 Beale St,12th Floor, San Francisco, CA 94105 USA.	grutherford@psg.ucsf.edu			US Department of Veterans AffairsUS Department of Veterans Affairs	This study was supported by a contract from the US Department of Veterans Affairs to the National Academy of Sciences, Institute of Medicine.	ANNEGERS JF, 1979, NEUROSURGERY, V4, P203, DOI 10.1227/00006123-197903000-00001; Baguley I, 2000, BRAIN INJURY, V14, P505; Bianco M, 2007, INT J SPORTS MED, V28, P697, DOI 10.1055/s-2007-964863; Brown AW, 2004, NEUROREHABILITATION, V19, P37; BURCH JD, 1987, J NATL CANCER I, V78, P601; CARPENTER AV, 1987, AM J PUBLIC HEALTH, V77, P1180, DOI 10.2105/AJPH.77.9.1180; CHOI NW, 1970, AM J EPIDEMIOL, V91, P467, DOI 10.1093/oxfordjournals.aje.a121158; CORKIN S, 1984, ARCH NEUROL-CHICAGO, V41, P975, DOI 10.1001/archneur.1984.04050200081022; Credner L, 1930, Z GESAMTE NEUROL PSY, V126, P721, DOI 10.1007/BF02864129; Engberg AW, 2004, ACTA NEUROL SCAND, V110, P281, DOI 10.1111/j.1600-0404.2004.00323.x; Fakhry SM, 2004, J TRAUMA, V56, P492, DOI 10.1097/01.TA.0000115650.07193.66; FEARNSIDE MR, 1993, BRIT J NEUROSURG, V7, P267, DOI 10.3109/02688699309023809; Flaada JT, 2007, J NEUROTRAUM, V24, P435, DOI 10.1089/neu.2006.0119; Gomez PA, 2000, ACTA NEUROCHIR, V142, P373, DOI 10.1007/s007010050445; Harris C, 2003, J AM COLL SURGEONS, V197, P711, DOI 10.1016/S1072-7515(03)00729-4; Harrison-Felix C, 2004, NEUROREHABILITATION, V19, P45; Henry PT, 2000, BRIT J NEUROSURG, V14, P64; HOCHBERG F, 1984, NEUROLOGY, V34, P1511, DOI 10.1212/WNL.34.11.1511; Hu JF, 1998, CANCER DETECT PREV, V22, P100, DOI 10.1046/j.1525-1500.1998.CDOA22.x; Hukkelhoven CWPM, 2003, J NEUROSURG, V99, P666, DOI 10.3171/jns.2003.99.4.0666; Inskip PD, 1998, CANCER CAUSE CONTROL, V9, P109, DOI 10.1023/A:1008861722901; Institute of Medicine, 2009, GULF WAR HLTH, V7; Lai Y. C., 1998, Annals Academy of Medicine Singapore, V27, P326; Leung Lai Yee, 2008, Molecular & Cellular Biomechanics, V5, P155; LEWIN W, 1979, BRIT MED J, V2, P1533, DOI 10.1136/bmj.2.6204.1533; LING G, 2009, J NEUROTRAUMA   0427; Lu J, 2005, ACT NEUR S, V95, P281; McMillan TM, 2007, BRAIN, V130, P2520, DOI 10.1093/brain/awm185; MILLER JD, 1968, LANCET, V2, P991; Monteiro GTR, 2006, EUR J CANCER, V42, P917, DOI 10.1016/j.ejca.2005.11.028; *NAT CTR INJ PREV, TRAUM BRAIN INJ; Nygren C, 2001, CANCER CAUSE CONTROL, V12, P733, DOI 10.1023/A:1011227617256; Pentland B, 2005, J NEUROL NEUROSUR PS, V76, P395, DOI 10.1136/jnnp.2004.037861; Phillips LE, 2002, NEUROLOGY, V58, P1849, DOI 10.1212/WNL.58.12.1849; Preston-Martin S, 1998, INT J EPIDEMIOL, V27, P579, DOI 10.1093/ije/27.4.579; PRESTONMARTIN S, 1980, JNCI-J NATL CANCER I, V65, P67; PRESTONMARTIN S, 1989, CANCER RES, V49, P6137; PRESTONMARTIN S, 1983, J NATL CANCER I, V70, P863; Ratcliff G, 2005, DISABIL REHABIL, V27, P305, DOI 10.1080/09638280400018338; RISH BL, 1983, J NEUROSURG, V59, P775, DOI 10.3171/jns.1983.59.5.0775; Salvati M, 2004, TUMORI J, V90, P416, DOI 10.1177/030089160409000410; SCHLEHOFER B, 1992, CANCER, V69, P2541, DOI 10.1002/1097-0142(19920515)69:10<2541::AID-CNCR2820691025>3.0.CO;2-H; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Selassie AW, 2005, J HEAD TRAUMA REHAB, V20, P257, DOI 10.1097/00001199-200505000-00008; Shavelle R, 2000, J Insur Med, V32, P163; WALKER AE, 1971, ARCH NEUROL-CHICAGO, V24, P95, DOI 10.1001/archneur.1971.00480320023001; WALKER AE, 1968, HEAD INJURED MEN 15, P106; WEISS GH, 1982, ARCH NEUROL-CHICAGO, V39, P741, DOI 10.1001/archneur.1982.00510240003001; Winqvist S, 2007, NEUROEPIDEMIOLOGY, V29, P136, DOI 10.1159/000110741; ZAMPIERI P, 1994, J NEURO-ONCOL, V19, P61, DOI 10.1007/BF01051049	50	8	8	0	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0885-9701			J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	NOV-DEC	2009	24	6					468	474		10.1097/HTR.0b013e3181c133d2			7	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	528VW	WOS:000272476100007	19940680				2022-02-06	
J	Sollid, S; Sundstrom, T; Ingebrigtsen, T; Romner, B; Wester, K				Sollid, S.; Sundstrom, T.; Ingebrigtsen, T.; Romner, B.; Wester, Knut			Organisation of traumatic head injury management in the Nordic countries	EMERGENCY MEDICINE JOURNAL			English	Article							BRAIN-INJURY; DECOMPRESSIVE SURGERY; NORTHERN NORWAY; GUIDELINES; HEMATOMA; IMPACT; DEATH; MILD; CARE	Objective: The aim of this study is to map and evaluate the available resources and the premises of traumatic head injury management in the Nordic countries, before the implementation of a Nordic adaption of the Brain Trauma Foundation guidelines for prehospital management. Methods: The study is a synthesis of two cross-sectional surveys. Questionnaires were used to collect data on the annual number of acute head injury operations, the infrastructure, the level of education, the use of trauma protocols and the management of traumatic head injury at Nordic hospitals. Results: The proportion of acute head injury operations performed outside a neurosurgical department was 0% in Denmark, 16% in Finland, 19% in Norway and 33% in Sweden. Eighty-four per cent of Nordic hospitals had written protocols for the assessment and treatment of trauma patients and 78% had regular training in trauma management; 67% had specific protocols for the treatment of traumatic head injury. Computed tomography (CT) was available in 93% of the hospitals, and 59% of the hospitals could link CT scans to the regional neurosurgical department. Conclusions: Most Nordic hospitals are well prepared to manage patients with acute traumatic head injury. A substantial proportion of the operations are performed at local and central hospitals without neurosurgical expertise, despite an efficient pre and interhospital transport system. The Nordic adaption of the Brain Trauma Foundation guidelines recommends that this practice is terminated.	[Sollid, S.] Univ Hosp N Norway, Dept Neurosurg, N-9038 Tromso, Norway; [Sundstrom, T.; Wester, Knut] Haukeland Hosp, Dept Neurosurg, N-5021 Bergen, Norway; [Ingebrigtsen, T.; Romner, B.] Univ Tromso, Inst Clin Med, Tromso, Norway; [Wester, Knut] Univ Bergen, Inst Surg Sci, Neurosurg Sect, Bergen, Norway		Sollid, S (corresponding author), Univ Hosp N Norway, Dept Neurosurg, N-9038 Tromso, Norway.	snorre.sollid@unn.no		Ingebrigtsen, Tor/0000-0001-5966-9786; Sundstrom, Terje/0000-0002-6503-7141			Bartlett J, 1998, BRIT J NEUROSURG, V12, P349, DOI 10.1080/02688699844871; Biros M H, 2001, Curr Opin Crit Care, V7, P444, DOI 10.1097/00075198-200112000-00012; *BRAIN TRAUM FDN, 2000, J NEUROTRAUMA, V17; Bulger EM, 2002, CRIT CARE MED, V30, P1870, DOI 10.1097/00003246-200208000-00033; Finfer SR, 2001, RESUSCITATION, V48, P77, DOI 10.1016/S0300-9572(00)00321-X; Garner AA, 2002, INJURY, V33, P329, DOI 10.1016/S0020-1383(02)00011-6; GENTLEMAN D, 1993, BRIT MED J, V307, P547, DOI 10.1136/bmj.307.6903.547; Ingebrigtsen T, 2000, J TRAUMA, V48, P760, DOI 10.1097/00005373-200004000-00029; Jennett B, 1996, J NEUROL NEUROSUR PS, V60, P362, DOI 10.1136/jnnp.60.4.362; Kristiansen I S, 2000, Tidsskr Nor Laegeforen, V120, P2023; Langhelle A, 2004, RESUSCITATION, V61, P9, DOI 10.1016/j.resuscitation.2003.12.008; Maas AIR, 1997, ACTA NEUROCHIR, V139, P286, DOI 10.1007/BF01808823; MENDELOW AD, 1979, BRIT MED J, V1, P1240, DOI 10.1136/bmj.1.6173.1240; Meyer AA, 1998, J TRAUMA, V44, P1, DOI 10.1097/00005373-199801000-00001; Muller K, 2003, J TRAUMA, V55, P1029, DOI 10.1097/01.TA.0000100371.49160.2A; Murray GD, 1999, ACTA NEUROCHIR, V141, P223, DOI 10.1007/s007010050292; Palmer S, 2001, J TRAUMA, V50, P657, DOI 10.1097/00005373-200104000-00010; Piek J, 1998, INTENS CARE MED, V24, P1221, DOI 10.1007/s001340050748; Rogers FB, 1999, J TRAUMA, V46, P328, DOI 10.1097/00005373-199902000-00022; Rosenfeld JV, 2000, J CLIN NEUROSCI, V7, P507, DOI 10.1054/jocn.1999.0694; SEELIG JM, 1981, NEW ENGL J MED, V304, P1511, DOI 10.1056/NEJM198106183042503; Sollid S, 2003, J NEUROTRAUM, V20, P309, DOI 10.1089/089771503321532897; Sollid Snorre, 2008, Tidsskr Nor Laegeforen, V128, P1524; Stewart RM, 2003, J TRAUMA, V54, P66, DOI 10.1097/00005373-200301000-00009; Stormo A, 2004, J TELEMED TELECARE, V10, P135, DOI 10.1258/135763304323070760; Thelle D S, 2000, Tidsskr Nor Laegeforen, V120, P2018; Unterberg A, 1999, INTENS CARE MED, V25, P348, DOI 10.1007/s001340050855; Wester K, 1999, NEUROSURGERY, V44, P495, DOI 10.1097/00006123-199903000-00034; Wester T, 1999, J TRAUMA, V46, P914, DOI 10.1097/00005373-199905000-00023	29	8	8	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1472-0205	1472-0213		EMERG MED J	Emerg. Med. J.	NOV	2009	26	11					769	772		10.1136/emj.2008.061630			4	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	509NB	WOS:000271023600003	19850795				2022-02-06	
J	Tawfeeq, NA; Halawani, MM; Al-Faridi, K; Al-Shaya, WA; Taha, WS				Tawfeeq, Nasser A.; Halawani, Mohammed M.; Al-Faridi, Khulood; Al-Shaya, Wa'el A.; Taha, Wa'el S.			Traumatic brain injury: neuroprotective anaesthetic techniques, an update	INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED			English	Article						Traumatic brain injury; anaesthesia; neuroprotective; perioperative	RANDOMIZED CONTROLLED-TRIAL; UNCONTROLLED HEMORRHAGIC-SHOCK; CEREBRAL BLOOD-FLOW; SEVERE HEAD-INJURY; NITROUS-OXIDE; HYPERTONIC SALINE; IN-VITRO; ISCHEMIA; RESUSCITATION; ISOFLURANE	Traumatic brain injuries remain an area of great challenge to both neurosurgeons and neuroanaesthesiologists. The management of these injuries starts at the scene of the accident. However, strategies for preventing secondary brain injury and its sequelae are continuing to evolve. These strategies include the use of pharmacological and nonpharmacological techniques. Preventing hypoxia and the use of hypertonic saline have been shown to have favourable results on the outcome of these injuries. The use of isoflurane has been shown to have a neuron-protective effect. Propofol is thought to be the future drug of choice because of its neuroprotective properties, although these still need to be further proven through research. In this review an understanding of the pathophysiology of traumatic brain injury will be outlined in order to understand the effects of pharmacological and nonpharmacological agents on secondary brain injury.	[Tawfeeq, Nasser A.; Al-Faridi, Khulood] King Abdul Aziz Med City, Dept Anaesthesia, Riyadh 11426, Saudi Arabia; [Halawani, Mohammed M.; Al-Shaya, Wa'el A.; Taha, Wa'el S.] King Abdul Aziz Med City, Dept Surg, Riyadh 11426, Saudi Arabia		Taha, WS (corresponding author), King Abdul Aziz Med City, Dept Surg 1446, POB 22490, Riyadh 11426, Saudi Arabia.						Adembri C, 2006, ANESTHESIOLOGY, V104, P80, DOI 10.1097/00000542-200601000-00014; Alspaugh DM, 2000, J TRAUMA, V48, P851, DOI 10.1097/00005373-200005000-00008; BARRY KG, 1961, NEW ENGL J MED, V264, P1085, DOI 10.1056/NEJM196105252642105; Bartsch T, 2005, HBK DIFF EQUAT STATI, V2, P1, DOI 10.1016/S1874-5733(05)80009-9; Belpomme V, 2005, AM J EMERG MED, V23, P852, DOI 10.1016/j.ajem.2005.04.011; BLOCH M, 1967, BRAIN, V90, P769, DOI 10.1093/brain/90.4.769; BOUMA GJ, 1992, J NEUROSURG, V77, P360, DOI 10.3171/jns.1992.77.3.0360; BOUMA GJ, 1992, J NEUROTRAUM, V9, pS333; Bourguignon PR, 1998, ARCH SURG-CHICAGO, V133, P390, DOI 10.1001/archsurg.133.4.390; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS14, DOI 10.1089/neu.2007.9994; Brasel KJ, 2008, J AM COLL SURGEONS, V206, P220, DOI 10.1016/j.jamcollsurg.2007.07.020; BRATTON SL, 2007, J NEUROTRAUMA S1, V24, pS87; BURKE AM, 1981, J NEUROSURG, V55, P550, DOI 10.3171/jns.1981.55.4.0550; Busija DW, 2004, BRAIN RES REV, V46, P282, DOI 10.1016/j.brainresrev.2004.06.011; CHAN KH, 1992, J NEUROL NEUROSUR PS, V55, P787, DOI 10.1136/jnnp.55.9.787; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; CHESNUT RM, 1993, ACTA NEUROCHIR, P121; Chiarugi A, 2005, PHARMACOL RES, V52, P15, DOI 10.1016/j.phrs.2005.02.018; Clifton GL, 2002, J NEUROTRAUM, V19, P293, DOI 10.1089/089771502753594864; Coburn M, 2008, CRIT CARE MED, V36, P588, DOI 10.1097/01.CCM.0B013E3181611F8A6; Cooper DJ, 2004, JAMA-J AM MED ASSOC, V291, P1350, DOI 10.1001/jama.291.11.1350; Cruz J, 2004, J NEUROSURG, V100, P376, DOI 10.3171/jns.2004.100.3.0376; Davis D P, 2001, Prehosp Emerg Care, V5, P163, DOI 10.1080/10903120190940065; Doyle JA, 2001, J TRAUMA, V50, P367, DOI 10.1097/00005373-200102000-00030; DUBICK MA, 1994, J TRAUMA, V36, P323, DOI 10.1097/00005373-199403000-00007; Elsersy H, 2004, ANESTHESIOLOGY, V100, P1160, DOI 10.1097/00000542-200405000-00018; Ferrer Isidro, 2006, Cerebrovasc Dis, V21 Suppl 2, P9, DOI 10.1159/000091699; Grasso G, 2007, BRAIN RES, V1182, P99, DOI 10.1016/j.brainres.2007.08.078; Grasso G, 2007, DRUG NEWS PERSPECT, V20, P315, DOI 10.1358/dnp.2007.20.5.1120219; Hatton J, 2008, J NEUROSURG, V109, P699, DOI 10.3171/JNS/2008/109/10/0699; Inoue S, 2006, ANESTH ANALG, V102, P1548, DOI 10.1213/01.ane.0000202381.40516.8d; Ishikawa Y, 2006, ACTA NEUROCHIR SUPPL, V96, P163; Jain KK, 2008, DRUG DISCOV TODAY, V13, P1082, DOI 10.1016/j.drudis.2008.09.006; Johnson SA, 2008, J NEUROSURG ANESTH, V20, P21, DOI 10.1097/ANA.0b013e3181271850; Kawaguchi M, 2000, ANESTHESIOLOGY, V92, P1335, DOI 10.1097/00000542-200005000-00023; Kumagai M, 2008, ANESTH ANALG, V107, P643, DOI 10.1213/ane.0b013e3181770e6f; Lees KR, 2004, LANCET, V363, P439, DOI 10.1016/S0140-6736(04)15490-1; MARTINI RP, 2009, J NEUROSURG; McGregor DG, 2008, ANESTHESIOLOGY, V108, P568, DOI 10.1097/ALN.0b013e31816721fa; Minambres E, 2008, J NEUROTRAUM, V25, P581, DOI 10.1089/neu.2007.0398; Pasternak JJ, 2009, J NEUROSURG ANESTH, V21, P73, DOI 10.1097/ANA.0b013e31819a0103; Pasternak JJ, 2009, ANESTHESIOLOGY, V110, P563, DOI 10.1097/ALN.0b013e318197ff81; Peters CE, 2001, ANESTHESIOLOGY, V94, P313, DOI 10.1097/00000542-200102000-00022; Sturgess J, 2008, BEST PRACT RES-CLIN, V22, P167, DOI 10.1016/j.bpa.2007.09.002; Taninishi H, 2008, ANESTHESIOLOGY, V108, P1063, DOI 10.1097/ALN.0b013e318173f684; Temkin NR, 2007, LANCET NEUROL, V6, P29, DOI 10.1016/S1474-4422(06)70630-5; Uyar AS, 2008, J NEUROSURG ANESTH, V20, P174, DOI 10.1097/ANA.0b013e318177e5eb	47	8	8	0	3	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0020-1383	1879-0267		INJURY	Injury-Int. J. Care Inj.	NOV	2009	40			4			S75	S81		10.1016/j.injury.2009.10.040			7	Critical Care Medicine; Emergency Medicine; Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Emergency Medicine; Orthopedics; Surgery	534YI	WOS:000272933100011	19895957				2022-02-06	
J	Afifi, AM; Medoro, A; Salas, C; Taha, MR; Cheema, T				Afifi, Ahmed M.; Medoro, Amanda; Salas, Christina; Taha, Mahmoud Reda; Cheema, Tahseen			A Cadaver Model That Investigates Irreducible Metacarpophalangeal joint Dislocation	JOURNAL OF HAND SURGERY-AMERICAN VOLUME			English	Article						Metacarpophalangeal joint; dislocation; volar plate; deep transverse metacarpal ligament	COMPLEX DISLOCATION; INDEX FINGER	Purpose Controversy exists over the pathologic anatomy of irreducible dorsal metacarpophalangeal (MCP) dislocation. The aim of this work is to develop a cadaveric model of MCP joint dislocation that closely simulates the clinical situation and to study the structures around the MCP joint and their contribution to irreducibility of the dislocation. Methods Nine fresh-frozen cadaveric specimens were amputated at the radiocarpal joint and stabilized in a specially formulated fixture. The dislocation was created by an impact load delivered by a servohydraulic testing machine, at a displacement rate of 1000 mm/s and with a maximum displacement of 60 mm. An irreducible dislocation was successfully created in 6 index fingers. An attempt at closed reduction was followed by a dissection of the dislocated joint. Results In the 6 examined specimens, the flexor tendons were ulnar to the joint in all cases, the radial digital nerve was superficial (5 cases) or radial (5 cases) to the metacarpal head, and the lumbrical was usually radial (5 of 6 cases) to the joint. Division of the superficial transverse metacarpal ligaments, natatory ligaments, flexor tendons, or lumbricals does not aid reduction of the dislocation. Division of the volar plate was necessary for reduction of the dislocation in all 6 cases, whereas division of the deep transverse metacarpal ligaments does not allow reduction of the dislocation. Conclusions We present a model for creating an irreducible MCP joint dislocation using an impact load that simulates the clinical situation. The volar plate is the primary structure preventing reduction of the dislocation. Division of the deep transverse metacarpal ligament is not effective in reducing the dislocation. The flexor tendons, lumbricals, superficial transverse metacarpal ligament and natatory ligaments do not contribute to irreducibility. The anatomy of the structures surrounding the MCP joint is variable, and careful dissection to prevent iatrogenic injuries is mandatory. (J Hand Surg 2009;34A:1506-1511. Copyright (C) 2009 by the American Society for Surgery of the Hand. All rights reserved.)	[Afifi, Ahmed M.] Cleveland Clin, Dept Plast Surg, Cleveland, OH 44195 USA; Univ New Mexico, Dept Civil Engn, Albuquerque, NM 87131 USA; Univ New Mexico, Dept Orthoped, Albuquerque, NM 87131 USA; Cairo Univ, Dept Plast Surg, Cairo, Egypt		Afifi, AM (corresponding author), Cleveland Clin, Dept Plast Surg, A60,9500 Euclid Ave, Cleveland, OH 44195 USA.	ahafifi@yahoo.com					BARRY K, 1988, J HAND SURG-BRIT EUR, V13B, P466, DOI 10.1016/0266-7681(88)90182-9; BECTON JL, 1975, J BONE JOINT SURG AM, V57, P698, DOI 10.2106/00004623-197557050-00024; DeCoster TA, 1988, IOWA ORTHO J, V8, P9; GREEN DP, 1973, J BONE JOINT SURG AM, VA 55, P1480, DOI 10.2106/00004623-197355070-00015; KAPLAN EB, 1957, J BONE JOINT SURG AM, V39, P1081, DOI 10.2106/00004623-195739050-00008; Lattanza L L, 2004, HAND SURG, P176; McLaughlin H L, 1965, J Trauma, V5, P683, DOI 10.1097/00005373-196511000-00001; MURPHY AF, 1967, J BONE JOINT SURG AM, VA 49, P1579, DOI 10.2106/00004623-196749080-00009; NUSSBAUM R, 1986, J HAND SURG-AM, V11A, P558, DOI 10.1016/S0363-5023(86)80198-8; Orozco JR, 2008, J HAND SURG-AM, V33A, P555, DOI 10.1016/j.jhsa.2007.12.018; SLADE JF, 2007, HAND SURG UPDATE, P1; Sodha S, 2004, ANN PLAS SURG, V52, P562, DOI 10.1097/01.sap.0000123351.12922.f4; YU HI, 2004, ATLAS HAND ANATOMY C, P228; ZANCOLLI EA, 1979, STRUCTURE DYNAMICS B, P23	14	8	8	0	2	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0363-5023			J HAND SURG-AM	J. Hand Surg.-Am. Vol.	OCT	2009	34A	8					1506	1511		10.1016/j.jhsa.2009.06.001			6	Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Surgery	506EU	WOS:000270757500019	19703736				2022-02-06	
J	Ann, DH; Kim, DW; Kang, SD				Ann, Duck-Hyung; Kim, Dae-Won; Kang, Sung-Don			In Situ Floating Resin Cranioplasty for Cerebral Decompression	JOURNAL OF KOREAN NEUROSURGICAL SOCIETY			English	Article						Decompressive craniectomy; Floating; Resin cranioplasty	TRAUMATIC BRAIN-INJURY; CRANIECTOMY; CRANIOTOMY; MANAGEMENT	The purpose of this report is to describe our surgical experiences in the treatment of cerebral decompression with in situ floating resin cranioplasty. We included in this retrospective study 7 patients who underwent in situ floating resin cranioplasty for cerebral decompression between December 2006 and March 2008. Of these patients, 3 patients had traumatic brain injury, 3 cerebral infarction, and one subarachnoid hemorrhage due to aneurysmal rupture. In situ floating resin cranioplasty for cerebral decompression can reduce complications related to the absence of a bone flap and allow reconstruction by secondary cranioplasty without difficulty. Furthermore, it provides cerebral protection and selectively eliminates the need for secondary cranioplasty in elderly patients or patients who have experienced unfavorable outcome.	[Ann, Duck-Hyung; Kim, Dae-Won; Kang, Sung-Don] Wonkwang Univ, Sch Med, Dept Neurosurg, Inst Wonkwang Med Sci, Iksan 570749, South Korea		Kim, DW (corresponding author), Wonkwang Univ, Sch Med, Dept Neurosurg, Inst Wonkwang Med Sci, 22 Wongwangdaehak Ro, Iksan 570749, South Korea.	kimdw@wku.ac.kr			Wonkwang University	This paper was supported by Wonkwang University in 2009.	Bayir H, 2003, CRIT CARE MED, V31, pS112, DOI 10.1097/01.CCM.0000042464.46603.0E; Coplin WM, 2001, J TRAUMA, V50, P1050, DOI 10.1097/00005373-200106000-00013; FODSTAD H, 1984, ACTA NEUROCHIR, V70, P21, DOI 10.1007/BF01406039; Hejazi N, 2002, EUR J PEDIATR, V161, P99, DOI 10.1007/s00431-001-0864-x; Hofmeijer J, 2003, CRIT CARE MED, V31, P617, DOI 10.1097/01.CCM.0000050446.16158.80; Hutchinson P J, 2004, Curr Opin Crit Care, V10, P101, DOI 10.1097/00075198-200404000-00004; Jaeger M, 2003, J NEUROL NEUROSUR PS, V74, P513, DOI 10.1136/jnnp.74.4.513; Ko K, 2007, NEUROSURGERY, V60, P255, DOI 10.1227/01.NEU.0000255380.64969.81; Kontopoulos V, 2002, ACTA NEUROCHIR, V144, P791, DOI 10.1007/s00701-002-0948-z; Munch E, 2000, NEUROSURGERY, V47, P315, DOI 10.1097/00006123-200008000-00009; Park J, 2009, J NEUROSURG, V110, P101, DOI 10.3171/2008.4.17540; Schmidt JH, 2007, J NEUROSURG, V107, P678, DOI 10.3171/JNS-07/09/0678; Schneider GH, 2002, ACT NEUR S, V81, P77; Stefini R, 1999, NEUROSURGERY, V45, P626, DOI 10.1097/00006123-199909000-00038; TABADDOR K, 1976, J NEUROSURG, V44, P506, DOI 10.3171/jns.1976.44.4.0506; Traxler H, 2002, CLIN ANAT, V15, P173, DOI 10.1002/ca.10022; YAMAURA A, 1977, Neurologia Medico-Chirurgica, V17, P43, DOI 10.2176/nmc.17pt1.43	17	8	8	0	1	KOREAN NEUROSURGICAL SOC	SEOUL	BLDG B, #402, 27, CHILPAE-RO, JUNG-GU, SEOUL, 04511, SOUTH KOREA	2005-3711	1598-7876		J KOREAN NEUROSURG S	J. Korean. Neurosurg. Soc.	OCT	2009	46	4					417	420		10.3340/jkns.2009.46.4.417			4	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	513FT	WOS:000271308600024	19893737	gold, Green Published			2022-02-06	
J	Bahraini, NH; Brenner, LA; Harwood, JEF; Homaifar, BY; Ladley-O'Brien, SE; Filley, CM; Kelly, JP; Adler, LE				Bahraini, Nazanin H.; Brenner, Lisa A.; Harwood, Jeri E. F.; Homaifar, Beeta Y.; Ladley-O'Brien, Susan E.; Filley, Christopher M.; Kelly, James P.; Adler, Lawrence E.			Utility of the Trauma Symptom Inventory for the Assessment of Post-Traumatic Stress Symptoms in Veterans With a History of Psychological Trauma and/or Brain Injury	MILITARY MEDICINE			English	Article							PREVALENCE; DISORDER; PTSD	Correspondence of three core Trauma Symptom Inventory (TSI) posttraumatic stress disorder (PTSD) scales (Intrusive Experiences, Defensive Avoidance, and Anxious Arousal) and the Structured Clinical Interview for DSM-IV Axis I Disorders (SCID-IV) PTSD module were examined among 72 veterans with traumatic brain injury (TBI), PTSD, or both conditions. Subjects were classified into PTSD only, TBI only, or co-occurring PTSD and TBI groups based on TBI assessment and SCID-IV PTSD diagnosis. Linear regression was used to model TSI T-Scores as a function of group. Scores on all three scales significantly differed between the TBI and PTSD groups (PTSD only and co-occurring PTSD and TBI) in the expected direction. Study findings indicate that despite the potential overlap of symptoms between PTSD and TBI, the TSI appears to be a useful measure of trauma-related symptoms in veterans who may also have a TBI, particularly mild TBI. Limitations and areas for future research are discussed.	[Bahraini, Nazanin H.; Brenner, Lisa A.; Homaifar, Beeta Y.; Adler, Lawrence E.] MIRECC, VA VISN 19, Denver, CO 80220 USA; [Brenner, Lisa A.; Homaifar, Beeta Y.; Filley, Christopher M.; Adler, Lawrence E.] Univ Colorado, Sch Med, Dept Psychiat, Aurora, CO 80045 USA; [Brenner, Lisa A.; Ladley-O'Brien, Susan E.; Kelly, James P.] Univ Colorado, Sch Med, Dept Phys Med & Rehabil, Aurora, CO 80045 USA; [Brenner, Lisa A.; Filley, Christopher M.] Univ Colorado, Sch Med, Dept Neurol, Aurora, CO 80045 USA; [Harwood, Jeri E. F.] Univ Colorado, Sch Med, Dept Pediat, Aurora, CO 80045 USA; [Kelly, James P.] Univ Colorado, Sch Med, Dept Neurosurg, Aurora, CO 80045 USA		Bahraini, NH (corresponding author), MIRECC, VA VISN 19, 1055 Clermont St, Denver, CO 80220 USA.		Brenner, Lisa A./AAG-2442-2019		Colorado Traumatic Brain Injury Trust; VA VISN 19 MIRECC	Funding for this project was provided by the Colorado Traumatic Brain Injury Trust Fund Research Program and the VA VISN 19 MIRECC.	American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; Brenner LA, 2009, MIL MED, V174, P347, DOI 10.7205/MILMED-D-01-5808; BRIERE J, 1995, J INTERPERS VIOLENCE, V10, P387, DOI 10.1177/088626095010004001; Briere J., 1995, TRAUMA SYMPTOM INVEN; Brown G.K., 1996, BDI 2 BECK DEPRESSIO; Bryant RA, 2001, J CLIN EXP NEUROPSYC, V23, P718, DOI 10.1076/jcen.23.6.718.1024; *DEP VET AFF, 2004, VETEESA138 SP DEP VE; First MB, 1995, STRUCTURED CLIN INTE; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Ivins BJ, 2003, J TRAUMA, V55, P617, DOI 10.1097/01.TA.0000052368.97573.D4; King NS, 2008, BRAIN INJURY, V22, P1, DOI 10.1080/02699050701829696; Kulka RA, 1990, TRAUMA VIETNAM WAR G; McDevitt-Murphy ME, 2005, J TRAUMA STRESS, V18, P63, DOI 10.1002/jts.20003; Merrill LL, 2001, MIL MED, V166, P621, DOI 10.1093/milmed/166.7.621; Ommaya AK, 1996, J TRAUMA, V40, P211, DOI 10.1097/00005373-199602000-00007; Roche D.N., 1999, CHILD MALTREATMENT, V4, P69, DOI [DOI 10.1177/1077559599004001007, 10.1177/1077559599004001007]; SCHLENGER WE, 1992, J TRAUMA STRESS, V5, P333, DOI 10.1002/jts.2490050303; Shear MK, 2000, AM J PSYCHIAT, V157, P581, DOI 10.1176/appi.ajp.157.4.581; Sumpter RE, 2006, BRAIN INJURY, V20, P93, DOI 10.1080/02699050500394090; Thurman DJ., 1995, GUIDELINES SURVEILLA; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; WATSON P, 2000, PRACTICE GUIDELINES	22	8	9	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0026-4075	1930-613X		MIL MED	Milit. Med.	OCT	2009	174	10					1005	1009		10.7205/MILMED-D-00-9509			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	601LI	WOS:000278060500001	19891210	Bronze			2022-02-06	
J	Ballweg, JA; Ittenbach, RF; Bernbaum, J; Gerdes, M; Dominguez, TE; Zackai, EH; Clancy, RR; Gaynor, JW				Ballweg, Jean A.; Ittenbach, Richard F.; Bernbaum, Judy; Gerdes, Marsha; Dominguez, Troy E.; Zackai, Elaine H.; Clancy, Robert R.; Gaynor, James William			Hyperglycaemia after Stage I palliation does not adversely affect neurodevelopmental outcome at 1 year of age in patients with single-ventricle physiology	EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY			English	Article; Proceedings Paper	22nd Annual Meeting of the European-Association-for-Cardio-Thoracic-Surgery	SEP 14-17, 2008	Lisbon, PORTUGAL	European Assoc Cardio Thorac Surg		Congenital heart disease; Hyperglycaemia; Patient outcomes; Postoperative care	NORWOOD PROCEDURE; DIABETIC-PATIENTS; CARDIAC-SURGERY; GLUCOSE	Objective: Hyperglycaemia has been associated with worse outcome following traumatic brain injury and cardiac surgery in adults. We have previously reported no relationship between early postoperative hyperglycaemia and worse neurodevelopmental outcome at 1 year following biventricular repair of congenital heart disease. It is not known if postoperative hyperglycaemia results in worse neurodevelopmental outcome after infant cardiac surgery for single-ventricle lesions. Methods: Secondary analysis of postoperative glucose levels in infants <6 months of age undergoing Stage I palliation for various forms of single ventricle with arch obstruction. The patients were enrolled in a prospective study of genetic polymorphisms and neurodevelopmental outcomes assessed at 1 year of age with the Bayley Scales of Infant Development-H yielding two indices: mental developmental index (MDI) and psychomotor developmental index (PDI). Results: Stage I palliation was performed on 162 infants with 13 hospital and 15 late deaths (17.3% 1-year mortality). Neurodevelopmental evaluation was performed in 89 of 134 (66.4%) survivors. Glucose levels at admission to the cardiac intensive care unit and during the first 48 postoperative hours were available for 85 of 89 (96%) patients. Mean admission glucose value was 274 +/- 91 mg dl(-1); the maximum was 291 +/- 90 mg dt(-1), With 69 of 85 (81 %) patients having at least one glucose value >200 mg dl(-1). Only two patients had a value <50 mg dl(-1). Mean MDI and PDI scores were 88 +/- 16 and 71 +/- 18, respectively. There were no statistically significant correlations between initial, mean, minimum or maximum glucose measurements and MDI or PDI scores. Only delayed sternal closure resulted in a statistically significant relationship between initial, minimum and maximum glucose values within the context of a multivariate analysis of variance model. Conclusions: Hyperglycaemia following Stage I palliation in the neonatal period was not associated with lower MDI or PDI scores at 1 year of age. (C) 2009 European Association for Cardio-Thoracic Surgery. Published by Elsevier B.V. All rights reserved.	[Ballweg, Jean A.] Univ Penn, Dept Anesthesia & Crit Care Med, Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA		Ballweg, JA (corresponding author), Univ Penn, Dept Anesthesia & Crit Care Med, Childrens Hosp Philadelphia, 34th & Civ Ctr Blvd,Suite 6121, Philadelphia, PA 19104 USA.	ballweg@email.chop.edu	Ittenbach, Richard F/Q-1806-2015; gaynor, J william/E-5194-2013	gaynor, J william/0000-0001-7955-5604	NHLBI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [R01 HL071834, R01 HL071834-01A1] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [R01HL071834] Funding Source: NIH RePORTER		Ballweg JA, 2007, ANN THORAC SURG, V84, P2052, DOI 10.1016/j.athoracsur.2007.06.099; CALLAHAN DJ, 1990, PEDIATR RES, V27, P186, DOI 10.1203/00006450-199002000-00020; Capes SE, 2001, STROKE, V32, P2426, DOI 10.1161/hs1001.096194; de Ferranti S, 2004, ANESTHESIOLOGY, V100, P1345, DOI 10.1097/00000542-200406000-00005; Dent CL, 2006, J THORAC CARDIOV SUR, V131, P190, DOI 10.1016/j.jtcvs.2005.10.003; DOENST T, 2005, J THORAC CARDIOVASC, V130; Foo K, 2003, HEART, V89, P512, DOI 10.1136/heart.89.5.512; Gaynor JW, 2006, J THORAC CARDIOV SUR, V131, P181, DOI 10.1016/j.jtcvs.2005.08.062; Gaynor JW, 2003, J THORAC CARDIOV SUR, V126, P1736, DOI 10.1016/S0022-5223(03)01188-7; Guvener M, 2002, ENDOCR J, V49, P531, DOI 10.1507/endocrj.49.531; HATTORI H, 1990, ANN NEUROL, V28, P122, DOI 10.1002/ana.410280203; Hoffman GM, 2005, J THORAC CARDIOV SUR, V130, P1094, DOI 10.1016/j.jtcvs.2005.06.029; Hollingshead AB., 1975, 4 FACTOR INDEX SOCIA; Krinsley JS, 2004, MAYO CLIN PROC, V79, P992, DOI 10.4065/79.8.992; Licht DJ, 2004, J THORAC CARDIOV SUR, V128, P841, DOI 10.1016/j.jtcvs.2004.07.022; Mahle WT, 2000, PEDIATRICS, V105, P1082, DOI 10.1542/peds.105.5.1082; Malmberg K, 1997, BRIT MED J, V314, P1512, DOI 10.1136/bmj.314.7093.1512; Ouattara A, 2005, ANESTHESIOLOGY, V103, P687, DOI 10.1097/00000542-200510000-00006; Rossano JW, 2008, J THORAC CARDIOV SUR, V135, P739, DOI 10.1016/j.jtcvs.2007.11.030; Rovlias A, 2000, NEUROSURGERY, V46, P335, DOI 10.1097/00006123-200002000-00015; Shillingford AJ, 2007, CARDIOL YOUNG, V17, P189, DOI 10.1017/S1047951107000248; SIEBER FE, 1992, CRIT CARE MED, V20, P104, DOI 10.1097/00003246-199201000-00022; Tabbutt S, 2008, PEDIATRICS, V121, P476, DOI 10.1542/peds.2007-1282; VANNUCCI RC, 1992, BIOL NEONATE, V62, P215; Yates AR, 2006, PEDIATR CRIT CARE ME, V7, P351, DOI 10.1097/01.PCC.0000227755.96700.98	25	8	8	0	0	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	1010-7940	1873-734X		EUR J CARDIO-THORAC	Eur. J. Cardio-Thorac. Surg.	OCT	2009	36	4					688	693		10.1016/j.ejcts.2009.04.021			6	Cardiac & Cardiovascular Systems; Respiratory System; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Cardiovascular System & Cardiology; Respiratory System; Surgery	504UV	WOS:000270644100014	19699107	Green Accepted			2022-02-06	
J	Kejriwal, R; Civil, I				Kejriwal, Ritwik; Civil, Ian			Time to definitive care for patients with moderate and severe traumatic brain injury-does a trauma system matter?	NEW ZEALAND MEDICAL JOURNAL			English	Article								Aim The presence of a trauma system has been associated with improved outcomes in patients with traumatic brain injury (TBI) by speeding up transfers to a neurosurgical centre. Improved outcomes are associated with time to neurosurgical intervention for those with significant extradural and subdural haemorrhages of less than 4 hours. To compare the outcomes for patients with TBI transferred directly from the scene of injury to Auckland City Hospital (ACH) with those transferred from other hospitals, transfer times and outcomes were evaluated in a consecutive cohort of patients recorded on the ACH trauma registry. Method Patients admitted to ACH in 2004 and recorded on the trauma registry with a moderate or severe head injury (Abbreviated Injury Scale (AIS) score of 3 or greater) were included. The primary outcomes assessed were median time from injury to arrival and surgery, patient mortality, length of ICU stay and length of hospital stay. Results 198 patients were admitted at ACH in 2004 with moderate and severe TBI. 95 patients (48%) were transferred from another hospital. Patients transported to ACH from the scene of injury arrived to ACH and underwent neurosurgery within a mean of 3 hours 50 minutes, whereas patients transferred from another hospital took significantly longer than 4 hours to arrive at ACH. Patients transferred from another hospital had similar mortality rate, length of ICU stay and length of hospital stay to those admitted directly. Conclusion TBI patients who were transferred from another hospital arrived well outside the recommended guidelines. While no significant difference in outcome was noted in this small cohort of patients further studies are warranted. The development of a national trauma registry would allow accumulation of data on larger numbers of patients and determine the true relevance of international best practice guidelines in New Zealand.	[Kejriwal, Ritwik; Civil, Ian] Auckland City Hosp, Trauma Serv, Auckland, New Zealand		Kejriwal, R (corresponding author), 6U Carlton Gore Rd, Auckland, New Zealand.	ritwikkejriwal@gmail.com		Civil, Ian/0000-0002-1371-1114			American College of Surgeons Committee on Trauma, 1997, ADV TRAUM LIF SUPP D; Bartlett J, 1998, BRIT J NEUROSURG, V12, P349, DOI 10.1080/02688699844871; Brain Trauma Foundation, SURG MAN TRAUM BRAIN; Civil Ian, 2004, N Z Med J, V117, pU1042; Cooper DJ, 1998, J TRAUMA, V45, P772, DOI 10.1097/00005373-199810000-00027; DENT DL, 1995, J TRAUMA, V39, P36, DOI 10.1097/00005373-199507000-00005; Gabriel Edward J., 2002, Journal of Neurotrauma, V19, P111; Harrington DT, 2005, ANN SURG, V241, P961, DOI 10.1097/01.sla.0000164178.62726.f1; Holmen CD, 2002, J TRAUMA, V53, P345, DOI 10.1097/00005373-200208000-00026; Lind CRP, 2005, ANZ J SURG, V75, P858, DOI 10.1111/j.1445-2197.2005.03574.x; Mullins RJ, 1998, J TRAUMA, V44, P609, DOI 10.1097/00005373-199804000-00009; Patel HC, 2005, LANCET, V366, P1538, DOI 10.1016/S0140-6736(05)67626-X; POON WS, 1991, INJURY, V22, P323, DOI 10.1016/0020-1383(91)90016-8; Review of Trauma and Emergency Services-Victoria, 1999, FIN REP MIN TASKF TR; Schoettker P, 2003, INJURY, V34, P187, DOI 10.1016/S0020-1383(02)00280-2; *SCOTT INT GUID NE, 2000, EARL MAN PAT HEAD IN; SEELIG JM, 1981, NEW ENGL J MED, V304, P1511, DOI 10.1056/NEJM198106183042503; The Abbreviated Injury Scale (AIS) 1990-Update 98, ABBR INJ SCAL 1990 U; WILBERGER JE, 1991, J NEUROSURG, V74, P212, DOI 10.3171/jns.1991.74.2.0212; Young JS, 1998, AM SURGEON, V64, P88	20	8	8	0	0	NEW ZEALAND MEDICAL ASSOC	CHRISTCHURCH	C/O BRENNAN EDWARDES, DEPT SURGERY, CHRISTCHURCH HOSPITAL, PO BOX 4345, CHRISTCHURCH, 00000, NEW ZEALAND	0028-8446	1175-8716		NEW ZEAL MED J	N. Z. Med. J.	SEP 11	2009	122	1302					40	46					7	Medicine, General & Internal	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	V7P9C	WOS:000421183100005	19834521				2022-02-06	
J	Brady, SL; Pape, TLB; Darragh, M; Escobar, NG; Rao, N				Brady, Susan L.; Pape, Theresa L. -B.; Darragh, Meghan; Escobar, Nelson G.; Rao, Noel			Feasibility of Instrumental Swallowing Assessments in Patients With Prolonged Disordered Consciousness While Undergoing Inpatient Rehabilitation	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						brain injury; coma; deglutition; disordered consciousness; dysphagia; rehabilitation	TRAUMATIC BRAIN-INJURY; DYSPHAGIA; ADMISSION; FEEDINGS; OUTCOMES	Objective: To evaluate the feasibility, safety, and potential benefit of instrumental swallowing assessments for patients with prolonged disordered consciousness participating in rehabilitation. Design: Case-control, retrospective. Participants: Thirty-five participants divided into 2 cohorts according to cognitive level at the time of baseline instrumental swallowing assessment. Group 1 (n = 17) participants were at Rancho Los Amigo (RLA) level II/III or RLA level III, while Group 2 (n = 18) participants were rated better than RLA level III. Results: Aspiration and laryngeal penetration rates for both groups were similar (aspiration rate Group 1 = 41%, Group 2 = 39%; laryngeal penetration rate Group 1 = 59%, Group 2 = 61%). Overall, 76% (13/17) of Group I and 72% (13/18) of Group 2 were able to receive some type of oral feedings following baseline video fluoroscopic swallow study (VFSS) or endoscopic exam of the swallow (FEES). Conclusion: The majority of participants who underwent an instrumental swallowing examination while still functioning at RLA level II/III or RLA level III were able to return to some form of oral feedings immediately following their baseline examination. Swallowing as a treatment modality can be considered a part of the overall plan to facilitate neurobehavioral recovery for patients with prolonged disordered consciousness participating in rehabilitation.	[Brady, Susan L.] Voice & Swallowing Ctr, Dept Speech Language Pathol, Wheaton, IL USA; [Darragh, Meghan; Escobar, Nelson G.] Brain Injury Program, Wheaton, IL USA; [Pape, Theresa L. -B.; Rao, Noel] Marianjoy Rehabil Hosp, Wheaton, IL USA; [Pape, Theresa L. -B.] Rehabil Res & Dev Serv, Dept Vet Affairs, Off Res & Dev, Hines, IL USA; [Pape, Theresa L. -B.] Northwestern Univ, Dept Phys Med & Rehabil, Feinberg Sch Med, Evanston, IL 60208 USA; [Pape, Theresa L. -B.] Northwestern Univ, Inst Hlth Care Studies, Feinberg Sch Med, Evanston, IL 60208 USA		Brady, SL (corresponding author), 26 W 171 Roosevelt Rd, Wheaton, IL 60187 USA.	sbrady@marianjoy.org		Bender Pape, Theresa/0000-0001-7738-5963			Brady SL, 2006, BRAIN INJURY, V20, P1329, DOI 10.1080/02699050601111435; Brown AW, 2007, BRAIN INJURY, V21, P673, DOI 10.1080/02699050701468925; Cherney LR, 1996, SEMIN NEUROL, V16, P349, DOI 10.1055/s-2008-1040993; Darragh AR, 2001, AM J OCCUP THER, V55, P191, DOI 10.5014/ajot.55.2.191; DODDS TA, 1993, ARCH PHYS MED REHAB, V74, P531, DOI 10.1016/0003-9993(93)90119-U; Giacino JT, 1997, J HEAD TRAUMA REHAB, V12, P79, DOI 10.1097/00001199-199708000-00008; Halper AS, 1999, J HEAD TRAUMA REHAB, V14, P486, DOI 10.1097/00001199-199910000-00009; HEGAN C, 1982, COGNITIVE REHABILITA, P131; Kunik CL, 2006, ARCH PHYS MED REHAB, V87, P1590, DOI 10.1016/j.apmr.2006.09.001; Leder SB, 2005, DYSPHAGIA, V20, P163, DOI 10.1007/s10350-005-0002-4; Mackay LE, 1999, ARCH PHYS MED REHAB, V80, P365, DOI 10.1016/S0003-9993(99)90271-X; Metheny NA, 2008, AM J CRIT CARE, V17, P512; Murray HM, 2006, BRAIN INJURY, V20, P575, DOI 10.1080/02699050600664590; O'Neil-Pirozzi TM, 2003, BRAIN INJURY, V17, P389, DOI 10.1080/0269905031000070251; Sasaki CT, 2006, ANN OTO RHINOL LARYN, V115, P759, DOI 10.1177/000348940611501008; Wade SL, 2006, J HEAD TRAUMA REHAB, V21, P57, DOI 10.1097/00001199-200601000-00006; Ward EC, 2007, J HEAD TRAUMA REHAB, V22, P184, DOI 10.1097/01.HTR.0000271119.96780.f5	17	8	10	0	6	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0885-9701			J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	SEP-OCT	2009	24	5					384	391		10.1097/HTR.0b013e3181a8d38e			8	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	509WG	WOS:000271049300009	19858972				2022-02-06	
J	Higgins, MJ; Tierney, RT; Caswell, S; Driban, JB; Mansell, J; Clegg, S				Higgins, M. J.; Tierney, R. T.; Caswell, S.; Driban, J. B.; Mansell, J.; Clegg, S.			An in-vivo model of functional head impact testing in non-helmeted athletes	PROCEEDINGS OF THE INSTITUTION OF MECHANICAL ENGINEERS PART P-JOURNAL OF SPORTS ENGINEERING AND TECHNOLOGY			English	Article						impact acceleration; helmet; head injury; measurement techniques; soccer	FOOTBALL SOCCER PLAY; BRAIN-INJURY; NEUROPSYCHOLOGICAL IMPAIRMENT; NEUROCOGNITIVE PERFORMANCE; PROFESSIONAL FOOTBALL; CONCUSSION HISTORY; UNITED-STATES; ACCELERATION; CONSEQUENCE; SPORTS	Development of a functional in-vivo head impact testing model would enhance the ability to elucidate mechanisms underlying individual responses to head impact in sports where a helmet is not worn. The objective of this paper is to describe a novel in-vivo method of assessing human head linear impact acceleration during the functional activity of soccer heading, using a repeated-measures design in a university research laboratory. 17 college-aged soccer players (age, 20.93 years (standard deviation (SD), 1.17 years); height, 170.39 cm (SD, 10.15 cm); mass, 71.50 kg (SD, 9.89 kg); head neck mass, 5.90 kg (SD, 0.83 kg)) participated in this study. All participants read and signed a university Institutional-Review-Board-approved informed consent before participating. The resultant linear head acceleration (in units of g) was measured for each participant during soccer heading. The head impact model consisted of controlled soccer headers and a triaxial accelerometer affixed to a custom-fitted mouthpiece. A force-sensitive resistor on the forehead assessed impact quality. Standard soccer balls were projected from a JUGS soccer machine travelling at 11.10 m/s (25 mile/h) and covering a distance of 11 m (35 ft). The subjects performed standing or simulated headers while aiming at a target positioned 5 m in front of them. The intra-class correlation coefficient (ICC2,1) was 0.845 for resultant accelerations. In this paper, the development and testing of a novel in-vivo functional human head impact testing model are described. Results suggest that this methodology has potential for assessing resultant peak linear head impact accelerations during the functional activity of soccer heading and in other non-helmet-wearing sports.	[Higgins, M. J.] Towson Univ, Dept Kinesiol, Towson, MD 21252 USA; [Tierney, R. T.; Driban, J. B.; Mansell, J.; Clegg, S.] Temple Univ, Dept Kinesiol, Athlet Trainnig Div, Biokinet Res Lab, Philadelphia, PA 19122 USA; [Caswell, S.] George Manson Univ, Sports Med Assessment Res & Testing Lab, Sch Recreat Hlth & Tourism, Fairfax, VA USA		Higgins, MJ (corresponding author), Towson Univ, Dept Kinesiol, 8000 York Rd, Towson, MD 21252 USA.	mhiggins@towson.edu	Driban, Jeffrey/H-3486-2019	Driban, Jeffrey/0000-0001-6098-4273	Towson University Faculty Research Grant Foundation; Pennsylvania Athletic Trainers' Association	This study was funded by grants from the Towson University Faculty Research Grant Foundation and Pennsylvania Athletic Trainers' Association.	Barnes BC, 1998, AM J SPORT MED, V26, P433, DOI 10.1177/03635465980260031601; Binder S, 2003, REPORT C MILD TRAUMA; Boden BP, 1998, AM J SPORT MED, V26, P238, DOI 10.1177/03635465980260021301; Broglio SP, 2006, BRIT J SPORT MED, V40, P802, DOI 10.1136/bjsm.2006.028019; Covassin T, 2003, APPL NEUROPSYCHOL, V10, P12, DOI 10.1207/S15324826AN1001_3; de Bruijn S F T M, 2004, Ned Tijdschr Geneeskd, V148, P2209; Delaney TS, 2002, CLIN J SPORT MED, V12, P331, DOI 10.1097/00042752-200211000-00003; Duma SM, 2005, CLIN J SPORT MED, V15, P3, DOI 10.1097/00042752-200501000-00002; Frechede B, 2009, MED SCI SPORT EXER, V41, P390, DOI 10.1249/MSS.0b013e318186b1c5; Green GA, 1998, CLIN SPORT MED, V17, P795, DOI 10.1016/S0278-5919(05)70120-4; Guskiewicz K., 2005, J ATHL TRAIN S, V40, pS81; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Guskiewicz KM, 2002, AM J SPORT MED, V30, P157, DOI 10.1177/03635465020300020201; Higgins M, 2007, J ATHL TRAINING, V42, P5; Johnston KM, 2001, CLIN J SPORT MED, V11, P150, DOI 10.1097/00042752-200107000-00005; Jordan SE, 1996, AM J SPORT MED, V24, P205, DOI 10.1177/036354659602400216; Lewis LM, 2001, ACAD EMERG MED, V8, P604, DOI 10.1111/j.1553-2712.2001.tb00171.x; Macciocchi SN, 1998, CLIN SPORT MED, V17, P27, DOI 10.1016/S0278-5919(05)70058-2; MANOOGIAN S, 2006, BIOMED SCI INSTRUMN, V2, P383; Matser EJT, 1999, JAMA-J AM MED ASSOC, V282, P971, DOI 10.1001/jama.282.10.971; McCrory Paul, 2005, Clin J Sport Med, V15, P48; McCrory PR, 2003, BRIT MED J, V327, P351, DOI 10.1136/bmj.327.7411.351; MIHALIK JP, 2005, J ATHL TRAINING, V40, pS82; Naunheim RS, 2000, J TRAUMA, V48, P938, DOI 10.1097/00005373-200005000-00020; Naunheim RS, 2003, MED SCI SPORT EXER, V35, P1406, DOI 10.1249/01.MSS.0000078933.84527.AE; Naunheim RS, 2003, ACAD EMERG MED, V10, P85, DOI 10.1197/aemj.10.1.85; Pellman EJ, 2003, NEUROSURGERY, V53, P799, DOI 10.1093/neurosurgery/53.3.799; Putukian M, 2000, CLIN J SPORT MED, V10, P104, DOI 10.1097/00042752-200004000-00004; Rabadi MH, 2001, CLIN J SPORT MED, V11, P194, DOI 10.1097/00042752-200107000-00011; Rutherford A, 2005, J CLIN EXP NEUROPSYC, V27, P299, DOI 10.1080/13803390490515504; Shewchenko N, 2005, BRIT J SPORT MED, V39, pI10, DOI 10.1136/bjsm.2005.019034; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; STALNAKE B, 2004, BRIT J SPORT MED, V40, P313; Stephens R, 2005, CHILD NEUROPSYCHOL, V11, P513, DOI 10.1080/092970490959629; Straume-Naesheim TM, 2005, BRIT J SPORT MED, V39, pI70, DOI 10.1136/bjsm.2005.019646; Thurman DJ, 1998, J HEAD TRAUMA REHAB, V13, P1, DOI 10.1097/00001199-199804000-00003; Tierney RT, 2008, J ATHL TRAINING, V43, P578, DOI 10.4085/1062-6050-43.6.578; TYSVAER AT, 1989, ACTA NEUROL SCAND, V80, P151, DOI 10.1111/j.1600-0404.1989.tb03858.x; TYSVAER AT, 1991, AM J SPORT MED, V19, P56, DOI 10.1177/036354659101900109; Vanderploeg RD, 2005, J INT NEUROPSYCH SOC, V11, P228, DOI 10.1017/S1355617705050289; Zetterberg H, 2007, BRIT J SPORT MED, V41, DOI 10.1136/bjsm.2007.037143	41	8	8	0	6	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1754-3371	1754-338X		P I MECH ENG P-J SPO	Proc. Inst. Mech. Eng. Part P-J. Sport. Eng. Technol.	SEP	2009	223	P3					117	123		10.1243/17543371JSET15			7	Engineering, Mechanical; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Sport Sciences	664CC	WOS:000282935500004					2022-02-06	
J	Mussig, K; Leyhe, T; Besemer, B; Saur, R; Haring, HU; Gallwitz, B; Klingberg, S				Muessig, Karsten; Leyhe, Thomas; Besemer, Britta; Saur, Ralf; Haering, Hans-Ulrich; Gallwitz, Baptist; Klingberg, Stefan			Younger age is a good predictor of better executive function after surgery for pituitary adenoma in adults	JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY			English	Article						Neuropsychological testing; Pituitary surgery; Prolactinoma; Cushing's disease; Acromegaly; Nonfunctioning adenoma	TRAUMATIC BRAIN-INJURY; COGNITIVE DYSFUNCTION; RECOVERY; TUMORS	Pituitary adenomas, even after successful treatment, are associated with cognitive dysfunctions. We hypothesized that an association between the age of the patients at pituitary Surgery and neuropsychological outcome may exist. Forty-two patients (mean age 51 +/- 10 years) who had been successfully treated for pituitary adenoma (surgery with or without subsequent radiotherapy) underwent neuropsychological testing. Age at treatment (mean 37 +/- 11 years) was significantly associated with Trail Making Test, Part B (TMT-B) results, a measure of executive control and attention (r = .60, p < .0001). This association remained significant after adjustment for age at testing and time since treatment (r = .42, p = .008). No associations were detected between age at treatment and Trail Making Test, Part A (TMT-A, attentional speed), the digit span test (acoustic working memory), and the German version of the Auditory Verbal Learning and Memory, and Memory Test (Verbal memory, all p >= .3). Our data Suggest a favorable effect of younger age at treatment in adults on neurocognitive outcome after Surgery for pituitary adenoma. (JINS, 2009, 15, 803-806.)	[Muessig, Karsten; Besemer, Britta; Haering, Hans-Ulrich; Gallwitz, Baptist] Univ Tubingen Hosp, Dept Internal Med, Div Endocrinol Diabet Angiol Nephrol & Clin Chem, Tubingen, Germany; [Leyhe, Thomas; Saur, Ralf; Klingberg, Stefan] Univ Tubingen Hosp, Dept Psychiat & Psychotherapy, Tubingen, Germany; [Leyhe, Thomas] Univ Tubingen Hosp, Geriatr Ctr, Tubingen, Germany; [Saur, Ralf] Univ Tubingen Hosp, Dept Neuroradiol, Sect Expt Magnet Resonance CNS, Tubingen, Germany		Mussig, K (corresponding author), Univ Klinikum Tubingen, Med Klin 4, Otfried Muller Str 10, D-72076 Tubingen, Germany.	Karsten.Muessig@med.uni-tuebingen.de	Gallwitz, Baptist/AAQ-2051-2020; Klingberg, Stefan/E-6676-2010	Gallwitz, Baptist/0000-0002-8880-6409; Klingberg, Stefan/0000-0001-8081-7181			Burke SN, 2006, NAT REV NEUROSCI, V7, P30, DOI 10.1038/nrn1809; Drane DL, 2002, NEUROPSY NEUROPSY BE, V15, P39; GRATTANSMITH PJ, 1992, ACTA NEUROL SCAND, V86, P626, DOI 10.1111/j.1600-0404.1992.tb05500.x; Green RE, 2008, ARCH PHYS MED REHAB, V89, pS16, DOI 10.1016/j.apmr.2008.09.551; Guinan EM, 1998, J NEUROL NEUROSUR PS, V65, P870, DOI 10.1136/jnnp.65.6.870; Heaton RK, 1999, J CLIN EXP NEUROPSYC, V21, P571, DOI 10.1076/jcen.21.4.572.882; Helmstaedter C., 2001, VERBALER LERN MERKFA; Kulchycki LK, 2006, EMERG MED CLIN N AM, V24, P273, DOI 10.1016/j.emc.2006.01.013; Lehrl S., 2005, MEHRFACHWAHL WORTSCH; Peace KA, 1997, J CLIN EXP NEUROPSYC, V19, P1, DOI 10.1080/01688639708403831; Peace KA, 1998, CLIN ENDOCRINOL, V49, P391; Reeder KP, 1996, J HEAD TRAUMA REHAB, V11, P22, DOI 10.1097/00001199-199606000-00006; Reitan RM, 1992, TRAIL MAKING TEST MA; Son AHPWV, 2007, CLIN REHABIL, V21, P1024, DOI 10.1177/0269215507077603; Sonntag WE, 2005, AGEING RES REV, V4, P195, DOI 10.1016/j.arr.2005.02.001; Testa JA, 2005, ARCH PHYS MED REHAB, V86, P1815, DOI 10.1016/j.apmr.2005.03.010; TEWES U, 1999, HAWIE HAMBURGWECHSLE; Wilson BA, 1998, CURR OPIN NEUROBIOL, V8, P281, DOI 10.1016/S0959-4388(98)80152-9	18	8	9	0	4	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1355-6177	1469-7661		J INT NEUROPSYCH SOC	J. Int. Neuropsychol. Soc.	SEP	2009	15	5					803	806		10.1017/S1355617709990324			4	Clinical Neurology; Neurosciences; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry; Psychology	489IZ	WOS:000269415100018	19638252				2022-02-06	
J	Cherian, KA; Weidenheim, K; Legatt, AD; Shifteh, K; Abbott, IR; Moshe, SL				Cherian, Koshi A.; Weidenheim, Karen; Legatt, Alan D.; Shifteh, Keivan; Abbott, I. Richmond; Moshe, Solomon L.			Extensive apoptosis in a case of intractable infantile status epilepticus	EPILEPSY RESEARCH			English	Article						Status epitepticus; Infant; Apoptosis; Epilepsy surgery	TRAUMATIC BRAIN-INJURY; PROGRAMMED CELL-DEATH; ANTIEPILEPTIC DRUGS; INFECTED-CELLS; NEURODEGENERATION; ENCEPHALOPATHY	A previously healthy 81/2-month-old girl underwent epilepsy surgery for intractable focal seizures with secondary generalization that progressed to status epilepticus. The major neuropathologic finding was extensive apoptosis. Investigations did not reveal any etiology for the apoptosis or the seizures. This is the first report of apoptosis, without necrosis, in association with intractable status epilepticus in the developing human brain. The findings suggest that new treatment strategies targeted to prevent apoptosis may be useful in children with prolonged status epilepticus. (C) 2009 Elsevier B.V. All rights reserved.	[Cherian, Koshi A.; Weidenheim, Karen; Legatt, Alan D.; Shifteh, Keivan; Abbott, I. Richmond; Moshe, Solomon L.] Montefiore Med Ctr, Bronx, NY 10467 USA; [Cherian, Koshi A.; Weidenheim, Karen; Legatt, Alan D.; Moshe, Solomon L.] Albert Einstein Coll Med, Saul R Korey Dept Neurol, New York, NY USA; [Legatt, Alan D.; Moshe, Solomon L.] Albert Einstein Coll Med, Dominick P Purpura Dept Neurosci, New York, NY USA; [Cherian, Koshi A.; Moshe, Solomon L.] Albert Einstein Coll Med, Dept Pediat, New York, NY USA; [Legatt, Alan D.; Moshe, Solomon L.] Albert Einstein Coll Med, Montefiore Einstein Epilepsy Management Ctr, New York, NY USA; [Weidenheim, Karen] Albert Einstein Coll Med, Dept Pathol Neuropathol, New York, NY USA; [Shifteh, Keivan] Albert Einstein Coll Med, Dept Radiol Neuroradiol, New York, NY USA; [Weidenheim, Karen; Abbott, I. Richmond] Albert Einstein Coll Med, Leo M Davidoff Dept Neurol Surg, New York, NY USA		Cherian, KA (corresponding author), Montefiore Med Ctr, 111 E 210th St, Bronx, NY 10467 USA.	Kcherian@montefiore.org		Moshe, Solomon/0000-0001-9427-9476	Heffer Family Medical Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS020253] Funding Source: NIH RePORTER	This work was supported by the Heffer Family Medical Foundation. Dr. S.L. Moshe is the recipient of the Martin A. and Emily L. Fisher Fellowship in Neurology and Pediatrics.	AMEISEN JC, 1991, IMMUNOL TODAY, V12, P102; ANTONI BA, 1995, J VIROL, V69, P2384, DOI 10.1128/JVI.69.4.2384-2392.1995; Baxter P, 2003, SEIZURE-EUR J EPILEP, V12, P379, DOI 10.1016/S1059-1311(02)00340-0; Ben-Ari Y, 2006, LANCET NEUROL, V5, P1055, DOI 10.1016/S1474-4422(06)70626-3; Bittigau P, 2002, P NATL ACAD SCI USA, V99, P15089, DOI 10.1073/pnas.222550499; Crowe MJ, 1997, NAT MED, V3, P73, DOI 10.1038/nm0197-73; DOBBING J, 1979, P NUTR SOC, V38, pA99; ELLIS HM, 1986, CELL, V44, P817, DOI 10.1016/0092-8674(86)90004-8; FINKEL TH, 1995, NAT MED, V1, P129, DOI 10.1038/nm0295-129; Haut SR, 2004, LANCET NEUROL, V3, P608, DOI 10.1016/S1474-4422(04)00881-6; Ikonomidou C, 1999, SCIENCE, V283, P70, DOI 10.1126/science.283.5398.70; Ikonomidou C, 2000, SCIENCE, V287, P1056, DOI 10.1126/science.287.5455.1056; Jevtovic-Todorovic V, 2003, J NEUROSCI, V23, P876, DOI 10.1523/jneurosci.23-03-00876.2003; Kaindl AM, 2006, CELL MOL LIFE SCI, V63, P399, DOI 10.1007/s00018-005-5348-0; Liou AKF, 2003, PROG NEUROBIOL, V69, P103, DOI 10.1016/S0301-0082(03)00005-4; MacManus JP, 2000, J NEUROTRAUM, V17, P899, DOI 10.1089/neu.2000.17.899; Mikaeloff Y, 2006, EPILEPSY RES, V69, P67, DOI 10.1016/j.eplepsyres.2006.01.002; RINK A, 1995, AM J PATHOL, V147, P1575; Uren AG, 1996, PHARMACOL THERAPEUT, V72, P37, DOI 10.1016/S0163-7258(96)00098-8; Zhang Aiqun, 2004, Neuroembryology, V3, P47, DOI 10.1159/000085404	20	8	8	0	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0920-1211	1872-6844		EPILEPSY RES	Epilepsy Res.	AUG	2009	85	2-3					305	310		10.1016/j.eplepsyres.2009.03.009			6	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	485ET	WOS:000269104500022	19464149	Green Accepted			2022-02-06	
J	Fishman, G; Fliss, DM; Benjamin, S; Margalit, N; Gil, Z; Derowe, A; Constantini, S; Beni-Adani, L				Fishman, Gadi; Fliss, Dan M.; Benjamin, Shlomi; Margalit, Nevo; Gil, Ziv; Derowe, Ari; Constantini, Shlomi; Beni-Adani, Liana			Multidisciplinary surgical approach for cerebrospinal fluid leak in children with complex head trauma	CHILDS NERVOUS SYSTEM			English	Article						Base of skull; Fractures; Pediatric head trauma; Craniofacial trauma; CSF leak; Reconstruction; Craniotomy; Combined extracranial-intracranial approach	SKULL BASE FRACTURES; SUBCRANIAL APPROACH; MANAGEMENT; MENINGITIS	Post-traumatic cerebrospinal fluid leak from the anterior cranial fossa in children may be isolated or combined with severe facial and calvarial injury. Untreated leak may result with meningitis, hydrocephalus, and abnormal neurocognitive development. We present nine children, ages 4-16 years, with complicated craniofacial injury treated by a combined subcranial and intracranial approach. A continuous lumbar drainage was kept for several days, and prophylactic antibiotics and anti-convulsive medications were routinely given. A multidisciplinary approach including discussion before surgery about other surgical options (endoscopic extracranial and intracranial alone) were performed. None of the operated children had episodes of meningitis/leak after the combined approach, suggesting that appropriate sealing of the base of the skull has been achieved. There was no mortality, and the long-term follow-up showed good developmental and cosmetic results. Most of the children had significant brain contusions prior to surgery; however, these did not progress as minimal retraction was enabled by the extensive subcranial and intracranial approach. Child's age, anatomy of the bone, extent of cranial injury, and clinical parameters should be seriously considered when choosing the technical methods as for sealing base of skull and reconstruction of facial/cranial bones. Young age does not seem to be a contraindication to the combined approach, thus, we recommend considering it in extensive base of skull fractures when concomitant cranial, maxillofacial, and orbital fractures coexist, as alternative options may not suffice in these cases.	[Constantini, Shlomi; Beni-Adani, Liana] Tel Aviv Univ, Dept Pediat Neurosurg, Tel Aviv Sourasky Med Ctr, Sackler Fac Med, IL-64239 Tel Aviv, Israel; [Fishman, Gadi; Fliss, Dan M.; Benjamin, Shlomi; Margalit, Nevo; Gil, Ziv; Derowe, Ari; Constantini, Shlomi; Beni-Adani, Liana] Tel Aviv Univ, Dana Childrens Hosp, Sackler Fac Med, IL-64239 Tel Aviv, Israel; [Fishman, Gadi; Fliss, Dan M.; Gil, Ziv; Derowe, Ari] Tel Aviv Univ, Sackler Fac Med, Dept Otolaryngol Head & Neck Surg, Tel Aviv Sourasky Med Ctr, IL-64239 Tel Aviv, Israel; [Benjamin, Shlomi] Tel Aviv Univ, Sackler Fac Med, Dept Oral & Maxillofacial Surg, Tel Aviv Sourasky Med Ctr, IL-64239 Tel Aviv, Israel; [Margalit, Nevo] Tel Aviv Univ, Sackler Fac Med, Dept Neurosurg, Tel Aviv Sourasky Med Ctr, IL-64239 Tel Aviv, Israel		Beni-Adani, L (corresponding author), Tel Aviv Univ, Dept Pediat Neurosurg, Tel Aviv Sourasky Med Ctr, Sackler Fac Med, Weizmann 6, IL-64239 Tel Aviv, Israel.	lianabenia@gmail.com					Ash G. J., 1992, Brain Injury, V6, P521, DOI 10.3109/02699059209008149; Clauser L, 2004, CHILD NERV SYST, V20, P168, DOI 10.1007/s00381-003-0868-0; DAGI TF, 1988, MANAGEMENT CEREBROSP; Eftekhar B, 2004, J NEUROSURG, V101, P757, DOI 10.3171/jns.2004.101.5.0757; Friedman JA, 2001, WORLD J SURG, V25, P1062, DOI 10.1007/s00268-001-0059-7; Gliklich R E, 1995, J Craniomaxillofac Trauma, V1, P56; Imola M J, 2001, Arch Facial Plast Surg, V3, P79, DOI 10.1001/archfaci.3.2.79; Kanowitz SJ, 2006, INT J PEDIATR OTORHI, V70, P2087, DOI 10.1016/j.ijporl.2006.08.007; Kassam A, 2007, J NEUROSURG, V106, P75, DOI 10.3171/ped.2007.106.2.75; Kelley TF, 1996, NEUROSURGERY, V39, P743, DOI 10.1097/00006123-199610000-00019; Kendirli T, 2006, PEDIATR INT, V48, P91, DOI 10.1111/j.1442-200X.2006.02165.x; Lee TJ, 2008, J NEUROSURG, V108, P729, DOI 10.3171/JNS/2008/108/4/0729; Lim LHY, 2004, OTOLARYNG HEAD NECK, V130, P255, DOI 10.1016/j.otohns.2003.11.010; Locatelli D, 2006, CHILD NERV SYST, V22, P1411, DOI 10.1007/s00381-006-0114-7; Mandrioli S, 2008, J CRANIOFAC SURG, V19, P713, DOI 10.1097/SCS.0b013e31816aac44; MATTOX DE, 1990, LARYNGOSCOPE, V100, P857; Ort S, 2004, OTOLARYNG HEAD NECK, V131, P433, DOI 10.1016/j.otohns.2004.04.006; PARK JI, 1983, LARYNGOSCOPE, V93, P1294; Piek J, 2000, Neurosurg Focus, V9, pe2; RAVEH J, 1993, ARCH OTOLARYNGOL, V119, P385; RAVEH J, 1992, ARCH OTOLARYNGOL, V118, P605; Scholsem M, 2008, NEUROSURGERY, V62, P463, DOI [10.1227/01.NEU.0000297037.51609.07, 10.1227/01.neu.0000316014.97926.82, 10.1227/01.neu.0000325884.05871.aa]; Shlomi B, 2007, OTOLARYNG HEAD NECK, V136, P27, DOI 10.1016/j.otohns.2006.07.019; SPONSEL C, 1994, POSTGRAD MED, V95, P109, DOI 10.1080/00325481.1994.11945784; Teo C, 1999, CHILD NERV SYST, V15, P103, DOI 10.1007/s003810050343; Villalobos T, 1998, CLIN INFECT DIS, V27, P364, DOI 10.1086/514666; Wetmore RF, 1996, INT J PEDIATR OTORHI, V36, P109, DOI 10.1016/0165-5876(96)01342-0; Zrebeet H A, 1986, Del Med J, V58, P741	28	8	8	0	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0256-7040	1433-0350		CHILD NERV SYST	Childs Nerv. Syst.	AUG	2009	25	8					915	923		10.1007/s00381-009-0887-6			9	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	464DH	WOS:000267484800003	19415300				2022-02-06	
J	Courville, XF; Koval, KJ; Carney, BT; Spratt, KF				Courville, Xan F.; Koval, Kenneth J.; Carney, Brian T.; Spratt, Kevin F.			Early Prediction of Posttraumatic In-hospital Mortality in Pediatric Patients	JOURNAL OF PEDIATRIC ORTHOPAEDICS			English	Article	75th Annual Meeting of the American-Academy-of-Orthopaedic-Surgeons	MAR, 2008	San Francisco, CA	Amer Acad Orthopaed Surg		pediatric; mortality; trauma; triage	TRAUMATIC BRAIN-INJURY; HEAD-INJURY; CHILDREN; HYPOTENSION; SEVERITY; IMPACT; EPIDEMIOLOGY; INTUBATION; CHILDHOOD; PRESSURE	Background: The purpose of this study was to develop a triaging tool to predict pediatric in-hospital mortality from data available soon after emergency department (ED) presentation. Methods: The study group consisted of patients of less than 18 years of age from the National Trauma Data Bank with a reported in-hospital mortality status. Variables analyzed were (1) patient demographics, (2) Glasgow Coma Scale (GCS) values, (3) ED vital signs, (4) injury mechanism, and (5) number of days from trauma until admission. Chi-square-assisted interaction detection (CHAID) profiled patient subgroups. The final cohort was randomly divided into 2 equal sets: a training set to subgroup patients and a testing set to validate the prediction accuracy. Results: The cohort consisted of 224,628 patients with 2.29% in-hospital mortality. Sixteen of 19 potential variables were associated with increased risk of in-hospital mortality. The relative risk of dying was 61.7 times greater (95% confidence interval 57.5-66.1) when CHAID predicted mortality relative to when the model predicted survival (P<0.0001). The most powerful variables of the CHAID model were low total GCS scores and systolic blood pressure in the ED. The CHAID model had an improved relative risk and a better combination of sensitivity and positive predictive value compared with GCS and systolic blood pressure in predicting mortality. Conclusions: The risk of in-hospital mortality for injured children may be identified soon after arrival in the ED. This information may be used by frontline providers to appropriately triage patients to pediatric trauma centers quickly, to guide resuscitation, and for teaching purposes.	[Courville, Xan F.] Dartmouth Hitchcock Med Ctr, Dept Orthopaed, Lebanon, NH 03756 USA; [Koval, Kenneth J.; Spratt, Kevin F.] Dartmouth Med Sch, Dept Orthopaed, Hanover, NH USA; [Spratt, Kevin F.] Multidisciplinary Clin Res Ctr, Dept Orthopaed, Lebanon, NH USA		Courville, XF (corresponding author), Dartmouth Hitchcock Med Ctr, Dept Orthopaed, 1 Med Ctr Dr, Lebanon, NH 03756 USA.	Xan.Courville@hitchcock.org					Chiaretti A, 2002, CHILD NERV SYST, V18, P54, DOI 10.1007/s00381-001-0533-4; Coates BM, 2005, CRIT CARE MED, V33, P2645, DOI 10.1097/01.CCM.0000186417.19199.9B; COOPER A, 1994, J PEDIATR SURG, V29, P33, DOI 10.1016/0022-3468(94)90518-5; Cooper A, 2000, J TRAUMA, V48, P16, DOI 10.1097/00005373-200001000-00004; Cuff S, 2007, J TRAUMA, V63, P172, DOI 10.1097/TA.0b013e31805c14b1; Davis DP, 2005, J TRAUMA, V58, P933, DOI 10.1097/01.TA.0000162731.53812.58; Ducrocq SC, 2006, PEDIATR CRIT CARE ME, V7, P461, DOI 10.1097/01.PCC.0000235245.49129.27; Hall JR, 1996, J PEDIATR SURG, V31, P72, DOI 10.1016/S0022-3468(96)90322-X; Hannan EL, 2000, J PEDIATR SURG, V35, P155, DOI 10.1016/S0022-3468(00)90001-0; Hannan EL, 2000, J TRAUMA, V48, P76, DOI 10.1097/00005373-200001000-00013; Haque IU, 2007, PEDIATR CRIT CARE ME, V8, P138, DOI 10.1097/01.PCC.0000257039.32593.DC; Hill T, 2007, STAT METHODS APPL CO; Holmes JF, 2005, ACAD EMERG MED, V12, P814, DOI 10.1197/j.aem.2005.04.019; Inan M, 2007, ANZ J SURG, V77, P682, DOI 10.1111/j.1445-2197.2007.04186.x; Kass GV., 1980, J R STAT SOC C-APPL, V29, P119, DOI DOI 10.2307/2986296; Kokoska ER, 1998, J PEDIATR SURG, V33, P333, DOI 10.1016/S0022-3468(98)90457-2; LUERSSEN TG, 1988, J NEUROSURG, V68, P409, DOI 10.3171/jns.1988.68.3.0409; MACKENZIE EJ, 1990, J PEDIATR SURG, V25, P970, DOI 10.1016/0022-3468(90)90240-A; MANCIAUX MRG, 1985, ACTA PAEDIATR SCAND, V74, P163, DOI 10.1111/j.1651-2227.1985.tb10944.x; *NAT TRAUM DAT BAN, 2007, INST INSTR DAT FIL F; Ott R, 2000, J TRAUMA, V49, P729, DOI 10.1097/00005373-200010000-00023; PIGULA FA, 1993, J PEDIATR SURG, V28, P310, DOI 10.1016/0022-3468(93)90223-8; Pigula FA, 1993, J PEDIATR SURG, V28, P5; Potoka DA, 2000, J TRAUMA, V49, P237, DOI 10.1097/00005373-200008000-00009; TEPAS JJ, 1988, J TRAUMA, V28, P425, DOI 10.1097/00005373-198804000-00001; TEPAS JJ, 1987, J PEDIATR SURG, V22, P14, DOI 10.1016/S0022-3468(87)80006-4; Vavilala MS, 2003, J TRAUMA, V55, P1039, DOI 10.1097/01.TA.0000101759.23607.57; White JRM, 2001, CRIT CARE MED, V29, P534, DOI 10.1097/00003246-200103000-00011	28	8	8	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0271-6798			J PEDIATR ORTHOPED	J. Pediatr. Orthop.	JUL-AUG	2009	29	5					439	444		10.1097/BPO.0b013e3181aad60f			6	Orthopedics; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Pediatrics	468BS	WOS:000267789000004	19568013				2022-02-06	
J	Giuffrida, CG; Demery, JA; Reyes, LR; Lebowitz, BK; Hanlon, RE				Giuffrida, Clare G.; Demery, Jason A.; Reyes, Lisa R.; Lebowitz, Brian K.; Hanlon, Robert E.			Functional Skill Learning in Men With Traumatic Brain Injury	AMERICAN JOURNAL OF OCCUPATIONAL THERAPY			English	Article						brain injuries; cognition disorders; learning; motor skills; task performance and analysis	MEMORY-IMPAIRED PATIENTS; CONTEXTUAL INTERFERENCE; MOTOR SKILL; OCCUPATIONAL-THERAPY; ALZHEIMERS-DISEASE; ORGANIC AMNESIA; ACQUISITION; KNOWLEDGE; ADULTS; TASK	The number of people with traumatic brain injury (TBI) having persistent deficits that compromise their ability to perform everyday skills is increasing. Previous occupation-based studies indicate that computer-based skills using repetitive practice may be a viable option for retraining. We investigated the effects of different practice schedules on skill learning in 6 men with TBI. Participants with significant impairments in processing and fine motor control practiced 3 tasks using a random (n=3) or a blocked (n=3) ordered practice schedule. Practice occurred for 55 min/day for 13 days with retention and transfer trials taking place 2 weeks after training. Both groups showed a significant increase in performance during skill acquisition and maintained this performance. Only the random-practice group, however, was able to transfer this learning to another task. The findings provide evidence that people with TBI can improve their everyday skills with randomly structured practice.	[Giuffrida, Clare G.] Rush Univ, Dept Occupat Therapy, Chicago, IL 60612 USA; [Demery, Jason A.] Gainesville Vet Affairs Med Ctr, Gainesville, FL USA; [Lebowitz, Brian K.] SUNY Stony Brook, Dept Neurol, Med Ctr, Stony Brook, NY 11794 USA; [Hanlon, Robert E.] Northwestern Univ, Feinberg Sch Med, Evanston, IL 60208 USA; [Hanlon, Robert E.] Neuropsychol Associates Chicago, Chicago, IL USA		Giuffrida, CG (corresponding author), Rush Univ, Dept Occupat Therapy, 600 S Paulina, Chicago, IL 60612 USA.	clare_giuffrida@rush.edu		Lebowitz, Brian/0000-0001-8845-8136			BATTIG WF, 1972, TOPICS LEARNING PERF, P134; Brady F, 1998, QUEST, V50, P266, DOI 10.1080/00336297.1998.10484285; CARNAHAN H, 1990, J MOTOR BEHAV, V22, P159; Centers for Disease Control Prevention [CDC], 2007, TRAUM BRAIN INJ; DeLuca J, 2000, ARCH PHYS MED REHAB, V81, P1327, DOI 10.1053/apmr.2000.9390; Dick MB, 2000, BRAIN COGNITION, V44, P470, DOI 10.1006/brcg.2000.1206; Dick MB, 2000, AGING NEUROPSYCHOL C, V7, P273, DOI 10.1076/anec.7.4.273.793; Giles GM, 1997, AM J OCCUP THER, V51, P256, DOI 10.5014/ajot.51.4.256; GIUFFRIDA C, 1998, WILLARD SPACKMANS OC, P560; GLISKY EL, 1989, NEUROPSYCHOLOGIA, V27, P107, DOI 10.1016/0028-3932(89)90093-6; GLISKY EL, 1986, NEUROPSYCHOLOGIA, V24, P313, DOI 10.1016/0028-3932(86)90017-5; GLISKY EL, 1987, NEUROPSYCHOLOGIA, V25, P893, DOI 10.1016/0028-3932(87)90094-7; GLISKY EL, 1992, NEUROPSYCHOLOGIA, V30, P899, DOI 10.1016/0028-3932(92)90034-J; GLISKY EL, 1995, NEUROPSYCHOL REHABIL, V5, P299, DOI 10.1080/09602019508401474; HANLON R, 1994, NEUROPSYCHOLOGY, P317; Hanlon RE, 1996, ARCH PHYS MED REHAB, V77, P811, DOI 10.1016/S0003-9993(96)90262-2; HIEW CC, 1977, AM J PSYCHOL, V90, P207, DOI 10.2307/1422043; HORAK M, 1992, J MOTOR BEHAV, V24, P58, DOI 10.1080/00222895.1992.9941601; JELSMA O, 1989, PERCEPT MOTOR SKILL, V68, P1055, DOI 10.2466/pms.1989.68.3c.1055; Langlois JA, 2006, TRAUMATIC BRAIN INJU; Liu KPY, 2004, BRAIN INJURY, V18, P1163, DOI 10.1080/02699050410001671883; Liu KPY, 2002, BRAIN INJURY, V16, P817, DOI 10.1080/02699050210127295; MAGILL RA, 1990, HUM MOVEMENT SCI, V9, P241, DOI 10.1016/0167-9457(90)90005-X; MATHIOWETZ V, 1994, AM J OCCUP THER, V48, P733, DOI 10.5014/ajot.48.8.733; McGraw-Hunter M, 2006, BRAIN INJURY, V20, P1061, DOI 10.1080/02699050600912163; MELTON AW, 1967, SCIENCE, V158, P532, DOI 10.1126/science.158.3800.532-b; NEISTADT ME, 1992, AM J OCCUP THER, V46, P141, DOI 10.5014/ajot.46.2.141; NEWELL KM, 1992, AM ACAD PE, V25, P51; NICHOLSON D, 1996, PATHOPHYSIOLOGY MOTO, P238; Ollis S, 2005, ACTA PSYCHOL, V118, P229, DOI 10.1016/j.actpsy.2004.08.003; Page S, 2003, BRAIN INJURY, V17, P675, DOI 10.1080/0269905031000107160; POOLE JL, 1991, AM J OCCUP THER, V45, P531, DOI 10.5014/ajot.45.6.531; PORRETTA DL, 1991, ADAPTED PHYS ACTIVIT, V5, P332; SABARI JS, 1991, AM J OCCUP THER, V45, P523, DOI 10.5014/ajot.45.6.523; Schmidt R. A., 1999, MOTOR CONTROL LEARNI; Schmidt R. A., 1988, MOTOR CONTROL LEARNI; Schmidt RA., 1991, CONT MANAGEMENT MOTO, P49; Schmitter-Edgecombe M, 2006, J HEAD TRAUMA REHAB, V21, P131, DOI 10.1097/00001199-200603000-00006; SHEA JB, 1979, J EXP PSYCHOL-HUM L, V5, P179, DOI 10.1037/0278-7393.5.2.179; Shea JB, 1983, MEMORY CONTROL ACTIO, P345, DOI [DOI 10.1016/S0166.4115(08)61998, 10.1016/S0166-4115(08)61998-6, DOI 10.1016/S0166-4115(08)61998-6]; SHIMELMAN A, 1995, AM J OCCUP THER, V49, P973, DOI 10.5014/ajot.49.10.973; SIETSEMA JM, 1993, AM J OCCUP THER, V47, P19, DOI 10.5014/ajot.47.1.19; TEASDALE G, 1974, LANCET, V2, P81; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; 1996, TYPING TUTOR COMPUTE	45	8	10	0	14	AMER OCCUPATIONAL THERAPY ASSOC, INC	BETHESDA	4720 MONTGOMERY LANE, BETHESDA, MD 20814-3425 USA	0272-9490			AM J OCCUP THER	Am. J. Occup. Ther.	JUL-AUG	2009	63	4					398	407		10.5014/ajot.63.4.398			10	Rehabilitation	Social Science Citation Index (SSCI)	Rehabilitation	474NN	WOS:000268291000003	19708468				2022-02-06	
J	Bujan, A; Lindin, M; Diaz, F				Bujan, Ana; Lindin, Monica; Diaz, Fernando			Movement related cortical potentials in a face naming task: Influence of the tip-of-the-tongue state	INTERNATIONAL JOURNAL OF PSYCHOPHYSIOLOGY			English	Article						Movement related cortical potentials; Tip-of-the-tongue state; Speech-related movements; Naming task; sLORETA/eLORETA	TRAUMATIC BRAIN-INJURY; EVENT-RELATED FMRI; CEREBRAL POTENTIALS; PRECEDING SPEECH; VOLUNTARY MOVEMENT; FINGER MOVEMENTS; TEMPORAL CORTEX; DIFFERENT MODES; TIME-COURSE; NAMES	The aim of the present study was evaluate the movement-related cortical potentials (MRCPs) associated with manual and speech movements during a face naming task carried out by the same participants as in a previous study, in order to: 1) determine whether the slowing down of the reaction time observed in the tip-of-the-tongue (TOT) state was caused by motor processes; 2) compare the MRCPs among the three response categories (tip-of-the-tongue, successful retrieval and not knowing the name); and 3) determine whether the MRCPs modulated the differences in amplitude of the late negative wave among response categories. The first component of readiness potential, the negative slope, the motor potential and the reafferent potential associated with the manual response, and two components associated with the verbal responses-the speech-related motor potential and the speech-related reafferent potential-were identified. The slowing down of reaction time observed in the TOT category may be due to a temporal interruption in the motor programming of the responses due to the TOT state. The longer latency in speech-related components in the KNOW with respect to the TOT category can be attributed to the greater cognitive demands involved in the retrieval of proper names in the former category. The brain activity associated with the preparation and execution of the responses had a differential modulatory effect on the amplitude of the LNW component. which may partially explain the differences between the categories observed in the previous study by Diaz et al. [Diaz, F., Lindin, M., Galdo-Alvarez, S., Facal, D., Juncos-Rabadan, O., 2007. An event-related potentials study of face identification and naming: the tip-of-the-tongue state. Psychophysiology 44. 50-68]. (C) 2008 Elsevier B.V. All rights reserved.	[Bujan, Ana; Lindin, Monica; Diaz, Fernando] Univ Santiago de Compostela, Fac Psicoloxia, Lab Psicofisioloxia & Neurociencia Cognit, Santiago De Compostela 15782, Galiza, Spain		Diaz, F (corresponding author), Univ Santiago de Compostela, Fac Psicoloxia, Lab Psicofisioloxia & Neurociencia Cognit, Santiago De Compostela 15782, Galiza, Spain.	fernando.diaz@usc.es	Lindin, Monica/L-3418-2014; Diaz, Fernando/C-9217-2011; Bujan, Ana/E-2356-2014	Lindin, Monica/0000-0001-5936-9644; Diaz, Fernando/0000-0003-3373-4855; Bujan, Ana/0000-0002-9807-4205; , Gerontology Research Group/0000-0001-7207-9481	Spanish Ministerio de Ciencia y TecnologiaSpanish GovernmentEuropean Commission [BSO2002-03122]; Ministerio de Educacion y CulturaGerman Research Foundation (DFG) [SEF2007-67964-C02-02]; Galician Conselleria de Innovacion e Industria [PGIDIT07PXIB211018PR]	This work was supported by funds from the Spanish Ministerio de Ciencia y Tecnologia (BSO2002-03122), the Ministerio de Educacion y Cultura (SEF2007-67964-C02-02), and the Galician Conselleria de Innovacion e Industria (PGIDIT07PXIB211018PR). We thank Dr. Santiago Galdo-Alvarez for his helpful comments and support with the sLORETA/eLORETA software.	Bentin S, 2000, COGN NEUROPSYCHOL, V17, P35, DOI 10.1080/026432900380472; Bentin S, 1996, J COGNITIVE NEUROSCI, V8, P551, DOI 10.1162/jocn.1996.8.6.551; BOSCHERT J, 1986, BRAIN RES, V376, P175, DOI 10.1016/0006-8993(86)90913-3; Botzel K, 1997, EXP BRAIN RES, V114, P352, DOI 10.1007/PL00005643; BRENNEN T, 1990, MEM COGNITION, V18, P339, DOI 10.3758/BF03197123; Brett M, 2002, NAT REV NEUROSCI, V3, P243, DOI 10.1038/nrn756; BROOKER BH, 1980, BRAIN LANG, V9, P226, DOI 10.1016/0093-934X(80)90143-1; BROWN R, 1966, J VERB LEARN VERB BE, V5, P325, DOI 10.1016/S0022-5371(66)80040-3; Brunia C.H.M., 2000, HDB PSYCHOPHYSIOLOGY, P507; BURKE DM, 1991, J MEM LANG, V30, P542, DOI 10.1016/0749-596X(91)90026-G; DEECKE L, 1969, EXP BRAIN RES, V7, P158; DEECKE L, 1976, BIOL CYBERN, V23, P99, DOI 10.1007/BF00336013; DEECKE L, 1986, EXP BRAIN RES, V65, P219; Diaz F, 2007, PSYCHOPHYSIOLOGY, V44, P50, DOI 10.1111/j.1469-8986.2006.00483.x; Dirnberger G, 2000, EXP BRAIN RES, V135, P231, DOI 10.1007/s002210000522; Eimer M, 2000, CLIN NEUROPHYSIOL, V111, P694, DOI 10.1016/S1388-2457(99)00285-0; ELLIS AW, 1989, BRAIN, V112, P1469, DOI 10.1093/brain/112.6.1469; EVANS JJ, 1995, BRAIN, V118, P1, DOI 10.1093/brain/118.1.1; FREUDE G, 1988, INT J PSYCHOPHYSIOL, V6, P291, DOI 10.1016/0167-8760(88)90016-5; Fuchs M, 2002, CLIN NEUROPHYSIOL, V113, P702, DOI 10.1016/S1388-2457(02)00030-5; Gerloff C, 1998, BRAIN, V121, P1513, DOI 10.1093/brain/121.8.1513; GRABOW JD, 1974, J SPEECH HEAR RES, V17, P64, DOI 10.1044/jshr.1701.64; GRATTON G, 1983, ELECTROEN CLIN NEURO, V55, P468, DOI 10.1016/0013-4694(83)90135-9; GROZINGER B, 1975, NEUROPSYCHOLOGIA, V13, P263, DOI 10.1016/0028-3932(75)90002-0; GROZINGER B, 1977, LANGUAGE HEMISPHERIC, P87; Henson RNA, 2003, HIPPOCAMPUS, V13, P301, DOI 10.1002/hipo.10117; Henson RNA, 2003, NEUROPSYCHOLOGIA, V41, P263, DOI 10.1016/S0028-3932(02)00159-8; Holmes AP, 1996, J CEREBR BLOOD F MET, V16, P7, DOI 10.1097/00004647-199601000-00002; Huddy V, 2003, COGNITIVE BRAIN RES, V17, P314, DOI 10.1016/S0926-6410(03)00131-9; Indefrey P, 2004, COGNITION, V92, P101, DOI 10.1016/j.cognition.2002.06.001; Jahanshahi M., 2003, BEREITSCHAFTSPOTENTI, P1, DOI DOI 10.1007/978-1-4615-0189-3; Kemeny S, 2006, CEREB CORTEX, V16, P587, DOI 10.1093/cercor/bhj006; KORNHUBE.HH, 1965, PFLUG ARCH GES PHYS, V284, P1, DOI 10.1007/BF00412364; LEVY RS, 1977, STUDIES NEUROLINGUIS, P287; LIBET B, 1983, BRAIN, V106, P623, DOI 10.1093/brain/106.3.623; Maril A, 2005, NEUROIMAGE, V24, P1130, DOI 10.1016/j.neuroimage.2004.10.024; Maril A, 2001, NEURON, V31, P653, DOI 10.1016/S0896-6273(01)00396-8; Mazziotta J, 2001, PHILOS T R SOC B, V356, P1293, DOI 10.1098/rstb.2001.0915; MCADAM DW, 1971, SCIENCE, V172, P499, DOI 10.1126/science.172.3982.499; MCCALLUM WC, 1993, NATO ADV SCI INST SE, V254, P1; Milivojevic B, 2003, PSYCHOPHYSIOLOGY, V40, P967, DOI 10.1111/1469-8986.00115; Mulert C, 2001, NEUROIMAGE, V13, P589, DOI 10.1006/nimg.2000.0727; Pascual-Marqui RD, 2002, METHOD FIND EXP CLIN, V24, P5; Pfutze EM, 2002, PSYCHOL AGING, V17, P140, DOI 10.1037//0882-7974.17.1.140; PRAAMSTRA P, 1995, EXP BRAIN RES, V103, P429; Praamstra P, 1996, J NEUROL SCI, V140, P67, DOI 10.1016/0022-510X(96)00076-7; Proverbio AM, 2001, NEUROPSYCHOLOGIA, V39, P815, DOI 10.1016/S0028-3932(01)00003-3; Rahman RA, 2002, J EXP PSYCHOL LEARN, V28, P366, DOI 10.1037//0278-7393.28.2.366; REKTOR I, 2003, BEREITSCHAFTSPOTENTI, P61; Schweinberger SR, 2002, COGNITIVE BRAIN RES, V14, P398, DOI 10.1016/S0926-6410(02)00142-8; Seidenberg M, 2002, NEUROPSYCHOLOGIA, V40, P446, DOI 10.1016/S0028-3932(01)00096-3; Semenza C, 1995, NEUROCASE, V1, P183, DOI 10.1080/13554799508402362; SHIBASAKI H, 1980, ELECTROEN CLIN NEURO, V49, P213, DOI 10.1016/0013-4694(80)90216-3; Shibasaki H, 2006, CLIN NEUROPHYSIOL, V117, P2341, DOI 10.1016/j.clinph.2006.04.025; Talairach J., 1988, COPLANAR STEREOTAXIC; TARKKA IM, 1990, ELECTROEN CLIN NEURO, V75, P36, DOI 10.1016/0013-4694(90)90150-I; Tarkka IM, 2001, NEUROSCI LETT, V298, P203, DOI 10.1016/S0304-3940(00)01764-X; Tremblay P, 2008, CLIN NEUROPHYSIOL, V119, P88, DOI 10.1016/j.clinph.2007.09.063; Tsukiura T, 2002, J COGNITIVE NEUROSCI, V14, P922, DOI 10.1162/089892902760191144; TULVING E, 1994, P NATL ACAD SCI USA, V91, P2016, DOI 10.1073/pnas.91.6.2016; Valentine Tim., 1996, COGNITIVE PSYCHOL PR; Wiese H, 2004, CLIN NEUROPHYSIOL, V115, P2677, DOI 10.1016/j.clinph.2004.06.015; Wiese H, 2004, CLIN NEUROPHYSIOL, V115, P289, DOI 10.1016/S1388-2457(03)00348-1; WOHLERT AB, 1991, J SPEECH HEAR RES, V34, P1387, DOI 10.1044/jshr.3406.1387; WOHLERT AB, 1993, J SPEECH HEAR RES, V36, P897, DOI 10.1044/jshr.3605.897; YARMEY AD, 1973, MEM COGNITION, V1, P287, DOI 10.3758/BF03198110	66	8	9	0	4	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0167-8760	1872-7697		INT J PSYCHOPHYSIOL	Int. J. Psychophysiol.	JUN	2009	72	3					235	245		10.1016/j.ijpsycho.2008.12.012			11	Psychology, Biological; Neurosciences; Physiology; Psychology; Psychology, Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology; Physiology	454WD	WOS:000266713400001	19162095				2022-02-06	
J	Tauber, SC; Bunkowski, S; Ebert, S; Schulz, D; Kellert, B; Nau, R; Gerber, J				Tauber, Simone C.; Bunkowski, Stephanie; Ebert, Sandra; Schulz, Daniela; Kellert, Benedikt; Nau, Roland; Gerber, Joachim			Enriched Environment Fails To Increase Meningitis-Induced Neurogenesis and Spatial Memory in a Mouse Model of Pneumococcal Meningitis	JOURNAL OF NEUROSCIENCE RESEARCH			English	Article						neurogenesis; dentate gyrus; Morris water maze; Streptococcus pneumoniae; bacterial meningitis	FOCAL CEREBRAL-ISCHEMIA; TRAUMATIC BRAIN-INJURY; ADULT-RAT HIPPOCAMPUS; AGE-RELATED DECLINE; DENTATE GYRUS; CELL-PROLIFERATION; ANTIDEPRESSANT TREATMENT; MICE; COMPLEXITY; INFLAMMATION	An increase in adult neurogenesis was observed after exposure to enriched environment (EE) and during reconvalescence from experimental pneumococcal meningitis. This study investigated neurogenesis and spatial learning performance 5 weeks after bacterial meningitis and exposure to EE. C57BL/6 mice were infected by intracerebral injection of Streptococcus pneumoniae and treated with ceftriaxone for 5 days. Forty-eight hours after infection, one group (n = 22) was exposed to EE and the other group (n = 23) housed under standard conditions. Another set of mice was kept under either enriched (n = 16) or standard (n = 15) conditions without bacterial meningitis. Five weeks later, the Morris water maze was performed, and neurogenesis was evaluated by means of immunohistochemistry. Mice housed in EE without prior bacterial infection displayed both increased neurogenesis and improved water maze performance in comparison with uninfected control animals. Bacterial meningitis stimulated neurogenesis in the granular cell layer of the dentate gyrus: with standard housing conditions, we observed a higher density of BrdU-immunolabeled and TUC-4-expressing cells 5 weeks after induction of bacterial meningitis than in the noninfected control group. EE did not further increase progenitor cell proliferation and neuronal differentiation in the subgranular cell layer of the dentate gyrus after bacterial meningitis in comparison with infected mice housed under standard conditions. Moreover, the Morris water maze showed no significant differences between survivors of meningitis exposed to EE and animals kept in standard housing. In summary, exposure to EE after pneumococcal meningitis did not further increase meningitis-induced neurogenesis or improve spatial learning. (C) 2009 Wiley-Liss, Inc.	[Gerber, Joachim] RWTH Univ Hosp, Dept Neurol, D-52074 Aachen, Germany; [Tauber, Simone C.; Bunkowski, Stephanie; Ebert, Sandra; Schulz, Daniela; Kellert, Benedikt; Nau, Roland] Univ Gottingen, Dept Neurol, D-3400 Gottingen, Germany		Gerber, J (corresponding author), RWTH Univ Hosp, Dept Neurol, Pauwelsstr 30, D-52074 Aachen, Germany.	jgerber@gwdg.de			Else Kroner-Fresenius-Stiftung [1161/06//A70/06]	Contract grant sponsor: Else Kroner-Fresenius-Stiftung; Contract grant number: 1161/06//A70/06.	Auvergne R, 2002, BRAIN RES, V954, P277, DOI 10.1016/S0006-8993(02)03355-3; Bonde S, 2006, EUR J NEUROSCI, V23, P965, DOI 10.1111/j.1460-9568.2006.04635.x; Butovsky O, 2006, MOL CELL NEUROSCI, V31, P149, DOI 10.1016/j.mcn.2005.10.006; Cameron HA, 1999, NAT NEUROSCI, V2, P894, DOI 10.1038/13197; Czeh B, 2001, P NATL ACAD SCI USA, V98, P12796, DOI 10.1073/pnas.211427898; Danilov AI, 2006, EUR J NEUROSCI, V23, P394, DOI 10.1111/j.1460-9568.2005.04563.x; Ekdahl CT, 2003, P NATL ACAD SCI USA, V100, P13632, DOI 10.1073/pnas.2234031100; FORDYCE DE, 1993, BRAIN RES, V619, P111, DOI 10.1016/0006-8993(93)91602-O; Gerber J, 2003, J NEUROSCI RES, V73, P441, DOI 10.1002/jnr.10682; GREENOUGH WT, 1973, EXP NEUROL, V41, P371, DOI 10.1016/0014-4886(73)90278-1; GREENOUGH WT, 1973, EXP NEUROL, V40, P491, DOI 10.1016/0014-4886(73)90090-3; Hamm RJ, 1996, J NEUROTRAUM, V13, P41, DOI 10.1089/neu.1996.13.41; Hattiangady B, 2004, NEUROBIOL DIS, V17, P473, DOI 10.1016/j.nbd.2004.08.008; Hoffmann O, 2007, INFECT IMMUN, V75, P4289, DOI 10.1128/IAI.01679-06; Johansson BB, 1996, STROKE, V27, P324, DOI 10.1161/01.STR.27.2.324; Kempermann G, 1997, NATURE, V386, P493, DOI 10.1038/386493a0; Kempermann G, 1998, CURR BIOL, V8, P939, DOI 10.1016/S0960-9822(07)00377-6; Kronenberg G, 2006, NEUROBIOL AGING, V27, P1505, DOI 10.1016/j.neurobiolaging.2005.09.016; Kuhn HG, 1996, J NEUROSCI, V16, P2027; Lazarov O, 2005, CELL, V120, P701, DOI 10.1016/j.cell.2005.01.015; Liu JL, 1998, J NEUROSCI, V18, P7768; Malberg JE, 2000, J NEUROSCI, V20, P9104, DOI 10.1523/jneurosci.20-24-09104.2000; Matsumori Y, 2006, NEUROBIOL DIS, V22, P187, DOI 10.1016/j.nbd.2005.10.015; Meshi D, 2006, NAT NEUROSCI, V9, P729, DOI 10.1038/nn1696; Montaron MF, 2006, NEUROBIOL AGING, V27, P645, DOI 10.1016/j.neurobiolaging.2005.02.014; OHLSSON AL, 1995, STROKE, V26, P644, DOI 10.1161/01.STR.26.4.644; ROSENZWEIG MR, 1962, J COMP PHYSIOL PSYCH, V55, P429, DOI 10.1037/h0041137; SELDEN JR, 1993, CYTOMETRY, V14, P154, DOI 10.1002/cyto.990140207; Tauber SC, 2005, J NEUROPATH EXP NEUR, V64, P806, DOI 10.1097/01.jnen.0000178853.21799.88; Tureyen K, 2004, J NEUROSURG, V101, P799, DOI 10.3171/jns.2004.101.5.0799; Urrea C, 2007, RESTOR NEUROL NEUROS, V25, P65; van Dellen A, 2000, NATURE, V404, P721, DOI 10.1038/35008142; van Praag H, 1999, NAT NEUROSCI, V2, P266, DOI 10.1038/6368; WASEEM NH, 1990, J CELL SCI, V96, P121; Wellmer A, 2000, NEUROSCI LETT, V296, P137, DOI 10.1016/S0304-3940(00)01645-1; Wu CW, 2007, J NEUROCHEM, V103, P2471, DOI 10.1111/j.1471-4159.2007.04987.x; Ziv Y, 2006, NAT NEUROSCI, V9, P268, DOI 10.1038/nn1629	37	8	8	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0360-4012	1097-4547		J NEUROSCI RES	J. Neurosci. Res.	JUN	2009	87	8					1877	1883		10.1002/jnr.22010			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	437CD	WOS:000265462800015	19170185				2022-02-06	
J	Katayama, T; Ito, M; Kaneko, S; Satoh, M; Uehara, T; Minami, M				Katayama, Takahiro; Ito, Misato; Kaneko, Shuji; Satoh, Masamichi; Uehara, Takashi; Minami, Masabumi			Reciprocal Regulation of ATP gamma S-induced Monocyte Chemoattractant Protein-1 Production by ERK and p38 MAP Kinases in Rat Corticostriatal Slice Cultures	JOURNAL OF NEUROSCIENCE RESEARCH			English	Article						astrocyte; ATP; chemokine; MCP-1; organotypic slice culture	MULTIPLE-SCLEROSIS LESIONS; CENTRAL-NERVOUS-SYSTEM; EXTRACELLULAR ATP; ISCHEMIC BRAIN; MESSENGER-RNA; GROWTH-FACTOR; EXPRESSION; ASTROCYTES; CHEMOKINES; RECEPTORS	Monocyte chemoattractant protein-1 (MCP-1, CCL2) is a well-defined chemokine implicated in the pathology of various neurodegenerative diseases and brain injuries, such as Alzheimer's disease, multiple sclerosis, stroke, and traumatic injury. We investigated the effect of the activation of P2 purinoceptors on MCP-1 production in rat corticostriatal slice cultures. Treatment with adenosine 5'-O-(3-thiotriphosphate) (ATP gamma S), a hydrolysis-resistant adenosine triphosphate (ATP) analog, induced MCP-1 production in astrocytes. The induction was in a concentration-dependent manner and was antagonized by a P2 purinoceptor antagonist pyridoxal phosphate-6-azophenyl-2',4'-disulfonic acid. The inhibition of an extracellular signal-regulated kinase (ERK) pathway by PD98059 and U0126 significantly suppressed ATP gamma S-induced MCP-1 mRNA expression and protein production, while inhibition of c-Jun N-terminal kinase by SP600125 resulted in the partial suppression. Conversely, S13203580, a p38 mitogen-activated protein (MAP) kinase inhibitor, significantly enhanced ATP gamma S-induced MCP-1 production. Similar effects of ERK and p38 MAP kinase inhibitors on MCP-1 production were observed in the slices stimulated by ATP and BzATP. These results demonstrate that astrocytic MCP-1 production induced by P2 purinoceptor stimulation is reciprocally regulated by ERK and p38 MAP kinases in the organotypic slice cultures. (C) 2009 Wiley-Liss, Inc.	[Katayama, Takahiro; Uehara, Takashi; Minami, Masabumi] Hokkaido Univ, Dept Pharmacol, Grad Sch Pharmaceut Sci, Sapporo, Hokkaido 0600812, Japan; [Ito, Misato; Kaneko, Shuji] Kyoto Univ, Dept Mol Pharmacol, Grad Sch Pharmaceut Sci, Kyoto, Japan; [Satoh, Masamichi] Yasuda Womens Univ, Fac Pharm, Hiroshima, Japan		Minami, M (corresponding author), Hokkaido Univ, Dept Pharmacol, Grad Sch Pharmaceut Sci, Sapporo, Hokkaido 0600812, Japan.	mminami@pharm.hokudai.ac.jp	Minami, Masabumi/A-3883-2012; Kaneko, Shuji/AAR-1005-2021	Minami, Masabumi/0000-0002-0144-0679; Kaneko, Shuji/0000-0001-5152-5809; Uehara, Takashi/0000-0002-8545-4006			Burnstock G, 2006, PHARMACOL REV, V58, P58, DOI 10.1124/pr.58.1.5; Burnstock G, 2008, NAT REV DRUG DISCOV, V7, P575, DOI 10.1038/nrd2605; COCHRAN BH, 1983, CELL, V33, P939, DOI 10.1016/0092-8674(83)90037-5; Davalos D, 2005, NAT NEUROSCI, V8, P752, DOI 10.1038/nn1472; de Haas AH, 2007, MOL NEUROBIOL, V36, P137, DOI 10.1007/s12035-007-0036-8; DUBYAK GR, 1993, AM J PHYSIOL, V265, pC577, DOI 10.1152/ajpcell.1993.265.3.C577; Fields RD, 2006, NAT REV NEUROSCI, V7, P423, DOI 10.1038/nrn1928; Galasso JM, 2000, EXP NEUROL, V165, P295, DOI 10.1006/exnr.2000.7466; Gendaszewska-Darmach E, 2003, ACTA BIOCHIM POL, V50, P973; Gerard C, 2001, NAT IMMUNOL, V2, P108, DOI 10.1038/84209; Glabinski AR, 1996, J IMMUNOL, V156, P4363; Hide I, 2000, J NEUROCHEM, V75, P965, DOI 10.1046/j.1471-4159.2000.0750965.x; Katayama T, 2002, NEUROSCI LETT, V328, P277, DOI 10.1016/S0304-3940(02)00550-5; Kawamura M, 2004, J NEUROSCI, V24, P10835, DOI 10.1523/JNEUROSCI.3028-04.2004; KIM JS, 1995, J NEUROIMMUNOL, V56, P127, DOI 10.1016/0165-5728(94)00138-E; Lutz PL, 1997, BRAIN RES, V769, P281, DOI 10.1016/S0006-8993(97)00719-1; McManus C, 1998, J NEUROIMMUNOL, V86, P20, DOI 10.1016/S0165-5728(98)00002-2; Mennicken F, 1999, TRENDS PHARMACOL SCI, V20, P73, DOI 10.1016/S0165-6147(99)01308-5; Minami M, 2003, LIFE SCI, V74, P321, DOI 10.1016/j.lfs.2003.09.019; MINAMI M, 1991, BIOCHEM BIOPH RES CO, V176, P593, DOI 10.1016/S0006-291X(05)80225-6; Neary JT, 2004, NEUROCHEM RES, V29, P2037, DOI 10.1007/s11064-004-6876-y; Panenka W, 2001, J NEUROSCI, V21, P7135, DOI 10.1523/JNEUROSCI.21-18-07135.2001; ROLLINS BJ, 1988, P NATL ACAD SCI USA, V85, P3738, DOI 10.1073/pnas.85.11.3738; Shigemoto-Mogami Y, 2001, J NEUROCHEM, V78, P1339, DOI 10.1046/j.1471-4159.2001.00514.x; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; Van der Voorn P, 1999, AM J PATHOL, V154, P45, DOI 10.1016/S0002-9440(10)65249-2; White FA, 2005, NAT REV DRUG DISCOV, V4, P834, DOI 10.1038/nrd1852; Yamagami S, 1999, J LEUKOCYTE BIOL, V65, P744, DOI 10.1002/jlb.65.6.744; Yamakuni H, 2002, J NEUROIMMUNOL, V129, P43, DOI 10.1016/S0165-5728(02)00179-0	29	8	9	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0360-4012	1097-4547		J NEUROSCI RES	J. Neurosci. Res.	MAY 15	2009	87	7					1573	1581		10.1002/jnr.21982			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	434ZF	WOS:000265312100007	19125410				2022-02-06	
J	Ordia, JI				Ordia, Joe I.			Brain impalement by an angle metal bar	CLINICAL NEUROLOGY AND NEUROSURGERY			English	Article						Brain impalement; Craniocerebral trauma; Penetrating brain injury; Traumatic brain injury; Post-traumatic epilepsy	CROWBAR IMPALEMENT; MICTURITION; INJURY; HEAD; RECOVERY; STEM	The author reports the case of a 37-year-old right-handed man who was impaled in the head by an angle metal bar at a construction work site. Impalement injuries of the brain are rare, and their management is complex. The surgical treatment of the injury and the medical management of complications are described in detail. The patient made a good recovery although he has functional deficits related to the injury to his frontal lobes. (C) 2008 Elsevier B.V. All rights reserved.	[Ordia, Joe I.] Pain & Wellness Ctr, Peabody, MA 01960 USA; [Ordia, Joe I.] Boston Univ, Sch Med, Boston Med Ctr, Boston, MA 02118 USA; [Ordia, Joe I.] Boston Univ, Sch Med, Dept Neurosurg, Boston, MA 02118 USA		Ordia, JI (corresponding author), Pain & Wellness Ctr, 10 Centennial Dr, Peabody, MA 02467 USA.	jordia@post.harvard.edu					Barrington FJF, 1921, BRAIN, V44, P23, DOI 10.1093/brain/44.1.23; BIGELOW HJ, 1850, AM J MED SCI, V20, P13; Blok BFM, 1997, BRAIN, V120, P111, DOI 10.1093/brain/120.1.111; Buzelin J M, 1995, Rev Prat, V45, P286; Cazalis F, 2006, BRAIN INJURY, V20, P1019, DOI 10.1080/02699050600664384; CUMMINGS JL, 1993, ARCH NEUROL-CHICAGO, V50, P873, DOI 10.1001/archneur.1993.00540080076020; Cushing H, 1918, Br Med J, V1, P221; Doughty K, 2005, J TRAUMA, V58, P1290, DOI 10.1097/01.TA.0000082494.34381.D9; Fukuyama H, 1996, NEUROREPORT, V7, P3009, DOI 10.1097/00001756-199611250-00042; GRIFFITHS D, 1990, NEUROUROL URODYNAM, V9, P63, DOI 10.1002/nau.1930090108; HARLOW JM, 1869, PASSAGE IRON ROD HEA; HOROWITZ MD, 1985, J TRAUMA, V25, P914, DOI 10.1097/00005373-198509000-00017; Imre Szirmai, 2004, Ideggyogy Sz, V57, P292; JACOBS LM, 1985, J TRAUMA, V25, P359, DOI 10.1097/00005373-198504000-00016; KURU M, 1964, J COMP NEUROL, V123, P161, DOI 10.1002/cne.901230203; Lauterbach A, 2006, INT J LEGAL MED, V120, P380, DOI 10.1007/s00414-006-0097-7; NEMETH G, 1988, EUR ARCH PSY CLIN N, V237, P218, DOI 10.1007/BF00449910; Nozawa H, 2005, MED SCI LAW, V45, P176, DOI 10.1258/rsmmsl.45.2.176; OKUMORI M, 1981, J TRAUMA, V21, P240, DOI 10.1097/00005373-198103000-00008; ORDIA JI, 1989, SURG NEUROL, V32, P152, DOI 10.1016/0090-3019(89)90204-8; STONE JL, 1981, SURG NEUROL, V15, P369, DOI 10.1016/0090-3019(81)90173-7	21	8	9	0	5	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0303-8467	1872-6968		CLIN NEUROL NEUROSUR	Clin. Neurol. Neurosurg.	MAY	2009	111	4					368	372		10.1016/j.clineuro.2008.10.016			5	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	440SE	WOS:000265719200012	19091457				2022-02-06	
J	Finlay-Morreale, HE; Tsuei, BJ; Fisher, BS; Davis, K; Johannigman, JA				Finlay-Morreale, Heather E.; Tsuei, Betty J.; Fisher, Bonnie S.; Davis, Kenneth; Johannigman, Jay A.			Close Is Dead: Determinants of Firearm Injury Lethality in Women	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article						Intimate partner violence; Firearm; Homicide; Female	INTIMATE PARTNER VIOLENCE; DOMESTIC VIOLENCE; EMERGENCY-DEPARTMENT; HOMICIDE; TRAUMA; OFFENDERS; VICTIMS; POLICY	Background: Accurate data regarding intimate partner violence is difficult to obtain, particularly when examining only homicides or trauma registries. This study characterizes firearm violence against women by examining data from both the county coroner and an urban level I trauma center. Methods: The Trauma Registry and Coroners database were reviewed for female victims of firearm assault from 1998 to 2006. Data collected included age, race, location of assault (home, public, unknown), mortality, and injuries. Assailants were categorized as intimate partners (IP), acquaintances, strangers, or undetermined. Adjusted odds ratios for effects of assailant and location were calculated using logistic regression analysis, with statistical significance at alpha = 0.05. Results: Of 115 victims identified, 51 (44%) were fatally injured. Forty-two (37%) of assailants were IP. Fatalities occurred in 71% of IP, 50% of acquaintance, and 20% of stranger assaults. Firearm assault by IP was 10 times more lethal than injury by stranger (p < 0.0005). Assaults at home occurred 54% of the time and had 60% mortality. Assault at home was 3.8 times more lethal than assault in public (p < 0.002). Seventy-nine percent of IP assaults, 63% of acquaintance assaults, and 29% of stranger assaults occurred in the home. In 99 victims with documented injuries, head injuries were found in 68% of IP assaults, compared with 33% and 16% of acquaintance and stranger assaults. Conclusion: IP firearm assaults against women may be underrepresented in current databases. These assaults are highly lethal, frequently occur at home, and often involve head injury. These observations may lend to strategies for trauma prevention.	[Tsuei, Betty J.; Davis, Kenneth; Johannigman, Jay A.] Univ Cincinnati, Coll Med, Dept Surg, Cincinnati, OH USA; [Fisher, Bonnie S.] Univ Cincinnati, Coll Educ, Cincinnati, OH 45221 USA; [Fisher, Bonnie S.] Univ Cincinnati, Human Serv, Cincinnati, OH 45221 USA		Finlay-Morreale, HE (corresponding author), Cincinnati Coll Med, Deans Off Student Affairs, Student Mail,231 Albert Sabin Way, Cincinnati, OH 45267 USA.	finlayhe@email.uc.edu		Finlay-Morreale, Heather/0000-0002-1541-3268	University of Cincinnati Medical Student Summer Research Program (NIDDK)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) [DK060444-06]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) [T35DK060444] Funding Source: NIH RePORTER	This work was supported in part by a grant from the University of Cincinnati Medical Student Summer Research Program (NIDDK grant DK060444-06).	Arbuckle J, 1996, ANN EMERG MED, V27, P210, DOI 10.1016/S0196-0644(96)70325-6; Beaman V, 2000, ANN EMERG MED, V35, P258, DOI 10.1016/S0196-0644(00)70077-1; Campbell JC, 2007, TRAUMA VIOLENCE ABUS, V8, P246, DOI 10.1177/1524838007303505; Campbell JC, 2003, AM J PUBLIC HEALTH, V93, P1089, DOI 10.2105/AJPH.93.7.1089; Coker AL, 2002, AM J PREV MED, V23, P260, DOI 10.1016/S0749-3797(02)00514-7; DICK G, 2006, HAMILTON COUNTY VIOL; Efron DT, 2006, ARCH SURG-CHICAGO, V141, P800, DOI 10.1001/archsurg.141.8.800; Fanslow JL, 1998, ANN EMERG MED, V32, P341, DOI 10.1016/S0196-0644(98)70011-3; Feldhaus KM, 1997, JAMA-J AM MED ASSOC, V277, P1357, DOI 10.1001/jama.277.17.1357; Fox J.A., 2007, HOMICIDE TRENDS US; Grisso JA, 1999, NEW ENGL J MED, V341, P1899, DOI 10.1056/NEJM199912163412506; Halpern LR, 2006, J TRAUMA, V60, P1101, DOI 10.1097/01.ta.0000218247.58465.db; MacMillan HL, 2006, JAMA-J AM MED ASSOC, V296, P530, DOI 10.1001/jama.296.5.530; Melnick DM, 2002, J TRAUMA, V53, P33, DOI 10.1097/00005373-200207000-00007; Moracco KE, 2007, WOMEN HEALTH ISS, V17, P3, DOI 10.1016/j.whi.2006.03.007; Moskowitz H, 2005, ARCH PEDIAT ADOL MED, V159, P356, DOI 10.1001/archpedi.159.4.356; Nicolaidis C, 2003, J GEN INTERN MED, V18, P788, DOI 10.1046/j.1525-1497.2003.21202.x; Paul BC, 1998, ENVIRON MONIT ASSESS, V50, P1, DOI 10.1023/A:1005751605393; Plichta SB, 2007, TRAUMA VIOLENCE ABUS, V8, P226, DOI 10.1177/1524838007301220; Rennison Callie Marie, 2000, 178247 NCJ US DEP JU; Tjaden P., 2000, 183781 NCJ US DEP JU, V183781; Vigdor ER, 2006, EVALUATION REV, V30, P313, DOI 10.1177/0193841X06287307; Wadman MC, 1999, AM J EMERG MED, V17, P689, DOI 10.1016/S0735-6757(99)90161-4; Weinsheimer RL, 2005, J TRAUMA, V58, P22, DOI 10.1097/01.TA.0000151180.77168.A6; Wiebe DJ, 2003, ANN EMERG MED, V42, P405, DOI 10.1016/S0196-0644(03)00509-2	25	8	8	0	8	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0022-5282	1529-8809		J TRAUMA	J. Trauma-Injury Infect. Crit. Care	APR	2009	66	4					1207	1211		10.1097/TA.0b013e31819a05da			5	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Surgery	431KI	WOS:000265059800046	19359939				2022-02-06	
J	Hadjizacharia, P; Plurad, DS; Green, DJ; DuBose, J; Benfield, R; Shiflett, A; Inaba, K; Chan, LS; Demetriades, D				Hadjizacharia, Pantelis; Plurad, David S.; Green, Donald J.; DuBose, Joseph; Benfield, Rodd; Shiflett, Anthony; Inaba, Kenji; Chan, Linda S.; Demetriades, Demetrios			Outcomes of Blunt Assault at a Level I Trauma Center	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article						Assault; Blunt injury; Cervical spine; Mortality; Traumatic brain injury	CERVICAL-SPINE; INJURY; SEVERITY; VICTIMS	Background: Physical assault is common in trauma patients. Penetrating injuries resulting from interpersonal violence have been well described in literature, but there have been few studies examining the injury patterns due to assaults with hands and feet or blunt instruments. Methods: The Trauma Registry of an American College of Surgeons Level I center was queried for all patients with an E-code diagnosis of assault by hands and feet or blunt instrument for the period of January 1, 1992 to September 30, 2005. Demographic and injury pattern data were analyzed. Univariate and multivariable analysis was performed to identify independent predictors of mortality. Results: There were 3,286 patients identified (89.7% male) with a mean age of 36 years +/- 13 years and mean injury severity score of 8 +/- 7. Overall, 65 (2.0%) patients required laparotomy, 1.0 (0.3%) required craniectomy, and 1 (0.03%) patient required thoracotomy. Traumatic brain injury was present in 66.5% (2,184). Mortality was 2.4% (80). Patients older than 55 years were more likely to be severely injured (injury severity score >= 16) (23.4% vs. 14.6%, p < 0.001) and were more likely to die of injuries (4.8% vs. 2.1%, p < 0.05). Nineteen (0.6%) patients had documented fractures of the cervical spine and cervical spinal cord injury was not observed in any patient. Conclusions: Injuries due to assault rarely require operative intervention and have a low risk of cervical spine or cord injuries. However, many result in traumatic brain injury. Patients older than 55 years tend to be more severely injured and at higher risk of mortality.	[Hadjizacharia, Pantelis; Plurad, David S.; Green, Donald J.; DuBose, Joseph; Benfield, Rodd; Shiflett, Anthony; Inaba, Kenji; Chan, Linda S.; Demetriades, Demetrios] LAC USC Med Ctr, Div Trauma Surg Crit Care, Dept Surg, Los Angeles, CA 90033 USA		Plurad, DS (corresponding author), LAC USC Med Ctr, Div Trauma Surg Crit Care, Dept Surg, 1200 N State St,Room, Los Angeles, CA 90033 USA.	plurad@usc.edu	INABA, KENJI/AAC-8532-2020				American College of Surgeons, 1997, ADV TRAUM LIF SUPP; Brennan IR, 2006, INJURY PREV, V12, P395, DOI 10.1136/ip.2006.011858; Demetriades D, 1998, J AM COLL SURGEONS, V187, P373, DOI 10.1016/S1072-7515(98)00209-9; Demetriades D, 2001, J TRAUMA, V51, P754, DOI 10.1097/00005373-200110000-00022; GROLEAU GA, 1993, J TRAUMA, V34, P366, DOI 10.1097/00005373-199303000-00010; Muehlbauer M, 2006, J PSYCHOSOC NURS, V44, P43, DOI 10.3928/02793695-20061101-07; Mulholland MW, 2006, GREENFIELDS SURG SCI; Patton JH, 2000, AM SURGEON, V66, P326; Rhee P, 2006, J TRAUMA, V61, P1166, DOI 10.1097/01.ta.0000188163.52226.97; SHEPHERD JP, 1990, J ROY SOC MED, V83, P75, DOI 10.1177/014107689008300206; *US DEP HHS, 1989, HEAD INJ TASK FORC R; Watts DD, 2003, J TRAUMA, V54, P289, DOI 10.1097/01.TA.0000046261.06976.6A; Wieland D, 2000, Holist Nurs Pract, V14, P40	13	8	8	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0022-5282	1529-8809		J TRAUMA	J. Trauma-Injury Infect. Crit. Care	APR	2009	66	4					1202	1206		10.1097/TA.0b013e318180f5a0			5	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	431KI	WOS:000265059800045	19359938				2022-02-06	
J	Nahed, BV; Ferreira, M; Naunheim, MR; Kahle, KT; Proctor, MR; Smith, ER				Nahed, Brian V.; Ferreira, Manuel, Jr.; Naunheim, Matthew R.; Kahle, Kristopher T.; Proctor, Mark R.; Smith, Edward R.			Intracranial vasospasm with subsequent stroke after traumatic subarachnoid hemorrhage in a 22-month-old child Case report	JOURNAL OF NEUROSURGERY-PEDIATRICS			English	Article						angiogram; stroke; subarachnoid hemorrhage; traumatic brain injury; vasospasm	CEREBRAL VASOSPASM; BRAIN-INJURY; ANEURYSMS; PREVENTION; HYPERVOLEMIA; HYPERTENSION; ADOLESCENTS; TOMOGRAPHY; THERAPY; PATIENT	Clinical and radiographic evidence of subarachnoid hemorrhage (SAH)-related vasospasm is rare in children and has not been reported in infants. In this report the authors present the case of a 22-month-old child who developed clinically symptomatic, radiographically identifiable vasospasm after traumatic SAH. To the authors' knowledge, this is the first report of vasospasm associated with SAH in a child this young. This 22-month-old boy fell and had a dense SAH. He had a history of surgically corrected craniosynostosis and nonsymptomatic ventriculomegaly. The boy was evaluated for occult vascular lesions using imaging; none were found and normal vessel caliber was noted. Ten days later, the child developed left-sided weakness and a right middle cerebral artery infarct was identified. Evaluation disclosed significant intracranial vasospasm. This diagnosis was supported by findings on CT angiography, transcranial Doppler ultrasonography, MR imaging, and conventional angiography. The child was treated using intraarterial verapamil with a good result, as well as with conventional intensive care measures to reduce vasospasm. This report documents the first known case of intracranial vasospasm with stroke after SAH in a patient under the age of 2 years. This finding is important because it demonstrates that the entity of SAH-associated vasospasni can affect the very young, widening the spectrum of ages susceptible to this condition. This case is also important because it demonstrates that even very young children can respond to conventional therapeutic interventions such as intraarterial verapamil. Thus,, clinicians need to be alert to the possibility of vasospasm as a potential diagnosis when evaluating Young children with SAH. (DOI: 10.3171/2008.12.PEDS08206)	[Ferreira, Manuel, Jr.; Proctor, Mark R.; Smith, Edward R.] Harvard Univ, Sch Med, Childrens Hosp, Dept Neurosurg, Boston, MA 02115 USA; [Nahed, Brian V.; Ferreira, Manuel, Jr.; Naunheim, Matthew R.; Kahle, Kristopher T.] Massachusetts Gen Hosp, Dept Neurosurg, Boston, MA 02114 USA		Smith, ER (corresponding author), Harvard Univ, Sch Med, Childrens Hosp, Dept Neurosurg, 300 Longwood Ave, Boston, MA 02115 USA.	edward.smith@childrens.harvard.edu	; Nahed, Brian/E-4239-2014	Naunheim, Matthew/0000-0002-3927-3984; Nahed, Brian/0000-0001-8537-106X			Albright AL, 1999, PRINCIPLES PRACTICE; Anderson RC, 2002, PEDIATR NEUROSURG, V37, P258, DOI 10.1159/000066218; Aryan HE, 2006, J CLIN NEUROSCI, V13, P188, DOI 10.1016/j.jocn.2005.07.006; Borel CO, 2003, STROKE, V34, P427, DOI 10.1161/01.STR.0000053848.06436.AB; Danchaivijitr N, 2006, DEV MED CHILD NEUROL, V48, P139, DOI 10.1017/S0012162206000302; Getzoff M, 1999, Pediatr Rev, V20, P422; HOURIHAN MD, 1984, J NEUROSURG, V60, P1163, DOI 10.3171/jns.1984.60.6.1163; Keyrouz SG, 2007, CRIT CARE, V11, DOI 10.1186/cc5958; Koebbe CJ, 2006, NEUROSURGERY, V59, P93; Komotar RJ, 2007, J NEUROL SCI, V261, P134, DOI 10.1016/j.jns.2007.04.046; KRAUS JF, 1986, AM J DIS CHILD, V140, P687, DOI 10.1001/archpedi.1986.02140210085032; Langlois JA, 2005, J HEAD TRAUMA REHAB, V20, P229, DOI 10.1097/00001199-200505000-00006; Linn FHH, 1996, STROKE, V27, P625, DOI 10.1161/01.STR.27.4.625; Mandera M, 2002, CHILD NERV SYST, V18, P124, DOI 10.1007/s00381-002-0572-5; Mattioli C, 2003, J NEUROSURG, V98, P37, DOI 10.3171/jns.2003.98.1.0037; Miller CA, 2006, NEUROCRIT CARE, V5, P215, DOI 10.1385/NCC:5:3:215; Muench E, 2007, CRIT CARE MED, V35, P1844, DOI 10.1097/01.CCM.0000275392.08410.DD; OSTERGAARD JR, 1983, J NEUROSURG, V58, P832, DOI 10.3171/jns.1983.58.6.0832; PASQUALIN A, 1986, CHILD NERV SYST, V2, P185, DOI 10.1007/BF00706808; PATEL AN, 1971, J NEUROSURG, V35, P571, DOI 10.3171/jns.1971.35.5.0571; Rothoerl RD, 2007, NEUROL RES, V29, P636, DOI 10.1179/016164107X240224; Sert A, 2005, PEDIATR NEUROL, V32, P275, DOI 10.1016/j.pediatrneurol.2004.09.011; Treggiari MM, 2003, J NEUROSURG, V98, P978, DOI 10.3171/jns.2003.98.5.0978; Weyer George W, 2006, Neurosurg Focus, V21, pE8, DOI 10.3171/foc.2006.21.3.8	24	8	10	0	0	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1933-0707	1933-0715		J NEUROSURG-PEDIATR	J. Neurosurg.-Pediatr.	APR	2009	3	4					311	315		10.3171/2008.12.PEDS08206			5	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	424UT	WOS:000264594500013	19338410				2022-02-06	
J	Degeneffe, CE				Degeneffe, Charles			The Rehabilitation Needs of Adult Siblings of Persons With Traumatic Brain Injury: A Quantitative Investigation	AUSTRALIAN JOURNAL OF REHABILITATION COUNSELLING			English	Article						siblings; traumatic brain injury; family; caregiving; coping; social support		This study examined the post-injury rehabilitation needs of 158 adult siblings of persons with traumatic brain injury (TBI) in the United States. The mean age of participants was 37.0 years (SD = 10.0 years), and their ages ranged from 19 to 72 years. A total of 120 (75.9%) of the participants were female. Participants completed the Family Needs Questionnaire (FNQ) (Kreutzer, 1988), which measures the unique needs of families following TBI. The FNQ counts the types of needs rated as important and the frequency in which those needs have been met. Data were analysed via hierarchical multiple regression analysis with the number of met needs set as the outcome variable. A total of 15 predictor variables assessed direct and indirect markers of caregiving related stresses corresponding to position in the Pearlin stress process model. Participants indicated that health information was the most important need while needs for involvement with care were the most often met. Results also indicated that participant feelings of more restrictions in valued family activities and perceptions of greater cognitive-behavioural impairments with their injured siblings were associated with lower number of met rehabilitation needs. Participants reported that the use of effective coping behaviours and access to social support were associated with higher numbers of met rehabilitation needs. Findings suggest adult siblings share similar needs to parents and spouses (i.e., the most common primary caregivers) and require professional attention and support following TBI.	[Degeneffe, Charles] San Diego State Univ, San Diego, CA 92182 USA		Degeneffe, CE (corresponding author), San Diego State Univ, Interwork Inst, Dept Adm Rehabil & Postsecondary Educ, Rehabil Counseling Program, 3590 Camino Rio North, San Diego, CA 92108 USA.	cdegenef@mail.sdsu.edu			Waisman Center at the University of Wisconsin-Madison	This study is based on a doctoral dissertation conducted under the supervision of Ruth Torkelson Lynch at the University of Wisconsin-Madison. This study was financially supported by the Merck Scholars II Program offered by the Waisman Center at the University of Wisconsin-Madison.	ALLEN K, 1994, REHABIL PSYCHOL, V39, P29, DOI 10.1037/0090-5550.39.1.29; Bishop M, 2006, AUST J REHABIL COUNS, V12, P73, DOI 10.1375/jrc.12.2.73; Brain Injury Association of America, 2006, FACTS TRAUM BRAIN IN; Burke HS, 2009, J REHABIL, V75, P5; Cunningham J. M., 2005, HLTH CARE DISABILITY, P475; Cutrona C, 1987, ADV PERSONAL RELATIO, V1, P33; Degeneffe C.E., 2008, J APPL REHABIL COUS, V39, P42; Degeneffe CE, 2006, REHABIL COUNS BULL, V49, P130, DOI 10.1177/00343552060490030101; Degeneffe CE, 2001, HEALTH SOC WORK, V26, P257, DOI 10.1093/hsw/26.4.257; Degeneffe CE, 2008, J REHABIL, V74, P10; Degeneffe CE, 2008, REHABIL COUNS BULL, V51, P240, DOI 10.1177/0034355207311319; Elliott TR, 1999, REHABIL PSYCHOL, V44, P104, DOI 10.1037/0090-5550.44.1.104; Gan C, 2002, BRAIN INJURY, V16, P311, DOI 10.1080/02699050110104426; Gill D. J., 2000, REHABILITATION NURSI, V25, P48, DOI [10.1002/j.2048-7940.2000.tb01862.x, DOI 10.1002/J.2048-7940.2000.TB01862.X]; Gray J.M, 1994, CLIN REHABIL, V8, P188, DOI [10.1177/026921559400800302, DOI 10.1177/026921559400800302, DOI 10.1080/09602010902949207]; GRIFFITHS DL, 1994, FAM RELAT, V43, P221, DOI 10.2307/585326; Harris JKJ, 2001, BRAIN INJURY, V15, P223; Hauser R. M., 2002, WISCONSIN LONGITUDIN; HOLROYD J, 1985, QUESTIONNAIRE RESOUR; Kolakowsky-Hayner SA, 2001, J HEAD TRAUMA REHAB, V16, P374, DOI 10.1097/00001199-200108000-00007; Kosciulek J. F, 1993, THESIS; KOSCIULEK JF, 1994, REHABIL PSYCHOL, V39, P215, DOI 10.1037/h0080325; Kreutzer J. S., 1988, FAMILY NEEDS QUESTIO; KREUTZER JS, 1992, ARCH PHYS MED REHAB, V73, P771; KREUTZER JS, 1994, J HEAD TRAUMA REHAB, V9, P104, DOI 10.1097/00001199-199409000-00009; MARASCUILO L. A., 1983, MULTIVARIATE STAT SO; National Institutes of Health, 1999, REP NIH CONS DEV C R; Orsillo SM, 1993, J HEAD TRAUMA REHAB, V8, DOI [10.1097/00001199-199303000-00010, DOI 10.1097/00001199-199303000-00010]; PEARLIN LI, 1989, J HEALTH SOC BEHAV, V30, P241, DOI 10.2307/2136956; PEARLIN LI, 1990, GERONTOLOGIST, V30, P583, DOI 10.1093/geront/30.5.583; Sander AM, 1997, BRAIN INJURY, V11, P235, DOI 10.1080/026990597123548; Seltzer M. M., 1996, AGING FAMILIES ADULT; Seltzer MM, 1997, FAM RELAT, V46, P395, DOI 10.2307/585099; SERIO CD, 1995, J HEAD TRAUMA REHAB, V10, P32, DOI 10.1097/00001199-199504000-00005; SPRIGGS VT, 1998, PROMOTING CULTURAL C, P149; Stebbins P, 1998, J REHABIL, V64, P15; Willer B, 1999, ARCH PHYS MED REHAB, V80, P399, DOI 10.1016/S0003-9993(99)90276-9; Witol AD, 1996, NEUROREHABILITATION, V7, P175, DOI 10.3233/NRE-1996-7303	38	8	8	0	0	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1323-8922	1838-6059		AUST J REHABIL COUNS	Aust. J. Rehabil. Couns.	MAR	2009	15	1					12	27		10.1375/jrc.15.1.12			16	Rehabilitation	Emerging Sources Citation Index (ESCI)	Rehabilitation	V64KV	WOS:000211100800002					2022-02-06	
J	Molina, DK; McCutcheon, JR; Rulon, JJ				Molina, D. Kimberley; McCutcheon, J. R.; Rulon, Jennifer J.			Head Injuries, Pentobarbital, and the Determination of Death	AMERICAN JOURNAL OF FORENSIC MEDICINE AND PATHOLOGY			English	Article						drug-induced coma; death; barbiturate; pentobarbital; brain death; craniocerebral trauma; closed head injury	BRAIN-DEATH; PHARMACOKINETICS	The Bexar County Medical Examiner's Office in San Antonio, Texas, has encountered 3 cases within a 15-month period involving decedents who were pronounced dead by brain death or cardiac death examination and who had elevated, if not toxic concentrations of pentobarbital present at the time of examination. The elevated levels of pentobarbital were discovered during an autopsy examination performed for medicolegal reasons. The diagnosis of brain death and the implications of pentobarbital intoxication during a brain death examination are discussed.	[Molina, D. Kimberley; McCutcheon, J. R.; Rulon, Jennifer J.] Bexar Cty Med Examiners Off, San Antonio, TX 78229 USA		Molina, DK (corresponding author), Bexar Cty Med Examiners Off, 7337 Louis Pasteur Dr, San Antonio, TX 78229 USA.	kmolina@bexar.org					BASELT RC, 2004, DISPOSITION TOXIC DR, P668; BAYLIFF CD, 1985, CLIN PHARMACOL THER, V38, P457, DOI 10.1038/clpt.1985.204; GOLAN D, 2007, PRINCIPLES PHARM, P44; KOZLOWSKI KH, 1977, POL J PHARMACOL PHAR, V29, P497; Powner DJ, 2004, CRIT CARE MED, V32, P1284, DOI 10.1097/01.ccm.0000127265.62431.0d; SCHAIBLE DH, 1982, J PEDIATR-US, V100, P655, DOI 10.1016/S0022-3476(82)80780-4; WERMELING DP, 1987, DRUG INTEL CLIN PHAR, V21, P459, DOI 10.1177/106002808702100517; Wijdicks EFM, 2001, NEW ENGL J MED, V344, P1215, DOI 10.1056/NEJM200104193441606	8	8	8	0	6	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0195-7910			AM J FOREN MED PATH	Am. J. Forensic Med. Pathol.	MAR	2009	30	1					75	77		10.1097/PAF.0b013e31818738dd			3	Medicine, Legal; Pathology	Science Citation Index Expanded (SCI-EXPANDED)	Legal Medicine; Pathology	409TE	WOS:000263527900020	19237862				2022-02-06	
J	Wang, L; Wang, XF; Yuan, J; Xi, ZQ; Xue, T; Li, YQ; Xiao, Z				Wang, Liang; Wang, Xuefeng; Yuan, Jie; Xi, Zhiqin; Xue, Tao; Li, Yuqin; Xiao, Zheng			Nestin in the Temporal Neocortex of the Intractable Epilepsy Patients	NEUROCHEMICAL RESEARCH			English	Article						Epilepsy; Nestin; Neurogenesis; Gliosis	INTERMEDIATE FILAMENT PROTEIN; TRAUMATIC BRAIN-INJURY; RAT NEOCORTEX; DENTATE GYRUS; ADULT-RAT; CELLS; EXPRESSION; MARKER; ASTROCYTES; MOUSE	Nestin is one kind of intermediate filament protein, which is considered as a typical marker of neural precursor cells. Considerable evidence supports nestin may have actively functions in neurogenesis and gliosis. Our aim was to investigate nestin expression in the temporal neocortex of patients with intractable epilepsy (IE), and then to discuss the possible role of nestin in IE. Tissue samples from the temporal neocortex of 32 patients who had surgery for IE were used to detect nestin expression by immunohistochemistry, immunofluorescence. We compared these tissues with 12 histologically normal temporal neocortex from intracranial hypertension patients who had decompression procedures. In this study, we found some nestin positive cells in the normal temporal neocortex, but in the intractable epilepsy, they were upregulated, increasing with length of course and seizure frequency. Optical density (OD) value in epileptic tissue was determined 0.246 +/- A 0.030, and 0.134 +/- A 0.040 in the control (P < 0.05). Double lables of immunofluorescence showed some nestin positive cells coexpression with glial fibrillary acidic protein (GFAP), while some coexpression with microtubule-associated protein-2 (MAP(2)). These findings provided some evidence for increased neurogenesis and gliosis in epilepsy, which could be associated with intractable epilepsy.	[Wang, Liang; Wang, Xuefeng; Yuan, Jie; Xi, Zhiqin; Xiao, Zheng] Chongqing Med Univ, Affiliated Hosp 1, Dept Neurol, Chongqing 400016, Peoples R China; [Xue, Tao; Li, Yuqin] Chongqing Med Univ, Affiliated Hosp 2, Dept Neurol, Chongqing 400010, Peoples R China		Wang, XF (corresponding author), Chongqing Med Univ, Affiliated Hosp 1, Dept Neurol, Chongqing 400016, Peoples R China.	wang0128_0@163.com; xfyp@163.com					Almazan G, 2001, MICROSC RES TECHNIQ, V52, P753, DOI 10.1002/jemt.1060; Blumcke I, 2001, HIPPOCAMPUS, V11, P311, DOI 10.1002/hipo.1045; Carbonnel WS, 1999, ACTA NEUROPATHOL, V98, P396, DOI 10.1007/s004010051100; DAHLSTRAND J, 1995, DEV BRAIN RES, V84, P109, DOI 10.1016/0165-3806(94)00162-S; Duggal N, 2001, J NEUROSURG, V95, P459, DOI 10.3171/jns.2001.95.3.0459; Ehrmann J, 2005, J CLIN PATHOL, V58, P222, DOI 10.1136/jcp.2004.021238; Ernst C, 2006, NEUROSCIENCE, V138, P183, DOI 10.1016/j.neuroscience.2005.10.065; Ernst C, 2005, EUR J NEUROSCI, V22, P3059, DOI 10.1111/j.1460-9568.2005.04499.x; Fukuda S, 2003, J NEUROSCI, V23, P9357; HOCKFIELD S, 1985, J NEUROSCI, V5, P3310; Holmin S, 1997, EUR J NEUROSCI, V9, P65, DOI 10.1111/j.1460-9568.1997.tb01354.x; Kalman M, 2001, INT J DEV NEUROSCI, V19, P101, DOI 10.1016/S0736-5748(00)00058-7; Kaya SS, 1999, BRAIN RES, V840, P153, DOI 10.1016/S0006-8993(99)01757-6; Kernie SG, 2001, J NEUROSCI RES, V66, P317, DOI 10.1002/jnr.10013; LENDAHL U, 1990, CELL, V60, P585, DOI 10.1016/0092-8674(90)90662-X; Nakagawa T, 2004, CAN J NEUROL SCI, V31, P514, DOI 10.1017/S0317167100003747; Rogawski MA, 2005, NAT MED, V11, P919, DOI 10.1038/nm0905-919; Scorza CA, 2005, NEUROSCI RES, V51, P285, DOI 10.1016/j.neures.2004.12.002; Sharp FR, 2002, DEV BRAIN RES, V134, P23, DOI 10.1016/S0165-3806(01)00286-3; Siebzehnrubl FA, 2008, EPILEPSIA, V49, P55, DOI 10.1111/j.1528-1167.2008.01638.x; Song SH, 2002, NATURE, V417, P39, DOI 10.1038/417039a; Sosunov A. A., 2002, Ontogenez, V33, P405; Sugawara K, 2002, LAB INVEST, V82, P345, DOI 10.1038/labinvest.3780428; Umeoka S, 2001, EPILEPSY RES, V43, P249, DOI 10.1016/S0920-1211(00)00200-X	24	8	9	0	1	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0364-3190	1573-6903		NEUROCHEM RES	Neurochem. Res.	MAR	2009	34	3					574	580		10.1007/s11064-008-9824-4			7	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	404JQ	WOS:000263148200022	18719994				2022-02-06	
J	Papadimos, TJ; Medhkour, A; Yermal, S				Papadimos, Thomas J.; Medhkour, Azedine; Yermal, Sooraj			Successful use of inhaled nitric oxide to decrease intracranial pressure in a patient with severe traumatic brain injury complicated by acute respiratory distress syndrome: a role for an anti-inflammatory mechanism?	SCANDINAVIAN JOURNAL OF TRAUMA RESUSCITATION & EMERGENCY MEDICINE			English	Article							ACUTE LUNG INJURY; PITUITARY-ADRENAL AXIS; MESSENGER-RNA LEVELS; HIPPOCAMPAL-NEURONS; MECONIUM ASPIRATION; STRESS; NEUROENDOCRINOLOGY; RESPONSES; OUTCOMES; THERAPY	Use of inhaled nitric oxide in humans with traumatic brain injury and acute respiratory distress syndrome has twice previously been reported to be beneficial. Here we report a third case. We propose that INO may decrease the inflammatory response in patients with increased intracranial pressure caused by traumatic brain injury accompanied by acute respiratory distress syndrome thereby contributing to improved outcomes.	[Papadimos, Thomas J.; Yermal, Sooraj] Univ Toledo, Coll Med, Dept Anesthesiol, Toledo, OH 43614 USA; [Papadimos, Thomas J.] Univ Michigan, Sch Med, Dept Anesthesiol, Ann Arbor, MI 48109 USA; [Medhkour, Azedine] Univ Toledo, Coll Med, Div Neurosurg, Dept Surg, Toledo, OH 43614 USA		Papadimos, TJ (corresponding author), Univ Toledo, Coll Med, Dept Anesthesiol, 3000 Arlington Ave, Toledo, OH 43614 USA.	thomas.papadimos@utoledo.edu; azedine.medhkour@utoledo.edu; sooraj.yermal@utoledo.edu		Papadimos, Thomas/0000-0002-4024-227X			Aaltonen M, 2005, ACTA PAEDIATR, V94, P1468, DOI 10.1080/08035250510042816; Aaltonen M, 2007, EARLY HUM DEV, V83, P77, DOI 10.1016/j.earlhumdev.2006.05.003; ABMAN SH, 1994, J PEDIATR-US, V124, P881, DOI 10.1016/S0022-3476(05)83175-0; Bondanelli M, 2005, EUR J ENDOCRINOL, V152, P679, DOI 10.1530/eje.1.01895; COHEN SM, 2005, TXB CRITICAL CARE, P377; Da JP, 2007, CRIT CARE MED, V35, P26, DOI 10.1097/01.CCM.0000250319.91575.BB; Day RW, 2001, AM J PERINAT, V18, P185, DOI 10.1055/s-2001-15502; Doctor A, 2005, P NATL ACAD SCI USA, V102, P5709, DOI 10.1073/pnas.0407490102; DUNN JD, 1984, EXP BRAIN RES, V54, P1; FENDLER K, 1961, ACTA PHYSIOL HUNG, V20, P293; FINKELSEIN E, 2006, GLOBAL HLTH STAT; Goldfarb RD, 2007, CRIT CARE MED, V35, P290, DOI 10.1097/01.CCM.0000251290.41866.2B; Gow Andrew J, 2006, Proc Am Thorac Soc, V3, P150, DOI 10.1513/pats.200506-058BG; Griffiths MJD, 2005, NEW ENGL J MED, V353, P2683, DOI 10.1056/NEJMra051884; Grundy PL, 2001, J NEUROTRAUM, V18, P1373, DOI 10.1089/08977150152725669; Herman JP, 2006, NEUROL CLIN, V24, P461, DOI 10.1016/j.ncl.2006.03.006; Herman JP, 1997, TRENDS NEUROSCI, V20, P78, DOI 10.1016/S0166-2236(96)10069-2; HERMAN JP, 1989, J NEUROSCI, V9, P3072; HERMAN JP, 1992, BRAIN RES, V592, P228, DOI 10.1016/0006-8993(92)91680-D; HERMAN JP, 1995, J NEUROENDOCRINOL, V7, P475, DOI 10.1111/j.1365-2826.1995.tb00784.x; Herridge MS, 2005, NEW ENGL J MED, V353, P1736, DOI 10.1056/NEJMe058205; Herridge MS, 2003, NEW ENGL J MED, V348, P683, DOI 10.1056/NEJMoa022450; Holland MC, 2003, J TRAUMA, V55, P106, DOI 10.1097/01.TA.0000071620.27375.BE; JACOBSON L, 1991, ENDOCR REV, V12, P118, DOI 10.1210/edrv-12-2-118; Jourd'heuil D, 2000, BIOCHEM BIOPH RES CO, V273, P22, DOI 10.1006/bbrc.2000.2892; KNIGGE KM, 1963, P SOC EXP BIOL MED, V114, P67; KNIGGE KM, 1961, P SOC EXP BIOL MED, V108, P18; Koiv L, 1997, ACTA NEUROL SCAND, V96, P52; KOSAKA H, 1992, BIOCHEM BIOPH RES CO, V184, P1119, DOI 10.1016/0006-291X(92)90708-S; Lee BH, 2007, NEONATOLOGY, V91, P12, DOI 10.1159/000096966; LindeZwirble W, 1996, 9TH EUROPEAN CONGRESS ON INTENSIVE CARE MEDICINE, P243; Llompart-Pou JA, 2007, J TRAUMA, V62, P1457, DOI 10.1097/01.ta.0000219143.69483.71; Lopez-Aguilar J, 2005, CRIT CARE MED, V33, P1077, DOI 10.1097/01.CCM.0000162913.72479.F7; Luchsinger BP, 2003, P NATL ACAD SCI USA, V100, P461, DOI 10.1073/pnas.0233287100; McCullers D, 2002, NEUROSCIENCE, V109, P219, DOI 10.1016/S0306-4522(01)00477-8; McCullers DL, 2001, J NEUROSCI RES, V64, P277; McCullers DL, 2002, BRAIN RES, V947, P41, DOI 10.1016/S0006-8993(02)02904-9; MORANTIKOSSMAN MC, 2002, CURR OPIN CRIT CARE, V8, P101; Peillon D, 1999, ANN FR ANESTH, V18, P225, DOI 10.1016/S0750-7658(99)80073-2; Rall JM, 2003, NEUROPATH APPL NEURO, V29, P118, DOI 10.1046/j.1365-2990.2003.00439.x; Robinson JM, 2005, AM J RESP CELL MOL, V32, P257, DOI 10.1165/rcmb.F292; ROSNER MJ, 1993, INTRACRANIAL PRESSUR, V8, P540; Rubenfeld GD, 2005, NEW ENGL J MED, V353, P1685, DOI 10.1056/NEJMoa050333; RUBIN RT, 1966, SCIENCE, V153, P767, DOI 10.1126/science.153.3737.767; SAPOLSKY RM, 1986, ENDOCR REV, V7, P284, DOI 10.1210/edrv-7-3-284; SAPOLSKY RM, 1984, P NATL ACAD SCI-BIOL, V81, P6174, DOI 10.1073/pnas.81.19.6174; Stocchetti N, 2005, CHEST, V127, P1812, DOI 10.1378/chest.127.5.1812; STRIETER RM, 1994, J INVEST MED, V42, P640; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Van den Berghe G, 2000, EUR J ENDOCRINOL, V143, P1, DOI 10.1530/eje.0.1430001; Vavilala MS, 2001, ANESTH ANALG, V93, P351, DOI 10.1097/00000539-200108000-00023; Yildirim E, 2004, EUR J CARDIO-THORAC, V25, P523, DOI 10.1016/j.ejcts.2003.12.021; Zygun DA, 2005, CRIT CARE MED, V33, P654, DOI 10.1097/01.ccm.0000155911.01844.54; Zygun DA, 2006, NEUROCRIT CARE, V5, P108, DOI 10.1385/NCC:5:2:108	54	8	8	0	2	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1757-7241			SCAND J TRAUMA RESUS	Scand. J. Trauma Resusc. Emerg. Med.	FEB 17	2009	17								5	10.1186/1757-7241-17-5			6	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	665HE	WOS:000283025200001	19222848	Green Published, gold			2022-02-06	
J	Kane, SM; White, RA				Kane, Steven M.; White, Richard A.			Medical Malpractice and the Sports Medicine Clinician	CLINICAL ORTHOPAEDICS AND RELATED RESEARCH			English	Article							ASSOCIATION POSITION STATEMENT; HIGH-SCHOOL; SUDDEN-DEATH; PREPARTICIPATION EXAMINATION; HYPERTROPHIC CARDIOMYOPATHY; CARDIOVASCULAR-DISEASE; MEDICOLEGAL ISSUES; TACKLE FOOTBALL; CERVICAL-SPINE; INJURY	More individuals are participating in athletics today than ever before. Physicians treating athletes confront unique diagnostic and treatment challenges and an increased risk of legal liability. The key areas regarding liability are preparticipation examinations, determination of eligibility, evaluation of significant on-field injuries, and information disclosure. The issues surrounding preparticipation physicals and determination of eligibility are closely linked. Physicians must be prepared to seek guidance from specialists, particularly when there are cardiac, spinal, or neurologic issues. Appropriate on-field evaluation of potential concussions, spinal injuries, and heat stroke are key areas of concern for the physician. Privacy issues have become more complex in the age of federal regulation. Physicians and all athletic staff should be aware of privacy laws and ensure proper consent documentation is obtained from all athletes or their parents. All athletic programs should develop a plan that details roles and procedures to be followed in a medical emergency. Sports caregivers must take affirmative steps that better protect their patients from harm and physicians from legal liability.	[Kane, Steven M.] Atlanta Med Ctr, Dept Orthopaed Surg, Atlanta, GA 30312 USA; [White, Richard A.] Univ Missouri, Dept Orthopaed Surg, Columbia, MO USA		Kane, SM (corresponding author), Atlanta Med Ctr, Dept Orthopaed Surg, 303 Pkwy Dr NE,Box 442, Atlanta, GA 30312 USA.	StevenM.Kane@tenethealth.com					*AM HEART ASS AM C, 2002, MED SCI SPORTS EXERC, V34, P239; *AM ORTH AC SPORTS, TEAM PHYS CONS STAT; Andersen JC, 2002, J ATHL TRAINING, V37, P99; Bailes JE, 2001, J ATHL TRAINING, V36, P236; BIRRER RB, 2002, PEDIAT SPORTS MED PR, P9; Bonci CM, 2008, J ATHL TRAINING, V43, P80, DOI 10.4085/1062-6050-43.1.80; Cantu RC, 1998, CLIN SPORT MED, V17, P37, DOI 10.1016/S0278-5919(05)70059-4; Cantu Robert V, 2005, Curr Sports Med Rep, V4, P27; COLLUM J, 2001, SPORTS PARKS REC LAW, V14, P56; Corrado D, 2006, JAMA-J AM MED ASSOC, V296, P1593, DOI 10.1001/jama.296.13.1593; DURANT RH, 1985, AM J DIS CHILD, V139, P657; Echemendia RJ, 2001, CLIN J SPORT MED, V11, P23, DOI 10.1097/00042752-200101000-00005; FAHRENBACH M C, 1992, Cardiology Clinics, V10, P319; Feinstein RA, 1994, CLIN J SPORT MED, V3, P149; GALLOP EM, 1995, LAW TEAM PHYS, pR9; Ghiselli G, 2003, CLIN SPORT MED, V22, P445, DOI 10.1016/S0278-5919(02)00109-6; Glover DW, 1998, JAMA-J AM MED ASSOC, V279, P1817, DOI 10.1001/jama.279.22.1817; Gomez JE, 1999, ARCH PEDIAT ADOL MED, V153, P723, DOI 10.1001/archpedi.153.7.723; Graf-Baumann T, 2006, BRIT J SPORT MED, V40, P55, DOI 10.1136/bjsm.2006.027979; HASSANEIN T, 1992, AM J GASTROENTEROL, V87, P1382; Heck JF, 2004, J ATHL TRAINING, V39, P101; HERBERT DL, 2007, SPORTS MED STAN MAL, V19, P17; Isaacs Craig A., 1992, ALB LJ SCI TECH, V2, P147; Kim DH, 2003, CLIN SPORT MED, V22, P501, DOI 10.1016/S0278-5919(02)00105-9; KLOSSNER D, 2005, NCAA SPORTS MED HDB; LEWIS JF, 1989, AM J CARDIOL, V64, P1029, DOI 10.1016/0002-9149(89)90802-3; Lovell MR, 2004, AM J SPORT MED, V32, P47, DOI 10.1177/0363546503260723; Majerske CW, 2008, J ATHL TRAINING, V43, P265, DOI 10.4085/1062-6050-43.3.265; Maron BJ, 2002, JAMA-J AM MED ASSOC, V287, P1308, DOI 10.1001/jama.287.10.1308; MARON BJ, 1994, MED SCI SPORT EXER, V26, pS261; Maron BJ, 1998, J AM COLL CARDIOL, V32, P1881, DOI 10.1016/S0735-1097(98)00491-4; MARON BJ, 1993, NEW ENGL J MED, V329, P55, DOI 10.1056/NEJM199307013290113; MARON BJ, 1986, J AM COLL CARDIOL, V7, P204, DOI 10.1016/S0735-1097(86)80283-2; Maron BJ, 1996, CIRCULATION, V94, P850, DOI 10.1161/01.CIR.94.4.850; Martineau Chad, 2007, JAAPA, V20, P22; Mathieson G., 2005, PREPARTICIPATION PHY, P1; MITTEN MJ, 2002, ST JOHNS LAW REV, V76, P7; MURRY PM, 1995, AM J CARDIOL, V76, P849, DOI 10.1016/S0002-9149(99)80244-6; Nofsinger CC, 2007, CLIN SPORT MED, V26, P193, DOI 10.1016/j.csm.2007.01.010; Paterick TE, 2005, JAMA-J AM MED ASSOC, V294, P3011, DOI 10.1001/jama.294.23.3011; PATTERSON D, 1987, CLIN SPORT MED, V6, P197; Pearsall AW, 2005, CLIN ORTHOP RELAT R, P50, DOI 10.1097/01.blo.0000159896.64176.72; PEARSALL Z, 2004, NEWSLET AM ORTHOP SO, P4; Phillips George C, 2004, Curr Sports Med Rep, V3, P224, DOI 10.1249/00149619-200408000-00009; RUTHERFORD GJ, 1998, SPORTS RELATED INJUR, P4; RYAN E, WASHINGTON POST; Sanders AK, 2005, CLIN ORTHOP RELAT R, P38, DOI 10.1097/01.blo.0000159764.03919.33; Suk M, 2005, J AM ACAD ORTHOP SUR, V13, P397, DOI 10.5435/00124635-200510000-00004; TORG JS, 1993, AM J SPORT MED, V21, P640, DOI 10.1177/036354659302100502; Van Kampen DA, 2006, AM J SPORT MED, V34, P1630, DOI 10.1177/0363546506288677; VANCAMP SP, 1995, MED SCI SPORT EXER, V27, P641; WEIDENBENER EJ, 1995, CLIN J SPORT MED, V5, P86, DOI 10.1097/00042752-199504000-00003; Wen DY, 2005, PHYSICIAN SPORTSMED, V33, P31, DOI 10.3810/psm.2005.12.274; Wharton SJ, 2005, MED SCI SPORT EXER, V37, pS356, DOI 10.1097/00005768-200505001-01867; 2007, SPORTS MED STAND OCT, P58; 2004 05 NFHS HIGH SC; 1982 2001 NCAA PARTI; 2006, SPORTS MED STAN  APR, P28	58	8	8	0	14	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0009-921X			CLIN ORTHOP RELAT R	Clin. Orthop. Rel. Res.	FEB	2009	467	2					412	419		10.1007/s11999-008-0589-5			8	Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Surgery	395XE	WOS:000262556000013	18989733	Green Published			2022-02-06	
J	Bailey, M; Amato, S; Mouhlas, C				Bailey, Marci; Amato, Shelly; Mouhlas, Christopher			A Creative Alternative for Providing Constant Observation on an Acute-Brain-Injury Unit	REHABILITATION NURSING			English	Article						constant observation		A performance improvement project to explore creative alternatives to improve the efficiency of constant observation was performed on an acute-brain-injury rehabilitation unit. The goals of the project were to increase opportunities for therapeutic cognitive stimulation among patients, increase nursing satisfaction regarding efficient use of resources to deliver rehabilitative care, decrease constant-observation salary costs, and maintain fall and restraint rates within 10% of baseline. Implementing the project involved developing a new job description (rehabilitation patient comparison) and creating a day room where patients receiving constant observation could go between therapies to receive therapeutic cognitive stimulation. The program benefited patients, staff, and the hospital. This project illustrates how a creative alternative to constant observation proves beneficial on many levels and improves the delivery of rehabilitative care to patients with traumatic brain injury.	[Bailey, Marci; Amato, Shelly; Mouhlas, Christopher] MetroHlth Rehabil Inst, Cleveland, OH USA		Bailey, M (corresponding author), MetroHlth Rehabil Inst, Cleveland, OH USA.	mbailey@metrohealth.org					Evans D, 2003, J ADV NURS, V41, P274, DOI 10.1046/j.1365-2648.2003.02501.x; Finkelstein E., 2006, INCIDENCE EC BURDEN; Kadyan V, 2004, AM J PHYS MED REHAB, V83, P747, DOI 10.1097/01.PHM.0000140790.30468.F4; Moore P, 1995, J Psychosoc Nurs Ment Health Serv, V33, P46; [No title captured]	5	8	8	0	2	ASSOC REHABILITATION NURSES	GLENVIEW	4700 W LAKE AVE, GLENVIEW, IL 60025-1485 USA	0278-4807			REHABIL NURS	Rehabil. Nurs.	JAN-FEB	2009	34	1					11	+		10.1002/j.2048-7940.2009.tb00242.x			7	Nursing; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Nursing; Rehabilitation	391AI	WOS:000262204400003	19160919				2022-02-06	
J	Blake, TM; Fichtenberg, NL; Abeare, CA				Blake, Treena M.; Fichtenberg, Norman L.; Abeare, Christopher A.			Clinical Utility of Demographically Corrected WAIS-III Subtest Scores After Traumatic Brain Injury	CLINICAL NEUROPSYCHOLOGIST			English	Article						WAIS-III; Traumatic brain injury; Demographic norms	NEUROPSYCHOLOGICAL TEST-PERFORMANCE; ADULT INTELLIGENCE SCALE; MEMORY MALINGERING TOMM; 3RD EDITION; DIGIT SPAN; EDUCATION; NORMS; AGE; SPECIFICITY; SENSITIVITY	The present study explored the diagnostic accuracy of demographically corrected norms for the Wechsler Adult Intelligence Scale-Third Edition (WAIS-III) in a diverse sample of 57 patients with traumatic brain injury (TBI) and a matched group of 61 pseudoneurologic controls. The use of demographic corrections did not significantly improve the sensitivity or specificity of WAIS-III subtest scores to TBI relative to traditional age-corrected norms. Overall classification rates were quite good for both normative systems. Although the demographic corrections attenuate ethnicity differences on the subtest scores of TBI patients, the updated norms are no more or less beneficial than traditional age-corrected norms for neurodiagnostic purposes.	[Blake, Treena M.; Abeare, Christopher A.] Univ Windsor, Windsor, ON N9B 3P4, Canada; [Fichtenberg, Norman L.] Rehabil Inst Michigan, Detroit, MI USA		Blake, TM (corresponding author), Univ Windsor, 401 Sunset Ave, Windsor, ON N9B 3P4, Canada.	blakea@uwindsor.ca		Abeare, Christopher/0000-0002-7163-7434			Axelrod BN, 2002, INT J NEUROSCI, V112, P1479, DOI 10.1080/00207450290158377; Axelrod BN, 1996, CLIN NEUROPSYCHOL, V10, P159, DOI 10.1080/13854049608406677; Axelrod BN, 2006, CLIN NEUROPSYCHOL, V20, P513, DOI 10.1080/13854040590967117; Babikian T, 2006, CLIN NEUROPSYCHOL, V20, P145, DOI 10.1080/13854040590947362; Donders J, 2001, J INT NEUROPSYCH SOC, V7, P892, DOI 10.1017/S1355617701777132; Fisher D C, 2000, Appl Neuropsychol, V7, P126, DOI 10.1207/S15324826AN0703_2; Gladsjo JA, 1999, ASSESSMENT, V6, P147, DOI 10.1177/107319119900600204; Hawkins KA, 1998, CLIN NEUROPSYCHOL, V12, P535, DOI 10.1076/clin.12.4.535.7236; Heaton RK, 1996, NEUROPSYCHOLOGICAL A, P141; Langeluddecke PM, 2003, CLIN NEUROPSYCHOL, V17, P273, DOI 10.1076/clin.17.2.273.16499; LECKLITER IN, 1989, J CLIN PSYCHOL, V45, P484, DOI 10.1002/1097-4679(198907)45:4<484::AID-JCLP2270450402>3.0.CO;2-L; Manly J., 2003, CLIN INTERPRETATION, P181, DOI DOI 10.1016/B978-012703570-3/50010-9; Manly JJ, 1998, NEUROLOGY, V50, P1238, DOI 10.1212/WNL.50.5.1238; Martin TA, 2000, REHABIL PSYCHOL, V45, P402, DOI 10.1037/0090-5550.45.4.402; MILLIS SR, 1992, CLIN NEUROPSYCHOL, V6, P406; Norman MA, 2000, J CLIN EXP NEUROPSYC, V22, P80, DOI 10.1076/1380-3395(200002)22:1;1-8;FT080; *PSYCH CORP, 2001, WAIS 3 WMS 3 WIAT 2; Rees LM, 1998, PSYCHOL ASSESSMENT, V10, P10, DOI 10.1037/1040-3590.10.1.10; Reitan R M, 1997, Appl Neuropsychol, V4, P16, DOI 10.1207/s15324826an0401_3; REITAN RM, 1995, CLIN NEUROPSYCHOL, V9, P151, DOI 10.1080/13854049508401597; Sherrill-Pattison S, 2000, CLIN NEUROPSYCHOL, V14, P496, DOI 10.1076/clin.14.4.496.7196; Strong CAH, 2005, J CLIN EXP NEUROPSYC, V27, P746, DOI 10.1081/13803390490919155; Taylor MJ, 2001, J INT NEUROPSYCH SOC, V7, P867, DOI 10.1017/S1355617701777107; TEASDALE G, 1974, LANCET, V2, P81; Tombaugh T.N., 1996, TEST MEMORY MALINGER; Tombaugh TN, 1997, PSYCHOL ASSESSMENT, V9, P260, DOI 10.1037/1040-3590.9.3.260; Vanderploeg RD, 1997, CLIN NEUROPSYCHOL, V11, P210, DOI 10.1080/13854049708407054; Warrington E, 1984, RECOGNITION MEMORY T, V1; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird	29	8	8	0	8	TAYLOR & FRANCIS INC	PHILADELPHIA	325 CHESTNUT ST, SUITE 800, PHILADELPHIA, PA 19106 USA	1385-4046			CLIN NEUROPSYCHOL	Clin. Neuropsychol.		2009	23	3					373	384	PII 795445658	10.1080/13854040802279691			12	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	423QH	WOS:000264510300001	18671155				2022-02-06	
J	Conde-Guzon, PA; Conde-Guzon, MJ; Bartolome-Albistegui, MT; Quiros-Exposito, P				Conde-Guzon, P. A.; Conde-Guzon, M. J.; Bartolome-Albistegui, M. T.; Quiros-Exposito, P.			NEUROPSYCHOLOGICAL PROFILES ASSOCIATED WITH THE CHILDREN'S ORAL LANGUAGE DISORDERS	REVISTA DE NEUROLOGIA			Spanish	Article						Cognitive processes; Dysarthrias; Dyslalias; Language disorders; Memory; Neuropsychology	TRAUMATIC BRAIN-INJURY; SHORT-TERM-MEMORY; MOLECULAR-BIOLOGY; DEFICITS; SPEECH; FOXP2; INDIVIDUALS; CHILDHOOD; SECONDARY	Introduction. Oral language disorders constitute a group of syndromes with a high prevalence among the childhood population. They from a heterogeneous group that ranges from simple problems in articulating a phoneme (dyslalias) to severe disorders affecting communication, such a children's dysarthrias and aphasias. In this paper our objective is to review the neuropsychological profiles of children who manifest different oral language disorders. Development. Due to the wide range of clinical pictures and causations covered by children's oral language disorders, very few systematic reviews have been conducted to obtain an overall view of the neuropsychological profiles of these children. Although the linguistic signs and symptoms of these disorders are well understood, the associated neuropsychological signs and symptoms have not been studied. In some cases, these neuropsychological signs cause greater learning problems in children than the actual language problems themselves. Conclusions. Childhood language disorders are associated with different neuropsychological problems. The most commonly associated neuropsychological deficits are problems involving memory, attention, executive functions, motor dsyfunctions, temporal perception, tactile recognition, body scheme, spatial orientation and difficulties in visual discrimination. Mnemonic disorders (essentially in short-term and working auditory memory) are usually a common denominator in the different clinical pictures that make up language disorders. The mnemonic impairment associated to dyslalias deserves special attention as this disorder is sometimes similar to that seen in language problems deriving from clinical pictures with important neurological alterations. [REV NEUROL 2009; 48: 32-8]	[Conde-Guzon, P. A.; Conde-Guzon, M. J.] Univ Leon, Fac Educ, Area Personalidad Evaluac & Tratamientos Psicol, E-24071 Leon, Spain; [Bartolome-Albistegui, M. T.] Obra Hosp Nuestra Senora Regla, Serv Neurol, Leon, Spain; [Quiros-Exposito, P.] Univ Nacl Educ Distancia, Dept Psicol Basica 2, Madrid, Spain		Conde-Guzon, PA (corresponding author), Univ Leon, Fac Educ, Area Personalidad Evaluac & Tratamientos Psicol, E-24071 Leon, Spain.	pacong@unileon.es	CONDE-GUZON, PABLO A/K-8927-2014; Quiros, Pilar/L-9548-2014	Quiros, Pilar/0000-0002-2942-2018			Adams AM, 2000, INT J LANG COMM DIS, V35, P95; Arboleda-Ramirez A, 2007, REV NEUROLOGIA, V44, P596, DOI 10.33588/rn.4410.2006565; Baldo JV, 2006, NEUROPSYCHOLOGY, V20, P529, DOI 10.1037/0894-4105.20.5.529; BATES E, 1992, HDB NEUROPSYCHOLOGY, V7, P69; Benitez-Burraco A, 2008, REV NEUROLOGIA, V46, P351, DOI 10.33588/rn.4606.2008124; Benitez-Burraco A, 2008, REV NEUROLOGIA, V46, P289, DOI 10.33588/rn.4605.2007052; Benitez-Burraco A, 2005, REV NEUROLOGIA, V40, P671, DOI 10.33588/rn.4011.2005147; Bigler ED, 2001, ARCH CLIN NEUROPSYCH, V16, P95; BISHOP DVM, 1987, J SPEECH HEAR DISORD, V52, P156, DOI 10.1044/jshd.5202.156; BRUNO C, 1985, REV LOGOPEDIA FONIAT, V5, P69; Buiza-Navarrete JJ, 2007, REV NEUROLOGIA, V44, P326, DOI 10.33588/rn.4406.2006066; Carlesimo GA, 2006, J INTELL DISABIL RES, V50, P81, DOI 10.1111/j.1365-2788.2005.00725.x; CERVERA J, 1994, REV LOGOPEDIA FONIAT, V14, P19; Chevrie-Muller C., 1997, LENGUAJE NINO DESARR, P249; CONDEGUZON P, 2006, NEUROLOGIA, V21, P608; CRESPOEGUILAZ N, 2006, REV NEUROLOGIA, V43, P193; DODD B, 1993, LINGUISTIC DISORDERS, P825; GATHERCOLE SE, 1990, J MEM LANG, V29, P336, DOI 10.1016/0749-596X(90)90004-J; Idiazabal-Aletxa M A, 2008, Rev Neurol, V46 Suppl 1, pS91; Ingram D., 1976, PHONOLOGICAL DISABIL; JACOBSON R, 1974, LENGUAJE INFANTIL AF; Jennett B, 1996, J NEUROL NEUROSUR PS, V60, P362, DOI 10.1136/jnnp.60.4.362; JIMENEZ J, 1988, REV LOGOPEDIA FONIAT, V8, P173; JUNQUE C, 1984, REV LOGOPEDIA FONIAT, V4, P69; Kenney MK, 2006, BRAIN LANG, V96, P178, DOI 10.1016/j.bandl.2005.04.002; KLEES MA, 1983, REV LOGOPEDIA FONIAT, V11, P139; Levin HS, 2005, PEDIATR NEUROL, V33, P79, DOI 10.1016/j.pediatrneurol.2005.02.002; Levisohn L, 2000, BRAIN, V123, P1041, DOI 10.1093/brain/123.5.1041; Linassi Lisiane Zorzella, 2005, Pró-Fono R. Atual. Cient., V17, P383, DOI 10.1590/S0104-56872005000300012; Manga D., 1997, NEUROPSICOLOGIA CLIN; Manga D., 1991, NEUROPSICOLOGIA EDAD; MENDOZA E, 1990, REV LOGOPEDIA FONIAT, V10, P84; MORENO JM, 2004, RETRASOS ADQUISICION; MORTON MV, 1995, BRAIN INJURY, V9, P81, DOI 10.3109/02699059509004574; MUNOZ J, 2005, REV NEUROL S1, V40, pS57; Narbona J, 2008, Rev Neurol, V46 Suppl 1, pS87; PACKER RJ, 1989, J NEUROSURG, V70, P707, DOI 10.3171/jns.1989.70.5.0707; PENACASANOVA J, 1993, REV LOGOPEDIA FONIAT, V13, P191; Perez-Andrade MA, 2007, REV NEUROLOGIA, V45, P62, DOI 10.33588/rn.4501.2007135; Puyuelo-Sanclemente M, 2001, REV NEUROLOGIA, V32, P975, DOI 10.33588/rn.3210.2000182; RAINE A, 1991, CHILD DEV, V62, P415, DOI 10.2307/1131013; RANTALA H, 1991, DEV MED CHILD NEUROL, V33, P858; Rapin I., 1983, NEUROPSYCHOLOGY LANG, P155; REYNOLDS CR, 1989, HDB CLIN CHILD NEURO, P17; Rios-Lago M, 2007, REV NEUROLOGIA, V44, P291, DOI 10.33588/rn.4405.2006208; Ronning C, 2005, PEDIATR NEUROSURG, V41, P15, DOI 10.1159/000084860; Sander AM, 1997, ARCH PHYS MED REHAB, V78, P353, DOI 10.1016/S0003-9993(97)90225-2; SERRA Miguel, 1997, REV LOGOPEDIA FONIAT, V27, P79; TALLAL P, 1991, READ WRIT, V3, P363, DOI 10.1007/BF00354968; TALLAL P, 1978, DEV DYSPHASIA, P63; Torgesen J.K., 1997, SCI STUD READ, V1, P161, DOI [DOI 10.1207/S1532799XSSR0102_4, 10.1207/s1532799xssr0102_4, https://doi.org/10.1207/s1532799xssr0102_4]; van Zomeren AH, 1984, CLOSED HEAD INJURY P, P74; VANHOUT A, 1997, MASSON, P277; VANHOUT A, 1997, LENGUAJE NINO DESARR, P277; VANZOMEREN AH, 1985, J NEUROL NEUROSUR PS, V48, P21, DOI 10.1136/jnnp.48.1.21; VERDU A, 2000, HIPERTENSION CRANEAL; VERGER K, 2003, MANUAL DESARROLLO AL, P413; WECHSLER D, 2001, MANUAL ESCALA INTELI; Wells B, 2003, J SPEECH LANG HEAR R, V46, P5, DOI 10.1044/1092-4388(2003/001); WILLIAMS N, 1993, CLIN LINGUIST PHONET, V7, P145, DOI 10.3109/02699209308985551; Ygual-Fernandez A, 2008, Rev Neurol, V46 Suppl 1, pS97; [No title captured]	62	8	9	1	13	REVISTA DE NEUROLOGIA	BARCELONA	C/O CESAR VIGUERA, EDITOR, APDO 94121, 08080 BARCELONA, SPAIN	0210-0010	1576-6578		REV NEUROLOGIA	Rev. Neurologia	JAN 1	2009	48	1					32	38		10.33588/rn.4801.2008164			7	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	404PH	WOS:000263165000008	19145564				2022-02-06	
J	Crandon, IW; Harding, HE; Cawich, SO; McDonald, AH; Fearron-Boothe, D				Crandon, I. W.; Harding, H. E.; Cawich, S. O.; McDonald, A. H.; Fearron-Boothe, D.			Motorcycle accident injury profiles in Jamaica: an audit from the University Hospital of the West Indies	INTERNATIONAL JOURNAL OF INJURY CONTROL AND SAFETY PROMOTION			English	Article						road traffic accident; traumatic brain injury; head injury; motorcycle; motor vehicle incident		There is little data available on the prevalence of motorcycle accidents, their resultant injuries and the demand on the health care services in Jamaica. We performed a descriptive, analytical study to evaluate the extent of this problem and the need for preventative national policy measures. Between 1 January 2000 and 1 January 2007, demographic and clinical data on all motorcycle accident victims admitted to the University Hospital of the West Indies were collected in a prospective database. The data were analysed using the SPSS version 12.0. Of 270 motorcycle accident victims, there were 257 (95.2%) males and 13 (4.8%) females. Overall, 134 (49.6%) victims wore helmets at the time of their accident. The more common injuries were as follows: soft tissue trauma 270 (100%); head injuries 143 (53.0%); long bone fractures 126 (46.7%); abdominal injuries 38 (14.1%); thoracic injuries 71 (26.3%); vascular injuries 11 (4.1%). The mean injury severity score was 9.0 (SD 9.4; Median 8; Mode 4). There were 195 patients needing surgical intervention in the form of orthopaedic operations (94), neurosurgical operations (43), abdominal operations (49) and vascular operations (14). The mean duration of hospitalisation was 10 days (SD 11.2; Range 0115; Median 6; Mode 3). There were 12 (4.4%) deaths, 9 (75%) due to traumatic brain injuries. Fatal injuries were more common in males (11) and un-helmeted patients (10). Motorcycle accidents take a heavy toll on this health care facility in Jamaica. Measures to prevent motorcycle accidents and reduce consequent injuries may be one way in which legislators can preserve precious resources that are spent during these incidents. This can be achieved through active measures such as educational campaigns, adherence to traffic regulations and enforcement of helmet laws.	[Crandon, I. W.; Cawich, S. O.; McDonald, A. H.; Fearron-Boothe, D.] Univ W Indies, Dept Surg Radiol & Anaesthesia, Sect Surg, Kingston 7, Jamaica; [Harding, H. E.] Univ W Indies, Dept Surg Radiol & Anaesthesia, Sect Anaesthesia, Kingston 7, Jamaica		Cawich, SO (corresponding author), Univ W Indies, Dept Surg Radiol & Anaesthesia, Sect Surg, Kingston 7, Jamaica.	socawich@hotmail.com					Brandt MM, 2002, J TRAUMA, V53, P469, DOI 10.1097/00005373-200209000-00012; CRANDON I, 1994, W INDIAN MED J, V43, P117; Eastridge BJ, 2006, J TRAUMA, V60, P978, DOI 10.1097/01.ta.0000215582.86115.01; Escoffery CT, 2002, MED SCI LAW, V42, P185, DOI 10.1177/002580240204200301; Forjuoh Samuel N, 2003, Inj Control Saf Promot, V10, P109, DOI 10.1076/icsp.10.1.109.14115; Hurt HH, 2008, MOTORCYCLE ACCIDENT; King JT, 2005, J NEUROTRAUM, V22, P947, DOI 10.1089/neu.2005.22.947; Miller KJ, 2005, J NEUROSURG, V103, P239, DOI 10.3171/jns.2005.103.2.0239; Oluwadiya K S, 2004, West Afr J Med, V23, P42; Peden M., 2004, WORLD REPORT ROAD TR; Scarlett MD, 2001, TRAUMA CARE, V11, P86; Solagberu BA, 2006, INJURY PREV, V12, P266, DOI 10.1136/ip.2005.011221; [No title captured]	13	8	8	1	5	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	1745-7300	1745-7319		INT J INJ CONTROL SA	Int. J. Inj. Control Saf. Promot.		2009	16	3					175	178		10.1080/17457300903024236			4	Public, Environmental & Occupational Health	Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health	618ZD	WOS:000279394700009	19941216				2022-02-06	
J	Fergenbaum, JH; Bruce, S; Spence, JD; Lou, W; Hanley, AJG; Greenwood, C; Young, TK				Fergenbaum, J. H.; Bruce, S.; Spence, J. D.; Lou, W.; Hanley, A. J. G.; Greenwood, C.; Young, T. K.			Carotid Atherosclerosis and a Reduced Likelihood for Lowered Cognitive Performance in a Canadian First Nations Population	NEUROEPIDEMIOLOGY			English	Article						Cognitive function; Executive function; Carotid stenosis; Anthropometric risk factors; Native Americans	INTIMA-MEDIA THICKNESS; CARDIOVASCULAR RISK-FACTORS; TRAUMATIC BRAIN-INJURY; METABOLIC SYNDROME; PLAQUE VOLUME; YOUNG-ADULTS; ARTERY; TRAIL; IMPAIRMENT; ULTRASOUND	Background: We investigated the associations among cardiovascular risk factors, carotid atherosclerosis and cognitive function in a Canadian First Nations population. Methods: Individuals aged >= 18 years, without stroke, nonpregnant and with First Nations status were assessed by the Trail Making Test Parts A and B. Results were combined into a Trail Making Test executive function score (TMT-exec). Doppler ultrasonography assessed carotid stenosis and plaque volume. Anthropometric, vascular and metabolic risk factors were assessed by interview, clinical examinations and blood tests. Results: For 190 individuals with TMT-exec scores, the median age of the population was 39 years. Compared to the reference group, individuals with elevated levels of left carotid stenosis (LCS) and total carotid stenosis (TCS) were less likely to demonstrate lowered cognitive performance [LCS, odds ratio (OR): 0.47, 95% confidence interval (CI): 0.24-0.96; TCS, OR: 0.40, 95% CI: 0.20-0.80]. No effect was shown for plaque volume. In structural equation modeling, we found that for every 1-unit change in the anthropometric factor in kg/m(2), there was a 0.86-fold decrease in the percent of TCS (p < 0.05). Conclusions: Individuals with elevated levels of LCS and TCS were less likely to demonstrate lowered performance. There was some suggestion that TCS mediates the effect of anthropometric risk factors on cognitive function. Copyright (C) 2009 S. Karger AG, Basel	[Fergenbaum, J. H.] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON M5T 3M7, Canada; [Bruce, S.] Univ Manitoba, Winnipeg, MB, Canada; [Spence, J. D.] Univ Western Ontario, London, ON, Canada		Fergenbaum, JH (corresponding author), Univ Toronto, Dalla Lana Sch Publ Hlth, Hlth Sci Bldg,155 Coll St, Toronto, ON M5T 3M7, Canada.	jennifer.fergenbaum@utoronto.ca	Spence, J. David/K-6396-2013; Duran, Bonnie m/A-3029-2009	Spence, J. David/0000-0001-7478-1098; Salerno, Jennifer/0000-0001-7282-5579	Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR) [CRT-43825]; Canadian Stroke Network; Canadian Institute of Health Research doctoral awardCanadian Institutes of Health Research (CIHR)	Funding for the study was provided by the Canadian Institutes of Health Research (CRT-43825, PI: Kue Young) and the Canadian Stroke Network (PI: Sharon Bruce). Jennifer H. Fergenbaum is the recipient of a Canadian Institute of Health Research doctoral award.	Al-Shali K, 2005, ATHEROSCLEROSIS, V178, P319, DOI 10.1016/j.atherosclerosis.2004.08.016; Bakker FC, 2000, J NEUROL, V247, P669, DOI 10.1007/s004150070108; Beydoun MA, 2008, OBES REV, V9, P204, DOI 10.1111/j.1467-789X.2008.00473.x; Brohall G, 2006, DIABETIC MED, V23, P609, DOI 10.1111/j.1464-5491.2005.01725.x; Bruce SG, 2008, DIABETES CARE, V31, P1837, DOI 10.2337/dc08-0278; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Fidell L.S., 2007, USING MULTIVARIATE S, V5, P481; GLAGOV S, 1987, NEW ENGL J MED, V316, P1371, DOI 10.1056/NEJM198705283162204; Goiledge J, 2008, EUR J VASC ENDOVASC, V35, P2, DOI 10.1016/j.ejvs.2007.09.004; Grant EG, 2003, RADIOLOGY, V229, P340, DOI 10.1148/radiol.2292030516; Gustafson D, 2008, EUR J PHARMACOL, V585, P163, DOI 10.1016/j.ejphar.2008.01.052; Hachinski V, 2006, STROKE, V37, P2220, DOI 10.1161/01.STR.0000237236.88823.47; Haley AP, 2007, INT J CARDIOL, V121, P148, DOI 10.1016/j.ijcard.2006.10.032; HATCHER H, 1994, STEP BY STEP APPROAC; Hester RL, 2005, CLIN NEUROPSYCHOL, V19, P45, DOI 10.1080/13854040490524137; *HLTH CAN, 2005, STAT PROF HLTH 1 NAT; Hofman A, 1997, LANCET, V349, P151, DOI 10.1016/S0140-6736(96)09328-2; Johnston SC, 2004, ANN INTERN MED, V140, P237, DOI 10.7326/0003-4819-140-4-200402170-00005; Juby A, 2002, CAN MED ASSOC J, V167, P859; Keaney John F. Jr., 2000, Molecular Aspects of Medicine, V21, P99, DOI 10.1016/S0098-2997(00)00005-4; Kenny D.A., MEDIATION; Landry A, 2004, STROKE, V35, P864, DOI 10.1161/01.STR.0000121161.61324.ab; Landry A, 2002, MED PHYS, V29, P2319, DOI 10.1118/1.1510130; Lange RT, 2005, J CLIN EXP NEUROPSYC, V27, P897, DOI 10.1080/1380339049091290; Lau DCW, 2005, AM J PHYSIOL-HEART C, V288, pH2031, DOI 10.1152/ajpheart.01058.2004; Launer LJ, 2005, NEUROBIOL AGING, V26, P335, DOI 10.1016/j.neurobiolaging.2004.03.016; Li SX, 2003, JAMA-J AM MED ASSOC, V290, P2271, DOI 10.1001/jama.290.17.2271; Lusis AJ, 2000, NATURE, V407, P233, DOI 10.1038/35025203; Mathiesen EB, 2004, NEUROLOGY, V62, P695, DOI 10.1212/01.WNL.0000113759.80877.1F; Moorhouse P, 2008, LANCET NEUROL, V7, P246, DOI 10.1016/S1474-4422(08)70040-1; Naismith SL, 2003, J CLIN EXP NEUROPSYC, V25, P866, DOI 10.1076/jcen.25.6.866.16472; National Institutes of Health, 2000, NIH PUBL; NORRIS JW, 1992, STROKE, V23, P483, DOI 10.1161/01.STR.23.4.483; Oscar-Berman M, 2007, NEUROPSYCHOL REV, V17, P239, DOI 10.1007/s11065-007-9038-6; Perianez JA, 2007, ARCH CLIN NEUROPSYCH, V22, P433, DOI 10.1016/j.acn.2007.01.022; Qiu CX, 2007, CURR OPIN PSYCHIATR, V20, P380, DOI 10.1097/YCO.0b013e32816ebc7b; Raitakari OT, 2003, JAMA-J AM MED ASSOC, V290, P2277, DOI 10.1001/jama.290.17.2277; Rao R, 2001, EUR NEUROL, V46, P63, DOI 10.1159/000050765; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; Scuteri A, 2004, J AM COLL CARDIOL, V43, P1388, DOI 10.1016/j.jacc.2003.10.061; Stuss DT, 2001, PSYCHOL ASSESSMENT, V13, P230, DOI 10.1037//1040-3590.13.2.230; Tombaugh TN, 2004, ARCH CLIN NEUROPSYCH, V19, P203, DOI 10.1016/S0887-6177(03)00039-8; Tzou WS, 2005, J AM COLL CARDIOL, V46, P457, DOI 10.1016/j.jacc.2005.04.046; Urbina EM, 2002, AM J CARDIOL, V90, P953, DOI 10.1016/S0002-9149(02)02660-7; Wallace TM, 2004, DIABETES CARE, V27, P1487, DOI 10.2337/diacare.27.6.1487	45	8	10	0	3	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	0251-5350	1423-0208		NEUROEPIDEMIOLOGY	Neuroepidemiology		2009	33	4					321	328		10.1159/000254294			8	Public, Environmental & Occupational Health; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health; Neurosciences & Neurology	530MU	WOS:000272597800016	19887837	Bronze			2022-02-06	
J	Hejcl, A; Bolcha, M; Prochazka, J; Sames, M				Hejcl, A.; Bolcha, M.; Prochazka, J.; Sames, M.			Multi-Modal Monitoring of the Brain in Patients with Severe Craniocerebral Trauma and Subarachnoid Hemorrhage in Neurolocritical Care	CESKA A SLOVENSKA NEUROLOGIE A NEUROCHIRURGIE			Czech	Article						traumatic brain injury; vasospasm; monitoring; microdialysis; oxymetry	MICRODIALYSIS; INJURY; HYPERTENSION	The therapy of patients with severe traumatic brain injury and subarachnoid hemorrhage is focused on the prevention and therapy of brain ischemia caused by brain edema and vasospasm. Invasive monitoring of the intracranial pressure and evaluation of vasospasm by transcranial Doppler ultrasonography are a part of clinical routine; while new methods - tissue oxymetry, brain metabolism and cerebral blood flow (so called multimodal monitoring) are still at an early stage in clinical practice. The purpose of implementing these methods is to improve our diagnosis of brain metabolism and early diagnosis of brain ischemia. In this paper we present the contribution of multimodal monitoring in the therapy of patients with brain trauma and subarachnoid hemorrhage as illustrated in four case reports.	[Hejcl, A.; Bolcha, M.; Sames, M.] Masarykova Nemocnice, Neurochirurg Klin, UJEP & Krajska Zdravotni AS, Usti Nad Labem 40113, Czech Republic; [Prochazka, J.] Masarykova Nemocnice, Oddeleni Intenzivni Med, Krajska Zdravotni AS, Usti Nad Labem 40113, Czech Republic		Hejcl, A (corresponding author), Masarykova Nemocnice, Neurochirurg Klin, UJEP & Krajska Zdravotni AS, Socialni Pece 12A, Usti Nad Labem 40113, Czech Republic.	ales.hejcl@mnul.cz	sames, martin/AAJ-2845-2021				Adamides AA, 2006, J NEUROTRAUM, V23, P784; Boret H, 2006, ACTA ANAESTH SCAND, V50, P252, DOI 10.1111/j.1399-6576.2005.00862.x; Filaun M, 2008, CESK SLOV NEUROL N, V71, P657; Flaada JT, 2007, J NEUROTRAUM, V24, P435, DOI 10.1089/neu.2006.0119; Hejcl A, 2007, Cas Lek Cesk, V146, P307; Molyneux AJ, 2005, LANCET, V366, P809, DOI 10.1016/S0140-6736(05)67214-5; Otevrel F, 2007, CESK SLOV NEUROL N, V70, P168; Persson L, 1996, J NEUROSURG, V84, P606, DOI 10.3171/jns.1996.84.4.0606; Sakowitz OW, 2007, J TRAUMA, V62, P292, DOI 10.1097/01.ta.0000203560.03937.2d; Stahl N, 2003, ACTA NEUROL SCAND, V108, P211, DOI 10.1034/j.1600-0404.2003.00095.x; Tisdall MM, 2007, BRIT J ANAESTH, V99, P61, DOI 10.1093/bja/aem143; Unterberg AW, 2001, J NEUROSURG, V94, P740, DOI 10.3171/jns.2001.94.5.0740	12	8	8	0	0	CZECH MEDICAL SOC	PRAGUE 2	SOKOLSKA 31, PRAGUE 2 120 26, CZECH REPUBLIC	1210-7859			CESK SLOV NEUROL N	Cesk. Slov. Neurol. Neurochir.		2009	72	4					383	387					5	Neurosciences; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	486HZ	WOS:000269188200015					2022-02-06	
J	Malec, JF; Mandrekar, JN; Brown, AW; Moessner, AM				Malec, James F.; Mandrekar, Jayawant N.; Brown, Allen W.; Moessner, Anne M.			Injury severity and disability in the selection of next level of care following acute medical treatment for traumatic brain injury	BRAIN INJURY			English	Article						Brain Injury; medical decision-making; rehabilitation	RATING-SCALE; REHABILITATION; PREDICTORS; DISCHARGE; RECOVERY	Primary objective: To evaluate the association of demographic factors, post-traumatic amnesia (PTA) and a standardized measure of ability limitations with clinical decisions for Next Level of Care following acute hospital treatment for moderate-severe traumatic brain injury (TBI). Research design: A TBI Clinical Nurse specialist recorded PTA for 212 individuals and rated 159 on the Ability and Adjustment Indices of the Mayo-Portland Adaptability Inventory (MPAI-4) for comparison with clinical decisions. Main outcomes and results: Multivariate logistic regression analyses revealed that independent ratings on the MPAI-4 Ability Index and PTA were associated with the clinical decision to admit to Inpatient Rehabilitation vs discharge to Home in 92.7% of the sample; ratings on the Ability Index alone were associated with this decision in 92.2% of cases. Age over 65 was the only variable associated with discharge to a Skilled Nursing Facility, correctly predicting this decision in 64% of cases. Conclusions: Use of a standardized measure of ability limitations appears feasible to provide supportive documentation and potentially improve the consistency of decision-making in recommending Inpatient Rehabilitation vs discharge to Home. Although age is a significant factor in the decision to discharge to a Skilled Nursing Facility, this decision appears complex and merits further study.	[Malec, James F.] Rehabil Hosp Indiana, Indianapolis, IN 46254 USA; [Mandrekar, Jayawant N.; Brown, Allen W.; Moessner, Anne M.] Mayo Clin, Coll Med, Rochester, MN USA		Malec, JF (corresponding author), Rehabil Hosp Indiana, 4141 Shore Dr, Indianapolis, IN 46254 USA.	jmalec@rhin.com		Brown, Allen W./0000-0001-7228-3351	National Institute of Disability and Rehabilitation Research (NIDRR)	This research was supported in part by a TBI Model System grant from the National Institute of Disability and Rehabilitation Research (NIDRR) to the Mayo Clinic in Rochester, MN.	Atchison TB, 2004, CLIN NEUROPSYCHOL, V18, P249, DOI 10.1080/13854040490501475; Boake C, 1996, ARCH PHYS MED REHAB, V77, P765, DOI 10.1016/S0003-9993(96)90254-3; Boake C, 2001, ARCH PHYS MED REHAB, V82, P761, DOI 10.1053/apmr.2001.23753; Brown AW, 2005, J NEUROTRAUM, V22, P1040, DOI 10.1089/neu.2005.22.1040; Bush BA, 2003, ARCH PHYS MED REHAB, V84, P1803, DOI 10.1016/S0003-9993(03)00367-8; Chan L, 2001, ARCH PHYS MED REHAB, V82, P1151, DOI 10.1053/apmr.2001.24892; Cifu DX, 1997, ARCH PHYS MED REHAB, V78, P125, DOI 10.1016/S0003-9993(97)90252-5; CREPEAU F, 1993, NEUROPSYCHOL REHABIL, V3, P5; DIKMEN SS, 1994, ARCH NEUROL-CHICAGO, V51, P177, DOI 10.1001/archneur.1994.00540140087018; Esselman PC, 2004, ARCH PHYS MED REHAB, V85, P1445, DOI 10.1016/j.apmr.2003.10.018; EZRACHI O, 1991, J HEAD TRAUMA REHAB, V0006, P00071, DOI DOI 10.1097/00001199-199109000-00010; LEVIN HS, 1995, J NEUROTRAUM, V12, P913, DOI 10.1089/neu.1995.12.913; Malec JF, 2004, BRAIN INJURY, V18, P563, DOI 10.1080/02699050310001646134; Malec JF, 2003, J HEAD TRAUMA REHAB, V18, P479, DOI 10.1097/00001199-200311000-00002; Malec JF, 2000, J HEAD TRAUMA REHAB, V15, P670, DOI 10.1097/00001199-200002000-00006; Mellick D, 2003, BRAIN INJURY, V17, P55, DOI 10.1080/0269905021000010159; Novack TA, 2001, ARCH PHYS MED REHAB, V82, P300, DOI 10.1053/apmr.2001.18222; Wagner AK, 2000, AM J PHYS MED REHAB, V79, P235, DOI 10.1097/00002060-200005000-00004	18	8	8	0	8	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2009	23	1					22	29	PII 906992040	10.1080/02699050802590320			8	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	399FY	WOS:000262787000006	19096971				2022-02-06	
S	Morie, JF; Antonisse, J; Bouchard, S; Chance, E		Wiederhold, BK; Riva, G		Morie, Jacquelyn Ford; Antonisse, Jamie; Bouchard, Sean; Chance, Eric			Virtual Worlds as a Healing Modality for Returning Soldiers and Veterans	ANNUAL REVIEW OF CYBERTHERAPY AND TELEMEDICINE 2009: ADVANCED TECHNOLOGIES IN THE BEHAVIORAL, SOCIAL AND NEUROSCIENCES	Studies in Health Technology and Informatics		English	Article; Book Chapter						Virtual worlds for healing; PTSD; TBI; Complementary and Alternative Medicine; immersion; interactive agents; agent avatars	STRESS REDUCTION; CANCER	Those who have served in recent conflicts face many challenges as they reintegrate into society. In addition to recovering from physical wounds, traumatic brain injury, and post-traumatic stress disorders, many soldiers also face basic psychological issues about who they are and how to find their place in a society that has not shared their experiences. To address these challenges, we have created a space that provides ongoing opportunities for healing activities, personal exploration and social camaraderie in an online virtual world, Second Life. In such worlds, where each avatar is controlled by a live individual, experiences can be unintuitive, uninviting, considered boring, or difficult to control. To counter this, we are implementing autonomous intelligent agent avatars that can be "on duty" 24/7, serving as guides and information repositories, making the space and activities easy to find and even personalized to the visitor's needs. We report the results of usability testing with an in-world veterans' group. Tests comparing soldiers who use this space as part of their reintegration regimen compared to those who do not are being scheduled as part of the Army's Warriors in Transition program.	[Morie, Jacquelyn Ford; Antonisse, Jamie; Bouchard, Sean; Chance, Eric] Univ So Calif, Inst Creat Technol, Los Angeles, CA 90089 USA		Morie, JF (corresponding author), Univ So Calif, Inst Creat Technol, Los Angeles, CA 90089 USA.						Carlson LE, 2005, INT J BEHAV MED, V12, P278, DOI 10.1207/s15327558ijbm1204_9; Holland P., 1995, ART SCI MUSIC THERAP, P406; MILLER JJ, 1995, GEN HOSP PSYCHIAT, V17, P192, DOI 10.1016/0163-8343(95)00025-M; Milliken CS, 2007, JAMA-J AM MED ASSOC, V298, P2141, DOI 10.1001/jama.298.18.2141; *NAT CTR COMPL ALT, CAM IS GROW RESP ASP; Silverman MJ, 2006, MUSIC THER PERSPECT, V24, P4, DOI 10.1093/mtp/24.1.4; Witek-Janusek L, 2008, BRAIN BEHAV IMMUN, V22, P969, DOI 10.1016/j.bbi.2008.01.012	7	8	8	2	4	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	0926-9630		978-1-60750-017-9	STUD HEALTH TECHNOL			2009	144						273	276		10.3233/978-1-60750-017-9-273			4	Psychology, Clinical; Computer Science, Cybernetics; Computer Science, Interdisciplinary Applications; Health Policy & Services; Psychology; Psychology, Social	Book Citation Index – Social Sciences & Humanities (BKCI-SSH); Book Citation Index – Science (BKCI-S)	Psychology; Computer Science; Health Care Sciences & Services	BKZ13	WOS:000269659900063	19592780				2022-02-06	
J	Schlosser, HG; Lindemann, JN; Vajkoczy, P; Clarke, AH				Schlosser, Hans-Georg; Lindemann, Jan-Nikolaus; Vajkoczy, Peter; Clarke, Andrew H.			Vestibulo-ocular monitoring as a predictor of outcome after severe traumatic brain injury	CRITICAL CARE			English	Article							SEVERE HEAD-INJURY; MULTIMODALITY EVOKED-POTENTIALS; VESTIBULAR-NERVE AFFERENTS; APPLIED GALVANIC CURRENTS; MAGNETIC-RESONANCE; COMATOSE PATIENTS; SQUIRREL-MONKEY; STEM LESIONS; CLASSIFICATION; DYSFUNCTION	Introduction Based on the knowledge that traumatic brainstem damage often leads to alteration in brainstem functions, including the vestibulo-ocular reflex, the present study is designed to determine whether prediction of outcome in the early phase after severe traumatic brain injury is possible by means of vestibulo-ocular monitoring. Methods Vestibulo-ocular monitoring is based on video-oculographic recording of eye movements during galvanic labyrinth polarization. The integrity of vestibulo-ocular reflex is determined from the eye movement response during vestibular galvanic labyrinth polarization stimulation. Vestibulo-ocular monitoring is performed within three days after traumatic brain injury and the oculomotor response compared to outcome after six months (Glasgow Outcome Score). Results Twenty-seven patients underwent vestibulo-ocular monitoring within three days after severe traumatic brain injury. One patient was excluded from the study. In 16 patients oculomotor response was induced, in the remaining 11 patients no oculomotor response was observed. The patients' outcome was classified as Glasgow Outcome Score 1-2 or as Glasgow Outcome Score 3 to 5. Statistical testing supported the hypothesis that those patients with oculomotor response tended to recover (exact two-sided Fisher-Test (P<10-3)). Conclusions The results indicate that vestibulo-ocular monitoring with galvanic labyrinth polarization performed during the first days after traumatic brain injury helps to predict favourable or unfavourable outcome. As an indicator of brainstem function, vestibulo-ocular monitoring provides a useful, complementary approach to the identification of brainstem lesions by imaging techniques.	[Schlosser, Hans-Georg; Lindemann, Jan-Nikolaus; Vajkoczy, Peter] Univ Med Berlin, Charite Campus Virchow Klinikum, Dept Neurosurg, D-13353 Berlin, Germany; [Schlosser, Hans-Georg] Univ Med Berlin, Charite Campus Benjamin Franklin, Inst Physiol, D-14195 Berlin, Germany; [Clarke, Andrew H.] Univ Med Berlin, Charite Campus Benjamin Franklin, ENT Vestibular Res Lab, D-12200 Berlin, Germany		Schlosser, HG (corresponding author), Univ Med Berlin, Charite Campus Virchow Klinikum, Dept Neurosurg, Augustenburger Pl 1, D-13353 Berlin, Germany.	hans-georg.schlosser@charite.de			Charite	The authors wish to thank Corinna Naujok (Department of Scientific Graphics, Charite), Sabine Seidlitz (Department of Neurosurgery, Charite), Deniz Saydan (Vestibular Research Laboratory, Charite) and Gerald Splettstosser (Coordinating Center for Clinical Studies, Charite) for their support. This study was supported by university research grants from the Charite (research commission and committee for young scientists).	ADAMS JH, 1985, NEUROPATH APPL NEURO, V11, P299, DOI 10.1111/j.1365-2990.1985.tb00027.x; Amantini A, 2005, CLIN NEUROPHYSIOL, V116, P229, DOI 10.1016/j.clinph.2004.07.008; BOUMA GJ, 1991, J NEUROSURG, V75, P685, DOI 10.3171/jns.1991.75.5.0685; Buettner U W, 1992, Baillieres Clin Neurol, V1, P289; BUETTNER UW, 1989, ARCH NEUROL-CHICAGO, V46, P561, DOI 10.1001/archneur.1989.00520410095030; Bullock R, 1998, J NEUROSURG, V89, P507, DOI 10.3171/jns.1998.89.4.0507; Carpentier A, 2006, J NEUROTRAUM, V23, P674, DOI 10.1089/neu.2006.23.674; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Firsching R, 2002, NEUROL RES, V24, P145, DOI 10.1179/016164102101199684; Firsching R, 2001, ACTA NEUROCHIR, V143, P263; Firsching R, 1998, J NEUROSURG, V89, P707, DOI 10.3171/jns.1998.89.5.0707; Gaetz M, 2004, CLIN NEUROPHYSIOL, V115, P4, DOI 10.1016/S1388-2457(03)00258-X; GALVANI L, 1937, CURA COMITATO CELEBR; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; GOLDBERG JM, 1984, J NEUROPHYSIOL, V51, P1236, DOI 10.1152/jn.1984.51.6.1236; GOLDBERG JM, 1982, BRAIN RES, V252, P156, DOI 10.1016/0006-8993(82)90990-8; GREENBERG RP, 1977, J NEUROSURG, V47, P150, DOI 10.3171/jns.1977.47.2.0150; GREENBERG RP, 1977, J NEUROSURG, V47, P163, DOI 10.3171/jns.1977.47.2.0163; Hillered L, 1998, J NEUROL NEUROSUR PS, V64, P486, DOI 10.1136/jnnp.64.4.486; KIRKPATRICK PJ, 1995, J NEUROSURG, V83, P963, DOI 10.3171/jns.1995.83.6.0963; Mannion RJ, 2007, J NEUROTRAUM, V24, P128, DOI 10.1089/neu.2006.0127; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; MARSHALL LF, 1991, J NEUROSURG, V75, pS28, DOI 10.3171/sup.1991.75.1s.0s28; MARSHALL LF, 1996, OUTCOME PREDICTION S; MEIXENSBERGER J, 1993, ACTA NEUROCHIR, P28; MUELLERJENSEN A, 1987, J NEUROL NEUROSUR PS, V50, P389, DOI 10.1136/jnnp.50.4.389; RAPPAPORT M, 1977, ARCH PHYS MED REHAB, V58, P333; RIFFEL B, 1994, DIAGNOSTIK PROGNOSTI; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Schlosser HG, 2008, EUR J NEUROSCI, V28, P372, DOI 10.1111/j.1460-9568.2008.06331.x; Schlosser HG, 2005, J NEUROSCI METH, V145, P127, DOI 10.1016/j.jneumeth.2004.12.004; Schlosser HG, 2001, NEUROREPORT, V12, P1443, DOI 10.1097/00001756-200105250-00029; SCHLOSSER HG, 2009, MED SCI MONIT, V14; SMITH CE, 1986, BIOL CYBERN, V54, P41, DOI 10.1007/BF00337114; Todd NPM, 2007, CLIN NEUROPHYSIOL, V118, P381, DOI 10.1016/j.clinph.2006.09.025; TOGLIA JU, 1981, ANN NEUROL, V9, P294, DOI 10.1002/ana.410090314	36	8	9	0	5	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1466-609X	1364-8535		CRIT CARE	Crit. Care		2009	13	6							R192	10.1186/cc8187			10	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	556DF	WOS:000274567900021	19948056	Green Published, gold			2022-02-06	
J	Vidali, A				Vidali, Amy			Rhetorical Hiccups: Disability Disclosure in Letters of Recommendation	RHETORIC REVIEW			English	Article								This article positions letters of recommendation as important and troubling indicators of faculty beliefs about diversity and access in higher education. I focus on the disclosure of disability, both by examining the history of disclosing stigmatized difference and by analyzing five letters of recommendation for an aspiring graduate student with a traumatic brain injury. I suggest that faculty must revise their letter-writing practices and engage in a type of rhetorical forecasting that questions well-intentioned disclosures of difference and imagines how various letters form a composite sketch of a candidate.	Univ Colorado Denver, Composit Program, Denver, CO 80202 USA		Vidali, A (corresponding author), Univ Colorado Denver, Composit Program, Denver, CO 80202 USA.						AULT RL, 1993, TEACHING PSYCHOL FEB, P44; BOUTON L, 1995, STUDIES 2 LANGUAGE A, P211; CECI SJ, 1984, AM PSYCHOL       JAN, P29; CHAMBERS E, 2003, DISABILITY STUDI WIN, P3; COLARELLI S, 2002, HUMAN RELATIONS  MAR, P315; COTTON H, 1985, AM J PHILOLOGY   AUT, P328; Cotton Hannah, 1981, DOCUMENTARY LETT REC; DAVIS L, 1999, DISABILITY DIVERS AB, P35; EGER H, 1991, WRITER PERCEPTION WR; FORREST L, 1999, COUNSELING PSYCH SEP, P627; GREENBURG AG, 1994, J SURG RES, V56, P192, DOI 10.1006/jsre.1994.1031; GROTE CL, 2001, PROFESSIONAL PSYCHOL, P655; ILARDI V, 1987, AM HIST REV      DEC, P1127; IVES M, 2000, ADE B, V125, P44; JUNI S, 1997, AM PSYCHOL       DEC, P1386; JURECIC A, 2007, COLL ENGLISH     MAY, P421; LEWIECKIWILSON C, 2008, COLL ENGLISH     JAN, P314; Linton Simi, 1998, CLAIMING DISABILITY; Longmore Paul K., 2001, NEW DISABILITY HIST; LUNNEBORG P, 1973, AM PSYCHOL       FEB, P187; MACFARQUHAR N, 1995, NY TIMES        1012, pB1; MILLER RK, 1988, PROFESSIONAL PSYCHOL, P115; MYERS KR, 2004, J MED HUMANITIES WIN, P255; PETRESS KC, 1999, COLL STUDENT J, P485; PRECHT K, 1998, ENGL SPECIF PURP, P241; RYAN M, 2000, JOURNALISM MASS COMM, P40; SCHALL J, 2006, ACADEME          MAY; SCHALL J, 2005, WRITING LETT RECOMME; SCHNEIDER A, 2000, CHRONICLE HIGHE 0630, pA14; SEKAS G, 1995, ANN INTERNAL ME 0701, P38; SISKIND G, 1966, AM PSYCHOL       AUG, P804; STAKE JE, 1981, PSYCHOL WOMEN Q  SUM, P515; Thomson Rosemarie Garland, 1997, EXTRAORDINARY BODIES; TOMMASI GW, 1998, J BUSINESS PSYCH FAL, P5; TOMPKINS EJ, 1990, ENGLISH J        SEP, P34; Tremain S., 2005, FOUCAULT GOVERNMENTA; Trix F, 2003, DISCOURSE SOC, V14, P191, DOI 10.1177/0957926503014002277; Tsay A, 2003, POETICS, V31, P23, DOI 10.1016/S0304-422X(03)00002-0; Vidali A, 2007, COLL ENGL, V69, P615, DOI 10.2307/25472242; WALTERS AM, 2006, J COLL ADMISSION, P9; WATSON C, 1987, WOMEN LANGUAGE, P26; WEISS GG, 2004, CONT OB GYN     0701, P83; WHALLEY S, 2000, WRITE POWERFUL LETT; Wilcox A, 2005, AM J PHILOLOGY, V126, P237, DOI 10.1353/ajp.2005.0034; [No title captured]; [No title captured]	46	8	8	0	3	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0735-0198	1532-7981		RHETOR REV	Rhetor. Rev.		2009	28	2					185	204		10.1080/07350190902740042			20	Language & Linguistics; Literature	Arts &amp; Humanities Citation Index (A&amp;HCI)	Linguistics; Literature	498CB	WOS:000270112800005					2022-02-06	
J	Patton, D; McIntosh, A				Patton, Declan; McIntosh, Andrew			Head and neck injury risks in heavy metal: head bangers stuck between rock and a hard bass	BMJ-BRITISH MEDICAL JOURNAL			English	Article								Objective To investigate the risks of mild traumatic brain injury and neck injury associated with head banging, a popular dance form accompanying heavy metal music. Design Observational studies, focus group, and biomechanical analysis. Participants Head bangers. Main outcome measures Head Injury Criterion and Neck Injury Criterion were derived for head banging styles and both popular heavy metal songs and easy listening music controls. Results An average head banging song has a tempo of about 146 beats per minute, which is predicted to cause mild head injury when the range of motion is greater than 75 degrees. At higher tempos and greater ranges of motion there is a risk of neck injury. Conclusion To minimise the risk of head and neck injury, head bangers should decrease their range of head and neck motion, head bang to slower tempo songs by replacing heavy metal with adult oriented rock, only head bang to every second beat, or use personal protective equipment.	[Patton, Declan; McIntosh, Andrew] Univ New S Wales, Sch Risk & Safety Sci, Sydney, NSW 2052, Australia		McIntosh, A (corresponding author), Univ New S Wales, Sch Risk & Safety Sci, Sydney, NSW 2052, Australia.	a.mcintosh@unsw.edu.au					BALSAMO T, 2006, EVANESCENCE GUITARIS; BASHAM D, 2001, BASSIST J NEWSTED LE; BENNETT J, 2008, SKY NEWS; BOSTROM O, 1996, INT RES COUNC BIOM I; BRANDLE L, 2003, BILLBOARD B; Brault JR, 1998, ARCH PHYS MED REHAB, V79, P72, DOI 10.1016/S0003-9993(98)90212-X; Clauser CE, 1969, WEIGHT VOLUME CTR MA; DANENBERG MA, 1987, LANG SPEECH HEAR SER, V8, P267; EGNOR M R, 1991, Pediatric Neurosurgery, V17, P135, DOI 10.1159/000120583; Ferrario VF, 2002, J ORTHOPAED RES, V20, P122, DOI 10.1016/S0736-0266(01)00079-1; FINE M, 2008, NIELSEN SOUNDSCAN; JAKOBSSON L, 1999, INT RES COUNC BIOM I; KIMPTON P, 2008, OBSERVER; Kunin M, 2007, J NEUROPHYSIOL, V98, P3095, DOI 10.1152/jn.00764.2007; LEWIS D, 1997, L ZEPPELIN CONCERT F; McConville JT, 1980, ANTHROPOMETRIC RELAT; Neyaz Z, 2006, NEUROL INDIA, V54, P319; Panjabi MM, 2005, J BIOMECH, V38, P1694, DOI 10.1016/j.jbiomech.2004.07.015; SPHEERIS P, 1992, WAYNES WORLD; Spheeris P., 1988, DECLINE W CIVILIZA 2; THOMPSON B, 2008, DAILY TELEGRAPH; TYRELL D, 1998, CRASHWORTHINESS PASS	22	8	8	0	49	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 17	2008	337								a2825	10.1136/bmj.a2825			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	390SW	WOS:000262185000007	19091761	Green Published, hybrid			2022-02-06	
J	Infanti, JL				Infanti, Jennifer L.			Challenging the Gold Standard: Should Mannitol Remain Our First-Line Defense Against Intracranial Hypertension?	JOURNAL OF NEUROSCIENCE NURSING			English	Article								Mannitol has long been the "gold standard" for treatment of cerebral edema and refractory intracranial hypertension in traumatic brain injury, subarachnoid hemorrhage, and stroke. Studies performed in animals have shown that hypertonic saline (HS), in doses ranging from 3% to 10%, may be more effective than mannitol in treating these populations. Recently, randomized clinical trials have evaluated the efficacy and safety of HS versus mannitol in the treatment of elevated intracranial pressure (ICP). This research has been prompted by mounting concern about the side effects of mannitol, the limited ability to give multiple doses of the drug, and an increased understanding of cerebral physiology. Four studies have compared the use of HS and mannitol in brain-injured populations. These studies have shown that not only is HS a safe drug (no patients experienced adverse effects), it is also more efficient in reducing ICP. Efficiency is defined as the drug's ability to decrease ICP to acceptable levels and to maintain lower ICPs for a longer duration of time. It is important for nurses who administer osmotic diuretics to evaluate and understand the current research to provide educated and appropriate care.	Hosp Univ Penn, Surg ICU, Philadelphia, PA 19104 USA		Infanti, JL (corresponding author), Hosp Univ Penn, Surg ICU, 3400 Spruce St, Philadelphia, PA 19104 USA.	j_infanti@yahoo.com					Abadal-Centellas JM, 2007, J TRAUMA, V62, P282, DOI 10.1097/01.ta.0000199422.01949.78; Anderson JT, 1997, J TRAUMA, V42, P592, DOI 10.1097/00005373-199704000-00003; Battison C, 2005, CRIT CARE MED, V33, P196, DOI 10.1097/01.CCM.0000150269.65485.A6; Decaux G, 2003, AM J MED SCI, V326, P25, DOI 10.1097/00000441-200307000-00004; Doyle JA, 2001, J TRAUMA, V50, P367, DOI 10.1097/00005373-200102000-00030; Hariri R J, 1994, Neurosurg Clin N Am, V5, P687; Prough DS, 1998, CRIT CARE MED, V26, P997, DOI 10.1097/00003246-199806000-00013; Qureshi AI, 1999, NEUROSURGERY, V44, P1055, DOI 10.1097/00006123-199905000-00064; Qureshi AI, 1998, CRIT CARE MED, V26, P440, DOI 10.1097/00003246-199803000-00011; Rabinstein AA, 2006, NEUROLOGIST, V12, P59, DOI 10.1097/01.nrl.0000186810.62736.f0; Schwarz S, 1998, STROKE, V29, P1550, DOI 10.1161/01.STR.29.8.1550; Schwarz S, 2002, STROKE, V33, P136, DOI 10.1161/hs0102.100877; Treib J, 1996, TRANSFUSION, V36, P450, DOI 10.1046/j.1537-2995.1996.36596282590.x; Vialet R, 2003, CRIT CARE MED, V31, P1683, DOI 10.1097/01.CCM.0000063268.91710.DF; WALSH JC, 1991, J SURG RES, V50, P284, DOI 10.1016/0022-4804(91)90192-O; Zemlan FP, 2002, BRAIN RES, V947, P131, DOI 10.1016/S0006-8993(02)02920-7	16	8	10	1	7	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0888-0395			J NEUROSCI NURS	J. Neurosci. Nurs.	DEC	2008	40	6					362	368		10.1097/01376517-200812000-00009			7	Clinical Neurology; Nursing	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Nursing	V13AM	WOS:000207639700009	19170304				2022-02-06	
J	Long, E; McDonald, S; Tate, R; Togher, L; Bornhofen, C				Long, Esther; McDonald, Skye; Tate, Robyn; Togher, Leanne; Bornhofen, Cristina			Assessing Social Skills in People With Very Severe Traumatic Brain Injury: Validity of the Social Performance Survey Schedule (SPSS)	BRAIN IMPAIRMENT			English	Article						social skills; traumatic brain injury; assessment	KATZ ADJUSTMENT SCALE; BLUNT HEAD-INJURY; PSYCHOSOCIAL RECOVERY; COMMUNICATION-SKILLS; BEHAVIOR; REHABILITATION; IMPAIRMENT; PREDICTION; RATIONALE; COMMUNITY	The current study was designed to determine whether the Social Performance Survey Schedule (SPSS; Lowe & Cautela, 1978) is a useful measure of social skills in people with traumatic brain injuries (TBI). Forty-nine adults with TBI were compared on the SPSS to 190 adults without injuries. The validity of the SPSS was also investigated in relation to another measure of social performance, the first scale of the Katz Adjustment Scale (KAS-R1; Katz & Lyerly, 1963) and a broad measure of social function (the SPRS; Tate, Hodgkinson, Veerabangsa, & Maggiotto, 1999). Individuals with TBI had significantly lower scores on the positive scale of the SPSS than nonbrain-injured individuals. They did not have lower scores on the SPSS negative scale relative to the normative sample. Significant correlations with the KAS-R1 and SPRS provided evidence for the construct and criterion validity of SPSS within this population. In conclusion, this study suggests that where an appropriate normative sample is used, the positive subscale of the SPSS is a sound measure for detecting the extent and nature of deficits in prosocial behaviour seen in TBI, but raises the question as to how we define negative behaviours in the 21st century on scales such as the SPSS.	[Long, Esther; McDonald, Skye; Bornhofen, Cristina] Univ New S Wales, Sch Psychol, Sydney, NSW 2052, Australia; [Tate, Robyn; Togher, Leanne] Univ Sydney, Rehabil Studies Unit, Fac Med, Sydney, NSW 2006, Australia; Univ Sydney, Fac Hlth Sci, Sydney, NSW 2006, Australia		McDonald, S (corresponding author), Univ New S Wales, Sch Psychol, Sydney, NSW 2052, Australia.	smcdonald@psy.unsw.edu.au	Togher, Leanne/AAC-7083-2019; McDonald, Skye/G-4118-2014	McDonald, Skye/0000-0003-0723-6094; Togher, Leanne/0000-0002-4518-6748			Azouvi P, 1999, BRAIN INJURY, V13, P797, DOI 10.1080/026990599121188; Baker KA, 1998, REHABIL PSYCHOL, V43, P30, DOI 10.1037/0090-5550.43.1.30; BOND MR, 1976, ACTA NEUROCHIR, V34, P57, DOI 10.1007/BF01405863; BOND MR, 1975, OUTC SEV DAM CENTR N, P34; BROOKS N, 1986, J NEUROL NEUROSUR PS, V49, P764, DOI 10.1136/jnnp.49.7.764; Brooks N, 1987, Brain Inj, V1, P5, DOI 10.3109/02699058709034439; Dahlberg C, 2006, BRAIN INJURY, V20, P425, DOI 10.1080/02699050600664574; Dahlberg CA, 2007, ARCH PHYS MED REHAB, V88, P1561, DOI 10.1016/j.apmr.2007.07.033; ELSASS L, 1987, PSYCHOL MED, V17, P67, DOI 10.1017/S003329170001299X; EZRACHI O, 1991, J HEAD TRAUMA REHAB, V0006, P00071, DOI DOI 10.1097/00001199-199109000-00010; FABIANO RJ, 1992, REHABIL PSYCHOL, V37, P75, DOI 10.1037/h0079096; Godfrey HPD, 2000, APHASIOLOGY, V14, P433, DOI 10.1080/026870300401441; GORAN DA, 1993, BRAIN INJURY, V7, P219, DOI 10.3109/02699059309029674; Hanks RA, 1999, ARCH PHYS MED REHAB, V80, P991, DOI 10.1016/S0003-9993(99)90049-7; HOGARTY GE, 1971, ARCH GEN PSYCHIAT, V25, P470; JACKSON H F, 1992, Brain Injury, V6, P109, DOI 10.3109/02699059209029650; JOHNSON DA, 1987, BRIT J CLIN PSYCHOL, V26, P289, DOI 10.1111/j.2044-8260.1987.tb01362.x; KATZ MM, 1963, PSYCHOL REP, V13, P503, DOI 10.2466/pr0.1963.13.2.503; KINSELLA G, 1991, J NEUROL NEUROSUR PS, V54, P422, DOI 10.1136/jnnp.54.5.422; Kuipers P, 2004, BRAIN INJURY, V18, P161, DOI 10.1080/0269905031000149524; Lanham RA, 2000, J HEAD TRAUMA REHAB, V15, P1123, DOI 10.1097/00001199-200010000-00006; Lezak M.D., 1987, J HEAD TRAUMA REHAB, V2, P57, DOI DOI 10.1097/00001199-198703000-00009; LOWE MR, 1985, BEHAV MODIF, V9, P193, DOI 10.1177/01454455850092004; LOWE MR, 1978, BEHAV THER, V9, P535, DOI 10.1016/S0005-7894(78)80126-9; LOWE MR, 1982, PSYCHOL REP, V50, P83, DOI 10.2466/pr0.1982.50.1.83; LOWE MR, 1985, J PSYCHOPATHOL BEHAV, V7, P13, DOI 10.1007/BF00961843; MARSH NV, 1999, BRAIN DAM B, P175; MATSON JL, 1983, APPL RES MENT RETARD, V4, P399, DOI 10.1016/0270-3092(83)90038-3; McDonald S, 2004, NEUROPSYCHOL REHABIL, V14, P285, DOI 10.1080/09602010343000237; McDonald S., 2003, BRAIN IMPAIR, V4, P36, DOI [10.1375/brim.4.1.36.27032, DOI 10.1375/BRIM.4.1.36.27032, DOI 10.1375/brim.4.1.36.27032]; McDonald S, 2008, ARCH PHYS MED REHAB, V89, P1648, DOI 10.1016/j.apmr.2008.02.029; MCMORDIE W R, 1990, Brain Injury, V4, P57, DOI 10.3109/02699059009026149; MILLER LS, 1984, BEHAV ASSESS, V6, P33; NEWTON A, 1985, BRIT J CLIN PSYCHOL, V24, P225, DOI 10.1111/j.2044-8260.1985.tb00655.x; PONSFORD JL, 1995, BRAIN INJURY, V9, P1, DOI 10.3109/02699059509004565; PONSFORD JL, 1995, BRAIN INJURY, V9, P11, DOI 10.3109/02699059509004566; STAMBROOK M, 1990, COGNITIVE REHABILITA, V8, P26; Tate R, 1999, J HEAD TRAUMA REHAB, V14, P543, DOI 10.1097/00001199-199912000-00003; TATE RL, 1991, J NERV MENT DIS, V179, P117, DOI 10.1097/00005053-199103000-00001; TATE RL, 1989, ACTA NEUROL SCAND, V79, P97, DOI 10.1111/j.1600-0404.1989.tb03719.x; TATE RL, 1999, J NEUROL NEUROSUR PS, V52, P1128; THOMSEN IV, 1984, J NEUROL NEUROSUR PS, V47, P260, DOI 10.1136/jnnp.47.3.260; VILKKI J, 1994, J CLIN EXP NEUROPSYC, V16, P325, DOI 10.1080/01688639408402643; WechslerD, 2001, WECHSLER TEST ADULT; WEDDELL R, 1980, PSYCHOL MED, V10, P257, DOI 10.1017/S0033291700044019; Ylvisaker Mark, 2005, Seminars in Speech and Language, V26, P256, DOI 10.1055/s-2005-922104	46	8	8	0	11	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1443-9646	1839-5252		BRAIN IMPAIR	Brain Impair.	DEC	2008	9	3					274	281		10.1375/brim.9.3.274			8	Clinical Neurology; Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	390UT	WOS:000262189900004					2022-02-06	
J	Schoenberg, MR; Saklofske, DH; Lange, RT; Suarez, M; Brickell, TA				Schoenberg, Mike R.; Saklofske, Donald H.; Lange, Rael T.; Suarez, Mariann; Brickell, Tracey A.			Validation of the Child Premorbid Intelligence Estimate Method to Predict Premorbid Wechsler Intelligence Scale for Children-Fourth Edition Full Scale IQ Among Children With Brain Injury	PSYCHOLOGICAL ASSESSMENT			English	Article						premorbid; intelligence; IQ; WISC-IV; predict	REGRESSION-BASED METHODS; FALSE DISCOVERY RATE; PERFORMANCE; REORGANIZATION; ACHIEVEMENT; PLASTICITY; HEMISPHERE; ACCURACY; LANGUAGE; OUTCOMES	Determination of neuropsychological impairment involves contrasting obtained performances with a comparison standard, which is often an estimate of premorbid IQ. M. R. Schoenberg, R. T. Lange, T. A. Brickell, and D. H. Saklofske (2007) proposed the Child Premorbid Intelligence Estimate (CPIE) to predict premorbid Full Scale IQ (FSIQ) using the Wechsler Intelligence Scale for Children-4th Edition (WISC-IV; Wechsler, 2003). The CPIE includes 12 algorithms to predict FSIQ, 1 using demographic variables and 11 algorithms combining WISC-IV subtest raw scores with demographic variables. The CPIE was applied to a sample of children with acquired traumatic brain injury (TBI sample; n = 40) and a healthy demographically matched sample (n = 40). Paired-samples t tests found estimated premorbid FSIQ differed from obtained FSIQ when applied to the TBI sample (ps <=.01). When applied to healthy peers, estimated and obtained FSIQ did not differ(ps >.02). The demographic only algorithm performed well at a group level, but estimates were restricted in range. Algorithms combining single subtest scores with demographics performed adequately. Results support the clinical application of the CPIE algorithms. However, limitations to estimating individual premorbid ability, including statistical and developmental factors, must be considered.	[Schoenberg, Mike R.; Suarez, Mariann] Univ S Florida, Coll Med, Dept Psychiat & Behav Sci, Tampa, FL 33613 USA; [Lange, Rael T.; Brickell, Tracey A.] British Columbia Mental Hlth & Addict Serv, Dept Res, Vancouver, BC, Canada; [Lange, Rael T.] Univ British Columbia, Dept Psychiat, Vancouver, BC, Canada; [Saklofske, Donald H.] Univ Calgary, Div Appl Psychol, Calgary, AB, Canada		Schoenberg, MR (corresponding author), Univ S Florida, Coll Med, Dept Psychiat & Behav Sci, 3515 E Fletcher Ave, Tampa, FL 33613 USA.	mschoenb@health.usf.edu	Schoenberg, Mike R/J-9018-2012	Schoenberg, Mike/0000-0003-1355-3651			Baade LE, 2004, ARCH CLIN NEUROPSYCH, V19, P227, DOI 10.1016/S0887-6177(03)00092-1; Baron I. S., 2004, NEUROPSYCHOLOGICAL E; Benjamini Y, 2001, ANN STAT, V29, P1165; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; *DSS RES, 2006, STAT POW CALC 2 SAMP; Ewing-Cobbs L, 2003, DEV NEUROPSYCHOL, V24, P669, DOI 10.1207/S15326942DN242&3_08; Graves RE, 1999, PSYCHOL ASSESSMENT, V11, P29, DOI 10.1037/1040-3590.11.1.29; Hertz-Pannier L, 2002, BRAIN, V125, P361, DOI 10.1093/brain/awf020; Kaufman AlanS., 1990, ASSESSING ADOLESCENT; KLESGES RC, 1981, J CONSULT CLIN PSYCH, V49, P141, DOI 10.1037/0022-006X.49.1.141; Lezak MD., 1995, NEUROPSYCHOLOGICAL A, V3rd; Liegeois F, 2004, BRAIN, V127, P1229, DOI 10.1093/brain/awh159; MCFIE J, 1975, ASSESSMENT ORGANIC I; McNemar Q, 1947, PSYCHOMETRIKA, V12, P153, DOI 10.1007/BF02295996; Papanicolaou AC, 2001, J CHILD NEUROL, V16, P241; Powell BD, 2003, ARCH CLIN NEUROPSYCH, V18, P277, DOI 10.1016/S0887-6177(02)00135-X; Psychological Corporation, 2001, MAN WECHSL TEST AD R; Reynolds CR, 1997, ARCH CLIN NEUROPSYCH, V12, P769, DOI 10.1016/S0887-6177(97)00051-6; REYNOLDS CR, 1979, CLIN NEUROPSYCHOLOGY, V1, P36; ROSENTHAL R, 1994, PSYCHOL SCI, V5, P329, DOI 10.1111/j.1467-9280.1994.tb00281.x; Sattler J.M., 2001, ASSESSMENT CHILDREN; Schinka J. A., 2000, CLIN GUIDE NEUROPSYC, P39; Schoenberg MR, 2007, J CHILD NEUROL, V22, P379, DOI 10.1177/0883073807301925; Schoenberg MR, 2004, ARCH CLIN NEUROPSYCH, V19, P1103, DOI 10.1016/j.acn.2003.12.008; Schoenberg MR, 2002, CLIN NEUROPSYCHOL, V16, P426, DOI 10.1076/clin.16.4.426.13913; Tabachnick B. G., 2013, USING MULTIVARIATE S, V6th; Taylor H G, 1997, J Int Neuropsychol Soc, V3, P555; Taylor HG, 2002, NEUROPSYCHOLOGY, V16, P15, DOI 10.1037//0894-4105.16.1.15; Taylor HG, 2001, J INT NEUROPSYCH SOC, V7, P755, DOI 10.1017/S1355617701766118; Vanderploeg RD, 1998, PSYCHOL ASSESSMENT, V10, P277, DOI 10.1037/1040-3590.10.3.277; Veiel HOF, 2001, PSYCHOL ASSESSMENT, V13, P356, DOI 10.1037/1040-3590.13.3.356; Wechsler D., 1974, MANUAL WECHSLER INTE; Wechsler D, 2003, WECHSLER INTELLIGENC; Wechsler D., 1958, MEASUREMENT APPRAISA; Wechsler D, 1991, WECHSLER INTELLIGENC, VTHIRD; WILSON RS, 1978, J CONSULT CLIN PSYCH, V46, P1554, DOI 10.1037/0022-006X.46.6.1554; YATES AJ, 1956, J MENT SCI, V102, P409, DOI 10.1192/bjp.102.428.409; YEATES K, 1997, J INT NEUROPSYCH SOC, V6, P617; Yeates KO, 1997, J CLIN EXP NEUROPSYC, V19, P825, DOI 10.1080/01688639708403763; [No title captured]	40	8	8	0	4	AMER PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA	1040-3590	1939-134X		PSYCHOL ASSESSMENT	Psychol. Assess.	DEC	2008	20	4					377	384		10.1037/a0014010			8	Psychology, Clinical	Social Science Citation Index (SSCI)	Psychology	383HD	WOS:000261663800007	19086761				2022-02-06	
J	Sinha, VD; Gupta, V; Singh, DK; Chopra, S; Gupta, P; Bagaria, H				Sinha, V. D.; Gupta, Vishnu; Singh, Deepak Kumar; Chopra, Sanjeev; Gupta, Pankaj; Bagaria, H.			Geriatric head injuries - Experience and expectations	INDIAN JOURNAL OF NEUROTRAUMA			English	Article						aged population; elderly trauma; geriatric; head injury; outcome		It is widely known that global citizenry is continuing to age. The elderly head trauma patients, comprising 4.83% in our series are important from neurosurgical aspects. We conducted a study of elderly head injury patients admitted to our unit in last 11 years. Out of 620 patients, 423 males and 197 female, constituting a ratio of 2.1: 1. Fall constitutes the principle mode of injury (56.29%) followed by RTA (44.1%). We analyzed all the cases for surgical intervention after careful assessment of neurological condition. Amongst all cases operated for acute trauma, good recovery was seen in 51.8% and mortality in 41.7%, whereas in chronic subdural haematoma 84.2% cases showed good recovery as against mortality in 10.5%. In our society, due to very close family ties and desperation of family members to try active intervention even in patients with expected bleak outcome, we operated a fairly large number of cases and concluded that outcome was better after operative intervention.	[Sinha, V. D.; Gupta, Vishnu; Singh, Deepak Kumar; Chopra, Sanjeev; Gupta, Pankaj; Bagaria, H.] SMS Med Coll & Hosp, Dept Neurosurg, Jaipur 302004, Rajasthan, India		Sinha, VD (corresponding author), 53 Moji Colony Pradhan Marg,Malviya Nagar, Jaipur 302017, Rajasthan, India.	sinhavd@yahoo.com	Singh, Deepak/ABE-3605-2020	Singh, Deepak/0000-0001-9973-5557			AMACHER AL, 1987, NEUROSURGERY, V20, P954; BRAAKMAN R, 1980, J NEUROSURG, V6, P362; Callaway DW, 2007, EMERG MED CLIN N AM, V25, P837, DOI 10.1016/j.emc.2007.06.005; JAMJOOM A, 1992, BRIT J NEUROSURG, V6, P27, DOI 10.3109/02688699209002898; JENNETT B, 1975, LANCET, V1, P480; Jennett B., 1982, NEUROLOGICAL DISORDE, P202; KLUN B, 1984, ACTA NEUROCHIR, V71, P171, DOI 10.1007/BF01401312; KOTWICA Z, 1992, ACTA NEUROCHIR, V118, P98, DOI 10.1007/BF01401293; Le Roux AA, 2007, BRIT J NEUROSURG, V21, P16, DOI 10.1080/02688690601170692; LEVATI A, 1982, J NEUROSURG, V57, P779, DOI 10.3171/jns.1982.57.6.0779; Lewis Michael C, 2007, Anesthesiol Clin, V25, P75, DOI 10.1016/j.atc.2006.11.002; Maurice-Williams RS, 1999, BRIT J NEUROSURG, V13, P5, DOI 10.1080/02688699944104; MILLER JD, 1992, BRIT J SURG, V79, P60, DOI 10.1002/bjs.1800790122; ORESKOVICH MR, 1984, J TRAUMA, V24, P565, DOI 10.1097/00005373-198407000-00003; Park K., 2005, TXB PREVENTIVE SOCIA, P434; PENTLAND B, 1986, AGE AGEING, V15, P193, DOI 10.1093/ageing/15.4.193; Reuter F, 1989, ADV NEUROSURG, V17, P43; Thompson HJ, 2006, J AM GERIATR SOC, V54, P1590, DOI 10.1111/j.1532-5415.2006.00894.x; ZWIMPFER TJ, 1993, CRIT CARE CLIN, V9, P727, DOI 10.1016/S0749-0704(18)30166-0	19	8	8	0	0	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0973-0508	2213-3739		INDIAN J NEUROTRAUM	Indian J. Neurotrauma	DEC	2008	5	2					69	73					5	Neurosciences	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	V3M0P	WOS:000218379000003					2022-02-06	
J	Aguerrevere, LE; Greve, KW; Bianchini, KJ; Meyers, JE				Aguerrevere, Luis E.; Greve, Kevin W.; Bianchini, Kevin J.; Meyers, John E.			Detecting malingering in traumatic brain injury and chronic pain with an abbreviated version of the Meyers Index for the MMPI-2	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article						MMPI; Malingering; Chronic pain; Traumatic brain injury	RELIABLE DIGIT SPAN; NEUROCOGNITIVE DYSFUNCTION; SENSITIVITY; SPECIFICITY	Meyers, Millis, and Volkert [Meyers, J. E., Millis, S. R., & Volkert, K. (2002). A validity index for the MMPI-2. Archives of Clinical Neuropsychology, 17, 157-169] developed a method to detect malingering in chronic pain patients using seven scales from the Minnesota Multiphasic Inventory-2 (MMPI-2). This method may be impractical because two of the scales (Obvious minus Subtle and Dissimulation-revised) are not reported by the commercially available Pearson computerized scoring system. The current study recalculated the Meyers Index using the five Pearson-provided scales in the chronic pain data sets of Meyers et al. [Meyers, J. E., Millis, S. R., & Volkert, K. (2002). A validity index for the MMPI-2. Archives of Clinical Neuropsychology, 17, 157-169] and Bianchini, Etherton, Greve, Heinly, and Meyers [Bianchini, K. J., Etherton, J. L., Greve, K. W., Heinly, M. T., & Meyers, J. E. (in press). Classification accuracy of MMPI-2 validity scales in the detection of pain-related malingering: A known-groups approach. Assessment], and the traumatic brain injury data of Greve, Bianchini, Love, Brennan, and Heinly [Greve, K. W., Bianchini, K. J., Love, J. M., Brennan, A., & Heinly, M. T. (2006). Sensitivity and specificity of MMPI-2 validity scales and indicators to malingered neurocognitive dysfunction in traumatic brain injury. The Clinical Neuropsychologist, 20, 491-512]. Classification accuracy of the abbreviated Meyers Index was comparable to the original. These findings demonstrate that the abbreviated Meyers Index can be used as a substitute of the original Meyers Index without decrements in classification accuracy. (C) 2008 Published by Elsevier Ltd on behalf of National Academy of Neuropsychology.	[Aguerrevere, Luis E.; Greve, Kevin W.; Bianchini, Kevin J.] Univ New Orleans Lakefront, Dept Psychol, New Orleans, LA 70148 USA; [Aguerrevere, Luis E.; Greve, Kevin W.; Bianchini, Kevin J.] Jefferson Neurobehav Grp, Metairie, LA USA; [Meyers, John E.] Ctr Neurosci Orthoped & Spine, Dakota Dunes, SD USA		Greve, KW (corresponding author), Univ New Orleans Lakefront, Dept Psychol, New Orleans, LA 70148 USA.	kgreve@uno.edu	Aguerrevere, Luis/P-5684-2019	Aguerrevere, Luis/0000-0001-9160-1044			Bianchini Kevin J, 2005, Spine J, V5, P404, DOI 10.1016/j.spinee.2004.11.016; BIANCHINI KJ, ASSESSMENT IN PRESS; Etherton J, 2005, ASSESSMENT, V12, P130, DOI 10.1177/1073191105274859; Etherton JL, 2005, ASSESSMENT, V12, P101, DOI 10.1177/1073191104270789; Friedman A.F., 2001, PSYCHOL ASSESSMENT M, V2nd ed.; Graham J.R., 1990, MMPI 2 ASSESSING PER; Greene RL, 2000, MMPI 2 INTERPRETIVE; Greve KW, 2006, CLIN NEUROPSYCHOL, V20, P491, DOI 10.1080/13854040590967144; Kaemmer, 1989, MMPI 2 MANUAL ADM SC; Lees-Haley PR, 2002, J FORENSIC NEUROPSYC, V3, P167, DOI DOI 10.1300/J151V03N01_01; LEESHALEY PR, 1991, PSYCHOL REP, V68, P203, DOI 10.2466/PR0.68.1.203-210; Meyers JE, 2002, ARCH CLIN NEUROPSYCH, V17, P157, DOI 10.1016/S0887-6177(00)00107-4; Slick DJ, 1999, CLIN NEUROPSYCHOL, V13, P545, DOI 10.1076/1385-4046(199911)13:04;1-Y;FT545	13	8	9	0	7	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0887-6177	1873-5843		ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	NOV-DEC	2008	23	7-8					831	838		10.1016/j.acn.2008.06.008			8	Psychology, Clinical; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	384QI	WOS:000261758900009	18715751	Bronze			2022-02-06	
J	Bell, MJ; Kochanek, PM				Bell, Michael J.; Kochanek, Patrick M.			Traumatic Brain Injury in Children: Recent Advances in Management	INDIAN JOURNAL OF PEDIATRICS			English	Article						Head injury; Child abuse; Shaken baby syndrome; Hypothermia; Treatment; Guidelines; Pediatric	EARLY DECOMPRESSIVE CRANIECTOMY; CEREBRAL PERFUSION-PRESSURE; MILD SYSTEMIC HYPOTHERMIA; SEVERE HEAD-INJURIES; CEREBROSPINAL-FLUID; INTRACRANIAL-PRESSURE; TRANSCRANIAL DOPPLER; TISSUE PO2; INFANTS; TRIAL	To define and discuss new developments in the field of pediatric traumatic brain injury (TBI). Review of several recent key studies on therapy since publication of the first U. S. traumatic brain injury guidelines in 2003. In addition, we discuss new developments in the use of biomarkers of brain injury in TBI diagnosis and also discuss recent advances in bedside neuromonitoring that may be helpful in the setting of pediatric brain injury. Important new information on optimal cerebral perfusion pressure management, cerebrospinal fluid drainage, decompressive craniectomy, hypothermia, biomarkers of brain injury along with advances in neuromonitoring are presented. The 2003 guidelines have stimulated important new research. This is reshaping bedside care. [Indian J Pediatr 2008; 75 (11) : 1159-1165] E-mail: kochanekpm@ccm.upmc.edu	[Kochanek, Patrick M.] Univ Pittsburgh, Sch Med, Dept Crit Care Med, Safar Ctr Resuscitat Res, Pittsburgh, PA 15260 USA; Univ Pittsburgh, Med Ctr, Childrens Hosp Pittsburgh, Pittsburgh, PA 15260 USA		Kochanek, PM (corresponding author), Univ Pittsburgh, Sch Med, Dept Crit Care Med, Safar Ctr Resuscitat Res, 3434 5th Ave, Pittsburgh, PA 15260 USA.		Kochanek, Patrick M/D-2371-2015	Kochanek, Patrick M/0000-0002-2627-913X	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS38087, NS 30318]; CDC/University of Pittsburgh Center for Injury Research and ControlUniversity of PittsburghUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA; United Cerebral Palsy Foundation;  [HD044716];  [HD049981];  [NS052478]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [U10HD049981, UG1HD049981] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K08HD044716] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P50NS030318, P20NS030318, R01NS038087, P01NS030318, U01NS052478] Funding Source: NIH RePORTER	Dr. Kochanek is supported by NIH NS38087 and NS 30318, and the CDC/University of Pittsburgh Center for Injury Research and Control. Dr. Bell is supported by HD044716, HD049981, NS052478 and United Cerebral Palsy Foundation.	Adelson PD, 2003, CRIT CARE MED, V31, pS418, DOI 10.1097/00003246-200306006-00002; Adelson PD, 2005, NEUROSURGERY, V56, P740, DOI 10.1227/01.NEU.0000156471.50726.26; American Association for the Surgery of Trauma, 2003, J Trauma, V54, pS235; Bardt TF, 1998, ACT NEUR S, V71, P153; BARZILAY Z, 1988, INTENS CARE MED, V14, P417, DOI 10.1007/BF00262899; Battin MR, 2003, PEDIATRICS, V111, P244, DOI 10.1542/peds.111.2.244; Bayir H, 2007, ANN NEUROL, V62, P154, DOI 10.1002/ana.21168; Berger RP, 2006, DEV NEUROSCI-BASEL, V28, P327, DOI 10.1159/000094158; Berger RP, 2006, PEDIATRICS, V117, P325, DOI 10.1542/peds.2005-0711; Bernard SA, 2002, NEW ENGL J MED, V346, P557, DOI 10.1056/NEJMoa003289; Buttram SDW, 2007, J NEUROTRAUM, V24, P1707, DOI 10.1089/neu.2007.0349; Carney Nancy A, 2003, Pediatr Crit Care Med, V4, pS1; Chambers IR, 2005, CHILD NERV SYST, V21, P195, DOI 10.1007/s00381-004-1060-x; Clifton GL, 2001, NEW ENGL J MED, V344, P556, DOI 10.1056/NEJM200102223440803; Clifton GL, 2001, J NEUROSURG, V95, P751, DOI 10.3171/jns.2001.95.5.0751; COURJON J, 1970, EPILEPSIA, V11, P29, DOI 10.1111/j.1528-1157.1970.tb03863.x; Downard C, 2000, J TRAUMA, V49, P654, DOI 10.1097/00005373-200010000-00012; ELIASJONES AC, 1992, ARCH DIS CHILD, V67, P1430, DOI 10.1136/adc.67.12.1430; Figaji AA, 2003, CHILD NERV SYST, V19, P666, DOI 10.1007/s00381-003-0804-3; Forsyth RJ, 2008, PEDIATR CRIT CARE ME, V9, P8, DOI 10.1097/01.PCC.0000298759.78616.3A; Gao WM, 2007, J NEUROTRAUM, V24, P43, DOI 10.1089/neu.2006.0061; Gleckman AM, 1999, ARCH PATHOL LAB MED, V123, P146; Gluckman PD, 2005, LANCET, V365, P663, DOI 10.1016/S0140-6736(05)17946-X; GRAND W, 1974, J NEUROL NEUROSUR PS, V37, P178, DOI 10.1136/jnnp.37.2.178; Hartl R, 1997, ACT NEUR S, V70, P40; Hutchison JS, 2008, NEW ENGL J MED, V358, P2447, DOI 10.1056/NEJMoa0706930; Imberti R, 2002, J NEUROSURG, V96, P97, DOI 10.3171/jns.2002.96.1.0097; Jagannathan J, 2007, J NEUROSURG, V106, P268, DOI 10.3171/ped.2007.106.4.268; Jenny C, 1999, JAMA-J AM MED ASSOC, V281, P621, DOI 10.1001/jama.281.7.621; KAISER G, 1984, NEUROPEDIATRICS, V15, P68, DOI 10.1055/s-2008-1052344; Kiening KL, 1997, NEUROL RES, V19, P233, DOI 10.1080/01616412.1997.11740805; Kochanek AR, 2006, DEV NEUROSCI-BASEL, V28, P410, DOI 10.1159/000094167; Kochanek PM, 2006, DEV NEUROSCI-BASEL, V28, P244, DOI 10.1159/000094151; Lang EW, 2003, CRIT CARE MED, V31, P267, DOI 10.1097/00003246-200301000-00042; MARION DW, 2002, NEW ENGL J MED, V346, P549; Narotam PK, 2006, J PEDIATR SURG, V41, P505, DOI 10.1016/j.jpedsurg.2005.11.069; Natale JE, 2007, PEDIATR CRIT CARE ME, V8, P1, DOI 10.1097/01.pcc.0000256620.55512.5f; Nenadovic V, 2008, J NEUROTRAUM, V25, P615, DOI 10.1089/neu.2007.0474; Berger RP, 2006, PEDIATR CRIT CARE ME, V7, P557, DOI 10.1097/01.PCC.0000244426.37793.23; POVLISHOCK JT, 1992, J NEUROTRAUM, V9, pS189; Ract C, 2007, INTENS CARE MED, V33, P645, DOI 10.1007/s00134-007-0558-6; Rozsa L, 1989, Radiol Diagn (Berl), V30, P151; Ruf B, 2003, CRIT CARE, V7, pR133, DOI 10.1186/cc2361; Shankaran S, 2005, NEW ENGL J MED, V353, P1574, DOI 10.1056/NEJMcps050929; Shields DC, 2007, SURG NEUROL, V67, P354, DOI 10.1016/j.surneu.2006.09.036; Shore PM, 2004, J NEUROTRAUM, V21, P1113; Soustiel JF, 2002, ACTA NEUROCHIR, V144, P137, DOI 10.1007/s007010200016; Soustiel JF, 1998, NEUROSURGERY, V43, P282, DOI 10.1097/00006123-199808000-00061; Stiefel MF, 2005, J NEUROSURG, V103, P805, DOI 10.3171/jns.2005.103.5.0805; Stiefel MF, 2006, J NEUROSURG, V105, P281, DOI 10.3171/ped.2006.105.4.281; Taylor A, 2001, CHILD NERV SYST, V17, P154, DOI 10.1007/s003810000410; Vavilala MS, 2007, J NEUROTRAUM, V24, P87, DOI 10.1089/neu.2006.0058; Vavilala Monica S, 2004, Pediatr Crit Care Med, V5, P257, DOI 10.1097/01.PCC.0000123545.69133.C3; Vespa PM, 2007, CRIT CARE MED, V35, P2830, DOI 10.1097/01.CCM.0000295667.66853.BC; YOSHII N, 1973, Keio Journal of Medicine, V22, P27	55	8	9	0	2	SPRINGER INDIA	NEW DELHI	7TH FLOOR, VIJAYA BUILDING, 17, BARAKHAMBA ROAD, NEW DELHI, 110 001, INDIA	0019-5456	0973-7693		INDIAN J PEDIATR	Indian J. Pediatr.	NOV	2008	75	11					1159	1165		10.1007/S12098-008-0240-1			7	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics	403RE	WOS:000263098900009	19132318				2022-02-06	
J	Griffin, R; Parks, CT; Rue, LW; McGwin, G				Griffin, Russell; Parks, Chris T.; Rue, Loring W., III; McGwin, Gerald, Jr.			Comparison of Severe Injuries Between Powered and Nonpowered Scooters Among Children Aged 2 to 12 in the United States	AMBULATORY PEDIATRICS			English	Article						child; epidemiology; injury, powered scooter; scooter	NONMOTORIZED SCOOTERS; SPORTS; US	Objective.-A substantial increase in the number of nonpowered and powered scooter injuries since 2000 has occurred in the United States. Because of differences in weight and operational speed between scooter types, it is possible that the type and severity of injuries may differ. The purpose of the current study is to compare demographics and injury characteristics between scooter types, focusing on differences in injury severity. Methods.-The 2002-2006 National Electronic Injury Surveillance System provided information about individuals aged 2 to 12 years who sought treatment at an emergency department due to powered or nonpowered scooter-related injury in the United States. We defined severe injury as an injury resulting in the hospitalization, staying in the hospital for observation, or transfer of the injured patient. Logistic regression analysis, adjusted for sex, age, and geographic location in which the injury occurred, estimated odds ratios (ORs) and 95% confidence intervals (CI) for the association between scooter type and severe injury. Results.-There were an estimated 15 752 and 185 007 injuries related to powered and nonpowered scooters, respectively. Powered scooter-related injuries were over 3 times as likely to be severe (OR 3.57, 95% CI, 1.91-6.65). This association was more prominent among females (OR 5.80, 95% CI, 2.02-16.63) than males (OR 2.90, 95% CI, 1.44-5.82). Conclusion.-Data suggest that, compared with nonpowered scooter-related injuries, powered scooter-related injuries are more often severe. This association is stronger among females than males. The higher risk of severe injury due to powered scooter use could result from increases in concussions and hip and lower extremity injuries.	[Griffin, Russell; Parks, Chris T.; Rue, Loring W., III; McGwin, Gerald, Jr.] Univ Alabama, Ctr Injury Sci, Birmingham, AL 35294 USA; [Griffin, Russell; Parks, Chris T.; Rue, Loring W., III; McGwin, Gerald, Jr.] Univ Alabama, Sect Trauma Burns & Surg Crit Care, Div Gen Surg, Dept Surg,Sch Med, Birmingham, AL 35294 USA; [Griffin, Russell; McGwin, Gerald, Jr.] Univ Alabama, Dept Epidemiol & Int Hlth, Sch Publ Hlth, Birmingham, AL 35294 USA		Griffin, R (corresponding author), Univ Alabama, Ctr Injury Sci, 115 Kracke Bldg,1922 7th Ave S, Birmingham, AL 35294 USA.	russellg@uab.edu					Conn JM, 2003, INJURY PREV, V9, P117, DOI 10.1136/ip.9.2.117; Gaines BA, 2004, J TRAUMA, V57, P111, DOI 10.1097/01.TA.0000082156.67895.C8; Josefson D, 2000, WESTERN J MED, V173, P297, DOI 10.1136/ewjm.173.5.297-a; Mankovsky AB, 2002, J PEDIATR SURG, V37, P755, DOI 10.1053/jpsu.2002.32271; MARCY N, 2003, POWERED SCOOTER SPEC; *NAT SPORT GOODS A, 10 YEAR HIST SEL SPO; Powell EC, 2004, AMBUL PEDIATR, V4, P495, DOI 10.1367/A04-074R1.1; Rutherford GW, 2001, JAMA-J AM MED ASSOC, V285, P36; Schalamon J, 2003, J PEDIATR SURG, V38, P1612, DOI 10.1016/S0022-3468(03)00571-2; *US CONS PROD SAF, SCOOT DAT; US Consumer Product Safety Commission, 2000, NEISS NAT EL INJ SUR; Yang JZ, 2007, PEDIATRICS, V119, pE813, DOI 10.1542/peds.2006-2140	12	8	8	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1530-1567			AMBUL PEDIATR	Ambul. Pediatr.	NOV-DEC	2008	8	6					379	382		10.1016/j.ambp.2008.08.002			4	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics	377MS	WOS:000261255900009	19084788				2022-02-06	
J	Kehoe, AD; Eleftheriou, KI; Heron, M; Coats, TJ; Montgomery, HE				Kehoe, A. D.; Eleftheriou, K. I.; Heron, M.; Coats, T. J.; Montgomery, H. E.			Angiotensin-converting enzyme genotype may predict survival following major trauma	EMERGENCY MEDICINE JOURNAL			English	Article							BRAIN-INJURY; POLYMORPHISM; RECEPTOR; FAILURE; ACE	Background: As a key component of the endocrine renin-angiotensin system (RAS), angiotensin-converting enzyme (ACE) regulates circulatory homeostasis. Meanwhile, the local RAS influences tissue growth, inflammatory and metabolic responses. The absence (deletion, D) rather than the presence (insertion, I) of a 287 base pair fragment in the ACE gene is associated with higher circulating and tissue ACE activity, with excess mortality in critical illness (including adult acute respiratory distress syndrome and paediatric meningococcal infection) and with worse functional outcome from traumatic brain injury. Objective: To determine if the ACE genotype is associated with mortality following major trauma. Methods: 41 subjects with major trauma admitted to the Royal London Hospital over a 2-year period via the Helicopter Emergency Medical Service were enrolled. ACE genotype was available in 36. Injury Severity Score (ISS), Revised Trauma Score (RTS), age, sex and outcome data were recorded for each. ACE genotype was determined from leucocyte DNA using well described techniques. Results: The presence of one or more D alleles was associated with a mortality of 36.4% compared with 7.1% for II alleles (p = 0.048). Age (p = 0.044) also predicted mortality whereas RTS (p = 0.08) and ISS (p = 0.46) did not. ACE genotype was significantly associated with RTS but not age or ISS. Conclusion: The ACE D allele may be associated with mortality from major trauma. Replication of these findings in larger studies may aid definition of high-risk subgroups that would benefit from early intensive management. New therapeutic targets might also be suggested.	[Kehoe, A. D.; Eleftheriou, K. I.; Montgomery, H. E.] UCL, Inst Human Hlth & Performance, London N19 5LW, England; [Heron, M.] Royal London Hosp, Emergency Dept, London E1 1BB, England; [Coats, T. J.] Univ Leicester, Dept Emergency Med, Leicester, England		Kehoe, AD (corresponding author), UCL, Inst Human Hlth & Performance, Charterhouse Bldg,Archway Campus, London N19 5LW, England.	anthonykehoe@hotmail.com	Montgomery, Hugh/L-1229-2019; Coats, Timothy/AAW-1254-2021; Montgomery, Hugh/C-2592-2008	Coats, Timothy/0000-0003-2736-2784; Montgomery, Hugh/0000-0001-8797-5019			Ariza M, 2006, J NEUROPSYCH CLIN N, V18, P39, DOI 10.1176/appi.neuropsych.18.1.39; Baranov D, 2003, ANESTHESIOLOGY, V99, P1118, DOI 10.1097/00000542-200311000-00018; Guba M, 2000, SHOCK, V13, P190, DOI 10.1097/00024382-200003000-00004; Harding D, 2002, AM J RESP CRIT CARE, V165, P1103, DOI 10.1164/ajrccm.165.8.2108089; Imai Y, 2005, NATURE, V436, P112, DOI 10.1038/nature03712; Laesser M, 2005, INTENS CARE MED, V31, P1109, DOI 10.1007/s00134-005-2686-1; Lobo SMA, 2003, CHEST, V123, P2043, DOI 10.1378/chest.123.6.2043; Marshall RP, 2002, AM J RESP CRIT CARE, V166, P646, DOI 10.1164/rccm.2108086; Pola E, 2002, J AM GERIATR SOC, V50, P2025, DOI 10.1046/j.1532-5415.2002.50616.x; Reilly PM, 2001, SHOCK, V15, P329, DOI 10.1097/00024382-200115050-00001; TIRET L, 1992, AM J HUM GENET, V51, P197	11	8	9	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1472-0205			EMERG MED J	Emerg. Med. J.	NOV	2008	25	11					759	761		10.1136/emj.2006.045336			3	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	365RJ	WOS:000260425200017	18955615				2022-02-06	
J	Lee, DJ; Moftakhar, P; Glenn, TC; Vespa, PM; Martin, NA				Lee, Darrin J.; Moftakhar, Parham; Glenn, Thomas C.; Vespa, Paul M.; Martin, Neil A.			INTRA-ARTERIAL CALCIUM CHANNEL BLOCKER INFUSION FOR TREATMENT OF SEVERE VASOSPASM IN TRAUMATIC BRAIN INJURY: CASE REPORT	NEUROSURGERY			English	Article						Cerebral vasospasm; Chemical angioplasty; Nicardipine; Verapamil		OBJECTIVE: The authors describe a case of severe traumatic arterial vasospasm and its subsequent management using angiography and multiple infusions of calcium channel blockers. CLINICAL PRESENTATION: A 26-year-old man presented with subarachnoid hemorrhage and an initial Glasgow Coma Scale score of 4 after a motor vehicle accident. The patient underwent a bifrontal craniotomy and right frontal decompressive craniectomy for bilateral frontal epidural and subdural hematomas secondary to subarachnoid hemorrhage. INTERVENTION: While the patient was in the intensive care unit, severe vasospasm developed, as documented by transcranial Doppler ultrasonography, cerebral blood flow monitoring, and angiography. The patient was treated on 3 separate days with either nicardipine or verapamil infusions during angiography. After each infusion, the middle cerebral artery diameter improved (diameter increased 23.1-60.5%). The arterial vasospasm eventually resolved after 22 days, and the patient was discharged to acute rehabilitation. Four months after discharge, the patient had a Barthel index of 90 and has relatively slow speech but was able to ambulate without assistance and follow complex commands. CONCLUSION: To our knowledge, this is the first reported case of multiple intra-arterial calcium channel blocker infusions for severe posttraumatic vasospasm, as assessed by transcranial Doppler ultrasonography, cerebral blood flow monitoring, and angiography. This case reinforces that arterial vasospasm does occur in response to traumatic brain injury and further demonstrates that treatment with calcium channel blocker infusions is associated with angiographic changes and a subsequent reversal of ischemic blood flow.	[Lee, Darrin J.; Moftakhar, Parham; Glenn, Thomas C.; Vespa, Paul M.; Martin, Neil A.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurosurg, Los Angeles, CA 90095 USA; [Vespa, Paul M.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, Los Angeles, CA 90095 USA		Lee, DJ (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurosurg, Los Angeles, CA 90095 USA.			Martin, Neil/0000-0002-6565-4131				0	8	8	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0148-396X			NEUROSURGERY	Neurosurgery	NOV	2008	63	5					1004	1006		10.1227/01.NEU.0000327685.90800.F7			3	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	372VC	WOS:000260929100047	19005366				2022-02-06	
J	Ooba, S; Hasuo, H; Shigemori, M; Akasu, T				Ooba, S.; Hasuo, H.; Shigemori, M.; Akasu, T.			Diazepam attenuates the post-traumatic hyperactivity of excitatory synapses in rat hippocampal CA1 neurons	NEUROSCIENCE RESEARCH			English	Article						Traumatic brain injury; Hippocampal CA1; Benzodiazepine; GABA receptors; Neuroprotection	TRAUMATIC BRAIN-INJURY; LONG-TERM POTENTIATION; FLUID PERCUSSION INJURY; APOPTOTIC CELL-DEATH; AMINO-ACIDS; SYNAPTIC-TRANSMISSION; ANIMAL-MODELS; GLUTAMATE; SLICES; MECHANISMS	The effect of diazepam, a benzodiazepine derivative, on the post-traumatic hyperactivity of excitatory synaptic transmission was examined in Fat hippocampal CA1 area. Optical recordings showed that the activity of hippocampal neurons was enhanced in Fats treated with fluid percussion injury (FPI) as compared with that of sham-operated rats. Tire optical response was characterized by fast and slow components. FPI did not affect the fast component that reflects presynaptic action potentials, but enhanced the slow component that reflects excitatory synaptic responses. Intracellular recordings showed that the amplitude and duration of the excitatory postsynaptic potential (EPSP) were increased after FPI. However, FPI did not affect the resting membrane potential and action potentials of hippocampal neurons. Intraperitoneal (i.p.) administration of diazepam (30 and 90 min after FPI) attenuated the post-traumatic hyperactivity of the Slow Optical response. The slope of input-to-output relation of excitatory synapses was decreased by acute administration of diazepam to FPI Fats, but not by delayed administration of diazepam (4 and 5 h after FPI). The fast optical responses were not affected by either FPI OF i.p. administration of diazepam. These results suggest that administration of diazepam at early post-traumatic period prevents the FPI-induced delayed enhancement of excitatory synaptic transmission in rat hippocampal CA1 neurons. (C) 2008 Elsevier Ireland Ltd and the Japan Neuroscience Society. All rights reserved.	[Ooba, S.; Hasuo, H.; Akasu, T.] Kurume Univ, Sch Med, Dept Physiol, Kurume, Fukuoka 8300011, Japan; [Ooba, S.; Shigemori, M.] Kurume Univ, Sch Med, Dept Neurosurg, Kurume, Fukuoka 8300011, Japan; [Akasu, T.] Kurume Univ, Cognit & Mol Res Inst Brain Dis, Open Res Ctr, Kurume, Fukuoka 8300011, Japan		Hasuo, H (corresponding author), Kurume Univ, Sch Med, Dept Physiol, Kurume, Fukuoka 8300011, Japan.	hhasuo@med.kurume-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of JapanMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT) [17500279]; Ministry of Education, Culture, Sports, Science and TechnologyMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT)	This work was supported by a Grant-in-Aid for Scientific Research (C) (17500279) from the Ministry of Education, Culture, Sports, Science and Technology of Japan. This research was also supported from the Ministry of Education, Culture, Sports, Science and Technology as a part of a project for establishing open research centers in private universities.	Akasu T, 2002, NEUROSCI LETT, V329, P305, DOI 10.1016/S0304-3940(02)00707-3; Annegers JF, 1998, NEW ENGL J MED, V338, P20, DOI 10.1056/NEJM199801013380104; Atkins CM, 2006, J CEREBR BLOOD F MET, V26, P1507, DOI 10.1038/sj.jcbfm.9600301; BAKER AJ, 1993, J NEUROSURG, V79, P369, DOI 10.3171/jns.1993.79.3.0369; Bernert H, 1996, P NATL ACAD SCI USA, V93, P5235, DOI 10.1073/pnas.93.11.5235; Bullock MR, 1999, NEUROSURGERY, V45, P207, DOI 10.1097/00006123-199908000-00001; Cao R, 2006, NEUROSCI LETT, V401, P136, DOI 10.1016/j.neulet.2006.03.005; CAPRUSO DX, 1992, NEUROL CLIN, V10, P879, DOI 10.1016/S0733-8619(18)30185-3; CHOI DW, 1990, ANNU REV NEUROSCI, V13, P171, DOI 10.1146/annurev.neuro.13.1.171; Conti AC, 1998, J NEUROSCI, V18, P5663; D'Ambrosio R, 1998, BRAIN RES, V786, P64, DOI 10.1016/S0006-8993(97)01412-1; Dave JR, 1997, NEUROREPORT, V8, P395, DOI 10.1097/00001756-199701200-00002; DELCERRO S, 1992, NEUROSCIENCE, V49, P1, DOI 10.1016/0306-4522(92)90071-9; DIETRICH WD, 1994, ACTA NEUROPATHOL, V87, P250, DOI 10.1007/BF00296740; DIETRICH WD, 1994, J NEUROTRAUM, V11, P289, DOI 10.1089/neu.1994.11.289; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; Dowden J, 1999, BRAIN RES, V829, P1, DOI 10.1016/S0006-8993(99)01229-9; Eghbali M, 1997, NATURE, V388, P71, DOI 10.1038/40404; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; Faden AI, 1997, J NEUROTRAUM, V14, P885, DOI 10.1089/neu.1997.14.885; Farrant M, 2005, NAT REV NEUROSCI, V6, P215, DOI 10.1038/nrn1625; GONG QZ, 1995, BRAIN RES, V700, P299, DOI 10.1016/0006-8993(95)01081-6; GRINVALD A, 1988, PHYSIOL REV, V68, P1285, DOI 10.1152/physrev.1988.68.4.1285; Hasuo H, 2001, NEUROSCI RES, V40, P265, DOI 10.1016/S0168-0102(01)00235-8; HAYES RL, 1992, J NEUROTRAUM, V9, pS173; Hu XD, 2006, NEUROPHARMACOLOGY, V50, P238, DOI 10.1016/j.neuropharm.2005.09.010; JENG JM, 1998, SOC NEUR ABSTR, V24; JIANG JY, 1992, ACTA NEUROPATHOL, V84, P495, DOI 10.1007/BF00304468; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; KOGA S, 2005, NEUROSCI RES, V52, pS166; KOGA S, 2005, JPN J PHYSL, V55, pS233; Kojima S, 1999, J NEUROSCI, V19, P2580; KONNERTH A, 1987, J PHYSIOL-LONDON, V393, P681, DOI 10.1113/jphysiol.1987.sp016848; LOWENSTEIN DH, 1992, J NEUROSCI, V12, P4846; LYETH BG, 1993, J NEUROTRAUM, V10, P57, DOI 10.1089/neu.1993.10.57; MADISON DV, 1991, ANNU REV NEUROSCI, V14, P379, DOI 10.1146/annurev.ne.14.030191.002115; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; Marklund N, 2006, CURR PHARM DESIGN, V12, P1645, DOI 10.2174/138161206776843340; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; McIntosh TK, 1989, J NEUROTRAUM, V6, P247, DOI 10.1089/neu.1989.6.247; MCNAUGHTON BL, 1993, ANNU REV PHYSIOL, V55, P375, DOI 10.1146/annurev.physiol.55.1.375; Momose-Sato Y, 1999, J MEMBRANE BIOL, V172, P145, DOI 10.1007/s002329900592; Muraoka Norihiro, 2002, Kurume Medical Journal, V49, P15; Nakagami Y, 1997, NEUROSCIENCE, V81, P1, DOI 10.1016/S0306-4522(97)00161-9; O'Dell DM, 2000, BRAIN RES, V861, P325, DOI 10.1016/S0006-8993(00)02055-2; Obrenovitch TP, 1997, PROG NEUROBIOL, V51, P39, DOI 10.1016/S0301-0082(96)00049-4; PALMER AM, 1994, NEUROREPORT, V6, P153, DOI 10.1097/00001756-199412300-00039; POVLISHOCK JT, 1994, J NEUROTRAUM, V11, P723, DOI 10.1089/neu.1994.11.723; Raghupathi R, 2002, NEUROSCIENCE, V110, P605, DOI 10.1016/S0306-4522(01)00461-4; RINK A, 1995, AM J PATHOL, V147, P1575; Rudolph U, 1999, NATURE, V401, P796, DOI 10.1038/44579; Santhakumar V, 2000, J PHYSIOL-LONDON, V524, P117, DOI 10.1111/j.1469-7793.2000.00117.x; SCHWARTZ RD, 1995, J NEUROSCI, V15, P529; SHUAIB A, 1995, NEUROSCI LETT, V197, P109, DOI 10.1016/0304-3940(95)11934-O; SMITH DH, 1993, J NEUROSCI, V13, P5383, DOI 10.1523/JNEUROSCI.13-12-05383.1993; Stover JF, 2000, BRAIN RES, V875, P51, DOI 10.1016/S0006-8993(00)02597-X; STUDY RE, 1982, JAMA-J AM MED ASSOC, V247, P2147, DOI 10.1001/jama.247.15.2147; Takeya Mitsue, 2001, Kurume Medical Journal, V48, P205; Thompson HJ, 2005, J NEUROTRAUM, V22, P42, DOI 10.1089/neu.2005.22.42; Toth Z, 1997, J NEUROSCI, V17, P8106; Vakil E, 2005, J CLIN EXP NEUROPSYC, V27, P977, DOI 10.1080/13803390490919245; Zhang L, 1996, SCIENCE, V274, P1921, DOI 10.1126/science.274.5294.1921	62	8	10	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0168-0102			NEUROSCI RES	Neurosci. Res.	NOV	2008	62	3					195	205		10.1016/j.neures.2008.08.005			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	372VH	WOS:000260929600007	18793683				2022-02-06	
J	Stadhouder, A; Oner, FC; Wilson, KW; Vaccaro, AR; Williamson, OD; Verbout, AJ; Verhaar, JA; de Klerk, LWL; Buskens, E				Stadhouder, A.; Oener, F. C.; Wilson, K. W.; Vaccaro, A. R.; Williamson, O. D.; Verbout, A. J.; Verhaar, J. A.; de Klerk, L. W. L.; Buskens, E.			Surgeon equipoise as an inclusion criterion for the evaluation of nonoperative versus operative treatment of thoracolumbar spinal injuries	SPINE JOURNAL			English	Article						Thoracolumbar fracture; Randomized controlled trial; Restricted cohort study; Expertise-based trials; Equipoise; Observational studies; Operative and nonoperative treatment	RANDOMIZED CONTROLLED-TRIALS; JUNCTION BURST FRACTURES; CLINICAL RESEARCH; NEUROLOGICAL DEFICIT; PROPENSITY SCORE; MULTICENTER; INSTRUMENTATION; SOCIETY; ETHICS; NEED	BACKGROUND CONTEXT: Prospective studies have failed to demonstrate the superiority of either operative or nonoperative treatment of thoracolumbar fractures. Similar to other surgical fields, research has been limited by the variability in surgical interventions, difficult recruitment, infrequent pathology, and the urgency of interventions. PURPOSE: To outline factors precluding randomized controlled trials in spinal fractures research, and describe a novel methodology that seeks to improve on the design of observational studies. STUDY DESIGN/SETTING: A preliminary report describing an observational study design with clinical equipoise as an inclusion criterion. The proposed methodology is a cohort study with head-to-head comparison of operative and nonoperative treatment regimens in an expertise-based trial fashion. Patients are selected retrospectively by an expert panel and clinical outcomes are assessed to compare competing treatment regimens. Surgeon equipoise served as an inclusion criterion. PATIENT SAMPLE: Patients with closed or open thoracolumbar spinal fracture with or without neurological impairment, presenting to one of two different trauma centers between 1991 and 2005 (N=760). OUTCOME MEASURES: Homogeneity of baseline clinical and demographic data and distribution of prognostic risk factors between the operative and the nonoperative cohort. METHODS: Patients treated for spine fractures at two University hospitals practicing opposing methods of fracture intervention were identified by medical diagnosis code searches (n=760). A panel of spine treatment experts, blinded to the treatment received clinically has assessed each case retrospectively. Patients were included in the study when there was disagreement on the preferred treatment, that is, operative or nonoperative treatment of the injury. Baseline and initial data of a study evaluating nonoperative versus operative spinal fracture treatment are presented. RESULTS: One hundred and ninety patients were included in the study accounting for a panel discordance rate of 29%. The distribution of baseline characteristics and demographics of the study populations were equal across the parallel cohorts enrolled in the study, that is, no differences in prognostic factors were observed. CONCLUSIONS: The use of clinical equipoise as an inclusion criterion in comparative studies may be used to avoid selection bias. Using multivariate analysis of retrospectively assembled parallel cohorts, a valid comparison of operative and nonoperative spine fracture treatment strategies and their outcomes is possible. (C) 2008 Elsevier Inc. All rights reserved.	[Stadhouder, A.; Oener, F. C.; Verbout, A. J.] Univ Med Ctr Utrecht, Dept Orthoped Surg, NL-3508 GA Utrecht, Netherlands; [Wilson, K. W.] Thomas Jefferson Univ, Jefferson Med Coll, Philadelphia, PA 19107 USA; [Vaccaro, A. R.] Thomas Jefferson Univ Hosp, Rothman Inst, Philadelphia, PA 19107 USA; [Williamson, O. D.] Monash Univ, Dept Epidemiol & Prevent Med, Clayton, Vic 3800, Australia; [Verhaar, J. A.; de Klerk, L. W. L.] Erasmus MC, Rotterdam, Netherlands; [Buskens, E.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, NL-3508 GA Utrecht, Netherlands		Stadhouder, A (corresponding author), Univ Med Ctr Utrecht, Dept Orthoped Surg, Heidelberglaan 100,POB 85500, NL-3508 GA Utrecht, Netherlands.	a.stadhouder-2@chir.azu.nl	Oner, FC/L-7769-2013; Verhaar, Jan/AAH-1372-2020	Oner, FC/0000-0003-0858-8243; Verhaar, Jan/0000-0003-3016-9600	The Netherlands Organisation for Scientific Research (ZonMW)Netherlands Organization for Scientific Research (NWO)Netherlands Organization for Health Research and Development; Federal/state agency [(sic) 180.887]	Research funding for this work was provided by the The Netherlands Organisation for Scientific Research (ZonMW) by the authors FCO and AJV and grant (sic) 180.887 received from Federal/state agency.	Aligizakis A, 2002, Acta Orthop Belg, V68, P279; Angell M, 1997, NEW ENGL J MED, V337, P847, DOI 10.1056/NEJM199709183371209; Black N, 1996, BRIT MED J, V312, P1215; Chard JA, 1998, SOC SCI MED, V47, P891, DOI 10.1016/S0277-9536(98)00153-1; Chene G, 1998, CONTROL CLIN TRIALS, V19, P233, DOI 10.1016/S0197-2456(97)00145-1; Chiong W, 2006, AM J BIOETHICS, V6, P37, DOI 10.1080/15265160600755565; Chukwuemeka A, 2005, ANN THORAC SURG, V80, P2148, DOI 10.1016/j.athoracsur.2005.06.015; Concato J, 2000, NEW ENGL J MED, V342, P1887, DOI 10.1056/NEJM200006223422507; DARIANO GD, 1995, CURR OPIN ORTHOP, V6, P95; Devereaux PJ, 2005, BMJ-BRIT MED J, V330, P88, DOI 10.1136/bmj.330.7482.88; Doyal L, 1997, BMJ-BRIT MED J, V314, P1107, DOI 10.1136/bmj.314.7087.1107; FREEDMAN B, 1987, NEW ENGL J MED, V317, P141, DOI 10.1056/NEJM198707163170304; GARTLAND JJ, 1988, J BONE JOINT SURG AM, V70A, P1357, DOI 10.2106/00004623-198870090-00013; GERTZBEIN SD, 1992, SPINE, V17, P528, DOI 10.1097/00007632-199205000-00010; HORWITZ RI, 1990, AM J MED, V89, P630, DOI 10.1016/0002-9343(90)90182-D; Houston Thomas P., 1998, American Journal of Preventive Medicine, V14, P374; Knop C, 2001, UNFALLCHIRURG, V104, P583, DOI 10.1007/s001130170089; Laursen M, 1999, Ugeskr Laeger, V161, P1910; Localio AR, 2001, ANN INTERN MED, V135, P112, DOI 10.7326/0003-4819-135-2-200107170-00012; Luellen JK, 2005, EVALUATION REV, V29, P530, DOI 10.1177/0193841X05275596; MCCORMACK T, 1994, SPINE, V19, P1741, DOI 10.1097/00007632-199408000-00014; McCulloch P, 2002, BRIT MED J, V324, P1448, DOI 10.1136/bmj.324.7351.1448; MCLAIN RF, 1993, J BONE JOINT SURG AM, V75A, P162, DOI 10.2106/00004623-199302000-00002; Orosz GM, 2004, JAMA-J AM MED ASSOC, V291, P1738, DOI 10.1001/jama.291.14.1738; Parker JW, 2000, SPINE, V25, P1157, DOI 10.1097/00007632-200005010-00018; Resch H, 2000, UNFALLCHIRURG, V103, P281, DOI 10.1007/s001130050537; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; Shen WJ, 2001, SPINE, V26, P1038, DOI 10.1097/00007632-200105010-00010; Shen WJ, 1999, SPINE, V24, P412, DOI 10.1097/00007632-199902150-00024; SOLOMON MJ, 1995, SURGERY, V118, P459, DOI 10.1016/S0039-6060(05)80359-9; SOLOMON MJ, 1994, SURGERY, V115, P707; SPETH MJGM, 1995, ACTA ORTHOP SCAND, V66, P406, DOI 10.3109/17453679508995575; Stromsoe K, 1997, Eur Spine J, V6, P239, DOI 10.1007/BF01322445; Veatch RM, 2007, J MED PHILOS, V32, P167, DOI 10.1080/03605310701255776; Verlaan JJ, 2004, J BONE JOINT SURG AM, V86A, P649, DOI 10.2106/00004623-200403000-00037; Wehbe MA, 1998, J BONE JOINT SURG AM, V80A, P1395, DOI 10.2106/00004623-199809000-00022; Wood K, 2003, J BONE JOINT SURG AM, V85A, P773, DOI 10.2106/00004623-200305000-00001	37	8	11	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1529-9430			SPINE J	Spine Journal	NOV-DEC	2008	8	6					975	981		10.1016/j.spinee.2007.11.008			7	Clinical Neurology; Orthopedics	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Orthopedics	373KN	WOS:000260970600015	18261964				2022-02-06	
J	Czerwinski, M; Parker, WL; Williams, HB				Czerwinski, Marcin; Parker, Wendy L.; Williams, H. Bruce			Algorithm for head computed tomography imaging in patients with mandible fractures	JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY			English	Article							INJURY	Purpose: Trauma to the mandible can potentially increase our predictive accuracy for intracranial injuries (ICIs) because of the mandible's strength, anatomic proximity, and direct connection to the skull base. Our goals were to: 1) investigate the association of mandible fractures with traumatic brain injury (TBI) and intracranial lesions (ICLs); and 2) determine predictors of ICIs in a level If Canadian trauma center with distinct patient demographics and fracture etiologies. Patients and Methods: A retrospective chart review was performed of medical records of mandible-fracture patients treated at our institution from 1997 to 2003. Patients who had undergone postinjury computed tomography (CT) of the head with a minimum of 4 weeks' follow-up were considered eligible. Data collected included patient and fracture characteristics, neurologic evaluation, and the presence of concomitant injuries. Results: One hundred eighty-one patients were reviewed, of whom 86 were found eligible, with demographics representative of an urban-trauma population. The incidence of TBI was 68.6%, and of ICLs, 27%. Logistic regression identified alcohol (odds ratio [OR], 3.97), concomitant facial fracture (OR, 2.77), and other systemic injury (OR, 2.59) as independent predictors of an ICI in mandibular fracture patients. Importantly, ICIs were observed in 19% of mandible-fracture patients, satisfying the criteria for mild TBI, and in 17% of patients without any evidence of TBI. Conclusions: Some authors have advocated treating mandible fractures on an outpatient basis, with a focused workup. Our results of significant concomitant ICI in mandible-fracture patients, conversely, suggest that such management may inadvertently result in the oversight of potentially life-threatening injuries. Thus, we recommend mandatory intracranial CT imaging if the patient's neurologic status at time of injury is unknown or meets the criteria of TBI, or if positive predictors for ICL are present. (C) 2008 American Association of Oral and Maxillofacial Surgeons.	[Czerwinski, Marcin] McGill Univ, Hlth Sci Ctr, Div Plast Surg, Montreal Childrens Hosp, Montreal, PQ H3G 1P3, Canada; [Parker, Wendy L.] McGill Univ, Ctr Hlth, Div Plast Surg, Jewish Gen Hosp,St Marys Hosp, Montreal, PQ H3G 1P3, Canada; [Williams, H. Bruce] McGill Univ, Ctr Hlth, Div Plast Surg, Montreal Childrens Hosp,Royal Victoria Hosp, Montreal, PQ H3G 1P3, Canada		Czerwinski, M (corresponding author), McGill Univ, Hlth Sci Ctr, Div Plast Surg, Montreal Childrens Hosp, Plast Surg Off C 1135,2300 Tupper St, Montreal, PQ H3G 1P3, Canada.	marcin.czerwinski@mail.mcgill.ca					Carlin C B, 1998, J Craniomaxillofac Trauma, V4, P44; Fischer K, 2001, PLAST RECONSTR SURG, V108, P328, DOI 10.1097/00006534-200108000-00006; Gomez PA, 1996, BRIT J NEUROSURG, V10, P453, DOI 10.1080/02688699647078; Hung YC, 2004, J ORAL MAXIL SURG, V62, P938, DOI 10.1016/j.joms.2004.01.018; Kraus JF, 2003, ANN EMERG MED, V41, P18, DOI 10.1067/mem.2003.1; MARSHALL LF, 1991, J NEUROSURG, V75, pS28, DOI 10.3171/sup.1991.75.1s.0s28; Murphy LS, 1999, BRIT J NEUROSURG, V13, P564, DOI 10.1080/02688699943060; Murray GD, 1999, ACTA NEUROCHIR, V141, P223, DOI 10.1007/s007010050292; MURRAY LS, 1993, LANCET, V341, P1487, DOI 10.1016/0140-6736(93)90631-P; Murshid WR, 1998, ACTA NEUROCHIR, V140, P56, DOI 10.1007/s007010050058; Rees PM, 2003, ARCH PHYS MED REHAB, V84, P1885, DOI 10.1016/j.apmr.2003.03.001; SLUPCHYNSKYJ OS, 1992, LARYNGOSCOPE, V102, P1247, DOI 10.1288/00005537-199211000-00008; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X	13	8	8	0	0	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0278-2391	1531-5053		J ORAL MAXIL SURG	J. Oral Maxillofac. Surg.	OCT	2008	66	10					2093	2097		10.1016/j.joms.2008.04.011			5	Dentistry, Oral Surgery & Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Dentistry, Oral Surgery & Medicine	355QL	WOS:000259723300017	18848107				2022-02-06	
J	Monroe, SM; Mineka, S				Monroe, Scott M.; Mineka, Susan			Placing the Mnemonic Model in Context: Diagnostic, Theoretical, and Clinical Considerations	PSYCHOLOGICAL REVIEW			English	Article						posttraumatic stress disorder; memory; classification and diagnosis; life events	POSTTRAUMATIC-STRESS-DISORDER; TRAUMATIC BRAIN-INJURY; COGNITIVE THERAPY; MEMORY; PTSD; EVENT; RISK; DSM; ADAPTATION; DEPRESSION	The mnemonic model of posttraumatic stress disorder (PTSD) proposed by D. C. Rubin, D. Berntsen, and M. K. Bohni (2008) presents some provocative and potentially insightful ideas about this mental disorder. D. C. Rubin et al. suggested that PTSD is caused and maintained through a "pathogenic memory" (D. C. Rubin et al., 2008, p. 985) of a negative event rather than by exposure to a traumatic event per se. The present authors examine the mnemonic model in the context of relevant diagnostic, theoretical, and clinical considerations. Specifically, to evaluate the arguments and evidence provided in support of the mnemonic model of PTSD, the present authors focus on 4 issues: (a) problems inherent with comparing a theoretical model (i.e., the mnemonic model) with a diagnostic model (i.e., the DSM-IV-TR model), (b) problems with not comparing the mnemonic model with relevant cognitive and memory models of PTSD, (c) problems with the degree to which the research reviewed provides support for the mnemonic model, and (d) concerns that memory in PTSD is confounded with the basic disorder, rather than causing PTSD. The present authors conclude with suggestions for future theory and research to help differentiate between memory's role in the origins of PTSD and memory's role in the clinical course of the disorder.	[Monroe, Scott M.] Univ Notre Dame, Dept Psychol, Notre Dame, IN 46556 USA; [Mineka, Susan] Northwestern Univ, Dept Psychol, Evanston, IL 60208 USA		Monroe, SM (corresponding author), Univ Notre Dame, Dept Psychol, Notre Dame, IN 46556 USA.	smonroe1@nd.edu					American Psychiatric Association, 1987, DIAGN STAT MAN MENT, V3; American Psychiatric Association, 1980, DIAGN STAT MAN MENT; American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th; American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; Andreasen NC, 2007, SCHIZOPHRENIA BULL, V33, P108, DOI 10.1093/schbul/sbl054; BARNETT PA, 1988, PSYCHOL BULL, V104, P97, DOI 10.1037/0033-2909.104.1.97; Berntsen D, 2003, APPL COGNITIVE PSYCH, V17, P675, DOI 10.1002/acp.894; Breslau N, 2001, BIOL PSYCHIAT, V50, P699, DOI 10.1016/S0006-3223(01)01167-2; Brewin C. R., 2003, POSTTRAUMATIC STRESS; Brewin CR, 2007, PROG BRAIN RES, V167, P217, DOI 10.1016/S0079-6123(07)67015-0; Brewin CR, 1996, PSYCHOL REV, V103, P670, DOI 10.1037/0033-295X.103.4.670; Brewin CR, 2003, CLIN PSYCHOL REV, V23, P339, DOI 10.1016/S0272-7358(03)00033-3; Caspi Y, 2005, J LOSS TRAUMA, V10, P319, DOI 10.1080/15325020590956756; Charney DS, 2004, AM J PSYCHIAT, V161, P195, DOI 10.1176/appi.ajp.161.2.195; CRONBACH LJ, 1955, PSYCHOL BULL, V52, P281, DOI 10.1037/h0040957; Dalgleish T, 2004, PSYCHOL BULL, V130, P228, DOI 10.1037/0033-2909.130.2.228; Dalgleish T, 1999, WIL CL PSY, P193; de Kloet ER, 2005, NAT REV NEUROSCI, V6, P463, DOI 10.1038/nrn1683; Dunmore E, 2001, BEHAV RES THER, V39, P1063, DOI 10.1016/S0005-7967(00)00088-7; Ehlers A, 2000, J ABNORM PSYCHOL, V109, P45, DOI 10.1037/0021-843X.109.1.45; Ehlers A, 2000, BEHAV RES THER, V38, P319, DOI 10.1016/S0005-7967(99)00123-0; Ehlers A, 1998, J ABNORM PSYCHOL, V107, P508, DOI 10.1037/0021-843X.107.3.508; FOA EB, 1989, BEHAV THER, V20, P155, DOI 10.1016/S0005-7894(89)80067-X; FOA EB, 1995, J TRAUMA STRESS, V8, P675, DOI 10.1007/BF02102894; Foa EB, 1998, TREATING TRAUMA RAPE; Garratt G, 2007, CLIN PSYCHOL-SCI PR, V14, P224, DOI 10.1111/j.1468-2850.2007.00081.x; Gil S, 2005, AM J PSYCHIAT, V162, P963, DOI 10.1176/appi.ajp.162.5.963; Gunnar M, 2007, ANNU REV PSYCHOL, V58, P145, DOI 10.1146/annurev.psych.58.110405.085605; Gunnar MR, 2007, PROG BRAIN RES, V167, P137, DOI 10.1016/S0079-6123(07)67010-1; HAAGA DAF, 1991, PSYCHOL BULL, V110, P215, DOI 10.1037/0033-2909.110.2.215; Halligan SL, 2003, J CONSULT CLIN PSYCH, V71, P419, DOI 10.1037/0022-006X.71.3.419; Harvey AG, 2003, J INT NEUROPSYCH SOC, V9, P663, DOI 10.1017/S1355617703940069; Heim C, 2004, NEUROPSYCHOPHARMACOL, V29, P641, DOI 10.1038/sj.npp.1300397; Horowitz MJ, 1986, STRESS RESPONSE SYND; Janoff-Bulman R., 1992, SHATTERED ASSUMPTION; Kendell R, 2003, AM J PSYCHIAT, V160, P4, DOI 10.1176/appi.ajp.160.1.4; Kraemer HC, 2001, AM J PSYCHIAT, V158, P848, DOI 10.1176/appi.ajp.158.987.848; Kraemer HC, 2007, INT J METH PSYCH RES, V16, pS8, DOI 10.1002/mpr.211; McNally R. J., 2004, POSTTRAUMATIC STRESS, P1, DOI DOI 10.1002/9780470713570.CH1; MCNALLY RJ, OXFORD TXB IN PRESS; MEEHL PE, 1977, J MED PHILOS, V2, P33, DOI 10.1093/jmp/2.1.33; MONROE SM, 1982, J ABNORM PSYCHOL, V91, P14, DOI 10.1037/0021-843X.91.1.14; MONROE SM, 1986, J ABNORM PSYCHOL, V95, P29, DOI 10.1037/0021-843X.95.1.29; Pitman RK, 2002, BIOL PSYCHIAT, V51, P189, DOI 10.1016/S0006-3223(01)01279-3; Power M., 1999, BEHAV COGN PSYCHOTH, V27, P129, DOI [10.1017/S1352465899272049, DOI 10.1017/S1352465899272049]; Roemer L, 1998, J TRAUMA STRESS, V11, P597, DOI 10.1023/A:1024469116047; Rothman KJ, 2005, AM J PUBLIC HEALTH, V95, pS144, DOI 10.2105/AJPH.2004.059204; Rubin DC, 2008, PSYCHOL REV, V115, P985, DOI 10.1037/a0013397; Rubin DC, 2004, APPL COGNITIVE PSYCH, V18, P17, DOI 10.1002/acp.950; SIMONS AD, 1984, ARCH GEN PSYCHIAT, V41, P45; Southwick SM, 1997, AM J PSYCHIAT, V154, P173; Vaiva G, 2003, BIOL PSYCHIAT, V54, P947, DOI 10.1016/S0006-3223(03)00412-8; Weathers FW, 2007, J TRAUMA STRESS, V20, P107, DOI 10.1002/jts.20210; WEINER H, 1977, PSYCHOBIOLOGY HUMAN	54	8	8	2	7	AMER PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA	0033-295X	1939-1471		PSYCHOL REV	Psychol. Rev.	OCT	2008	115	4					1084	1096		10.1037/a0013723			13	Psychology; Psychology, Multidisciplinary	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	362PU	WOS:000260210400012	18954216				2022-02-06	
J	Aufdenblatten, CA; Altermatt, S				Aufdenblatten, Christoph Alexander; Altermatt, Stefan			Intraventricular catheter placement by electromagnetic navigation safely applied in a paediatric major head injury patient	CHILDS NERVOUS SYSTEM			English	Article						intracranial pressure; children; neuronavigation; traumatic brain injury; monitoring; lateral ventricle; intraventricular pressure	INTRACRANIAL-PRESSURE; CHILDREN; COMPLICATIONS	Introduction In the management of severe head injuries, the use of intraventricular catheters for intracranial pressure (ICP) monitoring and the option of cerebrospinal fluid drainage is gold standard. In children and adolescents, the insertion of a cannula in a compressed ventricle in case of elevated intracranial pressure is difficult; therefore, a pressure sensor is placed more often intraparenchymal as an alternative option. Discussion In cases of persistent elevated ICP despite maximal brain pressure management, the use of an intraventricular monitoring device with the possibility of cerebrospinal fluid drainage is favourable. We present the method of intracranial catheter placement by means of an electromagnetic navigation technique.	[Altermatt, Stefan] Childrens Hosp, Dept Pediat Surg, CH-6000 Luzern, Switzerland; [Aufdenblatten, Christoph Alexander; Altermatt, Stefan] Univ Childrens Hosp Zurich, Dept Pediat Surg, CH-8032 Zurich, Switzerland		Aufdenblatten, CA (corresponding author), Childrens Hosp, Dept Pediat Surg, CH-6000 Luzern, Switzerland.	christoph.aufdenblatten@ksl.ch					Anderson RCE, 2004, J NEUROSURG, V101, P53, DOI 10.3171/ped.2004.101.2.0053; BROWN E, 1988, INTRACRANIAL PRESSUR; Bullock RM, 2000, J NEUROTRAUM, V17, P449; Carney Nancy A, 2003, Pediatr Crit Care Med, V4, pS1; Gelabert-Gonzalez M, 2006, ACTA NEUROCHIR, V148, P435, DOI 10.1007/s00701-005-0683-3; Gil Z, 2002, CHILD NERV SYST, V18, P26, DOI 10.1007/s00381-001-0550-3; Kiefer M, 2002, UNFALLCHIRURG, V105, P578, DOI 10.1007/s00113-002-0469-5; Luerssen T G, 1997, Semin Pediatr Neurol, V4, P146, DOI 10.1016/S1071-9091(97)80033-2; LUNDBERG N, 1960, Acta Psychiatr Scand Suppl, V36, P1; LUNDBERG N, 1965, J NEUROSURG, V22, P581, DOI 10.3171/jns.1965.22.6.0581; LUNDBERG N, 1965, ACTA NEUROL SCAND, VS 41, P115; MARMAROU A, 1991, J NEUROSURG, V75, pS59, DOI 10.3171/sup.1991.75.1s.0s59; Miller MT, 2004, J TRAUMA, V56, P967, DOI 10.1097/01.TA.0000123699.16465.8B; Morris KP, 2006, INTENS CARE MED, V32, P1606, DOI 10.1007/s00134-006-0285-4; NARAYAN RK, 1981, J NEUROSURG, V54, P751, DOI 10.3171/jns.1981.54.6.0751; POPLE IK, 1995, PEDIATR NEUROSURG, V23, P64, DOI 10.1159/000120938; Rossi S, 1998, ACT NEUR S, V71, P91; Tilford JM, 2001, CRIT CARE MED, V29, P1056, DOI 10.1097/00003246-200105000-00037; Wiegand C, 2007, DEV MED CHILD NEUROL, V49, P935, DOI 10.1111/j.1469-8749.2007.00935.x	19	8	8	0	0	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0256-7040	1433-0350		CHILD NERV SYST	Childs Nerv. Syst.	SEP	2008	24	9					1047	1050		10.1007/s00381-008-0657-x			4	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	335TY	WOS:000258315100013	18560840	Green Submitted			2022-02-06	
J	Janssen, K; Woiciechowski, M; Poot, S; De Keyser, K; Ceulemans, B				Janssen, Karen; Woiciechowski, Marek; Poot, Sandra; De Keyser, Katrien; Ceulemans, Berten			Isolated abducens nerve palsy after closed head trauma - A pediatric case report	PEDIATRIC EMERGENCY CARE			English	Article						abducens nerve; abducens nerve palsy; cranial nerve palsy; craniocerebral trauma	PARESIS; INJURY	Cranial nerve lessions often accompany head trauma. Nevertheless, isolated involvement of the sixth nerve without any cranial or cervical fracture is rare. Nerve injury could occur at the sites of the dural entry points and at the petrous apex during down or upward movement of the brain caused by violent linear force to the head. Management is symptomatic. Most cases improve within three months and many resolve by six months, but spontaneous recovery does not always occur. We describe the case of a 13-year-old boy who developed isolated abducens nerve palsy after closed head trauma.	[Janssen, Karen; Woiciechowski, Marek; Poot, Sandra] Univ Antwerp, Univ Antwerp Hosp, Dept Pediat, Edegem, Belgium; [De Keyser, Katrien] Univ Antwerp, Univ Antwerp Hosp, Dept Ophthalmol, Edegem, Belgium; [Ceulemans, Berten] Univ Antwerp, Univ Antwerp Hosp, Dept Pediat Neurol, Edegem, Belgium		Woiciechowski, M (corresponding author), Univ Ziekenhuis Antwerpen, Wilrijkstr 10, B-2650 Edegem, Belgium.	marek.wojciechowski@uza.be					Advani RM, 2003, ANN EMERG MED, V41, P27, DOI 10.1067/mem.2003.46; Aroichane M, 1995, J Pediatr Ophthalmol Strabismus, V32, P152; BAKER RS, 1991, SURV OPHTHALMOL, V35, P245, DOI 10.1016/0039-6257(91)90046-I; Hanson RA, 2004, NEUROLOGY, V62, P33, DOI 10.1212/WNL.62.1.33; Hollis GJ, 1997, J ACCID EMERG MED, V14, P172; Holmes J M, 1998, J AAPOS, V2, P265, DOI 10.1016/S1091-8531(98)90081-7; Holmes JM, 2001, OPHTHALMOLOGY, V108, P1457, DOI 10.1016/S0161-6420(01)00633-9; Holmes JM, 2000, J AAPOS, V4, P145, DOI 10.1067/mpa.2000.103875; Mutyala S, 1996, AM J OPHTHALMOL, V122, P898, DOI 10.1016/S0002-9394(14)70394-0; Sam B, 2004, FORENSIC SCI INT, V140, P25, DOI 10.1016/j.forsciint.2003.11.020; Yilmaz N, 2003, J PEDIAT NEUROL, V1, P107	11	8	9	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0749-5161			PEDIATR EMERG CARE	Pediatr. Emerg. Care	SEP	2008	24	9					621	623		10.1097/PEC.0b013e3181850c5c			3	Emergency Medicine; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine; Pediatrics	349BH	WOS:000259253300008	18797373				2022-02-06	
J	Santos, A; Goncalves, P; Araujo, JR; Martel, F				Santos, Alejandro; Goncalves, Pedro; Araujo, Joao R.; Martel, Fatima			Intestinal permeability to glucose after experimental traumatic brain injury: Effect of gadopentetate dimeglumine administration	BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY			English	Article							BRUSH-BORDER MEMBRANE; MULTIPLE ORGAN FAILURE; AXONAL INJURY; NA+/GLUCOSE COTRANSPORTER; SUGAR ABSORPTION; ION CHANNELS; AMINO-ACIDS; HEAD-INJURY; GLUT2; RATS	Traumatic injuries are the leading cause of mortality in individuals aged 1-44 years, and brain injury significantly contributes to the outcome in nearly one half of all deaths from trauma. At the intestinal level, traumatic brain injury (TBI) induces profound effects, including gastrointestinal mucosa ischaemia and motility dysfunction. However, nothing is known concerning the effect of TBI on the intestinal absorption of glucose. Hence, the aim of this study was to investigate the effect of TBI on the intestinal absorption of glucose by investigating the effect of TBI on the jejunal mucosal-to-serosal apparent permeability (AP-to-BL P(app)) to two glucose model substrates, (3)H-2-deoxy-D-glucose ((3)H-DG) and (3)H-3-O-methyl-D-glucose ((3)H-OMG), and to (14)C-sorbitol. Additionally, we tested if gadopentetate dimeglumine administration could prevent any of the changes observed after TBI. Traumatic brain injury induced an increase in the AP-to-BL P(app) to (3)H-DG. After a 100-min. perfusion of the jejunum, the AP-to-BL P(app) to (3)H-DG in TBI rats was almost 70% higher than in the control rats. There was no change, however, in the AP-to-BL P(app) to neither (3)H-OMG nor (14)C-sorbitol. Interestingly enough, gadopentetate dimeglumine was able to prevent the increase in the AP-to-BL P(app) to (3)H-DG observed after TBI. Given the differences in transport characteristics between (3)H-DG and (3)H-OMG, our results point to the possibility of the Na(+)-independent glucose transporter 2 (GLUT2) being activated by TBI (as the P(app) to (3)H-DG, a GLUT2 substrate, was increased) and the Na(+)-dependent glucose co-transporter (SGLT1) being inhibited by TBI (as the P(app) to (3)H-OMG, a GLUT2 and SGLT1 substrate, remained unchanged). Moreover, gadopentetate dimeglumine prevented these changes associated with TBI.	[Santos, Alejandro; Goncalves, Pedro; Araujo, Joao R.; Martel, Fatima] Univ Porto, Fac Med, Dept Biochem U38 FCT, P-4200319 Oporto, Portugal; [Santos, Alejandro] Univ Porto, Fac Nutr & Food Sci, P-4200319 Oporto, Portugal		Martel, F (corresponding author), Univ Porto, Fac Med, Dept Biochem U38 FCT, P-4200319 Oporto, Portugal.	fmartel@med.up.pt		Martel, Fatima/0000-0002-0525-3416; Santos, Alejandro/0000-0003-0706-5301; Goncalves, Pedro/0000-0002-4127-1152	Fundacao para a Ciencia e a TecnologiaPortuguese Foundation for Science and TechnologyEuropean Commission; Programa Ciencia, Tecnologia e Inovacao do Quadro Comunitario de ApoioSpanish Government [PTDC/SAU-FCF/67805/2006]	This work was supported by Fundacao para a Ciencia e a Tecnologia and Programa Ciencia, Tecnologia e Inovacao do Quadro Comunitario de Apoio (PTDC/SAU-FCF/67805/2006).	Adding LC, 2001, CARDIOVASC DRUG REV, V19, P41; Affleck JA, 2003, J HISTOCHEM CYTOCHEM, V51, P1567, DOI 10.1177/002215540305101116; Au A, 2002, BIOCHEM J, V367, P247, DOI 10.1042/BJ20020393; Aydin S, 2005, SURG TODAY, V35, P751, DOI 10.1007/s00595-005-3034-3; Belli A, 2006, J NEUROCHEM, V96, P861, DOI 10.1111/j.1471-4159.2005.03602.x; Bergmeyer H.U., 1974, METHODS ENZYMATIC AN, Vsecond, P574; Bissonnette P, 1996, AM J PHYSIOL-GASTR L, V270, pG833, DOI 10.1152/ajpgi.1996.270.5.G833; Borges N, 2004, INT J NEUROSCI, V114, P217, DOI 10.1080/00207450490249419; Boudry G, 2007, AM J PHYSIOL-REG I, V292, pR862, DOI 10.1152/ajpregu.00655.2006; *BRAIN TRAUM FDN, 2007, J NEUROTRAUMA S1, V24, pS77, DOI DOI 10.1089/NEU.2006.9984; CRANE RK, 1989, HDB PHYSL GASTROINTE, P1323; Doig CJ, 1998, AM J RESP CRIT CARE, V158, P444, DOI 10.1164/ajrccm.158.2.9710092; Drozdowski LA, 2006, WORLD J GASTROENTERO, V12, P1657, DOI 10.3748/wjg.v12.i11.1657; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; FODA MAA, 1994, J NEUROSURG, V80, P301, DOI 10.3171/jns.1994.80.2.0301; Gotoh H, 1999, NEUROSCIENCE, V92, P1323, DOI 10.1016/S0306-4522(99)00032-9; Gouyon F, 2003, J PHYSIOL-LONDON, V552, P823, DOI 10.1113/jphysiol.2003.049247; Grotz MRW, 1999, ANN SURG, V229, P478, DOI 10.1097/00000658-199904000-00005; Hamill OP, 1996, PHARMACOL REV, V48, P231; Hang CH, 2003, WORLD J GASTROENTERO, V9, P2776; HEDIGER MA, 1989, P NATL ACAD SCI USA, V86, P5748, DOI 10.1073/pnas.86.15.5748; HEDIGER MA, 1987, NATURE, V330, P379, DOI 10.1038/330379a0; Higuchi T, 2007, J NUCL MED, V48, P288; Kellett GL, 2001, J PHYSIOL-LONDON, V531, P585, DOI 10.1111/j.1469-7793.2001.0585h.x; Kellett GL, 2005, DIABETES, V54, P3056, DOI 10.2337/diabetes.54.10.3056; Lewen A, 2000, J NEUROTRAUM, V17, P871, DOI 10.1089/neu.2000.17.871; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Martinac B, 2004, J CELL SCI, V117, P2449, DOI 10.1242/jcs.01232; Maxwell WL, 1997, J NEUROTRAUM, V14, P419, DOI 10.1089/neu.1997.14.419; Moore FA, 1999, AM J SURG, V178, P449, DOI 10.1016/S0002-9610(99)00231-7; MORRIS TW, 1991, INVEST RADIOL, V26, P1087, DOI 10.1097/00004424-199112000-00011; NILSSON P, 1990, J CEREBR BLOOD F MET, V10, P631, DOI 10.1038/jcbfm.1990.115; Obrenovitch TP, 1997, J NEUROTRAUM, V14, P677, DOI 10.1089/neu.1997.14.677; Ott L, 1999, J NEUROTRAUM, V16, P233, DOI 10.1089/neu.1999.16.233; PALMER AM, 1993, J NEUROCHEM, V61, P2015, DOI 10.1111/j.1471-4159.1993.tb07437.x; PRAGER C, 1990, ACTA ENDOCRINOL-COP, V122, P585, DOI 10.1530/acta.0.1220585; Regner A, 2001, J NEUROTRAUM, V18, P783, DOI 10.1089/089771501316919148; Reinert MM, 1999, NEUROL RES, V21, P330, DOI 10.1080/01616412.1999.11740940; Santer R, 2003, GASTROENTEROLOGY, V124, P34, DOI 10.1053/gast.2003.50009; Santos A, 2005, NEUROCHEM RES, V30, P625, DOI 10.1007/s11064-005-2750-9; Shepherd EJ, 2004, J PHYSIOL-LONDON, V560, P281, DOI 10.1113/jphysiol.2004.072447; Siesjo BK, 1996, EUR J ANAESTH, V13, P247, DOI 10.1046/j.1365-2346.1996.00976.x; STAHL B, 1989, J NEUROCHEM, V53, P665, DOI 10.1111/j.1471-4159.1989.tb11755.x; Stumpel F, 2001, P NATL ACAD SCI USA, V98, P11330, DOI 10.1073/pnas.211357698; Swank GM, 1996, WORLD J SURG, V20, P411, DOI 10.1007/s002689900065; THORENS B, 1990, AM J PHYSIOL, V259, pC279; THORENS B, 1988, CELL, V55, P281, DOI 10.1016/0092-8674(88)90051-7; TURK E, 1994, J BIOL CHEM, V269, P15204; Vagnozzi R, 1999, J NEUROTRAUM, V16, P903, DOI 10.1089/neu.1999.16.903; van Laarhoven HWM, 2005, RADIOLOGY, V237, P181, DOI 10.1148/radiol.2371041397; Vaz R, 1998, ACTA NEUROCHIR, V140, P371, DOI 10.1007/s007010050111; Walker J, 2005, BIOCHEM J, V385, P485, DOI 10.1042/BJ20040694; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Wolf JA, 2001, J NEUROSCI, V21, P1923, DOI 10.1523/JNEUROSCI.21-06-01923.2001; Wright EM, 2003, BEST PRACT RES CL GA, V17, P943, DOI 10.1016/S1521-6918(03)00107-0	55	8	9	0	3	WILEY-BLACKWELL	MALDEN	COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA	1742-7835			BASIC CLIN PHARMACOL	Basic Clin. Pharmacol. Toxicol.	SEP	2008	103	3					247	254		10.1111/j.1742-7843.2008.00272.x			8	Pharmacology & Pharmacy; Toxicology	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy; Toxicology	337YV	WOS:000258472300007	18684234	Bronze			2022-02-06	
J	Jin, PHPFK; Penning, N; Joosse, P; Hijdra, AHJ; Bouma, GJ; Ponsen, KJ; Goslings, JC				Jin, P. H. Ping Fung Kon; Penning, Niels; Joosse, Pieter; Hijdra, Albert H. J.; Bouma, Gert Joan; Ponsen, Kees Jan; Goslings, J. Carel			The effect of the introduction of the Amsterdam trauma workflow concept on mortality and functional outcome of patients with severe traumatic brain injury	JOURNAL OF NEUROTRAUMA			English	Article						adult brain injury; clinical management of CNS injury; head trauma	SEVERE HEAD-INJURY; COMPUTED-TOMOGRAPHY; MANAGEMENT; SCALE; ROOM; CARE	The purpose of this study was to analyze the effect of the introduction of an all-in workflow concept that included direct computed tomography (CT) scanning in the trauma room on mortality and functional outcome of trauma patients with severe traumatic brain injury (TBI) admitted to a level-1 trauma center. To this end, a retrospective comparison was made of a 1-year cohort prior to the implementation of the all-in workflow concept (Pre-CT in trauma room cohort [Pre-TRCT]) and a 1-year cohort after the implementation (Post-TRCT). All severely injured TBI patients aged 16 years or older that were presented in our level-1 trauma center and that underwent a CT of the head were initially included. Severe TBI was defined as an Abbreviated Injury Scale (AIS) score of > 2 of the head region following trauma. Primary outcome parameter was TBI-related mortality during primary hospital admission. Secondary outcome parameter was the functional outcome based on GOS-Extended. A total of 59 patients were included in the Pre-TRCT and 49 in the Post-TRCT. Median age was 49 years in the Post-TRCT and 44 years in the Pre-TRCT (not significant [NS]). Median ISS was similar (ISS = 25). Median Head-AIS was higher in the Post-TRCT (5 vs. 4, NS). Initial CT scanning was completed faster in the Post-TRCT. There was a significant difference of 23% mortality in favor of the Post-TRCT for TBI-related mortality during primary hospital admission (p < 0.05). For acute neurosurgical interventions, time until intervention tended to be faster in the Post-TRCT (NS). Functional outcomes for survivors were higher in the Post-TRCT (6 vs. 5, NS).	[Jin, P. H. Ping Fung Kon; Penning, Niels; Joosse, Pieter; Ponsen, Kees Jan; Goslings, J. Carel] Univ Amsterdam, Dept Surg, Trauma Unit, Acad Med Ctr, NL-1105 AZ Amsterdam, Netherlands; [Hijdra, Albert H. J.] Univ Amsterdam, Acad Med Ctr, Dept Neurol, NL-1105 AZ Amsterdam, Netherlands; [Bouma, Gert Joan] Univ Amsterdam, Acad Med Ctr, Dept Neurosurg, NL-1105 AZ Amsterdam, Netherlands		Jin, PHPFK (corresponding author), Univ Amsterdam, Dept Surg, Trauma Unit, Acad Med Ctr, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	p.fungkonjin@amc.uva.nl		Bouma, Gerrit/0000-0002-2772-7475			*AANS, 1996, J NEUROTRAUM, V13, P639; *AM COLL SURG COMM, 1993, RES OPT CAR INJ PAT; *AM COLL SURG COMM, 2004, ATLS ADV TRAUM LIF S; Bulger EM, 2002, CRIT CARE MED, V30, P1870, DOI 10.1097/00003246-200208000-00033; Celli P, 1997, Minerva Chir, V52, P1467; Gray DS, 2000, BRAIN INJURY, V14, P1003, DOI 10.1080/02699050050191940; Hauser H, 1998, UNFALLCHIRURG, V101, P129, DOI 10.1007/s001130050245; Hudak AM, 2005, J NEUROTRAUM, V22, P1319, DOI 10.1089/neu.2005.22.1319; Hukkelhoven CWPM, 2003, J NEUROSURG, V99, P666, DOI 10.3171/jns.2003.99.4.0666; Inamasu J, 2000, AM J EMERG MED, V18, P810, DOI 10.1053/ajem.2000.18111; Jin PHPFK, 2008, J TRAUMA, V64, P1320, DOI 10.1097/TA.0b013e318059b9ae; Lannoo E, 2000, J NEUROTRAUM, V17, P403, DOI 10.1089/neu.2000.17.403; LEVATI A, 1982, J NEUROSURG, V57, P779, DOI 10.3171/jns.1982.57.6.0779; Livingston DH, 2005, J TRAUMA, V59, P1298, DOI 10.1097/01.ta.0000196002.03681.18; LIVINGSTON DH, 1991, J TRAUMA, V31, P483, DOI 10.1097/00005373-199104000-00006; Mandavia DP, 2001, PEDIATR EMERG CARE, V17, P193, DOI 10.1097/00006565-200106000-00011; Munch E, 2000, NEUROSURGERY, V47, P315, DOI 10.1097/00006123-200008000-00009; Murray GD, 1999, ACTA NEUROCHIR, V141, P223, DOI 10.1007/s007010050292; NARAYAN RK, 1982, J NEUROSURG, V56, P650, DOI 10.3171/jns.1982.56.5.0650; Patel HC, 2002, INTENS CARE MED, V28, P547, DOI 10.1007/s00134-002-1235-4; Poletti PA, 2002, EUR RADIOL, V12, P969, DOI 10.1007/s00330-002-1353-y; Self ML, 2003, AM J SURG, V186, P609, DOI 10.1016/j.amjsurg.2003.08.003; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Thornhill S, 2000, BRIT MED J, V320, P1631, DOI 10.1136/bmj.320.7250.1631; Trupka A, 1997, J TRAUMA, V43, P405, DOI 10.1097/00005373-199709000-00003; Velmahos GC, 2005, J TRAUMA, V59, P1155, DOI 10.1097/01.ta.0000196435.18073.6d; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573	27	8	8	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	AUG	2008	25	8					1003	1009		10.1089/neu.2007.0463			7	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	343ZT	WOS:000258895700006	18699728				2022-02-06	
J	Koyuturk, AE; Kusgoz, A				Koyuturk, Alp Erdin; Kusgoz, Adem			Multiple dentoalveolar traumatic injury: a case report (3 years follow up)	DENTAL TRAUMATOLOGY			English	Article							DENTAL TRAUMA; PERMANENT INCISORS; EPIDEMIOLOGY; CHILDREN	Dental trauma with children and adolescents is a serious dental public health problem. Traumatic injuries on permanent teeth are common, and dramatic episodes can occur during childhood. Cases of dental avulsions and reimplantations, dentoalveolar fractures, several forms (lateral, extrusive and intrusive) of luxations, concussion, subluxation, gingival lacerations and hard, pulpal dental tissue lesions have been extensively reported. This case report presents the therapy for severe trauma caused by multiple traumatic injuries to the dentoalveolar complex of a patient.	[Koyuturk, Alp Erdin] Ondokuz Mayis Univ, Dept Pediat Dent, Fac Dent, Samsun, Turkey; [Kusgoz, Adem] Selcuk Univ, Dept Pediat Dent, Fac Dent, Konya, Turkey		Koyuturk, AE (corresponding author), Ondokuz Mayis Univ Hekimligi, Fak Pedodonti AD, TR-55139 Kurupelit, Turkey.	ekoyuturk2000@yahoo.com					Altay N, 2001, DENT TRAUMATOL, V17, P201; Andreasen JO, 2002, DENT TRAUMATOL, V18, P1; Andreasen JO, 1994, TXB COLOR ATLAS TRAU; Bakland LK, 2004, ENDODONTIC TOPICS, V7, P14; Bastone EB, 2000, AUST DENT J, V45, P2, DOI 10.1111/j.1834-7819.2000.tb00234.x; CALISKAN MK, 1995, ENDOD DENT TRAUMATOL, V11, P210; DELATTRE JP, 1994, ENDOD DENT TRAUMATOL, V11, P186; Gottrup F, 1993, TXB COLOR ATLAS TRAU, P13; KABA AD, 1989, J DENT CHILD, V56, P417; LIEW VP, 1986, COMMUNITY DENT ORAL, V14, P362, DOI 10.1111/j.1600-0528.1986.tb01092.x; ONETTO JE, 1994, ENDOD DENT TRAUMATOL, V10, P223; Pohl Y, 2005, DENT TRAUMATOL, V21, P80, DOI 10.1111/j.1600-9657.2004.00297.x; SCHATZ JP, 1994, ENDOD DENT TRAUMATOL, V10, P11; Sheroan MM, 2004, DENT TRAUMATOL, V20, P222, DOI 10.1111/j.1600-9657.2004.00226.x; Wilson S, 1997, PEDIATR EMERG CARE, V13, P12, DOI 10.1097/00006565-199702000-00004; Zerfowski M, 1998, Clin Oral Investig, V2, P120, DOI 10.1007/s007840050056; ZERMAN N, 1993, ENDOD DENT TRAUMATOL, V9, P61	17	8	8	0	5	WILEY-BLACKWELL	MALDEN	COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA	1600-4469			DENT TRAUMATOL	Dent. Traumatol.	AUG	2008	24	4					16	19		10.1111/j.1600-9657.2008.00579.x			4	Dentistry, Oral Surgery & Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Dentistry, Oral Surgery & Medicine	327UM	WOS:000257754000004	18557754				2022-02-06	
J	Wongvatunyu, S; Porter, EJ				Wongvatunyu, Suporn; Porter, Eileen J.			Changes in family life perceived by mothers of young adult TBI survivors	JOURNAL OF FAMILY NURSING			English	Article						traumatic brain injury; maternal caregiving; descriptive phenomenology	TRAUMATIC BRAIN-INJURY; HEAD-INJURY; UNITED-STATES; STRESS; NEEDS; INVOLVEMENT; EXPERIENCE; CAREGIVERS; BURDEN; IMPACT	Little is known about changes in family life perceived by mothers of young adult survivors of a traumatic brain injury (TBI). A phenomenological method was used to describe the changes that seven mothers of TBI survivors perceived in family life 6 months or more after the TBI. The five basic changes in family life reported by mothers were: getting attention from each other for different reasons now, getting along with each other since the injury, facing new financial hurdles, going our separate ways down this new path, and splitting the family apart against our will. Compared to literature on stress and coping, the findings offered a unique perspective on changes in family life. Nurses call use the findings to initiate therapeutic conversations with mothers about changes in family life after a TBI.	[Porter, Eileen J.] Univ Missouri, S424 Sch Nursing, Columbia, MO 65211 USA; [Wongvatunyu, Suporn] Mahidol Univ, Ramathibodi Hosp, Fac Med, Ramathibodi Sch Nursing, Bangkok 10400, Thailand		Porter, EJ (corresponding author), Univ Missouri, S424 Sch Nursing, Columbia, MO 65211 USA.	PorterEJ@missouri.edu			Alpha Iota Chapter of Sigma Theta Tau International Honor Society of Nursing	This study was partly supported by Alpha Iota Chapter of Sigma Theta Tau International Honor Society of Nursing.	Allen SM, 1999, J MARRIAGE FAM, V61, P199, DOI 10.2307/353894; Blais MC, 2005, BRAIN INJURY, V19, P1223, DOI 10.1080/02699050500309387; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Carnes S.L., 2005, FAM SYST HEALTH, V23, P186, DOI DOI 10.1037/1091-7527.23.2.186; Chronister J, 2006, REHABIL PSYCHOL, V51, P190, DOI 10.1037/0090-5550.51.3.190; Chwalisz K, 1996, REHABIL PSYCHOL, V41, P91, DOI 10.1037/0090-5550.41.2.91; Cope DN, 2005, J HEAD TRAUMA REHAB, V20, P128, DOI 10.1097/00001199-200503000-00002; DEGENEFFE CE, 2001, FAMILY CAREGIVING TR; Florian V, 1989, Brain Inj, V3, P219, DOI 10.3109/02699058909029637; FRIEDMAN MM, 1998, FAMILY NURSING RES T, P293; Ganong L.H., 2003, J FAM NURS, V9, P184, DOI [10.1177/1074840703009002005, DOI 10.1177/1074840703009002005]; Glover A, 2000, DISABIL REHABIL, V22, P471, DOI 10.1080/09638280050045956; HAASE JE, 1987, ADV NURS SCI, V9, P64, DOI 10.1097/00012272-198701000-00010; Hammell K., 2000, USING QUALITATIVE RE, P1; Hemingway S, 1997, Nurs Stand, V12, P40; Husserl E., 1962, IDEAS GEN INTRO PURE; Jennings B, 2006, HASTINGS CENT REP, V36, P29, DOI 10.1353/hcr.2006.0026; Kao Hsueh-Fen S, 2004, J Neurosci Nurs, V36, P73; Kneafsey R, 2004, J CLIN NURS, V13, P601, DOI 10.1111/j.1365-2702.2004.00903.x; Kolakowsky-Hayner SA, 2001, J HEAD TRAUMA REHAB, V16, P374, DOI 10.1097/00001199-200108000-00007; Kosciulek J. F., 1994, REHABILITATION COUNS, V37, P245; KOSCIULEK JF, 1993, J REHABIL, V59, P40; KOSCIULEK JF, 1995, J APPL REHABILITATIO, V26, P13; Kraus J, 2000, HEAD INJURY, P1; KREUTZER JS, 1994, BRAIN INJURY, V8, P211, DOI 10.3109/02699059409150974; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Leathem J, 1996, BRAIN INJURY, V10, P27; Leith KH, 2004, BRAIN INJURY, V18, P1191, DOI 10.1080/02699050410001719943; MCCUBBIN MA, 2001, FAMILY ASSESSMENT IN, P3; Morse J., 1989, QUALITATIVE NURSING, P117; Nelson AM, 2002, QUAL HEALTH RES, V12, P515, DOI 10.1177/104973202129120043; Nolan S, 2005, CRIT CARE NURS Q, V28, P188, DOI 10.1097/00002727-200504000-00010; Perlesz A, 1998, INT J REHABIL RES, V21, P339, DOI 10.1097/00004356-199812000-00001; Perlesz A, 1999, REHABIL PSYCHOL, V44, P6, DOI 10.1037/0090-5550.44.1.6; Porter EJ, 1998, ADV NURS SCI, V21, P16, DOI 10.1097/00012272-199809000-00003; Porter EJ, 1995, J WOMEN AGING, V7, P31; Rotondi AJ, 2007, J HEAD TRAUMA REHAB, V22, P14, DOI 10.1097/00001199-200701000-00002; Russell WR, 1932, BRAIN, V55, P549, DOI 10.1093/brain/55.4.549; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Schutz A., 1973, STRUCTURES LIFE WORL; Selassie AW, 2008, J HEAD TRAUMA REHAB, V23, P123, DOI 10.1097/01.HTR.0000314531.30401.39; Smith A M, 1998, Rehabil Nurs, V23, P252; Verhaeghe S, 2005, J CLIN NURS, V14, P1004, DOI 10.1111/j.1365-2702.2005.01126.x; Wells R, 2005, BRAIN INJURY, V19, P1105, DOI 10.1080/02699050500150062; Wongvatunyu S, 2005, J NURS SCHOLARSHIP, V37, P48, DOI 10.1111/j.1547-5069.2005.00015.x; WONGVATUNYU S, QUALITATIVE IN PRESS	46	8	8	0	4	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1074-8407	1552-549X		J FAM NURS	J. Fam. Nurs.	AUG	2008	14	3					314	332		10.1177/1074840708321473			19	Family Studies; Nursing	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Family Studies; Nursing	349KR	WOS:000259280200003	18617710				2022-02-06	
J	Abate, MG; Cadore, B; Citerio, G				Abate, M. G.; Cadore, B.; Citerio, G.			Hypothermia in adult neurocritical patients: a very "hot" strategy not to be hibernated yet!	MINERVA ANESTESIOLOGICA			English	Article						hypothermia; brain injuries; metabolism; stroke	TRAUMATIC BRAIN-INJURY; INTENSIVE-CARE-UNIT; INTERNATIONAL LIAISON COMMITTEE; INTRACRANIAL ANEURYSM SURGERY; PROMISING TREATMENT MODALITY; SUPPORT TASK-FORCE; THERAPEUTIC HYPOTHERMIA; CARDIAC-ARREST; HEAD-INJURY; INTRAOPERATIVE HYPOTHERMIA	Therapeutic moderate hypothermia (32-34 degrees C) is currently recommended for patients with out-of-hospital cardiac arrest (OHCA) and for newborns exhibiting neonatal hypoxic/ischemic encephalopathy. Hypothermia as neuroprotective strategy has been extensively studied in other scenarios, mainly for traumatic brain injury. Despite a negative result reported by a multicenter trial conducted in 2001 by Clifton et al. regarding the use of hypothermia oil head injury patients, several Studies in both clinical and laboratory settings have continued to report positive Outcomes with hypothermia use in neurocritical care. 16 date, no adequate consensus has been reached. Though the topic is still under debate, emerging data Suggest that there may not be a clear-cut answer as to whether hypothermia is beneficial. However, new research may indicate what target populations can benefit most from this therapy. Furthermore, issues of timing (when and for how long hypothermia is applied) seem to be the primary drivers of the most unambiguous findings in this matter. For the time being, we conclude that further Studies are needed to assess how to better administer this possibly beneficial therapy, and who might benefit most from the technique.	[Abate, M. G.; Cadore, B.; Citerio, G.] Osped San Gerardo, Neuroanesthesia & NeuroIntens Care Unit, Dept Perioperat Med & Intens Care, I-20052 Milan, Italy; [Abate, M. G.] Univ Cambridge, Addenbrookes Hosp, Div Anaesthesia, Cambridge CB2 2QQ, England		Citerio, G (corresponding author), Osped San Gerardo, Neuroanesthesia & NeuroIntens Care Unit, Dept Perioperat Med & Intens Care, Via Pergolesi 33, I-20052 Milan, Italy.	g.citerio@hsgerardo.org		Citerio, Giuseppe/0000-0002-5374-3161			Abella BS, 2005, RESUSCITATION, V64, P181, DOI 10.1016/j.resuscitation.2004.09.014; Alderson P, 2004, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001048.pub2, DOI 10.1002/14651858.CD001048.PUB2]; Anderson SW, 2006, ANN NEUROL, V60, P518, DOI 10.1002/ana.21018; Berger C, 2002, STROKE, V33, P519, DOI 10.1161/hs0102.100878; Clifton GL, 2001, NEW ENGL J MED, V344, P556, DOI 10.1056/NEJM200102223440803; Clifton GL, 2002, J NEUROTRAUM, V19, P293, DOI 10.1089/089771502753594864; Clifton Guy L, 2004, Curr Opin Crit Care, V10, P116, DOI 10.1097/00075198-200404000-00007; Coles JP, 2004, J CEREBR BLOOD F MET, V24, P202, DOI 10.1097/01.WCB.0000103022.98348.24; Diringer MN, 2004, CRIT CARE MED, V32, P559, DOI 10.1097/01.CCM.0000108868.97433.3F; Gaetz M, 2004, CLIN NEUROPHYSIOL, V115, P4, DOI 10.1016/S1388-2457(03)00258-X; Guluma KZ, 2008, NEUROCRIT CARE, V8, P42, DOI 10.1007/s12028-007-9009-z; Gupta AK, 2002, BRIT J ANAESTH, V88, P188, DOI 10.1093/bja/88.2.188; Hindman BJ, 1999, NEUROSURGERY, V44, P23, DOI 10.1097/00006123-199901000-00009; Hoedemaekers CW, 2007, CRIT CARE, V11, DOI 10.1186/cc6104; Hutchison J, 2006, DEV NEUROSCI-BASEL, V28, P291, DOI 10.1159/000094155; Inamasu J, 2002, ANN EMERG MED, V40, P220, DOI 10.1067/mem.2002.123697; Jacobs SE, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003311.pub3; Jia XF, 2008, RESUSCITATION, V76, P431, DOI 10.1016/j.resuscitation.2007.08.014; Kawai N, 2000, J NEUROTRAUM, V17, P193, DOI 10.1089/neu.2000.17.193; Larrey IJ, 1814, MEMOIRS MILITARY SER, V2, P156; Lavinio A, 2007, BRIT J ANAESTH, V99, P237, DOI 10.1093/bja/aem118; MARMAROU A, 1994, ACTA NEUROCHIR, P421; Menon DK, 2004, CRIT CARE MED, V32, P1384, DOI 10.1097/01.CCM.0000127777.16609.08; Nolan JP, 2005, RESUSCITATION, V67, P175, DOI 10.1016/j.resuscitation.2005.09.008; Nolan JP, 2003, CIRCULATION, V108, P118, DOI 10.1161/01.CIR.0000079019.02601.90; Nolan JP, 2003, RESUSCITATION, V57, P231, DOI 10.1016/S0300-9572(03)00184-9; Polderman KH, 2004, INTENS CARE MED, V30, P556, DOI 10.1007/s00134-003-2152-x; Polderman KH, 2004, INTENS CARE MED, V30, P757, DOI 10.1007/s00134-003-2151-y; Roth J, 2004, FRONT BIOSCI-LANDMRK, V9, P290, DOI 10.2741/1241; Sahuquillo J, 2007, CURR PHARM DESIGN, V13, P2310; Shann F, 2003, LANCET, V362, P1950, DOI 10.1016/S0140-6736(03)15083-0; SIGGAARDANDERSEN O, 1995, ACTA ANAESTH SCAND, V39, P137; Thompson HJ, 2003, NEUROBIOL DIS, V12, P163, DOI 10.1016/S0969-9961(02)00030-X; Tisherman SA, 1999, SURG CLIN N AM, V79, P1269, DOI 10.1016/S0039-6109(05)70077-3; Todd MM, 2005, NEW ENGL J MED, V352, P135, DOI 10.1056/NEJMoa040975; Tokutomi T, 2003, NEUROSURGERY, V52, P102, DOI 10.1097/00006123-200301000-00013; van Zanten ARH, 2005, CRIT CARE MED, V33, P1449, DOI 10.1097/01.CCM.0000166710.64724.34; Vespa P, 2005, J CEREBR BLOOD F MET, V25, P763, DOI 10.1038/sj.jcbfm.9600073	38	8	8	0	0	EDIZIONI MINERVA MEDICA	TURIN	CORSO BRAMANTE 83-85 INT JOURNALS DEPT., 10126 TURIN, ITALY	0375-9393	1827-1596		MINERVA ANESTESIOL	Minerva Anestesiol.	JUL-AUG	2008	74	7-8					425	430					6	Anesthesiology; Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology; General & Internal Medicine	326NI	WOS:000257665800009	18356803				2022-02-06	
J	Karaoglan, A; Kaya, E; Akdemir, O; Sagmanligil, A; Bilguvar, K; Cirakoglu, B; Sahan, E; Erdogan, N; Barut, S; Colak, A				Karaoglan, Alper; Kaya, Ekrem; Akdemir, Osman; Sagmanligil, Ayhan; Bilguvar, Kaya; Cirakoglu, Beyazit; Sahan, Elife; Erdogan, Nusret; Barut, Seref; Colak, Ahmet			Neuroprotective effects of Ac.YVAD.cmk on experimental spinal cord injury in rats	SURGICAL NEUROLOGY			English	Article						Ac.YVAD.cmk; apoptosis; caspases; SCI; secondary damage	CASPASE INHIBITORS; CELL-DEATH; NEURONAL APOPTOSIS; CEREBRAL-ISCHEMIA; FAMILY PROTEASES; BRAIN-INJURY; INTERLEUKIN-1-BETA; ICE; IDENTIFICATION; EXPRESSION	Background: Apoptosis as a cell death mechanism is important in numerous diseases, including traumatic SCI. We evaluated the neuroprotective effects of Ac.YVAD.cmk and functional outcomes in a rat SCI model. Methods: Thirty rats were randomized into 3 groups of 10: sham-operated, trauma only, and trauma plus Ac.YVAD.cmk treatment. Trauma was produced in the thoracic region by a weight-drop technique. Group 3 rats received Ac.YVAD.cmk (1 mg/kg, ip) 1 minute after trauma. The rats were killed at 24 hours and 5 days after injury. Efficacy was evaluated with light microscopy and TUNEL staining. Functional outcomes were assessed with the inclined plane technique and a modified version of the Tarlov grading system. Results: At 24 hours postinjury, the respective mean number of apoptotic cells in groups 1, 2, and 3 were 0, 5.26 +/- 0.19, and 0.97 +/- 0.15. Microscopic examination of group 2 tissues showed widespread hemorrhage, edema, necrosis, and polymorphic nuclear leukocyte infiltration and vascular thrombi. Group 3 tissues revealed similar features, but cavitation and demyelination were less prominent than those in group 2 samples at this period. At 5 days postinjury, the respective mean 5 inclined plane angles in groups 1, 2, and 3 were 61.5 +/- 2.09, 42.00 +/- 2.74, and 52.5 +/- 1.77. Motor grading of animals revealed a similar trend. These differences were statistically significant (P < .05). Conclusions: Ac.YVAD.cmk inhibited postraumatic apoptosis in a rat SCI model. This may provide the basis for development of new therapeutic strategies for the treatment of SCI. (C) 2008 Elsevier Inc. All rights reserved.	[Karaoglan, Alper; Kaya, Ekrem; Akdemir, Osman; Sagmanligil, Ayhan; Barut, Seref; Colak, Ahmet] Taksim Educ & Res Hosp, Clin Neurosurg, Istanbul, Turkey; [Sahan, Elife; Erdogan, Nusret] Taksim Educ & Res Hosp, Clin Pathol, Istanbul, Turkey; [Bilguvar, Kaya; Cirakoglu, Beyazit] Marmara Univ, Sch Med, Dept Med Biol, Istanbul, Turkey		Colak, A (corresponding author), Taksim Educ & Res Hosp, Clin Neurosurg, Istanbul, Turkey.	drahmetcolak@yahoo.com	Erdogan, Nusret/K-6413-2018; Kaya, Ekrem/AAG-7319-2021	Erdogan, Nusret/0000-0002-0333-8600; Kaya, Ekrem/0000-0002-9562-4195			Allen AR, 1914, J NERV MENT DIS, V41, P141, DOI 10.1097/00005053-191403000-00002; Azari MF, 2006, J NEUROPATH EXP NEUR, V65, P914, DOI 10.1097/01.jnen.0000235855.77716.25; Barut S, 2005, SURG NEUROL, V64, P213, DOI 10.1016/j.surneu.2005.03.042; Bresnahan J. C., 1996, Society for Neuroscience Abstracts, V22, P1185; Casha S, 2001, NEUROSCIENCE, V103, P203, DOI 10.1016/S0306-4522(00)00538-8; Cid C, 2003, J NEUROIMMUNOL, V136, P119, DOI 10.1016/S0165-5728(02)00467-8; Colak A, 2005, J NEUROSURG-SPINE, V2, P327, DOI 10.3171/spi.2005.2.3.0327; Crowe MJ, 1997, NAT MED, V3, P73, DOI 10.1038/nm0197-73; Deveraux QL, 1999, J CLIN IMMUNOL, V19, P388, DOI 10.1023/A:1020502800208; Dinarello CA, 1998, ANN NY ACAD SCI, V856, P1, DOI 10.1111/j.1749-6632.1998.tb08307.x; Ekert PG, 1999, CELL DEATH DIFFER, V6, P1081, DOI 10.1038/sj.cdd.4400594; Emery E, 1998, J NEUROSURG, V89, P911, DOI 10.3171/jns.1998.89.6.0911; ENARI M, 1995, NATURE, V375, P78, DOI 10.1038/375078a0; FIEDLANDER RM, 1996, J EXP MED, V184, P717; Fink KB, 1999, NEUROSCIENCE, V94, P1213, DOI 10.1016/S0306-4522(99)00345-0; Friedlander RM, 1997, NATURE, V388, P31, DOI 10.1038/40299; Friedlander RM, 1998, CELL DEATH DIFFER, V5, P823, DOI 10.1038/sj.cdd.4400433; GAVRIELI Y, 1992, J CELL BIOL, V119, P493, DOI 10.1083/jcb.119.3.493; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; Hara H, 1997, P NATL ACAD SCI USA, V94, P2007, DOI 10.1073/pnas.94.5.2007; Hayashi Y, 2001, BRAIN RES, V893, P113, DOI 10.1016/S0006-8993(00)03307-2; Hwan AY, 2006, BIOCHEM BIOPH RES CO, V348, P560, DOI 10.1016/j.bbrc.2006.07.105; Kato H, 1997, EXP NEUROL, V148, P464, DOI 10.1006/exnr.1997.6707; Katoh K, 1996, NEUROSCI LETT, V216, P9; Keane RW, 2001, J NEUROPATH EXP NEUR, V60, P422, DOI 10.1093/jnen/60.5.422; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; KOSTURA MJ, 1989, P NATL ACAD SCI USA, V86, P5227, DOI 10.1073/pnas.86.14.5227; KUIDA K, 1995, SCIENCE, V267, P2000, DOI 10.1126/science.7535475; Li GL, 1996, J NEUROPATH EXP NEUR, V55, P280, DOI 10.1097/00005072-199603000-00003; Li H, 2000, STROKE, V31, P176, DOI 10.1161/01.STR.31.1.176; Li M, 2000, NEUROSCIENCE, V99, P333, DOI 10.1016/S0306-4522(00)00173-1; Liu XZ, 1997, J NEUROSCI, V17, P5395; Loddick SA, 1996, J CEREBR BLOOD F MET, V16, P932, DOI 10.1097/00004647-199609000-00017; Lou J, 1998, SPINAL CORD, V36, P683, DOI 10.1038/sj.sc.3100632; Lu JK, 2000, SPINE, V25, P1859, DOI 10.1097/00007632-200007150-00022; Nicholson DW, 2000, NATURE, V407, P810, DOI 10.1038/35037747; Okuda Y, 2000, BIOCHEM BIOPH RES CO, V267, P826, DOI 10.1006/bbrc.1999.2049; QUAGLIARELLO VJ, 1991, J CLIN INVEST, V87, P1360, DOI 10.1172/JCI115140; Raff M, 1998, NATURE, V396, P119, DOI 10.1038/24055; Ray AM, 2000, BRAIN RES, V867, P62, DOI 10.1016/S0006-8993(00)02230-7; RINK A, 1995, AM J PATHOL, V147, P1575; RIVLIN AS, 1977, J NEUROSURG, V47, P577, DOI 10.3171/jns.1977.47.4.0577; Rudel T, 1999, HERZ, V24, P236, DOI 10.1007/BF03044967; Samali A, 1999, CELL DEATH DIFFER, V6, P495, DOI 10.1038/sj.cdd.4400520; Springer JE, 1999, NAT MED, V5, P943, DOI 10.1038/11387; TARLOV IM, 1957, SPINAL CORD COMPRESS, P147; TEWARI M, 1995, CELL, V81, P801, DOI 10.1016/0092-8674(95)90541-3; THOMPSON CB, 1995, SCIENCE, V267, P1456, DOI 10.1126/science.7878464; Troy CM, 1996, P NATL ACAD SCI USA, V93, P5635, DOI 10.1073/pnas.93.11.5635; Van de Craen M, 1998, CELL DEATH DIFFER, V5, P838, DOI 10.1038/sj.cdd.4400444; Villa P, 1997, TRENDS BIOCHEM SCI, V22, P388, DOI 10.1016/S0968-0004(97)01107-9	51	8	9	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0090-3019			SURG NEUROL	Surg. Neurol.	JUN	2008	69	6					561	567		10.1016/j.surneu.2007.03.041			7	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	306UZ	WOS:000256274600003	18262241				2022-02-06	
J	Keenan, HT; Nocera, M; Runyan, DK				Keenan, Heather T.; Nocera, Maryalice; Runyan, Desmond K.			Race matters in the prosecution of perpetrators of inflicted traumatic brain injury	PEDIATRICS			English	Article						child abuse; judicial decisions; disparity; race	YOUNG-CHILDREN; SEXUAL ABUSE	OBJECTIVE. The goal was to examine the case flow of child physical abuse prosecutions through the judicial system and to examine determinants of charges and sentencing decisions. METHODS. This prospective cohort study monitored all defendants in identified cases of inflicted traumatic brain injury in North Carolina in 2000 and 2001. Victims were identified prospectively through surveillance at all PICUs in North Carolina and the Office of the Chief Medical Examiner. Suspected perpetrators were identified through information from families, hospital records, newspaper clippings, the Department of Corrections, and Clerks of Superior Court. Judicial case flow from original charges through sentencing was mapped. The victims' injury characteristics and suspects' characteristics, including potential mitigating and aggravating factors, were examined. Suspected perpetrator and victim characteristics were entered into multivariate models for examination of associations with charges and sentencing decisions. RESULTS. Original and final charges varied widely. The most frequent original and final charge was the lowest-class felony child abuse charge. The child's death was predictive of higher felony charges. Sentences ranged from probation to life in prison. Of the defendants who were found to be guilty, 63% were incarcerated for some period of time. Severe sentences were associated with perpetrator race. CONCLUSIONS. Prosecutors frequently charged the lowest felony child abuse charge available unless the child died. Minority status was not important in the decision to bring charges against a suspect but was the most important measured factor in rendering a sentence. Although the most appropriate charges and sentences can be argued, there seems to be a statewide bias toward harsher sentences for minority perpetrators.	[Keenan, Heather T.] Univ Utah, Dept Pediat, Div Crit Care, Salt Lake City, UT USA; [Nocera, Maryalice] Univ N Carolina, Injury Prevent Res Ctr, Chapel Hill, NC USA; [Runyan, Desmond K.] Univ N Carolina, Dept Social Med, Chapel Hill, NC USA; [Runyan, Desmond K.] Univ N Carolina, Dept Pediat, Chapel Hill, NC USA		Keenan, HT (corresponding author), 295 Chipeta Way,POB 581289, Salt Lake City, UT 84158 USA.	heather.keenan@hsc.utah.edu	Runyan, Desmond/S-3974-2016	Runyan, Desmond/0000-0001-5571-9029	NICHD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K23 HD041040, K23 HD041040-01A2] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K23HD041040] Funding Source: NIH RePORTER		BARLOW KM, 2005, PEDIATRICS, V116; Barth RP, 2002, CHILD YOUTH SERV REV, V24, P513; BOURASSA S, 2004, RACIAL FAIRNESS SENT; Cross Theodore P, 2003, Trauma Violence Abuse, V4, P323, DOI 10.1177/1524838003256561; CROSS TP, 1994, CHILD ABUSE NEGLECT, V18, P663, DOI 10.1016/0145-2134(94)90016-7; DIXON J, 1995, AM J SOCIOL, V100, P1157, DOI 10.1086/230635; Heger A, 2002, CHILD ABUSE NEGLECT, V26, P645, DOI 10.1016/S0145-2134(02)00339-3; Keenan HT, 2004, PEDIATRICS, V114, P633, DOI 10.1542/peds.2003-1020-L; Keenan HT, 2003, JAMA-J AM MED ASSOC, V290, P621, DOI 10.1001/jama.290.5.621; Keenan HT., 2007, PEDIATRICS, V119; MASON MARY ANN, 1994, FATHERS PROPERTY CHI; RUNYAN DK, 1988, J PEDIATR-US, V113, P647, DOI 10.1016/S0022-3476(88)80373-1; UNAH I, 2001, RACE DEATH PENALTY N; US Census Bureau, STAT COUNT QUICKF N	14	8	9	0	4	AMER ACAD PEDIATRICS	ELK GROVE VILLAGE	141 NORTH-WEST POINT BLVD,, ELK GROVE VILLAGE, IL 60007-1098 USA	0031-4005			PEDIATRICS	Pediatrics	JUN	2008	121	6					1174	1180		10.1542/peds.2007-1846			7	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Pediatrics	307IX	WOS:000256313700048	18519487				2022-02-06	
J	Mascia, L; Mastromauro, I; Viberti, S				Mascia, L.; Mastromauro, I.; Viberti, S.			High tidal volume as a predictor of acute lung injury in neurotrauma patients	MINERVA ANESTESIOLOGICA			English	Article; Proceedings Paper	19th Smart Congress	MAY 28-30, 2008	Milan, ITALY				TRAUMATIC BRAIN-INJURY; RESPIRATORY-DISTRESS-SYNDROME; INFLAMMATION; VENTILATION; MECHANISMS		[Mascia, L.; Mastromauro, I.; Viberti, S.] Univ Turin, S Giovanni Battista Hosp, Anesthesiol & Resuscitat Dept, I-10126 Turin, Italy		Mascia, L (corresponding author), Univ Turin, S Giovanni Battista Hosp, Anesthesiol & Resuscitat Dept, Corso Dogliotti 14, I-10126 Turin, Italy.	luciana.mascia@unito.it	mascia, Luciana/L-3039-2018				BERNARD GR, 1994, AM J RESP CRIT CARE, V149, P818, DOI 10.1164/ajrccm.149.3.7509706; Bratton SL, 1997, NEUROSURGERY, V40, P707, DOI 10.1097/00006123-199704000-00009; Brower RG, 2000, NEW ENGL J MED, V342, P1301, DOI 10.1056/nejm200005043421801; Chen HI, 1995, BIOL SIGNAL, V4, P186; Contant CF, 2001, J NEUROSURG, V95, P560, DOI 10.3171/jns.2001.95.4.0560; Fisher AJ, 1999, LANCET, V353, P1412, DOI 10.1016/S0140-6736(99)00494-8; Gajic O, 2004, CRIT CARE MED, V32, P1817, DOI 10.1097/01.CCM.0000133019.52531.30; Gruber A, 1999, CRIT CARE MED, V27, P505, DOI 10.1097/00003246-199903000-00026; Hager DN, 2005, AM J RESP CRIT CARE, V172, P1241, DOI 10.1164/rccm.200501-048CP; Holland MC, 2003, J TRAUMA, V55, P106, DOI 10.1097/01.TA.0000071620.27375.BE; Kalsotra A, 2007, J CEREBR BLOOD F MET, V27, P963, DOI 10.1038/sj.jcbfm.9600396; Lopez-Aguilar J, 2005, CRIT CARE MED, V33, P1077, DOI 10.1097/01.CCM.0000162913.72479.F7; Mascia L, 2008, INTENS CARE MED, V34, P720, DOI 10.1007/s00134-007-0974-7; Mascia L, 2007, CRIT CARE MED, V35, P1815, DOI 10.1097/01.CCM.0000275269.77467.DF; McKeating EG, 1997, BRIT J ANAESTH, V78, P520, DOI 10.1093/bja/78.5.520; Yildirim E, 2004, EUR J CARDIO-THORAC, V25, P523, DOI 10.1016/j.ejcts.2003.12.021; 2007, J NEUROTRAUMA S1, V24, P1	17	8	9	0	0	EDIZIONI MINERVA MEDICA	TURIN	CORSO BRAMANTE 83-85 INT JOURNALS DEPT., 10126 TURIN, ITALY	0375-9393			MINERVA ANESTESIOL	Minerva Anestesiol.	JUN	2008	74	6					325	327					3	Anesthesiology; Critical Care Medicine	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology; General & Internal Medicine	306EE	WOS:000256230300019	18500208				2022-02-06	
J	Pedersen, MV; Helweg-Larsen, RB; Nielsen, FC; Berezin, V; Bock, E; Penkowa, M				Pedersen, Martin Volmer; Helweg-Larsen, Rehannah Borup; Nielsen, Finn Cilius; Berezin, Vladimir; Bock, Elisabeth; Penkowa, Milena			The synthetic NCAM-derived peptide, FGL, modulates the transcriptional response to traumatic brain injury	NEUROSCIENCE LETTERS			English	Article						FGL peptide; traumatic brain injury; neurodegeneration; microarray	MOLECULAR-MECHANISMS; NEURITE OUTGROWTH; RECEPTOR AGONIST; EXPRESSION; NEURONS; DISRUPTION; PROTEIN; DEATH	Cerebral responses to traumatic brain injury (TBI) include up- and downregulation of a vast number of proteins involved in endogenous inflammatory responses and defense mechanisms developing postinjury. The present study analyzed the global gene expression profile in response to cryo-induced TBI by means of microarray analysis. Adolescent rats were subjected to TBI and treated with either placebo or a neural cell adhesion molecule (NCAM)-derived fibroblast growth factor receptor (FGFR) agonist, FGL peptide, which has been demonstrated to have neuroprotective effects. mRNA levels were measured at various time-points postlesion (6 h, 1 day and 4 days). The effects of injury, treatment, and injury-treatment interaction were observed. TBI alone rendered a large number of genes affected. Analysis of lesion and treatment interactions resulted in a clear effect of the interaction between injury and FGL-treatment compared to injury and placebo-treatment. Genes affected by TBI alone included inflammation markers, protein kinases, ion channel members and growth factors. Genes encoding regulators of apoptosis, signal transduction and metabolism were altered by the interaction between FGL-treatment and TBI. FGL-treatment in non-injured animals rendered genes regulating signaling, transport and cytoskeleton maintenance significantly increased. Thus, the hypothesis of a putative neuroprotective role of FGL was supported by our findings. (c) 2008 Elsevier Ireland Ltd. All rights reserved.	[Pedersen, Martin Volmer; Berezin, Vladimir; Bock, Elisabeth] Univ Copenhagen, Fac Hlth Sci, Dept Neurosci & Pharmacol, Protein Lab, DK-2200 Copenhagen, Denmark; [Pedersen, Martin Volmer; Penkowa, Milena] Univ Copenhagen, Fac Hlth Sci, Dept Neurosci & Pharmacol, Sect Neuroprotect, DK-2200 Copenhagen, Denmark; [Helweg-Larsen, Rehannah Borup; Nielsen, Finn Cilius] Univ Copenhagen, Rigshosp, Dept Clin Biochem, DK-2200 Copenhagen, Denmark		Pedersen, MV (corresponding author), Univ Copenhagen, Fac Hlth Sci, Dept Neurosci & Pharmacol, Protein Lab, Blegdamsvej 3C,Bldg 24-2, DK-2200 Copenhagen, Denmark.	mets@plab.ku.dk	Nielsen, Finn Cilius/AAA-4926-2020	Nielsen, Finn Cilius/0000-0002-9829-1031			Cambon K, 2004, J NEUROSCI, V24, P4197, DOI 10.1523/JNEUROSCI.0436-04.2004; Engel S, 2000, ACTA NEUROPATHOL, V100, P313, DOI 10.1007/s004019900172; Enriquez P, 2004, CURR PHARM DESIGN, V10, P2131; Ettinger RA, 2004, IMMUNOGENETICS, V56, P585, DOI 10.1007/s00251-004-0725-7; Fernandez T, 2004, AM J HUM GENET, V74, P1286, DOI 10.1086/421474; Griffiths MM, 1999, CURR OPIN IMMUNOL, V11, P689, DOI 10.1016/S0952-7915(99)00038-2; Hinsby AM, 2004, FRONT BIOSCI-LANDMRK, V9, P2227, DOI 10.2741/1393; Kiryushko D, 2006, MOL CELL BIOL, V26, P3625, DOI 10.1128/MCB.26.9.3625-3638.2006; Kiselyov VV, 2003, STRUCTURE, V11, P691, DOI 10.1016/S0969-2126(03)00096-0; Klementiev B, 2007, NEUROSCIENCE, V145, P209, DOI 10.1016/j.neuroscience.2006.11.060; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Madden TL, 1996, METHOD ENZYMOL, V266, P131; Martino G, 2004, LANCET NEUROL, V3, P372, DOI 10.1016/S1474-4422(04)00771-9; Neiiendam JL, 2004, J NEUROCHEM, V91, P920, DOI 10.1111/j.1471-4159.2004.02779.x; Pedersen MV, 2004, J NEUROSCI RES, V77, P777, DOI 10.1002/jnr.20221; PENKOWA M, 1995, GLIA, V13, P217, DOI 10.1002/glia.440130308; Poulsen CB, 2005, J NEUROCHEM, V92, P417, DOI 10.1111/j.1471-4159.2004.02877.x; Prins ML, 2003, J NEUROTRAUM, V20, P123, DOI 10.1089/08977150360547053; Secher T, 2006, NEUROSCIENCE, V141, P1289, DOI 10.1016/j.neuroscience.2006.04.059; Skibo GG, 2005, EUR J NEUROSCI, V22, P1589, DOI 10.1111/j.1460-9568.2005.04345.x; Sole C, 2004, J CELL BIOL, V167, P479, DOI 10.1083/jcb.200403093; Truettner JS, 2007, J NEUROTRAUM, V24, P599, DOI 10.1089/neu.2006.0186; von Gertten C, 2005, BMC NEUROSCI, V6, DOI 10.1186/1471-2202-6-69; Wang XF, 2001, EMBO REP, V2, P628, DOI 10.1093/embo-reports/kve135	24	8	10	0	3	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0304-3940	1872-7972		NEUROSCI LETT	Neurosci. Lett.	MAY 30	2008	437	2					148	153		10.1016/j.neulet.2008.03.070			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	307PN	WOS:000256330900017	18436381				2022-02-06	
J	Greve, KW; Bianchini, KJ; Heinly, MT; Love, JM; Swift, DA; Ciota, M				Greve, Kevin W.; Bianchini, Kevin J.; Heinly, Matthew T.; Love, Jeffrey M.; Swift, Douglas A.; Ciota, Megan			Classification accuracy of the Portland digit recognition test in persons claiming exposure to environmental and industrial toxins	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article						neurotoxic exposure; cognition; malingering; neuropsychological assessment; known-groups design; symptom validity test	MALINGERED NEUROCOGNITIVE DYSFUNCTION; TRAUMATIC BRAIN-INJURY; VERBAL-LEARNING TEST; REPORTING EXPOSURE; INDICATORS; ENCEPHALOPATHY; SPECIFICITY; SENSITIVITY; PERFORMANCE; CRITERIA	The classification accuracy of the Portland digit recognition test (PDRT) in detecting cognitive malingering was studied in patients claiming cognitive deficits due to exposure to environmental or industrial toxins. Twenty-nine patients alleging toxic exposure and who met Slick et al. [Slick, D. J., Sherman, E. M. S., & Iverson, G. L. (1999). Diagnostic criteria for malingering neurocognitive dysfunction: Proposed standards for clinical practice and research. The Clinical Neuropsychologist, 13, 545-561] criteria for malingered neurocognitive dysfunction were compared to 14 toxic exposure patients negative for evidence of malingering. The published cutoffs were associated with a false positive error rate of 0% and sensitivity of more than 50%. When criterion for a PDRT failure was a positive PDRT finding on more than one section, the FP rate remained 0% while sensitivity improved to about 70%. The results indicate that a failed PDRT is an indication of malingering and not the neurological effect of a toxic substance or some other clinical phenomenon. The PDRT can be used with confidence as an indicator of negative response bias in cases of alleged exposure to neurotoxic substances. (C) 2007 National Academy of Neuropsychology. Published by Elsevier Ltd. All rights reserved.	[Greve, Kevin W.; Bianchini, Kevin J.; Heinly, Matthew T.; Love, Jeffrey M.] Univ New Orleans, Dept Psychol, New Orleans, LA 70148 USA; [Greve, Kevin W.; Bianchini, Kevin J.; Heinly, Matthew T.; Love, Jeffrey M.; Ciota, Megan] Jefferson Neurobehav Grp, Metairie, LA USA; [Swift, Douglas A.] Occupat Med Clin, Metairie, LA USA		Greve, KW (corresponding author), Univ New Orleans Lakefront, Dept Psychol, New Orleans, LA 70148 USA.	kgreve@uno.edu					Bianchini KJ, 2003, J OCCUP ENVIRON MED, V45, P1087, DOI 10.1097/01.jom.0000085886.18136.7d; Bianchini KJ, 2001, CLIN NEUROPSYCHOL, V15, P19, DOI 10.1076/clin.15.1.19.1907; Binder Laurence M, 1990, Clin Neuropsychol, V4, P25, DOI 10.1080/13854049008401494; BINDER LM, 1996, ASSESSMENT, V3, P403, DOI DOI 10.1177/107319119600300405; BINDER LM, 1991, PSYCHOL ASSESSMENT J, V3, P175, DOI DOI 10.1037/1040-3590.3.2.175; Bush SS, 2005, ARCH CLIN NEUROPSYCH, V20, P419, DOI 10.1016/j.acn.2005.02.002; Curtis KL, 2006, ASSESSMENT, V13, P46, DOI 10.1177/1073191105285210; Etherton Joseph L, 2006, Spine J, V6, P61, DOI 10.1016/j.spinee.2005.05.382; Etherton JL, 2006, J CLIN EXP NEUROPSYC, V28, P1218, DOI 10.1080/13803390500346595; Greiffenstein MF., 1994, PSYCHOL ASSESS, V6, P218, DOI [10.1037/1040-3590.6.3.218, DOI 10.1037/1040-3590.6.3.218]; Greve KW, 2006, NEUROTOXICOLOGY, V27, P940, DOI 10.1016/j.neuro.2006.06.009; Greve KW, 2007, ASSESSMENT, V14, P12, DOI 10.1177/1073191106295095; Greve KW, 2006, CLIN NEUROPSYCHOL, V20, P816, DOI 10.1080/13854040500346610; Greve KW, 2006, ARCH CLIN NEUROPSYCH, V21, P439, DOI 10.1016/j.acn.2006.06.004; Greve KW, 2006, J CLIN EXP NEUROPSYC, V28, P1176, DOI 10.1080/13803390500263550; Greve KW, 2006, CLIN NEUROPSYCHOL, V20, P491, DOI 10.1080/13854040590967144; GREVE KW, CLIN NEURO IN PRESS; Heinly MT, 2005, ASSESSMENT, V12, P429, DOI 10.1177/1073191105281099; Hilsabeck RC, 2003, ARCH CLIN NEUROPSYCH, V18, P71, DOI 10.1016/S0887-6177(01)00180-9; Ju D, 2000, Appl Neuropsychol, V7, P201, DOI 10.1207/S15324826AN0704_1; Millis S. R., 2004, PRINCIPLES PRACTICE, P1077; Millis SR, 1995, PSYCHOL ASSESSMENT, V7, P463; Millis SR, 2001, J CLIN EXP NEUROPSYC, V23, P809, DOI 10.1076/jcen.23.6.809.1017; Mittenberg W, 2002, J CLIN EXP NEUROPSYC, V24, P1094, DOI 10.1076/jcen.24.8.1094.8379; MITTENBERG W, 1993, PSYCHOL ASSESSMENT, V5, P34, DOI DOI 10.1037/1040-3590.5.1.34; ORD JS, CLIN NEUROP IN PRESS; Slick DJ, 2004, ARCH CLIN NEUROPSYCH, V19, P465, DOI 10.1016/j.acn.2003.04.001; Slick DJ, 1999, CLIN NEUROPSYCHOL, V13, P545, DOI 10.1076/1385-4046(199911)13:04;1-Y;FT545; Sweet J. J., 2002, J FORENSIC NEUROPSYC, V3, P241; Tombaugh T.N., 1996, TEST MEMORY MALINGER; van Hout MSE, 2006, J NEUROL NEUROSUR PS, V77, P296, DOI 10.1136/jnnp.2004.047167; van Hout MSE, 2003, NEUROTOXICOLOGY, V24, P547, DOI 10.1016/S0161-813X(03)00054-8	32	8	8	1	3	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0887-6177	1873-5843		ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	MAY	2008	23	3					341	350		10.1016/j.acn.2007.12.001			10	Psychology, Clinical; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	310VT	WOS:000256559500009	18261882	Bronze			2022-02-06	
J	Sauvageau, A; Bourgault, A; Racette, S				Sauvageau, Anny; Bourgault, Andre; Racette, Stephanie			Cerebral traumatism with a playground rocking toy mimicking shaken baby syndrome	JOURNAL OF FORENSIC SCIENCES			English	Article						forensic science; forensic pathology; traumatic brain injury; shaken baby syndrome; child abuse	NONTRAUMATIC INFANT DEATHS; DIFFUSE AXONAL INJURY; HEAD-INJURY; DURAL HEMORRHAGE; CRANIAL INJURIES; CHILD SYNDROME; SHAKING; MODEL; DIAGNOSIS; EXPLAIN	Shaken baby syndrome (SBS), one of the most deadly and devastating forms of child abuse, is caused by violent shaking. The combination of subdural hematoma, retinal hemorrhage, brain swelling, and diffuse axonal injury is highly typical of this syndrome and faced with these autopsy findings, induced traumatic lesions are strongly considered. However, it is known that motor-vehicle accidents and falls from great height can also produce this pattern of injury. Nevertheless, stories of arms fall, couch fall, or bumped head while the baby is being carried are generally considered incompatible with SBS. We here report a case of a 2-year-old boy presenting with all the classic autopsy findings of SBS from a playground rocking toy shaken by an older child.	[Sauvageau, Anny; Bourgault, Andre; Racette, Stephanie] Lab Sci Judiciaires & Med Legale, Montreal, PQ H2K 3S7, Canada		Sauvageau, A (corresponding author), Lab Sci Judiciaires & Med Legale, 1701 Parthenais St,12th Floor, Montreal, PQ H2K 3S7, Canada.	a.sauvageau@msp.gouv.qc.ca					ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; ALEXANDER R, 1990, AM J DIS CHILD, V144, P724, DOI 10.1001/archpedi.1990.02150300124032; Bandak FA, 2005, FORENSIC SCI INT, V151, P71, DOI 10.1016/j.forsciint.2005.02.033; Barr RG, 2006, CHILD ABUSE NEGLECT, V30, P7, DOI 10.1016/j.chiabu.2005.06.009; Block RW, 2004, PEDIATRICS, V113, P432, DOI 10.1542/peds.113.2.432; Blumenthal I, 2002, POSTGRAD MED J, V78, P732, DOI 10.1136/pmj.78.926.732; Bonnier C, 2002, BRAIN PATHOL, V12, P320; CAFFEY J, 1972, AM J DIS CHILD, V124, P161, DOI 10.1001/archpedi.1972.02110140011001; Case ME, 2001, AM J FOREN MED PATH, V22, P112, DOI 10.1097/00000433-200106000-00002; Cory CZ, 2003, MED SCI LAW, V43, P317, DOI 10.1258/rsmmsl.43.4.317; DUHAIME AC, 1987, J NEUROSURG, V66, P409, DOI 10.3171/jns.1987.66.3.0409; ELNER SG, 1990, ARCH OPHTHALMOL-CHIC, V108, P1094, DOI 10.1001/archopht.1990.01070100050033; Geddes JF, 2003, NEUROPATH APPL NEURO, V29, P14, DOI 10.1046/j.1365-2990.2003.00434.x; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; Gilliland MGF, 1996, J FORENSIC SCI, V41, P114; HADLEY MN, 1989, NEUROSURGERY, V24, P536, DOI 10.1227/00006123-198904000-00008; Harding B, 2004, BMJ-BRIT MED J, V328, P720, DOI 10.1136/bmj.328.7442.720; Jones MD, 2003, FORENSIC SCI INT, V131, P14, DOI 10.1016/S0379-0738(02)00382-1; Kairys SW, 2001, PEDIATRICS, V108, P206; KEMPE CH, 1962, JAMA-J AM MED ASSOC, V181, P17, DOI 10.1001/jama.1962.03050270019004; Lantz PE, 2004, BRIT MED J, V328, P754, DOI 10.1136/bmj.328.7442.754; Lazoritz S, 1997, CHILD ABUSE NEGLECT, V21, P1009, DOI 10.1016/S0145-2134(97)00061-6; LeFanu J, 2004, BMJ-BRIT MED J, V328, P767, DOI 10.1136/bmj.328.7442.767; Lucey JF, 2004, PEDIATRICS, V113, P432; Miller M, 2004, PEDIATRICS, V114, P326, DOI 10.1542/peds.114.1.326; Punt J, 2004, Pediatr Rehabil, V7, P173, DOI 10.1080/13638490410001711515; Richards PG, 2006, ARCH DIS CHILD, V91, P205, DOI 10.1136/adc.2005.090761; Salehi-Had H, 2006, PEDIATRICS, V117, pE1039, DOI 10.1542/peds.2005-0811; Smith C, 2003, NEUROPATH APPL NEURO, V29, P411, DOI 10.1046/j.1365-2990.2003.00500.x; Smith SL, 1998, J NEUROTRAUM, V15, P693, DOI 10.1089/neu.1998.15.693	30	8	8	1	2	BLACKWELL PUBLISHING	OXFORD	9600 GARSINGTON RD, OXFORD OX4 2DQ, OXON, ENGLAND	0022-1198			J FORENSIC SCI	J. Forensic Sci.	MAR	2008	53	2					479	482		10.1111/j.1556-4029.2008.00664.x			4	Medicine, Legal	Science Citation Index Expanded (SCI-EXPANDED)	Legal Medicine	278SF	WOS:000254305900037	18366585				2022-02-06	
J	Ulrich, D; Fuchs, P; Pallua, N				Ulrich, Dietmar; Fuchs, Paul; Pallua, Norbert			Preexpanded vertical trapezius musculocutaneous flap for reconstruction of a severe neck contracture after burn injury	JOURNAL OF BURN CARE & RESEARCH			English	Article							RADIAL FREE FLAP; ISLAND FLAP; TISSUE EXPANSION; SURGERY; FACE; HEAD; DEFECTS	Preexpanded flaps are a method to replace a larger postburn contracture area. We describe the use of a preexpanded vertical trapezius musculocutaneous flap for reconstruction of a severe mentosternal contracture in a 10-year-old male patient with second- to third-degree burn wounds. A 500 cm(3) rectangular-shaped tissue expander was inserted under the trapezius muscle via a lateral incision in first stage. Two months later, after serial expansion of the expander, the neck scar was excised. The preexpanded flap (size = 27 X 9 cm) was harvested and rotated into the defect. The donor site could be closed primarily. The flap totally survived. The hospital stay was 7 days. After 6 months follow-up, a significant improved range of motion with good esthetic outcome was achieved. The use of a preexpanded trapezius flap can provide thin, large, and pliable tissue for reconstruction of a severe mentosternal scar contracture with excellent functional outcomes.	[Ulrich, Dietmar; Fuchs, Paul; Pallua, Norbert] Univ Hosp Aachen, Dept Plast Surg, Burn Ctr, D-52074 Aachen, Germany		Ulrich, D (corresponding author), Univ Hosp Aachen, Dept Plast Surg, Burn Ctr, Pauwelsstr 30, D-52074 Aachen, Germany.		Ulrich, D.J.O./H-8099-2014				BAKER SR, 1990, LARYNGOSCOPE, V100, P313; BALAKRISHNAN C, 1991, PLAST RECONSTR SURG, V88, P171, DOI 10.1097/00006534-199107000-00040; BERTOTTI JA, 1980, PLAST RECONSTR SURG, V65, P16, DOI 10.1097/00006534-198001000-00004; CHERRY GW, 1983, PLAST RECONSTR SURG, V72, P680, DOI 10.1097/00006534-198311000-00018; Horch RE, 2000, HEAD NECK-J SCI SPEC, V22, P513, DOI 10.1002/1097-0347(200008)22:5<513::AID-HED12>3.0.CO;2-N; KENNEY J G, 1990, Journal of Burn Care and Rehabilitation, V11, P443, DOI 10.1097/00004630-199009000-00012; KOBUS K, 1987, ANN PLAS SURG, V19, P162, DOI 10.1097/00000637-198708000-00010; LAITUNG JKG, 1990, ANN PLAS SURG, V25, P205, DOI 10.1097/00000637-199009000-00010; LEIGHTON WD, 1988, PLAST RECONSTR SURG, V82, P76, DOI 10.1097/00006534-198882010-00014; MASSER MR, 1990, PLAST RECONSTR SURG, V86, P295, DOI 10.1097/00006534-199008000-00016; MCCARTY JG, 1990, PLASTIC SURG, P2189; Motamed S, 2004, BURNS, V30, P476, DOI 10.1016/j.burns.2004.02.006; Ninkovic M, 2004, PLAST RECONSTR SURG, V113, P61, DOI 10.1097/01.PRS.0000090726.45594.6B; Pallua N, 2005, PLAST RECONSTR SURG, V115, P1837, DOI 10.1097/01.PRS.0000165080.70891.88; Pallua N, 1997, PLAST RECONSTR SURG, V99, P1878, DOI 10.1097/00006534-199706000-00011; Pallua N, 2000, PLAST RECONSTR SURG, V105, P842, DOI 10.1097/00006534-200003000-00003; SPENCE RJ, 1992, ANN PLAS SURG, V28, P453, DOI 10.1097/00000637-199205000-00009; Takei T, 1998, PLAST RECONSTR SURG, V102, P247, DOI 10.1097/00006534-199807000-00044; Unglaub F, 2005, ZBL CHIR, V130, P157, DOI 10.1055/s-2005-836367	19	8	10	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1559-047X			J BURN CARE RES	J. Burn Care Res.	MAR-APR	2008	29	2					386	389		10.1097/BCR.0b013e31816677d9			4	Critical Care Medicine; Dermatology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Dermatology; Surgery	280EQ	WOS:000254408500017	18354298				2022-02-06	
J	Yoganandan, N; Pintar, FA; Zhang, J; Stemper, BD; Philippens, M				Yoganandan, Narayan; Pintar, Frank A.; Zhang, Jiangyue; Stemper, Brian D.; Philippens, Mat			Upper neck forces and moments and cranial angular accelerations in lateral impact	ANNALS OF BIOMEDICAL ENGINEERING			English	Article						neck forces and moments; lateral impact; head acceleration; biomechanics	SIDE IMPACT; BIOMECHANICS; INJURY	Biomechanical studies using postmortem human subjects (PMHS) in lateral impact have focused primarily on chest and pelvis injuries, mechanisms, tolerances, and comparison with side impact dummies. A paucity of data exists on the head-neck junction, i.e., forces and moments, and cranial angular accelerations. The objective of this study was to determine lateral impact-induced three-dimensional temporal forces and moments at the head-neck junction and cranial linear and angular accelerations from sled tests using PMHS and compare with responses obtained from an anthropomorphic test device (dummy) designed for lateral impact. Following initial evaluations, PMHS were seated on a sled, restrained using belts, and lateral acceleration was applied. Specimens were instrumented with a pyramid-shaped nine-accelerometer package to record cranial accelerations. A sled accelerometer was used to record the input acceleration. Radiographs and computed tomography scans were obtained to identify pathology. A similar testing protocol was adopted for dummy tests. Results indicated that profiles of forces and moments at the head-neck junction and cranial accelerations were similar between the two models. However, peak forces and moments at the head-neck junction were lower in the dummy than PMHS. Peak cranial linear and angular accelerations were also lower in the dummy than in the PMHS. Fractures to the head-neck complex were not identified in PMHS tests. Peak cranial angular accelerations were suggestive of mild traumatic brain injury with potential for loss of consciousness. Findings from this study with a limited dataset are valuable in establishing response corridors for side impacts and evaluating side impact dummies used in crashworthiness and safety-engineering studies.	[Yoganandan, Narayan; Pintar, Frank A.; Zhang, Jiangyue; Stemper, Brian D.] Med Coll Wisconsin, Dept Neurosurg, Milwaukee, WI 53226 USA; [Yoganandan, Narayan; Pintar, Frank A.; Zhang, Jiangyue; Stemper, Brian D.] VA Med Ctr, Milwaukee, WI USA; [Philippens, Mat] TNO Def Secur & Safety, Rijswijk, Netherlands		Yoganandan, N (corresponding author), Med Coll Wisconsin, Dept Neurosurg, 9200 W Wisconsin Ave, Milwaukee, WI 53226 USA.	yoga@mcw.edu	Stemper, Brian/AAX-7611-2020				*AIS, 1990, ABBR INJ SCAL; [Anonymous], 1999, ISOTR9790; BACKAITIS SH, 1994, 1 HUMAN LIKE CRASH T; BEEN B, 2004, WORLDSID DUMMY HEAD, P431; Bogduk N, 2000, CLIN BIOMECH, V15, P633, DOI 10.1016/S0268-0033(00)00034-6; CHENG R, 1982, STAPP CAR CRASH C, P1; GENNARELLI T, 2003, AAAM; HALL MC, 1965, LUSCHKAS JOINT, P141; KUMARESAN S, 1997, J MUSCULOSKELET RES, V1, P1; Kuppa Shashi, 2003, Stapp Car Crash J, V47, P189; MARGULIES SS, 1992, J BIOMECH, V25, P917, DOI 10.1016/0021-9290(92)90231-O; *NHTSA, 2002, FMVSS FEDERAL MOTOR; OMMAYA AK, 1974, BRAIN, V97, P633, DOI 10.1093/brain/97.1.633; PADGAONKAR AJ, 1975, J APPL MECH-T ASME, V42, P552, DOI 10.1115/1.3423640; PENNING L, 1989, FUNCTIOANAL ANATOMY, P33; Pintar Frank A, 2005, Stapp Car Crash J, V49, P33; *SAE, 1995, HUM TOL IMP COND REL; SHERK HH, 1989, CERVICAL SPINE, P881; SOLTIS S, 2003, NATO; *STAND, 1991, GAS POW CHAIN SAWS S; WISMANS J, 1986, 30 STAPP CAR CRASH C, P313; Yoganandan N, 2006, J BIOMECH, V39, P1347, DOI 10.1016/j.jbiomech.2005.03.016; Yoganandan N, 2005, ACCIDENT ANAL PREV, V37, P495, DOI 10.1016/j.aap.2004.12.007; YOGANANDAN N, 1989, Journal of Biomechanical Engineering, V111, P250; Yoganandan N, 1998, FRONTIERS HEAD NECK, P743; Yoganandan Narayan, 2005, Traffic Inj Prev, V6, P379, DOI 10.1080/15389580500256888; Yoganandan N, 2007, J BIOMECH, V40, P227, DOI 10.1016/j.jbiomech.2006.01.002; Yoganandan N, 2007, J BONE JOINT SURG AM, V89A, P1066, DOI 10.2106/JBJS.F.00200	28	8	8	0	5	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0090-6964	1573-9686		ANN BIOMED ENG	Ann. Biomed. Eng.	MAR	2008	36	3					406	414		10.1007/s10439-007-9422-7			9	Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Engineering	261AC	WOS:000253050500006	18181019				2022-02-06	
J	Mihalik, JP; Kohli, L; Whitton, MC				Mihalik, Jason P.; Kohli, Luv; Whitton, Mary C.			Do the physical characteristics of a virtual reality device contraindicate its use for balance assessment?	JOURNAL OF SPORT REHABILITATION			English	Article						mild traumatic brain injury; virtual environment; athletic injuries; postural stability; college	TRAUMATIC BRAIN-INJURY; ERROR SCORING SYSTEM; POSTURAL STABILITY; PLATFORM MEASURES; HEALTHY-YOUNG; CONCUSSION; STEADINESS; STANCE; ADULTS; SWAY	Context: Virtual reality environments may allow researchers to investigate functional balance performance without risks associated with testing in the real world. Objective: To investigate the effects of the mass of a head-mounted display (HMD) on balance performance. Design: Counterbalanced pretest-posttest. Setting: Virtual reality laboratory. Participants: 20 healthy college students. Intervention(s): Balance Error Scoring System (BESS) with a tracker-only headband and again with tracker plus HMD was performed. Main Outcome Measures: BESS error scores, elliptical sway area, and center of pressure travel distance were recorded. Results: No effect of the HMD mass on balance performance was observed. A significant stance by surface interaction was present but was negated when the HMD conditions were included in the model. Conclusions: The mass of a HMD has not been proven to adversely affect balance performance. These data suggest the HMD mass is not a contraindication to the use of immersive virtual environments in future concussion research involving balance.	[Mihalik, Jason P.] Univ N Carolina, Dept Exercise & Sport Sci, Chapel Hill, NC 27515 USA; [Kohli, Luv; Whitton, Mary C.] Univ N Carolina, Dept Comp Sci, Chapel Hill, NC USA		Mihalik, JP (corresponding author), Univ N Carolina, Dept Exercise & Sport Sci, Chapel Hill, NC 27515 USA.	jmihalik@email.unc.edu	Whitton, Mary/AAN-2378-2021; Mihalik, Jason P/E-7059-2010	Mihalik, Jason/0000-0001-6085-8322			Bisson E, 2007, CYBERPSYCHOL BEHAV, V10, P16, DOI 10.1089/cpb.2006.9997; DAY BL, 1993, J PHYSIOL-LONDON, V469, P479, DOI 10.1113/jphysiol.1993.sp019824; GOLDIE PA, 1989, ARCH PHYS MED REHAB, V70, P510; GOLDIE PA, 1992, ARCH PHYS MED REHAB, V73, P348, DOI 10.1016/0003-9993(92)90008-K; Guskiewicz KM, 1996, J SPORT REHABIL, V5, P45, DOI 10.1123/jsr.5.1.45; GUSKIEWICZ KM, 1997, MED SCI SPORTS EXERC, V29, P213; GUSKIEWICZ KM, 1999, REHABILITATION TECHN; HASAN SS, 1990, J BIOMECH, V23, P783, DOI 10.1016/0021-9290(90)90025-X; Horak FB, 2002, EXP BRAIN RES, V144, P95, DOI 10.1007/s00221-002-1041-9; Johnston KM, 2001, CLIN J SPORT MED, V11, P150, DOI 10.1097/00042752-200107000-00005; KIRBY RL, 1987, J BIOMECH, V20, P423, DOI 10.1016/0021-9290(87)90049-2; Kuo AD, 1998, EXP BRAIN RES, V122, P185, DOI 10.1007/s002210050506; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Leclerc S, 2001, SPORTS MED, V31, P629, DOI 10.2165/00007256-200131080-00007; MAJERSKE CW, 2008, IN PRESS ATHL TRAIN; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McLeod TCV, 2004, CLIN J SPORT MED, V14, P287, DOI 10.1097/00042752-200409000-00007; MURRAY MP, 1975, J BONE JOINT SURG AM, VA 57, P510, DOI 10.2106/00004623-197557040-00012; Nault ML, 2002, SPINE, V27, P1911, DOI 10.1097/00007632-200209010-00018; Powell JW, 1999, JAMA-J AM MED ASSOC, V282, P958, DOI 10.1001/jama.282.10.958; Prieto TE, 1996, IEEE T BIO-MED ENG, V43, P956, DOI 10.1109/10.532130; Riemann BL, 1999, J SPORT REHABIL, V8, P71, DOI 10.1123/jsr.8.2.71; Riemann BL, 2000, J ATHL TRAINING, V35, P19; Salazar AM, 2000, JAMA-J AM MED ASSOC, V283, P3075, DOI 10.1001/jama.283.23.3075; Slobounov S, 2006, CYBERPSYCHOL BEHAV, V9, P188, DOI 10.1089/cpb.2006.9.188; Sokal RR., 1995, STAT TABLES, V3rd ed; Susco TM, 2004, J ATHL TRAINING, V39, P241; Thornton M, 2005, BRAIN INJURY, V19, P989, DOI 10.1080/02699050500109944; Warden DL, 2000, J HEAD TRAUMA REHAB, V15, P1092, DOI 10.1097/00001199-200010000-00003; Wilkins JC, 2004, J ATHL TRAINING, V39, P156	30	8	9	0	0	HUMAN KINETICS PUBL INC	CHAMPAIGN	1607 N MARKET ST, PO BOX 5076, CHAMPAIGN, IL 61820-2200 USA	1056-6716			J SPORT REHABIL	J. Sport Rehabil.	FEB	2008	17	1					38	49		10.1123/jsr.17.1.38			12	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	261SG	WOS:000253099700005	18270385	Green Published			2022-02-06	
J	Paci, GM; Sise, MJ; Sise, CB; Sack, DI; Swanson, SM; Holbrook, TL; Hunstock, AM; Altenau, LL; Carver, TW				Paci, Gabrielle M.; Sise, Michael J.; Sise, C. Beth; Sack, Daniel I.; Swanson, Sophia M.; Holbrook, Troy L.; Hunstock, Amy M.; Altenau, Lance L.; Carver, Thomas W.			The need for immediate computed tomography scan after emergency craniotomy for head injury	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article; Proceedings Paper	66th Annual Meeting of the American-Association-for-the-Surgery-of-Trauma	SEP 27-29, 2007	Las Vegas, NV	Amer Assoc Surg Trauma		traumatic brain injury; craniotomy; computed tomography; head injury requiring craniotomy	TRAUMATIC BRAIN-INJURY; MANAGEMENT; HEMATOMA; GUIDELINES; OUTCOMES	Background: Patients who undergo emergency craniotomy for head injury require vigilant postoperative (postop) care to obtain the best possible outcome. Although repeat head computed tomography (CT) scans are a key component of the management of these patients, there is no consensus on the optimal timing of the initial postop CT. Methods: We conducted a retrospective registry-based review of the care of 199 consecutive trauma patients who underwent craniotomy for head injury at a Level I trauma center to evaluate the role of postop CT in their management. Results: One hundred and ninety-nine patients underwent 218 craniotomies for head injury during the 78-month study period. Mean age was 48 years and 73.9% were men. Overall survival was 71.4%. The primary indication for operation included subdural hematoma (SDH) in 136 (62.4%), epidural hematoma (EDH) in 32 (14.7%), intraparenchymal hemorrhage or contusion in 21 (9.6%), depressed skull fracture in 17 (7.8%), and other indications in 12 (5.5%). Postop CTs were obtained after 197 (90.4%) of the operations at a mean of 19.2 hours and revealed a variety of unexpected findings with clinical implications. The only variable statistically associated with unexpected findings was SDH as an indication for operation (p < 0.01). Fourteen (7.0%) patients required a second craniotomy in the 2 days after their initial operation. In six (3.0%) patients, postop CTs were obtained between 4.2 hours and 21.1 hours after initial craniotomy and an earlier postop CT would most likely have prevented a significant delay in operation. Findings in these six patients included recurrent SDH or EDH in two, new SDH or EDH in two, and intraparenchymal hemorrhage in two. Neither neurologic examination nor postop intracranial pressure monitoring reliably predicted the presence of new or recurrent hemorrhage or other significant findings. Conclusion: Early, if not immediate, postop CT after emergency craniotomy for head trauma appears to be warranted. We found a significant incidence of unexpected findings on postop CT and encountered avoidable delays in treatment of new or recurrent findings.	[Paci, Gabrielle M.; Sise, Michael J.; Sise, C. Beth; Sack, Daniel I.; Swanson, Sophia M.; Holbrook, Troy L.; Hunstock, Amy M.; Altenau, Lance L.; Carver, Thomas W.] Scripps Mercy Hosp, Div Trauma, San Diego, CA 92103 USA		Sise, MJ (corresponding author), Scripps Mercy Hosp, Div Trauma, 4077 5th Ave, San Diego, CA 92103 USA.	sise.mike@scrippshealth.org					*BRAIN TRAUM FDN A, 2007, J NEUROTRAUMA, V24; Brown CVR, 2007, J TRAUMA, V62, P1339, DOI 10.1097/TA.0b013e318054e25a; Brown CVR, 2004, J TRAUMA, V57, P939, DOI 10.1097/01.TA.0000149492.92558.03; Bulger EM, 2002, CRIT CARE MED, V30, P1870, DOI 10.1097/00003246-200208000-00033; Bullock R, 1995, GUIDELINES MANAGEMEN; Bullock RM, 2000, J NEUROTRAUM, V17, P449; Caroli M, 2001, SURG NEUROL, V56, P82, DOI 10.1016/S0090-3019(01)00540-7; *CDCP NAT CTR INJ, 2006, TRAUM BRAIN INJ; Fakhry SM, 2004, J TRAUMA, V56, P492, DOI 10.1097/01.TA.0000115650.07193.66; Figg RE, 2003, J TRAUMA, V55, P1061, DOI 10.1097/01.TA.0000096712.90133.5C; Furukawa M, 2006, ACTA NEUROCHIR SUPPL, V96, P48; HURST JM, 1992, J TRAUMA, V33, P582, DOI 10.1097/00005373-199210000-00015; Kaups KL, 2004, J TRAUMA, V56, P475, DOI 10.1097/01.TA.0000114304.56006.D4; Lubillo S, 1999, J NEUROSURG, V91, P581, DOI 10.3171/jns.1999.91.4.0581; Marion DW, 2006, NEUROSURGERY, V58, P655; MIRVIS SE, 1997, EMERG RADIOL, V4, P212; Palmer S, 2001, J TRAUMA, V50, P657, DOI 10.1097/00005373-200104000-00010; Stearley H E, 1998, Am J Crit Care, V7, P282; Toyama Yoshihiro, 2005, Radiat Med, V23, P309; Valadka A. B., 2004, TRAUMA, P385; Wang MC, 2006, J TRAUMA, V61, P226, DOI 10.1097/01.ta.0000197385.18452.89; WILBERGER JE, 1991, J NEUROSURG, V74, P212, DOI 10.3171/jns.1991.74.2.0212	22	8	8	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0022-5282	1529-8809		J TRAUMA	J. Trauma-Injury Infect. Crit. Care	FEB	2008	64	2					326	333		10.1097/TA.0b013e318163358a			8	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine; Surgery	264KV	WOS:000253287100016	18301194				2022-02-06	
J	Blicher, JU; Nielsen, JF				Blicher, Jakob Udby; Nielsen, Jorgen Feldbaek			Does long-term outcome after intensive inpatient rehabilitation of acquired brain injury depend on etiology?	NEUROREHABILITATION			English	Article						brain injuries; rehabilitation; age factors; stroke; muscle spasticity	MOTOR CORTEX DISINHIBITION; SUBARACHNOID HEMORRHAGE; UNAFFECTED HEMISPHERE; HEAD-INJURY; STROKE; DEPRESSION; SPASTICITY; FLUOXETINE; RECOVERY; LENGTH	Purpose: To identify predictors of outcome, epilepsy, spasticity and depression one year after severe acquired brain injury. Method: Retrospective cohort study. A consecutive sample of 165 patients with severe acquired brain injury admitted for inpatient rehabilitation during a 18-month time period, was contacted and offered home visits one-year after brain injury. Of the 165 patients 12 did not participate. The cohort included patients with different etiologies primarily traumatic brain injury (65), stroke (25) and subarachnoid hemorrhage (34). Functional independent measure (FIM) was measured at admission at rehabilitation unit and at follow-up. At follow-up the presence of epilepsy, spasticity, and depression was evaluated. Results: Using multiple logistic regression a short length of stay at acute hospital (LOS1) (P = 0.004), a high FIM score at admission (P < 0.001), and low age (P = 0.003), were all predictors of good outcome. No difference was found between etiologies (P = 0.077). The presence of spasticity was predicted by low FIM score (P < 0.001), longer LOS1 (P < 0.036), etiology (P < 0.001), and lower age (P = 0.001). Depression was predicted by higher age (P = 0.035). Conclusions: Age, functional status, and length of acute hospital stay are associated with outcome one year after brain injury. The functional outcome was not correlated to etiology.	[Blicher, Jakob Udby; Nielsen, Jorgen Feldbaek] Aarhus Univ Hosp, Hammel Neuroctr, DK-8450 Hammel, Denmark		Blicher, JU (corresponding author), Aarhus Univ Hosp, Hammel Neuroctr, Voldbyvej 15, DK-8450 Hammel, Denmark.	neujbl@sc.aaa.dk	Nielsen, Jorgen Feldbak/AAR-6384-2021; Blicher, Jakob U/E-3037-2010	Nielsen, Jorgen Feldbak/0000-0001-5339-171X; Blicher, Jakob/0000-0003-3443-4790			Ada L, 2006, DISABIL REHABIL, V28, P891, DOI 10.1080/09638280500535165; Beekman ATF, 1999, BRIT J PSYCHIAT, V174, P307, DOI 10.1192/bjp.174.4.307; Bellebaum C, 2004, J CLIN EXP NEUROPSYC, V26, P1081, DOI 10.1080/13803390490515342; Bode RK, 2002, ARCH PHYS MED REHAB, V83, P100, DOI 10.1053/apmr.2002.26073; BROTT T, 1989, STROKE, V20, P864, DOI 10.1161/01.STR.20.7.864; BROWN P, 1994, J NEUROL NEUROSUR PS, V57, P773, DOI 10.1136/jnnp.57.7.773; Busch CR, 1998, NEUROPSYCHOL REV, V8, P95, DOI 10.1023/A:1025661200911; CAREY RG, 1988, ARCH PHYS MED REHAB, V69, P337; Carson AJ, 2000, LANCET, V356, P122, DOI 10.1016/S0140-6736(00)02448-X; Carter BS, 2000, NEUROSURGERY, V46, P1326, DOI 10.1097/00006123-200006000-00008; Catano A, 1997, ELECTROMYOGR MOTOR C, V105, P290, DOI 10.1016/S0924-980X(97)00021-0; COWEN TD, 1995, ARCH PHYS MED REHAB, V76, P797, DOI 10.1016/S0003-9993(95)80542-7; Dam M, 1996, STROKE, V27, P1211, DOI 10.1161/01.STR.27.7.1211; Deb S, 1999, AM J PSYCHIAT, V156, P374; Dikmen SS, 2004, ARCH PHYS MED REHAB, V85, P1457, DOI 10.1016/j.apmr.2003.12.041; Dobkin BH, 2005, NEW ENGL J MED, V352, P1677, DOI 10.1056/NEJMcp043511; Dombovy ML, 1998, BRAIN INJURY, V12, P887; Edwards MJ, 2003, DISABIL REHABIL, V25, P405, DOI 10.1080/0963828031000062642; Eng JJ, 2002, ARCH PHYS MED REHAB, V83, P483, DOI 10.1053/apmr.2002.31203; FEARNSIDE MR, 1993, BRIT J NEUROSURG, V7, P267, DOI 10.3109/02688699309023809; Hacke W, 2004, LANCET, V363, P768; Hackett ML, 2005, STROKE, V36, P2296, DOI 10.1161/01.STR.0000183622.75135.a4; Hackett ML, 2000, NEUROLOGY, V55, P658, DOI 10.1212/WNL.55.5.658; HAMILTON BB, 1994, SCAND J REHABIL MED, V26, P115; Hankey GJ, 2003, CEREBROVASC DIS, V16, P14, DOI 10.1159/000069936; Hobart JC, 2001, NEUROLOGY, V57, P639, DOI 10.1212/WNL.57.4.639; Huang ME, 2000, AM J PHYS MED REHAB, V79, P327, DOI 10.1097/00002060-200007000-00003; Hukkelhoven CWPM, 2005, J NEUROTRAUM, V22, P1025, DOI 10.1089/neu.2005.22.1025; HUNT WE, 1968, J NEUROSURG, V28, P14, DOI 10.3171/jns.1968.28.1.0014; JONGBLOED L, 1986, STROKE, V17, P765, DOI 10.1161/01.STR.17.4.765; Jorge RE, 2004, ARCH GEN PSYCHIAT, V61, P42, DOI 10.1001/archpsyc.61.1.42; Langhorne P, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000197.pub3; Leathley MJ, 2004, CLIN REHABIL, V18, P438, DOI 10.1191/0269215504cr727oa; LEROUX PD, 1995, J NEUROSURG, V83, P394, DOI 10.3171/jns.1995.83.3.0394; LeRoux PD, 1996, J NEUROSURG, V85, P39, DOI 10.3171/jns.1996.85.1.0039; Lew HL, 2002, AM J PHYS MED REHAB, V81, P830, DOI 10.1097/00002060-200211000-00005; Liepert J, 2000, CLIN NEUROPHYSIOL, V111, P671, DOI 10.1016/S1388-2457(99)00312-0; Liepert J, 2000, MUSCLE NERVE, V23, P1761, DOI 10.1002/1097-4598(200011)23:11<1761::AID-MUS14>3.0.CO;2-M; Luk JKH, 2006, CEREBROVASC DIS, V21, P229, DOI 10.1159/000091219; Manganotti P, 2002, CLIN NEUROPHYSIOL, V113, P936, DOI 10.1016/S1388-2457(02)00062-7; Meijer R, 2003, CLIN REHABIL, V17, P119, DOI 10.1191/0269215503cr585oa; Moldover JE, 2004, NEUROPSYCHOL REV, V14, P143, DOI 10.1023/B:NERV.0000048181.46159.61; O'Dell MW, 2002, ARCH PHYS MED REHAB, V83, P678, DOI 10.1053/apmr.2002.32305; Pariente J, 2001, ANN NEUROL, V50, P718, DOI 10.1002/ana.1257; Pleger B, 2004, CLIN NEUROPHYSIOL, V115, P2157, DOI 10.1016/j.clinph.2004.04.015; Rapoport MJ, 2005, J NEUROPSYCH CLIN N, V17, P61, DOI 10.1176/appi.neuropsych.17.1.61; Rapoport MJ, 2001, BRAIN INJURY, V15, P857, DOI 10.1080/02699050110065303; Reeder KP, 1996, J HEAD TRAUMA REHAB, V11, P22, DOI 10.1097/00001199-199606000-00006; Rosenthal M, 1998, ARCH PHYS MED REHAB, V79, P90, DOI 10.1016/S0003-9993(98)90215-5; Rothwell PM, 2004, LANCET, V363, P1925, DOI 10.1016/S0140-6736(04)16405-2; Singer BJ, 2004, ARCH PHYS MED REHAB, V85, P1465, DOI 10.1016/j.apmr.2003.08.103; Sommerfeld DK, 2004, STROKE, V35, P134, DOI 10.1161/01.STR.0000105386.05173.5E; TEASDALE G, 1974, LANCET, V2, P81; Thornhill S, 2000, BRIT MED J, V320, P1631, DOI 10.1136/bmj.320.7250.1631; Tooth L, 2001, BRAIN INJURY, V15, P613, DOI 10.1080/02699050010013923; Truelsen T, 2005, EUR J NEUROL, V12, P78, DOI 10.1111/j.1468-1331.2005.01199.x; Turner-Stokes L, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004170.pub2; Watkins CL, 2002, CLIN REHABIL, V16, P515, DOI 10.1191/0269215502cr512oa	58	8	8	0	2	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135	1878-6448		NEUROREHABILITATION	Neurorehabilitation		2008	23	2					175	183					9	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	311II	WOS:000256593500007	18525139				2022-02-06	
J	Garza, AG; Gratton, MC; McElroy, J; Lindholm, D; Coontz, D				Garza, Alex G.; Gratton, Matthew C.; McElroy, James; Lindholm, Daniel; Coontz, Darryl			Environmental factors encountered during out-of-hospital intubation attempts	PREHOSPITAL EMERGENCY CARE			English	Article; Proceedings Paper	Annual Meeting of the Society-for-Academic-Emergency-Medicine (SAEM)	MAY 22-25, 2005	New York, NY	Soc Acad Emergency Med		emergency medical services; paramedics; prehospital; intubation; environmental factors	PREHOSPITAL ENDOTRACHEAL INTUBATION; TRAUMATIC BRAIN-INJURY	Objectives. Emergency medical services (EMS) literature has studied paramedic performance with endotracheal intubation; however, there are few data describing environmental differences between out-of-hospital and in-hospital providers during intubation attempts. The purpose of this study was to describe the environmental factors encountered by paramedics. Methods. Setting: Midwest, urban, public utility model, all-advanced life support (ALS) ambulance service with 85,000 calls and 55,000 transports per year. Design: Prospective, observational study using a standardized data-collection tool completed on all adult cardiac arrest patients for whom intubation was attempted during the period from September 1, 2000, through September 1, 2004. Descriptive data including count and frequency statistics of environmental factors were calculated. Results. There were 1,894 attempts on 1,396 patients during the study period; 236 (12.5%) attempts on 161 patients (11.5%) were removed from the analysis because of incomplete data, leaving 1,658 attempts on 1,235 patients. The intubation success rate was 85% (95% confidence interval [CI] 83, 97). Paramedics most frequently attempt intubation indoors (1,239, 75%), prefer to kneel at the patient's head (899, 54%), encounter significant scene distractions (340, 20%), have optimal lighting (1,271, 77%), but frequently have suboptimal space (655, 40%). Patients are most often supine (1,653, 99%). Conclusions. The out-of-hospital intubation environment is significantly different from that of in-hospital providers. Paramedics frequently have a poor physical operating environment and encounter significant distractions while trying to perform endotracheal intubation. Future studies should analyze the association of these factors with intubation success.	[Garza, Alex G.] Georgetown Univ, Washington Hosp Ctr, Sch Med, Dept Emergency Med, Washington, DC USA; [Gratton, Matthew C.; McElroy, James; Lindholm, Daniel] Kansas City Missouri Hlth Dept, Emergency Med Serv Sect, Kansas City, MO USA; [Gratton, Matthew C.] Univ Missouri, Kansas City Sch Med, Truman Med Ctr, Dept Emergency Med, Kansas City, MO 64110 USA; [Coontz, Darryl] Metropolitan Ambulance Serv Trust, Kansas City, MO USA		Garza, AG (corresponding author), 2309 Colonel Lindsay Court, Falls Church, VA 22043 USA.	alexgarza@cox.net					Davis DP, 2005, J TRAUMA, V58, P933, DOI 10.1097/01.TA.0000162731.53812.58; Davis DP, 2003, J TRAUMA, V54, P444, DOI 10.1097/01.TA.0000053396.02126.CD; Doran J V, 1995, Prehosp Disaster Med, V10, P259; Garza Alex G, 2005, Prehosp Emerg Care, V9, P163, DOI 10.1080/10903120590924654; Gausche M, 2000, JAMA-J AM MED ASSOC, V283, P783, DOI 10.1001/jama.283.6.783; GOUGH JE, 1996, PREHOSP DISASTER MED, V11, P75; JACOBS LM, 1983, JAMA-J AM MED ASSOC, V250, P2175, DOI 10.1001/jama.250.16.2175; Krisanda T J, 1992, Prehosp Disaster Med, V7, P121; Schwartz RB, 2001, MIL MED, V166, P984, DOI 10.1093/milmed/166.11.984; STEWART RD, 1984, ANN EMERG MED, V13, P1032, DOI 10.1016/S0196-0644(84)80064-5; Thomas S H, 1996, Air Med J, V15, P65, DOI 10.1016/S1067-991X(96)90003-6; Wang HE, 2003, ACAD EMERG MED, V10, P717, DOI 10.1197/aemj.10.7.717; Wang Henry E, 2005, Prehosp Emerg Care, V9, P145	13	8	8	0	4	TAYLOR & FRANCIS INC	PHILADELPHIA	325 CHESTNUT ST, SUITE 800, PHILADELPHIA, PA 19106 USA	1090-3127			PREHOSP EMERG CARE	Prehosp. Emerg. Care		2008	12	3					286	289		10.1080/10903120802100480			4	Emergency Medicine; Public, Environmental & Occupational Health	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine; Public, Environmental & Occupational Health	319EN	WOS:000257147000003	18584493				2022-02-06	
J	Kara, A; Celik, SE; Dalbayrak, S; Yilmaz, M; Akansel, G; Tireli, G				Kara, Ayhan; Celik, Suat Eral; Dalbayrak, Sedat; Yilmaz, Mesuit; Akansel, Guer; Tireli, Guercan			Magnetic resonance imaging finding in severe head injury patients with normal computerized tomography	TURKISH NEUROSURGERY			English	Article						computed tomography; magnetic resonance imaging; severe head injury; shear injury	DIFFUSE AXONAL INJURY; TRAUMATIC BRAIN-INJURY; CORPUS-CALLOSUM; FIELD MR; LESIONS; MILD; CT; FEATURES	AIM: Computerized tomography (CT) has been the primary diagnostic instrument of neurosurgical centers for head injury until now. However, there is a subgroup of patients who have persisting neurological deficits without visible pathology on CT. MATERIAL and METHODS: Between 2000 and 2002, 3000 patients were enrolled in this prospective study in emergency unit. There was a total of 124 patients (4.1%) who had persisting severe neurological deficits with normal findings on repeated CT scans. These patients underwent 1.5 Tesla cranial MRI study between posttraumatic days 2 and 10 (5.2 +/- 4.5). Data-on epidemiological, clinical, radiological factors and final outcome were collected. RESULTS: 76 (1.2%) of the patients were male and 48 (38.7%) were female. 113 (91.1%) of the 124 patients showed significant primary pathology on MRI study. The most common pathology was shear injuries in 75 (60.4%) followed by cortical contusion in 45 (36.2%) cases. 27 (21.7%) patients showed primary brain stem lesions and 8 (0.6%) patients showed subcortical gray matter lesions. 32 patients showed mixed lesions. There was one traumatic aneurysm detected. CONCLUSION: The MRI examination in head injury is informative in detecting subtle lesions when the neurological condition cannot be explained by CT.	[Kara, Ayhan; Celik, Suat Eral] Beyoglu Goz Egitim Arastirma Hastanesi, Dept Neurosurg, Istanbul, Turkey; [Dalbayrak, Sedat; Yilmaz, Mesuit] Kartal Egitim Arastirma Hastanesi, Dept Neurosurg, Istanbul, Turkey; [Akansel, Guer; Tireli, Guercan] Kartal Egitim Arastirma Hastanesi, Dept Neuroradiol, Istanbul, Turkey		Celik, SE (corresponding author), Beyoglu Goz Egitim Arastirma Hastanesi, Dept Neurosurg, Istanbul, Turkey.	suaterolcelik@yahoo.com	Akansel, Gur/G-4636-2018				Cecil KM, 1998, J NEUROSURG, V88, P795, DOI 10.3171/jns.1998.88.5.0795; DOEZEMA D, 1991, ANN EMERG MED, V20, P1281, DOI 10.1016/S0196-0644(05)81065-0; Firsching R, 1998, J NEUROSURG, V89, P707, DOI 10.3171/jns.1998.89.5.0707; Garnett MR, 2001, J NEUROTRAUM, V18, P585, DOI 10.1089/089771501750291828; GENNARELLI TA, 1985, TRAUMA CENTRAL NERVO, P169; GENTRY LR, 1988, AM J NEURORADIOL, V9, P101, DOI 10.2214/ajr.150.3.663; GENTRY LR, 1988, AM J NEURORADIOL, V9, P91; GENTRY LR, 1988, AM J NEURORADIOL, V9, P1129; GENTRY LR, 1994, RADIOLOGY, V191, P1; GOMORI JM, 1985, RADIOLOGY, V157, P87, DOI 10.1148/radiology.157.1.4034983; Hergan K, 2002, EUR RADIOL, V12, P2536, DOI 10.1007/s00330-002-1333-2; HOLBOURN AHS, 1945, BRIT MED BULL, V3, P147, DOI 10.1093/oxfordjournals.bmb.a071895; Hughes DG, 2004, NEURORADIOLOGY, V46, P550, DOI 10.1007/s00234-004-1227-x; Huisman TAGM, 2003, J COMPUT ASSIST TOMO, V27, P5, DOI 10.1097/00004728-200301000-00002; JANE JA, 1985, J NEUROSURG, V62, P96, DOI 10.3171/jns.1985.62.1.0096; JENNETT B, 1975, LANCET, V1, P480; KOMATSU S, 1979, NEUROSURGERY, P32; Lee TT, 1998, ACTA NEUROCHIR, V140, P41, DOI 10.1007/s007010050055; LEVIN HS, 1987, J NEUROSURG, V66, P706, DOI 10.3171/jns.1987.66.5.0706; MEYER CA, 1991, RADIOLOGY, V179, P813, DOI 10.1148/radiology.179.3.2027997; MITTL RL, 1994, AM J NEURORADIOL, V15, P1583; Prat R, 1998, ACTA NEUROCHIR, V140, P1257, DOI 10.1007/s007010050247; SAHUQUILLOBARRIS J, 1988, J NEUROSURG, V68, P894, DOI 10.3171/jns.1988.68.6.0894; Scheid R, 2003, AM J NEURORADIOL, V24, P1049; SNOW RB, 1986, NEUROSURGERY, V18, P45, DOI 10.1227/00006123-198601000-00008; Takanashi Y, 2001, J CLIN NEUROSCI, V8, P240, DOI 10.1054/jocn.2000.0804; Tong KA, 2003, RADIOLOGY, V227, P332, DOI 10.1148/radiol.2272020176	27	8	9	0	0	TURKISH NEUROSURGICAL SOC	BAHCELIEVLER	TASKENT CADDESI 13-4, BAHCELIEVLER, ANKARA 06500, TURKEY	1019-5149			TURK NEUROSURG	Turk. Neurosurg.	JAN	2008	18	1					1	9					9	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	314ET	WOS:000256793000001	18382970				2022-02-06	
B	Medved, MI; Brockmeier, J		Hyden, LC; Brockmeier, J		Medved, Maria I.; Brockmeier, Jens			Talking About the Unthinkable Neurotrauma and the "Catastrophic Reaction"	HEALTH, ILLNESS AND CULTURE: BROKEN NARRATIVES	Routledge Studies in Health and Social Welfare		English	Article; Book Chapter							SENSE		[Medved, Maria I.] Univ Manitoba, Dept Psychol, Winnipeg, MB R3T 2N2, Canada; [Brockmeier, Jens] Free Univ Berlin, Dept Psychol, D-1000 Berlin, Germany		Medved, MI (corresponding author), Univ Manitoba, Dept Psychol, Winnipeg, MB R3T 2N2, Canada.						Brockmeier J, 2005, DEVELOPMENT OF SOCIAL COGNITION AND COMMUNICATION, P291; Brockmeier J, 2002, NARRAT INQ, V12, P455, DOI 10.1075/ni.12.2.18bro; Brockmeier J, 2004, COMMUNICATION METACO, P285; Bruner Jerome, 2002, LITERACY NARRATIVE C, P86; Bruner Jerome S., 1990, ACTS MEANING; DELUCA J, 1995, J CLIN EXP NEUROPSYC, V17, P100, DOI 10.1080/13803399508406586; FREEMAN M, 2008, ILLNESS HLTH CULTURE, P169; Goldstein K, 1995, ORGANISM HOLISTIC AP; Goldstein K., 1942, AFTEREFFECTS BRAIN I; Goldstein K, 1952, PSYCHIATR, V15, P245, DOI 10.1080/00332747.1952.11022878; Hyden LC, 2008, ROUT STUD HLTH SOC W, V2, P36; Medved Maria I, 2007, Psychol Health Med, V12, P603, DOI 10.1080/13548500601164404; Medved MI, 2008, QUAL HEALTH RES, V18, P469, DOI 10.1177/1049732308315731; Medved MI, 2004, QUAL HEALTH RES, V14, P741, DOI 10.1177/1049732304265972; Nochi M, 1998, SOC SCI MED, V46, P869, DOI 10.1016/S0277-9536(97)00211-6; Prigatano G.P., 1999, PRINCIPLES NEUROPSYC; Ricoeur P., 1991, P RICOEUR NARRATIVE; Sacks O., 1995, ORGANISM HOLISTIC AP, P7; Vygotsky Lev Semionovich, 1994, VYGOTSKY READER, P99; Vygotsky LS., 1978, MIND SOC DEV HIGHER; Young K, 2001, SUB-STANCE, P72	21	8	8	0	0	ROUTLEDGE	ABINGDON	2 PARK SQ, MILTON PARK, ABINGDON OX14 4RN, OXFORD, ENGLAND			978-0-203-89430-9	ROUT STUD HLTH SOC W			2008	2						54	72					19	Public, Environmental & Occupational Health	Book Citation Index – Social Sciences & Humanities (BKCI-SSH)	Public, Environmental & Occupational Health	BNU38	WOS:000275567000004					2022-02-06	
J	Merrick, S; Harnden, S; Shetty, S; Chopra, P; Clamp, P; Kapadia, S				Merrick, Susan; Harnden, Sarah; Shetty, Shishir; Chopra, Preeti; Clamp, Philip; Kapadia, Suneil			An evaluation of the "Cut and Push" method of percutaneous endoscopic gastrostomy (PEG) removal	JOURNAL OF PARENTERAL AND ENTERAL NUTRITION			English	Article							TUBES	Background: This study aimed to establish whether 15-Fr gauge percutaneous endoscopic gastrostomy (PEG) tubes can be safely-removed by "cut and push." Methods: Patients were prospectively recruited who were found to be without significant intestinal dysfunction requiring removal of Freka (Fresenius Kabi) 15-Fr gauge PEG tubes. The PEG tube was cut close to the stoma and the remnant pushed into the gastric lumen with a 14-Fr nasogastric tube. Patients were asked to. observe their stool for the remnant. Patients were contacted at day 7 and an abdominal x-ray was arranged for those who had not seen the remnant in the stool. If the remnant was still present as seen on plain x-ray' the patient was contacted on day 14. A second x-ray was ordered if the patient reported that they had still not seen the remnant. Outcome measures were PEG remnant observed in stool or not seen on plain abdominal x-ray, and adverse events. Results: Forty-two patients were recruited over 29 months: 38 head and neck patients and 4 others (stroke, head injury, cystic fibrosis [CF], and lung cancer). Of these, 41 had passed the remnant by day 8 and all by day 14. No adverse events occurred. Conclusions: We have concluded that cut and push is a safe method of removal for Freka 15-Fr PEG tubes in ambulant patients without significant gastrointestinal history.	[Merrick, Susan] Royal Wolverhampton Hosp NHS Trust, New Cross Hosp, Dept Nutr & Dietet, Wolverhampton WV10 0QP, W Midlands, England; [Harnden, Sarah; Kapadia, Suneil] Royal Wolverhampton Hosp NHS Trust, Dept Gastroenterol, Wolverhampton, W Midlands, England; [Shetty, Shishir] W Birmingham Hosp NHS Trust, Dept Gastroenterol, Birmingham, W Midlands, England; [Chopra, Preeti] Coventry & Warwickshire NHS Trust, Dept Gastroenterol, Coventry, W Midlands, England; [Clamp, Philip] Gen Practice Partner, Bromsgrove, England		Merrick, S (corresponding author), Royal Wolverhampton Hosp NHS Trust, New Cross Hosp, Dept Nutr & Dietet, Wolverhampton WV10 0QP, W Midlands, England.	sue.merrick@rwh-tr.nhs.uk	Shetty, Shishir/AAU-4047-2021	Shetty, Shishir/0000-0002-4729-2173			*BAPEN, 2005, ANN BANS REP TRENDS; CAMPBELL TA, 1992, JAMA-J AM MED ASSOC, V268, P1270, DOI 10.1001/jama.268.10.1270; COVENTRY BJ, 1994, J GASTROEN HEPATOL, V9, P311, DOI 10.1111/j.1440-1746.1994.tb01732.x; Duncan HD, 1996, CLIN NUTR, V15, P317, DOI 10.1016/S0261-5614(96)80007-0; GAUDERER MWL, 1980, J PEDIATR SURG, V15, P872, DOI 10.1016/S0022-3468(80)80296-X; KORULA J, 1991, JAMA-J AM MED ASSOC, V265, P1426, DOI 10.1001/jama.265.11.1426; *NAT I CLIN EXC, 2004, SERV GUID NHS ENGL W; NCEPOD, SCOP OUR PRACT 2004; Payne-James J J, 1992, J R Coll Surg Edinb, V37, P34; Pearce CB, 2000, CLIN NUTR, V19, P133, DOI 10.1054/clnu.2000.0100; PONSKY JL, 1992, GASTROINTEST ENDOSC, V2, P215; Yaseen M, 1996, GASTROINTEST ENDOSC, V44, P235, DOI 10.1016/S0016-5107(96)70157-8	12	8	8	0	1	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0148-6071			JPEN-PARENTER ENTER	J. Parenter. Enter. Nutr.	JAN-FEB	2008	32	1					78	80		10.1177/014860710803200178			3	Nutrition & Dietetics	Science Citation Index Expanded (SCI-EXPANDED)	Nutrition & Dietetics	247IO	WOS:000252072000012	18165451				2022-02-06	
J	Proctor, A; Zhang, J				Proctor, Adele; Zhang, Jie			Performance of three racial/ethnic groups on two tests of executive function: Clinical implications for traumatic brain injury (TBI)	NEUROREHABILITATION			English	Article						Executive function; BADS; WCST; race/ethnicity; executive dysfunction	CLOSED-HEAD-INJURY; AFRICAN-AMERICANS; ACCULTURATION; CHILDREN; DISPARITIES; DISCOURSE; NORMS; MODEL	The purpose of this study was to determine if race/ethnicity may influence performance of college students on the Behavioral Assessment of Dysexecutive Syndrome (BADS) and the Wisconsin Card Sorting Test (WCST), two different tests of executive function (EF). A total of 149 participants who self-identified as African American (AA), European American (EA), and Latina/o American (LA) constituted the three different racial/ethnic groups. Participants ranged in age range from 18 to 24 years old (SD = 1.29) and none reported histories of disabilities. The BADS was administered to 149 college students and the WCST was administered to 142 of the same participants. No statistically significant differences were found for race/ethnicity or gender on the WCST. Statistically significant differences were found for race/ethnicity on the Profile Scores (raw scores), standard scores (SS) and the Zoo Map subtest of the BADS, but no statistically significant differences were found for gender on these same tasks. While there should be less concern in administering WCST to diverse groups who are English speakers, caution should be taken in administering and interpreting the BADS for individuals from diverse cultural and linguistic backgrounds.	[Proctor, Adele] Univ Illinois, Dept Speech & Hearing Sci, Coll Appl Hlth Sci, Champaign, IL 61820 USA; [Zhang, Jie] Univ Illinois, Dept Educ Psychol, Urbana, IL 61801 USA		Proctor, A (corresponding author), Univ Illinois, Dept Speech & Hearing Sci, Coll Appl Hlth Sci, 901 S 6th St, Champaign, IL 61820 USA.	aproctor@uiuc.edu					Baron I. S., 2004, NEUROPSYCHOLOGICAL E; Bazarian JJ, 2003, ACAD EMERG MED, V10, P1209, DOI 10.1197/S1069-6563(03)00491-3; Berg EA, 1948, J GEN PSYCHOL, V39, P15, DOI 10.1080/00221309.1948.9918159; Boone KB, 2007, ARCH CLIN NEUROPSYCH, V22, P355, DOI 10.1016/j.acn.2007.01.010; Burgess P, 1996, BEHAV ASSESSMENT DYS; Burnett DM, 2000, BRAIN INJURY, V14, P713; Campbell AL, 2002, J NATL MED ASSOC, V94, P591; CHAPMAN SB, 1992, BRAIN LANG, V43, P42, DOI 10.1016/0093-934X(92)90020-F; CHAPMAN SB, 1996, DIAGNOSIS THERAPY PA, P41; CHAPMAN SB, 1997, AM J SPEECH-LANG PAT, V6, P50, DOI DOI 10.1044/1058-0360.0602.50; Cicerone K. D., 2005, REHABILITATION TRAUM, P71; CICERONE KD, 2007, BRAIN INJURY MED PRI, P765; COELHO CA, 1995, BRAIN INJURY, V9, P471, DOI 10.3109/02699059509008206; Coelho CA, 2002, J SPEECH LANG HEAR R, V45, P1232, DOI 10.1044/1092-4388(2002/099); Coffey DM, 2005, ARCH CLIN NEUROPSYCH, V20, P795, DOI 10.1016/j.acn.2005.04.009; Ferraro FR, 2002, STUD NEUROPSYCHOL DE, P227; Fletcher-Janzen E., 2000, HDB CROSS CULTURAL N; Goldberg E., 2001, EXECUTIVE BRAIN FRON; Haider AH, 2007, J TRAUMA, V62, P1259, DOI 10.1097/TA.0b013e31803c760e; Heaton RK, 2000, PSYCHOL ASSESSMENT R; HELMS JE, 1992, AM PSYCHOL, V47, P1083, DOI 10.1037/0003-066X.47.9.1083; Homskaya E., 2001, AR LURIA SCI BIOGRAP; HORTON AM, 2008, NEUROPSYCHOLOGY HDB, P345; Kennepohl S, 2004, J INT NEUROPSYCH SOC, V10, P566, DOI 10.1017/S1355617704104128; Langlois JA, 2005, J HEAD TRAUMA REHAB, V20, P229, DOI 10.1097/00001199-200505000-00006; Lezak MD., 1995, NEUROPSYCHOLOGICAL A, V3rd; Manly JJ, 2007, ARCH CLIN NEUROPSYCH, V22, P319, DOI 10.1016/j.acn.2007.01.006; Manly JJ, 1998, NEUROLOGY, V50, P1238, DOI 10.1212/WNL.50.5.1238; Manly JJ, 2005, CLIN NEUROPSYCHOL, V19, P270, DOI 10.1080/13854040590945346; Manly JJ, 2002, STUD NEUROPSYCHOL DE, P79; Miles GT, 2002, STUD NEUROPSYCHOL DE, P63; Niemeier J, 2007, J HEAD TRAUMA REHAB, V22, P75, DOI 10.1097/01.HTR.0000265095.06565.7b; Norris G, 2000, NEUROPSYCHOL REHABIL, V10, P33, DOI 10.1080/096020100389282; Rutland-Brown W, 2005, J HEAD TRAUMA REHAB, V20, P205, DOI 10.1097/00001199-200505000-00004; Shafi S, 2007, J TRAUMA, V63, P1138, DOI 10.1097/TA.0b013e3181568cd4; Simpson G, 2000, BRAIN INJURY, V14, P125, DOI 10.1080/026990500120790; Uomoto JM, 2000, CRIT ISS NE, P169; Van Gorp WG, 2000, CRIT ISS NE, P19; Wong TM, 2000, CRIT ISS NE, P3	39	8	8	0	8	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135	1878-6448		NEUROREHABILITATION	Neurorehabilitation		2008	23	6					529	536					8	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	391CI	WOS:000262210200009	19127006				2022-02-06	
J	Whitney, KA; Hook, JN; Steiner, AR; Shepard, PH; Callaway, S				Whitney, Kriscinda A.; Hook, Julie N.; Steiner, Amy R.; Shepard, Polly H.; Callaway, Stephanie			Is the Rey 15-Item Memory Test II (Rey II) a Valid Symptom Validity Test?: Comparison with the TOMM	APPLIED NEUROPSYCHOLOGY			English	Article						malingering; memory; military veterans; neuropsychology; test validity; traumatic brain injury	PREDICTIVE-VALUE; CLINICIAN; RATES	The Rey 15-Item Memory Test II (Rey II) is a revised version of the original Rey Memory Test and is used as a measure of test-taking effort. In the present study, the concurrent validity of the Rey II was examined by comparing Rey II test scores to a well-established measure of symptom validity, the Test of Memory Malingering (TOMM). Retrospective chart review was conducted using the records of 60 veterans who were referred for outpatient neuropsychological testing and suspected of possible symptom exaggeration. Results of the study suggest that when compared to the TOMM, the Qualitative, as opposed to the Quantitative, scoring method of the Rey II was more discriminative, but showed both positive and negative predictive power that was unacceptably low, falling at .62 and .64, respectively. Clinical implications are discussed.	[Whitney, Kriscinda A.; Hook, Julie N.; Steiner, Amy R.; Shepard, Polly H.; Callaway, Stephanie] Richard L Roudebush VAMC 116P, Indianapolis, IN 46202 USA; [Whitney, Kriscinda A.; Callaway, Stephanie] Richard L Roudebush Vet Affairs Med Ctr, Indianapolis, IN 46202 USA; [Whitney, Kriscinda A.; Shepard, Polly H.; Callaway, Stephanie] Indiana Univ, Sch Med, Indianapolis, IN USA; [Hook, Julie N.] Rush Univ, Med Ctr, Chicago, IL 60612 USA; [Steiner, Amy R.] Univ Virginia, Charlottesville, VA USA		Whitney, KA (corresponding author), Richard L Roudebush VAMC 116P, 1481 W 10th St, Indianapolis, IN 46202 USA.	kamarks@iupui.edu					Ashendorf L, 2004, ARCH CLIN NEUROPSYCH, V19, P125, DOI 10.1016/S0887-6177(02)00218-4; Constantinou M, 2005, ARCH CLIN NEUROPSYCH, V20, P191, DOI 10.1016/j.acn.2004.06.002; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Gervais RO, 2004, ARCH CLIN NEUROPSYCH, V19, P475, DOI 10.1016/j.acn.2003.05.001; GLAROS AG, 1988, J CLIN PSYCHOL, V44, P1013, DOI 10.1002/1097-4679(198811)44:6<1013::AID-JCLP2270440627>3.0.CO;2-Z; GREEN, 1996, WORD MEMORY TEST USE; Griffin GAE, 1997, J CLIN PSYCHOL, V53, P757, DOI 10.1002/(SICI)1097-4679(199711)53:7<757::AID-JCLP14>3.0.CO;2-K; HAYS JR, 1993, PERCEPT MOTOR SKILL, V76, P1331, DOI 10.2466/pms.1993.76.3c.1331; Lezak MD., 1983, NEUROPSYCHOLOGICAL A, V2nd ed.; McCaffrey R. J., 2003, PRACTITIONERS GUIDE; Mittenberg W, 2002, J CLIN EXP NEUROPSYC, V24, P1094, DOI 10.1076/jcen.24.8.1094.8379; O'Bryant SE, 2006, CLIN NEUROPSYCHOL, V20, P533, DOI 10.1080/13854040590967568; Reitan R.M., 1993, HALSTEADREITAN NEURO; Rey A., 1964, EXAMEN CLIN PSYCHOL; Reznek L, 2005, BRAIN INJURY, V19, P539, DOI 10.1080/02699050400005242; Schretlen D., 1991, PSYCHOL ASSESSMENT J, V3, P667, DOI [10.1037/1040-3590.3.4.667, DOI 10.1037/1040-3590.3.4.667]; Siegel S., 1956, NONPARAMETRIC STAT B, pXVII, 312; Slick DJ, 2004, ARCH CLIN NEUROPSYCH, V19, P465, DOI 10.1016/j.acn.2003.04.001; Slick DJ, 1999, CLIN NEUROPSYCHOL, V13, P545, DOI 10.1076/1385-4046(199911)13:04;1-Y;FT545; Tombaugh T.N., 1996, TOMM TEST MEMORY MAL; Wechsler D., 1981, WAIS R MANUAL WECHSL	21	8	8	0	3	PSYCHOLOGY PRESS	HOVE	27 CHURCH RD, HOVE BN3 2FA, EAST SUSSEX, ENGLAND	0908-4282	1532-4826		APPL NEUROPSYCHOL	Appl. Neuropsychol.		2008	15	4					287	292	PII 905789898	10.1080/09084280802325215			6	Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	375DQ	WOS:000261094300007	19023746				2022-02-06	
J	Wicklund, AH; Ammar, A; Weitlauf, JC; Heilbronner, RL; Fink, J; Lee, RC; Kelley, K; Pliskin, NH				Wicklund, A. H.; Ammar, A.; Weitlauf, J. C.; Heilbronner, R. L.; Fink, J.; Lee, R. C.; Kelley, K.; Pliskin, N. H.			Mmpi-2 patterns in electrical injury: A controlled investigation	CLINICAL NEUROPSYCHOLOGIST			English	Article							NEUROPSYCHIATRIC ASPECTS; CONSEQUENCES	The psychological consequences of electrical injury (EI) are many. Depression, posttraumatic stress disorder, anxiety, and somatic preoccupation are often concomitant with this type of injury (Kelley, Pliskin, Meyer, & Lee, 1994). The present study utilized the MMPI-2 as a tool for characterizing profiles of psychological distress in El. We examined MMPI-2 profiles in 79 EI patients and their relationship to both injury parameters (i.e., time since injury, LOC, voltage), and extra-diagnostic factors, such as litigation status. EI patient profiles were also compared to individuals with mild traumatic brain injury (TBI), and chronic pain sufferers (CP). Results indicated that in El, clinical elevations ( T >= 65) were found on the Hs and Hy scales, and approached clinical levels oil the D scale. The injury parameter of time since injury was predictive of a distinctive profile, with individuals in the post acute phase experiencing more distress. Compared to other clinical groups, MMPI-2 scores on the Hs and Hy scales were significantly higher within the EI cohort as compared with their CP peers, with higher scores on the Pd scale for CP than EI. No statistically significant differences emerged between the EI and TBI groups. However, TBI patients showed significant elevations on Hy and D compared to CP, and El patients endorsed more somatic symptoms than CP patients. Implications of these findings and future directions will be discussed.	[Wicklund, A. H.; Ammar, A.; Pliskin, N. H.] Univ Illinois, Dept Psychiat, Chicago, IL 60612 USA; [Wicklund, A. H.] Northwestern Univ, Feinberg Sch Med, NW Alzheimers Dis Ctr, Evanston, IL 60208 USA; [Weitlauf, J. C.] Vet Affairs Palo Alto Hlth Care Syst, Palo Alto, CA USA; [Weitlauf, J. C.] Stanford Univ, Sch Med, Stanford, CA 94305 USA; [Wicklund, A. H.; Heilbronner, R. L.] Chicago Neuropsychol Grp, Chicago, IL USA; [Fink, J.; Lee, R. C.; Kelley, K.] Univ Chicago, Sch Med, Chicago, IL 60637 USA		Pliskin, NH (corresponding author), Univ Illinois, Dept Psychiat, 912 S Wood St,MC 913, Chicago, IL 60612 USA.	NPliskin@uic.edu		Lee, Raphael C./0000-0002-6628-1867			Alfano Dennis P, 1990, Clin Neuropsychol, V4, P69, DOI 10.1080/13854049008401498; AMMAR AM, 2003, J INT NEUROPSYCH SOC, V9, P308; Barrash J, 1996, Appl Neuropsychol, V3, P75, DOI 10.1207/s15324826an0302_5; Butcher J, 1989, MANUAL ADM SCORING M; Crews WD, 1997, APPL NEUROPSYCHOL, V4, P208, DOI 10.1207/s15324826an0404_2; DANIEL M, 1985, INT J CLIN NEUROPSYC, V7, P102; Duff K, 2001, NEUROPSYCHOL REV, V11, P101, DOI 10.1023/A:1016623318049; GASS CS, 1991, PSYCHOL ASSESSMENT J, V3, P27; GRAHAM JR, 1993, MMPI 2 ASSESSING PRO; GRAHAM JR, 2000, MMPI 2 ASSESSING PRO; GRUBE BJ, 1994, ANN NY ACAD SCI, V720, P133; Heilbronner RL, 1999, NEUROREHABILITATION, V13, P127; HOOSHMAND H, 1989, CLIN ELECTROENCEPHAL, V20, P111, DOI 10.1177/155005948902000208; HOPEWELL CA, 1983, INT J CLIN NEUROPSYC, V5, P61; Janus Todd J., 1996, Journal of Burn Care and Rehabilitation, V17, P409, DOI 10.1097/00004630-199609000-00007; Keller L S., 1991, ASSESSMENT CHRONIC P; KELLEY KM, 1994, ANN NY ACAD SCI, V720, P213, DOI 10.1111/j.1749-6632.1994.tb30449.x; Kelley KM, 1999, ANN NY ACAD SCI, V888, P356, DOI 10.1111/j.1749-6632.1999.tb07970.x; LEESHALEY PR, 1991, PSYCHOL REP, V68, P203, DOI 10.2466/PR0.68.1.203-210; Mancusi-Ungaro H R Jr, 1986, J Burn Care Rehabil, V7, P521, DOI 10.1097/00004630-198611000-00015; Martin TA, 2003, BRAIN INJURY, V17, P817, DOI 10.1080/0269905031000088604; MILLER L, 1993, J COGNIT REHABIL, V1, P6; Pliskin NH, 2006, J INT NEUROPSYCH SOC, V12, P17, DOI 10.1017/S1355617706060061; Pliskin NH, 1998, J TRAUMA, V44, P709, DOI 10.1097/00005373-199804000-00027; Pliskin NH, 1999, ANN NY ACAD SCI, V888, P140, DOI 10.1111/j.1749-6632.1999.tb07952.x; PLISKIN NH, 1994, ANN NY ACAD SCI, V720, P219, DOI 10.1111/j.1749-6632.1994.tb30450.x; PLISKIN NH, 1993, CLIN NEUROPSYCHOL, V7, P351; PRIMEAU M, 1995, SEMIN NEUROL, V15, P279, DOI 10.1055/s-2008-1041033; RAMATI A, 2006, PSYCHIAT MORBIDITY S; Riley JL, 1998, CLIN J PAIN, V14, P324, DOI 10.1097/00002508-199812000-00010; Slesinger D, 2002, ASSESSMENT, V9, P406, DOI 10.1177/1073191102238153; TEASDALE G, 1974, LANCET, V2, P81; Tkachenko TA, 1999, ANN NY ACAD SCI, V888, P42, DOI 10.1111/j.1749-6632.1999.tb07941.x; YOUNGJOHN JR, 1995, CLIN NEUROPSYCHOL, V9, P112, DOI 10.1080/13854049508401593	34	8	8	0	2	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1385-4046	1744-4144		CLIN NEUROPSYCHOL	Clin. Neuropsychol.	JAN	2008	22	1					98	111		10.1080/13825580601025924			14	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	258TF	WOS:000252891700008	18247220				2022-02-06	
J	Zou, H; Schmiedeler, JP				Zou, H.; Schmiedeler, J. P.			Predicting brain injury under impact with a strain measure from analytical models	INTERNATIONAL JOURNAL OF CRASHWORTHINESS			English	Article						head impact; head injury criterion; diffuse axonal injury; strain deformation; analytical models; finite element models	FINITE-ELEMENT-ANALYSIS; LOW-SEVERITY IMPACTS; AXONAL INJURY; HEAD; DEFORMATION; ACCELERATION; DISPLACEMENT; CONTUSION; SKULL	Caused by strain deformation in brain tissue, diffuse axonal injury (DAI) is one of the most devastating types of traumatic brain injury; it frequently occurs in automobile crashes. Although offering detailed anatomical structures, finite-element human head models require complete knowledge of material properties of the head and need high computational capacity. Similar to a brain injury model developed in the sagittal plane in an earlier work, an analytical model in the coronal plane is developed for brain injury study. A measure of strain for DAI prediction is presented on the basis of the two planar models. With the maximum shear strain selected as the injury indicator of DAI, the strain measure was applied to frontal and side impact tests conducted by the National Highway Traffic Safety Administration. The results of the crash reconstructions from the planar models were compared with the injury predictions using the head injury criterion and the SIMon finite-element head model. It shows that the simple measure of strain has the capability to predict brain injuries from automobile crashes. The maximum shear strain from the planar models can be used as a critical element to predict DAI.	[Zou, H.; Schmiedeler, J. P.] Ohio State Univ, Dept Mech Engn, Columbus, OH 43210 USA		Zou, H (corresponding author), Ohio State Univ, Dept Mech Engn, Columbus, OH 43210 USA.	zou.26@osu.edu	/B-9681-2012	/0000-0002-1692-4414			ALEM NM, 1974, P 18 STAPP CAR CRASH, V18, P579; Anderson RWG, 2003, J NEUROTRAUM, V20, P961, DOI 10.1089/089771503770195812; Bain AC, 2000, J BIOMECH ENG-T ASME, V122, P615, DOI 10.1115/1.1324667; BANDAK FA, 1994, P 38 STAPP CAR CRASH, P145; Bayly PV, 2005, J NEUROTRAUM, V22, P845, DOI 10.1089/neu.2005.22.845; BRINN J, 1970, P 14 STAPP CAR CRASH, P188; BYCROFT GN, 1973, J BIOMECH, V6, P487, DOI 10.1016/0021-9290(73)90007-9; *CDCP, 2005, FACTS TRAUM BRAIN IN; Centers for Disease Control and Prevention, 2002, CDC INJ RES AG; CHU CS, 1994, J BIOMECH, V27, P187, DOI 10.1016/0021-9290(94)90208-9; CLAESSENS M, 1997, P 41 STAPP CAR CRASH, P315, DOI DOI 10.4271/973338; DiMasi F. P., 1995, P 39 STAPP CAR CRASH; FIROOZBAKHSH KK, 1975, J BIOMECH, V8, P65, DOI 10.1016/0021-9290(75)90044-5; GALFORD JE, 1970, J BIOMECH, V3, P211, DOI 10.1016/0021-9290(70)90007-2; Hardy W N, 2001, Stapp Car Crash J, V45, P337; Hosey R. R., 1982, FINITE ELEMENTS BIOM, P379; Huang HM, 1999, J TRAUMA, V47, P538, DOI 10.1097/00005373-199909000-00019; Huang HM, 2000, MED BIOL ENG COMPUT, V38, P253, DOI 10.1007/BF02347044; KHALIL TB, 1982, P 26 STAPP CAR CRASH, P87; King A. I., 2003, IRCOBI C LISB PORT; KINGLIU Y, 1975, J BIOMECH, V8, P285, DOI 10.1016/0021-9290(75)90080-9; KLEIVEN S, 2005, P 2005 IRCOBI C, P41; Kleiven Svein, 2002, Stapp Car Crash J, V46, P123; LJUNG C, 1975, J BIOMECH, V8, P263, DOI 10.1016/0021-9290(75)90078-0; MARGULIES SS, 1992, J BIOMECH, V25, P917, DOI 10.1016/0021-9290(92)90231-O; Morrison Barclay 3rd, 2003, Stapp Car Crash J, V47, P93; Mueller FO, 1998, CLIN SPORT MED, V17, P169, DOI 10.1016/S0278-5919(05)70071-5; RUAN JS, 1991, J BIOMECH ENG-T ASME, V113, P276, DOI 10.1115/1.2894885; SLATTENSCHEK A, 1970, INT AUT SAF C COMP, P1084; STALNAKER RL, 1971, J BIOMECH, V4, P127, DOI 10.1016/0021-9290(71)90023-6; Takhounts Erik G, 2003, Stapp Car Crash J, V47, P107; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; UENO K, 1995, J NEUROTRAUM, V12, P695, DOI 10.1089/neu.1995.12.695; Ward C., 1980, P 24 STAPP CAR CRASH, P163; Willinger R, 1999, ANN BIOMED ENG, V27, P403, DOI 10.1114/1.165; Young PG, 2003, J SOUND VIB, V267, P1107, DOI 10.1016/S0022-460X(03)00200-1; Zhang L, 2001, Stapp Car Crash J, V45, P369; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446; Zhang LY, 2001, J NEUROTRAUM, V18, P21, DOI 10.1089/089771501750055749; Zhou C., 1995, P 39 STAPP CAR CRASH, P121; Zou H, 2007, INT J CRASHWORTHINES, V12, P341, DOI 10.1080/13588260701433024; ZOU H, 2007, THESIS OHIO STATE U; Zou H, 2007, J BIOMECH, V40, P1183, DOI 10.1016/j.jbiomech.2006.06.018	43	8	8	2	10	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	1358-8265	1754-2111		INT J CRASHWORTHINES	Int. J. Crashworthiness		2008	13	3					337	348		10.1080/13588260801943047			12	Engineering, Manufacturing; Engineering, Mechanical	Science Citation Index Expanded (SCI-EXPANDED)	Engineering	298LO	WOS:000255689400011					2022-02-06	
J	Rapp, PE				Rapp, Paul Ernest			Quantitative characterization of animal behavior following blast exposure	COGNITIVE NEURODYNAMICS			English	Article						Animal behavior; Complexity; Lempel-Ziv complexity; Markov surrogates; Traumatic brain injury; Blast injury		The simplest approach to quantifying animal behavior begins by identifying a list of discrete behaviors and observing the animal's behavior at regular intervals for a specified period of time. The behavioral distribution (the fraction of observations corresponding to each behavior) is then determined. This is an incomplete characterization of behavior, and in some instances, mild injury is not reflected by statistically significant changes in the distribution even though a human observer can confidently and correctly assert that the animal is not behaving normally. In these circumstances, an examination of the sequential structure of the animal's behavior may, however, show significant alteration. This contribution describes procedures derived from symbolic dynamics for quantifying the sequential structure of animal behavior. Normalization procedures for complexity estimates are presented, and the limitations of complexity measures are discussed.	Uniformed Serv Univ Hlth Sci, Dept Mil & Emergency Med, Bethesda, MD 20814 USA		Rapp, PE (corresponding author), Uniformed Serv Univ Hlth Sci, Dept Mil & Emergency Med, Bethesda, MD 20814 USA.	prapp@usuhs.mil			Naval Medical Research Center; Uniformed Services University	This research was supported by the Naval Medical Research Center. I also acknowledge support from the Traumatic Injury Research Program of the Uniformed Services University. The opinions and assertions contained herein are the private ones of the authors and are not to be construed as official or reflecting the views of the Navy Department or the naval service at large.	Braida D, 1996, EUR J PHARMACOL, V302, P13, DOI 10.1016/0014-2999(96)00072-6; EBELING W, 1980, MATH BIOSCI, V52, P53, DOI 10.1016/0025-5564(80)90004-8; LEMPEL A, 1976, IEEE T INFORM THEORY, V22, P75, DOI 10.1109/TIT.1976.1055501; Neumeister H, 2004, J EXP BIOL, V207, P697, DOI 10.1242/jeb.00811; PAULUS MP, 1992, NEUROPSYCHOPHARMACOL, V7, P15; Paulus MP, 1996, AM J PSYCHIAT, V153, P714; PAULUS MP, 1993, PSYCHOPHARMACOLOGY, V113, P177, DOI 10.1007/BF02245695; PAULUS MP, 1993, PSYCHOPHARMACOLOGY, V113, P187, DOI 10.1007/BF02245696; PAULUS MP, 1990, P NATL ACAD SCI USA, V87, P723, DOI 10.1073/pnas.87.2.723; Picciotto MR, 2003, TRENDS PHARMACOL SCI, V24, P493, DOI 10.1016/S0165-6147(03)00230-X; RAPP PE, 1993, PHYS REV E, V47, P2289, DOI 10.1103/PhysRevE.47.2289; Rapp PE, 2005, INT J BIFURCAT CHAOS, V15, P1737, DOI 10.1142/S0218127405012764; Rapp PE, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.016209; RAPP PE, 1991, MATH BIOSCI, V105, P207, DOI 10.1016/0025-5564(91)90082-T; Rapp PE, 1996, MOL PSYCHIATR, V1, P408; RAPP PE, 1994, PHYS LETT A, V192, P27, DOI 10.1016/0375-9601(94)91010-3; RAPP PE, 2000, CHAOS BRAIN, P52; RAPP PE, 2004, P COMPL LIV ROM 2004; THEILER J, 1992, PHYSICA D, V58, P77, DOI 10.1016/0167-2789(92)90102-S; Watanabe TAA, 2003, PSYCHOPHYSIOLOGY, V40, P77, DOI 10.1111/1469-8986.00009; Zernig G, 2004, PSYCHOPHARMACOLOGY, V171, P349, DOI 10.1007/s00213-003-1601-0	21	8	8	0	2	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1871-4080			COGN NEURODYNAMICS	Cogn. Neurodynamics	DEC	2007	1	4					287	293		10.1007/s11571-007-9027-8			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	V04IR	WOS:000207052600002	19003499	Green Published			2022-02-06	
J	Wheeler, SD; Lane, SJ; McMahon, BT				Wheeler, Steven D.; Lane, Shelly J.; McMahon, Brian T.			Community participation and life satisfaction following intensive, community-based rehabilitation using a life skills training approach	OTJR-OCCUPATION PARTICIPATION AND HEALTH			English	Article; Proceedings Paper	Annual Meeting of the Canadian-Association-of-Occupational-Therapists	JUN 24-26, 2004	Charlottetown, CANADA	Canadian Assoc Occupat Therapy		traumatic brain injury; life skills training; community integration	TRAUMATIC BRAIN-INJURY; INTEGRATION; INDIVIDUALS; OUTCOMES; HANDICAP; PEOPLE; SCALE; MODEL	This pilot study examined the effect of an intensive, community-based life skills training program on community integration and life satisfaction among individuals with traumatic brain injuries. Statistically significant improvements, were found for subjects receiving intensive life skills training (n = 18) on two of three Community Integration Questionnaire subscales at the follow-up evaluation, whereas no changes were found for a group of community-dwelling, demographically matched control subjects (n = 18). No significant differences were found within or between groups on life satisfaction scores. However, pretreatment differences were present between groups on both community integration and life satisfaction. Findings of this study support community-based life skills training as a means to increase independence in home management and participation in productive activities for individuals with severe traumatic brain injuries.	W Virginia Univ, Sch Med, Morgantown, WV 26506 USA; Virginia Commonwealth Univ, Dept Rehabil Med, Richmond, VA USA; Virginia Commonwealth Univ, Dept Rehabil Counseling, Richmond, VA USA; Virginia Commonwealth Univ, Dept Occupat Therapy, Richmond, VA USA		Wheeler, SD (corresponding author), W Virginia Univ, Sch Med, Morgantown, WV 26506 USA.	swheeler@hsc.wvu.edu	Lane, Shelly J/AAQ-4071-2020; Wheeler, Steven/AAK-8237-2020	Lane, Shelly J/0000-0002-3689-1760; 			*AM AC CERT BRAIN, 1998, TRAIN MAN CERT BRAIN; Burleigh SA, 1998, AM J OCCUP THER, V52, P45, DOI 10.5014/ajot.52.1.45; Cicerone KD, 2004, J HEAD TRAUMA REHAB, V19, P494, DOI 10.1097/00001199-200411000-00006; Corrigan JD, 1998, ARCH PHYS MED REHAB, V79, P298, DOI 10.1016/S0003-9993(98)90010-7; Corrigan JD, 2001, J HEAD TRAUMA REHAB, V16, P543, DOI 10.1097/00001199-200112000-00003; DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13; Dijkers M, 1997, J HEAD TRAUMA REHAB, V12, P74, DOI 10.1097/00001199-199712000-00007; Feeney TJ, 2001, J HEAD TRAUMA REHAB, V16, P61, DOI 10.1097/00001199-200102000-00008; Forsyth K, 2003, PERSPECTIVES HUMAN O, P45; Goranson TE, 2003, BRAIN INJURY, V17, P759, DOI 10.1080/0269905031000088513; GORDON WA, 1999, REHABILITATION ADULT, P312; Hayden ME, 2000, J HEAD TRAUMA REHAB, V15, P1000, DOI 10.1097/00001199-200008000-00004; HEINEMANN AW, 1995, J HEAD TRAUMA REHAB, V10, P54, DOI 10.1097/00001199-199508000-00006; Hibbard MR, 2002, J HEAD TRAUMA REHAB, V17, P112, DOI 10.1097/00001199-200204000-00004; HIGH WM, 1995, J HEAD TRAUMA REHAB, V10, P14, DOI 10.1097/00001199-199502000-00004; Huebner RA, 2003, AM J OCCUP THER, V57, P177, DOI 10.5014/ajot.57.2.177; Johansson U, 2001, DISABIL REHABIL, V23, P474; JONES M, 1991, ADV BRAIN INJURY REH, P279; KREUTZER J, 1999, NEUROBEHAVIORAL FUNC; McColl MA, 2001, ARCH PHYS MED REHAB, V82, P429, DOI 10.1053/apmr.2001.22195; National Institutes of Health, 1998, NIH CONSENSUS STATEM, V16, P1; PAVOT W, 1991, J PERS ASSESS, V57, P149, DOI 10.1207/s15327752jpa5701_17; Pavot W., 1993, PSYCHOL ASSESSMENT, V52, P164, DOI DOI 10.1037/1040-3590.5.2.164; Sander AM, 1997, ARCH PHYS MED REHAB, V78, P353, DOI 10.1016/S0003-9993(97)90225-2; Sander AM, 1999, ARCH PHYS MED REHAB, V80, P1303, DOI 10.1016/S0003-9993(99)90034-5; Scherer MJ, 2002, DISABIL REHABIL, V24, P1, DOI 10.1080/09638280110066262; Seale GS, 2002, BRAIN INJURY, V16, P955, DOI 10.1080/02699050210155258; Shevlin M, 1998, PERS INDIV DIFFER, V25, P911, DOI 10.1016/S0191-8869(98)00088-9; Sokol K, 1999, 127 ANN M AM PUBL HL; *US DEP HHS, 2001, HLTH PEOPL 2010; VITALIANO PP, 1991, GERONTOLOGIST, V31, P76, DOI 10.1093/geront/31.1.76; Warren L, 1996, J REHABIL RES DEV, V33, P404; Wehman P, 1999, REHABILITATION ADULT, P326; Whiteneck GG, 2004, J HEAD TRAUMA REHAB, V19, P191, DOI 10.1097/00001199-200405000-00001; Willer B, 1999, ARCH PHYS MED REHAB, V80, P399, DOI 10.1016/S0003-9993(99)90276-9; WILLER B, 1994, BRAIN INJURY, V8, P647, DOI 10.3109/02699059409151017; Willer B., 1993, J HEAD TRAUMA REHAB, V8, P5; World Health Organization, 2007, INT CLASS FUNCT DIS; [No title captured]	39	8	9	0	6	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1539-4492	1938-2383		OTJR-OCCUP PART HEAL	OTJR-Occup. Particip. Health	WIN	2007	27	1					13	22		10.1177/153944920702700103			10	Rehabilitation	Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Social Science &amp; Humanities (CPCI-SSH)	Rehabilitation	132NW	WOS:000243950500003					2022-02-06	
J	Gabella, BA; Mangione, EJ; Hedegaard, H; Kelly, JP				Gabella, Barbara A.; Mangione, Ellen J.; Hedegaard, Holly; Kelly, James P.			Comparison of nursing home residents with and without traumatic brain injury: Use of the minimum data set	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						epidemiology; prevalence; residential facilities; traumatic brain injuries	MENTAL-STATE; MDS; REHABILITATION; SCALE	Objective: To describe the magnitude of the population with traumatic brain injury (TBI) in Colorado living in nursing homes and compare these residents to the nursing home residents with neither TBI nor dementia. Methods: The standardized Minimum Data Set of resident assessments was used to describe the behavior, cognitive performance, activities of daily living, and discharge potential of residents. Results: There were 16,478 nursing home residents in 2005, of whom 1.4% had TBI but not dementia, 0.7% had both TBI and dementia, and 50.2% had neither diagnosis. The prevalence of TBI in this population was 2.1%. TBI residents without dementia were younger (median age 53 years). A larger proportion consisted of men (64%), from a racial/ethnic minority (24%), and needed greater assistance with eating, toileting, and hygiene. The percent with severe cognitive impairment was greater for individuals with TBI (22%) compared to those with neither TBI nor dementia (5%). Fewer TBI residents expressed a preference to return to the community. Conclusion: These differences suggest the need for increased training and staffing to care for nursing home residents with TBI.	Colorado Dept Publ Hlth & Environm, Hlth Facil & Emergency Med Serv Div, Denver, CO 80246 USA; Univ Colorado Denver & Hlth Sci Ctr, Dept Neurosurg, Denver, CO 80217 USA; Univ Colorado Denver & Hlth Sci Ctr, Dept Phys Med & Rehabil, Denver, CO 80217 USA		Gabella, BA (corresponding author), Colorado Dept Publ Hlth & Environm, Hlth Facil & Emergency Med Serv Div, Denver, CO 80246 USA.				NCIPC CDC HHS [U49CE000354] Funding Source: Medline; NATIONAL CENTER FOR INJURY PREVENTION AND CONTROLUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA [U49CE000354] Funding Source: NIH RePORTER		Andrews K, 1996, BRIT MED J, V313, P13, DOI 10.1136/bmj.313.7048.13; BROWN DL, 2004, MDS 2 0 USERS MANUAL; Buchanan RJ, 2003, BRAIN INJURY, V17, P507, DOI 10.1080/0269905031000070215; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Giacino JT, 2002, NEUROLOGY, V58, P349, DOI 10.1212/WNL.58.3.349; HARTMAIER SL, 1994, J AM GERIATR SOC, V42, P1173, DOI 10.1111/j.1532-5415.1994.tb06984.x; HARTMAIER SL, 1995, J GERONTOL A-BIOL, V50, pM128, DOI 10.1093/gerona/50A.2.M128; IKGAMI N, 2004, GERIATR GERONTOL INT, V4, pS271; KARON SL, IN PRESS J HEAD TRAU; Lawton MP, 1998, J AM GERIATR SOC, V46, P736, DOI 10.1111/j.1532-5415.1998.tb03809.x; Marr A., 2004, CENTRAL NERVOUS SYST; Morris JN, 1999, J GERONTOL A-BIOL, V54, pM546, DOI 10.1093/gerona/54.11.M546; MORRIS JN, 1994, J GERONTOL, V49, pM174, DOI 10.1093/geronj/49.4.M174; Ragnarsson KT, 1999, JAMA-J AM MED ASSOC, V282, P974; SAS software, 2002, SAS SOFTW VERS 9 1; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009	16	8	8	0	6	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0885-9701			J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	NOV-DEC	2007	22	6					368	376		10.1097/01.HTR.0000300232.98242.ce			9	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	234RN	WOS:000251181500007	18025969				2022-02-06	
J	Ruocco, AC; Swirsky-Sacchett, T; Choca, JP				Ruocco, Anthony C.; Swirsky-Sacchett, Thomas; Choca, James P.			Assessing personality and psychopathology after traumatic brain injury with the Millon Clinical Multiaxial Inventory-III	BRAIN INJURY			English	Article						traumatic brain injury; personality; psychopathology; MCMI-III	HEAD-INJURY; FOLLOW-UP; AXIS-I; PSYCHIATRIC-DISORDERS; NEUROPSYCHOLOGY; METAANALYSIS; INDIVIDUALS; PROFILES; COHORT	Purpose: Despite the widespread use of objective personality inventories as part of neuropsychological assessments of traumatic brain injury (TBI) patients, little research exists to support the use of these instruments with TBI populations. The purpose of the present study is two-fold: first, to examine the prevalence and extent of personality and psychopathological disturbance in TBI patients compared with a general psychiatric sample and, secondly, to determine whether personality profiles of TBI patients fall within a pathological range relative to normative psychiatric and nonpsychiatric populations. Methods: Age-, gender- and ethnically-matched TBI and psychiatric patients (n = 462) completed the Millon Clinical Multiaxial Inventory-III (MCMI-III). Results: TBI patients had more frequent elevations on histrionic, compulsive and somatoform scales compared with the matched psychiatric sample. Most scales for TBI patients fell outside of the range of the test's normative psychiatric population. Conclusions: Implications for interpretation of MCMI-III profiles of TBI patients are discussed.	[Ruocco, Anthony C.] Drexel Univ, Dept Psychol, Neuropsychol Program, Philadelphia, PA 19104 USA; [Swirsky-Sacchett, Thomas] Thomas Jefferson Univ, Jefferson Med Coll, Dept Psychiat & Human Behav, Philadelphia, PA 19107 USA; [Choca, James P.] Roosevelt Univ, Dept Psychol, Chicago, IL 60605 USA		Ruocco, AC (corresponding author), Drexel Univ, Dept Psychol, Neuropsychol Program, Philadelphia, PA 19104 USA.	acr32@drexel.edu	Ruocco, Anthony C./B-4915-2010; Ruocco, Anthony Charles/AAM-4794-2021	Ruocco, Anthony C./0000-0002-1942-7181; 			American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th; American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; Bombardier CH, 2003, ARCH PHYS MED REHAB, V84, P185, DOI 10.1053/apmr.2003.50002; Burke J M, 1989, Brain Inj, V3, P35, DOI 10.3109/02699058909008071; Camara WJ, 2000, PROF PSYCHOL-RES PR, V31, P141, DOI 10.1037/0735-7028.31.2.141; Choca J.P., 2004, INTERPRETIVE GUIDE M, V3rd; Costa P. T., 1992, REVISED NEO PERSONAL; DAVIS RD, 1997, MILLON INVENTORIES C, P59; Dunlap WP, 1996, PSYCHOL METHODS, V1, P170, DOI 10.1037/1082-989X.1.2.170; Evered L, 2003, ASSESSMENT, V10, P420, DOI 10.1177/1073191103259539; Fann JR, 2002, J NEUROL NEUROSUR PS, V72, P615, DOI 10.1136/jnnp.72.5.615; GASS CS, 1992, ARCH CLIN NEUROPSYCH, V7, P17, DOI 10.1016/0887-6177(92)90015-F; Golden Z, 2003, INT J NEUROSCI, V113, P733, DOI 10.1080/00207450390200044; Greiffenstein MF, 2001, CLIN NEUROPSYCHOL, V15, P162, DOI 10.1076/clin.15.2.162.1895; Haddy C, 2005, J PERS ASSESS, V84, P193, DOI 10.1207/s15327752jpa8402_09; Hibbard MR, 1998, J HEAD TRAUMA REHAB, V13, P24, DOI 10.1097/00001199-199808000-00003; Hibbard MR, 2000, BRAIN INJURY, V14, P45, DOI 10.1080/026990500120925; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Koponen S, 2006, PSYCHIAT RES-NEUROIM, V146, P263, DOI 10.1016/j.pscychresns.2005.05.015; Koponen S, 2002, AM J PSYCHIAT, V159, P1315, DOI 10.1176/appi.ajp.159.8.1315; Kreutzer JS, 1996, J HEAD TRAUMA REHAB, V11, P58, DOI 10.1097/00001199-199610000-00006; Lannoo E, 1997, J PSYCHOSOM RES, V43, P505, DOI 10.1016/S0022-3999(97)00152-9; LEAF RC, 1992, J PERS DISORD, V6, P134, DOI 10.1521/pedi.1992.6.2.134; MALIA K, 1995, BRAIN INJURY, V9, P697, DOI 10.3109/02699059509008226; Marschark M, 2000, J HEAD TRAUMA REHAB, V15, P1227, DOI 10.1097/00001199-200012000-00004; Mathias JL, 1999, J CLIN EXP NEUROPSYC, V21, P200, DOI 10.1076/jcen.21.2.200.930; MILLON T, 1997, MAN MILL CLIN MULT I; Mychack P, 2001, NEUROCASE, V7, P131, DOI 10.1093/neucas/7.2.131; Rayls KR, 2000, CLIN NEUROPSYCHOL, V14, P546, DOI 10.1076/clin.14.4.546.7194; Reitan RM, 1997, NEUROPSYCHOL REV, V7, P3, DOI 10.1007/BF02876970; Ruocco AC, 2005, PSYCHIAT RES, V137, P191, DOI 10.1016/j.psychres.2005.07.004; RUOCCO AC, IN PRESS CLIN NEUROP; Ruocco AC, 2007, J NEUROPSYCH CLIN N, V19, P27, DOI 10.1176/appi.neuropsych.19.1.27; SWIRSKYSACCHETTI T, 1993, J CLIN PSYCHOL, V49, P385, DOI 10.1002/1097-4679(199305)49:3<385::AID-JCLP2270490313>3.0.CO;2-4; Timonen M, 2002, PSYCHIAT RES, V113, P217, DOI 10.1016/S0165-1781(02)00269-X; TROBST KK, 1999, 4 ANN INTR SCI RETR; TUOKKO H, 1991, Brain Injury, V5, P287, DOI 10.3109/02699059109008098; Whitnall L, 2006, J NEUROL NEUROSUR PS, V77, P640, DOI 10.1136/jnnp.2005.078246; WOOTEN AJ, 1983, J CLIN PSYCHOL, V39, P392, DOI 10.1002/1097-4679(198305)39:3<392::AID-JCLP2270390313>3.0.CO;2-H; [No title captured]	40	8	8	0	7	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	NOV	2007	21	12					1233	1244		10.1080/02699050701716919			12	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	249HP	WOS:000252219200003	18236199				2022-02-06	
J	Schoenberg, MR; Lange, RT; Saklofske, DH				Schoenberg, Mike R.; Lange, Rael T.; Saklofske, Donald H.			A proposed method to estimate premorbid full scale intelligence quotient (FSIQ) for the Canadian Wechsler Intelligence Scale for Children-Fourth Edition (WISC-IV) using demographic and combined estimation procedures	JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY			English	Article; Proceedings Paper	26th Annual Meeting of the National-Academy-of-Neuropsychology	OCT 25-28, 2006	San Antonio, TX	Natl Acad Neuropsychol			REGRESSION-BASED METHODS; TRAUMATIC BRAIN INJURY; GENERAL ABILITY INDEX; COMBINED PERFORMANCE; CHILDREN; REORGANIZATION; PLASTICITY; VARIABLES; LANGUAGE; VALIDATION	Establishing a comparison standard in neuropsychological assessment is crucial to determining change in function. There is no available method to estimate premorbid intellectual functioning for the Wechsler Intelligence Scale for Children-Fourth Edition (WISC-IV). The WISC-IV provided normative data for both American and Canadian children aged 6 to 16 years old. This study developed regression algorithms as a proposed method to estimate full-scale intelligence quotient (FSIQ) for the Canadian WISC-IV. Participants were the Canadian WISC-IV standardization sample (n = 1, 100). The sample was randomly divided into two groups (development and validation groups). The development group was used to generate regression algorithms; 1 algorithm only included demographics, and 11 combined demographic variables with WISC-IV subtest raw scores. The algorithms accounted for 18% to 70% of the variance in FSIQ (standard error of estimate, SEE=8.6 to 14.2). Estimated FSIQ significantly correlated with actual FSIQ (r=.30 to .80), and the majority of individual FSIQ estimates were within 10 points of actual FSIQ. The demographic-only algorithm was less accurate than algorithms combining demographic variables with subtest raw scores. The current algorithms yielded accurate estimates of current FSIQ for Canadian individuals aged 6-16 years old. The potential application of the algorithms to estimate premorbid FSIQ is reviewed. While promising, clinical validation of the algorithms in a sample of children and/or adolescents with known neurological dysfunction is needed to establish these algorithms as a premorbid estimation procedure.	[Schoenberg, Mike R.] Univ Hosp Cleveland, Dept Neurol, Cleveland, OH 44106 USA; [Schoenberg, Mike R.] Case Western Reserve Univ, Sch Med, Cleveland, OH USA; [Lange, Rael T.] Riverview Hosp, Dept Res, BC Mental Hlth & Addict Serv, Coquitlam, BC, Canada; [Saklofske, Donald H.] Univ Calgary, Div Appl Psychol, Calgary, AB T2N 1N4, Canada		Schoenberg, MR (corresponding author), Univ Hosp Cleveland, Dept Neurol, HH 5,11100 Euclid Ave, Cleveland, OH 44106 USA.	Michael.Schoenberg@uhhs.com	Schoenberg, Mike R/J-9018-2012	Schoenberg, Mike/0000-0003-1355-3651			*AM COLL TEST PROG, 1987, ACT ASS PROGR TECHN; Baade LE, 2004, ARCH CLIN NEUROPSYCH, V19, P227, DOI 10.1016/S0887-6177(03)00092-1; BARONA A, 1984, J CONSULT CLIN PSYCH, V52, P885, DOI 10.1037/0022-006X.52.5.885; Chugani HT, 1996, BRAIN DEV-JPN, V18, P347, DOI 10.1016/0387-7604(96)00032-0; *COLL BOARD TEST, 1995, SAT TECHN MAN; CRAWFORD JR, 1990, PERS INDIV DIFFER, V11, P1153, DOI 10.1016/0191-8869(90)90028-P; Donders J, 2001, J INT NEUROPSYCH SOC, V7, P892, DOI 10.1017/S1355617701777132; Ewing-Cobbs L, 2003, DEV NEUROPSYCHOL, V24, P669, DOI 10.1207/S15326942DN242&3_08; Fisher D C, 2000, Appl Neuropsychol, V7, P126, DOI 10.1207/S15324826AN0703_2; Hertz-Pannier L, 2002, BRAIN, V125, P361, DOI 10.1093/brain/awf020; Ivnik RJ, 1992, CLIN NEUROPSYCHOL, V6, P1, DOI DOI 10.1080/13854049208401877; Kaufman AlanS., 1990, ASSESSING ADOLESCENT; KLESGES RC, 1981, J CONSULT CLIN PSYCH, V49, P141, DOI 10.1037/0022-006X.49.1.141; KLESGES RC, 1982, INT J CLIN NEUROPSYC, V4, P15; Kolb B, 2000, DEV NEUROPSYCHOL, V18, P423, DOI 10.1207/S1532694208Kolb; KRULL KR, 1995, CLIN NEUROPSYCHOL, V9, P83, DOI 10.1080/13854049508402063; Lange RT, 2005, ARCH CLIN NEUROPSYCH, V20, P1009, DOI 10.1016/j.acn.2005.06.004; Lange RT, 2005, CLIN NEUROPSYCHOL, V19, P73, DOI 10.1080/13854040490888549; LARRABEE GJ, 1985, J CLIN EXP NEUROPSYC, V7, P497, DOI 10.1080/01688638508401281; Lezak MD., 1983, NEUROPSYCHOLOGICAL A, V2nd ed.; Lezak MD., 1995, NEUROPSYCHOLOGICAL A, V3rd; Liegeois F, 2004, BRAIN, V127, P1229, DOI 10.1093/brain/awh159; MCFIE J, 1975, ASSESSMENT ORGANIC I; Nelson H.E., 1982, NATL ADULT READING T; NELSON HE, 1978, CORTEX, V14, P234, DOI 10.1016/S0010-9452(78)80049-5; Papanicolaou AC, 2001, J CHILD NEUROL, V16, P241; Powell BD, 2003, ARCH CLIN NEUROPSYCH, V18, P277, DOI 10.1016/S0887-6177(02)00135-X; *PSYCH CORP, 2004, WISC 4 TECHN INT MAN; *PSYCH CORP, 1997, WECHS AD INT SCAL; Psychological Corporation, 2001, MAN WECHSL TEST AD R; Putnam SH, 1999, STUD NEUROPSYCHOL DE, P39; Reynolds CR, 1997, ARCH CLIN NEUROPSYCH, V12, P769, DOI 10.1016/S0887-6177(97)00051-6; REYNOLDS CR, 1979, CLIN NEUROPSYCHOLOGY, V1, P36; Sattler J.M., 2001, ASSESSMENT CHILDREN; Sattler J. M., 1988, ASSESSMENT CHILDREN; SCHINKA JA, 2000, CLINICIANS GUIDE NEU; Schoenberg MR, 2006, CLIN NEUROPSYCHOL, V20, P365, DOI 10.1080/138540491005866; Schoenberg MR, 2004, CLIN NEUROPSYCHOL, V18, P266, DOI 10.1080/13854040490501501; Schoenberg MR, 2004, ARCH CLIN NEUROPSYCH, V19, P1103, DOI 10.1016/j.acn.2003.12.008; Schoenberg MR, 2003, CLIN NEUROPSYCHOL, V17, P308, DOI 10.1076/clin.17.3.308.18088; Schoenberg MR, 2002, CLIN NEUROPSYCHOL, V16, P426, DOI 10.1076/clin.16.4.426.13913; SCHOENBERG MR, J CHILD NEUROLOGY; SCHWARTZ M, 1987, AM NART REPLICATION; Scott JG, 1997, CLIN NEUROPSYCHOL, V11, P146, DOI 10.1080/13854049708407043; Spreen O., 1989, CLIN NEUROPSYCHOL, V3, P129, DOI [10.1080/13854048908403285, DOI 10.1080/13854048908403285]; *STAT CAN, 2002, 2001 CENS POP 20 SAM; Taylor H G, 1997, J Int Neuropsychol Soc, V3, P555; Taylor HG, 2002, NEUROPSYCHOLOGY, V16, P15, DOI 10.1037//0894-4105.16.1.15; Taylor HG, 2001, J INT NEUROPSYCH SOC, V7, P755, DOI 10.1017/S1355617701766118; Tremont G, 1999, CHILD NEUROPSYCHOL, V5, P104, DOI 10.1076/chin.5.2.104.3166; VANDERPLOEG RD, 1995, ARCH CLIN NEUROPSYCH, V10, P225, DOI 10.1016/0887-6177(94)00042-O; Vanderploeg RD, 1998, PSYCHOL ASSESSMENT, V10, P277, DOI 10.1037/1040-3590.10.3.277; Wechsler D., 1974, MANUAL WECHSLER INTE; Wechsler D, 2003, WECHSLER INTELLIGENC; Wechsler D., 1958, MEASUREMENT APPRAISA; Wechsler D, 1991, WECHSLER INTELLIGENC, VTHIRD; WILSON RS, 1978, J CONSULT CLIN PSYCH, V46, P1554, DOI 10.1037/0022-006X.46.6.1554; YATES AJ, 1956, J MENT SCI, V102, P409, DOI 10.1192/bjp.102.428.409; YATES KO, 1997, J INT NEUROPSYCH SOC, V3, P617; Yuan WH, 2006, EPILEPSIA, V47, P593, DOI 10.1111/j.1528-1167.2006.00474.x	60	8	8	0	2	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1380-3395	1744-411X		J CLIN EXP NEUROPSYC	J. Clin. Exp. Neuropsychol.	NOV	2007	29	8					867	878		10.1080/13803390601147678			12	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Science (CPCI-S); Conference Proceedings Citation Index - Social Science &amp; Humanities (CPCI-SSH)	Psychology; Neurosciences & Neurology	245JW	WOS:000251931900009	17852603				2022-02-06	
J	Dabrowski, W				Dabrowski, Wojciech			Do changes in S100 beta protein correlate with serum magnesium concentrations in patients undergoing extracorporeal circulation?	MAGNESIUM RESEARCH			English	Article						protein S100 beta; magnesium; brain injury; extracorporeal circulation; CABG	TRAUMATIC BRAIN-INJURY; CARDIAC-SURGERY; S-100 PROTEIN; AXONAL INJURY; S100 PROTEIN; BLOOD; RELEASE; CALCIUM; MARKER; DAMAGE	There are many biochemical markers demonstrating the central nervous system (CNS) damage following coronary artery bypass grafting (CABG). The protein S100 beta is one of them and its concentrations depend on the severity of CNS damage. On the other hand, it is well known that the brain injury results in a decrease in brain magnesium (Mg) concentration, which is strictly correlated with the serum Mg concentration. Therefore, analysis of the correlation between serum total Mg and S100 beta concentrations may be important and interesting, particularly in patients undergoing surgical myocardial revascularization. Patients undergoing CABG with extracorporeal circulation under general anaesthesia were included in the study. Serum Mg and S100 beta concentrations were measured at 5 measurement points: 1) just after the radial artery cannulation, 2) 10 min after completion of ECC, 3) just after surgery, 4) in the morning of the 1(st) postoperative day, 5) in the morning of the 2(nd) postoperative day. The Kruskall-Wallis ANOVA and Spearman correlation tests were used; p < 0.05 was considered as significant. Twenty male patients, aged 54-70 years (63.3 +/- 49.5) were examined. The mean blood concentration of S100 beta was 0.13 mu g/L 0.08 and of Mg-0.99mmol/L +/- 0.13 at measurement point 1. S100 beta increased from point 2 to 4. Mg decreased at points 2 and 3. Moreover, there were significant negative correlations between S100 beta and Mg at point 3 and 4 (p < 0.001; R = -0.76; p < 0.05; R = -0.5, respectively) and between Mg at point I and S100 beta at point 3 and 5 (p < 0.05, R = -0.498; p < 0.05, R = -0.488, respectively), Mg at point 2 and S100 beta at point 4 (p < 0.05, R = -0.523) as well as Mg at point 4 and S100 beta at point 5 (p < 0.01, R = - 0.584). In conclusion: 1) S100 beta increased while total Mg decreased during CABG, 2) The highest serum S100 beta concentrations were noted just after surgery, 3) The changes in serum S100 beta concentrations correlated with those in serum total Mg concentrations, 4) The decrease in senim magnesium concentrations resulted in an elevation in serum S100 beta concentrations.	Feliks Skubiszewski Med Univ, Dept Anaesthesiol Intens Therapy, PL-20954 Lublin, Poland		Dabrowski, W (corresponding author), Feliks Skubiszewski Med Univ, Dept Anaesthesiol Intens Therapy, Jaczewskiego 8, PL-20954 Lublin, Poland.	wojciechdabrowski@interia.pl	Dabrowski, Wojciech/AAN-8425-2020	Dabrowski, Wojciech/0000-0003-0449-2375			Abdul-Khaliq H, 1999, J THORAC CARDIOV SUR, V117, P1027, DOI 10.1016/S0022-5223(99)70389-2; Agus ZS, 1999, J AM SOC NEPHROL, V10, P1616; Ali MS, 2000, BRIT J ANAESTH, V85, P287, DOI 10.1093/bja/85.2.287; Blomquist S, 1997, J CARDIOTHOR VASC AN, V11, P699, DOI 10.1016/S1053-0770(97)90160-9; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cormio M, 1997, J CLIN NEUROSCI, V4, P132, DOI 10.1016/S0967-5868(97)90062-X; EBEL H, 1980, J CLIN CHEM CLIN BIO, V18, P257; FANO G, 1993, NEUROSCIENCE, V53, P919, DOI 10.1016/0306-4522(93)90477-W; FIGEN E, 2003, J NEUROSURG ANESTH, V15, P119; Frankel H, 1999, WORLD J SURG, V23, P966; Gao F, 1999, BRIT J ANAESTH, V82, P266, DOI 10.1093/bja/82.2.266; GOZDZIK W, 2002, ANAESTH INT THERAPY, V34, P91; Heath DL, 1998, SCAND J CLIN LAB INV, V58, P161, DOI 10.1080/00365519850186751; Heath DL, 1996, BRAIN RES, V738, P150, DOI 10.1016/0006-8993(96)00957-2; Herrmann M, 2000, STROKE, V31, P645, DOI 10.1161/01.STR.31.3.645; Inoue Soichiro, 2004, J Anesth, V18, P216; Jonsson H, 1998, ANN THORAC SURG, V65, P1639, DOI 10.1016/S0003-4975(98)00229-X; Jonsson H, 2001, ANN THORAC SURG, V71, P1433, DOI 10.1016/S0003-4975(00)02612-6; Jonsson H, 2004, BMC NEUROL, V4, DOI 10.1186/1471-2377-4-24; Kristian T, 1998, STROKE, V29, P705, DOI 10.1161/01.STR.29.3.705; MCINTOSH TK, 1994, CEREBROVAS BRAIN MET, V6, P109; Meloni BP, 2006, MAGNESIUM RES, V19, P123; Mendez DR, 2005, PEDIATR RES, V57, P347, DOI 10.1203/01.PDR.0000150803.36315.FF; Miller S, 2005, HEART, V91, P618, DOI 10.1136/hrt.2004.033811; Muir KW, 1998, STROKE, V29, P918, DOI 10.1161/01.STR.29.5.918; Nair RR, 2002, MAGNESIUM RES, V15, P287; Ozgurtas T, 2004, MAGNESIUM RES, V17, P327; Pasternak K, 2006, MAGNESIUM RES, V19, P107; Polderman KH, 2004, CRIT CARE, V8, pR459, DOI 10.1186/cc2973; POVLISHOCK JT, 1995, J NEUROTRAUM, V12, P555, DOI 10.1089/neu.1995.12.555; Sakamoto T, 2005, J TRAUMA, V58, P1103, DOI 10.1097/01.TA.0000169950.51735.C4; Samejima H, 1999, JPN CIRC J, V63, P267, DOI 10.1253/jcj.63.267; SATUR CMR, 1994, ANN THORAC SURG, V58, P1674, DOI 10.1016/0003-4975(94)91657-8; Snyder-Ramos SA, 2004, ANAESTHESIA, V59, P1150, DOI 10.1111/j.1365-2044.2004.04004.x; SOARES HD, 1992, J NEUROCHEM, V58, P1845, DOI 10.1111/j.1471-4159.1992.tb10061.x; SOTANIEMI KA, 1995, ANN THORAC SURG, V59, P1336, DOI 10.1016/0003-4975(95)00095-3; Takahashi M, 1999, CLIN CHEM, V45, P1307; Vink R, 2000, FRONT BIOSCI, V5, pD656, DOI 10.2741/Vink; VINK R, 1987, BIOCHEM BIOPH RES CO, V149, P594, DOI 10.1016/0006-291X(87)90409-8; Weis Margaret T., 1993, Magnesium Research, V6, P179; WRONSKA J, 2005, ANN U M CURIE SKLO D, V60, P610; ZIMMER DB, 1995, BRAIN RES BULL, V37, P417, DOI 10.1016/0361-9230(95)00040-2; Zimmer DB, 2003, MICROSC RES TECHNIQ, V60, P552, DOI 10.1002/jemt.10297	43	8	8	0	2	JOHN LIBBEY EUROTEXT LTD	ARCUEIL	30, RUE BERTHOLLET, BATIMENT A, 94110 ARCUEIL, FRANCE	0953-1424	1952-4021		MAGNESIUM RES	Magnes. Res.	SEP	2007	20	3					168	176					9	Biochemistry & Molecular Biology; Endocrinology & Metabolism	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Endocrinology & Metabolism	220IB	WOS:000250149300002	17972459				2022-02-06	
J	Heinrich, SD; Butler, RA				Heinrich, Stephen D.; Butler, R. Allen			Late radial head dislocation with radial head fracture and ulnar plastic deformation	CLINICAL ORTHOPAEDICS AND RELATED RESEARCH			English	Article							MONTEGGIA LESIONS; OPEN REDUCTION; CHILDREN; OSTEOTOMY; RECONSTRUCTION; FIXATION; FOREARM; NECK; BONE	Type 11 Monteggia lesion equivalents produced by plastic deformation of the ulna are rare. Radial head fractures in skeletally immature patients are also uncommon. We report a late presentation of a Type 11 Monteggia equivalent injury with a fracture of the radial head and neck and plastic deformation of the ulna in an 11-year-old boy. The radial head was located on the initial injury radiographs and subsequently dislocated in a posterior direction. The radial head fracture was misdiagnosed as a coronoid fracture at presentation. The plastic deformation of the ulna was diagnosed several weeks after the injury when the dislocation was first noted. Magnetic resonance imaging was used to establish the diagnosis of a radial head fracture at the same time. The patient was treated successfully with an open reduction and internal fixation of the radial head combined with a dorsal closing-wedge ulnar osteotomy.	Childrens Hosp, Dept Orthopaed Surg, New Orleans, LA 70118 USA; Starkville Orthopaed Clin, Starkville, MS USA		Heinrich, SD (corresponding author), Childrens Hosp, Dept Orthopaed Surg, 200 Henry Clay Ave, New Orleans, LA 70118 USA.	Awilliam@chnola.org					Bado J L, 1967, Clin Orthop Relat Res, V50, P71; Bado JL, 1958, INT MED SARANDI, P328; BORDEN S, 1975, AM J ROENTGENOL, V125, P524, DOI 10.2214/ajr.125.3.524; BORDEN S, 1974, J BONE JOINT SURG AM, VA 56, P611, DOI 10.2106/00004623-197456030-00019; CHAMAY A, 1972, J BIOMECH, V5, P173, DOI 10.1016/0021-9290(72)90053-X; CHAMAY A, 1970, J BIOMECH, V3, P263, DOI 10.1016/0021-9290(70)90028-X; Cooper AS, 1844, DISLOCATIONS FRACTUR, P391; Degreff I, 2004, J ORTHOP TRAUMA, V18, P375, DOI 10.1097/00005131-200407000-00008; Exner GU, 2001, J BONE JOINT SURG BR, V83B, P547, DOI 10.1302/0301-620X.83B4.11103; Inoue G, 1998, ACTA ORTHOP SCAND, V69, P73, DOI 10.3109/17453679809002361; Kay R M, 1998, Am J Orthop (Belle Mead NJ), V27, P606; Kemnitz S, 2000, Acta Orthop Belg, V66, P359; Leung AG, 2000, J PEDIATR ORTHOPED, V20, P7; MABREY JD, 1989, J PEDIATR ORTHOPED, V9, P310; Malmvik J, 2003, J PEDIATR ORTHOP B, V12, P63, DOI 10.1097/00009957-200301000-00012; MONTEGGIA GB, 1814, I CHIRURG; PAVEL A, 1965, J Trauma, V5, P185, DOI 10.1097/00005373-196503000-00006; PEIRO A, 1977, J BONE JOINT SURG AM, V59, P92, DOI 10.2106/00004623-197759010-00017; Rauber A. A., 1876, ELASTICITAT FESTIGKE; Ring D, 2002, J BONE JOINT SURG AM, V84A, P1811, DOI 10.2106/00004623-200210000-00011; Ring D, 1996, J BONE JOINT SURG BR, V78B, P734, DOI 10.1302/0301-620X.78B5.0780734; Ring D, 1998, J Am Acad Orthop Surg, V6, P215; Rodgers WB, 1996, J BONE JOINT SURG AM, V78A, P1322, DOI 10.2106/00004623-199609000-00005; RYDHOLM R, 1979, CLIN ORTHOP RELAT R, V139, P121; Sai S, 2005, J ORTHOP SCI, V10, P103, DOI 10.1007/s00776-004-0860-x; SANDERS WE, 1984, CLIN ORTHOP RELAT R, P58; Wang MN, 2006, J ORTHOP TRAUMA, V20, P1, DOI 10.1097/01.bot.0000189881.75421.92; Weisman DS, 1999, J PEDIATR ORTHOPED, V19, P523, DOI 10.1097/00004694-199907000-00020; Wilkins KE, 2002, J PEDIATR ORTHOPED, V22, P548, DOI 10.1097/01.BPO.0000019211.02000.60	29	8	8	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0009-921X	1528-1132		CLIN ORTHOP RELAT R	Clin. Orthop. Rel. Res.	JUL	2007		460					258	262		10.1097/BLO.0b013e31804b20fa			5	Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Surgery	190RN	WOS:000248076800039	17414169				2022-02-06	
J	Medic-Stoianoska, M; Pekic, S; Curic, N; Djilas-Ivanovic, D; Popovic, V				Medic-Stoianoska, Milica; Pekic, Sandra; Curic, Nikola; Djilas-Ivanovic, Dragana; Popovic, Vera			Evolving hypopituitarism as a consequence of traumatic brain injury (TBI) in childhood - call for attention	ENDOCRINE			English	Article						hypopituitarism; traumatic brain injury	GROWTH-HORMONE DEFICIENCY; GH-RELEASING-HORMONE; NEUROENDOCRINE DYSFUNCTION; SUBARACHNOID HEMORRHAGE; RESEARCH SOCIETY; HEAD TRAUMA; ACUTE-PHASE; HIGH-RISK; ADULTS; DIAGNOSIS	Hypopituitarism is a common complication of TBI in long-term survivors, more frequent than previously realized. It may be partial or complete, sometimes very subtle without visible lesions in hypothalamo-pituitary region and is diagnosed only by biochemical means. Neuroendocrine abnormalities caused by TBI may have significant implications for the recovery and rehabilitation of these patients. The subjects at risk are those who have suffered moderate to severe trauma, although mild intensity trauma may precede hypopituitarism also. Particular attention should be paid to this problem in children and adolescents. We describe a patient with hypopituitarism thought to be idiopathic due to mild head trauma which caused diabetes insipidus in childhood, gradual failure of pituitary hormones during the period of growth and development, and metabolic (dyslipidemia), physical (obesity), and cognitive impairments in the adult period.	Univ Clin Ctr, Clin Endocrinol Diabet & Metab Dis, Novi Sad 21000, Serbia; Univ Clin Ctr, Inst Endocrinol, Neuroendocrine Unit, Belgrade, Serbia; Univ Clin Ctr, Inst Lab Med, Novi Sad, Serbia; Inst Oncol, Ctr MRI, Sremska Kamenica, Serbia		Medic-Stoianoska, M (corresponding author), Univ Clin Ctr, Clin Endocrinol Diabet & Metab Dis, Hajduk Veijkova 1-3, Novi Sad 21000, Serbia.	medsto@eunet.yu	Pekic, Sandra/S-7175-2016				Agha A, 2006, CLIN ENDOCRINOL, V64, P481, DOI 10.1111/j.1365-2265.2006.02517.x; Agha A, 2004, CLIN ENDOCRINOL, V60, P584, DOI 10.1111/j.1365-2265.2004.02023.x; Agha Amar, 2005, Pituitary, V8, P245, DOI 10.1007/s11102-005-3463-4; Aimaretti G, 2004, CLIN ENDOCRINOL, V61, P320, DOI 10.1111/j.1365-2265.2004.02094.x; Aimaretti G, 2000, J CLIN ENDOCR METAB, V85, P3693, DOI 10.1210/jc.85.10.3693; Attanasio A, 1998, J CLIN ENDOCR METAB, V83, P379; Benvenga S, 2004, AM J MED, V116, P767, DOI 10.1016/j.amjmed.2003.12.038; Benvenga S, 2000, J CLIN ENDOCR METAB, V85, P1353, DOI 10.1210/jc.85.4.1353; Bondanelli M, 2004, J NEUROTRAUM, V21, P685, DOI 10.1089/0897715041269713; CAIN JP, 1972, CAN MED ASSOC J, V107, P617; Christiansen JS, 2001, J CLIN ENDOCR METAB, V86, P1868; Ghigo E, 1996, EUR J ENDOCRINOL, V134, P352, DOI 10.1530/eje.0.1340352; Ho KKY, 2000, LANCET, V356, P1125, DOI 10.1016/S0140-6736(00)02748-3; HOFFMAN DM, 1994, LANCET, V343, P1065; Jorgensen JOL, 2003, CLIN ENDOCRINOL, V58, P18, DOI 10.1046/j.1365-2265.2003.01711.x; Kelestimur F, 2006, CLIN ENDOCRINOL, V64, P667, DOI 10.1111/j.1365-2265.2006.02525.x; Kelly DF, 2000, J NEUROSURG, V93, P743, DOI 10.3171/jns.2000.93.5.0743; Leal-Cerro A, 2005, CLIN ENDOCRINOL, V62, P525, DOI 10.1111/j.1365-2265.2005.02250.x; Lieberman SA, 2001, J CLIN ENDOCR METAB, V86, P2752, DOI 10.1210/jc.86.6.2752; Popovic V, 2004, J ENDOCRINOL INVEST, V27, P1048, DOI 10.1007/BF03345308; Popovic V, 2003, CLIN ENDOCRINOL, V59, P251, DOI 10.1046/j.1365-2265.2003.01835.x; Popovic V, 2000, LANCET, V356, P1137, DOI 10.1016/S0140-6736(00)02755-0; Popovic Vera, 2005, Pituitary, V8, P239, DOI 10.1007/s11102-006-6047-z; Springer J, 2001, LANCET, V357, P1848, DOI 10.1016/S0140-6736(00)04953-9; Tanriverdi F, 2006, J CLIN ENDOCR METAB, V91, P2105, DOI 10.1210/jc.2005-2476; van Aken M O, 2005, Pituitary, V8, P183	26	8	8	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1355-008X	1559-0100		ENDOCRINE	Endocrine	JUN	2007	31	3					268	271		10.1007/s12020-007-0037-4			4	Endocrinology & Metabolism	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism	216IM	WOS:000249871700007	17906374				2022-02-06	
J	Peeters, MYM; Kuiper, H; Greijdanus, B; van der Naalt, J; Knibbe, CAJ; Uges, DRA				Peeters, Mariska Y. M.; Kuiper, Hiltjo; Greijdanus, Ben; van der Naalt, Joukje; Knibbe, Catherijne A. J.; Uges, Donald R. A.			Gas chromatography-mass spectrometric assay for propofol in cerebrospinal fluid of traumatic brain patients	JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES			English	Article						propofol; CSF; GC-MS	HUMAN PLASMA; BLOOD; QUANTITATION; EXTRACTION; ANESTHESIA; INFUSION; SAMPLES; HPLC	A sensitive gas chromatography-mass spectrometry method for measuring propofol in cerebrospinal fluid is described, validated and applied to four patients after traumatic brain injury. The limit of quantitation was 2 mu g/L using a volume of 0.5 mL. The inter- and intra-assay coefficients of variation were 5.9 and 5.1%, respectively. The assay covers the linear concentration range of 2-50 mu g/L, which is relevant in clinical pharmacokinetic studies when propofol is used in the Intensive Care Unit as a sedative agent or to lower the intracranial pressure. (c) 2007 Elsevier B.V. All rights reserved.	St Antonius Hosp, Dept Clin Pharm, NL-3430 EM Nieuwegein, Netherlands; Univ Groningen, Med Ctr, Dept Pharm, Lab Clin & Forens Toxicol & Drug Anal, Groningen, Netherlands; Univ Groningen, Med Ctr, Dept Neurol, Groningen, Netherlands; Leiden Univ, Div Pharmacol, Leiden Amsterdam Ctr Drug Res, NL-2300 RA Leiden, Netherlands		Peeters, MYM (corresponding author), St Antonius Hosp, Dept Clin Pharm, POB 2500, NL-3430 EM Nieuwegein, Netherlands.	r.peeters@antoniusmesosgroep.nl		van der Naalt, Joukje/0000-0001-9873-2418			Bajpai L, 2004, J CHROMATOGR B, V810, P291, DOI 10.1016/j.jchromb.2004.08.023; Beaudry F, 2005, J PHARMACEUT BIOMED, V39, P411, DOI 10.1016/j.jpba.2005.04.041; Cremer OL, 2001, LANCET, V357, P117, DOI 10.1016/S0140-6736(00)03547-9; Dawidowicz AL, 2003, BIOMED CHROMATOGR, V17, P447, DOI 10.1002/bmc.269; Dawidowicz AL, 2003, BRIT J ANAESTH, V90, P84, DOI 10.1093/bja/aeg009; DAWIDOWICZ AL, 1995, J CHROMATOGR SCI, V33, P377, DOI 10.1093/chromsci/33.7.377; Dawidowicz AL, 2000, ANESTHESIOLOGY, V93, P992, DOI 10.1097/00000542-200010000-00020; Dawidowicz AL, 2000, BIOMED CHROMATOGR, V14, P249, DOI 10.1002/1099-0801(200006)14:4<249::AID-BMC981>3.0.CO;2-H; Engdahl O, 1998, BRIT J ANAESTH, V81, P957, DOI 10.1093/bja/81.6.957; Favetta P, 2000, RAPID COMMUN MASS SP, V14, P1932, DOI 10.1002/1097-0231(20001030)14:20<1932::AID-RCM114>3.3.CO;2-G; GUITTON J, 1995, J CHROMATOGR B, V669, P358, DOI 10.1016/0378-4347(95)00105-R; Knibbe CAJ, 1998, J CHROMATOGR B, V706, P305, DOI 10.1016/S0378-4347(97)00571-9; Knibbe CAJ, 2002, BRIT J CLIN PHARMACO, V54, P415, DOI 10.1046/j.1365-2125.2002.01652.x; MAZZI G, 1990, J CHROMATOGR-BIOMED, V528, P537, DOI 10.1016/S0378-4347(00)82415-9; STETSON PL, 1993, J CHROMATOGR-BIOMED, V620, P260, DOI 10.1016/0378-4347(93)80014-U; Vasile B, 2003, INTENS CARE MED, V29, P1417, DOI 10.1007/s00134-003-1905-x	16	8	9	0	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1570-0232			J CHROMATOGR B	J. Chromatogr. B	JUN 1	2007	852	1-2					635	639		10.1016/j.jchromb.2007.01.001			5	Biochemical Research Methods; Chemistry, Analytical	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Chemistry	179JV	WOS:000247286700088	17239666				2022-02-06	
J	Fonseca, RP; Parente, MADP; Cote, H; Joanette, Y				Fonseca, Rochele Paz; de Mattos Pimenta Parente, Maria Alice; Cote, Helene; Joanette, Yves			Adaptation process to Brazilian Portuguese of the montreal communication evaluation battery - MAC battery	PSICOLOGIA-REFLEXAO E CRITICA			Spanish	Article						neuropsychology; communication; language; right hemisphere; psychological evaluation		This research aims to present the adaptation of the "Protocole Montreal d'Evaluation de la Communciation - Protocole MEC" (Montreal Communication Evaluation Battery -MAC Battery) to Brazilian Portuguese, in accordance with psycholinguistics criteria. MAC Battery is a Canadian instrument constructed to evaluate right hemisphere communicative and linguistic abilities, considering four processing domains: discoursive, pragmatic-inferential, lexical-semantic and prosodic. The participants were six translators, three specialist judges, 54 non-specialist judges and 16 subjects from pilot studies. Adaptation procedures included translation, judge analysis of psycholinguistics criteria and two pilot tests. Some tasks required a harder stimulus adaptation process - Metaphor interpretation, Narrative discourse and Semantic judgement - focusing a main finality: to keep each task's objective as idealized in the original instrument. This neuropsychological test can be used to evaluate communication abilities of patients with right brain damage, frontal lesion, traumatic brain injury and dementia.	[Fonseca, Rochele Paz; de Mattos Pimenta Parente, Maria Alice] Univ Fed Rio Grande do Sul, Porto Alegre, RS, Brazil; [Cote, Helene; Joanette, Yves] Univ Montreal, Montreal, PQ, Canada		Fonseca, RP (corresponding author), Rua Elias Bothome 275, Porto Alegre, RS, Brazil.	rochele.fonseca@terra.com.br		Joanette, Yves/0000-0001-9212-1827			ANASTASI A, 2000, TESTAGEM PSICOLOGIA; BERTOLUCCI PHF, 1994, ARQ NEURO-PSIQUIAT, V52, P1, DOI 10.1590/S0004-282X1994000100001; Bertolucci PHF, 1998, REV PSIQUIATRIA CLIN, V25, P80; Biaggio A., 1991, ARQUIVOS BRASILEIROS, V43, P107; BIAGGIO AMB, 1980, ARQ BRAS PSICOL APL, V32, P106; Bogen JE, 1997, BRAIN LANG, V57, P12, DOI 10.1006/brln.1997.1831; CADILLAC C, 2000, THESIS U TOULOUSE LE; Chan AS, 2003, PSYCHOL ASSESSMENT, V15, P257, DOI 10.1037/1040-3590.15.3.257; Cote H., 2004, REEDUCATION ORTHOPHO, V219, P107; Cote H, 2007, APHASIOLOGY, V21, P739, DOI 10.1080/02687030701192331; ECK K, 2001, AN 2 C SOC LAT NEUR, P27; FONSECA RP, 2004, THESIS U FEDERAL RIO; FONSECA RP, 2005, DISTURBIOS NEUROLOGI, P136; Joanette Y., 1990, RIGHT HEMISPHERE VER; Joanette Y., 2004, PROTOCOLE MEC PROTOC, VOrtho ed; LATORRE C, 1987, 7 C NAC NEUR, P33; Nascimento Ed, 2002, PSICOL-REFLEX CRIT, V15, P603, DOI DOI 10.1590/S0102-79722002000300014; Pasquali L., 1999, INSTRUMENTOS PSICOLO; SCHULTZ RR, 1999, DESEMPENHO POPULACAO; Searle J. R., 1969, SPEECH ACTS ESSAY PH	20	8	16	0	3	UNIV FEDERAL RIO GRANDE SUL	PORTO ALEGRE RS	INST PSICOLOGIA, PPG EM PSICOLOGIA DA UFRGS, RUA RAMIRO BARCELOS 2600, PORTO ALEGRE RS, 90035-003, BRAZIL	0102-7972			PSICOL-REFLEX CRIT	Psicol.-Reflex. Crit.	MAY-AUG	2007	20	2					259	267		10.1590/S0102-79722007000200012			9	Psychology, Multidisciplinary	Social Science Citation Index (SSCI)	Psychology	339JN	WOS:000258574000012		gold, Green Published, Green Submitted			2022-02-06	
J	Mix, E; Goertsches, R; Zettl, UK				Mix, Eilhard; Goertsches, Robert; Zettl, Uwe K.			Immunology and neurology	JOURNAL OF NEUROLOGY			English	Article; Proceedings Paper	6th Baltic Symposium on Clinical Neuroimmunology	2006	Rostock, GERMANY			immunological privilege; HPA axis; neural and immunological synapses; neurotransmitter and cytokine receptors; electroimmunology	CENTRAL-NERVOUS-SYSTEM; IMMUNE-SYSTEM; MULTIPLE-SCLEROSIS; T-CELLS; COMMUNICATION; INFLAMMATION; HOMUNCULUS; INJURY; BRAIN; KV1.3	The classical field of neuroimmunology deals with the immune response in infectious, autoimmune-mediated, ischemic, degenerative, traumatic, and neoplastic diseases of the nervous system with a major focus on immune-mediated demyelination. Recently more and more evidence points to a broader interaction between the immune and nervous systems via morphological connections, shared signal molecules and common mechanisms of signal transduction. Consequently, immune processes affect nervous functions and vice versa under both physiologic and pathologic conditions. This includes neuroendocrine (hormonal) and vegetative (neurotransmitter-mediated) influences on the immune response including conditioned immunostimulation and immunosuppression (neuroimmunomodulation) as well as effects of immune mediators (cytokines) on neuronal and psychic functions (psychoneuroimmunology). These findings have a strong impact on future strategies for the treatment of somatic as well as psychiatric diseases.	Univ Rostock, Dept Neurol, D-18147 Rostock, Germany; Univ Rostock, Dept Immunol, D-2500 Rostock 1, Germany		Mix, E (corresponding author), Univ Rostock, Dept Neurol, Gehlsheimer Str 20, D-18147 Rostock, Germany.						ADER R, 1990, ANNU REV PHARMACOL, V30, P561, DOI 10.1146/annurev.pa.30.040190.003021; Antel J.P, 2005, CLIN NEUROIMMUNOLOGY; BARKER CF, 1977, ADV IMMUNOL, V25, P1; Bechmann I, 2005, NEUROMOL MED, V7, P217, DOI 10.1385/NMM:7:3:217; Beeton C, 2006, P NATL ACAD SCI USA, V103, P17414, DOI 10.1073/pnas.0605136103; BESEDOVSKY HO, 2000, Z RHEUMATOL S2, V59; BLALOCK JE, 1997, CHEM IMMUNOLOGY, V69; Blass S, 2001, Z RHEUMATOL, V60, P1, DOI 10.1007/s003930170093; Cahalan MD, 2001, J CLIN IMMUNOL, V21, P235, DOI 10.1023/A:1010958907271; CHANDY KG, 1985, J IMMUNOL, V135, P787; CHOFFLON M, 1996, IMMUNONEUROLOGY; COHEN IR, 1991, IMMUNOL TODAY, V12, P105, DOI 10.1016/0167-5699(91)90093-9; CSERR HF, 1997, IMMUNOLOGY NERVOUS S, P134; Dustin ML, 2002, SCIENCE, V298, P785, DOI 10.1126/science.1076386; Fields RD, 2002, SCIENCE, V298, P556, DOI 10.1126/science.298.5593.556; GAILLARD RC, 2002, NEUROENDOCRINE IMMUN; Hadjilambreva G, 2005, J NEUROPHYSIOL, V93, P843, DOI 10.1152/jn.01224.2003; Hemmer B, 2002, NAT REV NEUROSCI, V3, P291, DOI 10.1038/nrn784; Hershberg Uri, 2001, Complexity, V6, P14, DOI 10.1002/cplx.1046; HICKEY WF, 1991, J NEUROSCI RES, V28, P254, DOI 10.1002/jnr.490280213; Khan AA, 2001, SCIENCE, V292, P1681, DOI 10.1126/science.1056594; KOLLER H, 1999, IMMUNOLOGISCHELEKTRO; KUGLER J, 1995, PSYCHONEUROIIMUNOLOG; Lassmann H, 2007, J NEUROL, V254, P15, DOI 10.1007/s00415-007-2005-6; Levite M, 2000, ANN NY ACAD SCI, V917, P307; LEVY JK, 1997, NEUROIMMUNOLOGY CLIN, P35; MARTINO G, 1999, BASIC IMMUNOLOGY IMM; Matsue H, 2006, J IMMUNOL, V176, P181, DOI 10.4049/jimmunol.176.1.181; Meisel C, 2005, NAT REV NEUROSCI, V6, P775, DOI 10.1038/nrn1765; Merrill JE, 1996, TRENDS NEUROSCI, V19, P331, DOI 10.1016/0166-2236(96)10047-3; Oviedo-Orta E, 2004, BBA-BIOMEMBRANES, V1662, P102, DOI 10.1016/j.bbamem.2003.10.021; Pavlov VA, 2004, CELL MOL LIFE SCI, V61, P2322, DOI 10.1007/s00018-004-4102-3; Poletaev AB, 2002, BIOCHEMISTRY-MOSCOW+, V67, P600, DOI 10.1023/A:1015514732179; Ringheim GE, 2004, J NEUROIMMUNOL, V147, P43, DOI 10.1016/j.jneuroim.2003.10.013; Roberts JE, 2000, ANN NY ACAD SCI, V917, P435; ROLAK LA, 1997, NEUROIMMUNOLOGY CLIN; Rooker S, 2006, MEDIAT INFLAMM, V2006, DOI 10.1155/MI/2006/90123; ROSCH PJ, 1995, STRESS IMMUNE SYSTEM, P207; Rus H, 2005, P NATL ACAD SCI USA, V102, P11094, DOI 10.1073/pnas.0501770102; Rustom A, 2004, SCIENCE, V303, P1007, DOI 10.1126/science.1093133; Saha B, 2001, NEUROIMMUNOMODULAT, V9, P23, DOI 10.1159/000049004; Schuld A, 2004, NERVENHEILKUNDE, V23, P110; SCHULZ KH, 1997, PSYCHONEUROIMMUNOLOG; Schwartz M, 2005, J NEUROL SCI, V233, P163, DOI 10.1016/j.jns.2005.03.014; SEDGWICK JD, 1997, IMMUNOLOGY NERVOUS S, P364; Shaw AS, 2001, NAT IMMUNOL, V2, P575, DOI 10.1038/89712; SPERNERUNTERWEG.B, 2001, PSYCHONEUROIMMUNOLOG; STERNBERG E, 2005, CLIN NEUROIMMUNOLOGY; Stoll G, 2002, ADV EXP MED BIOL, V513, P87; Strauss U, 2005, NEUROIMMUNOMODULAT, V12, P45, DOI 10.1159/000082363; Strauss U, 1998, RECEPTOR CHANNEL, V6, P73; Strauss U, 2000, IMMUNOPHARMACOLOGY, V48, P51, DOI 10.1016/S0162-3109(00)00177-6; TOYKA KV, 1988, KLIN NEUROIMMUNOLOGI; Wang H, 2003, NATURE, V421, P384, DOI 10.1038/nature01339; Watkins SC, 2005, IMMUNITY, V23, P309, DOI 10.1016/j.immuni.2005.08.009; WONG PKY, 1998, NEUROIMMUNODEGENERAT; ZETTL UK, 1999, KLIN NEUROIMMUNOLOGI	57	8	10	0	4	DR DIETRICH STEINKOPFF VERLAG	DARMSTADT	PO BOX 10 04 62, D-64204 DARMSTADT, GERMANY	0340-5354			J NEUROL	J. Neurol.	MAY	2007	254			2			2	7		10.1007/s00415-007-2002-9			6	Clinical Neurology	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	175SM	WOS:000247034300002					2022-02-06	
J	Ohlsson, M; Svensson, M				Ohlsson, Marcus; Svensson, Mikael			Early decompression of the injured optic nerve reduces axonal degeneration and improves functional outcome in the adult rat	EXPERIMENTAL BRAIN RESEARCH			English	Article						CNS; decompression; optic nerve; regeneration; visual evoked potentials	SPINAL-CORD-INJURY; RANDOMIZED CONTROLLED-TRIAL; TRAUMATIC BRAIN-INJURY; GANGLION-CELL AXONS; COMPLEMENT ACTIVATION; TIRILAZAD MESYLATE; CRUSH INJURY; GLIAL SCAR; REGENERATION; SYSTEM	The putative beneficial role of an early decompression of injured CNS tissue following trauma remains controversial. In this study, we approach this scientific query using a standardized injury of the optic nerve in adult rats. Adult Sprague-Dawley rats were subjected to a standardized optic nerve constriction injury by applying a loose ligature around the nerve for 5 min, 1, 6 or 24 h. All animals were sacrificed at 28 dpi. Viable axons distal to the injury were quantified using semithin sections, and regenerative fibers were studied using antisera to neurofilament and GAP43. Axonal degeneration and glial scar development were analyzed using Fluoro-Jade staining and anti-GFAP, respectively. Visual function was studied with visual evoked potentials (VEP). No significant differences were observed between 1 and 6 h of optic nerve compression. However, the number of viable axons analyzed with neurofilament and on semithin sections, decreased significantly between 6 and 24 h, paralleled by an increase in Fluoro-Jade labeled axonal debris (P < 0.001). GFAP-IR density was significantly higher (P < 0.001) in the 24 h compression group in comparison to 6 h. VEP showed preserved, but impaired visual function in animals subjected to compression up to 6 h, compared to an abolished cortical response at 24 h. Regenerative GAP43-positive sprouts were occasionally found distal to the lesion in animals subjected to compression up to 6 h, but not at 24 h. These findings suggest that early optic nerve decompression within hours after the initial trauma is beneficial for functional outcome.	Karolinska Hosp, Karolinska Inst, Dept Clin Neurosci, Sect Neurosurg, S-17176 Stockholm, Sweden		Ohlsson, M (corresponding author), Karolinska Hosp, Karolinska Inst, Dept Clin Neurosci, Sect Neurosurg, S-17176 Stockholm, Sweden.	marcus.ohlsson@karolinska.se; mikael.a.svensson@karolinska.se	Svensson, Mikael/F-8662-2012	Svensson, Mikael/0000-0003-1179-7003			American Association of Neurological Surgeons (AANS) and Congress of Neurological Surgeons (CNS), 2002, NEUROSURGERY S, V50, pS7; Bellander BM, 1996, J NEUROSURG, V85, P468, DOI 10.3171/jns.1996.85.3.0468; Bellander BM, 2001, J NEUROTRAUM, V18, P1295, DOI 10.1089/08977150152725605; Bracken MB, 1998, J NEUROSURG, V89, P699, DOI 10.3171/jns.1998.89.5.0699; Bracken MB, 1997, JAMA-J AM MED ASSOC, V277, P1597, DOI 10.1001/jama.277.20.1597; Brecknell JE, 1996, BIOL REV, V71, P227, DOI 10.1111/j.1469-185X.1996.tb00748.x; Campbell G, 1999, NEUROREPORT, V10, P3955, DOI 10.1097/00001756-199912160-00042; Davies SJA, 1997, NATURE, V390, P680, DOI 10.1038/37776; Dezawa M, 1999, BRAIN RES BULL, V48, P573, DOI 10.1016/S0361-9230(99)00035-0; Dimar JR, 1999, SPINE, V24, P1623, DOI 10.1097/00007632-199908150-00002; DOSTER SK, 1991, NEURON, V6, P635, DOI 10.1016/0896-6273(91)90066-9; Fawcett JW, 1999, BRAIN RES BULL, V49, P377, DOI 10.1016/S0361-9230(99)00072-6; Fehlings MG, 1999, J NEUROSURG, V91, P1, DOI 10.3171/spi.1999.91.1.0001; Fischer D, 2001, EXP NEUROL, V172, P257, DOI 10.1006/exnr.2001.7822; Foerster AP, 1999, EUR J NEUROSCI, V11, P3151, DOI 10.1046/j.1460-9568.1999.00735.x; FORRESTER J, 1967, NATURE, V214, P245, DOI 10.1038/214245a0; Frank M, 1996, GLIA, V16, P227, DOI 10.1002/(SICI)1098-1136(199603)16:3<227::AID-GLIA5>3.0.CO;2-Z; Gasque P, 2002, MOL NEUROBIOL, V25, P1, DOI 10.1385/MN:25:1:001; Gellrich NC, 2002, BRIT J OPHTHALMOL, V86, P233, DOI 10.1136/bjo.86.2.233; Gellrich NC, 1997, OPHTHALMOLOGE, V94, P807, DOI 10.1007/s003470050208; Greenberg M.S., 1997, HDB NEUROSURGERY; Guest J, 2002, J NEUROSURG, V97, P25, DOI 10.3171/spi.2002.97.1.0025; Gunnarsson T, 2003, CURR OPIN NEUROL, V16, P717, DOI 10.1097/00019052-200312000-00012; Heiduschka P, 2005, RESTOR NEUROL NEUROS, V23, P303; Huber AB, 2000, BIOL CHEM, V381, P407, DOI 10.1515/BC.2000.053; Ide C, 1996, NEUROSCI RES, V25, P101; LazarovSpiegler O, 1996, FASEB J, V10, P1296, DOI 10.1096/fasebj.10.11.8836043; Levin LA, 1999, OPHTHALMOLOGY, V106, P1268, DOI 10.1016/S0161-6420(99)00707-1; LEVIN LA, 1994, OPHTHALMOLOGY, V101, P566; LINDA H, 1992, EXP BRAIN RES, V91, P284; MacLaren RE, 1999, EYE, V13, P277, DOI 10.1038/eye.1999.77; MacLaren RE, 1998, BRIT J OPHTHALMOL, V82, P577, DOI 10.1136/bjo.82.5.577; Mattsson P, 1998, J NEUROIMMUNOL, V91, P180, DOI 10.1016/S0165-5728(98)00178-7; Monsul NT, 2004, EXP NEUROL, V186, P124, DOI 10.1016/S0014-4886(03)00311-X; Ohlsson M, 2004, RESTOR NEUROL NEUROS, V22, P33; Ohlsson M, 2004, RESTOR NEUROL NEUROS, V22, P1; Ohlsson M, 2004, J NEURO-OPHTHALMOL, V24, P11, DOI 10.1097/00041327-200403000-00003; Ohlsson M, 2003, J NEUROTRAUM, V20, P895, DOI 10.1089/089771503322385827; Olson L, 2002, NATURE, V416, P589, DOI 10.1038/416589a; Paxinos G, 1995, RAT NERVOUS SYSTEM; Podhajsky RJ, 1997, EXP NEUROL, V143, P153, DOI 10.1006/exnr.1996.6354; Ramon y Cajal, 1928, DEGENERATION REGENER; Schmued LC, 1997, BRAIN RES, V751, P37, DOI 10.1016/S0006-8993(96)01387-X; Thakar A, 2003, LARYNGOSCOPE, V113, P112, DOI 10.1097/00005537-200301000-00021; Thanos S, 1997, EXP BRAIN RES, V114, P483, DOI 10.1007/PL00005657; Ueda Y, 2006, ACTA NEUROPATHOL, V112, P85, DOI 10.1007/s00401-005-0029-5; Wohlrab TM, 2002, ACTA OPHTHALMOL SCAN, V80, P287, DOI 10.1034/j.1600-0420.2002.800311.x; Yang WG, 2004, ANN PLAS SURG, V52, P36, DOI 10.1097/01.sap.0000096442.82059.6d; Yoles E, 1997, J NEUROTRAUM, V14, P665, DOI 10.1089/neu.1997.14.665; [No title captured]	50	8	8	0	2	SPRINGER	NEW YORK	233 SPRING STREET, NEW YORK, NY 10013 USA	0014-4819			EXP BRAIN RES	Exp. Brain Res.	MAY	2007	179	1					121	130		10.1007/s00221-006-0775-1			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	160XH	WOS:000245976700011	17103208				2022-02-06	
J	Powell, JM; Temkin, NR; Machamer, JE; Dikmen, SS				Powell, Janet M.; Temkin, Nancy R.; Machamer, Joan E.; Dikmen, Sureyya S.			Gaining insight into patients' perspectives on participation in home management activities after traumatic brain	AMERICAN JOURNAL OF OCCUPATIONAL THERAPY			English	Article						domestic activities; home management; instrumental activities of daily living (IADLs); traumatic brain injury	SELF-REPORTED DISABILITY; HEAD-INJURY; MODERATE; REHABILITATION; CONSCIOUSNESS; PREDICTORS; MORTALITY; HANDICAP; OUTCOMES; QUALITY	OBJECTIVE. This study investigated performance of home management activities I year after traumatic brain injury (TBI), as reported on the Functional Status Examination. METHOD. Home management performance of 164 rehabilitation inpatients (mean age 35.4 years 77% men,, 75% white) with moderate to severe TBI was examined in relation to demographics, injury severity, neuropsychological functioning, and living situation. RESULTS. Fifty-nine percent reported more difficulty or more assistance with home management at 1 year. Nonperformance of individual activities before injury ranged from 16% to 76%. Age (p =.001), living situation after injury (p =.002), and neuropsychological function at 1 year (p = 001) were associated with more limited home management performance after injury as compared to premorbid function. CONCLUSIONS. Home management is challenging 1 year after TBI, especially for older adults and those with greater cognitive impairments. Accurate preinjury information is needed to determine the nature and extent of subsequent losses, guide treatment planning and interventions, and characterize recovery of function.	Univ Washington, Div Occupat Therapy, Dept Rehabil Med, Seattle, WA 98195 USA; Univ Washington, Dept Neurol Surg & Psychiat & Behav Sci, Seattle, WA 98195 USA		Powell, JM (corresponding author), Univ Washington, Div Occupat Therapy, Dept Rehabil Med, 1959 NE Pacific St, Seattle, WA 98195 USA.	jmpowell@u.washington.edu					[Anonymous], 1989, INSTR GROOV PEGB TES; Bell KR, 2005, ARCH PHYS MED REHAB, V86, P851, DOI 10.1016/j.apmr.2004.09.015; BERGNER M, 1976, MED CARE, V14, P57, DOI 10.1097/00005650-197601000-00006; Colantonio A, 2004, DISABIL REHABIL, V26, P253, DOI 10.1080/09638280310001639722; Corrigan JD, 1998, ARCH PHYS MED REHAB, V79, P298, DOI 10.1016/S0003-9993(98)90010-7; DACEY R, 1991, J TRAUMA, V31, P217, DOI 10.1097/00005373-199131020-00011; DIKMEN S, 1993, BRAIN INJURY, V7, P113, DOI 10.3109/02699059309008165; Dikmen S, 2001, J NEUROTRAUM, V18, P127, DOI 10.1089/08977150150502578; Dikmen S S, 1995, J Int Neuropsychol Soc, V1, P67; DIKMEN SS, 1994, ARCH NEUROL-CHICAGO, V51, P177, DOI 10.1001/archneur.1994.00540140087018; Dikmen SS, 2003, ARCH PHYS MED REHAB, V84, P1449, DOI 10.1016/S0003-9993(03)00287-9; Doig E, 2001, BRAIN INJURY, V15, P747, DOI 10.1080/02699050110034343; FIELDS J, 2001, CURRENT POPULATION R, P20; FISHER AG, 2001, ASSESSMENT MOTOR PRO; GALE JL, 1983, NEUROSURGERY, V12, P487, DOI 10.1227/00006123-198305000-00001; HALLETT JD, 1994, AM J OCCUP THER, V48, P241, DOI 10.5014/ajot.48.3.241; Harrison-Felix C, 2004, NEUROREHABILITATION, V19, P45; JENNETT B, 1975, LANCET, V1, P480; Johnston MV, 2005, ARCH PHYS MED REHAB, V86, P735, DOI 10.1016/j.apmr.2004.10.031; Kreutzer J., 1993, J HEAD TRAUMA REHAB, V8, P75, DOI [10.1097/00001199-199308020-00009, DOI 10.1097/00001199-199308020-00009]; Lannoo E, 2000, J NEUROTRAUM, V17, P403, DOI 10.1089/neu.2000.17.403; Lehtonen S, 2005, BRAIN INJURY, V19, P239, DOI 10.1080/0269905040004310; Merrill SS, 1997, J GERONTOL A-BIOL, V52, pM19, DOI 10.1093/gerona/52A.1.M19; Meythaler JM, 2002, J HEAD TRAUMA REHAB, V17, P300, DOI 10.1097/00001199-200208000-00004; Ownsworth T, 2004, DISABIL REHABIL, V26, P765, DOI 10.1080/09638280410001696700; PATRICK DL, 1988, J GEN INTERN MED, V3, P218, DOI 10.1007/BF02596335; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Rosner B., 1995, FUNDAMENTALS BIOSTAT; Schmidt M., 1996, REY AUDITORY VERBAL; Sherer M, 2002, CLIN NEUROPSYCHOL, V16, P157, DOI 10.1076/clin.16.2.157.13238; Smith A., 1985, SYMBOL DIGIT MODALIT; TEASDALE G, 1974, LANCET, V2, P81; TEMKIN NR, 1995, J NEUROSURG, V82, P764, DOI 10.3171/jns.1995.82.5.0764; Temkin NR, 2003, J NEUROTRAUM, V20, P229, DOI 10.1089/089771503321532815; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; van den Brink CL, 2003, J AM GERIATR SOC, V51, P782, DOI 10.1046/j.1365-2389.2003.51258.x; Verplancke D, 2005, CLIN REHABIL, V19, P117, DOI 10.1191/0269215505cr827oa; Wagner AK, 2002, ARCH PHYS MED REHAB, V83, P107, DOI 10.1053/apmr.2002.27470; WECHSLER D, 1981, WAIS R MANUAL ADULT; WHITENECK GG, 1992, ARCH PHYS MED REHAB, V73, P519; Whyte J, 2005, ARCH PHYS MED REHAB, V86, P453, DOI 10.1016/j.apmr.2004.05.016; WILLER B, 1994, AM J PHYS MED REHAB, V73, P103; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; World Health Organization, 1993, INT CLASS IMP DIS HA; World Health Organization, 2007, INT CLASS FUNCT DIS; Youngstrom MJ, 2002, AM J OCCUP THER, V56, P609	46	8	10	0	8	AMER OCCUPATIONAL THERAPY ASSOC, INC	BETHESDA	4720 MONTGOMERY LANE, BETHESDA, MD 20814-3425 USA	0272-9490	1943-7676		AM J OCCUP THER	Am. J. Occup. Ther.	MAY-JUN	2007	61	3					269	279		10.5014/ajot.61.3.269			11	Rehabilitation	Social Science Citation Index (SSCI)	Rehabilitation	169ML	WOS:000246596200003	17569384				2022-02-06	
J	Chen, M; Tao, YX; Gu, JGG				Chen, Meng; Tao, Yuan-Xiang; Gu, Jianguo G.			Inward currents induced by ischemia in rat spinal cord dorsal horn neurons	MOLECULAR PAIN			English	Article							GLUTAMATE TRANSPORTER GLT-1; HIPPOCAMPAL CA1; NERVOUS-SYSTEM; IN-VITRO; BRAIN; EXPRESSION; DEPRIVATION; RELEASE; GLUCOSE; OXYGEN	Hypoxia and ischemia occur in the spinal cord when blood vessels of the spinal cord are compressed under pathological conditions such as spinal stenosis, tumors, and traumatic spinal injury. Here by using spinal cord slice preparations and patch-clamp recordings we investigated the influence of an ischemia-simulating medium on dorsal horn neurons in deep lamina, a region that plays a significant role in sensory hypersensitivity and pathological pain. We found that the ischemia-simulating medium induced large inward currents in dorsal horn neurons recorded. The onset of the ischemia-induced inward currents was age-dependent, being onset earlier in older animals. Increases of sensory input by the stimulation of afferent fibers with electrical impulses or by capsaicin significantly speeded up the onset of the ischemia-induced inward currents. The ischemia-induced inward currents were abolished by the glutamate receptor antagonists CNQX (20 M) and APV (50 M). The ischemia-induced inward currents were also substantially inhibited by the glutamate transporter inhibitor TBOA (100 M). Our results suggest that ischemia caused reversal operation of glutamate transporters, leading to the release of glutamate via glutamate transporters and the subsequent activation of glutamate receptors in the spinal dorsal horn neurons.	McKnight Brain Inst, Dept Oral & Maxillofacial Surg, Gainesville, FL 32610 USA; Univ Florida, Coll Dent, Gainesville, FL 32610 USA; Johns Hopkins Univ, Sch Med, Dept Anesthesiol & Crit Care Med, Baltimore, MD 21205 USA		Gu, JGG (corresponding author), McKnight Brain Inst, Dept Oral & Maxillofacial Surg, Gainesville, FL 32610 USA.	meng.chen@duke.edu; ytau@jhmi.edu; jgu@dental.ufl.edu					Anderson CM, 2000, GLIA, V32, P1; Arriza JL, 1997, P NATL ACAD SCI USA, V94, P4155, DOI 10.1073/pnas.94.8.4155; Bal S, 2006, AM J PHYS MED REHAB, V85, P135, DOI 10.1097/01.phm.0000197586.91860.a1; Berger UV, 1998, ANAT EMBRYOL, V198, P13, DOI 10.1007/s004290050161; Carlson Gregory D, 2002, Spine J, V2, P116, DOI 10.1016/S1529-9430(01)00029-8; CHOI DW, 1988, NEURON, V1, P623, DOI 10.1016/0896-6273(88)90162-6; Danbolt NC, 2001, PROG NEUROBIOL, V65, P1, DOI 10.1016/S0301-0082(00)00067-8; DANBOLT NC, 1992, NEUROSCIENCE, V51, P295, DOI 10.1016/0306-4522(92)90316-T; Dehnes Y, 1998, J NEUROSCI, V18, P3606; GLIA YX, 2005, MOL PAIN, V1, P30; Jabaudon D, 2000, P NATL ACAD SCI USA, V97, P5610, DOI 10.1073/pnas.97.10.5610; Kudo Y, 2006, CRIT CARE MED, V34, P2820, DOI 10.1097/01.CCM.0000242522.48734.64; Kugler P, 1999, GLIA, V27, P129, DOI 10.1002/(SICI)1098-1136(199908)27:2<129::AID-GLIA3>3.0.CO;2-Y; LEHRE KP, 1995, J NEUROSCI, V15, P1835; Levy LM, 1998, J NEUROSCI, V18, P9620, DOI 10.1523/jneurosci.18-23-09620.1998; Liaw WJ, 2005, PAIN, V115, P60, DOI 10.1016/j.pain.2005.02.006; Lievens JC, 2000, GLIA, V29, P222, DOI 10.1002/(SICI)1098-1136(20000201)29:3<222::AID-GLIA4>3.0.CO;2-0; Mennerick S, 1999, J NEUROSCI, V19, P9242; Minami T, 2001, BRAIN RES, V895, P178, DOI 10.1016/S0006-8993(01)02069-8; Mitani A, 2003, J NEUROSCI, V23, P7176, DOI 10.1523/JNEUROSCI.23-18-07176.2003; Nakatsuka T, 2001, J NEUROSCI, V21, P6522, DOI 10.1523/JNEUROSCI.21-17-06522.2001; Niederberger E, 2003, NEUROSCIENCE, V116, P81, DOI 10.1016/S0306-4522(02)00547-X; Novy J, 2006, ARCH NEUROL-CHICAGO, V63, P1113, DOI 10.1001/archneur.63.8.1113; PHILLIS JW, 1994, BRAIN RES BULL, V34, P457, DOI 10.1016/0361-9230(94)90019-1; Rossi DJ, 2000, NATURE, V403, P316, DOI 10.1038/35002090; ROTHSTEIN JD, 1994, NEURON, V13, P713, DOI 10.1016/0896-6273(94)90038-8; Rothstein JD, 1996, NEURON, V16, P675, DOI 10.1016/S0896-6273(00)80086-0; Shimamoto K, 1998, MOL PHARMACOL, V53, P195, DOI 10.1124/mol.53.2.195; Tanaka E, 1997, J NEUROPHYSIOL, V78, P891, DOI 10.1152/jn.1997.78.2.891; Tao F, 2004, NEUROSCIENCE, V123, P1045, DOI 10.1016/j.neuroscience.2003.11.026; Traul DE, 2007, LANCET ONCOL, V8, P35, DOI 10.1016/S1470-2045(06)71009-9; Yamamoto S, 1997, J NEUROPHYSIOL, V78, P903, DOI 10.1152/jn.1997.78.2.903; YOSHIMURA M, 1990, J PHYSIOL-LONDON, V430, P315, DOI 10.1113/jphysiol.1990.sp018293; Zerangue N, 1996, NATURE, V383, P634, DOI 10.1038/383634a0	34	8	8	0	1	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1744-8069			MOL PAIN	Mol. Pain	APR 25	2007	3								10	10.1186/1744-8069-3-10			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	166CH	WOS:000246354300001	17459156	Green Published, gold			2022-02-06	
J	Nomoto, J; Seiki, Y; Nemoto, M; Takahashi, H; Terashima, H; Yokota, K; Kondo, K; Kano, T; Goto, S; Sugo, N				Nomoto, Jun; Seiki, Yoshikatsu; Nemoto, Masaaki; Takahashi, Hiroshi; Terashima, Hiroshi; Yokota, Kyosuke; Kondo, Kosuke; Kano, Toshiyuki; Goto, Syozo; Sugo, Nobuo			Head trauma in female professional wrestlers	NEUROLOGIA MEDICO-CHIRURGICA			English	Article						head trauma; medical check; body mass index; female; wrestling	CEREBRAL CONCUSSION; GUIDELINES; INJURIES; SPORTS; MANAGEMENT; BOXERS; AUSTRALIA; VICTORIA; RETURN; BRAIN	The clinical characteristics of head trauma were evaluated in 18 wrestlers belonging to a female professional wrestling organization, 13 regular members and five trainees aged 15-34 years. Medical examinations for head trauma were performed in all wrestlers, and wrestlers treated at our emergency outpatient department were clinically evaluated. In addition, the relationships of head trauma with duration of the wrestling career of 1-16 years (mean 8 years) in the regular members, and less than 1 year in the five trainees, and body mass index (BMI) of 21.0-32.0 in the 16 subjects, excluding two trainees, was evaluated. Chronic symptoms were noted in four of the 18 wrestlers with long wrestling careers (16 years in 1, 13 years in 1, and 5 years in 2). Three wrestlers with symptoms immediately after head trauma showed recurrent retrograde amnesia and had low BMI (21.6, 21.6, and 23.1). Five wrestlers were treated at our emergency outpatient clinic, three required hospitalization and two showed intracranial traumatic changes on computed tomography (acute subdural hematoma in 1 and diffuse brain swelling in 1). Head trauma in female professional wrestlers is associated with longer wrestling career and low BMI. Periodic medical examinations are recommended to monitor for signs of head trauma.	Toho Univ, Dept Neurosurg, Omori Med Ctr, Ota Ku, Tokyo 1430015, Japan; Toho Univ, Dept Orthoped Surg, Tokyo 1430015, Japan		Nomoto, J (corresponding author), Toho Univ, Dept Neurosurg, Omori Med Ctr, Ota Ku, 6-11-1 Omori Nishi, Tokyo 1430015, Japan.						Boden BP, 2002, AM J SPORT MED, V30, P791, DOI 10.1177/03635465020300060601; Burke DT, 2003, BRIT J SPORT MED, V37, P401, DOI 10.1136/bjsm.37.5.401; CANTU RC, 1986, PHYSICIAN SPORTSMED, V14, P75, DOI 10.1080/00913847.1986.11709197; Cantu RC, 1998, CLIN SPORT MED, V17, P37, DOI 10.1016/S0278-5919(05)70059-4; Cantu RC, 1998, CLIN SPORT MED, V17, P45, DOI 10.1016/S0278-5919(05)70060-0; Critchley GR, 1999, BRIT J SPORT MED, V33, P174, DOI 10.1136/bjsm.33.3.174; Dane S, 2002, PERCEPT MOTOR SKILL, V95, P329, DOI 10.2466/pms.2002.95.1.329; GUTERMAN A, 1987, SPORTS MED, V4, P194, DOI 10.2165/00007256-198704030-00004; HAGA D, 2003, NEUROTRAUMA RES, V15, P45; JORDAN B, 1998, SPORTS NEUROLOGY, P277; Kelly JP, 1998, J HEAD TRAUMA REHAB, V13, P53, DOI 10.1097/00001199-199804000-00008; KELLY JP, 1991, JAMA-J AM MED ASSOC, V266, P2867, DOI 10.1001/jama.266.20.2867; Leclerc S, 1999, BRIT J SPORT MED, V33, P426, DOI 10.1136/bjsm.33.6.426; MAWDSLEY C, 1963, LANCET, V186, P799; McCrea M, 2002, NEUROSURGERY, V50, P1032, DOI 10.1097/00006123-200205000-00017; McCrea M, 2001, J ATHL TRAINING, V36, P274; McCrory P, 2002, BRIT J SPORT MED, V36, P2, DOI 10.1136/bjsm.36.1.2; McCrory P, 2001, BRIT J SPORT MED, V35, P380, DOI 10.1136/bjsm.35.6.380; Nakaguchi H, 1999, J TRAUMA, V46, P1066, DOI 10.1097/00005373-199906000-00017; Ohhashi G, 2002, BRIT J SPORT MED, V36, P346, DOI 10.1136/bjsm.36.5.346; Oliaro S, 2001, J ATHL TRAINING, V36, P257; PUDENZ RH, 1946, J NEUROSURG, V3, P487, DOI 10.3171/jns.1946.3.6.0487; Zazryn TR, 2003, BRIT J SPORT MED, V37, P448, DOI 10.1136/bjsm.37.5.448; Zazryn TR, 2003, BRIT J SPORT MED, V37, P321, DOI 10.1136/bjsm.37.4.321; Zhang LJ, 2003, AM J NEURORADIOL, V24, P52; 2000, NIKKAN SPORTS N 0420	26	8	8	0	1	JAPAN NEUROSURGICAL SOC	TOKYO	C/O AKAMON-MAE IWATA BLDG, 5-27-8 HONGO, BUNKYO-KU, TOKYO, 113-0033, JAPAN	0470-8105			NEUROL MED-CHIR	Neurol. Med.-Chir.	APR	2007	47	4					147	151		10.2176/nmc.47.147			5	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	157NN	WOS:000245727000001	17457017	Bronze			2022-02-06	
S	Panourias, IG; Themistocleous, M; Sakas, DE		Sakas, DE; Simpson, BA; Krames, ES		Panourias, I. G.; Themistocleous, M.; Sakas, D. E.			Intrathecal baclofen in current neuromodulatory practice: established indications and emerging applications	OPERATIVE NEUROMODULATION, VOL 1: FUNCTIONAL NEUROPROSTHETIC SURGERY, AN INTRODUCTION	Acta Neurochirurgica Supplementum		English	Article; Book Chapter						Neuromodulation; spasticity; hypertonia; pain; intrathecal baclofen therapy; spinal injury; head injury; multiple sclerosis; cerebral palsy; vegetative state	TRAUMATIC BRAIN-INJURY; ALLEVIATES AUTONOMIC DYSFUNCTION; AMYOTROPHIC-LATERAL-SCLEROSIS; SEVERE SPINAL SPASTICITY; TERM-FOLLOW-UP; CEREBRAL-PALSY; INTRACTABLE SPASTICITY; ADMINISTERED BACLOFEN; MULTIPLE-SCLEROSIS; PROGRAMMABLE PUMP	Intrathecal baclofen (ITB) has evolved into a standard treatment for severe spasticity of both spinal and cerebral origin. The accumulated promising data from reported series of patients receiving ITB therapy together with the fact that spastic hypertonia commonly coexists with other neurological disorders have constituted a solid basis for offering this kind of treatment to patients suffering from other movement disorders. These include motor disorders such as dystonia, amyotrophic lateral sclerosis, status dystonicus, Hallervorden-Spatz disease, Freidreich's ataxia, "stiff-man'' syndrome, but also vegetative states after severe brain trauma, anoxic encephalopathy or other pathology and more recently, various chronic pain syndromes. In this article, on the basis of the established applications of ITB therapy, we review the important emerging indications of this rewarding neuromodulation method and attempt to identify its future potential beneficial role in other chronic and otherwise refractory neurological disorders.	[Panourias, I. G.; Themistocleous, M.; Sakas, D. E.] PS Kokkalis Hellen Ctr Neurosurg Res, Athens 10675, Greece		Sakas, DE (corresponding author), PS Kokkalis Hellen Ctr Neurosurg Res, 3 Ploutarchou Str, Athens 10675, Greece.	sakasde@med.uoa.gr					ALBRIGHT AL, 1991, JAMA-J AM MED ASSOC, V265, P1418, DOI 10.1001/jama.265.11.1418; Albright AL, 2003, J NEUROSURG, V98, P291, DOI 10.3171/jns.2003.98.2.0291; ALBRIGHT AL, 1993, JAMA-J AM MED ASSOC, V270, P2475, DOI 10.1001/jama.270.20.2475; Albright AL, 2001, DEV MED CHILD NEUROL, V43, P652, DOI 10.1017/S0012162201001190; AMANO M, 1993, N-S ARCH PHARMACOL, V348, P146, DOI 10.1007/BF00164791; Armstrong RW, 1997, J NEUROSURG, V87, P409, DOI 10.3171/jns.1997.87.3.0409; ASHWORTH B, 1964, PRACTITIONER, V192, P540; Azouvi P, 1996, ARCH PHYS MED REHAB, V77, P35, DOI 10.1016/S0003-9993(96)90217-8; Baguley IJ, 1999, J NEUROL NEUROSUR PS, V67, P39, DOI 10.1136/jnnp.67.1.39; Barnes Michael P., 2001, Age and Ageing, V30, P13; Barry MJ, 2000, PEDIAT PHYS THER, V12, P77; Becker R, 1999, J NEUROL NEUROSUR PS, V66, P114, DOI 10.1136/jnnp.66.1.114; Becker R, 2000, J CLIN NEUROSCI, V7, P316, DOI 10.1054/jocn.1999.0227; Becker R, 1997, J NEUROL, V244, P160, DOI 10.1007/s004150050067; Boeve BF, 1998, MAYO CLIN PROC, V73, P148; BOHANNON RW, 1987, PHYS THER, V67, P206, DOI 10.1093/ptj/67.2.206; Boviatsis EJ, 2005, CLIN NEUROL NEUROSUR, V107, P289, DOI 10.1016/j.clineuro.2004.09.007; Bowery NG, 2002, PHARMACOL REV, V54, P247, DOI 10.1124/pr.54.2.247; BOWERY NG, 1993, ANNU REV PHARMACOL, V33, P109, DOI 10.1146/annurev.pa.33.040193.000545; Burns AS, 2001, SPINAL CORD, V39, P413, DOI 10.1038/sj.sc.3101178; CAMPBELL SK, 1995, PHYS THER, V75, P352, DOI 10.1093/ptj/75.5.352; Carswell Anne, 2004, Can J Occup Ther, V71, P210; Coffey RJ, 2002, ARCH PHYS MED REHAB, V83, P735, DOI 10.1053/apmr.2002.32820; Cuny E, 2001, BRAIN INJURY, V15, P917, DOI 10.1080/02699050110065277; DONES I, 2006, ACTA NEUR S IN PRESS; DYKSTRA D, 2006, ACTA NEUR S IN PRESS; Dykstra DD, 2005, ARCH PHYS MED REHAB, V86, P830, DOI 10.1016/j.apmr.2004.11.001; FANN S, 1988, ADV NEUROL, V50, P1; FOX S, 1978, NEUROSCIENCE, V3, P495, DOI 10.1016/0306-4522(78)90016-7; Francisco GE, 2001, STROKE, V32, P2108; Gatscher S, 2002, ACT NEUR S, V79, P75; Gerszten PC, 1998, J NEUROSURG, V88, P1009, DOI 10.3171/jns.1998.88.6.1009; Gianino J M, 1998, J Neurosci Nurs, V30, P47; Grabb PA, 1999, NEUROSURGERY, V45, P833, DOI 10.1097/00006123-199910000-00020; GRADES JM, 1997, MUSCLE NERVE       S, V6, pS92; Guillaume D, 2005, ARCH PHYS MED REHAB, V86, P2165, DOI 10.1016/j.apmr.2005.05.018; Hagglund G, 2005, J PEDIATR ORTHOP B, V14, P269; HERMAN RM, 1992, CLIN J PAIN, V8, P338, DOI 10.1097/00002508-199212000-00008; Horn TS, 2005, ARCH PHYS MED REHAB, V86, P1127, DOI 10.1016/j.apmr.2004.11.013; Ivanhoe CB, 2004, AM J PHYS MED REHAB, V83, pS3, DOI 10.1097/01.PHM.0000141125.28611.3E; KENDALL DA, 1982, J PHARMACOL EXP THER, V220, P482; KROIN JS, 1993, NEUROSURGERY, V33, P226; KROIN JS, 1991, PARENTERAL DRUG THER, P73; Kyriagis M, 2004, J PAEDIATR CHILD H, V40, P322, DOI 10.1111/j.1440-1754.2004.00374.x; Lance J.W., 1980, SPASTICITY DISORDERE, P485; Law M, 1990, Can J Occup Ther, V57, P82; LEVY RA, 1979, EUR J PHARMACOL, V57, P43, DOI 10.1016/0014-2999(79)90102-X; Lind G, 2004, EUR J PAIN, V8, P377, DOI 10.1016/j.ejpain.2003.11.002; LIND G, 2006, ACTA NEUR S IN PRESS; Loubser PG, 1996, J PAIN SYMPTOM MANAG, V12, P241, DOI 10.1016/0885-3924(96)00152-2; Marquardt G, 2002, J NEUROL NEUROSUR PS, V72, P275, DOI 10.1136/jnnp.72.2.275; Marquardt G, 1999, J NEUROL, V246, P619, DOI 10.1007/s004150050417; Mayer N.H., 2002, SPASTICITY ETIOLOGY, P1; *MEDTR, 2002, UC19961184CENNP2584C; Meythaler JM, 1999, ARCH PHYS MED REHAB, V80, P13, DOI 10.1016/S0003-9993(99)90301-5; Meythaler JM, 1999, AM J PHYS MED REHAB, V78, P247, DOI 10.1097/00002060-199905000-00012; MEYTHALER JM, 1992, AM J PHYS MED REHAB, V71, P321, DOI 10.1097/00002060-199212000-00003; MEYTHALER JM, 1992, ARCH PHYS MED REHAB, V73, P794; Meythaler JM, 2001, ARCH PHYS MED REHAB, V82, P155, DOI 10.1053/apmr.2001.19246; Meythaler JM, 2001, STROKE, V32, P2099, DOI 10.1161/hs0901.095682; Meythaler JM, 1996, ARCH PHYS MED REHAB, V77, P461, DOI 10.1016/S0003-9993(96)90034-9; Middleton JW, 1996, ARCH PHYS MED REHAB, V77, P824, DOI 10.1016/S0003-9993(96)90264-6; Molteni F, 2005, AM J PHYS MED REHAB, V84, P303, DOI 10.1097/01.PHM.0000156892.04239.B6; Murphy NA, 2002, ARCH PHYS MED REHAB, V83, P1721, DOI 10.1053/apmr.2002.36068; OCHS G, 1989, J NEUROL NEUROSUR PS, V52, P933, DOI 10.1136/jnnp.52.8.933; Ordia JI, 2002, NEUROMODULATION, V5, P16, DOI 10.1046/j.1525-1403.2002._2004.x; PENN RD, 1985, LANCET, V2, P125; PENN RD, 1984, LANCET, V1, P1078; PENN RD, 1989, NEW ENGL J MED, V320, P1517, DOI 10.1056/NEJM198906083202303; PETROPOULOU K, 2006, ACTA NEUR S IN PRESS; Plassat R, 2004, SPINAL CORD, V42, P686, DOI 10.1038/sj.sc.3101647; Pohl M, 2003, J NEUROL, V250, P1195, DOI 10.1007/s00415-003-0178-1; Remy-Neris O, 2003, ARCH PHYS MED REHAB, V84, P643, DOI 10.1016/S0003-9993(02)04906-7; Ridley B, 2006, REHABIL NURS, V31, P158, DOI 10.1002/j.2048-7940.2006.tb00381.x; SAITO K, 1975, BRAIN RES, V97, P177, DOI 10.1016/0006-8993(75)90928-2; Sallerin B, 2003, NEUROCHIRURGIE, V49, P271; SAWYNOK J, 1986, BRAIN RES, V386, P341, DOI 10.1016/0006-8993(86)90171-X; Shakespeare DT, 2001, COCHRANE COLLABORATI; SILBERT PL, 1995, NEUROLOGY, V45, P1893, DOI 10.1212/WNL.45.10.1893; Sitaram BR, 1997, INT J PHARMACEUT, V153, P13, DOI 10.1016/S0378-5173(97)04926-0; Slonimski M, 2004, REGION ANESTH PAIN M, V29, P269, DOI 10.1016/j.rapm.2004.01.005; SMAIL DB, 2005, MOVEMENT DISORD, V20, P758; Stempien L, 2000, AM J PHYS MED REHAB, V79, P536, DOI 10.1097/00002060-200011000-00010; Taira T, 1995, STEREOT FUNCT NEUROS, V65, P101, DOI 10.1159/000098905; TAIRA T, 2006, ACTA NEUR S IN PRESS; Takenaka K., 1995, Clinical and Experimental Pharmacology and Physiology, V22, pS48, DOI 10.1111/j.1440-1681.1995.tb02966.x; TSUI M, 1992, Australian Journal of Hospital Pharmacy, V22, P258; Turner MS, 2003, ACT NEUR S, V87, P81; Van Hilten BJ, 2000, NEW ENGL J MED, V343, P625, DOI 10.1056/NEJM200008313430905; Vasconcelos Olavo M., 2003, Curr Treat Options Neurol, V5, P79, DOI 10.1007/s11940-003-0024-x; VATINE JJ, 1989, PAIN CLINIC, V2, P207; VLOEBERGHS M, 2002, ADV CLIN NEUROSCI RE, V2, P11; Walker RH, 2000, MOVEMENT DISORD, V15, P1242, DOI 10.1002/1531-8257(200011)15:6<1242::AID-MDS1028>3.0.CO;2-Z; WILSON PR, 1978, EUR J PHARMACOL, V51, P323, DOI 10.1016/0014-2999(78)90423-5; Zahavi A, 2004, J NEUROL NEUROSUR PS, V75, P1553, DOI 10.1136/jnnp.2003.014282; ZHANG SLJ, 1993, SCIENCE, V259, P531, DOI 10.1126/science.8380942; Zuniga RE, 2002, REGION ANESTH PAIN M, V27, P90, DOI 10.1053/rapm.2002.29244; Zuniga RE, 2000, ANESTHESIOLOGY, V92, P876, DOI 10.1097/00000542-200003000-00037	98	8	11	0	1	SPRINGER	NEW YORK	233 SPRING STREET, NEW YORK, NY 10013, UNITED STATES	0065-1419		978-3-211-33079-1	ACTA NEUROCHIR SUPPL	Acta Neurochir. Suppl.		2007	97		1				145	154			10.1007/978-3-211-33079-1		10	Clinical Neurology; Neurosciences; Surgery	Book Citation Index – Science (BKCI-S)	Neurosciences & Neurology; Surgery	BNJ32	WOS:000274733900021	17691370				2022-02-06	
J	Xu, XY; Liu, WG; Yang, XF; Li, LQ				Xu, Xiao Yan; Liu, Wei Guo; Yang, Xiao Feng; Li, Lei Qing			Evaluation of models that predict short-term outcome after traumatic brain injury	BRAIN INJURY			English	Article						traumatic brain injury; short-term outcome; prediction	CEREBRAL-BLOOD-FLOW; HEAD-INJURY; SURVIVAL	Primary objective: This study aimed to identify models that predicted the short-term outcome after traumatic brain injury (TBI) from the literature and to evaluate their clinical significance. Methods: Literatures from PubMED were reviewed. Regression coefficients and intercepts were extracted. A group of 229 cases was used for validation and the unfavourable rate was calculated to assess the validity of these models by the area under receiver operating. Characteristic curve (AUC), C-statistic and Brier score. Main Results: In total, 13 studies of 18 different models were included. Data from the validation group were in accordance with the indicators of the studies reviewed. All models got an AUC value ranging from 0.644 - 0.890 except two (AUC value < 0.6) and their Brier scores were near zero. However, the calibration of most studies was insufficient ( p< 0.05). Conclusions: Most of the models included in this study have a good discriminatory power while lacking sufficient calibration. However, they all predict with relative accuracy at the level of individuals. Therefore, current models can be used to predict the survival rate of individual patients and may be useful to inform patients and relatives about the likelihood of a beneficial outcome.	Zhejiang Univ, Sch Med, Affilliated Hosp 2, Sch Med,Dept Intens Care Unit, Hangzhou 310009, Zhejiang, Peoples R China; Zhejiang Univ, Sch Med, Affilliated Hosp 2, Sch Med,Dept Neurosurg, Hangzhou 310009, Zhejiang, Peoples R China		Li, LQ (corresponding author), Zhejiang Univ, Sch Med, Affilliated Hosp 2, Sch Med,Dept Intens Care Unit, Hangzhou 310009, Zhejiang, Peoples R China.	lileiqing_0912@163.com					Afessa B, 2003, CRIT CARE MED, V31, P1715, DOI 10.1097/01.CCM.0000065761.51367.2D; Ariesen MJ, 2005, J NEUROL NEUROSUR PS, V76, P839, DOI 10.1136/jnnp.2004.048223; Bahloul M, 2004, J TRAUMA, V57, P255, DOI 10.1097/01.TA.0000083004.35231.1E; Brier GW, 1950, MON WEATHER REV, V78, P1, DOI DOI 10.1175/1520-0493(1950)078<0001:VOFEIT>2.0.CO;2; d'Avella D, 2003, ACTA NEUROCHIR, V145, P1037, DOI 10.1007/s00701-003-0150-y; den Boer S, 2005, CRIT CARE, V9, pR458, DOI 10.1186/cc3765; Dimopoulou I, 2004, INTENS CARE MED, V30, P1216, DOI 10.1007/s00134-004-2297-2; Hukkelhoven CWPM, 2003, J NEUROSURG, V99, P666, DOI 10.3171/jns.2003.99.4.0666; JAGGI JL, 1990, J NEUROSURG, V72, P176, DOI 10.3171/jns.1990.72.2.0176; KLAUBER MR, 1989, NEUROSURGERY, V24, P31, DOI 10.1227/00006123-198901000-00005; Lee JH, 1997, J NEUROSURG, V87, P221, DOI 10.3171/jns.1997.87.2.0221; Mamelak AN, 1996, J TRAUMA, V41, P91, DOI 10.1097/00005373-199607000-00014; MICHAUD LJ, 1992, NEUROSURGERY, V31, P254, DOI 10.1227/00006123-199208000-00010; Pillai SV, 2003, NEUROL INDIA, V51, P345; ROBERTSON CS, 1992, J NEUROL NEUROSUR PS, V55, P594, DOI 10.1136/jnnp.55.7.594; Rovlias A, 2001, SURG NEUROL, V55, P190, DOI 10.1016/S0090-3019(01)00414-1; Signorini DF, 1999, J NEUROL NEUROSUR PS, V66, P20, DOI 10.1136/jnnp.66.1.20; Tan H, 2001, Chin J Traumatol, V4, P156; Wiedemayer H, 2002, BRAIN INJURY, V16, P323, DOI 10.1080/02699050110102077	19	8	8	0	2	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2007	21	6					575	582		10.1080/02699050701426881			8	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	192LU	WOS:000248204100004	17577708				2022-02-06	
J	Leroy-Malherbe, V; Bonnier, C; Papiernik, E; Groos, E; Landrieu, P				Leroy-Malherbe, V.; Bonnier, C.; Papiernik, E.; Groos, E.; Landrieu, P.			The association between developmental handicaps and traumatic brain injury during pregnancy: An issue that deserves more systematic evaluation	BRAIN INJURY			English	Article						fetus; brain injury; developmental handicap	MATERNAL TRAUMA; FETAL TRAUMA; FETOMATERNAL HEMORRHAGE; ABDOMINAL-TRAUMA; SPLENIC RUPTURE; CEREBRAL-PALSY	Aims: Trauma during pregnancy is commonly viewed as benign for the foetus when the delivery occurs normally. This study revisits that point of view. Method: We included eighteen patients having a neurological handicap with an anamnesis of an accident during pregnancy and a follow-up sufficient to determine a definite outcome. Results: Pregnancy outcome and observed management. Foetal abnormalities were detected in six cases between the first and the thirteenth day after the trauma. Emergency delivery or rapid birth after signs of foetal distress occurred in five cases. One baby died soon after birth. One-third of cases were not submitted to any investigation. Various neurological handicaps were recorded: Congenital microcephaly (three patients), congenital hydrocephalus (three), Infantile cerebral hemiplegy (six), quadriplegy with severe encephalopathy (four), diplegy (one), clumsiness with cerebellar atrophy (one), Moebius syndrome (one), mental retardation with autistic features (two), learning disability (one) auditory agnosia (one). Cerebral imaging showed macroscopic abnormalities in fourteen patients, evoking various pathogenetic hypotheses. Conclusion: The association between maternal trauma and foetal brain lesions lacks sufficient investigation in many cases. Prospective studies are needed to clarify both medical and legal issues. Guidelines are proposed for obstetrical and paediatric management after significant maternal trauma.	Hop Bicetre, Serv Neurol Pediat, F-94275 Le Kremlin Bicetre, France; Catholic Univ Louvain, Clin St Luc, Serv Neurol Pediat, Brussels, Belgium; Univ Paris 05, F-75014 Paris, France; Hop Natl St Maurice, Ctr Ressources Enfant Les Cerebrale Acquise, F-94275 St Maurice, France		Landrieu, P (corresponding author), Hop Bicetre, Serv Neurol Pediat, 78 Rue Gen Leclerc, F-94275 Le Kremlin Bicetre, France.	pierre.landrieu@bct.aphp.fr					AHMED SAA, 1998, J GYNECOL OBST BIO R, V27, P825; AICARDI J, 1981, NEUROPEDIATRICS, V12, P319, DOI 10.1055/s-2008-1059664; Anquist K. Warren, 1994, Obstetrics and Gynecology, V84, P656; Baethmann M, 1996, ACTA PAEDIATR, V85, P1331, DOI 10.1111/j.1651-2227.1996.tb13920.x; BARKOVICH AJ, 1992, AM J NEURORADIOL, V13, P85; Bonnier C, 2002, BRAIN PATHOL, V12, P320; Breysem L, 2004, EUR RADIOL, V14, P1609, DOI 10.1007/s00330-004-2357-6; Connolly AM, 1997, AM J PERINAT, V14, P331, DOI 10.1055/s-2007-994155; EATON DGM, 1991, BRIT J OBSTET GYNAEC, V98, P1292, DOI 10.1111/j.1471-0528.1991.tb15406.x; Ewing-Cobbs L, 1999, PEDIATR NEUROSURG, V31, P251, DOI 10.1159/000028872; FARMER DL, 1990, J PEDIATR SURG, V25, P711, DOI 10.1016/S0022-3468(05)80002-8; FIELD DR, 1998, JAMA-J AM MED ASSOC, V260, P820; Gilles MT, 1996, MED J AUSTRALIA, V164, P500, DOI 10.5694/j.1326-5377.1996.tb122138.x; GOODWIN TM, 1990, AM J OBSTET GYNECOL, V162, P665, DOI 10.1016/0002-9378(90)90979-H; GREISS FC, 1996, OBSTET GYNECOLOGY, V27, P49; HELTON AS, 1987, AM J PUBLIC HEALTH, V77, P1337, DOI 10.2105/AJPH.77.10.1337; HIGGINS SD, 1984, OBSTET GYNECOL, V63, pS10; Karimi Prameela, 2004, J Perinatol, V24, P454, DOI 10.1038/sj.jp.7211143; Krabchi K, 2001, CLIN GENET, V60, P145, DOI 10.1034/j.1399-0004.2001.600209.x; LAVIN JP, 1983, CLIN PERINATOL, V10, P423, DOI 10.1016/S0095-5108(18)30976-X; Lipitz S, 1997, EUR J OBSTET GYN R B, V71, P21, DOI 10.1016/S0301-2115(96)02607-3; Lipson AH, 1996, EUR J PEDIATR, V155, P800, DOI 10.1007/s004310050491; Morris JA, 1996, ANN SURG, V223, P481, DOI 10.1097/00000658-199605000-00004; MOSTELLO DJ, 1990, P 10 ANN M SOC PER O; MYERS RE, 1975, AM J OBSTET GYNECOL, V122, P47, DOI 10.1016/0002-9378(75)90614-6; Occelli B, 1998, CONTRACEPT FERTIL S, V26, P869; Pak LL, 1998, AM J OBSTET GYNECOL, V179, P1140, DOI 10.1016/S0002-9378(98)70121-8; PARKER B, 1994, OBSTET GYNECOL, V84, P323; PATTERSON RM, 1984, CLIN OBSTET GYNECOL, V27, P32, DOI 10.1097/00003081-198403000-00007; PEARLMAN MD, 1990, AM J OBSTET GYNECOL, V162, P1502, DOI 10.1016/0002-9378(90)90913-R; PEARLMAN MD, 1990, NEW ENGL J MED, V323, P1609; PEARLMAN MD, 1991, OBSTET GYN CLIN N AM, V18, P371; PECKHAM CH, 1963, AM J OBSTET GYNECOL, V87, P609, DOI 10.1016/0002-9378(63)90055-3; Peleg D, 1998, EUR J OBSTET GYN R B, V80, P175, DOI 10.1016/S0301-2115(98)00128-6; ROSE D, 1990, AM J OBSTET GYNECOL, V76, P974; ROTHENBERGER D, 1978, J TRAUMA, V18, P173, DOI 10.1097/00005373-197803000-00004; ROTHENBERGER DA, 1981, J PEDIATR SURG, V16, P754, DOI 10.1016/S0022-3468(81)80573-8; Sebire G, 1996, J NEUROL NEUROSUR PS, V61, P52, DOI 10.1136/jnnp.61.1.52; Shah KH, 1998, J TRAUMA, V45, P83, DOI 10.1097/00005373-199807000-00018; SOKAL MM, 1980, J REPROD MED, V24, P131; STAFFORD PA, 1988, AM J OBSTET GYNECOL, V159, P485, DOI 10.1016/S0002-9378(88)80115-7; TOSHIYUKI Y, 1999, BRAIN DEV, V21, P334	42	8	10	0	7	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	DEC	2006	20	13-14					1355	1365		10.1080/02699050601102202			11	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	130GF	WOS:000243787100005	17378227				2022-02-06	
J	Loftspring, MC; Beiler, S; Beiler, C; Wagner, KR				Loftspring, Matthew C.; Beiler, Shauna; Beiler, Christian; Wagner, Kenneth R.			Plasma proteins in edematous white matter after intracerebral hemorrhage confound immunoblots: An ELISA to quantify contamination	JOURNAL OF NEUROTRAUMA			English	Article						blood-brain barrier; immunoblots; stroke; traumatic brain injury; vascular injury	BLOOD-BRAIN-BARRIER; INJURY; TRAUMA; STROKE; DAMAGE; MODEL	Intracerebral hemorrhage (ICH) and traumatic brain injury can induce brain tissue edema (i.e., interstitial and/or vasogenic), containing high concentrations of plasma proteins. To understand biochemical processes in edema development following these insults, it would be useful to examine alterations in various proteins (e.g., transcription factors, signaling). However, determining altered protein responses in edematous brain tissue using standard immunoblotting techniques is problematic due to contaminating plasma proteins. To solve this problem, we developed an enzyme-linked immunosorbent assay (ELISA) method to quantify the two major plasma proteins, albumin and immunoglobulin G (IgG), that comprise about 80% of the total plasma proteins. We tested our method on edematous white matter samples from our porcine ICH model. To induce ICH, we infused autologous arterial whole blood (3 mL) into frontal hemispheric white matter of pentobarbital-anesthetized pigs (similar to 20 kg) over 15 min. We froze brains in situ at various times up to 24 h post-ICH and sampled white matter adjacent and contralateral to hematomas. We prepared cytoplasmic extracts that we subjected to ELISA and immunoblotting analyses. Our results demonstrate that this ELISA method is accurate, reproducible, and enables the concentrations of albumin and IgG in edematous brain tissue samples to be accurately determined. By using this correction method, equal amounts of cellular protein can be loaded onto gels during immunoblotting procedures. This method is applicable to edematous tissue samples in brain injury models in which high plasma protein concentrations result from interstitial or vasogenic edema development.	Dept Vet Affairs Med Ctr, Med Res Serv, Cincinnati, OH USA; Univ Cincinnati, Coll Med, Dept Neurol, Cincinnati, OH USA; Univ Cincinnati, Coll Med, Grad Program Neurosci, Cincinnati, OH USA		Wagner, KR (corresponding author), Vet Affairs Med Ctr, 3200 Vine St, Cincinnati, OH 45220 USA.	wagnerkr@uc.edu			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS030652] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [5R01NS030652-11] Funding Source: Medline		Aronowski J, 2005, NEUROL RES, V27, P268, DOI 10.1179/016164105X25225; Bethea JR, 1998, J NEUROSCI, V18, P3251; BRODERICK JP, 1993, STROKE, V24, P987, DOI 10.1161/01.STR.24.7.987; Budka H, 1991, BRAIN PATHOL, V1, P163, DOI 10.1111/j.1750-3639.1991.tb00656.x; Butcher KS, 2004, STROKE, V35, P1879, DOI 10.1161/01.STR.0000131807.54742.1a; DELBIGIO MR, 1993, ACTA NEUROPATHOL, V85, P573, DOI 10.1007/BF00334666; Dul K, 1994, INTRACEREBRAL HEMORR, P73; FOULKES MA, 1988, STROKE, V19, P547, DOI 10.1161/01.STR.19.5.547; GAY D, 1991, BRAIN, V114, P557, DOI 10.1093/brain/114.1.557; Gebel JM, 1998, STROKE, V29, P563, DOI 10.1161/01.STR.29.3.563; Hoff JT, 2003, ACT NEUR S, V86, P11; KALIMO H, 1994, ACTA NEUROL SCAND, V89, P353; KASE CCL, 1994, INTRACEREBRAL HEMORR; Keep RF, 2005, STROKE, V36, P1594, DOI 10.1161/01.STR.0000170701.41507.e1; LIU HM, 1988, FORENSIC SCI INT, V38, P285, DOI 10.1016/0379-0738(88)90174-0; LOFTSPRING MC, 2005, QUANTITATION CONTAMI; Lucchinetti CF, 2005, MULT SCLER, V11, P99, DOI 10.1177/135245850501100120; Perlman JM, 1998, EARLY HUM DEV, V53, P99, DOI 10.1016/S0378-3782(98)00037-1; Qureshi AI, 2001, NEW ENGL J MED, V344, P1450, DOI 10.1056/NEJM200105103441907; RHODES RH, 1991, J NEUROPATH EXP NEUR, V50, P171, DOI 10.1097/00005072-199103000-00008; RIBAS GC, 1992, J NEUROTRAUM, V9, pS265; Unterberg AW, 2004, NEUROSCIENCE, V129, P1021, DOI 10.1016/j.neuroscience.2004.06.046; Wagner KR, 1998, J NEUROSURG, V88, P1058, DOI 10.3171/jns.1998.88.6.1058; Wagner KR, 1996, STROKE, V27, P490, DOI 10.1161/01.STR.27.3.490; Wagner KR, 2003, J CEREBR BLOOD F MET, V23, P629, DOI 10.1097/01.WCB.0000073905.87928.6D; Wagner KR, 2005, CURR NEUROVASC RES, V2, P149, DOI 10.2174/1567202053586785; Wagner KR, 1999, J NEUROSURG, V90, P491, DOI 10.3171/jns.1999.90.3.0491; WAGNER KR, 2001, NEUROPROTECTION, P471; WAGNER KR, 2004, PHARM CEREBRAL ISCHE, P185; Wardlaw JM, 2003, STROKE, V34, P806, DOI 10.1161/01.STR.0000058480.77236.B3; Xi GH, 2003, J NEUROCHEM, V84, P3, DOI 10.1046/j.1471-4159.2003.01268.x; YAMANOUCHI H, 1991, ACTA NEUROL SCAND, V83, P301, DOI 10.1111/j.1600-0404.1991.tb04706.x	32	8	8	0	0	MARY ANN LIEBERT INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151			J NEUROTRAUM	J. Neurotrauma	DEC	2006	23	12					1904	1911		10.1089/neu.2006.23.1904			8	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	120AP	WOS:000243056100016	17184198				2022-02-06	
J	McCollum, AT; Jafarifar, F; Lynn, BC; Agu, RU; Stinchcomb, AL; Wang, S; Chen, QH; Guttmann, RP				McCollum, Adrian T.; Jafarifar, Faegheh; Lynn, Bert C.; Agu, Remigius U.; Stinchcomb, Audra L.; Wang, Susan; Chen, Qinghua; Guttmann, Rodney P.			Inhibition of calpain-mediated cell death by a novel peptide inhibitor	EXPERIMENTAL NEUROLOGY			English	Article						calcium; calpain; phage-display; cell death; peptide	FOCAL CEREBRAL-ISCHEMIA; IN-VITRO; CALPASTATIN; PROTEOLYSIS; RECEPTOR; BRAIN; HIPPOCAMPUS; ACTIVATION; SUBSTRATE; CASPASE-3	Calpains are calcium- and thiol-dependent proteases whose overactivation and degradation of various substrates have been implicated in a number of diseases and conditions such as cardiovascular dysfunction and ischemic stroke. With increasing evidence for calpain's role in cellular damage, the development of calpain inhibitors continues to be an important objective. Previously, we identified a highly specific calciumdependent, calpain interacting peptide L-S-E-A-L, that showed homology to domains A and C of the only known endogenous inhibitor of calpains, calpastatin. This suggested that LSEAL had a calpain inhibitory function and synthetic LSEAL inhibited calpain I and II proteolysis of two calpain substrates, tau and alpha-synuclein. In the present study, we demonstrate that synthetic LSEAL is membrane permeable and is a potent inhibitor in two established models of calpain-mediated cell death using primary rat cortical neurons and SH-SY5Y neuroblastoma cells. In addition, we show that LSEAL inhibits calpain activity towards protein substrates as detected by an antibody to a calpain-specific breakdown product of spectrin. Taken together, these results suggest that LSEAL may represent a novel calpastatin mimetic with the potential for benefit in conditions of increased calpain activity such as stroke, traumatic brain injury or heart attack. (C) 2006 Elsevier Inc. All rights reserved.	Florida A&M Univ, Dept Biol, Tallahassee, FL 32307 USA; Univ Kentucky, Dept Gerontol, Lexington, KY USA; Univ Kentucky, Dept Chem, Lexington, KY 40506 USA; Univ Kentucky, Dept Pharmaceut Sci, Lexington, KY USA; Dalhousie Univ, Coll Pharm, Halifax, NS B3H 3J5, Canada; Univ Kentucky, Dept Physiol, Lexington, KY USA; Univ Kentucky, Sanders Brown Ctr Aging, Lexington, KY 40536 USA		Guttmann, RP (corresponding author), Univ Kentucky, Dept Gerontol & Physiol, 800 S Limestone,Room 305 SB, Lexington, KY 40536 USA.	rodneyg@uky.edu	guttmann, rodney/AAN-8880-2021	guttmann, rodney/0000-0001-5553-3099; Lynn, Bert/0000-0001-8426-3024; AGU, REMIGIUS/0000-0001-6091-1840; Stinchcomb, Audra/0000-0001-7316-969X	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R21NS047635] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS047635] Funding Source: Medline		BARTUS RT, 1994, J CEREBR BLOOD F MET, V14, P537, DOI 10.1038/jcbfm.1994.67; BARTUS RT, 1995, NEUROL RES, V17, P249, DOI 10.1080/01616412.1995.11740322; BLOMGREN K, 1995, BRAIN RES, V684, P143, DOI 10.1016/0006-8993(95)00399-B; Blomgren K, 1999, ANN NY ACAD SCI, V890, P270, DOI 10.1111/j.1749-6632.1999.tb08002.x; Chemuturi NV, 2005, J PHARM SCI-US, V94, P1976, DOI 10.1002/jps.20404; DeRidder MN, 2006, NEUROBIOL DIS, V22, P165, DOI 10.1016/j.nbd.2005.10.011; Dutt P, 1998, FEBS LETT, V436, P367, DOI 10.1016/S0014-5793(98)01167-3; Goll DE, 2003, PHYSIOL REV, V83, P731, DOI 10.1152/physrev.00029.2002; Guttmann RP, 1998, J BIOL CHEM, V273, P13331, DOI 10.1074/jbc.273.21.13331; Guttmann RP, 1997, J BIOL CHEM, V272, P2005, DOI 10.1074/jbc.272.3.2005; Guttmann RP, 2005, BIOCHEM BIOPH RES CO, V333, P1087, DOI 10.1016/j.bbrc.2005.06.036; Guttmann RP, 2002, J PHARMACOL EXP THER, V302, P1023, DOI 10.1124/jpet.102.036962; Guttmann RP, 2001, J NEUROCHEM, V78, P1083, DOI 10.1046/j.1471-4159.2001.00493.x; HONG SC, 1994, STROKE, V25, P663, DOI 10.1161/01.STR.25.3.663; Huang YH, 2001, TRENDS MOL MED, V7, P355, DOI 10.1016/S1471-4914(01)02049-4; MA H, 1994, J BIOL CHEM, V269, P24430; MAKI M, 1987, FEBS LETT, V223, P174, DOI 10.1016/0014-5793(87)80531-8; Marcum JL, 2005, BIOCHEM BIOPH RES CO, V334, P342, DOI 10.1016/j.bbrc.2005.06.089; Markgraf CG, 1998, STROKE, V29, P152, DOI 10.1161/01.STR.29.1.152; McCollum AT, 2004, J NEUROSCI RES, V77, P552, DOI 10.1002/jnr.20184; McCollum AT, 2004, J NEUROSCI RES, V76, P104, DOI 10.1002/jnr.20059; McCollum AT, 2002, J NEUROCHEM, V82, P1208, DOI 10.1046/j.1471-4159.2002.01057.x; MELLONI E, 1989, TRENDS NEUROSCI, V12, P438, DOI 10.1016/0166-2236(89)90093-3; Minger SL, 1998, BRAIN RES, V810, P181, DOI 10.1016/S0006-8993(98)00921-4; Mishizen-Eberz AJ, 2003, J NEUROCHEM, V86, P836, DOI 10.1046/j.1471-4159.2003.01878.x; Moldoveanu T, 2002, CELL, V108, P649, DOI 10.1016/S0092-8674(02)00659-1; MURACHI T, 1981, ADV ENZYME REGUL, V19, P407; Neumar RW, 2001, EXP NEUROL, V170, P27, DOI 10.1006/exnr.2001.7708; Ohba H, 2003, CANCER CHEMOTH PHARM, V51, P451, DOI 10.1007/s00280-003-0607-y; Rackoff J, 2001, NEUROSCI LETT, V311, P129, DOI 10.1016/S0304-3940(01)02161-9; RAMI A, 1993, BRAIN RES, V609, P67, DOI 10.1016/0006-8993(93)90856-I; Robinson A, 1996, CAN MED ASSOC J, V154, P193; Sun AY, 1999, CLIN NEUROPHARMACOL, V22, P164; Tompa P, 2002, J BIOL CHEM, V277, P9022, DOI 10.1074/jbc.C100700200; Vanderklish PW, 2000, INT J EXP PATHOL, V81, P323, DOI 10.1111/j.1365-2613.2000.00169.x; Wang K K, 1997, Adv Pharmacol, V37, P117; Wang KKW, 2000, TRENDS NEUROSCI, V23, P20, DOI 10.1016/S0166-2236(99)01479-4; WANG KKW, 1990, TRENDS PHARMACOL SCI, V11, P139, DOI 10.1016/0165-6147(90)90060-L; Yadavalli R, 2004, J BIOL CHEM, V279, P21948, DOI 10.1074/jbc.M400793200; Zalewska T, 1996, FOLIA NEUROPATHOL, V34, P121	40	8	8	0	2	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4886			EXP NEUROL	Exp. Neurol.	DEC	2006	202	2					506	513		10.1016/j.expneurol.2006.07.016			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	106NJ	WOS:000242107300026	16956607				2022-02-06	
J	Rivera, PA; Elliott, TR; Berry, JW; Shewchuk, RM; Oswald, KD; Grant, J				Rivera, Patricia A.; Elliott, Timothy R.; Berry, Jack W.; Shewchuk, Richard M.; Oswald, Kimberly D.; Grant, Joan			Family caregivers of women with physical disabilities	JOURNAL OF CLINICAL PSYCHOLOGY IN MEDICAL SETTINGS			English	Article						caregiver; women; disability	PROBLEM-SOLVING ABILITIES; MAJOR DEPRESSIVE DISORDER; SELF-REPORT SCALE; MEMBER ADJUSTMENT; SYMPTOMS; STROKE; HEALTH; ILLNESS; SUPPORT; STRESS	Cross-sectional, correlational analyses of data from two separate studies were conducted to examine the correlates of adjustment among family caregivers of women with disabilities. Participants included 40 caregivers of women with spinal cord injuries in the first study and 53 caregivers of women with cerebral palsy, traumatic brain injury, and other neuromuscular disabilities in the second study. It was hypothesized that a negative problem-solving style would be associated with greater caregiver distress in both studies, and that caregiver adjustment would be associated with care recipient depression in the second study. As expected, results indicated that a higher negative orientation toward solving problems was associated with caregiver depression and lower well-being. However, in the second study, caregiver characteristics were not associated with care recipient depression. These data indicate that considerable variability exists in caregiver adjustment. Methodological limitations and the implications for research, service, and policy formation are! discussed.	Univ Alabama, Dept Psychol, Birmingham, AL 35294 USA		Rivera, PA (corresponding author), Univ Alabama, Dept Psychol, CH 415,1530 3rd Ave S, Birmingham, AL 35294 USA.	rivera@uab.edu	Elliott, Timothy R./I-5301-2012	Elliott, Timothy R./0000-0002-6608-7714; Grant, Joan/0000-0001-6000-4060	NICHD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01 HD037661, R01 HD037661-04, T32 HD007420] Funding Source: Medline; NCIPC CDC HHS [R49 CE000191] Funding Source: Medline		Aneshensel C. S., 1995, PROFILES CAREGIVING; Braddock D, 1999, MENT RETARD, V37, P155, DOI 10.1352/0047-6765(1999)037<0155:AADDDA>2.0.CO;2; Carey P J, 1991, Oncol Nurs Forum, V18, P1341; Chau N, 1994, Disabil Rehabil, V16, P63; Chwalisz K, 1996, REHABIL PSYCHOL, V41, P91, DOI 10.1037/0090-5550.41.2.91; CRAIG TJ, 1978, AM J PSYCHIAT, V135, P1036; D'Zurilla T.J., 2002, SOCIAL PROBLEM SOLVI; DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13; DODDS TA, 1993, ARCH PHYS MED REHAB, V74, P531, DOI 10.1016/0003-9993(93)90119-U; Donelan K, 2002, HEALTH AFFAIR, V21, P222, DOI 10.1377/hlthaff.21.4.222; Donelan K, 2001, WOMEN HEALTH ISS, V11, P185, DOI 10.1016/S1049-3867(01)00080-9; ELLIOTT T, CAREGIVING INDIVIDUA; Elliott TR, 1999, REHABIL PSYCHOL, V44, P104, DOI 10.1037/0090-5550.44.1.104; Elliott TR, 2001, J COUNS PSYCHOL, V48, P223, DOI 10.1037//0022-0167.48.2.223; FINE M, 1988, J SOC ISSUES, V44, P3, DOI 10.1111/j.1540-4560.1988.tb02045.x; FOLSTEIN MF, 1975, J PSYCHIATR RES, V12, P198; FRANK RG, 1992, PSYCHIAT RES, V43, P231, DOI 10.1016/0165-1781(92)90056-9; GRANGER CV, 1993, ARCH PHYS MED REHAB, V74, P133; Grant JS, 2001, REHABIL PSYCHOL, V46, P44, DOI 10.1037/0090-5550.46.1.44; Hanna W. J., 1991, DISABILITY HANDICAP, V6, P49, DOI DOI 10.1080/02674649166780041; Hoffman C, 1996, JAMA-J AM MED ASSOC, V276, P1473, DOI 10.1001/jama.276.18.1473; Hughes RB, 2005, ARCH PHYS MED REHAB, V86, P473, DOI 10.1016/j.apmr.2004.06.068; Kramer B., 1997, GERONTOLOGIST, V33, P240; Kurylo M, 2004, J CLIN PSYCHOL MED S, V11, P151, DOI 10.1023/B:JOCS.0000037609.23007.24; MOEN P, 1995, J HEALTH SOC BEHAV, V36, P259, DOI 10.2307/2137342; Navaie-Waliser M, 2002, AM J PUBLIC HEALTH, V92, P409, DOI 10.2105/AJPH.92.3.409; Nosek MA, 2003, REHABIL COUNS BULL, V46, P224, DOI 10.1177/003435520304600403; Nosek MA, 2003, SOC SCI MED, V56, P1737, DOI 10.1016/S0277-9536(02)00169-7; Nosek MA, 2001, SEX DISABIL, V19, P5, DOI 10.1023/A:1010716820677; OBERST MT, 1989, CANCER NURS, V12, P209; OSullivan RL, 1997, ACTA PSYCHIAT SCAND, V95, P379, DOI 10.1111/j.1600-0447.1997.tb09649.x; Parish SL, 2003, MENT RETARD, V41, P174, DOI 10.1352/0047-6765(2003)41<174:FSITUS>2.0.CO;2; Pennebaker JW., 1982, PSYCHOL PHYS SYMPTOM; Shewchuk R, 2000, HANDBOOK OF REHABILITATION PSYCHOLOGY, P553, DOI 10.1037/10361-026; Stein PN, 1996, CLIN NEUROPSYCHOL, V10, P141, DOI 10.1080/13854049608406674; *UN DAT SET MED RE, 1996, GUID US UN DAT SET M; Vitaliano PP, 2004, CURR DIR PSYCHOL SCI, V13, P13, DOI 10.1111/j.0963-7214.2004.01301004.x; Vitaliano PP, 2003, PSYCHOL BULL, V129, P946, DOI 10.1037/0033-2909.129.6.946; Ware J.E., 1993, SF 36 HLTH SURVEY MA; ZIMMERMAN M, 1987, J CONSULT CLIN PSYCH, V55, P55, DOI 10.1037/0022-006X.55.1.55; ZIMMERMAN M, 1986, ARCH GEN PSYCHIAT, V43, P1076; ZIMMERMAN M, 1986, J NERV MENT DIS, V174, P150, DOI 10.1097/00005053-198603000-00004; [No title captured]	43	8	8	1	5	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1068-9583			J CLIN PSYCHOL MED S	J. Clin. Psychol. Med. Settings	DEC	2006	13	4					431	440		10.1007/s10880-006-9043-6			10	Psychology, Clinical	Social Science Citation Index (SSCI)	Psychology	096TU	WOS:000241400500010	18716670	Green Accepted			2022-02-06	
J	Splavski, B; Radanovic, B; Muzevic, D; Has, B; Janculjak, D; Kristek, J; Jukic, D				Splavski, Bruno; Radanovic, Branko; Muzevic, Dario; Has, Borislav; Janculjak, Davor; Kristek, Jozo; Jukic, Dubravko			Assessment of intra-cranial pressure after severe traumatic brain injury by transcranial Doppler ultrasonography	BRAIN INJURY			English	Article						ultrasonography; Doppler; brain injuries; intracranial pressure	CEREBRAL-BLOOD-FLOW; ACUTE HEAD-INJURY; PERFUSION-PRESSURE; VELOCITY; ULTRASOUND; ISCHEMIA; HYPERTENSION; PATHOPHYSIOLOGY; SONOGRAPHY; RABBITS	Primary objective: To investigate the potential of transcranial Doppler ultrasonography in estimating post-traumatic intra-cranial pressure early after severe traumatic brain injury. Research design: The group of 24 patients was analysed for the observation of an early post-traumatic cerebral haemodynamic by middle cerebral artery blood velocity measuring. Methods and procedures: The standard method of measuring the mean blood middle cerebral artery velocity by transcranial Doppler ultrasonic device was performed. Main outcomes and results: The increased duration of intra-cranial hypertension correlated to the middle cerebral artery low blood velocity (p = 0.042; r = -0.498) (n = 17) and to elevated pulsatility indices (p = 0.007; r = 0.753) (n = 11) significantly. The increased duration of lowered cerebral perfusion pressure correlated to the middle cerebral artery low blood velocity significantly (p = 0.001; r = -0.619) (n = 24). Conclusions: The significance of transcranial Doppler ultrasonography as a method to estimate an early post-traumatic intra-cranial pressure after severe brain injury was confirmed. This simple and non-invasive technique could be easily used in daily clinical practice and precede intra-cranial pressure monitoring in selected patients.	Clin Hosp, Div Neurosurg, Osijek, Croatia; Clin Hosp, Dept Neurol, Osijek, Croatia; Clin Hosp, Dept Surg, Osijek, Croatia; Integra Neurosci, Zagreb, Croatia		Splavski, B (corresponding author), Osijek Univ Hosp, Div Neurosurg, Huttlerova 4, Osijek 31000, Croatia.	splavski.bruno@kbo.hr	Splavski, Bruno/AAM-1579-2020	Splavski, Bruno/0000-0002-4483-9364			BARZO P, 1991, NEUROSURGERY, V28, P821, DOI 10.1227/00006123-199106000-00006; BOUMA GJ, 1991, J NEUROSURG, V75, P685, DOI 10.3171/jns.1991.75.5.0685; Brauer P, 1998, J NEUROSURG ANESTH, V10, P80, DOI 10.1097/00008506-199804000-00003; CHAN KH, 1992, J NEUROSURG, V77, P55, DOI 10.3171/jns.1992.77.1.0055; CHAN KH, 1992, NEUROSURGERY, V30, P697; CZOSNYKA M, 1994, ACTA NEUROCHIR, V126, P113, DOI 10.1007/BF01476419; Czosnyka M, 1998, J NEUROSURG, V88, P802, DOI 10.3171/jns.1998.88.5.0802; CZOSNYKA M, 1994, ACTA NEUROCHIR, V60, P4068; GORAJ B, 1994, AM J NEURORADIOL, V15, P1333; HENNERICI M, 1987, SURG NEUROL, V27, P439, DOI 10.1016/0090-3019(87)90251-5; HOMBURG AM, 1993, ACTA NEUROL SCAND, V87, P488; Iida K, 2003, J NEUROSURG, V98, P793, DOI 10.3171/jns.2003.98.4.0793; Iida K, 1997, AM J EMERG MED, V15, P587, DOI 10.1016/S0735-6757(97)90164-9; Kelly DF, 1996, J NEUROSURG, V85, P762, DOI 10.3171/jns.1996.85.5.0762; KLINGELHOFER J, 1988, J NEUROL, V235, P159, DOI 10.1007/BF00314307; Lang EW, 2003, J NEUROL NEUROSUR PS, V74, P1053, DOI 10.1136/jnnp.74.8.1053; LARSEN FS, 1994, STROKE, V25, P1985, DOI 10.1161/01.STR.25.10.1985; Levis S, 1998, ACT NEUR S, V71, P174; MARMAROU A, 1991, J NEUROSURG, V75, pS59, DOI 10.3171/sup.1991.75.1s.0s59; McQuire JC, 1998, J NEUROSURG, V89, P526, DOI 10.3171/jns.1998.89.4.0526; Murillo-Cabezas F, 2002, NEUROCIRUGIA, V13, P196; Nagai H, 1997, STROKE, V28, P603, DOI 10.1161/01.STR.28.3.603; Newell DW, 1997, ACTA NEUROCHIR, V139, P804, DOI 10.1007/BF01411398; PFENNINGER EG, 1989, J NEUROSURG, V70, P774, DOI 10.3171/jns.1989.70.5.0774; RATH SA, 1993, UNFALLCHIRURG, V96, P569; SAHUQUILLO J, 1993, ACTA NEUROCHIR, V122, P204, DOI 10.1007/BF01405530; SAUNDERS FW, 1988, SURG NEUROL, V29, P401, DOI 10.1016/0090-3019(88)90049-3; Schmidt EA, 2001, J NEUROL NEUROSUR PS, V70, P198, DOI 10.1136/jnnp.70.2.198; Shigemori M, 1992, Acta Neurochir Suppl (Wien), V55, P6; SIESJO BK, 1992, J NEUROSURG, V77, P337, DOI 10.3171/jns.1992.77.3.0337; SIESJO BK, 1992, J NEUROSURG, V77, P169, DOI 10.3171/jns.1992.77.2.0169; Steiner LA, 2002, BRIT J NEUROSURG, V16, P429, DOI 10.1080/0268869021000030221; UNGERSBOCK K, 1995, NEUROSURGERY, V36, P147, DOI 10.1227/00006123-199501000-00019; van Santbrink H, 2002, ACTA NEUROCHIR, V144, P1141, DOI 10.1007/s00701-002-1012-8; Voulgaris SG, 2005, MED SCI MONITOR, V11, pCR49; WEBER M, 1990, NEUROSURGERY, V27, P106, DOI 10.1227/00006123-199007000-00015	36	8	8	0	1	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	NOV	2006	20	12					1265	1270		10.1080/02699050601082099			6	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	110DF	WOS:000242357800005	17132549				2022-02-06	
J	Tao, LY; Chen, XP; Qin, ZH; Bian, SZ				Tao, Luyang; Chen, Xiping; Qin, Zhenghong; Bian, Shizhong			Could NF-kappa B and caspase-3 be markers for estimation of post-interval of human traumatic brain injury?	FORENSIC SCIENCE INTERNATIONAL			English	Article; Proceedings Paper	17th Meeting of the International-Association-of-Forensic-Sciences (IAFS 2005)	AUG 21-26, 2005	Hong Kong, PEOPLES R CHINA	Int Assoc Forens Sci		post-traumatic intervals; immunohistochemical staining; caspase-3; NF-kappa B; forensic	TRANSCRIPTION FACTOR; CEREBRAL-ISCHEMIA; ACTIVATION; CELLS; INFLAMMATION; APOPTOSIS; ROLES	Background: Previous studies in a rat model showed expressions of caspase-3 (p20) and NF-KB (p65) in different time after TBI. We test the activation changes of caspase-3 and NF-KB of human specimen after traumatic brain injury (TBI) in this study to see whether they could be markers to estimate post-intervals of TBI for forensic practice. Material and methods: Caspase-3 (p20) and NF-KB (p65) immunohistochemical staining were performed on 39 TBI specimens (dead from TBI) and eight controls (dead from none TBI reasons) grouped 0, 12, 24, 48, 72, 168, 264 and 480 h. Positive cells were counted and image analysis techniques were used to determine the morphological changes in each group. Results: Immunohistochemical analysis showed a marked induction of caspase-3 (p20) in every injured group compared with normal controls; each positive group has it's morphological character with variant positive cell count. NF-KB (p65) did not showed markedly change compared with normal controls until 168 It after TBI and almost all nerve cells were stained by NF-KB (p65) in 264 and 480 h groups. Conclusion: NF-KB (p65) could contribute to estimate delayed death cases after TBI for forensic applications. Caspase-3 (p20) estimating post-TBI intervals are dubious but could suggest TBI exists. (c) 2006 Elsevier Ireland Ltd. All rights reserved.				x.p.chen1@163.com					Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649; Barnes PJ, 1997, NEW ENGL J MED, V336, P1066, DOI 10.1056/NEJM199704103361506; Bhakar AL, 2002, J NEUROSCI, V22, P8466; Blomgren K, 2001, J BIOL CHEM, V276, P10191, DOI 10.1074/jbc.M007807200; Hu SM, 1998, J BIOL CHEM, V273, P29648, DOI 10.1074/jbc.273.45.29648; Ichiyama T, 1999, EXP NEUROL, V157, P359, DOI 10.1006/exnr.1999.7064; Irazuzta JE, 2002, CRIT CARE MED, V30, P2553, DOI 10.1097/00003246-200211000-00025; LEDEBUR HC, 1995, J BIOL CHEM, V270, P933, DOI 10.1074/jbc.270.2.933; Namura S, 1998, J NEUROSCI, V18, P3659; Rami A, 2003, NEUROCHEM INT, V43, P79, DOI 10.1016/S0197-0186(02)00194-8; Rossiter JP, 1996, EXP NEUROL, V138, P33, DOI 10.1006/exnr.1996.0044; Sakai T, 2000, CAN J ANAESTH, V47, P1019, DOI 10.1007/BF03024876; Schottelius AJG, 1999, INT J COLORECTAL DIS, V14, P18, DOI 10.1007/s003840050178; SIEBENLIST U, 1994, ANNU REV CELL BIOL, V10, P405, DOI 10.1146/annurev.cellbio.10.1.405; Tao Lu-yang, 2004, Fa Yi Xue Za Zhi, V20, P9; TAO LY, 2004, J FORENSIC MED, V20, P73; Yamamoto K, 1995, J BIOL CHEM, V270, P31315, DOI 10.1074/jbc.270.52.31315	17	8	10	0	3	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0379-0738			FORENSIC SCI INT	Forensic Sci.Int.	OCT 16	2006	162	1-3					174	177		10.1016/j.forsciint.2006.06.021			4	Medicine, Legal	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Legal Medicine	094IR	WOS:000241233600032	16854541				2022-02-06	
J	McIntire, A; Langan, J; Halterman, C; Drew, A; Osternig, L; Chou, LS; van Donkelaar, P				McIntire, Alicia; Langan, Jeanne; Halterman, Charlene; Drew, Anthony; Osternig, Louis; Chou, Li-Shan; van Donkelaar, Paul			The influence of mild traumatic brain injury on the temporal distribution of attention	EXPERIMENTAL BRAIN RESEARCH			English	Article							CLOSED-HEAD INJURY; DEFICIT HYPERACTIVITY DISORDER; DUAL-TASK PERFORMANCE; ALZHEIMERS-DISEASE; DIVIDED ATTENTION; VISUAL-ATTENTION; TIME-COURSE; BLINK; MEMORY; CONCUSSION	The purpose of this study was to examine whether the temporal dynamics of attention was deficient in participants who have recently experienced mild traumatic brain injury (mTBI). For this purpose the rapid serial visual presentation (RSVP) task was used and the performance of participants with mTBI was compared to that of controls matched for age, gender, education, and activity type. In the RSVP task a stream of rapidly presented letters is displayed with target and probe letters separated by varying durations. The participant is required to identify the target letter and determine whether the probe letter was present or not. Previous research has shown that healthy participants display an attentional blink: they fail to detect the probe letter when it appears within similar to 500 ms of the target letter. We found that participants with mTBI had a normal attentional blink-it was neither greater in magnitude nor longer in duration than that displayed by the control participants. However, the participants with mTBI did show evidence of attentional competition-making more errors in identifying the target letter when the probe letter was presented-that was not present in the control participants. Taken together, these results suggest that the temporal constraints of attention are subtly but systematically affected by mTBI.	Univ Oregon, Dept Human Physiol, Eugene, OR 97403 USA; Univ Oregon, Inst Neurosci, Eugene, OR 97403 USA		van Donkelaar, P (corresponding author), Univ Oregon, Dept Human Physiol, Eugene, OR 97403 USA.	paulvd@darkwing.uoregon.edu		Langan, Jeanne/0000-0003-1417-2180	PHS HHSUnited States Department of Health & Human ServicesUnited States Public Health Service [R49-CCR021735] Funding Source: Medline		Armstrong IT, 2003, EXP BRAIN RES, V152, P243, DOI 10.1007/s00221-003-1535-0; Booth JR, 2005, J CHILD PSYCHOL PSYC, V46, P94, DOI 10.1111/j.1469-7610.2004.00337.x; Chan RCK, 2003, BRAIN INJURY, V17, P131, DOI 10.1080/0269905021000010168; Chan RCK, 2002, J CLIN EXP NEUROPSYC, V24, P1081, DOI 10.1076/jcen.24.8.1081.8371; Chuah YML, 2004, BRAIN COGNITION, V56, P304, DOI 10.1016/j.bandc.2004.08.002; Cicerone KD, 1996, BRAIN INJURY, V10, P79, DOI 10.1080/026990596124566; Dell'Acqua R, 2003, EXP BRAIN RES, V152, P29, DOI 10.1007/s00221-003-1512-7; Dell'Acqua R, 2001, EXP BRAIN RES, V136, P364, DOI 10.1007/s002210000586; DELLACQUA R, 2005, PSYCHOL RES, P1; Felmingham KL, 2004, NEUROPSYCHOLOGY, V18, P564, DOI 10.1037/0894-4105.18.3.564; Halterman CI, 2006, BRAIN, V129, P747, DOI 10.1093/brain/awh705; Hao J, 2005, NEUROSCI LETT, V385, P18, DOI 10.1016/j.neulet.2005.05.028; Hein G, 2005, EXP BRAIN RES, V160, P223, DOI 10.1007/s00221-004-2006-y; Heitger MH, 2004, BRAIN, V127, P575, DOI 10.1093/brain/awh066; Hollmann T, 2001, MARK RES, V13, P3; Husain M, 1997, NATURE, V385, P154, DOI 10.1038/385154a0; Johannsen P, 1999, NEUROIMAGE, V10, P269, DOI 10.1006/nimg.1999.0475; Kavcic V, 2003, BRAIN, V126, P1173, DOI 10.1093/brain/awg105; Kranczioch C, 2005, NEUROIMAGE, V24, P704, DOI 10.1016/j.neuroimage.2004.09.024; Leclercq M, 2000, J CLIN EXP NEUROPSYC, V22, P339, DOI 10.1076/1380-3395(200006)22:3;1-V;FT339; Marcantoni WS, 2003, BRAIN COGNITION, V53, P318, DOI 10.1016/S0278-2626(03)00134-9; Marois R, 2000, NEURON, V28, P299, DOI 10.1016/S0896-6273(00)00104-5; McAllister TW, 2001, NEUROIMAGE, V14, P1004, DOI 10.1006/nimg.2001.0899; Parker TM, 2005, CLIN BIOMECH, V20, P389, DOI 10.1016/j.clinbiomech.2004.12.004; PARKER TM, 2006, IN PRESS MED SCI SPO; PONSFORD J, 1992, J CLIN EXP NEUROPSYC, V14, P822, DOI 10.1080/01688639208402865; Potter MC, 2002, J EXP PSYCHOL HUMAN, V28, P1149, DOI 10.1037//0096-1523.28.5.1149; Potter MC, 2002, J EXP PSYCHOL HUMAN, V28, P1163, DOI 10.1037//0096-1523.28.5.1163; Prvulovic D, 2002, NEUROIMAGE, V17, P1403, DOI 10.1006/nimg.2002.1271; RAYMOND JE, 1995, J EXP PSYCHOL HUMAN, V21, P653, DOI 10.1037/0096-1523.21.3.653; RAYMOND JE, 1992, J EXP PSYCHOL HUMAN, V18, P849, DOI 10.1037/0096-1523.18.3.849; Rizzo M, 2001, NEUROLOGY, V57, P795, DOI 10.1212/WNL.57.5.795; SHAPIRO KL, 1994, J EXP PSYCHOL HUMAN, V20, P357, DOI 10.1037/0096-1523.20.2.357; Spikman JM, 1996, J CLIN EXP NEUROPSYC, V18, P755, DOI 10.1080/01688639608408298; STABLUM F, 1994, CORTEX, V30, P603, DOI 10.1016/S0010-9452(13)80238-9; STUSS DT, 1989, J NEUROL NEUROSUR PS, V52, P742, DOI 10.1136/jnnp.52.6.742; Vaidya CJ, 1998, P NATL ACAD SCI USA, V95, P14494, DOI 10.1073/pnas.95.24.14494; van Donkelaar P, 2005, BRAIN INJURY, V19, P1031, DOI 10.1080/02699050500110363	38	8	8	0	7	SPRINGER	NEW YORK	233 SPRING STREET, NEW YORK, NY 10013 USA	0014-4819			EXP BRAIN RES	Exp. Brain Res.	SEP	2006	174	2					361	366		10.1007/s00221-006-0469-8			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	081HR	WOS:000240308400016	16676168				2022-02-06	
J	Koslowsky, TC; Mader, K; Siedek, M; Pennig, D				Koslowsky, Thomas Christian; Mader, Konrad; Siedek, Michel; Pennig, Dietmar			Treatment of bilateral elbow dislocation using external fixation with motion capacity - A report of 2 cases	JOURNAL OF ORTHOPAEDIC TRAUMA			English	Article						bilateral elbow dislocation; external fixation; ligament disruption; elbow joint instability	RADIAL HEAD; POSTERIOR DISLOCATION; FRACTURES; PROTOCOL; COMPLEX	Bilateral elbow dislocation is a rare injury and only 11 cases are described in the literature, including 8 patients with isolated ligamentous and 3 patients with an additional osseous injury. We present 2 cases of bilateral posterior elbow dislocations treated with a bilateral hinged elbow fixator with motion capacity to allow for early physiotherapy. Both patients had a high-energy trauma with one who fell off a ladder from a 5 m height and the second from a mountain bike injury during off-road biking. All extremities were neurovascularly intact. In the operating room, severe instability was detected in all 4 elbows: after closed reduction in 3 elbows and open reduction in I elbow for a Mason type 4 fracture of the radial head that was internally fixed using fine threaded implants, an elbow fixator with motion capacity was applied in all 4 elbows for a period of 6 weeks. One year after surgery, the active range of motion was 0/10/140 degrees of extension and flexion on the right and 0/0/130 degrees on the left side. The second patient achieved 0/0/125 degrees and 0/10/130, respectively. Pro- and supination was full in both patients. All 4 elbows were stable and there were no radiologic signs of degenerative changes at the 1 year follow-up. Treatment of bilateral elbow dislocation using external fixation with early motion capacity allows for active physiotherapy although maintaining joint stability, thus minimizing complications normally associated with the injury. Using this method resulted in an excellent clinical outcome for both patients.	St Elizabeth Hosp, Dept Surg, D-50935 Cologne, Germany; St Vinzenz Hosp, Dept Traumatol Hand & Reconstruct Surg, D-50733 Cologne, Germany		Koslowsky, TC (corresponding author), St Elizabeth Hosp, Dept Surg, Werthmannstr 1, D-50935 Cologne, Germany.	tkoslowsky@web.de					Cohen M S, 1998, J Am Acad Orthop Surg, V6, P15; DURIG M, 1979, J BONE JOINT SURG AM, V61, P239, DOI 10.2106/00004623-197961020-00012; GAUSEPOHL T, 1997, HEFTE UNFALLCHIR, V268, P32; GAUSEPOHL T, 1998, J BONE JOINT SURG S2, V81, P126; Hildebrand KA, 1999, ORTHOP CLIN N AM, V30, P63, DOI 10.1016/S0030-5898(05)70061-4; JENSEN UH, 1936, UGESKRIFT LAEGER, V145, P1784; JOHANSSON O, 1962, ACTA CHIR SCAND    S, V287, P5; KLEVER H, 1961, UNFALLHEILKUNDE, P190; Kotter A, 1999, CHIRURG, V70, P285, DOI 10.1007/s001040050644; KOYRIZHNYI VG, 1969, KLIN KHIR KIEV, V5, P65; MAITRA AK, 1979, BRIT J CLIN PRACT, V33, P233; McKee MD, 2003, J SHOULDER ELB SURG, V12, P391, DOI 10.1016/S1058-2746(03)00027-2; MEHLHOFF T, 1992, ELBOW DISLOCATION RE; OURY JH, 1972, J TRAUM, V12, P170, DOI 10.1097/00005373-197202000-00011; Pennig D, 2000, INJURY, V31, P35, DOI 10.1016/S0020-1383(99)00261-2; Pugh DMW, 2004, J BONE JOINT SURG AM, V86A, P1122, DOI 10.2106/00004623-200406000-00002; Raman R, 2005, ORTHOPEDICS, V28, P503, DOI 10.3928/0147-7447-20050501-21; Ring D, 2002, J BONE JOINT SURG AM, V84A, P547, DOI 10.2106/00004623-200204000-00006; Ring D, 2004, J HAND SURG-AM, V29A, P470, DOI 10.1016/j.jhsa.2004.01.005; Ring D, 2005, J BONE JOINT SURG AM, V87A, P1293, DOI 10.2106/JBJS.D.02462; Ross G, 1999, AM J SPORT MED, V27, P308, DOI 10.1177/03635465990270030701; Ruch D S, 2001, Injury, V32 Suppl 4, pSD70; Schippinger G, 1999, LANGENBECK ARCH SURG, V384, P294, DOI 10.1007/s004230050206; SCHONBAUER H R, 1957, Monatsschr Unfallheilkd Versicherungsmed, V60, P119; Syed AA, 1999, BRIT J SPORT MED, V33, P132, DOI 10.1136/bjsm.33.2.132; TAYOB AA, 1980, J TRAUMA, V20, P332, DOI 10.1097/00005373-198004000-00008; WILSON A, 1990, AUST NZ J SURG, V60, P553, DOI 10.1111/j.1445-2197.1990.tb07426.x; WOO SLY, 1975, ARTHRITIS RHEUM, V18, P257, DOI 10.1002/art.1780180311; Yamamoto Kengo, 2003, Hand Surg, V8, P163, DOI 10.1142/S0218810403001674	29	8	8	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0890-5339			J ORTHOP TRAUMA	J. Orthop. Trauma	JUL	2006	20	7					499	502		10.1097/00005131-200608000-00009			4	Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Sport Sciences	073LI	WOS:000239744000009	16891943				2022-02-06	
J	Togher, L; Balandin, S; Young, K; Given, F; Canty, M				Togher, Leanne; Balandin, Susan; Young, Katherine; Given, Fiona; Canty, Michael			Development of a communication training program to improve access to legal services for people with complex communication needs	TOPICS IN LANGUAGE DISORDERS			English	Article						augmentative and alternative communication; communication disability; legal issues; complex communication needs; training program	TRAUMATIC BRAIN-INJURY; KNOWLEDGE; BELIEFS	People with communication disabilities experience problems in accessing the justice system. In this article we describe the development of a multimedia package designed to train legal personnel to identify and reduce communication barriers to their services. The training package is being developed collaboratively by a diverse team that included researchers, a clinician, legal personnel, and people who use augmentative and alternative communication. The focus of the training is to improve the knowledge and skills of legal personnel regarding how to communicate effectively with people who use augmentative and alternative communication, thus enabling greater access to the legal system for such individuals. In this article, development of training vignettes is described. The next step will be to evaluate the effectiveness of the training materials. Suggestions are offered for conducting this evaluation and future research in this important area.	Univ Sydney, Fac Hlth Sci, Sch Commun Sci & Disorders, Lidcombe, NSW 1825, Australia; Crown Solicitors Off, Sydney, NSW, Australia		Togher, L (corresponding author), Univ Sydney, Fac Hlth Sci, Sch Commun Sci & Disorders, POB 170,E St, Lidcombe, NSW 1825, Australia.	L.Togher@fhs.usyd.edu.au	Togher, Leanne/AAC-7083-2019	Togher, Leanne/0000-0002-4518-6748			BALANDIN S, 2000, INTELLECTUAL DISABIL, P31; Bedrosian JL, 2003, J SPEECH LANG HEAR R, V46, P800, DOI 10.1044/1092-4388(2003/063); Beukelman D. R., 2005, AUGMENTATIVE ALTERNA; BORTHWICK C, 1998, 8 BIENN ISAAC C DUBL; BRYEN D, 2003, AUGMENTATIVE ALTERNA, V16, P125; Carmody M., 1991, AUST NEW ZEAL J DEV, V17, P229; Collier B, 2006, AUGMENT ALTERN COMM, V22, P62, DOI 10.1080/07434610500387490; COLLIER B, 2004, SAFEGUARDING PEOPLE; CONWAY RNF, 1996, ABUSE ADULTS INTELLE; FYFE M, 2001, AGE, V9; GIVEN F, 2005, EQUAL ACCESS PEOPLE; Hastings RP, 2002, J INTELL DISABIL RES, V46, P144, DOI 10.1046/j.1365-2788.2002.00378.x; Hastings RP, 1997, CLIN PSYCHOL REV, V17, P775, DOI 10.1016/S0272-7358(97)00050-0; Mostert MP, 2001, BEHAV DISORDERS, V27, P53; PREMSTEIN J, 1996, 7 BIENN C INT SOC AU; SOBSEY D, 1994, VIOLENCE ABUASE LIVE; TAMURA S, 1992, AUGMENTATIVE ALTERNA, V8, P172; TOEFY F, 1994, COMMUNICATING TOGETH, V19; Togher L, 1997, BRAIN INJURY, V11, P169, DOI 10.1080/026990597123629; Togher L, 1997, APHASIOLOGY, V11, P491, DOI 10.1080/02687039708248486; Togher L, 2004, APHASIOLOGY, V18, P313, DOI 10.1080/02687030344000535; TOGHER L, 2006, IMPROVING ACCESS JUS	22	8	8	0	7	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0271-8294	1550-3259		TOP LANG DISORD	Top. Lang. Disord.	JUL-SEP	2006	26	3					199	209		10.1097/00011363-200607000-00004			11	Linguistics; Rehabilitation	Social Science Citation Index (SSCI)	Linguistics; Rehabilitation	080BC	WOS:000240220800004					2022-02-06	
J	Atabaki, SM				Atabaki, Shireen M.			Prehospital Evaluation and Management of Traumatic Brain Injury in Children	CLINICAL PEDIATRIC EMERGENCY MEDICINE			English	Article						head trauma; traumatic brain injury; intracranial injury; subdural hematoma; epidural hematoma; concussion		Prehospital providers are often the first line of response for the triage and treatment of children with traumatic brain injury (TBI). New advances in diagnosis and management in the prehospital setting have led to a dramatic improvement in the care of patients with TBI. The past 3 decades have witnessed an estimated 20% reduction in mortality rates from TBI. However, a great deal of variation still exists in practice with respect to the diagnosis and management of pediatric head trauma. Training programs should be developed to educate emergency medical services providers and medical control physicians on evidence-based management of pediatric TBI. Early intervention with new therapies should be incorporated into prehospital care to decrease secondary injury. Clin Ped Emerg Med 7: 94-104 (C) 2006 Elsevier Inc. All rights reserved.	[Atabaki, Shireen M.] Childrens Natl Med Ctr, Div Emergency Med, 111 Michigan Ave,NW, Washington, DC 20010 USA; [Atabaki, Shireen M.] George Washington Univ, Sch Med & Hlth Sci, Washington, DC 20052 USA		Atabaki, SM (corresponding author), Childrens Natl Med Ctr, Div Emergency Med, 111 Michigan Ave,NW, Washington, DC 20010 USA.						American College of Surgeons, 1996, ADV TRAUM LIFE SUPP; Aubry Mark, 2002, Phys Sportsmed, V30, P57, DOI 10.3810/psm.2002.02.176; BAXT WG, 1987, J TRAUMA, V27, P365, DOI 10.1097/00005373-198704000-00004; Bazarian JJ, 2001, ACAD EMERG MED, V8, P788, DOI 10.1111/j.1553-2712.2001.tb00208.x; Bergman DA, 1999, PEDIATRICS, V104, P1407; BILLMIRE ME, 1985, PEDIATRICS, V75, P340; Brain Trauma Foundation, 1995, GUID MAN SEV HEAD IN; Brain Trauma Foundation, 2000, GUID PREH MAN TRAUM; Brenner DJ, 2001, AM J ROENTGENOL, V176, P289, DOI 10.2214/ajr.176.2.1760289; CANTU RC, 1995, PHYSICIAN SPORTSMED, V23, P27, DOI 10.1080/00913847.1995.11947799; Cantu RC, 1998, PHYS SPORT MED, V14, P755; Center for Disease Control, 2004, SURV FAT NON FAT INJ, P1; Centers for Disease Control and Prevention (CDC), 1997, MMWR Morb Mortal Wkly Rep, V46, P8; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; CLIFTON G L, 1989, Journal of Neurotrauma, V6, P71, DOI 10.1089/neu.1989.6.71; COLLINS M, 2004, CURR OPIN ORTHOP, V15, P100; Covassin T, 2003, APPL NEUROPSYCHOL, V10, P12, DOI 10.1207/S15324826AN1001_3; Dayan P, 2006, CLIN PEDIATR EMERG M, V7, P128, DOI 10.1016/j.cpem.2006.03.006; Duhaime AC, 1996, PEDIATR NEUROSURG, V24, P292, DOI 10.1159/000121058; Duhaime AC, 1998, NEW ENGL J MED, V338, P1822, DOI 10.1056/NEJM199806183382507; DUHAIME AC, 1987, J NEUROSURG, V66, P409, DOI 10.3171/jns.1987.66.3.0409; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; GOLDSTEIN B, 1993, CRIT CARE MED, V21, P1328, DOI 10.1097/00003246-199309000-00016; Greenes DS, 2001, PEDIATR EMERG CARE, V17, P88, DOI 10.1097/00006565-200104000-00002; HADLEY MN, 1989, NEUROSURGERY, V24, P536, DOI 10.1227/00006123-198904000-00008; Hartl R, 1997, ACT NEUR S, V70, P126; Haydel MJ, 2003, ANN EMERG MED, V42, P507, DOI 10.1067/S0196-0644(03)00512-2; KAWAMATA T, 1995, BRAIN RES, V674, P196, DOI 10.1016/0006-8993(94)01444-M; LAVERY RF, 1991, AM J EMERG MED, V9, P304, DOI 10.1016/0735-6757(91)90046-M; Luber SD, 1996, AM J EMERG MED, V14, P543, DOI 10.1016/S0735-6757(96)90094-7; Mettler Fred A. Jr., 2000, Journal of Radiological Protection, V20, P353, DOI 10.1088/0952-4746/20/4/301; MEYER S, 1993, ANN EMERG MED, V22, P1052, DOI 10.1016/S0196-0644(05)82750-7; MUIZELAAR JP, 1991, J NEUROSURG, V75, P731, DOI 10.3171/jns.1991.75.5.0731; *NCCSIR, 2000, 18 ANN REP FALL 1982; NCSISC, 2001, SPIN CORD INJ INF NE; Orsborn R, 1998, COMMON CHILDHOOD INJ, pl12; Palchak MJ, 2003, ANN EMERG MED, V42, P492, DOI 10.1067/S0196-0644(03)00425-6; PIGULA FA, 1993, J PEDIATR SURG, V28, P310, DOI 10.1016/0022-3468(93)90223-8; Raichle ME, 1972, STROKE, V3, P566, DOI 10.1161/01.STR.3.5.566; Saul TG, 1996, THINK 1 PROGR NEUR; Sayre MR, 1996, ACAD EMERG MED, V3, P840, DOI 10.1111/j.1553-2712.1996.tb03528.x; SHEINBERG M, 1992, J NEUROSURG, V76, P212, DOI 10.3171/jns.1992.76.2.0212; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X; STRICH SJ, 1961, LANCET, V2, P443; Sullivan PG, 2000, EXP NEUROL, V161, P631, DOI 10.1006/exnr.1999.7282; VASSAR MJ, 1991, ARCH SURG-CHICAGO, V126, P1065; Vu TT, 2004, PEDIATR EMERG CARE, V20, P821, DOI 10.1097/01.pec.0000148031.99339.b7; Wade CE, 1997, J TRAUMA, V42, pS61, DOI 10.1097/00005373-199705001-00011; Watts Dorraine D, 2004, Prehosp Emerg Care, V8, P254; WEI EP, 1981, CIRC RES, V48, P95, DOI 10.1161/01.RES.48.1.95; Wright J, 2001, CLIN PEDIAT EMERG ME, V2, P3	52	8	9	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1522-8401	1558-2310		CLIN PEDIATR EMERG M	Clin. Pediatr. Emerg. Med.	JUN	2006	7	2					94	104		10.1016/j.cpem.2006.03.003			11	Pediatrics	Emerging Sources Citation Index (ESCI)	Pediatrics	V5E6N	WOS:000219538400005					2022-02-06	
J	Chua, SGK; Kong, KH				Chua, S. G. Karen; Kong, K. H.			Complete semimembranosus rupture following therapeutic stretching after a traumatic brain injury	BRAIN INJURY			English	Article						semi-membranosus; hamstring; rupture; brain injury	SURGICAL REPAIR; TENDON; AVULSION; ORIGIN	Acute hamstring rupture is an uncommon event often occurring during high impact sports. Such events have not been previously reported during neurological rehabilitation. This case report describes a 30 year-old Chinese male presenting in a minimally responsive state 5 years after a severe traumatic brain injury. He was tetraplegic and bed-bound with spasticity involving all four limbs and flexion contracture of the right knee. During an episode of inpatient rehabilitation, he developed acute swelling and bruising of the posterior proximal thigh region associated with fever, tachycardia and diaphoresis. MRI showed a large soft tissue rim-enhancing mass in the right proximal hamstring muscle. During surgical exploration, complete rupture of the right semi-membranosus muscle was found without evidence of pus. The possible causative factors of hamstring rupture in this subject and a brief literature review are discussed. To the authors' knowledge, this is the first such reported case.	Tan Tock Seng Hosp, Dept Rehabil Med, Singapore 596766, Singapore		Chua, SGK (corresponding author), Tan Tock Seng Hosp, Dept Rehabil Med, 17 Ang Mo Kio Ave 9, Singapore 596766, Singapore.	karen_chua@ttsh.com.sg					ALIOTO RJ, 1997, CLIN ORTHOPEDIC RELA, V226, P162; BLASIER RB, 1990, AM J SPORT MED, V18, P435, DOI 10.1177/036354659001800419; BOHANNON RW, 1987, PHYS THER, V67, P206, DOI 10.1093/ptj/67.2.206; BREWER BJ, 1960, INSTR COURSE LECT, V17, P354; Clanton T O, 1998, J Am Acad Orthop Surg, V6, P237; Cross MJ, 1998, AM J SPORT MED, V26, P785, DOI 10.1177/03635465980260060801; Friden J, 2003, MUSCLE NERVE, V27, P157, DOI 10.1002/mus.10247; GARDEN F, 2002, ESSENTIALS PHYS MED, P525; GIACINO JT, 1995, ARCH PHYS MED REHAB, V76, P205; GORIGANTI MR, 1990, ARCH PHYS MED REHAB, V80, P117; ISHIKAWA K, 1988, CLIN ORTHOP RELAT R, V232, P153; Johnson AE, 2003, MIL MED, V168, P40; Klingele KE, 2002, AM J SPORT MED, V30, P742, DOI 10.1177/03635465020300051901; Kujala UM, 1997, SPORTS MED, V23, P397, DOI 10.2165/00007256-199723060-00005; Kurosawa H, 1996, BRIT J SPORT MED, V30, P72, DOI 10.1136/bjsm.30.1.72; ROSE J, 1994, J ORTHOP RES, V12, P758, DOI 10.1002/jor.1100120603; Varela JR, 2000, SKELETAL RADIOL, V29, P362, DOI 10.1007/s002560000216; YOUNG JL, 1996, PHYSICAL MED REHABIL, P783; ZENI AZ, 2002, ESSENTIALS PHYS MED, P323; Zhang LQ, 2002, IEEE T NEUR SYS REH, V10, P149, DOI 10.1109/TNSRE.2002.802857	20	8	9	0	2	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JUN	2006	20	6					669	672		10.1080/02699050600676842			4	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	062LU	WOS:000238947100012	16754292				2022-02-06	
J	Deem, S				Deem, S			Management of acute brain injury and associated respiratory issues	RESPIRATORY CARE			English	Article; Proceedings Paper	21st Annual New Horizons Symposium	DEC 04, 2005	San Antonio, TX			acute brain injury; respiratory; intracranial pressure; cerebral blood flow; hyperventilation; lung-protective ventilation; closed head injury; subarachnoid hemmorhage	CEREBRAL-BLOOD-FLOW; END-EXPIRATORY PRESSURE; INTENSIVE-CARE-UNIT; PLACEBO-CONTROLLED TRIAL; INTRA-CRANICAL PRESSURE; SEVERE HEAD-INJURY; ACUTE LUNG INJURY; LENGTH-OF-STAY; INTRACRANIAL-PRESSURE; PERFUSION-PRESSURE	Acute brain injury, in the form of trauma, stroke, or spontaneous hemorrhage, occurs commonly and in all age groups. Although the management of these conditions differs considerably, certain physiologic principles are shared by all and are useful in guiding the management of the most severely injured patients. This article reviews basic cerebral physiology and describes the links between physiology and management principles, emphasizing subjects relevant to the respiratory management of patients with acute brain injury.	Univ Washington, Harborview Med Ctr, Dept Anesthesiol, Seattle, WA 98104 USA		Deem, S (corresponding author), Univ Washington, Harborview Med Ctr, Dept Anesthesiol, Box 359724, Seattle, WA 98104 USA.	sdeem@u.washington.edu					*AC RESP DISTR SYN, 2000, NEW ENGL J MED, V342, P1301, DOI DOI 10.1056/NEJM200005043421801; AIDINIS SJ, 1976, ANESTHESIOLOGY, V45, P275, DOI 10.1097/00000542-197609000-00004; Albrecht RF, 1998, MAYO CLIN PROC, V73, P629; APUZZO MLJ, 1977, J NEUROSURG, V46, P227, DOI 10.3171/jns.1977.46.2.0227; BARBER RE, 1970, NEW ENGL J MED, V283, P1478, DOI 10.1056/NEJM197012312832702; Battison C, 2005, CRIT CARE MED, V33, P196, DOI 10.1097/01.CCM.0000150269.65485.A6; Bernard SA, 2002, NEW ENGL J MED, V346, P557, DOI 10.1056/NEJMoa003289; BOUMA GJ, 1991, J NEUROSURG, V75, P685, DOI 10.3171/jns.1991.75.5.0685; Brain Trauma Foundation, 2003, MAN PROGN SEV TRAUM; Bratton SL, 1997, NEUROSURGERY, V40, P707, DOI 10.1097/00006123-199704000-00009; Bruno A, 1999, NEUROLOGY, V52, P280, DOI 10.1212/WNL.52.2.280; Bruno A, 2002, NEUROLOGY, V59, P669, DOI 10.1212/WNL.59.5.669; BURCHIEL KJ, 1981, NEUROSURGERY, V8, P443, DOI 10.1227/00006123-198104000-00007; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; CHESNUT RM, 1993, ACTA NEUROCHIR, P121; Clifton GL, 2001, NEW ENGL J MED, V344, P556, DOI 10.1056/NEJM200102223440803; Clifton GL, 2002, CRIT CARE MED, V30, P739, DOI 10.1097/00003246-200204000-00003; Coles JP, 2002, CRIT CARE MED, V30, P1950, DOI 10.1097/00003246-200209000-00002; Contant CF, 2001, J NEUROSURG, V95, P560, DOI 10.3171/jns.2001.95.4.0560; Coplin WM, 2000, AM J RESP CRIT CARE, V161, P1530, DOI 10.1164/ajrccm.161.5.9905102; Cremer OL, 2001, LANCET, V357, P117, DOI 10.1016/S0140-6736(00)03547-9; Cruz J, 1998, CRIT CARE MED, V26, P344, DOI 10.1097/00003246-199802000-00039; Dippel DWJ, 2003, BMC CARDIOVASC DISOR, V3, DOI 10.1186/1471-2261-3-2; Diringer MN, 2004, CRIT CARE MED, V32, P2170; Diringer MN, 2004, CRIT CARE MED, V32, P1489, DOI 10.1097/01.CCM.0000129484.61912.84; Diringer MN, 2004, CRIT CARE MED, V32, P559, DOI 10.1097/01.CCM.0000108868.97433.3F; Diringer MN, 2001, CRIT CARE MED, V29, P635, DOI 10.1097/00003246-200103000-00031; Diringer MN, 2000, J NEUROSURG, V92, P7, DOI 10.3171/jns.2000.92.1.0007; Drummond JC, 1997, ANESTHESIOLOGY, V86, P1431, DOI 10.1097/00000542-199706000-00034; Edwards P, 2005, LANCET, V365, P1957; EISENBERG HM, 1988, J NEUROSURG, V69, P15, DOI 10.3171/jns.1988.69.1.0015; ELLINGSEN I, 1987, ACTA PHYSIOL SCAND, V129, P157, DOI 10.1111/j.1748-1716.1987.tb08054.x; Ely EW, 1996, NEW ENGL J MED, V335, P1864, DOI 10.1056/NEJM199612193352502; FROST EAM, 1977, J NEUROSURG, V47, P195, DOI 10.3171/jns.1977.47.2.0195; GENTILE NT, 2003, ACAD EMERG MED, V10, P432; Georgiadis D, 2001, STROKE, V32, P2088, DOI 10.1161/hs0901.095406; Hajat C, 2000, STROKE, V31, P410, DOI 10.1161/01.STR.31.2.410; Hemphill JC, 2001, NEUROSURGERY, V48, P377, DOI 10.1097/00006123-200102000-00028; Holland MC, 2003, J TRAUMA, V55, P106, DOI 10.1097/01.TA.0000071620.27375.BE; HUSEBY JS, 1981, J NEUROSURG, V55, P704, DOI 10.3171/jns.1981.55.5.0704; Huynh T, 2002, J TRAUMA, V53, P488, DOI 10.1097/00005373-200209000-00016; HYDE RW, 1969, ANN INTERN MED, V71, P517, DOI 10.7326/0003-4819-71-3-517; Imberti R, 2002, J NEUROSURG, V96, P97, DOI 10.3171/jns.2002.96.1.0097; Juul N, 2000, J NEUROSURG, V92, P1, DOI 10.3171/jns.2000.92.1.0001; KAHN JM, 2004, AM J RESP CRIT CARE, V169, pA780; Kelly DF, 1997, J NEUROSURG, V86, P633, DOI 10.3171/jns.1997.86.4.0633; Kiening KL, 1997, NEUROL RES, V19, P233, DOI 10.1080/01616412.1997.11740805; Koh WY, 1997, ANAESTH INTENS CARE, V25, P365, DOI 10.1177/0310057X9702500407; LAM AM, 1991, J NEUROSURG, V75, P545, DOI 10.3171/jns.1991.75.4.0545; Leonardi-Bee J, 2002, STROKE, V33, P1315, DOI 10.1161/01.STR.0000014509.11540.66; LODATO RF, 1990, CRIT CARE CLIN, V6, P749; Maddock RJ, 2001, J NEUROPSYCH CLIN N, V13, P22, DOI 10.1176/appi.neuropsych.13.1.22; Mascia L, 2005, INTENS CARE MED, V31, P373, DOI 10.1007/s00134-004-2491-2; Mayer SA, 2001, NEUROLOGY, V56, P292, DOI 10.1212/WNL.56.3.292; Mayer SA, 2004, CRIT CARE MED, V32, P2508, DOI 10.1097/01.CCM.0000147441.39670.37; Menzel M, 1999, J NEUROSURG ANESTH, V11, P240, DOI 10.1097/00008506-199910000-00003; Mirski MA, 2001, J NEUROSURG ANESTH, V13, P83, DOI 10.1097/00008506-200104000-00004; Moore F, 2002, J TRAUMA, V53, P492; MUIZELAAR JP, 1991, J NEUROSURG, V75, P731, DOI 10.3171/jns.1991.75.5.0731; Mullner M, 1997, J CEREBR BLOOD F MET, V17, P430; Mulvey JM, 2004, NEUROCRIT CARE, V1, P391, DOI 10.1385/NCC:1:3:391; Muzha I, 2004, LANCET, V364, P1321, DOI 10.1016/S0140-6736(04)17188-2; Namen AM, 2001, AM J RESP CRIT CARE, V163, P658, DOI 10.1164/ajrccm.163.3.2003060; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; Patel HC, 2002, INTENS CARE MED, V28, P547, DOI 10.1007/s00134-002-1235-4; Polderman KH, 2004, INTENS CARE MED, V30, P556, DOI 10.1007/s00134-003-2152-x; Poulin MJ, 1998, J APPL PHYSIOL, V85, P388, DOI 10.1152/jappl.1998.85.2.388; RAICHLE ME, 1970, ARCH NEUROL-CHICAGO, V23, P394, DOI 10.1001/archneur.1970.00480290014002; Reinert M, 2003, ACTA NEUROCHIR, V145, P341, DOI 10.1007/s00701-003-0027-0; Roberts IG, 2003, COCHRANE DB SYST REV, V2; Robertson CS, 1999, CRIT CARE MED, V27, P2086, DOI 10.1097/00003246-199910000-00002; Rovlias A, 2000, NEUROSURGERY, V46, P335, DOI 10.1097/00006123-200002000-00015; Salam A, 2004, INTENS CARE MED, V30, P1334, DOI 10.1007/s00134-004-2231-7; Schierhout G, 2001, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD000173; SCHIERHOUT G, 2000, COCHRANE DB SYST REV, V2; SHAPIRO HM, 1978, J TRAUMA, V18, P254, DOI 10.1097/00005373-197804000-00005; Steiner LA, 2004, INTENS CARE MED, V30, P2180, DOI 10.1007/s00134-004-2463-6; Stocchetti N, 2005, CHEST, V127, P1812, DOI 10.1378/chest.127.5.1812; Suarez JI, 2004, CRIT CARE MED, V32, P2311, DOI 10.1097/01.CCM.0000146132.29042.4c; Van den Berghe G, 2005, NEUROLOGY, V64, P1348, DOI 10.1212/01.WNL.0000158442.08857.FC; Van den Berghe G, 2001, NEW ENGL J MED, V345, P1359, DOI 10.1056/NEJMoa011300; Videtta W, 2002, ACT NEUR S, V81, P93; White H, 2002, CAN J ANAESTH, V49, P623, DOI 10.1007/BF03017393; Wolf S, 2002, ACT NEUR S, V81, P99; [No title captured]	85	8	10	0	3	DAEDALUS ENTERPRISES INC	IRVING	9425 N MAC ARTHUR BLVD, STE 100, IRVING, TX 75063-4706 USA	0020-1324	1943-3654		RESP CARE	Respir. Care	APR	2006	51	4					357	367					11	Critical Care Medicine; Respiratory System	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine; Respiratory System	031SI	WOS:000236723900002	16563190				2022-02-06	
J	Gleissner, U; Lendt, M; Mayer, S; Elger, C; Heimstaedter, C				Gleissner, U; Lendt, M; Mayer, S; Elger, C; Heimstaedter, C			A new questionnaire for recognizing cognitive problems in children and adolescents	NERVENARZT			German	Article						children; cognitive problems; parental rating; questionnaire	TRAUMATIC BRAIN-INJURY; FRONTAL-LOBE EPILEPSY; SURGERY; MEMORY; PERFORMANCE; CHILDHOOD; RATINGS	Background. Patients with psychiatric or neurologic disease often suffer from neuropsychologic problems. The purpose of this study was to present a parental questionnaire (KOPKIJ) that assesses neuropsychologic problems in children and adolescents between 6 and 16 years of age. Methods. We tested theoretical analysis, standardization, and validation of the questionnaire in 352 healthy controls and 116 pediatric patients with epilepsy. Results. The objectivity of this standardized questionnaire can be considered high, and the reliability of the subscales is satisfying. Epileptic patients had higher scores than healthy controls, and the validation displayed reasonable connections with clinical factors and the results of neuropsychological evaluation. Conclusion. The KOPKIJ allows an orientating appraisal clear picture of cognitive problems of children and adolescents at home and at school, simplifies anamnesis, and eases the planning of therapy strategies.	Univ Klin Bonn, D-53105 Bonn, Germany; St Mauritius Therapieklin, Meerbusch, Germany; Ambulantes Neurol Rehabilitationscentrum Bad Neue, Ahrweiler, Germany		Gleissner, U (corresponding author), Univ Klin Bonn, Sigmund Freud Str 25, D-53105 Bonn, Germany.	ulrike.gleissner@ukb.uni-bonn.de					BEARDSWORTH ED, 1994, J CLIN EXP NEUROPSYC, V16, P589, DOI 10.1080/01688639408402670; Blanchette N, 2002, BRAIN COGNITION, V48, P280, DOI 10.1006/brcg.2001.1362; Bourgeois M, 1999, J NEUROSURG, V90, P833, DOI 10.3171/jns.1999.90.5.0833; Corcoran R, 1992, Seizure, V1, P37, DOI 10.1016/1059-1311(92)90053-4; Dewey D, 2000, J DEV BEHAV PEDIATR, V21, P37, DOI 10.1097/00004703-200002000-00006; Elixhauser A, 1999, EPILEPSY RES, V37, P13, DOI 10.1016/S0920-1211(99)00036-4; ESSER G, 1996, LEHRBUCH KLINISCHEN; Gleissner U, 2002, EPILEPSY RES, V51, P287, DOI 10.1016/S0920-1211(02)00158-4; Gleissner U., 2003, Z NEUROPSYCHOL, V14, P3; HELMSTAEDTER C, 1997, NEUROPSYCHOLOGY CHIL, P215; Hernandez MT, 2002, NEUROPSYCHOLOGIA, V40, P384, DOI 10.1016/S0028-3932(01)00130-0; Heubrock D, 1997, VERHALTENSTHERAPIE, V7, P153, DOI 10.1159/000259023; HEUBROCK D, 1998, KINDH ENTWICKL, V7, P50; Kadis DS, 2004, EPILEPSY BEHAV, V5, P37, DOI 10.1016/j.yebeh.2003.10.008; Lendt M, 2002, EPILEPSY BEHAV, V3, P51, DOI 10.1006/ebeh.2001.0296; LIENERT GA, 1994, TESTAUFBAU TESTANALY; LOSSLEIN H, 1998, HIRNFUNKTIONSSTORUNG; MAYER H, 1999, EPILEPSIEBLATTER, V12, P21; MAYER S, 2002, THESIS PSYCHOL I U B; Muir-Broaddus JE, 2002, ARCH CLIN NEUROPSYCH, V17, P671, DOI 10.1016/S0887-6177(01)00170-6; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Silver CH, 2000, J HEAD TRAUMA REHAB, V15, P973, DOI 10.1097/00001199-200008000-00002; Spreen O., 1998, COMPENDIUM NEUROPSYC, V2nd ed.); STEINHAUSEN HC, 1996, PSYCHISCHE STORUNGEN; Vasconcellos E, 2001, EPILEPSIA, V42, P268; VONCRAMON DY, 1995, NEUROSPYCHOLOGISCHE; Vriezen ER, 2002, CHILD NEUROPSYCHOL, V8, P296, DOI 10.1076/chin.8.4.296.13505; Wasterlain CG, 1997, EPILEPSIA, V38, P728, DOI 10.1111/j.1528-1157.1997.tb01244.x	28	8	8	0	2	SPRINGER	NEW YORK	233 SPRING STREET, NEW YORK, NY 10013 USA	0028-2804			NERVENARZT	Nervenarzt	APR	2006	77	4					449	+		10.1007/s00115-005-2050-2			13	Clinical Neurology; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry	043VT	WOS:000237631700006	16425050				2022-02-06	
J	Grindstaff, TL; Christiano, KEJ; Broos, AM; Straub, DA; Darr, NS; Westphal, KA				Grindstaff, Terry L.; Christiano, Katherine E. J.; Broos, Allison M.; Straub, Dawn A.; Darr, Nancy S.; Westphal, Kathleen A.			Assessment of a practice effect in serial sensory organization testing scores of healthy adults	PERCEPTUAL AND MOTOR SKILLS			English	Article							POSTURAL STABILITY; DYNAMIC POSTUROGRAPHY; HIGH-SCHOOL; BALANCE; CONCUSSION; RELIABILITY; COLLEGIATE; PEOPLE	This study assessed whether a practice effect occurs across five serial administrations of the sensory organization test. Composite equilibrium scores and mean equilibrium scores from 3 0 healthy volunteers (M age = 36.9, SD = 12.2 yr.) performing each of the six test conditions were examined using a two-way repeated-measures analysis of variance. Analysis yielded a significant interaction between testing condition and time, as well as significant main effects for both condition and time. Pairwise comparisons showed significant differences among test conditions and the first and second times of test administration. Analysis of simple effects between the two administrations identified significant increases in composite equilibrium scores and mean equilibrium scores on two sway-referenced support surface conditions, vision removed and sway-referenced visual surround. An immediate increase in equilibrium scores suggests clinicians and researchers allow one pracatice trial before recording test scores for baseline measurements.	Univ Virginia, Charlottesville, VA 22904 USA; BenchMark Phys Therapy, Chattanooga, TN USA; Belmont Univ, Nashville, TN 37212 USA; St Marys RehabCare Ctr, Knoxville, TN USA; Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA; Univ Montana, Missoula, MT 59812 USA		Grindstaff, TL (corresponding author), Univ Virginia, POB 400407,210 Emmet St,S, Charlottesville, VA 22904 USA.	tlg6q@virginia.edu		Grindstaff, Terry/0000-0001-8707-2522			Carter ND, 2001, BRIT J SPORT MED, V35, P348, DOI 10.1136/bjsm.35.5.348; FORDSMITH CD, 1995, ARCH PHYS MED REHAB, V76, P77, DOI 10.1016/S0003-9993(95)80047-6; Gill-Body KM, 2000, PHYS THER, V80, P748, DOI 10.1093/ptj/80.8.748; Guskiewicz KM, 1996, J ATHL TRAINING, V31, P300; Guskiewicz KM, 2001, J ATHL TRAINING, V36, P263; Guskiewicz KM, 2001, CLIN J SPORT MED, V11, P182, DOI 10.1097/00042752-200107000-00009; HAMMAN RG, 1992, ARCH PHYS MED REHAB, V73, P738; Henriksson M, 2001, AM J SPORT MED, V29, P359, DOI 10.1177/03635465010290031801; Hertel J, 2000, J SPORT REHABIL, V9, P104, DOI 10.1123/jsr.9.2.104; HORAK FB, 1990, EXP BRAIN RES, V82, P167; Kammerlind ASC, 2001, CLIN REHABIL, V15, P463, DOI 10.1191/026921501680425180; McLeod TCV, 2004, CLIN J SPORT MED, V14, P287, DOI 10.1097/00042752-200409000-00007; NASHNER LM, 1990, NEUROL CLIN, V8, P331, DOI 10.1016/S0733-8619(18)30359-1; NeuroCom International Inc, 1992, EQUITEST SYST OP MAN; Nordahl SHG, 2000, AVIAT SPACE ENVIR MD, V71, P889; Randolph C, 2001, J ATHL TRAINING, V36, P288; Riley MA, 2003, NEUROSCI LETT, V342, P45, DOI 10.1016/S0304-3940(03)00229-5; Shahal B, 1999, LARYNGOSCOPE, V109, P1996, DOI 10.1097/00005537-199912000-00019; SHUMWAYCOOK A, 1986, PHYS THER, V66, P1548, DOI 10.1093/ptj/66.10.1548; Valovich TC, 2003, J ATHL TRAINING, V38, P51; VOIGHT ML, 1999, PHYS THER, V79, pS57; WOOLLACOTT MH, 1986, INT J AGING HUM DEV, V23, P97, DOI 10.2190/VXN3-N3RT-54JB-X16X	22	8	8	0	1	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0031-5125	1558-688X		PERCEPT MOTOR SKILL	Percept. Mot. Skills	APR	2006	102	2					379	386					8	Psychology, Experimental	Social Science Citation Index (SSCI)	Psychology	049PK	WOS:000238028300013	16826659				2022-02-06	
J	Ahmad, FU; Mahapatra, AK; Mehta, VS				Ahmad, Faiz Uddin; Mahapatra, Ashok Kumar; Mehta, Veer Singh			Outcome of "unknown" head injury patients at a tertiary care neurosurgical centre	NEUROLOGY INDIA			English	Article						head injury; unknown; trauma; unidentified patients	TRAUMATIC BRAIN-INJURY	Context: A large number of patients are admitted to hospitals in large cities without any identification. These "unknown" patients represent a unique problem in developing countries. There is no systematic study in world literature on this subgroup of patients. Aims: To elucidate the natural history and outcome of traumatic brain injury patients admitted in the department of neurosurgery as "unknowns". Settings and Design: Retrospective analysis of all traumatic brain injury patients admitted to the department of neurosurgery as "unknown", between January 2002 and March 2005. Results: Three hundred and twenty five patients were admitted as unknowns over a 3 year and 3 months period. Most of the patients were young males and became known during their hospital stay. Overall, 33 patients stayed for longer than one month, with 4 of them staying for longer than 6 months. Mortality in mild, moderate and severe head injury group was 1%, 6% and 46% respectively. Conclusions: Unknown patients represent a unique subgroup in metropolitan cities like Delhi. Managing them raises several medico-legal issues. Many of them occupy hospital beds for longer duration than required. There is an acute shortage of rehabilitation homes in Delhi for long term care and rehabilitation of such patients.	All India Inst Med Sci, Ctr Neurosci, Dept Neurosurg, New Delhi 110029, India		Ahmad, FU (corresponding author), All India Inst Med Sci, Ctr Neurosci, Dept Neurosurg, New Delhi 110029, India.	drfaizns@yahoo.co.in					de Guise E, 2005, CAN J NEUROL SCI, V32, P186, DOI 10.1017/S0317167100003954; JINDAL A, 2001, TXN HEAD INJURY, P113; Lehtonen S, 2005, BRAIN INJURY, V19, P239, DOI 10.1080/0269905040004310; LEURSSEN TG, 1988, J NEUROSURG, V68, P409; Mathias JL, 2005, BRAIN INJURY, V19, P271, DOI 10.1080/02699050400005028	5	8	8	0	1	WOLTERS KLUWER MEDKNOW PUBLICATIONS	MUMBAI	WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2 VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA	0028-3886	1998-4022		NEUROL INDIA	Neurol. India	MAR	2006	54	1					73	74					2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	045VG	WOS:000237770100019	16679648				2022-02-06	
J	Jennings, B				Jennings, B			The ordeal of reminding: Traumatic brain injury and the goals of care	HASTINGS CENTER REPORT			English	Article																	Bermudez Jose Luis, 1998, BODY SELF; Brock D., 1993, QUALITY LIFE, P95, DOI [10.1093/0198287976.003.0009, DOI 10.1093/0198287976.003.0009]; Cassell EJ, 1991, NATURE SUFFERING GOA; CRIMMINS C, 2000, WHERE IS MANGO PRINC; Harr?, 1992, AGEING SOC, V12, P443, DOI DOI 10.1017/S0144686X00005262; Harre R., 1994, DISCURSIVE MIND; Harre Rom, 1998, SINGULAR SELF; IRVING J, 1990, WORLD ACCORDING GARP, P15; IRVING J, 1990, WORLD ACCORDING GARP; Jaworska A, 1999, PHILOS PUBLIC AFF, V28, P105, DOI 10.1111/j.1088-4963.1999.00105.x; JENNINGS B, 2000, QUALITY LIFE ALZHEIM, P165; Killick J., 2001, COMMUNICATION CARE P; KITWOOD T, DEMENTIA RECONSIDERE, P144; Kitwood T., 1997, DEMENTIA RECONSIDERE; Marsh NV, 1998, BRAIN INJURY, V12, P1045, DOI 10.1080/026990598121954; Parfit Derek., 1984, REASONS PERSONS, P493; Radden J., 1996, DIVIDED MINDS SUCCES; Roessler J., 2003, AGENCY SELF AWARENES; STEVENS W, 1990, COLLECTED POEMS, P128; Thomas Lewis, 1974, LIVES CELL NOTES BIO; TUGENDHAT E, 1986, SELF CONSCIOUSNESS S; WINSLADE, CONFRONTING TRAUMATI, P11; WINSLADE WJ, 1998, UNLESSS OTHERWISE NO; 2001, GEORGIA LAW REV, V35, P593	24	8	8	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0093-0334	1552-146X		HASTINGS CENT REP	Hastings Cent. Rep.	MAR-APR	2006	36	2					29	37		10.1353/hcr.2006.0026			9	Ethics; Health Care Sciences & Services; Medical Ethics; Social Sciences, Biomedical	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Social Sciences - Other Topics; Health Care Sciences & Services; Medical Ethics; Biomedical Social Sciences	023ZE	WOS:000236163900019	16604896				2022-02-06	
J	Leinenweber, SB; Sheng, HX; Lynch, JR; Wang, HC; Batinic-Haberle, I; Laskowitz, DT; Crapo, JD; Pearlstein, RD; Warner, DS				Leinenweber, SB; Sheng, HX; Lynch, JR; Wang, HC; Batinic-Haberle, I; Laskowitz, DT; Crapo, JD; Pearlstein, RD; Warner, DS			Effects of a manganese(III) porphyrin catalytic antioxidant in a mouse closed head injury model	EUROPEAN JOURNAL OF PHARMACOLOGY			English	Article						aconitase; antioxidant; closed cranial impact; Mn (III) porphyrin; superoxide dismutase; traumatic brain injury; (Mouse)	TRAUMATIC BRAIN-INJURY; CONTROLLED CORTICAL IMPACT; FLUID PERCUSSION INJURY; SUPEROXIDE-DISMUTASE; APOLIPOPROTEIN-E; NITRIC-OXIDE; NEURONAL DEGENERATION; LIPID-PEROXIDATION; CELLULAR-DAMAGE; FLUORO-JADE	Closed head injury induces cerebral oxidative stress. The efficacy of a Mn (III) porphyrin catalytic antioxidant was assessed in a mouse closed head injury model. Mice were subjected to closed head injury and treated 15 min later with air i.v. bolus of vehicle or 3 mg/kg MnTE-2-pyp(5+). Aconitase activity, Fluoro-Jade staining, glial fibrillary acidic protein immunoreactivity, and rotarod failing latencies were measured. Closed head injury altered all variables. MnTE-2-PyP5+ had no effect on any variable with the exception of attenuation of aconitase inactivation at 2 h post-closed head injury. In a second experiment, mice received 3 mg/kg or 6 mg/kg MnTE-2-PyP5+ or vehicle i.v. 15 min post-closed head injury. Rotarod and Morris water maze latencies were measured. Closed head injury altered performance in both tests. No statistically significant effect of MnTE-2-PyP5+ was observed. We conclude that single dose MnTE-2-PyP5+ does not alter outcome in this mouse closed head injury model. (c) 2005 Elsevier B.V. All rights reserved.	Duke Univ, Med Ctr, Dept Anesthesiol, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Pediat, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Med Neurol, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Radiat Oncol, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Surg Neurosurg, Durham, NC 27710 USA; Natl Jewish Med & Res Ctr, Dept Med, Denver, CO 80206 USA; Duke Univ, Med Ctr, Multidisciplinary Neuroprotect Labs, Durham, NC 27710 USA		Warner, DS (corresponding author), Duke Univ, Med Ctr, Dept Anesthesiol, Box 3094, Durham, NC 27710 USA.	warne002@mc.duke.edu			NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [P01HL042444] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [T32GM008600] Funding Source: NIH RePORTER; NHLBI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [P01HL42444] Funding Source: Medline; NIGMS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [T32 GM08600] Funding Source: Medline		Aoyama N, 2002, BRAIN RES, V934, P117, DOI 10.1016/S0006-8993(02)02366-1; Batinic-Haberle I, 1999, INORG CHEM, V38, P4011, DOI 10.1021/ic990118k; Batinic-Haberle I, 1998, J BIOL CHEM, V273, P24521, DOI 10.1074/jbc.273.38.24521; Batinic-Haberle I, 2002, METHOD ENZYMOL, V349, P223, DOI 10.1016/S0076-6879(02)49337-8; Bayir H, 2004, J NEUROTRAUM, V21, P1, DOI 10.1089/089771504772695896; Bayir H, 2002, PEDIATR RES, V51, P571, DOI 10.1203/00006450-200205000-00005; BECKMAN JS, 1990, P NATL ACAD SCI USA, V87, P1620, DOI 10.1073/pnas.87.4.1620; Belayev L, 2002, J NEUROSURG, V96, P1077, DOI 10.3171/jns.2002.96.6.1077; Chen S, 2003, EXP NEUROL, V182, P87, DOI 10.1016/S0014-4886(03)00002-5; Cherian L, 2003, J NEUROTRAUM, V20, P77, DOI 10.1089/08977150360517209; Fabian RH, 1998, J NEUROTRAUM, V15, P433, DOI 10.1089/neu.1998.15.433; GARDNER PR, 1992, J BIOL CHEM, V267, P8757; Hamm RJ, 1996, J NEUROTRAUM, V13, P325, DOI 10.1089/neu.1996.13.325; HAMM RJ, 1994, J NEUROTRAUM, V11, P187, DOI 10.1089/neu.1994.11.187; Kochanek OM, 1995, J NEUROTRAUM, V12, P1015, DOI 10.1089/neu.1995.12.1015; KONTOS HA, 1986, J NEUROSURG, V64, P803, DOI 10.3171/jns.1986.64.5.0803; Laskowitz DT, 2001, EXP NEUROL, V167, P74, DOI 10.1006/exnr.2001.7541; Lewen A, 2001, NEUROBIOL DIS, V8, P380, DOI 10.1006/nbdi.2001.0396; Lynch JR, 2002, ANN NEUROL, V51, P113, DOI 10.1002/ana.10098; Lynch JR, 2005, EXP NEUROL, V192, P109, DOI 10.1016/j.expneurol.2004.11.014; Mackensen GB, 2001, J NEUROSCI, V21, P4582, DOI 10.1523/JNEUROSCI.21-13-04582.2001; Marklund N, 2001, J NEUROTRAUM, V18, P821, DOI 10.1089/089771501316919184; Mesenge C, 1998, EUR J PHARMACOL, V353, P53, DOI 10.1016/S0014-2999(98)00432-4; Mikawa S, 1996, J NEUROSURG, V85, P885, DOI 10.3171/jns.1996.85.5.0885; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; Philip S, 2003, BRAIN RES, V979, P98, DOI 10.1016/S0006-8993(03)02879-8; Pineda JA, 2001, J NEUROTRAUM, V18, P625, DOI 10.1089/089771501750291864; RADI R, 1991, ARCH BIOCHEM BIOPHYS, V288, P481, DOI 10.1016/0003-9861(91)90224-7; Schmued LC, 1997, BRAIN RES, V751, P37, DOI 10.1016/S0006-8993(96)01387-X; Schmued LC, 2000, BRAIN RES, V874, P123, DOI 10.1016/S0006-8993(00)02513-0; Sheng HX, 2002, DRUG NEWS PERSPECT, V15, P654, DOI 10.1358/dnp.2002.15.10.740236; Sheng HX, 2002, FREE RADICAL BIO MED, V33, P947, DOI 10.1016/S0891-5849(02)00979-6; Sheng HX, 2004, NEUROSCI LETT, V366, P220, DOI 10.1016/j.neulet.2004.05.050; SMITH DH, 1995, J NEUROTRAUM, V12, P169, DOI 10.1089/neu.1995.12.169; Young B, 1996, JAMA-J AM MED ASSOC, V276, P538, DOI 10.1001/jama.276.7.538; Yunoki M, 2003, SURG NEUROL, V59, P156, DOI 10.1016/S0090-3019(02)01040-6	37	8	9	0	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0014-2999	1879-0712		EUR J PHARMACOL	Eur. J. Pharmacol.	FEB 15	2006	531	1-3					126	132		10.1016/j.ejphar.2005.12.031			7	Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	015QP	WOS:000235566200019	16455070				2022-02-06	
J	Demir, SO; Gorgulu, G; Koseoglu, F				Demir, SO; Gorgulu, G; Koseoglu, F			Comparison of rehabilitation outcome in patients with aphasic and non-aphasic traumatic brain injury	JOURNAL OF REHABILITATION MEDICINE			English	Article						traumatic brain injury; aphasia; rehabilitation	HEAD-INJURY	Objective: To compare the functional, cognitive and disability status of aphasic and non-aphasic traumatic brain injury patients. Design: A prospective comparative study in which 103 patients with traumatic brain injury participated. Subjects: Fifty-one aphasic and 52 non-aphasic patients with traumatic brain injury. Methods: Functional Independence Measure and Disability Rating Scale were used to determine functional status and disability. Cognitive status was evaluated by the Mini-Mental Status Examination. Aphasic patients were evaluated using the Gulhane Aphasia Test for language disorders. Results: The most frequent type of aphasia was Broca aphasia at 26.49% followed by anomic at 19.6% and trans-cortical motor at 15.6%. Functional Independence Measure, Disability Rating Scale and Mini-Mental Status Examination scores at admission and at discharge showed significant differences in aphasic patients (p <0.001). There were no significant differences in the Functional Independence Measure, Disability Rating Scale and Mini-Mental Status Examination gains between the aphasic and non-aphasic patients (p >0.01). Conclusion: Although aphasia could be accepted as a negative prognostic indicator in patients with traumatic brain injury, we could not detect any difference in functional and cognitive gains between the aphasic and non-aphasic patients.	Minist Hlth, Ankara Phys Med & Rehabil Educ & Res Hosp, Dept Phys Med & Rehabil, Ankara, Turkey		Demir, SO (corresponding author), Turan Gunes Bulvari 12 Cadde 11-4, TR-06450 Oran Ankara, Turkey.	sibiozbudak@hotmail.com					[Anonymous], 1993, GUID UN DAT SET MED; Connolly JF, 1999, ARCH PHYS MED REHAB, V80, P1309, DOI 10.1016/S0003-9993(99)90035-7; Duff MC, 2002, BRAIN INJURY, V16, P773, DOI 10.1080/02699050210128870; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Gil M, 1996, BRAIN INJURY, V10, P39, DOI 10.1080/026990596124700; HARASYMIW SJ, 1981, BRAIN LANG, V12, P190, DOI 10.1016/0093-934X(81)90012-2; Huebner RA, 2003, AM J OCCUP THER, V57, P177, DOI 10.5014/ajot.57.2.177; Jain N, 2000, CLIN NEUROPSYCHOL, V14, P13, DOI 10.1076/1385-4046(200002)14:1;1-8;FT013; JOHNSON VM, 1996, MED REHABILITATION T, P197; MACKAY LE, 1992, ARCH PHYS MED REHAB, V73, P635; Moran C, 2004, BRAIN INJURY, V18, P273, DOI 10.1080/02699050310001617415; Musso M, 1999, BRAIN, V122, P1781, DOI 10.1093/brain/122.9.1781; PETRY MC, 1994, NEUROPSYCHOLOGIA, V32, P1397, DOI 10.1016/0028-3932(94)00072-7; PRITAGONA GP, 1997, ARCH PHYS MED REHAB, V78, P612; Rao RP, 1996, PHYS MED REHABILITAT, P55; SARNO MT, 1980, J NERV MENT DIS, V168, P685, DOI 10.1097/00005053-198011000-00008; TAYLORSARNO M, 1992, SCAND J REHABIL MED, P43; THOMSEN IV, 1975, J NEUROL NEUROSUR PS, V38, P713, DOI 10.1136/jnnp.38.7.713; Yavuzer G, 2001, INT J REHABIL RES, V24, P241, DOI 10.1097/00004356-200109000-00011	19	8	8	1	2	FOUNDATION REHABILITATION INFORMATION	UPPSALA	TRADGARDSGATAN 14, UPPSALA, SE-753 09, SWEDEN	1650-1977	1651-2081		J REHABIL MED	J. Rehabil. Med.	JAN	2006	38	1					68	71		10.1080/16501970510041262			4	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	005SV	WOS:000234845000012	16548091	gold			2022-02-06	
J	Ranjan, D; Schmonsky, K; Johnston, T; Jeon, H; Bouneva, I; Erway, E				Ranjan, D; Schmonsky, K; Johnston, T; Jeon, H; Bouneva, I; Erway, E			Financial analysis of potential donor management at a Medicare-approved transplant hospital	AMERICAN JOURNAL OF TRANSPLANTATION			English	Article						brain injury; donor; financial analysis; Medicare cost report	TRAUMATIC BRAIN-INJURY	The purpose of this study was to perform a financial analysis of severe brain injured (SBI) patient management to determine potential reimbursement versus net losses in relation to organ donation and transplantation at a transplant center. We undertook a retrospective analysis of financial records of medically suitable referrals to the organ procurement organization (OPO) from our institution for fiscal years 2002-2003. This included (1) hospital cost and reimbursement, (2) OPO reimbursement for actual donors, (3) financial returns on local transplant activity solely supported by local donor activity and (4) Medicare incentives for local organ donation. There were 48 potential and 18 organ donors for this period. The consent rate reduced from 50% to 25% if family was offered withdrawal of care. After reimbursements from OPO, Medicare incentives and kidney transplant activity solely supported by local organ donation were figured in, the total returns were 244% of total cost of SBI patient management. Aggressive proactive management of severely brain injured patients remains a good medical practice. For Medicare-approved transplant centers, there are additional financial incentives to aggressively treat these patients and pursue organ donation. Prematurely offering withdrawal of care negatively impacts on the organ donation process and hurts institutions financially.	Univ Kentucky, Div Transplant Surg, Lexington, KY 40506 USA; Univ Kentucky, Div Gastroenterol, Lexington, KY 40506 USA; VA Med Ctr, Lexington, KY USA		Ranjan, D (corresponding author), Univ Kentucky, Div Transplant Surg, Lexington, KY 40506 USA.	dranj1@uky.edu					COCANOUR CS, 1995, J TRAUMA, V39, P968, DOI 10.1097/00005373-199511000-00024; Foster J, 1996, AACN Clin Issues, V7, P168, DOI 10.1097/00044067-199602000-00016; Hauptman PJ, 1997, NEW ENGL J MED, V336, P422, DOI 10.1056/NEJM199702063360607; LEIGHTON C, 2001, ARCH PHYS MED REHAB, V82, P1151; McGarry LJ, 2002, J TRAUMA, V53, P1152, DOI 10.1097/00005373-200212000-00020; Mendcloff J, 2004, TRANSPLANTATION, V78, P1704, DOI 10.1097/01.TP.0000149787.97288.A2; SMITH S, 2005, QUALITY ASPECTS TRAN; Spain DA, 1998, J TRAUMA, V45, P101, DOI 10.1097/00005373-199807000-00022; TABARROK A, 2004, LIFE SAVING INCENTIV	9	8	8	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1600-6135	1600-6143		AM J TRANSPLANT	Am. J. Transplant.	JAN	2006	6	1					199	204		10.1111/j.1600-6143.2005.01150.x			6	Surgery; Transplantation	Science Citation Index Expanded (SCI-EXPANDED)	Surgery; Transplantation	998UH	WOS:000234344900030	16433775	Bronze			2022-02-06	
J	Ries, M; Marks, W				Ries, Michele; Marks, William			Heightened false memory: A long-term sequela of severe closed head injury	NEUROPSYCHOLOGIA			English	Article; Proceedings Paper	31st Annual Meeting of the International-Neuropsychological-Society	FEB 05-08, 2003	HONOLULU, HI	Int Neuropsychol Soc		closed head injury; traumatic brain injury; memory; false memory	TRAUMATIC BRAIN INJURY; FUZZY-TRACE THEORY; RIGHT FRONTAL-LOBE; NEUROPSYCHOLOGICAL DEFICITS; SELECTIVE ATTENTION; ILLUSORY MEMORIES; OLDER-ADULTS; RECOGNITION; CONFABULATION; AMNESIA	Declarative memory impairment is a common long-term sequela of severe closed head injury (CHI). Although veridical memory performance following severe CHI has received attention in the literature, little is known about false memory production in this population. Within the present study, both long-term survivors of severe CHI and matched control participants studied and were tested on six 12-items word lists from the Deese Roediger McDermott (DRM) paradigm. Word lists from the DRM are composed of words that are strongly semantically associated to a non-presented word (i.e., the critical lure). Prior studies have shown that healthy young adults show a high level of false recall and recognition memory for the critical lures, and it was hypothesized individuals with severe CHI would show heightened susceptibility to false memory compared to control participants due to difficulty with monitoring of memory. It was further hypothesized that severe CHI participants would show high confidence in their false memories. Consistent with hypotheses, results indicated that although severe CHI participants remembered fewer actual list items, they made more semantically related intrusion errors (recall) and false-positive responses (recognition) than the control participants. Severe CHI participants also showed greater confidence in their false memories than did control participants. The results are interpreted in the context of theoretical accounts of false memory, and possible structural and functional brain changes that might account for the Severe CHI group's memory performance are discussed. (c) 2006 Elsevier Ltd. All rights reserved.	Univ Memphis, Memphis, TN 38152 USA		Ries, M (corresponding author), Univ Wisconsin, Sch Med, Vet Adm Hosp, GRECC 11G,2500 Overlook Terrace, Madison, WI 53705 USA.	mlr@medicine.wisc.edu					Balota DA, 1999, COGNITIVE NEUROPSYCH, V16, P361, DOI 10.1080/026432999380834; Bergeson AG, 2004, CLIN NEUROPSYCHOL, V18, P509, DOI 10.1080/1385404049052414; Bigler ED, 2003, ARCH CLIN NEUROPSYCH, V18, P595; Bigler ED, 2001, ARCH CLIN NEUROPSYCH, V16, P95; BOAKE C, 1995, BRAIN INJURY, V9, P273, DOI 10.3109/02699059509008198; Box O, 1999, NEUROCASE, V5, P251, DOI 10.1080/13554799908402730; Brainerd CJ, 1998, J EXP CHILD PSYCHOL, V71, P81, DOI 10.1006/jecp.1998.2464; Budson AE, 2005, NEUROPSYCHOLOGIA, V43, P860, DOI 10.1016/j.neuropsychologia.2004.09.011; Budson AE, 2002, BRAIN, V125, P2750, DOI 10.1093/brain/awf277; Budson AE, 2003, COGN BEHAV NEUROL, V16, P16, DOI 10.1097/00146965-200303000-00003; Curran T, 1997, NEUROPSYCHOLOGIA, V35, P1035, DOI 10.1016/S0028-3932(97)00029-8; DEESE J, 1959, J EXP PSYCHOL, V58, P17, DOI 10.1037/h0046671; Delis D.C., 2000, CALIFORNIA VERBAL LE; DeLuca J., 2000, NEUROPSYCHOANALYSIS, V2, P119, DOI [https://doi.org/10.1080/15294145.2000.10773294, DOI 10.1080/15294145.2000.10773294]; Demery JA, 2001, NEUROCASE, V7, P295, DOI 10.1076/neur.7.4.295.16258; Dodson CS, 2001, PSYCHON B REV, V8, P155, DOI 10.3758/BF03196152; Fontaine A, 1999, NEUROLOGY, V53, P1963, DOI 10.1212/WNL.53.9.1963; Heaton R.K., 1981, WISCONSIN CARD SORTI; Hege ACG, 2004, J EXP PSYCHOL LEARN, V30, P787, DOI 10.1037/0278-7393.30.4.787; Henson RNA, 1999, BRAIN, V122, P1367, DOI 10.1093/brain/122.7.1367; Jenkins J, 1970, NORMS WORD ASS, P1; Johnson MK, 2000, MEMORY, BRAIN, AND BELIEF, P35; Kennedy MRT, 2001, BRAIN INJURY, V15, P469, DOI 10.1080/02699050010007380; LEVIN HS, 1990, J CLIN EXP NEUROPSYC, V12, P129, DOI 10.1080/01688639008400960; LEVIN HS, 1988, J NEUROL NEUROSUR PS, V51, P1294, DOI 10.1136/jnnp.51.10.1294; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; LOFTUS EF, 1993, AM PSYCHOL, V48, P518, DOI 10.1037/0003-066X.48.5.518; McDermott KB, 1998, J MEM LANG, V39, P508, DOI 10.1006/jmla.1998.2582; McMillan TM, 1996, J NEUROL NEUROSUR PS, V60, P422, DOI 10.1136/jnnp.60.4.422; Melo B, 1999, COGNITIVE NEUROPSYCH, V16, P343, DOI 10.1080/026432999380825; Moscovitch M, 1997, NEUROPSYCHOLOGIA, V35, P1017, DOI 10.1016/S0028-3932(97)00028-6; Norman KA, 1997, MEM COGNITION, V25, P838, DOI 10.3758/BF03211328; Port A, 2002, BRAIN INJURY, V16, P277, DOI 10.1080/02699050110103274; Prigatano G. P., 1991, AWARENESS DEFICIT BR; RAJARAM S, 1993, MEM COGNITION, V21, P89, DOI 10.3758/BF03211168; Reyna VF, 1998, J EXP CHILD PSYCHOL, V71, P194, DOI 10.1006/jecp.1998.2472; Ries M, 2005, NEUROPSYCHOLOGY, V19, P476, DOI 10.1037/0894-4105.19.4.476; Roediger H. L. I., 2000, OXFORD HDB MEMORY, P149; ROEDIGER HL, 1995, J EXP PSYCHOL LEARN, V21, P803, DOI 10.1037/0278-7393.21.4.803; RUSSELL WR, 1961, ARCH NEUROL-CHICAGO, V5, P4, DOI 10.1001/archneur.1961.00450130006002; Schacter DL, 1996, NEUROPSYCHOLOGIA, V34, P793, DOI 10.1016/0028-3932(95)00165-4; Schacter DL, 1997, NEUROPSYCHOLOGY, V11, P331, DOI 10.1037/0894-4105.11.3.331; Schacter DL, 2004, NEURON, V44, P149, DOI 10.1016/j.neuron.2004.08.017; Schacter DL, 2000, FALSE-MEMORY CREATION IN CHILDREN AND ADULTS, P129; Schnider A, 2000, J NEUROSCI, V20, P5880, DOI 10.1523/JNEUROSCI.20-15-05880.2000; Seamon JG, 2002, MEM COGNITION, V30, P1054, DOI 10.3758/BF03194323; SHIMAMURA AP, 1986, J EXP PSYCHOL LEARN, V12, P452, DOI 10.1037/0278-7393.12.3.452; STUSS DT, 1978, NEUROLOGY, V28, P1166, DOI 10.1212/WNL.28.11.1166; Tun PA, 1998, PSYCHOL AGING, V13, P230, DOI 10.1037/0882-7974.13.2.230; Vakil E, 1997, NEUROPSYCHOLOGY, V11, P545, DOI 10.1037/0894-4105.11.4.545; VAKIL E, 1995, J CLIN EXP NEUROPSYC, V17, P335, DOI 10.1080/01688639508405127; Wechsler D., 2011, WECHSLER ABBREVIATED; Wiese H, 2004, CLIN NEUROPHYSIOL, V115, P289, DOI 10.1016/S1388-2457(03)00348-1; Zec RF, 2001, J CLIN EXP NEUROPSYC, V23, P671, DOI 10.1076/jcen.23.5.671.1247; [No title captured]; [No title captured]	56	8	9	0	8	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0028-3932	1873-3514		NEUROPSYCHOLOGIA	Neuropsychologia		2006	44	12					2233	2240		10.1016/j.neuropsychologia.2006.05.021			8	Behavioral Sciences; Neurosciences; Psychology, Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Science (CPCI-S); Conference Proceedings Citation Index - Social Science &amp; Humanities (CPCI-SSH)	Behavioral Sciences; Neurosciences & Neurology; Psychology	074EI	WOS:000239795100004	16814819				2022-02-06	
J	Sugden, SG; Kile, SJ; Farrimond, DD; Hilty, DM; Bourgeois, JA				Sugden, Steven G.; Kile, Shawn J.; Farrimond, Derald D.; Hilty, Donald M.; Bourgeois, James A.			Pharmacological intervention for cognitive deficits and aggression in frontal lobe injury	NEUROREHABILITATION			English	Article						amantadine; donepezil; valproate; aggression; frontal lobe syndrome; traumatic brain injury	TRAUMATIC BRAIN-INJURY; HEAD-INJURY; AMANTADINE; ATTENTION; MEMORY; METHYLPHENIDATE; DYSFUNCTION; IMPROVEMENT; DONEPEZIL; MODERATE	We present a case that promotes early intervention and pharmacological treatment for the neuropsychiatric sequelae (frontal lobe syndrome, including cognitive impairment and aggressive behavior) associated with traumatic brain injury (TBI) and delirium. The patient, who sustained significant systemic complications related to his trauma, was previously diagnosed with alcohol and drug dependence and antisocial personality disorder. These antecedent conditions and prolonged systemic complications likely played a complicating role in his course of recovery.	Univ Calif Davis, Dept Psychiat & Behav Sci, Sacramento, CA 95817 USA		Bourgeois, JA (corresponding author), Univ Calif Davis, Dept Psychiat & Behav Sci, 2230 Stockton Blvd, Sacramento, CA 95817 USA.	james.bourgeois@ucdmc.ucdavis.edu					Andersson Stein, 1992, Tidsskrift for den Norske Laegeforening, V112, P2070; Arciniegas D, 1999, BRAIN INJURY, V13, P1, DOI 10.1080/026990599121827; Bode RK, 2002, ARCH PHYS MED REHAB, V83, P100, DOI 10.1053/apmr.2002.26073; CARDENAS DD, 1994, BRAIN INJURY, V8, P579, DOI 10.3109/02699059409151010; Fann JR, 2001, PSYCHOSOMATICS, V42, P48, DOI 10.1176/appi.psy.42.1.48; Gennarelli T. A., 1987, HEAD INJURY, P108; Gennarelli TA, 1998, SEMIN CLIN NEUROPSYC, V3, P73; Goldstein LB, 2003, BRAIN INJURY, V17, P685, DOI 10.1080/0269905031000107179; GUALTIERI T, 1989, CLIN NEUROPHARMACOL, V12, P258, DOI 10.1097/00002826-198908000-00003; Kraus MF, 1997, J NEUROPSYCH CLIN N, V9, P222; Lindenmayer JP, 2000, J CLIN PSYCHIAT, V61, P123, DOI 10.4088/JCP.v61n0207; MALDONADO VC, 1991, J NEUROL SCI, V103, pS15; Marshall LF, 2000, NEUROSURGERY, V47, P546, DOI 10.1097/00006123-200009000-00002; Meythaler JM, 2002, J HEAD TRAUMA REHAB, V17, P300, DOI 10.1097/00001199-200208000-00004; Plenger PM, 1996, ARCH PHYS MED REHAB, V77, P536, DOI 10.1016/S0003-9993(96)90291-9; Rao V, 2000, PSYCHOSOMATICS, V41, P95, DOI 10.1176/appi.psy.41.2.95; Rao V, 2002, PSYCHIAT CLIN N AM, V25, P43, DOI 10.1016/S0193-953X(03)00052-2; RUSSELL WR, 1961, ARCH NEUROL-CHICAGO, V5, P4, DOI 10.1001/archneur.1961.00450130006002; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Tenovuo O, 2005, PROG NEURO-PSYCHOPH, V29, P61, DOI 10.1016/j.pnpbp.2004.10.006; van der Naalt J, 1999, J NEUROL NEUROSUR PS, V66, P207, DOI 10.1136/jnnp.66.2.207; VANPRAAG HM, 1990, BRIT J PSYCHIAT, V157, P723, DOI 10.1192/bjp.157.5.723; VANREEKUM R, 1995, BRAIN INJURY, V9, P49, DOI 10.3109/02699059509004571; Whelan F J, 2000, Ann Clin Psychiatry, V12, P131; WHITLOCK JA, 1995, ARCH PHYS MED REHAB, V76, P1103, DOI 10.1016/S0003-9993(95)80117-0; Whitlock JA, 1999, J HEAD TRAUMA REHAB, V14, P424, DOI 10.1097/00001199-199908000-00010; Whyte J, 2004, AM J PHYS MED REHAB, V83, P401, DOI 10.1097/01.PHM.0000128789.75375.D3; Whyte J, 2001, ARCH PHYS MED REHAB, V82, P1355, DOI 10.1053/apmr.2001.26091; Zhang L, 2004, ARCH PHYS MED REHAB, V85, P1050, DOI 10.1016/j.apmr.2003.10.014	29	8	9	0	2	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135	1878-6448		NEUROREHABILITATION	Neurorehabilitation		2006	21	1					3	7					5	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	045KY	WOS:000237742200002	16720932				2022-02-06	
J	Lee, JI; Kim, JH; Kim, HW; Choi, ES; Lim, SH; Ko, YJ; Han, YM				Lee, JI; Kim, JH; Kim, HW; Choi, ES; Lim, SH; Ko, YJ; Han, YM			Changes in bone metabolism in a rat model of traumatic brain injury	BRAIN INJURY			English	Article						traumatic brain injury; immobilization; osteoporosis	LATERAL FLUID-PERCUSSION; HEAD-INJURY; CIRCULATING LEVELS; CANCELLOUS BONE; MINERAL DENSITY; IMMOBILIZATION; STROKE; ADAPTATION; FRACTURES	Primary objective: To evaluate the process of bone metabolism after traumatic brain injury. Research design: Randomized controlled trial. Methods and procedures: Rats were randomly assigned to either the brain injury group or to the sham-operation group using a fluid percussion device. The BMDs of lumbar vertebrae and proximal femur and bone turnover markers, osteocalcin and carboxy-terminal telopeptide, were measured at three points: the day before surgery and 1 and 3 weeks post-operatively. The biomechanics (maximum load of tibia and femoral neck) were measured 3 weeks post-operatively. Main outcomes and results: There was significant change in the BMDs of lumbar vertebrae 1 week post-operatively and of both distal femurs 3 weeks post-operatively (p < 0.05). A significant change in the maximum load of femoral neck was also observed 3 weeks post-operatively between the brain injury and the sham-operation groups (p = 0.044). Conclusions: This finding suggests that brain injury could induce osteoporosis by immobilization.	Catholic Univ Korea, Coll Med, Dept Rehabil Med, Seoul 137701, South Korea; Catholic Univ Korea, Coll Med, Catholic Neurosci Ctr, Seoul 137701, South Korea		Ko, YJ (corresponding author), Catholic Univ Korea, Coll Med, Dept Rehabil Med, 505 Banpo Dong, Seoul 137701, South Korea.	yjko@catholic.ac.kr		Lim, Seong Hoon/0000-0002-5475-4153			Beeton CA, 2004, J BONE JOINT SURG BR, V86B, P912, DOI 10.1302/0301-620x.86b6.14176; Beeton CA, 2002, J BONE JOINT SURG BR, V84B, P434, DOI 10.1302/0301-620X.84B3.12027; CHEN MM, 1992, ANAT RECORD, V234, P317, DOI 10.1002/ar.1092340304; Clement EV, 1999, BONE, V24, P131; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; Hallam TM, 2004, J NEUROTRAUM, V21, P521, DOI 10.1089/089771504774129865; Jorgensen L, 2000, OSTEOPOROSIS INT, V11, P381, DOI 10.1007/s001980070103; Lee JS, 2004, J NEUROTRAUM, V21, P549, DOI 10.1089/089771504774129883; LI XJ, 1990, ANAT RECORD, V227, P12, DOI 10.1002/ar.1092270103; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; Mosekilde L, 2000, BONE, V27, P639, DOI 10.1016/S8756-3282(00)00375-6; PERKINS R, 1987, J BONE JOINT SURG BR, V69, P521, DOI 10.1302/0301-620X.69B4.3611150; Sato Y, 2000, ARCH PHYS MED REHAB, V81, P117, DOI 10.1053/apmr.2000.0810117; Sato Y, 2000, J NEUROL SCI, V175, P135, DOI 10.1016/S0022-510X(00)00298-7; Sato Y, 1998, STROKE, V29, P1373, DOI 10.1161/01.STR.29.7.1373; Scott JF, 2000, AGE AGEING, V29, P197, DOI 10.1093/ageing/29.3.197; SPENCER RF, 1987, J BONE JOINT SURG BR, V69, P525, DOI 10.1302/0301-620X.69B4.3611151; VANDERWIEL HE, 1994, J BONE JOINT SURG AM, V76A, P230, DOI 10.2106/00004623-199402000-00009; Wildburger R, 1998, J ENDOCRINOL INVEST, V21, P78, DOI 10.1007/BF03350319	19	8	8	0	1	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	DEC	2005	19	14					1207	1211		10.1080/02699050500309338			5	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	983ZF	WOS:000233270200004	16286336				2022-02-06	
J	Ptok, M				Ptok, M			Pragmatic language impairment in children	HNO			German	Article						pragmatic language impairment; specific language impairment; children; therapeutic interventions; autism	COMMUNICATION CHECKLIST CCC; NONVERBAL-COMMUNICATION; AUTISTIC SYMPTOMATOLOGY; EXECUTIVE DYSFUNCTION; EMOTIONAL EXPRESSIONS; ASPERGER-SYNDROME; DISORDER; INTERVENTION; PRESCHOOLERS; INDIVIDUALS	When a child's language development does not follow the normal developmental course for no known reasons specific language impairment (SLI) is diagnosed. In contrast, pragmatic language impairment (PLI) refers to children who experience significant difficulties with the use of language. Clinical accounts of PLI have suggested that unlike children with more typical SLI, children with PLI have adequate syntax and phonology and are often verbally fluent. However, they may exhibit a range of linguistic and communicative deficits such as comprehension deficits for connected speech, conversational inadequacies, poor turn-taking, atypical word choices, literal interpretation of figurative language, and poor topic maintenance. There also may be fundamental deficits in social cognition, such as appreciating the thoughts and feelings of others. PLI may be found in SLI children, children with learning disabilities, autism and traumatic brain injuries. Here we review aspects of pragmatic communication skills, the development of emotion recognition, and diagnostic and therapeutic procedures. Otolaryngologists have to be aware of PLI in case children with communication problems are referred to them. This may enable a timely diagnosis and early intervention.	MHH, Klin & Poliklin Phoniatrie & Padaudiol, D-30625 Hannover, Germany		Ptok, M (corresponding author), MHH, Klin & Poliklin Phoniatrie & Padaudiol, Carl Neuberg Str 1, D-30625 Hannover, Germany.	ptok.martin@mh-hannover.de	Ptok, Martin/AAB-7021-2020		NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R01MH068286] Funding Source: NIH RePORTER; NIMH NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R01 MH068286] Funding Source: Medline		Adams C, 2001, INT J LANG COMM DIS, V36, P289, DOI 10.1080/13682820110055161; Baron-cohen S., 1995, JOINT ATTENTION ITS; Barrett S, 2004, AUTISM, V8, P61, DOI 10.1177/1362361304040640; Bishop DVM, 2005, AUTISM, V9, P29, DOI 10.1177/1362361305049028; Bishop DVM, 2005, AUTISM, V9, P7, DOI 10.1177/1362361305049027; Bishop DVM, 1998, J CHILD PSYCHOL PSYC, V39, P879, DOI 10.1017/S0021963098002832; Bishop DVM, 2002, J CHILD PSYCHOL PSYC, V43, P917, DOI 10.1111/1469-7610.00114; BISHOP DVM, 1987, CHILDHOOD LANGUAGE D; Botting N, 2004, INT J LANG COMM DIS, V39, P215, DOI 10.1080/13682820310001617001; Botting N., 1999, AUTISM, V3, P371, DOI DOI 10.1177/1362361399003004005; Camarata SM, 1999, MENT RETARD DEV D R, V5, P207, DOI 10.1002/(SICI)1098-2779(1999)5:3<207::AID-MRDD7>3.0.CO;2-O; CARON AJ, 1988, CHILD DEV, V59, P604, DOI 10.1111/j.1467-8624.1988.tb03219.x; CARON RF, 1985, CHILD DEV, V56, P1552, DOI 10.1111/j.1467-8624.1985.tb00220.x; Celani G, 1999, J AUTISM DEV DISORD, V29, P57, DOI 10.1023/A:1025970600181; Cohen NJ, 1998, J CHILD PSYCHOL PSYC, V39, P853, DOI 10.1111/1469-7610.00286; DAVIES S, 1994, J CHILD PSYCHOL PSYC, V35, P1033, DOI 10.1111/j.1469-7610.1994.tb01808.x; Denham SA, 2003, CHILD DEV, V74, P238, DOI 10.1111/1467-8624.00533; Denham SA, 2002, J CHILD PSYCHOL PSYC, V43, P901, DOI 10.1111/1469-7610.00139; DENHAM SA, 1990, CHILD STUDY J, V20, P171; Drew A, 2002, EUR CHILD ADOLES PSY, V11, P266, DOI 10.1007/s00787-002-0299-6; Ford JA, 2003, J SPEECH LANG HEAR R, V46, P21, DOI 10.1044/1092-4388(2003/002); Geurts HM, 2004, J CHILD PSYCHOL PSYC, V45, P1437, DOI 10.1111/j.1469-7610.2004.00326.x; Hadwin J, 1996, DEV PSYCHOPATHOL, V8, P345, DOI 10.1017/S0954579400007136; HADWIN J, 1991, BRIT J DEV PSYCHOL, V9, P215, DOI 10.1111/j.2044-835X.1991.tb00872.x; Harris P., 1989, CHILDREN EMOTION; HARRIS PL, 1981, J CHILD PSYCHOL PSYC, V22, P247, DOI 10.1111/j.1469-7610.1981.tb00550.x; HARRIS PL, 1987, INT J BEHAV DEV, V10, P319, DOI 10.1177/016502548701000304; Hughes C, 1998, J CHILD PSYCHOL PSYC, V39, P981, DOI 10.1017/S0021963098003059; Martin I, 2004, J AUTISM DEV DISORD, V34, P311, DOI 10.1023/B:JADD.0000029553.52889.15; Martin I, 2003, BRAIN LANG, V85, P451, DOI 10.1016/S0093-934X(03)00070-1; MCDONALD S, 1995, BRAIN INJURY, V9, P255, DOI 10.3109/02699059509008197; MUNDY P, 1995, J SPEECH HEAR RES, V38, P157, DOI 10.1044/jshr.3801.157; Nelson LD, 2001, J INTELL DISABIL RES, V45, P450, DOI 10.1046/j.1365-2788.2001.00379.x; Norbury CF, 2004, INT J LANG COMM DIS, V39, P345, DOI 10.1080/13682820410001654883; Norbury CF, 2002, INT J LANG COMM DIS, V37, P227, DOI 10.1080/13682820210136269; NOWICKI S, 1994, J NONVERBAL BEHAV, V18, P9, DOI 10.1007/BF02169077; Ozonoff S, 1996, BRAIN LANG, V52, P411, DOI 10.1006/brln.1996.0022; PERNER J, 1985, J EXP CHILD PSYCHOL, V39, P437, DOI 10.1016/0022-0965(85)90051-7; Rapin I, 1996, J CHILD PSYCHOL PSYC, V37, P643, DOI 10.1111/j.1469-7610.1996.tb01456.x; Rapin I, 2003, BRAIN DEV-JPN, V25, P166, DOI 10.1016/S0387-7604(02)00191-2; Rapin I, 1983, NEUROPSYCHOLOGY LANG; Shields J, 1996, DEV MED CHILD NEUROL, V38, P487; Silver M, 2001, AUTISM, V5, P299, DOI 10.1177/1362361301005003007; Swettenham J, 1996, J CHILD PSYCHOL PSYC, V37, P157, DOI 10.1111/j.1469-7610.1996.tb01387.x; Timler Geralyn R., 2003, Seminars in Speech and Language, V24, P121, DOI 10.1055/s-2003-38903; TIMLER GR, 2000, DISS ABSTR INT B, V61, P3034; Volden J, 2004, INT J LANG COMM DIS, V39, P171, DOI 10.1080/13682820410001663252; Volden J, 1997, APPL PSYCHOLINGUIST, V18, P181, DOI 10.1017/S0142716400009966; WALDEN TA, 1988, CHILD DEV, V59, P1230, DOI 10.2307/1130486; WENIGER D, 1997, KLINISCHE NEUROPSYCH; WINTRE MG, 1994, DEV PSYCHOL, V30, P509, DOI 10.1037/0012-1649.30.4.509; Yeates KO, 2004, J INT NEUROPSYCH SOC, V10, P412, DOI 10.1017/S1355617704103093; YUILL N, 1984, BRIT J DEV PSYCHOL, V2, P73, DOI 10.1111/j.2044-835X.1984.tb00536.x	53	8	8	3	45	SPRINGER	NEW YORK	233 SPRING STREET, NEW YORK, NY 10013 USA	0017-6192			HNO	HNO	NOV	2005	53	11					978	982		10.1007/s00106-005-1267-5			5	Otorhinolaryngology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Otorhinolaryngology	987ZC	WOS:000233555500010	15909145				2022-02-06	
J	Tse, YH; Leung, GKK; Fan, YW				Tse, Yat-Hang; Leung, Gilberto Ka-Kit; Fan, Yiu-Wah			Cerebral protection in traumatic brain injury	SURGICAL PRACTICE			English	Article						brain injury; neuroprotection	CLOSED-HEAD INJURY; DEXANABINOL HU-211; NEUROPROTECTION; MULTICENTER; HYPOTHERMIA; INHIBITOR; TRIALS	With advances in the understanding of the pathophysiology of traumatic brain injury, many novel cerebroprotective measures have been developed. Many of them have undergone preclinical trials and have shown promising results, but the results have not translated into clinical benefits. Evidence of these cerebroprotective measures including NMDA-receptor antagonist, steroids, free radial scavengers, nimodipine, ziconotide, brady-kinin receptor antagonist and dexanabinol has been reviewed. Problems encountered in clinical studies of traumatic brain injury are mainly related to the heterogenicity of traumatic brain injury and the design of clinical studies. Given all these difficulties, clear benefit of these measures cannot be shown and an optimum treatment strategy has yet been developed.	[Tse, Yat-Hang; Leung, Gilberto Ka-Kit; Fan, Yiu-Wah] Univ Hong Kong, Queen Mary Hosp, Dept Surg, Div Neurosurg, Hong Kong, Hong Kong, Peoples R China		Tse, YH (corresponding author), Univ Hong Kong, Queen Mary Hosp, Dept Surg, Div Neurosurg, Hong Kong, Hong Kong, Peoples R China.	philipyhtse@yahoo.com	Leung, Gilberto Ka Kit/C-4337-2009	Leung, Gilberto Ka Kit/0000-0003-3147-3057			Adelson PD, 2005, NEUROSURGERY, V56, P740, DOI 10.1227/01.NEU.0000156471.50726.26; Alderson P, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000196.pub2; Alderson P, 2004, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001048.pub2, DOI 10.1002/14651858.CD001048.PUB2]; BRAAKMAN R, 1994, J NEUROSURG, V80, P797; Bullock MR, 1999, NEUROSURGERY, V45, P207, DOI 10.1097/00006123-199908000-00001; Darlington CL, 2003, IDRUGS, V6, P976; Hortobagyi T, 2003, NEUROSCIENCE, V121, P983, DOI 10.1016/S0306-4522(03)00482-2; Knoblach SM, 2004, J CEREBR BLOOD F MET, V24, P1119, DOI 10.1097/01.WCB.0000138664.17682.32; Knoller N, 2002, CRIT CARE MED, V30, P548, DOI 10.1097/00003246-200203000-00009; Marion DW, 1997, NEW ENGL J MED, V336, P540, DOI 10.1056/NEJM199702203360803; Marmarou A, 1999, J NEUROTRAUM, V16, P431, DOI 10.1089/neu.1999.16.431; Marshall LF, 1998, J NEUROSURG, V89, P519, DOI 10.3171/jns.1998.89.4.0519; Morris GF, 1999, J NEUROSURG, V91, P737, DOI 10.3171/jns.1999.91.5.0737; Murray GD, 1996, ACTA NEUROCHIR, V138, P1163, DOI 10.1007/BF01809745; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; Shohami E, 1997, J NEUROIMMUNOL, V72, P169, DOI 10.1016/S0165-5728(96)00181-6; TEASDALE G, 1992, J NEUROTRAUM, V9, pS545; Teasdale GM, 1998, J NEUROTRAUM, V15, P587, DOI 10.1089/neu.1998.15.587; Tolias Christos M, 2004, NeuroRx, V1, P71, DOI 10.1007/BF03206568	19	8	8	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1744-1625	1744-1633		SURG PRACT	Surg. Pract.	NOV	2005	9	4					122	125		10.1111/j.1744-1633.2005.00271.x			4	Surgery	Emerging Sources Citation Index (ESCI)	Surgery	V85MV	WOS:000212525600004					2022-02-06	
J	Silverberg, N; Barrash, J				Silverberg, N; Barrash, J			Further validation of the expanded auditory verbal learning test for detecting poor effort and response bias: Data from temporal lobectomy candidates	JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY			English	Article							TRAUMATIC BRAIN-INJURY; RECOGNITION MEMORY TEST; MILD HEAD-INJURY; DEFICITS; EXAGGERATION; IMPAIRMENT; VERSION; INDEX	The present study aimed to further examine the specificity of the Exaggeration Index of the expanded Auditory Verbal Learning Test procedure for detecting inadequate effort or response bias (Barrash, Suhr, & Manzel, 2004) in a nonlitigating sample with unequivocal brain damage. Data from 56 patients with intractable epilepsy undergoing presurgical evaluation for temporal lobectomy were analyzed. In this sample, specificity was excellent at the recommended cut-off (94%), and comparable to that of another well-researched instrument for detecting inadequate effort, the Recognition Memory Test. Findings strongly support the generalizability of the specificity estimates obtained by Barrash et al. (2004) and, more broadly, the clinical utility of the Exaggeration Index. To facilitate diagnostic decision-making, the probability of invalid performances associated with each score on the Exaggeration Index, based on all clinical cross-validation samples reported to date, is also presented.	Vet Affairs Med Ctr, Dept Psychol, Iowa City, IA 52246 USA; Univ Windsor, Dept Psychol, Windsor, ON N9B 3P4, Canada; Univ Iowa, Dept Neurol, Iowa City, IA 52242 USA; Univ British Columbia, Dept Psychol, Vancouver, BC V5Z 1M9, Canada		Barrash, J (corresponding author), Vet Affairs Med Ctr, Dept Psychol, 116B,601 Highway 6 W, Iowa City, IA 52246 USA.	Joseph.Barrash@med.va.gov		Barrash, Joseph/0000-0001-9827-0110			Allen LM, 2001, ARCH CLIN NEUROPSYCH, V16, P846; Barrash J, 2004, J CLIN EXP NEUROPSYC, V26, P125, DOI 10.1076/jcen.26.1.125.23928; Binder LM, 1996, AM J PSYCHIAT, V153, P7; Binder LM, 1998, ARCH CLIN NEUROPSYCH, V13, P513, DOI 10.1016/S0887-6177(97)00042-5; BINDER LM, 1993, PORTLAND DIGIT RECOG; Cato MA, 2002, CLIN NEUROPSYCHOL, V16, P524, DOI 10.1076/clin.16.4.524.13901; Coleman RD, 1998, J CLIN EXP NEUROPSYC, V20, P201, DOI 10.1076/jcen.20.2.201.1164; Greenhalgh T, 1997, BRIT MED J, V315, P540, DOI 10.1136/bmj.315.7107.540; GREIFFENSTEIN MF, 1995, CLIN NEUROPSYCHOL, V9, P230, DOI 10.1080/13854049508400485; Hilsabeck RC, 2003, ARCH CLIN NEUROPSYCH, V18, P71, DOI 10.1016/S0887-6177(01)00180-9; Iverson GL, 1998, BRAIN INJURY, V12, P275, DOI 10.1080/026990598122575; Lee TMC, 2002, EPILEPSIA, V43, P283, DOI 10.1046/j.1528-1157.2002.09901.x; Lezak MD., 1995, NEUROPSYCHOLOGICAL A, V3rd; Millis S. R., 2002, J FORENSIC NEUROPSYC, V2, P147; Millis SR, 2001, J CLIN EXP NEUROPSYC, V23, P809, DOI 10.1076/jcen.23.6.809.1017; MILLIS SR, 1994, PERCEPT MOTOR SKILL, V79, P384, DOI 10.2466/pms.1994.79.1.384; MILLIS SR, 1992, CLIN NEUROPSYCHOL, V6, P406; Mittenberg W, 2002, J CLIN EXP NEUROPSYC, V24, P1094, DOI 10.1076/jcen.24.8.1094.8379; Paniak C, 2002, ARCH CLIN NEUROPSYCH, V17, P319, DOI 10.1016/S0887-6177(01)00115-9; Powell MR, 2004, ARCH CLIN NEUROPSYCH, V19, P693, DOI 10.1016/j.acn.2004.04.001; Rey A, 1941, ARCH PSYCHOLOGIE, V28, P286; SLICK D, 1997, VICTORIAN SYMPTOM VA; Slick DJ, 1999, CLIN NEUROPSYCHOL, V13, P545, DOI 10.1076/1385-4046(199911)13:04;1-Y;FT545; Suhr J, 2004, J CLIN EXP NEUROPSYC, V26, P416, DOI 10.1080/13803390490510121; Suhr JA, 2000, ARCH CLIN NEUROPSYCH, V15, P415, DOI 10.1016/S0887-6177(99)00033-5; Sweet JJ, 2000, ARCH CLIN NEUROPSYCH, V15, P105, DOI 10.1016/S0887-6177(98)00153-X; Tan JE, 2002, CLIN NEUROPSYCHOL, V16, P495, DOI 10.1076/clin.16.4.495.13909; Tombaugh T.N., 1996, TEST MEMORY MALINGER; Warrington E, 1984, RECOGNITION MEMORY T, V1; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird; Williams JM, 1998, CRIT ISS NE, P105; [No title captured]	32	8	8	0	2	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1380-3395	1744-411X		J CLIN EXP NEUROPSYC	J. Clin. Exp. Neuropsychol.	OCT	2005	27	7					907	914		10.1080/13803390490919326			8	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	970GN	WOS:000232293400011	16183623				2022-02-06	
J	Timofeev, I; Gupta, A				Timofeev, Ivan; Gupta, Arun			Monitoring of head injured patients	CURRENT OPINION IN ANESTHESIOLOGY			English	Article						brain tissue oxygen; cerebral blood flow; cerebral perfusion pressure; head injury; intracranial pressure; microdialysis; monitoring	TRAUMATIC BRAIN-INJURY; CEREBRAL PERFUSION-PRESSURE; TRANSCRANIAL DOPPLER SONOGRAPHY; BLOOD-FLOW VELOCITY; INTRACRANIAL-PRESSURE; EMERGENCY-DEPARTMENT; PULSATILITY INDEX; WAVE-FORM; OXYGENATION; MICRODIALYSIS	Purpose of review This article reviews recent advances in multimodality monitoring of patients following severe head injury during the period of 2004-2005. Recent findings Whilst intracranial pressure measurement remains the cornerstone of neuromonitoring, analysis of the intracranial pressure waveform provides additional information, which may help guide treatment and predict outcome. Noninvasive detection of intracranial hypertension and assessment of cerebral perfusion pressure and autoregulation is the focus of ongoing research. Although jugular venous saturation monitoring remains a useful method for detecting global hypoperfusion its sensitivity to regional ischaemia is low. Brain tissue oxygen monitoring overcomes this deficiency and sheds new light on the pathophysiology of cerebral ischaemia following brain injury. Further studies are required to define ischaemic thresholds and their association with outcome. Extracellular brain pH has been recently linked to outcome and further studies are required to establish the role of pH regulation. Monitoring of brain metabolism using a cerebral microdialysis continues to develop its niche in clinical neuromonitoring, although it currently remains a research tool. Summary Multimodality neuromonitoring plays an important role in managing patients with severe head injury. It helps guide treatment, provides prognostic information and explores the pathophysiology of evolving brain injury.	[Timofeev, Ivan] Addenbrookes Hosp, Dept Neurosurg, Cambridge, England; [Gupta, Arun] Addenbrookes Hosp, Dept Anaesthesia, Cambridge, England		Gupta, A (corresponding author), Addenbrookes NHS Trust, Dept Anaesthet, Box 93, Cambridge CB2 2QQ, England.	arun.gupta@addenbrookes.nhs.uk	Timofeev, Ivan/AAE-7019-2019	Timofeev, Ivan/0000-0002-1168-0393	Codman division, Johnson & Johnson Corporation	Sponsorship: Mr Ivan Timofeev is currently supported by a grant from Codman division, Johnson & Johnson Corporation	[Anonymous], 2000, MAN PROGN SEV TRAUM; [Anonymous], 2003, GUID MAN SEV TRAUM B; Artru F, 2004, J NEUROSURG ANESTH, V16, P226, DOI 10.1097/00008506-200407000-00007; Balestreri M, 2004, ACTA NEUROCHIR, V146, P131, DOI 10.1007/s00701-003-0187-y; Bellander BM, 2004, INTENS CARE MED, V30, P2166, DOI 10.1007/s00134-004-2461-8; Bellner J, 2004, SURG NEUROL, V62, P45, DOI 10.1016/j.surneu.2003.12.007; Bor-Seng-Shu E, 2004, ARQ NEURO-PSIQUIAT, V62, P715, DOI 10.1590/S0004-282X2004000400028; Coles Jonathan P, 2004, Curr Opin Crit Care, V10, P120, DOI 10.1097/00075198-200404000-00008; Coles JP, 2004, J CEREBR BLOOD F MET, V24, P202, DOI 10.1097/01.WCB.0000103022.98348.24; Cremer OL, 2004, ANESTH ANALG, V99, P1211, DOI 10.1213/01.ANE.0000133917.67728.2A; Czosnyka M, 2004, J NEUROL NEUROSUR PS, V75, P813, DOI 10.1136/jnnp.2003.033126; Czosnyka M, 1999, J NEUROL NEUROSUR PS, V66, P606, DOI 10.1136/jnnp.66.5.606; De Georgia MA, 2005, NEUROLOGIST, V11, P45, DOI 10.1097/01.nrl.0000149993.99956.09; Dominguez-Roldan JM, 2004, TRANSPL P, V36, P2898, DOI 10.1016/j.transproceed.2004.11.017; Dominguez-Roldan JM, 2004, TRANSPL P, V36, P2896, DOI 10.1016/j.transproceed.2004.10.052; Ederoth P, 2004, BRIT J CLIN PHARMACO, V57, P427, DOI 10.1046/j.1365-2125.2003.02032.x; Edouard AR, 2005, BRIT J ANAESTH, V94, P216, DOI 10.1093/bja/aei034; Engelhard K, 2004, ACTA ANAESTH SCAND, V48, P396, DOI 10.1111/j.0001-5172.2004.00348.x; Engstrom M, 2005, J NEUROSURG, V102, P460, DOI 10.3171/jns.2005.102.3.0460; Fan Jun-Yu, 2004, J Neurosci Nurs, V36, P278; Fountas KN, 2005, MED SCI MONITOR, V11, pCR58; Fountas KN, 2002, CHILD NERV SYST, V18, P211, DOI 10.1007/s00381-002-0573-4; Gracias VH, 2004, J TRAUMA, V56, P469, DOI 10.1097/01.TA.0000114274.95423.C0; Gupta AK, 2004, J NEUROTRAUM, V21, P678, DOI 10.1089/0897715041269722; Hillered L, 2005, J NEUROTRAUM, V22, P3, DOI 10.1089/neu.2005.22.3; Hlatky R, 2004, NEUROSURGERY, V55, P1318, DOI 10.1227/01.NEU.0000143029.42638.2C; Hlatky R, 2004, J NEUROTRAUM, V21, P894, DOI 10.1089/0897715041526195; Jaeger M, 2005, ACTA NEUROCHIR, V147, P51, DOI 10.1007/s00701-004-0408-z; Johnston AJ, 2005, CRIT CARE MED, V33, P189, DOI 10.1097/01.CCM.0000149837.09225.BD; Johnston AJ, 2004, INTENS CARE MED, V30, P791, DOI 10.1007/s00134-003-2155-7; Lescot T, 2005, ACTA NEUROCHIR, V147, P125, DOI 10.1007/s00701-004-0355-8; Longhi Luca, 2004, Curr Opin Crit Care, V10, P105, DOI 10.1097/00075198-200404000-00005; Meixensberger J, 2004, NEUROL RES, V26, P414, DOI 10.1179/016164104225014094; Menon DK, 2004, CRIT CARE MED, V32, P1384, DOI 10.1097/01.CCM.0000127777.16609.08; Meyer PG, 2005, CHILD NERV SYST, V21, P133, DOI 10.1007/s00381-004-1016-1; Mileski WJ, 2004, J TRAUMA, V56, P472; Nelson DW, 2004, CRIT CARE MED, V32, P2428, DOI 10.1097/01.CCM.0000147688.08813.9C; Ng I, 2004, NEUROSURGERY, V54, P593, DOI 10.1227/01.NEU.0000108639.16783.39; Poca MA, 2004, J NEUROSURG, V100, P260, DOI 10.3171/jns.2004.100.2.0260; Pou JAL, 2004, INTENS CARE MED, V30, P1672, DOI 10.1007/s00134-004-2348-8; Schurr A, 2002, INT J MOL MED, V10, P131, DOI 10.3892/ijmm.10.2.131; Shafe M, 2004, ACAD EMERG MED, V11, P774, DOI 10.1197/j.aem.2004.02.518; Soustiel JF, 2004, SURG NEUROL, V62, P201, DOI 10.1016/j.surneu.2003.10.037; Steiner LA, 2004, INTENS CARE MED, V30, P2180, DOI 10.1007/s00134-004-2463-6; Steiner LA, 2004, CRIT CARE MED, V32, P1049, DOI 10.1097/01.CCM.0000120054.32845.A6; Stiefel MF, 2004, J NEUROSURG, V101, P241, DOI 10.3171/jns.2004.101.2.0241; Stocchetti N, 2004, ANESTH ANALG, V99, P230, DOI 10.1213/01.ane.0000130393.08355.d4; Tolias CM, 2004, J NEUROSURG, V101, P435, DOI 10.3171/jns.2004.101.3.0435; Trabold F, 2004, INTENS CARE MED, V30, P108, DOI 10.1007/s00134-003-2057-8; Tsung JW, 2005, PEDIATR EMERG CARE, V21, P94, DOI 10.1097/01.pec.0000159052.64930.64; Vavilala Monica S, 2004, Pediatr Crit Care Med, V5, P257, DOI 10.1097/01.PCC.0000123545.69133.C3; Venkatesh B, 2004, INTENS CARE MED, V30, P510, DOI 10.1007/s00134-003-2102-7; Voulgaris SG, 2005, MED SCI MONITOR, V11, pCR49; Winter CD, 2004, BRAIN, V127, P315, DOI 10.1093/brain/awh039; Zygun DA, 2004, NEUROSURGERY, V55, P877, DOI 10.1227/01.NEU.0000137658.14906.E4	55	8	9	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0952-7907	1473-6500		CURR OPIN ANESTHESIO	Curr. Opin. Anesthesiol.	OCT	2005	18	5					477	483		10.1097/01.aco.0000183107.19673.ed			7	Anesthesiology	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology	V40ZR	WOS:000209517000004	16534279				2022-02-06	
J	Baird, A; Papadopoulou, K; Greenwood, R; Cipolotti, L				Baird, A; Papadopoulou, K; Greenwood, R; Cipolotti, L			Memory function after resolution of post-traumatic amnesia	BRAIN INJURY			English	Article						post-traumatic amnesia; memory; traumatic brain injury	TRAUMATIC BRAIN-INJURY; CLOSED-HEAD-INJURY; GALVESTON ORIENTATION; RECOVERY; OUTCOMES; SCALE	Primary objectives: The aims of this pilot study were (1) to examine neuropsychological, particularly memory functions immediately after post-traumatic amnesia (PTA) resolution according to the Galveston Orientation and Amnesia Test (GOAT), and (2) to provide a preliminary exploration of pattern of performance on GOAT items across PTA duration. Methods and procedures: Thirty-seven head injured patients were administered the Recognition Memory Tests on the day that PTA resolved. Formal neuropsychological assessment was conducted on average 10 days after PTA resolution. Main outcomes and results: All the patients in the series showed memory impairment which varied in severity but was typically characterized as global and severe. Deficits in executive and speed and attention functions were common. GOAT items relating to orientation were typically passed, while items concerning anterograde and retrograde recall were most commonly failed across all stages of PTA duration. Conclusions: These findings suggest that reliance on memory performance as a measure of PTA is not ideal and highlight the need for further research of this issue.	UCL Natl Hosp Neurol & Neurosurg, Dept Neuropsychol, London WC1N 3BG, England; UCL Natl Hosp Neurol & Neurosurg, Acute Brain Injury Unit, London WC1N 3BG, England		Cipolotti, L (corresponding author), UCL Natl Hosp Neurol & Neurosurg, Dept Neuropsychol, Queen Sq, London WC1N 3BG, England.	l.cipolotti@ion.ucl.ac.uk		cipolotti, lisa/0000-0001-5838-3647; Baird, Amee/0000-0002-0752-8049			Benton A., 1976, MULTILINGUAL APHASIA; Bigler ED, 2003, ARCH CLIN NEUROPSYCH, V18, P595; Bigler ED, 2001, ARCH CLIN NEUROPSYCH, V16, P95; BISHARA S N, 1992, Brain Injury, V6, P373, DOI 10.3109/02699059209034952; Bode RK, 2000, J HEAD TRAUMA REHAB, V15, P637, DOI 10.1097/00001199-200002000-00004; Dawson DR, 2004, BRAIN INJURY, V18, P221, DOI 10.1080/02699050310001617406; DIKMEN S, 1987, J NEUROL NEUROSUR PS, V50, P1613, DOI 10.1136/jnnp.50.12.1613; DIKMEN SS, 1995, NEUROPSYCHOLOGY, V9, P80, DOI 10.1037/0894-4105.9.1.80; EWERT J, 1989, ARCH NEUROL-CHICAGO, V46, P911, DOI 10.1001/archneur.1989.00520440105027; FODOR IE, 1972, J NEUROL NEUROSUR PS, V35, P818, DOI 10.1136/jnnp.35.6.818; GASQUOINE P G, 1991, Brain Injury, V5, P169, DOI 10.3109/02699059109008087; KATZ DI, 1994, ARCH NEUROL-CHICAGO, V51, P661, DOI 10.1001/archneur.1994.00540190041013; Kesler SR, 2000, BRAIN INJURY, V14, P851; LEVIN HS, 1988, J NEUROL NEUROSUR PS, V51, P14, DOI 10.1136/jnnp.51.1.14; LEVIN HS, 1990, J CLIN EXP NEUROPSYC, V12, P129, DOI 10.1080/01688639008400960; Levin HS, 1998, CURR OPIN NEUROL, V11, P643, DOI 10.1097/00019052-199812000-00006; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; LEVIN HS, 1989, TRAUMATIC BRAIN INJU, P53; MANDLEBERG IA, 1975, J NEUROL NEUROSUR PS, V38, P1127, DOI 10.1136/jnnp.38.11.1127; McKenna P., 1983, GRADED NAMING TEST; McMillan TM, 1996, J NEUROL NEUROSUR PS, V60, P422, DOI 10.1136/jnnp.60.4.422; Nakase-Thompson R, 2004, BRAIN INJURY, V18, P131, DOI 10.1080/0269905031000149542; O'Bryant SE, 2003, ARCH CLIN NEUROPSYCH, V18, P135, DOI 10.1016/S0887-6177(01)00189-5; OLDFIELD RC, 1965, Q J EXP PSYCHOL, V17, P273, DOI 10.1080/17470216508416445; RUSSELL WR, 1961, ARCH NEUROL-CHICAGO, V5, P4, DOI 10.1001/archneur.1961.00450130006002; SCHACTER DL, 1977, CORTEX, V13, P150, DOI 10.1016/S0010-9452(77)80006-3; Schwartz ML, 1998, CAN J NEUROL SCI, V25, P108, DOI 10.1017/S0317167100033709; Sherer M, 2002, ARCH PHYS MED REHAB, V83, P183, DOI 10.1053/apmr.2002.28802; Stuss DT, 1999, J NEUROSURG, V90, P635, DOI 10.3171/jns.1999.90.4.0635; Tate RL, 2000, J NEUROL NEUROSUR PS, V68, P178, DOI 10.1136/jnnp.68.2.178; Trenerry MR, 1989, STROOP NEUROPSYCHOLO; War Department Adjutant General's Office, 1944, ARM IND TEST BATT MA; Warrington E, 1984, RECOGNITION MEMORY T, V1; Warrington E. K., 1991, VISUAL OBJECT SPACE; Wechsler, 1997, WECHSLER ADULT INTEL; Weigl E, 1941, J ABNORM SOC PSYCH, V36, P3, DOI 10.1037/h0055544; Wilson BA, 1999, BRAIN INJURY, V13, P505, DOI 10.1080/026990599121412; Wilson BA., 1992, NEUROPSYCHOL REHABIL, V2, P231, DOI [DOI 10.1080/09602019208401410, 10.1080/09602019208401410]; Zec RF, 2001, J CLIN EXP NEUROPSYC, V23, P671, DOI 10.1076/jcen.23.5.671.1247	39	8	9	0	3	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	SEP	2005	19	10					811	817		10.1080/02699050500149213			7	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	945EI	WOS:000230484800007	16175841				2022-02-06	
J	Rotenberg, BW; Makhija, M; Papsin, BC				Rotenberg, BW; Makhija, M; Papsin, BC			Conversion disorder in a child presenting as sudden sensorineural hearing loss	INTERNATIONAL JOURNAL OF PEDIATRIC OTORHINOLARYNGOLOGY			English	Article						sensorineural hearing loss; conversion disorder; pseudohypoacusis	PSEUDOHYPOACUSIS; PSEUDOHYPACUSIS	Pseudohypoacacusis is a form of conversion disorder in which a hearing toss is found in the absence of organic disease. A case of an 11-year-old boy with auditory conversion disorder after mild head trauma is reported. The child presented with unilateral hearing Loss, with no accompanying vestibular symptoms and no history of otologic disease. Auditory testing revealed severe right-sided sensorineural hearing Loss, however, CT scan was normal. There was a family history of conversion disorder and the child was undergoing an emotionally stressful period. It was decided to treat the child conservatively with close monitoring and a repeat audiogram 2 weeks later. One week after presentation, the child's hearing suddenly returned to normal after a second very minor head injury. It is important to consider pseudohypoacusis or conversion disorder even in cases such as trauma, when the clinical history supports a diagnosis of hearing toss. (c) 2005 Elsevier Ireland Ltd. All rights reserved.	Hosp Sick Children, Dept Otolaryngol, Toronto, ON M5G 1X8, Canada; Univ Toronto, Fac Med, Toronto, ON, Canada		Papsin, BC (corresponding author), Hosp Sick Children, Dept Otolaryngol, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.						American Psychiatric Association, 1994, AM PSYCH ASS DIAGN S, V4th; BARR B, 1957, ACTA OTOLARYNGOL, V52, P337; BERGER K, 1965, LARYNGOSCOPE, V75, P447; BOWDLER DA, 1989, CLIN OTOLARYNGOL, V52, P337; BROCKMAN S J, 1960, Laryngoscope, V70, P825; CAMPANELLI PA, 1963, J AUD RES, V3, P91; CARHART R, 1961, MT AM ACAD OPHTHALMO, V65, P437; ENGELBERG MW, 1978, OTOLARYNGOL CLIN N A, V11, P49; KLOTZ R E, 1960, Ann Otol Rhinol Laryngol, V69, P199; MARTIN FN, 1978, HDB CLIN AUDIOLOGY; Pracy JP, 1996, INT J PEDIATR OTORHI, V37, P143, DOI 10.1016/0165-5876(96)01397-3; RADKOWSKI D, 1968, LARYNGOSCOPE, V108, P1534; RINTELMANN W, 1963, J SPEECH HEAR DISORD, V28, P141, DOI 10.1044/jshd.2802.141; ROCK NL, 1971, J AMER ACAD CHILD PS, V10, P65, DOI 10.1016/S0002-7138(09)61725-8; SANDERS JW, 1983, AM J OTOL, V4, P292; VENIAR FA, 1983, AM J DIS CHILD, V137, P34, DOI 10.1001/archpedi.1983.02140270030011; WOLF M, 1993, ANN OTO RHINOL LARYN, V102, P349, DOI 10.1177/000348949310200505; YOSHIDA M, 1989, INT J PEDIATR OTORHI, V17, P287, DOI 10.1016/0165-5876(89)90054-2	18	8	9	0	3	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0165-5876			INT J PEDIATR OTORHI	Int. J. Pediatr. Otorhinolaryngol.	SEP	2005	69	9					1261	1264		10.1016/j.ijporl.2005.03.012			4	Otorhinolaryngology; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Otorhinolaryngology; Pediatrics	956UK	WOS:000231325200017	15964081				2022-02-06	
J	Strong, CAH; Donders, J; Van Dyke, S				Strong, CAH; Donders, J; Van Dyke, S			Validity of demographically corrected norms for the WAIS-III	JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY			English	Article							NEUROPSYCHOLOGICAL TEST-PERFORMANCE; INDEX SCORE PATTERNS; EDUCATION; AGE; REITAN; VARIABLES	The diagnostic validity of new demographically corrected WAIS-III norms was investigated using a sample of 100 patients with traumatic brain injury (TBI) and a matched control group from the standardization sample. Demographically corrected norms were compared to traditional age-corrected norms. Although education accounted for incremental variance in WAIS-III factor scores in patients with TBI, above and beyond the effects of injury severity, the demographically corrected norms did not yield statistically different diagnostic classification of individuals with moderate-severe TBI than the traditional norms. In participants with relatively low levels of educational attainment, sensitivity to length of coma was less for demographically corrected norms then for traditional age-corrected norms. Nevertheless, when using a discrepancy between Verbal Comprehension and Processing speed, diagnostic accuracy rates were again similar for both sets of norms. It is concluded that the demographically corrected WAIS-III norms do not offer a clear advantage or disadvantage compared to traditional age-corrected norms in the assessment of patients with TBI who are Caucasian and who have at least a middle school level of education.	Mary Free Bed Hosp, Psychol Serv, Grand Rapids, MI 49503 USA; Calvin Coll, Grand Rapids, MI 49506 USA		Donders, J (corresponding author), Mary Free Bed Hosp, Psychol Serv, 235 Wealthy SE, Grand Rapids, MI 49503 USA.	jdonders@mfbrc.com					Axelrod BN, 1996, CLIN NEUROPSYCHOL, V10, P159, DOI 10.1080/13854049608406677; BORNSTEIN RA, 1988, DEV NEUROPSYCHOL, V4, P17, DOI 10.1080/87565648809540386; Donders J, 2001, J INT NEUROPSYCH SOC, V7, P892, DOI 10.1017/S1355617701777132; Donders J, 2001, ASSESSMENT, V8, P193, DOI 10.1177/107319110100800207; Gladsjo JA, 1999, ASSESSMENT, V6, P147, DOI 10.1177/107319119900600204; Hawkins KA, 1998, CLIN NEUROPSYCHOL, V12, P535, DOI 10.1076/clin.12.4.535.7236; Heaton RK, 1996, NEUROPSYCHOLOGICAL A, P141; Jones R. D., 1996, P395; LECKLITER IN, 1989, J CLIN PSYCHOL, V45, P484, DOI 10.1002/1097-4679(198907)45:4<484::AID-JCLP2270450402>3.0.CO;2-L; Manly J., 2003, CLIN INTERPRETATION, P181, DOI DOI 10.1016/B978-012703570-3/50010-9; Manly JJ, 2002, STUD NEUROPSYCHOL DE, P79; Martin TA, 2000, REHABIL PSYCHOL, V45, P402, DOI 10.1037/0090-5550.45.4.402; McKay PF, 2003, J BUS PSYCHOL, V18, P1, DOI 10.1023/A:1025062703113; Millis SR, 2003, CHILD NEUROPSYCHOL, V9, P221, DOI 10.1076/chin.9.3.221.16455; Moses JA, 1999, ARCH CLIN NEUROPSYCH, V14, P445, DOI 10.1016/S0887-6177(98)00030-4; Nixon S.J., 1996, NEUROPSYCHOLOGY CLIN, P9, DOI [DOI 10.1037/10198-001, https://doi.org/10.1037/10198-001]; *PSYCH CORP, 2001, WIAT 2 SCOR ASS; Reitan R M, 1997, Appl Neuropsychol, V4, P16, DOI 10.1207/s15324826an0401_3; REITAN RM, 1995, CLIN NEUROPSYCHOL, V9, P151, DOI 10.1080/13854049508401597; Ross TP, 1997, AGING NEUROPSYCHOL C, V4, P74, DOI 10.1080/13825589708256637; Sherrill-Pattison S, 2000, CLIN NEUROPSYCHOL, V14, P496, DOI 10.1076/clin.14.4.496.7196; Taylor MJ, 2001, J INT NEUROPSYCH SOC, V7, P867, DOI 10.1017/S1355617701777107; Tombaugh T.N., 1996, TEST MEMORY MALINGER; Uchiyama C L, 1996, J Int Neuropsychol Soc, V2, P299; van der Heijden P, 2003, ASSESSMENT, V10, P115, DOI 10.1177/1073191103010002001; Vanderploeg RD, 1997, CLIN NEUROPSYCHOL, V11, P210, DOI 10.1080/13854049708407054; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird; Wechsler D., 1997, WAIS 3 WMS 3 TECHNIC	28	8	8	0	7	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1380-3395	1744-411X		J CLIN EXP NEUROPSYC	J. Clin. Exp. Neuropsychol.	AUG	2005	27	6					746	758		10.1081/13803390490919155			13	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	946NO	WOS:000230579300010	16019650				2022-02-06	
J	Ek, L; Smits, A; Pahlson, A; Almkvist, O				Ek, L; Smits, A; Pahlson, A; Almkvist, O			Analysis of cognitive dysfunction in patients with low-grade glioma	JOURNAL OF CLINICAL PSYCHOLOGY IN MEDICAL SETTINGS			English	Article						cognition; low-grade glioma; neuropsychological tests	QUALITY-OF-LIFE; TRAUMATIC BRAIN-INJURY; SUPRATENTORIAL GLIOMAS; YOUNG-ADULTS; RADIOTHERAPY; CHILDHOOD; SEQUELAE; TUMORS; ASTROCYTOMAS; CHILDREN	All living adults with histopatologically proven diagnosis of low-grade glioma in a Swedish county were identified with help of the Regional Cancer Register, half of them (n = 24) participated in a neuropsychological evaluation. A considerable variation was found in cognitive function within this group of patients, ranging from good ability to severe disturbance. Different patterns of cognitive dysfunction emerged resulting in three subgroups; patients with severe, mild, and minimal selective dysfunction. The patients with severe disturbance had a global dysfunction covering most assessed cognitive domains. Slow information-processing speed was obvious in the subgroups with both severe and mild dysfunction. Cognitive problems present in the best performing group seemed related to tumor localization. Cognitive function in the whole sample was related to histopathological diagnosis of the tumor, as well as to educational level of the patients. The nonworking patients had significantly poorer performance than the working patients.	Orebro Univ Hosp, Dept Neurol, S-70185 Orebro, Sweden; Univ Uppsala Hosp, Dept Neurosci, Uppsala, Sweden; Stockholm Univ, Dept Psychol, S-10691 Stockholm, Sweden		Ek, L (corresponding author), Orebro Univ Hosp, Dept Neurol, S-70185 Orebro, Sweden.	lena.ek@orebroll.se		Almkvist, Ove/0000-0003-0556-625X			Armstrong CL, 2000, NEUROPSY NEUROPSY BE, V13, P101; Ater JL, 1996, J CHILD NEUROL, V11, P462, DOI 10.1177/088307389601100610; Benton A., 1994, CONTRIBUTIONS NEUROP; BERGMAN I, 2004, UNPUB VARIATION HLTH; CHADDERTON RD, 1995, CHILD NERV SYST, V11, P443, DOI 10.1007/BF00334961; Drake AI, 2000, J HEAD TRAUMA REHAB, V15, P1103, DOI 10.1097/00001199-200010000-00004; GLADSJO JA, 1999, NORMS LETTER CATEGOR; HOFFMAN HJ, 1990, MANAGEMENT CHILDHOOD, P441; HUNT E, 1995, AM SCI           JUL; Jagaroo V, 2000, J NEURO-ONCOL, V49, P235, DOI 10.1023/A:1006442124300; KERNOHAN JW, 1949, STAFF M MAYO CLIN, V2, P71; Kleihues P, 2002, J NEUROPATH EXP NEUR, V61, P215, DOI 10.1093/jnen/61.3.215; Klein M, 2002, LANCET, V360, P1361, DOI 10.1016/S0140-6736(02)11398-5; Klein M, 2003, ANN NEUROL, V54, P514, DOI 10.1002/ana.10712; LAURSEN P, 1997, ACTA NEUROLOGICA S S, V96; Malm J, 1998, NEUROLOGY, V51, P433, DOI 10.1212/WNL.51.2.433; MATHIOWETZ V, 1985, OCCUP THER J RES, V5, P24, DOI 10.1177/153944928500500102; Meyers C A, 1990, Oncology (Williston Park), V4, P115; Meyers CA, 2002, CANC NERVOUS SYSTEM, P557; Meyers CA, 1986, CANC B, V38, P30; MULHERN RK, 1988, J CHILD NEUROL, V3, P47, DOI 10.1177/088307388800300111; MULHERN RK, 1985, MED PEDIATR ONCOL, V13, P318, DOI 10.1002/mpo.2950130604; NELSON DF, 1993, CLIN ONCOLOGY, P617; Nybo T, 1999, BRAIN INJURY, V13, P759; Pahlson A, 2003, J NEURO-ONCOL, V65, P149, DOI 10.1023/B:NEON.0000003727.09448.dd; Pignatti F, 2002, J CLIN ONCOL, V20, P2076, DOI 10.1200/JCO.2002.08.121; RIVA D, 1993, CORTEX, V29, P141, DOI 10.1016/S0010-9452(13)80218-3; Schmidt M., 1996, REY AUDITORY VERBAL; Sichez N, 1996, REV NEUROL, V152, P261; Smith A., 1982, SYMBOL DIGIT MODALIT; Steinlin M, 2003, BRAIN, V126, P1998, DOI 10.1093/brain/awg195; Surma-aho O, 2001, NEUROLOGY, V56, P1285, DOI 10.1212/WNL.56.10.1285; SWEET JJ, 1994, J CLIN PSYCHOL MED S, V1, P83, DOI 10.1007/BF01991726; TAPHOORN MJB, 1992, J NEUROL NEUROSUR PS, V55, P372, DOI 10.1136/jnnp.55.5.372; TAPHOORN MJB, 1994, ANN NEUROL, V36, P48, DOI 10.1002/ana.410360111; Tucha O, 2000, NEUROSURGERY, V47, P324, DOI 10.1097/00006123-200008000-00011; Vigliani MC, 1996, INT J RADIAT ONCOL, V35, P527, DOI 10.1016/0360-3016(96)00097-1; Wechsler D., 1994, WECHSLER ADULT INTEL	38	8	9	0	4	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1068-9583	1573-3572		J CLIN PSYCHOL MED S	J. Clin. Psychol. Med. Settings	JUN	2005	12	2					165	173		10.1007/s10880-005-3276-7			9	Psychology, Clinical	Social Science Citation Index (SSCI)	Psychology	922RM	WOS:000228855600007					2022-02-06	
J	Chalmers, RJG; Jobling, R; Chalmers, I				Chalmers, RJG; Jobling, R; Chalmers, I			Is the NHS willing to help clinicians and patients reduce uncertainties about the effects of treatments?	CLINICAL MEDICINE			English	Article						health policy; NHS clinical research; patient involvement; psoriasis; uncertainty	TRAUMATIC BRAIN-INJURY; HEAD-INJURY; PSORIASIS; TRIALS; CORTICOSTEROIDS	Uncertainty is an inevitable component of clinical practice. Clinicians have a responsibility to minimise it by keeping up-to-date with current knowledge: but what is the responsibility of individual clinicians in reducing collective uncertainty? In all fields of medicine there are important questions relevant to both patients and clinicians, which can be answered only by clinical research. Unfortunately, much of the clinical research that attracts funding does not address the questions that both patients and clinicians regard as important. Furthermore, although the NHS has a proud record of innovation and clinical research, recent changes are Jeopardising the ability and willingness of NHS clinicians to continue undertaking such work. A combination of increased bureaucracy in obtaining research ethics and local research and development (R&D) governance approval and the pressures on management to deliver service targets threaten to strangle research by NHS clinicians. Policy makers argue for informed patient choice, modernisation and improved quality. It is not in the interest of patients when research designed to address important therapeutic uncertainties is seen as an optional extra, rather than an intrinsic element of a health service interested in improving quality. The NHS needs to listen to its users, ie the patients, and to its clinical staff, and to encourage them to engage in research to help reduce those uncertainties.	Hope Hosp, Dermatol Ctr, Manchester M6 8HD, Lancs, England; Psoriasis Assoc, Northampton, England; James Lind Alliance Secretariat, Oxford, England		Chalmers, RJG (corresponding author), Hope Hosp, Dermatol Ctr, Stott Lane, Manchester M6 8HD, Lancs, England.	r.chalmers@man.ac.uk					Alderson P, 1998, BRIT MED J, V316, P396; Alderson P, 1997, BRIT MED J, V314, P1855, DOI 10.1136/bmj.314.7098.1855; ALTMAN DG, 1994, BRIT MED J, V308, P283, DOI 10.1136/bmj.308.6924.283; [Anonymous], 2005, CLIN MED, V5, P5; ANTMAN EM, 1992, JAMA-J AM MED ASSOC, V268, P240, DOI 10.1001/jama.268.2.240; CHALMERS I, 2004, BAMM NEWS        JUN, P3; Chalmers Iain, 2004, BMJ, V328, P475, DOI 10.1136/bmj.328.7438.475; Chalmers Iain, 2000, Curr Control Trials Cardiovasc Med, V1, P3, DOI 10.1186/CVM-1-1-003; CREAM J, 2001, CPD B OLD AGE PSYCHI, V2, P80; Heydendael VMR, 2003, NEW ENGL J MED, V349, P658, DOI 10.1056/NEJMoa021359; Mallett Susan, 2003, ACP J Club, V139, pA11; Maurice PDL, 2005, BRIT J DERMATOL, V152, P451, DOI 10.1111/J.1365-2133.2005.06459.X; Muzha I, 2004, LANCET, V364, P1321, DOI 10.1016/S0140-6736(04)17188-2; Naldi L, 2003, J INVEST DERMATOL, V120, P738, DOI 10.1046/j.1523-1747.2003.12145.x; Partridge N, 2004, LANCET, V364, P1923, DOI 10.1016/S0140-6736(04)17494-1; Peters K, 2004, CLIN MED, V4, P551, DOI 10.7861/clinmedicine.4-6-551; Rapp SR, 1999, J AM ACAD DERMATOL, V41, P401, DOI 10.1016/S0190-9622(99)70112-X; Sauerland S, 2004, LANCET, V364, P1291, DOI 10.1016/S0140-6736(04)17202-4; SEGELOV E, 1992, ANN ONCOL, V3, P103, DOI 10.1093/oxfordjournals.annonc.a058119; SEVILLE RH, 1966, BRIT J DERMATOL, V78, P269, DOI 10.1111/j.1365-2133.1966.tb12221.x; SEVILLE RH, 1977, BRIT J DERMATOL, V97, P297, DOI 10.1111/j.1365-2133.1977.tb15186.x; SMITHELLS RW, 1975, POSTGRAD MED J, V51, P39; Tallon D, 2000, LANCET, V355, P2037, DOI 10.1016/S0140-6736(00)02351-5; The duties of a doctor registered with the General Medical Council, 2001, GOOD MED PRACT; Warlow C, 2005, CLIN MED, V5, P33, DOI 10.7861/clinmedicine.5-1-33	25	8	8	0	0	ROY COLL PHYS LONDON EDITORIAL OFFICE	LONDON	11 ST ANDREWS PLACE REGENTS PARK, LONDON NW1 4LE, ENGLAND	1470-2118	1473-4893		CLIN MED	Clin. Med.	MAY-JUN	2005	5	3					230	234		10.7861/clinmedicine.5-3-230			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	941NW	WOS:000230222500009	16011213	Green Published			2022-02-06	
J	McLeod, TCV				McLeod, TCV			The prediction of intracranial injury after minor head trauma in the pediatric population	JOURNAL OF ATHLETIC TRAINING			English	Article							COLLEGIATE FOOTBALL PLAYERS; HIGH-SCHOOL; NCAA CONCUSSION; MANAGEMENT; RECOVERY; CHILDREN; SPORTS	Reference: Dunning J, Batchelor J, Stratford-Smith P, et al. A meta-analysis of variables that predict significant intracranial injury in minor head trauma. Arch Dis Child. 2004;89:653-659. Clinical Question: Which clinical signs or symptoms of minor head trauma are predictive of intracranial hemorrhage in children and adolescents? Data Sources: Investigations were identified by MEDLINE and EMBASE searches from 1990 through 2002 by a search of the grey literature and by contacting experts for additional papers. The search terms were selected to find all studies reporting intracranial hemorrhage (ICH) or complications after head trauma. Study Selection: A full systematic review was conducted, and all cohort or nested cohort studies that presented data on minor head injuries in children less than 18 years old, with or without ICH, were identified. Studies were then judged for inclusion based on the presentation of a series of at least 100 patients and a documented reliable standard for the detection of ICH for all patients in the study. The use of computed tomography (CT) and medical follow-up was considered an acceptable gold standard. Intracranial hemorrhage was defined as any abnormality detected on the CT scan due to the traumatic presence of extravascular blood. Minor head trauma was defined as patients presenting with a Glasgow Coma Scale (GCS) score of 13-15. Data Extraction: Seven clinical correlates were used for data extraction, including skull fracture, headache, vomiting, focal neurology, seizure, loss of consciousness, and a GCS score of less than 15. Data were analyzed using a pooled estimate of the relative risk ratio with a random-effects model. Main Results: The searches identified a total of 2134 studies for the initial review. After an abstract review by 2 independent examiners, 98 studies were identified for a full-paper review. Each study was graded on a 4-point scale according to the level of evidence provided, using scales consistent with the Oxford Centre for Evidence-Based Medicine and the National Institute for Clinical Excellence. Thirty-four of these articles were of adequate quality for inclusion; however, many did not include data that could be separated into a specific data set for children, had too small a sample size, or lacked enough data on individual correlates to head trauma. Nineteen studies provided data on children, but 3 of these were excluded due to poor quality or lack of a reported CT scan, leaving a total of 16 studies for the meta-analysis. The analysis included a total of 22 420 patients ranging between 0 and 18 years of age. The meta-analysis showed a significant increased relative risk of ICH for patients sustaining loss of consciousness (2.23), GCS < 15 (5.51), skull fracture (6.13), and focal neurology (9.43). No significant increases in risk for headache (1.02), vomiting (0.878), or seizure (2.82) were noted; however, heterogeneity was significant for this last correlate. The prevalence of ICH ranged from 1.3 to 36%, supporting the notion of a large amount of heterogeneity or variability in the inclusion criteria among the studies. Conclusions: These findings demonstrate that loss of consciousness, decreased level of consciousness (GCS < 15), skull fracture, and focal neurology are risk factors for ICH in the pediatric population. However, these findings are not definitive enough to establish pediatric head-injury guidelines regarding CT scanning or admission to hospital after minor head trauma.	Arizona Sch Hlth Sci, Dept Sports Hlth Care, Mesa, AZ 85206 USA		McLeod, TCV (corresponding author), Arizona Sch Hlth Sci, Dept Sports Hlth Care, 5850 E Still Circle, Mesa, AZ 85206 USA.	tmcleod@atsu.edu	Valovich McLeod, Tamara/AAU-9435-2020	Valovich McLeod, Tamara/0000-0001-9082-8722			Bergman DA, 1999, PEDIATRICS, V104, P1407; BRUCE DA, 1981, J NEUROSURG, V54, P170, DOI 10.3171/jns.1981.54.2.0170; CANTU RC, 2000, NEUROLOGIC ATHLETIC, P124; Collins MW, 2003, AM J SPORT MED, V31, P168, DOI 10.1177/03635465030310020301; Dunning J, 2004, ARCH DIS CHILD, V89, P653, DOI 10.1136/adc.2003.027722; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; Giza CC, 2000, NEUROLOGIC ATHLETIC, P80; Guskiewicz KM, 2004, J ATHL TRAINING, V39, P280; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Guskiewicz KM, 2000, AM J SPORT MED, V28, P643, DOI 10.1177/03635465000280050401; Lovell MR, 2004, AM J SPORT MED, V32, P47, DOI 10.1177/0363546503260723; Lovell MR, 2003, J NEUROSURG, V98, P296, DOI 10.3171/jns.2003.98.2.0296; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrea M, 1998, J HEAD TRAUMA REHAB, V13, P27, DOI 10.1097/00001199-199804000-00005; McLeod TCV, 2004, CLIN J SPORT MED, V14, P287, DOI 10.1097/00042752-200409000-00007; Miller Erik C., 1997, Journal of Emergency Medicine, V15, P453, DOI 10.1016/S0736-4679(97)00071-1; Oliaro S, 2001, J ATHL TRAINING, V36, P257; Piland SG, 2003, J ATHL TRAINING, V38, P104; SNOEK JW, 1984, BRAIN, V107, P15, DOI 10.1093/brain/107.1.15; Warren W. L., 2000, NEUROLOGIC ATHLETIC, P52	20	8	8	0	3	NATL ATHLETIC TRAINERS ASSOC INC	DALLAS	2952 STEMMONS FREEWAY, DALLAS, TX 75247 USA	1062-6050	1938-162X		J ATHL TRAINING	J. Athl. Train.	APR-JUN	2005	40	2					123	125					3	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	934OJ	WOS:000229717800010	15970960				2022-02-06	
J	Wright, JE				Wright, Joanna E.			Therapeutic Hypothermia in Traumatic Brain Injury	CRITICAL CARE NURSING QUARTERLY			English	Article						secondary brain injury; therapeutic hypothermia; traumatic brain injury		Traumatic brain injury is a leading cause of death by trauma in adults in the United States and a major contributor to permanent physical, emotional, and psychological disabilities. Therapeutic hypothermia, defined as cooling of the body to less than 36(circle)C, has been shown to decrease mortality and morbidity and improve long-term outcomes by protecting the brain from secondary brain injury. The most commonly seen benefits of hypothermic temperatures of 32(circle)C to 33(circle)C are a significant reduction in intracranial hypertension and improved cerebral perfusion and oxygenation. Although evidence to date is insufficient to recommend the routine use of therapeutic hypothermia outside of the research setting, therapeutic hypothermia is used in multiple healthcare facilities in theworld. The following article will define hypothermia and provide critical information necessary to provide care for the critically ill patient under therapeutic hypothermia. It will define the processes of brain injury and how hypothermia is thought to counteract those to protect the brain. Also included is a review of 2 major randomized, controlled trials of hypothermia for traumatic brain injury that have been instrumental in establishing guidelines and directing further research.	[Wright, Joanna E.] Scripps Mercy Hosp, Crit Care Serv, 4077,5th Ave, San Diego, CA 92103 USA		Wright, JE (corresponding author), Scripps Mercy Hosp, Crit Care Serv, 4077,5th Ave, San Diego, CA 92103 USA.	joright@cox.net					Bader MK, 2004, AANN CORE CURRICULUM, P965; BAKER AJ, 1993, J NEUROSURG, V79, P369, DOI 10.3171/jns.1993.79.3.0369; BUSTO R, 1987, J CEREBR BLOOD F MET, V7, P729, DOI 10.1038/jcbfm.1987.127; Clifton GL, 2001, NEW ENGL J MED, V344, P556, DOI 10.1056/NEJM200102223440803; Clifton GL, 2001, J NEUROSURG, V95, P751, DOI 10.3171/jns.2001.95.5.0751; CLIFTON GL, 1993, J NEUROTRAUM, V10, P263, DOI 10.1089/neu.1993.10.263; Drew KL, 2001, FREE RADICAL BIO MED, V31, P563, DOI 10.1016/S0891-5849(01)00628-1; Gupta AK, 2002, BRIT J ANAESTH, V88, P188, DOI 10.1093/bja/88.2.188; Harris OA, 2002, ARCH NEUROL-CHICAGO, V59, P1077, DOI 10.1001/archneur.59.7.1077; Haymore JB, 2004, ANN M AM ASS NEUR NU; Hildebrand F, 2004, AM J SURG, V187, P363, DOI 10.1016/j.amjsurg.2003.12.016; Iida K, 2003, J NEUROSURG, V98, P793, DOI 10.3171/jns.2003.98.4.0793; Inamasu J, 2002, ANN EMERG MED, V40, P220, DOI 10.1067/mem.2002.123697; Ishikawa K, 2000, J TRAUMA, V49, P912, DOI 10.1097/00005373-200011000-00020; Jeremitsky E, 2003, J TRAUMA, V54, P312, DOI 10.1097/01.TA.0000037876.37236.D6; Kinoshita K, 2003, ACTA NEUROCHIR SUPPL, V86, P377; March K., 2004, AANN CORE CURRICULUM, P87; March K, 2004, AANN CORE CURRICULUM, P277; Marik PE, 2002, CHEST, V122, P699, DOI 10.1378/chest.122.2.699; Marion DW, 1997, NEW ENGL J MED, V336, P540, DOI 10.1056/NEJM199702203360803; MARION DW, 1993, J NEUROSURG, V79, P354, DOI 10.3171/jns.1993.79.3.0354; McInerney JJ, 2002, EMERG MED J, V19, P219, DOI 10.1136/emj.19.3.219; McIntyre LA, 2003, JAMA-J AM MED ASSOC, V289, P2992, DOI 10.1001/jama.289.22.2992; Metz C, 1996, J NEUROSURG, V85, P533, DOI 10.3171/jns.1996.85.4.0533; Nolan JP, 2003, CIRCULATION, V108, P118, DOI 10.1161/01.CIR.0000079019.02601.90; Sherwood L., 1997, HUMAN PHYSIOLOGY CEL, P16; Shiozaki T, 2003, J NEUROSURG, V99, P47, DOI 10.3171/jns.2003.99.1.0047; SHIOZAKI T, 1993, J NEUROSURG, V79, P363, DOI 10.3171/jns.1993.79.3.0363; Shiozaki T, 2001, J NEUROSURG, V94, P50, DOI 10.3171/jns.2001.94.1.0050; Soukup J, 2002, J NEUROTRAUM, V19, P559, DOI 10.1089/089771502753754046; Tokutomi T, 2003, NEUROSURGERY, V52, P102, DOI 10.1097/00006123-200301000-00013; Urden L, 2002, CRITICAL CARE NURSIN, P891; Urden L, 2002, CRITICAL CARE NURSIN, P497; Wong FWH, 2002, CRIT CARE NURSE, V20, P18	34	8	8	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0887-9303	1550-5111		CRIT CARE NURS Q	Crit. Care Nurs. Q.	APR-JUN	2005	28	2					150	161		10.1097/00002727-200504000-00007			12	Critical Care Medicine	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	V1Y5O	WOS:000217351900007	15875445				2022-02-06	
J	Stewart, B; Brennan, DM				Stewart, B; Brennan, DM			Auditory hallucinations after right temporal gyri resection	JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES			English	Article							TRAUMATIC BRAIN-INJURY	The authors present a case study on the development of auditory hallucinations secondary to right temporal lobe damage. Surgical resection in the study patient was of the right superficial middle and inferior temporal gyri. Carbamazepine at a dosage of 800 mg daily was the most effective medication used. A multidisciplinary approach involving the neurosurgeon, psychiatrist, family, and rehabilitation specialist is necessary in managing the psychiatric sequelae of brain injury.	Mater Hosp, Dept Psychiat, Belfast, Antrim, North Ireland		Stewart, B (corresponding author), 33 Blacksgrove,Grove Rd, Ballymena BT43 6AS, North Ireland.	bronaghstewart@msn.com					ACHTE K, 1991, PSYCHOPATHOLOGY, V24, P309, DOI 10.1159/000284731; ACHTE KA, 1969, ACTA PSYCHIAT SCAND, V45, P1, DOI 10.1111/j.1600-0447.1969.tb06197.x; Davison K, 1969, CURRENT PROBLEMS NEU, P113; Fujii D, 2002, J NEUROPSYCH CLIN N, V14, P130, DOI 10.1176/appi.neuropsych.14.2.130; Fujii DE, 2001, J NEUROPSYCH CLIN N, V13, P61, DOI 10.1176/appi.neuropsych.13.1.61; LISHMAN WA, 1998, ORGANIC PSYCHIAT PSY; Rao V, 2000, PSYCHOSOMATICS, V41, P95, DOI 10.1176/appi.psy.41.2.95; Sachdev P, 2001, PSYCHOL MED, V31, P231, DOI 10.1017/S0033291701003336; THOMSEN IV, 1984, J NEUROL NEUROSUR PS, V47, P260, DOI 10.1136/jnnp.47.3.260; Violon A, 1988, Acta Neurochir Suppl (Wien), V44, P67	10	8	8	0	0	AMER PSYCHIATRIC PUBLISHING, INC	ARLINGTON	1000 WILSON BOULEVARD, STE 1825, ARLINGTON, VA 22209-3901 USA	0895-0172			J NEUROPSYCH CLIN N	J. Neuropsychiatr. Clin. Neurosci.	SPR	2005	17	2					243	245		10.1176/appi.neuropsych.17.2.243			3	Clinical Neurology; Neurosciences; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry	932GA	WOS:000229541000017	15939981				2022-02-06	
J	Zuckerbraun, NS; Saladino, RA				Zuckerbraun, Noel S.; Saladino, Richard A.			Pediatric Drowning: Current Management Strategies for Immediate Care	CLINICAL PEDIATRIC EMERGENCY MEDICINE			English	Article						pediatric drowning; hypoxia; hypothermia; cerebral encephalopathy		This review will introduce new universal terminology recommended for drowning, review the pathophysiology of drowning, and discuss current management strategies for treating the drowning victim. Drowning is a major burden of injury for children. The drowning process results in hypoxia, the degree of which ultimately determines clinical outcome. No single or combination of variables has proven to be reliably predictive of poor outcome. Initial care is focused on reversing the hypoxia and maintaining cardiovascular stability. Injuries associated with drowning can be complicated by hypothermia as well as predisposing medical and traumatic conditions, all of which will need to be addressed concomitantly. Posthypoxic cerebral encephalopathy is a delayed outcome of drowning associated with the greatest morbidity. Thus, early measures to prevent secondary brain injury are important. (C) 2005 Published by Elsevier Inc.	[Zuckerbraun, Noel S.; Saladino, Richard A.] Childrens Hosp Pittsburgh, Div Pediat Emergency Med, 3705 Fifth Ave, Pittsburgh, PA 15213 USA		Zuckerbraun, NS (corresponding author), Childrens Hosp Pittsburgh, Div Pediat Emergency Med, 3705 Fifth Ave, Pittsburgh, PA 15213 USA.						Ackerman MJ, 1998, PEDIATR RES, V44, P148, DOI 10.1203/00006450-199808000-00002; Ackerman MJ, 1999, MAYO CLIN PROC, V74, P1088, DOI 10.4065/74.11.1088; ALLMAN FD, 1986, AM J DIS CHILD, V140, P571, DOI 10.1001/archpedi.1986.02140200081033; BELL TS, 1985, NEUROSURGERY, V17, P604, DOI 10.1227/00006123-198510000-00012; Bernard SA, 2002, NEW ENGL J MED, V346, P557, DOI 10.1056/NEJMoa003289; Biem J, 2003, CAN MED ASSOC J, V168, P305; Bierens JJ, 2004, HDB DROWNING; BIERENS JJLM, 1990, ANN EMERG MED, V19, P1390, DOI 10.1016/S0196-0644(05)82604-6; Bierens Joost J L M, 2002, Curr Opin Crit Care, V8, P578, DOI 10.1097/00075198-200212000-00016; BIGGART MJ, 1990, J PEDIATR-US, V117, P179, DOI 10.1016/S0022-3476(05)80526-8; BOHN DJ, 1986, CRIT CARE MED, V14, P529, DOI 10.1097/00003246-198606000-00002; BOLTE RG, 1988, JAMA-J AM MED ASSOC, V260, P377, DOI 10.1001/jama.260.3.377; Brenner RA, 2001, PEDIATRICS, V108, P85, DOI 10.1542/peds.108.1.85; Cairns CB, 2002, ACAD EMERG MED, V9, P613, DOI 10.1111/j.1553-2712.2002.tb02299.x; Causey AL, 2000, AM J EMERG MED, V18, P9, DOI 10.1016/S0735-6757(00)90039-1; Christensen DW, 1997, PEDIATRICS, V99, P715; DANZL DF, 1994, NEW ENGL J MED, V331, P1756, DOI 10.1056/NEJM199412293312607; DIEKEMA DS, 1993, PEDIATRICS, V91, P612; FREWEN TC, 1985, J PEDIATR-US, V106, P615, DOI 10.1016/S0022-3476(85)80085-8; Gerardi MJ, 1996, ANN EMERG MED, V28, P55, DOI 10.1016/S0196-0644(96)70140-3; GIAMMONA ST, 1967, AM J DIS CHILD, V114, P612, DOI 10.1001/archpedi.1967.02090270068005; Giesbrecht G G, 2001, Emerg Med (Fremantle), V13, P9; Gilchrist J., 2004, Morbidity and Mortality Weekly Report, V53, P447; Goh S. H., 1999, Annals Academy of Medicine Singapore, V28, P183; Golden FS, 1997, BRIT J ANAESTH, V79, P214, DOI 10.1093/bja/79.2.214; Gooden BA, 1922, MED J AUSTRALIA, V157, P629; GRAF WD, 1995, ANN EMERG MED, V26, P312, DOI 10.1016/S0196-0644(95)70079-X; HALL KN, 1990, ANN EMERG MED, V19, P204, DOI 10.1016/S0196-0644(05)81810-4; Halmalgyi DF, 1966, J APPL PHYSIOL, V16, P681; Harries M, 2003, BRIT MED J, V327, P1336, DOI 10.1136/bmj.327.7427.1336; Hickey RW, 2000, PEDIATRICS, V106, P118, DOI 10.1542/peds.106.1.118; Hodge D., 2004, ADV PEDIAT LIFE SUPP, P220; Holzer M, 2002, NEW ENGL J MED, V346, P549; Idris AH, 2003, RESUSCITATION, V59, P45, DOI 10.1016/j.resuscitation.2003.09.003; KRISTENSEN G, 1985, ACTA ANAESTH SCAND, V29, P846, DOI 10.1111/j.1399-6576.1985.tb02308.x; LAVELLE JM, 1993, CRIT CARE MED, V21, P368, DOI 10.1097/00003246-199303000-00013; LUCKING SE, 1986, J PEDIATR-US, V108, P359, DOI 10.1016/S0022-3476(86)80873-3; MODELL JH, 1966, ANESTHESIOLOGY, V27, P33, DOI 10.1097/00000542-196601000-00007; MODELL JH, 1976, CHEST, V70, P231, DOI 10.1378/chest.70.2.231; Modell JH, 1999, J FORENSIC SCI, V44, P1119; MODELL JH, 1969, ANESTHESIOLOGY, V30, P414, DOI 10.1097/00000542-196904000-00011; NICHTER MA, 1989, CRIT CARE MED, V17, P993, DOI 10.1097/00003246-198910000-00005; ORLOWSKI JP, 1979, JACEP-J AM COLL EMER, V8, P176, DOI 10.1016/S0361-1124(79)80121-5; ORLOWSKI JP, 1987, PEDIATR CLIN N AM, V34, P75; Orlowski JP, 2001, PEDIATR CLIN N AM, V48, P627, DOI 10.1016/S0031-3955(05)70331-X; Peden M M, 2003, Inj Control Saf Promot, V10, P195, DOI 10.1076/icsp.10.4.195.16772; PETERSON B, 1977, PEDIATRICS, V59, P364; Quan L, 2003, INJURY PREV, V9, P163, DOI 10.1136/ip.9.2.163; QUAN L, 1990, PEDIATRICS, V86, P586; Quan L, 1999, Pediatr Rev, V20, P255, DOI 10.1542/pir.20-8-255; Rosen Peter, 1995, Journal of Emergency Medicine, V13, P397, DOI 10.1016/0736-4679(95)00022-3; SARNAIK AP, 1985, CRIT CARE MED, V13, P224, DOI 10.1097/00003246-198504000-00003; SHIELDS CP, 1990, ANN EMERG MED, V19, P1093, DOI 10.1016/S0196-0644(05)81510-0; SIEBKE H, 1975, LANCET, V1, P1275; Steele MT, 1996, ANN EMERG MED, V27, P479, DOI 10.1016/S0196-0644(96)70237-8; Suominen PK, 1997, RESUSCITATION, V35, P111, DOI 10.1016/S0300-9572(97)00036-1; Szpilman D, 1997, CHEST, V112, P660, DOI 10.1378/chest.112.3.660; Thalmann M, 2001, ANN THORAC SURG, V72, P607, DOI 10.1016/S0003-4975(00)02307-9; Thompson DC, 2000, COCHRANE DB SYST REV; TIPTON MJ, 1989, CLIN SCI, V77, P581, DOI 10.1042/cs0770581; TROELSEN S, 1986, SCAND J UROL NEPHROL, V20, P221, DOI 10.3109/00365598609024499; VRETENAR DF, 1994, ANN THORAC SURG, V58, P895, DOI 10.1016/0003-4975(94)90784-6; Walpoth BH, 1997, NEW ENGL J MED, V337, P1500, DOI 10.1056/NEJM199711203372103; Watson RS, 2001, J TRAUMA, V51, P658, DOI 10.1097/00005373-200110000-00006; Weinberg AD, 1998, RESUSCITATION, V36, P101, DOI 10.1016/S0300-9572(98)00004-5	65	8	8	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1522-8401	1558-2310		CLIN PEDIATR EMERG M	Clin. Pediatr. Emerg. Med.	MAR	2005	6	1					49	56		10.1016/j.cpem.2004.12.001			8	Pediatrics	Emerging Sources Citation Index (ESCI)	Pediatrics	V5E3G	WOS:000219529900008					2022-02-06	
S	Ghebremariam, YT; Odunuga, OO; Janse, K; Kotwal, GJ		Kotwal, GJ; Lahiri, DK		Ghebremariam, YT; Odunuga, OO; Janse, K; Kotwal, GJ			Humanized recombinant vaccinia virus complement control protein (hrVCP) with three amino acid changes, H98Y, E102K, and E120K creating an additional putative heparin binding site, is 100-fold more active than rVCP in blocking both classical and alternative complement pathways	NATURAL PRODUCTS AND MOLECULAR THERAPY	Annals of the New York Academy of Sciences		English	Article; Proceedings Paper	1st International Conference on Natural Products and Molecular Medicine	JAN 13-15, 2005	Univ Cape Town, Cape Town, SOUTH AFRICA		Univ Cape Town	site-directed mutagenesis; rVCP; humanized rVCPs; 100-fold potency; complement; heparin	IMMUNE-RESPONSE; SURFACE; ACTIVATION; CELLS; XENOREJECTION; INHIBITION; COMPONENTS; MECHANISM; EVASION; SYSTEM	Vaccinia virus complement control protein (VCP) is able to modulate the host complement system by regulating both pathways of complement activation. Efficient downregulation of complement activation depends on the ability of the regulatory protein to effectively bind the activated third (C3b) and fourth (C4b) complement components. Based on native crystallographic structure, molecular modeling, and sequence alignment with other Orthopoxviral complement control proteins (CCPs) and their host homologs, putative sites have been found on VCP as contact points for C3b/C4b. Here, we report that using site-directed mutagenesis, modified proteins have been generated. In addition, we report that the generated modified proteins with postulated contact point substitutions have shown greater ability to regulate both the classical and the alternative pathways of complement activation than the recombinant Western Reserve VCP, with one modified protein showing nearly 100-fold more potency in regulating both complement activation pathways independently. The augmented in vitro inhibitory activity of the modified protein together with the newly created putative heparin binding site suggests its promising potential as a competent therapeutic agent in modulating various complement-mediated ailments, for example, traumatic brain injury, Alzheimer's disease, rheumatoid arthritis, multiple organ dysfunction syndrome, reperfusion injury, and xenorejection.	Univ Cape Town, Sch Med, Div Med Virol, IIDMM,Fac Hlth Sci, ZA-7925 Cape Town, South Africa		Kotwal, GJ (corresponding author), Univ Cape Town, Sch Med, Div Med Virol, IIDMM,Fac Hlth Sci, ZA-7925 Cape Town, South Africa.	gjkotw01@yahoo.com	Odunuga, Odutayo/W-2141-2019		Wellcome TrustWellcome TrustEuropean Commission Funding Source: Medline		Al-Mohanna F, 2001, TRANSPLANTATION, V71, P796, DOI 10.1097/00007890-200103270-00019; Alcami A, 2000, J VIROL, V74, P11230, DOI 10.1128/JVI.74.23.11230-11239.2000; Anderson JB, 2003, TRANSPL IMMUNOL, V11, P129, DOI 10.1016/S0966-3274(02)00149-1; Jha P, 2003, TRANSPLANT P, V35, P3160, DOI 10.1016/j.transproceed.2003.10.045; KAZATCHKINE MD, 1979, J EXP MED, V150, P1202, DOI 10.1084/jem.150.5.1202; Kotwal GJ, 2000, IMMUNOL TODAY, V21, P242, DOI 10.1016/S0167-5699(00)01606-6; KOTWAL GJ, 1988, NATURE, V335, P176, DOI 10.1038/335176a0; KOTWAL GJ, 1990, SCIENCE, V250, P827, DOI 10.1126/science.2237434; Kotwal GJ, 1997, J LEUKOCYTE BIOL, V62, P415, DOI 10.1002/jlb.62.4.415; Lachmann PJ, 2002, P NATL ACAD SCI USA, V99, P8461, DOI 10.1073/pnas.132284499; Liszewski MK, 2000, J BIOL CHEM, V275, P37692, DOI 10.1074/jbc.M004650200; Mahesh J, 1999, SHOCK, V12, P340, DOI 10.1097/00024382-199911000-00003; MAHESH J, 1997, 4 INT C IMM CONS TRA; Murthy KHM, 2001, CELL, V104, P301, DOI 10.1016/S0092-8674(01)00214-8; *QUID CORP, 2004, ENZ IMM QUANT FRAGM; Rosengard AM, 2002, P NATL ACAD SCI USA, V99, P8808, DOI 10.1073/pnas.112220499; Sfyroera G, 2005, J IMMUNOL, V174, P2143, DOI 10.4049/jimmunol.174.4.2143; Smith SA, 2000, J VIROL, V74, P5659, DOI 10.1128/JVI.74.12.5659-5666.2000; Smith SA, 2003, BBA-PROTEINS PROTEOM, V1650, P30, DOI 10.1016/S1570-9639(03)00189-4; Smith SA, 2002, CRIT REV MICROBIOL, V28, P149, DOI 10.1080/1040-840291046722; Stahl GL, 2003, AM J PATHOL, V162, P449, DOI 10.1016/S0002-9440(10)63839-4; Suankratay C, 1999, CLIN EXP IMMUNOL, V117, P442; VANNAKAMBADI GK, 2004, P NATL ACAD SCI USA, V101, P8924	23	8	8	0	2	NEW YORK ACAD SCIENCES	NEW YORK	2 EAST 63RD ST, NEW YORK, NY 10021 USA	0077-8923		1-57331-595-8; 1-57331-594-X	ANN NY ACAD SCI	Ann.NY Acad.Sci.		2005	1056						113	122		10.1196/annals.1352.024			10	Biochemistry & Molecular Biology; Integrative & Complementary Medicine; Medicine, Research & Experimental; Multidisciplinary Sciences	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Integrative & Complementary Medicine; Research & Experimental Medicine; Science & Technology - Other Topics	BDU43	WOS:000235433100010	16387681				2022-02-06	
J	Sai, S; Fujii, K; Chino, H; Inoue, J				Sai, S; Fujii, K; Chino, H; Inoue, J			Radial head dislocation with acute plastic bowing of the ulna	JOURNAL OF ORTHOPAEDIC SCIENCE			English	Article						acute plastic bowing; ulnar bow; radial head dislocation; monteggia fracture-dislocation	MONTEGGIA FRACTURE; CHILDREN; FOREARM; ETIOLOGY	Five radial head dislocations with acute plastic bowing of the ulna in patients aged 6-12 years were reviewed. Closed reduction was successful in two, and open reduction was required in three patients in whom treatment was started more than 2 weeks after injury. In one child who presented 2 months after injury, realignment by osteotomy of the ulna as well as open reduction of the radial head was necessary. Follow-up evaluations at 6-24 months revealed good clinical outcomes in all patients. Awareness of this type of radial head dislocation is important to avoid delays in diagnosis and treatment.	Jikei Univ, Sch Med, Dept Orthopaed Surg, Minato Ku, Tokyo 1058461, Japan		Sai, S (corresponding author), Jikei Univ, Sch Med, Dept Orthopaed Surg, Minato Ku, 3-25-8 Nishi Shinbashi, Tokyo 1058461, Japan.						Armstrong R D, 1987, Orthop Rev, V16, P104; Attia MW, 1997, PEDIATR EMERG CARE, V13, P392, DOI 10.1097/00006565-199712000-00009; BORDEN S, 1974, J BONE JOINT SURG AM, VA 56, P611, DOI 10.2106/00004623-197456030-00019; BRUCE HE, 1974, J BONE JOINT SURG AM, VA 56, P1563, DOI 10.2106/00004623-197456080-00003; CHAMAY A, 1970, J BIOMECH, V3, P263, DOI 10.1016/0021-9290(70)90028-X; Demos T C, 1980, Orthopedics, V3, P1108, DOI 10.3928/0147-7447-19801101-12; EVANS EM, 1949, J BONE JOINT SURG BR, V31, P578, DOI 10.1302/0301-620X.31B4.578; HAMILTON W, 1973, CLIN ORTHOP RELAT R, P94; LETTS M, 1985, J BONE JOINT SURG BR, V67, P724, DOI 10.1302/0301-620X.67B5.4055869; LINCOLN TL, 1994, J PEDIATR ORTHOPED, V14, P454, DOI 10.1097/01241398-199407000-00006; LLOYDROBERTS GC, 1977, J BONE JOINT SURG BR, V59, P402, DOI 10.1302/0301-620X.59B4.925049; NEVIASER RJ, 1971, CLIN ORTHOP RELAT R, P72; RYDHOLM U, 1979, CLIN ORTHOP RELAT R, P121; SANO S, 2003, SEIKEIGEKA, V54, P1619; STRUM PF, 1989, MT SINAI J MED, V56, P304; TOMPKINS DG, 1971, J BONE JOINT SURG AM, VA 53, P1109, DOI 10.2106/00004623-197153060-00007; Vesely D G, 1967, Clin Orthop Relat Res, V50, P31; VINZ H, 1989, Beitraege zur Orthopaedie und Traumatologie, V36, P169; WILEY JJ, 1974, J BONE JOINT SURG BR, VB 56, P501, DOI 10.1302/0301-620X.56B3.501; Yamamoto M, 2003, SEIKEIGEKA, V54, P663	20	8	8	0	0	SPRINGER TOKYO	TOKYO	3-3-13, HONGO, BUNKYO-KU, TOKYO, 113-0033, JAPAN	0949-2658			J ORTHOP SCI	J. Orthop. Sci.		2005	10	1					103	107		10.1007/s00776-004-0860-x			5	Orthopedics	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics	896XL	WOS:000226967700019	15666132				2022-02-06	
J	Winterberg, DH; Wever, PC; van Rheenen-Verberg, C; Kempers, S; Durand, R; Bos, AP; Teeuw, AH; Spanjaard, L; Dankert, J				Winterberg, DH; Wever, PC; van Rheenen-Verberg, C; Kempers, S; Durand, R; Bos, AP; Teeuw, AH; Spanjaard, L; Dankert, J			A boy with nosocomial malaria tropica contracted in a Dutch hospital	PEDIATRIC INFECTIOUS DISEASE JOURNAL			English	Article						hospital-acquired malaria; nosocomial transmission; Plasmodium falciparum; occult blood; genotyping	PLASMODIUM-FALCIPARUM MALARIA; TRANSMISSION; BLOOD; INFECTIONS	A 12-year-old Dutch boy was admitted because of severe neurotrauma after a traffic accident. On day 33 after admission, a Plasmodium falciparum infection was found in a routine blood smear. Most probably he was infected by blood of a patient next to him, a girl with severe malaria tropica. The genotype of the P. falciparum in both patients was identical.	Univ Amsterdam, AMC, Emma Childrens Hosp, NL-1100 DE Amsterdam, Netherlands; Univ Amsterdam, Acad Med Ctr, Dept Med Microbiol, NL-1105 AZ Amsterdam, Netherlands; Univ Paris, Lab Parasitol Mycol, Hop Bichat Claude Bernard, F-75252 Paris, France		Winterberg, DH (corresponding author), Univ Amsterdam, AMC, Emma Childrens Hosp, Room H8-240,POB 22700, NL-1100 DE Amsterdam, Netherlands.	d.h.winterberg@amc.uva.nl		Teeuw, Arianne/0000-0002-9804-5578			Abulrahi HA, 1997, LANCET, V349, P23, DOI 10.1016/S0140-6736(96)03508-8; Al-Saigul AM, 2000, INFECT CONT HOSP EP, V21, P329, DOI 10.1086/501765; Alweis RL, 2004, INFECT CONT HOSP EP, V25, P55, DOI 10.1086/502293; DANKERT J, 1976, J INFECT DIS, V134, P123, DOI 10.1093/infdis/134.2.123; Felger I, 1999, T ROY SOC TROP MED H, V93, pS3; Guillet P, 1998, TROP MED INT HEALTH, V3, P700; Herwaldt BL, 2001, CLIN MICROBIOL REV, V14, P659, DOI 10.1128/CMR.14.3.659-688.2001; Kirchgatter K, 2002, ACTA TROP, V84, P199, DOI 10.1016/S0001-706X(02)00181-X; LETTAU LA, 1991, INFECT CONT HOSP EP, V12, P111, DOI 10.1086/646297; MICHELS W, 1997, HYG MED, V22, P173; Piro S, 2001, J HOSP INFECT, V47, P156, DOI 10.1053/jhin.2000.0907; Raffenot D, 1999, EUR J CLIN MICROBIOL, V18, P680, DOI 10.1007/s100960050378; SNEWIN VA, 1991, MOL BIOCHEM PARASIT, V49, P265, DOI 10.1016/0166-6851(91)90070-M	13	8	8	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0891-3668			PEDIATR INFECT DIS J	Pediatr. Infect. Dis. J.	JAN	2005	24	1					89	91		10.1097/01.inf.0000148881.92329.f6			3	Immunology; Infectious Diseases; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Immunology; Infectious Diseases; Pediatrics	889UC	WOS:000226467100018	15665720				2022-02-06	
J	Donders, J; Wildeboer, MA				Donders, J; Wildeboer, MA			Validity of the WCST-64 after traumatic brain injury in children	CLINICAL NEUROPSYCHOLOGIST			English	Article							CARD SORTING TEST; TEST SHORT FORMS; EXECUTIVE FUNCTION; HEAD-INJURY; PERFORMANCE; ADOLESCENTS; DEFICITS; SCORES	The Wisconsin Card Sorting Test-64 (WCST-64) is a recently normed modification of the Wisconsin Card Sorting Test (WCST) that utilizes only one deck of cards. The present study investigated the validity of the WCST-64 in a sample of fifty-six 10- to 16-year-old children with traumatic brain injury (TBI). Standard scores for perseverative responses from the WCST-64 and from the full-length WCST shared 83% of common variance. Less than 10% of this sample had a discrepancy between the respective indexes that was greater than one standard deviation. Correlations with external criteria such as length of coma and Full Scale IQ were not significantly different between the two versions of the instrument. The findings suggest that the WCST-64 may be used interchangeably with the original WCST in older children with TBI.	Mary Free Bed Hosp, Dept Psychol, Psychol Serv, Grand Rapids, MI 49503 USA; Calvin Coll, Dept Psychol, College Rapids, MI USA		Donders, J (corresponding author), Mary Free Bed Hosp, Dept Psychol, Psychol Serv, 235 Wealthy St SE, Grand Rapids, MI 49503 USA.	jdonders@mfbrc.com					Ardila A, 2000, ARCH CLIN NEUROPSYCH, V15, P31, DOI 10.1016/S0887-6177(98)00159-0; Axelrod BN, 2002, CLIN NEUROPSYCHOL, V16, P7, DOI 10.1076/clin.16.1.7.8331; Chase-Carmichael CA, 1999, CLIN NEUROPSYCHOL, V13, P405, DOI 10.1076/1385-4046(199911)13:04;1-Y;FT405; CHELUNE GJ, 1987, DEV NEUROPSYCHOL, V3, P81, DOI 10.1080/87565648709540365; CHELUNE GJ, 1986, J CLIN EXP NEUROPSYC, V8, P219, DOI 10.1080/01688638608401314; Donders J, 2002, PSYCHOL ASSESSMENT, V14, P360, DOI 10.1037//1040-3590.14.3.360; DONDERS J, IN PRESS CHILD NEURO; Fisher NJ, 1997, CHILD NEUROPSYCHOL, V3, P61, DOI 10.1080/09297049708401368; GIOIA GA, 2000, BEAHV RATING INVENTO; Gutentag SS, 1998, ASSESSMENT, V5, P263, DOI 10.1177/107319119800500306; Heaton RK, 1999, WISCONSIN CARD SORTI; HEATON RK, 1993, WISCONSIN SORTING TE; HEATON RK, 2000, WCST64 COMPUTER VERS; Kizilbash A, 1999, CHILD NEUROPSYCHOL, V5, P224, DOI 10.1076/0929-7049(199912)05:04;1-R;FT224; KONGS SK, 2000, WSCT64 WISCONSIN CAR; Kraus JF, 1995, TRAUMATIC HEAD INJUR, P22; Levin H S, 1997, J Int Neuropsychol Soc, V3, P598; LEVY P, 1967, J CLIN PSYCHOL, V23, P84, DOI 10.1002/1097-4679(196701)23:1<84::AID-JCLP2270230123>3.0.CO;2-2; Liss M, 2001, J CHILD PSYCHOL PSYC, V42, P261, DOI 10.1017/S0021963001006679; Mangeot S, 2002, CHILD NEUROPSYCHOL, V8, P271, DOI 10.1076/chin.8.4.271.13503; Merrick EE, 2003, CLIN NEUROPSYCHOL, V17, P153, DOI 10.1076/clin.17.2.153.16512; Reitan R. M., 1992, NEUROPSYCHOLOGICAL E; Robinson L J, 1991, Arch Clin Neuropsychol, V6, P27, DOI 10.1016/0887-6177(91)90019-6; Seidman LJ, 1997, J CONSULT CLIN PSYCH, V65, P150, DOI 10.1037/0022-006X.65.1.150; Sherer M, 2003, J CLIN EXP NEUROPSYC, V25, P512, DOI 10.1076/jcen.25.4.512.13877; Silver CH, 2000, J HEAD TRAUMA REHAB, V15, P973, DOI 10.1097/00001199-200008000-00002; Slomine BS, 2002, BRAIN INJURY, V16, P759, DOI 10.1080/02699050210127286; Smith-Seemiller L, 1997, CLIN NEUROPSYCHOL, V11, P421, DOI 10.1080/13854049708400472; Smith-Seemiller L, 2001, ARCH CLIN NEUROPSYCH, V16, P489, DOI 10.1016/S0887-6177(00)00062-7; TEASDALE G, 1974, LANCET, V2, P81; Tombaugh T.N., 1996, TEST MEMORY MALINGER; Vriezen ER, 2002, CHILD NEUROPSYCHOL, V8, P296, DOI 10.1076/chin.8.4.296.13505; Watkins KE, 1998, DEV MED CHILD NEUROL, V40, P536; Wechsler D, 1991, WECHSLER INTELLIGENC, VTHIRD; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014	35	8	8	0	7	TAYLOR & FRANCIS INC	PHILADELPHIA	325 CHESTNUT ST, SUITE 800, PHILADELPHIA, PA 19106 USA	1385-4046			CLIN NEUROPSYCHOL	Clin. Neuropsychol.	DEC	2004	18	4					521	527		10.1080/11385404049052411			7	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	895BH	WOS:000226835400004	15841955				2022-02-06	
J	Hanson, EK; Beukelman, DR; Fager, S; Ullman, C				Hanson, EK; Beukelman, DR; Fager, S; Ullman, C			Listener attitudes toward speech supplementation strategies used by speakers with dysarthria	JOURNAL OF MEDICAL SPEECH-LANGUAGE PATHOLOGY			English	Article; Proceedings Paper	Conference on Motor Speech	MAR, 2004	Albuquerque, NM				SPEAKING RATE; INTELLIGIBILITY; HEARING; CLEAR	This study examined listener attitudes toward (1) habitual speech, (2) alphabet supplemented speech, (3) topic supplemented speech, and (4) clear speech produced by nine survivors of traumatic brain injury who had dysarthria at varying levels of severity. Four listener groups were used: (1) members of the general public, (2) speech-language pathologists, (3) allied health professionals, and (4) family members of survivors of brain injury. The listeners viewed videotape showing each speaker in four speaking conditions and ranked each according to the effectiveness and acceptability of the strategy. The results demonstrated that alphabet supplementation was the most preferred speaking strategy among the four conditions viewed. Negative correlations between the attitude rankings and speaker intelligibility scores for alphabet supplementation suggest that some listeners do not prefer the strategy that, in fact, produced the highest intelligibility scores.	Univ Nebraska, Lincoln, NE 68583 USA; Madonna Rehabil Hosp, Lincoln, NE USA		Hanson, EK (corresponding author), Univ Nebraska, 253 Barkley Mem Ctr, Lincoln, NE 68583 USA.	ehanson@unlserve.unl.edu	Hanson, Elizabeth/C-2690-2013				Barker R.G., 1953, ADJUSTMENT PHYS HAND; Beukelman DR, 2002, J MED SPEECH-LANG PA, V10, P237; Dickerson Suzanne Steffan, 2002, Rehabil Nurs, V27, P215; GORENFLO CW, 1991, J SPEECH HEAR RES, V34, P19, DOI 10.1044/jshr.3401.19; Hanson EK, 2004, J MED SPEECH-LANG PA, V12, pIX; Hustad KC, 2004, AM J SPEECH-LANG PAT, V13, P168, DOI 10.1044/1058-0360(2004/017); Hustad KC, 2002, J SPEECH LANG HEAR R, V45, P545, DOI 10.1044/1092-4388(2002/043); HUSTAD KC, 2001, AUGMENTATIVE ALTERNA, V17, P213, DOI DOI 10.1080/AAC.17.4.213.220; Jones W., 2004, AUGMENTATIVE ALTERNA, V20, P22, DOI DOI 10.1080/07434610310001615981; Lasker J, 1999, APHASIOLOGY, V13, P857, DOI 10.1080/026870399401920; LASKER JP, 2000, AUGMENTATIVE ALTERNA; Lass Norman J., 1993, Journal of Communication Disorders, V26, P3, DOI 10.1016/0021-9924(93)90012-Y; NILSSON M, 1994, J ACOUST SOC AM, V95, P1085, DOI 10.1121/1.408469; PICHENY MA, 1989, J SPEECH HEAR RES, V32, P600, DOI 10.1044/jshr.3203.600; SILLER J, 1976, REHABILITATION MED P, P455; Ullman, 2003, AUGMENTATIVE ALTERNA, V19, P170, DOI [10.1080/0743461031000116544, DOI 10.1080/0743461031000116544]	16	8	8	0	4	DELMAR LEARNING	CLIFTON PARK	EXECUTIVE WOODS, 5 MAXWELL DR, CLIFTON PARK, NY 12065 USA	1065-1438			J MED SPEECH-LANG PA	J. Med. Speech-Lang. Pathol.	DEC	2004	12	4					161	166					6	Audiology & Speech-Language Pathology; Clinical Neurology	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Audiology & Speech-Language Pathology; Neurosciences & Neurology	877IT	WOS:000225562500008					2022-02-06	
J	Himmelseher, S; Werner, C				Himmelseher, S; Werner, C			Therapeutic hypothermia after traumatic brain injury or subarachnoid hemorrhage. Current practices of German anaesthesia departments in intensive care	ANAESTHESIST			German	Article						therapeutic hypothermia; prophylactic; neuroprotection; intracranial hypertension; traumatic brain injury; subarachnoid hemorrhage	SEVERE HEAD-INJURY; PROMISING TREATMENT MODALITY; MILD HYPOTHERMIA; INTRACRANIAL-PRESSURE; WORKING GROUP; TEMPERATURE; NEUROANESTHESIA; NEUROPROTECTION; OPPORTUNITIES; EXPERIENCE	Background. We aimed to explore current practices in use of therapeutic hypothermia after traumatic brain injury (TBI) or subarachnoid hemorrhage (SAH) in intensive care of adults. Methods. Questionnaires were sent to anaesthesia department chairs in German hospitals with neurosurgical care in January 2004 with a survey focussing on cooling procedures, temperature measurement, depth and duration of hypothermia, and re-warming after therapy. Results. 99 (67%) questionnaires on TBI and 95 (64%) on SAH could be analysed. Hypothermia was used in 39% after TBI and 18% after SAH. Its aims were neuroprotection in approximately 45% and control of refractory intracranial hypertension in approximately 50%. However, in most cases (69% TBI, 59% SAH) hypothermia was used in less than a quarter of patients treated. A criterion for hypothermia was severe disease in approximately 40% and refractory intracranial hypertension in approximately 50%. Temperatures were targeted to 36-34degreesC in 77% after TBI and 88% after SAH. In more than 80%, bladder temperatures were measured. For induction of hypothermia, surface cooling was applied in approximately 90%. The duration of hypothermia was 24-48 h in 62% after TBI and 29% after SAH. Cooling was orientated at the intracranial pressure (ICP) in 31% after TBI and 47% after SAH, and was used for more than 48 h in approximately 25%. After hypothermia was stopped, a rewarming rate of 0.5degreesC/h was applied in 38% after TBI and 53% after SAH. In approximately 35%, rewarming was orientated at the ICP, and in 33% after TBI and 24% after SAH, it was performed over 24 h. After SAH, spontaneous rewarming was used in 24%. Conclusion. Therapeutic hypothermia is used in 39% after TBI and 18% after SAH in the intensive care of German anaesthesia departments. There is no standard in management, and there is wide variation in practices of duration of cooling and rewarming. For patients' benefit, evidence-based recommendations on therapeutic hypothermia should be published by the appropriate medical societies in the German language.	Tech Univ Munich, Klinikum Rechts Isar, Anasthesiol Klin, D-81675 Munich, Germany; Univ Mainz Klinikum, Anasthesiol Klin, D-6500 Mainz, Germany		Himmelseher, S (corresponding author), Tech Univ Munich, Klinikum Rechts Isar, Anasthesiol Klin, Ismaningerstr 22, D-81675 Munich, Germany.	s.himmelseher@lrz.tu-muenchen.de					Bernard SA, 1999, CRIT CARE, V3, P167, DOI 10.1186/cc371; Clifton GL, 2001, NEW ENGL J MED, V344, P556, DOI 10.1056/NEJM200102223440803; Clifton GL, 2001, J NEUROSURG, V95, P751, DOI 10.3171/jns.2001.95.5.0751; Clifton Guy L, 2004, Curr Opin Crit Care, V10, P116, DOI 10.1097/00075198-200404000-00007; Dinkel M, 1998, ANASTH INTENSIVMED, V39, P399; Gasser S, 2003, J NEUROSURG ANESTH, V15, P240, DOI 10.1097/00008506-200307000-00012; Georgiadis D, 2002, STROKE, V33, P3026, DOI 10.1161/01.STR.0000038423.35569.93; Gupta AK, 2002, BRIT J ANAESTH, V88, P188, DOI 10.1093/bja/88.2.188; Henker RA, 1998, NEUROSURGERY, V42, P1071, DOI 10.1097/00006123-199805000-00071; Himmelseher S, 2000, ANAESTHESIST, V49, P412, DOI 10.1007/s001010070109; Himmelseher S, 2004, ANASTH INTENSIVMED, V45, P262; Inamasu J, 2002, NEUROSURGERY, V50, P1199, DOI 10.1097/00006123-200206000-00005; Jiang JY, 2000, J NEUROSURG, V93, P546, DOI 10.3171/jns.2000.93.4.0546; Keller E, 2003, INTENS CARE MED, V29, P939, DOI 10.1007/s00134-003-1685-3; Lefrant JY, 2003, INTENS CARE MED, V29, P414, DOI 10.1007/s00134-002-1619-5; LIDA K, 2003, J NEUROSURG, V98, P793; McIntyre LA, 2003, JAMA-J AM MED ASSOC, V289, P2992, DOI 10.1001/jama.289.22.2992; Miyamoto TA, 2004, ANESTHESIOLOGY, V100, P455, DOI 10.1097/00000542-200402000-00047; Nagao S, 2003, J CLIN NEUROSCI, V10, P208, DOI 10.1016/S0967-5868(02)00322-3; Nakamura T, 2002, ACTA NEUROL SCAND, V106, P314, DOI 10.1034/j.1600-0404.2002.01300.x; Pemberton PL, 2003, ANAESTHESIA, V58, P370; Polderman KH, 2004, INTENS CARE MED, V30, P556, DOI 10.1007/s00134-003-2152-x; Polderman KH, 2002, INTENS CARE MED, V28, P1563, DOI 10.1007/s00134-002-1511-3; Polderman KH, 2004, INTENS CARE MED, V30, P757, DOI 10.1007/s00134-003-2151-y; Rumana CS, 1998, CRIT CARE MED, V26, P562, DOI 10.1097/00003246-199803000-00032; Sakamoto T, 2004, J THORAC CARDIOV SUR, V127, P12, DOI 10.1016/j.jtcvs.2003.08.033; Schmutzhard E, 2002, CRIT CARE MED, V30, P2481, DOI 10.1097/00003246-200211000-00013; Soukup J, 2002, J NEUROTRAUM, V19, P559, DOI 10.1089/089771502753754046; Yasui N, 2002, ACT NEUR S, V82, P93; Zhi DS, 2003, SURG NEUROL, V59, P381, DOI 10.1016/S0090-3019(03)00148-4	30	8	9	0	1	SPRINGER	NEW YORK	233 SPRING STREET, NEW YORK, NY 10013 USA	0003-2417			ANAESTHESIST	Anaesthesist	DEC	2004	53	12					1168	+		10.1007/s00101-004-0778-x			8	Anesthesiology	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology	882ET	WOS:000225922500003	15597156				2022-02-06	
J	Herold, TJS; Taylor, S; Abbrescia, K; Hunter, C				Herold, TJS; Taylor, S; Abbrescia, K; Hunter, C			Post-traumatic Subdural Hygroma: Case report	JOURNAL OF EMERGENCY MEDICINE			English	Article						subdural hygroma; subdural hematoma; closed head injury; computed tomography	HEMATOMA; PATHOGENESIS; FATE	Subdural Hygroma (SDG) is described in the literature as a common complication of blunt head trauma occurring in a reported 5-20% of all closed head injuries (1-3). The Emergency Physician will likely encounter this type of lesion and it is useful to have an understanding of its significance, its relationship to subdural hematoma (SDH), and management strategies. Although surgical intervention is often advocated in the treatment of intracranial fluid collections causing mass effect, there are several reported cases of spontaneous resolution of uncal and central herniation via conservative management alone (4,5). The authors report a case of a 90-year-old woman who presented to the Emergency Department 5 days after falling and sustaining a closed head injury with computed tomography (CT) scan evidence of mid-line shift. (C) 2004 Elsevier Inc.	Brooke Army Med Ctr, San Antonio Uniformed Serv Hlth Educ Consortium, Dept Emergency Med, Ft Sam Houston, TX 78234 USA		Herold, TJS (corresponding author), Darnall Army Community Hosp, Dept Emergency Med, 36000 Darnall Loop, Ft Hood, TX 76544 USA.						BULLOCK R, 2000, MANAGEMENT PROGNOS 1, P101; DIERCKX RA, 1989, ACTA NEUROL BELG, V89, P352; GURDJIAN ES, 1978, ACTA NEUROCHIR WIE S, V25, P36; KENTARO M, 2000, SURG NEUROL, V53, P303; KUNIHIDE I, 2003, NEUROL MED CHIR TOKY, V43, P125; Lee KS, 2000, J KOREAN MED SCI, V15, P560, DOI 10.3346/jkms.2000.15.5.560; LEE KS, 1994, BRIT J NEUROSURG, V8, P551, DOI 10.3109/02688699409002947; Lee KS, 1998, BRAIN INJURY, V12, P595, DOI 10.1080/026990598122359; LUSINS JO, 1993, MT SINAI J MED, V60, P161; Matsuyama T, 1997, SURG NEUROL, V48, P193, DOI 10.1016/S0090-3019(96)00484-3; Mayo CH, 1894, NEW YORK M J, V59, P434; NAFZIGER HC, 1924, JAMA-J AM MED ASSOC, V82, P265; OHNO K, 1987, J NEUROL NEUROSUR PS, V50, P1694, DOI 10.1136/jnnp.50.12.1694; PARK CK, 1994, ACTA NEUROCHIR, V127, P41, DOI 10.1007/BF01808545; Payr E, 1916, MED KLIN, V12, P841; Prough DS, 1998, CRIT CARE MED, V26, P997, DOI 10.1097/00003246-199806000-00013; Roberts I, 1998, J NEUROL NEUROSUR PS, V65, P729, DOI 10.1136/jnnp.65.5.729; STJOHN JN, 1981, NEUROSURGERY, V9, P621, DOI 10.1227/00006123-198112000-00002; VONKOPP W, 1988, ROFO-FORTSCHR RONTG, V148, P530; WETTERLING T, 1986, ACTA NEUROCHIR, V83, P99, DOI 10.1007/BF01402385	20	8	10	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0736-4679			J EMERG MED	J. Emerg. Med.	NOV	2004	27	4					361	366		10.1016/j.jemermed.2004.03.018			6	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	866OK	WOS:000224782600006	15498616				2022-02-06	
J	Uomoto, JM; Fann, JR				Uomoto, JM; Fann, JR			Explanatory style and perception of recovery in symptomatic mild traumatic brain injury	REHABILITATION PSYCHOLOGY			English	Article; Proceedings Paper	Joint Conference of the 79th Annual Meeting American-Congress-of-Rehabilitation-Medicine/9th Annual Meeting of the American-Society-of-Neurorehabilitation	OCT 02-06, 2002	PHILADELPHIA, PA	American Congress Rehabilitat Med, American Soc Neurorehabilitat			POSTCONCUSSION SYNDROME; HEAD-INJURY; SELF	Objective: To examine perception of injury and explanatory style in symptomatic mild traumatic brain injury (MTBI). Study Design: Cross-sectional comparisons. Setting: Outpatient brain injury rehabilitation clinic. Participants: Twenty-two adults with MTBI and 11 with moderate/severe traumatic brain injury (TBI). Measures: Questionnaires addressing self-perception of injury severity and recovery and explanatory style. Results: MTBI patients reported greater injury severity and poorer cognitive recovery and rated their brain injury. as affecting more areas of life than the moderate/severe TBI group. Pessimistic explanatory style was associated with poorer perceived recovery. Conclusions: The results provide a stimulus for future research on self-perception and explanatory style as significant psychological variables and should be considered as relevant for interventions.	Seattle Pacific Univ, Dept Grad Psychol, Seattle, WA 98119 USA; Univ Washington, Dept Psychiat & Behav Sci, Sch Med, Seattle, WA 98195 USA		Uomoto, JM (corresponding author), Seattle Pacific Univ, Dept Grad Psychol, 3307 3rd Ave W, Seattle, WA 98119 USA.	uomoto@spu.edu	Uomoto, Jay/AAF-4809-2019				ABRAMSON LY, 1978, J ABNORM PSYCHOL, V87, P49, DOI 10.1037/0021-843X.87.1.49; Buchanan G. M., 1995, EXPLANATORY STYLE; Davis CH, 2002, AM J PHYS MED REHAB, V81, P609, DOI 10.1097/00002060-200208000-00009; DIKMEN S, 1986, J NEUROL NEUROSUR PS, V49, P227; EVANS RW, 1992, NEUROL CLIN, V10, P815, DOI 10.1016/S0733-8619(18)30182-8; FANN JR, 1995, AM J PSYCHIAT, V152, P1493; Gunstad J, 2001, J INT NEUROPSYCH SOC, V7, P323, DOI 10.1017/S1355617701733061; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; King NS, 1999, BRIT J CLIN PSYCHOL, V38, P15, DOI 10.1348/014466599162638; KLONOFF PS, 1993, B MENNINGER CLIN, V57, P227; KRAUS JF, 1989, MILD HEAD INJURY, P8; LEVIN HS, 1987, J NEUROSURG, V66, P234, DOI 10.3171/jns.1987.66.2.0234; Mittenberg W, 2000, J HEAD TRAUMA REHAB, V15, P783, DOI 10.1097/00001199-200004000-00003; MITTENBERG W, 1992, J NEUROL NEUROSUR PS, V55, P2000; Nochi M, 1998, SOC SCI MED, V46, P869, DOI 10.1016/S0277-9536(97)00211-6; Peterson C, 2000, LAWS LIF SYMP SER, V2, P145; Rapoport MJ, 2003, PSYCHOSOMATICS, V44, P31, DOI 10.1176/appi.psy.44.1.31; REIVICH K, 1995, EXPLANATORY STYLE, P2	18	8	8	0	2	EDUCATIONAL PUBLISHING FOUNDATION-AMERICAN PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST, NE, WASHINGTON, DC 20002-4242 USA	0090-5550			REHABIL PSYCHOL	Rehabil. Psychol.	NOV	2004	49	4					334	337		10.1037/0090-5550.49.4.334			4	Psychology, Clinical; Rehabilitation	Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Social Science &amp; Humanities (CPCI-SSH)	Psychology; Rehabilitation	874OR	WOS:000225360200010					2022-02-06	
J	Armstead, WM				Armstead, WM			NMDA and age dependent cerebral hemodynamics after traumatic brain injury	EXPERIMENTAL AND TOXICOLOGIC PATHOLOGY			English	Article; Proceedings Paper	4th International Congress of Pathophysiology	JUN 29-JUL 05, 2002	BUDAPEST, HUNGARY			newborn; cerebral circulation; excitator amino acids; brain injury; cyclooxygenase; oxygen free radicals; opioids	METHYL-D-ASPARTATE; NOC/OFQ-INDUCED IMPAIRMENT; BLOOD-FLOW; NOCICEPTIN/ORPHANIN FQ; SUPEROXIDE GENERATION; HEAD-INJURY; CEREBROVASODILATION; RAT; RESPONSES; ISCHEMIA	Activation of N-methyl-D-aspartate (NMDA) glutamatergic receptors elicits cerebrovascular dilation, may couple local cerebral metabolism to blood flow but contribute to excitotoxic neuronal cell death. While cerebral hemodynamics following traumatic brain injury may correlate with neurologic status, the role of NMDA vascular activity is uncertain in the sequelae of brain injury. NMDA dilation was impaired following fluid percussion brain injury (FPI) in an age dependent manner in the pig and the newly described opioid nociceptin/orphanin FQ (NOC/ oFQ) contributes to such impairment via the cyclooxygenase dependent generation of superoxide. Further, hypotensive pial artery dilation (PAD) was blunted after FPI but partially protected by pretreatment with the NMDA antagonist MK801. Cerebral blood flow (CBF) was reduced during normotension by FPI, further reduced by hypotension, but both were partially protected by MK801 in the newborn. In contrast, blunted hypotensive PAD was protected significantly less by MK801 in the juvenile pig. Similarly, MK801 had less protective effect on normotensive and hypotensive CBF values post FPI in the juvenile. These data indicate that NMDA receptor activation contributes to impaired hypotensive cerebral hemodynamics following FPI in an age dependent manner. Further, these data suggest that NMDA receptor activation, NOC/oFQ, and prostaglandins dynamically interact to impair cerebral hemodynamics following FPI. (C) 2004 Elsevier GmbH. All rights reserved.	Univ Penn, Dept Anesthesia & Pharmacol, Philadelphia, PA 19104 USA		Armstead, WM (corresponding author), Univ Penn, Dept Anesthesia & Pharmacol, 3400 Spruce St, Philadelphia, PA 19104 USA.	armsteaw@uphs.upenn.edu					Armstead WM, 2000, AM J PHYSIOL-HEART C, V279, pH2188, DOI 10.1152/ajpheart.2000.279.5.H2188; ARMSTEAD WM, 1994, J NEUROTRAUM, V11, P487, DOI 10.1089/neu.1994.11.487; Armstead WM, 1996, J NEUROSURG, V85, P901, DOI 10.3171/jns.1996.85.5.0901; Armstead WM, 1999, STROKE, V30, P153, DOI 10.1161/01.STR.30.1.153; Armstead WM, 2002, DEV BRAIN RES, V139, P19, DOI 10.1016/S0165-3806(02)00511-4; Armstead WM, 2001, PEPTIDES, V22, P39, DOI 10.1016/S0196-9781(00)00354-5; Armstead WM, 2001, J NEUROTRAUM, V18, P615, DOI 10.1089/089771501750291855; Armstead WM, 1999, AM J PHYSIOL-HEART C, V277, pH1884; Armstead WM, 1997, P SOC EXP BIOL MED, V214, P210; ARMSTEAD WM, 1989, AM J PHYSIOL, V257, P707; BUCHAN AM, 1990, CEREBROVAS BRAIN MET, V2, P1; BUCKLEY NM, 1986, COMP BIOCHEM PHYS A, V83, P1, DOI 10.1016/0300-9629(86)90080-0; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; CHOI DW, 1992, J NEUROBIOL, V23, P1261, DOI 10.1002/neu.480230915; CROCKARD HA, 1977, SURG NEUROL, V7, P281; DEWITT DS, 1992, J NEUROSURG, V76, P812, DOI 10.3171/jns.1992.76.5.0812; DEWITT DS, 1992, AM J PHYSIOL, V263, pH1276, DOI 10.1152/ajpheart.1992.263.4.H1276; DICKERSON JW, 1967, PROC R SOC SER B-BIO, V166, P384, DOI 10.1098/rspb.1967.0002; Dobbing J., 1981, SCI F PAEDIATRICS, P744; Duhaime AC, 1999, EXP TOXICOL PATHOL, V51, P172, DOI 10.1016/S0940-2993(99)80091-8; Faber ESL, 1996, BRIT J PHARMACOL, V119, P189, DOI 10.1111/j.1476-5381.1996.tb15969.x; FARACI FM, 1993, CIRC RES, V72, P476, DOI 10.1161/01.RES.72.2.476; GENNARELLI TA, 1994, J NEUROTRAUM, V11, P357, DOI 10.1089/neu.1994.11.357; Kasemsri T, 1997, STROKE, V28, P190, DOI 10.1161/01.STR.28.1.190; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; KAWAMATA T, 1992, J CEREBR BLOOD F MET, V12, P12, DOI 10.1038/jcbfm.1992.3; Kulkarni M, 2002, J NEUROTRAUM, V19, P965, DOI 10.1089/089771502320317113; Kulkarni M, 2000, STROKE, V31, P1990, DOI 10.1161/01.STR.31.8.1990; LaPlaca MC, 1998, J NEUROSCI RES, V52, P220, DOI 10.1002/(SICI)1097-4547(19980415)52:2<220::AID-JNR10>3.0.CO;2-B; LEWELT W, 1980, J NEUROSURG, V53, P500, DOI 10.3171/jns.1980.53.4.0500; LUERSSEN TG, 1988, J NEUROSURG, V68, P409, DOI 10.3171/jns.1988.68.3.0409; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; Merchant RE, 1999, ANN NY ACAD SCI, V890, P42, DOI 10.1111/j.1749-6632.1999.tb07979.x; Meunier JC, 1997, EUR J PHARMACOL, V340, P1, DOI 10.1016/S0014-2999(97)01411-8; Nicol B, 1996, BRIT J PHARMACOL, V119, P1081, DOI 10.1111/j.1476-5381.1996.tb16007.x; PAMPIGLIONE G, 1971, P ROY SOC MED, V64, P429, DOI 10.1177/003591577106400441; PARK CK, 1989, J CEREBR BLOOD F MET, V9, P617, DOI 10.1038/jcbfm.1989.88; RODRIGUEZ JG, 1990, AM J DIS CHILD, V144, P625, DOI 10.1001/archpedi.1990.02150300019014; Shaver EG, 1996, PEDIATR NEUROSURG, V25, P123, DOI 10.1159/000121109; SWAN JH, 1988, J CEREBR BLOOD F MET, V8, P64, DOI 10.1038/jcbfm.1988.9; TAKIZAWA S, 1991, J CEREBR BLOOD F MET, V11, P786, DOI 10.1038/jcbfm.1991.136; THOMAS JM, 1971, GROWTH, V35, P259; WEI EP, 1980, CIRC RES, V46, P37, DOI 10.1161/01.RES.46.1.37; YANAGISAWA M, 1988, NATURE, V332, P411, DOI 10.1038/332411a0; Zhao J, 1998, NEUROREPORT, V9, P631, DOI 10.1097/00001756-199803090-00013	45	8	8	0	1	URBAN & FISCHER VERLAG	JENA	BRANCH OFFICE JENA, P O BOX 100537, D-07705 JENA, GERMANY	0940-2993			EXP TOXICOL PATHOL	Exp. Toxicol. Pathol.	OCT	2004	56	1-2					75	81		10.1016/j.etp.2004.04.003			7	Pathology; Toxicology	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Pathology; Toxicology	872QF	WOS:000225221900010	15581278				2022-02-06	
J	Nirula, R; Mock, CN; Nathens, AB; Grossman, DC				Nirula, R; Mock, CN; Nathens, AB; Grossman, DC			The New Car Assessment Program: Does it predict the relative safety of vehicles in actual crashes?	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article						New Car Assessment Program; federal motor vehicle safety standards; traumatic brain injury; severe thoracic injury; National Automotive Sampling System		Background: Federal motor vehicle safety standards are based on crash test dummy analyses that estimate the relative risk of traumatic brain injury (TBI) and severe thoracic injury (STI) by quantifying head (Head Injury Criterion [HIC]) and chest (Chest Gravity Score [CGS]) acceleration. The New Car Assessment Program (NCAP) combines these probabilities to yield the vehicle's five-star rating. The validity of the NCAP system as it relates to an actual motor vehicle crash (MVC) remains undetermined. We therefore sought to determine whether HIC and CGS accurately predict TBI and STI in actual crashes, and compared the NCAP five-star rating system to the rates of TBI and/or STI in actual MVCs. Methods: We analyzed frontal crashes with restrained drivers from the 1994 to 1998 National Automotive Sampling System. The relationship of HIC and CGS to the probabilities of TBI and STI derived from crash tests were respectively compared with the HIC-TBI and CGS-STI risk relationships observed in actual crashes while controlling for covariates. Receiver operating characteristic curves determined the sensitivity and specificity of HIC and CGS as predictors of TBI and STI, respectively. Estimates of the likelihood of TBI and/or STI (in actual MVCs) were compared with the expected probabilities of TBI and STI (determined by crash test analysis), as they relate to NCAP ratings. Results: The crash tests overestimate TBI likelihood at HIC scores > 800 and underestimate it at scores < 500. STI likelihood is overestimated when CGS exceeds 40 g. Receiver operating characteristic curves demonstrated poor sensitivity and specificity of HIC and CGS in predicting injury. The actual MVC injury probability estimates did not vary between vehicles of different NCAP rating. Conclusion: HIC and CGS are poor predictors of TBI and STI in actual MVCs. The NCAP five-star rating system is unable to differentiate vehicles of varying crash-worthiness in actual MVCs. More sensitive parameters need to be developed and incorporated into vehicle crash safety testing to provide consumers and automotive manufacturers with useful tools with which to measure vehicle safety.	Univ Washington, Harborview Med Ctr, Dept Epidemiol, Dept Surg, Seattle, WA 98104 USA; Univ Washington, Harborview Med Ctr, Dept Epidemiol, Dept Pediat, Seattle, WA 98104 USA; Harborview Injury Prevent & Res Ctr, Seattle, WA USA		Nirula, R (corresponding author), Froedtert Med Ctr, Trauma Crit Care Div, 9200 W Wisconsin Ave, Milwaukee, WI 53226 USA.	rnirula@mcw.edu		Mock, Charles/0000-0002-0564-568X			*ASS ADV AUT MED, ABBR INJ SCAL 1990 R; Got C., 1978, P 22 STAPP CAR CRASH; GRUSH ES, 1983, 27 ANN P SAN ANT TX, P189; HODGSON VR, 1977, DOT PUBLICATION; HODGSON VR, 1973, P 17 STAPP CAR CRASH; JONES IS, 1988, ACCIDENT ANAL PREV, V20, P411, DOI 10.1016/0001-4575(88)90039-5; Martin PG, 2000, ACCIDENT ANAL PREV, V32, P541, DOI 10.1016/S0001-4575(99)00076-7; NAHUM AM, 1976, P 21 STAPP CAR CRASH; *NAT HIGHW TRAFF S, 1998, NAT AUT SAMPL SYST C; *NAT HIGHW TRAFF S, 1993, NEW CAR ASS PROGR RE; Prasad P., 1985, POSITION US DELEGATI; Segui-Gomez M, 2002, Annu Proc Assoc Adv Automot Med, V46, P1; *STAT CORP, 1998, STAT STAT SOFTW REL; TARRIERE C, 1982, ACCELERATION JERK NE; VIANO DC, 1988, J BIOMECH, V21, P387, DOI 10.1016/0021-9290(88)90145-5; VIANO DC, 1990, ASSESSING SAFETY PER	16	8	8	1	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0022-5282	1529-8809		J TRAUMA	J. Trauma-Injury Infect. Crit. Care	OCT	2004	57	4					779	786		10.1097/01.TA.0000106506.34691.B6			8	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	871EN	WOS:000225112300019	15514531				2022-02-06	
J	Longman, RS				Longman, RS			Values for comparison of WAIS-III index scores with overall means	PSYCHOLOGICAL ASSESSMENT			English	Article							TRAUMATIC BRAIN INJURY; STANDARDIZATION SAMPLE	The Wechsler Adult Intelligence Scale-Third Edition (WAIS-III; Wechsler, 1997b) provides factor-based index scores but allows only for pairwise comparison of these scores, producing inflated Type I error rates and reducing profile interpretability. This article provides tables for simultaneous comparison to the overall mean index score, thus reducing error rates and aiding interpretation. The Working Memory index or Processing Speed Index can also be specifically compared when an individual is believed to have a condition, such as a learning disability or traumatic brain injury, associated with the selective depression of these indexes. Tables for the infrequency of specific differences are also provided, allowing the practitioner to note how unusual an obtained difference is in the general population.	Foothills Prov Gen Hosp, Dept Psychol, Calgary, AB T2N 2T9, Canada		Longman, RS (corresponding author), Foothills Prov Gen Hosp, Dept Psychol, 1403 29th St NW, Calgary, AB T2N 2T9, Canada.	Stewart.Longman@calgaryhealthregion.ca					Axelrod BN, 2002, INT J NEUROSCI, V112, P1479, DOI 10.1080/00207450290158377; DAVIS FB, 1959, J EDUC PSYCHOL, V50, P162, DOI 10.1037/h0044024; Donders J, 2001, J INT NEUROPSYCH SOC, V7, P892, DOI 10.1017/S1355617701777132; Donders J, 1996, PSYCHOL ASSESSMENT, V8, P312, DOI 10.1037/1040-3590.8.3.312; Donders J, 2001, ASSESSMENT, V8, P193, DOI 10.1177/107319110100800207; Glutting JJ, 1997, SCHOOL PSYCHOL REV, V26, P176; Kaufman AlanS., 1990, ASSESSING ADOLESCENT; KNIGHT RG, 1984, J CLIN PSYCHOL, V40, P808, DOI 10.1002/1097-4679(198405)40:3<808::AID-JCLP2270400330>3.0.CO;2-E; NAGLIERI JA, 1993, PSYCHOL ASSESSMENT, V5, P113; Nunnally JC., 1978, PSYCHOMETRIC THEORY, V2; PAYNE RW, 1957, J CLIN PSYCHOL, V13, P115, DOI 10.1002/1097-4679(195704)13:2<115::AID-JCLP2270130203>3.0.CO;2-1; WECHSLER D, 1997, WAIS III WMS III TEC; Wechsler D, 1991, WECHSLER INTELLIGENC, VTHIRD; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird	14	8	8	0	3	AMER PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA	1040-3590			PSYCHOL ASSESSMENT	Psychol. Assess.	SEP	2004	16	3					323	325		10.1037/1040-3590.16.3.323			3	Psychology, Clinical	Social Science Citation Index (SSCI)	Psychology	854QE	WOS:000223917600010	15456387				2022-02-06	
J	Shum, DHK; O'Gorman, JG; Alpar, A				Shum, DHK; O'Gorman, JG; Alpar, A			Effects of incentive and preparation time on performance and classification accuracy of standard and malingering-specific memory tests	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article						malingering; memory impairment; memory tests	DEFICITS	The effects of incentive and preparation on performance and classification accuracy of standard and malingering-specific tests were investigated in a simulation study using a 2 (no incentive vs. a $20 incentive) x 2 (immediate vs. delayed preparation) factorial design. Eighty undergraduate students and 15 individuals with traumatic brain injury were administered standard (viz., Digit Span and Visual Memory Span from the WMS-R) and malingering-specific (viz., the Rey 15-Item Memory Test and the Multi-Digit Memory Test) memory tests. Preparation time was found to have a significant effect on performance and classification accuracy on a number of these tests, but incentive was found to have a significant effect on the performance but not the classification accuracy of one test (viz., the Multi-Digit Memory Test). These findings suggest that extra-test variables such as incentive and preparation time should be taken into consideration in evaluating the utility of standard and malingering-specific memory tests in detecting malingering. (C) 2003 National Academy of Neuropsychology. Published by Elsevier Ltd. All rights reserved.	Griffith Univ, Sch Appl Psychol, Nathan, Qld 4111, Australia; Griffith Univ, Appl Cognit Neurosci Res Ctr, Nathan, Qld 4111, Australia		Shum, DHK (corresponding author), Griffith Univ, Sch Appl Psychol, Nathan, Qld 4111, Australia.	d.shum@griffith.edu.au	Shum, David/A-3914-2008	Shum, David/0000-0002-4810-9262			BERNARD LC, 1990, J CLIN EXP NEUROPSYC, V12, P715, DOI 10.1080/01688639008401014; Bianchini KJ, 2001, CLIN NEUROPSYCHOL, V15, P19, DOI 10.1076/clin.15.1.19.1907; Frederick RI, 1994, NEUROPSYCHOLOGY, V8, P118, DOI 10.1037/0894-4105.8.1.118; GUILMETTE TJ, 1994, CLIN NEUROPSYCHOL, V8, P283, DOI 10.1080/13854049408404135; Iverson GL, 1998, BRAIN INJURY, V12, P275, DOI 10.1080/026990598122575; Johnson JL, 1997, ARCH CLIN NEUROPSYCH, V12, P231, DOI 10.1016/S0887-6177(96)00040-6; Martin RC, 1996, J CLIN EXP NEUROPSYC, V18, P265, DOI 10.1080/01688639608408281; MARTIN RC, 1993, J CLIN EXP NEUROPSYC, V15, P867, DOI 10.1080/01688639308402604; Niccolls R., 1991, MULTIDIGIT MEMORY TE; Orey SA, 2000, ARCH CLIN NEUROPSYCH, V15, P335, DOI 10.1016/S0887-6177(99)00024-4; Rey A., 1964, EXAMEN CLIN PSYCHOL; Rose FE, 1998, ARCH CLIN NEUROPSYCH, V13, P349, DOI 10.1016/S0887-6177(97)00025-5; Vickery CD, 2001, ARCH CLIN NEUROPSYCH, V16, P45, DOI 10.1016/S0887-6177(99)00058-X; Wechsler D, 1987, MEMORY SCALE REVISED	14	8	8	0	8	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0887-6177			ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	SEP	2004	19	6					817	823		10.1016/j.acn.2003.10.002			7	Psychology, Clinical; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	847SF	WOS:000223414500009	15288334	Bronze			2022-02-06	
J	Dias, MS; Lillis, KA; Calvo, C; Shaha, SH; Li, V				Dias, MS; Lillis, KA; Calvo, C; Shaha, SH; Li, V			Management of accidental minor head injuries in children: a prospective outcomes study	JOURNAL OF NEUROSURGERY			English	Article						trauma; head injury; concussion; skull fracture; pediatric neurosurgery	COMPUTED TOMOGRAPHIC SCANS; INTRACRANIAL INJURY; PEDIATRIC-PATIENTS; SKULL FRACTURE; REQUIRE HOSPITALIZATION; NEUROLOGIC EXAMINATION; RISK; HEMATOMAS; TRAUMA; CT	Object. The authors conducted a study to determine clinical, patient/family satisfaction, and financial outcomes following application of a management scheme that involves evaluation of computerized tomography (CT) scans and emergency department observation, rather than overnight admission, for children who have sustained accidental minor closed head injuries (Glasgow Coma Scale Scores 13-15) and who have met predefined clinical and radiographic criteria. Methods. During 18 consecutive months, all children age 24 months and older who sustained accidental minor head injuries were managed prospectively according to a standard protocol. All children meeting prospectively established clinical criteria underwent immediate CT scanning and were observed in the emergency department. Those in whom there were no intracranial radiographically demonstrated abnormalities and who met established clinical criteria were discharged to home observation. Two hundred fifteen children met the criteria for the study. Falls (53%) and motor vehicle accidents (13%) constituted the most common mechanisms of injury. Of the patients for whom information was recorded, 40% experienced a loss of consciousness and 49% had amnesia. Repeated vomiting occurred in 45%. Skull fractures were rare. No child suffered a clinical complication or neurological deterioration. Two patients (0.9%) underwent reevaluation within 48 hours for persistent symptoms; no intracranial abnormality was demonstrated in either on repeated CT scanning and both recovered uneventfully. Follow-up phone surveys in a subgroup of patients indicated universal parent satisfaction. Compared with a control group that underwent both CT scanning and were admitted to the hospital, statistically significant cost savings were realized in the cohort. Conclusions. A management scheme that involves routine initial CT studies and a brief period of observation in the emergency department is safe and readily accepted by patients and families and can achieve significant cost savings.	Inst Integrated Outcomes, Salt Lake City, UT USA; SUNY Buffalo, Womens & Childrens Hosp Buffalo, Ctr Pediat Qual, Div Pediat Neurosurg, Buffalo, NY USA; SUNY Buffalo, Womens & Childrens Hosp Buffalo, Dept Pediat, Div Emeregency Med, Buffalo, NY USA		Dias, MS (corresponding author), Penn State Milton S Hershey Med Ctr, Div Neurosurg, 850 Univ Dr, Hershey, PA 17033 USA.	mdias@psu.edu					Bergman DA, 1999, PEDIATRICS, V104, P1407; BROWN FD, 1978, J NEUROSURG, V48, P1019, DOI 10.3171/jns.1978.48.6.1019; BRUCE DA, 1981, J NEUROSURG, V54, P170, DOI 10.3171/jns.1981.54.2.0170; CHAN KH, 1990, J NEUROSURG, V72, P189, DOI 10.3171/jns.1990.72.2.0189; CHAN KH, 1990, CHILD NERV SYST, V6, P27, DOI 10.1007/BF00262262; CHOUX M, 1975, CHILD BRAIN, V1, P337; DACEY RG, 1986, J NEUROSURG, V65, P203, DOI 10.3171/jns.1986.65.2.0203; DAVIES RL, 1995, PEDIATRICS, V95, P345; DEITCH D, 1989, NEUROLOGY, V39, P985, DOI 10.1212/WNL.39.7.985; DIETRICH AM, 1993, ANN EMERG MED, V22, P1535, DOI 10.1016/S0196-0644(05)81254-5; DOMENICUCCI M, 1995, NEUROSURG REV, V18, P109, DOI 10.1007/BF00417668; FEUERMAN T, 1988, NEUROSURGERY, V22, P449, DOI 10.1227/00006123-198803000-00001; GLANTZ GA, 1987, PRIMER BIOSTATISTICS; GODANO U, 1992, CHILD NERV SYST, V8, P136, DOI 10.1007/BF00298269; Greenes DS, 1997, ANN EMERG MED, V30, P253, DOI 10.1016/S0196-0644(97)70158-6; Greenes DS, 1999, PEDIATRICS, V104, P861, DOI 10.1542/peds.104.4.861; HAHN YS, 1993, PEDIATR NEUROSURG, V19, P135, DOI 10.1159/000120718; HENNES H, 1988, AM J DIS CHILD, V142, P1045, DOI 10.1001/archpedi.1988.02150100039021; Hsiang JNK, 1997, J NEUROSURG, V87, P234, DOI 10.3171/jns.1997.87.2.0234; Ingebrigtsen T, 1996, ACTA NEUROL SCAND, V93, P207; JAIMOVICH R, 1992, PEDIATR NEUROSURG, V17, P25, DOI 10.1159/000120562; KADISH HA, 1995, ANN EMERG MED, V26, P37, DOI 10.1016/S0196-0644(95)70235-0; KAUFMAN BA, 1996, PEDIATR NEUROSURG, V25, P204; KLAUBER MR, 1989, NEUROSURGERY, V24, P31, DOI 10.1227/00006123-198901000-00005; KNUCKEY NW, 1989, J NEUROSURG, V70, P392, DOI 10.3171/jns.1989.70.3.0392; LEE ST, 1995, ACTA NEUROCHIR, V135, P136, DOI 10.1007/BF02187757; LIPPER MH, 1979, RADIOLOGY, V133, P645, DOI 10.1148/133.3.645; Lloyd DA, 1997, LANCET, V349, P821, DOI 10.1016/S0140-6736(96)09356-7; MARSHALL LF, 1983, J NEUROSURG, V59, P285, DOI 10.3171/jns.1983.59.2.0285; MITCHELL KA, 1994, J PEDIATR SURG, V29, P851, DOI 10.1016/0022-3468(94)90001-9; POON WS, 1992, NEUROSURGERY, V30, P681; RIMEL RW, 1981, NEUROSURGERY, V9, P221, DOI 10.1227/00006123-198109000-00001; RIVARA F, 1987, PEDIATRICS, V80, P579; ROCKSWOLD GL, 1987, NEUROSURGERY, V21, P51, DOI 10.1227/00006123-198707000-00010; Roddy SP, 1998, PEDIATRICS, V101, P575, DOI 10.1542/peds.101.4.575; ROS S P, 1989, Pediatric Emergency Care, V5, P216, DOI 10.1097/00006565-198912000-00003; ROSE J, 1977, BRIT MED J, V2, P615, DOI 10.1136/bmj.2.6087.615; SAINSBURY CPQ, 1984, ARCH DIS CHILD, V59, P856, DOI 10.1136/adc.59.9.856; Schunk JE, 1996, PEDIATR EMERG CARE, V12, P160, DOI 10.1097/00006565-199606000-00004; SHACKFORD SR, 1992, J TRAUMA, V33, P385, DOI 10.1097/00005373-199209000-00009; SNOEK JW, 1984, BRAIN, V107, P15, DOI 10.1093/brain/107.1.15; SOLONIUK D, 1986, J TRAUMA, V26, P787, DOI 10.1097/00005373-198609000-00003; STEIN SC, 1991, ANN EMERG MED, V20, P1286, DOI 10.1016/S0196-0644(05)81066-2; STEIN SC, 1990, NEUROSURGERY, V26, P638, DOI 10.1227/00006123-199004000-00012; STEIN SC, 1992, J TRAUMA, V33, P11, DOI 10.1097/00005373-199207000-00003; STEIN SC, 1993, NEUROSURGERY, V32, P25, DOI 10.1227/00006123-199301000-00004; TEASDALE G, 1974, LANCET, V2, P81; TEASDALE GM, 1990, BRIT MED J, V300, P363, DOI 10.1136/bmj.300.6721.363; ZIMMERMAN RA, 1978, RADIOLOGY, V126, P403, DOI 10.1148/126.2.403	49	8	8	0	1	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	AUG	2004	101	1		S			38	43		10.3171/ped.2004.101.2.0038			6	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	843QS	WOS:000223100100007	16206970				2022-02-06	
J	Leon-Diaz, A; Gonzalez-Rabelino, G; Alonso-Cervino, M				Leon-Diaz, A; Gonzalez-Rabelino, G; Alonso-Cervino, M			Analysis of the aetiologies of headaches in a paediatric emergency service	REVISTA DE NEUROLOGIA			Spanish	Article						aetiology; casualty; children; emergency; headaches; infancy	CHILDREN; CHILDHOOD	Introduction. Headaches are a frequent cause of children's visits to different health care Services but the epidemiological profile ivories widely according to whether the sample is taken from among visits to hospital clinics, neuropaediatric units or emergency services. Aims. The aim of this study was to analyse the aetiologies of the cases of headache attended in a paediatric emergency service. Patients and methods. We conducted a retrospective analysis of patient records with headache as the main reason for visiting over a six month period at the Paediatric Emergency Department at the Centro Hospitalario Pereira Rossell. Aetiologies were classified according to International Headache Society (IHS) criteria and the information was completed by telephone if the medical records contained insufficient data. Results. The records of 185 children were studied, which represented 0.58% of the total number of visits. The most common aetiologies were non-cranial infections (43.1%), migraines (14.6%), tension-type headaches (9.2%), traumatic injury (8.1%)and sinusitis (5.4%). Serious causes constituted 4.9% of the total, with a predominance of tumours and infections of the central nervous system. The low percentage of viral meningitis in our series (1%) leads its to suspect an underdiagnosis of this disorder; given the scant number of cases in which the cerebrospinal fluid was examined. Conclusions. Our study confirmed the existence of a wide and varied range of aetiologies causing headache, with a clear predominance of extracranial disorders and a low percentage of serious intracranial causes. Non-classifiable headaches made lip 10.8% of the sample. Brain Imaging studies were performed in 9.7% of cases, which is a considerably lower percentage than that of other series and demonstrates a rational use of this resource.	Ctr Hosp Pereira Rossell, Serv Neuropediat, Dept Emergencia Pediat, Montevideo, Uruguay		Leon-Diaz, A (corresponding author), Federico Garcia Lorca 7-814,Parque Miramar, Canelones 15000, Uruguay.	aloleon@adinet.com.uy					Annequin D, 2000, PEDIATR CLIN N AM, V47, P617, DOI 10.1016/S0031-3955(05)70229-7; Arroyo HA, 2003, REV NEUROLOGIA, V37, P364, DOI 10.33588/rn.3704.2003202; Burton LJ, 1997, PEDIATR EMERG CARE, V13, P1, DOI 10.1097/00006565-199702000-00001; DEPANDO ELG, 1999, AN ESP PEDIATR, V50, P562; Dominguez Salgado M, 2002, An Esp Pediatr, V57, P432; FORSYTH R, 1999, PEDIAT REV ESPANOL, V20, P130; Kan L, 2000, HEADACHE, V40, P25, DOI 10.1046/j.1526-4610.2000.00004.x; Lewis D W, 2001, Semin Pediatr Neurol, V8, P46, DOI 10.1053/spen.2001.23331; MAYTAL J, 1995, PEDIATRICS, V96, P413; MITCHELL CS, 1993, HEADACHE, V33, P82, DOI 10.1111/j.1526-4610.1993.hed3302082.x; ROTHNER AD, 1979, HEADACHE, V19, P156, DOI 10.1111/j.1526-4610.1979.hed1903156.x; Rufo M, 1996, Rev Neurol, V24, P268; RUFOCAMPOS M, 2003, CEFALEAS INFANCIA AD, P46; SESHIA SS, 1994, DEV MED CHILD NEUROL, V36, P419; SORGE F, 1988, CEPHALALGIA, V8, P1, DOI 10.1046/j.1468-2982.1988.0801001.x	15	8	11	0	0	REVISTA DE NEUROLOGIA	BARCELONA	C/O CESAR VIGUERA, EDITOR, APDO 94121, 08080 BARCELONA, SPAIN	0210-0010	1576-6578		REV NEUROLOGIA	Rev. Neurologia	AUG 1	2004	39	3					217	221		10.33588/rn.3903.2004043			5	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	853TI	WOS:000223851400004	15284960				2022-02-06	
J	Clancy, EA; Cairns, KD; Riley, PO; Meister, M; Kerrigan, DC				Clancy, EA; Cairns, KD; Riley, PO; Meister, M; Kerrigan, DC			Effects of treadmill walking speed on lateral gastrocnemius muscle firing	AMERICAN JOURNAL OF PHYSICAL MEDICINE & REHABILITATION			English	Article						gait; electromyography; plantar flexors; gastrocnemius	BODY-WEIGHT SUPPORT; VERTICAL DISPLACEMENT; FLOOR WALKING; EMG PROFILES; GAIT; FEEDBACK; STROKE; TRUNK	Objective: To study the electromyographic profile-including ON, OFF, and peak timing locations-of the lateral gastrocnemius muscle over a wide range of walking speeds (0.5-2.1 m/sec) in healthy young adults. Design: We studied gastrocnemius muscle-firing patterns using an electromyographic surface electrode in 15 healthy subjects ambulating on a treadmill at their normal walking speed and at three paced walking speeds (0.5, 1.8, and 2.1 m/sec). Initial heel contact was determined from a force-sensitive switch secured to the skin over the calcaneous. Results: For all speeds, the gastrocnemius firing pattern was characterized by a main peak, occurring 40-45% into the gait cycle, that increased in amplitude with walking speed. Speeds of greater than or equal to1.3 m/sec produced a common electromyographic timing profile, when the profile is expressed relative to the stride duration. However, at 0.5 m/sec (a speed typical of individuals with upper-motor neuron lesions), the onset of gastrocnemius firing was significantly delayed by 3-6% of the gait cycle and was prolonged by 8-11% the gait cycle. Conclusion: Many patients with upper motor neuron lesions (e.g., stroke and traumatic brain injury) walk at speeds much slower than those commonly described in the literature for normal gait. At the slow walking speed of 0.5 m/sec, we have measured noticeable changes in the electromyographic timing profile of the gastrocnemius muscle. Given the importance of appropriate plantar flexor firing patterns to maximize walking efficiency, understanding the speed-related changes in gastrocnemius firing patterns may be essential to gait restoration.	Worcester Polytech Inst, Dept Elect & Comp Engn, Worcester, MA 01609 USA; Worcester Polytech Inst, Dept Biomed Engn, Worcester, MA 01609 USA; Harvard Univ, Sch Med, Spaulding Rehabil Hosp Network, Mot Anal Lab, Boston, MA 02115 USA; Harvard Univ, Sch Med, Spaulding Rehabil Hosp Network, Dept Phys Med & Rehabil, Boston, MA 02115 USA; Univ Virginia, Sch Med, Mcclure Musculoskeletal Res Ctr, Dept Phys Med & Rehabil, Charlottesville, VA 22901 USA		Clancy, EA (corresponding author), Worcester Polytech Inst, Dept Elect & Comp Engn, 100 Inst Rd, Worcester, MA 01609 USA.		Riley, Patrick O/B-3053-2009		EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K24HD001351] Funding Source: NIH RePORTER; NICHD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K24 HD01351] Funding Source: Medline		BASMAJIAN JV, 1988, MUSCLES ALIVE THEIR; COLBORNE GR, 1994, ARCH PHYS MED REHAB, V75, P40; Gard SA, 1997, GAIT POSTURE, V5, P233, DOI 10.1016/S0966-6362(96)01089-2; Gard SA, 1999, ARCH PHYS MED REHAB, V80, P26, DOI 10.1016/S0003-9993(99)90303-9; GARD SA, 2000, P 5 ANN GAIT CLIN MO; Hesse S, 1999, ARCH PHYS MED REHAB, V80, P421, DOI 10.1016/S0003-9993(99)90279-4; Hesse S, 2001, NEUROREHAB NEURAL RE, V13, P157; Hesse Stefan, 2003, Phys Med Rehabil Clin N Am, V14, pS111, DOI 10.1016/S1047-9651(02)00061-X; Heus R, 1998, EUR J APPL PHYSIOL O, V77, P388, DOI 10.1007/s004210050349; Hof AL, 2002, GAIT POSTURE, V16, P78, DOI 10.1016/S0966-6362(01)00206-5; Kerrigan DC, 2000, ARCH PHYS MED REHAB, V81, P1077, DOI 10.1053/apmr.2000.6306; Kerrigan DC, 1997, J HEAD TRAUMA REHAB, V12, P29, DOI 10.1097/00001199-199712000-00004; Kerrigan DC, 2001, ARCH PHYS MED REHAB, V82, P217, DOI 10.1053/apmr.2001.18063; McGuire J R, 2001, Top Stroke Rehabil, V8, P47; MIDDAUGH SJ, 1980, ARCH PHYS MED REHAB, V61, P24; Moreland JD, 1998, ARCH PHYS MED REHAB, V79, P134, DOI 10.1016/S0003-9993(98)90289-1; MURRAY M P, 1984, Journal of Orthopaedic Research, V2, P272, DOI 10.1002/jor.1100020309; MURRAY MP, 1985, J APPL PHYSIOL, V59, P87, DOI 10.1152/jappl.1985.59.1.87; Perry J, 1992, GAIT ANAL NORMAL PAT; Riley PO, 2001, J BIOMECH, V34, P197, DOI 10.1016/S0021-9290(00)00174-3; SAUNDERS JBDM, 1953, J BONE JOINT SURG AM, V35-A, P543, DOI 10.2106/00004623-195335030-00003; Shiavi R, 1987, J Rehabil Res Dev, V24, P24; SHIAVI R, 1983, IEEE T BIO-MED ENG, V30, P73, DOI 10.1109/TBME.1983.325171; SUTHERLAND DH, 1980, J BONE JOINT SURG AM, V62, P354, DOI 10.2106/00004623-198062030-00005; Visintin M, 1998, STROKE, V29, P1122, DOI 10.1161/01.STR.29.6.1122; YANG JF, 1985, ELECTROEN CLIN NEURO, V60, P485, DOI 10.1016/0013-4694(85)91108-3	26	8	8	1	7	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0894-9115			AM J PHYS MED REHAB	Am. J. Phys. Med. Rehabil.	JUL	2004	83	7					507	514		10.1097/01.PHM.0000130033.91894.5A			8	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	831IP	WOS:000222188400003	15213474				2022-02-06	
J	Pramuk, LA; Sirotnak, A; Friedman, NR				Pramuk, LA; Sirotnak, A; Friedman, NR			Esophageal perforation preceding fatal closed head injury in a child abuse case	INTERNATIONAL JOURNAL OF PEDIATRIC OTORHINOLARYNGOLOGY			English	Article						esophageal perforation; non-accidental trauma; child abuse	MANAGEMENT; TRAUMA; FORM	This is a case describing an extensive esophageal perforation in a 15-day-old infant with an unclear mechanism of injury, who at 3 months of age presented as the victim of child abuse from a fatal closed head injury. Extensive esophageal perforation in a neonate or infant is usually induced by trauma, either accidental or non-accidental. When the given history does not correlate with the degree of injury, child abuse must be strongly suspected and a thorough social investigation must be undertaken. (C) 2004 Elsevier Ireland Ltd. All rights reserved.	Univ Colorado, Dept Pediat, Childrens Hosp, Denver, CO 80218 USA; Navarre Pediat Grp, South Bend, IN 46616 USA		Pramuk, LA (corresponding author), Univ Colorado, Dept Pediat, Childrens Hosp, 1056 E 19th Ave, Denver, CO 80218 USA.	pramuks@sbcglobal.net; sirotnak.andrew@tchden.org; friedman.norman@tchden.org					ABLIN DS, 1990, PEDIATR RADIOL, V20, P524, DOI 10.1007/BF02011381; BEAL SL, 1988, J TRAUMA, V28, P1425, DOI 10.1097/00005373-198810000-00003; DODDS WJ, 1982, RADIOLOGY, V144, P439, DOI 10.1148/radiology.144.2.7089304; Engum SA, 1996, ARCH SURG-CHICAGO, V131, P604; FRIEDMAN EM, 1987, ANN OTO RHINOL LARYN, V96, P709, DOI 10.1177/000348948709600621; Ludwig S, 2001, CHILD ABUSE MED DIAG; MCDOWELL HP, 1984, ARCH DIS CHILD, V59, P888, DOI 10.1136/adc.59.9.888; Morzaria S, 1998, J PEDIATR SURG, V33, P871, DOI 10.1016/S0022-3468(98)90663-7; Panieri E, 1996, J PEDIATR SURG, V31, P890, DOI 10.1016/S0022-3468(96)90404-2; Tavill MA, 1996, INT J PEDIATR OTORHI, V35, P263, DOI 10.1016/0165-5876(95)01302-4; *US DEP HHS ADM CH, 2003, CHILD MALTR 2001; VANDERZEE DC, 1988, J THORAC CARDIOV SUR, V95, P692	12	8	8	0	0	ELSEVIER SCI IRELAND LTD	CLARE	CUSTOMER RELATIONS MANAGER, BAY 15, SHANNON INDUSTRIAL ESTATE CO, CLARE, IRELAND	0165-5876			INT J PEDIATR OTORHI	Int. J. Pediatr. Otorhinolaryngol.	JUN	2004	68	6					831	835		10.1016/j.ijporl.2004.01.014			5	Otorhinolaryngology; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Otorhinolaryngology; Pediatrics	823CX	WOS:000221588400014	15126027				2022-02-06	
J	McLeod, A; Wills, A; Etherington, J				McLeod, A; Wills, A; Etherington, J			Employment retention after moderate-severe traumatic brain injury (TBI) in the British Army 1989-98	OCCUPATIONAL AND ENVIRONMENTAL MEDICINE			English	Article							FOLLOW-UP; HEAD-INJURY; RETURN; WORK; PREDICTORS; MODEL	Aims: To examine retention in employment of subjects with moderate-severe traumatic brain injury (TBI) in the British Army. Methods: Comparative groups study of retention in Army employment after TBI using 564 TBI, 368 lower limb fracture, and 25 575 healthy subjects. Kaplan-Meier survival analysis was used to examine, stratifying for age, continuation in Army employment for six years after TBI. Results: Subjects in the younger groups ( mean ages 23 years and 27 years respectively) with either TBI or lower limb fracture remained in employment longer than healthy peers ( median time for TBI, 3.91 years, lower limb fracture, 4.39 years, and healthy, 1.74 years). This trend changed through age stratification and for older subjects the reverse pattern was seen. In group 4 ( mean age 41 years), median retention time for TBI was 3.33 years, for lower limb fracture, 3.75 years, healthy 5.55 years. Older subjects also showed a marked drop out rate at one year after injury; 32.7% of those with TBI in group 3 ( mean age 31 years) had left Army employment at the end of year one compared with 19% in age group 1 ( mean age 23 years). Conclusions: Younger soldiers with either TBI or lower limb fracture are retained in Army employment longer than their healthy peers. This may be due to sheltered employment, the availability of ongoing support, or transience of the healthy population. Since these results were drawn from incidence data on moderate and severe TBI it may be that those who serve on after TBI will do so with some degree of disability which affects occupational performance. There may be a significant unmet rehabilitation need for this group which is the focus of ongoing research.	Barts & London NHS Trust, Outpatients Dept, London E1 1BB, England; Def Med Rehabil Ctr, Surrey, England		McLeod, A (corresponding author), Barts & London NHS Trust, Outpatients Dept, Stepney Way, London E1 1BB, England.	mandymcleod@hotmail.com	Wills, Andrew/AAO-5279-2020	Wills, Andrew/0000-0002-9751-4707			Cattelani R, 2002, BRAIN INJURY, V16, P51, DOI 10.1080/02699050110088821; EZRACHI O, 1991, J HEAD TRAUMA REHAB, V0006, P00071, DOI DOI 10.1097/00001199-199109000-00010; Felmingham KL, 2001, ARCH PHYS MED REHAB, V82, P435, DOI 10.1053/apmr.2001.21985; Gray J.M, 1994, CLIN REHABIL, V8, P188, DOI [10.1177/026921559400800302, DOI 10.1177/026921559400800302, DOI 10.1080/09602010902949207]; Groswasser Z, 1998, J HEAD TRAUMA REHAB, V13, P69, DOI 10.1097/00001199-199802000-00009; Isaki E, 2000, BRAIN INJURY, V14, P441; JORGE RE, 1994, J NEUROSURG, V81, P726, DOI 10.3171/jns.1994.81.5.0726; KAITARO T, 1995, BRAIN INJURY, V9, P713, DOI 10.3109/02699059509008227; Keyser-Marcus LA, 2002, ARCH PHYS MED REHAB, V83, P635, DOI 10.1053/apmr.2002.31605; KRAFT JF, 1993, ARCH PHYS MED REHAB, V74, P596, DOI 10.1016/0003-9993(93)90157-6; Kregel J, 1994, NeuroRehabilitation, V4, P1, DOI 10.3233/NRE-1994-4103; Kreutzer J S, 1988, Brain Inj, V2, P205, DOI 10.3109/02699058809150945; MACNIVEN E, 1993, BRAIN INJURY, V7, P241, DOI 10.3109/02699059309029676; Mazaux JM, 1997, ARCH PHYS MED REHAB, V78, P1316, DOI 10.1016/S0003-9993(97)90303-8; MCLEOD A, UNPUB INCIDENCE TRAU; MELAMED S, 1992, Brain Injury, V6, P233, DOI 10.3109/02699059209029665; ROA N, 1992, ARCH PHYS MED REHAB, V73, P911; ROESSLER RT, 1992, J REHABIL, P17; SCHWAB K, 1993, NEUROLOGY, V43, P95, DOI 10.1212/WNL.43.1_Part_1.95; Sherer M, 1999, BRAIN INJURY, V13, P973; Sherer M, 2002, ARCH PHYS MED REHAB, V83, P183, DOI 10.1053/apmr.2002.28802; STUSS DT, 1992, J CONSULT CLIN PSYCH, V60, P349, DOI 10.1037/0022-006X.60.3.349; Wagner AK, 2002, ARCH PHYS MED REHAB, V83, P107, DOI 10.1053/apmr.2002.27470; Watts R, 1999, BRAIN INJURY, V13, P113, DOI 10.1080/026990599121773; WEHMAN PH, 1995, J HEAD TRAUMA REHAB, V10, P27; Ylvisaker M, 2000, APHASIOLOGY, V14, P407, DOI 10.1080/026870300401432; YLVISAKER M, 1998, COLLABORATIVE BRAIN, P52	27	8	9	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1351-0711			OCCUP ENVIRON MED	Occup. Environ. Med.	MAY 1	2004	61	5					414	418		10.1136/oem.2003.007336			5	Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED)	Public, Environmental & Occupational Health	813DI	WOS:000220887400006	15090661	Green Published, Bronze			2022-02-06	
J	Wang, YT; Han, S; Zhang, KH; Jin, Y; Xu, XM; Lu, PH				Wang, YT; Han, S; Zhang, KH; Jin, Y; Xu, XM; Lu, PH			Upregulation of heparin-binding growth-associated molecule after spinal cord injury in adult rats	ACTA PHARMACOLOGICA SINICA			English	Article						heparin-binding growth-associated molecule; spinal cord injuries; immunohistochemistry; reverse transcriptase polymerase chain reaction; astrocytes; neurons	HB-GAM; EXPRESSION; PROTEIN; REGENERATION; INDUCTION; CLONING; SYSTEM; CELLS; BRAIN	AIM: To investigate whether traumatic spinal cord injury (SCI) induces changes of gene expression of heparin-binding growth-associated molecule (HB-GAM). METHODS: In a spinal cord transection model, HB-GAM expression and cellular localization were examined using Northern blot, RT-PCR, immunohistochemistry and immunofluorescence double-labeling methods. RESULTS: HB-GAM mRNA was significantly upregulated in spinal cord tissues rostral and caudal to the injury at 7 d after SCI. HB-GAM gene expression was markedly increased at 3 d, peaked at 7 d, and declined to the baseline level at 28 d post-injury. During its peak expression, HB-GAM was colocalized in astrocytes, oligodendrocytes, and neurons in spinal cord tissues within 7 mm from the site of spinal transection. CONCLUSION: SCI induces HB-GAM expression at both mRNA and protein levels in areas close to the injury. Both neurons and glial cells expressed HB-GAM implying that HB-GAM played a role in the process of injury and/or repair following SCI.	Shanghai Med Univ 2, Dept Neurobiol, Shanghai 200025, Peoples R China; Shanghai Med Univ 2, Xinhua Hosp Affiliated, Dept Surg, Shanghai, Peoples R China; Univ Louisville, Sch Med, Dept Neurol Surg, Kentucky Spinal Cord Injury Res Ctr, Louisville, KY 40292 USA		Lu, PH (corresponding author), Shanghai Med Univ 2, Dept Neurobiol, Shanghai 200025, Peoples R China.	neuron@shsmu.edu.cn		Xu, Xiao-ming/0000-0002-7229-0081			Goldberg JL, 2000, ANNU REV NEUROSCI, V23, P579, DOI 10.1146/annurev.neuro.23.1.579; Lauri SE, 1996, NEUROREPORT, V7, P1670, DOI 10.1097/00001756-199607080-00029; LI YS, 1990, SCIENCE, V250, P1690, DOI 10.1126/science.2270483; Liu Y, 1999, J NEUROSCI, V19, P4370; MCMILLIAN MK, 1994, TRENDS NEUROSCI, V17, P138, DOI 10.1016/0166-2236(94)90086-8; MERENMIES J, 1990, J BIOL CHEM, V265, P16721; PENG HB, 1995, J NEUROSCI, V15, P3027; RAULO E, 1992, J BIOL CHEM, V267, P11408; RAUVALA H, 1994, DEV BRAIN RES, V79, P157, DOI 10.1016/0165-3806(94)90121-X; Szabat E, 1996, DEV BIOL, V178, P77, DOI 10.1006/dbio.1996.0199; TAKEDA A, 1995, NEUROSCIENCE, V68, P57, DOI 10.1016/0306-4522(95)00110-5; WANAKA A, 1993, DEV BRAIN RES, V72, P133, DOI 10.1016/0165-3806(93)90166-8	12	8	9	0	3	ACTA PHARMACOLOGICA SINICA	SHANGHAI	294 TAI-YUAN RD, SHANGHAI, 200031, PEOPLES R CHINA	1671-4083	1745-7254		ACTA PHARMACOL SIN	Acta Pharmacol. Sin.	MAY	2004	25	5					611	616					6	Chemistry, Multidisciplinary; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Chemistry; Pharmacology & Pharmacy	819TA	WOS:000221337100012	15132827				2022-02-06	
J	Pape, TLB; Jaffe, NO; Savage, T; Collins, E; Warden, D				Pape, TLB; Jaffe, NO; Savage, T; Collins, E; Warden, D			Unresolved legal and ethical issues in research of adults with severe traumatic brain injury: Analysis of an ongoing protocol	JOURNAL OF REHABILITATION RESEARCH AND DEVELOPMENT			English	Article						altered consciousness; bioethics; regulations; statutes; traumatic brain injury	CLINICAL-RESEARCH; CONSENT; DECISIONS; RECOVERY; PROXIES; CARE	This paper synthesizes federal and state laws and bioethics literature with observations from an ongoing research protocol to identify, define, and clarify the unresolved legal and ethical issues regarding research involving adults with traumatic brain injury (TBI). Solutions that protect rights and minimize unnecessary impediments to valuable clinical and scientific inquiry are also illustrated using the same protocol. Research was performed at intensive care, inpatient rehabilitation, and long-term acute chronic hospitals. Our research protocol identified five areas of law impacting adults with TBI: advanced directives, healthcare surrogacy acts, probate acts, power of attorney acts, and the Health Insurance Portability and Accountability Act. The published bioethics literature and responses from local human subject institutional review boards (IRBs) suggest that some of the unresolved ethical issues in research include defining vulnerability, defining informed voluntary consent, determining competency and/or decision-making capacity, using caregivers as subjects, and conducting multisite cooperative studies. Collaboration with IRB members and administrators as well as legal and research ethic scholars developed procedures that protect rights while avoiding unnecessary impediments to research. Investigations of persons with TBI and other cognitive impairments are governed by complicated and inconsistent regulations within the Common Rule and federal and state statues. A need for clear and consistent regulatory guidance regarding multisite studies of TBI persists. In lieu of regulatory guidance, carefully researched solutions for critical peer review are needed to guide future multisite investigations of TBI.	Edward Hines Jr VA Hosp, Dept Vet Affairs, Res Serv, Hines, IL 60141 USA; Rehabil Inst Chicago, Ctr Rehabil Outcomes Res, Chicago, IL 60611 USA; Northwestern Univ, Sch Med, Dept Phys Med & Rehabil, Off Med Educ, Chicago, IL 60611 USA; Rush N Shore Med Ctr, Off Legal Affairs, Skokie, IL USA; Walter Reed Army Med Ctr, Def & Vet Head Injury Program, Washington, DC 20307 USA; Univ Illinois, Coll Nursing, Dept Med Surg Nursing, Chicago, IL USA; Univ Illinois, Coll Nursing, Dept Maternal Child Nursing, Chicago, IL USA; Uniformed Serv Univ Hlth Sci, Bethesda, MD 20814 USA		Pape, TLB (corresponding author), Edward Hines Jr VA Hosp, Dept Vet Affairs, Res Serv, POB 5000,151-H, Hines, IL 60141 USA.	pape@research.hines.med.va.gov		Bender Pape, Theresa/0000-0001-7738-5963			Andrews K, 1998, LANCET, V351, P1751, DOI 10.1016/S0140-6736(05)78740-7; ANDREWS K, 1993, BRIT MED J, V306, P1597, DOI 10.1136/bmj.306.6892.1597; ArboledaFlorez J, 1997, CAN J PSYCHIAT, V42, P485, DOI 10.1177/070674379704200504; Backlar P, 1996, COMMUNITY MENT HLT J, V32, P321, DOI 10.1007/BF02249450; Baskin SA, 1998, J AM GERIATR SOC, V46, P287, DOI 10.1111/j.1532-5415.1998.tb01039.x; Bonnie RJ, 1997, ARCH GEN PSYCHIAT, V54, P105; Coppolino M, 2001, CHEST, V119, P603, DOI 10.1378/chest.119.2.603; Damasio A., 1999, FEELING WHAT HAPPENS; *DEP VET AFF, 1992, VET HLTH ADM, pCH9; Dunn LB, 2001, AM J PSYCHIAT, V158, P1911, DOI 10.1176/appi.ajp.158.11.1911; Eker C, 2000, BRAIN INJURY, V14, P605; Giacino JT, 2002, NEUROLOGY, V58, P349, DOI 10.1212/WNL.58.3.349; GUERRO JL, 2000, EMERGENCY DEP VISITS; JENNETT B, 1974, LANCET, V1, P132; Karlawish JHT, 2001, NEUROLOGY, V56, P789, DOI 10.1212/WNL.56.6.789; Levine R. J., 1986, ETHICS REGULATION CL, V2nd; Meslin EM, 1999, BIOL PSYCHIAT, V46, P1011; Mesulam MM, 2000, PRINCIPLES BEHAV COG; Moreno J, 1998, JAMA-J AM MED ASSOC, V280, P1951, DOI 10.1001/jama.280.22.1951; Muncie HL, 1997, J AM GERIATR SOC, V45, P929, DOI 10.1111/j.1532-5415.1997.tb02961.x; *NAT BIOETH ADV CO, 1999, RES INV PERS MENT DI, V2; National Bioethics Advisory Commission, 1998, RES INV PERS MENT DI; OKAMAYA AK, 1996, J TRAUMA, V40, P211; Phipps EJ, 2000, J HEAD TRAUMA REHAB, V15, P965, DOI 10.1097/00001199-200006000-00010; Ragnarsson KT, 1999, JAMA-J AM MED ASSOC, V282, P974; Roberts LW, 1999, BIOL PSYCHIAT, V46, P1106, DOI 10.1016/S0006-3223(99)00146-8; SHELDON M, 1996, FDN MORAL PHILOS BIO; Shore D, 1999, BIOL PSYCHIAT, V46, P1013; Sugarman J, 2001, J AM GERIATR SOC, V49, P1110, DOI 10.1046/j.1532-5415.2001.49218.x; THURMAN D, 1997, MMWR-MORBID MORTAL W, V46, P8; Weisstub DN, 1997, CAN J PSYCHIAT, V42, P492, DOI 10.1177/070674379704200505; Wendler D, 2002, AM J PSYCHIAT, V159, P585, DOI 10.1176/appi.ajp.159.4.585	32	8	8	0	9	JOURNAL REHAB RES & DEV	BALTIMORE	DEPT OF VETERANS AFFAIRS REHABIL RES & DEVELOP CTR 103 SOUTH GAY STREET, BALTIMORE, MD 21202-4051 USA	0748-7711	1938-1352		J REHABIL RES DEV	J. Rehabil. Res. Dev.	MAR-APR	2004	41	2					155	173		10.1682/JRRD.2004.02.0155			19	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	826CW	WOS:000221807600009	15558370				2022-02-06	
J	Demakis, GJ				Demakis, GJ			Application of clinically-derived malingering cutoffs on the California Verbal Learning Test and the Wechsler Adult Intelligence Test-Revised to an analog malingering study	APPLIED NEUROPSYCHOLOGY			English	Article						malingering cutoffs; California Verbal Learning Test; Wechsler Adult Intelligence Scale-Revised; analog study	TRAUMATIC BRAIN-INJURY; INCOMPLETE EFFORT; HEAD-INJURY; WAIS-R; SCALE	This study examined the comparability of the California Verbal Learning Test (CVLT) and subtests of the Wechsler Adult Intelligence Scale-Revised (WAIS-R) in clinically identified malingerers and undergraduates instructed to malinger in an analog design. Cutoffs on these measures were derived from various clinical samples of identified malingerers and were applied to these simulating malingerers to distinguish them from controls. Simulating malingerers performed significantly more poorly than controls on both tests and clinically derived cutoffs accurately discriminated between groups. As compared to the clinically-based findings from which these cutoffs were derived, sensitivity (detection of simulating malingering) tended to be lower, specificity (detection of not malingering) tended to be higher, but the overall classification rate was only slightly lower These findings were consistent across the CVLT and subtests of the WAIS-R, several different sets of clinically derived cutoffs, and two base rates. Reasons for this pattern of findings are discussed, as are implications of the similarity between clinical and analog studies of malingering.	Univ N Carolina, Dept Psychol, Charlotte, NC 28223 USA		Demakis, GJ (corresponding author), Univ N Carolina, Dept Psychol, 9201 Univ City Blvd, Charlotte, NC 28223 USA.	gdemakis@email.uncc.edu					American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; Cato MA, 2002, CLIN NEUROPSYCHOL, V16, P524, DOI 10.1076/clin.16.4.524.13901; Coleman RD, 1998, J CLIN EXP NEUROPSYC, V20, P201, DOI 10.1076/jcen.20.2.201.1164; Delis DC, 1987, CALIFORNIA VERBAL LE; Demakis GJ, 1999, ARCH CLIN NEUROPSYCH, V14, P401, DOI 10.1016/S0887-6177(98)00039-0; Demakis GJ, 2001, PSYCHOL ASSESSMENT, V13, P240, DOI 10.1037//1040-3590.13.2.240; Iverson GL, 2000, J HEAD TRAUMA REHAB, V15, P829, DOI 10.1097/00001199-200004000-00006; Millis SR, 1995, PSYCHOL ASSESSMENT, V7, P463; Millis SR, 1998, J CLIN EXP NEUROPSYC, V20, P167, DOI 10.1076/jcen.20.2.167.1171; MITTENBERG W, 1995, PROF PSYCHOL-RES PR, V26, P491, DOI 10.1037/0735-7028.26.5.491; NIES KJ, 1994, ARCH CLIN NEUROPSYCH, V9, P501, DOI 10.1016/0887-6177(94)90041-8; ROGERS R, 1993, CLIN PSYCHOL REV, V13, P255, DOI 10.1016/0272-7358(93)90023-F; ROGERS R, 1983, J PSYCHIAT LAW, V11, P443, DOI 10.1177/009318538301100404; Slick DJ, 1999, CLIN NEUROPSYCHOL, V13, P545, DOI 10.1076/1385-4046(199911)13:04;1-Y;FT545; Suhr J, 1997, J CLIN EXP NEUROPSYC, V19, P500, DOI 10.1080/01688639708403740; Sweet JJ, 2002, CLIN NEUROPSYCHOL, V16, P481, DOI 10.1076/clin.16.4.481.13914; Sweet JJ, 1999, STUD NEUROPSYCHOL DE, P255; Sweet JJ, 2000, ARCH CLIN NEUROPSYCH, V15, P105, DOI 10.1016/S0887-6177(98)00153-X; Tan JE, 2002, CLIN NEUROPSYCHOL, V16, P495, DOI 10.1076/clin.16.4.495.13909; TRUEBLOOD W, 1994, J CLIN EXP NEUROPSYC, V16, P597, DOI 10.1080/01688639408402671; Wechsler, 1997, WECHSLER ADULT INTEL	21	8	10	0	0	PSYCHOLOGY PRESS	HOVE	27 CHURCH RD, HOVE BN3 2FA, EAST SUSSEX, ENGLAND	0908-4282	1532-4826		APPL NEUROPSYCHOL	Appl. Neuropsychol.		2004	11	4					222	228					7	Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychology	898TH	WOS:000227098600008	15673496				2022-02-06	
J	van Loo, MA; Moseley, AM; Bosman, JM; de Bie, RA; Hassett, L				van Loo, MA; Moseley, AM; Bosman, JM; de Bie, RA; Hassett, L			Inter-rater reliability and concurrent validity of step length and step width measurement after traumatic brain injury	DISABILITY AND REHABILITATION			English	Article							CLINICAL METHOD; GAIT ANALYSIS	Purpose: To determine the inter-rater reliability and concurrent validity of step length and step width measurement after traumatic brain injury. Method: Twelve people with traumatic brain injury completed six comfortable and six fast paced walking trials over a 10 m distance. Step length and step width were measured by five observers using two procedures. First, using pens taped on the subjects' heels which marked the floor at each heel strike and a tape measure. Second, by videotaping the subjects' feet as they walked on a mat marked with 5 cm grids and using a computer program to digitize foot position and calculate step length and width. Results: The inter-rater reliability of step length and width measurements was very high, with intraclass correlation coefficients between 0.94 and 1.00, for both procedures. Concurrent validity was excellent, with correlations between the procedures ranging from 0.93 to 1.00. However, attaching pens to the heels did cause a slight reduction in right step length and walking speed when walking at a fast or comfortable pace, respectively. Conclusions: Assessing step length and width using pens taped to the subjects' heels and a tape measure is a reliable and valid clinical measure after traumatic brain injury.	Maastricht Univ, Dept Epidemiol, Maastricht, Netherlands; Univ Sydney, Dept Med, Rehabil Studies Unit, Sydney, NSW 2006, Australia; Liverpool Hlth Serv, Brain Injury Rehabil Unit, Sydney, NSW, Australia		Moseley, AM (corresponding author), Royal Rehabil Ctr Sydney, Fac Med, Dept Med, Rehabil Studies Unit, POB 6, Ryde, NSW 1680, Australia.			Hassett, Leanne/0000-0002-3546-1822			ADAMS RD, 1995, P 12 INT C WORLD CON, P362; BOENIG DD, 1977, PHYS THER, V57, P795, DOI 10.1093/ptj/57.7.795; CERNY K, 1983, PHYS THER, V63, P1125, DOI 10.1093/ptj/63.7.1125; Evans MD, 1997, ARCH PHYS MED REHAB, V78, P725, DOI 10.1016/S0003-9993(97)90080-0; Falconer J, 1991, Arthritis Care Res, V4, P52, DOI 10.1002/art.1790040110; Fransen M, 1999, RHEUMATOLOGY, V38, P663, DOI 10.1093/rheumatology/38.7.663; Fransen M, 1997, PHYS THER, V77, P944, DOI 10.1093/ptj/77.9.944; HILL KD, 1994, ARCH PHYS MED REHAB, V75, P577; HOLDEN MK, 1984, PHYS THER, V64, P35, DOI 10.1093/ptj/64.1.35; SHORES M, 1980, PHYS THER, V60, P1163, DOI 10.1093/ptj/60.9.1163; VANDERLINDEN DW, 1992, PHYS THER, V75, P653; VANLOO MA, IN PRESS CLIN REHABI; Wade LD, 1997, ARCH PHYS MED REHAB, V78, P1107, DOI 10.1016/S0003-9993(97)90136-2; Wall JC, 2000, J ORTHOP SPORT PHYS, V30, P410, DOI 10.2519/jospt.2000.30.7.410; WHITTLE M, 1991, GAIT ANAL INTRO, P55; WOLFSON L, 1990, J GERONTOL, V45, P12	16	8	8	0	1	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	1464-5165			DISABIL REHABIL	Disabil. Rehabil.	NOV	2003	25	21					1195	1200		10.1080/09638280310001599989			6	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	733KJ	WOS:000185999200001	14578058				2022-02-06	
J	Martin, EM; Coyle, MK; Warden, DL; Salazar, A				Martin, EM; Coyle, MK; Warden, DL; Salazar, A			Telephonic nursing in traumatic brain injury	AMERICAN JOURNAL OF NURSING			English	Article							REHABILITATION; PROGRAM; TRIAL		DVBIC, Walter Reed Army Med Ctr, Henry M Jackson Fdn Advancement Mil Med, Washington, DC USA; Prince Georges Community Coll, Largo, MD USA; Uniformed Serv Univ Hlth Sci, Bethesda, MD 20814 USA		Martin, EM (corresponding author), DVBIC, Walter Reed Army Med Ctr, Henry M Jackson Fdn Advancement Mil Med, Washington, DC USA.						Braverman SE, 1999, BRAIN INJURY, V13, P405; CHESTNUT RM, 1999, REHABILITATION TRAUM; Riegel B, 2002, ARCH INTERN MED, V162, P705, DOI 10.1001/archinte.162.6.705; Rutenberg CD, 2000, AM J NURS, V100, P77, DOI 10.2307/3522072; Salazar AM, 2000, JAMA-J AM MED ASSOC, V283, P3075, DOI 10.1001/jama.283.23.3075; Warden DL, 2000, J HEAD TRAUMA REHAB, V15, P1092, DOI 10.1097/00001199-200010000-00003	6	8	8	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0002-936X			AM J NURS	Am. J. Nurs.	OCT	2003	103	10					75	+		10.1097/00000446-200310000-00036			4	Nursing	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Nursing	732EL	WOS:000185927800035	14530713				2022-02-06	
J	Schmitter-Edgecombe, M; Wright, MJ				Schmitter-Edgecombe, M; Wright, MJ			Content memory and temporal order memory for performed activities after severe closed-head injury	JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY			English	Article							TRAUMATIC BRAIN INJURY; DIFFUSE AXONAL INJURY; ADULT AGE-DIFFERENCES; INFORMATION; RECALL; INTENTIONALITY; EVENTS; DAMAGE; AUTOMATICITY; RETRIEVAL	Thirty severe closed-head injured (CHI) participants (more than I year postinjury) and 30 matched controls completed eight different cognitive activities. Participants' free recall and recognition of the activities provided a measure of content memory. Temporal order memory was assessed with a reconstruction task. CHI participants recalled and recognized fewer activities than did controls. However, the CHI and control groups did not differ in temporal order memory. For both groups, recognition memory was not correlated with temporal order memory. These results demonstrate intact temporal order memory for performed activities in a severe CHI population, and support the notion of separate processing of content memory and order information. Issues related to automaticity and the roles of the frontal lobes in temporal order memory are also discussed.	Washington State Univ, Dept Psychol, Pullman, WA 99164 USA		Schmitter-Edgecombe, M (corresponding author), Washington State Univ, Dept Psychol, POB 644820, Pullman, WA 99164 USA.	schmitter-e@wsu.edu			NICHD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R03 HD35838] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R03HD035838] Funding Source: NIH RePORTER		ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; ADAMS JH, 1982, ANN NEUROL, V12, P557, DOI 10.1002/ana.410120610; ADAMS JH, 1980, J CLIN PATHOL, V33, P1132, DOI 10.1136/jcp.33.12.1132; BARONA A, 1984, J CONSULT CLIN PSYCH, V52, P885, DOI 10.1037/0022-006X.52.5.885; Benton A., 1976, MULTILINGUAL APHASIA; BROWN JI, 1993, NELSONDENNY READING; Butters M.A., 1994, NEUROPSYCHOLOGY, V8, P343, DOI DOI 10.1037/0894-4105.8.3.343; Cohen J., 2013, STAT POWER ANAL BEHA; COHEN RL, 1983, MEM COGNITION, V11, P575, DOI 10.3758/BF03198282; COHEN RL, 1987, MEM COGNITION, V15, P109, DOI 10.3758/BF03197022; COHEN RL, 1981, SCAND J PSYCHOL, V22, P267, DOI 10.1111/j.1467-9450.1981.tb00402.x; COOKE DL, 1995, J CLIN EXP NEUROPSYC, V17, P90, DOI 10.1080/13803399508406585; DANEMAN M, 1980, J VERB LEARN VERB BE, V19, P450, DOI 10.1016/S0022-5371(80)90312-6; Delis DC, 1987, CALIFORNIA VERBAL LE; ENGELKAMP J, 1989, PSYCHOL RES-PSYCH FO, V51, P153, DOI 10.1007/BF00309142; Estes W.K., 1972, CODING PROCESS HUM, P161; ESTES WK, 1987, MEMORY LEARNING EBBI, P11; Golden J. C., 1978, STROOP COLOR WORD TE; Heaton RK, 1981, MANUAL WISCONSIN CAR; HELSTRUP T, 1987, ACTA PSYCHOL, V66, P37, DOI 10.1016/0001-6918(87)90017-5; HELSTRUP T, 1986, SCAND J PSYCHOL, V27, P1, DOI 10.1111/j.1467-9450.1986.tb01183.x; HELSTRUP T, 1989, PSYCHOL RES-PSYCH FO, V50, P237, DOI 10.1007/BF00309258; Hill OW, 1995, PERCEPT MOTOR SKILL, V81, P1339, DOI 10.2466/pms.1995.81.3f.1339; Hurst W, 1982, Brain Cogn, V1, P294; JACKSON JL, 1986, ACTA PSYCHOL, V62, P199, DOI 10.1016/0001-6918(86)90087-9; JACKSON JL, 1984, ACTA PSYCHOL, V57, P83, DOI 10.1016/0001-6918(84)90036-2; JANOWSKY JS, 1989, BEHAV NEUROSCI, V103, P548, DOI 10.1037/0735-7044.103.3.548; KAPLAN E, 1991, MANUAL WAIS R NEUROP; KAUSLER DH, 1988, EXP AGING RES, V14, P195; KAUSLER DH, 1983, DEV PSYCHOL, V19, P889, DOI 10.1037/0012-1649.19.6.889; KAUSLER DH, 1985, DEV PSYCHOL, V21, P1132, DOI 10.1037/0012-1649.21.6.1132; KAUSLER DH, 1988, COGNITIVE DEV ADULTH, P93, DOI DOI 10.1007/978-1-4612-3852-2_4; KESNER RP, 1994, NEUROPSYCHOLOGIA, V32, P881, DOI 10.1016/0028-3932(94)90040-X; LARSSON C, 1987, SCAND J REHABIL MED, V19, P99; LEVIN HS, 1990, J CLIN EXP NEUROPSYC, V12, P129, DOI 10.1080/01688639008400960; Mangels JA, 1997, NEUROPSYCHOLOGY, V11, P207, DOI 10.1037/0894-4105.11.2.207; MARSHALL PH, 1989, AM J PSYCHOL, V102, P39, DOI 10.2307/1423115; MCANDREWS MP, 1991, NEUROPSYCHOLOGIA, V29, P849, DOI 10.1016/0028-3932(91)90051-9; MICHON JA, 1984, ANN NY ACAD SCI, V423, P298, DOI 10.1111/j.1749-6632.1984.tb23440.x; MILNER B, 1985, HUM NEUROBIOL, V4, P137; MILNER B, 1971, BRIT MED BULL, V27, P272, DOI 10.1093/oxfordjournals.bmb.a070866; MURDOCK BB, 1983, PSYCHOL REV, V90, P316, DOI 10.1037/0033-295X.90.4.316; NAIRNE JS, 1992, J MEM LANG, V31, P396, DOI 10.1016/0749-596X(92)90020-X; NAVEHBENJAMIN M, 1990, J EXP PSYCHOL LEARN, V16, P117, DOI 10.1037/0278-7393.16.1.117; NAVEHBENJAMIN M, 1986, J EXP PSYCHOL LEARN, V12, P378, DOI 10.1037/0278-7393.12.3.378; PANIAK CE, 1989, J CLIN EXP NEUROPSYC, V11, P631, DOI 10.1080/01688638908400921; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; SALTHOUSE TA, 1988, PSYCHOL AGING, V3, P29, DOI 10.1037/0882-7974.3.1.29; Sattler J. M., 1988, ASSESSMENT CHILDREN; SCHACTER DL, 1987, PSYCHOBIOLOGY, V15, P21; Schmitter-Edgecombe M, 2001, AGING NEUROPSYCHOL C, V8, P81, DOI 10.1076/anec.8.2.81.844; Serra M, 2000, MEM COGNITION, V28, P847, DOI 10.3758/BF03198420; SHIMAMURA AP, 1990, NEUROPSYCHOLOGIA, V28, P803, DOI 10.1016/0028-3932(90)90004-8; Smith EE, 1999, SCIENCE, V283, P1657, DOI 10.1126/science.283.5408.1657; SNODGRASS JG, 1988, J EXP PSYCHOL GEN, V117, P34, DOI 10.1037/0096-3445.117.1.34; Stuss D.T., 1994, NEUROPSYCHOLOGY, V8, P355, DOI [https://doi.org/10.1037/0894-4105.8.3.355, DOI 10.1037/0894-4105.8.3.355]; TEASDALE G, 1974, LANCET, V2, P81; TZENG OJL, 1979, J EXP PSYCHOL-HUM L, V5, P52, DOI 10.1037/0278-7393.5.1.52; Vakil E, 1998, NEUROPSY NEUROPSY BE, V11, P212; VAKIL E, 1994, J CLIN EXP NEUROPSYC, V16, P539, DOI 10.1080/01688639408402665; VAKIL E, 1994, NEUROPSY NEUROPSY BE, V7, P281; VAKIL E, 1991, J CLIN EXP NEUROPSYC, V13, P291, DOI 10.1080/01688639108401044; VAKIL E, 1994, J CLIN PSYCHOL, V50, P240, DOI 10.1002/1097-4679(199403)50:2<240::AID-JCLP2270500215>3.0.CO;2-5; Vanderploeg RD, 2001, J CLIN EXP NEUROPSYC, V23, P185, DOI 10.1076/jcen.23.2.185.1210; Wechsler D, 1987, MEMORY SCALE REVISED; Wechsler D, 1981, WECHSLER ADULT INTEL; WILSON JTL, 1995, J NEUROL NEUROSUR PS, V59, P328, DOI 10.1136/jnnp.59.3.328; YNTEMA DB, 1963, J VERB LEARN VERB BE, V2, P65, DOI 10.1016/S0022-5371(63)80069-9; ZACKS RT, 1984, MEM COGNITION, V12, P387, DOI 10.3758/BF03198299	69	8	8	0	2	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1380-3395	1744-411X		J CLIN EXP NEUROPSYC	J. Clin. Exp. Neuropsychol.	OCT	2003	25	7					933	948		10.1076/jcen.25.7.933.16493			16	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	739WM	WOS:000186369800004	13680441				2022-02-06	
J	Kadyan, V; Colachis, SC; Depalma, MJ; Sanderson, JD; Mysiw, WJ				Kadyan, V; Colachis, SC; Depalma, MJ; Sanderson, JD; Mysiw, WJ			Early recognition of neuroleptic malignant syndrome during traumatic brain injury rehabilitation	BRAIN INJURY			English	Article							DIFFERENTIAL-DIAGNOSIS; HEAD-INJURY; AGITATION; HALOPERIDOL; PATIENT; RECOVERY	Neuroleptic malignant syndrome is a rare disorder that manifests with hyperthermia, muscle rigidity and autonomic instability. Presented is a case series of individuals with traumatic brain injury and agitation who, when treated with neuroleptics, developed neuroleptic malignant syndrome. Although the incidence of this syndrome is rare, it is associated with significant morbidity and mortality. The onset of symptoms inconsistent with the patient's current level of recovery should alert the clinician to consider other possible diagnosis and failure to distinguish the features of neuroleptic malignant syndrome from post-traumatic agitation will delay appropriate intervention for this potentially life-threatening disorder.	Ohio State Univ, Med Ctr, Dept Phys Med & Rehabil, Columbus, OH 43210 USA		Kadyan, V (corresponding author), 480 W,9th Ave, Columbus, OH 43210 USA.		Mysiw, Walter/E-3724-2011				ADDONIZIO G, 1987, BIOL PSYCHIAT, V22, P1004, DOI 10.1016/0006-3223(87)90010-2; CAROFF SN, 1980, J CLIN PSYCHIAT, V41, P79; CLARKE CE, 1988, LANCET, V2, P969; CONTROL COD, 2001, TRAUMATIC BRAIN INJU; CORRIGAN JD, 1988, ARCH PHYS MED REHAB, V69, P487; DAVE M, 1995, AM J PSYCHIAT, V152, P1233; DELAY J, 1960, Ann Med Psychol (Paris), V118(1), P145; FEENEY DM, 1982, SCIENCE, V217, P855, DOI 10.1126/science.7100929; FRIEDMAN JH, 1985, JAMA-J AM MED ASSOC, V254, P2792, DOI 10.1001/jama.254.19.2792; Fugate LP, 1997, ARCH PHYS MED REHAB, V78, P924, DOI 10.1016/S0003-9993(97)90051-4; KECK PE, 1989, ARCH GEN PSYCHIAT, V46, P914; KONTAXAKIS V, 1988, J NEUROL NEUROSUR PS, V51, P1001, DOI 10.1136/jnnp.51.7.1001; LEVENSON JL, 1985, AM J PSYCHIAT, V142, P1137; MYSIW W, UNPUB IMPACT ACUTE C; Mysiw WJ, 1997, ARCH PHYS MED REHAB, V78, P213, DOI 10.1016/S0003-9993(97)90266-5; MYSIW WJ, 1995, NEUROREHABILITATION, V5, P197, DOI 10.3233/NRE-1995-5302; Pelonero AL, 1998, PSYCHIATR SERV, V49, P1163, DOI 10.1176/ps.49.9.1163; POPE HG, 1986, AM J PSYCHIAT, V143, P1227; RAO N, 1985, ARCH PHYS MED REHAB, V66, P30; SACHDEV P, 1995, J CLIN PSYCHOPHARM, V15, P365, DOI 10.1097/00004714-199510000-00010; Sandel ME, 1996, ARCH PHYS MED REHAB, V77, P617, DOI 10.1016/S0003-9993(96)90306-8; VELAMOOR VR, 1994, J NERV MENT DIS, V182, P168, DOI 10.1097/00005053-199403000-00007; Wilkinson R, 1999, BRAIN INJURY, V13, P1025	23	8	8	0	2	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.	JUL	2003	17	7					631	637		10.1080/0269905031000070224			7	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	690HG	WOS:000183541900007	12775273				2022-02-06	
J	Burns, SP; Rivara, FP; Johansen, JM; Thompson, DC				Burns, SP; Rivara, FP; Johansen, JM; Thompson, DC			Rehabilitation of traumatic injuries - Use of the Delphi method to identify topics for evidence-based review	AMERICAN JOURNAL OF PHYSICAL MEDICINE & REHABILITATION			English	Article						rehabilitation; spinal cord injuries; brain injuries; Delphi technique; evidence-based medicine		Evidence-based reviews of research literature are useful in determining the efficacy of specific clinical practices, but the review process is frequently time-consuming and costly. The purpose of this study was to identify important research questions in rehabilitation that are appropriate for evidence-based reviews. The focus of this study was rehabilitation after traumatic injuries. Topics were identified using the Delphi method, which utilized a panel of 24 researchers and clinicians with expertise in rehabilitation of traumatic injuries. The experts identified 71 topics, predominantly in the areas of spinal cord injury and traumatic brain injury rehabilitation. The most commonly suggested intervention topics involved assessment of, pharmacologic agents, the timing or intensity of interventions, or specific nonpharmacologic therapies and exercises. Topics were ranked by mean importance score. Ten of 24 questions in the top tertile were considered to have some or a substantial amount of available research and thus may be appropriate for structured evidence-based reviews. Similar methods could be used to identify appropriate topics in other areas of rehabilitation.	VA Puget Sound Hlth Care Syst, Spinal Cord Injury Serv 128, Seattle, WA 98108 USA; Univ Washington, Harborview Injury Prevent & Res Ctr, Dept Rehabil Med, Seattle, WA 98195 USA; Univ Washington, Harborview Injury Prevent & Res Ctr, Dept Pediat, Seattle, WA 98195 USA; Univ Washington, Harborview Injury Prevent & Res Ctr, Dept Epidemiol, Seattle, WA 98195 USA		Burns, SP (corresponding author), VA Puget Sound Hlth Care Syst, Spinal Cord Injury Serv 128, 1660 S Columbian Way, Seattle, WA 98108 USA.						Carney N, 1999, REHABILITATION TRAUM; *CONS SPIN CORD ME, 1998, J SPINAL CORD MED, V21, P248; *CONS SPIN CORD ME, 1997, J SPINAL CORD MED, V20, P259; CUSTER RL, 2001, J VOCATIONAL TECHNOL, P11; DELBECQ AL, 1986, DELPHI TECHNIQUE GRO, P83; FINK A, 1984, AM J PUBLIC HEALTH, V74, P979, DOI 10.2105/AJPH.74.9.979; Jolliffe J.A., 2001, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001800, DOI 10.1002/14651858.CD001800]; LINSTROME HA, 1975, DELPHI METHOD TECHNI; Loetscher T., COCHRANE DB SYST REV, DOI [10.1002/14651858.CD002842, DOI 10.1002/14651858.CD002842]; Ottenbacher KJ, 2001, AM J PHYS MED REHAB, V80, P786, DOI 10.1097/00002060-200110000-00014; REID NM, 1988, PROFESSIONAL COMPETE, P239; ROWE G, 1991, TECHNOL FORECAST SOC, V39, P235, DOI 10.1016/0040-1625(91)90039-I; WILLIAMS PL, 1994, J ADV NURS, V19, P180, DOI 10.1111/j.1365-2648.1994.tb01066.x; WOOFF SH, 1992, ARCH INTERN MED, V152, P946; WOUDENBERG F, 1991, TECHNOL FORECAST SOC, V40, P131, DOI 10.1016/0040-1625(91)90002-W	15	8	8	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0894-9115	1537-7385		AM J PHYS MED REHAB	Am. J. Phys. Med. Rehabil.	MAY	2003	82	5					410	414		10.1097/00002060-200305000-00019			5	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	670AY	WOS:000182385800014	12704283				2022-02-06	
J	Amsellem, PM; Toombs, JP; Laverty, PH; Breur, GJ				Amsellem, PM; Toombs, JP; Laverty, PH; Breur, GJ			Loss of deep pain sensation following thoracolumbar intervertebral disk herniation in dogs: Pathophysiology	COMPENDIUM ON CONTINUING EDUCATION FOR THE PRACTICING VETERINARIAN			English	Article							SPINAL-CORD; PATHOGENESIS; COMPRESSION; PROTRUSIONS; MANAGEMENT; MYELOPATHY; TRAUMA	Spinal cord injury following intervertebral disk herniation is a combination of a concussive and a compressive injury. Concussion of the spinal cord acutely damages meninges, blood supply, and neural tissue. This constitutes the primary injury. Following the primary injury, a cascade of vascular, biochemical, and cellular events results in additional secondary injury to the spinal cord. Compression of the spinal cord following intervertebral disk herniation may result from a mass of herniated disk material and hematoma within,the vertebral canal (extradural compression) or spinal cord swelling within a rigid dura mater (intramedullary compression). Knowledge and understanding of,the pathophysiology are important for appropriate diagnosis and treatment of spinal cord injury.	Purdue Univ, W Lafayette, IN 47907 USA		Amsellem, PM (corresponding author), Anim Emergency Clin, W Palm Beach, FL USA.						Anderson S.M., 1991, CALIF VET, V45, P24; BERG RJ, 1985, COMP CONT EDUC PRACT, V7, P646; BORGENS RB, 1993, RESTOR NEUROL NEUROS, V5, P305, DOI 10.3233/RNN-1993-55601; Braund KG, 1993, DIS MECH SMALL ANIMA, P1140; Bray JP, 1998, J AM ANIM HOSP ASSOC, V34, P55, DOI 10.5326/15473317-34-1-55; BROWN SA, 1992, J AM VET MED ASSOC, V200, P1849; Dumont RJ, 2001, CLIN NEUROPHARMACOL, V24, P254, DOI 10.1097/00002826-200109000-00002; GRIFFITHS IR, 1972, J SMALL ANIM PRACT, V13, P425, DOI 10.1111/j.1748-5827.1972.tb06870.x; GRIFFITHS IR, 1972, J NEUROL NEUROSUR PS, V35, P403, DOI 10.1136/jnnp.35.3.403; GRIFFITHS IR, 1975, J NEUROSURG, V42, P155, DOI 10.3171/jns.1975.42.2.0155; GRIFFITHS IR, 1979, J NEUROSURG, V50, P353, DOI 10.3171/jns.1979.50.3.0353; GUHA A, 1988, J TRAUMA, V28, P481, DOI 10.1097/00005373-198804000-00011; HALL ED, 1989, FREE RADICAL BIO MED, V6, P303, DOI 10.1016/0891-5849(89)90057-9; HALL ED, 1986, J NEUROSURG, V64, P951, DOI 10.3171/jns.1986.64.6.0951; Ichihara K, 2001, J NEUROTRAUM, V18, P361, DOI 10.1089/08977150151071053; KATO A, 1985, J NEUROSURG, V63, P260, DOI 10.3171/jns.1985.63.2.0260; Leskovar A, 2001, CELL TISSUE RES, V304, P311, DOI 10.1007/s004410000325; LORENTZ MD, 1993, HDB VET NEUROLOGY, P8; Olby N, 1999, J VET INTERN MED, V13, P399, DOI 10.1892/0891-6640(1999)013&lt;0399:CCITMO&gt;2.3.CO;2; Puerto D. A., 2000, Veterinary Surgery, V29, P473; SALISBURY SK, 1988, J AM ANIM HOSP ASSOC, V24, P227; Scott HW, 1999, J SMALL ANIM PRACT, V40, P417, DOI 10.1111/j.1748-5827.1999.tb03114.x; SHORES A, 1992, VET CLIN N AM-SMALL, V22, P859, DOI 10.1016/S0195-5616(92)50080-8; TOOMBS JP, 1993, TXB SMALL ANIMAL SUR, V1, P1070; VANDEVELDE M, 1993, DIS MECH SMALL ANIMA, P1152; Wheeler S.J., 1994, SMALL ANIMAL SPINAL, V2nd	26	8	8	0	4	VETERINARY LEARNING SYSTEMS	YARDLEY	780 TOWNSHIP LINE RD, YARDLEY, PA 19067-4200 USA	0193-1903			COMP CONT EDUC PRACT	Compend. Contin. Educ. Pract. Vet.	APR	2003	25	4					256	+					6	Veterinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Veterinary Sciences	674YM	WOS:000182665300001					2022-02-06	
J	Kaplanski, J; Asa, I; Artru, AA; Azez, A; Ivashkova, Y; Rudich, Z; Pruneau, D; Shapira, Y				Kaplanski, J; Asa, I; Artru, AA; Azez, A; Ivashkova, Y; Rudich, Z; Pruneau, D; Shapira, Y			LF 16-0687 Ms, a new bradykinin B-2 receptor antagonist, decreases ex vivo brain tissue prostaglandin E-2 synthesis after closed head trauma in rats	RESUSCITATION			English	Article						brain injury; inflammatory response; intracranial pressure; neurologic dysfunction; trauma	INJURY; EDEMA; INDOMETHACIN; INHIBITION; RECOVERY; MODEL	Objective: Bradykinin (B) contributes to secondary brain injury. This injury is mediated in part by prostaglandin (PG). Antagonism of B-2 receptors improves neurological status after brain injury, but the effect of B-2 antagonism on brain tissue PG is unknown. This study examined the effect of LF 16-0687 Ms, a new B-2 receptor antagonist, on brain tissue PGE(2) after closed head trauma (CHT). Methods: Rats were anesthetized and received sham+saline, sham+LF 16-0687 Ms, CHT+saline, or CHT+LF 16-0687 Ms. Brain tissue samples were obtained at 24 h for determination of PGE(2) (after 2 h of ex vivo incubation) and water content. Neurological severity score (NSS) was assessed at 1 and 24 h. Results: In the group receiving CHT+LF 16-0687 Ms, brain tissue PGE(2) (77.7 +/- 65.9 pg/mg tissue, mean +/- SD) was less than in the group receiving CHT+saline (368.1 +/- 186.2 pg/mg tissue) and not different than sham +saline (78.7 +/- 30.7 pg/mg tissue). LF 16-0687 Ms also improved NSS and decreased brain water content by 51%. Conclusion: We conclude that the beneficial effect of LF 16-0687 Ms on outcome after CHT is accompanied by blockade of PGE(2) increase in injured brain tissue. (C) 2002 Elsevier Science Ireland Ltd. All rights reserved.	Univ Washington, Sch Med, Dept Anesthesiol, Seattle, WA 98195 USA; Ben Gurion Univ Negev, Soroka Med Ctr, Dept Pharmacol, Fac Hlth Sci, IL-84101 Beer Sheva, Israel; Ben Gurion Univ Negev, Soroka Med Ctr, Dept Anesthesiol, Fac Hlth Sci, IL-84101 Beer Sheva, Israel; Ctr Rech, Grp Pharmacochim Recepteurs, Lab Fournier, F-21121 Daix, France		Artru, AA (corresponding author), Univ Washington, Sch Med, Dept Anesthesiol, POB 356540, Seattle, WA 98195 USA.	artruaa@u.washington.edu					BIESTRO AA, 1995, J NEUROSURG, V83, P627, DOI 10.3171/jns.1995.83.4.0627; Clark R. A. F., 1988, MOL CELLULAR BIOL WO; Dash PK, 2000, J NEUROTRAUM, V17, P69, DOI 10.1089/neu.2000.17.69; DEMOPOULOS HB, 1972, STEROIDS BRAIN EDEMA, P29; Dixon CE, 1996, NEUROTRAUMA, P1337; DOPPENBERG EMR, 1997, ANN NY ACAD SCI, V825, P305; ELLIS EF, 1989, J NEUROSURG, V71, P437, DOI 10.3171/jns.1989.71.3.0437; Feldman Z, 1997, J TRAUMA, V43, P667, DOI 10.1097/00005373-199710000-00017; FELETOU M, 1994, BRIT J PHARMACOL, V112, P683, DOI 10.1111/j.1476-5381.1994.tb13130.x; GAMACHE DA, 1986, J NEUROSURG, V65, P686, DOI 10.3171/jns.1986.65.5.0686; Gecse A, 1989, Adv Exp Med Biol, V247A, P249; Gorlach C, 2001, J NEUROTRAUM, V18, P833, DOI 10.1089/089771501316919193; Hsu CY, 1996, NEUROTRAUMA, P1433; Jeftinija SD, 1996, J NEUROCHEM, V66, P676; JONES S, 1995, NEURON, V14, P399, DOI 10.1016/0896-6273(95)90295-3; Kaplanski J, 2002, J NEUROTRAUM, V19, P953, DOI 10.1089/089771502320317104; Koyfman L, 2000, J NEUROSURG ANESTH, V12, P44, DOI 10.1097/00008506-200001000-00009; Marmarou A, 1999, J NEUROTRAUM, V16, P431, DOI 10.1089/neu.1999.16.431; Narotam PK, 1998, ACTA NEUROCHIR, V140, P793, DOI 10.1007/s007010050181; PARPURA V, 1994, NATURE, V369, P744, DOI 10.1038/369744a0; Plesnila N, 2001, J NEUROTRAUM, V18, P1049, DOI 10.1089/08977150152693746; Pruneau D, 1999, J NEUROTRAUM, V16, P1057, DOI 10.1089/neu.1999.16.1057; Pruneau D, 1999, IMMUNOPHARMACOLOGY, V43, P187, DOI 10.1016/S0162-3109(99)00128-9; Relton JK, 1997, STROKE, V28, P1430, DOI 10.1161/01.STR.28.7.1430; SHAPIRA Y, 1988, CRIT CARE MED, V16, P258, DOI 10.1097/00003246-198803000-00010; SHAPIRA Y, 1992, ANESTH ANALG, V75, P238; SHAPIRA Y, 1988, J CEREBR BLOOD F MET, V8, P395, DOI 10.1038/jcbfm.1988.75; Smith DH, 1996, NEUROTRAUMA, P1445; Stover JF, 2000, J NEUROSURG, V92, P853, DOI 10.3171/jns.2000.92.5.0853; VERRECCHIA C, 2000, RESTOR NEUROL NEUROS, V16, P177; Wang Q, 1997, J CELL PHYSIOL, V172, P171, DOI 10.1002/(SICI)1097-4652(199708)172:2<171::AID-JCP4>3.0.CO;2-L; Xing MZ, 1997, AM J PHYSIOL-CELL PH, V272, pC1380, DOI 10.1152/ajpcell.1997.272.4.C1380	32	8	8	1	1	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0300-9572			RESUSCITATION	Resuscitation	FEB	2003	56	2					207	213	PII S0300-9572(02)00371-4	10.1016/S0300-9572(02)00371-4			7	Critical Care Medicine; Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Emergency Medicine	657NQ	WOS:000181673600014	12589996				2022-02-06	
J	Lifshitz, J; McIntosh, TK				Lifshitz, J; McIntosh, TK			Age-associated mitochondrial DNA deletions are not evident chronically after experimental brain injury in the rat	JOURNAL OF NEUROTRAUMA			English	Article						cortex; deoxyguanosine; head injury; hippocampus; mitochondrial genome	FLUID-PERCUSSION INJURY; OXIDATIVE DAMAGE; PERMEABILITY TRANSITION; REACTIVE OXYGEN; ENERGY; MULTIPLE; NUCLEAR; STRESS; REARRANGEMENTS; REPLICATION	The enduring cognitive and sensorimotor deficits that result from traumatic brain injury (TBI) are associated with metabolic stress and free radical cascades, which establish conditions that may promote mitochondrial DNA (mtDNA) deletion and oxidation, often observed as a consequence of normal aging. Without substantial mtDNA repair mechanisms, permanent alterations to essential mitochondrial enzymes could perpetuate post-injury pathologic cascades. To determine whether mitochondria from the injured cortex and hippocampus sustain mtDNA damage after TBI, we evaluated mtDNA deletion and oxidation following lateral fluid percussion TBI in the anesthetized adult Sprague-Dawley rat (4 months) compared with uninjured adult and aged rats (n = 4/group). The presence of the 4.8-KB common deletion in mtDNA was assessed by conventional PCR to generate products representing total, non-deleted wild-type, and deleted mtDNA in homogenized tissue and isolated mitochondria 3 and 14 days following TBI. Total and wild-type mtDNA amplification products were obtained from cortical and hippocampal. tissue and mitochondria for all conditions. Although no mtDNA deletions were observed following experimental TBI, mtDNA deletion was detected in cortical tissue, but not isolated mitochondria, of naive, aged (24 months) Sprague-Dawley rats, suggesting that the isolation protocol may exclude mitochondria harboring mtDNA damage. Oxidative mtDNA damage in isolated mitochondria assayed by ELISA for 8-hydroxy-2'-deoxyguanosine (8-OHdG) from cortical (0.50 +/- 0.08 pg 8-OHdG/mug mitochondria) and hippocampal (0.35 +/- 0.02) regions were unaffected by TBI. However, mitochondrial protein yields from injured and aged brains were comparable and significantly lower than uninjured brain, suggesting that the underlying pathology between TBI and aging may be similar.	Univ Penn, Dept Neurosurg, Head Injury Ctr, Philadelphia, PA 19104 USA; VA Med Ctr, Philadelphia, PA USA		McIntosh, TK (corresponding author), Univ Penn, Dept Neurosurg, Head Injury Ctr, Philadelphia, PA 19104 USA.	mcintosh@seas.upenn.edu			NIA NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [T32 AG-00255] Funding Source: Medline; NIGMS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R01-GM 34690, 5-T32-GM07517] Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01-NS 40978, P50-NS08803] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R01GM034690, T32GM007517] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P50NS008803, R01NS040978] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [T32AG000255] Funding Source: NIH RePORTER		Ahmed F, 1999, BIOTECHNIQUES, V26, P290, DOI 10.2144/99262st03; ANDERSEN BJ, 1992, BRAIN RES, V585, P184, DOI 10.1016/0006-8993(92)91205-S; ARNHEIM N, 1992, MUTAT RES, V275, P157, DOI 10.1016/0921-8734(92)90020-P; BEAL MF, 1995, ANN NEUROL, V38, P357, DOI 10.1002/ana.410380304; Bentzer P, 2000, J NEUROTRAUM, V17, P441, DOI 10.1089/neu.2000.17.441; Bramlett HM, 1997, ACTA NEUROPATHOL, V93, P190, DOI 10.1007/s004010050602; Bzymek M, 2001, P NATL ACAD SCI USA, V98, P8319, DOI 10.1073/pnas.111008398; Chen H, 2001, STROKE, V32, P2382, DOI 10.1161/hs1001.097099; CORRALDEBRINSKI M, 1992, NAT GENET, V2, P324, DOI 10.1038/ng1292-324; Croteau DL, 1997, J BIOL CHEM, V272, P25409, DOI 10.1074/jbc.272.41.25409; DeLaAsuncion JG, 1996, FASEB J, V10, P333, DOI 10.1096/fasebj.10.2.8641567; DiMauro S, 1998, NEUROSCIENTIST, V4, P53, DOI 10.1177/107385849800400113; Filburn CR, 1996, MECH AGEING DEV, V87, P35, DOI 10.1016/0047-6374(96)01696-X; FLEMING JE, 1982, GERONTOLOGY, V28, P44, DOI 10.1159/000212510; Friberg H, 1999, J NEUROCHEM, V72, P2488, DOI 10.1046/j.1471-4159.1999.0722488.x; Gershon D, 1999, EXP GERONTOL, V34, P613, DOI 10.1016/S0531-5565(99)00010-8; Ginsberg MD, 1997, AM J PHYSIOL-HEART C, V272, pH2859, DOI 10.1152/ajpheart.1997.272.6.H2859; Goodman JC, 1999, CRIT CARE MED, V27, P1965, DOI 10.1097/00003246-199909000-00041; Hamilton ML, 2001, P NATL ACAD SCI USA, V98, P10469, DOI 10.1073/pnas.171202698; HAYAKAWA M, 1991, BIOCHEM BIOPH RES CO, V176, P87, DOI 10.1016/0006-291X(91)90893-C; HOLT IJ, 1989, ANN NEUROL, V26, P699, DOI 10.1002/ana.410260603; HOVDA DA, 1992, J NEUROTRAUM, V9, pS47; KAWAMATA T, 1995, BRAIN RES, V674, P196, DOI 10.1016/0006-8993(94)01444-M; Ko LW, 2001, J MOL NEUROSCI, V17, P361, DOI 10.1385/JMN:17:3:361; Korr H, 1998, BRAZ J MED BIOL RES, V31, P289, DOI 10.1590/S0100-879X1998000200012; Korzeniewski B, 2001, BIOCHEM J, V357, P835, DOI 10.1042/0264-6021:3570835; Kroemer G, 2000, NAT MED, V6, P513, DOI 10.1038/74994; Lee SM, 1999, ANN NY ACAD SCI, V893, P337, DOI 10.1111/j.1749-6632.1999.tb07849.x; Lemasters JJ, 1998, BBA-BIOENERGETICS, V1366, P177, DOI 10.1016/S0005-2728(98)00112-1; Lewen A, 1998, J NEUROTRAUM, V15, P521, DOI 10.1089/neu.1998.15.521; Lifshitz J, 2003, J CEREBR BLOOD F MET, V23, P219, DOI 10.1097/01.WCB.0000040581.43808.03; Marklund N, 2001, J NEUROTRAUM, V18, P821, DOI 10.1089/089771501316919184; McDonald RPA, 1999, NEUROREPORT, V10, P1875, DOI 10.1097/00001756-199906230-00014; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; MECOCCI P, 1994, ANN NEUROL, V36, P747, DOI 10.1002/ana.410360510; Melov S, 1999, NEUROBIOL AGING, V20, P565, DOI 10.1016/S0197-4580(99)00092-5; MITA S, 1990, NUCLEIC ACIDS RES, V18, P561, DOI 10.1093/nar/18.3.561; Nagley P, 2001, NEUROBIOL AGING, V22, P635, DOI 10.1016/S0197-4580(01)00228-7; OLDFORS A, 1995, ACTA NEUROPATHOL, V90, P328; Pierce JES, 1998, NEUROSCIENCE, V87, P359, DOI 10.1016/S0306-4522(98)00142-0; Polidori MC, 1999, NEUROSCI LETT, V272, P53, DOI 10.1016/S0304-3940(99)00578-9; RICHTER C, 1992, MUTAT RES, V275, P249, DOI 10.1016/0921-8734(92)90029-O; Schmerold I, 2001, EXP GERONTOL, V36, P1375, DOI 10.1016/S0531-5565(01)00103-6; SHEN CC, 1995, MUTAT RES-DNA REPAIR, V337, P19, DOI 10.1016/0921-8777(95)00008-8; SHOFFNER JM, 1989, P NATL ACAD SCI USA, V86, P7952, DOI 10.1073/pnas.86.20.7952; Signoretti S, 2001, J NEUROTRAUM, V18, P977, DOI 10.1089/08977150152693683; SIMS NR, 1990, J NEUROCHEM, V55, P698, DOI 10.1111/j.1471-4159.1990.tb04189.x; Smith DH, 1997, J NEUROTRAUM, V14, P715, DOI 10.1089/neu.1997.14.715; Sohal RS, 1996, SCIENCE, V273, P59, DOI 10.1126/science.273.5271.59; SOONG NW, 1992, NAT GENET, V2, P318; Soultanakis RP, 2000, FREE RADICAL BIO MED, V28, P987, DOI 10.1016/S0891-5849(00)00185-4; SUNAMI K, 1989, Neurosurgical Review, V12, P400, DOI 10.1007/BF01790682; Tang YY, 2000, MOL BIOL CELL, V11, P1471, DOI 10.1091/mbc.11.4.1471; TANHAUSER SM, 1995, J BIOL CHEM, V270, P24769, DOI 10.1074/jbc.270.42.24769; Van Remmen H, 2001, EXP GERONTOL, V36, P957; VanTuyle GC, 1996, MUTAT RES-FUND MOL M, V349, P95, DOI 10.1016/0027-5107(95)00165-4; Vink R, 1990, J NEUROTRAUM, V7, P21, DOI 10.1089/neu.1990.7.21; WALLACE DC, 1987, CURR GENET, V12, P81, DOI 10.1007/BF00434661; Wang XD, 2001, GENE DEV, V15, P2922; Wei YH, 2001, ANN NY ACAD SCI, V928, P97; WEI YH, 1992, MUTAT RES, V275, P145, DOI 10.1016/0921-8734(92)90019-L; Yakes FM, 1997, P NATL ACAD SCI USA, V94, P514, DOI 10.1073/pnas.94.2.514; YOSHINO A, 1991, BRAIN RES, V561, P106, DOI 10.1016/0006-8993(91)90755-K; Zeng ZH, 1999, J CELL BIOCHEM, V73, P545, DOI 10.1002/(SICI)1097-4644(19990615)73:4<545::AID-JCB12>3.0.CO;2-Q	64	8	9	1	2	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	FEB	2003	20	2					139	149		10.1089/08977150360547062			11	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	652XV	WOS:000181406900002	12675968				2022-02-06	
J	Lacerda-Gallardo, AJ; Abreu-Perez, D				Lacerda-Gallardo, AJ; Abreu-Perez, D			Traumatic brain injury in paediatrics our results	REVISTA DE NEUROLOGIA			French	Article						brain injury; traumatic injuries in paediatrics; treatment	HEAD-INJURY	Introduction. 75% of all children admitted to hospital with traumatic injuries involve traumatic brain injuries (TBI), 70% of the deaths occur within the first 48 hours and mortality fluctuates between 20 and 35%. It is estimated that every year 600,000 consultations are made for this reason, 300 out of every 100,000 children suffer a TBI and about 250,000 cases involve hospitalisation. Patients and methods. A descriptive observational study was carried out of all the patients of paediatric age,who attended our Casualty Department in the period between January and December 2001, and had suffered a TBI in any of its clinical variations. The Glasgow coma scale (GCS) was used to classify cases according to their seriousness and results were defined by employing the Glasgow results scale (GRS). Results. A survey of 339 cases with TBI was performed, of which 329 (97016) were mild, eight (2.4%) moderate and two (0.6%) were serious. Of the first, 122 (36%) required hospitalisation and the remaining 21 7 (64%) were given ambulatory treatment (all of them had mild TBI). Complementary examinations carried out were simple head X-rays in 117 (95.9%). CAT (computerised axial tomography) scans were only performed in three cases (2.5%). Only two (1.8%) deaths occurred in our series and there were no cases of disability, according to the GRS. Conclusions. Mild TRI was the common event in our series. Application of treatment systems that are suited to the conditions in each medical centre helps to reduce the number of hospital admissions for mild TBI.	Hosp Gen Moron, Serv Neurochirurg, Moron, Ciego de Avila, Cuba				Gallardo, Angel Jesus Lacerda/AAZ-9478-2020	Gallardo, Angel Jesus Lacerda/0000-0001-9171-2000			Artru F, 1988, Agressologie, V29, P365; BASSON MD, 1991, J TRAUMA, V31, P1363, DOI 10.1097/00005373-199110000-00008; Chesnut RM, 1998, SURG NEUROL, V50, P187, DOI 10.1016/S0090-3019(98)00075-5; Convert J, 1988, Agressologie, V29, P273; FEIDMAN Z, 1995, J NEUROSURG, V83, P1060; Hammer Gregory, 1993, P391; HANNES H, 1988, AJDC, V43, P1045; JAMES HE, 1985, BRAIN INSULTS INFANT, P237; Kiening KL, 1996, J NEUROSURG, V85, P751, DOI 10.3171/jns.1996.85.5.0751; LAURSSEN T, 1991, NEUROSURG CLIN N AM, V4, P399; LOBATO RD, 1991, J NEUROSURG, V75, P256, DOI 10.3171/jns.1991.75.2.0256; MEDINA C, 1986, TRAUMA ENCEFALO CRAN, P287; MORRAY F, 1987, PEDIAT INTENSIVE CAR, P235; PLEGUEZUELORODR.EM, 2001, REV CUB PEDIAT, V2, P115; SHAPIRA Y, 1995, J NEUROSURG ANESTH, V7, P17, DOI 10.1097/00008506-199501000-00004; Vollmer D G, 1991, Neurosurg Clin N Am, V2, P437; Wardlaw JM, 2002, J NEUROL NEUROSUR PS, V72, P188, DOI 10.1136/jnnp.72.2.188; YOKOTA H, 1991, J TRAUMA, V31, P351, DOI 10.1097/00005373-199103000-00007	18	8	9	0	5	REVISTA DE NEUROLOGIA	BARCELONA	C/O CESAR VIGUERA, EDITOR, APDO 94121, 08080 BARCELONA, SPAIN	0210-0010			REV NEUROLOGIA	Rev. Neurologia	JAN 16	2003	36	2					108	112		10.33588/rn.3602.2002213			5	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	646BN	WOS:000181015100003	12589594				2022-02-06	
J	Axelrod, BN; Fichtenberg, NL; Liethen, PC; Czarnota, MA; Stucky, K				Axelrod, BN; Fichtenberg, NL; Liethen, PC; Czarnota, MA; Stucky, K			Index, summary, and subtest discrepancy scores on the WAIS-III in postacute traumatic brain injury patients	INTERNATIONAL JOURNAL OF NEUROSCIENCE			English	Article						cognitive; intellectual testing; neuropsychology; traumatic brain injury; WAIS-III		WAIS-III profile interpretation typically involves the analysis of disparities between summary and subtest scores. Determination of clinically meaningful differences has been guided by published rates of discrepancies based upon the normative sample. However, noting that a particular profile discrepancy is uncommon among normals only represents one step in the interpretive process. Rates of such pairwise differences have yet to be published for clinical samples. In order to begin filling this void in the literature, we present frequencies of composite and subtest differences from a postacute traumatic brain injury sample. The practical utility of these tables, in conjunction with the normative tables, is demonstrated.	John D Dingell Dept Vet Affairs Med Ctr, Detroit, MI USA; Wayne State Univ, Sch Med, Rehabil Inst Michigan, Detroit, MI USA; Beaumont Hosp, Hlth & Rehabil Ctr, Royal Oak, MI USA; Lakeland NeuroCare Ctr, Southfield, MI USA; Hurley Med Ctr, Flint, MI USA		Axelrod, BN (corresponding author), Psychol Sect 11MHPS, 4646 John Rd, Detroit, MI 48201 USA.						Atkinson L., 1991, PSYCHOL ASSESSMENT, V3, P292; ATKINSON L, 1991, PSYCHOL ASSESSMENT J, V3, P288; MATARAZZO JD, 1988, J CLIN PSYCHOL, V44, P940, DOI 10.1002/1097-4679(198811)44:6<940::AID-JCLP2270440615>3.0.CO;2-A; Ryan JJ, 1996, ARCH CLIN NEUROPSYCH, V11, P207, DOI 10.1016/0887-6177(95)00054-2; Ryan JJ, 1998, ASSESSMENT CHILDRE S; RYAN JJ, 1992, NEUROPSYCHOLOGY, V6, P293; Schinka JA, 1998, PSYCHOL ASSESSMENT, V10, P171, DOI 10.1037/1040-3590.10.2.171; Tulsky DS, 2000, CLIN NEUROPSYCHOL, V14, P451, DOI 10.1076/clin.14.4.451.7202; Wechsler D., 1997, WAIS 3 ADM SCORING M WAIS 3 ADM SCORING M; Wechsler D, 1981, WECHSLER ADULT INTEL; Wechsler D., 1997, WAIS 3 WMS 3 TECHNIC	11	8	8	0	2	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0020-7454			INT J NEUROSCI	Int. J. Neurosci.	DEC	2002	112	12					1479	1487		10.1080/00207450290158377			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	633XA	WOS:000180308900007	12652899				2022-02-06	
J	Bendszus, M; Burger, R; Vince, GH; Solymosi, L				Bendszus, M; Burger, R; Vince, GH; Solymosi, L			A reproducible model of an epidural mass lesion in rodents. Part II: Characterization by in vivo magnetic resonance imaging	JOURNAL OF NEUROSURGERY			English	Article						magnetic resonance imaging; mass lesion; trauma; ischemia-reperfusion; blood-brain barrier; balloon expansion; rat	FOCAL CEREBRAL-ISCHEMIA; TRAUMATIC BRAIN INJURY; CELLULAR EDEMA; WEIGHTED NMR; RAT-BRAIN; DIFFUSION; MRI; COMA	Object. The goal of this study was to characterize a novel epidural space-occupying lesion caused by balloon expansion in rodents by using sequential in vivo magnetic resonance (MR) imaging. Methods. Ten Sprague-Dawley rats were intraperitoneally sedated. A trephination was performed over the left parietal cortex to attach a balloon-expansion device, which was secured with dental cement. Measurements were performed using a 1.5-tesla MR imaging device to obtain sequential T-2-weighted and diffusion-weighted (DW) sequences in the coronal plane. A three-dimensional, constructed interference in steady state sequence was used for calculation of the balloon volume. The animal's temperature, heartbeat, and the arterial percentage of oxygen saturation were monitored continuously. After a baseline examination had been performed, the balloon was inflated for a 30-minute period until it reached a maximum volume of 0.3 ml; this procedure was followed by a period of sustained inflation lasting 30 minutes, balloon deflation, and a period of reperfusion lasting 3 hours. After perfusion fixation of the animals, morphometric analysis of the lesion size and examination of the percentage of viable neurons in the hippocampus were performed. Magnetic resonance imaging allowed for the precise visualization of the extension and location of the epidural mass lesion, narrowing of the basal cisterns, and development of a midline shift. A white-matter focus of hyperintensity, consistent with brain edema, developed predominantly in the contralateral temporal lobe. During sustained inflation the volume of the balloon did not change and comprised 5 to 7% of total intracranial volume. During the same period the white-matter edema progressed further but no increased signal was revealed on DW images. After balloon deflation the brain reexpanded to the calvaria and imaging signs of raised intracranial pressure subsided. A cortical area of hyperintensity on T-2-weighted images developed in the parietal lobe in the region of the former balloon compression. This area appeared bright on DW images, a finding that corresponded to an early cytotoxic edema. After deflation white-matter vasogenic edema in the temporal lobes regressed within 3 hours after reperfusion. The cortical edema in the parietal lobe and the ipsilateral basal ganglia became sharply demarcated. The histopathological results (that is, the extent of tissue damage) corresponded with findings of the authors' companion investigation, which appears in this issue. Conclusions. Magnetic resonance imaging allows for a precise and sequential in vivo monitoring of a space-occupying epidural mass lesion and visualizes the time course of vasogenic and cytotoxic brain edema. This rodent model of an epidural mass lesion proved to be reproducible.	Univ Wurzburg, Dept Neuroradiol, D-97080 Wurzburg, Germany; Univ Wurzburg, Dept Neurosurg, D-97080 Wurzburg, Germany; Univ Regensburg, Dept Neurosurg, D-8400 Regensburg, Germany		Bendszus, M (corresponding author), Univ Wurzburg, Dept Neuroradiol, Josef Schneider Str 11, D-97080 Wurzburg, Germany.		Solymosi, Laszlo/E-6449-2018	Solymosi, Laszlo/0000-0001-9647-8647; Vince, Giles/0000-0002-0222-8733			Albensi BC, 1998, INVEST RADIOL, V33, P377, DOI 10.1097/00004424-199807000-00001; Assaf Y, 1997, MAGN RESON IMAGING, V15, P77, DOI 10.1016/S0730-725X(96)00246-9; Barzo P, 1996, J NEUROSURG, V85, P1113, DOI 10.3171/jns.1996.85.6.1113; Barzo P, 1997, J NEUROSURG, V87, P900, DOI 10.3171/jns.1997.87.6.0900; Barzo P, 1997, ACT NEUR S, V70, P119; Burger R, 2002, J NEUROSURG, V97, P1410, DOI 10.3171/jns.2002.97.6.1410; Busch E, 1996, J CEREBR BLOOD F MET, V16, P1090, DOI 10.1097/00004647-199611000-00002; CASSELMAN JW, 1993, AM J NEURORADIOL, V14, P47; HANSTOCK CC, 1994, STROKE, V25, P843, DOI 10.1161/01.STR.25.4.843; HOEHNBERLAGE M, 1995, J CEREBR BLOOD F MET, V15, P1002, DOI 10.1038/jcbfm.1995.126; Ito J, 1996, J NEUROSURG, V84, P97, DOI 10.3171/jns.1996.84.1.0097; JAKOBSSON KE, 1990, ACTA NEUROCHIR, V104, P126, DOI 10.1007/BF01842830; JIANG Q, 1994, J CEREBR BLOOD F MET, V14, P732, DOI 10.1038/jcbfm.1994.94; LOBATO RD, 1991, J NEUROSURG, V75, P256, DOI 10.3171/jns.1991.75.2.0256; LOBATO RD, 1988, J NEUROSURG, V68, P48, DOI 10.3171/jns.1988.68.1.0048; MINTOROVITCH J, 1991, MAGNET RESON MED, V18, P39, DOI 10.1002/mrm.1910180106; MORIKAWA E, 1992, J CEREBR BLOOD F MET, V12, P380, DOI 10.1038/jcbfm.1992.55; MOSELEY ME, 1990, AM J NEURORADIOL, V11, P423; Unterberg AW, 1997, ACT NEUR S, V70, P106	19	8	8	0	1	AMER ASSOC NEUROLOGICAL SURGEONS	CHARLOTTESVILLE	UNIV VIRGINIA, 1224 WEST MAIN ST, STE 450, CHARLOTTESVILLE, VA 22903 USA	0022-3085			J NEUROSURG	J. Neurosurg.	DEC	2002	97	6					1419	1423		10.3171/jns.2002.97.6.1419			5	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	626YG	WOS:000179901000024	12507142				2022-02-06	
J	Freed, P				Freed, P			Meeting of the minds: Ego reintegration after traumatic brain injury	BULLETIN OF THE MENNINGER CLINIC			English	Article							CLOSED HEAD-INJURY; DISORDERS				Freed, P (corresponding author), 108 Main St, Oceanport, NJ 07757 USA.						BUTLER RW, 1988, PROF PSYCHOL-RES PR, V19, P536, DOI 10.1037/0735-7028.19.5.536; CICERONE KD, 1991, J HEAD TRAUMA REHAB, V6, P30, DOI DOI 10.1097/00001199-199112000-00007; FEIGELSON C, 1993, INT J PSYCHOANAL, V74, P331; FREED P, 1997, MIND BODY PROBLEMS P, P311; FREUD S, 1959, STANDARD EDITION COM, V20, P75; Freud Sigmund, 1955, STANDARD EDITION COM, V18, P1; Goldstein K, 1952, PSYCHIATR, V15, P245, DOI 10.1080/00332747.1952.11022878; KLONOFF PS, 1993, B MENNINGER CLIN, V57, P227; Kohut H., 1972, PSYCHOANAL STUD C, V27, P360, DOI [DOI 10.1080/00797308.1972.11822721, 10.1080/00797308.1972.11822721]; LERMAN A, 1979, AM J PSYCHOANAL, V39, P265, DOI 10.1007/BF01253572; LEWIS L, 1990, J NERV MENT DIS, V178, P69, DOI 10.1097/00005053-199002000-00001; LEWIS L, 1986, B MENNINGER CLIN, V50, P75; LEZAK MD, 1983, NEUROPSYCHOLOGICAL A; Prigatano G.P., 1991, J HEAD TRAUMA REHAB, V6, P1, DOI [10.1097/00001199-199112000-00004, DOI 10.1097/00001199-199112000-00004]; PRIGATANO GP, 1984, J NEUROL NEUROSUR PS, V47, P505, DOI 10.1136/jnnp.47.5.505; SLAGLE DA, 1990, INT J PSYCHIAT MED, V20, P1, DOI 10.2190/BE6W-DCY1-V71N-N7J7; STERN JM, 1985, ISRAEL J PSYCHIAT, V22, P83; Winnicott D.W, 1971, PLAYING REALITY	18	8	10	0	0	GUILFORD PUBLICATIONS INC	NEW YORK	72 SPRING STREET, NEW YORK, NY 10012 USA	0025-9284			B MENNINGER CLIN	Bull. Menninger Clin.	WIN	2002	66	1					61	78		10.1521/bumc.66.1.61.23375			18	Psychiatry; Psychology, Psychoanalysis	Social Science Citation Index (SSCI)	Psychiatry; Psychology	538AC	WOS:000174791000004	11999104				2022-02-06	
J	Dutton, RP; Sewell, J; Aarabi, B; Scalea, TM				Dutton, RP; Sewell, J; Aarabi, B; Scalea, TM			Preliminary trial of a noninvasive brain acoustic monitor in trauma patients with severe closed head injury	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article						traumatic brain injury; monitoring; acoustics; brain death; noninvasive		Background: There is no simple way to assess the injured patient after a loss of consciousness. Computed tomographic scanning is required to rule out anatomic injuries, and invasive intracranial pressure monitoring is needed for the patient with severe traumatic brain injury (TBI). We hypothesized that a noninvasive acoustic monitoring system could provide useful clinical data on the severity and progression of TBI. Methods: Twenty-eight consecutive patients with severe TBI and an indication for invasive intracranial pressure monitoring were studied using the Brain Acoustic Monitor (BAM). Monitoring occurred for 1- to 3-hour time periods on the day of enrollment and each day until the patient's condition stabilized. BAM signals were categorized on the basis of amplitude and positive-to-negative deflection ratio, and then compared with the patient's clinical outcome. Results: BAM signal correlated very strongly with clinical outcome: in 27 of 29 sessions with a normal signal, patients were discharged at a Glasgow Coma Scale score > 13, whereas in 36 of 42 sessions with an abnormal signal, the patient either died or left the hospital with a Glasgow Coma Scale score < 9 (p < 0.00001). The correlation between clinical outcome and initial BAM reading was even stronger: 10 of 10 patients with a normal signal did well, as compared with 3 of 18 patients with an abnormal signal. Conclusion: Noninvasive monitoring of the injured brain can discriminate those patients who will have a poor clinical outcome from those who will do well. Further trials of the BAM are indicated.	Univ Maryland, Sch Med, R Adams Cowley Shock Trauma Ctr, Div Trauma Anesthesiol,Dept Anesthesiol, Baltimore, MD 21201 USA; Univ Maryland, Sch Med, R Adams Cowley Shock Trauma Ctr, Dept Neurosurg, Baltimore, MD 21201 USA; Univ Maryland, Sch Med, R Adams Cowley Shock Trauma Ctr, Dept Surg, Baltimore, MD 21201 USA		Dutton, RP (corresponding author), Univ Maryland, Sch Med, R Adams Cowley Shock Trauma Ctr, Div Trauma Anesthesiol,Dept Anesthesiol, 22 S Greene St, Baltimore, MD 21201 USA.	rdutton@umaryland.edu			NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [1R43NS38825-01] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R43NS038825] Funding Source: NIH RePORTER		BULLOCK R, 1996, GUIDELINES MANAGEMEN; Chesnut Randall M., 1997, Emergency Medicine Clinics of North America, V15, P581, DOI 10.1016/S0733-8627(05)70319-9; Ghajar J, 1995, New Horiz, V3, P395; Guyot LL, 1998, ACT NEUR S, V71, P47; HOMBURG AM, 1993, ACTA NEUROL SCAND, V87, P488; Kraus JF, 1987, HEAD INJURY, V2, P1; Liboni W, 1983, J Neurosurg Sci, V27, P23; MARION DW, 1999, TRAUMATIC BRAIN INJU, P6; *NATL AC PRES, 1985, INJ AM CONT PUBL HLT; Newell D W, 1995, New Horiz, V3, P423; Newell DW, 1997, ACTA NEUROCHIR, V139, P804, DOI 10.1007/BF01411398; Rossi S, 1998, ACT NEUR S, V71, P91; SHIOGAI T, 1990, Neurological Research, V12, P205; Townsend RN, 1998, J TRAUMA, V44, P977, DOI 10.1097/00005373-199806000-00008; WAXWEILER RJ, 1995, J NEUROTRAUM, V12, P509, DOI 10.1089/neu.1995.12.509	15	8	10	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0022-5282	1529-8809		J TRAUMA	J. Trauma-Injury Infect. Crit. Care	NOV	2002	53	5					857	863		10.1097/00005373-200211000-00009			7	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	618DV	WOS:000179403900009	12435935				2022-02-06	
J	Mey, J; Henkes, L				Mey, J; Henkes, L			Retinoic acid enhances leukemia inhibitory factor expression in OLN-93 oligodendrocytes	CELL AND TISSUE RESEARCH			English	Article						retinoic acid; cytokine; oligodendrocyte; OLN-93 cells; quantitative RT-PCR; cell culture (rat)	CILIARY NEUROTROPHIC FACTOR; NEURITE OUTGROWTH; SPINAL-CORD; BINDING PROTEINS; FACTOR CNTF; FACTOR LIF; ADULT-RAT; IN-VITRO; NERVE; BRAIN	Brain injuries trigger physiological reactions which are mediated by a number of cytokines including interleukin-6 (IL-6), ciliary neurotrophic factor (CNTF), and leukemia inhibitory factor (LIF). Astrocytes and microglia, the protagonists in these traumatic responses, are known to secrete a variety of paracrine signals. Oligodendrocytes are involved as well and constitute another possible source of cytokines. Here we show the expression of IL-6, CNTF, and LIF in OLN-93 cells, derived from rat oligodendrocyte primary cultures. While differential gene transcription after injury has been described for many cytokines, the regulation of these physiological responses is unknown in many instances. Recent experiments indicate that the transcriptional activator retinoic acid (RA) plays a role in peripheral nerve regeneration. Transcripts of the retinoic acid receptors and the retinoid X receptors were also detected in OLN-93 oligo-dendrocytes. Using quantitative RT-PCR, we have therefore investigated the effect of RA on the expression of neuropoietic cytokines in these cells. Treatment with 1 muM all-trans RA for 24 h increased the mRNA concentration of LIF by a factor of 3.1 (P<0.01). In contrast, RA had no significant effect on the expression of CNTF The results suggest RA as a possible regulator of cytokine signaling in the CNS.	Rhein Westfal TH Aachen, Inst Biol 2, D-52074 Aachen, Germany		Mey, J (corresponding author), Rhein Westfal TH Aachen, Inst Biol 2, Kopernikusstr 16, D-52074 Aachen, Germany.						Ahmed N, 2000, CYTOKINE, V12, P289, DOI 10.1006/cyto.1999.0588; Ballot B, 1996, J PHYS IV, V6, P171, DOI 10.1051/jp4:1996224; BARRES BA, 1994, DEVELOPMENT, V120, P1097; BOUMAN HGA, 1995, ANAT RECORD, V243, P101, DOI 10.1002/ar.1092430112; Chiang MY, 1998, NEURON, V21, P1353, DOI 10.1016/S0896-6273(00)80654-6; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; Corcoran J, 1999, NAT NEUROSCI, V2, P307, DOI 10.1038/7214; Corcoran J, 2000, J CELL SCI, V113, P2567; DEV S, 1993, BRAIN RES, V632, P325, DOI 10.1016/0006-8993(93)91170-W; Dezawa M, 1999, BRAIN RES BULL, V48, P573, DOI 10.1016/S0361-9230(99)00035-0; Drager UC, 1997, PROG RETIN EYE RES, V16, P323, DOI 10.1016/S1350-9462(96)00029-8; DSouza SD, 1996, J NEUROSCI RES, V43, P289, DOI 10.1002/(SICI)1097-4547(19960201)43:3<289::AID-JNR4>3.0.CO;2-F; GRANDE A, 1995, EXP HEMATOL, V23, P117; Haas CA, 1999, J NEUROBIOL, V41, P559, DOI 10.1002/(SICI)1097-4695(199912)41:4<559::AID-NEU11>3.0.CO;2-A; Holst Alexander V., 1995, Molecular and Cellular Neuroscience, V6, P185, DOI 10.1006/mcne.1995.1016; HUNTER K, 1991, P NATL ACAD SCI USA, V88, P3666, DOI 10.1073/pnas.88.9.3666; Ito Y, 1998, BRAIN RES, V793, P321, DOI 10.1016/S0006-8993(98)00242-X; Kastner P, 1997, DEVELOPMENT, V124, P313; Kossmann T, 1996, BRAIN RES, V713, P143, DOI 10.1016/0006-8993(95)01501-9; Kreutz M, 1998, BLOOD, V91, P4796, DOI 10.1182/blood.V91.12.4796.412k39_4796_4802; Kurek JB, 1998, NEUROSCI LETT, V249, P1, DOI 10.1016/S0304-3940(98)00360-7; Lee SH, 2001, NATURE, V414, P909, DOI 10.1038/414909a; Lemke R, 1999, GLIA, V27, P75, DOI 10.1002/(SICI)1098-1136(199907)27:1<75::AID-GLIA8>3.0.CO;2-J; LI M, 1995, NATURE, V378, P724, DOI 10.1038/378724a0; Liu J, 2000, ANTICANCER RES, V20, P2659; MCCAFFERY P, 1994, P NATL ACAD SCI USA, V91, P7772, DOI 10.1073/pnas.91.16.7772; Mey J, 1999, NEUROREPORT, V10, P3573, DOI 10.1097/00001756-199911260-00020; Mey J, 2001, DEV BRAIN RES, V127, P135, DOI 10.1016/S0165-3806(01)00127-4; Mey J, 2001, Z NATURFORSCH C, V56, P163; MEY J, 2001, SOC NEUR ABSTR, V27; Nakashima K, 1999, SCIENCE, V284, P479, DOI 10.1126/science.284.5413.479; NOLL E, 1994, DEVELOPMENT, V120, P649; Oyesiku NM, 1997, J NEUROBIOL, V32, P251, DOI 10.1002/(SICI)1097-4695(199703)32:3<251::AID-NEU1>3.0.CO;2-6; Park SK, 2001, DEV NEUROSCI-BASEL, V23, P327, DOI 10.1159/000048716; Raivich G, 1999, BRAIN RES REV, V30, P77, DOI 10.1016/S0165-0173(99)00007-7; RichterLandsberg C, 1996, J NEUROSCI RES, V45, P161, DOI 10.1002/(SICI)1097-4547(19960715)45:2<161::AID-JNR8>3.0.CO;2-8; Ridet JL, 1997, TRENDS NEUROSCI, V20, P570, DOI 10.1016/S0166-2236(97)01139-9; Ross SA, 2000, PHYSIOL REV, V80, P1021, DOI 10.1152/physrev.2000.80.3.1021; Sendtner M, 1996, CURR BIOL, V6, P686, DOI 10.1016/S0960-9822(09)00450-3; SENDTNER M, 1992, J CELL BIOL, V118, P139, DOI 10.1083/jcb.118.1.139; Yee KK, 2000, DEV BRAIN RES, V124, P129, DOI 10.1016/S0165-3806(00)00108-5; ZETTERSTROM RH, 1994, NEUROSCIENCE, V62, P899, DOI 10.1016/0306-4522(94)90482-0; Zetterstrom RH, 1999, EUR J NEUROSCI, V11, P407, DOI 10.1046/j.1460-9568.1999.00444.x	43	8	9	0	1	SPRINGER-VERLAG	NEW YORK	175 FIFTH AVE, NEW YORK, NY 10010 USA	0302-766X			CELL TISSUE RES	Cell Tissue Res.	NOV	2002	310	2					155	161		10.1007/s00441-002-0624-x			7	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	619PR	WOS:000179485600003	12397370				2022-02-06	
J	Bonilha, L; Fernandes, YB; Mattos, JPD; Borges, WAA; Borges, G				Bonilha, L; Fernandes, YB; Mattos, JPD; Borges, WAA; Borges, G			Bilateral internuclear ophthalmoplegia and clivus fracture following head injury - Case report	ARQUIVOS DE NEURO-PSIQUIATRIA			English	Article						head injury; internuclear ophthalmoplegia; skull base; clivus fracture		Internuclear ophthalmoplegia is a remarkable finding, particularly in patients victims of head injury. The medial longitudinal fasciculus, which is believed to be lesioned in cases of internuclear ophthalmoplegia, has an unique brain stem position and the mechanism involved in brain stem contusions implies a maximal intensity of shearing forces on the skull base. We describe a very rare association of bilateral ophthalmoplegia and clivus fracture following head injury; without further neurological signs. The patient history; his physical examination and the image investigation provide additional evidence to some of the mechanisms of injury proposed to explain post-traumatic internuclear ophthalmoplegia.	UNICAMP, Fac Ciencias Med, Dept Neurol, Disciplina Neurocirurgia, Campinas, SP, Brazil								ANTHONY DC, 1987, J NEUROSURG, V66, P929, DOI 10.3171/jns.1987.66.6.0929; BAKER RS, 1979, J NEUROSURG, V51, P552, DOI 10.3171/jns.1979.51.4.0552; BECK RW, 1981, ANN OPHTHALMOL, V13, P671; CATALANO RA, 1986, AM J OPHTHALMOL, V101, P491, DOI 10.1016/0002-9394(86)90657-4; COGAN DG, 1970, ARCH OPHTHALMOL-CHIC, V84, P583; CORRADINO G, 1990, NEUROSURGERY, V27, P592, DOI 10.1227/00006123-199010000-00015; DEVEREAUX MW, 1979, NEUROLOGY, V29, P251, DOI 10.1212/WNL.29.2.251; DOLAN KD, 1979, CRIT REV DIAGN IMAGI, V120, P101; GONYEA EF, 1974, ARCH NEUROL-CHICAGO, V31, P168, DOI 10.1001/archneur.1974.00490390050004; GURDJIAN ES, 1945, SURG GYNECOL OBSTET, V85, P195; LINDENBERG R, 1966, J NEUROSURG, V24, P908, DOI 10.3171/jns.1966.24.5.0908; LOOP JW, 1964, RADIOLOGY, V83, P36, DOI 10.1148/83.1.36; MEGURO K, 1985, NEUROSURGERY, V16, P66; Nelson J, 1942, J AMER MED ASSOC, V119, P864, DOI 10.1001/jama.1942.02830280010003; RICH JR, 1974, ARCH OPHTHALMOL-CHIC, V92, P66; RUSSELL WR, 1972, J NEUROL NEUROSUR PS, V35, P247; SIGHTS WP, 1968, J NEUROSURG, V28, P588, DOI 10.3171/jns.1968.28.6.0588; SMITH JL, 1959, ARCH OPHTHALMOL-CHIC, V61, P687, DOI 10.1001/archopht.1959.00940090689003; ZAUEL D, 1977, ANN NEUROL, V1, P308, DOI 10.1002/ana.410010325	19	8	8	0	1	ASSOC ARQUIVOS DE NEURO- PSIQUIATRIA	SAO PAULO SP	PR AMADEU AMARAL 47/33, 01327-010 SAO PAULO SP, BRAZIL	0004-282X			ARQ NEURO-PSIQUIAT	Arq. Neuro-Psiquiatr.	SEP	2002	60	3A					636	638		10.1590/S0004-282X2002000400023			3	Neurosciences; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry	589NW	WOS:000177767200023	12244406	Green Published, Green Submitted, gold			2022-02-06	
J	Pokela, M; Romsi, P; Biancari, F; Kiviluoma, K; Vainionpaa, V; Heikkinen, J; Ronka, E; Kaakinen, T; Hirvonen, J; Rimpilainen, J; Anttila, V; Leo, E; Juvonen, T				Pokela, M; Romsi, P; Biancari, F; Kiviluoma, K; Vainionpaa, V; Heikkinen, J; Ronka, E; Kaakinen, T; Hirvonen, J; Rimpilainen, J; Anttila, V; Leo, E; Juvonen, T			Increase of intracranial pressure after hypothermic circulatory arrest in a chronic porcine model	SCANDINAVIAN CARDIOVASCULAR JOURNAL			English	Article						brain infarction; hypothermic circulatory arrest; intracranial pressure	CEREBRAL BLOOD-FLOW; PERFUSION; ICP	Objective-An increase in intracranial pressure has been shown to threaten the outcome of patients with ischemic or traumatic brain injury. Its impact on the outcome of pigs undergoing hypothermic circulatory arrest has been evaluated in this study. Design-Fifty-six pigs underwent a 75-min period of hypothermic circulatory arrest at 20degreesC. Intracranial pressure, cerebral microdialysis, hemodynamic and metabolic parameters were monitored throughout the experiment. The animals were allowed to survive until the 7th postoperative day and, then, electively killed. Results-The 7-day survival rate was 60.7%, and among survivors, 20 of them (58.8%) developed brain infarction. A significant increase in intracranial pressure as compared with the baseline level was observed since the end of cooling (p = 0.047) and the difference became larger during all the postoperative intervals (p < 0.0001). Animals that died postoperatively tended to have higher intracranial pressure levels during all the postoperative intervals, but such a difference reached significance only at the 4-h postoperative interval (p = 0.040). The same tendency was observed among animals that survived until the 7th postoperative day and that developed brain infarction or not, but the difference between these two groups did not reach statistical significance. The animals that died or developed postoperatively brain infarction had higher intracranial pressure values postoperatively as compared with those that survived without developing brain infarction and such a difference reached significance at the 2-h (p = 0.0 15) and 4-h postoperative intervals (p = 0.035). The peak intracranial pressure was 17.2 mmHg (IQR, 13.7-20.8) in animals that died or developed brain infarction and 14.1 mmHg (IQR, 11.8-16.4) in those that survived 7 days without developing brain infarction (p = NS). Conclusion-Intracranial pressure increases significantly after 75 min of experimental hypothermic circulatory arrest and such an increase is associated with a high risk of postoperative death and brain infarction.	Oulu Univ, Dept Surg, Oulu, Finland; Oulu Univ, Dept Anesthesiol, Oulu, Finland; Oulu Univ, Dept Forens Med, Oulu, Finland		Juvonen, T (corresponding author), Oulu Univ Hosp, Dept Surg, POB 21, FI-90029 Oulu, Finland.		Biancari, Fausto/A-1039-2008	Biancari, Fausto/0000-0001-5028-8186; Kaakinen, Timo/0000-0001-5125-245X; Kiviluoma, Kai/0000-0002-7480-8657			BURROWS FA, 1993, CAN J ANAESTH, V40, P291; Ehrlich MP, 2001, J THORAC CARDIOV SUR, V121, P923, DOI 10.1067/mtc.2001.113175; GREELEY WJ, 1991, J THORAC CARDIOV SUR, V101, P783; HEKMATPANAH J, 1970, J NEUROSURG, V32, P21, DOI 10.3171/jns.1970.32.1.0021; JOHNSTON WE, 1991, ANN THORAC SURG, V52, P417; Juvonen T, 2001, EUR J CARDIO-THORAC, V20, P803, DOI 10.1016/S1010-7940(01)00955-1; LUNDAR T, 1983, SCAND J THORAC CARD, V17, P149, DOI 10.3109/14017438309109880; McCullough JN, 1999, ANN THORAC SURG, V67, P1895, DOI 10.1016/S0003-4975(99)00441-5; MCDANIEL LB, 1994, ANESTH ANALG, V78, P435; Nagai H, 1997, STROKE, V28, P603, DOI 10.1161/01.STR.28.3.603; OHARE B, 1995, CAN J ANAESTH, V42, P964, DOI 10.1007/BF03011066; Pokela M, 2001, SCAND CARDIOVASC J, V35, P395, DOI 10.1080/14017430152754880; Price DJ, 1998, ACT NEUR S, V71, P297; Romsi P, 2002, J THORAC CARDIOV SUR, V123, P724, DOI 10.1067/mtc.2002.119069; ROMSI P, 2002, IN PRESS J THORAC CA; Rossi S, 1998, ACT NEUR S, V71, P91; Schneweis S, 2001, STROKE, V32, P1863, DOI 10.1161/01.STR.32.8.1863	17	8	8	0	1	TAYLOR & FRANCIS AS	OSLO	CORT ADELERSGT 17, PO BOX 2562, SOLLI, 0202 OSLO, NORWAY	1401-7431			SCAND CARDIOVASC J	Scand. Cardiovasc. J.	SEP	2002	36	5					302	307		10.1080/140174302320774528			6	Cardiac & Cardiovascular Systems	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology	618DD	WOS:000179402300010	12470399				2022-02-06	
J	Reinert, M; Alessandri, B; Seiler, R; Bullock, R				Reinert, M; Alessandri, B; Seiler, R; Bullock, R			Influence of inspired oxygen on glucose-lactate dynamics after subdural hematoma in the rat	NEUROLOGICAL RESEARCH			English	Article						severe traumatic brain injury; hyperoxygenation; glucose; lactate; microdialysis; subdural hematoma	ISCHEMIC BRAIN-DAMAGE; SEVERE HEAD-INJURY; EXTRACELLULAR POTASSIUM; INTRACRANIAL-PRESSURE; TISSUE; METABOLISM; MODEL; GLYCOLYSIS; ASTROCYTES; ANTAGONIST	The mechanisms causing brain damage after acute subdural hematoma (SDH) are poorly understood. A decrease in cerebral blood flow develops immediately after the hematoma forms, thus reducing cerebral oxygenation. This in turn may activate mitochondrial failure and tissue damage leading to ionic imbalance and possibly to cellular breakdown. The purpose of this study was to test whether a simple therapeutic measure, namely increased fraction of inspired oxygen (FiO(2) 100), and hence increased arterial and brain tissue oxygen tension, can influence brain glucose and lactate dynamics acutely after subdural hematoma in the rat. Twenty-five male Sprague-Dawley anesthetized rats were studied before, during and after induction of the SDH in two separate groups. The Oxygen group (n = 10) was ventilated with 100% oxygen immediately after induction of the SDH. The Air group (n = 10) was ventilated during the entire study with 21% oxygen. Brain microdialysate samples were analyzed for glucose and lactate. All rats were monitored with femoral arterial blood pressure catheters, arterial blood gas analysis, arterial glucose, lactate and end tidal CO2 (EtCO2). Five male Sprague-Dawley rats were sham operated to measure the effect of oxygen challenge on glucose-lactate dynamics without injury. Arterial oxygen tension in the Oxygen group was 371 +/- 30 mmHg and was associated with significantly greater increase in dialysate lactate in the first 30 min after induction of SDH. Dialysate glucose initially dropped in both groups, after SDH, but then reverted significantly faster to values above baseline in the Oxygen group. Changes in ventilatory parameters had no significant effect on dialysate glucose and lactate parameters in the sham group. Extracellular dialysate lactate and glucose are influenced by administration of 100% 02 after SDH. Dialysate glucose normalizes significantly quicker upon 100% oxygen ventilation. We hypothesize that increased neural tissue oxygen tension, in presence of reduced regional CBF, and possibly compromised mitochondrial function, after acute SDH results in upregulation of rate-limiting enzyme systems responsible for both glycolytic and aerobic metabolism. Similar changes have been seen in severe human head injury and suggest that a simple therapeutic measure, such as early ventilation with 100% O-2, may improve cerebral energy metabolism, early after SDH. Further studies to measure the generation of adenosine triphosphate (ATP) are needed to validate the hypothesis.	Univ Bern, Inselspital, Neurochirurg Klin, Dept Neurosurg, CH-3010 Bern, Switzerland; Virginia Commonwealth Univ, Med Coll Virginia, Div Neurosurg, Richmond, VA 23298 USA		Reinert, M (corresponding author), Univ Bern, Inselspital, Neurochirurg Klin, Dept Neurosurg, CH-3010 Bern, Switzerland.	michael.reinert@neurochirurgie-bern.ch	Reinert, Michael/AAA-3929-2019; Reinert, Michael/E-4964-2011	Reinert, Michael/0000-0002-0971-9543; 	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01NS012587, P50NS012587] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS 12587] Funding Source: Medline		Alessandri B, 1999, BRAIN RES, V845, P232, DOI 10.1016/S0006-8993(99)01948-4; ANDERSEN BJ, 1992, BRAIN RES, V585, P184, DOI 10.1016/0006-8993(92)91205-S; ANDERSEN BJ, 1989, INTRACRANIAL PRESSUR, V7, P575; Bergsneider M, 1997, J NEUROSURG, V86, P241, DOI 10.3171/jns.1997.86.2.0241; BOUMA GJ, 1991, J NEUROSURG, V75, P685, DOI 10.3171/jns.1991.75.5.0685; BULLOCK R, 1990, BRIT MED J, V300, P1515, DOI 10.1136/bmj.300.6738.1515; BULLOCK R, 1995, ANN NY ACAD SCI, V15, P290; Doppenberg EMR, 1999, J NEUROTRAUM, V16, P123, DOI 10.1089/neu.1999.16.123; Doppenberg EMR, 1998, J NEUROTRAUM, V15, P337, DOI 10.1089/neu.1998.15.337; GENARELLI T, 2001, J NEUROSURG, V56, P26; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; KURODA Y, 1994, NEUROSURGERY, V35, P106, DOI 10.1227/00006123-199407000-00016; LEVASSEUR J, 1998, J NEUROTRAUM, V15, P879; LOBATO RD, 1988, J NEUROSURG, V68, P417, DOI 10.3171/jns.1988.68.3.0417; MAAS AIR, 1993, ACTA NEUROCHIR, P50; MAGISTRETTI PJ, 1993, DEV NEUROSCI-BASEL, V15, P306, DOI 10.1159/000111349; Magistretti PJ, 1999, SCIENCE, V283, P496, DOI 10.1126/science.283.5401.496; Menzel M, 1998, ACT NEUR S, V71, P183; Menzel M, 1999, J NEUROSURG, V91, P1, DOI 10.3171/jns.1999.91.1.0001; Muizelaar JP, 1996, NEUROTRAUMA, P553; PELLERIN L, 1994, P NATL ACAD SCI USA, V91, P10625, DOI 10.1073/pnas.91.22.10625; Reinert M, 2000, J NEUROSURG, V93, P800, DOI 10.3171/jns.2000.93.5.0800; ROBERTSON CS, 1987, J NEUROSURG, V67, P361, DOI 10.3171/jns.1987.67.3.0361; Rossi S, 2001, J NEUROTRAUM, V18, P163, DOI 10.1089/08977150150502596; SALVANT JB, 1993, NEUROSURGERY, V33, P387; Schurr A, 1999, J NEUROSCI, V19, P34, DOI 10.1523/JNEUROSCI.19-01-00034.1999; SCHURR A, 1988, SCIENCE, V240, P1326, DOI 10.1126/science.3375817; Tsuchida E, 1996, J NEUROSURG, V85, P104, DOI 10.3171/jns.1996.85.1.0104; Tsuchida E, 1997, J NEUROTRAUM, V14, P409, DOI 10.1089/neu.1997.14.409; vanSantbrink H, 1996, NEUROSURGERY, V38, P21, DOI 10.1097/00006123-199601000-00007	30	8	14	0	3	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0161-6412	1743-1328		NEUROL RES	Neurol. Res.	SEP	2002	24	6					601	606		10.1179/016164102101200438			6	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	606WD	WOS:000178756900015	12238629				2022-02-06	
J	Landry, GL				Landry, GL			Central nervous system trauma - Management of concussions in athletes	PEDIATRIC CLINICS OF NORTH AMERICA			English	Article							SPORT-RELATED CONCUSSION; MILD HEAD-INJURY; CEREBRAL CONCUSSION; BRAIN-INJURY; 2ND IMPACT; COMPUTED-TOMOGRAPHY; FOOTBALL; SOCCER; PERFORMANCE; CT	No injury creates more anxiety in the team physician than a concussion. The young athlete often wants to know how soon he can resume play, whereas the physician worries about whether the athlete is being truthful about his symptoms, There may also be a question of whether the athlete and the athlete's parents are being truthful about a history of concussions. There are numerous reviews and opinions on concussion, but they are based on little scientific evidence. Most studies are done on inpatients who have moderate to severe brain injuries. There is a gap between the knowledge about brain injuries and their treatment in the office and on the athletic field. The physician's discomfort is a result of the high stakes. Virtually any concussion can result in permanent brain injury. Fortunately, the new interest in the sports medicine community has begun to provide some information about the management of concussions.	Univ Wisconsin, Dept Pediat, Madison, WI 53705 USA		Landry, GL (corresponding author), Univ Wisconsin, Dept Pediat, 2870 Univ Ave,Suite 200, Madison, WI 53705 USA.	gllandry@facstaff.wisc.edu					Baroff GS, 1998, J HEAD TRAUMA REHAB, V13, P45, DOI 10.1097/00001199-199804000-00007; Bergman DA, 1999, PEDIATRICS, V104, P1407; *C NEUR SURG, 1966, CLIN NEUROSURG, V12, P386; CANTU RC, 1986, PHYSICIAN SPORTSMED, V14, P75, DOI 10.1080/00913847.1986.11709197; CANTU RC, 1995, PHYSICIAN SPORTSMED, V23, P27, DOI 10.1080/00913847.1995.11947799; *COL MED SOC, 1991, REP SPORTS MED COMM; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P964, DOI 10.1001/jama.282.10.964; DAVIS RL, 1994, ANN EMERG MED, V24, P640, DOI 10.1016/S0196-0644(94)70273-X; Delaney JS, 2000, CLIN J SPORT MED, V10, P9, DOI 10.1097/00042752-200001000-00003; GERBERICH SG, 1983, AM J PUBLIC HEALTH, V73, P1370, DOI 10.2105/AJPH.73.12.1370; GOLDBERG B, 1984, PHYSICIAN SPORTSMED, V12, P122; GOLDBERG G, 2001, PHYS MED REHABIL STA, V15, P363; Green GA, 1998, CLIN SPORT MED, V17, P795, DOI 10.1016/S0278-5919(05)70120-4; Guskiewicz KM, 2001, CLIN J SPORT MED, V11, P182, DOI 10.1097/00042752-200107000-00009; HOFFMAN JR, 1994, ANN EMERG MED, V24, P713; JERET JS, 1993, NEUROSURGERY, V32, P9, DOI 10.1227/00006123-199301000-00002; Johnston KM, 2001, CLIN J SPORT MED, V11, P150, DOI 10.1097/00042752-200107000-00005; Johnston KM, 2001, J AM COLL SURGEONS, V192, P515, DOI 10.1016/S1072-7515(01)00797-9; Johnston KM, 2000, CLIN J SPORT MED, V10, P209; Jordan BD, 2000, NEUROLOGY, V54, pA410; Jordan BD, 1997, JAMA-J AM MED ASSOC, V278, P136, DOI 10.1001/jama.278.2.136; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Kelly JP, 1998, J HEAD TRAUMA REHAB, V13, P53, DOI 10.1097/00001199-199804000-00008; KELLY JP, 1991, JAMA-J AM MED ASSOC, V266, P2867, DOI 10.1001/jama.266.20.2867; Kelly JP, 1997, NEUROLOGY, V48, P581; Kutner KC, 2000, NEUROSURGERY, V47, P651, DOI 10.1097/00006123-200009000-00026; Lovell MR, 1999, CLIN J SPORT MED, V9, P193, DOI 10.1097/00042752-199910000-00002; Macciocchi SN, 1996, NEUROSURGERY, V39, P510, DOI 10.1097/00006123-199609000-00014; Maroon JC, 2000, NEUROSURGERY, V47, P659, DOI 10.1097/00006123-200009000-00027; Matser JT, 1998, NEUROLOGY, V51, P791, DOI 10.1212/WNL.51.3.791; McCrea M, 1997, NEUROLOGY, V48, P586, DOI 10.1212/WNL.48.3.586; McCrory P, 2001, CLIN J SPORT MED, V11, P160, DOI 10.1097/00042752-200107000-00006; McCrory P, 2001, CLIN J SPORT MED, V11, P144, DOI 10.1097/00042752-200107000-00004; McCrory PR, 1998, NEUROLOGY, V50, P677, DOI 10.1212/WNL.50.3.677; MCGUINE T, 1996, SAFETY AM FOOTBALL, P83; MENDEZ MF, 1995, INT J PSYCHIAT MED, V25, P249, DOI 10.2190/CUMK-THT1-X98M-WB4C; *NAT ATHL TRAIN AS, 1994, P MILD BRAIN INJ SUM; OMMAYA AK, 1974, BRAIN, V97, P633, DOI 10.1093/brain/97.1.633; Powell JW, 1999, JAMA-J AM MED ASSOC, V282, P958, DOI 10.1001/jama.282.10.958; Putukian M, 2000, CLIN J SPORT MED, V10, P104, DOI 10.1097/00042752-200004000-00004; Rabadi MH, 2001, CLIN J SPORT MED, V11, P194, DOI 10.1097/00042752-200107000-00011; Rivara F P, 1999, Inj Prev, V5, P194; Roberts AH, 1969, BRAIN DAMAGE BOXERS; Sallis RE, 2000, MED SCI SPORT EXER, V32, P1820, DOI 10.1097/00005768-200011000-00002; SAUNDERS RL, 1984, JAMA-J AM MED ASSOC, V252, P538, DOI 10.1001/jama.252.4.538; STEIN SC, 1992, J TRAUMA, V33, P11, DOI 10.1097/00005373-199207000-00003; Thurman DJ, 1998, J HEAD TRAUMA REHAB, V13, P1, DOI 10.1097/00001199-199804000-00003; TYSVAER AT, 1991, AM J SPORT MED, V19, P56, DOI 10.1177/036354659101900109; Wojtys EM, 1999, AM J SPORT MED, V27, P676, DOI 10.1177/03635465990270052401; Young CC, 1997, CLIN J SPORT MED, V7, P196, DOI 10.1097/00042752-199707000-00008; Zemper Eric D., 1994, Journal of Athletic Training, V29, P44	51	8	8	0	3	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0031-3955	1557-8240		PEDIATR CLIN N AM	Pediatr. Clin. N. Am.	AUG	2002	49	4					723	+	PII S0031-3955(02)00024-X	10.1016/S0031-3955(02)00024-X			20	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics	594GH	WOS:000178040600004	12296529				2022-02-06	
J	Moon, HS; Nam, SI; Kim, SD; Kim, DY; Gwag, BJ; Lee, YA; Yoon, SH				Moon, HS; Nam, SI; Kim, SD; Kim, DY; Gwag, BJ; Lee, YA; Yoon, SH			Structural requirements for the neuroprotective effects of aspirin analogues against N-methyl-D-aspartate and zinc ion neurotoxicity	JOURNAL OF PHARMACY AND PHARMACOLOGY			English	Article							TRAUMATIC BRAIN INJURY; CORTICAL CELL-CULTURES; NEURONAL INJURY; KAPPA-B; RECEPTORS; GLUTAMATE; DISEASE; ACIDS; ACTIVATION; BLOCKADE	In order to elucidate the structural requirements for the dual neuroprotective activity of aspirin against N-methyl-D-aspartate (NMDA) and zinc ion neurotoxicity, various aspirin analogues and derivatives, modified at the carboxylic group, the acetyl group, and the chain length between the carboxylic acid moiety and phenyl ring, were synthesized. Replacement of the carboxylic acid group with alkyl groups (compounds 2c and 2d) resulted in a dramatic increase in neuroprotective activity against NMDA neurotoxicity, while reduction of the carboxylic acid group to the alcohol (compound 2g) completely abolished this activity. In contrast to NMDA neurotoxicity, compounds that are devoid of the carboxylic acid group did not show any activity against zinc ion neurotoxicity. Replacement of the acetyl group with a propionyl (compound 5a) or butyryl group (compound 5b) did not significantly change the activity against NMDA neurotoxicity, but replacement of the acetyl group with a propionyl group (compound 5a) resulted in a slight decrease in activity against zinc ion neurotoxicity. Compound 12, which has ethylene units between the carboxylic acid moiety and phenyl ring in the structure of aspirin, exhibited greater neuroprotective activity against NMDA neurotoxicity than the compared compounds (aspirin, compound 9 and compound 17), which have different chain lengths. A similar trend was also observed in the neuroprotective activity against zinc ion neurotoxicity. These results indicate that the carboxylic acid group in aspirin is not indispensable for the inhibitory effect against NMDA neurotoxicity, but is essential for the inhibitory effect against zinc ion neurotoxicity. The acetyl group and ethylene unit's distance are favourable for the inhibitory effect against NMDA neurotoxicity as well as zinc ion neurotoxicity.	Ajou Univ, Dept Mol Sci & Technol, Suwon 442749, South Korea; Ajou Univ, Sch Med, Dept Neurosci & Pharmacol, Suwon 442749, South Korea; Neurotech Pharmaceut Co, Suwon 442380, South Korea		Yoon, SH (corresponding author), Ajou Univ, Dept Mol Sci & Technol, Suwon 442749, South Korea.						BROWN HC, 1973, J ORG CHEM, V38, P912, DOI 10.1021/jo00945a015; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; Frederickson C. J., 1994, Biological Signals, V3, P127; FREUND WD, 1994, BRAIN RES, V654, P257, DOI 10.1016/0006-8993(94)90487-1; Friedman H.L., 1951, INFLUENCE ISOSTERIC, P295; GREENAMYRE JT, 1986, ARCH NEUROL-CHICAGO, V43, P1058, DOI 10.1001/archneur.1986.00520100062016; Grilli M, 1996, SCIENCE, V274, P1383, DOI 10.1126/science.274.5291.1383; Kim EY, 1999, EUR J NEUROSCI, V11, P327, DOI 10.1046/j.1460-9568.1999.00437.x; Kim EY, 2001, NEUROBIOL DIS, V8, P774, DOI 10.1006/nbdi.2001.0421; KIM S, 1985, J ORG CHEM, V50, P560, DOI 10.1021/jo00205a004; KNOEPFEL T, 1995, J MED CHEM, V38, P1417, DOI 10.1021/jm00009a001; Ko HW, 1998, J NEUROCHEM, V71, P1390; KOH JY, 1987, J NEUROSCI METH, V20, P83, DOI 10.1016/0165-0270(87)90041-0; Parmar VS, 1997, TETRAHEDRON, V53, P2163, DOI 10.1016/S0040-4020(96)01118-0; PATEL PM, 1993, BRAIN RES, V614, P315, DOI 10.1016/0006-8993(93)91050-3; RICH JB, 1995, NEUROLOGY, V45, P51, DOI 10.1212/WNL.45.1.51; Ridker PM, 1997, NEW ENGL J MED, V336, P973, DOI 10.1056/NEJM199704033361401; Sensi SL, 1997, J NEUROSCI, V17, P9554; SIMON RP, 1984, SCIENCE, V226, P850, DOI 10.1126/science.6093256; Suh SW, 2000, BRAIN RES, V852, P268, DOI 10.1016/S0006-8993(99)02095-8; VITALI R, 1972, J ORG CHEM, V37, P3745, DOI 10.1021/jo00796a040; YOON NM, 1985, J ORG CHEM, V50, P2443, DOI 10.1021/jo00214a009	22	8	8	0	1	ROYAL PHARMACEUTICAL SOC GREAT BRITAIN	LONDON	1 LAMBETH HIGH ST, LONDON SE1 7JN, ENGLAND	0022-3573			J PHARM PHARMACOL	J. Pharm. Pharmacol.	JUL	2002	54	7					935	944		10.1211/002235702760089054			10	Pharmacology & Pharmacy	Index Chemicus (IC); Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	574YY	WOS:000176919300007	12162712				2022-02-06	
J	Beierle, EA; Chen, MK; Langham, MR; Kays, DW; Talbert, JL				Beierle, EA; Chen, MK; Langham, MR; Kays, DW; Talbert, JL			Small watercraft injuries in children	AMERICAN SURGEON			English	Article; Proceedings Paper	Annual Meeting of the Southeastern Surgical Congress	FEB 01-05, 2002	NASHVILLE, TENNESSEE				JET-SKI ACCIDENT; PERSONAL WATERCRAFT	The speed and use of small watercraft have increased dramatically in recent years. We report our experience with pediatric trauma resulting from small watercraft accidents. We conducted a retrospective chart review including all children admitted with injuries sustained in small watercraft accidents. Sixteen children were included; nine were injured in jet ski accidents and seven in accidents involving other craft. jet ski accidents tended to result in more serious injuries (closed-head injuries, hollow and solid viscus injuries, chest trauma, spinal injuries leading to paralysis, and death) than those sustained in accidents with small boats. Skin and soft-tissue injuries and long-bone fractures were the most frequent injuries following accidents with other small boats. Six of eight children (75%) injured on jet skis required operative interventions. Only three of seven (43%) children in other watercraft accidents required surgery (P < 0.05 jet ski vs other watercraft). When compared with children injured in accidents involving small boats those involved in jet ski accidents tended to have more serious injuries and require operative intervention more frequently. A high index of suspicion for serious injuries must be maintained when evaluating children with this mechanism of injury.	Univ Florida, Dept Surg, Div Pediat Surg, Gainesville, FL 32610 USA		Beierle, EA (corresponding author), Univ Florida, Dept Surg, Div Pediat Surg, POB 100286,JHMHSC, Gainesville, FL 32610 USA.		Langham, Max/U-4060-2019	Langham, Max/0000-0002-3195-4857			Branche CM, 1997, JAMA-J AM MED ASSOC, V278, P663, DOI 10.1001/jama.278.8.663; *FLOR DEP ENV PROT, 2000, 2000 FLOR RECR BOAT; HAEFNER HK, 1991, OBSTET GYNECOL, V78, P986; HAMMAN BL, 1993, J PEDIATR SURG, V28, P920, DOI 10.1016/0022-3468(93)90697-J; Laraque D, 2000, PEDIATRICS, V105, P452, DOI 10.1542/peds.105.2.452; Morrison DM, 1998, J TRAUMA, V45, P816, DOI 10.1097/00005373-199810000-00037; Shatz DV, 1998, J TRAUMA, V44, P198, DOI 10.1097/00005373-199801000-00029; TEPAS JJ, 1987, J PEDIATR SURG, V22, P14, DOI 10.1016/S0022-3468(87)80006-4; *US COAST GUARD, 2000, P1675414 COMDTPUB US; WEIN P, 1990, AUST NZ J OBSTET GYN, V30, P384, DOI 10.1111/j.1479-828X.1990.tb02038.x; White MW, 1999, AM SURGEON, V65, P865	11	8	8	0	0	SOUTHEASTERN SURGICAL CONGRESS	ATLANTA	141 WEST WIEUCA RD, STE B100, ATLANTA, GA 30342 USA	0003-1348			AM SURGEON	Am. Surg.	JUN	2002	68	6					535	538					4	Surgery	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Surgery	562LV	WOS:000176199000009	12079135				2022-02-06	
J	Glenn, TC; Patel, AB; Martin, NA; Samii, A; De Jesus, C; Hovda, DA				Glenn, TC; Patel, AB; Martin, NA; Samii, A; De Jesus, C; Hovda, DA			Subarachnoid hemorrhage induces dynamic changes in regional cerebral metabolism in rats	JOURNAL OF NEUROTRAUMA			English	Article						cytochrome oxidase; glucose utilization; subarachnoid hemorrhage	TRAUMATIC BRAIN-INJURY; SEVERE HEAD-INJURY; BLOOD-FLOW; CYTOCHROME-OXIDASE; GLUCOSE-METABOLISM; INTRACEREBRAL MICRODIALYSIS; MITOCHONDRIAL DYSFUNCTION; CATECHOLAMINE SYSTEMS; TRANSCRANIAL DOPPLER; ENERGY-METABOLISM	Following a subarachnoid hemorrhage (SAH), adult rats exhibit dynamic regional changes in cerebral glucose metabolism characterized by an increase in metabolic rates and a subsequent upregulation of cytochrome oxidase (CO). We evaluated both local cerebral metabolic rates for glucose (ICMRglc: (mol/100 g/min) and CO in 23 brain regions of interest (ROI). Sham animals underwent anesthesia and superficial surgery; saline-controls received an injection of 0.9% saline into the cisterna magna; and SAH rats received an injection of autologous blood into the cisterna magna. This blood, measured by albumin labeled with radioactive carbon 14, distributed throughout the brain but predominated ventrally. After experimental animals were sacrificed at day 0 (3 h), 1, 3, and 7 days postinjection, ROI were analyzed using [C-14]2-deoxy-D-glucose autoradiography and CO histochemistry. ICMRglc in SAH rats increased in many regions (ranging from 0.7% to 32.2% above sham levels). Cytochrome oxidase also increased from 1% to 9% above sham levels, peaking on day 3. Conversely, saline-controls exhibited prolonged depression of ICMRglc (ranging from 11% to 35% below sham levels) and CO (ranging from 4% to 11% below sham levels) from day 0 through day 7. All saline-control ROI for all time points showed this metabolic depression, and between 91% and 95% of saline-control ROI presented lower CO levels as compared to sham. Overall, ICMRglc and CO levels were greater in SAH than in saline-control ROI. However, when considering the influence of subarachnoid blood on metabolic changes in SAH animals, both CO and 2DG levels did not correlate well with the amount of C-14-albumin binding. While previous studies have measured both metabolic rates of glucose and CO soon after SAH, this is the first to simultaneously conduct these measurements in the same SAH rat model.	Univ Calif Los Angeles, Sch Med, Div Neurosurg, Dept Surg, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Sch Med, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA		Glenn, TC (corresponding author), Univ Calif Los Angeles, Sch Med, Div Neurosurg, Dept Surg, Box 957039, Los Angeles, CA 90095 USA.	tglenn@mednet.ucla.edu		Glenn, Thomas/0000-0003-4273-3408; Martin, Neil/0000-0002-6565-4131	NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS27544, NS30308] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P50NS030308, R01NS027544] Funding Source: NIH RePORTER		ACKERMANN RF, 1989, J CEREBR BLOOD F MET, V9, P774, DOI 10.1038/jcbfm.1989.111; ALDRICH EF, 1992, SURG NEUROL, V38, P418, DOI 10.1016/0090-3019(92)90109-Z; Bergsneider M, 1997, J NEUROSURG, V86, P241, DOI 10.3171/jns.1997.86.2.0241; CARPENTER DA, 1991, J CEREBR BLOOD F MET, V11, P837, DOI 10.1038/jcbfm.1991.143; dAvella D, 1996, ACTA NEUROCHIR, V138, P737, DOI 10.1007/BF01411481; DELGADO TJ, 1986, J CEREBR BLOOD F MET, V6, P600, DOI 10.1038/jcbfm.1986.107; DELGADO TJ, 1986, J CEREBR BLOOD F MET, V6, P590, DOI 10.1038/jcbfm.1986.106; DELGADOZYGMUNT T, 1993, ACTA NEUROCHIR, V121, P166, DOI 10.1007/BF01809270; EISENBERG HM, 1990, J NEUROSURG, V73, P688, DOI 10.3171/jns.1990.73.5.0688; FEIN JM, 1975, STROKE, V6, P1; FISHER M, 1980, ANAESTH INTENS CARE, V8, P367, DOI 10.1002/ana.410080405; FOGELHOLM R, 1993, STROKE, V24, P1649, DOI 10.1161/01.STR.24.11.1649; FOX PT, 1988, SCIENCE, V241, P462, DOI 10.1126/science.3260686; Fukuda T, 1998, NEUROSURGERY, V43, P1040, DOI 10.1097/00006123-199811000-00022; GINSBERG MD, 1990, CEREBROVAS BRAIN MET, V2, P58; GLENN TC, 2000, J RESTOR NEUROL NEUR, V16, P161; Greene KA, 1996, J TRAUMA, V41, P964, DOI 10.1097/00005373-199612000-00004; Hovda DA, 1996, J CEREBR BLOOD F MET, V16, P134, DOI 10.1097/00004647-199601000-00016; HOVDA DA, 1991, BRAIN RES, V567, P1, DOI 10.1016/0006-8993(91)91429-5; JAKOBSEN M, 1990, ACTA NEUROL SCAND, V82, P174, DOI 10.1111/j.1600-0404.1990.tb04485.x; JOSEPH R, 1991, STROKE, V22, P1448, DOI 10.1161/01.STR.22.11.1448; JOSEPH R, 1992, BRAIN RES, V577, P268, DOI 10.1016/0006-8993(92)90283-F; KAWAMATA T, 1992, J CEREBR BLOOD F MET, V12, P12, DOI 10.1038/jcbfm.1992.3; Klinge PM, 1999, J NEUROSURG, V91, P843, DOI 10.3171/jns.1999.91.5.0843; LANGEMANN H, 1995, CLIN NEUROL NEUROSUR, V97, P149, DOI 10.1016/0303-8467(94)00067-G; LEAR JL, 1990, METAB BRAIN DIS, V5, P45, DOI 10.1007/BF00996977; Lee JH, 1997, J NEUROSURG, V87, P221, DOI 10.3171/jns.1997.87.2.0221; Lee KR, 1997, J NEUROSURG, V87, P73, DOI 10.3171/jns.1997.87.1.0073; MARSHALL LF, 1990, ACT NEUR S, V51, P300; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; MARSHALL LF, 1991, J NEUROSURG, V75, pS28, DOI 10.3171/sup.1991.75.1s.0s28; MARZATICO F, 1988, STROKE, V19, P378, DOI 10.1161/01.STR.19.3.378; MARZATICO F, 1990, SURG NEUROL, V34, P294, DOI 10.1016/0090-3019(90)90004-9; NEDERGAARD M, 1988, J CEREBR BLOOD F MET, V8, P763, DOI 10.1038/jcbfm.1988.125; Nemoto EM, 1997, ADV EXP MED BIOL, V411, P313; Nilsson OG, 1999, NEUROSURGERY, V45, P1176, DOI 10.1097/00006123-199911000-00032; OBRIST WD, 1984, J NEUROSURG, V61, P241, DOI 10.3171/jns.1984.61.2.0241; Patel HC, 1999, HOSP MED, V60, P497, DOI 10.12968/hosp.1999.60.7.1155; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Persson L, 1996, J NEUROSURG, V84, P606, DOI 10.3171/jns.1996.84.4.0606; Regan RF, 1996, J NEUROTRAUM, V13, P223, DOI 10.1089/neu.1996.13.223; REGAN RF, 1993, NEUROSCI LETT, V153, P219, DOI 10.1016/0304-3940(93)90326-G; ROBERTSON CS, 1992, J NEUROL NEUROSUR PS, V55, P594, DOI 10.1136/jnnp.55.7.594; Runnerstam M, 1999, NEUROL RES, V21, P404, DOI 10.1080/01616412.1999.11740951; Schievink WI, 1997, NEW ENGL J MED, V336, P28, DOI 10.1056/NEJM199701023360106; Schievink WI, 1997, NEW ENGL J MED, V336, P1267; SILVERMAN MS, 1987, J NEUROSCI METH, V19, P1, DOI 10.1016/0165-0270(87)90016-1; SOKOLOFF L, 1977, J NEUROCHEM, V28, P897, DOI 10.1111/j.1471-4159.1977.tb10649.x; SOKOLOFF L, 1977, NEUROSURGICAL TREATM, P111; SOLOMON RA, 1987, J CEREBR BLOOD F MET, V7, P193, DOI 10.1038/jcbfm.1987.44; SOLOMON RA, 1985, STROKE, V16, P58, DOI 10.1161/01.STR.16.1.58; Soustiel JF, 1998, NEUROSURGERY, V43, P282, DOI 10.1097/00006123-199808000-00061; Stein H, 1996, ZBL CHIR, V121, P985; SUNAMI K, 1989, Neurosurgical Review, V12, P400, DOI 10.1007/BF01790682; Svendgaard NA, 1998, NEUROL MED-CHIR, V38, P146, DOI 10.2176/nmc.38.suppl_146; TANAKA K, 1985, J CEREBR BLOOD F MET, V5, P502, DOI 10.1038/jcbfm.1985.76; Turjman F, 1999, J NEURORADIOLOGY, V26, p1S9; Turner CP, 1998, J CEREBR BLOOD F MET, V18, P257, DOI 10.1097/00004647-199803000-00004; Wang XY, 1999, NEUROSCI LETT, V274, P79, DOI 10.1016/S0304-3940(99)00682-5; WONGRILEY M, 1979, BRAIN RES, V171, P11, DOI 10.1016/0006-8993(79)90728-5; WONGRILEY MTT, 1989, TRENDS NEUROSCI, V12, P94, DOI 10.1016/0166-2236(89)90165-3; WONGRILEY MTT, 1980, P NATL ACAD SCI-BIOL, V77, P2333, DOI 10.1073/pnas.77.4.2333; Xiong Y, 1998, J NEUROTRAUM, V15, P531, DOI 10.1089/neu.1998.15.531; Xiong Y, 1997, J NEUROTRAUM, V14, P23, DOI 10.1089/neu.1997.14.23; YAMAKAMI I, 1983, NEUROSURGERY, V13, P394, DOI 10.1227/00006123-198310000-00008; YOSHINO A, 1991, BRAIN RES, V561, P106, DOI 10.1016/0006-8993(91)90755-K; Zubkov AY, 1999, J NEUROTRAUM, V16, P763, DOI 10.1089/neu.1999.16.763; ZURYNSKI YA, 1995, J NEUROL SCI, V134, P41, DOI 10.1016/0022-510X(95)00178-X	68	8	8	0	1	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	APR	2002	19	4					449	466		10.1089/08977150252932406			18	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	542XP	WOS:000175071200006	11990351				2022-02-06	
J	Inamasu, J; Ichikizaki, K; Matsumoto, S; Nakamura, Y; Saito, R; Horiguchi, T; Kanai, R				Inamasu, J; Ichikizaki, K; Matsumoto, S; Nakamura, Y; Saito, R; Horiguchi, T; Kanai, R			Mild hypothermia for hemispheric cerebral infarction after evacuation of an acute subdural hematoma in an infant	CHILDS NERVOUS SYSTEM			English	Article						hypothermia; acute subdural hematoma; infant; hemispheric infarction	MODERATE HYPOTHERMIA; BRAIN; ISCHEMIA; RAT; INJURY	The use of mild hypothermia to treat hemispheric infarction after evacuation of an acute subdural hematoma in an infant is reported. The patient, a 2-year-old boy, presented with a deteriorating level of consciousness after a fall from a tree. Computed tomography (CT) scan revealed an acute subdural hematoma on the right side with marked midline shift, and emergency evacuation of the hematoma was performed. The postoperative course was uneventful until the patient's intracranial pressure (ICP) rose and his condition deteriorated 3 days after surgery. CT scan revealed a hemispheric infarction on the injured side. Mild hypothermia was induced to control the ICP and protect the brain. While the hypothermia was effective in lowering the elevated ICP, it failed to arrest progression of the infarction. The patient was discharged with mild disability 2 months after the injury. No serious complications occurred during or after the hypothermia. Our experience indicates that hypothermia can be a useful procedure for controlling the ICP in children with severe traumatic brain injury including acute subdural hematoma, although its capability to protect the brain from severe, progressive ischemia appears to be limited.	Natl Tokyo Med Ctr, Dept Neurosurg, Meguro Ku, Tokyo 1528902, Japan; Natl Tokyo Med Ctr, Dept Pediat, Tokyo 1528902, Japan		Inamasu, J (corresponding author), Natl Tokyo Med Ctr, Dept Neurosurg, Meguro Ku, Higashigaoka 2-5-1, Tokyo 1528902, Japan.	georges@med.keio.ac.jp	Inamasu, Joji/R-7314-2019				Biagas Katherine V., 1998, Current Opinion in Pediatrics, V10, P271, DOI 10.1097/00008480-199806000-00009; BUSTO R, 1989, STROKE, V20, P904, DOI 10.1161/01.STR.20.7.904; DIETRICH WD, 1990, J NEUROPATH EXP NEUR, V49, P486, DOI 10.1097/00005072-199009000-00004; FUJIMOTO K, 1999, CHILD NERV SYST, V24, P504; Greenwald B M, 1995, Adv Pediatr, V42, P47; Hayashi N, 2000, No To Hattatsu, V32, P122; Inamasu J, 2000, J NEUROIMMUNOL, V109, P66, DOI 10.1016/S0165-5728(00)00211-3; KANNUKI S, 1986, PROGR COMPUT TOMOGR, V8, P559; Kawai N, 2000, J NEUROTRAUM, V17, P193, DOI 10.1089/neu.2000.17.193; Marion DW, 1997, NEW ENGL J MED, V336, P540, DOI 10.1056/NEJM199702203360803; Meyer P, 1999, CHILD NERV SYST, V15, P732, DOI 10.1007/s003810050462; Schwab S, 1998, STROKE, V29, P2461, DOI 10.1161/01.STR.29.12.2461; Shiozaki T, 1998, J NEUROSURG, V89, P206, DOI 10.3171/jns.1998.89.2.0206; SHIOZAKI T, 1993, J NEUROSURG, V79, P363, DOI 10.3171/jns.1993.79.3.0363; TAKAHASHI Y, 1996, NEUROTRAUMATOLOGY, V19, P150; TAKAHASHI Y, 1997, NEUROTRAUMATOLOGY, V20, P104; TOMITA H, 1994, SURG NEUROL, V42, P498, DOI 10.1016/0090-3019(94)90080-9; Tsuchida E, 1999, J NEUROTRAUM, V16, P595, DOI 10.1089/neu.1999.16.595	18	8	10	0	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0256-7040	1433-0350		CHILD NERV SYST	Childs Nerv. Syst.	APR	2002	18	3-4					175	178		10.1007/s003810100506			4	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	555LU	WOS:000175796200017	11981630				2022-02-06	
J	Greve, KW; Love, J; Sherwin, E; Stanford, MS; Mathias, C; Houston, R				Greve, KW; Love, J; Sherwin, E; Stanford, MS; Mathias, C; Houston, R			Cognitive strategy usage in long-term survivors of severe traumatic brain injury with persisting impulsive aggression	PERSONALITY AND INDIVIDUAL DIFFERENCES			English	Article						impulsive aggression; cognition; frontal lobes; traumatic brain injury	FRONTAL-LOBE LESIONS; SELF-REGULATION; DAMAGE; DISTURBANCE; BEHAVIOR	Impulsive aggression (IA) is a relatively common phenomenon in the general nonpatient population and IA, among other forms of impaired self regulatory behavior, is common sequelae of traumatic brain injury. Impaired self regulatory behavior has been associated with dysfunction of orbital frontal cortex. This study examined strategy development and usage in a group of survivors of traumatic brain injury (TBI) who exhibited persisting problems with impulsive expressions of aggression. All participants were administered the Revised Strategy Application Task (R-SAT) and a series of personality questionnaires. The results indicated that the subjects with IA selected and used strategies that were significantly less efficient than those of the nonaggressive controls. The present study confirms, using an explicit and direct measure, previously reported deficits in strategy usage in IA and supports the notion of inefficient cognitive processing indicated by event related potential (ERP) studies. Additionally, as impaired performance on the R-SAT has been associated with lesions of ventromedial prefrontal cortex, this study provides the first concrete neuropsychological data implicating this region in IA. Further study is necessary to clarify the nature of the apparent orbital frontal dysfunction in IA and to delineate the role of impaired strategic processing and related deficits in the genesis and expression of impulsive aggression. (C) 2002 Elsevier Science Ltd. All rights reserved.	Univ New Orleans, Dept Psychol, UNO Lakefront, New Orleans, LA 70148 USA; Georgia So Univ, Dept Psychol, Statesboro, GA 30460 USA		Greve, KW (corresponding author), Univ New Orleans, Dept Psychol, UNO Lakefront, New Orleans, LA 70148 USA.			Mathias, Charles/0000-0003-1902-673X			Barratt ES, 1997, BIOL PSYCHIAT, V41, P1045, DOI 10.1016/S0006-3223(96)00175-8; BECHARA A, 1994, COGNITION, V50, P7, DOI 10.1016/0010-0277(94)90018-3; BUSS AH, 1992, J PERS SOC PSYCHOL, V63, P452, DOI 10.1037/0022-3514.63.3.452; Cicerone KD, 1997, ARCH CLIN NEUROPSYCH, V12, P173, DOI 10.1016/S0887-6177(96)00022-4; COCCARO EF, 1989, ARCH GEN PSYCHIAT, V46, P587; Coccaro EF, 1997, PSYCHIAT RES, V73, P147, DOI 10.1016/S0165-1781(97)00119-4; Dunn L.M., 1997, PEABODY PICTURE VOCA, V3rd Edition; ESLINGER PJ, 1985, NEUROLOGY, V35, P1731, DOI 10.1212/WNL.35.12.1731; ESLINGER PJ, 1995, NEUROREHABILITATION, V5, P161, DOI 10.3233/NRE-1995-5206; Eysenck H.J., 1975, EYSENCK PERSONALITY; FAVA M, 1991, PSYCHOPHARMACOL BULL, V27, P275; Goel V, 1997, BRAIN, V120, P1805, DOI 10.1093/brain/120.10.1805; Grafman J, 1996, NEUROLOGY, V46, P1231, DOI 10.1212/WNL.46.5.1231; Grafman J., 1994, HDB PERCEPTION COGNI, P159, DOI 10.1016/b978-0-08-092668-1.50014-4; Grafman J, 1994, HDB NEUROPSYCHOLOGY, P187; Grafman J., 1989, INTEGRATING THEORY P, P93; Greve KW, 2001, BRAIN INJURY, V15, P255; Levine B, 1999, NEUROCASE, V5, P263, DOI 10.1080/13554799908402731; Levine B, 1998, J INT NEUROPSYCH SOC, V4, P247, DOI 10.1017/S1355617798002471; Levine B, 2000, NEUROPSYCHOLOGY, V14, P491, DOI 10.1037/0894-4105.14.4.491; Mathias CW, 1999, PROG NEURO-PSYCHOPH, V23, P1037, DOI 10.1016/S0278-5846(99)00053-6; MUNGAS D, 1988, BRIT J PSYCHIAT, V152, P180, DOI 10.1192/bjp.152.2.180; Patton JH, 1995, J CLIN PSYCHOL, V51, P768, DOI 10.1002/1097-4679(199511)51:6<768::AID-JCLP2270510607>3.0.CO;2-1; SHALLICE T, 1991, BRAIN, V114, P727, DOI 10.1093/brain/114.2.727; STANFORD MS, 1995, PERS INDIV DIFFER, V19, P757, DOI 10.1016/0191-8869(95)00144-U; Stanford MS, 1997, PERS INDIV DIFFER, V23, P961, DOI 10.1016/S0191-8869(97)00120-7	26	8	8	1	6	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0191-8869			PERS INDIV DIFFER	Pers. Individ. Differ.	MAR	2002	32	4					639	647	PII S0191-8869(01)00066-6	10.1016/S0191-8869(01)00066-6			9	Psychology, Social	Social Science Citation Index (SSCI)	Psychology	525XF	WOS:000174098800007					2022-02-06	
S	Kotwal, GJ; Lahiri, DK; Hicks, R		Diederich, M		Kotwal, GJ; Lahiri, DK; Hicks, R			Potential intervention by vaccinia virus complement control protein of the signals contributing to the progression of central nervous system injury to Alzheimer's disease	CELL SIGNALING, TRANSCRIPTION, AND TRANSLATION AS THERAPEUTIC TARGETS	ANNALS OF THE NEW YORK ACADEMY OF SCIENCES		English	Article; Proceedings Paper	4th International Conference on Cell Signaling, Transcription and Translation as Therapeutic Targets	JAN 30-FEB 02, 2002	LUXEMBOURG			traumatic brain injury; Alzheimer's disease; vaccinia virus complement control protein; inflammation	TRAUMATIC BRAIN INJURY; AMYLOID PRECURSOR PROTEIN; A-BETA PEPTIDE; HEAD-INJURY; ACTIVATION; RATS; EPIDEMIOLOGY; ACCUMULATION; COMPONENTS; PATHWAY	Traumatic brain injury TB1) is one of the few known risk factors for Alzheimer's disease (AD) and for depression. The mechanisms by which trauma causes delayed cognitive deficits are largely unknown. In recent studies, it was demonstrated that the complement system (an important component of the immune system and a mediator of inflammation) is activated both in human AD and following experimental TBI in rats. Amyloid proteins are also present in AD and following TBI, and are known to activate complement in vitro. Based on these and other previous studies, it was hypothesized that regulation of the complement system will attenuate the long-term consequences of TBI. Vaccinia virus complement control protein (VCP) is a protein encoded by vaccinia virus. It blocks both the classic and alternative pathways of complement activation in vitro, and by doings so prevents the generation of proinflammatory chemotactic factors. Based on in vitro studies VCP can block the complement activation by the amyloid beta peptide. Using a fluid percussion rat model that causes traumatic brain injury (TBI), it was found that VCP significantly enhances functional recovery as determined by the Morris Water Maze test. Taken togther these studies indicate that potentially VCP could block molecular signals such as the formation of amyloid beta or the activation of complement to inhibit formation of AD following TBI.	Univ Louisville, Sch Med, Dept Immunol & Microbiol, Louisville, KY 40202 USA; Indiana Univ, Sch Med, Dept Psychiat, Indianapolis, IN 46202 USA; Univ Washington, Dept Rehabil Med, Seattle, WA 98195 USA		Kotwal, GJ (corresponding author), Univ Louisville, Sch Med, Dept Immunol & Microbiol, Louisville, KY 40202 USA.						Bergamaschini L, 1999, CLIN EXP IMMUNOL, V115, P526; Bramlett HM, 1997, J NEUROPATH EXP NEUR, V56, P1132, DOI 10.1097/00005072-199710000-00007; Brooks WM, 2000, J NEUROTRAUM, V17, P629, DOI 10.1089/089771500415382; Cotman CW, 1996, NEUROBIOL AGING, V17, P723; Daly J, 1998, NEUROBIOL AGING, V19, P619, DOI 10.1016/S0197-4580(98)00100-6; DALY J, 1997, IMMUNOLOGIST, V5, P157; Emmerling MR, 2000, ANN NY ACAD SCI, V903, P118, DOI 10.1111/j.1749-6632.2000.tb06357.x; FANTONE JC, 1995, ESSENTIAL PATHOLOGY, P33; Fratiglioni L, 1993, Acta Neurol Scand Suppl, V145, P1; FULLER KS, 1998, PATHOLOGY IMPLICATIO, P763; GALLINARO R, 1992, SURG GYNECOL OBSTET, V174, P435; Graham D.I., 1996, NEUROTRAUMA, P43; GRAHAM DI, 1995, NEUROPATH APPL NEURO, V21, P27, DOI 10.1111/j.1365-2990.1995.tb01025.x; GRAVES AB, 1990, AM J EPIDEMIOL, V131, P491, DOI 10.1093/oxfordjournals.aje.a115523; Halliday G, 2000, CLIN EXP PHARMACOL P, V27, P1, DOI 10.1046/j.1440-1681.2000.03200.x; HEYMAN A, 1984, ANN NEUROL, V15, P335, DOI 10.1002/ana.410150406; Holmin S, 1999, NEUROREPORT, V10, P1889, DOI 10.1097/00001756-199906230-00017; Hoshino S, 1998, NEUROREPORT, V9, P1879, DOI 10.1097/00001756-199806010-00039; JENNETT B, 1981, BRIT MED J, V282, P101, DOI 10.1136/bmj.282.6258.101; Keeling KL, 2000, J NEUROIMMUNOL, V105, P20, DOI 10.1016/S0165-5728(00)00183-1; Kotwal GJ, 2000, IMMUNOL TODAY, V21, P242, DOI 10.1016/S0167-5699(00)01606-6; KOTWAL GJ, 1988, NATURE, V335, P176, DOI 10.1038/335176a0; KOTWAL GJ, 1990, SCIENCE, V250, P827, DOI 10.1126/science.2237434; Kotwal GJ, 1997, J LEUKOCYTE BIOL, V62, P415, DOI 10.1002/jlb.62.4.415; KOTWAL GJ, 1996, IMMUNOLOGIST, V4, P157; KRAUS JF, 1988, J TRAUMA, V28, P1637, DOI 10.1097/00005373-198812000-00004; LANGFITT TW, 1982, J NEUROSURG, V56, P19, DOI 10.3171/jns.1982.56.1.0019; LEVIN HS, 1985, STATUS REPORT CENTRA, P281; LEWEN A, 1995, NEUROREPORT, V6, P357, DOI 10.1097/00001756-199501000-00032; MCGEER PL, 1989, NEUROSCI LETT, V107, P341, DOI 10.1016/0304-3940(89)90843-4; MORTIMER JA, 1991, INT J EPIDEMIOL, V20, pS28, DOI 10.1093/ije/20.Supplement_2.S28; Nakagawa Y, 1999, J COMP NEUROL, V411, P390; Nemetz PN, 1999, AM J EPIDEMIOL, V149, P32; Nybo M, 1999, AMYLOID, V6, P265, DOI 10.3109/13506129909007338; Pierce JES, 1998, NEUROSCIENCE, V87, P359, DOI 10.1016/S0306-4522(98)00142-0; ROTHER K, 1988, COMPLEMENT SYSTEM, P535; Smith DH, 1999, J NEUROPATH EXP NEUR, V58, P982, DOI 10.1097/00005072-199909000-00008; Smith DH, 1998, AM J PATHOL, V153, P1005, DOI 10.1016/S0002-9440(10)65643-X; WATSON MR, 1995, BRIT J PSYCHIAT, V167, P514, DOI 10.1192/bjp.167.4.514; Webster SD, 2000, EXP NEUROL, V161, P127, DOI 10.1006/exnr.1999.7260	40	8	8	0	2	NEW YORK ACAD SCIENCES	NEW YORK	2 EAST 63RD ST, NEW YORK, NY 10021 USA	0077-8923		1-57331-428-5	ANN NY ACAD SCI	Ann.NY Acad.Sci.		2002	973						317	322		10.1111/j.1749-6632.2002.tb04659.x			6	Biochemistry & Molecular Biology; Cell Biology; Multidisciplinary Sciences	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Science & Technology - Other Topics	BV70N	WOS:000179853000065	12485887				2022-02-06	
J	Nakamura, N; Yamaura, A; Shigemori, M; Ono, J; Kawamata, T; Sakamoto, T				Nakamura, N; Yamaura, A; Shigemori, M; Ono, J; Kawamata, T; Sakamoto, T		Japanese Data Bank Comm Traumatic	Epidemiology, prevention and countermeasures against severe traumatic brain injury in Japan and abroad	NEUROLOGICAL RESEARCH			English	Article						head injury; brain injury; traffic accident; data bank; epidemiology; prevention		On the basis of accurate statistical reports in regard to traffic accidents and safety in Japan, it is clear that traffic accidents on the road, injured victims and all other losses due to these accidents have been increasing since around 1980. Nevertheless, the number of deaths due to traffic accidents has been gradually declining over the last six years. More detailed analysis of data revealed that the most significant factor for the recent reduction of traffic accident deaths was the marked reduction of deaths related to head injury. From the neurosurgical viewpont, the Japanese Data Bank Committee for Traumatic Brain Injury began its formal activity in 1998. Although the registered number of severe head injuries is statistically too small at present to arrive at conclusions, some interesting points draw our attention. As for intracranial pathology diagnosed by the image of cranial CT scans, two thirds of nontraffic cases have focal brain lesions alone. On the other hand, in traffic cases one third of patients have focal lesions alone and one fourth have diffuse brain lesion exclusively, In this study, in 23% of traffic accidents and 12% of nontraffic accidents, consumption of alcohol led indirectly to head injuries, The schedule and details of countermeasures taken against traffic accidents are discussed from an international viewpoint.	Tokyo Jikeikai Univ, Sch Med, Dept Neurosurg, Off Japan Soc Neurotraumatol, Tokyo, Japan		Nakamura, N (corresponding author), 2-11-7 Nishiogi Minami,Suginami Ku, Tokyo 1670053, Japan.						*AM ASS NEUR SURG, 1991, J NEUROSURG S, V25; *I TRAFF ACC RES D, 1998, TRAFF STAT; *TRAFF SAF OFF, 1996, 6 FUND TRAFF SAF PRO	3	8	9	1	6	FOREFRONT PUBL GROUP	WILTON	C/O MARY J RAWLINS, 5 RIVER RD, STE 113, WILTON, CT 06897 USA	0161-6412			NEUROL RES	Neurol. Res.	JAN	2002	24	1					45	53		10.1179/016164102101199530			9	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	519WJ	WOS:000173748200008	11783753				2022-02-06	
J	Shafer, LL; McNulty, JA; Young, MRI				Shafer, LL; McNulty, JA; Young, MRI			Brain activation of monocyte-lineage cells: Involvement of interleukin-6	NEUROIMMUNOMODULATION			English	Article						brain injury; phagocytosis; MHC II expression	CENTRAL-NERVOUS-SYSTEM; ORGANOTYPIC SLICE CULTURES; MESSENGER-RNA EXPRESSION; CLASS-II EXPRESSION; CYTOKINES TGF-BETA; MICROGLIAL CELLS; IN-VITRO; NITRIC-OXIDE; TNF-ALPHA; TRAUMATIC INJURY	Immune processes such as phagocytosis of debris and antigen presentation can be damaging to the function and survival of brain cells. Understanding what conditions and factors mediate immune processes in the brain is central to ameliorating the pathology associated with brain injury and disease. The elevation of secreted interleukin (IL)-6 is a common feature of brain injury and neurodegenerative pathology. Using organotypic brain slice coculture, the effects of brain-derived soluble factors on immune functions in the BV2 microglial cell line were studied. We have previously shown that brain-derived soluble factors upregulated phagocytic activity and class II major histocompatibility complex (MHC II) expression and altered BV2 morphology in a manner selective for microglia and not peripheral macrophages. The present study used IL-6-neutralizing antibody to show that brain-derived IL-6 was at least partially responsible for the brain coculture-induced upregulation of MHC II expression in the BV2 microglia. Additionally, IL-6 upregulated phagocytic activity and induced morphological changes in the BV2 cells similar to brain coculture. These effects were selective for microglia, as they were not observed in peripheral macrophage cell types. The ability of IL-6-neutralizing antibody to downregulate MHC II expression while maintaining enhanced phagocytic activity could potentially evade an antagonizing immune response associated with brain injury or disease.	Hines VA Hosp, Res Serv 151 Z2, Hines, IL 60141 USA; Loyola Univ, Med Ctr, Dept Cell Biol Neurobiol & Anat, Maywood, IL 60153 USA; Loyola Univ, Med Ctr, Dept Pathol, Maywood, IL 60153 USA; Loyola Univ, Med Ctr, Dept Otolaryngol, Maywood, IL 60153 USA		Young, MRI (corresponding author), Hines VA Hosp, Res Serv 151 Z2, Bldg 1,Rm A319, Hines, IL 60141 USA.	myoung1@lumc.edu					Acarin L, 1999, NEUROSCIENCE, V89, P549, DOI 10.1016/S0306-4522(98)00331-5; Acarin L, 2000, EUR J NEUROSCI, V12, P3505, DOI 10.1046/j.1460-9568.2000.00226.x; AGRELLO D, 2000, BRAIN RES, V869, P241; BARKER R, 1992, MED HYPOTHESES, V37, P40, DOI 10.1016/0306-9877(92)90011-Z; Barron KD, 1995, J NEUROL SCI, V134, P57, DOI 10.1016/0022-510X(95)00209-K; BELL MD, 1994, J NEUROCYTOL, V23, P605, DOI 10.1007/BF01191555; Benveniste EN, 1997, CHEM IMMUNOL, V69, P31; BENVENISTE EN, 1995, INT J DEV NEUROSCI, V13, P341, DOI 10.1016/0736-5748(94)00061-7; Beyer M, 2000, GLIA, V31, P262, DOI 10.1002/1098-1136(200009)31:3<262::AID-GLIA70>3.0.CO;2-2; BLASI E, 1990, J NEUROIMMUNOL, V27, P229, DOI 10.1016/0165-5728(90)90073-V; BOCCHINI V, 1992, J NEUROSCI RES, V31, P616, DOI 10.1002/jnr.490310405; Boehm U, 1998, J IMMUNOL, V161, P6715; Calvo CF, 1998, GLIA, V24, P180, DOI 10.1002/(SICI)1098-1136(199810)24:2<180::AID-GLIA3>3.0.CO;2-8; Chang RCC, 2000, BRAIN RES, V853, P236, DOI 10.1016/S0006-8993(99)02255-6; COX GW, HETEROGENEITY HEMATO; Czapiga M, 1999, J NEUROSCI RES, V56, P644, DOI 10.1002/(SICI)1097-4547(19990615)56:6<644::AID-JNR10>3.0.CO;2-9; DAS GD, 1976, VIRCHOWS ARCH B, V20, P287; FROHMAN EM, 1988, J NEUROIMMUNOL, V17, P89, DOI 10.1016/0165-5728(88)90017-3; GADIENT RA, 1994, NEUROSCI LETT, V182, P243, DOI 10.1016/0304-3940(94)90807-9; Gadient RA, 1997, PROG NEUROBIOL, V52, P379, DOI 10.1016/S0301-0082(97)00021-X; Gahwiler BH, 1997, TRENDS NEUROSCI, V20, P471, DOI 10.1016/S0166-2236(97)01122-3; GIULIAN D, 1989, J NEUROSCI, V9, P4416; Gruol DL, 1997, MOL NEUROBIOL, V15, P307, DOI 10.1007/BF02740665; HAMA T, 1991, NEUROSCIENCE, V40, P445, DOI 10.1016/0306-4522(91)90132-8; Han YF, 2000, NEUROSCI LETT, V288, P95, DOI 10.1016/S0304-3940(00)01198-8; HARIRI RJ, 1994, BRAIN RES, V636, P139, DOI 10.1016/0006-8993(94)90188-0; Heesen M, 1996, ACTA NEUROCHIR, V138, P77, DOI 10.1007/BF01411728; Heyen JRR, 2000, MOL BRAIN RES, V77, P138, DOI 10.1016/S0169-328X(00)00042-5; HICKEY WF, 1988, SCIENCE, V239, P290, DOI 10.1126/science.3276004; Hoek RM, 2000, SCIENCE, V290, P1768, DOI 10.1126/science.290.5497.1768; HOPKINS SJ, 1995, TRENDS NEUROSCI, V18, P83; Keidar S, 2001, ARTERIOSCL THROM VAS, V21, P1464, DOI 10.1161/hq0901.095547; KENNEDY MK, 1992, J IMMUNOL, V149, P2496; KOSSMANN T, 1995, SHOCK, V4, P311, DOI 10.1097/00024382-199511000-00001; Kossmann T, 1996, BRAIN RES, V713, P143, DOI 10.1016/0006-8993(95)01501-9; Kreutzberg GW, 1996, TRENDS NEUROSCI, V19, P312, DOI 10.1016/0166-2236(96)10049-7; KUBY J, 1996, IMMUNOLOGY, P47; KUSHIMA Y, 1992, NEUROSCI RES, V13, P267, DOI 10.1016/0168-0102(92)90039-F; LaPlaca MC, 1997, J NEUROTRAUM, V14, P355, DOI 10.1089/neu.1997.14.355; Lemke R, 1998, J NEUROSCI RES, V51, P223, DOI 10.1002/(SICI)1097-4547(19980115)51:2<223::AID-JNR11>3.3.CO;2-Z; Liva SM, 1999, GLIA, V26, P344, DOI 10.1002/(SICI)1098-1136(199906)26:4<344::AID-GLIA8>3.0.CO;2-L; Lue LF, 2001, GLIA, V35, P72, DOI 10.1002/glia.1072; MADDEN KS, 1995, PHYSIOL REV, V75, P77, DOI 10.1152/physrev.1995.75.1.77; MAIMONE D, 1993, J NEUROIMMUNOL, V47, P73, DOI 10.1016/0165-5728(93)90286-8; Melillo G, 1996, J IMMUNOL, V157, P2638; Morrison B, 1998, J NEUROTRAUM, V15, P911, DOI 10.1089/neu.1998.15.911; NAVARRA P, 1991, ENDOCRINOLOGY, V128, P37, DOI 10.1210/endo-128-1-37; Neumann H, 2001, GLIA, V36, P191, DOI 10.1002/glia.1108; O'Keefe GM, 1999, EUR J IMMUNOL, V29, P1275, DOI 10.1002/(SICI)1521-4141(199904)29:04<1275::AID-IMMU1275>3.0.CO;2-T; Prechel MM, 2000, NEUROCHEM RES, V25, P357, DOI 10.1023/A:1007588903897; RIGHI M, 1989, EUR J IMMUNOL, V19, P1443, DOI 10.1002/eji.1830190815; Ringheim GE, 1995, J NEUROIMMUNOL, V63, P113, DOI 10.1016/0165-5728(95)00134-4; SAWADA M, 1992, BRAIN RES, V583, P296, DOI 10.1016/S0006-8993(10)80037-X; Shafer LL, 2002, NEUROIMMUNOMODULAT, V10, P283, DOI 10.1159/000069972; Smith ME, 1999, NEUROCHEM RES, V24, P261, DOI 10.1023/A:1022566121967; Staniek V, 1997, ARCH DERMATOL RES, V289, P285, DOI 10.1007/s004030050194; STREIT WJ, 1993, J CHEM NEUROANAT, V6, P261, DOI 10.1016/0891-0618(93)90047-8; Sudo S, 1998, EXP NEUROL, V154, P499, DOI 10.1006/exnr.1998.6911; Sugaya K, 1997, NEUROREPORT, V8, P2241, DOI 10.1097/00001756-199707070-00030; Van Wagoner NJ, 1999, J NEUROIMMUNOL, V100, P124, DOI 10.1016/S0165-5728(99)00187-3; WOODROOFE MN, 1991, J NEUROIMMUNOL, V33, P227, DOI 10.1016/0165-5728(91)90110-S; Zimmer J, 2000, AMINO ACIDS, V19, P7, DOI 10.1007/s007260070029	62	8	8	0	4	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	1021-7401	1423-0216		NEUROIMMUNOMODULAT	Neuroimmunomodulation		2002	10	5					295	304		10.1159/000069973			10	Endocrinology & Metabolism; Immunology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism; Immunology; Neurosciences & Neurology	681RR	WOS:000183049600005	12759566				2022-02-06	
J	Schlund, MW; Pace, GM; McGready, J				Schlund, MW; Pace, GM; McGready, J			Relations between decision-making deficits and discriminating contingencies following brain injury	BRAIN INJURY			English	Article							ANTICIPATORY BEHAVIOR DEFICITS; CLOSED-HEAD-INJURY; REINFORCEMENT CONTINGENCIES; PREFRONTAL CORTEX; LOBE LESIONS; ENVIRONMENT; SENSITIVITY; DAMAGE	Deficits in decision-making characterized by failures to respond adaptively to consequences that follow responding are common following brain injury. To examine decision-making about consequences, individuals with and without acquired brain injury responded under different response-reinforcer contingencies. In two control conditions, reinforcement was contingent on responding and response repetition. Results showed responding (pressing four computer keys) by both groups produced similar amounts of reinforcement (money) and highlight equal sensitivity to money as a reinforcer. In subsequent experimental conditions, reinforcement was contingent upon varying responses. Results showed both groups produced variable response patterns, but injured subjects earned less reinforcement than controls. With instructions to vary responding across trials, injured subjects earned similar amounts of reinforcement as controls. Collectively, the results suggest reductions in sensitivity to contingencies may be present following injury and function as one behavioural mechanism of maladaptive decision-making.	Kennedy Krieger Inst, Baltimore, MD 21224 USA; Johns Hopkins Univ, Sch Med, Baltimore, MD USA; May Inst, Norwood, MA USA; Northeastern Univ, Boston, MA 02115 USA; Johns Hopkins Univ, Sch Publ Hlth, Baltimore, MD 21218 USA		Schlund, MW (corresponding author), Kennedy Krieger Inst, 333 Cassell Dr,Triad Technol Bldg Suite 4200, Baltimore, MD 21224 USA.						Al-Adawi S, 1998, NEUROPSYCHOLOGY, V12, P115, DOI 10.1037/0894-4105.12.1.115; Baldo JV, 1998, NEUROPSYCHOLOGY, V12, P259, DOI 10.1037/0894-4105.12.2.259; Bechara A, 2000, BRAIN, V123, P2189, DOI 10.1093/brain/123.11.2189; BECHARA A, 1994, COGNITION, V50, P7, DOI 10.1016/0010-0277(94)90018-3; BLEIBERG J, 1985, INT J CLIN NEUROPSYC, V7, P153; CHANNON S, 1993, CORTEX, V29, P315, DOI 10.1016/S0010-9452(13)80184-0; CRITCHFIELD TS, 2000, EXPT ANAL HUMAN BEHA, V18, P15; Damasio A.R., 1993, CLIN NEUROPSYCHOLOGY, P409; FREEDMAN PE, 1987, J NEUROL NEUROSUR PS, V50, P398, DOI 10.1136/jnnp.50.4.398; HAYES SC, 1996, ADV PSYCHOL, P279; Heaton PDRK., 1993, WISCONSIN CARD SORTI; Hunziker MHL, 1996, J EXP ANAL BEHAV, V65, P129, DOI 10.1901/jeab.1996.65-129; JASON GW, 1985, NEUROPSYCHOLOGIA, V24, P463; KOSMIDIS MH, 1995, J CLIN EXP NEUROPSYC, V17, P622, DOI 10.1080/01688639508405150; Levine B, 1998, J INT NEUROPSYCH SOC, V4, P247, DOI 10.1017/S1355617798002471; Nabors NA, 1997, J HEAD TRAUMA REHAB, V12, P79, DOI 10.1097/00001199-199706000-00008; NEWLAND MC, 1994, TOXICOL APPL PHARM, V126, P6, DOI 10.1006/taap.1994.1084; *NO CA NEUR GROUP, 1995, MAN COGN; Odum AL, 2000, J EXP ANAL BEHAV, V74, P229, DOI 10.1901/jeab.2000.74-229; Reitan R., 1979, MANUAL ADM NEUROPSYC; ROLLS ET, 1994, J NEUROL NEUROSUR PS, V57, P1518, DOI 10.1136/jnnp.57.12.1518; Schlund MW, 1999, BRAIN INJURY, V13, P889; Schlund MW, 2000, BRAIN INJURY, V14, P573, DOI 10.1080/026990500120475; Schlund MW, 2000, BEHAV INTERVENT, V15, P155, DOI 10.1002/1099-078X(200007/09)15:3<155::AID-BIN53>3.0.CO;2-F; SCHLUND MW, IN PRESS BRAIN INJUR; SHALLICE T, 1993, ATTENTION SELECTION, P00171; Skinner BF, 1938, BEHAV ORGANISMS; *STAT U NEW YORK B, 1993, GUID UN DAT SET MED; WEBB PM, 1994, REHABIL PSYCHOL, V39, P179, DOI 10.1037/h0080321	29	8	8	1	4	TAYLOR & FRANCIS LTD	LONDON	11 NEW FETTER LANE, LONDON EC4P 4EE, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.	DEC	2001	15	12					1061	1071		10.1080/02699050110086887			11	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	493CM	WOS:000172204500005	11712952				2022-02-06	
J	Fluharty, G; Glassman, N				Fluharty, G; Glassman, N			Use of antecedent control to improve the outcome of rehabilitation for a client with frontal lobe injury and intolerance for auditory and tactile stimuli	BRAIN INJURY			English	Article							ACOUSTIC HYPERESTHESIA; BRAIN-INJURY; BEHAVIOR	KM, a single 23-year-old male, sustained a severe traumatic brain injury in a motor vehicle accident. Aggressive and uncooperative behaviour, resulting from the client's cognitive deficits and hypersensitivity to stimuli, made him unmanageable in a subacute rehabilitation setting. Minimizing sources of agitation reduced the client's outbursts and facilitated the completion of functional tasks, such as bathing and dressing. Modifying his environment also increased the client's participation in social and leisure activities. These changes improved the outcome of the client's rehabilitation.	Sacred Heart Rehabil Inst, Milwaukee, WI USA; St Marys Nursing Home, Brain Injury Subacute Unit, Milwaukee, WI USA		Fluharty, G (corresponding author), 3302 N Humboldt Blvd, Milwaukee, WI 53212 USA.						Ayres A. J., 1972, SENSORY INTEGRATION; Baranek GT, 1997, AM J OCCUP THER, V51, P91, DOI 10.5014/ajot.51.2.91; Benton A., 1978, MULTILINGUAL APHASIA; BOHNEN N, 1991, J NEUROL, V238, P443, DOI 10.1007/BF00314651; BOHNEN N, 1992, J NEUROL NEUROSUR PS, V55, P222, DOI 10.1136/jnnp.55.3.222; BOHNEN N, 1991, BRIT J PSYCHIAT, V159, P860, DOI 10.1192/bjp.159.6.860; Brookshire R. H., 1993, DISCOURSE COMPREHENS; FISSHER AG, 1991, SENSORY INTEGRATION; Fluharty G, 1997, NEUROREHABILITATION, V9, P221, DOI 10.3233/NRE-1997-9307; Fugate LP, 1997, ARCH PHYS MED REHAB, V78, P917, DOI 10.1016/S0003-9993(97)90050-2; Goodglass H, 1983, ASSESSMENT APHASIA R; Hart T, 1993, J HEAD TRAUMA REHAB, V8, P1; KNICKERBOCKER BM, 1980, HOLISTIC APPROACH LE; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; Lezak MD., 1995, NEUROPSYCHOLOGICAL A, V3rd; OMALLEY PJ, 1977, DEV MED CHILD NEUROL, V19, P172; Shintani S, 1998, NEUROLOGY, V51, P297, DOI 10.1212/WNL.51.1.297; Sohlberg M.M., 1989, INTRO COGNITIVE REHA; Stedman Thomas Lathrop, 2000, STEDMANS MED DICT; ULATOWSKA HK, 1983, BRAIN LANG, V18, P315, DOI 10.1016/0093-934X(83)90023-8; Vaughan N, 1997, BRAIN INJURY, V11, P815, DOI 10.1080/026990597123025; Wilson B.A., 1985, RIVERMEAD BEHAV MEMO; Wolfensberger W., 1972, PRINCIPLE NORMALIZAT; Ylvisaker Mark, 1996, Seminars in Speech and Language, V17, P217, DOI 10.1055/s-2008-1064100; Yuen HK, 1996, BRAIN INJURY, V10, P229, DOI 10.1080/026990596124548; Zencius A H, 1989, Brain Inj, V3, P199, DOI 10.3109/02699058909004553	26	8	8	0	0	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	NOV	2001	15	11					995	1002		10.1080/02699050010025795			8	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	490VF	WOS:000172073900006	11689097				2022-02-06	
J	Prueter, C; Schiefer, J; Norra, C; Podoll, K; Sass, H				Prueter, C; Schiefer, J; Norra, C; Podoll, K; Sass, H			Ping-pong gaze in combined intoxication with tranylcypromine, thioridazine, and clomipramine	NEUROPSYCHIATRY NEUROPSYCHOLOGY AND BEHAVIORAL NEUROLOGY			English	Article							MONOAMINE-OXIDASE INHIBITOR; PERIODIC ALTERNATING GAZE; OVERDOSE	Objective: This paper reports the occurrence of ping-pong gaze, a neuro-ophthalmological syndrome usually related to severe structural brain damage, in a patient intoxicated with tranylcypromine, thioridazine, and clomipramine. Background: Although there have been some reports about the occurence of Ping-pong gaze after intoxications. it is usually related to severe bilateral hemispheric brain damage following stroke or traumatic injuries. Method: We report the case of a 56-year old woman who developed a neurotoxic syndrome with coma, hyperthermia, muscular rigidity, myoclonic jerks and tachycardia following an intoxication. Additionally rhythmic and pendular conjugate horizontal eye movements could be observed for three days, so that the diagnosis of ping-pong gaze was made. Results: A treatment with dantrolene lead to complete remission of the neurotoxic syndrome with no signs of neurological or physical deficits. At the stage of regaining consciousness the eve movements became normal. Conclusion: In our case the combined intoxication with an monoamine oxidase inhibitor, a neuroleptic and a tricyclic agent lead to a neurotoxic syndrome and the occurrence of a rare neuro-ophthalmological syndrome usually related to bilateral hemispheric brain dysfunction.	Rhein Westfal TH Aachen, RWTH, Dept Psychiat & Psychotherapy, D-52074 Aachen, Germany; Rhein Westfal TH Aachen, RWTH, Dept Neurol, D-52074 Aachen, Germany		Prueter, C (corresponding author), Rhein Westfal TH Aachen, RWTH, Dept Psychiat & Psychotherapy, Pauwelsstr 30, D-52074 Aachen, Germany.						CHATTERJEE A, 1995, J CLIN PSYCHOPHARM, V15, P143, DOI 10.1097/00004714-199504000-00013; COULTER C, 1971, ANAESTHESIA, V26, P500, DOI 10.1111/j.1365-2044.1971.tb04828.x; CRAMON DV, 1977, ARCH PSYCHIAT NERVEN, V224, P247; CREVITS L, 1992, NEURO-OPHTHALMOLOGY, V12, P121, DOI 10.3109/01658109209058127; Erich Jennifer L., 1995, Journal of Emergency Medicine, V13, P653, DOI 10.1016/0736-4679(95)00072-I; Fink M, 1996, PHARMACOPSYCHIATRY, V29, P159; FISHER CM, 1967, J NEUROL NEUROSUR PS, V30, P383, DOI 10.1136/jnnp.30.5.383; ISHIKAWA H, 1993, NEUROLOGY, V43, P1067, DOI 10.1212/WNL.43.6.1067; Johkura K, 1998, J NEURO-OPHTHALMOL, V18, P43; MADHUMATI M, 1994, INDIAN J OPHTHALMOL, V41, P212; ROBERTSON JC, 1972, POSTGRAD MED J, V48, P64, DOI 10.1136/pgmj.48.555.64; SENELICK RC, 1976, NEUROLOGY, V26, P532, DOI 10.1212/WNL.26.6.532; STEWART JD, 1979, NEUROLOGY, V29, P222, DOI 10.1212/WNL.29.2.222; Thorp M, 1997, WESTERN J MED, V166, P275; WATKINS HC, 1989, J NEUROL NEUROSUR PS, V52, P539, DOI 10.1136/jnnp.52.4.539	15	8	8	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0894-878X			NEUROPSY NEUROPSY BE	Neuropsychiatr. Neuropsychol. Behav. Neurol.	OCT-DEC	2001	14	4					246	247					2	Clinical Neurology; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry; Psychology	491QF	WOS:000172119300008	11725219				2022-02-06	
J	Hoffmann, ME; Ma, OJ; Gaddis, G				Hoffmann, ME; Ma, OJ; Gaddis, G			Utility of an initial D-dimer assay in screening for traumatic or spontaneous intracranial hemorrhage	ACADEMIC EMERGENCY MEDICINE			English	Article; Proceedings Paper	SAEM Annual Meeting	MAY, 2000	SAN FRANCISCO, CA	SAEM		D-dimer assay; intracranial hemorrhage; computed tomography; head injury	S-100 PROTEIN MEASUREMENTS; BRAIN-DAMAGE; HEAD-INJURY; COAGULATION; MARKERS	Objective: To evaluate the sensitivity of a D-dimer assay as a screening tool for possible traumatic or spontaneous intracranial hemorrhage. If adequately sensitive, the D-dimer assay may potentially permit omission of a more expensive computed tomography (CT) scan of the head when such hemorrhage is clinically suspected. Methods: Prospective, consecutive, blinded study of patients (age > 16 years) requiring a CT scan of the head for suspected intracranial hemorrhage over a five-month period at a university, Level I trauma center. All study patients had a serum D-dimer assay obtained prior to their CT scans. Sensitivity and specificity, with 95% confidence intervals (95% CIs), of the enzyme-linked immunosorbent assay (ELISA) D-dimer assay for the detection of intracranial hemorrhage were calculated. Results: Of the 319 patients entered in the study, 25 (7.8%) had a CT scan positive for intracranial hemorrhage. Patients with intracranial hemorrhage were more likely to have a positive D-dimer assay (chi-square = 13.075, p < 0.001). The D-dimer assay had 21 true-positive and four false-negative tests, resulting in a sensitivity of 84.0% (95% CI 63.7% to 95.5%) and a specificity of 55.8% (95% CI 55.5% to 55.9%). The four false-negative cases included one small intraparenchymal hemorrhage, one small subarachnoid hemorrhage, one moderate-sized intraparenchymal. hemorrhage with mid-line shift, and one large subdural hematoma requiring emergent surgery. Conclusions: Due to the catastrophic nature of missing an intracranial hemorrhage in the emergency department, the D-dimer assay is not adequately sensitive or predictive to use as a screening tool to allow routine omission of head CT scanning.	Univ Missouri, Sch Med, St Lukes Hosp, Dept Emergency Med, Kansas City, MO 64108 USA; Univ Missouri, Sch Med, Truman Med Ctr, Dept Emergency Med, Kansas City, MO 64108 USA		Hoffmann, ME (corresponding author), 7092 SE 43rd Ave, St Cloud, MN 56304 USA.	crazydiamond@aol.com					Becker S, 1999, EUR J PEDIATR, V158, pS197, DOI 10.1007/PL00014355; BICK RL, 1992, THROMB RES, V65, P785, DOI 10.1016/0049-3848(92)90116-R; BREDBACKA S, 1994, J NEUROSURG ANESTH, V6, P75; BROTT T, 1986, STROKE, V17, P1078, DOI 10.1161/01.STR.17.6.1078; de Maat MPM, 2000, SEMIN THROMB HEMOST, V26, P625; Gando S, 1999, J TRAUMA, V46, P1070, DOI 10.1097/00005373-199906000-00018; Germano A, 2000, ACTA NEUROCHIR, V142, P575, DOI 10.1007/s007010050472; Glantz SA, 1992, PRIMER BIOSTATISTICS; Herrmann M, 2000, J NEUROTRAUM, V17, P113, DOI 10.1089/neu.2000.17.113; Hulka F, 1996, ARCH SURG-CHICAGO, V131, P923; Ingebrigtsen T, 1999, NEUROSURGERY, V45, P468, DOI 10.1097/00006123-199909000-00010; JOHSHITA H, 1990, STROKE, V21, P1051, DOI 10.1161/01.STR.21.7.1051; KALSBEEK WD, 1980, J NEUROSURG, V53, pS19; KEARNEY TJ, 1992, J TRAUMA, V32, P608, DOI 10.1097/00005373-199205000-00012; OLSON JD, 1989, NEUROSURGERY, V24, P825, DOI 10.1227/00006123-198906000-00007; Raabe A, 1999, BRIT J NEUROSURG, V13, P56, DOI 10.1080/02688699944195; Raabe A, 1998, ACTA NEUROCHIR, V140, P787, DOI 10.1007/s007010050180; Raabe A, 1999, NEUROSURGERY, V45, P477, DOI 10.1097/00006123-199909000-00012; Romner B, 2000, J NEUROTRAUM, V17, P641, DOI 10.1089/089771500415391; Rothoerl RD, 1998, J TRAUMA, V45, P765, DOI 10.1097/00005373-199810000-00025; Scherer RU, 1998, CRIT CARE MED, V26, P149, DOI 10.1097/00003246-199801000-00031; STEIN SC, 1992, NEUROSURGERY, V30, P160, DOI 10.1227/00006123-199202000-00002; Takahashi H, 1997, J NEUROSURG, V86, P768, DOI 10.3171/jns.1997.86.5.0768; TROJANOWSKI T, 1982, ACTA NEUROCHIR, V60, P45, DOI 10.1007/BF01401749; van der Graaf F, 2000, THROMB HAEMOSTASIS, V83, P191; Woertgen C, 1999, J TRAUMA, V47, P1126, DOI 10.1097/00005373-199912000-00026	26	8	8	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1069-6563	1553-2712		ACAD EMERG MED	Acad. Emerg. Med.	SEP	2001	8	9					859	865		10.1111/j.1553-2712.2001.tb01145.x			7	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Emergency Medicine	469XK	WOS:000170841200001	11535477				2022-02-06	
J	Brouwer, W; Verzendaal, M; van der Naalt, J; Smit, J; van Zomeren, E				Brouwer, W; Verzendaal, M; van der Naalt, J; Smit, J; van Zomeren, E			Divided attention years after severe closed head injury: The effect of dependencies between the subtasks	BRAIN AND COGNITION			English	Article; Proceedings Paper	11th Annual Meeting on Theoretical and Experimental Neuropsychology	JUN 15-17, 2000	MONTREAL, CANADA	Univ Quebec, Montreal, Minist Rech, Sci & Technol, Quebec, Med Res Council, Ottawa				Lesions of white matter which connects distant brain areas are characteristic for closed head injury (CHI). It was predicted that this impairs divided attention only if dependent subtasks are used which require communication between corresponding brain processes. Fourteen chronic severe CHI patients (mean age 42 years) and 14 healthy controls, matched on age, gender, and education, participated in an experiment on divided attention. A typical left hemisphere task and a typical right hemisphere task must be simultaneously performed in a condition where they are completely independent and in conditions with dependencies between the tasks. Only in the dependent conditions the CHI group showed poor divided attention performance. (C) 2001 Academic Press.	Univ Groningen, Dept Psychol, NL-9712 TS Groningen, Netherlands; Univ Groningen, Dept Neurol, NL-9712 TS Groningen, Netherlands		Brouwer, W (corresponding author), Univ Groningen, Dept Psychol, Grote Kruisstr 2-1, NL-9712 TS Groningen, Netherlands.			van der Naalt, Joukje/0000-0001-9873-2418			BROUWER WH, 1989, CORTEX, V25, P219, DOI 10.1016/S0010-9452(89)80038-3; STRICH SJ, 1961, LANCET, V2, P443; Veltman JC, 1996, NEUROPSYCHOLOGY, V10, P357, DOI 10.1037/0894-4105.10.3.357; VUILLEUMIER P, 1995, CLIN NEUROL NEUROSUR, V97, P39, DOI 10.1016/0303-8467(94)00056-C; WICKENS C. D., 1984, VARIETIES ATTENTION, P63	5	8	8	0	1	ACADEMIC PRESS INC	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0278-2626			BRAIN COGNITION	Brain Cogn.	JUN-JUL	2001	46	1-2					54	56		10.1016/S0278-2626(01)80033-6			3	Neurosciences; Psychology, Experimental	Conference Proceedings Citation Index - Science (CPCI-S); Conference Proceedings Citation Index - Social Science &amp; Humanities (CPCI-SSH); Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	436JT	WOS:000168933300031	11527363				2022-02-06	
J	Marin, R				Marin, R			Physical medicine and rehabilitation in the military: The Bosnian mass casualty experience	MILITARY MEDICINE			English	Article							WARFARE	On February 5, 1994, a 120-mm. mortar shell crashed into the main Market Square of Sarajevo, Bosnia. The explosion killed 66 and injured 206. The United States evacuated 71 of the injured to Landstuhl Regional Medical Center, where the Physical Medicine and Rehabilitation Service evaluated 28 victims. This mass casualty evacuation underscores the role of Army physiatrists in humanitarian assistance and wartime casualty management. The author collected data regarding demographic factors, injury types, complications, and functional limitations. Seventeen of the 28 patients evaluated were injured during the market bombing, with the rest being injured before the bombing. Of 132 diagnoses in these 28 patients, 31 were fractures, 14 were amputations, 8 were peripheral neuropathies, 3 were spinal cord injuries, and 1 was a traumatic brain injury. Contractures and decubitus ulcers, both complications of immobility, accounted for 18 of the diagnoses. Ambulatory impairments were present in all of the patients, and 4 patients had major impairments in activities of daily living.	Walter Reed Army Inst Res, Mil Casualty Res Div, Washington, DC 20307 USA		Marin, R (corresponding author), Walter Reed Army Inst Res, Mil Casualty Res Div, Washington, DC 20307 USA.						APTAKER RL, 1994, ARCH PHYS MED REHAB, V75, P80; BELLAMY RF, 1984, MIL MED, V149, P55; BELLAMY RF, 1990, TXB MILITARY MED 1, V5, P62; BRAY T, 1985, JAMA-J AM MED ASSOC, V254, P2452, DOI 10.1001/jama.254.17.2452; BROWN PW, 1970, J BONE JOINT SURG AM, VA 52, P687, DOI 10.2106/00004623-197052040-00003; BUNNELL S, 1955, HAND SURG; DILLINGHAM TR, 1993, AM J PHYS MED REHAB, V72, P214, DOI 10.1097/00002060-199308000-00008; DILLINGHAM TR, 1998, TXB MILITARY MED REH, V1; GARFIELD RM, 1991, JAMA-J AM MED ASSOC, V266, P688, DOI 10.1001/jama.266.5.688; GREATHOUSE DG, 1998, TXB MILITARY MED REH, V1, P19; GROSWASSER Z, 1985, ISRAEL J MED SCI, V21, P957; HARDAWAY RM, 1978, J TRAUMA, V18, P635, DOI 10.1097/00005373-197809000-00004; HARTWICK AM, 1993, ARMY MED SPECIALIST; Haywood BG, 1999, MIL MED, V164, P319, DOI 10.1093/milmed/164.5.319; HERTZMAN CA, 1968, AMER J PHYSICAL MED, V47, P113; Rusk H A, 1969, Arch Phys Med Rehabil, V50, P463; SCHWAB K, 1993, NEUROLOGY, V43, P95, DOI 10.1212/WNL.43.1_Part_1.95; *SPEC EXH COMM PHY, 1946, ARCH PHYS MED REHAB, V27, P491; STRICKLAND B A Jr, 1947, Arch Phys Med Rehabil, V28, P229; WEBB SB, 1978, PARAPLEGIA, V15, P311, DOI 10.1038/sc.1977.47	20	8	8	0	0	ASSN MILITARY SURG US	BETHESDA	9320 OLD GEORGETOWN RD, BETHESDA, MD 20814 USA	0026-4075			MIL MED	Milit. Med.	APR	2001	166	4					335	337		10.1093/milmed/166.4.335			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	653CZ	WOS:000181418800012	11315475				2022-02-06	
J	Ohta, M; Matsuno, H				Ohta, M; Matsuno, H			Proximal ma false aneurysm after head trauma - Case report	NEUROLOGIA MEDICO-CHIRURGICA			English	Article						false aneurysm; head injury; subarachnoid hemorrhage; cerebral hematoma; middle cerebral artery		A 72-year-old male presented with a post-traumatic false aneurysm of the right proximal Mt artery with massive subarachnoid hemorrhage after closed head injury. Serial computed tomography (CT) and angiography showed the development of the aneurysm which was verified at autopsy. He was admitted in a drowsy state just after a motorcycle accident. Initial brain CT showed subarachnoid hemorrhage without skull fracture. Follow-up brain CT showed a huge hematoma in the right temporal lobe. He died 47 hours after the accident. Histological examination of the aneurysm showed a false aneurysm. Delayed diagnosis of traumatic aneurysms leads to high mortality, so early surgical treatment is essential to save such patients.	Kyushu Rosai Hosp, Dept Neurosurg, Minami Ku, Kitakyushu, Fukuoka 8000296, Japan; Saga Prefectural Hosp, Dept Neurosurg, Saga, Japan		Ohta, M (corresponding author), Kyushu Rosai Hosp, Dept Neurosurg, Minami Ku, 1-3-1 Takamatsu, Kitakyushu, Fukuoka 8000296, Japan.						BENOIT BG, 1973, J NEUROL NEUROSUR PS, V36, P127, DOI 10.1136/jnnp.36.1.127; BURTON C, 1968, J NEUROSURG, V28, P468, DOI 10.3171/jns.1968.28.5.0468; FLEISCHER A S, 1975, Surgical Neurology, V4, P233; HANDA J, 1970, AMER J ROENTGENOL RA, V109, P127, DOI 10.2214/ajr.109.1.127; Kamijo Y, 1968, No To Shinkei, V20, P965; PARKINSON D, 1980, J NEUROSURG, V52, P11, DOI 10.3171/jns.1980.52.1.0011; RAIMONDI AJ, 1968, NEUROCHIRURGIA, V11, P219; RUMBAUGH CL, 1970, RADIOLOGY, V96, P49, DOI 10.1148/96.1.49; SMITH DR, 1970, J NEUROSURG, V32, P357, DOI 10.3171/jns.1970.32.3.0357; Tsubokawa T, 1975, No Shinkei Geka, V3, P663	10	8	9	0	1	JAPAN NEUROSURGICAL SOC	TOKYO	C/O AKAMON-MAE IWATA BLDG, 5-27-8 HONGO, BUNKYO-KU, TOKYO, 113-0033, JAPAN	0387-2572			NEUROL MED-CHIR	Neurol. Med.-Chir.	MAR	2001	41	3					131	134		10.2176/nmc.41.131			4	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	412LG	WOS:000167555600014	11372556	Bronze			2022-02-06	
J	Vaughn, SL; King, A				Vaughn, SL; King, A			A survey of state programs to finance rehabilitation and community services for individuals with brain injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						designated state agency; eligibility; services; state appropriations; state programs; trust funds		This article will review and compare existing state-funded programs and their approaches to financing, administering, and delivering an array of services, including rehabilitation and home and community-based services and supports to individuals with traumatic brain injury (TBI) and their families. A state-by-state chart provides funding and operational characteristics of the programs. The state menu of services provided and how they are delivered are also described. The article addresses how these programs fit within their overall state service delivery system, trends and changes that programs may be undergoing, and the influences that shape these programs.	Missouri Off Adm, Missouri Head Injury Advisory Council, Div Gen Serv, Jefferson City, MO USA; N Carolina Div Mental Hlth Dev Disabil & Subst Ab, Dev Disabil Sect, Raleigh, NC USA		Vaughn, SL (corresponding author), Missouri Off Adm, Missouri Head Injury Advisory Council, Div Gen Serv, Jefferson City, MO USA.						*BRAIN INJ ASS INC, 2000, PUBL SPEND TRAUM BRA; DIGRE PG, 1994, J HEAD TRAUMA REHAB, V9, P12; *NAT C STAT LEG, 1993, WHAT LEG NEED KNOW T; 1998, GAOHEHS9855	4	8	8	0	0	ASPEN PUBL INC	GAITHERSBURG	200 ORCHARD RIDGE DR, STE 200, GAITHERSBURG, MD 20878 USA	0885-9701			J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	FEB	2001	16	1					20	33		10.1097/00001199-200102000-00005			14	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	403ZC	WOS:000167072100007	11277848				2022-02-06	
J	Barisa, MT; Barisa, MW				Barisa, MT; Barisa, MW			Neuropsychological evaluation applied to vocational rehabilitation	NEUROREHABILITATION			English	Article						neuropsychological evaluation; vocational rehabilitation; vocational evaluation; neurological injury; traumatic brain injury		On the surface, the use of neuropsychological evaluation to guide vocational rehabilitation does not appear controversial. However, complexities and discrepancies emerge when traditional uses of neuropsychological evaluation are reviewed and compared to the needs of vocational rehabilitation counselors. This article highlights differences in focus between traditional neuropsychological evaluations and vocational evaluations. It identifies ways to effectively merge them so that neuropsychological evaluations for vocational rehabilitation are mutually beneficial to neuropsychologists and vocational rehabilitation counselors.	Mem Med Ctr, Ctr Neuromuscular Sci, Springfield, IL 62781 USA		Barisa, MT (corresponding author), Mem Med Ctr, Ctr Neuromuscular Sci, 701 N 1st, Springfield, IL 62781 USA.	barisa.mark@mhsil.com					BENYISHAY Y, 1986, ROLE CLIN NEUROPSYCH; Brooks N, 1987, Brain Inj, V1, P5, DOI 10.3109/02699058709034439; Guilmette T J, 1990, Arch Clin Neuropsychol, V5, P373, DOI 10.1016/0887-6177(90)90016-I; *NATL CTR INJ PREV, 2000, EP TRAUM BRAIN INJ U; POWER P, 1984, GUIDE VOCATIONAL ASS; ROBERTS R, 1992, HDB HEAD TRAUMA ACUT, P371; Sbordone RJ, 1999, STUD NEUROPSYCHOL DE, P227	7	8	8	2	3	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135	1878-6448		NEUROREHABILITATION	Neurorehabilitation		2001	16	4					289	293					5	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	521VC	WOS:000173861200014	11790916				2022-02-06	
J	Maria, MPS; Martin, JA; Morrow, CM; Gouvier, WD				Maria, MPS; Martin, JA; Morrow, CM; Gouvier, WD			On the duration of spatial fluency measures	INTERNATIONAL JOURNAL OF NEUROSCIENCE			English	Article						spatial fluency; reliability; frontal lobes; traumatic brain injury; base rates		Various measures of spatial fluency have been developed and have been shown to be sensitive ru right Frontal lobe dysfunction. Patients with diffuse cerebral injuries (traumatic brain injury) also show impaired performance. Administration times for these tests range from three to five minutes. It is well known that longer tests provide more reliable data. In the present study. the base rates of unique designs and perseverative errors on the Five-point Test were examined minute-by-minute For ten minutes, in a sample of healthy young adults (n = 80). Contrasts between each minute showed significant decreases in number of unique designs to the ninth minute (significant at p <.001). Contrasts between each minute revealed significant increases (significant at p <.001) in percentage of perseverative errors to the eighth minute. Data demonstrating the progressive decrease of unique designs and progressive increase of perseverative errors as a function of time have important implications for clinical practice. Optimal administration rime is considered in the context of clinicians' objectives.	Louisiana State Univ, Dept Psychol, Baton Rouge, LA 70803 USA; SE Louisiana Univ, Dept Psychol, Hammond, LA 70402 USA		Maria, MPS (corresponding author), Louisiana State Univ, Dept Psychol, Baton Rouge, LA 70803 USA.						JONESGOTMAN M, 1977, NEUROPSYCHOLOGIA, V15, P653, DOI 10.1016/0028-3932(77)90070-7; Lee H, 1997, INT J ONCOL, V11, P965; REGARD M, 1982, PERCEPT MOTOR SKILL, V55, P839, DOI 10.2466/pms.1982.55.3.839; RISSER AH, 1996, J INT NEUROPSYCH SOC, V2, P3; RUFF RM, 1987, DEV NEUROPSYCHOL, V3, P37, DOI 10.1080/87565648709540362; Walker HM, 1953, STAT INFERENCE	6	8	8	0	0	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0020-7454	1563-5279		INT J NEUROSCI	Int. J. Neurosci.		2001	106	3-4					125	130		10.3109/00207450109149743			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	420MQ	WOS:000168009100001	11264914				2022-02-06	
J	McQuatt, A; Sleeman, D; Andrews, PJD; Corruble, V; Jones, PA				McQuatt, A; Sleeman, D; Andrews, PJD; Corruble, V; Jones, PA			Discussing anomalous situations using decision trees: A head injury case study	METHODS OF INFORMATION IN MEDICINE			English	Article						anomalies; decision tree analysis; demographic data; traumatic brain injuries; temporal/physiological data		Objectives. Predicting the outcome of seriously ill patients is a challenging problem for clinicians. Methods: One alternative to clinical trials is to analyse existing patient data in an attempt to predict the. several outcomes, and to suggest therapies. In this paper we use decision tree techniques to predict the outcome of head injury patients. The work is based on patient data from the Edinburgh Royal Infirmary which contains both background (demographic) data and temporal (Physiological) data. Results. The focus of this paper is the discussion of The anomalous cases in the decision trees with the domain experts (the clinicians). Conclusions: These analyses led to the detection of several situations where both the data analysis and patient data collection should be enhanced, which in turn should lead to improved patient care.	Univ Aberdeen, Dept Comp Sci, Aberdeen AB24 3UE, Scotland; Western Gen Hosp, Dept Clin Neurosci, Edinburgh EH4 2XU, Midlothian, Scotland		Sleeman, D (corresponding author), Univ Aberdeen, Dept Comp Sci, Aberdeen AB24 3UE, Scotland.						Breiman L., 1984, CLASSIFICATION REGRE; CHOI SC, 1991, J NEUROSURG, V75, P251, DOI 10.3171/jns.1991.75.2.0251; GERSTENBRAND F, 1990, NEUROLOGIA, V39, P71; JENNETT B, 1975, LANCET, V1, P480; JONES KC, 1994, J HOME HLTH CARE PRA, V6, P1; MCQUATT A, 1999, THESIS U ABERDEEN; MLADENIC D, 1990, THESIS U LJUBLJANA S; PILIH IA, 1997, INTELLIGENT DATA ANA; Quinlan J. R., 1986, Machine Learning, V1, P81, DOI 10.1023/A:1022643204877; Quinlan J.R., 2014, C4 5 PROGRAMS MACHIN; Quinlan John Ross, 1990, MACHINE LEARNING ART, P5; QUINLAN JR, 1997, DATA MINING TOOLS C5; TEASDALE G, 1974, LANCET, V2, P81	13	8	8	0	0	F K SCHATTAUER VERLAG GMBH	STUTTGART	P O BOX 10 45 43, LENZHALDE 3, D-70040 STUTTGART, GERMANY	0026-1270			METHOD INFORM MED	Methods Inf. Med.		2001	40	5					373	379		10.1055/s-0038-1634195			7	Computer Science, Information Systems; Health Care Sciences & Services; Medical Informatics	Science Citation Index Expanded (SCI-EXPANDED)	Computer Science; Health Care Sciences & Services; Medical Informatics	501EJ	WOS:000172654200003	11776734				2022-02-06	
J	Walski, M; Gajkowska, B				Walski, M; Gajkowska, B			The changes in the ultrastructure of the cerebrovascular junction after traumatic injury of the cerebral cortex in rats	NEUROENDOCRINOLOGY LETTERS			English	Article						cerebrovascular junction; trauma; brain macrophages; apoptosis	BLOOD-BRAIN-BARRIER; NERVOUS-SYSTEM; CARDIAC-ARREST; MICROGLIA; CELL; DAMAGE; PROLIFERATION; MACROPHAGES; EXPRESSION; MECHANISMS	OBJECTIVES: The effect of the traumatic injury of the cerebral cortex on the ultrastructure of the cerebrovascular junction was studied in rats. The aim of the present study is to describe the ultrastructural alterations in the cerebrovascular junction in rat cerebral cortex after traumatic injury. We were particularly interested in the alterations in endothelium, pericytes and the differentiated population of cerebral macrophages. MATERIAL AND METHODS: The observations were conducted four days (group I-five animals) and seven days (group II-five animals) after induction of cortical trauma. Traumatic injury was induced in the fronto-temporal region of cerebral cortex in general anesthesia with 20 mg/kg ketamine hydrochloride. RESULTS: In the first group we found the features of damage of the blood-brain barrier and migration of the morphological blood components to the perivascular space. The trauma caused necrosis and apoptosis within brain tissue. An important observation was the presence of numerous brain macrophages that participated in phagocytosis of damaged cellular elements. Additionally, we found an increase in the connective tissue ground substance around brain capillaries. In the second experimental group we noted an increased number of pericytes (1-3) near capillary walls. In some instances, the basement membrane surrounding the pericytes was interrupted and these cells were also located beyond the rim of the vessel wall. Some pericytes showed numerous phagolysosomes indicating that these cells belonged to perivascular macrophages. Moreover, we observed a population of phagocytes residing in dose contact with neurons. These cells were different from the typical perivascular macrophages. CONCLUSIONS: These observations indicate that the traumatic injury of the brain results in mobilization of a heterogeneous population of brain macrophages. This study indicates that different subpopulations of macrophages emerge in the region of traumatic brain damage, and that the morphology and dynamics of these phagocytes changes and depends on the time elapsed after the initial traumatic incident.	Polish Acad Sci, Med Res Ctr, Lab Cell Ultrastruct, PL-02106 Warsaw, Poland		Walski, M (corresponding author), Polish Acad Sci, Med Res Ctr, Lab Cell Ultrastruct, Pawinski ST 5, PL-02106 Warsaw, Poland.	puun@cmdik.pan.pl					Akins PT, 1996, STROKE, V27, P1682, DOI 10.1161/01.STR.27.9.1682; Alliot F, 1999, DEV BRAIN RES, V117, P145, DOI 10.1016/S0165-3806(99)00113-3; Allport JR, 1997, J EXP MED, V186, P517, DOI 10.1084/jem.186.4.517; Andjelkovic AV, 1998, BRAIN RES, V814, P13, DOI 10.1016/S0006-8993(98)00830-0; Berger R, 1999, BRAIN RES REV, V30, P107, DOI 10.1016/S0165-0173(99)00009-0; Bolton SJ, 1998, NEUROSCIENCE, V86, P1245, DOI 10.1016/S0306-4522(98)00058-X; CACERES MJ, 1995, ACTA NEUROPATHOL, V90, P582, DOI 10.1007/BF00318570; CAVEDA L, 1994, ENDOTHELIUM, V2, P1; Fujita T, 1998, ACTA NEUROCHIR, V140, P275, DOI 10.1007/s007010050095; GEHRMANN J, 1995, BRAIN RES REV, V20, P269, DOI 10.1016/0165-0173(94)00015-H; GIORDANA MT, 1994, NEUROPATH APPL NEURO, V20, P163, DOI 10.1111/j.1365-2990.1994.tb01175.x; Gonzalez-Scarano F, 1999, ANNU REV NEUROSCI, V22, P219, DOI 10.1146/annurev.neuro.22.1.219; Grzybicki D, 1998, ACTA NEUROPATHOL, V95, P98, DOI 10.1007/s004010050770; Jensen MB, 1997, EXP NEUROL, V143, P103, DOI 10.1006/exnr.1996.6337; Lipton P, 1999, PHYSIOL REV, V79, P1431, DOI 10.1152/physrev.1999.79.4.1431; Merrill JE, 1996, TRENDS NEUROSCI, V19, P331, DOI 10.1016/0166-2236(96)10047-3; MIES G, 1997, MATURATION PHENOMENO, V2, P43; MIGHELI A, 1994, J NEUROPATH EXP NEUR, V53, P606, DOI 10.1097/00005072-199411000-00008; Nijhawan D, 2000, ANNU REV NEUROSCI, V23, P73, DOI 10.1146/annurev.neuro.23.1.73; Oehmichen M, 1999, ACTA NEUROPATHOL, V97, P491, DOI 10.1007/s004010051018; Rubin LL, 1999, ANNU REV NEUROSCI, V22, P11, DOI 10.1146/annurev.neuro.22.1.11; Siesjo BK, 1999, ACTA NEUROCHIR SUPPL, V73, P7; SIMS DE, 1991, CAN J CARDIOL, V7, P431; Sundberg C, 1996, LAB INVEST, V74, P452; Thomas WE, 1999, BRAIN RES REV, V31, P42, DOI 10.1016/S0165-0173(99)00024-7; VENSTROM KA, 1993, FASEB J, V7, P996, DOI 10.1096/fasebj.7.11.8370483; Walski M, 1997, J INVEST DERMATOL, V109, P479; Walski M, 1993, J Hirnforsch, V34, P503; Walski M, 1998, J BRAIN RES, V39, P183; Zagzag D, 2000, LAB INVEST, V80, P837, DOI 10.1038/labinvest.3780088; Ziaja M, 1999, J NEUROSCI RES, V58, P379, DOI 10.1002/(SICI)1097-4547(19991101)58:3<379::AID-JNR3>3.3.CO;2-A	31	8	8	0	0	MAGHIRA & MAAS PUBLICATIONS	MUNSBACH	MAGHIRA & MAAS S A R L, 6C, RUE GABRIEL LIPPMANN, L-5365 MUNSBACH, LUXEMBOURG	0172-780X	2354-4716		NEUROENDOCRINOL LETT	Neuroendocrinol. Lett.		2001	22	1					19	26					8	Endocrinology & Metabolism; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism; Neurosciences & Neurology	408PU	WOS:000167337500005	11335875				2022-02-06	
J	Wijdicks, EFM; Atkinson, JLD; Okazaki, H				Wijdicks, EFM; Atkinson, JLD; Okazaki, H			Isolated medulla oblongata function after severe traumatic brain injury	JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY			English	Article						brain death; head injury; apnoea test; outcome	DEATH	The objective was to report the first pathologically confirmed case of partly functionally preserved medulla oblongata in a patient with catastrophic traumatic brain injury. A patient is described with epidural haematoma with normal breathing and blood pressure and a retained coughing reflex brought on only by catheter suctioning of the carina. Multiple contusions in the thalami and pens were found but the medulla oblongata was spared at necropsy. In conclusion, medulla oblongata function may persist despite rostrocaudal deterioration. This comatose state ("medulla man") closely mimics brain death.	St Marys Hosp, Dept Neurol, Neurol Neurosurg Intens Care Unit, Rochester, MN 55905 USA; Mayo Clin & Mayo Fdn, Dept Neurosurg, Rochester, MN 55905 USA; Mayo Clin & Mayo Fdn, Dept Anat Pathol & Neuropathol, Rochester, MN 55905 USA		Wijdicks, EFM (corresponding author), Mayo Clin & Mayo Fdn, Dept Neurol, 200 1st St SW, Rochester, MN 55905 USA.						Ashwal S, 1997, CLIN PERINATOL, V24, P859, DOI 10.1016/S0095-5108(18)30154-4; Firsching R, 1998, J NEUROSURG, V89, P707, DOI 10.3171/jns.1998.89.5.0707; Goudreau JL, 2000, NEUROLOGY, V55, P1045, DOI 10.1212/WNL.55.7.1045; Pallis CA, ABC BRAINSTEM DEATH; ROPPER AH, 1981, J NEUROSURG, V55, P942, DOI 10.3171/jns.1981.55.6.0942; Shewmon DA, 1998, NEUROLOGY, V51, P1538, DOI 10.1212/WNL.51.6.1538; WIJDICKS EFM, 1995, NEUROLOGY, V45, P1003, DOI 10.1212/WNL.45.5.1003	7	8	8	1	2	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0022-3050			J NEUROL NEUROSUR PS	J. Neurol. Neurosurg. Psychiatry	JAN	2001	70	1					127	129		10.1136/jnnp.70.1.127			3	Clinical Neurology; Psychiatry; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry; Surgery	388KC	WOS:000166178800028	11118264	Green Published, Bronze			2022-02-06	
J	Armstead, WM				Armstead, WM			Role of altered cyclooxygenase metabolism in impaired cerebrovasodilation to nociceptin/orphanin FQ following brain injury	BRAIN RESEARCH BULLETIN			English	Article						newborn pig; cerebral circulation; opioids; prostaglandins	RECEPTOR GENE FAMILY; TISSUE DISTRIBUTION; MOLECULAR-CLONING; HEAD-INJURY; RAT; MEMBER; CATS; ABNORMALITIES; ACTIVATION; RESPONSES	This study was designed to determine the role of altered cyclooxygenase metabolism in impaired pial artery dilation to the newly described opioid, nociceptin orphanin FQ (NOC/oFQ), following fluid percussion brain injury (FPI) in newborn pigs equipped with a closed cranial window, Recent studies show that NOC/oFQ contributes to oxygen free radical generation observed post FPI in a cyclooxygenase dependent manner. FPI was produced by using a pendulum to strike a piston on a saline filled cylinder that was fluid coupled to the brain via a hollow screw inserted through the cranium, NOC/oFQ (10(-8), 10(-6) M) modestly increased cerebrospinal fluid (CSF) 6-keto-PGF(1 alpha), and thromboxane B-2 (TXB2) the stable breakdown products of PGI(2) and TXA(2), in sham animals (1148 +/- 83 to 1681 +/- 114 and 308 +/- 16 to 424 +/- 21 pg/ml for control and 10(-6) M NOC/oFQ 6-keto-PGF(1 alpha), and TXB2, respectively). In 1-h post FPI animals, basal levels of 6-keto-PGF(1 alpha), and TXB2 were elevated. NOC/oFQ stimulated release of 6-keto-PGF(1 alpha), was blocked while such release of TXB2 was enhanced (720 +/- 63 to 1446 +/- 117 pg/ml for control and 10(-6) M NOC/oFQ CSF TXB2). NOC/oFQ (10(-8), 10(-6) M) induced pial artery dilation that was reversed to vasoconstriction by FPI while the cyclooxygenase inhibitor indomethacin (5 mg/kg, intravenous) partially restored such vascular responses (8 +/- 1 and 15 +/- 1 vs, -7 +/- 1 and -12 +/- 1 vs, 7 +/- 1 and 12 +/- 1% for 10(-8), 10(-6) M NOC/oFQ in sham, FPI and FPI-Indo pretreated animals). Similar observations were made in FPI animals pretreated with the thromboxane receptor antagonist SQ 29,548 or the free radical scavenger polyethylene glycol superoxide dismutase and catalase, These data indicate that altered NOC/oFQ induced cyclooxygenase metabolism contributes to impairment of dilation to this opioid following FPI. (C) 2001 Elsevier Science Inc.	Univ Penn, Dept Anesthesia, Philadelphia, PA 19104 USA; Univ Penn, Dept Pharmacol, Philadelphia, PA 19104 USA		Armstead, WM (corresponding author), Univ Penn, Dept Anesthesia, 3400 Spruce St, Philadelphia, PA 19104 USA.						Al-Turki A, 1998, CRIT CARE MED, V26, P917, DOI 10.1097/00003246-199805000-00029; Armstead WM, 2000, J NEUROTRAUM, V17, P751, DOI 10.1089/neu.2000.17.751; ARMSTEAD WM, 1994, BRAIN RES, V660, P19, DOI 10.1016/0006-8993(94)90834-6; ARMSTEAD WM, 1994, J NEUROTRAUM, V11, P487, DOI 10.1089/neu.1994.11.487; Armstead WM, 1999, STROKE, V30, P153, DOI 10.1161/01.STR.30.1.153; Armstead WM, 1999, BRAIN RES, V835, P315, DOI 10.1016/S0006-8993(99)01623-6; ARMSTEAD WM, 1989, J PHARMACOL EXP THER, V251, P1012; ARMSTEAD WM, 1997, P SOC EXP BIOL MED, V21, P210; BUNZOW JR, 1994, FEBS LETT, V347, P284, DOI 10.1016/0014-5793(94)00561-3; CHEN Y, 1994, FEBS LETT, V347, P279, DOI 10.1016/0014-5793(94)00560-5; DeWitt DS, 1988, J NEUROTRAUM, V5, P303, DOI 10.1089/neu.1988.5.303; ELLIS EF, 1981, J NEUROCHEM, V37, P892, DOI 10.1111/j.1471-4159.1981.tb04476.x; ELLIS EF, 1989, J NEUROTRAUM, V6, P331; FUKUDA K, 1994, FEBS LETT, V343, P42, DOI 10.1016/0014-5793(94)80603-9; GENNARELLI TA, 1994, J NEUROTRAUM, V11, P357, DOI 10.1089/neu.1994.11.357; Hall E D, 1985, Cent Nerv Syst Trauma, V2, P75; HAYES RL, 1983, J NEUROSURG, V58, P720, DOI 10.3171/jns.1983.58.5.0720; Kulkarni M, 2000, STROKE, V31, P1990, DOI 10.1161/01.STR.31.8.1990; LEFFLER CW, 1985, PROSTAGLANDINS, V30, P811, DOI 10.1016/0090-6980(85)90009-7; MCINTOSH TK, 1993, J NEUROTRAUM, V10, P373, DOI 10.1089/neu.1993.10.373; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; MEUNIER JC, 1995, NATURE, V377, P532, DOI 10.1038/377532a0; MOLLEREAU C, 1994, FEBS LETT, V341, P33, DOI 10.1016/0014-5793(94)80235-1; REINSCHEID RK, 1995, SCIENCE, V270, P792, DOI 10.1126/science.270.5237.792; RODRIGUEZ JG, 1990, AM J DIS CHILD, V144, P625, DOI 10.1001/archpedi.1990.02150300019014; SHOHAMI E, 1987, J CEREBR BLOOD F MET, V7, P58, DOI 10.1038/jcbfm.1987.8; Tepas J J 3rd, 1995, Semin Pediatr Surg, V4, P120; THOROGOOD MC, 1995, AM J PHYSIOL-HEART C, V269, pH1776; WEI EP, 1980, CIRC RES, V46, P37, DOI 10.1161/01.RES.46.1.37; WEI EP, 1981, CIRC RES, V48, P95, DOI 10.1161/01.RES.48.1.95	30	8	8	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0361-9230			BRAIN RES BULL	Brain Res. Bull.	DEC	2000	53	6					807	812		10.1016/S0361-9230(00)00417-2			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	403UH	WOS:000167060500011	11179847				2022-02-06	
J	Nishiyama, T; Hanaoka, K				Nishiyama, T; Hanaoka, K			A traumatic asphyxia in a child	CANADIAN JOURNAL OF ANAESTHESIA-JOURNAL CANADIEN D ANESTHESIE			English	Article								Purpose: Traumatic asphyxia in a child is rare and the pathophysiology is different from that occurring in an adult. We report a case of traumatic asphyxia in a child who recovered without specific treatment, even though chest and abdominal compression was severe. Clinical features: A three-year-old boy (14.2 kg) was run over by the rear wheel of a jeep, He was under the tire for about three minutes and then was transferred to our hospital, When he arrived, he was lethargic with Glasgow Coma Scale of E3V4M6 (coma score of 13). He was cyanotic in his face and had a tire mark from the lek shoulder to the right abdomen, petechia on the head, face, conjunctiva and chest, oral bleeding, and facial edema, Serum concentrations of liver enzymes were increased and microhematuria was detected. However, no injuries were seen in the brain, eye, chest, or abdomen. Cyanosis disappeared in a few hours. Facial and thoracic petechia disappeared in three days and that of the conjunctiva in five days. He was discharged from hospital on the 13th day without any disturbances. Conclusion: We present a three-year-old boy with traumatic asphyxia. He had no complications although he received severe thoraco-abdominal compression by a jeep.	Univ Tokyo, Fac Med, Dept Anesthesiol, Bunkyo Ku, Tokyo 1138655, Japan		Nishiyama, T (corresponding author), 3-2-6-603 Kawaguchi, Kawaguchi, Saitama 3320015, Japan.						BALDWIN GA, 1988, J TRAUMA, V28, P557, DOI 10.1097/00005373-198804000-00029; CampbellHewson G, 1997, J ACCID EMERG MED, V14, P47; FRED HL, 1960, AM J MED, V29, P508, DOI 10.1016/0002-9343(60)90046-2; Furuya Y, 1981, Igaku Kenkyu, V51, P117; GORENSTEIN L, 1986, J PEDIATR SURG, V21, P753, DOI 10.1016/S0022-3468(86)80358-X; LANDERCASPER J, 1985, J TRAUMA, V25, P838, DOI 10.1097/00005373-198509000-00005; LOWE L, 1990, J AM ACAD DERMATOL, V23, P972, DOI 10.1016/0190-9622(90)70316-A; MELLER JL, 1984, PEDIATRICS, V74, P813; Sarihan H, 1997, J CARDIOVASC SURG, V38, P93; THOMPSON A, 1989, ANN THORAC SURG, V47, P247, DOI 10.1016/0003-4975(89)90279-8	10	8	8	0	0	CANADIAN ANESTHESIOLOGISTS SOC	TORONTO	1 EGLINTON AVE EAST, SUITE 208, TORONTO, ONTARIO M4P 3A1, CANADA	0832-610X			CAN J ANAESTH	Can. J. Anaesth.-J. Can. Anesth.	NOV	2000	47	11					1099	1102		10.1007/BF03027962			4	Anesthesiology	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology	372JA	WOS:000165229500009	11097540	Bronze			2022-02-06	
J	Donnelly, KZ; Donnelly, JP; Grohman, KJ				Donnelly, KZ; Donnelly, JP; Grohman, KJ			Cognitive, emotional, and behavioral problems associated with traumatic brain injury: A concept map of patient, family, and provider perspectives	BRAIN AND COGNITION			English	Article								The purpose of this study was to elicit an exhaustive list of problems associated with TBI, as characterized by the patient, significant others, and health care providers, to identify the underlying structure from the expert perspective, and to evaluate severity and frequency of the symptoms. Forty-seven participants generated a list of 174 discrete problems. These items were then sorted and rated for severity and frequency by a panel of six neuropsychologists. Concept mapping yielded a best-fit map of eight content clusters to characterize these symptoms. The clusters included independence, intimacy, treatment complications, executive functioning, nonexecutive cognitive functions, mood, and psychotic symptoms. Intimacy and treatment complications were rated as the most severe problems, with treatment complications and executive functioning rated as the most frequent, (C) 2000 Academic Press.	Louisiana State Univ, Baton Rouge, LA 70803 USA; VA Western New York Heatlthcare Syst, Buffalo, NY USA; Matrix Inc, Baton Rouge, LA USA		Donnelly, KZ (corresponding author), Louisiana State Univ, Baton Rouge, LA 70803 USA.		Donnelly, James/AAI-4840-2020				Bennett T L, 1997, Appl Neuropsychol, V4, P55, DOI 10.1207/s15324826an0401_7; HINKELDEY N S, 1990, Brain Injury, V4, P115, DOI 10.3109/02699059009026157; LEZAK MD, 1995, NEUROPSYCHOLOGICAL A; TROCHIM WMK, 1989, EVAL PROGRAM PLANN, V12, P1, DOI 10.1016/0149-7189(89)90016-5; VANZOMEREN AH, 1985, J NEUROL NEUROSUR PS, V48, P21, DOI 10.1136/jnnp.48.1.21	5	8	8	0	2	ACADEMIC PRESS INC	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0278-2626			BRAIN COGNITION	Brain Cogn.	OCT	2000	44	1					21	25					5	Neurosciences; Psychology, Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	358FJ	WOS:000089547300006					2022-02-06	
J	Heitkamp, HC; Horstmann, T; Schalinski, H				Heitkamp, HC; Horstmann, T; Schalinski, H			In-line skating: injuries and prevention	JOURNAL OF SPORTS MEDICINE AND PHYSICAL FITNESS			English	Article						athletic injuries prevention and control; protective devices	FRACTURES	Background. Most reports on in-line skating injuries describe severe injuries admitted to injury clinics. Little is known about the overall rate of injury and the contribution of the different disciplines. Methods. In a retrospective inquiry data on injuries were obtained of 105 in-line skaters of whose 69% were active in fitness skating, 59% in jumping/grinding and 51% in the halfpipe. Beside the nature, location and degree of the injury, information was given on where the injury happened and whether protectors were worn at the time of injury. Results. Of 197 injuries 145 healed without medical treatment, 28 needed medical advice once, 22 several times and 2 needed hospitalisation. Injury location were 38% in the upper, 31% in the lower extremities, 21% in the hip/pelvis region and 10% on the head. The most frequent injuries pertained to concussions and skin lesions, 35% each, followed by ligament injuries with 10% and fractures with 5%. Simple injuries mere 83% in fitness skating, 70% in jumping/grinding and 60% in the halfpipe. Several visits were necessary for 4% of fitness skaters, 10% of jumpers/grinders and 23% in halfpipe injured persons. All four protectors were worn at the time of injury by 5% in fitness skating, 18% in jumping/grinding and 55% in the halfpipe. No protectors were worn in 26% of the fitness injuries, in 9% jumping/grinding and in 6% in the halfpipe. Conclusions. The results reveal an apparent discipline specific degree of danger and that fitness in-line skating is less dangerous than the resulting benefits for preventive medicine.	Univ Tubingen, Abt Sportmed, Dept Sports Med, Med Clin & Polyclin, D-72074 Tubingen, Germany		Heitkamp, HC (corresponding author), Univ Tubingen, Abt Sportmed, Dept Sports Med, Med Clin & Polyclin, Holderlinstr 11, D-72074 Tubingen, Germany.						Adams SL, 1996, ACAD EMERG MED, V3, P304, DOI 10.1111/j.1553-2712.1996.tb03442.x; Banas M P, 1992, J Orthop Trauma, V6, P301, DOI 10.1097/00005131-199209000-00006; CALLE SC, 1993, J TRAUMA, V35, P946, DOI 10.1097/00005373-199312000-00024; CALLE SC, 1994, AM J PUBLIC HEALTH, V84, P675, DOI 10.2105/AJPH.84.4.675; Cheng SL, 1995, J TRAUMA, V39, P1194, DOI 10.1097/00005373-199512000-00036; Eingartner C, 1997, Sportverletz Sportschaden, V11, P48, DOI 10.1055/s-2007-993365; Giacobetti FB, 1997, AM J SPORT MED, V25, P223, DOI 10.1177/036354659702500215; HACKL W, 1997, SPORTORTHOP SPORTTRA, V13, P104; Heitkamp HC, 1998, INT J SPORTS MED, V19, P260, DOI 10.1055/s-2007-971915; Hilgert R. E., 1996, Deutsche Zeitschrift fuer Sportmedizin, V47, P574; HOFMAN J, 1996, SPORTORTHOP SPORTTRA, V12, P287; Jerosch J., 1998, Deutsche Zeitschrift fuer Sportmedizin, V49, P3; Jerosch J, 1997, Sportverletz Sportschaden, V11, P43, DOI 10.1055/s-2007-993364; LARGIADER U, 1998, DTSCH Z SPORTMED, V49, P119; MALANGA GA, 1995, MAYO CLIN PROC, V70, P752, DOI 10.4065/70.8.752; MOORE MS, 1997, AM J SPORTS MED, V12, P204; Orenstein JB, 1996, ANN EMERG MED, V27, P204, DOI 10.1016/S0196-0644(96)70324-4; SCHIEBER RA, 1994, JAMA-J AM MED ASSOC, V271, P1856, DOI 10.1001/jama.271.23.1856; Schieber RA, 1996, NEW ENGL J MED, V335, P1630, DOI 10.1056/NEJM199611283352202; SCHIEBER RA, 1995, SPORTS MED, V19, P427, DOI 10.2165/00007256-199519060-00006; WEINBERGER DG, 1994, J TRAUMA, V37, P500, DOI 10.1097/00005373-199409000-00028	21	8	8	0	3	EDIZIONI MINERVA MEDICA	TURIN	CORSO BRAMANTE 83-85 INT JOURNALS DEPT., 10126 TURIN, ITALY	0022-4707	1827-1928		J SPORT MED PHYS FIT	J. Sports Med. Phys. Fit.	SEP	2000	40	3					247	253					7	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	381RR	WOS:000165777500009	11125768				2022-02-06	
J	Shewmon, DA				Shewmon, DA			Coma prognosis in children - Part I: Definitional and methodological challenges	JOURNAL OF CLINICAL NEUROPHYSIOLOGY			English	Article; Proceedings Paper	Annual Meeting of the American-Neurophysiology-Society	OCT 29-NOV 01, 1999	ST LOUIS, MO	Amer Neurophysiol Soc		coma; prognosis; children; EEG; evoked potentials	PERSISTENT VEGETATIVE STATE; SOMATOSENSORY-EVOKED-POTENTIALS; EVENT-RELATED POTENTIALS; CLOSED-HEAD-INJURY; NON-TRAUMATIC COMA; CEREBRAL BLOOD-FLOW; INTRACRANIAL-PRESSURE; NONTRAUMATIC COMA; CARDIAC-ARREST; YOUNG-CHILDREN	Prediction of outcome fi;om coma is a frequent and important task of neurologists. It is difficult enough in adult patients and even more difficult in children. Part I of this review considers some of the methodological problems and caveats besetting clinical research in this field: the very definition of coma, definition of the study population and outcome variables, study design, the fallacy of self-fulfilling prophecy, early death rate from nonneurologic causes resulting in low statistical power, and invalid attempts to compensate for that by combining outcome categories, lumping together age groups, short and inhomogeneous follow-up, and failure to provide confidence intervals. Part II reviews the clinical pediatric coma-prognosis literature, first according to etiology and then according to electrodiagnostic tests.	Univ Calif Los Angeles, Sch Med, Los Angeles, CA USA		Shewmon, DA (corresponding author), Olive View UCLA Med Ctr, Dept Neurol, Div Pediat, 14445 Olive View Dr,N Annex, Sylmar, CA 91342 USA.						ALDRICH EF, 1992, J NEUROSURG, V76, P450, DOI 10.3171/jns.1992.76.3.0450; [Anonymous], 1990, JAMA, V263, P426; ARKIN CF, 1990, JAMA-J AM MED ASSOC, V263, P275, DOI 10.1001/jama.263.2.275; ASHWAL S, 1994, NEW ENGL J MED, V330, P1499; ASHWAL S, 1994, NEW ENGL J MED, V330, P1572; BECA J, 1995, J PEDIATR-US, V126, P44, DOI 10.1016/S0022-3476(95)70498-1; BENNETT HL, 1985, BRIT J ANAESTH, V57, P174, DOI 10.1093/bja/57.2.174; BENZER A, 1991, LANCET, V338, P977, DOI 10.1016/0140-6736(91)91840-Q; BOYD K, 1991, LANCET, V337, P96; BOYER MG, 1991, INJURY, V22, P315, DOI 10.1016/0020-1383(91)90014-6; BOZZAMARRUBINI M L, 1964, Acta Neurochir (Wien), V12, P352; CARROLL WM, 1979, ARCH NEUROL-CHICAGO, V36, P46, DOI 10.1001/archneur.1979.00500370076020; CELESIA, 1993, ANN NEUROL, V33, P386; CHUGANI HT, 1987, ANN NEUROL, V22, P487, DOI 10.1002/ana.410220408; CONN AW, 1980, CAN ANAESTH SOC J, V27, P201, DOI 10.1007/BF03007429; DEGIORGIO C M, 1989, Issues in Law and Medicine, V5, P141; DEGIORGIO CM, 1993, ACTA NEUROL SCAND, V87, P423; deJong BM, 1997, CLIN NEUROL NEUROSUR, V99, P213, DOI 10.1016/S0303-8467(97)00024-3; DEVOLDER AG, 1990, ARCH NEUROL-CHICAGO, V47, P197, DOI 10.1001/archneur.1990.00530020103022; DIMANCESCU MD, 1989, ARCH NEUROL-CHICAGO, V46, P14, DOI 10.1001/archneur.1989.00520370016010; EDGREN E, 1987, CRIT CARE MED, V15, P820, DOI 10.1097/00003246-198709000-00004; GLOOR P, 1986, EPILEPSIA, V27, pS14, DOI 10.1111/j.1528-1157.1986.tb05737.x; GOTO I, 1993, J NEUROL SCI, V114, P1, DOI 10.1016/0022-510X(93)90040-6; GOTT PS, 1991, ARCH NEUROL-CHICAGO, V48, P1267, DOI 10.1001/archneur.1991.00530240071024; HALFEN D, 1986, ANESTHESIOLOGY  0312; HANLEY JA, 1983, JAMA-J AM MED ASSOC, V249, P1743, DOI 10.1001/jama.249.13.1743; Harley DH, 1996, ABC BRAINSTEM DEATH; HEIDEN JS, 1983, PHYS THER, V63, P1946, DOI 10.1093/ptj/63.12.1946; Hendrickson S L, 1987, J Neurosci Nurs, V19, P14; HERHOLZ K, 1995, ALZ DIS ASSOC DIS, V9, P6, DOI 10.1097/00002093-199505000-00004; HIGASHI K, 1977, J NEUROL NEUROSUR PS, V40, P876, DOI 10.1136/jnnp.40.9.876; HILGENBERG JC, 1981, ANESTHESIOLOGY, V54, P341, DOI 10.1097/00000542-198104000-00018; Hofer T, 1993, J Neurosci Nurs, V25, P218; Howsepian A A, 1998, Linacre Q, V65, P39; Howsepian AA, 1996, ISSUES LAW MED, V12, P3; HOWSEPIAN AA, 1994, REV METAPHYS, V47, P735; JENNETT B, 1972, LANCET, V1, P734; JENNETT B, 1975, LANCET, V1, P480; JOHNSON GM, 1987, AM J CLIN HYPN, V29, P255, DOI 10.1080/00029157.1987.10402705; JOHNSON SM, 1989, HEART LUNG, V18, P56; Kane NM, 1996, INTENS CARE MED, V22, P39, DOI 10.1007/BF01728329; Keren O, 1998, J HEAD TRAUMA REHAB, V13, P15; KUMAR SM, 1978, ANESTH ANALG, V57, P267; LAPUMA J, 1988, ARCH NEUROL-CHICAGO, V45, P20; LEVI L, 1991, BRIT J NEUROSURG, V5, P617, DOI 10.3109/02688699109002885; LEVIN HS, 1991, ARCH NEUROL-CHICAGO, V48, P580, DOI 10.1001/archneur.1991.00530180032013; Levy D E, 1978, Ann N Y Acad Sci, V315, P293, DOI 10.1111/j.1749-6632.1978.tb50347.x; LEVY DE, 1981, ANN INTERN MED, V94, P293, DOI 10.7326/0003-4819-94-3-293; LEVY DE, 1987, ANN NEUROL, V22, P673, DOI 10.1002/ana.410220602; LONGSTRETH WT, 1983, NEW ENGL J MED, V308, P1378, DOI 10.1056/NEJM198306093082302; LUERSSEN TG, 1988, J NEUROSURG, V68, P409, DOI 10.3171/jns.1988.68.3.0409; LUTSCHG J, 1983, AM J DIS CHILD, V137, P421; Mayes S D, 1989, Brain Inj, V3, P301, DOI 10.3109/02699058909029643; Menon DK, 1998, LANCET, V352, P200, DOI 10.1016/S0140-6736(05)77805-3; Mitchell P H, 1985, Nurs Adm Q, V9, P38; MITCHELL PH, 1978, NURS RES, V27, P4; MODELL JH, 1980, CAN ANAESTH SOC J, V27, P211, DOI 10.1007/BF03007430; MORRAY JP, 1984, CRIT CARE MED, V12, P1018, DOI 10.1097/00003246-198412000-00002; Multi -Society Task Force on PVS, 1995, NEW ENGL J MED, V333, P130; OMAHONY D, 1990, LANCET, V336, P1265, DOI 10.1016/0140-6736(90)92887-N; ORLOWSKI JP, 1979, JACEP-J AM COLL EMER, V8, P176, DOI 10.1016/S0361-1124(79)80121-5; PAPPATA S, 1994, J NEURAL TRANSM-PARK, V8, P131, DOI 10.1007/BF02250924; Plum F., 1982, DIAGNOSIS STUPOR COM, V3rd; PODURGIEL M, 1990, J NEUROSCI NURS, V22, P52; POLLACK LD, 1981, NEW ENGL J MED, V304, P732; RAIMONDI AJ, 1984, CHILD BRAIN, V11, P12; Rappaport M, 1991, J Neuropsychiatry Clin Neurosci, V3, P180; REILLY PL, 1988, CHILD NERV SYST, V4, P30; Reuter B M, 1989, Arch Psychol (Frankf), V141, P155; RUIJS MBM, 1993, NEUROPEDIATRICS, V24, P307, DOI 10.1055/s-2008-1071562; SAUCIER N, 1983, ANESTH ANALG, V62, P239; SCHNAPER N, 1975, J TRAUMA, V15, P94, DOI 10.1097/00005373-197502000-00002; SESHIA SS, 1991, CAN J NEUROL SCI, V18, P472, DOI 10.1017/S0317167100032182; SHEWMON DA, 1987, STAT MED, V6, P535, DOI 10.1002/sim.4780060503; SHEWMON DA, 1989, NEUROL CLIN, V7, P823, DOI 10.1016/S0733-8619(18)30392-X; SIMPSON DA, 1991, CHILD NERV SYST, V7, P183; SNYDER M, 1983, J ADV NURS, V8, P273; TASKER RC, 1988, ARCH DIS CHILD, V63, P895, DOI 10.1136/adc.63.8.895; TEASDALE G, 1974, LANCET, V2, P81; TESSERIS J, 1991, ACTA NEUROCHIR, V110, P65, DOI 10.1007/BF01402050; Tosch P, 1988, J Neurosci Nurs, V20, P223; TRUSTMAN R, 1977, INT J CLIN EXP HYP, V25, P88, DOI 10.1080/00207147708415969; VOLLMER DG, 1991, J NEUROSURG, V75, pS37, DOI 10.3171/sup.1991.75.1s.0s37; WHYTE K M, 1989, Australasian Radiology, V33, P344, DOI 10.1111/j.1440-1673.1989.tb03308.x; YINGLING CD, 1990, LANCET, V336, P873, DOI 10.1016/0140-6736(90)92372-O	85	8	8	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0736-0258	1537-1603		J CLIN NEUROPHYSIOL	J. Clin. Neurophysiol.	SEP	2000	17	5					457	466		10.1097/00004691-200009000-00004			10	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Science (CPCI-S)	Neurosciences & Neurology	371MQ	WOS:000165183100004	11085549				2022-02-06	
J	Skell, RL; Johnstone, B; Schopp, L; Shaw, J; Petroski, GF				Skell, RL; Johnstone, B; Schopp, L; Shaw, J; Petroski, GF			Neuropsychological predictors of distress following traumatic brain injury	BRAIN INJURY			English	Article							CLOSED-HEAD-INJURY; PREMORBID INTELLIGENCE; RECOVERY; EXTENT; MMPI; RISK	Emotional and behavioural difficulties are one of the most common difficulties following traumatic brain injury (TBI), although it is not clear which individuals with TBI become most distressed. Numerous factors contribute to adjustment following TBI, and the current study examined degree of cognitive decline as one potential contributor to distress following TBI. The relationship between cognitive functioning and distress may be conceptualized as being related to (a) an individual's absolute level of cognitive ability following TBI, or (b) relative degree of decline following TBI (i.e. the greater the decline, the greater the distress, regardless of absolute level of ability). The current study tested these hypotheses by comparing a measure of global emotional distress with measures of absolute level of neuropsychological functioning and indices of cognitive decline. In contrast to hypotheses, regression analyses indicated that estimated pre-morbid ability accounted for more variance in distress following TBI than either absolute level of functioning or indices of cognitive decline, with individuals with higher estimated pre-morbid abilities reporting lower levels of distress. Treatment implications are discussed.	Univ Missouri, Columbia, MO USA		Skell, RL (corresponding author), DC046-00,1 Hosp Dr, Columbia, MO 65212 USA.			Johnstone, Brick/0000-0001-8845-9649			Alfano Dennis P, 1992, Clin Neuropsychol, V6, P134, DOI 10.1080/13854049208401850; ALFANO DP, 1993, NEUROPSY NEUROPSY BE, V6, P111; BORNSTEIN RA, 1985, J CLIN PSYCHOL, V41, P651, DOI 10.1002/1097-4679(198509)41:5<651::AID-JCLP2270410511>3.0.CO;2-C; Boss MW, 1991, PSYCHOL ASSESS, V3, P433, DOI DOI 10.1037/1040-3590.3.3.433; Bowen A, 1998, BRAIN INJURY, V12, P177, DOI 10.1080/026990598122656; Brulot MM, 1997, CLIN NEUROPSYCHOL, V11, P391, DOI 10.1080/13854049708400468; BURTON LA, 1994, J NEUROLOGICAL REHAB, V8, P63, DOI DOI 10.1177/136140969400800202; Ceci SJ, 1997, AM PSYCHOL, V52, P1051, DOI 10.1037/0003-066X.52.10.1051; Derogatis L.R., 1977, SCL 90 MANUAL SCORIN; Gass CS, 1996, PSYCHOL ASSESSMENT, V8, P135, DOI 10.1037/1040-3590.8.2.135; Jastak J., 1984, WIDE RANGE ACHIEVEME; Johnstone B, 1996, J Int Neuropsychol Soc, V2, P282; JOHNSTONE B, 1995, BRAIN INJURY, V9, P377, DOI 10.3109/02699059509005777; Johnstone B, 1999, J HEAD TRAUMA REHAB, V14, P220, DOI 10.1097/00001199-199906000-00003; Johnstone B, 1997, ARCH CLIN NEUROPSYCH, V12, P591, DOI 10.1016/S0887-6177(97)00002-4; KAITARO T, 1995, BRAIN INJURY, V9, P713, DOI 10.3109/02699059509008227; KARZMARK P, 1995, BRAIN INJURY, V9, P21, DOI 10.3109/02699059509004567; Lezak M.D., 1987, J HEAD TRAUMA REHAB, V2, P57, DOI DOI 10.1097/00001199-198703000-00009; MACNIVEN E, 1993, BRAIN INJURY, V7, P241, DOI 10.3109/02699059309029676; MALEC JF, 1993, CLIN NEUROPSYCHOL, V7, P48, DOI DOI 10.1080/13854049308401887; MITTENBERG W, 1996, ASSESSMENT, V3, P157; Perlesz A, 1999, REHABIL PSYCHOL, V44, P6, DOI 10.1037/0090-5550.44.1.6; Reitan RM, 1992, TRAIL MAKING TEST MA; Satz P, 1998, BRAIN INJURY, V12, P555, DOI 10.1080/026990598122322; Satz P, 1998, BRAIN INJURY, V12, P537, DOI 10.1080/026990598122313; SELZER ME, 1995, J NEUROL REHABIL, V9, P55; Slaughter J, 1999, BRAIN INJURY, V13, P125, DOI 10.1080/026990599121782; Watts R, 1999, BRAIN INJURY, V13, P113, DOI 10.1080/026990599121773; Wechsler D, 1987, MANUAL WECHSLER MEMO; Wechsler D, 1981, WECHSLER ADULT INTEL	30	8	9	0	3	TAYLOR & FRANCIS LTD	LONDON	11 NEW FETTER LANE, LONDON EC4P 4EE, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.	AUG	2000	14	8					705	712					8	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	342XT	WOS:000088672000003	10969888				2022-02-06	
J	Facco, E; Munari, M				Facco, E; Munari, M			The role of evoked potentials in severe head injury	INTENSIVE CARE MEDICINE			English	Article							EVENT-RELATED POTENTIALS; SEVERE BRAIN INJURY; COMATOSE PATIENTS; TRAUMATIC COMA; ORIGIN; PREDICTION; P300; CONDUCTION; LESIONS; N18		Univ Padua, Dept Pharmacol & Anesthesiol, I-35128 Padua, Italy		Facco, E (corresponding author), Univ Padua, Dept Pharmacol & Anesthesiol, Via C Battisti 267, I-35128 Padua, Italy.	efacco@ux1.unipd.it	Facco, Enrico/ABB-3874-2021	FACCO, ENRICO/0000-0001-8780-3620			ANDERSON, 1990, ARCH NEUROL-CHICAGO, V41, P369; BECA J, 1995, J PEDIATR-US, V126, P44, DOI 10.1016/S0022-3476(95)70498-1; Brown JIM, 1998, NEUROSURGERY, V42, P1057, DOI 10.1097/00006123-199805000-00060; CHIAPPA, 1997, EVOKED POTENTIALS CL; CUSUMANO S, 1992, ELECTROEN CLIN NEURO, V84, P499, DOI 10.1016/0168-5597(92)90039-E; DESMEDT, 1984, ELECT CLIN NEUROPHYS, V56, P628; Diringer MN, 1997, ARCH NEUROL-CHICAGO, V54, P606, DOI 10.1001/archneur.1997.00550170078017; FACCO, 1990, NEW TRENDS ADV TECHN, P330; FACCO, 1991, BRAIN TOP, V4, P447; FACCO, 1996, ANESTHESIA PAIN INTE, P537; FACCO, 1994, MINERVA ANESTESIOL, V60, P593; FACCO, 1994, CENTRAL NERVOUS SYST, P257; FACCO E, 1985, ELECTROEN CLIN NEURO, V62, P332, DOI 10.1016/0168-5597(85)90041-3; Facco E, 1999, INTENS CARE MED, V25, P872, DOI 10.1007/s001340050970; Facco E, 1998, ELECTROEN CLIN NEURO, V107, P332, DOI 10.1016/S0013-4694(98)00080-7; FACCO E, 1988, INTENS CARE MED, V14, P422, DOI 10.1007/BF00262900; Facco E., 1993, Neurophysiologie Clinique, V23, P237, DOI 10.1016/S0987-7053(05)80233-3; FACCO E, 1991, ELECTROEN CLIN NEURO, V80, P469, DOI 10.1016/0168-5597(91)90128-K; FACCO E, 1986, CHILD NERV SYST, V2, P67; FACCO E, 1990, ELECTROEN CLIN NEURO, P330; Firsching R, 1998, J NEUROSURG, V89, P707, DOI 10.3171/jns.1998.89.5.0707; Garcia-Larrea L, 1988, Agressologie, V29, P329; GOTT PS, 1991, ARCH NEUROL-CHICAGO, V48, P1267, DOI 10.1001/archneur.1991.00530240071024; GUTLING E, 1994, ELECTROEN CLIN NEURO, V92, P568, DOI 10.1016/0168-5597(94)90141-4; GUTLING E, 1993, ELECTROEN CLIN NEURO, V88, P369, DOI 10.1016/0168-5597(93)90013-F; Kane NM, 1996, INTENS CARE MED, V22, P39, DOI 10.1007/BF01728329; LINDSAY K, 1990, NEUROSURGERY, V26, P278, DOI 10.1227/00006123-199002000-00015; MARTIN WH, 1995, EVOKED POTENTIAL, V96, P357, DOI 10.1016/0168-5597(94)00326-A; Mauguiere F, 1988, Agressologie, V29, P351; MOULTON, 1993, J TRAUMA, V31, P676; Moulton RJ, 1998, CAN J NEUROL SCI, V25, pS7, DOI 10.1017/S031716710003465X; Mutschler V, 1996, NEUROPHYSIOL CLIN, V26, P158, DOI 10.1016/0987-7053(96)89626-2; Niedermeyer E, 1999, ITAL J NEUROL SCI, V20, P7, DOI 10.1007/s100720050004; Noel P, 1996, ELECTROEN CLIN NEURO, V98, P167, DOI 10.1016/0013-4694(95)00233-2; RESTUCCIA D, 1995, EVOKED POTENTIAL, V96, P371, DOI 10.1016/0168-5597(95)00054-V; ROSSINI, 1994, SEGNALI CERVELLO; ROSSINI PM, 1989, ELECTROEN CLIN NEURO, V74, P277, DOI 10.1016/0168-5597(89)90058-0; SIGNORINO M, 1995, LANCET, V345, P255, DOI 10.1016/S0140-6736(95)90252-X; SONOO M, 1992, ELECTROEN CLIN NEURO, V84, P418, DOI 10.1016/0168-5597(92)90028-A; *TASK FORC GUID, 1988, CRIT CARE MED, V16, P807; YINGLING CD, 1990, LANCET, V336, P873, DOI 10.1016/0140-6736(90)92372-O; POPPER 1934 LOGIK FO	42	8	9	0	1	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0342-4642	1432-1238		INTENS CARE MED	Intensive Care Med.	JUL	2000	26	7					998	1005		10.1007/s001340051294			8	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	342AR	WOS:000088623500026	10990119				2022-02-06	
J	Cannon, BJ				Cannon, BJ			A comparison of self- and other-rated forms of the neuropsychology behavior and affect profile in a traumatic brain injury population	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article						traumatic brain injury; neuropsychology behavior and affect profile (NBAP)	RATING-SCALE; HEAD TRAUMA; LIMITATIONS; AWARENESS; VALIDITY	The current study is the first reported use of both the other rated and the self-rated forms of the Neuropsychology Behavior and Affect Profile (NBAP; Nelson, Satz, & D 'Elia, 1994). Twenty eight adult patients who were 7 to 27 months post predominantly mild closed head injury completed the self-report form of the NBAP, and their identified relatives/close friends completed the other-rated form of the NBAP. Patients and their relatives endorsed more items on the Inappropriateness and Depression scales for "now", as compared to "before" the injury. Only the patients endorsed more items on the Pragnosia scale for "now" as compared to "before." Comparisons of the NBAP pairs found no significant differences between the patients' self-reports and those of their significant others for "before" the injury. Patients endorsed move items on the indifference and Pragnosia scales for "now," as compared to their relatives. (C) 2000 National Academy of Neuropsychology Published by Elsevier Science Ltd.	Marywood Univ, Dept Counseling Psychol, Scranton, PA 18509 USA		Cannon, BJ (corresponding author), Marywood Univ, Dept Counseling Psychol, 2300 Adams Ave, Scranton, PA 18509 USA.						FORDYCE DJ, 1983, J NEUROL NEUROSUR PS, V46, P620, DOI 10.1136/jnnp.46.7.620; Groom KN, 1998, ARCH CLIN NEUROPSYCH, V13, P695, DOI 10.1016/S0887-6177(98)00005-5; Leathem JM, 1998, J CLIN EXP NEUROPSYC, V20, P694, DOI 10.1076/jcen.20.5.694.1122; MELLO AE, 1998, PERSONALITY CHANGE B; NELSON L, 1995, AM J MENT RETARD, V99, P616; NELSON L, 1994, NEUROPSYCHOLOGY BEHA; Nelson LD, 1998, ARCH CLIN NEUROPSYCH, V13, P549, DOI 10.1016/S0887-6177(97)00052-8; NELSON LD, 1993, PSYCHOL ASSESSMENT, V5, P374; Prigatano GP, 1998, CLIN NEUROPSYCHOL, V12, P56, DOI 10.1076/clin.12.1.56.1721; Prigatano GP, 1996, CLIN NEUROPSYCHOL, V10, P191, DOI 10.1080/13854049608406680; PRIGATANO GP, 1990, ARCH PHYS MED REHAB, V71, P1058; PRIGATANO GP, 1990, CLIN NEUROPSYCHOL, V4, P163, DOI DOI 10.1080/13854049008401509; PRIGATINO GP, 1986, NEURPSYCHOLOGICAL RE; Satz P, 1996, PSYCHOL ASSESSMENT, V8, P115; Uchiyama C L, 1996, J Int Neuropsychol Soc, V2, P299; [No title captured]	16	8	8	0	2	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0887-6177			ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	MAY	2000	15	4					327	334					8	Psychology, Clinical; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	310KR	WOS:000086827800005	14590229				2022-02-06	
J	Theilen, HJ; Ragaller, M; von Kummer, R; Pohlmann-Eden, B; Schackert, G; Albrecht, MD				Theilen, HJ; Ragaller, M; von Kummer, R; Pohlmann-Eden, B; Schackert, G; Albrecht, MD			Functional recovery despite prolonged bilateral loss of somatosensory evoked potentials: report on two patients	JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY			English	Article						somatosensory evoked potentials; bilateral loss; outcome	CEREBRAL BLOOD-FLOW; FOCAL ISCHEMIA; INJURY	A bilateral loss of short latency somatosensory evoked potentials (SSEPs) after head trauma or non-traumatic brain damage is normally associated with a deleterious neurological outcome. An adequate recovery in reported in two deeply comatose patients with head trauma or severe hypertensive encephalopathy despite prolonged bilateral loss of SSEPs over days, found in repeated recordings. Hence, a bilateral loss of SSEPs should not be considered alone for prediction of outcome in cerebral injury.	Tech Univ Dresden, Univ Hosp Carl Gustav Carus, Dept Anaesthesiol & Intens Care Med, D-01309 Dresden, Germany; Univ Heidelberg, Mannheim Hosp, Dept Neurol, D-68135 Mannheim, Germany; Tech Univ Dresden, Univ Hosp Carl Gustav Carus, Dept Neuroradiol, D-01309 Dresden, Germany; Tech Univ Dresden, Univ Hosp Carl Gustav Carus, Dept Neurosurg, D-01309 Dresden, Germany		Theilen, HJ (corresponding author), Tech Univ Dresden, Univ Hosp Carl Gustav Carus, Dept Anaesthesiol & Intens Care Med, Fetscherstr 74, D-01309 Dresden, Germany.		von Kummer, Rudiger/AAA-4478-2019	von Kummer, Rudiger/0000-0003-0119-4604			BARRON KD, 1982, HEAD INJURY BASIC CL, P45; Beese U, 1998, STROKE, V29, P2032, DOI 10.1161/01.STR.29.10.2032; BOUMA GJ, 1991, J NEUROSURG, V75, P685, DOI 10.3171/jns.1991.75.5.0685; GRAF R, 1986, J CEREBR BLOOD F MET, V6, P566, DOI 10.1038/jcbfm.1986.103; KATAOKA K, 1987, STROKE, V18, P188, DOI 10.1161/01.STR.18.1.188; LINDSAY K, 1990, NEUROSURGERY, V26, P278, DOI 10.1227/00006123-199002000-00015; MIZOI K, 1987, ACTA NEUROCHIR, V88, P126, DOI 10.1007/BF01404149; PohlmannEden B, 1997, INTENS CARE MED, V23, P301, DOI 10.1007/s001340050332; Schwarz S, 1999, CRIT CARE MED, V27, P182, DOI 10.1097/00003246-199901000-00049	9	8	10	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0022-3050			J NEUROL NEUROSUR PS	J. Neurol. Neurosurg. Psychiatry	MAY	2000	68	5					657	660		10.1136/jnnp.68.5.657			4	Clinical Neurology; Psychiatry; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry; Surgery	309KD	WOS:000086766300025	10766902	Green Published, Bronze			2022-02-06	
J	Tolat, RD; O'Dell, MW; Golamco-Estrella, SP; Avella, H				Tolat, RD; O'Dell, MW; Golamco-Estrella, SP; Avella, H			Cocaine-associated stroke: three cases and rehabilitation considerations	BRAIN INJURY			English	Article							BUPROPION SUSTAINED-RELEASE; TRAUMATIC BRAIN INJURY; ALKALOIDAL COCAINE; DOUBLE-BLIND; METHYLPHENIDATE; DEPRESSION; BROMOCRIPTINE; DEFICITS; ABUSERS; SYSTEM	Cocaine-associated stroke (CAS) is an important cause of disability, especially among younger adults. Improved management has increased survival but little has been discussed about rehabilitation, including medication management. Therefore, experience and therapeutic drug management are described during inpatient rehabilitation with three patients with GAS. Case 1 is a 50-year-old male with a history of hypertension who presented with right hemiparesis, aphasia and depression. He was treated with paroxetine for depression and bromocriptine for poor initation with a good response, improving by 50 FIM points in 44 days. Case 2 is a 44 year-old female with quadriparesis, aphasia, and deficits in attention and initiation. Methylphenidate for attention deficits and bromocriptine for poor initation was associated with an excellent functional gain (50 FIM points in 37 days). She eventually returned to work. Case 3 is a 46-year-old female with a history of hypertension who presented with right hemiparesis, aphasia and depression. Without neuropharmacologic intervention, she gained 35 FIM points during an uneventful 47 day rehabilitation stay. Acutely, cocaine can induce cerebral vasconstriction, cerebovascular spasm, cerebal vasculitis and intracerebral haemorrhage. Chronic use depletes and destroys dopaminergic pathways, which may be a major factor in depression, and attention and initiation deficits-all observed in these cases. Generally, rapid improvements were seen in mood and cognition in two cases where medication was used. Based on the current literature and pathophysiology of GAS, it is suggested that trials of dopaminergic agents for cognition and extremely cautious use of buproprion for depression may be warrented. Details of the above cases and the practical and theoretical issues of neuropharmacologic intervention in CAS are discussed.	Southside Hosp, Reg Ctr Brain Injury Rehabil, Bay Shore, NY USA; Long Isl Jewish Med Ctr, New Hyde Park, NY 11042 USA		Tolat, RD (corresponding author), 257-05 87th Rd, Floral Pk, NY 11001 USA.						ARDILA A, 1991, INT J NEUROSCI, V57, P73, DOI 10.3109/00207459109150348; Brust JC, 1993, STROKE, V24, P1129; Cantwell DP, 1998, J CLIN PSYCHIAT, V59, P92; CATSMANBERREVOETS CE, 1988, NEUROLOGY, V38, P647, DOI 10.1212/WNL.38.4.647; Cornelius JR, 1998, PSYCHOPHARMACOL BULL, V34, P117; Dunner DL, 1998, J CLIN PSYCHIAT, V59, P366, DOI 10.4088/JCP.v59n0705; EVANS RG, 1987, HLTH POLICY, V7, P175; Fiedler RC, 1998, AM J PHYS MED REHAB, V77, P444, DOI 10.1097/00002060-199809000-00019; FREDERICKS RK, 1991, STROKE, V22, P1437, DOI 10.1161/01.STR.22.11.1437; GALLOWAY MP, 1988, TRENDS PHARMACOL SCI, V9, P452; GARRISON SJ, 1993, REHABILITATION MED P, P801; Grade C, 1998, ARCH PHYS MED REHAB, V79, P1047, DOI 10.1016/S0003-9993(98)90169-1; Inoue T, 1996, BIOL PSYCHIAT, V40, P151, DOI 10.1016/0006-3223(95)00666-4; Kaelin DL, 1996, ARCH PHYS MED REHAB, V77, P6, DOI 10.1016/S0003-9993(96)90211-7; Kaufman MJ, 1998, JAMA-J AM MED ASSOC, V279, P376, DOI 10.1001/jama.279.5.376; Kavoussi RJ, 1997, J CLIN PSYCHIAT, V58, P532, DOI 10.4088/JCP.v58n1204; KLEINMAN PH, 1990, J NERV MENT DIS, V178, P442, DOI 10.1097/00005053-199007000-00005; KOKKINOS J, 1993, NEUROL CLIN, V11, P577, DOI 10.1016/S0733-8619(18)30140-3; KONZEN JP, 1995, STROKE, V26, P1114, DOI 10.1161/01.STR.26.6.1114; LEVINE SR, 1990, NEW ENGL J MED, V323, P699, DOI 10.1056/NEJM199009133231102; MARTIN K, 1995, J RHEUMATOL, V22, P780; MENDLESON JH, 1990, HARRISONS PRINCIPLES, P2429; Petrakis I, 1998, DRUG ALCOHOL DEPEN, V50, P221, DOI 10.1016/S0376-8716(98)00032-5; POST RM, 1975, AM J PSYCHIAT, V132, P225; Qureshi AI, 1997, NEUROLOGY, V48, P341, DOI 10.1212/WNL.48.2.341; RITCHIE JM, 1990, PHARMACOL BASIS THER, P311; Rosenthal M, 1998, ARCH PHYS MED REHAB, V79, P90, DOI 10.1016/S0003-9993(98)90215-5; SAUER CM, 1991, STROKE, V22, P1203, DOI 10.1161/01.STR.22.9.1203; Starkstein S. E., 1993, DEPRESSION NEUROLOGI, P28; STRICKLAND TL, 1995, NEUROPSYCHOL REV, V5, P69, DOI 10.1007/BF02214930; STRICKLAND TL, 1993, J NEUROPSYCH CLIN N, V5, P419; Terry P, 1997, PSYCHOPHARMACOLOGY, V134, P201, DOI 10.1007/s002130050443; VOLKOW N D, 1989, Journal of Nuclear Medicine, V30, P730; Whyte J, 1997, AM J PHYS MED REHAB, V76, P440, DOI 10.1097/00002060-199711000-00002; WROBLEWSKI BA, 1994, J HEAD TRAUMA REHAB, V9, P19, DOI 10.1097/00001199-199409000-00004; WROBLEWSKI BA, 1990, J CLIN PSYCHOPHARM, V10, P124, DOI 10.1097/00004714-199004000-00009	36	8	8	0	2	TAYLOR & FRANCIS LTD	LONDON	11 NEW FETTER LANE, LONDON EC4P 4EE, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.	APR	2000	14	4					383	391					9	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	302UE	WOS:000086383400008	10815846				2022-02-06	
J	Zaricznyj, B				Zaricznyj, B			Transverse divergent dislocation of the elbow	CLINICAL ORTHOPAEDICS AND RELATED RESEARCH			English	Article								A girl 6 years 5 months old sustained a rare transverse (mediolateral) divergent dislocation of the elbow and was treated by closed reduction, The arm was immobilized in a cast. Followup was 7 years 5 months, Five Sears after injury, the patient had recurrent popping on the lateral aspect of the injured elbow during active flexion from complete extension and tenderness on the anterior aspect of the radiohumeral joint. To determine the exact anatomic relation of the proximal radius and ulna to each other and to the distal humerus after transverse dislocation, a skeleton of the elbow was assembled in the dislocated position, and multiple radiographs and photographs were taken and compared with the radiographs of the patient's injured elbow. This showed that the ulna was displaced posteromedially, with the coronoid process impinged against the distal and medial portions of the trochlea, and that the radial head was displaced lateral to the capitellum, anterior and distal to the lateral epicondyle, The distal end of the humerus was caught by the radius and the ulna and was rotated anteriorly and laterally, primarily by the displaced coronoid process, Because of this rotation of the humerus, the lateral radiograph of the elbow gave the impression that the head of the radius was displaced posteriorly.	So Illinois Univ, Sch Med, Div Orthopaed Surg & Rehabil, Springfield, IL 62704 USA		Zaricznyj, B (corresponding author), So Illinois Univ, Sch Med, Div Orthopaed Surg & Rehabil, 125 Oakmont Dr, Springfield, IL 62704 USA.						ANDERSEN K, 1985, ACTA ORTHOP SCAND, V56, P442, DOI 10.3109/17453678508994369; SOVIO OM, 1986, J PEDIATR ORTHOPED, V6, P96, DOI 10.1097/01241398-198601000-00018; STIMSON LA, 1900, PRACTICAL TREATISE F, P639; WARMONT A, 1854, MON HOSP J PROG MED, P961; WATSONJONES R, 1955, FRACTURES JOINT INJU, P559; WILKINS KE, 1991, FRACTURES CHILDREN, P806	6	8	8	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0009-921X			CLIN ORTHOP RELAT R	Clin. Orthop. Rel. Res.	APR	2000		373					146	152					7	Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Surgery	303RJ	WOS:000086437400019	10810472				2022-02-06	
J	von Oettingen, G; Bergholt, B; Rasmussen, M; Ostergaard, L; Astrup, J				von Oettingen, G; Bergholt, B; Rasmussen, M; Ostergaard, L; Astrup, J			Pulmonary function affects the quantification of rCBF by non-invasive xenon methods	JOURNAL OF NEUROSCIENCE METHODS			English	Article						input function; computer simulation; quantitative cerebral blood flow; xenon/CT CBF; traumatic brain injury	CEREBRAL BLOOD-FLOW; COMPUTED-TOMOGRAPHY; HEAD-INJURY; BRAIN; ISCHEMIA; CT; METABOLISM; INHALATION; XE-133	Estimates of regional cerebral blood flow (rCBF) by non-invasive xenon methods (133-xenon inhalation, xenon-enhanced computed tomography (Xe/CT) and 133-xenon iv injection) are frequently applied in the diagnosis and evaluation of patients suffering from diseases which cause disturbances in the cerebrovascular circulation. These methods all depend on an estimate of the arterial xenon concentration curve derived non-invasively from measurements of the end-tidal xenon concentration curve and used as brain input function in the Kety equation. We have studied the influence of impaired pulmonary gas exchange on the end-tidal and arterial xenon concentration curves in nine anaesthetized pigs by simultaneously measurements of both the end-tidal xenon and arterial xenon concentration curves. Computer simulations were performed to determine the deviations in the calculated rCBF values when using the end-tidal as compared to the arterial xenon concentration curve as brain input function. The results indicated that impairment of the pulmonary gas exchange caused a significant further 'delay' in the arterial xenon concentration curve in comparison to the end-tidal xenon concentration curve. The time constants of arterial curve delay were 11.9 s in the normal pulmonary group, 21 s in the right lung atelectasis group, and 19.7 s in the left pulmonary artery occlusion group. Accordingly, computer simulations indicated a statistically significant 'underestimation' of rCBF due to: (1) pulmonary gas exchange; (2) high or low levels of rCBF; (3) partition coefficient (lambda) of gray and white matter; and (4) xenon inhalation protocols. Our results indicate that quantitative measurements of rCBF by non-invasive xenon methods are markedly affected by deviations between the end-tidal and arterial xenon concentration curve, so that estimates of flow thresholds for infarction are problematic under conditions of impaired pulmonary gas exchange. (C) 2000 Elsevier Science B.V. All rights reserved.	Aarhus Univ Hosp, Dept Neurosurg, DK-8000 Aarhus C, Denmark; Aarhus Univ Hosp, Dept Neuroradiol, DK-8000 Aarhus, Denmark		von Oettingen, G (corresponding author), Aarhus Univ Hosp, Dept Neurosurg, DK-8000 Aarhus C, Denmark.		Rasmussen, Mads/R-4876-2019; Ostergaard, Leif/A-9281-2008; Ostergaard, Lars/AAA-3020-2020	Rasmussen, Mads/0000-0002-0416-6767; Ostergaard, Leif/0000-0003-2930-6997; Ostergaard, Lars/0000-0003-2459-0511; Ostergaard, Lars/0000-0002-7619-605X			AGNOLI A, 1969, CEREBRAL BLOOD FLOW, P31; ASTRUP J, 1995, QUANTITATIVE CEREBRAL BLOOD FLOW MEASUREMENTS USING STABLE XENON/CT: CLINICAL APPLICATIONS, P267; AUSTIN G, 1972, EUR NEUROL, V8, P43, DOI 10.1159/000114549; BOUMA GJ, 1991, J NEUROSURG, V75, P685, DOI 10.3171/jns.1991.75.5.0685; EGER EH, 1964, ANESTHESIOLOGY, V25, P20; FATOUROS PP, 1987, INVEST RADIOL, V22, P705, DOI 10.1097/00004424-198709000-00003; FATOUROS PP, 1995, QUANTITATIVE CEREBRAL BLOOD FLOW MEASUREMENTS USING STABLE XENON/CT: CLINICAL APPLICATIONS, P73; GOOD WF, 1987, MED PHYS, V14, P377, DOI 10.1118/1.596051; GUR D, 1984, MED PHYS, V11, P209, DOI 10.1118/1.595604; HANSEN M, 1990, STROKE, V21, P745, DOI 10.1161/01.STR.21.5.745; HOLL K, 1995, CLIN APPL, P41; KASHIWAGI S, 1992, AM J NEURORADIOL, V13, P49; KETY SS, 1951, PHARMACOL REV, V3, P1; Lassen N A, 1972, Prog Nucl Med, V1, P376; MALLETT BL, 1963, LANCET, V1, P1081; MEYER JS, 1980, AM J ROENTGENOL, V135, P239, DOI 10.2214/ajr.135.2.239; MILLER JD, 1985, BRIT J ANAESTH, V57, P120, DOI 10.1093/bja/57.1.120; NORTH JB, 1974, ARCH NEUROL-CHICAGO, V31, P338, DOI 10.1001/archneur.1974.00490410086010; OBRIST WD, 1990, CEREBROVAS BRAIN MET, V2, P283; OBRIST WD, 1984, J NEUROSURG, V61, P241, DOI 10.3171/jns.1984.61.2.0241; Obrist WD, 1998, J CEREBR BLOOD F MET, V18, P1192, DOI 10.1097/00004647-199811000-00005; OBRIST WD, 1967, CIRC RES, V20, P124, DOI 10.1161/01.RES.20.1.124; OBRIST WD, 1988, HDB REGIONAL CEREBRA, P37; POLACIN A, 1991, MED PHYS, V18, P1025, DOI 10.1118/1.596738; Press WH., 1992, NUMERICAL RECIPES FO, V2; SHIMODA M, 1992, NEURORADIOLOGY, V35, P66, DOI 10.1007/BF00588282; STOELTING RK, 1972, ANESTHESIOLOGY, V36, P352, DOI 10.1097/00000542-197204000-00009; SUGA S, 1992, CEREBRAL BLOOD FLOW MEASUREMENT WITH STABLE XENON-ENHANCED COMPUTED TOMOGRAPHY, P50; VEALL N, 1966, CLIN SCI, V30, P353; WINKLER S, 1985, CEREBRAL BLOOD FLOW, P356; WINKLER SS, 1977, INVEST RADIOL, V12, P15, DOI 10.1097/00004424-197701000-00005; YONAS H, 1989, NEUROSURGERY, V24, P368, DOI 10.1227/00006123-198903000-00010	32	8	8	0	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0165-0270			J NEUROSCI METH	J. Neurosci. Methods	FEB 15	2000	95	2					159	169		10.1016/S0165-0270(99)00179-X			11	Biochemical Research Methods; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	287NR	WOS:000085512600009	10752487				2022-02-06	
J	Wright, J; Bushnik, T; O'Hare, P				Wright, J; Bushnik, T; O'Hare, P			The Center for Outcome Measurement in Brain Injury (COMBI): An Internet resource you should know about	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						Internet; outcome measurement; traumatic brain injury	RATING-SCALE	Objective: This article describes the Center for Outcome Measurement in Brain Injury (COMBI), an Internet resource that provides information on brain injury outcome measures. Funded by the National institute on Disability and Rehabilitation Research (NIDRR), the COMBI is a collaborative project of eight Traumatic Brain Injury (TBI) Model System centers, Information the COMBI provides includes rating, scales and form(s) syllabus and administration guidelines, descriptions of properties, references In the literature, a frequently asked questions (FAQ) section, training and resting materials, and contact information. Conclusions: As a dissemination effort, the results of the COMBI project have been outstanding with over 1,500 users accessing information every month. The project has a truly international scope, with 20% of its users being outside the United States.	Santa Clara Valley Med Ctr, San Jose, CA 95128 USA		Wright, J (corresponding author), 950 S Bascom Ave,Suite 2011, San Jose, CA 95128 USA.			Bushnik, Tamara/0000-0003-3328-257X	PHS HHSUnited States Department of Health & Human ServicesUnited States Public Health Service [H133A970018] Funding Source: Medline		[Anonymous], 1997, GUIDE UNIFORM DATA S; Boake C, 1996, ARCH PHYS MED REHAB, V77, P765, DOI 10.1016/S0003-9993(96)90254-3; CORRIGAN JD, 1989, J CLIN EXP NEUROPSYC, V11, P261, DOI 10.1080/01688638908400888; DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13; Hagen C., 1972, LEVELS COGNITIVE FUN; Hal KM, 1997, J REHABILITATION OUT, V1, P63; JENNETT B, 1975, LANCET, V1, P480; KREUTZER J, 1999, NEUROBEHAVIORAL FUNC; Malec J. F., 1994, J HEAD TRAUMA REHAB, V9, P1, DOI [10. 1097/ 00001199- 199412000- 00003, DOI 10.1097/00001199-199412000-00003]; Prigatano G.P., 1986, NEUROPSYCHOLOGICAL R; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; WHITENECK GG, 1992, ARCH PHYS MED REHAB, V73, P519; WILLER B, 1993, J HEAD TRAUMA REHABI, V0003, P00075, DOI DOI 10.1097/00001199-199308020-00009	13	8	9	0	1	ASPEN PUBL INC	FREDERICK	7201 MCKINNEY CIRCLE, FREDERICK, MD 21704 USA	0885-9701			J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	FEB	2000	15	1					734	738		10.1097/00001199-200002000-00011			5	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	287MX	WOS:000085510800012	10745188				2022-02-06	
J	Jiang, ZW; Gong, QZ; Di, X; Zhu, JP; Lyeth, BG				Jiang, ZW; Gong, QZ; Di, X; Zhu, JP; Lyeth, BG			Dicyclomine, an M1 muscarinic antagonist, reduces infarct volume in a rat subdural hematoma model	BRAIN RESEARCH			English	Article						acetylcholine; muscarinic; receptor; dicyclomine; traumatic brain injury; rat	EXPERIMENTAL BRAIN INJURY; SIGNAL-TRANSDUCTION PATHWAY; CEREBRAL BLOOD-FLOW; PHOSPHATIDYLINOSITOL BISPHOSPHATE; HYPERTENSIVE RATS; TISSUE-LEVELS; ACETYLCHOLINE; ISCHEMIA; METABOLISM; PHARMACOLOGY	The rat subdural hematoma (SDH) model produces a zone of ischemic brain damage within the hemisphere beneath the SDH. Previous studies have measured large increases in extracellular acetylcholine during cerebral ischemia in the rat. We examined infarct volume after selectively blocking muscarinic M1 receptors with dicyclomine during SDH. Rats were anesthetized with isoflurane (2%), intubated, and femoral artery and vein cannulated. Autologous blood (0.375 ml) was injected (0.05 ml/min) under the dura of the right parietal cortex. Dicyclomine (5 mg/kg, i.v.) was injected at 5 min after and again at 2 h after completion of the subdural blood infusion. Blood pressure and intracranial pressure (ICP) were continuously measured. At 4 h after SDH rats were euthanized, brains sectioned, and immunoreacted with glia fibrillary acidic protein. Cortical infarct volume was quantified in coronal brain sections at 0.7-mm intervals from +1.0 mm to -3.9 mm relative to bregma. Infarct volume in drug-treated rats (n = 10) 22.1 +/- 6.99 mm(3) was significantly smaller (p < 0.02) than vehicle treated rats (n = 10) 56.7 +/- 9.59 mm(3). ICP, blood pressure and cerebral perfusion pressure were not significantly different between groups. These data suggest that activation of M1 muscarinic receptors during an ischemic event may contribute to the development of subsequent pathology. (C) 2000 Elsevier Science B.V. All rights reserved.	Univ Calif Davis, Dept Neurol Surg, Davis, CA 95616 USA; Virginia Commonwealth Univ, Div Neurosurg, Richmond, VA USA		Lyeth, BG (corresponding author), Univ Calif Davis, Dept Neurol Surg, 1515 Newton Court,1 Shields Ave, Davis, CA 95616 USA.			Lyeth, Bruce/0000-0003-4811-1474	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS029995] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS29995] Funding Source: Medline		Bertrand N, 1996, NEUROCHEM INT, V28, P293, DOI 10.1016/0197-0186(95)00086-0; DAUPHIN F, 1990, EUR J PHARMACOL, V178, P203, DOI 10.1016/0014-2999(90)90476-M; DHILLON HS, 1995, BRAIN RES, V698, P100, DOI 10.1016/0006-8993(95)00840-M; DOODS HN, 1987, J PHARMACOL EXP THER, V242, P257; FRANDSEN A, 1993, J NEUROCHEM, V60, P1202, DOI 10.1111/j.1471-4159.1993.tb03278.x; FROLICH L, 1993, NEUROCHEM RES, V18, P1239, DOI 10.1007/BF00975041; GORMAN LK, 1989, J NEUROTRAUM, V6, P203; HAYES RL, 1992, J NEUROTRAUMA S1, V9, P173; JONES SVP, 1993, LIFE SCI, V52, P457, DOI 10.1016/0024-3205(93)90302-J; KOZUKA M, 1995, NEUROCHEM RES, V20, P23, DOI 10.1007/BF00995148; KUMAGAE Y, 1991, J NEUROCHEM, V56, P1169, DOI 10.1111/j.1471-4159.1991.tb11407.x; KURODA Y, 1992, NEUROSURGERY, V30, P687; KURODA Y, 1992, J NEUROSURG, V76, P471, DOI 10.3171/jns.1992.76.3.0471; Liu D, 1999, MOL BRAIN RES, V68, P29, DOI 10.1016/S0169-328X(99)00063-7; Lyeth BG, 1996, BRAIN RES, V742, P63, DOI 10.1016/S0006-8993(96)01002-5; LYETH BG, 1992, BRAIN RES, V569, P281, DOI 10.1016/0006-8993(92)90640-U; LYETH BG, 1988, BRAIN RES, V448, P88, DOI 10.1016/0006-8993(88)91104-3; LYETH BG, 1993, MOL CHEM NEUROPATHOL, V18, P247, DOI 10.1007/BF03160117; LYETH BG, 1988, BRAIN RES, V452, P39, DOI 10.1016/0006-8993(88)90006-6; MENDELOW AD, 1986, INTRACRANIAL PRESSUR, P515; MICHEL RP, 1988, J MICROSC-OXFORD, V150, P117, DOI 10.1111/j.1365-2818.1988.tb04603.x; MILLER JD, 1990, NEUROSURGERY, V27, P433, DOI 10.1227/00006123-199009000-00016; OLNEY JW, 1983, NATURE, V301, P520, DOI 10.1038/301520a0; Patel TR, 1999, BRAIN RES, V829, P125, DOI 10.1016/S0006-8993(99)01378-5; PRASAD MR, 1994, J NEUROCHEM, V63, P773; ROBINSON SE, 1990, BRAIN RES, V511, P141, DOI 10.1016/0006-8993(90)90233-2; ROBINSON SE, 1990, BRAIN RES, V509, P41, DOI 10.1016/0006-8993(90)90306-V; SADOSHIMA S, 1995, J CEREBR BLOOD F MET, V15, P845, DOI 10.1038/jcbfm.1995.105; SCREMIN OU, 1991, STROKE, V22, P643, DOI 10.1161/01.STR.22.5.643; WALLIS RM, 1995, LIFE SCI, V56, P861, DOI 10.1016/0024-3205(94)00021-J	30	8	8	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993			BRAIN RES	Brain Res.	JAN 3	2000	852	1					37	44		10.1016/S0006-8993(99)02230-1			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	269XC	WOS:000084501900005	10661493				2022-02-06	
J	Jaffe, MP; O'Neill, J; Vandergoot, D; Gordon, WA; Small, B				Jaffe, MP; O'Neill, J; Vandergoot, D; Gordon, WA; Small, B			The unveiling of traumatic brain injury in an HIV/AIDS population	BRAIN INJURY			English	Article							INTRAVENOUS-DRUG-USERS; HUMAN-IMMUNODEFICIENCY-VIRUS; HIV-INFECTION; HEAD-INJURY; AIDS; PERFORMANCE; COHORT; RISK	This study examines the frequency of traumatic brain injury (TBI) in an HIV/AIDS population and its associated symptomatology. A panel of 173 individuals with HIV were split into two groups-those who have: experienced a blow to the head within their lifetime (n = 128) and those who have nor (n = 45). Self-reported symptoms from the TIRR Symptom Checklist were compared across both HIV panels, individuals who identified as traumatically brain injured (n = 416), and individuals with no disability (n = 282.). Six clusters of symptoms (total, cognitive, physical, affective/behavioural, five symptoms sensitive and specific to TBI in general and 25 symptoms sensitive and specific to mild TBI) were analysed in a MANOVA, controlling for the demographic variables that were correlated with total symptoms, including panel membership, education, annual household income and substance use history:. Significant main effects were found for panel membership. Individuals with HIV and a history of blow to the head reported a higher number of total symptoms and the 25 symptoms specific to mild TBI The significance of these findings acknowledges the need to recognize the frequency of TBI in an HIV population and the subsequent need to provide the appropriate interventions that will lead to an enhanced overall quality of life.	CUNY Mt Sinai Sch Med, Dept Rehabil Med, New York, NY 10029 USA; Ctr Essential Management Serv, Jericho Turnpike, NY USA; CUNY Hunter Coll, New York, NY 10021 USA; Mobilizing Talents & Skills, New York, NY USA		Gordon, WA (corresponding author), CUNY Mt Sinai Sch Med, Dept Rehabil Med, Box 1240,1425 Madison Ave, New York, NY 10029 USA.	Wayne_Gordon@mssm.edu					ALLEN DN, 1998, CLIN NEUROPSYCHOLOGY, P591; Castellon SA, 1998, J NEUROPSYCH CLIN N, V10, P320, DOI 10.1176/jnp.10.3.320; CLAYPOOLE KH, 1993, INT J NEUROSCI, V70, P13, DOI 10.3109/00207459309000557; EGAN VG, 1990, AIDS, V4, P651, DOI 10.1097/00002030-199007000-00007; GORDON WA, 1999, IN PRESS BRAIN INJUR; Gordon WR, 1998, J HEAD TRAUMA REHAB, V13, P39, DOI 10.1097/00001199-199812000-00006; Heaton R K, 1995, J Int Neuropsychol Soc, V1, P231; HEATON RK, 1995, PSYCHOSOM MED, V52, P1174; HESTAD K, 1995, SCAND J PSYCHOL, V36, P246, DOI 10.1111/j.1467-9450.1995.tb00984.x; Lehmkuhl D, 1988, TIRR SYMPTOM CHECKLI; Lopez OL, 1998, J NEUROPSYCH CLIN N, V10, P343, DOI 10.1176/jnp.10.3.343; LOPEZ OL, 1998, CLIN NEUROPSYCHOLOGY, P341; MARDER K, 1992, ARCH NEUROL-CHICAGO, V49, P1169, DOI 10.1001/archneur.1992.00530350083023; MARDER K, 1995, ARCH NEUROL-CHICAGO, V52, P1174, DOI 10.1001/archneur.1995.00540360052016; Mason KI, 1998, J NATL MED ASSOC, V90, P665; McGuire LM, 1998, BRAIN INJURY, V12, P207, DOI 10.1080/026990598122683; PERDICES M, 1990, J ACQ IMMUN DEF SYND, V3, P555; WELLMAN MC, 1992, INT J NEUROSCI, V64, P183, DOI 10.3109/00207459209000544; WILKINS JW, 1990, J ACQ IMMUN DEF SYND, V3, P938; 1994, QUALITY LIFE INTERVI; 1998, SPSS WINDOWS VERSION	21	8	8	0	1	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JAN	2000	14	1					35	44		10.1080/026990500120916			10	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	274CY	WOS:000084747200005	10670660				2022-02-06	
J	Rayls, KR; Mittenberg, W; Burns, WJ; Theroux, S				Rayls, KR; Mittenberg, W; Burns, WJ; Theroux, S			Prospective study of the MMPI-2 correction factor after mild head injury	CLINICAL NEUROPSYCHOLOGIST			English	Article							POSTCONCUSSION SYNDROME; TRAUMA	Gass (1991) proposed a correction factor composed of 14 MMPI-2 items that were characteristically endorsed by patients with closed-head injury. Their frequency of occurrence suggested that the items reflected the neurological rather than emotional consequences of head injury. The current study was designed to evaluate the interpretive significance of correction factor items after mild head trauma. Patients were examined immediately upon hospitalization and followed prospectively for at least 3 months. Correction factor items were endorsed more frequently during acute hospitalization than in the MMPI-2 standardization sample. At follow-up, none of the items were endorsed more often by patients with chronic mild head injury than by uninjured controls. These results suggest that the correction factor is sensitive to the acute neurological consequences of mild head trauma, but that these symptoms can typically be expected to resolve. Chronic endorsement of the items in this population is therefore most likely related to psychological factors.	Nova SE Univ, Ctr Psychol Studies, Ft Lauderdale, FL 33314 USA; Utah State Hosp, Provo, UT USA		Mittenberg, W (corresponding author), Nova SE Univ, Ctr Psychol Studies, 3301 Coll Ave, Ft Lauderdale, FL 33314 USA.	wiley@cps.nova.edu					Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P421, DOI 10.1080/01688639708403870; Brulot MM, 1997, CLIN NEUROPSYCHOL, V11, P391, DOI 10.1080/13854049708400468; Butcher J.N., 1989, MANUAL RESTANDARDIZE; Dunn JT, 1995, ASSESSMENT, V2, P47; Eisenberg H.M., 1989, MILD HEAD INJURY, P133; Ferguson RJ, 1999, NEUROPSYCHOLOGY, V13, P582, DOI 10.1037/0894-4105.13.4.582; Gass CS, 1997, ARCH CLIN NEUROPSYCH, V12, P199, DOI 10.1016/S0887-6177(96)00032-7; GASS CS, 1991, PSYCHOL ASSESSMENT J, V3, P27; Guilmette T J, 1990, Arch Clin Neuropsychol, V5, P373, DOI 10.1016/0887-6177(90)90016-I; LARRABEE GJ, 2000, IN PRESS DIFFERERNTI; LEVIN HS, 1992, J NEUROL NEUROSUR PS, V55, P255, DOI 10.1136/jnnp.55.4.255; LEVIN HS, 1987, J NEUROSURG, V66, P234, DOI 10.3171/jns.1987.66.2.0234; Miller L J, 1998, Appl Neuropsychol, V5, P172, DOI 10.1207/s15324826an0504_2; Mittenberg W, 1997, NEUROPSYCHOLOGY, V11, P447, DOI 10.1037/0894-4105.11.3.447; Mittenberg W, 1996, ARCH CLIN NEUROPSYCH, V11, P139, DOI 10.1016/0887-6177(95)00006-2; MITTENBERG W, 2000, IN PRESS J HEAD TRAU; MITTENBERG W, 1992, J NEUROL NEUROSUR PS, V41, P611; Ruff R. M., 1989, MILD HEAD INJURY, P176; World Health Organization, 2004, ICD 10 INT STAT CLAS	19	8	8	0	0	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1385-4046	1744-4144		CLIN NEUROPSYCHOL	Clin. Neuropsychol.		2000	14	4					546	550		10.1076/clin.14.4.546.7194			5	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	398CD	WOS:000166737600010	11262723				2022-02-06	
J	Ishikawa, M; Sekizuka, E; Sato, S; Yamaguchi, N; Inamasu, J; Kawase, T				Ishikawa, M; Sekizuka, E; Sato, S; Yamaguchi, N; Inamasu, J; Kawase, T			Glycerol attenuates the adherence of leukocytes in rat pial venules after transient middle cerebral artery occlusion	NEUROLOGICAL RESEARCH			English	Article						glycerol; leukocyte adhesion; leukocyte velocity; pial venule; focal ischemia	ISCHEMIC CELL-DAMAGE; TRAUMATIC BRAIN INJURY; BLOOD-FLOW; INFARCTION; MICROCIRCULATION; ACCUMULATION; NEUTROPHIL; ADHESION; INFUSION	Intravenous infusion of glycerol has been used in patients with a cerebral infarction, expecting improvement in brain edema and cerebral blood flow (CBF). However, the mechanism of the improvement of CBF has not been clearly demonstrated. The aim of this study in the rat pial microvasculature after transient middle cerebral artery occlusion (MCAO) is to examine the effects of glycerol on leukocyte-endothelium interaction, which plays a critical role in the pathogenesis of brain injury by ischemia/reperfusion and concerns induction of secondary brain damage. Rhodamine 6G-labeled leukocytes at the brain surface were visualized with intra-vital fluorescence videomicroscopy through a closed cranial window and an analysis was made of the number of adherent leukocytes and the centerline leukocyte velocity in the venule before MCAO, after reperfusion of MCAO and after infusion of glycerol (Group 1) or saline (Group 2). The number of adherent leukocytes decreased and the centerline leukocyte velocity increased statistically significantly immediately after the infusion of glycerol in Group 1, but there was no significant change in Group 2. The infusion of glycerol washes away the adherent leukocytes and prevents them from interfering with the blood cell and plasma flow Furthermore, secondary brain damage may be relieved by decreasing the adherence of leukocytes. In conclusion, modulating the adherence of leukocytes is one of the important factors in the neuroprotective effect of glycerol.	Keio Univ, Sch Med, Dept Neurosurg, Tokyo 160, Japan		Ishikawa, M (corresponding author), Philipps Univ Hosp, Dept Neurosurg, Baldingerstr, D-35033 Marburg, Germany.		Inamasu, Joji/R-7314-2019				ANTONINI FM, 1977, GERONTOLOGY, V23, P376, DOI 10.1159/000212211; CHEN H, 1994, ANN NEUROL, V35, P458, DOI 10.1002/ana.410350414; CHOPP M, 1994, STROKE, V25, P869, DOI 10.1161/01.STR.25.4.869; Del Zoppo GJ., 1995, PHYSL PATHOPHYSIOLOG, P408; DIRNAGL U, 1994, STROKE, V25, P1028, DOI 10.1161/01.STR.25.5.1028; GARCIASOLA R, 1991, ACTA NEUROCHIR, V109, P114, DOI 10.1007/BF01403005; GRANGER DN, 1994, J LEUKOCYTE BIOL, V55, P662, DOI 10.1002/jlb.55.5.662; GUTE D, 1995, PHYSL PATHOPHYSIOLOG, P359; HALLENBECK JM, 1986, STROKE, V17, P246, DOI 10.1161/01.STR.17.2.246; Hartl R, 1997, J TRAUMA, V42, pS41, DOI 10.1097/00005373-199705001-00008; Hartl R, 1996, J CEREBR BLOOD F MET, V16, P1108; Hartl R, 1997, J CEREBR BLOOD F MET, V17, P1210; HATASHITA S, 1982, Neurologia Medico-Chirurgica, V22, P972, DOI 10.2176/nmc.22.972; Ishikawa M, 1998, MICROVASC RES, V56, P166, DOI 10.1006/mvre.1998.2100; Ishikawa M, 1999, NEUROSURGERY, V44, P156, DOI 10.1097/00006123-199901000-00096; ISHIKAWA M, 1998, MICROCIRC ANN, V14, P83; KOCHANEK PM, 1992, STROKE, V23, P1367, DOI 10.1161/01.STR.23.9.1367; MATSUO Y, 1994, STROKE, V25, P1469, DOI 10.1161/01.STR.25.7.1469; MEMEZAWA H, 1992, EXP BRAIN RES, V89, P67; MEYER JS, 1975, CIRCULATION, V51, P701, DOI 10.1161/01.CIR.51.4.701; MEYER JS, 1971, LANCET, V2, P993; MORI E, 1992, STROKE, V23, P712, DOI 10.1161/01.STR.23.5.712; MORII S, 1986, J CEREBR BLOOD F MET, V6, P34, DOI 10.1038/jcbfm.1986.5; MUIZELAAR JP, 1986, STROKE, V17, P44, DOI 10.1161/01.STR.17.1.44; OTT EO, 1974, NEUROLOGY, V24, P1117, DOI 10.1212/WNL.24.12.1117; SASAKI T, 1983, BRAIN NERVE JPN, V35, P505; SEKIZUKA E, 1991, GASTROINTESTINAL FUN, V9, P93; SHIGA Y, 1991, NEUROSCI LETT, V125, P110, DOI 10.1016/0304-3940(91)90003-C; Tomita M, 1996, ACT NEUR S, V66, P32; VILLRINGER A, 1991, MICROVASC RES, V42, P305, DOI 10.1016/0026-2862(91)90064-I; ZHANG RL, 1995, STROKE, V26, P1438, DOI 10.1161/01.STR.26.8.1438; ZHANG RL, 1994, NEUROLOGY, V44, P1747, DOI 10.1212/WNL.44.9.1747	32	8	8	0	0	FOREFRONT PUBL GROUP	WILTON	C/O MARY J RAWLINS, 5 RIVER RD, STE 113, WILTON, CT 06897 USA	0161-6412			NEUROL RES	Neurol. Res.	DEC	1999	21	8					785	790		10.1080/01616412.1999.11741015			6	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	260KA	WOS:000083947500013	10596390				2022-02-06	
J	Rockich, KT; Hatton, JC; Kryscio, RJ; Young, BA; Blouin, RA				Rockich, KT; Hatton, JC; Kryscio, RJ; Young, BA; Blouin, RA			Effect of recombinant human growth hormone and insulin-like growth factor-1 administration on IGF-1 and IGF-binding protein-3 levels in brain injury	PHARMACOTHERAPY			English	Article; Proceedings Paper	37th Interscience Conference on Antimicrobial Agents and Chemotherapy	SEP 28-OCT 03, 1997	TORONTO, CANADA				FACTOR-I; SOMATOMEDIN-C; COMPLEX; SERUM; DEGRADATION; FIBROBLAST; PHASE; ACID	Study Objective. To assess the effect of recombinant human growth hormone (rhGH) on the insulin-like growth factor-1 (IGF-1) plasma concentration versus time profile during continuous infusion of recombinant human (rh)IGF-1 to patients with traumatic brain injury (TBI). Setting, University of Kentucky Chandler Medical Center. Patients. Twenty-three patients with TBI (aged 18-59 yrs) with Glascow Coma Scale scores of 4-10. Intervention. Patients were randomized to receive rhIGF-1 0.01 mg/kg/hour and daily subcutaneous doses of rhGH 0.05 mg/kg/day or saline for 14 days. Measurements and Main Results. Plasma concentrations of IGF-1 and IGF-binding protein (BP)-3 were quantified by radioimmunoassay. Patients receiving rhIGF-1/rhGH reached a peak IGF-1 concentration (1199.3 +/- 84.0 mu g/L) at 72 hours and maintained it throughout the study. Levels of IGF-1 in the control group did not change significantly above baseline throughout the study. Concentrations of IGFBP-3 were significantly higher after 48 hours in the treated group (5.1 +/- 0.4 mg/L) than in controls (2.9 +/- 0.5 mg/L) and continued until the end of the study (p<0.05). Conclusion. Infusion of rhIGF-1 in conjunction with rhGH effectively achieved, and maintained supraphysiologic IGF-1 plasma concentrations throughout the dosing period in patients with TBI. It. appears that rhGH alters the IGF-1 plasma concentration versus time profile during continuous administration. Although speculative, changes in protein binding of IGF-1 are the most likely mechanism.	Univ Kentucky, Coll Pharm, Div Pharmaceut Sci, Lexington, KY 40536 USA; Univ Kentucky, Coll Pharm, Div Pharm Practice & Sci, Lexington, KY 40536 USA; Univ Kentucky, Coll Pharm, Div Stat, Lexington, KY 40536 USA; Univ Kentucky, Coll Pharm, Div Neurosurg, Lexington, KY 40536 USA; Univ Kentucky, Albert B Chandler Med Ctr, Lexington, KY 40536 USA		Blouin, RA (corresponding author), Univ Kentucky, Coll Pharm, Div Pharmaceut Sci, 907 Rose St, Lexington, KY 40536 USA.						BAXTER RC, 1989, J BIOL CHEM, V264, P11843; BAXTER RC, 1989, P NATL ACAD SCI USA, V86, P6898, DOI 10.1073/pnas.86.18.6898; BLAINE CW, 1993, ANN EMERG MED, V22, P970; BLUM WF, 1989, ENDOCRINOLOGY, V125, P766, DOI 10.1210/endo-125-2-766; BUSBY WH, 1989, ENDOCRINOLOGY, V125, P773, DOI 10.1210/endo-125-2-773; CLEMMONS DR, 1986, J CLIN INVEST, V77, P1548, DOI 10.1172/JCI112470; DAUGHADAY WH, 1989, ENDOCR REV, V10, P68, DOI 10.1210/edrv-10-1-68; DERCOLE AJ, 1977, ENDOCRINOLOGY, V101, P577, DOI 10.1210/endo-101-2-577; DOBERSTEIN CE, 1993, ANN EMERG MED, V22, P993, DOI 10.1016/S0196-0644(05)82740-4; ELGIN RG, 1987, P NATL ACAD SCI USA, V84, P3254, DOI 10.1073/pnas.84.10.3254; GENNARELLI TA, 1993, J EMERG MED, V1, P5; GILLETTE JR, 1973, ANN NY ACAD SCI, V226, P6, DOI 10.1111/j.1749-6632.1973.tb20464.x; Hatton J, 1997, J NEUROSURG, V86, P779, DOI 10.3171/jns.1997.86.5.0779; Hintz Raymond, 1995, Progress in Growth Factor Research, V6, P79, DOI 10.1016/0955-2235(96)00012-9; JEEVANANDAM M, 1992, CLIN NUTR, V11, P352, DOI 10.1016/0261-5614(92)90086-6; JEEVANANDAM M, 1992, SURGERY, V111, P495; JONES JI, 1995, ENDOCR REV, V16, P3, DOI 10.1210/er.16.1.3; Kelley KM, 1996, INT J BIOCHEM CELL B, V28, P619, DOI 10.1016/1357-2725(96)00005-2; KUPFER SR, 1993, J CLIN INVEST, V91, P391, DOI 10.1172/JCI116212; MCCUSKER RH, 1990, J CELL PHYSIOL, V144, P244, DOI 10.1002/jcp.1041440210; ODARCEDERLOF I, 1974, EUR J CLIN PHARMACOL, V7, P31, DOI 10.1007/BF00614387; PETERSEN SR, 1995, J TRAUMA, V39, P295, DOI 10.1097/00005373-199508000-00018; Rabkin R, 1996, KIDNEY INT, V49, P1134, DOI 10.1038/ki.1996.164; RECHLER MM, 1993, VITAM HORM, V47, P1, DOI 10.1016/S0083-6729(08)60444-6; RECHLER MM, 1992, GROWTH REGULAT, V2, P55; THISSEN JP, 1992, AM J PHYSIOL, V262, pE406, DOI 10.1152/ajpendo.1992.262.4.E406; TONSHOFF B, 1995, EUR J ENDOCRINOL, V132, P433, DOI 10.1530/eje.0.1320433; *US DEP HHS, 1982, VIT STAT US; WOJNAR MM, 1995, AM J PHYSIOL-REG I, V268, pR970, DOI 10.1152/ajpregu.1995.268.4.R970; YAMAMOTO H, 1995, J CLIN ENDOCR METAB, V80, P1179, DOI 10.1210/jc.80.4.1179	30	8	9	0	3	PHARMACOTHERAPY PUBLICATIONS INC	BOSTON	NEW ENGLAND MEDICAL CENTER BOX 806 171 HARRISON AVE, BOSTON, MA 02111 USA	0277-0008			PHARMACOTHERAPY	Pharmacotherapy	DEC	1999	19	12					1432	1436		10.1592/phco.19.18.1432.30891			5	Pharmacology & Pharmacy	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	262HZ	WOS:000084062400012	10600092				2022-02-06	
J	Arboleda-Florez, J				Arboleda-Florez, J			Mental illness in jails and prisons	CURRENT OPINION IN PSYCHIATRY			English	Article							TRAUMATIC BRAIN INJURY; REGIONAL SECURE UNIT; ILL SEX OFFENDERS; SUBSTANCE-ABUSE; DISORDERED OFFENDERS; RISK ASSESSMENT; VIOLENCE; POPULATION; HEALTH; MANAGEMENT	The large number of mental patients in prisons and jails and the challenges that they pose for proper services have become a problem that is practically intractable. With the concerns about the violence perpetrated by the mentally ill adding further to the problem, more research is required into coordination of services among branches of government, interinstitutional arrangements, and better community best practices to divert the mentally ill and to prevent reincarceration, Curr Opin Psychiatry 12:677-882. (C) 1999 Lippincott Wiliiams & Wilkins.	Queens Univ, Dept Psychiat, Kingston, ON K7L 3N6, Canada		Arboleda-Florez, J (corresponding author), Queens Univ, Dept Psychiat, Kingston, ON K7L 3N6, Canada.	ja9@post.queensu.ca					Andersen HS, 1999, ACTA PSYCHIAT SCAND, V99, P33, DOI 10.1111/j.1600-0447.1999.tb05382.x; Arboleda-Florez J, 1998, SOC PSYCH PSYCH EPID, V33, pS38, DOI 10.1007/s001270050208; Arboleda-Florez J, 1998, CAN J PSYCHIAT, V43, P989, DOI 10.1177/070674379804301002; Barnfield TV, 1998, BRAIN INJURY, V12, P951, DOI 10.1080/026990598122007; Barnfield TV, 1998, BRAIN INJURY, V12, P455, DOI 10.1080/026990598122421; Belfrage H, 1998, J FORENSIC PSYCHIATR, V9, P328, DOI 10.1080/09585189808402200; Brownlee I, 1998, J FORENSIC PSYCHIATR, V9, P413, DOI 10.1080/09585189808402207; Chesterman P, 1998, J FORENSIC PSYCHIATR, V9, P150, DOI 10.1080/09585189808402185; Chung MC, 1999, MED SCI LAW, V39, P31, DOI 10.1177/002580249903900107; De Taranto N, 1998, J FORENSIC PSYCHIATR, V9, P369, DOI 10.1080/09585189808402203; Deane MW, 1999, PSYCHIATR SERV, V50, P99, DOI 10.1176/ps.50.1.99; Draine J, 1999, PSYCHIATR SERV, V50, P56, DOI 10.1176/ps.50.1.56; Eastman N, 1999, BRIT MED J, V318, P206; Eronen M, 1998, SOC PSYCH PSYCH EPID, V33, pS13, DOI 10.1007/s001270050205; Estroff SE, 1998, SOC PSYCH PSYCH EPID, V33, pS95, DOI 10.1007/s001270050216; Exworthy T, 1998, J FORENSIC PSYCHIATR, V9, P395, DOI 10.1080/09585189808402206; Freer R, 1998, LANCET, V352, P1853, DOI 10.1016/S0140-6736(05)79917-7; Fryers T, 1998, BMJ-BRIT MED J, V317, P1025; Gordon H, 1998, J FORENSIC PSYCHIATR, V9, P571, DOI 10.1080/09585189808405374; Hart S.D., 1997, HCR 20 ASSESSING RIS; Hobson J, 1998, BRIT J CRIMINOL, V38, P504; James D, 1998, J FORENSIC PSYCHIATR, V9, P74, DOI 10.1080/09585189808402180; Jones J, 1998, J FORENSIC PSYCHIATR, V9, P58, DOI 10.1080/09585189808402179; Kaye S, 1998, DRUG ALCOHOL DEPEN, V53, P79, DOI 10.1016/S0376-8716(98)00107-0; Laing JM, 1998, MED SCI LAW, V38, P301, DOI 10.1177/002580249803800405; Lamb HR, 1998, PSYCHIATR SERV, V49, P483, DOI 10.1176/ps.49.4.483; Link BG, 1998, SOC PSYCH PSYCH EPID, V33, pS55, DOI 10.1007/s001270050210; MARSHALL M, 1999, COCHRANE LIBRARY, V1, P1; Mitchell EW, 1999, MED SCI LAW, V39, P23, DOI 10.1177/002580249903900106; Modestin J, 1998, PSYCHIAT CLIN NEUROS, V52, P547, DOI 10.1111/j.1440-1819.1998.tb02699.x; Peters RH, 1998, AM J DRUG ALCOHOL AB, V24, P573, DOI 10.3109/00952999809019608; Reith M, 1998, MED SCI LAW, V38, P221, DOI 10.1177/002580249803800307; Sahota K, 1998, J FORENSIC PSYCHIATR, V9, P161, DOI 10.1080/09585189808402186; Sahota K, 1998, J FORENSIC PSYCHIATR, V9, P267, DOI 10.1080/09585189808402196; Stueve A, 1998, SOC PSYCH PSYCH EPID, V33, pS61, DOI 10.1007/s001270050211; Swartz MS, 1998, SOC PSYCH PSYCH EPID, V33, pS75, DOI 10.1007/s001270050213; Thorburn KM, 1998, LANCET, V351, P1003, DOI 10.1016/S0140-6736(05)78993-5; Ventura LA, 1998, PSYCHIATR SERV, V49, P1330, DOI 10.1176/ps.49.10.1330; Warden J, 1998, BRIT MED J, V317, P1611, DOI 10.1136/bmj.317.7173.1611a; Watson W, 1998, J FORENSIC PSYCHIATR, V9, P519, DOI 10.1080/09585189808405371; Wolff N, 1998, J HEALTH POLIT POLIC, V23, P133	41	8	9	0	7	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0951-7367	1473-6578		CURR OPIN PSYCHIATR	Curr. Opin. Psychiatr.	NOV	1999	12	6					677	682		10.1097/00001504-199911000-00016			6	Psychiatry	Social Science Citation Index (SSCI)	Psychiatry	261YN	WOS:000084039000016					2022-02-06	
J	Hill, H				Hill, H			Traumatic brain injury: a view from the inside	BRAIN INJURY			English	Article								Information about the outcomes alter traumatic brain injury comes from observational studies and, increasingly, subjective sources. Narrative analysis provides an avenue to explore lire after the trauma, and a perspective that may illuminate critical aspects of the relationship between the health professional and health consumer. Language use by health professionals in their interactions with health consumers may profoundly bias expectations and outcomes. Terms such as 'recovery', for example, may be inappropriate, as severe traumatic brain injury may not be an injury that one is able to 'recover' from. If the brain is seen as the basis of the personality and is altered by the trauma, then, philosophically, it is difficult to argue that the person is the same as before. Concepts of rehabilitation alter severe traumatic brain injury should, therefore, take into account the expectation of the health consumer in shaping the outcomes and the possibility that new and adaptive patterns of behaviour need to be developed rather than focusing on returning to the pre-injured person. This introduces the notion of rehabilitation as assisting the injured person to re-orientate or rebuild their life using a new sec of 'maps' with which to navigate through life. The paradigm of 'new maps' is,positive, challenging, and honest as far as expectations are concerned, and encompasses the idea of actively exploring new and unknown territory.	Univ New S Wales, Sch Community Med, Sydney, NSW 2052, Australia		Hill, H (corresponding author), Univ New S Wales, Sch Community Med, Sydney, NSW 2052, Australia.	z1074237@student.unsw.edu.au					Antonak R. F., 1993, J HEAD TRAUMA REHAB, V8, P87, DOI DOI 10.1097/00001199-199312000-00009; BROOKS C, 1992, J AM STUD, V26, P126, DOI 10.1017/S002187580003053X; Finger S., 1982, BRAIN DAMAGE RECOVER; Frank Arthur W., 1997, WOUNDED STORYTELLER; GAGE FH, 1995, ANNU REV NEUROSCI, V18, P159, DOI 10.1146/annurev.ne.18.030195.001111; GRONWALL D, 1990, HEAD INJURY FACTS, P105; JENNETT B, 1975, LANCET, V1, P480; LANGFITT TW, 1978, J NEUROSURG, V48, P673, DOI 10.3171/jns.1978.48.5.0673; MERCER J.R., 1992, MENTAL RETARDATION Y, P15; Olver JH, 1996, BRAIN INJURY, V10, P841, DOI 10.1080/026990596123945; Sbordone RJ, 1998, BRAIN INJURY, V12, P505, DOI 10.1080/026990598122467; STUSS DT, 1992, J CONSULT CLIN PSYCH, V60, P349, DOI 10.1037/0022-006X.60.3.349; TELLIER A, 1990, J CONSULT CLIN PSYCH, V58, P531; THOMSEN IV, 1992, SCAND J REHABIL MED, P142; WILLER B, 1994, BRAIN INJURY, V8, P647, DOI 10.3109/02699059409151017	15	8	8	0	1	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	NOV	1999	13	11					839	844		10.1080/026990599121043			6	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	253FZ	WOS:000083547000001	10579656				2022-02-06	
J	Hoppers, P; Holm, SE				Hoppers, P; Holm, SE			The role of fiberoptic endoscopy in dysphagia rehabilitation	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						dysphagia; endoscopy; fluoroscopy; rehabilitation; traumatic brain injury	ASPIRATION	The clinical bedside swallow evaluation and videofluoroscopy routinely have been used for dysphagia management. This article explores clinical issues for dysphagia management in the population with brain injury in the acute rehabilitation setting. Citing the dysphagia, cognitive, and other relevant issues present in the population with brain injury the use of fiberoptic endoscopy to address dysphagia assessment and intervention is presented. Factors for decision making, a retrospective review of recent studies, and relevant cases are discussed.	Bayler Inst Rehabil, Dept Phys Med & Rehabil, Dallas, TX 75246 USA		Hoppers, P (corresponding author), Bayler Inst Rehabil, Dept Phys Med & Rehabil, 3505 Gaston Ave, Dallas, TX 75246 USA.						BASTIAN RW, 1991, OTOLARYNG HEAD NECK, V104, P339, DOI 10.1177/019459989110400309; Cherney LR, 1996, SEMIN NEUROL, V16, P349, DOI 10.1055/s-2008-1040993; FIELD LH, 1989, BRAIN INJURY, V3, P9; Kaye GM, 1997, ANN OTO RHINOL LARYN, V106, P705, DOI 10.1177/000348949710600817; Kim T, 1998, ANN OTO RHINOL LARYN, V107, P378, DOI 10.1177/000348949810700503; Langmore S E, 1988, Dysphagia, V2, P216, DOI 10.1007/BF02414429; Langmore SE, 1998, DYSPHAGIA, V13, P69, DOI 10.1007/PL00009559; LANGMORE SE, 1991, ANN OTO RHINOL LARYN, V100, P678; LAZARUS C, 1987, ARCH PHYS MED REHAB, V68, P79; Leder SB, 1998, DYSPHAGIA, V13, P19, DOI 10.1007/PL00009544; Logemann JA, 1983, EVALUATION TREATMENT; Logemann JA., 1993, MANUAL VIDEOFLUOROGR, V2nd ed.; Murray J, 1996, DYSPHAGIA, V11, P99, DOI 10.1007/BF00417898	13	8	8	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	OCT	1999	14	5					475	485		10.1097/00001199-199910000-00008			11	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	245MW	WOS:000083113600008	10653943				2022-02-06	
J	Stewart, L; Bullock, R; Teasdale, GM; Wagstaff, A				Stewart, L; Bullock, R; Teasdale, GM; Wagstaff, A			First observations of the safety and tolerability of a competitive antagonist to the glutamate NMDA receptor (CGS 19755) in patients with severe head injury	JOURNAL OF NEUROTRAUMA			English	Article						N-methyl-D-aspartate; head injury; neuroprotection; intracranial pressure; blood pressure; cerebral perfusion pressure; temperature	METHYL-D-ASPARTATE; EXCITATORY AMINO-ACIDS; FOCAL CEREBRAL-ISCHEMIA; TRAUMATIC BRAIN INJURY; CGS-19755; RAT; BINDING; MK-801; DAMAGE; SIZE	A dose escalation, safety, and tolerability study of a competitive antagonist to the N-methyl-D-aspartate (NMDA) glutamate receptor (CGS 19755, Selfotel) in patients with severe head injury is reported. The drug was administered i.v. on two separate occasions, 24 h apart, to 31 patients. The dosage was escalated during the study from 1 mg/kg to 6 mg/kg. Continuous monitoring of mean arterial pressure (MABP), intracranial. pressure (ICP), cerebral pressure (CPP), arterial oxygen saturation (SaO(2)), jugular bulb oxygen saturation (SJO2), and temperature was performed. Intermittent measurements of middle cerebral artery (MCA) velocity via transcranial Doppler ultrasound were also made 2 h before drug administration and continued for 24 h after dosing. The patients were ventilated and sedated with morphine and either midazolam or propofol. There were no behavioral changes during or after administration of the drug, and disorders of perception were reported by only three subjects, several days after relatively low doses; these were transient and were not recalled at later follow-up. We did not detect consistent changes in any of the hemodynamic parameters monitored, up to dosages of 3 mg/kg. After higher doses, some patients showed changes in MABP, ICP, and temperature during the 4 to 8-h period following the first bolus of the drug, with a return toward baseline afterwards. No consistent, serious, adverse events were considered to be due to drug effects, and death, in the one patient who died, was due to the effects of the injury. Our results indicate that CGS 19755 may be given at dosages less than or equal to 3-5 mg/kg with acceptable safety and tolerability in stable, ventilated, and carefully monitored severe head-injured patients.	So Gen Hosp, Inst Neurol Sci, Dept Neuroanesthesia, Glasgow G51 4TF, Lanark, Scotland; So Gen Hosp, Inst Neurol Sci, Dept Neurosurg, Glasgow G51 4TF, Lanark, Scotland; Virginia Commonwealth Univ, Med Coll Virginia, Dept Neurosurg, Richmond, VA 23298 USA		Stewart, L (corresponding author), So Gen Hosp, Inst Neurol Sci, Dept Neuroanesthesia, Glasgow G51 4TF, Lanark, Scotland.						BAKER AJ, 1993, J NEUROSURG, V79, P369, DOI 10.3171/jns.1993.79.3.0369; BENNETT DA, 1989, J PHARMACOL EXP THER, V250, P454; BERNARD PS, 1993, CGS 19755 EFFECTS FU; BIELENBERG GW, 1991, BRAIN RES, V552, P338, DOI 10.1016/0006-8993(91)90101-Z; BOAST CA, 1988, BRAIN RES, V442, P345, DOI 10.1016/0006-8993(88)91522-3; BULLOCK R, 1990, J CEREBR BLOOD F MET, V10, P668, DOI 10.1038/jcbfm.1990.120; Bullock R, 1995, ANN NY ACAD SCI, V765, P290, DOI 10.1111/j.1749-6632.1995.tb16586.x; BULLOCK R, 1991, J NEUROSURG, V74, P794, DOI 10.3171/jns.1991.74.5.0794; CHEN MH, 1991, J NEUROSURG, V74, P944, DOI 10.3171/jns.1991.74.6.0944; *CIBA GEIGY PROT 0, 199 CIB GEIG US; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; FRANCE CP, 1990, J PHARMACOL EXP THER, V255, P1271; FRANCE CP, 1989, EUR J PHARMACOL, V159, P133, DOI 10.1016/0014-2999(89)90697-3; GROTTA J, 1994, STROKE, V25, P255; GROTTA JC, 1990, ANN NEUROL, V27, P612, DOI 10.1002/ana.410270605; JENNETT WB, 1975, LANCET, V4, P480; KOEK W, 1990, J PHARMACOL EXP THER, V252, P349; KOEK W, 1988, FRONTIERS EXCITATORY, P535; KURAMAJI A, 1989, BRAIN RES, V496, P268; KURODA Y, 1994, NEUROSURGERY, V35, P106, DOI 10.1227/00006123-199407000-00016; LEHMANN J, 1988, EUR J PHARMACOL, V154, P89, DOI 10.1016/0014-2999(88)90368-8; LEHMANN J, 1988, J PHARMACOL EXP THER, V246, P65; MCCULLOCH J, 1991, EXCITATORY AMINO ACI, P287; MCCULLOCH J, 1992, 92029 CIB GEIG; MCINTOSH TK, 1992, FIDIA RES F S SERIES, V9, P247; MOERSCHBAECHER JM, 1991, EXCITATORY AMINO ACI, V5, P515; MURPHY DE, 1988, BRIT J PHARMACOL, V95, P932, DOI 10.1111/j.1476-5381.1988.tb11723.x; OHNO M, 1992, J PHARMACOL EXP THER, V263, P943; PANTER S S, 1990, Society for Neuroscience Abstracts, V16, P1340; PANTER SS, 1992, NEUROSCI LETT, V136, P165, DOI 10.1016/0304-3940(92)90040-E; PARK CK, 1988, ANN NEUROL, V24, P543, DOI 10.1002/ana.410240411; PERSSON L, 1989, J CEREB BLOOD FLOW M, V9, P5584; SANDA T, 1990, SOC NEUR ABSTR, V16, P1340; SAUER D, 1993, J CEREBR BLOOD F MET, V13, P595, DOI 10.1038/jcbfm.1993.77; Simmonds J. T., 1993, Society for Neuroscience Abstracts, V19, P1647; SIMON R, 1990, ANN NEUROL, V27, P606, DOI 10.1002/ana.410270604; STEWART L, 1997, IN PRESS HAEMODYNAMI; TAKIZAWA S, 1991, J CEREBR BLOOD F MET, V11, P786, DOI 10.1038/jcbfm.1991.136; TEASDALE G, 1974, LANCET, V2, P81; WILLETTS J, 1992, FIDIA RES FDN S SERI, V9, P203; WINGER G, 1991, FIDIA RES F S SERIES, V5, P539	41	8	8	0	0	MARY ANN LIEBERT INC PUBL	LARCHMONT	2 MADISON AVENUE, LARCHMONT, NY 10538 USA	0897-7151			J NEUROTRAUM	J. Neurotrauma	SEP	1999	16	9					843	850		10.1089/neu.1999.16.843			8	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	241EL	WOS:000082869700009	10521143				2022-02-06	
J	Tobe, EH; Schneider, JS; Mrozik, T; Lidsky, TI				Tobe, EH; Schneider, JS; Mrozik, T; Lidsky, TI			Persisting insomnia following traumatic brain injury	JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES			English	Article							SLEEP PHASE SYNDROME; DEPRIVATION	Persisting insomnia secondary to traumatic brain injury, rarely reported and documented, is described in an adult male following head injury. The neuronal mechanisms underlying this sleep disorder as well as the neuropsychological concomitants and therapeutic approaches are discussed.	New York State Inst Basic Res Dev Disabil, Dept Psychobiol, Staten Isl, NY 10314 USA; Thomas Jefferson Univ, Jefferson Med Coll, Dept Pathol Anat & Cell Biol, Philadelphia, PA 19107 USA		Lidsky, TI (corresponding author), New York State Inst Basic Res Dev Disabil, Dept Psychobiol, 1050 Forest Hill Rd, Staten Isl, NY 10314 USA.						ALEXANDER M, 1996, NEUROLOGY, V47, P592; COHEN M, 1992, J NEUROL NEUROSUR PS, V55, P313, DOI 10.1136/jnnp.55.4.313; Dagan Y, 1998, CHRONOBIOL INT, V15, P181, DOI 10.3109/07420529808998682; Mahowald Mark W., 1996, P285; MCCANN UD, 1992, BIOL PSYCHIAT, V31, P1082, DOI 10.1016/0006-3223(92)90153-Q; Nagtegaal JE, 1997, FUNCT NEUROL, V12, P345; PATTEN SB, 1992, J AM ACAD CHILD PSY, V31, P100, DOI 10.1097/00004583-199201000-00015; SAHAKIAN BJ, 1992, J ROY SOC MED, V85, P399; Schneider JS, 1998, OCCUP MED-OXFORD, V48, P255, DOI 10.1093/occmed/48.4.255; TINUPER P, 1989, ELECTROEN CLIN NEURO, V73, P117, DOI 10.1016/0013-4694(89)90190-9; WU JC, 1991, SLEEP, V14, P155	11	8	10	0	4	AMER PSYCHIATRIC PRESS, INC	WASHINGTON	1400 K ST, N W, STE 1101, WASHINGTON, DC 20005 USA	0895-0172			J NEUROPSYCH CLIN N	J. Neuropsychiatr. Clin. Neurosci.	FAL	1999	11	4					504	506		10.1176/jnp.11.4.504			3	Clinical Neurology; Neurosciences; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry	254QC	WOS:000083622800014	10570765				2022-02-06	
J	Axelrod, BN; Vanderploeg, RD; Rawlings, DB				Axelrod, BN; Vanderploeg, RD; Rawlings, DB			WAIS-R prediction equations in patients with traumatic brain injury	JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY			English	Article							PREMORBID INTELLIGENCE; PERFORMANCE; ABILITY; INDEX	Arithmetic algorithms for predicting premorbid Full Scale IQ were evaluated in a sample of 125 brain injured adults who had been evaluated within two months of their injury, and then again one year later. FSIQ at post-test was used as the criterion variable. The prediction equation, based on demographic information only (Barona, Chastain, & Reynolds, 1984), proved to be a modest predictor of premorbid FSIQ. The BEST-3 (Vanderploeg & Schinka, 1995), a prediction equation that incorporates demographic information and performance data, was sensitive to the severity of the brain injury. Subsequent analyses found the BEST-3 to be a better predictor of rec every of function than it was an estimate of premorbid functioning. This study demonstrates the need for flexibility in the interpretation of results, as what was thought to be a prediction equation for premorbid functioning was better viewed as an estimate of recovery.	John D Dingell Dept Vet Affairs Med Ctr, Detroit, MI USA; James A Haley Dept Vet Affairs Med Ctr, Tampa, FL USA; Collier Neurol Specialists, Naples, FL USA		Axelrod, BN (corresponding author), Psychiat Serv 116, 4646 John R St, Detroit, MI 48201 USA.	axelrod.bradley@forum.va.gov					AXELROD BN, IN PRESS ARCH CLIN N; BARONA A, 1984, J CONSULT CLIN PSYCH, V52, P885, DOI 10.1037/0022-006X.52.5.885; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P421, DOI 10.1080/01688639708403870; DIKMEN SS, 1995, NEUROPSYCHOLOGY, V9, P80, DOI 10.1037/0894-4105.9.1.80; EPPINGER MG, 1987, J CONSULT CLIN PSYCH, V55, P86, DOI 10.1037/0022-006X.55.1.86; GOLDSTEIN FC, 1986, J CLIN EXP NEUROPSYC, V8, P405, DOI 10.1080/01688638608401330; KRULL KR, 1995, CLIN NEUROPSYCHOL, V9, P83, DOI 10.1080/13854049508402063; MALKUMUS D, 1974, LEVELS COGNITIVE FUN; RAWLINGS DB, 1992, CLIN NEUROPSYCHOL, V6, P415, DOI 10.1080/13854049208401868; Scott JG, 1997, CLIN NEUROPSYCHOL, V11, P146, DOI 10.1080/13854049708407043; VANDERPLOEG RD, 1995, ARCH CLIN NEUROPSYCH, V10, P225, DOI 10.1016/0887-6177(94)00042-O; Vanderploeg RD, 1996, PSYCHOL ASSESSMENT, V8, P404, DOI 10.1037/1040-3590.8.4.404; VANDERPLOEG RD, 1994, CLIN GUIDE NEUROPSYC, P43; Wechsler D, 1981, WECHSLER ADULT INTEL	14	8	8	0	0	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1380-3395	1744-411X		J CLIN EXP NEUROPSYC	J. Clin. Exp. Neuropsychol.	JUN	1999	21	3					368	374		10.1076/jcen.21.3.368.916			7	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	234FW	WOS:000082474700008	10474175				2022-02-06	
J	Yu, WR; Westergren, H; Farooque, M; Holtz, A; Olsson, Y				Yu, WR; Westergren, H; Farooque, M; Holtz, A; Olsson, Y			Systemic hypothermia following compression injury of rat spinal cord: An immunohistochemical study on the expression of vimentin and GFAP	NEUROPATHOLOGY			English	Article						glial fibrillary acidic protein; hypothermia; immunohistochemistry; spinal cord trauma; vimentin	FIBRILLARY ACIDIC PROTEIN; TRAUMATIC BRAIN INJURY; MODERATE HYPOTHERMIA; ISCHEMIA; TEMPERATURE; ASTROCYTES; TISSUE; COEXPRESSION; PROTECTION; RESPONSES	The objective of the present study was to determine whether systemic hypothermia up-regulated vimentin and glial fibrillary acidic protein (GFAP) expression in the spinal cord as a result of trauma in normothermic rats. Experimental rats underwent thoracic laminectomy alone or laminectomy plus severe spinal cord compression, with or without reduction of core temperature. In hypothermic rats without trauma, vimentin was expressed in ependymal cells and a few intramedullary vessels but not in capillaries. Normothermic rats with trauma exhibited a marked upregulation of vimentin in the capillaries and in reactive astrocytes in all thoracic segments of the spinal cord. Expression of vimentin was significantly reduced in hypothermic rats with trauma. Expression of GFAP was reduced in hypothermic rats without trauma. However, trauma induced up-regulation of GFAP in astrocytes in all thoracic segments. Hypothermia reduced this response in rats with trauma but to a lesser extent than vimentin, These results suggest that systemic hypothermia reduces the upregulation of vimentin in capillaries and reactive astrocytes in injured normothermic rats and support the hypothesis that systemic hypothermia influences microvascular and astrocyte responses in the peri-injury zones following spinal cord compression trauma.	Univ Uppsala, Dept Genet & Pathol, Res Grp Neuropathol, Uppsala, Sweden; Univ Uppsala, Dept Neurosci, Neurosurg Unit, Uppsala, Sweden								BERNTMAN L, 1981, ANESTHESIOLOGY, V55, P495, DOI 10.1097/00000542-198111000-00003; Bignami A., 1991, DISCUSS NEUROSCI, V111, P9; Bracken MB, 1997, JAMA-J AM MED ASSOC, V277, P1597, DOI 10.1001/jama.277.20.1597; CALVO JL, 1991, BRAIN RES, V566, P333, DOI 10.1016/0006-8993(91)91720-L; CHEN H, 1992, ACTA NEUROPATHOL, V84, P184, DOI 10.1007/BF00311393; CLIFTON GL, 1991, J CEREBR BLOOD F MET, V11, P114, DOI 10.1038/jcbfm.1991.13; DAHL D, 1981, J NEUROSCI RES, V6, P741, DOI 10.1002/jnr.490060608; DAHL D, 1981, EUR J CELL BIOL, V24, P191; DIETRICH WD, 1990, J NEUROPATH EXP NEUR, V49, P486, DOI 10.1097/00005072-199009000-00004; FAROOQUE M, 1995, J NEUROTRAUM, V12, P41, DOI 10.1089/neu.1995.12.41; FERNAUDESPINOSA I, 1993, GLIA, V8, P277, DOI 10.1002/glia.440080408; GEISLER FH, 1996, PRINCIPLES SPINAL SU, P769; GLOBUS MYT, 1995, J NEUROCHEM, V65, P1250; HEROLD JA, 1994, J THORAC CARDIOV SUR, V107, P536, DOI 10.1016/S0022-5223(12)70100-9; Holtz Anders, 1995, Upsala Journal of Medical Sciences, V100, P93; IIZUKA H, 1987, J NEUROSURG, V66, P595, DOI 10.3171/jns.1987.66.4.0595; JANECZKO K, 1993, INT J DEV NEUROSCI, V11, P139, DOI 10.1016/0736-5748(93)90074-N; KLATZO I, 1967, J NEUROPATHOL EXP NE, V1, P1; KUMAR K, 1996, METAB BRAIN DIS, V12, P21; Marion DW, 1997, NEW ENGL J MED, V336, P540, DOI 10.1056/NEJM199702203360803; MARSALA M, 1994, STROKE, V25, P2038, DOI 10.1161/01.STR.25.10.2038; NORENBERG MD, 1994, J NEUROPATH EXP NEUR, V53, P213, DOI 10.1097/00005072-199405000-00001; NYSTROM B, 1988, ACTA NEUROL SCAND, V78, P467, DOI 10.1111/j.1600-0404.1988.tb03689.x; ROBERTSON CS, 1986, J NEUROSURG, V64, P633, DOI 10.3171/jns.1986.64.4.0633; TATOR CH, 1995, BRAIN PATHOL, V5, P407, DOI 10.1111/j.1750-3639.1995.tb00619.x; TATOR CH, 1991, J NEUROSURG, V75, P15, DOI 10.3171/jns.1991.75.1.0015; Wang X, 1997, EXP NEUROL, V148, P568, DOI 10.1006/exnr.1997.6702; Westergren H, 1998, J NEUROTRAUM, V15, P943, DOI 10.1089/neu.1998.15.943; YAMADA T, 1992, ACTA NEUROPATHOL, V84, P157, DOI 10.1007/BF00311389	29	8	8	1	4	BLACKWELL SCIENCE ASIA	CARLTON	54 UNIVERSITY ST, P O BOX 378, CARLTON, VICTORIA 3053, AUSTRALIA	0919-6544			NEUROPATHOLOGY	Neuropathology	JUN	1999	19	2					172	180		10.1046/j.1440-1789.1999.00227.x			9	Clinical Neurology; Neurosciences; Pathology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pathology	208FN	WOS:000080980300004					2022-02-06	
J	Simon, R; Slobounov, S; Tutwiler, R; Sebastianelli, W; Kraemer, W				Simon, R; Slobounov, S; Tutwiler, R; Sebastianelli, W; Kraemer, W			Developing and implementing a force production analysis algorithm to assess people with concussions	JOURNAL OF STRENGTH AND CONDITIONING RESEARCH			English	Article						force trajectory formation; head injury; concussion; isometric force; movement	MINOR HEAD-INJURIES; FOOTBALL; SWAY; PREVENTION; SYMPTOMS; SCHOOL; SPORTS	The twofold goal of this study was to show how a specially designed algorithm can assist in the assessment of a concussion's effect on movement and to investigate whether subjects who had suffered a head injury demonstrated deficiencies in terms of completing various force production tasks. Twelve healthy subjects and 5 people who had histories of head injuries participated in this study. Each subject was presented with 4 different targets on a computer monitor and asked to create force trajectories by gradually applying pressure to a load cell while maintaining a constant slope of force production. Specially written MATLAB programs were used to calculate various parameters of force production trajectories. Healthy subjects' means and standard deviations were compared individually with those of head-injured subjects. Only 1 head-injured subject showed any significant departure from the means of the healthy subjects. However, this person had suffered the most severe trauma of the 5 injured subjects, indicating that this task may be a quantifier of head injury severity. This investigation demonstrated how the algorithm may be used to assess severity of head injury and to track recovery.	Penn State Univ, Coll Hlth & Human Dev, Dept Kinesiol, University Pk, PA 16802 USA; Penn State Univ, Appl Res Lab, University Pk, PA 16802 USA; Penn State Univ, Ctr Sports Med, University Pk, PA 16802 USA		Simon, R (corresponding author), Penn State Univ, Coll Hlth & Human Dev, Dept Kinesiol, University Pk, PA 16802 USA.						BOHNEN N, 1992, J NERV MENT DIS, V180, P683, DOI 10.1097/00005053-199211000-00002; CANTU RC, 1992, SPORTS MED, V14, P64, DOI 10.2165/00007256-199214010-00005; GERBERICH SG, 1983, AM J PUBLIC HEALTH, V73, P1370, DOI 10.2105/AJPH.73.12.1370; INGERSOLL CD, 1992, MED SCI SPORT EXER, V24, P739; LEBLANC KE, 1994, AM FAM PHYSICIAN, V50, P801; LEHMANN JF, 1990, ARCH PHYS MED REHAB, V71, P955; Martland HS, 1928, J AMER MED ASSOC, V91, P1103, DOI 10.1001/jama.1928.02700150029009; MCCLATCHIE GR, 1980, J TRAUMA, V2, P956; MCCOY GF, 1984, J BONE JOINT SURG BR, V66, P500, DOI 10.1302/0301-620X.66B4.6746681; MUELLER FO, 1990, MED SCI SPORT EXER, V22, P737, DOI 10.1249/00005768-199012000-00001; NEWELL KM, 1985, J MOTOR BEHAV, V17, P230; NEWELL KM, 1995, VARIABILITY MOTOR CO; PUTNAM P, 1983, SPORTS ILLUSTRA 0606, P23; RUTHERFORD WH, 1979, INJURY, V10, P225, DOI 10.1016/0020-1383(79)90015-9; SZYMANSKI HV, 1992, INT J PSYCHIAT MED, V22, P357, DOI 10.2190/XARA-B1EF-J2HC-VAE0; WALKER AE, 1994, J NEUROSURG, V81, P493, DOI 10.3171/jns.1994.81.3.0493; WILBERGER JE, 1993, SPORTS MED, V15, P338, DOI 10.2165/00007256-199315050-00005; WOBER C, 1993, ARCH PHYS MED REHAB, V74, P1151	18	8	8	0	0	HUMAN KINETICS PUBL INC	CHAMPAIGN	1607 N MARKET ST, CHAMPAIGN, IL 61820-2200 USA	1064-8011			J STRENGTH COND RES	J. Strength Cond. Res.	MAY	1999	13	2					139	147					9	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	206MW	WOS:000080884200008					2022-02-06	
J	Blond, L; Hansen, LB				Blond, L; Hansen, LB			Injuries caused by falling soccer goalposts in Denmark	BRITISH JOURNAL OF SPORTS MEDICINE			English	Article						trauma; injury; soccer; goalposts; prevention	CONCUSSION	Objective-A falling soccer goalpost is associated with the potential risk of serious injury that can sometimes even be fatal. The aim of the study was to analyse the extent of the problem in Denmark and focus on the mechanism of injury and prevention. Methods-Data were analysed for the period 1989-1997 from the European Home and Leisure Accident Surveillance System, which is an electronic register of the injuries seen in the casualty departments of the hospitals of five selected cities in Denmark representing 14% of the Danish population; in addition, fatal accidents in the whole of Denmark since 1981 were examined. Forty two injured persons were interviewed about the circumstances of the accident. Attempts were made to estimate the proportion of goalposts secured by counterweight in the five different regions, compared with the proportion secured with ground stakes and those that were unsecured, by analysing data from the largest producers of goalposts in Denmark. Results-In the period 1981-1988, two fatal accidents were recorded. In the period 1989-1997, 117 people were injured by a falling goalpost; six of the injuries required hospitalisation. Some 88% of the injured were under the age of 15, In a telephone interview with 42 of the injured, 50% stated that the goalpost fell because someone was hanging on the crossbar. Comparing the five different regions with respect to the proportion of goalposts secured by counterweight and the number of accidents, the following relation was found. Areas in which a high percentage of the goalposts were secured by a counterweight correlated inversely with a high number of accidents (r = -0.9; p = 0.04). Conclusion-Soccer is a widely played sport and it is important to be aware that accidents caused by falling goalposts can occur and that they presumably can be prevented by proper use of goalposts, by using secure goalposts, and by securing old goalposts with a counterweight.	Glostrup Hosp, Dept Orthopaed Surg, Copenhagen, Denmark		Blond, L (corresponding author), Egevej 9, DK-2680 Solrod Strand, Denmark.		Blond, Lars/B-6857-2014	Blond, Lars/0000-0002-4750-2724			Boden BP, 1998, AM J SPORT MED, V26, P238, DOI 10.1177/03635465980260021301; JANDA DH, 1995, AM J SPORT MED, V23, P340, DOI 10.1177/036354659502300316; KELLY JP, 1991, JAMA-J AM MED ASSOC, V266, P2867, DOI 10.1001/jama.266.20.2867; WAGNER AL, 1990, UGESKRIFT LAEGER, V152, P424; 1994, MORB MORT WKLY REP, V43, P153	5	8	8	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0306-3674			BRIT J SPORT MED	Br. J. Sports Med.	APR	1999	33	2					110	112		10.1136/bjsm.33.2.110			3	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	184CT	WOS:000079592300017	10205692	Green Published, Bronze			2022-02-06	
J	Milders, M; Deelman, B; Berg, I				Milders, M; Deelman, B; Berg, I			Retrieving familiar people's names in patients with severe closed-head injuries	JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY			English	Article							BRAIN INJURY; ANOMIA; PROPER; FACES; TONGUE; TIP; RECOGNITION; INFORMATION; MEMORY	Patients with closed-head injury frequently complain about difficulties with retrieving the names of familiar people, bur very few studies have investigated these complaints by objective measurements. Three experiments are reported that compared personal name retrieval in patients with severe closed-head injuries and normal controls. The patients more frequently failed to produce the names of famous persons, and had longer naming latencies than the controls. Accuracy of recognizing familiar persons was normal in the patients, even though they were slower in this task than the controls. The patients' main problem appeared to involve a disturbance in activating the stored name information. The patients' response pattern shows clear resemblance with simulations of the effects of brain damage in models for person naming.	Univ Aberdeen, Dept Psychol, Aberdeen AB24 2UB, Scotland; Univ Groningen, Dept Neuropsychol, NL-9700 AB Groningen, Netherlands		Milders, M (corresponding author), Univ Aberdeen, Dept Psychol, Aberdeen AB24 2UB, Scotland.		Milders, Maarten/C-5560-2008				BREDART S, 1995, Q J EXP PSYCHOL-A, V48, P466, DOI 10.1080/14640749508401400; Bredart S, 1997, COGNITIVE NEUROPSYCH, V14, P209, DOI 10.1080/026432997381556; BRENNEN T, 1990, MEM COGNITION, V18, P339, DOI 10.3758/BF03197123; BROOKS N, 1984, CLOSED HEAD INJURY P; BROUWER WH, 1985, THESIS U GRONINGEN; BROWN AS, 1991, PSYCHOL BULL, V109, P204, DOI 10.1037/0033-2909.109.2.204; BURKE DM, 1991, J MEM LANG, V30, P542, DOI 10.1016/0749-596X(91)90026-G; BURTON AM, 1991, COGNITION, V39, P129, DOI 10.1016/0010-0277(91)90041-2; BURTON AM, 1992, BRIT J PSYCHOL, V83, P45, DOI 10.1111/j.2044-8295.1992.tb02424.x; CARNEY R, 1993, COGNITIVE NEUROPSYCH, V10, P185, DOI 10.1080/02643299308253460; COHEN G, 1986, BRIT J DEV PSYCHOL, V4, P187, DOI 10.1111/j.2044-835X.1986.tb01010.x; Ferraro FR, 1996, BRAIN COGNITION, V32, P429, DOI 10.1006/brcg.1996.0075; FERY P, 1995, CORTEX, V31, P191, DOI 10.1016/S0010-9452(13)80117-7; HANLEY JR, 1988, MEM COGNITION, V16, P545, DOI 10.3758/BF03197056; HAUT MW, 1991, BRAIN COGNITION, V17, P31, DOI 10.1016/0278-2626(91)90064-F; HAY DC, 1991, Q J EXP PSYCHOL-A, V43, P761, DOI 10.1080/14640749108400957; HITTMAIRDELAZER M, 1994, NEUROPSYCHOLOGIA, V32, P465, DOI 10.1016/0028-3932(94)90091-4; JOHNSTON RA, 1990, PSYCHOL RES-PSYCH FO, V52, P62, DOI 10.1007/BF00867213; KAY J, 1987, BRAIN, V110, P613, DOI 10.1093/brain/110.3.613; KERR C, 1995, BRAIN INJURY, V9, P777, DOI 10.3109/02699059509008234; LEVELT WJM, 1989, SPEAKING INTENTION A; LEVIN HS, 1976, J NEUROL NEUROSUR PS, V39, P1062, DOI 10.1136/jnnp.39.11.1062; LUCCHELLI F, 1992, CORTEX, V28, P221, DOI 10.1016/S0010-9452(13)80050-0; MacKay DG., 1990, AGING COGNITION KNOW, P213, DOI DOI 10.1016/S0166-4115(08)60159-4; Maylor E. A., 1992, PSYCHOL AGING, V7, P217; MILDERS M, 1998, UNPUB CATEGORIZING F; PARRY FM, 1991, J CLIN EXP NEUROPSYC, V13, P545, DOI 10.1080/01688639108401070; SALTHOUSE TA, 1985, THOERY COGNITIVE AGI; Spikman JM, 1996, J CLIN EXP NEUROPSYC, V18, P755, DOI 10.1080/01688639608408298; THOMSEN IV, 1975, J NEUROL NEUROSUR PS, V38, P713, DOI 10.1136/jnnp.38.7.713; VALENTINE T, 1996, COGJITIVE PSYCHOL PR; Van Zomeren A. H., 1981, REACTION TIME ATTENT; Van Zomeren AH., 1994, CLIN NEUROPSYCHOLOGY; VANZOMEREN AH, 1978, J NEUROL NEUROSUR PS, V41, P452, DOI 10.1136/jnnp.41.5.452; YOUNG AW, 1985, BRIT J PSYCHOL, V76, P495, DOI 10.1111/j.2044-8295.1985.tb01972.x; YOUNG AW, 1986, Q J EXP PSYCHOL-A, V38, P297, DOI 10.1080/14640748608401599; YOUNG AW, 1988, PSYCHOL RES-PSYCH FO, V50, P111, DOI 10.1007/BF00309210; [No title captured]; [No title captured]	39	8	8	0	2	SWETS ZEITLINGER PUBLISHERS	LISSE	P O BOX 825, 2160 SZ LISSE, NETHERLANDS	1380-3395			J CLIN EXP NEUROPSYC	J. Clin. Exp. Neuropsychol.	APR	1999	21	2					171	185		10.1076/jcen.21.2.171.932			15	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	226CL	WOS:000082002700003	10425515				2022-02-06	
J	Eastwood, EA; Schechtman, J				Eastwood, EA; Schechtman, J			Direct observation nursing: Adverse patient behaviors and functional outcomes	NURSING ECONOMICS			English	Article							STROKE PATIENTS; REHABILITATION; PREDICTORS; AGITATION; INJURY	The authors describe a study at a rehabilitation facility that was designed to enhance understanding of which patient: behaviors and cognitive problems were predictive of the need for 1:1 or 1:2 full-time staff direct observation (DO). The costs associated with such 1:1 monitoring are substantial, having been estimated at $6,000 for a typical 3 week LOS, or $78,000 per year for each patient so monitored. Traumatic brain injury, stroke, and poor mental status had previously been associated with impulsivity, patient falls, and other adverse events, and thus such patients were frequently subjected to medical immobilization (restraints). Such immobilization has serious negative consequences for rehabilitation patients, so nursing assistants would frequently be assigned to stay with, observe, and redirect such patients around the clock. This study, which was designed to ascertain the significant differences between the patients who were placed on physician-ordered direct observation status when compared with those not needing DO, encompassed all patients admitted to a 36-bed rehabilitation unit between October 1995 and April 1996.	Mt Sinai Med Ctr, Dept Rehabil Med, New York, NY 10029 USA; Allied Hlth Grp, Dept Rehabil Med, Hackensack, NJ USA		Eastwood, EA (corresponding author), Mt Sinai Med Ctr, Dept Rehabil Med, New York, NY 10029 USA.						BROOKE MM, 1992, ARCH PHYS MED REHAB, V73, P320, DOI 10.1016/0003-9993(92)90003-F; BROOKE MM, 1992, ARCH PHYS MED REHAB, V73, P917; CAPEZUTI E, 1996, J AM GERIATR SOC, V44, P727; DEBOSKEY DS, 1985, HANDLE MANUAL FAMILI; EVANS LK, 1989, J AM GERIATR SOC, V37, P65, DOI 10.1111/j.1532-5415.1989.tb01571.x; FIELDER RC, 1996, AM J PHYSICAL MED RE, V75, P125; Gregory H H Jr, 1995, Md Med J, V44, P279; Mauthe RW, 1996, ARCH PHYS MED REHAB, V77, P10, DOI 10.1016/S0003-9993(96)90212-9; RAPPORT LJ, 1993, ARCH PHYS MED REHAB, V74, P621, DOI 10.1016/0003-9993(93)90160-C; SCHLEENBAKER RE, 1994, ARCH PHYS MED REHAB, V75, P427, DOI 10.1016/0003-9993(94)90166-X; Stineman MG, 1996, AM J PHYS MED REHAB, V75, P68, DOI 10.1097/00002060-199601000-00018; TIDEIKSAAR R, 1993, MOUNT SINAI J MED, V60, P552; YUDOFSKY SC, 1986, AM J PSYCHIAT, V143, P35	13	8	8	0	2	JANNETTI PUBLICATIONS, INC	PITMAN	EAST HOLLY AVENUE, BOX 56, PITMAN, NJ 08071-0056 USA	0746-1739			NURS ECON	Nurs. Econ.	MAR-APR	1999	17	2					96	102					7	Nursing	Social Science Citation Index (SSCI)	Nursing	183LV	WOS:000079555800005	10410028				2022-02-06	
J	Guilmette, TJ; Dabrowski, J; Kennedy, ML; Gnys, J				Guilmette, TJ; Dabrowski, J; Kennedy, ML; Gnys, J			A comparison of nine WAIS-R short forms in individuals with mild to severe traumatic brain injury	ASSESSMENT			English	Article; Proceedings Paper	103rd Annual Meeting of the American-Psychological-Association	AUG 11-15, 1995	NEW YORK, NEW YORK	Amer Psychol Assoc		traumatic brain injury; intelligence; intelligence testing; cognition; IQ; IQ short forms	IMPAIRMENT; VALIDITY	Scores from nine WAIS-R short forms were calculated for a sample of 75 adults with mild to severe traumatic brain injury (TBI). Although all nine of the short forms were significantly correlated with the WAIS-R Full Scale IQ, three of the short forms (Vocabulary-Block Design; Vocabulary-Block Design-Arithmetic-Similarities; Vocabulary-Arithmetic-Picture Arrangement-Block Design) significantly overestimated the WAIS-R IQ and thus may be inappropriate to use with this population. The remaining six short forms did not differ significantly from the WAIS-R Full Scale IQ. Among these six, Ward's seven-subtest short form appeared to exhibit the least variability in predicting the WAIS-R Full Scale IQ. Information is presented and discussed regarding the absolute difference scores between short form IQ estimates and the WAIS-R as well as the proportion of short forms which significantly under- and overestimate the Full Scale IQ.	Providence Coll, Dept Psychol, So New England Rehabil Ctr, Providence, RI 02918 USA; Rehab Solut, Tampa, FL USA		Guilmette, TJ (corresponding author), Providence Coll, Dept Psychol, So New England Rehabil Ctr, Providence, RI 02918 USA.						Benedict R. H. B., 1992, PSYCHOL ASSESSMENT, V4, P322, DOI DOI 10.1037//1040-3590.4.3.322; BROOKER BH, 1986, J CLIN PSYCHOL, V42, P982, DOI 10.1002/1097-4679(198611)42:6<982::AID-JCLP2270420624>3.0.CO;2-G; CYR JJ, 1984, J CONSULT CLIN PSYCH, V52, P903, DOI 10.1037/0022-006X.52.5.903; GUILMETTE TJ, 1994, CLIN NEUROPSYCHOL, V8, P283, DOI 10.1080/13854049408404135; Iverson GL, 1996, PSYCHOL ASSESSMENT, V8, P319, DOI 10.1037/1040-3590.8.3.319; Kaufman AlanS., 1990, ASSESSING ADOLESCENT; KAUFMAN AS, 1991, J PSYCHOEDUC ASSESS, V9, P4, DOI 10.1177/073428299100900101; KEPPEL G, 1982, DESIGN ANAL RES HDB; McCusker P. J., 1994, PSYCHOL ASSESSMENT, V6, P246; Mild Traumatic Brain Injury Committee, 1993, J HEAD TRAUMA REHAB, V8, P86; Reynolds C. R., 1983, CLIN NEUROPSYCHOLOGY, V5, P111; Robiner WD, 1988, CLIN NEUROPSYCHOL, V2, P365, DOI [10.1080/13854048808403274, DOI 10.1080/13854048808403274]; ROTH DL, 1984, J CONSULT CLIN PSYCH, V52, P722, DOI 10.1037/0022-006X.52.4.722; SATZ P, 1962, J CLIN PSYCHOL, V18, P77, DOI 10.1002/1097-4679(196201)18:1<77::AID-JCLP2270180124>3.0.CO;2-R; SILVERSTEIN AB, 1982, J CONSULT CLIN PSYCH, V50, P415, DOI 10.1037/0022-006X.50.3.415; WARD LC, 1990, J CLIN PSYCHOL, V46, P436, DOI 10.1002/1097-4679(199007)46:4<436::AID-JCLP2270460411>3.0.CO;2-M; Ward LC, 1996, PSYCHOL ASSESSMENT, V8, P69; Wechsler D., 1997, MANUAL WECHSLER ADUL; Wechsler D, 1981, WECHSLER ADULT INTEL; [No title captured]	20	8	8	0	1	PSYCHOLOGICAL ASSESSMENT RESOURCES INC	ODESSA	PO BOX 998, ODESSA, FL 33556 USA	1073-1911			ASSESSMENT	Assessment	MAR	1999	6	1					33	41		10.1177/107319119900600104			9	Psychology, Clinical	Conference Proceedings Citation Index - Social Science &amp; Humanities (CPCI-SSH); Social Science Citation Index (SSCI)	Psychology	174LX	WOS:000079037600004	9971881				2022-02-06	
J	Robinson-Boone, KA				Robinson-Boone, KA			Attention in adolescents following brain injury	JOURNAL OF MEDICAL SPEECH-LANGUAGE PATHOLOGY			English	Article							CLOSED-HEAD-INJURY; REACTION-TIME; PERFORMANCE; CHILDREN	This study investigated the effect of traumatic brain injury (TBI) on attention in an adolescent sample. Measures included mean reaction time, variability of performance, total number of errors, and type of errors. Ten adolescents with TBI, and 10 adolescents with no history of neurological insult participated in the study. A protocol designed to assess attentional skills (inhibition, sustained attention, and anticipation) was used to determine the effects of TBI on attention. Results of this experiment indicate that adolescents with TBI exhibit attentional deficits. The hypothesis that TBI in adolescents would uniformly affect attention was not supported by the data. Rather, there was a differential effect across the three components of attention. On the basis of reaction time, the groups performed comparably on the inhibition, sustained attention, and anticipation tasks. Neither group showed a difference in variability of performance on the sustained attention task or on the anticipation task. However, there was a significant difference in variability of performance between the two groups on the inhibition task. On the basis of total errors for all three tasks, the brain-injured group demonstrated a greater number of total errors and errors of omission than the control group.	Emerson Coll, Sch Commun Sci & Disorders, Boston, MA 02116 USA		Robinson-Boone, KA (corresponding author), Emerson Coll, Sch Commun Sci & Disorders, Boston, MA 02116 USA.						Allport A., 1989, FDN COGNITIVE SCI, P631; ARCIA E, 1994, BRAIN INJURY, V8, P395, DOI 10.3109/02699059409150991; AUERBACH SH, 1986, J HEAD TRAUMA REHAB, V1, P1, DOI DOI 10.1097/00001199-198609000-00004; BROUWER WH, 1989, CORTEX, V25, P219, DOI 10.1016/S0010-9452(89)80038-3; CHADWICK O, 1981, Journal of Clinical Neuropsychology, V3, P101, DOI 10.1080/01688638108403117; Cohen R. A., 1993, NEUROPSYCHOLOGY ATTE; CORRIGAN J D, 1992, Brain Injury, V6, P155, DOI 10.3109/02699059209029653; CREMONAMETEYARD SL, 1992, NEUROPSYCHOLOGIA, V30, P123, DOI 10.1016/0028-3932(92)90022-E; GRONWALL D, 1987, EXPT TECHNIQUES HUMA, P355; Gronwall D, 1974, PSYCHOL EFFECTS CONC; KAUFMANN PM, 1993, J CHILD NEUROL, V8, P348, DOI 10.1177/088307389300800410; LEVY F, 1980, J CHILD PSYCHOL PSYC, V21, P77, DOI 10.1111/j.1469-7610.1980.tb00018.x; LEZAK MD, 1995, NEUROPSYCHOLOGICAL A; LODGEMILLER KA, 1993, J MED SPEECH-LANG PA, V1, P133; MACFLYNN G, 1984, J NEUROL NEUROSUR PS, V47, P1326, DOI 10.1136/jnnp.47.12.1326; Mesulam M -M, 1985, PRINCIPLES BEHAV NEU, P125; MESULAM MM, 1981, ANN NEUROL, V10, P309, DOI 10.1002/ana.410100402; MIRSKY A, 1989, INTEGRATING THEORY P, P111; *NAT HEAD INJ FDN, 1989, BAS QUEST HEAD INJ D; PARASURAMAN R, 1991, J CLIN EXP NEUROPSYC, V13, P789, DOI 10.1080/01688639108401090; POSNER MI, 1990, ANNU REV NEUROSCI, V13, P25, DOI 10.1146/annurev.ne.13.030190.000325; POSNER MI, 1971, PSYCHOL REV, V78, P391, DOI 10.1037/h0031333; Posner Michael I., 1992, CURRENT DIRECTIONS P, V1, P11, DOI [DOI 10.1111/1467-8721.EP10767759, 10.1111/1467-8721.ep10767759]; PRATHER P, 1991, FIDIA BIOMEDICAL INF; STABLUM F, 1994, CORTEX, V30, P603, DOI 10.1016/S0010-9452(13)80238-9; STUSS DT, 1989, J NEUROL NEUROSUR PS, V52, P742, DOI 10.1136/jnnp.52.6.742; TREXLER LE, 1988, BRAIN COGNITION, V8, P291, DOI 10.1016/0278-2626(88)90056-5; VANZOMERAN AH, 1994, CLIN NEUROPSYCHOLOGY; VANZOMEREN AH, 1978, J NEUROL NEUROSUR PS, V41, P452, DOI 10.1136/jnnp.41.5.452; Ward J D, 1987, Brain Inj, V1, P21, DOI 10.3109/02699058709034440; WEISSBERG R, 1990, J DEV BEHAV PEDIATR, V11, P59; YLVISAKER M, 1986, HEAD INJURY REHABILI; [No title captured]; [No title captured]	34	8	8	0	1	SINGULAR PUBLISHING GROUP INC	SAN DIEGO	401 WEST A ST, STE 325, SAN DIEGO, CA 92101-7904 USA	1065-1438			J MED SPEECH-LANG PA	J. Med. Speech-Lang. Pathol.	MAR	1999	7	1					47	60					14	Audiology & Speech-Language Pathology; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Audiology & Speech-Language Pathology; Neurosciences & Neurology	228DP	WOS:000082122100005					2022-02-06	
J	Eijkenboom, M; Gerlach, I; Van der Staay, FJ				Eijkenboom, M; Gerlach, I; Van der Staay, FJ			The effects of subdural haematoma on spatial learning in the rat	NEUROSCIENCE			English	Article						Morris water maze; rat; recovery of function; sensorimotor functioning; subdural haematoma; traumatic brain injury	TRAUMATIC BRAIN INJURY; MORRIS WATER MAZE; PARIETAL CORTEX; HEAD-INJURY; HIPPOCAMPAL-FORMATION; REFERENCE MEMORY; HEMATOMA; LOCALIZATION; DEFICITS; DAMAGE	Although memory deficits are one of the most persistent consequences of human subdural haematoma, cognitive functioning has hardly been investigated in the rat subdural haematoma model. In the present study, the effects on spatial learning of right- and left-sided unilateral subdural haematoma and of bilateral subdural haematoma induced above the sensorimotor cortical areas were evaluated. Spatial learning was assessed by standard acquisition in the Morris water escape task (five sessions). Additional issues addressed were sensorimotor functioning (footprint analysis), recovery of cognitive functioning (tested by an overtraining and a reversal training) and replicability of induced cognitive deficits. Following unilateral subdural haematoma surgery, hardly any impairments in the Morris water escape task were observed: rats with a unilateral right-sided subdural haematoma showed very mild, transient deficits, whereas rats with left-sided subdural haematoma were indistinguishable from controls. Bilateral subdural haematoma surgery led to a clear, although transient, performance deficit. We conclude that animals with bilateral subdural haematoma may provide a promising cognitive deficit model for investigating recovery of function. (C) 1999 IBRO. Published by Elsevier Science Ltd.	Bayer AG, CNS Res, D-5600 Wuppertal, Germany		Eijkenboom, M (corresponding author), Aprather Weg 18A, D-42096 Wuppertal, Germany.			van der Staay, F. Josef/0000-0002-8704-3366			Adams J H, 1983, Acta Neurochir Suppl (Wien), V32, P15; Cain DP, 1998, NEUROSCI BIOBEHAV R, V22, P181, DOI 10.1016/S0149-7634(97)00005-5; CHIAMULERA C, 1993, BRAIN RES, V606, P251, DOI 10.1016/0006-8993(93)90992-V; CROWNE DP, 1992, BEHAV NEUROSCI, V106, P808, DOI 10.1037/0735-7044.106.5.808; DEVAN BD, 1992, PSYCHOBIOLOGY, V20, P120; DIAMOND MC, 1983, EXP NEUROL, V81, P1, DOI 10.1016/0014-4886(83)90153-X; DIMATTIA BD, 1988, BEHAV NEUROSCI, V102, P471, DOI 10.1037/0735-7044.102.4.471; EIJKENBOOM M, 1998, P MEAS BEH 98 2 INT, P137; FREDERICKSON RG, 1991, ANAT RECORD, V230, P38, DOI 10.1002/ar.1092300105; FREUND RJ, 1985, SAS LINEAR MODELS; GENNARELLI TA, 1982, J NEUROSURG, V56, P26, DOI 10.3171/jns.1982.56.1.0026; GERLACH I, 1998, J NEUROTRAUM, V15, P870; GRAHAM DI, 1978, J NEUROL SCI, V39, P213, DOI 10.1016/0022-510X(78)90124-7; HAINES DE, 1993, NEUROSURGERY, V32, P111, DOI 10.1227/00006123-199301000-00017; Hamm RJ, 1996, J NEUROTRAUM, V13, P317, DOI 10.1089/neu.1996.13.317; HERRMANN T, 1985, BEHAV NEUROSCI, V99, P631, DOI 10.1037/0735-7044.99.4.631; JONES RSG, 1993, TRENDS NEUROSCI, V16, P58, DOI 10.1016/0166-2236(93)90018-H; KATZ RT, 1992, AM FAM PHYSICIAN, V46, P1491; Klapdor K, 1997, NEUROSCI RES COMMUN, V20, P79; Klapdor K, 1997, J NEUROSCI METH, V75, P49, DOI 10.1016/S0165-0270(97)00042-3; KLAPDORDULFER K, 1996, THESIS U UTRECHT NET; KLUN B, 1984, ACTA NEUROCHIR, V71, P171, DOI 10.1007/BF01401312; KOLB B, 1987, BEHAV BRAIN RES, V23, P127, DOI 10.1016/0166-4328(87)90050-7; KOLB B, 1983, BEHAV NEUROSCI, V97, P13, DOI 10.1037/0735-7044.97.1.13; KURODA Y, 1992, NEUROSURGERY, V31, P1062, DOI 10.1227/00006123-199212000-00012; LaMendola NP, 1997, SCIENCE, V278, P483, DOI 10.1126/science.278.5337.483; LEVIN HS, 1988, J NEUROL NEUROSUR PS, V51, P1294, DOI 10.1136/jnnp.51.10.1294; Lindner MD, 1997, COGNITIVE BRAIN RES, V5, P329, DOI 10.1016/S0926-6410(97)00006-2; LYETH BG, 1990, BRAIN RES, V526, P249, DOI 10.1016/0006-8993(90)91229-A; MACPHERSON P, 1978, J NEUROL NEUROSUR PS, V41, P122, DOI 10.1136/jnnp.41.2.122; MARSHALL JF, 1982, J GERONTOL, V37, P548, DOI 10.1093/geronj/37.5.548; MCALLISTER TW, 1992, PSYCHIAT CLIN N AM, V15, P395; MEHTA C, 1997, STATXACT 3 WINDOWS; MILLER JD, 1990, NEUROSURGERY, V27, P433, DOI 10.1227/00006123-199009000-00016; Morrison M. L., 1986, Western Journal of Applied Forestry, V1, P38; MOSER E, 1993, J NEUROSCI, V13, P3916; OLTON DS, 1979, NEUROPSYCHOLOGIA, V17, P669, DOI 10.1016/0028-3932(79)90042-3; ORLIN JR, 1991, ANAT RECORD, V230, P22, DOI 10.1002/ar.1092300104; Paxinos G, 1996, RAT BRAIN STEREOTAXI; Paxinos G, 1986, RAT BRAIN STEREOTAXI; Pike BR, 1997, PHARMACOL BIOCHEM BE, V57, P785, DOI 10.1016/S0091-3057(96)00453-4; SAVE E, 1992, BEHAV NEUROSCI, V106, P447, DOI 10.1037/0735-7044.106.3.447; Scheff SW, 1997, J NEUROTRAUM, V14, P615, DOI 10.1089/neu.1997.14.615; Schmued LC, 1997, BRAIN RES, V751, P37, DOI 10.1016/S0006-8993(96)01387-X; SEELIG JM, 1981, NEW ENGL J MED, V304, P1511, DOI 10.1056/NEJM198106183042503; Soblosky JS, 1996, BEHAV BRAIN RES, V80, P185, DOI 10.1016/0166-4328(96)00034-4; STONE JL, 1983, SURG NEUROL, V19, P216, DOI 10.1016/S0090-3019(83)80005-6; Swanson LW, 1992, BRAIN MAPS STRUCTURE; ThinusBlanc C, 1996, BEHAV BRAIN RES, V81, P115, DOI 10.1016/S0166-4328(96)00050-2; VANDERSTAAY FJ, 1993, BEHAV NEURAL BIOL, V60, P33, DOI 10.1016/0163-1047(93)90690-J; WANG D, 1990, BRAIN RES, V533, P78, DOI 10.1016/0006-8993(90)91798-L; WHISHAW IQ, 1984, BEHAV BRAIN RES, V11, P123, DOI 10.1016/0166-4328(84)90135-9; WHYTE J, 1994, AM J PHYS MED REHAB, V73, P2	53	8	8	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0306-4522			NEUROSCIENCE	Neuroscience		1999	94	2					373	388		10.1016/S0306-4522(99)00332-2			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	245YE	WOS:000083135600004	10579201				2022-02-06	
J	Platz, T; Hesse, S; Mauritz, KH				Platz, T; Hesse, S; Mauritz, KH			Motor rehabilitation after traumatic brain injury and stroke - Advances in assessment and therapy	RESTORATIVE NEUROLOGY AND NEUROSCIENCE			English	Article						TBJ; stroke; movement; arm; gait; therapy; assessment	BODY-WEIGHT SUPPORT; NONAMBULATORY HEMIPARETIC PATIENTS; GAIT; PERFORMANCE; RESTORATION	A long-term goal in motor rehabilitation is that treatment is not selected on the basis of 'schools of thought', but rather, based on knowledge about efficacy and effectiveness of specific interventions for specific situations (e.g. functional syndromes). Motor dysfunction after stroke or TBI can be caused by many different functional syndromes such as paresis, ataxia, deafferentaion, visuoperceptual deficits, or apraxia, Examples are provided showing that theory-based analysis of motor behavior makes it possible to describe 'syndrome-specific motor deficits'. Its potential implications for motor rehabilitation are that our understanding of altered motor behavior as well as specific therapeutic approaches might be promoted. A methodological prerequisite for clinical trials in rehabilitation is knowledge about test properties of assessment tools in follow-up situations such as test-retest reliability and responsiveness to change. Test-retest reliability assesses whether a test can produce stable measures with test repetition, while sensitivity to change reflects whether a test detects changes that occur over time. Exemplifying these considerations, a reliability and validity study of a kinematic arm movement analysis is summarized. In terms of new therapeutic developments, two examples of clinical therapeutic studies are provided assessing the efficacy of specific interventions for specific situations in arm and gait rehabilitation: the Arm Ability Training for high functioning hemiparetic stroke and TBI patients, and the treadmill training for non-ambulatory hemiparetic patients. In addition, a new technical development, a machine-controlled gait trainer ist introduced.	Free Univ Berlin, Klinikum Benjamin Franklin, Klin Berlin, Dept Neurol Rehabil, D-12200 Berlin, Germany		Platz, T (corresponding author), Free Univ Berlin, Klin Berlin, Kladower Damm 223, D-14089 Berlin, Germany.			Platz, Thomas/0000-0003-2629-9744			Aisen ML, 1997, ARCH NEUROL-CHICAGO, V54, P443, DOI 10.1001/archneur.1997.00550160075019; Asanuma H., 1991, CONCEPTS NEUROSCIENC, V2, P1; Asplund K, 1997, BMJ-BRIT MED J, V314, P1151; BARBEAU H, 1987, MED BIOL ENG COMPUT, V25, P341, DOI 10.1007/BF02447435; DESROSIERS J, 1995, ARCH PHYS MED REHAB, V76, P1125, DOI 10.1016/S0003-9993(95)80120-0; Desrosiers J, 1993, CAN J OCCUP THER, V60, P9, DOI DOI 10.1177/000841749306000104; DIETZ V, 1994, LANCET, V344, P1260, DOI 10.1016/S0140-6736(94)90751-X; Hesse S, 1997, J NEUROL REHABIL, V11, P15; Hesse S, 1995, SCAND J REHABIL MED, V27, P199; HESSE S, 1995, STROKE, V26, P976, DOI 10.1161/01.STR.26.6.976; HESSE S, 1994, ARCH PHYS MED REHAB, V75, P1087, DOI 10.1016/0003-9993(94)90083-3; Jeannerod M., 1997, COGNITIVE NEUROSCIEN; Platz T, 1997, BEHAV NEUROL, V10, P15, DOI 10.3233/BEN-1997-10103; PLATZ T, 1995, EUR J NEUROSCI, V7, P1536, DOI 10.1111/j.1460-9568.1995.tb01149.x; Rothi LJG, 1997, BRAIN DAM B, P29; Schoppe KJ., 1974, DIAGNOSTICA, V20, P43; STURM W, 1985, DIAGNOSTICA, V3, P234; Uhlenbrock D, 1997, BIOMED TECH, V42, P196, DOI 10.1515/bmte.1997.42.7-8.196; Wade D, 1992, MEASUREMENT NEUROLOG; WADE DT, 1987, J NEUROL NEUROSUR PS, V50, P177, DOI 10.1136/jnnp.50.2.177; WERNIG A, 1992, PARAPLEGIA, V30, P229, DOI 10.1038/sc.1992.61	21	8	8	0	11	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	0922-6028	1878-3627		RESTOR NEUROL NEUROS	Restor. Neurol. Neurosci.		1999	14	2-3					161	166					6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	183XN	WOS:000079579700011					2022-02-06	
J	Vakil, E; Sherf, R; Hoffman, M; Stern, M				Vakil, E; Sherf, R; Hoffman, M; Stern, M			Direct and indirect memory measures of temporal order and spatial location: Control versus closed-head injury participants	NEUROPSYCHIATRY NEUROPSYCHOLOGY AND BEHAVIORAL NEUROLOGY			English	Article							AMNESIC PATIENTS; INFORMATION; IMPLICIT; RETRIEVAL; MODALITY; CONTEXT; TESTS; FACT	Objective: The goal of the study was to compare control participants and participants with closed-head injury (CHI) on direct and indirect memory measures of temporal order and spatial location. Method: Twenty-seven CHI patients and 27 control participants were tested on "item" (i.e., words) and "contextual" (temporal order and spatial location) information. Contextual information was tested directly and indirectly by means of a format in which lists of words were presented repeatedly eight times in fixed or varying order for the temporal task and in a fixed or varying spatial position for the spatial task. The number of words recalled as well as their temporal and spatial judgment were the direct measure of item and contextual memory, respectively. The effect of the consistency of order or location was the indirect measure of contextual memory. Results: As expected, the CHI group was impaired on the direct measures of item memory. Also as expected, the groups did not differ in the indirect memory measures of contextual information. Contrary to predictions, however, the groups did not differ in the direct measure of contextual information. Conclusions: Item memory, when measured directly, is impaired in CHI patients. The finding that the groups did not differ on the direct measure of contextual information is possibly due to ceiling-level performance of the control group. Contextual information seems to be preserved in CHI patients when measured indirectly.	Bar Ilan Univ, Dept Psychol, IL-52900 Ramat Gan, Israel; Loewenstein Hosp & Rehabil Ctr, Raanana, Israel; Tel Aviv Univ, Sackler Fac Med, IL-69978 Tel Aviv, Israel		Vakil, E (corresponding author), Bar Ilan Univ, Dept Psychol, IL-52900 Ramat Gan, Israel.						Balgur R., 1968, LIST BASIC WORDS SCH; Butters M.A., 1994, NEUROPSYCHOLOGY, V8, P343, DOI DOI 10.1037/0894-4105.8.3.343; Deutsch J.A., 1975, SHORT TERM MEMORY, P258; DYWAN J, 1993, BRAIN COGNITION, V21, P20, DOI 10.1006/brcg.1993.1002; ESLINGER PJ, 1994, NEUROPSYCHOLOGIA, V32, P729, DOI 10.1016/0028-3932(94)90032-9; GILCHRIST E, 1979, ARCH NEUROL-CHICAGO, V36, P355, DOI 10.1001/archneur.1979.00500420065008; GRAF P, 1985, J EXP PSYCHOL LEARN, V11, P501, DOI 10.1037/0278-7393.11.3.501; Hall K. M., 1993, J HEAD TRAUMA REHAB, V8, P60, DOI DOI 10.1097/00001199-199308020-00008; HIRST W, 1984, HDB COGNITIVE NEUROS, P369; HUPPERT FA, 1976, CORTEX, V12, P3, DOI 10.1016/S0010-9452(76)80024-X; JOHNSON MK, 1987, ANNU REV PSYCHOL, V38, P631, DOI 10.1146/annurev.ps.38.020187.003215; Levin H. S., 1989, J CLIN EXP NEUROPSYC, V12, P129; MAYES AR, 1992, Q J EXP PSYCHOL-A, V45, P265, DOI 10.1080/14640749208401327; MCANDREWS MP, 1991, NEUROPSYCHOLOGIA, V29, P849, DOI 10.1016/0028-3932(91)90051-9; MUTTER SA, 1990, COGNITIVE NEUROPSYCH, V7, P329, DOI 10.1080/02643299008253447; PELLEGRINO JW, 1974, J EXP PSYCHOL, V102, P463, DOI 10.1037/h0035898; PICKERING AD, 1989, NEUROPSYCHOLOGIA, V27, P1249, DOI 10.1016/0028-3932(89)90037-7; RICHARDSONKLAVEHN A, 1988, ANNU REV PSYCHOL, V39, P475, DOI 10.1146/annurev.ps.39.020188.002355; SCHACTER DL, 1987, J EXP PSYCHOL LEARN, V13, P501, DOI 10.1037/0278-7393.13.3.501; SCHACTER DL, 1984, J VERB LEARN VERB BE, V23, P593, DOI 10.1016/S0022-5371(84)90373-6; SHIMAMURA AP, 1986, Q J EXP PSYCHOL-A, V38, P619, DOI 10.1080/14640748608401617; SHIMAMURA AP, 1990, NEUROPSYCHOLOGIA, V28, P803, DOI 10.1016/0028-3932(90)90004-8; SHIMAMURA AP, 1991, PSYCHOBIOLOGY, V19, P1; SHIMAMURA AP, 1987, J EXP PSYCHOL LEARN, V13, P464, DOI 10.1037/0278-7393.13.3.464; TZENG OJL, 1979, J EXP PSYCHOL-HUM L, V5, P52, DOI 10.1037/0278-7393.5.1.52; Vakil E, 1996, NEUROPSY NEUROPSY BE, V9, P176; Vakil E, 1997, NEUROPSYCHOLOGY, V11, P545, DOI 10.1037/0894-4105.11.4.545; VAKIL E, 1994, J CLIN EXP NEUROPSYC, V16, P539, DOI 10.1080/01688639408402665; VAKIL E, 1994, NEUROPSY NEUROPSY BE, V7, P281; VAKIL E, 1991, J CLIN EXP NEUROPSYC, V13, P291, DOI 10.1080/01688639108401044; WINOGRAD E, 1971, J EXP PSYCHOL, V88, P223, DOI 10.1037/h0030913; [No title captured]	32	8	9	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0894-878X			NEUROPSY NEUROPSY BE	Neuropsychiatr. Neuropsychol. Behav. Neurol.	OCT	1998	11	4					212	217					6	Clinical Neurology; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry; Psychology	173JD	WOS:000078976600006	9845413				2022-02-06	
J	Islam, A; Kalaria, RN; Winblad, B; Adem, A				Islam, A; Kalaria, RN; Winblad, B; Adem, A			Enhanced localization of amyloid beta precursor protein in the rat hippocampus following long-term adrenalectomy	BRAIN RESEARCH			English	Article						adrenalectomy; Alzheimer's disease; amyloid protein precursor; glucocorticoid; hippocampus; vascular cell	MESSENGER-RNA; ALZHEIMERS-DISEASE; BRAIN; EXPRESSION; INJURY; CELLS; ISCHEMIA; DAMAGE; DEGENERATION; ASSOCIATION	Using various antibodies to the amyloid beta precursor protein (APP) associated with Alzheimer's disease, we investigated changes in the distribution of APP in the hippocampus and neocortex of adrenalectomized (ADX) rats. In contrast to sham-operated controls, ADX rats euthanised after a survival period of 5 months showed striking APP reactivity in the CA1-CA4 fields and in the surviving cells in the dentate gyrus. Our results suggest the enhanced APP reactivity in hippocampal neurons may pertain to previous observations on the accumulation of APP fragments in the neocortex during ischemic or traumatic injury. Thus, long-term hormone deprivation would be another factor, which may influence the expression of APP in brain. (C) 1998 Elsevier Science B.V. All rights reserved.	Karolinska Inst, KFC Novum, Dept Clin Neurosci & Family Med, S-14186 Huddinge, Sweden; Case Western Reserve Univ, Dept Neurol, Cleveland, OH 44106 USA; Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA		Kalaria, RN (corresponding author), Newcastle Gen Hosp, CBV Path Grp, MRC Unit, Westgate Rd, Newcastle Upon Tyne NE4 6BE, Tyne & Wear, England.	r.n.kalaria@ncl.ac.uk	Kalaria, Raj/AAX-2630-2020; Adem, Abdu/AAN-8271-2021	Adem, Abdu/0000-0002-9289-5301	NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R35AG008992, R01AG010030] Funding Source: NIH RePORTER; NIA NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [AG08992, AG10030] Funding Source: Medline		ABE K, 1991, NEUROSCI LETT, V125, P169, DOI 10.1016/0304-3940(91)90019-P; ABE K, 1991, NEUROSCI LETT, V125, P172, DOI 10.1016/0304-3940(91)90020-T; ADEM A, 1994, NEUROREPORT, V5, P2285, DOI 10.1097/00001756-199411000-00020; BRUGG B, 1995, P NATL ACAD SCI USA, V92, P3032, DOI 10.1073/pnas.92.7.3032; CHAO HM, 1994, J NEUROENDOCRINOL, V6, P517, DOI 10.1111/j.1365-2826.1994.tb00614.x; GAMES D, 1992, SOC NEUR ABSTR, V18, P533; GOLDGABER D, 1989, P NATL ACAD SCI USA, V86, P7606, DOI 10.1073/pnas.86.19.7606; Islam A, 1997, NEUROREPORT, V8, P987, DOI 10.1097/00001756-199703030-00033; KALARIA RN, 1993, NEUROREPORT, V4, P211, DOI 10.1097/00001756-199302000-00025; KALARIA RN, 1993, ANN NY ACAD SCI, V695, P190, DOI 10.1111/j.1749-6632.1993.tb23050.x; Kalaria RN, 1996, NEUROREPORT, V7, P1377, DOI 10.1097/00001756-199605310-00009; KALARIA RN, 1995, J CEREB BLOOD FLOW M, V15, pS599; KAWARABAYASHI T, 1991, BRAIN RES, V563, P334, DOI 10.1016/0006-8993(91)91558-I; NAKAMURA Y, 1992, NEUROSCI LETT, V136, P95, DOI 10.1016/0304-3940(92)90656-R; OTSUKA N, 1991, BRAIN RES, V568, P335, DOI 10.1016/0006-8993(91)91422-W; PALACIOS G, 1995, EUR J NEUROSCI, V7, P501, DOI 10.1111/j.1460-9568.1995.tb00346.x; POIRIER J, 1993, NEUROSCIENCE, V55, P81, DOI 10.1016/0306-4522(93)90456-P; ROBERTS GW, 1994, J NEUROL NEUROSUR PS, V57, P419, DOI 10.1136/jnnp.57.4.419; SAIDO TC, 1994, J BIOL CHEM, V269, P15253; SHERRIFF FE, 1994, ACTA NEUROPATHOL, V87, P55; SHIGEMATSU K, 1992, J NEUROSCI RES, V31, P443, DOI 10.1002/jnr.490310306; SIMAN R, 1989, NEURON, V3, P275, DOI 10.1016/0896-6273(89)90252-3; SLOVITER RS, 1989, SCIENCE, V243, P535, DOI 10.1126/science.2911756; SLOVITER RS, 1993, J COMP NEUROL, V330, P337, DOI 10.1002/cne.903300305; STEPHENSON DT, 1992, BRAIN RES, V593, P128, DOI 10.1016/0006-8993(92)91274-I	25	8	8	0	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	SEP 21	1998	806	1					108	112		10.1016/S0006-8993(98)00711-2			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	125MJ	WOS:000076241100013	9739118				2022-02-06	
J	Gatherer, M; Sundstrom, LE				Gatherer, M; Sundstrom, LE			Mossy fibre innervation is not required for the development of kainic acid toxicity in organotypic hippocampal slice cultures	NEUROSCIENCE LETTERS			English	Article						hippocampus; epilepsy; mossy fibres; kainic acid; neurodegeneration; seizures	RAT HIPPOCAMPUS; NEUROTOXICITY; SEIZURES; LESIONS; NEURONS; DEGENERATION; RECEPTORS	The glutamate analogue kainic acid (KA) generates convulsions when applied systemically or directly into the brain and produces lesions comparable to those seen in Ammon's horn sclerosis, observed in many patients with temporal lobe epilepsy. The neurotoxic actions of KA in-vivo appear to be mediated by a combination of direct effects on neurons and indirect effects mediated by seizures. Understanding the contribution of both direct and indirect effects of KA towards neuronal cell death is important for elucidating excitotoxic mechanisms, which may represent a common final pathway in a variety of neurodegenerative disorders including stroke, traumatic brain injury and epilepsy. We have investigated the effects of mossy fibre innervation on the development of KA toxicity in organotypic hippocampal slice cultures in order to assess the role of this input pathway on the specific toxicity of KA toward CA3 pyramidal neurones in vitro. (C) 1998 Elsevier Science Ireland Ltd. All rights reserved.	Univ Southampton, Southampton Gen Hosp, Dept Clin Neurosci, Southampton S016 6YD, Hants, England		Sundstrom, LE (corresponding author), Univ Southampton, Southampton Gen Hosp, Dept Clin Neurosci, Southampton S016 6YD, Hants, England.	les@soton.ac.uk					ARI YB, 1985, NEUROSCIENCE, V14, P375, DOI DOI 10.1016/0306-4522(85)90299-4; Bahr BA, 1995, HIPPOCAMPUS, V5, P425, DOI 10.1002/hipo.450050505; Best N, 1996, EUR J NEUROSCI, V8, P1209, DOI 10.1111/j.1460-9568.1996.tb01289.x; BETTLER B, 1995, NEUROPHARMACOLOGY, V34, P123, DOI 10.1016/0028-3908(94)00141-E; BIRD SJ, 1979, NEUROSCI LETT, V15, P55, DOI 10.1016/0304-3940(79)91529-5; BIZIERE K, 1979, J NEUROSCI RES, V4, P383, DOI 10.1002/jnr.490040507; BRUCE AJ, 1995, EXP NEUROL, V132, P209, DOI 10.1016/0014-4886(95)90026-8; CASSACIABONNEFI.P, 1993, NEUROSCI LETT, V154, P5; COYLE JT, 1978, J COMP NEUROL, V180, P301, DOI 10.1002/cne.901800208; DANSCHER G, 1981, HISTOCHEMISTRY, V71, P1, DOI 10.1007/BF00592566; DEMONTIGNY C, 1987, EXP BRAIN RES, V65, P605, DOI 10.1007/BF00235983; KEILHOFF G, 1991, NEUROSCIENCE, V43, P35, DOI 10.1016/0306-4522(91)90414-J; MCGEER EG, 1978, BRAIN RES, V139, P381, DOI 10.1016/0006-8993(78)90941-1; Mulle C, 1998, NATURE, V392, P601, DOI 10.1038/33408; NADLER JV, 1980, BRAIN RES, V195, P47; OKAZAKI MM, 1988, NEUROSCIENCE, V26, P763, DOI 10.1016/0306-4522(88)90097-8; Pringle AK, 1997, BRAIN RES, V755, P36, DOI 10.1016/S0006-8993(97)00089-9; RIMVALL K, 1987, ACTA NEUROPATHOL, V74, P183, DOI 10.1007/BF00692850; ROBINSON JH, 1981, BRAIN RES, V221, P117, DOI 10.1016/0006-8993(81)91067-2; SHINOZAKI H, 1970, Brain Research, V24, P368, DOI 10.1016/0006-8993(70)90122-8; SPERBER EF, 1991, DEV BRAIN RES, V60, P88, DOI 10.1016/0165-3806(91)90158-F; SPERK G, 1994, PROG NEUROBIOL, V42, P1, DOI 10.1016/0301-0082(94)90019-1; STAFSTROM CE, 1992, DEV BRAIN RES, V65, P227, DOI 10.1016/0165-3806(92)90184-X; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; ZIMMER J, 1984, J COMP NEUROL, V228, P432, DOI 10.1002/cne.902280310	25	8	8	0	1	ELSEVIER SCI IRELAND LTD	CLARE	CUSTOMER RELATIONS MANAGER, BAY 15, SHANNON INDUSTRIAL ESTATE CO, CLARE, IRELAND	0304-3940			NEUROSCI LETT	Neurosci. Lett.	SEP 4	1998	253	2					119	122		10.1016/S0304-3940(98)00619-3			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	121NH	WOS:000076019700012	9774164				2022-02-06	
J	Voiglio, EJ; du Retail, CB; Neidhardt, JPH; Caillot, JL; Barale, F; Mertens, P				Voiglio, EJ; du Retail, CB; Neidhardt, JPH; Caillot, JL; Barale, F; Mertens, P			Gastrocolic vein - Definition and report of two cases of avulsion	SURGICAL AND RADIOLOGIC ANATOMY			English	Article						portal system; mesenteric veins; portal vein; splenic vein; abdominal injuries	TRUNK	The gastrocolic v. or Henle's gastrocolic trunk was described in 1868 [9]. we suggest defining this vein as the confluence of the right gastroepiploic and right upper colic vv. We report two original cases of avulsion of the gastrocolic v. occurring during a blunt abdominal trauma. The aim of this paper is a description, based on the literature, of the anatomy of the gastracolic v. in order to precise the lesional mechanism. The gastrocolic v. is present in 70% of individuals. It is short (less than 25 mm) but of major calibre (3 to 10 mm). The gastrocolic v. is situated close beneath the root of the transverse mesocolon, and travels along the anterior surface of the head of the pancreas. Anatomic variations are detailed and a meta-analysis of interpretable studies was made. Bath the supra- and infra-mesocolic surgical approaches are described. The radiologic and surgical importance of the gastrocolic v. is discussed. The lesional mechanism in both our cases of injury of the gastrocolic v. is explained.	Univ Claude Bernard, Fac Med, Lab Anat Medicochirurg, F-69373 Lyon 08, France; Ctr Hosp Lyon Sud, Serv Chirurg Urgence, F-69495 Pierre Benite, France; INRETS LBSU, F-69675 Bron, France; CHRU Besancon, Serv Anesthesie Reanimat, F-25030 Besancon, France		Voiglio, EJ (corresponding author), Univ Claude Bernard, Fac Med, Lab Anat Medicochirurg, Domaine Rockefeller, F-69373 Lyon 08, France.						Chambon JP, 1979, J CHIR-PARIS, V12, P725; COUPPIE G, 1957, THESIS VALENCE; CRABO LG, 1993, AM J ROENTGENOL, V160, P1039, DOI 10.2214/ajr.160.5.8385877; Descomps P, 1912, J ANAT PHYSIO NORM P, V48, P337; DOUGLASS BE, 1950, SURG GYNECOL OBSTET, V91, P562; DRAPANAS T, 1975, ANN SURG, V181, P523, DOI 10.1097/00000658-197505000-00004; FALCONER CWA, 1950, BRIT J SURG, V37, P334, DOI 10.1002/bjs.18003714721; Gillot C, 1962, MEMOIRE LAB ANATOMIE, P20; HENLE J, 1868, HDB SYSTEMATISCHEN A, P391; Maeda Tohru, 1993, Nippon Acta Radiologica, V53, P419; MALLETGUY P, 1949, CR C FRANC CHIR, P179; MORI H, 1992, RADIOLOGY, V182, P871, DOI 10.1148/radiology.182.3.1535911; Rossle M, 1996, J GASTROEN HEPATOL, V11, P293, DOI 10.1111/j.1440-1746.1996.tb00079.x; ZHANG J, 1994, SURG RADIOL ANAT, V16, P413, DOI 10.1007/BF01627663	14	8	10	0	4	SPRINGER VERLAG	NEW YORK	175 FIFTH AVE, NEW YORK, NY 10010 USA	0930-1038			SURG RADIOL ANAT	Surg. Radiol. Anat.	JUN	1998	20	3					197	201					5	Anatomy & Morphology; Radiology, Nuclear Medicine & Medical Imaging; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Anatomy & Morphology; Radiology, Nuclear Medicine & Medical Imaging; Surgery	102ZJ	WOS:000074955900009	9706679				2022-02-06	
J	Sandel, ME; Bell, KR; Michaud, LJ				Sandel, ME; Bell, KR; Michaud, LJ			Brain injury rehabilitation. 1. Traumatic brain injury: Prevention, pathophysiology, and outcome prediction	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article							CLOSED-HEAD-INJURY; SOMATOSENSORY-EVOKED-POTENTIALS; POSITRON EMISSION TOMOGRAPHY; BETA-AMYLOID PROTEIN; CEREBRAL BLOOD-FLOW; FUNCTIONAL-ANATOMY; HELMET-USE; GLUTAMATE ANTAGONISTS; POSTTRAUMATIC AMNESIA; ALZHEIMERS-DISEASE	This self-directed learning module highlights new advances in the understanding of the pathophysiologic mechanisms underlying traumatic brain injury (TBT) and outcome prediction, and outlines effective strategies for the prevention of TBI and associated impairments and disability in children and adults. It is part of the chapter on brain injury rehabilitation in the Self-Directed Physiatric Education Program for practitioners and trainees in physical medicine and rehabilitation. In this article, cellular, biochemical, and genetic mechanisms that contribute to primary and secondary injury in mild and moderate to severe injury are discussed, with information on current neuroimaging and neurophysiologic tools for patient assessment, New advances described include investigations of the association between Alzheimer's disease and brain injury, and possible pathophysiologic correlates to the cognitive deficits seen in mild traumatic brain injury. New neuroimaging techniques may offer greater possibilities for correlation with clinical findings in patients with mild as well as more severe injury, (C) 1998 by the American Academy of Physical Medicine and Rehabilitation.	Kaiser Fdn Rehabil Ctr, Vallejo, CA 94589 USA; Univ Washington, Sch Med, Seattle, WA 98195 USA; Childrens Hosp, Med Ctr, Cincinnati, OH 45229 USA		Sandel, ME (corresponding author), Kaiser Fdn Rehabil Ctr, Vallejo, CA 94589 USA.			Bell, Kathleen/0000-0002-0928-2046			ASHWAL S, 1994, NEW ENGL J MED, V330, P1499; ASHWAL S, 1994, NEW ENGL J MED, V330, P1572; BJORNSTIG U, 1992, J TRAUMA, V33, P887; BROOKE MM, 1992, ARCH PHYS MED REHAB, V73, P320, DOI 10.1016/0003-9993(92)90003-F; BROOKE MM, 1992, ARCH PHYS MED REHAB, V73, P917; Bullock R, 1995, ANN NY ACAD SCI, V765, P272, DOI 10.1111/j.1749-6632.1995.tb16584.x; CHOLLET F, 1991, ANN NEUROL, V29, P63, DOI 10.1002/ana.410290112; COBLE YD, 1992, JAMA-J AM MED ASSOC, V267, P3067, DOI 10.1001/jama.1992.03480220085033; COLE TM, 1994, PREV MED, V23, P670, DOI 10.1006/pmed.1994.1112; COLEBATCH JG, 1991, J NEUROPHYSIOL, V65, P1392, DOI 10.1152/jn.1991.65.6.1392; COPE DN, 1995, BRAIN INJURY, V9, P649, DOI 10.3109/02699059509008224; CORRIGAN J D, 1992, Brain Injury, V6, P155, DOI 10.3109/02699059209029653; Dixon CE, 1993, J HEAD TRAUMA REHAB, V8, P1; DOBERSTEIN CE, 1993, ANN EMERG MED, V22, P993, DOI 10.1016/S0196-0644(05)82740-4; DUFFY FH, 1994, CLIN ELECTROENCEPHAL, V25, pR6, DOI 10.1177/155005949402500403; ELOVIC E, 1996, MED REHABILITATION T, P1; Ford MR, 1996, J HEAD TRAUMA REHAB, V11, P1, DOI 10.1097/00001199-199606000-00004; Ford MR, 1996, J HEAD TRAUMA REHAB, V11, P16, DOI 10.1097/00001199-199606000-00005; FORRESTER G, 1994, BRAIN INJURY, V8, P175, DOI 10.3109/02699059409150969; FRACKOWIAK RSJ, 1991, CIBA F SYMP, V163, P235; GIACINO JT, 1995, ARCH PHYS MED REHAB, V76, P205; GOLDENBERG G, 1992, J NEUROL NEUROSUR PS, V55, P362, DOI 10.1136/jnnp.55.5.362; GRAFTON ST, 1992, BRAIN, V115, P565, DOI 10.1093/brain/115.2.565; GRAHAM DI, 1995, NEUROPATH APPL NEURO, V21, P27, DOI 10.1111/j.1365-2990.1995.tb01025.x; HASLAM C, 1994, BRAIN INJURY, V8, P519, DOI 10.3109/02699059409151004; HAWKINS RD, 1993, ANNU REV NEUROSCI, V16, P625, DOI 10.1146/annurev.ne.16.030193.003205; HICKS RR, 1993, J NEUROTRAUM, V10, P405, DOI 10.1089/neu.1993.10.405; HORN LJ, 1996, MED REHABILITATION T; JAGGER J, 1987, NEUROSURGERY, V20, P815, DOI 10.1227/00006123-198705000-00028; JAGGER J, 1992, J NEUROTRAUM, V9, pS313; JANE JA, 1992, J NEUROTRAUMA S1, V9; KATZ DI, 1994, ARCH NEUROL-CHICAGO, V51, P661, DOI 10.1001/archneur.1994.00540190041013; KELLY JP, 1991, JAMA-J AM MED ASSOC, V266, P2867, DOI 10.1001/jama.266.20.2867; KEREN O, 1994, BRAIN INJURY, V8, P239, DOI 10.3109/02699059409150976; KINNEY HC, 1994, NEW ENGL J MED, V330, P1469, DOI 10.1056/NEJM199405263302101; KIRBY BS, 1996, NEUROPSYCHOLOGIA, V34, P689; Kotapka MJ, 1991, J NEUROTRAUM, V8, P247, DOI 10.1089/neu.1991.8.247; KRAUS JF, 1994, JAMA-J AM MED ASSOC, V272, P1506, DOI 10.1001/jama.272.19.1506; KRUGMAN RD, 1993, PEDIATRICS, V92, P872; LEBIHAN D, 1995, ANN INTERN MED, V122, P296, DOI 10.7326/0003-4819-122-4-199502150-00010; LEININGER BE, 1990, J NEUROL NEUROSUR PS, V53, P293, DOI 10.1136/jnnp.53.4.293; LEVIN HS, 1992, J NEUROL NEUROSUR PS, V55, P255, DOI 10.1136/jnnp.55.4.255; MACINTOSH TK, 1995, J HEAD TRAUMA REHABI, V10, P1; Madl C, 1996, ARCH NEUROL-CHICAGO, V53, P512, DOI 10.1001/archneur.1996.00550060054017; Marion DW, 1997, NEW ENGL J MED, V336, P540, DOI 10.1056/NEJM199702203360803; MAYEUX R, 1995, NEUROLOGY, V45, P555, DOI 10.1212/WNL.45.3.555; Merzenich M M, 1993, J Hand Ther, V6, P89; MICHAUD LJ, 1993, PEDIATR CLIN N AM, V40, P553; MITTL RL, 1994, AM J NEURORADIOL, V15, P1583; MOATS RA, 1995, J COMPUT ASSIST TOMO, V19, P480, DOI 10.1097/00004728-199505000-00025; MORTIMER JA, 1991, INT J EPIDEMIOL, V20, pS28, DOI 10.1093/ije/20.Supplement_2.S28; Myseros JS, 1995, ANN NY ACAD SCI, V765, P262, DOI 10.1111/j.1749-6632.1995.tb16583.x; Mysiw WJ, 1997, ARCH PHYS MED REHAB, V78, P213, DOI 10.1016/S0003-9993(97)90266-5; Newberg AB, 1996, J HEAD TRAUMA REHAB, V11, P65, DOI 10.1097/00001199-199612000-00009; NEWTON MR, 1992, J NEUROL NEUROSUR PS, V55, P92, DOI 10.1136/jnnp.55.2.92; ODell MW, 1996, NEUROREHABILITATION, V6, P45, DOI 10.3233/NRE-1996-6106; ODER W, 1992, J NEUROL NEUROSUR PS, V55, P475, DOI 10.1136/jnnp.55.6.475; Pierce JES, 1996, J NEUROSCI, V16, P1083; PONSFORD JL, 1995, BRAIN INJURY, V9, P11, DOI 10.3109/02699059509004566; POVLISHOCK JT, 1992, J NEUROTRAUM, V9, pS189; RAICHLE ME, 1994, CEREB CORTEX, V4, P8, DOI 10.1093/cercor/4.1.8; RAPPAPORT M, 1992, ARCH PHYS MED REHAB, V73, P628; RAPPAPORT M, 1994, J HEAD TRAUMA REHAB, V9, P94; RIVARA FP, 1994, PEDIATRICS, V93, P567; RIVARA FP, 1994, PEDIATR ANN, V23, P12, DOI 10.3928/0090-4481-19940101-06; ROBERTS GW, 1994, J NEUROL NEUROSUR PS, V57, P419, DOI 10.1136/jnnp.57.4.419; ROBERTS GW, 1990, J NEUROL NEUROSUR PS, V53, P373, DOI 10.1136/jnnp.53.5.373; ROSENTHAL M, 1990, REHABILITATOIN ADULT; RUFF RM, 1994, BRAIN INJURY, V8, P297, DOI 10.3109/02699059409150981; Sandel ME, 1996, ARCH PHYS MED REHAB, V77, P617, DOI 10.1016/S0003-9993(96)90306-8; SHIN DY, 1989, ARCH PHYS MED REHAB, V70, P189; SLOAN JH, 1990, NEW ENGL J MED, V322, P369, DOI 10.1056/NEJM199002083220605; SMITH DH, 1995, J NEUROTRAUM, V12, P573, DOI 10.1089/neu.1995.12.573; THOMSEN IV, 1984, J NEUROL NEUROSUR PS, V47, P260, DOI 10.1136/jnnp.47.3.260; TINETTI ME, 1994, NEW ENGL J MED, V331, P821, DOI 10.1056/NEJM199409293311301; VARNEY NR, 1995, J HEAD TRAUMA REHAB, V10, P18; WHITLOCK JA, 1995, ARCH PHYS MED REHAB, V76, P1103, DOI 10.1016/S0003-9993(95)80117-0; Winston FK, 1997, JAMA-J AM MED ASSOC, V277, P11; YING Z, 1992, J NEUROL NEUROSUR PS, V55, P470, DOI 10.1136/jnnp.55.6.470	79	8	9	0	5	W B SAUNDERS CO	PHILADELPHIA	INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA 19106-3399 USA	0003-9993			ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	MAR	1998	79	3		1			S3	S9		10.1016/S0003-9993(98)90113-7			7	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	ZC421	WOS:000072576300002					2022-02-06	
J	Anderson, GD; Awan, AB; Adams, CA; Temkin, NR; Winn, HR				Anderson, GD; Awan, AB; Adams, CA; Temkin, NR; Winn, HR			Increases in metabolism of valproate and excretion of 6 beta-hydroxycortisol in patients with traumatic brain injury	BRITISH JOURNAL OF CLINICAL PHARMACOLOGY			English	Article						valproate; 6-beta-hydroxycortisol; cortisol; brain injury; metabolism	HEPATIC DRUG-METABOLISM; ENZYME-INDUCTION; URINARY 6-BETA-HYDROXYCORTISOL; PROTEIN-BINDING; RAT; PHENYTOIN; INDICATOR; HUMANS; ACID	Aims The objectives of this study were to determine the effect of brain trauma on the multiple pathways of metabolism of valproate and to evaluate the use of the urinary 6 beta-hydroxycortisol to cortisol ratio in predicting changes in hepatic metabolism induced by brain injury. Methods Fourteen patients with severe head injuries received a 15 mg kg(-1) loading dose and a maintenance dose of valproate to maintain therapeutic plasma concentrations. A minimum of one steady state trough blood sample and one dosage interval urine were collected during days 3-6 and during days 7-14 post-injury. Total and unbound valproate plasma concentrations were determined by gas chromatography-flame ionization detection (GC-FID) with and without ultrafiltration. Urinary valproate metabolites were measured by gas chromatography/mass spectrometry (GC-MS) (n=10). Urinary 6 beta-hydroxycortisol and cortisol concentrations were determined by high performance liquid chromatography (h.p.l.c.) (n=14). Total intrinsic clearance (CLint) for valproate and individual formation clearances (CLf) to its major metabolites were calculated. Data obtained during baseline (days 3-6) were averaged for each patient and were compared with averaged data obtained from days 7 to 14 using a paired t-test. Results Statistically significant increases in the CLint, CLf of VPA glucuronide, 2-ene-VPA, and 4-OH-VPA pathways and the 6 beta-hydroxycortisol to cortisol ratio were found. The percent change in the 6 beta-hydroxycortisol to cortisol ratio correlated significantly with the changes in the CLint of valproate. Conclusions Brain trauma results in induction of multiple pathways of valproate metabolism and increases in the 6 beta-hydroxycortisol to cortisol ratio, suggesting a non-specific enzyme induction in response to head injury.	Univ Washington, Dept Pharm, Sch Pharm, Seattle, WA 98195 USA; Univ Washington, Dept Neurol Surg, Sch Med, Seattle, WA 98195 USA; Univ Washington, Dept Biostat, Sch Publ Hlth, Seattle, WA 98195 USA		Anderson, GD (corresponding author), Univ Washington, Dept Pharm, Sch Pharm, Box 357630, Seattle, WA 98195 USA.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS019643] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS19643, R01 NS019643] Funding Source: Medline		ANDERSON GD, 1994, BRIT J CLIN PHARMACO, V37, P559, DOI 10.1111/j.1365-2125.1994.tb04304.x; Anderson GD, 1997, ANN PHARMACOTHER, V31, P279, DOI 10.1177/106002809703100301; Baillie Thomas A., 1995, P589; BIENVENU T, 1991, INT J CLIN PHARM TH, V29, P441; BOUCHER BA, 1988, CLIN PHARMACOL THER, V44, P675, DOI 10.1038/clpt.1988.211; BOUCHER BA, 1991, CLIN PHARMACOL THER, V50, P487, DOI 10.1038/clpt.1991.173; DESAGER JP, 1987, PHARMACOL THERAPEUT, V33, P197, DOI 10.1016/0163-7258(87)90051-9; GED C, 1989, BRIT J CLIN PHARMACO, V28, P373, DOI 10.1111/j.1365-2125.1989.tb03516.x; GRIEBEL ML, 1990, CRIT CARE MED, V18, P385, DOI 10.1097/00003246-199004000-00007; GRIFFETH LK, 1983, DRUG METAB DISPOS, V11, P517; GRIFFETH LK, 1984, DRUG METAB DISPOS, V12, P582; GRIFFETH LK, 1985, DRUG METAB DISPOS, V13, P391; GRIFFETH LK, 1985, DRUG METAB DISPOS, V13, P398; LARKIN JG, 1991, BRIT J CLIN PHARMACO, V31, P65, DOI 10.1111/j.1365-2125.1991.tb03858.x; Levy Rene H., 1995, P605; OHNHAUS EE, 1983, EUR J CLIN PHARMACOL, V24, P247, DOI 10.1007/BF00613826; RENTON KW, 1993, HUMAN DRUG METABOLIS, P143; RETTENMEIER AW, 1986, DRUG METAB DISPOS, V14, P443; RETTENMEIER AW, 1989, BIOMED ENVIRON MASS, V18, P192, DOI 10.1002/bms.1200180308; ROOTS I, 1979, EUR J CLIN PHARMACOL, V16, P63, DOI 10.1007/BF00644969; SADEQUE AJM, 1995, ISSX P, V8, P87; SADEQUE AJM, 1994, ISSX P, V6, P273; SAENGER P, 1983, CLIN PHARMACOL THER, V34, P818, DOI 10.1038/clpt.1983.255; TEMKIN NR, 1990, NEW ENGL J MED, V323, P497, DOI 10.1056/NEJM199008233230801; TOLER SM, 1993, DRUG METAB DISPOS, V21, P1064; WATKINS PB, 1994, PHARMACOGENETICS, V4, P171, DOI 10.1097/00008571-199408000-00001; WINTERS ME, 1996, BASIC CLIN PHARM, P73	27	8	8	0	2	BLACKWELL SCIENCE LTD	OXFORD	P O BOX 88, OSNEY MEAD, OXFORD OX2 0NE, OXON, ENGLAND	0306-5251			BRIT J CLIN PHARMACO	Br. J. Clin. Pharmacol.	FEB	1998	45	2					101	105		10.1046/j.1365-2125.1998.00652.x			5	Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	YU876	WOS:000071764900003	9491821	Green Published			2022-02-06	
J	Henigsberg, N; Lagerkvist, B; Matek, Z; Kostovic, I				Henigsberg, N; Lagerkvist, B; Matek, Z; Kostovic, I			War victims in need of physical rehabilitation in Croatia	SCANDINAVIAN JOURNAL OF SOCIAL MEDICINE			English	Article							WOUNDS	A Rehabilitation Information System was created in July 1993 in order to register war victims in need of physical rehabilitation all over Croatia. The system is currently operating and presented data covers the period from July 1991 to July 1995. Approximately 15,000 questionnaires had been completed and returned from medical institutions on in total 8589 disabled war victims in need of rehabilitation. People with severe disabilities comprised about 20% of all in need of rehabilitation. Those reported injured were 3.5 times more than those in need of physical rehabilitation. Most common types of injuries were fractures with a permanent disabling condition (3109 persons), peripheral nerve injuries (1213 persons) and amputations (956 persons). Traumatic brain injuries were registered for 594 and spinal cord injuries for 262 persons. Causes of injuries were explosive devices (such as mines, mortar shell shrapnel, etc.) in 37% of cases, bullets in 22%, accidents in 7%, other (such as fire, blast injuries, etc.) and unknown causes in 34%.	WHO,REG OFF EUROPE,REHABIL WAR VICTIMS PROJECT,GENEVA,SWITZERLAND								BOBINACGEORGIEV.A, 1993, SURVEY DISABILITIES; BOWYER GW, 1993, INJURY, V24, P597, DOI 10.1016/0020-1383(93)90121-L; BZIK KD, 1987, MIL MED, V149, P229; CAFAR M, 1992, KLIN MED MOSCOW, V1, P35; CAREY ME, 1987, MIL MED, V25, P191; DILLINGHAM TR, 1993, AM J PHYS MED REHAB, V72, P214, DOI 10.1097/00002060-199308000-00008; DOUCET, 1993, MED WAR, V9, P304; Greenwood R. J., 1993, CLIN REHABIL, V7, P248; IVEKOVIC V, 1992, KLIN MED MOSCOW, V1, P31; LEEDHAM CS, 1993, MIL MED, V158, P508, DOI 10.1093/milmed/158.8.508; REISTER FA, 1973, US ARMY EXPERIENCE K; RIGNAULT DP, 1992, WORLD J SURG, V16, P940, DOI 10.1007/BF02066996; *SOC, 1994, WAR SURG TREATM PRIN, P11; SPALDING TJW, 1991, BRIT J SURG, V78, P1102, DOI 10.1002/bjs.1800780921	14	8	9	0	1	SCANDINAVIAN UNIVERSITY PRESS	OSLO	PO BOX 2959 TOYEN, JOURNAL DIVISION CUSTOMER SERVICE, N-0608 OSLO, NORWAY	0300-8037			SCAND J SOC MED	Scand. J. Soc. Med.	SEP	1997	25	3					202	206		10.1177/140349489702500309			5	Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health	YB024	WOS:A1997YB02400009	9360277				2022-02-06	
J	Clinchot, DM; Otis, S; Colachis, SC				Clinchot, DM; Otis, S; Colachis, SC			Incidence of fever in the rehabilitation phase following brain injury	AMERICAN JOURNAL OF PHYSICAL MEDICINE & REHABILITATION			English	Article						brain injury; fever; aneurysm	RECOVERY	There appears to be high incidence of fever after brain injury. The most common cause for fever is infection. The incidence of fever occurring as a result of hypothalamic thermoregulatory dysfunction after brain injury is less clear. This study retrospectively reviewed the charts of 286 subjects with brain injuries. Subject subpopulations were divided into traumatic brain injuries, anoxic brain injuries, and brain injuries resulting from aneurysmal subarachnoid hemorrhage. Fever events were described as any core temperature greater than 99.9 degrees F. Most subjects suffered a severe brain injury and had an average acute hospital length of stay ranging from 35.4 to 60 days. The average rehabilitation length of stay ranged from 38.4 to 45.1 days. Twenty-four percent of subjects experienced fevers, with each of the populations having similar occurrence rates. Unexplained fever events were found in the traumatic brain injury (7%) and aneurysmal subarachnoid hemorrhage (8%) subpopulations only. No unexplained fever event was associated with a temperature greater than 100.8 degrees F.			Clinchot, DM (corresponding author), OHIO STATE UNIV,COLL MED,DEPT PHYS MED & REHABIL,DODD HALL 480 W 9TH AVE,COLUMBUS,OH 43210, USA.			Clinchot, Daniel/0000-0002-2810-7227			AUER LM, 1980, ACTA NEUROCHIR, V52, P225, DOI 10.1007/BF01402078; BENEDEK G, 1987, CAN J NEUROL SCI, V14, P145; BONTKE CF, 1989, PHYS MED REHABIL STA, V3, P43; CORRIGAN JD, 1985, ARCH PHYS MED REHAB, V66, P626; CROMPTON MR, 1971, BRAIN, V94, P165, DOI 10.1093/brain/94.1.165; JACKSON R D, 1991, Brain Injury, V5, P93, DOI 10.3109/02699059108998518; JENNETT B, 1981, MANAGEMENT HEAD INJU, P211; LABI MLC, 1996, NEUROENDOCRINE DISOR, P543; MEYTHALER JM, 1994, ARCH PHYS MED REHAB, V75, P816; MOLTZ H, 1993, NEUROSCI BIOBEHAV R, V17, P237, DOI 10.1016/S0149-7634(05)80009-0; Rotello LC, 1996, CRIT CARE MED, V24, P1501, DOI 10.1097/00003246-199609000-00012; RUDY TA, 1979, S PHARM THERM OXF, P75; Russell WR, 1932, BRAIN, V55, P549, DOI 10.1093/brain/55.4.549; SAZBON L, 1990, J NEUROSURG, V72, P75, DOI 10.3171/jns.1990.72.1.0075; Schmitz T, 1995, Am J Crit Care, V4, P286; Segatore M, 1992, J Neurosci Nurs, V24, P104; STOVER SL, 1976, ARCH PHYS MED REHAB, V57, P201	17	8	9	0	1	WILLIAMS & WILKINS	BALTIMORE	351 WEST CAMDEN ST, BALTIMORE, MD 21201-2436	0894-9115			AM J PHYS MED REHAB	Am. J. Phys. Med. Rehabil.	JUL-AUG	1997	76	4					323	327		10.1097/00002060-199707000-00012			5	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	XQ786	WOS:A1997XQ78600011	9267193				2022-02-06	
J	Nolan, KA; Volpe, BT; Burton, LA				Nolan, KA; Volpe, BT; Burton, LA			The continuum of deep/surface dyslexia	JOURNAL OF PSYCHOLINGUISTIC RESEARCH			English	Article							RIGHT-HEMISPHERE; PATIENT	A right-handed male sustained traumatic brain injury which resulted in anemia, dyslexia, and agraphia. The most severe CT(computed tomography)-identified brain damage was located in the right parieto-temporal lobe. In the first months following the injury, the pattern of reading errors was similar to that associated with deep dyslexia. However, nonlexical derivation of phonology from print was not abolished. As the patient's ability to associate letter. patterns with sounds improved, oral reading also improved Although he no longer produced semantic errors in oral reading, he continued to produce oral reading errors that were visually and phonologically related to the targets. Four months after the injury, the error pattern observed in the patient's oval reading was consistent with very mild surface dyslexia. The significance of these observations to dual-deficit models of acquired dyslexia is discussed, as are their implications for rehabilitation.	NYU,SCH MED,NEW YORK,NY 10016; CORNELL UNIV,COLL MED,BURKE MED RES INST,WHITE PLAINS,NY 10605; CORNELL UNIV,COLL MED,NEW YORK,NY 10021; FORDHAM UNIV,BRONX,NY 10458		Nolan, KA (corresponding author), NATHAN S KLINE INST PSYCHIAT RES,140 OLD ORANGEBURG RD,ORANGEBURG,NY 10962, USA.		volpe, b/U-8409-2019	Volpe, Bruce/0000-0002-1098-1848; Nolan, Karen/0000-0001-7097-5549			ALEXANDER MP, 1989, BRAIN, V112, P923; ALLPORT DA, 1981, PHILOS T ROY SOC B, V295, P397, DOI 10.1098/rstb.1981.0148; Benton A.L., 1983, CONTRIBUTIONS NEUROP; Coltheart M., 1980, DEEP DYSLEXIA, P326; FREIDRICH FJ, 1985, COGNITIVE NEUROPSYCH, V2, P253; GLOSSER G, 1990, CORTEX, V26, P343, DOI 10.1016/S0010-9452(13)80085-8; Heaton R.K., 1981, WISCONSIN CARD SORTI; Kaplan E, 1983, BOSTON NAMING TEST; Kertesz A., 1980, W APHASIA BATTERY; KINSBOURNE M, 1962, J NEUROL NEUROSUR PS, V25, P339, DOI 10.1136/jnnp.25.4.339; Kuera H., 1967, COMPUTATIONAL ANAL P; LAINE M, 1990, BRAIN LANG, V38, P207, DOI 10.1016/0093-934X(90)90111-S; Marshall, 1980, DEEP DYSLEXIA, P119; Marshall J. C., 1977, STUDIES NEUROLINGUIS, V3, P257, DOI 10.1016/b978-0-12-746303-2.50012-9; NOLAN KA, 1982, BRAIN LANG, V16, P237, DOI 10.1016/0093-934X(82)90085-2; OGDEN JA, 1984, NEUROPSYCHOLOGIA, V22, P265, DOI 10.1016/0028-3932(84)90074-5; Raven JC, 1947, COLORED PROGR MATRIC; Saffran E. M., 1980, DEEP DYSLEXIA, P381; SCHWEIGER A, 1989, BRAIN LANG, V37, P73, DOI 10.1016/0093-934X(89)90102-8; SIDTIS JJ, 1981, SCIENCE, V212, P344, DOI 10.1126/science.6782673; Spreen O., 1969, NEUROSENSORY CTR COM; Wechsler, 1997, WECHSLER ADULT INTEL; Wechsler D, 1987, MEMORY SCALE REVISED; YOUNG AW, 1985, BRAIN LANG, V24, P326, DOI 10.1016/0093-934X(85)90139-7; ZAIDEL E, 1981, BRAIN LANG, V14, P205, DOI 10.1016/0093-934X(81)90077-8; ZAIDEL E, 1984, COGN NEUROPSYCHOL, V1, P351, DOI 10.1080/02643298408252858; ZAIDEL E, 1984, PSYCHOBIOLOGY LANGUA, P105	27	8	9	0	1	PLENUM PUBL CORP	NEW YORK	233 SPRING ST, NEW YORK, NY 10013	0090-6905			J PSYCHOLINGUIST RES	J. Psycholinguist. Res.	JUL	1997	26	4					413	424		10.1023/A:1025078003177			12	Linguistics; Psychology, Experimental	Social Science Citation Index (SSCI)	Linguistics; Psychology	XL385	WOS:A1997XL38500003	9232009				2022-02-06	
J	Hopkins, RO; Abildskov, TJ; Bigler, ED				Hopkins, RO; Abildskov, TJ; Bigler, ED			Three dimensional image reconstruction of neuroanatomical structures: Methods for isolation of the cortex, ventricular system, hippocampus, and fornix	NEUROPSYCHOLOGY REVIEW			English	Article						quantitative magnetic resonance imaging; neocortex; ventricles; hippocampus	BRAIN INJURY; MEMORY	Magnetic Resonance (MR) imaging allows volumetric quantification of a variety of neuroanatomical structures using two dimensional (2D) images as well as three-dimensional (3D) reconstruction of the brain and any of its constituent pasts. Three-dimensional analysis permits integration of the neuroanatomical changes which occur in pathologic states, with the cognitive and behavioral changes elucidated through neuropsychological assessment. This paper describes uniform methods for 3D neuroanatomical isolation of the neocortex, ventricular system, and hippocampus in both normal and pathologic states. The 3D methods are described in detail using two different software programs, ANALYZE and IMAGE. Three-dimensional neuroanatomical reconstructions were carried out on a patient who sustained a very severe traumatic brain injury. The 3D image analysis in the patient with traumatic brain injury, revealed structural changes in frontal and temporal cortex, ventricular dilation, and hippocampal atropy. The neuropsychological impairments in this patient, were consistent with the observed neuroanatomical changes revealed on 3D image reconstruction. This technology permits precise determinations of the extent and severity of the neuroanatomical changes which follow neurological injury disease.	BRIGHAM YOUNG UNIV, DEPT PSYCHOL, PROVO, UT 84602 USA		Hopkins, RO (corresponding author), LATTER DAY ST HOSP, DEPT HYPERBAR MED, 8TH AVE & C ST, SALT LAKE CITY, UT 84143 USA.						BLATTER DD, 1995, AM J NEURORADIOL, V16, P241; GALE SD, 1994, NEUROPSY NEUROPSY BE, V7, P160; Heaton RK, 1991, COMPREHENSIVE NORMS; HOHNE KH, 1990, NATO ADV SCI I F-COM, V60, P197; HOPKINS RO, 1995, BRAIN COGNITION, V27, P180, DOI 10.1006/brcg.1995.1016; Katsaggelos A., 1991, DIGITAL IMAGE RESTOR; KUCHARCZYK J, 1994, MAGNETIC RESONANCE N; PRESS GA, 1989, NATURE, V341, P54, DOI 10.1038/341054a0; RASBAND WS, 1995, MICROBEAM ANAL, V4, P137; ROBB RA, 1995, 3 DIMENSIONAL BIOMED; THATCHER RW, 1994, FUNCTIONAL NEUROSCIE; YEO RA, 1990, NEUROPSY NEUROPSY BE, V3, P290	12	8	8	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1040-7308			NEUROPSYCHOL REV	Neuropsychol. Rev.	JUN	1997	7	2					87	104		10.1023/B:NERV.0000005946.46506.a9			18	Psychology, Clinical; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	XN256	WOS:A1997XN25600003	9253771				2022-02-06	
J	Kanayama, G; Takeda, M; Morihara, T; Miyamae, Y; Shinozaki, K; Nishikawa, T; Niigawa, H; Nishimura, T				Kanayama, G; Takeda, M; Morihara, T; Miyamae, Y; Shinozaki, K; Nishikawa, T; Niigawa, H; Nishimura, T			Temporal and egional profiles of cytoskeletal protein accumulation in the rat brain following traumatic brain injury	PSYCHIATRY AND CLINICAL NEUROSCIENCES			English	Article						axonal transport; heat shock protein 72; microtubule-associated protein 2; neurofilament heavy subunit protein; traumatic brain injury	HEAT-SHOCK PROTEIN; MICROTUBULE-ASSOCIATED PROTEIN-2; FLUID-PERCUSSION MODEL; NEUROFILAMENT PROTEIN; LEVELS DECREASE; AXONAL DAMAGE; EXPRESSION; PHOSPHORYLATION; CALCIUM; TISSUE	To characterize the cytoskeletal aberration due to traumatic injury, temporal and regional profiles of changes in immunoreactivity of microtubule-associated protein 2 (MAP2), neurofilament heavy subunit protein (NFH) and heat shock protein 72 (HSP72) were investigated after different magnitudes of traumatic brain injury by fluid percussion. The experimental rat brain was perfusion-fixed at 1, 6 and 24 hours after traumatic brain injury. Conventional histological staining has demonstrated that the mildest traumatic brain injury (1.0 atm) induced no neuronal loss at the impact site and that neuron loss was apparent when traumatic brain injury was increased to 4.3 arm. The mildest traumatic brain injury, however, caused a significant increase in HSP72 immunoreactivity in the superficial cortical layers at the impact site as early as 1 hour after the injury. In the case of severe traumatic brain injury (4.3 atm), neuron loss was apparent in the area at the impact site, but the increase in HSP72 immunoreactivity was moderate, and it was observed only after 6 hours in the deep cortical layers under the necrotic area. The increased immunostaining of MAP2 was demonstrated in damaged axons and neuronal perikarya in the wider area surrounding the impact site at 6 and 24 hours after the injury. Six and 24 hows after the injury, perikaryal accumulation of neurofilament was observed, and the accumulated neurofilament was mostly phosphorylated. These results indicate that the severe traumatic brain injury of 4.3 atm triggers the abnormal accumulation of cytoskeletal proteins in neuronal perikarya, most probably due to an impairment of axonal transport. It is implied that the increased expression of HSP72 may be involved in the protective process of neurons after traumatic brain injury.	OSAKA UNIV,SCH MED,DEPT NEUROPSYCHIAT,SUITA,OSAKA 565,JAPAN; KOSHIEN UNIV,DEPT NUTR,OSAKA,JAPAN; BELL LAND HOSP,DEPT PSYCHIAT,OSAKA,JAPAN				Morihara, Takashi/AAK-2709-2021				ADAMS JH, 1991, J NEUROL NEUROSUR PS, V54, P481, DOI 10.1136/jnnp.54.6.481; ALLEN IV, 1983, ACTA NEUROPATHOL, V59, P277, DOI 10.1007/BF00691493; BERNHARDT R, 1984, J COMP NEUROL, V226, P203, DOI 10.1002/cne.902260205; BROWN IR, 1989, NEURON, V2, P1559, DOI 10.1016/0896-6273(89)90044-5; CORTEZ SC, 1989, BRAIN RES, V482, P272; DEWITT DS, 1992, J NEUROSURG, V76, P812, DOI 10.3171/jns.1992.76.5.0812; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; DRAGER UC, 1984, NATURE, V309, P624, DOI 10.1038/309624a0; ERB DE, 1988, ACTA NEUROPATHOL, V76, P347, DOI 10.1007/BF00686971; FINEMAN I, 1993, BRAIN RES, V624, P94, DOI 10.1016/0006-8993(93)90064-T; FOSTER GA, 1987, J NEUROSCI, V7, P2651; GOLDSTEIN ME, 1987, J NEUROIMMUNOL, V14, P135, DOI 10.1016/0165-5728(87)90048-8; GONZALEZ MF, 1989, MOL BRAIN RES, V6, P93, DOI 10.1016/0169-328X(89)90033-8; GORMAN LK, 1993, BRAIN RES, V614, P29, DOI 10.1016/0006-8993(93)91014-J; GORMAN LK, 1989, J NEUROTRAUM, V6, P203; HOWLAND RD, 1986, BRAIN RES, V363, P333, DOI 10.1016/0006-8993(86)91019-X; INAO S, 1988, J NEUROSURG, V69, P736, DOI 10.3171/jns.1988.69.5.0736; LOWENSTEIN DH, 1994, MOL BRAIN RES, V22, P299, DOI 10.1016/0169-328X(94)90058-2; MCINTOSH T, 1989, Society for Neuroscience Abstracts, V15, P132; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; MUMA NA, 1988, MOL BRAIN RES, V3, P115, DOI 10.1016/0169-328X(88)90056-3; MUNOZ DG, 1988, J NEUROPATH EXP NEUR, V47, P9, DOI 10.1097/00005072-198801000-00002; NOWAK TS, 1990, STROKE, V21, P107; OBLINGER MM, 1987, J NEUROSCI, V7, P2510; POSMANTUR R, 1994, J NEUROTRAUM, V11, P533, DOI 10.1089/neu.1994.11.533; POVLISHOCK JT, 1983, J NEUROPATH EXP NEUR, V42, P225, DOI 10.1097/00005072-198305000-00002; POVLISHOCK JT, 1992, BRAIN PATHOL, V2, P1; POVLISHOCK JT, 1986, ACTA NEUROPATHOL, V70, P53, DOI 10.1007/BF00689514; RAGHUPATHI R, 1995, J CEREBR BLOOD F MET, V15, P467, DOI 10.1038/jcbfm.1995.58; RIEDERER B, 1985, P NATL ACAD SCI USA, V82, P6006, DOI 10.1073/pnas.82.17.6006; SCHLAEPFER WW, 1985, J NEUROCHEM, V44, P502, DOI 10.1111/j.1471-4159.1985.tb05442.x; TAFT WC, 1992, J NEUROTRAUM, V9, P281, DOI 10.1089/neu.1992.9.281; TAKEDA M, 1991, ACTA NEUROPATHOL, V82, P346, DOI 10.1007/BF00296545; TAKEDA M, 1995, ANN PSYCHIAT, V5, P113; TANNO H, 1993, J CEREBR BLOOD F MET, V13, P116, DOI 10.1038/jcbfm.1993.14	35	8	10	0	0	BLACKWELL SCIENCE	CARLTON	54 UNIVERSITY ST, P O BOX 378, CARLTON VICTORIA 3053, AUSTRALIA	1323-1316			PSYCHIAT CLIN NEUROS	Psychiatry Clin. Neurosci.	JUN	1997	51	3					157	165		10.1111/j.1440-1819.1997.tb02379.x			9	Clinical Neurology; Neurosciences; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry	XH885	WOS:A1997XH88500013	9225381				2022-02-06	
J	Leplow, B; Dierks, CH; Lehnung, M; Kenkel, S; Behrens, C; Frank, G; Mehdorn, M				Leplow, B; Dierks, CH; Lehnung, M; Kenkel, S; Behrens, C; Frank, G; Mehdorn, M			Remote memory in patients with acute brain injuries	NEUROPSYCHOLOGIA			English	Article						remote memory; memory; anemia; temporal lobe; excisions; brain injury; neuropsychology	UNILATERAL TEMPORAL LOBECTOMY; RETROGRADE-AMNESIA; PEOPLES NAMES; PROPER-NAMES; PREMORBID INTELLIGENCE; SELECTIVE IMPAIRMENT; LOBE ATROPHY; APHASIA; ANOMIA; RECOGNITION	Remote memory was investigated in an unselected sample of 26 patients with either unilateral rumours in the temporal lobes or traumatic brain injuries. Six patients underwent excisions within the left temporal lobe, and nine patients were operated on within the right temporal lobe. In both groups, patients with excisions including and sparing the hippocampal formation were studied. Their performance was compared to that of 11 patients with moderate to severe head trauma and to a normative sample of 214 healthy controls. Remote memory was assessed using a famous events test with items of extremely low salience that had been proven to be of low difficulty for those old enough at the time of the event's actuality. The results show severely disturbed retrograde memory functions in the left temporal tumour group. These patients achieved similar scores to patients with severe traumatic brain injury. Right hemispheric patients showed a pattern of results comparable to that of healthy controls. The strongest effects were in the free recall part of the test. In most of the patients, no graded memory loss was observable. No consistent association to recent memory function could be identified. Since most of the remote memory test items used denoted famous names which were cued by rich semantic information, the type of deficit seen may be best understood in terms of a specific dysfunction of the semantic stores containing information about famous proper names. (C) 1997 Elsevier Science Ltd.	CHRISTIAN ALBRECHTS UNIV KIEL,CLIN NEUROSURG,D-24106 KIEL,GERMANY; AUGUST BIER CLIN TRAUMAT BRAIN INJURIES,D-23714 MALENTE,GERMANY		Leplow, B (corresponding author), CHRISTIAN ALBRECHTS UNIV KIEL,INST PSYCHOL,OLSHAUSSENSTR 40,D-24098 KIEL,GERMANY.		Mehdorn, Maximilian/D-2495-2010				ALBERT MS, 1979, ARCH NEUROL-CHICAGO, V36, P211, DOI 10.1001/archneur.1979.00500400065010; BARONA A, 1984, J CONSULT CLIN PSYCH, V52, P885, DOI 10.1037/0022-006X.52.5.885; BARR WB, 1990, NEUROPSYCHOLOGIA, V28, P243, DOI 10.1016/0028-3932(90)90018-J; BOCHER W, 1963, DIAGNOSTICA, V9, P56; Boehnke K., 1990, VERTEILUNGSFREIE MET; CIPOLOTTI L, 1993, MEMORY, V4, P289; CUMMINGS JL, 1984, NEUROLOGY, V34, P679, DOI 10.1212/WNL.34.5.679; DEJONG RN, 1969, ARCH NEUROL-CHICAGO, V20, P339, DOI 10.1001/archneur.1969.00480100015001; DERENZI E, 1987, CORTEX, V23, P575, DOI 10.1016/S0010-9452(87)80050-3; DIMSDALE H, 1964, NEUROPSYCHOLOGIA, V1, P287, DOI 10.1016/0028-3932(64)90022-3; ELLIS AW, 1989, BRAIN, V112, P1469, DOI 10.1093/brain/112.6.1469; EVANS J, 1993, J NEUROL NEUROSUR PS, V56, P1227, DOI 10.1136/jnnp.56.11.1227; EVANS JJ, 1995, BRAIN, V118, P1, DOI 10.1093/brain/118.1.1; FERY P, 1995, CORTEX, V31, P191, DOI 10.1016/S0010-9452(13)80117-7; GOLDSTEIN LH, 1988, CORTEX, V24, P41, DOI 10.1016/S0010-9452(88)80016-9; GROSSI D, 1988, CORTEX, V24, P457, DOI 10.1016/S0010-9452(88)80009-1; HANLEY JR, 1989, COGNITIVE NEUROPSYCH, V6, P179, DOI 10.1080/02643298908253418; HARRIS DM, 1995, CORTEX, V31, P575, DOI 10.1016/S0010-9452(13)80068-8; HITTMAIRDELAZER M, 1994, NEUROPSYCHOLOGIA, V32, P465, DOI 10.1016/0028-3932(94)90091-4; HODGES JR, 1992, BRAIN, V115, P1783, DOI 10.1093/brain/115.6.1783; HUBER W, 1988, AACHENER APHASIE TES; KAPUR N, 1994, NEUROPSYCHOLOGIA, V32, P23, DOI 10.1016/0028-3932(94)90066-3; KAPUR N, 1992, BRAIN, V115, P71; KESSLER J, 1988, DEMENZ TEST; Langfitt JT, 1996, ARCH NEUROL-CHICAGO, V53, P72, DOI 10.1001/archneur.1996.00550010090021; LEHRL S, 1975, MEHRFACHWAHL WORTSCH; Leplow B, 1997, NEUROPSYCHOLOGIA, V35, P547, DOI 10.1016/S0028-3932(96)00116-9; LEPLOW B, 1993, DIAGNOSTICA, V39, P240; LUCCHELLI F, 1992, CORTEX, V28, P221, DOI 10.1016/S0010-9452(13)80050-0; MARKOWITSCH HJ, 1993, J NEUROL NEUROSUR PS, V56, P988, DOI 10.1136/jnnp.56.9.988; MARKOWITSCH HJ, 1993, J CLIN EXP NEUROPSYC, V15, P947, DOI 10.1080/01688639308402610; MCCARTHY RA, 1992, NEUROPSYCHOLOGIA, V30, P633, DOI 10.1016/0028-3932(92)90068-W; MCCARTHY RA, 1990, COGNITIVE NEUROPSYCH; MCKENNA P, 1980, J NEUROL NEUROSUR PS, V43, P781, DOI 10.1136/jnnp.43.9.781; MCNEIL JE, 1994, NEUROPSYCHOLOGIA, V32, P193, DOI 10.1016/0028-3932(94)90005-1; NELSON HE, 1978, CORTEX, V14, P234, DOI 10.1016/S0010-9452(78)80049-5; PARKIN A, 1993, MEMORY; PENFIELD W, 1974, ARCH NEUROL-CHICAGO, V31, P145, DOI 10.1001/archneur.1974.00490390027001; PENFIELD W, 1958, ARCH NEURO PSYCHIATR, V79, P475, DOI 10.1001/archneurpsyc.1958.02340050003001; Pfeifer B., 1910, ARCH PSYCHIAT NERVEN, V47, P558; ROCCHETTA D, 1994, 17 ANN M EUR NEUR AS; SCOVILLE WB, 1957, J NEUROL NEUROSUR PS, V20, P11, DOI 10.1136/jnnp.20.1.11; Semenza C, 1993, Memory, V1, P265, DOI 10.1080/09658219308258238; SEMENZA C, 1989, NATURE, V342, P678, DOI 10.1038/342678a0; SEMENZA C, 1988, COGNITIVE NEUROPSYCH, V5, P711, DOI 10.1080/02643298808253279; SHALLICE T, 1993, CORTEX, V29, P281, DOI 10.1016/S0010-9452(13)80181-5; SIMPSON BA, 1985, J NEUROL NEUROSUR PS, V48, P90, DOI 10.1136/jnnp.48.1.90-a; SPREEN O, 1991, NEUROPSYCHOLOGICAL T; SQUIRE LR, 1992, PSYCHOL REV, V99, P195, DOI 10.1037/0033-295X.99.2.195; SQUIRE LR, 1988, TRENDS NEUROSCI, V11, P170, DOI 10.1016/0166-2236(88)90144-0; TRANEL D, 1991, BRAIN COGNITION, V15, P187, DOI 10.1016/0278-2626(91)90025-4; VANLANCKER D, 1990, BRAIN LANG, V39, P511, DOI 10.1016/0093-934X(90)90159-E; WALKER AE, 1957, ARCH NEURO PSYCHIATR, V78, P543, DOI 10.1001/archneurpsyc.1957.02330420003001; ZERSSEN D, 1976, BEFINDLICHKEITSSKALA	54	8	8	0	2	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, ENGLAND OX5 1GB	0028-3932			NEUROPSYCHOLOGIA	Neuropsychologia	JUN	1997	35	6					881	892		10.1016/S0028-3932(96)00130-3			12	Behavioral Sciences; Neurosciences; Psychology, Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Behavioral Sciences; Neurosciences & Neurology; Psychology	XE587	WOS:A1997XE58700011	9204492				2022-02-06	
J	Lai, JM; Yablon, SA; Ivanhoe, CB				Lai, JM; Yablon, SA; Ivanhoe, CB			Incidence and sequelae of symptomatic venous thromboembolic disease among patients with traumatic brain injury	BRAIN INJURY			English	Article							DEEP-VEIN THROMBOSIS; PULMONARY-EMBOLISM	Venous thromboembolism (VTE) is a potentially life-threatening complication among patients with traumatic brain injury (TBI). However, few reports describe the incidence of this important disease. We reviewed the incidence of symptomatic VTE among 124 consecutive admissions with TBI to a free-standing rehabilitation hospital over an 18-month period. Four patients manifested evidence of VTE within 2 months of injury: two with leg swelling, one with an oedematous arm, and one with respiratory distress. None of the patients with suspected VTE received prophylactic anticoagulant therapy. Diagnosis of VTE was confirmed with venograph in two of the four patients. Although VTE is frequently asymptomatic, the incidence of symptomatic VTE (1.6%) among this series of rehabilitation inpatients with TBI still appears surprisingly low. These results have implications regarding the utility of non-invasive diagnostic screening of asymptomatic VTE and routine anticoagulant prophylaxis of high-risk patients with TBI.	INST REHABIL & RES,BRAIN INJURY PROGRAM,HOUSTON,TX; BAYLOR COLL MED,DEPT PHYS MED & REHABIL,HOUSTON,TX 77030								CIFU DX, 1995, ARCH PHYSICAL MED RE, V76, P1024; GEERTS WH, 1994, NEW ENGL J MED, V331, P1601, DOI 10.1056/NEJM199412153312401; HAMILTON MG, 1994, NEUROSURGERY, V34, P280, DOI 10.1227/00006123-199402000-00012; JOFFE SN, 1975, J NEUROSURG, V42, P201, DOI 10.3171/jns.1975.42.2.0201; KAUFMAN HH, 1983, ANGIOLOGY, V34, P627, DOI 10.1177/000331978303401001; LEVINE MN, 1995, CHEST, V108, pS276, DOI 10.1378/chest.108.4_Supplement.276S; LONG DF, 1996, MED REHABILITATION T, P333; Meythaler JM, 1996, ARCH PHYS MED REHAB, V77, P1, DOI 10.1016/S0003-9993(96)90210-5; SOBUS KM, 1994, ARCH PHYS MED REHAB, V75, P362, DOI 10.1016/0003-9993(94)90044-2; STONE LR, 1992, ARCH PHYS MED REHAB, V73, P486	10	8	8	0	0	TAYLOR & FRANCIS LTD	LONDON	ONE GUNPOWDER SQUARE, LONDON, ENGLAND EC4A 3DE	0269-9052			BRAIN INJURY	Brain Inj.	MAY	1997	11	5					331	334		10.1080/026990597123485			4	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	WW455	WOS:A1997WW45500003	9146838				2022-02-06	
J	SmithSeemiller, L; Lovell, MR; Smith, S; Markosian, N; Townsend, RN				SmithSeemiller, L; Lovell, MR; Smith, S; Markosian, N; Townsend, RN			Impact of skull fracture on neuropsychological functioning following closed head injury	BRAIN INJURY			English	Article								The role of skull facture in affecting morbidity following closed head injury (CHI) has received a significant amount, of attention from researchers. While there is fairly widespread agreement that skull fractures increase the risk of complications such as haematoma, it us unclear whether the presence of skull fracture has predictive value in terms of the neuropsychological sequelae of CHI. The purpose of the current study was to further investigate the role of skull fracture in predicting neuropsychological dysfunction following CHI. Subjects included patients admitted to the trauma service of a large teaching hospital who were suspected of having suffered CHI. All patients completed neuropsychological testing and had normal computerized tomography (CT) scans. Patients who had suffered skull fracture were compared to those who had not suffered skull fracture on selected neuropsychological measures. Groups did not differ in terms of CHI severity as assessed by the Glasgow Coma Scale (GCS). Multivariate analysis of variance revealed that the groups did differ in terms of neuropsychological functioning. Results are interpreted as suggesting that the presence of a skull fracture is predictive of additional neuropsychological dysfunction, even in the absence of intracranial pathology or more severe disturbance of consciousness on the GCS.	MED COLL PENN & HAHNEMANN UNIV,PITTSBURGH,PA								BECKER D, 1989, TXB HEAD INJURY; Brandt J, 1991, CLIN NEUROPSYCHOL, V5, P125, DOI [10.1080/13854049108403297, DOI 10.1080/13854049108403297]; Jennett B, 1981, MANAGEMENT HEAD INJU; KOONSMAN M, 1992, AM J SURG, V164, P487, DOI 10.1016/S0002-9610(05)81186-9; LOVELL MR, 1995, 15 ANN M NAT AC NEUR; Miller J, 1982, NEUROLOGICAL SURG, P1896; NEDD K, 1993, BRAIN INJURY, V7, P469, DOI 10.3109/02699059309008174; NEE PA, 1993, INJURY, V24, P471, DOI 10.1016/0020-1383(93)90153-W; Reitan R, 1986, TRAIL MAKING TEST MA; Robinson L J, 1991, Arch Clin Neuropsychol, V6, P27, DOI 10.1016/0887-6177(91)90019-6; TAHERI PA, 1993, ARCH SURG-CHICAGO, V128, P289; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014; Wood RL, 1981, APPL CONDITIONING TH, P81	13	8	8	0	0	TAYLOR & FRANCIS LTD	LONDON	ONE GUNPOWDER SQUARE, LONDON, ENGLAND EC4A 3DE	0269-9052			BRAIN INJURY	Brain Inj.	MAR	1997	11	3					191	196					6	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	WL158	WOS:A1997WL15800003	9058000				2022-02-06	
J	Hill, D; Stalley, P; Pennington, D; Besser, M; McCarthy, W				Hill, D; Stalley, P; Pennington, D; Besser, M; McCarthy, W			Competency-based learning in traumatology	AMERICAN JOURNAL OF SURGERY			English	Article							STRUCTURED CLINICAL EXAMINATION; SURGICAL CURRICULUM; MEDICAL-STUDENTS; SCHOOLS	BACKGROUND: A multidisciplinary, competency-based trauma teaching program was introduced for final year medical students (n = 67) at Royal Prince Alfred Hospital (RPAH) in 1934 to complement the surgical clerkship. METHODS: The method involved small groups rotating through a series of teaching stations each structured to address a predetermined competency, Four 3-hour sessions were held on the subject areas of resuscitation, plastic, orthopedic, and neurotrauma. Performance in the trauma section of a summative Objective Structured Clinical Examination (OSCE), 6 months after the teaching, was compared with that of a control group (n = 121) from other campuses where trauma was taught by a series of discipline-based lectures. Three trauma OSCE stations were designed to test psychomotor skills while five addressed aspects of the cognitive domain. Checklists were used to ensure standardization of scoring in a range of questions asked or skills tested at each station. RESULTS: The marks of the RPAH students (mean 78% +/- SD 9%) were significantly higher (P < 0.0005) than the controls (mean 70% +/- SD 9%) in the 8 trauma questions. There was no significant difference (P = 0.8) in marks obtained by the study group (mean 61% +/- SD 8%) and controls (mean 63% +/- SD 7%) in 22 questions sampling a wide spectrum of nontrauma subject areas. The study group performed significantly better in one of the three skills stations and three of the five problem-solving stations when compared with the control group. CONCLUSION: The innovation has the potential to fulfill a need for an integrated trauma program in the undergraduate core curriculum. (C) 1997 by Excerpta Medica, Inc.	UNIV SYDNEY,DEPT SURG,EDUC CTR,SYDNEY,NSW,AUSTRALIA		Hill, D (corresponding author), ROYAL PRINCE ALFRED HOSP,MISSENDEN RD,CAMPERDOWN,NSW 2050,AUSTRALIA.						BAKER SP, 1987, J TRAUMA, V27, P343, DOI 10.1097/00005373-198704000-00001; BIRAN LA, 1991, MED EDUC, V25, P475, DOI 10.1111/j.1365-2923.1991.tb00100.x; DUTHIE RB, 1987, MED EDUC, V21, P63, DOI 10.1111/j.1365-2923.1987.tb00516.x; Harden R M, 1984, Med Educ, V18, P284; HARDEN RM, 1979, MED EDUC, V13, P41; HARDEN RM, 1975, BRIT MED J, V1, P447, DOI 10.1136/bmj.1.5955.447; HILL DA, 1992, MED TEACH, V14, P37, DOI 10.3109/01421599209044013; HILL DA, 1994, MED EDUC, V28, P394, DOI 10.1111/j.1365-2923.1994.tb02550.x; HILL DA, 1993, MED TEACH, V15, P179, DOI 10.3109/01421599309006712; LAIDLAW JM, 1990, MED TEACH, V12, P7, DOI 10.3109/01421599009010556; LAWRENCE PF, 1983, SURGERY, V94, P309; LEHMAN RAW, 1991, NEUROSURGERY, V29, P624, DOI 10.1227/00006123-199110000-00027; LUCAS CE, 1986, J TRAUMA, V26, P1024, DOI 10.1097/00005373-198611000-00011; MAUDSLEY RF, 1989, MED TEACH, V11, P285, DOI 10.3109/01421598909146414; NEWBLE DI, 1983, MED EDUC, V17, P165, DOI 10.1111/j.1365-2923.1983.tb00657.x; PRATER MA, 1989, PLAST RECONSTR SURG, V84, P529, DOI 10.1097/00006534-198909000-00028; *PROV MAN AM COLL, 1988, ADV TRAUM LIF SUPP C; SNOW N, 1986, SURGERY, V100, P83; STILLMAN PL, 1990, ACAD MED, V65, P320, DOI 10.1097/00001888-199005000-00013; TRUNKEY DD, 1982, SURGERY, V92, P123; Walton H.J., 1993, MED ED S1, V28, P140; WEBBER RH, 1992, MED EDUC, V26, P58, DOI 10.1111/j.1365-2923.1992.tb00124.x	22	8	8	1	3	CAHNERS PUBL CO	NEW YORK	249 WEST 17 STREET, NEW YORK, NY 10011	0002-9610			AM J SURG	Am. J. Surg.	FEB	1997	173	2					136	140		10.1016/S0002-9610(96)00412-6			5	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	WM662	WOS:A1997WM66200017	9074381				2022-02-06	
J	Gordon, I				Gordon, I			Cerebral blood flow imaging in paediatrics: A review	NUCLEAR MEDICINE COMMUNICATIONS			English	Article							EMISSION COMPUTED-TOMOGRAPHY; TC-99M HMPAO SPECT; BRAIN SPECT; TECHNETIUM-99M-HMPAO; MIGRAINE; CHILDREN; DEATH; PALSY	The ability to study regional cerebral blood flow (rCBF) is available in many institutions, especially with the spread of multi-headed gamma cameras. The use of this technique in paediatrics requires special attention to detail in the manner of data acquisition and handling the child. The interpretation of the rCBF study in a child requires knowledge of normal brain maturation. The major clinical use in paediatrics is epilepsy because of the advances in surgery and the frequency of complex partial seizures. Other indications in paediatric neurology include brain death, acute neurological loss including stroke, language disorders, cerebral palsy, hypertension due to renovascular disease, traumatic brain injury and migraine. There are paediatric psychological conditions in which rCBF assessment has been undertaken, including anorexia nervosa, autism, Gilles de la Tourette Syndrome (GTS) and attention deficit disorder-hyperactivity (ADHD). This article attempts to review all aspects of rCBF studies in paediatrics.			Gordon, I (corresponding author), GREAT ORMOND ST HOSP CHILDREN,GREAT ORMOND ST,LONDON WC1N 3JH,ENGLAND.		Zamora, Cristina Cuesta/E-2864-2016	Zamora, Cristina Cuesta/0000-0003-1121-9561			Adelstein W, 1994, J Neurosci Nurs, V26, P118; *AM INT, AM INT PLC PACK INS; BATTISTELLA PA, 1990, HEADACHE, V30, P646, DOI 10.1111/j.1526-4610.1990.hed3010646.x; CROSS JH, 1995, DEV MED CHILD NEUROL, V37, P673; CROSS JH, IN PRESS J NEUROL NE; CROSS JH, UNPUB FOCAL CEREBRAL; DELARIVA A, 1992, BRIT J RADIOL, V65, P289, DOI 10.1259/0007-1285-65-772-289; DENAYS R, 1989, J NUCL MED, V30, P1825; DENAYS R, 1992, J NUCL MED, V33, P485; DENAYS R, 1990, RADIOLOGY, V175, P111, DOI 10.1148/radiology.175.1.2315468; DENAYS R, 1993, J NUCL MED, V34, P1223; GEORGE MS, 1992, PSYCHIAT RES-NEUROIM, V45, P143, DOI 10.1016/0925-4927(92)90022-V; GORDON I, IN PRESS INT J EATIN; GORDON I, 1996, BRIT J RADIOL, V66, P971; Goshen E, 1996, NUCL MED COMMUN, V17, P418, DOI 10.1097/00006231-199605000-00011; MAINI CL, 1990, NUKLEARMED-NUCL MED, V29, P210; MOUNTZ JM, 1995, J NUCL MED, V36, P1156; Muttini P, 1994, J Nucl Biol Med, V38, P14; OLESEN J, 1990, ANN NEUROL, V28, P791, DOI 10.1002/ana.410280610; OTUAMA LA, 1993, SEMIN NUCL MED, V23, P255, DOI 10.1016/S0001-2998(05)80106-0; PELLETIER G, 1995, J AM ACAD CHILD PSY, V34, P297, DOI 10.1097/00004583-199503000-00013; PINTON F, 1995, P 2 EUR S PAED NUCL; RUBINSTEIN M, 1989, J NUCL MED, V30, P1982; SPIETH ME, 1994, CLIN NUCL MED, V19, P867, DOI 10.1097/00003072-199410000-00005; Spina A, 1992, Acta Neurol (Napoli), V14, P10; VALENZUELA H, 1995, P 2 EUR S PAED NUCL; VESTERGREN E, P 5 INT C RAD DOS	27	8	8	0	1	CHAPMAN HALL LTD	LONDON	2-6 BOUNDARY ROW, LONDON, ENGLAND SE1 8HN	0143-3636			NUCL MED COMMUN	Nucl. Med. Commun.	DEC	1996	17	12					1021	1029		10.1097/00006231-199612000-00004			9	Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Radiology, Nuclear Medicine & Medical Imaging	WB132	WOS:A1996WB13200004	9004297				2022-02-06	
J	Jordan, FM; Murdoch, B; HudsonTennent, LJ; Boon, DL				Jordan, FM; Murdoch, B; HudsonTennent, LJ; Boon, DL			Naming performance of brain-injured children	APHASIOLOGY			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; LONG-TERM SURVIVORS; CLOSED HEAD-INJURY; ADOLESCENTS; IMPAIRMENT; ABILITIES; DEMENTIA	The naming performance of three groups of children who had experienced brain injury, children with a severe closed-head injury, children treated for posterior fossa tumour, and children treated for acute lymphoblastic leukaemia was compared to a matched control group. Only the children who had experienced a closed-head injury demonstrated significant impairment on the confrontation-naming task; however, all groups performed more poorly than the control group on a word-association task. Results are considered in light of the mechanisms of brain injury involved in each experimental group. In addition, naming tasks are considered in terms of their utility in characterizing the language skills of children with brain injury and in terms of the task demands each requires to allow adequate performance.			Jordan, FM (corresponding author), UNIV QUEENSLAND, DEPT PSYCHOL, ST LUCIA, QLD 4072, AUSTRALIA.		Murdoch, Bruce E/C-1397-2012				ADAMOVICH B, 1984, CLIN APHASIOLOGY C P, P124; APPLETON RE, 1990, ARCH DIS CHILD, V65, P530, DOI 10.1136/adc.65.5.530; BERKOGLEASON J, 1988, APHASIOLOGY, V2, P289; CHERTKOW H, 1990, BRAIN, V113, P397, DOI 10.1093/brain/113.2.397; DALBY PR, 1991, DEV NEUROPSYCHOL, V7, P35, DOI 10.1080/87565649109540476; DENNIS M, 1992, TOP LANG DISORD, V13, P66, DOI 10.1097/00011363-199211000-00008; Dennis M., 1988, CLIN NEUROPSYCHOLOGY, P85; FLETCHER JM, 1988, HDB PEDIATRIC PSYCHO, P258; GERRYTAYLOR H, 1987, J PEDIATR PSYCHOL, V12, P395; HOLM S, 1979, SCAND J STAT, V6, P65; JACKEL CA, 1990, APHASIOLOGY, V4, P45, DOI 10.1080/02687039008249053; JORDAN F M, 1990, Brain Injury, V4, P27; JORDAN FM, 1995, APHASIOLOGY, V9, P23, DOI 10.1080/02687039508248686; Kaplan E, 1983, BOSTON NAMING TEST; Kay J., 1992, PSYCHOLINGUISTIC ASS; KENNEDY M, 1990, AUSTR J HUMAN COMMUN, V18, P3; Kirk Ursula, 1992, Clin Neuropsychol, V6, P156, DOI 10.1080/13854049208401852; KOHN SE, 1985, BRAIN LANG, V24, P266, DOI 10.1016/0093-934X(85)90135-X; LEONARD LB, 1983, J SPEECH HEAR RES, V26, P609, DOI 10.1044/jshr.2604.609; LEVIN HS, 1979, NEUROPSYCHOLOGICAL I; LOHMAN T, 1989, APHASIOLOGY, V3, P685, DOI 10.1080/02687038908249036; MURRAY R, 1992, BRAIN COGNITION, V18, P99, DOI 10.1016/0278-2626(92)90072-T; Ozanne AE, 1990, ACQUIRED NEUROLOGICA, P1; PFEFFERBAUMLEVINE B, 1984, AM J PEDIAT HEMATOL, V6, P123; SARNO MT, 1984, J NERV MENT DIS, V172, P475, DOI 10.1097/00005053-198408000-00006; SEMELMINTZ E, 1982, CLIN EVALUATION LANG; SMITH SR, 1989, BRAIN LANG, V36, P314, DOI 10.1016/0093-934X(89)90068-0; SUC E, 1990, ACTA NEUROCHIR, V106, P93, DOI 10.1007/BF01809448; TEASDALE G, 1974, LANCET, V2, P81; TOMPKINS CA, 1990, BRAIN COGNITION, V13, P86, DOI 10.1016/0278-2626(90)90042-M; WIIG EH, 1984, TOP LANG DISORD, V49, P1	31	8	8	0	1	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0268-7038	1464-5041		APHASIOLOGY	Aphasiology	NOV-DEC	1996	10	8					755	766		10.1080/02687039608248448			12	Audiology & Speech-Language Pathology; Linguistics; Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Audiology & Speech-Language Pathology; Linguistics; Neurosciences & Neurology; Rehabilitation	VW009	WOS:A1996VW00900002					2022-02-06	
J	Besenski, N; Broz, R; JadroSantel, D; Pavic, D; Mikulic, D				Besenski, N; Broz, R; JadroSantel, D; Pavic, D; Mikulic, D			The course of the traumatising force in acceleration head injury: CT evidence	NEURORADIOLOGY			English	Article						computed tomography; closed head injury; site of impact		Since brain damage in closed head injury of acceleration-deceleration type depends on the site of impact and on the course of the traumatising force, a reconstruction of these was attempted using CT. The study included 45 standard CT studies of adults with closed acceleration-deceleration head injuries. We selected 32 patients exclusively on the basis of CT findings of soft tissue contusion, skull fractures and cerebral contusions (coup and/or contrecoup, as well as other parenchymal lesions), while in the remaining 13 patients clinical findings were also used. On CT, the axial section of the skull was divided into 12 sections imitating the clock-face, to permit computerised graphic presentation of the direction of the traumatising force. Analysis of cerebral contusions on different CT studies in each case allowed location of ''dominant coup'' and ''dominant contrecoup'' lesions to be determined. The site of impact and the course of the traumatising force were reconstructed and graphically presented on the basis of these findings, supplemented with data on soft tissue contusions (present in 71% of cases), skull fractures (in 36%) and sometimes on other brain lesions. Comparison of the computerised graphic presentation of the site of impact and direction of the traumatic force and the location of lesions revealed a high correlation between them. In 80% of cases, the site of impact could be visualised only by CT. The acceleration force acted along the longer axis of the head (centroaxial or semioblique) in 87% and along the shorter axis in 13% of cases. Multiple lesions were found in 87% of cases. The lesions were most frequent in the frontal (51%) and temporal (26%) lobes. CT was very useful for reconstruction of the site of impact and of the course of the traumatising force in acceleration head injury. Data obtained by this procedure may have far-reaching prognostic and forensic implications.	UNIV ZAGREB, UNIV HOSP TUMORS, DEPT NEUROSURG, HR-10002 ZAGREB, CROATIA; UNIV ZAGREB, UNIV HOSP, DEPT NEUROPATHOL, HR-10002 ZAGREB, CROATIA		Besenski, N (corresponding author), UNIV ZAGREB, UNIV HOSP, DEPT RADIOL, KISPATICEVA 12, HR-10002 ZAGREB, CROATIA.						BESENSKI N, 1992, NEURORADIOLOGY, V34, P126, DOI 10.1007/BF00588158; COURVILLE CB, 1937, PATHOLOGY CENTRAL 4; GRCEVIC N, 1988, SCAND J REHABIL MED, P25; GRCEVIC N, 1982, RAD JAZU, P265; GRCEVIC N, 1988, INVESTIGATIONS NEURO; GRCEVIC N, 1988, SCAND J REHAB MED S, V17, P87; JADROSANTEL D, 1988, CLIN NEUROPATHOL, V7, P173; JADROSANTEL D, 1989, NEUROIMAGING, V2, P263; LEESTMA JE, 1988, FORENSIC NEUROPATHOL, P184; LINDENBERG R, 1960, ARCH PATHOL, V69, P440; LINDENBERG R, 1957, ARCH PATHOL, V63, P23; LINDENBERG R, 1955, AM J PATHOL, V31, P297; SELLIER K, 1963, UNFALLHEILKUNDE, V76, P1; Tatalovic-Osterman L, 1991, Neurol Croat, V40, P231; Zarkovic K, 1991, Neurol Croat, V40, P129	15	8	8	0	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0028-3940	1432-1920		NEURORADIOLOGY	Neuroradiology	MAY	1996	38			1			S36	S41					6	Clinical Neurology; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	UT592	WOS:A1996UT59200009	8811677				2022-02-06	
J	Swaine, BR; Sullivan, SJ				Swaine, BR; Sullivan, SJ			Reliability of early motor function testing in persons following severe traumatic brain Injury	BRAIN INJURY			English	Article							STROKE	The purpose of this study was to determine the intra- and inter-rater reliability of selected variables measuring motor function in adults following severe traumatic brain injury (TBI). Twelve adults with a severe TBI participated in the study and were assessed (independently) by two physical therapists with extensive clinical experience. Standardized testing protocols and two- or three-point ordinal rating scales were used to evaluate the following categories of variables: primitive reflexes, equilibrium/protective reactions and several motor skills. Intra-rater reliability was generally high for all variables, with kappa values exceeding 0 . 65 except for the scoring of equilibrium reactions in sitting and standing. Overall, inter-rater reliability was slightly lower, with kappa values ranging from 0 . 39 to 1 . 0, indicating 'fair' to 'almost perfect' agreement. The highest level of agreement was consistently reported for the scoring of motor skills. These results suggest that physical therapists trained in the use of standardized testing and scoring procedures can reliably assess primitive reflexes, equilibrium and protective reactions and a range of motor skills in TBI adults during the acute stage of recovery. Moreover, the results provide important information which will assist in the interpretation of data collected as part of a concurrently conducted longitudinal study of early motor recovery.	INST READAPTAT MONTREAL, CTR RECH, MONTREAL, PQ H3S 2J4, CANADA; UNIV MONTREAL, FAC MED, ECOLE READAPTAT, MONTREAL, PQ H3C 3J7, CANADA; CONCORDIA UNIV, DEPT EXERCISE SCI, MONTREAL, PQ, CANADA								Badke Mary Beth, 1993, Physiotherapy Canada, V45, P15; BARAT M, 1986, REEDUCATION READAPTA, P13; Bobath, 1978, ADULT HEMIPLEGIA EVA; Bond M R, 1979, Int Rehabil Med, V1, P155; CHARNESS A, 1986, STROKE HEAD INJURY G; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; DIFABIO RP, 1990, PHYS THER, V70, P542, DOI 10.1093/ptj/70.9.542; DUNCAN PW, 1990, REHABILITATION ADULT, P264; EVANS CD, 1976, INJURY, V8, P80, DOI 10.1016/0020-1383(76)90040-1; Finger S., 1982, BRAIN DAMAGE RECOVER; FLEISS JL, 1978, APPL PSYCH MEAS, V3, P113; FOX JMS, 1988, COGNITIVE REHABI MAY, P38; GOLDIE PA, 1990, PHYS THER, V70, P234, DOI 10.1093/ptj/70.4.234; GOWLAND C, 1993, STROKE, V24, P58, DOI 10.1161/01.STR.24.1.58; HALEY S M, 1986, Physical and Occupational Therapy in Pediatrics, V6, P21, DOI 10.1300/J006v06n01_04; JOHNSTON MV, 1994, ARCH PHYS MED REHAB, V75, pSC2; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; LEAHY P, 1994, PHYSICAL REHABILITAT, P111; MAYO NE, 1991, AM J PHYS MED REHAB, V70, P118, DOI 10.1097/00002060-199106000-00002; MERBITZ C, 1989, ARCH PHYS MED REHAB, V70, P308; NORUSIS MJ, 1990, STAT PACKAGE SOCIAL; OSULLIVAN SB, 1994, PHYSICAL REHABILITAT, P111; OTTENBACHER KJ, 1993, AM J OCCUP THER, V47, P10, DOI 10.5014/ajot.47.1.10; PIPER MC, 1992, CANADIAN J PUBLIC S, V2, P46; ROTHSTEIN JM, 1985, MEASUREMENT PHYSICAL, P8; SANFORD J, 1993, PHYS THER, V73, P447, DOI 10.1093/ptj/73.7.447; SEABY L, 1989, Physiotherapy Canada, V41, P264; SULLIVAN MR, 1990, REFLEX TESTING METHO; SULLIVAN SJ, 1990, BILAN EVOLUTION MORT; SWAIN B, 1994, PHYSICAL THERAPY S, V74, P123; SWAIN BR, IN PRESS BRAIN INJUR, V10; SWAINE BR, 1993, PHYS THER, V73, P71, DOI 10.1093/ptj/73.2.71; SWAINE BR, 1994, BRAIN INJURY, V8, P323, DOI 10.3109/02699059409150983; THOMSEN IV, 1984, J NEUROL NEUROSUR PS, V47, P260, DOI 10.1136/jnnp.47.3.260; ZOLTAN B, 1990, REHABILITATION ADULT, P284	35	8	8	0	1	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	APR	1996	10	4					263	276		10.1080/026990596124449			14	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	UJ541	WOS:A1996UJ54100004	9044692				2022-02-06	
J	Rutherfoord, GS; Dada, MA; Nel, JP				Rutherfoord, GS; Dada, MA; Nel, JP			Cerebral infarction and intracranial arterial dissection in closed head injury	AMERICAN JOURNAL OF FORENSIC MEDICINE AND PATHOLOGY			English	Article						intracranial arterial dissection; cerebral infarction; dissecting aneurysm; head injury; trauma	VERTEBRAL ARTERY; ANEURYSMS; ANTERIOR; TRAUMA	This report describes the autopsy findings in three cases of closed head injury dying of cerebral infarction, with brain swelling and herniation. In each instance the cause of the infarct was found to be subintimal dissection involving intracranial anterior circulation arteries. The autopsy findings underscore the value of histological examination of vessels that macroscopically appear thrombosed. We discuss factors that impact on the reported incidence and make brief mention of problems surrounding the true pathogenesis of this lesion.			Rutherfoord, GS (corresponding author), UNIV STELLENBOSCH,NEUROPATHOL UNIT,CAPE TOWN,SOUTH AFRICA.						Adams JH, 1992, GREENFIELDS NEUROPAT, P106; Adams JH, 1975, HDB CLIN NEUROLOGY, V23, P35; ARSENI C, 1971, ACTA NEUROCHIR, V24, P25, DOI 10.1007/BF01403138; AUSTIN MG, 1957, ARCH PATHOL, V64, P205; BIGELOW NH, 1955, ARCH PATHOL, V60, P271; BILLER J, 1986, ARCH NEUROL-CHICAGO, V43, P1234, DOI 10.1001/archneur.1986.00520120019010; DADA MA, 1993, AM J FOREN MED PATH, V14, P58, DOI 10.1097/00000433-199303000-00014; DEVEER JA, 1942, NEUROPATHOL EXP NEUR, V1, P24; DRATZ HM, 1947, J NEUROPATHOL EXP NE, V6, P288; DUJOVNY M, 1979, J TRAUMA, V19, P775, DOI 10.1097/00005373-197910000-00011; DUMAN S, 1963, NEUROLOGY, V13, P613, DOI 10.1212/WNL.13.7.613; ELGINDI S, 1979, ACTA NEUROCHIR, V48, P237, DOI 10.1007/BF02056972; ENGESET A, 1967, ACTA NEUROL SCAND, VS 43, P122; Fang H., 1958, CEREBRAL VASCULAR DI, P17; FUJIWARA S, 1993, ACTA NEUROCHIR, V121, P123, DOI 10.1007/BF01809262; GROSMAN H, 1980, J NEUROSURG, V53, P693, DOI 10.3171/jns.1980.53.5.0693; GURIDI J, 1993, STROKE, V24, P1400, DOI 10.1161/01.STR.24.9.1400; HALBACH VV, 1993, J NEUROSURG, V79, P183, DOI 10.3171/jns.1993.79.2.0183; Hart R G, 1983, Neurol Clin, V1, P155; Hassin GB, 1933, ARCH NEURO PSYCHIATR, V30, P1046, DOI 10.1001/archneurpsyc.1933.02240170098006; HINSE P, 1991, J NEUROL NEUROSUR PS, V54, P863, DOI 10.1136/jnnp.54.10.863; HOLLIN SA, 1966, J NEUROSURG, V25, P526, DOI 10.3171/jns.1966.25.5.0526; KASSEL NF, 1987, HEAD INJURY, P327; KIDOOKA M, 1993, SURG NEUROL, V39, P53, DOI 10.1016/0090-3019(93)90111-D; LINELL E A, 1959, Can Med Assoc J, V81, P808; LOAR CR, 1973, J NEUROSURG, V39, P753, DOI 10.3171/jns.1973.39.6.0753; MCCORMICK GF, 1993, STROKE, V24, P598, DOI 10.1161/01.STR.24.4.598; MORGAN MK, 1987, J NEUROSURG, V66, P192, DOI 10.3171/jns.1987.66.2.0192; OCONNELL BK, 1985, NEUROLOGY, V35, P993, DOI 10.1212/WNL.35.7.993; PETITO CK, 1993, PRINCIPLES PRACTICE, P436; POZZATI E, 1989, STROKE, V20, P412, DOI 10.1161/01.STR.20.3.412; RINGEL SP, 1977, ANN NEUROL, V1, P301, DOI 10.1002/ana.410010320; ROBBINS SL, 1979, PATHOLOGIC BASIS DIS, P623; SASAKI O, 1991, J NEUROSURG, V75, P874, DOI 10.3171/jns.1991.75.6.0874; SCHMITT HP, 1991, FORENSIC SCI INT, V49, P113, DOI 10.1016/0379-0738(91)90178-L; SINCLAIR W, 1953, AM J PATHOL, V29, P1083; Stehbens W.E., 1972, PATHOLOGY CEREBRAL B, P1; THAPEDI IM, 1970, ARCH NEUROL-CHICAGO, V23, P549, DOI 10.1001/archneur.1970.00480300071009; WATRIDGE CB, 1989, J NEUROSURG, V71, P854, DOI 10.3171/jns.1989.71.6.0854; WILKINS RH, 1970, J NEUROSURG, V32, P626, DOI 10.3171/jns.1970.32.6.0626; WILKINS RH, 1975, HDB CLIN NEUROLOGY 1, V23, P163; WILKINSON IM, 1972, ARCH NEUROL-CHICAGO, V27, P392, DOI 10.1001/archneur.1972.00490170024004; WOLMAN L, 1959, BRAIN, V82, P276, DOI 10.1093/brain/82.2.276	43	8	8	0	0	LIPPINCOTT-RAVEN PUBL	PHILADELPHIA	227 EAST WASHINGTON SQ, PHILADELPHIA, PA 19106	0195-7910			AM J FOREN MED PATH	Am. J. Forensic Med. Pathol.	MAR	1996	17	1					53	57		10.1097/00000433-199603000-00009			5	Medicine, Legal; Pathology	Science Citation Index Expanded (SCI-EXPANDED)	Legal Medicine; Pathology	TW072	WOS:A1996TW07200009	8838471				2022-02-06	
J	Mayfrank, L; Gilsbach, JM; Hegemann, S; KreitschmannAndermahr, I; Schmitz, HJ; Bertalanffy, H				Mayfrank, L; Gilsbach, JM; Hegemann, S; KreitschmannAndermahr, I; Schmitz, HJ; Bertalanffy, H			Osteoplastic frontal sinusotomy and extradural microsurgical repair of frontobasal cerebrospinal fluid fistulas	ACTA NEUROCHIRURGICA			English	Article						cerebrospinal rhinorrhoea; ethmoid sinus; frontal sinus; head injury; skull base tumours	DIGITAL SUBTRACTION CISTERNOGRAPHY; EXTRACRANIAL REPAIR; CT CISTERNOGRAPHY; RHINORRHEA; MANAGEMENT; FRACTURES; LOCALIZATION; EXPERIENCE; DIAGNOSIS; INJURIES	The choice of the surgical approach and operative technique for the management of cerebrospinal fluid (CSF) fistulas of the anterior cranial fossa are still a controversially discussed topic. Although ''extracranial'' approaches through the paranasal sinuses are becoming increasingly more popular among otolaryngologists and maxillo-facial surgeons, most neurosurgeons traditionally prefer the ''intracranial'' repair of CSF fistulas by a craniotomy. We present an approach through the frontal sinus for the repair of dural defects behind the posterior wall of the frontal sinus and at the floor of the anterior cranial fossa. The operative procedure comprises the following main steps: 1) exposure of the anterior wall of the frontal sinus by a bicoronal incision; 2) excision of the anterior wall without frontal bun holes; 3) bilateral removal of the posterior wall of the fronal sinus; 4) extradural inspection of the dura behind the frontal sinus and above the cribriform plate, ethmoidal roof, and orbital roof bilaterally; 5) closure of dural tears by direct suture and a periosteal graft; 6) reinsertion of the anterior wall of the frontal sinus and fixation with titanium micro plates. Twenty-five patients operated upon using this technique are described. The aetiology of the frontobasal lesion was traumatic in 23, and an ethmoid carcinoma in two. In all patients, the dural fistulas were successfully repaired during the initial procedure. One patient died from sudden circulatory arrest after an uneventful postoperative course of nine days. Otherwise, there were no postoperative complications. This technique affords atraumatic extradural inspection and repair of dural fistulas bilaterally behind the frontal sinus, and above the cribriform plate and the ethmoidal and orbital roofs with none or minimal brain retraction. It therefore allows early repair of CSF fistulas also in patients with severe brain injury. Although we consider the extradural closure of fistulas the method of choice, this approach also allows for a combined extradural-intradural procedure, thus enabling the surgeon to treat associated intradural pathologies, such as traumatic lesions or rumours of the frontal cranial base.	RHEIN WESTFAL TH AACHEN,FAC MED,DEPT OTORHINOLARYNGOL,D-52057 AACHEN,GERMANY; RHEIN WESTFAL TH AACHEN,FAC MED,DEPT MAXILLOFACIAL SURG,D-52057 AACHEN,GERMANY		Mayfrank, L (corresponding author), RHEIN WESTFAL TH AACHEN,FAC MED,DEPT NEUROSURG,PAUWELSSTR 30,D-52057 AACHEN,GERMANY.		Hegemann, Stefan/AAT-4425-2020; Hegemann, Stefan/B-4640-2013	Hegemann, Stefan/0000-0002-9464-352X; Hegemann, Stefan/0000-0002-9464-352X			AARABI B, 1992, Ear Nose and Throat Journal, V71, P300; BECKHARDT RN, 1991, OTOLARYNG HEAD NECK, V104, P425, DOI 10.1177/019459989110400402; BENEDICT M, 1991, HNO, V39, P1; BENZIL DL, 1992, NEUROSURGERY, V30, P166, DOI 10.1227/00006123-199202000-00003; BYRNE JV, 1990, J NEUROL NEUROSUR PS, V53, P1072, DOI 10.1136/jnnp.53.12.1072; CALCATERRA TC, 1985, OTOLARYNG CLIN N AM, V18, P99; DALY D T, 1992, Ear Nose and Throat Journal, V71, P311; Dandy WE, 1926, ARCH SURG-CHICAGO, V12, P949, DOI 10.1001/archsurg.1926.01130050003001; DAVID D J, 1990, Facial Plastic Surgery, V7, P152, DOI 10.1055/s-2008-1064677; DIETMER T, 1988, LARYN RHINOL OTOL, V67, P13; Dietrich U, 1993, Zentralbl Neurochir, V54, P24; ELJAMEL M S M, 1990, British Journal of Neurosurgery, V4, P479, DOI 10.3109/02688699008993796; FARRELL VJ, 1993, SURG NEUROL, V37, P378; GRUSS JS, 1989, BRIT J PLAST SURG, V42, P385, DOI 10.1016/0007-1226(89)90003-9; HELMY ES, 1990, ORAL SURG ORAL MED O, V69, P137, DOI 10.1016/0030-4220(90)90314-I; HUBBARD JL, 1985, NEUROSURGERY, V16, P314, DOI 10.1227/00006123-198503000-00006; Joos U, 1991, Fortschr Kiefer Gesichtschir, V36, P136; Loew F, 1984, Adv Tech Stand Neurosurg, V11, P169; LUCE EA, 1987, PLAST RECONSTR SURG, V80, P500, DOI 10.1097/00006534-198710000-00003; LUHR HG, 1988, J CRANIO MAXILL SURG, V16, P312, DOI 10.1016/S1010-5182(88)80069-6; MATTOX DE, 1990, LARYNGOSCOPE, V100, P857; MCCORMACK B, 1990, NEUROSURGERY, V27, P412, DOI 10.1227/00006123-199009000-00012; ONISHI K, 1989, J CRANIO MAXILL SURG, V17, P58, DOI 10.1016/S1010-5182(89)80046-0; OZGEN T, 1990, NEURORADIOLOGY, V32, P481; PERSKY MS, 1991, LARYNGOSCOPE, V101, P134; PIOTROWSKI WP, 1992, J ORAL MAXIL SURG, V50, P1264, DOI 10.1016/0278-2391(92)90224-N; PROBST C, 1990, ACTA NEUROCHIR, V106, P37, DOI 10.1007/BF01809331; RAJSHEKHAR V, 1989, ACTA NEUROCHIR, V96, P114, DOI 10.1007/BF01456168; RAVEH J, 1988, J CRANIO MAXILL SURG, V16, P160, DOI 10.1016/S1010-5182(88)80042-8; RAVEH J, 1992, ARCH OTOLARYNGOL, V118, P605; ROHRICH RJ, 1992, CLIN PLAST SURG, V19, P219; ROSS IB, 1990, CAN J NEUROL SCI, V17, P320, DOI 10.1017/S0317167100030663; Russegger L, 1988, Zentralbl Neurochir, V49, P290; STANLEY RB, 1989, CLIN PLAST SURG, V16, P115; STANLEY RB, 1991, OTOLARYNG CLIN N AM, V24, P139; Stoll W, 1993, Eur Arch Otorhinolaryngol Suppl, V1, P287; TAKAHASHI T, 1988, J NEUROSURG, V68, P721, DOI 10.3171/jns.1988.68.5.0721; TAKEUCHI H, 1992, AM J NEURORADIOL, V13, P379; VONHAACKE NP, 1983, CLIN OTOLARYNGOL, V8, P317; WAKHLOO AK, 1991, ACTA NEUROCHIR, V111, P119, DOI 10.1007/BF01400499; WALLIS A, 1988, LARYNGOSCOPE, V98, P593; WILSON BC, 1988, LARYNGOSCOPE, V98, P516; WOLFE SA, 1988, PLAST RECONSTR SURG, V82, P781, DOI 10.1097/00006534-198811000-00009; YESSENOW RS, 1989, OTOLARYNG HEAD NECK, V101, P555, DOI 10.1177/019459988910100507; ZLAB MK, 1992, EAR NOSE THROAT J, V71, P313	45	8	9	0	3	SPRINGER-VERLAG WIEN	VIENNA	SACHSENPLATZ 4-6, PO BOX 89, A-1201 VIENNA, AUSTRIA	0001-6268			ACTA NEUROCHIR	Acta Neurochir.		1996	138	3					245	253		10.1007/BF01411734			9	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	UB183	WOS:A1996UB18300001	8861692				2022-02-06	
J	Milanovich, JR; Axelrod, BN; Millis, SR				Milanovich, JR; Axelrod, BN; Millis, SR			Validation of the simulation index-revised with a mixed clinical population	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article							MEMORY	The Simulation Index-Revised (SI-R) was previously developed to differentiate impaired motivation from traumatic brain injury sequelae in patients referred for neuropsychological assessment. Rather than using quantitative comparisons of performance, the SI-R evaluates qualitative errors on the WAIS-R and WMS. The present study examined the specificity of the SI-R in a clinical sample of 338 patients of mixed diagnoses. The overall level of specificity was 62% in this sample. patient groups with diagnoses of schizophrenia, vascular dementia, and alcohol dependence had lower specificity than did the mean of the entire sample. The need for additional studies and SI-R item analyses are discussed.	DEPT VET AFFAIRS MED CTR,PSYCHOL SERV 116B,ALLEN PK,MI 48101; REHABIL INST MICHIGAN,DETROIT,MI; WAYNE STATE UNIV,SCH MED,DETROIT,MI 48202								GUDJONSSON GH, 1986, BRIT J CLIN PSYCHOL, V25, P35, DOI 10.1111/j.2044-8260.1986.tb00668.x; GUILMETTE TJ, 1993, CLIN NEUROPSYCHOL, V7, P59, DOI 10.1080/13854049308401888; Lee G. P., 1992, PSYCHOL ASSESSMENT, V4, P43, DOI DOI 10.1037/1040-3590.4.1.43; MILLIS SR, 1992, CLIN NEUROPSYCHOL, V6, P406; MORGNA SF, 1989, CLIN NEUROPSYCHOLOGI, V3, P292; Raven J. C., 1960, GUIDE STANDARD PROGR; RAWLING P J, 1992, Brain Injury, V6, P381, DOI 10.3109/02699059209034953; Rawling P, 1990, NEUROPSYCHOLOGY, V4, P223, DOI 10.1037/0894-4105.4.4.223; RAWLING PJ, 1993, SIMULATION INDEX REV; Rey A., 1964, EXAMEN CLIN PSYCHOL; [No title captured]	11	8	8	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, ENGLAND OX5 1GB	0887-6177			ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	JAN-FEB	1996	11	1					53	59		10.1016/0887-6177(95)00016-X			7	Psychology, Clinical; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	TM579	WOS:A1996TM57900006		Bronze			2022-02-06	
J	MARTINEZMURILLO, R; BENTURA, ML; FERNANDEZ, AM; NIETOSAMPEDRO, M; RODRIGO, J				MARTINEZMURILLO, R; BENTURA, ML; FERNANDEZ, AM; NIETOSAMPEDRO, M; RODRIGO, J			CHEMICAL HETEROGENEITY IN ADULT-RAT CEREBELLAR PURKINJE-CELLS AS REVEALED BY ZEBRIN-I AND LOW-AFFINITY NERVE GROWTH-FACTOR RECEPTOR IMMUNOCYTOCHEMICAL EXPRESSION FOLLOWING INJURY	JOURNAL OF NEUROCYTOLOGY			English	Article							MESSENGER-RNA; OLIVOCEREBELLAR PROJECTION; PARASAGITTAL ORGANIZATION; CHOLINERGIC NEURONS; ACID DECARBOXYLASE; GENE-EXPRESSION; BRAIN-STEM; NGF; CORTEX; IMMUNOREACTIVITY	Cerebellar Purkinje cells in rat express low-affinity nerve growth factor receptor during development, but rarely in normal adult animals. However, after either mechanical injury or colchicine treatment during adulthood, these cells re-express low-affinity nerve growth factor receptor-immunoreactive protein. Two Purkinje cell subpopulations were defined in normal adult cerebellum by the presence or the absence of zebrin I antigen. Nevertheless, it remains an open question as to whether low-affinity nerve growth factor receptor-immunoreactive protein can be expressed by all damaged Purkinje cells, independent of their location and their staining with antibodies against intrinsic molecular markers that reveal Purkinje cell heterogeneity, such as zebrin I. In this study, a serial-section immunocytochemical mapping of the expression zebrin I and low-affinity nerve growth factor receptor, using specific monoclonal antibodies, was carried out in colchicine-treated rats. After mechanical damage of the cerebellar cortex, co-localization of these antigens at the cellular level was also analysed in thin adjacent sections, and by using a combined immunocytochemical staining method in individual sections. The findings revealed the existence of three sub-sets of Purkinje cells: (1) two complementary groups distinctly immunoreactive to one antibody, but not to the other and (2) a third group that contained double-labelled cells. In contrast, co-expression of both antigens was never observed following mechanical lesions. The seemingly independent response to mechanical injury of Purkinje cells located in different zebrin-defined compartments, indicates that particular subpopulations of Purkinje cells may respond differentially to traumatic injury.	CSIC,INST CAJAL,DEPT NEURAL PLASTIC,E-28002 MADRID,SPAIN		MARTINEZMURILLO, R (corresponding author), CSIC,INST CAJAL,DEPT NEUROANAT,DOCTOR ARCE 37,E-28002 MADRID,SPAIN.		Martinez-Murillo, Ricardo/K-7596-2014	Martinez-Murillo, Ricardo/0000-0003-3657-3890; Fernandez, Ana M./0000-0001-5160-3854			AGUADO F, 1994, NEUROSCIENCE, V59, P641, DOI 10.1016/0306-4522(94)90183-X; ARMSTRONG DM, 1974, J COMP NEUROL, V154, P278; Arsenio Nunes M L, 1988, J Comp Neurol, V273, P120; BROCHU G, 1990, J COMP NEUROL, V291, P538, DOI 10.1002/cne.902910405; CAJAL SRY, 1914, ESTUDIOS SOBRE DEGEN, V2; CAVICCHIOLI L, 1989, EUR J NEUROSCI, V1, P258, DOI 10.1111/j.1460-9568.1989.tb00793.x; CHANDLER CE, 1984, J BIOL CHEM, V259, P6882; CHANPALAY V, 1981, P NATL ACAD SCI-BIOL, V78, P7787, DOI 10.1073/pnas.78.12.7787; CHANPALAY V, 1982, P NATL ACAD SCI-BIOL, V79, P4221, DOI 10.1073/pnas.79.13.4221; CHEN S, 1993, NEUROSCIENCE, V56, P177, DOI 10.1016/0306-4522(93)90572-W; COHENCORY S, 1991, J NEUROSCI, V11, P462; COHENCORY S, 1993, EXP NEUROL, V119, P165, DOI 10.1006/exnr.1993.1018; DORE L, 1990, J COMP NEUROL, V291, P431, DOI 10.1002/cne.902910309; DUSART I, 1994, J COMP NEUROL, V347, P211, DOI 10.1002/cne.903470206; FUSCO M, 1991, J COMP NEUROL, V312, P477, DOI 10.1002/cne.903120313; GRAVEL C, 1987, J COMP NEUROL, V265, P294, DOI 10.1002/cne.902650211; GRAVEL C, 1990, J COMP NEUROL, V291, P79, DOI 10.1002/cne.902910107; GROENEWEGEN HJ, 1977, J COMP NEUROL, V174, P417, DOI 10.1002/cne.901740304; HAWKES R, 1992, BIOCHEM SOC T, V20, P391, DOI 10.1042/bst0200391; HAWKES R, 1987, J COMP NEUROL, V256, P29, DOI 10.1002/cne.902560104; HAWKES R, 1991, PROG NEUROBIOL, V36, P309, DOI 10.1016/0301-0082(91)90004-K; HAWKES R, 1985, BRAIN RES, V333, P359, DOI 10.1016/0006-8993(85)91593-8; HOLTZMAN DM, 1992, NEURON, V9, P465, DOI 10.1016/0896-6273(92)90184-F; INGRAM VM, 1985, P NATL ACAD SCI USA, V82, P7131, DOI 10.1073/pnas.82.20.7131; KAWAMURA K, 1979, NEUROSCIENCE, V4, P1615, DOI 10.1016/0306-4522(79)90024-1; KOH S, 1989, EXP NEUROL, V106, P209, DOI 10.1016/0014-4886(89)90154-4; LAMS BE, 1988, BRAIN RES, V475, P401, DOI 10.1016/0006-8993(88)90635-X; LECLERC N, 1988, J COMP NEUROL, V273, P399, DOI 10.1002/cne.902730310; LEVIMONTALCINI R, 1968, PHYSIOL REV, V48, P534, DOI 10.1152/physrev.1968.48.3.534; LU B, 1989, EXP NEUROL, V104, P191, DOI 10.1016/0014-4886(89)90029-0; MAISONPIERRE PC, 1990, NEURON, V5, P501, DOI 10.1016/0896-6273(90)90089-X; MARTINEZMURILLO R, 1993, NEUROSCIENCE, V52, P587, DOI 10.1016/0306-4522(93)90408-8; OSCARSSON O, 1979, TRENDS NEUROSCI, V2, P143, DOI 10.1016/0166-2236(79)90057-2; PIORO EP, 1991, J COMP NEUROL, V305, P189, DOI 10.1002/cne.903050203; PIORO EP, 1990, NEUROSCIENCE, V34, P89, DOI 10.1016/0306-4522(90)90305-N; PIORO EP, 1988, BRAIN RES, V455, P182, DOI 10.1016/0006-8993(88)90131-X; RUBINSTEIN M, 1992, MOL CELL NEUROSCI, V3, P152, DOI 10.1016/1044-7431(92)90019-X; SCOTT TG, 1964, J COMP NEUROL, V122, P1, DOI 10.1002/cne.901220102; SHELTON DL, 1986, P NATL ACAD SCI USA, V83, P2714, DOI 10.1073/pnas.83.8.2714; SOTELO C, 1991, PHILOS T R SOC B, V331, P307, DOI 10.1098/rstb.1991.0022; SOTELO C, 1989, NESTLE NUTRITION WOR, V12, P155; STAINIER DY, 1989, J NEUROSCI, V9, P2468; VOOGD J, 1987, NEW CONCEPTS CEREBEL, V22, P183; WANAKA A, 1990, DEV BRAIN RES, V55, P288, DOI 10.1016/0165-3806(90)90211-G; YAN Q, 1988, J NEUROSCI, V8, P3481; YANKNER BA, 1982, ANNU REV BIOCHEM, V51, P845, DOI 10.1146/annurev.bi.51.070182.004213	46	8	8	0	2	CHAPMAN HALL LTD	LONDON	2-6 BOUNDARY ROW, LONDON, ENGLAND SE1 8HN	0300-4864			J NEUROCYTOL	J. Neurocytol.	NOV	1995	24	11					807	817		10.1007/BF01179980			11	Cell Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Neurosciences & Neurology	TG185	WOS:A1995TG18500001	8576710				2022-02-06	
J	GRIGORIANTS, OO; PRAVDENKOVA, SV; ANDERSEN, BJ; DESIDERIO, DM				GRIGORIANTS, OO; PRAVDENKOVA, SV; ANDERSEN, BJ; DESIDERIO, DM			ALTERATION OF OPIOID PEPTIDE CONCENTRATIONS IN THE RAT PITUITARY FOLLOWING SURVIVABLE CLOSED-HEAD INJURY	NEUROCHEMICAL RESEARCH			English	Article						OPIOID; PEPTIDE; HEAD INJURY; HPLC; RIA	TRAUMATIC BRAIN INJURY; BETA-ENDORPHIN LEVELS; SPINAL-CORD; ENDOGENOUS OPIOIDS; RADIOIMMUNOASSAY TECHNIQUE; CEREBROSPINAL-FLUID; OPIATE ANTAGONISTS; DYNORPHIN; NALOXONE; PLASMA	Concentration changes of methionine enkephalin-like immunoreactivity (ME-li) and beta-endorphin-like immunoreactivity (BE-li) in the rat pituitary following diffuse brain injury were studied. Closed head injury was induced by a weight-drop trauma device (450 g X 2 m). The level of closed head injury used in this study altered the pituitary opioid peptide concentrations. The level of ME-li did not change in the experimental groups 3 hours, 10 hours, 24 hours, and 3 days after the trauma, but significantly increased by 34% 10 days after the trauma. BE-li remained constant 3 hours and 10 hours following the injury, increased by 48% at 24 hours, and remained at this level for 10 days after the trauma (44% at 3 days, and 40% at 10 days). The levels of ME-li and BE-li in the control sham-operated rats did not change during these times. The present measurements of BE-li and ME-li in the pituitary indicate that the opioid peptides that derive from two different neuropeptidergic systems, proopiomelanocortin (POMC) and preproenkephalin A, respectively, may participate in the pathophysiology of a closed head injury.	UNIV TENNESSEE,DEPT NEUROL,CHARLES B STOUT NEUROSCI MASS SPECT LAB,MEMPHIS,TN 38163; UNIV TENNESSEE,DEPT BIOCHEM,MEMPHIS,TN 38163; UNIV ARKANSAS,DEPT NEUROSURG,LITTLE ROCK,AR 72205						NIGMS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [GM26666] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R01GM026666] Funding Source: NIH RePORTER		ADAMS JH, 1983, ADV NEUROTRAUMATOLOG, P53; BASKIN DS, 1986, J NEUROSURG, V64, P99, DOI 10.3171/jns.1986.64.1.0099; BASKIN DS, 1981, LANCET, V2, P272; BECKER DP, 1986, MECH SECONDARY BRAIN, P47; BECKMAN DL, 1979, P SOC EXP BIOL MED, V160, P200; BRADFORD HF, 1986, CHEM NEUROBIOLOGY; CLIFTON GL, 1983, NEUROSURGERY, V8, P10; DEITCH EA, 1988, SURGERY, V104, P41; DESIDERIO DM, 1992, MASS SPECTROMETRY CL, V1, P133; ERB DE, 1988, ACTA NEUROPATHOL, V76, P347, DOI 10.1007/BF00686971; FADEN AI, 1981, ANN NEUROL, V10, P326, DOI 10.1002/ana.410100403; FADEN AI, 1985, REGUL PEPTIDES, V11, P35, DOI 10.1016/0167-0115(85)90029-1; FADEN AI, 1993, HDB EXP PHARM, V104, P325; FODA MAA, 1994, J NEUROSURG, V80, P301, DOI 10.3171/jns.1994.80.2.0301; FURUI T, 1984, J NEUROSURG, V61, P748, DOI 10.3171/jns.1984.61.4.0748; Gennarelli T.A., 1986, MECHANISMS SECONDARY, P15; Gennarelli T.A., 1985, CENTRAL NERVOUS SYST, P391; Gennarelli TA, 1993, HEAD INJURY, P137; GENTLEMAN SM, 1993, NEUROSCI LETT, V160, P139, DOI 10.1016/0304-3940(93)90398-5; GENTLEMAN SM, 1993, PROGR BRAIN RES, P237; GUILLEMIN R, 1977, SCIENCE, V197, P1367, DOI 10.1126/science.197601; HAYES RL, 1990, J NEUROSURG, V72, P252, DOI 10.3171/jns.1990.72.2.0252; HIGA T, 1989, INT J PEPT PROT RES, V33, P250; HOSOBUCHI Y, 1982, SCIENCE, V215, P69, DOI 10.1126/science.6274019; IADAROLA MJ, 1988, BRAIN RES, V455, P205, DOI 10.1016/0006-8993(88)90078-9; Jacobson L., 1994, PITUITARY GLAND, P117; JENKINS LW, 1986, MECHANISMS SECONDARY, P273; Jessel T.M., 1983, P315; LEAO APP, 1944, J NEUROPHYSIOL, V7, P33; LOPEZ JA, 1991, NEUROSURGERY, V28, P335; LYETH BG, 1992, J NEUROTRAUM, V9, pS463; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; MCINTOSH TK, 1987, AM J PHYSIOL, V253, pE565, DOI 10.1152/ajpendo.1987.253.5.E565; MCINTOSH TK, 1987, BRAIN RES, V425, P225, DOI 10.1016/0006-8993(87)90505-1; MCINTOSH TK, 1986, ANN EMERG MED, V15, P1462, DOI 10.1016/S0196-0644(86)80944-1; MCINTOSH TK, 1985, PSYCHONEUROENDOCRINO, V10, P303, DOI 10.1016/0306-4530(85)90007-1; MCNAMARA RK, 1993, BRAIN RES REV, V18, P33, DOI 10.1016/0165-0173(93)90006-L; OPPENHEI.DR, 1968, J NEUROL NEUROSUR PS, V31, P299, DOI 10.1136/jnnp.31.4.299; PAPPIUS HM, 1986, MECHANISMS SECONDARY, P151; PERRY DC, 1992, MOL CHEM NEUROPATHOL, V16, P95, DOI 10.1007/BF03159963; PRZEWLOCKI R, 1988, MOL BRAIN RES, V4, P37, DOI 10.1016/0169-328X(88)90016-2; ROSSIER J, 1977, NATURE, V270, P618, DOI 10.1038/270618a0; ROSTOVTSEV AP, 1994, MOL CELL ENDOCRINOL, V101, P277, DOI 10.1016/0303-7207(94)90244-5; SHARMA HS, 1993, NEUROPHARMACOLOGY, V32, P711, DOI 10.1016/0028-3908(93)90085-H; SHARMA HS, 1992, NEUROSCI RES, V14, P195; STRICH SJ, 1961, LANCET, V2, P443; TOMLINSON BC, 1970, J CLIN PATHOL S, V423, P154; UDENFRIEND S, 1984, PEPTIDES, V6, P25; WHITE BC, 1993, ANN EMERG MED, V22, P970, DOI 10.1016/S0196-0644(05)82737-4; WOLF ME, 1990, RES COMMUN PSYCH PSY, V15, P73; YAN L, 1994, LIFE SCI, V55, P1937, DOI 10.1016/0024-3205(94)00526-5; YOUNG AB, 1988, J NEUROSURG, V69, P375, DOI 10.3171/jns.1988.69.3.0375; ZAGON IS, 1990, BRAIN RES, V511, P181, DOI 10.1016/0006-8993(90)90159-9; ZIMMERMAN RS, 1990, NEUROSURGERY, V26, P764, DOI 10.1227/00006123-199005000-00005	54	8	10	0	0	PLENUM PUBL CORP	NEW YORK	233 SPRING ST, NEW YORK, NY 10013	0364-3190			NEUROCHEM RES	Neurochem. Res.	JUL	1995	20	7					827	831		10.1007/BF00969695			5	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	RP138	WOS:A1995RP13800009	7477676				2022-02-06	
J	WOLF, AP; GLECKMAN, AD				WOLF, AP; GLECKMAN, AD			SINEMET AND BRAIN INJURY - FUNCTIONAL VERSUS STATISTICAL CHANGE AND SUGGESTIONS FOR FUTURE-RESEARCH DESIGNS	BRAIN INJURY			English	Article							RECOVERY	During the past decade the usage of dopaminergic agonists for the brain-injured population has become a more common treatment option during both the acute and subacute phases of recovery. We attempted to use Sinemet to address the functional limitations of a 74-year-old woman who was 7 months status post-traumatic brain injury secondary to a motor vehicle accident. The patient was administered a S-month trial of Sinemet while continuing to receive structured sensory stimulation. Her baseline performance using Rappaport's Coma/Near-Coma (CNC) scale yielded a score in the moderate coma range. Weekly evaluations were conducted throughout the drug trial period using the CNC scale. Although the patient displayed modest improvement in her total score, functional change was negligible. Long-term follow-up suggested an absence of retention of earlier gains obtained on the CNC scale. The authors suggest that flawed research methodologies, heterogeneous patient populations, and potential difficulties obtaining reliable dependent measures makes the interpretation of brain injury research findings equivocal. However, given the many limitations, the current research design suggested that the long-term practical utility of Sinemet was unremarkable. Suggestions for future pharmacological research designs with the brain-injured population are discussed.	CONNECTICUT SUBACUTE CORP,WATERBURY,CT								ANSELL BJ, 1989, ARCH PHYS MED REHAB, V70, P104; BELLACK AS, 1987, RES METHODS CLIN PSY; Christensen L.B., 1991, EXPT METHODOLOGY, V5th; GIACINO JT, 1991, ARCH PHYS MED REHAB, V72, P897, DOI 10.1016/0003-9993(91)90008-7; HAIG AJ, 1990, ARCH PHYS MED REHAB, V71, P1081; KAZDIN AE, 1978, J CONSULT CLIN PSYCH, V46, P629, DOI 10.1037/0022-006X.46.4.629; Lal S, 1988, Brain Inj, V2, P225, DOI 10.3109/02699058809150946; Rader M A, 1989, Brain Inj, V3, P141, DOI 10.3109/02699058909004545; RAPPAPORT M, 1992, ARCH PHYS MED REHAB, V73, P628; VANWOERKOM TCAM, 1982, EUR NEUROL, V21, P227, DOI 10.1159/000115485; ZASLER ND, 1992, S REHABILITATION ISS	11	8	8	0	0	TAYLOR & FRANCIS LTD LONDON	LONDON	ONE GUNDPOWDER SQUARE, LONDON, ENGLAND EC4A 3DE	0269-9052			BRAIN INJURY	Brain Inj.	JUL	1995	9	5					487	493		10.3109/02699059509008208			7	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	RJ331	WOS:A1995RJ33100007	7550220				2022-02-06	
J	ONUMA, T; SHIMOSEGAWA, Y; KAMEYAMA, M; ARAI, H; ISHII, K				ONUMA, T; SHIMOSEGAWA, Y; KAMEYAMA, M; ARAI, H; ISHII, K			CLINICOPATHOLOGICAL INVESTIGATION OF GYRAL HIGH-DENSITY ON COMPUTERIZED-TOMOGRAPHY FOLLOWING SEVERE HEAD-INJURY IN CHILDREN	JOURNAL OF NEUROSURGERY			English	Article						GYRAL HIGH DENSITY; HEMORRHAGIC INFARCTION; SEVERE HEAD INJURY; CHILDREN	TRAUMATIC BRAIN INJURY; CEREBRAL BLOOD-FLOW; COMATOSE PATIENTS; ENHANCEMENT; INFARCTION; METABOLISM; HYPOXIA; CT; MANAGEMENT; DIAGNOSIS	The authors have treated five cases of severe head trauma in children in which abnormally high density along gyri, ''gyral high density,'' was seen on plain computerized tomography (CT) scans in the subacute stage of the injury. The prognosis in all cases was poor, with either severe disability or a vegetative state as the outcome due to significant brain atrophy following gyral high density. This pathology was classified into three clinical stages: 1) acute stage, cerebral ischemia in which there is diffuse low density of the cerebrum on CT scans (most marked on the 3rd and 4th days); 2) subacute stage, hemorrhagic infarction showing gyral high density on plain CT scans (between 1 and 4 weeks); and 3) chronic stage, brain atrophy (beginning 4 weeks after the trauma). In their consecutive series of head-injured patients (516 children, 1459 adults), the authors did not find gyral high density on CT scan in adults. This is probably due to the fact that adults who suffer the severe head trauma associated with diffuse brain swelling or diffuse brain edema cannot survive, thus making this gyral high density unique to children.	SENDAI CITY HOSP, DEPT RADIOL, WAKABAYASHI KU, SENDAI, MIYAGI 980, JAPAN		ONUMA, T (corresponding author), SENDAI CITY HOSP, DEPT NEUROSURG, WAKABAYASHI KU, SHIMIZUKOJI 3-1, SENDAI, MIYAGI 980, JAPAN.						ADAMS JH, 1989, SCOT MED J, V34, P399, DOI 10.1177/003693308903400106; BERGER MS, 1985, J NEUROSURG, V62, P194, DOI 10.3171/jns.1985.62.2.0194; BRUCE DA, 1981, J NEUROSURG, V54, P170, DOI 10.3171/jns.1981.54.2.0170; BRUCE DA, 1973, J NEUROSURG, V38, P131, DOI 10.3171/jns.1973.38.2.0131; CAILLE JM, 1980, COMPUT TOMOGR, V4, P73, DOI 10.1016/0363-8235(80)90001-0; CHUGANI HT, 1987, ANN NEUROL, V22, P487, DOI 10.1002/ana.410220408; CLASEN RA, 1987, HEAD INJURY, P285; GRAHAM DI, 1989, J NEUROL NEUROSUR PS, V52, P346, DOI 10.1136/jnnp.52.3.346; HECHTLEAVITT C, 1986, AM J NEURORADIOL, V7, P581; HORNIG CR, 1986, STROKE, V17, P179, DOI 10.1161/01.STR.17.2.179; ISHIGE N, 1987, NEUROSURGERY, V20, P854, DOI 10.1227/00006123-198706000-00006; ISHIGE N, 1987, NEUROSURGERY, V20, P848, DOI 10.1227/00006123-198706000-00005; KETY S S, 1956, J Chronic Dis, V3, P478, DOI 10.1016/0021-9681(56)90146-1; KINKEL WR, 1980, NEUROLOGY, V30, P810, DOI 10.1212/WNL.30.8.810; KOO AH, 1977, RADIOLOGY, V123, P345, DOI 10.1148/123.2.345; KRIEL RL, 1988, ARCH PHYS MED REHAB, V69, P678; LANGFITT TW, 1982, CLIN NEUR, V29, P353; LANKSCH W, 1981, BRAIN EDEMA, P67; LOBATO RD, 1988, J NEUROSURG, V68, P417, DOI 10.3171/jns.1988.68.3.0417; LOBATO RD, 1983, J NEUROSURG, V59, P762, DOI 10.3171/jns.1983.59.5.0762; LUERSSEN TG, 1988, J NEUROSURG, V68, P409, DOI 10.3171/jns.1988.68.3.0409; MASDEU JC, 1977, ARCH NEUROL-CHICAGO, V34, P417, DOI 10.1001/archneur.1977.00500190051007; OBRIST WD, 1984, J NEUROSURG, V61, P241, DOI 10.3171/jns.1984.61.2.0241; OGAWA A, 1989, Neurological Research, V11, P173; PRICE DJE, 1972, INJURY-BR J ACCIDENT, V3, P218, DOI 10.1016/0020-1383(72)90104-0; RAIMONDI AJ, 1984, CHILD BRAIN, V11, P12; Sarabia R, 1988, Acta Neurochir Suppl (Wien), V42, P40; SKRIVER EB, 1982, NEURORADIOLOGY, V23, P259, DOI 10.1007/BF00339392; SMALL JM, 1957, J NEUROL NEUROSUR PS, V20, P293, DOI 10.1136/jnnp.20.4.293; TRAUPE H, 1979, J COMPUT ASSIST TOMO, V3, P627, DOI 10.1097/00004728-197910000-00011; WEISBERG LA, 1980, ARCH NEUROL-CHICAGO, V37, P21, DOI 10.1001/archneur.1980.00500500051006; YOSHINO E, 1985, J NEUROSURG, V63, P830, DOI 10.3171/jns.1985.63.6.0830; ZIMMERMAN RA, 1978, AM J ROENTGENOL, V131, P27, DOI 10.2214/ajr.131.1.27; ZIMMERMAN RA, 1978, RADIOLOGY, V126, P403, DOI 10.1148/126.2.403; ZIMMERMAN RA, 1981, J NEURORADIOLOGY, V8, P257; ZIMMERMAN RA, 1986, AM J ROENTGENOL, V147, P1215, DOI 10.2214/ajr.147.6.1215	36	8	8	0	0	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	JUN	1995	82	6					995	1001		10.3171/jns.1995.82.6.0995			7	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	QZ904	WOS:A1995QZ90400013	7760204				2022-02-06	
J	SMITH, RL; GOODE, KT; LAMARCHE, JA; BOLL, TJ				SMITH, RL; GOODE, KT; LAMARCHE, JA; BOLL, TJ			SELECTIVE REMINDING TEST SHORT-FORM ADMINISTRATION - A COMPARISON OF 2 THROUGH 12 TRIALS	PSYCHOLOGICAL ASSESSMENT			English	Article							MEMORY; DEMENTIA	The Selective Reminding Test (SRT) is a list-learning task developed to assess verbal memory. The goal of this study was to assess the clinical utility of fewer trials of the SRT as compared with a 12-trial administration, using 2 clinical populations. One sample consisted of 100 end-stage cardiac patients undergoing evaluation for heart transplantation. The other group was made up of 100 patients being evaluated after traumatic brain injury. Scores were derived for Trials 2 through 12. Correlational analyses conducted among these scores revealed correlations exceeding 90 between 6 and 12 trials and correlations exceeding 95 between 8 and 12 trials. These results suggest that fewer trials of the SRT would provide information highly consistent with that provided by 12 trials while reducing administration time.	UNIV ALABAMA,DEPT SURG,BIRMINGHAM,AL 35294		SMITH, RL (corresponding author), UNIV ALABAMA,DEPT PSYCHOL,NEUROPSYCHOL LAB,1521 11TH AVE S,BIRMINGHAM,AL 35294, USA.						BUSCHKE H, 1973, J VERB LEARN VERB BE, V12, P543, DOI 10.1016/S0022-5371(73)80034-9; CAINE ED, 1977, NEUROLOGY, V27, P1087, DOI 10.1212/WNL.27.11.1087; GOETHE KE, 1989, ARCH NEUROL-CHICAGO, V46, P129, DOI 10.1001/archneur.1989.00520380029008; HANNAY HJ, 1985, J CLIN EXP NEUROPSYC, V7, P251, DOI 10.1080/01688638508401258; KAISER HF, 1958, PSYCHOMETRIKA, V23, P187, DOI 10.1007/BF02289233; KRAEMER HC, 1983, PSYCHOL BULL, V94, P367, DOI 10.1037/0033-2909.94.2.367; LEE GP, 1989, PSYCHOL ASSESS J CON, V1, P192; Levin HS., 1982, NEUROBEHAVIORAL CONS; Loring D W, 1986, Arch Clin Neuropsychol, V1, P335, DOI 10.1016/0887-6177(86)90137-X; LORING DW, 1987, J CLIN EXP NEUROPSYC, V9, P340, DOI 10.1080/01688638708405055; Martin R C, 1988, Arch Clin Neuropsychol, V3, P351, DOI 10.1016/0887-6177(88)90048-0; MASUR DM, 1989, J CLIN EXP NEUROPSYC, V11, P615, DOI 10.1080/01688638908400920; MURAMOTO O, 1984, CORTEX, V20, P461, DOI 10.1016/S0010-9452(84)80052-0; PANIAK CE, 1989, J CLIN EXP NEUROPSYC, V11, P631, DOI 10.1080/01688638908400921; Spreen O, 1991, COMPENDIUM NEUROPSYC; TUOKKO H, 1989, J CLIN EXP NEUROPSYC, V11, P278, DOI 10.1080/01688638908400889; Wechsler, 1997, WECHSLER ADULT INTEL; Wechsler D, 1987, MEMORY SCALE REVISED; Zachary R. A., 1986, SHIPLEY I LIVING SCA	19	8	8	0	1	AMER PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST NE, WASHINGTON, DC 20002-4242	1040-3590			PSYCHOL ASSESSMENT	Psychol. Assess.	JUN	1995	7	2					177	182					6	Psychology, Clinical	Social Science Citation Index (SSCI)	Psychology	RC775	WOS:A1995RC77500007					2022-02-06	
J	GUSTAFSSON, O; ROSSITTI, S				GUSTAFSSON, O; ROSSITTI, S			INTRACRANIAL-PRESSURE IS A FRACTION OF ARTERIAL BLOOD-PRESSURE	EUROPEAN JOURNAL OF NEUROLOGY			English	Article						AUTOREGULATION; BRAIN EDEMA; CEREBROSPINAL FLUID PRESSURE; FLOW DYNAMICS; HEMODYNAMICS; INTRACRANIAL PRESSURE; PIG; RABBIT	HEAD-INJURY; FLOW	The relation between cerebrospinal fluid pressure (p(csf)) and arterial blood pressure (p(a)) was studied in pigs and in rabbits before and after an ischemia-induced impairment of the cerebral autoregulation, in order to predict the effect of changes of p(a) on the p(csf). Before the ischemic brain episode no clear correlation between p(a) and p(csf) was found. A close dependence emerged after the ischemic episode, and after each change in p(a) the p(csf) assumed immediately a new stationary level. The results suggest that intracranial pressure is at any moment a fraction of arterial blood pressure quantitatively determined by the coordinated action of cerebrovascular resistance, i.e. arteriolar resistance R(a), regulated by vasomotor tonus, and venous resistance R(v), which is mechanically passive in the same manner as a Starling resistor device. The relation is given by p(csf) = p(a)[1 + (R(a)/ R(v))](-1). Induced changes in p(a) have different effects on p(csf). However, this effect may be predicted to some extent because the relation between p(csf) and p(a) may be represented mathematically as a rectangular hyperbola. This observation may be of relevance in neurological intensive care. Changes in arterial blood pressure are known to influence intracranial pressure in patients with deranged intracranial dynamics, as in the case of severe head injury. In clinical practice, both raising systemic arterial blood pressure in order to preserve cerebral perfusion pressure and induced arterial hypotension to reduce hydrostatic capillary pressure with consequent reduction of brain edema have been used in the management of patients with severe brain injury. While theoretical models of biological systems often have a limited value in practice because of inability to measure the relevant parameters from clinical data, the ratio of cerebrovascular resistances may be calculated at the bedside.	GOTHENBURG UNIV,SAHLGRENS HOSP,DEPT CLIN NEUROSCI,NEUROSURG SECT,S-41345 GOTHENBURG,SWEDEN								ASGEIRSSON B, 1994, INTENS CARE MED, V20, P260, DOI 10.1007/BF01708961; AVEZAAT CJJ, 1984, THEORETICAL CLIN EXP, P131; BOUMA GJ, 1992, J NEUROSURG, V77, P15, DOI 10.3171/jns.1992.77.1.0015; Fremont-Smith F, 1933, ARCH NEURO PSYCHIATR, V30, P1309, DOI 10.1001/archneurpsyc.1933.02240180131010; FRY DL, 1980, BASIC HEMODYNAMICS I, P407; IKEYAMA A, 1978, NEUROCHIRURGIA, V21, P43; LEECH P, 1974, J NEUROL NEUROSUR PS, V37, P1099, DOI 10.1136/jnnp.37.10.1099; LOFGREN J, 1973, ACTA NEUROL SCAND, V49, P586; LOFGREN J, 1973, THESIS GOTEBORGS U G; LUCE JM, 1982, J APPL PHYSIOL, V53, P1496, DOI 10.1152/jappl.1982.53.6.1496; MILLER JD, 1992, J NEUROTRAUM, V9, pS317; ROSNER MJ, 1990, J TRAUMA, V30, P933, DOI 10.1097/00005373-199008000-00001; ROSNER MJ, 1984, J NEUROSURG, V60, P312, DOI 10.3171/jns.1984.60.2.0312; ROSSITTI S, 1994, BIOMECH SEM, V8, P75; SCHRADER H, 1985, ACTA NEUROL SCAND, V71, P114; SCREMIN OU, 1982, J CEREBR BLOOD F MET, V2, P55, DOI 10.1038/jcbfm.1982.6; Zwetnow N N, 1970, Acta Physiol Scand Suppl, V339, P1	17	8	8	0	0	RAPID SCIENCE PUBLISHERS	LONDON	2-6 BOUNDARY ROW, LONDON, ENGLAND SE1 8NH	1351-5101			EUR J NEUROL	Eur. J. Neurol.	MAR	1995	2	1					31	37		10.1111/j.1468-1331.1995.tb00090.x			7	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	RB292	WOS:A1995RB29200004	24283578				2022-02-06	
J	MOESCHLER, O; BOULARD, G; RAVUSSIN, P				MOESCHLER, O; BOULARD, G; RAVUSSIN, P			SECONDARY SYSTEMIC INSULTS TO THE BRAIN	ANNALES FRANCAISES D ANESTHESIE ET DE REANIMATION			French	Article; Proceedings Paper	Joint 16th Meeting on Neuro-Anesthesiology-Resuscitation in French-Speaking Areas/10th Conference on Italian/French Neuro-Anesthesiology-Resuscitation	NOV 17-18, 1994	LAUSANNE, SWITZERLAND			HEAD INJURY; SECONDARY INSULTS		The prevention and treatment of secondary insults to the brain of systemic origin in severely head injured patients remain of utmost importance. Head injury remains the leading cause of traumatic death, being responsible for 50-60 % of fatalities. Head-injured patients not only suffer from the primary injury at the time of trauma, but also from the secondary, largely ischaemic, brain damage that occurs later. Some of these insults are of extracranial origin (or systemic), such as arterial hypotension, hypoxaemia, hypercarbia and anaemia. Their impact on mortality and morbidity is extremely high and requires greater efforts in improving the care of head-injured patients. Systemic insults occur either before the patient reaches hospital or during interfacilty transfer or, in a surprisingly large number of cases, within hospital during emergency procedures, intrahospital transport or during their stay in intensive care units. Hypoxaemia, although quite easy to treat, is still common. This calls for better and earlier protection of the airway, more systematic administration of oxygen to trauma patients and wider use of pulse oximetry. Arterial hypotension has even more dramatic consequences in severe head injury. Recent studies indicate that short episodes of hypotension may induce severe brain ischaemia, that will be present even after complete systemic haemodynamic restoration. The treatment of hypotensive episodes should be immediate and agressive. In some circumstances, restoration of an adequate cerebral perfusion pressure may not be obtained sufficiently rapidly with fluids alone and may require early use of vasopressors. Optimal haemodynamic resuscitation of the trauma patient with haemorrhagic hypotension and severe head injury remains a special challenge. Hypertonic saline, with or without additional colloids, could be beneficial, especially in the prehospital setting. Numerous experimental and a few recent clinical studies are promising but need further clinical investigations.			MOESCHLER, O (corresponding author), CHU VAUDOIS,ANESTHESIOL SERV,CH-1011 LAUSANNE,SWITZERLAND.		Moeschler, Olivier/B-1694-2008					0	8	9	0	0	EDITIONS SCIENTIFIQUES ELSEVIER	PARIS CEDEX 15	141 RUE JAVEL, 75747 PARIS CEDEX 15, FRANCE	0750-7658			ANN FR ANESTH	Ann. Fr. Anest. Reanim.		1995	14	1					114	121		10.1016/S0750-7658(05)80159-5			8	Anesthesiology	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology	QM390	WOS:A1995QM39000017	7677275				2022-02-06	
J	NAGAMACHI, S; NISHIKAWA, T; ONO, S; KAWASAKI, K; EGUCHI, G; HOSHI, H; JINNOUCHI, S; OHNISHI, T; FUTAMI, S; WATANABE, K				NAGAMACHI, S; NISHIKAWA, T; ONO, S; KAWASAKI, K; EGUCHI, G; HOSHI, H; JINNOUCHI, S; OHNISHI, T; FUTAMI, S; WATANABE, K			A COMPARATIVE-STUDY OF I-123 IMP SPET AND CT IN THE INVESTIGATION OF CHRONIC-STAGE HEAD TRAUMA PATIENTS	NUCLEAR MEDICINE COMMUNICATIONS			English	Article								The aims of this study were (1) to compare N-isopropyl-p-[I-123] iodoamphetamine (I-123-IMP) SPET with computed tomography (CT) in chronic-stage head trauma patients with neurological abnormalities and (2) to quantify regional cerebral blood flow (rCBF) in patients with chronic-stage head trauma. I-123-IMP SPET and CT were performed in 23 patients with chronic-stage head trauma and 12 normal controls. Both types of imaging were evaluated visually. In addition for the SPET images, the rCBF in 12 regions (bilateral frontal cortex, temporal cortex, parietal cortex, occipital cortex, perilolandic area, cerebellum: total 276 regions) was analysed quantitatively using a reference sampling method. In total, 39 focal lesions related to neurological abnormalities were detected. Athough 22 (56.4%) lesions were observed using both CT and SPET, another 17 (43.6%) were detected by SPET only. The mean rCBF in the localized lesions of each lobe, which correspond to low-density areas (LDAs), were lower on CT than those of each lobe seen only on SPET. These rCBF values were lower than the mean rCBF values in the lobes of the controls. The mean rCBF values in each lobe with visually normal tracer uptakes were also significantly lower in the 23 patients than in the controls. I-123-IMP SPET is useful for demonstrating brain dysfunction in morphologically intact brain regions and for providing objective evidence to account for the clinical presentation of patients presenting with chronic traumatic brain injury.			NAGAMACHI, S (corresponding author), MIYAZAKI MED COLL,DEPT RADIOL,KIHARA 5200,MIYAZAKI 88916,JAPAN.		Nagamachi, Shigeki/AAI-6978-2020					0	8	8	0	1	CHAPMAN HALL LTD	LONDON	2-6 BOUNDARY ROW, LONDON, ENGLAND SE1 8HN	0143-3636			NUCL MED COMMUN	Nucl. Med. Commun.	JAN	1995	16	1					17	25		10.1097/00006231-199501000-00006			9	Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Radiology, Nuclear Medicine & Medical Imaging	QB114	WOS:A1995QB11400005	7609930				2022-02-06	
J	PARZHUBER, A; WIEDEMANN, E; RICHTERTURTUR, M; WALDNER, H; SCHWEIBERER, L				PARZHUBER, A; WIEDEMANN, E; RICHTERTURTUR, M; WALDNER, H; SCHWEIBERER, L			THE IMPORTANCE OF GENERAL AND TRAUMASURGERY IN NEUROTRAUMATOLOGY - EXPERIENCES AND RESULTS OF 10 YEARS	UNFALLCHIRURG			German	Article								In acute medical service, general and traumatic surgeons are faced with the problem of treating severe head and brain injuries. In the department of surgery of the University Hospital in Munich, we have been performing neurotraumatological treatment since 1982. Within 10 years we saw 138 patients with severe head and brain injury. We had 48 cases of epidural hematoma. 81 of acute subdural hematoma. 84 of intracerebral contusional bleeding, 5 of depression fractures and 3 of hygromas. All these patients underwent surgical treatment. Osteoplastic trepanation was performed in 49 patients and osteoclastic trepanation in 60. Further interventions were elevation of the 5 depression fractures and evacuation of the 3 hygromas. Comparison with other investigations in departments of neurological surgery in the United States suggest that our results reflect a similar outcome (according to Jennet and Bond's outcome scale: 1, cured; 2, slightly handicapped; 3, sevenely handicapped; 4, vegetative state; 5, expired). The Traumatic Coma Data Bank (1991) recorded outcome of severe head and brain injuries as follows: 1, 27%; 2, 16%; 3, 16%; 4, 5%; 5, 36%; and our own results were: 1, 24%; 2, 17%; 3, 15%; 4, 5%; 5, 39%. Organization procedures and treatment strategies are suggested.										0	8	8	0	0	SPRINGER VERLAG	NEW YORK	175 FIFTH AVE, NEW YORK, NY 10010	0177-5537			UNFALLCHIRURG	Unfallchirurg	DEC	1994	97	12					615	618					4	Emergency Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine; Surgery	PY236	WOS:A1994PY23600001	7855604				2022-02-06	
J	FRASER, RT; BAARSLAGBENSON, R				FRASER, RT; BAARSLAGBENSON, R			CROSS-DISCIPLINARY COLLABORATION IN THE REMOVAL OF WORK BARRIERS AFTER TRAUMATIC BRAIN INJURY	TOPICS IN LANGUAGE DISORDERS			English	Article						COLLABORATION; COMMUNICATION DISORDERS; INTERDISCIPLINARY INTERVENTION; TRAUMATIC BRAIN INJURY; VOCATIONAL REHABILITATION	EMPLOYMENT	This article provides a comprehensive perspective on cross-disciplinary collaboration by the speech-language pathologist and the rehabilitation counselor on removing barriers to employment for survivors of traumatic brain injury (TBI). It emphasizes that for many individuals, the primary obstacles to vocational success are cognitive deficits that affect their capacity for communication. Complementary roles are described for these two rehabilitation professionals in collaboratively addressing these cognitive concerns and others. The role of the speech-language pathologist in job-site intervention is particularly underscored and illustrated through case studies. The success of rehabilitation is based on job-related performance for many individuals with TBI. It should be emphasized that other members of the rehabilitation team, family members/significant others, and coworkers can obviously play significant roles in facilitating a survivor's job-site adaptation, but this article focuses on the rehabilitation counselor's and speech-language pathologist's collaboration, which has not been well described to date.	UNIV WASHINGTON,REG EPILEPSY CTR,DEPT REHABIL MED,SEATTLE,WA 98195; UNIV WASHINGTON,HARBORVIEW MED CTR,DEPT REHABIL MED,SEATTLE,WA 98104		FRASER, RT (corresponding author), UNIV WASHINGTON,REG EPILEPSY CTR,DEPT NEUROL SURG,SEATTLE,WA 98195, USA.						American Psychiatric Association, 1987, DIAGN STAT MAN MENT, V3; Ben-Yishay Y., 1987, J HEAD TRAUMA REHAB, V2, P35, DOI [10.1097/00001199-198703000-00007, DOI 10.1097/00001199-198703000-00007]; BEUKELMAN DR, 1988, AUGMENTATIVE ALTERNA, V4, P101; Brooks N, 1987, J HEAD TRAUMA REHAB, V2, P1, DOI [10.1097/00001199-198709000-00003, DOI 10.1097/00001199-198709000-00003]; CURL RM, 1987, PUT PERSON WORK COWO; ELLERD D, 1990, VOCATIONAL REHABILIT; *EQ EMPL OPP COMM, 1991, AM DIS ACT HDB; FRASER R, 1988, REHABIL COUNS BULL, V31, P276; FRASER R, 1990, SUMMARY NIDRR STUDIE; FRASER RT, 1993, EMPLOYEE ASSISTANCE, V5, P36; FRASER RT, 1977, J REHABIL, V1, P13; FRASER RT, 1991, TRAUMATIC BRAIN INJU; HAFFEY W, 1989, REHAB PSYCHOL, V2, P147; HAFFEY WJ, 1991, J HEAD TRAUMA REHAB, V6, P24; KIRSCH NL, 1987, J HEAD TRAUMA REHAB, V2, P77; KLONOFF H, 1993, J NEUROL NEUROSUR PS, V56, P410, DOI 10.1136/jnnp.56.4.410; MCMORDIE W R, 1990, Brain Injury, V4, P57, DOI 10.3109/02699059009026149; PARENTE R, 1990, COMMUNITY INTEGRATIO; PARENTE R, 1991, COMMUNITY INTEGRATIO; RUBIN SE, 1984, REHABIL COUNS BULL, V27, P199; RUFF RM, 1993, BRAIN INJURY, V1, P101; Sohlberg M.M., 1989, INTRO COGNITIVE REHA; STAPLETON M, 1989, COGNITIVE REHABILITA, V7, P18; TEASDALE G, 1974, LANCET, V2, P81; *US OFF PERS MAN, 1982, FED PERS MAN; WARREN GC, 1991, ASSISTIVE TECHNOLOGY; Wehman P, 1989, Brain Inj, V3, P397, DOI 10.3109/02699058909004563; Wehman Paul, 1993, Brain Injury, V7, P31, DOI 10.3109/02699059309008154; WEHMAN PH, 1990, ARCH PHYS MED REHAB, V71, P1047; [No title captured]	30	8	8	0	5	ASPEN PUBL INC	FREDERICK	7201 MCKINNEY CIRCLE, FREDERICK, MD 21701	0271-8294			TOP LANG DISORD	Top. Lang. Disord.	NOV	1994	15	1					55	67		10.1097/00011363-199411000-00006			13	Linguistics; Rehabilitation	Social Science Citation Index (SSCI)	Linguistics; Rehabilitation	PL838	WOS:A1994PL83800006					2022-02-06	
J	SULLIVAN, SJ; ORNSTEIN, AE; SWAINE, BR				SULLIVAN, SJ; ORNSTEIN, AE; SWAINE, BR			AGREEMENT OF CLASSIFICATION DECISIONS USING 2 MEASURES OF MOTOR COORDINATION IN PERSONS WITH A TRAUMATIC BRAIN INJURY	BRAIN INJURY			English	Article							COORDINATION; PATIENT; SYSTEM	Identification of motor co-ordination deficits in persons with a traumatic brain injury (TBI) is a vital part of both assessment and rehabilitation. The purpose of this study was to investigate the agreement of classification decisions based on clinical (subjective) and instrumented (objective) tests for measuring upper-limb co-ordination in persons with a TBI. Twenty-two subjects with TBI performed the 'finger-to-nose' test and a 'lateral reach tapping test' 12 months post-injury. After reduction to categorical form (deficit/no deficit), the data were interpreted using a generalized kappa statistic, to estimate the agreement between the two tests. The kappa values for the right and left upper extremities were 0.625 and 0.360, respectively, while the combined (right and left) value was 0.500, representing only 'moderate' agreement between the two testing protocols. This indicates that motor co-ordination deficits in persons with TBI can be documented using either clinical or instrumented tests. The choice of test does not appear to be based on the subjective/objective nature (dimension) of each test, but rather on more practical factors such as administration time, cost and level of objectivity desired by the clinician.	CONCORDIA UNIV,DEPT EXERCISE SCI,MONTREAL H3G 1M8,QUEBEC,CANADA; UNIV MONTREAL,FAC MED,ECOLE READAPTAT,MONTREAL H3C 3J7,QUEBEC,CANADA		SULLIVAN, SJ (corresponding author), INST READAPTAT MONTREAL,CTR RECH,6300 DARLINGTON AVE,MONTREAL H3S 2J4,PQ,CANADA.						ADAMS RD, 1989, PRINCIPLES NEUROLOGY, P73; ATKINSON HW, 1986, CASHS TXB NEUROLOGY, P104; BEHBEHANI K, 1990, ARCH PHYS MED REHAB, V71, P106; BORN JD, 1982, NEUROCHIRURGIE, V28, P1; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; CURRIER DP, 1984, ELEMENTS RES PHYSICA; DROUIN G, 1991, CANADIAN J REHABILIT, V4, P28; FITTS PM, 1954, J EXP PSYCHOL, V47, P381, DOI 10.1037/h0055392; GRINKER RR, 1966, NEUROLOGY, P40; HELD JP, 1975, ANN MED PHYS, V18, P337; JENETT B, 1972, SCANDINAVIAN J REHAB, V4, P16; Jones R D, 1981, Int Rehabil Med, V3, P71; KONDRASKE GV, 1984, IEEE T BIO-MED ENG, V31, P401, DOI 10.1109/TBME.1984.325279; KONDRASKE GV, 1989, PHYS MED REHAB, V3, P9; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; MERBITZ C, 1989, ARCH PHYS MED REHAB, V70, P308; MERCER L, 1983, PHYS THER, V63, P1988, DOI 10.1093/ptj/63.12.1988; Nunnally JC., 1978, PSYCHOMETRIC THEORY, V2; POTVIN AR, 1985, QUANTITATIVE EXAMINA, V1; ROTHSTEIN JM, 1989, PHYS THER, V69, P577, DOI 10.1093/ptj/69.7.577; ROTHSTEIN JM, 1985, MEASUREMENT PHYSICAL, P1; SAFRIT M J, 1981, Journal of Human Movement Studies, V7, P131; SCHMITZ TJ, 1988, PHYSICAL REHABILITAT, P121; SMITH SS, 1987, PHYS THER, V67, P1860, DOI 10.1093/ptj/67.12.1860; SWAINE BR, 1993, PHYS THER, V73, P71, DOI 10.1093/ptj/73.2.71; SWAINE BR, 1992, ARCH PHYS MED REHAB, V73, P55; VANIER M, 1993, M S-MED SCI, V9, P624, DOI 10.4267/10608/2969; WHYTE J, 1988, REHABILITATION MED P, P585; WINSTEIN CJ, 1990, PHYS THER, V70, P759, DOI 10.1093/ptj/70.12.759; WISE MF, 1985, 8TH P ANN RESNA C, P168; 1976, SCANDINAVIAN J REHAB, V8, P127	31	8	8	0	3	TAYLOR & FRANCIS LTD	LONDON	ONE GUNDPOWDER SQUARE, LONDON, ENGLAND EC4A 3DE	0269-9052			BRAIN INJURY	Brain Inj.	OCT	1994	8	7					613	621		10.3109/02699059409151014			9	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	PH426	WOS:A1994PH42600005	7804298				2022-02-06	
J	WASS, AR; WILLIAMS, MJ; GIBSON, MF				WASS, AR; WILLIAMS, MJ; GIBSON, MF			A REVIEW OF THE MANAGEMENT OF A MAJOR INCIDENT INVOLVING PREDOMINANTLY PEDIATRIC CASUALTIES	INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED			English	Article								On 27 September 1993 a double-decker bus full of secondary school children was involved in a collision with a lorry. A total of 58 people were injured, including two fatalities. All except two of the casualties were children. Forty-two casualties, including all of the seriously injured, were taken to the Accident & Emergency Department at York District Hospital. Fifteen casualties were admitted, the majority with closed head injuries. Most of the injuries were of a minor nature, predominantly soft-tissue damage and superficial lacerations. This paper reviews these injuries and the implementation of the hospital major accident (MAJAX) plan. It identifies specific problems encountered with this incident. It also describes the measures taken retrospectively to upgrade the MAJAX plan. It highlights the difficulties encountered by medical staff called to the incident who were unfamiliar with managing injuries and describes retrospective attempts to improve the awareness of trauma management skills.	YORK DIST GEN HOSP,WIGGINTON RD,YORK YO3 7HE,N YORKSHIRE,ENGLAND									0	8	9	0	1	BUTTERWORTH-HEINEMANN LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, OXON, ENGLAND OX5 1GB	0020-1383			INJURY	Injury-Int. J. Care Inj.	AUG	1994	25	6					371	374		10.1016/0020-1383(94)90128-7			4	Critical Care Medicine; Emergency Medicine; Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Emergency Medicine; Orthopedics; Surgery	NV934	WOS:A1994NV93400005	8045640				2022-02-06	
J	WRIGHT, MJ; CREMONAMETEYARD, SL; GEFFEN, LB; GEFFEN, GM				WRIGHT, MJ; CREMONAMETEYARD, SL; GEFFEN, LB; GEFFEN, GM			THE EFFECTS OF CLOSED-HEAD INJURY, SENILE DEMENTIA OF THE ALZHEIMERS TYPE, AND PARKINSONS-DISEASE ON COVERT ORIENTATION OF VISUAL-ATTENTION	AUSTRALIAN JOURNAL OF PSYCHOLOGY			English	Article							EVENT RELATED POTENTIALS; AUDITORY ODDBALL TASK; BRAIN POTENTIALS; ELECTROPHYSIOLOGICAL EVIDENCE; DIRECTED ATTENTION; DIVIDED ATTENTION; WORKING MEMORY; REACTION-TIME; MILD; DYSFUNCTION	Covert orientation of visual attention was studied in four clinical groups: mild closed head injury (CHI mild), moderate to severe closed head injury (CHI mod/severe), dementia of the Alzheimer type (DAT), and Parkinson's disease (PD). Subjects rapidly pressed a button in response to one of two lateral peripheral targets. The target was preceded by a central cue that was either neutral, valid or invalid with respect to target location. A NoGo cue indicated that no response should be made. Whereas the normal control subjects of all age groups showed a benefit in reaction time (RT) to targets in expected locations and a RT cost when targets occurred in the unexpected side of space, both CHI groups showed reduced or no benefit but a normal cost. The PD group showed a reduced cost but normal benefit, and the DAT group were faster in response to targets after valid than invalid cues, but slowest to neutrally cued targets. Analysis of the amplitude of the contingent negative variation (CNV) and the amplitude and latency of the P3 related to targets supported the implication that different mechanisms of visual attention are impaired in these groups with different brain disorders. In the CHI groups, the focusing of attention during the cue-target interval was impaired. In DAT, division of attention was compromised, and in PD there was poor maintenance of attention. The impairments may be attributed to dysfunction of the distributed brain regions of the cortico-cortical network subserving visual spatial attention.			WRIGHT, MJ (corresponding author), UNIV QUEENSLAND, SCH MED, COGNIT PSYCHOPHYSIOL LAB, HERSTON, QLD 4006, AUSTRALIA.		Wright, Margaret Jane/A-4560-2016	Wright, Margaret Jane/0000-0001-7133-4970			ADAMS JH, 1977, BRAIN, V100, P489, DOI 10.1093/brain/100.3.489; AGID Y, 1989, MOVEMENT DISORD, V4, pS126, DOI 10.1002/mds.870040514; AMABILE G, 1986, ELECTROEN CLIN NEURO, V64, P521, DOI 10.1016/0013-4694(86)90189-6; ANNETT M, 1970, BRIT J PSYCHOL, V61, P303, DOI 10.1111/j.2044-8295.1970.tb01248.x; BADDELEY A, 1986, Q J EXP PSYCHOL-A, V38, P603, DOI 10.1080/14640748608401616; BADDELEY AD, 1991, BRAIN, V114, P2521, DOI 10.1093/brain/114.6.2521; BODISWOLLNER I, 1982, ANN NEUROL, V11, P478, DOI 10.1002/ana.410110507; BOHNEN N, 1992, NEUROSURGERY, V30, P692, DOI 10.1097/00006123-199205000-00007; BROOKS N, 1984, CLOSED HEAD INJURY P; BROWN RG, 1987, MOVEMENT DISORD, V2, P99; BRUNIA CHM, 1988, ELECTROEN CLIN NEURO, V69, P234, DOI 10.1016/0013-4694(88)90132-0; Clark C. R., 1992, Brain Injury, V6, P509, DOI 10.3109/02699059209008148; CLARK CR, 1988, NEUROPSYCHOLOGIA, V27, P172; CREMONAMETEYARD SL, 1992, NEUROPSYCHOLOGIA, V30, P123, DOI 10.1016/0028-3932(92)90022-E; CREMONAMETEYARD SL, IN PRESS NEUROPSYCHO, V32; CREMONAMETEYARD SL, IN PRESS BRAIN INJUR; DICK JPR, 1989, BRAIN, V112, P233, DOI 10.1093/brain/112.1.233; DONCHIN E, 1988, BEHAV BRAIN SCI, V11, P357, DOI 10.1017/S0140525X00058027; DUNCAN SB, 1994, UNPUB EFFECTS TASK D; EBMEIER KP, 1992, BIOL PSYCHOL, V33, P73, DOI 10.1016/0301-0511(92)90007-H; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; GEFFEN GM, 1991, J CLIN EXP NEUROPSYC, V13, P423; GEFFEN GM, 1991, NEUROREPORT, V2, P105, DOI 10.1097/00001756-199102000-00010; GOODIN DS, 1978, BRAIN, V101, P635, DOI 10.1093/brain/101.4.635; HANSCH EC, 1982, ANN NEUROL, V11, P599, DOI 10.1002/ana.410110608; Harter M R, 1989, J Cogn Neurosci, V1, P223, DOI 10.1162/jocn.1989.1.3.223; HARTER MR, 1991, ELECTROEN CLIN NEURO, P183; HEINZE HJ, 1992, NEUROPSYCHOLOGIA, V30, P495, DOI 10.1016/0028-3932(92)90054-P; HOEHN MM, 1967, NEUROLOGY, V17, P427, DOI 10.1212/WNL.17.5.427; HUGENHOLTZ H, 1988, NEUROSURGERY, V22, P853, DOI 10.1227/00006123-198805000-00006; Kemper T.N., 1984, CLIN NEUROLOGY AGING, P9; KEPPEL S, 1991, RES DESIGN ANAL RES; Klem G H, 1999, Electroencephalogr Clin Neurophysiol Suppl, V52, P3; Laberge D, 1990, J Cogn Neurosci, V2, P358, DOI 10.1162/jocn.1990.2.4.358; LEVIN HS, 1987, J NEUROSURG, V66, P706, DOI 10.3171/jns.1987.66.5.0706; Mangun G R, 1987, Electroencephalogr Clin Neurophysiol Suppl, V40, P118; Mangun G. R., 1990, NEUROBIOLOGY HIGHER, P271; MANGUN GR, 1991, J EXP PSYCHOL HUMAN, V17, P1057, DOI 10.1037/0096-1523.17.4.1057; MANGUN GR, 1988, ELECTROEN CLIN NEURO, V70, P417, DOI 10.1016/0013-4694(88)90019-3; MESULAM MM, 1981, ANN NEUROL, V10, P309, DOI 10.1002/ana.410100402; MORRISON JH, 1990, RES PER ALZ, P19; MOUNTCASTLE VB, 1978, J ROY SOC MED, V71, P14; NAATANEN R, 1987, PSYCHOPHYSIOLOGY, V24, P375, DOI 10.1111/j.1469-8986.1987.tb00311.x; NEBES RD, 1989, CORTEX, V25, P305, DOI 10.1016/S0010-9452(89)80045-0; Nelson H. E, 1982, NATIONAL ADULT READI; NESTOR PG, 1991, NEUROPSYCHOLOGIA, V29, P379, DOI 10.1016/0028-3932(91)90026-5; NISSEN MJ, 1981, 4TH ANN C AM AG ASS; PARASURAMAN R, 1992, BRAIN, V115, P711, DOI 10.1093/brain/115.3.711; Parasuraman R., 1990, EVENT RELATED BRAIN, P279; Parasuraman R., 1993, NEUROPSYCHOLOGY, V7, P242, DOI [10.1037/0894-4105.7.3.242, DOI 10.1037/0894-4105.7.3.242]; POLICH J, 1990, ELECTROEN CLIN NEURO, V77, P179, DOI 10.1016/0168-5597(90)90036-D; Posner M I, 1989, J Cogn Neurosci, V1, P50, DOI 10.1162/jocn.1989.1.1.50; POSNER MI, 1988, SCIENCE, V240, P1627, DOI 10.1126/science.3289116; POSNER MI, 1980, Q J EXP PSYCHOL, V32, P3, DOI 10.1080/00335558008248231; POSNER MI, 1984, J NEUROSCI, V4, P1863; POSNER MI, 1990, ANNU REV NEUROSCI, V13, P25, DOI 10.1146/annurev.ne.13.030190.000325; RIZZO PA, 1984, NEUROPSYCHOBIOLOGY, V12, P112; RIZZOLATTI G, 1987, NEUROPHYSIOLOGICAL N, P289; RUCHKIN DS, 1986, ELECTROEN CLIN NEURO, V63, P445, DOI 10.1016/0013-4694(86)90127-6; RUGG MD, 1988, J NEUROL NEUROSUR PS, V51, P691, DOI 10.1136/jnnp.51.5.691; RUGG MD, 1993, NEUROPSYCHOLOGIA, V31, P373, DOI 10.1016/0028-3932(93)90161-R; RUGG MD, 1989, BRAIN, V112, P489, DOI 10.1093/brain/112.2.489; SAINTCYR JA, 1988, BRAIN, V111, P941, DOI 10.1093/brain/111.4.941; SHORES EA, 1989, J NEUROL NEUROSUR PS, V52, P126, DOI 10.1136/jnnp.52.1.126-a; SHUM DHK, 1988, J CLIN EXPT NEUROPSY, V12, P125; SPINNLER H, 1991, HDB NEUROPSYCHOLOGY, V5, P79; *SPSS INC, 1983, SPSS STAT PACK SOC S; STUSS DT, 1989, J NEUROL NEUROSUR PS, V52, P742, DOI 10.1136/jnnp.52.6.742; Van Zomeren A. H., 1981, REACTION TIME ATTENT; VOGANTHALER DR, 1987, BRAIN INJURY, V1, P113; WEINGARTNER H, 1984, PSYCHIAT RES, V11, P223, DOI 10.1016/0165-1781(84)90071-4; WRIGHT MJ, 1993, NEUROPSYCHOLOGIA, V31, P1283, DOI 10.1016/0028-3932(93)90098-K; WRIGHT MJ, 1990, NEUROPSYCHOLOGIA, V28, P151, DOI 10.1016/0028-3932(90)90097-8; YESAVAGE JA, 1983, J PSYCHIATR RES, V17, P37, DOI 10.1016/0022-3956(82)90033-4; ZUNG WWK, 1965, ARCH GEN PSYCHIAT, V12, P63, DOI 10.1001/archpsyc.1965.01720310065008; [No title captured], DOI DOI 10.1037/0894-4105.5.4.253; [No title captured]	77	8	8	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0004-9530	1742-9536		AUST J PSYCHOL	Aust. J. Psychol.	AUG	1994	46	2					63	72		10.1080/00049539408259475			10	Psychology, Multidisciplinary	Social Science Citation Index (SSCI)	Psychology	PV964	WOS:A1994PV96400002					2022-02-06	
J	MATTSON, AJ; LEVIN, HS; BREITMEYER, BG				MATTSON, AJ; LEVIN, HS; BREITMEYER, BG			VISUAL INFORMATION-PROCESSING AFTER SEVERE CLOSED-HEAD INJURY - EFFECTS OF FORWARD AND BACKWARD-MASKING	JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY			English	Article							AGE-DIFFERENCES	Three tachistoscopic tasks were employed to assess whether survivors of severe closed head injury (CHI) exhibit a disturbance of information processing within peripheral and/or central visual pathways. Twelve survivors of severe CHI and 12 individually matched control subjects completed a recognition threshold (no mask) task, a monoptic, forward masking by visual noise task (to assess processing within relatively peripheral pathways), and a dichoptic, backward masking by pattern task (to assess processing within central pathways). For each experimental procedure, the minimum exposure durations required by subjects to identify correctly single consonants and triple consonants were determined. Survivors of severe CHI showed deficits on all three visual tasks. Both groups also had higher threshold durations for the more complex stimuli (triple v single consonants), but differences in threshold were greater in the patients with CHI. The degree of perceptual impairment exhibited by patients with CHI was highly variable and not consistently related to injury characteristics or residual motor or speech and language impariment.	UNIV TEXAS, MED BRANCH, DIV NEUROSURG, GALVESTON, TX 77550 USA; UNIV HOUSTON, DEPT PSYCHOL, HOUSTON, TX USA						NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS021889] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS-21889] Funding Source: Medline		ADAMS JH, 1985, CENTRAL NERVOUS SYST; Breitmeyer B., 1984, VISUAL MASKING INTEG; BREITMEYER BG, 1976, PSYCHOL REV, V83, P1, DOI 10.1037/0033-295X.83.1.1; COYNE AC, 1984, J GERONTOL, V39, P711, DOI 10.1093/geronj/39.6.711; DILOLLO V, 1982, J EXP PSYCHOL HUMAN, V8, P225, DOI 10.1037/0096-1523.8.2.225; DILOLLO V, 1983, J EXP PSYCHOL HUMAN, V9, P923, DOI 10.1037/0096-1523.9.6.923; HANNAY HJ, 1982, J CLIN NEUROPSYCHOL, V2, P117; HARRINGTON DO, 1976, VISUAL FIELDS TXB AT; KAHNEMAN D, 1968, PSYCHOL BULL, V70, P404, DOI 10.1037/h0026731; KLATZKY RL, 1980, HUMAN MEMORY; LEVIN HS, 1988, SCAND J REHABIL MED, P33; MICHAELS CF, 1979, PSYCHOL RES-PSYCH FO, V41, P1, DOI 10.1007/BF00309423; Reitan RM, 1985, HALSTEADREITAN NEURO; Ruesch J, 1944, J NEUROSURG, V1, P243, DOI 10.3171/jns.1944.1.4.0243; STOKX LC, 1986, J CLIN EXP NEUROPSYC, V8, P421, DOI 10.1080/01688638608401332; TEASDALE G, 1974, LANCET, V2, P81; TURVEY MT, 1973, PSYCHOL REV, V80, P1, DOI 10.1037/h0033872; van Zomeren AH, 1984, CLOSED HEAD INJURY P, P74; VANZOMEREN AH, 1978, J NEUROL NEUROSUR PS, V41, P452, DOI 10.1136/jnnp.41.5.452; WALSH DA, 1976, J GERONTOL, V31, P178, DOI 10.1093/geronj/31.2.178; WALSH DA, 1978, J EXP PSYCHOL HUMAN, V4, P232, DOI 10.1037/0096-1523.4.2.232; Wechsler, 1997, WECHSLER ADULT INTEL; Witmer LR, 1935, PEDAGOG SEMIN J GEN, V47, P337	23	8	8	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0022-3050	1468-330X		J NEUROL NEUROSUR PS	J. Neurol. Neurosurg. Psychiatry	JUL	1994	57	7					818	824		10.1136/jnnp.57.7.818			7	Clinical Neurology; Psychiatry; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry; Surgery	NV921	WOS:A1994NV92100011	8021668	Green Published, Bronze			2022-02-06	
J	BERRY, K; RICE, J				BERRY, K; RICE, J			TRAUMATIC TEAR OF TELA-CHOROIDEA RESULTING IN FATAL INTRAVENTRICULAR HEMORRHAGE	AMERICAN JOURNAL OF FORENSIC MEDICINE AND PATHOLOGY			English	Article						HEAD INJURY; INTRAVENTRICULAR HEMORRHAGE; CHOROID PLEXUS; TELA-CHOROIDEA; INNER CEREBRAL TRAUMA		A 39-year-old man was rendered comatose after being struck repeatedly on the head in an altercation. After admission to the hospital, he had computed tomographic scan evidence of diffuse intraventricular and subarachnoid hemorrhage as well as cerebral edema. He shortly thereafter became ''brain dead'' and life-support systems were discontinued the following day. At autopsy, he had a swollen brain as well as evidence of intraventricular and subarachnoid hemorrhage. No aneurysm or other grossly obvious cause for the hemorrhage was detected. There was, however, a small laceration of the lateral wall of the right lateral ventricle in the region of the caudate nucleus and thalamus, the choroid plexus was detached bilaterally, and the fornices were separated from the corpus callosum. Microscopically, there was further evidence of disruption of the lateral wall of the lateral ventricles, with fragments of ependymal lining mixed in with choroid plexus as well as blood between the fronds of the choroid plexus, and blood dissecting along the wall of the lateral ventricle deep to the ependyma. These findings were felt to be consistent with the recently proposed thesis that tears of the tela choroidea, as part of a so-called inner cerebral trauma, might produce intraventricular and subarachnoid hemorrhage, which, in this case, proved to be fatal.			BERRY, K (corresponding author), VANCOUVER GEN HOSP,NEUROPATHOL SERV,VANCOUVER V5Z 1M9,BC,CANADA.							0	8	10	0	0	LIPPINCOTT-RAVEN PUBL	PHILADELPHIA	227 EAST WASHINGTON SQ, PHILADELPHIA, PA 19106	0195-7910			AM J FOREN MED PATH	Am. J. Forensic Med. Pathol.	JUN	1994	15	2					132	137		10.1097/00000433-199406000-00008			6	Medicine, Legal; Pathology	Science Citation Index Expanded (SCI-EXPANDED)	Legal Medicine; Pathology	NP050	WOS:A1994NP05000008	8074104				2022-02-06	
J	JACKSON, JD				JACKSON, JD			AFTER REHABILITATION - MEETING THE LONG-TERM NEEDS OF PERSONS WITH TRAUMATIC BRAIN INJURY	AMERICAN JOURNAL OF OCCUPATIONAL THERAPY			English	Article						LONG-TERM CARE		Many survivors of traumatic brain injury have significant needs for long-term support. The rehabilitation professions, including occupational therapy, have begun to recognize these needs more fully during the last decade. The literature describes various models of supported living that provide housing, support services, and vocational assistance, however, these pro grams are not widely available due to limitations in public funding and inadequate insurance coverage for long-term care. Occupational therapists can contribute a broad expertise to the provision of supported living services, and the profession is encouraged to provide leadership and advocacy with respect to the long-term care needs of survivors of traumatic brain injury.			JACKSON, JD (corresponding author), LEARNING SERV CAROLINA,DURHAM,NC 27707, USA.						Bush G. W., 1990, J HEAD TRAUMA REHAB, V5, P47; CONDELUCI A, 1987, COMMUNITY REENTRY HE, P301; CONDELUCI A, 1990, INTERDEPENDENCE ROUT; Condeluci A., 1992, J HEAD TRAUMA REHAB, V7, P37; DELOCH C, 1983, INDEPENDENT LIVING P; EVANS RW, 1991, MAR INT TRAUM BRAIN; GIRONIMO E, 1992, INT J FAMILY CARE, V4, P239; HALAMANDARIS V, 1992, CARING           MAR, P4; HOSACK K, 1991, UNPUB FAMILY PRIORIT; JACKSON JD, 1992, CARING           MAR, P74; JACOBS HE, 1990, J HEAD TRAUMA REHAB, V5, P1; JOE BE, 1992, OT WEEK         0709, V6, P12; JONES M, 1991, CASE MANAGER, V2, P44; JONES M, 1991, WORK WORTH DOING ADV, P279; McKnight J., 1988, COMMUNITY SERVICES; PELOQUIN SM, 1989, AM J OCCUP THER, V43, P219, DOI 10.5014/ajot.43.4.219; Reed KL, 1983, CONCEPTS OCCUPATIONA; ROYBAL ER, 1992, CARING           MAR, P8; TAPPER BE, 1992, OT WEEK, V6, P14; VANDERSCHAAF S, 1990, J HEAD TRAUMA REHABI, V5, P40; ZITNAY G, 1992, COMMUNICATION   0221; 1992, COMMUNITY PROGRAMS I; 1992, OT WEEK, V6, P24	23	8	8	0	2	AMER OCCUPATION THERAPY ASSN	ROCKVILLE	1383 PICCARD DRIVE PO BOX ROCKVILLE, MD 20850-4375	0272-9490			AM J OCCUP THER	Am. J. Occup. Ther.	MAR	1994	48	3					251	255		10.5014/ajot.48.3.251			5	Rehabilitation	Social Science Citation Index (SSCI)	Rehabilitation	MW828	WOS:A1994MW82800009	8178920				2022-02-06	
J	BOOCK, RJ; DOAN, D; GOLDSTEIN, D; THIBAULT, LE				BOOCK, RJ; DOAN, D; GOLDSTEIN, D; THIBAULT, LE			MODEL FOR SHORT-TERM INTRACRANIAL-PRESSURE CHANGES FOLLOWING TRAUMATIC INJURY	ANNALS OF BIOMEDICAL ENGINEERING			English	Article							DIFFUSE AXONAL INJURY; HEAD-INJURY; ISCHEMIA; BRAIN; HYPOXIA; PRIMATE	Results from primate studies show a transient increase in intracranial pressure (ICP) after a nonimpact inertial loading condition. The measured ICP increase varies linearly with the peak tangential load of these experiments. These experiments point to possible alterations in cerebral blood flow. This paper investigates the possible etiology of this particular phenomenon, and presents a simple analytical model that could explain the changes in intracranial pressure. The model combines the effects of cerebral venous constriction, arterial dilatation, and raised mean blood pressure to yield the characteristic immediate rise and exponential decay of ICP. The main contributor to the increase in intracranial pressure is believed to be vasodilation of cerebral arteries following venous constriction. Passive release of cerebrospinal fluid (CSF) is believed to mediate the long-term decay of intracranial pressure and possibly contribute to local hyperemia.	UNIV PENN,DEPT BIOENGN,PHILADELPHIA,PA 19104		BOOCK, RJ (corresponding author), NIH,SURG NEUROL BRANCH,BLDG 10-5D37,BETHESDA,MD 20892, USA.				PHS HHSUnited States Department of Health & Human ServicesUnited States Public Health Service [R49 CCR 302265, R49 CCR 303681, R49 CCR 304684] Funding Source: Medline		BOOCK RJ, 1991, THESIS U PENNSYLVANI; COX RH, 1979, AM J PHYSIOL, V237, pH159, DOI 10.1152/ajpheart.1979.237.2.H159; Cushing H, 1902, AM J MED SCI, V124, P375, DOI 10.1097/00000441-190209000-00001; EMOTO SE, 1988, J NEUROCHEM, V50, P1952, DOI 10.1111/j.1471-4159.1988.tb02502.x; Fung, 1990, BIOMECHANICS MOTION; GENNARELLI TA, 1989, J NEUROSURG, V71, P244, DOI 10.3171/jns.1989.71.2.0244; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; GENNARELLI TA, 1971, SAE T, P797; GOMEZ CR, 1991, SURG NEUROL, V35, P30, DOI 10.1016/0090-3019(91)90198-I; GYULAI L, 1987, J CEREBR BLOOD F MET, V7, P543, DOI 10.1038/jcbfm.1987.103; HEFFEZ DS, 1985, J CEREBR BLOOD F MET, V5, P523, DOI 10.1038/jcbfm.1985.79; MARGULIES SS, 1990, J BIOMECH, V23, P823, DOI 10.1016/0021-9290(90)90029-3; Miller J D, 1972, Prog Brain Res, V35, P411; OHTA T, 1968, J NEUROSURG, V28, P405, DOI 10.3171/jns.1968.28.5.0405; PFENNINGER EG, 1989, J NEUROSURG, V70, P774, DOI 10.3171/jns.1989.70.5.0774; WADSTROM J, 1990, SCAND J PLAST RECO S, V21, P1	16	8	8	0	1	BLACKWELL SCIENCE INC	CAMBRIDGE	238 MAIN ST, CAMBRIDGE, MA 02142	0090-6964			ANN BIOMED ENG	Ann. Biomed. Eng.	NOV-DEC	1993	21	6					645	653		10.1007/BF02368644			9	Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Engineering	MN227	WOS:A1993MN22700007	8116916				2022-02-06	
J	FRANZEN, MD; HARRIS, CV				FRANZEN, MD; HARRIS, CV			NEUROPSYCHOLOGICAL REHABILITATION - APPLICATION OF A MODIFIED MULTIPLE BASE-LINE DESIGN	BRAIN INJURY			English	Article								The treatment of brain impairment following traumatic injury has proliferated in the past few years. Because many proposed treatment methods have not yet been proven, an important aspect of each treatment attempt is the evaluation of possible gains derived as a result of treatment. A modified multiple baseline design has been suggested as a means of partialling out extraneous influences in the assessment of treatment effects. This paper presents data from the application of a modified multiple baseline design to the treatment of memory and abstraction deficits in a young man who had experienced a closed head injury. Both psychometric-nomothetic and idiographic data are presented and discussed.			FRANZEN, MD (corresponding author), W VIRGINIA UNIV,HLTH SCI CTR,DEPT BEHAV MED & PSYCHIAT,POB 6302,MORGANTOWN,WV 26506, USA.						BARLOW DH, SINGLE CASE EXPT DES; CRAINE JF, 1981, REHABILITATION BRAIN; DeFilippis NA, 1979, BOOKLET CATEGORY TES; Franzen M D, 1987, Arch Clin Neuropsychol, V2, P265, DOI 10.1016/0887-6177(87)90014-X; Franzen M D, 1991, Prog Behav Modif, V27, P56; FRANZEN MD, 1985, INT J CLIN NEUROPSYC, V7, P190; FRANZEN MD, 1987, TEST RETEST RELIABIL; FRANZEN MD, 1990, BEHAV CLIN NEUROPSYC, P155; GIANUTSOS R, 1979, Journal of Clinical Neuropsychology, V1, P117, DOI 10.1080/01688637908414446; GIANUTSOS R, 1987, REHABIL PSYCHOL, P453; GOLDEN CJ, 1982, J CONSULT CLIN PSYCH, V50, P452, DOI 10.1037/0022-006X.50.3.452; Golden CJ, 1978, STROOP COLOR WORD TE; Golden CJ, 1985, LURIA NEBRASKA NEURO; HEATON RK, 1987, WISCONSIN CARD SORTI; Luria A.R., 1980, HIGHER CORTICAL FUNC, V2d; MILLER E, 1984, RECOVERY MANAGEMENT; PLAISTED JR, 1982, INT J NEUROSCI, V17, P163, DOI 10.3109/00207458208985919; Sidman M., 1960, TACTICS SCI RES; SOHLBERG MM, 1987, J CLIN EXP NEUROPSYC, V9, P117, DOI 10.1080/01688638708405352; STONE MH, 1980, KNOXS CUBE TEST MANU; TEASDALE G, 1974, LANCET, V2, P81; WEBSTER JS, 1986, NEUROPSYCHOLOGY HDB; WILSON B, 1987, J CLIN EXP NEUROPSYC, V9, P527, DOI 10.1080/01688638708410767	23	8	8	0	3	TAYLOR & FRANCIS LTD	LONDON	ONE GUNDPOWDER SQUARE, LONDON, ENGLAND EC4A 3DE	0269-9052			BRAIN INJURY	Brain Inj.	NOV-DEC	1993	7	6					525	534		10.3109/02699059309008180			10	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	MA173	WOS:A1993MA17300007	8260956				2022-02-06	
J	BIASCA, N; SIMMEN, HP; TRENTZ, O				BIASCA, N; SIMMEN, HP; TRENTZ, O			HEAD-INJURIES RELATED TO ICE HOCKEY - SURVEY OF THE NORTH-AMERICAN NATIONAL-HOCKEY-LEAGUE, HOCKEY-CANADA, AND EUROPEAN TEAMS	UNFALLCHIRURG			German	Article								Ice hockey is one of the fastest and roughest of all sports. Based on prospective injuries reports of the North American National Hockey League, the Canadian Amateur Hockey Association and three European teams (USSR, Sweden and Switzerland) the patterns, topography, circumstances and sequelae of the head injuries related to ice hockey are described. Although mandatory helmets and face masks have reduced the large number of facial and eye injuries, the rates of head injury and concussion are still to high. A number of steps must be taken by the hockey organisations, players, equipment manufacturers and health-care professionals to prevent injuries for specific prevention of head, face and eye injuries the rules should be strictly enforced, e.g. no checks from behind, high-sticking penalties, and mandatory helmets with face masks.			BIASCA, N (corresponding author), UNIV HOSP ZURICH,UNFALLCHIRURG KLIN,DEPT CHIRURG,CH-8091 ZURICH,SWITZERLAND.							0	8	8	1	10	SPRINGER VERLAG	NEW YORK	175 FIFTH AVE, NEW YORK, NY 10010	0177-5537			UNFALLCHIRURG	Unfallchirurg	MAY	1993	96	5					259	264					6	Emergency Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine; Surgery	LG588	WOS:A1993LG58800006	8327899				2022-02-06	
J	HILL, DA; WEST, RH; ABRAHAM, KJ; OCONNELL, AJ; CUNNINGHAM, P				HILL, DA; WEST, RH; ABRAHAM, KJ; OCONNELL, AJ; CUNNINGHAM, P			IMPACT OF PEDESTRIAN INJURY ON INNER-CITY TRAUMA SERVICES	AUSTRALIAN AND NEW ZEALAND JOURNAL OF SURGERY			English	Article						EPIDEMIOLOGY SURGERY; PEDESTRIAN; TRAUMA	CARE	This report describes the epidemiology of pedestrian injury in four inner metropolitan local government areas of Sydney. These data were obtained from the Roads and Traffic Authority of New South Wales. The spectrum of injury and clinical outcome was defined in patients with an Injury Severity Score (ISS) > 15 admitted from the study area, during a 1 year period, to the four inner metropolitan teaching hospitals. The incidence of pedestrian death was 3.3 times the state average of 32/10(6)/year. An average of 235 pedestrians, injured in the study area, were hospitalized each year during the period 1987-89. On average 24 pedestrians died each year, seven at the scene and 17 in hospital. Fifty patients (ISS > 15) were admitted to the four teaching hospitals during a 1 year period 1990-91. Forty-five were adults and five children. Multiplicity of injury was seen in 68% of patients. The pelvis and lower extremities were involved in 70%, the head in 66% and chest in 42%. The hospital mortality rate was 30% with five patients dying on the first day from blood loss and nine dying during subsequent days from head injury. This study has important implications for trauma service development. Successful clinical management of the severely injured pedestrian requires close co-operation between pre-hospital and hospital care providers. An integrated hospital trauma team response is mandatory to ensure appropriate management of what is often a shocked, hypoxic, head-injured patient.	ROYAL ALEXANDRA HOSP CHILDREN,CAMPERDOWN,NSW 2050,AUSTRALIA; ST VINCENTS HOSP,SYDNEY,NSW 2010,AUSTRALIA; SYDNEY HOSP,SYDNEY,NSW 2000,AUSTRALIA		HILL, DA (corresponding author), ROYAL PRINCE ALFRED HOSP,MISSENDEN RD,CAMPERDOWN,NSW 2050,AUSTRALIA.						BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; BAXT WG, 1987, J TRAUMA, V27, P356; BLICAVS C, 1973, MED J AUSTRALIA, V1, P1039; BOYD CR, 1987, J TRAUMA, V27, P370, DOI 10.1097/00005373-198704000-00005; BRAINARD BJ, 1989, ANN EMERG MED, V18, P881, DOI 10.1016/S0196-0644(89)80218-5; BURGESS AR, 1990, J TRAUMA, V30, P848, DOI 10.1097/00005373-199007000-00015; CHAMPION HR, 1990, J TRAUMA, V30, P1356, DOI 10.1097/00005373-199011000-00008; Fisher A J, 1967, Med J Aust, V1, P55; HALL RR, 1972, MED J AUSTRALIA, V1, P313, DOI 10.5694/j.1326-5377.1972.tb46799.x; HILL DA, 1991, AUST NZ J SURG, V62, P204; HOSSACK DW, 1975, MED J AUSTRALIA, V1, P678, DOI 10.5694/j.1326-5377.1975.tb111746.x; KAWESKI SM, 1990, J TRAUMA, V30, P1215, DOI 10.1097/00005373-199010000-00005; MATTOX KL, 1986, J TRAUMA, V26, P779, DOI 10.1097/00005373-198609000-00002; RAMENOFSKY ML, 1988, PEDIATRIC EMERGENCY, V4, P77; SCHWAB CW, 1988, J TRAUMA, V28, P939, DOI 10.1097/00005373-198807000-00006; THAL ER, 1991, SURG CLIN N AM, V71, P209; TRUNKEY D, 1991, NEW ENGL J MED, V324, P1259; TRUNKEY DD, 1984, J TRAUMA, V24, P86, DOI 10.1097/00005373-198401000-00017; VESTRUP JA, 1989, J TRAUMA, V29, P741, DOI 10.1097/00005373-198906000-00007; WHEATLEY J, 1989, MED J AUSTRALIA, V150, P72, DOI 10.5694/j.1326-5377.1989.tb136366.x	20	8	8	0	0	BLACKWELL SCIENCE	CARLTON	54 UNIVERSITY ST, P O BOX 378, CARLTON VICTORIA 3053, AUSTRALIA	0004-8682			AUST NZ J SURG	Aust. N. Z. J. Surg.	JAN	1993	63	1					20	24		10.1111/j.1445-2197.1993.tb00027.x			5	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	LA129	WOS:A1993LA12900005	8466454				2022-02-06	
J	CHENG, CLY; WOLF, AL; MIRVIS, S; ROBINSON, WL				CHENG, CLY; WOLF, AL; MIRVIS, S; ROBINSON, WL			BODYSURFING ACCIDENTS RESULTING IN CERVICAL SPINAL-INJURIES	SPINE			English	Article						BODYSURFING; CERVICAL SPINE INJURIES; DIVING; OCEAN SPORTS; WATER ACCIDENTS		During the summers of 1987 and 1988,14 cervical spine injuries sustained during bodysurfing accidents at the beaches around Ocean City, Maryland presented to our Neurotrauma service. All the patients were men, predominantly in their middle years (mean age = 40), and otherwise healthy. Likely mechanisms of injury suggested by radiography and computed tomography-myelography included hyperflexion, hyperextension, and axial loading. Clinically, neurologic deficits were found in 10 patients (71%), of whom 2 were complete sensorimotor quadriplegics below the level of injury, and 8 were incomplete injuries. Of the eight incomplete injuries, two-thirds were central cord syndromes associated with narrow spinal canals and prominent osteophytes, and one-third had Brown-Sequard or anterior cord syndromes. After initial anatomic realignment by closed or open reduction, the injured cervical spines were stabilized either externally or internally. Two patients underwent laminectomies. These bodysurfing accidents, in marked contrast to other types of shallow water-diving accidents, predominantly involved older men and produced incomplete injuries. It is concluded that bodysurfing is peculiarly hazardous to healthy, middle-aged men, especially those endowed with a narrow spinal canal with or without osteophyte formation.	UNIV MARYLAND,MARYLAND INST EMERGENCY MED SERV SYST,DIV NEUROL SURG,BALTIMORE,MD 21201									0	8	8	0	4	LIPPINCOTT-RAVEN PUBL	PHILADELPHIA	227 EAST WASHINGTON SQ, PHILADELPHIA, PA 19106	0362-2436			SPINE	SPINE	MAR	1992	17	3					257	260		10.1097/00007632-199203000-00002			4	Clinical Neurology; Orthopedics	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Orthopedics	HJ537	WOS:A1992HJ53700002	1566160				2022-02-06	
J	JONES, JH; VIOLA, SL; LABAN, MM; SCHYNOLL, WG; KROME, RL				JONES, JH; VIOLA, SL; LABAN, MM; SCHYNOLL, WG; KROME, RL			THE INCIDENCE OF POST MINOR TRAUMATIC BRAIN INJURY SYNDROME - A RETROSPECTIVE SURVEY OF TREATING PHYSICIANS	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						BRAIN INJURIES; EPIDEMIOLOGIC METHODS; INCIDENCE STUDIES; PRIMARY HEALTH CARE	HEAD-INJURY; MILD; SEQUELAE	There is a relative lack of information in the literature regarding the epidemiology, functional significance, and clinical resolution of the consequences of minor traumatic brain injury (MTBI). Most retrospective studies to date have been elicited by direct patient interview. Because it was supposed that a minor, but significant, traumatic brain injury would require continuing medical intervention beyond the emergency room contact, a survey was conducted of primary care physicians who were believed to be providing continuing medical care. Had their patients required reevaluations for symptoms of the post-MTBI syndrome? Two hundred fifty-six patients with traumatic brain injury initially seen in the emergency room of two community hospitals were reviewed. One hundred ninety-two (75%) had MTBIs (Glasgow coma scale more than 12 and a negative head CAT scan). One hundred twenty-two physicians were surveyed by mail; 67 (55%) responded. Twenty-one percent of their patients were experiencing symptoms of the post-MTBI syndrome from two to six months after their injuries. Studies relying on patient interviews have also estimated the post-MTBI syndrome at 20%. This correlation implies that "suggestion" does not bias patient interview style research in evaluating the post-MTBI syndrome.	WILLIAM BEAUMONT HOSP,DEPT PHYS MED & REHABIL,ROYAL OAK,MI 48072								ANDERSON DW, 1980, J NEUROSURG, V53, pS1; COONLEYHOGANSON R, 1984, NEUROSURGERY, V14, P315, DOI 10.1227/00006123-198403000-00009; DIKMEN S, 1986, J NEUROL NEUROSUR PS, V49, P1227, DOI 10.1136/jnnp.49.11.1227; Edna T H, 1987, J Oslo City Hosp, V37, P41; HUGENHOLTZ H, 1988, NEUROSURGERY, V22, P853, DOI 10.1227/00006123-198805000-00006; KRAUS JF, 1988, J TRAUMA, V28, P1637, DOI 10.1097/00005373-198812000-00004; LEVIN HS, 1987, J NEUROSURG, V66, P234, DOI 10.3171/jns.1987.66.2.0234; OSHAUGHNESSY EJ, 1984, J FAM PRACTICE, V18, P391; WRIGHTSON P, 1981, INJURY, V12, P445, DOI 10.1016/0020-1383(81)90161-3; Yarnell P R, 1988, Brain Inj, V2, P255, DOI 10.3109/02699058809150950	10	8	8	0	0	W B SAUNDERS CO	PHILADELPHIA	INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA 19106-3399	0003-9993			ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	FEB	1992	73	2					145	146					2	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	HC991	WOS:A1992HC99100006	1543408				2022-02-06	
J	MACNAMARA, SE; BIGLER, ED; BLATTER, D; POMPA, J; RYSER, D; KURTH, SM				MACNAMARA, SE; BIGLER, ED; BLATTER, D; POMPA, J; RYSER, D; KURTH, SM			MAGNETIC-RESONANCE IDENTIFIED VENTRICULAR DILATION IN TRAUMATIC BRAIN INJURY - COMPARISON OF PREINJURY AND POSTINJURY SCAN AND POSTINJURY RESULTS	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article							CLOSED HEAD-INJURY; ATROPHY; SIZE	A case study is presented in which a patient received magnetic resonance (MR) imaging of the brain 3 months prior to a severe traumatic brain injury (TBI). The post-TBI MR findings are compared and contrasted with the pre-TBI MR images. The posttraumatic changes demonstrate a significant dilation of the ventricular system which reflects diffuse axonal injury and loss of brain substance. Correspondingly, the neuropsychological studies in this individual reflect global deficits which match the nonspecific, traumatically induced degenerative changes found in the postinjury MR scan. This case study is unique in that specific preinjury MR findings are available for direct comparison and quantitative analysis of TBI-associated changes in brain structure with neuropsychological outcome.	BRIGHAM YOUNG UNIV,DEPT PSYCHOL,1086 SWKT,PROVO,UT 84602; LATTER DAY ST HOSP,SALT LAKE CITY,UT 84143								Bigler E, 1990, TRAUMATIC BRAIN INJU, P13; BIGLER ED, 1988, DIAGNOSTIC CLIN NEUR; CULLUM CM, 1986, J CLIN EXP NEUROPSYC, V8, P437, DOI 10.1080/01688638608401333; DEFILIPPIS NA, 1987, BOOKLET CATEGORY TES; EISENBERG HM, 1990, J NEUROSURG, V73, P688, DOI 10.3171/jns.1990.73.5.0688; Gurdjian ES, 1975, IMPACT HEAD INJURY; Heaton RK, 1991, COMPREHENSIVE NORMS; LEVI L, 1990, NEUROSURGERY, V27, P429, DOI 10.1227/00006123-199009000-00015; LEVIN HS, 1990, J NEUROSURG, V73, P77, DOI 10.3171/jns.1990.73.1.0077; Levin HS., 1982, NEUROBEHAVIORAL CONS; Ruff RM, 1989, NEUROPSYCHOLOGICAL F, P161; SYNEK V, 1976, NEUROLOGY, V26, P231, DOI 10.1212/WNL.26.3.231; Wechsler, 1997, WECHSLER ADULT INTEL; [No title captured]	14	8	8	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, ENGLAND OX5 1GB	0887-6177			ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.		1992	7	3					275	284		10.1016/0887-6177(92)90169-N			10	Psychology, Clinical; Psychology	Social Science Citation Index (SSCI)	Psychology	HQ922	WOS:A1992HQ92200008	14591261				2022-02-06	
J	OSHIRO, Y; SAKURAI, Y; TANAKA, T; UEDA, H; KIKUCHI, T; TOTTORI, K				OSHIRO, Y; SAKURAI, Y; TANAKA, T; UEDA, H; KIKUCHI, T; TOTTORI, K			NOVEL CEREBROPROTECTIVE AGENTS WITH CENTRAL-NERVOUS-SYSTEM STIMULATING ACTIVITY .1. SYNTHESIS AND PHARMACOLOGY OF 1-AMINO-7-HYDROXYINDAN DERIVATIVES	JOURNAL OF MEDICINAL CHEMISTRY			English	Article							LIPID-PEROXIDATION; CEREBRAL-ISCHEMIA; SALURETIC AGENTS; 2-(AMINOMETHYL)PHENOLS; HYPOXIA; TRAUMA; STROKE	To develop a novel cerebroprotective agent with central nervous system (CNS) stimulating activity, a series of 1-amino-7-hydroxyindan derivatives was synthesized, and their effects on the survival time of mice under hypoxic conditions were tested. CNS-stimulating activity was also evaluated by examining the promotional effect on the recovery from cerebral concussion induced coma in mice. Several compounds prolonged the survival time of mice in hypoxic conditions at a dose of 30 mg/kg (sc or ip) and 100 mg/kg (po). They also exhibited the promotional effects on recovery from coma at a dose of 100 mg/kg po. The three most potent compounds in both tests, 1-amino-7-hydroxy-6-(1-methylpropyl)indan (20), 1-amino-7-hydroxy-4,6-dimethyl-2-phenylidan (30), and 1-amino-7-hydroxy-2,2,4,6-tetramethylindan (35) were selected for further investigations. Structure-activity relationships were also discussed.			OSHIRO, Y (corresponding author), OTSUKA PHARMACEUT CO LTD,INST NEW DRUG RES 3,463-10 KAGASUNO,TOKUSHIMA 77101,JAPAN.						BEURSKENS PT, 18841 CRYST LAB TECH; BRAUGHLER JM, 1989, FREE RADICAL BIO MED, V6, P289, DOI 10.1016/0891-5849(89)90056-7; BRESLOW R, 1976, J AM CHEM SOC, V98, P258, DOI 10.1021/ja00417a054; CANNON JG, 1985, J MED CHEM, V28, P515, DOI 10.1021/jm00382a024; CLARK IA, 1985, MED RES REV, V5, P297, DOI 10.1002/med.2610050303; DEAN RE, 1961, J CHEM SOC, P2773, DOI 10.1039/jr9610002773; DEANA AA, 1983, J MED CHEM, V26, P580, DOI 10.1021/jm00358a023; DESOLMS SJ, 1976, J ORG CHEM, V41, P2650, DOI 10.1021/jo00877a034; GILMORE CJ, 1984, J APPL CRYSTALLOGR, V17, P42, DOI 10.1107/S0021889884010992; HALL ED, 1989, FREE RADICAL BIO MED, V6, P303, DOI 10.1016/0891-5849(89)90057-9; HAYES NF, 1956, J CHEM SOC, P1585, DOI 10.1039/jr9560001585; JOHNSON H, 1986, SIGPLAN NOTICES, V21, P109; KARASAWA A, 1982, J PHARMACOBIO-DYNAM, V5, P295; MANAKA S, 1977, IGAKU NO AYUMI, V102, P867; MIYAMOTO M, 1981, LIFE SCI, V28, P861, DOI 10.1016/0024-3205(81)90047-3; NAKANISHI M, 1973, LIFE SCI, V13, P467, DOI 10.1016/0024-3205(73)90038-6; NEMOTO EM, 1977, BRAIN HEART INFARCT, P306; NEUREKAR NB, 1983, CHEM IND, P206; OSHIRO Y, 1983, Patent No. 36429; SAFAR P, 1977, BRAIN HEART INFARCT, V2, P251; SMITH AL, 1974, STROKE, V5, P1; STOKKER GE, 1980, J MED CHEM, V23, P1414, DOI 10.1021/jm00186a024; TADIC D, 1988, HETEROCYCLES, V27, P407; WAGATSUMA S, 1974, Patent No. 109359; WARD M, 1973, Patent No. 3709996; WOLTERSDORF OW, 1977, J MED CHEM, V20, P1400, DOI 10.1021/jm00221a010; YAMAMOTO M, 1983, STROKE, V14, P977, DOI 10.1161/01.STR.14.6.977; YASUDA H, 1973, ARCH INT PHARMACOD T, V233, P133; Zaugg H.E., 1965, ORG REACT, V14, P52; [No title captured]; 1971, Patent No. 1249375; 1985, TEXRAY STRUCTURE ANA	32	8	8	0	0	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036	0022-2623			J MED CHEM	J. Med. Chem.	JUL	1991	34	7					2004	2013		10.1021/jm00111a013			10	Chemistry, Medicinal	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	FW170	WOS:A1991FW17000013	1676756				2022-02-06	
J	Haut, MW; Petros, TV; Frank, RG				Haut, Marc; Petros, Thomas; Frank, Robert			Semantic Sensitivity in the Acute Phase of Recovery From Moderate and Severe Closed Head Injury	NEUROPSYCHOLOGY			English	Article						Closed head injury; semantic processing; memory		This study examined the differential effects of moderate and severe closed head injury in the acute phase of recovery on sensitivity to the semantic structure of prose. The prose passages from the Wechsler Memory Scale-Revised were used to determine whether the most important information was recalled at a greater rate than nonessential details. Total recall varied according to the initial severity of the injury and retention interval. However, all groups were equally capable of distinguishing important from less important information in their recall. The results indicate intact semantic processing in acute recovery from moderate and severe closed head injury.	[Haut, Marc] W Virginia Univ, Sch Med, Dept Behav Med & Psychiat, Morgantown, WV 26506 USA; [Haut, Marc] W Virginia Univ, Sch Med, Dept Neurol, Morgantown, WV USA; [Petros, Thomas] Univ North Dakota, Dept Psychol, Grand Forks, ND 58201 USA; [Frank, Robert] Univ Missouri, Columbia Sch Med, Dept Phys Med & Rehabil, Columbia, MO 65211 USA		Haut, MW (corresponding author), W Virginia Univ, Sch Med, Dept Behav Med & Psychiat, Morgantown, WV 26506 USA.			Haut, Marc/0000-0003-0235-362X			BROWN AL, 1977, CHILD DEV, V48, P1, DOI 10.2307/1128873; CERMAK LS, 1979, LEVELS PROCESSING HU, P119; CROSSON B, 1988, J CLIN EXP NEUROPSYC, V10, P754, DOI 10.1080/01688638808402812; DANEMAN M, 1980, J VERB LEARN VERB BE, V19, P450, DOI 10.1016/S0022-5371(80)90312-6; GOLDSTEIN FC, 1989, CORTEX, V25, P541, DOI 10.1016/S0010-9452(89)80016-4; GOLDSTEIN FC, 1990, J CLIN EXP NEUROPSYC, V12, P286, DOI 10.1080/01688639008400975; Haut M W, 1990, Arch Clin Neuropsychol, V5, P299, DOI 10.1016/0887-6177(90)90028-N; HAUT M W, 1990, Brain Injury, V4, P281, DOI 10.3109/02699059009026178; Haut M. W., 1990, SPEED PROCESSI UNPUB; JOHNSON RE, 1970, J VERB LEARN VERB BE, V9, P12, DOI 10.1016/S0022-5371(70)80003-2; KINTSCH W, 1978, PSYCHOL REV, V85, P363, DOI 10.1037/0033-295X.85.5.363; LEVIN HS, 1986, J CLIN EXP NEUROPSYC, V8, P643, DOI 10.1080/01688638608405185; LEVIN HS, 1988, J NEUROL NEUROSUR PS, V51, P1294, DOI 10.1136/jnnp.51.10.1294; LEVIN HS, 1988, BRAIN COGNITION, V7, P283, DOI 10.1016/0278-2626(88)90003-6; MEYER J, 1979, FUNDAMENTALS EXPT DE; PERFETTI C., 1985, READING ABILITY; TEASDALE G, 1974, LANCET, V2, P81; Wechsler D, 1987, MANUAL WECHSLER MEMO	18	8	8	0	0	AMER PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA	0894-4105	1931-1559		NEUROPSYCHOLOGY	Neuropsychology	APR	1991	5	2					81	88		10.1037/0894-4105.5.2.81			8	Psychology, Clinical; Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	V74CV	WOS:000211756000002					2022-02-06	
J	SIMPSON, DA; BLUMBERGS, PC				SIMPSON, DA; BLUMBERGS, PC			EMBOLISM OF CEREBRAL TISSUE - A CAUSE OF COAGULOPATHY AND CEREBRAL INFARCTION - REPORT OF A CASE	SURGICAL NEUROLOGY			English	Article						HEAD INJURY; COAGULOPATHY; CEREBRAL INFARCTION		We report a case of potentially survivable closed head injury, which was complicated by disseminated intravascular coagulation and bilateral cerebral infarction. Autopsy disclosed pulmonary emboli composed of cerebral tissue. We suggest that the entry of brain tissue into the systemic blood circulation caused severe disseminated intravascular coagulation, with consequent thrombosis of cerebral veins and spreading infarction.	ADELAIDE CHILDRENS HOSP INC,DEPT HAEMATOL,ADELAIDE,SA 5006,AUSTRALIA; INST MED & VET SCI,DIV TISSUE PATHOL,ADELAIDE,SA 5000,AUSTRALIA		SIMPSON, DA (corresponding author), UNIV ADELAIDE,NH&MRC RD ACCID RES UNIT,GPO BOX 498,ADELAIDE,SA 5001,AUSTRALIA.						GARVEY MB, 1972, J CLIN PATHOL, V25, P680, DOI 10.1136/jcp.25.8.680; KAUFMAN HH, 1985, CENTRAL NERVOUS SYST, P187; LEWIS IH, 1962, J LAB CLIN MED, V60, P261; OGILVY CS, 1980, NEUROSURGERY, V23, P511; RYLATT DB, 1983, THROMB RES, V31, P767, DOI 10.1016/0049-3848(83)90108-1; TOUHO H, 1986, NEUROSURGERY, V19, P523, DOI 10.1227/00006123-198610000-00005; VANDERSANDE JJ, 1978, J NEUROSURG, V49, P357, DOI 10.3171/jns.1978.49.3.0357	7	8	8	0	0	ELSEVIER SCIENCE INC	NEW YORK	655 AVENUE OF THE AMERICAS, NEW YORK, NY 10010	0090-3019			SURG NEUROL	Surg. Neurol.	FEB	1991	35	2					159	162		10.1016/0090-3019(91)90270-J			4	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	EV912	WOS:A1991EV91200014	1990485				2022-02-06	
J	KULALT, A; AKAR, M; BAYKUT, L				KULALT, A; AKAR, M; BAYKUT, L			DIMETHYL-SULFOXIDE IN THE MANAGEMENT OF PATIENT WITH BRAIN-SWELLING AND INCREASED INTRACRANIAL-PRESSURE AFTER SEVERE CLOSED HEAD-INJURY	NEUROCHIRURGIA			English	Article											KULALT, A (corresponding author), DICLE UNIV DIYARBAKIR,SCH MED,NEUROSURG CLIN,DIYARBAKIR,TURKEY.							0	8	10	0	1	GEORG THIEME VERLAG	STUTTGART	P O BOX 30 11 20, D-70451 STUTTGART, GERMANY	0028-3819			NEUROCHIRURGIA		NOV	1990	33	6					177	180					4	Neurosciences; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	EL819	WOS:A1990EL81900002	2290457				2022-02-06	
J	HALL, ED				HALL, ED			STEROIDS AND NEURONAL DESTRUCTION OR STABILIZATION	CIBA FOUNDATION SYMPOSIA			English	Article							POTENTIATE ISCHEMIC-INJURY; MOTOR-NERVE DEGENERATION; CAT SPINAL-CORD; GLUCOCORTICOID TREATMENT; LIPID-PEROXIDATION; THERAPEUTIC IMPLICATIONS; CEREBRAL ATROPHY; BRAIN FUELS; HIPPOCAMPUS; TOXICITY	Extensive work has indicated that glucocorticoid steroids may play a role in promoting age-related central neuronal degeneration. It has also been shown that glucocorticoid supplementation may intensify acute post-ischaemic neuronal necrosis and that prior adrenalectomy is protective. A glucocorticoid inhibition of injury-induced axonal reactive sprouting has also been reported. The mechanism of this deleterious effect on chronic or acute neuronal degeneration and regenerative responses is thought to involve specific glucocorticoid receptors either on susceptible nerve cells or on adjacent glial cells. However, other studies have shown that intensive short-term glucocorticoid treatment may attenuate post-traumatic and post-ischaemic central neuronal damage. Anterograde degeneration of motor nerve fibres can also be retarded by intensive glucocorticoid pretreatment. The mechanism of these high dose protective effects appears to involve an intrinsic ability of certain glucocorticoids to inhibit oxygen free radical-induced lipid peroxidation, a phenomenon that may be fundamentally involved in neuronal degeneration. Recently, steroid analogues which lack glucocorticoid receptor affinity have been shown to duplicate the antioxidant and cerebroprotective actions of the glucocorticoids in models of neuronal damage. Thus, the deleterious and protective effects of steriods on neuronal viability depend on two different mechanisms, separable by dose, duration of treatment, specific situation and chemical structure.			HALL, ED (corresponding author), UPJOHN CO, CENT NERVOUS SYST DIS RES UNIT, KALAMAZOO, MI 49001 USA.		Hall, Edward D/F-8930-2013				Braughler J M, 1986, Cent Nerv Syst Trauma, V3, P153; BRAUGHLER JM, 1985, J NEUROCHEM, V44, P1282, DOI 10.1111/j.1471-4159.1985.tb08755.x; BRAUGHLER JM, 1989, FREE RADICAL BIO MED, V7, P125, DOI 10.1016/0891-5849(89)90003-8; BRAUGHLER JM, 1982, J NEUROSURG, V56, P838, DOI 10.3171/jns.1982.56.6.0838; BRAUGHLER JM, 1987, J NEUROSURG, V67, P102, DOI 10.3171/jns.1987.67.1.0102; DEMOPOULOS HB, 1972, STEROIDS BRAIN EDEMA, P29; DRAKONTIDES AB, 1982, BRAIN RES, V239, P175, DOI 10.1016/0006-8993(82)90840-X; Hall E D, 1987, Acta Anaesthesiol Belg, V38, P405; HALL ED, 1983, EXP NEUROL, V79, P488, DOI 10.1016/0014-4886(83)90228-5; HALL ED, 1982, INT REV NEUROBIOL, V23, P165, DOI 10.1016/S0074-7742(08)60625-X; HALL ED, 1985, J NEUROSURG, V62, P882, DOI 10.3171/jns.1985.62.6.0882; HALL ED, 1984, EXP NEUROL, V84, P715, DOI 10.1016/0014-4886(84)90219-X; HALL ED, 1981, EXP NEUROL, V73, P321, DOI 10.1016/0014-4886(81)90067-4; HALL ED, 1987, BRAIN RES, V413, P175, DOI 10.1016/0006-8993(87)90166-1; HALL ED, 1987, J PHARMACOL EXP THER, V242, P137; HEINZ ER, 1977, J COMPUT ASSIST TOMO, V1, P415, DOI 10.1097/00004728-197710000-00006; KERR DS, 1989, SCIENCE, V245, P1505, DOI 10.1126/science.2781293; KOIDE T, 1985, J CEREB BLOOD FLOW M, V5, pS251; LANDFIELD PW, 1978, SCIENCE, V202, P1098, DOI 10.1126/science.715460; LANDFIELD PW, 1981, SCIENCE, V214, P581, DOI 10.1126/science.6270791; MCEWEN BS, 1969, BRAIN RES, V16, P227, DOI 10.1016/0006-8993(69)90096-1; OKUNO T, 1980, J COMPUT ASSIST TOMO, V4, P20, DOI 10.1097/00004728-198002000-00004; RIKER WF, 1975, ARCH NEUROL-CHICAGO, V32, P688, DOI 10.1001/archneur.1975.00490520058009; SAPOLSKY RM, 1985, J NEUROSCI, V5, P1222; SAPOLSKY RM, 1986, ENDOCR REV, V7, P284, DOI 10.1210/edrv-7-3-284; SAPOLSKY RM, 1985, SCIENCE, V229, P1397, DOI 10.1126/science.4035356; SAPOLSKY RM, 1986, J NEUROSCI, V6, P2240; SAPOLSKY RM, 1985, J NEUROSCI, V5, P1228; SCHEFF SW, 1982, EXP NEUROL, V76, P644, DOI 10.1016/0014-4886(82)90131-5; UNO H, 1989, J NEUROSCI, V9, P1705, DOI 10.1523/jneurosci.09-05-01705.1989	30	8	8	0	0	JOHN WILEY & SONS LTD	CHICHESTER	THE ATRIUM, SOUTHERN GATE, CHICHESTER PO19 8SQ, W SUSSEX, ENGLAND	0300-5208			CIBA F SYMP	CIBA Found. Symp.		1990	153						206	219					14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EX260	WOS:A1990EX26000013					2022-02-06	
J	DAVIDOFF, G; DOLJANAC, R; BERENT, S; JOHNSON, MB; THOMAS, P; DIJKERS, M; KLISZ, D				DAVIDOFF, G; DOLJANAC, R; BERENT, S; JOHNSON, MB; THOMAS, P; DIJKERS, M; KLISZ, D			GALVESTON ORIENTATION AND AMNESIA TEST - ITS UTILITY IN THE DETERMINATION OF CLOSED HEAD-INJURY IN ACUTE SPINAL-CORD INJURY PATIENTS	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article									UNIV MICHIGAN,MED CTR,ANN ARBOR,MI 48109; DETROIT RECEIVING HOSP,DETROIT,MI 48231; REHABIL INST,DETROIT,MI 48231					Dijkers, Marcel/0000-0002-8362-5596	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [K08NS001120] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS-01120-01] Funding Source: Medline		COLOHAN ART, 1985, SEP C NEUR SURG M HO; DACEY RG, 1984, APR ANN M AM ASS NEU; DAVIDOFF G, 1985, ARCH PHYS MED REHAB, V66, P41; DUBO H, 1983, P AM SPINAL INJURY A, P35; FISCHER RP, 1981, J TRAUMA, V21, P920, DOI 10.1097/00005373-198111000-00002; LANDIS JR, 1985, ANAL CATEGORICAL DAT, P6; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; Morris J, 1986, J HEAD TRAUMA REHAB, V1, P31; RIMEL RW, 1981, NEUROSURGERY, V9, P221, DOI 10.1227/00006123-198109000-00001; RUSSELL WR, 1946, BRAIN, V69, P280, DOI 10.1093/brain/69.4.280; RUSSELL WR, 1961, ARCH NEUROL-CHICAGO, V5, P4, DOI 10.1001/archneur.1961.00450130006002; SILVER JR, 1980, INJURY, V12, P219, DOI 10.1016/0020-1383(80)90011-X; WAGNER KA, 1983, P AM SPINAL INJURY A, P96; WILMOT CB, 1985, ARCH PHYS MED REHAB, V66, P227, DOI 10.1016/0003-9993(85)90148-0	14	8	9	0	1	W B SAUNDERS CO	PHILADELPHIA	INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA 19106-3399	0003-9993			ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	JUN	1988	69	6					432	434					3	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	N8323	WOS:A1988N832300009	3377668				2022-02-06	
J	CULLUM, CM; BIGLER, ED				CULLUM, CM; BIGLER, ED			LATE EFFECTS OF HEMATOMA ON BRAIN MORPHOLOGY AND MEMORY IN CLOSED HEAD-INJURY	INTERNATIONAL JOURNAL OF NEUROSCIENCE			English	Article									UNIV TEXAS,AUSTIN,TX 78712; AUSTIN NEUROL CLIN,AUSTIN,TX 78705				Cullum, C. Munro/AAC-2496-2019	Cullum, C. Munro/0000-0001-9706-5465			BIGLER ED, 1985, J NERV MENT DIS, V173, P347, DOI 10.1097/00005053-198506000-00004; BIGLER ED, 1984, INT J NEUROSCI, V24, P295, DOI 10.3109/00207458409089820; CLIFTON GL, 1980, J NEUROSURG, V52, P611, DOI 10.3171/jns.1980.52.5.0611; CULLUM CM, 1985, 13TH ANN M INT NEUR; GALBRAITH S, 1976, LANCET, V1, P501; HAWKINS TD, 1976, CLIN RADIOL, V27, P279, DOI 10.1016/S0009-9260(76)80069-4; Jennett B, 1981, MANAGEMENT HEAD INJU; LEVIN HS, 1981, ARCH NEUROL-CHICAGO, V38, P623, DOI 10.1001/archneur.1981.00510100051007; Levin HS., 1982, NEUROBEHAVIORAL CONS; MILLER E, 1980, J NEUROL NEUROSUR PS, V43, P525, DOI 10.1136/jnnp.43.6.525; NIE HN, 1975, STATISTICAL PACKAGE; TURKHEIMER E, 1984, J NEUROL NEUROSUR PS, V47, P1314, DOI 10.1136/jnnp.47.12.1314; UZZELL BP, 1979, CORTEX, V15, P391, DOI 10.1016/S0010-9452(79)80066-0; Wechsler D, 1945, J PSYCHOL, V19, P87, DOI 10.1080/00223980.1945.9917223; [No title captured]	15	8	8	0	0	GORDON BREACH SCI PUBL LTD	READING	C/O STBS LTD, PO BOX 90, READING, BERKS, ENGLAND RG1 8JL	0020-7454			INT J NEUROSCI	Int. J. Neurosci.		1985	28	3-4					279	283		10.3109/00207458508985395			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	C6525	WOS:A1985C652500010	4093263				2022-02-06	
J	MCHEDLISHVILI, G; AKHOBADZE, VA				MCHEDLISHVILI, G; AKHOBADZE, VA			CEREBRAL ARTERIAL SYSTEM IN BRAIN INJURY AND DURING TRAUMATIC OEDEMA	PHYSIOLOGIA BOHEMOSLOVACA			English	Article																	AUGUSTIN GM, 1956, ARCH NEUROL PSYCHIAT, V75, P447; BAKAY L, 1955, AMA Arch Neurol Psychiatry, V73, P2; BERANEK R, 1955, POKUSNE STUDIE MOZKO; BERANEK R, 1952, PHYSIOL BOHEMOSLOV, V1, P142; BORNSTEIN MB, 1946, J NEUROPHYSIOL, V9, P349, DOI 10.1152/jn.1946.9.5.349; GRASHCHENKOV N I, 1959, Zh Nevropatol Psikhiatr Im S S Korsakova, V59, P351; Hyman C, 1944, AM J PHYSIOL, V142, P0671, DOI 10.1152/ajplegacy.1944.142.5.671; KAMENETSKAIA B I, 1958, Biull Eksp Biol Med, V45, P41; KASSIL GN, 1957, DOKL AKAD NAUK SSSR+, V115, P833; KLOSOVSKIY BN, 1946, BYUL EKSPER BIOL MED, V21, P5; KOREISHA LA, 1956, CDDBT, P95; MCHEDLISHVILI G I, 1960, Fiziol Zh SSSR Im I M Sechenova, V46, P1210; MCHEDLISHVILI GI, 1960, PATOL FIZIOL EKSP TE, V4, P14; MCHEDLISHVILI GI, 1959, DOKL AKAD NAUK SSSR, V126, P1371; MCHEDLISHVILI GI, 1958, CAPILLARY CIRCULATIO; MCHEDLISHVILI GI, 1960, BYUL EKSPER BIOL MED, V47, P21; MCHEDLISHVILI GI, 1959, FIZIOL ZH SSSR, V45, P1221; MCHEDLISHVILI GI, 1960, VOPR NEIROKHIRURGII, V2, P13; PRADOS M, 1945, ARCH NEURO PSYCHIATR, V54, P290, DOI 10.1001/archneurpsyc.1945.02300100064007; PRADOS M, 1945, ARCH NEURO PSYCHIATR, V54, P163, DOI 10.1001/archneurpsyc.1945.02300090002001; SAMORAJSKI T, 1957, ARCH NEURO PSYCHIATR, V78, P369, DOI 10.1001/archneurpsyc.1957.02330400043004; SMIRNOV LI, 1949, PANS, V2; SMIRNOV LI, 1947, PANS, V1; SNESAREV PE, 1946, GHBT	24	8	8	0	0	ACADEMIA	PRAGUE 1	PUBL HOUSE CZECH ACAD SCI VODICKOVA 40, PRAGUE 1 112 29, CZECH REPUBLIC	0014-1291			PHYSIOL BOHEMOSLOV			1961	10	1					8	+					1	Physiology	Science Citation Index Expanded (SCI-EXPANDED)	Physiology	1748C	WOS:A19611748C00005					2022-02-06	
J	RAAB, W				RAAB, W			HYPERTENSION AND TACHYCARDIA DUE TO CONCUSSION OF THE BRAIN	AMERICAN HEART JOURNAL			English	Article																	Ayman D, 1939, ARCH INTERN MED, V63, P899, DOI 10.1001/archinte.1939.00180220089008; BEIGLBOCK W, 1934, Z KLIN MED, V127, P144; BENON R, 1946, SEM HOP PARIS, V22, P65, DOI 10.1007/BF01734345; BISCONS, 1917, ARCH MAL COEUR, V10, P336; Blix G, 1929, SKAND ARCH PHYSIOL, V56, P131, DOI 10.1111/j.1748-1716.1929.tb00885.x; COX LB, 1946, SURGERY, V19, P669; Danielopolu D, 1940, CR SOC BIOL, V133, P12; DIXON WE, 1932, ARCH EXP PATHOL PH, V166, P265; DOLGIN W, 1945, ARCH PATHOL, V40, P135; DRAKE EL, 1944, AMA ARCH PATHOL, V37, P351; ELAUT L, 1929, ARCH INT MED EXPERIM, V5, P69; ENGEL GL, 1945, ARCH NEURO PSYCHIATR, V54, P37, DOI 10.1001/archneurpsyc.1945.02300070047004; FARRIS EJ, 1945, AM J PHYSIOL, V144, P331, DOI 10.1152/ajplegacy.1945.144.3.331; Feldberg W, 1934, J PHYSIOL-LONDON, V81, P286, DOI 10.1113/jphysiol.1934.sp003136; Fishback HR, 1943, J LAB CLIN MED, V28, P1187; Freeman NE, 1940, AM J PHYSIOL, V128, P0662, DOI 10.1152/ajplegacy.1940.128.4.662; FRIEDMAN ED, 1931, M CLIN N AM, V14, P1419; Gilchrist A Rae, 1941, Edinb Med J, V48, P752; Gollwitzer-Meier K, 1936, PFLUG ARCH GES PHYS, V237, P639, DOI 10.1007/BF01753049; Griffith FR, 1935, AM J PHYSIOL, V111, P369; GRUNTHAL E, 1929, ARCH EXP PATHOL PH, V145, P35; GUBNER R, 1946, JAMA-J AM MED ASSOC, V130, P325, DOI 10.1001/jama.1946.02870060011003; HARRER G, COMMUNICATION; HARRER G, UNPUB; HELLER H, 1933, KLIN WCHNSCHR, V12, P1260; HILLER F, 1936, HDB NEUROLOGIE, V2, P10; Hines EA, 1933, ANN INTERN MED, V7, P209, DOI 10.7326/0003-4819-7-2-209; Jones RJ, 1944, AM J PHYSIOL, V142, P0744, DOI 10.1152/ajplegacy.1944.142.5.744; KLEMME RM, 1943, J MISSOURI M A, V40, P241; McLean AJ, 1934, ARCH NEURO PSYCHIATR, V32, P189, DOI 10.1001/archneurpsyc.1934.02250070195012; MEYER A, 1932, KLIN WCHNSCHR, V11, P1873; MORTELL EJ, 1945, J CLIN ENDOCR METAB, V5, P396, DOI 10.1210/jcem-5-9-396; MOUTIER F, 1918, PRESSE MED, V26, P12; NAGL F, 1936, WIEN KLIN WCHNSCHR, V2, P1114; NORDMANN M, 1932, VERHANDL DTSCH GESEL, V5, P145; NOWAK SJG, 1939, NEW ENGL J MED, V220, P269; Penfield W, 1929, ARCH NEURO PSYCHIATR, V22, P358, DOI 10.1001/archneurpsyc.1929.02220020174010; PFALZ W, 1922, DTSCH MED WCHNSCHR, V48, P1647; RAAB W, 1948, AM J PHYSIOL, V152, P324, DOI 10.1152/ajplegacy.1948.152.2.324; RAAB W, 1947, AM J PHYSIOL, V148, P460, DOI 10.1152/ajplegacy.1947.148.2.460; Raab W, 1941, ANN INTERN MED, V14, P1981, DOI 10.7326/0003-4819-14-11-1981; Raab W, 1931, ARCH INTERN MED, V47, P727, DOI 10.1001/archinte.1931.00140230054004; RAAB W, 1943, EXP MED SURG, V1, P188; RAAB W, IN PRESS J CLIN ENDO; Roest J, 1926, BIOCHEM Z, V176, P17; RUSKIN A, 1948, AM J MED, V4, P228, DOI 10.1016/0002-9343(48)90239-3; SALUS F, 1932, KLIN WCHNSCHR, V11, P1542; SCANTLEBURY RE, 1948, FED PROC, V7, P41; SCHONBRUNNER E, COMMUNICATION; Segerath F, 1921, Z GESAMTE NEUROL PSY, V63, P245, DOI 10.1007/BF02872622; Sigler LH, 1942, ARCH INTERN MED, V70, P983, DOI 10.1001/archinte.1942.00200240067006; WASHINGTON EL, 1946, J CLIN ENDOCR METAB, V6, P688, DOI 10.1210/jcem-6-10-688; Weber C, 1927, ARCH MAL COEUR, V20, P598; WEISSMANN A, 1935, WIEN KLIN WOCH I, V48, P494	54	8	8	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0002-8703	1097-5330		AM HEART J	Am. Heart J.		1949	37	2					237	248		10.1016/0002-8703(49)90565-7			12	Cardiac & Cardiovascular Systems	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology	XU260	WOS:A1949XU26000004	18107389				2022-02-06	
J	SPIEGEL, EA; SPIEGELADOLF, M; WYCIS, HT				SPIEGEL, EA; SPIEGELADOLF, M; WYCIS, HT			CEREBRAL CONCUSSION - HISTOCHEMICAL DEMONSTRATION OF NUCLEASES IN THE CEREBROSPINAL FLUID	ARCHIVES OF PATHOLOGY			English	Article																	BIELSCHOWSKY M, 1928, HDB MIKROSKOPISCHEN, V4, P8; Held Hs., 1895, Arch Anat, P396; SPIEGELADOLF M, 1946, FED PROC, V5, P156; SUMMER JB, 1943, CHEM METHODS ENZYMES, P103	4	8	8	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0003-9985			ARCH PATHOL			1946	42	2					175	181					7	Pathology	Science Citation Index Expanded (SCI-EXPANDED)	Pathology	UE272	WOS:A1946UE27200005	20999917				2022-02-06	
J	SYMONDS, CP				SYMONDS, CP			PROGNOSIS IN CLOSED HEAD INJURIES	BRITISH MEDICAL BULLETIN			English	Article																	[Anonymous], 1942, Proc R Soc Med, V35, P601; BOWMAN KM, 1943, INJURIES SKULL BRAIN; CAIRNS H, 1942, P ROY SOC MED, V35, P299; DAVIS BF, 1938, AM J SURG, V39, P512; Denny-Brown D, 1943, ANN INTERN MED, V19, P427, DOI 10.7326/0003-4819-19-3-427; Denny-Brown D., 1942, NEW ENGL J MED, V227, P771; DENNYBROWN D, 1943, CLINICS, V1, P1405; DENNYBROWN D, 1944, AM J PSYCHIAT, V100, P585; FEINBERG P, 1934, EPILEPSIE TRAUMA; GARLAND HG, 1942, P ROY SOC MED, V35, P773; Goldstein K., 1942, AFTEREFFECTS BRAIN I; Guttmann E, 1943, BRIT MED J, V1943, P94; Guttmann E, 1943, LANCET, V1, P10; Jefferson G, 1933, BRIT MED J, V1933, P807, DOI 10.1136/bmj.2.3800.807; Leigh AD, 1943, LANCET, V1, P38; LYLE TK, 1941, T OPHTHAL SOC UK, V61, P189; Mapother E, 1937, BMJ-BRIT MED J, V1937, P1055; Meyer A, 1904, AM J INSANITY, V60, P373, DOI 10.1176/ajp.60.3.373; Munro D, 1934, NEW ENGL J MED, V210, P287, DOI 10.1056/NEJM193402082100601; O'Connell JEA, 1941, LANCET, V2, P719; PATERSON A, 1944, P ROY SOC MED, V37, P556; Paterson JH, 1943, J NEUROL PSYCHIATRY, V6, P87, DOI 10.1136/jnnp.6.3-4.87; Paterson R, 1942, LANCET, V2, P317; Reynell WR, 1944, J MENT SCI, V90, P710; Rowbotham GF, 1942, ACUTE INJURIES HEAD; Ruesch J, 1944, AM J PSYCHIAT, V100, P480, DOI 10.1176/ajp.100.4.480; Russell W Ritchie, 1934, Edinb Med J, V41, P129; Russell WR, 1932, BRAIN, V55, P549, DOI 10.1093/brain/55.4.549; Schilder P, 1934, AM J PSYCHIAT, V91, P155, DOI 10.1176/ajp.91.1.155; SCHILDER P, 1943, INJURIES SKULL BRAIN; Strecker EA, 1924, ARCH NEURO PSYCHIATR, V12, P443, DOI 10.1001/archneurpsyc.1924.02200040092006; Symonds C P, 1937, Proc R Soc Med, V30, P1081; Symonds Charles, 1937, GUYS HOSP GAZ, V51, P461; Symonds CP, 1943, LANCET, V1, P7; Symonds CP, 1928, BRIT MED J, V1928, P829, DOI 10.1136/bmj.2.3540.829; Symonds CP, 1932, LANCET, V1, P820; SYMONDS CP, 1941, J ROY ARMY MED CORPS, V76, P320; SYMONDS CP, 1935, LANCET, V2, P1217; SYMONDS CP, 1943, INJURIES SKULL BRAIN; Trotter W, 1925, LANCET, V2, P953; Turner IJA, 1941, BRIT MED J, V1941, P569, DOI 10.1136/bmj.2.4216.569; Turner JWA, 1944, LANCET, V1, P756; Turner JWA, 1943, BRAIN, V66, P140; Wagstaffe WW, 1928, LANCET, V2, P861; Williams D, 1941, J NEUROL PSYCHIATRY, V4, P107, DOI 10.1136/jnnp.4.2.107; Williams D, 1941, J NEUROL PSYCHIATRY, V4, P131, DOI 10.1136/jnnp.4.2.131; Woodhall B, 1936, ARCH SURG-CHICAGO, V33, P560, DOI 10.1001/archsurg.1936.01190040018003; [No title captured]; 1941, 4 MED RES COUNC WAR; [No title captured]	50	8	8	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0007-1420	1471-8391		BRIT MED BULL	Br. Med. Bull.		1945	3	1-3					14	18		10.1093/oxfordjournals.bmb.a071858			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	XV114	WOS:A1945XV11400005					2022-02-06	
J	Turner, IJA				Turner, IJA			Observations on the cerebrospinal fluid in closed head injuries	BRITISH MEDICAL JOURNAL			English	Article																	BROWN DD, 1941, LANCET, V1, P371; McKissock W, 1941, LANCET, V1, P593; Russell WR, 1932, BRAIN, V55, P549, DOI 10.1093/brain/55.4.549	3	8	8	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUL-DEC	1941	1941		2				569	571		10.1136/bmj.2.4216.569			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	V07WN	WOS:000200531700553	20783921	Green Published			2022-02-06	
J	McAllister-Deitrick, J; Beidler, E; Wallace, J; Anderson, M				McAllister-Deitrick, Jamie; Beidler, Erica; Wallace, Jessica; Anderson, Morgan			Concussion Knowledge and Reporting Behaviors Among Collegiate Athletes	CLINICAL JOURNAL OF SPORT MEDICINE			English	Article						concussion; mTBI; concussion reporting; symptoms; collegiate sport	SCHOOL; ATTITUDES; EDUCATION; SYMPTOMS; DISCLOSURE; IMPACT	Objective: The purpose of the current study was to explore knowledge surrounding sport-related concussions (SRCs) and the impact on reporting behaviors in collegiate athletes, including sex differences. Design: Cross-sectional. Setting: Institutional. Participants: Participants were 986 collegiate athletes (607 men), aged 19.7 years (SD = 1.4) from 6 institutions, who completed a survey, including items on personal/sport demographics and SRC knowledge and reporting behaviors. Interventions: Athletes were given a short (15-minute) survey to complete during team meetings and preparticipation physicals. Main Outcome Measures: Athletes' scores on the survey, and reporting behaviors (ie, whether or not they failed to report a suspected SRC and reasons for not reporting SRCs), were examined. Results: Independent samples t tests revealed female athletes scored significantly higher than male athletes on total SRC knowledge [t (926.6) = -10.6, P < 0.01] and symptom knowledge (t (859) = -7.0, P < 0.01). Approximately one-quarter of athletes reported continuing to play after sustaining a suspected SRC. Chi-square analyses exposed significant differences between male and female athletes failing to report a suspected SRC (chi(2) = 7.69, P < 0.01). Conclusions: Given the current findings, educational efforts aimed at collegiate athletes may not be enough. Furthermore, it is apparent that sex differences exist in SRC knowledge and reporting behaviors among collegiate athletes.	[McAllister-Deitrick, Jamie] Coastal Carolina Univ, Dept Kinesiol, Williams Brice 111,POB 261954, Conway, SC 29528 USA; [Beidler, Erica] Duquesne Univ, Dept Athlet Training, Pittsburgh, PA 15219 USA; [Wallace, Jessica] Univ Alabama, Dept Hlth Sci & Athlet Training, Tuscaloosa, AL USA; [Anderson, Morgan] Michigan State Univ, Dept Kinesiol, E Lansing, MI 48824 USA		McAllister-Deitrick, J (corresponding author), Coastal Carolina Univ, Dept Kinesiol, Williams Brice 111,POB 261954, Conway, SC 29528 USA.	jdeitrick@coastal.edu					[Anonymous], 2011, 2011 12 NCAA SPORTS; Broglio SP, 2014, J ATHL TRAINING, V49, P245, DOI 10.4085/1062-6050-49.1.07; Buckley TA, 2017, ORTHOP J SPORTS MED, V5, DOI 10.1177/2325967117702606; Cournoyer J, 2014, J ATHL TRAINING, V49, P654, DOI 10.4085/1062-6050-49.3.34; Delaney JS, 2015, CLIN J SPORT MED, V25, P113, DOI 10.1097/JSM.0000000000000112; Eagly A.H., 1987, SEX DIFFERENCES SOCI; Festinger L, 1954, HUM RELAT, V7, P117, DOI 10.1177/001872675400700202; Kaut KP, 2003, CLIN J SPORT MED, V13, P213, DOI 10.1097/00042752-200307000-00004; Kerr ZY, 2016, AM J SPORT MED, V44, P220, DOI 10.1177/0363546515612082; Kerr ZY, 2014, BRAIN INJURY, V28, P1009, DOI 10.3109/02699052.2014.904049; Kroshus E, 2015, HEALTH EDUC RES, V30, P1004, DOI 10.1093/her/cyv047; Kroshus E, 2014, BRIT J SPORT MED, V48, P135, DOI 10.1136/bjsports-2013-092498; Kurowski B, 2014, J TRAUMA ACUTE CARE, V77, pS12, DOI 10.1097/TA.0000000000000316; Kurowski BG, 2015, J TRAUMA ACUTE CARE, V79, pS21, DOI 10.1097/TA.0000000000000675; Llewellyn T, 2014, CLIN J SPORT MED, V24, P76, DOI 10.1097/01.jsm.0000432853.77520.3d; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Miyashita TL, 2013, CLIN J SPORT MED, V23, P349, DOI 10.1097/JSM.0b013e318289c321; Register-Mihalik JK, 2017, CLIN J SPORT MED, V27, P321, DOI 10.1097/JSM.0000000000000349; Register-Mihalik JK, 2013, BRAIN INJURY, V27, P878, DOI 10.3109/02699052.2013.775508; Wallace J, 2017, J ATHL TRAINING, V52, P682, DOI 10.4085/1062-6050-52.3.06	21	7	7	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1050-642X	1536-3724		CLIN J SPORT MED	Clin. J. Sport Med.	JAN	2022	32	1					56	61		10.1097/JSM.0000000000000833			6	Orthopedics; Physiology; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Physiology; Sport Sciences	XQ7WF	WOS:000731754000017	33914496				2022-02-06	
J	Levin, HS; Temkin, NR; Barber, J; Nelson, LD; Robertson, C; Brennan, J; Stein, MB; Yue, JK; Giacino, JT; McCrea, MA; Diaz-Arrastia, R; Mukherjee, P; Okonkwo, DO; Boase, K; Markowitz, AJ; Bodien, Y; Taylor, S; Vassar, MJ; Manley, GT				Levin, Harvey S.; Temkin, Nancy R.; Barber, Jason; Nelson, Lindsay D.; Robertson, Claudia; Brennan, Jeffrey; Stein, Murray B.; Yue, John K.; Giacino, Joseph T.; McCrea, Michael A.; Diaz-Arrastia, Ramon; Mukherjee, Pratik; Okonkwo, David O.; Boase, Kim; Markowitz, Amy J.; Bodien, Yelena; Taylor, Sabrina; Vassar, Mary J.; Manley, Geoffrey T.		TRACK-TBI Investigators	Association of Sex and Age With Mild Traumatic Brain Injury-Related Symptoms: A TRACK-TBI Study	JAMA NETWORK OPEN			English	Article								IMPORTANCE Knowledge of differences in mild traumatic brain injury (mTBI) recovery by sex and age may inform individualized treatment of these patients. OBJECTIVE To identify sex-related differences in symptom recovery from mTBI; secondarily, to explore age differences within women, who demonstrate poorer outcomes after TBI. DESIGN, SETTING, AND PARTICIPANTS The prospective cohort study Transforming Research and Clinical Knowledge in Traumatic Brain Injury (TRACK-TBI) recruited 2000 patients with mTBI from February 26, 2014, to July 3, 2018, and 299 patients with orthopedic trauma (who served as controls) from January 26, 2016, to July 27, 2018. Patients were recruited from 18 level I trauma centers and followed up for 12 months. Data were analyzed from August 19, 2020, to March 3, 2021. EXPOSURES Patients with mTBI (defined by a Glasgow Coma Scale score of 13-15) triaged to head computed tomography in 24 hours or less; patients with orthopedic trauma served as controls. MAIN OUTCOMES AND MEASURES Measured outcomes included (1) the Rivermead Post Concussion Symptoms Questionnaire (RPQ), a 16-item self-report scale that assesses postconcussion symptom severity over the past 7 days relative to preinjury; (2) the Posttraumatic Stress Disorder Checklist for the Diagnostic and Statistical Manual of Mental Disorders (Fifth Edition) (PCL-5), a 20-item test that measures the severity of posttraumatic stress disorder symptoms; (3) the Patient Health Questionnaire-9 (PHQ-9), a 9-item scale that measures depression based on symptom frequency over the past 2 weeks; and (4) the Brief Symptom Inventory-18 (BSI-18), an 18-item scale of psychological distress (split into Depression and Anxiety subscales). RESULTS A total of 2000 patients with mTBI (1331 men [67%; mean (SD) age, 41.0 (17.3) years; 1026 White (78%)] and 669 women [33%; mean (SD) age, 43.0 (18.5) years; 505 (76%) White]). After adjustment of multiple comparisons, significant TBI x sex interactions were observed for cognitive symptoms (B = 0.76; 5% false discovery rate-corrected P = .02) and somatic RPQ symptoms (B = 0.80; 5% false discovery rate-corrected P = .02), with worse symptoms in women with mTBI than men, but no sex difference in symptoms in control patients with orthopedic trauma. Within the female patients evaluated, there was a significant TBI x age interaction for somatic RPQ symptoms, which were worse in female patients with mTBI aged 35 to 49 years compared with those aged 17 to 34 years (B = 1.65; P = .02) or older than 50 years (B = 1.66; P = .02). CONCLUSIONS AND RELEVANCE This study found that women were more vulnerable than men to persistent mTBI-related cognitive and somatic symptoms, whereas no sex difference in symptom burden was seen after orthopedic injury. Postconcussion symptoms were also worse in women aged 35 to 49 years than in younger and older women, but further investigation is needed to corroborate these findings and to identify the mechanisms involved. Results suggest that individualized clinical management of mTBI should consider sex and age, as some women are especially predisposed to chronic postconcussion symptoms even 12 months after injury.	[Levin, Harvey S.; Brennan, Jeffrey] Baylor Coll Med, One Baylor Plaza,MS637, Houston, TX 77030 USA; [Levin, Harvey S.; Robertson, Claudia] Michael E DeBakey VA Med Ctr, Houston, TX USA; [Temkin, Nancy R.; Barber, Jason; Boase, Kim] Univ Washington, Dept Neurol Surg, Seattle, WA 98195 USA; [Temkin, Nancy R.] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Nelson, Lindsay D.; McCrea, Michael A.] Med Coll Wisconsin, Dept Neurosurg, Milwaukee, WI 53226 USA; [Nelson, Lindsay D.; McCrea, Michael A.] Med Coll Wisconsin, Dept Neurol, Milwaukee, WI 53226 USA; [Stein, Murray B.] Univ Calif San Diego, San Diego, CA USA; [Yue, John K.; Mukherjee, Pratik; Markowitz, Amy J.; Taylor, Sabrina; Vassar, Mary J.; Manley, Geoffrey T.] Univ Calif San Francisco, San Francisco, CA USA; [Giacino, Joseph T.; Bodien, Yelena] Spaulding Rehabil Ctr, Boston, MA USA; [Giacino, Joseph T.; Bodien, Yelena] Massachusetts Gen Hosp, Boston, MA USA; [Diaz-Arrastia, Ramon] Univ Penn, Dept Neurol, Philadelphia, PA 19104 USA; [Okonkwo, David O.] Univ Pittsburgh, Dept Neurosurg, Pittsburgh, PA USA		Levin, HS (corresponding author), Baylor Coll Med, One Baylor Plaza,MS637, Houston, TX 77030 USA.; Markowitz, AJ (corresponding author), Univ Calif San Francisco, Brain & Spinal Injury Ctr, Zuckerberg San Francisco Gen Hosp & Trauma Ctr, 1001 Potrero Ave,Bldg 1,Room 101,Box 0899, San Francisco, CA 94143 USA.	hlevin@bcm.edu; amymarkowitz@gmail.com	Giacino, Joseph/AAF-1952-2021	Giacino, Joseph/0000-0002-7916-9698; Badjatia, Neeraj/0000-0003-1509-9034; Hemphill, Claude/0000-0003-4019-7525	NINDS/TRACK-TBI [5U01NS086090-05]; NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS110856]; US Department of DefenseUnited States Department of Defense [W81XWH-14-2-0176]	This work was supported by the grant 5U01NS086090-05 from the NINDS/TRACK-TBI (Dr Manley), grant R01NS110856 from NINDS (Dr Nelson), and grant W81XWH-14-2-0176 from the US Department of Defense (Dr Manley).	Austin PC, 2011, MULTIVAR BEHAV RES, V46, P399, DOI 10.1080/00273171.2011.568786; Beltz AM, 2020, ANN NY ACAD SCI, V1464, P156, DOI 10.1111/nyas.14255; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Covassin T, 2018, INT J PSYCHOPHYSIOL, V132, P9, DOI 10.1016/j.ijpsycho.2017.09.010; Derogatis L.R., 2001, BRIEF SYMPTOM INVENT; Draper NR., 2014, WILEY STATSREF STAT, DOI [10.1002/9781118445112.stat03134, DOI 10.1002/9781118445112.STAT03134]; Gold EB, 2001, AM J EPIDEMIOL, V153, P865, DOI 10.1093/aje/153.9.865; Gupte R, 2019, J NEUROTRAUM, V36, P3063, DOI 10.1089/neu.2018.6171; Helson R, 2005, J PERS SOC PSYCHOL, V89, P194, DOI 10.1037/0022-3514.89.2.194; Kase NG, 2009, GENDER MED, V6, P37, DOI 10.1016/j.genm.2009.02.001; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; McCrory P, 2017, BRIT J SPORT MED, V51, P837, DOI 10.1136/bjsports-2017-097878; McHenry J, 2014, FRONT NEUROENDOCRIN, V35, P42, DOI 10.1016/j.yfrne.2013.09.001; Mikolic A, 2021, J NEUROTRAUM, V38, P235, DOI 10.1089/neu.2020.7228; Ouyang P, 2016, BIOL SEX DIFFER, V7, DOI 10.1186/s13293-016-0073-y; Potter S, 2006, J NEUROL, V253, P1603, DOI 10.1007/s00415-006-0275-z; Ramikie TS, 2018, BIOL PSYCHIAT, V83, P876, DOI 10.1016/j.biopsych.2017.11.016; Stein DG, 2019, NEUROPHARMACOLOGY, V147, P66, DOI 10.1016/j.neuropharm.2018.04.006; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; TEASDALE G, 1974, LANCET, V2, P81; Weathers FW, PTSD CHECKLIST DSM 5; Wilde EA, 2010, ARCH PHYS MED REHAB, V91, P1650, DOI 10.1016/j.apmr.2010.06.033; Wright DW, 2014, NEW ENGL J MED, V371, P2457, DOI 10.1056/NEJMoa1404304; Wunderle K, 2014, J HEAD TRAUMA REHAB, V29, pE1, DOI 10.1097/HTR.0000000000000006; Yue JK, 2019, NEUROL RES, V41, P609, DOI 10.1080/01616412.2019.1602312	26	7	7	4	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	2574-3805			JAMA NETW OPEN	JAMA Netw. Open	APR 6	2021	4	4							e213046	10.1001/jamanetworkopen.2021.3046			17	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	RK4SW	WOS:000638288200002	33822070	gold, Green Published			2022-02-06	
J	Howell, DR; Myer, GD; Brilliant, A; Foss, KB; Meehan, WP				Howell, David R.; Myer, Gregory D.; Brilliant, Anna; Foss, Kim Barber; Meehan, William P.			Quantitative Multimodal Assessment of Concussion Recovery in Youth Athletes	CLINICAL JOURNAL OF SPORT MEDICINE			English	Article						mild traumatic brain injury; pediatric; gait; EEG; vision	DUAL-TASK GAIT; SINGLE-TASK; ADOLESCENTS; SYMPTOMS; UTILITY; RETURN; TIME	Objective: To evaluate recovery trajectories among youth athletes with a concussion and healthy controls across different domains using a quantitative and multifaceted protocol. Study Design: Prospective repeated measures. Participants: Youth athletes diagnosed with a concussion between the ages of 8 and 18 years were evaluated (1) within 10 days after injury, (2) approximately 3 weeks after injury, and (3) after return-to-play clearance. Control participants completed the same protocol. Setting: Sport concussion clinic. Interventions: N/A. Main Outcome Measures: Participants underwent a multifaceted protocol that assessed symptoms (postconcussion symptom scale [PCSS]), dual-task gait, event-related potentials (ERPs), and eye tracking. Results: Sixty-seven athletes participated: 36 after concussion (age = 14.0 +/- 2.6 years; 44% female) and 31 controls (age = 14.6 +/- 2.2 years; 39% female). Concussion symptoms were higher for the concussion group compared with controls at the first (PCSS = 31.7 +/- 18.8 vs 1.9 +/- 2.9; P < 0.001) and second time points (PCSS = 10.8 +/- 11.2 vs 1.8 +/- 3.6; P = 0.001) but resolved by the final assessment (PCSS = 1.7 +/- 3.6 vs 2.0 +/- 3.8; P = 0.46). The concussion group walked slower during dual-task gait than controls at all 3 tests including after return-to-play clearance (0.83 +/- 0.19 vs 0.95 +/- 0.15 m/s; P = 0.049). There were no between-group differences for ERP connectivity or eye tracking. Those with concussions had a decrease in ERP connectivity recovery over the 3 time points, whereas control participants' scores increased (concussion Delta = -8.7 +/- 28.0; control Delta = 13.9 +/- 32.2; chi(2) = 14.1, P = 0.001). Conclusions: Concussion is associated with altered dual-task gait speeds after resolution of concussion symptoms, but ERP and eye tracking measures did not demonstrate between-group differences across time. Some objective approaches to concussion monitoring may support with identifying deficits after concussion, but further work is required to delineate the role of gait, electrophysiological, and eye tracking methods for clinical decision-making.	[Howell, David R.] Childrens Hosp Colorado, Sports Med Ctr, Aurora, CO USA; [Howell, David R.] Univ Colorado, Sch Med, Dept Orthoped, Aurora, CO USA; [Howell, David R.; Brilliant, Anna; Meehan, William P.] Micheli Ctr Sports Injury Prevent, Waltham, MA USA; [Myer, Gregory D.; Foss, Kim Barber] Cincinnati Childrens Hosp Med Ctr, SPORT Ctr, Div Sports Med, Cincinnati, OH 45229 USA; [Brilliant, Anna; Meehan, William P.] Boston Childrens Hosp, Div Sports Med, Boston, MA USA; [Meehan, William P.] Harvard Med Sch, Dept Orthopaed Surg, Boston, MA 02115 USA; [Meehan, William P.] Harvard Med Sch, Dept Pediat, Boston, MA 02115 USA		Howell, DR (corresponding author), Univ Colorado, Sch Med, Childrens Hosp Colorado, Sports Med Ctr,Dept Orthoped, 13123 E 16th Ave,B060, Aurora, CO 80045 USA.	David.Howell@ucdenver.edu			ElMindA, Ltd	The authors acknowledge the support of ElMindA, Ltd, for providing the EEG equipment and supportive analyses, and Oculogica, Inc, for providing the eye tracking equipment.	Baugh CM, 2016, AM J SPORT MED, V44, P1391, DOI 10.1177/0363546516635639; Berkner J, 2017, J ATHL TRAINING, V52, P1089, DOI 10.4085/1062-6050-52.11.23; Broglio SP, 2018, SPORTS MED, V48, P1255, DOI 10.1007/s40279-017-0813-0; Broglio SP, 2015, CLIN SPORT MED, V34, P213, DOI 10.1016/j.csm.2014.12.005; Broglio SP, 2011, INT J PSYCHOPHYSIOL, V82, P16, DOI 10.1016/j.ijpsycho.2011.02.010; Fino PC, 2018, GAIT POSTURE, V62, P157, DOI 10.1016/j.gaitpost.2018.03.021; Fitzmaurice GM, 2008, CIRCULATION, V118, P2005, DOI 10.1161/CIRCULATIONAHA.107.714618; Guy Jeffrey A, 2016, Prim Care Companion CNS Disord, V18, DOI 10.4088/PCC.16m01937; Howel DR, 2017, J APPL BIOMECH, V33, P24, DOI 10.1123/jab.2015-0323; Howell DR, 2018, J NEUROTRAUM, V35, P1630, DOI 10.1089/neu.2017.5570; Howell DR, 2020, CLIN J SPORT MED, V30, P444, DOI 10.1097/JSM.0000000000000630; Howell DR, 2018, ARCH PHYS MED REHAB, V99, P1318, DOI 10.1016/j.apmr.2018.01.025; Howell DR, 2018, J SCI MED SPORT, V21, P358, DOI 10.1016/j.jsams.2017.08.004; Howell DR, 2016, GAIT POSTURE, V49, P176, DOI 10.1016/j.gaitpost.2016.07.008; Howell DR, 2016, ACTA PAEDIATR, V105, pE426, DOI 10.1111/apa.13486; Howell DR, 2015, MED SCI SPORT EXER, V47, P673, DOI 10.1249/MSS.0000000000000462; Howell DR, 2014, EXP BRAIN RES, V232, P1773, DOI 10.1007/s00221-014-3869-1; Kamins J, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097464; Kerr ZY, 2016, JAMA PEDIATR, V170, P647, DOI 10.1001/jamapediatrics.2016.0073; Kiefer AW, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00243; Kontos AP, 2016, BRAIN IMAGING BEHAV, V10, P594, DOI 10.1007/s11682-015-9412-6; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; Master CL, 2016, CLIN PEDIATR, V55, P260, DOI 10.1177/0009922815594367; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Mott M., 2015, CONCUSSION, V1, pCNC10; Read PJ, 2016, SPORTS MED, V46, P1059, DOI 10.1007/s40279-016-0479-z; Reches A, 2017, BRAIN INJURY, V31, P237, DOI 10.1080/02699052.2016.1231343; Samadani Uzma, 2016, Concussion, V1, pCNC3, DOI 10.2217/cnc.15.3; Samadani U, 2015, NEURAL REGEN RES, V10, P1231, DOI 10.4103/1673-5374.162752; Samadani U, 2015, J NEUROTRAUM, V32, P548, DOI 10.1089/neu.2014.3687; Stache S, 2016, CLIN J SPORT MED, V26, P381, DOI 10.1097/JSM.0000000000000270; Teel EF, 2014, CLIN NEUROPHYSIOL, V125, P703, DOI 10.1016/j.clinph.2013.08.027	32	7	7	2	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1050-642X	1536-3724		CLIN J SPORT MED	Clin. J. Sport Med.	MAR	2021	31	2					133	138		10.1097/JSM.0000000000000722			6	Orthopedics; Physiology; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Physiology; Sport Sciences	SL0TF	WOS:000656628200011	30762699				2022-02-06	
J	Nagakannan, P; Islam, MI; Conrad, M; Eftekharpour, E				Nagakannan, Pandian; Islam, Md Imamul; Conrad, Marcus; Eftekharpour, Eftekhar			Cathepsin B is an executioner of ferroptosis	BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH			English	Article						Lysosomes; Autophagy; Lipid peroxidation; Glutathione; GPX4; Histone H3	DEPENDENT ANION CHANNEL; AUTOPHAGIC CELL-DEATH; HISTONE H3; LIPID-PEROXIDATION; OXIDATIVE STRESS; LYSOSOMES; AIF; DEGRADATION; GLUTATHIONE; PROTEASOME	Ferroptosis is a necrotic form of cell death caused by inactivation of the glutathione system and uncontrolled iron-mediated lipid peroxidation. Increasing evidence implicates ferroptosis in a wide range of diseases from neurotrauma to cancer, highlighting the importance of identifying an executioner system that can be exploited for clinical applications. In this study, using pharmacological and genetic models of ferroptosis, we observed that lysosomal membrane permeabilization and cytoplasmic leakage of cathepsin B unleashes structural and functional changes in mitochondria and promotes a not previously reported cleavage of histone H3. Inhibition of cathepsin-B robustly rescued cellular membrane integrity and chromatin degradation. We show that these protective effects are independent of glutathione peroxidase-4 and are mediated by preventing lysosomal membrane damage. This was further confirmed when cathepsin B knockout primary fibroblasts remained unaffected in response to various ferroptosis inducers. Our work identifies new and yet-unrecognized aspects of ferroptosis and identifies cathepsin B as a mediator of ferroptotic cell death.	[Nagakannan, Pandian; Islam, Md Imamul; Eftekharpour, Eftekhar] Univ Manitoba, Regenerat Med Program, Dept Physiol & Pathophysiol, Winnipeg, MB, Canada; [Nagakannan, Pandian; Islam, Md Imamul; Eftekharpour, Eftekhar] Univ Manitoba, Spinal Cord Res Ctr, Winnipeg, MB, Canada; [Conrad, Marcus] Helmholtz Zentrum Munchen, Inst Metab & Cell Death, Neuherberg, Germany		Eftekharpour, E (corresponding author), 631 BMSB,745 Bannatyne Ave, Winnipeg, MB R3E 0J9, Canada.	eftekhar@umanitoba.ca	Conrad, Marcus/E-8792-2015	Conrad, Marcus/0000-0003-1140-5612	Wings for Life foundation, Austria; Will-to-Win foundation	Funding was provided by Wings for Life foundation, Austria to EE. PN was supported by a doctoral studentship from Will-to-Win foundation.	Abrahamson M, 2003, BIOCHEM SOC SYMP, V70, P179, DOI 10.1042/bss0700179; Angeli J.P. Friedmann, NATURE CELL BIOL, V16, P1180; Appelqvist H, 2013, J MOL CELL BIOL, V5, P214, DOI 10.1093/jmcb/mjt022; Arbel N, 2012, J BIOL CHEM, V287, P23152, DOI 10.1074/jbc.M112.345918; Baxter PS, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7761; Bersuker K, 2019, NATURE, V575, P688, DOI 10.1038/s41586-019-1705-2; Bidere N, 2003, J BIOL CHEM, V278, P31401, DOI 10.1074/jbc.M301911200; BLOIS MS, 1958, NATURE, V181, P1199, DOI 10.1038/1811199a0; Brahimi-Horn MC, 2015, CANCER METAB, V3, DOI 10.1186/s40170-015-0133-5; Brahimi-Horn MC, 2015, MOL CELL BIOL, V35, P1491, DOI 10.1128/MCB.01402-14; Brown CW, 2017, J CELL BIOL, V216, P4287, DOI 10.1083/jcb.201701136; Cai YJ, 2017, CHEM SCI, V8, P7593, DOI 10.1039/c7sc03515b; Circu ML, 2012, BBA-MOL CELL RES, V1823, P1767, DOI 10.1016/j.bbamcr.2012.06.019; Cohen-Kaplan V, 2016, INT J BIOCHEM CELL B, V79, P403, DOI 10.1016/j.biocel.2016.07.019; Cong L, 2019, EUR J MED CHEM, V166, P11, DOI 10.1016/j.ejmech.2019.01.039; Conrad M, 2019, NAT CHEM BIOL, V15, P1137, DOI 10.1038/s41589-019-0408-1; Conrad M, 2018, GENE DEV, V32, P602, DOI 10.1101/gad.314674.118; Conrad M, 2016, NAT REV DRUG DISCOV, V15, P348, DOI 10.1038/nrd.2015.6; Derry PJ, 2020, PROG NEUROBIOL, V184, DOI 10.1016/j.pneurobio.2019.101716; Dixon SJ, 2012, CELL, V149, P1060, DOI 10.1016/j.cell.2012.03.042; Doll S, 2019, NATURE, V575, P693, DOI 10.1038/s41586-019-1707-0; Duarte LF, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6210; Duncan EM, 2008, CELL, V135, P284, DOI 10.1016/j.cell.2008.09.055; Eaton JK, 2020, NAT CHEM BIOL, V16, P497, DOI 10.1038/s41589-020-0501-5; Fang XX, 2019, P NATL ACAD SCI USA, V116, P2672, DOI 10.1073/pnas.1821022116; Feng HZ, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.2006203; Feng YC, 2014, CELL RES, V24, P24, DOI 10.1038/cr.2013.168; Forcina GC, 2019, PROTEOMICS, V19, DOI 10.1002/pmic.201800311; Fukui M, 2009, EUR J PHARMACOL, V617, P1, DOI 10.1016/j.ejphar.2009.06.059; Gao H, 2018, BIOCHEM BIOPH RES CO, V503, P1550, DOI 10.1016/j.bbrc.2018.07.078; Gao MH, 2019, MOL CELL, V73, P354, DOI 10.1016/j.molcel.2018.10.042; Gao MH, 2016, CELL RES, V26, P1021, DOI 10.1038/cr.2016.95; Gaschler MM, 2018, ACS CHEM BIOL, V13, P1013, DOI 10.1021/acschembio.8b00199; Gaschler MM, 2017, BIOCHEM BIOPH RES CO, V482, P419, DOI 10.1016/j.bbrc.2016.10.086; Girotti AW, 1998, J LIPID RES, V39, P1529; Guan XY, 2019, LIFE SCI, V235, DOI 10.1016/j.lfs.2019.116795; Hao SH, 2017, NEOPLASIA, V19, P1022, DOI 10.1016/j.neo.2017.10.005; Hillmer EJ, 2016, CYTOKINE GROWTH F R, V31, P1, DOI 10.1016/j.cytogfr.2016.05.001; Hirata Y, 2011, J NEUROCHEM, V119, P839, DOI 10.1111/j.1471-4159.2011.07464.x; Holland P, 2014, TRAFFIC, V15, P1390, DOI 10.1111/tra.12227; Hook G, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00178; Islam MI, 2019, FREE RADICAL BIO MED, V134, P567, DOI 10.1016/j.freeradbiomed.2019.02.010; Jacobson LS, 2013, J BIOL CHEM, V288, P7481, DOI 10.1074/jbc.M112.400655; Johnston PA, 2011, MOL INTERV, V11, P18, DOI 10.1124/mi.11.1.4; Jung M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116972; Jung T, 2014, REDOX BIOL, V2, P99, DOI 10.1016/j.redox.2013.12.008; Katsnelson MA, 2016, AM J PHYSIOL-CELL PH, V311, pC83, DOI 10.1152/ajpcell.00298.2015; Kaur G, 2010, AM J PATHOL, V177, P2256, DOI 10.2353/ajpath.2010.100461; Kaushik S, 2011, J CELL SCI, V124, P495, DOI 10.1242/jcs.073874; Kavcic N, 2017, BIOL CHEM, V398, P289, DOI 10.1515/hsz-2016-0252; Keinan N, 2010, MOL CELL BIOL, V30, P5698, DOI 10.1128/MCB.00165-10; Khalkhali-Ellis Z, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103230; Kim K, 2016, GENE DEV, V30, P208, DOI 10.1101/gad.268714.115; Kimura S, 2007, AUTOPHAGY, V3, P452, DOI 10.4161/auto.4451; Kroemer G, 2008, NAT REV MOL CELL BIO, V9, P1004, DOI 10.1038/nrm2529; Kubota C, 2010, J BIOL CHEM, V285, P667, DOI 10.1074/jbc.M109.053058; Kurz T, 2011, INT J BIOCHEM CELL B, V43, P1686, DOI 10.1016/j.biocel.2011.08.016; Landshamer S, 2008, CELL DEATH DIFFER, V15, P1553, DOI 10.1038/cdd.2008.78; Maiorino M, 2003, J BIOL CHEM, V278, P34286, DOI 10.1074/jbc.M305327200; Mandal P, 2012, BIOCHEM BIOPH RES CO, V421, P261, DOI 10.1016/j.bbrc.2012.03.149; Mazure NM, 2016, FRONT ONCOL, V6, DOI 10.3389/fonc.2016.00193; Mrschtik M, 2015, FEBS J, V282, P1858, DOI 10.1111/febs.13253; Nagakannan P, 2019, CELL MOL NEUROBIOL, V39, P73, DOI 10.1007/s10571-018-0634-1; Nagakannan P, 2017, FREE RADICAL BIO MED, V108, P819, DOI 10.1016/j.freeradbiomed.2017.05.005; Nagakannan P, 2016, FREE RADICAL BIO MED, V101, P53, DOI 10.1016/j.freeradbiomed.2016.09.026; Neitemeier S, 2017, REDOX BIOL, V12, P558, DOI 10.1016/j.redox.2017.03.007; Ono K, 2003, MOL CELL BIOL, V23, P665, DOI 10.1128/MCB.23.2.665-676.2003; Pandian N, 2017, FREE RADICAL BIO MED, V112, P76, DOI 10.1016/j.freeradbiomed.2017.10.111; Patlevic P, 2016, INTEGR MED RES, V5, P250, DOI 10.1016/j.imr.2016.07.004; PORTER NA, 1995, LIPIDS, V30, P277, DOI 10.1007/BF02536034; Reinheckel T, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00133; Reiser J, 2010, J CLIN INVEST, V120, P3421, DOI 10.1172/JCI42918; Rodriguez-Franco EJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036571; Sanderson TH, 2015, MOL CELL NEUROSCI, V64, P116, DOI 10.1016/j.mcn.2014.12.007; Sandilands E, 2012, NAT CELL BIOL, V14, P51, DOI 10.1038/ncb2386; Seiler A, 2008, CELL METAB, V8, P237, DOI 10.1016/j.cmet.2008.07.005; Shen J, 2017, EMBO REP, V18, P2131, DOI 10.15252/embr.201743892; Shimada K, 2016, NAT CHEM BIOL, V12, P497, DOI [10.1038/NCHEMBIO.2079, 10.1038/nchembio.2079]; Shimizu S, 2000, P NATL ACAD SCI USA, V97, P3100, DOI 10.1073/pnas.97.7.3100; Shoshan-Barmatz V, 2010, BBA-BIOENERGETICS, V1797, P1281, DOI 10.1016/j.bbabio.2010.03.003; Stahl S, 2007, BBA-PROTEINS PROTEOM, V1774, P1237, DOI 10.1016/j.bbapap.2007.07.004; Torii S, 2016, BIOCHEM J, V473, P769, DOI 10.1042/BJ20150658; Tramer F, 2002, INT J ANDROL, V25, P72, DOI 10.1046/j.1365-2605.2002.00327.x; van Leyen K, 2005, J NEUROCHEM, V92, P824, DOI 10.1111/j.1471-4159.2004.02915.x; Voronina SG, 2004, J BIOL CHEM, V279, P27327, DOI 10.1074/jbc.M311698200; Vossaert L, 2014, STEM CELL RES, V13, P123, DOI 10.1016/j.scr.2014.05.002; Walkley SU, 2009, BBA-MOL CELL RES, V1793, P726, DOI 10.1016/j.bbamcr.2008.11.014; Wang FJ, 2018, TRAFFIC, V19, P918, DOI 10.1111/tra.12613; Wang YS, 2020, FEBS OPEN BIO, V10, P637, DOI 10.1002/2211-5463.12823; Williamson K. S., 2003, METHOD PHARMACOL TOX, P57; Wu ZM, 2019, P NATL ACAD SCI USA, V116, P2996, DOI 10.1073/pnas.1819728116; Xu HX, 2015, ANNU REV PHYSIOL, V77, P57, DOI 10.1146/annurev-physiol-021014-071649; Yagoda N, 2007, NATURE, V447, P864, DOI 10.1038/nature05859; Yang WS, 2014, CELL, V156, P317, DOI 10.1016/j.cell.2013.12.010; Yao X, 2019, NEURAL REGEN RES, V14, P532, DOI 10.4103/1673-5374.245480; Yi SJ, 2018, BMB REP, V51, P211, DOI 10.5483/BMBRep.2018.51.5.053; Zhang YH, 2003, J GEN VIROL, V84, P2279, DOI 10.1099/vir.0.19153-0; Zilka O, 2017, ACS CENTRAL SCI, V3, P232, DOI 10.1021/acscentsci.7b00028	98	7	7	5	27	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0167-4889	1879-2596		BBA-MOL CELL RES	Biochim. Biophys. Acta-Mol. Cell Res.	MAR	2021	1868	3							118928	10.1016/j.bbamcr.2020.118928			21	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	PT5VX	WOS:000608683900009	33340545				2022-02-06	
J	Chen, YH; Li, Y; Guo, LM; Hong, J; Zhao, WJ; Hu, XM; Chang, CC; Liu, W; Xiong, K				Chen, Yuhua; Li, Yan; Guo, Limin; Hong, Jun; Zhao, Wenjuan; Hu, Ximin; Chang, Cuicui; Liu, Wei; Xiong, Kun			Bibliometric Analysis of the Inflammasome and Pyroptosis in Brain	FRONTIERS IN PHARMACOLOGY			English	Article						bibliometric analysis; pyroptosis; inflammasome; brain; web of science		Background: Considering the pivotal role of inflammasome/pyroptosis in biological function, we visually analyzed the research hotspots of inflammasome/pyroptosis related to the brain in this work through the method of bibliometrics from the Web of Science (WOS) Core database over the past two decades. Methods: Documents were retrieved from WOS Core Collection on October 16, 2020. The search terms and strategies used for the WOS database are as follow: # 1, "pyroptosis"; # 2, "pyroptotic"; # 3, "inflammasome"; # 4, "pyroptosome"; # 5 "brain"; # 6, "# 1" OR "# 2" OR "# 3" OR "# 4"; # 7, "# 5" AND "# 6". We selected articles and reviews published in English from 2000 to 2020. Visualization analysis and statistical analysis were performed by VOSviewer 1.6.15 and CiteSpace 5.7. R2. Results: 1,222 documents were selected for analysis. In the approximately 20 years since the pyroptosis was first presented, the publications regarding the inflammasome and pyroptosis in brain were presented since 2005. The number of annual publications increased gradually over a decade, which are involved in this work, and will continue to increase in 2020. The most prolific country was China with 523 documents but the United States was with 16,328 citations. The most influential author was Juan Pablo de Rivero Vaccari with 27 documents who worked at the University of Miami. The bibliometric analysis showed that inflammasome/pyroptosis involved a variety of brain cell types (microglia, astrocyte, neuron, etc.), physiological processes, ER stress, mitochondrial function, oxidative stress, and disease (traumatic brain injuries, stroke, Alzheimer's disease, and Parkinson's disease). Conclusion: The research of inflammasome/pyroptosis in brain will continue to be the hotspot. We recommend investigating the mechanism of mitochondrial molecules involved in the complex crosstalk of pyroptosis and regulated cell deaths (RCDs) in brain glial cells, which will facilitate the development of effective therapeutic strategies targeting inflammasome/pyroptosis and large-scale clinical trials. Thus, this study presents the trend and characteristic of inflammasome/pyroptosis in brain, which provided a helpful bibliometric analysis for researchers to further studies.	[Chen, Yuhua; Chang, Cuicui] Xian Peihua Univ, Cent Lab Med Sch, Xian, Peoples R China; [Chen, Yuhua; Guo, Limin; Hong, Jun; Zhao, Wenjuan; Xiong, Kun] Cent South Univ, Sch Basic Med Sci, Dept Anat & Neurobiol, Changsha, Peoples R China; [Chen, Yuhua; Liu, Wei] Xiamen Univ, Dept Neurosurg, Affiliated Hosp 1, Xiamen, Peoples R China; [Li, Yan] Xinjiang Med Univ, Sch Basic Med Sci, Dept Histol & Embryol, Urumqi, Peoples R China; [Hu, Ximin] Cent South Univ, Xiangya Sch Med, Clin Med Eight Year Program, 02 Class,17 Grade, Changsha, Peoples R China; [Xiong, Kun] Hunan Key Lab Ophthalmol, Changsha, Peoples R China		Xiong, K (corresponding author), Cent South Univ, Sch Basic Med Sci, Dept Anat & Neurobiol, Changsha, Peoples R China.; Liu, W (corresponding author), Xiamen Univ, Dept Neurosurg, Affiliated Hosp 1, Xiamen, Peoples R China.; Xiong, K (corresponding author), Hunan Key Lab Ophthalmol, Changsha, Peoples R China.	vincelau@sina.com; xiongkun2001@163.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81772134, 81971891, 81901270, 82072229]; Key Research and Development Program of Hunan Province [2018SK2091]; Wu Jie-Ping Medical Foundation of the Minister of Health of China [320.6750.14118]	This study was supported by the National Natural Science Foundation of China (nos. 81772134, 81971891, 81901270, and 82072229), Key Research and Development Program of Hunan Province (2018SK2091), and Wu Jie-Ping Medical Foundation of the Minister of Health of China (no. 320.6750.14118).	Abulafia DP, 2009, J CEREBR BLOOD F MET, V29, P534, DOI 10.1038/jcbfm.2008.143; Adamczak S, 2012, J NEUROSURG, V117, P1119, DOI 10.3171/2012.9.JNS12815; Adamczak SE, 2014, J CEREBR BLOOD F MET, V34, P621, DOI 10.1038/jcbfm.2013.236; Alfonso-Loeches S, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00216; Alimov I, 2019, J BIOL CHEM, V294, P3359, DOI 10.1074/jbc.RA118.005103; Back M, 2019, NAT REV CARDIOL, V16, P389, DOI 10.1038/s41569-019-0169-2; Bassett DS, 2020, NAT REV NEUROSCI, V21, P524, DOI 10.1038/s41583-020-0363-6; Broz P, 2020, NAT REV IMMUNOL, V20, P143, DOI 10.1038/s41577-019-0228-2; Broz P, 2016, NAT REV IMMUNOL, V16, P407, DOI 10.1038/nri.2016.58; Chen KW, 2019, EMBO J, V38, DOI 10.15252/embj.2019101638; Chen XL, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-2157-1; Chen YH, 2019, FRONT MOL NEUROSCI, V12, DOI 10.3389/fnmol.2019.00202; Chen YH, 2019, BRAIN RES, V1710, P163, DOI 10.1016/j.brainres.2019.01.005; Codolo G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055375; Coll RC, 2019, NAT CHEM BIOL, V15, P556, DOI 10.1038/s41589-019-0277-7; Coll RC, 2015, NAT MED, V21, P248, DOI 10.1038/nm.3806; Cookson BT, 2001, TRENDS MICROBIOL, V9, P113, DOI 10.1016/S0966-842X(00)01936-3; Cribbs DH, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-179; Dai JZ, 2019, FRONT PHARMACOL, V10, DOI 10.3389/fphar.2019.01292; Dempsey C, 2017, BRAIN BEHAV IMMUN, V61, P306, DOI 10.1016/j.bbi.2016.12.014; Duan YH, 2020, NEURAL REGEN RES, V15, P1249, DOI 10.4103/1673-5374.272576; Dumas A, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004150; Ebrahimi T, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1319-x; Fan J, 2017, ADV NEUROBIOL, V15, P403, DOI 10.1007/978-3-319-57193-5_16; Fann DYW, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.326; Flores J, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06449-x; Frank D, 2019, CELL DEATH DIFFER, V26, P99, DOI 10.1038/s41418-018-0212-6; Freeman L, 2017, J EXP MED, V214, P1351, DOI 10.1084/jem.20150237; Freeman LC, 2016, J NEUROCHEM, V136, P29, DOI 10.1111/jnc.13217; Fu Q, 2019, INFLAMMATION, V42, P306, DOI 10.1007/s10753-018-0894-4; Galluzzi L, 2018, CELL DEATH DIFFER, V25, P486, DOI 10.1038/s41418-017-0012-4; Glinsky GV, 2008, CELL CYCLE, V7, P3564, DOI 10.4161/cc.7.22.7073; Guo HT, 2019, LIFE SCI, V223, P69, DOI 10.1016/j.lfs.2019.02.060; Gustin A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130624; Halle A, 2008, NAT IMMUNOL, V9, P857, DOI 10.1038/ni.1636; Hanamsagar R, 2014, J NEUROCHEM, V129, P704, DOI 10.1111/jnc.12669; Hauff K, 2005, ARCH IMMUNOL THER EX, V53, P308; Heneka MT, 2018, NAT REV NEUROSCI, V19, P610, DOI 10.1038/s41583-018-0055-7; Heneka MT, 2014, NAT REV IMMUNOL, V14, P463, DOI 10.1038/nri3705; Heneka MT, 2013, NATURE, V493, P674, DOI 10.1038/nature11729; Irrera N, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21176204; Ising C, 2019, NATURE, V575, P669, DOI 10.1038/s41586-019-1769-z; Israelov H, 2020, J NEUROINFLAMM, V17, DOI 10.1186/s12974-020-01927-w; Iwata M, 2013, BRAIN BEHAV IMMUN, V31, P105, DOI 10.1016/j.bbi.2012.12.008; Jabir MS, 2015, AUTOPHAGY, V11, P166, DOI 10.4161/15548627.2014.981915; Jia X, 2020, J HAZARD MATER, V399, DOI 10.1016/j.jhazmat.2020.123034; Jiao JH, 2020, FRONT MOL BIOSCI, V7, DOI 10.3389/fmolb.2020.00037; Jo EK, 2016, CELL MOL IMMUNOL, V13, P148, DOI 10.1038/cmi.2015.95; Johnson DC, 2018, NAT MED, V24, P1151, DOI 10.1038/s41591-018-0082-y; Jorgensen I, 2017, NAT REV IMMUNOL, V17, P151, DOI 10.1038/nri.2016.147; Kayagaki N, 2015, NATURE, V526, P666, DOI 10.1038/nature15541; Keane RW, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00135; Kelley N, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20133328; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; Kerr N, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0210128; Kerr N, 2018, FRONT MOL NEUROSCI, V11, DOI 10.3389/fnmol.2018.00309; Kolb JP, 2017, TRENDS IMMUNOL, V38, P705, DOI 10.1016/j.it.2017.06.009; Latz E, 2013, NAT REV IMMUNOL, V13, P397, DOI 10.1038/nri3452; Lee JS, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19113289; Lee SW, 2019, J NEUROINFLAMM, V16, DOI 10.1186/s12974-019-1423-6; Li SF, 2020, CELL REP, V30, P4370, DOI 10.1016/j.celrep.2020.02.105; Li XJ, 2018, ACTA BIOCH BIOPH SIN, V50, P888, DOI 10.1093/abbs/gmy088; Liu W, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1083-y; Lu YY, 2019, CURR MED SCI, V39, P899, DOI 10.1007/s11596-019-2121-4; Man SM, 2017, IMMUNOL REV, V277, P61, DOI 10.1111/imr.12534; Man SM, 2015, IMMUNOL REV, V265, P6, DOI 10.1111/imr.12296; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; McKenzie BA, 2018, P NATL ACAD SCI USA, V115, pE6065, DOI 10.1073/pnas.1722041115; Miller AH, 2016, NAT REV IMMUNOL, V16, P22, DOI 10.1038/nri.2015.5; Mitchell PS, 2019, CURR OPIN IMMUNOL, V60, P37, DOI 10.1016/j.coi.2019.04.015; O'Brien WT, 2020, J NEUROINFLAMM, V17, DOI 10.1186/s12974-020-01778-5; Paldino E, 2020, CELL DEATH DISCOV, V6, DOI 10.1038/s41420-020-00293-z; Pan T, 2020, NEURAL REGEN RES, V15, P2154, DOI 10.4103/1673-5374.282271; Paunkov A, 2019, ANTIOXIDANTS-BASEL, V8, DOI 10.3390/antiox8090353; Perez-Barcena J, 2021, J NEUROSURG, V134, P1644, DOI 10.3171/2020.2.JNS193079; Poh L, 2019, BRAIN BEHAV IMMUN, V75, P34, DOI 10.1016/j.bbi.2018.09.001; Rathinam VAK, 2016, CELL, V165, P792, DOI 10.1016/j.cell.2016.03.046; Ren PP, 2020, J AM HEART ASSOC, V9, DOI 10.1161/JAHA.119.014044; Rogers C, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09397-2; Rogers C, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14128; Ruan ZH, 2019, CURR MED SCI, V39, P513, DOI 10.1007/s11596-019-2067-6; Salminen A, 2009, PROG NEUROBIOL, V87, P181, DOI 10.1016/j.pneurobio.2009.01.001; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Schuh E, 2019, CLIN IMMUNOL, V203, P45, DOI 10.1016/j.clim.2019.04.004; Shi JJ, 2017, TRENDS BIOCHEM SCI, V42, P245, DOI 10.1016/j.tibs.2016.10.004; Shimada K, 2012, IMMUNITY, V36, P401, DOI 10.1016/j.immuni.2012.01.009; Soulika AM, 2009, J NEUROSCI, V29, P14965, DOI 10.1523/JNEUROSCI.3794-09.2009; Strowig T, 2012, NATURE, V481, P278, DOI 10.1038/nature10759; Swanson KV, 2019, NAT REV IMMUNOL, V19, P477, DOI 10.1038/s41577-019-0165-0; Taabazuing CY, 2017, CELL CHEM BIOL, V24, P507, DOI 10.1016/j.chembiol.2017.03.009; Tang DL, 2019, CELL RES, V29, P347, DOI 10.1038/s41422-019-0164-5; Tapia-Abelian A, 2019, NAT CHEM BIOL, V15, P560, DOI 10.1038/s41589-019-0278-6; Vaccari JPDR, 2008, J NEUROSCI, V28, P3404, DOI 10.1523/JNEUROSCI.0157-08.2008; Vaccari JPD, 2012, J NEUROSCI, V32, P3058, DOI 10.1523/JNEUROSCI.4930-11.2012; Vaccari JPD, 2009, J CEREBR BLOOD F MET, V29, P1251, DOI 10.1038/jcbfm.2009.46; Van Opdenbosch N, 2019, IMMUNITY, V50, P1352, DOI 10.1016/j.immuni.2019.05.020; Vande Walle L, 2016, CURR BIOL, V26, pR568, DOI 10.1016/j.cub.2016.02.019; Venegas C, 2017, NATURE, V552, P355, DOI 10.1038/nature25158; Voet S, 2019, EMBO MOL MED, V11, DOI 10.15252/emmm.201810248; Wallisch JS, 2017, NEUROCRIT CARE, V27, P44, DOI 10.1007/s12028-017-0378-7; Walsh JG, 2014, NAT REV NEUROSCI, V15, P84, DOI 10.1038/nrn3638; Wang K, 2020, CELL, V180, P941, DOI 10.1016/j.cell.2020.02.002; Wang M, 2020, J ANAT, V237, P29, DOI 10.1111/joa.13185; Wang YP, 2017, NATURE, V547, P99, DOI 10.1038/nature22393; Wiegman CH, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.01957; Xu KY, 2020, TRANSPLANTATION, V104, pE151, DOI 10.1097/TP.0000000000003208; Xu XE, 2019, BRAIN BEHAV IMMUN, V80, P859, DOI 10.1016/j.bbi.2019.05.038; Yan YQ, 2020, NEUROSCIENCE, V446, P323, DOI 10.1016/j.neuroscience.2020.08.004; Yang F, 2014, J CEREBR BLOOD F MET, V34, P660, DOI 10.1038/jcbfm.2013.242; Youm YH, 2013, CELL METAB, V18, P519, DOI 10.1016/j.cmet.2013.09.010; Yuan JY, 2016, CELL, V167, P1693, DOI 10.1016/j.cell.2016.11.047; Zeng ZL, 2019, CELL PROLIFERAT, V52, DOI 10.1111/cpr.12563; Zheng XB, 2020, LIFE SCI, V242, DOI 10.1016/j.lfs.2019.117186; Zhong ZY, 2018, NATURE, V560, P198, DOI 10.1038/s41586-018-0372-z; Zhou RB, 2011, NATURE, V469, P221, DOI 10.1038/nature09663	115	7	7	19	25	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND		1663-9812		FRONT PHARMACOL	Front. Pharmacol.	JAN 20	2021	11								626502	10.3389/fphar.2020.626502			15	Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	QB1PT	WOS:000613916000001	33551822	gold, Green Published			2022-02-06	
J	Agostini, M; Amato, F; Vieri, ML; Greco, G; Tonazzini, I; Baroncelli, L; Caleo, M; Vannini, E; Santi, M; Signore, G; Cecchini, M				Agostini, M.; Amato, F.; Vieri, M. L.; Greco, G.; Tonazzini, I.; Baroncelli, L.; Caleo, M.; Vannini, E.; Santi, M.; Signore, G.; Cecchini, M.			Glial-fibrillary-acidic-protein (GFAP) biomarker detection in serum-matrix: Functionalization strategies and detection by an ultra-high-frequency surface-acoustic-wave (UHF-SAW) lab-on-chip	BIOSENSORS & BIOELECTRONICS			English	Article						Biosensor; Lab-on-chip; Quartz crystal microbalance (QCM); Surface acoustic wave (SAW); Glial fibrillary acidic protein (GFAP); Brain damage; Point of care	TRAUMATIC BRAIN-INJURY; DIAGNOSTIC MARKER; ACOUSTOFLUIDICS; MANIPULATION	Glial-fibrillary-acidic-protein (GFAP) has recently drawn significant attention from the clinical environment as a promising biomarker. The pathologies which can be linked to the presence of GFAP in blood severely affect the human central nervous system. These pathologies are glioblastoma multiforme (GBM), traumatic brain injuries (TBIs), multiple sclerosis (MS), intracerebral hemorrhage (ICH), and neuromyelitis optica (NMO). Here, we develop three different detection strategies for GFAP, among the most popular in the biosensing field and never examined side by side within the experimental frame. We compare their capability of detecting GFAP in a clean buffer and serum-matrix by using gold-coated quartz-crystal-microbalance (QCM) sensors. All the three detection strategies are based on antibodies, and each of them focuses on a key aspect of the biosensing process. The first is based on a polyethylene glycol (PEG) chain for antifouling, the second on a protein-G linker for controlling antibody-orientation, and the third on antibody-splitting and direct surface immobilization for high-surface coverage. Then, we select the best-performing protocol and validate its detection performance with an ultrahigh-frequency (UHF) surface-acoustic-wave (SAW) based lab-on-chip (LoC). GFAP successful detection is demonstrated in a clean-buffer and serum-matrix at a concentration of 35 pM. This GFAP level is compatible with clinical diagnostics. This result suggests the use of our technology for the realization of a point-of-care biosensing platform for the detection of multiple brain-pathology biomarkers.	[Agostini, M.; Amato, F.; Vieri, M. L.; Greco, G.; Tonazzini, I.; Santi, M.; Signore, G.; Cecchini, M.] Ist Nanosci CNR, NEST, Piazza San Silvestro 12, I-56127 Pisa, Italy; [Agostini, M.; Amato, F.; Vieri, M. L.; Greco, G.; Tonazzini, I.; Santi, M.; Signore, G.; Cecchini, M.] Scuola Normale Super Pisa, Piazza San Silvestro 12, I-56127 Pisa, Italy; [Agostini, M.; Cecchini, M.] INTA Srl, Intelligent Acoust Syst, Via Nino Pisano 14, I-56122 Pisa, Italy; [Baroncelli, L.; Caleo, M.; Vannini, E.] Natl Res Council CNR, Inst Neurosci, Via G Moruzzi 1, I-56124 Pisa, Italy; [Baroncelli, L.] IRCCS Stella Maris Fdn, Dept Dev Neurosci, Viale Tirreno 331, I-56128 Pisa, Italy; [Caleo, M.] Univ Padua, Dept Biomed Sci, Via G Colombo 3, I-35121 Padua, Italy; [Signore, G.] Fdn Pisana Sci, Via Ferruccio Giovannini 13, I-56017 Pisa, Italy		Cecchini, M (corresponding author), Ist Nanosci CNR, NEST, Piazza San Silvestro 12, I-56127 Pisa, Italy.; Cecchini, M (corresponding author), Scuola Normale Super Pisa, Piazza San Silvestro 12, I-56127 Pisa, Italy.	marco.cecchini@nano.cnr.it	Baroncelli, Laura/K-5823-2016	Baroncelli, Laura/0000-0001-6739-2860; CALEO, MATTEO/0000-0002-4333-6378; Santi, Melissa/0000-0002-9374-883X; Vieri, Maria Laura/0000-0002-7309-0647			Abdelhak A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-33158-8; Agostini M, 2019, IEEE ACCESS, V7, P70901, DOI 10.1109/ACCESS.2019.2919000; Agostini M, 2019, APL MATER, V7, DOI 10.1063/1.5070136; Agostini M, 2018, SENSOR ACTUAT B-CHEM, V254, P1, DOI 10.1016/j.snb.2017.07.014; Arya SK, 2013, LANGMUIR, V29, P6770, DOI 10.1021/la401109r; Axelsson M, 2011, J NEUROL, V258, P882, DOI 10.1007/s00415-010-5863-2; Cecchini M, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2889951; De Simoni G, 2015, BIOSENS BIOELECTRON, V68, P570, DOI 10.1016/j.bios.2014.12.058; Destgeer G, 2015, LAB CHIP, V15, P2722, DOI 10.1039/c5lc00265f; Ding PF, 2013, SENSOR ACTUAT B-CHEM, V188, P1277, DOI 10.1016/j.snb.2013.07.099; Franke T, 2009, LAB CHIP, V9, P2625, DOI 10.1039/b906819h; Frankel M, 2019, J NEUROTRAUM, V36, P2863, DOI 10.1089/neu.2018.5809; Friend J, 2011, REV MOD PHYS, V83, P647, DOI 10.1103/RevModPhys.83.647; Greco G, 2018, ANAL CHEM, V90, P7450, DOI 10.1021/acs.analchem.8b00972; Greco G, 2017, SENSORS-BASEL, V17, DOI 10.3390/s17112452; Greco G, 2017, SENSOR ACTUAT B-CHEM, V250, P525, DOI 10.1016/j.snb.2017.04.186; Humphreys I, 2013, CLINICOECONOMIC OUTC, V5, P281, DOI 10.2147/CEOR.S44625; Jung CS, 2007, BRAIN, V130, P3336, DOI 10.1093/brain/awm263; Limousin G, 2007, APPL GEOCHEM, V22, P249, DOI 10.1016/j.apgeochem.2006.09.010; Lowe S, 2015, POLYM CHEM-UK, V6, P198, DOI 10.1039/c4py01356e; Ma YS, 2018, NANOTECHNOLOGY, V29, DOI 10.1088/1361-6528/aaabea; Masdor NA, 2016, BIOSENS BIOELECTRON, V78, P328, DOI 10.1016/j.bios.2015.11.033; Nylen K, 2006, J NEUROL SCI, V240, P85, DOI 10.1016/j.jns.2005.09.007; Preston AN, 2019, METHOD ENZYMOL, V622, P129, DOI 10.1016/bs.mie.2019.02.006; Sharma H, 2013, ANAL CHEM, V85, P2472, DOI 10.1021/ac3035426; Shilton RJ, 2015, ADV FUNCT MATER, V25, P5895, DOI 10.1002/adfm.201501130; Shilton RJ, 2014, ADV MATER, V26, P4941, DOI 10.1002/adma.201400091; Song J, 2017, ADV FUNCT MATER, V27, DOI 10.1002/adfm.201606506; Soutar MPM, 2019, AUTOPHAGY, V15, P2002, DOI 10.1080/15548627.2019.1603549; Takano R, 2010, NEUROLOGY, V75, P208, DOI 10.1212/WNL.0b013e3181e2414b; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Tichy J, 2016, J NEURO-ONCOL, V126, P361, DOI 10.1007/s11060-015-1978-8; Travagliati M, 2014, ANAL CHEM, V86, P10633, DOI 10.1021/ac502465s; Travagliati M, 2012, LAB CHIP, V12, P2621, DOI 10.1039/c2lc40396j; Vaisocherova H, 2015, ANAL BIOANAL CHEM, V407, P3927, DOI 10.1007/s00216-015-8606-5; Vogt BD, 2004, J PHYS CHEM B, V108, P12685, DOI 10.1021/jp0481005; Vos PE, 2004, NEUROLOGY, V62, P1303, DOI 10.1212/01.WNL.0000120550.00643.DC; Wang KK, 2018, EXPERT REV MOL DIAGN, V18, P165, DOI 10.1080/14737159.2018.1428089; Wang T, 2017, INT J ELECTROCHEM SC, V12, P7341, DOI 10.20964/2017.08.69; Yue JK, 2019, LANCET NEUROL, V18, P953, DOI 10.1016/S1474-4422(19)30282-0; Zhang J, 2013, NEUROL SCI, V34, P1887, DOI 10.1007/s10072-013-1541-3; Zhao Z, 2007, SMALL, V3, P1390, DOI 10.1002/smll.200700006	42	7	7	14	39	ELSEVIER ADVANCED TECHNOLOGY	OXFORD	OXFORD FULFILLMENT CENTRE THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0956-5663	1873-4235		BIOSENS BIOELECTRON	Biosens. Bioelectron.	JAN 15	2021	172								112774	10.1016/j.bios.2020.112774			8	Biophysics; Biotechnology & Applied Microbiology; Chemistry, Analytical; Electrochemistry; Nanoscience & Nanotechnology	Science Citation Index Expanded (SCI-EXPANDED)	Biophysics; Biotechnology & Applied Microbiology; Chemistry; Electrochemistry; Science & Technology - Other Topics	PM1FW	WOS:000603555300003	33160234				2022-02-06	
J	Yates, AG; Jogia, T; Gillespie, ER; Couch, Y; Ruitenberg, MJ; Anthony, DC				Yates, Abi G.; Jogia, Trisha; Gillespie, Ellen R.; Couch, Yvonne; Ruitenberg, Marc J.; Anthony, Daniel C.			Acute IL-1RA treatment suppresses the peripheral and central inflammatory response to spinal cord injury	JOURNAL OF NEUROINFLAMMATION			English	Article						Neurotrauma; Systemic inflammatory response syndrome; Acute phase response; IL-1 receptor antagonist; Neutrophils; Macrophage		Background: The acute phase response (APR) to CNS insults contributes to the overall magnitude and nature of the systemic inflammatory response. Aspects of this response are thought to drive secondary inflammatory pathology at the lesion site, and suppression of the APR can therefore afford some neuroprotection. In this study, we examined the APR in a mouse model of traumatic spinal cord injury (SCI), along with its relationship to neutrophil recruitment during the immediate aftermath of the insult. We specifically investigated the effect of IL-1 receptor antagonist (IL-1RA) administration on the APR and leukocyte recruitment to the injured spinal cord. Methods: Adult female C57BL/6 mice underwent either a 70kD contusive SCI, or sham surgery, and tissue was collected at 2, 6, 12, and 24 hours post-operation. For IL-1RA experiments, SCI mice received two intraperitoneal injections of human IL-1RA (100mg/kg), or saline as control, immediately following, and 5 hours after impact, and animals were sacrificed 6 hours later. Blood, spleen, liver and spinal cord were collected to study markers of central and peripheral inflammation by flow cytometry, immunohistochemistry and qPCR. Results were analysed by two-way ANOVA or student's t-test, as appropriate. Results: SCI induced a robust APR, hallmarked by elevated hepatic expression of pro-inflammatory marker genes and a significantly increased neutrophil presence in the blood, liver and spleen of these animals, as early as 2 hours after injury. This peripheral response preceded significant neutrophil infiltration of the spinal cord, which peaked 24 hours post-SCI. Although expression of IL-1RA was also induced in the liver following SCI, its response was delayed compared to IL-1 beta. Exogenous administration of IL-1RA during this putative therapeutic window was able to suppress the hepatic APR, as evidenced by a reduction in CXCL1 and SAA-2 expression as well as a significant decrease in neutrophil infiltration in both the liver and the injured spinal cord itself. Conclusions: Our data indicate that peripheral administration of IL-1RA can attenuate the APR which in turn reduces immune cell infiltration at the spinal cord lesion site. We propose IL-1RA treatment as a viable therapeutic strategy to minimise the harmful effects of SCI-induced inflammation.	[Yates, Abi G.; Anthony, Daniel C.] Univ Oxford, Dept Pharmacol, Mansfield Rd, Oxford, England; [Yates, Abi G.; Jogia, Trisha; Gillespie, Ellen R.; Ruitenberg, Marc J.] Univ Queensland, Sch Biomed Sci, Fac Med, St Lucia, Qld, Australia; [Couch, Yvonne] Univ Oxford, Acute Stroke Programme, RDM Invest Med, Oxford, England; [Anthony, Daniel C.] Sechenov First Moscow State Med Univ, Moscow, Russia		Anthony, DC (corresponding author), Univ Oxford, Dept Pharmacol, Mansfield Rd, Oxford, England.; Anthony, DC (corresponding author), Sechenov First Moscow State Med Univ, Moscow, Russia.	daniel.anthony@pharm.ox.ac.uk	Anthony, Daniel C/F-7765-2010	Anthony, Daniel C/0000-0003-1380-6655	International Spinal Research Trust; SpinalCure Australia; Research Training Program Scholarship (Australian Government); UK MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [MC-PC-15029]	This work was made possible by a Nathalie Rose Barr Award from the International Spinal Research Trust to AY and the support of SpinalCure Australia to MJR's laboratory. TJ and ERG are supported by a Research Training Program Scholarship (Australian Government). DA is supported by the UK MRC under grant MC-PC-15029.	Akuzawa S, 2008, J VASC SURG, V48, P694, DOI 10.1016/j.jvs.2008.04.011; Allan SM, 2005, NAT REV IMMUNOL, V5, P629, DOI 10.1038/nri1664; Anwar MA, 2016, FRONT CELL NEUROSCI, V10, DOI 10.3389/fncel.2016.00098; Bao F, 2009, EXP NEUROL, V215, P308, DOI 10.1016/j.expneurol.2008.10.022; Bastien D, 2015, J NEUROSCI, V35, P10715, DOI 10.1523/JNEUROSCI.0498-15.2015; Blomster LV, 2013, EXP NEUROL, V247, P226, DOI 10.1016/j.expneurol.2013.05.002; Blomster LV, 2013, NMR BIOMED, V26, P141, DOI 10.1002/nbm.2829; Blond D, 2002, BRAIN RES, V958, P89, DOI 10.1016/S0006-8993(02)03473-X; Boato F, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-6; Brennan FH, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.98254; Brennan FH, 2016, ANN CLIN TRANSL NEUR, V3, P495, DOI 10.1002/acn3.318; Campbell SJ, 2008, NEUROPHARMACOLOGY, V55, P780, DOI 10.1016/j.neuropharm.2008.06.074; Campbell SJ, 2008, J NEUROPATH EXP NEUR, V67, P223, DOI 10.1097/NEN.0b013e3181654957; Campbell SJ, 2007, J NEUROCHEM, V103, P2245, DOI 10.1111/j.1471-4159.2007.04928.x; Campbell SJ, 2007, NEUROBIOL DIS, V27, P151, DOI 10.1016/j.nbd.2007.04.013; Campbell SJ, 2003, FASEB J, V17, P1168, DOI 10.1096/fj.02-0757fje; Campbell SJ, 2005, AM J PATHOL, V166, P1487, DOI 10.1016/S0002-9440(10)62365-6; Campbell SJ, 2002, J NEUROCHEM, V83, P432, DOI 10.1046/j.1471-4159.2002.01166.x; Ching S, 2005, BRAIN BEHAV IMMUN, V19, P127, DOI 10.1016/j.bbi.2004.06.001; Clausen BH, 2014, J NEUROINFLAMM, V11, DOI 10.1186/s12974-014-0203-6; Clausen F, 2011, EUR J NEUROSCI, V34, P110, DOI 10.1111/j.1460-9568.2011.07723.x; Donnelly DJ, 2008, EXP NEUROL, V209, P378, DOI 10.1016/j.expneurol.2007.06.009; Emsley HCA, 2005, J NEUROL NEUROSUR PS, V76, P1366, DOI 10.1136/jnnp.2004.054882; Fleming JC, 2006, BRAIN, V129, P3249, DOI 10.1093/brain/awl296; Galea J, 2011, J CEREBR BLOOD F MET, V31, P439, DOI 10.1038/jcbfm.2010.103; Greenhalgh AD, 2010, BRIT J PHARMACOL, V160, P153, DOI 10.1111/j.1476-5381.2010.00684.x; Gris D, 2008, EXP NEUROL, V211, P259, DOI 10.1016/j.expneurol.2008.01.033; Harrison M, 2013, NEUROIMAGE, V68, P22, DOI 10.1016/j.neuroimage.2012.11.048; Hasturk AE, 2015, NEUROSCIENCES, V20, P124, DOI 10.17712/nsj.2015.2.20140483; Helmy A, 2016, J CEREBR BLOOD F MET, V36, P1434, DOI 10.1177/0271678X15620204; Helmy A, 2014, J CEREBR BLOOD F MET, V34, P845, DOI 10.1038/jcbfm.2014.23; Kesani AK, 2014, J NEUROSURG-SPINE, V21, P296, DOI 10.3171/2014.3.SPINE13784; Lee SM, 2011, J NEUROTRAUM, V28, P1893, DOI 10.1089/neu.2011.1860; Li T, 2018, INT J NEUROSCI, V128, P778, DOI 10.1080/00207454.2018.1424154; Liu S, 2008, BRAIN RES, V1231, P63, DOI 10.1016/j.brainres.2008.07.035; Maysami S, 2016, J CEREBR BLOOD F MET, V36, P596, DOI 10.1177/0271678X15606714; McColl BW, 2007, J NEUROSCI, V27, P4403, DOI 10.1523/JNEUROSCI.5376-06.2007; Morganti-Kossmann C., 2012, TRAUMATIC BRAIN SPIN, DOI [10.1017/CBO9781139030564, DOI 10.1017/CBO9781139030564]; Neirinckx V, 2014, J NEUROINFLAMM, V11, DOI 10.1186/s12974-014-0150-2; Nesic O, 2001, J NEUROTRAUM, V18, P947, DOI 10.1089/089771501750451857; Newell EA, 2018, ENEURO, V5, DOI 10.1523/ENEURO.0385-17.2018; Otxoa-de-Amezaga A, 2019, ACTA NEUROPATHOL, V137, P321, DOI 10.1007/s00401-018-1954-4; Pineau I, 2010, BRAIN BEHAV IMMUN, V24, P540, DOI 10.1016/j.bbi.2009.11.007; Pineau I, 2007, J COMP NEUROL, V500, P267, DOI 10.1002/cne.21149; Pradillo JM, 2017, BRAIN BEHAV IMMUN, V61, P117, DOI 10.1016/j.bbi.2016.11.013; Pradillo JM, 2012, J CEREBR BLOOD F MET, V32, P1810, DOI 10.1038/jcbfm.2012.101; Sato A, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-65; Scheff SW, 2003, J NEUROTRAUM, V20, P179, DOI 10.1089/08977150360547099; Schnell L, 1999, J NEUROPATH EXP NEUR, V58, P245, DOI 10.1097/00005072-199903000-00004; Sun MJ, 2017, BRAIN BEHAV IMMUN, V66, P359, DOI 10.1016/j.bbi.2017.08.005; Vaccari JPDR, 2008, J NEUROSCI, V28, P3404, DOI 10.1523/JNEUROSCI.0157-08.2008; Vitkovic L, 2000, J NEUROCHEM, V74, P457, DOI 10.1046/j.1471-4159.2000.740457.x; Wang CX, 1997, BRAIN RES, V759, P190, DOI 10.1016/S0006-8993(97)00254-0; Wilcockson DC, 2002, J CEREBR BLOOD F MET, V22, P318, DOI 10.1097/00004647-200203000-00009; Yang LQ, 2005, J CLIN NEUROSCI, V12, P276, DOI 10.1016/j.jocn.2004.06.011; Zhang DD, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1058-z; Zhu L, 2019, BRAIN BEHAV IMMUN, V81, P292, DOI 10.1016/j.bbi.2019.06.026; Zong SH, 2012, INFLAMMATION, V35, P520, DOI 10.1007/s10753-011-9341-5	58	7	7	1	3	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1742-2094		J NEUROINFLAMM	J. Neuroinflamm.	JAN 6	2021	18	1							15	10.1186/s12974-020-02050-6			12	Immunology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Immunology; Neurosciences & Neurology	PS6NX	WOS:000608044400007	33407641	Green Published, gold			2022-02-06	
J	Alvarado-Velez, M; Enam, SF; Mehta, N; Lyon, JG; LaPlaca, MC; Bellamkonda, RV				Alvarado-Velez, Melissa; Enam, Syed Faaiz; Mehta, Nalini; Lyon, Johnathan G.; LaPlaca, Michelle C.; Bellamkonda, Ravi V.			Immuno-suppressive hydrogels enhance allogeneic MSC survival after transplantation in the injured brain	BIOMATERIALS			English	Article						Stem cell transplantation; Hydrogel; Brain injury; Immune response	MESENCHYMAL STEM-CELLS; MARROW STROMAL CELLS; NEUROTROPHIC FACTORS; FUNCTIONAL RECOVERY; NEURONAL DAMAGE; MOUSE-BRAIN; RAT; EXPRESSION; THERAPY; HOST	Traumatic brain injury (TBI) triggers multiple biochemical and cellular processes that exacerbate brain tissue damage through a secondary injury. Therapies that prevent or limit the evolution of secondary injury could significantly reduce the neurological deficits associated with TBI. Mesenchymal stem cell (MSC) transplantation after TBI can ameliorate neurological deficits by modulating inflammation and enhancing the expression of neurotrophic factors. However, transplanted MSCs can be actively rejected by host immune responses, such as those mediated by cytotoxic CD8(+) T cells, thereby limiting their therapeutic efficacy. Here, we designed an agarose hydrogel that releases Fas ligand (FasL), a protein that can induce apoptosis of cytotoxic CD8(+) T cells. We studied the immunosuppressive effect of this hydrogel near the allogeneic MSC transplantation site and its impact on the survival of transplanted MSCs in the injured brain. Agarose-FasL hydrogels locally reduced the host cytotoxic CD8(+) T cell population and enhanced the survival of allogeneic MSCs transplanted near the injury site. Furthermore, the expression of crucial neurotrophic factors was elevated in the injury penumbra, suggesting an enhanced therapeutic effect of MSCs. These results suggest that the development of immunosuppressive hydrogels for stem cell delivery can enhance the benefits of stem cell therapy for TBI.	[Alvarado-Velez, Melissa; LaPlaca, Michelle C.] Georgia Inst Technol, Dept Biomed Engn, Atlanta, GA 30332 USA; [Enam, Syed Faaiz; Mehta, Nalini; Lyon, Johnathan G.; Bellamkonda, Ravi V.] Duke Univ, Dept Biomed Engn, Durham, NC 27708 USA		Bellamkonda, RV (corresponding author), Duke Univ, Dept Biomed Engn, Durham, NC 27708 USA.	ravi@duke.edu		Lyon, Johnathan/0000-0002-0926-231X	National Institute of Neurological Disorders and Stroke (NINDS) of the National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS079739-05]	We are grateful to Dr. Jason Chu, Sheridan Carroll, Martha I. Betancur, and Zhinous Hosseini for their intellectual and technical support in this project. Also, thank you to Dr. Allan Johnson, Gary Cofer, and the Center for In Vivo Microscopy at Duke for the magnetic resonance imaging. This work was funded by the National Institute of Neurological Disorders and Stroke (NINDS) of the National Institutes of Health (NIH) under award number R01NS079739-05.	Badillo AT, 2008, BRIT J HAEMATOL, V141, P224, DOI 10.1111/j.1365-2141.2008.07040.x; Chen Q, 2005, J NEUROSCI RES, V80, P611, DOI 10.1002/jnr.20494; Coyne TM, 2007, TRANSPLANTATION, V84, P1507, DOI 10.1097/01.tp.0000288185.09601.4d; Dekmak A, 2018, BEHAV BRAIN RES, V340, P49, DOI 10.1016/j.bbr.2016.12.039; Dimitriou H, 2009, CELL PROLIFERAT, V42, P276, DOI 10.1111/j.1365-2184.2009.00603.x; Eliopoulos N, 2005, BLOOD, V106, P4057, DOI 10.1182/blood-2005-03-1004; Enam SF, 2020, J NEUROINFLAMM, V17, DOI 10.1186/s12974-020-01860-y; English K, 2009, CLIN EXP IMMUNOL, V156, P149, DOI 10.1111/j.1365-2249.2009.03874.x; Fox C, 2005, J CEREBR BLOOD F MET, V25, P1138, DOI 10.1038/sj.jcbfm.9600121; Galindo LT, 2011, NEUROL RES INT, V2011, DOI 10.1155/2011/564089; Herz J, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01696; Hoves S, 2004, IMMUNOBIOLOGY, V208, P463, DOI 10.1078/0171-2985-00293; Jain A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016135; Jin X, 2012, J SOFTWARE, V7, P6, DOI DOI 10.1371/J0URNAL.P0NE.0041892; Johnson GA, 2007, NEUROIMAGE, V37, P82, DOI 10.1016/j.neuroimage.2007.05.013; Kadle RL, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193178; Kaplan DR, 2000, CURR OPIN NEUROBIOL, V10, P381, DOI 10.1016/S0959-4388(00)00092-1; Kenne E, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-17; Kim H, 2012, TRENDS BIOTECHNOL, V30, P55, DOI 10.1016/j.tibtech.2011.07.002; Kim HJ, 2010, J NEUROTRAUM, V27, P131, DOI [10.1089/neu.2008.0818, 10.1089/neu.2008-0818]; Lee H, 2010, P NATL ACAD SCI USA, V107, P3340, DOI 10.1073/pnas.0905437106; Lenardo M, 1999, ANNU REV IMMUNOL, V17, P221, DOI 10.1146/annurev.immunol.17.1.221; Lenardo M J, 1995, Int Rev Immunol, V13, P115, DOI 10.3109/08830189509061742; Li PY, 2013, ANN NEUROL, V74, P458, DOI 10.1002/ana.23815; Liesz A, 2015, J NEUROSCI, V35, P583, DOI 10.1523/JNEUROSCI.2439-14.2015; Loane DJ, 2010, TRENDS PHARMACOL SCI, V31, P596, DOI 10.1016/j.tips.2010.09.005; Longhi L, 2005, TRANSPL IMMUNOL, V15, P143, DOI 10.1016/j.trim.2005.09.003; Mahmood A, 2004, J NEUROTRAUM, V21, P33, DOI 10.1089/089771504772695922; Mahmood A, 2002, J NEUROTRAUM, V19, P1609, DOI 10.1089/089771502762300265; Mahmood A., 2001, J NEUROSURG, V94; Margulies S, 2009, J NEUROTRAUM, V26, P925, DOI [10.1089/neu.2008.0794, 10.1089/neu.2008-0794]; Meilander NJ, 2001, J CONTROL RELEASE, V71, P141, DOI 10.1016/S0168-3659(01)00214-0; Moloney TC, 2010, NEUROREHAB NEURAL RE, V24, P645, DOI 10.1177/1545968309357745; Nauta AJ, 2006, BLOOD, V108, P2114, DOI 10.1182/blood-2005-11-011650; Oliver L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019820; Prevention CfDCa, 2019, SURV REP TRAUM BRAIN; Price L., 2016, TRANSLATIONAL RES TR; Pushkarna A, 2010, Med J Armed Forces India, V66, P321, DOI 10.1016/S0377-1237(10)80008-5; RELTON JK, 1992, BRAIN RES BULL, V29, P243, DOI 10.1016/0361-9230(92)90033-T; Rippo MR, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.115; Sato M, 2001, BRAIN RES, V917, P45, DOI 10.1016/S0006-8993(01)02905-5; Shen LH, 2010, GLIA, V58, P1074, DOI 10.1002/glia.20988; Shen LH, 2008, GLIA, V56, P1747, DOI 10.1002/glia.20722; Siegel RM, 2000, NAT IMMUNOL, V1, P469, DOI 10.1038/82712; Sinden J.D., 2017, STEM CELL DEV, V26; Solis MA, 2012, BIOCHEM RES INT, V2012, DOI 10.1155/2012/346972; TOULMOND S, 1995, BRAIN RES, V671, P261, DOI 10.1016/0006-8993(94)01343-G; Wakabayashi K, 2010, J NEUROSCI RES, V88, P1017, DOI 10.1002/jnr.22279; Walker PA, 2012, SURGERY, V152, P790, DOI 10.1016/j.surg.2012.06.006; Wennersten A, 2003, ACTA NEUROPATHOL, V105, P281, DOI 10.1007/s00401-002-0649-y; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Yang GY, 1998, J CEREBR BLOOD F MET, V18, P840, DOI 10.1097/00004647-199808000-00004; Yoo SW, 2008, EXP MOL MED, V40, P387, DOI 10.3858/emm.2008.40.4.387; Yu SP, 2013, TRANSL STROKE RES, V4, P76, DOI 10.1007/s12975-012-0251-0; Zanier ER, 2014, NEUROTHERAPEUTICS, V11, P679, DOI 10.1007/s13311-014-0277-y; Zhang Z, 2006, NEUROSCIENCE, V141, P637, DOI 10.1016/j.neuroscience.2006.04.027	56	7	7	13	35	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0142-9612	1878-5905		BIOMATERIALS	Biomaterials	JAN	2021	266								120419	10.1016/j.biomaterials.2020.120419			11	Engineering, Biomedical; Materials Science, Biomaterials	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Materials Science	OU6CR	WOS:000591615100001	33038594				2022-02-06	
J	Bloom, MB; Noorzad, A; Lin, C; Little, M; Lee, EY; Margulies, DR; Torbati, SS				Bloom, Matthew B.; Noorzad, Ali; Lin, Carol; Little, Milton; Lee, Ernest Y.; Margulies, Daniel R.; Torbati, Sam S.			Standing electric scooter injuries: Impact on a community	AMERICAN JOURNAL OF SURGERY			English	Article						Electric scooters; Injury prevention; Helmet use; Bicycle lanes; Pedestrian		Background: This study investigates the impact of standing electric scooter-related injuries within an entire integrated hospital system. Methods: We performed a retrospective review of patients involved in standing electric scooter incidents presenting throughout an urban hospital network over a 10 month period. Rates of Google searches of scooter-related terms performed locally were used as a surrogate for ride frequency. Injury, mechanism, and cost data were analyzed. Results: Data on 248 patients were reviewed. Twenty-three (9%) were under 18 years old. Loss of balance was the most common cause of injury accounting for nearly half, while tripping over a scooter 14 (6%) affected the elderly disproportionately. Eight (3%) riders wore helmets. All TBI and closed head injuries occurred in unhelmeted patients. Most incidents occurred in the street, only one in a bicycle lane. Facilities costs were greater for patients under the influence of alcohol and marijuana. Conclusion: Policies related to the use of mandated safety equipment, dedicated bicycle lanes, and the proper storage of empty vehicles should be further investigated. (C) 2020 Elsevier Inc. All rights reserved.	[Bloom, Matthew B.; Margulies, Daniel R.] Cedars Sinai Med Ctr, Dept Surg, Div Trauma & Crit Care, Los Angeles, CA 90048 USA; [Noorzad, Ali; Lin, Carol; Little, Milton] Cedars Sinai Med Ctr, Dept Orthoped Surg, Los Angeles, CA 90048 USA; [Lee, Ernest Y.] UCLA, David Geffen Sch Med, UCLA Caltech Med Scientist Training Program, Los Angeles, CA 90095 USA; [Torbati, Sam S.] Cedars Sinai Med Ctr, Dept Emergency Med, Los Angeles, CA 90048 USA		Bloom, MB (corresponding author), Cedars Sinai Med Ctr, 8635 W 3rd St,Suite 650, Los Angeles, CA 90048 USA.	Matthew.Bloom@cshs.org; Ali.Noorzad@cshs.org; Carol.Lin@cshs.org; Milton.Little@cshs.org; Ernest.Lee@ucla.edu; Daniel.Margulies@cshs.org; Sam.Torbati@cshs.org	Bloom, Matthew/E-5660-2013	Bloom, Matthew/0000-0001-8102-4394; Lee, Ernest Y./0000-0001-5144-2552; Torbati, Sam/0000-0001-8424-8764	NIGMS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [T32 GM008042] Funding Source: Medline		Azad A, 2018, CNN; Bach T., 2018, US NEWS; Badeau A, 2019, AM J EMERG MED, V37, P1531, DOI 10.1016/j.ajem.2019.05.003; California Legislative Information, 2018, AB2989 CAL LEG INF; Irfan U, 2018, VOX; Liew YK, 2019, SINGAP MED J; Mayhew LJ, 2019, J MED IMAG RADIAT ON, V63, P461, DOI 10.1111/1754-9485.12889; Ndmiri NK, 2020, JAMA SURG; ninon NK, 2020, J AM COLL SURG; Populus, 2018, MICROMOBILITY REVOIN; Siracuse BL, 2017, INJURY, V48, P1110, DOI 10.1016/j.injury.2017.03.028; Sisson P, 2018, CURBED; Trivedi TK, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2018.7381	13	7	7	3	5	EXCERPTA MEDICA INC-ELSEVIER SCIENCE INC	BRIDGEWATER	685 ROUTE 202-206 STE 3, BRIDGEWATER, NJ 08807 USA	0002-9610	1879-1883		AM J SURG	Am. J. Surg.	JAN	2021	221	1					227	232		10.1016/j.amjsurg.2020.07.020			6	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	PI3LE	WOS:000600995200045	32778397	Bronze, Green Accepted			2022-02-06	
J	El Ahmadieh, TY; Bedros, N; Stutzman, SE; Nyancho, D; Venkatachalam, AM; MacAllister, M; Ban, VS; Dahdaleh, NS; Aiyagari, V; Figueroa, S; White, JA; Batjer, HH; Bagley, CA; Olson, DM; Aoun, SG				El Ahmadieh, Tarek Y.; Bedros, Nicole; Stutzman, Sonja E.; Nyancho, Daniel; Venkatachalam, Aardhra M.; MacAllister, Matthew; Ban, Vin Shen; Dahdaleh, Nader S.; Aiyagari, Venkatesh; Figueroa, Stephen; White, Jonathan A.; Batjer, H. Hunt; Bagley, Carlos A.; Olson, DaiWai M.; Aoun, Salah G.			Automated Pupillometry as a Triage and Assessment Tool in Patients with Traumatic Brain Injury	WORLD NEUROSURGERY			English	Article						Craniectomy; Field injury; Head trauma; Pupil; Pupillometry; Traumatic brain injury; Triage	GLASGOW COMA SCALE; PUPILLARY LIGHT REFLEX; OBJECTIVE PUPILLOMETRY; INTENSIVE-CARE; RELIABILITY; GUIDELINES; MANAGEMENT; MORTALITY; SCORE	OBJECTIVE: Traumatic brain injury (TBI) is a leading cause of morbidity and mortality in young adults. Automated infrared pupillometry (AIP) has shown promising results in predicting neural damage in aneurysmal subarachnoid hemorrhage and ischemic stroke. We aimed to explore potential uses of AIP in triaging patients with TBI. We hypothesized that a brain injury severe enough to require an intervention would show Neurologic Pupil Index (NPI) changes. METHODS: We conducted a prospective pilot study at a level-1 trauma center between November 2019 and February 2020. AIP readings of consecutive patients seen in the emergency department with blunt TBI and abnormal imaging findings on computed tomography were recorded by the assessing neurosurgery resident. The relationship between NPI and surgical intervention was studied. RESULTS: Thirty-six patients were enrolled, 9 of whom received an intervention. NPI was dichotomized into normal (>= 3) versus abnormal (<3) and was predictive of intervention (Fisher exact test; P < 0.0001). Six of the 9 patients had a Glasgow Coma Scale (GCS) score <= 8 and imaging signs of increased intracranial pressure (ICP) and underwent craniectomy (a = 4) or ICP monitor placement (n = 2) and had an abnormal NPI. Three patients underwent ICP monitor placement for GCS score <= 8 in accordance with TBI guidelines despite minimal imaging findings and had a normal NPI. The GCS score of these patients improved within 24 hours, requiring ICP monitor removal. NPI was normal in all patients who did not require intervention. CONCLUSIONS: AIP could be useful in triaging comatose patients after blunt TBI. An NPI >= 3 may be reassuring in patients with no signs of mass effect or increased ICP.	[El Ahmadieh, Tarek Y.; MacAllister, Matthew; Ban, Vin Shen; White, Jonathan A.; Batjer, H. Hunt; Bagley, Carlos A.; Aoun, Salah G.] Univ Texas Southwestern Med Ctr Dallas, Dept Neurol Surg, Dallas, TX 75390 USA; [Aiyagari, Venkatesh; Figueroa, Stephen; Olson, DaiWai M.] Univ Texas Southwestern Med Ctr Dallas, Dept Neurol & Neurotherapeut, Dallas, TX 75390 USA; [Aiyagari, Venkatesh; Figueroa, Stephen; Olson, DaiWai M.] Univ Texas Southwestern Med Ctr Dallas, Dept Neurocrit Care, Dallas, TX 75390 USA; [Bagley, Carlos A.] Univ Texas Southwestern Med Ctr Dallas, Dept Orthoped Surg, Dallas, TX 75390 USA; [Stutzman, Sonja E.; Venkatachalam, Aardhra M.] Univ Texas Southwestern Med Ctr Dallas, ODonnell Brain Inst, Dallas, TX 75390 USA; [Bedros, Nicole] Baylor Univ, Med Ctr, Div Trauma, Dept Surg, Baylor, TX USA; [Nyancho, Daniel; Dahdaleh, Nader S.] Northwestern Univ, Dept Neurosurg, Chicago, IL 60611 USA		Aoun, SG (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Neurol Surg, Dallas, TX 75390 USA.	Salah.aoun@utsouthwestern.edu		Venkatachalam, Aardhra/0000-0001-8449-042X; Ban, Vin Shen/0000-0002-4532-8101; Nyancho, Daniel/0000-0002-7753-5244			Anderson M, 2018, J NEUROSCI NURS, V50, P30, DOI 10.1097/JNN.0000000000000333; Aoun SG, 2020, J NEUROSURG, V132, P27, DOI 10.3171/2018.9.JNS181928; Aoun SG, 2019, WORLD NEUROSURG, V121, pE475, DOI 10.1016/j.wneu.2018.09.140; Binda P, 2013, J NEUROSCI, V33, P2199, DOI 10.1523/JNEUROSCI.3440-12.2013; Blennow K, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.84; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Dewan MC, 2019, J NEUROSURG, V130, P1080, DOI 10.3171/2017.10.JNS17352; Donnelly J, 2019, NEUROSURGERY, V85, pE75, DOI 10.1093/neuros/nyy468; ELLIS CJK, 1981, BRIT J OPHTHALMOL, V65, P754, DOI 10.1136/bjo.65.11.754; Hoffmann M, 2012, BRIT J SURG, V99, P122, DOI 10.1002/bjs.7707; Jahns FP, 2019, CRIT CARE, V23, DOI 10.1186/s13054-019-2436-3; Klooster J, 1998, ANAT EMBRYOL, V198, P123, DOI 10.1007/s004290050170; Lussier BL, 2019, J NEUROSCI NURS, V51, P335, DOI 10.1097/JNN.0000000000000478; Lussier BL, 2019, CURR NEUROL NEUROSCI, V19, DOI 10.1007/s11910-019-0994-z; Mader MM, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-61513-1; Majdan M, 2015, J NEUROTRAUM, V32, P101, DOI 10.1089/neu.2014.3438; Marshall M, 2019, J NEUROSCI NURS, V51, P84, DOI 10.1097/JNN.0000000000000416; Mathot S, 2014, J VISION, V14, DOI 10.1167/14.14.7; Mease L, 2018, MIL MED, V183, pE291, DOI 10.1093/milmed/usy011; Olson DM, 2017, J NEUROSCI NURS, V49, P251, DOI 10.1097/JNN.0000000000000296; Olson DM, 2016, NEUROCRIT CARE, V24, P251, DOI 10.1007/s12028-015-0182-1; Osman M, 2019, J STROKE CEREBROVASC, V28, P1902, DOI 10.1016/j.jstrokecerebrovasdis.2019.03.055; Tamura T, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0228224; Tavakoli S, 2017, NEUROSURG FOCUS, V43, DOI 10.3171/2017.8.FOCUS17450; TEASDALE G, 1974, LANCET, V2, P81; Truong JQ, 2016, BRAIN INJURY, V30, P1378, DOI 10.1080/02699052.2016.1195922; Volovici V, 2017, NEUROSURGERY, V81, pE21, DOI 10.1093/neuros/nyx183; Wijdicks EFM, 2015, CRIT CARE MED, V43, P439, DOI 10.1097/CCM.0000000000000707; Wijdicks EFM, 2005, ANN NEUROL, V58, P585, DOI 10.1002/ana.20611; Zafar SF, 2014, J CRIT CARE, V29, P599, DOI 10.1016/j.jcrc.2014.01.012; Zhao WD, 2016, J CLIN NEUROSCI, V33, P79, DOI 10.1016/j.jocn.2016.01.039	31	7	7	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	JAN	2021	145						E163	E169		10.1016/j.wneu.2020.09.152			7	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	PH8NR	WOS:000600662600020	33011358				2022-02-06	
J	Li, Y; Ritzel, RM; He, JY; Cao, TX; Sabirzhanov, B; Li, H; Liu, S; Wu, LJ; Wu, JF				Li, Yun; Ritzel, Rodney M.; He, Junyun; Cao, Tuoxin; Sabirzhanov, Boris; Li, Hui; Liu, Simon; Wu, Long-Jun; Wu, Junfang			The voltage-gated proton channel Hv1 plays a detrimental role in contusion spinal cord injury via extracellular acidosis-mediated neuroinflammation	BRAIN BEHAVIOR AND IMMUNITY			English	Article						Spinal cord injury; Voltage-gated proton channel; Hv1; Acidosis; Microglia; Oxidative stress; Motor function	TRAUMATIC BRAIN-INJURY; SENSING ION CHANNELS; SECONDARY DAMAGE; TISSUE PH; INFLAMMATION; CONTRIBUTES; MODULATION; NEUTROPHIL; ACTIVATION; MICROGLIA	Tissue acidosis is an important secondary injury process in the pathophysiology of traumatic spinal cord injury (SCI). To date, no studies have examined the role of proton extrusion as mechanism of pathological acidosis in SCI. In the present study, we hypothesized that the phagocyte-specific proton channel Hv1 mediates hydrogen proton extrusion after SCI, contributing to increased extracellular acidosis and poor long-term outcomes. Using a contusion model of SCI in adult female mice, we demonstrated that tissue pH levels are markedly lower during the first week after SCI. Acidosis was most evident at the injury site, but also extended into proximal regions of the cervical and lumbar cord. Tissue reactive oxygen species (ROS) levels and expression of Hv1 were significantly increased during the week of injury. Hv1 was exclusively expressed in microglia within the CNS, suggesting that microglia contribute to ROS production and proton extrusion during respiratory burst. Depletion of Hv1 significantly attenuated tissue acidosis, NADPH oxidase 2 (NOX2) expression, and ROS production at 3 d post-injury. Nanostring analysis revealed decreased gene expression of neuroinflammatory and cytokine signaling markers in Hv1 knockout (KO) mice. Furthermore, Hv1 deficiency reduced microglia proliferation, leukocyte infiltration, and phagocytic oxidative burst detected by flow cytometry. Importantly, Hv1 KO mice exhibited significantly improved locomotor function and reduced histopathology. Overall, these data suggest an important role for Hv1 in regulating tissue acidosis, NOX2-mediated ROS production, and functional outcome following SCI. Thus, the Hv1 proton channel represents a potential target that may lead to novel therapeutic strategies for SCI.	[Li, Yun; Ritzel, Rodney M.; He, Junyun; Cao, Tuoxin; Sabirzhanov, Boris; Li, Hui; Liu, Simon; Wu, Junfang] Univ Maryland, Sch Med, Dept Anesthesiol, Baltimore, MD 21201 USA; [Li, Yun; Ritzel, Rodney M.; He, Junyun; Cao, Tuoxin; Sabirzhanov, Boris; Li, Hui; Liu, Simon; Wu, Junfang] Univ Maryland, Sch Med, Ctr Shock Trauma & Anesthesiol Res STAR, Baltimore, MD 21201 USA; [Wu, Long-Jun] Mayo Clin, Dept Neurol, Rochester, MN 55905 USA; [Wu, Junfang] Univ Maryland, Ctr Adv Chron Pain Res, Baltimore, MD 21201 USA		Wu, LJ; Wu, JF (corresponding author), Univ Maryland, Sch Med, Baltimore, MD 21201 USA.	wu.longjun@mayo.edu; junfang.wu@som.umaryland.edu	Wu, Long-Jun/AAK-7113-2020	Wu, Long-Jun/0000-0001-8019-3380; Liu, Simon/0000-0002-1182-5492; Li, Yun/0000-0003-2040-4451	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01 NS110825, R01 NS094527, RF1 NS110637, K99 NS116032]	The work was supported by the National Institutes of Health Grants R01 NS110825 (JW and LW), R01 NS094527 (JW), RF1 NS110637 (JW), and K99 NS116032 (RMR). We would like to thank Dr. Zhuofan Lei, Ms. Lulu Liu, Ms. Jordan Carter, and Mr. Niaz Khan for assistance with the Hv1 antibody testing, tissue sectioning, and the cytometer.	ANDERSON DK, 1976, J NEUROSURG, V44, P715, DOI 10.3171/jns.1976.44.6.0715; ANDERSON DK, 1980, J NEUROSURG, V52, P387, DOI 10.3171/jns.1980.52.3.0387; Basso DM, 2006, J NEUROTRAUM, V23, P635, DOI 10.1089/neu.2006.23.635; Bellver-Landete V, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08446-0; Caterina MJ, 2000, SCIENCE, V288, P306, DOI 10.1126/science.288.5464.306; Chesler M, 2003, PHYSIOL REV, V83, P1183, DOI 10.1152/physrev.00010.2003; Clark RA, 2016, J LEUKOCYTE BIOL, V99, P1, DOI 10.1189/jlb.4CE0515-188RR; Clausen T, 2005, J NEUROSURG, V103, P597, DOI 10.3171/jns.2005.103.4.0597; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Constantinides Christakis, 2011, ILAR J, V52, pe21; de Ceglia R, 2015, BRAIN BEHAV IMMUN, V45, P263, DOI 10.1016/j.bbi.2014.12.003; DeCoursey TE, 2015, BIOCHEMISTRY-US, V54, P3250, DOI 10.1021/acs.biochem.5b00353; DeCoursey TE, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2013.0799; DELHEIMER SC, 1980, J NEUROCHEM, V34, P1514, DOI 10.1111/j.1471-4159.1980.tb11232.x; Deval E, 2010, PHARMACOL THERAPEUT, V128, P549, DOI 10.1016/j.pharmthera.2010.08.006; Dodge JC, 2013, P NATL ACAD SCI USA, V110, P10812, DOI 10.1073/pnas.1308421110; El Chemaly A, 2014, J LEUKOCYTE BIOL, V95, P827, DOI 10.1189/jlb.0513251; Falconer JC, 1996, J NEUROCHEM, V66, P717; Farooque M, 1997, J NEUROTRAUM, V14, P63, DOI 10.1089/neu.1997.14.63; Friese MA, 2007, NAT MED, V13, P1483, DOI 10.1038/nm1668; GIFFARD RG, 1990, BRAIN RES, V506, P339, DOI 10.1016/0006-8993(90)91276-M; Gupta AK, 2004, J NEUROTRAUM, V21, P678, DOI 10.1089/0897715041269722; Hasse W, 2000, UNFALLCHIRURG, V103, P495, DOI 10.1007/s001130050571; Henry RJ, 2020, J NEUROSCI, V40, P2960, DOI 10.1523/JNEUROSCI.2402-19.2020; Hu R, 2011, ANN SURG, V254, P353, DOI 10.1097/SLA.0b013e31822645b4; Jalalvand E, 2016, CURR BIOL, V26, P1346, DOI 10.1016/j.cub.2016.03.048; Koehn Liam M, 2016, F1000Res, V5, P1822, DOI 10.12688/f1000research.9094.2; KOLLER ME, 1984, ACTA ANAESTH SCAND, V28, P87, DOI 10.1111/j.1399-6576.1984.tb02017.x; LAMID S, 1983, J UROLOGY, V129, P845, DOI 10.1016/S0022-5347(17)52396-4; Lee S, 2018, MOL PAIN, V14, DOI 10.1177/1744806918764979; Li X, 2020, BIOCH BIOPHYS RES CO; Marmarou A, 1993, Acta Neurochir Suppl (Wien), V57, P160; Matyas JJ, 2017, J NEUROSCI, V37, P3956, DOI 10.1523/JNEUROSCI.3353-16.2017; Musset B, 2008, P NATL ACAD SCI USA, V105, P11020, DOI 10.1073/pnas.0800886105; Neelands TR, 2005, MOL PAIN, V1, DOI 10.1186/1744-8069-1-28; Pukos N, 2019, GLIA, V67, P2178, DOI 10.1002/glia.23702; Ramsey IS, 2009, P NATL ACAD SCI USA, V106, P7642, DOI 10.1073/pnas.0902761106; Ratanayotha A, 2019, AM J PHYSIOL-REG I, V316, pR819, DOI 10.1152/ajpregu.00326.2018; Ritzel RM, 2020, NEUROBIOL DIS, V136, DOI 10.1016/j.nbd.2019.104713; Ritzel RM, 2019, NEUROBIOL AGING, V77, P194, DOI 10.1016/j.neurobiolaging.2019.02.010; Ro HA, 2004, J BIOL CHEM, V279, P37115, DOI 10.1074/jbc.M403099200; Ruffin VA, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00043; Sabirzhanov B, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-2079-y; Sabirzhanov B, 2019, BRAIN BEHAV IMMUN, V80, P73, DOI 10.1016/j.bbi.2019.02.024; Sasaki M, 2013, BIOCHEM J, V450, P295, DOI 10.1042/BJ20121188; Seredenina T, 2015, ANTIOXID REDOX SIGN, V23, P490, DOI 10.1089/ars.2013.5806; Simon RP, 2006, ARCH NEUROL-CHICAGO, V63, P1368, DOI 10.1001/archneur.63.10.1368; Stirling DP, 2010, TRENDS MOL MED, V16, P160, DOI 10.1016/j.molmed.2010.02.002; TANG CM, 1990, P NATL ACAD SCI USA, V87, P6445, DOI 10.1073/pnas.87.16.6445; Tian DS, 2016, J NEUROCHEM, V139, P96, DOI 10.1111/jnc.13751; VINK R, 1987, J CEREBR BLOOD F MET, V7, P563, DOI 10.1038/jcbfm.1987.106; VINK R, 1989, ANN NEUROL, V25, P26, DOI 10.1002/ana.410250105; Waldmann R, 1997, NATURE, V386, P173, DOI 10.1038/386173a0; Wu JF, 2016, J NEUROTRAUM, V33, P1919, DOI 10.1089/neu.2015.4348; Wu JF, 2015, CELL CYCLE, V14, P3698, DOI 10.1080/15384101.2015.1104436; Wu JF, 2014, J NEUROSCI, V34, P10989, DOI 10.1523/JNEUROSCI.5110-13.2014; Wu LJ, 2004, J BIOL CHEM, V279, P43716, DOI 10.1074/jbc.M403557200; Wu LJ, 2014, NEUROSCIENTIST, V20, P599, DOI 10.1177/1073858413519864; Wu LJ, 2012, NAT NEUROSCI, V15, P565, DOI 10.1038/nn.3059; ZAKS I O, 1976, Byulleten' Eksperimental'noi Biologii i Meditsiny, V82, P1303; Zhang B, 2019, BRAIN BEHAV IMMUN, V76, P139, DOI 10.1016/j.bbi.2018.11.013; Zhou X, 2014, NEURAL REGEN RES, V9, P1787, DOI 10.4103/1673-5374.143423; Zygun DA, 2004, NEUROSURGERY, V55, P877, DOI 10.1227/01.NEU.0000137658.14906.E4	63	7	7	3	5	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0889-1591	1090-2139		BRAIN BEHAV IMMUN	Brain Behav. Immun.	JAN	2021	91						267	283		10.1016/j.bbi.2020.10.005			17	Immunology; Neurosciences; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Immunology; Neurosciences & Neurology; Psychiatry	PI9OG	WOS:000601410600007	33039662	Green Accepted, hybrid			2022-02-06	
J	Xu, LB; Yue, JK; Korley, F; Puccio, AM; Yuh, EL; Sun, XY; Rabinowitz, M; Vassar, MJ; Taylor, SR; Winkler, EA; Puffer, RC; Deng, H; McCrea, M; Stein, MB; Robertson, CS; Levin, HS; Dikmen, S; Temkin, NR; Giacino, JT; Mukherjee, P; Wang, KKW; Okonkwo, DO; Markowitz, AJ; Jain, S; Manley, GT; Diaz-Arrastia, R				Xu, Linda B.; Yue, John K.; Korley, Frederick; Puccio, Ava M.; Yuh, Esther L.; Sun, Xiaoying; Rabinowitz, Miri; Vassar, Mary J.; Taylor, Sabrina R.; Winkler, Ethan A.; Puffer, Ross C.; Deng, Hansen; McCrea, Michael; Stein, Murray B.; Robertson, Claudia S.; Levin, Harvey S.; Dikmen, Sureyya; Temkin, Nancy R.; Giacino, Joseph T.; Mukherjee, Pratik; Wang, Kevin K. W.; Okonkwo, David O.; Markowitz, Amy J.; Jain, Sonia; Manley, Geoffrey T.; Diaz-Arrastia, Ramon		TRACK-TBI Investigators	High-Sensitivity C-Reactive Protein Is a Prognostic Biomarker of Six-Month Disability after Traumatic Brain Injury: Results from the TRACK-TBI Study	JOURNAL OF NEUROTRAUMA			English	Article						biomarkers; head trauma; traumatic brain injury	COMMON DATA ELEMENTS; SEVERE HEAD-INJURY; INFLAMMATORY RESPONSE; CONCOMITANT INJURIES; RANDOMIZED-TRIAL; ISCHEMIC-STROKE; STATIN THERAPY; FOLLOW-UP; AMYLOID-P; SERUM	Systemic inflammation impacts outcome after traumatic brain injury (TBI), but most TBI biomarker studies have focused on brain-specific proteins. C-reactive protein (CRP) is a widely used biomarker of inflammation with potential as a prognostic biomarker after TBI. The Transforming Research and Clinical Knowledge in Traumatic Brain Injury (TRACK-TBI) study prospectively enrolled TBI patients within 24 h of injury, as well as orthopedic injury and uninjured controls; biospecimens were collected at enrollment. A subset of hospitalized participants had blood collected on day 3, day 5, and 2 weeks. High-sensitivity CRP (hsCRP) and glial fibrillary acidic protein (GFAP) were measured. Receiver operating characteristic analysis was used to evaluate the prognostic ability of hsCRP for 6-month outcome, using the Glasgow Outcome Scale-Extended (GOSE). We included 1206 TBI subjects, 122 orthopedic trauma controls (OTCs), and 209 healthy controls (HCs). Longitudinal biomarker sampling was performed in 254 hospitalized TBI subjects and 19 OTCs. hsCRP rose between days 1 and 5 for TBI and OTC subjects, and fell by 2 weeks, but remained elevated compared with HCs (p < 0.001). Longitudinally, hsCRP was significantly higher in the first 2 weeks for subjects with death/severe disability (GOSE <5) compared with those with moderate disability/good recovery (GOSE >= 5); AUC was highest at 2 weeks (AUC = 0.892). Combining hsCRP and GFAP at 2 weeks produced AUC = 0.939 for prediction of disability. Serum hsCRP measured within 2 weeks of TBI is a prognostic biomarker for disability 6 months later. hsCRP may have utility as a biomarker of target engagement for anti-inflammatory therapies.	[Xu, Linda B.; Diaz-Arrastia, Ramon] Univ Penn, Dept Neurol, Philadelphia, PA 19104 USA; [Yue, John K.; Vassar, Mary J.; Taylor, Sabrina R.; Winkler, Ethan A.; Manley, Geoffrey T.] Univ Calif San Francisco, Dept Neurosurg, San Francisco, CA USA; [Yuh, Esther L.; Mukherjee, Pratik] Univ Calif San Francisco, Dept Radiol, San Francisco, CA USA; [Yue, John K.; Yuh, Esther L.; Vassar, Mary J.; Taylor, Sabrina R.; Winkler, Ethan A.; Mukherjee, Pratik; Markowitz, Amy J.; Manley, Geoffrey T.] Zuckerberg San Francisco Gen Hosp, Brain & Spinal Injury Ctr, San Francisco, CA USA; [Korley, Frederick] Univ Michigan, Dept Emergency Med, Ann Arbor, MI USA; [Sun, Xiaoying; Jain, Sonia] Univ Calif San Diego, Dept Family Med & Publ Hlth, San Diego, CA 92103 USA; [Stein, Murray B.] Univ Calif San Diego, Dept Psychiat & Family Med, San Diego, CA 92103 USA; [Puccio, Ava M.; Rabinowitz, Miri; Puffer, Ross C.; Deng, Hansen; Okonkwo, David O.] Univ Pittsburgh, Dept Neurosurg, Med Ctr, Pittsburgh, PA USA; [Puffer, Ross C.] Mayo Clin, Dept Neurosurg, Rochester, MN USA; [McCrea, Michael] Med Coll Wisconsin, Dept Neurosurg, Milwaukee, WI 53226 USA; [Robertson, Claudia S.; Levin, Harvey S.] Baylor Coll Med, Dept Neurosurg, Houston, TX 77030 USA; [Robertson, Claudia S.] Baylor Coll Med, Dept Crit Care, Houston, TX 77030 USA; [Levin, Harvey S.] Baylor Coll Med, Dept Neurol, Houston, TX 77030 USA; [Dikmen, Sureyya] Univ Washington, Dept Rehabil Med, Seattle, WA 98195 USA; [Temkin, Nancy R.] Univ Washington, Dept Neurosurg, Seattle, WA 98195 USA; [Temkin, Nancy R.] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Giacino, Joseph T.] Harvard Med Sch, Dept Rehabil Med, Spaulding Rehabil Hosp, Boston, MA 02115 USA; [Wang, Kevin K. W.] Univ Florida, Dept Psychiat & Neurosci, McKnight Brain Inst, Gainesville, FL USA		Diaz-Arrastia, R (corresponding author), Univ Penn, Dept Neurol, Perelman Sch Med, Penn Presbyterian Med Ctr, 51 North 39th St,Andrew Mutch Bldg,Room 409, Philadelphia, PA 19104 USA.	Ramon.Diaz-Arrastia@pennmedicine.upenn.edu	Giacino, Joseph/AAF-1952-2021	Giacino, Joseph/0000-0002-7916-9698; Hemphill, Claude/0000-0003-4019-7525	NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [1RC2NS069409-01, 3RC2NS069409-02S1, 5RC2NS069409-02, 1U01NS086090-01, 3U01NS086090-02S1, 3U01NS086090-02S2, 3U01NS086090-03S1, 5U01NS086090-02, 5U01NS086090-03]; U.S. Department of Defense (DOD)United States Department of Defense [W81XWH-13-10441]; US DODUnited States Department of Defense [W81XWH-14-2-0176]	This work was supported by the following grants: NINDS 1RC2NS069409-01, 3RC2NS069409-02S1, 5RC2NS069409-02, 1U01NS086090-01, 3U01NS086090-02S1, 3U01NS086090-02S2, 3U01NS086090-03S1, 5U01NS086090-02, and 5U01NS086090-03; U.S. Department of Defense (DOD) W81XWH-13-10441, US DOD W81XWH-14-2-0176 (to G.T.M.).	Albert MA, 2001, JAMA-J AM MED ASSOC, V286, P64, DOI 10.1001/jama.286.1.64; Anada RP, 2018, ELECTROPHORESIS, V39, P2308, DOI 10.1002/elps.201700407; Dadas A, 2018, NEUROPSYCH DIS TREAT, V14, P2989, DOI 10.2147/NDT.S125620; Di Napoli M, 2001, STROKE, V32, P917, DOI 10.1161/01.STR.32.4.917; Di Napoli M, 2014, STROKE, V45, P59, DOI 10.1161/STROKEAHA.113.001721; Di Napoli M, 2012, NEUROLOGY, V79, P690, DOI 10.1212/WNL.0b013e318264e3be; Diaz-Arrastia R, 2014, J NEUROTRAUM, V31, P135, DOI 10.1089/neu.2013.3019; Emsley HCA, 2003, J NEUROIMMUNOL, V139, P93, DOI 10.1016/S0165-5728(03)00134-6; Foreman BP, 2007, J TRAUMA, V62, P946, DOI 10.1097/01.ta.0000229796.14717.3a; Gabay C, 1999, NEW ENGL J MED, V340, P448, DOI 10.1056/NEJM199902113400607; GROSWASSER Z, 1990, Brain Injury, V4, P161, DOI 10.3109/02699059009026161; Haacke EM, 2010, J MAGN RESON IMAGING, V32, P516, DOI 10.1002/jmri.22259; Hensler T, 2002, J TRAUMA, V52, P962, DOI 10.1097/00005373-200205000-00023; HICKS PS, 1992, J IMMUNOL, V149, P3689; Ikonomidis I, 1999, CIRCULATION, V100, P793, DOI 10.1161/01.CIR.100.8.793; Is M, 2007, J CLIN NEUROSCI, V14, P1163, DOI 10.1016/j.jocn.2006.05.020; Jagoda AS, 2002, ANN EMERG MED, V40, P231, DOI [10.1067/mem.2002.125782, 10.1016/j.jen.2008.12.010]; Koulouris S, 2005, AM J CARDIOL, V95, P1386, DOI 10.1016/j.amjcard.2005.01.092; Kumar A, 2012, BRAIN BEHAV IMMUN, V26, P1191, DOI 10.1016/j.bbi.2012.06.008; Kumar RG, 2015, BRAIN BEHAV IMMUN, V45, P253, DOI 10.1016/j.bbi.2014.12.021; Leitgeb J, 2013, ARCH ORTHOP TRAUM SU, V133, P659, DOI 10.1007/s00402-013-1710-0; Leong BK, 2013, DISABIL REHABIL, V35, P1546, DOI 10.3109/09638288.2012.748832; Lingsma H, 2013, J TRAUMA ACUTE CARE, V74, P639, DOI 10.1097/TA.0b013e31827d602e; Lucas SM, 2006, BRIT J PHARMACOL, V147, pS232, DOI 10.1038/sj.bjp.0706400; Lust JA, 2016, AM J HEMATOL, V91, P571, DOI 10.1002/ajh.24352; Lustenberger T, 2016, IMMUNOBIOLOGY, V221, P427, DOI 10.1016/j.imbio.2015.11.011; Manley GT, 2010, ARCH PHYS MED REHAB, V91, P1667, DOI 10.1016/j.apmr.2010.05.018; McDonald SJ, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0555-1; Nelson LD, 2019, JAMA NEUROL, V76, P1049, DOI 10.1001/jamaneurol.2019.1313; Nissen SE, 2005, NEW ENGL J MED, V352, P29, DOI 10.1056/NEJMoa042000; Peyrin-Biroulet L, 2014, GUT, V63, P88, DOI 10.1136/gutjnl-2013-304984; Pietila KO, 1996, EUR HEART J, V17, P1345; Prasad K, 2006, CARDIOVASC DRUG REV, V24, P33, DOI 10.1111/j.1527-3466.2006.00033.x; Probst C, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/136020; Reichle A, 2007, MELANOMA RES, V17, P360, DOI 10.1097/CMR.0b013e3282f1d2c8; Ridker PM, 2017, NEW ENGL J MED, V377, P1119, DOI 10.1056/NEJMoa1707914; Rocco A, 2015, NEUROL SCI, V36, P2235, DOI 10.1007/s10072-015-2342-7; Carabias CS, 2020, WORLD NEUROSURG, V134, pE120, DOI 10.1016/j.wneu.2019.09.143; Sandsmark DK, 2016, CURR NEUROL NEUROSCI, V16, DOI 10.1007/s11910-016-0654-5; Sarrafzadeh AS, 2001, CRIT CARE MED, V29, P1116, DOI 10.1097/00003246-200106000-00004; Sharma R, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173798; Shetty T, 2019, J HEAD TRAUMA REHAB, V34, pE28, DOI 10.1097/HTR.0000000000000450; SIEGEL JH, 1991, CRIT CARE MED, V19, P1252, DOI 10.1097/00003246-199110000-00007; Sogut O, 2010, J INT MED RES, V38, P1708, DOI 10.1177/147323001003800516; Soilu-Hanninen M, 2005, NEUROLOGY, V65, P153, DOI 10.1212/01.WNL.0000167129.90918.f5; Strober B, 2008, BRIT J DERMATOL, V159, P322, DOI 10.1111/j.1365-2133.2008.08628.x; Stulemeijer M, 2006, J NEUROTRAUM, V23, P1561, DOI 10.1089/neu.2006.23.1561; Su SH, 2014, BRAIN BEHAV IMMUN, V38, P111, DOI 10.1016/j.bbi.2014.01.009; Thompson D, 1999, STRUCTURE, V7, P169, DOI 10.1016/S0969-2126(99)80023-9; Toedter GP, 2009, AM J GASTROENTEROL, V104, P2768, DOI 10.1038/ajg.2009.454; Trikha M, 2003, CLIN CANCER RES, V9, P4653; Utagawa A, 2008, EXP NEUROL, V211, P283, DOI 10.1016/j.expneurol.2008.02.001; van Leeuwen N, 2012, NEUROSURGERY, V70, P811, DOI 10.1227/NEU.0b013e318235d640; Warren MS, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0578-5; Watanabe T, 2018, NEUROL MED-CHIR, V58, P393, DOI 10.2176/nmc.oa.2018-0116; Weckbach S, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/890816; Winbeck K, 2002, STROKE, V33, P2459, DOI 10.1161/01.STR.0000029828.51413.82; Wolbink GJ, 1996, J IMMUNOL, V157, P473; Woodcock T, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00018; Yasojima K, 2000, BRAIN RES, V887, P80, DOI 10.1016/S0006-8993(00)02970-X; Yasojima K, 2001, AM J PATHOL, V158, P1039, DOI 10.1016/S0002-9440(10)64051-5; Yue JK, 2019, LANCET NEUROL, V18, P953, DOI 10.1016/S1474-4422(19)30282-0	62	7	7	1	7	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	APR 1	2021	38	7					918	927		10.1089/neu.2020.7177		DEC 2020	10	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	RI3KN	WOS:000603688900001	33161875				2022-02-06	
J	Agtarap, SD; Campbell-Sills, L; Jain, S; Sun, XY; Dikmen, S; Levin, H; McCrea, MA; Mukherjee, P; Nelson, LD; Temkin, N; Yuh, EL; Giacino, JT; Manley, GT; Stein, MB				Agtarap, Stephanie D.; Campbell-Sills, Laura; Jain, Sonia; Sun, Xiaoying; Dikmen, Sureyya; Levin, Harvey; McCrea, Michael A.; Mukherjee, Pratik; Nelson, Lindsay D.; Temkin, Nancy; Yuh, Esther L.; Giacino, Joseph T.; Manley, Geoffrey T.; Stein, Murray B.		TRACK-TBI Investigators	Satisfaction with Life after Mild Traumatic Brain Injury: A TRACK-TBI Study	JOURNAL OF NEUROTRAUMA			English	Article						concussion; life satisfaction; post-concussive symptoms; traumatic brain injury; well-being	POSTTRAUMATIC-STRESS-DISORDER; PHYSICAL FUNCTION; SYMPTOMS; PAIN; VALIDITY; TRAJECTORIES; POPULATION; DISABILITY; DEPRESSION; FATIGUE	Identifying the principal determinants of life satisfaction following mild TBI (mTBI) may inform efforts to improve subjective well-being in this population. We examined life satisfaction among participants in the Transforming Research and Clinical Knowledge in Traumatic Brain Injury (TRACK-TBI) study who presented with mTBI (Glasgow Coma Scale [GCS] score = 13-15; n = 1152). An L1-regularization path algorithm was used to select optimal sets of baseline and concurrent symptom measures for prediction of scores on the Satisfaction with Life Scale (SWLS) at 2 weeks and 3, 6, and 12 months post-injury. Multi-variable linear regression models (all n = 744-894) were then fit to evaluate associations between the empirically selected predictors and SWLS scores at each follow-up visit. Results indicated that emotional post-TBI symptoms (all b = -1.27 to -0.77, all p < 0.05), anhedonia (all b = -1.59 to -1.08, all p < 0.01), and pain interference (all b = -1.38 to -0.89, all p < 0.001) contributed to the prediction of lower SWLS scores at all follow-ups. Insomnia predicted lower SWLS scores at 2 weeks, 3 months, and 6 months (all b = -1.11 to -0.83, all ps < 0.01); and negative affect predicted lower SWLS scores at 2 weeks, 3 months, and 12 months (all b = -1.38 to -0.80, all p < 0.005). Other post-TBI symptom domains and baseline socio-demographic, injury-related, and clinical characteristics did not emerge as robust predictors of SWLS scores during the year after mTBI. Efforts to improve satisfaction with life following mTBI may benefit from a focus on the detection and treatment of affective symptoms, pain, and insomnia. The results reinforce the need for tailoring of evidence-based treatments for these conditions to maximize efficacy in patients with mTBI.	[Agtarap, Stephanie D.; Campbell-Sills, Laura; Stein, Murray B.] Univ Calif San Diego, Dept Psychiat, 9500 Gilman Dr,Mail Code 0855, La Jolla, CA 92093 USA; [Jain, Sonia; Sun, Xiaoying; Stein, Murray B.] Univ Calif San Diego, Dept Family Med & Publ Hlth, La Jolla, CA 92093 USA; [Dikmen, Sureyya] Univ Washington, Dept Rehabil Med, Seattle, WA 98195 USA; [Temkin, Nancy] Univ Washington, Dept Neurol Surg, Seattle, WA 98195 USA; [Temkin, Nancy] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Levin, Harvey] Baylor Coll Med, Dept Phys Med & Rehabil, Houston, TX 77030 USA; [McCrea, Michael A.; Nelson, Lindsay D.] Med Coll Wisconsin, Dept Neurosurg, Milwaukee, WI 53226 USA; [McCrea, Michael A.; Nelson, Lindsay D.] Med Coll Wisconsin, Dept Neurol, Milwaukee, WI 53226 USA; [Mukherjee, Pratik; Yuh, Esther L.] Univ Calif San Francisco, Dept Radiol & Biomed Imaging, San Francisco, CA 94143 USA; [Mukherjee, Pratik; Yuh, Esther L.] Univ Calif San Francisco, Dept Bioengn & Therapeut Serv, San Francisco, CA 94143 USA; [Manley, Geoffrey T.] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA USA; [Mukherjee, Pratik; Yuh, Esther L.; Manley, Geoffrey T.] Zuckerberg San Francisco Gen Hosp, Brain & Spinal Injury Ctr, San Francisco, CA USA; [Giacino, Joseph T.] Harvard Med Sch, Dept Phys Med & Rehabil, Boston, MA 02115 USA; [Giacino, Joseph T.] Spaulding Rehabil Hosp, Dept Phys Med & Rehabil, Charlestown, MA USA; [Stein, Murray B.] VA San Diego Healthcare Syst, Psychiat Serv, San Diego, CA USA		Campbell-Sills, L (corresponding author), Univ Calif San Diego, Dept Psychiat, 9500 Gilman Dr,Mail Code 0855, La Jolla, CA 92093 USA.	l2campbellsills@health.ucsd.edu	Giacino, Joseph/AAF-1952-2021	Giacino, Joseph/0000-0002-7916-9698; Hemphill, Claude/0000-0003-4019-7525	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [U01NS086090]; U.S. Department of DefenseUnited States Department of Defense [W81XWH-14-2-0176]; Abbott LaboratoriesAbbott Laboratories; OneMind	This research was supported by the National Institutes of Health (grant U01NS086090) and the U.S. Department of Defense (grantW81XWH-14-2-0176). Abbott Laboratories provided funding for add-in TRACK-TBI clinical studies. OneMind provided funding for TRACK-TBI patients' stipends and support to clinical sites.	Agtarap S, 2021, ASSESSMENT, V28, P1656, DOI 10.1177/1073191120913941; Amtmann D, 2010, PAIN, V150, P173, DOI 10.1016/j.pain.2010.04.025; [Anonymous], 2015, C TRAUM BRAIN INJ US; Armour C, 2015, J PSYCHIATR RES, V61, P106, DOI 10.1016/j.jpsychires.2014.10.012; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Bastien CH, 2001, SLEEP MED, V2, P297, DOI 10.1016/S1389-9457(00)00065-4; Blennow K, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.84; Blevins CA, 2015, J TRAUMA STRESS, V28, P489, DOI 10.1002/jts.22059; Boonstra AM, 2013, QUAL LIFE RES, V22, P93, DOI 10.1007/s11136-012-0132-8; Bovin MJ, 2016, PSYCHOL ASSESSMENT, V28, P1379, DOI 10.1037/pas0000254; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Cella D, 2010, J CLIN EPIDEMIOL, V63, P1179, DOI 10.1016/j.jclinepi.2010.04.011; Cook KF, 2016, J CLIN EPIDEMIOL, V73, P89, DOI 10.1016/j.jclinepi.2015.08.038; Corrigan JD, 2001, J HEAD TRAUMA REHAB, V16, P543, DOI 10.1097/00001199-200112000-00003; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P318, DOI 10.1097/01.HTR.0000300227.67748.77; Davis LC, 2012, ARCH PHYS MED REHAB, V93, P1324, DOI 10.1016/j.apmr.2012.02.036; Derogatis LR., 2001, BSI 18 BRIEF SYMPTOM; DIENER E, 1984, PSYCHOL BULL, V95, P542, DOI 10.1037/0033-2909.95.3.542; DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13; FUHRER MJ, 1994, AM J PHYS MED REHAB, V73, P358, DOI 10.1097/00002060-199409000-00010; Haarbauer-Krupa J, 2017, J NEUROTRAUM, V34, P50, DOI 10.1089/neu.2015.4158; Harfmann EJ, 2020, J NEUROTRAUM, V37, P1408, DOI 10.1089/neu.2019.6746; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Jackowska M, 2016, J PSYCHOSOM RES, V84, P52, DOI 10.1016/j.jpsychores.2016.03.017; Kaufmann CN, 2019, BEHAV SLEEP MED, V17, P12, DOI 10.1080/15402002.2016.1266490; Keurn BT, 2018, PSYCHOL ASSESSMENT, V30, P1096, DOI 10.1037/pas0000550; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Kreitzer NP, 2019, J HEAD TRAUMA REHAB, V34, pE10, DOI 10.1097/HTR.0000000000000457; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Kuppens P, 2008, J PERS SOC PSYCHOL, V95, P66, DOI 10.1037/0022-3514.95.1.66; Losoi H, 2016, J NEUROTRAUM, V33, P766, DOI 10.1089/neu.2015.4070; Mailhan L, 2005, BRAIN INJURY, V19, P227, DOI 10.1080/02699050410001720149; McMahon P, 2014, J NEUROTRAUM, V31, P26, DOI 10.1089/neu.2013.2984; Nelson LD, 2019, JAMA NEUROL, V76, P1049, DOI 10.1001/jamaneurol.2019.1313; Park MY, 2007, J ROY STAT SOC B, V69, P659, DOI 10.1111/j.1467-9868.2007.00607.x; Pavot W, 2009, SOC INDIC RES SER, V39, P101, DOI 10.1007/978-90-481-2354-4_5; Pierce CA, 2006, AM J PHYS MED REHAB, V85, P889, DOI 10.1097/01.phm.0000242615.43129.ae; Resch JA, 2009, REHABIL PSYCHOL, V54, P51, DOI 10.1037/a0015051; Seidl JNT, 2015, REHABIL PSYCHOL, V60, P335, DOI 10.1037/rep0000064; Silverberg ND, 2020, ARCH PHYS MED REHAB, V101, P382, DOI 10.1016/j.apmr.2019.10.179; Stalnacke BM, 2007, BRAIN INJURY, V21, P933, DOI 10.1080/02699050701553189; Stein MB, 2019, JAMA PSYCHIAT, V76, P249, DOI 10.1001/jamapsychiatry.2018.4288; Stone AA, 2016, J CLIN EPIDEMIOL, V74, P194, DOI 10.1016/j.jclinepi.2015.08.029; Styrke J, 2013, J REHABIL MED, V45, P749, DOI 10.2340/16501977-1215; Thomas ML, 2012, PSYCHOL ASSESSMENT, V24, P101, DOI 10.1037/a0024712; von Steinbuechel N, 2005, ACTA NEUROCHIR SUPPL, V93, P43; Whiteneck GG, 2016, J HEAD TRAUMA REHAB, V31, pE55, DOI 10.1097/HTR.0000000000000140; Whiteneck GG, 2016, J HEAD TRAUMA REHAB, V31, pE43, DOI 10.1097/HTR.0000000000000141; Wilde EA, 2010, ARCH PHYS MED REHAB, V91, P1650, DOI 10.1016/j.apmr.2010.06.033; Williamson MLC, 2016, J HEAD TRAUMA REHAB, V31, P167, DOI 10.1097/HTR.0000000000000111; Yue JK, 2018, NEUROREHABILITATION, V43, P169, DOI 10.3233/NRE-172375; Zahniser E, 2019, ARCH CLIN NEUROPSYCH, V34, P1165, DOI 10.1093/arclin/acy103; Zheng Jie, 1800, Curr Epidemiol Rep, V4, P330, DOI 10.1007/s40471-017-0128-6	53	7	7	0	1	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	MAR 1	2021	38	5					546	554		10.1089/neu.2020.7055		DEC 2020	9	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	QP9GR	WOS:000599325200001	33107371				2022-02-06	
J	Niquen-Jimenez, M; Wishart, D; Garcia, RM; Shlobin, NA; Steinle, J; Weiss, H; Reynolds, RA; Lam, S; Rosseau, G				Niquen-Jimenez, Milagros; Wishart, Danielle; Garcia, Roxanna M.; Shlobin, Nathan A.; Steinle, Julia; Weiss, Hannah; Reynolds, Rebecca A.; Lam, Sandi; Rosseau, Gail			A Bibliographic Analysis of the Most Cited Articles in Global Neurosurgery	WORLD NEUROSURGERY			English	Article						Global neurosurgery; Global surgery; Neurosurgery	TRAUMATIC BRAIN-INJURY; BIBLIOMETRIC ANALYSIS; SURGERY; HEALTH; NEED; MISSION; COMMISSION; CAPACITY; EPILEPSY; HEAD	OBJECTIVE: Global neurosurgery is the practice of neurosurgery with the primary purpose of delivering timely, safe, and affordable neurosurgical care to all who need it. The aim of this study is to identify the most frequently cited articles in global neurosurgery through a bibliographic review to characterize articles and trends around this growing topic. METHODS: The top most-cited articles in global neurosurgery were determined by searching the Web of Science database using a priori search terms. Articles with at least 5 citations were selected, and there were no time period or language restrictions. The data were extracted from each included article and all characteristics were summarized. RESULTS: A total of 932 articles were identified using the search terms; 69 articles fulfilled inclusion criteria and 17 articles were selected that had more than 5 citations. The articles' number of citations ranged from 6 to 98 for the most-cited article. Authors from, or affiliated with, 14 countries contributed to the 17 articles, and the country that had the greatest representation was the United States. The main topic discussed was surgical capacity, the second topic was the treatment of different neurosurgical conditions, and volunteerism was the third topic. CONCLUSIONS: There is currently a deficit in both the amount of literature surrounding the topic of global neurosurgery and how much that literature is cited. Developing innovative ways to increase academic productivity within, or in collaboration with, low-middle income countries is essential to contribute to global neurosurgery.	[Niquen-Jimenez, Milagros] Univ Peruana Cayetano Heredia, Fac Med Humana Alberto Hurtado, Lima, Peru; [Wishart, Danielle; Garcia, Roxanna M.; Shlobin, Nathan A.; Weiss, Hannah; Lam, Sandi] Northwestern Univ, Northwestern Feinberg Sch Med, Chicago, IL 60611 USA; [Garcia, Roxanna M.; Lam, Sandi] Northwestern Med, Dept Neurol Surg, Chicago, IL 60611 USA; [Garcia, Roxanna M.] Northwestern Univ, Ctr Healthcare Studies, Inst Global Hlth, Chicago, IL 60611 USA; [Steinle, Julia] Univ Munster, Fac Med, Munster, Germany; [Reynolds, Rebecca A.] Vanderbilt Univ, Dept Neurosurg, Med Ctr, Nashville, TN USA; [Lam, Sandi] Ann & Robert H Lurie Childrens Hosp, Div Neurosurg, Chicago, IL USA; [Rosseau, Gail] George Washington Univ, Sch Med & Hlth Sci, Dept Neurosurg, Washington, DC 20052 USA		Garcia, RM (corresponding author), Northwestern Univ, Northwestern Feinberg Sch Med, Chicago, IL 60611 USA.; Garcia, RM (corresponding author), Northwestern Med, Dept Neurol Surg, Chicago, IL 60611 USA.; Garcia, RM (corresponding author), Northwestern Univ, Ctr Healthcare Studies, Inst Global Hlth, Chicago, IL 60611 USA.	roxanna.garcia@northwestern.edu		Niquen-Jimenez, Milagros/0000-0001-5590-9076; Garcia, Roxanna/0000-0002-4083-9893; Shlobin, Nathan/0000-0003-2079-6125; Wishart, Danielle/0000-0001-7301-0806	Fogarty International Center at the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC) [R25TW009337]; Fogarty International Center through the Harvard [D43TW010543]; Boston University; Northwestern University; University of New Mexico consortium	Dr. Reynolds serves as a Fogarty Global Health Trainee affiliated with the Vanderbilt eEmoryeCornelleDuke consortium and is supported by the Fogarty International Center at the National Institutes of Health under grant number R25TW009337. Dr. Garcia serves as a Fogarty Global Health Trainee and is supported by the Fogarty International Center under grant number D43TW010543 through the Harvard, Boston University, Northwestern University, and University of New Mexico consortium. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abbott R, 2009, CHILD NERV SYST, V25, P1157, DOI 10.1007/s00381-009-0929-0; Akhaddar A, 2019, WORLD NEUROSURG, V126, P314, DOI 10.1016/j.wneu.2019.03.095; Akhaddar A, 2019, WORLD NEUROSURG, V126, P59, DOI 10.1016/j.wneu.2019.02.122; Bradko V, 2019, NEUROSPINE, V16, P715, DOI 10.14245/ns.1836342.171; Cebron U, 2019, ANN PLAS SURG, V83, P334, DOI 10.1097/SAP.0000000000001787; Charry JD, 2017, WORLD NEUROSURG, V101, P554, DOI 10.1016/j.wneu.2017.02.051; Corley JA, 2016, NEUROSURGERY, V79, pE544, DOI 10.1227/NEU.0000000000001351; Dempsey RJ, 2018, NEUROSURG FOCUS, V45, DOI 10.3171/2018.7.FOCUS18363; Dempsey RJ, 2018, WORLD NEUROSURG, V112, P325, DOI 10.1016/j.wneu.2018.02.099; Dempsey RJ, 2013, NEUROSURGERY, V73, P1070, DOI 10.1227/NEU.0000000000000136; Dewan MC, 2019, J NEUROSURG, V130, P1055, DOI 10.3171/2017.11.JNS171500; Donnally CJ, 2019, WORLD NEUROSURG, V123, P41, DOI 10.1016/j.wneu.2018.11.205; Ellegala DB, 2014, J NEUROSURG, V121, P1526, DOI 10.3171/2014.7.JNS122153; Fallah PN, 2019, J NEUROSURG, V130, P1157, DOI 10.3171/2017.10.JNS17435; Franzen SRP, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-012332; Fuller Anthony, 2016, eNeurologicalSci, V3, P1, DOI 10.1016/j.ensci.2015.10.003; Green BN, 2018, EUR SPINE J, V27, P838, DOI 10.1007/s00586-018-5635-8; Hartl R, 2010, WORLD NEUROSURG, V73, P259, DOI 10.1016/j.wneu.2010.02.047; Haglund MM, 2019, J NEUROSURG, V131, P993, DOI 10.3171/2019.4.JNS181747; Johnson Walter D, 2013, Surg Neurol Int, V4, P47, DOI 10.4103/2152-7806.110030; Laxe S, 2013, BRAIN INJURY, V27, P379, DOI 10.3109/02699052.2012.750757; Li L, 2018, WORLD NEUROSURG, V113, pE82, DOI 10.1016/j.wneu.2018.01.164; Liu BL, 2019, CUREUS, V11, DOI 10.7759/cureus.4498; Madhugiri VS, 2013, J NEUROSURG, V119, P1274, DOI 10.3171/2013.8.JNS122379; Mansouri A, 2015, BRIT J NEUROSURG, V29, P751, DOI 10.3109/02688697.2015.1100269; Mansouri A, 2014, WORLD NEUROSURG, V81, pE14, DOI 10.1016/j.wneu.2013.09.049; Meara JG, 2015, AM J OBSTET GYNECOL, V213, P338, DOI 10.1016/j.ajog.2015.04.010; Mendelsohn D, 2013, STEREOT FUNCT NEUROS, V91, P306, DOI 10.1159/000348323; Muir RT, 2016, NEUROSURG FOCUS, V41, DOI 10.3171/2016.7.FOCUS16273; Nasir SAR, 2018, WORLD NEUROSURG, V110, P445, DOI 10.1016/j.wneu.2017.09.077; Ohba Norio, 2005, Nippon Ganka Gakkai Zasshi, V109, P115; Onyia CU, 2019, J NEUROSURG, V130, P1402, DOI 10.3171/2018.5.JNS181337; Oravec CS, 2019, PEDIATR NEUROSURG, V54, P85, DOI 10.1159/000495790; Park KB, 2016, WORLD NEUROSURG, V88, P32, DOI 10.1016/j.wneu.2015.12.048; Piquer J, 2014, EANS 2014 15 EUR C N; Prabhu VC, 2015, WORLD NEUROSURG, V84, P1544, DOI 10.1016/j.wneu.2015.07.048; Ramos MB, 2019, WORLD NEUROSURG, V129, P261, DOI 10.1016/j.wneu.2019.06.048; Ramos RD, 2019, NEUROSURGERY, V85, pE917, DOI 10.1093/neuros/nyz178; Ravindra VM, 2015, WORLD NEUROSURG, V84, P1458, DOI 10.1016/j.wneu.2015.06.046; Rigoard P, 2015, NEUROCHIRURGIE, V61, pS131, DOI 10.1016/j.neuchi.2014.04.003; Rosseau G, 2018, NEUROSURG FOCUS, V45, DOI 10.3171/2018.7.FOCUS18295; Sabatino ME, 2019, JAMA SURG, V154, P475, DOI 10.1001/jamasurg.2019.0044; Sacco A, 2018, PRENATAL DIAG, V38, P1020, DOI 10.1002/pd.5383; Sader E, 2017, WORLD NEUROSURG, V98, P397, DOI 10.1016/j.wneu.2016.07.098; Samanci Y, 2019, NEUROL INDIA, V67, P78, DOI 10.4103/0028-3886.253969; Saunders TFC, 2017, CLIN OTOLARYNGOL, V42, P1338, DOI 10.1111/coa.12910; Servadei F, 2018, WORLD NEUROSURG, V112, P315, DOI 10.1016/j.wneu.2018.01.047; Sgro A, 2019, WORLD J SURG, V43, P2689, DOI 10.1007/s00268-019-05112-w; Silfvenius H, 1997, EPILEPSIA, V38, P249; Street J, 2010, SPINE, V35, P1377, DOI 10.1097/BRS.0b013e3181db96a5; Vervoort D, 2019, HEART ASIA, V11, DOI 10.1136/heartasia-2018-011125; Warf B, 2016, LANCET NEUROL, V15, P898, DOI 10.1016/S1474-4422(16)30141-7; World Health Organization, 2015, WHA6815 WHO	53	7	7	1	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	DEC	2020	144						E195	E203		10.1016/j.wneu.2020.08.084			9	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	PH8PV	WOS:000600668300022	32829020	Green Accepted			2022-02-06	
J	Braun, NJ; Yao, KR; Alford, PW; Liao, DZ				Braun, Nicholas J.; Yao, Katherine R.; Alford, Patrick W.; Liao, Dezhi			Mechanical injuries of neurons induce tau mislocalization to dendritic spines and tau-dependent synaptic dysfunction	PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA			English	Article						traumatic brain injuries; dendritic spines; tau; chronic traumatic; encephalopathy; synaptic deficits	CHRONIC TRAUMATIC ENCEPHALOPATHY; BRAIN-INJURY; ALZHEIMERS-DISEASE; AXONAL-TRANSPORT; VISCOELASTIC PROPERTIES; HEAD-INJURY; CA1 REGION; IN-VIVO; DEPRESSION; RISK	Chronic traumatic encephalopathy (CTE) is associated with re-peated traumatic brain injuries (TBI) and is characterized by cognitive decline and the presence of neurofibrillary tangles (NFTs) of the protein tau in patients' brains. Here we provide direct evidence that cell-scale mechanical deformation can elicit tau abnormalities and synaptic deficits in neurons. Using computational modeling, we find that the early pathological loci of NFTs in CTE brains are regions of high deformation during injury. The mechanical energy associated with high-strain rate deformation alone can induce tau mislocalization to dendritic spines and synaptic deficits in cultured rat hippocampal neurons. These cellular changes are mediated by tau hyperphosphorylation and can be reversed through inhibition of GSK3 beta and CDK5 or genetic deletion of tau. Together, these findings identify a mechanistic pathway that directly relates mechanical deformation of neurons to tau-mediated synaptic impairments and provide a possibly exploitable therapeutic pathway to combat CTE.	[Braun, Nicholas J.; Alford, Patrick W.] Univ Minnesota, Dept Biomed Engn, Minneapolis, MN 55455 USA; [Yao, Katherine R.; Liao, Dezhi] Univ Minnesota, Dept Neurosci, Minneapolis, MN 55455 USA		Alford, PW (corresponding author), Univ Minnesota, Dept Biomed Engn, Minneapolis, MN 55455 USA.; Liao, DZ (corresponding author), Univ Minnesota, Dept Neurosci, Minneapolis, MN 55455 USA.	pwalford@umn.edu; liaox020@umn.edu	Lang, Steven/AAE-8102-2021	Lang, Steven/0000-0003-1669-9146; Yao, Katherine/0000-0002-6539-7630; Liao, Dezhi/0000-0003-0342-4493	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R21NS096437-01, R61 NS115089-01]; Minnesota Higher Education Grant; Institute of Engineering Medicine at the University of Minnesota (UMN) seed grant; UMNMayo Partnership Grant; NSF Grant Civil, Mechanical and Manufacturing Innovation (CMMI) [1553255]; NSFNational Science Foundation (NSF) [CMMI 1935834]	We thank Peter Teravskis for his technical expertise and thoughtful discussions. Funding was provided by NIH Grants R21NS096437-01 (D.L. and P.W.A.) and R61 NS115089-01 (D.L.), Minnesota Higher Education Grant (D.L. and P.W.A.), Institute of Engineering Medicine at the University of Minnesota (UMN) seed grant (P.W.A. and D.L.), UMNMayo Partnership Grant (D.L.), and NSF Grants Civil, Mechanical and Manufacturing Innovation (CMMI) 1553255 (P.W.A.) and CMMI 1935834 (P.W.A. and D.L.).	Abisambra JF, 2014, J ALZHEIMERS DIS, V40, P495, DOI 10.3233/JAD-131019; Ahmadzadeh H, 2014, BIOPHYS J, V106, P1123, DOI 10.1016/j.bpj.2014.01.024; Alford PW, 2011, P NATL ACAD SCI USA, V108, P12705, DOI 10.1073/pnas.1105860108; Bayly PV, 2006, J BIOMECH, V39, P1086, DOI 10.1016/j.jbiomech.2005.02.014; Bower JH, 2003, NEUROLOGY, V60, P1610, DOI 10.1212/01.WNL.0000068008.78394.2C; Brown NJ, 2014, PEDIATRICS, V133, pE299, DOI 10.1542/peds.2013-2125; Budday S, 2017, J MECH BEHAV BIOMED, V74, P463, DOI 10.1016/j.jmbbm.2017.07.014; Budday S, 2015, J MECH BEHAV BIOMED, V46, P318, DOI 10.1016/j.jmbbm.2015.02.024; CHEN J, 1992, NATURE, V360, P674, DOI 10.1038/360674a0; Chen Y, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00117; Chong FP, 2018, CELL MOL NEUROBIOL, V38, P965, DOI 10.1007/s10571-017-0574-1; Clayton EH, 2011, PHYS MED BIOL, V56, P2391, DOI 10.1088/0031-9155/56/8/005; Conde C, 2009, NAT REV NEUROSCI, V10, P319, DOI 10.1038/nrn2631; DELCASTILLO J, 1954, J PHYSIOL-LONDON, V124, P560, DOI 10.1113/jphysiol.1954.sp005129; Earnshaw BA, 2006, J NEUROSCI, V26, P12362, DOI 10.1523/JNEUROSCI.3601-06.2006; Feng Y, 2013, J BIOMECH, V46, P863, DOI 10.1016/j.jbiomech.2012.12.024; Fleminger S, 2003, J NEUROL NEUROSUR PS, V74, P857, DOI 10.1136/jnnp.74.7.857; Gavett BE, 2011, CLIN SPORT MED, V30, P179, DOI 10.1016/j.csm.2010.09.007; Ghajari M, 2017, BRAIN, V140, P333, DOI 10.1093/brain/aww317; Grevesse T, 2015, SCI REP-UK, V5, DOI 10.1038/srep09475; Guedes-Dias P, 2019, SCIENCE, V366, P199, DOI 10.1126/science.aaw9997; Hemphill MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022899; Hoover BR, 2010, NEURON, V68, P1067, DOI 10.1016/j.neuron.2010.11.030; Jawaid A, 2009, NEURODEGENER DIS, V6, P219, DOI 10.1159/000258704; Jayapalan S, 2013, BIOINFORMATION, V9, P1023, DOI 10.6026/97320630091023; Kanaan NM, 2011, J NEUROSCI, V31, P9858, DOI 10.1523/JNEUROSCI.0560-11.2011; Kim E, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006849; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lee HK, 1998, NEURON, V21, P1151, DOI 10.1016/S0896-6273(00)80632-7; Lee VMY, 2001, ANNU REV NEUROSCI, V24, P1121, DOI 10.1146/annurev.neuro.24.1.1121; Liao DZ, 2014, EUR J NEUROSCI, V39, P1202, DOI 10.1111/ejn.12504; LIAO DZ, 1995, NATURE, V375, P400, DOI 10.1038/375400a0; Lin H, 2004, BIOCHEM BIOPH RES CO, V316, P501, DOI 10.1016/j.bbrc.2004.02.086; Lu YB, 2006, P NATL ACAD SCI USA, V103, P17759, DOI 10.1073/pnas.0606150103; Lucke-Wold BP, 2014, J NEUROTRAUM, V31, P1129, DOI 10.1089/neu.2013.3303; McKee AC, 2015, BRAIN PATHOL, V25, P350, DOI 10.1111/bpa.12248; Mckee Ann C, 2015, Handb Clin Neurol, V127, P45, DOI 10.1016/B978-0-444-52892-6.00004-0; McKee AC, 2014, ALZHEIMERS DEMENT, V10, pS242, DOI 10.1016/j.jalz.2014.04.003; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Meaney DF, 2014, J BIOMECH ENG-T ASME, V136, DOI 10.1115/1.4026364; Meythaler JM, 2001, ARCH PHYS MED REHAB, V82, P1461, DOI 10.1053/apmr.2001.25137; Miller EC, 2014, EUR J NEUROSCI, V39, P1214, DOI 10.1111/ejn.12507; Min SW, 2010, NEURON, V67, P953, DOI 10.1016/j.neuron.2010.08.044; Montenigro PH, 2015, BRAIN PATHOL, V25, P304, DOI 10.1111/bpa.12250; Montenigro PH, 2015, ANNU REV CLIN PSYCHO, V11, P309, DOI 10.1146/annurev-clinpsy-032814-112814; Morrison B, 2011, ANNU REV BIOMED ENG, V13, P91, DOI 10.1146/annurev-bioeng-071910-124706; Nemetz PN, 1999, AM J EPIDEMIOL, V149, P32; OKADA Y, 1995, CELL, V81, P769, DOI 10.1016/0092-8674(95)90538-3; Omalu BI, 2006, NEUROSURGERY, V59, P1086, DOI 10.1227/01.NEU.0000245601.69451.27; Omalu BI, 2010, AM J FOREN MED PATH, V31, P130, DOI 10.1097/PAF.0b013e3181ca7f35; Omalu BI, 2005, NEUROSURGERY, V57, P128, DOI 10.1227/01.NEU.0000163407.92769.ED; Plassman BL, 2000, NEUROLOGY, V55, P1158, DOI 10.1212/WNL.55.8.1158; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Rose JK., 2003, CURR PROTOC MOL BIOL, V9, pUNIT 9 1; Schneggenburger R, 2015, NAT NEUROSCI, V18, P935, DOI 10.1038/nn.4044; Song HL, 2018, BEHAV BRAIN RES, V340, P147, DOI 10.1016/j.bbr.2016.08.037; Tang-Schomer MD, 2012, EXP NEUROL, V233, P364, DOI 10.1016/j.expneurol.2011.10.030; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Teravskis PJ, 2020, NEUROSCIENTIST, V26, P503, DOI 10.1177/1073858420916696; Teravskis PJ, 2021, J PHYSIOL-LONDON, V599, P2483, DOI 10.1113/JP277459; Tracy TE, 2016, NEURON, V90, P245, DOI 10.1016/j.neuron.2016.03.005; Vogel EW, 2017, J NEUROTRAUM, V34, P1063, DOI 10.1089/neu.2016.4578; Yang JZ, 2015, DEV NEUROPSYCHOL, V40, P18, DOI 10.1080/87565641.2014.973499; Zhang JC, 2005, BRAIN RES, V1050, P110, DOI 10.1016/j.brainres.2005.05.032; Zhao XH, 2016, NAT MED, V22, P1268, DOI 10.1038/nm.4199; Zhou LJ, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15295	67	7	7	4	9	NATL ACAD SCIENCES	WASHINGTON	2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA	0027-8424			P NATL ACAD SCI USA	Proc. Natl. Acad. Sci. U. S. A.	NOV 17	2020	117	46					29069	29079		10.1073/pnas.2008306117			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OU2LW	WOS:000591366000019	33139536	Bronze, Green Published			2022-02-06	
J	Alessandrino, F; Keraliya, A; Lebovic, J; Dyer, GSM; Harris, MB; Tornetta, P; Boland, GWL; Seltzer, SE; Khurana, B				Alessandrino, Francesco; Keraliya, Abhishek; Lebovic, Jordan; Dyer, George Sinclair Mitchell; Harris, Mitchel B.; Tornetta, Paul, III; Boland, Giles W. L.; Seltzer, Steven E.; Khurana, Bharti			Intimate Partner Violence: A Primer for Radiologists to Make the "Invisible" Visible	RADIOGRAPHICS			English	Article							TRAUMATIC BRAIN-INJURY; BLUNT PANCREATIC TRAUMA; MAXILLOFACIAL INJURIES; DOMESTIC VIOLENCE; EMERGENCY-DEPARTMENT; COMPUTED-TOMOGRAPHY; RETAINED PRODUCTS; PRIMARY-CARE; WOMEN; STRANGULATION	Intimate partner violence (IPV) is the physical, sexual, or emotional violence between current or former partners. It is a major public health issue that affects nearly one out of four women. Nonetheless, IPV is greatly underdiagnosed. Imaging has played a significant role in identifying cases of nonaccidental trauma in children, and similarly, it has the potential to enable the identification of injuries resulting from IPV. Radiologists have early access to the radiologic history of such victims and may be the first to diagnose IPV on the basis of the distribution and imaging appearance of the patient's currrent and past injuries. Radiologists must be familiar with the imaging findings that are suggestive of injuries resulting from IPV. Special attention should be given to cases in which there are multiple visits for injury care; coexistent fractures at different stages of healing, which may help differentiate injuries related to IPV from those caused by a stranger; and injuries in defensive locations and target areas such as the face and upper extremities. The authors provide an overview of current methods for diagnosing IPV and define the role of the radiologist in cases of IPV. They also describe a successful diagnostic imaging-based approach for helping to identify IPV, with a specific focus on the associated imaging findings and mechanisms of injuries. In addition, current needs and future perspectives for improving the diagnosis of this hidden epidemic are identified. This information is intended to raise awareness among radiologists, with the ultimate goal of improving the diagnosis of IPV and thus reducing the devastating effects on victims' lives. (C) RSNA, 2020.	[Alessandrino, Francesco; Keraliya, Abhishek; Boland, Giles W. L.; Seltzer, Steven E.; Khurana, Bharti] Brigham & Womens Hosp, Dept Radiol, 75 Francis St, Boston, MA 02115 USA; [Dyer, George Sinclair Mitchell] Brigham & Womens Hosp, Dept Orthopaed Surg, 75 Francis St, Boston, MA 02115 USA; [Khurana, Bharti] Brigham & Womens Hosp, Trauma Imaging Res & Innovat Ctr, 75 Francis St, Boston, MA 02115 USA; [Harris, Mitchel B.] Massachusetts Gen Hosp, Dept Orthopaed Surg, 75 Francis St, Boston, MA 02115 USA; [Lebovic, Jordan] Harvard Med Sch, 75 Francis St, Boston, MA 02115 USA; [Tornetta, Paul, III] Boston Univ, Med Sch, Dept Orthopaed Surg, Boston Med Ctr, Boston, MA 02215 USA		Khurana, B (corresponding author), Brigham & Womens Hosp, Dept Radiol, 75 Francis St, Boston, MA 02115 USA.; Khurana, B (corresponding author), Brigham & Womens Hosp, Trauma Imaging Res & Innovat Ctr, 75 Francis St, Boston, MA 02115 USA.	bkhurana@bwh.harvard.edu		keraliya, abhishek/0000-0001-7850-8144; Lebovic, Jordan/0000-0003-0932-8195; Alessandrino, Francesco/0000-0002-1681-1284; Seltzer, Steven/0000-0002-1265-8040			Abbasi S, 2008, ULTRASOUND OBST GYN, V32, P704, DOI 10.1002/uog.5391; Arosarena OA, 2009, ARCH FACIAL PLAST S, V11, P48, DOI 10.1001/archfacial.2008.507; Bennett GL, 1996, RADIOLOGY, V200, P803, DOI 10.1148/radiology.200.3.8756935; Bergaminelli C, 1999, Minerva Chir, V54, P697; Berhanie E, 2019, REPROD HEALTH, V16, DOI 10.1186/s12978-019-0670-4; Bhandari M, 2006, J TRAUMA, V61, P1473, DOI 10.1097/01.ta.0000196419.36019.5a; Bhandari S, 2011, HEALTH CARE WOMEN IN, V32, P833, DOI 10.1080/07399332.2011.585532; Bhole S, 2014, EMERG RADIOL, V21, P407, DOI 10.1007/s10140-014-1225-1; Bodenheimer T, 2002, JAMA-J AM MED ASSOC, V288, P1775, DOI 10.1001/jama.288.14.1775; Boyes H, 2020, BRIT J ORAL MAX SURG, V58, P185, DOI 10.1016/j.bjoms.2019.11.009; Bruguier C, 2020, FOREN SCI RES, V5, P113, DOI 10.1080/20961790.2019.1592314; Campbell JC, 2002, LANCET, V359, P1331, DOI 10.1016/S0140-6736(02)08336-8; Clinical Stand Comm, 2019, ULTRASOUND OBST GYN, V53, P715, DOI 10.1002/uog.20272; Cockenpot E, 2016, RADIOLOGY, V279, P674, DOI 10.1148/radiol.2016150995; Coughlin JM, 2017, JAMA NEUROL, V74, P67, DOI 10.1001/jamaneurol.2016.3764; Curry SJ, 2018, JAMA-J AM MED ASSOC, V320, P1678, DOI 10.1001/jama.2018.14741; Dicola D, 2016, AM FAM PHYSICIAN, V94, P646; Dreizin D, 2018, RADIOGRAPHICS, V38, P248, DOI 10.1148/rg.2018170074; Durfee SM, 2005, J ULTRAS MED, V24, P1181; European Union Agency for Fundamental Rights, 2014, VIOL WOM EU WID SURV, P17; Fanslow JL, 1998, ANN EMERG MED, V32, P341, DOI 10.1016/S0196-0644(98)70011-3; Farley M, 2018, DIGNITY, V2, P5; Feldman KW, 2001, PEDIATRICS, V108, P636, DOI 10.1542/peds.108.3.636; Feltner C, 2018, JAMA-J AM MED ASSOC, V320, P1688, DOI 10.1001/jama.2018.13212; Fennema-Notestine C, 2002, BIOL PSYCHIAT, V52, P1089, DOI 10.1016/S0006-3223(02)01413-0; Ford H, 2003, J TRAUMA, V54, P645; Garbin Cléa Adas Saliba, 2012, Braz. Dent. J., V23, P72, DOI 10.1590/S0103-64402012000100013; Garcia-Moreno C., 2005, WHO MULTICOUNTRY STU; Gazmararian JA, 1996, JAMA-J AM MED ASSOC, V275, P1915, DOI 10.1001/jama.275.24.1915; George E, 2019, RADIOLOGY, V291, P61, DOI 10.1148/radiol.2019180801; Glass N, 2008, J EMERG MED, V35, P329, DOI 10.1016/j.jemermed.2007.02.065; Goldberg Stuart H., 2000, Orbit, V19, P143, DOI 10.1076/orbi.19.3.143.2659; Greene D, 1999, Arch Facial Plast Surg, V1, P288, DOI 10.1001/archfaci.1.4.288; Haag HL, 2019, TRAUMA VIOLENCE ABUS, DOI [10.1177/1524838019850623, DOI 10.1177/1524838019850623.PUBLISHED]; Hartzell KN, 1996, OPHTHALMOLOGY, V103, P953, DOI 10.1016/S0161-6420(96)30580-0; Heise L, 1999, POPULATION REPORTS E; HELTON AS, 1987, PROTOCOL CARE BATTER; Huang V, 1998, ANN PLAS SURG, V41, P482, DOI 10.1097/00000637-199811000-00005; Isaac NE, 2001, NATL I JUSTICE RES B; Jackson H, 2002, PROF PSYCHOL-RES PR, V33, P39, DOI 10.1037//0735-7028.33.1.39; Kamaya A, 2009, J ULTRAS MED, V28, P1031, DOI 10.7863/jum.2009.28.8.1031; Karangelis D, 2011, J FORENSIC LEG MED, V18, P119, DOI 10.1016/j.jflm.2011.01.007; Kemp AM, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a1518; Khurana B, 2020, BMJ QUAL SAF, V29, P241, DOI 10.1136/bmjqs-2019-009905; Killeen KL, 2001, J TRAUMA, V51, P26, DOI 10.1097/00005373-200107000-00005; Klap R, 2007, J GEN INTERN MED, V22, P579, DOI 10.1007/s11606-006-0097-9; KURILOFF DB, 1989, ANN OTO RHINOL LARYN, V98, P824, DOI 10.1177/000348948909801014; Kwako LE, 2011, TRAUMA VIOLENCE ABUS, V12, P115, DOI 10.1177/1524838011404251; Le Blanc-Louvry I, 2013, J FORENSIC SCI, V58, P1640, DOI 10.1111/1556-4029.12197; Le BT, 2001, J ORAL MAXIL SURG, V59, P1277, DOI 10.1053/joms.2001.27490; LE BT, 2001, J ORAL MAXILLOFAC SU, V59, P1283; Lee P, 2004, RADIOGRAPHICS, V24, P1009, DOI 10.1148/rg.244045015; Lee Stephen, 2010, Australas J Ultrasound Med, V13, P31, DOI 10.1002/j.2205-0140.2010.tb00161.x; Linsenmaier U, 2008, RADIOGRAPHICS, V28, P1591, DOI 10.1148/rg.286085524; Loureiro RM, 2019, RADIOGRAPHICS, V39, P1782, DOI 10.1148/rg.2019190019; Lozano JD, 2013, RADIOGRAPHICS, V33, P341, DOI 10.1148/rg.332125006; Malek AM, 2000, J NEUROSURG, V92, P481, DOI 10.3171/jns.2000.92.3.0481; Matteoli M, 2016, VIOLENCE VICTIMS, V31, P85, DOI 10.1891/0886-6708.VV-D-14-00107; McClane GE, 2001, J EMERG MED, V21, P311, DOI 10.1016/S0736-4679(01)00400-0; Miller E, 2019, NEW ENGL J MED, V380, P850, DOI 10.1056/NEJMra1807166; Nadareishvili Z, 1999, LANCET, V354, P159, DOI 10.1016/S0140-6736(05)75289-2; Narayan AK, 2019, J AM COLL RADIOL, V16, P631, DOI 10.1016/j.jacr.2018.12.026; Overstreet NM, 2013, BASIC APPL SOC PSYCH, V35, P109, DOI 10.1080/01973533.2012.746599; Panda A, 2015, ACTA RADIOL, V56, P387, DOI 10.1177/0284185114529949; Petridou E, 2002, INJ PREV, V8, P197, DOI 10.1136/ip.8.3.197; Petrisor BA, 2013, LANCET, V382, P866, DOI 10.1016/S0140-6736(13)61205-2; Phillips CH, 2018, EMERG RADIOL, V25, P61, DOI 10.1007/s10140-017-1556-9; Reijnders U J L, 2006, Ned Tijdschr Geneeskd, V150, P429; Reis BY, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b3677; Rodrigues LG, 2020, DENT TRAUMATOL, V36, P69, DOI 10.1111/edt.12509; Rodriguez MA, 1999, JAMA-J AM MED ASSOC, V282, P468, DOI 10.1001/jama.282.5.468; Scheinfeld MH, 2012, RADIOGRAPHICS, V32, P1927, DOI 10.1148/rg.327125717; Schweitzer AD, 2019, RADIOGRAPHICS, V39, P1571, DOI 10.1148/rg.2019190076; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; SHEPHERD JP, 1990, J ROY SOC MED, V83, P75, DOI 10.1177/014107689008300206; Sheridan DJ, 2007, TRAUMA VIOLENCE ABUS, V8, P281, DOI 10.1177/1524838007303504; Smith S. G., 2018, NATL INTIMATE PARTNE; Srisajjakul S, 2016, CLIN IMAG, V40, P1173, DOI 10.1016/j.clinimag.2016.08.007; Sutton M, 2019, J WOMENS HEALTH, V28, P473, DOI 10.1089/jwh.2018.7282; Swailes Alexa L, 2017, Prev Med Rep, V8, P215, DOI 10.1016/j.pmedr.2017.10.017; United Nations, HELP GOV STAK MAK SD; United Nations Office on Drugs and Crimes, 2018, GLOB STUD HOM; United Nations Women, GLOB DAT VIOL WOM; Valera EM, 2019, J NEUROTRAUM, V36, P661, DOI 10.1089/neu.2018.5734; Venkatesh SK, 2008, EUR J RADIOL, V67, P311, DOI 10.1016/j.ejrad.2007.07.003; Watts C, 2002, LANCET, V359, P1232, DOI 10.1016/S0140-6736(02)08221-1; Wieschhoff GG, 2016, RADIOGRAPHICS, V36, P1106, DOI 10.1148/rg.2016150216; World Health Organization, 2001, WHO MULT STUD WOM HL; Wu V, 2010, TRAUMA VIOLENCE ABUS, V11, P71, DOI 10.1177/1524838010367503; Yamabe E, 2012, SEMIN MUSCULOSKEL R, V16, P331, DOI 10.1055/s-0032-1327006; Yen K, 2005, J MAGN RESON IMAGING, V22, P501, DOI 10.1002/jmri.20396; Yen K, 2007, INT J LEGAL MED, V121, P115, DOI 10.1007/s00414-006-0121-y	92	7	7	0	5	RADIOLOGICAL SOC NORTH AMERICA	OAK BROOK	820 JORIE BLVD, OAK BROOK, IL 60523 USA	0271-5333			RADIOGRAPHICS	Radiographics	NOV-DEC	2020	40	7					2080	2097		10.1148/rg.2020200010			18	Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Radiology, Nuclear Medicine & Medical Imaging	OM9NL	WOS:000586341600021	33006922				2022-02-06	
J	Carlozzi, NE; Boileau, NR; Kallen, MA; Nakase-Richardson, R; Hahn, EA; Tulsky, DS; Miner, JA; Hanks, RA; Massengale, JP; Lange, RT; Brickell, TA; French, LM; Ianni, PA; Sander, AM				Carlozzi, Noelle E.; Boileau, Nicholas R.; Kallen, Michael A.; Nakase-Richardson, Risa; Hahn, Elizabeth A.; Tulsky, David S.; Miner, Jennifer A.; Hanks, Robin A.; Massengale, Jill P.; Lange, Rael T.; Brickell, Tracey A.; French, Louis M.; Ianni, Phillip A.; Sander, Angelle M.			Reliability and Validity Data to Support the Clinical Utility of the Traumatic Brain Injury Caregiver Quality of Life (TBI-CareQOL)	REHABILITATION PSYCHOLOGY			English	Article						quality of life; traumatic brain injury; caregiver; caregiver burden; patient-reported outcome	FAMILY INTERVENTION IMPACT; ITEM BANKS; TIME-COURSE; RECOVERY; HEALTH; BURDEN; INDIVIDUALS; NEEDS; MOTOR; ASSOCIATION	Objective: The Traumatic Brain Injury Caregiver Quality of Life (TBI-CareQOL) is a patient-reported outcome measurement system that is specific to caregivers of civilians and service members/veterans (SMVs) with traumatic brain injury (TBI). This measurement system includes 26 item banks that represent both generic (i.e., borrowed from existing measurement systems) and caregiver-specific components of health-related quality of life (HRQOL). This report provides reliability and validity data for measures within the TBI-CareQOL that have not previously been reported (i.e., 4 caregiver-specific and 7 generic measures of HRQOL). Design: Three hundred eighty-five caregivers of persons with TBI completed caregiver-specific computer adaptive tests (CATs) for Feelings of Loss-Self, Caregiver Strain, Caregiver-Specific Anxiety, and Feeling Trapped, as well as generic measures of HRQOL from complementary measurement systems (i.e.. Neuro-QoL Positive Affect and Well-Being; PROMIS Sleep-Related Impairment; NIH Toolbox Perceived Stress. General Life Satisfaction, and Self Efficacy; TBI-QOL Resilience and Grief/Loss). Caregivers also completed several additional measures to establish convergent and discriminant validity, as well as the Mayo Portland Adaptability Index, 4th ed. Results: Findings support the internal consistency reliability (all alphas >.85) and test-retest stability (all alphas >.73) of the TBI-CareQOL measures. Convergent validity was supported by moderate to high correlations between the TBI-CareQOL measures and related measures, whereas discriminant validity was supported by low correlations between the TBI-CareQOL measures and unrelated constructs. Known-groups validity was also supported. Conclusions: Findings support the reliability and validity of the item banks that comprise the TBI-CareQOL Measurement System. These measures should be considered for any standardized assessment of HRQOL in caregivers of civilians and SMVs with TBI.	[Carlozzi, Noelle E.; Boileau, Nicholas R.; Miner, Jennifer A.] Univ Michigan, Dept Phys Med & Rehabil, North Campus Res Complex,2800 Plymouth Rd, Ann Arbor, MI 48109 USA; [Kallen, Michael A.; Hahn, Elizabeth A.] Northwestern Univ, Dept Med Social Sci, Feinberg Sch Med, Evanston, IL 60208 USA; [Nakase-Richardson, Risa] James A Haley Vet Hosp, Mental Hlth & Behav Sci & Def & Vet Brain Injury, Tampa, FL 33612 USA; [Nakase-Richardson, Risa] Univ S Florida, Dept Internal Med, Morsani Coll Med, Tampa, FL 33620 USA; [Tulsky, David S.] Univ Delaware, Ctr Hlth Assessment Res & Translat, Newark, DE 19716 USA; [Tulsky, David S.] Univ Delaware, Dept Phys Therapy, Newark, DE 19716 USA; [Tulsky, David S.] Univ Delaware, Dept Psychol Brain Sci, Newark, DE 19716 USA; [Hanks, Robin A.] Rehabil Inst Michigan, Dept Psychol & Neuropsychol, Detroit, MI USA; [Hanks, Robin A.] Wayne State Univ, Dept Phys Med & Rehabil, Detroit, MI 48202 USA; [Massengale, Jill P.] James A Haley Vet Hosp, Nursing Serv, Tampa, FL 33612 USA; [Lange, Rael T.] Def & Vet Brain Injury Ctr, Bethesda, MD USA; [Lange, Rael T.] Walter Reed Natl Mil Med Ctr, Natl Intrepid Ctr Excellence, Bethesda, MD USA; [Lange, Rael T.] Univ British Columbia, Dept Psychiat, Vancouver, BC, Canada; [Brickell, Tracey A.; French, Louis M.] Uniformed Serv Univ Hlth Sci, Def & Vet Brain Injury Ctr, Bethesda, MD 20814 USA; [Brickell, Tracey A.; French, Louis M.] Uniformed Serv Univ Hlth Sci, Walter Reed Natl Mil Med Ctr, Bethesda, MD 20814 USA; [Ianni, Phillip A.] Univ Michigan, Michigan Inst Clin & Hlth Res, Ann Arbor, MI 48109 USA; [Sander, Angelle M.] Baylor Coll Med, H Ben Taub Dept Phys Med & Rehabil, Harris Hlth Syst, Houston, TX 77030 USA; [Sander, Angelle M.] TIRR Mem Hermann, Brain Injury Res Ctr, Houston, TX USA		Carlozzi, NE (corresponding author), Univ Michigan, Dept Phys Med & Rehabil, North Campus Res Complex,2800 Plymouth Rd, Ann Arbor, MI 48109 USA.	carlozzi@med.umich.edu	Boileau, Nicholas/V-4832-2019	Boileau, Nicholas/0000-0002-4056-4404; Tulsky, David/0000-0002-4335-4509; french, louis/0000-0002-9451-0604	National Institutes of Health (NIH), National Institute of Nursing ResearchUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR) [R01NR013658]; General Dynamics Information Technology, Inc. [DVBIC-SC-14-003, W91YTZ-13-C-0015]; National Center for Advancing Translational SciencesUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR000433]	Work on this article was supported by Grant R01NR013658 from the National Institutes of Health (NIH), National Institute of Nursing Research, as well as contract funding from the General Dynamics Information Technology, Inc., subcontractor for the Defense and Veterans Brain Injury Center (DVBIC; DVBIC-SC-14-003; W91YTZ-13-C-0015). Funding from the National Center for Advancing Translational Sciences (UL1TR000433) provided support for data collection. We thank the investigators and research associates/coordinators who worked on the study, the study participants, and organizations who supported recruitment efforts. The content is solely the responsibility of the authors and does not necessarily represent the official views of the funding agencies.	Andresen EM, 2000, ARCH PHYS MED REHAB, V81, pS15, DOI 10.1053/apmr.2000.20619; BECK KH, 1981, J APPL SOC PSYCHOL, V11, P401, DOI 10.1111/j.1559-1816.1981.tb00832.x; BORNSTEIN RA, 1987, J NERV MENT DIS, V175, P229, DOI 10.1097/00005053-198704000-00007; Bulmer, 1979, PRINCIPLES STAT; Burns Anthony S, 2012, Handb Clin Neurol, V109, P47, DOI 10.1016/B978-0-444-52137-8.00003-6; CAMPBELL DT, 1959, PSYCHOL BULL, V56, P81, DOI 10.1037/h0046016; Carlozzi N. E., 2019, REHABILITATION UNPUB; Carlozzi NE, 2020, REHABIL PSYCHOL, V65, P455, DOI 10.1037/rep0000291; Carlozzi NE, 2021, J HEALTH PSYCHOL, V26, P1455, DOI 10.1177/1359105319877448; Carlozzi NE, 2019, ARCH PHYS MED REHAB, V100, pS1, DOI 10.1016/j.apmr.2018.08.175; Carlozzi NE, 2019, ARCH PHYS MED REHAB, V100, pS110, DOI 10.1016/j.apmr.2018.06.026; Carlozzi NE, 2019, ARCH PHYS MED REHAB, V100, pS43, DOI 10.1016/j.apmr.2018.06.025; Carlozzi NE, 2019, ARCH PHYS MED REHAB, V100, pS13, DOI 10.1016/j.apmr.2018.05.033; Carlozzi NE, 2019, ARCH PHYS MED REHAB, V100, pS85, DOI 10.1016/j.apmr.2018.05.034; Carlozzi NE, 2019, ARCH PHYS MED REHAB, V100, pS31, DOI 10.1016/j.apmr.2018.05.026; Carlozzi NE, 2019, ARCH PHYS MED REHAB, V100, pS22, DOI 10.1016/j.apmr.2018.05.027; Carlozzi NE, 2019, ARCH PHYS MED REHAB, V100, pS94, DOI 10.1016/j.apmr.2018.05.021; Carlozzi NE, 2019, ARCH PHYS MED REHAB, V100, pS102, DOI 10.1016/j.apmr.2018.05.020; Carlozzi NE, 2016, J REHABIL RES DEV, V53, P669, DOI 10.1682/JRRD.2015.07.0136; Carlozzi NE, 2015, ARCH PHYS MED REHAB, V96, P105, DOI 10.1016/j.apmr.2014.08.021; Cella D, 2012, NEUROLOGY, V78, P1860, DOI 10.1212/WNL.0b013e318258f744; Cella D, 2010, J CLIN EPIDEMIOL, V63, P1179, DOI 10.1016/j.jclinepi.2010.04.011; CELLA DF, 1995, SEMIN ONCOL, V22, P73; Chronister J, 2010, NEUROREHABILITATION, V27, P49, DOI 10.3233/NRE-2010-0580; Cohen J., 2013, STAT POWER ANAL BEHA; Corrigan JD, 2012, J HEAD TRAUMA REHAB, V27, P391, DOI 10.1097/HTR.0b013e3182238cdd; Cramer D, 2004, SAGE DICT STAT PRACT, DOI [10.4135/9780857020123, DOI 10.4135/9780857020123]; Defense and Veterans Brain Injury Center, 2018, DOD WORLDW NUMB TBI; DeVellis R.F., 2017, SCALE DEV THEORY APP; Dias R, 2016, ARQ NEURO-PSIQUIAT, V74, P967, DOI [10.1590/0004-282X20160162, 10.1590/0004-282x20160162]; DIKMEN S, 1983, ARCH NEUROL-CHICAGO, V40, P333, DOI 10.1001/archneur.1983.04050060033004; DIKMEN S, 1986, J NEUROL NEUROSUR PS, V49, P1227, DOI 10.1136/jnnp.49.11.1227; DIKMEN SS, 1995, NEUROPSYCHOLOGY, V9, P80, DOI 10.1037/0894-4105.9.1.80; Dikmen SS, 2009, J HEAD TRAUMA REHAB, V24, P430, DOI 10.1097/HTR.0b013e3181c133e9; DITUNNO JF, 1992, ARCH PHYS MED REHAB, V73, P431; Gershon Richard C, 2010, J Appl Meas, V11, P304; Gershon RC, 2013, NEUROLOGY, V80, pS2, DOI 10.1212/WNL.0b013e3182872e5f; Gershon RC, 2012, QUAL LIFE RES, V21, P475, DOI 10.1007/s11136-011-9958-8; Grandmougin D, 1996, ANN CHIR, V50, P381; Griffin JM, 2017, AM J ORTHOPSYCHIAT, V87, P139, DOI 10.1037/ort0000207; Hanauer DA, 2015, J BIOMED INFORM, V55, P290, DOI 10.1016/j.jbi.2015.05.003; Hertenstein E, 2019, SLEEP MED REV, V43, P96, DOI 10.1016/j.smrv.2018.10.006; JORGENSEN HS, 1995, ARCH PHYS MED REHAB, V76, P406, DOI 10.1016/S0003-9993(95)80568-0; JORGENSEN HS, 1995, ARCH PHYS MED REHAB, V76, P399, DOI 10.1016/S0003-9993(95)80567-2; Kreutzer JS, 2015, J HEAD TRAUMA REHAB, V30, P249, DOI 10.1097/HTR.0000000000000144; Kreutzer JS, 2009, BRAIN INJURY, V23, P535, DOI 10.1080/02699050902926291; KREUTZER JS, 1994, J HEAD TRAUMA REHAB, V9, P104, DOI 10.1097/00001199-199409000-00009; Lai JS, 2011, ARCH PHYS MED REHAB, V92, pS20, DOI 10.1016/j.apmr.2010.08.033; LAWTON MP, 1989, J GERONTOL, V44, pP61, DOI 10.1093/geronj/44.3.P61; Malec J., 2005, MAYO PORTLAND ADAPTA; MONTGOMERY RJV, 1985, FAM RELAT, V34, P19, DOI 10.2307/583753; National Alliance for Caregiving, 2010, CAREGIVERS VETERANS; Niemeier JP, 2019, ARCH PHYS MED REHAB, V100, pS65, DOI 10.1016/j.apmr.2018.07.422; NOVAK M, 1989, GERONTOLOGIST, V29, P798, DOI 10.1093/geront/29.6.798; Ornstein K, 2012, INT PSYCHOGERIATR, V24, P1536, DOI 10.1017/S1041610212000737; Powell JM, 2016, J HEAD TRAUMA REHAB, V31, P180, DOI 10.1097/HTR.0000000000000167; Rivera PA, 2008, ARCH PHYS MED REHAB, V89, P931, DOI 10.1016/j.apmr.2007.12.032; Saban KL, 2016, J REHABIL RES DEV, V53, P681, DOI 10.1682/JRRD.2015.07.0143; Sander A. M., 2005, REHABILITATION TRAUM, P156; Sander AM, 2020, J HEAD TRAUMA REHAB, V35, pE10, DOI 10.1097/HTR.0000000000000507; SAS Institute, 2013, SAS 9 4 LANG REF CON; SERIO CD, 1995, J HEAD TRAUMA REHAB, V10, P32, DOI 10.1097/00001199-199504000-00005; Struchen MA, 2002, J HEAD TRAUMA REHAB, V17, P132, DOI 10.1097/00001199-200204000-00005; Tulsky DS, 2016, J HEAD TRAUMA REHAB, V31, P40, DOI 10.1097/HTR.0000000000000131; van der Linden W. J., 2013, HDB MODERN ITEM RESP, P51, DOI [10.1007/978-1-4757-2691-6, DOI 10.1007/978-1-4757-2691-6]; Verhaeghe S, 2005, J CLIN NURS, V14, P1004, DOI 10.1111/j.1365-2702.2005.01126.x; Waters R L, 1998, J Spinal Cord Med, V21, P195; WATERS RL, 1993, ARCH PHYS MED REHAB, V74, P242; WATERS RL, 1992, ARCH PHYS MED REHAB, V73, P784; WATERS RL, 1994, ARCH PHYS MED REHAB, V75, P67; Witol AD, 1996, NEUROREHABILITATION, V7, P175, DOI 10.3233/NRE-1996-7303; World Health Organization, 1946, INT HLTH C NEW YORK; ZARIT SH, 1980, GERONTOLOGIST, V20, P649, DOI 10.1093/geront/20.6.649	73	7	7	0	1	EDUCATIONAL PUBLISHING FOUNDATION-AMERICAN PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST, NE, WASHINGTON, DC 20002-4242 USA	0090-5550	1939-1544		REHABIL PSYCHOL	Rehabil. Psychol.	NOV	2020	65	4					323	336		10.1037/rep0000295			14	Psychology, Clinical; Rehabilitation	Social Science Citation Index (SSCI)	Psychology; Rehabilitation	OW5SF	WOS:000592945400002	31829641	Bronze, Green Accepted			2022-02-06	
J	Ramage, AE				Ramage, Amy E.			Potential for Cognitive Communication Impairment in COVID-19 Survivors: A Call to Action for Speech-Language Pathologists	AMERICAN JOURNAL OF SPEECH-LANGUAGE PATHOLOGY			English	Article							OBSTRUCTIVE SLEEP-APNEA; CONFUSION ASSESSMENT METHOD; TRAUMATIC BRAIN-INJURY; INCOG RECOMMENDATIONS; CRITICAL ILLNESS; RISK-FACTORS; DELIRIUM; REHABILITATION; OUTCOMES; CARE	Purpose: Severe acute respiratory syndrome coronavirus 2 is the virus resulting in COVID-19 infections in nearly 4.3 million Americans with COVID-19 in the United States as of July 29, 2020, with nearly 150,000 deaths and hundreds of thousands of survivors (https://www.coronavirus.jhu.edu/map. html). This tutorial reviews (a) what has been reported about neurological insults in cases of COVID-19 infection, (b) what is known from similar conditions in other disorders, and (c) how that combined information can inform clinical decision making. Method: PubMed and the Cochrane Central Register of Controlled Trials were searched for COVID-19 or other coronavirus infections, cognitive impairment observed following critical care, and disorders for which intermittent or chronic hypoxia is characteristic. These were combined with searches relating to cognition, brain, and communication. All searches were conducted between April 8 and May 23, 2020. Metaanalyses and randomized clinical trials addressing other critical illnesses were also included to extend findings to potential cognitive communication outcomes following COVID-19. Results: COVID-19 infection results in a combination of (a) respiratory infection with mechanical ventilation secondary to inadequate oxygenation, (b) inflammatory system reactivity, and (c) increased blood clotting factors. These affect central nervous system function incurring long-term cognitive communication impairment in a proportion of survivors. Diagnostic and intervention approaches for such impairments are discussed. Conclusions: The existing literature on cognitive sequela of COVID-19 infection is small to date, but much can be learned from similar viral infections and disorders. Although COVID-19 is novel, the speech-language pathology approaches to evaluation and intervention of other populations of critical care patients are applicable. However, speech-language pathologists have not routinely been involved in these patients' acute care. As such, this is a call to action to speech-language pathologists to address the unprecedented numbers of patients who will need their services early in the disease process and throughout recovery.	[Ramage, Amy E.] Univ New Hampshire, Dept Commun Sci & Disorders, Durham, NH 03824 USA		Ramage, AE (corresponding author), Univ New Hampshire, Dept Commun Sci & Disorders, Durham, NH 03824 USA.	amy.ramage@unh.edu	Ramage, Amy/S-9227-2018	Ramage, Amy/0000-0001-8554-555X			Ahern E, 2017, NEUROPSYCHOLOGY, V31, P52, DOI 10.1037/neu0000319; Akshoomoff N, 2014, NEUROPSYCHOLOGY, V28, P1, DOI 10.1037/neu0000001; Arabi YM, 2015, INFECTION, V43, P495, DOI 10.1007/s15010-015-0720-y; Ayalon L, 2010, AM J RESP CRIT CARE, V182, P413, DOI 10.1164/rccm.200912-1805OC; BROADBENT DE, 1982, BRIT J CLIN PSYCHOL, V21, P1, DOI 10.1111/j.2044-8260.1982.tb01421.x; Brodsky MB, 2020, AM J PHYS MED REHAB, V99, P1164, DOI 10.1097/PHM.0000000000001440; Bruck E, 2019, CRIT CARE, V23, DOI 10.1186/s13054-019-2527-1; Castronovo V, 2014, SLEEP, V37, P1465, DOI 10.5665/sleep.3994; Castronovo V, 2009, SLEEP, V32, P1161, DOI 10.1093/sleep/32.9.1161; Chen T, 2020, BMJ-BRIT MED J, V368, DOI [10.1136/bmj.m1091, 10.1136/bmj.m1295]; Colbenson GA, 2019, BREATHE, V15, P98, DOI 10.1183/20734735.0013-2019; Deemer K, 2020, CAN J ANESTH, V67, P1016, DOI 10.1007/s12630-020-01670-z; Denke C, 2018, J INT MED RES, V46, P2265, DOI 10.1177/0300060518762040; Douglas JM, 2000, APHASIOLOGY, V14, P251, DOI 10.1080/026870300401469; Ely EW, 2001, JAMA-J AM MED ASSOC, V286, P2703, DOI 10.1001/jama.286.21.2703; European Delirium Association, 1800, BMC Med, V12, P141, DOI 10.1186/s12916-014-0141-2; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; FRANCIS J, 1992, J AM GERIATR SOC, V40, P601, DOI 10.1111/j.1532-5415.1992.tb02111.x; Frontera W. R., 2020, SPECIAL SECTION COVI, V99; Fuke R, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-019998; Garg S, 2020, MMWR-MORBID MORTAL W, V69, P458, DOI 10.15585/mmwr.mm6915e3; Garrouste-Orgeas M, 2017, TRIALS, V18, DOI 10.1186/s13063-017-2283-y; Gershon RC, 2013, NEUROLOGY, V80, pS2, DOI 10.1212/WNL.0b013e3182872e5f; Gioia GA, 2005, PSYCHOL ASSESS RESOU; Girard TD, 2018, LANCET RESP MED, V6, P213, DOI 10.1016/S2213-2600(18)30062-6; Guo YR, 2020, MILITARY MED RES, V7, DOI 10.1186/s40779-020-00240-0; Han JH, 2009, ACAD EMERG MED, V16, P193, DOI 10.1111/j.1553-2712.2008.00339.x; Harper RM, 2013, RESP PHYSIOL NEUROBI, V188, P383, DOI 10.1016/j.resp.2013.04.021; Helm-Estabrooks N., 2018, ENCY CLIN NEUROPSYCH, P1, DOI [10.1007/978-3-319-56782-2_9082-2, DOI 10.1007/978-3-319-56782-2_9082-2]; Herridge MS, 2016, INTENS CARE MED, V42, P725, DOI 10.1007/s00134-016-4321-8; Hess DC, 2020, TRANSL STROKE RES, V11, P322, DOI 10.1007/s12975-020-00818-9; Hopkins RO, 2006, CURR OPIN CRIT CARE, V12, P388, DOI 10.1097/01.ccx.0000244115.24000.f5; Hopper T, 2005, J MED SPEECH-LANG PA, V13, pXXVII; INOUYE SK, 1990, ANN INTERN MED, V113, P941, DOI 10.7326/0003-4819-113-12-941; Jiang R, 2008, AM J EPIDEMIOL, V168, P602, DOI 10.1093/aje/kwn174; Joo EY, 2013, SLEEP, V36, P1153, DOI 10.5665/sleep.2876; Klok FA, 2020, THROMB RES, V191, P145, DOI 10.1016/j.thromres.2020.04.013; Kondo Y, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-013828; Kotfis K, 2020, CRIT CARE, V24, DOI 10.1186/s13054-020-02882-x; Kumar R, 2014, NEUROIMAGE-CLIN, V4, P383, DOI 10.1016/j.nicl.2014.01.009; Lew HL, 2020, AM J PHYS MED REHAB, V99, P571, DOI 10.1097/PHM.0000000000001460; Lin WC, 2016, J TRANSL MED, V14, DOI 10.1186/s12967-016-0887-8; Lutsey PL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158758; MacDonald S, 2017, BRAIN INJURY, V31, P1760, DOI 10.1080/02699052.2017.1379613; Maheswaran J, 2020, CRIT CARE RES PRACT, V2020, DOI 10.1155/2020/3281394; Marra A, 2018, CRIT CARE MED, V46, P1393, DOI 10.1097/CCM.0000000000003218; Mart MF, 2020, EXPERT REV RESP MED, V14, P577, DOI 10.1080/17476348.2020.1743182; McIntyre M, 2020, AM J PHYS MED REHAB, V99, P464, DOI 10.1097/PHM.0000000000001453; McKinnon MC, 2016, NEUROPSYCHOLOGIA, V90, P210, DOI 10.1016/j.neuropsychologia.2016.07.017; Mehta Puja, 2020, Lancet, V395, P1033, DOI 10.1016/S0140-6736(20)30628-0; Mikkelsen ME, 2012, AM J RESP CRIT CARE, V185, P1307, DOI 10.1164/rccm.201111-2025OC; Mogi T, 2017, PSYCHIAT CLIN NEUROS, V71, P214, DOI 10.1111/pcn.12492; Moriguchi T, 2020, INT J INFECT DIS, V94, P55, DOI 10.1016/j.ijid.2020.03.062; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; Needham EJ, 2020, NEUROCRIT CARE, V32, P667, DOI 10.1007/s12028-020-00978-4; Otero L., 2019, UPDATES SLEEP NEUROL, DOI [10.5772/intechopen.82756, DOI 10.5772/INTECHOPEN.82756]; Panigada M, 2020, J THROMB HAEMOST, V18, P1738, DOI 10.1111/jth.14850; Park B, 2016, BRAIN BEHAV, V6, DOI 10.1002/brb3.441; Paul-Brown D., 2003, EV TREAT COMM COGN D, DOI [10.1044/policy. TR2003-00137, DOI 10.1044/POLICY.TR2003-00137]; Payne A, 2019, J AFFECT DISORDERS, V253, P193, DOI 10.1016/j.jad.2019.04.055; Pinna P, 2020, J NEUROL SCI, V415, DOI 10.1016/j.jns.2020.116969; Ponsford J, 2020, J HEAD TRAUMA REHAB, V35, P117, DOI 10.1097/HTR.0000000000000510; Ponsford J, 2014, J HEAD TRAUMA REHAB, V29, P307, DOI 10.1097/HTR.0000000000000074; Poyiadji N, 2020, RADIOLOGY, V296, pE119, DOI 10.1148/radiol.2020201187; Ramsey A, 2020, AM J SPEECH-LANG PAT, V29, P741, DOI 10.1044/2020_AJSLP-19-00082; Randolph C., 1998, REPEATABLE BATTERY A, DOI [10.1037/t15149-000, DOI 10.1037/T15149-000]; Ranucci M, 2020, J THROMB HAEMOST, V18, P1747, DOI 10.1111/jth.14854; Revet M, 2021, DISABIL REHABIL, V43, P2233, DOI 10.1080/09638288.2019.1693642; Richardson Safiya, 2020, JAMA, V323, P2052, DOI 10.1001/jama.2020.6775; Rosenzweig I, 2016, EBIOMEDICINE, V7, P221, DOI 10.1016/j.ebiom.2016.03.020; Sasannejad C, 2019, CRIT CARE, V23, DOI 10.1186/s13054-019-2626-z; Silver JK, 2020, AM J PHYS MED REHAB, V99, P459, DOI 10.1097/PHM.0000000000001452; Sohlberg M.M., 2011, OPTIMIZING COGNITIVE; Spiezia L, 2020, THROMB HAEMOSTASIS, V120, P998, DOI 10.1055/s-0040-1710018; Stam HJ, 2020, J REHABIL MED, V52, DOI 10.2340/16501977-2677; Steel J, 2017, BRAIN INJURY, V31, P1889, DOI 10.1080/02699052.2017.1373200; Stevens RD, 2011, INTENS CARE MED, V37, P1054, DOI 10.1007/s00134-011-2233-1; Tahmasian M, 2016, NEUROSCI BIOBEHAV R, V65, P142, DOI 10.1016/j.neubiorev.2016.03.026; Takanashi J, 2009, BRAIN DEV-JPN, V31, P521, DOI 10.1016/j.braindev.2009.02.012; Tang N, 2020, J THROMB HAEMOST, V18, P844, DOI 10.1111/jth.14768; TEASDALE G, 1974, LANCET, V2, P81; Thakur ER, 2018, INT J BEHAV MED, V25, P74, DOI 10.1007/s12529-017-9663-2; Tisoncik JR, 2012, MICROBIOL MOL BIOL R, V76, P16, DOI 10.1128/MMBR.05015-11; Togher L, 2014, J HEAD TRAUMA REHAB, V29, P353, DOI 10.1097/HTR.0000000000000071; Torelli F, 2011, NEUROIMAGE, V54, P787, DOI 10.1016/j.neuroimage.2010.09.065; Tsivgoulis G, 2020, THER ADV NEUROL DISO, V13, DOI 10.1177/1756286420932036; Vallila-Rohter S, 2018, SEMIN SPEECH LANG, V39, P37, DOI 10.1055/s-0037-1608857; Wadman M, 2020, SCIENCE, DOI [10.1126/science.abc3208, DOI 10.1126/SCIENCE.ABC3208]; Wang S, 2018, TRIALS, V19, DOI 10.1186/s13063-018-2569-8; Wassenaar A, 2018, AM J CRIT CARE, V27, P124, DOI 10.4037/ajcc2018467; Wassenaar A, 2018, CRIT CARE MED, V46, P79, DOI 10.1097/CCM.0000000000002806; Weisel JW, 2017, SUBCELL BIOCHEM, V82, P405, DOI 10.1007/978-3-319-49674-0_13; Wen XD, 2018, MEDICINE, V97, DOI 10.1097/MD.0000000000010092; Weuve J, 2011, J AM GERIATR SOC, V59, P1283, DOI 10.1111/j.1532-5415.2011.03487.x; WHO, 2020, CLIN MAN COVID 19 IN; Whyte J., 2011, ENCY CLIN NEUROPSYCH, DOI DOI 10.1007/978-0-387-79948-3_67; Wilber ST, 2016, EMERG MED CLIN N AM, V34, P649, DOI 10.1016/j.emc.2016.04.012; Wilcox ME, 2013, CRIT CARE MED, V41, pS81, DOI 10.1097/CCM.0b013e3182a16946; Wu YS, 2020, BRAIN BEHAV IMMUN, V87, P18, DOI 10.1016/j.bbi.2020.03.031; Yaouhi K, 2009, J SLEEP RES, V18, P36, DOI 10.1111/j.1365-2869.2008.00705.x; Yin MM, 2019, BMC PULM MED, V19, DOI 10.1186/s12890-019-0955-y; Zhang Q, 2015, SLEEP MED, V16, P1062, DOI 10.1016/j.sleep.2015.04.018; Zhang X, 2011, SLEEP MED, V12, P335, DOI 10.1016/j.sleep.2010.08.015	103	7	7	2	6	AMER SPEECH-LANGUAGE-HEARING ASSOC	ROCKVILLE	2200 RESEARCH BLVD, #271, ROCKVILLE, MD 20850-3289 USA	1058-0360	1558-9110		AM J SPEECH-LANG PAT	Am. J. Speech-Lang. Pathol.	NOV	2020	29	4					1821	1832		10.1044/2020_AJSLP-20-00147			12	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	OU0CU	WOS:000591205400004	32946270	hybrid			2022-02-06	
J	Yao, Y; Wang, JY; He, T; Li, HY; Hu, J; Zheng, MZ; Ding, YM; Chen, YY; Shen, YL; Wang, LL; Zhu, YJ				Yao, Ying; Wang, Jingyu; He, Teng; Li, Heyangzi; Hu, Jue; Zheng, Mingzhi; Ding, Yueming; Chen, Ying-ying; Shen, Yueliang; Wang, Lin-lin; Zhu, Yongjian			Microarray assay of circular RNAs reveals cicRNA.7079 as a new anti-apoptotic molecule in spinal cord injury in mice	BRAIN RESEARCH BULLETIN			English	Article						Circular RNA; cicRNA.7079; Spinal cord injury; Apoptosis; Mouse	EXPRESSION PROFILES; CELL-GROWTH; GALECTIN-3; PI3K/AKT; BRAIN; INFLAMMATION; PROTECTS; PATHWAY; FAMILY; GENES	Traumatic spinal cord injury (SCI) can lead to motor disturbance, sensory deficit, or autonomic dysfunction. The role of circRNAs in the pivotal physiopathological processes of SCI has been demonstrated recently. However, no similar research has been performed to explore the circRNAs involved in apoptosis after SCI. The differentially expressed circRNAs in mice spinal cord three days after SCI were originally detected with microarray assay (n = 4/group). Subsequently, potential apoptosis-related circRNAs were predicted by comprehensive bioinformatics analysis. In total, 1131 circRNAs varied (>2-fold change, p < 0.05) in the injured mice spinal cord. The characters of these circRNAs were summarized. Gene ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analysis was applied to predict the primary function of these circRNAs. 148 circRNAs were found to be correlated to the apoptosis injury progress in after SCI. Moreover, an apoptosis-related ceRNA network was constructed. In loss-of-function experiments, cicRNA.7079 knockdown enhanced apoptosis in NSC-34 motor neurons. This study may contribute to new insights into the mechanism of apoptosis after SCI. The anticipation of anti-apoptosis circRNA. 7079 may provide potential research targets for SCI in mice.	[Yao, Ying; Wang, Jingyu; Zhu, Yongjian] Zhejiang Univ, Affiliated Hosp 2, Dept Neurosurg, Sch Med, Hangzhou 310009, Zhejiang, Peoples R China; [He, Teng; Li, Heyangzi; Wang, Lin-lin] Zhejiang Univ, Sir Run Run Shaw Hosp, Sch Med, Dept Basic Med Sci, Hangzhou 310058, Zhejiang, Peoples R China; [He, Teng; Li, Heyangzi; Wang, Lin-lin] Zhejiang Univ, Sir Run Run Shaw Hosp, Sch Med, Dept Orthopaed, Hangzhou 310058, Zhejiang, Peoples R China; [Hu, Jue; Zheng, Mingzhi] Hangzhou Med Coll, Dept Pharmacol, Hangzhou, Zhejiang, Peoples R China; [Ding, Yueming] Zhejiang Univ City Coll, Sch Med, Hangzhou, Zhejiang, Peoples R China; [Chen, Ying-ying; Shen, Yueliang] Zhejiang Univ, Dept Basic Med Sci, Sch Med, Hangzhou 310058, Zhejiang, Peoples R China		Zhu, YJ (corresponding author), Zhejiang Univ, Affiliated Hosp 2, Dept Neurosurg, Sch Med, Hangzhou 310009, Zhejiang, Peoples R China.; Wang, LL (corresponding author), Zhejiang Univ, Sir Run Run Shaw Hosp, Sch Med, Dept Basic Med Sci, Hangzhou 310058, Zhejiang, Peoples R China.; Wang, LL (corresponding author), Zhejiang Univ, Sir Run Run Shaw Hosp, Sch Med, Dept Orthopaed, Hangzhou 310058, Zhejiang, Peoples R China.	wanglinlin@zju.edu.cn; neurosurgery@zju.edu.cn	yongjian, zhu/AAR-5445-2021	Wang, Jingyu/0000-0003-0433-9549	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81673777, 81572229, 81972138]; Zhejiang Provincial Natural Science Foundation of ChinaNatural Science Foundation of Zhejiang Province [Y19H170008]; Key Program of Administration of Traditional Chinese Medicine, Zhejiang Province [2018ZZ015]	This study was supported by National Natural Science Foundation of China (No. 81673777, 81572229 and 81972138), Zhejiang Provincial Natural Science Foundation of China (No. Y19H170008) and Key Program of Administration of Traditional Chinese Medicine, Zhejiang Province (No. 2018ZZ015).	Ahuja CS, 2017, NAT REV DIS PRIMERS, V3, DOI 10.1038/nrdp.2017.18; Akahani S, 1997, CANCER RES, V57, P5272; Al-Salam Suhail, 2020, Cell Physiol Biochem, V54, P287, DOI 10.33594/000000220; Beattie MS, 2000, J NEUROTRAUM, V17, P915, DOI 10.1089/neu.2000.17.915; Chiricosta L, 2019, NUTRIENTS, V11, DOI 10.3390/nu11051081; Cory S, 2002, NAT REV CANCER, V2, P647, DOI 10.1038/nrc883; Dayangac-Erden D, 2018, OMICS, V22, P598, DOI 10.1089/omi.2018.0106; Dou MY, 2016, EUR J PHARMACOL, V789, P395, DOI 10.1016/j.ejphar.2016.08.002; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; Gu SX, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18040732; Hansen TB, 2013, CANCER RES, V73, P5609, DOI 10.1158/0008-5472.CAN-13-1568; Hatakeyama S, 1998, INT IMMUNOL, V10, P631, DOI 10.1093/intimm/10.5.631; Hsu DK, 2000, AM J PATHOL, V156, P1073, DOI 10.1016/S0002-9440(10)64975-9; Kang Y, 2018, J NEURORESTORATOLOGY, V6, P1, DOI 10.2147/JN.S143236; Kiraz Y, 2016, TUMOR BIOL, V37, P8471, DOI 10.1007/s13277-016-5035-9; Kumar L, 2017, MOL NEUROBIOL, V54, P7224, DOI 10.1007/s12035-016-0213-8; Lasda E, 2014, RNA, V20, P1829, DOI 10.1261/rna.047126.114; Li HT, 2019, INT J BIOL SCI, V15, P277, DOI 10.7150/ijbs.30348; Li XJ, 2015, INT J CLIN EXP MED, V8, P8197; Lin SP, 2016, BIOCHEM BIOPH RES CO, V471, P52, DOI 10.1016/j.bbrc.2016.01.183; Lukiw Walter J., 2013, Frontiers in Genetics, V4, P77, DOI [10.3389/fgene.2013.00077, 10.3389/fgene.2013.00307]; Mehta SL, 2017, STROKE, V48, P2541, DOI 10.1161/STROKEAHA.117.017469; Moursel LG, 2018, FRONT AGING NEUROSCI, V10, DOI 10.3389/fnagi.2018.00102; Nan A, 2017, ARCH TOXICOL, V91, P1671, DOI 10.1007/s00204-016-1837-1; Park JH, 2016, SPINE J, V16, P1392, DOI 10.1016/j.spinee.2016.06.018; Pasquini LA, 2011, CELL DEATH DIFFER, V18, P1746, DOI 10.1038/cdd.2011.40; Qin C, 2019, FRONT MOL NEUROSCI, V11, DOI 10.3389/fnmol.2018.00497; Qu SB, 2015, CANCER LETT, V365, P141, DOI 10.1016/j.canlet.2015.06.003; Shi ZJ, 2019, J CELL PHYSIOL, V234, P8918, DOI 10.1002/jcp.27560; SOBRIDOCAMEAN D, 2018, FRONT MOL NEUROSCI, V11, DOI DOI 10.3389/J.36529; Vogler M, 2012, CELL DEATH DIFFER, V19, P67, DOI 10.1038/cdd.2011.158; Wang CX, 2020, J CELL BIOCHEM, V121, P3730, DOI 10.1002/jcb.29507; Wang CY, 2011, J BIOMED SCI, V18, DOI 10.1186/1423-0127-18-13; Wang JY, 2018, NEUROSCIENCE, V383, P12, DOI 10.1016/j.neuroscience.2018.04.045; Wang SJ, 2019, ACS APPL MATER INTER, V11, P41829, DOI 10.1021/acsami.9b09560; Wiberg R, 2017, J NEUROTRAUM, V34, P652, DOI 10.1089/neu.2015.4378; Wu QL, 2016, NEUROCHEM RES, V41, P2810, DOI 10.1007/s11064-016-1997-7; Xie BS, 2018, J NEUROTRAUM, V35, P1659, DOI 10.1089/neu.2017.5468; Xu HY, 2015, SCI REP-UK, V5, DOI 10.1038/srep12453; Yang RY, 1996, P NATL ACAD SCI USA, V93, P6737, DOI 10.1073/pnas.93.13.6737; Yang ZH, 2017, ONCOL REP, V37, P1011, DOI 10.3892/or.2017.5358; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Zhang K, 2018, EUR J PHARMACOL, V833, P63, DOI 10.1016/j.ejphar.2018.05.034; Zhang PX, 2015, AM J TRANSL RES, V7, P2223; Zhao W, 2019, WORLD NEUROSURG, V127, pE346, DOI 10.1016/j.wneu.2019.03.116; Zhou J, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00091; Zhou Y, 2014, CELL MOL NEUROBIOL, V34, P1151, DOI 10.1007/s10571-014-0090-5; Zhou ZB, 2019, J NEUROTRAUM, V36, P2287, DOI 10.1089/neu.2018.6366; Zhu HX, 2020, NEUROSCIENCE, V428, P50, DOI 10.1016/j.neuroscience.2019.12.018; Zhu LL, 2017, CELL PHYSIOL BIOCHEM, V44, P388, DOI 10.1159/000484919	50	7	7	2	5	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0361-9230	1873-2747		BRAIN RES BULL	Brain Res. Bull.	NOV	2020	164						157	171		10.1016/j.brainresbull.2020.08.004			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	OH2JL	WOS:000582395500016	32882320	hybrid			2022-02-06	
J	Bartsch, AJ; Hedin, D; Alberts, J; Benzel, EC; Cruickshank, J; Gray, RS; Cameron, K; Houston, MN; Rooks, T; McGinty, G; Kozlowski, E; Rowson, S; Maroon, JC; Miele, VJ; Ashton, JC; Siegmund, GP; Shah, A; McCrea, M; Stemper, B				Bartsch, Adam J.; Hedin, Daniel; Alberts, Jay; Benzel, Edward C.; Cruickshank, Jason; Gray, Robert S.; Cameron, Kenneth; Houston, Megan N.; Rooks, Tyler; McGinty, Gerald; Kozlowski, Erick; Rowson, Steven; Maroon, Joseph C.; Miele, Vincent J.; Ashton, J. Chris; Siegmund, Gunter P.; Shah, Alok; McCrea, Michael; Stemper, Brian			High Energy Side and Rear American Football Head Impacts Cause Obvious Performance Decrement on Video	ANNALS OF BIOMEDICAL ENGINEERING			English	Article						Concussion; American football; Head impact sensor; Mouthguard; Video review; Obvious performance decrement	TRAUMATIC BRAIN-INJURY; PROFESSIONAL FOOTBALL; CONCUSSION; PLAYERS; RISK; ENCEPHALOPATHY; NONDISCLOSURE; EPIDEMIOLOGY; PREDICTION; SEVERITY	The objective of this study was to compare head impact data acquired with an impact monitoring mouthguard (IMM) to the video-observed behavior of athletes' post-collision relative to their pre-collision behaviors. A total of n = 83 college and high school American football players wore the IMM and were video-recorded over 260 athlete-exposures. Ex-athletes and clinicians reviewed the video in a two-step process and categorized abnormal post-collision behaviors according to previously published Obvious Performance Decrement (OPD) definitions. Engineers qualitatively reviewed datasets to check head impact and non-head impact signal frequency and magnitude. The ex-athlete reviewers identified 2305 head impacts and 16 potential OPD impacts, 13 of which were separately categorized as Likely-OPD impacts by the clinical reviewers. All 13 Likely-OPD impacts were in the top 1% of impacts measured by the IMM (ranges 40-100 g, 3.3-7.0 m/s and 35-118 J) and 12 of the 13 impacts (92%) were to the side or rear of the head. These findings require confirmation in a larger data set before proposing any type of OPD impact magnitude or direction threshold exists. However, OPD cases in this study compare favorably with previously published impact monitoring studies in high school and college American football players that looked for OPD signs, impact magnitude and direction. Our OPD findings also compare well with NFL reconstruction studies for ranges of concussion and sub-concussive impact magnitudes in side/rear collisions, as well as prior theory, analytical models and empirical research that suggest a directional sensitivity to brain injury exists for single high-energy impacts.	[Bartsch, Adam J.] Prevent Biometr, Minneapolis, MN 55435 USA; [Hedin, Daniel] Adv Med Elect, Maple Grove, MN USA; [Alberts, Jay; Benzel, Edward C.; Cruickshank, Jason; Gray, Robert S.] Cleveland Clin, Cleveland, OH 44106 USA; [Cameron, Kenneth; Houston, Megan N.] Keller Army Community Hosp, West Point, NY USA; [Rooks, Tyler] US Army Aeromed Res Lab, Ft Rucker, AL USA; [McGinty, Gerald; Kozlowski, Erick] US Air Force Acad, Air Force Acad, CO USA; [Rowson, Steven] Virginia Tech Univ, Blacksburg, VA USA; [Maroon, Joseph C.; Miele, Vincent J.] Univ Pittsburgh, Med Ctr, Pittsburgh, PA USA; [Ashton, J. Chris] Twin Cities Orthoped, Maple Grove, MN USA; [Siegmund, Gunter P.] Univ British Columbia, Sch Kinesiol, Vancouver, BC, Canada; [Shah, Alok; McCrea, Michael; Stemper, Brian] Med Coll Wisconsin, Wauwatosa, WI USA		Bartsch, AJ (corresponding author), Prevent Biometr, Minneapolis, MN 55435 USA.	abartsch@preventbiometrics.com	Rowson, Steven/B-1270-2012	Rowson, Steven/0000-0002-3227-0596	DOD BAAUnited States Department of Defense [W81XWH-17-1-0019]; NIH SBIRUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R44HD090763-01A1]; Office of the Assistant Secretary of Defense for Health Affairs [W81XWH-14-2-0151]	This research was supported by DOD BAA W81XWH-17-1-0019 to Prevent Biometrics (PI: A. Bartsch), NIH SBIR R44HD090763-01A1 to Advanced Medical Electronics (PI: D. Hedin) and performed in conjunction with the NCAA-DOD Grand Alliance CARE Consortium award from the Office of the Assistant Secretary of Defense for Health Affairs, W81XWH-14-2-0151 (PI: M. McCrea). Drs. Jason Mihalik and Joel Stitzel reviewed the manuscript and the data as part of their roles on the Advisory Panel for the DOD BAA award. The authors acknowledge the participation and efforts of individuals at colleges and high schools, including Alexa Wild, Rachel Chiarello, Jennifer Hill, Dominic Calhoun, Lauren Hatch, Jeremy Ross, and Michael Aderman. Opinions, interpretations, conclusions, and recommendations are those of the authors and are not necessarily endorsed by the DOD or NIH. Its contents are solely the responsibility of the authors. Drew Goodger and Jack Sill assisted with the extensive video review. Dr. Jeff Crandall, Dr. Andrew Gardner, Dr. Declan Patton, and Dr. Scott Zuckerman provided guidance on prior studies and video review.	Arbogast KB, 2013, CLIN PEDIATR, V52, P397, DOI 10.1177/0009922813478160; Barton-Hulsey A, 2020, AM J SPEECH-LANG PAT, V29, P1475, DOI [10.1044/2020_AJSLP-19-00156, 10.1080/23279095.2020.1753744]; Bartsch A., 2019, BIOMED SCI INSTRUM, V55, P224; Bartsch A, 2020, MIL MED, V185, P190, DOI 10.1093/milmed/usz334; Bartsch Adam, 2014, Stapp Car Crash J, V58, P1; Bartsch AJ, 2019, IEEE ENG MED BIO, P2068, DOI 10.1109/EMBC.2019.8856907; Bruce JM, 2018, BRIT J SPORT MED, V52, DOI 10.1136/bjsports-2016-097091; Camarillo DB, 2013, ANN BIOMED ENG, V41, P1939, DOI 10.1007/s10439-013-0801-y; Cantu RC, 1998, CLIN SPORT MED, V17, P37, DOI 10.1016/S0278-5919(05)70059-4; Cantu RC, 2010, J NEUROTRAUM, V27, P1557, DOI 10.1089/neu.2010.1334; Celorrio-Navarro M, 2019, J NEUROTRAUM, V36, pA2; Centers for Disease Control, 2011, 6039 MMWR; Daneshvar DH, 2011, PHYS MED REH CLIN N, V22, P683, DOI 10.1016/j.pmr.2011.08.009; Davis GA, 2019, BRIT J SPORT MED, V53, P1299, DOI 10.1136/bjsports-2018-099727; Domel A, 2020, ABME UNPUB; Duma SM, 2005, CLIN J SPORT MED, V15, P3, DOI 10.1097/00042752-200501000-00002; Echemendia RJ, 2018, BRIT J SPORT MED, V52, P1149, DOI 10.1136/bjsports-2016-097090; Elbin RJ, 2020, NEUROSURGERY, V87, P530, DOI 10.1093/neuros/nyaa072; Elkin BS, 2019, CLIN BIOMECH, V64, P49, DOI 10.1016/j.clinbiomech.2018.03.021; Elliott MR, 2015, J BIOMECH, V48, P3059, DOI 10.1016/j.jbiomech.2015.07.026; Foust D.R, 1978, 6 ANN INT WORKSH HUM, pi; Funk JR, 2011, ANN BIOMED ENG, V39, P766, DOI 10.1007/s10439-010-0183-3; Gardner AJ, 2018, SPORTS MED-OPEN, V4, DOI 10.1186/s40798-018-0133-4; Gardner AJ, 2018, SPORTS MED-OPEN, V4, DOI 10.1186/s40798-017-0117-9; Gardner AJ, 2017, SPORTS MED-OPEN, V3, DOI 10.1186/s40798-017-0097-9; Gennarelli T, 1987, P 31 STAPP CAR CRASH; Greenwald RM, 2008, NEUROSURGERY, V62, P789, DOI 10.1227/01.neu.0000318162.67472.ad; Guskiewicz KM, 2007, NEUROSURGERY, V61, P1244, DOI 10.1227/01.neu.0000306103.68635.1a; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Harmon KG, 2019, BRIT J SPORT MED, V53, P213, DOI 10.1136/bjsports-2018-100338; Hedin DS, 2016, IEEE ENG MED BIO, P2007, DOI 10.1109/EMBC.2016.7591119; Holbourn AHS, 1943, LANCET, V2, P438; Jordan BD, 2000, SEMIN NEUROL, V20, P179, DOI 10.1055/s-2000-9826; Kerr ZY, 2018, AM J SPORT MED, V46, P22, DOI 10.1177/0363546517728264; Kerr ZY, 2016, AM J SPORT MED, V44, P220, DOI 10.1177/0363546515612082; Kerr ZY, 2014, BRAIN INJURY, V28, P1009, DOI 10.3109/02699052.2014.904049; Kieffer EE, 2019, BIOMED SCI INSTRUM, V55, P236; Kieffer EE, 2020, ANN BIOMED ENG, V48, P2613, DOI 10.1007/s10439-020-02647-1; Kleiven, 2005, P IRCOBI C PRAG CZEC, P21; Kleiven S, 2003, J NEUROTRAUM, V20, P365, DOI 10.1089/089771503765172327; Kuo C, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0199238; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lessley DJ, 2018, AM J SPORT MED, V46, P3502, DOI 10.1177/0363546518804498; Liu YZ, 2020, ANN BIOMED ENG, V48, P2580, DOI 10.1007/s10439-020-02629-3; Makdissi M, 2016, J SCI MED SPORT, V19, P958, DOI 10.1016/j.jsams.2016.02.014; Makdissi M, 2016, J SCI MED SPORT, V19, P859, DOI 10.1016/j.jsams.2016.02.015; Mc Fie S., 2016, BMJ OPEN SPORT EXERC, V2, P000053, DOI [10.1136/bmjsem-2015-000053, DOI 10.1136/BMJSEM-2015-000053]; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McIntosh AS, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005078; McIntosh AS, 2000, MED SCI SPORT EXER, V32, P1980, DOI 10.1097/00005768-200012000-00002; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Meaney DF, 2014, J BIOMECH ENG-T ASME, V136, DOI 10.1115/1.4026364; Newman J, 2000, NEW BIOMECHANICAL 2; Newman J.A., 2000, STAPP CAR CRASH J; O'Connor KL, 2017, J ATHL TRAINING, V52, P206, DOI 10.4085/1062-6050.52.2.05; Omalu Bennet I, 2010, J Forensic Nurs, V6, P130, DOI 10.1111/j.1939-3938.2010.01078.x; Omalu BI, 2005, NEUROSURGERY, V57, P128, DOI 10.1227/01.NEU.0000163407.92769.ED; Patrick LM, 1965, 7TH P STAPP CAR CRAS, P483; Patton DA, 2020, AM J SPORT MED, V48, P1246, DOI 10.1177/0363546520906406; Patton DA, 2016, APPL BIONICS BIOMECH, V2016, DOI 10.1155/2016/7049743; Pellman EJ, 2003, NEUROSURGERY, V53, P799, DOI 10.1093/neurosurgery/53.3.799; Plassman BL, 2000, NEUROLOGY, V55, P1158, DOI 10.1212/WNL.55.8.1158; Press JN, 2017, CLIN J SPORT MED, V27, P104, DOI 10.1097/JSM.0000000000000313; Rowson B, 2019, ANN BIOMED ENG, V47, P2045, DOI 10.1007/s10439-019-02379-x; Rowson S, 2013, ANN BIOMED ENG, V41, P873, DOI 10.1007/s10439-012-0731-0; Siegmund GP, 2016, ANN BIOMED ENG, V44, P1257, DOI 10.1007/s10439-015-1420-6; Stapp JP, 1961, GRAVITATIONAL STRESS, P165; Stemper BD, 2019, ANN BIOMED ENG, V47, P2057, DOI 10.1007/s10439-018-02136-6; Thomas M, 2011, PEDIATRICS, V128, pE1, DOI 10.1542/peds.2010-2743; Tyson AM, 2018, J APPL BIOMECH, V34, P320, DOI 10.1123/jab.2017-0256; Wu LC, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17864-3; Zhang LY, 2001, J NEUROTRAUM, V18, P21, DOI 10.1089/089771501750055749; Zuckerman SL, 2020, PHYSICIAN SPORTSMED, V48, P424, DOI 10.1080/00913847.2020.1731379	73	7	7	1	4	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0090-6964	1573-9686		ANN BIOMED ENG	Ann. Biomed. Eng.	NOV	2020	48	11			SI		2667	2677		10.1007/s10439-020-02640-8		OCT 2020	11	Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Engineering	PB5UI	WOS:000584557200001	33111969	Green Accepted			2022-02-06	
J	Servia, L; Montserrat, N; Badia, M; Llompart-Pou, JA; Barea-Mendoza, JA; Chico-Fernandez, M; Sanchez-Casado, M; Jimenez, JM; Mayor, DM; Trujillano, J				Servia, Luis; Montserrat, Neus; Badia, Mariona; Antonio Llompart-Pou, Juan; Abelardo Barea-Mendoza, Jesus; Chico-Fernandez, Mario; Sanchez-Casado, Marcelino; Manuel Jimenez, Jose; Maria Mayor, Dolores; Trujillano, Javier			Machine learning techniques for mortality prediction in critical traumatic patients: anatomic and physiologic variables from the RETRAUCI study	BMC MEDICAL RESEARCH METHODOLOGY			English	Article						Intensive care unit; Machine learning techniques; Supervised algorithms; Traumatic patient; Mortality	BAYESIAN NETWORKS; EPIDEMIOLOGY; REGISTRY; WORLD	Background Interest in models for calculating the risk of death in traumatic patients admitted to ICUs remains high. These models use variables derived from the deviation of physiological parameters and/or the severity of anatomical lesions with respect to the affected body areas. Our objective is to create different predictive models of the mortality of critically traumatic patients using machine learning techniques. Methods We used 9625 records from the RETRAUCI database (National Trauma Registry of 52 Spanish ICUs in the period of 2015-2019). Hospital mortality was 12.6%. Data on demographic variables, affected anatomical areas and physiological repercussions were used. The Weka Platform was used, along with a ten-fold cross-validation for the construction of nine supervised algorithms: logistic regression binary (LR), neural network (NN), sequential minimal optimization (SMO), classification rules (JRip), classification trees (CT), Bayesian networks (BN), adaptive boosting (ADABOOST), bootstrap aggregating (BAGGING) and random forest (RFOREST). The performance of the models was evaluated by accuracy, specificity, precision, recall, F-measure, and AUC. Results In all algorithms, the most important factors are those associated with traumatic brain injury (TBI) and organic failures. The LR finds thorax and limb injuries as independent protective factors of mortality. The CT generates 24 decision rules and uses those related to TBI as the first variables (range 2.0-81.6%). The JRip detects the eight rules with the highest risk of mortality (65.0-94.1%). The NN model uses a hidden layer of ten nodes, which requires 200 weights for its interpretation. The BN find the relationships between the different factors that identify different patient profiles. Models with the ensemble methodology (ADABOOST, BAGGING and RandomForest) do not have greater performance. All models obtain high values in accuracy, specificity, and AUC, but obtain lower values in recall. The greatest precision is achieved by the SMO model, and the BN obtains the best recall, F-measure, and AUC. Conclusion Machine learning techniques are useful for creating mortality classification models in critically traumatic patients. With clinical interpretation, the algorithms establish different patient profiles according to the relationship between the variables used, determine groups of patients with different evolutions, and alert clinicians to the presence of rules that indicate the greatest severity.	[Servia, Luis; Montserrat, Neus; Badia, Mariona; Trujillano, Javier] Univ Lleida, IRBLIeida, Hosp Univ Arnau de Vilanova, Serv Med Intens, Avda Rovira Roure 80, Lleida 25198, Spain; [Antonio Llompart-Pou, Juan] Hosp Univ Son Espases, Inst Invest Sanitaria Illes Balears, Serv Med Intens, Palma De Mallorca, Spain; [Abelardo Barea-Mendoza, Jesus; Chico-Fernandez, Mario] Hosp Univ 12 Octubre, UCI Trauma & Emergencias Serv Med Intens, Madrid, Spain; [Sanchez-Casado, Marcelino] Hosp Virgen Salud, Serv Med Intens, Toledo, Spain; [Manuel Jimenez, Jose] Hosp Univ Puerta Mar, Serv Med Intens, Cadiz, Spain; [Maria Mayor, Dolores] Complejo Hosp Torrecardenas, Serv Med Intens, Almeria, Spain		Trujillano, J (corresponding author), Univ Lleida, IRBLIeida, Hosp Univ Arnau de Vilanova, Serv Med Intens, Avda Rovira Roure 80, Lleida 25198, Spain.	jtruji@cmb.udl.es	Trujillano, Javier/A-4325-2010; Trujillano, Javier/AAZ-8142-2021; Goixart, Lluis Servia/C-6561-2011	Trujillano, Javier/0000-0001-8071-7711; Trujillano, Javier/0000-0001-8071-7711; Goixart, Lluis Servia/0000-0001-9513-1465; Barea-mendoza, Jesus A/0000-0002-1858-525X			Llompart-Pou JA, 2016, INJURY, V47, pS61, DOI 10.1016/S0020-1383(16)30608-8; Banu A Bazila, 2018, Asian Pac J Cancer Prev, V19, P2917; CHAMPION HR, 1989, J TRAUMA, V29, P623, DOI 10.1097/00005373-198905000-00017; Chico-Fernandez M, 2016, MED INTENSIVA, V40, P395, DOI 10.1016/j.medin.2015.11.003; Chico-Fernandez M, 2016, MED INTENSIVA, V40, P327, DOI 10.1016/j.medin.2015.07.011; Chico-Fernandez M, 2018, J TRAUMA ACUTE CARE, V84, P217, DOI 10.1097/TA.0000000000001696; de Munter L, 2017, INJURY, V48, P221, DOI 10.1016/j.injury.2016.12.009; Deist TM, 2018, MED PHYS, V45, P3449, DOI 10.1002/mp.12967; DiMaggio CJ, 2017, ACAD EMERG MED, V24, P1244, DOI 10.1111/acem.13223; Frank E, 2004, BIOINFORMATICS, V20, P2479, DOI 10.1093/bioinformatics/bth261; Friedman N, 1997, MACH LEARN, V29, P131, DOI 10.1023/A:1007465528199; Frohlich M, 2014, J TRAUMA ACUTE CARE, V76, P921, DOI 10.1097/TA.0000000000000199; Gennarelli TA, 2006, INJURY, V37, P1083, DOI 10.1016/j.injury.2006.07.009; Gholipour C, 2015, J CLIN DIAGN RES, V9, pOC19, DOI 10.7860/JCDR/2015/9467.5828; Gnanambal S., 2018, International Journal of Advanced Networking and Applications, V9, P3640; Gomez D, 2016, NEURAL COMPUT, V28, P216, DOI 10.1162/NECO_a_00793; Hall M, 2009, SIGKDD EXPLOR, V11, P10, DOI 10.1145/1656274.1656278; Hosni M, 2019, COMPUT METH PROG BIO, V177, P89, DOI 10.1016/j.cmpb.2019.05.019; Lee KH, 2019, J CLIN MED, V8, DOI 10.3390/jcm8101592; Lefering R, 2021, EUR J TRAUMA EMERG S, V47, P1837, DOI 10.1007/s00068-020-01373-6; Lin FCF, 2013, J INT MED RES, V41, P1310, DOI 10.1177/0300060513489921; Llau JV, 2015, MED INTENSIVA, V39, P483, DOI [10.1016/j.medine.2015.10.001, 10.1016/j.medin.2015.05.002]; Luo W, 2016, J MED INTERNET RES, V18, DOI 10.2196/jmir.5870; Ma H, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/4304376; Pourhoseingholi Mohamad Amin, 2017, Acta Inform Med, V25, P254, DOI 10.5455/aim.2017.25.254-258; Rajput A., 2011, INT J COMPUT SCI SEC, V5, P201; Rau Cheng-Shyuan, 2018, PLoS One, V13, pe0207192, DOI 10.1371/journal.pone.0207192; Sandri M, 2014, J BIOMED INFORM, V48, P106, DOI 10.1016/j.jbi.2013.12.008; Servia L, 2019, MED INTENSIVA, V43, P26, DOI 10.1016/j.medin.2017.11.008; Shillan D, 2019, CRIT CARE, V23, DOI 10.1186/s13054-019-2564-9; Sidey-Gibbons JAM, 2019, BMC MED RES METHODOL, V19, DOI 10.1186/s12874-019-0681-4; Sierra B, 2001, ARTIF INTELL MED, V22, P233, DOI 10.1016/S0933-3657(00)00111-1; Smith TC, 2016, METHODS MOL BIOL, V1418, P353, DOI 10.1007/978-1-4939-3578-9_17; Somnay YR, 2017, SURGERY, V161, P1113, DOI 10.1016/j.surg.2016.09.044; Sovik S, 2019, INTENS CARE MED, V45, P407, DOI 10.1007/s00134-019-05535-y; Spahn DR, 2019, CRIT CARE, V23, DOI 10.1186/s13054-019-2347-3; Trujillano J, 2009, BMC MED RES METHODOL, V9, DOI 10.1186/1471-2288-9-83; Wang HL, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00910; Zador Z, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158762; Zampieri FG, 2019, INTENS CARE MED, V45, P1156, DOI 10.1007/s00134-019-05595-0; Zhang YH, 2018, BBA-MOL BASIS DIS, V1864, P2255, DOI 10.1016/j.bbadis.2017.12.003	41	7	7	0	4	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1471-2288		BMC MED RES METHODOL	BMC Med. Res. Methodol.	OCT 20	2020	20	1							262	10.1186/s12874-020-01151-3			12	Health Care Sciences & Services	Science Citation Index Expanded (SCI-EXPANDED)	Health Care Sciences & Services	OK3PV	WOS:000584566800002	33081694	Green Published, Green Submitted, gold			2022-02-06	
J	Kessler, RC; Ressler, KJ; House, SL; Beaudoin, FL; An, XM; Stevens, JS; Zeng, DL; Neylan, TC; Linnstaedt, SD; Germine, LT; Musey, PI; Hendry, PL; Sheikh, S; Storrow, AB; Jones, CW; Punches, BE; Datner, EM; Mohiuddin, K; Gentile, NT; McGrath, ME; van Rooij, SJ; Hudak, LA; Haran, JP; Peak, DA; Domeier, RM; Pearson, C; Sanchez, LD; Rathlev, NK; Peacock, WF; Bruce, SE; Miller, MW; Joormann, J; Barch, DM; Pizzagalli, DA; Sheridan, JF; Smoller, JW; Pace, TWW; Harte, SE; Elliott, JM; Harnett, NG; Lebois, LAM; Hwang, I; Sampson, NA; Koenen, KC; McLean, SA				Kessler, Ronald C.; Ressler, Kerry J.; House, Stacey L.; Beaudoin, Francesca L.; An, Xinming; Stevens, Jennifer S.; Zeng, Donglin; Neylan, Thomas C.; Linnstaedt, Sarah D.; Germine, Laura T.; Musey, Paul I.; Hendry, Phyllis L.; Sheikh, Sophia; Storrow, Alan B.; Jones, Christopher W.; Punches, Brittany E.; Datner, Elizabeth M.; Mohiuddin, Kamran; Gentile, Nina T.; McGrath, Meghan E.; van Rooij, Sanne J.; Hudak, Lauren A.; Haran, John P.; Peak, David A.; Domeier, Robert M.; Pearson, Claire; Sanchez, Leon D.; Rathlev, Niels K.; Peacock, William F.; Bruce, Steven E.; Miller, Mark W.; Joormann, Jutta; Barch, Deanna M.; Pizzagalli, Diego A.; Sheridan, John F.; Smoller, Jordan W.; Pace, Thaddeus W. W.; Harte, Steven E.; Elliott, James M.; Harnett, Nathaniel G.; Lebois, Lauren A. M.; Hwang, Irving; Sampson, Nancy A.; Koenen, Karestan C.; McLean, Samuel A.			Socio-demographic and trauma-related predictors of PTSD within 8 weeks of a motor vehicle collision in the AURORA study	MOLECULAR PSYCHIATRY			English	Article							POSTTRAUMATIC-STRESS-DISORDER; CONCUSSION SYMPTOMS; HEAD-INJURY	This is the initial report of results from the AURORA multisite longitudinal study of adverse post-traumatic neuropsychiatric sequelae (APNS) among participants seeking emergency department (ED) treatment in the aftermath of a traumatic life experience. We focus onn = 666 participants presenting to EDs following a motor vehicle collision (MVC) and examine associations of participant socio-demographic and participant-reported MVC characteristics with 8-week posttraumatic stress disorder (PTSD) adjusting for pre-MVC PTSD and mediated by peritraumatic symptoms and 2-week acute stress disorder (ASD). Peritraumatic Symptoms, ASD, and PTSD were assessed with self-report scales. Eight-week PTSD prevalence was relatively high (42.0%) and positively associated with participant sex (female), low socioeconomic status (education and income), and several self-report indicators of MVC severity. Most of these associations were entirely mediated by peritraumatic symptoms and, to a lesser degree, ASD, suggesting that the first 2 weeks after trauma may be a uniquely important time period for intervening to prevent and reduce risk of PTSD. This observation, coupled with substantial variation in the relative strength of mediating pathways across predictors, raises the possibility of diverse and potentially complex underlying biological and psychological processes that remain to be elucidated with more in-depth analyses of the rich and evolving AURORA data.	[Kessler, Ronald C.; Hwang, Irving; Sampson, Nancy A.] Harvard Med Sch, Dept Hlth Care Policy, Boston, MA 02115 USA; [Ressler, Kerry J.; Germine, Laura T.; Pizzagalli, Diego A.; Harnett, Nathaniel G.; Lebois, Lauren A. M.] Harvard Med Sch, Dept Psychiat, Boston, MA 02115 USA; [Ressler, Kerry J.; Harnett, Nathaniel G.; Lebois, Lauren A. M.] McLean Hosp, Div Depress & Anxiety Disorders, 115 Mill St, Belmont, MA 02178 USA; [House, Stacey L.] Washington Univ, Dept Emergency Med, Sch Med, St Louis, MO USA; [Beaudoin, Francesca L.] Brown Univ, Dept Emergency Med, Alpert Med Sch, Providence, RI USA; [Beaudoin, Francesca L.] Brown Univ, Dept Hlth Serv Policy & Practice, Sch Publ Hlth, Providence, RI USA; [Beaudoin, Francesca L.] Rhode Isl Hosp, Providence, RI USA; [Beaudoin, Francesca L.] Miriam Hosp, Providence, RI USA; [An, Xinming; Linnstaedt, Sarah D.; McLean, Samuel A.] Univ N Carolina, Inst Trauma Recovery, Dept Anesthesiol, Chapel Hill, NC 27515 USA; [Stevens, Jennifer S.; van Rooij, Sanne J.; Pace, Thaddeus W. W.] Emory Univ, Sch Med, Dept Psychiat & Behav Sci, Atlanta, GA 30322 USA; [Zeng, Donglin] Univ N Carolina, Sch Global Publ Hlth, Dept Biostat, Chapel Hill, NC 27515 USA; [Neylan, Thomas C.] San Francisco VA Healthcare Syst, San Francisco, CA USA; [Neylan, Thomas C.] Univ Calif San Francisco, Dept Psychiat & Neurol, San Francisco, CA 94143 USA; [Germine, Laura T.] McLean Hosp, Inst Technol Psychiat, 115 Mill St, Belmont, MA 02178 USA; [Germine, Laura T.] Many Brains Project, Acton, MA USA; [Musey, Paul I.] Indiana Univ Sch Med, Dept Emergency Med, Indianapolis, IN 46202 USA; [Hendry, Phyllis L.; Sheikh, Sophia] Univ Florida, Coll Med, Dept Emergency Med, Jacksonville, FL USA; [Storrow, Alan B.] Vanderbilt Univ, Dept Emergency Med, Med Ctr, Nashville, TN USA; [Jones, Christopher W.] Rowan Univ, Dept Emergency Med, Cooper Med Sch, Camden, NJ USA; [Punches, Brittany E.] Univ Cincinnati, Dept Emergency Med, Coll Med, Cincinnati, OH USA; [Punches, Brittany E.] Univ Cincinnati, Coll Nursing, Cincinnati, OH USA; [Datner, Elizabeth M.] Einstein Healthcare Network, Dept Emergency Med, Philadelphia, PA USA; [Datner, Elizabeth M.] Thomas Jefferson Univ, Dept Emergency Med, Sidney Kimmel Med Coll, Philadelphia, PA 19107 USA; [Mohiuddin, Kamran] Einstein Med Ctr, Dept Internal Med, Philadelphia, PA USA; [Mohiuddin, Kamran] Einstein Med Ctr, Dept Emergency Med, Philadelphia, PA USA; [Gentile, Nina T.] Temple Univ, Dept Emergency Med, Lewis Katz Sch Med, Philadelphia, PA 19122 USA; [McGrath, Meghan E.] Boston Med Ctr, Dept Emergency Med, Boston, MA USA; [Hudak, Lauren A.] Emory Univ, Dept Emergency Med, Sch Med, Atlanta, GA 30322 USA; [Hudak, Lauren A.] Grady Mem Hosp, Emergency Med, Atlanta, GA USA; [Haran, John P.] Univ Massachusetts, Dept Emergency Med, Sch Med, Worcester, MA 01605 USA; [Peak, David A.] Massachusetts Gen Hosp, Dept Emergency Med, Boston, MA 02114 USA; [Domeier, Robert M.] St Joseph Mercy Hosp, Dept Emergency Med, Ann Arbor, MI USA; [Pearson, Claire] Wayne State Univ, Dept Emergency Med, Ascens St John Hosp, Detroit, MI USA; [Sanchez, Leon D.] Beth Israel Deaconess Med Ctr, Dept Emergency Med, Boston, MA 02215 USA; [Sanchez, Leon D.] Harvard Med Sch, Dept Emergency Med, Boston, MA 02115 USA; [Rathlev, Niels K.] Univ Massachusetts, Dept Emergency Med, Med Sch Baystate, Springfield, MA USA; [Peacock, William F.] Baylor Coll Med, Henry JN Taub Dept Emergency Med, Houston, TX 77030 USA; [Bruce, Steven E.] Univ Missouri, Dept Psychol Sci, St Louis, MO 63121 USA; [Miller, Mark W.] VA Boston Healthcare Syst, Natl Ctr PTSD, Boston, MA USA; [Miller, Mark W.] Boston Univ, Dept Psychiat, Sch Med, Boston, MA 02215 USA; [Joormann, Jutta] Yale Univ, Dept Psychol, New Haven, CT USA; [Barch, Deanna M.] Washington Univ, Dept Psychol & Brain Sci, St Louis, MO USA; [Barch, Deanna M.] Washington Univ, Dept Psychiat, St Louis, MO USA; [Barch, Deanna M.] Washington Univ, Dept Radiol, St Louis, MO USA; [Sheridan, John F.] Ohio State Univ, Div Biosci, Coll Dent, Columbus, OH 43210 USA; [Sheridan, John F.] Ohio State Univ, Inst Behav Med Res, Wexner Med Ctr, Columbus, OH 43210 USA; [Sheridan, John F.] Ohio State Univ, Inst Behav Med Res, Wexner Med Ctr, Columbus, OH USA; [Smoller, Jordan W.] Massachusetts Gen Hosp, Dept Psychiat, Boston, MA 02114 USA; [Smoller, Jordan W.] Massachusetts Gen Hosp, Psychiat & Neurodev Genet Unit, Ctr Genom Med, Boston, MA 02114 USA; [Smoller, Jordan W.] Broad Inst, Stanley Ctr Psychiat Res, Boston, MA USA; [Harte, Steven E.] Univ Michigan, Chron Pain & Fatigue Res Ctr, Sch Med, Ann Arbor, MI 48109 USA; [Harte, Steven E.] Univ Michigan, Dept Anesthesiol, Sch Med, Ann Arbor, MI 48109 USA; [Harte, Steven E.] Univ Michigan, Dept Internal Med Rheumatol, Sch Med, Ann Arbor, MI 48109 USA; [Elliott, James M.] Univ Sydney, Kolling Inst Med Res, Northern Clin Sch, St Leonards, St Leonards, NSW, Australia; [Elliott, James M.] Univ Sydney, Fac Hlth Sci, St Leonards, NSW, Australia; [Elliott, James M.] Northwestern Univ, Phys Therapy & Human Movement Sci, Feinberg Sch Med, Chicago, IL 60611 USA; [Koenen, Karestan C.] Harvard TH Chan Sch Publ Hlth, Dept Epidmiol, Boston, MA USA; [McLean, Samuel A.] Univ N Carolina, Dept Emergency Med, Chapel Hill, NC 27515 USA		Kessler, RC (corresponding author), Harvard Med Sch, Dept Hlth Care Policy, Boston, MA 02115 USA.	kessler@hcp.med.harvard.edu	Stevens, Jennifer/T-4290-2018; PUNCHES, BRITTANY/AAO-9768-2021; Sheikh, Sophia/F-9746-2015; Lebois, Lauren/AAB-3224-2021; Sanchez, Leon/R-7681-2019; Ressler, Kerry/N-8741-2018	Stevens, Jennifer/0000-0003-4674-0314; Sheikh, Sophia/0000-0003-1939-3126; Lebois, Lauren/0000-0001-5816-9181; Sanchez, Leon/0000-0002-8807-0913; Ressler, Kerry/0000-0002-5158-1103; Linnstaedt, Sarah/0000-0001-5295-7072; Germine, Laura/0000-0001-8690-8412; Punches, Brittany/0000-0002-7546-1966	NIMHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [U01MH110925]; US Army Medical Research and Material CommandU.S. Army Medical Research & Materiel Command (USAMRMC); One Mind Foundation; Mayday Fund	AURORA is supported by NIMH U01MH110925, the US Army Medical Research and Material Command, The One Mind Foundation, and The Mayday Fund. Verily Life Sciences and Mindstrong Health provide some of the hardware and software used to perform study assessments.	Atwoli L, 2015, CURR OPIN PSYCHIATR, V28, P307, DOI 10.1097/YCO.0000000000000167; Benjet C, 2016, PSYCHOL MED, V46, P327, DOI 10.1017/S0033291715001981; Boscarino JA, 2006, ANN EPIDEMIOL, V16, P248, DOI 10.1016/j.annepidem.2005.03.009; Bovin MJ, 2016, PSYCHOL ASSESSMENT, V28, P1379, DOI 10.1037/pas0000254; Brunet A, 2001, AM J PSYCHIAT, V158, P1480, DOI 10.1176/appi.ajp.158.9.1480; Bryant RA, 2017, CURR OPIN PSYCHOL, V14, P127, DOI 10.1016/j.copsyc.2017.01.005; Bryant RA, 2013, JAMA PSYCHIAT, V70, P839, DOI 10.1001/jamapsychiatry.2013.1137; Dean KR, 2020, MOL PSYCHIATR, V25, P3337, DOI 10.1038/s41380-019-0496-z; Farrar JT, 2001, PAIN, V94, P149, DOI 10.1016/S0304-3959(01)00349-9; Feinberg RK, 2017, PAIN, V158, P682, DOI 10.1097/j.pain.0000000000000818; Heron-Delaney M, 2013, INJURY, V44, P1413, DOI 10.1016/j.injury.2013.07.011; Kazantzis N, 2012, CULT MED PSYCHIAT, V36, P442, DOI 10.1007/s11013-012-9265-z; Kessler RC, 2018, MOL PSYCHIATR, V23, DOI 10.1038/mp.2017.194; KESSLER RC, 1995, ARCH GEN PSYCHIAT, V52, P1048, DOI 10.1001/archpsyc.1995.03950240066012; Kessler RC, 2000, J CLIN PSYCHIAT, V61, P4; Kessler RC, 2017, EUR J PSYCHOTRAUMATO, V8, DOI 10.1080/20008198.2017.1353383; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Koenen KC, 2017, PSYCHOL MED, V47, P2260, DOI 10.1017/S0033291717000708; Lanius RA, 2018, CURR PSYCHIAT REP, V20, DOI 10.1007/s11920-018-0983-y; Linnstaedt SD, 2018, J NEUROSCI, V38, P8407, DOI 10.1523/JNEUROSCI.3458-17.2018; Loftis KL, 2018, TRAFFIC INJ PREV, V19, pS109, DOI 10.1080/15389588.2018.1512747; Lowe SR, 2021, PSYCHOL MED, V51, P1129, DOI 10.1017/S0033291719004008; McLean SA, 2020, MOL PSYCHIATR, V25, P283, DOI 10.1038/s41380-019-0581-3; McLean SA, 2009, AM J EMERG MED, V27, P182, DOI 10.1016/j.ajem.2008.01.054; Michaels AJ, 1999, J TRAUMA, V47, P460, DOI 10.1097/00005373-199909000-00005; National Center for Statistics and Analysis, 2018, 812580 DOT HS NAT CT; Pacella ML, 2013, J ANXIETY DISORD, V27, P33, DOI 10.1016/j.janxdis.2012.08.004; Platts-Mills TF, 2012, ACAD EMERG MED, V19, P821, DOI 10.1111/j.1553-2712.2012.01383.x; Robbins J.M., 1991, CURRENT CONCEPTS SOM, P21; Roberts AL, 2011, PSYCHOL MED, V41, P71, DOI 10.1017/S0033291710000401; Santiago PN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059236; Stein DJ, 2016, BMC PSYCHIATRY, V16, DOI 10.1186/s12888-016-0957-8; Utzon-Frank N, 2014, SCAND J WORK ENV HEA, V40, P215, DOI 10.5271/sjweh.3420; van der Velden PG, 2008, CLIN PSYCHOL REV, V28, P1009, DOI 10.1016/j.cpr.2008.02.006; Vance MC, 2018, J CLIN PSYCHOL, V74, P1457, DOI 10.1002/jclp.22612; Zuromski KL, 2019, DEPRESS ANXIETY, V36, P790, DOI 10.1002/da.22942	36	7	7	1	3	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	1359-4184	1476-5578		MOL PSYCHIATR	Mol. Psychiatr.	JUL	2021	26	7					3108	3121		10.1038/s41380-020-00911-3		OCT 2020	14	Biochemistry & Molecular Biology; Neurosciences; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Biochemistry & Molecular Biology; Neurosciences & Neurology; Psychiatry	WF6IT	WOS:000579696500003	33077855	Green Accepted			2022-02-06	
J	Bailey, AM; Sherwood, CP; Funk, JR; Crandall, JR; Carter, N; Hessel, D; Beier, S; Neale, W				Bailey, Ann M.; Sherwood, Christopher P.; Funk, James R.; Crandall, Jeff R.; Carter, Neal; Hessel, David; Beier, Stephen; Neale, William			Characterization of Concussive Events in Professional American Football Using Videogrammetry	ANNALS OF BIOMEDICAL ENGINEERING			English	Article						Concussion; Helmet; Kinematics; Biomechanics	HEAD IMPACT KINEMATICS; VIDEO ANALYSIS; STRAIN RESPONSES; BRAIN-INJURY; SYSTEM; RUGBY; VALIDATION; ACCURACY; SPORTS	Sports concussions offer a unique opportunity to study head kinematics associated with mild traumatic brain injury. In this study, a model-based image matching (MBIM) approach was employed to analyze video footage of 57 concussions which occurred in National Football League (NFL) games. By utilizing at least two camera views, higher frame rate footage (> 60 images s(-1)), and laser scans of the field and helmets involved in each case, it was possible to calculate the change in velocity of the helmet during impact in six degrees of freedom. The average impact velocity for these concussive events was 8.9 +/- 2.0 m s(-1). The average changes in translational and rotational velocity for the concussed players' helmets were 6.6 +/- 2.1 m s(-1)and 29 +/- 13 rad s(-1), respectively. The average change in translational velocity was higher for helmet-to-ground (n = 16) impacts compared to helmet-to-helmet (n = 30) or helmet-to-shoulder (n = 11) events (p < 0.001), while helmet-to-shoulder impacts had a smaller change in rotational velocity compared to the other impact sources (p < 0.001). By quantifying the impact velocities and locations associated with concussive impacts in professional American football, this study provides information that may be used to improve upon current helmet testing methodologies.	[Bailey, Ann M.; Sherwood, Christopher P.; Funk, James R.; Crandall, Jeff R.] Biomech Consulting & Res LLC, Charlottesville, VA 22911 USA; [Carter, Neal; Hessel, David; Beier, Stephen; Neale, William] Kineticorp, Greenwood Village, CO USA		Bailey, AM (corresponding author), Biomech Consulting & Res LLC, Charlottesville, VA 22911 USA.	abailey@bicorellc.com					ADKISON JW, 1974, CLIN ORTHOP RELAT R, P131; Allison MA, 2015, ANN BIOMED ENG, V43, P1896, DOI 10.1007/s10439-014-1197-z; Anderson B.E., 2015, INT J INSTRUM TECHNO, V1, P282, DOI [10.1504/IJIT.2015.075925, DOI 10.1504/IJIT.2015.075925]; Bailey A., 2018, SPORTS BIOMECH, P1; Bartsch Adam, 2014, Stapp Car Crash J, V58, P1; Beckwith JG, 2012, ANN BIOMED ENG, V40, P237, DOI 10.1007/s10439-011-0422-2; Camarillo DB, 2013, ANN BIOMED ENG, V41, P1939, DOI 10.1007/s10439-013-0801-y; Christopher J. J, 2013, 2013010805 SAE; Churchill E, 1976, SAMPLING DATA GATHER; Davis GA, 2019, BRIT J SPORT MED, V53, P1299, DOI 10.1136/bjsports-2018-099727; Ellenbogen RG, 2018, BRIT J SPORT MED, V52, P894, DOI 10.1136/bjsports-2018-099203; Fuller GW, 2017, J SCI MED SPORT, V20, P246, DOI 10.1016/j.jsams.2016.07.008; Funk JR, 2012, ANN BIOMED ENG, V40, P79, DOI 10.1007/s10439-011-0400-8; Gabler LF, 2018, ANN BIOMED ENG, V46, P972, DOI 10.1007/s10439-018-2015-9; Gabler LF, 2016, ANN BIOMED ENG, V44, P3705, DOI 10.1007/s10439-016-1697-0; Gardner AJ, 2015, BRAIN INJURY, V29, P1182, DOI 10.3109/02699052.2015.1034179; Gennarelli TA, 1987, DIRECTIONAL DEPENDEN; Gilchrist, 2013, P INT RES COUNC BIOM; Guidice JS, 2018, ANN BIOMED ENG, V47, P464; Hirsch AE, 1970, PROTECTION BRAIN INJ; Hutchison MG, 2015, BRIT J SPORT MED, V49, P547, DOI 10.1136/bjsports-2013-092234; Jadischke R, 2013, J BIOMECH, V46, P2310, DOI 10.1016/j.jbiomech.2013.05.030; Joodaki H, 2019, J BIOMECH ENG; Kerr ZY, 2017, J ATHL TRAINING, V52, P167, DOI 10.4085/1062-6050-51.6.05; Koh JO, 2004, BRAIN INJURY, V18, P1287, DOI 10.1080/02699050410001719907; Kuo C, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0199238; Lessley DJ, 2018, AM J SPORT MED, V46, P3502, DOI 10.1177/0363546518804498; McIntosh AS, 2000, MED SCI SPORT EXER, V32, P1980, DOI 10.1097/00005768-200012000-00002; Miller LE, 2018, J BIOMECH ENG; Myers B., 2009, SHOCK, V1, P54; Neale W., 2016, SAE TECHNICAL PAPER; Neale W. T, 2011, SAE TECHNICAL PAPER; Newman JA, 2005, J BIOMECH, V38, P1469, DOI 10.1016/j.jbiomech.2004.06.025; Oeur R. A., 2015, ISBS C P ARCH; Patton DA, 2020, AM J SPORT MED, V48, P1246, DOI 10.1177/0363546520906406; Pellman EJ, 2003, NEUROSURGERY, V53, P1328, DOI 10.1227/01.NEU.0000093499.20604.21; Pellman EJ, 2003, NEUROSURGERY, V53, P799, DOI 10.1093/neurosurgery/53.3.799; Pfister T, 2016, BRIT J SPORT MED, V50, P292, DOI 10.1136/bjsports-2015-094978; Prange MT, 2002, J BIOMECH ENG-T ASME, V124, P244, DOI 10.1115/1.1449907; Rich AM, 2019, ANN BIOMED ENG, V47, P2109, DOI 10.1007/s10439-019-02313-1; Rowson S, 2011, J APPL BIOMECH, V27, P8, DOI 10.1123/jab.27.1.8; Sanchez EJ, 2019, CLIN BIOMECH, V64, P82, DOI 10.1016/j.clinbiomech.2018.02.019; Siegmund GP, 2016, ANN BIOMED ENG, V44, P1257, DOI 10.1007/s10439-015-1420-6; Society of Automotive Engineers, 2014, J2111201403 SAE INT; Stemper BD, 2019, ANN BIOMED ENG, V47, P2057, DOI 10.1007/s10439-018-02136-6; Takhounts E. G., 2011, P 22 ENH SAF VEH C; Thurman DJ, 1998, J HEAD TRAUMA REHAB, V13, P1, DOI 10.1097/00001199-199804000-00003; Tierney GJ, 2019, INT J SPORTS SCI COA, V14, P190, DOI 10.1177/1747954119833477; Wu LC, 2014, IEEE T BIO-MED ENG, V61, P2659, DOI 10.1109/TBME.2014.2320153; Yamazaki J, 2015, MED SCI SPORT EXER, V47, P1113, DOI 10.1249/MSS.0000000000000511	50	7	7	1	1	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0090-6964	1573-9686		ANN BIOMED ENG	Ann. Biomed. Eng.	NOV	2020	48	11			SI		2678	2690		10.1007/s10439-020-02637-3		OCT 2020	13	Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Engineering	PB5UI	WOS:000575717000003	33025319				2022-02-06	
J	Bae, S; Sheth, C; Legarreta, M; McGlade, E; Lyoo, IK; Yurgelun-Todd, DA				Bae, Sujin; Sheth, Chandni; Legarreta, Margaret; McGlade, Erin; Lyoo, In Kyoon; Yurgelun-Todd, Deborah A.			Volume and shape analysis of the Hippocampus and amygdala in veterans with traumatic brain injury and posttraumatic stress disorder	BRAIN IMAGING AND BEHAVIOR			English	Article						Hippocampus; Amygdala; Shape analysis; PTSD; Depression; TBI; Veterans	SERVICE MEMBERS; GYRUS VOLUME; METAANALYSIS; DEFICITS; ATROPHY; ADULTS; HEALTH; MRI; RELIABILITY; ASSOCIATION	There is a need to improve the understanding of the neurobiological underpinnings of traumatic brain injury (TBI). Individuals with TBI experience comorbidities such as posttraumatic stress disorder (PTSD) with considerable symptom overlap including depression and hyperarousal, confounding the ability to identify specific TBI-related brain changes. The aims of the current study were to investigate hippocampal and amygdalar volumes in Veterans with TBI with (TBI + PTSD,n = 32) and without (TBI - PTSD,n = 25) PTSD. Shape analysis was employed to reveal any relationship between the hippocampus and depressive symptoms in TBI subgroups. 32 TBI + PTSD, 25 TBI - PTSD, and 25 age-matched healthy male Veterans underwent an MRI scan on a 3 Tesla scanner and a clinical evaluation. The TBI + PTSD and the TBI + hyperarousal (met criteria for the hyperarousal symptom cluster, regardless of PTSD diagnosis) subgroup had trend-level larger left amygdalar volume than the TBI - PTSD subgroup and the TBI - hyperarousal subgroup, respectively. However, there was no significant difference between the TBI group as a whole and healthy controls (HC). There was a significant negative correlation between the Hamilton Rating Scale for Depression score (HAM-D) and left hippocampal volume and a positive correlation between the HAM-D score and left amygdalar volume in the TBI group. Left hippocampal volume was correlated with the HAM-D score only in the TBI + PTSD and not in TBI - PTSD subgroup. Shape analyses revealed a significant correlation between the HAM-D score and the CA1 and subiculum regions of the left hippocampus. Our results suggest that the amygdala may be a neuroanatomical correlate in mediating PTSD-like symptoms in Veterans with TBI. The results of shape analysis suggest that alterations in the CA1 and subiculum subregions of hippocampus may have a role in depression and PTSD.	[Bae, Sujin] Chung Ang Univ, Coll Med, Dept Psychiat, Seoul, South Korea; [Sheth, Chandni; McGlade, Erin; Lyoo, In Kyoon; Yurgelun-Todd, Deborah A.] Univ Utah, Sch Med, Dept Psychiat, Salt Lake City, UT 84112 USA; [Sheth, Chandni; Legarreta, Margaret; McGlade, Erin; Yurgelun-Todd, Deborah A.] Univ Utah, Diagnost Neuroimaging, Salt Lake City, UT 84112 USA; [Legarreta, Margaret; McGlade, Erin; Yurgelun-Todd, Deborah A.] George E Wahlen Dept Vet Affairs Med Ctr, VA VISN Mental Illness Res 19, Educ & Clin Ctr MIRECC, Salt Lake City, UT 84148 USA; [Lyoo, In Kyoon] Ewha Womans Univ, Ewha Brain Inst, Seoul, South Korea; [Lyoo, In Kyoon] Ewha Womans Univ, Dept Brain & Cognit Sci, Seoul, South Korea; [Lyoo, In Kyoon] Ewha Womans Univ, Coll Pharm, Grad Sch Pharmaceut Sci, Seoul, South Korea; [Yurgelun-Todd, Deborah A.] Brain Inst, 383 Colorow Dr, Salt Lake City, UT 84108 USA		Yurgelun-Todd, DA (corresponding author), Univ Utah, Sch Med, Dept Psychiat, Salt Lake City, UT 84112 USA.; Yurgelun-Todd, DA (corresponding author), Univ Utah, Diagnost Neuroimaging, Salt Lake City, UT 84112 USA.; Yurgelun-Todd, DA (corresponding author), George E Wahlen Dept Vet Affairs Med Ctr, VA VISN Mental Illness Res 19, Educ & Clin Ctr MIRECC, Salt Lake City, UT 84148 USA.; Yurgelun-Todd, DA (corresponding author), Brain Inst, 383 Colorow Dr, Salt Lake City, UT 84108 USA.	deborah.yurgelun-todd@hsc.utah.edu	Bae, Sujin/AAQ-7572-2021	Sheth, Chandni/0000-0003-0876-1675	Merit ReviewUS Department of Veterans Affairs [5101 CX000253-02]; VISN 19 MIRECC (The Mental Illness Research, Education and Clinical Centers), Salt Lake City, UT, USA	This study was supported by funds from Merit Review 5101 CX000253-02 and VISN 19 MIRECC (The Mental Illness Research, Education and Clinical Centers), Salt Lake City, UT, USA.	Anderson CV, 1996, J NEUROTRAUM, V13, P59, DOI 10.1089/neu.1996.13.59; Arciniegas DB, 2001, J NEUROPSYCH CLIN N, V13, P213, DOI 10.1176/appi.neuropsych.13.2.213; Ariza M, 2006, NEUROPSYCHOLOGIA, V44, P1956, DOI 10.1016/j.neuropsychologia.2005.11.007; Averill C. L., 2017, CHRONIC STRESS, V1, DOI [10.1177/2470547017744538, DOI 10.1177/2470547017744538]; Belanger HG, 2009, J HEAD TRAUMA REHAB, V24, P4, DOI 10.1097/HTR.0b013e3181957032; Bigler ED, 2002, AM J NEURORADIOL, V23, P255; Bigler ED, 1997, AM J NEURORADIOL, V18, P11; Bigler ED, 2010, NEUROIMAGE, V50, P1017, DOI 10.1016/j.neuroimage.2010.01.003; Bolzenius JD, 2018, J HEAD TRAUMA REHAB, V33, P113, DOI 10.1097/HTR.0000000000000379; BREMNER JD, 1995, AM J PSYCHIAT, V152, P973; Calder AJ, 2001, NAT REV NEUROSCI, V2, P352, DOI 10.1038/35072584; Carlson KF, 2011, J HEAD TRAUMA REHAB, V26, P103, DOI 10.1097/HTR.0b013e3181e50ef1; Cole J, 2010, J AFFECT DISORDERS, V126, P272, DOI 10.1016/j.jad.2010.03.004; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P318, DOI 10.1097/01.HTR.0000300227.67748.77; Davis M, 2001, MOL PSYCHIATR, V6, P13, DOI 10.1038/sj.mp.4000812; Defense & Center V. B. I, 2012, DOD WORLDW NUMB TBI; Depue BE, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/691505; Dixon KJ, 2017, PHYS MED REH CLIN N, V28, P215, DOI 10.1016/j.pmr.2016.12.001; Duvernoy HM, 2005, AM J NEURORADIOL, V26, P2702; Faul M, 2010, TRAUMATIC BRAIN INJU; First M., 1995, STRUCTURED CLIN INTE, V9, P92; Geuze E, 2005, MOL PSYCHIATR, V10, P160, DOI 10.1038/sj.mp.4001579; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; HAMILTON M, 1959, BRIT J MED PSYCHOL, V32, P50, DOI 10.1111/j.2044-8341.1959.tb00467.x; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Huang YS, 2013, BIOL PSYCHIAT, V74, P62, DOI 10.1016/j.biopsych.2013.01.005; Isikli S, 2013, J PSYCHIATR RES, V47, P50, DOI 10.1016/j.jpsychires.2012.08.022; Ji JZ, 2008, LEARN MEMORY, V15, P244, DOI 10.1101/lm.794808; Kaplan GB, 2018, J NEUROTRAUM, V35, P210, DOI 10.1089/neu.2016.4953; Karl A, 2006, NEUROSCI BIOBEHAV R, V30, P1004, DOI 10.1016/j.neubiorev.2006.03.004; Kim GH, 2015, NEUROBIOL AGING, V36, P485, DOI 10.1016/j.neurobiolaging.2014.08.009; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Lindqvist D, 2014, PSYCHIAT RES-NEUROIM, V224, P168, DOI 10.1016/j.pscychresns.2014.09.002; Maller JJ, 2014, BEHAV BRAIN RES, V271, P147, DOI 10.1016/j.bbr.2014.05.047; Maren S, 1999, BEHAV NEUROSCI, V113, P283, DOI 10.1037/0735-7044.113.2.283; McDonald BC, 2012, BRAIN IMAGING BEHAV, V6, P193, DOI 10.1007/s11682-012-9173-4; McGlade E, 2015, BRAIN IMAGING BEHAV, V9, P535, DOI 10.1007/s11682-015-9379-3; McKinnon MC, 2009, J PSYCHIATR NEUROSCI, V34, P41; Morey RA, 2012, ARCH GEN PSYCHIAT, V69, P1169, DOI 10.1001/archgenpsychiatry.2012.50; Nugent AC, 2013, HUM BRAIN MAPP, V34, P2313, DOI 10.1002/hbm.22068; O'Mara S, 2006, BEHAV BRAIN RES, V174, P304, DOI 10.1016/j.bbr.2006.08.018; Palacios EM, 2013, CORTEX, V49, P646, DOI 10.1016/j.cortex.2012.02.011; Patenaude B, 2011, NEUROIMAGE, V56, P907, DOI 10.1016/j.neuroimage.2011.02.046; Ross DE, 2011, BRAIN INJURY, V25, P1271, DOI 10.3109/02699052.2011.624568; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Stein MB, 2009, AM J PSYCHIAT, V166, P768, DOI 10.1176/appi.ajp.2009.08101604; Suvak MK, 2011, J TRAUMA STRESS, V24, P3, DOI 10.1002/jts.20618; Tae WS, 2011, AM J NEURORADIOL, V32, P671, DOI 10.3174/ajnr.A2367; Tate DF, 2019, BRAIN IMAGING BEHAV, V13, P377, DOI 10.1007/s11682-018-9854-8; Tate DF, 2000, LEARN MEMORY, V7, P442, DOI 10.1101/lm.33000; Tatel DF, 2016, J NEUROL, V263, P2065, DOI 10.1007/s00415-016-8236-7; Tomaiuolo F, 2004, J NEUROL NEUROSUR PS, V75, P1314, DOI 10.1136/jnnp.2003.017046; Travis S, 2015, J AFFECT DISORDERS, V172, P159, DOI 10.1016/j.jad.2014.09.048; Van Boven RW, 2009, J REHABIL RES DEV, V46, P717, DOI 10.1682/JRRD.2008.12.0161; Vanderploeg RD, 2009, ARCH PHYS MED REHAB, V90, P1084, DOI 10.1016/j.apmr.2009.01.023; Videbech P, 2004, AM J PSYCHIAT, V161, P1957, DOI 10.1176/appi.ajp.161.11.1957; Wade BSC, 2015, NEUROIMAGE-CLIN, V9, P564, DOI 10.1016/j.nicl.2015.10.006; Warner MA, 2010, ARCH NEUROL-CHICAGO, V67, P1336, DOI 10.1001/archneurol.2010.149; Wechsler D, 2011, WASI 2 WECHSLER ABBR; Woon FL, 2008, HIPPOCAMPUS, V18, P729, DOI 10.1002/hipo.20437; Woon FL, 2009, J NEUROPSYCH CLIN N, V21, P5, DOI 10.1176/appi.neuropsych.21.1.5; Woon FL, 2010, PROG NEURO-PSYCHOPH, V34, P1181, DOI 10.1016/j.pnpbp.2010.06.016; Yurgil KA, 2014, JAMA PSYCHIAT, V71, P149, DOI 10.1001/jamapsychiatry.2013.3080; Zatzick DF, 2010, ARCH GEN PSYCHIAT, V67, P1291, DOI 10.1001/archgenpsychiatry.2010.158	67	7	7	4	13	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	1931-7557	1931-7565		BRAIN IMAGING BEHAV	Brain Imaging Behav.	OCT	2020	14	5					1850	1864		10.1007/s11682-019-00127-2			15	Neuroimaging	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	OC9YM	WOS:000579512100048	31250267				2022-02-06	
J	Mendes-Gomes, J; Paschoalin-Maurin, T; Donaldson, LF; Lumb, BM; Blanchard, DC; Coimbra, NC				Mendes-Gomes, Joyce; Paschoalin-Maurin, Tatiana; Donaldson, Lucy F.; Lumb, Bridget M.; Blanchard, D. Caroline; Coimbra, Norberto Cysne			Repeated exposure of naive and peripheral nerve-injured mice to a snake as an experimental model of post-traumatic stress disorder and its co-morbidity with neuropathic pain	BRAIN RESEARCH			English	Article						Chronic pain; Post-traumatic stress disorder; Defensive reaction; Pain modulation; Prey versus serpents confrontation paradigm; Epicrates cenchria crassus	FEAR-INDUCED ANTINOCICEPTION; ELEVATED PLUS-MAZE; ELABORATED DEFENSIVE BEHAVIOR; MEDIAL PREFRONTAL CORTEX; ANXIETY-LIKE BEHAVIORS; NOCICEPTION PAW TEST; PERIAQUEDUCTAL GRAY; RAT MODEL; GABA(A) RECEPTOR; BRAIN CHANGES	Confrontation of rodents by natural predators provides a number of advantages as a model for traumatic or stressful experience. Using this approach, one of the aims of this study was to investigate a model for the study of post-traumatic stress disorder (PTSD)-related behaviour in mice. Moreover, because PTSD can facilitate the establishment of chronic pain (CP), and in the same way, patients with CP have an increased tendency to develop PTSD when exposed to a traumatic event, our second aim was to analyse whether this comorbidity can be verified in the new paradigm. C57BL/6 male mice underwent chronic constriction injury of the sciatic nerve (CCI), a model of neuropathic CP, or not (sham groups) and were submitted to different threatening situations. Threatened mice exhibited enhanced defensive behaviours, as well as significantly enhanced risk assessment and escape behaviours during context reexposure. Previous snake exposure reduced open-arm time in the elevated plus-maze test, suggesting an increase in anxiety levels. Sham mice showed fear-induced antinociception immediately after a second exposure to the snake, but 1 week later, they exhibited allodynia, suggesting that multiple exposures to the snake led to increased nociceptive responses. Moreover, after reexposure to the aversive environment, allodynia was maintained. CCI alone produced intense allodynia, which was unaltered by exposure to either the snake stimuli or reexposure to the experimental context. Together, these results specifically parallel the behavioural symptoms of PTSD, suggesting that the snake/exuvia/reexposure procedure may constitute a useful animal model to study PTSD.	[Mendes-Gomes, Joyce; Paschoalin-Maurin, Tatiana; Coimbra, Norberto Cysne] Univ Sao Paulo FMRP USP, Dept Pharmacol, Lab Neuroanat & Neuropsychobiol, Ribeirao Preto Med Sch, Av Bandeirantes 3900, BR-14049900 Ribeirao Preto, SP, Brazil; [Mendes-Gomes, Joyce; Paschoalin-Maurin, Tatiana; Coimbra, Norberto Cysne] Univ Sao Paulo, Ribeirao Preto Med Sch, Ophidiarium LNN FMRP USP INeC, Av Bandeirantes 3900, BR-14049900 Ribeirao Preto, SP, Brazil; [Mendes-Gomes, Joyce; Paschoalin-Maurin, Tatiana; Coimbra, Norberto Cysne] Behav Neurosci Inst INeC, Ave Cafe 2450, BR-14050220 Ribeirao Preto, SP, Brazil; [Mendes-Gomes, Joyce] Dracena Med Sch UNIFADRA FUNDEC, Rua Bahia 332, BR-17900000 Dracena, SP, Brazil; [Donaldson, Lucy F.] Univ Nottingham, Arthrit Res UK Pain Ctr, QMC, Nottingham NG7 2UH, England; [Donaldson, Lucy F.] Univ Nottingham, Sch Life Sci, QMC, Nottingham NG7 2UH, England; [Lumb, Bridget M.] Univ Bristol, Sch Physiol Pharmacol & Neurosci, Med Sci Bldg, Bristol BS8 1TD, Avon, England; [Blanchard, D. Caroline] Univ Hawaii Manoa, Pacific Biosci Res Ctr, Honolulu, HI 96822 USA; [Coimbra, Norberto Cysne] Univ Sao Paulo FMRP USP, Ribeirao Preto Med Sch, Emot Res Ctr NAP USP NuPNE, Univ Sao Paulo Neurobiol, Av Bandeirantes 3900, BR-14049900 Ribeirao Preto, SP, Brazil		Coimbra, NC (corresponding author), Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Farmacol, Lab Neuroanat & Neuropsicobiol, Av Bandeirantes 3900, BR-14049900 Ribeirao Preto, SP, Brazil.	nccoimbr@fmrp.usp.br			Fundacao de Apoio ao Ensino, Pesquisa e Assistencia do HC-FMRP-USP (FAEPA) [1291/97, 355/2000, 68/2001, 15/2003]; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2007/01174-1, 2012/03798-0, 2017/11855-8]; Conselho Nacional de Pesquisa e Desenvolvimento Tecnologico (CNPq)Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ) [483763/2010-1, 474853/2013-6, 427397/2018-9]; Pro-Rectory of the University of Sao Paulo (USP) research grant (NAP-USP-NuPNE) [IaPQ2012-156-USP-12.1.25440.01.6]; FAPESPFundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2013/13398-2]; CNPqConselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ) [470119/2004-7, 301905/2010-0, 301341/2015-0]; CAPES (PNPD Post-Doctorate fellowship)Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); MEDUSA Project-LNN-FMRP-USP/INeC Ophidiarium	This study was supported by Fundacao de Apoio ao Ensino, Pesquisa e Assistencia do HC-FMRP-USP (FAEPA) (grants 1291/97, 355/2000, 68/2001 and 15/2003), Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) (grants 2007/01174-1, 2012/03798-0 and 2017/11855-8), Conselho Nacional de Pesquisa e Desenvolvimento Tecnologico (CNPq) (grants 483763/2010-1, 474853/2013-6, and 427397/2018-9) and a Pro-Rectory of the University of Sao Paulo (USP) research grant (NAP-USP-NuPNE; grant IaPQ2012-156-USP-12.1.25440.01.6). J. Mendes-Gomes was supported by FAPESP (process 2013/13398-2). T. Paschoalin-Maurin was supported by CNPq (Sc.D. fellowship, process 470119/2004-7) and CAPES (PNPD Post-Doctorate fellowship). We thank the Instituto Butantan for the support of the MEDUSA Project-LNN-FMRP-USP/INeC Ophidiarium. N.C. Coimbra was granted research fellowships (level 1A) from CNPq (grants 301905/2010-0 and 301341/2015-0) and was a CNPq post-doctoral fellow (process 200629/2005-0) in the Physiology, Anatomy and Genetics Department and in the Clinical Neurology (FMRIB Centre) Department of the University of Oxford, England, United Kingdom.	Almada RC, 2015, NEUROSCIENCE, V303, P503, DOI 10.1016/j.neuroscience.2015.06.048; Almada RC, 2015, SYNAPSE, V69, P299, DOI 10.1002/syn.21814; American Psychiatric Association, 2013, DIAGN STAT MAN MENT; Apfelbach R, 2005, NEUROSCI BIOBEHAV R, V29, P1123, DOI 10.1016/j.neubiorev.2005.05.005; Asmundson GJG, 2000, BEHAV RES THER, V38, P801, DOI 10.1016/S0005-7967(99)00101-1; Baptista-de-Souza D, 2015, BEHAV PHARMACOL, V26, P664, DOI 10.1097/FBP.0000000000000170; Beck JG, 2011, PSYCHOL TRAUMA-US, V3, P101, DOI 10.1037/a0021263; Bender K, 2015, CHILD MALTREATMENT, V20, P115, DOI 10.1177/1077559514562859; BENNETT GJ, 1988, PAIN, V33, P87, DOI 10.1016/0304-3959(88)90209-6; Bertaina-Anglade V, 2017, AUSTRALAS PSYCHIATRY, V25, P342, DOI 10.1177/1039856217716288; Blanchard DC, 2011, NEUROSCI BIOBEHAV R, V35, P991, DOI 10.1016/j.neubiorev.2010.10.016; Blanchard DC, 2001, NEUROSCI BIOBEHAV R, V25, P205, DOI 10.1016/S0149-7634(01)00009-4; BLANCHARD DC, 1989, PSYCHOPHARMACOLOGY, V97, P392, DOI 10.1007/BF00439457; BLANCHARD RJ, 1993, BEHAV BRAIN RES, V58, P155, DOI 10.1016/0166-4328(93)90100-5; BLANCHARD RJ, 1989, PROG NEURO-PSYCHOPH, V13, pS3, DOI 10.1016/0278-5846(89)90105-X; Blanchard RJ, 1997, NEUROSCI BIOBEHAV R, V21, P783, DOI 10.1016/S0149-7634(96)00062-0; Boasso AM, 2015, J TRAUMA STRESS, V28, P73, DOI 10.1002/jts.21988; BOLLES RC, 1980, BEHAV BRAIN SCI, V3, P291, DOI 10.1017/S0140525X0000491X; Brunello N, 2001, NEUROPSYCHOBIOLOGY, V43, P150, DOI 10.1159/000054884; Buccafusco JJ, 2009, FRONT NEUROSCI, P1; Butler RK, 2009, PROG NEUROBIOL, V88, P184, DOI 10.1016/j.pneurobio.2009.04.003; Calvo F, 2019, J PSYCHOPHARMACOL, V33, P577, DOI 10.1177/0269881118822078; Calvo F, 2019, J PSYCHOPHARMACOL, V33, P51, DOI 10.1177/0269881118806301; Campos AC, 2013, NEUROSCI LETT, V533, P34, DOI 10.1016/j.neulet.2012.11.016; Carere C, 1999, BEHAV PROCESS, V47, P1, DOI 10.1016/S0376-6357(99)00048-0; COHEN JA, 1979, BEHAV NEURAL BIOL, V26, P177, DOI 10.1016/S0163-1047(79)92563-9; Coimbra NC, 2006, EXP NEUROL, V197, P93, DOI 10.1016/j.expneurol.2005.08.022; Coimbra NC, 2017, REV BRAS PSIQUIATR, V39, P72, DOI 10.1590/1516-4446-2015-1895; Coimbra NC, 2017, NEUROSCIENCE, V354, P178, DOI 10.1016/j.neuroscience.2017.04.032; Cornelio AM, 2011, BRAIN RES, V1415, P56, DOI 10.1016/j.brainres.2011.07.058; Cunha TM, 2004, BRAZ J MED BIOL RES, V37, P401, DOI 10.1590/S0100-879X2004000300018; Dalvi A, 1996, PSYCHOPHARMACOLOGY, V128, P380, DOI 10.1007/s002130050148; de Freitas RL, 2014, CEREB CORTEX, V24, P1518, DOI 10.1093/cercor/bht001; de Freitas RL, 2013, INT J NEUROPSYCHOPH, V16, P1781, DOI 10.1017/S1461145713000163; DELLOMO G, 1994, PHYSIOL BEHAV, V55, P125, DOI 10.1016/0031-9384(94)90019-1; Dias QM, 2013, BRAZ J MED BIOL RES, V46, P253, DOI 10.1590/1414-431X20122462; Dielenberg RA, 2001, NEUROSCI BIOBEHAV R, V25, P597, DOI 10.1016/S0149-7634(01)00044-6; dos Anjos-Garcia T, 2019, PSYCHOPHARMACOLOGY, V236, P1863, DOI 10.1007/s00213-019-5170-2; Dunne-Proctor RL, 2016, CLIN J PAIN, V32, P645, DOI 10.1097/AJP.0000000000000309; FENTRESS JC, 1988, ANN NY ACAD SCI, V525, P18, DOI 10.1111/j.1749-6632.1988.tb38592.x; Gibson CA, 2012, J REHABIL RES DEV, V49, P753, DOI 10.1682/JRRD.2011.09.0158; Goswami S, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00089; GRAEFF FG, 1994, BRAZ J MED BIOL RES, V27, P811; Gray JA., 2000, NEUROPSYCHOLOGY ANXI; Greenwood-Van Meerveld B, 2016, J NEUROENDOCRINOL, V28, DOI 10.1111/jne.12361; Guimaraes-Costa R, 2007, J NEUROSCI METH, V165, P25, DOI 10.1016/j.jneumeth.2007.05.023; HANDLEY SL, 1984, N-S ARCH PHARMACOL, V327, P1, DOI 10.1007/BF00504983; Hasnie FS, 2007, BRIT J ANAESTH, V98, P816, DOI 10.1093/bja/aem087; He YQ, 2013, MOL PAIN, V9, DOI 10.1186/1744-8069-9-35; Heinricher MM, 2009, BRAIN RES REV, V60, P214, DOI 10.1016/j.brainresrev.2008.12.009; Hubbard CS, 2015, NEUROIMAGE, V107, P333, DOI 10.1016/j.neuroimage.2014.12.024; Hubbard DT, 2004, PHYSIOL BEHAV, V80, P525, DOI 10.1016/j.physbeh.2003.10.006; Jennings EM, 2014, PROG NEUROBIOL, V121, P1, DOI 10.1016/j.pneurobio.2014.06.003; Kalueff AV, 2016, NAT REV NEUROSCI, V17, P45, DOI 10.1038/nrn.2015.8; Kalueff AV, 2005, J NEUROSCI METH, V143, P169, DOI 10.1016/j.jneumeth.2004.10.001; Koenen KC, 2003, TWIN RES, V6, P218, DOI 10.1375/twin.6.3.218; Kroncke BM, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1501228; Lancaster CL, 2016, J CLIN MED, V5, DOI 10.3390/jcm5110105; Langford DJ, 2006, SCIENCE, V312, P1967, DOI 10.1126/science.1128322; Lee B, 2016, J NAT MED-TOKYO, V70, P133, DOI 10.1007/s11418-015-0943-3; LISTER RG, 1987, PSYCHOPHARMACOLOGY, V92, P180; Lobao-Soares B, 2008, BEHAV BRAIN RES, V194, P129, DOI 10.1016/j.bbr.2008.06.006; Mackenzie L, 2010, NEUROSCIENCE, V169, P733, DOI 10.1016/j.neuroscience.2010.05.005; Matar MA, 2006, NEUROPSYCHOPHARMACOL, V31, P2610, DOI 10.1038/sj.npp.1301132; McNaughton N, 2004, NEUROSCI BIOBEHAV R, V28, P285, DOI 10.1016/j.neubiorev.2004.03.005; McNaughton Neil, 2011, Psychol. Neurosci., V4, P173, DOI 10.3922/j.psns.2011.2.002; Medeiros P, 2020, J NEUROSCI RES, V98, P338, DOI 10.1002/jnr.24501; Mendes-Gomes J, 2005, BRAIN RES, V1047, P97, DOI 10.1016/j.brainres.2005.04.026; Mendes-Gomes J, 2011, HORM BEHAV, V60, P408, DOI 10.1016/j.yhbeh.2011.07.004; Mendes-Gomes J, 2011, BEHAV BRAIN RES, V219, P248, DOI 10.1016/j.bbr.2011.01.012; Mendes-Gomes J, 2009, BEHAV BRAIN RES, V203, P180, DOI 10.1016/j.bbr.2009.04.032; Moeller-Bertram T, 2014, PAIN MED, V15, P762, DOI 10.1111/pme.12424; Moller KA, 1998, J NEUROSCI METH, V84, P41, DOI 10.1016/S0165-0270(98)00083-1; MONTI PM, 1976, J EXP PSYCHOL GEN, V105, P148, DOI 10.1037/0096-3445.105.2.148; Morey RA, 2015, TRANSL PSYCHIAT, V5, DOI 10.1038/tp.2015.196; Narita M, 2006, NEUROPSYCHOPHARMACOL, V31, P739, DOI 10.1038/sj.npp.1300858; Nemeroff CB, 2006, J PSYCHIATR RES, V40, P1, DOI 10.1016/j.jpsychires.2005.07.005; Nunes-de-Souza RL, 2002, BRAIN RES, V927, P87, DOI 10.1016/S0006-8993(01)03335-2; Nyland JE, 2015, BURNS, V41, P1796, DOI 10.1016/j.burns.2015.09.007; OSBORNE FH, 1975, J EXP PSYCHOL ANIM B, V1, P364; Paschoalin-Maurin T, 2018, NEUROSCIENCE, V369, P336, DOI 10.1016/j.neuroscience.2017.11.031; PELLOW S, 1985, J NEUROSCI METH, V14, P149, DOI 10.1016/0165-0270(85)90031-7; Perrine SA, 2016, BEHAV BRAIN RES, V303, P228, DOI 10.1016/j.bbr.2016.01.056; Pitzer C, 2019, EUR J PAIN, V23, P285, DOI 10.1002/ejp.1303; Prado WA, 2002, EUR J PHARMACOL, V441, P57, DOI 10.1016/S0014-2999(02)01413-9; Puetz TW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126529; Reeves SL, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1005115; Ribeiro-Barbosa ER, 2005, NEUROSCI BIOBEHAV R, V29, P1255, DOI 10.1016/j.neubiorev.2005.04.006; Schoner J, 2017, J CELL MOL MED, V21, P2248, DOI 10.1111/jcmm.13161; Seminowicz DA, 2009, NEUROIMAGE, V47, P1007, DOI 10.1016/j.neuroimage.2009.05.068; Sharp Timothy J, 2004, Curr Pain Headache Rep, V8, P111, DOI 10.1007/s11916-004-0024-x; Sharp TJ, 2001, CLIN PSYCHOL REV, V21, P857, DOI 10.1016/S0272-7358(00)00071-4; Sillivan SE, 2017, BIOL PSYCHIAT, V82, P924, DOI 10.1016/j.biopsych.2017.06.030; Sipos ML, 2014, DEPRESS ANXIETY, V31, P124, DOI 10.1002/da.22157; SOMMER C, 1995, J NEUROPATH EXP NEUR, V54, P635, DOI 10.1097/00005072-199509000-00004; Sorregotti T, 2013, BEHAV BRAIN RES, V246, P76, DOI 10.1016/j.bbr.2013.02.035; Souza RR, 2016, BEHAV BRAIN RES, V315, P160, DOI 10.1016/j.bbr.2016.08.021; STEPHENS DN, 1986, PSYCHOPHARMACOLOGY, V90, P166; Takahashi LK, 2005, NEUROSCI BIOBEHAV R, V29, P1157, DOI 10.1016/j.neubiorev.2005.04.008; TOMB DA, 1994, PSYCHIAT CLIN N AM, V17, P237; Twardowschy A, 2013, J PSYCHOPHARMACOL, V27, P1149, DOI 10.1177/0269881113493363; Uribe-Marino A, 2012, NEUROPSYCHOPHARMACOL, V37, P412, DOI 10.1038/npp.2011.188; van der Kolk BA, 2001, HUM PSYCHOPHARM CLIN, V16, pS49, DOI 10.1002/hup.270; Villano CL, 2007, J REHABIL RES DEV, V44, P167, DOI 10.1682/JRRD.2006.05.0052; Vivancos GG, 2004, BRAZ J MED BIOL RES, V37, P391, DOI 10.1590/S0100-879X2004000300017; Zhang SZ, 2014, PAIN, V155, P1504, DOI 10.1016/j.pain.2014.04.026; Zhang Y, 2012, MOL PAIN, V8, DOI 10.1186/1744-8069-8-76	107	7	7	0	11	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	OCT 1	2020	1744								146907	10.1016/j.brainres.2020.146907			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	LZ5FN	WOS:000541249900001	32474017	Green Accepted			2022-02-06	
J	Nascimento, H; Martinez-Perez, C; Alvarez-Peregrina, C; Sanchez-Tena, MA				Nascimento, Henrique; Martinez-Perez, Clara; Alvarez-Peregrina, Cristina; Sanchez-Tena, Miguel Angel			Citations Network Analysis of Vision and Sport	INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH			English	Article						sport; vision; performance	PERCEPTUAL-COGNITIVE EXPERTISE; QUIET EYE DURATION; INJURIES; PERFORMANCE; GAZE; CITNETEXPLORER; PUBLICATIONS; ANTICIPATION; CONCUSSION; BASEBALL	Background: Sports vision is a relatively new specialty, which has attracted particular interest in recent years from trainers and athletes, who are looking at ways of improving their visual skills to attain better performance on the field of play. The objective of this study was to use citation networks to analyze the relationships between the different publications and authors, as well as to identify the different areas of research and determine the most cited publication. Methods: The search for publications was carried out in the Web of Science database, using the terms "sport", "vision", and "eye" for the period between 1911 and August 2020. The publication analysis was performed using the Citation Network Explorer and CiteSpace software. Results: In total, 635 publications and 801 citations were found across the network, with 2019 being the year with the highest number of publications. The most cited publication was published in 2002 by Williams et al. By using the clustering functionality, four groups covering the different research areas in this field were found: ocular lesion, visual training methods and efficiency, visual fixation training, and concussions. Conclusions: The citation network offers an objective and comprehensive analysis of the main papers on sports vision.	[Nascimento, Henrique] Inst Educ & Ciencia Lisboa, ISEC Lisboa, P-1750179 Lisbon, Portugal; [Nascimento, Henrique; Martinez-Perez, Clara; Alvarez-Peregrina, Cristina] Univ Europea Madrid, Fac Biomed & Hlth Sci, Madrid 28670, Spain; [Sanchez-Tena, Miguel Angel] Univ Europea Madrid, Fac Sport Sci, Madrid 28670, Spain		Martinez-Perez, C (corresponding author), Univ Europea Madrid, Fac Biomed & Hlth Sci, Madrid 28670, Spain.	henrique.nascimento@iseclisboa.pt; claramarperez@hotmail.com; cristina.alvarez@universidadeuropea.es; miguelangel.sanchez@universidadeuropea.es	Alvarez-Peregrina, Cristina/AAI-1053-2019; nascimento, Henrique/ABE-8630-2020	Alvarez-Peregrina, Cristina/0000-0003-1097-4581; Sanchez-Tena, Miguel Angel/0000-0002-2583-1789; Nascimento, Henrique/0000-0002-6779-3418; Martinez Perez, Clara/0000-0002-0996-5007			Abernethy B, 2001, J SPORT SCI, V19, P203, DOI 10.1080/026404101750095376; Abernethy B., 1986, CLIN EXP OPTOM, V69, P189, DOI 10.1111/j.1444-0938.1986.tb04589.x; Abernethy B., 1989, SPORTS COACH, V12, P15; Alves H, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00036; APARICIOMARTINEZ P, 2019, INT J ENV RES PUB HE, V16, DOI DOI 10.3390/IJERPH1620402431640168; Appelbaum LG, 2018, INT REV SPORT EXER P, V11, P160, DOI 10.1080/1750984X.2016.1266376; Appelbaum LG, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00276; APPLEGATE RA, 1992, OPTOMETRY VISION SCI, V69, P765, DOI 10.1097/00006324-199210000-00004; Biswal AK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084334; BLONSTEIN JL, 1975, PRACTITIONER, V215, P208; Blundell NL., 1985, AUSTR J SCI MED SPOR, V17, P3; Broadbent DP, 2015, EUR J SPORT SCI, V15, P322, DOI 10.1080/17461391.2014.957727; Burris K, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-18565-7; Causer J, 2011, MED SCI SPORT EXER, V43, P1042, DOI 10.1249/MSS.0b013e3182035de6; Causer J, 2010, MED SCI SPORT EXER, V42, P1599, DOI 10.1249/MSS.0b013e3181d1b059; Chen CM, 2006, J AM SOC INF SCI TEC, V57, P359, DOI 10.1002/asi.20317; Ciumaski B., 2005, STUDIA I MONOGRAFIE, V33, P298; Clark JF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029109; de Solla Derek J., 1963, LITTLE SCI BIG SCI; Deveau J, 2014, CURR BIOL, V24, pR146, DOI 10.1016/j.cub.2014.01.004; Di Noto P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059244; Erickson G., 2007, SPORTS VISION VISION; Espar X., 2001, BALONMANO; Fischer L, 2016, J SPORT SCI, V34, P1637, DOI 10.1080/02640414.2015.1128558; FULLERTON C, 1925, W OPTOMETRY WORLD, V13, P160; Galetta KM, 2015, J NEURO-OPHTHALMOL, V35, P235, DOI 10.1097/WNO.0000000000000226; Garcia T., 1993, REV GACETA OPTICA; Gonzalez Claudia Marcela, 2009, Ciencia da Informacao, V38, P46, DOI 10.1590/S0100-19652009000200004; GREGORY PTS, 1986, BRIT J OPHTHALMOL, V70, P748, DOI 10.1136/bjo.70.10.748; Hausegger T, 2019, J SPORT EXERCISE PSY, V41, P137, DOI 10.1123/jsep.2018-0091; Hirsch JE, 2005, P NATL ACAD SCI USA, V102, P16569, DOI 10.1073/pnas.0507655102; Jorge J, 2019, CLIN EXP OPTOM, V102, P51, DOI 10.1111/cxo.12812; Kirschen DG, 2011, EYE CONTACT LENS, V37, P127, DOI 10.1097/ICL.0b013e3182126a08; Klostermann A, 2014, J SPORT EXERCISE PSY, V36, P392, DOI 10.1123/jsep.2013-0273; Kriz PK, 2015, PEDIATRICS, V136, P521, DOI 10.1542/peds.2015-0216; Lee MH, 2009, INT J SCI EDUC, V31, P1999, DOI 10.1080/09500690802314876; Leydesdorff L, 2006, J AM SOC INF SCI TEC, V57, P601, DOI 10.1002/asi.20322; MACEWEN CJ, 1987, BRIT J OPHTHALMOL, V71, P701, DOI 10.1136/bjo.71.9.701; MacEwen CJ, 1999, BRIT J OPHTHALMOL, V83, P933, DOI 10.1136/bjo.83.8.933; Maman P., 2011, SERB J SPORTS SCI, V5, P6; Mann DTY, 2007, J SPORT EXERCISE PSY, V29, P457, DOI 10.1123/jsep.29.4.457; Mann DTY, 2011, COGN PROCESS, V12, P223, DOI 10.1007/s10339-011-0398-8; Manso J.M.G., 2003, TALENTO DEPORTIVO; Mashkovskiy E, 2019, J SPORT MED PHYS FIT, V59, P376, DOI 10.23736/S0022-4707.18.08232-4; Master CL, 2016, CLIN PEDIATR, V55, P260, DOI 10.1177/0009922815594367; Micieli JA, 2017, CLIN SPORT MED, V36, P299, DOI 10.1016/j.csm.2016.11.006; Morilla R.R.G., 2006, LIBRO VISION DEPORTI; Napier SM, 1996, SURV OPHTHALMOL, V41, P229, DOI 10.1016/S0039-6257(96)80025-7; Panchuk D, 2006, HUM MOVEMENT SCI, V25, P733, DOI 10.1016/j.humov.2006.07.001; Peiffer AJ, 2020, CLIN PEDIATR, V59, P961, DOI 10.1177/0009922820927477; PLANER PM, 1994, SPORTS VISION MANUAL; Raczek J., 1991, SPORT WYCZYNOWY, V5-6, P8; Romeas T, 2016, PSYCHOL SPORT EXERC, V22, P1, DOI 10.1016/j.psychsport.2015.06.002; Savelsbergh GJP, 2002, J SPORT SCI, V20, P279, DOI 10.1080/026404102317284826; Schumacher N, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16245001; Schwab S, 2012, J SPORT SCI MED, V11, P624; SHERMAN A, 1980, J AM OPTOM ASSOC, V51, P661; Smith Trevor Q, 2012, Int J Exerc Sci, V5, P344; Sole J., 2007, APUNTS, V88, P75; Spera R, 2019, J HUM SPORT EXERC, V14, pS937, DOI 10.14198/jhse.2019.14.Proc4.56; STINE CD, 1982, J AM OPTOM ASSOC, V53, P627; Toldi JP, 2020, CURR SPORT MED REP, V19, P29, DOI 10.1249/JSR.0000000000000677; Van der Kamp J, 2008, INT J SPORT PSYCHOL, V39, P100; van Eck NJ, 2017, SCIENTOMETRICS, V111, P1053, DOI 10.1007/s11192-017-2300-7; van Eck NJ, 2014, J INFORMETR, V8, P802, DOI 10.1016/j.joi.2014.07.006; van Eck NJ., 2014, MEASURING SCHOLARLY, P285, DOI [DOI 10.1007/978-3-319-10377-8_13, 10.1007/978-3-319-10377-8_13(InEng.)]; Vera J, 2020, EUR J SPORT SCI, V20, P407, DOI 10.1080/17461391.2019.1632385; Vickers JN, 2009, PROG BRAIN RES, V174, P279, DOI 10.1016/S0079-6123(09)01322-3; Vine SJ, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00008; Vine SJ, 2011, ACTA PSYCHOL, V136, P340, DOI 10.1016/j.actpsy.2010.12.008; Vine SJ., 2012, EUR J SPORT SCI, P1, DOI [10.1080/17461391.2012.683815, DOI 10.1080/17461391.2012.683815]; VINGER P, 1983, JAMA-J AM MED ASSOC, V250, P3322, DOI 10.1001/jama.250.24.3322; VINGER PF, 1980, SURV OPHTHALMOL, V25, P47, DOI 10.1016/0039-6257(80)90075-2; VINGER PF, 1981, OPHTHALMOLOGY, V88, P108; Voss MW, 2010, APPL COGNITIVE PSYCH, V24, P812, DOI 10.1002/acp.1588; Walker C., 1911, BMJ-BRIT MED J, V1, P49, DOI [10.1136/bmj.1.2610.49, DOI 10.1136/BMJ.1.2610.49]; Ward P, 2003, J SPORT EXERCISE PSY, V25, P93, DOI 10.1123/jsep.25.1.93; Williams AM, 1997, BEHAV RES METH INS C, V29, P364, DOI 10.3758/BF03200589; Williams AM, 2002, J MOTOR BEHAV, V34, P197, DOI 10.1080/00222890209601941; Winograd S, 1942, RES QUART, V13, P481, DOI 10.1080/10671188.1942.10624778; Witkowski M, 2020, BIOMED RES INT, V2020, DOI 10.1155/2020/4636271; Woo JH, 2006, ANN ACAD MED SINGAP, V35, P706; Wood JM, 1997, OPTOMETRY VISION SCI, V74, P646, DOI 10.1097/00006324-199708000-00026	83	7	7	11	24	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		1660-4601		INT J ENV RES PUB HE	Int. J. Environ. Res. Public Health	OCT	2020	17	20							7574	10.3390/ijerph17207574			22	Environmental Sciences; Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Environmental Sciences & Ecology; Public, Environmental & Occupational Health	OL8PX	WOS:000585595600001	33081012	Green Published, gold			2022-02-06	
J	Newell-Rogers, MK; Rogers, SK; Tobin, RP; Mukherjee, S; Shapiro, LA				Newell-Rogers, M. Karen; Rogers, Susannah K.; Tobin, Richard P.; Mukherjee, Sanjib; Shapiro, Lee A.			Antagonism of Macrophage Migration Inhibitory Factory (MIF) after Traumatic Brain Injury Ameliorates Astrocytosis and Peripheral Lymphocyte Activation and Expansion	INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES			English	Article						post traumatic epilepsy; immune cells; inflammation; neuroinflammation; adaptive immune response; innate immune response	DENTATE GRANULE CELLS; HILAR BASAL DENDRITES; INTERLEUKIN-1 RECEPTOR; SIGNAL-TRANSDUCTION; INDUCED SEIZURES; EPILEPSY; CD74; EPIDEMIOLOGY; PROGNOSIS; PREDICTS	Traumatic brain injury (TBI) precedes the onset of epilepsy in up to 15-20% of symptomatic epilepsies and up to 5% of all epilepsy. Treatment of acquired epilepsies, including post-traumatic epilepsy (PTE), presents clinical challenges, including frequent resistance to anti-epileptic therapies. Considering that over 1.6 million Americans present with a TBI each year, PTE is an urgent clinical problem. Neuroinflammation is thought to play a major causative role in many of the post-traumatic syndromes, including PTE. Increasing evidence suggests that neuroinflammation facilitates and potentially contributes to seizure induction and propagation. The inflammatory cytokine, macrophage migration inhibitory factor (MIF), is elevated after TBI and higher levels of MIF correlate with worse post-traumatic outcomes. MIF was recently demonstrated to directly alter the firing dynamics of CA1 pyramidal neurons in the hippocampus, a structure critically involved in many types of seizures. We hypothesized that antagonizing MIF after TBI would be anti-inflammatory, anti-neuroinflammatory and neuroprotective. The results show that administering the MIF antagonist ISO1 at 30 min after TBI prevented astrocytosis but was not neuroprotective in the peri-lesion cortex. The results also show that ISO1 inhibited the TBI-induced increase in gamma delta T cells in the gut, and the percent of B cells infiltrating into the brain. The ISO1 treatment also increased this population of B cells in the spleen. These findings are discussed with an eye towards their therapeutic potential for post-traumatic syndromes, including PTE.	[Newell-Rogers, M. Karen; Rogers, Susannah K.; Mukherjee, Sanjib] Texas A&M Univ, Coll Med, Dept Med Physiol, Bryan, TX 77807 USA; [Newell-Rogers, M. Karen; Rogers, Susannah K.; Tobin, Richard P.; Shapiro, Lee A.] Texas A&M Univ, Coll Med, Dept Neurosci & Expt Therapeut, Bryan, TX 77807 USA; [Newell-Rogers, M. Karen] B Cell Solut, Colorado Springs, CO 80907 USA; [Tobin, Richard P.] Univ Colorado, Div Surg Oncol, Dept Surg, Anschutz Med Campus, Aurora, CO 80045 USA		Newell-Rogers, MK (corresponding author), Texas A&M Univ, Coll Med, Dept Med Physiol, Bryan, TX 77807 USA.; Newell-Rogers, MK; Shapiro, LA (corresponding author), Texas A&M Univ, Coll Med, Dept Neurosci & Expt Therapeut, Bryan, TX 77807 USA.; Newell-Rogers, MK (corresponding author), B Cell Solut, Colorado Springs, CO 80907 USA.	mknewellrogers@tamu.edu; suekrogers3@gmail.com; richard.tobin@cuanschutz.edu; mukherjeesanjib@gmail.com; lshapiro@tamu.edu			NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [RO1 NS104282]; Citizens United for Research in Epilepsy (CURE)	This research was funded by NIH RO1 NS104282 (MKNR and LAS) and funding from Citizens United for Research in Epilepsy (CURE) (MKNR and LAS).	Al-Abed Y, 2011, FUTURE MED CHEM, V3, P45, DOI 10.4155/FMC.10.281; Alexander JK, 2012, EXP NEUROL, V236, P351, DOI 10.1016/j.expneurol.2012.04.018; ANNEGERS JF, 1980, NEUROLOGY, V30, P683, DOI 10.1212/WNL.30.7.683; ANNEGERS JF, 1994, NEUROL CLIN, V12, P15, DOI 10.1016/S0733-8619(18)30108-7; Bancroft E, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21010276; Bar-Klein G, 2014, ANN NEUROL, V75, P864, DOI 10.1002/ana.24147; Bekhbat M, 2017, FRONT NEUROENDOCRIN, V46, P15, DOI 10.1016/j.yfrne.2017.05.001; Benakis C, 2016, NAT MED, V22, P516, DOI 10.1038/nm.4068; Bertani I, 2017, J NEUROSCI, V37, P10278, DOI 10.1523/JNEUROSCI.1301-17.2017; Bucala R, 1996, FASEB J, V10, P1607, DOI 10.1096/fasebj.10.14.9002552; Bucala R, 2014, MINI-REV MED CHEM, V14, P1132; Cacheaux LP, 2009, J NEUROSCI, V29, P8927, DOI 10.1523/JNEUROSCI.0430-09.2009; CAVENESS WF, 1979, J NEUROSURG, V50, P545, DOI 10.3171/jns.1979.50.5.0545; Chen HR, 2015, BIOL OPEN, V4, P244, DOI 10.1242/bio.201410322; Cho KO, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7606; DAVID JR, 1966, P NATL ACAD SCI USA, V56, P72, DOI 10.1073/pnas.56.1.72; Dragic M, 2019, NEUROSCIENCE, V423, P38, DOI 10.1016/j.neuroscience.2019.10.022; Foresti ML, 2009, J NEUROINFLAMM, V6, DOI 10.1186/1742-2094-6-40; Frey LC, 2003, EPILEPSIA, V44, P11, DOI 10.1046/j.1528-1157.44.s10.4.x; Garga Nina, 2006, Epilepsy Curr, V6, P1, DOI 10.1111/j.1535-7511.2005.00083.x; Gil-Yarom N, 2017, P NATL ACAD SCI USA, V114, P562, DOI 10.1073/pnas.1612195114; Gore Y, 2008, J BIOL CHEM, V283, P2784, DOI 10.1074/jbc.M703265200; Helmy A, 2016, J CEREBR BLOOD F MET, V36, P1434, DOI 10.1177/0271678X15620204; Huttl S, 2016, BIOCHEM J, V473, P1405, DOI 10.1042/BCJ20160156; Huttl S, 2015, J IMMUNOL, V195, P1548, DOI 10.4049/jimmunol.1403171; Inacio AR, 2011, J CEREBR BLOOD F MET, V31, P1093, DOI 10.1038/jcbfm.2010.194; Jameson JM, 2004, FRONT BIOSCI-LANDMRK, V9, P2640, DOI 10.2741/1423; Kim B, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-14298-9; Larkin M, 2016, CUREUS, V8, DOI 10.7759/cureus.744; Lawrence T, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001651; Leng L, 2003, J EXP MED, V197, P1467, DOI 10.1084/jem.20030286; Leng L, 2011, J IMMUNOL, V186, P527, DOI 10.4049/jimmunol.1001767; Liu YC, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-16927-9; Lo J, 2021, ARCH PHYS MED REHAB, V102, P115, DOI 10.1016/j.apmr.2020.04.001; Matsuura T, 2006, J NEUROPHYSIOL, V95, P1042, DOI 10.1152/jn.00499.2005; Medel-Matus Jesus-Servando, 2018, Epilepsia Open, V3, P290, DOI 10.1002/epi4.12114; Moretti R, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00040; Morgan RJ, 2008, P NATL ACAD SCI USA, V105, P6179, DOI 10.1073/pnas.0801372105; Mukherjee S, 2020, J NEUROINFLAMM, V17, DOI 10.1186/s12974-020-01854-w; Mukherjee S, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00028; Mukherjee S, 2011, FRONT MOL NEUROSCI, V4, DOI 10.3389/fnmol.2011.00021; Newell MK, 2010, J LEUKOCYTE BIOL, V88, P1279, DOI 10.1189/jlb.0410237err; Owens GC, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00121; Owens GC, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0352-2; Pekny M, 2014, NEUROSCI LETT, V565, P30, DOI 10.1016/j.neulet.2013.12.071; Pittman QJ, 2019, EPILEPSIA OPEN, V4, P230, DOI 10.1002/epi4.12326; Robinson C, 2016, NEURAL PLAST, V2016, DOI 10.1155/2016/1347987; Samland H, 2003, J NEUROSCI RES, V73, P176, DOI 10.1002/jnr.10635; Schroder B, 2016, BBA-MOL CELL RES, V1863, P1269, DOI 10.1016/j.bbamcr.2016.03.026; Semple BD, 2017, J NEUROSCI, V37, P7864, DOI 10.1523/JNEUROSCI.0982-17.2017; Shahrokhi A, 2014, J NEUROL SCI, V342, P25, DOI 10.1016/j.jns.2014.04.003; Shapiro LA, 2006, EPILEPSY RES, V69, P53, DOI 10.1016/j.eplepsyres.2005.12.003; Shapiro LA, 2005, NEUROSCIENCE, V136, P823, DOI 10.1016/j.neuroscience.2005.03.059; Shapiro LA, 2005, BRAIN RES REV, V48, P43, DOI 10.1016/j.brainresrev.2004.08.003; Shapiro LA, 2008, EPILEPSIA, V49, P13, DOI 10.1111/j.1528-1167.2008.01633.x; Shapiro LA, 2008, EPILEPSIA, V49, P33, DOI 10.1111/j.1528-1167.2008.01491.x; Sharma R, 2019, BRAIN SCI, V9, DOI 10.3390/brainsci9110318; Su Y, 2017, ONCOTARGET, V8, P2719, DOI 10.18632/oncotarget.13739; Suhail A, 2019, CELL REP, V29, P3522, DOI 10.1016/j.celrep.2019.11.028; Sun Y, 2019, J NEUROINFLAMM, V16, DOI 10.1186/s12974-019-1452-1; Svenningsen AF, 2017, CELL MOL LIFE SCI, V74, P4561, DOI 10.1007/s00018-017-2592-z; Tobin RP, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/s40478-014-0143-5; Urban RJ, 2020, J NEUROTRAUM, V37, P1037, DOI 10.1089/neu.2019.6688; Wang CW, 2019, CYTOKINE, V115, P8, DOI 10.1016/j.cyto.2018.11.029; Wang FS, 2017, BRAIN STRUCT FUNCT, V222, P1543, DOI 10.1007/s00429-016-1292-z; Weissberg I, 2015, NEUROBIOL DIS, V78, P115, DOI 10.1016/j.nbd.2015.02.029; Willis EF, 2020, CELL, V180, P833, DOI 10.1016/j.cell.2020.02.013; Yang DB, 2017, CLIN CHIM ACTA, V469, P99, DOI 10.1016/j.cca.2017.03.030; Yang YB, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01483	69	7	7	0	1	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		1422-0067		INT J MOL SCI	Int. J. Mol. Sci.	OCT	2020	21	20							7448	10.3390/ijms21207448			13	Biochemistry & Molecular Biology; Chemistry, Multidisciplinary	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Chemistry	OL8DU	WOS:000585564100001	33050322	gold, Green Published			2022-02-06	
J	Patsimas, T; Howell, DR; Potter, MN; Provance, AJ; Kirkwood, MW; Wilson, JC				Patsimas, Tatiana; Howell, David R.; Potter, Morgan N.; Provance, Aaron J.; Kirkwood, Michael W.; Wilson, Julie C.			Concussion-Symptom Rating Correlation Between Pediatric Patients and Their Parents	JOURNAL OF ATHLETIC TRAINING			English	Article						adolescence; mild traumatic brain injury; symptom severity; sports	SPORT-RELATED CONCUSSION; CHILDREN; AGREEMENT; RECOVERY; CARE	Context: Understanding how parents and their children perceive concussion symptoms may provide insights into optimal concussion-management strategies. Objective: To examine patient-parent correlations and agreement on concussion-symptom ratings, to identify differences in patient-parent symptom reporting between children (8-12 years of age) and adolescents (13-18 years of age), and to evaluate the correlation between patient and parent initial symptom-severity ratings with symptom duration and return-to-play time. Design: Cross-sectional study. Setting: Primary care sports medicine clinic. Patients or Other Participants: A total of 267 patients aged 8 to 18 years seen for care within 21 days of sustaining a concussion. Patients were classified as children (n = 65; age = 11.3 +/- 1.4 years; age range, 8-12 years) or adolescents (n = 202; age = 15.5 +/- 1.4 years; age range, 13-18 years). Main Outcome Measure(s): Each patient and his or her parent (or legal guardian) completed a concussion-symptom-frequency inventory, the Health and Behavior Inventory (HBI), at the initial postinjury examination. Patients were followed until they no longer reported concussion symptoms (symptom-resolution time) and were allowed to return to unrestricted sport participation (return-to-play time). Results: At the initial examination (8.9 +/- 5.2 days postinjury), the symptom-frequency correlation between children and their parents was high (r(s) = 0.88; 95% confidence interval [CI] = 0.80, 0.95). Adolescents' symptom-frequency reports were also highly correlated with those of their parents (r(s) = 0.78; 95% CI = 0.71, 0.85). However, the child-parent correlation was higher than the adolescent-parent agreement (z = 2.21, P =.03). Greater patient (consolidated child and adolescent) HBI ratings were associated with longer symptom-resolution times (coefficient = 0.019; 95% CI = 0.007, 0.031; P =.002) and longer return-to-play times (coefficient = 0.012; 95% CI = 0.002, 0.022; P =.02), whereas parent HBI ratings were not. Conclusions: Our findings may help to set expectations regarding concussion-symptom durations and return-to-play timing for pediatric patients and their families. Given the patient-parent correlations in our sample, substantial reporting discrepancies between patients and their parents may be a relevant factor for clinicians to investigate further during concussion evaluations.	[Patsimas, Tatiana; Wilson, Julie C.] Univ Colorado, Sch Med, Dept Pediat, Aurora, CO USA; [Howell, David R.; Provance, Aaron J.; Wilson, Julie C.] Univ Colorado, Sch Med, Dept Orthoped, Aurora, CO USA; [Kirkwood, Michael W.] Univ Colorado, Sch Med, Dept Phys Med & Rehabil, Aurora, CO USA; [Howell, David R.; Potter, Morgan N.; Provance, Aaron J.; Wilson, Julie C.] Childrens Hosp Colorado, Sports Med Ctr, 13123 East 16th Ave,B060, Aurora, CO 80045 USA; [Kirkwood, Michael W.] Childrens Hosp Colorado, Rehabil Med, Aurora, CO 80045 USA		Howell, DR (corresponding author), Childrens Hosp Colorado, Sports Med Ctr, 13123 East 16th Ave,B060, Aurora, CO 80045 USA.	David.Howell@ucdenver.edu			Eunice Kennedy Shriver National Institute of Child Health & Human DevelopmentUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R03HD094560]; National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS100952, R41NS103698]	Dr Howell receives research support not related to this study from the Eunice Kennedy Shriver National Institute of Child Health & Human Development grant R03HD094560 and the National Institute of Neurological Disorders and Stroke grants R01NS100952 and R41NS103698.	Ayr LK, 2009, J INT NEUROPSYCH SOC, V15, P19, DOI 10.1017/S1355617708090188; Babikian T, 2011, J INT NEUROPSYCH SOC, V17, P886, DOI 10.1017/S1355617711000907; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Bryan MA, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2015-4635; Chrisman SP, 2013, J ADOLESCENT HEALTH, V52, P330, DOI 10.1016/j.jadohealth.2012.10.271; Gibson TB, 2015, JAMA PEDIATR, V169, P163, DOI 10.1001/jamapediatrics.2014.2320; Hajek CA, 2011, CHILD NEUROPSYCHOL, V17, P17, DOI 10.1080/09297049.2010.495058; Halstead ME, 2018, PEDIATRICS, V142, DOI 10.1542/peds.2018-3074; Heyer GL, 2016, J PEDIATR-US, V174, P33, DOI 10.1016/j.jpeds.2016.03.014; Howell DR, 2019, CLIN PEDIATR, V58, P42, DOI 10.1177/0009922818806308; Iverson GL, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097729; Kirkwood MW, 2014, PEDIATRICS, V133, P643, DOI 10.1542/peds.2013-3195; LaRoche AA, 2016, CLIN J SPORT MED, V26, P33, DOI 10.1097/JSM.0000000000000192; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McLeod TCV, 2017, ORTHOP J SPORTS MED, V5, DOI 10.1177/2325967117745033; Meehan WP, 2014, NEUROLOGY, V83, P2204, DOI 10.1212/WNL.0000000000001073; Meehan WP, 2013, J PEDIATR-US, V163, P721, DOI 10.1016/j.jpeds.2013.03.012; Mukaka MM, 2012, MALAWI MED J, V24, P69; Rowhani-Rahbar A, 2016, J NEUROTRAUM, V33, P784, DOI 10.1089/neu.2015.4100; Spicer M.A.C.M., 2014, SPORTS RELATED CONCU; Stein CJ, 2016, CLIN J SPORT MED, V26, P386, DOI 10.1097/JSM.0000000000000268; Wray-Lake L, 2010, CHILD DEV, V81, P636, DOI 10.1111/j.1467-8624.2009.01420.x; Zemek R, 2016, JAMA-J AM MED ASSOC, V315, P1014, DOI 10.1001/jama.2016.1203; Zick CD, 1996, SOC SCI RES, V25, P260, DOI 10.1006/ssre.1996.0012	24	7	7	0	0	NATL ATHLETIC TRAINERS ASSOC INC	DALLAS	2952 STEMMONS FREEWAY, DALLAS, TX 75247 USA	1062-6050	1938-162X		J ATHL TRAINING	J. Athl. Train.	OCT	2020	55	10					1020	1026		10.4085/1062-6050-200-19			7	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Sport Sciences	OH5SX	WOS:000582645900002	32031884	Green Published, gold			2022-02-06	
J	Goodman, AM; Allendorfer, JB; Blum, AS; Bolding, MS; Correia, S; Hoef, LWV; Gaston, TE; Grayson, LE; Kraguljac, NV; Lahti, AC; Martin, AN; Monroe, WS; Philip, NS; Tocco, K; Vogel, V; LaFrance, WC; Szaflarski, JP				Goodman, Adam M.; Allendorfer, Jane B.; Blum, Andrew S.; Bolding, Mark S.; Correia, Stephen; Hoef, Lawrence W. Ver; Gaston, Tyler E.; Grayson, Leslie E.; Kraguljac, Nina V.; Lahti, Adrienne C.; Martin, Amber N.; Monroe, William S.; Philip, Noah S.; Tocco, Krista; Vogel, Valerie; LaFrance, W. Curt, Jr.; Szaflarski, Jerzy P.			White matter and neurite morphology differ in psychogenic nonepileptic seizures	ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY			English	Article							TRAUMATIC BRAIN-INJURY; CORTICAL THICKNESS; DISSOCIATION; ABNORMALITIES; CONNECTIVITY; DISPERSION; NETWORKS; EPILEPSY; ANXIETY; SCALE	Objective To further evaluate the relationship between the clinical profiles and limbic and motor brain regions and their connecting pathways in psychogenic nonepileptic seizures (PNES). Neurite Orientation Dispersion and Density Indices (NODDI) multicompartment modeling was used to test the relationships between tissue alterations in patients with traumatic brain injury (TBI) and multiple psychiatric symptoms. Methods The sample included participants with prior TBI (TBI; N = 37) but no PNES, and with TBI and PNES (TBI + PNES; N = 34). Participants completed 3T Siemens Prisma MRI high angular resolution imaging diffusion protocol. Statistical maps, including fractional anisotropy (FA), mean diffusivity (MD), neurite dispersion [orientation dispersion index (ODI)] and density [intracellular volume fraction (ICVF), and free water (i.e., isotropic) volume fraction (V-ISO)] signal intensity, were generated for each participant. Linear mixed-effects models identified clusters of between-group differences in indices of white matter changes. Pearson's r correlation tests assessed any relationship between signal intensity and psychiatric symptoms. Results Compared to TBI, TBI + PNES revealed decreases in FA, ICVF, and V-ISO and increases in MD for clusters within cingulum bundle, uncinate fasciculus, fornix/stria terminalis, and corticospinal tract pathways (cluster threshold alpha = 0.05). Indices of white matter changes for these clusters correlated with depressive, anxiety, PTSD, psychoticism, and somatization symptom severity (FDR threshold alpha = 0.05). A follow-up within-group analysis revealed that these correlations failed to reach the criteria for significance in the TBI + PNES group alone. Interpretation The results expand support for the hypothesis that alterations in pathways comprising the specific PNES network correspond to patient profiles. These findings implicate myelin-specific changes as possible contributors to PNES, thus introducing novel potential treatment targets.	[Goodman, Adam M.; Allendorfer, Jane B.; Hoef, Lawrence W. Ver; Gaston, Tyler E.; Grayson, Leslie E.; Martin, Amber N.; Szaflarski, Jerzy P.] Univ Alabama Birmingham, Dept Neurol, Birmingham, AL USA; [Goodman, Adam M.; Allendorfer, Jane B.; Hoef, Lawrence W. Ver; Gaston, Tyler E.; Grayson, Leslie E.; Martin, Amber N.; Szaflarski, Jerzy P.] Univ Alabama Birmingham, UAB Epilepsy Ctr, Birmingham, AL USA; [Blum, Andrew S.; Tocco, Krista; Vogel, Valerie; LaFrance, W. Curt, Jr.] Rhode Isl Hosp, Dept Neurol, Providence, RI USA; [Blum, Andrew S.; Correia, Stephen; Philip, Noah S.; Tocco, Krista; Vogel, Valerie; LaFrance, W. Curt, Jr.] Brown Univ, Providence, RI 02912 USA; [Bolding, Mark S.] Univ Alabama Birmingham, Dept Radiol, Birmingham, AL USA; [Correia, Stephen] Brown Univ, Rhode Isl Hosp, Alpert Med Sch, Dept Psychiat & Human Behav, Providence, RI 02912 USA; [Correia, Stephen; Philip, Noah S.; Tocco, Krista; Vogel, Valerie; LaFrance, W. Curt, Jr.] Providence VA Med Ctr, Ctr Neurorestorat & Neurotechnol, Providence, RI USA; [Hoef, Lawrence W. Ver; Gaston, Tyler E.; Grayson, Leslie E.] Birmingham VA Med Ctr, Birmingham, AL USA; [Grayson, Leslie E.; Szaflarski, Jerzy P.] Univ Alabama Birmingham, Childrens Alabama, Birmingham, AL USA; [Kraguljac, Nina V.; Lahti, Adrienne C.] Univ Alabama Birmingham, Dept Psychiat & Behav Neurobiol, Birmingham, AL USA; [Lahti, Adrienne C.; Szaflarski, Jerzy P.] Univ Alabama Birmingham, Dept Neurobiol, Birmingham, AL USA; [Lahti, Adrienne C.; Szaflarski, Jerzy P.] Univ Alabama Birmingham, Dept Neurosurg, Birmingham, AL USA; [Monroe, William S.] Univ Alabama Birmingham, Dept Res Comp, Birmingham, AL USA; [LaFrance, W. Curt, Jr.] Rhode Isl Hosp, Dept Psychiat, Providence, RI USA; [LaFrance, W. Curt, Jr.] Rhode Isl Hosp, Dept Neurol, Providence, RI USA; [Szaflarski, Jerzy P.] Univ Alabama Birmingham, Comprehens Neurosci Ctr, Birmingham, AL USA		Goodman, AM (corresponding author), Univ Alabama Birmingham UAB, Dept Neurol, Epilepsy Ctr, 312 Civitan Int Res Ctr,1719 6th Ave South, Birmingham, AL 35294 USA.	agoodman@uabmc.edu	LaFrance, W Curt/AAN-6707-2021; Goodman, Adam/AAI-3643-2021	LaFrance, W Curt/0000-0002-4901-3852; Goodman, Adam/0000-0002-7550-679X; Ver Hoef, Lawrence/0000-0002-1026-550X; Bolding, Mark/0000-0002-7684-4125	US Department of DefenseUnited States Department of Defense [DOD EP160028 (W81XH-17-0619)]	This research was supported by the US Department of Defense [DOD EP160028 (W81XH-17-0619)]. PIs: LaFrance Jr, WC, and Szaflarski, JP.	Allendorfer JB, 2019, NEUROIMAGE-CLIN, V24, DOI 10.1016/j.nicl.2019.101967; Armstrong RC, 2016, EXP NEUROL, V275, P328, DOI 10.1016/j.expneurol.2015.02.011; Association A. P., 1994, DIAGN STAT MAN MENT; Beck A.T., 1996, BECK DEPRESSION INVE, DOI DOI 10.1037/T00742-000; BECK AT, 1988, J CONSULT CLIN PSYCH, V56, P893, DOI 10.1037/0022-006X.56.6.893; Berman MG, 2011, SOC COGN AFFECT NEUR, V6, P548, DOI 10.1093/scan/nsq080; BERNSTEIN EM, 1986, J NERV MENT DIS, V174, P727, DOI 10.1097/00005053-198612000-00004; Bodde NMG, 2009, CLIN NEUROL NEUROSUR, V111, P1, DOI 10.1016/j.clineuro.2008.09.028; Dedovic K, 2009, NEUROIMAGE, V47, P864, DOI 10.1016/j.neuroimage.2009.05.074; Derogatis L.R., 1994, SYMPTOM CHECKLIST 90, V3rd ed.; Diez I, 2019, J NEUROL NEUROSUR PS, V90, P929, DOI 10.1136/jnnp-2018-319657; Ding JR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063850; Edwards LJ, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00720; ENDICOTT J, 1976, ARCH GEN PSYCHIAT, V33, P766; Feinstein A, 2001, NEUROPSY NEUROPSY BE, V14, P169; Filippi, 2018, MOL PSYCHIATR, DOI 10.1038/s41380-018-0222-2; Friedman L, 2006, J MAGN RESON IMAGING, V23, P827, DOI 10.1002/jmri.20583; Ganos C, 2019, NEUROLOGY, V93, P750, DOI 10.1212/WNL.0000000000008372; Grussu F, 2017, ANN CLIN TRANSL NEUR, V4, P663, DOI 10.1002/acn3.445; Gupta RK, 2005, EPILEPSIA, V46, P1465, DOI 10.1111/j.1528-1167.2005.01205.x; Hernando KA, 2015, EPILEPSY BEHAV, V45, P68, DOI 10.1016/j.yebeh.2015.02.022; Hua K, 2008, NEUROIMAGE, V39, P336, DOI 10.1016/j.neuroimage.2007.07.053; Ito M, 2009, EPILEPSY BEHAV, V16, P491, DOI 10.1016/j.yebeh.2009.08.017; Jalilianhasanpour R, 2019, PSYCHOSOMATICS, V60, P365, DOI 10.1016/j.psym.2018.08.004; Jalilianhasanpour R, 2018, J PSYCHOSOM RES, V107, P55, DOI 10.1016/j.jpsychores.2018.02.005; Kennis M, 2016, NEUROIMAGE-CLIN, V11, P539, DOI 10.1016/j.nicl.2016.03.022; Kraguljac NV, 2019, NEUROPSYCHOPHARMACOL, V44, P1932, DOI 10.1038/s41386-019-0427-3; Labate A, 2012, EPILEPSIA, V53, P377, DOI 10.1111/j.1528-1167.2011.03347.x; LaFrance WC, 2014, JAMA PSYCHIAT, V71, P997, DOI 10.1001/jamapsychiatry.2014.817; LaFrance WC, 2013, EPILEPSIA, V54, P2005, DOI 10.1111/epi.12356; LaFrance WC, 2013, EPILEPSIA, V54, P718, DOI 10.1111/epi.12053; Lee S, 2015, BRAIN RES, V1620, P169, DOI 10.1016/j.brainres.2015.04.050; Lozano D, 2015, NEUROPSYCH DIS TREAT, V11, P97, DOI 10.2147/NDT.S65815; Mori S, 2005, MRI ATLAS HUMAN WHIT; Myers L, 2013, EPILEPSY BEHAV, V26, P153, DOI 10.1016/j.yebeh.2012.11.054; Palacios EM, 2018, BIORXIV; Pasternak O, 2012, J NEUROSCI, V32, P17365, DOI 10.1523/JNEUROSCI.2904-12.2012; Perez DL, 2018, J NEUROL NEUROSUR PS, V89, P1221, DOI 10.1136/jnnp-2017-317305; Perez DL, 2018, HUM BRAIN MAPP, V39, P428, DOI 10.1002/hbm.23853; Perez DL, 2017, J NEUROL NEUROSUR PS, V88, P1052, DOI 10.1136/jnnp-2017-316359; Perez DL, 2017, J NEUROL NEUROSUR PS, V88, P491, DOI 10.1136/jnnp-2016-314998; Popkirov S, 2018, SEIZURE-EUR J EPILEP, V58, P127, DOI 10.1016/j.seizure.2018.04.009; Pruessner JC, 2010, PSYCHONEUROENDOCRINO, V35, P179, DOI 10.1016/j.psyneuen.2009.02.016; Rae CL, 2017, BIOL PSYCHIAT, V82, P716, DOI 10.1016/j.biopsych.2017.02.008; Reuber M, 2003, EPILEPSY RES, V57, P159, DOI 10.1016/j.eplepsyres.2003.11.004; Riggio S, 2011, NEUROL CLIN, V29, P35, DOI 10.1016/j.ncl.2010.10.008; Rosello-Mecho X, 2019, INT CONF ADV OPTOEL, P1, DOI 10.1109/CAOL46282.2019.9019536; Sepehrband F, 2015, HUM BRAIN MAPP, V36, P3687, DOI 10.1002/hbm.22872; Sone D, 2019, NEUROPSYCH DIS TREAT, V15, P3549, DOI 10.2147/NDT.S235159; Szaflarski JP, 2018, EPILEPSY CURR, V18, P211, DOI 10.5698/1535-7597.18.4.211; Ulrich-Lai YM, 2009, NAT REV NEUROSCI, V10, P397, DOI 10.1038/nrn2647; van der Kruijs SJM, 2014, J PSYCHIATR RES, V54, P126, DOI 10.1016/j.jpsychires.2014.03.010; van der Kruijs SJM, 2012, J NEUROL NEUROSUR PS, V83, P239, DOI 10.1136/jnnp-2011-300776; Weathers F, 1994, WHITE RIVER JUNCTION; White Tonya, 2008, Top Magn Reson Imaging, V19, P97, DOI 10.1097/RMR.0b013e3181809f1e; Whitfield-Gabrieli S, 2012, ANNU REV CLIN PSYCHO, V8, P49, DOI 10.1146/annurev-clinpsy-032511-143049; Zhang H, 2012, NEUROIMAGE, V61, P1000, DOI 10.1016/j.neuroimage.2012.03.072	57	7	7	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	2328-9503			ANN CLIN TRANSL NEUR	Ann. Clin. Transl. Neurol.	OCT	2020	7	10					1973	1984		10.1002/acn3.51198		SEP 2020	12	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	OV0OD	WOS:000573414500001	32991786	Green Published, gold			2022-02-06	
J	Lin, S; Tian, H; Lin, JQ; Xu, C; Yuan, YJ; Gao, S; Song, CW; Lv, PF; Mei, XF				Lin, Sen; Tian, He; Lin, Jiaquan; Xu, Chang; Yuan, Yajiang; Gao, Shuang; Song, Changwei; Lv, Pengfei; Mei, Xifan			Zinc promotes autophagy and inhibits apoptosis through AMPK/mTOR signaling pathway after spinal cord injury	NEUROSCIENCE LETTERS			English	Article						Spinal cord injury; Zinc; Autophagy; AMPK	NEURAL TISSUE-DAMAGE; LOCOMOTOR IMPAIRMENT; BRAIN-INJURY	Autophagy is a intracellular biological process that controls the homeostasis of nutrition deprivation and starvation and has been associated with the development of traumatic diseases. Zinc, an important chemical element involved in life activities, has improved nerve recovery effects through intraperitoneal injection. The purpose of this study was to probe the possible modulation of autophagy and apoptosis from the injured spinal cord and neurons by zinc administration. It was shown that zinc significantly induced the level of Beclinl and LC3B by activating adenosine 5'-monophosphate (AMP)-activated protein kinase (AMPK) signaling pathway. In addition, zinc suppressed apoptosis in the injured spinal cord. Taken together, these findings suggested that zinc through promoting neurons autophagy and inhibiting apoptosis.	[Lin, Sen; Lin, Jiaquan; Xu, Chang; Yuan, Yajiang; Gao, Shuang; Song, Changwei; Mei, Xifan] Jinzhou Med Univ, Dept Orthoped, Affiliated Hosp 1, Jinzhou 121000, Peoples R China; [Tian, He; Lv, Pengfei] Jinzhou Med Univ, Jinzhou 121000, Peoples R China		Mei, XF (corresponding author), Jinzhou Med Univ, Dept Orthoped, Affiliated Hosp 1, Jinzhou 121000, Peoples R China.	meixifan@jzmu.edu.cn			National Natural Science Foundation of China (NSFC)National Natural Science Foundation of China (NSFC) [81671907, 81871556]; Liaoning Natural Science Foundation of China [201602309, 20170540330]	The authors thank other researchers for the valuable technical assistance in this work. This work was supported by the National Natural Science Foundation of China (NSFC) (NO. 81671907 and 81871556) and Liaoning Natural Science Foundation of China (NO. 201602309 and 20170540330).	Alers S, 2012, MOL CELL BIOL, V32, P2, DOI 10.1128/MCB.06159-11; Angeli C, 2012, SPINAL CORD, V50, P925, DOI 10.1038/sc.2012.93; Bisicchia E, 2017, MOL NEUROBIOL, V54, P4896, DOI 10.1007/s12035-016-0031-z; Cao CJ, 2017, BIOMED PHARMACOTHER, V93, P1128, DOI 10.1016/j.biopha.2017.07.036; Che W, 2017, BRAIN RES BULL, V131, P100, DOI 10.1016/j.brainresbull.2017.03.014; Choi DW, 1996, COLD SPRING HARB SYM, V61, P385; Codogno P, 2012, NAT REV MOL CELL BIO, V13, P7, DOI 10.1038/nrm3249; Cordaro M, 2017, MOL NEUROBIOL, V54, P2415, DOI 10.1007/s12035-016-9827-0; Dou Y, 2017, J NEUROCHEM, V142, P478, DOI 10.1111/jnc.14075; Espinoza A., IRON COPPER ZINC TRA, V146, P281; Golub VM, 2015, FRONT AGING NEUROSCI, V7, DOI [10.5589/fnagi.2015.00196, 10.3389/fnagi.2015.00196]; He M, 2016, P NATL ACAD SCI USA, V113, P11324, DOI 10.1073/pnas.1611282113; James ND, 2018, LANCET NEUROL, V17, P905, DOI 10.1016/S1474-4422(18)30287-4; Kalkan E, 2007, SPINAL CORD, V45, P722, DOI 10.1038/sj.sc.3102035; Kawamata T, 2017, J BIOL CHEM, V292, P8520, DOI 10.1074/jbc.M116.762948; Kijima K, 2019, EBIOMEDICINE, V41, P659, DOI 10.1016/j.ebiom.2019.03.003; Kusanaga M, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20092192; Li DY, 2020, LIFE SCI, V245, DOI 10.1016/j.lfs.2020.117351; Li X, 2019, FRONT MOL NEUROSCI, V12, DOI 10.3389/fnmol.2019.00018; Lopez-Perez O, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-38500-2; Morris DR, 2012, J TOXICOL-US, V2012, DOI 10.1155/2012/785647; Pavlica S, 2010, NEUROCHEM INT, V56, P84, DOI 10.1016/j.neuint.2009.09.005; Saper CB, 2005, J COMP NEUROL, V493, P477, DOI 10.1002/cne.20839; Sekiguchi A, 2012, J NEUROTRAUM, V29, P946, DOI 10.1089/neu.2011.1919; VALLEE BL, 1993, PHYSIOL REV, V73, P79, DOI 10.2466/pr0.1993.73.1.79; Wang YS, 2014, BRAIN RES, V1545, P45, DOI 10.1016/j.brainres.2013.12.015; Yamasaki S, 2007, J CELL BIOL, V177, P637, DOI 10.1083/jcb.200702081; Yao XM, 2009, NEUROTOXICOLOGY, V30, P121, DOI 10.1016/j.neuro.2008.11.002; Yun SM, 2014, PHYTOTHER RES, V28, P458, DOI 10.1002/ptr.5015; Zhao H., NEUROSCIENCE, V348, P241; Zhou Z., NEUROSCIENCE, V329, P193	31	7	7	4	13	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0304-3940	1872-7972		NEUROSCI LETT	Neurosci. Lett.	SEP 25	2020	736								135263	10.1016/j.neulet.2020.135263			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	NS7GQ	WOS:000572426200011	32682846				2022-02-06	
J	Zeiler, FA; Ercole, A; Placek, MM; Hutchinson, PJ; Stocchetti, N; Czosnyka, M; Smielewski, P				Zeiler, Frederick A.; Ercole, Ari; Placek, Michal M.; Hutchinson, Peter J.; Stocchetti, Nino; Czosnyka, Marek; Smielewski, Peter		CENTER-TBI High-Resolution ICU HR	Association between Physiological Signal Complexity and Outcomes in Moderate and Severe Traumatic Brain Injury: A CENTER-TBI Exploratory Analysis of Multi-Scale Entropy	JOURNAL OF NEUROTRAUMA			English	Article						autoregulation; cerebral physiology; complexity; multi-scale entropy; outcome	NEUROTRAUMA EFFECTIVENESS RESEARCH; HEART-RATE-VARIABILITY; CLASSIFICATION; PREDICTION; MANAGEMENT	In traumatic brain injury (TBI), preliminary retrospective work on signal entropy suggests an association with global outcome. The goal of this study was to provide multi-center validation of the association between multi-scale entropy (MSE) of cardiovascular and cerebral physiological signals, with six-month outcome. Using the Collaborative European NeuroTrauma Effectiveness Research in TBI (CENTER-TBI) high-resolution intensive care unit (ICU) cohort, we selected patients with a minimum of 72 h of physiological recordings and a documented six-month Glasgow Outcome Scale Extended (GOSE) score. The 10-sec summary data for heart rate (HR), mean arterial pressure (MAP), intracranial pressure (ICP), and pulse amplitude of ICP (AMP) were derived across the first 72 h of data. The MSE complexity index (MSE-Ci) was determined for HR, MAP, ICP, and AMP, with the association between MSE and dichotomized six-month outcomes assessed using Mann-WhitneyUtesting and logistic regression analysis. A total of 160 patients had a minimum of 72 h of recording and a documented outcome. Decreased HR MSE-Ci (7.3 [interquartile range (IQR) 5.4 to 10.2] vs. 5.1 [IQR 3.1 to 7.0];p = 0.002), lower ICP MSE-Ci (11.2 [IQR 7.5 to 14.2] vs. 7.3 [IQR 6.1 to 11.0];p = 0.009), and lower AMP MSE-Ci (10.9 [IQR 8.0 to 13.7] vs. 8.7 [IQR 6.6 to 11.0];p = 0.022), were associated with death. Similarly, lower HR MSE-Ci (8.0 [IQR 6.2 to 10.9] vs. 6.2 [IQR 3.9 to 8.7];p = 0.003) and lower ICP MSE-Ci (11.4 [IQR 8.6 to 14.4)] vs. 9.2 [IQR 6.0 to 13.5]), were associated with unfavorable outcome. Logistic regression analysis confirmed that lower HR MSE-Ci and ICP MSE-Ci were associated with death and unfavorable outcome at six months. These findings suggest that a reduction in cardiovascular and cerebrovascular system entropy is associated with worse outcomes. Further work in the field of signal complexity in TBI multi-modal monitoring is required.	[Zeiler, Frederick A.; Ercole, Ari] Univ Cambridge, Addenbrookes Hosp, Div Anaesthesia, Cambridge, England; [Hutchinson, Peter J.] Univ Cambridge, Addenbrookes Hosp, Dept Clin Neurosci, Cambridge, England; [Placek, Michal M.; Czosnyka, Marek; Smielewski, Peter] Univ Cambridge, Addenbrookes Hosp, Div Neurosurg, Brain Phys Lab, Cambridge, England; Univ Manitoba, Rady Fac Hlth Sci, Dept Surg, Winnipeg, MB R3A 1R9, Canada; Univ Manitoba, Rady Fac Hlth Sci, Dept Human Anat & Cell Sci, Winnipeg, MB, Canada; Univ Manitoba, Fac Engn, Biomed Engn, Winnipeg, MB, Canada; [Zeiler, Frederick A.] Univ Manitoba, Ctr Aging, Winnipeg, MB, Canada; [Placek, Michal M.] Wroclaw Univ Sci & Technol, Fac Fundamental Problems Technol, Dept Biomed Engn, Wroclaw, Poland; [Stocchetti, Nino] Neuro ICU Fdn IRCCS Ca Granda Osped Maggiore Poli, Milan, Italy; [Stocchetti, Nino] Milan Univ, Dept Physiopathol & Transplantat, Milan, Italy; [Czosnyka, Marek] Warsaw Univ Technol, Inst Elect Syst, Warsaw, Poland		Zeiler, FA (corresponding author), Univ Manitoba, Rady Fac Hlth Sci, Dept Surg, Winnipeg, MB R3A 1R9, Canada.	frederick.zeiler@umanitoba.ca	Sahuquillo, Juan/B-3577-2008; Ercole, Ari/B-6288-2009; Raj, Rahul/K-7693-2012; Moller, Kirsten/A-4751-2009	Sahuquillo, Juan/0000-0003-0713-5875; Ercole, Ari/0000-0001-8350-8093; Raj, Rahul/0000-0003-4243-9591; Zeiler, Frederick/0000-0003-1737-0510; Radoi, Andreea/0000-0002-0677-3544; Kondziella, Daniel/0000-0001-5562-9808; Sakowitz, Oliver/0000-0003-3248-6335; Takala, Riikka/0000-0001-6342-0043; Moller, Kirsten/0000-0003-3058-1072			Bernard F, 2020, CAN J NEUROL SCI, V47, P551, DOI 10.1017/cjn.2020.54; Buchman Timothy G, 2002, Curr Opin Crit Care, V8, P311, DOI 10.1097/00075198-200208000-00007; Busa MA, 2016, J SPORT HEALTH SCI, V5, P44, DOI 10.1016/j.jshs.2016.01.018; Calviello L, 2018, NEUROCRIT CARE, V28, P212, DOI 10.1007/s12028-017-0475-7; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Costa M, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.068102; da Costa CS, 2017, J CEREBR BLOOD F MET, V37, P3368, DOI 10.1177/0271678X16687314; Doiron D, 2017, INT J EPIDEMIOL, V46, P1372, DOI 10.1093/ije/dyx180; Gao L, 2020, J NEUROTRAUM, V37, P1011, DOI 10.1089/neu.2019.6631; Gao L, 2016, J NEUROTRAUM, V33, P2011, DOI 10.1089/neu.2015.4228; Hasen M, 2019, J NEUROTRAUM, V36, P1491, DOI 10.1089/neu.2018.6073; Karmali SN, 2017, INTENS CARE MED EXP, V5, DOI 10.1186/s40635-017-0146-1; Kim DJ, 2009, NEUROSURGERY, V64, P494, DOI 10.1227/01.NEU.0000338434.59141.89; Lavinio A, 2008, ACTA NEUROCHIR SUPPL, V102, P3, DOI 10.1007/978-3-211-85578-2_1; Liu N, 2020, BMC CARDIOVASC DISOR, V20, DOI 10.1186/s12872-020-01455-8; Lu CW, 2012, BRAIN, V135, P2399, DOI 10.1093/brain/aws155; Luo X., 2019, EUR J TRAUMA EMERG S; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; Maas AIR, 2015, NEUROSURGERY, V76, P67, DOI 10.1227/NEU.0000000000000575; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; Packiasabapathy S, 2020, BMC ANESTHESIOL, V20, DOI 10.1186/s12871-020-00972-5; Raj R, 2014, NEUROSURGERY, V75, P632, DOI 10.1227/NEU.0000000000000533; Soehle M, 2013, J CLIN MONIT COMPUT, V27, P395, DOI 10.1007/s10877-012-9427-0; Sorrentino E, 2012, NEUROCRIT CARE, V16, P258, DOI 10.1007/s12028-011-9630-8; Stein PK, 2005, CRIT CARE MED, V33, P2128, DOI 10.1097/01.CCM.0000178369.64672.4E; Wettervik TS, 2020, J CLIN MONIT COMPUT, V34, P733, DOI 10.1007/s10877-019-00387-9; Sykora M, 2016, CRIT CARE MED, V44, P1173, DOI 10.1097/CCM.0000000000001624; Thelin EP, 2020, J CLIN MONIT COMPUT, V34, P971, DOI 10.1007/s10877-019-00392-y; Vande Vyvere T, 2019, J NEUROTRAUM, V36, P1080, DOI 10.1089/neu.2018.6061; Wenneberg SB, 2020, ACTA ANAESTH SCAND, V64, P945, DOI 10.1111/aas.13582; Wettervik TS, 2020, NEUROSURGERY, V86, pE300, DOI 10.1093/neuros/nyz515; Zeiler FA, 2020, J NEUROTRAUM, V37, P1854, DOI 10.1089/neu.2020.7024; Zeiler FA, 2019, J NEUROTRAUM, V36, P1505, DOI 10.1089/neu.2018.6182; Zeiler FA, 2019, ACTA NEUROCHIR, V161, P1955, DOI 10.1007/s00701-019-03980-8; Zeiler FA, 2019, ACTA NEUROCHIR, V161, P1275, DOI 10.1007/s00701-019-03915-3; Zeiler FA, 2019, ACTA NEUROCHIR, V161, P1217, DOI 10.1007/s00701-019-03844-1; Zeiler FA, 2018, ACTA NEUROCHIR, V160, P2277, DOI 10.1007/s00701-018-3681-y; Zeiler FA, 2021, J NEUROTRAUM, V38, P1107, DOI 10.1089/neu.2017.5583; Zeiler FA, 2018, J NEUROTRAUM, V35, P1107, DOI 10.1089/neu.2017.5472	39	7	7	1	2	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN 15	2021	38	2					272	282		10.1089/neu.2020.7249		SEP 2020	11	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	PP0TL	WOS:000574498200001	32814492				2022-02-06	
J	Daugherty, JC; Verdejo-Roman, J; Perez-Garcia, M; Hidalgo-Ruzzante, N				Daugherty, Julia C.; Verdejo-Roman, Juan; Perez-Garcia, Miguel; Hidalgo-Ruzzante, Natalia			Structural Brain Alterations in Female Survivors of Intimate Partner Violence	JOURNAL OF INTERPERSONAL VIOLENCE			English	Article; Early Access						Intimate partner violence; traumatic brain injury; strangulation; mental health; structural brain alterations	ADVERSE CHILDHOOD EXPERIENCES; SURFACE-BASED ANALYSIS; CULTURAL-DIFFERENCES; INJURY; WOMEN; DEPRESSION; VICTIMS; DISORDER; PTSD; ACTIVATION	Intimate partner violence (IPV) has been related to brain alterations in female survivors. Nonetheless, few studies have used an exploratory approach, focusing on brain regions that are traditionally studied in other populations with post-traumatic stress. Traumatic brain injury (TBI), strangulation, and childhood trauma are highly prevalent among this population, and have also been associated with brain alterations and functional deterioration. As such, it is difficult to determine how different brain regions are affected by the complex interplay of these factors in female survivors. The aim of this study is to assess (a) brain alterations in female survivors of IPV as compared to non-victim females and (b) the potential causal mechanisms associated with such alterations. We hypothesized that structural brain differences would be found between female survivors of IPV and non-victims, and that these differences would be related to IPV-related TBI, strangulation, IPV severity, depression, post-traumatic stress, generalized anxiety, and childhood adverse experiences. A total of 27 non-victims and 28 survivors completed structural magnetic resonance imaging and questionnaires to measure the potential causal mechanisms for brain alterations. Structural brain differences were found between groups, principally in volumetric analyses. The brain regions in which between-group differences were found were related to attempted strangulation, IPV-related TBI, severity of IPV, adverse childhood experiences, and post-traumatic stress. These results demonstrate that a wider range of brain regions may be impacted by IPV and that various factors are implicated in the structural brain alterations found in female survivors. This study demonstrates the importance of post-traumatic stress, childhood and adult trauma, and physical violence in assessing brain alterations in IPV survivors. Further, it serves as a critical first step in assessing an extensive list of potential causal mechanisms for structural brain alterations, using a more comprehensive a whole-brain structural analysis of IPV female victims, a largely understudied and vulnerable population.	[Daugherty, Julia C.; Verdejo-Roman, Juan; Perez-Garcia, Miguel; Hidalgo-Ruzzante, Natalia] Univ Granada, CIMCYC UGR, Granada, Spain; [Verdejo-Roman, Juan] UPM, UCM, Ctr Biomed Technol CTB, Lab Cognit & Computat Neurosci, Madrid, Spain		Verdejo-Roman, J (corresponding author), Ctr Biomed Technol CTB, Lab Cognit & Computat Neurosci, Montegancedo Campus, Pozuelo De Alarcon Madri 28223, Spain.	juanverdejo@ucm.es	Roman, Juan Verdejo/B-5188-2017; Daugherty, Julia C./Q-8716-2017; Garcia, Miguel Perez/F-9630-2010	Roman, Juan Verdejo/0000-0001-5112-8918; Daugherty, Julia C./0000-0002-1221-4394; Garcia, Miguel Perez/0000-0003-4775-7556	I+D+I Operative Program FEDER project of the Andalusian Government in 2018 [B-CTS-493-UGR18]; Ministry of Education and Professional Training in Spain; University of Granada (Spain); Spanish Ministry of Science, Innovation and Universities [FJCI-2017-33396]	The author(s) disclosed receipt of the following financial support for the research, authorship and/or publication of this article: The study was funded by the I+D+I Operative Program FEDER project of the Andalusian Government in 2018 (B-CTS-493-UGR18). J.C.D. was funded by a predoctoral fellowship of the Ministry of Education and Professional Training in Spain as well as the postdoctoral Puente contract at the University of Granada (Spain). J.V.R was funded by a Grant from the Spanish Ministry of Science, Innovation and Universities (FJCI-2017-33396).	Afari N, 2014, PSYCHOSOM MED, V76, P2, DOI 10.1097/PSY.0000000000000010; [Anonymous], 1993, RELIG SOC, V8, P48; Aupperle RL, 2016, J TRAUMA STRESS, V29, P33, DOI 10.1002/jts.22068; Aupperle RL, 2013, PSYCHIAT RES-NEUROIM, V214, P48, DOI 10.1016/j.pscychresns.2013.05.001; Aupperle RL, 2012, ARCH GEN PSYCHIAT, V69, P360, DOI 10.1001/archgenpsychiatry.2011.1539; Banks ME, 2007, TRAUMA VIOLENCE ABUS, V8, P290, DOI 10.1177/1524838007303503; Barrios YV, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116609; Beydoun HA, 2012, SOC SCI MED, V75, P959, DOI 10.1016/j.socscimed.2012.04.025; Blevins CA, 2015, J TRAUMA STRESS, V28, P489, DOI 10.1002/jts.22059; Bovin MJ, 2016, PSYCHOL ASSESSMENT, V28, P1379, DOI 10.1037/pas0000254; Bradley KA, 2003, ARCH INTERN MED, V163, P821, DOI 10.1001/archinte.163.7.821; Bush K, 1998, ARCH INTERN MED, V158, P1789, DOI 10.1001/archinte.158.16.1789; Campbell JC, 2018, J WOMENS HEALTH, V27, P761, DOI 10.1089/jwh.2016.6311; Cavanaugh CE, 2012, PSYCHOL TRAUMA-US, V4, P169, DOI 10.1037/a0023314; Chandan JS, 2020, BRIT J PSYCHIAT, V217, P562, DOI 10.1192/bjp.2019.124; Cimino AN, 2019, J AGGRESS MALTREAT T, V28, P714, DOI 10.1080/10926771.2019.1587657; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; Destrieux C, 2010, NEUROIMAGE, V53, P1, DOI 10.1016/j.neuroimage.2010.06.010; Devries KM, 2013, SCIENCE, V340, P1527, DOI 10.1126/science.1240937; Do Khanh Ngoc, 2013, Int Perspect Psychol, V2, DOI 10.1037/ipp0000004; Estefan LF, 2016, VIOLENCE AGAINST WOM, V22, P1397, DOI 10.1177/1077801215624792; Felitti VJ, 2019, AM J PREV MED, V56, P774, DOI 10.1016/j.amepre.2019.04.001; Fennema-Notestine C, 2002, BIOL PSYCHIAT, V52, P1089, DOI 10.1016/S0006-3223(02)01413-0; Fischl B, 1999, NEUROIMAGE, V9, P195, DOI 10.1006/nimg.1998.0396; Fischl B, 2000, P NATL ACAD SCI USA, V97, P11050, DOI 10.1073/pnas.200033797; Flegar SJ, 2011, AFR J PSYCHIATRY, V14, P310, DOI [10.4314/ajpsy.v14i4.9, http://dx.doi.org/10.4314/ajpsy.v14i4.9]; Fonzo GA, 2013, PSYCHIAT RES-NEUROIM, V211, P93, DOI 10.1016/j.pscychresns.2012.08.006; Fonzo GA, 2010, BIOL PSYCHIAT, V68, P433, DOI 10.1016/j.biopsych.2010.04.028; Ford DC, 2014, PSYCHOL VIOLENCE, V4, P432, DOI 10.1037/a0037723; Ford JD, 2015, EUR J PSYCHOTRAUMATO, V6, DOI 10.3402/ejpt.v6.27584; Garcia-Campayo J, 2010, HEALTH QUAL LIFE OUT, V8, DOI 10.1186/1477-7525-8-8; Goldin Y, 2016, PM&R, V8, P1104, DOI 10.1016/j.pmrj.2016.05.006; Grandhi R, 2017, BRAIN SCI, V7, DOI 10.3390/brainsci7120160; Gregoire J, 2018, INT J TEST, V18, P101, DOI 10.1080/15305058.2017.1398166; Haag H, 2019, J WOMENS HEALTH, V28, P990, DOI 10.1089/jwh.2018.7299; Han SH, 2014, NEUROIMAGE, V99, P293, DOI 10.1016/j.neuroimage.2014.05.062; Hebenstreit CL, 2014, J AGGRESS MALTREAT T, V23, P168, DOI 10.1080/10926771.2014.872749; Hegarty K., 2012, COMPOSITE ABUSE SCAL, DOI [10.1037/t04578-000, DOI 10.1037/T04578-000]; Instituto Nacional de Estadistica [National Statistics Institute] (INE), 2019, INE EL DISTR EST ESP; Krause ED, 2007, PSYCHOL ASSESSMENT, V19, P165, DOI 10.1037/1040-3590.19.2.165; Kroenke K, 2002, PSYCHIAT ANN, V32, P509, DOI 10.3928/0048-5713-20020901-06; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Kwako LE, 2011, TRAUMA VIOLENCE ABUS, V12, P115, DOI 10.1177/1524838011404251; Lacey KK, 2015, AM J PUBLIC HEALTH, V105, P719, DOI 10.2105/AJPH.2014.301886; Lagdon S, 2014, EUR J PSYCHOTRAUMATO, V5, DOI 10.3402/ejpt.v5.24794; Lobo A., 1979, LUSO SPANISH ACTS NE, V3, P189; Moser DA, 2015, SOC COGN AFFECT NEUR, V10, P645, DOI 10.1093/scan/nsu099; Murray CE, 2016, TRAUMA VIOLENCE ABUS, V17, P298, DOI 10.1177/1524838015584364; Neumeister P, 2018, PSYCHOL MED, V48, P1209, DOI 10.1017/S0033291717002513; Puetz VB, 2017, HUM BRAIN MAPP, V38, P855, DOI 10.1002/hbm.23423; Roos A, 2017, BRAIN IMAGING BEHAV, V11, P1629, DOI 10.1007/s11682-016-9644-0; Ruff RM, 2009, ARCH CLIN NEUROPSYCH, V24, P3, DOI 10.1093/arclin/acp006; Seedat S, 2005, PSYCHIAT RES-NEUROIM, V139, P249, DOI 10.1016/j.pscychresns.2005.06.001; Shields LBE, 2010, AM J FOREN MED PATH, V31, P320, DOI 10.1097/PAF.0b013e3181d3dc02; Simmons AN, 2008, BIOL PSYCHIAT, V64, P681, DOI 10.1016/j.biopsych.2008.05.027; Smith DJ, 2001, J EMERG MED, V21, P323, DOI 10.1016/S0736-4679(01)00402-4; Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092; Strigo IA, 2010, BIOL PSYCHIAT, V68, P442, DOI 10.1016/j.biopsych.2010.03.034; Sui SG, 2010, ACTA NEUROPSYCHIATR, V22, P118, DOI 10.1111/j.1601-5215.2010.00459.x; Valera E. M., 1997, BRAIN INJURY SEVERIT; Valera EM, 2003, J CONSULT CLIN PSYCH, V71, P797, DOI 10.1037/0022-006X.71.4.797; Valera E, 2017, BRAIN IMAGING BEHAV, V11, P1664, DOI 10.1007/s11682-016-9643-1; Valera EM, 2019, J NEUROTRAUM, V36, P661, DOI 10.1089/neu.2018.5734; Weston CSE, 2014, FRONT PSYCHIATRY, V5, DOI 10.3389/fpsyt.2014.00037; Whalley MG, 2013, BRAIN COGNITION, V81, P151, DOI 10.1016/j.bandc.2012.10.002; White ME, 2015, AGGRESS VIOLENT BEH, V24, P120, DOI 10.1016/j.avb.2015.05.005; WHO, 2017, VIOL MUJ VIOL PAR VI; Wong JYH, 2014, TRAUMA VIOLENCE ABUS, V15, P22, DOI 10.1177/1524838013496333; World Health Organization (WHO), 2013, ESTIMACIONES MUNDIAL; World Health Organization (WHO), 2013, EST MUND REG VIOL MU; Wortmann JH, 2016, PSYCHOL ASSESSMENT, V28, P1392, DOI 10.1037/pas0000260; Zieman G, 2017, J NEUROTRAUM, V34, P876, DOI 10.1089/neu.2016.4579	72	7	7	4	9	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0886-2605	1552-6518		J INTERPERS VIOLENCE	J. Interpers. Violence											0886260520959621	10.1177/0886260520959621		SEP 2020	34	Criminology & Penology; Family Studies; Psychology, Applied	Social Science Citation Index (SSCI)	Criminology & Penology; Family Studies; Psychology	NS6ZG	WOS:000572406900001	32954938	Green Published			2022-02-06	
J	Tierney, GJ; Kuo, C; Wu, L; Weaving, D; Camarillo, D				Tierney, Gregory J.; Kuo, Calvin; Wu, Lyndia; Weaving, Dan; Camarillo, David			Analysis of head acceleration events in collegiate-level American football: A combination of qualitative video analysis and in-vivo head kinematic measurement	JOURNAL OF BIOMECHANICS			English	Article						Concussion; Biomechanics; Instrumented mouthguards; Video analysis	PROFESSIONAL FOOTBALL; CONCUSSION; IMPACTS; RECONSTRUCTION	The contact nature of American football has made head acceleration exposure a concern. We aimed to quantify the head kinematics associated with direct helmet contact and inertial head loading events in collegiate-level American football. A cohort of collegiate-level players were equipped with instrumented mouthguards synchronised with time-stamped multiple camera-view video footage of matches and practice. Video-verified contact events were identified as direct helmet contact or inertial head loading events and categorised as blocking, blocked, tackling, tackled or ground contact. Linear mixed-effects models were utilised to compare peak head kinematics between contact event categories. The timestampbased cross-verification of the video analysis and instrumented mouthguard approach resulted in 200 and 328 direct helmet contact and inertial head loading cases, respectively. Median linear acceleration, angular acceleration and angular velocity for inertial head loading cases was greater than direct helmet contact events by 8% (p = 0.007), 55% (p 0.001) and 4% (p = 0.007), respectively. Median head kinematics for all contact event categories appeared similar with no pairwise comparison resulting in statistical significance (p > 0.05). The study highlights the potential of combining qualitative video analysis with in vivo head kinematics measurements. The findings suggest that a number of direct helmet contact events sustained in American football are of lower magnitude to what is sustained during regular play (i.e. from inertial head loading). Additionally, the findings illustrate the importance of including all contact events, including direct helmet contact and inertial head loading cases, when assessing head acceleration exposure and player load during a season of American football. (C) 2020 Elsevier Ltd. All rights reserved.	[Tierney, Gregory J.] Univ Leeds, Sch Biomed Sci, 4-02 Miall Bldg, Leeds LS2 9NL, W Yorkshire, England; [Kuo, Calvin] Univ British Columbia, Sch Kinesiol, Vancouver, BC, Canada; [Wu, Lyndia] Univ British Columbia, Dept Mech Engn, Vancouver, BC, Canada; [Weaving, Dan] Leeds Beckett Univ, Carnegie Appl Rugby Res Ctr, Leeds, W Yorkshire, England; [Camarillo, David] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA		Tierney, GJ (corresponding author), Univ Leeds, Sch Biomed Sci, 4-02 Miall Bldg, Leeds LS2 9NL, W Yorkshire, England.	g.tierney@leeds.ac.uk	Kuo, Calvin/AAH-1933-2019	Kuo, Calvin/0000-0001-8401-9136; Tierney, Gregory/0000-0002-4666-4473	Leeds Mobility Award	This research was funded by the Leeds Mobility Award.	Abrahams S, 2014, BRIT J SPORT MED, V48, P91, DOI 10.1136/bjsports-2013-092734; Bartsch AJ, 2019, IEEE ENG MED BIO, P2068, DOI 10.1109/EMBC.2019.8856907; Baugh C.M., 2016, CONCUSSION, V1; Baugh CM, 2012, BRAIN IMAGING BEHAV, V6, P244, DOI 10.1007/s11682-012-9164-5; Beckwith JG, 2013, MED SCI SPORT EXER, V45, P737, DOI 10.1249/MSS.0b013e3182792ed7; Brolinson P Gunnar, 2006, Curr Sports Med Rep, V5, P23; Cross M, 2016, BRIT J SPORT MED, V50, P926, DOI 10.1136/bjsports-2015-094982; Cunningham J., 2018, BMJ OPEN SPORT EXERC, V4; Duma SM, 2005, CLIN J SPORT MED, V15, P3, DOI 10.1097/00042752-200501000-00002; Kawata K, 2017, J NEUROTRAUM, V34, P2254, DOI 10.1089/neu.2016.4786; Kelley ME, 2019, J NEUROSURG-PEDIATR, V23, P381, DOI 10.3171/2018.9.PEDS18314; Kuo C, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0199238; Kuo C, 2016, J BIOMECH, V49, P1845, DOI 10.1016/j.jbiomech.2016.04.017; Lessley DJ, 2018, AM J SPORT MED, V46, P3502, DOI 10.1177/0363546518804498; Merchant-Borna K, 2016, ANN BIOMED ENG, V44, P3679, DOI 10.1007/s10439-016-1680-9; Nathanson JT, 2016, ORTHOP J SPORTS MED, V4, DOI 10.1177/2325967115622621; Ng TP, 2006, BIOMED SCI INSTRUM, V42, P25; Pellman EJ, 2003, NEUROSURGERY, V53, P799, DOI 10.1093/neurosurgery/53.3.799; Rowson S, 2012, ANN BIOMED ENG, V40, P1, DOI 10.1007/s10439-011-0392-4; Simms CK., 2016, ISBS C P ARCH, DOI DOI 10.1016/J.PUHE.2015.10.038; Stemper BD, 2019, ANN BIOMED ENG, V47, P2073, DOI 10.1007/s10439-019-02335-9; Stemper BD, 2019, ANN BIOMED ENG, V47, P2057, DOI 10.1007/s10439-018-02136-6; Stern RA, 2011, PM&R, V3, pS460, DOI 10.1016/j.pmrj.2011.08.008; Talavage TM, 2014, J NEUROTRAUM, V31, P327, DOI 10.1089/neu.2010.1512; Tierney GJ, 2018, J BIOMECH, V72, P29, DOI 10.1016/j.jbiomech.2018.02.023; Tierney GJ, 2018, SPORT BIOMECH, V17, P33, DOI 10.1080/14763141.2016.1271905; Tierney GJ, 2017, BRAIN INJURY, V31, P1925, DOI 10.1080/02699052.2017.1385853; Tierney GJ, 2016, BRAIN INJURY, V30, P1350, DOI 10.1080/02699052.2016.1193630; Viano DC, 2007, NEUROSURGERY, V61, P313, DOI 10.1227/01.NEU.0000279969.02685.D0; Wu LC, 2016, J BIOMECH, V49, P2918, DOI 10.1016/j.jbiomech.2016.07.004; Wu LC, 2016, ANN BIOMED ENG, V44, P1234, DOI 10.1007/s10439-015-1423-3; Wu LC, 2014, IEEE T BIO-MED ENG, V61, P2659, DOI 10.1109/TBME.2014.2320153; Xing JL, 2011, IEEE T IMAGE PROCESS, V20, P1652, DOI 10.1109/TIP.2010.2102045	33	7	7	0	4	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0021-9290	1873-2380		J BIOMECH	J. Biomech.	SEP 18	2020	110								109969	10.1016/j.jbiomech.2020.109969			7	Biophysics; Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Biophysics; Engineering	NP6AA	WOS:000570255800021	32827770	Green Accepted			2022-02-06	
J	Fong, TG; Vasunilashorn, SM; Ngo, L; Libermann, TA; Dillon, ST; Schmitt, EM; Pascual-Leone, A; Arnold, SE; Jones, RN; Marcantonio, ER; Inouye, SK				Fong, Tamara G.; Vasunilashorn, Sarinnapha M.; Ngo, Long; Libermann, Towia A.; Dillon, Simon T.; Schmitt, Eva M.; Pascual-Leone, Alvaro; Arnold, Steven E.; Jones, Richard N.; Marcantonio, Edward R.; Inouye, Sharon K.		SAGES Study Grp	Association of Plasma Neurofilament Light with Postoperative Delirium	ANNALS OF NEUROLOGY			English	Article							TRAUMATIC BRAIN-INJURY; CEREBROSPINAL-FLUID; ELECTIVE SURGERY; OLDER; BIOMARKERS; VALIDATION; PROTEIN; SEVERITY; OUTCOMES; DESIGN	Objective To examine the association of the plasma neuroaxonal injury markers neurofilament light (NfL), total tau, glial fibrillary acid protein, and ubiquitin carboxyl-terminal hydrolase L1 with delirium, delirium severity, and cognitive performance. Methods Delirium case-no delirium control (n = 108) pairs were matched by age, sex, surgery type, cognition, and vascular comorbidities. Biomarkers were measured in plasma collected preoperatively (PREOP), and 2 days (POD2) and 30 days postoperatively (PO1MO) using Simoa technology (Quanterix, Lexington, MA). The Confusion Assessment Method (CAM) and CAM-S (Severity) were used to measure delirium and delirium severity, respectively. Cognitive function was measured with General Cognitive Performance (GCP) scores. Results Delirium cases had higher NfL on POD2 and PO1MO (median matched pair difference = 16.2pg/ml and 13.6pg/ml, respectively;p< 0.05). Patients with PREOP and POD2 NfL in the highest quartile (Q4) had increased risk for incident delirium (adjusted odds ratio [OR] = 3.7 [95% confidence interval (CI) = 1.1-12.6] and 4.6 [95% CI = 1.2-18.2], respectively) and experienced more severe delirium, with sum CAM-S scores 7.8 points (95% CI = 1.6-14.0) and 9.3 points higher (95% CI = 3.2-15.5). At PO1MO, delirium cases had continued high NfL (adjusted OR = 9.7, 95% CI = 2.3-41.4), and those with Q4 NfL values showed a -2.3 point decline in GCP score (-2.3 points, 95% CI = -4.7 to -0.9). Interpretation Patients with the highest PREOP or POD2 NfL levels were more likely to develop delirium. Elevated NfL at PO1MO was associated with delirium and greater cognitive decline. These findings suggest NfL may be useful as a predictive biomarker for delirium risk and long-term cognitive decline, and once confirmed would provide pathophysiological evidence for neuroaxonal injury following delirium. ANN NEUROL 2020	[Fong, Tamara G.] Beth Israel Deaconess Med Ctr, Dept Neurol, Boston, MA 02215 USA; [Fong, Tamara G.; Vasunilashorn, Sarinnapha M.; Ngo, Long; Libermann, Towia A.; Dillon, Simon T.; Arnold, Steven E.; Marcantonio, Edward R.; Inouye, Sharon K.] Harvard Med Sch, Boston, MA 02115 USA; [Fong, Tamara G.; Schmitt, Eva M.; Inouye, Sharon K.] Hebrew SeniorLife, Aging Brain Ctr, Boston, MA USA; [Fong, Tamara G.; Schmitt, Eva M.; Pascual-Leone, Alvaro; Inouye, Sharon K.] Hebrew SeniorLife, Hinda & Arthur Marcus Inst Aging Res, Boston, MA USA; [Vasunilashorn, Sarinnapha M.; Ngo, Long; Marcantonio, Edward R.] Beth Israel Deaconess Med Ctr, Div Gen Med, Boston, MA 02215 USA; [Vasunilashorn, Sarinnapha M.] Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA USA; [Ngo, Long] Harvard TH Chan Sch Publ Hlth, Dept Biostat, Boston, MA USA; [Libermann, Towia A.; Dillon, Simon T.] Beth Israel Deaconess Med Ctr, Div Interdisciplinary Med & Biotechnol, Boston, MA 02215 USA; [Libermann, Towia A.; Dillon, Simon T.] Beth Israel Deaconess Med Ctr Genom, Prote, Bioinformat & Syst Biol Ctr, Boston, MA USA; [Pascual-Leone, Alvaro] Harvard Med Sch, Dept Neurol, Boston, MA 02115 USA; [Pascual-Leone, Alvaro] Autonomous Univ Barcelona, Guttmann Brain Hlth Inst, Guttmann Inst, Barcelona, Spain; [Arnold, Steven E.] Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA; [Jones, Richard N.] Brown Univ, Warren Alpert Med Sch, Dept Psychiat & Human Behav, Providence, RI 02912 USA; [Jones, Richard N.] Brown Univ, Warren Alpert Med Sch, Dept Neurol, Providence, RI 02912 USA; [Marcantonio, Edward R.; Inouye, Sharon K.] Beth Israel Deaconess Med Ctr, Dept Med, Div Gerontol, Boston, MA 02215 USA		Fong, TG (corresponding author), Hebrew SeniorLife, Inst Aging Res, Aging Brain Ctr, 1200 Ctr St, Boston, MA 02131 USA.	tfong@bidmc.harvard.edu	Pascual-Leone, Alvaro/AAC-5101-2019; Marcantonio, Edward/U-3929-2017	Pascual-Leone, Alvaro/0000-0001-8975-0382; Marcantonio, Edward/0000-0002-2911-4250	NIH National Institute on AgingUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R21AG057955, P01AG031720, R24AG054259, K07AG041835, R01AG051658, K24AG035075, R03AG061582, K01AG057836]; Alzheimer's AssociationAlzheimer's Association [AARF-18-560786]	This article was funded by R21AG057955 (T.G.F.), P01AG031720 (S.K.I.), R24AG054259 (S.K.I.), K07AG041835 (S.K.I.), R01AG051658 (E.R.M.), K24AG035075 (E.R.M.), R03AG061582 (S.M.V.), and K01AG057836 (S.M.V.) from the NIH National Institute on Aging and AARF-18-560786 from the Alzheimer's Association (S.M.V.). S.K.I. holds the Milton and Shirley F. Levy Family Chair at Hebrew SeniorLife/Harvard Medical School. The funding sources had no role in the design, conduct, or reporting of this study.	Caplan GA, 2010, J GERONTOL A-BIOL, V65, P1130, DOI 10.1093/gerona/glq090; Casey CP, 2020, BRAIN, V143, P47, DOI 10.1093/brain/awz354; Cavallari M, 2016, BRAIN, V139, P1282, DOI 10.1093/brain/aww010; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Cortese GP, 2017, BEHAV BRAIN RES, V322, P269, DOI 10.1016/j.bbr.2016.08.027; Diaz-Arrastia R, 2014, J NEUROTRAUM, V31, P19, DOI 10.1089/neu.2013.3040; Dillon ST, 2017, BIOL PSYCHIAT, V81, P145, DOI 10.1016/j.biopsych.2016.03.2098; ERNSTER VL, 1994, PREV MED, V23, P587, DOI 10.1006/pmed.1994.1093; Evered L, 2018, JAMA NEUROL, V75, P542, DOI 10.1001/jamaneurol.2017.4913; Fong TG, 2019, INT J GERIATR PSYCH, V34, P781, DOI 10.1002/gps.5088; Gaetani L, 2019, J NEUROL NEUROSUR PS, V90, P870, DOI 10.1136/jnnp-2018-320106; Gailiusas Mindaugas, 2019, Acta Med Litu, V26, P8, DOI 10.6001/actamedica.v26i1.3949; Gleason LJ, 2015, JAMA SURG, V150, P1134, DOI 10.1001/jamasurg.2015.2606; Glushakova Olena Y, 2016, Brain Circ, V2, P28, DOI 10.4103/2394-8108.178546; Grandi C, 2011, J CRIT CARE, V26, P133, DOI 10.1016/j.jcrc.2010.10.006; Gross AL, 2014, NEUROEPIDEMIOLOGY, V42, P144, DOI 10.1159/000357647; Halaas NB, 2018, DEMENT GERIATR COGN, V46, P346, DOI 10.1159/000494754; Hughes CG, 2016, CRIT CARE MED, V44, pE809, DOI 10.1097/CCM.0000000000001739; Inouye SK, 2016, ALZHEIMERS DEMENT, V12, P766, DOI 10.1016/j.jalz.2016.03.005; Inouye SK, 2014, ANN INTERN MED, V160, P526, DOI 10.7326/M13-1927; Inouye SK, 2014, LANCET, V383, P911, DOI 10.1016/S0140-6736(13)60688-1; Inouye SK, 2006, NEW ENGL J MED, V354, P1157, DOI 10.1056/NEJMra052321; Jones RN, 2010, J CLIN EXP NEUROPSYC, V32, P1041, DOI 10.1080/13803391003662728; JORM AF, 1994, PSYCHOL MED, V24, P145, DOI 10.1017/S003329170002691X; Kalm M, 2017, BRAIN RES, V1668, P12, DOI 10.1016/j.brainres.2017.05.011; Khan BA, 2011, J AM GERIATR SOC, V59, pS256, DOI 10.1111/j.1532-5415.2011.03702.x; Kuhle J, 2020, MULT SCLER J, V26, P1691, DOI 10.1177/1352458519885613; Langa KM, 2005, NEUROEPIDEMIOLOGY, V25, P181, DOI 10.1159/000087448; Marcantonio ER, 2017, NEW ENGL J MED, V377, P1456, DOI 10.1056/NEJMcp1605501; Marcantonio ER, 2012, JAMA-J AM MED ASSOC, V308, P73, DOI 10.1001/jama.2012.6857; Ngo LH, 2017, BMC MED RES METHODOL, V17, DOI 10.1186/s12874-017-0359-8; Racine AM, 2018, ALZHEIMERS DEMENT, V14, P590, DOI 10.1016/j.jalz.2017.10.010; Rissin DM, 2013, LAB CHIP, V13, P2902, DOI 10.1039/c3lc50416f; Saczynski JS, 2014, J AM GERIATR SOC, V62, P518, DOI 10.1111/jgs.12684; Saczynski JS, 2012, NEW ENGL J MED, V367, P30, DOI 10.1056/NEJMoa1112923; Saller T, 2019, BIOMED PAP, V163, P241, DOI 10.5507/bp.2019.043; Schmitt EM, 2015, J AM GERIATR SOC, V63, P2463, DOI 10.1111/jgs.13793; Schmitt EM, 2012, J AM MED DIR ASSOC, V13, DOI 10.1016/j.jamda.2012.08.004; Schraen-Maschke S, 2008, BIOMARK MED, V2, P363, DOI 10.2217/17520363.2.4.363; Shahim P, 2018, NEUROLOGY, V90, pE1780, DOI 10.1212/WNL.0000000000005518; Simone MJ, 2011, CNS NEUROSCI THER, V17, P506, DOI 10.1111/j.1755-5949.2010.00173.x; van Montfort SJT, 2019, NEUROIMAGE-CLIN, V23, DOI 10.1016/j.nicl.2019.101809; van Munster BC, 2009, BMC NEUROL, V9, DOI 10.1186/1471-2377-9-21; Vasunilashorn SM, 2020, ALZHEIMERS DEMENT, V16, P572, DOI 10.1016/j.jalz.2019.09.080; Vasunilashorn SM, 2017, J AM GERIATR SOC, V65, pE109, DOI 10.1111/jgs.14913; YESAVAGE JA, 1983, J PSYCHIATR RES, V17, P37, DOI 10.1016/0022-3956(82)90033-4; Zetterberg H, 2016, NAT REV NEUROL, V12, P563, DOI 10.1038/nrneurol.2016.127	47	7	8	3	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0364-5134	1531-8249		ANN NEUROL	Ann. Neurol.	NOV	2020	88	5					984	994		10.1002/ana.25889		SEP 2020	11	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	OG3VJ	WOS:000569816100001	32881052	Green Accepted			2022-02-06	
J	Michinaga, S; Inoue, A; Yamamoto, H; Ryu, R; Inoue, A; Mizuguchi, H; Koyama, Y				Michinaga, Shotaro; Inoue, Anna; Yamamoto, Hayato; Ryu, Ryotaro; Inoue, Ayana; Mizuguchi, Hiroyuki; Koyama, Yutaka			Endothelin receptor antagonists alleviate blood-brain barrier disruption and cerebral edema in a mouse model of traumatic brain injury: A comparison between bosentan and ambrisentan	NEUROPHARMACOLOGY			English	Article						Endothelin; Ambrisentan; Bosentan; Vasogenic edema; Blood-brain barrier; Traumatic brain injury	CEREBROSPINAL-FLUID; ARTERY OCCLUSION; EXPRESSION; MATRIX-METALLOPROTEINASE-9; ACTIVATION; OVEREXPRESSION; ANGIOPOIETIN-1; PERMEABILITY; ASSOCIATION; RESPONSES	Traumatic brain injury (TBI) is induced by the immediate physical disruption of brain tissue. TBI causes disruption of the blood-brain barrier (BBB) and brain edema. In the cerebrospinal fluid (CSF) of TBI patients, endothelin-1 (ET-1) is increased, suggesting that ET-1 aggravates TBI-induced brain damage. In this study, the effect of bosentan (ETA/ETB antagonist) and ambrisentan (ETA antagonist) on BBB dysfunction and brain edema were examined in a mouse model of TBI using lateral fluid percussion injury (FPI). FPI to the mouse cerebrum increased the expression levels of ET-1 and ETB receptors. Administration of bosentan (3 or 15 mg/kg/day) and ambrisentan (0.1 or 0.5 mg/kg/day) at 6 and 24 h after FPI ameliorated BBB disruption and cerebral brain edema. Delayed administration of bosentan from 2 days after FPI also reduced BBB disruption and brain edema, while ambrisentan had no significant effects. FPI-induced expression levels of ET-1 and ETB receptors were reduced by bosentan, but not by ambrisentan. In cultured mouse astrocytes and brain microvessel endothelial cells, ET-1 (100 nM) increased prepro-ET-1 mRNA, which was inhibited by bosentan, but not by ambrisentan. FPI-induced alterations of the expression levels of matrix metalloproteinase-9, vascular endothelial growth factor-A, and angiopoietin-1 in the mouse cerebrum were reduced by delayed administration of bosentan, while ambrisentan had no significant effects. These results suggest that ET antagonists are effective in improving BBB disruption and cerebral edema in TBI patients and that an ETA/ETB non-selective type of antagonists is more effective.	[Michinaga, Shotaro; Inoue, Anna; Yamamoto, Hayato; Ryu, Ryotaro; Inoue, Ayana; Mizuguchi, Hiroyuki] Osaka Ohtani Univ, Fac Pharm, Lab Pharmacol, 3-11-1 Nishikiori Kita, Osaka 5848540, Japan; [Koyama, Yutaka] Kobe Pharmaceut Univ, Lab Pharmacol, 4-19-1 Motoyama Kita Higashinada, Kobe, Hyogo 6688558, Japan		Koyama, Y (corresponding author), Kobe Pharmaceut Univ, Lab Pharmacol, 4-19-1 Motoyama Kita Higashinada, Kobe, Hyogo 6688558, Japan.	koyama-y@kobepharma-u.ac.jp			Japan Society for the Promotion of ScienceMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science [18K06695, 16K18890]	This work was supported by a Grant-in-Aid for Scientific Research (C) (Grant Number: 18K06695) and Grant-in-Aid for Young Scientists (B) (Grant Number: 16K18890) from the Japan Society for the Promotion of Science. We would like to thank Editage (www.editage.com) for English language editing.	Alluri H, 2015, METAB BRAIN DIS, V30, P1093, DOI 10.1007/s11011-015-9651-7; Barone FC, 2000, J CARDIOVASC PHARM, V36, pS357, DOI 10.1097/00005344-200036001-00104; Barton M, 2019, HYPERTENSION, V74, P1232, DOI 10.1161/HYPERTENSIONAHA.119.12105; Blezer ELA, 1999, HYPERTENSION, V33, P137, DOI 10.1161/01.HYP.33.1.137; Blixt J, 2018, J NEUROTRAUM, V35, P671, DOI 10.1089/neu.2017.5015; Chatfield DA, 2011, NEUROCRIT CARE, V14, P55, DOI 10.1007/s12028-010-9413-7; CLOZEL M, 1994, J PHARMACOL EXP THER, V270, P228; CLOZEL M, 1993, LIFE SCI, V52, P825, DOI 10.1016/0024-3205(93)90081-D; Davenport AP, 2016, PHARMACOL REV, V68, P357, DOI 10.1124/pr.115.011833; Didier N, 2003, J NEUROCHEM, V86, P246, DOI 10.1046/j.1471-4159.2003.01829.x; Ding JY, 2009, BRAIN RES, V1268, P125, DOI 10.1016/j.brainres.2009.02.060; FEUERSTEIN G, 1994, PEPTIDES, V15, P467, DOI 10.1016/0196-9781(94)90207-0; Fischer M, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-59; Gao WW, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00281; Gao WW, 2015, BRAIN RES, V1622, P230, DOI 10.1016/j.brainres.2015.04.035; Gong D, 2011, J TRAUMA, V70, P1480, DOI 10.1097/TA.0b013e31821ac9e1; Hostenbach S, 2016, PROG NEUROBIOL, V144, P88, DOI 10.1016/j.pneurobio.2016.04.009; Jha RM, 2019, NEUROPHARMACOLOGY, V145, P230, DOI 10.1016/j.neuropharm.2018.08.004; Jia F, 2014, J NEUROTRAUM, V31, P1225, DOI 10.1089/neu.2013.3230; Kim JY, 2015, NEUROSCIENCE, V304, P355, DOI 10.1016/j.neuroscience.2015.07.065; Koyama Y, 2011, NEUROSCIENCE, V192, P689, DOI 10.1016/j.neuroscience.2011.05.058; Koyama Y, 2003, EUR J NEUROSCI, V18, P887, DOI 10.1046/j.1460-9568.2003.02797.x; Koyama Y, 2012, GLIA, V60, P1954, DOI 10.1002/glia.22411; Koyama Y, 2012, J PHARMACOL SCI, V118, P401, DOI 10.1254/jphs.11R13CP; Koyama Y, 2010, J PHARMACOL SCI, V114, P433, DOI 10.1254/jphs.10195FP; LeComte MD, 2015, P NATL ACAD SCI USA, V112, P8726, DOI 10.1073/pnas.1501029112; Leung JWC, 2009, BRAIN RES, V1266, P121, DOI 10.1016/j.brainres.2009.01.070; Lin Y, 2012, LAB INVEST, V92, P1623, DOI 10.1038/labinvest.2012.118; Lo ACY, 2005, J CEREBR BLOOD F MET, V25, P998, DOI 10.1038/sj.jcbfm.9600108; Loane David J, 2015, Handb Clin Neurol, V127, P343, DOI 10.1016/B978-0-444-52892-6.00022-2; Maier B, 2007, SHOCK, V27, P610, DOI 10.1097/shk.0b013e31802f9eaf; Matsuo Y, 2001, STROKE, V32, P2143, DOI 10.1161/hs0901.94259; Michinaga S, 2020, J NEUROCHEM, V154, P330, DOI 10.1111/jnc.14957; Michinaga S, 2018, J NEUROTRAUM, V35, P1481, DOI 10.1089/neu.2017.5421; Moldes O, 2012, NEUROPHARMACOLOGY, V63, P1279, DOI 10.1016/j.neuropharm.2012.08.019; Morga E, 2000, J NEUROCHEM, V74, P603, DOI 10.1046/j.1471-4159.2000.740603.x; Muradashvili N, 2015, METAB BRAIN DIS, V30, P411, DOI 10.1007/s11011-014-9550-3; Peters CM, 2003, EXP NEUROL, V180, P1, DOI 10.1016/S0014-4886(02)00023-7; Petrov T, 2009, CAN J PHYSIOL PHARM, V87, P379, DOI [10.1139/Y09-022, 10.1139/y09-022]; Reynolds CA, 2011, NEUROL RES, V33, P197, DOI 10.1179/016164111X12881719352499; SAGHER O, 1994, BRAIN RES, V658, P179, DOI 10.1016/S0006-8993(09)90024-5; SAIJONMAA O, 1992, BIOCHEM BIOPH RES CO, V188, P286, DOI 10.1016/0006-291X(92)92382-8; SAITO S, 1995, J CARDIOVASC PHARM, V26, pS84; Salonia R, 2010, J NEUROTRAUM, V27, P1819, DOI 10.1089/neu.2010.1402; Skold MK, 2005, J NEUROTRAUM, V22, P353, DOI 10.1089/neu.2005.22.353; Suehiro E, 2004, J NEUROTRAUM, V21, P1706, DOI 10.1089/0897715042664957; Thal SC, 2014, ARCH MED RES, V45, P698, DOI 10.1016/j.arcmed.2014.11.006; Unterberg AW, 2004, NEUROSCIENCE, V129, P1021, DOI 10.1016/j.neuroscience.2004.06.046; Vatter H, 2006, CARDIOVASC DRUG REV, V24, P63, DOI 10.1111/j.1527-3466.2006.00063.x; Wang HH, 2010, J NEUROCHEM, V113, P1133, DOI 10.1111/j.1471-4159.2010.06680.x; Wang MM, 2002, EXP NEUROL, V173, P283, DOI 10.1006/exnr.2001.7844; Wilhelmsson U, 2004, J NEUROSCI, V24, P5016, DOI 10.1523/JNEUROSCI.0820-04.2004; Yeung PKK, 2009, J CEREBR BLOOD F MET, V29, P1891, DOI 10.1038/jcbfm.2009.175; YU JCM, 1995, BRIT J PHARMACOL, V116, P2441, DOI 10.1111/j.1476-5381.1995.tb15093.x	54	7	7	0	2	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0028-3908	1873-7064		NEUROPHARMACOLOGY	Neuropharmacology	SEP 15	2020	175								108182	10.1016/j.neuropharm.2020.108182			13	Neurosciences; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pharmacology & Pharmacy	NS0OC	WOS:000571958600001	32561219				2022-02-06	
J	Vogel, A; Wilken-Schmitz, A; Hummel, R; Lang, M; Gurke, R; Schreiber, Y; Schafer, MKE; Tegeder, I				Vogel, Alexandra; Wilken-Schmitz, Annett; Hummel, Regina; Lang, Manuel; Gurke, Robert; Schreiber, Yannick; Schaefer, Michael K. E.; Tegeder, Irmgard			Low brain endocannabinoids associated with persistent non-goal directed nighttime hyperactivity after traumatic brain injury in mice	SCIENTIFIC REPORTS			English	Article							POSTTRAUMATIC-STRESS-DISORDER; ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; CB1 CANNABINOID RECEPTORS; NEUROPATHIC PAIN; ANANDAMIDE; SYSTEM; PALMITOYLETHANOLAMIDE; MODEL; OLEOYLETHANOLAMIDE; NEUROINFLAMMATION	Traumatic brain injury (TBI) is a frequent cause of chronic headache, fatigue, insomnia, hyperactivity, memory deficits, irritability and posttraumatic stress disorder. Recent evidence suggests beneficial effects of pro-cannabinoid treatments. We assessed in mice levels of endocannabinoids in association with the occurrence and persistence of comparable sequelae after controlled cortical impact in mice using a set of long-term behavioral observations in IntelliCages, motor and nociception tests in two sequential cohorts of TBI/sham mice. TBI mice maintained lower body weights, and they had persistent low levels of brain ethanolamide endocannabinoids (eCBs: AEA, OEA, PEA) in perilesional and subcortical ipsilateral brain tissue (6 months), but rapidly recovered motor functions (within days), and average nociceptive responses were within normal limits, albeit with high variability, ranging from loss of thermal sensation to hypersensitivity. TBI mice showed persistent non-goal directed nighttime hyperactivity, i.e. they visited rewarding and non-rewarding operant corners with high frequency and random success. On successful visits, they made more licks than sham mice resulting in net over-licking. The lower the eCBs the stronger was the hyperactivity. In reward-based learning and reversal learning tasks, TBI mice were not inferior to sham mice, but avoidance memory was less stable. Hence, the major late behavioral TBI phenotype was non-goal directed nighttime hyperactivity and "over-licking" in association with low ipsilateral brain eCBs. The behavioral phenotype would agree with a "post-TBI hyperactivity disorder". The association with persistently low eCBs in perilesional and subcortical regions suggests that eCB deficiency contribute to the post-TBI psychopathology.	[Vogel, Alexandra; Wilken-Schmitz, Annett; Gurke, Robert; Schreiber, Yannick; Tegeder, Irmgard] Goethe Univ Frankfurt, Med Fac, Inst Clin Pharmacol, Frankfurt, Germany; [Hummel, Regina; Lang, Manuel; Schaefer, Michael K. E.] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Anesthesiol, Mainz, Germany		Tegeder, I (corresponding author), Goethe Univ Frankfurt, Med Fac, Inst Clin Pharmacol, Frankfurt, Germany.	tegeder@em.uni-frankfurt.de			Deutsche ForschungsgemeinschaftGerman Research Foundation (DFG) [CRC1080, CRC1039]	The study was supported by the Deutsche Forschungsgemeinschaft (CRC1080, A03 to IT and CRC1039 A03 to IT). The funding institution had no role in the conceptualization, design, data collection, analysis, decision to publish, or preparation of the manuscript.	Adeyemo BO, 2014, J ATTEN DISORD, V18, P576, DOI 10.1177/1087054714543371; Aghaei I, 2015, EPILEPSY RES, V117, P23, DOI 10.1016/j.eplepsyres.2015.08.010; Ahmad A, 2012, BRAIN BEHAV IMMUN, V26, P1310, DOI 10.1016/j.bbi.2012.07.021; Albuquerque B, 2013, FRONT BEHAV NEUROSCI, V7, DOI 10.3389/fnbeh.2013.00174; Almeida-Suhett CP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102627; Altmann C, 2016, MOL NEURODEGENER, V11, DOI 10.1186/s13024-016-0132-1; Altmann C, 2016, NEUROBIOL DIS, V96, P294, DOI 10.1016/j.nbd.2016.09.010; Amenta PS, 2014, J NEUROINFLAMM, V11, DOI 10.1186/s12974-014-0191-6; Amenta PS, 2012, J NEUROSCI RES, V90, P2293, DOI 10.1002/jnr.23114; Bishay P, 2013, NEUROPHARMACOLOGY, V71, P204, DOI 10.1016/j.neuropharm.2013.03.021; Bishay P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010628; Braun M, 2018, BRAIN BEHAV IMMUN, V68, P224, DOI 10.1016/j.bbi.2017.10.021; Bree D, 2018, CEPHALALGIA, V38, P246, DOI 10.1177/0333102416681571; Brunkhorst-Kanaan N, 2019, METABOLISM, V95, P65, DOI 10.1016/j.metabol.2019.04.002; Burda JE, 2016, EXP NEUROL, V275, P305, DOI 10.1016/j.expneurol.2015.03.020; Campolongo P, 2009, P NATL ACAD SCI USA, V106, P8027, DOI 10.1073/pnas.0903038106; Cantu D, 2015, CEREB CORTEX, V25, P2306, DOI 10.1093/cercor/bhu041; Chauhan NB, 2014, RESTOR NEUROL NEUROS, V32, P337, DOI 10.3233/RNN-130354; Chiarlone A, 2014, P NATL ACAD SCI USA, V111, P8257, DOI 10.1073/pnas.1400988111; Choi GS, 2018, J REHABIL MED, V50, P246, DOI 10.2340/16501977-2321; Cohen J, 2020, J CLIN NEUROPHYSIOL, V37, P28, DOI 10.1097/WNP.0000000000000612; Cooper RE, 2017, EUR NEUROPSYCHOPHARM, V27, P795, DOI 10.1016/j.euroneuro.2017.05.005; Corps KN, 2015, JAMA NEUROL, V72, P355, DOI 10.1001/jamaneurol.2014.3558; Cristino L, 2020, NAT REV NEUROL, V16, P9, DOI 10.1038/s41582-019-0284-z; Dalla Vecchia E, 2019, PSYCHIAT GENET, V29, P1, DOI 10.1097/YPG.0000000000000211; Danandeh A, 2018, PSYCHOPHARMACOLOGY, V235, P3211, DOI 10.1007/s00213-018-5020-7; Davies AJ, 2019, PAIN, V160, P1059, DOI 10.1097/j.pain.0000000000001482; de Fonseca FR, 2001, NATURE, V414, P209, DOI 10.1038/35102582; Drexel M, 2015, NEUROPHARMACOLOGY, V88, P122, DOI 10.1016/j.neuropharm.2014.08.023; Esposito E, 2013, CNS NEUROL DISORD-DR, V12, P55, DOI 10.2174/1871527311312010010; Firsching R, 2012, J NEUROL SURG PART A, V73, P204, DOI 10.1055/s-0032-1304815; Fischer C, 2021, CELL MOL LIFE SCI, V78, P1029, DOI 10.1007/s00018-020-03553-4; Gardner RC, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002246; Gebremedhin D, 1999, AM J PHYSIOL-HEART C, V276, pH2085, DOI 10.1152/ajpheart.1999.276.6.H2085; Griebel G, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20895-z; Gunduz-Cinar O, 2013, TRENDS PHARMACOL SCI, V34, P637, DOI 10.1016/j.tips.2013.08.008; Gurke R, 2019, TALANTA, V204, P386, DOI 10.1016/j.talanta.2019.06.004; Haller J, 2013, PSYCHOPHARMACOLOGY, V230, P353, DOI 10.1007/s00213-013-3161-2; Hardt S, 2019, PAIN, V160, P1431, DOI 10.1097/j.pain.0000000000001518; Hardt S, 2017, BBA-MOL BASIS DIS, V1863, P2727, DOI 10.1016/j.bbadis.2017.07.014; Honig MG, 2019, EXP NEUROL, V322, DOI 10.1016/j.expneurol.2019.113063; Iljazi A, 2020, NEUROL SCI, V41, P2737, DOI 10.1007/s10072-020-04458-7; Jang SH, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000004017; Kanngiesser M, 2014, ANTIOXID REDOX SIGN, V20, P2555, DOI 10.1089/ars.2013.5494; Kathuria S, 2003, NAT MED, V9, P76, DOI 10.1038/nm803; Katona I, 2008, NAT MED, V14, P923, DOI 10.1038/nm.f.1869; Katz PS, 2015, J NEUROTRAUM, V32, P297, DOI 10.1089/neu.2014.3508; Khoury S, 2018, PROG NEURO-PSYCHOPH, V87, P224, DOI 10.1016/j.pnpbp.2017.06.007; Krackow S, 2010, GENES BRAIN BEHAV, V9, P722, DOI 10.1111/j.1601-183X.2010.00606.x; Kramer T, 2017, J NEUROCHEM, V143, P523, DOI 10.1111/jnc.14220; Leonard J, 2015, SCAND J TRAUMA RESUS, V23, DOI 10.1186/s13049-015-0180-5; Leung A, 2018, MOL PAIN, V14, DOI 10.1177/1744806918810297; Leung A, 2016, MOL PAIN, V12, DOI 10.1177/1744806916662661; Leung A, 2016, PAIN PHYSICIAN, V19, pE347; Lisboa SF, 2019, PSYCHOPHARMACOLOGY, V236, P201, DOI 10.1007/s00213-018-5127-x; Lotsch J, 2018, EUR J PAIN, V22, P471, DOI 10.1002/ejp.1148; Ludanyi A, 2008, J NEUROSCI, V28, P2976, DOI 10.1523/JNEUROSCI.4465-07.2008; MacDonald SWS, 2009, PSYCHOL AGING, V24, P792, DOI 10.1037/a0017798; Magid L, 2019, J NEUROTRAUM, V36, P1836, DOI 10.1089/neu.2018.6063; Mahler SV, 2007, NEUROPSYCHOPHARMACOL, V32, P2267, DOI 10.1038/sj.npp.1301376; Marsicano G, 2003, SCIENCE, V302, P84, DOI 10.1126/science.1088208; Matynia A, 2016, FRONT NEURAL CIRCUIT, V10, DOI 10.3389/fncir.2016.00060; Mechoulam R, 2007, MOL NEUROBIOL, V36, P68, DOI 10.1007/s12035-007-8008-6; Menzel L, 2017, GLIA, V65, P278, DOI 10.1002/glia.23091; Moise AM, 2008, PSYCHOPHARMACOLOGY, V200, P333, DOI 10.1007/s00213-008-1209-5; Monory K, 2006, NEURON, V51, P455, DOI 10.1016/j.neuron.2006.07.006; Murillo-Rodniguez E, 2006, LIFE SCI, V79, P30, DOI 10.1016/j.lfs.2005.12.028; Mustafa G, 2016, NEUROPHARMACOLOGY, V107, P27, DOI 10.1016/j.neuropharm.2016.03.016; Neumeister A, 2013, MOL PSYCHIATR, V18, P1034, DOI 10.1038/mp.2013.61; Nguyen BM, 2014, AM SURGEON, V80, P979; Panikashvili D, 2001, NATURE, V413, P527, DOI 10.1038/35097089; Perez-Morales M, 2014, NEUROREPORT, V25, P1437, DOI 10.1097/WNR.0000000000000287; Pernici CD, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-44174-7; Piro JR, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1166-9; Pottker B, 2017, BRAIN STRUCT FUNCT, V222, P4005, DOI 10.1007/s00429-017-1452-9; Post JM, 2018, FRONT MOL NEUROSCI, V11, DOI 10.3389/fnmol.2018.00067; Rabinak CA, 2020, PSYCHOPHARMACOLOGY, V237, P1813, DOI 10.1007/s00213-020-05499-8; Rabinak CA, 2014, NEUROBIOL LEARN MEM, V113, P125, DOI 10.1016/j.nlm.2013.09.009; Radabaugh HL, 2017, EXP NEUROL, V294, P12, DOI 10.1016/j.expneurol.2017.04.013; Ratliff WA, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-59252-4; Rowe RK, 2016, MOL PAIN, V12, DOI 10.1177/1744806916647055; Sbarski B, 2020, PHARMACOL THERAPEUT, V211, DOI 10.1016/j.pharmthera.2020.107551; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schmitz K, 2014, EMBO MOL MED, V6, P1398, DOI 10.15252/emmm.201404168; Scholz J, 2002, NAT NEUROSCI, V5, P1062, DOI 10.1038/nn942; Schurman LD, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00069; Selvaraj P, 2019, J NEUROTRAUM, V36, P1655, DOI 10.1089/neu.2018.6226; Shohami E, 2011, BRIT J PHARMACOL, V163, P1402, DOI 10.1111/j.1476-5381.2011.01343.x; Soria-Gomez E, 2010, PHARMACOL RES, V61, P379, DOI 10.1016/j.phrs.2010.01.010; Spencer AE, 2016, J CLIN PSYCHIAT, V77, P72, DOI 10.4088/JCP.14r09479; Suardiaz M, 2007, PAIN, V133, P99, DOI 10.1016/j.pain.2007.03.008; Tchantchou F, 2014, NEUROPHARMACOLOGY, V85, P427, DOI 10.1016/j.neuropharm.2014.06.006; Tyburski AL, 2017, J HEADACHE PAIN, V18, DOI 10.1186/s10194-017-0726-1; Valenti M, 2004, CELL MOL LIFE SCI, V61, P945, DOI 10.1007/s00018-003-3453-5; van der Naalt J, 2017, LANCET NEUROL, V16, P532, DOI 10.1016/S1474-4422(17)30117-5; van Hell HH, 2012, PSYCHOPHARMACOLOGY, V219, P981, DOI 10.1007/s00213-011-2428-8; Vaughn LK, 2010, BRIT J PHARMACOL, V160, P530, DOI 10.1111/j.1476-5381.2010.00790.x; Voikar V, 2018, BEHAV BRAIN RES, V352, P8, DOI 10.1016/j.bbr.2017.08.048; Wenzel JM, 2018, NEUROPSYCHOPHARMACOL, V43, P103, DOI 10.1038/npp.2017.126; Widerstrom-Noga E, 2016, J NEUROTRAUM, V33, P1380, DOI 10.1089/neu.2015.4098; Wilker S, 2016, PSYCHONEUROENDOCRINO, V67, P198, DOI 10.1016/j.psyneuen.2016.02.010; Wu XH, 2016, WORLD NEUROSURG, V88, P483, DOI 10.1016/j.wneu.2015.10.011	102	7	7	1	2	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	2045-2322			SCI REP-UK	Sci Rep	SEP 10	2020	10	1							14929	10.1038/s41598-020-71879-x			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NR9XJ	WOS:000571915100050	32913220	Green Published, gold			2022-02-06	
J	Zhang, XS; Lu, Y; Tao, T; Wang, H; Liu, GJ; Liu, XZ; Liu, C; Xia, DY; Hang, CH; Li, W				Zhang, Xiang-Sheng; Lu, Yue; Tao, Tao; Wang, Han; Liu, Guang-Jie; Liu, Xun-Zhi; Liu, Cang; Xia, Da-Yong; Hang, Chun-Hua; Li, Wei			Fucoxanthin Mitigates Subarachnoid Hemorrhage-Induced Oxidative Damage via Sirtuin 1-Dependent Pathway	MOLECULAR NEUROBIOLOGY			English	Article						Subarachnoid hemorrhage; Oxidative stress; Fucoxanthin; Apoptosis; Sirtuin 1	EARLY BRAIN-INJURY; PROTECTS; ACTIVATION; MECHANISMS; APOPTOSIS	Oxidative stress is a key component of the pathological cascade in subarachnoid hemorrhage (SAH). Fucoxanthin (Fx) possesses a strong antioxidant property and has shown neuroprotective effects in acute brain injuries such as ischemic stroke and traumatic brain injury. Here, we investigated the beneficial effects of Fx against SAH-induced oxidative insults and the possible molecular mechanisms. Our data showed that Fx could significantly inhibit SAH-induced reactive oxygen species production and lipid peroxidation, and restore the impairment of endogenous antioxidant enzymes activities. In addition, Fx supplementation improved mitochondrial morphology, ameliorated neural apoptosis, and reduced brain edema after SAH. Moreover, Fx administration exerted an improvement in short-term and long-term neurobehavior functions after SAH. Mechanistically, Fx inhibited oxidative damage and brain injury after SAH by deacetylation of forkhead transcription factors of the O class and p53 via sirtuin 1 (Sirt1) activation. EX527, a selective Sirt1 inhibitor, significantly abated Fx-induced Sirt1 activation and abrogated the antioxidant and neuroprotective effects of Fx after SAH. In primary neurons, Fx similarly suppressed oxidative insults and improved cell viability. These effects were associated with Sirt1 activation and were reversed by EX527 treatment. Taken together, our study explored that Fx provided protection against SAH-induced oxidative insults by inducing Sirt1 signaling, indicating that Fx might serve as a potential therapeutic drug for SAH.	[Zhang, Xiang-Sheng; Liu, Cang] Capital Med Univ, Beijing Friendship Hosp, Dept Neurosurg, Beijing 100050, Peoples R China; [Zhang, Xiang-Sheng; Lu, Yue; Tao, Tao; Wang, Han; Liu, Guang-Jie; Liu, Xun-Zhi; Hang, Chun-Hua; Li, Wei] Nanjing Univ, Med Sch, Affiliated Hosp, Dept Neurosurg,Nanjing Drum Tower Hosp, Nanjing 210008, Jiangsu, Peoples R China; [Xia, Da-Yong] Wannan Med Coll, Yijishan Hosp, Affiliated Hosp 1, Dept Neurosurg, Wuhu 241001, Peoples R China		Li, W (corresponding author), Nanjing Univ, Med Sch, Affiliated Hosp, Dept Neurosurg,Nanjing Drum Tower Hosp, Nanjing 210008, Jiangsu, Peoples R China.	lwxzlw@126.com	Li, Wei/ABE-4301-2021	LU, Yue/0000-0001-9111-5943	National Natural Science Foundation of China (NSFC)National Natural Science Foundation of China (NSFC) [81870922, 81771291, 81971127, 81901203]; Medical Science and technology development Foundation, Nanjing Department of Health [JQX18001]; Fundamental Research Funds for the Central UniversitiesFundamental Research Funds for the Central Universities [021414380361]; Natural Science Research Project in Higher Education of Anhui Province [KJ2018A0253]; Science Research Project of Professional personnel of the First Affiliated Hospital of Wannan Medical College [YR201911]	This work was supported by grants from the National Natural Science Foundation of China (NSFC) (No. 81870922 for W.L., NO.81771291 for C.-H.H., No. 81971127 for Z.Z., 81901203 for Y.L.), Key Project supported by Medical Science and technology development Foundation, Nanjing Department of Health (No. JQX18001 for W.L.), Fundamental Research Funds for the Central Universities (No. 021414380361 for W. L.), Natural Science Research Project in Higher Education of Anhui Province (No. KJ2018A0253 for D.-Y.X.), and the Science Research Project of Professional personnel of the First Affiliated Hospital of Wannan Medical College (No. YR201911).	Alghazwi M, 2019, NEUROCHEM INT, V124, P215, DOI 10.1016/j.neuint.2019.01.010; Chang YH, 2018, BIOCHEM BIOPH RES CO, V495, P197, DOI 10.1016/j.bbrc.2017.11.022; Chen JY, 2014, J PINEAL RES, V56, P12, DOI 10.1111/jpi.12086; Chen S, 2014, PROG NEUROBIOL, V115, P64, DOI 10.1016/j.pneurobio.2013.09.002; Chen XR, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1345-8; Han XN, 2016, J CEREBR BLOOD F MET, V36, P1059, DOI 10.1177/0271678X15606462; Hernandez-Jimenez M, 2013, STROKE, V44, P2333, DOI 10.1161/STROKEAHA.113.001715; Hu LX, 2018, BIOMED PHARMACOTHER, V106, P1484, DOI 10.1016/j.biopha.2018.07.088; Ji LL, 2019, OXID MED CELL LONGEV, V2019, DOI 10.1155/2019/3286928; Jin QH, 2007, J CELL PHYSIOL, V213, P88, DOI 10.1002/jcp.21091; Kong ZL, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20184485; Liu HX, 2020, FRONT PHARMACOL, V11, DOI 10.3389/fphar.2020.00712; Lu Y, 2019, FASEB J, V33, P3051, DOI 10.1096/fj.201801150R; McGrath JC, 2015, BRIT J PHARMACOL, V172, P3189, DOI 10.1111/bph.12955; Ou HC, 2019, MOL NUTR FOOD RES, V63, DOI 10.1002/mnfr.201801353; Sugawara T, 2008, J NEUROSCI METH, V167, P327, DOI 10.1016/j.jneumeth.2007.08.004; Tao T, 2019, J NEUROINFLAMM, V16, DOI 10.1186/s12974-019-1641-y; Terasaki M, 2020, J CLIN MED, V9, DOI 10.3390/jcm9010090; Tsai YR, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19103252; Yang GY, 2019, MAR DRUGS, V17, DOI 10.3390/md17120702; Yu LM, 2019, CHEM-BIOL INTERACT, V306, P152, DOI 10.1016/j.cbi.2019.05.003; Zhang DD, 2016, ACS CHEM NEUROSCI, V7, P710, DOI 10.1021/acschemneuro.5b00306; Zhang F, 2011, PROG NEUROBIOL, V95, P373, DOI 10.1016/j.pneurobio.2011.09.001; Zhang L, 2017, SCI REP-UK, V7, DOI 10.1038/srep46763; Zhang TY, 2019, STROKE, V50, P978, DOI 10.1161/STROKEAHA.118.021590; Zhang XS, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.292; Zhang XS, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17081331; Zhang XS, 2019, FASEB J, V33, P722, DOI 10.1096/fj.201800642RR; Zhang XS, 2018, FREE RADICAL BIO MED, V124, P504, DOI 10.1016/j.freeradbiomed.2018.06.035; Zhang YH, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-1561-x; Zhao L, 2017, MOL NEUROBIOL, V54, P1612, DOI 10.1007/s12035-016-9776-7; Zhao L, 2015, J PINEAL RES, V59, P230, DOI 10.1111/jpi.12254; Zheng JW, 2019, MAR DRUGS, V17, DOI 10.3390/md17100552; Zuo G, 2019, FREE RADICAL BIO MED, V143, P441, DOI 10.1016/j.freeradbiomed.2019.09.002	34	7	7	1	4	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0893-7648	1559-1182		MOL NEUROBIOL	Mol. Neurobiol.	DEC	2020	57	12					5286	5298		10.1007/s12035-020-02095-x		SEP 2020	13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	NX8NH	WOS:000565477600001	32876840				2022-02-06	
J	Hawryluk, GWJ; Nielson, JL; Huie, JR; Zimmermann, L; Saigal, R; Ding, Q; Hirschi, R; Zeiler, FA; Ferguson, AR; Manley, GT				Hawryluk, Gregory W. J.; Nielson, Jessica L.; Huie, J. Russell; Zimmermann, Lara; Saigal, Rajiv; Ding, Quan; Hirschi, Ryan; Zeiler, Frederick A.; Ferguson, Adam R.; Manley, Geoffrey T.			Analysis of Normal High-Frequency Intracranial Pressure Values and Treatment Threshold in Neurocritical Care Patients Insights into Normal Values and a Potential Treatment Threshold	JAMA NEUROLOGY			English	Article							VENTRICULAR-FLUID PRESSURE; MANAGEMENT; HYPERTENSION; INJURY	Importance Intracranial pressure (ICP) elevation is a compartment syndrome that impairs blood flow to the brain. Despite the importance of ICP values in neurocritical care, normal ICP values and the precise ICP threshold at which treatment should be initiated remain uncertain. Objective To refine our understanding of normal ICP values and determine the ICP threshold most strongly associated with outcome. Design, Setting, and Participants Prospective observational study (2004-2010), with outcomes determined at hospital discharge. The study included neurocritical care patients from a single level I trauma center, San Francisco General Hospital. Three hundred eighty-three patients had a traumatic brain injury with or without craniectomy; 140 patients had another indication for ICP monitoring. Consecutive patients were studied. Data analyses were completed between March 2015 and December 2019. Exposures Five hundred twenty-three ICP-monitored patients. Main Outcomes and Measures A computer system prospectively and automatically collected 1-minute physiologic data from patients in the intensive care unit during a 6-year period. Mean ICP was calculated, as was the proportion of ICP values greater than thresholds from 1 to 80 mm Hg in 1-mm Hg increments. The association between these measures and outcome was explored for various epochs up to 30 days from the time of injury. A principal component analysis was used to explore physiologic changes at various ICP thresholds, and elastic net regression was used to identify ICP thresholds most strongly associated with Glasgow Outcome Scale score at discharge. Results Of the 523 studied patients, 70.7% of studied patients were men (n = 370) and 72.1% had a traumatic brain injury (n = 377). A total of 4090964 1-minute ICP measurements were recorded for the included patients (7.78 years of recordings). Intracranial pressure values of 8 to 9 mm Hg were most commonly recorded and could possibly reflect normal values. The principal component analysis suggested state shifts in the physiome occurred at ICPs greater than 19 mm Hg and 24 mm Hg. Elastic net regression identified an ICP threshold of 19 mm Hg as most robustly associated with outcome when considering all neurocritical care patients, patients with TBI, and patients with TBI who underwent craniectomy. Intracranial pressure values greater than 19 mm Hg were associated with mortality, while lower values were associated with outcome in surviving patients. Conclusions and Relevance This study provides insight into what normal ICP values could be. An ICP threshold of 19 mm Hg was robustly associated with outcome in studied patients, although lower ICP values were associated with outcome in surviving patients. This study investigates associations between intracranial pressure values and outcomes in neurocritical care patients. Questions In neurocritical care patients, what intracranial pressure values are normal and what intracranial pressure threshold is most strongly associated with Glasgow Outcome Scale score at hospital discharge? Findings In this observational study, intracranial pressure values of 8 to 9 mm Hg were most commonly recorded and could reflect normal values. An intracranial pressure threshold of 19 mm Hg was robustly associated with outcome in studied patients, although lower intracranial pressure values were associated with outcome in surviving patients. Meaning This study provides insight into what normal intracranial pressure values may be and suggests that threshold values lower than 20 mm Hg should be studied in future prospective studies.	[Hawryluk, Gregory W. J.; Zeiler, Frederick A.] Univ Manitoba, Sect Neurosurg, GB1 Hlth Sci Ctr,820 Sherbrook St, Winnipeg, MB R3A 1R9, Canada; [Nielson, Jessica L.] Univ Minnesota, Dept Psychiat & Behav Sci, Inst Hlth Informat, Minneapolis, MN USA; [Huie, J. Russell; Ferguson, Adam R.; Manley, Geoffrey T.] Univ Calif San Francisco, Brain & Spinal Cord Injury Ctr BASIC, San Francisco, CA 94143 USA; [Huie, J. Russell; Ferguson, Adam R.; Manley, Geoffrey T.] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA USA; [Zimmermann, Lara] Univ Calif Davis, Dept Neurosurg, Davis, CA 95616 USA; [Saigal, Rajiv] Univ Washington, Dept Neurosurg, Seattle, WA 98195 USA; [Ding, Quan] Univ Calif San Francisco, Dept Nursing, San Francisco, CA 94143 USA; [Hirschi, Ryan] Univ Utah, Sch Med, Salt Lake City, UT USA; [Ferguson, Adam R.] San Francisco VA Med Ctr, San Francisco, CA USA		Hawryluk, GWJ (corresponding author), Univ Manitoba, Sect Neurosurg, GB1 Hlth Sci Ctr,820 Sherbrook St, Winnipeg, MB R3A 1R9, Canada.	ghawryluk@hsc.mb.ca		Zeiler, Frederick/0000-0003-1737-0510; Ferguson, Adam/0000-0001-7102-1608	National Institute of Mental HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R01MH116156]; Department of Veteran AffairsUS Department of Veterans Affairs [VAI01RX002245/VAI01RX002787]; National Institues of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [UG3NS106899]; National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS088475]; Wings for Life Foundation; Craig H. Neilsen Foundation; National Cancer Institute, National Institute on Aging, National Institute of Neurological Disorders and Stroke, US Department of Defense	Dr Nielson reported grants from the National Institute of Mental Health (R01MH116156) and the Department of Veteran Affairs (I01RX002245) during the conduct of the study. Dr Ferguson reported grants from the National Institues of Health (UG3NS106899)/National Institute of Neurological Disorders and Stroke (R01NS088475), the Department of Veteran Affairs (VAI01RX002245/VAI01RX002787,), and Wings for Life Foundation during the conduct of the study and grants from Craig H. Neilsen Foundation, National Cancer Institute, National Institute on Aging, National Institute of Neurological Disorders and Stroke, US Department of Defense, and US Department of Energy outside the submitted work. No other disclosures were reported.	ALBECK MJ, 1991, J NEUROSURG, V74, P597, DOI 10.3171/jns.1991.74.4.0597; [Anonymous], 2007, J NEUROTRAUM, V24, pS1, DOI 10.1089/neu.2007.9997; Bratton SL, 2007, J NEUROTRAUMA S1, V24, P555, DOI DOI 10.1089/NEU.2007.9988; Bullock R, 1996, Eur J Emerg Med, V3, P109, DOI 10.1097/00063110-199606000-00010; BUXTON RL, 1970, LANCET, V2, P498; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Chambers IR, 2001, J NEUROSURG, V94, P412, DOI 10.3171/jns.2001.94.3.0412; CHAPMAN PH, 1990, NEUROSURGERY, V26, P181, DOI 10.1227/00006123-199002000-00001; Chesnut R, 2015, J NEUROTRAUMA; Chesnut RM, 2015, ANN NY ACAD SCI, V1345, P74, DOI 10.1111/nyas.12482; Chesnut RM, 2012, NEW ENGL J MED, V367, P2471, DOI 10.1056/NEJMoa1207363; Czosnyka M, 2004, J NEUROL NEUROSUR PS, V75, P813, DOI 10.1136/jnnp.2003.033126; Fleischer A S, 1976, Surg Neurol, V6, P31; Hawryluk GWJ, 2010, J THROMB HAEMOST, V8, P1500, DOI 10.1111/j.1538-7836.2010.03882.x; Hirschi R, 2019, J NEUROSURG, V131, P1216, DOI 10.3171/2018.4.JNS172604; JENNETT B, 1975, LANCET, V1, P480; JOHNSTON IH, 1973, ACTA NEUROCHIR, V29, P53, DOI 10.1007/BF01414616; Kolecki R, 2018, J NEUROSURG, V128, P811, DOI 10.3171/2016.12.JNS161265; LUNDBERG N, 1960, Acta Psychiatr Scand Suppl, V36, P1; LUNDBERG N, 1965, J NEUROSURG, V22, P581, DOI 10.3171/jns.1965.22.6.0581; MARSHALL LF, 1979, J NEUROSURG, V50, P20, DOI 10.3171/jns.1979.50.1.0020; MILLER JD, 1977, J NEUROSURG, V47, P503, DOI 10.3171/jns.1977.47.4.0503; Prossinger HHH, 2019, CLIN MED RES, V8, P6, DOI [10.11648/j.cmr.20190801.12, DOI 10.11648/J.CMR.20190801.12]; SAUL TG, 1982, J NEUROSURG, V56, P498, DOI 10.3171/jns.1982.56.4.0498; Schreiber MA, 2002, ARCH SURG-CHICAGO, V137, P285, DOI 10.1001/archsurg.137.3.285; Sorrentino E, 2012, NEUROCRIT CARE, V16, P258, DOI 10.1007/s12028-011-9630-8; Srinivasan VM, 2014, J NEUROSURG, V120, P228, DOI 10.3171/2013.6.JNS121577; The Brain Trauma Foundation, 2000, J NEUROTRAUM, V17, P493, DOI DOI 10.1089/NEU.2000.17.493; TROUPP J, 1965, J Trauma, V5, P373; Vik A, 2008, J NEUROSURG, V109, P678, DOI 10.3171/JNS/2008/109/10/0678	30	7	7	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	2168-6149	2168-6157		JAMA NEUROL	JAMA Neurol.	SEP	2020	77	9					1150	1158		10.1001/jamaneurol.2020.1310			9	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	NW2DP	WOS:000574820700013	32539101	Green Published			2022-02-06	
J	Howell, DR; Brilliant, AN; Master, CL; Meehan, WP				Howell, David R.; Brilliant, Anna N.; Master, Christina L.; Meehan, William P., III			Reliability of Objective Eye-Tracking Measures Among Healthy Adolescent Athletes	CLINICAL JOURNAL OF SPORT MEDICINE			English	Article						vision; disconjugacy; concussion; eye tracking	TEST-RETEST RELIABILITY; DEFICIT HYPERACTIVITY DISORDER; DUAL-TASK GAIT; CONCUSSION; HISTORY	Objective: To determine the test-retest correlation of an objective eye-tracking device among uninjured youth athletes. Design: Repeated-measures study. Setting: Sports-medicine clinic. Participants: Healthy youth athletes (mean age = 14.6 +/- 2.2 years; 39% women) completed a brief, automated, and objective eye-tracking assessment. Independent variables: Participants completed the eye-tracking assessment at 2 different testing sessions. Main outcome measures: During the assessment, participants watched a 220-second video clip while it moved around a computer monitor in a clockwise direction as an eye tracker recorded eye movements. We obtained 13 eye movement outcome variables and assessed correlations between the assessments made at the 2 time points using Spearman's Rho (r(s)). Results: Thirty-one participants completed the eye-tracking evaluation at 2 time points [median = 7 (interquartile range = 6-9) days between tests]. No significant differences in outcomes were found between the 2 testing times. Several eye movement variables demonstrated moderate to moderately high test-retest reliability. Combined eye conjugacy metric (BOX score, r(s)= 0.529,P= 0.008), the variance of the ratio for both eye movements in the horizontal (r(s)= 0.497,P= 0.013) and vertical (r(s)= 0.446;P= 0.029) movement planes along the top/bottom of the computer screen, and the variance of the left and right eye movement along the bottom segment of the computer screen (r(s)= 0.565;P= 0.004) each demonstrated moderate between-test correlations. Conclusions: Automated and quantitative eye movement and conjugacy metrics provide relatively stable measurements among a group of healthy youth athletes. Thus, their inclusion as a visual tracking metric may be complementary to other visual examination techniques when monitoring concussion recovery across time.	[Howell, David R.] Childrens Hosp Colorado, Sports Med Ctr, Aurora, CO USA; [Howell, David R.] Univ Colorado, Dept Orthoped, Sch Med, Aurora, CO USA; [Howell, David R.; Brilliant, Anna N.; Meehan, William P., III] Micheli Ctr Sports Injury Prevent, Waltham, MA USA; [Brilliant, Anna N.; Meehan, William P., III] Boston Childrens Hosp, Dept Orthopaed, Div Sports Med, Boston, MA USA; [Master, Christina L.] Childrens Hosp Philadelphia, Sports Med & Performance Ctr, Philadelphia, PA 19104 USA; [Master, Christina L.] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA; [Meehan, William P., III] Harvard Med Sch, Dept Pediat & Orthopaed Surg, Boston, MA 02115 USA		Howell, DR (corresponding author), Univ Colorado, Childrens Hosp Colorado, ATC Sports Med Ctr, Dept Orthoped,Sch Med, 13123 E 16th Ave, Aurora, CO 80045 USA.	David.Howell@ucdenver.edu			Boston Children's Hospital; Cincinnati Children's Hospital Medical Center; ElMindA Ltd.; National Hockey League Alumni Association through the Corey C. Griffin Pro-Am Tournament; Football Players Health Study at Harvard University - NFL Players Association	D. R. Howell's research has been funded, in part, through a research contract between Boston Children's Hospital, Cincinnati Children's Hospital Medical Center, and ElMindA Ltd. W. P. Meehan receives royalties from (1) ABC-Clio publishing for the sale of his books, Kids, Sports, and Concussion: A guide for coaches and parents, and Concussions; (2) Springer International for the book Head and Neck Injuries in Young Athlete; and (3) Wolters Kluwer for working as an author for UpToDate. His research is funded, in part, by philanthropic support from the National Hockey League Alumni Association through the Corey C. Griffin Pro-Am Tournament and by a grant from the Football Players Health Study at Harvard University, which is funded by the NFL Players Association.	Amin DJ, 2014, J SPORTS SCI, V2, P200, DOI DOI 10.17265/2332-7839/2014.04.005; Baugh CM, 2016, AM J SPORT MED, V44, P1391, DOI 10.1177/0363546516635639; Broglio SP, 2007, J ATHL TRAINING, V42, P509; Buckley TA, 2016, J SPORT HEALTH SCI, V5, P417, DOI 10.1016/j.jshs.2015.03.010; DeCarlo DK, 2016, OPTOMETRY VISION SCI, V93, P459, DOI 10.1097/OPX.0000000000000823; Ellis MJ, 2017, J NEUROSURG-PEDIATR, V19, P38, DOI 10.3171/2016.7.PEDS16310; Gronlund MA, 2007, EYE, V21, P494, DOI 10.1038/sj.eye.6702240; Howel DR, 2017, J APPL BIOMECH, V33, P24, DOI 10.1123/jab.2015-0323; Howell DR, 2018, CLIN J SPORT MED, V28, P262, DOI 10.1097/JSM.0000000000000439; Howell DR, 2017, CLIN J SPORT MED, V27, P444, DOI 10.1097/JSM.0000000000000374; Howell DR, 2017, J NEUROTRAUM, V34, P838, DOI 10.1089/neu.2016.4609; Howell DR, 2016, GAIT POSTURE, V49, P176, DOI 10.1016/j.gaitpost.2016.07.008; Howell DR, 2016, J PEDIATR ORTHOP B, V25, P310, DOI 10.1097/BPB.0000000000000275; Iverson GL, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097729; Iverson GL, 2016, J NEUROTRAUM, V33, P2077, DOI 10.1089/neu.2014.3424; Kamins J, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097464; Kontos AP, 2016, AM J SPORT MED, V44, P1400, DOI 10.1177/0363546516632754; Littleton AC, 2015, SPORTS HEALTH, V7, P443, DOI 10.1177/1941738115586997; Littleton AC, 2015, ARCH CLIN NEUROPSYCH, V30, P683, DOI 10.1093/arclin/acv043; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; Master CL, 2016, CLIN PEDIATR, V55, P260, DOI 10.1177/0009922815594367; Mautner K, 2015, CLIN J SPORT MED, V25, P355, DOI 10.1097/JSM.0000000000000151; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Miller JH, 2016, J NEUROSURG-PEDIATR, V17, P491, DOI 10.3171/2015.8.PEDS14332; Poltavski D, 2017, OPTOMETRY VISION SCI, V94, P742, DOI 10.1097/OPX.0000000000001094; Resch J, 2013, J ATHL TRAINING, V48, P506, DOI 10.4085/1062-6050-48.3.09; Safrit M, 1995, INTRO MEASUREMENT PH, V3rd, P71; Samadani U, 2017, BRIT J SPORT MED, V51, pA5, DOI DOI 10.1136/bjsports-2016-097270.12; Samadani Uzma, 2016, Concussion, V1, pCNC3, DOI 10.2217/cnc.15.3; Samadani U, 2015, J NEUROTRAUM, V32, P548, DOI 10.1089/neu.2014.3687; Schatz P, 2010, AM J SPORT MED, V38, P47, DOI 10.1177/0363546509343805; Simon M, 2017, DEV NEUROPSYCHOL, V42, P446, DOI 10.1080/87565641.2017.1383994; Sixty-fourth World Health Assembly, 2011, YOUTH HLTH RISKS; Stache S, 2016, CLIN J SPORT MED, V26, P381, DOI 10.1097/JSM.0000000000000270; Vokaty S, 2013, BRIT J SPORT MED, V47, pe1, DOI [10.1136/bjsports-2012-092101.18, DOI 10.1136/BJSPORTS-2012-092101.18]; Zuckerman SL, 2016, NEUROSURG FOCUS, V40, DOI 10.3171/2016.1.FOCUS15593	36	7	7	2	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1050-642X	1536-3724		CLIN J SPORT MED	Clin. J. Sport Med.	SEP	2020	30	5					444	450		10.1097/JSM.0000000000000630			7	Orthopedics; Physiology; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Physiology; Sport Sciences	NX9CH	WOS:000575999300020	29933280				2022-02-06	
J	Marin, JR; Rodean, J; Hall, M; Alpern, ER; Aronson, PL; Chaudhari, PP; Cohen, E; Freedman, SB; Morse, RB; Peltz, A; Samuels-Kalow, M; Shah, SMS; Simon, HK; Neuman, MI				Marin, Jennifer R.; Rodean, Jonathan; Hall, Matt; Alpern, Elizabeth R.; Aronson, Paul L.; Chaudhari, Pradip P.; Cohen, Eyal; Freedman, Stephen B.; Morse, Rustin B.; Peltz, Alon; Samuels-Kalow, Margaret; Shah, Samir S.; Simon, Harold K.; Neuman, Mark I.			Trends in Use of Advanced Imaging in Pediatric Emergency Departments, 2009-2018	JAMA PEDIATRICS			English	Article							COMPUTED-TOMOGRAPHY UTILIZATION; UNITED-STATES; HEAD-INJURY; APPENDICITIS; DIAGNOSIS; CHILDREN; CT; RISK; ULTRASOUND; RADIATION	This cross-sectional study of pediatric emergency department visits evaluates changes over time and hospital variation in advanced imaging use. Question How has the use of advanced imaging changed during the past 10 years across pediatric emergency departments in the US? Findings This cross-sectional study of 26 million pediatric emergency department visits revealed that, overall, the rate of advanced imaging increased from 6.4% of encounters in 2009 to 8.7% in 2018; specifically, the rate of computed tomography decreased from 3.9% to 2.9%, the rate of ultrasonography increased from 2.5% to 5.8%, and the rate of magnetic resonance imaging increased from 0.3% to 0.6%. Meaning Overall use of advanced imaging has increased during the past decade, driven by the use of nonradiating modalities replacing the use of computed tomography. Importance There is increased awareness of radiation risks from computed tomography (CT) in pediatric patients. In emergency departments (EDs), evidence-based guidelines, improvements in imaging technology, and availability of nonradiating modalities have potentially reduced CT use. Objective To evaluate changes over time and hospital variation in advanced imaging use. Design, Setting, and Participants This cross-sectional study assessed 26x202f;082x202f;062 ED visits by children younger than 18 years from the Pediatric Health Information System administrative database from January 1, 2009, through December 31, 2018. Exposures Imaging. Main Outcomes and Measures The primary outcome was the change in CT, ultrasonography, and magnetic resonance imaging (MRI) rates from January 1, 2009, to December 31, 2018. Imaging for specific diagnoses was examined using all patient-refined diagnosis related groups. Secondary outcomes were hospital admission and 3-day ED revisit rates and ED length of stay. Results There were a total of 26x202f;082x202f;062 visits by 9 868 406 children (mean [SD] age, 5.59 [5.15] years; 13x202f;842x202f;567 [53.1%] male; 9x202f;273x202f;181 [35.6%] non-Hispanic white) to 32 US pediatric EDs during the 10-year study period, with 1 or more advanced imaging studies used in 1x202f;919x202f;283 encounters (7.4%). The proportion of ED encounters with any advanced imaging increased from 6.4% (95% CI, 6.2%-6.2%) in 2009 to 8.7% (95% CI, 8.7%-8.8%) in 2018. The proportion of ED encounters with CT decreased from 3.9% (95% CI, 3.9%-3.9%) to 2.9% (95% CI, 2.9%-3.0%) (P < .001 for trend), with ultrasonography increased from 2.5% (95% CI, 2.5%-2.6%) to 5.8% (95% CI, 5.8%-5.9%) (P < .001 for trend), and with MRI increased from 0.3% (95% CI, 0.3%-0.4%) to 0.6% (95% CI, 0.6%-0.6%) (P < .001 for trend). The largest decreases in CT rates were for concussion (-23.0%), appendectomy (-14.9%), ventricular shunt procedures (-13.3%), and headaches (-12.4%). Factors associated with increased use of nonradiating imaging modalities included ultrasonography for abdominal pain (20.3%) and appendectomy (42.5%) and MRI for ventricular shunt procedures (17.9%) (P < .001 for trend). Across the study period, EDs varied widely in the use of ultrasonography for appendectomy (median, 57.5%; interquartile range [IQR], 40.4%-69.8%) and MRI (median, 15.8%; IQR, 8.3%-35.1%) and CT (median, 69.5%; IQR, 54.5%-76.4%) for ventricular shunt procedures. Overall, ED length of stay did not change, and hospitalization and 3-day ED revisit rates decreased during the study period. Conclusions and Relevance This study found that use of advanced imaging increased from 2009 to 2018. Although CT use decreased, this decrease was accompanied by a greater increase in the use of ultrasonography and MRI. There appears to be substantial variation in practice and a need to standardize imaging practices.	[Marin, Jennifer R.] UPMC Childrens Hosp Pittsburgh, Div Pediat Emergency Med, 4401 Penn Ave,Adm Off Bldg,Ste 2400, Pittsburgh, PA 15224 USA; [Rodean, Jonathan; Hall, Matt] Childrens Hosp Assoc, Lenexa, KS USA; [Alpern, Elizabeth R.] Northwestern Univ, Dept Pediat, Div Emergency Med, Ann & Robert H Lurie Childrens Hosp Chicago,Feinb, Chicago, IL 60611 USA; [Aronson, Paul L.] Yale Sch Med, Dept Pediat, New Haven, CT USA; [Aronson, Paul L.] Yale Sch Med, Dept Emergency Med, New Haven, CT USA; [Chaudhari, Pradip P.] Univ Southern Calif, Div Emergency & Transport Med, Childrens Hosp Los Angeles, Keck Sch Med, Los Angeles, CA 90007 USA; [Cohen, Eyal] Univ Toronto, Dept Pediat, Hosp Sick Children, Toronto, ON, Canada; [Freedman, Stephen B.] Univ Calgary, Alberta Childrens Hosp, Res Inst, Calgary, AB, Canada; [Freedman, Stephen B.] Univ Calgary, Alberta Childrens Hosp, Dept Pediat, Sect Pediat Emergency Med, Calgary, AB, Canada; [Freedman, Stephen B.] Univ Calgary, Alberta Childrens Hosp, Dept Pediat, Gastroenterol Sect, Calgary, AB, Canada; [Morse, Rustin B.] Nationwide Childrens Hosp, Dept Pediat, Columbus, OH USA; [Peltz, Alon] Harvard Med Sch, Dept Populat Med, Harvard Pilgrim Hlth Care Inst, Boston, MA 02115 USA; [Samuels-Kalow, Margaret] Massachusetts Gen Hosp, Dept Emergency Med, Boston, MA 02114 USA; [Shah, Samir S.] Cincinnati Childrens Hosp Med Ctr, Dept Pediat, Div Hosp Med, Cincinnati, OH 45229 USA; [Shah, Samir S.] Cincinnati Childrens Hosp Med Ctr, Dept Pediat, Div Infect Dis, Cincinnati, OH 45229 USA; [Simon, Harold K.] Emory Univ, Sch Med, Dept Pediat, Childrens Healthcare Atlanta, Atlanta, GA USA; [Simon, Harold K.] Emory Univ, Sch Med, Dept Emergency Med, Childrens Healthcare Atlanta, Atlanta, GA USA; [Neuman, Mark I.] Harvard Med Sch, Div Emergency Med, Boston Childrens Hosp, Boston, MA 02115 USA		Marin, JR (corresponding author), UPMC Childrens Hosp Pittsburgh, Div Pediat Emergency Med, 4401 Penn Ave,Adm Off Bldg,Ste 2400, Pittsburgh, PA 15224 USA.	jennifer.marin@chp.edu	Hall, Matt/AAT-1349-2021	Hall, Matt/0000-0001-7778-5887; Chaudhari, Pradip/0000-0002-7732-632X; Marin, Jennifer/0000-0003-3090-664X; Alpern, Elizabeth/0000-0001-7887-3563	Agency for Healthcare Research and QualityUnited States Department of Health & Human ServicesAgency for Healthcare Research & Quality	Dr Aronson reported receiving grant support from the Agency for Healthcare Research and Quality during the conduct of the study. Dr Freedman reported receiving grant support from the Alberta Children's Hospital Foundation Professorship in Child Health andWellness. Dr Samuels-Kalow reported receiving a career development grant from the Harvard Catalyst-Harvard Clinical and Translational Science Center (National Center for Advancing Translational Sciences, National Institutes of Health) and financial contributions from Harvard University and its affiliated academic health care centers. No other disclosures were reported.	ALVARADO A, 1986, ANN EMERG MED, V15, P557, DOI 10.1016/S0196-0644(86)80993-3; [Anonymous], 2001, US TODAY CT SCANS CH; Ash AS, 1994, RISK ADJUSTMENT MEAS, P1; Aspelund G, 2014, PEDIATRICS, V133, P586, DOI 10.1542/peds.2013-2128; Averill R, 2003, ALL PATIENT REFINED; Bachur RG, 2012, J PEDIATR-US, V160, P1034, DOI 10.1016/j.jpeds.2011.11.037; Boutis K, 2013, PEDIATRICS, V132, P305, DOI 10.1542/peds.2013-0378; Boyle TP, 2014, PEDIATRICS, V134, pE47, DOI 10.1542/peds.2013-3739; Broder JS, 2016, EMERG RADIOL, V23, P221, DOI 10.1007/s10140-016-1382-5; Cassel CK, 2012, JAMA-J AM MED ASSOC, V307, P1801, DOI 10.1001/jama.2012.476; Choosing Wisely, IN AB FDN; Dayan PS, 2017, PEDIATRICS, V139, DOI 10.1542/peds.2016-2709; DeFlorio RM, 2014, SEMIN ULTRASOUND CT, V35, P365, DOI 10.1053/j.sult.2014.05.002; Dolan TG, 2011, CT ER; Dunning J, 2006, ARCH DIS CHILD, V91, P885, DOI 10.1136/adc.2005.083980; Ellison JS, 2019, J PEDIATR UROL, V15, DOI 10.1016/j.jpurol.2019.06.014; Expert Panel on Pediatric Imaging:, 2019, J Am Coll Radiol, V16, pS252, DOI 10.1016/j.jacr.2019.02.022; Feinstein JA, 2018, JAMA PEDIATR, V172, P596, DOI 10.1001/jamapediatrics.2018.0256; Flom L, 2016, PEDIATR RADIOL, V46, P519, DOI 10.1007/s00247-015-3500-z; Goske MJ, 2008, PEDIATR RADIOL, V38, P265, DOI 10.1007/s00247-007-0743-3; Holmes JF, 2013, ANN EMERG MED, V62, P107, DOI 10.1016/j.annemergmed.2012.11.009; Hong JY, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2019.10584; Imler D, 2017, ACAD EMERG MED, V24, P569, DOI 10.1111/acem.13180; Iskandar BJ, 2004, J NEUROSURG, V101, P147, DOI 10.3171/ped.2004.101.2.0147; Kharbanda AB, 2018, PEDIATRICS, V141, DOI 10.1542/peds.2017-2699; Kharbanda AB, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2015-1745; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Larson DB, 2011, RADIOLOGY, V259, P793, DOI 10.1148/radiol.11101939; Lindberg DM, 2019, PEDIATRICS, V144, DOI 10.1542/peds.2019-0419; Lodwick DL, 2015, PEDIATRICS, V136, pE1212, DOI 10.1542/peds.2015-1671; Lu TT, 2015, J CIRCUIT SYST COMP, V24, DOI 10.1142/S0218126615500188; Lumba-Brown A, 2018, JAMA PEDIATR, V172, DOI 10.1001/jamapediatrics.2018.2847; Lyons TW, 2017, ACAD EMERG MED, V24, P1349, DOI 10.1111/acem.13304; Mannix R, 2012, J PEDIATR-US, V160, P136, DOI 10.1016/j.jpeds.2011.06.024; Marchione M, 2010, CT SCANS POSE RISKS; Marin JR, 2012, J ULTRAS MED, V31, P1357; Mathews JD, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2360; Menoch MJA, 2012, PEDIATRICS, V129, pE690, DOI 10.1542/peds.2011-2548; Miller JH, 2010, AM J NEURORADIOL, V31, P430, DOI 10.3174/ajnr.A1866; Missios S, 2008, J NEUROS-PEDIATR, V2, P438, DOI 10.3171/PED.2008.2.12.438; Mittal MK, 2013, ACAD EMERG MED, V20, P697, DOI 10.1111/acem.12161; Osmond MH, 2010, CAN MED ASSOC J, V182, P341, DOI 10.1503/cmaj.091421; Otero HJ, 2019, J AM COLL RADIOL, V16, P1636, DOI 10.1016/j.jacr.2019.04.011; Otero HJ, 2017, J AM COLL RADIOL, V14, P603, DOI 10.1016/j.jacr.2016.12.013; Pearce MS, 2012, LANCET, V380, P499, DOI 10.1016/S0140-6736(12)60815-0; Polites SE, 2014, SURGERY, V156, P448, DOI 10.1016/j.surg.2014.04.001; Ramgopal S, 2020, BMC PEDIATR, V20, DOI 10.1186/s12887-020-1919-3; Redberg RF., 2014, NEW YORK TIMES; Riccabona M, 2009, PEDIATR RADIOL, V39, P891, DOI 10.1007/s00247-009-1233-6; Russell WS, 2013, PEDIATR EMERG CARE, V29, P568, DOI 10.1097/PEC.0b013e31828e5718; Samuel M, 2002, J PEDIATR SURG, V37, P877, DOI 10.1053/jpsu.2002.32893; Samuels-Kalow M, 2019, ACAD PEDIATR, V19, P942, DOI 10.1016/j.acap.2019.03.004; Shah SR, 2016, ANN SURG, V264, P474, DOI 10.1097/SLA.0000000000001867; Smith-Bindman R, 2019, JAMA-J AM MED ASSOC, V322, P843, DOI 10.1001/jama.2019.11456; Swenson DW, 2018, AM J ROENTGENOL, V211, P901, DOI 10.2214/AJR.18.19778; Trost MJ, 2018, PEDIATR NEUROSURG, V53, P116, DOI 10.1159/000485923; Yue EL, 2015, J NEUROSURG-PEDIATR, V15, P420, DOI 10.3171/2014.9.PEDS14207	57	7	7	1	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	2168-6203	2168-6211		JAMA PEDIATR	JAMA Pediatr.	SEP	2020	174	9							e202209	10.1001/jamapediatrics.2020.2209			10	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics	NR9FJ	WOS:000571868200017	32761186	Green Published			2022-02-06	
J	Posti, JP; Sipila, JOT; Luoto, TM; Rautava, P; Kyto, V				Posti, Jussi P.; Sipila, Jussi O. T.; Luoto, Teemu M.; Rautava, Paivi; Kyto, Ville			A decade of geriatric traumatic brain injuries in Finland: population-based trends	AGE AND AGEING			English	Article						geriatric; traumatic; brain; injury; incidence; older people	CHRONIC SUBDURAL-HEMATOMA; OLDER-ADULTS; HEAD-INJURY; MORTALITY; EPIDEMIOLOGY; MANAGEMENT	Background: we investigated trends of traumatic brain injury (TBI)-related hospitalisations, deaths, acute neurosurgical operations (ANO), and lengths of hospital stay (LOS) in patients aged >= 70 years in Finland using a population-based cohort. Methods: nationwide databases were searched for all admissions with a TBI diagnosis as well as later deaths for persons >= 70 years of age during 2004-2014. Results: the study period included 20,259 TBI-related hospitalisations (mean age = 80.7 years, men = 48.9%). The incidence of TBI-related hospitalisations was 283/100,000 person-years with an estimated overall annual increase of 2.9% (95% CI: 0.4-5.9%). There was an annual decrease of 2.2% in in-hospital mortality (IHM) in men (95% CI: 0.1-4.3%), with no change in women or overall. There was an annual decrease of 1.1% in odds for ANOs among hospitalised overall (95% CI: 0.1-2.1%) and of 1.4% in men (95% CI: 0.0-2.7%), while no change was observed in women. LOS decreased annually by 2.5% (95% CI: 2.1-2.9%). The incidence of TBI-related deaths was 70/100,000 person-years with an estimated annual increase of 1.6% in women (95% CI: 0.2-2.9%), but no change in men or overall. Mean ages of TBI-related admissions and deaths increased (P<0.001). Interpretation: the incidence rate of geriatric TBI-related hospitalisations increased, especially in women, but LOS and the rate of ANOs among hospitalised decreased. The overall TBI-related mortality remained stable, and IHM decreased in men, while in women, the overall mortality increased and IHM remained stable. However, the overall incidence rates of TBI-related hospitalisations and deaths and the number of cases of IHM were still higher in men.	[Posti, Jussi P.] Turku Univ Hosp, Dept Neurosurg, Div Clin Neurosci, Turku, Finland; [Posti, Jussi P.] Turku Univ Hosp, Turku Brain Injury Ctr, Turku, Finland; [Posti, Jussi P.; Sipila, Jussi O. T.] Univ Turku, Dept Clin Neurosci, Turku, Finland; [Sipila, Jussi O. T.] Turku Univ Hosp, Dept Neurol, Div Clin Neurosci, Turku, Finland; [Sipila, Jussi O. T.] North Karelia Cent Hosp, Dept Neurol, Siun Sote, Joensuu, Finland; [Luoto, Teemu M.] Tampere Univ, Tampere Univ Hosp, Dept Neurosurg, Tampere, Finland; [Rautava, Paivi] Turku Univ Hosp, Clin Res Ctr, Turku, Finland; [Rautava, Paivi] Univ Turku, Dept Publ Hlth, Turku, Finland; [Kyto, Ville] Univ Turku, Res Ctr Appl & Prevent Cardiovasc Med, Turku, Finland; [Kyto, Ville] Univ Turku, Turku Univ Hosp, Heart Ctr, Turku, Finland; [Kyto, Ville] Univ Turku, Turku Univ Hosp, Ctr Populat Hlth Res, Turku, Finland; [Kyto, Ville] Hosp Dist Southwest Finland, Administat Ctr, Turku, Finland		Kyto, V (corresponding author), Turku Univ Hosp, Heart Ctr, POB 52, FI-20521 Turku, Finland.	ville.kyto@utu.fi	Kyto, Ville/D-7971-2014; Luoto, Teemu/W-6468-2018; Posti, Jussi P./Y-2908-2019	Kyto, Ville/0000-0002-4521-1093; Luoto, Teemu/0000-0002-7329-3284; Posti, Jussi P./0000-0002-5925-5193	Academy of FinlandAcademy of FinlandEuropean Commission [17379]; Government's Special Financial Transfer tied to academic research in health sciences (Finland); Finnish Brain Foundation; Emil Aaltonen Foundation; Maire Taposen Foundation; Finnish Brain Foundation sr; Emil Aaltonen Foundation sr; Science Fund of the City of Tampere; Finnish Medical Society Duodecim; Academy of FinlandAcademy of FinlandEuropean Commission; Finnish Cultural FoundationFinnish Cultural FoundationFinnish IT center for science	J.P.P. has received funding from the Academy of Finland (#17379) and Government's Special Financial Transfer tied to academic research in health sciences (Finland). J.P.P. has also received a grant from the Finnish Brain Foundation, a grant from Emil Aaltonen Foundation and a grant from Maire Taposen Foundation. T.M.L. has received funding from Government's Special Financial Transfer tied to academic research in health sciences (Finland). Additionally, T.M.L. has received research grants from the Finnish Brain Foundation sr, the Emil Aaltonen Foundation sr, the Maire Taposen Foundation, the Science Fund of the City of Tampere and The Finnish Medical Society Duodecim. V.K. received funding from the Academy of Finland and Government's Special Financial Transfer tied to academic research in health sciences (Finland). V.K. has also received a grant from the Finnish Cultural Foundation.	Adhiyaman V, 2002, POSTGRAD MED J, V78, P71, DOI 10.1136/pmj.78.916.71; Asghar M, 2002, J ROY SOC MED, V95, P290, DOI 10.1258/jrsm.95.6.290; Bouras T, 2007, J NEUROTRAUM, V24, P1355, DOI 10.1089/neu.2005.370; Brazinova A, 2010, J NEUROTRAUM, V27, P1549, DOI 10.1089/neu.2010.1315; Dams-O'Connor K, 2013, J NEUROTRAUM, V30, P2001, DOI 10.1089/neu.2013.3047; Faul M, 2010, INJURY PREV, V16, pA268, DOI 10.1136/ip.2010.029215.951; Fu TS, 2015, J TRAUMA ACUTE CARE, V79, P449, DOI 10.1097/TA.0000000000000733; Gardner RC, 2018, J NEUROTRAUM, V35, P889, DOI 10.1089/neu.2017.5371; Hamill V, 2015, J NEUROTRAUM, V32, P689, DOI 10.1089/neu.2014.3670; Haring RS, 2015, J SURG RES, V195, P1, DOI 10.1016/j.jss.2015.01.017; Haydel MJ, 2000, NEW ENGL J MED, V343, P100, DOI 10.1056/NEJM200007133430204; Kolias AG, 2014, NAT REV NEUROL, V10, P570, DOI 10.1038/nrneurol.2014.163; Korhonen N, 2013, JAMA-J AM MED ASSOC, V309, P1891, DOI 10.1001/jama.2013.3356; Koskinen S, 2008, BRAIN INJURY, V22, P205, DOI 10.1080/02699050801938975; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Majdan M, 2016, LANCET PUBLIC HEALTH, V1, pE76, DOI 10.1016/S2468-2667(16)30017-2; McIntyre A, 2013, BRAIN INJURY, V27, P31, DOI 10.3109/02699052.2012.700086; Miranda LB, 2011, J NEUROSURG, V114, P72, DOI 10.3171/2010.8.JNS10298; Mitra B, 2008, ANZ J SURG, V78, P588, DOI 10.1111/j.1445-2197.2008.04579.x; Peeters W, 2015, ACTA NEUROCHIR, V157, P1683, DOI 10.1007/s00701-015-2512-7; Perez K, 2012, ACCIDENT ANAL PREV, V46, P37, DOI 10.1016/j.aap.2011.12.004; Petridis AK, 2009, CENT EUR NEUROSURG, V70, P73, DOI 10.1055/s-0029-1224096; Posti JP, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-41913-8; Ramanathan DM, 2012, J NEUROTRAUM, V29, P1371, DOI 10.1089/neu.2011.2197; Santarius Thomas, 2010, Clin Neurosurg, V57, P112; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X; Styrke J, 2007, J NEUROTRAUM, V24, P1425, DOI 10.1089/neu.2007.0266; Utomo WK, 2009, INJURY, V40, P973, DOI 10.1016/j.injury.2009.05.034	28	7	7	1	1	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0002-0729	1468-2834		AGE AGEING	Age Ageing	SEP	2020	49	5					779	785		10.1093/ageing/afaa037			7	Geriatrics & Gerontology	Science Citation Index Expanded (SCI-EXPANDED)	Geriatrics & Gerontology	OF1IX	WOS:000580971800019	32134443	Bronze			2022-02-06	
J	Raikes, AC; Dailey, NS; Shane, BR; Forbeck, B; Alkozei, A; Killgore, WDS				Raikes, Adam C.; Dailey, Natalie S.; Shane, Bradley R.; Forbeck, Brittany; Alkozei, Anna; Killgore, William D. S.			Daily Morning Blue Light Therapy Improves Daytime Sleepiness, Sleep Quality, and Quality of Life Following a Mild Traumatic Brain Injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						actigraphy; brain concussion; fatigue; phototherapy; postconcussion syndrome; sleep	CONCUSSION SYMPTOMS; GANGLION-CELLS; INSOMNIA; METAANALYSIS; DEPRIVATION; VALIDITY; EXPOSURE; IDENTIFICATION; DISTURBANCES; ARCHITECTURE	Objective: Identify the treatment effects of 6 weeks of daily 30-minute sessions of morning blue light therapy compared with placebo amber light therapy in the treatment of sleep disruption following mild traumatic brain injury. Design: Placebo-controlled randomized trial. Participants: Adults aged 18 to 45 years with a mild traumatic brain injury within the past 18 months (n= 35). Main Outcome Measures: Epworth Sleepiness Scale, Pittsburgh Sleep Quality Index, Beck Depression Inventory II, Rivermead Post-concussion Symptom Questionnaire, Functional Outcomes of Sleep Questionnaire, and actigraphy-derived sleep measures. Results: Following treatment, moderate to large improvements were observed with individuals in the blue light therapy group reporting lower Epworth Sleepiness Scale (Hedges'g= 0.882), Beck Depression Inventory II (g= 0.684), Rivermead Post-concussion Symptom Questionnaire chronic (g= 0.611), and somatic (g= 0.597) symptoms, and experiencing lower normalized wake after sleep onset (g= 0.667) than those in the amber light therapy group. In addition, individuals in the blue light therapy group experienced greater total sleep time (g= 0.529) and reported improved Functional Outcomes of Sleep Questionnaire scores (g= 0.929) than those in the amber light therapy group. Conclusion: Daytime sleepiness, fatigue, and sleep disruption are common following a mild traumatic brain injury. These findings further substantiate blue light therapy as a promising nonpharmacological approach to improve these sleep-related complaints with the added benefit of improved postconcussion symptoms and depression severity.	[Raikes, Adam C.] Univ Arizona, Ctr Innovat Brain Sci, Tucson, AZ 85724 USA; [Dailey, Natalie S.; Shane, Bradley R.; Forbeck, Brittany; Killgore, William D. S.] Univ Arizona, Social Cognit & Affect Neurosci Scan Lab, Dept Psychiat, Coll Med, 1501 N Campbell Ave,Rm 7303B,POB 245005, Tucson, AZ 85724 USA; [Alkozei, Anna] Univ Arizona, Dept Psychiat, Coll Med, Tucson, AZ 85724 USA		Killgore, WDS (corresponding author), Univ Arizona, Social Cognit & Affect Neurosci Scan Lab, Dept Psychiat, Coll Med, 1501 N Campbell Ave,Rm 7303B,POB 245005, Tucson, AZ 85724 USA.	killgore@psychiatry.arizona.edu	Raikes, Adam/M-2600-2019	Raikes, Adam/0000-0002-1609-6727; Dailey, Natalie S./0000-0003-4800-4118	US Army Medical Research and Materiel Command (USAMRMC)U.S. Army Medical Research & Materiel Command (USAMRMC) [W81XWH-14-1-0571]	This study was funded by an award to Dr Killgore from the US Army Medical Research and Materiel Command (USAMRMC; award number: W81XWH-14-1-0571).	Alkozei A, 2016, SLEEP, V39, P1671, DOI 10.5665/sleep.6090; Alkozei A, 2016, NEUROSCI LETT, V616, P5, DOI 10.1016/j.neulet.2016.01.034; Alsalaheen B, 2017, J ATHL TRAINING, V52, P834, DOI 10.4085/1062-6050-52.7.05; Arbour C, 2015, SLEEP MED, V16, P534, DOI 10.1016/j.sleep.2014.12.002; Bajaj S, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00616; Bei B, 2016, SLEEP MED REV, V28, P108, DOI 10.1016/j.smrv.2015.06.003; Berson DM, 2002, SCIENCE, V295, P1070, DOI 10.1126/science.1067262; Bloomfield ILM, 2010, J INT NEUROPSYCH SOC, V16, P17, DOI 10.1017/S1355617709990798; Brown G.K., 1996, BDI 2 BECK DEPRESSIO; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Chellappa SL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016429; Cnossen MC, 2017, J NEUROTRAUM, V34, P2396, DOI 10.1089/neu.2016.4819; COLE RJ, 1992, SLEEP, V15, P461, DOI 10.1093/sleep/15.5.461; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P318, DOI 10.1097/01.HTR.0000300227.67748.77; Dacey DM, 2005, NATURE, V433, P749, DOI 10.1038/nature03387; Defense and Veterans Brain Injury Center, 2018, DOD WORLDW TBI NUMB; Dewan K, 2011, SLEEP, V34, P593, DOI 10.1093/sleep/34.5.593; Eyres S, 2005, CLIN REHABIL, V19, P878, DOI 10.1191/0269215505cr905oa; Farrell-Carnahan L, 2015, BRAIN INJURY, V29, P1400, DOI 10.3109/02699052.2015.1063161; Faul M, 2010, TRAUMATIC BRAIN INJU; Fichtenberg NL, 2001, AM J PHYS MED REHAB, V80, P339, DOI 10.1097/00002060-200105000-00003; Fultz NE, 2019, SCIENCE, V366, P628, DOI 10.1126/science.aax5440; Galea OA, 2018, NEUROREHAB NEURAL RE, V32, P115, DOI 10.1177/1545968318760728; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Hattar S, 2002, SCIENCE, V295, P1065, DOI 10.1126/science.1069609; Heaton KJ, 2014, AVIAT SPACE ENVIR MD, V85, P497, DOI 10.3357/ASEM.3882.2014; Heritier SR, 2003, MED J AUSTRALIA, V179, P438, DOI 10.5694/j.1326-5377.2003.tb05627.x; Ho J, 2019, NAT METHODS, V16, P565, DOI 10.1038/s41592-019-0470-3; Hoffman NL, 2019, SLEEP, V42, DOI 10.1093/sleep/zsy222; Johns M, 1997, SLEEP, V20, P844, DOI 10.1093/sleep/20.10.844; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Kaplan KA, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2019.11944; Kaufman Y, 2001, PEDIATR NEUROL, V24, P129, DOI 10.1016/S0887-8994(00)00254-X; Kerr ZY, 2016, AM J SPORT MED, V44, P220, DOI 10.1177/0363546515612082; Kerr ZY, 2014, BRAIN INJURY, V28, P1009, DOI 10.3109/02699052.2014.904049; Killgore WDS, 2020, NEUROBIOL DIS, V134, DOI 10.1016/j.nbd.2019.104679; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lasa L, 2000, J AFFECT DISORDERS, V57, P261, DOI 10.1016/S0165-0327(99)00088-9; Lequerica A, 2015, ARCH PHYS MED REHAB, V96, P1802, DOI 10.1016/j.apmr.2015.05.011; Ma J, 2009, J INT MED RES, V37, P1311, DOI 10.1177/147323000903700506; Management of Concussion-mTBI Working Group, 2016, VA DOD CLIN PRACT GU; Manley G, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097791; Mantua J, 2018, SLEEP MED REV, V41, P61, DOI 10.1016/j.smrv.2018.01.004; Mantua J, 2017, SLEEP, V40, DOI 10.1093/sleep/zsx062; Mathias JL, 2012, SLEEP MED, V13, P898, DOI 10.1016/j.sleep.2012.04.006; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Menn SJ, 2014, J CLIN SLEEP MED, V10, P1181, DOI 10.5664/jcsm.4196; MESA: Multi-Ethnic Study of Atherosclerosis, 2016, MESA ACT SCOR PROC G; Ohayon MM, 2004, SLEEP, V27, P1255, DOI 10.1093/sleep/27.7.1255; Ouellet MC, 2006, J HEAD TRAUMA REHAB, V21, P199, DOI 10.1097/00001199-200605000-00001; Patrick Y, 2017, SLEEP BIOL RHYTHMS, V15, P217, DOI 10.1007/s41105-017-0099-5; Phipps-Nelson J, 2003, SLEEP, V26, P695, DOI 10.1093/sleep/26.6.695; Raikes AC, 2019, SLEEP MED, V58, P66, DOI 10.1016/j.sleep.2019.03.008; Raikes AC, 2019, SLEEP MED, V54, P62, DOI 10.1016/j.sleep.2018.09.018; Raikes Adam C, 2018, Concussion, V3, pCNC57, DOI 10.2217/cnc-2018-0006; Raikes AC, 2016, SLEEP, V39, P2141, DOI 10.5665/sleep.6314; Ruff RL, 2012, J REHABIL RES DEV, V49, P1305, DOI 10.1682/JRRD.2011.12.0251; Sinclair KL, 2014, NEUROREHAB NEURAL RE, V28, P303, DOI 10.1177/1545968313508472; Sufrinko AM, 2018, J HEAD TRAUMA REHAB, V33, pE64, DOI 10.1097/HTR.0000000000000387; Sullivan KA, 2018, J NEUROTRAUM, V35, P195, DOI 10.1089/neu.2016.4958; Sullivan KA, 2016, APPL NEUROPSYCH-ADUL, V23, P426, DOI 10.1080/23279095.2016.1172229; Tham SW, 2015, J NEUROTRAUM, V32, P847, DOI 10.1089/neu.2014.3559; Theadom A, 2015, SLEEP MED, V16, P926, DOI 10.1016/j.sleep.2015.04.013; Towns SJ, 2015, BRAIN INJURY, V29, P1337, DOI 10.3109/02699052.2015.1045030; van Maanen A, 2016, SLEEP MED REV, V29, P52, DOI 10.1016/j.smrv.2015.08.009; von Rosen P, 2017, SCAND J MED SCI SPOR, V27, P1364, DOI 10.1111/sms.12735; Watson NF, 2015, SLEEP, V38, P843, DOI 10.5665/sleep.4716; Weaver TE, 1997, SLEEP, V20, P835; Williams BR, 2008, CLIN NEUROPHYSIOL, V119, P429, DOI 10.1016/j.clinph.2007.11.003; Williams RM, 2015, SPORTS MED, V45, P893, DOI 10.1007/s40279-015-0325-8; Wiseman-Hakes C, 2019, ASN NEURO, V11, DOI 10.1177/1759091418822405; Xie LL, 2013, SCIENCE, V342, P373, DOI 10.1126/science.1241224	73	7	7	2	6	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	SEP-OCT	2020	35	5			SI		E405	E421		10.1097/HTR.0000000000000579			17	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	NP5SO	WOS:000570236100011	32472836				2022-02-06	
J	Sun, GC; Miao, Z; Ye, YF; Zhao, PZ; Fan, L; Bao, ZY; Tu, YM; Li, C; Chao, HL; Xu, XP; Ji, J				Sun, Guangchi; Miao, Zong; Ye, Yangfan; Zhao, Pengzhan; Fan, Liang; Bao, Zhongyuan; Tu, Yiming; Li, Chong; Chao, Honglu; Xu, Xiupeng; Ji, Jing			Curcumin alleviates neuroinflammation, enhances hippocampal neurogenesis, and improves spatial memory after traumatic brain injury	BRAIN RESEARCH BULLETIN			English	Article						Traumatic brain injury; Curcumin; Inflammation; Neurogenesis	MITOCHONDRIAL DYSFUNCTION; ADULT NEUROGENESIS; COGNITIVE DEFICITS; MODEL; PROLIFERATION; DEGENERATION; PRETREATMENT; INFLAMMATION; RECOVERY; STRESS	Cognitive decline is one of the most obvious symptoms of traumatic brain injury (TBI). Previous studies have demonstrated that cognitive decline is related to substantially increased neuroinflammation and decreased neurogenesis in the hippocampus in a rat model of TBI. Using this model, we explored the role of curcumin (Cur) in ameliorating TBI-impaired spatial memory because Cur has been shown to exhibit anti-chronic-neuroinflammatory, neurogenesis-promoting, and memory-improving properties. Animals received daily Cur or vehicle treatment for 28 days after TBI and also received 50-bromodeoxyuridine(BrdU) for the first 7 days of the treatment for assaying neurogenesis. An optimal Cur dose of 30 mg/kg, selected from a range of 10-50 mg/kg, was used for the present study. Neuroinflammation was evaluated by astrocyte hypertrophy, activated microglia, and inflammatory factors in the hippocampus. Behavioral water-maze studies were conducted for 5 days, starting at 35-day post-TBI. The tropomyosin receptor kinase B (Trkb) inhibitor, ANA-12, was used to test the role of the brain-derived neurotrophic factor (BDNF)/TrkB/Phosphoinositide 3-kinase (PI3K)/Akt signaling pathway in regulating inflammation and neurogenesis in the hippocampus. Treatment with Cur ameliorated the spatial memory of TBI rats, reduced TBI-induced chronic inflammation, typified by diminished astrocyte hypertrophy, reduction in activated microglia, declined inflammatory factors, and increased neurogenesis in the hippocampus. We also found that BDNF/Trkb/PI3K/Akt signaling was involved in the effects of Cur in TBI rats. Thus, Cur treatment can ameliorate the spatial memory in a murine model of TBI, which may be attributable to decreased chronic neuroinflammation, increased hippocampal neurogenesis, and/or BDNF/Trkb/PI3K/Akt signaling.	[Sun, Guangchi; Miao, Zong; Ye, Yangfan; Zhao, Pengzhan; Bao, Zhongyuan; Tu, Yiming; Li, Chong; Chao, Honglu; Xu, Xiupeng; Ji, Jing] Nanjing Med Univ, Dept Neurosurg, Affiliated Hosp 1, 300 Guangzhou Rd, Nanjing 210029, Jiangsu, Peoples R China; [Fan, Liang] Nanchang Univ, Dept Trauma Ctr, Affiliated Hosp 3, 128 Xiangshan North Rd, Nanchang 330008, Jiangxi, Peoples R China		Ji, J (corresponding author), Nanjing Med Univ, Dept Neurosurg, Affiliated Hosp 1, 300 Guangzhou Rd, Nanjing 210029, Jiangsu, Peoples R China.	15720803050@163.com; 301218@163.com; jijing@njmu.edu.cn			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81972153]; Priority Academic Program Development of Jiangsu Higher Education Institution [PAPD]	This study was supported by grants from National Natural Science Foundation of China [81972153] and the Priority Academic Program Development of Jiangsu Higher Education Institution [PAPD].	Bassani TB, 2017, BEHAV BRAIN RES, V335, P41, DOI 10.1016/j.bbr.2017.08.014; Blaiss CA, 2011, J NEUROSCI, V31, P4906, DOI 10.1523/JNEUROSCI.5265-10.2011; Bye N, 2011, J NEUROSCI RES, V89, P986, DOI 10.1002/jnr.22635; Carlson SW, 2017, EXP NEUROL, V289, P55, DOI 10.1016/j.expneurol.2016.12.006; Chen GL, 2018, CELL MOL NEUROBIOL, V38, P1465, DOI 10.1007/s10571-018-0616-3; Chiu CH, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19020341; Crane PK, 2016, JAMA NEUROL, V73, P1062, DOI 10.1001/jamaneurol.2016.1948; Dai W, 2018, BRAIN RES BULL, V140, P65, DOI 10.1016/j.brainresbull.2018.03.020; Dong SZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031211; Drew MR, 2017, NEUROTHERAPEUTICS, V14, P646, DOI 10.1007/s13311-017-0528-9; Erturk A, 2016, J NEUROSCI, V36, P9962, DOI 10.1523/JNEUROSCI.1898-15.2016; Fotuhi M, 2012, NAT REV NEUROL, V8, P189, DOI 10.1038/nrneurol.2012.27; Franca TFA, 2017, HIPPOCAMPUS, V27, P937, DOI 10.1002/hipo.22746; Haider S, 2015, BRAIN RES BULL, V115, P1, DOI 10.1016/j.brainresbull.2015.04.001; Hattiangady B, 2008, EXP NEUROL, V212, P468, DOI 10.1016/j.expneurol.2008.04.040; Kaur H, 2015, NEUROCHEM INT, V89, P40, DOI 10.1016/j.neuint.2015.07.009; Khorsandi K, 2019, J CELL BIOCHEM, V120, P4998, DOI 10.1002/jcb.27775; Kim SJ, 2008, J BIOL CHEM, V283, P14497, DOI 10.1074/jbc.M708373200; Ko HR, 2018, STEM CELL RES THER, V9, DOI 10.1186/s13287-018-1052-5; Kodali M, 2018, BRAIN BEHAV IMMUN, V69, P499, DOI 10.1016/j.bbi.2018.01.009; Kodali M, 2015, SCI REP-UK, V5, DOI 10.1038/srep08075; Kulkarni SK, 2008, PSYCHOPHARMACOLOGY, V201, P435, DOI 10.1007/s00213-008-1300-y; Li QZ, 2019, J MOL NEUROSCI, V67, P574, DOI 10.1007/s12031-019-01263-6; Li X, 2016, BRAIN RES BULL, V120, P34, DOI 10.1016/j.brainresbull.2015.11.006; Liang JD, 2019, EXP THER MED, V17, P1688, DOI 10.3892/etm.2018.7109; Miao YP, 2016, BRAIN RES BULL, V121, P9, DOI 10.1016/j.brainresbull.2015.11.019; Mishra V, 2015, SCI REP-UK, V5, DOI 10.1038/srep17807; Pettemeridou E, 2020, NEUROREHABILITATION, V46, P109, DOI 10.3233/NRE-192963; Rahimifard M, 2017, AGEING RES REV, V36, P11, DOI 10.1016/j.arr.2017.02.004; Ren YZ, 2020, J NEUROCHEM, V154, P530, DOI 10.1111/jnc.14962; Ryan SM, 2016, NEUROSCI BIOBEHAV R, V61, P121, DOI 10.1016/j.neubiorev.2015.12.004; Saatman KE, 2006, J NEUROTRAUM, V23, P1241, DOI 10.1089/neu.2006.23.1241; Shetty AK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043286; Shi LY, 2018, PHARMACOL REP, V70, P1040, DOI 10.1016/j.pharep.2018.05.006; Shi XL, 2015, NEUROSCI LETT, V594, P105, DOI 10.1016/j.neulet.2015.03.045; Theadom A, 2017, ARCH PHYS MED REHAB, V98, P1560, DOI 10.1016/j.apmr.2017.01.010; Tiwari SK, 2014, ACS NANO, V8, P76, DOI 10.1021/nn405077y; Truelle JL, 2010, BRAIN INJURY, V24, P1272, DOI 10.3109/02699052.2010.506865; Ullah F, 2017, ARCH TOXICOL, V91, P1623, DOI 10.1007/s00204-017-1939-4; Vassoler FM, 2013, NAT NEUROSCI, V16, P42, DOI 10.1038/nn.3280; Viscomi MT, 2012, AUTOPHAGY, V8, P222, DOI 10.4161/auto.8.2.18599; Wang H, 2020, J SURG RES, V245, P321, DOI 10.1016/j.jss.2019.07.082; Wang XT, 2016, J NEUROTRAUM, V33, P721, DOI 10.1089/neu.2015.4097; Wurzelmann M, 2017, NEURAL REGEN RES, V12, P7, DOI 10.4103/1673-5374.198964; Xu DF, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0930-6; Xu XP, 2016, BRAIN RES BULL, V124, P214, DOI 10.1016/j.brainresbull.2016.05.010; Yang JQ, 2014, PATHOL RES PRACT, V210, P357, DOI 10.1016/j.prp.2014.02.005; Yu MM, 2019, NEUROSCI LETT, V705, P206, DOI 10.1016/j.neulet.2019.04.034; Zhang B, 2020, NEUROSCIENCE, V424, P1, DOI 10.1016/j.neuroscience.2019.10.026; Zhao J, 2018, J NEUROTRAUM, V35, P362, DOI 10.1089/neu.2017.5102; Zhao SH, 2017, BRAIN RES BULL, V135, P53, DOI 10.1016/j.brainresbull.2017.09.011; Zhao YY, 2017, NEUROCHEM INT, V111, P82, DOI 10.1016/j.neuint.2017.03.017; Zhu HT, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-59	53	7	7	2	12	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0361-9230	1873-2747		BRAIN RES BULL	Brain Res. Bull.	SEP	2020	162						84	93		10.1016/j.brainresbull.2020.05.009			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	MO2BR	WOS:000551338700010	32502596				2022-02-06	
J	Wang, RR; He, M; Ou, XF; Xie, XQ; Kang, Y				Wang, Ruoran; He, Min; Ou, Xiao Feng; Xie, Xiao Qi; Kang, Yan			Serum Procalcitonin Level Predicts Acute Kidney Injury After Traumatic Brain Injury	WORLD NEUROSURGERY			English	Article						Acute kidney injury; Procalcitonin; Traumatic brain injury	INFLAMMATORY RESPONSE SYNDROME; CRITICALLY-ILL; SEVERE SEPSIS; EXPRESSION; MORTALITY; HYPERCHLOREMIA; CELLS; SCORE; RISK; SIRS	BACKGROUND: A common non-neurologic complication after traumatic brain injury (TBI), acute kidney injury (AKI) is a risk factor of mortality. Some studies confirmed the predictive value of procalcitonin (PCT) on AKI in several clinical settings. We designed this study to explore the predictive value of PCT on AKI after TBI. METHODS: We retrospectively enrolled patients with TBI admitted to our hospital from February 2015 to June 2019. Multivariate logistic regression analysis was performed to find the risk factors of AKI and construct a predictive model for AKI. Receiver operating characteristics curves were drawn to compare the predictive value of PCT and the constructed model. RESULTS: A total of 214 patients were included in this study. The incidence of AKI after TBI was 25.70% in this study. Compared with the non-AKI group, the AKI group had higher age (P = 0.031), lower Glasgow Coma Scale (P < 0.001), and higher incidence of coagulopathy (P < 0.001) and shock (P < 0.001). Moreover, patients complicated with AKI had higher in-hospital mortality (P < 0.001) and worse 90-day outcome (P < 0.001). Multivariate logistic regression analysis indicated that age (P = 0.033), PCT (P = 0.002), serum chlorine (P = 0.011), and creatinine (P < 0.001) were independent risk factors of AKI. We constructed a predictive model using these 4 risk factors. The area under receiver operating characteristics curves of the predictive model was 0.928, which was significantly higher than that of a single PCT value (area under receiver operating characteristics curves = 0.833) (Z = 2.395, P < 0.05). CONCLUSIONS: PCT is valuable in predicting AKI after TBI. To avoid AKI after TBI, physicians can adjust treatment strategies according to the level of PCT.	[Wang, Ruoran; He, Min; Ou, Xiao Feng; Xie, Xiao Qi; Kang, Yan] Sichuan Univ, West China Hosp, Dept Crit Care Med, Chengdu, Sichuan, Peoples R China		Kang, Y (corresponding author), Sichuan Univ, West China Hosp, Dept Crit Care Med, Chengdu, Sichuan, Peoples R China.	kangyan@scu.edu.cn					Ahmed M, 2015, BRIT J NEUROSURG, V29, P544, DOI 10.3109/02688697.2015.1016892; Andriolo BNG, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010959.pub2; [Anonymous], 2010, LANCET NEUROL, V9, P331, DOI 10.1016/S1474-4422(10)70069-7; Araujo M, 2013, INFLAMM RES, V62, P887, DOI 10.1007/s00011-013-0646-8; Cabral L, 2018, BURNS TRAUMA, V6, DOI 10.1186/s41038-018-0112-5; Commereuc M, 2019, ANN INTENSIVE CARE, V9, DOI 10.1186/s13613-019-0570-3; Cooper DJ, 2018, JAMA-J AM MED ASSOC, V320, P2211, DOI 10.1001/jama.2018.17075; Corral L, 2012, CRIT CARE, V16, DOI 10.1186/cc11243; de Vasconcellos K, 2018, J CRIT CARE, V45, P45, DOI 10.1016/j.jcrc.2018.01.019; Dewan MC, 2019, J NEUROSURG, V130, P1039; Feigin VL, 2010, BEST PRACT RES-CLIN, V24, P485, DOI 10.1016/j.bpa.2010.10.006; Hang CH, 2005, J SURG RES, V123, P188, DOI 10.1016/j.jss.2004.08.002; Huang HZ, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0076982, 10.1371/journal.pone.0059482, 10.1371/journal.pone.0071808]; Huang Wei-ping, 2012, Zhongguo Wei Zhong Bing Ji Jiu Yi Xue, V24, P294; Jacome T, 2018, NEUROCRIT CARE, V28, P110, DOI 10.1007/s12028-017-0410-y; Kimura S, 2019, J CARDIOTHOR VASC AN, V33, P1939, DOI 10.1053/j.jvca.2018.12.009; Kofoed K, 2007, CRIT CARE, V11, DOI 10.1186/cc5723; Kurtul A, 2015, ANGIOLOGY, V66, P957, DOI 10.1177/0003319715572218; Li N, 2011, NEUROCRIT CARE, V14, P377, DOI 10.1007/s12028-011-9511-1; Linscheid P, 2004, CRIT CARE MED, V32, P1715, DOI 10.1097/01.CCM.0000134404.63292.71; Maiwall R, 2016, DIGEST DIS SCI, V61, P920, DOI 10.1007/s10620-015-3921-4; Martinez J M, 2001, Surg Infect (Larchmt), V2, P193, DOI 10.1089/109629601317202678; Martinez JM, 2001, SURG INFECT LARCHMT, V2, P202; Meisner M, 2002, CLIN CHIM ACTA, V323, P17, DOI 10.1016/S0009-8981(02)00101-8; Montoya-Ruiz C, 2016, IMMUNOL RES, V64, P1168, DOI 10.1007/s12026-016-8860-4; Moore EM, 2010, RENAL FAILURE, V32, P1060, DOI 10.3109/0886022X.2010.510234; MOYA F, 1975, EUR J BIOCHEM, V55, P407, DOI 10.1111/j.1432-1033.1975.tb02176.x; Oberhoffer M, 1999, J LAB CLIN MED, V134, P49, DOI 10.1016/S0022-2143(99)90053-7; Oh TK, 2019, WORLD NEUROSURG, V125, pE1226, DOI 10.1016/j.wneu.2019.02.015; Oh TK, 2019, J NEUROSURG ANESTH, V31, P311, DOI 10.1097/ANA.0000000000000512; Raddant AC, 2014, HEADACHE, V54, P472, DOI 10.1111/head.12301; Rodney T, 2018, CYTOKINE, V110, P248, DOI 10.1016/j.cyto.2018.01.012; Rodriguez A, 2018, MED INTENSIVA, V42, P399, DOI 10.1016/j.medin.2017.12.004; Rugeri L, 2007, J THROMB HAEMOST, V5, P289, DOI 10.1111/j.1538-7836.2007.02319.x; Sakran JV, 2012, J TRAUMA ACUTE CARE, V73, P413, DOI 10.1097/TA.0b013e31825ff5b7; Schuetz P, 2017, CRIT CARE MED, V45, P781, DOI [10.1097/CCM.0000000000002321, 10.1097/ccm.0000000000002321]; Skrifvars MB, 2019, ACTA ANAESTH SCAND, V63, P200, DOI 10.1111/aas.13244; Suetrong B, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1499-7; Sun YH, 2018, DNA CELL BIOL, V37, P967, DOI 10.1089/dna.2018.4156; Rosanova MT, 2015, ARCH ARGENT PEDIATR, V113, P41, DOI 10.5546/aap.2015.36; Toyonaga Y, 2017, ACTA ANAESTH SCAND, V61, P1253, DOI 10.1111/aas.12965; Wagner KE, 2002, CRIT CARE MED, V30, P2313, DOI 10.1097/00003246-200210000-00021; Wright DW, 2013, MMWR-MORBID MORTAL W, V62, P549; Zygun DA, 2005, CRIT CARE MED, V33, P654, DOI 10.1097/01.ccm.0000155911.01844.54	44	7	8	1	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	SEP	2020	141						E112	E117		10.1016/j.wneu.2020.04.245			6	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	NG9RY	WOS:000564320300006	32438001				2022-02-06	
J	Ozturk, S; Elcin, AE; Koca, A; Elcin, YM				Ozturk, Selcuk; Elcin, Ayse Eser; Koca, Ayca; Elcin, Yasar Murat			Therapeutic Applications of Stem Cells and Extracellular Vesicles in Emergency Care: Futuristic Perspectives	STEM CELL REVIEWS AND REPORTS			English	Article						Stem cell therapy; Extracellular vesicle therapy; Acute emergency care; Trauma and critical care medicine	TRAUMATIC BRAIN-INJURY; RESPIRATORY-DISTRESS-SYNDROME; MESENCHYMAL STROMAL CELLS; UMBILICAL-CORD BLOOD; ACUTE LUNG INJURY; BONE-MARROW; CELLULAR THERAPIES; LOCOMOTOR RECOVERY; PROTEOMIC ANALYSIS; RADIATION-INJURY	Regenerative medicine (RM) is an interdisciplinary field that aims to repair, replace or regenerate damaged or missing tissue or organs to function as close as possible to its physiological architecture and functions. Stem cells, which are undifferentiated cells retaining self-renewal potential, excessive proliferation and differentiation capacity into offspring or daughter cells that form different lineage cells of an organism, are considered as an important part of the RM approaches. They have been widely investigated in preclinical and clinical studies for therapeutic purposes. Extracellular vesicles (EVs) are the vital mediators that regulate the therapeutic effects of stem cells. Besides, they carry various types of cargo between cells which make them a significant contributor of intercellular communication. Given their role in physiological and pathological conditions in living cells, EVs are considered as a new therapeutic alternative solution for a variety of diseases in which there is a high unmet clinical need. This review aims to summarize and identify therapeutic potential of stem cells and EVs in diseases requiring acute emergency care such as trauma, heart diseases, stroke, acute respiratory distress syndrome and burn injury. Diseases that affect militaries or societies including acute radiation syndrome, sepsis and viral pandemics such as novel coronavirus disease 2019 are also discussed. Additionally, featuring and problematic issues that hamper clinical translation of stem cells and EVs are debated in a comparative manner with a futuristic perspective.	[Ozturk, Selcuk; Elcin, Ayse Eser; Elcin, Yasar Murat] Ankara Univ, Tissue Engn Biomat & Nanobiotechnol Lab, Fac Sci, Ankara, Turkey; [Elcin, Ayse Eser; Elcin, Yasar Murat] Ankara Univ, Grad Sch Hlth Sci, Interdisciplinary Dept Stem Cell & Regenerat Med, Ankara, Turkey; [Koca, Ayca] Ankara Univ, Sch Med, Dept Emergency Med, Ankara, Turkey; [Elcin, Yasar Murat] Biovalda Hlth Technol Inc, Ankara, Turkey; [Elcin, Yasar Murat] Ankara Univ, Fac Sci, Biochem Div, TR-06100 Ankara, Turkey		Elcin, YM (corresponding author), Ankara Univ, Tissue Engn Biomat & Nanobiotechnol Lab, Fac Sci, Ankara, Turkey.; Elcin, YM (corresponding author), Ankara Univ, Grad Sch Hlth Sci, Interdisciplinary Dept Stem Cell & Regenerat Med, Ankara, Turkey.; Elcin, YM (corresponding author), Biovalda Hlth Technol Inc, Ankara, Turkey.; Elcin, YM (corresponding author), Ankara Univ, Fac Sci, Biochem Div, TR-06100 Ankara, Turkey.	elcin@ankara.edu.tr	Elcin, Yasar Murat/O-2435-2019	Elcin, Yasar Murat/0000-0003-1037-0825; koca, ayca/0000-0002-1546-3150			Adamiak M, 2018, CIRC RES, V122, P296, DOI 10.1161/CIRCRESAHA.117.311769; Al-Mayah AHJ, 2012, RADIAT RES, V177, P539, DOI 10.1667/RR2868.1; Ambrosy AP, 2014, J AM COLL CARDIOL, V63, P1123, DOI 10.1016/j.jacc.2013.11.053; Amosse Jeremy, 2017, Stem Cell Investig, V4, P102, DOI 10.21037/sci.2017.11.07; Arno A, 2011, PHARMACEUTICALS, V4, P1355, DOI 10.3390/ph4101355; Balsam LB, 2004, NATURE, V428, P668, DOI 10.1038/nature02460; Bari E, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9040924; Barile Lucio, 2017, Stem Cell Investig, V4, P93, DOI 10.21037/sci.2017.11.06; Baulch JE, 2016, P NATL ACAD SCI USA, V113, P4836, DOI 10.1073/pnas.1521668113; Bein T, 2016, INTENS CARE MED, V42, P699, DOI 10.1007/s00134-016-4325-4; Besalti O, 2016, J VET MED SCI, V78, P1465, DOI 10.1292/jvms.15-0571; Bey E, 2010, WOUND REPAIR REGEN, V18, P50, DOI 10.1111/j.1524-475X.2009.00562.x; Bogatcheva NV, 2019, BIOCHEMISTRY-MOSCOW+, V84, P1375, DOI 10.1134/S0006297919110129; Bogin V., 2015, REGEN MED, P33; Borlongan CV, 2019, STEM CELL TRANSL MED, V8, P983, DOI 10.1002/sctm.19-0076; Calfee CS, 2007, CHEST, V131, P913, DOI 10.1378/chest.06-1743; Cambria E, 2017, NPJ REGEN MED, V2, DOI 10.1038/s41536-017-0024-1; Cancio LC, 2005, J BURN CARE REHABIL, V26, P151, DOI 10.1097/01.BCR.0000155540.31879.FB; Chang Y, 2014, J KOREAN MED SCI, V29, P438, DOI 10.3346/jkms.2014.29.3.438; Chaubey S, 2018, STEM CELL RES THER, V9, DOI 10.1186/s13287-018-0903-4; Chen JL, 2018, STROKE, V49, P1083, DOI 10.1161/STROKEAHA.117.018292; Chen JL, 2017, TRANSL STROKE RES, V8, P374, DOI 10.1007/s12975-017-0520-z; Christopherson GT, 2011, STEM CELL RES THER, V2, DOI 10.1186/scrt81; Cibelli J, 2013, CELL STEM CELL, V12, P271, DOI 10.1016/j.stem.2013.01.004; Cofano F, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20112698; Coleman CN, 2009, ANN EMERG MED, V53, P213, DOI 10.1016/j.annemergmed.2007.12.021; Correa BL, 2021, CARDIOVASC RES, V117, P292, DOI 10.1093/cvr/cvaa028; Cossu G, 2018, LANCET, V391, P883, DOI 10.1016/S0140-6736(17)31366-1; Cox CS, 2017, STEM CELLS, V35, P1065, DOI 10.1002/stem.2538; Cox CS, 2011, NEUROSURGERY, V68, P588, DOI 10.1227/NEU.0b013e318207734c; Cruz FF, 2016, EXPERT OPIN BIOL TH, V16, P1353, DOI 10.1080/14712598.2016.1218845; Cruz FF, 2015, STEM CELL TRANSL MED, V4, P1302, DOI 10.5966/sctm.2014-0280; Curley GF, 2013, ANESTHESIOLOGY, V118, P924, DOI 10.1097/ALN.0b013e318287ba08; Cyranoski D., 2017, NATURE, V10, P1038; Das S, 2015, CARDIOVASC PATHOL, V24, P199, DOI 10.1016/j.carpath.2015.04.007; De Meyer J, 2018, INT J CRITICAL CARE, V4; Ortuno-Costela MD, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20246305; Diamandis T, 2015, STROKE, V46, P588, DOI 10.1161/STROKEAHA.114.007105; DiCarlo AL, 2017, RADIAT RES, V188, pE54, DOI 10.1667/RR14810.1; Doeppner TR, 2015, STEM CELL TRANSL MED, V4, P1131, DOI 10.5966/sctm.2015-0078; Dogan A, 2017, CURR PHARM DESIGN, V23, P903, DOI 10.2174/1381612823666161111141954; Dogan A, 2016, STEM CELL REV REP, V12, P202, DOI 10.1007/s12015-015-9641-5; Eding JEC, 2015, CIRC RES, V116, P80, DOI 10.1161/CIRCRESAHA.116.304872; Eirin A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174303; Eirin A, 2016, SCI REP-UK, V6, DOI 10.1038/srep36120; Eirin A, 2014, GENE, V551, P55, DOI 10.1016/j.gene.2014.08.041; El Harane N, 2018, EUR HEART J, V39, P1835, DOI 10.1093/eurheartj/ehy012; Ela S, 2013, DRUG DISCOVERY, V12, P347; Emmerich Christoph H, 2020, Handb Exp Pharmacol, V257, P177, DOI 10.1007/164_2019_284; Escudier B, 2005, J TRANSL MED, V3, DOI 10.1186/1479-5876-3-10; Fischer UM, 2009, STEM CELLS DEV, V18, P683, DOI 10.1089/scd.2008.0253; Frantz S, 2012, NAT BIOTECHNOL, V30, P12, DOI 10.1038/nbt0112-12; Gaberman E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066549; Galstyan G, 2018, INT J BLOOD RES DISO, V5; Gardiner C, 2016, J EXTRACELL VESICLES, V5, DOI 10.3402/jev.v5.32945; Glicksman MA, 2018, CLIN THER, V40, P1060, DOI 10.1016/j.clinthera.2018.06.004; Glotzbach JP, 2011, CURR PROB SURG, V48, P148, DOI 10.1067/j.cpsurg.2010.11.002; Gnecchi M, 2006, FASEB J, V20, P661, DOI 10.1096/fj.05-5211com; Golchin A, 2020, STEM CELL REV REP, V16, P427, DOI 10.1007/s12015-020-09973-w; Gourmelon P, 2010, HEALTH PHYS, V98, P825, DOI 10.1097/HP.0b013e3181ce64d4; Hao ZC, 2017, CELL PROLIFERAT, V50, DOI 10.1111/cpr.12359; Hare JM, 2017, J AM COLL CARDIOL, V69, P526, DOI 10.1016/j.jacc.2016.11.009; Hare JM, 2012, JAMA-J AM MED ASSOC, V308, P2369, DOI 10.1001/jama.2012.25321; Harting MT, 2009, J NEUROSURG, V110, P1189, DOI 10.3171/2008.9.JNS08158; Hayes M, 2012, CRIT CARE, V16, DOI 10.1186/cc10570; Henderson SJ, 2018, J THROMB HAEMOST, V16, P1932, DOI 10.1111/jth.14215; Heslet L, 2012, INT J GEN MED, V5, P105, DOI 10.2147/IJGM.S22177; Hess DC, 2017, LANCET NEUROL, V16, P360, DOI 10.1016/S1474-4422(17)30046-7; Hotchkiss RS, 2013, NAT REV IMMUNOL, V13, P862, DOI 10.1038/nri3552; Hu CX, 2018, J CELL MOL MED, V22, P1428, DOI 10.1111/jcmm.13492; Hu KX, 2010, BRIT J RADIOL, V83, P52, DOI 10.1259/bjr/61042310; Hu P, 2019, BURNS TRAUMA, V7, DOI 10.1186/s41038-019-0178-8; Huang S, 2015, CELL TRANSPLANT, V24, P2643, DOI 10.3727/096368915X687219; Jansen SJ, 2014, EUR J CLIN INVEST, V44, P892, DOI 10.1111/eci.12299; Joo HS, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21030727; Jung JH, 2017, CIRC RES, V120, P407, DOI 10.1161/CIRCRESAHA.116.309307; Kabat M, 2020, STEM CELL TRANSL MED, V9, P17, DOI 10.1002/sctm.19-0202; Keel M, 2005, INJURY, V36, P691, DOI 10.1016/j.injury.2004.12.037; Kern S, 2006, STEM CELLS, V24, P1294, DOI 10.1634/stemcells.2005-0342; Kervadec A, 2016, J HEART LUNG TRANSPL, V35, P795, DOI 10.1016/j.healun.2016.01.013; Kim HS, 2012, J PROTEOME RES, V11, P839, DOI 10.1021/pr200682z; Kink JA, 2019, BIOL BLOOD MARROW TR, V25, P2124, DOI 10.1016/j.bbmt.2019.07.026; Konoshenko MY, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/8545347; Kordelas L, 2014, LEUKEMIA, V28, P970, DOI 10.1038/leu.2014.41; Kuravi SJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183640; Kusuma GD, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.01199; Lackland DT, 2014, STROKE, V45, P315, DOI 10.1161/01.str.0000437068.30550.cf; Lai RC, 2010, STEM CELL RES, V4, P214, DOI 10.1016/j.scr.2009.12.003; Lalegul-Ulker O, 2019, ARTIF CELL NANOMED B, V47, P10, DOI 10.1080/21691401.2018.1540426; Lalu M. M., 2019, TRANSLATIONAL STROKE, V11, P345; Lange C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014486; Laroye C, 2017, STEM CELLS, V35, P2331, DOI 10.1002/stem.2695; Lee JH, 2019, TRANSFUSION, V59, P876, DOI 10.1111/trf.14838; Lees JS, 2012, INT J STROKE, V7, P582, DOI 10.1111/j.1747-4949.2012.00797.x; Lener T, 2015, J EXTRACELL VESICLES, V4, DOI 10.3402/jev.v4.30087; Leng ZK, 2020, AGING DIS, V11, P216, DOI 10.14336/AD.2020.0228; Li X, 2014, AM J RESP CELL MOL, V51, P455, DOI 10.1165/rcmb.2013-0529OC; Liang B, 2020, MEDICINE, V99, DOI 10.1097/MD.0000000000021429; Liao GP, 2015, PEDIATR CRIT CARE ME, V16, P245, DOI 10.1097/PCC.0000000000000324; Liu AR, 2020, EXPERT OPIN BIOL TH, V20, P125, DOI 10.1080/14712598.2020.1689954; Lopes-Pacheco M, 2020, CELL BIOL TOXICOL, V36, P83, DOI 10.1007/s10565-019-09493-5; Lowthian JA, 2012, MED J AUSTRALIA, V196, P128, DOI 10.5694/mja11.10955; Lu HY, 2018, STEM CELLS INT, V2018, DOI 10.1155/2018/7537589; Lynge E, 2011, SCAND J PUBLIC HEALT, V39, P30, DOI 10.1177/1403494811401482; Mahla RS., 2016, INT J CELL BIOL, V2016; Mandai M, 2017, NEW ENGL J MED, V376, P1038, DOI 10.1056/NEJMoa1608368; Marks PW, 2017, NEW ENGL J MED, V376, P1007, DOI 10.1056/NEJMp1613723; Mason C, 2008, REGEN MED, V3, P1, DOI 10.2217/17460751.3.1.1; Mathur A, 2017, EUR HEART J, V38, P2930, DOI 10.1093/eurheartj/ehw640; Matthay MA, 2019, LANCET RESP MED, V7, P154, DOI 10.1016/S2213-2600(18)30418-1; Melling GE, 2019, EUR J PHARM BIOPHARM, V144, P50, DOI 10.1016/j.ejpb.2019.08.009; Menasche P, 2018, NAT REV CARDIOL, V15, P659, DOI 10.1038/s41569-018-0013-0; Menasche P, 2018, J AM COLL CARDIOL, V71, P429, DOI 10.1016/j.jacc.2017.11.047; Meng WR, 2020, DRUG DELIV, V27, P585, DOI 10.1080/10717544.2020.1748758; Meng Y, 2018, DIABETOL METAB SYNDR, P10; Mettler FA, 2007, HEALTH PHYS, V93, P462, DOI 10.1097/01.HP.0000278843.27969.74; Moghaddam AS, 2019, ATHEROSCLEROSIS, V285, P1, DOI 10.1016/j.atherosclerosis.2019.03.016; Monsel A, 2015, AM J RESP CRIT CARE, V192, P324, DOI 10.1164/rccm.201410-1765OC; Moon GJ, 2019, TRANSL STROKE RES, V10, P509, DOI 10.1007/s12975-018-0668-1; Morse MA, 2005, J TRANSL MED, V3, DOI 10.1186/1479-5876-3-9; Murry CE, 2004, NATURE, V428, P664, DOI 10.1038/nature02446; Murry CE, 2020, SCIENCE, V367, P854, DOI 10.1126/science.aaz3650; Nassar Wael, 2016, Biomater Res, V20, P21, DOI 10.1186/s40824-016-0068-0; Nowbar AN, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g2688; Ojeh N, 2015, INT J MOL SCI, V16, P25476, DOI 10.3390/ijms161025476; Oliveri RS, 2014, NEUROBIOL DIS, V62, P338, DOI 10.1016/j.nbd.2013.10.014; Osborne N, 2018, EMBO REP, V19, DOI 10.15252/embr.201846069; Ozturk S, 2018, CURR PHARM DESIGN, V24, P3101, DOI 10.2174/1381612824666180903123817; Parmaksiz M, 2017, J TISSUE ENG REGEN M, V11, P1754, DOI 10.1002/term.2071; Pati S, 2015, SHOCK, V44, P505, DOI 10.1097/SHK.0000000000000482; Pelizzo G, 2018, REGEN MED, V13, P385, DOI 10.2217/rme-2018-0001; Peng WJ, 2015, STEM CELL RES THER, V6, DOI 10.1186/s13287-015-0034-0; Petrenko Y, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-61167-z; Qureshi AI, 2009, LANCET, V373, P1632, DOI 10.1016/S0140-6736(09)60371-8; Raghavendran K, 2008, CURR MED CHEM, V15, P1911, DOI 10.2174/092986708785132942; Rastogi S, 2018, MOL BIOL CELL, V29, P2228, DOI 10.1091/mbc.E18-02-0130; Rezaie J, 2019, J CELL PHYSIOL, V234, P21732, DOI 10.1002/jcp.28894; Rios C, 2017, RADIAT RES, V188, P242, DOI 10.1667/RR14835.1; Ritenour AE, 2010, ANN SURG, V251, P1140, DOI 10.1097/SLA.0b013e3181e01270; Roccaro AM, 2013, J CLIN INVEST, V123, P1542, DOI 10.1172/JCI66517; Romagnuolo R, 2019, STEM CELL REP, V12, P967, DOI 10.1016/j.stemcr.2019.04.005; Ross JS, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000144; Rubenfeld GD, 2005, NEW ENGL J MED, V353, P1685, DOI 10.1056/NEJMoa050333; Saha Bitan, 2018, Med J Armed Forces India, V74, P313, DOI 10.1016/j.mjafi.2018.03.005; Schneider C. M., 2019, PRINCIPLES REGENERAT, P369; Sena ES, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000344; Shah TG, 2019, CLIN TRANSL MED, V8, DOI 10.1186/s40169-019-0242-9; Shao LB, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/4150705; Shetty AK, 2020, AGING DIS, V11, P462, DOI 10.14336/AD.2020.0301; Shimokawa H, 2015, EUR J HEART FAIL, V17, P884, DOI 10.1002/ejhf.319; Shpichka A, 2019, STEM CELL RES THER, V10, DOI 10.1186/s13287-019-1203-3; Silva PL, 2020, EXPERT OPIN INV DRUG, V29, P49, DOI 10.1080/13543784.2020.1699531; Silvestre JS, 2015, EBIOMEDICINE, V2, P1871, DOI 10.1016/j.ebiom.2015.11.010; Simonson OE, 2015, STEM CELL TRANSL MED, V4, P1199, DOI 10.5966/sctm.2015-0021; Singh VK, 2012, RADIAT RES, V177, P781, DOI 10.1667/RR2894.1; Stonesifer C, 2017, PROG NEUROBIOL, V158, P94, DOI 10.1016/j.pneurobio.2017.07.004; Sun XY, 2020, STEM CELL RES THER, V11, DOI 10.1186/s13287-020-01730-7; Szatmari T, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00347; Sze SK, 2007, MOL CELL PROTEOMICS, V6, P1680, DOI 10.1074/mcp.M600393-MCP200; Tanriverdi AK, 2020, EUR J TRAUMA EMERG S, V46, P53, DOI 10.1007/s00068-019-01101-9; Thery C, 2018, J EXTRACELL VESICLES, V7, DOI 10.1080/20013078.2018.1535750; Thurairajah K, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18030577; Tian CL, 2013, EXP CLIN TRANSPLANT, V11, P176, DOI 10.6002/ect.2012.0053; Tian T, 2018, BIOMATERIALS, V150, P137, DOI 10.1016/j.biomaterials.2017.10.012; Tisherman SA, 2018, CRIT CARE MED, V46, P1991, DOI 10.1097/CCM.0000000000003407; Tisherman SA, 2015, ANN SURG, V261, P586, DOI 10.1097/SLA.0000000000000837; Trounson A, 2015, CELL STEM CELL, V17, P11, DOI 10.1016/j.stem.2015.06.007; Ude CC, 2018, MILITARY MED RES, V5, DOI 10.1186/s40779-018-0154-9; van der Worp HB, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000245; Van Roosbroeck K, 2017, ADV CANCER RES, V135, P119, DOI 10.1016/bs.acr.2017.06.002; Vivo C, 2016, MED INTENSIVA, V40, P49, DOI 10.1016/j.medin.2015.11.010; Weber B, 2019, J TRANSL MED, V17, DOI 10.1186/s12967-019-2052-7; Weisdorf D, 2007, BIOL BLOOD MARROW TR, V13, P103, DOI 10.1016/j.bbmt.2006.10.002; Weston NM, 2018, CURR NEUROL NEUROSCI, V18, DOI 10.1007/s11910-018-0812-z; Wiklander OPB, 2019, SCI TRANSL MED, V11, DOI 10.1126/scitranslmed.aav8521; Wiklander OPB, 2015, J EXTRACELL VESICLES, V4, DOI 10.3402/jev.v4.26316; Willing AE, 2020, CNS NEUROSCI THER, V26, P616, DOI 10.1111/cns.13300; Wilson JG, 2015, LANCET RESP MED, V3, P24, DOI [10.1016/s2213-2600(14)70291-7, 10.1016/S2213-2600(14)70291-7]; Witwer KW, 2019, J EXTRACELL VESICLES, V8, DOI 10.1080/20013078.2019.1648167; Wu JJ, 2017, BBA-MOL BASIS DIS, V1863, P292, DOI 10.1016/j.bbadis.2016.10.024; Wu PP, 2018, CYTOTHERAPY, V20, P291, DOI 10.1016/j.jcyt.2017.11.002; Yang JL, 2017, MOL THER-NUCL ACIDS, V7, P278, DOI 10.1016/j.omtn.2017.04.010; Yang PC, 2018, CIRC RES, V122, P661, DOI 10.1161/CIRCRESAHA.118.312657; Yang X, 2012, ADV HEMATOLOGY, V2012; Yates AG, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.02723; Zhang LL, 2020, CELL DEATH DIS, V11, DOI 10.1038/s41419-019-2182-0; Zhang YL, 2017, NEUROCHEM INT, V111, P69, DOI 10.1016/j.neuint.2016.08.003; Zhang ZG, 2019, NAT REV NEUROL, V15, P193, DOI 10.1038/s41582-018-0126-4; Zhang ZG, 2016, J CLIN INVEST, V126, P1190, DOI 10.1172/JCI81133; Zheng GP, 2014, RESP RES, V15, DOI 10.1186/1465-9921-15-39; Zhu Y, 2017, STEM CELL RES THER, V8, DOI 10.1186/s13287-017-0510-9; Zipkin M, 2019, NAT BIOTECHNOL, V37, P1395, DOI 10.1038/s41587-019-0326-5	192	7	7	3	6	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	2629-3269	2629-3277		STEM CELL REV REP	Stem Cell Rev. Rep.	APR	2021	17	2			SI		390	410		10.1007/s12015-020-10029-2		AUG 2020	21	Cell & Tissue Engineering; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Research & Experimental Medicine	RL3NC	WOS:000562342300001	32839921	Green Published, Bronze			2022-02-06	
J	Pallast, N; Wieters, F; Nill, M; Fink, GR; Aswendt, M				Pallast, Niklas; Wieters, Frederique; Nill, Marieke; Fink, Gereon R.; Aswendt, Markus			Graph theoretical quantification of white matter reorganization after cortical stroke in mice	NEUROIMAGE			English	Article							TRAUMATIC BRAIN-INJURY; PHOTOTHROMBOTIC STROKE; CONNECTIVITY ANALYSES; FUNCTIONAL RECOVERY; CONNECTOME; MRI; NETWORKS; TISSUE		[Pallast, Niklas; Wieters, Frederique; Nill, Marieke; Fink, Gereon R.; Aswendt, Markus] Univ Cologne, Fac Med, Cologne, Germany; [Pallast, Niklas; Wieters, Frederique; Nill, Marieke; Fink, Gereon R.; Aswendt, Markus] Univ Hosp Cologne, Dept Neurol, Cologne, Germany; [Fink, Gereon R.; Aswendt, Markus] Res Ctr Juelich, Inst Neurosci & Med INM 3, Cognit Neurosci, Julich, Germany		Aswendt, M (corresponding author), Res Ctr Juelich, Inst Neurosci & Med INM 3, Cognit Neurosci, Julich, Germany.	markus.aswendt@uk-koeln.de	Aswendt, Markus/L-2743-2019; Fink, Gereon R./E-1616-2012	Aswendt, Markus/0000-0003-1423-0934; Fink, Gereon R./0000-0002-8230-1856	Friebe Foundation [T0498/28960/16]	The authors acknowledge help with histology performed by Olivia Kasgen, Veronika Fritz, and Michele Tegtmeier as well as with statistics by Felix Schmitt. This work was supported by funding from the Friebe Foundation (T0498/28960/16).	Balbinot G, 2019, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.01023; Baskin YK, 2003, J NEUROSCI METH, V129, P87, DOI 10.1016/S0165-0270(03)00212-7; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Boretius S, 2012, NEUROIMAGE, V59, P2678, DOI 10.1016/j.neuroimage.2011.08.051; Budde MD, 2011, BRAIN, V134, P2248, DOI 10.1093/brain/awr161; Calabrese E, 2015, CEREB CORTEX, V25, P4628, DOI 10.1093/cercor/bhv121; Carmichael S Thomas, 2005, NeuroRx, V2, P396; Carrera E, 2014, BRAIN, V137, P2408, DOI 10.1093/brain/awu101; Carter R J, 2001, Curr Protoc Neurosci, VChapter 8, DOI 10.1002/0471142301.ns0812s15; Chen F, 2007, EUR J RADIOL, V63, P68, DOI 10.1016/j.ejrad.2007.01.005; Cheng MY, 2014, P NATL ACAD SCI USA, V111, P12913, DOI 10.1073/pnas.1404109111; Chon U, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-13057-w; Clarkson AN, 2013, J CEREBR BLOOD F MET, V33, P716, DOI 10.1038/jcbfm.2013.7; Crofts JJ, 2011, NEUROIMAGE, V54, P161, DOI 10.1016/j.neuroimage.2010.08.032; Ding SL, 2017, J COMP NEUROL, V525, P407, DOI 10.1002/cne.24130; du Sert NP, 2017, J CEREBR BLOOD F MET, V37, P3488, DOI 10.1177/0271678X17709185; Ebner F.F., 2015, RAT NERVOUS SYSTEM, DOI [10.1016/b978-0-12-374245-2.00024-3, DOI 10.1016/B978-0-12-374245-2.00024-3]; Filippi M, 2019, NEUROIMAGE, V190, P32, DOI 10.1016/j.neuroimage.2017.09.021; Fischer FU, 2015, NEUROIMAGE-CLIN, V8, P660, DOI 10.1016/j.nicl.2015.06.007; Fornito A, 2015, NAT REV NEUROSCI, V16, P159, DOI 10.1038/nrn3901; Franklin KBJ, 2013, PAXINOS FRANKLINS MO; Goubran M, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-13374-0; Granziera C, 2007, Open Neuroimag J, V1, P10, DOI 10.2174/1874440000701010010; Green C, 2018, J NEUROSCI, V38, P1648, DOI 10.1523/JNEUROSCI.2715-17.2018; Hua Y, 2002, STROKE, V33, P2478, DOI 10.1161/01.STR.0000032302.91894.0F; Hubner NS, 2017, NEUROIMAGE, V146, P1, DOI 10.1016/j.neuroimage.2016.11.008; Jiang Y, 2011, NEUROIMAGE, V56, P1235, DOI 10.1016/j.neuroimage.2011.03.031; Johansen-Berg H, 2007, NEUROIMAGE, V36, pT16, DOI 10.1016/j.neuroimage.2007.03.041; Kaiser M, 2011, NEUROIMAGE, V57, P892, DOI 10.1016/j.neuroimage.2011.05.025; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Koch P, 2016, ANN CLIN TRANSL NEUR, V3, P233, DOI 10.1002/acn3.278; Lee T, 2012, J COMP NEUROL, V520, P1021, DOI 10.1002/cne.22767; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Li HL, 2014, BMC NEUROSCI, V15, DOI 10.1186/1471-2202-15-58; Maier-Hein KH, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01285-x; Milidonis X, 2015, STROKE, V46, P843, DOI 10.1161/STROKEAHA.114.007560; Moura LM, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00445; Nowicka D, 2008, ACTA NEUROBIOL EXP, V68, P155; Oh SW, 2014, NATURE, V508, P207, DOI 10.1038/nature13186; Pallast N, 2019, J NEUROSCI METH, V326, DOI 10.1016/j.jneumeth.2019.108394; Pallast N, 2019, FRONT NEUROINFORM, V13, DOI 10.3389/fninf.2019.00042; Pallast N, 2018, DATABASE-OXFORD, DOI 10.1093/database/bay124; Rehme AK, 2013, J PHYSIOL-LONDON, V591, P17, DOI 10.1113/jphysiol.2012.243469; Roome RB, 2015, JOVE-J VIS EXP, DOI 10.3791/52701; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Schaechter JD, 2009, HUM BRAIN MAPP, V30, P3461, DOI 10.1002/hbm.20770; Schober P, 2018, ANESTH ANALG, V127, P569, DOI 10.1213/ANE.0000000000003511; Silasi G, 2014, NEURON, V83, P1354, DOI 10.1016/j.neuron.2014.08.052; Skare S, 2000, J MAGN RESON, V147, P340, DOI 10.1006/jmre.2000.2209; Tae WS, 2018, J CLIN NEUROL, V14, P129, DOI 10.3988/jcn.2018.14.2.129; van den Heuvel MP, 2019, NAT REV NEUROSCI, V20, P435, DOI 10.1038/s41583-019-0177-6; van der Zijden JP, 2008, EXP NEUROL, V212, P207, DOI 10.1016/j.expneurol.2008.03.027; van Meer MPA, 2012, J NEUROSCI, V32, P4495, DOI 10.1523/JNEUROSCI.3662-11.2012; Zhang Y, 2017, ELIFE, V6, DOI 10.7554/eLife.26653	54	7	7	0	4	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1053-8119	1095-9572		NEUROIMAGE	Neuroimage	AUG 15	2020	217								116873	10.1016/j.neuroimage.2020.116873			12	Neurosciences; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	MB1LY	WOS:000542369500014	32380139	gold			2022-02-06	
J	Gagner, C; Tuerk, C; De Beaumont, L; Bernier, A; Beauchamp, MH				Gagner, Charlotte; Tuerk, Carola; De Beaumont, Louis; Bernier, Annie; Beauchamp, Miriam H.			Brain-Derived Neurotrophic Factor Val66Met Polymorphism and Internalizing Behaviors after Early Mild Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						behaviors; children; concussions; genetic; traumatic brain injury	ACTIVITY-DEPENDENT SECRETION; PSYCHOSOCIAL OUTCOMES; GENETIC-FACTORS; LIFE STRESS; HEAD-INJURY; BDNF; CHILDREN; PLASTICITY; DEPRESSION; RECOVERY	Pediatric traumatic brain injury (TBI) can lead to adverse emotional, social, and behavioral consequences. However, outcome is difficult to predict due to significant individual variability, likely reflecting a complex interaction between injury- and child-related variables. Among these variables are genetically determined individual differences, which can modulate TBI outcome through their influence on neuroplasticity mechanisms. In this study, we examined the effect of Val66Met, a common polymorphism of the brain-derived neurotrophic factor gene known to be involved in neuroplasticity mechanisms, on behavioral symptoms of mild TBI (mTBI) sustained in early childhood. This work is part of a prospective, longitudinal cohort study of early TBI. The current sample consisted of 145 children between ages 18 and 60 months assigned to one of three participant groups: mild TBI, orthopedic injury, or typically developing children. Participants provided a saliva sample to detect the presence of the Val66Met polymorphism, and the Child Behavior Checklist was used to document the presence of behavioral symptoms at 6- and 18-months post-injury. Contrary to our initial hypothesis, at 6 months post-injury, non-carriers of the Val66Met polymorphism in the mTBI group presented significantly more internalizing symptoms (e.g., anxiety/depression and somatic complaints) than Val66Met carriers, who were similar to orthopedically injured and typically developing children. However, at 18 months post-injury, all children with mTBI presented more internalizing symptoms, independent of genotype. The results of the study provide evidence for a protective effect of the Val66Met polymorphism on internalizing behavior symptoms 6 months after early childhood mTBI.	[Gagner, Charlotte; Tuerk, Carola; Bernier, Annie; Beauchamp, Miriam H.] Univ Montreal, Dept Psychol, CP 6128 Succursale Ctr Ville, Montreal, PQ H3C 3J7, Canada; [De Beaumont, Louis] Univ Montreal, Dept Surg, Montreal, PQ, Canada; [Gagner, Charlotte; Beauchamp, Miriam H.] St Justine Hosp Res Ctr, Montreal, PQ, Canada; [De Beaumont, Louis] Hop Sacre Coeur Montreal, Res Ctr, Montreal, PQ, Canada		Beauchamp, MH (corresponding author), Univ Montreal, Dept Psychol, CP 6128 Succursale Ctr Ville, Montreal, PQ H3C 3J7, Canada.	miriam.beauchamp@umontreal.ca		Tuerk, Carola/0000-0002-0910-846X	Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR) [MOP111036]	This work was supported by the Canadian Institutes of Health Research (grant number MOP111036).	Achenbach T, 2000, MANUAL FOR THE ASEBA; Anderson V, 2005, PEDIATRICS, V116, P1374, DOI 10.1542/peds.2004-1728; Anderson V, 1995, CHILD NEUROPSYCHOL, V1, P187, DOI 10.1080/09297049508400224; Anderson V, 2011, BRAIN, V134, P2197, DOI 10.1093/brain/awr103; Babikian T, 2009, NEUROPSYCHOLOGY, V23, P283, DOI 10.1037/a0015268; Barbey AK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088733; Barde Y A, 1994, Prog Clin Biol Res, V390, P45; Bellerose J, 2015, J INT NEUROPSYCH SOC, V21, P483, DOI 10.1017/S1355617715000569; Binder DK, 2001, TRENDS NEUROSCI, V24, P47, DOI 10.1016/S0166-2236(00)01682-9; Casey BJ, 2009, NEUROSCIENCE, V164, P108, DOI 10.1016/j.neuroscience.2009.03.081; Chen ZY, 2004, J NEUROSCI, V24, P4401, DOI 10.1523/JNEUROSCI.0348-04.2004; Chiaretti A, 2003, INTENS CARE MED, V29, P1329, DOI 10.1007/s00134-003-1852-6; Cohen J., 2013, STAT POWER ANAL BEHA; D'Hondt F, 2017, COGN AFFECT BEHAV NE, V17, P124, DOI 10.3758/s13415-016-0467-7; Davidson J, 2015, NEUROSCIENTIST, V21, P424, DOI 10.1177/1073858414543150; Degeilh F, 2018, DEV PSYCHOBIOL, V60, P1037, DOI 10.1002/dev.21786; Egan MF, 2003, CELL, V112, P257, DOI 10.1016/S0092-8674(03)00035-7; Failla MD, 2015, NEUROREHAB NEURAL RE, V29, P234, DOI 10.1177/1545968314542617; Gabrys RL, 2019, CLIN J SPORT MED, V29, P494, DOI 10.1097/JSM.0000000000000550; Gagner C, 2018, PSYCHOL MED, V48, P1551, DOI 10.1017/S0033291717003221; Garraway SM, 2016, NEURAL PLAST, V2016, DOI 10.1155/2016/9857201; Gatt JM, 2009, MOL PSYCHIATR, V14, P681, DOI 10.1038/mp.2008.143; Giza CC, 2007, CURR OPIN CRIT CARE, V13, P143, DOI 10.1097/MCC.0b013e32808255dc; Giza CC, 2006, DEV NEUROSCI-BASEL, V28, P364, DOI 10.1159/000094163; Hosang GM, 2014, BMC MED, V12, DOI 10.1186/1741-7015-12-7; Huang EJ, 2001, ANNU REV NEUROSCI, V24, P677, DOI 10.1146/annurev.neuro.24.1.677; Keightley Michelle L, 2014, Arch Phys Med Rehabil, V95, pS192, DOI 10.1016/j.apmr.2013.12.018; Khalin I, 2016, DRUG DELIV, V23, P3520, DOI 10.1080/10717544.2016.1199609; Krueger F, 2011, J NEUROSCI, V31, P598, DOI 10.1523/JNEUROSCI.1399-10.2011; Kurowski B.G., 2019, FRONT GENET, V10; Kurowski B, 2012, J PEDIATR REHAB MED, V5, P217, DOI 10.3233/PRM-2012-0214; Lalonde G, 2018, J NEUROPSYCHOL, V12, P1, DOI 10.1111/jnp.12104; Landry-Roy C, 2017, J HEAD TRAUMA REHAB, V32, pE13, DOI 10.1097/HTR.0000000000000303; Liu JH, 2013, BRAIN INJURY, V27, P1263, DOI 10.3109/02699052.2013.804205; MATTSON MP, 1994, J NEUROTRAUM, V11, P3, DOI 10.1089/neu.1994.11.3; McAllister TW, 2010, PM&R, V2, pS241, DOI 10.1016/j.pmrj.2010.10.005; McKinlay A, 2008, BRAIN INJURY, V22, P175, DOI 10.1080/02699050801888824; McKinlay A, 2010, CHILD CARE HLTH DEV, V36, P22, DOI 10.1111/j.1365-2214.2009.00947.x; MOCCHETTI I, 1995, J NEUROTRAUM, V12, P853, DOI 10.1089/neu.1995.12.853; Pearson-Fuhrhop KM, 2012, CURR OPIN NEUROL, V25, P682, DOI 10.1097/WCO.0b013e32835a360a; Royo JL, 2007, NAT PROTOC, V2, P1734, DOI 10.1038/nprot.2007.244; Shimizu E, 2004, AM J MED GENET B, V126B, P122, DOI 10.1002/ajmg.b.20118; SNIDER WD, 1994, CELL, V77, P627, DOI 10.1016/0092-8674(94)90048-5; Su Y.S., 2016, FRONT NEUROSCI; THOENEN H, 1995, SCIENCE, V270, P593, DOI 10.1126/science.270.5236.593; Treble-Barna A, 2020, J NEUROTRAUM, V37, P1491, DOI 10.1089/neu.2019.6866; Trenchard SO, 2013, BRAIN INJURY, V27, P1217, DOI 10.3109/02699052.2013.812240; Tsai S.J., 2018, FRONT MOL NEUROSCI, V11; Wade SL, 2011, DEV PSYCHOL, V47, P119, DOI 10.1037/a0021028; Wang YJ, 2018, BMC MED GENET, V19, DOI 10.1186/s12881-017-0518-0; Yeates KO, 2010, NEUROPSYCHOLOGY, V24, P345, DOI 10.1037/a0018387; Yeates KO, 2004, J INT NEUROPSYCH SOC, V10, P412, DOI 10.1017/S1355617704103093; Zemek R, 2016, JAMA-J AM MED ASSOC, V315, P1014, DOI 10.1001/jama.2016.1203; Zhao MZ, 2018, J AFFECT DISORDERS, V227, P226, DOI 10.1016/j.jad.2017.10.024	54	7	7	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN 1	2021	38	1					102	110		10.1089/neu.2019.6936		AUG 2020	9	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	PN6IA	WOS:000558943200001	32605421				2022-02-06	
J	Klein, SP; Fieuws, S; Meyfroidt, G; Depreitere, B				Klein, Samuel P.; Fieuws, Steffen; Meyfroidt, Geert; Depreitere, Bart			Effects of Norepinephrine, Propofol, and Hemoglobin Concentration on Dynamic Measurements of Cerebrovascular Reactivity in Acute Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						brain injury; cerebral autoregulation; hemoglobin concentration; norepinephrine; propofol	CEREBRAL AUTOREGULATION; PRESSURE REACTIVITY; BLOOD-FLOW; TRANSFUSION; VALIDATION	Effects of treatment-associated variables on cerebrovascular autoregulation (CA) in acute brain injury patients remain unclear. As deficient CA is associated with worse outcomes and ideas about CA-steered management are emerging, this question is relevant. We investigated effects of norepinephrine and propofol infusion rates and hemoglobin concentration on dynamic measurements of cerebrovascular reactivity as surrogate for CA. A retrospective analysis of 91 traumatic brain injury (TBI) and 13 stroke patients admitted to the intensive care unit (ICU) of the Leuven University Hospitals was performed. Low-resolution autoregulation index (LAx) and high-frequency pressure reactivity index (PRx) were calculated as measurements of cerebrovascular reactivity. Data was binned into 5-, 15-, and 60-min intervals. Bivariate time-series analysis using lagged cross-correlations were calculated after pre-whitening and differencing. Linear mixed models evaluated effects of age, gender, cardiovascular risk, brain comorbidity, Glasgow Coma Scale (GCS), pupil reactivity, and type of injury. Median dose of norepinephrine, propofol and hemoglobin concentration was 7.8 mu g/kg/h (Q1 3.6-Q3 13.8), 3 mg/kg/h (Q1 1.9-Q3 4.3), and 9.2 g center dot dL(-1)(Q1 8.2-Q3 10.5), respectively. Mean cross-correlations for 24 lags were close to zero and not significant for all variables. No significant differences as function of age, gender, cardiovascular risk, brain comorbidity, GCS, pupil reactivity, and type of injury were found. Dynamic intracranial pressure-based measurements of cerebrovascular reactivity in acute brain injured patients are not affected by gradually adjusted norepinephrine or propofol infusion rates or slow changes in hemoglobin concentration within the typical ranges during ICU admission. Future trials on cerebrovascular reactivity-steered management and treatment of CA impairment may not have to take these variables into account.	[Klein, Samuel P.; Depreitere, Bart] Univ Hosp Leuven, Dept Neurosurg, Herestr 49, B-3000 Leuven, Belgium; [Meyfroidt, Geert] Univ Hosp Leuven, Intens Care Med, Leuven, Belgium; [Fieuws, Steffen] Katholieke Univ Leuven, Leuven Biostat & Stat Bioinformat Ctr L BioStat, Leuven, Belgium		Depreitere, B (corresponding author), Univ Hosp Leuven, Dept Neurosurg, Herestr 49, B-3000 Leuven, Belgium.	bart.depreitere@uzleuven.be	Klein, Samuel/AAB-3327-2020	Klein, Samuel/0000-0001-5595-4440	Johnson & Johnson Research Chair in Profound analysis of cerebrovascular pressure autoregulation	This work was supported in part by a Johnson & Johnson Research Chair in Profound analysis of cerebrovascular pressure autoregulation and associated physiological variables in severe traumatic brain injury at KU Leuven University.	Armstead WM, 2016, J NEUROTRAUM, V33, P1761, DOI 10.1089/neu.2015.4290; Armstead William M, 2016, Anesthesiol Clin, V34, P465, DOI 10.1016/j.anclin.2016.04.002; Bennis FC, 2020, NEUROCRIT CARE, V33, P542, DOI 10.1007/s12028-020-00930-6; Czosnyka M, 1996, STROKE, V27, P1829, DOI 10.1161/01.STR.27.10.1829; Czosnyka M, 1997, NEUROSURGERY, V41, P11, DOI 10.1097/00006123-199707000-00005; D'Agostino RB, 2008, CIRCULATION, V117, P743, DOI 10.1161/CIRCULATIONAHA.107.699579; Dean RT, 2016, BEHAV RES METHODS, V48, P783, DOI 10.3758/s13428-015-0611-2; Depreitere B, 2014, J NEUROSURG, V120, P1451, DOI 10.3171/2014.3.JNS131500; Harrell FE., 2001, MULTIVARIABLE MODELI, P53, DOI [DOI 10.1007/978-1-4757-3462-1_4, 10.1007/978-1-4757-3462-1_4]; Klein SP, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-50046-x; Klein SP, 2019, CRIT CARE, V23, DOI 10.1186/s13054-019-2454-1; Ogawa Y, 2007, ANESTH ANALG, V105, P1389, DOI 10.1213/01.ane.0000281910.95740.e4; OVERGAARD J, 1974, J NEUROSURG, V41, P531, DOI 10.3171/jns.1974.41.5.0531; Sankoh AJ, 1997, STAT MED, V16, P2529, DOI 10.1002/(SICI)1097-0258(19971130)16:22<2529::AID-SIM692>3.0.CO;2-J; Sekhon MS, 2015, NEUROCRIT CARE, V23, P210, DOI 10.1007/s12028-015-0141-x; Slupe AM, 2018, J CEREBR BLOOD F MET, V38, P2192, DOI 10.1177/0271678X18789273; Steiner LA, 2003, STROKE, V34, P2404, DOI 10.1161/01.STR.0000089014.59668.04; Steiner LA, 2003, ANESTH ANALG, V97, P572, DOI 10.1213/01.ANE.0000070234.17226.B0; STREBEL S, 1995, ANESTHESIOLOGY, V83, P66, DOI 10.1097/00000542-199507000-00008; Thelin E.P., 2019, J CLIN MONIT COMPUT; Vavilala MS, 2001, J NEUROSURG ANESTH, V13, P233, DOI 10.1097/00008506-200107000-00009; Walsh TS, 2006, BRIT J ANAESTH, V97, P278, DOI 10.1093/bja/ael189; Zeiler F.A., 2020, J NEUROTRAUM, V9, P1; Zeiler F.A., 2019, J NEUROTRAUM, V1241, P1233; Zeiler FA, 2018, J NEUROTRAUM, V35, P2803, DOI 10.1089/neu.2017.5603; Zeiler FA, 2018, J NEUROTRAUM, V35, P1559, DOI 10.1089/neu.2017.5596; Zeiler FA, 2019, J NEUROTRAUM, V36, P713, DOI 10.1089/neu.2018.5987	27	7	7	0	1	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	FEB 15	2021	38	4					506	512		10.1089/neu.2020.7160		AUG 2020	7	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	QC1FI	WOS:000558942100001	32611275	Green Accepted			2022-02-06	
J	Vedantam, A; Brennan, J; Levin, HS; McCarthy, JJ; Dash, PK; Redell, JB; Yamal, JM; Robertson, CS				Vedantam, Aditya; Brennan, Jeffrey; Levin, Harvey S.; McCarthy, James J.; Dash, Pramod K.; Redell, John B.; Yamal, Jose-Miguel; Robertson, Claudia S.			Early versus Late Profiles of Inflammatory Cytokines after Mild Traumatic Brain Injury and Their Association with Neuropsychological Outcomes	JOURNAL OF NEUROTRAUMA			English	Article						cytokines; inflammation; mild TBI; post-concussion syndrome	POSTTRAUMATIC-STRESS-DISORDER; CONCUSSION SYMPTOMS QUESTIONNAIRE; C-TERMINAL HYDROLASE; CEREBROSPINAL-FLUID; CORTICAL THICKNESS; SERUM-LEVELS; BIOMARKERS; MODERATE; IL-10; INTERLEUKIN-6	Despite pre-clinical evidence for the role of inflammation in traumatic brain injury (TBI), there is limited data on inflammatory biomarkers in mild TBI (mTBI). In this study, we describe the profile of plasma inflammatory cytokines and explore associations between these cytokines and neuropsychological outcomes after mTBI. Patients with mTBI with negative computed tomography and orthopedic injury (OI) controls without mTBI were prospectively recruited from emergency rooms at three trauma centers. Plasma inflammatory cytokine levels were measured from venous whole-blood samples that were collected at enrollment (within 24 h of injury) and at 6 months after injury. Neuropsychological tests were performed at 1 week, 1 month, 3 months, and 6 months after the injury. Multivariate regression analysis was performed to identify associations between inflammatory cytokines and neuropsychological outcomes. A total of 53 mTBI and 24 OI controls were included in this study. The majority of patients were male (62.3%), and injured in motor vehicle accidents (37.7%). Plasma interleukin (IL)-2 (p = 0.01) and IL-6 (p = 0.01) within 24 h post-injury were significantly higher for mTBI patients compared with OI controls. Elevated plasma IL-2 at 24 h was associated with more severe 1-week post-concussive symptoms (p = 0.001). At 6 months, elevated plasma IL-10 was associated with greater depression scores (p = 0.004) and more severe post-traumatic stress disorder (PTSD) symptoms (p = 0.001). Plasma cytokine levels (within 24 h and at 6 months post-injury) were significantly associated with early and late post-concussive symptoms, PTSD, and depression scores after mTBI. These results highlight the potential role of inflammation in the pathophysiology of post-traumatic symptoms after mTBI.	[Vedantam, Aditya; Robertson, Claudia S.] Baylor Coll Med, Dept Neurosurg, 7200 Cambridge St,Suite 9A,MS BCM650, Houston, TX 77030 USA; [Brennan, Jeffrey; Levin, Harvey S.] Baylor Coll Med, Dept Phys Med & Rehabil, Houston, TX 77030 USA; [McCarthy, James J.] Univ Texas Hlth Sci Ctr Houston, Dept Emergency Med, Houston, TX 77030 USA; [Dash, Pramod K.; Redell, John B.] Univ Texas Hlth Sci Ctr Houston, Dept Neurobiol & Anat, Houston, TX 77030 USA; [Yamal, Jose-Miguel] Univ Texas Hlth Sci Ctr Houston, Sch Publ Hlth, Dept Biostat & Data Sci, Houston, TX 77030 USA		Robertson, CS (corresponding author), Baylor Coll Med, Dept Neurosurg, 7200 Cambridge St,Suite 9A,MS BCM650, Houston, TX 77030 USA.	claudiar@bcm.edu			Department of Defense CDMRPUnited States Department of Defense [W81XWH-08-2-0132, W81XWH-08-2-0131, W81XWH-08-2-0133, W81XWH-08-2-0134]; National Institutes of Health NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS088298]	Department of Defense CDMRP grants W81XWH-08-2-0132 (CSR), W81XWH-08-2-0131 (JJM), W81XWH-08-2-0133 (HSL), W81XWH-08-2-0134 (PKD), and National Institutes of Health NINDS Grant #NS088298 (PKD).	Abbas AH, 2018, GREEN ENERGY TECHNOL, P3, DOI 10.1007/978-3-319-62575-1_1; Bazarian JJ, 1999, BRAIN INJURY, V13, P173, DOI 10.1080/026990599121692; Bell MJ, 1997, J NEUROTRAUM, V14, P451, DOI 10.1089/neu.1997.14.451; Benedict R.H., 1995, BRIEF VISUOSPATIAL M; Berger RP, 2009, PEDIATR RES, V65, P97, DOI 10.1203/PDR.0b013e31818c7e27; Blanchard EB, 1996, BEHAV RES THER, V34, P669, DOI 10.1016/0005-7967(96)00033-2; Ferreira LCB, 2014, BRAIN INJURY, V28, P1311, DOI 10.3109/02699052.2014.916818; Carroll Linda J, 2014, Arch Phys Med Rehabil, V95, pS152, DOI 10.1016/j.apmr.2013.08.300; Csuka E, 1999, J NEUROIMMUNOL, V101, P211, DOI 10.1016/S0165-5728(99)00148-4; de Oliveira JF, 2018, PSYCHIAT RES, V260, P111, DOI 10.1016/j.psychres.2017.11.061; Dedert EA, 2010, ANN BEHAV MED, V39, P61, DOI 10.1007/s12160-010-9165-9; Delis DC., 2001, DELIS KAPLAN EXECUTI; Dey S, 2017, NEUROL INDIA, V65, P761, DOI 10.4103/neuroindia.NI_884_15; Di Battista AP, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0500-3; Faul M, 2010, TRAUMATIC BRAIN INJU; Gatson JW, 2014, J NEUROSURG, V121, P1232, DOI 10.3171/2014.7.JNS132474; Gill J, 2018, BRAIN INJURY, V32, P1277, DOI 10.1080/02699052.2018.1471738; Goodman JC, 2008, ACTA NEUROCHIR SUPPL, V102, P437, DOI 10.1007/978-3-211-85578-2_85; Govindarajan KA, 2016, J NEUROTRAUM, V33, P1809, DOI 10.1089/neu.2015.4253; Guo M, 2012, ASIAN PAC J TROP MED, V5, P323, DOI 10.1016/S1995-7645(12)60048-0; Herrmann N, 2009, J NEUROPSYCH CLIN N, V21, P181, DOI 10.1176/appi.neuropsych.21.2.181; Iwakura Y, 2008, IMMUNOL REV, V226, P57, DOI 10.1111/j.1600-065X.2008.00699.x; Juengst SB, 2015, J HEAD TRAUMA REHAB, V30, P207, DOI 10.1097/HTR.0000000000000031; Kirchhoff C, 2008, EUR J MED RES, V13, P464; Knoblach SM, 1998, EXP NEUROL, V153, P143, DOI 10.1006/exnr.1998.6877; KOSSMANN T, 1995, SHOCK, V4, P311, DOI 10.1097/00024382-199511000-00001; Kulbe JR, 2016, EXP NEUROL, V275, P334, DOI 10.1016/j.expneurol.2015.05.004; Kumar RG, 2015, BRAIN BEHAV IMMUN, V45, P253, DOI 10.1016/j.bbi.2014.12.021; Lagerstedt L, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193278; Lewis LM, 2017, ACAD EMERG MED, V24, P710, DOI 10.1111/acem.13174; McCauley SR, 2014, J NEUROTRAUM, V31, P914, DOI 10.1089/neu.2012.2826; McCauley SR, 2013, J NEUROTRAUM, V30, P642, DOI 10.1089/neu.2012.2393; Nwachuku EL, 2016, CLIN NEUROL NEUROSUR, V149, P1, DOI 10.1016/j.clineuro.2016.06.009; Oehr L, 2017, ARCH PHYS MED REHAB, V98, P2308, DOI 10.1016/j.apmr.2017.03.019; Ojo JO, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00213; Palacios EM, 2017, J NEUROTRAUM, V34, P1546, DOI 10.1089/neu.2016.4752; Papa L, 2012, J TRAUMA ACUTE CARE, V72, P1335, DOI 10.1097/TA.0b013e3182491e3d; Patterson ZR, 2012, FRONT CELL NEUROSCI, V6, DOI 10.3389/fncel.2012.00058; Potter S, 2006, J NEUROL, V253, P1603, DOI 10.1007/s00415-006-0275-z; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Rodney T, 2018, CYTOKINE, V110, P248, DOI 10.1016/j.cyto.2018.01.012; Santhanam P, 2019, BRAIN RES, V1711, P77, DOI 10.1016/j.brainres.2019.01.015; Siman R, 2015, J NEUROTRAUM, V32, P1294, DOI 10.1089/neu.2014.3698; Siman R, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00190; Simon DW, 2017, NAT REV NEUROL, V13, P171, DOI 10.1038/nrneurol.2017.13; Smith A., 1982, SYMBOL DIGIT MODALIT; Strong CAH, 2011, J INT NEUROPSYCH SOC, V17, P230, DOI 10.1017/S1355617710001451; TAUPIN V, 1993, J NEUROIMMUNOL, V42, P177, DOI 10.1016/0165-5728(93)90008-M; Truettner JS, 2005, MOL BRAIN RES, V138, P124, DOI 10.1016/j.molbrainres.2005.04.006; Urban KJ, 2017, J NEUROTRAUM, V34, P816, DOI 10.1089/neu.2016.4502; Ware JE, 1996, MED CARE, V34, P220, DOI 10.1097/00005650-199603000-00003; Yousefzadeh-Chabok S, 2015, ARCH TRAUMA RES, V4, DOI 10.5812/atr.18357; Ziebell JM, 2010, NEUROTHERAPEUTICS, V7, P22, DOI 10.1016/j.nurt.2009.10.016	53	7	7	3	4	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN 1	2021	38	1					53	62		10.1089/neu.2019.6979		AUG 2020	10	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	PN6IA	WOS:000558263700001	32600167	Green Published			2022-02-06	
J	Alexiou, GA; Lianos, GD; Tzima, A; Sotiropoulos, A; Nasios, A; Metaxas, D; Zigouris, A; Zika, RNJ; Mitsis, M; Voulgaris, S				Alexiou, George A.; Lianos, Georgios D.; Tzima, Aggeliki; Sotiropoulos, Athanasios; Nasios, Anastasios; Metaxas, Dimitris; Zigouris, Andreas; Zika, Jolanda R. N.; Mitsis, Michail; Voulgaris, Spyridon			Neutrophil to lymphocyte ratio as a predictive biomarker for computed tomography scan use in mild traumatic brain injury	BIOMARKERS IN MEDICINE			English	Article						biomarkers; CT; emergency department setting; GCS; headache; head trauma; ionizing radiation; mild traumatic brain injury; neutrophil-to-lymphocytes ratio; radiation exposure		Aim:Traumatic brain injury (TBI) is a serious health concern. We set out to investigate the role of neutrophil-to-lymphocytes ratio (NLR) at admission for predicting the need for computed tomography (CT) in mild-TBI.Materials & methods:A retrospective study of adult patients who presented with mild-TBIResults:One hundred and thirty patients met the inclusion criteria. Seventy-four patients had positive CT-findings. The mean NLR-levels at presentations were 5.6 +/- 4.8. Patients with positive CT-findings had significant higher NLR-levels. Receiver operating characteristic curve analysis was conducted and the threshold of NLR-levels for detecting the cases with positive CT-findings was 2.5, with 78.1% sensitivity and 63% specificityConclusion:To the best of our knowledge no previous study has assessed the value of NLR-levels for predicting the need for CT in mild-TBI.	[Alexiou, George A.; Tzima, Aggeliki; Sotiropoulos, Athanasios; Nasios, Anastasios; Metaxas, Dimitris; Zigouris, Andreas; Zika, Jolanda R. N.; Voulgaris, Spyridon] Univ Hosp Ioannina, Dept Neurosurg, Ioannina, Greece; [Lianos, Georgios D.; Mitsis, Michail] Univ Hosp Ioannina, Dept Surg, Ioannina, Greece		Lianos, GD (corresponding author), Univ Hosp Ioannina, Dept Surg, Ioannina, Greece.	georgiolianos@yahoo.gr	Alexiou, George A/B-3995-2012	Alexiou, George A/0000-0003-0257-4481			Alexiou GA., 2014, NEUROIMMUNOL NEUROIN, V1, P131, DOI DOI 10.4103/2347-8659.143666; Alexiou GA, 2019, BIOMARK MED, V13, P1055, DOI 10.2217/bmm-2019-0277; Alexiou GA, 2019, DIS MARKERS, V2019, DOI 10.1155/2019/1065254; Alexiou GA, 2014, BRAIN INJURY, V28, P438, DOI 10.3109/02699052.2014.888769; Argyropoulou MI, 2020, NEURORADIOLOGY, V62, P251, DOI 10.1007/s00234-019-02326-6; Bazarian JJ, 2018, LANCET NEUROL, V17, P782, DOI 10.1016/S1474-4422(18)30231-X; Calcagnile O, 2016, BMC NEUROL, V16, DOI 10.1186/s12883-016-0723-z; Chen JG, 2019, NEUROCRIT CARE, V30, P334, DOI 10.1007/s12028-018-0622-9; Corbett JM, 2020, J NEUROSURG, V132, P545, DOI 10.3171/2018.10.JNS182293; Dilektasli E, 2016, J TRAUMA ACUTE CARE, V81, P882, DOI 10.1097/TA.0000000000000980; Ebell MH, 2006, AM FAM PHYSICIAN, V73, P2205; Gan ZS, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00446; Gomez PA, 1996, BRIT J NEUROSURG, V10, P453, DOI 10.1080/02688699647078; Hartl R, 1997, J CEREBR BLOOD F MET, V17, P1210; Kelmendi FM, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/6954045; Kimball R, 2020, CLIN NEUROL NEUROSUR, V193, DOI 10.1016/j.clineuro.2020.105772; Lattanzi S, 2016, STROKE, V47, P1654, DOI 10.1161/STROKEAHA.116.013627; Lee JS, 2018, MEDICINE, V97, DOI 10.1097/MD.0000000000011138; Lianos GD, 2020, BIOMARK MED, V14, P169, DOI 10.2217/bmm-2019-0497; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Mack LR, 2003, J EMERG MED, V24, P157, DOI 10.1016/S0736-4679(02)00714-X; Marincowitz C, 2020, J NEUROTRAUM, V37, P324, DOI 10.1089/neu.2019.6652; Mathews JD, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2360; McDonald SJ, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0555-1; Ritzel RM, 2019, NEUROBIOL AGING, V77, P194, DOI 10.1016/j.neurobiolaging.2019.02.010; Sharif-Alhoseini Mahdi, 2011, J Emerg Trauma Shock, V4, P472, DOI 10.4103/0974-2700.86631; Shultz SR, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-26; Weng WJ, 2018, NEUROL RES, V40, P917, DOI 10.1080/01616412.2018.1497271; Zhao JL, 2019, WORLD NEUROSURG	29	7	7	0	0	FUTURE MEDICINE LTD	LONDON	UNITEC HOUSE, 3RD FLOOR, 2 ALBERT PLACE, FINCHLEY CENTRAL, LONDON, N3 1QB, ENGLAND	1752-0363	1752-0371		BIOMARK MED	Biomark. Med.	AUG	2020	14	12					1085	1090		10.2217/bmm-2020-0150			6	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	NS6XA	WOS:000572401100003	32969245				2022-02-06	
J	Schumacher, DJ; Holmboe, E; Carraccio, C; Martini, A; van der Vleuten, C; Busari, J; Sobolewski, B; Byczkowski, TL				Schumacher, Daniel J.; Holmboe, Eric; Carraccio, Carol; Martini, Abigail; van der Vleuten, Cees; Busari, Jamiu; Sobolewski, Brad; Byczkowski, Terri L.			Resident-Sensitive Quality Measures in the Pediatric Emergency Department: Exploring Relationships With Supervisor Entrustment and Patient Acuity and Complexity	ACADEMIC MEDICINE			English	Article							ENTRUSTABLE PROFESSIONAL ACTIVITIES; CARE; ASSOCIATION; OUTCOMES; PHYSICIANS; EDUCATION; FUTURE	Purpose This study explores the associations between resident-sensitive quality measures (RSQMs) and supervisor entrustment as well as between RSQMs and patient acuity and complexity for encounters in the pediatric emergency department (PED) in which residents are caring for patients. Method Pediatric residents rotating through Cincinnati Children's Hospital Medical Center PED as well as supervising pediatric emergency medicine faculty and fellows were recruited during the 2017-2018 academic year for the purpose of collecting the following data from the residents' patient encounters for 3 illnesses (acute asthma exacerbation, bronchiolitis, and closed head injury [CHI]): supervisor entrustment decision rating, RSQMs relevant to the care provided, and supervisor patient acuity and complexity ratings. To measure the association of RSQM composite scores with the other variables of interest, mixed models were used. Results A total of 83 residents cared for 110 patients with asthma, 112 with bronchiolitis, and 77 with CHI. Entrustment decision ratings were positively associated with asthma RSQM composite scores (beta coefficient = 0.03; P < .001). There was no significant association between RSQM composite scores and entrustment decision ratings for bronchiolitis or CHI. RSQM composite scores were significantly higher when acuity was also higher and significantly lower when acuity was also lower for both asthma (P < .001) and bronchiolitis (P = .01). However, RSQM composite scores were almost identical between levels of acuity for CHI (P = .94). There were no significant differences in RSQM composite scores when complexity varied. Conclusion This study found limited associations between RSQM composite scores and entrustment decision ratings but offers insight into how RSQMs could be used for the purposes of resident assessment and feedback.	[Martini, Abigail] Cincinnati Childrens Hosp Med Ctr, Div Emergency Med, MLC 2008,3333 Burnet Ave, Cincinnati, OH 45226 USA; [Schumacher, Daniel J.; Sobolewski, Brad; Byczkowski, Terri L.] Cincinnati Childrens Hosp Med Ctr, Pediat, Cincinnati, OH 45229 USA; [Schumacher, Daniel J.; Sobolewski, Brad; Byczkowski, Terri L.] Univ Cincinnati, Coll Med, Cincinnati, OH USA; [Holmboe, Eric] Accreditat Council Grad Med Educ, Milestones Dev & Evaluat, Chicago, IL USA; [Carraccio, Carol] Amer Board Pediat Inc, Competency Based Assessment, Chapel Hill, NC USA; [van der Vleuten, Cees] Maastricht Univ, Educ, Dept Educ Dev & Res, Fac Hlth Med & Life Sci, Maastricht, Netherlands; [van der Vleuten, Cees] Maastricht Univ, Sch Hlth Profess Educ, Maastricht, Netherlands; [Busari, Jamiu] Maastricht Univ, Med Educ, Maastricht, Netherlands		Schumacher, DJ (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Emergency Med, MLC 2008,3333 Burnet Ave, Cincinnati, OH 45226 USA.	daniel.schumacher@cchmc.org	Busari, Jamiu/C-9425-2018	Busari, Jamiu/0000-0002-8616-5564	Place Outcomes Research Award from Cincinnati Children's Hospital Medical Center	This study was funded by the Place Outcomes Research Award from Cincinnati Children's Hospital Medical Center. The authors also wish to thank Larissa Fomum-Mugri and Carter Richardson for their help with chart reviews for this study.	American Board of Pediatrics, ENTR PROF ACT GEN PE; Apramian T, 2018, ANN SURG, V268, P385, DOI 10.1097/SLA.0000000000002284; Asch DA, 2009, JAMA-J AM MED ASSOC, V302, P1277, DOI 10.1001/jama.2009.1356; Bansal N, 2016, JAMA SURG, V151, P111, DOI 10.1001/jamasurg.2015.3637; Butler JM, 2017, ACAD MED, V92, P984, DOI 10.1097/ACM.0000000000001474; Carraccio C, 2002, ACAD MED, V77, P361, DOI 10.1097/00001888-200205000-00003; Carraccio C, 2016, ACAD MED, V91, P199, DOI 10.1097/ACM.0000000000000985; Chen C, 2014, JAMA-J AM MED ASSOC, V312, P2385, DOI 10.1001/jama.2014.15973; Chen HC, 2015, ACAD MED, V90, P431, DOI 10.1097/ACM.0000000000000586; Denson JL, 2016, JAMA-J AM MED ASSOC, V316, P2204, DOI 10.1001/jama.2016.17424; Driessen E, 2013, MED TEACH, V35, P569, DOI 10.3109/0142159X.2013.798403; Frenk J, 2010, LANCET, V376, P1923, DOI 10.1016/S0140-6736(10)61854-5; Gingerich A, 2018, MED EDUC, V52, P1028, DOI 10.1111/medu.13621; Haan CK, 2008, ACAD MED, V83, P574, DOI 10.1097/ACM.0b013e318172318d; Hauer KE, 2014, ADV HEALTH SCI EDUC, V19, P435, DOI 10.1007/s10459-013-9474-4; Hicks PJ, 2016, ACAD MED, V91, P701, DOI 10.1097/ACM.0000000000001057; Holmboe ES, 2015, ACAD MED, V90, P411, DOI 10.1097/ACM.0000000000000515; Kalet AL, 2010, ACAD MED, V85, P844, DOI 10.1097/ACM.0b013e3181d734a5; Kennedy TJT, 2008, ACAD MED, V83, pS89, DOI 10.1097/ACM.0b013e318183c8b7; Kennedy TJT, 2009, MED EDUC, V43, P645, DOI 10.1111/j.1365-2923.2009.03382.x; Kogan JR, 2014, ACAD MED, V89, P721, DOI 10.1097/ACM.0000000000000221; Lau BD, 2015, JAMA SURG, V150, P813, DOI 10.1001/jamasurg.2015.0891; McGaghie W C, 1978, Public Health Pap, P11; Messick S, 1995, ED MEAS, V14, P5, DOI [10.1111/j.17453992.1995.tb00881.x, 10.1111/j.1745-3992.1995.tb00881.x]; Norman G, 2010, ADV HEALTH SCI EDUC, V15, P625, DOI 10.1007/s10459-010-9222-y; Phillips RL, 2017, ANN FAM MED, V15, P140, DOI 10.1370/afm.2044; Rekman J, 2016, ACAD MED, V91, P186, DOI 10.1097/ACM.0000000000001045; *SAS I, 2006, MIX MOD AN US SAS SY; Schumacher DJ, 2020, ACAD MED, V95, P1248, DOI 10.1097/ACM.0000000000003147; Schumacher DJ, 2019, ACAD PEDIATR, V19, P399, DOI 10.1016/j.acap.2018.10.006; Schumacher DJ, 2019, ACAD PEDIATR, V19, P177, DOI 10.1016/j.acap.2018.09.013; Schumacher DJ, 2018, ACAD MED, V93, P1071, DOI 10.1097/ACM.0000000000002093; Schumacher DJ, 2019, ACAD PEDIATR, V19, P144, DOI 10.1016/j.acap.2018.06.002; Schumacher DJ, 2016, JAMA PEDIATR, V170, P1131, DOI 10.1001/jamapediatrics.2016.2715; Sirovich BE, 2014, JAMA INTERN MED, V174, P1640, DOI 10.1001/jamainternmed.2014.3337; Smirnova A, 2017, ACAD MED, V92, P1740, DOI 10.1097/ACM.0000000000001964; Swing SR, 2007, ACAD EMERG MED, V14, P463, DOI 10.1197/j.aem.2006.12.011; ten Cate O, 2007, ACAD MED, V82, P542, DOI 10.1097/ACM.0b013e31805559c7; ten Cate O, 2017, MED EDUC, V51, P879, DOI 10.1111/medu.13362; van der Leeuw RM, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-65; Willis G. B., 2004, COGNITIVE INTERVIEWI; Willis Gordon B, 2013, J Grad Med Educ, V5, P353, DOI 10.4300/JGME-D-13-00154.1; Yin HS, 2015, J GEN INTERN MED, V30, P1363, DOI 10.1007/s11606-015-3329-z	43	7	7	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1040-2446	1938-808X		ACAD MED	Acad. Med.	AUG	2020	95	8					1256	1264		10.1097/ACM.0000000000003242			9	Education, Scientific Disciplines; Health Care Sciences & Services	Science Citation Index Expanded (SCI-EXPANDED)	Education & Educational Research; Health Care Sciences & Services	NE8CS	WOS:000562831800048	32101934	Bronze			2022-02-06	
J	VanGilder, JL; Walter, CS; Hengge, CR; Schaefer, SY				VanGilder, Jennapher Lingo; Walter, Christopher S.; Hengge, Caitlin R.; Schaefer, Sydney Y.			Exploring the relationship between visuospatial function and age-related deficits in motor skill transfer	AGING CLINICAL AND EXPERIMENTAL RESEARCH			English	Article						Motor control; Rehabilitation; Cognitive aging	MONTREAL COGNITIVE ASSESSMENT; MENTAL-STATE-EXAMINATION; TRAUMATIC BRAIN-INJURY; OLDER-ADULTS; TASK; STROKE; FEASIBILITY; PERFORMANCE; IMPAIRMENT; ABILITIES	Background Generalizing learned information from one motor task to another is critical for effective motor rehabilitation. A recent study demonstrated age-related declines in motor skill transfer, yet findings from other motor learning studies suggest that visuospatial impairments may explain such aging effects. Aims The purpose of this secondary analysis was to test whether age-related deficits in motor skill transfer were related to low visuospatial ability. Methods Forty-two participants (mean +/- SD age: 72.1 +/- 9.9 years) were tested on an upper extremity dexterity task before and after 3 days of training on an upper extremity reaching task. Training and control data have been published previously. Prior to training, global cognitive status and specific cognitive domains (visuospatial/executive, attention, and delayed memory) were evaluated using the Montreal Cognitive Assessment. Results Backward-stepwise linear regression indicated that the Visuospatial/Executive subtest was related to motor skill transfer (i.e., the amount of change in performance on the untrained motor task), such that participants with higher visuospatial scores improved more on the untrained dexterity task than those with lower scores. Global cognitive status was unrelated to motor skill transfer. Discussion Consistent with previous studies showing a positive relationship between visuospatial function and other aspects of motor learning, this secondary analysis indicates that less motor skill transfer among older adults may indeed be due to declines in visuospatial function. Conclusions The present study highlights the potential utility of assessing older patients' visuospatial ability within motor rehabilitation to provide valuable insight into the extent to which they may learn and generalize motor skills through training.	[VanGilder, Jennapher Lingo; Schaefer, Sydney Y.] Arizona State Univ, Sch Biol & Hlth Syst Engn, 501 E Tyler Mall,MC 9709, Tempe, AZ 85287 USA; [Walter, Christopher S.] Univ Arkansas Med Sci, Dept Phys Therapy, 4301 W Markham St, Little Rock, AR 72205 USA; [Hengge, Caitlin R.] Univ Utah Hosp, 50 N Med Dr, Salt Lake City, UT 84132 USA; [Schaefer, Sydney Y.] Univ Utah, Dept Phys Therapy & Athlet Training, Salt Lake City, UT 84112 USA		Schaefer, SY (corresponding author), Arizona State Univ, Sch Biol & Hlth Syst Engn, 501 E Tyler Mall,MC 9709, Tempe, AZ 85287 USA.; Schaefer, SY (corresponding author), Univ Utah, Dept Phys Therapy & Athlet Training, Salt Lake City, UT 84112 USA.	sydney.schaefer@asu.edu			NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [K01AG047926, F31AG062057] Funding Source: NIH RePORTER; Achievement Rewards for College Scientists FoundationGeneral Electric [Spetzler Scholarship] Funding Source: Medline; NIA NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [K01 AG047926, F31 AG062057] Funding Source: Medline; HRSA HHS [U1QHP28723] Funding Source: Medline		Bendayan R, 1800, J Aging Res, V2017, P6210105, DOI 10.1155/2017/6210105; Bo J, 2009, J NEUROPHYSIOL, V101, P3116, DOI 10.1152/jn.00006.2009; Bosco A, 2017, AGING CLIN EXP RES, V29, P1113, DOI 10.1007/s40520-017-0727-6; Burton L, 2015, J REHABIL MED, V47, P193, DOI 10.2340/16501977-1930; Cheong YS, 2018, ANN REHABIL MED-ARM, V42, P18, DOI 10.5535/arm.2018.42.1.18; Cumming TB, 2013, ACTA NEUROL SCAND, V128, P122, DOI 10.1111/ane.12084; FLEISHMAN EA, 1963, J EXP PSYCHOL, V66, P6, DOI 10.1037/h0046677; Frankel JE, 2006, ARCH PHYS MED REHAB, V87, P57, DOI 10.1016/j.apmr.2005.07.309; Godfrey SB, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0205653; Hoeft F, 2007, J NEUROSCI, V27, P11960, DOI 10.1523/JNEUROSCI.3591-07.2007; Hopman-Rock M, 2019, AGING CLIN EXP RES, V31, P917, DOI 10.1007/s40520-018-1034-6; Horvat M, 2013, RES DEV DISABIL, V34, P3517, DOI 10.1016/j.ridd.2013.06.038; KATZ S, 1970, GERONTOLOGIST, V10, P20, DOI 10.1093/geront/10.1_Part_1.20; Krishna R, 2012, COGN BEHAV NEUROL, V25, P7, DOI 10.1097/WNN.0b013e318248ff1b; Malek-Ahmadi M, 2018, AGING CLIN EXP RES, V30, P993, DOI 10.1007/s40520-017-0865-x; Malek-Ahmadi M, 2016, AGING CLIN EXP RES, V28, P333, DOI 10.1007/s40520-015-0388-2; Masiero S, 2006, AGING CLIN EXP RES, V18, P261; McLafferty FS, 2016, NEUROREHABILITATION, V39, P423, DOI 10.3233/NRE-161373; Moafmashhadi P, 2013, J GERIATR PSYCH NEUR, V26, P19, DOI 10.1177/0891988712473802; Mohabbati-Kalejahi N, 2017, SCIENTOMETRICS, V113, P969, DOI 10.1007/s11192-017-2482-z; Mosenthal AC, 2004, J TRAUMA, V56, P1042, DOI 10.1097/01.TA.0000127767.83267.33; Muniz-Terrera G, 2019, J AGING HEALTH, V31, P743, DOI 10.1177/0898264317753878; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Page SJ, 2004, ARCH PHYS MED REHAB, V85, P14, DOI 10.1016/S0003-9993(03)00481-7; Ridley N, 2018, J CLIN EXP NEUROPSYC, V40, P107, DOI 10.1080/13803395.2017.1316970; Rodrigue KM, 2005, J GERONTOL B-PSYCHOL, V60, pP174, DOI 10.1093/geronb/60.4.P174; Schaefer SY, 2016, EXP BRAIN RES, V234, P229, DOI 10.1007/s00221-015-4454-y; Schaefer SY, 2017, J CLIN EXP NEUROPSYC, V39, P473, DOI 10.1080/13803395.2016.1236905; Schaefer SY, 2015, NEUROREHAB NEURAL RE, V29, P636, DOI 10.1177/1545968314558604; Schaefer SY, 2015, NEUROSCIENCE, V294, P51, DOI 10.1016/j.neuroscience.2015.03.013; Schaefer SY, 2013, NEUROREHAB NEURAL RE, V27, P602, DOI 10.1177/1545968313481279; Schaefer SY, 2012, J MOTOR BEHAV, V44, P313, DOI 10.1080/00222895.2012.708367; Schmidt R, 2005, MOTOR CONTROL LEARNI, V4th; Seidler RD, 2010, EXERC SPORT SCI REV, V38, P3, DOI 10.1097/JES.0b013e3181c5cce7; Shea CH, 2006, PHYS THER, V86, P478, DOI 10.1093/ptj/86.4.478; SOLIVERI P, 1992, J NEUROL NEUROSUR PS, V55, P454, DOI 10.1136/jnnp.55.6.454; Steele CJ, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00289; Talwar NA, 2019, FRONT HUM NEUROSCI, V13, DOI 10.3389/fnhum.2019.00025; Toglia J, 2011, ARCH PHYS MED REHAB, V92, P792, DOI 10.1016/j.apmr.2010.12.034; TOGLIA JP, 1991, AM J OCCUP THER, V45, P505, DOI 10.5014/ajot.45.6.505; VanGilder JL, 2018, NEUROSCI LETT, V664, P139, DOI 10.1016/j.neulet.2017.11.032; Vogel Sally J, 2015, Alzheimers Dement (Amst), V1, P289, DOI 10.1016/j.dadm.2015.05.002; Waddell KJ, 2014, AM J OCCUP THER, V68, P444, DOI 10.5014/ajot.2014.011619; Walmsley N, 2017, INVISIBLE EFFECTS ST; Walter CS, 2019, EXP GERONTOL, V116, P14, DOI 10.1016/j.exger.2018.12.012; Wittenberg GF, 2014, BRAIN IMAGING BEHAV, V8, P335, DOI 10.1007/s11682-012-9204-1	47	7	7	1	3	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	1594-0667	1720-8319		AGING CLIN EXP RES	Aging Clin. Exp. Res.	AUG	2020	32	8					1451	1458		10.1007/s40520-019-01345-w			8	Geriatrics & Gerontology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Geriatrics & Gerontology	NF2JG	WOS:000563125700006	31520336	Green Accepted			2022-02-06	
J	Williamson, T; Ryser, MD; Ubel, PA; Abdelgadir, J; Spears, CA; Liu, BY; Komisarow, J; Lemmon, ME; Elsamadicy, A; Lad, SP				Williamson, Theresa; Ryser, Marc D.; Ubel, Peter A.; Abdelgadir, Jihad; Spears, Charis A.; Liu, Beiyu; Komisarow, Jordan; Lemmon, Monica E.; Elsamadicy, Aladine; Lad, Shivanand P.			Withdrawal of Life-supporting Treatment in Severe Traumatic Brain Injury	JAMA SURGERY			English	Article							ADULT PATIENTS; CARE; PROGNOSIS; MORTALITY	This cohort study examines the demographic and clinical factors associated with the decision to withdraw life-supporting treatment in patients with severe traumatic brain injury. Importance There are limited data on which factors affect the critical and complex decision to withdraw life-supporting treatment (LST) in patients with severe traumatic brain injury (sTBI). Objective To determine demographic and clinical factors associated with the decision to withdraw LST in patients with sTBI. Design, Setting, and Participants This retrospective analysis of inpatient data from more than 825 trauma centers across the US in the American College of Surgeons Trauma Quality Improvement Program database from January 2013 to December 2015 included adult patients with sTBI and documentation of a decision regarding withdrawal of LST (WLST). Data analysis was conducted in September 2019. Main Outcomes and Measures Factors associated with WLST in sTBI. Results A total of 37931 patients (9817 women [25.9%]) were included in the multivariable analysis; 7864 (20.7%) had WLST. Black patients (4806 [13.2%]; odds ratio [OR], 0.66; 95% CI, 0.59-0.72; P < .001) and patients of other race (4798 [13.2%]; OR, 0.83; 95% CI, 0.76-0.91; P < .001) were less likely than white patients (26.864 [73.7%]) to have WLST. Patients from hospitals in the Midwest (OR, 1.12; 95% CI, 1.04-1.20; P = .002) or Northeast (OR, 1.23; 95% CI, 1.13-1.34; P < .001) were more likely to have WLST than patients from hospitals in the South. Patients with Medicare (OR, 1.55; 95% CI, 1.43-1.69; P < .001) and self-pay patients (OR, 1.36; 95% CI, 1.25-1.47; P < .001) were more likely to have WLST than patients with private insurance. Older patients and those with lower Glasgow Coma Scale scores, higher Injury Severity Scores, or craniotomy were generally more likely to have WLST. Withdrawal of LST was more likely for patients with functionally dependent health status (OR, 1.30; 95% CI, 1.08-1.58; P = .01), hematoma (OR, 1.19; 95% CI, 1.12-1.27; P < .001), dementia (OR, 1.29; 95% CI, 1.08-1.53; P = .004), and disseminated cancer (OR, 2.82; 95% CI, 2.07-3.82; P < .001) than for patients without these conditions. Conclusions and Relevance Withdrawal of LST is common in sTBI and socioeconomic factors are associated with the decision to withdraw LST. These results highlight the many factors that contribute to decision-making in sTBI and demonstrate that in a complex and variable disease process, variation based on race, payment, and region presents as a potential challenge. Question Which factors are associated with the decision to withdraw life-supporting treatment (LST) in patients with severe traumatic brain injury in the US? Findings In this large, multicenter cohort study, race, geographic region, and payment status were significantly associated with the decision to withdraw LST. Associated clinical factors included older age, lower Glasgow Coma Scale score, functionally dependent health status, hematoma, dementia, and disseminated cancer. Meaning In addition to clinical factors, there is evidence for socioeconomic variation in the decision to withdraw LST in patients with severe traumatic brain injury.	[Williamson, Theresa; Abdelgadir, Jihad; Spears, Charis A.; Komisarow, Jordan; Elsamadicy, Aladine; Lad, Shivanand P.] Duke Univ, Med Ctr, Dept Neurosurg, DUMC Box 3807, Durham, NC 27710 USA; [Williamson, Theresa; Abdelgadir, Jihad; Spears, Charis A.; Liu, Beiyu; Komisarow, Jordan; Lemmon, Monica E.; Lad, Shivanand P.] Duke Univ, Sch Med, Durham, NC 27710 USA; [Ryser, Marc D.] Duke Univ, Dept Populat Hlth Sci, Med Ctr, Durham, NC 27710 USA; [Ubel, Peter A.] Duke Margolis Ctr Hlth Policy, Durham, NC USA; [Ubel, Peter A.] Duke Univ, Fuqua Sch Business, Durham, NC 27710 USA; [Lemmon, Monica E.] Duke Univ, Dept Pediat, Med Ctr, Durham, NC 27710 USA		Williamson, T (corresponding author), Duke Univ, Med Ctr, Dept Neurosurg, DUMC Box 3807, Durham, NC 27710 USA.	williamson@duke.edu		Komisarow, Jordan/0000-0003-3919-7931; Spears, Charis/0000-0003-2814-2767	Duke University; National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS); Derfner Foundation	Dr Liu reported grants from Duke University during the conduct of the study. Dr Lemmon reported grants from the National Institute of Neurological Disorders and Stroke and Derfner Foundation during the conduct of the study. No other disclosures were reported.	Anderson WG, 2008, J GEN INTERN MED, V23, P1871, DOI 10.1007/s11606-008-0770-2; Carney N., 2016, GUIDELINES MANAGEMEN, V4th; Cote N, 2013, NEUROCRIT CARE, V18, P154, DOI 10.1007/s12028-012-9787-9; Diringer MN, 2001, CRIT CARE MED, V29, P1792, DOI 10.1097/00003246-200109000-00023; Feeney JM, 2016, J TRAUMA ACUTE CARE, V81, P843, DOI 10.1097/TA.0000000000001245; Finkelstein E.A., 2006, INCIDENCE EC BURDEN, DOI [10.1093/acprof:oso/9780195179484.001.0001, DOI 10.1093/ACPROF:OSO/9780195179484.001.0001]; Fiscella K, 2016, ANNU REV PUBL HEALTH, V37, P375, DOI 10.1146/annurev-publhealth-032315-021439; Gorji N, 2018, AMIA ANN S P, V2017, P780; Honeybul S, 2016, ACTA NEUROCHIR, V158, P1251, DOI 10.1007/s00701-016-2818-0; Livingston DH, 2009, J TRAUMA, V67, P341, DOI 10.1097/TA.0b013e3181a5cc34; McCredie VA, 2016, J TRAUMA ACUTE CARE, V80, P484, DOI 10.1097/TA.0000000000000922; Murray GD, 2007, J NEUROTRAUM, V24, P329, DOI 10.1089/neu.2006.0035; National Scientific Advisory Committee, 2004, ID PRIOR RES CAP DEV; Orlovic M, 2019, SSM-POPUL HLTH, V7, DOI 10.1016/j.ssmph.2018.100331; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Quinn T, 2017, NEUROCRIT CARE, V27, P154, DOI 10.1007/s12028-017-0427-2; Rocker GM, 2006, CAN J ANAESTH, V53, P814, DOI 10.1007/BF03022799; Rodrigo C, 2013, INT J CLIN PRACT, V67, P97, DOI 10.1111/ijcp.12043; Rubin M, 2017, CURR OPIN CRIT CARE, V23, P134, DOI 10.1097/MCC.0000000000000396; Souter MJ, 2015, NEUROCRIT CARE, V23, P4, DOI 10.1007/s12028-015-0137-6; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Turgeon AF, 2019, CAN MED ASSOC J, V191, pE652, DOI 10.1503/cmaj.190154; Turgeon AF, 2013, CRIT CARE MED, V41, P1086, DOI 10.1097/CCM.0b013e318275d046; Turgeon AF, 2011, CAN MED ASSOC J, V183, P1581, DOI 10.1503/cmaj.101786; White DB, 2016, JAMA-J AM MED ASSOC, V315, P2086, DOI 10.1001/jama.2016.5351; Williamson T, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0228947; Zeitoun N, 2015, HOSPITALIST, V2015, P1	27	7	7	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	2168-6254	2168-6262		JAMA SURG	JAMA Surg.	AUG	2020	155	8					723	731		10.1001/jamasurg.2020.1790			9	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	NG9HT	WOS:000564292600011	32584926	Green Published			2022-02-06	
J	Wu, JC; He, JC; Tian, XC; Li, H; Wen, Y; Shao, Q; Cheng, CJ; Wang, GY; Sun, XC				Wu, Jingchuan; He, Junchi; Tian, Xiaocui; Li, Hui; Wen, Yi; Shao, Qiang; Cheng, Chongjie; Wang, Guangyu; Sun, Xiaochuan			Upregulation of miRNA-9-5p Promotes Angiogenesis after Traumatic Brain Injury by Inhibiting Ptch-1	NEUROSCIENCE			English	Article						microRNA-9-5p; Ptch-1; Hedgehog pathway; Angiogenesis; Traumatic brain injury	SONIC HEDGEHOG; CELL-PROLIFERATION; ENDOTHELIAL-CELLS; TUMOR-GROWTH; MIGRATION; EXPRESSION; PATHWAY; MICRORNAS; RECOVERY; PI3K/AKT	MicroRNA-9-5p (miRNA-9-5p) is an important regulator of angiogenesis in many pathological states. However, the effect of miRNA-9-5p on angiogenesis after traumatic brain injury (TBI) has not been elucidated. In this study, a controlled cortical impact (CCI) model was used to induce TBI in Sprague-Dawley rats, and an oxygen glucose deprivation (OGD) model was used to mimic the pathological state in vitro. Brain microvascular endothelial cells (BMECs) were extracted from immature rats. The results showed that the level of miRNA-9-5p was significantly increased in the traumatic foci after TBI, and the upregulation of miRNA9-5p promoted the recovery of neurological function. Moreover, the upregulation of miRNA-9-5p with miRNA agomir significantly increased the density of the microvascular and neurons around the traumatic foci in rats after TBI. The results of the in vitro experiments confirmed that the upregulation of miRNA-9-5p with a miRNA mimic improved cellular viability and alleviated cellular apoptosis. Dual luciferase reporter assay validated that miRNA-9-5p was a post-transcriptional modulator of Ptch-1. Activation of the Hedgehog pathway by increasing the level of miRNA-9-5p promoted the migration and tube formation of BMECs in vitro. In addition, we found that the upregulation of miRNA-9-5p activated the Hedgehog pathway and increased the phosphorylation of AKT, which promoted the expression of cyclin D1, MMP-9 and VEGF in BMECs. All these results indicate that the upregulation of miRNA9-5p promotes angiogenesis and improves neurological functional recovery after TBI, mainly by activating the Hedgehog pathway. MiRNA-9-5p may be a potential new therapeutic target for TBI. (C) 2020 IBRO. Published by Elsevier Ltd. All rights reserved.	[Wu, Jingchuan; Wen, Yi; Shao, Qiang] Wuhan Brain Hosp, Gen Hosp YangTze River Shipping, Dept Neurosurg, Wuhan 430014, Hubei, Peoples R China; [Wu, Jingchuan; He, Junchi; Li, Hui; Cheng, Chongjie; Sun, Xiaochuan] Chongqing Med Univ, Affiliated Hosp 1, Dept Neurosurg, Chongqing 400016, Peoples R China; [Tian, Xiaocui] Chongqing Med Univ, Coll Pharm, Chongqing Key Lab Biochem & Mol Pharmacol, Chongqing 400016, Peoples R China; [Wang, Guangyu] Shandong Univ, Qi Lu Childrens Hosp, Dept Neurosurg, Jinan 250022, Shandong, Peoples R China		Cheng, CJ; Sun, XC (corresponding author), Chongqing Med Univ, Affiliated Hosp 1, Dept Neurosurg, Chongqing 400016, Peoples R China.; Wang, GY (corresponding author), Shandong Univ, Qi Lu Childrens Hosp, Dept Neurosurg, Jinan 250022, Shandong, Peoples R China.	358187887@qq.com; wgywjc@163.com; sunxch1445@qq.com	Wu, Jingchuan/AAV-7799-2020; 风, 张/AAR-1410-2020	Wu, Jingchuan/0000-0002-1213-4888; 	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81571159]; National Natural Science Foundation for Youth of ChinaNational Natural Science Foundation of China (NSFC) [81601072]; Health Commission of Wuhan Municipality scientific research Funding [WX19Q17]; Health Commission of Hubei Province scientific research project [WJ2019H364]; Health Commission of Wuhan Municipality Guidance Project	This work was supported by grants from the National Natural Science Foundation of China (NO. 81571159), and National Natural Science Foundation for Youth of China (No. 81601072), and Health Commission of Wuhan Municipality scientific research Funding (No. WX19Q17), and Health Commission of Hubei Province scientific research project (No. WJ2019H364), and Health Commission of Wuhan Municipality Guidance Project (No.WX18Z23).	Agimi Y, 2018, AM J PUBLIC HEALTH, V108, P683, DOI 10.2105/AJPH.2018.304347; Alvarez-Buylla A, 2014, SEMIN CELL DEV BIOL, V33, P105, DOI 10.1016/j.semcdb.2014.05.008; Andreuzzi E, 2017, MATRIX BIOL, V64, P40, DOI 10.1016/j.matbio.2017.04.002; Buller B, 2012, GLIA, V60, P1906, DOI 10.1002/glia.22406; Calcaterra A, 2018, J ENZYM INHIB MED CH, V33, P349, DOI 10.1080/14756366.2017.1419221; Cao F, 2016, J NEUROTRAUM, V33, P175, DOI 10.1089/neu.2015.3887; Chakraborty S, 2015, AM J PHYSIOL-CELL PH, V309, pC680, DOI 10.1152/ajpcell.00122.2015; Chen X, 2019, J EXP CLIN CANC RES, V38, DOI 10.1186/s13046-019-1078-2; Churov A, 2019, INT J MOL SCI, V20; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Fu W, 2020, EXP THER MED, V19, P165, DOI 10.3892/etm.2019.8194; Ge XT, 2014, SCI REP-UK, V4, DOI 10.1038/srep06718; Giedt RJ, 2012, ANN BIOMED ENG, V40, P1903, DOI 10.1007/s10439-012-0568-6; Gonzalez A, 2015, INT J MOL MED, V36, P1671, DOI 10.3892/ijmm.2015.2360; Greenberg DA, 2005, NATURE, V438, P954, DOI 10.1038/nature04481; Huang XT, 2013, J NEUROTRAUM, V30, P2080, DOI 10.1089/neu.2013.2996; Kim A, 2014, SCI REP-UK, V4, DOI 10.1038/srep06994; Lei P, 2009, BRAIN RES, V1284, P191, DOI 10.1016/j.brainres.2009.05.074; Leng XY, 2018, BRAZ J MED BIOL RES, V51, DOI [10.1590/1414-431X20187862, 10.1590/1414-431x20187862]; Li SH, 2016, J MOL NEUROSCI, V60, P71, DOI 10.1007/s12031-016-0793-9; Li Y, 2019, INT J CLIN EXP PATHO, V12, P4181; Li Y, 2017, CANCER LETT, V397, P111, DOI 10.1016/j.canlet.2017.03.032; Liang H, 2017, SCI REP-UK, V7, DOI 10.1038/srep40361; Liang Z, 2018, EUR REV MED PHARMACO, V22, P3485, DOI 10.26355/eurrev_201806_15175; Liao K, 2014, INT J CLIN EXP PATHO, V7, P8684; Lin Y, 2018, INVEST OPHTH VIS SCI, V59, P5431, DOI 10.1167/iovs.17-23558; Lu HY, 2012, STROKE, V43, P838, DOI 10.1161/STROKEAHA.111.635235; LU Y, 2019, EXP CELL RES, DOI DOI 10.1002/FUCE.201900097; Madeddu P, 2005, EXP PHYSIOL, V90, P315, DOI 10.1113/expphysiol.2004.028571; Mayilsamy K, 2019, REV NEUROSCI; Nampoothiri SS, 2019, CELL MOL NEUROBIOL, V39, P223, DOI 10.1007/s10571-018-0642-1; Nie DM, 2016, AM J PHYSIOL-CELL PH, V310, pC821, DOI 10.1152/ajpcell.00372.2015; Ning RZ, 2011, BRAIN RES, V1384, P140, DOI 10.1016/j.brainres.2011.01.099; Niu C, 2019, AUTOPHAGY, V15, P843, DOI 10.1080/15548627.2019.1569913; Pan PJ, 2019, J CLIN MED, V8; Petri R, 2014, EXP CELL RES, V321, P84, DOI 10.1016/j.yexcr.2013.09.022; Pietzka S, 2019, CLIN ORAL INVESTIG; Redell JB, 2009, J NEUROSCI RES, V87, P1435, DOI 10.1002/jnr.21945; Renault MA, 2010, J MOL CELL CARDIOL, V49, P490, DOI 10.1016/j.yjmcc.2010.05.003; Sengupta D, 2018, ACS CHEM NEUROSCI, V9, P725, DOI 10.1021/acschemneuro.7b00423; Shahror RA, 2019, J NEUROTRAUM, DOI 10.1089/neu.2019.6422; Singh VB, 2016, SCI REP-UK, V6, DOI 10.1038/srep26876; Sun TY, 2014, J HUAZHONG U SCI-MED, V34, P548, DOI 10.1007/s11596-014-1313-1; Tang H, 2019, EXP CELL RES, V383, DOI 10.1016/j.yexcr.2019.111541; Tang YL, 2015, ONCOTARGET, V6, P9031, DOI 10.18632/oncotarget.3320; Tian XC, 2016, J NEUROCHEM, V139, P757, DOI 10.1111/jnc.13833; Tiwari A, 2018, CURR CANCER DRUG TAR, V18, P266, DOI 10.2174/1568009617666170630142725; Truettner JS, 2011, J CEREBR BLOOD F MET, V31, P1897, DOI 10.1038/jcbfm.2011.33; Wang C, 2019, INT J BIOL MACROMOL, V135, P212, DOI 10.1016/j.ijbiomac.2019.05.101; Xie YL, 2019, BIOSCI REP; Yan N, 2012, CANCER SCI, V103, P1631, DOI 10.1111/j.1349-7006.2012.02350.x; Yao HB, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4943; Zeng Q, 2017, CELL PHYSIOL BIOCHEM, V43, P1813, DOI 10.1159/000484068; Zheng K, 2013, J HUAZHONG U SCI-MED, V33, P335, DOI 10.1007/s11596-013-1120-0; Zhong JJ, 2017, BRAIN BEHAV IMMUN, V65, P183, DOI 10.1016/j.bbi.2017.05.001; Zhou Y, 2018, BRAIN SCI, V8; Zhu LF, 2019, CLIN ORAL INVEST, V23, P2497, DOI 10.1007/s00784-018-2699-0	57	7	7	0	4	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0306-4522	1873-7544		NEUROSCIENCE	Neuroscience	AUG 1	2020	440						160	174		10.1016/j.neuroscience.2020.05.045			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	MJ4QM	WOS:000548076800012	32502567				2022-02-06	
J	Bohnert, S; Seiffert, A; Trella, S; Bohnert, M; Distel, L; Ondruschka, B; Monoranu, CM				Bohnert, Simone; Seiffert, Anja; Trella, Stefanie; Bohnert, Michael; Distel, Luitpold; Ondruschka, Benjamin; Monoranu, Camelia-Maria			TMEM119 as a specific marker of microglia reaction in traumatic brain injury in postmortem examination	INTERNATIONAL JOURNAL OF LEGAL MEDICINE			English	Article						Cerebrospinal fluid; Forensic neuropathology; Forensic neurotraumatology; Immunohistochemistry; Immunocytochemistry; Biomarker	PERIVASCULAR MACROPHAGES; SPINAL-CORD; EXPRESSION; BIOMARKERS; ACTIVATION; REVEALS; CELLS	The aim of the present study was a refined analysis of neuroinflammation including TMEM119 as a useful microglia-specific marker in forensic assessments of traumatic causes of death, e.g., traumatic brain injury (TBI). Human brain tissue samples were obtained from autopsies and divided into cases with lethal TBI (n = 25) and subdivided into three groups according to their trauma survival time and compared with an age-, gender-, and postmortem interval-matched cohort of sudden cardiovascular fatalities as controls (n = 23). Brain tissue samples next to cortex contusions and surrounding white matter as well as samples of the ipsilateral uninjured brain stem and cerebellum were collected and stained immunohistochemically with antibodies against TMEM119, CD206, and CCR2. We could document the highest number of TMEM119-positive cells in acute TBI death with highly significant differences to the control numbers. CCR2-positive monocytes showed a significantly higher cell count in the cortex samples of TBI cases than in the controls with an increasing number of immunopositive cells over time. The number of CD206-positive M2 microglial cells increased survival time-dependent. After 3 days of survival, the cell number increased significantly in all four regions investigated compared with controls. In sum, we validate a specific and robustly expressed as well as fast reacting microglia marker, TMEM119, which distinguishes microglia from resident and infiltrating macrophages and thus offers a great potential for the estimation of the minimum survival time after TBI.	[Bohnert, Simone; Seiffert, Anja; Trella, Stefanie; Bohnert, Michael] Univ Wurzburg, Inst Forens Med, Versbacher Str 3, D-97078 Wurzburg, Germany; [Distel, Luitpold] Friedrich Alexander Univ Erlangen Nurnberg, Dept Radiat Oncol, Univ Str 27, D-91054 Erlangen, Germany; [Ondruschka, Benjamin] Univ Med Ctr Hamburg Eppendorf, Inst Legal Med, Butenfeld 34, D-22529 Hamburg, Germany; [Monoranu, Camelia-Maria] Univ Wurzburg, Inst Pathol, Dept Neuropathol, Josef Schneider Str 2, D-97080 Wurzburg, Germany		Bohnert, S (corresponding author), Univ Wurzburg, Inst Forens Med, Versbacher Str 3, D-97078 Wurzburg, Germany.	simone.bohnert@uni-wuerzburg.de	Distel, Luitpold/ABD-9880-2020	Distel, Luitpold/0000-0002-8040-3226	Projekt DEAL	Open Access funding provided by Projekt DEAL. We would like to thank the technical assistants Heiko Besenfelder and Max Perschneck, Institute of Forensic Medicine, University of Wuerzburg, for their excellent support in collecting the specimens, and Michaela Hartmann, Institute of Forensic Medicine, University of Wuerzburg, for her help with the preparations and stains.	Agoston DV, 2017, BRAIN INJURY, V31, P1195, DOI 10.1080/02699052.2017.1357836; Aguzzi A, 2013, SCIENCE, V339, P156, DOI 10.1126/science.1227901; Auffray C, 2007, SCIENCE, V317, P666, DOI 10.1126/science.1142883; Bennett ML, 2016, P NATL ACAD SCI USA, V113, pE1738, DOI 10.1073/pnas.1525528113; Boche D, 2013, NEUROPATH APPL NEURO, V39, P3, DOI 10.1111/nan.12011; Bohnert S, 2019, INT J LEGAL MED, V133, P1141, DOI 10.1007/s00414-019-02050-z; Bratzke H, 2011, RECHTSMEDIZIN, V21, P177, DOI 10.1007/s00194-011-0768-7; Buttner A, 2011, NEUROPATH APPL NEURO, V37, P118, DOI 10.1111/j.1365-2990.2010.01131.x; Dave JR, 1997, NEUROREPORT, V8, P395, DOI 10.1097/00001756-199701200-00002; David S, 2011, NAT REV NEUROSCI, V12, P388, DOI 10.1038/nrn3053; Dettmeyer R.B., 2018, FORENSIC HISTOPATHOL; Donat CK, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00208; Fenn AM, 2014, BIOL PSYCHIAT, V76, P575, DOI 10.1016/j.biopsych.2013.10.014; Galea I, 2005, GLIA, V49, P375, DOI 10.1002/glia.20124; Garre JM, 2018, J MOL MED, V96, P873, DOI 10.1007/s00109-018-1672-3; Harel A, 2016, ENEURO, V3, DOI 10.1523/ENEURO.0139-16.2016; Hausmann R, 2000, INT J LEGAL MED, V113, P288, DOI 10.1007/s004149900126; Hausmann R, 2007, INT J LEGAL MED, V121, P175, DOI 10.1007/s00414-006-0122-x; Hickman SE, 2013, NAT NEUROSCI, V16, P1896, DOI 10.1038/nn.3554; Holder GE, 2014, J NEUROIMMUNE PHARM, V9, P716, DOI 10.1007/s11481-014-9564-y; Hu XM, 2015, NAT REV NEUROL, V11, P56, DOI 10.1038/nrneurol.2014.207; Jin XM, 2016, J BIOCHEM, V159, P491, DOI 10.1093/jb/mvw009; Kalkman HO, 2016, PHARMACOL THERAPEUT, V163, P82, DOI 10.1016/j.pharmthera.2016.04.001; Kettenmann H, 2011, PHYSIOL REV, V91, P461, DOI 10.1152/physrev.00011.2010; Kumar A, 2016, J NEUROTRAUM, V33, P1732, DOI 10.1089/neu.2015.4268; Kumar A, 2012, BRAIN BEHAV IMMUN, V26, P1191, DOI 10.1016/j.bbi.2012.06.008; Loane DJ, 2016, EXP NEUROL, V275, P316, DOI 10.1016/j.expneurol.2015.08.018; Miron VE, 2013, NAT NEUROSCI, V16, P1211, DOI 10.1038/nn.3469; Nimmerjahn A, 2005, SCIENCE, V308, P1314, DOI 10.1126/science.1110647; Oehmichen M, 1999, ACTA NEUROPATHOL, V97, P491, DOI 10.1007/s004010051018; Oerter S, 2019, INT J LEGAL MED, V133, P1107, DOI 10.1007/s00414-018-1893-6; Olczak M, 2017, FORENSIC SCI INT, V280, P1, DOI 10.1016/j.forsciint.2017.09.008; Ondruschka B, 2018, J NEUROTRAUM, V35, P2044, DOI 10.1089/neu.2017.5441; Ondruschka B, 2018, INT J LEGAL MED, V132, P531, DOI 10.1007/s00414-017-1768-2; Orihuela R, 2016, BRIT J PHARMACOL, V173, P649, DOI 10.1111/bph.13139; Perry VH, 2010, NAT REV NEUROL, V6, P193, DOI 10.1038/nrneurol.2010.17; Piek J., 2018, HDB SCHADELHIRN TRAU; Pretscher D, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-292; Satoh J, 2016, NEUROPATHOLOGY, V36, P39, DOI 10.1111/neup.12235; Schober K, 2015, INT J LEGAL MED, V129, P701, DOI 10.1007/s00414-014-1129-3; Shechter R, 2013, IMMUNITY, V38, P555, DOI 10.1016/j.immuni.2013.02.012; Sieber M, 2018, J FORENSIC LEG MED, V55, P65, DOI 10.1016/j.jflm.2018.02.016; Trautz F, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-48145-w; Trautz F, 2018, INT J LEGAL MED, V132, P1103, DOI 10.1007/s00414-017-1767-3; Wang KK, 2018, EXPERT REV MOL DIAGN, V18, P165, DOI 10.1080/14737159.2018.1428089; Weber M, 2006, NEUROSCIENCE, V138, P1215, DOI 10.1016/j.neuroscience.2005.11.059; Wei J, 2013, CLIN DEV IMMUNOL, V2013, P1; Xu HZ, 2017, NEURAL PLAST, V2017, DOI 10.1155/2017/5405104; Xue J, 2014, IMMUNITY, V40, P274, DOI 10.1016/j.immuni.2014.01.006; Yokobori S, 2013, CNS NEUROSCI THER, V19, P556, DOI 10.1111/cns.12127; Zetterberg H, 2013, NAT REV NEUROL, V9, P201, DOI 10.1038/nrneurol.2013.9	51	7	7	5	8	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0937-9827	1437-1596		INT J LEGAL MED	Int. J. Legal Med.	NOV	2020	134	6					2167	2176		10.1007/s00414-020-02384-z		JUL 2020	10	Medicine, Legal	Science Citation Index Expanded (SCI-EXPANDED)	Legal Medicine	OE5OZ	WOS:000552966900001	32719959	Green Published, hybrid			2022-02-06	
J	Furman, NT; Gottlieb, A; Prabhakara, KS; Bedi, S; Caplan, HW; Ruppert, KA; Srivastava, AK; Olson, SD; Cox, CS				Furman, Naama Toledano; Gottlieb, Assaf; Prabhakara, Karthik S.; Bedi, Supinder; Caplan, Henry W.; Ruppert, Katherine A.; Srivastava, Amit K.; Olson, Scott D.; Cox, Charles S., Jr.			High-resolution and differential analysis of rat microglial markers in traumatic brain injury: conventional flow cytometric and bioinformatics analysis	SCIENTIFIC REPORTS			English	Article							MICROGLIA/MACROPHAGE POLARIZATION DYNAMICS; ALZHEIMERS-DISEASE; ACTIVATION; RECEPTOR; CELLS; IDENTIFICATION; MACROPHAGES; EXPRESSION; MECHANISM	Traumatic brain injury (TBI) results in a cascade of cellular responses, which produce neuroinflammation, partly due to microglial activation. Transforming from surveying to primed phenotypes, microglia undergo considerable molecular changes. However, specific microglial profiles in rat remain elusive due to tedious methodology and limited availability of reagents. Here, we present a flow cytometry-based analysis of rat microglia 24 h after TBI using the controlled cortical impact model, validated with a bioinformatics approach. Isolated microglia are analyzed for morphological changes and their expression of activation markers using flow cytometry, traditional gating-based analysis methods and support the data by employing bioinformatics statistical tools. We use CD45, CD11b/c, and p2y12 receptor to identify microglia and evaluate their activation state using CD32, CD86, RT1B, CD200R, and CD163. The results from logic-gated flow cytometry analysis was validated with bioinformatics-based analysis and machine learning algorithms to detect quantitative changes in morphology and marker expression in microglia due to activation following TBI.	[Furman, Naama Toledano; Prabhakara, Karthik S.; Bedi, Supinder; Caplan, Henry W.; Ruppert, Katherine A.; Srivastava, Amit K.; Olson, Scott D.; Cox, Charles S., Jr.] Univ Texas Hlth Sci Ctr Houston, McGovern Sch Med, Dept Pediat Surg, 6431 Fannin St MSB 5-230, Houston, TX 77030 USA; [Gottlieb, Assaf] Univ Texas Hlth Sci Ctr Houston, Sch Biomed Informat, Ctr Precis Hlth, Houston, TX 77030 USA		Olson, SD (corresponding author), Univ Texas Hlth Sci Ctr Houston, McGovern Sch Med, Dept Pediat Surg, 6431 Fannin St MSB 5-230, Houston, TX 77030 USA.	Scott.D.Olson@uth.tmc.edu		Caplan, Henry/0000-0003-0012-1606; Srivastava, Amit/0000-0001-7554-7201	Clare A. Glassell Family Pediatric Stem Cell Research Fund; Grace Reynolds Wall Research Fund; NIH 2T32 GrantUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [GM0879201-11A1]	This project was performed with generous support from the Clare A. Glassell Family Pediatric Stem Cell Research Fund and the Grace Reynolds Wall Research Fund. Figure 1: Rat Microglial Activation 24 h after TBI, was made in (c) BioRender-biorender.com. This project was performed with generous support from the Clare A. Glassell Family Pediatric Stem Cell Research Fund and the Grace Reynolds Wall Research Fund and funding from NIH 2T32 Grant GM0879201-11A1.	Bartolomeo P, 2016, NEUROPSYCHOLOGIA, V93, P407, DOI 10.1016/j.neuropsychologia.2016.06.016; Bedi SS, 2013, STEM CELL TRANSL MED, V2, P953, DOI 10.5966/sctm.2013-0100; Boche D, 2013, NEUROPATH APPL NEURO, V39, P3, DOI 10.1111/nan.12011; Butovsky O, 2014, NAT NEUROSCI, V17, P131, DOI 10.1038/nn.3599; Chen X, 2012, GENOMICS, V99, P323, DOI 10.1016/j.ygeno.2012.04.003; Cherry JD, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-98; Cohen J., 1988, STAT POWER ANAL BEHA, V2nd; Colton CA, 2009, J NEUROIMMUNE PHARM, V4, P399, DOI 10.1007/s11481-009-9164-4; Davalos D, 2005, NAT NEUROSCI, V8, P752, DOI 10.1038/nn1472; Fabriek BO, 2005, GLIA, V51, P297, DOI 10.1002/glia.20208; Fan Y, 2017, MOL CELLS, V40, P163, DOI 10.14348/molcells.2017.0011; Furman NET, 2018, CYTOM PART A, V93A, P182, DOI 10.1002/cyto.a.23267; Gardner RC, 2015, ANN NEUROL, V77, P987, DOI 10.1002/ana.24396; Ginhoux F, 2010, SCIENCE, V330, P841, DOI 10.1126/science.1194637; Graeber MB, 2010, ACTA NEUROPATHOL, V119, P89, DOI 10.1007/s00401-009-0622-0; Hanisch UK, 2007, NAT NEUROSCI, V10, P1387, DOI 10.1038/nn1997; Hernandez A, 2016, J NEUROCHEM, V136, P18, DOI 10.1111/jnc.13402; Hernandez-Ontiveros DG, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00030; Hickman SE, 2013, NAT NEUROSCI, V16, P1896, DOI 10.1038/nn.3554; Hoek RM, 2000, SCIENCE, V290, P1768, DOI 10.1126/science.290.5497.1768; Holfelder K, 2011, HISTOL HISTOPATHOL, V26, P1007, DOI 10.14670/HH-26.1007; Hu XM, 2015, NAT REV NEUROL, V11, P56, DOI 10.1038/nrneurol.2014.207; Hu XM, 2012, STROKE, V43, P3063, DOI 10.1161/STROKEAHA.112.659656; Jaroszeski MJ, 1999, MOL BIOTECHNOL, V11, P37, DOI 10.1007/BF02789175; Jassam YN, 2017, NEURON, V95, P1246, DOI 10.1016/j.neuron.2017.07.010; Jin XM, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0041892, 10.1371/journal.pone.0040637]; Kigerl KA, 2009, J NEUROSCI, V29, P13435, DOI 10.1523/JNEUROSCI.3257-09.2009; Kim JY, 2015, CNS NEUROSCI THER, V21, P309, DOI 10.1111/cns.12360; Kota DJ, 2016, STEM CELL TRANSL MED, V5, P33, DOI 10.5966/sctm.2015-0065; Kozlowski C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031814; Lau SK, 2004, AM J CLIN PATHOL, V122, P794, DOI 10.1309/QHD6YFN81KQXUUH6; Li T, 2016, NEUROSCIENTIST, V22, P165, DOI 10.1177/1073858415572079; Li W, 2016, J NEUROL, V263, P1280, DOI 10.1007/s00415-016-8093-4; Loane DJ, 2016, EXP NEUROL, V275, P316, DOI 10.1016/j.expneurol.2015.08.018; Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015; Mckee CA, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00556; Mildner A, 2017, GLIA, V65, P375, DOI 10.1002/glia.23097; Moore CS, 2015, NEUROL-NEUROIMMUNOL, V2, DOI 10.1212/NXI.0000000000000080; Morrison H, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13581-z; Pey PX, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/2051-5960-2-21; Rajan WD, 2020, NEUROBIOL DIS, V137, DOI 10.1016/j.nbd.2019.104722; Ritzel RM, 2020, NEUROBIOL DIS, V136, DOI 10.1016/j.nbd.2019.104713; Ritzel RM, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0329-1; Sankowski R, 2019, NAT NEUROSCI, V22, P2098, DOI 10.1038/s41593-019-0532-y; Susarla BTS, 2014, ASN NEURO, V6, DOI 10.1042/AN20130034; Tatsumi E, 2015, GLIA, V63, P216, DOI 10.1002/glia.22745; Taylor PR, 2005, ANNU REV IMMUNOL, V23, P901, DOI 10.1146/annurev.immunol.23.021704.115816; Turtzo LC, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-82; Varin A, 2009, IMMUNOBIOLOGY, V214, P630, DOI 10.1016/j.imbio.2008.11.009; Walker DG, 2009, EXP NEUROL, V215, P5, DOI 10.1016/j.expneurol.2008.09.003; Wang GH, 2013, J CEREBR BLOOD F MET, V33, P1864, DOI 10.1038/jcbfm.2013.146; Weiner MW, 2014, ALZHEIMERS DEMENT, V10, pS226, DOI 10.1016/j.jalz.2014.04.005; Wennstrom M, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0109387, 10.1371/journal.pone.0053250]; Wilcock DM, 2014, NEURODEGENER DIS, V13, P183, DOI 10.1159/000354228; Witcher KG, 2015, TRENDS NEUROSCI, V38, P609, DOI 10.1016/j.tins.2015.08.002; Zhang ZR, 2012, BRAIN RES, V1461, P102, DOI 10.1016/j.brainres.2012.04.038	56	7	7	1	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	JUL 20	2020	10	1							11991	10.1038/s41598-020-68770-0			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MR4KC	WOS:000553556900007	32686718	Green Published, gold			2022-02-06	
J	Anderson, JFI; Fitzgerald, P				Anderson, Jacqueline F., I; Fitzgerald, Paul			Associations between coping style, illness perceptions and self-reported symptoms after mild traumatic brain injury in prospectively studied pre-morbidly healthy individuals	NEUROPSYCHOLOGICAL REHABILITATION			English	Article						Mild traumatic brain injury; Coping; Illness perceptions; Self-reported symptoms; Post-concussion syndrome	POST-CONCUSSION SYMPTOMS; HEAD-INJURY; QUESTIONNAIRE; COMPLAINTS; BEHAVIOR; RISK; LONG	This study investigated whether coping style and/or illness perceptions are related to the severity of self-reported post-concussion syndrome (PCS) symptoms in the postacute period after mild traumatic brain injury (mTBI). We hypothesised that reporting of early and late enduring-type PCS symptomatology (self-reported symptoms) would be significantly and negatively associated with: (a) an active "approach" coping style and (b) the belief that the injury would have negative consequences on the respondent's life. Using a prospective observational design we assessed 61 pre-morbidly healthy individuals who were admitted to hospital after an mTBI. Participants were assessed with measures of coping style and illness perception as well as PCS, depressive, anxiety and post-traumatic stress symptomatology. After controlling for current psychological distress, approach coping style significantly and independently predicted the severity of self-reported symptoms for early-type PCS symptomatology, but not late enduring-type PCS symptoms. The extent to which the respondent believed their symptoms were due to the mTBI significantly and independently predicted both early and late enduringtype PCS symptoms. This study indicates that different patterns of coping and illness perceptions are associated with early vs. late enduring types of PCS symptoms; this may have implications for the treatment of post-injury self-reported symptoms.	[Anderson, Jacqueline F., I] Univ Melbourne, Melbourne Sch Psychol Sci, Melbourne, Vic 3010, Australia; [Anderson, Jacqueline F., I] Alfred Hosp, Psychol Dept, Commercial Rd, Melbourne, Vic, Australia; [Fitzgerald, Paul] Epworth Ctr Innovat Mental Hlth, Epworth HealthCare, Camberwell, Vic, Australia; [Fitzgerald, Paul] Monash Univ, Monash Alfred Psychiat Res Ctr, Cent Clin Sch, Melbourne, Vic, Australia		Anderson, JFI (corresponding author), Univ Melbourne, Melbourne Sch Psychol Sci, Melbourne, Vic 3010, Australia.; Anderson, JFI (corresponding author), Alfred Hosp, Psychol Dept, Commercial Rd, Melbourne, Vic, Australia.	jfande@unimelb.edu.au		Anderson, Jacqueline/0000-0003-4996-8189			Ashbaugh AR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161645; Austin PC, 2015, J CLIN EPIDEMIOL, V68, P627, DOI 10.1016/j.jclinepi.2014.12.014; Barker-Collo S, 2018, BRAIN INJURY, V32, P453, DOI 10.1080/02699052.2018.1429659; Beck AT, 1993, BECK ANXIETY INVENTO; Carroll Linda J, 2014, Arch Phys Med Rehabil, V95, pS152, DOI 10.1016/j.apmr.2013.08.300; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Carver CS, 1997, INT J BEHAV MED, V4, P92, DOI 10.1207/s15327558ijbm0401_6; Clarke LA, 2012, BRAIN INJURY, V26, P298, DOI 10.3109/02699052.2012.654588; Cnossen MC, 2018, J NEUROTRAUM, V35, P2691, DOI 10.1089/neu.2017.5486; Eyres S, 2005, CLIN REHABIL, V19, P878, DOI 10.1191/0269215505cr905oa; Hou RH, 2012, J NEUROL NEUROSUR PS, V83, P217, DOI 10.1136/jnnp-2011-300767; Iverson GL, 2005, CURR OPIN PSYCHIATR, V18, P301, DOI 10.1097/01.yco.0000165601.29047.ae; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Leventhal H, 1998, PSYCHOL HEALTH, V13, P717, DOI 10.1080/08870449808407425; Leventhal H, 2008, ANNU REV PSYCHOL, V59, P477, DOI 10.1146/annurev.psych.59.103006.093643; Losoi H, 2016, J NEUROTRAUM, V33, P766, DOI 10.1089/neu.2015.4070; Losoi H, 2015, J HEAD TRAUMA REHAB, V30, pE24, DOI 10.1097/HTR.0000000000000055; Luoto TM, 2013, J NEUROTRAUM, V30, P11, DOI 10.1089/neu.2012.2611; Maestas KL, 2014, J HEAD TRAUMA REHAB, V29, P407, DOI 10.1097/HTR.0b013e31828654b4; Medvedev ON, 2018, PEERJ, V6, DOI 10.7717/peerj.5676; Mooney G, 2001, BRAIN INJURY, V15, P865, DOI 10.1080/02699050110065286; Moss-Morris R, 2002, PSYCHOL HEALTH, V17, P1, DOI 10.1080/08870440290001494; Mounce LTA, 2013, J HEAD TRAUMA REHAB, V28, P397, DOI 10.1097/HTR.0b013e318252dd75; Rush AJ, 1996, PSYCHOL MED, V26, P477, DOI 10.1017/S0033291700035558; Scheenen ME, 2017, SOC SCI MED, V181, P184, DOI 10.1016/j.socscimed.2017.03.025; Scheenen ME, 2017, J NEUROTRAUM, V34, P31, DOI 10.1089/neu.2015.4381; Sigurdardottir S, 2009, BRAIN INJURY, V23, P489, DOI 10.1080/02699050902926309; Snell DL, 2013, NEUROPSYCHOL REHABIL, V23, P333, DOI 10.1080/09658211.2012.758419; Snell DL, 2011, BRAIN INJURY, V25, P1126, DOI 10.3109/02699052.2011.607786; Snell DL, 2011, J HEAD TRAUMA REHAB, V26, P468, DOI 10.1097/HTR.0b013e3181fc5e1e; Snell DL, 2010, BRAIN INJURY, V24, P1595, DOI 10.3109/02699052.2010.523048; Stulemeijer M, 2007, J PSYCHOSOM RES, V63, P637, DOI 10.1016/j.jpsychores.2007.06.023; Sveen U, 2010, SCAND J OCCUP THER, V17, P225, DOI 10.3109/11038120903171295; Tabachnick B.G., 2001, USING MULTIVARIATE S; Taylor SE, 2007, ANNU REV CLIN PSYCHO, V3, P377, DOI 10.1146/annurev.clinpsy.3.022806.091520; Weathers F.W., 2013, PTSD CHECKLIST DSM 5; Whittaker R, 2007, J NEUROL NEUROSUR PS, V78, P644, DOI 10.1136/jnnp.2006.101105	38	7	7	0	9	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0960-2011	1464-0694		NEUROPSYCHOL REHABIL	Neuropsychol. Rehabil.	JUL 2	2020	30	6					1115	1128		10.1080/09602011.2018.1556706			14	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	LW7VY	WOS:000539353100001	30560733				2022-02-06	
J	Belanger, HG; Vanderploeg, RD; Curtiss, G; Armistead-Jehle, P; Kennedy, JE; Tate, DF; Eapen, BC; Bowles, AO; Cooper, DB				Belanger, Heather G.; Vanderploeg, Rodney D.; Curtiss, Glenn; Armistead-Jehle, Patrick; Kennedy, Jan E.; Tate, David F.; Eapen, Blessen C.; Bowles, Amy O.; Cooper, Douglas B.			Self-efficacy predicts response to cognitive rehabilitation in military service members with post-concussive symptoms	NEUROPSYCHOLOGICAL REHABILITATION			English	Article						Concussion; Rehabilitation; Self-efficacy; Traumatic brain injury	TRAUMATIC BRAIN-INJURY; QUALITY-OF-LIFE; BEHAVIORAL THERAPY; HEAD-INJURY; FOLLOW-UP; PARTICIPATION; SATISFACTION; PERFORMANCE; DISORDER; RECOVERY	This study examined whether self-efficacy differentiated treatment responders from non-responders in a trial of cognitive rehabilitation (CR) for postconcussive symptoms. 126 service members with mild TBI seen on average 9.5 months since injury completed one of four cognitive rehabilitation treatments for 6 weeks. The four treatment arms were: (1) Psychoeducation control, (2) Self-administered computerized CR, (3) Interdisciplinary CR, and (4) Interdisciplinary CR integrated with CBT. Outcome was assessed across time (baseline, and 6, 12, and 18 weeks post-treatment) for three domains: psychological (Symptom Checklist-90-Revised; SCL-90-R), cognitive (Paced Auditory Serial Addition Test; PASAT), and functional/behavioural (Key Behaviors Change Inventory; KBCI). Mixed model ANOVAs tested for self-efficacy differences across time in treatment responders versus non-responders, as defined by reliable change indices. A significant interaction was found on the SCL-90 such that responders had increasing self-efficacy with respect to psychological symptoms across four time points, whereas non-responders' self-efficacy did not change. Perceived self-efficacy at the beginning of treatment was associated with treatment engagement within the psychological domain for responders only, suggesting a mediating role in treatment outcome. Overall, results suggest that increasing patients' level of self-efficacy may be important for successful treatment of psychological distress in those with remote concussion.	[Belanger, Heather G.] Special Operat Command SOCOM, Def & Vet Brain Injury Ctr, Tampa, FL USA; [Belanger, Heather G.; Vanderploeg, Rodney D.] Univ S Florida, Dept Psychiat & Behav Neurosci, Tampa, FL 33620 USA; [Belanger, Heather G.; Vanderploeg, Rodney D.; Curtiss, Glenn] Univ S Florida, Dept Psychol, Tampa, FL 33620 USA; [Armistead-Jehle, Patrick] Munson Army Hlth Ctr, Concuss Clin, Ft Leavenworth, KS USA; [Kennedy, Jan E.; Bowles, Amy O.] Brooke Army Med Ctr, Dept Rehabil Med, San Antonio, TX USA; [Tate, David F.] Missouri Inst Mental Hlth, St Louis, MO USA; [Tate, David F.] Univ Missouri, St Louis, MO 63121 USA; [Tate, David F.] Univ Utah, Sch Med, Dept Neurol, Salt Lake City, UT USA; [Eapen, Blessen C.; Cooper, Douglas B.] South Texas Vet Hlth Care Syst, Polytrauma Rehabil Ctr, San Antonio, TX USA; [Eapen, Blessen C.] Univ Texas Hlth, Dept Rehabil Med, San Antonio, TX USA; [Bowles, Amy O.] Uniformed Serv Univ Hlth Sci, Dept Phys Med & Rehabil, Bethesda, MD 20814 USA; [Cooper, Douglas B.] South Texas Vet Hlth Care Syst, Def & Vet Brain Injury Ctr, San Antonio, TX USA; [Cooper, Douglas B.] Univ Texas Hlth Sci Ctr San Antonio, Dept Psychiat, San Antonio, TX 78229 USA		Belanger, HG (corresponding author), USSOCOM Command Surg Off, 7701 Tampa Pointe Blvd,MacDill AFB, Tampa, FL 33621 USA.	heather.belanger@socom.mil	Curtiss, Glenn/ABB-5566-2020; Armistead-Jehle, Patrick/AAU-5741-2020; Tate, David/G-5166-2011	Tate, David/0000-0003-0213-1920; Armistead-Jehle, Patrick/0000-0002-6784-1432	Department of Veterans Affairs, Veterans Health Administration (VHA)US Department of Veterans Affairs; Department of Defense (DoD)United States Department of Defense; 9 Line LLC; Defense and Veterans Brain Injury CenterUS Department of Veterans Affairs [MDA 905-03-2-0003]; James A. Haley Veterans' HospitalUS Department of Veterans Affairs	The research reported here was supported by the Department of Veterans Affairs, Veterans Health Administration (VHA), the Department of Defense (DoD), and 9 Line LLC. Further support was provided by the Defense and Veterans Brain Injury Center, Grant number MDA 905-03-2-0003, and the James A. Haley Veterans' Hospital. The views expressed herein are those of the authors and do not necessarily reflect the views of the VHA, Department of the Army, Department of Health Affairs or the DoD.	Andersson EE, 2011, J REHABIL MED, V43, P323, DOI 10.2340/16501977-0666; Azulay J, 2013, J HEAD TRAUMA REHAB, V28, P323, DOI 10.1097/HTR.0b013e318250ebda; Bandura A., 1995, SELF EFFICACY CHANGI; Bandura A., 1997, SELF EFFICACY EXERCI; Barnwell AM, 1997, SOC SCI MED, V45, P411, DOI 10.1016/S0277-9536(96)00356-5; Belanger HG, 2015, MIL MED, V180, P192, DOI 10.7205/MILMED-D-14-00388; Brands I, 2017, NEUROREHABILITATION, V40, P587, DOI 10.3233/NRE-171446; Brands I, 2014, ARCH PHYS MED REHAB, V95, P2327, DOI 10.1016/j.apmr.2014.06.006; Brands IMH, 2019, CLIN REHABIL, V33, P327, DOI 10.1177/0269215518795249; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Cicerone KD, 2007, J HEAD TRAUMA REHAB, V22, P257, DOI 10.1097/01.HTR.0000290970.56130.81; Cooper DB, 2017, J HEAD TRAUMA REHAB, V32, pE1, DOI 10.1097/HTR.0000000000000254; Deci E. L., 1975, INTRINSIC MOTIVATION; Defense and Veterans Brain Injury Center, 2017, SCORE STUD MAN; Department of Veterans Affairs and Department of Defense, 2009, VA DOD CLIN PRACT GU; Derogatis L., 1994, ADM SCORING PROCEDUR; DIKMEN S, 1986, J NEUROL NEUROSUR PS, V49, P1227, DOI 10.1136/jnnp.49.11.1227; Eisenberg H.M., 1989, MILD HEAD INJURY, P133; French MA, 2016, TOP STROKE REHABIL, V23, P77, DOI 10.1080/10749357.2015.1110306; Gallagher MW, 2013, BEHAV RES THER, V51, P767, DOI 10.1016/j.brat.2013.09.001; GRONWALL DMA, 1977, PERCEPT MOTOR SKILL, V44, P367, DOI 10.2466/pms.1977.44.2.367; Hutchinson JC, 2008, J APPL SPORT PSYCHOL, V20, P457, DOI 10.1080/10413200802351151; Iverson GL, 2005, CURR OPIN PSYCHIATR, V18, P301, DOI 10.1097/01.yco.0000165601.29047.ae; Iverson GL, 2003, CLIN NEUROPSYCHOL, V17, P460, DOI 10.1076/clin.17.4.460.27934; Jak AJ, 2015, CONTEMP CLIN TRIALS, V45, P210, DOI 10.1016/j.cct.2015.10.009; Kadden RM, 2011, ADDICT BEHAV, V36, P1120, DOI 10.1016/j.addbeh.2011.07.032; Kolitz BP, 2003, ARCH PHYS MED REHAB, V84, P277, DOI 10.1053/apmr.2003.50100; Korpershoek C, 2011, J ADV NURS, V67, P1876, DOI 10.1111/j.1365-2648.2011.05659.x; LEVIN HS, 1987, J NEUROSURG, V66, P234, DOI 10.3171/jns.1987.66.2.0234; McCaffrey RJ, 1995, NEUROPSYCHOL REV, V5, P203, DOI 10.1007/BF02214762; McCrea M., 2008, MILD TRAUMATIC BRAIN; McMillan TM, 2012, J NEUROL NEUROSUR PS, V83, P1086, DOI 10.1136/jnnp-2012-302746; Mittenberg W, 1996, ARCH CLIN NEUROPSYCH, V11, P139, DOI 10.1016/0887-6177(95)00006-2; Mittenberg W, 1993, PSYCHOTHERAPY PRIVAT, V12, P37, DOI DOI 10.1300/1294V12N02_03; Ouweneel E, 2013, APPL PSYCHOL-HLTH WE, V5, P225, DOI 10.1111/aphw.12008; Parker HA, 2018, REHABIL PSYCHOL, V63, P595, DOI 10.1037/rep0000243; Pegg PO, 2005, REHABIL PSYCHOL, V50, P366, DOI 10.1037/0090-5550.50.4.366; Potter SDS, 2016, J NEUROL NEUROSUR PS, V87, P1075, DOI 10.1136/jnnp-2015-312838; Scheenen ME, 2017, SOC SCI MED, V181, P184, DOI 10.1016/j.socscimed.2017.03.025; Schmitt JS, 2004, J CLIN EPIDEMIOL, V57, P1008, DOI 10.1016/j.jclinepi.2004.02.007; Shnek ZM, 1997, ANN BEHAV MED, V19, P287, DOI 10.1007/BF02892293; Sigurdardottir S, 2009, BRAIN INJURY, V23, P489, DOI 10.1080/02699050902926309; Stajkovic AD, 1998, PSYCHOL BULL, V124, P240, DOI 10.1037/0033-2909.124.2.240; Sterr A, 2006, BMC NEUROL, V6, DOI 10.1186/1471-2377-6-7; Storzbach D, 2017, J HEAD TRAUMA REHAB, V32, P16, DOI 10.1097/HTR.0000000000000228; Twamley EW, 2015, J HEAD TRAUMA REHAB, V30, P391, DOI 10.1097/HTR.0000000000000076; Vanderploeg RD, 2018, REHABIL PSYCHOL, V63, P194, DOI 10.1037/rep0000215; Zumstein MA, 2011, J TRAUMA, V71, P120, DOI 10.1097/TA.0b013e3181f2d670	48	7	7	1	7	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0960-2011	1464-0694		NEUROPSYCHOL REHABIL	Neuropsychol. Rehabil.	JUL 2	2020	30	6					1190	1203		10.1080/09602011.2019.1575245			14	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	LU7DF	WOS:000537910900011	30764711				2022-02-06	
J	Diaz-Chavez, A; Lajud, N; Roque, A; Cheng, JP; Melendez-Herrera, E; Valdez-Alarcon, JJ; Bondi, CO; Kline, AE				Diaz-Chavez, Arturo; Lajud, Naima; Roque, Angelica; Cheng, Jeffrey P.; Melendez-Herrera, Esperanza; Jose Valdez-Alarcon, Juan; Bondi, Corina O.; Kline, Anthony E.			Early life stress increases vulnerability to the sequelae of pediatric mild traumatic brain injury	EXPERIMENTAL NEUROLOGY			English	Article						Behavioral outcome; Controlled cortical impact; Early life stress; Functional recovery; Learning and memory; Maternal separation; Traumatic brain injury	PITUITARY-ADRENAL AXIS; NEONATAL MATERNAL SEPARATION; LONG-TERM-POTENTIATION; ENVIRONMENTAL ENRICHMENT; ADULT NEUROGENESIS; HPA AXIS; HIPPOCAMPAL NEUROGENESIS; MICROGLIAL ACTIVATION; INFLAMMATORY RESPONSE; SYNAPTIC PLASTICITY	Early life stress (ELS) is a risk factor for many psychopathologies that happen later in life. Although stress can occur in cases of child abuse, studies on non-accidental brain injuries in pediatric populations do not consider the possible increase in vulnerability caused by ELS. Hence, we sought to determine whether ELS increases the effects of pediatric mild traumatic brain injury (mTBI) on cognition, hippocampal inflammation, and plasticity. Male rats were subjected to maternal separation for 180 min per day (MS180) or used as controls (CONT) during the first 21 post-natal (P) days. At P21 the rats were anesthetized with isoflurane and subjected to a mild controlled cortical impact or sham injury. At P32 the rats were injected with the cell proliferation marker bromodeoxyuridine (BrdU, 500 mg/kg), then evaluated for spatial learning and memory in a water maze (P35-40) and sacrificed for quantification of Ki67(+), BrdU(+) and Iba1(+) (P42). Neither MS180 nor mTBI impacted cognitive outcome when provided alone but their combination (MS180 + mTBI) decreased spatial learning and memory relative to Sham controls (p <.01). mTBI increased microglial activation and affected BrdU(+) cell survival in the ipsilateral hippocampus without affecting proliferation rates. However, only MS180+ mTBI increased microglial activation in the area adjacent to the injury and the contralateral CA1 hippocampal subfield, and decreased cell proliferation in the ipsilateral neurogenic niche. Overall, the data show that ELS increases the vulnerability to the sequelae of pediatric mTBI and may be mediated by increased neuroinflammation.	[Diaz-Chavez, Arturo; Lajud, Naima; Roque, Angelica] Inst Mexicano Seguro Social, Ctr Invest Biomed Michoaccin, Div Neurociencias, Morelia, Michoacan, Mexico; [Diaz-Chavez, Arturo; Melendez-Herrera, Esperanza] Univ Michoacana, Inst Invest Recursos Nat Benemerita & Centenaria, Morelia, Michoacan, Mexico; [Cheng, Jeffrey P.; Bondi, Corina O.; Kline, Anthony E.] Univ Pittsburgh, Phys Med & Rehabil, Pittsburgh, PA 15224 USA; [Cheng, Jeffrey P.; Bondi, Corina O.; Kline, Anthony E.] Univ Pittsburgh, Safar Ctr Resuscitat Res, Pittsburgh, PA 15224 USA; [Jose Valdez-Alarcon, Juan] Univ Michoacana, Ctr Multidisciplinario Estudios Biotecnol Benemer, Morelia, Michoacan, Mexico; [Bondi, Corina O.] Univ Pittsburgh, Neurobiol, Pittsburgh, PA 15224 USA; [Bondi, Corina O.; Kline, Anthony E.] Univ Pittsburgh, Ctr Neurosci, Pittsburgh, PA 15224 USA; [Kline, Anthony E.] Univ Pittsburgh, Ctr Neural Basis Cognit, Pittsburgh, PA 15224 USA; [Kline, Anthony E.] Univ Pittsburgh, Crit Care Med, Pittsburgh, PA 15224 USA; [Kline, Anthony E.] Univ Pittsburgh, Psychol, Pittsburgh, PA 15224 USA		Kline, AE (corresponding author), Univ Pittsburgh, Phys Med & Rehabil, Crit Care Med & Psychol, Sch Med,Childrens Hosp Pittsburgh,Rangos Res Ctr, Room 6126,4401 Penn Ave, Pittsburgh, PA 15224 USA.	klineae@upmc.edu	Lajud, Naima/B-4605-2018	Lajud, Naima/0000-0003-3905-798X	CONACyT-FOSISS [FIS/IMSS/PROT/1769]; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [HD069620, NS060005, NS084967, NS094950, NS099683]; University of Pittsburgh Physicians/UPMC Academic Foundation; UMPC Rehabilitation Institute; Programa de Cooperacion Internacional (PCI)-Instituto Mexicano del Seguro Social (NLA); CONACYTConsejo Nacional de Ciencia y Tecnologia (CONACyT) [CVU 885201]; Programa para la Formacion de Investigadores de la Coordinacion de Investigacion en Salud-IMSS	Funding for this study was provided by grants CONACyT-FOSISS No. FIS/IMSS/PROT/1769 (NLA), NIH grants HD069620, NS060005, NS084967 (AEK), NS094950, NS099683 (COB), the University of Pittsburgh Physicians/UPMC Academic Foundation, and the UMPC Rehabilitation Institute (COB), Programa de Cooperacion Internacional (PCI)-Instituto Mexicano del Seguro Social (NLA). Arturo Diaz-Chavez is a graduate student in the Programa de Maestria en Recursos Naturales -Universidad Michoacana de San Nicolas de Hidalgo and was supported by CONACYT (CVU 885201) and a complementary stipend from Programa para la Formacion de Investigadores de la Coordinacion de Investigacion en Salud-IMSS.	Acosta SA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081585; Aisa B, 2007, PSYCHONEUROENDOCRINO, V32, P256, DOI 10.1016/j.psyneuen.2006.12.013; Aisa B, 2009, HIPPOCAMPUS, V19, P1222, DOI 10.1002/hipo.20586; Algamal M, 2019, J NEUROTRAUM, V36, P2590, DOI 10.1089/neu.2018.6314; ALTMAN J, 1965, J COMP NEUROL, V124, P319, DOI 10.1002/cne.901240303; Aungst SL, 2014, J CEREBR BLOOD F MET, V34, P1223, DOI 10.1038/jcbfm.2014.75; Banqueri M, 2019, STRESS, V22, P563, DOI 10.1080/10253890.2019.1604666; Benetti F, 2009, INT J DEV NEUROSCI, V27, P59, DOI 10.1016/j.ijdevneu.2008.09.200; Berger RP, 2004, J NEUROTRAUM, V21, P1123; Bisicchia E, 2019, SEMIN CELL DEV BIOL, V94, P104, DOI 10.1016/j.semcdb.2019.01.011; Blandino P, 2006, J NEUROIMMUNOL, V173, P87, DOI 10.1016/j.jneuroim.2005.11.021; Blandino P, 2009, BRAIN BEHAV IMMUN, V23, P958, DOI 10.1016/j.bbi.2009.04.013; Bondi CO, 2014, J NEUROTRAUM, V31, P926, DOI 10.1089/neu.2013.3295; Bondi CO, 2014, J NEUROTRAUM, V31, P873, DOI 10.1089/neu.2014.3328; Burton DL, 2008, SEX ABUSE-J RES TR, V20, P102, DOI 10.1177/1079063208315352; Calvete E, 2014, CHILD ABUSE NEGLECT, V38, P735, DOI 10.1016/j.chiabu.2013.10.014; Cao XJ, 2014, DEV PSYCHOBIOL, V56, P1102, DOI 10.1002/dev.21130; Carr CP, 2013, J NERV MENT DIS, V201, P1007, DOI 10.1097/NMD.0000000000000049; Chapman DP, 2004, J AFFECT DISORDERS, V82, P217, DOI 10.1016/j.jad.2003.12.013; Cheng JP, 2008, BEHAV BRAIN RES, V194, P79, DOI 10.1016/j.bbr.2008.06.025; Cheng JP, 2012, J NEUROTRAUM, V29, P2684, DOI 10.1089/neu.2012.2560; Chevignard MP, 2014, PEDIATR RADIOL, V44, P548, DOI 10.1007/s00247-014-3169-8; Chiu CC, 2016, J NEUROSCI METH, V272, P38, DOI 10.1016/j.jneumeth.2016.06.018; Cunningham CL, 2013, J NEUROSCI, V33, P4216, DOI 10.1523/JNEUROSCI.3441-12.2013; Dash PK, 2001, J NEUROSCI RES, V63, P313, DOI 10.1002/1097-4547(20010215)63:4<313::AID-JNR1025>3.0.CO;2-4; Davies DR, 2016, FRONT BEHAV NEUROSCI, V10, DOI [10.3389/fnbeh.2016.00071, 10.3339/fnbeh.2015.00071]; Delpech JC, 2016, BRAIN BEHAV IMMUN, V57, P79, DOI 10.1016/j.bbi.2016.06.006; DeMaster D, 2017, BRAIN BEHAV, V7, DOI 10.1002/brb3.832; Donat CK, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00208; Frank MG, 2011, BRAIN BEHAV IMMUN, V25, pS21, DOI 10.1016/j.bbi.2011.01.005; Gould E, 1999, NAT NEUROSCI, V2, P260, DOI 10.1038/6365; Grabert K, 2016, NAT NEUROSCI, V19, P504, DOI 10.1038/nn.4222; Gracia-Rubio I, 2016, PROG NEURO-PSYCHOPH, V65, P104, DOI 10.1016/j.pnpbp.2015.09.003; Guo L., 2018, EVID BASED COMPLEMEN; HAMM RJ, 1992, J NEUROTRAUM, V9, P11, DOI 10.1089/neu.1992.9.11; Hanlon LA, 2019, EXP NEUROL, V316, P39, DOI 10.1016/j.expneurol.2019.04.004; Heim C, 1997, ANN NY ACAD SCI, V821, P194, DOI 10.1111/j.1749-6632.1997.tb48279.x; Heim C, 2008, PSYCHONEUROENDOCRINO, V33, P693, DOI 10.1016/j.psyneuen.2008.03.008; Hernandez-Ontiveros DG, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00030; Hui JJ, 2011, BEHAV BRAIN RES, V217, P122, DOI 10.1016/j.bbr.2010.10.014; Huot RL, 2002, BRAIN RES, V950, P52, DOI 10.1016/S0006-8993(02)02985-2; JANS JE, 1990, DEV PSYCHOBIOL, V23, P519, DOI 10.1002/dev.420230607; Jin XM, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0041892, 10.1371/journal.pone.0040637]; Johnson FK, 2018, BRAIN BEHAV IMMUN, V69, P18, DOI 10.1016/j.bbi.2017.06.008; Johnson JD, 2005, NEUROSCIENCE, V135, P1295, DOI 10.1016/j.neuroscience.2005.06.090; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; Karve IP, 2016, BRIT J PHARMACOL, V173, P692, DOI 10.1111/bph.13125; Klevens J, 2010, CHILD ABUSE NEGLECT, V34, P262, DOI 10.1016/j.chiabu.2009.07.005; Kline AE, 2002, BRAIN RES, V937, P22, DOI 10.1016/S0006-8993(02)02458-7; Kline AE, 2012, J NEUROTRAUM, V29, P1960, DOI 10.1089/neu.2012.2385; Kline AE, 2010, J NEUROTRAUM, V27, P2021, DOI 10.1089/neu.2010.1535; Kochanek PM, 2017, CHILD NERV SYST, V33, P1693, DOI 10.1007/s00381-017-3474-2; Kochanek PM, 2015, SEMIN NEUROL, V35, P83, DOI 10.1055/s-0035-1544237; Krug EG, 2002, LANCET, V360, P1083, DOI 10.1016/S0140-6736(02)11133-0; Kwon Sook-Kyung C, 2011, Front Neurol, V2, P12, DOI 10.3389/fneur.2011.00012; Lajud N, 2019, J NEUROTRAUM, V36, P756, DOI 10.1089/neu.2018.5866; Lajud N, 2012, PSYCHONEUROENDOCRINO, V37, P410, DOI 10.1016/j.psyneuen.2011.07.011; Lehmann J, 2000, REV NEUROSCIENCE, V11, P383; LEVINE S, 1967, SCIENCE, V156, P258, DOI 10.1126/science.156.3772.258; LEVINE S, 1957, SCIENCE, V126, P405, DOI 10.1126/science.126.3270.405; Loane DJ, 2010, NEUROTHERAPEUTICS, V7, P366, DOI 10.1016/j.nurt.2010.07.002; McEwen BS, 2012, P NATL ACAD SCI USA, V109, P17180, DOI 10.1073/pnas.1121254109; MEANEY MJ, 1989, NEUROENDOCRINOLOGY, V50, P597, DOI 10.1159/000125287; Mirescu C, 2004, NAT NEUROSCI, V7, P841, DOI 10.1038/nn1290; Molet J, 2016, TRANSL PSYCHIAT, V6, DOI 10.1038/tp.2015.200; Monaco CM, 2014, J NEUROTRAUM, V31, P1934, DOI 10.1089/neu.2014.3541; Monaco CM, 2013, EXP NEUROL, V247, P410, DOI 10.1016/j.expneurol.2013.01.007; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; Nasr IW, 2019, EXP NEUROL, V320, DOI 10.1016/j.expneurol.2019.112957; Neuberger EJ, 2017, STEM CELL REP, V9, P972, DOI 10.1016/j.stemcr.2017.07.015; Niederkrotenthaler T, 2013, CHILD ABUSE NEGLECT, V37, P446, DOI 10.1016/j.chiabu.2013.02.002; Niesman IR, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-39; Njoku I, 2019, EXP NEUROL, V315, P32, DOI 10.1016/j.expneurol.2019.01.019; Ogier M, 2017, J NEUROTRAUM, V34, P1645, DOI 10.1089/neu.2016.4741; Ojo JO, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00213; Olsen AS, 2012, J NEUROTRAUM, V29, P1898, DOI 10.1089/neu.2012.2358; Oomen CA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0003675; Paolicelli RC, 2011, SCIENCE, V333, P1456, DOI 10.1126/science.1202529; Pechtel P, 2011, PSYCHOPHARMACOLOGY, V214, P55, DOI 10.1007/s00213-010-2009-2; Pesonen AK, 2007, AM J EPIDEMIOL, V166, P1126, DOI 10.1093/aje/kwm254; PLOTSKY PM, 1993, MOL BRAIN RES, V18, P195, DOI 10.1016/0169-328X(93)90189-V; Prins ML, 1998, J NEUROTRAUM, V15, P799, DOI 10.1089/neu.1998.15.799; Radabaugh HL, 2017, EXP NEUROL, V294, P12, DOI 10.1016/j.expneurol.2017.04.013; Raghupathi R, 2017, NEURAL REGEN RES, V12, P741, DOI 10.4103/1673-5374.206639; Ramlackhansingh AF, 2011, ANN NEUROL, V70, P374, DOI 10.1002/ana.22455; Reshetnikov VV, 2020, GENES BRAIN BEHAV, V19, DOI 10.1111/gbb.12541; Rice CJ, 2008, ENDOCRINOLOGY, V149, P4892, DOI 10.1210/en.2008-0633; Riveros-Barrera I, 2016, BIOMEDICA, V36, P67, DOI 10.7705/biomedica.v36i1.2830; Roque A, 2016, BRAIN BEHAV IMMUN, V55, P39, DOI 10.1016/j.bbi.2015.09.017; ROSENFELD P, 1993, DEV PSYCHOBIOL, V26, P261, DOI 10.1002/dev.420260504; Ruiz R, 2018, PSYCHONEUROENDOCRINO, V96, P203, DOI 10.1016/j.psyneuen.2018.07.012; Schloesser RJ, 2009, NEUROREPORT, V20, P553, DOI 10.1097/WNR.0b013e3283293e59; Secretaria de Salud, 2006, INF NAC VIOL SAL; Semple BD, 2016, METHODS MOL BIOL, V1462, P325, DOI 10.1007/978-1-4939-3816-2_18; Simon DW, 2017, NAT REV NEUROL, V13, P171, DOI 10.1038/nrneurol.2017.13; Sousa VC, 2014, NEUROBIOL AGING, V35, P1680, DOI 10.1016/j.neurobiolaging.2014.01.024; SUCHECKI D, 1995, PSYCHONEUROENDOCRINO, V20, P169, DOI 10.1016/0306-4530(94)00051-B; SUCHECKI D, 1993, DEV BRAIN RES, V75, P185, DOI 10.1016/0165-3806(93)90022-3; Suri D, 2014, INT J NEUROPSYCHOPH, V17, P289, DOI 10.1017/S1461145713001004; Taib T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184811; Teicher MH, 2016, J CHILD PSYCHOL PSYC, V57, P241, DOI 10.1111/jcpp.12507; Teicher MH, 2003, NEUROSCI BIOBEHAV R, V27, P33, DOI 10.1016/S0149-7634(03)00007-1; Tractenberg SG, 2016, NEUROSCI BIOBEHAV R, V68, P489, DOI 10.1016/j.neubiorev.2016.06.021; van Bodegom M, 2017, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00087; Wang Q, 2015, BEHAV BRAIN RES, V280, P16, DOI 10.1016/j.bbr.2014.11.040; Wigger A, 1999, PHYSIOL BEHAV, V66, P293, DOI 10.1016/S0031-9384(98)00300-X; Xing GQ, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00196; Ziebell JM, 2015, METAB BRAIN DIS, V30, P393, DOI 10.1007/s11011-014-9539-y	108	7	7	0	3	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4886	1090-2430		EXP NEUROL	Exp. Neurol.	JUL	2020	329								113318	10.1016/j.expneurol.2020.113318			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	LT0MX	WOS:000536772200007	32305419	Green Accepted			2022-02-06	
J	Kumar, RG; Ketchum, JM; Corrigan, JD; Hammond, FM; Sevigny, M; Dams-O'Connor, K				Kumar, Raj G.; Ketchum, Jessica M.; Corrigan, John D.; Hammond, Flora M.; Sevigny, Mitch; Dams-O'Connor, Kristen			The Longitudinal Effects of Comorbid Health Burden on Functional Outcomes for Adults With Moderate to Severe Traumatic Brain Injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						comorbidity; function; individual growth curve; life satisfaction; traumatic brain injury	DEMENTIA RISK; OLDER-ADULTS; REHABILITATION; EPIDEMIOLOGY; ASSOCIATION; DEPRESSION; DISEASE; WELL; AGE	Objective: To evaluate the impact of physical, mental, and total health condition burden on functional outcome and life satisfaction up to 10 years after moderate to severe traumatic brain injury (TBI). Setting: Six TBI Model Systems centers. Participants: Three hundred ninety-three participants in the TBI Model Systems National Database. Design: Retrospective cohort study. Main Measures: Self-reported physical and mental health conditions at 10 years postinjury. Functional Independence Measure Motor and Cognitive subscales and the Satisfaction With Life Scale measured at 1, 2, 5, and 10 years. Results: In 10-year longitudinal individual growth curve models adjusted for covariates and inverse probability weighted to account for selection bias, greater physical and mental health comorbidity burden was negatively associated with functional cognition and life satisfaction trajectories. Physical, but not mental, comorbidity burden was negatively associated with functional motor trajectories. Higher total health burden was associated with poorer functional motor and cognitive trajectories and lower life satisfaction. Conclusions: This study offers evidence that comorbidity burden negatively impacts longitudinal functional and life satisfaction outcomes after TBI. The findings suggest that better identification and treatment of comorbidities may benefit life satisfaction, functional outcome, reduce healthcare costs, and decrease reinjury. Specific guidelines are needed for the management of comorbidities in TBI populations.	[Kumar, Raj G.; Dams-O'Connor, Kristen] Icahn Sch Med Mt Sinai, Dept Rehabil & Human Performance, New York, NY 10029 USA; [Dams-O'Connor, Kristen] Icahn Sch Med Mt Sinai, Dept Rehabil Med, 5 East 98th St, New York, NY 10029 USA; [Dams-O'Connor, Kristen] Icahn Sch Med Mt Sinai, Dept Neurol, 5 East 98th St, New York, NY 10029 USA; [Ketchum, Jessica M.; Sevigny, Mitch] Traumat Brain Injury Model Syst Natl Data & Stat, Englewood, CO USA; [Ketchum, Jessica M.; Sevigny, Mitch] Craig Hosp, Res Dept, Englewood, CO USA; [Corrigan, John D.] Ohio State Univ, Dept Phys Med & Rehabil, Columbus, OH 43210 USA; [Hammond, Flora M.] Indiana Univ Sch Med, Dept Phys Med & Rehabil, Indianapolis, IN 46202 USA; [Hammond, Flora M.] Rehabil Hosp Indiana, Indianapolis, IN USA		Dams-O'Connor, K (corresponding author), Icahn Sch Med Mt Sinai, Dept Rehabil Med, 5 East 98th St, New York, NY 10029 USA.; Dams-O'Connor, K (corresponding author), Icahn Sch Med Mt Sinai, Dept Neurol, 5 East 98th St, New York, NY 10029 USA.	kristen.dams-o'connor@mountsinai.org			National Institute of Disability, Independent Living, and Rehabilitation Research (NI-DILRR) [90DP0038, 90DPTB0009, 90DPTB0007, 90DPTB0001, 90DP0036, 90DRTB0002, 90DP0084]; National Institute of Child Health and Development (NIH-NICHD) [K01 HD074651-01A1]	The contents of this article were developed under grants from the National Institute of Disability, Independent Living, and Rehabilitation Research (NI-DILRR) to Icahn School of Medicine at Mount Sinai (90DP0038 and 90DPTB0009), Craig (90DPTB0007), Ohio State (90DPTB0001), Indiana (90DP0036 and 90DRTB0002), and the Traumatic Brain Injury National Data and Statistical Center (90DP0084), and K01 HD074651-01A1 from the National Institute of Child Health and Development (NIH-NICHD). NIDILRR is a center within the Administration for Community Living (ACL), Department of Health and Human Services (HHS).	Assari S, 2016, FRONT PSYCHIATRY, V7, DOI 10.3389/fpsyt.2016.00140; Barnes DE, 2014, NEUROLOGY, V83, P312, DOI 10.1212/WNL.0000000000000616; Barnett K, 2012, LANCET, V380, P37, DOI 10.1016/S0140-6736(12)60240-2; Bogner JA, 2017, J HEAD TRAUMA REHAB, V32, pE1, DOI 10.1097/HTR.0000000000000291; Byers AL, 2011, NAT REV NEUROL, V7, P323, DOI 10.1038/nrneurol.2011.60; Centers for Disease Control and Prevention National Center for Health Statistics, 2019, NAT HLTH NUTR EXAM S; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Coronado VG, 2005, J HEAD TRAUMA REHAB, V20, P215, DOI 10.1097/00001199-200505000-00005; Corrigan JD, 2014, J HEAD TRAUMA REHAB, V29, pE1, DOI 10.1097/HTR.0000000000000020; Corrigan JD, 2013, ARCH PHYS MED REHAB, V94, P1199, DOI 10.1016/j.apmr.2013.01.023; Dams-O'Connor K, 2016, J AM GERIATR SOC, V64, P844, DOI 10.1111/jgs.14014; Diener E., 2008, J POSIT PSYCHOL, V3, P137, DOI [10.1080/17439760701756946, DOI 10.1080/17439760701756946]; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; Friedman EM, 2012, J GERONTOL B-PSYCHOL, V67, P535, DOI 10.1093/geronb/gbr152; Gardner RC, 2014, JAMA NEUROL, V71, P1490, DOI 10.1001/jamaneurol.2014.2668; Hammond FM, 2019, J HEAD TRAUMA REHAB, V34, pE1, DOI 10.1097/HTR.0000000000000465; Harrison-Felix C, 2015, J NEUROTRAUM, V32, P1893, DOI 10.1089/neu.2014.3353; Hernan MA, 2004, EPIDEMIOLOGY, V15, P615, DOI 10.1097/01.ede.0000135174.63482.43; Horn SD, 2013, ARCH PHYS MED REHAB, V94, pS75, DOI 10.1016/j.apmr.2012.10.036; Kessler RC, 2004, INT J METH PSYCH RES, V13, P60, DOI 10.1002/mpr.166; Kuller LH, 2016, EXPERT REV CARDIOVAS, V14, P771, DOI 10.1080/14779072.2016.1185366; Kumar RG, 2019, J HEAD TRAUMA REHAB, V34, P224, DOI 10.1097/HTR.0000000000000470; Kumar RG, 2018, J HEAD TRAUMA REHAB, V33, P15, DOI 10.1097/HTR.0000000000000273; Lecours A, 2012, J HEAD TRAUMA REHAB, V27, P379, DOI 10.1097/HTR.0b013e31823b2385; LINACRE JM, 1994, ARCH PHYS MED REHAB, V75, P127; MADDOX GL, 1973, J HEALTH SOC BEHAV, V14, P87, DOI 10.2307/2136940; Malec JF, 2019, J HEAD TRAUMA REHAB, V34, pE24, DOI 10.1097/HTR.0000000000000459; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; Moussavi S, 2007, LANCET, V370, P851, DOI 10.1016/S0140-6736(07)61415-9; Piazza JR, 2007, J GERONTOL B-PSYCHOL, V62, pP313, DOI 10.1093/geronb/62.6.P313; SAS Institute Inc, 2002, SAS VERS 9 4; Thompson HJ, 2006, J AM GERIATR SOC, V54, P1590, DOI 10.1111/j.1532-5415.2006.00894.x; Thompson HJ, 2012, RES GERONTOL NURS, V5, P17, DOI 10.3928/19404921-20111206-02; Violan C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102149	34	7	7	1	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JUL-AUG	2020	35	4			SI		E372	E381		10.1097/HTR.0000000000000572			10	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	MR1MK	WOS:000553355300012	32108718	Green Accepted			2022-02-06	
J	Cheng, SQ; Zhang, Y; Chen, SZ; Zhou, YL				Cheng, Shiqi; Zhang, Yan; Chen, Shuzhen; Zhou, Yongliang			LncRNA HOTAIR Participates in Microglia Activation and Inflammatory Factor Release by Regulating the Ubiquitination of MYD88 in Traumatic Brain Injury	JOURNAL OF MOLECULAR NEUROSCIENCE			English	Article						LncRNA HOTAIR; MYD88; Ubiquitination; Microglia activation; An inflammatory factor	NONCODING RNA MALAT1; ANDROGEN-RECEPTOR; EXPRESSION; NEUROPROTECTION; NEUROINFLAMMATION; CONTRIBUTES; PATHWAY; NRDP1; TLR	Traumatic brain injury (TBI) is one of the leading causes of death worldwide. Long non-coding RNAs (LncRNAs) have been reported to be closely associated with various diseases, but their roles in TBI has not been fully elucidated. The purpose of this study was to elucidate the underlying mechanism of LncRNA HOTAIR in TBI-induced microglial activation and inflammatory factor release. In vivo mouse TBI model and in vitro microglia activation model were established by Feeney's free-fall impact method and by LPS stimulation, respectively. The expression of LncRNA HOTAIR in activated microglia was detected by qRT-PCR. After shRNA knocked down, the expressions of LncRNA HOTAIR and microglia activation marker Iba-1 in microglia were detected by qRT-PCR and Western blot and by ELISA that detected the concentration of inflammatory factor in cell culture supernatants. The relationship between LncRNA HOTAIR and MYD88 in mouse microglia BV2 cells was observed by RNA pull-down assay. Furthermore, the effect of LncRNA HOTAIR on MYD88 stability was assessed by cycloheximide (CHX)-chase and by immunoprecipitation and ubiquitination assays that analyzed MYD88 ubiquitination. LncRNA HOTAIR was abnormally highly expressed in activated microglia. By Western blot and ELISA, the knockdown of LncRNA HOTAIR in microglia significantly repressed microglia activation and inflammatory factor release. By RNA pull-down assay, LncRNA HOTAIR could bind to MYD88 protein. Besides, by cycloheximide (CHX)-chase and immunoprecipitation and ubiquitination assays, the overexpression of the LncRNA HOTAIR enhanced the stability of MYD88 protein and inhibited Nrdp1-mediated ubiquitination of MYD88 protein. After the transfection of shRNA-HOTAIR and shRNA-HOTAIR+pcDNA-MYD88 into microglia, shRNA-HOTAIR could significantly inhibit the activation of microglia and the release of inflammatory factors, while these effects were reversed after the transfection of pcDNA-MYD88. Our experimental data indicated that LncRNA HOTAIR was highly expressed in activated microglia, and our further studies had found that the interference with LncRNA HOTAIR could repress microglia activation and inflammatory factor release via promoting Nrdp1-mediated ubiquitination of MYD88 protein.	[Cheng, Shiqi; Chen, Shuzhen; Zhou, Yongliang] Nanchang Univ, Dept Neurol, Jiangxi Prov Peoples Hosp, 92 Aiguo Rd, Nanchang 330006, Jiangxi, Peoples R China; [Zhang, Yan] Nanchang Univ, Dept Neurosurg, Affiliated Hosp 2, Nanchang, Jiangxi, Peoples R China		Zhou, YL (corresponding author), Nanchang Univ, Dept Neurol, Jiangxi Prov Peoples Hosp, 92 Aiguo Rd, Nanchang 330006, Jiangxi, Peoples R China.	157141192@qq.com			Natural Science Fund of Jiangxi Province [20192BBH80016]	This work was funded by the Natural Science Fund of Jiangxi Province (20192BBH80016).	Batista PJ, 2013, CELL, V152, P1298, DOI 10.1016/j.cell.2013.02.012; Beermann J, 2016, PHYSIOL REV, V96, P1297, DOI 10.1152/physrev.00041.2015; Chen LQ, 2010, CANCER RES, V70, P5994, DOI 10.1158/0008-5472.CAN-09-4440; Corrigan F, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0738-9; Diaz-Trujillo A, 2009, NEUROBIOL LEARN MEM, V91, P308, DOI 10.1016/j.nlm.2008.10.006; Ding FJ, 2016, BIOMED REP, V5, P623, DOI 10.3892/br.2016.776; Echizen K, 2016, CANCER SCI, V107, P391, DOI 10.1111/cas.12901; Gruenbaum SE, 2016, CNS DRUGS, V30, P791, DOI 10.1007/s40263-016-0355-2; Hoogland ICM, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0332-6; Kfoury A, 2014, CURR OPIN ONCOL, V26, P86, DOI 10.1097/CCO.0000000000000037; Kim C, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/2062384; Kim SY, 2019, INT J MOL MED, V43, P682, DOI 10.3892/ijmm.2018.3993; Kumar A, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0819-4; Loane DJ, 2010, TRENDS PHARMACOL SCI, V31, P596, DOI 10.1016/j.tips.2010.09.005; Leite FRM, 2015, INFLAMMATION, V38, P1, DOI 10.1007/s10753-014-0001-4; Meng H, 2018, ONCOL RES, V26, P809, DOI 10.3727/096504017X15123872205507; Pallante P, 2013, EUR J CANCER, V49, P1117, DOI 10.1016/j.ejca.2012.09.033; Patel NA, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1240-3; Qi X, 2017, NEUROSCIENCE, V348, P98, DOI 10.1016/j.neuroscience.2017.02.002; Qiu XB, 2004, EMBO J, V23, P800, DOI 10.1038/sj.emboj.7600075; Shi HL, 2014, IUBMB LIFE, V66, P704, DOI 10.1002/iub.1320; St Laurent G, 2015, TRENDS GENET, V31, P239, DOI 10.1016/j.tig.2015.03.007; Stein SC, 2010, J NEUROTRAUM, V27, P1343, DOI 10.1089/neu.2009.1206; Tischer J, 2016, GLIA, V64, P1562, DOI 10.1002/glia.23024; Wang C, 2009, NAT IMMUNOL, V10, P744, DOI 10.1038/ni.1742; Wang CF, 2017, J NEUROTRAUM, V34, P2100, DOI 10.1089/neu.2016.4642; Wang J, 2017, STROKE, V48, P2211, DOI 10.1161/STROKEAHA.117.017387; Wang L.-M., 2018, SCI REP, V8, P1, DOI DOI 10.1038/s41598-017-18730-y; WIDELITZ RB, 1986, MOL CELL BIOL, V6, P1088, DOI 10.1128/MCB.6.4.1088; Yan H, 2014, ACTA PHARMACOL SIN, V35, P994, DOI 10.1038/aps.2014.52; Yang HM, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00193; Yang L, 2016, BIOCHEM BIOPH RES CO, V479, P186, DOI 10.1016/j.bbrc.2016.09.023; Yoon JH, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3939; Zhang A, 2015, CELL REP, V13, P209, DOI 10.1016/j.celrep.2015.08.069; Zhang HS, 2016, BRAIN RES, V1643, P130, DOI 10.1016/j.brainres.2016.05.003; Zhang JZ, 2013, IRAN J PHARM RES, V12, P15; Zhang X, 2019, J NEUROINFLAMM, V16, DOI 10.1186/s12974-019-1464-x; Zheng N, 2017, ANNU REV BIOCHEM, V86, P129, DOI 10.1146/annurev-biochem-060815-014922; Zhong JJ, 2017, BRAIN BEHAV IMMUN, V65, P183, DOI 10.1016/j.bbi.2017.05.001; Zhou HJ, 2018, AM J PHYSIOL-CELL PH, V315, pC52, DOI 10.1152/ajpcell.00278.2017; Zhu HT, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-59	41	7	7	1	9	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	0895-8696	1559-1166		J MOL NEUROSCI	J. Mol. Neurosci.	JAN	2021	71	1					169	177		10.1007/s12031-020-01623-7		JUN 2020	9	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	PI6HN	WOS:000544154300002	32602030				2022-02-06	
J	Li, FF; Lu, LY; Shang, SA; Hu, LY; Chen, HY; Wang, P; Zhang, H; Chen, YC; Yin, XD				Li, Fengfang; Lu, Liyan; Shang, Song'an; Hu, Lanyue; Chen, Huiyou; Wang, Peng; Zhang, Hong; Chen, Yu-Chen; Yin, Xindao			Disrupted functional network connectivity predicts cognitive impairment after acute mild traumatic brain injury	CNS NEUROSCIENCE & THERAPEUTICS			English	Article						cognitive impairment; functional network connectivity; mild traumatic brain injury; resting-state fMRI	DEFAULT-MODE NETWORK; RESTING-STATE NETWORKS; INDEPENDENT COMPONENT; SALIENCE NETWORK; FMRI; MRI	Aims This study aimed to detect alterations of brain functional connectivity (FC) in acute mild traumatic brain injury (mTBI) and to estimate the extent to which these FC differences predicted the characteristics of posttraumatic cognitive impairment. Methods Resting-state fMRI data were acquired from acute mTBI patients (n = 50) and healthy controls (HCs) (n = 43). Resting-state networks (RSNs) were established based on independent component analysis (ICA), and functional network connectivity (FNC) analysis was performed. Subsequently, we analyzed the correlations between FNC abnormalities and cognitive impairment outcomes. Results Altered FC within the salience network (SN), sensorimotor network (SMN), default mode network (DMN), executive control network (ECN), visual network (VN), and cerebellum network (CN) was found in the mTBI group relative to the HC group. Moreover, different patterns of altered network interactions were found between the mTBI patients and HCs, including the SN-CN, VN-SMN, and ECN-DMN connections. Correlations between functional disconnection and cognitive impairment measurements in acute mTBI patients were also found. Conclusion This study indicated that widespread FNC impairment and altered integration existed in mTBI patients at acute stage, suggesting that FNC disruption as a biomarker may be applied for the early diagnosis and prediction of cognitive impairment in mTBI.	[Li, Fengfang; Lu, Liyan; Shang, Song'an; Hu, Lanyue; Chen, Huiyou; Wang, Peng; Chen, Yu-Chen; Yin, Xindao] Nanjing Med Univ, Nanjing Hosp 1, Dept Radiol, 68 Changle Rd, Nanjing 210006, Peoples R China; [Zhang, Hong] Nanjing Med Univ, Dept Radiol, Jiangning Hosp, Nanjing, Peoples R China		Chen, YC; Yin, XD (corresponding author), Nanjing Med Univ, Nanjing Hosp 1, Dept Radiol, 68 Changle Rd, Nanjing 210006, Peoples R China.	chenyuchen1989@126.com; y.163yy@163.com		Wei, Heng-Le/0000-0001-5827-2488; Chen, Yu-Chen/0000-0002-8539-7224	333 High-level Talents Training Project of Jiangsu Province [BRA2019122]	This work was supported by 333 High-level Talents Training Project of Jiangsu Province (No. BRA2019122).	Allin M, 2001, BRAIN, V124, P60, DOI 10.1093/brain/124.1.60; Bernier RA, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00297; Calhoun VD, 2001, HUM BRAIN MAPP, V14, P140, DOI 10.1002/hbm.1048; Capo-Aponte JE, 2017, OPTOMETRY VISION SCI, V94, P7, DOI 10.1097/OPX.0000000000000825; Cerliani L, 2015, JAMA PSYCHIAT, V72, P767, DOI 10.1001/jamapsychiatry.2015.0101; Chand GB, 2016, NEUROIMAGE, V134, P85, DOI 10.1016/j.neuroimage.2016.04.018; de Guise E, 2014, APPL NEUROPSYCH-ADUL, V21, P128, DOI 10.1080/09084282.2013.778260; De Luca M, 2006, NEUROIMAGE, V29, P1359, DOI 10.1016/j.neuroimage.2005.08.035; Dretsch MN, 2019, J EXP NEUROSCI, V13, DOI [10.1177/1179069519833966, 10.1177/1179069619833966]; Dumkrieger G, 2019, CEPHALALGIA, V39, P1366, DOI 10.1177/0333102419847728; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Iraji A, 2015, J NEUROTRAUM, V32, P1031, DOI 10.1089/neu.2014.3610; Jafri MJ, 2008, NEUROIMAGE, V39, P1666, DOI 10.1016/j.neuroimage.2007.11.001; Jilka SR, 2014, J NEUROSCI, V34, P10798, DOI 10.1523/JNEUROSCI.0518-14.2014; Li FF, 2019, AGING-US, V11, P10684, DOI 10.18632/aging.102484; Li FF, 2020, BRAIN IMAGING BEHAV, V14, P907, DOI 10.1007/s11682-019-00053-3; Li Lianyang, 2018, Annu Int Conf IEEE Eng Med Biol Soc, V2018, P3165, DOI 10.1109/EMBC.2018.8513045; Li YO, 2007, HUM BRAIN MAPP, V28, P1251, DOI 10.1002/hbm.20359; Lu LY, 2019, EUR J RADIOL, V114, P69, DOI 10.1016/j.ejrad.2019.03.002; McHugh PR, 2007, J ANXIETY DISORD, V21, P211, DOI 10.1016/j.janxdis.2006.09.003; Mufti O, 2020, EUR J OPHTHALMOL, V30, P867, DOI 10.1177/1120672119866974; Nathan DE, 2015, BRAIN CONNECT, V5, P102, DOI 10.1089/brain.2014.0273; Palacios EM, 2017, J NEUROTRAUM, V34, P1546, DOI 10.1089/neu.2016.4752; Palacios EM, 2013, JAMA NEUROL, V70, P845, DOI 10.1001/jamaneurol.2013.38; Qin Y, 2018, NEURAL PLAST, V2018, DOI 10.1155/2018/7058953; Rockswold SB, 2019, J NEUROTRAUM, V36, P1099, DOI 10.1089/neu.2018.5796; Sharp DJ, 2011, BRAIN, V134, P2233, DOI 10.1093/brain/awr175; Slobounov SM, 2011, NEUROIMAGE, V55, P1716, DOI 10.1016/j.neuroimage.2011.01.024; Sullivan DR, 2018, J INT NEUROPSYCH SOC, V24, P662, DOI 10.1017/S1355617718000279; Uddin LQ, 2015, NAT REV NEUROSCI, V16, P55, DOI 10.1038/nrn3857; van der Horn HJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171031; Vergara VM, 2017, BRAIN BEHAV, V7, DOI 10.1002/brb3.809; Vergara VM, 2017, J NEUROTRAUM, V34, P1045, DOI 10.1089/neu.2016.4526; Wang S, 2018, FRONT NEURAL CIRCUIT, V12, DOI 10.3389/fncir.2018.00107; Wang ZQ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151489; Wylie GR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126110; Yan CG, 2016, NEUROINFORMATICS, V14, P339, DOI 10.1007/s12021-016-9299-4; Zhou YX, 2014, J MAGN RESON IMAGING, V39, P1558, DOI 10.1002/jmri.24310; Zhu DC, 2015, J NEUROTRAUM, V32, P327, DOI 10.1089/neu.2014.3413	39	7	8	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1755-5930	1755-5949		CNS NEUROSCI THER	CNS Neurosci. Ther.	OCT	2020	26	10					1083	1091		10.1111/cns.13430		JUN 2020	9	Neurosciences; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pharmacology & Pharmacy	NL7ZE	WOS:000543031000001	32588522	gold, Green Published			2022-02-06	
J	Kempuraj, D; Ahmed, ME; Selvakumar, GP; Thangavel, R; Raikwar, SP; Zaheer, SA; Iyer, SS; Burton, C; James, D; Zaheer, A				Kempuraj, Duraisamy; Ahmed, Mohammad Ejaz; Selvakumar, Govindhasamy Pushpavathi; Thangavel, Ramasamy; Raikwar, Sudhanshu P.; Zaheer, Smita A.; Iyer, Shankar S.; Burton, Casey; James, Donald; Zaheer, Asgar			Mast Cell Activation, Neuroinflammation, and Tight Junction Protein Derangement in Acute Traumatic Brain Injury	MEDIATORS OF INFLAMMATION			English	Article							GLIA MATURATION FACTOR; COGNITIVE DEFICITS; MOUSE MODEL; MICROGLIA; CCL2; MECHANISMS; EXPRESSION; BARRIER; VEGFR2	Traumatic brain injury (TBI) is one of the major health problems worldwide that causes death or permanent disability through primary and secondary damages in the brain. TBI causes primary brain damage and activates glial cells and immune and inflammatory cells, including mast cells in the brain associated with neuroinflammatory responses that cause secondary brain damage. Though the survival rate and the neurological deficiencies have shown significant improvement in many TBI patients with newer therapeutic options, the underlying pathophysiology of TBI-mediated neuroinflammation, neurodegeneration, and cognitive dysfunctions is understudied. In this study, we analyzed mast cells and neuroinflammation in weight drop-induced TBI. We analyzed mast cell activation by toluidine blue staining, serum chemokine C-C motif ligand 2 (CCL2) level by enzyme-linked immunosorbent assay (ELISA), and proteinase-activated receptor-2 (PAR-2), a mast cell and inflammation-associated protein, vascular endothelial growth factor receptor 2 (VEGFR2), and blood-brain barrier tight junction-associated claudin 5 and Zonula occludens-1 (ZO-1) protein expression in the brains of TBI mice. Mast cell activation and its numbers increased in the brains of 24 h and 72 h TBI when compared with sham control brains without TBI. Mouse brains after TBI show increased CCL2, PAR-2, and VEGFR2 expression and derangement of claudin 5 and ZO-1 expression as compared with sham control brains. TBI can cause mast cell activation, neuroinflammation, and derangement of tight junction proteins associated with increased BBB permeability. We suggest that inhibition of mast cell activation can suppress neuroimmune responses and glial cell activation-associated neuroinflammation and neurodegeneration in TBI.	[Kempuraj, Duraisamy; Ahmed, Mohammad Ejaz; Selvakumar, Govindhasamy Pushpavathi; Thangavel, Ramasamy; Raikwar, Sudhanshu P.; Zaheer, Smita A.; Iyer, Shankar S.; Zaheer, Asgar] Univ Missouri, Sch Med, Dept Neurol, Columbia, MO 65211 USA; [Kempuraj, Duraisamy; Ahmed, Mohammad Ejaz; Selvakumar, Govindhasamy Pushpavathi; Thangavel, Ramasamy; Raikwar, Sudhanshu P.; Zaheer, Smita A.; Iyer, Shankar S.; Zaheer, Asgar] Univ Missouri, Ctr Translat Neurosci, Sch Med, Columbia, MO 65211 USA; [Kempuraj, Duraisamy; Ahmed, Mohammad Ejaz; Selvakumar, Govindhasamy Pushpavathi; Thangavel, Ramasamy; Raikwar, Sudhanshu P.; Iyer, Shankar S.; Zaheer, Asgar] US Dept Vet Affairs, Harry S Truman Mem Vet Hosp, Columbia, MO 65201 USA; [Burton, Casey; James, Donald] Phelps Hlth, Rolla, MO USA		Kempuraj, D; Zaheer, A (corresponding author), Univ Missouri, Sch Med, Dept Neurol, Columbia, MO 65211 USA.; Kempuraj, D; Zaheer, A (corresponding author), Univ Missouri, Ctr Translat Neurosci, Sch Med, Columbia, MO 65211 USA.; Kempuraj, D; Zaheer, A (corresponding author), US Dept Vet Affairs, Harry S Truman Mem Vet Hosp, Columbia, MO 65201 USA.	duraisamyk@health.missouri.edu; zaheera@health.missouri.edu	Raikwar, Sudhanshu/AAT-5128-2021	Raikwar, Sudhanshu/0000-0001-8549-8570	Leonard Wood Institute; U.S. Army Research LaboratoryUnited States Department of DefenseUS Army Research Laboratory (ARL) [W911NF-14-2-0034]; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [AG048205]; VA Research Career Scientist Award	The research was sponsored by the Leonard Wood Institute in cooperation with the U.S. Army Research Laboratory (accomplished under Cooperative Agreement Number W911NF-14-2-0034). The authors express their gratitude for the Acute Effects of Neurotrauma Consortium in assisting and coordinating the conduct of this project at Fort Leonard Wood. This research was also supported by NIH grant AG048205 and VA Research Career Scientist Award to Asgar Zaheer.	Aerbajinai W, 2011, J LEUKOCYTE BIOL, V90, P529, DOI 10.1189/jlb.0710424; Ahmed ME, 2020, J NEUROTRAUM, V37, P1645, DOI 10.1089/neu.2019.6932; Ahmed ME, 2019, MOL NEUROBIOL, V56, P6964, DOI 10.1007/s12035-019-1544-z; Arac A, 2019, FRONT CELL NEUROSCI, V13, DOI 10.3389/fncel.2019.00126; Bader M, 2020, FRONT CELL DEV BIOL, V7, DOI 10.3389/fcell.2019.00356; Beazley-Long N, 2018, BRAIN BEHAV IMMUN, V74, P49, DOI 10.1016/j.bbi.2018.03.012; Bhowmick S, 2019, EXP NEUROL, V317, P260, DOI 10.1016/j.expneurol.2019.03.014; Bree D, 2019, PAIN, V160, P1050, DOI 10.1097/j.pain.0000000000001481; Bushell T, 2007, J PHYSIOL-LONDON, V581, P7, DOI 10.1113/jphysiol.2007.129577; Cedile O, 2017, APMIS, V125, P945, DOI 10.1111/apm.12740; Dong HQ, 2014, MED SCI MONIT BASIC, V20, P200, DOI 10.12659/MSMBR.893093; Dore-Duffy P., 2013, NEUROL RES, V29, P395; Dwyer B, 2018, SEMIN NEUROL, V38, P619, DOI 10.1055/s-0038-1673692; Esposito P, 2001, BRAIN RES, V888, P117, DOI 10.1016/S0006-8993(00)03026-2; Harris R, 2018, J ALZHEIMERS DIS, V61, P741, DOI 10.3233/JAD-170745; Hendriksen E, 2017, NEUROSCI BIOBEHAV R, V79, P119, DOI 10.1016/j.neubiorev.2017.05.001; Huang LQ, 2016, BMC NEUROSCI, V17, DOI 10.1186/s12868-016-0299-y; Jones MK, 2019, FRONT CELL NEUROSCI, V13, DOI 10.3389/fncel.2019.00171; Kamins J, 2018, HEADACHE, V58, P811, DOI 10.1111/head.13312; Kempuraj D., 2016, J NEUROLOGY NEUROSUR, V1; Kempuraj D, 2020, NEUROSCIENTIST, V26, P134, DOI 10.1177/1073858419848293; Kempuraj D, 2019, FRONT CELL NEUROSCI, V13, DOI 10.3389/fncel.2019.00054; Kempuraj D, 2018, J ALZHEIMERS DIS, V66, P1117, DOI 10.3233/JAD-180786; Kempuraj D, 2019, MOL NEUROBIOL, V56, P1681, DOI 10.1007/s12035-018-1177-7; Kempuraj D, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00703; Kempuraj D, 2016, NEUROCHEM RES, V41, P1042, DOI 10.1007/s11064-015-1790-z; Kempuraj D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135776; Khellaf A, 2019, J NEUROL, V266, P2878, DOI 10.1007/s00415-019-09541-4; Ladak AA, 2019, WORLD NEUROSURG, V131, P126, DOI 10.1016/j.wneu.2019.07.039; Landreneau MJ, 2018, ANN CLIN TRANSL NEUR, V5, P962, DOI 10.1002/acn3.595; Liu P, 2014, BRAIN RES, V1565, P82, DOI 10.1016/j.brainres.2014.04.014; Lucas S, 2017, NEUROL CLIN, V35, P501, DOI 10.1016/j.ncl.2017.03.012; Ma XT, 2019, MOL NEUROBIOL, V56, P5332, DOI 10.1007/s12035-018-1454-5; McKittrick CM, 2015, J CEREBR BLOOD F MET, V35, P638, DOI 10.1038/jcbfm.2014.239; Milman A, 2005, J NEUROTRAUM, V22, P1003, DOI 10.1089/neu.2005.22.1003; Mittal A, 2019, FRONT CELL NEUROSCI, V13, DOI 10.3389/fncel.2019.00110; Moretti R, 2016, J NEUROSCI RES, V94, P1546, DOI 10.1002/jnr.23911; Morgan R., 2013, NEUROL RES, V29, P375; Mrozkova P, 2016, PHYSIOL RES, V65, P357, DOI 10.33549/physiolres.933269; Needham EJ, 2019, J NEUROIMMUNOL, V332, P112, DOI 10.1016/j.jneuroim.2019.04.005; Nishida K, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-47132-5; Noorbakhsh F, 2006, J EXP MED, V203, P425, DOI 10.1084/jem.20052148; Ocak U, 2019, BRAIN INJURY, V33, P723, DOI 10.1080/02699052.2018.1556807; Parrella E, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8050437; Raikwar SP, 2019, MOL NEUROBIOL, V56, P378, DOI 10.1007/s12035-018-1068-y; Rowland B, 2020, SHOCK, V53, P24, DOI 10.1097/SHK.0000000000001349; Selvakumar GP, 2020, BRAIN BEHAV IMMUN, V87, P429, DOI 10.1016/j.bbi.2020.01.013; Selvakumar GP, 2019, MOL NEUROBIOL, V56, P3865, DOI 10.1007/s12035-018-1340-1; Shaik-Dasthagirisaheb YB, 2016, ADV CLIN EXP MED, V25, P781, DOI 10.17219/acem/61914; Shishido H, 2019, BEHAV NEUROL, V2019, DOI 10.1155/2019/3248519; Silver R, 2013, TRENDS NEUROSCI, V36, P513, DOI 10.1016/j.tins.2013.06.001; Skaper SD, 2014, CNS NEUROL DISORD-DR, V13, P1654; Sokolova E, 2012, NEUROCHEM INT, V60, P276, DOI 10.1016/j.neuint.2011.12.016; Stamatovic SM, 2009, J BIOL CHEM, V284, P19053, DOI 10.1074/jbc.M109.000521; Tadepalli SA, 2020, BEHAV BRAIN RES, V378, DOI 10.1016/j.bbr.2019.112268; Thangavel R, 2018, J ALZHEIMERS DIS, V61, P553, DOI 10.3233/JAD-170777; Theoharides TC, 2019, FRONT CELL NEUROSCI, V13, DOI 10.3389/fncel.2019.00353; Theoharides TC, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20153701; Traina G, 2019, FRONT CELL NEUROSCI, V13, DOI 10.3389/fncel.2019.00345; Trettel F, 2020, NEUROSCIENCE, V439, P230, DOI 10.1016/j.neuroscience.2019.07.035; Wernersson S, 2014, NAT REV IMMUNOL, V14, P478, DOI 10.1038/nri3690; Yehya M, 2018, NEUROCRIT CARE, V28, P288, DOI 10.1007/s12028-017-0416-5; Zhang S, 2012, CELL PHYSIOL BIOCHEM, V29, P931, DOI 10.1159/000171029; Zimmermann C, 2019, P NATL ACAD SCI USA, V116, P20500, DOI 10.1073/pnas.1908816116; Zohar O, 2003, NEUROSCIENCE, V118, P949, DOI 10.1016/S0306-4522(03)00048-4; Zvejniece L, 2020, J NEUROTRAUM, V37, P295, DOI 10.1089/neu.2019.6524; Zysk M, 2019, J ALZHEIMERS DIS, V72, P161, DOI 10.3233/JAD-190572	67	7	8	1	1	HINDAWI LTD	LONDON	ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND	0962-9351	1466-1861		MEDIAT INFLAMM	Mediat. Inflamm.	JUN 24	2020	2020								4243953	10.1155/2020/4243953			12	Cell Biology; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Immunology	MM2FI	WOS:000549972500001	32684835	gold, Green Published			2022-02-06	
J	Chen, LP; Song, QX; Chen, YX; Meng, S; Zheng, MN; Huang, JL; Zhang, Q; Jiang, JY; Feng, JF; Chen, HZ; Jiang, G; Gao, XL				Chen, Lepei; Song, Qingxiang; Chen, Yaoxing; Meng, Shuang; Zheng, Mengna; Huang, Jialin; Zhang, Qian; Jiang, Jiyao; Feng, Junfeng; Chen, Hongzhuan; Jiang, Gan; Gao, Xiaoling			Tailored Reconstituted Lipoprotein for Site-Specific and Mitochondria-Targeted Cyclosporine A Delivery to Treat Traumatic Brain Injury	ACS NANO			English	Article						reconstituted lipoprotein; mitochondria; traumatic brain injury; cyclosporine A; matrix metalloproteinase-9	TRANSITION PORE; NEUROINFLAMMATION; DYSFUNCTION; PATHOPHYSIOLOGY; NANOPARTICLES; PEPTIDES; DISEASE; DAMAGE; DEATH	The secondary damage in traumatic brain injury (TBI) can lead to lifelong disabilities, bringing enormous economic and psychological burden to patients and their families. Mitochondria, as the core mediator of the secondary injury cascade reaction in TBI, is an important target to prevent the spread of cell death and dysfunction. Thus, therapeutics that can accumulate at the damaged sites and subsequently rescue the functions of mitochondria would largely improve the outcome of TBI. Cyclosporine A (CsA), which can maintain the integrity of mitochondrial function, is among the most promising neuroprotective therapeutics for TBI treatment. However, the clinical application of CsA in TBI is largely hindered because of its poor access to the targets. Here, to realize targeted intracellular CsA delivery, we designed a lipoprotein biomimetic nanocarrier by incorporating CsA in the core and decorating a matrix metalloproteinase-9 activatable cell-penetrating peptide onto the surface of the lipoprotein-mimic nanocarrier. This CsA-loaded tailored reconstituted lipoprotein efficiently accumulated at the damaged brain sites, entered the target cells, bound to the membrane of mitochondria, more efficiently reduced neuronal damage, alleviated neuro-inflammation, and rescued memory deficits at the dose 1/16 of free CsA in a controlled cortical impact injury mice model. The findings provide strong evidence that the secondary damages in TBI can be well controlled through targeted CsA delivery and highlight the potential of a lipoprotein biomimetic nanocarrier as a flexible nanoplatform for the management of TBI.	[Chen, Lepei; Song, Qingxiang; Chen, Yaoxing; Zheng, Mengna; Huang, Jialin; Zhang, Qian; Chen, Hongzhuan; Jiang, Gan; Gao, Xiaoling] Shanghai Jiao Tong Univ, Dept Pharmacol & Chem Biol, State Key Lab Oncogenes & Related Genes, Sch Med,Shanghai Univ Collaborat Innovat Ctr Tran, Shanghai 200025, Peoples R China; [Meng, Shuang] Shanghai Jiao Tong Univ, Core Facil Basic Med Sci, Sch Med, Shanghai 200025, Peoples R China; [Huang, Jialin; Jiang, Jiyao; Feng, Junfeng] Shanghai Jiao Tong Univ, Dept Neurol Surg, Renji Hosp, Sch Med, Shanghai 200127, Peoples R China; [Chen, Hongzhuan] Shanghai Univ Tradit Chinese Med, Inst Interdisciplinary Integrat Biomed Res, Shuguang Hosp, Shanghai 201210, Peoples R China		Jiang, G; Gao, XL (corresponding author), Shanghai Jiao Tong Univ, Dept Pharmacol & Chem Biol, State Key Lab Oncogenes & Related Genes, Sch Med,Shanghai Univ Collaborat Innovat Ctr Tran, Shanghai 200025, Peoples R China.	scmcyidingkaixin@163.com; shellygao1@sjtu.edu.cn	Jiang, Gan/J-6421-2017	Jiang, Gan/0000-0003-2011-741X; Chen, Yaoxing/0000-0003-2632-3783	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81573382, 81722043, 81803089, 81903582, 81973272, 81971825]; National Science and Technology Major Project [2018ZX09734005, 2017ZX09304016]; Shanghai Science and Technology CommitteeShanghai Science & Technology Committee [19410710100, 18ZR1421900]; National Youth Talent Support Program; Shanghai Jiaotong University; "Shu Guang" project - Shanghai Municipal Education CommissionChinese Academy of Sciences; Shanghai Education Development Foundation [15SG14]	This work was supported by the National Natural Science Foundation of China (nos. 81573382, 81722043, 81803089, 81903582, 81973272, and 81971825), the National Science and Technology Major Project (2018ZX09734005 and 2017ZX09304016), a grant from Shanghai Science and Technology Committee (19410710100 and 18ZR1421900), the National Youth Talent Support Program, Shanghai Jiaotong University fund for young teacher, and the "Shu Guang" project supported by Shanghai Municipal Education Commission and Shanghai Education Development Foundation (15SG14).	Almeida AJ, 2007, ADV DRUG DELIVER REV, V59, P478, DOI 10.1016/j.addr.2007.04.007; ANANTHARAMAIAH GM, 1985, J BIOL CHEM, V260, P248; Aungst SL, 2014, J CEREBR BLOOD F MET, V34, P1223, DOI 10.1038/jcbfm.2014.75; Bony BA, 2019, PHARMACEUTICS, V11, DOI 10.3390/pharmaceutics11090473; Cook AM, 2009, EXPERT OPIN DRUG SAF, V8, P411, DOI 10.1517/14740330903066742; Galgano M, 2017, CELL TRANSPLANT, V26, P1118, DOI 10.1177/0963689717714102; Hadass O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076904; Hayashi T, 2009, BRAIN RES, V1280, P172, DOI 10.1016/j.brainres.2009.05.040; Hill CS, 2016, TRENDS NEUROSCI, V39, P311, DOI 10.1016/j.tins.2016.03.002; HOYER PF, 1988, TRANSPLANTATION, V46, P73, DOI 10.1097/00007890-198807000-00013; Huang M, 2015, ACS NANO, V9, P10801, DOI 10.1021/acsnano.5b03124; Jassam YN, 2017, NEURON, V95, P1246, DOI 10.1016/j.neuron.2017.07.010; Jiang G, 2020, ADV SCI, V7, DOI 10.1002/advs.201903290; Jiang JY, 2019, LANCET NEUROL, V18, P286, DOI 10.1016/S1474-4422(18)30469-1; Kaur P, 2018, CURR NEUROPHARMACOL, V16, P1224, DOI 10.2174/1570159X15666170613083606; Kelsen J, 2019, J NEUROTRAUM, V36, P3253, DOI 10.1089/neu.2018.6369; Kulbe JR, 2017, J NEUROTRAUM, V34, P1291, DOI 10.1089/neu.2016.4628; Lamade AM, 2019, NEUROPHARMACOLOGY, V145, P209, DOI 10.1016/j.neuropharm.2018.07.014; Lee J, 2010, TOX RESEARCH, V26, P163, DOI 10.5487/TR.2010.26.3.163; Lim D, 2008, J BIOL CHEM, V283, P5780, DOI 10.1074/jbc.M704704200; Lin QY, 2014, SMALL, V10, P3072, DOI 10.1002/smll.201303842; Luetjens CM, 2000, J NEUROSCI, V20, P5715; Lulic D, 2011, NEUROSURGERY, V68, P1172, DOI 10.1227/NEU.0b013e31820c6cdc; Ma XY, 2018, ACTA PHARM SIN B, V8, P51, DOI 10.1016/j.apsb.2017.11.006; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Mac Donald CL, 2017, JAMA NEUROL, V74, P821, DOI 10.1001/jamaneurol.2017.0143; Mazzeo AT, 2009, EXP NEUROL, V218, P363, DOI 10.1016/j.expneurol.2009.05.026; McConeghy KW, 2012, CNS DRUGS, V26, P613, DOI 10.2165/11634020-000000000-00000; Moutinho CG, 2012, J DRUG TARGET, V20, P114, DOI 10.3109/1061186X.2011.628397; Mu XY, 2019, NANO LETT, V19, P4527, DOI 10.1021/acs.nanolett.9b01333; Okonkwo DO, 2003, NEUROREPORT, V14, P463, DOI 10.1097/01.wnr.0000058958.85541.d3; Okonkwo DO, 1999, NEUROREPORT, V10, P353, DOI 10.1097/00001756-199902050-00026; Partoazar A, 2017, FUND CLIN PHARMACOL, V31, P185, DOI 10.1111/fcp.12244; Rasola A, 2007, APOPTOSIS, V12, P815, DOI 10.1007/s10495-007-0723-y; Sharp DJ, 2014, NAT REV NEUROL, V10, P156, DOI 10.1038/nrneurol.2014.15; Shigemori Y, 2006, ACTA NEUROCHIR SUPPL, V96, P130; Simon DW, 2017, NAT REV NEUROL, V13, P171, DOI 10.1038/nrneurol.2017.13; Song QX, 2016, MOL PHARMACEUT, V13, P3976, DOI 10.1021/acs.molpharmaceut.6b00781; Song QX, 2014, ACS NANO, V8, P2345, DOI 10.1021/nn4058215; Sonnino S, 2010, ADV EXP MED BIOL, V688, P165; Sullivan PG, 2011, J NEUROTRAUM, V28, P311, DOI 10.1089/neu.2010.1646; Tran LV, 2014, J TRAUMA NURS, V21, P30, DOI 10.1097/JTN.0000000000000026; Vilalta A, 2008, INTENS CARE MED, V34, P1384, DOI 10.1007/s00134-008-1056-1; Wofford KL, 2019, NEURAL REGEN RES, V14, P1481, DOI 10.4103/1673-5374.255958; Yao L, 2016, J CONTROL RELEASE, V226, P1, DOI 10.1016/j.jconrel.2016.01.055	45	7	7	11	36	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1936-0851	1936-086X		ACS NANO	ACS Nano	JUN 23	2020	14	6					6636	6648		10.1021/acsnano.9b09186			13	Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience & Nanotechnology; Materials Science, Multidisciplinary	Science Citation Index Expanded (SCI-EXPANDED)	Chemistry; Science & Technology - Other Topics; Materials Science	MD1OH	WOS:000543744100024	32464051				2022-02-06	
J	Liu, XY; Czosnyka, M; Donnelly, J; Cardim, D; Cabeleira, M; Lalou, DA; Hu, X; Hutchinson, PJ; Smielewski, P				Liu, Xiuyun; Czosnyka, Marek; Donnelly, Joseph; Cardim, Danilo; Cabeleira, Manuel; Lalou, Despina Aphroditi; Hu, Xiao; Hutchinson, Peter J.; Smielewski, Peter			Assessment of cerebral autoregulation indices - a modelling perspective	SCIENTIFIC REPORTS			English	Article							BLOOD-FLOW VELOCITY; SPONTANEOUS FLUCTUATIONS; PRESSURE AUTOREGULATION; DYNAMIC AUTOREGULATION; TRANSCRANIAL DOPPLER; PERFUSION-PRESSURE; INJURY	Various methodologies to assess cerebral autoregulation (CA) have been developed, including model - based methods (e.g. autoregulation index, ARI), correlation coefficient - based methods (e.g. mean flow index, Mx), and frequency domain - based methods (e.g. transfer function analysis, TF). Our understanding of relationships among CA indices remains limited, partly due to disagreement of different studies by using real physiological signals, which introduce confounding factors. The influence of exogenous noise on CA parameters needs further investigation. Using a set of artificial cerebral blood flow velocities (CBFV) generated from a well-known CA model, this study aims to cross-validate the relationship among CA indices in a more controlled environment. Real arterial blood pressure (ABP) measurements from 34 traumatic brain injury patients were applied to create artificial CBFVs. Each ABP recording was used to create 10 CBFVs corresponding to 10 CA levels (ARI from 0 to 9). Mx, TF phase, gain and coherence in low frequency (LF) and very low frequency (VLF) were calculated. The influence of exogenous noise was investigated by adding three levels of colored noise to the artificial CBFVs. The result showed a significant negative relationship between Mx and ARI (r=-0.95, p<0.001), and it became almost purely linear when ARI is between 3 to 6. For transfer function parameters, ARI positively related with phase (r=0.99 at VLF and 0.93 at LF, p<0.001) and negatively related with gain_VLF(r=-0.98, p<0.001). Exogenous noise changed the actual values of the CA parameters and increased the standard deviation. Our results show that different methods can lead to poor correlation between some of the autoregulation parameters even under well controlled situations, undisturbed by unknown confounding factors. They also highlighted the importance of exogenous noise, showing that even the same CA value might correspond to different CA levels under different 'noise' conditions.	[Liu, Xiuyun; Czosnyka, Marek; Donnelly, Joseph; Cardim, Danilo; Cabeleira, Manuel; Lalou, Despina Aphroditi; Hutchinson, Peter J.; Smielewski, Peter] Univ Cambridge, Addenbrookes Hosp, Div Neurosurg, Dept Clin Neurosci,Brain Phys Lab, Cambridge, England; [Liu, Xiuyun] Johns Hopkins Univ, Sch Med, Dept Anesthesiol & Crit Care Med, Baltimore, MD USA; [Czosnyka, Marek] Warsaw Univ Technol, Inst Elect Syst, Warsaw, Poland; [Donnelly, Joseph] Univ Auckland, Dept Anaesthesiol, Auckland, New Zealand; [Cardim, Danilo] Univ Texas Southwestern Med Ctr Dallas, Dept Neurol & Neurotherapeut, Dallas, TX 75390 USA; [Hu, Xiao] Duke Univ, Sch Nursing, Durham, NC USA		Liu, XY (corresponding author), Univ Cambridge, Addenbrookes Hosp, Div Neurosurg, Dept Clin Neurosci,Brain Phys Lab, Cambridge, England.; Liu, XY (corresponding author), Johns Hopkins Univ, Sch Med, Dept Anesthesiol & Crit Care Med, Baltimore, MD USA.	liuxiuyun1@gmail.com	Cardim, Danilo Augusto/B-8447-2012; Liu, Xiuyun/V-4427-2017; Lalou, Afroditi Despina/D-2938-2017; Donnelly, Joseph/E-9235-2018	Cardim, Danilo Augusto/0000-0002-9261-1321; Liu, Xiuyun/0000-0001-9540-4865; Lalou, Afroditi Despina/0000-0003-3768-8681; Smielewski, Peter/0000-0001-5096-3938; Donnelly, Joseph/0000-0002-6502-8069	NIHR Research Professorship; Royal College of Surgeons of England; NIHR Cambridge Biomedical Research CentreNational Institute for Health Research (NIHR); Bill Gates Scholarship (University of Cambridge); Woolf Fisher Trust, NZ (Woolf Fisher Scholarship); Cambridge Commonwealth, European AMP; International Trust Scholarship, University of Cambridge	ICM+ Software is licensed by Cambridge Enterprise, Cambridge, UK, http://icmplus.neurosurg.cam.ac.uk.Peter Smielewski and Marek Czosnyka have a financial interest in a fraction of the licensing fee. Peter J. Hutchinson is supported by a NIHR Research Professorship, the Royal College of Surgeons of England and the NIHR Cambridge Biomedical Research Centre. Xiuyun Liu was a recipient of Bill Gates Scholarship (University of Cambridge). Joseph Donnelly was funded by the Woolf Fisher Trust, NZ (Woolf Fisher Scholarship). Danilo Cardim was supported by a Cambridge Commonwealth, European & International Trust Scholarship, University of Cambridge.	Aries MJH, 2012, CRIT CARE MED, V40, P2456, DOI 10.1097/CCM.0b013e3182514eb6; Blaber AP, 1997, STROKE, V28, P1686, DOI 10.1161/01.STR.28.9.1686; Blockley NP, 2011, MAGN RESON MED, V65, P1278, DOI 10.1002/mrm.22719; Brady KM, 2010, STROKE, V41, P1957, DOI 10.1161/STROKEAHA.109.575167; Budohoski KP, 2013, NAT REV NEUROL, V9, P152, DOI 10.1038/nrneurol.2013.11; Caldas J. R., 2018, THORAC SURG, V26; Claassen JAHR, 2016, J CEREBR BLOOD F MET, V36, P665, DOI 10.1177/0271678X15626425; Claassen JAHR, 2009, J APPL PHYSIOL, V106, P153, DOI 10.1152/japplphysiol.90822.2008; Czosnyka M, 2008, ANESTH ANALG, V106, P234, DOI 10.1213/01.ane.0000295802.89962.13; DIEHL RR, 1995, STROKE, V26, P1801, DOI 10.1161/01.STR.26.10.1801; Donnelly J, 2017, CRIT CARE MED, V45, P1464, DOI 10.1097/CCM.0000000000002575; Eriksen VR, 2015, J BIOMED OPT, V20, DOI 10.1117/1.JBO.20.3.037009; Ferradal SL, 2017, SCI REP-UK, V7, DOI 10.1038/srep44117; Guo ZN, 2015, SCI REP-UK, V5, DOI 10.1038/srep15269; Hamner JW, 2012, J PHYSIOL-LONDON, V590, P6343, DOI 10.1113/jphysiol.2012.245100; Hamner JW, 2004, J PHYSIOL-LONDON, V559, P965, DOI 10.1113/jphysiol.2004.066969; Horiuchi M, 2016, EXP PHYSIOL, V82, P1496; Katsogridakis E, 2011, ULTRASOUND MED BIOL, V37, P530, DOI 10.1016/j.ultrasmedbio.2010.12.015; Labrecque L, 2017, PHYSIOL REP, V5, DOI 10.14814/phy2.13486; Lang EW., 2005, ANAESTH AUSTRALAS, P161; Lee JK, 2017, J PERINATOL, V37, P938, DOI 10.1038/jp.2017.64; Lee JK, 2017, DEV NEUROSCI-BASEL, V39, P248, DOI 10.1159/000452833; Liu X, 2017, APOLLO U CAMBRIDGE R, DOI [10.17863/cam.11213, DOI 10.17863/CAM.11213]; Liu XN, 2014, J GEOPHYS ENG, V11, DOI 10.1088/1742-2132/11/1/015006; Liu XY, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002348; Meel-van den Abeelen ASS, 2014, MED ENG PHYS, V36, P620, DOI 10.1016/j.medengphy.2014.02.002; Menon DK, 1999, BRIT MED BULL, V55, P226, DOI 10.1258/0007142991902231; Muller MWD, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00327; Ogoh S, 2010, J PHYSIOL-LONDON, V588, P365, DOI 10.1113/jphysiol.2009.180844; Panerai RB, 2016, PHYSIOL MEAS, V37, P661, DOI 10.1088/0967-3334/37/5/661; Panerai RB, 2015, AM J PHYSIOL-HEART C, V308, pH688, DOI 10.1152/ajpheart.00887.2014; Panerai RB, 1998, MED BIOL ENG COMPUT, V36, P315, DOI 10.1007/BF02522477; Panerai RB, 1998, PHYSIOL MEAS, V19, P305, DOI 10.1088/0967-3334/19/3/001; Panerai RB, 1998, STROKE, V29, P2341, DOI 10.1161/01.STR.29.11.2341; Panerai RB, 1999, AM J PHYSIOL-HEART C, V277, pH1089, DOI 10.1152/ajpheart.1999.277.3.H1089; Panerai RB, 2008, CARDIOVASC ENG, V8, P42, DOI 10.1007/s10558-007-9044-6; Panerai RB, 2014, MED ENG PHYS, V36, P576, DOI 10.1016/j.medengphy.2013.09.004; Panerai RB, 2009, CLIN AUTON RES, V19, P197, DOI 10.1007/s10286-009-0011-8; PAULSON OB, 1990, CEREBROVAS BRAIN MET, V2, P161; Piechnik SK, 1999, ANESTH ANALG, V89, P944, DOI 10.1097/00000539-199910000-00023; Placek MM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181851; Radolovich DK, 2011, NEUROCRIT CARE, V15, P379, DOI 10.1007/s12028-011-9553-4; Reinhard M, 2003, PHYSIOL MEAS, V24, P27, DOI 10.1088/0967-3334/24/1/303; Sanders ML, 2019, FRONT PHYSIOL, V10, DOI 10.3389/fphys.2019.00865; Simpson D, 2018, J PHYSIOL-LONDON, V596, P7, DOI 10.1113/JP273900; Simpson DM, 2004, IEEE T BIO-MED ENG, V51, P1284, DOI 10.1109/TBME.2004.827947; Smirl JD, 2016, J APPL PHYSIOL, V120, P552, DOI 10.1152/japplphysiol.00667.2015; Subudhi A, 2015, EXP PHYSIOL, V100, P173, DOI 10.1113/expphysiol.2014.082479; TIECKS FP, 1995, STROKE, V26, P1386, DOI 10.1161/01.STR.26.8.1386; TIECKS FP, 1995, STROKE, V26, P1014, DOI 10.1161/01.STR.26.6.1014; Tzeng YC, 2018, J PHYSIOL-LONDON, V596, P3, DOI 10.1113/JP273899; Tzeng YC, 2012, AM J PHYSIOL-HEART C, V303, pH658, DOI 10.1152/ajpheart.00328.2012; Tzeng YC, 2014, EUR J APPL PHYSIOL, V114, P545, DOI 10.1007/s00421-013-2667-y; van der Scheer JW, 2018, SPINAL CORD, V56, P469, DOI 10.1038/s41393-017-0021-7; WELCH PD, 1967, IEEE T ACOUST SPEECH, VAU15, P70, DOI 10.1109/TAU.1967.1161901; Zhang R, 1998, AM J PHYSIOL-HEART C, V274, pH233, DOI 10.1152/ajpheart.1998.274.1.H233	56	7	7	1	3	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	2045-2322			SCI REP-UK	Sci Rep	JUN 15	2020	10	1							9600	10.1038/s41598-020-66346-6			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ME8WZ	WOS:000544936100002	32541858	Green Published, Green Submitted, gold			2022-02-06	
J	Janigro, D; Kawata, K; Silverman, E; Marchi, N; Diaz-Arrastia, R				Janigro, Damir; Kawata, Keisuke; Silverman, Erika; Marchi, Nicola; Diaz-Arrastia, Ramon			Is Salivary S100B a Biomarker of Traumatic Brain Injury? A Pilot Study	FRONTIERS IN NEUROLOGY			English	Article						peripheral biomarkers; blood-brain barrier; saliva; mild traumatic brain injury; S100B	HIGH-RISK PATIENTS; PERIPHERAL MARKERS; BARRIER FUNCTION; IDENTIFICATION; DISRUPTION; S-100B; DAMAGE	Traumatic brain injury (TBI) results in short and long-term disability neurodegeneration. Mild traumatic brain injury (mTBI) represents up to 85% of head injuries; diagnosis and early management is based on computed tomography (CT) or in-hospital observation, which are time- and cost- intensive. CT involves exposure to potentially harmful ionizing radiation and >90% of the scans are negative. Blood-brain barrier (BBB) damage is suspected pathological event post-TBI contributing to long-term sequelae and a reliable and rapid point-of-care test to screen those who can safely forego acute head CT would be of great help in evaluating patients with an acute mTBI. In this pilot study, 15 adult patients with suspected TBI (mean age = 47 years, range 18-79) and 15 control subjects (mean age = 33 years, range 23-53) were enrolled. We found that the average salivary S100B level was 3.9 fold higher than blood S100B, regardless of the presence of pathology. [S100B](saliva)positively correlated with [S100B](serum)(Pearson' coefficient = 0.79;p< 0.01). Salivary S100B levels were as effective in differentiating TBI patients from control subjects as serum levels (Control vs. TBI:p< 0.01; Serum ROCAUC= 0.94 and Saliva ROCAUC= 0.75). I These initial results suggest that measuring salivary S100B could represent an alternative to serum S100B in the diagnosis of TBI. Larger and confirmatory trials are needed to define salivary biomarker kinetics in relation to TBI severity and the possible roles of gender, ethnicity and age in influencing salivary S100B levels.	[Janigro, Damir] FloTBI Inc, Cleveland, OH 44195 USA; [Janigro, Damir] Case Western Reserve Univ, Dept Physiol, Cleveland, OH 44106 USA; [Kawata, Keisuke] Indiana Univ, Coll Arts & Sci, Sch Publ Hlth, Dept Kinesiol,Program Neurosci, Bloomington, IN USA; [Silverman, Erika; Diaz-Arrastia, Ramon] Univ Penn, Dept Neurol, Philadelphia, PA 19104 USA; [Marchi, Nicola] Univ Montpellier, Cerebrovasc & Glia Res, Dept Neurosci, Inst Funct Genom CNRS INSERM, Montpellier, France		Janigro, D (corresponding author), FloTBI Inc, Cleveland, OH 44195 USA.; Janigro, D (corresponding author), Case Western Reserve Univ, Dept Physiol, Cleveland, OH 44106 USA.	djanigro@flocel.com	Marchi, Nicola/J-8607-2016	Marchi, Nicola/0000-0001-9124-0226			Ananthaharan A, 2018, BMC EMERG MED, V18, DOI 10.1186/s12873-018-0193-2; Atif H, 2019, J EXP NEUROSCI, V13, DOI 10.1177/1179069519832286; Bazarian JJ, 2018, LANCET NEUROL, V17, P782, DOI 10.1016/S1474-4422(18)30231-X; Biberthaler P, 2004, UNFALLCHIRURG, V107, P197, DOI 10.1007/s00113-004-0730-1; Biberthaler P, 2002, EUR J MED RES, V7, P164; Biberthaler P, 2001, WORLD J SURG, V25, P93, DOI 10.1007/s002680020370; Blyth BJ, 2011, J NEUROTRAUM, V28, P2453, DOI 10.1089/neu.2010.1653; Bouvier D, 2016, CLIN CHEM LAB MED, V54, P833, DOI 10.1515/cclm-2015-0771; Dadas A, 2018, NEUROPSYCH DIS TREAT, V14, P2989, DOI 10.2147/NDT.S125620; Dadas Aaron, 2018, Concussion, V3, pCNC53, DOI 10.2217/cnc-2017-0019; Dadas A, 2016, FLUIDS BARRIERS CNS, V13, DOI 10.1186/s12987-016-0045-y; Dashnaw ML, 2012, NEUROSURG FOCUS, V33, DOI 10.3171/2012.10.FOCUS12284; Di Pietro V, 2018, FRONT MOL NEUROSCI, V11, DOI 10.3389/fnmol.2018.00290; Johnson JJ, 2018, JAMA PEDIATR, V172, P65, DOI 10.1001/jamapediatrics.2017.3884; Johnson VE, 2018, ACTA NEUROPATHOL, V135, P711, DOI 10.1007/s00401-018-1824-0; Kanner AA, 2003, CANCER, V97, P2806, DOI 10.1002/cncr.11409; Kapural M, 2002, BRAIN RES, V940, P102, DOI 10.1016/S0006-8993(02)02586-6; Linsenmaier U, 2016, BRIT J RADIOL, V89, DOI 10.1259/bjr.20150827; Maas AIR, 2018, LANCET NEUROL, V17, P737, DOI 10.1016/S1474-4422(18)30275-8; Marchi N, 2004, CLIN CHIM ACTA, V342, P1, DOI 10.1016/j.cccn.2003.12.008; Marchi N, 2003, RESTOR NEUROL NEUROS, V21, P109; Marchi N, 2007, EPILEPSIA, V48, P732, DOI 10.1111/j.1528-1167.2007.00988.x; Ratcliff JJ, 2014, AM J EMERG MED, V32, P844, DOI 10.1016/j.ajem.2014.04.003; Shi ZS, 2018, J NEUROIMAGING, V28, P283, DOI 10.1111/jon.12504; Shlosberg D, 2010, NAT REV NEUROL, V6, P393, DOI 10.1038/nrneurol.2010.74; Tagge CA, 2018, BRAIN, V141, P422, DOI 10.1093/brain/awx350; Weissberg I, 2014, JAMA NEUROL, V71, P1453, DOI 10.1001/jamaneurol.2014.2682; Wilson L, 2017, LANCET NEUROL, V16, P813, DOI 10.1016/S1474-4422(17)30279-X; Yeung C, 2021, PEDIATR EMERG CARE, V37, pE1373, DOI 10.1097/PEC.0000000000002050	29	7	7	4	6	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	JUN 12	2020	11								528	10.3389/fneur.2020.00528			6	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	MD3JH	WOS:000543867000001	32595592	Green Published, gold			2022-02-06	
J	Zhou, YX; Chen, Q; Wang, YL; Wu, HJ; Xu, WL; Pan, YB; Gao, SQ; Dong, X; Zhang, JH; Shao, AW				Zhou, Yunxiang; Chen, Qiang; Wang, Yali; Wu, Haijian; Xu, Weilin; Pan, Yuanbo; Gao, Shiqi; Dong, Xiao; Zhang, John H.; Shao, Anwen			Persistent Neurovascular Unit Dysfunction: Pathophysiological Substrate and Trigger for Late-Onset Neurodegeneration After Traumatic Brain Injury	FRONTIERS IN NEUROSCIENCE			English	Article						traumatic brain injury; neurodegenerative disease; neurovascular unit; hypothesis; neuroinflammation; proteinopathy; oxidative stress; blood-brain barrier	FIBRILLARY ACIDIC PROTEIN; BASEMENT-MEMBRANE PROTEINS; PARKINSONS-DISEASE RISK; CENTRAL-NERVOUS-SYSTEM; HEAD-INJURY; AMYLOID-BETA; CEREBROSPINAL-FLUID; MUTANT HUNTINGTIN; OXIDATIVE STRESS; AXONAL INJURY	Traumatic brain injury (TBI) represents one of the major causes of death worldwide and leads to persisting neurological deficits in many of the survivors. One of the most significant long-term sequelae deriving from TBI is neurodegenerative disease, which is a group of incurable diseases that impose a heavy socio-economic burden. However, mechanisms underlying the increased susceptibility of TBI to neurodegenerative disease remain elusive. The neurovascular unit (NVU) is a functional unit composed of neurons, neuroglia, vascular cells, and the basal lamina matrix. The key role of NVU dysfunction in many central nervous system diseases has been revealed. Studies have proved the presence of prolonged structural and functional abnormalities of the NVU after TBI. Moreover, growing evidence suggests impaired NVU function is also implicated in neurodegenerative diseases. Therefore, we propose the Neurovascular Unit Dysfunction (NVUD) Hypothesis, in which the persistent NVU dysfunction is thought to underlie the development of post-TBI neurodegeneration. We deduce NVUD Hypothesis through relational inference and supporting evidence, and suggest continued NVU abnormalities following TBI serve as the pathophysiological substrate and trigger yielding chronic neuroinflammation, proteinopathies and oxidative stress, consequently leading to the progression of neurodegenerative diseases. The NVUD Hypothesis may provide potential treatment and prevention strategies for TBI and late-onset neurodegenerative diseases.	[Zhou, Yunxiang; Chen, Qiang; Wang, Yali] Zhejiang Univ, Affiliated Hosp 2, Sch Med, Dept Surg Oncol, Hangzhou, Peoples R China; [Wu, Haijian; Xu, Weilin; Pan, Yuanbo; Gao, Shiqi; Dong, Xiao; Shao, Anwen] Zhejiang Univ, Affiliated Hosp 2, Sch Med, Dept Neurosurg, Hangzhou, Peoples R China; [Zhang, John H.] Loma Linda Univ, Dept Physiol & Pharmacol, Basic Sci, Sch Med, Loma Linda, CA USA; [Zhang, John H.] Loma Linda Univ, Sch Med, Dept Anesthesiol Neurosurg & Neurol, Loma Linda, CA USA		Shao, AW (corresponding author), Zhejiang Univ, Affiliated Hosp 2, Sch Med, Dept Neurosurg, Hangzhou, Peoples R China.	21118116@zju.edu.cn	Zhou, Yunxiang/AAK-7758-2020	Zhou, Yunxiang/0000-0003-1000-0330; Shao, Anwen/0000-0001-9986-6290	China Postdoctoral Science FoundationChina Postdoctoral Science Foundation [2017M612010]; National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81701144]; Zhejiang Province Natural Science FoundationNatural Science Foundation of Zhejiang Province [LQ17H090003]	This work was funded by China Postdoctoral Science Foundation (2017M612010), National Natural Science Foundation of China (81701144), and Zhejiang Province Natural Science Foundation (LQ17H090003).	Abbott NJ, 2006, NAT REV NEUROSCI, V7, P41, DOI 10.1038/nrn1824; Abdul-Muneer PM, 2015, MOL NEUROBIOL, V51, P966, DOI 10.1007/s12035-014-8752-3; Anderson CM, 2000, GLIA, V32, P1; Anthonymuthu TS, 2018, FREE RADICAL BIO MED, V124, P493, DOI 10.1016/j.freeradbiomed.2018.06.031; Armulik A, 2010, NATURE, V468, P557, DOI 10.1038/nature09522; Ascherio A, 2016, LANCET NEUROL, V15, P1255, DOI 10.1016/S1474-4422(16)30230-7; Badaut J, 2014, TRANSL STROKE RES, V5, P394, DOI 10.1007/s12975-013-0304-z; BAKER AJ, 1993, J NEUROSURG, V79, P369, DOI 10.3171/jns.1993.79.3.0369; Barrio JR, 2015, P NATL ACAD SCI USA, V112, pE2039, DOI 10.1073/pnas.1409952112; Barshikar S, 2017, CURR NEUROL NEUROSCI, V17, DOI 10.1007/s11910-017-0792-4; Baugh CM, 2012, BRAIN IMAGING BEHAV, V6, P244, DOI 10.1007/s11682-012-9164-5; Bell RD, 2010, NEURON, V68, P409, DOI 10.1016/j.neuron.2010.09.043; Benarroch E, 2007, NEUROLOGY, V69, P306, DOI 10.1212/01.wnl.0000267407.79757.75; Bernick C, 2018, J NEUROTRAUM, V35, P2351, DOI 10.1089/neu.2017.5553; Bhowmick S, 2019, EXP NEUROL, V317, P260, DOI 10.1016/j.expneurol.2019.03.014; Blair LJ, 2015, ACTA NEUROPATHOL COM, V3, DOI 10.1186/s40478-015-0186-2; BLUMBERGS PC, 1989, J NEUROL NEUROSUR PS, V52, P838, DOI 10.1136/jnnp.52.7.838; Bohmer AE, 2011, NEUROSURGERY, V68, P1624, DOI 10.1227/NEU.0b013e318214a81f; Boespflug EL, 2018, BIOL PSYCHIAT, V83, P328, DOI 10.1016/j.biopsych.2017.11.031; Burda JE, 2016, EXP NEUROL, V275, P305, DOI 10.1016/j.expneurol.2015.03.020; Burda JE, 2014, NEURON, V81, P229, DOI 10.1016/j.neuron.2013.12.034; Cai W, 2017, TRANSL STROKE RES, V8, P107, DOI 10.1007/s12975-016-0504-4; Cai W, 2017, AGEING RES REV, V34, P77, DOI 10.1016/j.arr.2016.09.006; Castriotta RJ, 2007, J CLIN SLEEP MED, V3, P349; Chen HS, 2018, TRANSL STROKE RES, V9, P515, DOI 10.1007/s12975-017-0598-3; Chen HL, 2007, AM J EPIDEMIOL, V166, P810, DOI 10.1093/aje/kwm153; Chen XH, 2004, AM J PATHOL, V165, P357, DOI 10.1016/S0002-9440(10)63303-2; Chen XR, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1345-8; Chen XH, 2009, BRAIN PATHOL, V19, P214, DOI 10.1111/j.1750-3639.2008.00176.x; Chen ZZ, 2019, J NEUROINFLAMM, V16, DOI 10.1186/s12974-019-1443-2; Colangelo AM, 2012, BIOTECHNOL ADV, V30, P261, DOI 10.1016/j.biotechadv.2011.06.016; Cordone S, 2019, FRONT PHARMACOL, V10, DOI 10.3389/fphar.2019.00695; Cornelius C, 2013, ANTIOXID REDOX SIGN, V19, P836, DOI 10.1089/ars.2012.4981; Corps KN, 2015, JAMA NEUROL, V72, P355, DOI 10.1001/jamaneurol.2014.3558; Coughlin JM, 2015, NEUROBIOL DIS, V74, P58, DOI 10.1016/j.nbd.2014.10.019; Cregg JM, 2014, EXP NEUROL, V253, P197, DOI 10.1016/j.expneurol.2013.12.024; Cruz-Haces M, 2017, TRANSL NEURODEGENER, V6, DOI 10.1186/s40035-017-0088-2; Danbolt NC, 2001, PROG NEUROBIOL, V65, P1, DOI 10.1016/S0301-0082(00)00067-8; Daneman R, 2010, NATURE, V468, P562, DOI 10.1038/nature09513; de la Tremblaye PB, 2018, NEUROSCI BIOBEHAV R, V85, P160, DOI 10.1016/j.neubiorev.2017.05.022; de Lau LML, 2006, LANCET NEUROL, V5, P525, DOI 10.1016/S1474-4422(06)70471-9; Di Giovanni S, 2005, P NATL ACAD SCI USA, V102, P8333, DOI 10.1073/pnas.0500989102; Dringen R, 2000, EUR J BIOCHEM, V267, P4912, DOI 10.1046/j.1432-1327.2000.01597.x; Faideau M, 2010, HUM MOL GENET, V19, P3053, DOI 10.1093/hmg/ddq212; Fleminger S, 2003, J NEUROL NEUROSUR PS, V74, P857, DOI 10.1136/jnnp.74.7.857; Folkersma H, 2011, J NUCL MED, V52, P1235, DOI 10.2967/jnumed.110.084061; Fotuhi M, 2009, NAT REV NEUROL, V5, P649, DOI 10.1038/nrneurol.2009.175; Franz CK, 2019, J NEUROPHYSIOL, V122, P1174, DOI 10.1152/jn.00572.2018; Fujimoto M, 2008, J CEREBR BLOOD F MET, V28, P1674, DOI 10.1038/jcbfm.2008.59; Fujita T, 1998, ACTA NEUROCHIR, V140, P275, DOI 10.1007/s007010050095; Gentleman SM, 2004, FORENSIC SCI INT, V146, P97, DOI 10.1016/j.forsciint.2004.06.027; Goldman SM, 2006, ANN NEUROL, V60, P65, DOI 10.1002/ana.20882; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Gong L, 2018, NEUROPHARMACOLOGY, V138, P160, DOI 10.1016/j.neuropharm.2018.06.009; Graham NSN, 2019, J NEUROL NEUROSUR PS, V90, P1221, DOI 10.1136/jnnp-2017-317557; Gredilla R, 2010, EXP GERONTOL, V45, P478, DOI 10.1016/j.exger.2010.01.017; Gu XF, 2005, NEURON, V46, P433, DOI 10.1016/j.neuron.2005.03.025; Gu XF, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-8; Guo SZ, 2009, STROKE, V40, pS4, DOI 10.1161/STROKEAHA.108.534388; Gyoneva S, 2015, TRENDS PHARMACOL SCI, V36, P471, DOI 10.1016/j.tips.2015.04.003; Hailer NP, 2008, PROG NEUROBIOL, V84, P211, DOI 10.1016/j.pneurobio.2007.12.001; Halliday MR, 2013, JAMA NEUROL, V70, P1198, DOI 10.1001/jamaneurol.2013.3841; Hay JR, 2015, J NEUROPATH EXP NEUR, V74, P1147, DOI [10.1093/jnen/74.12.1147, 10.1097/NEN.0000000000000261]; Hayes JP, 2017, BRAIN, V140, P813, DOI 10.1093/brain/aww344; Heneka MT, 2015, LANCET NEUROL, V14, P388, DOI 10.1016/S1474-4422(15)70016-5; Hoffer ME, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0054163, 10.1371/journal.pone.0060061]; Hong YT, 2014, JAMA NEUROL, V71, P23, DOI 10.1001/jamaneurol.2013.4847; Hu XM, 2014, PROG NEUROBIOL, V119, P60, DOI 10.1016/j.pneurobio.2014.06.002; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; Iliff JJ, 2014, J NEUROSCI, V34, P16180, DOI 10.1523/JNEUROSCI.3020-14.2014; Iliff JJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003748; Jafari S, 2013, MOVEMENT DISORD, V28, P1222, DOI 10.1002/mds.25458; James SL, 2019, LANCET NEUROL, V18, P56, DOI 10.1016/S1474-4422(18)30415-0; Jansen AHP, 2017, GLIA, V65, P50, DOI 10.1002/glia.23050; Jayakumar AR, 2010, METAB BRAIN DIS, V25, P31, DOI 10.1007/s11011-010-9180-3; Jeong SR, 2012, EXP NEUROL, V233, P312, DOI 10.1016/j.expneurol.2011.10.021; Jessen NA, 2015, NEUROCHEM RES, V40, P2583, DOI 10.1007/s11064-015-1581-6; Ji BY, 2017, TRANSL STROKE RES, V8, P334, DOI 10.1007/s12975-017-0526-6; Johnson VE, 2018, ACTA NEUROPATHOL, V135, P711, DOI 10.1007/s00401-018-1824-0; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Johnson VE, 2011, ACTA NEUROPATHOL, V122, P715, DOI 10.1007/s00401-011-0909-9; Johnson VE, 2012, BRAIN PATHOL, V22, P142, DOI 10.1111/j.1750-3639.2011.00513.x; Kalia LV, 2016, NAT REV NEUROL, V12, P65, DOI 10.1038/nrneurol.2015.249; Kardos J, 2017, PROG NEUROBIOL, V153, P86, DOI 10.1016/j.pneurobio.2017.03.005; Karimi-Abdolrezaee S, 2012, MOL NEUROBIOL, V46, P251, DOI 10.1007/s12035-012-8287-4; Khaksari M, 2018, TRANSL STROKE RES, V9, P393, DOI 10.1007/s12975-017-0588-5; Kofuji P, 2004, NEUROSCIENCE, V129, P1045, DOI 10.1016/j.neurscience.2004.06.008; Kondo A, 2015, NATURE, V523, P431, DOI 10.1038/nature14658; Kumar A, 2004, J MOL MED, V82, P434, DOI 10.1007/s00109-004-0555-y; Kumar A, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0819-4; Kumar A, 2016, J FORMOS MED ASSOC, V115, P3, DOI 10.1016/j.jfma.2015.04.001; Ladwig A, 2017, MEDIAT INFLAMM, V2017, DOI 10.1155/2017/7189421; Lang F, 1998, PHYSIOL REV, V78, P247, DOI 10.1152/physrev.1998.78.1.247; Li CY, 2013, AGEING RES REV, V12, P116, DOI 10.1016/j.arr.2012.09.002; Liang CL, 2007, EXP NEUROL, V203, P370, DOI 10.1016/j.expneurol.2006.08.015; Lo EH, 2009, STROKE, V40, pS2, DOI 10.1161/STROKEAHA.108.534404; LoBue C, 2019, J ALZHEIMERS DIS, V70, P629, DOI 10.3233/JAD-190028; Logsdon AF, 2015, COMPR PHYSIOL, V5, P1147, DOI 10.1002/cphy.c140057; Lok J, 2015, CNS NEUROSCI THER, V21, P304, DOI 10.1111/cns.12359; Louveau A, 2017, J CLIN INVEST, V127, P3210, DOI 10.1172/JCI90603; Luna J, 2019, J NEUROL NEUROSUR PS, V90, P20, DOI 10.1136/jnnp-2018-318469; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Magistretti PJ, 2006, J EXP BIOL, V209, P2304, DOI 10.1242/jeb.02208; Magistretti PJ, 1999, PHILOS T R SOC B, V354, P1155, DOI 10.1098/rstb.1999.0471; Main BS, 2018, MOL NEURODEGENER, V13, DOI 10.1186/s13024-018-0249-5; Martland HS, 1928, J AMER MED ASSOC, V91, P1103, DOI 10.1001/jama.1928.02700150029009; Masters CL, 2015, NAT REV DIS PRIMERS, V1, DOI 10.1038/nrdp.2015.56; Maxwell WL, 2003, J NEUROTRAUM, V20, P151, DOI 10.1089/08977150360547071; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Mendiola-Precoma J, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/2589276; Michinaga S, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20030571; Mondello S, 2016, SCI REP-UK, V6, DOI 10.1038/srep28203; MORTIMER JA, 1991, INT J EPIDEMIOL, V20, pS28, DOI 10.1093/ije/20.Supplement_2.S28; Murakami K, 2011, TRANSL STROKE RES, V2, P72, DOI 10.1007/s12975-010-0052-2; Nagamoto-Combs K, 2007, J NEUROTRAUM, V24, P1719, DOI 10.1089/neu.2007.0377; Nagamoto-Combs K, 2010, J NEUROTRAUM, V27, P565, DOI 10.1089/neu.2009.0966; Najjar S, 2017, FRONT PSYCHIATRY, V8, DOI 10.3389/fpsyt.2017.00083; Neuwelt E, 2008, LANCET NEUROL, V7, P84, DOI 10.1016/S1474-4422(07)70326-5; Orimo Satoshi, 2017, Rinsho Shinkeigaku, V57, P259, DOI 10.5692/clinicalneurol.cn-000969; Ott M, 2007, APOPTOSIS, V12, P913, DOI 10.1007/s10495-007-0756-2; Papa L, 2016, J NEUROTRAUM, V33, P58, DOI 10.1089/neu.2015.3869; Pavlovic D, 2019, PITUITARY, V22, P270, DOI 10.1007/s11102-019-00957-9; Peng L, 2014, CURR NEUROPHARMACOL, V12, P303, DOI 10.2174/1570159X12999140829152550; Perez EJ, 2017, J CLIN INVEST, V127, P3114, DOI 10.1172/JCI92300; Petty MA, 2002, PROG NEUROBIOL, V68, P311, DOI 10.1016/S0301-0082(02)00128-4; Piao CS, 2019, J CEREBR BLOOD F MET, V39, P58, DOI 10.1177/0271678X17742792; Plemel JR, 2014, PROG NEUROBIOL, V117, P54, DOI 10.1016/j.pneurobio.2014.02.006; Pupillo E, 2018, AMYOTROPH LAT SCL FR, V19, P118, DOI 10.1080/21678421.2017.1386687; Raj R, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002316; Ramlackhansingh AF, 2011, ANN NEUROL, V70, P374, DOI 10.1002/ana.22455; Rascher G, 2002, ACTA NEUROPATHOL, V104, P85, DOI 10.1007/s00401-002-0524-x; Rasmussen MK, 2018, LANCET NEUROL, V17, P1016, DOI 10.1016/S1474-4422(18)30318-1; Ren ZG, 2013, J CEREBR BLOOD F MET, V33, P834, DOI 10.1038/jcbfm.2013.30; ROBERTS GW, 1991, LANCET, V338, P1422, DOI 10.1016/0140-6736(91)92724-G; Rodriguez M, 2015, AGING CELL, V14, P293, DOI 10.1111/acel.12312; Rodriguez M, 2014, FRONT NEUROANAT, V8, DOI 10.3389/fnana.2014.00080; Rothstein JD, 1996, NEURON, V16, P675, DOI 10.1016/S0896-6273(00)80086-0; Russo MV, 2016, SCIENCE, V353, P783, DOI 10.1126/science.aaf6260; Salminen A, 2011, EUR J NEUROSCI, V34, P3, DOI 10.1111/j.1460-9568.2011.07738.x; Scott G, 2018, BRAIN, V141, P459, DOI 10.1093/brain/awx339; Scott G, 2016, NEUROLOGY, V86, P821, DOI 10.1212/WNL.0000000000002413; Seals RM, 2016, AM J EPIDEMIOL, V183, P294, DOI 10.1093/aje/kwv169; Seo JH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103174; Sevenich L, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00697; Shahim P, 2017, NEUROLOGY, V88, P1788, DOI 10.1212/WNL.0000000000003912; Sharma K., 2015, ASTROGLIOSIS AXONAL; Shetty AK, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00232; Shin JY, 2005, J CELL BIOL, V171, P1001, DOI 10.1083/jcb.200508072; Shively SB, 2017, ACTA NEUROPATHOL, V133, P353, DOI 10.1007/s00401-016-1649-7; Shlosberg D, 2010, NAT REV NEUROL, V6, P393, DOI 10.1038/nrneurol.2010.74; Shokri-Kojori E, 2018, P NATL ACAD SCI USA, V115, P4483, DOI 10.1073/pnas.1721694115; Simon DW, 2017, NAT REV NEUROL, V13, P171, DOI 10.1038/nrneurol.2017.13; Sleigh JN, 2020, CELL REP, V30, P3655, DOI 10.1016/j.celrep.2020.02.078; Slemmer JE, 2008, CURR MED CHEM, V15, P404, DOI 10.2174/092986708783497337; Smith DH, 1997, J NEUROTRAUM, V14, P715, DOI 10.1089/neu.1997.14.715; Smith DH, 2013, NAT REV NEUROL, V9, P211, DOI 10.1038/nrneurol.2013.29; Sofroniew MV, 2015, NAT REV NEUROSCI, V16, P249, DOI 10.1038/nrn3898; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Sofroniew MV, 2009, TRENDS NEUROSCI, V32, P638, DOI 10.1016/j.tins.2009.08.002; Sullan MJ, 2018, NEUROSCI BIOBEHAV R, V84, P316, DOI 10.1016/j.neubiorev.2017.08.016; Susarla BTS, 2014, ASN NEURO, V6, DOI 10.1042/AN20130034; Suzuki H, 2010, CRIT CARE MED, V38, P612, DOI 10.1097/CCM.0b013e3181c027ae; Sweeney MD, 2018, NAT REV NEUROL, V14, P133, DOI 10.1038/nrneurol.2017.188; Sweeney MD, 2016, NAT NEUROSCI, V19, P771, DOI 10.1038/nn.4288; Tagge CA, 2018, BRAIN, V141, P422, DOI 10.1093/brain/awx350; Tilling T, 2002, CELL TISSUE RES, V310, P19, DOI 10.1007/s00441-002-0604-1; Tilling T, 1998, J NEUROCHEM, V71, P1151; Tran HT, 2011, J NEUROSCI, V31, P9513, DOI 10.1523/JNEUROSCI.0858-11.2011; Tso MK, 2014, TRANSL STROKE RES, V5, P174, DOI 10.1007/s12975-014-0323-4; Uryu K, 2007, EXP NEUROL, V208, P185, DOI 10.1016/j.expneurol.2007.06.018; Verkhratsky A, 2014, BIOCHEM SOC T, V42, P1291, DOI 10.1042/BST20140107; Viviani B, 2014, NEUROTOXICOLOGY, V43, P10, DOI 10.1016/j.neuro.2014.03.004; Voskuhl RR, 2009, J NEUROSCI, V29, P11511, DOI 10.1523/JNEUROSCI.1514-09.2009; Walz W, 2000, NEUROCHEM INT, V36, P291, DOI 10.1016/S0197-0186(99)00137-0; Wang Y, 2017, AGEING RES REV, V34, P39, DOI 10.1016/j.arr.2016.11.002; Weilinger NL, 2013, ACTA PHARMACOL SIN, V34, P39, DOI 10.1038/aps.2012.95; Welch RD, 2016, J NEUROTRAUM, V33, P203, DOI 10.1089/neu.2015.4149; Wiesner D, 2018, EXP NEUROL, V299, P15, DOI 10.1016/j.expneurol.2017.09.011; Williams SM, 2018, NEUROLOGY, V91, P702, DOI 10.1212/WNL.0000000000006322; Wimo A, 2017, ALZHEIMERS DEMENT, V13, P1, DOI 10.1016/j.jalz.2016.07.150; Wu JC, 2020, TRANSL STROKE RES, V11, P720, DOI 10.1007/s12975-019-00771-2; Xiong KL, 2014, BRAIN IMAGING BEHAV, V8, P487, DOI 10.1007/s11682-013-9288-2; Yang ZH, 2015, TRENDS NEUROSCI, V38, P364, DOI 10.1016/j.tins.2015.04.003; Ye ZC, 2003, J NEUROSCI, V23, P3588, DOI 10.1523/jneurosci.23-09-03588.2003; Zanier ER, 2018, BRAIN, V141, P2685, DOI 10.1093/brain/awy193; Zenaro E, 2017, NEUROBIOL DIS, V107, P41, DOI 10.1016/j.nbd.2016.07.007; Zhang DN, 2019, NEUROTOX RES, V35, P360, DOI 10.1007/s12640-018-9961-8; Zhang JH, 2012, NAT REV NEUROL, V8, P711, DOI 10.1038/nrneurol.2012.210; Zhang XP, 2005, CRIT CARE, V9, P66, DOI 10.1186/cc2950; Zhao HY, 2018, INT J NEUROSCI, V128, P1118, DOI 10.1080/00207454.2018.1486828; Zhao Z, 2015, CELL, V163, P1064, DOI 10.1016/j.cell.2015.10.067; ZHOU Y, 2019, FRONT CELL NEUROSCI, V13, DOI DOI 10.3389/fphar.2019.00301; Zhou YX, 2020, CELL COMMUN SIGNAL, V18, DOI 10.1186/s12964-020-00549-2; Ziebell JM, 2010, NEUROTHERAPEUTICS, V7, P22, DOI 10.1016/j.nurt.2009.10.016; Zou J, 2010, NEUROCHEM INT, V56, P577, DOI 10.1016/j.neuint.2009.12.021	196	7	7	1	5	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND		1662-453X		FRONT NEUROSCI-SWITZ	Front. Neurosci.	JUN 9	2020	14								581	10.3389/fnins.2020.00581			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	MC5SI	WOS:000543345900001	32581697	Green Published, gold			2022-02-06	
J	Rauen, K; Reichelt, L; Probst, P; Schapers, B; Muller, F; Jahn, K; Plesnila, N				Rauen, Katrin; Reichelt, Lara; Probst, Philipp; Schaepers, Barbara; Mueller, Friedemann; Jahn, Klaus; Plesnila, Nikolaus			Quality of life up to 10 years after traumatic brain injury: a cross-sectional analysis	HEALTH AND QUALITY OF LIFE OUTCOMES			English	Article						Traumatic brain injury; Long-term outcome; Health-related quality of life after brain injury; QOLIBRI; Adaptation and resilience; Autonomy and cognition as decisive outcome factors for satisfaction; Depressive disorder; Anxiety; Psychiatric disorders after brain injury; TBI guidelines	GLOBAL BURDEN; HEALTH; DISORDERS; PREVALENCE; MODERATE; QOLIBRI; DISEASE; DISTURBANCES; DISABILITY; DEPRESSION	Background Traumatic brain injury (TBI) is the leading cause of death and disability among children and young adults in industrialized countries, but strikingly little is known how patients cope with the long-term consequences of TBI. Thus, the aim of the current study was to elucidate health-related quality of life (HRQoL) and outcome predictors in chronic TBI adults. Methods In this cross-sectional study, 439 former patients were invited to report HRQoL up to 10 years after mild, moderate or severe TBI using the QOLIBRI (Quality of Life after Brain Injury) questionnaire. The QOLIBRI total score has a maximum score of 100. A score below 60 indicates an unfavorable outcome with an increased risk of an affective and/or anxiety disorder. Results were correlated with demographics and basic characteristics received from medical records (TBI severity, etiology, age at TBI, age at survey, time elapsed since TBI, and sex) using regression models. Differences were considered significant at p < 0.05. Results From the 439 invited patients, 135 out of 150 in principle eligible patients (90%) completed the questionnaire; 76% were male, and most patients experienced severe TBI due to a traffic-related accident (49%) or a fall (44%). The mean QOLIBRI total score was 65.5 (+/- 22.6), indicating good HRQoL. Factors for higher level of satisfaction (p = 0.03; adjusted R-2 = 0.1) were autonomy in daily life (p = 0.03; adjusted R-2 = 0.09) and cognition (p = 0.05; adjusted R-2 = 0.05). HRQoL was weakly correlated with initial TBI severity (p = 0.04; adjusted R-2 = 0.02). 36% of patients reported unfavorable HRQoL with increased risk of one (20%) or two (16%) psychiatric disorders. Conclusions The majority of chronic TBI patients reported good HRQoL and the initial TBI severity is a slight contributor but not a strong predictor of HRQoL. Autonomy and cognition are decisive factors for satisfied outcome and should be clearly addressed in neurorehabilitation. One third of patients, however, suffer from unsatisfactory outcome with psychiatric sequelae. Thus, an early neuropsychiatric assessment after TBI is necessary and need to be installed in future TBI guidelines.	[Rauen, Katrin; Reichelt, Lara; Schaepers, Barbara; Mueller, Friedemann; Jahn, Klaus] Schoen Clin Bad Aibling, Kolbermoorer Str 72, D-83043 Bad Aibling, Germany; [Rauen, Katrin; Reichelt, Lara; Plesnila, Nikolaus] Univ Munich, Inst Stroke & Dementia Res ISD, Med Ctr, Feodor Lynen Str 17, D-81377 Munich, Germany; [Rauen, Katrin] Univ Zurich, Dept Geriatr Psychiat, Univ Hosp Psychiat Zurich, Minervastr 145, CH-8032 Zurich, Switzerland; [Rauen, Katrin] Univ Zurich, Inst Regenerat Med IREM, Minervastr 145, CH-8032 Zurich, Switzerland; [Probst, Philipp] Univ Munich, Inst Med Informat Biometry & Epidemiol IBE, Munich, Germany; [Jahn, Klaus] Univ Munich, German Ctr Vertigo & Balance Disorders, Med Ctr, Munich, Germany; [Plesnila, Nikolaus] Munich Cluster Syst Neurol Synergy, Munich, Germany		Rauen, K (corresponding author), Schoen Clin Bad Aibling, Kolbermoorer Str 72, D-83043 Bad Aibling, Germany.; Rauen, K (corresponding author), Univ Munich, Inst Stroke & Dementia Res ISD, Med Ctr, Feodor Lynen Str 17, D-81377 Munich, Germany.; Rauen, K (corresponding author), Univ Zurich, Dept Geriatr Psychiat, Univ Hosp Psychiat Zurich, Minervastr 145, CH-8032 Zurich, Switzerland.; Rauen, K (corresponding author), Univ Zurich, Inst Regenerat Med IREM, Minervastr 145, CH-8032 Zurich, Switzerland.	Katrin.rauen@uzh.ch	Jahn, Klaus/F-9902-2010; Jahn, Klaus/AAC-4969-2021	Jahn, Klaus/0000-0002-1669-3652; Rauen, Katrin/0000-0003-4555-6697	ERA-NET NEURON/BMBF CnsAflame	No funding received for this cross-sectional study. NP was supported by ERA-NET NEURON/BMBF CnsAflame.	Allanson F, 2017, NEUROPSYCHOL REV, V27, P187, DOI 10.1007/s11065-017-9353-5; Bosma CM, 2018, ARCH PHYS MED REHAB, V99, P1576, DOI 10.1016/j.apmr.2018.02.008; Brown K, 2017, INJURY PREV, V23, P403, DOI 10.1136/injuryprev-2016-042192; Bryant RA, 2010, AM J PSYCHIAT, V167, P312, DOI 10.1176/appi.ajp.2009.09050617; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Corrigan JD, 2013, ARCH PHYS MED REHAB, V94, P1199, DOI 10.1016/j.apmr.2013.01.023; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; Einarsen CE, 2018, WORLD NEUROSURG, V114, pE1199, DOI 10.1016/j.wneu.2018.03.176; Ellert U, 2013, BUNDESGESUNDHEITSBLA, V56, P643, DOI 10.1007/s00103-013-1700-y; Feigin VL, 2014, LANCET, V383, P245, DOI 10.1016/S0140-6736(13)61953-4; Formisano R, 2017, NEUROL SCI, V38, P279, DOI 10.1007/s10072-016-2755-y; Georges A, 2018, TRAUMATIC BRAIN INJU; Grauwmeijer E, 2018, J NEUROTRAUM, V35, P1543, DOI 10.1089/neu.2017.5404; Grima NA, 2017, CURR OPIN PULM MED, V23, P493, DOI 10.1097/MCP.0000000000000429; Guilfoyle MR, 2010, J NEUROTRAUM, V27, P2173, DOI 10.1089/neu.2010.1353; Haagsma JA, 2016, INJURY PREV, V22, P3, DOI 10.1136/injuryprev-2015-041616; Haagsma JA, 2015, J NEUROTRAUM, V32, P853, DOI 10.1089/neu.2013.3283; Halvachizadeh S, 2019, J TRAUMA ACUTE CARE, V86, P1027, DOI 10.1097/TA.0000000000002232; Hammond FM, 2015, ARCH PHYS MED REHAB, V96, pS330, DOI 10.1016/j.apmr.2014.09.041; Hibbard MR, 1998, J HEAD TRAUMA REHAB, V13, P24, DOI 10.1097/00001199-199808000-00003; Humble SS, 2018, J TRAUMA ACUTE CARE, V85, P155, DOI 10.1097/TA.0000000000001852; Imbach LL, 2016, NEUROLOGY, V86, P1945, DOI 10.1212/WNL.0000000000002697; Jorge RE, 2014, PSYCHIAT CLIN N AM, V37, pXI, DOI 10.1016/j.psc.2013.12.002; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; Ma JW, 2016, NEURAL PLAST, V2016, DOI 10.1155/2016/9746313; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Machamer J, 2013, J NEUROTRAUM, V30, P1845, DOI 10.1089/neu.2013.2920; Majdan M, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002331; Mallya S, 2015, J NEUROTRAUM, V32, P411, DOI 10.1089/neu.2014.3504; Mathias JL, 2012, SLEEP MED, V13, P898, DOI 10.1016/j.sleep.2012.04.006; Ouellet MC, 2015, LANCET NEUROL, V14, P746, DOI 10.1016/S1474-4422(15)00068-X; Polinder S, 2015, POPUL HEALTH METR, V13, DOI 10.1186/s12963-015-0037-1; Ponsford J, 2008, J INT NEUROPSYCH SOC, V14, P233, DOI 10.1017/S1355617708080272; Ponsford J, 2018, J NEUROPSYCH CLIN N, V30, P262, DOI 10.1176/appi.neuropsych.18040093; Rauen K, 2017, BRAIN EDEMA: FROM MOLECULAR MECHANISMS TO CLINICAL PRACTICE, P353, DOI 10.1016/B978-0-12-803196-4.00019-9; Rickels EvW K, 2006, SCHADEL HIRN VERLETZ, P149; Riggio S, 2011, NEUROL CLIN, V29, P35, DOI 10.1016/j.ncl.2010.10.008; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Scholten AC, 2015, INJURY, V46, P616, DOI 10.1016/j.injury.2014.10.064; Scholten AC, 2016, J NEUROTRAUM, V33, P1969, DOI 10.1089/neu.2015.4252; TEASDALE G, 1974, LANCET, V2, P81; Truelle JL, 2010, BRAIN INJURY, V24, P1272, DOI 10.3109/02699052.2010.506865; Tsyben A, 2017, WIEN ACTA NEUROCHIR; van Eijck M, 2018, J NEUROTRAUM, V35, P2357, DOI 10.1089/neu.2018.5650; von Steinbuchel N, 2020, QOLIBRI N VONSTEINBU; von Steinbuchel N, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176668; von Steinbuechel N, 2016, BEHAV NEUROL, V2016, DOI 10.1155/2016/7928014; von Steinbuchel N, 2010, J NEUROTRAUM, V27, P1167, DOI 10.1089/neu.2009.1076; von Steinbuchel N, 2010, J NEUROTRAUM, V27, P1157, DOI 10.1089/neu.2009.1077; Whitnall L, 2006, J NEUROL NEUROSUR PS, V77, P640, DOI 10.1136/jnnp.2005.078246	51	7	7	1	3	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1477-7525		HEALTH QUAL LIFE OUT	Health Qual. Life Outcomes	JUN 4	2020	18	1							166	10.1186/s12955-020-01391-3			12	Health Care Sciences & Services; Health Policy & Services	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Health Care Sciences & Services	LY8MD	WOS:000540781500001	32498679	Green Accepted, gold, Green Published			2022-02-06	
J	Ghorbani, M; Shahabi, P; Karimi, P; Soltani-Zangbar, H; Morshedi, M; Bani, S; Jafarzadehgharehziaaddin, M; Sadeghzadeh-Oskouei, B; Ahmadalipour, A				Ghorbani, Meysam; Shahabi, Parviz; Karimi, Pouran; Soltani-Zangbar, Hamid; Morshedi, Mohammad; Bani, Soheila; Jafarzadehgharehziaaddin, Mohsen; Sadeghzadeh-Oskouei, Behnaz; Ahmadalipour, Ali			Impacts of epidural electrical stimulation on Wnt signaling, FAAH, and BDNF following thoracic spinal cord injury in rat	JOURNAL OF CELLULAR PHYSIOLOGY			English	Article						epidural subthreshold electrical stimulation; FAAH; spinal cord injury; Wnt signaling	N-TERMINAL KINASE; CULTURED CORTICAL-NEURONS; ENDOCANNABINOID SYSTEM; NEUROTROPHIC FACTOR; PROGENITOR CELLS; TRAUMATIC BRAIN; STEM-CELLS; ACTIVATION; ANANDAMIDE; MODULATION	Electrical stimulation (ES) has been shown to improve some of impairments after spinal cord injury (SCI), but the underlying mechanisms remain unclear. The Wnt signaling pathways and the endocannabinoid system appear to be modulated in response to SCI. This study aimed to investigate the effect of ES therapy on the activity of canonical/noncanonical Wnt signaling pathways, brain-derived neurotrophic factor (BDNF), and fatty-acid amide hydrolase (FAAH), which regulate endocannabinoids levels. Forty male Wistar rats were randomly divided into four groups: (a) Sham, (b) laminectomy + epidural subthreshold ES, (c) SCI, and (d) SCI + epidural subthreshold ES. A moderate contusion SCI was performed at the thoracic level (T10). Epidural subthreshold ES was delivered to upper the level of T10 segment every day (1 hr/rat) for 2 weeks. Then, animals were killed and immunoblotting was used to assess spinal cord parameters. Results revealed that ES intervention for 14 days could significantly increase wingless-type3 (Wnt3), Wnt7, beta-catenin, Nestin, and cyclin D1 levels, as well as phosphorylation of glycogen synthase kinase 3 beta and Jun N-terminal kinase. Additionally, SCI reduced BDNF and FAAH levels, and ES increased BDNF and FAAH levels in the injury site. We propose that ES therapy may improve some of impairments after SCI through Wnt signaling pathways. Outcomes also suggest that BDNF and FAAH are important players in the beneficial impacts of ES therapy. However, the precise mechanism of BDNF, FAAH, and Wnt signaling pathways on SCI requires further investigation.	[Ghorbani, Meysam; Shahabi, Parviz; Karimi, Pouran; Soltani-Zangbar, Hamid; Morshedi, Mohammad; Bani, Soheila; Sadeghzadeh-Oskouei, Behnaz] Tabriz Univ Med Sci, Neurosci Res Ctr NSRC, Tabriz, Iran; [Ghorbani, Meysam; Morshedi, Mohammad] Tabriz Univ Med Sci, Drug Appl Res Ctr, Tabriz, Iran; [Jafarzadehgharehziaaddin, Mohsen; Ahmadalipour, Ali] Tabriz Univ Med Sci, Res Ctr Psychiat & Behav Sci, Tabriz, Iran; [Ahmadalipour, Ali] Tabriz Univ Med Sci, Fac Med, Aging Res Inst, Tabriz, Iran		Shahabi, P (corresponding author), Tabriz Univ Med Sci, Fac Med, Golgasht Ave, Tabriz 5167677463, Iran.; Ahmadalipour, A (corresponding author), Tabriz Univ Med Sci, Res Ctr Psychiat & Behav Sci, Aging Res Inst, Tabriz 5167677463, Iran.	parvizshahabi@gmail.com; alipoura@tbzmed.ac.ir		ghorbani, meysam/0000-0003-2651-6008; Ahmadalipour, Ali/0000-0001-7092-0222	Tabriz University of Medical Sciences [1394.1116]	Tabriz University of Medical Sciences, Grant/Award Number: 1394.1116	Ahmadalipour A, 2020, GENOMICS, V112, P1330, DOI 10.1016/j.ygeno.2019.07.024; Ahmadalipour A, 2018, NEUROBIOL LEARN MEM, V147, P54, DOI 10.1016/j.nlm.2017.11.013; Alizadeh EM, 2018, TOXICOL MECH METHOD, V28, P622, DOI 10.1080/15376516.2018.1486495; Amantea D, 2007, FEBS J, V274, P4464, DOI 10.1111/j.1742-4658.2007.05975.x; Bacil Eliane Denise Araújo, 2015, Rev. paul. pediatr., V33, P114, DOI 10.1016/j.rpped.2014.11.003; Badri O, 2017, NEURAL REGEN RES, V12, P458, DOI 10.4103/1673-5374.202927; Baker D, 2001, FASEB J, V15, P300, DOI 10.1096/fj.00-0399fje; Barnat M, 2010, J NEUROSCI, V30, P7804, DOI 10.1523/JNEUROSCI.0372-10.2010; Becker D, 2010, EXP NEUROL, V222, P211, DOI 10.1016/j.expneurol.2009.12.029; Boyce VS, 2014, FRONT NEURAL CIRCUIT, V8, DOI 10.3389/fncir.2014.00059; Bradbury EJ, 2006, NAT REV NEUROSCI, V7, P644, DOI 10.1038/nrn1964; Campbell VA, 2001, NEUROPHARMACOLOGY, V40, P702, DOI 10.1016/S0028-3908(00)00210-0; Cernak I, 2004, J CEREBR BLOOD F MET, V24, P564, DOI 10.1097/00004647-200405000-00011; Chan GCK, 1998, J NEUROSCI, V18, P5322, DOI 10.1523/JNEUROSCI.18-14-05322.1998; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; DeMorrow S, 2008, AM J PHYSIOL-GASTR L, V295, pG1150, DOI 10.1152/ajpgi.90455.2008; Dougherty KD, 2000, NEUROBIOL DIS, V7, P574, DOI 10.1006/nbdi.2000.0318; Downer E, 2001, NEUROREPORT, V12, P3973, DOI 10.1097/00001756-200112210-00024; Downer EJ, 2003, BRIT J PHARMACOL, V140, P547, DOI 10.1038/sj.bjp.0705464; Eljaschewitsch E, 2006, NEURON, V49, P67, DOI 10.1016/j.neuron.2005.11.027; Galve-Roperh I, 2002, MOL PHARMACOL, V62, P1385, DOI 10.1124/mol.62.6.1385; Gao K, 2015, NEURAL REGEN RES, V10, P951, DOI 10.4103/1673-5374.158360; Garcia-Ovejero D, 2009, NEUROBIOL DIS, V33, P57, DOI 10.1016/j.nbd.2008.09.015; Ghorbani M, 2018, PHYSIOL PHARMACOL, V22, P228; Gu XD, 2015, AM J MED SCI, V349, P157, DOI 10.1097/MAJ.0000000000000385; Guzman M, 2003, BRIT J PHARMACOL, V140, P439, DOI 10.1038/sj.bjp.0705465; Habib AM, 2019, BRIT J ANAESTH, V123, pE249, DOI 10.1016/j.bja.2019.02.019; Hansen HH, 2001, J NEUROCHEM, V78, P1415, DOI 10.1046/j.1471-4159.2001.00542.x; Hiester BG, 2013, MOL CELL NEUROSCI, V56, P115, DOI 10.1016/j.mcn.2013.04.006; Hollis ER, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00005; Huang YH, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00586; Karanian DA, 2005, J NEUROSCI, V25, P7813, DOI 10.1523/JNEUROSCI.2347-05.2005; Kikuchi A, 2011, INT REV CEL MOL BIO, V291, P21, DOI 10.1016/B978-0-12-386035-4.00002-1; Li N, 2013, SCI REP-UK, V3, DOI 10.1038/srep01604; Lie DC, 2005, NATURE, V437, P1370, DOI 10.1038/nature04108; Liu HH, 2013, CHINESE MED J-PEKING, V126, P2361, DOI 10.3760/cma.j.issn.0366-6999.20130478; Liu J, 2015, EXP NEUROL, V263, P113, DOI 10.1016/j.expneurol.2014.09.014; Lukaszewicz AI, 2011, P NATL ACAD SCI USA, V108, P11632, DOI 10.1073/pnas.1106230108; Martinez-Galvez G, 2016, EXP NEUROL, V276, P31, DOI 10.1016/j.expneurol.2015.11.007; Mechoulam R, 2003, SCIENCE, V302, P65, DOI 10.1126/science.1091256; Mestre L, 2005, J NEUROCHEM, V92, P1327, DOI 10.1111/j.1471-4159.2004.02979.x; Movsesyan VA, 2004, CELL DEATH DIFFER, V11, P1121, DOI 10.1038/sj.cdd.4401442; Nomachi A, 2008, J BIOL CHEM, V283, P27973, DOI 10.1074/jbc.M802325200; Ortega-Gutierrez S, 2005, FASEB J, V19, P1338, DOI 10.1096/fj.04-2464fje; Panikashvili D, 2001, NATURE, V413, P527, DOI 10.1038/35097089; Park D, 2010, STEM CELLS, V28, P2162, DOI 10.1002/stem.541; Saadeddin A, 2009, MOL CANCER RES, V7, P1189, DOI 10.1158/1541-7786.MCR-09-0027; Sanchez C, 1998, FEBS LETT, V436, P6, DOI 10.1016/S0014-5793(98)01085-0; Sarker KP, 2003, CELL MOL LIFE SCI, V60, P1200, DOI 10.1007/s00018-003-3055-2; Shohami E, 2011, BRIT J PHARMACOL, V163, P1402, DOI 10.1111/j.1476-5381.2011.01343.x; Shruster A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040843; Sinor AD, 2000, NEUROSCI LETT, V278, P157, DOI 10.1016/S0304-3940(99)00922-2; Su ZD, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4338; Subbanna S, 2013, J NEUROSCI, V33, P6350, DOI 10.1523/JNEUROSCI.3786-12.2013; Suh HI, 2011, ACTA NEUROCHIR, V153, P1003, DOI 10.1007/s00701-011-0945-1; Sun SC, 2011, CELL RES, V21, P71, DOI 10.1038/cr.2010.177; Tsai EC, 2005, CURR PHARM DESIGN, V11, P1211, DOI 10.2174/1381612053507404; Valvezan AJ, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00001; van der Stelt M, 2001, J NEUROSCI, V21, P8765, DOI 10.1523/JNEUROSCI.21-22-08765.2001; Varela-Nallar L, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00100; Vilar M, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00026; Wisdom R, 1999, EMBO J, V18, P188, DOI 10.1093/emboj/18.1.188; Wisniewska MB, 2013, NEUROCHEM RES, V38, P1144, DOI 10.1007/s11064-013-0980-9; Wu J, 2019, ACTA PHARMACOL SIN, V40, P297, DOI 10.1038/s41401-019-0210-3; Yi H, 2012, NEUROREPORT, V23, P189, DOI 10.1097/WNR.0b013e32834fab06; Zhang JF, 2017, MOL MED REP, V16, P2185, DOI 10.3892/mmr.2017.6801	66	7	7	3	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0021-9541	1097-4652		J CELL PHYSIOL	J. Cell. Physiol.	DEC	2020	235	12					9795	9805		10.1002/jcp.29793		JUN 2020	11	Cell Biology; Physiology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Physiology	NT9RO	WOS:000537084000001	32488870				2022-02-06	
J	Alvikas, J; Myers, SP; Wessel, CB; Okonkwo, DO; Joseph, B; Pelaez, C; Doberstein, C; Guillotte, AR; Rosengart, MR; Neal, MD				Alvikas, Jurgis; Myers, Sara P.; Wessel, Charles B.; Okonkwo, David O.; Joseph, Bellal; Pelaez, Carlos; Doberstein, Cody; Guillotte, Andrew R.; Rosengart, Matthew R.; Neal, Matthew D.			A systematic review and meta-analysis of traumatic intracranial hemorrhage in patients taking prehospital antiplatelet therapy: Is there a role for platelet transfusions?	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article; Proceedings Paper	105th Annual Clinical Congress and Scientific Forum of the Division-of-Education of the American-College-of-Surgeons (ACS) / 5th Annual Sessions of the Owen-H-Wangensteen-Scientific-Forum / 4th Colon and Rectal Surgery Conference	OCT 27-31, 2019	San Francisco, CA	Amer Coll Surg, Div Educ, Owen H Wangensteen Sci Forum		Platelet transfusion; intracranial hemorrhage; brain injuries; traumatic; platelet aggregation inhibitors	BRAIN-INJURY PATIENTS; PREINJURY CLOPIDOGREL; HEAD-INJURY; OUTCOMES; ASPIRIN; AGENTS; RISK; ANTICOAGULANTS; HETEROGENEITY; MANAGEMENT	BACKGROUND Platelet transfusion has been utilized to reverse platelet dysfunction in patients on preinjury antiplatelets who have sustained a traumatic intracranial hemorrhage (tICH); however, there is little evidence to substantiate this practice. The objective of this study was to perform a systematic review on the impact of platelet transfusion on survival, hemorrhage progression and need for neurosurgical intervention in patients with tICH on prehospital antiplatelet medication. METHODS Controlled, observational and randomized, prospective and retrospective studies describing tICH, preinjury antiplatelet use, and platelet transfusion reported in PubMed, Embase, Cochrane Reviews, Cochrane Trials and Cochrane DARE databases between January 1987 and March 2019 were included. Investigations of concomitant anticoagulant use were excluded. Risk of bias was assessed using the Newcastle-Ottawa scale. We calculated pooled estimates of relative effect of platelet transfusion on the risk of death, hemorrhage progression and need for neurosurgical intervention using the methods of Dersimonian-Laird random-effects meta-analysis. Sensitivity analysis established whether study size contributed to heterogeneity. Subgroup analyses determined whether antiplatelet type, additional blood products/reversal agents, or platelet function assays impacted effect size using meta-regression. RESULTS Twelve of 18,609 screened references were applicable to our questions and were qualitatively and quantitatively analyzed. We found no association between platelet transfusion and the risk of death in patients with tICH taking prehospital antiplatelets (odds ratio [OR], 1.29; 95% confidence interval [CI], 0.76-2.18;p= 0.346;I-2= 32.5%). There was no significant reduction in hemorrhage progression (OR, 0.88; 95% CI, 0.34-2.28;p= 0.788;I-2= 78.1%). There was no significant reduction in the need for neurosurgical intervention (OR, 1.00; 95% CI, 0.53-1.90,p= 0.996;I-2= 59.1%;p= 0.032). CONCLUSION Current evidence does not support the use of platelet transfusion in patients with tICH on prehospital antiplatelets, highlighting the need for a prospective evaluation of this practice.	[Alvikas, Jurgis; Myers, Sara P.; Rosengart, Matthew R.; Neal, Matthew D.] Univ Pittsburgh, Med Ctr, Dept Surg, Pittsburgh, PA USA; [Wessel, Charles B.] Univ Pittsburgh, Hlth Sci Lib Syst, Pittsburgh, PA USA; [Okonkwo, David O.] Univ Pittsburgh, Med Ctr, Dept Neurol Surg, Pittsburgh, PA USA; [Joseph, Bellal] Univ Arizona, Dept Surg, Tucson, AZ USA; [Pelaez, Carlos] Iowa Clin, Des Moines, IA USA; [Doberstein, Cody] Brown Univ, Warren AlpertMed Sch, Providence, RI 02912 USA; [Guillotte, Andrew R.] Univ Missouri, Div Neurol Surg, Columbia, MO USA; [Rosengart, Matthew R.; Neal, Matthew D.] Univ Pittsburgh, Med Ctr, Dept Crit Care Med, Pittsburgh, PA USA		Neal, MD (corresponding author), 200 Lothrop St, Pittsburgh, PA 15213 USA.	nealm2@upmc.edu		Guillotte, Andrew/0000-0001-7222-5856	 [R35GM119526-04];  [R01 GM116929];  [R01 GM082852]	This workwas supported by the following grants: R35GM119526-04 (PI: Matthew D. Neal, MD), R01 GM116929 (PI: Matthew R. Rosengart, MD, MPH), R01 GM082852 (PI: Matthew R. Rosengart, MD, MPH).	Aguilar MI, 2011, NEUROHOSPITALIST, V1, P148, DOI 10.1177/1941875211409050; Bachelani AM, 2011, SURGERY, V150, P836, DOI 10.1016/j.surg.2011.07.059; Carnevale JA, 2018, J NEUROSURG, V129, P1305, DOI 10.3171/2017.7.JNS17988; Castellino FJ, 2014, J TRAUMA ACUTE CARE, V76, P1169, DOI 10.1097/TA.0000000000000216; Chang R, 2016, BLOOD, V128, P1043, DOI 10.1182/blood-2016-01-636423; Chen LQ, 2004, J THORAC CARDIOV SUR, V128, P425, DOI 10.1016/j.jtcvs.2004.02.019; Faul M, 2010, INJURY PREV, V16, pA268, DOI 10.1136/ip.2010.029215.951; Foreman PM, 2019, WORLD NEUROSURG, V125, pE671, DOI 10.1016/j.wneu.2019.01.151; Frontera JA, 2016, NEUROCRIT CARE, V24, P6, DOI 10.1007/s12028-015-0222-x; Guillotte AR, 2018, BRAIN INJURY, V32, P1849, DOI 10.1080/02699052.2018.1536805; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hoffman M, 2009, STROKE, V40, P2882, DOI 10.1161/STROKEAHA.109.555433; Holzmacher JL, 2018, BRAIN INJURY, V32, P325, DOI 10.1080/02699052.2018.1425804; Huang CH, 2018, BMC NEUROL, V18, DOI 10.1186/s12883-018-1187-0; Ivascu FA, 2008, J TRAUMA, V65, P785, DOI 10.1097/TA.0b013e3181848caa; Jehan F, 2019, J SURG RES, V236, P224, DOI 10.1016/j.jss.2018.11.050; Jones K, 2006, AM J SURG, V192, P743, DOI 10.1016/j.amjsurg.2006.08.037; Joseph B, 2014, J TRAUMA ACUTE CARE, V76, P817, DOI 10.1097/TA.0b013e3182aafcf0; Joseph B, 2014, AM SURGEON, V80, P43; Joseph B, 2013, J TRAUMA ACUTE CARE, V75, P990, DOI 10.1097/TA.0b013e3182a96591; Kaufman RM, 2015, ANN INTERN MED, V162, P205, DOI 10.7326/M14-1589; Kim DY, 2015, J NEUROTRAUM, V32, P1815, DOI 10.1089/neu.2014.3728; Larsen SB, 2017, J AM HEART ASSOC, V6, DOI 10.1161/JAHA.117.006050; Lee AT, 2017, ANESTH ANALG, V125, P514, DOI 10.1213/ANE.0000000000002053; Leong LB, 2015, J EMERG MED, V49, P561, DOI 10.1016/j.jemermed.2015.02.023; Li J, 2001, LANCET, V357, P771, DOI 10.1016/S0140-6736(00)04163-5; Lordkipanidze M, 2016, BIOMARK MED, V10, P903, DOI 10.2217/bmm-2016-0070; McMillian WD, 2009, J TRAUMA, V66, P942, DOI 10.1097/TA.0b013e3181978e7b; Melsen WG, 2014, CLIN MICROBIOL INFEC, V20, P123, DOI 10.1111/1469-0691.12494; Mina AA, 2002, J TRAUMA, V53, P668, DOI 10.1097/00005373-200210000-00008; Myers SP, 2019, J SURG RES, V236, P22, DOI 10.1016/j.jss.2018.10.015; Nekludov M, 2007, J NEUROTRAUM, V24, P1699, DOI 10.1089/neu.2007.0322; Nishijima DK, 2017, ANN EMERG MED, V70, P127, DOI 10.1016/j.annemergmed.2016.12.018; Ogunlade J, 2018, CLIN NEUROL NEUROSUR, V174, P163, DOI 10.1016/j.clineuro.2018.09.021; Ohm C, 2005, J TRAUMA, V58, P518, DOI 10.1097/01.TA.0000151671.35280.8B; Peck KA, 2014, J TRAUMA ACUTE CARE, V76, P431, DOI 10.1097/TA.0000000000000107; Pelaez CA, 2019, INJURY, V50, P73, DOI 10.1016/j.injury.2018.08.020; Powers AY, 2019, J NEUROSURG, P1; Salman RAS, 2018, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005951.pub4; Sampson M, 2009, J CLIN EPIDEMIOL, V62, P944, DOI 10.1016/j.jclinepi.2008.10.012; Schmidt AE, 2018, AM J CLIN PATHOL, V149, P87, DOI [10.1093/ajcp/aqx151, 10.1093/AJCP/AQX151]; Serebruany VL, 2003, AM HEART J, V146, P713, DOI 10.1016/S0002-8703(03)00260-6; Shamseer L, 2015, BMJ-BRIT MED J, V349, DOI [10.1136/bmj.g7647, 10.1016/j.ijsu.2010.02.007, 10.1186/2046-4053-4-1, 10.1136/bmj.i4086]; Topol EJ, 2011, NAT MED, V17, P40, DOI 10.1038/nm0111-40; van den Brand CL, 2017, J NEUROTRAUM, V34, P1, DOI 10.1089/neu.2015.4393; Washington CW, 2012, J NEUROSURG, V116, P549, DOI 10.3171/2011.11.JNS111092; Washington CW, 2011, J TRAUMA, V71, P358, DOI 10.1097/TA.0b013e318220ad7e; Wells G., NEWCASTLE OTTAWA SCA; Won YD, 2018, WORLD NEUROSURG, V111, pE120, DOI 10.1016/j.wneu.2017.12.025; Wong DK, 2008, J TRAUMA, V65, P1303, DOI 10.1097/TA.0b013e318185e234; Zhou YJ, 2014, PHARMACOEPIDEM DR S, V23, P43, DOI 10.1002/pds.3463	51	7	7	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	JUN	2020	88	6					847	854		10.1097/TA.0000000000002640			8	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine; Surgery	NE5VY	WOS:000562670100039	32118818	Green Accepted			2022-02-06	
J	Cho, H; Hyeon, SJ; Shin, JY; Alvarez, VE; Stein, TD; Lee, J; Kowall, NW; McKee, AC; Ryu, H; Seo, JS				Cho, Hyesun; Hyeon, Seung Jae; Shin, Jong-Yeon; Alvarez, Victor E.; Stein, Thor D.; Lee, Junghee; Kowall, Neil W.; McKee, Ann C.; Ryu, Hoon; Seo, Jeong-Sun			Alterations of transcriptome signatures in head trauma-related neurodegenerative disorders	SCIENTIFIC REPORTS			English	Article							LONG-TERM POTENTIATION; PROTEIN-KINASE-C; CELL-ADHESION MOLECULES; AMPA RECEPTOR EXOCYTOSIS; ALZHEIMERS-DISEASE; SYNAPTIC FUNCTION; PHOSPHORYLATION; CAMKII; PKC; ENCEPHALOPATHY	Chronic traumatic encephalopathy (CTE) is a neurodegenerative disease that is associated with repetitive traumatic brain injury (TBI). CTE is known to share similar neuropathological features with Alzheimer's disease (AD), but little is known about the molecular properties in CTE. To better understand the neuropathological mechanism of TBI-related disorders, we conducted transcriptome sequencing analysis of CTE including AD and CTE with AD (CTE/AD) post-mortem human brain samples. Through weighted gene co-expression network analysis (WGCNA) and principal component analysis (PCA), we characterized common and unique transcriptome signatures among CTE, CTE/AD, and AD. Interestingly, synapse signaling-associated gene signatures (such as synaptotagmins) were commonly down-regulated in CTE, CTE/AD, and AD. Quantitative real-time PCR (qPCR) and Western blot analyses confirmed that the levels of synaptotagmin 1 (SYT1) were markedly decreased in CTE and AD compared to normal. In addition, calcium/calmodulin-dependent protein kinase II (CaMKII), protein kinase A (PKA), protein kinase C (PKC), and AMPA receptor genes that play a pivotal role in memory function, were down-regulated in head trauma-related disorders. On the other hand, up-regulation of cell adhesion molecules (CAMs) associated genes was only found in CTE. Our results indicate that dysregulation of synaptic transmission- and memory function-related genes are closely linked to the pathology of head injury-related disorder and AD. Alteration of CAMs-related genes may be specific pathological markers for the CTE pathology.	[Cho, Hyesun; Seo, Jeong-Sun] Seoul Natl Univ, Gong Wu Genom Med Inst, Bundang Hosp, Seongnam 13605, South Korea; [Cho, Hyesun; Seo, Jeong-Sun] Seoul Natl Univ, Grad Sch, Dept Biomed Sci, Seoul 03080, South Korea; [Shin, Jong-Yeon; Seo, Jeong-Sun] Macrogen Inc, Genom Inst, Seoul 08511, South Korea; [Hyeon, Seung Jae; Ryu, Hoon] Korea Inst Sci & Technol, Brain Sci Inst, Ctr Neuromed, Seoul 02792, South Korea; [Alvarez, Victor E.; Stein, Thor D.; McKee, Ann C.] Boston Univ, Sch Med, Chron Traumat Encephalopathy CTE Ctr, Boston, MA 02118 USA; [Alvarez, Victor E.; Stein, Thor D.; Lee, Junghee; Kowall, Neil W.; McKee, Ann C.; Ryu, Hoon] VA Boston Healthcare Syst, Boston, MA 02130 USA; [Alvarez, Victor E.; Stein, Thor D.; Lee, Junghee; Kowall, Neil W.; McKee, Ann C.; Ryu, Hoon] Boston Univ, Sch Med, BU Alzheimers Dis Ctr, Boston, MA 02118 USA; [Alvarez, Victor E.; Stein, Thor D.; Lee, Junghee; Kowall, Neil W.; McKee, Ann C.; Ryu, Hoon] Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA		Seo, JS (corresponding author), Seoul Natl Univ, Gong Wu Genom Med Inst, Bundang Hosp, Seongnam 13605, South Korea.; Seo, JS (corresponding author), Seoul Natl Univ, Grad Sch, Dept Biomed Sci, Seoul 03080, South Korea.; Seo, JS (corresponding author), Macrogen Inc, Genom Inst, Seoul 08511, South Korea.; Ryu, H (corresponding author), Korea Inst Sci & Technol, Brain Sci Inst, Ctr Neuromed, Seoul 02792, South Korea.; McKee, AC (corresponding author), Boston Univ, Sch Med, Chron Traumat Encephalopathy CTE Ctr, Boston, MA 02118 USA.; McKee, AC; Ryu, H (corresponding author), VA Boston Healthcare Syst, Boston, MA 02130 USA.; McKee, AC; Ryu, H (corresponding author), Boston Univ, Sch Med, BU Alzheimers Dis Ctr, Boston, MA 02118 USA.; McKee, AC; Ryu, H (corresponding author), Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA.	amckee@bu.edu; hoonryu@bu.edu; jeongsun@snu.ac.kr	Lang, Steven/AAE-8102-2021; Seo, Jeong-Sun/J-2763-2012	Lang, Steven/0000-0003-1669-9146; Stein, Thor/0000-0001-6954-4477	Macrogen, Inc. [MGR17-04]; National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [1U01NS086659-01]; Department of Veterans AffairsUS Department of Veterans Affairs; Veterans Affairs Biorepository [CSP 501]; National Institute of Aging Boston University Alzheimer's Disease Center [P30AG13846, 0572063345-5]; National Institute of Aging Boston University Framingham Heart Study [R01AG1649]; Concussion Legacy Foundation; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01AG054156, R01NS109537]; National Research Foundation (NRF) [NRF-2016M3C7A1904233, NRF-2018M3C7A1056894]; National Research Council of Science & Technology (NST) Grant from Korea Ministry of Science, ICT and Future Planning (MSIP) [CRC-15-04-KIST]; Korea Institute of Science and TechnologyKorea Institute of Science & Technology (KIST) [2E30320]	This study was supported by a grant of the Macrogen, Inc. (grant no. MGR17-04). The authors gratefully acknowledge the use of the resources and facilities at the Edith Nourse Rogers Memorial Veterans Hospital (Bedford, MA, USA). This work was supported by the National Institute of Neurological Disorders and Stroke (1U01NS086659-01), Department of Veterans Affairs, the Veterans Affairs Biorepository (CSP 501), the National Institute of Aging Boston University Alzheimer's Disease Center (P30AG13846; supplement 0572063345-5), the National Institute of Aging Boston University Framingham Heart Study (R01AG1649), and the Concussion Legacy Foundation. This work was also supported by unrestricted gifts from the Andlinger Foundation, the World Wrestling Entertainment, and the National Football League. This study was supported by NIH Grant (R01AG054156 to T. S. and H. R. and R01NS109537 to J.L.). This study was also supported by the National Research Foundation (NRF) Grant (NRF-2016M3C7A1904233 and NRF-2018M3C7A1056894), the National Research Council of Science & Technology (NST) Grant (No. CRC-15-04-KIST) from Korea Ministry of Science, ICT and Future Planning (MSIP), and the Research Grant (2E30320) from Korea Institute of Science and Technology. We also thank Hannah Ryu for her assistance in preparing the manuscript.	ABELIOVICH A, 1993, CELL, V75, P1263, DOI 10.1016/0092-8674(93)90614-V; ABELIOVICH A, 1993, CELL, V75, P1253, DOI 10.1016/0092-8674(93)90613-U; Ahmad M, 2012, NEURON, V73, P260, DOI 10.1016/j.neuron.2011.11.020; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Barria A, 1997, J BIOL CHEM, V272, P32727, DOI 10.1074/jbc.272.52.32727; Baugh CM, 2014, CURR TREAT OPTION NE, V16, DOI 10.1007/s11940-014-0306-5; Baugh CM, 2012, BRAIN IMAGING BEHAV, V6, P244, DOI 10.1007/s11682-012-9164-5; Bomboi G, 2010, NEUROL SCI, V31, P1, DOI 10.1007/s10072-009-0151-6; Cai ZY, 2016, INT J NEUROSCI, V126, P97, DOI 10.3109/00207454.2015.1025778; Cebrian C, 2014, FRONT NEUROANAT, V8, DOI 10.3389/fnana.2014.00114; Chakravarthy B, 1999, TRENDS NEUROSCI, V22, P12, DOI 10.1016/S0166-2236(98)01288-0; Chater TE, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00401; CHEN L, 1992, NATURE, V356, P521, DOI 10.1038/356521a0; COLLEY PA, 1990, J NEUROSCI, V10, P3353; Correia SS, 2003, J BIOL CHEM, V278, P6307, DOI 10.1074/jbc.M205587200; Darmanis S, 2015, P NATL ACAD SCI USA, V112, P7285, DOI 10.1073/pnas.1507125112; Dean C, 2009, NAT NEUROSCI, V12, P767, DOI 10.1038/nn.2315; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Esteban JA, 2003, NAT NEUROSCI, V6, P136, DOI 10.1038/nn997; Gavett BE, 2011, CLIN SPORT MED, V30, P179, DOI 10.1016/j.csm.2010.09.007; Giese KP, 1998, SCIENCE, V279, P870, DOI 10.1126/science.279.5352.870; Hansen DV, 2018, J CELL BIOL, V217, P459, DOI 10.1083/jcb.201709069; Iverson GL, 2015, NEUROSCI BIOBEHAV R, V56, P276, DOI 10.1016/j.neubiorev.2015.05.008; Jo S, 2014, NAT MED, V20, P886, DOI 10.1038/nm.3639; Lee J, 2013, ACTA NEUROPATHOL, V125, P727, DOI 10.1007/s00401-013-1103-z; Li QY, 2018, NAT REV IMMUNOL, V18, P225, DOI 10.1038/nri.2017.125; LINDEN DJ, 1989, BRAIN RES REV, V14, P279, DOI 10.1016/0165-0173(89)90004-0; Lisman J, 2002, NAT REV NEUROSCI, V3, P175, DOI 10.1038/nrn753; Lisman J, 2012, NAT REV NEUROSCI, V13, P169, DOI 10.1038/nrn3192; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Lu W, 2010, P NATL ACAD SCI USA, V107, P22266, DOI 10.1073/pnas.1016289107; MacDonald JF, 2001, CURR DRUG TARGETS, V2, P299, DOI 10.2174/1389450013348452; Mammen AL, 1997, J BIOL CHEM, V272, P32528, DOI 10.1074/jbc.272.51.32528; Mandrekar-Colucci S, 2010, CNS NEUROL DISORD-DR, V9, P156, DOI 10.2174/187152710791012071; Marcello E, 2012, ADV EXP MED BIOL, V970, P573, DOI 10.1007/978-3-7091-0932-8_25; McAllister AK, 2014, BIOL PSYCHIAT, V75, P262, DOI 10.1016/j.biopsych.2013.10.003; McKee AC, 2015, BRAIN PATHOL, V25, P350, DOI 10.1111/bpa.12248; McKee AC, 2014, ACTA NEUROPATHOL, V127, P29, DOI 10.1007/s00401-013-1230-6; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Mukhin VN, 2017, NEUROSCI BEHAV PHYSI, V47, P508, DOI [DOI 10.1007/S11055-017-0427, 10.1007/ s11055 -017-0427]; Murray P, 1999, BMJ-BRIT MED J, V319, P332, DOI 10.1136/bmj.319.7206.332; Roche KW, 1996, NEURON, V16, P1179, DOI 10.1016/S0896-6273(00)80144-0; Sakisaka T, 2005, J CELL SCI, V118, P5407, DOI 10.1242/jcs.02672; Salter MW, 2017, NAT MED, V23, P1018, DOI 10.1038/nm.4397; Seo JS, 2017, EXP MOL MED, V49, DOI 10.1038/emm.2017.56; SILVA AJ, 1992, SCIENCE, V257, P201, DOI 10.1126/science.1378648; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tampellini D, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00423; Tartaglia MC, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00030; Togashi H, 2009, CELL ADHES MIGR, V3, P29, DOI 10.4161/cam.3.1.6773; Turner RC, 2016, BRAIN INJURY, V30, P1279, DOI 10.1080/02699052.2016.1193631; Tyler C. M, 2014, ELS, DOI [10.1002/9780470015902.a0025802, DOI 10.1002/9780470015902.A0025802]; Verkhratsky A, 2010, NEUROTHERAPEUTICS, V7, P399, DOI 10.1016/j.nurt.2010.05.017; Wang MH, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0355-3; Wu D, 2017, NATURE, V544, P316, DOI 10.1038/nature21720; Yang HW, 2004, J NEUROPHYSIOL, V91, P1122, DOI 10.1152/jn.00735.2003	56	7	7	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	JUN 1	2020	10	1							8811	10.1038/s41598-020-65916-y			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LY4EQ	WOS:000540482200003	32483284	Green Published, gold			2022-02-06	
J	Ware, AL; Wilde, EA; Newsome, MR; Moretti, P; Abildskov, T; Vogt, GS; McCauley, SR; Hanten, G; Hunter, JV; Chu, ZD; Levin, HS				Ware, Ashley L.; Wilde, Elisabeth A.; Newsome, Mary R.; Moretti, Paolo; Abildskov, Tracy; Vogt, Gregory S.; McCauley, Stephen R.; Hanten, Gerri; Hunter, Jill, V; Chu, Zili D.; Levin, Harvey S.			A preliminary investigation of corpus callosum subregion white matter vulnerability and relation to chronic outcome in boxers	BRAIN IMAGING AND BEHAVIOR			English	Article						Repetitive sports concussion; Boxing; DTI; Executive function; Depression; Corpus callosum	TRAUMATIC BRAIN-INJURY; DIFFUSION ANISOTROPY; PROFESSIONAL BOXERS; IMAGING FINDINGS; HEAD IMPACTS; AFTERMATH; INTEGRITY; EXPOSURE; DEFICITS; DAMAGE	Microstructural neuropathology occurs in the corpus callosum (CC) after repetitive sports concussion in boxers and can be dose-dependent. However, the specificity and relation of CC changes to boxing exposure extent and post-career psychiatric and neuropsychological outcomes are largely unknown. Using deterministic diffusion tensor imaging (DTI) techniques, boxers and demographically-matched, noncontact sport athletes were compared to address literature gaps. Ten boxers and 9 comparison athletes between 26 and 59 years old (M = 44.63, SD = 9.24) completed neuropsychological testing and MRI. Quantitative DTI metrics were estimated for CC subregions. GroupxRegion interaction effects were observed on fractional anisotropy (FA; eta(2)(p) >= .21). Follow-up indicated large effects of group (eta(2)(p) >= .26) on splenium FA (boxers<comparisons) and genu mean diffusivity (MD; boxers>comparisons), but not radial diffusivity (RD). The group of boxers had moderately elevated number of psychiatric symptoms and reduced neuropsychological scores relative to the comparison group. In boxers, years sparring, professional bouts, and knockout history correlated strongly (r > |.40|) with DTI metrics and fine motor dexterity. In the comparison group, splenium FA correlated positively with psychiatric symptoms. In the boxer group, neuropsychological scores correlated with DTI metrics in all CC subregions. Results suggested relative vulnerability of the splenium and, to a lesser extent, the genu to chronic, repetitive head injury from boxing. Dose-dependent associations of professional boxing history extent with DTI white matter structure indices as well as fine motor dexterity were supported. Results indicated that symptoms of depression and executive dysfunction may provide the strongest indicators of global CC disruption from boxing.	[Ware, Ashley L.] Univ Houston, Dept Psychol, Houston, TX 77204 USA; [Ware, Ashley L.] Univ Houston, Texas Inst Measurement Evaluat & Stat, Houston, TX 77204 USA; [Ware, Ashley L.; Wilde, Elisabeth A.; Newsome, Mary R.; Vogt, Gregory S.; McCauley, Stephen R.; Hanten, Gerri; Hunter, Jill, V; Levin, Harvey S.] Baylor Coll Med, Dept Phys Med & Rehabil, One Baylor Plaza BCM637, Houston, TX 77030 USA; [Ware, Ashley L.] Univ Calgary, Dept Psychol, 2500 Univ Way, Calgary, AB T2N 1N4, Canada; [Wilde, Elisabeth A.; Moretti, Paolo] George E Wahlen VA Salt Lake City Healthcare Syst, 550 Foothill Dr, Salt Lake City, UT 84108 USA; [Wilde, Elisabeth A.; Moretti, Paolo; McCauley, Stephen R.; Levin, Harvey S.] Baylor Coll Med, Dept Neurol, One Baylor Plaza BCM637, Houston, TX 77030 USA; [Wilde, Elisabeth A.; Hunter, Jill, V; Chu, Zili D.] Baylor Coll Med, Dept Radiol, One Baylor Plaza BCM637, Houston, TX 77030 USA; [Wilde, Elisabeth A.; Moretti, Paolo; Abildskov, Tracy] Univ Utah, Dept Neurol, 729 Arapeen Rd, Salt Lake City, UT 84108 USA; [Newsome, Mary R.; Vogt, Gregory S.; Levin, Harvey S.] Michael E DeBakey VA Med Ctr, 2002 Holcombe Blvd 153, Houston, TX 77030 USA; [McCauley, Stephen R.; Levin, Harvey S.] Baylor Coll Med, Dept Pediat, One Baylor Plaza BCM637, Houston, TX 77030 USA; [Hunter, Jill, V; Chu, Zili D.] Texas Childrens Hosp, Dept Pediat Radiol, 6621 Fannin St, Houston, TX 77030 USA		Ware, AL (corresponding author), Univ Houston, Dept Psychol, Houston, TX 77204 USA.; Ware, AL (corresponding author), Univ Houston, Texas Inst Measurement Evaluat & Stat, Houston, TX 77204 USA.; Ware, AL (corresponding author), Baylor Coll Med, Dept Phys Med & Rehabil, One Baylor Plaza BCM637, Houston, TX 77030 USA.; Ware, AL (corresponding author), Univ Calgary, Dept Psychol, 2500 Univ Way, Calgary, AB T2N 1N4, Canada.	aware2004@gmail.com		Vogt, Gregory/0000-0001-8259-5885	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [5P01-NS056202, 5R21-NS086714] Funding Source: Medline		[Anonymous], 1989, GROOV PEGB TEST US I; Areza-Fegyveres R, 2007, ARQ NEURO-PSIQUIAT, V65, P830, DOI 10.1590/S0004-282X2007000500019; Banks SJ, 2014, J NEUROPSYCH CLIN N, V26, P44, DOI 10.1176/appi.neuropsych.12070185; BECK AT, 1988, J CONSULT CLIN PSYCH, V56, P893, DOI 10.1037/0022-006X.56.6.893; Belanger HG, 2010, J INT NEUROPSYCH SOC, V16, P262, DOI 10.1017/S1355617709991287; Budde MD, 2011, BRAIN, V134, P2248, DOI 10.1093/brain/awr161; Chappell MH, 2006, J MAGN RESON IMAGING, V24, P537, DOI 10.1002/jmri.20656; Chepuri NB, 2002, AM J NEURORADIOL, V23, P803; Cohen J., 2013, STAT POWER ANAL BEHA; CORSELLIS JA, 1973, PSYCHOL MED, V3, P270, DOI 10.1017/S0033291700049588; Davenport EM, 2014, J NEUROTRAUM, V31, P1617, DOI 10.1089/neu.2013.3233; DeKosky ST, 2013, NAT REV NEUROL, V9, P192, DOI 10.1038/nrneurol.2013.36; Di Russo F, 2010, PSYCHOPHYSIOLOGY, V47, P425, DOI 10.1111/j.1469-8986.2009.00950.x; Heilbronner RL, 2009, ARCH CLIN NEUROPSYCH, V24, P11, DOI 10.1093/arclin/acp005; Herweh C, 2016, NEURORADIOLOGY, V58, P911, DOI 10.1007/s00234-016-1705-y; JORDAN BD, 1992, RADIOLOGY, V185, P509, DOI 10.1148/radiology.185.2.1410364; Jordan BD, 2000, SEMIN NEUROL, V20, P179, DOI 10.1055/s-2000-9826; KLOVE H, 1963, MED CLIN N AM, V47, P1647, DOI 10.1016/S0025-7125(16)33515-5; Knyazeva MG, 2013, NEURAL PLAST, V2013, DOI 10.1155/2013/639430; Koerte IK, 2015, BRAIN PATHOL, V25, P318, DOI 10.1111/bpa.12249; Koh JO, 2003, BRAIN INJURY, V17, P901, DOI 10.1080/0269905031000088869; Levin HS, 2008, J HEAD TRAUMA REHAB, V23, P197, DOI 10.1097/01.HTR.0000327252.54128.7c; LEVIN HS, 1987, J NEUROSURG, V67, P657, DOI 10.3171/jns.1987.67.5.0657; Lewinsohn PM, 1997, PSYCHOL AGING, V12, P277, DOI 10.1037/0882-7974.12.2.277; Lischke A, 2017, FRONT HUM NEUROSCI, V11, DOI 10.3389/fnhum.2017.00196; Marco EJ, 2012, J INT NEUROPSYCH SOC, V18, P521, DOI 10.1017/S1355617712000045; McAllister TW, 2014, NEUROLOGY, V82, P63, DOI 10.1212/01.wnl.0000438220.16190.42; McKee AC, 2015, BRAIN PATHOL, V25, P350, DOI 10.1111/bpa.12248; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Mouzon B, 2012, J NEUROTRAUM, V29, P2761, DOI 10.1089/neu.2012.2498; Orrison WW, 2009, J NEUROTRAUM, V26, P689, DOI 10.1089/neu.2008.0636; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Reitan R, 1985, HALSTEAD REITAN NEUR; ROBERTS GW, 1990, J NEUROL NEUROSUR PS, V53, P373, DOI 10.1136/jnnp.53.5.373; Shah S, 2012, BRAIN INJURY, V26, P201, DOI 10.3109/02699052.2012.654591; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Shin W, 2014, AM J NEURORADIOL, V35, P285, DOI 10.3174/ajnr.A3676; Smith DH, 2013, NAT REV NEUROL, V9, P211, DOI 10.1038/nrneurol.2013.29; Sollmann N, 2018, NEUROIMAGE-CLIN, V17, P642, DOI 10.1016/j.nicl.2017.11.020; Song SK, 2003, NEUROIMAGE, V20, P1714, DOI 10.1016/j.neuroimage.2003.07.005; Stern RA, 2013, NEUROLOGY, V81, P1122, DOI 10.1212/WNL.0b013e3182a55f7f; Stiller JW, 2014, FRONT PUBLIC HEALTH, V2, DOI 10.3389/fpubh.2014.00069; Voineskos AN, 2012, NEUROBIOL AGING, V33, P21, DOI 10.1016/j.neurobiolaging.2010.02.009; Wilde EA, 2006, J NEUROTRAUM, V23, P1412, DOI 10.1089/neu.2006.23.1412; Wilde EA, 2016, J NEUROTRAUM, V33, P672, DOI 10.1089/neu.2015.4035; Wilde EA, 2009, J CLIN EXP NEUROPSYC, V31, P205, DOI 10.1080/13803390802098118; Witelson SF, 2008, ARCH SEX BEHAV, V37, P857, DOI 10.1007/s10508-007-9276-y; Xu LY, 2016, EXP NEUROL, V275, P436, DOI 10.1016/j.expneurol.2014.11.004; Yeh FC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080713; Zhang L, 2006, AM J NEURORADIOL, V27, P2000; Zhang LJ, 2003, AM J NEURORADIOL, V24, P52	51	7	7	2	4	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	1931-7557	1931-7565		BRAIN IMAGING BEHAV	Brain Imaging Behav.	JUN	2020	14	3					772	786		10.1007/s11682-018-0018-7			15	Neuroimaging	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	LV2EP	WOS:000538253100011	30565025				2022-02-06	
J	Ruppert, KA; Prabhakara, KS; Toledano-Furman, NE; Udtha, S; Arceneaux, AQ; Park, H; Dao, A; Cox, CS; Olson, SD				Ruppert, Katherine A.; Prabhakara, Karthik S.; Toledano-Furman, Naama E.; Udtha, Sanjna; Arceneaux, Austin Q.; Park, Hyeonggeun; Dao, An; Cox, Charles S.; Olson, Scott D.			Human adipose-derived mesenchymal stem cells for acute and sub-acute TBI	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; SPINAL-CORD-INJURY; MICROGLIA/MACROPHAGE POLARIZATION DYNAMICS; MARROW STROMAL CELLS; THERAPEUTIC-EFFICACY; FUNCTIONAL RECOVERY; TRANSPLANTATION; RATS; EXPRESSION; PROMOTES	In the U.S., approximately 1.7 million people suffer traumatic brain injury each year, with many enduring long-term consequences and significant medical and rehabilitation costs. The primary injury causes physical damage to neurons, glia, fiber tracts and microvasculature, which is then followed by secondary injury, consisting of pathophysiological mechanisms including an immune response, inflammation, edema, excitotoxicity, oxidative damage, and cell death. Most attempts at intervention focus on protection, repair or regeneration, with regenerative medicine becoming an intensively studied area over the past decade. The use of stem cells has been studied in many disease and injury models, using stem cells from a variety of sources and applications. In this study, human adipose-derived mesenchymal stromal cells (MSCs) were administered at early (3 days) and delayed (14 days) time points after controlled cortical impact (CCI) injury in rats. Animals were routinely assessed for neurological and vestibulomotor deficits, and at 32 days post-injury, brain tissue was processed by flow cytometry and immunohistochemistry to analyze neuroinflammation. Treatment with HB-adMSC at either 3d or 14d after injury resulted in significant improvements in neurocognitive outcome and a change in neuroinflammation one month after injury.	[Ruppert, Katherine A.; Prabhakara, Karthik S.; Toledano-Furman, Naama E.; Udtha, Sanjna; Arceneaux, Austin Q.; Cox, Charles S.; Olson, Scott D.] Univ Texas Hlth Sci Ctr Houston, McGovern Med Sch, Dept Pediat Surg, Houston, TX 77030 USA; [Ruppert, Katherine A.; Park, Hyeonggeun; Dao, An] Hope Biosci, Sugar Land, TX USA		Olson, SD (corresponding author), Univ Texas Hlth Sci Ctr Houston, McGovern Med Sch, Dept Pediat Surg, Houston, TX 77030 USA.	scott.d.olson@uth.tmc.edu		Olson, Scott/0000-0001-8032-3755	Hope Bio; University of Texas Health Science System (UTHealth); Grace Reynolds Wall Research Fund; Clare A. Glassell Family Pediatric Stem Cell Research Fund	SDO and CSC have received research support from Hope Bio as part of a sponsored research agreement between Hope Bio and the University of Texas Health Science System (UTHealth). KAR performed the work in this study as an employee of UTHealth, but has since accepted paid employment at Hope Bio. Hope Bio also provided support for this study in the form of salaries for HP and AD. The specific roles of these authors are articulated in the 'author contributions' section. Additionally, this study received funding from the Grace Reynolds Wall Research Fund and the Clare A. Glassell Family Pediatric Stem Cell Research Fund. The funders had no role in study design, data collection and analysis, or decision to publish. Hope Biosciences received and approved a draft of the manuscript prior to submission and contributed some minor corrections and additional details for the methods, specifically the 'Isolation and Expansion of HB-adMSCs' section.	ALTMAN J, 1965, J COMP NEUROL, V124, P319, DOI 10.1002/cne.901240303; Bauer G, 2008, MOL THER, V16, P1308, DOI 10.1038/mt.2008.93; Bedi SS, 2013, J TRAUMA ACUTE CARE, V75, P410, DOI 10.1097/TA.0b013e31829617c6; Beschorner R, 2002, ACTA NEUROPATHOL, V103, P541, DOI 10.1007/s00401-001-0503-7; Bianchi ME, 2007, J LEUKOCYTE BIOL, V81, P1, DOI 10.1189/jlb.0306164; Brown JP, 2003, J COMP NEUROL, V467, P1, DOI 10.1002/cne.10874; Bunnell BA, 2008, METHODS, V45, P115, DOI 10.1016/j.ymeth.2008.03.006; Chan TM, 2014, CELL TRANSPLANT, V23, P541, DOI 10.3727/096368914X678409; Chan TM, 2014, CELL TRANSPLANT, V23, P399, DOI 10.3727/096368914X678292; Corps KN, 2015, JAMA NEUROL, V72, P355, DOI 10.1001/jamaneurol.2014.3558; Couillard-Despres S, 2005, EUR J NEUROSCI, V21, P1, DOI 10.1111/j.1460-9568.2004.03813.x; Meirelles LDS, 2006, J CELL SCI, V119, P2204, DOI 10.1242/jcs.02932; Ding DC, 2011, CELL TRANSPLANT, V20, P5, DOI 10.3727/096368910X; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; Fan L, 2008, CHIN J TRAUMATOL, V11, P94, DOI 10.1016/S1008-1275(08)60020-6; Finkelstein E., 2006, INCIDENCE EC BURDEN; Fischer UM, 2009, STEM CELLS DEV, V18, P683, DOI 10.1089/scd.2008.0253; Furman NET, 2018, CYTOM PART A, V93A, P182, DOI 10.1002/cyto.a.23267; Gennai S, 2015, BRIT J ANAESTH, V115, P203, DOI 10.1093/bja/aev229; Gimble JM, 2003, CYTOTHERAPY, V5, P362, DOI 10.1080/14653240310003026; Goncalves JT, 2016, CELL, V167, P897, DOI 10.1016/j.cell.2016.10.021; Guan J, 2013, BIOMATERIALS, V34, P5937, DOI 10.1016/j.biomaterials.2013.04.047; Guan QD, 2018, CYTOTHERAPY, V20, P639, DOI 10.1016/j.jcyt.2018.02.003; Hall ED, 2005, J NEUROTRAUM, V22, P252, DOI 10.1089/neu.2005.22.252; Hamm RJ, 2001, J NEUROTRAUM, V18, P1207, DOI 10.1089/089771501317095241; HAMM RJ, 1992, J NEUROTRAUM, V9, P11, DOI 10.1089/neu.1992.9.11; Harting MT, 2008, BRAIN, V131, DOI 10.1093/brain/awn142; Harting MT, 2009, J NEUROSURG, V110, P1189, DOI 10.3171/2008.9.JNS08158; Hass R, 2011, CELL COMMUN SIGNAL, V9, DOI 10.1186/1478-811X-9-12; Hastings NB, 1999, J COMP NEUROL, V413, P146, DOI 10.1002/(SICI)1096-9861(19991011)413:1<146::AID-CNE10>3.0.CO;2-B; Helmy A, 2014, J CEREBR BLOOD F MET, V34, P845, DOI 10.1038/jcbfm.2014.23; Hu XM, 2015, NAT REV NEUROL, V11, P56, DOI 10.1038/nrneurol.2014.207; HU XM, 2012, STROKE, V43, P3063, DOI DOI 10.1161/STR0KEAHA.112.659656; Jin XM, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0041892, 10.1371/journal.pone.0040637]; Kang SK, 2003, EXP NEUROL, V183, P355, DOI 10.1016/S0014-4886(03)00089-X; Kang SK, 2006, STEM CELLS DEV, V15, P583, DOI 10.1089/scd.2006.15.583; Khachatryan V, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.201803; Kigerl KA, 2009, J NEUROSCI, V29, P13435, DOI 10.1523/JNEUROSCI.3257-09.2009; Kim JW, 2013, SPINE, V38, pE1065, DOI 10.1097/BRS.0b013e31829839fa; Kim JM, 2007, BRAIN RES, V1183, P43, DOI 10.1016/j.brainres.2007.09.005; Kota DJ, 2017, STEM CELLS, V35, P1416, DOI 10.1002/stem.2603; Kota DJ, 2016, STEM CELL TRANSL MED, V5, P33, DOI 10.5966/sctm.2015-0065; Kota DJ, 2014, SCI REP-UK, V4, DOI 10.1038/srep04565; Kumar A, 2012, BRAIN BEHAV IMMUN, V26, P1191, DOI 10.1016/j.bbi.2012.06.008; Lee OK, 2004, BLOOD, V103, P1669, DOI 10.1182/blood-2003-05-1670; Lee RH, 2009, CELL STEM CELL, V5, P54, DOI 10.1016/j.stem.2009.05.003; Liao GP, 2014, J SURG RES, V190, P628, DOI 10.1016/j.jss.2014.05.011; Liddelow SA, 2017, NATURE, V541, P481, DOI 10.1038/nature21029; LOIS C, 1993, P NATL ACAD SCI USA, V90, P2074, DOI 10.1073/pnas.90.5.2074; Long JB, 1996, J NEUROTRAUM, V13, P149, DOI 10.1089/neu.1996.13.149; Mahmood A, 2006, J NEUROSURG, V104, P272, DOI 10.3171/jns.2006.104.2.272; Mahmood A, 2004, NEUROSURGERY, V55, P1185, DOI 10.1227/01.NEU.0000141042.14476.3C; Mahmood A, 2003, NEUROSURGERY, V53, P697, DOI 10.1227/01.NEU.0000079333.61863.AA; Mahmood A, 2005, NEUROSURGERY, V57, P5; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; Mastro-Martinez I, 2015, BRAIN INJURY, V29, P1497, DOI 10.3109/02699052.2015.1053525; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; MCNAMARA RK, 1993, BRAIN RES REV, V18, P33, DOI 10.1016/0165-0173(93)90006-L; Menge T, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004660; Morganti-Kossmann Maria Cristina, 2002, Curr Opin Crit Care, V8, P101; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; Nakajima H, 2012, J NEUROTRAUM, V29, P1614, DOI 10.1089/neu.2011.2109; Nayak D, 2014, ANNU REV IMMUNOL, V32, P367, DOI 10.1146/annurev-immunol-032713-120240; Nizamutdinov D, 2017, BRAIN SCI, V7, DOI 10.3390/brainsci7010011; Novikova LN, 2011, CYTOTHERAPY, V13, P873, DOI 10.3109/14653249.2011.574116; Oliveri RS, 2014, NEUROBIOL DIS, V62, P338, DOI 10.1016/j.nbd.2013.10.014; PALMER TD, 1995, MOL CELL NEUROSCI, V6, P474, DOI 10.1006/mcne.1995.1035; Peng WJ, 2015, STEM CELL RES THER, V6, DOI 10.1186/s13287-015-0034-0; Pischiutta F, 2014, NEUROPHARMACOLOGY, V79, P119, DOI 10.1016/j.neuropharm.2013.11.001; Prockop DJ, 2012, MOL THER, V20, P14, DOI 10.1038/mt.2011.211; Prockop DJ, 2010, J CELL MOL MED, V14, P2190, DOI 10.1111/j.1582-4934.2010.01151.x; Qu CS, 2011, BRAIN RES, V1371, P129, DOI 10.1016/j.brainres.2010.10.088; Qu CS, 2009, J NEUROSURG, V111, P658, DOI 10.3171/2009.4.JNS081681; Quertainmont R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039500; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; Ritfeld GJ, 2012, CELL TRANSPLANT, V21, P1561, DOI 10.3727/096368912X640484; Russo MV, 2016, SCIENCE, V353, P783, DOI 10.1126/science.aaf6260; Russo MV, 2015, TRENDS IMMUNOL, V36, P637, DOI 10.1016/j.it.2015.08.002; Sell SL, 2008, ANESTHESIOLOGY, V108, P873, DOI 10.1097/ALN.0b013e31816c8a15; Smith DH, 1991, J NEUROTRAUM, V8, P259, DOI 10.1089/neu.1991.8.259; Tang GH, 2014, STEM CELLS, V32, P3150, DOI 10.1002/stem.1808; Tang YH, 2015, ADV FUNCT MATER, V25, P1024, DOI 10.1002/adfm.201402930; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Urdzikova L, 2006, J NEUROTRAUM, V23, P1379, DOI 10.1089/neu.2006.23.1379; Walker DG, 2015, ALZHEIMERS RES THER, V7, DOI 10.1186/s13195-015-0139-9; Walker PA, 2012, SURGERY, V152, P790, DOI 10.1016/j.surg.2012.06.006; Walker PA, 2010, STEM CELLS INT, V2010, DOI 10.4061/2010/369578; Walker PA, 2010, STEM CELLS DEV, V19, P867, DOI 10.1089/scd.2009.0188; Walker PA, 2009, DIS MODEL MECH, V2, P23, DOI 10.1242/dmm.001198; Wang GH, 2013, J CEREBR BLOOD F MET, V33, P1864, DOI 10.1038/jcbfm.2013.146; Wang Y, 2014, NAT IMMUNOL, V15, P1009, DOI 10.1038/ni.3002; Woodcock T, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00018; Zheng B, 2016, THERANOSTICS, V6, P291, DOI 10.7150/thno.13728	93	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2020	15	5							e0233263	10.1371/journal.pone.0233263			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LU1NT	WOS:000537529500018	32453741	gold, Green Published			2022-02-06	
J	Bian, KW; Mao, HJ				Bian, Kewei; Mao, Haojie			Mechanisms and variances of rotation-induced brain injury: a parametric investigation between head kinematics and brain strain	BIOMECHANICS AND MODELING IN MECHANOBIOLOGY			English	Article						Concussion; Injury mechanism; Impact direction; Rotational velocity; Injury metric	MAXIMUM PRINCIPAL STRAIN; FINITE-ELEMENT-ANALYSIS; PROFESSIONAL FOOTBALL; CORPUS-CALLOSUM; CONCUSSION DIAGNOSIS; LATERAL IMPACTS; RISK; PREDICTORS; THRESHOLD; RESPONSES	There lacks a comprehensive understanding of the correlation between head kinematics and brain strain especially deep-brain strain, partially resulting the deficiency of understanding brain injury mechanisms and the difficulty of choosing appropriate brain injury metrics. Hence, we simulated 76 impacts that were focused on concussion-relevant rotational kinematics and evaluated cumulative strain damage measure (CSDM) and average strain that could represent brain strain distribution. For the whole brain, axial rotation induced the highest CSDM, while lateral bending produced the lowest CSDM. However, for the deep-brain components, lateral bending produced the highest CSDM to the corpus callosum and thalamus. We further confirmed that brain strain was mainly produced by rotational kinematics, for which the effect of rotational deceleration could not be ignored with the deceleration influencing CSDM20 up to 27%. Our data supported that peak rotational velocity correlated to brain strain with an average R-2 of 0.77 across various impact directions and different shapes of loading curves. The correlation between peak rotational velocity and brain strain reached to an average R-2 of 0.99 for each specific impact direction. Our results supported using direction-specific peak rotation velocity for predicting strain-related brain injury. Additionally, we highlighted the importance of investigating whole-brain and deep-brain strain, as well as considering rotational deceleration.	[Bian, Kewei; Mao, Haojie] Western Univ, Fac Engn, Dept Mech & Mat Engn, London, ON N6A 5B9, Canada; [Mao, Haojie] Western Univ, Sch Biomed Engn, London, ON N6A 5B9, Canada		Mao, HJ (corresponding author), Western Univ, Fac Engn, Dept Mech & Mat Engn, London, ON N6A 5B9, Canada.; Mao, HJ (corresponding author), Western Univ, Sch Biomed Engn, London, ON N6A 5B9, Canada.	hmao8@uwo.ca	Mao, Haojie/Q-7514-2018	Mao, Haojie/0000-0002-7563-9234	Canada Research Chairs programCanada Research Chairs [X2281B63]; NSERCNatural Sciences and Engineering Research Council of Canada (NSERC) [R5748A04]	We acknowledge the Canada Research Chairs program (X2281B63) and NSERC (R5748A04) for support. We acknowledge Dr. Youcai Wu and Dr. Cheng-Tang Wu from LSTC for their help with data analysis. We acknowledge Mr. Yanir Levy for the support in statistical analysis.	Bain AC, 2000, J BIOMECH ENG-T ASME, V122, P615, DOI 10.1115/1.1324667; Beckwith JG, 2013, MED SCI SPORT EXER, V45, P747, DOI 10.1249/MSS.0b013e3182793067; Chamard E, 2016, J NEUROTRAUM, V33, P1220, DOI 10.1089/neu.2015.3948; Elkin BS, 2019, CLIN BIOMECH, V64, P49, DOI 10.1016/j.clinbiomech.2018.03.021; Elkin BS, 2016, J ORTHOP SPORT PHYS, V46, P874, DOI 10.2519/jospt.2016.7049; Gabler LF, 2018, J BIOMECH ENG-T ASME, V140, DOI 10.1115/1.4038357; Gadd C., 1966, SAE TECHNICAL PAPER; Graybiel AM, 2000, CURR BIOL, V10, pR509, DOI 10.1016/S0960-9822(00)00593-5; Greenwald RM, 2008, NEUROSURGERY, V62, P789, DOI 10.1227/01.neu.0000318162.67472.ad; Grossman EJ, 2016, J NEUROTRAUM, V33, P163, DOI 10.1089/neu.2015.3965; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Guskiewicz KM, 2011, EXERC SPORT SCI REV, V39, P4, DOI 10.1097/JES.0b013e318201f53e; Hardy W N, 2001, Stapp Car Crash J, V45, P337; Hardy WN, 2007, STAPP CAR CRASH JO, V51, P17; Hernandez F, 2019, BIOMECH MODEL MECHAN, V18, P631, DOI 10.1007/s10237-018-01106-0; Hoshizaki TB, 2017, TRAUMA, V19, P196, DOI 10.1177/1460408616676503; Kimpara H, 2012, ANN BIOMED ENG, V40, P114, DOI 10.1007/s10439-011-0414-2; King A. I., 2003, IRCOBI C LISB PORT; Kleiven S, 2005, INT IRCOBI C; Kleiven S, 2007, STAPP CAR CRASH JO, V51, P81; Knowles BM, 2017, ANN BIOMED ENG, V45, P2146, DOI 10.1007/s10439-017-1848-y; Krave U, 2011, J NEUROTRAUM, V28, P57, DOI 10.1089/neu.2010.1431; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Mao HJ, 2013, J BIOMECH ENG-T ASME, V135, DOI 10.1115/1.4025101; MARGULIES SS, 1992, J BIOMECH, V25, P917, DOI 10.1016/0021-9290(92)90231-O; McAllister TW, 2012, ANN BIOMED ENG, V40, P127, DOI 10.1007/s10439-011-0402-6; McCrory P, 2009, J CLIN NEUROSCI, V16, P755, DOI [10.4085/1062-6050-44.4.434, 10.1016/j.jocn.2009.02.002]; Nahum AM, 1977, SAE TECHNICAL PAPER; Newman J., 1999, INT RES COUNC BIOM I, P17; Patton DA, 2013, J APPL BIOMECH, V29, P721, DOI 10.1123/jab.29.6.721; Pellman EJ, 2003, NEUROSURGERY, V53, P1328, DOI 10.1227/01.NEU.0000093499.20604.21; Pellman EJ, 2003, NEUROSURGERY, V53, P799, DOI 10.1093/neurosurgery/53.3.799; Post A, 2017, J BIOMECH, V61, P183, DOI 10.1016/j.jbiomech.2017.07.013; Post A, 2014, COMPUT METHOD BIOMEC, V17, P1785, DOI 10.1080/10255842.2013.766724; Post A, 2012, J BIOMECH, V45, P679, DOI 10.1016/j.jbiomech.2011.12.005; Rowson S, 2012, ANN BIOMED ENG, V40, P1, DOI 10.1007/s10439-011-0392-4; Rowson S, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3130454; Rush GA, 2017, SPORTS ENG, V20, P199, DOI 10.1007/s12283-017-0233-2; Sanchez EJ, 2019, CLIN BIOMECH, V64, P82, DOI 10.1016/j.clinbiomech.2018.02.019; Shreiber DI, 1997, SAE TECHNICAL PAPER; Takhounts EG, 2008, SAE TECHNICAL PAPER; Takhounts Erik G, 2003, Stapp Car Crash J, V47, P107; Takhounts Erik G, 2013, Stapp Car Crash J, V57, P243; Tang L, 2011, RADIOLOGY, V260, P831, DOI 10.1148/radiol.11110014; Thibault LE, 1990, INT C BIOM IMP BRON; Trosseille X, 1992, SAE TECHNICAL PAPER; Versace J, 1971, SAE TECHNICAL PAPER; Viano D. C., 1999, J CRASH PREVENTION I, V1, P35; Viano DC, 2005, NEUROSURGERY, V57, P891, DOI 10.1227/01.NEU.0000186950.54075.3B; Yoganandan N, 2008, J BIOMECH, V41, P2253, DOI 10.1016/j.jbiomech.2008.04.019; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446; Zhang LY, 2001, J NEUROTRAUM, V18, P21, DOI 10.1089/089771501750055749; Zhao W, 2017, BIOMECH MODEL MECHAN, V16, P449, DOI 10.1007/s10237-016-0829-7	53	7	7	1	2	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1617-7959	1617-7940		BIOMECH MODEL MECHAN	Biomech. Model. Mechanobiol.	DEC	2020	19	6					2323	2341		10.1007/s10237-020-01341-4		MAY 2020	19	Biophysics; Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Biophysics; Engineering	OI6BN	WOS:000535163600001	32449073				2022-02-06	
J	Arun, P; Rossetti, F; Wilder, DM; Sajja, S; Van Albert, SA; Wang, Y; Gist, ID; Long, JSB				Arun, Peethambaran; Rossetti, Franco; Wilder, Donna M.; Sajja, Sujith; Van Albert, Stephen A.; Wang, Ying; Gist, Irene D.; Long, Joseph B.			Blast Exposure Leads to Accelerated Cellular Senescence in the Rat Brain	FRONTIERS IN NEUROLOGY			English	Article						blast exposure; traumatic brain injury; aging; senescence; SA-beta-gal; SMP-30; p21	BIOLOGICAL-ACTIVITY; INJURY; MILITARY; TAU; DYSFUNCTION; EXPRESSION; CONSEQUENCES; DEGENERATION; RESTORATION; DEPLOYMENT	Blast-induced traumatic brain injury (bTBI) is one of the major causes of persistent disabilities in Service Members, and a history of bTBI has been identified as a primary risk factor for developing age-associated neurodegenerative diseases. Clinical observations of several military blast casualties have revealed a rapid age-related loss of white matter integrity in the brain. In the present study, we have tested the effect of single and tightly coupled repeated blasts on cellular senescence in the rat brain. Isoflurane-anesthetized rats were exposed to either a single or 2 closely coupled blasts in an advanced blast simulator. Rats were euthanized and brains were collected at 24 h, 1 month and 1 year post-blast to determine senescence-associated-beta-galactosidase (SA-beta-gal) activity in the cells using senescence marker stain. Single and repeated blast exposures resulted in significantly increased senescence marker staining in several neuroanatomical structures, including cortex, auditory cortex, dorsal lateral thalamic nucleus, geniculate nucleus, superior colliculus, ventral thalamic nucleus and hippocampus. In general, the increases in SA-beta-gal activity were more pronounced at 1 month than at 24 h or 1 year post-blast and were also greater after repeated than single blast exposures. Real-time quantitative RT-PCR analysis revealed decreased levels of mRNA for senescence marker protein-30 (SMP-30) and increased mRNA levels for p21 (cyclin dependent kinase inhibitor 1A, CDKN1A), two other related protein markers of cellular senescence. The increased senescence observed in some of these affected brain structures may be implicated in several long-term sequelae after exposure to blast, including memory disruptions and impairments in movement, auditory and ocular functions.	[Arun, Peethambaran; Rossetti, Franco; Wilder, Donna M.; Sajja, Sujith; Van Albert, Stephen A.; Wang, Ying; Gist, Irene D.; Long, Joseph B.] Walter Reed Army Inst Res, Blast Induced Neurotrauma Branch, Ctr Mil Psychiat & Neurosci, Silver Spring, MD 20910 USA		Arun, P (corresponding author), Walter Reed Army Inst Res, Blast Induced Neurotrauma Branch, Ctr Mil Psychiat & Neurosci, Silver Spring, MD 20910 USA.	peethambaran.arun.ctr@mail.mil	Sajja, Sujith/I-5289-2019	Sajja, Sujith/0000-0002-1992-9501	Military Operational Medicine Research Program at United States Army Medical Research and Development Command	This study was funded by the Military Operational Medicine Research Program at United States Army Medical Research and Development Command.	Arun P, 2020, J NEUROTRAUM, V37, P647, DOI 10.1089/neu.2019.6591; Arun P, 2015, NEUROSCI LETT, V609, P152, DOI 10.1016/j.neulet.2015.10.036; Bernardo-Colon A, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00719; Bogdanova Y, 2012, NEUROPSYCHOL REV, V22, P4, DOI 10.1007/s11065-012-9192-3; Burton DGA, 2015, AGE, V37, DOI 10.1007/s11357-015-9764-2; Campisi J, 2013, ANNU REV PHYSIOL, V75, P685, DOI 10.1146/annurev-physiol-030212-183653; Cao JQ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11654-7; Capo-Aponte JE, 2012, MIL MED, V177, P804, DOI 10.7205/MILMED-D-12-00061; Cernak I, 2001, J TRAUMA, V50, P695, DOI 10.1097/00005373-200104000-00017; Cernak I, 2011, NEUROBIOL DIS, V41, P538, DOI 10.1016/j.nbd.2010.10.025; Cheng X, 2019, NEUROCHEM INT, V122, P149, DOI 10.1016/j.neuint.2018.09.003; Cockerham GC, 2009, J REHABIL RES DEV, V46, P811, DOI 10.1682/JRRD.2008.08.0109; Conley YP, 2017, NEUROL-GENET, V3, DOI 10.1212/NXG.0000000000000196; de Lanerolle NC, 2014, ANN CLIN TRANSL NEUR, V1, P692, DOI 10.1002/acn3.98; Fausti SA, 2009, J REHABIL RES DEV, V46, P797, DOI 10.1682/JRRD.2008.09.0118; Fear NT, 2009, PSYCHOL MED, V39, P1379, DOI 10.1017/S0033291708004595; Fontana L, 2018, MECH AGEING DEV, V176, P19, DOI 10.1016/j.mad.2018.10.005; Fujisawa K, 2011, BIOCHEM BIOPH RES CO, V414, P331, DOI 10.1016/j.bbrc.2011.09.067; Fusco S, 2013, CELL MOL LIFE SCI, V70, P3157, DOI 10.1007/s00018-012-1223-y; Geng YQ, 2010, BIOCHEM BIOPH RES CO, V396, P866, DOI 10.1016/j.bbrc.2010.05.011; Gill J, 2017, NEUROL-GENET, V3, DOI 10.1212/NXG.0000000000000186; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004862; Goodrich GL, 2013, OPTOMETRY VISION SCI, V90, P105, DOI 10.1097/OPX.0b013e31827f15a1; Goodrich JA, 2016, ACTA NEUROPATHOL COM, V4, DOI 10.1186/s40478-016-0395-3; Grande LJ, 2018, J INT NEUROPSYCH SOC, V24, P466, DOI 10.1017/S1355617717001242; Graner J, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00016; Greer N, 2018, J HEAD TRAUMA REHAB, V33, pE16, DOI 10.1097/HTR.0000000000000304; HANGER DP, 1991, BIOCHEM J, V275, P99, DOI 10.1042/bj2750099; Heyburn L, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00766; Ho DH, 2019, CELL CYCLE, V18, P467, DOI 10.1080/15384101.2019.1577666; Hoffer ME, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0054163, 10.1371/journal.pone.0060061]; Hoffer ME, 2010, OTOL NEUROTOL, V31, P232, DOI 10.1097/MAO.0b013e3181c993c3; Huber BR, 2013, J ALZHEIMERS DIS, V37, P309, DOI 10.3233/JAD-130182; IQBAL K, 1994, FEBS LETT, V349, P104, DOI 10.1016/0014-5793(94)00650-4; Jang Y, 2019, MED SCI SPORT EXER, V51, P2012, DOI 10.1249/MSS.0000000000002011; Johnson VE, 2012, BRAIN PATHOL, V22, P142, DOI 10.1111/j.1750-3639.2011.00513.x; Kallakuri S, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193389; Kawoos U, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167510; Kontos Anthony P, 2015, J Trauma Acute Care Surg, V79, pS146, DOI 10.1097/TA.0000000000000667; Levin HS, 2010, J NEUROTRAUM, V27, P683, DOI 10.1089/neu.2009.1073; Lew HL, 2007, J REHABIL RES DEV, V44, P921, DOI 10.1682/JRRD.2007.09.0140; Li SN, 2017, MOL MED REP, V16, P4022, DOI 10.3892/mmr.2017.7106; Liu B, 2019, NEUROCHEM RES, V44, P1818, DOI 10.1007/s11064-019-02816-2; Luo H, 2017, NEUROSCIENCE, V340, P515, DOI 10.1016/j.neuroscience.2016.11.014; Mac Donald CL, 2017, NEUROIMAGE-CLIN, V14, P371, DOI 10.1016/j.nicl.2017.02.005; Magone MT, 2014, J REHABIL RES DEV, V51, P71, DOI 10.1682/JRRD.2013.01.0008; Maruyama N, 2010, GERIATR GERONTOL INT, V10, pS88, DOI 10.1111/j.1447-0594.2010.00586.x; Ning YL, 2015, CHIN J TRAUMATOL, V18, P204, DOI 10.1016/j.cjtee.2015.10.003; Petras JM, 1997, TOXICOLOGY, V121, P41, DOI 10.1016/S0300-483X(97)03654-8; Pizza V, 2011, REV RECENT CLIN TRIA, V6, P189, DOI 10.2174/157488711796575577; Reid MW, 2014, J NEUROTRAUM, V31, P1899, DOI 10.1089/neu.2014.3455; Ritzel RM, 2019, NEUROBIOL AGING, V77, P194, DOI 10.1016/j.neurobiolaging.2019.02.010; Sajja VSSS, 2015, SCI REP-UK, V5, DOI 10.1038/srep15075; Sajja VSSS, 2012, NMR BIOMED, V25, P1331, DOI 10.1002/nbm.2805; Serra MP, 2014, INT J RADIAT BIOL, V90, P876, DOI 10.3109/09553002.2014.922714; Taber KH, 2015, J HEAD TRAUMA REHAB, V30, pE15, DOI 10.1097/HTR.0000000000000030; Tominaga T, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0213673; Trotter BB, 2015, BRAIN, V138, P2278, DOI 10.1093/brain/awv139; Tweedie D, 2016, ALZHEIMERS DEMENT, V12, P34, DOI 10.1016/j.jalz.2015.07.489; Urosevich TG, 2018, MIL MED, V183, pE564, DOI 10.1093/milmed/usy102; Vanderploeg RD, 2007, J CLIN EXP NEUROPSYC, V29, P585, DOI 10.1080/13803390600826587; Wang JZ, 1996, MOL BRAIN RES, V38, P200, DOI 10.1016/0169-328X(95)00316-K; Wang Y, 2011, J NEUROTRAUM, V28, P2171, DOI 10.1089/neu.2011.1990; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; Wei WQ, 2018, J CELL PHYSIOL, V233, P9121, DOI 10.1002/jcp.26956; Weiner MW, 2013, ALZHEIMERS DEMENT, V9, P445, DOI 10.1016/j.jalz.2013.03.005; Yang C, 2018, MED SCI MONITOR, V24, P6882, DOI 10.12659/MSM.909353; Yumura W, 2006, HISTOL HISTOPATHOL, V21, P1151, DOI 10.14670/HH-21.1151; Zhang KX, 2014, CLIN EXP PHARMACOL P, V41, P965, DOI 10.1111/1440-1681.12328	69	7	7	3	7	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	MAY 21	2020	11								438	10.3389/fneur.2020.00438			10	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	LW9FI	WOS:000539447100001	32508743	Green Published, gold			2022-02-06	
J	Green, W; Shahzad, MW; Wood, S; Martinez, MM; Baines, A; Navid, A; Jay, R; Whysall, Z; Sandars, JE; Patel, R				Green, William; Shahzad, Muhammad Waseem; Wood, Stephen; Martinez, Maria Martinez; Baines, Andrew; Navid, Ahmad; Jay, Robert; Whysall, Zara; Sandars, John E.; Patel, Rakesh			Improving junior doctor medicine prescribing and patient safety: An intervention using personalised, structured, video-enhanced feedback and deliberate practice	BRITISH JOURNAL OF CLINICAL PHARMACOLOGY			English	Article						avoidable harm; deliberate practice; foundation training; junior doctors; patient safety; prescribing; video-enhanced feedback	TRAUMATIC BRAIN-INJURY; EDUCATIONAL INTERVENTIONS; PRESCRIPTION ERRORS; EXPERT-PERFORMANCE; MEDICATION ERRORS; RANDOMIZED-TRIAL; PRIMARY-CARE; ACQUISITION; SKILLS; MULTICENTER	Aims This research investigated the effectiveness of an intervention for improving the prescribing and patient safety behaviour among Foundation Year doctors. The intervention consisted of simulated clinical encounters with subsequent personalised, structured, video-enhanced feedback and deliberate practice, undertaken at the start of four-month sub-specialty rotations. Methods Three prospective, non-randomised control intervention studies were conducted, within two secondary care NHS Trusts in England. The primary outcome measure, error rate per prescriber, was calculated using daily prescribing data. Prescribers were grouped to enable a comparison between experimental and control conditions using regression analysis. A break-even analysis evaluated cost-effectiveness. Results There was no significant difference in error rates of novice prescribers who received the intervention when compared with those of experienced prescribers. Novice prescribers not participating in the intervention had significantly higher error rates (P = .026, 95% confidence interval [CI] Wald 0.093 to 1.436; P = .026, 95% CI 0.031 to 0.397) and patients seen by them experienced significantly higher prescribing error rates (P = .007, 95% CI 0.025 to 0.157). Conversely, patients seen by the novice prescribers who received the intervention experienced a significantly lower rate of significant errors compared to patients seen by the experienced prescribers (P = .04, 95% CI -0.068 to -0.001). The break-even analysis demonstrates cost-effectiveness for the intervention. Conclusion Simulated clinical encounters using personalised, structured, video-enhanced feedback and deliberate practice improves the prescribing and patient safety behaviour of Foundation Year doctors. The intervention is cost-effective with potential to reduce avoidable harm.	[Green, William; Shahzad, Muhammad Waseem; Wood, Stephen] Univ Leicester, Sch Business, Leicester LE1 7RH, Leics, England; [Martinez, Maria Martinez] Univ Hosp Leicester UHL NHS Trust, Leicester Gen Hosp, Leicester, Leics, England; [Baines, Andrew] United Lincolnshire Hosp ULH NHS Trust, Pilgrim Hosp Boston, Boston, Lincs, England; [Navid, Ahmad] Univ Hosp Birmingham NHS Fdn Trust, Queen Elizabeth Hosp Birmingham, Birmingham, W Midlands, England; [Jay, Robert; Patel, Rakesh] Univ Nottingham, Sch Med, Nottingham, England; [Whysall, Zara] Nottingham Trent Univ, Nottingham Business Sch, Dept Human Resource Management, Nottingham, England; [Sandars, John E.] Edge Hill Univ, Hlth Res Inst, Fac Hlth Social Care & Med, Ormskirk, Lancs, England		Green, W (corresponding author), Univ Leicester, Sch Business, Leicester LE1 7RH, Leics, England.	w.green@leicester.ac.uk	Patel, Rakesh/ABH-2246-2021; Green, William/R-6576-2016	Patel, Rakesh/0000-0002-5770-328X; Shahzad, Muhammad Waseem/0000-0002-6003-6000; Whysall, Zara/0000-0001-5833-9486; Sandars, John/0000-0003-3930-387X; Jay, Robert/0000-0001-7233-7874; Green, William/0000-0003-4161-4490	Academic Health Science Network; Health Education England [LEI0085]; National Institute for Health ResearchNational Institute for Health Research (NIHR); Pfizer UKPfizer	Academic Health Science Network, Grant/Award Number: Funding for Study 2 and 3; Health Education England, Grant/Award Number: LEI0085; National Institute for Health Research, Grant/Award Number: R.P.'s academic clinical lecturership; Pfizer UK, Grant/Award Number: Unrestricted Medical Education Grant (Study 1)	Aggarwal R, 2010, QUAL SAF HEALTH CARE, V19, DOI 10.1136/qshc.2009.038562; Angrist J, 2008, MOSTLY HARMLESS ECON, DOI [DOI 10.2307/J.CTVCM4J72, 10.2307/j.ctvcm4j72]; Avery AJ, 2012, LANCET, V379, P1310, DOI 10.1016/S0140-6736(11)61817-5; Backstein D, 2004, AM J SURG, V187, P427, DOI 10.1016/j.amjsurg.2003.12.011; Backstein D, 2005, CAN J SURG, V48, P195; Bannan DF, 2019, RES SOC ADMIN PHARM, V15, P546, DOI 10.1016/j.sapharm.2018.07.007; Basey AJ, 2014, BMJ QUAL SAF, V23, P17, DOI 10.1136/bmjqs-2013-001978; Birkmeyer JD, 2013, NEW ENGL J MED, V369, P1434, DOI 10.1056/NEJMsa1300625; Brennan N, 2013, BRIT J CLIN PHARMACO, V75, P359, DOI 10.1111/j.1365-2125.2012.04397.x; British Medical Association (BMA), 2018, ACT TEST RES EL WORL; British Pharmacological Society (BPS), 2019, PRESCR SAF ASS; Carayon P, 2010, STUD HEALTH TECHNOL, V153, P23, DOI 10.3233/978-1-60750-533-4-23; Charlton R, 2007, LEARNING TO CONSULT, P124; Claesson CB, 1995, INT J PHARM PRACT, V3, P151, DOI DOI 10.1111/j.2042-7174.1995.tb00809.x; Dean B, 2000, QUAL HEALTH CARE, V9, P232, DOI 10.1136/qhc.9.4.232; Dornan T., 2009, IN DEPTH INVESTIGATI IN DEPTH INVESTIGATI; Duvivier RJ, 2011, BMC MED EDUC, V11, DOI 10.1186/1472-6920-11-101; East Midlands Local Education and Training Board (EMLETB), 2017, POSTGR MED ED E MIDL; Ericsson KA, 2015, ACAD MED, V90, P1471, DOI 10.1097/ACM.0000000000000939; Ericsson KA, 2008, ACAD EMERG MED, V15, P988, DOI 10.1111/j.1553-2712.2008.00227.x; Eva KW, 2012, ADV HEALTH SCI EDUC, V17, P15, DOI 10.1007/s10459-011-9290-7; Farquharson AL, 2013, BRIT J SURG, V100, P1448, DOI 10.1002/bjs.9237; Firth-Cozen J, 2004, QUAL SAF HEALTH CARE, V13, P165, DOI 10.1136/qshc.2002.002725; FOLLI HL, 1987, PEDIATRICS, V79, P718; Hachambachari Y, 2013, J FAMILY MED, V7, P224; Hattie J, 2007, REV EDUC RES, V77, P81, DOI 10.3102/003465430298487; Hutchinson L, 1999, BRIT MED J, V318, P1267; Issenberg SB, 2005, MED TEACH, V27, P10, DOI 10.1080/01421590500046924; Issenberg SB, 2002, TEACH LEARN MED, V14, P223, DOI 10.1207/S15328015TLM1404_4; Issenberg SB, 1999, ACAD MED, V74, pS93, DOI 10.1097/00001888-199910000-00051; Jamtvedt G, 2006, QUAL SAF HEALTH CARE, V15, P433, DOI 10.1136/qshc.2006.018549; Kaltenthaler E, 2018, PREVALENCE EC BURDEN; Kamarudin G, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003291; Khoja T., 2011, Eastern Mediterranean Health Journal, V17, P156; Kirkham D, 2015, CLIN TEACH, V12, P187, DOI 10.1111/tct.12281; Lagerlov P, 2000, QUAL HEALTH CARE, V9, P159, DOI 10.1136/qhc.9.3.159; LESAR TS, 1990, JAMA-J AM MED ASSOC, V263, P2329, DOI 10.1001/jama.263.17.2329; Lesar TS, 1997, JAMA-J AM MED ASSOC, V277, P312, DOI 10.1001/jama.277.4.312; Lesar TS, 1997, ARCH INTERN MED, V157, P1569, DOI 10.1001/archinte.157.14.1569; Makary MA, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i2139; Maloney Stephen, 2016, Adv Simul (Lond), V1, P13, DOI 10.1186/s41077-016-0020-3; Marsden E, 2012, OXFORD REV EDUC, V38, P583, DOI 10.1080/03054985.2012.731208; McGraw-Hunter M, 2006, BRAIN INJURY, V20, P1061, DOI 10.1080/02699050600912163; McManus IC, 2004, BMC MED, V2, DOI 10.1186/1741-7015-2-29; Merten H, 2017, BMJ-BRIT MED J, V359, DOI 10.1136/bmj.j4328; Molloy E, 2020, MED EDUC, V54, P33, DOI 10.1111/medu.13802; Naik ND, 2018, SURGERY, V163, P921, DOI 10.1016/j.surg.2017.11.006; Nesbitt CI, 2015, J SURG EDUC, V72, P697, DOI 10.1016/j.jsurg.2014.12.013; Parker H, 2019, BRIT J CLIN PHARMACO, V85, P2405, DOI 10.1111/bcp.14065; Patanwala AE, 2012, ANN EMERG MED, V59, P369, DOI 10.1016/j.annemergmed.2011.11.013; Patel K, 2016, EUR J HOSP PHARM, V23, P294, DOI 10.1136/ejhpharm-2016-000915; Patel R, 2015, EUR J HOSP PHARM, V22, P291, DOI 10.1136/ejhpharm-2014-000620; Phillips AW, 2017, J SURG EDUC, V74, P612, DOI 10.1016/j.jsurg.2016.12.003; Reynolds M, 2017, BMJ QUAL SAF, V26, P240, DOI 10.1136/bmjqs-2015-004717; Ross S, 2013, BMJ QUAL SAF, V22, P97, DOI 10.1136/bmjqs-2012-001175; Ross S, 2009, BRIT J CLIN PHARMACO, V67, P662, DOI 10.1111/j.1365-2125.2009.03395.x; Royal College of Physicians (RCP), 2015, WARD ROUNDS MED PRIN; Schmidt J, 2013, NEUROREHAB NEURAL RE, V27, P316, DOI 10.1177/1545968312469838; Sullivan KM, 2013, BMJ QUAL SAF, V22, P256, DOI 10.1136/bmjqs-2012-001089; Thomas AN, 2008, QUAL SAF HEALTH CARE, V17, P360, DOI 10.1136/qshc.2007.023242; Tonelli M, 2018, JAMA NETW OPEN, V1, DOI 10.1001/jamanetworkopen.2018.4852; Tully MP, 2006, PATIENT SAFETY RES P; Westbrook JI, 2018, BMJ QUAL SAF, V27, P655, DOI 10.1136/bmjqs-2017-007333; Westbrook JI, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001164; WINFREY ML, 1993, PERCEPT MOTOR SKILL, V77, P907, DOI 10.2466/pms.1993.77.3.907; World Health Organization, 2017, WHO GLOB PAT SAF CHA; World Health Organization (WHO), 2017, WHOHISSDS201711; Zavaleta-Bustos M, 2008, REV BRAS CIENC FARM, V44, P115, DOI 10.1590/S1516-93322008000100013	68	7	7	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0306-5251	1365-2125		BRIT J CLIN PHARMACO	Br. J. Clin. Pharmacol.	NOV	2020	86	11					2234	2246		10.1111/bcp.14325		MAY 2020	13	Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	OD5CN	WOS:000533436800001	32343422	Green Published, hybrid, Green Accepted, Green Submitted			2022-02-06	
J	Sandera, AM; Clark, AN; Arciniegas, DB; Tran, K; Leon-Novelo, L; Ngan, E; Bogaards, J; Sherer, M; Walser, R				Sandera, Angelle M.; Clark, Allison N.; Arciniegas, David B.; Tran, Kim; Leon-Novelo, Luis; Ngan, Esther; Bogaards, Jay; Sherer, Mark; Walser, Robyn			A randomized controlled trial of acceptance and commitment therapy for psychological distress among persons with traumatic brain injury	NEUROPSYCHOLOGICAL REHABILITATION			English	Article						Traumatic brain injury; psychological distress; psychotherapy; psychotherapy trial	COGNITIVE-BEHAVIORAL THERAPY; SCHEDULED TELEPHONE INTERVENTION; PARTICIPATION ASSESSMENT; 1ST YEAR; ANXIETY; DEPRESSION; EFFICACY; DISORDERS; REHABILITATION; PSYCHOTHERAPY	Psychological distress is common in persons with traumatic brain injury (TBI) but treatments remain underdeveloped. This randomized controlled trial of Acceptance and Commitment Therapy (ACT) was designed to address this gap. Ninety-three persons with medically-documented complicated mild to severe TBI, normal-to-mildly impaired memory, and clinically significant psychological distress in the chronic phase of recovery were randomized to receive eight weeks of ACT (manualized with adaptations to address TBI-related cognitive impairments) or a single session of needs assessment, brief counseling/education, and referral. The ACT group showed significantly greater reduction of psychological distress (Brief Symptom Inventory 18) and demonstrated improvements in psychological flexibility and commitment to action (Acceptance and Action Questionnaire-II (AAQ-II) scores). The number of treatment responders (post-treatment BSI 18 GSI T scores <63) was larger in the ACT group than in the control group. Entry of AAQ-II scores into the model of between-group differences in BSI 18 GSI T scores indicated that core ACT processes explained the variance in treatment group outcomes. Provision of ACT reduces psychological distress in persons with TBI in the chronic phase of recovery when adaptations are made to accommodate TBI-related cognitive impairments. Additional clinical trials with a structurally equivalent control group are needed.	[Sandera, Angelle M.; Clark, Allison N.] Baylor Coll Med, H Ben Taub Dept Phys Med & Rehabil, Houston, TX 77030 USA; [Sandera, Angelle M.; Clark, Allison N.; Arciniegas, David B.; Tran, Kim; Bogaards, Jay; Sherer, Mark] TIRR Mem Hermann, Brain Injury Res Ctr, Houston, TX USA; [Sandera, Angelle M.; Clark, Allison N.] Harris Hlth Syst, Dept Phys Med & Rehabil, Houston, TX USA; [Arciniegas, David B.] Univ Colorado, Marcus Inst Brain Hlth, Denver, CO 80202 USA; [Leon-Novelo, Luis; Ngan, Esther] Univ Texas Hlth Sci Ctr Houston, Sch Publ Hlth, Dept Biostat & Data Sci, Houston, TX 77030 USA; [Walser, Robyn] Natl Ctr Posttraumat Stress Disorder, Palo Alto, CA USA		Sandera, AM (corresponding author), TIRR Mem Hermann Res Ctr, 1333 Moursund St, Houston, TX 77030 USA.	asander@bcm.edu			National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR)United States Department of Health & Human Services [90DPTB0016, 90DP0028]	The contents of this publication were developed under grants from the National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR; grant numbers 90DPTB0016 and 90DP0028-Traumatic Brain Injury Model Systems). NIDILRR is a Center within the Administration for Community Living (ACL), Department of Health and Human Services (HHS). The contents of this publication do not necessarily represent the policy or official views of NIDILRR, ACL, or HHS, and you should not assume endorsement by the Federal Government.	A-Tjak JGL, 2015, PSYCHOTHER PSYCHOSOM, V84, P30, DOI 10.1159/000365764; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; Anson K, 2006, BRAIN INJURY, V20, P167, DOI 10.1080/02699050500442956; Appleton S, 2011, BRAIN IMPAIR, V12, P210; Arch JJ, 2012, BEHAV RES THER, V50, P469, DOI 10.1016/j.brat.2012.04.007; Ashman TA, 2004, ARCH PHYS MED REHAB, V85, pS36, DOI 10.1016/j.apmr.2003.08.117; Ashman T, 2014, J HEAD TRAUMA REHAB, V29, P467, DOI 10.1097/HTR.0000000000000098; Backhaus SL, 2010, ARCH PHYS MED REHAB, V91, P840, DOI 10.1016/j.apmr.2010.03.015; Bell KR, 2011, ARCH PHYS MED REHAB, V92, P1552, DOI 10.1016/j.apmr.2011.05.018; Bluett EJ, 2014, J ANXIETY DISORD, V28, P612, DOI 10.1016/j.janxdis.2014.06.008; Bogner JA, 2011, ARCH PHYS MED REHAB, V92, P552, DOI 10.1016/j.apmr.2010.11.014; Bohlmeijer ET, 2011, BEHAV RES THER, V49, P62, DOI 10.1016/j.brat.2010.10.003; Bombardier CH, 2010, JAMA-J AM MED ASSOC, V303, P1938, DOI 10.1001/jama.2010.599; Bombardier CH, 2009, J HEAD TRAUMA REHAB, V24, P230, DOI 10.1097/HTR.0b013e3181ad65f0; Bomyea J, 2017, J HEAD TRAUMA REHAB, V32, pE35, DOI 10.1097/HTR.0000000000000278; Bond FW, 2011, BEHAV THER, V42, P676, DOI 10.1016/j.beth.2011.03.007; Brenner LA, 2018, J HEAD TRAUMA REHAB, V33, pE64, DOI 10.1097/HTR.0000000000000351; Derogatis L.R., 2001, BRIEF SYMPTOM INVENT; Fann JR, 2015, J NEUROTRAUM, V32, P45, DOI 10.1089/neu.2014.3423; Forman EM, 2007, BEHAV MODIF, V31, P772, DOI 10.1177/0145445507302202; Friedman LM, 2010, FUNDAMENTALS OF CLINICAL TRIALS, FOURTH EDITION, P1, DOI 10.1007/978-1-4419-1586-3_1; Gallagher M, 2019, NEUROPSYCHOL REHABIL, V29, P1, DOI 10.1080/09602011.2016.1258367; Gomez-de-Regil L, 2019, BEHAV NEUROL, V2019, DOI 10.1155/2019/6937832; Gould KR, 2011, PSYCHOL MED, V41, P2099, DOI 10.1017/S003329171100033X; Hart T, 2008, NEUROPSYCHOL REHABIL, V18, P1, DOI 10.1080/09602010601082359; Hart T, 2020, NEUROPSYCHOL REHABIL, V30, P1523, DOI 10.1080/09602011.2019.1592761; Hart T, 2016, ARCH PHYS MED REHAB, V97, P701, DOI 10.1016/j.apmr.2015.08.436; Hart T, 2011, ARCH PHYS MED REHAB, V92, P1211, DOI 10.1016/j.apmr.2011.03.005; Hayes SA, 2010, BEHAV RES THER, V48, P238, DOI 10.1016/j.brat.2009.11.006; Hayes SC, 2004, PSYCHOL REC, V54, P553, DOI 10.1007/BF03395492; Hayes SC, 2006, BEHAV RES THER, V44, P1, DOI 10.1016/j.brat.2005.06.006; Hays S. C., 2012, ACCEPTANCE COMMITMEN; Hsieh MY, 2012, NEUROPSYCHOL REHABIL, V22, P585, DOI 10.1080/09602011.2012.678860; Kangas M, 2011, NEUROPSYCHOL REHABIL, V21, P250, DOI 10.1080/09602011.2010.540920; Karlin BE, 2013, AGING MENT HEALTH, V17, P555, DOI 10.1080/13607863.2013.789002; Lappalainen R, 2007, BEHAV MODIF, V31, P488, DOI 10.1177/0145445506298436; Lezak MD., 1983, NEUROPSYCHOLOGICAL A, V2nd ed.; Lezak MD, 1976, NEUROPSYCHOLOGICAL A; Liu ZQ, 2018, J NEUROSURG SCI, V62, P24, DOI 10.23736/S0390-5616.17.03953-4; Meachen SJ, 2008, ARCH PHYS MED REHAB, V89, P958, DOI 10.1016/j.apmr.2007.12.028; Osborn AJ, 2016, NEUROPSYCHOLOGY, V30, P247, DOI 10.1037/neu0000221; Osborn AJ, 2014, NEUROSCI BIOBEHAV R, V47, P1, DOI 10.1016/j.neubiorev.2014.07.007; Ponsford J, 2016, PSYCHOL MED, V46, P1079, DOI 10.1017/S0033291715002640; Ponsford J, 2011, J NEUROTRAUM, V28, P937, DOI 10.1089/neu.2010.1516; Posner K, 2011, AM J PSYCHIAT, V168, P1266, DOI 10.1176/appi.ajp.2011.10111704; Prigatano G.P., 1999, PRINCIPLES NEUROPSYC; PRIGATANO GP, 1989, B MENNINGER CLIN, V53, P414; Rey A, 1958, LEXAMEN CLINIQUE PSY; Roemer L, 2007, BEHAV THER, V38, P72, DOI 10.1016/j.beth.2006.04.004; Roemer L, 2008, J CONSULT CLIN PSYCH, V76, P1083, DOI 10.1037/a0012720; Ruiz FJ., 2010, INT J PSYCHOL PSYCHO, V10, P125, DOI DOI 10.1080/028457199439937; SAUNDERS JB, 1993, ADDICTION, V88, P791, DOI 10.1111/j.1360-0443.1993.tb02093.x; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P22, DOI 10.4088/JCP.09m05305whi; Simpson GK, 2011, J HEAD TRAUMA REHAB, V26, P290, DOI 10.1097/HTR.0b013e3182225250; Soo C, 2011, BRAIN IMPAIR, V12, P54, DOI 10.1375/brim.12.1.54; TEASDALE G, 1974, LANCET, V2, P81; Tiersky LA, 2005, ARCH PHYS MED REHAB, V86, P1565, DOI 10.1016/j.apmr.2005.03.013; Waldron B, 2013, NEUROPSYCHOL REHABIL, V23, P64, DOI 10.1080/09602011.2012.724196; Walser RD, 2015, BEHAV RES THER, V74, P25, DOI 10.1016/j.brat.2015.08.012; Whiteneck GG, 2011, ARCH PHYS MED REHAB, V92, P542, DOI 10.1016/j.apmr.2010.08.002; Whiting D, 2020, NEUROPSYCHOL REHABIL, V30, P1348, DOI 10.1080/09602011.2019.1583582; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014; Zettle R D, 1986, Anal Verbal Behav, V4, P30; ZETTLE RD, 1989, J CLIN PSYCHOL, V45, P436, DOI 10.1002/1097-4679(198905)45:3<436::AID-JCLP2270450314>3.0.CO;2-L; Zettle RD, 2011, BEHAV MODIF, V35, P265, DOI 10.1177/0145445511398344	65	7	7	3	12	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0960-2011	1464-0694		NEUROPSYCHOL REHABIL	Neuropsychol. Rehabil.	AUG 9	2021	31	7					1105	1129		10.1080/09602011.2020.1762670		MAY 2020	25	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychology	SS3KN	WOS:000534901500001	32408846				2022-02-06	
J	Tchantchou, F; Goodfellow, M; Li, FY; Ramsue, L; Miller, C; Puche, A; Fiskum, G				Tchantchou, Flaubert; Goodfellow, Molly; Li, Fengying; Ramsue, Lyric; Miller, Catriona; Puche, Adam; Fiskum, Gary			Hyperhomocysteinemia-Induced Oxidative Stress Exacerbates Cortical Traumatic Brain Injury Outcomes in Rats	CELLULAR AND MOLECULAR NEUROBIOLOGY			English	Article						Heterogeneity; Hyperhomocysteinemia; Pathophysiology; Stress; Traumatic-brain injury	VON-WILLEBRAND-FACTOR; IMPROVES FUNCTIONAL RECOVERY; ENDOTHELIAL DYSFUNCTION; HOMOCYSTEINE LEVELS; SERUM HOMOCYSTEINE; VASCULAR-DISEASE; ISCHEMIC-STROKE; MOUSE MODEL; HEAD-INJURY; INFLAMMATION	Traumatic brain injury (TBI) is a leading cause of morbidity and mortality among military service members and civilians in the United States. Despite significant advances in the understanding of TBI pathophysiology, several clinical reports indicate that multiple genetic and epigenetic factors can influence outcome. Homocysteine (HCY) is a non-proteinogenic amino acid, the catabolism of which can be dysregulated by stress, lifestyle, aging, or genetic abnormalities leading to hyperhomocysteinemia (HHCY). HHCY is a neurotoxic condition and a risk factor for multiple neurological and cardiovascular disorders that occurs when HCY levels is clinically > 15 mu M. Although the deleterious impact of HHCY has been studied in human and animal models of neurological disorders such as stroke, Alzheimer's disease and Parkinson's disease, it has not been addressed in TBI models. This study tested the hypothesis that HHCY has detrimental effects on TBI pathophysiology. Moderate HHCY was induced in adult male Sprague Dawley rats via daily administration of methionine followed by impact-induced traumatic brain injury. In this model, HHCY increased oxidative stress, upregulated expression of proteins that promote blood coagulation, exacerbated TBI-associated blood-brain barrier dysfunction and promoted the infiltration of inflammatory cells into the cortex. We also observed an increase of brain injury-induced lesion size and aggravated anxiety-like behavior. These findings show that moderate HHCY exacerbates TBI outcomes and suggest that HCY catabolic dysregulation may be a significant biological variable that could contribute to TBI pathophysiology heterogeneity.	[Tchantchou, Flaubert; Goodfellow, Molly; Li, Fengying; Ramsue, Lyric; Fiskum, Gary] Univ Maryland, Sch Med, Dept Anesthesiol, 685 W Baltimore St, Baltimore, MD 21201 USA; [Tchantchou, Flaubert; Goodfellow, Molly; Li, Fengying; Ramsue, Lyric; Fiskum, Gary] Univ Maryland, Sch Med, Ctr Shock Trauma & Anesthesiol Res STAR, 685 W Baltimore St, Baltimore, MD 21201 USA; [Miller, Catriona] US Air Force Sch Aerosp Med, Aeromed Res, Dayton, OH USA; [Puche, Adam] Univ Maryland, Sch Med, Dept Anat & Neurobiol, Baltimore, MD 21201 USA		Tchantchou, F (corresponding author), Univ Maryland, Sch Med, Dept Anesthesiol, 685 W Baltimore St, Baltimore, MD 21201 USA.; Tchantchou, F (corresponding author), Univ Maryland, Sch Med, Ctr Shock Trauma & Anesthesiol Res STAR, 685 W Baltimore St, Baltimore, MD 21201 USA.	ftchantchou@som.umaryland.edu	Goodfellow, Molly/V-9947-2019		U. S Air Force [FA8650-17-2-6H10]	This study was funded by the U. S Air Force (Grant #FA8650-17-2-6H10).	ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; Ansari MA, 2008, FREE RADICAL BIO MED, V45, P443, DOI 10.1016/j.freeradbiomed.2008.04.038; Austin RC, 2004, CELL DEATH DIFFER, V11, pS56, DOI 10.1038/sj.cdd.4401451; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Cavaglia M, 2004, ANN THORAC SURG, V78, P1418, DOI 10.1016/j.athoracsur.2004.04.036; Cavalca V, 2001, CLIN CHEM, V47, P887; de Lima DS, 2017, AMINO ACIDS, V49, P337, DOI 10.1007/s00726-016-2365-2; Chung KH, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08568-9; Cooke JP, 2000, ARTERIOSCL THROM VAS, V20, P2032, DOI 10.1161/01.ATV.20.9.2032; Coppola A, 2000, SEMIN THROMB HEMOST, V26, P243, DOI 10.1055/s-2000-8469; Darwish H, 2012, BRAIN INJURY, V26, P1763, DOI [10.3109/02699052.2012.741452, 10.3109/02699052.2011.635362]; de Boer P, 2015, NAT METHODS, V12, P503, DOI 10.1038/nmeth.3400; De Oliveira CO, 2007, J NEUROTRAUM, V24, P1331, DOI 10.1089/neu.2006.0159; Dehdar K, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-55539-3; Di Lorenzo A, 2011, BLOOD, V117, P2284, DOI 10.1182/blood-2010-04-281956; Domagala T B, 1998, J Cardiovasc Risk, V5, P239, DOI 10.1097/00043798-199808000-00006; dos Santos TM, 2019, CELL MOL NEUROBIOL, V39, P687, DOI 10.1007/s10571-019-00674-8; Einarsen CE, 2018, WORLD NEUROSURG, V114, pE1199, DOI 10.1016/j.wneu.2018.03.176; Endres M, 2005, STROKE, V36, P321, DOI 10.1161/01.STR.0000153008.60517.ab; Evers S, 1997, ARCH NEUROL-CHICAGO, V54, P1276, DOI 10.1001/archneur.1997.00550220074017; Failla MD, 2015, J HEAD TRAUMA REHAB, V30, pE54, DOI 10.1097/HTR.0000000000000118; Faul Mark NC for IP Control (U.S.), 2010, TRAUMATIC BRAIN INJU; Folstein M, 2007, AM J PSYCHIAT; Forrester SJ, 2018, CIRC RES, V122, P877, DOI 10.1161/CIRCRESAHA.117.311401; Frost RB, 2013, NEUROEPIDEMIOLOGY, V40, P154, DOI 10.1159/000343275; Fukada S, 2006, BIOSCI BIOTECH BIOCH, V70, P2403, DOI 10.1271/bbb.60130; Garcia A, 2004, CAN MED ASSOC J, V171, P897, DOI 10.1503/cmaj.1031586; Garton T, 2016, STROKE VASC NEUROL, V1, P172, DOI 10.1136/svn-2016-000042; Goldsworthy MR, 2013, J NEUROSCI, V33, P12910, DOI 10.1523/JNEUROSCI.2252-13.2013; Harris RA, 2010, NAT BIOTECHNOL, V28, P1097, DOI 10.1038/nbt.1682; Hohsfield LA, 2010, CURR NEUROVASC RES, V7, P192; Holmin S, 1998, NEUROSURGERY, V42, P291, DOI 10.1097/00006123-199802000-00047; Jha RM, 2018, J NEUROL NEUROSUR PS, V89, P1152, DOI 10.1136/jnnp-2017-317741; Kade Grzegorz, 2012, Med Sci Monit, V18, pCR771; Kamat PK, 2016, MOL NEUROBIOL, V53, P2451, DOI 10.1007/s12035-015-9212-4; Kamath AF, 2006, BLOOD, V107, P591, DOI 10.1182/blood-2005-06-2506; Khatri N, 2018, CNS NEUROL DISORD-DR, V17, P689, DOI 10.2174/1871527317666180627120501; Kim LH, 2018, NEUROSURG FOCUS, V45, DOI 10.3171/2018.9.FOCUS18369; Kramer TJ, 2018, BMC NEUROSCI, V19, DOI 10.1186/s12868-018-0481-5; Kuriakose M, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-44147-w; Lazzari MA, 2012, HEMATOLOGY, V17, pS150, DOI 10.1179/102453312X13336169156618; Lee R, 2003, HEMATOL ONCOL CLIN N, V17, P85, DOI 10.1016/S0889-8588(02)00090-4; Lee WC, 2012, BIOCHEM BIOPH RES CO, V425, P842, DOI 10.1016/j.bbrc.2012.08.002; Lehner C, 2011, ANTIOXID REDOX SIGN, V15, P1305, DOI 10.1089/ars.2011.3923; Lip GYH, 1997, CARDIOVASC RES, V34, P255, DOI 10.1016/S0008-6363(97)00039-4; Liu Y, 2011, BLOOD, V172, P7; Maltsev AV, 2011, AGEING RES REV, V10, P440, DOI 10.1016/j.arr.2011.03.002; Mammana S, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19030831; Margulies S, 2009, J NEUROTRAUM, V26, P925, DOI [10.1089/neu.2008.0794, 10.1089/neu.2008-0794]; Mollayeva Tatyana, 2018, Concussion, V3, pCNC51, DOI 10.2217/cnc-2017-0015; Mudd SH, 2011, AM J MED GENET C, V157C, P3, DOI 10.1002/ajmg.c.30293; Nilsson K, 2007, DEMENT GERIATR COGN, V24, P162, DOI 10.1159/000105562; Papatheodorou L, 2007, ANTIOXID REDOX SIGN, V9, P1941, DOI 10.1089/ars.2007.1750; de la Ossa NP, 2010, STROKE, V41, P810, DOI 10.1161/STROKEAHA.109.570168; Perna AF, 2003, AMINO ACIDS, V25, P409, DOI 10.1007/s00726-003-0026-8; Pirchl M, 2010, EUR J NEUROSCI, V32, P1516, DOI 10.1111/j.1460-9568.2010.07434.x; Price BR, 2018, FRONT AGING NEUROSCI, V10, DOI 10.3389/fnagi.2018.00350; Rabinowitz AR, 2015, J NEUROTRAUM, V32, P1488, DOI 10.1089/neu.2014.3555; Rahmani A, 2016, WORLD NEUROSURG, V87, P507, DOI 10.1016/j.wneu.2015.09.016; Reddy VS, 2019, BIOCHIMIE, V165, P19, DOI 10.1016/j.biochi.2019.06.017; REES MM, 1993, THROMB RES, V71, P337, DOI 10.1016/0049-3848(93)90160-P; Rodriguez-Rodriguez A, 2014, CURR MED CHEM, V21, P1201, DOI 10.2174/0929867321666131217153310; Rosenberg GA, 2012, J CEREBR BLOOD F MET, V32, P1139, DOI 10.1038/jcbfm.2011.197; Royo NC, 1999, NEUROREPORT, V10, P1363, DOI 10.1097/00001756-199904260-00038; Sadler JE, 2005, J THROMB HAEMOST, V3, P1702, DOI 10.1111/j.1538-7836.2005.01369.x; Sang KN, 2018, MOL PAIN, V14, DOI 10.1177/1744806918783931; Scafidi S, 2010, DEV NEUROSCI-BASEL, V32, P480, DOI 10.1159/000323178; Schouten JW, 2007, CURR OPIN CRIT CARE, V13, P134, DOI 10.1097/MCC.0b013e3280895d5c; Schretlen DJ, 2003, INT REV PSYCHIATR, V15, P341, DOI 10.1080/09540260310001606728; Selhub J, 1999, ANNU REV NUTR, V19, P217, DOI 10.1146/annurev.nutr.19.1.217; Seshadri S, 2008, ARCH NEUROL-CHICAGO, V65, P642, DOI 10.1001/archneur.65.5.642; Sevenich L, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00697; Smith NM, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1227-0; Soares HD, 1995, J NEUROSCI, V15, P8223; Solleiro-Villavicencio H, 2018, FRONT CELL NEUROSCI, V12, DOI 10.3389/fncel.2018.00114; Tchantchou F, 2007, FASEB J, V21, P2400, DOI 10.1096/fj.06-7649com; Tchantchou F, 2006, J ALZHEIMERS DIS, V9, P421; Tchantchou F, 2018, J NEUROTRAUM, V35, P1192, DOI 10.1089/neu.2017.5401; Tchantchou F, 2017, EXP NEUROL, V289, P9, DOI 10.1016/j.expneurol.2016.12.001; Tchantchou F, 2014, NEUROPHARMACOLOGY, V85, P427, DOI 10.1016/j.neuropharm.2014.06.006; Tchantchou F, 2013, J NEUROTRAUM, V30, P565, DOI 10.1089/neu.2012.2647; Tucker KL, 2005, AM J CLIN NUTR, V82, P627; Tyagi N, 2005, AM J PHYSIOL-HEART C, V289, pH2649, DOI 10.1152/ajpheart.00548.2005; Undas A, 2005, THROMB HAEMOSTASIS, V94, P907, DOI 10.1160/TH05-05-0313; van der Naalt J, 1999, J NEUROL NEUROSUR PS, V66, P207, DOI 10.1136/jnnp.66.2.207; Vanderploeg RD, 2005, J INT NEUROPSYCH SOC, V11, P228, DOI 10.1017/S1355617705050289; Vegeto E, 2001, J NEUROSCI, V21, P1809, DOI 10.1523/JNEUROSCI.21-06-01809.2001; Wang BR, 2016, J STROKE CEREBROVASC, V25, P2746, DOI 10.1016/j.jstrokecerebrovasdis.2016.07.028; Worthylake RA, 2001, CURR OPIN CELL BIOL, V13, P569, DOI 10.1016/S0955-0674(00)00253-2; Yokota H, 2002, J NEUROTRAUM, V19, P1007, DOI 10.1089/089771502760341929; Zou CG, 2010, NEUROBIOL AGING, V31, P2069, DOI 10.1016/j.neurobiolaging.2008.11.007	91	7	8	0	4	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0272-4340	1573-6830		CELL MOL NEUROBIOL	Cell. Mol. Neurobiol.	APR	2021	41	3					487	503		10.1007/s10571-020-00866-7		MAY 2020	17	Cell Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Neurosciences & Neurology	QP7ZE	WOS:000532659300001	32405706				2022-02-06	
J	Salman, M; Tabassum, H; Parvez, S				Salman, Mohd; Tabassum, Heena; Parvez, Suhel			Tannic Acid Provides Neuroprotective Effects Against Traumatic Brain Injury Through the PGC-1 alpha/Nrf2/HO-1 Pathway	MOLECULAR NEUROBIOLOGY			English	Article						Traumatic brain injury; Oxidative stress; Inflammation; Tannic acid; PGC-1 alpha; Nrf2	OXIDATIVE STRESS; MITOCHONDRIAL-FUNCTION; RAT MODEL; CONFERS NEUROPROTECTION; MELATONIN; INFLAMMATION; EXPRESSION; OUTCOMES; PROTEIN; NRF2	The present research was conducted to elucidate a possible molecular mechanism related to neuromodulatory effects of tannic acid (TA) supplementation against traumatic brain injury (TBI) in a rodent model. Oxidative damage and neuroinflammation play a critical role in TBI and lead to behavioral alterations and neuronal dysfunction and death. These changes suggest a potential avenue in neurotherapeutic intervention. The aim of the present study was to investigate the neuroprotective effects of TA and potential mechanism of these effects in a controlled cortical impact injury model of TBI in Wistar rats that were treated with TA (50 mg/kg body weight. i.p.) before 30 min and 6 and 18 h after TBI. TBI-induced rats were examined after 24 h for behavioral dysfunction, Nissl stain, lipid peroxidation rate, glutathione level, activities of antioxidant enzymes (catalase, glutathione S-transferase, glutathione peroxidase, and superoxide dismutase), the expression level of 4-hydroxynonenal, pro-inflammatory cytokines such as tumor necrosis factor alpha and interleukin-1 beta, as well as brain edema and immunoreactivity of glial fibrillary acidic protein. Results indicated that TA supplementation significantly modulated above mentioned alterations. Moreover, TA treatment effectively upregulated the protein expression of peroxisome proliferator-activated receptor gamma co-activator 1 alpha (PGC-1 alpha) and nuclear factor-E2-related factor-2 (Nrf2) as well as mitochondrial transcription factor A and heme oxygenase-1 (HO-1) following TBI. Overall, our results suggest that TA effectively ameliorates the behavioral alterations, oxidative damage, mitochondrial impairment, and inflammation against TBI that may be attributed to activation of PGC-1 alpha/Nrf-2/HO-1 signaling pathway.	[Salman, Mohd; Parvez, Suhel] Jamia Hamdard, Dept Med Elementol & Toxicol, Sch Chem & Life Sci, New Delhi 110062, India; [Tabassum, Heena] Govt India, Div Biomed Sci, Minist Hlth & Family Welf, Indian Council Med Res, POB 4911, New Delhi 110029, India		Parvez, S (corresponding author), Jamia Hamdard, Dept Med Elementol & Toxicol, Sch Chem & Life Sci, New Delhi 110062, India.; Tabassum, H (corresponding author), Govt India, Div Biomed Sci, Minist Hlth & Family Welf, Indian Council Med Res, POB 4911, New Delhi 110029, India.	tabassum.h@icmr.gov.in; sparvez@jamiahamdard.ac.in	Salman, Mohd/AAN-8924-2021	Salman, Mohd/0000-0002-7330-8108	Indian Council of Medical Research, Government of IndiaIndian Council of Medical Research (ICMR) [3/1/2/4/Trauma/2019-NCD-1]; Department of Biotechnology, Ministry of Science and Technology, Government of India (DBT BioCARe Program) [BT/Bio-CARe/01/10219/2013-14]; DSTFIST prorgam from the Department of Science and Technology under Ministry of Science & Technology, Government of India [SR/FST/LS-I/2017/05(C), SR/PURSE Phase2/39 (C)]; DST-PURSE prorgam from the Department of Science and Technology under Ministry of Science & Technology, Government of India [SR/FST/LS-I/2017/05(C), SR/PURSE Phase2/39 (C)]	Mr. Mohd Salman is a recipient of Senior Research Fellowship from the Indian Council of Medical Research (File No. 3/1/2/4/Trauma/2019-NCD-1), Government of India. Dr. Heena Tabassum received financial grant from the Department of Biotechnology, Ministry of Science and Technology, Government of India (DBT BioCARe Program, sanction no. BT/Bio-CARe/01/10219/2013-14). The grant nos. [SR/FST/LS-I/2017/05(C)] and [SR/PURSE Phase2/39 (C)], received under DSTFIST and DST-PURSE prorgams from the Department of Science and Technology under Ministry of Science & Technology, Government of India are also acknowledged.	Agrawal R, 2015, BBA-MOL BASIS DIS, V1852, P862, DOI 10.1016/j.bbadis.2015.01.018; Anis E, 2020, PHYTOTHER RES, V34, P214, DOI 10.1002/ptr.6523; Ashafaq M, 2017, MOL NEUROBIOL, V54, P5941, DOI 10.1007/s12035-016-0096-8; Atalay T, 2017, TURK NEUROSURG, V27, P924, DOI 10.5137/1019-5149.JTN.17249-16.2; Bains M, 2012, BBA-MOL BASIS DIS, V1822, P675, DOI 10.1016/j.bbadis.2011.10.017; Casili G, 2018, J NEUROTRAUM, V35, P1437, DOI 10.1089/neu.2017.5260; Cebak JE, 2017, J NEUROTRAUM, V34, P1302, DOI 10.1089/neu.2016.4624; Chen XK, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0115462, 10.1371/journal.pone.0087752, 10.1371/journal.pone.0085716, 10.1371/journal.pone.0091830, 10.1371/journal.pone.0091809, 10.1371/journal.pone.0103330]; Corona JC, 2015, NEUROCHEM RES, V40, P308, DOI 10.1007/s11064-014-1377-0; Cullinan SB, 2004, MOL CELL BIOL, V24, P8477, DOI 10.1128/MCB.24.19.8477-8486.2004; Dai W, 2018, BRAIN RES BULL, V140, P65, DOI 10.1016/j.brainresbull.2018.03.020; Dash PK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024648; Di Pietro V, 2014, FREE RADICAL BIO MED, V69, P258, DOI 10.1016/j.freeradbiomed.2014.01.032; Dong N, 2017, EXP THER MED, V13, P3183, DOI 10.3892/etm.2017.4411; Erbil G, 2019, BRATISL MED J, V120, P372, DOI 10.4149/BLL_2019_061; Ge XH, 2018, METAB BRAIN DIS, V33, P1869, DOI 10.1007/s11011-018-0293-4; HABIG WH, 1974, J BIOL CHEM, V249, P7130; Harmon JL, 2017, J NEUROTRAUM, V34, P487, DOI 10.1089/neu.2015.4395; Ismael S, 2018, J NEUROTRAUM, V35, P1294, DOI 10.1089/neu.2017.5344; Krishna G, 2019, MOL NUTR FOOD RES, V63, DOI 10.1002/mnfr.201801055; Kurutas EB, 2016, NUTR J, V15, DOI 10.1186/s12937-016-0186-5; Le ZC, 2018, ACS APPL MATER INTER, V10, P42186, DOI 10.1021/acsami.8b18979; Lee JC, 2014, ANAT CELL BIOL, V47, P101, DOI [10.5115/acb.2014.47.3.149, 10.5115/acb.2014.47.2.101]; Li FY, 2019, J CELL BIOCHEM, V120, P14899, DOI 10.1002/jcb.28751; Li FY, 2018, NEUROPEPTIDES, V72, P58, DOI 10.1016/j.npep.2018.10.004; Li LT, 2017, CELL PHYSIOL BIOCHEM, V41, P2027, DOI 10.1159/000475433; Li X, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164237; Lin C, 2016, J PINEAL RES, V61, P177, DOI 10.1111/jpi.12337; Liu J, 2019, EXP THER MED, V18, P2437, DOI 10.3892/etm.2019.7859; Maynard ME, 2019, J NEUROTRAUM, V36, P2147, DOI 10.1089/neu.2018.6155; MOI P, 1994, P NATL ACAD SCI USA, V91, P9926, DOI 10.1073/pnas.91.21.9926; Naseem Mehar, 2014, ScientificWorldJournal, V2014, P586270, DOI 10.1155/2014/586270; Niu XL, 2018, MOL MED REP, V18, P4516, DOI 10.3892/mmr.2018.9465; Pandya JD, 2014, EXP NEUROL, V257, P106, DOI 10.1016/j.expneurol.2014.04.020; Picca A, 2014, BBA-GEN SUBJECTS, V1840, P2184, DOI 10.1016/j.bbagen.2014.03.004; Rasheed MZ, 2018, J ENVIRON PATHOL TOX, V37, P139, DOI 10.1615/JEnvironPatholToxicolOncol.2018025666; Robertson CL, 2015, J BIOENERG BIOMEMBR, V47, P43, DOI 10.1007/s10863-014-9585-5; SAVOLAINEN H, 1992, J APPL TOXICOL, V12, P191, DOI 10.1002/jat.2550120307; Scholpa NE, 2019, J NEUROTRAUM, V36, P962, DOI 10.1089/neu.2018.5669; Song D, 2018, BIOCHEM BIOPH RES CO, V503, P3078, DOI 10.1016/j.bbrc.2018.08.096; Soyocak A, 2019, HUM EXP TOXICOL, V38, P1296, DOI 10.1177/0960327119864154; Stevens MJ, 2000, DIABETES, V49, P1006, DOI 10.2337/diabetes.49.6.1006; Su Y, 2014, NEUROSCIENCE, V266, P56, DOI 10.1016/j.neuroscience.2014.02.006; Sweeney G, 2016, ANAT CELL BIOL, V49, P1, DOI 10.5115/acb.2016.49.1.1; Tabassum H, 2017, NEUROCHEM INT, V104, P11, DOI 10.1016/j.neuint.2016.12.010; Uttara B, 2009, CURR NEUROPHARMACOL, V7, P65, DOI 10.2174/157015909787602823; Wei G, 2017, NEUROIMMUNOMODULAT, V24, P348, DOI 10.1159/000487998; Winiarska-Mieczan A, 2013, ENVIRON TOXICOL PHAR, V36, P9, DOI 10.1016/j.etap.2013.02.018; Wu C, 2013, BIOCHEM BIOPH RES CO, V437, P469, DOI 10.1016/j.bbrc.2013.06.107; Wu HJ, 2016, J PINEAL RES, V61, P241, DOI 10.1111/jpi.12344; Xiang SY, 2017, MACROMOL RAPID COMM, V38, DOI 10.1002/marc.201700446; Xu X, 2017, BMC COMPLEM ALTERN M, V17, DOI 10.1186/s12906-017-1655-x; You Y, 2016, BRAIN RES, V1646, P34, DOI 10.1016/j.brainres.2016.04.076; Yu LM, 2017, SCI REP-UK, V7, DOI 10.1038/srep41337; Zhang GX, 2016, NEUROCHEM RES, V41, P2948, DOI 10.1007/s11064-016-2013-y; Zhang XJ, 2017, BIOL PHARM BULL, V40, P1490, DOI 10.1248/bpb.b17-00313; Zhou Y, 2015, J MOL NEUROSCI, V55, P941, DOI 10.1007/s12031-014-0449-6; Zhou Y, 2018, DRUG DES DEV THER, V12, P4117, DOI 10.2147/DDDT.S179227	58	7	7	0	16	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0893-7648	1559-1182		MOL NEUROBIOL	Mol. Neurobiol.	JUN	2020	57	6					2870	2885		10.1007/s12035-020-01924-3		MAY 2020	16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	LW8SJ	WOS:000532107300001	32399817				2022-02-06	
J	Chen, YH; Gong, K; Xu, QH; Meng, J; Long, TL; Chang, CC; Wang, ZX; Liu, W				Chen, Yuhua; Gong, Kai; Xu, Quanhua; Meng, Jiao; Long, Tianlin; Chang, Cuicui; Wang, Zhanxiang; Liu, Wei			Phosphoglycerate Mutase 5 Knockdown Alleviates Neuronal Injury After Traumatic Brain Injury Through Drp1-Mediated Mitochondrial Dysfunction	ANTIOXIDANTS & REDOX SIGNALING			English	Article						traumatic brain injury; PGAM5; Drp1; mitochondrial dysfunction; neuronal injury	CELL-DEATH; BARRIER DISRUPTION; PHOSPHATASE; MITOPHAGY; INFLAMMATION; DRP1; PATHOPHYSIOLOGY; NEUROPROTECTION; APOPTOSIS; AUTOPHAGY	Aims: Traumatic brain injury (TBI) is a major cause of disability and death, and a better understanding of the underlying mechanisms of mitochondrial dysfunction will provide important targets for preventing damage from neuronal insults. Phosphoglycerate mutase 5 (PGAM5) is localized to the mitochondrial outer-inner membrane contact sites, and the PGAM5-Drp1 pathway is involved in mitochondrial dysfunction and cell death. The purpose of this project was to evaluate the effects of PGAM5 on neuronal injury and mitochondrial dysfunction. Results: PGAM5 was overexpressed in mice subjected to TBI and in primary cortical neurons injured by mechanical equiaxial stretching. PGAM5 deficiency alleviated neuroinflammation, blocked Parkin, PINK1, and Drp1 translocation to mitochondria and abnormal phosphorylation of Drp1, mitochondrial ultrastructural changes, and nerve malfunction in TBI mouse model. PGAM5-shRNA (short hairpin RNA) reduced Drp1 translocation and activation, including dephosphorylation of p-Drp1 on Ser622 (human Drp1 Ser616) and phosphorylation of Drp1 on Ser643 (human Drp1 Ser637). The levels of inflammatory cytokines, the degree of mitochondrial impairment (mitochondrial membrane potential, ADP/ATP, AMP/ADP, antioxidant capacity), and neuronal injury in stretch-induced primary cortical neurons were reduced by blocking expression of PGAM5. The inhibition of PGAM5 is neuroprotective via attenuation of Drp1 activation, similar to that achieved by mitochondrial division inhibitor-1 (Mdivi1)-mediated Drp1 inhibition. Innovation and Conclusion: Our findings demonstrate the critical role of PGAM5 in progression of neuronal injury from TBI via Drp1 activation (dephosphorylation of p-Drp1 on Ser622 and phosphorylation of Drp1 on Ser643)-mediated mitochondrial dysfunction. The data may open a window for developing new drugs to prevent the neuropathology of TBI.	[Chen, Yuhua; Meng, Jiao; Chang, Cuicui] Xian Peihua Univ, Dept Cent Lab, Xian, Peoples R China; [Gong, Kai; Wang, Zhanxiang] Xiamen Univ, Dept Neurosurg, Affiliated Hosp 1, Xiamen, Peoples R China; [Xu, Quanhua; Long, Tianlin; Liu, Wei] Bijie First Peoples Hosp, Dept Neurosurg, Bijie 551700, Peoples R China		Liu, W (corresponding author), Bijie First Peoples Hosp, Dept Neurosurg, Bijie 551700, Peoples R China.	vincelau@sina.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81901270]	This study is supported by the National Natural Science Foundation of China (No. 81901270).	Akbar M, 2016, BRAIN RES, V1637, P34, DOI 10.1016/j.brainres.2016.02.016; Balog J, 2016, J CEREBR BLOOD F MET, V36, P2022, DOI 10.1177/0271678X16671528; Beltran-Parrazal L, 2006, AM J PHYSIOL-CELL PH, V291, pC1193, DOI 10.1152/ajpcell.00230.2006; Chae U, 2019, BIOSCI BIOTECH BIOCH, V83, P409, DOI 10.1080/09168451.2018.1549933; Chandrasekar A, 2019, CEREB CORTEX, V29, P2701, DOI 10.1093/cercor/bhy139; Chen G, 2014, MOL CELL, V54, P362, DOI 10.1016/j.molcel.2014.02.034; Chen T, 2019, NEUROSCIENCE, V416, P268, DOI 10.1016/j.neuroscience.2019.08.007; Cheng G, 2012, BRIT J PHARMACOL, V167, P699, DOI 10.1111/j.1476-5381.2012.02025.x; Corps KN, 2015, JAMA NEUROL, V72, P355, DOI 10.1001/jamaneurol.2014.3558; Di Pietro V, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09587-2; Dong XH, 2019, AM J TRANSL RES, V11, P499; Fan LF, 2017, FREE RADICAL BIO MED, V112, P336, DOI 10.1016/j.freeradbiomed.2017.08.003; Fischer TD, 2016, FRONT SYST NEUROSCI, V10, DOI [10.3389/fnsys.2016.00029, 10.3389/fnsys.2010.00020]; Fu CJ, 2018, DRUG DES DEV THER, V12, P77, DOI 10.2147/DDDT.S154391; Gamberini L, 2019, J EMERG MED, V56, P657, DOI 10.1016/j.jemermed.2019.02.005; Gao YY, 2017, AM J TRANSL RES, V9, P887; Hameed MQ, 2019, CEREB CORTEX, V29, P4506, DOI 10.1093/cercor/bhy328; Hammad A, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1066-z; He GW, 2017, GUT, V66, P716, DOI 10.1136/gutjnl-2015-311247; Hong JM, 2018, LIFE SCI, V200, P94, DOI 10.1016/j.lfs.2018.03.017; Imai Y, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001229; Ishida Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030265; Kang YJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9371; Khatri N, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00199; Kuwar R, 2019, J NEUROINFLAMM, V16, DOI 10.1186/s12974-019-1471-y; Lavie J, 2017, HUM MOL GENET, V26, P674, DOI 10.1093/hmg/ddw425; Liu W, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1083-y; Liu Z, 2019, ANTIOXID REDOX SIGN, V30, P1797, DOI 10.1089/ars.2017.7432; Lo SC, 2008, EXP CELL RES, V314, P1789, DOI 10.1016/j.yexcr.2008.02.014; Lu W, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5930; Luo FC, 2017, EXP NEUROL, V292, P21, DOI 10.1016/j.expneurol.2017.02.015; Luz NF, 2016, J IMMUNOL, V196, P5056, DOI 10.4049/jimmunol.1502492; Merrill RA, 2013, FEBS J, V280, P662, DOI 10.1111/j.1742-4658.2012.08631.x; Morganti JM, 2019, J NEUROINFLAMM, V16, DOI 10.1186/s12974-019-1493-5; Moriwaki K, 2016, J IMMUNOL, V196, P407, DOI 10.4049/jimmunol.1501662; Oliver D, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8090961; Park YS, 2018, TOXICOL LETT, V284, P120, DOI 10.1016/j.toxlet.2017.12.004; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Rosenfeld JV, 2012, LANCET, V380, P1088, DOI 10.1016/S0140-6736(12)60864-2; Sbodio JI, 2019, ANTIOXID REDOX SIGN, V30, P1450, DOI 10.1089/ars.2017.7321; Sekine S, 2012, J BIOL CHEM, V287, P34635, DOI 10.1074/jbc.M112.357509; Silveira GD, 2019, FRONT MOL NEUROSCI, V11, DOI 10.3389/fnmol.2018.00489; Sugo M, 2018, EMBO J, V37, DOI 10.15252/embj.201798899; Takeda K, 2009, P NATL ACAD SCI USA, V106, P12301, DOI 10.1073/pnas.0901823106; Tian H, 2020, J CELL PHYSIOL, V235, P1504, DOI 10.1002/jcp.29070; Wang JW, 2017, ANN CLIN LAB SCI, V47, P10; Wang Y, 2019, CNS NEUROSCI THER, V25, P859, DOI 10.1111/cns.13140; Wang Y, 2018, BIOCHEM BIOPH RES CO, V497, P80, DOI 10.1016/j.bbrc.2018.02.024; Wang ZG, 2012, CELL, V148, P228, DOI 10.1016/j.cell.2011.11.030; Waters RJ, 2013, J NEUROTRAUM, V30, P1710, DOI 10.1089/neu.2012.2792; Wu H, 2014, AUTOPHAGY, V10, P1712, DOI 10.4161/auto.29568; Wu JC, 2020, TRANSL STROKE RES, V11, P720, DOI 10.1007/s12975-019-00771-2; Wu Q, 2018, INT J BIOCHEM CELL B, V94, P44, DOI 10.1016/j.biocel.2017.11.007; Wu Q, 2017, HISTOL HISTOPATHOL, V32, P551, DOI 10.14670/HH-11-841; Wu Q, 2016, BRAIN RES, V1630, P134, DOI 10.1016/j.brainres.2015.11.016; Yang JP, 2018, CEREB CORTEX, V28, P2622, DOI 10.1093/cercor/bhy089; Zemirli N, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19020564; Zhou H, 2018, J PINEAL RES, V65, DOI 10.1111/jpi.12503; Zhou KC, 2019, PHYTOMEDICINE, V59, DOI 10.1016/j.phymed.2019.152922; Zhu JH, 2013, AUTOPHAGY, V9, P1663, DOI 10.4161/auto.24135; Ziebell JM, 2010, NEUROTHERAPEUTICS, V7, P22, DOI 10.1016/j.nurt.2009.10.016	61	7	7	9	17	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1523-0864	1557-7716		ANTIOXID REDOX SIGN	Antioxid. Redox Signal.	JAN 10	2021	34	2					154	170		10.1089/ars.2019.7982		MAY 2020	17	Biochemistry & Molecular Biology; Endocrinology & Metabolism	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Endocrinology & Metabolism	PF0CS	WOS:000532142700001	32253918				2022-02-06	
J	Xu, Y; Chen, X; Qian, Y; Tang, HZ; Song, JL; Qu, XH; Yue, B; Yuan, WE				Xu, Yang; Chen, Xuan; Qian, Yun; Tang, Haozheng; Song, Jialin; Qu, Xinhua; Yue, Bing; Yuan, Wei-En			Melatonin-Based and Biomimetic Scaffold as Muscle-ECM Implant for Guiding Myogenic Differentiation of Volumetric Muscle Loss	ADVANCED FUNCTIONAL MATERIALS			English	Article						biomimetic scaffold; melatonin; myogenic differentiation; nanofibers; volumetric muscle loss	GRAPHENE-BASED MATERIALS; TRAUMATIC BRAIN-INJURY; SKELETAL-MUSCLE; OXIDATIVE STRESS; IN-VITRO; TISSUE; HYDROGELS; CONSTRUCTION; REGENERATION; DISORDERS	Volumetric muscle loss (VML) caused by injury or trauma affects the quality of life directly, due to its high incidence, lingering healing, and prolonged duration. Tissue engineered scaffolds have been widely used in muscle regeneration for patients with massive muscle injury. Melatonin (MLT) is a bioactive substance secreted by the pineal gland, which can promote muscle recovery by inhibiting oxidative stress and inflammation. Herein, a biocompatible scaffold is developed using thiolated hyaluronic acid (HA-SH), collagen I (COL I), and polycaprolactone/melatonin (PCL/MLT) electrospun membranes. This scaffold mimics extracellular matrix (ECM) and architectural features of native muscle, possesses appropriate mechanical property, stiffness and promotes vascularization. It can provide adhesion sites for C2C12 cells and induce their proliferation and differentiation. Moreover, VML rat model is established to evaluate its effect on muscle regeneration. Results demonstrate that this scaffold possesses a practical application for VML.	[Xu, Yang; Chen, Xuan; Yuan, Wei-En] Shanghai Jiao Tong Univ, Sch Pharm, Minist Educ, Engn Res Ctr Cell & Therapeut Antibody, Shanghai 200240, Peoples R China; [Qian, Yun; Song, Jialin] Shanghai Jiao Tong Univ Affiliated Peoples Hosp 6, Dept Orthoped, Shanghai 200233, Peoples R China; [Tang, Haozheng; Qu, Xinhua; Yue, Bing] Shanghai Jiao Tong Univ, Sch Med, Renji Hosp, Dept Bone & Joint Surg,Dept Orthoped, 145 Shandong Middle Rd, Shanghai 200001, Peoples R China		Yuan, WE (corresponding author), Shanghai Jiao Tong Univ, Sch Pharm, Minist Educ, Engn Res Ctr Cell & Therapeut Antibody, Shanghai 200240, Peoples R China.; Qu, XH; Yue, B (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Renji Hosp, Dept Bone & Joint Surg,Dept Orthoped, 145 Shandong Middle Rd, Shanghai 200001, Peoples R China.	xinhua_qu@126.com; advbmp2@163.com; yuanweien@sjtu.edu.cn	Qian, Yun/U-9529-2019; Qu, Xinhua/Q-3950-2016	Qu, Xinhua/0000-0002-8889-0890; Tang, Haozheng/0000-0002-0058-7011	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81570992, 81972086, 81672196]; Projects of Nature Science Foundation of Shanghai, China [19ZR1439200]; Shanghai "Rising Stars of Medical Talent" Youth Development Program (Youth Medical Talents - Specialist Program) [201972]; Technology Development Foundation of Pudong New District, Shanghai, China [PKJ2016-Y55, PWZxq2017-03]; Interdisciplinary Program of Shanghai Jiao Tong University [ZH2018QNA56, YG2019QNA24, YG2017MS22, YG2017MS64, YG2017QN56]; National Science and Technology Major Projects for "Major New Drugs Innovation and Development" [2018ZX09711003-008-002]	This study was supported by National Natural Science Foundation of China (No. 81570992, 81972086 and 81672196). The study was partly supported by the Projects of Nature Science Foundation of Shanghai, China (Grant No. 19ZR1439200), Shanghai "Rising Stars of Medical Talent" Youth Development Program (Youth Medical Talents - Specialist Program) (Grant No. 201972), the Technology Development Foundation of Pudong New District, Shanghai, China (No. PKJ2016-Y55 and PWZxq2017-03). The study was also partly sponsored by the Interdisciplinary Program of Shanghai Jiao Tong University (No. ZH2018QNA56, YG2019QNA24, YG2017MS22, YG2017MS64, and YG2017QN56) and National Science and Technology Major Projects for "Major New Drugs Innovation and Development" (2018ZX09711003-008-002). The authors appreciate the help from faculties of Instrumental Analysis Centre (IAC) of Shanghai Jiao Tong University.	Beliveau PJH, 2018, OCCUP MED-OXFORD, V68, P332, DOI 10.1093/occmed/kqy066; Bermejo-Velasco D, 2019, BIOMACROMOLECULES, V20, P1412, DOI 10.1021/acs.biomac.8b01830; Bian SQ, 2016, COLLOID SURFACE B, V140, P392, DOI 10.1016/j.colsurfb.2016.01.008; Cai ZW, 2019, CHEM MATER, V31, P4710, DOI 10.1021/acs.chemmater.9b00706; Centola M, 2010, BIOFABRICATION, V2, DOI 10.1088/1758-5082/2/1/014102; Chan EC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149799; Chantre CO, 2019, ACS APPL MATER INTER, V11, P45498, DOI 10.1021/acsami.9b17322; Chen MX, 2019, ACS APPL MATER INTER, V11, P41626, DOI 10.1021/acsami.9b13611; Chen YF, 2018, CARBOHYD POLYM, V190, P57, DOI 10.1016/j.carbpol.2018.02.057; Choi S., 2019, ADV FUNCT MATER, V29, P9; Corona BT, 2016, BIOMATERIALS, V104, P238, DOI 10.1016/j.biomaterials.2016.07.020; Corona BT, 2015, J REHABIL RES DEV, V52, P785, DOI 10.1682/JRRD.2014.07.0165; Corona BT, 2013, BIOMATERIALS, V34, P3324, DOI 10.1016/j.biomaterials.2013.01.061; Ding K, 2014, FREE RADICAL BIO MED, V73, P1, DOI 10.1016/j.freeradbiomed.2014.04.031; Ding XL, 2015, ADV HEALTHC MATER, V4, P1451, DOI 10.1002/adhm.201500203; Du JP, 2015, J DRUG DELIV SCI TEC, V30, P74, DOI 10.1016/j.jddst.2015.09.015; Du YZ, 2018, BIOMATERIALS, V157, P40, DOI 10.1016/j.biomaterials.2017.12.005; Dunn A, 2019, J ORTHOP RES, V37, P1246, DOI 10.1002/jor.24212; Ebihara G, 2012, BIOMATERIALS, V33, P3846, DOI 10.1016/j.biomaterials.2012.01.056; Garcia JMS, 2019, ACTA BIOMATER, V84, P169, DOI 10.1016/j.actbio.2018.11.030; Gilbert-Honick J, 2020, ADV HEALTHC MATER, V9, DOI 10.1002/adhm.201900626; Gilbert-Honick J, 2018, BIOMATERIALS, V164, P70, DOI 10.1016/j.biomaterials.2018.02.006; Gillies AR, 2011, MUSCLE NERVE, V44, P318, DOI 10.1002/mus.22094; Gokcinar-Yagci B, 2015, STEM CELL REV REP, V11, P549, DOI 10.1007/s12015-015-9590-z; Han WM, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aar4008; Hiew SH, 2019, ADV SCI, V6, DOI 10.1002/advs.201901173; Jiang XS, 2011, INTERFACE FOCUS, V1, P725, DOI 10.1098/rsfs.2011.0033; Jordahl S, 2019, ADV MATER, V31, DOI 10.1002/adma.201904580; Juhas M, 2018, NAT BIOMED ENG, V2, P942, DOI 10.1038/s41551-018-0290-2; Kaur N, 2019, J CELL PHYSIOL, V234, P6194, DOI 10.1002/jcp.27348; Kheirabadi M, 2015, BIOMATER SCI-UK, V3, P1466, DOI 10.1039/c5bm00150a; Kim CH, 2011, J PINEAL RES, V50, P241, DOI 10.1111/j.1600-079X.2010.00833.x; Koivisto JT, 2019, ACS APPL MATER INTER, V11, P20589, DOI 10.1021/acsami.8b22343; Lee HJ, 2020, SMALL, V16, DOI 10.1002/smll.201903045; Levenberg S, 2005, NAT BIOTECHNOL, V23, P879, DOI 10.1038/nbt1109; Li LK, 2019, APPL PHYS REV, V6, DOI 10.1063/1.5088726; Morsy R, 2017, REACT FUNCT POLYM, V114, P8, DOI 10.1016/j.reactfunctpolym.2017.03.001; Mulder MM, 1998, J BIOMAT SCI-POLYM E, V9, P731, DOI 10.1163/156856298X00118; Nakayama KH, 2019, ADV HEALTHC MATER, V8, DOI 10.1002/adhm.201801168; Ning CY, 2018, PROG POLYM SCI, V81, P144, DOI 10.1016/j.progpolymsci.2018.01.001; Oh EJ, 2010, J CONTROL RELEASE, V141, P2, DOI 10.1016/j.jconrel.2009.09.010; Ostrovidov S, 2014, TISSUE ENG PART B-RE, V20, P403, DOI [10.1089/ten.TEB.2013.0534, 10.1089/ten.teb.2013.0534]; Patil R, 2019, INT J BIOL MACROMOL, V141, P232, DOI 10.1016/j.ijbiomac.2019.08.243; Qian Y, 2018, J PINEAL RES, V65, DOI 10.1111/jpi.12516; Ren KF, 2008, ADV FUNCT MATER, V18, P1378, DOI 10.1002/adfm.200701297; Salucci S, 2016, MICROSC RES TECHNIQ, V79, P532, DOI 10.1002/jemt.22663; Sass FA, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19030835; Seo J, 2019, ACS APPL MATER INTER, V11, P24984, DOI 10.1021/acsami.9b04979; Shah MS, 2016, CIRC RES, V118, P1808, DOI 10.1161/CIRCRESAHA.116.306923; Shandalov Y, 2014, P NATL ACAD SCI USA, V111, P6010, DOI 10.1073/pnas.1402679111; Shin SR, 2016, ADV DRUG DELIVER REV, V105, P255, DOI 10.1016/j.addr.2016.03.007; Silva PE, 2018, J CRIT CARE, V44, P87, DOI 10.1016/j.jcrc.2017.10.026; Smith LR, 2014, SKELET MUSCLE, V4, DOI [10.1186/2044-5040-4-21, 10.1038/srep03726]; Stabenfeldt SE, 2012, BIOMATERIALS, V33, P535, DOI 10.1016/j.biomaterials.2011.09.079; Thones S, 2019, ACTA BIOMATER, V86, P135, DOI 10.1016/j.actbio.2019.01.029; Tsou YH, 2018, ADV FUNCT MATER, V28, DOI 10.1002/adfm.201802607; Uguz AC, 2012, J PINEAL RES, V53, P91, DOI 10.1111/j.1600-079X.2012.00974.x; Walimbe T, 2019, ACTA BIOMATER, V87, P97, DOI 10.1016/j.actbio.2019.01.058; Wang LY, 2019, ADV FUNCT MATER, V29, DOI 10.1002/adfm.201806200; Wang L, 2015, ACS NANO, V9, P9167, DOI 10.1021/acsnano.5b03644; Wu CH, 2019, ACS APPL MATER INTER, V11, P22152, DOI 10.1021/acsami.9b05520; Wu XW, 2012, BIORESEARCH OPEN ACC, V1, P280, DOI 10.1089/biores.2012.0271; Xu SC, 2010, J PINEAL RES, V49, P86, DOI 10.1111/j.1600-079X.2010.00770.x; Xue JJ, 2019, CHEM REV, V119, P5298, DOI 10.1021/acs.chemrev.8b00593; Yi HL, 2017, ACTA BIOMATER, V62, P222, DOI 10.1016/j.actbio.2017.08.022; Zhang DY, 2017, TISSUE ENG PT A, V23, P784, DOI [10.1089/ten.tea.2016.0489, 10.1089/ten.TEA.2016.0489]	66	7	7	14	40	WILEY-V C H VERLAG GMBH	WEINHEIM	POSTFACH 101161, 69451 WEINHEIM, GERMANY	1616-301X	1616-3028		ADV FUNCT MATER	Adv. Funct. Mater.	JUL	2020	30	27							2002378	10.1002/adfm.202002378		MAY 2020	13	Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience & Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied; Physics, Condensed Matter	Science Citation Index Expanded (SCI-EXPANDED)	Chemistry; Science & Technology - Other Topics; Materials Science; Physics	MJ1OX	WOS:000530620500001		hybrid			2022-02-06	
J	Zhou, ZX; Xiang, WJ; Jiang, YL; Tian, N; Wei, ZW; Wen, XY; Wang, WJ; Liao, WX; Xia, XW; Li, QH; Liao, RJ				Zhou, Zixian; Xiang, Wenjing; Jiang, Yanlin; Tian, Ning; Wei, Zaiwa; Wen, Xueyi; Wang, Wenjing; Liao, Wenxiang; Xia, Xuewei; Li, Qinghua; Liao, Rujia			Withaferin A alleviates traumatic brain injury induced secondary brain injury via suppressing apoptosis in endothelia cells and modulating activation in the microglia	EUROPEAN JOURNAL OF PHARMACOLOGY			English	Article						Withaferin A; Traumatic brain injury; Endothelia cell; Microglia; Activation; Secondary brain injury	WITHANIA-SOMNIFERA; HEAD-INJURY; NEUROPROTECTION; INHIBITION; EXPRESSION; PROTECTS; MODEL; INFLAMMATION; CARE	Traumatic brain injury (TBI) is a major public health concern with high rates of morbidity and mortality worldwide. Currently used medications, though effective, are also associated with several adverse effects. Development of effective neuroprotective agents with fewer side-effects would be of clinical value. Previous studies have shown that withaferin compounds have a potential neuroprotective effect in nervous system disorders. However, the effect of withaferin compounds, especially withaferin A (WFA), on traumatic brain injury is unclear. In the present study, both in vivo and in vitro models were used to assess whether WFA could exert a neuroprotective effect after TBI and were used to explore the associated mechanisms. The results showed that WFA significantly improved neurobehavioral function in a dose-dependent fashion and alleviated histological alteration of injury to tissues in TBI mice. In vitro models of TBI revealed that dose-dependent WFA treatment increased the viability of SH-SY5Y cells. In addition, WFA treatment could attenuate blood-brain barrier disruption and brain edema via suppressing apoptosis in endothelial cells. Furthermore, both our in vivo and in vitro results reveal that WFA treatment could significantly reduce levels of several neuroinflammation cytokines (IL-1 beta, IL-6, and TNF-alpha), which correlate with an overall reduction in microglial activation. These data suggest that the neuroprotection by WFA is, at least in part, related to regulation of microglial activation and inhibition of vascular endothelial cell apoptosis. Taken together, these findings support further investigation of WFA as a promising therapeutic agent for promoting functional recovery after traumatic brain injury.	[Zhou, Zixian; Xiang, Wenjing; Liao, Wenxiang; Li, Qinghua; Liao, Rujia] Guilin Med Univ, Affiliated Hosp, Dept Neurol, Guilin 541004, Peoples R China; [Xia, Xuewei] Guilin Med Univ, Affiliated Hosp, Dept Neurosurg, Guilin 541004, Peoples R China; [Zhou, Zixian; Xiang, Wenjing; Tian, Ning; Liao, Wenxiang; Li, Qinghua; Liao, Rujia] Guilin Med Univ, Affiliated Hosp, Lab Neurosci, Guilin 541004, Peoples R China; [Tian, Ning; Wei, Zaiwa; Wen, Xueyi; Wang, Wenjing; Xia, Xuewei; Li, Qinghua; Liao, Rujia] Guilin Med Univ, Affiliated Hosp, Guangxi Clin Res Ctr Neurol Dis, Guilin 541004, Peoples R China; [Jiang, Yanlin] Guilin Med Univ, Affiliated Hosp, Dept Pharmacol, Guilin 541004, Peoples R China; [Tian, Ning; Wei, Zaiwa; Wen, Xueyi; Wang, Wenjing; Xia, Xuewei; Li, Qinghua; Liao, Rujia] Guilin Med Univ, Guangxi Key Lab Brain & Cognit Neurosci, Guilin 541004, Peoples R China		Liao, RJ (corresponding author), Guilin Med Univ, Affiliated Hosp, Guangxi Key Lab Brain & Cognit Neurosci, Lab Neurosci,Dept Neurol,Guangxi Clin Res Ctr Neu, 20 Lequn St, Xiufeng Dist 541004, Guilin, Peoples R China.	liaorujia@hotmail.com		liao, ru-jia/0000-0001-6928-4003	Youth Fund of GuangXi Natural Science Foundation [2018GXNSFBA138046]; Guangxi Science and Technology Project [Guike AD18281013]; National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81560413]	This work was supported by Grant Number 2018GXNSFBA138046 (Rujia Liao) from the Youth Fund of GuangXi Natural Science Foundation, and the Guangxi Science and Technology Project (Grant Number Guike AD18281013, Rujia Liao), and the National Natural Science Foundation of China (NO. 81560413, Xuewei Xia).	Ahmad S, 2019, EXP NEUROBIOL, V28, P216, DOI 10.5607/en.2019.28.2.216; Assis-Nascimento P, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-017-0016-5; Cait J, 2019, P NATL ACAD SCI USA, V116, P4518, DOI 10.1073/pnas.1814766116; Chaudhary G, 2003, CLIN EXP PHARMACOL P, V30, P399, DOI 10.1046/j.1440-1681.2003.03849.x; Chen XR, 2017, J NEUROINFLAMM, V14, DOI [10.1186/s12974-017-0917-3, 10.1186/s12974-018-1151-3]; Corps KN, 2015, JAMA NEUROL, V72, P355, DOI 10.1001/jamaneurol.2014.3558; Daneman R, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a020412; Donat CK, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00208; Faden AI, 2011, ANN NEUROL, V70, P345, DOI 10.1002/ana.22555; Flierl MA, 2009, NAT PROTOC, V4, P1328, DOI 10.1038/nprot.2009.148; Gao WW, 2018, EXP NEUROL, V307, P99, DOI 10.1016/j.expneurol.2018.06.001; Ghajar J, 2000, LANCET, V356, P923, DOI 10.1016/S0140-6736(00)02689-1; Harris NG, 2016, EXP NEUROL, V277, P124, DOI 10.1016/j.expneurol.2015.12.020; Heyninck K, 2016, BIOCHEM PHARMACOL, V109, P48, DOI 10.1016/j.bcp.2016.03.026; Janes KA, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.2005966; Jiang JY, 2019, LANCET NEUROL, V18, P286, DOI 10.1016/S1474-4422(18)30469-1; Kuboyama T, 2014, BIOL PHARM BULL, V37, P892, DOI 10.1248/bpb.b14-00022; Kumar A, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0819-4; Lee J, 2016, NAT MED, V22, P1023, DOI 10.1038/nm.4145; Lee W, 2012, TOXICOL APPL PHARM, V262, P91, DOI 10.1016/j.taap.2012.04.025; Li N, 2016, INT J PHARMACOL, V12, P789, DOI 10.3923/ijp.2016.789.800; Li QY, 2018, NAT REV IMMUNOL, V18, P225, DOI 10.1038/nri.2017.125; Liao RJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep15356; Liao RJ, 2019, STEM CELL REP, V12, P532, DOI 10.1016/j.stemcr.2019.01.004; Ma Z, 2019, PLOS PATHOG, V15, DOI 10.1371/journal.ppat.1007737; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Main BS, 2018, MOL NEURODEGENER, V13, DOI 10.1186/s13024-018-0249-5; Menge T, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004660; Min KJ, 2011, INT IMMUNOPHARMACOL, V11, P1137, DOI 10.1016/j.intimp.2011.02.029; Morrison B, 2011, ANNU REV BIOMED ENG, V13, P91, DOI 10.1146/annurev-bioeng-071910-124706; Pearn ML, 2017, CELL MOL NEUROBIOL, V37, P571, DOI 10.1007/s10571-016-0400-1; Saykally JN, 2017, CELL TRANSPLANT, V26, P1193, DOI 10.1177/0963689717714320; Segarra M, 2018, SCIENCE, V361, DOI 10.1126/science.aao2861; Song J, 2016, J MOL NEUROSCI, V60, P115, DOI 10.1007/s12031-016-0784-x; Sorensen HT, 2019, LANCET NEUROL, V18, P420, DOI 10.1016/S1474-4422(19)30027-4; Stocchetti N, 2017, LANCET NEUROL, V16, P452, DOI 10.1016/S1474-4422(17)30118-7; Tagge CA, 2018, BRAIN, V141, P422, DOI 10.1093/brain/awx350; Tatsuhiro A., 2018, EUR J PHARMACOL, V819, P190, DOI [10.1016/j.ejphar.2017.12.008, DOI 10.1016/J.EJPHAR.2017.12.008]; Trigunayat A, 2007, J CHROMATOGR B, V7, P439; Villalba N, 2017, J NEUROTRAUM, V34, P192, DOI 10.1089/neu.2015.4340; Wang GH, 2015, P NATL ACAD SCI USA, V112, P2853, DOI 10.1073/pnas.1501441112; Wang KW, 2014, ANN CLIN LAB SCI, V44, P145; Wu YG, 2018, BLOOD, V132, P1075, DOI 10.1182/blood-2018-03-841932; Xu ZM, 2017, J NEUROTRAUM, V34, P925, DOI 10.1089/neu.2016.4491; Yan XL, 2017, PHARM BIOL, V55, P1171, DOI 10.1080/13880209.2017.1288262; Young K, 2018, JOVE-J VIS EXP, DOI 10.3791/57648; Zhang JY, 2018, J NEUROTRAUM, V35, P802, DOI 10.1089/neu.2016.4871; Zhao QC, 2019, J NEUROINFLAMM, V16, DOI 10.1186/s12974-019-1495-3; Zhou YT, 2017, BRAIN BEHAV IMMUN, V60, P93, DOI 10.1016/j.bbi.2016.09.024	50	7	8	1	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0014-2999	1879-0712		EUR J PHARMACOL	Eur. J. Pharmacol.	MAY 5	2020	874								172988	10.1016/j.ejphar.2020.172988			13	Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	KU2JH	WOS:000519534200007	32032599				2022-02-06	
J	Grashow, R; Weisskopf, MG; Baggish, A; Speizer, FE; Whittington, AJ; Nadler, L; Connor, A; Keske, R; Taylor, H; Zafonte, R; Pascual-Leone, A				Grashow, Rachel; Weisskopf, Marc G.; Baggish, Aaron; Speizer, Frank E.; Whittington, Alicia J.; Nadler, Lee; Connor, Ann; Keske, Robyn; Taylor, Herman; Zafonte, Ross; Pascual-Leone, Alvaro			Premortem Chronic Traumatic Encephalopathy Diagnoses in Professional Football	ANNALS OF NEUROLOGY			English	Article							QUALITY-OF-LIFE; RISK; DEPRESSION; PREVALENCE; CONCUSSION; PLAYERS; INJURY	Objective American-style football (ASF) has gained attention because of possible links between repetitive head injury and neurodegenerative diseases. Although postmortem pathologic changes consistent with chronic traumatic encephalopathy (CTE) have been reported in ASF players, there are currently no established premortem diagnostic criteria for CTE. Nevertheless, presented with symptoms of cognitive impairment, clinicians treating former players may be inclined to suggest CTE without a thorough exploration of comorbid factors that demonstrate similar clinical phenotypes to putative CTE. Methods A survey of 3,913 former ASF players aged 24 to 89 was conducted for those who responded by March 2019. Results Despite being a postmortem diagnosis, 108 players (2.8%) self-reported clinician-diagnosed CTE. The percentage of players under age 60 years reporting a CTE diagnosis was 2.3% versus 3.7% in participants age 60 or older. Comorbidities in participants self-reporting CTE were significantly more common, including sleep apnea, hypercholesterolemia, obesity, indicators of past or current depression, hypertension, prescription pain medication use, heart conditions, and low testosterone when compared to non-CTE respondents. Patterns of reporting for obesity, hypertension, heart conditions, or hypercholesterolemia differed between older and younger participants. Cognitive impairment symptoms were significantly higher in participants self-reporting CTE. Interpretation Some former professional football players have been clinically diagnosed with CTE, a postmortem condition. Comorbidities that can affect cognition were associated with CTE diagnoses in both older and younger players. Although underlying neuropathology cannot be ruled out, treatable conditions should be explored in former athletes demonstrating CTE-linked clinical phenotypes or symptoms as a means of improving cognitive health in these patients. ANN NEUROL 2020	[Grashow, Rachel; Weisskopf, Marc G.; Baggish, Aaron; Speizer, Frank E.; Whittington, Alicia J.; Nadler, Lee; Connor, Ann; Keske, Robyn; Taylor, Herman; Zafonte, Ross; Pascual-Leone, Alvaro] Harvard Univ, Harvard Med Sch, Football Players Hlth Study, Boston, MA 02115 USA; [Grashow, Rachel; Weisskopf, Marc G.; Speizer, Frank E.] Harvard TH Chan Sch Publ Hlth, Dept Environm Hlth, Boston, MA USA; [Baggish, Aaron] Massachusetts Gen Hosp, Cardiovasc Performance Program, Boston, MA 02114 USA; [Baggish, Aaron; Zafonte, Ross] Harvard Med Sch, Boston, MA 02115 USA; [Speizer, Frank E.] Harvard Med Sch, Brigham & Womens Hosp, Channing Div Network Med, Boston, MA 02115 USA; [Nadler, Lee] Dana Farber Canc Inst, Boston, MA 02115 USA; [Connor, Ann; Pascual-Leone, Alvaro] Harvard Med Sch, Dept Neurol, Boston, MA 02115 USA; [Taylor, Herman] Morehouse Sch Med, Cardiovasc Res Inst, Atlanta, GA 30310 USA; [Zafonte, Ross] Massachusetts Gen Hosp, Brigham & Womens Hosp, Spaulding Rehabil Hosp, Dept Phys Med & Rehabil, Boston, MA 02114 USA; [Pascual-Leone, Alvaro] Harvard Med Sch, Hebrew Senior Life, Ctr Memory Hlth, Boston, MA 02115 USA; [Pascual-Leone, Alvaro] Harvard Med Sch, Hebrew Senior Life, Marcus Inst Aging Res, Boston, MA 02115 USA; [Pascual-Leone, Alvaro] Univ Autonoma Barcelona, Inst Guttmann, Barcelona, Spain		Zafonte, R (corresponding author), Harvard Med Sch, Brigham & Womens Hosp, Massachusetts Gen Hosp, Dept Phys Med & Rehabil,Spaulding Rehabil Hosp, 300 First Ave Boston, Boston, MA 02129 USA.	rzafonte@mgh.harvard.edu			Football Players Health Study at Harvard University; Harvard Catalyst \ The Harvard Clinical and Translational Science Center (NCRR); Harvard Catalyst \ The Harvard Clinical and Translational Science Center (NCATS NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1 RR025758]; Football Players Health Study at Harvard University - NFL Players Association (NFLPA)	This work was partly supported by the Football Players Health Study at Harvard University, and Harvard Catalyst vertical bar The Harvard Clinical and Translational Science Center (NCRR and the NCATS NIH, UL1 RR025758). The content is solely the responsibility of the authors and does not necessarily represent the official views of Harvard Catalyst, Harvard University and its affiliated academic healthcare centers, the National Institutes of Health, or the Sidney R. Baer Jr. Foundation. The authors wish to acknowledge the study participants, advisors, and staff of the Football Players Health Study for their time and effort. All of the authors named on this study are or were either partially or fully supported by the Football Players Health Study at Harvard University which is, in turn, sponsored by the NFL Players Association (NFLPA). Please note that the NFLPA had no role in: the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.	Alosco ML, 2019, FRONT HUM NEUROSCI, V13, DOI 10.3389/fnhum.2019.00440; Alosco ML, 2018, ANN NEUROL, V83, P886, DOI 10.1002/ana.25245; Bancks MP, 2017, JAMA-J AM MED ASSOC, V318, P2457, DOI 10.1001/jama.2017.19546; Bivens S., 1994, Journal of Sport Behavior, V17, P24; Cella D, 2012, NEUROLOGY, V78, P1860, DOI 10.1212/WNL.0b013e318258f744; Chatfield MD, 2005, J CLIN EPIDEMIOL, V58, P13, DOI 10.1016/j.jclinepi.2004.05.006; Churchill TW, 2018, AM J MED, V131, P1491, DOI 10.1016/j.amjmed.2018.07.042; Daniali H, 2019, FRONT PSYCHIATRY, V10, DOI 10.3389/fpsyt.2019.00242; Grashow R, 2019, JAMA NEUROL, V76, P1428, DOI 10.1001/jamaneurol.2019.2664; Grashow RG, 2019, ORTHOP J SPORTS MED, V7, DOI 10.1177/2325967119829212; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Harrison EA, 2014, AM J PUBLIC HEALTH, V104, P822, DOI 10.2105/AJPH.2013.301840; Hertz RP, 2005, ARCH INTERN MED, V165, P2098, DOI 10.1001/archinte.165.18.2098; Ho AK, 2011, J PERS SOC PSYCHOL, V100, P492, DOI 10.1037/a0021562; Iverson GL, 2019, BRAIN, V142, P3672, DOI 10.1093/brain/awz286; Iverson GL, 2020, J NEUROPSYCH CLIN N, V32, P139, DOI 10.1176/appi.neuropsych.19010021; Iverson GL, 2019, J NEUROPATH EXP NEUR, V78, P615, DOI 10.1093/jnen/nlz045; Jordan BD, 2013, NAT REV NEUROL, V9, P222, DOI 10.1038/nrneurol.2013.33; Kelly DF, 2014, J NEUROTRAUM, V31, P1161, DOI 10.1089/neu.2013.3212; Kim CT, 2018, J ALZHEIMERS DIS, V63, P395, DOI 10.3233/JAD-170951; Laffey M, 2018, NEUROREHABILITATION, V43, P431, DOI 10.3233/NRE-182452; Lowe B, 2005, J PSYCHOSOM RES, V58, P163, DOI 10.1016/j.jpsychores.2004.09.006; Mannix R, 2016, NAT REV NEUROL, V12, P486, DOI 10.1038/nrneurol.2016.99; Martland HS, 1928, J AMER MED ASSOC, V91, P1103, DOI 10.1001/jama.1928.02700150029009; McCullagh S, 2003, J NEUROL NEUROSUR PS, V74, P39, DOI 10.1136/jnnp.74.1.39; McKee AC, 2016, ACTA NEUROPATHOL, V131, P75, DOI 10.1007/s00401-015-1515-z; Meehan W, 2015, NEUROLOGY, V85, P1504, DOI 10.1212/WNL.0000000000001893; Mez J, 2017, JAMA-J AM MED ASSOC, V318, P360, DOI 10.1001/jama.2017.8334; Montenigro PH, 2017, J NEUROTRAUM, V34, P328, DOI 10.1089/neu.2016.4413; Montenigro PH, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/s13195-014-0068-z; Pascual-Leone A, 2018, ANN NEUROL, V83, P884, DOI 10.1002/ana.25258; Peck B, 2019, J SPORT REHABIL, V28, P126, DOI 10.1123/jsr.2017-0127; Polich G, 2020, AM J PHYS MED REHAB, V99, P71, DOI 10.1097/PHM.0000000000001290; R Development Core Team, 2012, R LANG ENV STAT COMP; Reams N, 2016, JAMA NEUROL, V73, P743, DOI 10.1001/jamaneurol.2015.5015; Roberts AL, 2019, AM J SPORT MED, V47, P2871, DOI 10.1177/0363546519868989; Rogers AJ, 2017, J SLEEP DISORD THER, V6, P1; Stein TD, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/alzrt234; Stern RA, 2019, NEW ENGL J MED, V380, P1716, DOI 10.1056/NEJMoa1900757; Turi Z, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-35124-w; Victoroff J, 2013, NEUROREHABILITATION, V32, P211, DOI 10.3233/NRE-130839; Zafonte R, 2019, AM J IND MED, V62, P643, DOI 10.1002/ajim.22991	42	7	7	3	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0364-5134	1531-8249		ANN NEUROL	Ann. Neurol.	JUL	2020	88	1					106	112		10.1002/ana.25747		MAY 2020	7	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	MA5OV	WOS:000530434900001	32281676	Green Published, hybrid			2022-02-06	
J	Heller, RA; Sperl, A; Seelig, J; Haubruck, P; Bock, T; Werner, T; Besseling, A; Sun, Q; Schomburg, L; Moghaddam, A; Biglari, B				Heller, Raban Arved; Sperl, Andre; Seelig, Julian; Haubruck, Patrick; Bock, Tobias; Werner, Theresa; Besseling, Albert; Sun, Qian; Schomburg, Lutz; Moghaddam, Arash; Biglari, Bahram			Zinc Concentration Dynamics Indicate Neurological Impairment Odds after Traumatic Spinal Cord Injury	ANTIOXIDANTS			English	Article						traumatic spinal cord injury; zinc; neuroprotection; neurotrauma; regeneration	SELENIUM STATUS; SERUM-LEVELS; NEUROTOXICITY; INFLAMMATION; REMISSION; POWER; REGENERATION; MECHANISMS; SCD95L; MARKER	Traumatic Spinal Cord Injury (TSCI) is debilitating and often results in a loss of motor and sensory function caused by an interwoven set of pathological processes. Oxidative stress and inflammatory processes are amongst the critical factors in the secondary injury phase after TSCI. The essential trace element Zinc (Zn) plays a crucial role during this phase as part of the antioxidant defense system. The study aims to determine dynamic patterns in serum Zn concentration in patients with TSCI and test for a correlation with neurological impairment. A total of 42 patients with TSCI were enrolled in this clinical observational study. Serum samples were collected at five different points in time after injury (at admission, and after 4 h, 9 h, 12 h, 24 h, and 3 days). The analysis of the serum Zn concentrations was conducted by total reflection X-ray fluorescence (TXRF). The patients were divided into two groups-a study group S (n = 33) with neurological impairment, including patients with remission (G1, n = 18) and no remission (G0, n = 15) according to a positive AIS (American Spinal Injury Association (ASIA) Impairment Scale) conversion within 3 months after the trauma; and a control group C (n = 9), consisting of subjects with vertebral fractures without neurological impairment. The patient data and serum concentrations were examined and compared by non-parametric test methods to the neurological outcome. The median Zn concentrations in group S dropped within the first 9 h after injury (964 mu g/L at admission versus 570 mu g/L at 9 h, p < 0.001). This decline was stronger than in control subjects (median of 751 <mu>g/L versus 729 mu g/L, p = 0.023). A binary logistic regression analysis including the difference in serum Zn concentration from admission to 9 h after injury yielded an area under the curve (AUC) of 82.2% (CI: 64.0-100.0%) with respect to persistent neurological impairment. Early Zn concentration dynamics differed in relation to the outcome and may constitute a helpful diagnostic indicator for patients with spinal cord trauma. The fast changes in serum Zn concentrations allow an assessment of neurological impairment risk on the first day after trauma. This finding supports strategies for improving patient care by avoiding strong deficits via adjuvant nutritive measures, e.g., in unresponsive patients after trauma.	[Heller, Raban Arved; Seelig, Julian; Sun, Qian; Schomburg, Lutz] Charite Univ Med Berlin, Inst Expt Endocrinol, D-13353 Berlin, Germany; [Heller, Raban Arved; Seelig, Julian; Sun, Qian; Schomburg, Lutz] Free Univ Berlin, D-13353 Berlin, Germany; [Heller, Raban Arved; Seelig, Julian; Sun, Qian; Schomburg, Lutz] Humboldt Univ, Berlin Inst Hlth, D-13353 Berlin, Germany; [Heller, Raban Arved; Sperl, Andre; Haubruck, Patrick; Bock, Tobias] Heidelberg Univ Hosp, Dept Trauma & Reconstruct Surg, Heidelberg Trauma Res Grp, Ctr Orthoped Trauma Surg & Spinal Cord Injury, D-68118 Heidelberg, Germany; [Haubruck, Patrick] Univ Sydney, Kolling Inst Med Res, Raymond Purves Bone & Joint Res Labs, Sydney, NSW 2065, Australia; [Werner, Theresa; Besseling, Albert] BG Trauma Ctr Ludwigshafen, Dept Physiotherapy, D-67071 Ludwigshafen, Germany; [Moghaddam, Arash] Hosp Aschaffenburg Alzenau, Aschaffenburg Trauma & Orthoped Res Grp, Ctr Orthoped Trauma Surg & Sports Med, D-63739 Aschaffenburg, Germany; [Biglari, Bahram] BG Trauma Ctr Ludwigshafen, Dept Paraplegiol, D-67071 Ludwigshafen, Germany		Heller, RA (corresponding author), Charite Univ Med Berlin, Inst Expt Endocrinol, D-13353 Berlin, Germany.; Heller, RA (corresponding author), Free Univ Berlin, D-13353 Berlin, Germany.; Heller, RA (corresponding author), Humboldt Univ, Berlin Inst Hlth, D-13353 Berlin, Germany.; Heller, RA (corresponding author), Heidelberg Univ Hosp, Dept Trauma & Reconstruct Surg, Heidelberg Trauma Res Grp, Ctr Orthoped Trauma Surg & Spinal Cord Injury, D-68118 Heidelberg, Germany.	raban.heller@outlook.com; andre.sperl@gmx.de; julian.seelig@charite.de; patrick.haubruck@sydney.edu.au; tobias.bock@outlook.com; theresa.werner@bgu-ludwigshafen.de; albertus.besseling@bgu-ludwigshafen.de; qian.sun@charite.de; lutz.schomburg@charite.de; arash.moghaddam-alvandi@klinikum-ab-alz.de; bahram.biglari@bgu-ludwigshafen.de	Heller, Raban/P-4152-2019; Seelig, Julian/AAU-6678-2021	Heller, Raban/0000-0001-8006-9742; Werner, Theresa/0000-0002-6871-2034; Sun, Qian/0000-0002-4458-6555; Schomburg, Lutz/0000-0001-9445-1555; Haubruck, Patrick/0000-0002-7045-0387; Sperl, Andre/0000-0001-8069-8389	German Research Foundation (DFG)German Research Foundation (DFG); Charite-Universitatsmedizin Berlin [AL 344/11-1, KU 3112/1-1]	We acknowledge support from the German Research Foundation (DFG) and the Open Access Publication Funds of Charite-Universitatsmedizin Berlin, AL 344/11-1 und KU 3112/1-1.	Al-Habib AF, 2011, J NEUROTRAUM, V28, P1431, DOI 10.1089/neu.2009.1157; [Anonymous], 2016, IEEE ASME T MECHATRO, VPP, P1; Auguie B., 2017, MISCELLANEOUS FUNCTI; Baptiste DC, 2006, J NEUROTRAUM, V23, P318, DOI 10.1089/neu.2006.23.318; Besecker BY, 2011, AM J CLIN NUTR, V93, P1356, DOI 10.3945/ajcn.110.008417; Biglari B, 2015, SPINAL CORD, V53, P510, DOI 10.1038/sc.2015.28; Biglari B, 2013, SPINAL CORD, V51, P183, DOI 10.1038/sc.2012.139; Biglari B, 2021, J SPINAL CORD MED, V44, P229, DOI 10.1080/10790268.2019.1632060; Biglari B, 2015, J INT MED RES, V43, P250, DOI 10.1177/0300060514559794; Chen J, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.490; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Collins GS, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.g7594; CRAGG JG, 1970, CAN J ECONOMICS, V3, P386, DOI 10.2307/133656; Doering P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010131; Farkas GJ, 2019, SPINAL CORD, V57, P3, DOI 10.1038/s41393-018-0218-4; Fawcett JW, 2007, SPINAL CORD, V45, P190, DOI 10.1038/sj.sc.3102007; Ferbert T, 2017, J NEUROTRAUM, V34, P607, DOI 10.1089/neu.2015.4294; Furlan JC, 2013, J NEUROTRAUM, V30, P487, DOI 10.1089/neu.2012.2539; Ganau Laura, 2018, Medicines (Basel), V5, DOI 10.3390/medicines5010022; Ganau Mario, 2018, Medicines (Basel), V5, DOI 10.3390/medicines5010019; Gower-Winter SD, 2012, BIOFACTORS, V38, P186, DOI 10.1002/biof.1012; Haase H, 2019, NUTRIENTS, V11, DOI 10.3390/nu11092078; HELLER R, 2016, INJURY, V47, pS35, DOI DOI 10.1016/S0020-1383(16)30580-0; Heller RA, 2017, SPINAL CORD, V55, P1002, DOI 10.1038/sc.2017.69; Heller RA, 2019, J TRACE ELEM MED BIO, V51, P141, DOI 10.1016/j.jtemb.2018.10.006; Hershfinkel M., 2005, MOL BIOL METAL HOMEO, P131; Hughes DJ, 2016, AM J CLIN NUTR, V104, P406, DOI 10.3945/ajcn.116.131672; Johnstone JT, 2013, J NEUROSCI RES, V91, P828, DOI 10.1002/jnr.23208; Jones SR, 2003, EMERG MED J, V20, P453, DOI 10.1136/emj.20.5.453; Kang H, 2013, KOREAN J ANESTHESIOL, V64, P402, DOI 10.4097/kjae.2013.64.5.402; Kawahara M, 2002, CELL MOL NEUROBIOL, V22, P87, DOI 10.1023/A:1015345813075; Khazaeipour Z, 2014, J SPINAL CORD MED, V37, P338, DOI 10.1179/2045772313Y.0000000174; Kigerl KA, 2007, J NEUROCHEM, V102, P37, DOI 10.1111/j.1471-4159.2007.04524.x; Kigerl KA, 2009, J NEUROSCI, V29, P13435, DOI 10.1523/JNEUROSCI.3257-09.2009; Kijima K, 2019, EBIOMEDICINE, V41, P659, DOI 10.1016/j.ebiom.2019.03.003; Kirshblum SC, 2011, J SPINAL CORD MED, V34, P547, DOI 10.1179/107902611X13186000420242; Koyama H., 2011, J CLIN TOXICOL, V3, DOI [10.4172/2161-0495.S3-002, DOI 10.4172/2161-0495.S3-002]; Krueger H, 2013, CHRON DIS INJ CAN, V33, P113; Kwon Brian K, 2004, Spine J, V4, P451, DOI 10.1016/j.spinee.2003.07.007; Li SX, 2000, J NEUROSCI, V20, P1190, DOI 10.1523/JNEUROSCI.20-03-01190.2000; Li X, 2019, FRONT MOL NEUROSCI, V12, DOI 10.3389/fnmol.2019.00018; Liu MJ, 2013, CELL REP, V3, P386, DOI 10.1016/j.celrep.2013.01.009; Lynch AC, 2002, SPINAL CORD, V40, P627, DOI 10.1038/sj.sc.3101382; Magerl F, 1994, Eur Spine J, V3, P184, DOI 10.1007/BF02221591; Maret W, 2006, J TRACE ELEM MED BIO, V20, P3, DOI 10.1016/j.jtemb.2006.01.006; MCCLAIN CJ, 1986, J NEUROSURG, V64, P224, DOI 10.3171/jns.1986.64.2.0224; MELLON PL, 1990, NEURON, V5, P1, DOI 10.1016/0896-6273(90)90028-E; Mizuno D, 2013, INT J MOL SCI, V14, P22067, DOI 10.3390/ijms141122067; Mocchegiani E, 2009, J CLIN IMMUNOL, V29, P416, DOI 10.1007/s10875-009-9298-4; Moghaddam A, 2017, SPINAL CORD, V55, P8, DOI 10.1038/sc.2016.104; Moghaddam A, 2016, SPINAL CORD, V54, P957, DOI 10.1038/sc.2016.44; Moghaddam A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159764; Moghaddam A, 2015, INT J MOL SCI, V16, P7900, DOI 10.3390/ijms16047900; Murray PJ, 2017, ANNU REV PHYSIOL, V79, P541, DOI 10.1146/annurev-physiol-022516-034339; Noonan VK, 2018, J NEUROTRAUM, V35, P478, DOI 10.1089/neu.2017.5036; Norenberg MD, 2004, J NEUROTRAUM, V21, P429, DOI 10.1089/089771504323004575; Porta C, 2009, P NATL ACAD SCI USA, V106, P14978, DOI 10.1073/pnas.0809784106; Prakash A, 2015, FUND CLIN PHARMACOL, V29, P131, DOI 10.1111/fcp.12110; REGAN RF, 1991, NEUROSCIENCE, V43, P585, DOI 10.1016/0306-4522(91)90317-H; Richard-Denis A, 2018, J SPINAL CORD MED, V41, P309, DOI 10.1080/10790268.2017.1279818; Rink L, 2000, P NUTR SOC, V59, P541, DOI 10.1017/S0029665100000781; Rolls A, 2009, NAT REV NEUROSCI, V10, P235, DOI 10.1038/nrn2591; Rowland JW, 2008, NEUROSURG FOCUS, V25, DOI 10.3171/FOC.2008.25.11.E2; Seelig J, 2020, J TRACE ELEM MED BIO, V57, P124, DOI 10.1016/j.jtemb.2019.126415; Shechter R, 2013, IMMUNITY, V38, P555, DOI 10.1016/j.immuni.2013.02.012; Shechter R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027969; Shechter R, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000113; Sperl A, 2019, ANTIOXIDANTS-BASEL, V8, DOI 10.3390/antiox8110509; Wang YS, 2014, BRAIN RES, V1545, P45, DOI 10.1016/j.brainres.2013.12.015; Wang YS, 2011, BIOL TRACE ELEM RES, V143, P351, DOI 10.1007/s12011-010-8845-4; Wang YS, 2011, MED HYPOTHESES, V77, P589, DOI 10.1016/j.mehy.2011.06.037; Wessels I, 2017, NUTRIENTS, V9, DOI 10.3390/nu9121286; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wu JF, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8070693; Yousefifard M, 2019, J NEUROCHEM, V149, P317, DOI 10.1111/jnc.14637; Yu WR, 2011, ACTA NEUROPATHOL, V122, P747, DOI 10.1007/s00401-011-0882-3; Zhang DQ, 2002, J NEUROPHYSIOL, V88, P1245, DOI 10.1152/jn.2002.88.3.1245	77	7	7	1	1	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2076-3921		ANTIOXIDANTS-BASEL	Antioxidants	MAY	2020	9	5							421	10.3390/antiox9050421			19	Biochemistry & Molecular Biology; Chemistry, Medicinal; Food Science & Technology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Pharmacology & Pharmacy; Food Science & Technology	LW6WJ	WOS:000539284200064	32414139	gold, Green Published			2022-02-06	
J	Knopp, RC; Lee, SH; Hollas, M; Nepomuceno, E; Gonzalez, D; Tam, K; Aamir, D; Wang, Y; Pierce, E; BenAissa, M; Thatcher, GRJ				Knopp, Rachel C.; Lee, Sue H.; Hollas, Michael; Nepomuceno, Emily; Gonzalez, David; Tam, Kevin; Aamir, Daniyal; Wang, Yueting; Pierce, Emily; BenAissa, Manel; Thatcher, Gregory R. J.			Interaction of oxidative stress and neurotrauma in ALDH2(-/-) mice causes significant and persistent behavioral and pro-inflammatory effects in a tractable model of mild traumatic brain injury	REDOX BIOLOGY			English	Article						Mild traumatic brain injury; Oxidative stress; Lipid peroxidation; Neuroinflammation; Drug discovery	LIPID-PEROXIDATION PRODUCT; AMYLOID-BETA PEPTIDE; KAPPA-B ACTIVATION; ALZHEIMERS-DISEASE; PROTEOMIC IDENTIFICATION; COGNITIVE IMPAIRMENT; ISCHEMIC-STROKE; MOUSE MODEL; IN-VITRO; CLOMETHIAZOLE	Oxidative stress induced by lipid peroxidation products (LPP) accompanies aging and has been hypothesized to exacerbate the secondary cascade in traumatic brain injury (TBI). Increased oxidative stress is a contributor to loss of neural reserve that defines the ability to maintain healthy cognitive function despite the accumulation of neuropathology. ALDH2(-/-) mice are unable to clear aldehyde LPP by mitochondrial aldehyde dehydrogenase-2 (Aldh2) detoxification and provide a model to study mild TBI (mTBI), therapeutic interventions, and underlying mechanisms. The ALDH2(-/-) mouse model presents with elevated LPP-mediated protein modification, lowered levels of PSD-95, PGC1-alpha, and SOD-1, and mild cognitive deficits from 4 months of age. LPP scavengers are neuroprotective in vitro and in ALDH2(-/-) mice restore cognitive performance. A single-hit, closed skull mTBI failed to elicit significant effects in WT mice; however, ALDH2(-/-) mice showed a significant inflammatory cytokine surge in the ipsilateral hemisphere 24 h post-mTBI, and increased GFAP cleavage, a biomarker for TBI. Known neuroprotective agents, were able to reverse the effects of mTBI. This new preclinical model of mTBI, incorporating significant perturbations in behavior, inflammation, and clinically relevant biomarkers, allows mechanistic study of the interaction of LPP and neurotrauma in loss of neural reserve.	[Knopp, Rachel C.; Lee, Sue H.; Hollas, Michael; Nepomuceno, Emily; Gonzalez, David; Tam, Kevin; Aamir, Daniyal; Wang, Yueting; Pierce, Emily; BenAissa, Manel; Thatcher, Gregory R. J.] Univ Illinois, Coll Pharm, Dept Pharmaceut Sci, Chicago, IL 60612 USA; [Hollas, Michael; BenAissa, Manel; Thatcher, Gregory R. J.] Univ Illinois, UICtr Drug Discovery UIC, 833 S Wood St, Chicago, IL 60612 USA		Thatcher, GRJ (corresponding author), Univ Illinois, 833 S Wood St, Chicago, IL 60612 USA.	thatcher@uic.edu	Knopp, Rachel/AAD-6940-2022; Hollas, Michael/Q-8201-2016	Knopp, Rachel/0000-0002-1091-3829; Hollas, Michael/0000-0002-0797-3134	National Institute of AgingUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [1T32AG057468-01]; National Center for Advancing Translational Sciences, National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR002003]	The work was supported by the National Institute of Aging through Grant 1T32AG057468-01 and the National Center for Advancing Translational Sciences, National Institutes of Health, through Grant UL1TR002003.	Abarikwu SO, 2012, BASIC CLIN PHARMACOL, V110, P441, DOI 10.1111/j.1742-7843.2011.00834.x; Al Nimer F, 2013, ANTIOXID REDOX SIGN, V18, P784, DOI 10.1089/ars.2011.4440; Ansari MA, 2008, FREE RADICAL BIO MED, V45, P443, DOI 10.1016/j.freeradbiomed.2008.04.038; Bennett BM, 2007, NEUROPSYCHOPHARMACOL, V32, P505, DOI 10.1038/sj.npp.1301054; Bennett DA, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002256; Butterfield DA, 2006, NEUROSCI LETT, V397, P170, DOI 10.1016/j.neulet.2005.12.017; Cebak JE, 2017, J NEUROTRAUM, V34, P1302, DOI 10.1089/neu.2016.4624; CECONI C, 1988, J MOL CELL CARDIOL, V20, P5, DOI 10.1016/S0022-2828(88)80174-3; Chakrabarti S, 2015, AGING DIS, V6, P282, DOI 10.14336/AD.2014.002; Clarkson AN, 2007, NEUROSCIENCE, V144, P547, DOI 10.1016/j.neuroscience.2006.09.040; Clarkson AN, 2005, FASEB J, V19, P1036, DOI 10.1096/fj.04-3367fje; Cristofori L, 2001, J INVEST MED, V49, P450, DOI 10.2310/6650.2001.33790; Cummings JL, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/alzrt269; D'Souza Y, 2015, MOL BRAIN, V8, DOI 10.1186/s13041-015-0117-y; Deacon RMJ, 2006, NAT PROTOC, V1, P1117, DOI 10.1038/nprot.2006.170; Dias CP, 2007, NEUROSCIENCE, V146, P1719, DOI 10.1016/j.neuroscience.2007.03.018; Dodson M, 2017, AUTOPHAGY, V13, P1828, DOI 10.1080/15548627.2017.1356948; Essani NA, 1997, SHOCK, V7, P90, DOI 10.1097/00024382-199702000-00003; Farooque M, 1999, ACTA NEUROPATHOL, V98, P22, DOI 10.1007/s004010051047; Green AR, 1998, PHARMACOL THERAPEUT, V80, P123, DOI 10.1016/S0163-7258(98)00024-2; Guiotto A, 2005, J MED CHEM, V48, P6156, DOI 10.1021/jm050507q; Hall ED, 2010, NEUROTHERAPEUTICS, V7, P51, DOI 10.1016/j.nurt.2009.10.021; Harmon D, 2003, ANESTH ANALG, V97, P13, DOI 10.1213/01.ANE.0000063821; Jenner P, 2003, ANN NEUROL, V53, pS26, DOI 10.1002/ana.10483; Kamino K, 2000, BIOCHEM BIOPH RES CO, V273, P192, DOI 10.1006/bbrc.2000.2923; Kim YW, 2014, BLOOD, V123, P625, DOI 10.1182/blood-2013-09-512749; Kitagawa K, 2000, FEBS LETT, V476, P306, DOI 10.1016/S0014-5793(00)01710-5; Kraeuter AK, 2019, METHODS MOL BIOL, V1916, P105, DOI 10.1007/978-1-4939-8994-2_10; Leger M, 2013, NAT PROTOC, V8, P2531, DOI 10.1038/nprot.2013.155; Lei J, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-1081-8; Lorente L, 2015, J NEUROTRAUM, V32, P1, DOI 10.1089/neu.2014.3456; Lorrio S, 2009, BRAIN RES, V1254, P128, DOI 10.1016/j.brainres.2008.11.095; Luo J, 2016, MOL NEURODEGENER, V11, DOI 10.1186/s13024-016-0103-6; Luo J, 2015, BMC NEUROSCI, V16, DOI 10.1186/s12868-015-0208-9; Luoto TM, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00652; Lyden P, 2002, STROKE, V33, P122, DOI 10.1161/hs0102.101478; Mariani E, 2005, J CHROMATOGR B, V827, P65, DOI 10.1016/j.jchromb.2005.04.023; Mark RJ, 1997, J NEUROCHEM, V68, P255; Markesbery WR, 2005, ANN NEUROL, V58, P730, DOI 10.1002/ana.20629; Marshall JWB, 1999, EXP NEUROL, V156, P121, DOI 10.1006/exnr.1998.6994; Melo JB, 2009, EUR J NEUROSCI, V29, P455, DOI 10.1111/j.1460-9568.2009.06612.x; Morel P, 1998, NEUROCHEM INT, V33, P531, DOI 10.1016/S0197-0186(98)00062-X; Mustafa AG, 2010, J NEUROCHEM, V114, P271, DOI 10.1111/j.1471-4159.2010.06749.x; Nam TG, 2011, TOX RESEARCH, V27, P1, DOI 10.5487/TR.2011.27.1.001; Nunomura A, 2001, J NEUROPATH EXP NEUR, V60, P759, DOI 10.1093/jnen/60.8.759; Ohsawa I, 2008, J NEUROSCI, V28, P6239, DOI 10.1523/JNEUROSCI.4956-07.2008; Ohta M, 2013, BRAIN RES, V1490, P184, DOI 10.1016/j.brainres.2012.09.011; Ohta S, 2004, ANN NY ACAD SCI, V1011, P36, DOI 10.1196/annals.1293.004; Ohta S, 2006, J ALZHEIMERS DIS, V9, P155; Okonkwo DO, 2013, J NEUROTRAUM, V30, P1490, DOI 10.1089/neu.2013.2883; Olivieri G, 2001, J NEUROCHEM, V76, P224, DOI 10.1046/j.1471-4159.2001.00090.x; Page S, 1999, J BIOL CHEM, V274, P11611, DOI 10.1074/jbc.274.17.11611; Patel MV, 2019, J NEUROTRAUM, V36, P2129, DOI 10.1089/neu.2018.6291; Patil SS, 2009, BEHAV BRAIN RES, V198, P58, DOI 10.1016/j.bbr.2008.10.029; Pizzimenti S, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00242; Pratico D, 2004, J ALZHEIMERS DIS, V6, P171; Rauniyar N, 2014, J PROTEOME RES, V13, P5293, DOI 10.1021/pr500880b; Reed T, 2008, NEUROBIOL DIS, V30, P107, DOI 10.1016/j.nbd.2007.12.007; Reed TT, 2009, BRAIN RES, V1274, P66, DOI 10.1016/j.brainres.2009.04.009; Rosenfeld CS, 2014, JOVE-J VIS EXP, DOI 10.3791/51194; Schneider JA, 2007, NEUROLOGY, V69, P2197, DOI 10.1212/01.wnl.0000271090.28148.24; Shahripour RB, 2014, BRAIN BEHAV, V4, P108, DOI 10.1002/brb3.208; Shao CX, 2006, FREE RADICAL BIO MED, V41, P77, DOI 10.1016/j.freeradbiomed.2006.03.007; Shringarpure R, 2000, CELL MOL LIFE SCI, V57, P1802, DOI 10.1007/PL00000660; Stern Y, 2009, NEUROPSYCHOLOGIA, V47, P2015, DOI 10.1016/j.neuropsychologia.2009.03.004; Tang SC, 2007, J NEUROCHEM, V101, P729, DOI 10.1111/j.1471-4159.2006.04412.x; Terry AV, 2011, PHARMACOL BIOCHEM BE, V99, P190, DOI 10.1016/j.pbb.2011.02.002; Uryu K, 2002, J NEUROSCI, V22, P446, DOI 10.1523/JNEUROSCI.22-02-00446.2002; VandeVrede L, 2014, BRIT J PHARMACOL, V171, P389, DOI 10.1111/bph.12454; Vos PE, 2010, NEUROLOGY, V75, P1786, DOI 10.1212/WNL.0b013e3181fd62d2; Wahlgren NG, 2000, STROKE, V31, P82, DOI 10.1161/01.STR.31.1.82; Wakade C, 2010, J NEUROSURG, V113, P1195, DOI 10.3171/2010.3.JNS091212; Wang LQ, 2011, J NEUROSCI, V31, P2868, DOI 10.1523/JNEUROSCI.3410-10.2011; Webster SJ, 2015, J NEUROSCI, V35, P6554, DOI 10.1523/JNEUROSCI.0291-15.2015; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Wey MCY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031522; Wilby MJ, 2004, CNS DRUG REV, V10, P281; Yu RL, 2016, SCI REP-UK, V6, DOI 10.1038/srep30424; Zhang ZQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092698; Zhu XW, 2004, LANCET NEUROL, V3, P219, DOI 10.1016/S1474-4422(04)00707-0; Zohar O, 2003, NEUROSCIENCE, V118, P949, DOI 10.1016/S0306-4522(03)00048-4	81	7	7	1	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	2213-2317			REDOX BIOL	Redox Biol.	MAY	2020	32								101486	10.1016/j.redox.2020.101486			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LU0NF	WOS:000537459900012	32155582	Green Published, gold			2022-02-06	
J	Tan, ZJ; Chen, LL; Ren, YC; Jiang, XH; Gao, W				Tan, Zhongju; Chen, Lili; Ren, Yucheng; Jiang, Xiaohang; Gao, Wei			Neuroprotective effects of FK866 against traumatic brain injury: Involvement of p38/ERK pathway	ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY			English	Article							NF-KAPPA-B; CEREBRAL EDEMA; NEURONAL INJURY; RAT-BRAIN; INHIBITOR; APOPTOSIS; NAMPT; INFLAMMATION; ACTIVATION; EXPRESSION	Objective FK866 is an inhibitor of nicotinamide phosphoribosyltransferase (NAMPT), which exhibits neuroprotective effects in ischemic brain injury. However, in traumatic brain injury (TBI), the role and mechanism of FK866 remain unclear. The present research was aimed to investigate whether FK866 could attenuate TBI and clarified the underlying mechanisms. Methods A controlled cortical impact model was established, and FK866 at a dose of 5 mg/kg was administered intraperitoneally at 1 h and 6 h, then twice per day post-TBI until sacrifice. Brain water content, Evans blue dye extravasation, modified neurological severity scores (mNSS), Morris water maze test, enzyme-linked immunosorbent assay (ELISA), immunofluorescence staining, and western blot were performed. Results The results demonstrated that FK866 significantly mitigated the brain edema, blood-brain barrier (BBB) disruption, and ameliorated the neurological function post-TBI. Moreover, FK866 decreased the number of Iba-1-positive cells, GFAP-positive astrocytes, and AQP4-positive cells. FK866 reduced the protein levels of proinflammatory cytokines and inhibited NF-kappa B from translocation to the nucleus. FK866 upregulated the expression of Bcl-2, diminished the expression of Bax and caspase 3, and the number of apoptotic cells. Moreover, p38 MAPK and ERK activation were significantly inhibited by FK866. Interpretation FK866 attenuated TBI-induced neuroinflammation and apoptosis, at least in part, through p38/ERK MAPKs signaling pathway.	[Tan, Zhongju] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Dept Geriatr, Hangzhou, Zhejiang, Peoples R China; [Chen, Lili] Zhejiang Univ, Sch Med, Sir Run Run Shaw Hosp, Dept Neurol, Xiasha Campus, Hangzhou, Zhejiang, Peoples R China; [Ren, Yucheng; Jiang, Xiaohang] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Neurosurg, Hangzhou, Zhejiang, Peoples R China; [Gao, Wei] Zhejiang Univ, Affiliated Hosp 2, Changxing Peoples Hosp, Dept Neurol, Changxing Campus, Changxing, Zhejiang, Peoples R China		Tan, ZJ (corresponding author), Zhejiang Univ, Sch Med, Affiliated Hosp 1, Dept Geriatr, Hangzhou, Zhejiang, Peoples R China.	1514048@zju.edu.cn			Medical and Health Technology Development Program of Zhejiang Province [2018KY462]; Chinese Medicine Science and Technology Program of Zhejiang Province [2018ZB076]; Medical and Health Technology Development Program of Hangzhou [2014A62]	This study was supported by the Medical and Health Technology Development Program of Zhejiang Province (No. 2018KY462), Chinese Medicine Science and Technology Program of Zhejiang Province (No. 2018ZB076) and the Medical and Health Technology Development Program of Hangzhou (No. 2014A62).	Amorini AM, 2016, BBA-MOL BASIS DIS, V1862, P679, DOI 10.1016/j.bbadis.2016.01.023; Barnes PJ, 1997, NEW ENGL J MED, V336, P1066, DOI 10.1056/NEJM199704103361506; Chen CX, 2017, NEUROSCIENCE, V356, P193, DOI 10.1016/j.neuroscience.2017.05.022; Chen JL, 2001, STROKE, V32, P2682, DOI 10.1161/hs1101.098367; Chen T, 2012, NEUROCHEM RES, V37, P983, DOI 10.1007/s11064-011-0691-z; Chu WH, 2013, J TRAUMA ACUTE CARE, V74, P1446, DOI 10.1097/TA.0b013e31829246ad; Cui CM, 2015, MOL MED REP, V12, P2323, DOI 10.3892/mmr.2015.3611; Del Nagro C, 2014, J BIOL CHEM, V289, P35182, DOI 10.1074/jbc.M114.580159; Esposito E, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-66; Fan YQ, 2011, INT J MOL MED, V27, P607, DOI 10.3892/ijmm.2011.621; Gehrke I, 2014, CLIN CANCER RES, V20, P4861, DOI 10.1158/1078-0432.CCR-14-0624; Gholinejad Z, 2017, PEPTIDES, V92, P9, DOI 10.1016/j.peptides.2017.04.007; Guo X, 2018, INT J MOL MED, V42, P505, DOI 10.3892/ijmm.2018.3621; Gupta RK, 2016, MOL NEUROBIOL, V53, P3377, DOI 10.1007/s12035-015-9287-y; Halvorsen B, 2015, ATHEROSCLEROSIS, V243, P204, DOI 10.1016/j.atherosclerosis.2015.09.010; Hudak AM, 2014, BRAIN INJURY, V28, P1602, DOI 10.3109/02699052.2014.936039; Jayakumar AR, 2014, J NEUROTRAUM, V31, P1249, DOI 10.1089/neu.2013.3169; Jha RM, 2018, J NEUROL NEUROSUR PS, V89, P1152, DOI 10.1136/jnnp-2017-317741; Kapoor S, 2013, J NEUROSCI, V33, P17398, DOI 10.1523/JNEUROSCI.2756-13.2013; Karve IP, 2016, BRIT J PHARMACOL, V173, P692, DOI 10.1111/bph.13125; Laiguillon MC, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/ar4467; Li JR, 2016, MOL NEUROBIOL, V53, P2668, DOI 10.1007/s12035-015-9318-8; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Matsuda A, 2014, ANN SURG, V259, P1007, DOI 10.1097/SLA.0000000000000329; Mori T, 2002, J CEREBR BLOOD F MET, V22, P444, DOI 10.1097/00004647-200204000-00008; Morisco C, 2007, CARDIOVASC RES, V76, P453, DOI 10.1016/j.cardiores.2007.07.012; Ng SY, 2019, FRONT CELL NEUROSCI, V13, DOI 10.3389/fncel.2019.00528; Otani N, 2002, J CEREBR BLOOD F MET, V22, P327, DOI 10.1097/00004647-200203000-00010; Presumey J, 2013, ANN RHEUM DIS, V72, P1717, DOI 10.1136/annrheumdis-2012-202403; Pulla VK, 2015, CHEM BIOL DRUG DES, V86, P881, DOI 10.1111/cbdd.12562; Winkler EA, 2016, NEUROSURG CLIN N AM, V27, P473, DOI 10.1016/j.nec.2016.05.008; Wu HJ, 2016, J PINEAL RES, V61, P241, DOI 10.1111/jpi.12344; Yang P, 2015, PHARMAZIE, V70, P650, DOI 10.1691/ph.2015.5614; Zador Z, 2007, PROG BRAIN RES, V161, P185, DOI 10.1016/S0079-6123(06)61012-1; Zhao ZL, 2017, PROTEIN CELL, V8, P801, DOI 10.1007/s13238-017-0414-6	36	7	7	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	2328-9503			ANN CLIN TRANSL NEUR	Ann. Clin. Transl. Neurol.	MAY	2020	7	5					742	756		10.1002/acn3.51044			15	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	LS6NX	WOS:000536499400012	32302063	Green Published, gold			2022-02-06	
J	Wellman, SM; Guzman, K; Stieger, KC; Brink, LE; Sridhar, S; Dubaniewicz, MT; Li, LH; Cambi, F; Kozai, TDY				Wellman, Steven M.; Guzman, Kelly; Stieger, Kevin C.; Brink, Lauren E.; Sridhar, Sadhana; Dubaniewicz, Mitchell T.; Li, Lehong; Cambi, Franca; Kozai, Takashi D. Y.			Cuprizone-induced oligodendrocyte loss and demyelination impairs recording performance of chronically implanted neural interfaces	BIOMATERIALS			English	Article							TRAUMATIC BRAIN-INJURY; WHITE-MATTER; PERINEURONAL OLIGODENDROCYTES; SATELLITE OLIGODENDROCYTES; INFLAMMATORY RESPONSE; MULTIPLE-SCLEROSIS; TISSUE RESPONSES; PRECURSOR CELLS; EEG COHERENCE; MYELIN LOSS	Biological inflammation induced during penetrating cortical injury can disrupt functional neuronal and glial activity within the cortex, resulting in potential recording failure of chronically implanted neural interfaces. Oligodendrocytes provide critical support for neuronal health and function through direct contact with neuronal soma and axons within the cortex. Given their fundamental role to regulate neuronal activity via myelin, coupled with their heightened vulnerability to metabolic brain injury due to high energetic demands, oligodendrocytes are hypothesized as a possible source of biological failure in declining recording performances of intracortical microelectrode devices. To determine the extent of their contribution to neuronal activity and function, a cuprizone-inducible model of oligodendrocyte depletion and demyelination in mice was performed prior to microelectrode implantation. At 5 weeks of cuprizone exposure, mice demonstrated significantly reduced cortical oligodendrocyte density and myelin expression. Mice were then implanted with functional recording microelectrodes in the visual cortex and neuronal activity was evaluated up to 7 weeks alongside continued cuprizone administration. Cuprizone-induced oligodendrocyte loss and demyelination was associated with significantly reduced recording performances at the onset of implantation, which remained relatively stable over time. In contast, recording performances for mice on a normal diet were intially elevated before decreasing over time to the recording level of tcuprizone-treated mice. Further electro-physiological analysis revealed deficits in multi-unit firing rates, frequency-dependent disruptions in neuronal oscillations, and altered laminar communication within the cortex of cuprizone-treated mice. Post-mortem immunohistochemistry revealed robust depletion of oligodendrocytes around implanted microelectrode arrays alongside comparable neuronal densities to control mice, suggesting that oligodendrocyte loss was a possible contributor to chronically impaired device performances. This study highlights potentially significant contributions from the oligodendrocyte lineage population concerning the biological integration and long-term functional performance of neural interfacing technology.	[Wellman, Steven M.; Stieger, Kevin C.; Dubaniewicz, Mitchell T.; Li, Lehong; Kozai, Takashi D. Y.] Univ Pittsburgh, Dept Bioengn, Pittsburgh, PA USA; [Wellman, Steven M.; Stieger, Kevin C.; Kozai, Takashi D. Y.] Ctr Neural Basis Cognit, Pittsburgh, PA 15213 USA; [Guzman, Kelly; Brink, Lauren E.; Sridhar, Sadhana; Cambi, Franca] Vet Adm Pittsburgh, Pittsburgh, PA USA; [Sridhar, Sadhana; Cambi, Franca] Univ Pittsburgh, Dept Neurol, Pittsburgh, PA 15260 USA; [Cambi, Franca] Univ Kentucky, Dept Neurol, Lexington, KY 40536 USA; [Kozai, Takashi D. Y.] Univ Pittsburgh, Ctr Neurosci, Pittsburgh, PA 15260 USA; [Kozai, Takashi D. Y.] Univ Pittsburgh, McGowan Inst Regenerat Med, Pittsburgh, PA USA; [Kozai, Takashi D. Y.] Univ Pittsburgh, Brain Inst, NeuroTech Ctr, Pittsburgh, PA USA		Kozai, TDY (corresponding author), Ctr Neural Basis Cognit, Pittsburgh, PA 15213 USA.	tdk18@pitt.edu		Dubaniewicz, Mitchell/0000-0003-4393-2185; Stieger, Kevin/0000-0002-5542-0956	NIH NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS062019, R21NS108098, R01NS089688, R01NS094396]; VA BLRD [I21BX003237]	This work was supported by NIH NINDS R01NS094396 and a diversity supplement to this parent grant as well as NIH NINDS R21NS108098, NIH NINDS R01NS089688, NIH NINDS R01NS062019, and VA BLRD I21BX003237.	Acs P, 2013, J NEUROIMMUNOL, V262, P128, DOI 10.1016/j.jneuroim.2013.06.012; Alba NA, 2015, BIOSENSORS-BASEL, V5, P618, DOI 10.3390/bios5040618; Alizadeh A, 2015, FRONT MOL NEUROSCI, V8, DOI 10.3389/fnmol.2015.00035; Almeida RG, 2017, J NEUROSCI, V37, P10023, DOI 10.1523/JNEUROSCI.3185-16.2017; Arvidsson A, 2002, NAT MED, V8, P963, DOI 10.1038/nm747; Barrese JC, 2013, J NEURAL ENG, V10, DOI 10.1088/1741-2560/10/6/066014; Barry RJ, 2004, CLIN NEUROPHYSIOL, V115, P2252, DOI 10.1016/j.clinph.2004.05.004; Battefeld A, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11298; Baumann N, 2001, PHYSIOL REV, V81, P871, DOI 10.1152/physrev.2001.81.2.871; Baxi EG, 2017, GLIA, V65, P2087, DOI 10.1002/glia.23229; Benardais K, 2013, NEUROTOX RES, V24, P244, DOI 10.1007/s12640-013-9380-9; Benetti F, 2010, NEUROTOXICOLOGY, V31, P509, DOI 10.1016/j.neuro.2010.05.008; Berninger B, 2007, J NEUROSCI, V27, P8654, DOI 10.1523/JNEUROSCI.1615-07.2007; Bowyer S.M., 2016, NEUROPSYCHIATR ELECT, V2, P1, DOI 10.1186/s40810-015-0015-7; Bradl M, 2010, ACTA NEUROPATHOL, V119, P37, DOI 10.1007/s00401-009-0601-5; Buzsaki G, 2015, NEURON, V86, P92, DOI 10.1016/j.neuron.2015.01.028; Chestek CA, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/4/045005; Clarke AR, 2008, INT J PSYCHOPHYSIOL, V67, P35, DOI 10.1016/j.ijpsycho.2007.10.001; Cody PA, 2018, BIOMATERIALS, V161, P117, DOI 10.1016/j.biomaterials.2018.01.025; Collinger JL, 2013, LANCET, V381, P557, DOI 10.1016/S0140-6736(12)61816-9; Dent KA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121541; Dewar D, 2003, J CEREBR BLOOD F MET, V23, P263, DOI 10.1097/01.WCB.0000053472.41007.F9; Dimou L, 2015, GLIA, V63, P1429, DOI 10.1002/glia.22859; Donkin JJ, 2010, CURR OPIN NEUROL, V23, P293, DOI 10.1097/WCO.0b013e328337f451; DOU CL, 1994, J NEUROSCI, V14, P7616; Dougherty KD, 2000, NEUROBIOL DIS, V7, P574, DOI 10.1006/nbdi.2000.0318; Du ZJ, 2017, ACTA BIOMATER, V53, P46, DOI 10.1016/j.actbio.2017.02.010; Eles JR, 2019, BIOMATERIALS, V195, P111, DOI 10.1016/j.biomaterials.2018.12.031; Eles JR, 2020, BIOMATERIALS, V234, DOI 10.1016/j.biomaterials.2020.119767; Eles JR, 2018, BIOMATERIALS, V174, P79, DOI 10.1016/j.biomaterials.2018.04.043; Eles JR, 2017, BIOMATERIALS, V113, P279, DOI 10.1016/j.biomaterials.2016.10.054; Ettle B, 2016, MOL NEUROBIOL, V53, P3046, DOI 10.1007/s12035-015-9205-3; Faizi M, 2016, TOXICOL MECH METHOD, V26, P276, DOI 10.3109/15376516.2016.1172284; Falco A, 2014, EXP BRAIN RES, V232, P2439, DOI 10.1007/s00221-014-3944-7; Filley CM, 2016, J NEUROPHYSIOL, V116, P2093, DOI 10.1152/jn.00221.2016; Filous AR, 2014, J NEUROSCI, V34, P16369, DOI 10.1523/JNEUROSCI.1309-14.2014; Fleck JI, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00392; Flygt J, 2013, EUR J NEUROSCI, V38, P2153, DOI 10.1111/ejn.12179; Franco-Pons N, 2009, J MOL NEUROSCI, V38, P2, DOI 10.1007/s12031-008-9151-x; FRIEDLANDER DR, 1994, J CELL BIOL, V125, P669, DOI 10.1083/jcb.125.3.669; Funfschilling U, 2012, NATURE, V485, P517, DOI 10.1038/nature11007; Golabchi A, 2018, BIOMATERIALS, V180, P225, DOI 10.1016/j.biomaterials.2018.07.026; Gudi V, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00073; Gudi V, 2009, BRAIN RES, V1283, P127, DOI 10.1016/j.brainres.2009.06.005; Gybina AA, 2008, BRAIN RES, V1204, P69, DOI 10.1016/j.brainres.2008.01.087; Hackett AR, 2016, NEUROBIOL DIS, V89, P10, DOI 10.1016/j.nbd.2016.01.017; Hamada MS, 2015, J NEUROSCI, V35, P7272, DOI 10.1523/JNEUROSCI.4747-14.2015; Hartline DK, 2008, NEURON GLIA BIOL, V4, P153, DOI 10.1017/S1740925X09990263; Hatsopoulos NG, 2009, ANNU REV NEUROSCI, V32, P249, DOI 10.1146/annurev.neuro.051508.135241; Hochberg LR, 2006, NATURE, V442, P164, DOI 10.1038/nature04970; Hoffmann K, 2008, EXP NEUROL, V210, P308, DOI 10.1016/j.expneurol.2007.11.005; Howarth C, 2012, J CEREBR BLOOD F MET, V32, P1222, DOI 10.1038/jcbfm.2012.35; Hughes EG, 2013, NAT NEUROSCI, V16, P668, DOI 10.1038/nn.3390; Iordanova B, 2018, J CEREBR BLOOD F MET, V38, P627, DOI 10.1177/0271678X18755225; Jana A, 2009, J NEUROL SCI, V278, P5, DOI 10.1016/j.jns.2008.12.010; Jeffries MA, 2016, J NEUROSCI, V36, P9186, DOI 10.1523/JNEUROSCI.1444-16.2016; Juurlink BHJ, 1997, NEUROSCI BIOBEHAV R, V21, P151, DOI 10.1016/S0149-7634(96)00005-X; Kasischke KA, 2004, SCIENCE, V305, P99, DOI 10.1126/science.1096485; Kipp M, 2009, ACTA NEUROPATHOL, V118, P723, DOI 10.1007/s00401-009-0591-3; Kiray H, 2016, EXP NEUROL, V283, P541, DOI 10.1016/j.expneurol.2016.03.009; Kolarcik CL, 2015, SOFT MATTER, V11, P4847, DOI 10.1039/c5sm00174a; Kotter MR, 2006, J NEUROSCI, V26, P328, DOI 10.1523/JNEUROSCI.2615-05.2006; Kozai TDY, 2010, J NEURAL ENG, V7, DOI 10.1088/1741-2560/7/4/046011; Kozai TDY, 2016, J NEUROSCI METH, V258, P46, DOI 10.1016/j.jneumeth.2015.10.007; Kozai TDY, 2016, IEEE T BIO-MED ENG, V63, P111, DOI 10.1109/TBME.2015.2445713; Kozai TDY, 2015, ACS CHEM NEUROSCI, V6, P48, DOI 10.1021/cn500256e; Kozai TDY, 2015, BIOMATERIALS, V37, P25, DOI 10.1016/j.biomaterials.2014.10.040; Kozai TDY, 2014, BIOMATERIALS, V35, P9620, DOI 10.1016/j.biomaterials.2014.08.006; Kozai TDY, 2014, BIOMATERIALS, V35, P9255, DOI 10.1016/j.biomaterials.2014.07.039; Kramer EM, 2001, MICROSC RES TECHNIQ, V52, P656, DOI 10.1002/jemt.1050; Kuhlmann T, 2008, BRAIN, V131, P1749, DOI 10.1093/brain/awn096; Lee YJ, 2012, NATURE, V487, P443, DOI 10.1038/nature11314; Levine JM, 1999, EXP NEUROL, V160, P333, DOI 10.1006/exnr.1999.7224; LEVINE SM, 1993, DEV BRAIN RES, V75, P279, DOI 10.1016/0165-3806(93)90032-6; Lotocki G, 2011, NEUROSCI LETT, V499, P143, DOI 10.1016/j.neulet.2011.05.056; Ludwig KA, 2009, J NEUROPHYSIOL, V101, P1679, DOI 10.1152/jn.90989.2008; LUDWIN SK, 1979, ACTA NEUROPATHOL, V47, P49, DOI 10.1007/BF00698272; Maier A, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00031; Markoullis K, 2014, J NEUROPATH EXP NEUR, V73, P865, DOI 10.1097/NEN.0000000000000106; Matsushima GK, 2001, BRAIN PATHOL, V11, P107; Michelson NJ, 2019, J NEUROSCI RES, V97, P620, DOI 10.1002/jnr.24370; Michelson NJ, 2018, J NEUROPHYSIOL, V120, P2232, DOI 10.1152/jn.00299.2018; Michelson NJ, 2018, J NEURAL ENG, V15, DOI 10.1088/1741-2552/aa9dae; Micheva KD, 2016, ELIFE, V5, DOI 10.7554/eLife.15784; Morell P, 1998, MOL CELL NEUROSCI, V12, P220, DOI 10.1006/mcne.1998.0715; Napoli I, 2010, EXP NEUROL, V225, P24, DOI 10.1016/j.expneurol.2009.04.024; Nguyen JK, 2016, ACTA BIOMATER, V29, P81, DOI 10.1016/j.actbio.2015.11.001; Nicolai E., 2018, DESIGN CHOICES NEXT, V9, P494; Nicolai EN, 2018, MICROMACHINES-BASEL, V9, DOI 10.3390/mi9100494; Nomura T, 2019, NEUROCHEM INT, V126, P229, DOI 10.1016/j.neuint.2019.03.018; Nualart-Marti A, 2013, BBA-BIOMEMBRANES, V1828, P69, DOI 10.1016/j.bbamem.2012.01.024; Pajevic S, 2014, NEUROSCIENCE, V276, P135, DOI 10.1016/j.neuroscience.2013.11.007; Parenti R, 2010, GLIA, V58, P1594, DOI 10.1002/glia.21032; Pasquini LA, 2007, NEUROCHEM RES, V32, P279, DOI 10.1007/s11064-006-9165-0; Pena K, 2015, CELL CALCIUM, V57, P257, DOI 10.1016/j.ceca.2015.01.005; Philips T, 2017, J CLIN INVEST, V127, P3277, DOI 10.1172/JCI90610; Potter KA, 2013, BIOMATERIALS, V34, P7001, DOI 10.1016/j.biomaterials.2013.05.035; Potter-Baker KA, 2014, J MATER CHEM B, V2, P2248, DOI 10.1039/c4tb00125g; Praet J, 2014, NEUROSCI BIOBEHAV R, V47, P485, DOI 10.1016/j.neubiorev.2014.10.004; Prasad A, 2012, J NEURAL ENG, V9, DOI 10.1088/1741-2560/9/5/056015; Prasad A, 2011, IEEE ENG MED BIO, P3020, DOI 10.1109/IEMBS.2011.6090827; Rash JE, 2010, NEUROSCIENCE, V168, P982, DOI 10.1016/j.neuroscience.2009.10.028; Rosko L, 2019, NEUROSCIENTIST, V25, P334, DOI 10.1177/1073858418793077; Rossi S, 2012, MULT SCLER J, V18, P1633, DOI 10.1177/1352458512440207; Roth AD, 2016, ADV EXP MED BIOL, V949, P167, DOI 10.1007/978-3-319-40764-7_8; Rousche PJ, 1998, J NEUROSCI METH, V82, P1, DOI 10.1016/S0165-0270(98)00031-4; Rowley CD, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00396; Rozai TDY, 2015, J NEUROSCI METH, V242, P15, DOI 10.1016/j.jneumeth.2014.12.010; Salatino JW, 2017, NAT BIOMED ENG, V1, P862, DOI 10.1038/s41551-017-0154-1; Schwartz AB, 2006, NEURON, V52, P205, DOI 10.1016/j.neuron.2006.09.019; Sen MK, 2019, NEUROSCI BIOBEHAV R, V107, P23, DOI 10.1016/j.neubiorev.2019.08.008; Skripuletz T, 2008, AM J PATHOL, V172, P1053, DOI 10.2353/ajpath.2008.070850; Smith KJ, 1999, PHILOS T R SOC B, V354, P1649, DOI 10.1098/rstb.1999.0510; Song J, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00055; Stocking KC, 2019, IEEE T BIO-MED ENG, V66, P2402, DOI 10.1109/TBME.2018.2889832; Streit WJ, 2012, IEEE PULSE, V3, P30, DOI 10.1109/MPUL.2011.2175632; Takasaki C, 2010, EUR J NEUROSCI, V32, P1326, DOI 10.1111/j.1460-9568.2010.07377.x; Takmakov P, 2015, J NEURAL ENG, V12, DOI 10.1088/1741-2560/12/2/026003; Taniike M, 2002, J NEUROSCI, V22, P4885, DOI 10.1523/JNEUROSCI.22-12-04885.2002; Taraboletti A, 2017, BIOCHEMISTRY-US, V56, P1518, DOI 10.1021/acs.biochem.6b01072; Thorburne SK, 1996, J NEUROCHEM, V67, P1014; Tomassy GS, 2014, SCIENCE, V344, P319, DOI 10.1126/science.1249766; Torkildsen O, 2008, ACTA NEUROL SCAND, V117, P72, DOI 10.1111/j.1600-0404.2008.01036.x; Tripathi RB, 2010, J NEUROSCI, V30, P16383, DOI 10.1523/JNEUROSCI.3411-10.2010; Valerio-Gomes B, 2018, FRONT NEUROANAT, V12, DOI 10.3389/fnana.2018.00090; Vickers JC, 1996, EXP NEUROL, V141, P1, DOI 10.1006/exnr.1996.0133; Wang G, 2016, IEEE J BIOMED HEALTH, V20, P873, DOI 10.1109/JBHI.2015.2424074; Wellman SM, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00493; Wellman SM, 2018, BIOMATERIALS, V183, P200, DOI 10.1016/j.biomaterials.2018.08.046; Wellman SM, 2018, ADV FUNCT MATER, V28, DOI 10.1002/adfm.201701269; Wellman SM, 2018, BIOMATERIALS, V164, P121, DOI 10.1016/j.biomaterials.2018.02.037; Wellman SM, 2017, ACS CHEM NEUROSCI, V8, P2578, DOI 10.1021/acschemneuro.7b00403; Werner SR, 2010, J MOL NEUROSCI, V42, P210, DOI 10.1007/s12031-010-9354-9; Williams JC, 1999, BRAIN RES PROTOC, V4, P303, DOI 10.1016/S1385-299X(99)00034-3; Williams JC, 2007, J NEURAL ENG, V4, P410, DOI 10.1088/1741-2560/4/4/007; Winslow BD, 2010, BIOMATERIALS, V31, P9163, DOI 10.1016/j.biomaterials.2010.05.050; Winslow BD, 2010, BIOMATERIALS, V31, P1558, DOI 10.1016/j.biomaterials.2009.11.049; Woolley AJ, 2011, J NEUROSCI METH, V201, P67, DOI 10.1016/j.jneumeth.2011.07.012; Xing B, 2018, GLIA, V66, P1999, DOI 10.1002/glia.23453; Zheng XS, 2019, ACTA BIOMATER, V99, P72, DOI 10.1016/j.actbio.2019.08.032; Zhong YH, 2007, BRAIN RES, V1148, P15, DOI 10.1016/j.brainres.2007.02.024	141	7	7	0	6	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0142-9612	1878-5905		BIOMATERIALS	Biomaterials	MAY	2020	239								119842	10.1016/j.biomaterials.2020.119842			23	Engineering, Biomedical; Materials Science, Biomaterials	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Materials Science	KT2TO	WOS:000518868700001	32065972	Green Accepted			2022-02-06	
J	Rodriguez-Barrera, R; Flores-Romero, A; Garcia, E; Fernandez-Presas, AM; Incontri-Abraham, D; Navarro-Torres, L; Garcia-Sanchez, J; Whaley, JJJV; Madrazo, I; Ibarra, A				Rodriguez-Barrera, Roxana; Flores-Romero, Adrian; Garcia, Elisa; Fernandez-Presas, Ana Maria; Incontri-Abraham, Diego; Navarro-Torres, Lisset; Garcia-Sanchez, Julian; Juarez-Vignon Whaley, Juan Jose; Madrazo, Ignacio; Ibarra, Antonio			Immunization with neural-derived peptides increases neurogenesis in rats with chronic spinal cord injury	CNS NEUROSCIENCE & THERAPEUTICS			English	Article						A91 peptide; INDP; neurogenesis; paraplegia; protective autoimmunity; SCI; chronic stage; motor recovery; sensitive recovery; protective autoimmunity; traumatic brain injury	CELL-PROLIFERATION; DENTATE GYRUS; ACTIVATION; EXPRESSION; GAP-43; DIFFERENTIATION; PATHOLOGY; DOPAMINE; OCCURS; CYCLE	Aims Immunization with neural-derived peptides (INDP) has demonstrated to be a promising therapy to achieve a regenerative effect in the chronic phase of the spinal cord injury (SCI). Nevertheless, INDP-induced neurogenic effects in the chronic stage of SCI have not been explored. Methods and Results In this study, we analyzed the effect of INDP on both motor and sensitive function recovery; afterward, we assessed neurogenesis and determined the production of cytokines (IL-4, IL-10, and TNF alpha) and neurotrophic factors (BDNF and GAP-43). During the chronic stage of SCI, rats subjected to INDP showed a significant increase in both motor and sensitive recovery when compared to the control group. Moreover, we found a significant increase in neurogenesis, mainly at the central canal and at both the dorsal and ventral horns of INDP-treated animals. Finally, INDP induced significant production of antiinflammatory and regeneration-associated proteins in the chronic stages of SCI. Conclusions These findings suggest that INDP has a neurogenic effect that could improve motor and sensitive recovery in the chronic stage of SCI. Moreover, our results also envision the use of INDP as a possible therapeutic strategy for other trauma-related disorders like traumatic brain injury.	[Rodriguez-Barrera, Roxana; Flores-Romero, Adrian; Garcia, Elisa; Incontri-Abraham, Diego; Navarro-Torres, Lisset; Garcia-Sanchez, Julian; Juarez-Vignon Whaley, Juan Jose; Ibarra, Antonio] Univ Anahuac Mexico Campus Norte, FCS, Ctr Invest Ciencias Salud CICSA, Huixquilucan 52786, Edo De Mexico, Mexico; [Fernandez-Presas, Ana Maria] Col Univ Nacl Autonoma Mexico, Dept Microbiol & Parasitol, Fac Med, Coyoacan, Mexico; [Madrazo, Ignacio; Ibarra, Antonio] Proyecto CAMINA AC, Tlalpan, Mexico; [Madrazo, Ignacio] IMSS, Unidad Invest Med Enfermedades Neurol, CMN Siglo XXI, Mexico City, DF, Mexico		Ibarra, A (corresponding author), Univ Anahuac Mexico Campus Norte, FCS, Ctr Invest Ciencias Salud CICSA, Huixquilucan 52786, Edo De Mexico, Mexico.	jose.ibarra@anahuac.mx		Rodriguez-Barrera, Roxana H./0000-0003-4457-1422; Juarez - Vignon Whaley, Juan Jose/0000-0001-5570-2147; garcia vences, edna elisa/0000-0001-7588-3846; Incontri, Diego/0000-0001-6764-129X	National Council of Science and Technology of Mexico (CONACyT)Consejo Nacional de Ciencia y Tecnologia (CONACyT) [178544]; Camina Research Center; Universidad Anahuac Mexico Campus Norte	AI has been partially funded by the National Council of Science and Technology of Mexico (CONACyT), grant No. 178544, Camina Research Center, and Universidad Anahuac Mexico Campus Norte.	Bambakidis NC, 2008, NEUROSURG FOCUS, V24, DOI 10.3171/FOC/2008/24/3-4/E19; Banasr M, 2001, EUR J NEUROSCI, V14, P1417, DOI 10.1046/j.0953-816x.2001.01763.x; Banasr M, 2004, NEUROPSYCHOPHARMACOL, V29, P450, DOI 10.1038/sj.npp.1300320; Foltran RB, 2016, J NEUROCHEM, V138, P204, DOI 10.1111/jnc.13658; Bhattarai P, 2016, CELL REP, V17, P941, DOI 10.1016/j.celrep.2016.09.075; Bravo G, 2007, BASIC CLIN PHARMACOL, V100, P67, DOI 10.1111/j.1742-7843.2007.00004.x; Brezun JM, 1999, NEUROSCIENCE, V89, P999, DOI 10.1016/S0306-4522(98)00693-9; Butovsky O, 2005, MOL CELL NEUROSCI, V29, P381, DOI 10.1016/j.mcn.2005.03.005; Carelli S, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8040329; Cheng LH, 2019, MOL PHARMACEUT, V16, P1423, DOI 10.1021/acs.molpharmaceut.8b00939; Colburn RW, 1999, EXP NEUROL, V157, P289, DOI 10.1006/exnr.1999.7065; Cruz Y, 2018, NEURAL REGEN RES, V13, P1743, DOI 10.4103/1673-5374.238615; Cruz Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121854; Decimo I, 2011, STEM CELLS, V29, P2062, DOI 10.1002/stem.766; Dehler S, 2018, FRONT MOL NEUROSCI, V11, DOI 10.3389/fnmol.2018.00443; Duan HM, 2016, SCI CHINA LIFE SCI, V59, P1313, DOI 10.1007/s11427-016-0205-2; Ermine CM, 2018, HIPPOCAMPUS, V28, P327, DOI 10.1002/hipo.22835; Garcia E, 2012, J NEUROSCI RES, V90, P656, DOI 10.1002/jnr.22771; Gonzalez-Perez Oscar, 2010, J Stem Cells, V5, P23, DOI jsc.2010.5.1.23; Hagen EM, 2015, WORLD J ORTHOP, V6, P17, DOI 10.5312/wjo.v6.i1.17; Huang R, 2015, INT J DEV NEUROSCI, V47, P333, DOI 10.1016/j.ijdevneu.2015.07.013; Hugnot JP, 2011, FRONT BIOSCI-LANDMRK, V16, P1044, DOI 10.2741/3734; Ibarra A, 2004, EUR J NEUROSCI, V19, P2984, DOI 10.1111/j.0953-816X.2004.03402.x; Ibarra A, 2019, CNS NEUROL DISORD-DR, V18, P52, DOI 10.2174/1871527317666181105101756; Ibarra A, 2010, NEUROSCI LETT, V476, P62, DOI 10.1016/j.neulet.2010.04.003; Jain NB, 2015, JAMA-J AM MED ASSOC, V313, P2236, DOI 10.1001/jama.2015.6250; Ke Y, 2006, STEM CELLS, V24, P1011, DOI 10.1634/stemcells.2005-0249; Kwon Brian K, 2004, Spine J, V4, P451, DOI 10.1016/j.spinee.2003.07.007; Lacroix S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085916; Liu TT, 2017, CNS NEUROSCI THER, V23, P885, DOI 10.1111/cns.12763; Mani S, 2001, MOL CELL NEUROSCI, V17, P54, DOI 10.1006/mcne.2000.0931; Martino G, 2011, PHYSIOL REV, V91, P1281, DOI 10.1152/physrev.00032.2010; Martinon S, 2016, BMC NEUROSCI, V17, DOI 10.1186/s12868-016-0267-6; Martinon S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032027; Norenberg MD, 2004, J NEUROTRAUM, V21, P429, DOI 10.1089/089771504323004575; Ohira K, 2020, NEURAL REGEN RES, V15, P390, DOI 10.4103/1673-5374.266052; Park Soo Dong, 2015, Korean J Neurotrauma, V11, P180, DOI 10.13004/kjnt.2015.11.2.180; Pereira L, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00057; Rodriguez-Barrera R, 2017, BMC NEUROSCI, V18, DOI 10.1186/s12868-016-0331-2; Rodriguez-Meza MV, 2016, SPINAL CORD, V54, P266, DOI 10.1038/sc.2015.164; Ruan LH, 2014, PROG NEUROBIOL, V115, P116, DOI 10.1016/j.pneurobio.2013.12.006; Savage S, 2015, BRIT J ANAESTH, V114, P721, DOI 10.1093/bja/aeu346; SCHOUENBORG J, 1992, EXP BRAIN RES, V90, P469; Schwartz M, 2005, J NEUROL SCI, V233, P163, DOI 10.1016/j.jns.2005.03.014; Shi Wang-Qing, 2013, Zhongguo Ying Yong Sheng Li Xue Za Zhi, V29, P63; Shohayeb B, 2018, TRANSL NEURODEGENER, V7, DOI 10.1186/s40035-018-0109-9; Su ZD, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4338; Tashiro S, 2017, NEURAL REGEN RES, V12, P43, DOI 10.4103/1673-5374.198972; Walsh James T, 2015, J Clin Invest, V125, P2547, DOI 10.1172/JCI82458; Wang JX, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00361; Wang SN, 2016, CNS NEUROSCI THER, V22, P431, DOI 10.1111/cns.12539; Weissman T, 2003, CEREB CORTEX, V13, P550, DOI 10.1093/cercor/13.6.550; Zhang B, 2019, CNS NEUROSCI THER, V25, P591, DOI 10.1111/cns.13092; Zhao JP, 2009, INT J DEV NEUROSCI, V27, P531, DOI 10.1016/j.ijdevneu.2009.06.013	54	7	7	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1755-5930	1755-5949		CNS NEUROSCI THER	CNS Neurosci. Ther.	JUN	2020	26	6			SI		650	658		10.1111/cns.13368		APR 2020	9	Neurosciences; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pharmacology & Pharmacy	LQ8CX	WOS:000529810700001	32352656	Green Published, Green Submitted, gold			2022-02-06	
J	Churchill, NW; Hutchison, MG; Graham, SJ; Schweizer, TA				Churchill, Nathan W.; Hutchison, Michael G.; Graham, Simon J.; Schweizer, Tom A.			Scale-free functional brain dynamics during recovery from sport-related concussion	HUMAN BRAIN MAPPING			English	Article						BOLD fMRI; brain injury; concussion; scale free	DEFAULT-MODE NETWORK; BOLD FMRI STATISTICS; EMPIRICAL ANALYSES; NULL-HYPOTHESIS; SEX-DIFFERENCES; MOTOR CONTROL; MILD; TIME; CONNECTIVITY; OSCILLATIONS	Studies using blood-oxygenation-level-dependent functional magnetic resonance imaging (BOLD fMRI) have characterized how the resting brain is affected by concussion. The literature to date, however, has largely focused on measuring changes in the spatial organization of functional brain networks. In the present study, changes in the temporal dynamics of BOLD signals are examined throughout concussion recovery using scaling (or fractal) analysis. Imaging data were collected for 228 university-level athletes, 61 with concussion and 167 athletic controls. Concussed athletes were scanned at the acute phase of injury (1-7 days postinjury), the subacute phase (8-14 days postinjury), medical clearance to return to sport (RTS), 1 month post-RTS and 1 year post-RTS. The wavelet leader multifractal approach was used to assess scaling ( c(1)) and multifractal ( c(2)) behavior. Significant longitudinal changes were identified for c(1), which was lowest at acute injury, became significantly elevated at RTS, and returned near control levels by 1 year post-RTS. No longitudinal changes were identified for c(2). Secondary analyses showed that clinical measures of acute symptom severity and time to RTP were related to longitudinal changes in c(1). Athletes with both higher symptoms and prolonged recovery had elevated c(1) values at RTS, while athletes with higher symptoms but rapid recovery had reduced c(1) at acute injury. This study provides the first evidence for long-term recovery of BOLD scale-free brain dynamics after a concussion.	[Churchill, Nathan W.; Hutchison, Michael G.; Schweizer, Tom A.] St Michaels Hosp, Neurosci Res Program, 209 Victoria St, Toronto, ON, Canada; [Churchill, Nathan W.; Hutchison, Michael G.; Schweizer, Tom A.] St Michaels Hosp, Keenan Res Ctr Biomed Sci, Toronto, ON, Canada; [Hutchison, Michael G.] Univ Toronto, Fac Kinesiol & Phys Educ, Toronto, ON, Canada; [Graham, Simon J.] Sunnybrook Res Inst, Phys Sci Platform, Toronto, ON, Canada; [Graham, Simon J.] Univ Toronto, Dept Med Biophys, Fac Med, Toronto, ON, Canada; [Schweizer, Tom A.] Univ Toronto, Fac Med Neurosurg, Toronto, ON, Canada		Churchill, NW (corresponding author), St Michaels Hosp, Neurosci Res Program, 209 Victoria St, Toronto, ON, Canada.	nchurchill.research@gmail.com			Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR) [RN356342-401065, RN294001-367456]; Canadian Institutes of Military and Veterans Health [W7714-145967]; Siemens Canada Ltd.	Canadian Institutes of Health Research, Grant/Award Number: RN356342-401065, RN294001-367456; Canadian Institutes of Military and Veterans Health, Grant/Award Number: W7714-145967; Siemens Canada Ltd.	Abry P, 1998, IEEE T INFORM THEORY, V44, P2, DOI 10.1109/18.650984; Abry P., 1995, WAVELETS STAT, DOI [10.1007/978-1-4612-2544-7_2, DOI 10.1007/978-1-4612-2544-7_2]; Aguirre GK, 1997, NEUROIMAGE, V5, P199, DOI 10.1006/nimg.1997.0264; Barnes A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006626; Behrmann M, 2004, CURR OPIN NEUROBIOL, V14, P212, DOI 10.1016/j.conb.2004.03.012; Brahm KD, 2009, OPTOMETRY VISION SCI, V86, P817, DOI 10.1097/OPX.0b013e3181adff2d; Capo-Aponte JE, 2012, MIL MED, V177, P804, DOI 10.7205/MILMED-D-12-00061; Churchill N, 2017, BRAIN INJURY, V31, P39, DOI 10.1080/02699052.2016.1221135; Churchill NW, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07742-3; Churchill NW, 2017, NEUROIMAGE-CLIN, V14, P480, DOI 10.1016/j.nicl.2017.02.015; Churchill NW, 2016, SCI REP-UK, V6, DOI 10.1038/srep30895; Churchill NW, 2015, HUM BRAIN MAPP, V36, P1077, DOI 10.1002/hbm.22687; Ciuciu P, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00186; Critchley HD, 2004, NAT NEUROSCI, V7, P189, DOI 10.1038/nn1176; Daneshvar DH, 2011, CLIN SPORT MED, V30, P1, DOI 10.1016/j.csm.2010.08.006; Daubechies I., 1992, 10 LECT WAVELETS, V61, DOI 10.1063/14823127; Dosenbach NUF, 2010, SCIENCE, V329, P1358, DOI 10.1126/science.1194144; Echemendia RJ, 2001, CLIN J SPORT MED, V11, P23, DOI 10.1097/00042752-200101000-00005; Echemendia RJ, 2017, BRIT J SPORT MED, V51, P895, DOI 10.1136/bjsports-2016-097466; Eierud C, 2014, NEUROIMAGE-CLIN, V4, P283, DOI 10.1016/j.nicl.2013.12.009; Eke A, 2000, PFLUG ARCH EUR J PHY, V439, P403, DOI 10.1007/s004249900135; Etkin A, 2011, TRENDS COGN SCI, V15, P85, DOI 10.1016/j.tics.2010.11.004; Fan LZ, 2016, CEREB CORTEX, V26, P3508, DOI 10.1093/cercor/bhw157; Fox MD, 2007, NEURON, V56, P171, DOI 10.1016/j.neuron.2007.08.023; Fuster JM, 2000, EXP BRAIN RES, V133, P66, DOI 10.1007/s002210000401; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Goldberger AL, 2002, P NATL ACAD SCI USA, V99, P2466, DOI 10.1073/pnas.012579499; Guo ZP, 2017, FRONT BEHAV NEUROSCI, V11, DOI 10.3389/fnbeh.2017.00072; Guskiewicz KM, 2013, BRIT J SPORT MED, V47, P289, DOI 10.1136/bjsports-2013-092225; Haas BW, 2007, BEHAV NEUROSCI, V121, P249, DOI 10.1037/0735-7044.121.2.249; He BYJ, 2014, TRENDS COGN SCI, V18, P480, DOI 10.1016/j.tics.2014.04.003; He BYJ, 2011, J NEUROSCI, V31, P13786, DOI 10.1523/JNEUROSCI.2111-11.2011; Hillary FG, 2017, TRENDS COGN SCI, V21, P385, DOI 10.1016/j.tics.2017.03.003; Hoffstaedter F, 2014, HUM BRAIN MAPP, V35, P2741, DOI 10.1002/hbm.22363; Hutchison MG, 2017, J HEAD TRAUMA REHAB, V32, pE38, DOI 10.1097/HTR.0000000000000252; Johnson B, 2012, NEUROIMAGE, V59, P511, DOI 10.1016/j.neuroimage.2011.07.081; Lashermes B, 2005, INT CONF ACOUST SPEE, P161; LeDoux J, 2003, CELL MOL NEUROBIOL, V23, P727, DOI 10.1023/A:1025048802629; Lissek S, 2007, NEUROIMAGE, V37, P912, DOI 10.1016/j.neuroimage.2007.05.037; Lovell MR, 2007, NEUROSURGERY, V61, P352, DOI 10.1227/01.NEU.0000279985.94168.7F; Mainwaring L, 2012, J CLIN SPORT PSYCHOL, V6, P247, DOI 10.1123/jcsp.6.3.247; Mandelbrot BB., 1983, FRACTAL GEOMETRY NAT; McAllister TW, 2006, J NEUROTRAUM, V23, P1450, DOI 10.1089/neu.2006.23.1450; McCrea M, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097447; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Peyron R, 2007, NEUROPHYSIOL CLIN, V37, P249, DOI 10.1016/j.neucli.2007.07.002; Sandel N, 2017, SPORT EXERC PERFORM, V6, P304, DOI 10.1037/spy0000098; Schomaker M, 2018, STAT MED, V37, P2252, DOI 10.1002/sim.7654; Shimizu Y, 2004, NEUROIMAGE, V22, P1195, DOI 10.1016/j.neuroimage.2004.03.007; Slobounov S, 2012, BRAIN IMAGING BEHAV, V6, P224, DOI 10.1007/s11682-012-9167-2; Smit DJA, 2011, J NEUROSCI, V31, P13128, DOI 10.1523/JNEUROSCI.1678-11.2011; Sporns O, 2014, NAT NEUROSCI, V17, P652, DOI 10.1038/nn.3690; Suckling J, 2008, J NEUROSCI METH, V174, P292, DOI 10.1016/j.jneumeth.2008.06.037; Terry DP, 2012, BRAIN INJURY, V26, P1684, DOI 10.3109/02699052.2012.722259; Tian LX, 2011, NEUROIMAGE, V54, P191, DOI 10.1016/j.neuroimage.2010.07.066; Tolkunov D, 2010, NEUROIMAGE, V50, P72, DOI 10.1016/j.neuroimage.2009.12.021; Vagnozzi R, 2008, NEUROSURGERY, V62, P1286, DOI 10.1227/01.neu.0000333300.34189.74; Van de Ville D, 2010, P NATL ACAD SCI USA, V107, P18179, DOI 10.1073/pnas.1007841107; Veitch D, 1999, IEEE T INFORM THEORY, V45, P878, DOI 10.1109/18.761330; Wei GX, 2010, BRAIN RES, V1341, P52, DOI 10.1016/j.brainres.2009.08.014; Wendt H, 2007, IEEE T SIGNAL PROCES, V55, P4811, DOI 10.1109/TSP.2007.896269; Wendt H, 2007, IEEE SIGNAL PROC MAG, V24, P38, DOI 10.1109/MSP.2007.4286563; Werner G, 2010, FRONT PHYSIOL, V1, DOI 10.3389/fphys.2010.00015; Wink AM, 2008, HUM BRAIN MAPP, V29, P791, DOI 10.1002/hbm.20593; Zarahn E, 1997, NEUROIMAGE, V5, P179, DOI 10.1006/nimg.1997.0263; Zhang K, 2012, J NEUROTRAUM, V29, P756, DOI 10.1089/neu.2011.2125; Zhu DC, 2015, J NEUROTRAUM, V32, P327, DOI 10.1089/neu.2014.3413; Zuo XN, 2010, J NEUROSCI, V30, P15034, DOI 10.1523/JNEUROSCI.2612-10.2010	69	7	7	2	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1065-9471	1097-0193		HUM BRAIN MAPP	Hum. Brain Mapp.	JUL	2020	41	10					2567	2582		10.1002/hbm.24962		APR 2020	16	Neurosciences; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	LX7LN	WOS:000529263100001	32348019	gold, Green Published			2022-02-06	
J	Ptito, A; Papa, L; Gregory, K; Folmer, RL; Walker, WC; Prabhakaran, V; Wardini, R; Skinner, K; Yochelson, M				Ptito, Alain; Papa, Linda; Gregory, Kenton; Folmer, Robert L.; Walker, William C.; Prabhakaran, Vivek; Wardini, Rima; Skinner, Kim; Yochelson, Michael			A Prospective, Multicenter Study to Assess the Safety and Efficacy of Translingual Neurostimulation Plus Physical Therapy for the Treatment of a Chronic Balance Deficit Due to Mild-to-Moderate Traumatic Brain Injury	NEUROMODULATION			English	Article						Balance; clinical trial; gait; randomized; traumatic brain injury	ELECTRICAL NERVE-STIMULATION; TRANSCRANIAL MAGNETIC STIMULATION; TONGUE STIMULATION; CONCUSSION SYMPTOMS; DOUBLE-BLIND; CHRONIC PAIN; NEUROMODULATION; FREQUENCY; REHABILITATION; IMPAIRMENT	Objectives Translingual neurostimulation (TLNS) studies indicate improved outcomes in neurodegenerative disease or spinal cord injury patients. This study was designed to assess the safety and efficacy of TLNS plus targeted physical therapy (PT) in people with a chronic balance deficit after mild-to-moderate traumatic brain injury (mmTBI). Materials and Methods This international, multicenter, randomized study enrolled 122 participants with a chronic balance deficit who had undergone PT following an mmTBI and had plateaued in recovery. Randomized participants received PT plus either high-frequency pulse (HFP; n = 59) or low-frequency pulse (LFP; n = 63) TLNS. The primary efficacy and safety endpoints were the proportion of sensory organization test (SOT) responders (SOT composite score improvement of >= 15 points) and fall frequency after five weeks of treatment, respectively. Results The proportion of SOT responders was significant in the HFP + PT (71.2%) and LFP + PT (63.5%) groups compared with baseline (p < 0.0005). For the pooled population, the SOT responder rate was 67.2% (p < 0.00005), and there were clinically and statistically significant improvements in SOT composite scores after two and five weeks (p < 0.0005). Both groups had reductions in falls and headache disability index scores. Mean dynamic gait index scores in both groups also significantly increased from baseline at weeks 2 and 5. Conclusions Significant improvements in balance and gait, in addition to headaches, sleep quality, and fall frequency, were observed with TLNS plus targeted PT; in participants who had a chronic balance deficit following an mmTBI and had plateaued on prior conventional physiotherapy.	[Ptito, Alain] McGill Univ, Psychol Dept, Hlth Ctr, 3801 Univ, Montreal, PQ H3A 2B4, Canada; [Ptito, Alain] Montreal Neurol Hosp & Inst, 3801 Univ, Montreal, PQ H3A 2B4, Canada; [Papa, Linda] Orlando Hlth, Dept Emergency Med, Orlando, FL USA; [Gregory, Kenton] Oregon Hlth & Sci Univ, Ctr Regenerat Med, Portland, OR 97201 USA; [Folmer, Robert L.] Oregon Hlth & Sci Univ, Dept Otolaryngol, Portland, OR 97201 USA; [Folmer, Robert L.] VA Portland Hlth Care Syst, Natl Ctr Rehabil Auditory Res, Portland, OR USA; [Walker, William C.] Virginia Commonwealth Univ, Dept Phys Med & Rehabil, Richmond, VA USA; [Prabhakaran, Vivek] Univ Wisconsin, Univ Wisconsin Hosp & Clin, Dept Radiol, Madison, WI 53706 USA; [Wardini, Rima] Helius Med Inc Canada, Vancouver, BC, Canada; [Skinner, Kim] Helius Med Inc, Newtown, PA USA; [Yochelson, Michael] Shepherd Ctr, Atlanta, GA USA; [Yochelson, Michael] MedStar Natl Rehabil Network, Washington, DC USA		Ptito, A (corresponding author), McGill Univ, Psychol Dept, Hlth Ctr, 3801 Univ, Montreal, PQ H3A 2B4, Canada.; Ptito, A (corresponding author), Montreal Neurol Hosp & Inst, 3801 Univ, Montreal, PQ H3A 2B4, Canada.	alain.ptito@mcgill.ca		prabhakaran, vivek/0000-0002-1974-3125	US Army Medical Research and Materiel Command (USAMRMC)U.S. Army Medical Research & Materiel Command (USAMRMC); Helius Medical Inc	US Army Medical Research and Materiel Command (USAMRMC) and Helius Medical Inc	Aaronson ST, 2013, BRAIN STIMUL, V6, P631, DOI 10.1016/j.brs.2012.09.013; Badke MB, 2004, ARCH PHYS MED REHAB, V85, P227, DOI 10.1016/j.apmr.2003.06.006; Bagalman E, 2015, HLTH CARE VETERANS T; Bastani Andisheh, 2018, Cerebellum Ataxias, V5, P6, DOI 10.1186/s40673-018-0084-z; Benson BW, 2011, CAN MED ASSOC J, V183, P905, DOI 10.1503/cmaj.092190; Bergeron-Vezina K, 2015, PAIN, V156, P2093, DOI 10.1097/j.pain.0000000000000276; Bland DC, 2011, BRAIN INJURY, V25, P664, DOI 10.3109/02699052.2011.576306; Broglio SP, 2008, CLIN J SPORT MED, V18, P148, DOI 10.1097/JSM.0b013e318164f42a; Centers for Disease Control and Prevention, 2017, TRAUM BRAIN INJ CONC; Centers for Disease Control and Prevention, 2015, TRAUMATIC BRAIN INJU; Centers for Disease Control and Prevention  National Center for Injury Prevention and Control, 2010, TRAUMATIC BRAIN INJU; Chamelian L, 2004, ARCH PHYS MED REHAB, V85, P1662, DOI 10.1016/j.apmr.2004.02.012; Chiluwal A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07219-3; Chisholm AE, 2014, J NEUROENG REHABIL, V11, DOI 10.1186/1743-0003-11-96; Danilov Y, 2015, BRAIN NEUROTRAUMA MO, P605, DOI DOI 10.1201/B18126-51; Danilov Y, 2017, INT J PHYS MED REHAB, V4; Danilov YP, 2007, J VESTIBUL RES-EQUIL, V17, P119; Deer TR, 2014, NEUROMODULATION, V17, P551, DOI 10.1111/ner.12215; Department of Veterans Affairs Department of Defense, 2016, VADOD CLIN PRACTICE; DeSantana JM, 2009, CLIN J PAIN, V25, P12, DOI 10.1097/AJP.0b013e31817d1070; DEYO RA, 1990, NEW ENGL J MED, V322, P1627, DOI 10.1056/NEJM199006073222303; Frehlick Z, 2019, J NEUROENG REHABIL, V16, DOI 10.1186/s12984-019-0538-4; Galea MP, 2017, BRAIN STIMUL, V10, P1133, DOI 10.1016/j.brs.2017.08.011; Goadsby PJ, 2018, CEPHALALGIA, V38, P959, DOI 10.1177/0333102417744362; Hamza MA, 1999, ANESTHESIOLOGY, V91, P1232, DOI 10.1097/00000542-199911000-00012; Han BI, 2011, J CLIN NEUROL, V7, P184, DOI 10.3988/jcn.2011.7.4.184; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Hillier SL, 1997, BRAIN INJURY, V11, P661; Hughes SC, 1988, ANESTHESIA ANALG S, V67, P99; Ignatova T, 2018, P 11 INT JOINT C BIO, V4, P332, DOI [10.5220/0006732403320337, DOI 10.5220/0006732403320337.IN]; James SL, 2019, LANCET NEUROL, V18, P56, DOI 10.1016/S1474-4422(18)30415-0; Kaczmarek KA, 2017, SCI IRAN, V24, P3171, DOI 10.24200/sci.2017.4489; Kandel ER, 1991, PRINCIPLES NEURAL SC, P691; Kaptchuk TJ, 2000, J CLIN EPIDEMIOL, V53, P786, DOI 10.1016/S0895-4356(00)00206-7; Katz Douglas I, 2015, Handb Clin Neurol, V127, P131, DOI 10.1016/B978-0-444-52892-6.00009-X; Kerr ZY, 2016, JAMA PEDIATR, V170, P647, DOI 10.1001/jamapediatrics.2016.0073; Kleffelgaard I, 2012, DISABIL REHABIL, V34, P788, DOI 10.3109/09638288.2011.619624; Koke AJA, 2004, PAIN, V108, P36, DOI 10.1016/j.pain.2003.11.013; Kontos AP, 2013, AM J SPORT MED, V41, P1497, DOI 10.1177/0363546513488751; LANGLEY GB, 1984, RHEUMATOL INT, V4, P119, DOI 10.1007/BF00541180; Leonard G, 2017, MULT SCLER J EXP TRA, V3; Li M, 2016, GEN MED OPEN ACCESS, V4, P1, DOI [10.4172/2327-5146.1000275, DOI 10.4172/2327-5146.1000275]; Malec JF, 2007, J NEUROTRAUM, V24, P1417, DOI 10.1089/neu.2006.0245; Marshall S, 2012, CAN FAM PHYSICIAN, V58, P257; Murray DA, 2017, BRIT J SPORT MED, V51, P442, DOI 10.1136/bjsports-2016-096081; Oken BS, 2008, BRAIN, V131, P2812, DOI 10.1093/brain/awn116; Palmer CS, 2016, INJURY, V47, P109, DOI 10.1016/j.injury.2015.07.003; Papa L, 2014, ARCH PHYS MED REHAB, V95, P2435, DOI 10.1016/j.apmr.2014.04.018; Penning S, 2017, ACTA NEUROL BELG, V117, P547, DOI 10.1007/s13760-017-0757-z; Peterson Michelle, 2015, Arch Phys Med Rehabil, V96, P379, DOI 10.1016/j.apmr.2013.06.012; Pogoda TK, 2012, J REHABIL RES DEV, V49, P971, DOI 10.1682/JRRD.2011.06.0099; Polich G, 2018, J NEUROTRAUM, V35, P1205, DOI 10.1089/neu.2017.5506; Polinder S, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.01113; Ptito M, 2005, BRAIN, V128, P606, DOI 10.1093/brain/awh380; Rau CS, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14111378; Romero S, 2011, J GERIATR PHYS THER, V34, P131, DOI 10.1519/JPT.0b013e3182048006; Schoenen J, 2013, NEUROLOGY, V80, P697, DOI 10.1212/WNL.0b013e3182825055; Selassie AW, 2008, J HEAD TRAUMA REHAB, V23, P123, DOI 10.1097/01.HTR.0000314531.30401.39; Shiflett JM, 2015, J NEUROL STROKE, V2; Silberstein SD, 2016, HEADACHE, V56, P1317, DOI 10.1111/head.12896; Smith C, 2013, NEUROPATH APPL NEURO, V39, P654, DOI 10.1111/nan.12008; Tassorelli C, 2018, NEUROLOGY, V91, pE364, DOI 10.1212/WNL.0000000000005857; TEASDALE G, 1974, LANCET, V2, P81; Thornton M, 2005, BRAIN INJURY, V19, P989, DOI 10.1080/02699050500109944; Thurman D, 1999, JAMA-J AM MED ASSOC, V282, P954, DOI 10.1001/jama.282.10.954; Tyler ME, 2014, J NEUROENG REHABIL, V11, DOI 10.1186/1743-0003-11-79; Villamar MF, 2012, NEUROMODULATION, V15, P326, DOI 10.1111/j.1525-1403.2012.00474.x; Wildenberg JC, 2013, BRAIN CONNECT, V3, P87, DOI 10.1089/brain.2012.0123; Wildenberg JC, 2011, BRAIN CONNECT, V1, P255, DOI 10.1089/brain.2011.0029; Wildenberg JC, 2011, NEUROIMAGE, V56, P2129, DOI 10.1016/j.neuroimage.2011.03.074; Wildenberg JC, 2010, BRAIN IMAGING BEHAV, V4, P199, DOI 10.1007/s11682-010-9099-7; Wrisley DM, 2007, ARCH PHYS MED REHAB, V88, P1049, DOI 10.1016/j.apmr.2007.05.003; Yan TT, 2017, J PSYCHIATR RES, V89, P125, DOI 10.1016/j.jpsychires.2017.02.021; Zhou DD, 2017, J AFFECT DISORDERS, V215, P187, DOI 10.1016/j.jad.2017.03.033	74	7	7	1	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1094-7159	1525-1403		NEUROMODULATION	Neuromodulation	DEC	2021	24	8					1412	1421		10.1111/ner.13159		APR 2020	10	Medicine, Research & Experimental; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Research & Experimental Medicine; Neurosciences & Neurology	XO7HO	WOS:000529223000001	32347591	hybrid			2022-02-06	
J	Ritz, PP; Rogers, MB; Zabinsky, JS; Hedrick, VE; Rockwell, JA; Rimer, EG; Kostelnik, SB; Hulver, MW; Rockwell, MS				Ritz, Peter P.; Rogers, Mark B.; Zabinsky, Jennifer S.; Hedrick, Valisa E.; Rockwell, John A.; Rimer, Ernest G.; Kostelnik, Samantha B.; Hulver, Matthew W.; Rockwell, Michelle S.			Dietary and Biological Assessment of the Omega-3 Status of Collegiate Athletes: A Cross-Sectional Analysis	PLOS ONE			English	Article							POLYUNSATURATED FATTY-ACIDS; FISH-OIL SUPPLEMENTATION; TRAUMATIC BRAIN-INJURY; DOCOSAHEXAENOIC ACID; OMEGA-3-FATTY-ACID SUPPLEMENTATION; EICOSAPENTAENOIC ACID; MUSCLE SORENESS; LIPID PROFILES; BLOOD-CELLS; INDEX	Omega-3 fatty acids (omega-3 FA) are associated with cardiovascular health, brain function, reduction of inflammation, and several other physiological roles of importance to competitive athletes. The omega-3 FA status of National Collegiate Athletic Association (NCAA) Division I athletes has not been well-described. The purpose of this study was to evaluate the omega-3 FA status of NCAA Division I athletes using dietary and biological assessment methodology. Athletes from nine NCAA Division I institutions from throughout the U.S. (n = 1,528, 51% male, 34 sports represented, 19.9 +/- 1.4 years of age) completed a food frequency questionnaire (FFQ) to assess omega-3 FA from diet and supplements. Omega-3 Index (O3i) was evaluated in a sub-set of these participants (n = 298, 55% male, 21 sports represented, 20.0 +/- 1.3 years of age) using dried blood spot sampling. Only 6% (n = 93) of athletes achieved the Academy of Nutrition & Dietetics' recommendation to consume 500 mg DHA+EPA per day. Use of omega-3 FA supplements was reported by 15% (n = 229) of participants. O3i was 4.33 +/- 0.81%, with no participants meeting the O3i benchmark of 8% associated with the lowest risk of cardiovascular disease. Every additional weekly serving of fish or seafood was associated with an absolute O3i increase of 0.27%. Overall, sub-optimal omega-3 FA status was observed among a large, geographically diverse group of male and female NCAA Division I athletes. These findings may inform interventions aimed at improving omega-3 FA status of collegiate athletes. Further research on athlete-specific omega-3 FA requirements is needed.	[Ritz, Peter P.; Rogers, Mark B.; Zabinsky, Jennifer S.] Virginia Tech, Athlet Dept, Blacksburg, VA USA; [Rogers, Mark B.] Edward Via Coll Osteopath Med, Blacksburg, VA USA; [Zabinsky, Jennifer S.; Hedrick, Valisa E.; Kostelnik, Samantha B.; Hulver, Matthew W.; Rockwell, Michelle S.] Virginia Tech, Dept Human Nutr Foods & Exercise, Blacksburg, VA 24061 USA; [Rockwell, John A.] Caril Clin, Dept Med, Roanoke, VA USA; [Rimer, Ernest G.] Univ Utah, Coll Hlth, Dept Exercise & Sport Sci, Salt Lake City, UT USA; [Rimer, Ernest G.] Univ Utah, Athlet Dept, Salt Lake City, UT USA; [Hulver, Matthew W.; Rockwell, Michelle S.] Fralin Biomed Res Inst Roanoke, Ctr Transformat Res Hlth Behav, Roanoke, VA 24016 USA; [Hulver, Matthew W.] Virginia Tech, Fralin Life Sci Inst, Blacksburg, VA USA		Rockwell, MS (corresponding author), Virginia Tech, Dept Human Nutr Foods & Exercise, Blacksburg, VA 24061 USA.; Rockwell, MS (corresponding author), Fralin Biomed Res Inst Roanoke, Ctr Transformat Res Hlth Behav, Roanoke, VA 24016 USA.	msrock@vt.edu			Collegiate and Professional Sports Dietitians Association Research Award	This research was supported by the Collegiate and Professional Sports Dietitians Association Research Award (www.sportsrd.org) which was awarded to first author Peter P. Ritz in 2018. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank the research collaborators at the nine participating institutions for their dedication to the project. This study was supported by the Collegiate and Professional Sports Dietitians Association Research Award. There was no additional external funding received for this study.	Amen DG, 2011, J PSYCHOACTIVE DRUGS, V43, P1, DOI 10.1080/02791072.2011.566489; Anzalone A, 2019, J ATHL TRAINING, V54, P7, DOI 10.4085/1062-6050-387-18; Arterburn LM, 2006, AM J CLIN NUTR, V83, p1467S, DOI 10.1093/ajcn/83.6.1467S; Barrett EC, 2014, ADV NUTR, V5, P268, DOI 10.3945/an.113.005280; Blasbalg TL, 2011, AM J CLIN NUTR, V93, P950, DOI 10.3945/ajcn.110.006643; Block Robert C, 2008, Open Biomark J, V1, P1, DOI 10.2174/1875318300801010001; Burdge GC, 2002, BRIT J NUTR, V88, P411, DOI 10.1079/BJN2002689; Calder PC, 2009, BIOCHIMIE, V91, P791, DOI 10.1016/j.biochi.2009.01.008; Cholewski M, 2018, NUTRIENTS, V10, DOI 10.3390/nu10111662; Corder KE, 2016, J SPORT SCI MED, V15, P176; Davinelli S, 2019, FRONT PHYSIOL, V10, DOI 10.3389/fphys.2019.00487; Drobnic F, 2017, J LIPIDS, V2017, DOI 10.1155/2017/1472719; Fenton JI, 2016, PROSTAG LEUKOTR ESS, V112, P12, DOI 10.1016/j.plefa.2016.06.004; Gravina L, 2017, INT J SPORT NUTR EXE, V27, P305, DOI 10.1123/ijsnem.2016-0325; Gray P, 2014, INT J SPORT NUTR EXE, V24, P206, DOI 10.1123/ijsnem.2013-0081; Gurzell EA, 2014, PROSTAG LEUKOTR ESS, V91, P87, DOI 10.1016/j.plefa.2014.04.001; Harris W, 2016, ANN CLIN LAB RES, V04, DOI [10.21767/2386-5180.10001.37, DOI 10.21767/2386-5180.10001.37]; Harris WS, 2007, AM J CLIN NUTR, V86, P1621; Harris WS, 2007, PHARMACOL RES, V55, P217, DOI 10.1016/j.phrs.2007.01.013; Harris WS, 2017, ATHEROSCLEROSIS, V262, P51, DOI 10.1016/j.atherosclerosis.2017.05.007; Harris WS, 2013, J CLIN LIPIDOL, V7, P433, DOI 10.1016/j.jacl.2013.05.001; Harris WS, 2010, CLIN BIOCHEM, V43, P338, DOI 10.1016/j.clinbiochem.2009.08.016; Harris WS, 2004, PREV MED, V39, P212, DOI 10.1016/j.ypmed.2004.02.030; Hingley L, 2017, INT J SPORT NUTR EXE, V27, P335, DOI 10.1123/ijsnem.2016-0150; Jackson KH, 2019, PROSTAG LEUKOTR ESS, V142, P4, DOI 10.1016/j.plefa.2019.01.002; JANG SY, 2019, JAMA CARDIOL, DOI DOI 10.1001/JAMACARDIO.2019.3909; Jouris KB, 2011, J SPORT SCI MED, V10, P432; Kelley DS, 2007, AM J CLIN NUTR, V86, P324, DOI 10.1093/ajcn/86.2.324; Kim JH, 2018, J AM HEART ASSOC, V7, DOI 10.1161/JAHA.118.008620; LEE TH, 1985, NEW ENGL J MED, V312, P1217, DOI 10.1056/NEJM198505093121903; Lewis MD, 2016, J AM COLL NUTR, V35, P469, DOI 10.1080/07315724.2016.1150796; Maron BJ, 2000, NEW ENGL J MED, V343, P1409, DOI 10.1056/NEJM200011093431911; Maughan RJ, 2018, BRIT J SPORT MED, V52, P439, DOI 10.1136/bjsports-2018-099027; McGlory C, 2019, FASEB J, V33, P4586, DOI 10.1096/fj.201801857RRR; McGlory C, 2016, PHYSIOL REP, V4, DOI 10.14814/phy2.12715; Mills JD, 2011, NEUROSURGERY, V68, P474, DOI 10.1227/NEU.0b013e3181ff692b; Mori TA, 2006, CURR OPIN CLIN NUTR, V9, P95, DOI 10.1097/01.mco.0000214566.67439.58; Mori TA, 2017, FITOTERAPIA, V123, P51, DOI 10.1016/j.fitote.2017.09.015; Nguyen VT, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2019.4223; Nikolaidis MG, 2004, SPORTS MED, V34, P1051, DOI 10.2165/00007256-200434150-00004; Ochi E, 2018, NUTRIENTS, V10, DOI 10.3390/nu10050552; Oliver JM, 2018, SPORTS MED, V48, pS39, DOI 10.1007/s40279-017-0847-3; Oliver JM, 2016, MED SCI SPORT EXER, V48, P974, DOI 10.1249/MSS.0000000000000875; Pennington JAT, 2005, BOWES CHURCHS FOOD V; Rohlman A, 2018, 2018 2019 NCAA DIV M; Sands SA, 2005, LIPIDS, V40, P343, DOI 10.1007/s11745-006-1392-2; Schmied C, 2014, J INTERN MED, V275, P93, DOI 10.1111/joim.12184; SISCOVICK DS, 1984, NEW ENGL J MED, V311, P874, DOI 10.1056/NEJM198410043111402; Smith GI, 2011, CLIN SCI, V121, P267, DOI 10.1042/CS20100597; Stark KD, 2016, PROG LIPID RES, V63, P132, DOI 10.1016/j.plipres.2016.05.001; Sublette ME, 2011, J AM DIET ASSOC, V111, P117, DOI 10.1016/j.jada.2010.10.007; Id BT, 2018, NUTRIENTS, V10, DOI 10.3390/nu10030309; Tartibian B, 2009, CLIN J SPORT MED, V19, P115, DOI 10.1097/JSM.0b013e31819b51b3; Tepsic J, 2009, EUR J APPL PHYSIOL, V107, P359, DOI 10.1007/s00421-009-1131-5; Thompson PD, 2007, CIRCULATION, V115, P2358, DOI 10.1161/CIRCULATIONAHA.107.181485; Tinsley Grant M., 2017, Journal of Dietary Supplements, V14, P89, DOI 10.1080/19390211.2016.1205701; US Department of Agriculture Agricultural Research Service. USDA National Nutrient Database for Standard Reference, 2009, NUTR DAT LAB HOM PAG; Vannice G, 2014, J ACAD NUTR DIET, V114, P136, DOI 10.1016/j.jand.2013.11.001; von Schacky C, 2014, INT J SPORT NUTR EXE, V24, P559, DOI 10.1123/ijsnem.2014-0041; Watkins BA, 2001, EXP BIOL MED, V226, P485, DOI 10.1177/153537020122600601; WHO, DIET NUTR PREV CHRON; Wilson PB, 2016, INT J SPORT NUTR EXE, V26, P497, DOI 10.1123/ijsnem.2015-0316; Yates A, 2009, SPORTS HEALTH, V1, P21, DOI 10.1177/1941738108326978; Youdim KA, 2000, INT J DEV NEUROSCI, V18, P383, DOI 10.1016/S0736-5748(00)00013-7	64	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2020	15	4							e0228834	10.1371/journal.pone.0228834			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LS8ZG	WOS:000536668200007	32348305	Green Published, gold, Green Submitted			2022-02-06	
J	Guell, X; Anteraper, SA; Gardner, AJ; Whitfield-Gabrieli, S; Kay-Lambkin, F; Iverson, GL; Gabrieli, J; Stanwell, P				Guell, Xavier; Anteraper, Sheeba Arnold; Gardner, Andrew J.; Whitfield-Gabrieli, Susan; Kay-Lambkin, Frances; Iverson, Grant L.; Gabrieli, John; Stanwell, Peter			Functional Connectivity Changes in Retired Rugby League Players: A Data-Driven Functional Magnetic Resonance Imaging Study	JOURNAL OF NEUROTRAUMA			English	Article						athlete; fMRI; functional connectivity; head trauma; MRI; sports concussion; traumatic brain injury	TRAUMATIC BRAIN-INJURY; DEFAULT MODE NETWORK; CONCUSSED INDIVIDUALS; COGNITIVE IMPAIRMENT; CEREBELLAR; HISTORY; SPORT; IMPACT; ORGANIZATION; DYSFUNCTION	There is considerable interest in the long-term brain health of retired contact and collision sport athletes; however, little is known about possible underlying changes in functional brain connectivity in this group. We evaluated whole-brain functional connectivity patterns using multi-voxel pattern analysis (MVPA) to determine whether alterations in functional connectivity distinguish retired professional athletes from a matched group of healthy community control subjects. Thirty-two retired athletes with a history of multiple self-reported sport-related concussions and 36 healthy community control subjects who were similar in age and education, completed functional magnetic resonance imaging. We identified brain regions with abnormal functional connectivity patterns using whole-brain MVPA as implemented in the Conn toolbox. First-level MVPA was performed using 64 principal component analysis (PCA) components. Second-level F test was performed using the first three MVPA components for retired athletes > controls group contrast. Post hoc seed-to-voxel analyses using the MVPA cluster results as seeds were performed to characterize functional connectivity abnormalities from brain regions identified by MVPA. MVPA revealed one cluster of abnormal functional connectivity located in cerebellar lobule V. This region of lobule V corresponded to the ventral attention network. Post hoc seed-to-voxel analysis using the cerebellar MVPA cluster as a seed revealed multiple areas of cerebral cortical hyper-connectivity and hypo-connectivity in retired athletes when compared with controls. This initial report suggests that cerebellar dysfunction might be present and clinically important in some retired athletes.	[Guell, Xavier; Gabrieli, John] MIT, McGovern Inst Brain Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Guell, Xavier] Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA; [Anteraper, Sheeba Arnold; Whitfield-Gabrieli, Susan] Northeastern Univ, Biomed Imaging Ctr, Boston, MA 02115 USA; [Gardner, Andrew J.] John Hunter Hosp, Hunter New England Local Hlth Dist Sport Concuss, New Lambton Hts, NSW, Australia; [Gardner, Andrew J.] Univ Newcastle, Ctr Stroke & Brain Injury, Sch Med & Publ Hlth, Callaghan, NSW, Australia; [Kay-Lambkin, Frances] Univ Newcastle, Sch Med & Publ Hlth, Callaghan, NSW, Australia; [Stanwell, Peter] Univ Newcastle, Sch Hlth Sci, Callaghan, NSW 2308, Australia; [Iverson, Grant L.] Harvard Med Sch, Dept Phys Med & Rehabil, Boston, MA 02115 USA; [Iverson, Grant L.] MassGen Hosp Children, Sports Concuss Program, Boston, MA USA		Stanwell, P (corresponding author), Univ Newcastle, Sch Hlth Sci, Callaghan, NSW 2308, Australia.	peter.stanwell@newcastle.edu.au	Gabrieli, John/AAJ-2869-2020; Stanwell, Peter/F-9136-2012	Stanwell, Peter/0000-0002-4780-0393; Gardner, Andrew/0000-0001-5031-5586	MGH Tosteson & Fund for Medical Discovery Fellowship; "La Caixa'' Foundation FellowshipLa Caixa Foundation; NHMRC Early Career FellowshipNational Health and Medical Research Council of Australia; Hunter New England Local Health District, Research, Innovation and Partnerships Health Research & Translation Centre and Clinical Research Fellowship Scheme; University of Newcastle's Priority Research Centre for Stroke and Brain Injury; National Football League; NSW Sporting Injuries Committee; Brain Foundation (Australia); Australian-American Fulbright Commission	Dr. Guell was supported by the MGH Tosteson & Fund for Medical Discovery Fellowship, and the "La Caixa'' Foundation Fellowship. Dr. Gardner is currently funded through an NHMRC Early Career Fellowship, and Hunter New England Local Health District, Research, Innovation and Partnerships Health Research & Translation Centre and Clinical Research Fellowship Scheme, and the University of Newcastle's Priority Research Centre for Stroke and Brain Injury. Dr. Iverson is funded in part through a grant from the National Football League. He also acknowledges unrestricted philanthropic support from the Mooney-Reed Charitable Foundation, ImPACT Applications, Inc., Heinz Family Foundation, and the Spaulding Research Institute. Dr. Stanwell was funded by the NSW Sporting Injuries Committee, the Brain Foundation (Australia), and the Australian-American Fulbright Commission. The other authors received no funding.	Abbas K, 2015, BRAIN CONNECT, V5, P91, DOI 10.1089/brain.2014.0279; Anteraper SA, 2019, BRAIN CONNECT, V9, P48, DOI 10.1089/brain.2018.0581; Barrio JR, 2015, P NATL ACAD SCI USA, V112, pE2039, DOI 10.1073/pnas.1409952112; Bayly PV, 2005, J NEUROTRAUM, V22, P845, DOI 10.1089/neu.2005.22.845; Behzadi Y, 2007, NEUROIMAGE, V37, P90, DOI 10.1016/j.neuroimage.2007.04.042; Buckner RL, 2011, J NEUROPHYSIOL, V106, P2322, DOI 10.1152/jn.00339.2011; Calhoun V.D., 2012, FRONT PSYCHIATRY, V2, P1, DOI DOI 10.3389/-; Churchill NW, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07742-3; Churchill NW, 2017, NEUROIMAGE-CLIN, V14, P480, DOI 10.1016/j.nicl.2017.02.015; Diedrichsen J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133402; Gardner A, 2015, BRIT J SPORT MED, V49, P495, DOI 10.1136/bjsports-2013-093102; Gardner AJ, 2017, INT J SPORTS MED, V38, P241, DOI 10.1055/s-0042-120843; Gardner RC, 2016, J NEUROTRAUM, V33, P157, DOI 10.1089/neu.2014.3805; Guell X, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0210028; Guell X, 2018, ELIFE, V7, DOI 10.7554/eLife.36652; Guell X, 2018, NEUROIMAGE, V172, P437, DOI 10.1016/j.neuroimage.2018.01.082; Guell X, 2015, CEREBELLUM, V14, P50, DOI 10.1007/s12311-014-0630-z; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Hammeke TA, 2013, J INT NEUROPSYCH SOC, V19, P863, DOI 10.1017/S1355617713000702; Hampshire A, 2013, SCI REP-UK, V3, DOI 10.1038/srep02972; Hoche F, 2016, CEREBELLUM, V15, P732, DOI 10.1007/s12311-015-0746-9; Hoche F, 2018, BRAIN, V141, P248, DOI 10.1093/brain/awx317; Hulkower MB, 2013, AM J NEURORADIOL, V34, P2064, DOI 10.3174/ajnr.A3395; Hume PA, 2017, SPORTS MED, V47, P1209, DOI 10.1007/s40279-016-0608-8; Johnson B, 2012, NEUROIMAGE, V59, P511, DOI 10.1016/j.neuroimage.2011.07.081; Kerr ZY, 2012, MED SCI SPORT EXER, V44, P377, DOI 10.1249/MSS.0b013e31823240f2; Koerte IK, 2016, BRAIN IMAGING BEHAV, V10, P792, DOI 10.1007/s11682-015-9442-0; Koerte IK, 2016, J NEUROTRAUM, V33, P346, DOI 10.1089/neu.2015.3880; Koerte IK, 2015, J NEUROTRAUM, V32, P1287, DOI 10.1089/neu.2014.3715; Kravitz DJ, 2013, TRENDS COGN SCI, V17, P26, DOI 10.1016/j.tics.2012.10.011; Leunissen I, 2014, CORTEX, V51, P67, DOI 10.1016/j.cortex.2013.10.009; LOVIBOND PF, 1995, BEHAV RES THER, V33, P335, DOI 10.1016/0005-7967(94)00075-U; Manley G, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097791; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McKee AC, 2016, ACTA NEUROPATHOL, V131, P75, DOI 10.1007/s00401-015-1515-z; MIDDLETON FA, 1994, SCIENCE, V266, P458, DOI 10.1126/science.7939688; Montenigro PH, 2017, J NEUROTRAUM, V34, P328, DOI 10.1089/neu.2016.4413; Omalu B, 2018, NEUROSURGERY, V82, P237, DOI 10.1093/neuros/nyx536; Ptak R, 2012, NEUROSCIENTIST, V18, P502, DOI 10.1177/1073858411409051; Ralchle ME, 2007, NEUROIMAGE, V37, P1083, DOI 10.1016/j.neuroimage.2007.02.041; Randolph C, 2013, J INT NEUROPSYCH SOC, V19, P873, DOI 10.1017/S1355617713000805; Robbins CA, 2014, OPEN ACCESS J SPORTS, V5, P99, DOI 10.2147/OAJSM.S58005; SAUNDERS JB, 1993, ADDICTION, V88, P791, DOI 10.1111/j.1360-0443.1993.tb02093.x; Schmahmann JD, 1998, BRAIN, V121, P561, DOI 10.1093/brain/121.4.561; Schmahmann JD, 1996, HUM BRAIN MAPP, V4, P174, DOI 10.1002/(SICI)1097-0193(1996)4:3<174::AID-HBM3>3.0.CO;2-0; Seghier ML, 2010, J NEUROSCI, V30, P16809, DOI 10.1523/JNEUROSCI.3377-10.2010; Spiotta AM, 2011, WORLD NEUROSURG, V75, P175, DOI 10.1016/j.wneu.2011.01.019; Stoodley CJ, 2012, NEUROIMAGE, V59, P1560, DOI 10.1016/j.neuroimage.2011.08.065; Stoodley CJ, 2010, CORTEX, V46, P831, DOI 10.1016/j.cortex.2009.11.008; Strain J, 2013, NEUROLOGY, V81, P25, DOI 10.1212/WNL.0b013e318299ccf8; Strain JF, 2015, JAMA NEUROL, V72, P773, DOI 10.1001/jamaneurol.2015.0206; Thompson WH, 2016, NEUROIMAGE-CLIN, V12, P1004, DOI 10.1016/j.nicl.2016.05.005; Whitfield-Gabrieli S, 2012, BRAIN CONNECT, V2, P125, DOI 10.1089/brain.2012.0073; Wojtowicz M, 2018, NEUROIMAGE-CLIN, V18, P377, DOI 10.1016/j.nicl.2018.01.005; Xu JP, 2015, SCI REP-UK, V5, DOI 10.1038/srep18883; Yeo BTT, 2011, J NEUROPHYSIOL, V106, P1125, DOI 10.1152/jn.00338.2011; Zahr NM, 2017, ALCOHOL RES-CURR REV, V38, P183; Zhang K, 2012, J NEUROTRAUM, V29, P756, DOI 10.1089/neu.2011.2125; Zhu DC, 2015, J NEUROTRAUM, V32, P327, DOI 10.1089/neu.2014.3413	59	7	7	4	11	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	AUG 15	2020	37	16					1788	1796		10.1089/neu.2019.6782		APR 2020	9	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	MW0CL	WOS:000529522200001	32183583				2022-02-06	
J	Gyawali, P; Chow, WZ; Hinwood, M; Kluge, M; English, C; Ong, LK; Nilsson, M; Walker, FR				Gyawali, Prajwal; Chow, Wei Zhen; Hinwood, Madeleine; Kluge, Murielle; English, Coralie; Ong, Lin Kooi; Nilsson, Michael; Walker, Frederick Rohan			Opposing Associations of Stress and Resilience With Functional Outcomes in Stroke Survivors in the Chronic Phase of Stroke: A Cross-Sectional Study	FRONTIERS IN NEUROLOGY			English	Article						stroke recovery; stress; resilience; mood; emotion; cognition	TRAUMATIC BRAIN-INJURY; QUALITY-OF-LIFE; COGNITIVE IMPAIRMENT; COPING STRATEGIES; SCALE; IMPACT; INTERVENTION; PREDICTORS; ADJUSTMENT; DEPRESSION	Stroke survivors report significant levels of psychological distress post stroke. To date, most studies conducted have focused on the relationship between psychological stress and functional outcomes in the acute phase of stroke. However, no studies had considered the role of stress over the chronic phase, where stress may continue to exert negative effects on cognitive and psychological processes. Further, the role of potentially modulatory variables, such as psychological resilience, on stroke outcomes has been understudied. The purpose of this study was to consider the relationships between stress and resilience with functional outcomes in long-term survivors of stroke. People (N = 70) who had experienced a stroke between 5 months and 28 years ago were included in the cross-sectional study, along with age-matched controls (N = 70). We measured stress using both the Perceived Stress Scale and biological markers, and resilience using both the Brief Resilience Scale and the Connor-Davidson Resilience Scale. Stroke outcomes were assessed using the Stroke Impact Scale. We found that, compared with age-matched controls, stroke survivors reported greater levels of perceived stress, and lower levels of resilience. In stroke survivors, both perceived stress and resilience were independently associated with stroke outcomes in linear regression models. In particular, these relationships were observed for cognitive outcomes including mood, memory, and communication. The association between stress and stroke outcome did not differ across time post stroke. Given that resilience is a modifiable psychological construct, future research may consider whether strategies directed at enhancing resilience may improve recovery from stroke. Australia and New Zealand Clinical Trials Registry: ACTRN12617000736347.	[Gyawali, Prajwal; Chow, Wei Zhen; Kluge, Murielle; Ong, Lin Kooi; Nilsson, Michael; Walker, Frederick Rohan] Univ Newcastle, Sch Biomed Sci & Pharm, Callaghan, NSW, Australia; [Gyawali, Prajwal; Chow, Wei Zhen; Kluge, Murielle; Ong, Lin Kooi; Nilsson, Michael; Walker, Frederick Rohan] Univ Newcastle, Prior Res Ctr Stroke & Brain Injury, Callaghan, NSW, Australia; [Gyawali, Prajwal; Chow, Wei Zhen; Hinwood, Madeleine; Kluge, Murielle; English, Coralie; Ong, Lin Kooi; Nilsson, Michael; Walker, Frederick Rohan] Hunter Med Res Inst, New Lambton Hts, NSW, Australia; [Gyawali, Prajwal; Chow, Wei Zhen; English, Coralie; Ong, Lin Kooi; Nilsson, Michael; Walker, Frederick Rohan] NHMRC Ctr Res Excellence Stroke Rehabil & Brain R, Heidelberg, Vic, Australia; [Hinwood, Madeleine] Univ Newcastle, Sch Med & Publ Hlth, Callaghan, NSW, Australia; [English, Coralie; Nilsson, Michael; Walker, Frederick Rohan] Univ Newcastle, Ctr Rehab Innovat, Callaghan, NSW, Australia; [English, Coralie] Univ Newcastle, Sch Hlth Sci, Callaghan, NSW, Australia; [Ong, Lin Kooi] Monash Univ Malaysia, Sch Pharm, Bandar Sunway, Malaysia		Walker, FR (corresponding author), Univ Newcastle, Sch Biomed Sci & Pharm, Callaghan, NSW, Australia.; Walker, FR (corresponding author), Univ Newcastle, Prior Res Ctr Stroke & Brain Injury, Callaghan, NSW, Australia.; Walker, FR (corresponding author), Hunter Med Res Inst, New Lambton Hts, NSW, Australia.; Walker, FR (corresponding author), NHMRC Ctr Res Excellence Stroke Rehabil & Brain R, Heidelberg, Vic, Australia.; Walker, FR (corresponding author), Univ Newcastle, Ctr Rehab Innovat, Callaghan, NSW, Australia.	Rohan.Walker@newcastle.edu.au	NILSSON, MICHAEL/ABE-7821-2020; English, Coralie/D-4591-2009; Ong, Lin Kooi/H-2797-2012	NILSSON, MICHAEL/0000-0002-8826-1621; English, Coralie/0000-0001-5910-7927; Gyawali, Prajwal/0000-0003-0975-5576; Ong, Lin Kooi/0000-0001-8664-0540; Hinwood, Madeleine/0000-0002-2225-973X	Hunter Medical Research Institute; John Hunter Charitable Trust; Priority Research Center for Stroke and Brain Injury Research Centre; National Health and Medical Research CouncilNational Health and Medical Research Council of Australia; Centre for Research Excellence in Stroke Recovery and Rehabilitation	This study was supported by the Hunter Medical Research Institute, the John Hunter Charitable Trust, the Priority Research Center for Stroke and Brain Injury Research Centre, the National Health and Medical Research Council, and the Centre for Research Excellence in Stroke Recovery and Rehabilitation.	Barugh AJ, 2014, J NEUROL, V261, P533, DOI 10.1007/s00415-013-7231-5; Ben Assayag E, 2017, PSYCHONEUROENDOCRINO, V82, P133, DOI 10.1016/j.psyneuen.2017.05.013; Castor N, 2018, BRAIN INJURY, V32, P1803, DOI 10.1080/02699052.2018.1508748; Chiu D, 2010, J STROKE CEREBROVASC, V19, P225, DOI 10.1016/j.jstrokecerebrovasdis.2009.06.002; COHEN S, 1983, J HEALTH SOC BEHAV, V24, P385, DOI 10.2307/2136404; Connor KM, 2003, DEPRESS ANXIETY, V18, P76, DOI 10.1002/da.10113; dos Santos EB, 2018, STRESS HEALTH, V34, P359, DOI 10.1002/smi.2791; Duncan PW, 1999, STROKE, V30, P2131, DOI 10.1161/01.STR.30.10.2131; FEIBEL JH, 1977, JAMA-J AM MED ASSOC, V238, P1374, DOI 10.1001/jama.238.13.1374; Glymour MM, 2008, NEUROEPIDEMIOLOGY, V31, P10, DOI 10.1159/000136646; HEWITT PL, 1992, J PSYCHOPATHOL BEHAV, V14, P247, DOI 10.1007/BF00962631; Jokinen H, 2015, EUR J NEUROL, V22, P1288, DOI 10.1111/ene.12743; Jonkman EJ, 1998, ACTA NEUROL SCAND, V98, P169, DOI 10.1111/j.1600-0404.1998.tb07289.x; Joyce S, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-017858; Kalafatakis K, 2018, P NATL ACAD SCI USA, V115, pE4091, DOI 10.1073/pnas.1714239115; Katzan IL, 2018, NEUROLOGY, V90, pE1364, DOI 10.1212/WNL.0000000000005327; Kreutzer JS, 2016, ARCH PHYS MED REHAB, V97, P708, DOI 10.1016/j.apmr.2015.12.003; Lee EH, 2012, ASIAN NURS RES, V6, P121, DOI 10.1016/j.anr.2012.08.004; Levine DA, 2015, JAMA-J AM MED ASSOC, V314, P41, DOI 10.1001/jama.2015.6968; Liman TG, 2011, DEMENT GERIATR COGN, V31, P291, DOI 10.1159/000327358; Lukow HR, 2015, J HEAD TRAUMA REHAB, V30, P241, DOI 10.1097/HTR.0000000000000137; McDonnell MN, 2013, STROKE, V44, P2519, DOI 10.1161/STROKEAHA.113.001538; McEwen Bruce S, 2017, Chronic Stress (Thousand Oaks), V1, DOI 10.1177/2470547017692328; McEwen BS, 2015, NAT NEUROSCI, V18, P1353, DOI 10.1038/nn.4086; Moran GM, 2014, EUR J NEUROL, V21, P1258, DOI 10.1111/ene.12469; Ostwald SK, 2009, TOP STROKE REHABIL, V16, P93, DOI 10.1310/tsr1602-93; Pangallo A, 2015, PSYCHOL ASSESSMENT, V27, P1, DOI 10.1037/pas0000024; Peters A, 2017, PROG NEUROBIOL, V156, P164, DOI 10.1016/j.pneurobio.2017.05.004; Reivich KJ, 2011, AM PSYCHOL, V66, P25, DOI 10.1037/a0021897; Richardson M, 2016, DISABIL REHABIL, V38, P1425, DOI 10.3109/09638288.2015.1102337; Sadler E, 2017, HEALTH SOC CARE COMM, V25, P1590, DOI 10.1111/hsc.12336; Sheerin CM, 2018, DEPRESS ANXIETY, V35, P140, DOI 10.1002/da.22700; Smith BW, 2008, INT J BEHAV MED, V15, P194, DOI 10.1080/10705500802222972; Southwick SM, 2012, SCIENCE, V338, P79, DOI 10.1126/science.1222942; Starr LR, 2019, PSYCHONEUROENDOCRINO, V100, P156, DOI 10.1016/j.psyneuen.2018.10.003; Steinhardt M, 2008, J AM COLL HEALTH, V56, P445, DOI 10.3200/JACH.56.44.445-454; Stwald SK, 2008, J CARDIOVASC NURS, V23, P371, DOI 10.1097/01.JCN.0000317435.29339.5d; Swartz RH, 2016, INT J STROKE, V11, P509, DOI 10.1177/1747493016641968; Tene O, 2018, J ALZHEIMERS DIS, V65, P1365, DOI 10.3233/JAD-180486; Terrill AL, 2018, REHABIL PSYCHOL, V63, P43, DOI 10.1037/rep0000181; Thompson NJ, 2018, J AFFECT DISORDERS, V225, P153, DOI 10.1016/j.jad.2017.08.049; THOMPSON SC, 1989, SOC SCI MED, V28, P239, DOI 10.1016/0277-9536(89)90267-0; Trabasso T, 1990, PSYCHOL BIOL APPROAC, P313; Vellone E, 2015, J CARDIOVASC NURS, V30, P229, DOI 10.1097/JCN.0000000000000145; von Elm E, 2007, LANCET, V370, P1453, DOI [10.1371/journal.pmed.0040297, 10.1371/journal.pmed.0040296, 10.1157/13119325, 10.1016/S0140-6736(07)61602-X]; Wardlaw C, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00563; WASHBURN RA, 1990, AM J EPIDEMIOL, V132, P107, DOI 10.1093/oxfordjournals.aje.a115622; Windle G, 2011, HEALTH QUAL LIFE OUT, V9, DOI 10.1186/1477-7525-9-8	48	7	7	4	7	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	APR 22	2020	11								230	10.3389/fneur.2020.00230			12	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	LN9VU	WOS:000533279500001	32390923	Green Accepted, Green Published, gold			2022-02-06	
J	Tapp, ZM; Kumar, JE; Witcher, KG; Atluri, RR; Velasquez, JA; O'Neil, SM; Dziabis, JE; Bray, CE; Sheridan, JF; Godbout, JP; Kokiko-Cochran, ON				Tapp, Zoe M.; Kumar, Julia E.; Witcher, Kristina G.; Atluri, Ravitej R.; Velasquez, John A.; O'Neil, Shane M.; Dziabis, Julia E.; Bray, Chelsea E.; Sheridan, John F.; Godbout, Jonathan P.; Kokiko-Cochran, Olga N.			Sleep Disruption Exacerbates and Prolongs the Inflammatory Response to Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						neuroinflammation; sleep disruption; traumatic brain injury	MOUSE MODEL; TREM2 DEFICIENCY; GENE-EXPRESSION; TAU PATHOLOGY; BEHAVIOR; NEUROINFLAMMATION; CONSEQUENCES; DEPRIVATION; HOMEOSTASIS; TRANSPORT	Traumatic brain injury (TBI) alters stress responses, which may influence neuroinflammation and behavioral outcome. Sleep disruption (SD) is an understudied post-injury environmental stressor that directly engages stress-immune pathways. Thus, we predicted that maladaptive changes in the hypothalamic-pituitary-adrenal (HPA) axis after TBI compromise the neuroendocrine response to SD and exacerbate neuroinflammation. To test this, we induced lateral fluid percussion TBI or sham injury in female and male C57BL/6 mice aged 8-10 weeks that were then left undisturbed or exposed to 3 days of transient SD. At 3 days post-injury (DPI) plasma corticosterone (CORT) was reduced in TBI compared with sham mice, indicating altered HPA-mediated stress response to SD. This response was associated with approach-avoid conflict behavior and exaggerated cortical neuroinflammation. Post-injury SD specifically enhanced neutrophil trafficking to the injured brain in conjunction with dysregulated aquaporin-4 (AQP4) polarization. Delayed and persistent effects of post-injury SD were determined 4 days after SD concluded at 7 DPI. SD prolonged anxiety-like behavior regardless of injury and was associated with increased cortical Iba1 labeling in both sham and TBI mice. Strikingly, TBI SD mice displayed an increased number of CD45(+) cells near the site of injury, enhanced cortical glial fibrillary acidic protein (GFAP) immunolabeling, and persistent expression of Trem2 and Tlr4 7 DPI compared with TBI mice. These results support the hypothesis that post-injury SD alters stress-immune pathways and inflammatory outcomes after TBI. These data provide new insight to the dynamic interplay between TBI, stress, and inflammation.	[Tapp, Zoe M.; Kumar, Julia E.; Witcher, Kristina G.; Atluri, Ravitej R.; Velasquez, John A.; O'Neil, Shane M.; Dziabis, Julia E.; Bray, Chelsea E.; Godbout, Jonathan P.; Kokiko-Cochran, Olga N.] Ohio State Univ, Coll Med, Dept Neurosci, Columbus, OH 43210 USA; [Sheridan, John F.] Ohio State Univ, Coll Dent, Div Biosci, Columbus, OH 43210 USA; [Sheridan, John F.; Godbout, Jonathan P.; Kokiko-Cochran, Olga N.] Ohio State Univ, Neurol Inst, IBMR, Columbus, OH 43210 USA; [Godbout, Jonathan P.; Kokiko-Cochran, Olga N.] Ohio State Univ, Chron Brain Injury Program, Columbus, OH 43210 USA		Kokiko-Cochran, ON (corresponding author), Ohio State Univ, 257 IBMR,460 Med Ctr Dr, Columbus, OH 43210 USA.	olga.kokiko-cochran@osumc.edu		Velasquez, John/0000-0003-2683-5498; O'Neil, Shane/0000-0002-6045-2012	National Institute of Neurological Disorders and Stroke (NINDS)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS109585]; NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R56NS090311]; College of Medicine Dean's Discovery Grant; Ohio State University Center for Brain and Spinal Cord Repair; National Institute of Dental and Craniofacial Research Training Grant [T32DE014320]; P30 Core Grant (NINDS) [P30NS045758]; Chronic Brain Injury Discovery Grant	This work was supported by National Institute of Neurological Disorders and Stroke (NINDS) Grant R01NS109585 (to O.K.C.), NINDS Grant R56NS090311 (to J.P.G.), a College of Medicine Dean's Discovery Grant (to J.P.G.), funding from The Ohio State University Center for Brain and Spinal Cord Repair (to J.P.G.), a Chronic Brain Injury Discovery Grant (to O.K.C. and J.F.S.), National Institute of Dental and Craniofacial Research Training Grant T32DE014320 (to K.G.W. and S.M.O.) and a P30 Core Grant (NINDS, P30NS045758).	Agha A, 2007, BRIT J NEUROSURG, V21, P210, DOI 10.1080/02688690701253331; Asgari M, 2015, SCI REP-UK, V5, DOI 10.1038/srep15024; Backhaus J, 2004, PSYCHONEUROENDOCRINO, V29, P1184, DOI 10.1016/j.psyneuen.2004.01.010; Bedrosian TA, 2016, ANNU REV PHYSIOL, V78, P109, DOI 10.1146/annurev-physiol-021115-105102; Bellesi M, 2015, GENOM DATA, V6, P114, DOI 10.1016/j.gdata.2015.08.031; Bemiller SM, 2017, MOL NEURODEGENER, V12, DOI 10.1186/s13024-017-0216-6; Benveniste H, 2017, ANESTHESIOLOGY, V127, P976, DOI 10.1097/ALN.0000000000001888; Bhaskar K, 2010, NEURON, V68, P19, DOI 10.1016/j.neuron.2010.08.023; Bittman EL, 2003, AM J PHYSIOL-REG I, V285, pR561, DOI 10.1152/ajpregu.00783.2002; Boespflug EL, 2018, BIOL PSYCHIAT, V83, P328, DOI 10.1016/j.biopsych.2017.11.031; Boisgontier MP, 2016, NEUROSCI BIOBEHAV R, V68, P1004, DOI 10.1016/j.neubiorev.2016.05.034; Boivin GP, 2017, J AM ASSOC LAB ANIM, V56, P491; Cernak I, 1999, BRAIN INJURY, V13, P1005; Corps KN, 2015, JAMA NEUROL, V72, P355, DOI 10.1001/jamaneurol.2014.3558; Dimitrov S, 2004, BRAIN BEHAV IMMUN, V18, P341, DOI 10.1016/j.bbi.2003.08.004; Fenn AM, 2015, J NEUROTRAUM, V32, P127, DOI 10.1089/neu.2014.3514; Fries E, 2005, PSYCHONEUROENDOCRINO, V30, P1010, DOI 10.1016/j.psyneuen.2005.04.006; Haack M, 2004, BRAIN BEHAV IMMUN, V18, P361, DOI 10.1016/j.bbi.2003.12.009; Halassa MM, 2009, NEURON, V61, P213, DOI 10.1016/j.neuron.2008.11.024; Huang SH, 2018, CLIN EXP RHEUMATOL, V36, P185; Iliff JJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003748; Jassam YN, 2017, NEURON, V95, P1246, DOI 10.1016/j.neuron.2017.07.010; Jay TR, 2017, J NEUROSCI, V37, P637, DOI [10.1523/JNEUROSCI.2110-16.2017, 10.1523/JNEUROSCI.2110-16.2016]; Jay TR, 2015, J EXP MED, V212, P287, DOI 10.1084/jem.20142322; Judd CM, 2012, J PERS SOC PSYCHOL, V103, P54, DOI 10.1037/a0028347; Kaushal N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045610; Kokiko-Cochran O, 2016, J NEUROTRAUM, V33, P625, DOI 10.1089/neu.2015.3970; Kokiko-Cochran ON, 2018, J NEUROTRAUM, V35, P73, DOI 10.1089/neu.2017.5203; Levenson JC, 2017, SLEEP, V40, DOI 10.1093/sleep/zsx113; Li XJ, 2013, NEURAL REGEN RES, V8, P338, DOI 10.3969/j.issn.1673-5374.2013.04.006; Liu YWY, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1173-x; Maphis N, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00196; McAlpine CS, 2018, ATHEROSCLEROSIS SUPP, V32, P97, DOI 10.1016/j.atherosclerosissup.2018.04.295; McKim DB, 2016, BIOL PSYCHIAT, V79, P803, DOI 10.1016/j.biopsych.2015.07.010; Mestre H, 2018, ELIFE, V7, DOI 10.7554/eLife.40070; MOORE RY, 1972, BRAIN RES, V42, P201, DOI 10.1016/0006-8993(72)90054-6; Muccigrosso MM, 2016, BRAIN BEHAV IMMUN, V54, P95, DOI 10.1016/j.bbi.2016.01.009; Neumann J, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193970; Nielsen S, 1997, J NEUROSCI, V17, P171; Niraula A, 2018, J NEUROSCI, V38, P2328, DOI 10.1523/JNEUROSCI.2568-17.2018; OHARA BF, 1993, SLEEP, V16, P1; Painter MM, 2015, MOL NEURODEGENER, V10, DOI 10.1186/s13024-015-0040-9; Patti CL, 2010, SLEEP, V33, P1669, DOI 10.1093/sleep/33.12.1669; Pelluru D, 2016, EUR J NEUROSCI, V43, P1298, DOI 10.1111/ejn.13074; Poskanzer KE, 2016, P NATL ACAD SCI USA, V113, pE2675, DOI 10.1073/pnas.1520759113; Ren ZG, 2013, J CEREBR BLOOD F MET, V33, P834, DOI 10.1038/jcbfm.2013.30; Rodgers RJ, 1997, NEUROSCI BIOBEHAV R, V21, P801, DOI 10.1016/S0149-7634(96)00058-9; Rosciszewski G, 2018, MOL NEUROBIOL, V55, P3875, DOI 10.1007/s12035-017-0618-z; Rowe RK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0082507; Saber M, 2017, J NEUROTRAUM, V34, P423, DOI 10.1089/neu.2016.4401; Salehi A, 2017, J CEREBR BLOOD F MET, V37, P2320, DOI 10.1177/0271678X17701460; Seelig AD, 2010, SLEEP, V33, P1615, DOI 10.1093/sleep/33.12.1615; Sethi M, 2015, NEUROSCIENCE, V290, P80, DOI 10.1016/j.neuroscience.2015.01.035; Spiegel K, 1999, LANCET, V354, P1435, DOI 10.1016/S0140-6736(99)01376-8; STEPHAN FK, 1972, P NATL ACAD SCI USA, V69, P1583, DOI 10.1073/pnas.69.6.1583; Tapp ZM, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00345; Taylor AN, 2008, J NEUROTRAUM, V25, P311, DOI 10.1089/neu.2007.0486; Taylor AN, 2010, J NEUROTRAUM, V27, P1081, DOI 10.1089/neu.2009.1252; Taylor AN, 2006, J NEUROTRAUM, V23, P1802, DOI 10.1089/neu.2006.23.1802; Thompson RS, 2014, ACTA PHYSIOL, V211, P447, DOI 10.1111/apha.12239; Turnbull IR, 2006, J IMMUNOL, V177, P3520, DOI 10.4049/jimmunol.177.6.3520; Waye KP, 2003, LIFE SCI, V72, P863, DOI 10.1016/S0024-3205(02)02336-6; Wesselius HM, 2018, JAMA INTERN MED, V178, P1201, DOI 10.1001/jamainternmed.2018.2669; Witcher KG, 2015, TRENDS NEUROSCI, V38, P609, DOI 10.1016/j.tins.2015.08.002; Xie LL, 2013, SCIENCE, V342, P373, DOI 10.1126/science.1241224; Zhang L, 2000, NEUROREPORT, V11, P409, DOI 10.1097/00001756-200002070-00037; Zhu Y, 2018, J NEUROSCI, V38, P10255, DOI 10.1523/JNEUROSCI.0275-18.2018; Ziebell JM, 2010, NEUROTHERAPEUTICS, V7, P22, DOI 10.1016/j.nurt.2009.10.016	68	7	7	1	3	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	AUG 15	2020	37	16					1829	1843		10.1089/neu.2020.7010		APR 2020	15	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	MW0CL	WOS:000527571100001	32164485	Green Published, Bronze			2022-02-06	
J	McKay, A; Love, J; Trevena-Peters, J; Gracey, J; Ponsford, J				McKay, Adam; Love, Jasmine; Trevena-Peters, Jessica; Gracey, Jacinta; Ponsford, Jennie			The relationship between agitation and impairments of orientation and memory during the PTA period after traumatic brain injury	NEUROPSYCHOLOGICAL REHABILITATION			English	Article						Traumatic brain injury (TBI); agitation; post-traumatic amnesia (PTA); cognitive; orientation; memory	CLOSED HEAD-INJURY; POSTTRAUMATIC AMNESIA; BEHAVIORAL DISTURBANCES; DOUBLE-BLIND; REHABILITATION; RECOVERY; MANAGEMENT; HALOPERIDOL; EFFICACY; OUTCOMES	Agitation is common during the post-traumatic amnesia (PTA) period after traumatic brain injury (TBI), although our knowledge of what causes or predicts agitation is limited. The current study aimed to examine the association of agitation in PTA with the concurrent impairments in orientation and memory while controlling for covariates of agitation. Participants were 125 patients in PTA following moderate to extremely severe TBI recruited from an inpatient brain injury rehabilitation service who were assessed throughout PTA on the Agitated Behavior Scale (ABS) and the Westmead PTA Scale (WPTAS). Agitation was observed in 42.4% of participants (ABS score > 21), with disinhibited behaviours (e.g., distractibility and impulsivity) most common. Multilevel modelling found daily ABS scores to be associated with daily scores on the WPTAS but in a non-linear pattern. Analysis of covariates found that shorter time post-admission, younger age, presence of infection and higher antipsychotic doses were associated with higher ABS scores. These results support a relationship between agitation and the concurrent cognitive impairment during PTA. While a causal link cannot yet be inferred, management strategies that can potentially interfere with cognition (e.g., sedating medications, environmental changes) should be used cautiously in case they exacerbate agitation.	[McKay, Adam; Love, Jasmine; Trevena-Peters, Jessica; Ponsford, Jennie] Monash Univ, Sch Psychol Sci, Melbourne, Vic, Australia; [McKay, Adam; Trevena-Peters, Jessica; Ponsford, Jennie] Monash Epworth Rehabil Res Ctr, Melbourne, Vic, Australia; [McKay, Adam; Gracey, Jacinta] Epworth HealthCare, Dept Psychol, Melbourne, Vic, Australia; [Ponsford, Jennie] Natl Trauma Res Inst, Melbourne, Vic, Australia		McKay, A (corresponding author), Monash Univ, Sch Psychol Sci, Clayton, Vic 3800, Australia.	adam.mckay@monash.edu	Ponsford, Jennie/H-8341-2014; McKay, Adam/M-6003-2017	Ponsford, Jennie/0000-0003-0430-125X; McKay, Adam/0000-0002-0479-7681			BOGNER J, 1995, NEUROREHABILITATION, V5, P293, DOI 10.3233/NRE-1995-5403; Bogner JA, 1999, J HEAD TRAUMA REHAB, V14, P91, DOI 10.1097/00001199-199902000-00012; Bogner JA, 2000, J HEAD TRAUMA REHAB, V15, P656, DOI 10.1097/00001199-200002000-00005; Bogner JA, 2001, AM J PHYS MED REHAB, V80, P636, DOI 10.1097/00002060-200109000-00002; Bogner J, 2015, ARCH PHYS MED REHAB, V96, pS274, DOI 10.1016/j.apmr.2015.04.020; BROOKE MM, 1992, ARCH PHYS MED REHAB, V73, P320, DOI 10.1016/0003-9993(92)90003-F; Brown AW, 2005, J NEUROTRAUM, V22, P1040, DOI 10.1089/neu.2005.22.1040; CORRIGAN J D, 1992, Brain Injury, V6, P155, DOI 10.3109/02699059209029653; CORRIGAN JD, 1994, J CLIN EXP NEUROPSYC, V16, P386, DOI 10.1080/01688639408402649; CORRIGAN JD, 1989, J CLIN EXP NEUROPSYC, V11, P261, DOI 10.1080/01688638908400888; CORRIGAN JD, 1988, ARCH PHYS MED REHAB, V69, P487; Deb S, 2004, BRAIN INJURY, V18, P1, DOI 10.1080/0269905031000110463; Eisenberg ME, 2009, CRIT REV PHYS REHABI, V21, P3; Folweiler KA, 2017, J NEUROTRAUM, V34, P451, DOI 10.1089/neu.2016.4417; Fugate LP, 1997, ARCH PHYS MED REHAB, V78, P917, DOI 10.1016/S0003-9993(97)90050-2; Gardner DM, 2010, AM J PSYCHIAT, V167, P686, DOI 10.1176/appi.ajp.2009.09060802; GEFFEN G, 1994, AUST OCCUP THER J, V41, P31, DOI DOI 10.1111/J.1440-1630.1994.TB01809.X; GEFFEN GM, 1991, NEUROREPORT, V2, P105, DOI 10.1097/00001756-199102000-00010; Harmsen M, 2004, BRAIN INJURY, V18, P787, DOI 10.1080/02699050410001671757; Hoffman AN, 2008, LIFE SCI, V83, P602, DOI 10.1016/j.lfs.2008.08.007; Janzen S, 2014, BRAIN INJURY, V28, P318, DOI 10.3109/02699052.2013.860478; Kadyan V, 2004, AM J PHYS MED REHAB, V83, P747, DOI 10.1097/01.PHM.0000140790.30468.F4; KATZ DI, 1994, ARCH NEUROL-CHICAGO, V51, P661, DOI 10.1001/archneur.1994.00540190041013; Keith R A, 1987, Adv Clin Rehabil, V1, P6; Kline AE, 2008, NEUROSCI LETT, V448, P263, DOI 10.1016/j.neulet.2008.10.076; Lequerica AH, 2007, J HEAD TRAUMA REHAB, V22, P177, DOI 10.1097/01.HTR.0000271118.96780.bc; MCNENY R, 1995, NEUROREHABILITATION, V5, P211, DOI 10.3233/NRE-1995-5304; McNett M, 2012, BRAIN INJURY, V26, P1155, DOI 10.3109/02699052.2012.667587; Meythaler JM, 2002, J HEAD TRAUMA REHAB, V17, P300, DOI 10.1097/00001199-200208000-00004; Mysiw WJ, 1997, ARCH PHYS MED REHAB, V78, P213, DOI 10.1016/S0003-9993(97)90266-5; Nakase-Richardson R, 2011, J NEUROL NEUROSUR PS, V82, P494, DOI 10.1136/jnnp.2010.222489; Nakase-Richardson R., 2014, HDB NEUROPSYCHOLOGY, P157; Noe E, 2007, BEHAV NEUROL, V18, P7, DOI 10.1155/2007/529076; Nott MT, 2006, BRAIN INJURY, V20, P1175, DOI 10.1080/02699050601049114; Nott MT, 2010, BRAIN INJURY, V24, P1214, DOI 10.3109/02699052.2010.506858; Phelps TI, 2015, J NEUROTRAUM, V32, P590, DOI 10.1089/neu.2014.3711; Ponsford J, 2014, J HEAD TRAUMA REHAB, V29, P307, DOI 10.1097/HTR.0000000000000074; RAO N, 1985, ARCH PHYS MED REHAB, V66, P30; Sherer M, 2005, ARCH PHYS MED REHAB, V86, P896, DOI 10.1016/j.apmr.2004.09.029; Sherer M, 2002, ARCH PHYS MED REHAB, V83, P183, DOI 10.1053/apmr.2002.28802; Shores E A, 1995, Appl Neuropsychol, V2, P167; Shutter LA, 1999, NEUROLOGIST, V5, P258, DOI 10.1097/00127893-199909000-00003; Silver JM., 2004, NEUROPSYCHIATRY TRAU, P313; Singh R, 2014, BRAIN INJURY, V28, P336, DOI 10.3109/02699052.2013.873142; Snijders TAB., 2012, MULTILEVEL ANAL INTR; Stuss DT, 1999, J NEUROSURG, V90, P635, DOI 10.3171/jns.1999.90.4.0635; Tate RL, 2001, J HEAD TRAUMA REHAB, V16, P525, DOI 10.1097/00001199-200112000-00002; Thomas H, 2003, J HEAD TRAUMA REHAB, V18, P292, DOI 10.1097/00001199-200305000-00007; van der Naalt J, 2000, BRAIN INJURY, V14, P781; Wheaton P, 2009, J CLIN PSYCHOPHARM, V29, P468, DOI 10.1097/JCP.0b013e3181b66f04; Wilde EA, 2006, BRAIN INJURY, V20, P695, DOI 10.1080/02699050600744079; Willmott C, 2009, J NEUROL NEUROSUR PS, V80, P552, DOI 10.1136/jnnp.2008.159632; Wolffbrandt MM, 2013, REHABIL NURS, V38, P133, DOI 10.1002/rnj.82	53	7	7	1	3	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0960-2011	1464-0694		NEUROPSYCHOL REHABIL	Neuropsychol. Rehabil.	APR 20	2020	30	4					579	590		10.1080/09602011.2018.1479276			12	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	KY5YS	WOS:000522649700001	29860914				2022-02-06	
J	Van Praag, DLG; Fardzadeh, HE; Covic, A; Maas, AIR; von Steinbuchel, N				Van Praag, Dominique L. G.; Fardzadeh, Haghish Ebad; Covic, Amra; Maas, Andrew I. R.; von Steinbuechel, Nicole			Preliminary validation of the Dutch version of the Posttraumatic stress disorder checklist for DSM-5 (PCL-5) after traumatic brain injury in a civilian population	PLOS ONE			English	Article							GENERALIZED ANXIETY DISORDER; CONFIRMATORY FACTOR-ANALYSIS; QUALITY-OF-LIFE; PTSD CHECKLIST; SOCIAL SUPPORT; RISK-FACTORS; HEART-RATE; FOLLOW-UP; PRIME-MD; 1ST YEAR	The Posttraumatic stress disorder checklist (PCL) is the most widely used questionnaire to screen for symptoms of posttraumatic stress disorder (PTSD), based on the Diagnostic and Statistical manual of Mental disorders (DSM-IV) criteria. In the latest edition of the DSM (DSM-5), the criteria for PTSD were revised leading to the development of the PCL-5. So far, there is no validated Dutch version of the PCL-5. The aim of this study is to determine psychometric characteristics of the Dutch translation and linguistic validation of the PCL-5 and to evaluate internal consistency, criterion and structural validity. In a population of 495 civilian, traumatic brain injury patients, the PCL-5, the Generalized anxiety disorder questionnaire and the Depression scale of the Patient health questionnaire were administered. The PCL-5 was translated in Dutch following a strict procedure of linguistic validation and cognitive debriefing. Results show an excellent internal consistency and high criterion validity. Confirmatory factor analysis demonstrated a good fit for the four-factor DSM-5 model, but a superior fit for the six-factor Anhedonia model and the seven-factor Hybrid model, similar to the English version of the PCL-5. Preliminary validation of the Dutch translation of the PCL-5 was proven to be psychometrically sound and can be used for clinical and academic purposes, specifically for TBI patients. Future research should examine concurrent and discriminant validity for the Dutch translation in broader populations at risk for PTSD, and include a structured interview to evaluate diagnostic utility.	[Van Praag, Dominique L. G.; Maas, Andrew I. R.] Antwerp Univ Hosp, Dept Neurosurg, Edegem, Belgium; [Van Praag, Dominique L. G.; Maas, Andrew I. R.] Univ Antwerp, Edegem, Belgium; [Fardzadeh, Haghish Ebad; Covic, Amra; von Steinbuechel, Nicole] Georg August Univ, Univ Med Ctr Gottingen UMG, Inst Med Psychol & Med Sociol, Gottingen, Germany		Van Praag, DLG (corresponding author), Antwerp Univ Hosp, Dept Neurosurg, Edegem, Belgium.; Van Praag, DLG (corresponding author), Univ Antwerp, Edegem, Belgium.	Dominique.vanpraag@uza.be	; Maas, Andrew I.R./C-5584-2013	Van Praag, Dominique/0000-0002-4279-6532; Maas, Andrew I.R./0000-0003-1612-1264	European UnionEuropean Commission [602150]; Hannelore Kohl Stiftung (Germany); OneMind (USA); Integra LifeSciences Corporation (USA)	This study was supported by the Framework 7 program of the European Union in the context of CENTER-TBI (grant number 602150). Additional funding was obtained from the Hannelore Kohl Stiftung (Germany), from OneMind (USA) and from Integra LifeSciences Corporation (USA). The funders did not play a role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	Ahman S, 2013, J REHABIL MED, V45, P758, DOI 10.2340/16501977-1182; Alexander M.P., 1992, J HEAD TRAUMA REHAB, V7, P60, DOI DOI 10.1097/00001199-199206000-00009; Alway Y, 2016, J NEUROTRAUM, V33, P825, DOI 10.1089/neu.2015.3992; Alway Y, 2016, DEPRESS ANXIETY, V33, P19, DOI 10.1002/da.22396; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5, DOI [10.1176/appi.books.9780890425596.dsm02, 10.1176/appi.books.9780890425596]; American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; Armour C, 2015, J PSYCHIATR RES, V61, P106, DOI 10.1016/j.jpsychires.2014.10.012; Ashbaugh AR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161645; Ashman TA, 2004, ARCH PHYS MED REHAB, V85, pS36, DOI 10.1016/j.apmr.2003.08.117; Asmundson GJG, 2000, BEHAV RES THER, V38, P203, DOI 10.1016/S0005-7967(99)00061-3; Bahraini NH, 2014, PSYCHIAT CLIN N AM, V37, P55, DOI 10.1016/j.psc.2013.11.002; Baranyi A, 2010, PSYCHOSOMATICS, V51, P237, DOI 10.1176/appi.psy.51.3.237; BECK AT, 1988, J CONSULT CLIN PSYCH, V56, P893, DOI 10.1037/0022-006X.56.6.893; Beck AT., 1979, COGNITIVE THERAPY DE; Blevins CA, 2015, J TRAUMA STRESS, V28, P489, DOI 10.1002/jts.22059; Bombardier CH, 2006, J NEUROPSYCH CLIN N, V18, P501, DOI 10.1176/appi.neuropsych.18.4.501; Bovin MJ, 2016, PSYCHOL ASSESSMENT, V28, P1379, DOI 10.1037/pas0000254; Boysan M, 2017, PSYCHIAT CLIN PSYCH, V27, P306, DOI 10.1080/24750573.2017.1342769; Bryant RA, 2004, PSYCHOSOM MED, V66, P760, DOI 10.1097/01.psy.0000138121.13198.84; Bryant RA, 1999, J NERV MENT DIS, V187, P302, DOI 10.1097/00005053-199905000-00006; Bryant RA, 1999, BRAIN INJURY, V13, P15, DOI 10.1080/026990599121836; Bryant Richard, 2011, Dialogues Clin Neurosci, V13, P251; Bryant RA, 2010, AM J PSYCHIAT, V167, P312, DOI 10.1176/appi.ajp.2009.09050617; Bryant RA, 2009, J INT NEUROPSYCH SOC, V15, P862, DOI 10.1017/S1355617709990671; Carlson KF, 2011, J HEAD TRAUMA REHAB, V26, P103, DOI 10.1097/HTR.0b013e3181e50ef1; Chalmers RP, 2012, J STAT SOFTW, V48, P1; Choi MS, 2014, J KOREAN NEUROSURG S, V55, P190, DOI 10.3340/jkns.2014.55.4.190; COCHRAN WG, 1952, ANN MATH STAT, V23, P315, DOI 10.1214/aoms/1177729380; Creamer M, 2005, BEHAV RES THER, V43, P1383, DOI 10.1016/j.brat.2004.11.001; Dahm J, 2015, INJURY, V46, P142, DOI 10.1016/j.injury.2014.07.012; Dams-O'Connor K, 2013, J NEUROTRAUM, V30, P2014, DOI 10.1089/neu.2013.3049; Dischinger P, 2003, Annu Proc Assoc Adv Automot Med, V47, P577; Donker T, 2011, PSYCHIAT RES, V188, P58, DOI 10.1016/j.psychres.2011.01.016; Gfeller JD, 2013, BEHAV SCI LAW, V31, P833, DOI 10.1002/bsl.2084; Gil S, 2005, AM J PSYCHIAT, V162, P963, DOI 10.1176/appi.ajp.162.5.963; Gould KR, 2011, PSYCHOL MED, V41, P2099, DOI 10.1017/S003329171100033X; Haagsma JA, 2015, J NEUROTRAUM, V32, P853, DOI 10.1089/neu.2013.3283; Haarbauer-Krupa J, 2017, J NEUROTRAUM, V34, P50, DOI 10.1089/neu.2015.4158; Hall BJ, 2019, EUR J OSYCHOTRAUMATO, V10, P23, DOI [10.1016/s0163-8343(03)00072-0, DOI 10.1016/S0163-8343(03)00072-0]; Harvey AG, 2000, AM J PSYCHIAT, V157, P626, DOI 10.1176/appi.ajp.157.4.626; HESBACHER PT, 1980, J CLIN PSYCHIAT, V41, P6; HICKLING EJ, 1992, J ANXIETY DISORD, V6, P285, DOI 10.1016/0887-6185(92)90040-E; Hoffman JM, 2012, ARCH PHYS MED REHAB, V93, P287, DOI 10.1016/j.apmr.2011.08.041; Hoofien D, 2001, BRAIN INJURY, V15, P189; HOROWITZ M, 1979, PSYCHOSOM MED, V41, P209, DOI 10.1097/00006842-197905000-00004; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Ibrahim H, 2018, BMC PSYCHIATRY, V18, DOI 10.1186/s12888-018-1839-z; Kjeldgaard D, 2014, CEPHALALGIA, V34, P191, DOI 10.1177/0333102413505236; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Kruger-Gottschalk A, 2017, BMC PSYCHIATRY, V17, DOI 10.1186/s12888-017-1541-6; Lagarde E, 2014, JAMA PSYCHIAT, V71, P1032, DOI 10.1001/jamapsychiatry.2014.666; Lamers F, 2008, J CLIN EPIDEMIOL, V61, P679, DOI 10.1016/j.jclinepi.2007.07.018; Levin HS, 2001, J CLIN EXP NEUROPSYC, V23, P754, DOI 10.1076/jcen.23.6.754.1021; Lima Eduardo de Paula, 2016, Trends Psychiatry Psychother., V38, P207, DOI 10.1590/2237-6089-2015-0074; Liu P, 2014, J ANXIETY DISORD, V28, P345, DOI 10.1016/j.janxdis.2014.03.008; Lowe B, 2008, MED CARE, V46, P266, DOI 10.1097/MLR.0b013e318160d093; Maas AIR, 2015, NEUROSURGERY, V76, P67, DOI 10.1227/NEU.0000000000000575; Majdan M, 2016, LANCET PUBLIC HEALTH, V1, pE76, DOI 10.1016/S2468-2667(16)30017-2; McCauley SR, 2001, J CLIN EXP NEUROPSYC, V23, P792, DOI 10.1076/jcen.23.6.792.1016; Meares S, 2011, NEUROPSYCHOLOGY, V25, P454, DOI 10.1037/a0022580; MONTGOMERY SA, 1979, BRIT J PSYCHIAT, V134, P382, DOI 10.1192/bjp.134.4.382; Moore EL, 2006, BRAIN INJURY, V20, P117, DOI 10.1080/02699050500443558; Ommaya AK, 1996, J TRAUMA, V41, P972, DOI 10.1097/00005373-199612000-00005; Persoons P, 2003, GEN HOSP PSYCHIAT, V25, P316, DOI 10.1016/S0163-8343(03)00072-0; Phelps LF, 2008, REHABIL PSYCHOL, V53, P28, DOI 10.1037/0090-5550.53.1.28; Pietrzak RH, 2009, J NERV MENT DIS, V197, P748, DOI 10.1097/NMD.0b013e3181b97a75; Polinder S, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-783; Powell TJ, 1996, DISABIL REHABIL, V18, P231, DOI 10.3109/09638289609166306; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Reid LM, 2011, J NEUROPSYCH CLIN N, V23, P454, DOI 10.1176/jnp.23.4.jnp454; Riggio S, 2011, NEUROL CLIN, V29, P35, DOI 10.1016/j.ncl.2010.10.008; Schinka JA, 2007, J TRAUMA STRESS, V20, P281, DOI 10.1002/jts.20202; Scholten AC, 2016, J NEUROTRAUM, V33, P1969, DOI 10.1089/neu.2015.4252; Spitzer RL, 1999, JAMA-J AM MED ASSOC, V282, P1737, DOI 10.1001/jama.282.18.1737; Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092; Sumpter RE, 2005, BRIT J PSYCHIAT, V186, P423, DOI 10.1192/bjp.186.5.423; Sveen J, 2016, EUR J PSYCHOTRAUMATO, V7, DOI 10.3402/ejpt.v7.30165; Van Praag DLG, 2019, J NEUROTRAUM, V36, P3220, DOI 10.1089/neu.2018.5759; Wang L, 2015, J ANXIETY DISORD, V31, P90, DOI 10.1016/j.janxdis.2015.02.006; Weathers F.W., 2013, PTSD CHECKLIST DSM 5; Weathers F.W., 1993, 9 ANN C ISTSS; Williams WH, 2002, BRAIN INJURY, V16, P673, DOI 10.1080/02699050210128861; Zatzick DF, 2010, ARCH GEN PSYCHIAT, V67, P1291, DOI 10.1001/archgenpsychiatry.2010.158; Zhong QY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125096; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	85	7	7	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2020	15	4							e0231857	10.1371/journal.pone.0231857			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LR9MR	WOS:000536019800042	32310970	Green Published, Green Submitted, gold			2022-02-06	
J	Kim, SK; Chong, CD; Dumkrieger, G; Ross, K; Berisha, V; Schwedt, TJ				Kim, Soo-Kyoung; Chong, Catherine D.; Dumkrieger, Gina; Ross, Katherine; Berisha, Visar; Schwedt, Todd J.			Clinical correlates of insomnia in patients with persistent post-traumatic headache compared with migraine	JOURNAL OF HEADACHE AND PAIN			English	Article						Posttraumatic headache; Migraine; Traumatic brain injury; Insomnia; Sleep	TRAUMATIC BRAIN-INJURY; VERBAL-LEARNING TEST; SEVERITY INDEX; SLEEP-DEPRIVATION; TEST-PERFORMANCE; HYPERACUSIS; PREVALENCE; PAIN; DEPRESSION; DISORDERS	Background Close associations between insomnia with other clinical factors have been identified in migraine, but there have been few studies investigating associations between insomnia and clinical factors in patients with persistent post-traumatic headache (PPTH). The study objective was to contrast the severity of insomnia symptoms in PPTH, migraine, and healthy controls, and to identify factors associated with insomnia in patients with PPTH vs. migraine. Methods In this cross-sectional cohort study, 57 individuals with PPTH attributed to mild traumatic brain injury, 39 with migraine, and 39 healthy controls were included. Participants completed a detailed headache characteristics questionnaire, the Migraine Disability Assessment Scale (MIDAS), Insomnia Severity Index (ISI), Hyperacusis Questionnaire (HQ), Allodynia Symptom Checklist, Photosensitivity Assessment Questionnaire, Beck Depression Inventory (BDI), State-Trait Anxiety Inventory, Post-Traumatic Stress Disorder (PTSD) checklist, Ray Auditory Verbal Learning Test, and the Trail Making Test A and B to assess headache characteristics, disability, insomnia symptoms, sensory hypersensitivities, and neuropsychological factors. Fisher's test and one-way ANOVA or Tukey's Honest Significant Difference were used to assess group differences of categorical and continuous data. Stepwise linear regression analyses were conducted to identify clinical variables associated with insomnia symptoms. Results Those with PPTH had significantly higher ISI scores (16.7 +/- 6.6) compared to migraine patients (11.3 +/- 6.4) and healthy controls (4.1 +/- 4.8) (p < 0.001). For those with PPTH, insomnia severity was most strongly correlated with the BDI (Spearman's rho (rho) = 0.634, p < 0.01), followed by Trait Anxiety (rho = 0.522, p < 0.01), PTSD (rho = 0.505, p < 0.01), HQ (rho = 0.469, p < 0.01), State Anxiety (rho = 0.437, p < 0.01), and MIDAS scores (rho = 0.364, p < 0.01). According to linear regression models, BDI, headache intensity, and hyperacusis scores were significantly positively associated with insomnia severity in those with PPTH, while only delayed memory recall was negatively associated with insomnia severity in those with migraine. Conclusions Insomnia symptoms were more severe in those with PPTH compared to migraine and healthy control cohorts. Depression, headache intensity, and hyperacusis were associated with insomnia in individuals with PPTH. Future studies should determine the bidirectional impact of treating insomnia and its associated symptoms.	[Kim, Soo-Kyoung] Gyeongsang Natl Univ, Dept Neurol, Coll Med, Jinju, South Korea; [Kim, Soo-Kyoung] Gyeongsang Natl Univ, Inst Hlth Sci, Coll Med, Jinju, South Korea; [Kim, Soo-Kyoung; Chong, Catherine D.; Dumkrieger, Gina; Schwedt, Todd J.] Mayo Clin, Dept Neurol, 5777 East Mayo Blvd, Phoenix, AZ 85054 USA; [Ross, Katherine] Phoenix VA Hlth Care Syst, Phoenix, AZ USA; [Berisha, Visar] Arizona State Univ, Tempe, AZ USA		Schwedt, TJ (corresponding author), Mayo Clin, Dept Neurol, 5777 East Mayo Blvd, Phoenix, AZ 85054 USA.	Schwedt.Todd@mayo.edu		Schwedt, Todd/0000-0002-7780-7086; chong, catherine/0000-0002-9035-8748	Office of the Assistant Secretary of Defense for Health Affairs, through the Peer Reviewed Medical Research Program [W81XWH-15-1-0286, W81XWH-19-1-0534]	This study was funded by the Office of the Assistant Secretary of Defense for Health Affairs, through the Peer Reviewed Medical Research Program under Award No. W81XWH-15-1-0286 and Award No. W81XWH-19-1-0534. Opinions, interpretations, conclusions, and recommendations are those of the authors and are not necessarily endorsed by the Department of Defense. The U.S. Army Medical Research Acquisition Activity, 820 Chandler Street, Fort Detrick MD 21702-5014 is the awarding and administering acquisition office.	Aazh H, 2019, J AM ACAD AUDIOL, V30, P802, DOI 10.3766/jaaa.18020; Aazh H, 2017, AM J AUDIOL, V26, P562, DOI 10.1044/2017_AJA-17-0008; Abouzari M, 2020, ANN OTO RHINOL LARYN, V129, P421, DOI 10.1177/0003489419892997; Adrien J, 2002, SLEEP MED REV, V6, P341, DOI 10.1053/smrv.2001.0200; [Anonymous], 2018, Cephalalgia, V38, P1, DOI 10.1177/0333102417738202; Ashina H, 2019, NAT REV NEUROL, V15, P607, DOI 10.1038/s41582-019-0243-8; Bastien CH, 2001, SLEEP MED, V2, P297, DOI 10.1016/S1389-9457(00)00065-4; Beck AT, 1996, J PERS ASSESS, V67, P588, DOI 10.1207/s15327752jpa6703_13; Bes A, 2013, CEPHALALGIA, V33, P629, DOI 10.1177/0333102413485658; Chaput G, 2009, SLEEP MED, V10, P713, DOI 10.1016/j.sleep.2008.07.015; Chen PY, 2015, SLEEP MED, V16, P598, DOI 10.1016/j.sleep.2014.11.016; Choi JY, 2009, CEPHALALGIA, V29, P953, DOI 10.1111/j.1468-2982.2008.01822.x; Chong CD, 2018, HEADACHE, V58, P53, DOI 10.1111/head.13223; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P318, DOI 10.1097/01.HTR.0000300227.67748.77; Davis JJ, 2012, CLIN NEUROPSYCHOL, V26, P1397, DOI 10.1080/13854046.2012.728627; DeKosky ST, 2010, NEW ENGL J MED, V363, P1293, DOI 10.1056/NEJMp1007051; Drummond SPA, 2013, SLEEP, V36, P1307, DOI 10.5665/sleep.2952; Dumkrieger G, 2019, CEPHALALGIA, V39, P1366, DOI 10.1177/0333102419847728; Fackrell K, 2019, LANCET, V393, P404, DOI 10.1016/S0140-6736(18)32616-3; Florencio LL, 2012, ARQ NEURO-PSIQUIAT, V70, P852, DOI 10.1590/S0004-282X2012001100006; Fortier-Brochu E, 2014, SLEEP, V37, P1789, DOI 10.5665/sleep.4172; Fulda S, 2001, SLEEP MED REV, V5, P423, DOI 10.1053/smrv.2001.0157; Hoffman JM, 2011, J NEUROTRAUM, V28, P1719, DOI 10.1089/neu.2011.1914; Hou LJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076087; Howard L, 2018, HEADACHE, V58, P1397, DOI 10.1111/head.13396; Ivnik R.J., 1990, PSYCHOL ASSESSMENT J, V2, P304, DOI [10.1037/1040-3590.2.3.304, DOI 10.1037/1040-3590.2.3.304]; Jaramillo CA, 2016, HEADACHE, V56, P528, DOI 10.1111/head.12726; Khalfa S, 2002, ORL-J OTO-RHIN-LARYN, V64, P436, DOI 10.1159/000067570; Knoll RM, 2020, LARYNGOSCOPE, V130, P761, DOI 10.1002/lary.28034; Kostyun RO, 2015, AM J SPORT MED, V43, P633, DOI 10.1177/0363546514560727; Lateef T, 2011, CEPHALALGIA, V31, P648, DOI 10.1177/0333102410390395; Lautenbacher S, 2006, SLEEP MED REV, V10, P357, DOI 10.1016/j.smrv.2005.08.001; Lavigne G, 2015, PAIN, V156, pS75, DOI 10.1097/j.pain.0000000000000111; Lew HL, 2006, AM J PHYS MED REHAB, V85, P619, DOI 10.1097/01.phm.0000223235.09931.c0; Lipton RB, 2008, ANN NEUROL, V63, P148, DOI 10.1002/ana.21211; Lucas S, 2014, CEPHALALGIA, V34, P93, DOI 10.1177/0333102413499645; Lucchesi LM, 2010, CEPHALALGIA, V30, P1477, DOI 10.1177/0333102410368440; Lustberg L, 2000, SLEEP MED REV, V4, P253, DOI 10.1053/smrv.1999.0075; Madsen T, 2018, JAMA-J AM MED ASSOC, V320, P580, DOI 10.1001/jama.2018.10211; MARRIAGE J, 1995, J LARYNGOL OTOL, V109, P915, DOI 10.1017/S0022215100131676; Mathias JL, 2012, SLEEP MED, V13, P898, DOI 10.1016/j.sleep.2012.04.006; Minen MT, 2016, CURR NEUROL NEUROSCI, V16, DOI 10.1007/s11910-016-0697-7; Morin CM, 2011, SLEEP, V34, P601, DOI 10.1093/sleep/34.5.601; Nampiaparampil DE, 2008, JAMA-J AM MED ASSOC, V300, P711, DOI 10.1001/jama.300.6.711; Odegard SS, 2013, J HEADACHE PAIN, V14, DOI 10.1186/1129-2377-14-24; Odegard SS, 2010, J HEADACHE PAIN, V11, P197, DOI 10.1007/s10194-010-0201-8; Onen SH, 2001, J SLEEP RES, V10, P35, DOI 10.1046/j.1365-2869.2001.00240.x; Ouellet MC, 2004, NEUROREHAB NEURAL RE, V18, P187, DOI 10.1177/1545968304271405; Pace-Schott EF, 2002, NAT REV NEUROSCI, V3, P591, DOI 10.1038/nrn895; Perianez JA, 2007, ARCH CLIN NEUROPSYCH, V22, P433, DOI 10.1016/j.acn.2007.01.022; Piantino J, 2019, CURR PAIN HEADACHE R, V23, DOI 10.1007/s11916-019-0799-4; Pompili M, 2012, PSYCHIAT RES, V200, P389, DOI 10.1016/j.psychres.2012.05.010; Ponsford JL, 2013, NEUROREHAB NEURAL RE, V27, P613, DOI 10.1177/1545968313481283; Prins A, 2016, J GEN INTERN MED, V31, P1206, DOI 10.1007/s11606-016-3703-5; RAMANAIAH NV, 1983, J PERS ASSESS, V47, P531, DOI 10.1207/s15327752jpa4705_14; Sahley TL, 1996, EAR HEARING, V17, P341, DOI 10.1097/00003446-199608000-00006; Sandsmark DK, 2017, SLEEP, V40, DOI 10.1093/sleep/zsx044; Schoenberg MR, 2006, ARCH CLIN NEUROPSYCH, V21, P693, DOI 10.1016/j.acn.2006.06.010; Scholten AC, 2016, J NEUROTRAUM, V33, P1969, DOI 10.1089/neu.2015.4252; Schwedt TJ, 2017, J HEADACHE PAIN, V18, DOI 10.1186/s10194-017-0796-0; Stewart WF, 2001, NEUROLOGY, V56, pS20, DOI 10.1212/WNL.56.suppl_1.S20; Szczepaniak WS, 1996, HEARING RES, V97, P46; Theeler BJ, 2012, CURR TREAT OPTION NE, V14, P36, DOI 10.1007/s11940-011-0157-2; Tombaugh TN, 2004, ARCH CLIN NEUROPSYCH, V19, P203, DOI 10.1016/S0887-6177(03)00039-8; Tyler RS, 2014, AM J AUDIOL, V23, P402, DOI 10.1044/2014_AJA-14-0010; Uhlig BL, 2014, CEPHALALGIA, V34, P745, DOI 10.1177/0333102414540058; Vargas BB, 2012, CURR OPIN NEUROL, V25, P284, DOI 10.1097/WCO.0b013e3283535bf5; Vgontzas A, 2008, HEADACHE, V48, P1451, DOI 10.1111/j.1526-4610.2008.01175.x; Vgontzas A, 2018, HEADACHE, V58, P1030, DOI 10.1111/head.13358; Walters AB, 2014, HEADACHE, V54, P116, DOI 10.1111/head.12168; Wu YW, 2017, TRANSL NEURODEGENER, V6, DOI 10.1186/s40035-017-0095-3	71	7	7	1	3	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1129-2369	1129-2377		J HEADACHE PAIN	J. Headache Pain	APR 15	2020	21	1							33	10.1186/s10194-020-01103-8			10	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	LD5AC	WOS:000526040500001	32295535	Green Published, Green Submitted, gold			2022-02-06	
J	Christensen, J; Wright, DK; Yamakawa, GR; Shultz, SR; Mychasiuk, R				Christensen, Jennaya; Wright, David K.; Yamakawa, Glenn R.; Shultz, Sandy R.; Mychasiuk, Richelle			Repetitive Mild Traumatic Brain Injury Alters Glymphatic Clearance Rates in Limbic Structures of Adolescent Female Rats	SCIENTIFIC REPORTS			English	Article							AMYLOID-BETA ACCUMULATION; SPORT-RELATED CONCUSSION; POSTCONCUSSION SYNDROME; TEMPORAL WINDOW; SLEEP; VULNERABILITY; TAU; MICRODIALYSIS; IMPAIRMENT; RECOVERY	The glymphatic system is the macroscopic waste clearance system for the central nervous system. Glymphatic dysfunction has been linked to several neurological conditions, including traumatic brain injury (TBI). Adolescents are at particularly high risk for experiencing a TBI, particularly mild TBI (mTBI) and repetitive mTBI (RmTBI); however, glymphatic clearance, and how it relates to behavioral outcomes, has not been investigated in this context. Therefore, this study examined glymphatic function in the adolescent brain following RmTBI. Female adolescent Sprague Dawley rats were subjected to either three mTBIs or sham injuries spaced three days apart. One-day after their final injury, the animals underwent a beam walking task to assess sensorimotor function, and contrast-enhanced MRI to visualize glymphatic clearance rate. Behavioural measures indicated that the RmTBI group displayed an increase in loss of consciousness as well as motor coordination and balance deficits consistent with our previous studies. The contrast-enhanced MRI results indicated that the female adolescent glymphatic system responds to RmTBI in a region-specific manner, wherein an increased influx but reduced efflux was observed throughout limbic structures (hypothalamus, hippocampus, and amygdala) and the olfactory bulb but neither the influx or efflux were altered in the cortical structures (primary motor cortex, insular cortex, and dorsolateral prefrontal cortex) examined. This may indicate a role for an impaired and/or inefficient glymphatic system in the limbic structures and cortical structures, respectively, in the development of post-concussive symptomology during adolescence.	[Christensen, Jennaya; Mychasiuk, Richelle] Univ Calgary, Dept Psychol, Calgary, AB, Canada; [Christensen, Jennaya; Wright, David K.; Yamakawa, Glenn R.; Shultz, Sandy R.; Mychasiuk, Richelle] Monash Univ, Dept Neurosci, Cent Clin Sch, Melbourne, Vic, Australia; [Shultz, Sandy R.] Univ Melbourne, Dept Med, Parkville, Vic, Australia; [Mychasiuk, Richelle] Univ Calgary, Hotchkiss Brain Inst, Calgary, AB, Canada; [Mychasiuk, Richelle] Univ Calgary, Alberta Childrens Hosp Res Inst, Calgary, AB, Canada		Mychasiuk, R (corresponding author), Univ Calgary, Dept Psychol, Calgary, AB, Canada.; Mychasiuk, R (corresponding author), Monash Univ, Dept Neurosci, Cent Clin Sch, Melbourne, Vic, Australia.; Mychasiuk, R (corresponding author), Univ Calgary, Hotchkiss Brain Inst, Calgary, AB, Canada.; Mychasiuk, R (corresponding author), Univ Calgary, Alberta Childrens Hosp Res Inst, Calgary, AB, Canada.	Richelle.mychasiuk@monash.edu		Yamakawa, Glenn/0000-0003-3079-6532	Alberta Children's Hospital Research Institute; Canadian Institute of Health ResearchCanadian Institutes of Health Research (CIHR); Natural Sciences and Engineering Research CouncilNatural Sciences and Engineering Research Council of Canada (NSERC); National Health and Medical Research CouncilNational Health and Medical Research Council of Australia	The authors would like to thank the Alberta Children's Hospital Research Institute, Canadian Institute of Health Research, Natural Sciences and Engineering Research Council, and National Health and Medical Research Council for their financial contributions. The authors would also like to thank Tadeusz Foniok and Dave Rushforth for their assistance within the University of Calgary MRI facility. The authors have no competing financial interests with respect to the work described here.	Albicini M, 2018, J HEAD TRAUMA REHAB, V33, P191, DOI 10.1097/HTR.0000000000000312; Barlow KM, 2015, PEDIATR NEUROL, V53, P491, DOI 10.1016/j.pediatrneurol.2015.04.011; Barlow KM, 2010, PEDIATRICS, V126, pE374, DOI 10.1542/peds.2009-0925; Blennow K, 2012, NEURON, V76, P886, DOI 10.1016/j.neuron.2012.11.021; Cai XZ, 2020, P NATL ACAD SCI USA, V117, P668, DOI 10.1073/pnas.1914017117; Catani M, 2013, NEUROSCI BIOBEHAV R, V37, P1724, DOI 10.1016/j.neubiorev.2013.07.001; Christensen J, 2020, J NEUROTRAUM, V37, P273, DOI 10.1089/neu.2019.6656; Giedd JN, 2008, J ADOLESCENT HEALTH, V42, P335, DOI 10.1016/j.jadohealth.2008.01.007; Giedd JN, 2004, ANN NY ACAD SCI, V1021, P77, DOI 10.1196/annals.1308.009; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Gogtay N, 2004, P NATL ACAD SCI USA, V101, P8174, DOI 10.1073/pnas.0402680101; Halstead ME, 2010, PEDIATRICS, V126, P597, DOI 10.1542/peds.2010-2005; Iliff JJ, 2014, J NEUROSCI, V34, P16180, DOI 10.1523/JNEUROSCI.3020-14.2014; Iliff JJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003748; Jessen NA, 2015, NEUROCHEM RES, V40, P2583, DOI 10.1007/s11064-015-1581-6; Kang JE, 2009, SCIENCE, V326, P1005, DOI 10.1126/science.1180962; Killen MJ, 2019, EXPERT REV NEUROTHER, V19, P227, DOI 10.1080/14737175.2019.1582332; Kostyun RO, 2015, AM J SPORT MED, V43, P633, DOI 10.1177/0363546514560727; Kumar A, 2012, BRAIN BEHAV IMMUN, V26, P1191, DOI 10.1016/j.bbi.2012.06.008; Laurer HL, 2001, J NEUROSURG, V95, P859, DOI 10.3171/jns.2001.95.5.0859; Lenzlinger PM, 2001, MOL NEUROBIOL, V24, P169; Long JA, 1920, ANA REC, V18, P244; Longhi L, 2005, NEUROSURGERY, V56, P364, DOI 10.1227/01.NEU.0000149008.73513.44; Lucey BP, 2018, ANN NEUROL, V83, P197, DOI 10.1002/ana.25117; MCCLINTOCK MK, 1978, HORM BEHAV, V10, P264, DOI 10.1016/0018-506X(78)90071-5; MCCLINTOCK MK, 1981, AM ZOOL, V21, P243; McLean CP, 2011, J PSYCHIATR RES, V45, P1027, DOI 10.1016/j.jpsychires.2011.03.006; Mendelsohn AR, 2013, REJUV RES, V16, P518, DOI 10.1089/rej.2013.1530; Murdaugh DL, 2018, ARCH PHYS MED REHAB, V99, P960, DOI 10.1016/j.apmr.2018.01.005; Murtha LA, 2014, FLUIDS BARRIERS CNS, V11, DOI 10.1186/2045-8118-11-12; Mychasiuk R, 2016, J NEUROSCI METH, V257, P168, DOI 10.1016/j.jneumeth.2015.10.002; Mychasiuk R, 2014, JOVE-J VIS EXP, DOI 10.3791/51820; Mychasiuk R, 2015, FRONT BEHAV NEUROSCI, V9, DOI 10.3389/fnbeh.2015.00017; Nedergaard M, 2013, SCIENCE, V340, P1529, DOI 10.1126/science.1240514; Piantino J, 2019, CURR PAIN HEADACHE R, V23, DOI 10.1007/s11916-019-0799-4; Prins ML, 2013, J NEUROTRAUM, V30, P30, DOI 10.1089/neu.2012.2399; Salberg S, 2018, J NEUROTRAUM, V35, P1895, DOI 10.1089/neu.2018.5744; Salberg S, 2017, NEUROSCIENCE, V365, P146, DOI 10.1016/j.neuroscience.2017.09.053; Schallert T., 2002, PHARM CEREB ISCHEMIA, V2002, P201; Scott C, 2015, NEUROPSYCHOLOGY, V29, P501, DOI 10.1037/neu0000074; Sengupta P, 2013, INT J PREVENTIVE MED, V4, P624; Shokri-Kojori E, 2018, P NATL ACAD SCI USA, V115, P4483, DOI 10.1073/pnas.1721694115; Smith AJ, 2017, ELIFE, V6, DOI [10.7554/elife.27679, 10.7554/eLife.27679]; Smith DH, 1999, J NEUROPATH EXP NEUR, V58, P982, DOI 10.1097/00005072-199909000-00008; Smith DH, 2003, J NEUROSURG, V98, P1072, DOI 10.3171/jns.2003.98.5.1072; Sullan M. J., 2017, NEUROSCIENCE BIOBEHA; Timofeev I, 2011, BRAIN, V134, P484, DOI 10.1093/brain/awq353; Toga AW, 2006, TRENDS NEUROSCI, V29, P148, DOI 10.1016/j.tins.2006.01.007; Tran HT, 2011, J NEUROSCI, V31, P9513, DOI 10.1523/JNEUROSCI.0858-11.2011; Uryu K, 2002, J NEUROSCI, V22, P446, DOI 10.1523/JNEUROSCI.22-02-00446.2002; Uryu K, 2007, EXP NEUROL, V208, P185, DOI 10.1016/j.expneurol.2007.06.018; Vagnozzi R, 2008, NEUROSURGERY, V62, P1286, DOI 10.1227/01.neu.0000333300.34189.74; Vespa P, 2005, J CEREBR BLOOD F MET, V25, P763, DOI 10.1038/sj.jcbfm.9600073; Vespa PM, 2003, J CEREBR BLOOD F MET, V23, P865, DOI 10.1097/01.WCB.0000076701.45782.EF; Wright DK, 2017, ANN CLIN TRANSL NEUR, V4, P640, DOI 10.1002/acn3.441; Xie LL, 2013, SCIENCE, V342, P373, DOI 10.1126/science.1241224; Yamakawa GR, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187218; Yang LJ, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-107; Yeates KO, 2010, J INT NEUROPSYCH SOC, V16, P953, DOI 10.1017/S1355617710000986; Young B, 1990, SURVEY ANESTHESIOLOG, V34, P273, DOI [10.1097/00132586-199008000-00066, DOI 10.1097/00132586-199008000-00066]	60	7	7	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	APR 10	2020	10	1							6254	10.1038/s41598-020-63022-7			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NA6TE	WOS:000559950200001	32277097	gold, Green Published			2022-02-06	
J	Cheng, Y; Pereira, M; Raukar, NP; Reagan, JL; Quesenberry, M; Goldberg, L; Borgovan, T; LaFrance, WC; Dooner, M; Deregibus, M; Camussi, G; Ramratnam, B; Quesenberry, P				Cheng, Yan; Pereira, Mandy; Raukar, Neha P.; Reagan, John L.; Quesenberry, Mathew; Goldberg, Laura; Borgovan, Theodor; LaFrance, W. Curt, Jr.; Dooner, Mark; Deregibus, Maria; Camussi, Giovanni; Ramratnam, Bharat; Quesenberry, Peter			Inflammation-related gene expression profiles of salivary extracellular vesicles in patients with head trauma	NEURAL REGENERATION RESEARCH			English	Article						chronic traumatic encephalopathy; emergency department; extracellular vesicles; inflammation; outpatient concussion clinic; real-time PCR analysis; saliva; traumatic brain injury	BRAIN-INJURY; PATHOPHYSIOLOGY; ENCEPHALOPATHY; COMMUNICATION; PATTERNS; EXOSOMES	At present, there is no reliable biomarker for the diagnosis of traumatic brain injury (TBI). Studies have shown that extracellular vesicles released by damaged cells into biological fluids can be used as potential biomarkers for diagnosis of TBI and evaluation of TBI severity. We hypothesize that the genetic profile of salivary extracellular vesicles in patients with head trauma differs from that in uninjured subjects. Findings from this hypothesis would help investigate the severity of TBI. This study included 19 subjects, consisting of seven healthy controls who denied history of head trauma, six patients diagnosed with concussion injury from an outpatient concussion clinic, and six patients with TBI who received treatment in the emergency department within 24 hours after injury. Real-time PCR analysis of salivary extracellular vesicles in participants was performed using TaqMan Human Inflammation array. Gene expression analysis revealed nine upregulated genes in emergency department patients (LOX5, ANXA3, CASP1, IL2RG, ITGAM, ITGB2, LTA4H, MAPK14, and TNFRSF1A) and 13 upregulated genes in concussion clinic patients compared with healthy participants (ADRB1, ADRB2, BDKRB1, HRH1, HRH2, LTB4R2, LTB4R, PTAFR, CYSLTR1, CES1, KLK1, MC2R, and PTGER3). Each patient group had a unique profile. Comparison between groups showed that 15 inflammation-related genes had significant expression change. Our results indicate that inflammation biomarkers can be used for diagnosis of TBI and evaluation of disease severity. This study was approved by the Institutional Review Board on December 18, 2015 (approval No. 0078-12) and on June 9, 2016 (approval No. 4093-16).	[Cheng, Yan; Pereira, Mandy; Reagan, John L.; Quesenberry, Mathew; Goldberg, Laura; Borgovan, Theodor; Dooner, Mark; Quesenberry, Peter] Rhode Isl Hosp, Dept Med, Div Hematol Oncol, Providence, RI 02903 USA; [Raukar, Neha P.] Mayo Clin, Dept Emergency Med, Rochester, MN USA; [LaFrance, W. Curt, Jr.] Rhode Isl Hosp, Dept Psychiat & Neurol, Providence, RI USA; [Ramratnam, Bharat] Rhode Isl Hosp, Dept Med, Div Infect Dis, Providence, RI 02903 USA; [Deregibus, Maria; Camussi, Giovanni] Univ Turin, Dept Med Sci, Turin, TO, Italy		Pereira, M (corresponding author), Rhode Isl Hosp, Dept Med, Div Hematol Oncol, Providence, RI 02903 USA.	mpereira7@lifespan.org	LaFrance, W Curt/AAN-6707-2021	LaFrance, W Curt/0000-0002-4901-3852; Dooner, Mark/0000-0003-0653-6562	National Heart, Lungs, and Blood Institute [T32HL116249]; National Institute of General Medical Sciences of the NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [P20GM103468]; National Center for Advancing Translational Sciences of the NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [5UH3TROOO880-05]	This project was supported by the National Heart, Lungs, and Blood Institute Grant #T32HL116249 (to PQ). Additional support from the National Institute of General Medical Sciences of the NIH through grant (COBRE) #P20GM103468 Flow Cytometry Core (to PQ), National Center for Advancing Translational Sciences of the NIH grant #5UH3TROOO880-05 (to PQ) and institutional support through the Division of Hematology/oncology, Rhode Island Hospital, Providence, RI.	Aliotta JM, 2012, STEM CELLS DEV, V21, P1627, DOI 10.1089/scd.2011.0550; Cheng Y, 2019, J CELL PHYSIOL, V234, P14377, DOI 10.1002/jcp.28139; Choi DS, 2015, MASS SPECTROM REV, V34, P474, DOI 10.1002/mas.21420; Chong KWY, 2010, NEUROSCI LETT, V485, P129, DOI 10.1016/j.neulet.2010.08.089; Dobrivojevic M, 2015, PFLUG ARCH EUR J PHY, V467, P201, DOI 10.1007/s00424-014-1519-x; Faden AI, 2016, BRIT J PHARMACOL, V173, P681, DOI 10.1111/bph.13179; Fields J, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-177; Gyoneva S, 2015, TRENDS PHARMACOL SCI, V36, P471, DOI 10.1016/j.tips.2015.04.003; Heneka MT, 2015, LANCET NEUROL, V14, P388, DOI 10.1016/S1474-4422(15)70016-5; Hijioka M, 2017, J PHARMACOL EXP THER, V360, P399, DOI 10.1124/jpet.116.238824; Junker H, 2007, GLIA, V55, P1630, DOI 10.1002/glia.20581; Li D, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0841-6; Lucas SM, 2006, BRIT J PHARMACOL, V147, pS232, DOI 10.1038/sj.bjp.0706400; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Mez J, 2017, JAMA-J AM MED ASSOC, V318, P360, DOI 10.1001/jama.2017.8334; Michael A, 2010, ORAL DIS, V16, P34, DOI 10.1111/j.1601-0825.2009.01604.x; NAVAZESH M, 1993, ANN NY ACAD SCI, V694, P72, DOI 10.1111/j.1749-6632.1993.tb18343.x; Orr SK, 2015, CRIT CARE MED, V43, P2642, DOI 10.1097/CCM.0000000000001312; Paolicelli RC, 2019, NEUROSCIENCE, V405, P148, DOI 10.1016/j.neuroscience.2018.04.003; Prins M, 2013, DIS MODEL MECH, V6, P1307, DOI 10.1242/dmm.011585; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Tkach M, 2016, CELL, V164, P1226, DOI 10.1016/j.cell.2016.01.043; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; White TE, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2412-0; Yang YY, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1204-7; Yin XJ, 2017, SCI REP-UK, V7, DOI 10.1038/srep40614; Zhang L, 2006, NEUROPATHOLOGY, V26, P99, DOI 10.1111/j.1440-1789.2006.00658.x	30	7	7	2	35	WOLTERS KLUWER MEDKNOW PUBLICATIONS	MUMBAI	WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2 VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA	1673-5374	1876-7958		NEURAL REGEN RES	Neural Regen. Res.	APR	2020	15	4					676	681		10.4103/1673-5374.266924			6	Cell Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Neurosciences & Neurology	JW7OL	WOS:000503237500013	31638091	Green Published, gold			2022-02-06	
J	Ganau, M; Cebula, H; Fricia, M; Zaed, I; Todeschi, J; Scibilia, A; Gallinaro, P; Coca, A; Chaussemy, D; Ollivier, I; Ligarotti, GKI; Santin, MD; Proust, F; Chibbaro, S				Ganau, Mario; Cebula, Helene; Fricia, Marco; Zaed, Ismail; Todeschi, Julien; Scibilia, Antonino; Gallinaro, Paolo; Coca, Andres; Chaussemy, Dominique; Ollivier, Irene; Ligarotti, Gianfranco K., I; Santin, Marie des Neiges; Proust, Francois; Chibbaro, Salvatore			Surgical preference regarding different materials for custom-made allograft cranioplasty in patients with calvarial defects: Results from an internal audit covering the last 20 years	JOURNAL OF CLINICAL NEUROSCIENCE			English	Article						Cranioplasty; Porous hydroxyapatite; Polymetylmethacrylate; Postoperative complications; Surgical outcomes	SECONDARY DATA SOURCES; CEREBRAL-BLOOD-FLOW; DECOMPRESSIVE CRANIECTOMY; RETROSPECTIVE DATABASE; TASK-FORCE; PROPHYLAXIS PROTOCOLS; INTRACRANIAL-PRESSURE; TITANIUM; HYDROXYAPATITE; NEUROSURGERY	Background: Secondary cranioplasty (CP) plays a key role in restoring cranial vault anatomy and normal brain function following decompressive craniectomy (DC). The scientific literature provides only fragmentary information regarding the best timing and material for CP, making a direct comparison of different materials difficult. Object: To identify and report according to STROBE guidelines local trends in choice of materials for CP, complications rate and surgical outcomes. Methods: We conducted an audit on secondary CP covering the last 20 years of surgical practice at our Institution. Custom-made CP used over the years were made of: porous hydroxyapatite (PHA), polymetyl-methacrylate (PMMA), polyetheretherketone (PEEK), acrylic and titanium. The primary endpoint of this study was the incidence of postoperative complications, such as: implant infection, fracture and dislocation. Secondary endpoints were the followings: patients satisfaction with cosmetic result, rate of implant integration, and long-term neurological outcome. Results: A total of 218 patients were included, given the predominance of PHA (Group A) or PMMA (Group B) CP, a direct comparison was made only between those two groups. Overall reoperation rate was 6.5% versus 28%; implants' osseointegration rate was of 69% versus 24%; satisfaction rate was 66% versus 44%, in Group A and B respectively. Conclusions: This single-centre study provides Level 3 evidence that PHA yields better outcomes than PMMA CP. Designing a management algorithm for planning and executing CP is difficult for clinical and organizational reasons; till a widespread consensus is reached, neurosurgeons with subspecialty interest in neurotrauma should favor pragmatism and patient safety over costs. (C) 2020 Elsevier Ltd. All rights reserved.	[Ganau, Mario; Cebula, Helene; Fricia, Marco; Zaed, Ismail; Todeschi, Julien; Scibilia, Antonino; Gallinaro, Paolo; Coca, Andres; Chaussemy, Dominique; Ollivier, Irene; Ligarotti, Gianfranco K., I; Santin, Marie des Neiges; Proust, Francois; Chibbaro, Salvatore] Strasbourg Univ Hosp, Dept Neurosurg, Strasbourg, France		Zaed, I (corresponding author), Strasbourg Univ Hosp, Dept Neurosurg, Strasbourg, France.	ismailzaed1@gmail.com	Ganau, Mario/AAY-7233-2020; Scibilia, Antonino/K-7941-2016	Ganau, Mario/0000-0002-8676-1147; 			[Anonymous], 1991, Law Med Health Care, V19, P247; Berger ML, 2009, VALUE HEALTH, V12, P1044, DOI 10.1111/j.1524-4733.2009.00600.x; Chesnut R, 2014, NEUROCRIT CARE, V21, P64, DOI 10.1007/s12028-014-0048-y; Chibbaro S, 2013, REV NEUROL-FRANCE, V169, P240, DOI 10.1016/j.neurol.2012.06.016; Chibbaro S, 2018, WORLD NEUROSURG, V109, pE510, DOI 10.1016/j.wneu.2017.10.012; Duric KS, 2019, BRIT J NEUROSURG, V33, P376, DOI 10.1080/02688697.2019.1566514; FABBRI M, 1995, BIOMATERIALS, V16, P225, DOI 10.1016/0142-9612(95)92121-L; Fiaschi P, 2016, J NEUROSURG-PEDIATR, V17, P705, DOI 10.3171/2015.10.PEDS15489; Fricia M, 2019, WORLD NEUROSURG, V121, P160, DOI 10.1016/j.wneu.2018.09.199; Ganau M, 2013, MINERVA ANESTESIOL, V79, P310; Ganau M, 2018, MEDICINES, V5; Ganau M, 2018, NEUROSURGERY, V83, pE87, DOI 10.1093/neuros/nyy205; Ganau M, 2017, J CLIN NEUROSCI, V45, P60, DOI 10.1016/j.jocn.2017.08.008; Giese H, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-009273; Gordon CR, 2014, OPER NEUROSURG, V10, P179, DOI 10.1227/NEU.0000000000000296; Halani SH, 2017, NEUROSURGERY, V81, P204, DOI 10.1093/neuros/nyx054; Hofmeijer J, 2009, LANCET NEUROL, V8, P326, DOI 10.1016/S1474-4422(09)70047-X; Honeybul S, 2017, J NEUROSURG, V126, P81, DOI 10.3171/2015.12.JNS152004; Hutchinson PJ, 2016, NEW ENGL J MED, V375, P1119, DOI 10.1056/NEJMoa1605215; Iaccarino C, 2015, J ORAL MAXIL SURG, V73, P2375, DOI 10.1016/j.joms.2015.07.008; Johnson ML, 2009, VALUE HEALTH, V12, P1062, DOI 10.1111/j.1524-4733.2009.00602.x; Kim Sung Hoon, 2017, Korean J Neurotrauma, V13, P15, DOI 10.13004/kjnt.2017.13.1.15; Kolias AG, 2014, BRIT J NEUROSURG, V28, P310, DOI 10.3109/02688697.2013.859657; Korhonen TK, 2019, ACTA NEUROCHIR, V161, P473, DOI 10.1007/s00701-018-03791-3; Korhonen TK, 2019, J NEUROSURG, V130, P1672, DOI 10.3171/2017.12.JNS172013; Lang J, 2016, IDEGGYOGY SZEMLE, V69, P227, DOI 10.18071/isz.69.0227; Lindner D, 2017, J NEUROSURG, V126, P175, DOI 10.3171/2015.10.JNS151245; Malcolm JG, 2018, NEUROSURGERY, V82, P278, DOI 10.1093/neuros/nyx182; Mazzeo AT, 2018, J NEUROSURG SCI, V62, P549, DOI 10.23736/S0390-5616.18.04465-X; Morales-Gomez JA, 2019, J NEUROSURG, V130, P1721, DOI 10.3171/2017.12.JNS172574; Morselli C, 2019, J NEUROSURG SCI, V63, P723, DOI 10.23736/S0390-5616.19.04779-9; Motheral B, 2003, VALUE HEALTH, V6, P90, DOI 10.1046/j.1524-4733.2003.00242.x; OCEBM Levels of Evidence Working Group Oxford Centre for Evidence Based Medicine, OXFORD 2011 LEVELS E; Rutka JT, 2000, NEUROSURGERY, V46, P1034, DOI 10.1097/00006123-200005000-00002; Salvatore C, 2013, J NEUROSCI RURAL PRA, V4, P421, DOI 10.4103/0976-3147.120244; Sarov M, 2010, STROKE, V41, P560, DOI 10.1161/STROKEAHA.109.568543; Servadei F, 2015, WORLD NEUROSURG, V83, P133, DOI 10.1016/j.wneu.2014.08.031; Sinha S, 2017, NEUROSURG FOCUS, V43, DOI 10.3171/2017.8.FOCUS17449; Stefini Roberto, 2013, Surg Neurol Int, V4, P12, DOI 10.4103/2152-7806.106290; Thien A, 2015, WORLD NEUROSURG, V83, P176, DOI 10.1016/j.wneu.2014.06.003; Wiggins A, 2013, NEUROSURGERY, V72, P248, DOI 10.1227/NEU.0b013e31827b98f3; World Medical Association General Assembly, 2004, J Int Bioethique, V15, P124; Worm P, 2016, SURG NEUROL INT, V7, P746, DOI DOI 10.4103/2152-7806.193725	43	7	7	0	11	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0967-5868	1532-2653		J CLIN NEUROSCI	J. Clin. Neurosci.	APR	2020	74						98	103		10.1016/j.jocn.2020.01.087			6	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	LF3HH	WOS:000527311400018	32033859				2022-02-06	
J	Gravesteijn, BY; Sewalt, CA; Ercole, A; Akerlund, C; Nelson, D; Maas, AIR; Menon, D; Lingsma, HF; Steyerberg, EW				Gravesteijn, Benjamin Y.; Sewalt, Charlie A.; Ercole, Ari; Akerlund, Cecilia; Nelson, David; Maas, Andrew I. R.; Menon, David; Lingsma, Hester F.; Steyerberg, Ewout W.		Collaborative European NeuroTrauma	Toward a New Multi-Dimensional Classification of Traumatic Brain Injury: A Collaborative European NeuroTrauma Effectiveness Research for Traumatic Brain Injury Study	JOURNAL OF NEUROTRAUMA			English	Article						classification; clustering; GCS; prospective	VALIDATION	Traumatic brain injury (TBI) is currently classified as mild, moderate, or severe TBI by trichotomizing the Glasgow Coma Scale (GCS). We aimed to explore directions for a more refined multidimensional classification system. For that purpose, we performed a hypothesis-free cluster analysis in the Collaborative European NeuroTrauma Effectiveness Research for TBI (CENTER-TBI) database: a European all-severity TBI cohort (n = 4509). The first building block consisted of key imaging characteristics, summarized using principal component analysis from 12 imaging characteristics. The other building blocks were demographics, clinical severity, secondary insults, and cause of injury. With these building blocks, the patients were clustered into four groups. We applied bootstrap resampling with replacement to study the stability of cluster allocation. The characteristics that predominantly defined the clusters were injury cause, major extracranial injury, and GCS. The clusters consisted of 1451, 1534, 1006, and 518 patients, respectively. The clustering method was quite stable: the proportion of patients staying in one cluster after resampling and reclustering was 97.4% (95% confidence interval [CI]: 85.6-99.9%). These clusters characterized groups of patients with different functional outcomes: from mild to severe, 12%, 19%, 36%, and 58% of patients had unfavorable 6 month outcome. Compared with the mild and the upper intermediate cluster, the lower intermediate and the severe cluster received more key interventions. To conclude, four types of TBI patients may be defined by injury mechanism, presence of major extracranial injury and GCS. Describing patients according to these three characteristics could potentially capture differences in etiology and care pathways better than with GCS only.	[Gravesteijn, Benjamin Y.; Sewalt, Charlie A.; Lingsma, Hester F.; Steyerberg, Ewout W.] Erasmus MC, Dept Publ Hlth, Rotterdam, Netherlands; [Ercole, Ari; Menon, David] Univ Cambridge, Div Anaesthesia, Cambridge, England; [Akerlund, Cecilia; Nelson, David] Karolinska Inst, Dept Physiol & Pharmacol, Sect Perioperat Med & Intens Care, Stockholm, Sweden; [Maas, Andrew I. R.] Antwerp Univ Hosp, Dept Neurosurg, Edegem, Belgium; [Maas, Andrew I. R.] Univ Antwerp, Edegem, Belgium; [Steyerberg, Ewout W.] Leiden Univ, Dept Biomed Data Sci, Med Ctr, Leiden, Netherlands		Gravesteijn, BY (corresponding author), Erasmus Univ, Dept Publ Hlth, Med Ctr, Na 2310,Wytemaweg 00, NL-3015 CN Rotterdam, Netherlands.	b.gravesteijn@erasmusmc.nl	Vande Vyvere, Thijs/AAB-5180-2022; Castano-Leon, Ana M/ABF-6322-2020; Volovici, Victor/AAZ-8901-2020; Sahuquillo, Juan/B-3577-2008; Cooper, D. James/G-7961-2013; Gravesteijn, Benjamin/AAN-9524-2020; Ercole, Ari/B-6288-2009; Posti, Jussi P./Y-2908-2019; Gomez, Pedro/E-2411-2014	Vande Vyvere, Thijs/0000-0003-4032-5443; Castano-Leon, Ana M/0000-0002-7918-5049; Volovici, Victor/0000-0002-5798-5360; Sahuquillo, Juan/0000-0003-0713-5875; Cooper, D. James/0000-0002-5872-9051; Ercole, Ari/0000-0001-8350-8093; Posti, Jussi P./0000-0002-5925-5193; Kolias, Angelos/0000-0003-3992-0587; Van Essen, Thomas/0000-0003-4657-5283; Sanchez-Porras, Renan/0000-0002-9084-8114; Radoi, Andreea/0000-0002-0677-3544; Newcombe, Virginia/0000-0001-6044-9035; Coles, Jonathan/0000-0003-4013-679X; Nelson, David/0000-0003-2530-8207; Rossi, Sandra/0000-0002-9963-8121; Zeiler, Frederick/0000-0003-1737-0510; Sakowitz, Oliver/0000-0003-3248-6335; Gomez, Pedro/0000-0002-4185-5238; Gravesteijn, Benjamin/0000-0001-8096-5803; Stewart, William/0000-0003-2199-2582			Chavent M., 2017, ARXIV14114911V4STATC; Feher MD, 2018, LANCET DIABETES ENDO, V6, P439, DOI 10.1016/S2213-8587(18)30126-8; Foks KA, 2018, BMJ-BRIT MED J, V362, DOI 10.1136/bmj.k3527; Foks KA, 2017, J NEUROTRAUM, V34, P2529, DOI 10.1089/neu.2016.4919; GOWER JC, 1971, BIOMETRICS, V27, P857, DOI 10.2307/2528823; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Maas AIR, 2015, NEUROSURGERY, V76, P67, DOI 10.1227/NEU.0000000000000575; Maas AIR, 2012, J NEUROTRAUM, V29, P32, DOI 10.1089/neu.2010.1599; Majdan M, 2016, LANCET PUBLIC HEALTH, V1, pE76, DOI 10.1016/S2468-2667(16)30017-2; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Roozenbeek B, 2009, CRIT CARE MED, V37, P2683, DOI 10.1097/CCM.0b013e3181ab85ec; ROUSSEEUW PJ, 1987, J COMPUT APPL MATH, V20, P53, DOI 10.1016/0377-0427(87)90125-7; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; TEASDALE G, 1974, LANCET, V2, P81; Thomas CM, 2009, NURS EDUC, V34, P176, DOI 10.1097/NNE.0b013e3181aaba54; Vande Vyvere T, 2019, J NEUROTRAUM, V36, P1080, DOI 10.1089/neu.2018.6061	18	7	8	2	2	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	APR 1	2020	37	7					1002	1010		10.1089/neu.2019.6764			9	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	LB3HP	WOS:000524528800009	31672086	Green Submitted			2022-02-06	
J	Kumar, RG; Kesinger, MR; Juengst, SB; Brooks, MM; Fabio, A; Dams-O'Connor, K; Pugh, MJ; Sperry, JL; Wagner, AK				Kumar, Raj G.; Kesinger, Matthew R.; Juengst, Shannon B.; Brooks, Maria M.; Fabio, Anthony; Dams-O'Connor, Kristen; Pugh, Mary Jo; Sperry, Jason L.; Wagner, Amy K.			Effects of hospital-acquired pneumonia on long-term recovery and hospital resource utilization following moderate to severe traumatic brain injury	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article						Traumatic brain injury; health services; hospital-acquired pneumonia; rehabilitation; long-term outcomes	VENTILATOR-ASSOCIATED PNEUMONIA; GLASGOW COMA SCALE; POSTTRAUMATIC HYDROCEPHALUS; DEIDENTIFIED DATA; EPIDEMIOLOGY; ADULTS; ANTICOAGULATION; HYPOTENSION; MORTALITY; REGISTRY	BACKGROUND Individuals with traumatic brain injury (TBI) have extended inpatient hospital stays that include prolonged mechanical ventilation, increasing risk for infections, including pneumonia. Studies show the negative short-term effects of hospital-acquired pneumonia (HAP) on hospital-based outcomes; however, little is known of its long-term effects. METHODS A prospective cohort study was conducted. National Trauma Databank and Traumatic Brain Injury Model Systems were merged to derive a cohort of 3,717 adults with moderate-to-severe TBI. Exposure data were gathered from the National Trauma Databank, and outcomes were gathered from the Traumatic Brain Injury Model Systems. The primary outcome was the Glasgow Outcome Scale-Extended (GOS-E), which was collected at 1, 2, and 5 years postinjury. The GOS-E was categorized as favorable (>5) or unfavorable (<= 5) outcomes. A generalized estimating equation model was fitted estimating the effects of HAP on GOS-E over the first 5 years post-TBI, adjusting for age, race, ventilation status, brain injury severity, injury severity score, thoracic Abbreviated Injury Scale score of 3 or greater, mechanism of injury, intraventricular hemorrhage, and subarachnoid hemorrhage. RESULTS Individuals with HAP had a 34% (odds ratio, 1.34; 95% confidence interval, 1.15-1.56) increased odds for unfavorable GOS-E over the first 5 years post-TBI compared with individuals without HAP, after adjustment for covariates. There was a significant interaction between HAP and follow-up, such that the effect of HAP on GOS-E declined over time. Sensitivity analyses that weighted for nonresponse bias and adjusted for differences across trauma facilities did not appreciably change the results. Individuals with HAP spent 10.1 days longer in acute care and 4.8 days longer in inpatient rehabilitation and had less efficient functional improvement during inpatient rehabilitation. CONCLUSION Individuals with HAP during acute hospitalization have worse long-term prognosis and greater hospital resource utilization. Preventing HAP may be cost-effective and improve long-term recovery for individuals with TBI. Future studies should compare the effectiveness of different prophylaxis methods to prevent HAP.	[Kumar, Raj G.; Brooks, Maria M.; Fabio, Anthony] Univ Pittsburgh, Dept Epidemiol, Pittsburgh, PA 15213 USA; [Kumar, Raj G.; Kesinger, Matthew R.; Wagner, Amy K.] Univ Pittsburgh, Dept Phys Med & Rehabil, 3471 Fifth Ave,Suite 202, Pittsburgh, PA 15213 USA; [Kesinger, Matthew R.; Sperry, Jason L.] Univ Pittsburgh, Dept Surg, Pittsburgh, PA 15213 USA; [Juengst, Shannon B.] UT Southwestern, Dept Phys Med & Rehabil, Dallas, TX USA; [Juengst, Shannon B.] UT Southwestern, Dept Rehabil Counseling, Dallas, TX USA; [Dams-O'Connor, Kristen] Icahn Sch Med Mt Sinai, Dept Rehabil Med, New York, NY 10029 USA; [Dams-O'Connor, Kristen] Icahn Sch Med Mt Sinai, Dept Neurol, New York, NY 10029 USA; [Pugh, Mary Jo] Univ Utah, Dept Internal Med, Epidemiol Div, Salt Lake City, UT 84112 USA; [Wagner, Amy K.] Univ Pittsburgh, Ctr Neurosci, Clin & Translat Sci Inst, Pittsburgh, PA 15213 USA; [Wagner, Amy K.] Univ Pittsburgh, Safar Ctr Resuscitat Res, Pittsburgh, PA 15213 USA		Wagner, AK (corresponding author), Univ Pittsburgh, Dept Phys Med & Rehabil, 3471 Fifth Ave,Suite 202, Pittsburgh, PA 15213 USA.	wagnerak@upmc.edu			National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R21 HD 089075-01]; National Institute on Disability, Independent Living, and Rehabilitation Research TBI Model Systems [TL1 TR001858];  [90DP0041-02-01]	Thiswork was funded byNational Institutes of Health R21 HD 089075-01; National Institutes of Health TL1 TR001858; and National Institute on Disability, Independent Living, and Rehabilitation Research TBI Model Systems 90DP0041-02-01.	Balestreri M, 2004, J NEUROL NEUROSUR PS, V75, P161; Batchelor JS, 2012, BRIT J NEUROSURG, V26, P525, DOI 10.3109/02688697.2011.650736; Calcagno J, 2018, J NEUROTRAUM, V35, pA135; Cazzadori A, 1997, RESP MED, V91, P193, DOI 10.1016/S0954-6111(97)90038-X; CHESNUT RM, 1993, ACTA NEUROCHIR, P121; Coplin WM, 2000, AM J RESP CRIT CARE, V161, P1530, DOI 10.1164/ajrccm.161.5.9905102; El-Rabbany M, 2015, INT J NURS STUD, V52, P452, DOI 10.1016/j.ijnurstu.2014.07.010; Esnault P, 2017, NEUROCRIT CARE, V27, P187, DOI 10.1007/s12028-017-0397-4; Foreman BP, 2007, J TRAUMA, V62, P946, DOI 10.1097/01.ta.0000229796.14717.3a; Francois B, 2019, NEW ENGL J MED, V381, P1831, DOI 10.1056/NEJMoa1812379; Franko J, 2006, J TRAUMA, V61, P107, DOI 10.1097/01.ta.0000224220.89528.fc; Hansen TS, 2008, ARCH PHYS MED REHAB, V89, P2114, DOI 10.1016/j.apmr.2008.04.013; Harvey LA, 2012, INJURY, V43, P1821, DOI 10.1016/j.injury.2012.07.188; Heffernan DS, 2012, CRIT CARE, V16, DOI 10.1186/cc11157; Hernan MA, 2004, EPIDEMIOLOGY, V15, P615, DOI 10.1097/01.ede.0000135174.63482.43; Hinchey JA, 2005, STROKE, V36, P1972, DOI 10.1161/01.STR.0000177529.86868.8d; Hui X, 2013, J SURG RES, V184, P438, DOI 10.1016/j.jss.2013.05.072; Karpur A, 2013, GUIDE TRAUMATIC BRAI; Kasten KR, 2010, BMC IMMUNOL, V11, DOI 10.1186/1471-2172-11-4; Kesinger MR, 2017, AM J PHYS MED REHAB, V96, P17, DOI 10.1097/PHM.0000000000000513; Kesinger MR, 2015, J TRAUMA ACUTE CARE, V78, P396, DOI 10.1097/TA.0000000000000526; KISHORE PRS, 1978, NEURORADIOLOGY, V16, P261, DOI 10.1007/BF00395266; Kollef MH, 2012, INFECT CONT HOSP EP, V33, P250, DOI 10.1086/664049; Kopp MA, 2013, BMC NEUROL, V13, DOI 10.1186/1471-2377-13-168; Kumar RG, 2018, AM J PHYS MED REHAB, V97, P236, DOI 10.1097/PHM.0000000000000838; Kumar RG, 2018, J HEAD TRAUMA REHAB, V33, P15, DOI 10.1097/HTR.0000000000000273; Kumar RG, 2015, J HEAD TRAUMA REHAB, V30, P369, DOI 10.1097/HTR.0000000000000067; Leonard KL, 2016, SURG INFECT, V17, P363, DOI 10.1089/sur.2014.076; Leone M, 2002, CRIT CARE MED, V30, P1741, DOI 10.1097/00003246-200208000-00011; Lucin KM, 2009, J NEUROCHEM, V110, P1409, DOI 10.1111/j.1471-4159.2009.06232.x; MARMAROU A, 1991, J NEUROSURG, V75, pS59, DOI 10.3171/sup.1991.75.1s.0s59; Mazzini L, 2003, ARCH PHYS MED REHAB, V84, P1637, DOI 10.1053/S0003-9993(03)00314-9; Mendez-Tellez PA, 2012, RESP CARE, V57, P1663, DOI 10.4187/respcare.01931; Mina AA, 2003, J TRAUMA, V54, P842, DOI 10.1097/01.TA.0000063271.05829.15; Patterson L, 1996, Am J Med Qual, V11, pS73; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Safdar N, 2005, CRIT CARE MED, V33, P2184, DOI 10.1097/01.CCM.0000181731.53912.D9; Shafi S, 2007, J TRAUMA, V63, P1263, DOI 10.1097/TA.0b013e31815b8f00; Solomon S, 2003, AM J INFECT CONTROL, V31, P481; Stirling DP, 2008, J NEUROSCI RES, V86, P1944, DOI 10.1002/jnr.21659; TEASDALE G, 1974, LANCET, V2, P81; Titsworth WL, 2012, J NEUROSURG, V116, P1379, DOI 10.3171/2012.2.JNS111881; U.S. Department of Health and Human Services Centers for Disease Control and Prevention Traumatic Brain Injury and Concussion, TRAUM BRAIN INJ CONC; Ullman JS, 2016, BRAIN INJ; Watanitanon A, 2018, CRIT CARE MED, V46, P781, DOI 10.1097/CCM.0000000000002991; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Yang CC, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-289; Zygun DA, 2006, NEUROCRIT CARE, V5, P108, DOI 10.1385/NCC:5:2:108	48	7	8	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	APR	2020	88	4					491	500		10.1097/TA.0000000000002562			10	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Surgery	NE5PN	WOS:000562653100005	31804412	Green Accepted			2022-02-06	
J	Mathieu, F; Zeiler, FA; Ercole, A; Monteiro, M; Kamnitsas, K; Glocker, B; Whitehouse, DP; Das, T; Smielewski, P; Czosnyka, M; Hutchinson, PJ; Newcombe, VFJ; Menon, DK				Mathieu, Francois; Zeiler, Frederick A.; Ercole, Ari; Monteiro, Miguel; Kamnitsas, Konstantinos; Glocker, Ben; Whitehouse, Daniel P.; Das, Tilak; Smielewski, Peter; Czosnyka, Marek; Hutchinson, Peter J.; Newcombe, Virginia F. J.; Menon, David K.		CTR-TBI High Resolution Sub-Study	Relationship between Measures of Cerebrovascular Reactivity and Intracranial Lesion Progression in Acute Traumatic Brain Injury Patients: A CENTER-TBI Study	JOURNAL OF NEUROTRAUMA			English	Article						cerebral autoregulation; intracranial hemorrhage; traumatic brain injury	INTRACEREBRAL HEMORRHAGE; SUBARACHNOID HEMORRHAGE; EDEMA FORMATION; AUTOREGULATION; SEGMENTATION; PREDICTORS	Failure of cerebral autoregulation has been linked to unfavorable outcome after traumatic brain injury (TBI). Preliminary evidence from a small, retrospective, single-center analysis suggests that autoregulatory dysfunction may be associated with traumatic lesion expansion, particularly for pericontusional edema. The goal of this study was to further explore these associations using prospective, multi-center data from the Collaborative European Neurotrauma Effectiveness Research in TBI (CENTER-TBI) and to further explore the relationship between autoregulatory failure, lesion progression, and patient outcome. A total of 88 subjects from the CENTER-TBI High Resolution ICU Sub-Study cohort were included. All patients had an admission computed tomography (CT) scan and early repeat scan available, as well as high-frequency neurophysiological recordings covering the between-scan interval. Using a novel, semiautomated approach at lesion segmentation, we calculated absolute changes in volume of contusion core, pericontusional edema, and extra-axial hemorrhage between the imaging studies. We then evaluated associations between cerebrovascular reactivity metrics and radiological lesion progression using mixed-model regression. Analyses were adjusted for baseline covariates and non-neurophysiological factors associated with lesion growth using multi-variate methods. Impairment in cerebrovascular reactivity was significantly associated with progression of pericontusional edema and, to a lesser degree, intraparenchymal hemorrhage. In contrast, there were no significant associations with extra-axial hemorrhage. The strongest relationships were observed between RAC-based metrics and edema formation. Pulse amplitude index showed weaker, but consistent, associations with contusion growth. Cerebrovascular reactivity metrics remained strongly associated with lesion progression after taking into account contributions from non-neurophysiological factors and mean cerebral perfusion pressure. Total hemorrhagic core and edema volumes on repeat CT were significantly larger in patients who were deceased at 6 months, and the amount of edema was greater in patients with an unfavourable outcome (Glasgow Outcome Scale-Extended 1-4). Our study suggests associations between autoregulatory failure, traumatic edema progression, and poor outcome. This is in keeping with findings from a single-center retrospective analysis, providing multi-center prospective data to support those results.	[Mathieu, Francois] Univ Toronto, Div Neurosurg, Toronto, ON, Canada; [Mathieu, Francois; Zeiler, Frederick A.; Ercole, Ari; Whitehouse, Daniel P.; Newcombe, Virginia F. J.; Menon, David K.] Univ Cambridge, Div Anaesthesia, Box 93 Addenbrookes Hosp,Hills Rd, Cambridge CB2 0QQ, England; [Mathieu, Francois] Univ Cambridge, Dept Clin Neurosci, Cambridge, England; [Zeiler, Frederick A.] Univ Manitoba, Dept Surg, Sect Neurosurg, Winnipeg, MB, Canada; [Zeiler, Frederick A.] Univ Manitoba, Dept Human Anat & Cell Sci, Rady Fac Hlth Sci, Winnipeg, MB, Canada; [Zeiler, Frederick A.] Univ Manitoba, Fac Engn, 10Biomed Engn, Winnipeg, MB, Canada; [Das, Tilak] Univ Cambridge, Addenbrookes Hosp, Dept Radiol, Cambridge, England; [Smielewski, Peter; Czosnyka, Marek] Univ Cambridge, Addenbrookes Hosp, Brain Phys Lab, Div Neurosurg, Cambridge, England; [Smielewski, Peter; Hutchinson, Peter J.] Univ Cambridge, Addenbrookes Hosp, Div Neurosurg, Cambridge, England; [Czosnyka, Marek] Warsaw Univ Technol, Inst Elect Syst, Warsaw, Poland; [Monteiro, Miguel; Kamnitsas, Konstantinos; Glocker, Ben] Imperial Coll London, Biomed Image Anal Grp, London, England		Mathieu, F (corresponding author), Univ Cambridge, Div Anaesthesia, Box 93 Addenbrookes Hosp,Hills Rd, Cambridge CB2 0QQ, England.	fm494@cam.ac.uk	Ercole, Ari/B-6288-2009; Monteiro, Miguel/AAE-6334-2021; Das, Tilak/AAY-5310-2020; Sahuquillo, Juan/B-3577-2008; Raj, Rahul/K-7693-2012; Moller, Kirsten/A-4751-2009	Ercole, Ari/0000-0001-8350-8093; Das, Tilak/0000-0003-0655-412X; Sahuquillo, Juan/0000-0003-0713-5875; Radoi, Andreea/0000-0002-0677-3544; Newcombe, Virginia/0000-0001-6044-9035; Zeiler, Frederick/0000-0003-1737-0510; Kondziella, Daniel/0000-0001-5562-9808; Raj, Rahul/0000-0003-4243-9591; Moller, Kirsten/0000-0003-3058-1072; Sakowitz, Oliver/0000-0003-3248-6335	Hannelore Kohl Stiftung (Germany); OneMind (USA); Integra LifeSciences Corporation (USA); Cambridge Commonwealth Trust; National Institutes of Health (NIH) through the National Institute for Neurological Diseases and Stroke (NINDS); National Institutes of Health (NIH) through the National Institute for Biomedical Imaging and Bioengineering (NIBIB); University of Manitoba Thorlakson Chair in Surgical Research Establishment Fund; University of Manitoba VPRI Research Investment Fund (RIF); Winnipeg Health Sciences Centre Foundation; University of Manitoba Rudy Falk Clinician-Scientist Professorship; Academy of Medical Sciences/The Health Foundation Clinician Scientist Fellowship; National Institute for Health Research (NIHR)National Institute for Health Research (NIHR); NIHR Research Professorship; NIHR Senior Investigator Award; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [G0601025] Funding Source: UKRI	Additional funding was obtained from the Hannelore Kohl Stiftung Germany), from OneMind (USA) and from Integra LifeSciences Corporation (USA). F.M. has received salary support for dedicated research time from the Canada Cambridge Scholarship funded by the Cambridge Commonwealth Trust. F.A.Z. receives support from the National Institutes of Health (NIH) through the National Institute for Neurological Diseases and Stroke (NINDS) and the National Institute for Biomedical Imaging and Bioengineering (NIBIB), University of Manitoba Thorlakson Chair in Surgical Research Establishment Fund, University of Manitoba VPRI Research Investment Fund (RIF), Winnipeg Health Sciences Centre Foundation, and the University of Manitoba Rudy Falk Clinician-Scientist Professorship. V.N. is supported by an Academy of Medical Sciences/The Health Foundation Clinician Scientist Fellowship. These studies were also supported by infrastructure provided by the NIHR Cambridge Biomedical Research Centre (BRC), which is a partnership between Cambridge University Hospitals NHS Foundation Trust and the University of Cambridge, funded by the National Institute for Health Research (NIHR). In addition, P.J.A.H. was supported by an NIHR Research Professorship and DKM by an NIHR Senior Investigator Award. The views expressed are those of the author(s) and not necessarily those of the NIHR or the Department of Health and Social Care.	Alahmadi H, 2010, J NEUROSURG, V112, P1139, DOI 10.3171/2009.5.JNS081369; Aries MJH, 2012, NEUROCRIT CARE, V17, P67, DOI 10.1007/s12028-012-9687-z; Beaumont A, 2000, ACT NEUR S, V76, P147; Broderick JP, 2007, STROKE, V38, P1072, DOI 10.1161/01.STR.0000258078.35316.30; Carnevale JA, 2018, J NEUROSURG, V129, P1305, DOI 10.3171/2017.7.JNS17988; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Chang EF, 2007, NEUROSURGERY, V61, P222, DOI [10.1227/01.NEU.0000197101.68538.E6, 10.1227/01.neu.0000279217.45881.69]; Chieregato A, 2005, NEUROSURGERY, V56, P671, DOI 10.1227/01.NEU.0000156200.76331.7A; Czosnyka M, 2005, J NEUROSURG, V102, P450, DOI 10.3171/jns.2005.102.3.0450; Czosnyka M, 2014, NEUROCRIT CARE, V21, P95, DOI 10.1007/s12028-014-0046-0; Fainardi E, 2004, ACTA NEUROCHIR, V146, P257, DOI 10.1007/s00701-003-0207-y; Flint AC, 2008, J NEUROTRAUM, V25, P503, DOI 10.1089/neu.2007.0442; Jha RM, 2019, NEUROPHARMACOLOGY, V145, P230, DOI 10.1016/j.neuropharm.2018.08.004; Kamnitsas K, 2017, MED IMAGE ANAL, V36, P61, DOI 10.1016/j.media.2016.10.004; Kroppenstedt SN, 2003, CRIT CARE MED, V31, P2211, DOI 10.1097/01.CCM.0000080482.06856.62; Kurland D, 2012, J NEUROTRAUM, V29, P19, DOI 10.1089/neu.2011.2122; Ledig C, 2015, MED IMAGE ANAL, V21, P40, DOI 10.1016/j.media.2014.12.003; Mahmood A, 2017, TRIALS, V18, DOI 10.1186/s13063-017-2073-6; Marcus DS, 2007, J COGNITIVE NEUROSCI, V19, P1498, DOI 10.1162/jocn.2007.19.9.1498; Mathieu F, 2020, NEUROCRIT CARE, V32, P373, DOI 10.1007/s12028-019-00885-3; Matsuyama T, 1997, SURG NEUROL, V48, P193, DOI 10.1016/S0090-3019(96)00484-3; Narayan RK, 2008, J NEUROTRAUM, V25, P629, DOI 10.1089/neu.2007.0385; Nasi D, 2019, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.01186; Oertel M, 2002, J NEUROSURG, V96, P109, DOI 10.3171/jns.2002.96.1.0109; Perel P, 2012, HEALTH TECHNOL ASSES, V16, P1, DOI 10.3310/hta16130; Perel P, 2009, BMC EMERG MED, V9, DOI 10.1186/1471-227X-9-15; Rivera-Lara L, 2017, CRIT CARE MED, V45, P695, DOI 10.1097/CCM.0000000000002251; Schiffler P, 2017, FRONT HUM NEUROSCI, V11, DOI 10.3389/fnhum.2017.00352; Simard JM, 2009, J NEUROTRAUM, V26, P2257, DOI 10.1089/neu.2009.1021; Stocchetti N, 2000, J NEUROL NEUROSUR PS, V68, P14, DOI 10.1136/jnnp.68.1.14; Unterberg AW, 2004, NEUROSCIENCE, V129, P1021, DOI 10.1016/j.neuroscience.2004.06.046; White CL, 2009, J TRAUMA, V67, P508, DOI 10.1097/TA.0b013e3181b2519f; Yushkevich PA, 2006, NEUROIMAGE, V31, P1116, DOI 10.1016/j.neuroimage.2006.01.015; Zeiler FA, 2018, J NEUROTRAUM, V35, P963, DOI 10.1089/neu.2017.5241; Zeiler FA, 2019, ACTA NEUROCHIR, V161, P1217, DOI 10.1007/s00701-019-03844-1	35	7	7	1	3	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUL 1	2020	37	13					1556	1565		10.1089/neu.2019.6814		APR 2020	10	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	ME4JC	WOS:000524259700001	31928143	Green Submitted, Green Published			2022-02-06	
J	Nowak, MK; Bevilacqua, ZW; Ejima, K; Huibregtse, ME; Chen, ZX; Mickleborough, TD; Newman, SD; Kawata, K				Nowak, Madeleine K.; Bevilacqua, Zachary W.; Ejima, Keisuke; Huibregtse, Megan E.; Chen, Zhongxue; Mickleborough, Timothy D.; Newman, Sharlene D.; Kawata, Keisuke			Neuro-Ophthalmologic Response to Repetitive Subconcussive Head Impacts A Randomized Clinical Trial	JAMA OPHTHALMOLOGY			English	Article							KING-DEVICK TEST; COLLEGIATE FOOTBALL PLAYERS; CONCUSSION; SEASON; ASSOCIATION; INTEGRITY; EXPOSURE	Importance Subconcussive head impacts have emerged as a complex public health concern. The oculomotor system is sensitive to brain trauma; however, neuro-ophthalmologic response to subconcussive head impacts remains unclear. Objective To examine whether subconcussive head impacts cause impairments in neuro-ophthalmologic function as measured by the King-Devick test (KDT) and oculomotor function as measured by the near point of convergence. Design, Setting, and Participants In this randomized clinical trial, adult soccer players were randomized into either a heading group or kicking (control) group. The heading group executed 10 headers with soccer balls projected at a speed of 25 mph. The kicking-control group followed the same protocol but with 10 kicks. Peak linear and rotational head accelerations were assessed with a triaxial accelerometer. The KDT speed and error and near point of convergence were assessed at baseline (preheading or prekicking) and at 0, 2, and 24 hours after heading or kicking. Exposures Ten soccer-ball headings or kicks. Main Outcomes and Measures The primary outcome was the group-by-time interaction of KDT speed at 0 hours after heading or kicking. The secondary outcomes included KDT speed at 2 hours and 24 hours after heading or kicking, KDT error, and near point of convergence. Results A total of 78 individuals enrolled (heading group, n = 40; kicking-control group, n = 38). Eleven individuals (heading group: 4 women; mean [SD] age, 22.5 [1.0] years; kicking-control group, 3 women and 4 men; mean [SD] age, 20.9 [1.1] years) voluntarily withdrew from the study. Data from 67 participants with a mean (SD) age of 20.6 (1.7) years were eligible for analysis (heading, n = 36; kicking-control, n = 31). Mean (SD) peak linear accelerations and peak rotational accelerations per impact for the heading group were 33.2 (6.8) g and 3.6 (1.4) krad/s(2), respectively. Conversely, soccer kicking did not induce a detectable level of head acceleration. Both groups showed improvements in KDT speed (heading group: 0 hours, -1.2 [95% CI, -2.2 to -0.1] seconds; P = .03; 2 hours, -1.3 [95% CI, -2.6 to 0] seconds; P = .05; 24 hours, -3.2 [95% CI, -4.3 to -2.2] seconds; P < .001; kicking-control group: 0 hours, -3.3 [95% CI, -4.1 to -2.5] seconds; P < .001; 2 hours, -4.1 [95% CI, -5.1 to -3.1] seconds; P < .001; 24 hours, -5.2 [95% CI, -6.2 to -4.2] seconds; P < .001). Group differences occurred at all postintervention points; the kicking-control group performed KDT faster at 0 hours (-2.2 [95% CI, -0.8 to -3.5] seconds; P = .001), 2 hours (-2.8 [95% CI, -1.2 to -4.4] seconds; P < .001), and 24 hours after the intervention (-2.0 [95% CI, -0.5 to -3.4] seconds; P = .007) compared with those of the heading group. Conclusions and Relevance These data support the hypothesis that neuro-ophthalmologic function is affected, at least in the short term, by subconcussive head impacts that may affect some individuals in some contact sports. Further studies may help determine if these measures can be a useful clinical tool in detecting acute subconcussive injury.	[Nowak, Madeleine K.; Bevilacqua, Zachary W.; Huibregtse, Megan E.; Mickleborough, Timothy D.; Kawata, Keisuke] Indiana Univ, Dept Kinesiol, Sch Publ Hlth Bloomington, 1025 E Seventh St, Bloomington, IN 47405 USA; [Ejima, Keisuke; Chen, Zhongxue] Indiana Univ, Dept Epidemiol & Biostat, Sch Publ Hlth Bloomington, Bloomington, IN 47405 USA; [Newman, Sharlene D.] Indiana Univ, Dept Psychol & Brain Sci, Coll Arts & Sci, Bloomington, IN 47405 USA; [Newman, Sharlene D.; Kawata, Keisuke] Indiana Univ, Program Neurosci, Coll Arts & Sci, Bloomington, IN 47405 USA		Kawata, K (corresponding author), Indiana Univ, Dept Kinesiol, Sch Publ Hlth Bloomington, 1025 E Seventh St, Bloomington, IN 47405 USA.	kkawata@indiana.edu		Mickleborough, Timothy/0000-0002-5118-268X	Indiana Spinal Cord and Brain Injury Research Fund from the Indiana State Department of Health [0019939]; Indiana University School of Public Health faculty research grant program [2246237]	This work was partly supported by the Indiana Spinal Cord and Brain Injury Research Fund from the Indiana State Department of Health (0019939 [Dr Kawata]) and the Indiana University School of Public Health faculty research grant program (2246237 [Dr Kawata]).	Bahrami N, 2016, RADIOLOGY, V281, P919, DOI 10.1148/radiol.2016160564; Bailes JE, 2013, J NEUROSURG, V119, P1235, DOI 10.3171/2013.7.JNS121822; Bazarian JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094734; Bevilacqua ZW, 2019, JOVE-J VIS EXP, DOI 10.3791/59381; Breedlove EL, 2012, J BIOMECH, V45, P1265, DOI 10.1016/j.jbiomech.2012.01.034; Caccese JB, 2019, MED SCI SPORT EXER, V51, P1355, DOI 10.1249/MSS.0000000000001905; Crisco JJ, 2010, J ATHL TRAINING, V45, P549, DOI 10.4085/1062-6050-45.6.549; Davenport EM, 2014, J NEUROTRAUM, V31, P1617, DOI 10.1089/neu.2013.3233; Davies EC, 2012, NEUROLOGY, V78, pE103, DOI 10.1212/WNL.0b013e318251833d; Di Virgilio TG, 2016, EBIOMEDICINE, V13, P66, DOI 10.1016/j.ebiom.2016.10.029; Duma SM, 2005, CLIN J SPORT MED, V15, P3, DOI 10.1097/00042752-200501000-00002; Galetta KM, 2011, NEUROLOGY, V76, P1456, DOI 10.1212/WNL.0b013e31821184c9; Galetta KM, 2011, J NEUROL SCI, V309, P34, DOI 10.1016/j.jns.2011.07.039; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Gong NJ, 2018, NEUROBIOL DIS, V119, P79, DOI 10.1016/j.nbd.2018.07.020; Guskiewicz KM, 2007, NEUROSURGERY, V61, P1244, DOI 10.1227/01.neu.0000306103.68635.1a; Johnson B, 2015, NEUROLOGY, V85, P1163, DOI 10.1212/WNL.0000000000001968; Johnson B, 2015, BRAIN IMAGING BEHAV, V9, P564, DOI 10.1007/s11682-014-9316-x; Kawata K, 2016, INT J SPORTS MED, V37, P405, DOI 10.1055/s-0035-1569290; Kawata K, 2016, JAMA OPHTHALMOL, V134, P763, DOI 10.1001/jamaophthalmol.2016.1085; King D, 2015, J NEUROL SCI, V357, P75, DOI 10.1016/j.jns.2015.06.069; King D, 2015, J NEUROL SCI, V351, P58, DOI 10.1016/j.jns.2015.02.035; Laksari K, 2018, PHYS REV LETT, V120, DOI 10.1103/PhysRevLett.120.138101; Linthorne NP, 2006, SPORT BIOMECH, V5, P243, DOI 10.1080/14763140608522877; Lipton ML, 2013, RADIOLOGY, V268, P850, DOI 10.1148/radiol.13130545; Matser JT, 1998, NEUROLOGY, V51, P791, DOI 10.1212/WNL.51.3.791; McAllister TW, 2014, NEUROLOGY, V82, P63, DOI 10.1212/01.wnl.0000438220.16190.42; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Mez J, 2017, JAMA-J AM MED ASSOC, V318, P360, DOI 10.1001/jama.2017.8334; National Collegiate Athletic Association, 2017, EST PROB COMP COLL A EST PROB COMP COLL A; Oberlander TJ, 2017, J ATHL TRAINING, V52, P439, DOI 10.4085/1062-6050-52.2.12; Reynolds BB, 2018, BRAIN IMAGING BEHAV, V12, P1332, DOI 10.1007/s11682-017-9790-z; Reynolds BB, 2016, J NEUROSURG, V124, P501, DOI 10.3171/2015.5.JNS15573; Rizzo JR, 2016, J NEUROL SCI, V362, P232, DOI 10.1016/j.jns.2016.01.045; Schnebel B, 2007, NEUROSURGERY, V60, P490, DOI 10.1227/01.NEU.0000249286.92255.7F; Slobounov SM, 2017, NEUROIMAGE-CLIN, V14, P708, DOI 10.1016/j.nicl.2017.03.006; Subotic A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183092; Talavage TM, 2014, J NEUROTRAUM, V31, P327, DOI 10.1089/neu.2010.1512; Wirsching A, 2019, J NEUROTRAUM, V36, P548, DOI 10.1089/neu.2018.5836; Zonner SW, 2019, JAMA OPHTHALMOL, V137, P265, DOI 10.1001/jamaophthalmol.2018.6193	40	7	7	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	2168-6165	2168-6173		JAMA OPHTHALMOL	JAMA Ophthalmol.	APR	2020	138	4					350	357		10.1001/jamaophthalmol.2019.6128			8	Ophthalmology	Science Citation Index Expanded (SCI-EXPANDED)	Ophthalmology	LE3FP	WOS:000526606900004	32053162	Green Published			2022-02-06	
J	Scholderle, T; Haas, E; Ziegler, W				Schoelderle, Theresa; Haas, Elisabet; Ziegler, Wolfram			Age Norms for Auditory-Perceptual Neurophonetic Parameters: A Prerequisite for the Assessment of Childhood Dysarthria	JOURNAL OF SPEECH LANGUAGE AND HEARING RESEARCH			English	Article							TRAUMATIC BRAIN-INJURY; NASALANCE SCORES; SPEECH DISORDERS; SPEAKING RATE; CHILDREN; GENDER; VOICE; RELIABILITY; IMPAIRMENT; COMPLEXITY	Purpose: The aim of this study was to collect auditory-perceptual data on established symptom categories of dysarthria from typically developing children between 3 and 9 years of age, for the purpose of creating age norms for dysarthria assessment. Method: One hundred forty-four typically developing children (3;0-9;11 [years:months], 72 girls and 72 boys) participated. We used a computer-based game specifically designed for this study to elicit sentence repetitions and spontaneous speech samples. Speech recordings were analyzed using the auditory-perceptual criteria of the Bogenhausen Dysarthria Scales, a standardized German assessment tool for dysarthria in adults. The Bogenhausen Dysarthria Scales (scales and features) cover clinically relevant dimensions of speech and allow for an evaluation of well-established symptom categories of dysarthria. Results: The typically developing children exhibited a number of speech characteristics overlapping with established symptom categories of dysarthria (e.g., breathy voice, frequent inspirations, reduced articulatory precision, decreased articulation rate). Substantial progress was observed between 3 and 9 years of age, but with different developmental trajectories across different dimensions. In several areas (e.g., respiration, voice quality), 9-year-olds still presented with salient developmental speech characteristics, while in other dimensions (e.g., prosodic modulation), features typically associated with dysarthria occurred only exceptionally, even in the 3-year-olds. Conclusions: The acquisition of speech motor functions is a prolonged process not yet completed with 9 years. Various developmental influences (e.g., anatomic- physiological changes) shape children's speech specifically. Our findings are a first step toward establishing auditory-perceptual norms for dysarthria in children of kindergarten and elementary school age.	[Schoelderle, Theresa; Haas, Elisabet; Ziegler, Wolfram] Ludwig Maximilian Univ Munich, Inst Phonet & Speech Proc, Clin Neuropsychol Res Grp, Munich, Germany		Scholderle, T (corresponding author), Ludwig Maximilian Univ Munich, Inst Phonet & Speech Proc, Clin Neuropsychol Res Grp, Munich, Germany.	theresa.schoelderle@ekn-muenchen.de		Haas, Elisabet/0000-0002-8667-772X	German Research Foundation (DFG)German Research Foundation (DFG) [SCHO 17421-1]; German National Academic Foundation	This research was supported by a grant from the German Research Foundation (DFG) awarded to the first author and the last author (SCHO 17421-1), as well as a PhD fellowship from the German National Academic Foundation awarded to the second author.	Allison KM, 2018, J SPEECH LANG HEAR R, V61, P462, DOI 10.1044/2017_JSLHR-S-16-0414; Allison KM, 2014, INT J SPEECH-LANG PA, V16, P396, DOI 10.3109/17549507.2013.876667; Awan SN, 2001, CLIN LINGUIST PHONET, V15, P117, DOI 10.3109/02699200109167642; Barbier G., 2017, 7 INT C SPEECH MOT C; Baty F, 2015, J STAT SOFTW, V66, P1; Berger T, 2019, J VOICE, V33, DOI 10.1016/j.jvoice.2018.01.006; Boliek CA, 2009, J SPEECH LANG HEAR R, V52, P990, DOI 10.1044/1092-4388(2009/07-0214); Brockmann-Bauser M, 2015, INT J PEDIATR OTORHI, V79, P2035, DOI 10.1016/j.ijporl.2015.09.005; Brunnegard K, 2009, CLIN LINGUIST PHONET, V23, P58, DOI 10.1080/02699200802491074; Cahill LM, 2005, BRAIN INJURY, V19, P41, DOI 10.1080/02699050410001719961; Cahill LM, 2002, BRAIN INJURY, V16, P415, DOI 10.1080/02699050110119871; Cahill LM, 2003, J HEAD TRAUMA REHAB, V18, P268, DOI 10.1097/00001199-200305000-00005; Cornwell PL, 2003, CLIN LINGUIST PHONET, V17, P597, DOI 10.1080/0269920031000111339; DARLEY FL, 1969, J SPEECH HEAR RES, V12, P246, DOI 10.1044/jshr.1202.246; Dodd B, 2018, CLIN LINGUIST PHONET, V32, P1027, DOI 10.1080/02699206.2018.1488994; Enderby P., 2012, FDA 2 FRENCHAY DYSAR; Ferguson AN, 2002, J EXP CHILD PSYCHOL, V81, P141, DOI 10.1006/jecp.2001.2646; Fox-Boyer A., 2007, TROG D TEST UBERPRUF; Frota S., 2016, INTONATIONAL GRAMMAR, V6, P295, DOI [10.1075/ihll.6.14fro, DOI 10.1075/IHLL.6.14FRO]; Ha S, 2015, INT J PEDIATR OTORHI, V79, P1235, DOI 10.1016/j.ijporl.2015.05.019; HOIT JD, 1990, J SPEECH HEAR RES, V33, P51, DOI 10.1044/jshr.3301.51; Huber JE, 1999, J ACOUST SOC AM, V106, P1532, DOI 10.1121/1.427150; Huber JE, 2011, J SPEECH LANG HEAR R, V54, P33, DOI 10.1044/1092-4388(2010/09-0184); Kent R. D., 1995, J MED SPEECH-LANG PA, V3, P145; Lee S, 1999, J ACOUST SOC AM, V105, P1455, DOI 10.1121/1.426686; Martins IP, 2007, CHILD NEUROPSYCHOL, V13, P319, DOI 10.1080/09297040600837370; MCALLISTER A, 1994, J VOICE, V8, P230, DOI 10.1016/S0892-1997(05)80294-2; Morgan AT, 2007, BRAIN INJURY, V21, P1183, DOI 10.1080/02699050701649573; Morgan AT, 2011, BRAIN LANG, V117, P69, DOI 10.1016/j.bandl.2011.01.002; MURDOCH BE, 1994, EUR J DISORDER COMM, V29, P379; Netelenbos N, 2018, FRONT PSYCHOL, V9, DOI 10.3389/fpsyg.2018.00172; NETSELL R, 1994, J VOICE, V8, P123, DOI 10.1016/S0892-1997(05)80304-2; Nicollas R, 2008, J VOICE, V22, P671, DOI 10.1016/j.jvoice.2007.01.009; Nip ISB, 2013, CHILD DEV, V84, P1324, DOI 10.1111/cdev.12052; Noiray A, 2018, J SPEECH LANG HEAR R, V61, P1355, DOI 10.1044/2018_JSLHR-S-17-0148; Patel RR, 2014, J VOICE, V28, P476, DOI 10.1016/j.jvoice.2013.12.010; Patel R, 2014, INT J SPEECH-LANG PA, V16, P337, DOI 10.3109/17549507.2014.894124; Pellowski MW, 2002, J SPEECH LANG HEAR R, V45, P20, DOI 10.1044/1092-4388(2002/002); Perry JL, 2017, CLEFT PALATE-CRAN J, V54, P408, DOI 10.1597/15-120; R Core Team, 2014, R LANG ENV STAT COMP; Ryan BP, 2000, CLIN LINGUIST PHONET, V14, P25, DOI 10.1080/026992000298931; Shriberg LD, 2010, CLIN LINGUIST PHONET, V24, P825, DOI 10.3109/02699206.2010.503007; Stathopoulos ET, 2011, J SPEECH LANG HEAR R, V54, P1011, DOI 10.1044/1092-4388(2010/10-0036); Vihman M. M., 2018, TRENDS LANGUAGE ACQU, V23, P185, DOI [10.1075/tilar. 23.10vih, DOI 10.1075/TILAR.23.10VIH]; Ziegler W, 2018, BODYS BOGENHAUSENER; Ziegler W, 2017, J SPEECH LANG HEAR R, V60, P1516, DOI 10.1044/2017_JSLHR-S-16-0336	46	7	7	0	1	AMER SPEECH-LANGUAGE-HEARING ASSOC	ROCKVILLE	2200 RESEARCH BLVD, #271, ROCKVILLE, MD 20850-3289 USA	1092-4388	1558-9102		J SPEECH LANG HEAR R	J. Speech Lang. Hear. Res.	APR	2020	63	4					1071	1082		10.1044/2020_JSLHR-19-00114			12	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	ND2UP	WOS:000561760500011	32310705				2022-02-06	
J	Zhang, L; Fei, MX; Wang, HD; Zhu, YH				Zhang, Li; Fei, Maoxing; Wang, Handong; Zhu, Yihao			Sodium aescinate provides neuroprotection in experimental traumatic brain injury via the Nrf2-ARE pathway	BRAIN RESEARCH BULLETIN			English	Article						Sodium aescinate; Neuroprotection; Traumatic brain injury; Nrf2-ARE pathway; Oxidative stress; Apoptosis	REDUCES OXIDATIVE STRESS; NEURONAL APOPTOSIS; ANTIOXIDANT; MODEL; MODULATION; MOUSE; MICE	Sodium aescinate (SA), a natural plant extract, has been proven to provide neuroprotection in neurological diseases. However, its role and the underlying pathophysiological mechanisms in traumatic brain injury (TBI) are still not well understood. The present study was aimed to investigate the protective effects of SA in both in vivo and in vitro TBI models. Mice or neurons were randomly divided into control, TBI, TBI + vehicle and TBI + SA groups. Neurologic severity score (NSS) was used to evaluate the neurological impairment. Brain water content and lesion volume were used to assess the brain injury degree. Malondialdehyde (MDA) and glutathione peroxidase (GPx) levels were used to estimate oxidative stress. Western blot was used to determine the protein levels. Nissl and terminal deoxynucleotidyl transferase-mediated dUTP nick 3'-end labeling (TUNEL) staining were used to measure cell death and apoptosis. Our results revealed that treatment of SA could improve neurological function, decrease cerebral edema and attenuate brain lesion after TBI. Furthermore, administration of SA suppressed TBI-induced oxidative stress, neuron cell death and apoptosis. In addition, SA activated the nudear factor erythroid 2-related factor 2 (Nrf2)-antioxidant response element (ARE) pathway after TBI. However, SA failed to provide neuroprotection following TBI in Nrf2(-/-) mice. Taken together, our results provided the first evidence that SA treatment played a key role in neuroprotection after TBI through the Nrf2-ARE pathway.	[Zhang, Li; Fei, Maoxing; Wang, Handong; Zhu, Yihao] Nanjing Univ, Jinling Hosp, Sch Med, Dept Neurosurg, Nanjing, Jiangsu, Peoples R China		Wang, HD (corresponding author), Jinling Hosp, Dept Neurosurg, 305 East Zhongshan Rd, Nanjing 210002, Jiangsu, Peoples R China.	njhdwang@hotmail.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81672503, 81702484]	This work was supported by Grants from the National Natural Science Foundation of China (No. 81672503) from Handong Wang and the National Natural Science Foundation of China (No. 81702484) from Li Zhang.	Angeloni C, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/370312; Bains M, 2012, BBA-MOL BASIS DIS, V1822, P675, DOI 10.1016/j.bbadis.2011.10.017; Brooks JC, 2013, ARCH PHYS MED REHAB, V94, P2203, DOI 10.1016/j.apmr.2013.07.005; Chen L, 2017, BRATISL MED J, V118, P223, DOI 10.4149/BLL_2017_044; Cheng P, 2016, FREE RADICAL BIO MED, V99, P405, DOI 10.1016/j.freeradbiomed.2016.09.002; de Vries HE, 2008, FREE RADICAL BIO MED, V45, P1375, DOI 10.1016/j.freeradbiomed.2008.09.001; Ding K, 2015, J SURG RES, V194, P239, DOI 10.1016/j.jss.2014.09.026; Ding K, 2014, FREE RADICAL BIO MED, V73, P1, DOI 10.1016/j.freeradbiomed.2014.04.031; Fan Xue-Ju, 2005, Zhong Nan Da Xue Xue Bao Yi Xue Ban, V30, P261; Fang J, 2018, DRUG DES DEV THER, V12, P2497, DOI 10.2147/DDDT.S163951; Farrell Deacon, 2018, Curr Anesthesiol Rep, V8, P279, DOI 10.1007/s40140-018-0286-1; Flierl MA, 2009, NAT PROTOC, V4, P1328, DOI 10.1038/nprot.2009.148; Glushakova Olena Y, 2017, Brain Circ, V3, P87, DOI 10.4103/bc.bc_27_16; Kobayashi A, 2004, MOL CELL BIOL, V24, P7130, DOI 10.1128/MCB.24.16.7130-7139.2004; Liang JW, 2018, DRUG DES DEV THER, V12, P845, DOI 10.2147/DDDT.S160046; Lorente L, 2015, ARCH TRAUMA RES, V4, DOI 10.5812/atr.30165; Ma MW, 2018, REDOX BIOL, V16, P285, DOI 10.1016/j.redox.2018.03.005; Sauzeau V, 2003, J BIOL CHEM, V278, P9472, DOI 10.1074/jbc.M212776200; Sun M, 2015, J NEUROTRAUM, V32, P66, DOI 10.1089/neu.2012.2432; Villeneuve NF, 2010, ANTIOXID REDOX SIGN, V13, P1699, DOI 10.1089/ars.2010.3211; Wang YK, 2012, MOLECULES, V17, P10267, DOI 10.3390/molecules170910267; Xie B.S., 2018, CNS NEUROSCI THER; Xu JG, 2014, FREE RADICAL BIO MED, V71, P186, DOI 10.1016/j.freeradbiomed.2014.03.009; Xu JG, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/187873; Yonutas HM, 2016, BRAIN RES, V1640, P77, DOI 10.1016/j.brainres.2016.02.007; Zhang C, 2017, NPJ QUANTUM MATER, V2, DOI 10.1038/s41535-016-0006-3; Zhang L, 2017, J LAB PRECIS MED, V2, P2, DOI DOI 10.1155/2017/2032697; Zhang L, 2018, FRONT MOL NEUROSCI, V11, DOI 10.3389/fnmol.2018.00190; Zhang L, 2018, NEUROCHEM INT, V118, P304, DOI 10.1016/j.neuint.2018.05.011; Zhang L, 2018, MOL NEUROBIOL, V55, P1773, DOI 10.1007/s12035-017-0456-z; Zhang Lijuan, 2016, Zhongguo Zhen Jiu, V36, P131; Zhang ZL, 2015, INFLAMMATION, V38, P1942, DOI 10.1007/s10753-015-0174-5; Zhao YB, 2012, EXP NEUROL, V237, P489, DOI 10.1016/j.expneurol.2012.07.004	33	7	7	1	2	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0361-9230	1873-2747		BRAIN RES BULL	Brain Res. Bull.	APR	2020	157						26	36		10.1016/j.brainresbull.2020.01.019			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	KT9ML	WOS:000519336000004	32014567				2022-02-06	
J	Resch, ZJ; Soble, JR; Ovsiew, GP; Castillo, LR; Saladino, KF; DeDios-Stern, S; Schulze, ET; Song, WJ; Pliskin, NH				Resch, Zachary J.; Soble, Jason R.; Ovsiew, Gabriel P.; Castillo, Liliam R.; Saladino, Kevin F.; DeDios-Stern, Samantha; Schulze, Evan T.; Song, Woojin; Pliskin, Neil H.			Working Memory, Processing Speed, and Memory Functioning Are Minimally Predictive of Victoria Symptom Validity Test Performance	ASSESSMENT			English	Article						performance validity test; effort; cognition; neuropsychology; assessment	TRAUMATIC BRAIN-INJURY; TEST CUTOFF SCORES; INTRAINDIVIDUAL VARIABILITY; COGNITIVE IMPAIRMENT; RECOGNITION TRIAL; CVLT-II; RATES; INTELLIGENCE; VALIDATION; INDICATOR	A sound performance validity test is accurate for detecting invalid neuropsychological test performance and relatively insensitive to actual cognitive ability or impairment. This study explored the relationship of several cognitive abilities to several performance indices on the Victoria Symptom Validity Test (VSVT), including accuracy and response latency. This cross-sectional study examined data from a mixed clinical sample of 88 adults identified as having valid neurocognitive test profiles via independent validity measures, and who completed the VSVT along with objective measures of working memory, processing speed, and verbal memory during their clinical neuropsychological evaluation. Results of linear regression analyses indicated that cognitive test performance accounted for 5% to 14% of total variance for VSVT performance across indices. Working memory was the only cognitive ability to predict significant, albeit minimal, variance on the VSVT response accuracy indices. Results show that VSVT performance is minimally predicted by working memory, processing speed, or delayed verbal memory recall.	[Resch, Zachary J.; Soble, Jason R.; Ovsiew, Gabriel P.; Castillo, Liliam R.; Saladino, Kevin F.; DeDios-Stern, Samantha; Song, Woojin; Pliskin, Neil H.] Univ Illinois, Coll Med, Chicago, IL USA; [Resch, Zachary J.] Rosalind Franklin Univ Med & Sci, N Chicago, IL USA; [Schulze, Evan T.] St Louis Univ, St Louis, MO 63103 USA		Resch, ZJ (corresponding author), Rosalind Franklin Univ Med & Sci, Dept Psychol, 3333 Green Bay Rd, N Chicago, IL 60064 USA.	zachary.resch@my.rfums.org		Resch, Zachary/0000-0002-3199-6168; Soble, Jason/0000-0003-3348-8762			Alverson WA, 2019, CLIN NEUROPSYCHOL, V33, P1420, DOI 10.1080/13854046.2019.1599071; Bailey KC, 2018, ARCH CLIN NEUROPSYCH, V33, P895, DOI 10.1093/arclin/acx111; Bailey KC, 2018, CLIN NEUROPSYCHOL, V32, P119, DOI 10.1080/13854046.2017.1333151; Bain KM, 2021, APPL NEUROPSYCH-ADUL, V28, P24, DOI 10.1080/23279095.2019.1585352; Bain KM, 2019, ASSESSMENT, V26, P1320, DOI 10.1177/1073191117725172; Bondi M. W., 2009, NEUROPSYCHOLOGICAL A, P159; Boone K. B., 2002, DOT COUNTING TEST MA; Boone K. B., 2002, B TESTTM MANUAL; Boone KB, 2009, CLIN NEUROPSYCHOL, V23, P729, DOI 10.1080/13854040802427803; Braun M, 2011, COGN BEHAV NEUROL, V24, P107, DOI 10.1097/WNN.0b013e3182351289; Chiaravalloti ND, 2008, LANCET NEUROL, V7, P1139, DOI 10.1016/S1474-4422(08)70259-X; Critchfield E, 2019, CLIN NEUROPSYCHOL, V33, P1083, DOI 10.1080/13854046.2018.1508615; Davis JJ, 2014, CLIN NEUROPSYCHOL, V28, P199, DOI 10.1080/13854046.2014.884633; Delis D.C., 2000, CALIFORNIA VERBAL LE; Dikmen SS, 2009, J HEAD TRAUMA REHAB, V24, P430, DOI 10.1097/HTR.0b013e3181c133e9; Donders J, 2008, ASSESSMENT, V15, P123, DOI 10.1177/1073191107310926; Doss R.C., 1999, J FORENSIC NEUROPSYC, V1, P5, DOI [https://doi.org/10.1300/J151v01n04_02, DOI 10.1300/J151V01N04_02, 10.1300/J151v01n04_02]; Frazier TW, 2008, ARCH CLIN NEUROPSYCH, V23, P501, DOI 10.1016/j.acn.2008.04.001; Gervais RO, 2004, ARCH CLIN NEUROPSYCH, V19, P475, DOI 10.1016/j.acn.2003.05.001; Green P., 2003, GREENS WORD MEMORY T; Green P, 2011, APPL NEUROPSYCHOL, V18, P86, DOI 10.1080/09084282.2010.523389; Greve KW, 2008, CLIN NEUROPSYCHOL, V22, P896, DOI 10.1080/13854040701565208; Greve K, 2009, CLIN NEUROPSYCHOL, V23, P343, DOI 10.1080/13854040802054169; Grote CL, 2000, J CLIN EXP NEUROPSYC, V22, P709, DOI 10.1076/jcen.22.6.709.958; Gunzler SA, 2011, LITTLE BLACK BOOK OF NEUROPSYCHOLOGY: A SYNDROME-BASED APPROACH, P567, DOI 10.1007/978-0-387-76978-3_19; Heilbronner RL, 2007, CLIN NEUROPSYCHOL, V21, P209, DOI 10.1080/13825580601025932; Hillary FG, 2010, BRAIN IMAGING BEHAV, V4, P141, DOI 10.1007/s11682-010-9094-z; Jones A, 2013, CLIN NEUROPSYCHOL, V27, P1373, DOI 10.1080/13854046.2013.851740; Keary TA, 2013, J INT NEUROPSYCH SOC, V19, P314, DOI 10.1017/S1355617712001397; Larrabee GJ, 2007, ASSESSMENT MALINGERE, P44; Larrabee GJ, 2014, ARCH CLIN NEUROPSYCH, V29, P695, DOI 10.1093/arclin/acu049; Larrabee GJ, 2014, ARCH CLIN NEUROPSYCH, V29, P364, DOI 10.1093/arclin/acu019; Livingston RB, 2003, ARCH CLIN NEUROPSYCH, V18, P487, DOI 10.1016/S0887-6177(02)00147-6; Loring DW, 2008, J INT NEUROPSYCH SOC, V14, P394, DOI 10.1017/S1355617708080582; Loring DW, 2007, CLIN NEUROPSYCHOL, V21, P522, DOI 10.1080/13854040600611384; Loring DW, 2016, ARCH CLIN NEUROPSYCH, V31, P313, DOI 10.1093/arclin/acw014; Loring DW, 2005, J CLIN EXP NEUROPSYC, V27, P610, DOI 10.1080/13803390490918471; Macciocchi SN, 2006, ARCH CLIN NEUROPSYCH, V21, P395, DOI 10.1016/j.acn.2006.06.003; Merten T, 2007, J CLIN EXP NEUROPSYC, V29, P308, DOI 10.1080/13803390600693607; Proto DA, 2014, ARCH CLIN NEUROPSYCH, V29, P614, DOI 10.1093/arclin/acu044; Schwartz ES, 2016, J INT NEUROPSYCH SOC, V22, P851, DOI 10.1017/S1355617716000746; Silk-Eglit GM, 2016, ARCH CLIN NEUROPSYCH, V31, P231, DOI 10.1093/arclin/acv108; Silverberg ND, 2007, CLIN NEUROPSYCHOL, V21, P841, DOI 10.1080/13854040600850958; Slick D.J., 1997, VICTORIA SYMPTOM VAL; Slick DJ, 1996, J CLIN EXP NEUROPSYC, V18, P911, DOI 10.1080/01688639608408313; Slick DJ, 1999, CLIN NEUROPSYCHOL, V13, P545, DOI 10.1076/1385-4046(199911)13:04;1-Y;FT545; Soble JR, 2018, J CLIN EXP NEUROPSYC, V40, P317, DOI 10.1080/13803395.2017.1342773; Soble JR, 2019, APPL NEUROPSYCH-ADUL, V26, P311, DOI 10.1080/23279095.2017.1418744; Strauss E, 2002, ARCH CLIN NEUROPSYCH, V17, P423, DOI 10.1016/S0887-6177(01)00126-3; Strauss E, 1999, CLIN NEUROPSYCHOL, V13, P420, DOI 10.1076/1385-4046(199911)13:04;1-Y;FT420; Tan JE, 2002, CLIN NEUROPSYCHOL, V16, P495, DOI 10.1076/clin.16.4.495.13909; Tombaugh T.N., 1996, TEST MEMORY MALINGER; Webber TA, 2020, ASSESSMENT, V27, P1399, DOI 10.1177/1073191118804874; Webber TA, 2018, CLIN NEUROPSYCHOL, V32, P657, DOI 10.1080/13854046.2017.1415374; Willcutt E. G., 2010, PEDIAT NEUROPSYCHOLO, P393	55	7	7	1	1	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1073-1911	1552-3489		ASSESSMENT	Assessment	SEP	2021	28	6					1614	1623	1073191120911102	10.1177/1073191120911102		MAR 2020	10	Psychology, Clinical	Social Science Citation Index (SSCI)	Psychology	UH1XZ	WOS:000523830900001	32174137				2022-02-06	
J	Treble-Barna, A; Pilipenko, V; Wade, SL; Jegga, AG; Yeates, KO; Taylor, HG; Martin, LJ; Kurowski, BG				Treble-Barna, Amery; Pilipenko, Valentina; Wade, Shari L.; Jegga, Anil G.; Yeates, Keith Owen; Taylor, H. Gerry; Martin, Lisa J.; Kurowski, Brad G.			Cumulative Influence of Inflammatory Response Genetic Variation on Long-Term Neurobehavioral Outcomes after Pediatric Traumatic Brain Injury Relative to Orthopedic Injury: An Exploratory Polygenic Risk Score	JOURNAL OF NEUROTRAUMA			English	Article						behavior; inflammatory response; pediatric brain injury; PRS; TBI	EARLY-CHILDHOOD; CEREBROSPINAL-FLUID; FAMILY ENVIRONMENT; EXECUTIVE DYSFUNCTION; WARM RESPONSIVENESS; LIFE STRESS; HEAD-INJURY; POLYMORPHISMS; ASSOCIATION; RECOVERY	The addition of genetic factors to prognostic models of neurobehavioral recovery following pediatric traumatic brain injury (TBI) may account for unexplained heterogeneity in outcomes. The present study examined the cumulative influence of candidate genes involved in the inflammatory response on long-term neurobehavioral recovery in children with early childhood TBI relative to children with orthopedic injuries (OI). Participants were drawn from a prospective, longitudinal study evaluating outcomes of children who sustained TBI (n = 67) or OI (n = 68) between the ages of 3 and 7 years. Parents completed ratings of child executive function and behavior at an average of 6.8 years after injury. Exploratory unweighted and weighted polygenic risk scores (PRS) were constructed from single nucleotide polymorphisms (SNPs) across candidate inflammatory response genes (i.e., angiotensin converting enzyme [ACE], brain-derived neurotrophic factor [BDNF], interleukin-1 receptor antagonist [IL1RN], and 5'-ectonucleotidase [NT5E]) that showed nominal (p <= 0.20) associations with outcomes in the TBI group. Linear regression models tested the PRS x injury group (TBI vs. OI) interaction term and post-hoc analyses examined the effect of PRS within each injury group. Higher inflammatory response PRS were associated with more executive dysfunction and behavior problems in children with TBI but not in children with OI. The cumulative influence of inflammatory response genes as measured by PRS explained additional variance in long-term neurobehavioral outcomes, over and above well-established predictors and single candidate SNPs tested individually. The results suggest that some of the unexplained heterogeneity in long-term neurobehavioral outcomes following pediatric TBI may be attributable to a child's genetic predisposition to a greater or lesser inflammatory response to TBI.	[Treble-Barna, Amery] Univ Pittsburgh, Sch Med, Dept Phys Med & Rehabil, Pittsburgh, PA USA; [Pilipenko, Valentina; Martin, Lisa J.] Div Human Genet, Cincinnati, OH USA; [Wade, Shari L.; Kurowski, Brad G.] Div Pediat Rehabil Med, Cincinnati, OH USA; [Jegga, Anil G.] Div Biomed Informat, Cincinnati, OH USA; [Jegga, Anil G.] Childrens Hosp Med Ctr, Cincinnati, OH USA; [Yeates, Keith Owen] Univ Calgary, Alberta Childrens Hosp, Res Inst, Dept Psychol, Calgary, AB, Canada; [Yeates, Keith Owen] Univ Calgary, Hotchkiss Brain Inst, Calgary, AB, Canada; [Taylor, H. Gerry] Ohio State Univ, Nationwide Childrens Hosp, Abigail Wexner Res Inst, Columbus, OH 43210 USA; [Taylor, H. Gerry] Ohio State Univ, Dept Pediat, Columbus, OH 43210 USA; [Wade, Shari L.; Jegga, Anil G.; Martin, Lisa J.; Kurowski, Brad G.] Univ Cincinnati, Coll Med, Dept Pediat, 3333 Burnet Ave, Cincinnati, OH 45229 USA; [Kurowski, Brad G.] Univ Cincinnati, Coll Med, Dept Neurol & Rehabil Med, 3333 Burnet Ave, Cincinnati, OH 45229 USA		Kurowski, BG (corresponding author), Univ Cincinnati, Coll Med, Dept Pediat, 3333 Burnet Ave, Cincinnati, OH 45229 USA.; Kurowski, BG (corresponding author), Univ Cincinnati, Coll Med, Dept Neurol & Rehabil Med, 3333 Burnet Ave, Cincinnati, OH 45229 USA.	brad.kurowski@cchmc.org	Martin, Lisa/E-2425-2016; Yeates, Keith/AAJ-4223-2020; Jegga, Anil/H-6140-2011	Martin, Lisa/0000-0001-8702-9946; Jegga, Anil/0000-0002-4881-7752	National Institute for Child Health and Human Development (NICHD)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [T32 HD040686]; Rehabilitation Medicine Scientist Training Program (RMSTP) [K12 HD001097-16, K01 HD097030, K23 HD074683, R01 HD42729]; National Institute of Neurological Disorders and Stroke grant from the National Center for Advancing Translational Sciences (NCATS) [1R01NS096053, 8 UL1 TR000077, KL2 TR001856]; Society for Clinical Neuropsychology Early Career Pilot Award; UPMC Children's Hospital of Pittsburgh Scientific Program; University of Pittsburgh/UPMC Rehabilitation Institute Pilot Award; Ronald and Irene Ward Chair in Pediatric Brain Injury - Alberta Children's Hospital Foundation	This study was supported in part by the National Institute for Child Health and Human Development (NICHD) grant T32 HD040686, and the Rehabilitation Medicine Scientist Training Program (RMSTP) grants K12 HD001097-16, K01 HD097030, K23 HD074683, and R01 HD42729. Additional support was provided by the National Institute of Neurological Disorders and Stroke grant 1R01NS096053, and grants 8 UL1 TR000077 and KL2 TR001856 from the National Center for Advancing Translational Sciences (NCATS), the Society for Clinical Neuropsychology Early Career Pilot Award, the UPMC Children's Hospital of Pittsburgh Scientific Program, and the University of Pittsburgh/UPMC Rehabilitation Institute Pilot Award. Keith Yeates is supported by the Ronald and Irene Ward Chair in Pediatric Brain Injury, funded by the Alberta Children's Hospital Foundation. The content is solely the responsibility of the authors and does not necessarily represent the official views of the funders.	Abecasis GR, 2001, BIOINFORMATICS, V17, P742, DOI 10.1093/bioinformatics/17.8.742; Achenbach T.M., 2000, MANUAL ASEBA SCH AGE, V4th; Ariza M, 2006, J NEUROPSYCH CLIN N, V18, P39, DOI 10.1176/appi.neuropsych.18.1.39; Barbey AK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088733; Bauer ME, 2019, ANN NY ACAD SCI, V1437, P57, DOI 10.1111/nyas.13712; Bell MJ, 1997, J NEUROTRAUM, V14, P451, DOI 10.1089/neu.1997.14.451; Bowen JM, 1997, DEV MED CHILD NEUROL, V39, P17; Ferreira LCB, 2014, BRAIN INJURY, V28, P1311, DOI 10.3109/02699052.2014.916818; Buttram SDW, 2007, J NEUROTRAUM, V24, P1707, DOI 10.1089/neu.2007.0349; Calabrese F, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00430; Caspi A, 2003, SCIENCE, V301, P386, DOI 10.1126/science.1083968; Caspi A, 2002, SCIENCE, V297, P851, DOI 10.1126/science.1072290; Centers for Disease Control and Prevention, 2019, SURV REP TRAUM BRAIN; Chiaretti A, 2005, CHILD NERV SYST, V21, P185, DOI 10.1007/s00381-004-1032-1; Chiaretti A, 2008, J NEUROTRAUM, V25, P225, DOI 10.1089/neu.2007.0405; Corlier F, 2018, NEUROIMAGE, V172, P118, DOI 10.1016/j.neuroimage.2017.12.027; da Silva JK, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18051081; Dalla Libera AL, 2011, BRAIN INJURY, V25, P365, DOI 10.3109/02699052.2011.556107; Dardiotis E, 2015, PHARMACOGENET GENOM, V25, P485, DOI 10.1097/FPC.0000000000000161; Dare E, 2007, PHYSIOL BEHAV, V92, P15, DOI 10.1016/j.physbeh.2007.05.031; Derringer J, 2010, PSYCHOL SCI, V21, P1282, DOI 10.1177/0956797610380699; Diamond ML, 2015, EPILEPSIA, V56, P1198, DOI 10.1111/epi.13044; Diamond ML, 2014, EPILEPSIA, V55, P1109, DOI 10.1111/epi.12628; Dick DM, 2011, ANNU REV CLIN PSYCHO, V7, P383, DOI 10.1146/annurev-clinpsy-032210-104518; Dincheva I, 2012, NEUROSCIENTIST, V18, P439, DOI 10.1177/1073858411431646; Dudbridge F, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003348; Durber CM, 2017, NEUROPSYCHOLOGY, V31, P499, DOI 10.1037/neu0000351; Durish CL, 2018, J INT NEUROPSYCH SOC, V24, P11, DOI 10.1017/S1355617717000595; Failla MD, 2016, NEUROREHAB NEURAL RE, V30, P83, DOI 10.1177/1545968315586465; Failla MD, 2015, NEUROREHAB NEURAL RE, V29, P234, DOI 10.1177/1545968314542617; Fairbanks JM, 2013, REHABIL PSYCHOL, V58, P223, DOI 10.1037/a0033119; Gerring JP, 2012, J NEUROTRAUM, V29, P621, DOI 10.1089/neu.2011.2234; Gioia GA, 2000, CHILD NEUROPSYCHOL, V6, P235, DOI 10.1076/chin.6.3.235.3152; Gonzalez-Villalobos RA, 2013, J MOL MED, V91, P1143, DOI 10.1007/s00109-013-1051-z; Gray JC, 2014, BRAIN BEHAV, V4, P812, DOI 10.1002/brb3.284; Grigorenko EL, 2016, DEV PSYCHOPATHOL, V28, P1285, DOI 10.1017/S0954579416000857; Hadjigeorgiou GM, 2005, NEUROLOGY, V65, P1077, DOI 10.1212/01.wnl.0000178890.93795.0e; Hagberg H, 2002, MENT RETARD DEV D R, V8, P30, DOI 10.1002/mrdd.10007; Haroon E, 2012, NEUROPSYCHOPHARMACOL, V37, P137, DOI 10.1038/npp.2011.205; Haselkorn ML, 2010, J NEUROTRAUM, V27, P901, DOI 10.1089/neu.2009.1075; Hawryluk Gregory W J, 2015, Handb Clin Neurol, V127, P15, DOI 10.1016/B978-0-444-52892-6.00002-7; Hong CJ, 2011, BRAIN RES BULL, V86, P287, DOI 10.1016/j.brainresbull.2011.08.019; Horne BD, 2005, ANN HUM GENET, V69, P176, DOI [10.1046/j.1469-1809.2005.00155.x, 10.1046/j.1529-8817.2005.00155.x]; Jeong Hey-Kyeong, 2013, Exp Neurobiol, V22, P59, DOI 10.5607/en.2013.22.2.59; Juengst SB, 2014, BRAIN BEHAV IMMUN, V41, P134, DOI 10.1016/j.bbi.2014.05.020; Juengst SB, 2015, J HEAD TRAUMA REHAB, V30, P207, DOI 10.1097/HTR.0000000000000031; Kannan S, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003162; Keenan HT, 2018, J NEUROTRAUM, V35, P286, DOI 10.1089/neu.2017.5265; Kircher M, 2014, NAT GENET, V46, P310, DOI 10.1038/ng.2892; Krueger F, 2011, J NEUROSCI, V31, P598, DOI 10.1523/JNEUROSCI.1399-10.2011; Kumar RG, 2015, BRAIN BEHAV IMMUN, V45, P253, DOI 10.1016/j.bbi.2014.12.021; Kumar RG, 2016, BRAIN BEHAV IMMUN, V53, P183, DOI 10.1016/j.bbi.2015.12.008; Kumar RG, 2015, J HEAD TRAUMA REHAB, V30, P369, DOI 10.1097/HTR.0000000000000067; Kurowski B.G., 2015, ARCH PHYS MED REHAB, V96, pe2, DOI DOI 10.1016/j.apmr.2015.08.004; Kurowski BG, 2017, J NEUROTRAUM, V34, P2280, DOI 10.1089/neu.2016.4856; Kurowski BG, 2011, PM&R, V3, P836, DOI 10.1016/j.pmrj.2011.05.016; Lawrence DW, 2015, BRAIN INJURY, V29, P1018, DOI 10.3109/02699052.2015.1005131; Lawrence DW, 2014, BRAIN INJURY, V28, P841; LEVIN HS, 1995, J NEUROTRAUM, V12, P913, DOI 10.1089/neu.1995.12.913; Li LD, 2016, IEEE T CYBERNETICS, V46, P39, DOI 10.1109/TCYB.2015.2392129; Loane DJ, 2010, NEUROTHERAPEUTICS, V7, P366, DOI 10.1016/j.nurt.2010.07.002; Maas Andrew I R, 2015, Handb Clin Neurol, V128, P455, DOI 10.1016/B978-0-444-63521-1.00029-7; Marousis N., 2019, J INT NEUROPSYCH SOC, V25, pe1; Max JE, 2004, DEV NEUROPSYCHOL, V25, P159, DOI 10.1207/s15326942dn2501&2_9; McCauley SR, 2012, J NEUROTRAUM, V29, P678, DOI 10.1089/neu.2011.1838; McGeary JE, 2012, SUBST ABUS-RES TREAT, V6, P107, DOI 10.4137/SART.S8866; Moran LM, 2015, BRAIN INJURY, V29, P1682, DOI 10.3109/02699052.2015.1075140; Myrga JM, 2016, J HEAD TRAUMA REHAB, V31, pE15, DOI 10.1097/HTR.0000000000000199; Narad M., 2019, J HEAD TRAUMA REHABI; Narad ME, 2018, JAMA PEDIATR, V172, P437, DOI 10.1001/jamapediatrics.2017.5746; Narad ME, 2017, J HEAD TRAUMA REHAB, V32, P98, DOI 10.1097/HTR.0000000000000247; Nielson JL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169490; Nwachuku EL, 2016, CLIN NEUROL NEUROSUR, V149, P1, DOI 10.1016/j.clineuro.2016.06.009; Osler T, 1997, J TRAUMA, V43, P922, DOI 10.1097/00005373-199712000-00009; Potter JL, 2011, REHABIL PSYCHOL, V56, P351, DOI 10.1037/a0025445; Prasad MR, 2002, PEDIATR NEUROSURG, V36, P64, DOI 10.1159/000048355; Ryan NP, 2019, J NEUROTRAUM, V36, P2895, DOI 10.1089/neu.2018.6308; Ryan NP, 2015, J HEAD TRAUMA REHAB, V30, P75, DOI 10.1097/HTR.0000000000000123; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Schmidt OI, 2005, BRAIN RES REV, V48, P388, DOI 10.1016/j.brainresrev.2004.12.028; Schork AJ, 2019, GENES BRAIN BEHAV, V18, DOI 10.1111/gbb.12480; Schorr E, 2020, DISABIL REHABIL, V42, P2437, DOI 10.1080/09638288.2019.1602676; Simon DW, 2017, NAT REV NEUROL, V13, P171, DOI 10.1038/nrneurol.2017.13; Smith-Paine J, 2018, J NEUROTRAUM, V35, P2796, DOI 10.1089/neu.2017.5388; Strater Norbert, 2006, Purinergic Signal, V2, P343, DOI 10.1007/s11302-006-9000-8; Tapp ZM, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00345; Taylor HG, 2008, J INT NEUROPSYCH SOC, V14, P734, DOI 10.1017/S1355617708081150; TEASDALE G, 1974, LANCET, V2, P81; Treble-Barna A, 2017, NEUROPSYCHOLOGY, V31, P486, DOI 10.1037/neu0000325; Treble-Barna A, 2017, J NEUROTRAUM, V34, P1919, DOI 10.1089/neu.2016.4840; Treble-Barna A, 2017, J NEUROTRAUM, V34, P353, DOI 10.1089/neu.2016.4476; Treble-Barna A, 2016, DEV PSYCHOL, V52, P1777, DOI 10.1037/dev0000208; Treble-Barna A, 2016, J INT NEUROPSYCH SOC, V22, P859, DOI 10.1017/S1355617716000631; Tsai SJ, 2017, CYTOKINE GROWTH F R, V37, P89, DOI 10.1016/j.cytogfr.2017.06.001; Uzan M, 2005, ACTA NEUROCHIR, V147, P715, DOI 10.1007/s00701-005-0529-z; Vaiserman AM, 2015, DEV DYNAM, V244, P254, DOI 10.1002/dvdy.24211; Wade SL, 2016, JAMA PEDIATR, V170, P343, DOI 10.1001/jamapediatrics.2015.4485; Wade SL, 2011, DEV PSYCHOL, V47, P119, DOI 10.1037/a0021028; Wagner A.K., 2019, NEUROPHARMACOLOGY; Wagner AK, 2010, EPILEPSY RES, V90, P259, DOI 10.1016/j.eplepsyres.2010.06.001; Waters RJ, 2013, J NEUROTRAUM, V30, P1710, DOI 10.1089/neu.2012.2792; Weder N, 2014, J AM ACAD CHILD PSY, V53, P417, DOI 10.1016/j.jaac.2013.12.025; Wilkinson AA, 2017, BMC PEDIATR, V17, DOI 10.1186/s12887-017-0925-6; Wimberley T, 2017, SCHIZOPHRENIA BULL, V43, P1064, DOI 10.1093/schbul/sbx007; Wray NR, 2014, J CHILD PSYCHOL PSYC, V55, P1068, DOI 10.1111/jcpp.12295; Yeates KO, 2010, NEUROPSYCHOLOGY, V24, P345, DOI 10.1037/a0018387; Zeiler FA, 2018, J NEUROTRAUM, V35, P2002	107	7	7	1	3	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUL 1	2020	37	13					1491	1503		10.1089/neu.2019.6866		MAR 2020	13	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	ME4JC	WOS:000525036600001	32024452	Green Published			2022-02-06	
J	Deshpande, SK; Hasegawa, RB; Weiss, J; Small, DS				Deshpande, Sameer K.; Hasegawa, Raiden B.; Weiss, Jordan; Small, Dylan S.			The association between adolescent football participation and early adulthood depression	PLOS ONE			English	Article							HIGH-SCHOOL FOOTBALL; LIFE COGNITIVE IMPAIRMENT; MENTAL-HEALTH; WHITE-MATTER; RECURRENT CONCUSSION; PERSONALITY-TRAITS; PHYSICAL-ACTIVITY; SPORT PARTICIPATION; BIAS REDUCTION; SINGLE SEASON	Concerned about potentially increased risk of neurodegenerative disease, several health professionals and policy makers have proposed limiting or banning youth participation in American-style tackle football. Given the large affected population (over 1 million boys play high school football annually), careful estimation of the long-term health effects of playing football is necessary for developing effective public health policy. Unfortunately, existing attempts to estimate these effects tend not to generalize to current participants because they either studied a much older cohort or, more seriously, failed to account for potential confounding. We leverage data from a nationally representative cohort of American men who were in grades 7-12 in the 1994-95 school year to estimate the effect of playing football in adolescent on depression in early adulthood. We control for several potential confounders related to subjects' health, behavior, educational experience, family background, and family health history through matching and regression adjustment. We found no evidence of even a small harmful effect of football participation on scores on a version of the Center for Epidemiological Studies Depression scale (CES-D) nor did we find evidence of adverse associations with several secondary outcomes including anxiety disorder diagnosis or alcohol dependence in early adulthood. For men who were in grades 7-12 in the 1994-95 school year, participating or intending to participate in school football does not appear to be a major risk factor for early adulthood depression.	[Deshpande, Sameer K.] MIT, Comp Sci & Artificial Intelligence Lab, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Hasegawa, Raiden B.; Small, Dylan S.] Univ Penn, Dept Stat, Philadelphia, PA USA; [Weiss, Jordan] Univ Penn, Ctr Populat Studies, Philadelphia, PA 19104 USA; [Hasegawa, Raiden B.] Google Inc, New York, NY USA		Deshpande, SK (corresponding author), MIT, Comp Sci & Artificial Intelligence Lab, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	sameerd@alum.mit.edu		Deshpande, Sameer/0000-0003-4116-5533; Weiss, Jordan/0000-0002-0392-3535	NICHD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [T32 HD007242, P01 HD031921] Funding Source: Medline		Alosco ML, 2017, TRANSL PSYCHIAT, V7, DOI 10.1038/tp.2017.197; Bachynski KE, 2016, NEW ENGL J MED, V374, P405, DOI 10.1056/NEJMp1513993; Bahrami N, 2016, RADIOLOGY, V281, P919, DOI 10.1148/radiol.2016160564; Bartko WT, 2003, J YOUTH ADOLESCENCE, V32, P233, DOI 10.1023/A:1023056425648; Bazarian JJ, 2012, MAGN RESON IMAGING, V30, P171, DOI 10.1016/j.mri.2011.10.001; Beauchamp MR, 2018, JAMA PSYCHIAT, V75, P543, DOI 10.1001/jamapsychiatry.2018.0385; Bohr AD, 2019, ORTHOP J SPORTS MED, V7, DOI 10.1177/2325967119868658; Broglio SP, 2011, J NEUROTRAUM, V28, P2069, DOI 10.1089/neu.2011.1825; Caccese JB, 2019, SPORTS MED, V49, P477, DOI 10.1007/s40279-019-01069-x; Chen HN, 2010, COMMUN STAT-SIMUL C, V39, P860, DOI 10.1080/03610911003650383; Chipman HA, 2010, ANN APPL STAT, V4, P266, DOI 10.1214/09-AOAS285; Chrisman SPD, 2019, PEDIATRICS, V143, DOI 10.1542/peds.2018-2402; COCHRAN WG, 1973, SANKHYA SER A, V35, P417; Cohen J., 2013, STAT POWER ANAL BEHA; Deshpande SK, 2017, JAMA NEUROL, V74, P909, DOI 10.1001/jamaneurol.2017.1317; Dimech AS, 2011, PSYCHOL SPORT EXERC, V12, P347, DOI 10.1016/j.psychsport.2011.03.007; Donnellan MB, 2006, PSYCHOL ASSESSMENT, V18, P192, DOI 10.1037/1040-3590.18.2.192; Eime RM, 2013, INT J BEHAV NUTR PHY, V10, DOI 10.1186/1479-5868-10-98; Fraser-Thomas J. L., 2005, Physical Education and Sport Pedagogy, V10, P19, DOI 10.1080/1740898042000334890; Gorry D, 2016, EDUC ECON, V24, P622, DOI 10.1080/09645292.2016.1143452; Gu Xing S., 1993, J COMPUTATIONAL GRAP, V2, P405, DOI DOI 10.1080/10618600.1993.10474623; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Harris KM, 2012, ADD HLTH STUDY DESIG; Harrison PA, 2003, J SCHOOL HEALTH, V73, P113, DOI 10.1111/j.1746-1561.2003.tb03585.x; Hart J, 2013, JAMA NEUROL, V70, P326, DOI 10.1001/2013.jamaneurol.340; Hazra E., 2016, SCH BASED PARTICIPAT; Hills AP, 2011, BRIT J SPORT MED, V45, P866, DOI 10.1136/bjsports-2011-090199; Janssen PHH, 2017, MAYO CLIN PROC, V92, P66, DOI 10.1016/j.mayocp.2016.09.004; Jewett R, 2014, J ADOLESCENT HEALTH, V55, P640, DOI 10.1016/j.jadohealth.2014.04.018; John O. P., 2001, HDB PERSONALITY THEO, P102; Kenning C., 2018, REUTERS; Klein DN, 2011, ANNU REV CLIN PSYCHO, V7, P269, DOI 10.1146/annurev-clinpsy-032210-104540; Kokko K, 2013, J RES PERS, V47, P748, DOI 10.1016/j.jrp.2013.07.002; Kotov R, 2010, PSYCHOL BULL, V136, P768, DOI 10.1037/a0020327; Kuzminski SJ, 2018, AM J NEURORADIOL, V39, P245, DOI 10.3174/ajnr.A5489; Lamers SMA, 2012, J RES PERS, V46, P517, DOI 10.1016/j.jrp.2012.05.012; Lehman EJ, 2012, NEUROLOGY, V79, P1970, DOI 10.1212/WNL.0b013e31826daf50; Leopold SS, 2016, CLIN ORTHOP RELAT R, V474, P2541, DOI [10.1007/s11999-016-5005-y, DOI 10.1007/S11999-016-5005-Y]; Margolis LH, 2017, PEDIATRICS, V139, DOI 10.1542/peds.2016-2604; Mez J, 2020, ANN NEUROL, V87, P116, DOI 10.1002/ana.25611; Mez J, 2017, JAMA-J AM MED ASSOC, V318, P360, DOI 10.1001/jama.2017.8334; Miles SH, 2016, AM J BIOETHICS, V16, P6, DOI 10.1080/15265161.2016.1128751; Ming KW, 2000, BIOMETRICS, V56, P118, DOI 10.1111/j.0006-341X.2000.00118.x; Montenigro PH, 2016, J NEUROTRAUM, V13; Nguyen VT, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2019.4223; Perreira KM, 2005, SOC FORCES, V83, P1567, DOI 10.1353/sof.2005.0077; Pimentel SD, 2015, STAT MED, V34, P4070, DOI 10.1002/sim.6593; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Ransom MR, 2018, ECON EDUC REV, V64, P75, DOI 10.1016/j.econedurev.2018.04.002; Resnick MD, 1997, JAMA-J AM MED ASSOC, V278, P823, DOI 10.1001/jama.278.10.823; Robbins CA, 2014, OPEN ACCESS J SPORTS, V5, P99, DOI 10.2147/OAJSM.S58005; Rosenbaum PR, 2002, STAT SCI, V17, P286; Rosenbaum PR., 1987, STAT SCI, V2, P313, DOI [10.1214/ss/1177013237, DOI 10.1214/SS/1177013237]; Rubin DB, 2008, ANN APPL STAT, V2, P808, DOI 10.1214/08-AOAS187; Saraulli D, 2017, CURR NEUROPHARMACOL, V15, P519, DOI 10.2174/1570159X14666160412150223; Savica R, 2012, MAYO CLIN PROC, V87, P335, DOI 10.1016/j.mayocp.2011.12.016; Sawilowsky SS, 2009, J MOD APPL STAT METH, V8, P597, DOI 10.22237/jmasm/1257035100; Seichepine DR, 2013, J NEUROTRAUM, V30, P1299, DOI 10.1089/neu.2012.2690; Silber JH, 2001, MED CARE, V39, P1048, DOI 10.1097/00005650-200110000-00003; Stamm JM, 2015, J NEUROTRAUM, V32, P1768, DOI 10.1089/neu.2014.3822; Stamm JM, 2015, NEUROLOGY, V84, P1114, DOI 10.1212/WNL.0000000000001358; Thomas AS, 2009, DIABETES CARE, V32, P9, DOI 10.2337/dc08-0780; Valois RF, 2004, J SCHOOL HEALTH, V74, P59, DOI 10.1111/j.1746-1561.2004.tb04201.x; Venkataramani AS, 2018, JAMA-J AM MED ASSOC, V319, P800, DOI 10.1001/jama.2018.0140; Wiebe DJ, 2018, JAMA-J AM MED ASSOC, V320, P2035, DOI 10.1001/jama.2018.14165; Yoon FB, 2011, STAT BIOSCI, V3, P63, DOI 10.1007/s12561-011-9035-4	68	7	7	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2020	15	3							e0229978	10.1371/journal.pone.0229978			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LQ8WI	WOS:000535278500047	32155206	gold, Green Published			2022-02-06	
J	Taylor, PN; da Silva, NM; Blamire, A; Wang, YJ; Forsyth, R				Taylor, Peter Neal; da Silva, Nadia Moreira; Blamire, Andrew; Wang, Yujiang; Forsyth, Rob			Early deviation from normal structural connectivity A novel intrinsic severity score for mild TBI	NEUROLOGY			English	Article							TRAUMATIC BRAIN-INJURY; CLASSIFICATION; ASSOCIATION; RAT	Objective Studies of outcome after traumatic brain injury (TBI) are hampered by the lack of robust injury severity measures that can accommodate spatial-anatomical and mechanistic heterogeneity. In this study we introduce a Mahalanobis distance measure (M) as an intrinsic injury severity measure that combines in a single score the many ways a given injured brain's connectivity can vary from that of healthy controls. Our objective is to test the hypotheses that M is superior to univariate measures in (1) discriminating patients and controls and (2) correlating with cognitive assessment. Methods Sixty-five participants (34 with mild TBI, 31 controls) underwent diffusion tensor MRI and extensive neuropsychological testing. Structural connectivity was inferred for all participants for 22 major white matter connections. Twenty-two univariate measures (1 per connection) and 1 multivariate measure (M), capturing and summarizing all connectivity change in a single score, were computed. Results Our multivariate measure (M) was able to better discriminate between patients and controls (area under the curve 0.81) than any individual univariate measure. M significantly correlated with cognitive outcome (Spearman rho = 0.31; p < 0.05). No univariate measure showed significant correlation after correction for multiple comparisons. Conclusions Heterogeneity in the severity and distribution of injuries after TBI has traditionally complicated the understanding of outcomes after TBI. Our approach provides a single, continuous variable that can fully capture individual heterogeneity. M's ability to distinguish even mildly injured patients from controls and its correlation with cognitive assessment suggest utility as an imaging-based marker of intrinsic injury severity.	[Taylor, Peter Neal; da Silva, Nadia Moreira; Wang, Yujiang] Newcastle Univ, Interdisciplinary Complex Syst Grp, Sch Comp, Newcastle Upon Tyne, Tyne & Wear, England; [Taylor, Peter Neal; Wang, Yujiang; Forsyth, Rob] Newcastle Univ, Inst Neurosci, Fac Med Sci, Newcastle Upon Tyne, Tyne & Wear, England; [Blamire, Andrew] Newcastle Univ, Inst Cellular Med, Newcastle Upon Tyne, Tyne & Wear, England; [Blamire, Andrew] Newcastle Univ, Newcastle MR Ctr, Newcastle Upon Tyne, Tyne & Wear, England; [Taylor, Peter Neal; Wang, Yujiang] UCL, Inst Neurol, London, England		Taylor, PN (corresponding author), Newcastle Univ, Interdisciplinary Complex Syst Grp, Sch Comp, Newcastle Upon Tyne, Tyne & Wear, England.; Taylor, PN (corresponding author), Newcastle Univ, Inst Neurosci, Fac Med Sci, Newcastle Upon Tyne, Tyne & Wear, England.; Taylor, PN (corresponding author), UCL, Inst Neurol, London, England.	peter.taylor@newcastle.ac.uk	Blamire, Andrew/AAU-6100-2021; Taylor, Peter/E-8927-2011	Blamire, Andrew/0000-0002-8749-1257; Taylor, Peter/0000-0003-2144-9838	Sir Jules Thorn Biomedical Research Award [SJT/05]; Wellcome TrustWellcome TrustEuropean Commission [105617/Z/14/Z]	Patient recruitment and acquisition of all MRI scans and experimental data was funded by a Sir Jules Thorn Biomedical Research Award (A.B.), SJT/05. P.N.T. was funded by Wellcome Trust (105617/Z/14/Z).	Bai F, 2009, J NEUROL SCI, V278, P102, DOI 10.1016/j.jns.2008.12.009; Benson RR, 2012, NEUROREHABILITATION, V31, P261, DOI 10.3233/NRE-2012-0795; Budde MD, 2011, BRAIN, V134, P2248, DOI 10.1093/brain/awr161; Croall ID, 2014, NEUROLOGY, V83, P494, DOI 10.1212/WNL.0000000000000666; Diaz-Arrastia R, 2014, J NEUROTRAUM, V31, P135, DOI 10.1089/neu.2013.3019; DSI Studio, TRACK SPEC AN NETW M; Foreman BP, 2007, J TRAUMA, V62, P946, DOI 10.1097/01.ta.0000229796.14717.3a; Hubert M, 2009, COMPUT STAT DATA AN, V53, P2264, DOI 10.1016/j.csda.2008.05.027; Ledoit O, 2018, 264 U ZUR DEP EC, DOI [10.2139/ssrn.3047302, DOI 10.2139/SSRN.3047302]; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; Maas AIR, 2012, J NEUROTRAUM, V29, P32, DOI 10.1089/neu.2010.1599; Mac Donald CL, 2007, EXP NEUROL, V205, P116, DOI 10.1016/j.expneurol.2007.01.035; Mahalanobis PC., 1936, P NATL I SCI INDIA, V2, P49; McHugh GS, 2007, J NEUROTRAUM, V24, P287, DOI 10.1089/neu.2006.0031; Newcombe VFJ, 2016, NEUROREHAB NEURAL RE, V30, P49, DOI 10.1177/1545968315584004; Rigon J, 2017, RESTOR NEUROL NEUROS, V35, P115, DOI 10.3233/RNN-150538; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Toth A, 2018, BEHAV BRAIN RES, V340, P106, DOI 10.1016/j.bbr.2017.02.039; Xu S, 2011, J NEUROTRAUM, V28, P2091, DOI 10.1089/neu.2010.1739; Yeh FC, 2018, NEUROIMAGE, V178, P57, DOI 10.1016/j.neuroimage.2018.05.027; Zahr NM, 2009, NEUROIMAGE, V44, P1050, DOI 10.1016/j.neuroimage.2008.09.046	21	7	7	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0028-3878	1526-632X		NEUROLOGY	Neurology	MAR 10	2020	94	10					E1021	E1026		10.1212/WNL.0000000000009053			6	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	LB2YJ	WOS:000524504000003	31937623				2022-02-06	
J	Gerhartl, A; Pracser, N; Vladetic, A; Hendrikx, S; Friedl, HP; Neuhaus, W				Gerhartl, Anna; Pracser, Nadja; Vladetic, Alexandra; Hendrikx, Sabrina; Friedl, Heinz-Peter; Neuhaus, Winfried			The pivotal role of micro-environmental cells in a human blood-brain barrier in vitro model of cerebral ischemia: functional and transcriptomic analysis	FLUIDS AND BARRIERS OF THE CNS			English	Article						Brain endothelial cells; Claudin; Cerebral ischemia; Stroke; Traumatic brain injury	MICROVASCULAR ENDOTHELIAL-CELLS; TIGHT JUNCTION PROTEINS; TRANSPORTER EXPRESSION; PROTEOMIC ANALYSIS; VALIDATION; PERMEABILITY; HCMEC/D3; HYPOXIA; ALPHA	Background The blood-brain barrier (BBB) is altered in several diseases of the central nervous system. For example, the breakdown of the BBB during cerebral ischemia in stroke or traumatic brain injury is a hallmark of the diseases' progression. This functional damage is one key event which is attempted to be mimicked in in vitro models. Recent studies showed the pivotal role of micro-environmental cells such as astrocytes for this barrier damage in mouse stroke in vitro models. The aim of this study was to evaluate the role of micro-environmental cells for the functional, paracellular breakdown in a human BBB cerebral ischemia in vitro model accompanied by a transcriptional analysis. Methods Transwell models with human brain endothelial cell line hCMEC/D3 in mono-culture or co-culture with human primary astrocytes and pericytes or rat glioma cell line C6 were subjected to oxygen/glucose deprivation (OGD). Changes of transendothelial electrical resistance (TEER) and FITC-dextran 4000 permeability were recorded as measures for paracellular tightness. In addition, qPCR and high-throughput qPCR Barrier chips were applied to investigate the changes of the mRNA expression of 38 relevant, expressed barrier targets (tight junctions, ABC-transporters) by different treatments. Results In contrast to the mono-culture, the co-cultivation with human primary astrocytes/pericytes or glioma C6 cells resulted in a significantly increased paracellular permeability after 5 h OGD. This indicated the pivotal role of micro-environmental cells for BBB breakdown in the human model. Hierarchical cluster analysis of qPCR data revealed differently, but also commonly regulated clustered targets dependent on medium exchange, serum reduction, hydrocortisone addition and co-cultivations. Conclusions The co-cultivation with micro-environmental cells is necessary to achieve a functional breakdown of the BBB in the cerebral ischemia model within an in vivo relevant time window. Comprehensive studies by qPCR revealed that distinct expression clusters of barrier markers exist and that these are regulated by different treatments (even by growth medium change) indicating that controls for single cell culture manipulation steps are crucial to understand the observed effects properly.	[Gerhartl, Anna; Pracser, Nadja; Vladetic, Alexandra; Hendrikx, Sabrina; Friedl, Heinz-Peter; Neuhaus, Winfried] AIT Austrian Inst Technol GmbH, Competence Unit Mol Diagnost, Ctr Hlth & Bioresources, Giefinggasse 4, A-1210 Vienna, Austria		Neuhaus, W (corresponding author), AIT Austrian Inst Technol GmbH, Competence Unit Mol Diagnost, Ctr Hlth & Bioresources, Giefinggasse 4, A-1210 Vienna, Austria.	winfried.neuhaus@ait.ac.at		Neuhaus, Winfried/0000-0002-6552-7183	SET foundation (Stiftung zur Forderung der Erforschung von Ersatz-und Erganzungsmethoden zur Einschrankung von Tierversuchen) project [060]	This study was supported by the SET foundation (Stiftung zur Forderung der Erforschung von Ersatz-und Erganzungsmethoden zur Einschrankung von Tierversuchen) project 060 to Winfried Neuhaus and Marco Metzger.	Appelt-Menzel A, 2017, STEM CELL REP, V8, P894, DOI 10.1016/j.stemcr.2017.02.021; Berg J, 2005, EUR J NEUROL, V12, P85, DOI 10.1111/j.1468-1331.2005.01200.x; Berndt P, 2019, CELL MOL LIFE SCI, V76, P1987, DOI 10.1007/s00018-019-03030-7; Brown RC, 2003, J CELL SCI, V116, P693, DOI 10.1242/jcs.00264; Brzica H, 2017, J CENT NERV SYST DIS, V9, DOI 10.1177/1179573517693802; Bucciol G, 2017, CURR OPIN ALLERGY CL, V17, P421, DOI 10.1097/ACI.0000000000000398; Cording J, 2015, ANTIOXID REDOX SIGN, V23, P1035, DOI 10.1089/ars.2014.6162; Daneman R, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a020412; Delsing L, 2018, STEM CELLS, V36, P1816, DOI 10.1002/stem.2908; Dias MC, 2019, FLUIDS BARRIERS CNS, V16, DOI 10.1186/s12987-019-0150-9; Dias MC, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-36731-3; Eigenmann DE, 2013, FLUIDS BARRIERS CNS, V10, DOI 10.1186/2045-8118-10-33; Fang ZD, 2011, BRIEF BIOINFORM, V12, P280, DOI 10.1093/bib/bbr004; Forster C, 2008, J PHYSIOL-LONDON, V586, P1937, DOI 10.1113/jphysiol.2007.146852; Gulati A, 2018, PEDIATR NEPHROL, V33, P745, DOI 10.1007/s00467-017-3698-0; He LQ, 2018, SCI DATA, V5, DOI 10.1038/sdata.2018.160; Jiang XY, 2018, PROG NEUROBIOL, V163, P144, DOI 10.1016/j.pneurobio.2017.10.001; JOO F, 1993, NEUROCHEM INT, V23, P499, DOI 10.1016/0197-0186(93)90098-P; Kleinschnitz C, 2011, STROKE, V42, P1081, DOI 10.1161/STROKEAHA.110.592238; Knowland D, 2014, NEURON, V82, P603, DOI 10.1016/j.neuron.2014.03.003; Kokubu Y, 2017, BIOCHEM BIOPH RES CO, V486, P577, DOI 10.1016/j.bbrc.2017.03.092; Kubota H, 2006, EPILEPSY RES, V68, P213, DOI 10.1016/j.eplepsyres.2005.11.011; Kurosawa T, 2018, MOL PHARMACEUT, V15, P5546, DOI 10.1021/acs.molpharmaceut.8b00697; Lim RG, 2017, CELL REP, V19, P1365, DOI 10.1016/j.celrep.2017.04.021; Liu SM, 2004, J CEREBR BLOOD F MET, V24, P343, DOI 10.1097/01.WCB.0000110047.43905.01; Lu T.M., 2019, 699173 BIORXIV, DOI [10.1101/699173, DOI 10.1101/699173]; Ma SC, 2017, CNS NEUROSCI THER, V23, P947, DOI 10.1111/cns.12764; Morris ME, 2017, AAPS J, V19, P1317, DOI 10.1208/s12248-017-0110-8; Mysiorek C, 2009, CURR NEUROVASC RES, V6, P181, DOI 10.2174/156720209788970081; Neuhaus W, 2009, TRANSPORTERS DRUG CA, P263; Neuhaus W, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00149; Neuhaus W, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00352; Neuhaus W, 2012, NEUROSCI LETT, V506, P44, DOI 10.1016/j.neulet.2011.10.045; Neuhaus W, 2008, J PHARM SCI-US, V97, P5158, DOI 10.1002/jps.21371; Ohtsuki S, 2013, MOL PHARMACEUT, V10, P289, DOI 10.1021/mp3004308; Page S, 2019, NEUROMOL MED, V21, P414, DOI 10.1007/s12017-019-08531-z; Page S, 2016, FLUIDS BARRIERS CNS, V13, DOI 10.1186/s12987-016-0042-1; Ramme AP, 2019, FUTUR SCI OA, V5, DOI 10.2144/fsoa-2019-0065; Sajja RK, 2015, NEUROSCI LETT, V598, P59, DOI 10.1016/j.neulet.2015.05.015; Shawahna R, 2011, MOL PHARMACEUT, V8, P1332, DOI 10.1021/mp200129p; Shi YJ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10523; Sladojevic N, 2019, J NEUROSCI, V39, P743, DOI 10.1523/JNEUROSCI.1432-18.2018; Thal SC, 2013, CRIT CARE MED, V41, P1305, DOI 10.1097/CCM.0b013e31827ca494; Tornabene E, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0221103; Towsend N, 2017, EUROPEAN CARDIOVASCU; Uchida Y, 2011, J NEUROCHEM, V117, P333, DOI 10.1111/j.1471-4159.2011.07208.x; Vanlandewijck M, 2018, NATURE, V554, P475, DOI 10.1038/nature25739; Vatine GD, 2017, CELL STEM CELL, V20, P831, DOI 10.1016/j.stem.2017.04.002; Veszelka S, 2018, FRONT MOL NEUROSCI, V11, DOI 10.3389/fnmol.2018.00166; Weksler B, 2013, FLUIDS BARRIERS CNS, V10, DOI 10.1186/2045-8118-10-16; Weksler BB, 2005, FASEB J, V19, P1872, DOI 10.1096/fj.04-3458fje; Yeh WL, 2008, MOL PHARMACOL, V73, P170, DOI 10.1124/mol.107.038851; Zaum S, 2017, THESIS, P1; Zhang Y, 2014, J NEUROSCI, V34, P11929, DOI [10.11772/j.issn.1001-9081.2014.07.1929, 10.1523/JNEUROSCI.1860-14.2014]	54	7	7	0	5	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-8118			FLUIDS BARRIERS CNS	Fluids Barriers CNS	MAR 5	2020	17	1							19	10.1186/s12987-020-00179-3			17	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	KT5CU	WOS:000519032300001	32138745	gold, Green Published			2022-02-06	
J	Beaudouin, F; der Fuenten, KA; Tross, T; Reinsberger, C; Meyer, T				Beaudouin, Florian; aus der Fuenten, Karen; Troess, Tobias; Reinsberger, Claus; Meyer, Tim			Match Situations Leading to Head Injuries in Professional Male Football (Soccer)-A Video-Based Analysis Over 12 Years	CLINICAL JOURNAL OF SPORT MEDICINE			English	Article						soccer; head impact; head trauma; injury situations; risk reduction	ELITE FOOTBALL; NECK INJURIES; RISK; INCIDENTS; CONCUSSION; MECHANISMS; EPIDEMIOLOGY; PERFORMANCE; PARAMETERS; STATEMENT	Objective: To identify risk situations promoting head injuries in professional male football (soccer) and to investigate the impact of a rule change in 2006 punishing elbow-head contacts. Design: Analysis of video sequences of head events leading to head injury. Participants: Professional football players of the first male German Bundesliga. Main Outcome Measures: Observational criteria of head impacts on video recordings (players' actions preceding head injuries, foul play-referee's decision and assessment of rater, ball possession, on-pitch medical treatment, and consequences of head impact). Results: Three hundred thirty-four head injuries were reported in kicker Sportmagazin corresponding to an incidence rate of 2.25 (95% confidence interval 2.01-2.51) per 1000 player match hours. The injured player predominantly jumped (60%), headed the ball (36%), or ran forwards (20%); the noninjured players mainly jumped (64%), headed the ball (27%), or raised the elbow to the head (23%). Free ball situations (2 players challenge for the ball) caused most of the head injuries (81%). The players' action "raising the elbow" during a head injury seemed to be lower after the rule change. Conclusions: Jumping for the ball with the intention of heading is the predominant action associated with head injury risk. Head injuries occur most often when players challenge for the ball in a header duel. As head injuries bear the potential risk of long-term health sequelae, the identification of situational circumstances is essential to develop preventative means in the future.	[Beaudouin, Florian; aus der Fuenten, Karen; Troess, Tobias; Meyer, Tim] Saarland Univ, Inst Sports & Prevent Med, FIFA Med Ctr Excellence, Saarbrucken, Germany; [Reinsberger, Claus] Univ Paderborn, Inst Sports Med, Paderborn, Germany		Beaudouin, F (corresponding author), Saarland Univ, Inst Sports & Prevent Med, Bldg B 8-2, D-66123 Saarbrucken, Germany.	florian.beaudouin@uni-saarland.de			German Federal Institute of Sports Science (BiSp)	Supported by the German Federal Institute of Sports Science (BiSp).	Andersen TE, 2004, BRIT J SPORT MED, V38, P690, DOI 10.1136/bjsm.2003.009357; Andersen TE, 2004, BRIT J SPORT MED, V38, P626, DOI 10.1136/bjsm.2003.007955; Arnason A, 2004, AM J SPORT MED, V32, P1459, DOI 10.1177/0363546504262973; Beaudouin F, 2019, BRIT J SPORT MED, V53, P948, DOI 10.1136/bjsports-2016-097217; Bjorneboe J, 2013, BRIT J SPORT MED, V47, P508, DOI 10.1136/bjsports-2012-091522; Bush M, 2015, HUM MOVEMENT SCI, V39, P1, DOI 10.1016/j.humov.2014.10.003; Caccese JB, 2016, SPORTS MED, V46, P1591, DOI 10.1007/s40279-016-0544-7; Delaney JS, 2014, CLIN J SPORT MED, V24, P233, DOI 10.1097/JSM.0000000000000017; Donaldson L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069122; Fuller CW, 2004, AM J SPORT MED, V32, p43S, DOI 10.1177/0363546503261248; Fuller CW, 2006, BRIT J SPORT MED, V40, P193, DOI 10.1136/bjsm.2005.025270; Fuller CW, 2005, BRIT J SPORT MED, V39, pI3, DOI 10.1136/bjsm.2005.018937; Hagglund M, 2006, BRIT J SPORT MED, V40, P767, DOI 10.1136/bjsm.2006.026609; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Hawkins RD, 1998, BRIT J SPORT MED, V32, P326, DOI 10.1136/bjsm.32.4.326; Hawkins RD, 1996, BRIT J SPORT MED, V30, P165, DOI 10.1136/bjsm.30.2.165; Hrysomallis C, 2016, SPORTS MED, V46, P1111, DOI 10.1007/s40279-016-0490-4; Khurana VG, 2012, J CLIN NEUROSCI, V19, P1, DOI 10.1016/j.jocn.2011.08.002; Leventer L, 2016, INT J SPORTS MED, V37, P898, DOI 10.1055/s-0042-108201; Manley G, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097791; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Nilsson M, 2013, CLIN J SPORT MED, V23, P255, DOI 10.1097/JSM.0b013e31827ee6f8; Noble JM, 2013, NEUROPSYCHOL REV, V23, P273, DOI 10.1007/s11065-013-9239-0; Rahnama N, 2002, BRIT J SPORT MED, V36, P354, DOI 10.1136/bjsm.36.5.354; Stern RA, 2011, PM&R, V3, pS460, DOI 10.1016/j.pmrj.2011.08.008; Tscholl P, 2007, BRIT J SPORT MED, V41, pI8, DOI 10.1136/bjsm.2007.036871; Tscholl P, 2007, BRIT J SPORT MED, V41, pI15, DOI 10.1136/bjsm.2007.036889; Zuckerman SL, 2015, AM J SPORT MED, V43, P2654, DOI 10.1177/0363546515599634	28	7	7	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1050-642X	1536-3724		CLIN J SPORT MED	Clin. J. Sport Med.	MAR	2020	30			1			S47	S52		10.1097/JSM.0000000000000572			6	Orthopedics; Physiology; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Physiology; Sport Sciences	NQ6DX	WOS:000570961700006	32132477				2022-02-06	
J	Caplan, HW; Cardenas, F; Gudenkauf, F; Zelnick, P; Xue, HS; Cox, CS; Bedi, SS				Caplan, Henry W.; Cardenas, Fanni; Gudenkauf, Franciska; Zelnick, Pamela; Xue, Hasen; Cox, Charles S.; Bedi, Supinder S.			Spatiotemporal Distribution of Microglia After Traumatic Brain Injury in Male Mice	ASN NEURO			English	Article						cell death; inflammation; microglia; neuro degeneration; neuro glia; neuro immunity; neuro repair; TBI; therapies	ACTIVATED MICROGLIAL/MACROPHAGE RESPONSE; UNITED-STATES; THERAPY; GENDER; SEX; SURVEILLANCE; RECRUITMENT; EXPRESSION; RECEPTOR; IMPACTS	Traumatic brain injury (TBI) disrupts the complex arrangement of glia and neuronal cells in the central nervous system. Microglia, the resident immune cells, survey the cellular milieu under homeostatic conditions and play a neuroprotective role via clearance of dead cells and debris such as axons and myelin. Resting (ramified) microglia possess a distinct morphology-small rod-shaped somata with thin processes. After TBI, microglia are activated and transition into an amoeboid morphology. To delineate the spatiotemporal morphological response of microglia after TBI, we used a controlled cortical impact injury model to quantify and characterize microglia at 24 hr and 28 days after TBI in the hippocampus (H) and lateral posterior nucleus of the thalamus (LPNT). Increased numbers of microglia were observed in the H and LPNT at 28 days after controlled cortical impact, but not at 24 hr in comparison to controls. Spatially, controlled cortical impact resulted in an increase of amoeboid microglia bilaterally at 24 hr and 28 days in H and ipsilaterally in LPNT. Temporally, at 28 days, TBI resulted in a significant increase in the number of amoeboid microglia in both H and LPNT. In addition, at 28 days after injury, we observed an increase in translocator protein, a marker for activated microglia, in the ipsilateral thalamus only. TBI results in a spatiotemporal increase in amoeboid microglia in the hippocampus and the LPNT over 28 days. Delineating their spatiotemporal phenotype is critical because it can help identify therapeutic targets with appropriate therapy.	[Caplan, Henry W.; Cardenas, Fanni; Gudenkauf, Franciska; Zelnick, Pamela; Xue, Hasen; Cox, Charles S.; Bedi, Supinder S.] Univ Texas Hlth Sci Ctr Houston, Dept Pediat Surg, McGovern Med Sch, Houston, TX 77030 USA		Bedi, SS (corresponding author), Univ Texas Hlth Sci Ctr Houston, 6431 Fannin Dr,MSB 5-230, Houston, TX 77030 USA.	supinder.bedi@uth.tmc.edu		Caplan, Henry/0000-0003-0012-1606; Cardenas, Fanni/0000-0002-2026-5351	National Institute of Neurological Disorders and Stroke, National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [5T35NS064931-04, GM0879201-11A1]; Athersys; CBR Systems; Hope Bio; Biostage	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This work was supported in part by grant 5T35NS064931-04 from the National Institute of Neurological Disorders and Stroke, National Institutes of Health (NIH) 2T32 grant GM0879201-11A1. C. S. C. has received research support from Athersys, CBR Systems, Hope Bio, Biostage, and is on the Scientific Advisory Board of Cellvation, Biostage, CBR, and Hope Bio.	Acaz-Fonseca E, 2015, GLIA, V63, P1966, DOI 10.1002/glia.22867; Aertker BM, 2019, J NEUROSCI RES, V97, P698, DOI 10.1002/jnr.24395; Aloisi F, 2001, GLIA, V36, P165, DOI 10.1002/glia.1106; Bedi SS, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1122-8; Bedi SS, 2013, STEM CELL TRANSL MED, V2, P953, DOI 10.5966/sctm.2013-0100; Bedi SS, 2013, J TRAUMA ACUTE CARE, V75, P410, DOI 10.1097/TA.0b013e31829617c6; Belarbi K, 2012, BRAIN BEHAV IMMUN, V26, P18, DOI 10.1016/j.bbi.2011.07.225; Berry C, 2009, J TRAUMA, V67, P950, DOI 10.1097/TA.0b013e3181ba3354; Cao T, 2012, NEUROSCIENCE, V225, P65, DOI 10.1016/j.neuroscience.2012.08.058; Caplan HW, 2017, J NEUROSCI RES, V95, P509, DOI 10.1002/jnr.23854; Chen S, 2003, EXP NEUROL, V182, P87, DOI 10.1016/S0014-4886(03)00002-5; Coimbra R, 2003, J TRAUMA, V54, P689, DOI 10.1097/01.TA.0000058314.31655.5F; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; Cox CS, 2019, TRANSFUSION, V59, P858, DOI 10.1111/trf.14834; Csuka E, 2000, NEUROREPORT, V11, P2587, DOI 10.1097/00001756-200008030-00047; Davalos D, 2005, NAT NEUROSCI, V8, P752, DOI 10.1038/nn1472; Eggen BJL, 2013, J NEUROIMMUNE PHARM, V8, P807, DOI 10.1007/s11481-013-9490-4; Graeber MB, 2010, SCIENCE, V330, P783, DOI 10.1126/science.1190929; Gunther M, 2015, ACTA NEUROCHIR, V157, P649, DOI 10.1007/s00701-014-2331-2; Haynes SE, 2006, NAT NEUROSCI, V9, P1512, DOI 10.1038/nn1805; Hernandez-Ontiveros DG, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00030; Hoffman AN, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-50312-y; Kalla R, 2001, J COMP NEUROL, V436, P182; Karlstetter M, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-3; Ley EJ, 2013, J TRAUMA ACUTE CARE, V75, P682, DOI 10.1097/TA.0b013e31829d024f; Liu N, 2009, CELL MOL IMMUNOL, V6, P207, DOI 10.1038/cmi.2009.28; Loram LC, 2012, PSYCHONEUROENDOCRINO, V37, P1688, DOI 10.1016/j.psyneuen.2012.02.018; Ma YS, 2016, BIOMED REP, V4, P246, DOI 10.3892/br.2015.560; Maeda J, 2007, BRAIN RES, V1157, P100, DOI 10.1016/j.brainres.2007.04.054; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; Nakajima K, 2001, J BIOCHEM-TOKYO, V130, P169, DOI 10.1093/oxfordjournals.jbchem.a002969; Nimmerjahn A, 2005, SCIENCE, V308, P1314, DOI 10.1126/science.1110647; Pannell M, 2020, GLIA, V68, P280, DOI 10.1002/glia.23716; Papadopoulos V, 1998, P SOC EXP BIOL MED, V217, P130; Phelan HA, 2007, J TRAUMA, V63, P1127, DOI 10.1097/TA.0b013e318154c1b8; RAGHAVENDRA RV, 2000, NEUROCHEM INT, V36, P531, DOI DOI 10.1016/S0197-0186(99)00153-9; Ramlackhansingh AF, 2011, ANN NEUROL, V70, P374, DOI 10.1002/ana.22455; Salter MW, 2014, CELL, V158, P15, DOI 10.1016/j.cell.2014.06.008; Sandhir R, 2008, EXP NEUROL, V213, P372, DOI 10.1016/j.expneurol.2008.06.013; Smith HS, 2010, PAIN PHYSICIAN, V13, P295; Thomas TC, 2018, BEHAV BRAIN RES, V340, P137, DOI 10.1016/j.bbr.2016.12.038; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Torres-Platas SG, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-12; Walker PA, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-228; Zhang B, 2008, BRAIN RES, V1226, P181, DOI 10.1016/j.brainres.2008.05.085; Zhang J, 2006, J NEUROCHEM, V97, P772, DOI 10.1111/j.1471-4159.2006.03746.x	46	7	8	0	3	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1759-0914			ASN NEURO	ASN Neuro	MAR	2020	12								1759091420911770	10.1177/1759091420911770			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	LB4HW	WOS:000524597600001	32146827	Green Published, gold			2022-02-06	
J	DiGiorgio, AM; Wittenberg, BA; Crutcher, CL; Kennamer, B; Greene, CS; Velander, AJ; Wilson, JD; Tender, GC; Culicchia, F; Hunt, JP				DiGiorgio, Anthony M.; Wittenberg, Blake A.; Crutcher, Clifford L., II; Kennamer, Brooke; Greene, Clarence S.; Velander, Alan J.; Wilson, Jason D.; Tender, Gabriel C.; Culicchia, Frank; Hunt, John P.			The Impact of Drug and Alcohol Intoxication on Glasgow Coma Scale Assessment in Patients with Traumatic Brain Injury	WORLD NEUROSURGERY			English	Article						Glasgow coma scale; Intoxication; Traumatic brain injury	SUBSTANCE USE; SCORE; ASSOCIATION; PREDICTORS; DEATHS; MILD	BACKGROUND: The effect of intoxicating substances on assessment of Glasgow Coma Scale (GCS) in the trauma setting has not been completely elucidated. METHODS: A trauma registry was queried for patients with blunt head trauma in 2013-2017. Initial GCS score and toxicology screening from the database were reviewed. Next recorded GCS score from the neurosurgery evaluation and change in GCS score (Delta GCS) were compared. RESULTS: We reviewed 468 patients. In 217 (46.4%) patients, no toxic substances were found, whereas >1 toxic substance was found in 104 (22.2%) patients. Alcohol level above the legal limit was found in 109 (23.3%) patients, marijuana was found in 105 (22.4%) patients, benzodiazepines were found in 94 (20.1%) patients, opiates were found in 48 (10.3%) patients, and cocaine was found in 41 (8.8%) patients. Mean change in GCS score was significantly higher in impaired patients compared with patients with a negative screening test (1.74 +/- 2.4 vs. 0.75 +/- 2.7, P < 0.001); this is despite both groups having a similar initial GCS score (6.23 +/- 3.86 in impaired group vs. 6.47 +/- 3.52 in sober group, P = 0.677). Initial GCS score was 3 in 187 patients, of whom 150 had a positive toxicology screen. Change in GCS score was significantly higher in the impaired group (2.75 +/- 2.7 vs. 1.19 +/- 1.8, P < 0.001). CONCLUSIONS: Intoxicating substances can confound GCS assessment in trauma patients. This can have effects on patient care as well as performance metrics and predictive analytics. These patients should be screened, and intoxicating substances should be reversed or allowed to wear off before GCS score is recorded for benchmarking or quality reporting.	[DiGiorgio, Anthony M.; Crutcher, Clifford L., II; Greene, Clarence S.; Velander, Alan J.; Wilson, Jason D.; Tender, Gabriel C.; Culicchia, Frank] Louisiana State Univ, Dept Neurosurg, Hlth Sci Ctr, New Orleans, LA 70112 USA; [Hunt, John P.] Louisiana State Univ, Dept Gen Surg, Hlth Sci Ctr, New Orleans, LA USA; [Wittenberg, Blake A.] Univ Colorado, Dept Neurosurg, Denver, CO USA; [Kennamer, Brooke] Univ Arizona, Div Neurosurg, Dept Surg, Coll Med,Maricopa Med Ctr, Phoenix, AZ USA; [Hunt, John P.] Univ Med Ctr New Orleans, Norman E McSwain Jr MD, Spirit Char Trauma Ctr, New Orleans, LA USA; [DiGiorgio, Anthony M.] San Francisco Gen Hosp, Brain & Spinal Injury Ctr, San Francisco, CA 94110 USA		DiGiorgio, AM (corresponding author), Louisiana State Univ, Dept Neurosurg, Hlth Sci Ctr, New Orleans, LA 70112 USA.; DiGiorgio, AM (corresponding author), San Francisco Gen Hosp, Brain & Spinal Injury Ctr, San Francisco, CA 94110 USA.	amdigiorgio@gmail.com		Tender, Gabriel/0000-0002-6367-004X			Baum J, 2016, WORLD NEUROSURG, V90, P525, DOI 10.1016/j.wneu.2015.12.012; Demetriades D, 2004, J AM COLL SURGEONS, V199, P687, DOI 10.1016/j.jamcollsurg.2004.07.017; Demetriades D, 2004, ARCH SURG-CHICAGO, V139, P1066, DOI 10.1001/archsurg.139.10.1066; Guly H, 2004, TRAUMA, V6, P205; Hadjizacharia P, 2011, EUR J TRAUMA EMERG S, V37, P169, DOI 10.1007/s00068-010-0038-5; Hemmila MR, 2010, J TRAUMA, V68, P253, DOI 10.1097/TA.0b013e3181cfc8e6; Lingsma HF, 2015, J NEUROTRAUM, V32, P83, DOI 10.1089/neu.2014.3384; London JA, 2007, ARCH SURG-CHICAGO, V142, P633, DOI 10.1001/archsurg.142.7.633; National Institute on Alcohol Abuse and Alcoholism, 2019, ALC US DIS; National Institute on Drug Abuse, 2015, DRUGFACTS NAT TRENDS; Newgard CD, 2013, J AM COLL SURGEONS, V216, P147, DOI 10.1016/j.jamcollsurg.2012.08.017; Parker CM, 2019, NEW ENGL J MED, V380, P1, DOI 10.1056/NEJMp1813836; Reith FCM, 2017, INJURY, V48, P1932, DOI 10.1016/j.injury.2017.05.038; RIVARA FP, 1993, ARCH SURG-CHICAGO, V128, P907; RIVARA FP, 1989, J TRAUMA, V29, P462, DOI 10.1097/00005373-198904000-00008; Rotondo MF, 2014, RESOURCES OPTIMAL CA, P109; Rudd RA, 2016, MMWR-MORBID MORTAL W, V64, P1378, DOI 10.15585/mmwr.mm6450a3; Rundhaug NP, 2015, J NEUROSURG, V122, P211, DOI 10.3171/2014.9.JNS14322; Soderstrom CA, 1997, JAMA-J AM MED ASSOC, V277, P1769, DOI 10.1001/jama.277.22.1769; Sperry JL, 2006, J TRAUMA, V61, P1305, DOI 10.1097/01.ta.0000240113.13552.96; TEASDALE G, 1974, LANCET, V2, P81; Teasdale G, 2014, LANCET NEUROL, V13, P844, DOI 10.1016/S1474-4422(14)70120-6; Valadka AB, 2001, NEUROSURGERY, V48, P17, DOI 10.1097/00006123-200101000-00004; Whaley CC, 2019, WORLD NEUROSURG, V130, P454, DOI 10.1016/j.wneu.2019.06.124; Yue JK, 2017, J CLIN NEUROSCI, V45, P293, DOI 10.1016/j.jocn.2017.07.022	25	7	7	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	MAR	2020	135									10.1016/j.wneu.2019.12.095			7	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	KR7GS	WOS:000517784600079	31881342				2022-02-06	
J	Dindo, L; Johnson, AL; Lang, B; Rodrigues, M; Martin, L; Jorge, R				Dindo, Lilian; Johnson, Adrienne L.; Lang, Brent; Rodrigues, Merlyn; Martin, Lindsey; Jorge, Ricardo			Development and evaluation of an 1-day Acceptance and Commitment Therapy workshop for Veterans with comorbid chronic pain, TBI, and psychological distress: Outcomes from a pilot study	CONTEMPORARY CLINICAL TRIALS			English	Article						Traumatic brain injury; Acceptance and commitment therapy; Veterans; Brief psychotherapies; Qualitative research; Quantitative evaluation	TRAUMATIC BRAIN-INJURY; POSTTRAUMATIC-STRESS-DISORDER; MENTAL-HEALTH-CARE; AFGHANISTAN VETERANS; IRAQ; METAANALYSIS; QUESTIONNAIRE; ASSOCIATION; PREVALENCE; VALIDITY	Objectives: To 1) develop and refine a 1-day trans-diagnostic psychotherapeutic "ACT on Life" workshop tailored for Veterans with mild traumatic brain injury, stress-based psychopathology, and pain; 2) examine the feasibility, acceptability, and preliminary effects of this intervention. Setting: A Veterans Health Administration medical center. Participants: Veterans returning from Operations Iraqi Freedom, Enduring Freedom, and New Dawn with mild TBI, stress-based psychopathology, and chronic pain. Design: Phase I involved development of the intervention by experts and subsequent refinement based on Veteran feedback (N = 11). Phase II was a pilot randomized controlled trial comparing the effects of the revised intervention (N = 20) to treatment as usual (TAU; N = 12). Main measures: For phase I, qualitative feedback at 2 weeks and 3 months post-workshop was obtained from Veterans. For phase II, quantitative measures included the PTSD Checklist, Depression Anxiety and Stress Scale, Military-to-Civilian Questionnaire, WHO-Disability Assessment Schedule, Brief Pain Inventory, Acceptance and Action Questionnaire. Results: Veterans found the workshop acceptable, innovative and useful. Quantitative data from phase II suggested that participants in the ACT group, relative to TAU, showed improvement in psychiatric symptoms, functioning, and reintegration 3 months post-workshop. Unexpectedly, pain interference was lower in the TAU group at follow-up. Conclusions: Preliminary results support the feasibility, acceptability, and promising effects on psychological distress and community reintegration of this 1-day, transdiagnostic workshop for Veterans. Future research examining the effectiveness of this workshop with a larger sample size is necessary.	[Dindo, Lilian; Martin, Lindsey; Jorge, Ricardo] Michael E DeBakey VA Med Ctr, Houston VA HSR&D Ctr Innovat Qual Effectiveness &, Houston, TX 77030 USA; [Dindo, Lilian; Lang, Brent; Rodrigues, Merlyn; Jorge, Ricardo] Baylor Coll Med, Menninger Dept Psychiat & Behav Sci, Houston, TX 77030 USA; [Johnson, Adrienne L.] William S Middleton Mem Vet Adm Med Ctr, Madison, WI USA; [Johnson, Adrienne L.] Univ Wisconsin, Ctr Tobacco Res & Intervent, Madison, WI USA; [Martin, Lindsey] Baylor Coll Med, Dept Med, Houston, TX 77030 USA		Dindo, L (corresponding author), Michael E DeBakey VA Med Ctr, Houston VA HSR&D Ctr Innovat Qual Effectiveness &, Houston, TX 77030 USA.	lilian.dindo@bcm.edu		Johnson, Adrienne/0000-0002-6422-8173	Veterans Affairs Rehabilitation Research and Development ServiceUS Department of Veterans Affairs [1 I21 RX002209-01A1]; Houston VA HSR&D Center for Innovations in Quality, Effectiveness and Safety [CIN13-413]	This work was made possible by grant number 1 I21 RX002209-01A1 from the Veterans Affairs Rehabilitation Research and Development Service awarded to Lilian N. Dindo and was partially supported by the use and resources of the Houston VA HSR&D Center for Innovations in Quality, Effectiveness and Safety (CIN13-413). The funding agency did not play a role in study design; in the collection, analysis and interpretation of data; in the writing of the report; or in the decision to submit the article for publication.The opinions expressed reflect those of the authors and not necessarily those of the Department of Veterans Affairs, the US government or Baylor College of Medicine.	A-Tjak JGL, 2015, PSYCHOTHER PSYCHOSOM, V84, P30, DOI 10.1159/000365764; Averill JB, 2002, QUAL HEALTH RES, V12, P855, DOI 10.1177/104973230201200611; BLAKE DD, 1995, J TRAUMA STRESS, V8, P75, DOI 10.1007/BF02105408; Blakey SM, 2018, J PAIN, V19, P797, DOI 10.1016/j.jpain.2018.02.012; Bond FW, 2011, BEHAV THER, V42, P676, DOI 10.1016/j.beth.2011.03.007; Cifu DX, 2013, J REHABIL RES DEV, V50, P1169, DOI 10.1682/JRRD.2013.01.0006; Dahm J, 2013, J AFFECT DISORDERS, V151, P392, DOI 10.1016/j.jad.2013.06.011; Department of Defense Department of Veterans Affairs, 2010, VA DOD CLIN PRACT GU; Department of Veterans Affairs, 2012, AN VA HLTH CAR UT OP; Dimidjian S, 2016, BEHAV THER, V47, P886, DOI 10.1016/j.beth.2016.07.002; Dindo L., 2019, ON DAY ACT WORKSH PA; Dindo L, 2017, NEUROTHERAPEUTICS, V14, P546, DOI 10.1007/s13311-017-0521-3; First M., 1995, STRUCTURED CLIN INTE, V9, P92; Fortier CB, 2014, J HEAD TRAUMA REHAB, V29, P89, DOI 10.1097/HTR.0b013e3182865859; Garcia HA, 2014, MIL MED, V179, P273, DOI 10.7205/MILMED-D-13-00076; Hayes A, 2012, FAMILY MATTERS, P2; Hayes S.C., 1999, COMMITMENT THERAPY E; Hayes SC, 2013, BEHAV THER, V44, P180, DOI 10.1016/j.beth.2009.08.002; Hoge CW, 2014, PSYCHIAT SERV, V65, P997, DOI 10.1176/appi.ps.201300307; Hughes LS, 2017, CLIN J PAIN, V33, P552, DOI 10.1097/AJP.0000000000000425; Kangas M, 2011, NEUROPSYCHOL REHABIL, V21, P250, DOI 10.1080/09602011.2010.540920; Keller S, 2004, CLIN J PAIN, V20, P309, DOI 10.1097/00002508-200409000-00005; Lew HL, 2009, J REHABIL RES DEV, V46, P697, DOI 10.1682/JRRD.2009.01.0006; Lippa SM, 2015, J TRAUMA STRESS, V28, P25, DOI 10.1002/jts.21979; Mott JM, 2015, J RURAL HEALTH, V31, P235, DOI 10.1111/jrh.12099; O'Donnell M, 2013, MIL MED, V178, P1328, DOI 10.7205/MILMED-D-13-00058; Rehm J., 2000, INT J METHODS PSYCHI, V8, P110; Rosen GM, 2003, BEHAV MODIF, V27, P300, DOI 10.1177/0145445503027003003; Ruiz FJ., 2010, INT J PSYCHOL PSYCHO, V10, P125, DOI DOI 10.1080/028457199439937; Sayer NA, 2011, J TRAUMA STRESS, V24, P660, DOI 10.1002/jts.20706; Sayer NA, 2010, PSYCHIAT SERV, V61, P589, DOI 10.1176/ps.2010.61.6.589; Seal KH, 2007, ARCH INTERN MED, V167, P476, DOI 10.1001/archinte.167.5.476; Seal KH, 2017, ARCH PHYS MED REHAB, V98, P1636, DOI 10.1016/j.apmr.2017.03.026; Seal KH, 2010, J TRAUMA STRESS, V23, P5, DOI 10.1002/jts.20493; Taylor B, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-019993; Taylor BC, 2012, MED CARE, V50, P342, DOI 10.1097/MLR.0b013e318245a558; Weathers F.W., 2013, SHOUTH THERE BE MORE; Wexler D. B., 2009, MEN THERAPY NEW APPR; WIERZBICKI M, 1993, PROF PSYCHOL-RES PR, V24, P190, DOI 10.1037/0735-7028.24.2.190	39	7	7	2	10	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1551-7144	1559-2030		CONTEMP CLIN TRIALS	Contemp. Clin. Trials	MAR	2020	90								105954	10.1016/j.cct.2020.105954			7	Medicine, Research & Experimental; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Research & Experimental Medicine; Pharmacology & Pharmacy	LG2DF	WOS:000527917400014	32032736				2022-02-06	
J	Ruan, W; Hu, JW; Zhou, H; Li, Y; Xu, CR; Luo, YJ; Chen, T; Xu, BL; Yan, F; Chen, G				Ruan, Wu; Hu, Junwen; Zhou, Hang; Li, Yin; Xu, Chaoran; Luo, Yujie; Chen, Ting; Xu, Bangliang; Yan, Feng; Chen, Gao			Intranasal wnt-3a alleviates neuronal apoptosis in early brain injury post subarachnoid hemorrhage via the regulation of wnt target PPAN mediated by the moonlighting role of aldolase C	NEUROCHEMISTRY INTERNATIONAL			English	Article						Neuronal apoptosis; Early brain injury; Subarachnoid hemorrhage; Wnt-3a; Aldolase C; PPAN	MITOCHONDRIAL PATHWAY; NEGATIVE REGULATOR; BETA; ACTIVATION; AXIN; PROTECTS; COMPLEX; DEATH; CELLS; GENE	Neuronal apoptosis is one of the main pathophysiological events in the early brain injury (EBI) post subarachnoid hemorrhage (SAH). Wnt-3a, one of the endogenous wnt ligands crucial in neurogenesis, has been proven to be efficacious in neuroprotection in traumatic brain injury and ischemic stroke. The glycolytic enzyme aldolase C and ribosome biogenesis protein PPAN were revealed to be linked to wnt signaling pathway. The aim of the study was to explore the antiapoptotic effects of intranasal wnt-3a through Frizzled-1 (Frz-1)/aldolase C/PPAN pathway in SAH. Approaches for assessment included SAH grade, Garcia test, brain water content evaluation, rotarod test, Morris water maze test, Western blot, immunofluorescence and transmission electron microscopy. The results showed that wnt-3a improved the neurological scores, brain water content and long-term neurobehavioral functions after SAH. Wnt-3a increased the level of Frz-1, aldolase C, B-catenin, PPAN and the Bcl-2/Bax ratio; and decreased the level of axin and cleaved caspase-3 (CC-3). The anti-apoptotic effect of wnt-3a was further evidenced by TUNEL staining and subcellular structure imaging. Frz-1 siRNA and aldolase C siRNA offset the effects of wnt-3a; and restoration of aldolase C by aldolase C CRISPR in Frz-1 siRNA preconditioned SAH rats salvaged the level of Frz-1, aldolase C, PPAN and reduced axin and CC-3. In summary, intranasal administration of wnt-3a alleviates neuronal apoptosis through Frz-1/aldolase C/PPAN pathway in the EBI of SAH rats. The feasible intranasal route and the long-lasting neuroprotective property of wnt-3a is of great clinical relevance.	[Ruan, Wu; Hu, Junwen; Zhou, Hang; Li, Yin; Xu, Chaoran; Luo, Yujie; Chen, Ting; Yan, Feng; Chen, Gao] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Neurosurg, Hangzhou, Peoples R China; [Xu, Bangliang] Zhejiang Univ, Sch Med, Sir Run Run Shaw Hosp, Dept Neurosurg, Hangzhou, Peoples R China		Yan, F; Chen, G (corresponding author), Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Neurosurg, Hangzhou, Peoples R China.	fengyanzju@zju.edu.cn; d-chengao@zju.edu.cn		yan, feng/0000-0001-8663-6859	National Key Research and Development Program of China [2018YFC1312600, 2018YFC1312603]; National Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81571106, 81771246, 81870908]; Key Research and Development Project of Zhejiang Province [2018C03011]; Science and Technology Project in Medicine and Health of Zhejiang Province [2018KY404]	This work was supported by the National Key Research and Development Program of China (2018YFC1312600, 2018YFC1312603), the National Science Foundation of China (No.81571106, 81771246, 81870908), the Key Research and Development Project of Zhejiang Province (No.2018C03011) and the Science and Technology Project in Medicine and Health of Zhejiang Province (No. 2018KY404).	AHN AH, 1994, DEVELOPMENT, V120, P2081; Bugner V, 2011, DEVELOPMENT, V138, P2369, DOI 10.1242/dev.060160; Caspi M, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-164; Chacon MA, 2008, J CELL PHYSIOL, V217, P215, DOI 10.1002/jcp.21497; Chen JL, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00382; Chen JY, 2014, J PINEAL RES, V56, P12, DOI 10.1111/jpi.12086; Copley SD, 2003, CURR OPIN CHEM BIOL, V7, P265, DOI 10.1016/S1367-5931(03)00032-2; Fatica A, 2002, CURR OPIN CELL BIOL, V14, P313, DOI 10.1016/S0955-0674(02)00336-8; Fujii M, 2013, TRANSL STROKE RES, V4, P432, DOI 10.1007/s12975-013-0257-2; Gao LS, 2018, BIOFACTORS, V44, P369, DOI 10.1002/biof.1433; GARCIA JH, 1995, STROKE, V26, P627, DOI 10.1161/01.STR.26.4.627; Gong Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012682; Gules I, 2003, ACT NEUR S, V86, P483; Habas Raymond, 2005, J Biol, V4, P2, DOI 10.1186/jbiol22; HAMM RJ, 1994, J NEUROTRAUM, V11, P187, DOI 10.1089/neu.1994.11.187; Huang J, 2002, NEUROSURGERY, V51, P1101, DOI 10.1097/00006123-200211000-00001; Huang SMA, 2009, NATURE, V461, P614, DOI 10.1038/nature08356; Inoue T, 2006, STEM CELLS, V24, P95, DOI 10.1634/stemcells.2005-0124; Jing CH, 2012, NEUROSCIENCE, V213, P144, DOI 10.1016/j.neuroscience.2012.03.055; Keil M, 2019, BBA-MOL CELL RES, V1866, P882, DOI 10.1016/j.bbamcr.2019.01.010; Kimelman D, 2006, ONCOGENE, V25, P7482, DOI 10.1038/sj.onc.1210055; Langellotti S, 2014, MABS-AUSTIN, V6, P707, DOI 10.4161/mabs.28191; LEBHERZ HG, 1969, BIOCHEMISTRY-US, V8, P109, DOI 10.1021/bi00829a016; Lee E, 2003, PLOS BIOL, V1, P116, DOI 10.1371/journal.pbio.0000010; Leung JY, 2002, J BIOL CHEM, V277, P21657, DOI 10.1074/jbc.M200139200; Li T, 2019, FASEB J, V33, P1727, DOI 10.1096/fj.201800227RR; Linke S, 2006, NEUROCHEM RES, V31, P1297, DOI 10.1007/s11064-006-9169-9; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Macdonald RL, 2017, LANCET, V389, P655, DOI 10.1016/S0140-6736(16)30668-7; Matei N, 2018, J NEUROSCI, V38, P6787, DOI 10.1523/JNEUROSCI.2352-17.2018; Oertel MF, 2007, J CLIN NEUROSCI, V14, P948, DOI 10.1016/j.jocn.2006.11.002; Park S, 2004, STROKE, V35, P2412, DOI 10.1161/01.STR.0000141162.29864.e9; Pfister AS, 2015, J BIOL CHEM, V290, P10905, DOI 10.1074/jbc.M114.634246; Piccin D, 2011, STEM CELLS, V29, P528, DOI 10.1002/stem.589; Rao TP, 2010, CIRC RES, V106, P1798, DOI 10.1161/CIRCRESAHA.110.219840; ROCCHI M, 1989, HUM GENET, V82, P279, DOI 10.1007/BF00291170; Rothe M, 2013, CURR GENE THER, V13, P453; Rubinfeld B, 1996, SCIENCE, V272, P1023, DOI 10.1126/science.272.5264.1023; Salic A, 2000, MOL CELL, V5, P523, DOI 10.1016/S1097-2765(00)80446-3; Schurr A, 1998, DEV NEUROSCI-BASEL, V20, P348, DOI 10.1159/000017330; Skalka N, 2013, ONCOGENE, V32, P2836, DOI 10.1038/onc.2012.308; Slemmer JE, 2007, EUR J NEUROSCI, V26, P649, DOI 10.1111/j.1460-9568.2007.05708.x; Wei ZZ, 2018, J CEREBR BLOOD F MET, V38, P404, DOI 10.1177/0271678X17702669; Weng CJ, 2005, J BIOL CHEM, V280, P10491, DOI 10.1074/jbc.M412819200; Westphal D, 2014, CELL DEATH DIFFER, V21, P196, DOI 10.1038/cdd.2013.139; Wu GY, 2018, NEUROBIOL DIS, V110, P59, DOI 10.1016/j.nbd.2017.11.009; Xie ZY, 2017, NEUROPHARMACOLOGY, V119, P123, DOI 10.1016/j.neuropharm.2017.03.025; Yamamoto H, 1999, J BIOL CHEM, V274, P10681, DOI 10.1074/jbc.274.16.10681; Yan F, 2013, NEUROSCI LETT, V543, P163, DOI 10.1016/j.neulet.2013.03.005; Yoshinaga Y, 2010, CELL MOL NEUROBIOL, V30, P1049, DOI 10.1007/s10571-010-9536-6; Yu SP, 2013, TRANSL STROKE RES, V4, P76, DOI 10.1007/s12975-012-0251-0; Zhang LB, 2017, MOL IMMUNOL, V87, P249, DOI 10.1016/j.molimm.2017.05.002	52	7	7	0	4	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0197-0186	1872-9754		NEUROCHEM INT	Neurochem. Int.	MAR	2020	134								104656	10.1016/j.neuint.2019.104656			15	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	KT0MH	WOS:000518704200010	31899197				2022-02-06	
J	Salva, MAQ; Azabou, E; Hartley, S; Sauvagnac, R; Leotard, A; Vaugier, I; Diehl, PP; Vallat-Azouvi, C; Barbot, F; Azouvi, P				Salva, Maria-Antonia Quera; Azabou, Eric; Hartley, Sarah; Sauvagnac, Rebecca; Leotard, Antoine; Vaugier, Isabelle; Diehl, Pascale Pradat; Vallat-Azouvi, Claire; Barbot, Frederic; Azouvi, Philippe			Blue-Enriched White Light Therapy Reduces Fatigue in Survivors of Severe Traumatic Brain Injury: A Randomized Controlled Trial	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						bright light therapy; clinical trial; cognitive functions; event-related potential; fatigue; head injury; P300; traumatic brain injury	EXCESSIVE DAYTIME SLEEPINESS; HEAD-INJURY; EXPOSURE; SCALE; COMPLAINTS; MODAFINIL; ALERTNESS; DEFICITS; P300; ERP	Objective: Fatigue is one of the disabling sequelae of traumatic brain injury (TBI), with repercussions on quality of life, rehabilitation, and professional reintegration. Research is needed on effective interventions. We evaluated efficacy of blue-enriched white light (BWL) therapy on fatigue of patients with severe TBI. Setting: Physical Medicine and Rehabilitation and Physiology departments of University hospitals. Participants: Adult patients with fatigue symptoms following severe TBI, Fatigue Severity Scale (FSS) score 4 or more, Epworth Sleepiness Scale (ESS) score 10 or more, and/or Pittsburgh Sleep Quality Index (PSQI]) more than 5 were randomly assigned to one of 2 parallel groups: a BWL therapy group, with 30-minute exposure to waking white light enriched with blue for 4 weeks, and a group without light therapy (N-BWL), no light. Design: Randomized controlled trial. number: NCT02420275. Main Measures: The primary outcome measure was the response of the FSS to 4 weeks of treatment. In addition, we assessed latency change of the P300 component of event-related potentials before and after therapy. Results: Significant improvement in the FSS score (P = .026) was found in the BWL group compared with the N-BWL group. Conclusion: BWL phototherapy reduces fatigue in patients with severe TBI.	[Salva, Maria-Antonia Quera; Azabou, Eric; Hartley, Sarah; Sauvagnac, Rebecca; Leotard, Antoine] Univ Paris 08, Dept Physiol, Sleep Unit, St Denis, France; [Salva, Maria-Antonia Quera; Azabou, Eric; Hartley, Sarah; Sauvagnac, Rebecca; Leotard, Antoine] Univ Paris 08, Dept Physiol, Clin Neurophysiol Unit, St Denis, France; [Vaugier, Isabelle; Barbot, Frederic] Univ Paris 08, INSERM CIC1429, St Denis, France; [Vallat-Azouvi, Claire; Azouvi, Philippe] Univ Paris 08, Dept Phys Med & Rehabil, Lab Psychopathol & Neuropsychol, EA 2027, St Denis, France; [Vallat-Azouvi, Claire] Hop Raymond Poincare, AP HP, Antenne UEROS UGECAMIF, Garches, France; [Salva, Maria-Antonia Quera; Azabou, Eric; Hartley, Sarah; Sauvagnac, Rebecca; Leotard, Antoine; Azouvi, Philippe] UVSQ, EA HANDIReSP 4047, Garches, France; [Diehl, Pascale Pradat] Grp Hosp Pitie Salpetriere, AP HP, Dept Phys Med & Rehabil, Paris, France; [Diehl, Pascale Pradat] Univ Paris 06, Paris, France		Salva, MAQ (corresponding author), Hop Raymond Poincare, Sleep Unit, F-92380 Garches, France.	ma.quera@aphp.fr		Hartley, Sarah/0000-0003-3028-4430; LEOTARD, Antoine/0000-0001-9120-9050	Fondation des Gueules Cassees; AP-HP, Hopitaux Universitaires Paris Ile-de-France Ouest; Fondation Garches	The authors thank the "Fondation des Gueules Cassees" and the "AP-HP, Hopitaux Universitaires Paris Ile-de-France Ouest" for funding and supporting this study. The authors also thank Lucimed Belgium for providing the light therapy devices (Luminettes) free of charge and the Fondation Garches for support.	Ashman TA, 2008, J HEAD TRAUMA REHAB, V23, P33, DOI 10.1097/01.HTR.0000308719.70288.22; Azabou E, 2017, NEUROL SCI, V38, P715, DOI 10.1007/s10072-017-2824-x; Belmont A., 2006, Annales de Readaptation et de Medecine Physique, V49, P370, DOI 10.1016/j.annrmp.2006.04.018; Belmont A, 2009, NEUROREHAB NEURAL RE, V23, P939, DOI 10.1177/1545968309340327; Brazinova A, 2021, J NEUROTRAUM, V38, P1411, DOI 10.1089/neu.2015.4126; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Chaumet G, 2008, NEUROLOGY, V71, P1609, DOI 10.1212/01.wnl.0000334753.49193.48; Grima NA, 2018, BMC MED, V16, DOI 10.1186/s12916-017-0995-1; GUILLEMINAULT C, 1993, EUR J PEDIATR, V152, P754, DOI 10.1007/BF01953995; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; Hansenne M, 2004, BIOL PSYCHOL, V67, P331, DOI 10.1016/j.biopsycho.2004.01.004; Hartley SL, 2013, NEUROPHYSIOL CLIN, V43, P161, DOI 10.1016/j.neucli.2013.04.001; Jha A, 2008, J HEAD TRAUMA REHAB, V23, P52, DOI 10.1097/01.HTR.0000308721.77911.ea; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Jourdan C, 2016, ANN PHYS REHABIL MED, V59, P100, DOI 10.1016/j.rehab.2015.10.009; Jourdan C, 2018, AM J PHYS MED REHAB, V97, P323, DOI 10.1097/PHM.0000000000000848; Kaiser PR, 2010, NEUROLOGY, V75, P1780, DOI 10.1212/WNL.0b013e3181fd62a2; KEREN O, 1991, Brain Injury, V5, P233, DOI 10.3109/02699059109008094; KRUPP LB, 1989, ARCH NEUROL-CHICAGO, V46, P1121, DOI 10.1001/archneur.1989.00520460115022; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; Mayaud L, 2013, NEUROPHYSIOL CLIN, V43, P217, DOI 10.1016/j.neucli.2013.06.002; Nguyen S, 2018, DISABIL REHABIL, V40, P1906, DOI 10.1080/09638288.2017.1315461; Okamoto Y, 2015, PHYSIOL BEHAV, V138, P313, DOI 10.1016/j.physbeh.2014.10.013; Okamoto Yosuke, 2014, BMC Res Notes, V7, P113, DOI 10.1186/1756-0500-7-113; OLBRICH HM, 1986, SURG NEUROL, V26, P112, DOI 10.1016/0090-3019(86)90362-9; Oluellet MC, 2007, ARCH PHYS MED REHAB, V88, P1581, DOI 10.1016/j.apmr.2007.09.006; Peeters W, 2015, ACTA NEUROCHIR, V157, P1683, DOI 10.1007/s00701-015-2512-7; Polich J, 2007, CLIN NEUROPHYSIOL, V118, P2128, DOI 10.1016/j.clinph.2007.04.019; Ponsford JL, 2012, J HEAD TRAUMA REHAB, V27, P224, DOI 10.1097/HTR.0b013e31824ee1a8; Reinvang I, 2000, NEUROPSYCHOLOGIA, V38, P995, DOI 10.1016/S0028-3932(99)00153-0; Rollag MD, 2003, J BIOL RHYTHM, V18, P227, DOI 10.1177/0748730403253382; Sahin L, 2013, PHYSIOL BEHAV, V116, P1, DOI 10.1016/j.physbeh.2013.03.014; Sinclair KL, 2014, NEUROREHAB NEURAL RE, V28, P303, DOI 10.1177/1545968313508472; Soldatovic-Stajic B, 2014, EUR REV MED PHARMACO, V18, P1632; Ulrichsen KM, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.00912; van der Naalt J, 1999, J NEUROL NEUROSUR PS, V66, P207, DOI 10.1136/jnnp.66.2.207; Vandewalle G, 2006, CURR BIOL, V16, P1616, DOI 10.1016/j.cub.2006.06.031; VANZOMEREN AH, 1985, J NEUROL NEUROSUR PS, V48, P21, DOI 10.1136/jnnp.48.1.21; Vera-Villarroel P, 2014, REV MED CHILE, V142, P1275, DOI 10.4067/S0034-98872014001000007; Wahnschaffe A, 2013, INT J MOL SCI, V14, P2573, DOI 10.3390/ijms14022573; Zhang WT, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000006960; Ziino C, 2005, J INT NEUROPSYCH SOC, V11, P416, DOI 10.1017/S1355617705050472	42	7	7	0	5	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAR-APR	2020	35	2			SI		E78	E85		10.1097/HTR.0000000000000500			8	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	LC0HT	WOS:000525012500001	31246878				2022-02-06	
J	Shallie, OF; Dalle, E; Mabandla, MV				Shallie, Oluwadamilola F.; Dalle, Ernest; Mabandla, Musa V.			Memory decline correlates with increased plasma cytokines in amyloid-beta (1-42) rat model of Alzheimer's disease	NEUROBIOLOGY OF LEARNING AND MEMORY			English	Article						Alzheimer's disease; Amyloid beta; Glial cells; Inflammatory cytokines; Memory; Neuroinflammation	TRAUMATIC BRAIN-INJURY; NECROSIS-FACTOR-ALPHA; CEREBROSPINAL-FLUID; INFLAMMATION; IL-10; NEURODEGENERATION; INTERLEUKIN-6; IMPAIRMENT; MICROGLIA; STRESS	Dysregulation of inflammatory markers like cytokines is implicated in the pathophysiology of Alzheimer's disease (AD). Altered level of these cytokines show that pathogenesis of AD is beyond dysfunction of neurons resulting from amyloid beta accumulation but involves neuroinflammatory mechanisms elicited by the neuroimmune cell. In this study, we investigated the effect of amyloid-beta (1-42) (A beta((1-42))) on memory and how inflammatory markers respond to this model of AD. Male Sprague-Dawley rats were used for this study. The animals were randomly divided into four groups euthanized on day 3, 7, 10 and 14 post-lesion with amyloid-beta (5 mu g/5 mu l) while corresponding control groups were stereotaxically injected with a vehicle (5 mu l of 0.01 M phosphate- buffered saline). The Morris water maze (MWM) test to access learning and memory was conducted pre and post-lesion and blood was collected through cardiac puncture on day 3, 7, 10 and 14 post lesion. Multiplex immunoassay was performed to determine the plasma levels of IL-1 beta, IL-6, IL-10 and TNF-alpha. Our results showed impaired spatial memory and elevated plasma levels of pro-inflammatory cytokines (IL-1 beta, IL-6 and TNF-alpha) with a concomitantly lowered level of the anti-inflammatory cytokine (IL-10) in the A beta((1-42)) lesioned rats when compared to the vehicle groups. This study showed a negative correlation between the decline in performance of the spatial memory task and plasma levels of the pro-inflammatory cytokines IL-1 beta, IL-6 and TNF-alpha and positive correlation with the anti-inflammatory cytokine IL-10. In conclusion, this study most importantly demonstrated an association between progressive decline in spatial memory and increased plasma cytokine level induced by the infusion of A beta((1-42)).	[Shallie, Oluwadamilola F.; Dalle, Ernest; Mabandla, Musa V.] Univ KwaZulu Natal, Sch Lab Med & Med Sci, Discipline Human Physiol, Westville Campus, ZA-4000 Durban, South Africa		Shallie, OF (corresponding author), Univ KwaZulu Natal, Sch Lab Med & Med Sci, Discipline Human Physiol, Westville Campus, ZA-4000 Durban, South Africa.	217082125@stu.ukzn.ac.za			College of Health Sciences, University of KwaZulu-Natal	This study was supported by grant from the College of Health Sciences, University of KwaZulu-Natal.	Ahmad M. H., 2018, J CLIN NEUROSCIENCE; Alam Q, 2016, CURR PHARM DESIGN, V22, P541, DOI 10.2174/1381612822666151125000300; Bagheri M, 2011, NEUROBIOL LEARN MEM, V95, P270, DOI 10.1016/j.nlm.2010.12.001; Block ML, 2005, PROG NEUROBIOL, V76, P77, DOI 10.1016/j.pneurobio.2005.06.004; Bondi MW, 2008, NEUROPSYCHOL REV, V18, P73, DOI 10.1007/s11065-008-9054-1; Braida D, 2004, BEHAV BRAIN RES, V153, P423, DOI 10.1016/j.bbr.2003.12.018; Butler MP, 2004, NEUROSCIENCE, V124, P319, DOI 10.1016/j.neuroscience.2003.11.040; Cassim S, 2015, NEUROBIOL LEARN MEM, V125, P195, DOI 10.1016/j.nlm.2015.09.002; Christensen R, 2008, EXP NEUROL, V210, P164, DOI 10.1016/j.expneurol.2007.10.009; Csuka E, 1999, J NEUROIMMUNOL, V101, P211, DOI 10.1016/S0165-5728(99)00148-4; Dantzer R, 2008, NAT REV NEUROSCI, V9, P46, DOI 10.1038/nrn2297; Domingues C, 2017, CURR ALZHEIMER RES, V14, P870, DOI 10.2174/1567205014666170317113606; Donovan NJ, 2018, AM J PSYCHIAT, V175, P530, DOI 10.1176/appi.ajp.2017.17040442; Donzis EJ, 2014, NEUROBIOL LEARN MEM, V115, P68, DOI 10.1016/j.nlm.2014.08.008; Eckman CB, 2007, NEUROL CLIN, V25, P669, DOI 10.1016/j.ncl.2007.03.007; Faucher P, 2016, FRONT AGING NEUROSCI, V7, DOI 10.3389/fnagi.2015.00245; Ferreira ST, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00191; Garcia JM, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00244; Garthe A, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00063; GIBERTINI M, 1995, BRAIN BEHAV IMMUN, V9, P113, DOI 10.1006/brbi.1995.1012; Glass CK, 2010, CELL, V140, P918, DOI 10.1016/j.cell.2010.02.016; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Hayashi T, 2015, PSYCHIAT CLIN NEUROS, V69, P179, DOI 10.1111/pcn.12262; Helmy A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039677; Hensler T, 2000, INFLAMM RES, V49, P524, DOI 10.1007/s000110050626; Hensler T, 2002, J TRAUMA, V52, P962, DOI 10.1097/00005373-200205000-00023; Heyser CJ, 1997, P NATL ACAD SCI USA, V94, P1500, DOI 10.1073/pnas.94.4.1500; Hopperton K, 2018, MOL PSYCHIATR, V23, P177, DOI 10.1038/mp.2017.246; Hruska Z, 2007, HORM BEHAV, V52, P297, DOI 10.1016/j.yhbeh.2007.05.010; Kametani F, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00025; Kamm K, 2006, J TRAUMA, V60, P152, DOI 10.1097/01.ta.0000196345.81169.a1; Kawahara K, 2012, NEUROSCIENCE, V207, P243, DOI 10.1016/j.neuroscience.2012.01.049; Khemka VK, 2014, AGING DIS, V5, P170, DOI 10.14336/AD.2014.0500170; Kiyota T, 2012, GENE THER, V19, P724, DOI 10.1038/gt.2011.126; Kumar RG, 2015, J HEAD TRAUMA REHAB, V30, P369, DOI 10.1097/HTR.0000000000000067; LeMoine O, 1996, J IMMUNOL, V156, P4408; Lonappan A., 2017, J ELECTROMAGNETIC AN, V9, P155; Maier B, 2001, SHOCK, V15, P421, DOI 10.1097/00024382-200115060-00002; McKenzie Jordan A, 2017, Curr Aging Sci, V10, P158, DOI 10.2174/1874609810666170315113244; Miller MW, 2014, MOL PSYCHIATR, V19, P1156, DOI 10.1038/mp.2014.111; Mohajeri MH, 2015, NUTRITION, V31, P261, DOI 10.1016/j.nut.2014.06.016; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; MORRIS RG, 1988, J CLIN EXP NEUROPSYC, V10, P279, DOI 10.1080/01688638808408242; Norris GT, 2019, J EXP MED, V216, P60, DOI 10.1084/jem.20180199; Paxinos G, 2006, RAT BRAIN STEREOTAXI; Perry RJ, 2000, NEUROPSYCHOLOGIA, V38, P252, DOI 10.1016/S0028-3932(99)00079-2; PLATZER C, 1995, INT IMMUNOL, V7, P517, DOI 10.1093/intimm/7.4.517; Ransohoff RM, 2012, J CLIN INVEST, V122, P1164, DOI 10.1172/JCI58644; Santos LE, 2016, BRAIN BEHAV IMMUN, V55, P151, DOI 10.1016/j.bbi.2015.11.011; Sasmita AO, 2018, INT J NEUROSCI, V128, P1061, DOI 10.1080/00207454.2018.1466781; Shasta A., 2013, MEDIATORS INFLAMMATI, V2013; Simard AR, 2006, NEURON, V49, P489, DOI 10.1016/j.neuron.2006.01.022; Steensberg A, 2003, AM J PHYSIOL-ENDOC M, V285, pE433, DOI 10.1152/ajpendo.00074.2003; Stopford CL, 2012, CORTEX, V48, P429, DOI 10.1016/j.cortex.2010.12.002; Strle K., 2001, CRITICAL REV IMMUNOL, V21; Swardfager W, 2010, BIOL PSYCHIAT, V68, P930, DOI 10.1016/j.biopsych.2010.06.012; Swartz KR, 2001, BRAIN RES, V896, P86, DOI 10.1016/S0006-8993(01)02013-3; von Bernhardi R, 2010, J NEUROCHEM, V112, P1099, DOI 10.1111/j.1471-4159.2009.06537.x; Wang R, 2017, NEUROSCIENCE, V344, P39, DOI 10.1016/j.neuroscience.2016.08.051; Wang WY, 2015, ANN TRANSL MED, V3, DOI 10.3978/j.issn.2305-5839.2015.03.49; Watson C., 1986, RAT BRAIN STEREOTAXI; Webster SJ, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00088; Wilson CJ, 2002, J AM GERIATR SOC, V50, P2041, DOI 10.1046/j.1532-5415.2002.50619.x	63	7	7	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1074-7427	1095-9564		NEUROBIOL LEARN MEM	Neurobiol. Learn. Mem.	MAR	2020	169								107187	10.1016/j.nlm.2020.107187			9	Behavioral Sciences; Neurosciences; Psychology; Psychology, Multidisciplinary	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Behavioral Sciences; Neurosciences & Neurology; Psychology	KW1RL	WOS:000520948500014	32059978				2022-02-06	
J	Smyth, EA; Piromalli, L; Antcliff, A; Newman, P; Waddington, G; Weissensteiner, JR; Drew, MK				Smyth, Erin A.; Piromalli, Laura; Antcliff, Alanna; Newman, Phillip; Waddington, Gordon; Weissensteiner, Juanita R.; Drew, Michael K.			A prospective study of health problems at the 2018 17/U and 19/U Australian National Netball Championships with comparison of surveillance methodology	JOURNAL OF SCIENCE AND MEDICINE IN SPORT			English	Article						Sports medicine; Surveillance; Sprains and strains; Athletic injuries	OVERUSE INJURIES; MATCH CONGESTION; LOWER-LIMB; SPORTS; EPIDEMIOLOGY; STATEMENT; RATES; STANDARDS; PATTERNS; INCREASE	Objective: To investigate the incidence, site, nature and cause of injuries sustained during and four weeks following the 2018 Australian National Netball Championships (ANNC's) using medical attention and self-report surveillance tools. Design: Prospective cohort study. Method: Injuries were recorded prospectively using medical attention and self-report data collection methods. One hundred and ninety-two athletes competed at the 2018 ANNC's with 96 athletes in each age group (17/U & 19/U). Results: There were 103 medical attention injuries sustained by 80 athletes resulting in an incidence rate of 89.4 per 1000 player hours. The most frequently recorded medical attention injury diagnoses across both age groups were lateral ankle ligament sprain (n =14, 13.6%), foot blisters (n =11, 10.7%), and lumbar pain (n =10, 9.7%). Ankle sprains (n =4), anterior cruciate ligament (ACL) ruptures (n =3) and concussion (n =3) recorded as the highest sports incapacity injuries. The self-report data collection revealed that 46 (27.2%) athletes arrived at the tournament with an existing self-reported injury/illness and 57 (39.3%) athletes had a self-reported injury/illness at the conclusion of the ANNC (RR 1.44 95%CI 1.05-1.99, p= 0.030). Conclusion: There are no recent studies reporting injury rates specifically in pre-elite netball players. This study found an incidence rate of 89.4 per 1000 player hours. Ankle sprains are the highest medical attention and sports-incapacity injury in pre-elite netball athletes. Foot blisters and low back pain also feature in the highest medical attention injuries and ACL rupture and concussion were high sports incapacity injuries at the ANNC's. Finally, combining both the medical attention and self-report injury/illness data collection methods identified more injuries/illnesses than the use of one method alone. (C) 2019 Sports Medicine Australia. Published by Elsevier Ltd. All rights reserved.	[Smyth, Erin A.; Waddington, Gordon; Drew, Michael K.] Australian Inst Sport, Athlete Availabil Program, Bruce, ACT, Australia; [Smyth, Erin A.; Newman, Phillip; Waddington, Gordon] Univ Canberra, Res Inst Sport & Exercise, Canberra, ACT, Australia; [Piromalli, Laura; Antcliff, Alanna] Netball Australia, Law Courts, Vic, Australia; [Drew, Michael K.] ACRISP, Perth, WA, Australia; [Newman, Phillip] Univ Canberra, Fac Hlth, Canberra, ACT, Australia; [Weissensteiner, Juanita R.] New South Wales Off Sport, Sport Dev Grp, Sydney Olympic Pk, NSW, Australia		Smyth, EA (corresponding author), Australian Inst Sport, Athlete Availabil Program, Bruce, ACT, Australia.; Smyth, EA (corresponding author), Univ Canberra, Res Inst Sport & Exercise, Canberra, ACT, Australia.	erin.smyth@ausport.gov.au	; Newman, Phil/H-4056-2017	Drew, Michael/0000-0002-7686-3780; Newman, Phil/0000-0001-5999-4001; Waddington, Gordon/0000-0002-4306-9193	University of Canberra scholarship	This study received no funding. This work was supported by a joint AIS and University of Canberra scholarship awarded to the author ES for support during her PhD.	Bengtsson H, 2013, BRIT J SPORT MED, V47, P743, DOI 10.1136/bjsports-2013-092383; Bergeron MF, 2015, BRIT J SPORT MED, V49, P843, DOI 10.1136/bjsports-2015-094962; Bromley Sally, 2018, JMIR Hum Factors, V5, pe27, DOI 10.2196/humanfactors.9541; Carling C, 2016, BRIT J SPORT MED, V50, P764, DOI 10.1136/bjsports-2015-095501; Clarsen B, 2014, BRIT J SPORT MED, V48, P754, DOI 10.1136/bjsports-2012-092087; Clarsen B, 2013, BRIT J SPORT MED, V47, P495, DOI 10.1136/bjsports-2012-091524; Cormack SJ, 2014, INT J SPORT PHYSIOL, V9, P283, DOI [10.1123/ijspp.2012-0216, 10.1123/IJSPP.2012-0216]; DiFiori JP, 2014, CLIN J SPORT MED, V24, P3, DOI 10.1097/JSM.0000000000000060; Drew MK, 2016, SPORTS MED, V46, P861, DOI 10.1007/s40279-015-0459-8; Ekegren CL, 2015, J SCI MED SPORT, V18, P651, DOI 10.1016/j.jsams.2014.11.390; Finch C, 2002, AUST NZ J PUBL HEAL, V26, P462, DOI 10.1111/j.1467-842X.2002.tb00348.x; Finch C, 2006, J SCI MED SPORT, V9, P3, DOI 10.1016/j.jsams.2006.02.009; Finch CF, 2014, BRIT J SPORT MED, V48, P552, DOI 10.1136/bjsports-2012-091219; Fincham JE, 2008, AM J PHARM EDUC, V72, DOI 10.5688/aj720243; Flood L, 2009, MED J AUSTRALIA, V190, P87, DOI 10.5694/j.1326-5377.2009.tb02285.x; Fuller C, 2004, SPORTS MED, V34, P349, DOI 10.2165/00007256-200434060-00001; Haroy J, 2017, AM J SPORT MED, V45, P1304, DOI 10.1177/0363546516687539; Hopper D, 1995, BRIT J SPORT MED, V29, P223, DOI 10.1136/bjsm.29.4.223; HOPPER D, 1993, SPORTS MED, V16, P148, DOI 10.2165/00007256-199316020-00006; Hume P A, 2000, J Sci Med Sport, V3, P406, DOI 10.1016/S1440-2440(00)80007-9; Huxley DJ, 2014, EUR J SPORT SCI, V14, P185, DOI 10.1080/17461391.2013.809153; Kreisfeld R, 2017, HOSP CARE AUSTR SPOR; Langeveld E, 2012, S AFR J RES SPORT PH, V34, P83; Loose O, 2019, KNEE SURG SPORT TR A, V27, P978, DOI 10.1007/s00167-018-5119-8; Lynall RC, 2015, MED SCI SPORT EXER, V47, P2487, DOI 10.1249/MSS.0000000000000716; Moseid CH, 2018, SCAND J MED SCI SPOR, V28, P1412, DOI 10.1111/sms.13047; Rae K, 2007, CLIN J SPORT MED, V17, P201, DOI 10.1097/JSM.0b013e318059b536; Smyth EA, 2019, J SCI MED SPORT, V22, P887, DOI 10.1016/j.jsams.2019.03.002; Stares JJ, 2019, AM J SPORT MED, V47, P2225, DOI 10.1177/0363546519852622; Timpka T, 2014, SPORTS MED, V44, P423, DOI 10.1007/s40279-014-0143-4; Toohey LA, 2019, J SCI MED SPORT, V22, P1108, DOI 10.1016/j.jsams.2019.06.002; Toohey LA, 2019, AM J SPORT MED, V47, P1302, DOI 10.1177/0363546518825380; Toohey LA, 2018, SPORTS MED, V48, P2199, DOI 10.1007/s40279-018-0879-3; Toohey LA, 2017, BRIT J SPORT MED, V51, P1670, DOI 10.1136/bjsports-2017-097500; von Elm E, 2007, LANCET, V370, P1453, DOI [10.1371/journal.pmed.0040297, 10.1371/journal.pmed.0040296, 10.1157/13119325, 10.1016/S0140-6736(07)61602-X]; Weissensteiner JR, 2017, HDB TALENT IDENTIFIC; Wollin M, 2018, J SPORT SCI, V36, P1167, DOI 10.1080/02640414.2017.1363452	37	7	7	3	12	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1440-2440	1878-1861		J SCI MED SPORT	J. Sci. Med. Sport	MAR	2020	23	3					215	221		10.1016/j.jsams.2019.10.004			7	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	KR5OW	WOS:000517668700003	31704027				2022-02-06	
J	Tepe, V; Papesh, M; Russell, S; Lewis, MS; Pryor, N; Guillory, L				Tepe, Victoria; Papesh, Melissa; Russell, Shoshannah; Lewis, M. Samantha; Pryor, Nina; Guillory, Lisa			Acquired Central Auditory Processing Disorder in Service Members and Veterans	JOURNAL OF SPEECH LANGUAGE AND HEARING RESEARCH			English	Article							TRAUMATIC BRAIN-INJURY; MASKING-LEVEL DIFFERENCES; POSTTRAUMATIC-STRESS-DISORDER; BLAST-EXPOSED VETERANS; LONG-TERM EXPOSURE; JET FUEL EXPOSURE; NOISE EXPOSURE; HEARING IMPAIRMENT; EVOKED-POTENTIALS; STEM RESPONSES	Purpose: A growing body of evidence suggests that military service members and military veterans are at risk for deficits in central auditory processing. Risk factors include exposure to blast, neurotrauma, hazardous noise, and ototoxicants. We overview these risk factors and comorbidities, address implications for clinical assessment and care of central auditory processing deficits in service members and veterans, and specify knowledge gaps that warrant research. Method: We reviewed the literature to identify studies of risk factors, assessment, and care of central auditory processing deficits in service members and veterans. We also assessed the current state of the science for knowledge gaps that warrant additional study. This literature review describes key findings relating to military risk factors and clinical considerations for the assessment and care of those exposed. Conclusions: Central auditory processing deficits are associated with exposure to known military risk factors. Research is needed to characterize mechanisms, sources of variance, and differential diagnosis in this population. Existing best practices do not explicitly consider confounds faced by military personnel. Assessment and rehabilitation strategies that account for these challenges are needed. Finally, investment is critical to ensure that Veterans Affairs and Department of Defense clinical staff are informed, trained, and equipped to implement effective patient care.	[Tepe, Victoria; Pryor, Nina] Dept Def Hearing Ctr Excellence, Jbsa Lackland, TX 78236 USA; [Tepe, Victoria] Geneva Fdn, Tacoma, WA 98402 USA; [Papesh, Melissa; Lewis, M. Samantha] VA Portland Hlth Care Syst, VA RR&D Natl Ctr Rehabil Auditory Res, Portland, OR USA; [Papesh, Melissa; Lewis, M. Samantha] Oregon Hlth & Sci Univ, Dept Otolaryngol Head & Neck Surg, Portland, OR 97201 USA; [Russell, Shoshannah] Walter Reed Natl Mil Med Ctr, Bethesda, MD USA; [Russell, Shoshannah] Henry Jackson Fdn, Bethesda, MD USA; [Lewis, M. Samantha] Pacific Univ, Sch Audiol, Hillsboro, OR USA; [Pryor, Nina] Air Force Res Lab, Wright Patterson AFB, OH USA; [Guillory, Lisa] Harry S Truman Mem Vet Hosp, Columbia, MO 65201 USA; [Guillory, Lisa] Univ Missouri, Sch Med, Dept Otolaryngol Head & Neck Surg, Columbia, MO USA		Tepe, V (corresponding author), Dept Def Hearing Ctr Excellence, Jbsa Lackland, TX 78236 USA.; Tepe, V (corresponding author), Geneva Fdn, Tacoma, WA 98402 USA.	vtepe@genevausa.org					Abramson M., 2018, HEAR REV, V25, P38; ALHADY MRA, 1990, J LARYNGOL OTOL, V104, P927, DOI 10.1017/S0022215100114410; Alwis DS, 2013, CLIN EXP PHARMACOL P, V40, P473, DOI 10.1111/1440-1681.12100; American Academy of Audiology, 2010, AM AC AUD CLIN PRACT; American Speech-Language-Hearing Association, 2005, CENTR AUD PROC DIS; [Anonymous], 2013, MSMR, V20, P9; Juarez-Perez CA, 2014, INT J AUDIOL, V53, P370, DOI 10.3109/14992027.2014.888597; Atcherson SR., 2016, BRAIN DISORDERS THER, V5, P204, DOI DOI 10.4172/2168-975X.1000204; Bae KY, 2011, PROG NEURO-PSYCHOPH, V35, P1908, DOI 10.1016/j.pnpbp.2011.08.002; Bahraini NH, 2014, PSYCHIAT CLIN N AM, V37, P55, DOI 10.1016/j.psc.2013.11.002; Bamiou DE, 2006, NEUROLOGY, V67, P614, DOI 10.1212/01.wnl.0000230197.40410.db; Beebe D., 2013, 57 SYR U; Bendlin BB, 2008, NEUROIMAGE, V42, P503, DOI 10.1016/j.neuroimage.2008.04.254; BENNA P, 1982, ITAL J NEUROL SCI, V3, P281, DOI 10.1007/BF02043575; Bergemalm P.-O., 2005, AUDIOL MED, V3, DOI [10.1080/16513860500291714, DOI 10.1080/16513860500291714]; Bergemalm PO, 2005, INT J AUDIOL, V44, P39, DOI 10.1080/14992020400022546; Bharadwaj HM, 2015, J NEUROSCI, V35, P2161, DOI 10.1523/JNEUROSCI.3915-14.2015; Bharadwaj HM, 2014, FRONT SYST NEUROSCI, V8, DOI 10.3389/fnsys.2014.00026; Billings CJ, 2015, EAR HEARING, V36, P710, DOI 10.1097/AUD.0000000000000191; Billings CJ, 2013, JARO-J ASSOC RES OTO, V14, P891, DOI 10.1007/s10162-013-0415-y; Billings CJ, 2009, HEARING RES, V254, P15, DOI 10.1016/j.heares.2009.04.002; Bishop DVM, 2007, PSYCHOL BULL, V133, P651, DOI 10.1037/0033-2909.133.4.651; Bochicchio GV, 2008, AM SURGEON, V74, P267; Bramhall N, 2019, HEARING RES, V377, P88, DOI 10.1016/j.heares.2019.02.016; Bramhall NF, 2018, EAR HEARING, V39, P881, DOI 10.1097/AUD.0000000000000544; Bramhall NF, 2017, EAR HEARING, V38, pE1, DOI 10.1097/AUD.0000000000000370; Brattico E, 2005, CLIN NEUROPHYSIOL, V116, P190, DOI 10.1016/j.clinph.2004.07.030; Bray RM, 2010, MIL MED, V175, P390, DOI 10.7205/MILMED-D-09-00132; Bressler S, 2017, HEARING RES, V349, P98, DOI 10.1016/j.heares.2016.10.018; Brungart D., 2014, AUDIOLOGY ONLIN 0310; Brungart DS, 2014, J ACOUST SOC AM, V136, P777, DOI 10.1121/1.4887440; Buritica E, 2009, J NEUROTRAUM, V26, P2145, DOI 10.1089/neu.2009.0894; BUTLER RW, 1990, AM J PSYCHIAT, V147, P1308; Cacace AT, 2013, J AM ACAD AUDIOL, V24, P572, DOI 10.3766/jaaa.24.7.6; Callahan ML, 2019, APPL NEUROPSYCH-ADUL, V26, P365, DOI 10.1080/23279095.2018.1433179; Campo P, 2007, TOXICOL SCI, V99, P582, DOI 10.1093/toxsci/kfm180; Campo P, 2013, DM-DIS MON, V59, P119, DOI 10.1016/j.disamonth.2013.01.003; Canadian Intreorganizational Steering Group for Speech-language Pathology and Audiology, 2012, CAN GUID AUD PROC DI; Carr W, 2015, J HEAD TRAUMA REHAB, V30, P47, DOI 10.1097/HTR.0000000000000064; Carron SF, 2016, FRONT SYST NEUROSCI, V10, DOI 10.3389/fnsys.2016.00047; Cernak I, 2001, J TRAUMA, V50, P695, DOI 10.1097/00005373-200104000-00017; Chermak GD, 2007, J AM ACAD AUDIOL, V18, P428, DOI 10.3766/jaaa.18.5.7; Chermak GD., 1997, CENTRAL AUDITORY PRO; Chisolm TH, 2013, AM J AUDIOL, V22, P339, DOI 10.1044/1059-0889(2013/12-0081); Coronado VG, 2015, J HEAD TRAUMA REHAB, V30, P185, DOI 10.1097/HTR.0000000000000156; Davenport ND, 2012, NEUROIMAGE, V59, P2017, DOI 10.1016/j.neuroimage.2011.10.050; Defense and Veterans Brain Injury Center, 2018, DOD WORLDW NUMB TBI; Draper K, 2008, NEUROPSYCHOLOGY, V22, P618, DOI 10.1037/0894-4105.22.5.618; Duncan CC, 2005, INT J PSYCHOPHYSIOL, V58, P133, DOI 10.1016/j.ijpsycho.2005.05.011; Eggermont JJ, 2004, TRENDS NEUROSCI, V27, P676, DOI 10.1016/j.tins.2004.08.010; Eggermont JJ, 2017, HEARING RES, V352, P12, DOI 10.1016/j.heares.2016.10.015; Emanuel Diana C, 2002, J Am Acad Audiol, V13, P93; ESCALONA E, 1995, AM J IND MED, V27, P15, DOI 10.1002/ajim.4700270103; Fausti SA, 2009, J REHABIL RES DEV, V46, P797, DOI 10.1682/JRRD.2008.09.0118; Fechter LD, 2012, J TOXICOL ENV HEAL A, V75, P299, DOI 10.1080/15287394.2012.652060; Fischer BL, 2014, J NEUROTRAUM, V31, P169, DOI 10.1089/neu.2013.2877; Folmer RL, 2011, INT J PSYCHOPHYSIOL, V82, P4, DOI 10.1016/j.ijpsycho.2011.03.005; Fuente A, 2006, ACTA OTO-LARYNGOL, V126, P1188, DOI 10.1080/00016480600681585; Fuente A, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-39; Furman AC, 2013, J NEUROPHYSIOL, V110, P577, DOI 10.1152/jn.00164.2013; Gallun F. J., 2017, PERSPECTIVES ASHA SP, V2, P147, DOI [10.1044/persp2.SIG2.147, DOI 10.1044/PERSP2.SIG2.147]; Gallun FJ, 2017, BRAIN INJURY, V31, P1183, DOI 10.1080/02699052.2016.1274781; Gallun FJ, 2016, J REHABIL RES DEV, V53, P705, DOI 10.1682/JRRD.2014.12.0313; Gallun FJ, 2012, J REHABIL RES DEV, V49, P1059, DOI 10.1682/JRRD.2010.09.0166; Gallun FJ, 2012, J REHABIL RES DEV, V49, P1005, DOI 10.1682/JRRD.2012.03.0038; Gopal KV, 2008, NOISE HEALTH, V10, P74, DOI 10.4103/1463-1741.44345; Greer N, 2016, PREVALENCE EPIDEMIOL; Grinn SK, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00465; Groenewold Matthew R., 2011, Morbidity and Mortality Weekly Report, V60, P955; Guest H, 2018, HEARING RES, V364, P142, DOI 10.1016/j.heares.2018.03.008; Guthrie OW, 2015, J TOXICOL ENV HEAL A, V78, P1154, DOI 10.1080/15287394.2015.1070389; Guthrie OW, 2014, J TOXICOL ENV HEAL A, V77, P261, DOI 10.1080/15287394.2013.862892; HAGLUND Y, 1990, ACTA NEUROL SCAND, V82, P353; Hall JW, 2016, J AUDIOL OTOL, V20, P59, DOI 10.7874/jao.2016.20.2.59; HANNLEY M, 1983, AUDIOLOGY, V22, P20; He SM, 2012, INT J AUDIOL, V51, P771, DOI 10.3109/14992027.2012.699198; Helfer TM, 2011, AM J AUDIOL, V20, P33, DOI 10.1044/1059-0889(2011/10-0033); HENDLER T, 1990, EAR HEARING, V11, P403, DOI 10.1097/00003446-199012000-00002; Hickman TT, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-28924-7; Hodgkinson Lyn, 2006, Noise Health, V8, P114; Holmes E, 2018, JARO-J ASSOC RES OTO, V19, P83, DOI 10.1007/s10162-017-0641-9; Hoover E, 2014, J ACOUST SOC AM, V135, P2166, DOI DOI 10.1121/1.4877039; Hoover EC, 2015, SIG 6 PERSPECT HEAR, V19, P12; Hoover EC, 2017, J AM ACAD AUDIOL, V28, P325, DOI 10.3766/jaaa.16051; Hope AJ, 2013, J LARYNGOL OTOL, V127, P233, DOI 10.1017/S002221511200299X; Huber BR, 2016, NEUROSCIENCE, V319, P206, DOI 10.1016/j.neuroscience.2016.01.022; Hurley R M, 1997, J Am Acad Audiol, V8, P257; Iliadou V., 2019, HEARING J, V72, P42; Institute of Medicine, 2006, NOISE MILITARY SERVI; Institute of Medicine, 2014, GULF WAR HLTH, V9; JABBARI B, 1987, Seminars in Hearing, V8, P261, DOI 10.1055/s-0028-1091376; Jenkins K., 2018, ASHA ACCESS AUDIOLOG, V23, P62; JERGER JF, 1976, ARCH OTOLARYNGOL, V102, P614; Jirsa Robert E., 2002, Seminars in Hearing, V23, P349, DOI 10.1055/s-2002-35883; Johnson KL, 2005, EAR HEARING, V26, P424, DOI 10.1097/01.aud.0000179687.71662.6e; Kaipio M.-L., 2016, THESIS; KARLSSON AK, 1995, SCAND AUDIOL, V24, P155, DOI 10.3109/01050399509047529; Kaufman LR, 2005, J OCCUP ENVIRON MED, V47, P212, DOI 10.1097/01.jom.0000155710.28289.0e; Keith R. W., 1994, J AM ACAD AUDIOL, V69, P286, DOI [10.1016/S0006-3223(99)00258-9, DOI 10.1016/S0006-3223(99)00258-9]; Kimble M, 2000, BIOL PSYCHIAT, V47, P880, DOI 10.1016/S0006-3223(99)00258-9; Kobel M, 2017, HEARING RES, V349, P148, DOI 10.1016/j.heares.2016.12.008; Koerner TK, 2016, HEARING RES, V339, P40, DOI 10.1016/j.heares.2016.06.001; Kokx-Ryan M., 2017, EAUDIOLOGY ONLI 0428; Kraus N, 2017, NEUROSCI LETT, V646, P21, DOI 10.1016/j.neulet.2017.03.008; Krause MO, 2014, BRAIN INJURY, V28, P1473, DOI 10.3109/02699052.2014.920520; Krishnamurti S., 2001, CONTEM ISSUES COMMUN, V28, P40; Kubli LR, 2018, EAR HEARING, V39, P457, DOI 10.1097/AUD.0000000000000517; Kubli LR, 2017, NOISE HEALTH, V19, P227, DOI 10.4103/nah.NAH_58_16; Kujala T, 2004, PSYCHOPHYSIOLOGY, V41, P875, DOI 10.1111/j.1469-8986.2004.00244.x; Kujawa SG, 2015, HEARING RES, V330, P191, DOI 10.1016/j.heares.2015.02.009; Kujawa SG, 2009, J NEUROSCI, V29, P14077, DOI 10.1523/JNEUROSCI.2845-09.2009; Kumar UA, 2012, NOISE HEALTH, V14, P100, DOI 10.4103/1463-1741.97252; Le Prell CG, 2019, INT J AUDIOL, V58, pS3, DOI 10.1080/14992027.2018.1534010; Lew HL, 2007, J REHABIL RES DEV, V44, P921, DOI 10.1682/JRRD.2007.09.0140; Lew HL, 2009, J REHABIL RES DEV, V46, P697, DOI 10.1682/JRRD.2009.01.0006; Lew HL, 2004, AM J PHYS MED REHAB, V83, P428, DOI 10.1097/00002060-200406000-00004; Liberman MC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162726; Liberman MC, 2014, J ACOUST SOC AM, V135, P2311, DOI DOI 10.1523/JNEUROSCI.2845-09.2009; Lin HW, 2011, JARO-J ASSOC RES OTO, V12, P605, DOI 10.1007/s10162-011-0277-0; Lindquist LK, 2017, J NEUROPSYCH CLIN N, V29, P254, DOI 10.1176/appi.neuropsych.16050100; Lister JJ, 2011, INT J AUDIOL, V50, P211, DOI 10.3109/14992027.2010.526967; Little DM, 2010, NEUROLOGY, V74, P558, DOI 10.1212/WNL.0b013e3181cff5d5; Luo H, 2017, NEUROSCIENCE, V340, P515, DOI 10.1016/j.neuroscience.2016.11.014; Luo H, 2014, J NEUROSCI RES, V92, P1466, DOI 10.1002/jnr.23424; LYNN GE, 1981, ARCH OTOLARYNGOL, V107, P357; Martin BA, 2000, J ACOUST SOC AM, V107, P2155, DOI 10.1121/1.428556; Mattie D. R., 2014, AFRLRHWPTR20140061; McAllister TW, 1999, NEUROLOGY, V53, P1300, DOI 10.1212/WNL.53.6.1300; McCullagh J, 2012, AUDIOL MED, V10, P114; Mesulam MM, 2002, PRINCIPLES FRONTAL L, P8, DOI [10.1093/acprof:oso/9780195134971.003.0002, DOI 10.1093/ACPROF:OSO/9780195134971.003.0002]; Moore DF, 2010, NEUROREHABILITATION, V26, P179, DOI 10.3233/NRE-2010-0553; Morgan CA, 1996, AM J PSYCHIAT, V153, P64; MUELLER H G, 1987, Seminars in Hearing, V8, P279; MUELLER H G, 1987, Seminars in Hearing, V8, P253, DOI 10.1055/s-0028-1091375; MUELLER H G, 1987, Seminars in Hearing, V8, P267, DOI 10.1055/s-0028-1091377; Mueller H. G., 1994, HDB CLIN AUDIOLOGY, P222; Musiek F, 1999, J AM ACAD AUDIOL, V10, P124; Musiek F E, 1992, J Am Acad Audiol, V3, P5; MUSIEK F E, 1990, Seminars in Hearing, V11, P372, DOI 10.1055/s-0028-1085516; Musiek F. E., 2014, HDB CENTRAL AUDITORY, V1; Musiek FE, 2005, EAR HEARING, V26, P608, DOI 10.1097/01.aud.0000188069.80699.41; MUSIEK FE, 1983, EAR HEARING, V4, P79, DOI 10.1097/00003446-198303000-00002; MUSIEK FE, 1983, EAR HEARING, V4, P318, DOI 10.1097/00003446-198311000-00010; MUSIEK FE, 1980, ARCH OTOLARYNGOL, V106, P610; MUSIEK FE, 1987, AUDIOLOGY, V26, P79; Musiek FE, 2011, J AM ACAD AUDIOL, V22, P342, DOI 10.3766/jaaa.22.6.4; Myers Paula J., 2009, Seminars in Hearing, V30, P5, DOI 10.1055/s-0028-1111103; NOFFSINGER D, 1982, SCAND AUDIOL, P157; NOFFSINGER D, 1982, SCAND AUDIOL, P81; Nolle C, 2004, J NEUROTRAUM, V21, P251, DOI 10.1089/089771504322972040; OBERT AD, 1990, AM J OTOL, V11, P447; Oleksiak M, 2012, J REHABIL RES DEV, V49, P995, DOI 10.1682/JRRD.2011.01.0001; Palacios EM, 2013, CORTEX, V49, P646, DOI 10.1016/j.cortex.2012.02.011; Palfery Tatra Dobrzanski, 2007, Axone, V28, P20; Papesh MA, 2019, J NEUROTRAUM, V36, P702, DOI 10.1089/neu.2018.5801; Parbery-Clark A, 2011, EUR J NEUROSCI, V33, P549, DOI 10.1111/j.1460-9568.2010.07546.x; Patterson JH, 1997, TOXICOLOGY, V121, P29, DOI 10.1016/S0300-483X(97)03653-6; Petrie EC, 2014, J NEUROTRAUM, V31, P425, DOI [10.1089/NEU.2013.2952, 10.1089/neu.2013.2952]; Phatak SA, 2019, EAR HEARING, V40, P426, DOI 10.1097/AUD.0000000000000635; Picton T, 2013, EAR HEARING, V34, P385, DOI 10.1097/AUD.0b013e31827ada02; Pienkowski M, 2017, EAR HEARING, V38, P135, DOI 10.1097/AUD.0000000000000388; Pienkowski M, 2012, EAR HEARING, V33, P305, DOI 10.1097/AUD.0b013e318241e880; Plack CJ, 2014, TRENDS HEAR, V18, DOI 10.1177/2331216514550621; Pleil JD, 2000, ENVIRON HEALTH PERSP, V108, P183, DOI 10.2307/3454432; Plumb TR, 2014, PSYCHOL SERV, V11, P209, DOI 10.1037/a0034958; POLICH J, 1986, ELECTROEN CLIN NEURO, V63, P251, DOI 10.1016/0013-4694(86)90093-3; Polo MD, 2002, NEUROPSYCHOLOGIA, V40, P2350, DOI 10.1016/S0028-3932(02)00127-6; Potter DD, 2001, NEUROPSYCHOLOGIA, V39, P1464, DOI 10.1016/S0028-3932(01)00057-4; Prasher Deepak, 2005, Noise Health, V7, P31; Prendergast G, 2017, HEARING RES, V344, P68, DOI 10.1016/j.heares.2016.10.028; Purcell DW, 2004, J ACOUST SOC AM, V116, P3581, DOI 10.1121/1.1798354; Reavis K. M., 2018, M AM PUBL HLTH ASS S; Richardson LK, 2010, AUST NZ J PSYCHIAT, V44, P4, DOI 10.3109/00048670903393597; Ridley CL, 2018, EAR HEARING, V39, P829, DOI 10.1097/AUD.0000000000000543; Ritchie GD, 2001, J TOXICOL ENV HEAL B, V4, P223, DOI 10.1080/109374001301419728; Ritchie GD, 2001, J TOXICOL ENV HEAL A, V64, P385, DOI 10.1080/152873901753170731; Rocha CN, 2010, ARQ NEURO-PSIQUIAT, V68, P18, DOI 10.1590/S0004-282X2010000100005; Roup C.M., 2016, J ACOUST SOC AM, V140, P3268, DOI [10.1121/1.4970370, DOI 10.1121/1.4970370]; Roup CM, 2018, J AM ACAD AUDIOL, V29, P477, DOI 10.3766/jaaa.16111; Russo N, 2004, CLIN NEUROPHYSIOL, V115, P2021, DOI 10.1016/j.clinph.2004.04.003; Saljo A, 2011, NEUROIMAGE, V54, pS83, DOI 10.1016/j.neuroimage.2010.05.050; Saunders GH, 2018, J AM ACAD AUDIOL, V29, P44, DOI 10.3766/jaaa.16143; Saunders GH, 2015, J REHABIL RES DEV, V52, P343, DOI 10.1682/JRRD.2014.11.0275; Saunders Gabrielle H., 2014, Seminars in Hearing, V35, P227, DOI 10.1055/s-0034-1383507; Saunders GH, 2012, J REHABIL RES DEV, V49, P1043, DOI 10.1682/JRRD.2010.08.0157; Saxena, 2017, INT J RES MED SCI, V5, P13, DOI [10.18203/2320-6012.ijrms20164525, DOI 10.18203/2320-6012.IJRMS20164525]; Schochat E, 2017, SPRINGER HANDB AUDIT, V61, P225, DOI 10.1007/978-3-319-47944-6_9; Schochat Eliane, 2004, Rev. Bras. Otorrinolaringol., V70, P353, DOI 10.1590/S0034-72992004000300011; Seal KH, 2007, ARCH INTERN MED, V167, P476, DOI 10.1001/archinte.167.5.476; Shinn, 2018, ASHA LEAD, V23, P6, DOI [10.1044/leader.FMP.23032018.6, DOI 10.1044/LEADER.FMP.23032018.6]; Shively SB, 2016, LANCET NEUROL, V15, P944, DOI 10.1016/S1474-4422(16)30057-6; Shu IW, 2014, PSYCHIAT RES-NEUROIM, V224, P58, DOI 10.1016/j.pscychresns.2014.07.010; Shub DE, 2020, EAR HEARING, V41, P39, DOI 10.1097/AUD.0000000000000745; Smith LB, 1997, J OCCUP ENVIRON MED, V39, P623, DOI 10.1097/00043764-199707000-00007; Soalheiro M, 2012, J OCCUP MED TOXICOL, V7, DOI 10.1186/1745-6673-7-26; Mendonca EBS, 2013, BRAZ J OTORHINOLAR, V79, P512, DOI 10.5935/1808-8694.20130091; Song HL, 2018, BEHAV BRAIN RES, V340, P147, DOI 10.1016/j.bbr.2016.08.037; Spankovich C, 2018, HEARING RES, V358, P30, DOI 10.1016/j.heares.2017.12.001; Spehar BP, 2018, OTOL NEUROTOL, V39, P950, DOI 10.1097/MAO.0000000000001903; Stamper GC, 2015, EAR HEARING, V36, P172, DOI 10.1097/AUD.0000000000000107; Sterner T. R., 2017, AFRLRHWPTR20170079; Steyger Peter S., 2009, Seminars in Hearing, V30, P38, DOI 10.1055/s-0028-1111105; Sun HY, 2015, NEURAL REGEN RES, V10, P618, DOI 10.4103/1673-5374.155437; Sweetow RW, 2010, J AM ACAD AUDIOL, V21, P586, DOI 10.3766/jaaa.21.9.4; Taber KH, 2015, J HEAD TRAUMA REHAB, V30, pE15, DOI 10.1097/HTR.0000000000000030; Tepe V, 2017, MIL MED, V182, pE1785, DOI 10.7205/MILMED-D-17-00025; Theodoroff SM, 2015, EPIDEMIOL REV, V37, P71, DOI 10.1093/epirev/mxu005; Thomas JL, 2010, ARCH GEN PSYCHIAT, V67, P614, DOI 10.1001/archgenpsychiatry.2010.54; Tompkins P, 2013, J NEUROTRAUM, V30, P1888, DOI 10.1089/neu.2012.2674; Tremblay Kelly L., 2007, Seminars in Hearing, V28, P120, DOI 10.1055/s-2007-973438; Tremblay KL, 2003, EAR HEARING, V24, P225, DOI 10.1097/01.AUD.0000069229.84883.03; Tu RH, 2004, AVIAT SPACE ENVIR MD, V75, P49; Tufts JB, 2009, J AM ACAD AUDIOL, V20, P539, DOI 10.3766/jaaa.20.9.3; Turgeon C, 2011, EAR HEARING, V32, P667, DOI 10.1097/AUD.0b013e31821209d6; U.S. Department of Health and Human Services, 2017, TOX PROF JP 5 JP 8 J; U.S. Department of the Air Force, 2013, 48123 US DEP AIR FOR; U.S. Department of the Navy, 2008, 626051992 TM US DEP; VA Health Services Research & Development, 2019, VA INF COMP INFR VIN; Varghese L, 2015, BRAIN RES, V1626, P146, DOI 10.1016/j.brainres.2015.06.038; Veterans Benefits Administration, 2018, VBA ANN BEN REP FY 2; von Steinbuchel N, 1999, NEUROSCI LETT, V264, P168, DOI 10.1016/S0304-3940(99)00204-9; Warner R, 2015, MIL MED, V180, P950, DOI 10.7205/MILMED-D-14-00733; Wells TS, 2015, NOISE HEALTH, V17, P34, DOI 10.4103/1463-1741.149574; Werff KRV, 2017, EAR HEARING, V38, pE200, DOI 10.1097/AUD.0000000000000411; Wilson C., 2007, IMPROVISED EXPLOSIVE; Wolf JA, 2016, FRONT SYST NEUROSCI, V10, DOI 10.3389/fnsys.2016.00043; Yeend I, 2019, EAR HEARING, V40, P458, DOI 10.1097/AUD.0000000000000640; Yeend I, 2017, HEARING RES, V353, P224, DOI 10.1016/j.heares.2017.07.006; Yi JH, 2006, NEUROCHEM INT, V48, P394, DOI 10.1016/j.neuint.2005.12.001; Yong JSE, 2015, MILITARY MED RES, V2, DOI 10.1186/s40779-015-0034-5	230	7	7	0	1	AMER SPEECH-LANGUAGE-HEARING ASSOC	ROCKVILLE	2200 RESEARCH BLVD, #271, ROCKVILLE, MD 20850-3289 USA	1092-4388	1558-9102		J SPEECH LANG HEAR R	J. Speech Lang. Hear. Res.	MAR	2020	63	3					834	857		10.1044/2019_JSLHR-19-00293			24	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	ND2WP	WOS:000561765700016	32163310	hybrid			2022-02-06	
J	Wright, AD; Smirl, JD; Bryk, K; Jakovac, M; van Donkelaar, P				Wright, Alexander D.; Smirl, Jonathan D.; Bryk, Kelsey; Jakovac, Michael; van Donkelaar, Paul			A Prospective Transcranial Doppler Ultrasound-Based Evaluation of the Effects of Repetitive Subconcussive Head Trauma on Neurovascular Coupling Dynamics	CLINICAL JOURNAL OF SPORT MEDICINE			English	Article						cerebral blood flow; neurovascular coupling; contact sport; subconcussive head trauma	HIGH-SCHOOL FOOTBALL; CEREBRAL-BLOOD-FLOW; PROFESSIONAL SOCCER PLAYERS; IMPACT EXPOSURE; WHITE-MATTER; BRAIN-INJURY; IN-VIVO; CONCUSSION; SPORT; FMRI	Objective: To determine the effects of repetitive subconcussive head trauma on neurovascular coupling (NVC) responses. Design: Prospective cohort study collected between September 2013 and December 2016. Setting: University laboratory. Participants: One hundred seventy-nine elite, junior-level (age, 19.6 +/- 1.5 years) contact sport (ice hockey, American football) athletes recruited for preseason testing. Fifty-two nonconcussed athletes returned for postseason testing. Fifteen noncontact sport athletes (age, 20.4 +/- 2.2 years) also completed preseason and postseason testing. Exposure(s): Subconcussive sport-related head trauma. Main Outcome Measures: Dynamics of NVC were estimated during cycles of 20 seconds eyes closed and 40 seconds eyes open to a visual stimulus (reading) by measuring cerebral blood flow (CBF) velocity in the posterior (PCA) and middle (MCA) cerebral arteries via transcranial Doppler ultrasound. Results: Both athlete groups demonstrated no significant differences in PCA or MCA NVC dynamics between preseason and postseason, despite exposure to a median of 353.5 (range, 295.0-587.3) head impacts (>2g) over the course of the season for contact sport athletes. Conclusions: Within the context of growing concern over detrimental effects of repetitive subconcussive trauma, the current results encouragingly suggest that the dynamics of NVC responses are not affected by 1 season of participation in junior-level ice hockey or American football. This is an important finding because it indicates an appropriate postseason CBF response to elevated metabolic demand with increases in neural activity.	[Wright, Alexander D.] Univ British Columbia, MD PhD Program, Vancouver, BC, Canada; [Wright, Alexander D.; Jakovac, Michael] Univ British Columbia Okanagan, Southern Med Program, Reichwald Hlth Sci Ctr, Kelowna, BC, Canada; [Wright, Alexander D.] Univ British Columbia, Expt Med Program, Fac Med, Vancouver, BC, Canada; [Wright, Alexander D.; Smirl, Jonathan D.; Bryk, Kelsey; van Donkelaar, Paul] Univ British Columbia Okanagan, Sch Hlth & Exercise Sci, Kelowna, BC V1V 1V7, Canada; [Bryk, Kelsey] Univ Delaware, Dept Kinesiol & Appl Physiol, Newark, DE USA		van Donkelaar, P (corresponding author), Univ British Columbia Okanagan, Sch Hlth & Exercise Sci, Kelowna, BC V1V 1V7, Canada.	paul.vandonkelaar@ubc.ca			CIHRCanadian Institutes of Health Research (CIHR); CFICanada Foundation for Innovation	Funding provided by the CIHR and CFI in support of this project.	Abbas K, 2015, BRAIN CONNECT, V5, P91, DOI 10.1089/brain.2014.0279; Azevedo E, 2007, J NEUROL, V254, P236, DOI 10.1007/s00415-006-0338-1; Bailes JE, 2013, J NEUROSURG, V119, P1235, DOI 10.3171/2013.7.JNS121822; Bailey DM, 2013, CLIN SCI, V124, P177, DOI 10.1042/CS20120259; Barlow KM, 2017, J NEUROTRAUM, V34, P996, DOI 10.1089/neu.2016.4634; Bazarian JJ, 2012, MAGN RESON IMAGING, V30, P171, DOI 10.1016/j.mri.2011.10.001; Beckwith JG, 2013, MED SCI SPORT EXER, V45, P737, DOI 10.1249/MSS.0b013e3182792ed7; Breedlove EL, 2012, J BIOMECH, V45, P1265, DOI 10.1016/j.jbiomech.2012.01.034; Broglio SP, 2013, AM J SPORT MED, V41, P2877, DOI 10.1177/0363546513502458; Broglio SP, 2009, J ATHL TRAINING, V44, P342, DOI 10.4085/1062-6050-44.4.342; Cauli B, 2004, J NEUROSCI, V24, P8940, DOI 10.1523/JNEUROSCI.3065-04.2004; Chun IY, 2015, DEV NEUROPSYCHOL, V40, P92, DOI 10.1080/87565641.2015.1020945; Ellis Michael J, 2016, Front Neurol, V7, P61, DOI 10.3389/fneur.2016.00061; Gommer ED, 2014, MED ENG PHYS, V36, P613, DOI 10.1016/j.medengphy.2014.01.006; Huber BR, 2016, PHYS MED REH CLIN N, V27, P503, DOI 10.1016/j.pmr.2015.12.007; Kawata K, 2016, JAMA OPHTHALMOL, V134, P763, DOI 10.1001/jamaophthalmol.2016.1085; Koerte IK, 2015, J NEUROTRAUM, V32, P1287, DOI 10.1089/neu.2014.3715; Koerte IK, 2012, NEUROSURG FOCUS, V33, DOI 10.3171/2012.10.FOCUS12303; Koerte IK, 2012, JAMA-J AM MED ASSOC, V308, P1859, DOI 10.1001/jama.2012.13735; Lecrux C, 2011, ACTA PHYSIOL, V203, P47, DOI 10.1111/j.1748-1716.2011.02256.x; Lipton ML, 2013, RADIOLOGY, V268, P850, DOI 10.1148/radiol.13130545; Marchi N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056805; Maugans TA, 2012, PEDIATRICS, V129, P28, DOI 10.1542/peds.2011-2083; Mayer AR, 2015, NEUROSCI BIOBEHAV R, V49, P8, DOI 10.1016/j.neubiorev.2014.11.016; Mayer AR, 2014, J NEUROTRAUM, V31, P189, DOI 10.1089/neu.2013.3069; McAllister TW, 2014, NEUROLOGY, V82, P63, DOI 10.1212/01.wnl.0000438220.16190.42; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McCuen E, 2015, J BIOMECH, V48, P3720, DOI 10.1016/j.jbiomech.2015.08.003; Meier TB, 2015, JAMA NEUROL, V72, P530, DOI 10.1001/jamaneurol.2014.4778; Mihalik JP, 2007, NEUROSURGERY, V61, P1229, DOI 10.1227/01.neu.0000306101.83882.c8; Montenigro PH, 2017, J NEUROTRAUM, V34, P328, DOI 10.1089/neu.2016.4413; Myer GD, 2016, BRIT J SPORT MED, V50, P1276, DOI 10.1136/bjsports-2016-096134; Nauman EA, 2015, DEV NEUROPSYCHOL, V40, P85, DOI 10.1080/87565641.2015.1016161; Patton DA, 2016, APPL BIONICS BIOMECH, V2016, DOI 10.1155/2016/7049743; Phillips AA, 2016, J CEREBR BLOOD F MET, V36, P647, DOI 10.1177/0271678X15617954; Phillips AA, 2014, J CEREBR BLOOD F MET, V34, P794, DOI 10.1038/jcbfm.2014.3; Poole VN, 2015, DEV NEUROPSYCHOL, V40, P12, DOI 10.1080/87565641.2014.984810; Robinson ME, 2015, DEV NEUROPSYCHOL, V40, P74, DOI 10.1080/87565641.2015.1012204; Rosengarten B, 2003, J NEUROIMAGING, V13, P43, DOI 10.1177/1051228402239716; Rosengarten B, 2001, ULTRASOUND MED BIOL, V27, P1499, DOI 10.1016/S0301-5629(01)00464-1; Rowson S, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3130454; Schnebel B, 2007, NEUROSURGERY, V60, P490, DOI 10.1227/01.NEU.0000249286.92255.7F; Schussler E, 2017, INT J SPORTS PHYS TH, V12, P592; Shenk TE, 2015, DEV NEUROPSYCHOL, V40, P63, DOI 10.1080/87565641.2015.1014088; Smirl JD, 2016, J NEUROSCI METH, V270, P92, DOI 10.1016/j.jneumeth.2016.06.007; Svaldi DO, 2017, BRAIN IMAGING BEHAV, V11, P98, DOI 10.1007/s11682-016-9509-6; Svaldi DO, 2015, DEV NEUROPSYCHOL, V40, P80, DOI 10.1080/87565641.2014.973959; Talavage TM, 2014, J NEUROTRAUM, V31, P327, DOI 10.1089/neu.2010.1512; Tan CO, 2014, NEUROLOGY, V83, P1665, DOI 10.1212/WNL.0000000000000944; Wang Y, 2015, DEV NEUROPSYCHOL, V40, P40, DOI 10.1080/87565641.2014.979927; Willie CK, 2011, J NEUROSCI METH, V198, P270, DOI 10.1016/j.jneumeth.2011.03.017; Willie CK, 2011, J NEUROSCI METH, V196, P221, DOI 10.1016/j.jneumeth.2011.01.011; Willie CK, 2014, J PHYSIOL-LONDON, V592, P841, DOI 10.1113/jphysiol.2013.268953; Wright AD, 2017, J NEUROTRAUM, V34, P3097, DOI 10.1089/neu.2017.5020; Wu LC, 2016, ANN BIOMED ENG, V44, P1234, DOI 10.1007/s10439-015-1423-3	55	7	7	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1050-642X	1536-3724		CLIN J SPORT MED	Clin. J. Sport Med.	MAR	2020	30			1			S53	S60		10.1097/JSM.0000000000000578			8	Orthopedics; Physiology; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Physiology; Sport Sciences	NQ6DX	WOS:000570961700007	32132478				2022-02-06	
J	Wang, L; Yin, ZY; Wang, F; Han, ZL; Wang, YF; Huang, S; Hu, TP; Guo, MT; Lei, P				Wang, Lu; Yin, Zhenyu; Wang, Feng; Han, Zhaoli; Wang, Yifeng; Huang, Shan; Hu, Tianpeng; Guo, Mengtian; Lei, Ping			Hydrogen exerts neuroprotection by activation of the miR-21/PI3K/AKT/GSK-3 beta pathway in an in vitro model of traumatic brain injury	JOURNAL OF CELLULAR AND MOLECULAR MEDICINE			English	Article						apoptosis; GSK-3 beta; hydrogen; miR-21; nerve regeneration; traumatic brain injury	HYPERBARIC-OXYGEN THERAPY; NEURONAL APOPTOSIS; SIGNALING PATHWAY; OXIDATIVE STRESS; PI3K/AKT/GSK-3-BETA PATHWAY; CORTICAL-NEURONS; PROTECTS; EXPOSURE; BETA; MICE	Few studies have explored the effect of hydrogen on neuronal apoptosis or impaired nerve regeneration after traumatic brain injury, and the mechanisms involved in these processes are unclear. In this study, we explored neuroprotection of hydrogen-rich medium through activation of the miR-21/PI3K/AKT/GSK-3 beta pathway in an in vitro model of traumatic brain injury. Such model adopted PC12 cells with manual scratching. Then, injured cells were cultured in hydrogen-rich medium for 48 hours. Expression of miR-21, p-PI3K, p-Akt, p-GSK-3 beta, Bax and Bcl-2 was measured using RT-qPCR, Western blot analysis and immunofluorescence staining. Rate of apoptosis was determined using TUNEL staining. Neuronal regeneration was assessed using immunofluorescence staining. The results showed that hydrogen-rich medium improved neurite regeneration and inhibited apoptosis in the injured cells. Scratch injury was accompanied by up-regulation of miR-21, p-PI3K, p-Akt and p-GSK-3 beta. A miR-21 antagomir inhibited the expression of these four molecules, while a PI3K blocker only affected the three proteins and not miR-21. Both the miR-21 antagomir and PI3K blocker reversed the protective effect of hydrogen. In conclusion, hydrogen exerted a neuroprotective effect against neuronal apoptosis and impaired nerve regeneration through activation of miR-21/PI3K/AKT/GSK-3 beta signalling in this in vitro model of traumatic brain injury.	[Wang, Lu; Yin, Zhenyu; Wang, Feng; Han, Zhaoli; Huang, Shan; Hu, Tianpeng; Guo, Mengtian; Lei, Ping] Tianjin Med Univ, Gen Hosp, Dept Geriatr, Tianjin Geriatr Inst, 154 Anshan Rd, Tianjin 300052, Peoples R China; [Wang, Yifeng] Tianjin Med Univ, Gen Hosp, Dept Intens Care Unit, Tianjin, Peoples R China		Lei, P (corresponding author), Tianjin Med Univ, Gen Hosp, Dept Geriatr, Tianjin Geriatr Inst, 154 Anshan Rd, Tianjin 300052, Peoples R China.	leiping_1974@163.com					Chen KY, 2017, CELL PHYSIOL BIOCHEM, V43, P1634, DOI 10.1159/000484024; Feng MG, 2018, BIOMED PHARMACOTHER, V101, P1003, DOI 10.1016/j.biopha.2018.02.043; Han ZL, 2014, BRAIN RES, V1582, P12, DOI 10.1016/j.brainres.2014.07.045; He H, 2019, NEUROPSYCH DIS TREAT, V15, P369, DOI 10.2147/NDT.S183632; Huang TT, 2009, J NEUROTRAUM, V26, P1535, DOI [10.1089/neu.2008.0743, 10.1089/neu.2008-0743]; Jha RM, 2018, CURR NEUROL NEUROSCI, V18, DOI 10.1007/s11910-018-0912-9; Jiang JY, 2019, LANCET NEUROL, V18, P286, DOI 10.1016/S1474-4422(18)30469-1; Jiang P, 2019, CHEMOSPHERE, V214, P430, DOI 10.1016/j.chemosphere.2018.09.095; Jiang XF, 2013, J SURG RES, V184, pE27, DOI 10.1016/j.jss.2013.03.067; Krishna SAM, 2016, INT J COMPUT MAT SCI, V5, DOI 10.1142/S204768411650007X; Li D, 2019, MED SCI MONITOR, V25, P1871, DOI 10.12659/MSM.915727; Liu LL, 2014, BRAIN RES, V1589, P78, DOI 10.1016/j.brainres.2014.09.030; Ma YH, 2011, BRAIN RES BULL, V86, P441, DOI 10.1016/j.brainresbull.2011.07.007; Mollayeva T, 2018, NAT REV NEUROL, V14, P712, DOI 10.1038/s41582-018-0091-y; Priya CS, 2019, INT IMMUNOPHARMACOL, V70, P396, DOI 10.1016/j.intimp.2019.02.053; Rather MA, 2019, NEUROTOX RES, V35, P955, DOI 10.1007/s12640-019-9999-2; Rong H, 2018, FREE RADICAL BIO MED, V120, P114, DOI 10.1016/j.freeradbiomed.2018.03.028; Tal S, 2017, FRONT HUM NEUROSCI, V11, DOI 10.3389/fnhum.2017.00508; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Tian RF, 2016, BRAIN RES, V1637, P1, DOI 10.1016/j.brainres.2016.01.029; Wang L, 2018, SHOCK, V50, P308, DOI 10.1097/SHK.0000000000001018; Wu X, 2018, NEUROCHEM RES, V43, P886, DOI 10.1007/s11064-018-2494-y; Wu YR, 2016, TUMOR BIOL, V37, P12061, DOI 10.1007/s13277-016-5074-2; Yonamine R, 2013, ANESTHESIOLOGY, V118, P105, DOI 10.1097/ALN.0b013e318275146d; Yu Y, 2015, GENET MOL RES, V14, P6202, DOI 10.4238/2015.June.9.6; Yuan J, 2018, J SURG RES, V228, P238, DOI 10.1016/j.jss.2018.03.024; Zhang MY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087241; Zhang WQ, 2018, MED SCI MONITOR, V24, P1588, DOI 10.12659/MSM.905700; Zhao YB, 2012, EXP NEUROL, V237, P489, DOI 10.1016/j.expneurol.2012.07.004; Zhou B, 2018, CELL PHYSIOL BIOCHEM, V46, P999, DOI 10.1159/000488831; Zhou W, 2019, NEUROREPORT, V30, P60, DOI 10.1097/WNR.0000000000001149; Zou Y, 2013, FREE RADICAL RES, V47, P55, DOI 10.3109/10715762.2012.742518	32	7	7	0	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1582-1838	1582-4934		J CELL MOL MED	J. Cell. Mol. Med.	APR	2020	24	7					4061	4071		10.1111/jcmm.15051		FEB 2020	11	Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Research & Experimental Medicine	MJ1LE	WOS:000516879600001	32108985	Green Published, gold			2022-02-06	
J	Moffet, EW; Subramaniam, T; Hirsch, LJ; Gilmore, EJ; Lee, JW; Rodriguez-Ruiz, AA; Haider, HA; Dhakar, MB; Jadeja, N; Osman, G; Gaspard, N; Struck, AF				Moffet, Eric W.; Subramaniam, Thanujaa; Hirsch, Lawrence J.; Gilmore, Emily J.; Lee, Jong Woo; Rodriguez-Ruiz, Andres A.; Haider, Hiba A.; Dhakar, Monica B.; Jadeja, Neville; Osman, Gamaledin; Gaspard, Nicolas; Struck, Aaron F.			Validation of the 2HELPS2B Seizure Risk Score in Acute Brain Injury Patients	NEUROCRITICAL CARE			English	Article						Critical care EEG; Continuous EEG; 2HELPS2B; Seizure; Acute brain injury	NONCONVULSIVE SEIZURES; HEMORRHAGE; ELECTROENCEPHALOGRAPHY; PROBABILITY	Background and Objective Seizures are common after traumatic brain injury (TBI), aneurysmal subarachnoid hemorrhage (aSAH), subdural hematoma (SDH), and non-traumatic intraparenchymal hemorrhage (IPH)-collectively defined herein as acute brain injury (ABI). Most seizures in ABI are subclinical, meaning that they are only detectable with EEG. A method is required to identify patients at greatest risk of seizures and thereby in need of prolonged continuous EEG monitoring. 2HELPS2B is a simple point system developed to address this need. 2HELPS2B estimates seizure risk for hospitalized patients using five EEG findings and one clinical finding (pre-EEG seizure). The initial 2HELPS2B study did not specifically assess the ABI subpopulation. In this study, we aim to validate the 2HELPS2B score in ABI and determine its relative predictive accuracy compared to a broader set of clinical and electrographic factors. Methods We queried the Critical Care EEG Monitoring Research Consortium database for ABI patients age >= 18 with > 6 h of continuous EEG monitoring; data were collected between February 2013 and November 2018. The primary outcome was electrographic seizure. Clinical factors considered were age, coma, encephalopathy, ABI subtype, and acute suspected or confirmed pre-EEG clinical seizure. Electrographic factors included 18 EEG findings. Predictive accuracy was assessed using a machine-learning paradigm with area under the receiver operator characteristic (ROC) curve as the primary outcome metric. Three models (clinical factors alone, EEG factors alone, EEG and clinical factors combined) were generated using elastic-net logistic regression. Models were compared to each other and to the 2HELPS2B model. All models were evaluated by calculating the area under the curve (AUC) of a ROC analysis and then compared using permutation testing of AUC with bootstrapping to generate confidence intervals. Results A total of 1528 ABI patients were included. Total seizure incidence was 13.9%. Seizure incidence among ABI subtype varied: IPH 17.2%, SDH 19.1%, aSAH 7.6%, TBI 9.2%. Age >= 65 (p = 0.015) and pre-cEEG acute clinical seizure (p < 0.001) positively affected seizure incidence. Clinical factors AUC = 0.65 [95% CI 0.60-0.71], EEG factors AUC = 0.82 [95% CI 0.77-0.87], and EEG and clinical factors combined AUC = 0.84 [95% CI 0.80-0.88]. 2HELPS2B AUC = 0.81 [95% CI 0.76-0.85]. The 2HELPS2B AUC did not differ from EEG factors (p = 0.51), or EEG and clinical factors combined (p = 0.23), but was superior to clinical factors alone (p < 0.001). Conclusions Accurate seizure risk forecasting in ABI requires the assessment of EEG markers of pathologic electro-cerebral activity (e.g., sporadic epileptiform discharges and lateralized periodic discharges). The 2HELPS2B score is a reliable and simple method to quantify these EEG findings and their associated risk of seizure.	[Moffet, Eric W.; Subramaniam, Thanujaa; Struck, Aaron F.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Neurol, 7131 MFCB,600 Highland Ave, Madison, WI 53705 USA; [Moffet, Eric W.] Northwestern Univ, Dept Neurol, Feinberg Sch Med, Chicago, IL 60611 USA; [Hirsch, Lawrence J.; Gilmore, Emily J.; Gaspard, Nicolas] Yale Univ, Sch Med, Dept Neurol, New Haven, CT 06510 USA; [Lee, Jong Woo] Harvard Med Sch, Brigham & Womens Hosp, Dept Neurol, Boston, MA 02115 USA; [Rodriguez-Ruiz, Andres A.; Haider, Hiba A.; Dhakar, Monica B.] Emory Univ, Sch Med, Dept Neurol, Atlanta, GA 30322 USA; [Jadeja, Neville] UMass Mem Med Ctr, Dept Neurol, Worcester, MA USA; [Osman, Gamaledin] Henry Ford Hosp, Dept Neurol, Detroit, MI 48202 USA; [Gaspard, Nicolas] Univ Libre Bruxelles, Hosp Erasme, Dept Neurol, Brussels, Belgium		Struck, AF (corresponding author), Univ Wisconsin, Sch Med & Publ Hlth, Dept Neurol, 7131 MFCB,600 Highland Ave, Madison, WI 53705 USA.	afstruck@wisc.edu	Struck, Aaron/AAP-7908-2021; Lee, Jongwoo/AAI-3617-2020	Struck, Aaron/0000-0002-9103-1798; Lee, Jongwoo/0000-0001-5283-7476; Hirsch, Lawrence/0000-0002-6333-832X; Subramaniam, Thanujaa/0000-0001-8034-3553; Haider, Hiba/0000-0001-7118-3690; Rodriguez Ruiz, Andres/0000-0002-1425-9035	American Epilepsy Society; Epilepsy Foundation	This study was supported by a Research Infrastructure Award from the American Epilepsy Society and the Epilepsy Foundation.	Annegers JF, 1998, NEW ENGL J MED, V338, P20, DOI 10.1056/NEJM199801013380104; Claassen J, 2004, NEUROLOGY, V62, P1743, DOI 10.1212/01.WNL.0000125184.88797.62; Claassen J, 2014, ANN NEUROL, V75, P771, DOI 10.1002/ana.24166; De Marchis GM, 2016, NEUROLOGY, V86, P253, DOI 10.1212/WNL.0000000000002281; Dennis LJ, 2002, NEUROSURGERY, V51, P1136, DOI 10.1097/00006123-200211000-00006; Maciel CB, 2016, J CLIN NEUROPHYSIOL, V33, P183, DOI 10.1097/WNP.0000000000000268; Newey CR, 2018, J CLIN NEUROPHYSIOL, V35, P325, DOI 10.1097/WNP.0000000000000475; Oddo M, 2009, CRIT CARE MED, V37, P2051, DOI 10.1097/CCM.0b013e3181a00604; Pollandt S, 2017, J CLIN NEUROPHYSIOL, V34, P55, DOI 10.1097/WNP.0000000000000311; R Foundation for Statistical Computing, 2013, LANG ENV STAT COMP; Rodriguez Ruiz A, 2017, JAMA NEUROL, V74, P181, DOI DOI 10.1001/jamaneurol.2016.4990; Shafi MM, 2012, NEUROLOGY, V79, P1796, DOI 10.1212/WNL.0b013e3182703fbc; Struck AF, 2020, JAMA NEUROL, V77, P500, DOI 10.1001/jamaneurol.2019.4656; Struck AF, 2019, ANN CLIN TRANSL NEUR, V6, P1239, DOI 10.1002/acn3.50817; Struck AF, 2017, JAMA NEUROL, V74, P1419, DOI 10.1001/jamaneurol.2017.2459; Struck AF, 2017, ANN NEUROL, V82, P177, DOI 10.1002/ana.24985; Struck AF, 2016, NEUROCRIT CARE, V24, P324, DOI 10.1007/s12028-016-0245-y; Subramaniam T, 2019, NEUROLOGY, V92, pe670, DOI 10.1212/WNL.0000000000006903; Vespa P, 2005, J CLIN NEUROPHYSIOL, V22, P99, DOI 10.1097/01.WNP.0000154919.54202.E0; Vespa PM, 1999, J NEUROSURG, V91, P750, DOI 10.3171/jns.1999.91.5.0750; Westover MB, 2015, CLIN NEUROPHYSIOL, V126, P463, DOI 10.1016/j.clinph.2014.05.037; Won SY, 2017, SEIZURE-EUR J EPILEP, V45, P28, DOI 10.1016/j.seizure.2016.11.017; Young GB, 1996, NEUROLOGY, V47, P83	23	7	7	2	3	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	DEC	2020	33	3					701	707		10.1007/s12028-020-00939-x		FEB 2020	7	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	PF0WI	WOS:000516969600001	32107733				2022-02-06	
J	Sandmo, SB; Filipcik, P; Cente, M; Hanes, J; Andersen, TE; Straume-Naesheim, TM; Bahr, R				Sandmo, Stian Bahr; Filipcik, Peter; Cente, Martin; Hanes, Jozef; Andersen, Thor Einar; Straume-Naesheim, Truls Martin; Bahr, Roald			Neurofilament light and tau in serum after head-impact exposure in soccer	BRAIN INJURY			English	Article						Subconcussive; TBI; chronic traumatic encephalopathy; football; repetitive head impacts	TRAUMATIC BRAIN-INJURY; MILD; ENCEPHALOPATHY; BIOMARKERS; EXERCISE; VALIDATION; MECHANISMS; FOOTBALL	Introduction: Blood-based biomarkers can provide valuable information on the effects of repetitive head impacts in sports. This study investigated if repetitive headers or accidental head impacts in soccer could cause structural brain injury, detected as an increase in serum neurofilament light (NfL) or tau. Methods: NfL and tau were measured in professional soccer players in pre-season. Then, the effect of three short-term exposures on biomarker levels was assessed: (1) high-intensity exercise, (2) repetitive headers, and (3) head impacts in a match. Results: We analyzed 354 samples and observed no effects on NfL from any of the three short-term exposures. Tau levels rose significantly from baseline to 1 h after (1) high-intensity exercise (Delta 0.50 pg/mL, 95% CI 0.19-0.81, p < .01); the same was observed after (2) repetitive headers (Delta 0.29 pg/mL, 95% CI 0.10-0.48, p < .01), but not after (3) accidental head-impact incidents (Delta 0.36 pg/mL, 95% CI -0.02-0.74, p = .06). The highest absolute values were seen 1 h after high-intensity exercise (mean +/- SD, 1.92 +/- 0.83 pg/mL). Conclusion: NfL and tau in serum were unaffected by head impacts in soccer. Importantly, tau levels seem to rise in response to exercise, emphasizing the need for control groups. Our findings highlight important characteristics and limitations when using these biomarkers in sports.	[Sandmo, Stian Bahr; Andersen, Thor Einar; Straume-Naesheim, Truls Martin; Bahr, Roald] Norwegian Sch Sport Sci, Oslo Sports Trauma Res Ctr, Dept Sports Med, PB 4014 Ulleval Stad, NO-0806 Oslo, Norway; [Sandmo, Stian Bahr] Univ Oslo, Fac Med, Oslo, Norway; [Filipcik, Peter; Cente, Martin; Hanes, Jozef] Slovak Acad Sci, Inst Neuroimmunol, Bratislava, Slovakia; [Straume-Naesheim, Truls Martin] Akershus Univ Hosp, Dept Orthoped Surg, Lorenskog, Norway; [Straume-Naesheim, Truls Martin] Haugesund Rheumatism Hosp, Dept Orthoped Surg, Haugesund, Norway		Sandmo, SB (corresponding author), Norwegian Sch Sport Sci, Oslo Sports Trauma Res Ctr, Dept Sports Med, PB 4014 Ulleval Stad, NO-0806 Oslo, Norway.	s.b.sandmo@nih.no	Hanes, Jozef/ABE-6106-2020	Filipcik, Peter/0000-0001-8919-5964; Cente, Martin/0000-0003-1420-1017; Andersen, Thor Einar/0000-0003-4172-4518	Research Council of Norway, ERANET NeuronResearch Council of Norway	This work was supported by the The Research Council of Norway, ERANET Neuron.	Andersen TE, 2004, BRIT J SPORT MED, V38, P690, DOI 10.1136/bjsm.2003.009357; Andersen TE, 2004, BRIT J SPORT MED, V38, P626, DOI 10.1136/bjsm.2003.007955; Andersen TE, 2003, BRIT J SPORT MED, V37, P226, DOI 10.1136/bjsm.37.3.226; Asken BM, 2017, JAMA NEUROL, V74, P1255, DOI 10.1001/jamaneurol.2017.2396; Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; Bazarian JJ, 2018, LANCET NEUROL, V17, P782, DOI 10.1016/S1474-4422(18)30231-X; Bergman L, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196025; Bigler ED, 2012, BRAIN IMAGING BEHAV, V6, P108, DOI 10.1007/s11682-011-9145-0; Catenaccio E, 2016, RES SPORTS MED, V24, P416, DOI 10.1080/15438627.2016.1234472; Chrisman SPD, 2016, J CHILD NEUROL, V31, P971, DOI 10.1177/0883073816634857; Di Battista AP, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159929; Gill J, 2017, NEUROLOGY, V88, P595, DOI 10.1212/WNL.0000000000003587; Giza CC, 2001, J ATHL TRAINING, V36, P228; Iliff JJ, 2014, J NEUROSCI, V34, P16180, DOI 10.1523/JNEUROSCI.3020-14.2014; Kawata K, 2018, J NEUROTRAUM, V35, P260, DOI 10.1089/neu.2017.5376; Khalil M, 2018, NAT REV NEUROL, V14, P577, DOI 10.1038/s41582-018-0058-z; Knaepen K, 2010, SPORTS MED, V40, P765, DOI 10.2165/11534530-000000000-00000; Kontos AP, 2017, BRIT J SPORT MED, V51, P1118, DOI 10.1136/bjsports-2016-096276; Lionnet A, 2018, ACTA NEUROPATHOL COM, V6, DOI 10.1186/s40478-018-0568-3; McCrea M, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097447; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Mez J, 2017, JAMA-J AM MED ASSOC, V318, P360, DOI 10.1001/jama.2017.8334; Montenigro PH, 2017, J NEUROTRAUM, V34, P328, DOI 10.1089/neu.2016.4413; Olivera A, 2015, JAMA NEUROL, V72, P1109, DOI 10.1001/jamaneurol.2015.1383; Preische O, 2019, NAT MED, V25, P277, DOI 10.1038/s41591-018-0304-3; Press JN, 2017, CLIN J SPORT MED, V27, P104, DOI 10.1097/JSM.0000000000000313; Rodrigues AC, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00038; Rubenstein R, 2017, JAMA NEUROL, V74, P1063, DOI 10.1001/jamaneurol.2017.0655; Rubin LH, 2019, BRAIN INJURY, V33, P456, DOI 10.1080/02699052.2019.1565895; Sandmo SB, 2019, AM J SPORT MED, V47, P974, DOI 10.1177/0363546519826953; Shahim P, 2018, NEUROLOGY, V90, pE1780, DOI 10.1212/WNL.0000000000005518; Shahim P, 2017, NEUROLOGY, V88, P1788, DOI 10.1212/WNL.0000000000003912; Shahim P, 2016, SCI REP-UK, V6, DOI 10.1038/srep36791; SHARMA HS, 1991, NEUROSCI RES, V10, P211; Straume-Naesheim TM, 2005, BRIT J SPORT MED, V39, pI70, DOI 10.1136/bjsm.2005.019646; Straume-Naesheim TM, 2009, NEUROSURGERY, V64, P719, DOI 10.1227/01.NEU.0000340681.12949.6D; Straume-Naesheim TM, 2008, NEUROSURGERY, V62, P1297, DOI 10.1227/01.neu.0000333301.34189.3d; Tarnutzer AA, 2017, BRIT J SPORT MED, V51, P1592, DOI 10.1136/bjsports-2016-096593; Unden L, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0533-y; Wang KK, 2018, EXPERT REV MOL DIAGN, V18, P165, DOI 10.1080/14737159.2018.1428089; Watson P, 2005, AM J PHYSIOL-REG I, V288, pR1689, DOI 10.1152/ajpregu.00676.2004; Zetterberg H, 2016, NAT REV NEUROL, V12, P563, DOI 10.1038/nrneurol.2016.127	43	7	7	0	7	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	APR 15	2020	34	5					602	609		10.1080/02699052.2020.1725129		FEB 2020	8	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	LB9LL	WOS:000516678700001	32096660	Green Accepted			2022-02-06	
J	Jing, Y; Yang, DX; Wang, W; Yuan, F; Chen, H; Ding, J; Geng, Z; Tian, HL				Jing, Yao; Yang, Dian-Xu; Wang, Wei; Yuan, Fang; Chen, Hao; Ding, Jun; Geng, Zhi; Tian, Heng-Li			Aloin Protects Against Blood-Brain Barrier Damage After Traumatic Brain Injury in Mice	NEUROSCIENCE BULLETIN			English	Article						Aloin; Blood-brain barrier; Traumatic brain injury; Oxidative stress; Apoptosis	NF-KAPPA-B; CELL APOPTOSIS; CYTOCHROME-C; INHIBITION; MITOCHONDRIA; DISRUPTION; MODEL; INFLAMMATION; TRANSITION; DEFICITS	Aloin is a small-molecule drug well known for its protective actions in various models of damage. Traumatic brain injury (TBI)-induced cerebral edema from secondary damage caused by disruption of the blood-brain barrier (BBB) often leads to an adverse prognosis. Since the role of aloin in maintaining the integrity of the BBB after TBI remains unclear, we explored the protective effects of aloin on the BBB using in vivo and in vitro TBI models. Adult male C57BL/6 mice underwent controlled cortical impact injury, and mouse brain capillary endothelial bEnd.3 cells underwent biaxial stretch injury, then both received aloin treatment. In the animal experiments, we found 20 mg/kg aloin to be the optimum concentration to decrease cerebral edema, decrease disruption of the BBB, and improve neurobehavioral performance after cortical impact injury. In the cellular studies, the optimum concentration of 40 mu g/mL aloin reduced apoptosis and reversed the loss of tight junctions by reducing the reactive oxygen species levels and changes in mitochondrial membrane potential after stretch injury. The mechanisms may be that aloin downregulates the phosphorylation of p38 mitogen-activated protein kinase, the activation of p65 nuclear factor-kappa B, and the ratios of B cell lymphoma (Bcl)-2-associated X protein/Bcl-2 and cleaved caspase-3/caspase-3. We conclude that aloin exhibits these protective effects on the BBB after TBI through its anti-oxidative stress and anti-apoptotic properties in mouse brain capillary endothelial cells. Aloin may thus be a promising therapeutic drug for TBI.	[Jing, Yao; Yang, Dian-Xu; Wang, Wei; Yuan, Fang; Chen, Hao; Ding, Jun; Tian, Heng-Li] Shanghai Jiao Tong Univ Affiliated Peoples Hosp 6, Dept Neurosurg, Shanghai 200233, Peoples R China; [Geng, Zhi] Shanghai Jiao Tong Univ Affiliated Peoples Hosp 6, Dept Neurol, Shanghai 200233, Peoples R China		Ding, J; Tian, HL (corresponding author), Shanghai Jiao Tong Univ Affiliated Peoples Hosp 6, Dept Neurosurg, Shanghai 200233, Peoples R China.; Geng, Z (corresponding author), Shanghai Jiao Tong Univ Affiliated Peoples Hosp 6, Dept Neurol, Shanghai 200233, Peoples R China.	djdjdoc@126.com; gengzhi1998@163.com; tianhlsh@126.com			Med-X Research Institute of Shanghai Jiao Tong University; National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81671207, 81701895, 81501048]; Shanghai Jiao Tong University Medicine-Engineering Research Fund [YG2016QN20]	We thank Prof. Guo-yuan Yang (School of Biomedical Engineering and Med-X Research Institute of Shanghai Jiao Tong University, Shanghai, China) for guidance in experiments. This work was supported by the National Natural Science Foundation of China (81671207, 81701895, and 81501048) and the Shanghai Jiao Tong University Medicine-Engineering Research Fund (YG2016QN20).	Abdul-Muneer PM, 2015, MOL NEUROBIOL, V51, P966, DOI 10.1007/s12035-014-8752-3; Ahmed SM, 2000, J NEUROCHEM, V74, P1951, DOI 10.1046/j.1471-4159.2000.0741951.x; Azarashvili T, 2010, BIOL CHEM, V391, P619, DOI 10.1515/BC.2010.070; Bhowmick S, 2019, EXP NEUROL, V317, P260, DOI 10.1016/j.expneurol.2019.03.014; Cernak I, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00209; Chae IH, 2004, CLIN CHIM ACTA, V341, P83, DOI 10.1016/j.cccn.2003.11.009; Chang RY, 2016, BRAIN RES BULL, V121, P75, DOI 10.1016/j.brainresbull.2016.01.001; Cheng G, 2012, BRIT J PHARMACOL, V167, P699, DOI 10.1111/j.1476-5381.2012.02025.x; Fang J, 2019, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.01006; Gao C, 2017, MOL NEUROBIOL, V54, P8348, DOI 10.1007/s12035-016-0318-0; Glober Nancy K, 2019, Neurosci J, V2019, P2831501, DOI 10.1155/2019/2831501; Hao FL, 2019, BIOMED PHARMACOTHER, V109, P181, DOI 10.1016/j.biopha.2018.10.064; Hu HM, 2018, NEUROSCI BULL, V34, P951, DOI 10.1007/s12264-018-0232-8; Huang SX, 2018, NEUROCHEM RES, V43, P1814, DOI 10.1007/s11064-018-2597-5; Jiang JY, 2019, LANCET NEUROL, V18, P286, DOI 10.1016/S1474-4422(18)30469-1; Jing Y, 2019, MED SCI MONITOR, V25, P1291, DOI 10.12659/MSM.912586; Knoblach SM, 2002, J NEUROTRAUM, V19, P1155, DOI 10.1089/08977150260337967; Lee W, 2019, FOOD CHEM TOXICOL, V126, P67, DOI 10.1016/j.fct.2019.02.025; Liu YL, 2018, J NEUROTRAUM, V35, P2850, DOI 10.1089/neu.2017.5397; Liu YL, 2017, ACTA PHARMACOL SIN, V38, P1445, DOI 10.1038/aps.2017.103; Luissint AC, 2012, FLUIDS BARRIERS CNS, V9, DOI 10.1186/2045-8118-9-23; Michinaga S, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20030571; Needham EJ, 2019, J NEUROIMMUNOL, V332, P112, DOI 10.1016/j.jneuroim.2019.04.005; Ni HQ, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00014; Pan Q, 2013, CANCER CELL INT, V13, DOI 10.1186/1475-2867-13-69; Rehman SU, 2018, CEREB CORTEX, V28, P2854, DOI 10.1093/cercor/bhx164; Sajja VSSS, 2018, J NEUROTRAUM, V35, P353, DOI 10.1089/neu.2017.5009; Sarkar C, 2014, AUTOPHAGY, V10, P2208, DOI 10.4161/15548627.2014.981787; Silva MA, 2014, J PHOTOCH PHOTOBIO B, V133, P47, DOI 10.1016/j.jphotobiol.2014.02.019; Tang GH, 2014, STEM CELLS, V32, P3150, DOI 10.1002/stem.1808; Tao L, 2018, BRAIN RES BULL, V140, P154, DOI 10.1016/j.brainresbull.2018.04.008; Vorhees CV, 2006, NAT PROTOC, V1, P848, DOI 10.1038/nprot.2006.116; Wang D, 2018, NEURAL REGEN RES, V13, P819, DOI 10.4103/1673-5374.232529; Wang XZ, 2019, NEUROSCI BULL, V35, P461, DOI 10.1007/s12264-018-00333-w; Wang X, 2018, AM J TRANSL RES, V10, P368; Wang ZF, 2019, NEUROBIOL LEARN MEM, V161, P12, DOI 10.1016/j.nlm.2019.03.002; Washington PM, 2012, J NEUROTRAUM, V29, P2283, DOI 10.1089/neu.2012.2456; Xie BS, 2019, CNS NEUROSCI THER, V25, P465, DOI 10.1111/cns.13069; Xu ZM, 2017, J NEUROTRAUM, V34, P925, DOI 10.1089/neu.2016.4491; Xu ZM, 2017, BMC NEUROSCI, V18, DOI 10.1186/s12868-017-0378-8; Yang DX, 2019, J NEUROTRAUM, V36, P1279, DOI 10.1089/neu.2018.5942; Yang J, 1997, SCIENCE, V275, P1129, DOI 10.1126/science.275.5303.1129; Yuan F, 2016, J NEUROCHEM, V136, P581, DOI 10.1111/jnc.13423; Yuan FJ, 2019, PHYTOMEDICINE, V57, P305, DOI 10.1016/j.phymed.2018.12.043; Zhang L, 2019, J CELL MOL MED, V23, P2995, DOI 10.1111/jcmm.14206; Zhang L, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00263; Zhong JJ, 2019, INT IMMUNOPHARMACOL, V72, P48, DOI 10.1016/j.intimp.2019.03.050; Zhou Q, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1287-1	48	7	8	6	9	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	1673-7067	1995-8218		NEUROSCI BULL	Neurosci. Bull.	JUN	2020	36	6					625	638		10.1007/s12264-020-00471-0		FEB 2020	14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	LU4TI	WOS:000518114300001	32100248	Green Published			2022-02-06	
J	Zeiler, FA; Aries, M; Cabeleira, M; van Essen, TA; Stocchetti, N; Menon, DK; Timofeev, I; Czosnyka, M; Smielewski, P; Hutchinson, P; Ercole, A				Zeiler, Frederick A.; Aries, Marcel; Cabeleira, Manuel; van Essen, Thomas A.; Stocchetti, Nino; Menon, David K.; Timofeev, Ivan; Czosnyka, Marek; Smielewski, Peter; Hutchinson, Peter; Ercole, Ari		CENTER-TBI High Resolution ICU HR	Statistical Cerebrovascular Reactivity Signal Properties after Secondary Decompressive Craniectomy in Traumatic Brain Injury: A CENTER-TBI Pilot Analysis	JOURNAL OF NEUROTRAUMA			English	Article						cerebrovascular reactivity; DC; decompressive craniectomy; PRx; TBI	CEREBRAL PERFUSION-PRESSURE; INTRACRANIAL-PRESSURE; LOWER LIMIT; PART II; AUTOREGULATION; VALIDATION; MANAGEMENT; INDEXES	Decompressive craniectomy (DC) in traumatic brain injury (TBI) has been suggested to influence cerebrovascular reactivity. We aimed to determine if the statistical properties of vascular reactivity metrics and slow-wave relationships were impacted after DC, as such information would allow us to comment on whether vascular reactivity monitoring remains reliable after craniectomy. Using the CENTER-TBI High Resolution Intensive Care Unit (ICU) Sub-Study cohort, we selected those secondary DC patients with high-frequency physiological data for both at least 24 h pre-DC, and more than 48 h post-DC. Data for all physiology measures were separated into the 24 h pre-DC, the first 48 h post-DC, and beyond 48 h post-DC. We produced slow-wave data sheets for intracranial pressure (ICP) and mean arterial pressure (MAP) per patient. We also derived a Pressure Reactivity Index (PRx) as a continuous cerebrovascular reactivity metric updated every minute. The time-series behavior of the PRx was modeled for each time period per patient. Finally, the relationship between ICP and MAP during these three time periods was assessed using time-series vector autoregressive integrative moving average (VARIMA) models, impulse response function (IRF) plots, and Granger causality testing. Ten patients were included in this study. Mean PRx and proportion of time above PRx thresholds were not affected by craniectomy. Similarly, PRx time-series structure was not affected by DC, when assessed in each individual patient. This was confirmed with Granger causality testing, and VARIMA IRF plotting for the MAP/ICP slow-wave relationship. PRx metrics and statistical time-series behavior appear not to be substantially influenced by DC. Similarly, there is little change in the relationship between slow waves of ICP and MAP before and after DC. This may suggest that cerebrovascular reactivity monitoring in the setting of DC may still provide valuable information regarding autoregulation.	[Zeiler, Frederick A.; Menon, David K.; Ercole, Ari] Univ Cambridge, Addenbrookes Hosp, Div Anesthesia, Cambridge, England; [Cabeleira, Manuel; Czosnyka, Marek; Smielewski, Peter] Univ Cambridge, Addenbrookes Hosp, Div Neurosurg, Brain Phys Lab, Cambridge, England; [Timofeev, Ivan; Hutchinson, Peter] Univ Cambridge, Addenbrookes Hosp, Div Neurosurg, Dept Clin Neurosci, Cambridge, England; [Zeiler, Frederick A.] Univ Manitoba, Rady Fac Hlth Sci, Dept Surg, Winnipeg, MB, Canada; [Zeiler, Frederick A.] Univ Manitoba, Rady Fac Hlth Sci, Dept Human Anat & Cell Sci, Winnipeg, MB, Canada; [Zeiler, Frederick A.] Univ Manitoba, Fac Engn, Biomed Engn, Winnipeg, MB, Canada; [Zeiler, Frederick A.] Univ Manitoba, Ctr Aging, Winnipeg, MB, Canada; [Aries, Marcel] Maastricht UMC, Dept Intens Care, Maastricht, Netherlands; [van Essen, Thomas A.] Leiden Univ, Med Ctr, Univ Neurosurg Ctr Holland, Dept Neurosurg, Leiden, Netherlands; [van Essen, Thomas A.] Haaglanden Med Ctr, The Hague, Netherlands; [Stocchetti, Nino] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Neuro ICU, Milan, Italy; [Stocchetti, Nino] Milan Univ, Dept Physiopathol & Transplantat, Milan, Italy; [Czosnyka, Marek] Warsaw Univ Technol, Inst Elect Syst, Warsaw, Poland		Zeiler, FA (corresponding author), Univ Manitoba, Rady Fac Hlth Sci, Sect Neurosurg, Dept Surg, Winnipeg, MB R3A 1R9, Canada.	umzeiler@myumanitoba.ca	Ercole, Ari/B-6288-2009; Sahuquillo, Juan/B-3577-2008; Raj, Rahul/K-7693-2012; Moller, Kirsten/A-4751-2009	Ercole, Ari/0000-0001-8350-8093; Sahuquillo, Juan/0000-0003-0713-5875; Zeiler, Frederick/0000-0003-1737-0510; Van Essen, Thomas/0000-0003-4657-5283; Raj, Rahul/0000-0003-4243-9591; Moller, Kirsten/0000-0003-3058-1072; Sakowitz, Oliver/0000-0003-3248-6335; Radoi, Andreea/0000-0002-0677-3544; Timofeev, Ivan/0000-0002-1168-0393	European UnionEuropean Commission [602150]; Hannelore Kohl Stiftung (Germany); OneMind (United States); Integra LifeSciences Corporation (United States); University of Manitoba VPRI Research Investment Fund (RIF); Winnipeg Health Sciences Center (HSC) Foundation; University of Manitoba Rudy Falk ClinicianScientist Professorship; National Institutes of Health (NIH) through the National Institute of Neurological Disorders and Stroke (NINDS) [R03 NS114335-01]; Canadian Institutes of Health Research (CIHR)Canadian Institutes of Health Research (CIHR) [432061]; University of Manitoba-Centre on Aging; National Institute for Health Research (NIHR)National Institute for Health Research (NIHR); Cambridge Biomedical Research Center at the Cambridge University Hospitals National Health Service (NHS) Foundation Trust; Hersenstichting Nederland (the Dutch Brian Foundation) [ps2014.06]	CENTER-TBI is a large collaborative project with the support of the European Union 7th Framework Program (European Commission grant 602150). Additional funding was obtained from the Hannelore Kohl Stiftung (Germany), OneMind (United States), and Integra LifeSciences Corporation (United States). The study also received additional support from the National Institute for Health Research (NIHR) Clinical Research Network.; FAZ is supported by the University of Manitoba VPRI Research Investment Fund (RIF), Winnipeg Health Sciences Center (HSC) Foundation, the University of Manitoba Rudy Falk ClinicianScientist Professorship, the National Institutes of Health (NIH) through the National Institute of Neurological Disorders and Stroke (NINDS) (R03 NS114335-01), the Canadian Institutes of Health Research (CIHR) (432061), and the University of Manitoba-Centre on Aging. DKM was supported by funding from the National Institute for Health Research (NIHR) through a Senior Investigator Award and the Cambridge Biomedical Research Center at the Cambridge University Hospitals National Health Service (NHS) Foundation Trust. TvE is supported by funding from the Hersenstichting Nederland (the Dutch Brian Foundation, grant number ps2014.06).	Aries MJH, 2012, CRIT CARE MED, V40, P2456, DOI 10.1097/CCM.0b013e3182514eb6; Aries MJH, 2012, NEUROCRIT CARE, V17, P67, DOI 10.1007/s12028-012-9687-z; Beez T, 2019, CRIT CARE, V23, DOI 10.1186/s13054-019-2490-x; Brady KM, 2008, STROKE, V39, P2531, DOI 10.1161/STROKEAHA.108.514877; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Chatfield C., 2016, ANAL TIME SERIES INT; Czosnyka M, 1997, NEUROSURGERY, V41, P11, DOI 10.1097/00006123-199707000-00005; Czosnyka M, 2014, NEUROCRIT CARE, V21, P95, DOI 10.1007/s12028-014-0046-0; Doiron D, 2017, INT J EPIDEMIOL, V46, P1372, DOI 10.1093/ije/dyx180; Donnelly J, 2019, NEUROSURGERY, V85, pE75, DOI 10.1093/neuros/nyy468; Douc R., 2014, NONLINEAR TIME SERIE, V1st edn; Gao L, 2017, J NEUROTRAUM, V34, P2743, DOI 10.1089/neu.2016.4787; Hutchinson PJ, 2016, NEW ENGL J MED, V375, P1119, DOI 10.1056/NEJMoa1605215; Kelly S, 2018, ACTA NEUROCHIR SUPPL, V126, P317, DOI 10.1007/978-3-319-65798-1_62; Le Roux P, 2014, INTENS CARE MED, V40, P1189, DOI 10.1007/s00134-014-3369-6; Maas AIR, 2015, NEUROSURGERY, V76, P67, DOI 10.1227/NEU.0000000000000575; Schmidt EA, 2003, J NEUROSURG, V99, P991, DOI 10.3171/jns.2003.99.6.0991; Sorrentino E, 2012, NEUROCRIT CARE, V16, P258, DOI 10.1007/s12028-011-9630-8; Steiner LA, 2002, CRIT CARE MED, V30, P733, DOI 10.1097/00003246-200204000-00002; Timofeev I, 2008, J NEUROSURG, V108, P66, DOI 10.3171/JNS/2008/108/01/0066; Zeiler F.A., 2018, J NEUROTRAUM, V36, P1505; Zeiler F.A., 2018, J NEUROTRAUM, V36, P713; Zeiler FA, 2018, J NEUROTRAUM, V35, P2812, DOI 10.1089/neu.2017.5604; Zeiler FA, 2018, J NEUROTRAUM, V35, P2803, DOI 10.1089/neu.2017.5603; Zeiler FA, 2018, J NEUROTRAUM, V35, P1559, DOI 10.1089/neu.2017.5596; Zeiler FA, 2019, ACTA NEUROCHIR, V161, P1217, DOI 10.1007/s00701-019-03844-1; Zeiler FA, 2018, J NEUROTRAUM, V35, P1107, DOI 10.1089/neu.2017.5472; Zeiler FA, 2017, J NEUROTRAUM, V34, P3224, DOI 10.1089/neu.2017.5086	28	7	7	0	1	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUN 1	2020	37	11					1306	1314		10.1089/neu.2019.6726		FEB 2020	9	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	LT0OT	WOS:000517890900001	31950876	Green Submitted, Bronze, Green Published			2022-02-06	
J	Gray, M; Adamson, MM; Thompson, RC; Kapphahn, KI; Han, S; Chung, JS; Harris, OA				Gray, Max; Adamson, Maheen M.; Thompson, Ryan C.; Kapphahn, Kristopher I.; Han, Summer; Chung, Joyce S.; Harris, Odette A.			Sex differences in symptom presentation and functional outcomes: a pilot study in a matched sample of veterans with mild TBI	BRAIN INJURY			English	Article						Sex; Traumatic Brain Injury; Veterans; Symptoms; Living Situation	TRAUMATIC BRAIN-INJURY; PERSISTENT POSTCONCUSSIVE SYMPTOMS; POSTTRAUMATIC-STRESS-DISORDER; GENDER-DIFFERENCES; HELP-SEEKING; HEALTH; COMBAT; AFGHANISTAN; IRAQ; PREVALENCE	Primary Objective: Research focused on mild traumatic brain injury in active military and veteran populations details the psychological, neurological and functional outcomes of mTBI, in a primarily male (similar to 95%) cohort. This may misrepresent female symptoms and outcomes. Here we assess for genuine sex differences in symptom presentation and functional outcomes. Research Design: We used matched pairs to preclude potential sex bias in outcome data. Methods and Procedures: We matched 49 female/male pairs on; 1) mechanism of injury, 2) time from injury to assessment and 3) age at assessment. Statistics were t-tests, chi-square, correlations and post hoc linear regression. Main outcomes and results: Outcome assessment revealed four significant (p < .05) sex differences; Living situation, Marital status, Vocation and Branch of service. Only the Neurobehavioral Symptom Inventory (NSI) composite cognitive domain factor was significantly different between females (mean: 10.26) and males (mean: 7.58). Linear regression confirmed a significant effect of sex for the cognitive composite (p = .002). Conclusion: We conclude that sex has a moderate effect on mTBI post-concussive symptom presentation. The significant sex difference in the NSI cognitive domain characterizes sex-related symptomology profiles providers can focus on for better rehabilitation management. Replication in the larger cohort would improve generalizability.	[Gray, Max; Adamson, Maheen M.; Thompson, Ryan C.; Harris, Odette A.] VAPAHCS, DVBIC, Palo Alto, CA USA; [Kapphahn, Kristopher I.; Han, Summer; Harris, Odette A.] Stanford Sch Med, Dept Neurosurg, Palo Alto, CA USA; [Chung, Joyce S.; Harris, Odette A.] VAPAHCS, Dept Polytrauma, Palo Alto, CA USA		Adamson, MM (corresponding author), VAPAHCS, DVBIC, Stanford Sch Med, 3801 Miranda Ave, Palo Alto, CA 94304 USA.; Adamson, MM (corresponding author), 3801 Miranda Ave, Palo Alto, CA 94304 USA.	madamson@stanford.edu		Adamson, Maheen/0000-0002-1534-4063	Clayman Institute for Gender Research at Stanford University; Veterans Brain Injury Center (DVBIC), VA Palo Alto Health Care System Polytrauma Department; Department of Neurosurgery at Stanford School of Medicine	This work was funded by the Clayman Institute for Gender Research at Stanford University awarded to Dr. Odette Harris. We acknowledge the support of Defense and Veterans Brain Injury Center (DVBIC), VA Palo Alto Health Care System Polytrauma Department and Department of Neurosurgery at Stanford School of Medicine.	Barsky AJ, 2001, J GEN INTERN MED, V16, P266, DOI 10.1046/j.1525-1497.2001.016004266.x; Blackstock OJ, 2012, MED CARE, V50, P347, DOI 10.1097/MLR.0b013e318245a738; Brickell TA, 2017, J NEUROTRAUM, V34, P300, DOI 10.1089/neu.2016.4403; Defense and Veterans Brain Injury Center, 2018, DOD WORLDW NUMB TBI; Fox AB, 2016, PSYCHOL TRAUMA-US, V8, P135, DOI 10.1037/tra0000033; French LM, 2014, J NEUROTRAUM, V31, P1607, DOI 10.1089/neu.2014.3401; Hamilton AB, 2011, WOMEN HEALTH ISS, V21, pS203, DOI 10.1016/j.whi.2011.04.005; Hendricks AM, 2013, BRAIN INJURY, V27, P125, DOI 10.3109/02699052.2012.729284; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hourani L, 2016, J WOMENS HEALTH, V25, P22, DOI 10.1089/jwh.2014.5078; IOM (Institute of Medicine), 2013, RET HOM IR AFGH ASS; Iverson KM, 2013, J WOMENS HEALTH, V22, P267, DOI 10.1089/jwh.2012.3755; Iverson KM, 2011, WOMEN HEALTH ISS, V21, pS210, DOI 10.1016/j.whi.2011.04.019; KESSLER RC, 1981, J HEALTH SOC BEHAV, V22, P49, DOI 10.2307/2136367; King N, 2014, NEUROREHABILITATION, V34, P741, DOI 10.3233/NRE-141072; Lew HL, 2009, J REHABIL RES DEV, V46, P819, DOI 10.1682/JRRD.2008.09.0129; Lew HL, 2009, J REHABIL RES DEV, V46, P697, DOI 10.1682/JRRD.2009.01.0006; Lew HL, 2005, J REHABIL RES DEV, V(2005, P8; MacGregor AJ, 2013, J HEAD TRAUMA REHAB, V28, P59, DOI 10.1097/HTR.0b013e3182596382; Maguen S, 2010, AM J PUBLIC HEALTH, V100, P2450, DOI 10.2105/AJPH.2009.166165; Meterko M, 2012, J HEAD TRAUMA REHAB, V27, P55, DOI 10.1097/HTR.0b013e318230fb17; Metraux S, 2013, AM J PUBLIC HEALTH, V103, pS255, DOI 10.2105/AJPH.2013.301432; Meyer K, 2011, TRAUMATIC BRAIN INJU; Okie S, 2006, NEW ENGL J MED, V355, P2609, DOI 10.1056/NEJMp068235; Parboteeah KP, 2003, ORGAN SCI, V14, P137, DOI 10.1287/orsc.14.2.137.14989; Pogoda TK, 2014, J REHABIL RES DEV, V51, P363, DOI 10.1682/JRRD.2013.05.0115; R Core Team, 2018, R LANGUAGE ENV STAT; Sayer NA, 2008, ARCH PHYS MED REHAB, V89, P163, DOI 10.1016/j.apmr.2007.05.025; Sayer NA, 2009, PM&R, V1, P23, DOI 10.1016/j.pmrj.2008.10.003; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Scholten JD, 2012, BRAIN INJURY, V26, P1177, DOI 10.3109/02699052.2012.661914; Schumm JA, 2012, ALCOHOL RES-CURR REV, V34, P401; Sharp ML, 2015, EPIDEMIOL REV, V37, P144, DOI 10.1093/epirev/mxu012; Sigford BJ, 2008, ARCH PHYS MED REHAB, V89, P160, DOI 10.1016/j.apmr.2007.09.015; Silva MA, 2013, CLIN NEUROPSYCHOL, V27, P601; Soble JR, 2014, CLIN NEUROPSYCHOL, V28, P614, DOI 10.1080/13854046.2014.894576; Taylor BC, 2012, MED CARE, V50, P342, DOI 10.1097/MLR.0b013e318245a558; Thomas JL, 2010, ARCH GEN PSYCHIAT, V67, P614, DOI 10.1001/archgenpsychiatry.2010.54; Torreon BS, 2016, US PERIODS WAR DATES; Vanderploeg RD, 2015, J HEAD TRAUMA REHAB, V30, P1, DOI 10.1097/HTR.0000000000000009; Wilk JE, 2012, PSYCHOSOM MED, V74, P249, DOI 10.1097/PSY.0b013e318244c604	41	7	7	0	7	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	MAR 20	2020	34	4					535	547		10.1080/02699052.2020.1725979		FEB 2020	13	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	KT8TS	WOS:000514498000001	32064965				2022-02-06	
J	Mortensen, JD; Vasavada, AN; Merryweather, AS				Mortensen, Jonathan D.; Vasavada, Anita N.; Merryweather, Andrew S.			Sensitivity analysis of muscle properties and impact parameters on head injury risk in American football	JOURNAL OF BIOMECHANICS			English	Article						Concussion; Musculoskeletal modeling; OpenSim; Simulation; Football	CHRONIC TRAUMATIC ENCEPHALOPATHY; DYNAMIC SIMULATIONS; IN-VIVO; COLLEGIATE; PLAYERS; STRENGTH; CONCUSSION; BIOMECHANICS; ACTIVATION; PREDICTION	Head injuries frequently occur in American football and other contact sports. Uncertainty on the effects of cervical muscle properties on head injury risk may be due to the limitations of previous observational studies. This simulation study employs a musculoskeletal model of the head and neck to investigate the effect of several factors related to head injury metrics in American Football. These factors include isometric muscle strength, the eccentric multiplier (which is related to the athlete's ability to apply greater muscle force during eccentric contractions), posture, muscle activation patterns, and impact properties. Impact properties were based on the literature and tuned to reproduce peak linear and rotational accelerations of the skull. We hypothesized that active neck muscles significantly reduce head injury metrics. We systematically altered each model parameter to test our hypothesis. We then determined which model parameters affect head injury metrics the most. The results of this study indicate that active neck muscles have a statistically significant effect on head injury metrics. Increasing muscle strength and eccentric multiplier also resulted in a statistically significant reduction of head injury metrics. However, posture prior to impact had a much stronger effect than any other factor on head injury metrics. A comprehensive approach to athlete training protocols is recommended, including exercises aimed at increasing eccentric muscle strength and preparation for impacts. Future studies should investigate how targeted muscle strengthening and impact training (i.e. activation patterns and posture) modifies risk. (C) 2019 Elsevier Ltd. All rights reserved.	[Mortensen, Jonathan D.; Merryweather, Andrew S.] Univ Utah, Dept Mech Engn, 1495 E 100 S 1550 MEK, Salt Lake City, UT 84112 USA; [Vasavada, Anita N.] Washington State Univ, Gene & Linda Voiland Sch Chem & Bioengn, Pullman, WA 99164 USA; [Vasavada, Anita N.] Washington State Univ, Dept Integrat Physiol & Neurosci, Pullman, WA 99164 USA; [Vasavada, Anita N.] Washington State Univ, Washington Ctr Muscle Biol, Pullman, WA 99164 USA		Mortensen, JD (corresponding author), Univ Utah, Dept Mech Engn, 1495 E 100 S 1550 MEK, Salt Lake City, UT 84112 USA.	jon.mortensen@utah.edu			National Science FoundationNational Science Foundation (NSF) [1622741]; NIOSH (NIOSH Education and Research Center) [T42/CCT810426-10]	This research was funded in part by grants from the National Science Foundation (#1622741) and NIOSH (NIOSH Education and Research Center training grant T42/CCT810426-10).	[Anonymous], 2016, INJ DAT 2016; Broglio SP, 2017, J NEUROTRAUM, V34, P2675, DOI 10.1089/neu.2016.4767; Cazzola D, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169329; Cowell JF, 2012, STRENGTH COND J, V34, P33, DOI 10.1519/SSC.0b013e318253f578; Delp SL, 2007, IEEE T BIO-MED ENG, V54, P1940, DOI 10.1109/TBME.2007.901024; Duma SM, 2005, CLIN J SPORT MED, V15, P3, DOI 10.1097/00042752-200501000-00002; Eckner JT, 2014, AM J SPORT MED, V42, P566, DOI 10.1177/0363546513517869; Fanta O, 2013, NEUROENDOCRINOL LETT, V34, P708; Fanton M, 2019, IEEE T BIO-MED ENG, V66, P988, DOI 10.1109/TBME.2018.2866147; Fernandez J., 2017, RAPID PREDICTION PER, P71; Funk JR, 2012, ANN BIOMED ENG, V40, P79, DOI 10.1007/s10439-011-0400-8; Gollapudi SK, 2013, ANN BIOMED ENG, V41, P1767, DOI 10.1007/s10439-013-0820-8; Guskiewicz KM, 2007, NEUROSURGERY, V61, P1244, DOI 10.1227/01.neu.0000306103.68635.1a; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Hasegawa K, 2014, DENT TRAUMATOL, V30, P259, DOI 10.1111/edt.12082; Hasson CJ, 2012, ANN BIOMED ENG, V40, P1088, DOI 10.1007/s10439-011-0481-4; Hasson CJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015953; Hedayatpour N, 2012, J ELECTROMYOGR KINES, V22, P329, DOI 10.1016/j.jelekin.2011.11.010; Hernandez F, 2015, ANN BIOMED ENG, V43, P1918, DOI 10.1007/s10439-014-1212-4; Hildenbrand KJ, 2013, J STRENGTH COND RES, V27, P3173, DOI 10.1519/JSC.0b013e31828a1fe2; Hutchinson J, 1998, APPL MATH COMPUT, V96, P1, DOI 10.1016/S0096-3003(97)10106-0; Isner-Horobeti ME, 2013, SPORTS MED, V43, P483, DOI 10.1007/s40279-013-0052-y; Jin X, 2017, J BIOMECH ENG-T ASME, V139, DOI 10.1115/1.4037399; Kuo C, 2018, J BIOMECH, V76, P220, DOI 10.1016/j.jbiomech.2018.05.024; Lisman P., 2012, INT J SPORTS SCI ENG, V6, P131; Mang DWH, 2015, SPINE J, V15, P153, DOI 10.1016/j.spinee.2014.08.002; Marjoux D, 2008, ACCIDENT ANAL PREV, V40, P1135, DOI 10.1016/j.aap.2007.12.006; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Mez J, 2017, JAMA-J AM MED ASSOC, V318, P360, DOI 10.1001/jama.2017.8334; Mihalik JP, 2007, NEUROSURGERY, V61, P1229, DOI 10.1227/01.neu.0000306101.83882.c8; Mihalik JP, 2011, CLIN J SPORT MED, V21, P416, DOI 10.1097/JSM.0B013E31822C8A5C; Millard M, 2013, J BIOMECH ENG-T ASME, V135, DOI 10.1115/1.4023390; Mortensen J, 2018, J BIOMECH, V71, P127, DOI 10.1016/j.jbiomech.2018.01.030; Mortensen JD, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0199912; Newman J.A., 2000, SAE TECHNICAL PAPER; Schmidt JD, 2014, AM J SPORT MED, V42, P2056, DOI 10.1177/0363546514536685; Schnebel B, 2007, NEUROSURGERY, V60, P490, DOI 10.1227/01.NEU.0000249286.92255.7F; Seth A, 2018, PLOS COMPUT BIOL, V14, DOI 10.1371/journal.pcbi.1006223; Takhounts Erik G, 2013, Stapp Car Crash J, V57, P243; Team R, 2016, RSTUDIO INT DEV R, V3.6.1; Thelen DG, 2003, J BIOMECH, V36, P321, DOI 10.1016/S0021-9290(02)00432-3; Vasavada AN, 1998, SPINE, V23, P412, DOI 10.1097/00007632-199802150-00002; Viano DC, 2007, NEUROSURGERY, V61, P313, DOI 10.1227/01.NEU.0000279969.02685.D0; Viano DC, 2005, SOLID MECH APPL, V124, P121	44	7	7	3	12	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0021-9290	1873-2380		J BIOMECH	J. Biomech.	FEB 13	2020	100								109411	10.1016/j.jbiomech.2019.109411			10	Biophysics; Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Biophysics; Engineering	KN3RE	WOS:000514757200002	31982110				2022-02-06	
J	Ratliff, WA; Mervis, RF; Citron, BA; Schwartz, B; Rubovitch, V; Schreiber, S; Pick, CG				Ratliff, Whitney A.; Mervis, Ronald F.; Citron, Bruce A.; Schwartz, Brian; Rubovitch, Vardit; Schreiber, Shaul; Pick, Chaim G.			Effect of mild blast-induced TBI on dendritic architecture of the cortex and hippocampus in the mouse	SCIENTIFIC REPORTS			English	Article							TRAUMATIC BRAIN-INJURY; IMPACT; MEMORY; MORPHOLOGY; VETERANS; SPINES; MODEL	Traumatic brain injury (TBI) has been designated as a signature injury of modern military conflicts. Blast trauma, in particular, has come to make up a significant portion of the TBIs which are sustained in warzones. Though most TBIs are mild, even mild TBI can induce long term effects, including cognitive and memory deficits. In our study, we utilized a mouse model of mild blast-related TBI (bTBI) to investigate TBI-induced changes within the cortex and hippocampus. We performed rapid Golgi staining on the layer IV and V pyramidal neurons of the parietal cortex and the CA1 basilar tree of the hippocampus and quantified dendritic branching and distribution. We found decreased dendritic branching within both the cortex and hippocampus in injured mice. Within parietal cortex, this decreased branching was most evident within the middle region, while outer and inner regions resembled that of control mice. This study provides important knowledge in the study of how the shockwave associated with a blast explosion impacts different brain regions.	[Ratliff, Whitney A.; Citron, Bruce A.] Bay PinesVA Healthcare Syst Res & Dev, Bay Pines, FL 33744 USA; [Mervis, Ronald F.] NeuroStructuralAnalyt Inc, Columbus, OH USA; [Mervis, Ronald F.] Univ S Florida, Dept Neurosurg & Brain Repair, Ctr Aging & Brain Repair, Morsani Coll Med, Tampa, FL USA; [Citron, Bruce A.] VA New Jersey Hlth Care Syst Res & Dev, E Orange, NJ USA; [Citron, Bruce A.] Rutgers New Jersey Med Sch, Dept Pharmacol Physiol & Neurosci, Newark, NJ USA; [Schwartz, Brian; Rubovitch, Vardit; Pick, Chaim G.] Tel Aviv Univ, Dept Anat & Anthropol, Sackler Sch Med, Tel Aviv, Israel; [Schreiber, Shaul] Tel Aviv Sourasky Med Ctr, Dept Psychiat, Tel Aviv, Israel; [Schreiber, Shaul; Pick, Chaim G.] Tel Aviv Univ, Dept Psychiat, Sackler Sch Med, Tel Aviv, Israel; [Schreiber, Shaul] Tel Aviv Univ, Sagol Sch Neurosci, Tel Aviv, Israel; [Pick, Chaim G.] Tel Aviv Univ, Dr Miriam & Sheldon G Adelson Chair, Tel Aviv, Israel; [Pick, Chaim G.] Tel Aviv Univ, Ctr Biol Addict Dis, Tel Aviv, Israel		Ratliff, WA (corresponding author), Bay PinesVA Healthcare Syst Res & Dev, Bay Pines, FL 33744 USA.	whitney.ratliff@va.gov	Schreiber, Shaul/E-5821-2010; Ratliff, Whitney/L-3556-2016	Schreiber, Shaul/0000-0002-2189-0693; Ratliff, Whitney/0000-0002-5461-7802	Ari and Regine Aprijaskis Fund; Dr. Miriam and Sheldon G. Adelson Chair and Center for the Biology of Addictive Diseases; Department of Veterans AffairsUS Department of Veterans Affairs; Bay Pines Foundation; Veterans Bio-Medical Research Institute	This research was supported in part by the Ari and Regine Aprijaskis Fund; and in part by the Dr. Miriam and Sheldon G. Adelson Chair and Center for the Biology of Addictive Diseases. This study was also supported by the Department of Veterans Affairs, The Bay Pines Foundation, and the Veterans Bio-Medical Research Institute. The contents do not represent the views of the Department of Veterans Affairs or the United States Government.	[Anonymous], 2018, DEFENSE VETERANS BRA, P1; Campbell JN, 2012, J NEUROTRAUM, V29, P201, DOI 10.1089/neu.2011.1761; Casella EM, 2014, CHILD NERV SYST, V30, P1333, DOI 10.1007/s00381-014-2446-z; Cernak I, 2011, NEUROBIOL DIS, V41, P538, DOI 10.1016/j.nbd.2010.10.025; Courtney AC, 2009, MED HYPOTHESES, V72, P76, DOI 10.1016/j.mehy.2008.08.015; Diamond DM, 2006, HIPPOCAMPUS, V16, P571, DOI 10.1002/hipo.20188; Elder GA, 2009, MT SINAI J MED, V76, P111, DOI 10.1002/msj.20098; Faul M, 2010, TRAUMATIC BRAIN INJU; Ferrante M, 2013, J NEUROSCI, V33, P2156, DOI 10.1523/JNEUROSCI.3495-12.2013; Gao X, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024566; Gao XA, 2011, J NEUROPATH EXP NEUR, V70, P183, DOI 10.1097/NEN.0b013e31820c6878; Granacher R. P., 2008, TRAUMATIC BRAIN INJU, VSecond; Haran FJ, 2021, APPL NEUROPSYCH-ADUL, V28, P297, DOI 10.1080/23279095.2019.1630627; Hoffer Michael E, 2009, Int Tinnitus J, V15, P115; Hoffer ME, 2010, OTOL NEUROTOL, V31, P232, DOI 10.1097/MAO.0b013e3181c993c3; Hoffman SW, 2017, BRAIN INJURY, V31, P1165, DOI 10.1080/02699052.2017.1359336; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoskison MM, 2009, NEUROSCIENCE, V159, P483, DOI 10.1016/j.neuroscience.2008.12.050; Ip EYY, 2002, J NEUROTRAUM, V19, P573, DOI 10.1089/089771502753754055; Isokuortti H, 2018, J NEUROSURG, V129, P1588, DOI 10.3171/2017.7.JNS17615; Ivanov I, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00127; Iverson GL, 2005, CURR OPIN PSYCHIATR, V18, P301, DOI 10.1097/01.yco.0000165601.29047.ae; Konan LM, 2019, J NEUROTRAUM, V36, P2117, DOI 10.1089/neu.2018.6260; Masel BE, 2012, J NEUROTRAUM, V29, P2143, DOI 10.1089/neu.2011.2258; Mayer AR, 2015, NEUROSCI BIOBEHAV R, V49, P8, DOI 10.1016/j.neubiorev.2014.11.016; McDonald AJ, 2017, J NEUROSCI RES, V95, P797, DOI 10.1002/jnr.23709; Moore DF, 2009, NEUROIMAGE, V47, pT10, DOI 10.1016/j.neuroimage.2009.02.019; Pagulayan K. F., 2018, BRAIN IMAGING BEHAV, P1; Pagulayan KF, 2018, J INT NEUROPSYCH SOC, V24, P324, DOI 10.1017/S1355617717001217; Rachmany L, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03792-9; Rafols JA, 2007, NEUROL RES, V29, P348, DOI 10.1179/016164107X204657; Ratliff WA, 2019, EXP NEUROL, V315, P9, DOI 10.1016/j.expneurol.2019.01.020; Robinson ME, 2019, NEUROIMAGE-CLIN, V21, DOI 10.1016/j.nicl.2019.101651; Rubovitch V, 2011, EXP NEUROL, V232, P280, DOI 10.1016/j.expneurol.2011.09.018; Ryan LM, 2003, INT REV PSYCHIATR, V15, P310, DOI 10.1080/09540260310001606692; Scalea T. M., 2005, NEUROTRAUMA EVIDENCE; Scheff SW, 2005, J NEUROTRAUM, V22, P719, DOI 10.1089/neu.2005.22.719; Semchenko V V, 2006, Neurosci Behav Physiol, V36, P613, DOI 10.1007/s11055-006-0065-1; Semple BD, 2017, BEHAV BRAIN RES, V319, P48, DOI 10.1016/j.bbr.2016.10.045; Shetty T, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00836; Shim SS, 2013, INT J NEUROPSYCHOPH, V16, P1373, DOI 10.1017/S1461145712001423; Shingo AS, 2015, BEHAV BRAIN RES, V280, P78, DOI 10.1016/j.bbr.2014.11.041; Shively SB, 2017, MIL MED, V182, P1461, DOI 10.7205/MILMED-D-16-00239; SHOLL DA, 1953, NATURE, V171, P387, DOI 10.1038/171387a0; Song HL, 2018, BEHAV BRAIN RES, V347, P148, DOI 10.1016/j.bbr.2018.03.007; Thomas TC, 2018, BEHAV BRAIN RES, V340, P137, DOI 10.1016/j.bbr.2016.12.038; Thompson JM, 2008, CAN FAM PHYSICIAN, V54, P1549; Tweedie D, 2016, ALZHEIMERS DEMENT, V12, P34, DOI 10.1016/j.jalz.2015.07.489; Tweedie D, 2013, NEUROBIOL DIS, V54, P1, DOI 10.1016/j.nbd.2013.02.006; Winston CN, 2013, J NEUROTRAUM, V30, P1966, DOI 10.1089/neu.2013.2960	50	7	7	3	3	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	2045-2322			SCI REP-UK	Sci Rep	FEB 10	2020	10	1							2206	10.1038/s41598-020-59252-4			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NB7IT	WOS:000560688800002	32042033	Green Published, gold			2022-02-06	
J	Ahmedy, F; Mazlan, M; Danaee, M; Abu Bakar, MZ				Ahmedy, Fatimah; Mazlan, Mazlina; Danaee, Mahmoud; Abu Bakar, Mohd Zulkiflee			Post-traumatic brain injury olfactory dysfunction: factors influencing quality of life	EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY			English	Article						Olfactory dysfunction; Traumatic brain injury; Quality of life; Disability rating scale; Anosmia	ODOR DISCRIMINATION; IDENTIFICATION; CONSEQUENCES; PERFORMANCE; DISORDERS; IMPACT	Purpose To evaluate if and how post-traumatic brain injury (TBI) olfactory dysfunction affects the quality of life (QoL). Methods In this case-control observational study, 32 adults with post-TBI olfactory dysfunction (cases) were matched with 32 TBI patients with intact olfactory function (controls). All subjects self-rated their olfactory function using the Visual Analogue Scale (VAS). Cases also underwent objective olfactory function assessment with the Sniffin' Sticks test, which generated a Threshold, Discrimination, and Identification (TDI) score. QoL was assessed with the Questionnaire for Olfactory Disorders (QOD). Factors evaluated included age, gender, smoking, TBI severity and duration, lesion localisation, and Disability Rating Scale (DRS) score. Results Cases had a higher mean QOD score than controls at 26.31 +/- 14.37 and 9.44 +/- 8.30, respectively (F = 16.426, p < 0.001, eta(2) = 0.224). The effect size was large (d = 1.07) with an odds ratio of 7.02. The features of QoL most affected were perception of smell changes, adapting to smell changes, and fear of hazardous substance exposure. DRS score and severity of olfactory dysfunction significantly affected QoL (p < 0.05). Conclusion Post-TBI olfactory dysfunction significantly lowered QoL and increased the likelihood of having a low QoL relative to TBI alone.	[Ahmedy, Fatimah; Mazlan, Mazlina] Univ Malaya, Fac Med, Dept Rehabil Med, Kuala Lumpur, Malaysia; [Ahmedy, Fatimah] Univ Malaysia Sabah, Dept Surg, Fac Med & Hlth Sci, Kota Kinabalu, Malaysia; [Danaee, Mahmoud] Univ Malaya, Fac Med, Dept Social & Prevent Med, Kuala Lumpur, Malaysia; [Abu Bakar, Mohd Zulkiflee] Univ Malaya, Fac Med, Dept Otorhinolaryngol, Kuala Lumpur, Malaysia		Mazlan, M (corresponding author), Univ Malaya, Fac Med, Dept Rehabil Med, Kuala Lumpur, Malaysia.	mazlinamazlan@ummc.edu.my	AHMEDY, FATIMAH/AAE-4890-2021; Mazlan, Mazlina/A-1015-2011; Zulkiflee/B-9142-2010	Mazlan, Mazlina/0000-0002-4012-1873; Zulkiflee/0000-0002-1019-1408; AHMEDY, FATIMAH/0000-0002-5811-4188	University of Malaya Postgraduate Research Grant, Phase 2015B	This work was supported by the University of Malaya Postgraduate Research Grant, Phase 2015B.	Ali N., 2012, MALAYSIA J SOC SPACE, V8, P157; Bramerson A, 2007, ACTA OTO-LARYNGOL, V127, P167, DOI 10.1080/00016480600801357; Callahan CD, 1999, J HEAD TRAUMA REHAB, V14, P581, DOI 10.1097/00001199-199912000-00006; Croy I, 2014, CHEM SENSES, V39, P185, DOI 10.1093/chemse/bjt072; Dijkers MP, 2004, ARCH PHYS MED REHAB, V85, pS21, DOI 10.1016/j.apmr.2003.08.119; Drummond M, 2013, BRAIN INJURY, V27, P332, DOI 10.3109/02699052.2012.750743; Emanuelson I, 2003, ACTA NEUROL SCAND, V108, P332, DOI 10.1034/j.1600-0404.2003.00155.x; Fan LY, 2015, J CHIN MED ASSOC, V78, P299, DOI 10.1016/j.jcma.2014.11.009; Frasnelli J, 2005, EUR ARCH OTO-RHINO-L, V262, P231, DOI 10.1007/s00405-004-0796-y; Gudziol V, 2014, EUR ARCH OTO-RHINO-L, V271, P1533, DOI 10.1007/s00405-013-2687-6; Haxel BR, 2008, J HEAD TRAUMA REHAB, V23, P407, DOI 10.1097/01.HTR.0000341437.59627.ec; Hummel T, 2005, ACTA OTO-LARYNGOL, V125, P116, DOI 10.1080/00016480410022787; Hummel T, 2007, EUR ARCH OTO-RHINO-L, V264, P237, DOI 10.1007/s00405-006-0173-0; Hummel T, 1997, CHEM SENSES, V22, P39, DOI 10.1093/chemse/22.1.39; Keller A, 2013, BMC EAR NOSE THROAT, V13, DOI 10.1186/1472-6815-13-8; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Reden J, 2006, ARCH OTOLARYNGOL, V132, P265, DOI 10.1001/archotol.132.3.265; Shu CH, 2011, RHINOLOGY, V49, P337, DOI 10.4193/Rhino10.130; Sigurdardottir S, 2010, NEUROPSYCHOLOGY, V24, P504, DOI 10.1037/a0018934; Simopoulos E, 2012, LARYNGOSCOPE, V122, P1450, DOI 10.1002/lary.23349; Williamson MLC, 2013, BRAIN INJURY, V27, P992, DOI 10.3109/02699052.2013.801512	21	7	7	0	2	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0937-4477	1434-4726		EUR ARCH OTO-RHINO-L	Eur. Arch. Oto-Rhino-Laryn.	MAY	2020	277	5					1343	1351		10.1007/s00405-020-05823-0		FEB 2020	9	Otorhinolaryngology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Otorhinolaryngology	LD5DA	WOS:000515945700002	32025786	Green Accepted			2022-02-06	
J	Thorpe, SG; Thibeault, CM; Canac, N; Jalaleddini, K; Dorn, A; Wilk, SJ; Devlin, T; Scalzo, F; Hamilton, RB				Thorpe, Samuel G.; Thibeault, Corey M.; Canac, Nicolas; Jalaleddini, Kian; Dorn, Amber; Wilk, Seth J.; Devlin, Thomas; Scalzo, Fabien; Hamilton, Robert B.			Toward automated classification of pathological transcranial Doppler waveform morphology via spectral clustering	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; INTRACRANIAL-PRESSURE; CEREBRAL-ANGIOGRAPHY; ARTERIAL-OCCLUSION; ISCHEMIC-STROKE; FLOW-VELOCITY; ULTRASONOGRAPHY; THROMBOLYSIS; SONOGRAPHY; PREDICTION	Cerebral Blood Flow Velocity waveforms acquired via Transcranial Doppler (TCD) can provide evidence for cerebrovascular occlusion and stenosis. Thrombolysis in Brain Ischemia (TIBI) flow grades are widely used for this purpose, but require subjective assessment by expert evaluators to be reliable. In this work we seek to determine whether TCD morphology can be objectively assessed using an unsupervised machine learning approach to waveform categorization. TCD beat waveforms were recorded at multiple depths from the Middle Cerebral Arteries of 106 subjects; 33 with Large Vessel Occlusion (LVO). From each waveform, three morphological features were extracted, quantifying onset of maximal velocity, systolic canopy length, and the number/prominence of peaks/troughs. Spectral clustering identified groups implicit in the resultant three-dimensional feature space, with gap statistic criteria establishing the optimal cluster number. We found that gap statistic disparity was maximized at four clusters, referred to as flow types I, II, III, and IV. Types I and II were primarily composed of control subject waveforms, whereas types III and IV derived mainly from LVO patients. Cluster morphologies for types I and IV aligned clearly with Normal and Blunted TIBI flows, respectively. Types II and III represented commonly observed flow-types not delineated by TIBI, which nonetheless deviate from normal and blunted flows. We conclude that important morphological variability exists beyond that currently quantified by TIBI in populations experiencing or at-risk for acute ischemic stroke, and posit that the observed flow-types provide the foundation for objective methods of real-time automated flow type classification.	[Thorpe, Samuel G.; Thibeault, Corey M.; Canac, Nicolas; Jalaleddini, Kian; Dorn, Amber; Wilk, Seth J.; Hamilton, Robert B.] Neural Analyt Inc, Dept Res, Los Angeles, CA 90064 USA; [Devlin, Thomas] Erlanger Med Ctr, Dept Neurol, Chattanooga, TN USA; [Scalzo, Fabien] Univ Calif Los Angeles, Dept Neurol, Los Angeles, CA 90024 USA		Thorpe, SG (corresponding author), Neural Analyt Inc, Dept Res, Los Angeles, CA 90064 USA.	samuel.thorpe@neuralanalytics.com		Thorpe, Samuel/0000-0002-1825-4207; Dorn, Amber/0000-0002-3139-4183	Neural Analytics, Inc.; National Institute of Neurological Disorders and Stroke (US) [1R43NS105340]	The primary funding Institution, Neural Analytics, Inc., provided support in the form of salaries for authors ST, CT, KJ, AD, NC, SW, and RH, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section. This research was also supported in part by National Institute of Neurological Disorders and Stroke (US), 1R43NS105340.	AASLID R, 1984, J NEUROSURG, V60, P37, DOI 10.3171/jns.1984.60.1.0037; AASLID R, 1982, J NEUROSURG, V57, P769, DOI 10.3171/jns.1982.57.6.0769; Aaslid R., 1986, TRANSCRANIAL DOPPLER, P39; Adams RJ, 1997, ANN NEUROL, V42, P699, DOI 10.1002/ana.410420505; ADAMS RJ, 1992, STROKE, V23, P1073, DOI 10.1161/01.STR.23.8.1073; Aggarwal S, 2008, LIVER TRANSPLANT, V14, P1048, DOI 10.1002/lt.21499; Aghoram R, 2018, ANN INDIAN ACAD NEUR, V21, P193, DOI 10.4103/aian.AIAN_417_17; Alberts MJ, 2005, STROKE, V36, P1597, DOI 10.1161/01.STR.0000170622.07210.b4; Alexandrov AV, 2012, J NEUROIMAGING, V22, P215, DOI 10.1111/j.1552-6569.2010.00523.x; Alexandrov AV, 2010, CLIN INDICATIONS EXP, P215; Alexandrov AV, 2011, CEREBROVASCULAR ULTR; Alexandrov AV, 2013, NEUROVASCULAR EXAMIN; Bailey DM, 2013, CLIN SCI, V124, P177, DOI 10.1042/CS20120259; Bathala L, 2013, ANN INDIAN ACAD NEUR, V16, P174, DOI 10.4103/0972-2327.112460; Benjamin EJ, 2017, CIRCULATION, V135, pE146, DOI 10.1161/CIR.0000000000000485; Brunser AM, 2009, STROKE, V40, P2037, DOI 10.1161/STROKEAHA.108.542704; Canac N, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.01072; Cardim D, 2017, NEUROCRIT CARE, V26, P330, DOI 10.1007/s12028-016-0356-5; Cardim D, 2016, NEUROCRIT CARE, V25, P473, DOI 10.1007/s12028-016-0258-6; CARDOSO ER, 1983, J NEUROSURG, V59, P817, DOI 10.3171/jns.1983.59.5.0817; D'Andrea A, 2016, WORLD J CARDIOL, V8, P383, DOI 10.4330/wjc.v8.i7.383; Demchuk AM, 2001, STROKE, V32, P89, DOI 10.1161/01.STR.32.1.89; Demchuk AM, 2000, J NEUROIMAGING, V10, P1; Demchuk AM, 2000, STROKE, V31, P140, DOI 10.1161/01.STR.31.1.140; Elzaafarany K, 2019, J ULTRAS MED, V38, P2191, DOI 10.1002/jum.14916; HASSLER W, 1988, J NEUROSURG, V68, P745; Hu X, 2009, IEEE T BIO-MED ENG, V56, P696, DOI 10.1109/TBME.2008.2008636; Jalaleddini K, 2020, IEEE T BIO-MED ENG, V67, P883, DOI 10.1109/TBME.2019.2923146; Kim S., 2011, P 2011 WORKSH DAT MI, P68; Kim S, 2013, IEEE T BIO-MED ENG, V60, P1126, DOI 10.1109/TBME.2012.2227477; Kim S, 2011, NEUROCRIT CARE, V14, P229, DOI 10.1007/s12028-010-9471-x; KLINGELHOFER J, 1987, KLIN WOCHENSCHR, V65, P542, DOI 10.1007/BF01727619; Kral MC, 2003, PEDIATRICS, V112, P324, DOI 10.1542/peds.112.2.324; Kumar S, 2016, J MOD TRANSP, V24, P62, DOI 10.1007/s40534-016-0095-5; Kurji A, 2006, MENOPAUSE, V13, P303, DOI 10.1097/01.gme.0000177905.94515.24; KUSHNER MJ, 1991, NEUROLOGY, V41, P109, DOI 10.1212/WNL.41.1.109; Larose D.T., 2005, DISCOVERING KNOWLEDG, P1; Latchaw RE, 2009, STROKE, V40, P3646, DOI 10.1161/STROKEAHA.108.192616; Len TK, 2011, MED SCI SPORT EXER, V43, P2241, DOI 10.1249/MSS.0b013e3182249539; Lockhart CJ, 2006, CLIN SCI, V111, P47, DOI 10.1042/cs20050365; Malhotra K, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00651; Malhotra K, 2015, J NEUROIMAGING, V25, P517, DOI 10.1111/jon.12272; Minhas JS, 2019, J CLIN ULTRASOUND, V47, P14, DOI 10.1002/jcu.22645; Mohamad I.B., 2013, RES J APPL SCI ENG T, V6, P3299; Ng AY, 2002, ADV NEUR IN, V14, P849; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Purvis D, 2013, J ULTRAS MED, V32, P1023, DOI 10.7863/ultra.32.6.1023; Rathod RR, 2017, INT J ENERGY SECT MA, V11, P295, DOI 10.1108/IJESM-02-2016-0005; Saqqur M, 2007, STROKE, V38, P948, DOI 10.1161/01.STR.0000257304.21967.ba; Saver JL, 2016, JAMA-J AM MED ASSOC, V316, P1279, DOI 10.1001/jama.2016.13647; Scalzo F, 2012, MED ENG PHYS, V34, P1058, DOI 10.1016/j.medengphy.2011.11.010; Schaafsma A, 2012, ULTRASOUND MED BIOL, V38, P1451, DOI 10.1016/j.ultrasmedbio.2012.03.016; Schmidt B, 1997, STROKE, V28, P2465, DOI 10.1161/01.STR.28.12.2465; Seera M, 2017, NEUROCOMPUTING, V249, P337, DOI 10.1016/j.neucom.2016.05.117; Sheth SA, 2015, ANN NEUROL, V78, P584, DOI 10.1002/ana.24474; Sloan MA, 2004, NEUROLOGY, V62, P1468, DOI 10.1212/WNL.62.9.1468; Smith WS, 2006, NEUROCRIT CARE, V4, P14, DOI 10.1385/NCC:4:1:014; Spencer MP, 1981, CEREBROVASCULAR EVAL; Thibeault CM, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00200; Thorpe SG, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00847; Thorpe SG, 2019, TRANSL STROKE RES, V10, P475, DOI 10.1007/s12975-018-0667-2; Tibshirani R, 2001, J ROY STAT SOC B, V63, P411, DOI 10.1111/1467-9868.00293; Tsivgoulis G, 2007, STROKE, V38, P1245, DOI 10.1161/01.STR.0000259712.64772.85; Uguz H, 2012, COMPUT METH PROG BIO, V107, P598, DOI 10.1016/j.cmpb.2011.03.013; von Luxburg U, 2007, STAT COMPUT, V17, P395, DOI 10.1007/s11222-007-9033-z; Wagshul ME, 2011, FLUIDS BARRIERS CNS, V8, DOI 10.1186/2045-8118-8-5; Wijnhoud AD, 2011, ACTA NEUROL SCAND, V124, P238, DOI 10.1111/j.1600-0404.2010.01462.x; Xiang LI, 2017, CHINESE J; ZANETTE EM, 1989, STROKE, V20, P899, DOI 10.1161/01.STR.20.7.899; Zelnik-Manor L., 2004, ADV NEURAL INFORM PR; Zerna C, 2016, CIRC RES, V118, P1425, DOI 10.1161/CIRCRESAHA.116.307005	71	7	7	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2020	15	2							e0228642	10.1371/journal.pone.0228642			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP9GK	WOS:000534623800062	32027714	gold, Green Published, Green Submitted			2022-02-06	
J	Leconte, C; Benedetto, C; Lentini, F; Simon, K; Ouaazizi, C; Taib, T; Cho, AG; Plotkine, M; Mongeau, R; Marchand-Leroux, C; Besson, VC				Leconte, Claire; Benedetto, Chiara; Lentini, Federica; Simon, Kristin; Ouaazizi, Chahid; Taib, Toufik; Cho, Angelo; Plotkine, Michel; Mongeau, Raymond; Marchand-Leroux, Catherine; Besson, Valerie C.			Histological and Behavioral Evaluation after Traumatic Brain Injury in Mice: A Ten Months Follow-Up Study	JOURNAL OF NEUROTRAUMA			English	Article						cognitive inflexibility; delayed and remote lesions; gray and white matter lesions; motor incoordination; risk-taking behavior; traumatic brain injury	CONTROLLED CORTICAL IMPACT; BLACK-GOLD; MILD; MODERATE; PERSIST; ATROPHY; WHITE; NEURODEGENERATION; NEUROGENESIS; IMPAIRMENT	Traumatic brain injury (TBI) is a chronic pathology, inducing long-term deficits that remain understudied in pre-clinical studies. In this context, exploration, anxiety-like behavior, cognitive flexibility, and motor coordination were assessed until 5 and 10 months after an experimental TBI in the adult mouse, using two cohorts. In order to differentiate age, surgery, and remote gray and white matter lesions, three groups (unoperated, sham-operated, and TBI) were studied. TBI induced delayed motor coordination deficits at the pole test, 4.5 months after injury, that could be explained by gray and white matter damages in ipsilateral nigrostriatal structures (striatum, internal capsule) that were spreading to new structures between cohorts, at 5 versus 10 months after the injury. Further, TBI induced an enhanced exploratory behavior during stressful situations (active phase during actimetry test, object exploration in an open field), risk-taking behaviors in the elevated plus maze 5 months after injury, and a cognitive inflexibility in the Barnes maze that persisted until 9 months after the injury. These behavioral modifications could be related to the white and gray matter lesions observed in ipsi- and contralateral limbic structures (amygdala, hilus/cornu ammonis 4, hypothalamus, external capsule, corpus callosum, and cingular cortex) that were spreading to new structures between cohorts, at 5 months versus 10 months after the injury. The present study corroborates clinical findings on TBI and provides a relevant rodent chronic model which could help in validating pharmacological strategies against the chronic consequences of TBI.	[Leconte, Claire; Benedetto, Chiara; Lentini, Federica; Simon, Kristin; Ouaazizi, Chahid; Taib, Toufik; Cho, Angelo; Plotkine, Michel; Mongeau, Raymond; Marchand-Leroux, Catherine; Besson, Valerie C.] Univ Paris 05, Sorbonne Paris Cite, Fac Pharm Paris, EA 4475,Pharmacol Circulat Cerebrale, Paris, France		Leconte, C (corresponding author), Univ Paris, Univ Paris Descartes, UMR S 1124 T3S Environm Tox Therapeut Targets Cel, Ctr Univ St Peres,ERL CNRS 3649 Pharmacol & Thera, Paris, France.	claire.leconte@parisdescartes.fr	BESSON, VALERIE/AAZ-9989-2020	BESSON, VALERIE/0000-0002-1491-2380	Ministry of Research and TechnologyMinistry of Research and Technology of the Republic of Indonesia (RISTEK) [EA6675]; Gueulles Cassees'' Foundation	This work was supported in part by funds from the Ministry of Research and Technology (EA6675) and in part by a grant from "Gueulles Cassees'' Foundation.	Acosta SA, 2017, J CELL PHYSIOL, V232, P665, DOI 10.1002/jcp.25629; Agoston Denes V, 2012, Front Neurol, V3, P3, DOI 10.3389/fneur.2012.00003; Bramlett HM, 2002, ACTA NEUROPATHOL, V103, P607, DOI 10.1007/s00401-001-0510-8; Chen XH, 2003, J NEUROTRAUM, V20, P623, DOI 10.1089/089771503322144545; Collins-Praino LE, 2018, BEHAV BRAIN RES, V336, P22, DOI 10.1016/j.bbr.2017.08.035; Corne R, 2019, PROG NEURO-PSYCHOPH, V88, P276, DOI 10.1016/j.pnpbp.2018.07.023; Coughlin JM, 2015, NEUROBIOL DIS, V74, P58, DOI 10.1016/j.nbd.2014.10.019; Currie S, 2016, POSTGRAD MED J, V92, P41, DOI 10.1136/postgradmedj-2014-133211; DeWitt DS, 2018, J NEUROTRAUM, V35, P2737, DOI 10.1089/neu.2018.5778; Dixon CE, 1999, J NEUROTRAUM, V16, P109, DOI 10.1089/neu.1999.16.109; Faden AI, 2015, NEUROTHERAPEUTICS, V12, P143, DOI 10.1007/s13311-014-0319-5; Gardner RC, 2018, NEUROLOGY, V90, pE1771, DOI 10.1212/WNL.0000000000005522; Hughes EJ, 2012, NEUROIMAGE, V63, P1134, DOI 10.1016/j.neuroimage.2012.07.043; Jamora CW, 2012, BRAIN INJURY, V26, P36, DOI 10.3109/02699052.2011.635352; Jiang JY, 2014, NEUROIMAGE, V86, P203, DOI 10.1016/j.neuroimage.2013.08.022; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; Kochanek PM, 2002, J NEUROTRAUM, V19, P1029, DOI 10.1089/089771502760341947; Lagraoui Mouna, 2012, Front Neurol, V3, P155, DOI 10.3389/fneur.2012.00155; Leconte C, 2011, NEUROPHARMACOLOGY, V60, P354, DOI 10.1016/j.neuropharm.2010.09.025; Loane DJ, 2014, J NEUROPATH EXP NEUR, V73, P14, DOI 10.1097/NEN.0000000000000021; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; Matsuura K, 1997, J NEUROSCI METH, V73, P45, DOI 10.1016/S0165-0270(96)02211-X; Osier ND, 2015, J NEUROTRAUM, V32, P1861, DOI 10.1089/neu.2014.3680; Pierce JES, 1998, NEUROSCIENCE, V87, P359, DOI 10.1016/S0306-4522(98)00142-0; Pischiutta F, 2018, EXP NEUROL, V300, P167, DOI 10.1016/j.expneurol.2017.11.003; Raikes AC, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00468; Ramirez C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022712; Sashindranath M, 2015, BEHAV BRAIN RES, V286, P33, DOI 10.1016/j.bbr.2015.02.038; Schmued L, 1999, BRAIN RES, V837, P289, DOI 10.1016/S0006-8993(99)01624-8; Schmued L, 2008, BRAIN RES, V1229, P210, DOI 10.1016/j.brainres.2008.06.129; Sell SL, 2017, J NEUROTRAUM, V34, P1086, DOI 10.1089/neu.2016.4616; Shoffstall AJ, 2018, J NEURAL ENG, V15, DOI 10.1088/1741-2552/aa9f32; Shultz SR, 2013, EPILEPSIA, V54, P1240, DOI 10.1111/epi.12223; Shultz SR, 2011, BEHAV BRAIN RES, V224, P326, DOI 10.1016/j.bbr.2011.06.012; Sick T, 2017, J NEUROTRAUM, V34, P2467, DOI 10.1089/neu.2016.4826; Siebold L, 2018, EXP NEUROL, V310, P48, DOI 10.1016/j.expneurol.2018.07.004; Smith DH, 1997, J NEUROTRAUM, V14, P715, DOI 10.1089/neu.1997.14.715; Svetlicky V, 2010, ISR J PSYCHIATR REL, V47, P276; Taib T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184811; Tashlykov V, 2007, BRAIN RES, V1130, P197, DOI 10.1016/j.brainres.2006.10.032; Vallez Garcia D, 2016, J NEUROTRAUM, V33, P1855, DOI 10.1089/neu.2015.4230; Veeramuthu V, 2016, J ORAL MAXIL SURG, V74, DOI 10.1016/j.joms.2016.01.042; Vincent AS, 2014, ALZHEIMERS DEMENT, V10, pS174, DOI 10.1016/j.jalz.2014.04.006; Wang ML, 2016, J NEUROL SCI, V370, P244, DOI 10.1016/j.jns.2016.09.049; Washington PM, 2012, J NEUROTRAUM, V29, P2283, DOI 10.1089/neu.2012.2456; Woods AS, 2013, ACS CHEM NEUROSCI, V4, P594, DOI 10.1021/cn300216h; Wright DK, 2017, CEREB CORTEX, V27, P4503, DOI 10.1093/cercor/bhw254; Xiong Y, 2018, CHIN J TRAUMATOL, V21, P137, DOI 10.1016/j.cjtee.2018.02.003; Zhou YX, 2017, J MAGN RESON IMAGING, V45, P1105, DOI 10.1002/jmri.25413	49	7	7	0	3	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUN 1	2020	37	11					1342	1357		10.1089/neu.2019.6679		FEB 2020	16	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	LT0OT	WOS:000512118000001	31830858	Bronze			2022-02-06	
J	Fucich, EA; Stielper, ZF; Cancienne, HL; Edwards, S; Gilpin, NW; Molina, PE; Middleton, JW				Fucich, Elizabeth A.; Stielper, Zachary F.; Cancienne, Heather L.; Edwards, Scott; Gilpin, Nicholas W.; Molina, Patricia E.; Middleton, Jason W.			Endocannabinoid degradation inhibitors ameliorate neuronal and synaptic alterations following traumatic brain injury	JOURNAL OF NEUROPHYSIOLOGY			English	Article						electrophysiology; fatty acid amide hydrolase; machine learning classification; monoacylglycerol lipase; sensorimotor cortex	PYRAMIDAL NEURONS; LIPASE; NEUROINFLAMMATION; DYSFUNCTION; CORTEX; ACTIVATION; EXCITATION; NEOCORTEX; BLOCKADE; BEHAVIOR	Our previous work showed that lateral fluid percussion injury to the sensorimotor cortex (SMC) of anesthetized rats increased neuronal synaptic hyperexcitability in layer 5 (L5) neurons in ex vivo brain slices 10 days postinjury. Furthermore, endocannabinoid (EC) degradation inhibition via intraperitoneal JZL184 injection 30 min postinjury attenuated synaptic hyperexcitability. This study tested the hypothesis that traumatic brain injury (TBI) induces synaptic and intrinsic neuronal alterations of L5 SMC pyramidal neurons and that these alterations are significantly attenuated by in vivo post-TBI treatment with EC degradation inhibitors. We tested the effects of systemically administered EC degradation enzyme inhibitors (JZL184, MJN110, URB597, or JZL195) with differential selectivity for fatty acid amide hydrolase (FAAH) and monoacylglycerol lipase (MAGL) on electrophysiological parameters in SMC neurons of TBI- and sham-treated rats 10 days post-TBI. We recorded intrinsic neuronal properties, including resting membrane voltage, input resistance, spike threshold, spiking responses to current input, voltage "sag" (rebound response to hyperpolarization-activated inward current), and burst firing. We also measured the frequency and amplitude of spontaneous excitatory postsynaptic currents. We then used the aggregate parameter sets (intrinsic + synaptic properties) to apply a machine learning classification algorithm to quantitatively compare neural population responses from each experimental group. Collectively, our electrophysiological and computational results indicate that sham neurons are the most distinguishable from TBI neurons. Administration of EC degradation inhibitors post-TBI exerted varying degrees of rescue, approximating the neuronal phenotype of sham neurons, with neurons from TBI/JZL195 (a dual MAGL/FAAH inhibitor) being most similar to neurons from sham rats. NEW & NOTEWORTHY This study elucidates neuronal properties altered by traumatic brain injury (TBI) in layer 5 of sensorimotor cortex. which may be implicated in post-TBI circuit dysfunction. We compared effects of systemic administration of four different endocannabinoid degradation inhibitors within a clinically relevant window postinjury. Electrophysiological measures and using a machine learning classification algorithm collectively suggest that pharmacological inhibitors targeting both monoacylglycerol lipase and fatty acid amide hydrolase (e.g., JZL195) may be most efficacious in attenuating Till-induced neuronal dysfunction at site of injury.	[Fucich, Elizabeth A.; Stielper, Zachary F.; Edwards, Scott; Gilpin, Nicholas W.; Molina, Patricia E.] Louisiana State Univ, Hlth Sci Ctr, Dept Physiol, New Orleans, LA USA; [Fucich, Elizabeth A.; Stielper, Zachary F.; Edwards, Scott; Gilpin, Nicholas W.; Molina, Patricia E.; Middleton, Jason W.] Louisiana State Univ, Alcohol & Drug Abuse Ctr Excellence, Hlth Sci Ctr, New Orleans, LA USA; [Cancienne, Heather L.; Middleton, Jason W.] Louisiana State Univ, Dept Cell Biol & Anat, Hlth Sci Ctr, New Orleans, LA USA		Middleton, JW (corresponding author), 1901 Perdido St,Rm 6103, New Orleans, LA 70112 USA.	jmidd3@lsuhsc.edu	Molina, Patricia E./AAK-9814-2021	Molina, Patricia E./0000-0002-3598-384X	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01 AA025792, T32 AA007577, F32 AA026779, F30 AA026468]	Support for this study was provided by National Institutes of Health Grants R01 AA025792, T32 AA007577, F32 AA026779, and F30 AA026468.	Allitt BJ, 2016, NEUROSCIENCE, V334, P290, DOI 10.1016/j.neuroscience.2016.08.018; Allitt BJ, 2016, J NEUROTRAUM, V33, P375, DOI 10.1089/neu.2015.3946; Alwis DS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052169; Brettschneider J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039216; Bryant RA, 2010, AM J PSYCHIAT, V167, P312, DOI 10.1176/appi.ajp.2009.09050617; Carron SF, 2016, FRONT SYST NEUROSCI, V10, DOI 10.3389/fnsys.2016.00047; Chang JW, 2012, CHEM BIOL, V19, P579, DOI 10.1016/j.chembiol.2012.03.009; Christianini N., 2000, INTRO SUPPORT VECTOR; CONNORS BW, 1990, TRENDS NEUROSCI, V13, P99, DOI 10.1016/0166-2236(90)90185-D; Cravatt BF, 1996, NATURE, V384, P83, DOI 10.1038/384083a0; Dembrow NC, 2010, J NEUROSCI, V30, P16922, DOI 10.1523/JNEUROSCI.3644-10.2010; Ding MC, 2011, J NEUROSCI, V31, P14085, DOI 10.1523/JNEUROSCI.3572-11.2011; Dinh TP, 2002, CHEM PHYS LIPIDS, V121, P149, DOI 10.1016/S0009-3084(02)00150-0; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; Eikelenboom P, 2010, NEURODEGENER DIS, V7, P38, DOI 10.1159/000283480; Fucich EA, 2019, J NEUROTRAUM, V36, P1847, DOI 10.1089/neu.2018.5854; Greer JE, 2012, J NEUROSCI, V32, P6682, DOI 10.1523/JNEUROSCI.0881-12.2012; Hanell A, 2015, J NEUROTRAUM, V32, P1590, DOI 10.1089/neu.2014.3592; Hibbard MR, 1998, J HEAD TRAUMA REHAB, V13, P24, DOI 10.1097/00001199-199808000-00003; ISAACSON JS, 1995, NEURON, V15, P875, DOI 10.1016/0896-6273(95)90178-7; Johnstone VPA, 2014, J NEUROTRAUM, V31, P1881, DOI 10.1089/neu.2014.3343; Johnstone VPA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063454; Jolliffe I.T., 2002, PRINCIPAL COMPONENT; Joshi A, 2015, J NEUROSCI, V35, P3112, DOI 10.1523/JNEUROSCI.0836-14.2015; Kathuria S, 2003, NAT MED, V9, P76, DOI 10.1038/nm803; Katz PS, 2015, J NEUROTRAUM, V32, P297, DOI 10.1089/neu.2014.3508; Kerr DM, 2013, BRIT J PHARMACOL, V169, P808, DOI 10.1111/j.1476-5381.2012.02237.x; Korn A, 2005, J CLIN NEUROPHYSIOL, V22, P1, DOI 10.1097/01.WNP.0000150973.24324.A7; Kumar A, 2012, BRAIN BEHAV IMMUN, V26, P1191, DOI 10.1016/j.bbi.2012.06.008; Lewicki MS, 1998, NETWORK-COMP NEURAL, V9, pR53, DOI 10.1088/0954-898X/9/4/001; Long JZ, 2009, P NATL ACAD SCI USA, V106, P20270, DOI 10.1073/pnas.0909411106; Long JZ, 2009, CHEM BIOL, V16, P744, DOI 10.1016/j.chembiol.2009.05.009; Lopes-dos-Santos V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020996; Mayeux J, 2017, J NEUROTRAUM, V34, P436, DOI 10.1089/neu.2016.4452; Nampiaparampil DE, 2008, JAMA-J AM MED ASSOC, V300, P711, DOI 10.1001/jama.300.6.711; Niphakis MJ, 2013, ACS CHEM NEUROSCI, V4, P1322, DOI 10.1021/cn400116z; Ofek H, 2007, PAIN, V131, P330, DOI 10.1016/j.pain.2007.06.015; Oleson EB, 2012, NEURON, V73, P360, DOI 10.1016/j.neuron.2011.11.018; Ooigawa H, 2006, ACTA NEUROPATHOL, V112, P471, DOI 10.1007/s00401-006-0108-2; Paxinos G., 2007, RAT BRAIN STEREOTAXI, V6; Ramlackhansingh AF, 2011, ANN NEUROL, V70, P374, DOI 10.1002/ana.22455; Roche RAP, 2004, NEUROSCI LETT, V362, P1, DOI 10.1016/j.neulet.2003.11.064; Seillier A, 2014, PHARMACOL BIOCHEM BE, V124, P153, DOI 10.1016/j.pbb.2014.05.022; Shlosberg D, 2010, NAT REV NEUROL, V6, P393, DOI 10.1038/nrneurol.2010.74; Sticht MA, 2016, NEUROPHARMACOLOGY, V102, P92, DOI 10.1016/j.neuropharm.2015.10.039; Teng SX, 2014, J NEUROTRAUM, V31, P378, DOI 10.1089/neu.2013.3093; Ting JT, 2014, METHODS MOL BIOL, V1183, P221, DOI 10.1007/978-1-4939-1096-0_14; Woodhams SG, 2012, BRIT J PHARMACOL, V167, P1609, DOI 10.1111/j.1476-5381.2012.02179.x; Xu JY, 2015, NEUROSCIENTIST, V21, P152, DOI 10.1177/1073858414524632; Yang L, 2010, J NEUROTRAUM, V27, P1541, DOI 10.1089/neu.2009.1244	50	7	7	0	1	AMER PHYSIOLOGICAL SOC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0022-3077	1522-1598		J NEUROPHYSIOL	J. Neurophysiol.	FEB	2020	123	2					707	717		10.1152/jn.00570.2019			11	Neurosciences; Physiology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Physiology	KT8EA	WOS:000519243600022	31913777	Green Published, Bronze			2022-02-06	
J	Hammer, E; Brooks, MA; Hetzel, S; Arakkal, A; Comstock, RD				Hammer, Erin; Brooks, M. Alison; Hetzel, Scott; Arakkal, Alan; Comstock, R. Dawn			Epidemiology of Injuries Sustained in Boys' High School Contact and Collision Sports, 2008-2009 Through 2012-2013	ORTHOPAEDIC JOURNAL OF SPORTS MEDICINE			English	Article						injury; high school; sports; epidemiology; football; ice hockey; soccer; lacrosse; wrestling	CONCUSSIONS; PARTICIPATION; PLAYERS	Background: Injury epidemiology for boys' high school contact and collision sport has been described in several overlapping but fragmented studies. Comprehensive comparisons of injuries sustained in boys' soccer, wrestling, football, ice hockey, and lacrosse are lacking. Purpose: To describe patterns of injury by severity, body site, and diagnosis among high school boys' contact and collision sports in the United States. Study Design: Descriptive epidemiology study. Methods: Injury rates and rate ratios (RRs) were calculated for injuries sustained in boys' high school soccer, wrestling, football, ice hockey, and lacrosse through use of the High School RIO (Reporting Information Online) surveillance data from 2008-2009 through 2012-2013. Injury patterns were described by site, diagnosis, time loss, and severity. Severe injury was defined as an injury that resulted in 21 days or more of time loss from sport participation. Risk of sustaining a concussion was compared between sports. Results: The risk of sustaining an injury was higher in competition compared with practice overall (RR, 4.01; 95% CI, 3.90-4.12); the same pattern was true for severe injuries (RR, 4.61; 95% CI, 4.34-4.90). Football players experienced the highest injury rate (3.87 per 1000 athlete-exposures [AEs]) and the highest severe injury rate (0.80 per 1000 AEs). Overall, the most commonly injured body site was the head/face (22.5%), and the most prevalent injury diagnosis was ligament sprain not requiring surgery (23.5%). The most frequently injured body site from severe injury was the knee (24.6%), and fracture or avulsion was the most prevalent severe injury diagnosis (37.0%). Football players had a significantly higher risk of sustaining a concussion compared with other contact or collision sport athletes (P < .05). Conclusion: Injuries rates were higher in competition than those in practice for boys' high school contact and collision athletes. Football players sustained the highest injury rate, the highest severe injury rate, and the highest concussion rate among the sports included in this analysis. Understanding these patterns of injury can generate policy and rule changes to make sports safer and maintain high levels of participation.	[Hammer, Erin; Brooks, M. Alison; Hetzel, Scott; Arakkal, Alan; Comstock, R. Dawn] Univ Wisconsin, Madison, WI USA; [Hammer, Erin; Brooks, M. Alison] Univ Wisconsin, Dept Orthoped & Rehabil, Madison, WI USA; [Hetzel, Scott] Univ Wisconsin, Dept Biostat & Med Informat, Madison, WI USA; [Arakkal, Alan; Comstock, R. Dawn] Univ Colorado Anschutz, Colorado Sch Publ Hlth, Dept Epidemiol, Aurora, CO USA		Hammer, E (corresponding author), 1685 Highland Ave, Madison, WI 53705 USA.	ehammer@uwhealth.org			Centers for Disease Control and PreventionUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA [R49/CE000674-01, R49/CE001172-01, R49/CE002106-01]; DJO; National Federation of State High School Associations; National Operating Committee on Standards for Athletic Equipment; DonJoy Orthotics; EyeBlack	funding for the HS RIO surveillance study was provided in part by the Centers for Disease Control and Prevention (grants R49/CE000674-01, R49/CE001172-01, and R49/CE002106-01). M.A.B. has received research support from DJO. S.H.'s spouse is employed by Exact Sciences. Both S.H. and his spouse have stock/stock options in Exact Sciences. R.D.C. has received research support from the National Federation of State High School Associations, National Operating Committee on Standards for Athletic Equipment, DonJoy Orthotics, and EyeBlack. AOSSM checks author disclosures against the Open Payments Database (OPD). AOSSM has not conducted an independent investigation on the OPD and disclaims any liability or responsibility relating thereto.	Bartley JH, 2017, ORTHOP J SPORTS MED, V5, DOI 10.1177/2325967117740887; Broglio SP, 2016, J ATHL TRAINING, V51, P511, DOI 10.4085/1062-6050-51.7.04; Cusimano MD, 2013, CAN MED ASSOC J, V185, pE57, DOI 10.1503/cmaj.112017; Darrow CJ, 2009, AM J SPORT MED, V37, P1798, DOI 10.1177/0363546509333015; Emery CA, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097452; Hebert JJ, 2017, MAYO CLIN PROC, V92, P57, DOI 10.1016/j.mayocp.2016.08.013; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; McCabe KO, 2016, J YOUTH ADOLESCENCE, V45, P2292, DOI 10.1007/s10964-016-0454-x; National Federation of State High School Associations, 2017, 2016 17 HIGH SCH ATH; Oosterhoff B, 2017, J ADOLESCENCE, V60, P83, DOI 10.1016/j.adolescence.2017.07.012; R Core Team, 2016, R LANG ENV STAT COMP; Rechel JA, 2008, J ATHL TRAINING, V43, P197, DOI 10.4085/1062-6050-43.2.197; Schallmo MS, 2017, J BONE JOINT SURG AM, V99, P1314, DOI 10.2106/JBJS.16.01573; Wiebe DJ, 2018, JAMA-J AM MED ASSOC, V320, P2035, DOI 10.1001/jama.2018.14165; Yang JZ, 2017, AM J PUBLIC HEALTH, V107, P1916, DOI 10.2105/AJPH.2017.304056; Yard EE, 2009, RES SPORTS MED, V17, P35, DOI 10.1080/15438620802678495	16	7	8	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA		2325-9671		ORTHOP J SPORTS MED	Orthop. J. Sports Med.	FEB	2020	8	2							2325967120903699	10.1177/2325967120903699			8	Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Orthopedics; Sport Sciences	KR2JI	WOS:000517445500001	32133385	Green Published, gold			2022-02-06	
J	Kofler, M; Gaasch, M; Rass, V; Schiefecker, AJ; Ianosi, B; Lindner, A; Beer, R; Stover, JF; Rhomberg, P; Pfausler, B; Thome, C; Schmutzhard, E; Helbok, R				Kofler, Mario; Gaasch, Maxime; Rass, Verena; Schiefecker, Alois J.; Ianosi, Bogdan; Lindner, Anna; Beer, Ronny; Stover, John F.; Rhomberg, Paul; Pfausler, Bettina; Thome, Claudius; Schmutzhard, Erich; Helbok, Raimund			The Importance of Probe Location for the Interpretation of Cerebral Microdialysis Data in Subarachnoid Hemorrhage Patients	NEUROCRITICAL CARE			English	Article						Cerebral microdialysis; Cerebral metabolism; Subarachnoid hemorrhage; Computed tomography; Secondary brain injury	TRAUMATIC BRAIN-INJURY; INTRACEREBRAL MICRODIALYSIS; METABOLISM; BLOOD; CHEMISTRY; ISCHEMIA; IMPACT; EDEMA; RISK; CT	Background There is no uniform definition for cerebral microdialysis (CMD) probe location with respect to focal brain lesions, and the impact of CMD-probe location on measured molecule concentrations is unclear. Methods We retrospectively analyzed data of 51 consecutive subarachnoid hemorrhage patients with CMD-monitoring between 2010 and 2016 included in a prospective observational cohort study. Microdialysis probe location was assessed on all brain computed tomography (CT) scans performed during CMD-monitoring and defined as perilesional in the presence of a focal hypodense or hyperdense lesion within a 1-cm radius of the gold tip of the CMD-probe, or otherwise as normal-appearing brain tissue. Results Probe location was detected in normal-appearing brain tissue on 53/143 (37%) and in perilesional location on 90/143 (63%) CT scans. In the perilesional area, CMD-glucose levels were lower (p = 0.003), whereas CMD-lactate (p = 0.002), CMD-lactate-to-pyruvate-ratio (LPR; p < 0.001), CMD-glutamate (p = 0.002), and CMD-glycerol levels (p < 0.001) were higher. Neuroglucopenia (CMD-glucose < 0.7 mmol/l, p = 0.002), metabolic distress (p = 0.002), and mitochondrial dysfunction (p = 0.005) were more common in perilesional compared to normal-appearing brain tissue. Development of new lesions in the proximity of the CMD-probe (n = 13) was associated with a decrease in CMD-glucose levels, evidence of neuroglucopenia, metabolic distress, as well as increasing CMD-glutamate and CMD-glycerol levels. Neuroglucopenia was associated with poor outcome independent of probe location, whereas elevated CMD-lactate, CMD-LPR, CMD-glutamate, and CMD-glycerol levels were only predictive of poor outcome in normal-appearing brain tissue. Conclusions Focal brain lesions significantly impact on concentrations of brain metabolites assessed by CMD. With the exception of CMD-glucose, the prognostic value of CMD-derived parameters seems to be higher when assessed in normal-appearing brain tissue. CMD was sensitive to detect the development of new focal lesions in vicinity to the neuromonitoring probe. Probe location should be described in the research reporting brain metabolic changes measured by CMD and integrated in statistical models.	[Kofler, Mario; Gaasch, Maxime; Rass, Verena; Schiefecker, Alois J.; Ianosi, Bogdan; Lindner, Anna; Beer, Ronny; Pfausler, Bettina; Schmutzhard, Erich; Helbok, Raimund] Med Univ Innsbruck, Dept Neurol, Neurol Intens Care Unit, Anichstr 35, A-6020 Innsbruck, Austria; [Ianosi, Bogdan] UMIT Univ Hlth Sci, Med Informat, Hall In Tirol, Austria; [Stover, John F.] Fresenius Kabi, Else Kroner Str 1, D-61352 Bad Homburg, Germany; [Rhomberg, Paul] Med Univ Innsbruck, Dept Neuroradiol, Innsbruck, Austria; [Thome, Claudius] Med Univ Innsbruck, Dept Neurosurg, Innsbruck, Austria		Helbok, R (corresponding author), Med Univ Innsbruck, Dept Neurol, Neurol Intens Care Unit, Anichstr 35, A-6020 Innsbruck, Austria.	Raimund.Helbok@tirol-kliniken.at	Rass, Verena/AAR-1731-2021; Helbok, Raimund/AAA-8361-2021	Rass, Verena/0000-0002-4241-5891; Schmutzhard, Erich/0000-0003-3295-7491	Austrian Science Fund FWFAustrian Science Fund (FWF) [P 29076] Funding Source: Medline		Bellander BM, 2004, INTENS CARE MED, V30, P2166, DOI 10.1007/s00134-004-2461-8; Claassen J, 2002, STROKE, V33, P1225, DOI 10.1161/01.STR.0000015624.29071.1F; Claassen J, 2001, STROKE, V32, P2012, DOI 10.1161/hs0901.095677; Connolly ES, 2012, STROKE, V43, P1711, DOI 10.1161/STR.0b013e3182587839; Engstrom M, 2005, J NEUROSURG, V102, P460, DOI 10.3171/jns.2005.102.3.0460; Fainardi E, 2006, NEURORADIOLOGY, V48, P685, DOI 10.1007/s00234-006-0111-2; Helbok R, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00565; Helbok R, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-0809-9; Helbok R, 2011, STROKE, V42, P1534, DOI 10.1161/STROKEAHA.110.604488; Helbok R, 2011, J NEUROL NEUROSUR PS, V82, P378, DOI 10.1136/jnnp.2009.198754; Helbok R, 2011, NEUROCRIT CARE, V14, P162, DOI 10.1007/s12028-010-9472-9; HIJDRA A, 1990, STROKE, V21, P1156, DOI 10.1161/01.STR.21.8.1156; HUNT WE, 1968, J NEUROSURG, V28, P14, DOI 10.3171/jns.1968.28.1.0014; Hutchinson PJ, 2015, INTENS CARE MED, V41, P1517, DOI 10.1007/s00134-015-3930-y; Jacobsen A, 2014, ACTA NEUROL SCAND, V130, P156, DOI 10.1111/ane.12258; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Kofler M, 2018, J CEREBR BLOOD F MET, V38, P518, DOI 10.1177/0271678X17700434; Nordstrom CH, 2003, ANESTHESIOLOGY, V98, P809, DOI 10.1097/00000542-200304000-00004; Oddo M, 2012, STROKE, V43, P1418, DOI 10.1161/STROKEAHA.111.648568; Reinstrup P, 2000, NEUROSURGERY, V47, P701, DOI 10.1097/00006123-200009000-00035; Sarrafzadeh A, 2003, STROKE, V34, P1382, DOI 10.1161/01.STR.0000074036.97859.02; Sarrafzadeh AS, 2002, CRIT CARE MED, V30, P1062, DOI 10.1097/00003246-200205000-00018; Schiefecker AJ, 2017, CURR DRUG TARGETS, V18, P1408, DOI 10.2174/1389450117666160201111804; Steiner T, 2013, CEREBROVASC DIS, V35, P93, DOI 10.1159/000346087; Timofeev I, 2011, J NEUROTRAUM, V28, P849, DOI 10.1089/neu.2010.1656; Timofeev I, 2011, BRAIN, V134, P484, DOI 10.1093/brain/awq353; Vergouwen MDI, 2010, STROKE, V41, P2391, DOI 10.1161/STROKEAHA.110.589275; Vespa PM, 2007, CRIT CARE MED, V35, P1153, DOI 10.1097/01.CCM.0000259466.66310.4F; Zazulia AR, 2009, STROKE, V40, P1638, DOI 10.1161/STROKEAHA.108.536037; Zetterling M, 2010, NEUROSURGERY, V66, P1102, DOI 10.1227/01.NEU.0000370893.04586.73	30	7	7	1	1	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	FEB	2020	32	1					135	144		10.1007/s12028-019-00713-8			10	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	KK6PD	WOS:000512861100009	31037640	hybrid, Green Published			2022-02-06	
J	Martin, K; Periard, J; Rattray, B; Pyne, DB				Martin, Kristy; Periard, Julien; Rattray, Ben; Pyne, David B.			Physiological Factors Which Influence Cognitive Performance in Military Personnel	HUMAN FACTORS			English	Article						soldier; fatigue; cognition; nutrition; decision making	HEART-RATE-VARIABILITY; NEUROPSYCHOLOGICAL ASSESSMENT METRICS; TRAUMATIC BRAIN-INJURY; ESSENTIAL FATTY-ACIDS; WORKING-MEMORY; AEROBIC FITNESS; MOTION-SICKNESS; OLDER-ADULTS; OMEGA-3-FATTY-ACID SUPPLEMENTATION; DEHYDROEPIANDROSTERONE-SULFATE	Objective: To identify and detail physiological factors that influence cognition in military personnel. Background: Maintenance of cognitive and task performance is important under several scenarios, none more so than in a military context. Personnel are prepared for and trained to tolerate many of the stressors they encounter; however, consideration of stressors typically extends only as far as the physical, psychological, and environmental requirements of a given task. While considering these factors certainly characterizes the broader picture, several physiological states and traits can influence cognition and thus, should also be considered. Method: A systematic review of the electronic databases Medline (PubMed), EMBASE (Scopus), PsycINFO, and Web of Science was conducted from inception up to January 2019. Eligibility criteria included current military personnel, an outcome of cognition, and the assessment of a physiological factor. Results: The search returned 60,564 records, of which 60 were included in the review. Eleven studies examined the impact of demographic factors on cognition, 16 examined fatigue, 10 investigated nutrition, and 24 the impact of biological factors on cognitive performance. Conclusion: Factors identified as having a positive impact on cognition include aerobic fitness, nutritional supplementation, and visual acuity. In contrast, factors identified as having a negative impact include fatigue arising from sustained operations, dehydration, undernutrition, and an exaggerated physiological stress response to a cognitive task or a stressor. A further subset of these factors was considered modifiable. Application: The modifiable factors identified provide avenues for training and preparation to enhance cognition in ways previously unconsidered.	[Martin, Kristy; Periard, Julien; Rattray, Ben; Pyne, David B.] Univ Canberra, Res Inst Sport & Exercise, Bldg 29, Canberra, ACT 2601, Australia		Martin, K (corresponding author), Univ Canberra, Res Inst Sport & Exercise, Bldg 29, Canberra, ACT 2601, Australia.	kristy.martin@canberra.edu.au		Pyne, David/0000-0003-1555-5079; , Julien/0000-0002-6266-4246; Rattray, Ben/0000-0002-1652-7726			Adan A, 2012, J AM COLL NUTR, V31, P71, DOI 10.1080/07315724.2012.10720011; af Klinteberg B, 1990, Neuropsychobiology, V23, P188, DOI 10.1159/000119451; Albinet CT, 2010, EUR J APPL PHYSIOL, V109, P617, DOI 10.1007/s00421-010-1393-y; Alfred P. E., 2012, P HUM FACT ERG SOC L; Angevaren M, 2008, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD005381.pub2, 10.1002/14651858.CD005381.pub3]; Antypa N, 2009, J PSYCHOPHARMACOL, V23, P831, DOI 10.1177/0269881108092120; Antypa N, 2012, J PSYCHOPHARMACOL, V26, P738, DOI 10.1177/0269881111424928; Appleton KM, 2010, AM J CLIN NUTR, V91, P757, DOI 10.3945/ajcn.2009.28313; Ardoy DN, 2014, SCAND J MED SCI SPOR, V24, pe52, DOI 10.1111/sms.12093; AVOLIO BJ, 1994, PSYCHOL AGING, V9, P430, DOI 10.1037/0882-7974.9.3.430; Bailey SP, 2008, MIL MED, V173, P187, DOI 10.7205/MILMED.173.2.187; Ball K, 2002, JAMA-J AM MED ASSOC, V288, P2271, DOI 10.1001/jama.288.18.2271; BANDERET LE, 1989, BRAIN RES BULL, V22, P759, DOI 10.1016/0361-9230(89)90096-8; BARBER AV, 1990, HUM FACTORS, V32, P217, DOI 10.1177/001872089003200208; Bhattacharyya D, 2017, PHYSIOL BEHAV, V179, P253, DOI 10.1016/j.physbeh.2017.06.014; BOHNKER B, 1991, AVIAT SPACE ENVIR MD, V62, P162; BONNET MH, 1980, PSYCHOPHYSIOLOGY, V17, P56, DOI 10.1111/j.1469-8986.1980.tb02460.x; Bourre J M, 2004, J Nutr Health Aging, V8, P163; Buckman JEJ, 2011, OCCUP ENVIRON MED, V68, P69, DOI 10.1136/oem.2009.054692; Buckwalter JG, 1999, PSYCHONEUROENDOCRINO, V24, P69; Buguet A, 1995, J SLEEP RES, V4, P229, DOI 10.1111/j.1365-2869.1995.tb00173.x; Calabrese EJ, 2007, TOXICOL APPL PHARM, V222, P122, DOI 10.1016/j.taap.2007.02.015; Caldwell JA, 1998, ERGONOMICS, V41, P1757, DOI 10.1080/001401398185956; Camm AJ, 1996, EUR HEART J, V17, P354; Campbell DJ, 2009, MIL PSYCHOL, V21, pS47, DOI 10.1080/08995600903249149; Cannon CM, 2003, J NEUROSCI, V23, P10827; Carter Evan C, 2013, BMC Psychol, V1, P22, DOI 10.1186/2050-7283-1-22; Chamberlain SR, 2006, PSYCHOPHARMACOLOGY, V188, P397, DOI 10.1007/s00213-006-0391-6; CHANCE JE, 1971, PERCEPT PSYCHOPHYS, V9, P33, DOI 10.3758/BF03213024; Chang YK, 2012, BRAIN RES, V1453, P87, DOI 10.1016/j.brainres.2012.02.068; Chatterjee T. K., 1992, Indian Journal of Experimental Biology, V30, P889; Christensen H., 1999, J REPROD INFANT PSYC, V17, P7, DOI [10.1080/02646839908404581, DOI 10.1080/02646839908404581]; Colcombe S, 2003, PSYCHOL SCI, V14, P125, DOI 10.1111/1467-9280.t01-1-01430; Colcombe SJ, 2003, J GERONTOL A-BIOL, V58, P176; COLE BJ, 1992, NEUROPSYCHOPHARMACOL, V7, P129; CONNOR JM, 1977, DEV PSYCHOL, V13, P293, DOI 10.1037/0012-1649.13.3.293; CONNOR WE, 1992, NUTR REV, V50, P21; CROWDY JP, 1982, HUM NUTR-APPL NUTR, V36, P325; Dahlman J, 2009, HUM FACTORS, V51, P56, DOI 10.1177/0018720809332848; De Groot RHM, 2006, PSYCHOL MED, V36, P1023, DOI 10.1017/S0033291706007380; Deary IJ, 2009, BRIT MED BULL, V92, P135, DOI 10.1093/bmb/ldp033; Deijen JB, 1999, BRAIN RES BULL, V48, P203, DOI 10.1016/S0361-9230(98)00163-4; Dretsch MN, 2014, MIL MED, V179, P396, DOI 10.7205/MILMED-D-13-00395; Dyrstad SM, 2006, MIL MED, V171, P736, DOI 10.7205/MILMED.171.8.736; Eddy MD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130817; EIDELMAN AI, 1993, OBSTET GYNECOL, V81, P764; FELIG P, 1969, J CLIN INVEST, V48, P584, DOI 10.1172/JCI106017; Flegr J, 2012, NEUROENDOCRINOL LETT, V33, P224; Flegr J, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-72; Fleshner M, 1997, BEHAV NEUROSCI, V111, P512, DOI 10.1037/0735-7044.111.3.512; FROOM P, 1987, AVIAT SPACE ENVIR MD, V58, P252; Frye CA, 1999, PHYSIOL BEHAV, V66, P85, DOI 10.1016/S0031-9384(98)00256-X; Goerres HP, 2003, AVIAT SPACE ENVIR MD, V74, P278; GOLDING JF, 1992, AVIAT SPACE ENVIR MD, V63, P491; Goldstein A. G., 1965, PSYCHON SCI, V3, P361, DOI DOI 10.3758/BF03343180; Greenwood PM, 2012, NEUROSCI BIOBEHAV R, V36, P1331, DOI 10.1016/j.neubiorev.2012.02.010; Guo WY, 2016, NEUROREPORT, V27, P367, DOI 10.1097/WNR.0000000000000537; Haag M, 2003, CAN J PSYCHIAT, V48, P195, DOI 10.1177/070674370304800308; Hansen AL, 2004, EUR J APPL PHYSIOL, V93, P263, DOI 10.1007/s00421-004-1208-0; Hansen AL, 2003, INT J PSYCHOPHYSIOL, V48, P263, DOI 10.1016/S0167-8760(03)00073-4; Harrison Y, 2000, J EXP PSYCHOL-APPL, V6, P236, DOI 10.1037//1076-898X.6.3.236; Hatch BC, 2009, OPTOMETRY VISION SCI, V86, P1359; Head J, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00680; Heaton RK, 1996, NEUROPSYCHOLOGICAL A, P141; Hellewell SC, 2018, J TRAUMA STRESS, V31, P89, DOI 10.1002/jts.22261; Hickey JP, 2012, J ROY ARMY MED CORPS, V158, P41, DOI 10.1136/jramc-158-01-11; Horrobin DF, 2002, PROSTAG LEUKOTR ESS, V66, P83, DOI 10.1054/plef.2001.0338; Hoyland A, 2008, NEUROSCI BIOBEHAV R, V32, P72, DOI 10.1016/j.neubiorev.2007.05.006; James JE, 1998, NEUROPSYCHOBIOLOGY, V38, P32, DOI 10.1159/000026514; Jha AP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116889; Jha AP, 2010, EMOTION, V10, P54, DOI 10.1037/a0018438; JOELS M, 1992, TRENDS NEUROSCI, V15, P25, DOI 10.1016/0166-2236(92)90345-9; Johnsen BRH, 2012, INT MARIT HEALTH, V63, P181; Jongkees BJ, 2015, J PSYCHIATR RES, V70, P50, DOI 10.1016/j.jpsychires.2015.08.014; Kalman DS, 2012, J INT SOC SPORT NUTR, V9, DOI 10.1186/1550-2783-9-1; Kemnitz CP, 2001, PERCEPT MOTOR SKILL, V93, P479, DOI 10.2466/PMS.93.5.479-485; Kidd PM, 2007, ALTERN MED REV, V12, P207; Knapik JJ, 1997, MIL MED, V162, P62, DOI 10.1093/milmed/162.1.62; Knapik JJ, 2009, J STRENGTH COND RES, V23, P1353, DOI 10.1519/JSC.0b013e318194df72; Kober PK, 2017, MIL PSYCHOL, V29, P560, DOI 10.1037/mil0000192; Kotani S, 2006, NEUROSCI RES, V56, P159, DOI 10.1016/j.neures.2006.06.010; LECKLITER IN, 1989, J CLIN PSYCHOL, V45, P484, DOI 10.1002/1097-4679(198907)45:4<484::AID-JCLP2270450402>3.0.CO;2-L; Legg SJ, 1996, ERGONOMICS, V39, P1403, DOI 10.1080/00140139608964560; Leino TK, 1999, AVIAT SPACE ENVIR MD, V70, P565; LERMAN Y, 1992, ISRAEL J MED SCI, V28, P610; Lezak M. D., 2004, NEUROPSYCHOLOGICAL A; Lieberman HR, 2007, J AM COLL NUTR, V26, p555S, DOI 10.1080/07315724.2007.10719658; Lieberman HR, 2014, HUM FACTORS, V56, P1113, DOI 10.1177/0018720813519472; Lieberman HR, 1997, J NUTR BIOCHEM, V8, P119, DOI 10.1016/S0955-2863(97)00008-9; Lieberman HR, 2003, APPETITE, V40, P245, DOI 10.1016/S0195-6663(03)00010-2; Lieberman HR, 2002, AM J CLIN NUTR, V76, P120, DOI 10.1093/ajcn/76.1.120; Lim J, 2010, PSYCHOL BULL, V136, P375, DOI 10.1037/a0018883; Lindseth PD, 2013, MIL MED, V178, P792, DOI 10.7205/MILMED-D-13-00013; Lorist MM, 2005, COGNITIVE BRAIN RES, V24, P199, DOI 10.1016/j.cogbrainres.2005.01.018; Bermejo JL, 2018, J SPORT SCI, V36, P429, DOI 10.1080/02640414.2017.1313443; Lupien SJ, 1999, BEHAV NEUROSCI, V113, P420, DOI 10.1037/0735-7044.113.3.420; Mahoney CR, 2007, AVIAT SPACE ENVIR MD, V78, pB51; Martin K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159907; Matsangas P, 2014, HUM FACTORS, V56, P1124, DOI 10.1177/0018720814522484; McEwen BS, 1999, ANNU REV NEUROSCI, V22, P105, DOI 10.1146/annurev.neuro.22.1.105; Milanez VF, 2011, INT J SPORT PHYSIOL, V6, P358, DOI 10.1123/ijspp.6.3.358; MILNER JD, 1986, BIOCHEM PHARMACOL, V35, P875, DOI 10.1016/0006-2952(86)90071-7; Milnik A, 2012, AM J MED GENET B, V159B, P958, DOI 10.1002/ajmg.b.32101; Miu AC, 2009, AUTON NEUROSCI-BASIC, V145, P99, DOI 10.1016/j.autneu.2008.11.010; Mohajeri MH, 2015, BRIT J NUTR, V113, P350, DOI 10.1017/S0007114514003754; Morgan CA, 2004, ARCH GEN PSYCHIAT, V61, P819, DOI 10.1001/archpsyc.61.8.819; Morgan CA, 2009, MIL MED, V174, P132, DOI 10.7205/MILMED-D-58-7808; Morgan CA, 2009, BIOL PSYCHIAT, V66, P334, DOI 10.1016/j.biopsych.2009.04.004; Morris N, 1998, APPL ERGON, V29, P377, DOI 10.1016/S0003-6870(97)00070-7; Murphy SE, 2006, PSYCHOPHARMACOLOGY, V187, P121, DOI 10.1007/s00213-006-0401-8; Nassef A., 2009, WORLD C MED PHYS BIO; NERI DF, 1995, AVIAT SPACE ENVIR MD, V66, P313; Nibbeling N, 2014, ERGONOMICS, V57, P1366, DOI 10.1080/00140139.2014.924572; O'Brien C, 2007, PHYSIOL BEHAV, V90, P301, DOI 10.1016/j.physbeh.2006.09.027; Owen G, 2004, AVIAT SPACE ENVIR MD, V 75, P240; Paul MA, 2005, AVIAT SPACE ENVIR MD, V76, P560; PETERS JC, 1985, J NUTR, V115, P382, DOI 10.1093/jn/115.3.382; Piccardi Laura, 2014, BMC Res Notes, V7, P524, DOI 10.1186/1756-0500-7-524; Piccardi L, 2013, AVIAT SPACE ENVIR MD, V84, P1092, DOI 10.3357/ASEM.3629.2013; Popova N K, 2001, Neurosci Behav Physiol, V31, P327, DOI 10.1023/A:1010346904526; Prinsloo GE, 2011, APPL COGNITIVE PSYCH, V25, P792, DOI 10.1002/acp.1750; Pruessner JC, 2005, NEUROIMAGE, V28, P815, DOI 10.1016/j.neuroimage.2005.06.014; Radakovic SS, 2007, MIL MED, V172, P133, DOI 10.7205/MILMED.172.2.133; Reed HL, 2001, J CLIN ENDOCR METAB, V86, P110, DOI 10.1210/jc.86.1.110; REPPERGER D, 1987, PERCEPT MOTOR SKILL, V65, P627, DOI 10.2466/pms.1987.65.2.627; Robbins TW, 2005, J COMP NEUROL, V493, P140, DOI 10.1002/cne.20717; Rocha KKF, 2012, CONSCIOUS COGN, V21, P843, DOI 10.1016/j.concog.2012.01.014; Roebuck-Spencer TM, 2008, MIL PSYCHOL, V20, P187, DOI 10.1080/08995600802118825; Rovira E, 2016, NEUROPSYCHOLOGY, V30, P709, DOI 10.1037/neu0000277; SALAMONE JD, 1991, PSYCHOPHARMACOLOGY, V104, P515, DOI 10.1007/BF02245659; Schmitt JAJ, 2006, CURR PHARM DESIGN, V12, P2473, DOI 10.2174/138161206777698909; Seeman TE, 2001, HEALTH PSYCHOL, V20, P243, DOI 10.1037//0278-6133.20.4.243; Selkirk GA, 2001, J APPL PHYSIOL, V91, P2055, DOI 10.1152/jappl.2001.91.5.2055; Sherratt S, 2010, INT J SPEECH-LANG PA, V12, P152, DOI 10.3109/17549500903521806; Shia RM, 2015, MIL MED, V180, P230, DOI 10.7205/MILMED-D-14-00363; ShukittHale B, 1997, PHYSIOL BEHAV, V62, P783, DOI 10.1016/S0031-9384(97)00236-9; Silverman MN, 2014, INTERFACE FOCUS, V4, DOI 10.1098/rsfs.2014.0040; Singh N., 1978, Q J CRUDE DRUG RES, V16, P125; SINYOR D, 1983, PSYCHOSOM MED, V45, P205, DOI 10.1097/00006842-198306000-00003; Smith PJ, 2010, PSYCHOSOM MED, V72, P239, DOI 10.1097/PSY.0b013e3181d14633; Srivastava KK, 1999, MIL MED, V164, P814, DOI 10.1093/milmed/164.11.814; Stellingwerff T, 2014, APPL PHYSIOL NUTR ME, V39, P998, DOI 10.1139/apnm-2014-0027; Tajalizadekhoob Y, 2011, EUR ARCH PSY CLIN N, V261, P539, DOI 10.1007/s00406-011-0191-9; Talukdar T, 2018, CEREB CORTEX, V28, P3600, DOI 10.1093/cercor/bhx232; Taylor MK, 2008, MIL MED, V173, P738, DOI 10.7205/MILMED.173.8.738; Tirre W. C., 1994, AVIAT SPACE ENV MED, V65, P49; Tomar V. S., 1984, PROBE, V24, P25; Trousselard M., 2009, RTO HUM FACT MED PAN; Van Cutsem J, 2017, SPORTS MED, V47, P1569, DOI 10.1007/s40279-016-0672-0; van der Linden D, 2003, ACTA PSYCHOL, V113, P45, DOI 10.1016/S0001-6918(02)00150-6; vanDokkum W, 1996, AVIAT SPACE ENVIR MD, V67, P819; Vasterling JJ, 2006, JAMA-J AM MED ASSOC, V296, P519, DOI 10.1001/jama.296.5.519; Verde P, 2016, AEROSP MED HUM PERF, V87, P528, DOI 10.3357/AMHP.4521.2016; Verde P, 2015, AEROSP MED HUM PERF, V86, P103, DOI 10.3357/AMHP.4024.2015; Vincent AS, 2008, MIL MED, V173, P836, DOI 10.7205/MILMED.173.9.836; Vincent AS, 2012, MIL MED, V177, P256, DOI 10.7205/MILMED-D-11-00289; Vincent AS, 2012, MIL MED, V177, P248, DOI 10.7205/MILMED-D-11-00156; Weerts AP, 2014, J PSYCHOPHARMACOL, V28, P655, DOI 10.1177/0269881113516201; Weiss EM, 2003, PERS INDIV DIFFER, V35, P863, DOI 10.1016/S0191-8869(02)00288-X; Wells KH, 2009, MIL MED, V174, P398, DOI 10.7205/MILMED-D-00-6408; Williams D, 1997, MIL PSYCHOL, V9, P329, DOI 10.1207/s15327876mp0904_5; Wilson MMG, 2003, EUR J CLIN NUTR, V57, pS24, DOI 10.1038/sj.ejcn.1601898; Yanovich Ran, 2015, Disaster Mil Med, V1, P6, DOI 10.1186/2054-314X-1-6; Young AH, 1999, PSYCHOPHARMACOLOGY, V145, P260, DOI 10.1007/s002130051057	164	7	7	0	13	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0018-7208	1547-8181		HUM FACTORS	Hum. Factors	FEB	2020	62	1					93	123		10.1177/0018720819841757			31	Behavioral Sciences; Engineering, Industrial; Ergonomics; Psychology, Applied; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Behavioral Sciences; Engineering; Psychology	KB1AP	WOS:000506234100007	31009241	Green Published			2022-02-06	
J	Moss, BP; Patel, DC; Tavee, JO; Culver, DA				Moss, B. P.; Patel, D. C.; Tavee, J. O.; Culver, D. A.			Evaluating S100B as a serum biomarker for central neurosarcoidosis	RESPIRATORY MEDICINE			English	Article						S100B; Biomarker; Sarcoidosis; Neurosarcoidosis	MARKER	Background: S100B is a calcium-binding protein found primarily in glial cells. In the setting of neuronal injury and disruption of the blood brain barrier, S100B can leak into the cerebrospinal fluid and systemic circulation. Objectives: To determine if serum S100B distinguishes patients with central neurosarcoidosis (NS) from patients with extra-neurologic sarcoidosis (ENS) and healthy controls, and if S100B levels correlate with MRI measures of disease burden. Methods: Patients were enrolled from the Cleveland Clinic Sarcoidosis Center. Patients with traumatic brain injury, central nervous system (CNS) infections, CNS malignancy, neurodegenerative disorders, schizophrenia, bipolar disorder, or melanoma were excluded. S100B levels were compared between patients with NS, ENS, and healthy controls, and between NS patients with varying degrees of post-contrast enhancement on MRI. Results: Median (interquartile range) S100B levels were 101 pg/mL (92, 136) for 11 NS patients, 89 pg/mL (73, 107) for 11 ENS patients, and 60 pg/mL (39, 74) for 26 healthy controls. There was a significant difference between NS and control groups (p = 0.01). The difference between NS and ENS groups did not rise to the level of statistical significance (p = 0.178). S100B levels were significantly different between NS patients with varying degrees of enhancement on MRI (p = 0.04). Conclusions: S100B deserves additional study as a biomarker for CNS injury in NS. It may be useful as a longitudinal measure of disease activity.	[Moss, B. P.] Cleveland Clin, Neurol Inst, Cleveland, OH 44106 USA; [Patel, D. C.] Univ Florida, Div Pulm Crit Care & Sleep Med, Gainesville, FL USA; [Tavee, J. O.] Northwestern Univ, Dept Neurol, Chicago, IL 60611 USA; [Culver, D. A.] Cleveland Clin, Resp Inst, Cleveland, OH 44106 USA		Moss, BP (corresponding author), 9500 Euclid Ave,U-10, Cleveland, OH 44195 USA.	mossb@ccf.org		Moss, Brandon/0000-0001-5319-5129			Bartosik-Psujek H, 2011, ACTA NEUROL SCAND, V123, P252, DOI 10.1111/j.1600-0404.2010.01393.x; Chopra A, 2016, EXPERT REV CLIN IMMU, V12, P1191, DOI 10.1080/1744666X.2016.1196135; Culver DA, 2017, SEMIN RESP CRIT CARE, V38, P499, DOI 10.1055/s-0037-1604165; Georgiadis D, 2000, J THORAC CARDIOV SUR, V119, P138, DOI 10.1016/S0022-5223(00)70229-7; Goncalves CA, 2008, CLIN BIOCHEM, V41, P755, DOI 10.1016/j.clinbiochem.2008.04.003; Hunninghake GW, 1999, SARCOIDOSIS VASC DIF, V16, P149; Judson MA, 2014, SARCOIDOSIS VASC DIF, V31, P19; Judson MA, 1999, SARCOIDOSIS VASC DIF, V16, P75; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Petzold A, 2004, MULT SCLER J, V10, P281, DOI 10.1191/1352458504ms1021sr; R Core Team, 2018, STATS PACK LANG ENV	11	7	7	1	3	W B SAUNDERS CO LTD	LONDON	32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND	0954-6111	1532-3064		RESP MED	Respir. Med.	FEB	2020	162								105855	10.1016/j.rmed.2019.105855			4	Cardiac & Cardiovascular Systems; Respiratory System	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology; Respiratory System	KK7MQ	WOS:000512923100005	31916532	Bronze			2022-02-06	
J	Pozzato, I; Meares, S; Kifley, A; Craig, A; Gillett, M; Van Vu, K; Liang, A; Cameron, I; Gopinath, B				Pozzato, Ilaria; Meares, Susanne; Kifley, Annette; Craig, Ashley; Gillett, Mark; Van Vu, Kim; Liang, Anthony; Cameron, Ian; Gopinath, Bamini			Challenges in the acute identification of mild traumatic brain injuries: results from an emergency department surveillance study	BMJ OPEN			English	Article							POSTTRAUMATIC AMNESIA SCALE; HEAD-INJURY; CONCUSSION; ACCURACY; SYMPTOMS	Objectives To establish the proportion of mild traumatic brain injury (mTBI) diagnosis among people presenting to an emergency department (ED), to determine the accuracy of recorded ED diagnoses. We also aimed to describe challenges in mTBI case identification and its acute hospital management. Design and setting A retrospective chart review of all ED attendances to a major trauma hospital, over a 9-month period (June 2015-February 2016). Participants Adults aged 18-65 years consecutively presenting to an ED. Primary outcome measures Proportion of mTBI diagnosis among ED attendances (ie, confirmed mTBI based on the WHO criteria or indeterminate mTBI based on secondary criteria), and proportion of accurately recorded mTBI diagnosis by ED clinicians (ie, 'mTBI', 'concussion'). Results Of 30 479 ED attendances, 351 (1.15%) confirmed mTBI diagnosis and 180 (0.6%) indeterminate diagnosis were identified. Only 81 (23.1%) individuals with a confirmed mTBI had a 'mTBI diagnosis' clearly recorded in the medical notes. Of the allocated discharge diagnosis codes to the two identified cohorts, 89.8% were not indicative of mTBI. Intracranial injuries were found in 31 (8.5%) confirmed cases. Glasgow Coma Scale scores were consistently assessed in the ED but identified only 117 (33.3%) confirmed mTBI cases. Post-traumatic amnesia (PTA) testing was able to confirm acute cognitive impairment in 113 (62.1%) of those who were tested (182, 51.3%). Conclusions mTBI is a common, but an under-recognised cause for ED attendance. Despite challenges, the use of an operational definition such as the WHO diagnostic criteria can improve accuracy in mTBI identification. Acute management may be enhanced by rapid assessment of PTA.	[Pozzato, Ilaria; Kifley, Annette; Craig, Ashley; Van Vu, Kim; Liang, Anthony; Cameron, Ian; Gopinath, Bamini] Univ Sydney, John Walsh Ctr Rehabil Res, Kolling Inst, St Leonards, NSW, Australia; [Meares, Susanne] Macquarie Univ, Dept Psychol, Sydney, NSW, Australia; [Gillett, Mark] Royal North Shore Hosp, Emergency Dept, Sydney, NSW, Australia		Gopinath, B (corresponding author), Univ Sydney, John Walsh Ctr Rehabil Res, Kolling Inst, St Leonards, NSW, Australia.	bamini.gopinath@sydney.edu.au		Pozzato, Ilaria/0000-0002-8752-1460; Craig, Ashley/0000-0001-7647-7604; Meares, Susanne/0000-0002-3859-9974	Ramsay Research and Teaching Fund-Northern Sydney Local Health District, Sydney, Australia	This study has received research grant support from the Ramsay Research and Teaching Fund-Northern Sydney Local Health District, Sydney, Australia. The funding source had no role in study design, data collection and analysis, decision to publish and in the writing of this manuscript.	Arneson D, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06222-0; Bazarian JJ, 2006, ACAD EMERG MED, V13, P31, DOI 10.1197/j.aem.2005.07.038; Bosch M, 2019, IMPLEMENT SCI, V14, DOI 10.1186/s13012-018-0841-7; Bosch M, 2014, TRIALS, V15, DOI 10.1186/1745-6215-15-281; Brennan JH, 2015, J CLIN NEUROSCI, V22, P1375, DOI 10.1016/j.jocn.2015.02.030; Cassidy J David, 2014, Arch Phys Med Rehabil, V95, pS278, DOI 10.1016/j.apmr.2013.08.295; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Gardner RC, 2015, MOL CELL NEUROSCI, V66, P75, DOI 10.1016/j.mcn.2015.03.001; Gaw CE, 2016, BMC EMERG MED, V16, DOI 10.1186/s12873-016-0071-8; GOLDSTEIN M, 1990, ANN NEUROL, V27, P327, DOI 10.1002/ana.410270315; Hocke LM, 2018, J NEUROTRAUM, V35, P1224, DOI 10.1089/neu.2017.5365; Karr JE, 2014, NEUROPSYCHOLOGY, V28, P321, DOI 10.1037/neu0000037; Kirsch NL, 2010, ARCH PHYS MED REHAB, V91, P35, DOI 10.1016/j.apmr.2009.09.019; Korley FK, 2017, J NEUROTRAUM, V34, P1531, DOI 10.1089/neu.2016.4723; Kristman Vicki L, 2014, Arch Phys Med Rehabil, V95, pS265, DOI 10.1016/j.apmr.2013.04.026; Luoto TM, 2013, J NEUROTRAUM, V30, P11, DOI 10.1089/neu.2012.2611; Marin JR, 2014, JAMA-J AM MED ASSOC, V311, P1917, DOI 10.1001/jama.2014.3979; Meares S, 2015, ARCH PHYS MED REHAB, V96, P956, DOI 10.1016/j.apmr.2014.12.014; Meares S, 2011, BRAIN INJURY, V25, P1198, DOI 10.3109/02699052.2011.608213; Michelson EA, 2018, WEST J EMERG MED, V19, P635, DOI 10.5811/westjem.2018.5.37293; Powell JM, 2008, ARCH PHYS MED REHAB, V89, P1550, DOI 10.1016/j.apmr.2007.12.035; Pozzato I, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-016222; Rowe BH, 2018, AM J EMERG MED, V36, P2144, DOI 10.1016/j.ajem.2018.03.040; Ruff RM, 2009, ARCH CLIN NEUROPSYCH, V24, P3, DOI 10.1093/arclin/acp006; Sharpe S, 2012, J PAEDIATR CHILD H, V48, P170, DOI 10.1111/j.1440-1754.2011.02068.x; Stein MB, 2019, JAMA PSYCHIAT, V76, P249, DOI 10.1001/jamapsychiatry.2018.4288; Stiell IG, 2010, CAN MED ASSOC J, V182, P1527, DOI 10.1503/cmaj.091974; Tellier A, 2009, BRAIN INJURY, V23, P879, DOI 10.1080/02699050903200555; Theadom A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191655; Voss JD, 2015, CURR PAIN HEADACHE R, V19, DOI 10.1007/s11916-015-0506-z; Watson CE, 2017, SCAND J SURG, V106, P356, DOI 10.1177/1457496917698642; Yue JK, 2019, LANCET NEUROL, V18, P953, DOI 10.1016/S1474-4422(19)30282-0; Yue JK, 2017, J CLIN NEUROSCI, V45, P293, DOI 10.1016/j.jocn.2017.07.022	33	7	7	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	2044-6055			BMJ OPEN	BMJ Open	FEB	2020	10	2							e034494	10.1136/bmjopen-2019-034494			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LG0FL	WOS:000527786700211	32019818	gold, Green Published			2022-02-06	
J	Wang, Y; Zhao, MM; Shang, L; Zhang, YG; Huang, CG; He, ZQ; Luo, M; Wu, B; Song, P; Wang, MY; Duan, FL				Wang, Yuan; Zhao, MingMing; Shang, Lv; Zhang, Yanguo; Huang, Conggang; He, Zhuqiang; Luo, Ming; Wu, Bin; Song, Ping; Wang, Mengyang; Duan, Faliang			Homer1a protects against neuronal injury via PI3K/AKT/mTOR signaling pathway	INTERNATIONAL JOURNAL OF NEUROSCIENCE			English	Article						Neurons; traumatic brain injury; Homer1a; PI3K; AKT; mTOR pathway; caspase	TRAUMATIC BRAIN-INJURY; AUTOPHAGY; EXPRESSION; PROTEINS; BECLIN-1; DISEASE	Purpose: Homer1a is a member of the post-synaptic density protein family that plays an important role in neuronal synaptic activity and is extensively involved in neurological disorders. The aim of this study is to investigate the role of Homer1a in modulating neuronal survival using an in vitro traumatic neuronal injury model. Materials and methods: Neurons were extracted from rats and identifited. Then, the cells were treated with Homerla overexpression or interference vectors. Western blot was performed to evaluate the expression of Homerla, apoptosis-related proteins(caspase3, caspase8, caspase9, Fasl, Bax, and p53), autophagy-related proteins (LC3ll and Beclin1), and the activiation of PI3K/AKT/mTOM pathway. In addition, the cell viability and apoptosis rate were measured. Results: After transfection with overexpression or interference vectors, the mRNA and protein expression of Homer1a increased or decreased significantly, respectively. Upregulation of Homer1a significantly alleviated apoptosis and enhanced cell viability and autophagy after traumatic neuronal injury. Homer1a overexpression also significantly decreased the expression of the pro-apoptosis proteins caspase 3, caspase 8, caspase 9, Fasl, Bax, and p53 in neurons. Furthermore, neuron autophagy was increased after traumatic neuronal injury as demonstrated by the greater accumulation of autophagosomes and higher expression of LC3II and Beclin1 induced by Homer1a overexpression. In addition, Homer1a overexpression inhibited the activation of PI3K/AKT/mTOR signaling. Conclusion: These findings indicated that Homer1a potentially protects neurons from traumatic injury by regulating apoptosis and autophagy via the caspase and PI3K/AKT/mTOR signaling pathways and may be an effective intervention target in traumatic brain injury.	[Wang, Yuan; Zhang, Yanguo; Huang, Conggang; He, Zhuqiang; Luo, Ming; Wu, Bin; Song, Ping; Wang, Mengyang; Duan, Faliang] Wuhan First Hosp, Dept Neurosurg, 215 Zhongshan St, Wuhan 430022, Peoples R China; [Zhao, MingMing] Navy Gen Hosp, Dept Neurosurg, Beijing, Peoples R China; [Shang, Lv] Wuhan Ctr Dis Prevent & Control, Wuhan, Peoples R China		Duan, FL (corresponding author), Wuhan First Hosp, Dept Neurosurg, 215 Zhongshan St, Wuhan 430022, Peoples R China.	duanfaliang@126.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81601076]	This work was supported by the National Natural Science Foundation of China (NO. 81601076).	Algattas H, 2014, INT J MOL SCI, V15, P309, DOI 10.3390/ijms15010309; Beer R, 2001, J NEUROCHEM, V78, P862, DOI 10.1046/j.1471-4159.2001.00460.x; Brakeman PR, 1997, NATURE, V386, P284, DOI 10.1038/386284a0; Brazinova A, 2021, J NEUROTRAUM, V38, P1411, DOI 10.1089/neu.2015.4126; Bursch W, 2006, ANN NY ACAD SCI, V926, P1; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Cernak I, 2006, EXPERT OPIN INV DRUG, V15, P1371, DOI 10.1517/13543784.15.11.1371; Clark RSB, 2008, AUTOPHAGY, V4, P88, DOI 10.4161/auto.5173; Cordaro M, 2016, J NEUROTRAUM, V33, P132, DOI 10.1089/neu.2014.3460; Darwish RS, 2010, NEUROCRIT CARE, V12, P337, DOI 10.1007/s12028-009-9328-3; Diskin T, 2005, J NEUROTRAUM, V22, P750, DOI 10.1089/neu.2005.22.750; El-Gazar AA, 2019, BRAIN RES, V1717, P104, DOI 10.1016/j.brainres.2019.04.003; Elbashir SM, 2001, GENE DEV, V15, P188, DOI 10.1101/gad.862301; Hayashi MK, 2009, CELL, V137, P159, DOI 10.1016/j.cell.2009.01.050; He PF, 2009, AUTOPHAGY, V5, P52, DOI 10.4161/auto.5.1.7247; Jung HS, 2010, ANN NY ACAD SCI, V1201, P79, DOI 10.1111/j.1749-6632.2010.05614.x; Kanbak G, 2013, GENE, V512, P492, DOI 10.1016/j.gene.2012.10.012; Kato A, 1998, J BIOL CHEM, V273, P23969, DOI 10.1074/jbc.273.37.23969; Kegel KB, 2000, J NEUROSCI, V20, P7268, DOI 10.1523/jneurosci.20-19-07268.2000; Luo CL, 2011, NEUROSCIENCE, V184, P54, DOI 10.1016/j.neuroscience.2011.03.021; Luo P, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.116; Ma JL, 2019, CELL TRANSPLANT, V28, P585, DOI 10.1177/0963689719840353; Maiti P, 2019, J CELL MOL MED, V23, P5211, DOI 10.1111/jcmm.14396; Nixon RA, 2006, TRENDS NEUROSCI, V29, P528, DOI 10.1016/j.tins.2006.07.003; SEGLEN PO, 1982, P NATL ACAD SCI-BIOL, V79, P1889, DOI 10.1073/pnas.79.6.1889; Shi CS, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000751; Shintani T, 2004, SCIENCE, V306, P990, DOI 10.1126/science.1099993; Shiraishi-Yamaguchi Y, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-206; Wang YZ, 2015, STAT INTERFACE, V8, P1; Wang ZY, 2017, NEUROSCI LETT, V656, P158, DOI 10.1016/j.neulet.2017.07.036; Xiao B, 1998, NEURON, V21, P707, DOI 10.1016/S0896-6273(00)80588-7; Yang T, 2014, CELL MOL NEUROBIOL, V34, P797, DOI 10.1007/s10571-014-0070-9; Zeng ZQ, 2020, J CELL PHYSIOL, V235, P1973, DOI 10.1002/jcp.29173; Zhang JY, 2018, J NEUROTRAUM, V35, P802, DOI 10.1089/neu.2016.4871; Zhou YL, 2010, STROKE, V41, P1521, DOI 10.1161/STROKEAHA.110.583757	35	7	8	2	5	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0020-7454	1563-5279		INT J NEUROSCI	Int. J. Neurosci.	JUN 2	2020	130	6					621	630		10.1080/00207454.2019.1702535		FEB 2020	10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	LO8MF	WOS:000512577600001	32013638				2022-02-06	
J	Montanino, A; Saeedimasine, M; Villa, A; Kleiven, S				Montanino, Annaclaudia; Saeedimasine, Marzieh; Villa, Alessandra; Kleiven, Svein			Localized Axolemma Deformations Suggest Mechanoporation as Axonal Injury Trigger	FRONTIERS IN NEUROLOGY			English	Article						mechanoporation; axolemma; axonal injury; membrane permeability; traumatic brain injury; finite element	TRAUMATIC BRAIN-INJURY; COARSE-GRAINED MODEL; FORCE-FIELD; NEUROFILAMENT COMPACTION; INITIAL SEGMENT; VIRIAL STRESS; TAU PROTEINS; STRAIN-RATE; CELL; MEMBRANE	Traumatic brain injuries are a leading cause of morbidity and mortality worldwide. With almost 50% of traumatic brain injuries being related to axonal damage, understanding the nature of cellular level impairment is crucial. Experimental observations have so far led to the formulation of conflicting theories regarding the cellular primary injury mechanism. Disruption of the axolemma, or alternatively cytoskeletal damage has been suggested mainly as injury trigger. However, mechanoporation thresholds of generic membranes seem not to overlap with the axonal injury deformation range and microtubules appear too stiff and too weakly connected to undergo mechanical breaking. Here, we aim to shed a light on the mechanism of primary axonal injury, bridging finite element and molecular dynamics simulations. Despite the necessary level of approximation, our models can accurately describe the mechanical behavior of the unmyelinated axon and its membrane. More importantly, they give access to quantities that would be inaccessible with an experimental approach. We show that in a typical injury scenario, the axonal cortex sustains deformations large enough to entail pore formation in the adjoining lipid bilayer. The observed axonal deformation of 10-12% agree well with the thresholds proposed in the literature for axonal injury and, above all, allow us to provide quantitative evidences that do not exclude pore formation in the membrane as a result of trauma. Our findings bring to an increased knowledge of axonal injury mechanism that will have positive implications for the prevention and treatment of brain injuries.	[Montanino, Annaclaudia; Kleiven, Svein] Royal Inst Technol KTH, Div Neuron Engn, Stockholm, Sweden; [Saeedimasine, Marzieh; Villa, Alessandra] Karolinska Inst, Dept Biosci & Nutr, Stockholm, Sweden		Montanino, A (corresponding author), Royal Inst Technol KTH, Div Neuron Engn, Stockholm, Sweden.	annacl2@kth.se			Swedish Research CouncilSwedish Research CouncilEuropean Commission [VR-2016-05314]; European UnionEuropean Commission [642662]; Swedish National Infrastructure for Computing [SNIC2017-1491, SNIC2018-3-548]	The authors thank the Swedish Research Council (VR-2016-05314), the European Union Horizon 2020 Research and Innovation Framework Programme under the Marie Sklodowska-Curie (grant agreement no. 642662), and the Swedish National Infrastructure for Computing (SNIC2017-1491 and SNIC2018-3-548) for the support.	Abraham Mark James, 2015, SoftwareX, V1-2, P19, DOI 10.1016/j.softx.2015.06.001; Ahmadzadeh H, 2015, BIOPHYS J, V109, P2328, DOI 10.1016/j.bpj.2015.09.010; Ahmadzadeh H, 2014, BIOPHYS J, V106, P1123, DOI 10.1016/j.bpj.2014.01.024; Bain AC, 2000, J BIOMECH ENG-T ASME, V122, P615, DOI 10.1115/1.1324667; Bain AC, 2003, J BIOMECH ENG-T ASME, V125, P798, DOI 10.1115/1.1632627; Bain AC, 2001, J NEUROTRAUM, V18, P499, DOI 10.1089/089771501300227305; Barreto S, 2013, BIOMATERIALS, V34, P6119, DOI 10.1016/j.biomaterials.2013.04.022; Bathe M, 2008, BIOPHYS J, V94, P2955, DOI 10.1529/biophysj.107.119743; Bavi N, 2014, P NATL ACAD SCI USA, V111, P13864, DOI 10.1073/pnas.1409011111; Bernal R, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.018301; Bianchi F, 2019, NEUROSCIENCE, V404, P165, DOI 10.1016/j.neuroscience.2019.02.014; BRAY D, 1981, J NEUROCYTOL, V10, P589, DOI 10.1007/BF01262592; Buffington SA, 2011, EUR J NEUROSCI, V34, P1609, DOI 10.1111/j.1460-9568.2011.07875.x; Bussi G, 2009, J CHEM PHYS, V130, DOI 10.1063/1.3073889; Catterall WA, 2005, PHARMACOL REV, V57, P397, DOI 10.1124/pr.57.4.4; Chen X, 2008, BIOPHYS J, V95, P563, DOI 10.1529/biophysj.107.128488; Chetta J, 2010, CYTOSKELETON, V67, P650, DOI 10.1002/cm.20478; Cinelli I, 2018, IEEE T BIO-MED ENG, V65, P1373, DOI 10.1109/TBME.2017.2752258; Cullen DK, 2006, J NEUROTRAUM, V23, P1304, DOI 10.1089/neu.2006.23.1304; Cullen DK, 2011, J NEUROTRAUM, V28, P2219, DOI 10.1089/neu.2011.1841; Dai JW, 1998, J NEUROSCI, V18, P6681; Dao M, 2003, J MECH PHYS SOLIDS, V51, P2259, DOI 10.1016/j.jmps.2003.09.019; Datar A, 2015, BIOPHYS J, V108, P489, DOI 10.1016/j.bpj.2014.11.3480; de Rooij R, 2018, FRONT CELL NEUROSCI, V12, DOI 10.3389/fncel.2018.00144; de Rooij R, 2018, BIOPHYS J, V114, P201, DOI 10.1016/j.bpj.2017.11.010; DENNERLL TJ, 1988, J CELL BIOL, V107, P665, DOI 10.1083/jcb.107.2.665; Duflocq A, 2008, MOL CELL NEUROSCI, V39, P180, DOI 10.1016/j.mcn.2008.06.008; Duke T, 1996, BIOPHYS J, V71, P1235, DOI 10.1016/S0006-3495(96)79323-2; Elkin BS, 2007, 51 STAPP CAR CRASH C, DOI [10.4271/2007-22-0005, DOI 10.4271/2007-22-0005]; EVANS EA, 1976, BIOPHYS J, V16, P585, DOI 10.1016/S0006-3495(76)85713-X; EVANS EA, 1977, J MEMBRANE BIOL, V30, P351; FADIC R, 1985, J COMP NEUROL, V236, P258, DOI 10.1002/cne.902360209; Farkas O, 2006, J NEUROSCI, V26, P3130, DOI 10.1523/JNEUROSCI.5119-05.2006; Fitzpatrick MO, 1998, J NEUROL NEUROSUR PS, V64, P285, DOI 10.1136/jnnp.64.3.285; Geddes DM, 2003, J NEUROTRAUM, V20, P1039, DOI 10.1089/089771503770195885; Geddes-Klein DM, 2006, J NEUROTRAUM, V23, P193, DOI 10.1089/neu.2006.23.193; Gennarelli TA, 1998, NEUROSCIENTIST, V4, P202, DOI 10.1177/107385849800400316; Greer JE, 2013, ACTA NEUROPATHOL, V126, P59, DOI 10.1007/s00401-013-1119-4; Harayama T, 2018, NAT REV MOL CELL BIO, V19, P281, DOI 10.1038/nrm.2017.138; Hemphill MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022899; Hill CS, 2016, TRENDS NEUROSCI, V39, P311, DOI 10.1016/j.tins.2016.03.002; Hu H, 2014, NAT NEUROSCI, V17, P686, DOI 10.1038/nn.3678; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Ingolfsson HI, 2014, J AM CHEM SOC, V136, P14554, DOI 10.1021/ja507832e; Iwata A, 2004, J NEUROSCI, V24, P4605, DOI 10.1523/JNEUROSCI.0515-03.2004; Jerusalem A, 2012, ACTA BIOMATER, V8, P3360, DOI 10.1016/j.actbio.2012.04.039; Ji SB, 2015, J NEUROTRAUM, V32, P441, DOI 10.1089/neu.2013.3268; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Karcher H, 2003, BIOPHYS J, V85, P3336, DOI 10.1016/S0006-3495(03)74753-5; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Kilinc D, 2008, EXP NEUROL, V212, P422, DOI 10.1016/j.expneurol.2008.04.025; Kleiven S., 2014, STAPP CAR CRASH J, V58, P29, DOI [DOI 10.4271/2014-22-0002, 10.4271/2014-22-0002]; Kraft RH, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002619; Kwong MT, 2019, COMPUT METHOD APPL M, V346, P1025, DOI 10.1016/j.cma.2018.09.006; LaPlaca MC, 1997, ANN BIOMED ENG, V25, P665, DOI 10.1007/BF02684844; LaPlaca MC, 2019, CLIN BIOMECH, V64, P2, DOI 10.1016/j.clinbiomech.2018.05.016; LaPlaca MC, 2010, J BIOMECH, V43, P71, DOI 10.1016/j.jbiomech.2009.09.011; Lazarus C, 2015, BIOPHYS J, V109, P231, DOI 10.1016/j.bpj.2015.06.029; Leterrier C, 2017, NAT REV NEUROSCI, V18, P713, DOI 10.1038/nrn.2017.129; Lomize MA, 2012, NUCLEIC ACIDS RES, V40, pD370, DOI 10.1093/nar/gkr703; MALBOUISSON AMB, 1985, ANAT EMBRYOL, V171, P339, DOI 10.1007/BF00347022; MALO MS, 1994, CYTOGENET CELL GENET, V67, P178, DOI 10.1159/000133818; MARGULIES SS, 1992, J BIOMECH, V25, P917, DOI 10.1016/0021-9290(92)90231-O; Marmarou CR, 2006, EXP NEUROL, V197, P353, DOI 10.1016/j.expneurol.2005.10.003; Marrink SJ, 2007, J PHYS CHEM B, V111, P7812, DOI 10.1021/jp071097f; Marrink SJ, 2019, CHEM REV, V119, P6184, DOI 10.1021/acs.chemrev.8b00460; Marrink SJ, 2009, BBA-BIOMEMBRANES, V1788, P149, DOI 10.1016/j.bbamem.2008.10.006; Marrink SJ, 2004, J PHYS CHEM B, V108, P750, DOI 10.1021/jp036508g; Maxwell WL, 1996, MICROSC RES TECHNIQ, V34, P522, DOI 10.1002/(SICI)1097-0029(19960815)34:6<522::AID-JEMT4>3.0.CO;2-L; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Meythaler JM, 2001, ARCH PHYS MED REHAB, V82, P1461, DOI 10.1053/apmr.2001.25137; MOHANDAS N, 1994, ANNU REV BIOPH BIOM, V23, P787, DOI 10.1146/annurev.bb.23.060194.004035; Montanino A, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00643; Monticelli L, 2008, J CHEM THEORY COMPUT, V4, P819, DOI 10.1021/ct700324x; Murphy MA, 2016, MODEL SIMUL MATER SC, V24, DOI 10.1088/0965-0393/24/5/055008; Nakadate H., 2017, 61 STAPP CAR CRASH C, DOI [10.4271/2017-22-0003, DOI 10.4271/2017-22-0003]; NEEDHAM D, 1990, BIOPHYS J, V58, P997, DOI 10.1016/S0006-3495(90)82444-9; Okonkwo DO, 1998, BRAIN RES, V784, P1, DOI 10.1016/S0006-8993(97)01075-5; OVERTON E, 1897, Z PHYS CHEM, V22, P189; Pall S, 2013, COMPUT PHYS COMMUN, V184, P2641, DOI 10.1016/j.cpc.2013.06.003; Pan Yi, 2013, Front Bioeng Biotechnol, V1, P19, DOI 10.3389/fbioe.2013.00019; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; Pastor RW, 2011, J PHYS CHEM LETT, V2, P1526, DOI 10.1021/jz200167q; Peeters W, 2015, ACTA NEUROCHIR, V157, P1683, DOI 10.1007/s00701-015-2512-7; Periole X, 2009, J CHEM THEORY COMPUT, V5, P2531, DOI 10.1021/ct9002114; Peter SJ, 2012, BIOPHYS J, V102, P749, DOI 10.1016/j.bpj.2011.11.4024; Pettus EH, 1996, BRAIN RES, V722, P1, DOI 10.1016/0006-8993(96)00113-8; PETTUS EH, 1994, J NEUROTRAUM, V11, P507, DOI 10.1089/neu.1994.11.507; Povlishock JT, 1997, J NEUROPATH EXP NEUR, V56, P347, DOI 10.1097/00005072-199704000-00003; Pullarkat PA, 2007, PHYS REP, V449, P29, DOI 10.1016/j.physrep.2007.03.002; Pullarkat PA, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.048104; Rajagopalan J, 2010, BIOPHYS J, V99, P3208, DOI 10.1016/j.bpj.2010.09.029; Reeves TM, 2010, BRAIN PATHOL, V20, P1055, DOI 10.1111/j.1750-3639.2010.00412.x; Reeves TM, 2005, EXP NEUROL, V196, P126, DOI 10.1016/j.expneurol.2005.07.014; Saeedimasine M, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-44318-9; Schafer DP, 2009, J NEUROSCI, V29, P13242, DOI 10.1523/JNEUROSCI.3376-09.2009; Shen HZ, 2017, SCIENCE, V355, DOI 10.1126/science.aal4326; Shi R, 2002, NEUROSCIENCE, V110, P765, DOI 10.1016/S0306-4522(01)00596-6; Shigematsu T, 2015, SCI REP-UK, V5, DOI 10.1038/srep15369; Shinoda W, 2016, BBA-BIOMEMBRANES, V1858, P2254, DOI 10.1016/j.bbamem.2016.03.032; Singh A, 2009, J NEUROTRAUM, V26, P627, DOI 10.1089/neu.2008.0621; Singh S, 2015, BIOMECH MODEL MECHAN, V14, P1303, DOI 10.1007/s10237-015-0675-z; Soheilypour M, 2015, BIOPHYS J, V108, P1718, DOI 10.1016/j.bpj.2015.01.030; Staal JA, 2011, J NEUROTRAUM, V28, P841, DOI 10.1089/neu.2010.1658; Stone JR, 2004, EXP NEUROL, V190, P59, DOI 10.1016/j.expneurol.2004.05.022; Subramaniyan AK, 2008, INT J SOLIDS STRUCT, V45, P4340, DOI 10.1016/j.ijsolstr.2008.03.016; Tang-Schomer MD, 2012, EXP NEUROL, V233, P364, DOI 10.1016/j.expneurol.2011.10.030; Tang-Schomer MD, 2010, FASEB J, V24, P1401, DOI 10.1096/fj.09-142844; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; TIRONI IG, 1995, J CHEM PHYS, V102, P5451, DOI 10.1063/1.469273; Vanegas JM, 2014, J CHEM THEORY COMPUT, V10, P691, DOI 10.1021/ct4008926; WALTER A, 1986, J MEMBRANE BIOL, V90, P207, DOI 10.1007/BF01870127; WANN KT, 1993, BRIT J ANAESTH, V71, P2, DOI 10.1093/bja/71.1.2; WAUGH R, 1979, BIOPHYS J, V26, P115, DOI 10.1016/S0006-3495(79)85239-X; Eswar Narayanan, 2006, Curr Protoc Bioinformatics, VChapter 5, pUnit, DOI [10.1002/cpbi.3, 10.1002/cpps.20, 10.1002/0471140864.ps0209s50, 10.1002/0471250953.bi0506s15]; WESTENBROEK RE, 1989, NEURON, V3, P695, DOI 10.1016/0896-6273(89)90238-9; Wolf JA, 2001, J NEUROSCI, V21, P1923, DOI 10.1523/JNEUROSCI.21-06-01923.2001; Wright RM, 2012, BIOMECH MODEL MECHAN, V11, P245, DOI 10.1007/s10237-011-0307-1; Xu K, 2013, SCIENCE, V339, P452, DOI 10.1126/science.1232251; Yesylevskyy SO, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000810; YU WQ, 1994, J NEUROSCI, V14, P2818; Yuen TJ, 2009, J NEUROSCI RES, V87, P3620, DOI 10.1002/jnr.22161; Zhang LL, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06827-3; Zhang LL, 2015, COMPUT METHOD APPL M, V283, P1010, DOI 10.1016/j.cma.2014.10.018; Zhang YH, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005407; Zhou M, 2003, P ROY SOC A-MATH PHY, V459, P2347, DOI 10.1098/rspa.2003.1127; Zhu F, 2016, J NEUROTRAUM, V33, P859, DOI 10.1089/neu.2015.4007; Zimmerman JA, 2003, COMPUTATIONAL FLUID AND SOLID MECHANICS 2003, VOLS 1 AND 2, PROCEEDINGS, P804	128	7	7	1	5	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	JAN 30	2020	11								25	10.3389/fneur.2020.00025			14	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	KN5WG	WOS:000514906900001	32082244	Green Submitted, gold, Green Published			2022-02-06	
J	Register-Mihalik, JK; Marshall, SW; Kay, MC; Kerr, ZY; Peck, KY; Houston, MN; Linnan, LA; Hennink-Kaminski, H; Gildner, P; Svoboda, SJ; Cameron, KL				Register-Mihalik, Johna K.; Marshall, Stephen W.; Kay, Melissa C.; Kerr, Zachary Y.; Peck, Karen Y.; Houston, Megan N.; Linnan, Laura A.; Hennink-Kaminski, Heidi; Gildner, Paula; Svoboda, Steven J.; Cameron, Kenneth L.			Perceived social norms and concussion-disclosure behaviours among first-year NCAA student-athletes: implications for concussion prevention and education	RESEARCH IN SPORTS MEDICINE			English	Article						Reporting; education; concussion recognition; brain; NCAA	SYMPTOMS; KNOWLEDGE; PLAYERS; REVEAL	Timely disclosure and identification of concussion symptoms are essential to proper care. Perceived social norms are a potential driving factor in many health-related decisions. The study purpose was to describe concussion disclosure behaviours and identify the association between perceived social norms and these disclosure behaviours. First-year student-athletes (n = 391) at two NCAA institutions completed a cross-sectional survey about concussion disclosure and disclosure determinants. Log-binomial regression models identified factors associated with concussion disclosure behaviour prevalence for: higher intention to disclose symptoms, disclosed all at time of injury, eventually disclosed all, and never participated with concussion symptoms. More favourable perceived social norms were associated with higher prevalence of intention to disclose (PR = 1.34; 95%CI: 1.18, 1.53) and higher prevalence of never participating in sports with concussion symptoms (PR = 1.50; 95%CI: 1.07, 2.10). Clinicians, coaches, sports administrators, and healthcare practitioners should be mindful of the need to create supportive social environments to improve concussion symptom disclosure.	[Register-Mihalik, Johna K.; Kay, Melissa C.; Kerr, Zachary Y.] Univ N Carolina, Matthew Gfeller Sport Related Traumat Brain Injur, Dept Exercise & Sport Sci, Chapel Hill, NC 27515 USA; [Register-Mihalik, Johna K.; Marshall, Stephen W.; Kerr, Zachary Y.; Gildner, Paula] Univ N Carolina, Injury Prevent Res Ctr, Chapel Hill, NC 27515 USA; [Marshall, Stephen W.] Univ N Carolina, Dept Epidemiol, Sch Publ Hlth, Chapel Hill, NC 27515 USA; [Kay, Melissa C.] Univ Southern Mississippi, Sch Hlth Profess, Hattiesburg, MS 39406 USA; [Peck, Karen Y.; Houston, Megan N.; Svoboda, Steven J.; Cameron, Kenneth L.] Keller Army Hosp, West Point, NY USA; [Linnan, Laura A.] Univ N Carolina, Dept Hlth Behav, Sch Publ Hlth, Chapel Hill, NC 27515 USA; [Hennink-Kaminski, Heidi] Univ N Carolina, Sch Media & Journalism, Chapel Hill, NC 27515 USA		Register-Mihalik, JK (corresponding author), 125 Fetzer Hall,CB 8700, Chapel Hill, NC 27599 USA.	johnakay@email.unc.edu			NCAA-DOD Mind Matters Research Challenge Award	This work was supported by the NCAA-DOD Mind Matters Research Challenge Award [n/a].	Baugh CM, 2014, J LAW MED ETHICS, V42, P314, DOI 10.1111/jlme.12148; Chandran A, 2020, RES SPORTS MED, V28, P42, DOI 10.1080/15438627.2019.1590834; Chrisman SP, 2013, J ADOLESCENT HEALTH, V52, P330, DOI 10.1016/j.jadohealth.2012.10.271; Conway FN, 2020, CLIN J SPORT MED, V30, P203, DOI 10.1097/JSM.0000000000000557; Craig DI, 2020, RES SPORTS MED, V28, P181, DOI 10.1080/15438627.2019.1586706; Cuff SC, 2019, RES SPORTS MED, V27, P11, DOI 10.1080/15438627.2018.1502186; Delaney JS, 2015, CLIN J SPORT MED, V25, P113, DOI 10.1097/JSM.0000000000000112; Delaney JS, 2018, CLIN J SPORT MED, V28, P1, DOI 10.1097/JSM.0000000000000495; Fishbein M., 2010, PREDICTING CHANGING, DOI DOI 10.4324/9780203838020; Granito V.J., 2002, J SPORT BEHAV, V25, P243; Howell DR, 2020, CLIN J SPORT MED, V30, pS42, DOI 10.1097/JSM.0000000000000570; Kaminski TW, 2020, RES SPORTS MED, V28, P217, DOI 10.1080/15438627.2019.1635130; Kerr ZY, 2016, AM J SPORT MED, V44, P220, DOI 10.1177/0363546515612082; Kerr ZY, 2014, BRAIN INJURY, V28, P1009, DOI 10.3109/02699052.2014.904049; Kroshus E, 2017, J ADOLESCENCE, V54, P110, DOI 10.1016/j.adolescence.2016.11.002; Kroshus E, 2015, HEALTH EDUC RES, V30, P1004, DOI 10.1093/her/cyv047; Kroshus E, 2015, SOC SCI MED, V134, P66, DOI 10.1016/j.socscimed.2015.04.011; Kroshus E, 2015, CLIN J SPORT MED, V25, P243, DOI 10.1097/JSM.0000000000000137; Kroshus E, 2015, ANN BEHAV MED, V49, P95, DOI 10.1007/s12160-014-9636-5; Kroshus E, 2014, J ADOLESCENT HEALTH, V54, P269, DOI 10.1016/j.jadohealth.2013.11.011; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Register-Mihalik J, 2017, J ATHL TRAINING, V52, P195, DOI 10.4085/1062-6050-51.12.02; Register-Mihalik JK, 2019, J SCI MED SPORT, V22, P509, DOI 10.1016/j.jsams.2018.11.003; Register-Mihalik JK, 2017, CLIN J SPORT MED, V27, P321, DOI 10.1097/JSM.0000000000000349; Register-Mihalik JK, 2013, J ATHL TRAINING, V48, P645, DOI 10.4085/1062-6050-48.3.20; Register-Mihalik JK, 2013, BRAIN INJURY, V27, P878, DOI 10.3109/02699052.2013.775508	26	7	7	2	14	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	1543-8627	1543-8635		RES SPORTS MED	Res. Sports Med.	JAN 2	2021	29	1					1	11		10.1080/15438627.2020.1719493		JAN 2020	11	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Sport Sciences	PM6WM	WOS:000509192700001	31984812				2022-02-06	
J	Fabricius, AM; D'Souza, A; Amodio, V; Colantonio, A; Mollayeva, T				Fabricius, Alexis M.; D'Souza, Andrea; Amodio, Vanessa; Colantonio, Angela; Mollayeva, Tatyana			Women's Gendered Experiences of Traumatic Brain Injury	QUALITATIVE HEALTH RESEARCH			English	Article						traumatic brain injury (TBI); gender; women; care; thematic analysis; knowledge translation; interviews; Canada	MENTAL-HEALTH; FEMININITY; OUTCOMES; PEOPLE; MASCULINITY; ADHERENCE; PATIENT; WORLD; CARE; SEX	Despite recognizing that women have worse outcomes after traumatic brain injury (TBI), little is known about how gender influences their experiences of this critical injury. Past research has been dominated by androcentrism and quantitative approaches, leaving the lived experience of women with TBI insufficiently examined. To gain insight into their experiences, this qualitative study interviewed 19 Canadian women with mild and moderate-to-severe TBIs. Applying a thematic analysis, we discerned three themes: Gender prevails considers choosing to do gender over complying with physician advice; Consequences of TBI impeding performativity explores how women frame themselves as terrible people for being unable to do gender post-TBI; and Perceptions of receiving care looks at gendered caregiving expectations. These results broadly align with research on how doing gender influences recovery and health outcomes. We discuss the implications of our findings for knowledge translation, future research on women's TBI recovery, and clinical practice.	[Fabricius, Alexis M.; D'Souza, Andrea; Amodio, Vanessa; Mollayeva, Tatyana] Univ Hlth Network, Toronto, ON, Canada; [Colantonio, Angela] Univ Hlth Network, KITE Toronto Rehabil Inst, Toronto, ON, Canada; [D'Souza, Andrea] Univ Toronto, Acquired Brain Injury Lab, Toronto, ON, Canada; [Colantonio, Angela] Univ Toronto, Rehabil Sci Inst, Toronto, ON, Canada; [Colantonio, Angela] Univ Toronto, Dept Occupat Sci & Occupat Therapy, Toronto, ON, Canada; [Mollayeva, Tatyana] Univ Toronto, Toronto, ON, Canada		Fabricius, AM (corresponding author), Univ Hlth Network, Acquired Brain Injury & Soc Res Lab, Toronto Rehabil Inst, 500 Univ Ave, Toronto, ON M5G 2A2, Canada.	alexis.fabricius@gmail.com	, Mollayeva/A-4522-2018; Fabricius, Alexis/AAZ-1569-2020	Fabricius, Alexis/0000-0003-0881-1273; D'Souza, Andrea/0000-0003-2611-2548	 [CGW-126580]	The authors disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This work was supported by the grant CGW-126580.	Alston M, 2012, AUST SOC WORK, V65, P39, DOI 10.1080/0312407X.2011.594898; Arbuthnott A, 2009, PATIENT EDUC COUNS, V77, P60, DOI 10.1016/j.pec.2009.03.022; Bar-Tal Y, 2005, SOC SCI MED, V60, P1459, DOI 10.1016/j.socscimed.2004.08.003; Braun V., 2013, SUCCESSFUL QUALITATI; Braun V., 2012, ENCY CRITICAL PSYCHO, DOI [10.1037/13620-000, DOI 10.1037/13620-004]; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [10.1191/1478088706qp063oa, DOI 10.1191/1478088706QP063OA]; Burr V., 2015, SOCIAL CONSTRUCTIONI; Butler J., 1990, GENDER TROUBLE; Canadian Institutes of Health Research, 2019, INT SEX GEND RES; Clarke V, 2017, J POSIT PSYCHOL, V12, P297, DOI 10.1080/17439760.2016.1262613; Colantonio A, 2016, ARCH PHYS MED REHAB, V97, pS1, DOI 10.1016/j.apmr.2015.12.002; Colantonio A, 2010, J WOMENS HEALTH, V19, P1109, DOI 10.1089/jwh.2009.1740; Day S, 2016, HEALTH RES POLICY SY, V14, DOI 10.1186/s12961-016-0147-7; Eliacin J, 2015, QUAL HEALTH RES, V25, P668, DOI 10.1177/1049732314551060; Farace E, 2000, J NEUROSURG, V93, P539, DOI 10.3171/jns.2000.93.4.0539; Freeman A, 2015, NEUROPSYCHOL REHABIL, V25, P189, DOI 10.1080/09602011.2014.917686; Gilligan C., 1982, DIFFERENT VOICE PSYC; GOVE WR, 1979, AM SOCIOL REV, V44, P126, DOI 10.2307/2094822; Gutman SA, 1999, AM J OCCUP THER, V53, P101, DOI 10.5014/ajot.53.1.101; Gutman SA, 1996, AM J OCCUP THER, V50, P535, DOI 10.5014/ajot.50.7.535; Haag HL, 2016, ARCH PHYS MED REHAB, V97, pS64, DOI 10.1016/j.apmr.2014.12.018; Hanlon N., 2009, MASCULINITIES CARE E; Hollander JA, 2016, FEM PSYCHOL, V26, P207, DOI 10.1177/0959353516637393; Howes H, 2005, PSYCHOL HEALTH, V20, P129, DOI 10.1080/0887044042000272903; Hunt AW, 2015, QUAL HEALTH RES, V25, P1044, DOI 10.1177/1049732315588759; Johnson JL, 2009, INT J EQUITY HEALTH, V8, DOI 10.1186/1475-9276-8-14; Jones JA, 2011, DISABIL REHABIL, V33, P1568, DOI 10.3109/09638288.2010.537803; Judd D. P., 1999, COUNSELLING PSYCHOL, V14, P4; Jumisko E, 2007, J FAM NURS, V13, P353, DOI 10.1177/1074840707303842; Kennelly I, 2001, AM SOCIOL REV, V66, P598, DOI 10.2307/3088925; Kimmel, 2017, GENDERED SOC; Kivunja S, 2018, J CLIN NURS, V27, P1304, DOI 10.1111/jocn.14283; Kleinman A, 2012, LANCET, V380, P1550, DOI 10.1016/S0140-6736(12)61870-4; Lloyd V, 2006, QUAL HEALTH RES, V16, P1386, DOI 10.1177/1049732306293846; Lorber J., 1994, PARADOXES GENDER; MacQueen R, 2020, NEUROPSYCHOL REHABIL, V30, P298, DOI 10.1080/09602011.2018.1466714; Malacrida C, 2009, INT J QUAL STUD EDUC, V22, P99, DOI 10.1080/09518390802581927; Mollayeva T, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-024674; Nalder E, 2016, ARCH PHYS MED REHAB, V97, pS46, DOI 10.1016/j.apmr.2014.07.428; O'Reilly K, 2018, DISABIL REHABIL, V40, P2331, DOI 10.1080/09638288.2017.1334838; Oyesanya TO, 2016, HEALTH CARE WOMEN IN, V37, P45, DOI 10.1080/07399332.2015.1005307; Paterson B, 2002, QUAL HEALTH RES, V12, P399, DOI 10.1177/104973202129119973; Pickens C, 2018, SEX ROLES, V79, P431, DOI 10.1007/s11199-017-0881-5; Schippers M, 2007, THEOR SOC, V36, P85, DOI 10.1007/s11186-007-9022-4; Schopp LH, 2006, BRAIN INJURY, V20, P1155, DOI 10.1080/02699050600983735; Senn CY, 2015, NEW ENGL J MED, V372, P2326, DOI 10.1056/NEJMsa1411131; St Ivany A, 2018, QUAL HEALTH RES, V28, P1708, DOI 10.1177/1049732318786705; Toor GK, 2016, ARCH PHYS MED REHAB, V97, pS54, DOI 10.1016/j.apmr.2015.02.010; Werner A, 2003, SOC SCI MED, V57, P1409, DOI 10.1016/S0277-9536(02)00520-8; West C, 1987, GENDER SOC, V1, P125, DOI 10.1177/0891243287001002002; Willis E, 2001, SOC SCI MED, V53, P1163, DOI 10.1016/S0277-9536(00)00416-0; Wright M. M., 2016, Journal of Communication in Healthcare, V9, P190	52	7	7	0	2	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1049-7323	1552-7557		QUAL HEALTH RES	Qual. Health Res.	JUN	2020	30	7					1033	1044	1049732319900163	10.1177/1049732319900163		JAN 2020	12	Public, Environmental & Occupational Health; Information Science & Library Science; Social Sciences, Interdisciplinary; Social Sciences, Biomedical	Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health; Information Science & Library Science; Social Sciences - Other Topics; Biomedical Social Sciences	LQ8OG	WOS:000509061400001	31971079				2022-02-06	
J	McPherson, AL; Shirley, MB; Schilaty, ND; Larson, DR; Hewett, TE				McPherson, April L.; Shirley, Matthew B.; Schilaty, Nathan D.; Larson, Dirk R.; Hewett, Timothy E.			Effect of a Concussion on Anterior Cruciate Ligament Injury Risk in a General Population	SPORTS MEDICINE			English	Article							EXTREMITY MUSCULOSKELETAL INJURY; MEDICAL-RECORDS-LINKAGE; TRAUMATIC BRAIN-INJURY; SUBSEQUENT INJURY; RETURN; PLAY; EPIDEMIOLOGY; MANAGEMENT; RECONSTRUCTION; CONSEQUENCES	Background Recent studies indicate concussion increases risk of musculoskeletal injury in specific groups of patients. The purpose of this study was to determine the odds of anterior cruciate ligament (ACL) injury after concussion in a population-based cohort. Methods International Classification of Diseases, 9th and 10th Revision (ICD-9, ICD-10) codes relevant to the diagnosis and treatment of a concussion and ACL tear were utilized to search the Rochester Epidemiology Project (REP) between 2000 and 2017. A total of 1653 unique patients with acute, isolated ACL tears were identified. Medical records for cases were reviewed to confirm ACL tear diagnosis and to determine history of concussion within 3 years prior to the ACL injury. Cases were matched by age, sex, and REP availability date to patients without an ACL tear (1:3 match), resulting in 4959 controls. The medical records of the matched control patients were reviewed to determine history of concussion. Results 39 patients with a concussion suffered an ACL injury up to 3 years after the concussion. The rate of prior concussion was higher in ACL-injured cases (2.4%) compared to matched controls with no ACL injury (1.5%). This corresponds to an odds ratio of 1.6 (95% CI 1.1-2.4; p = 0.015). Conclusions Although activity level could not be assessed, there are increased odds of ACL injury after concussion in a general population. Based on the evidence of increased odds of musculoskeletal injury after concussion, standard clinical assessments should consider concussion symptom resolution as well as assessment of neuromuscular factors associated with risk of injuries.	[McPherson, April L.] Mayo Clin, Grad Sch Biomed Sci, 200 First St SW, Rochester, MN 55902 USA; [McPherson, April L.; Shirley, Matthew B.; Schilaty, Nathan D.] Mayo Clin, Dept Orthoped Surg, Rochester, MN 55902 USA; [Schilaty, Nathan D.] Mayo Clin, Dept Physiol & Biomed Engn, Rochester, MN 55902 USA; [Schilaty, Nathan D.] Mayo Clin, Sports Med Ctr, Rochester, MN 55902 USA; [Larson, Dirk R.] Mayo Clin, Div Biomed Stat & Informat, Rochester, MN USA; [Hewett, Timothy E.] Univ Kentucky, Dept Rehabil Sci, Lexington, KY USA		Schilaty, ND (corresponding author), Mayo Clin, Dept Orthoped Surg, Rochester, MN 55902 USA.; Schilaty, ND (corresponding author), Mayo Clin, Dept Physiol & Biomed Engn, Rochester, MN 55902 USA.; Schilaty, ND (corresponding author), Mayo Clin, Sports Med Ctr, Rochester, MN 55902 USA.	Schilaty.Nathan@mayo.edu	Schilaty, Nathan/M-8606-2019	Schilaty, Nathan/0000-0002-6038-7126	Mayo Clinic Graduate School of Biomedical Sciences; National Institute of Arthritis and Musculoskeletal and Skin DiseasesUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS) [R01AR55563, L30AR070273]; National Institute of Children and Human Development [K12HD065987]; National Institute on Aging of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R01AG034676]	Fellowship funding was provided by the Mayo Clinic Graduate School of Biomedical Sciences [ALM]. Funding for this research was received from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (R01AR55563 [TEH] and L30AR070273 [NDS]) and the National Institute of Children and Human Development (K12HD065987 [NDS]). This study was also made possible using the resources of the Rochester Epidemiology Project, which is supported by the National Institute on Aging of the National Institutes of Health under Award R01AG034676.	Asplund CA, 2004, CLIN J SPORT MED, V14, P339, DOI 10.1097/00042752-200411000-00003; Baumeister J, 2008, SCAND J MED SCI SPOR, V18, P473, DOI 10.1111/j.1600-0838.2007.00702.x; Boden BP, 2010, J AM ACAD ORTHOP SUR, V18, P520, DOI 10.5435/00124635-201009000-00003; Borotikar BS, 2008, CLIN BIOMECH, V23, P81, DOI 10.1016/j.clinbiomech.2007.08.008; Brooks MA, 2016, AM J SPORT MED, V44, P742, DOI 10.1177/0363546515622387; Burman E, 2016, BMJ OPEN SPORT EXERC, V2, pe000092, DOI DOI 10.1136/BMJSEM-2015-000092; Cantu RC, 2001, J ATHL TRAINING, V36, P244; Cantu RC, 1998, CLIN SPORT MED, V17, P45, DOI 10.1016/S0278-5919(05)70060-0; Collins M, 2006, NEUROSURGERY, V58, P275, DOI 10.1227/01.NEU.0000200441.92742.46; Cross M, 2016, BRIT J SPORT MED, V50, P926, DOI 10.1136/bjsports-2015-094982; DeAngelis AI, 2015, SCAND J MED SCI SPOR, V25, P509, DOI 10.1111/sms.12315; DeMont RG, 1999, J ATHL TRAINING, V34, P115; Dubose DF, 2017, MED SCI SPORT EXER, V49, P167, DOI 10.1249/MSS.0000000000001067; Eagle SR, 2020, SPORTS MED, V50, P15, DOI 10.1007/s40279-019-01144-3; Echemendia RJ, 2017, BRIT J SPORT MED, V51, P895, DOI 10.1136/bjsports-2016-097466; Farnsworth JL, 2017, J ATHL TRAINING, V52, P826, DOI 10.4085/1062-6050-52.6.03; Faul M, 2010, TRAUMATIC BRAIN INJU; Fino PC, 2019, CLIN J SPORT MED, V29, P218, DOI 10.1097/JSM.0000000000000502; Griffin L Y, 2000, J Am Acad Orthop Surg, V8, P141; Hennessy S, 1999, AM J EPIDEMIOL, V149, P195; Herman DC, 2017, SPORTS MED, V47, P1003, DOI 10.1007/s40279-016-0607-9; Herzog MM, 2017, ORTHOP J SPORTS MED, V5, DOI 10.1177/2325967116684776; Hewett TE, 2006, AM J SPORT MED, V34, P490, DOI 10.1177/0363546505282619; Hewett TE, 2006, AM J SPORT MED, V34, P299, DOI 10.1177/0363546505284183; Howell DR, 2018, J NEUROTRAUM, V35, P1630, DOI 10.1089/neu.2017.5570; Howell DR, 2019, ARCH PHYS MED REHAB, V100, P613, DOI 10.1016/j.apmr.2018.07.441; Howell DR, 2018, SPORTS MED, V48, P1097, DOI 10.1007/s40279-018-0871-y; Ingersoll CD, 2008, CLIN SPORT MED, V27, P383, DOI 10.1016/j.csm.2008.03.004; Kamins J, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097464; Kardouni JR, 2018, J ORTHOP SPORT PHYS, V48, P533, DOI 10.2519/jospt.2018.8053; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lovell M, 2004, CLIN SPORT MED, V23, P421, DOI 10.1016/j.csm.2004.04.001; Lynall RC, 2019, J SCI MED SPORT, V22, P503, DOI 10.1016/j.jsams.2018.10.012; Lynall RC, 2017, J ATHL TRAINING, V52, P1028, DOI 10.4085/1062-6050-52.11.22; Lynall RC, 2015, MED SCI SPORT EXER, V47, P2487, DOI 10.1249/MSS.0000000000000716; Makdissi M, 2009, AM J SPORT MED, V37, P877, DOI 10.1177/0363546508328118; Mall NA, 2014, AM J SPORT MED, V42, P2363, DOI 10.1177/0363546514542796; McCrea M, 2001, J ATHL TRAINING, V36, P274; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McPherson AL, 2018, AM J SPORTS MED, V3, p363546518785901; Meehan WP, 2012, PEDIATRICS, V129, P38, DOI 10.1542/peds.2011-1972; Murray NG, 2019, PHYSIOL MEAS, V40, DOI 10.1088/1361-6579/aafcd8; Nordstrom A, 2014, BRIT J SPORT MED, V48, P1447, DOI 10.1136/bjsports-2013-093406; Nyberg G, 2015, CURR RES CONCUSSION, V2, P109; Register-Mihalik JK, 2013, NEUROPSYCHOL REV, V23, P300, DOI 10.1007/s11065-013-9238-1; Reneker JC, 2019, MUSCULOSKEL SCI PRAC, V42, P173, DOI 10.1016/j.msksp.2019.04.004; Rocca WA, 2012, MAYO CLIN PROC, V87, P1202, DOI 10.1016/j.mayocp.2012.08.012; Schilaty ND, 2017, ORTHOP J SPORTS MED, V5, DOI 10.1177/2325967117724196; Schilaty ND, 2017, AM J SPORT MED, V45, P1567, DOI 10.1177/0363546517694026; St Sauver JL, 2012, INT J EPIDEMIOL, V41, P1614, DOI 10.1093/ije/dys195; St Sauver JL, 2012, MAYO CLIN PROC, V87, P151, DOI 10.1016/j.mayocp.2011.11.009; St Sauver JL, 2011, AM J EPIDEMIOL, V173, P1059, DOI 10.1093/aje/kwq482; Swanik CB, 2007, AM J SPORT MED, V35, P943, DOI 10.1177/0363546507299532; Swanik C, 2015, J ATHL TRAINING, V50, P1100, DOI 10.4085/1062-6050-50.10.08; Sye G, 2006, BRIT J SPORT MED, V40, P1003, DOI 10.1136/bjsm.2005.020511; Tator CH, 2013, CAN MED ASSOC J, V185, P975, DOI 10.1503/cmaj.120039; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Wasserman EB, 2016, AM J SPORT MED, V44, P226, DOI 10.1177/0363546515610537; Zazulak BT, 2007, AM J SPORT MED, V35, P368, DOI 10.1177/0363546506297909	59	7	7	0	1	ADIS INT LTD	NORTHCOTE	5 THE WAREHOUSE WAY, NORTHCOTE 0627, AUCKLAND, NEW ZEALAND	0112-1642	1179-2035		SPORTS MED	Sports Med.	JUN	2020	50	6					1203	1210		10.1007/s40279-020-01262-3		JAN 2020	8	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	LP3XV	WOS:000508690300001	31970718	Green Accepted			2022-02-06	
J	Brett, BL; Wu, YC; Mustafi, SM; Saykin, AJ; Koch, KM; Nencka, AS; Giza, CC; Goldman, J; Guskiewicz, KM; Mihalik, JP; Duma, SM; Broglio, SP; McAllister, TW; McCrea, MA; Meier, TB				Brett, Benjamin L.; Wu, Yu-Chien; Mustafi, Sourajit M.; Saykin, Andrew J.; Koch, Kevin M.; Nencka, Andrew S.; Giza, Christopher C.; Goldman, Joshua; Guskiewicz, Kevin M.; Mihalik, Jason P.; Duma, Stefan M.; Broglio, Steven P.; McAllister, Thomas W.; McCrea, Michael A.; Meier, Timothy B.			The Association Between Persistent White-Matter Abnormalities and Repeat Injury After Sport-Related Concussion	FRONTIERS IN NEUROLOGY			English	Article						sport-related concussion; mTBI; diffusion tensor imaging; CARE; head injury; white matter	DIFFUSION TENSOR; FOOTBALL PLAYERS; AXONAL INJURY; VULNERABILITY; RECOVERY; TIME	Objective: A recent systematic review determined that the physiological effects of concussion may persist beyond clinical recovery. Preclinical models suggest that ongoing physiological effects are accompanied by increased cerebral vulnerability that is associated with risk for subsequent, more severe injury. This study examined the association between signal alterations on diffusion tensor imaging following clinical recovery of sport-related concussion in athletes with and without a subsequent second concussion. Methods: Average mean diffusivity (MD) was calculated in a region of interest (ROI) in which concussed athletes (n = 82) showed significantly elevated MD acutely after injury (<48 h), at an asymptomatic time point, 7 days post-return to play (RTP), and 6 months relative to controls (n = 69). The relationship between MD in the identified ROI and likelihood of sustaining a subsequent concussion over a 1-year period was examined with a binary logistic regression (re-injured, yes/no). Results: Eleven of 82 concussed athletes (13.4%) sustained a second concussion within 12 months of initial injury. Mean MD at 7 days post-RTP was significantly higher in those athletes who went on to sustain a repeat concussion within 1 year of initial injury than those who did not (p = 0.048; d = 0.75). In this underpowered sample, the relationship between MD at 7 days post-RTP and likelihood of sustaining a secondary injury approached significance [chi(2)((1)) = 4.17, p = 0.057; B = 0.03, SE = 0.017; OR = 1.03, CI = 0.99, 1.07]. Conclusions: These preliminary findings raise the hypothesis that persistent signal abnormalities in diffusion imaging metrics at RTP following concussion may be predictive of a repeat concussion. This may reflect a window of cerebral vulnerability or increased susceptibility following concussion, though understanding the clinical significance of these findings requires further study.	[Brett, Benjamin L.; McCrea, Michael A.; Meier, Timothy B.] Med Coll Wisconsin, Dept Neurosurg, Milwaukee, WI 53226 USA; [Brett, Benjamin L.; McCrea, Michael A.] Med Coll Wisconsin, Dept Neurol, Milwaukee, WI 53226 USA; [Wu, Yu-Chien; Mustafi, Sourajit M.; Saykin, Andrew J.] Indiana Univ Sch Med, Dept Radiol & Imaging Sci, Indianapolis, IN 46202 USA; [Koch, Kevin M.; Nencka, Andrew S.] Med Coll Wisconsin, Dept Radiol, 8700 W Wisconsin Ave, Milwaukee, WI 53226 USA; [Giza, Christopher C.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurosurg, Los Angeles, CA 90095 USA; [Goldman, Joshua] Univ Calif Los Angeles, Dept Family Med, Div Sports Med, Los Angeles, CA USA; [Goldman, Joshua] Univ Calif Los Angeles, Dept Orthoped, Div Sports Med, Los Angeles, CA USA; [Guskiewicz, Kevin M.; Mihalik, Jason P.] Univ N Carolina, Dept Exercise & Sport Sci, Matthew Gfeller Sport Related Traumat Brain Injur, Chapel Hill, NC 27515 USA; [Duma, Stefan M.] Wake Forest & Virginia Tech Univ, Sch Biomed Engn & Sci, Blacksburg, VA USA; [Broglio, Steven P.] Univ Michigan, Michigan Concuss Ctr, Sch Kinesiol, Ann Arbor, MI 48109 USA; [McAllister, Thomas W.] Indiana Univ Sch Med, Dept Psychiat, Bloomington, IN USA; [Meier, Timothy B.] Med Coll Wisconsin, Dept Biomed Engn, Milwaukee, WI 53226 USA; [Meier, Timothy B.] Med Coll Wisconsin, Dept Cell Biol Neurobiol & Anat, Milwaukee, WI 53226 USA		Brett, BL (corresponding author), Med Coll Wisconsin, Dept Neurosurg, Milwaukee, WI 53226 USA.; Brett, BL (corresponding author), Med Coll Wisconsin, Dept Neurol, Milwaukee, WI 53226 USA.	bbrett@mcw.edu	Koch, Kevin/AAD-6403-2021		Grand Alliance Concussion Assessment, Research, and Education (CARE) Consortium - National Collegiate Athletic Association (NCAA); Department of Defense (DOD)United States Department of Defense; Office of the Assistant Secretary of Defense for Health Affairs through the Psychological Health and Traumatic Brain Injury Program [W81XWH-14-2-0151]; National Institute of Neurological Disorders and Stroke (NINDS) under the National Institutes of Health [L301L30NS113158-01]; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R01AG053993] Funding Source: NIH RePORTER	This publication was made possible, in part, with support from the Grand Alliance Concussion Assessment, Research, and Education (CARE) Consortium, funded, in part, by the National Collegiate Athletic Association (NCAA) and the Department of Defense (DOD). The U.S. Army Medical Research Acquisition Activity, 820 Chandler Street, Fort Detrick, MD 21702-5014, is the awarding and administering acquisition office. This work was supported by the Office of the Assistant Secretary of Defense for Health Affairs through the Psychological Health and Traumatic Brain Injury Program under Award No. W81XWH-14-2-0151 and BB acknowledges support from the National Institute of Neurological Disorders and Stroke (NINDS) under the National Institutes of Health under the Award No. L301L30NS113158-01. Opinions, interpretations, conclusions, and recommendations are those of the author and are not necessarily endorsed by the Department of Defense (DHP funds).	Andersson JLR, 2016, NEUROIMAGE, V125, P1063, DOI 10.1016/j.neuroimage.2015.10.019; Avants BB, 2011, NEUROIMAGE, V54, P2033, DOI 10.1016/j.neuroimage.2010.09.025; Broglio SP, 2017, SPORTS MED, V47, P1437, DOI 10.1007/s40279-017-0707-1; Budde MD, 2009, J NEUROSCI, V29, P2805, DOI 10.1523/JNEUROSCI.4605-08.2009; Churchill NW, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07742-3; Churchill NW, 2017, NEUROIMAGE-CLIN, V14, P480, DOI 10.1016/j.nicl.2017.02.015; Dodd AB, 2014, J NEUROTRAUM, V31, P1235, DOI 10.1089/neu.2014.3337; Helmer KG, 2014, J NEUROSURG, V120, P864, DOI [10.3171/2013.12.JNS132090, 10.3171/2013.12.JNS132093]; Henry LC, 2011, J NEUROTRAUM, V28, P2049, DOI 10.1089/neu.2011.1836; Jones DK, 2013, NEUROIMAGE, V73, P239, DOI 10.1016/j.neuroimage.2012.06.081; Kamins J, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097464; Lancaster MA, 2016, HUM BRAIN MAPP, V37, P3821, DOI 10.1002/hbm.23278; Laurer HL, 2001, J NEUROSURG, V95, P859, DOI 10.3171/jns.2001.95.5.0859; Li J, 2011, EUR J NEUROSCI, V33, P933, DOI 10.1111/j.1460-9568.2010.07573.x; Longhi L, 2005, NEUROSURGERY, V56, P364, DOI 10.1227/01.NEU.0000149008.73513.44; Mac Donald CL, 2007, J NEUROSCI, V27, P11869, DOI 10.1523/JNEUROSCI.3647-07.2007; Manjon JV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073021; Manning KY, 2017, NEUROLOGY, V89, P2157, DOI 10.1212/WNL.0000000000004669; Mayinger MC, 2018, BRAIN IMAGING BEHAV, V12, P44, DOI 10.1007/s11682-017-9672-4; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrea M, 2009, NEUROSURGERY, V65, P876, DOI 10.1227/01.NEU.0000350155.89800.00; Meier TB, 2016, HUM BRAIN MAPP, V37, P833, DOI 10.1002/hbm.23072; Mustafi SM, 2018, J NEUROTRAUM, V35, P2653, DOI 10.1089/neu.2017.5158; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; Peled S, 2007, IEEE T MED IMAGING, V26, P1448, DOI 10.1109/TMI.2007.906787; Prins ML, 2013, J NEUROTRAUM, V30, P30, DOI 10.1089/neu.2012.2399; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Smith SM, 2009, NEUROIMAGE, V44, P83, DOI 10.1016/j.neuroimage.2008.03.061; Wu Y, NEUROLOGY; Yablonskiy DA, 2010, NMR BIOMED, V23, P661, DOI 10.1002/nbm.1520; Yang JZ, 2017, AM J PUBLIC HEALTH, V107, P1916, DOI 10.2105/AJPH.2017.304056	31	7	7	0	2	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	JAN 21	2020	10								1345	10.3389/fneur.2019.01345			7	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	KI4OX	WOS:000511330800001	32038451	gold, Green Published			2022-02-06	
J	Chen, K; Gu, H; Zhu, L; Feng, DF				Chen, Kui; Gu, Hao; Zhu, Liang; Feng, Dong-Fu			A New Model of Repetitive Traumatic Brain Injury in Mice	FRONTIERS IN NEUROSCIENCE			English	Article						repetitive traumatic brain injury; animal model; diffuse axonal injury; inflammatory response; learning and memory	COLLEGIATE FOOTBALL PLAYERS; CONTROLLED CORTICAL IMPACT; DIFFUSE AXONAL INJURY; PROFESSIONAL FOOTBALL; ROTATIONAL ACCELERATION; RECURRENT CONCUSSION; HEAD IMPACTS; MOUSE MODEL; HISTORY; ENCEPHALOPATHY	Repetitive traumatic brain injury (rTBI) is a major health care concern that causes substantial neurological impairment. To better understand rTBI, we introduced a new model of rTBI in mice induced by sudden rotation in the coronal plane combined with lateral translation delivered twice at an interval of 24 h. By routine histology, histological examination of Prussian blue-stained sections revealed the presence of microbleed in the corpus callosum and brain stem. Amyloid precursor protein (beta-APP) and neurofilament heavy-chain (NF-200) immunohistochemistry demonstrated axonal injury following rTBI. Swelling, waving, and enlargement axons were observed in the corpus callosum and brain stem 24 h after injury by Bielschowsky staining. Ultrastructural studies by electron microscopy provided further insights into the existence and progression of axonal injury. rTBI led to widespread astrogliosis and microgliosis in white matter, as well as significantly increased levels of tumor necrosis factor (TNF)-alpha and interleukin (IL)-1 beta. rTBI mice showed a significantly increased loss of righting reflex (LRR) duration within each time point compared with that of sham animals, which was under 15 min. rTBI mice exhibited depression-like behavior at 1 month. rTBI mice also demonstrated deficits in MWM testing. These results suggested that this model might be suitable for investigating rTBI pathophysiology and evaluating preclinical candidate therapeutics.	[Chen, Kui; Gu, Hao; Zhu, Liang; Feng, Dong-Fu] Shanghai Jiao Tong Univ, Sch Med, Dept Neurosurg, Shanghai Peoples Hosp 9, Shanghai, Peoples R China; [Chen, Kui; Gu, Hao; Zhu, Liang; Feng, Dong-Fu] Shanghai Jiao Tong Univ, Sch Med, Inst Traumat Med, Shanghai, Peoples R China		Feng, DF (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Dept Neurosurg, Shanghai Peoples Hosp 9, Shanghai, Peoples R China.; Feng, DF (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Inst Traumat Med, Shanghai, Peoples R China.	drneuro@163.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81372047, 81772059]	This work was supported by the National Natural Science Foundation of China (81372047 and 81772059).	Adelson PD, 2001, J NEUROTRAUM, V18, P967, DOI 10.1089/08977150152693674; Barrio JR, 2015, P NATL ACAD SCI USA, V112, pE2039, DOI 10.1073/pnas.1409952112; BIGNALL KE, 1974, EXP NEUROL, V42, P566, DOI 10.1016/0014-4886(74)90079-X; Bolton AN, 2014, J NEUROPATH EXP NEUR, V73, P933, DOI 10.1097/NEN.0000000000000115; Broglio SP, 2006, BRIT J SPORT MED, V40, P802, DOI 10.1136/bjsm.2006.028019; Bruce JM, 2009, NEUROSURGERY, V64, P100, DOI 10.1227/01.NEU.0000336310.47513.C8; Bye N, 2007, EXP NEUROL, V204, P220, DOI 10.1016/j.expneurol.2006.10.013; Cernak I, 1996, J TRAUMA, V40, pS100, DOI 10.1097/00005373-199603001-00023; Changa AR, 2018, BRAIN, V141, P318, DOI 10.1093/brain/awx349; Chen HZ, 2017, J NEUROTRAUM, V34, P2291, DOI 10.1089/neu.2016.4870; Clark JM, 2018, J MECH BEHAV BIOMED, V80, P20, DOI 10.1016/j.jmbbm.2018.01.020; Clark JM, 2016, AM J SPORT MED, V44, P1047, DOI 10.1177/0363546515623272; Collie A, 2006, BRIT J SPORT MED, V40, P550, DOI 10.1136/bjsm.2005.019802; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P964, DOI 10.1001/jama.282.10.964; Corso P, 2006, INJURY PREV, V12, P212, DOI 10.1136/ip.2005.010983; DeWitt DS, 2013, J NEUROTRAUM, V30, P688, DOI 10.1089/neu.2012.2349; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Ekmark-Lewen S, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-44; Geddes JF, 1999, ACTA NEUROPATHOL, V98, P171, DOI 10.1007/s004010051066; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Greenwald RM, 2008, NEUROSURGERY, V62, P789, DOI 10.1227/01.neu.0000318162.67472.ad; Guskiewicz KM, 2007, NEUROSURGERY, V61, P1244, DOI 10.1227/01.neu.0000306103.68635.1a; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Gutierrez E, 2001, J NEUROTRAUM, V18, P247, DOI 10.1089/08977150151070874; He XS, 2000, J NEUROSURG, V93, P626, DOI 10.3171/jns.2000.93.4.0626; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Johnson VE, 2010, NAT REV NEUROSCI, V11, P361, DOI 10.1038/nrn2808; Karton C, 2014, BRIT J SPORT MED, V48, P46, DOI 10.1136/bjsports-2012-091583; Kiernan PT, 2015, SEMIN NEUROL, V35, P20, DOI 10.1055/s-0035-1545080; Kleiven S, 2007, STAPP CAR CRASH JO, V51, P81; Langburt W, 2001, J CHILD NEUROL, V16, P83, DOI 10.1177/088307380101600203; Lasry O, 2017, NEUROLOGY, V89, P2198, DOI 10.1212/WNL.0000000000004671; Li XY, 2010, NEUROSCIENCE, V169, P357, DOI 10.1016/j.neuroscience.2010.04.075; Lighthall JW, 1988, J NEUROTRAUM, V5, P1, DOI 10.1089/neu.1988.5.1; Lloyd E, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-28; Longhi L, 2005, NEUROSURGERY, V56, P364, DOI 10.1227/01.NEU.0000149008.73513.44; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; McIntosh AS, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005078; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Meaney DF, 2011, CLIN SPORT MED, V30, P19, DOI 10.1016/j.csm.2010.08.009; Mierzwa AJ, 2015, J NEUROPATH EXP NEUR, V74, P218, DOI 10.1097/NEN.0000000000000165; Mouzon B, 2012, J NEUROTRAUM, V29, P2761, DOI 10.1089/neu.2012.2498; Namjoshi DR, 2017, EXP NEUROL, V292, P80, DOI 10.1016/j.expneurol.2017.03.003; Namjoshi DR, 2014, MOL NEURODEGENER, V9, DOI 10.1186/1750-1326-9-55; Omalu B, 2011, NEUROSURGERY, V69, P173, DOI 10.1227/NEU.0b013e318212bc7b; Panzer MB, 2014, EXP NEUROL, V261, P120, DOI 10.1016/j.expneurol.2014.07.002; Pavlovic D, 2019, PITUITARY, V22, P270, DOI 10.1007/s11102-019-00957-9; Pellman EJ, 2003, NEUROSURGERY, V53, P799, DOI 10.1093/neurosurgery/53.3.799; Petraglia AL, 2014, J NEUROTRAUM, V31, P1211, DOI 10.1089/neu.2013.3255; Petraglia AL, 2012, NEUROSURGERY, V70, P1520, DOI 10.1227/NEU.0b013e31824cebe8; PORSOLT RD, 1977, ARCH INT PHARMACOD T, V229, P327; Post A, 2012, J BIOMECH, V45, P679, DOI 10.1016/j.jbiomech.2011.12.005; Preiss-Farzanegan SJ, 2009, PM&R, V1, P245, DOI 10.1016/j.pmrj.2009.01.011; Rodowicz KA, 2015, ANN BIOMED ENG, V43, P949, DOI 10.1007/s10439-014-1154-x; Rowson S, 2013, ANN BIOMED ENG, V41, P873, DOI 10.1007/s10439-012-0731-0; Rowson S, 2012, ANN BIOMED ENG, V40, P1, DOI 10.1007/s10439-011-0392-4; Sajja VSSS, 2016, FRONT INTEGR NEUROSC, V10, DOI [10.3389/fnint.2016.00007, 10.3389/fnint.7016.00007]; Sauerbeck AD, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25737-6; Shewchenko N, 2005, BRIT J SPORT MED, V39, pI10, DOI 10.1136/bjsm.2005.019034; Shitaka Y, 2011, J NEUROPATH EXP NEUR, V70, P551, DOI 10.1097/NEN.0b013e31821f891f; STERU L, 1985, PSYCHOPHARMACOLOGY, V85, P367, DOI 10.1007/BF00428203; van Landeghem FKH, 2007, ACTA NEUROPATHOL, V113, P683, DOI 10.1007/s00401-007-0208-7; Viano DC, 2009, NEUROSURGERY, V64, P1162, DOI 10.1227/01.NEU.0000345863.99099.C7; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Yatsiv I, 2005, FASEB J, V19, P1701, DOI 10.1096/fj.05-3907fje; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446	70	7	7	4	4	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND		1662-453X		FRONT NEUROSCI-SWITZ	Front. Neurosci.	JAN 21	2020	13								1417	10.3389/fnins.2019.01417			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	KH8UZ	WOS:000510927200001	32038131	Green Published, gold			2022-02-06	
J	Mayer, AR; Cohen, DM; Wertz, CJ; Dodd, AB; Shoemaker, J; Pluto, C; Zumberge, NA; Park, G; Bangert, BA; Lin, C; Minich, NM; Bacevice, AM; Bigler, ED; Campbell, RA; Hanlon, FM; Meier, TB; Oglesbee, SJ; Phillips, JP; Pottenger, A; Shaff, NA; Taylor, HG; Yeo, RA; Arbogast, KB; Leddy, JJ; Master, CL; Mannix, R; Zemek, RL; Yeates, KO				Mayer, Andrew R.; Cohen, Daniel M.; Wertz, Christopher J.; Dodd, Andrew B.; Shoemaker, Jody; Pluto, Charles; Zumberge, Nicholas A.; Park, Grace; Bangert, Barbara A.; Lin, Cindy; Minich, Nori M.; Bacevice, Ann M.; Bigler, Erin D.; Campbell, Richard A.; Hanlon, Faith M.; Meier, Timothy B.; Oglesbee, Scott J.; Phillips, John P.; Pottenger, Amy; Shaff, Nicholas A.; Taylor, H. Gerry; Yeo, Ronald A.; Arbogast, Kristy B.; Leddy, John J.; Master, Christina L.; Mannix, Rebekah; Zemek, Roger L.; Yeates, Keith Owen			Radiologic common data elements rates in pediatric mild traumatic brain injury	NEUROLOGY			English	Article							WHITE-MATTER HYPERINTENSITIES; INCIDENTAL FINDINGS; POSTCONCUSSIVE SYMPTOMS; CHILDREN; CONCUSSION; PREVALENCE; MRI; DISORDERS; SPECTRUM; UTILITY	ObjectiveThe nosology for classifying structural MRI findings following pediatric mild traumatic brain injury (pmTBI) remains actively debated. Radiologic common data elements (rCDE) were developed to standardize reporting in research settings. However, some rCDE are more specific to trauma (probable rCDE). Other more recently proposed rCDE have multiple etiologies (possible rCDE), and may therefore be more common in all children. Independent cohorts of patients with pmTBI and controls were therefore recruited from multiple sites (New Mexico and Ohio) to test the dual hypothesis of a higher incidence of probable rCDE (pmTBI > controls) vs similar rates of possible rCDE on structural MRI.MethodsPatients with subacute pmTBI (n = 287), matched healthy controls (HC; n = 106), and orthopedically injured (OI; n = 71) patients underwent imaging approximately 1 week postinjury and were followed for 3-4 months.ResultsProbable rCDE were specific to pmTBI, occurring in 4%-5% of each sample, rates consistent with previous large-scale CT studies. In contrast, prevalence rates for incidental findings and possible rCDE were similar across groups (pmTBI vs OI vs HC). The prevalence of possible rCDE was also the only finding that varied as a function of site. Possible rCDE and incidental findings were not associated with postconcussive symptomatology or quality of life 3-4 months postinjury.ConclusionCollectively, current findings question the trauma-related specificity of certain rCDE, as well how these rCDE are radiologically interpreted. Refinement of rCDE in the context of pmTBI may be warranted, especially as diagnostic schema are evolving to stratify patients with structural MRI abnormalities as having a moderate injury.	[Mayer, Andrew R.; Wertz, Christopher J.; Dodd, Andrew B.; Shoemaker, Jody; Hanlon, Faith M.; Phillips, John P.; Shaff, Nicholas A.] Univ New Mexico, Lovelace Biomed & Environm Res Inst, Mind Res Network, Albuquerque, NM 87131 USA; [Mayer, Andrew R.] Univ New Mexico, Dept Psychiat & Behav Sci, Albuquerque, NM 87131 USA; [Mayer, Andrew R.; Campbell, Richard A.; Yeo, Ronald A.] Univ New Mexico, Dept Psychol, Albuquerque, NM 87131 USA; [Mayer, Andrew R.; Phillips, John P.] Univ New Mexico, Dept Neurol, Albuquerque, NM 87131 USA; [Cohen, Daniel M.; Taylor, H. Gerry] Ohio State Univ, Dept Pediat, Columbus, OH 43210 USA; [Cohen, Daniel M.] Nationwide Childrens Hosp, Div Emergency Med, Columbus, OH USA; [Zumberge, Nicholas A.] Nationwide Childrens Hosp, Dept Radiol, Columbus, OH USA; [Pluto, Charles] Radiol Associates Albuquerque, Albuquerque, NM USA; [Pluto, Charles; Oglesbee, Scott J.; Pottenger, Amy] Univ New Mexico Hosp, Emergency Med, Albuquerque, NM USA; [Bangert, Barbara A.] Case Western Reserve Univ, Dept Radiol, Sch Med, Cleveland, OH 44106 USA; [Lin, Cindy] Nationwide Childrens Hosp, Res Inst, Columbus, OH USA; [Minich, Nori M.; Bacevice, Ann M.] Case Western Reserve Univ, Rainbow Babies & Childrens Hosp, Dept Pediat, Cleveland, OH 44106 USA; [Bigler, Erin D.] Brigham Young Univ, Dept Psychol, Provo, UT 84602 USA; [Meier, Timothy B.] Med Coll Wisconsin, Dept Neurosurg, Milwaukee, WI 53226 USA; [Meier, Timothy B.] Med Coll Wisconsin, Dept Cell Biol Neurobiol & Anat, Milwaukee, WI 53226 USA; [Meier, Timothy B.] Med Coll Wisconsin, Dept Biomed Engn, Milwaukee, WI 53226 USA; [Arbogast, Kristy B.; Master, Christina L.] Childrens Hosp Philadelphia, Ctr Injury Res & Prevent, Philadelphia, PA 19104 USA; [Master, Christina L.] Childrens Hosp Philadelphia, Div Orthoped Surg, Philadelphia, PA 19104 USA; [Arbogast, Kristy B.; Master, Christina L.] Univ Penn, Dept Pediat, Philadelphia, PA 19104 USA; [Leddy, John J.] SUNY Buffalo, Jacobs Sch Med, UBMD Dept Orthopaed & Sports Med, Buffalo, NY USA; [Mannix, Rebekah] Boston Childrens Hosp, Div Emergency Med, Boston, MA USA; [Zemek, Roger L.] Univ Ottawa, Childrens Hosp Eastern Ontario, Res Inst, Dept Pediat & Emergency Med, Ottawa, ON, Canada; [Yeates, Keith Owen] Alberta Childrens Prov Gen Hosp, Res Inst, Dept Psychol, Edmonton, AB, Canada; [Yeates, Keith Owen] Univ Calgary, Hotchkiss Brain Inst, Calgary, AB, Canada		Mayer, AR (corresponding author), Univ New Mexico, Lovelace Biomed & Environm Res Inst, Mind Res Network, Albuquerque, NM 87131 USA.; Mayer, AR (corresponding author), Univ New Mexico, Dept Psychiat & Behav Sci, Albuquerque, NM 87131 USA.; Mayer, AR (corresponding author), Univ New Mexico, Dept Psychol, Albuquerque, NM 87131 USA.; Mayer, AR (corresponding author), Univ New Mexico, Dept Neurol, Albuquerque, NM 87131 USA.	amayer@mrn.org	Yeates, Keith/AAJ-4223-2020		NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NIH 01 R01 NS098494-01A1, NIH 5R01HD076885, NIH 01 R01 NS098494-03S1A1]	This research was supported by grants from the NIH (nih.gov) to Andrew Mayer (grants NIH 01 R01 NS098494-01A1 and -03S1A1) and Keith Yeates (grant NIH 5R01HD076885). The NIH had no role in study review, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarts AA, 2015, SCIENCE, V349, DOI 10.1126/science.aac4716; Ayr LK, 2009, J INT NEUROPSYCH SOC, V15, P19, DOI 10.1017/S1355617708090188; Bigler ED, 2016, SPORTS MED ARTHROSC, V24, pE42, DOI 10.1097/JSA.0000000000000119; Bonow RH, 2017, J NEUROTRAUM, V34, P2706, DOI 10.1089/neu.2017.4970; Broglio SP, 2018, J NEUROTRAUM, V35, P2776, DOI 10.1089/neu.2018.5643; Chern JJ, 2014, J NEUROSURG-PEDIATR, V14, P306, DOI 10.3171/2014.6.PEDS13682; Ellis MJ, 2015, J NEUROSURG-PEDIATR, V16, P248, DOI 10.3171/2015.1.PEDS14524; Ellis MJ, 2015, J NEUROSURG-PEDIATR, V16, P241, DOI 10.3171/2015.1.PEDS14510; Gioia GA, 2008, J HEAD TRAUMA REHAB, V23, P230, DOI 10.1097/01.HTR.0000327255.38881.ca; Gur RE, 2013, AM J NEURORADIOL, V34, P2021, DOI 10.3174/ajnr.A3525; Haacke EM, 2010, J MAGN RESON IMAGING, V32, P516, DOI 10.1002/jmri.22259; Haarbauer-Krupa J, 2018, J PEDIATR-US, V197, P241, DOI 10.1016/j.jpeds.2018.01.075; Hopkins RO, 2006, J NEUROIMAGING, V16, P243, DOI 10.1111/j.1552-6569.2006.00047.x; Jansen PR, 2017, NEW ENGL J MED, V377, P1593, DOI 10.1056/NEJMc1710724; Kaiser D, 2015, BRAIN IMAGING BEHAV, V9, P32, DOI 10.1007/s11682-014-9327-7; Kim BS, 2002, AM J NEURORADIOL, V23, P1674; Klein AP, 2019, J NEUROTRAUM, V36, P1776, DOI 10.1089/neu.2018.6055; Kloppenborg RP, 2014, NEUROLOGY, V82, P2127, DOI 10.1212/WNL.0000000000000505; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Lee H, 2008, J NEUROTRAUM, V25, P1049, DOI 10.1089/neu.2008.0566; Liu J, 2014, NEURAL REGEN RES, V9, P1222, DOI 10.4103/1673-5374.135330; Max JE, 2015, J NEUROPSYCH CLIN N, V27, P112, DOI 10.1176/appi.neuropsych.13080190; Mayer AR, 2018, NEUROSCI BIOBEHAV R, V94, P149, DOI 10.1016/j.neubiorev.2018.08.002; Mayer AR, 2017, NEUROLOGY, V89, P623, DOI 10.1212/WNL.0000000000004214; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Mehta H, 2016, AM J NEURORADIOL, V37, P11, DOI 10.3174/ajnr.A4464; Morgan CD, 2015, CHILD NERV SYST, V31, P2305, DOI 10.1007/s00381-015-2916-y; Osmond MH, 2018, CAN MED ASSOC J, V190, pE816, DOI 10.1503/cmaj.170406; Park E, 2009, J CEREBR BLOOD F MET, V29, P575, DOI 10.1038/jcbfm.2008.151; Porter Alyx, 2005, Curr Pain Headache Rep, V9, P289, DOI 10.1007/s11916-005-0039-y; Rice SG, 2008, PEDIATRICS, V121, P841, DOI 10.1542/peds.2008-0080; Riedy G, 2016, RADIOLOGY, V279, P207, DOI 10.1148/radiol.2015150438; Royal JM, 2008, J LAW MED ETHICS, V36, P305, DOI 10.1111/j.1748-720X.2008.00274.x; Ruff RM, 2009, ARCH CLIN NEUROPSYCH, V24, P3, DOI 10.1093/arclin/acp006; Saba L, 2013, J NEUROIMAGING, V23, P326, DOI 10.1111/jon.12004; SARWAR M, 1989, AM J NEURORADIOL, V10, P989; Schmidt Matthias H, 2015, IRB, V37, P11; Shoemaker JM, 2011, NEUROLOGY, V77, P2123, DOI 10.1212/WNL.0b013e31823d7687; Tate DF, 2017, MIL MED, V182, pE1651, DOI 10.7205/MILMED-D-16-00132; Trotter BB, 2015, BRAIN, V138, P2278, DOI 10.1093/brain/awv139; Varni JW, 1999, MED CARE, V37, P126, DOI 10.1097/00005650-199902000-00003; Vernooij MW, 2007, NEW ENGL J MED, V357, P1821, DOI 10.1056/NEJMoa070972; Wintermark M, 2015, AJNR Am J Neuroradiol, V36, pE1, DOI 10.3174/ajnr.A4181; Yeates KO, 2009, PEDIATRICS, V123, P735, DOI 10.1542/peds.2008-1056; Yue JK, 2013, J NEUROTRAUM, V30, P1831, DOI 10.1089/neu.2013.2970; Yuh EL, 2013, ANN NEUROL, V73, P224, DOI 10.1002/ana.23783	47	7	7	1	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0028-3878	1526-632X		NEUROLOGY	Neurology	JAN 21	2020	94	3					E241	E253		10.1212/WNL.0000000000008488			13	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	LJ4IW	WOS:000530131000008	31645467	Green Published			2022-02-06	
J	Diao, XJ; Zhou, ZX; Xiang, WJ; Jiang, YL; Tian, N; Tang, XL; Chen, SS; Wen, J; Chen, ML; Liu, KX; Li, QH; Liao, RJ				Diao, Xiaojun; Zhou, Zixian; Xiang, Wenjing; Jiang, Yanlin; Tian, Ning; Tang, Xiaoling; Chen, Sangsang; Wen, Jian; Chen, Meiling; Liu, Kaixiang; Li, Qinghua; Liao, Rujia			Glutathione alleviates acute intracerebral hemorrhage injury via reversing mitochondrial dysfunction	BRAIN RESEARCH			English	Article						Intracerebral hemorrhage; Glutathione; Mitochondrial; Mitochondrial oxidative respiration; Acute stage	TRAUMATIC BRAIN-INJURY; THERAPEUTIC STRATEGY; OXIDATIVE STRESS; METABOLISM; ELEVATION; DEPLETION; RECOVERY; SURVIVAL; RECEPTOR; RELEASE	Glutathione (GSH) has been studied for its neuroprotection value in several diseases, but the effect of GSH on intracerebral hemorrhage (ICH) is unclear. In this study, we examined the protective effects of GSH in an experimentally induced ICH model and investigated the relative mechanisms. Adult male C57BL/6j mice were randomized into Sham, ICH and GSH treatment groups. GSH was injected with the dose of 50, 100 or 200 mg/kg once per day for 3 days, starting immediately after operation. The results revealed a GSH-mediated improvement of neurological deficits score (NDS), motor and sensory functions impairment in a dose-dependent manner three days post ICH (p < 0.01, GSH 200 vs ICH. Sham, n = 12; ICH, n = 9; GSH 50, n = 10; GSH 100, n = 10; GSH 200, n = 11) in addition to significantly reduced mortality rate (p = 0.2632, GSH 200 vs ICH. n = 12 per group) and damage volume (p < 0.05, GSH 200 vs ICH. n = 12 per group). GSH treatment also attenuated injury measured by decreased brain edema (p < 0.05, GSH 200 vs ICH. Sham, n = 10; ICH, n = 10; GSH 200, n = 12), blood-brain barrier disruption (p < 0.05, GSH 200 vs ICH. Sham, n = 10; ICH, n = 10; GSH 200, n = 12), and histopathological damage (p < 0.05, GSH 200 vs ICH. Sham, n = 6; ICH, n = 6; GSH 200, n = 8) 72 h after ICH. In addition, GSH treatment also decreased cell apoptosis (p < 0.01, GSH 200 vs ICH. Sham, n = 6; ICH, n = 6; GSH 200, n = 8) and resulted in up-regulated protein expression of complex I (p < 0.01, GSH 200 vs ICH. Sham, n = 6; ICH, n = 6; GSH 200, n = 8), which was consistent with an overall up-regulation of complex I function in mitochondria using Oxygraph-2 K high resolution respirometry (p < 0.05, GSH 200 vs ICH. Sham, n = 4; ICH, n = 5; GSH 200, n = 6). In conclusion, GSH effectively improved the prognosis of ICH mice by attenuating neurological impairment, decreasing neural damage, and inhibiting apoptosis. The neuroprotection by GSH resulted from the up-regulation of mitochondrial oxidative respiration function. The results of our study suggest that GSH can be a potential therapeutic agent for ICH.	[Diao, Xiaojun; Li, Qinghua] Cent S Univ, Xiangya Hosp, Dept Neurol, Changsha 410000, Peoples R China; [Diao, Xiaojun] Guilin Med Univ, Guilin 541004, Peoples R China; [Zhou, Zixian; Xiang, Wenjing; Tang, Xiaoling; Chen, Sangsang; Chen, Meiling; Liu, Kaixiang; Li, Qinghua; Liao, Rujia] Guilin Med Univ, Affiliated Hosp, Dept Neurol, Guilin 541004, Peoples R China; [Zhou, Zixian; Xiang, Wenjing; Tian, Ning; Li, Qinghua; Liao, Rujia] Guilin Med Univ, Affiliated Hosp, Lab Neurosci, Guilin 541004, Peoples R China; [Tian, Ning; Wen, Jian; Li, Qinghua; Liao, Rujia] Guilin Med Univ, Affiliated Hosp, Guangxi Clin Res Ctr Neurol Dis, Guilin 541004, Peoples R China; [Jiang, Yanlin] Guilin Med Univ, Affiliated Hosp, Dept Pharmacol, Guilin 541004, Peoples R China; [Tian, Ning; Wen, Jian; Li, Qinghua; Liao, Rujia] Guilin Med Univ, Guangxi Key Lab Brain & Cognit Neurosci, Guilin 541004, Peoples R China		Li, QH (corresponding author), Cent S Univ, Xiangya Hosp, Dept Neurol, 20 Lequn St, Guilin 541004, Peoples R China.; Liao, RJ (corresponding author), Guilin Med Univ, Guangxi Key Lab Brain & Cognit Neurosci, Dept Neurol,Lab Neurosci, Guangxi Clin Res Ctr Neurol Dis,Affiliated Hosp, Guilin, Peoples R China.	qhli1999@163.com.cn; liaorujia@hotmail.com		liao, ru-jia/0000-0001-6928-4003; Li, Qinghua/0000-0002-4547-8513	Youth Fund of the Guangxi Natural Science Foundation [2018GXNSFBA138046]; Guangxi Science and Technology Project [Guike AD18281013]	This work was supported by Grant Number 2018GXNSFBA138046 (Rujia Liao) from the Youth Fund of the Guangxi Natural Science Foundation, and the Guangxi Science and Technology Project (Grant Number Guike AD18281013, Rujia Liao). We would like to thank Dr. John Hugh Snyder (Genesis Technology Communication (Beijing), Co, Ltd.) for linguistic assistance during the preparation of this manuscript.	Anderson MF, 2004, NEUROSCI LETT, V354, P163, DOI 10.1016/j.neulet.2003.09.067; Anderson MF, 2004, NEUROCHEM INT, V44, P153, DOI 10.1016/S0197-0186(03)00133-5; Carroll WM, 2019, LANCET NEUROL, V18, P418, DOI 10.1016/S1474-4422(19)30029-8; CHOWDHURY S, 2015, BIOSCIENCE REP, V36, DOI DOI 10.1088/1674-4926/36/4/044001; Clark W, 1998, STROKE, V29, P2136, DOI 10.1161/01.STR.29.10.2136; Cordonnier C, 2018, LANCET, V392, P1257, DOI 10.1016/S0140-6736(18)31878-6; Damiano M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099898; Di Domenico F, 2015, EXPERT REV NEUROTHER, V15, P19, DOI 10.1586/14737175.2015.955853; Egnatchik RA, 2014, MOL METAB, V3, P544, DOI 10.1016/j.molmet.2014.05.004; Gong Z, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1282-6; Gu F, 2015, CURR OPIN CLIN NUTR, V18, P89, DOI 10.1097/MCO.0000000000000134; Guizar-Sahagun G, 2005, NEUROSCIENCE, V130, P639, DOI 10.1016/j.neuroscience.2004.09.056; Hatem E, 2017, ANTIOXID REDOX SIGN, V27, P1217, DOI 10.1089/ars.2017.7134; Hawkins KE, 2017, BRAIN BEHAV, V7, DOI 10.1002/brb3.688; Hoehn B, 2003, STROKE, V34, P2489, DOI 10.1161/01.STR.0000091268.25816.19; Homsi S, 2009, BRAIN RES, V1291, P122, DOI 10.1016/j.brainres.2009.07.031; Huang J., 2019, J STROKE CEREBROVASC; Kahl A, 2018, STROKE, V49, P1223, DOI 10.1161/STROKEAHA.117.019687; Kim-Han JS, 2006, STROKE, V37, P2457, DOI 10.1161/01.STR.0000240674.99945.4e; Kramer T, 2017, J NEUROCHEM, V143, P523, DOI 10.1111/jnc.14220; Liao R., 2019, STEM CELL REP; Liao RJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep15356; Liao RJ, 2014, CLIN EXP PHARMACOL P, V41, P976, DOI 10.1111/1440-1681.12308; MacDougall G, 2019, NEUROBIOL DIS, V121, P17, DOI 10.1016/j.nbd.2018.09.010; MacLellan CL, 2010, STROKE, V41, pS95, DOI 10.1161/STROKEAHA.110.594457; Madsen PM, 2017, J NEUROSCI, V37, P10185, DOI 10.1523/JNEUROSCI.1378-17.2017; Mari M, 2009, ANTIOXID REDOX SIGN, V11, P2685, DOI [10.1089/ars.2009.2695, 10.1089/ARS.2009.2695]; MIZUI T, 1992, AM J PHYSIOL, V262, pH313, DOI 10.1152/ajpheart.1992.262.2.H313; Niizuma K, 2009, J NEUROCHEM, V109, P133, DOI 10.1111/j.1471-4159.2009.05897.x; Pocernich CB, 2012, BBA-MOL BASIS DIS, V1822, P625, DOI 10.1016/j.bbadis.2011.10.003; Qu J, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/2592935; Qureshi AI, 2001, NEW ENGL J MED, V344, P1450, DOI 10.1056/NEJM200105103441907; Reed TT, 2009, J NEUROSCI RES, V87, P408, DOI 10.1002/jnr.21872; Ribas V, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00151; Robaczewska J, 2016, J PHYSIOL PHARMACOL, V67, P331; Rushworth GF, 2014, PHARMACOL THERAPEUT, V141, P150, DOI 10.1016/j.pharmthera.2013.09.006; Rynkowski MA, 2008, NAT PROTOC, V3, P122, DOI 10.1038/nprot.2007.513; Saharan S, 2014, J ALZHEIMERS DIS, V40, P519, DOI 10.3233/JAD-132483; Shi JL, 2015, TUMOR BIOL, V36, P655, DOI 10.1007/s13277-014-2644-z; Smeyne M, 2013, FREE RADICAL BIO MED, V62, P13, DOI 10.1016/j.freeradbiomed.2013.05.001; Sugiyama T, 2018, BRAIN RES, V1701, P137, DOI 10.1016/j.brainres.2018.08.021; Tan Q., 2019, BRAIN RES; Tan Q, 2019, BRAIN RES, V1715, P41, DOI 10.1016/j.brainres.2019.01.033; Tanaka K, 2015, J CLIN INVEST, V125, P1591, DOI 10.1172/JCI78239; Taylor RA, 2017, J CLIN INVEST, V127, P280, DOI 10.1172/JCI88647; Tew K.D., 2016, CANCER RES, V54, P4313; Urday S, 2015, NAT REV NEUROL, V11, P111, DOI 10.1038/nrneurol.2014.264; Verma R, 2017, BRAIN BEHAV IMMUN, V66, P302, DOI 10.1016/j.bbi.2017.07.155; Vos T, 2017, LANCET, V390, P1211, DOI 10.1016/S0140-6736(17)32154-2; Wang Z, 2018, TRANSL STROKE RES, V9, P74, DOI 10.1007/s12975-017-0559-x; Wilkinson DA, 2018, NEUROPHARMACOLOGY, V134, P240, DOI 10.1016/j.neuropharm.2017.09.033; Xiong XY, 2016, CIRCULATION, V134, P1025, DOI 10.1161/CIRCULATIONAHA.116.021881; Yang YR, 2017, J AM HEART ASSOC, V6, DOI 10.1161/JAHA.117.005811; Zhang ZW, 2018, BRAIN RES, V1701, P112, DOI 10.1016/j.brainres.2018.09.012; Zheng J., 2018, FRONT NEUROSCI, V12	55	7	7	1	8	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	JAN 15	2020	1727								146514	10.1016/j.brainres.2019.146514			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	KE3ZH	WOS:000508497100024	31628933				2022-02-06	
J	Dodd, AB; Lu, HZ; Wertz, CJ; Ling, JM; Shaff, NA; Wasserott, BC; Meier, TB; Park, G; Oglesbee, SJ; Phillips, JP; Campbell, RA; Liu, PY; Mayer, AR				Dodd, Andrew B.; Lu, Hanzhang; Wertz, Christopher J.; Ling, Josef M.; Shaff, Nicholas A.; Wasserott, Benjamin C.; Meier, Timothy B.; Park, Grace; Oglesbee, Scott J.; Phillips, John P.; Campbell, Richard A.; Liu, Peiying; Mayer, Andrew R.			Persistent alterations in cerebrovascular reactivity in response to hypercapnia following pediatric mild traumatic brain injury	JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM			English	Article						Cerebral blood flow; cerebrovascular reactivity; concussion; functional magnetic resonance imaging; pediatric mild traumatic brain injury	CEREBRAL-BLOOD-FLOW; SPORTS-RELATED CONCUSSION; DEVELOPMENTAL TRAJECTORIES; CARBON-DIOXIDE; PERFUSION; FLUCTUATIONS; DYNAMICS; AGE; HETEROGENEITY; ABNORMALITIES	Much attention has been paid to the effects of mild traumatic brain injury (mTBI) on cerebrovascular reactivity in adult populations, yet it remains understudied in pediatric injury. In this study, 30 adolescents (12-18 years old) with pediatric mTBI (pmTBI) and 35 age- and sex-matched healthy controls (HC) underwent clinical and neuroimaging assessments during sub-acute (6.9 +/- 2.2 days) and early chronic (120.4 +/- 11.7 days) phases of injury. Relative to controls, pmTBI reported greater initial post-concussion symptoms, headache, pain, and anxiety, resolving by four months post-injury. Patients reported increased sleep issues and exhibited deficits in processing speed and attention across both visits. In grey-white matter interface areas throughout the brain, pmTBI displayed increased maximal fit/amplitude of a time-shifted end-tidal CO2 regressor to blood oxygen-level dependent response relative to HC, as well as increased latency to maximal fit. The alterations persisted through the early chronic phase of injury, with maximal fit being associated with complaints of ongoing sleep disturbances during post hoc analyses but not cognitive measures of processing speed or attention. Collectively, these findings suggest that deficits in the speed and degree of cerebrovascular reactivity may persist longer than current conceptualizations about clinical recovery within 30 days.	[Dodd, Andrew B.; Wertz, Christopher J.; Ling, Josef M.; Shaff, Nicholas A.; Wasserott, Benjamin C.; Phillips, John P.; Mayer, Andrew R.] Mind Res Network, Lovelace Biomed & Environm Res Inst, Albuquerque, NM 87106 USA; [Lu, Hanzhang; Liu, Peiying] Johns Hopkins Univ, Sch Med, Dept Radiol, Baltimore, MD 21205 USA; [Meier, Timothy B.] Med Coll Wisconsin, Dept Neurosurg, Milwaukee, WI 53226 USA; [Meier, Timothy B.] Med Coll Wisconsin, Dept Cell Biol, Milwaukee, WI 53226 USA; [Meier, Timothy B.] Med Coll Wisconsin, Dept Neurobiol, Milwaukee, WI 53226 USA; [Meier, Timothy B.] Med Coll Wisconsin, Dept Anat, Milwaukee, WI 53226 USA; [Meier, Timothy B.] Med Coll Wisconsin, Dept Biomed Engn, Milwaukee, WI 53226 USA; [Park, Grace; Oglesbee, Scott J.] Univ New Mexico, Dept Pediat Emergency, Albuquerque, NM 87131 USA; [Phillips, John P.; Mayer, Andrew R.] Univ New Mexico, Dept Neurol, Albuquerque, NM 87131 USA; [Campbell, Richard A.; Mayer, Andrew R.] Univ New Mexico, Dept Psychiat, Albuquerque, NM 87131 USA; [Mayer, Andrew R.] Univ New Mexico, Dept Psychol, Albuquerque, NM 87131 USA		Mayer, AR (corresponding author), Mind Res Network, Pete & Nancy Domen Hall,1101 Yale Blvd NE, Albuquerque, NM 87106 USA.	amayer@mrn.org			National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NIH 01 R01 NS098494-01A1, NIH 01 R01 NS098494-03S1A1]	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This work was supported by grants from the National Institutes of Health [https://www.nih.gov; grant numbers NIH 01 R01 NS098494-01A1 and -03S1A1] to Andrew Mayer. The NIH had no role in study review, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfini AJ, 2016, FRONT AGING NEUROSCI, V8, DOI 10.3389/fnagi.2016.00184; Allen M., 2017, J NEUROL NEUROPHYSIO, V8, P2; Alsop DC, 2015, MAGN RESON MED, V73, P102, DOI 10.1002/mrm.25197; Andersson JLR, 2003, NEUROIMAGE, V20, P870, DOI 10.1016/S1053-8119(03)00336-7; ATKINSON JLD, 1990, BRAIN RES, V517, P333, DOI 10.1016/0006-8993(90)91046-J; Attwell D, 2010, NATURE, V468, P232, DOI 10.1038/nature09613; Barlow KM, 2017, J NEUROTRAUM, V34, P996, DOI 10.1089/neu.2016.4634; Bhogal AA, 2015, NEUROIMAGE, V114, P239, DOI 10.1016/j.neuroimage.2015.04.014; Biagi L, 2004, IEEE NUCL SCI CONF R, P3258; Birn RM, 2008, NEUROIMAGE, V40, P644, DOI 10.1016/j.neuroimage.2007.11.059; Birn RM, 2006, NEUROIMAGE, V31, P1536, DOI 10.1016/j.neuroimage.2006.02.048; Blockley NP, 2011, MAGN RESON MED, V65, P1278, DOI 10.1002/mrm.22719; Bright MG, 2009, NEUROIMAGE, V48, P166, DOI 10.1016/j.neuroimage.2009.05.026; Coverdale NS, 2017, J CEREBR BLOOD F MET, V37, P344, DOI 10.1177/0271678X15626156; Cox RW, 2017, BRAIN CONNECT, V7, P152, DOI 10.1089/brain.2016.0475; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Crider T, 2018, CLIN NEUROL NEUROSUR, V170, P159, DOI 10.1016/j.clineuro.2018.05.019; Daneshvar DH, 2011, PHYS MED REH CLIN N, V22, P683, DOI 10.1016/j.pmr.2011.08.009; DUELLI R, 1993, J CEREBR BLOOD F MET, V13, P1025, DOI 10.1038/jcbfm.1993.129; DUVERNOY HM, 1981, BRAIN RES BULL, V7, P519, DOI 10.1016/0361-9230(81)90007-1; Eisenberg MA, 2014, PEDIATRICS, V133, P999, DOI 10.1542/peds.2014-0158; Ellis Michael J, 2016, Front Neurol, V7, P61, DOI 10.3389/fneur.2016.00061; Ewing-Cobbs L, 2018, PEDIATRICS, P142; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Gogtay N, 2004, P NATL ACAD SCI USA, V101, P8174, DOI 10.1073/pnas.0402680101; Golestani AM, 2016, NEUROIMAGE, V138, P147, DOI 10.1016/j.neuroimage.2016.05.025; Haarbauer-Krupa J, 2018, J PEDIATR-US, V197, P241, DOI 10.1016/j.jpeds.2018.01.075; Hoge RD, 1999, P NATL ACAD SCI USA, V96, P9403, DOI 10.1073/pnas.96.16.9403; Hutchinson EB, 2006, NEUROIMAGE, V32, P520, DOI 10.1016/j.neuroimage.2006.03.033; Jespersen SN, 2012, J CEREBR BLOOD F MET, V32, P264, DOI 10.1038/jcbfm.2011.153; Kamins J, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097464; Kassner A, 2010, J MAGN RESON IMAGING, V31, P298, DOI 10.1002/jmri.22044; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; Lenroot RK, 2007, NEUROIMAGE, V36, P1065, DOI 10.1016/j.neuroimage.2007.03.053; Leung J, 2016, J PHYSIOL-LONDON, V594, P2681, DOI 10.1113/JP271056; Liu PY, 2017, NEUROIMAGE, V146, P320, DOI 10.1016/j.neuroimage.2016.11.054; LU H, 2014, JOVE J VIS EXP DEC, V94, DOI DOI 10.3791/52306; Maugans TA, 2012, PEDIATRICS, V129, P28, DOI 10.1542/peds.2011-2083; Mayer AR, 2019, HUM BRAIN MAPP, V40, P3843, DOI 10.1002/hbm.24635; Mayer AR, 2018, NEUROSCI BIOBEHAV R, V94, P149, DOI 10.1016/j.neubiorev.2018.08.002; Mayer AR, 2015, HUM BRAIN MAPP, V36, P4394, DOI 10.1002/hbm.22930; Mayer AR, 2015, J NEUROTRAUM, V32, P723, DOI 10.1089/neu.2014.3534; Mayer AR, IMPACT DIFFUSE MILD; McAllister Thomas W, 2011, Dialogues Clin Neurosci, V13, P287; McCrory P, 2013, J ATHL TRAINING, V48, P554, DOI 10.4085/1062-6050-48.4.05; Meier TB, 2015, JAMA NEUROL, V72, P530, DOI 10.1001/jamaneurol.2014.4778; Militana AR, 2016, BRAIN IMAGING BEHAV, V10, P559, DOI 10.1007/s11682-015-9407-3; Mutch WAC, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00023; Mutch WAC, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00107; Mutch WAC, 2016, J NEUROSURG, V125, P648, DOI 10.3171/2015.6.JNS15972; Nofzinger EA, 2002, BRAIN, V125, P1105, DOI 10.1093/brain/awf103; Okamoto H, 1997, AM J PHYSIOL-HEART C, V272, pH559, DOI 10.1152/ajpheart.1997.272.1.H559; Poulin MJ, 1996, J APPL PHYSIOL, V81, P1084, DOI 10.1152/jappl.1996.81.3.1084; Ravi H, 2016, J MAGN RESON IMAGING, V43, P661, DOI 10.1002/jmri.25028; Rice SG, 2008, PEDIATRICS, V121, P841, DOI 10.1542/peds.2008-0080; Satterthwaite TD, 2014, P NATL ACAD SCI USA, V111, P8643, DOI 10.1073/pnas.1400178111; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Spano VR, 2013, RADIOLOGY, V266, P592, DOI 10.1148/radiol.12112795; Stephens JA, 2018, J NEUROTRAUM, V35, P241, DOI 10.1089/neu.2017.5237; Sullivan KA, 2015, J NEUROTRAUM, V32, P474, DOI 10.1089/neu.2013.3284; Svaldi DO, 2017, BRAIN IMAGING BEHAV, V11, P98, DOI 10.1007/s11682-016-9509-6; Talairach J., 1988, COPLANAR STERIOTAXIC; Tameem A, 2013, BJA EDUC, V13, P113, DOI 10.1093/bjaceaccp/mkt001; Thibeault CM, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00200; Thomas BP, 2014, J CEREBR BLOOD F MET, V34, P242, DOI 10.1038/jcbfm.2013.194; Wang JJ, 2005, RADIOLOGY, V235, P218, DOI 10.1148/radiol.2351031663; Wise RG, 2004, NEUROIMAGE, V21, P1652, DOI 10.1016/j.neuroimage.2003.11.025; Yezhuvath US, 2009, NMR BIOMED, V22, P779, DOI 10.1002/nbm.1392; Yoder N., 2009, PEAKFINDER COMPUTER	69	7	7	0	2	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0271-678X	1559-7016		J CEREBR BLOOD F MET	J. Cereb. Blood Flow Metab.	DEC	2020	40	12					2491	2504	0271678X19896883	10.1177/0271678X19896883		JAN 2020	14	Endocrinology & Metabolism; Hematology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism; Hematology; Neurosciences & Neurology	OX2WN	WOS:000507210100001	31903838	Green Published			2022-02-06	
J	Amyot, F; Kenney, K; Spessert, E; Moore, C; Haber, M; Silverman, E; Gandjbakhche, A; Diaz-Arrastia, R				Amyot, Franck; Kenney, Kimbra; Spessert, Emily; Moore, Carol; Haber, Margalit; Silverman, Erika; Gandjbakhche, Amir; Diaz-Arrastia, Ramon			Assessment of cerebrovascular dysfunction after traumatic brain injury with fMRI and fNIRS	NEUROIMAGE-CLINICAL			English	Article						Near-infrared spectroscopy; Functional magnetic resonance imaging; Traumatic brain injury (TBI); Cerebrovascular reactivity (CVR); Hypercapnia	NEAR-INFRARED SPECTROSCOPY; CEREBRAL-BLOOD-FLOW; AXONAL INJURY; REACTIVITY; MILD; AUTOREGULATION; ANGIOGENESIS; OSCILLATIONS; HYPERCAPNIA; CONCUSSION	Traumatic cerebral vascular injury (TCVI) is a frequent, but under-recognized, endophenotype of traumatic brain injury (TBI). It likely contributes to functional deficits after TBI and TBI-related chronic disability, and represents an attractive target for targeted therapeutic interventions. The aim of this prospective study is to assess microvascular injury/dysfunction in chronic TBI by measuring cerebral vascular reactivity (CVR) by 2 methods, functional magnetic resonance imaging (fMRI) and functional Near InfraRed Spectroscopy (fNIRS) imaging, as each has attractive features relevant to clinical utility. 42 subjects (27 chronic TBI, 15 age- and gender-matched non-TBI volunteers) were enrolled and underwent outpatient CVR testing by 2 methods, MRI-BOLD and fNIRS, each with hypercapnia challenge, a neuropsychological testing battery, and symptom survey questionnaires. Chronic TBI subjects showed a significant reduction in global CVR compared to HC (p < 0.0001). Mean CVR measures by fMRI were 0.225 +/- 0.014 and 0.183 +/- 0.026 %BOLD/mmHg for non-TBI and TBI subjects respectively and 12.3 +/- 1.8 and 9.2 +/- 1.7 mM/mmHg by fNIRS for non-TBI versus TBI subjects respectively. Global CVR measured by fNIRS imaging correlates with results by MRI-BOLD (R = 0.5). Focal CVR deficits seen on CVR maps by fMRI are also observed in the same areas by fNIRS in the frontal regions. Global CVR is significantly lower in chronic TBI patients and is reliably measured by both fMRI and fNIRS, the former with better spatial and the latter with better temporal resolution. Both methods show promise as non-invasive measures of CVR function and microvascular integrity after TBI.	[Amyot, Franck; Kenney, Kimbra; Spessert, Emily; Moore, Carol] Uniformed Serv Univ Hlth Sci, Dept Neurol, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA; [Amyot, Franck; Kenney, Kimbra; Spessert, Emily; Moore, Carol; Diaz-Arrastia, Ramon] Uniformed Serv Univ Hlth Sci, Dept Neurol, Ctr Neurosci & Regenerat Med, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA; [Haber, Margalit; Silverman, Erika; Diaz-Arrastia, Ramon] Univ Penn, Dept Neurol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Gandjbakhche, Amir] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Sect Analyt & Funct Biophoton, NICHD, NIH, Bethesda, MD USA		Amyot, F (corresponding author), Uniformed Serv Univ Hlth Sci, Dept Neurol, Ctr Neurosci & Regenerat Med, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA.	franck.g.amyot.civ@mail.mil			Center for Neuroscience and Regenerative Medicine (CNRM), Uniformed Services University of the Health Sciences (USUHS), Bethesda, MD; Military Clinical Neuroscience Center of Excellence (MCNCoE), Department of Neurology, USUHS; Intramural Research Program of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA	Work in the authors' laboratory was supported by the Center for Neuroscience and Regenerative Medicine (CNRM), Uniformed Services University of the Health Sciences (USUHS), Bethesda, MD, by the Military Clinical Neuroscience Center of Excellence (MCNCoE), Department of Neurology, USUHS, and by the Intramural Research Program of the National Institutes of Health. The contents of this paper are solely the responsibility of the authors and do not represent the official views of the Department of Defense, CNRM, MCNCoE, or the National Institutes of Health.	Alderliesten T, 2014, NEUROIMAGE, V85, P255, DOI 10.1016/j.neuroimage.2013.07.015; Amyot F., 2017, J NEUROTRAUMA; Ayaz H, 2010, FUNCTIONAL NEAR INFR; Ayaz H, 2012, NEUROIMAGE, V59, P36, DOI 10.1016/j.neuroimage.2011.06.023; Ayaz H, 2010, IEEE ENG MED BIO, P6567, DOI 10.1109/IEMBS.2010.5627113; Bailey DM, 2013, CLIN SCI, V124, P177, DOI 10.1042/CS20120259; Barkai G, 2004, PSYCHIAT RES-NEUROIM, V132, P279, DOI 10.1016/j.pscychresns.2004.09.004; Bartnik-Olson BL, 2014, J NEUROTRAUM, V31, P1497, DOI 10.1089/neu.2013.3213; BLUMBERGS PC, 1995, J NEUROTRAUM, V12, P565, DOI 10.1089/neu.1995.12.565; Bonne O, 2003, PSYCHIAT RES-NEUROIM, V124, P141, DOI 10.1016/S0925-4927(03)00109-4; Chassidim Y, 2013, FLUIDS BARRIERS CNS, V10, DOI 10.1186/2045-8118-10-9; Chernomordikl V, 2016, BRAIN RES, V1639, P194, DOI 10.1016/j.brainres.2016.02.018; Cui X, 2011, NEUROIMAGE, V54, P2808, DOI 10.1016/j.neuroimage.2010.10.069; Cui X, 2010, NEUROIMAGE, V49, P3039, DOI 10.1016/j.neuroimage.2009.11.050; DELPY DT, 1988, PHYS MED BIOL, V33, P1433, DOI 10.1088/0031-9155/33/12/008; Diedler J, 2011, ANESTH ANALG, V113, P849, DOI 10.1213/ANE.0b013e3182285dc0; Furuya Y, 2003, NEUROSURGERY, V52, P340, DOI 10.1227/01.NEU.0000043931.83041.AA; Gardner AJ, 2015, BRIT J SPORT MED, V49, P1050, DOI 10.1136/bjsports-2014-093901; Hasadsri L, 2013, J NEUROTRAUM, V30, P897, DOI 10.1089/neu.2012.2672; Huppert TJ, 2006, J BIOMED OPT, V11, DOI 10.1117/1.2400910; Izzetoglu M, 2007, IEEE ENG MED BIOL, V26, P38, DOI 10.1109/MEMB.2007.384094; Kainerstorfer JM, 2015, J CEREBR BLOOD F MET, V35, P959, DOI 10.1038/jcbfm.2015.5; Kainerstorfer JM, 2014, ACAD RADIOL, V21, P185, DOI 10.1016/j.acra.2013.10.012; Kassner Andrea, 2004, Top Magn Reson Imaging, V15, P58, DOI 10.1097/00002142-200402000-00006; Kenney K, 2018, ANN CLIN TRANSL NEUR, V5, P418, DOI 10.1002/acn3.541; Kenney K, 2016, EXP NEUROL, V275, P353, DOI 10.1016/j.expneurol.2015.05.019; Kim J, 2012, NEUROREHAB NEURAL RE, V26, P870, DOI 10.1177/1545968311434553; Kim J, 2010, J NEUROTRAUM, V27, P1399, DOI 10.1089/neu.2009.1215; Kreplin U, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00879; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lee JK, 2009, STROKE, V40, P1820, DOI 10.1161/STROKEAHA.108.536094; Lewine JD, 2007, J HEAD TRAUMA REHAB, V22, P141, DOI 10.1097/01.HTR.0000271115.29954.27; Li L, 2007, BRAIN RES, V1132, P185, DOI 10.1016/j.brainres.2006.10.098; Lu HZ, 2014, JOVE-J VIS EXP, DOI 10.3791/52306; Menon DK, 2006, CURR OPIN CRIT CARE, V12, P85, DOI 10.1097/01.ccx.0000216572.19062.8f; Merzagora ACR, 2014, BRAIN IMAGING BEHAV, V8, P446, DOI 10.1007/s11682-013-9258-8; Mutch WAC, 2016, J NEUROSURG, V125, P648, DOI 10.3171/2015.6.JNS15972; Mutch WAC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102181; Naseer N, 2013, NEUROSCI LETT, V553, P84, DOI 10.1016/j.neulet.2013.08.021; OPPENHEI.DR, 1968, J NEUROL NEUROSUR PS, V31, P299, DOI 10.1136/jnnp.31.4.299; Pereira AC, 2007, P NATL ACAD SCI USA, V104, P5638, DOI 10.1073/pnas.0611721104; Rodriguez-Baeza A, 2003, ANAT REC PART A, V273A, P583, DOI 10.1002/ar.a.10069; Scrimgeour AG, 2014, J NEUROTRAUM, V31, P989, DOI 10.1089/neu.2013.3234; Selb J, 2014, NEUROPHOTONICS, V1, DOI 10.1117/1.NPh.1.1.015005; Shlosberg D, 2010, NAT REV NEUROL, V6, P393, DOI 10.1038/nrneurol.2010.74; Stein SC, 2002, J NEUROSURG, V97, P1373, DOI 10.3171/jns.2002.97.6.1373; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Tomlinson B E, 1970, J Clin Pathol Suppl (R Coll Pathol), V4, P154; Tong KA, 2004, ANN NEUROL, V56, P36, DOI 10.1002/ana.20123; Villapol S, 2015, BRAIN, V138, DOI 10.1093/brain/awv172; Virtanen J, 2009, J BIOMED OPT, V14, DOI 10.1117/1.3253323; Wu HT, 2011, NEUROSURGERY, V68, P1363, DOI 10.1227/NEU.0b013e31820c06b9; Yezhuvath US, 2012, NEUROBIOL AGING, V33, P75, DOI 10.1016/j.neurobiolaging.2010.02.005; Yezhuvath US, 2009, NMR BIOMED, V22, P779, DOI 10.1002/nbm.1392; Yuh EL, 2013, ANN NEUROL, V73, P224, DOI 10.1002/ana.23783; Zhang F, 2006, J NEUROSCI RES, V83, P1241, DOI 10.1002/jnr.20816; Zhu YS, 2013, J CEREBR BLOOD F MET, V33, P1190, DOI 10.1038/jcbfm.2013.66; Zweifel C, 2010, J NEUROTRAUM, V27, P1951, DOI 10.1089/neu.2010.1388; Zweifel C, 2010, STROKE, V41, P1963, DOI 10.1161/STROKEAHA.109.577320; [No title captured]	60	7	9	3	7	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	2213-1582			NEUROIMAGE-CLIN	NeuroImage-Clin.		2020	25								102086	10.1016/j.nicl.2019.102086			7	Neuroimaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	KU2JR	WOS:000519535200012	31790877	Green Published, gold			2022-02-06	
J	Badaut, J; Adami, A; Huang, L; Obenaus, A				Badaut, Jerome; Adami, Arash; Huang, Lei; Obenaus, Andre			Noninvasive magnetic resonance imaging stratifies injury severity in a rodent model of male juvenile traumatic brain injury	JOURNAL OF NEUROSCIENCE RESEARCH			English	Article; Proceedings Paper	17th International Conference on Brain Edema and Cellular Injury	DEC 08-10, 2017	Guangzhou, PEOPLES R CHINA			blood; cell death; edema; hemorrhage; rat; white matter	CONTROLLED CORTICAL IMPACT; RATS; TBI; PATHOPHYSIOLOGY; EPIDEMIOLOGY; HEMORRHAGE; CONTUSION; CHILDREN	Age and severity are significant predictors of traumatic brain injury (TBI) outcomes in the immature brain. TBI studies have segregated TBI injury into three severity groups: mild, moderate, and severe. While mild TBI is most frequent form in children and adults, there is debate over the indicators used to denote mild injury. Clinically, magnetic resonance imaging (MRI) and computed tomography (CT) are used to diagnose the TBI severity when medically warranted. Herein, we induced mild, moderate, and severe TBI in juvenile rats (jTBI) using the controlled cortical impact model. We characterized the temporal and spatial injury after graded jTBI in vivo using high-field MRI at 0.25 (6 hr), 1 and 3 days post-injury (dpi) with comparative histology. Susceptibility-weighted imaging (SWI) for blood and T2-weighted imaging (T2WI) for edema were quantified over the 0.25-3 dpi. Edema volumes increased linearly with severity at 0.25 dpi that slowly continued to decrease over the 3 dpi. In contrast, blood volumes did not decrease over time. Mild TBI had the least amount of blood visible on SWI. Fluoro-jade B (FJB) staining for cell death confirmed increased cellular death with increasing severity and increased FJB + cells in the corpus callosum (CC). Interestingly, the strongest correlation was observed for cell death and the presence of extravascular blood. A clear understanding of acute brain injury (jTBI) and how blood/edema contribute to mild, moderate, and severe jTBI is needed prior to embarking on therapeutic interventions. Noninvasive imaging should be used in mild jTBI to verify lack of overt injury.	[Badaut, Jerome] Univ Bordeaux, CNRS, UMR5287, Bordeaux, France; [Badaut, Jerome; Adami, Arash; Huang, Lei; Obenaus, Andre] Loma Linda Univ, Sch Med, Dept Basic Sci, Loma Linda, CA USA; [Obenaus, Andre] UC Riverside, Div Biomed Sci, Ctr Glial Neuronal Interact, Riverside, CA USA; [Huang, Lei] Loma Linda Univ, Sch Med, Dept Neurosurg, Loma Linda, CA USA; [Obenaus, Andre] Univ Calif Irvine, Dept Pediat, Irvine, CA 92697 USA		Obenaus, A (corresponding author), Univ Calif Irvine, Dept Pediat, Irvine, CA 92697 USA.	obenausa@uci.edu		, Andre/0000-0003-0081-6950; Adami, Arash/0000-0003-2741-6690	Eunice Kennedy Shriver National Institute of Child Health and Human DevelopmentUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD061946] Funding Source: Medline		Ajao DO, 2012, J NEUROTRAUM, V29, P2060, DOI 10.1089/neu.2011.1883; Babikian T, 2015, J NEUROTRAUM, V32, P1849, DOI 10.1089/neu.2015.3971; Badaut J, 2011, CEREBROVASC DIS, V31, P521, DOI 10.1159/000324328; Baghchechi M, 2016, DEV NEUROSCI-BASEL, V38, P445, DOI 10.1159/000455837; Bajwa NM, 2019, J NEUROSCI RES, V97, P332, DOI 10.1002/jnr.24343; Bauer R, 2004, EXP TOXICOL PATHOL, V56, P65, DOI 10.1016/j.etp.2004.04.002; DeKosky ST, 2017, BRAIN INJURY, V31, P1177, DOI 10.1080/02699052.2017.1312528; Dewan MC, 2016, WORLD NEUROSURG, V91, P497, DOI 10.1016/j.wneu.2016.03.045; Di Battista A, 2012, J NEUROTRAUM, V29, P1717, DOI 10.1089/neu.2011.2157; Dikranian K, 2008, EXP NEUROL, V211, P551, DOI 10.1016/j.expneurol.2008.03.012; Donovan V, 2012, NEUROIMAGE-CLIN, V1, P18, DOI 10.1016/j.nicl.2012.08.001; Fukuda AM, 2013, J CEREBR BLOOD F MET, V33, P1621, DOI 10.1038/jcbfm.2013.118; Gardner RC, 2018, J NEUROTRAUM, V35, P2341, DOI 10.1089/neu.2018.5694; Giza CC, 2007, CURR OPIN CRIT CARE, V13, P143, DOI 10.1097/MCC.0b013e32808255dc; GOTSCHALL CS, 1995, J NEUROTRAUM, V12, P611, DOI 10.1089/neu.1995.12.611; Haacke EM, 2004, MAGN RESON MED, V52, P612, DOI 10.1002/mrm.20198; Haghbayan H, 2016, SYST REV-LONDON, V5, DOI 10.1186/s13643-016-0184-x; Hawkins BE, 2013, BRAIN RES, V1496, P28, DOI 10.1016/j.brainres.2012.12.027; Hochstadter E, 2014, NEUROCRIT CARE, V21, P505, DOI 10.1007/s12028-014-9986-7; Hyman S., 2017, THER DEV ABS PRED AN; Igarashi T, 2007, EXP NEUROL, V203, P258, DOI 10.1016/j.expneurol.2006.08.030; Immonen RJ, 2009, NEUROIMAGE, V45, P1, DOI 10.1016/j.neuroimage.2008.11.022; Isokuortti H, 2018, J NEUROSURG, V129, P1588, DOI 10.3171/2017.7.JNS17615; Jullienne A, 2018, J NEUROTRAUM, V35, P1646, DOI 10.1089/neu.2017.5547; Kharatishvili I, 2009, EXP NEUROL, V217, P154, DOI 10.1016/j.expneurol.2009.01.026; Kurland D, 2012, J NEUROTRAUM, V29, P19, DOI 10.1089/neu.2011.2122; Levin HS, 2008, J HEAD TRAUMA REHAB, V23, P197, DOI 10.1097/01.HTR.0000327252.54128.7c; Liu CL, 2015, J MAGN RESON IMAGING, V42, P23, DOI [10.3969/j.issn.1001-2400.2015.01.004, 10.1002/jmri.24768]; Manley GT, 2017, J NEUROTRAUM, V34, P2721, DOI 10.1089/neu.2016.4729; Manley GT, 2006, J NEUROTRAUM, V23, P128, DOI 10.1089/neu.2006.23.128; Mannix R, 2013, NEUROSURGERY, V73, P129, DOI 10.1227/01.neu.0000429846.14579.41; Mckee Ann C, 2015, Handb Clin Neurol, V127, P45, DOI 10.1016/B978-0-444-52892-6.00004-0; Obenaus A., 2012, MILD TRAUMATIC BRAIN, P53; Obenaus A., 2017, BRAIN EDEMA, P49; Obenaus A., 2012, ANIMAL MODELS; Obenaus A, 2007, J NEUROTRAUM, V24, P1147, DOI 10.1089/neu.2006.0211; Obenaus A, 2011, ANN NEUROL, V69, P282, DOI 10.1002/ana.22168; Oehmichen M, 2003, J NEUROTRAUM, V20, P87, DOI 10.1089/08977150360517218; Potts Mathew B, 2006, NeuroRx, V3, P143; Rodriguez-Grande B, 2018, GLIA, V66, P1663, DOI 10.1002/glia.23336; Rowe RK, 2018, J NEUROSURG-PEDIATR, V22, P22, DOI 10.3171/2018.1.PEDS17449; Sandhir R, 2008, EXP NEUROL, V213, P372, DOI 10.1016/j.expneurol.2008.06.013; Sarkar K, 2014, J NEUROSURG-PEDIATR, V13, P307, DOI 10.3171/2013.12.PEDS13223; Schmued LC, 2000, TOXICOL PATHOL, V28, P91, DOI 10.1177/019262330002800111; Semple BD, 2016, METHODS MOL BIOL, V1462, P325, DOI 10.1007/978-1-4939-3816-2_18; Semple BD, 2013, PROG NEUROBIOL, V106, P1, DOI 10.1016/j.pneurobio.2013.04.001; Siebold L, 2018, EXP NEUROL, V310, P48, DOI 10.1016/j.expneurol.2018.07.004; Thurman DJ, 2016, J CHILD NEUROL, V31, P20, DOI 10.1177/0883073814544363; Tong KA, 2008, AM J NEURORADIOL, V29, P9, DOI 10.3174/ajnr.A0786; Wendel KM, 2019, J NEUROTRAUM, V36, P152, DOI 10.1089/neu.2018.5670; Wilson ML, 2017, EUR J PAEDIATR NEURO, V21, P374, DOI 10.1016/j.ejpn.2016.10.008; Yu SJ, 2009, BRAIN RES, V1287, P157, DOI 10.1016/j.brainres.2009.06.067; Yue JK, 2016, NEUROSURG FOCUS, V40, DOI 10.3171/2016.1.FOCUS15612; Zhang LJ, 2013, NEUROL SCI, V34, P639, DOI 10.1007/s10072-012-1090-1; Zhao S, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25475-9	55	7	7	1	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0360-4012	1097-4547		J NEUROSCI RES	J. Neurosci. Res.	JAN	2020	98	1					129	140		10.1002/jnr.24415			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Neurosciences & Neurology	JM0CE	WOS:000495891200012	30916808	Green Published			2022-02-06	
J	Cullum, CM; Bunt, S; Hicks, C; Didehbani, N; Miller, S; Vargas, B; Sabo, T; Bell, K; Batjer, HH				Cullum, C. Munro; Bunt, Stephen; Hicks, Cason; Didehbani, Nyaz; Miller, Shane; Vargas, Bert; Sabo, Tonia; Bell, Kathleen; Batjer, H. Hunt			The North Texas Concussion Registry (ConTex)	BMJ OPEN			English	Article						sports medicine; neurology; psychiatry; rehabilitation medicine; neurosurgery; statistics & research methods	GENERALIZED ANXIETY DISORDER; SPORTS-RELATED CONCUSSION; HIGH-SCHOOL; UNITED-STATES; VALIDATION; TRENDS	Purpose The North Texas Concussion Registry (ConTex) was established in 2015 as a multi-institutional collaboration intended to study risk factors, recovery patterns and clinical outcomes associated with concussion across the lifespan, with a particular emphasis on sport-related concussion. Participants Prospective enrolment of individuals who sustained a concussion within the past 6 months who were seen at one of four North Texas ConTex concussion clinics which employ common diagnostic criteria and assessment metrics to evaluate effects of a concussion as well as longitudinal tracking of recovery. Findings to date The ConTex database and multidisciplinary oversight team has been established, and over 1700 participants aged 5-88 years have been enrolled. A majority of concussions were sport-related (60%), with a mean age of 17.5 years and similar numbers of males and females. Three-month follow-up compliance has been excellent (86%), with a majority of subjects reporting good recovery by that time. ConTex has provided a rich data source for multiple research projects focused on concussion characteristics, risk factors and outcomes, and led to the development of a statewide youth concussion registry. Future plans ConTex data are being analysed to add to the body of knowledge regarding concussion mechanisms, factors related to recovery and improving outcomes for concussion patients. ConTex will serve as a platform for future treatment studies and may serve as a model for other concussion surveillance programmes.	[Cullum, C. Munro; Bunt, Stephen; Hicks, Cason; Didehbani, Nyaz] Univ Texas Southwestern Med Ctr Dallas, Dept Psychiat, Dallas, TX 75390 USA; [Cullum, C. Munro; Vargas, Bert; Sabo, Tonia] Univ Texas Southwestern Med Ctr Dallas, Dept Neurol & Neurotherapeut, Dallas, TX 75390 USA; [Cullum, C. Munro; Batjer, H. Hunt] Univ Texas Southwestern Med Ctr Dallas, Dept Neurol Surg, Dallas, TX 75390 USA; [Miller, Shane] Texas Scottish Rite Hosp Crippled Children, Dept Orthoped, Dallas, TX USA; [Miller, Shane] Texas Scottish Rite Hosp Crippled Children, Dept Sports Med, Dallas, TX USA; [Miller, Shane] Univ Texas Southwestern Med Ctr Dallas, Dept Orthopaed Surg, Dallas, TX 75390 USA; [Miller, Shane] Univ Texas Southwestern Med Ctr Dallas, Dept Pediat, Dallas, TX 75390 USA; [Bell, Kathleen] Univ Texas Southwestern Med Ctr Dallas, Phys Med & Rehabil, Dallas, TX 75390 USA		Bunt, S (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Psychiat, Dallas, TX 75390 USA.	stephen.bunt@utsouthwestern.edu		Cullum, Munro/0000-0001-9706-5465; Miller, Shane/0000-0001-5002-5095; Bunt, Stephen/0000-0002-3631-4648	Texas Institute for Brain Injury and Repair (TIBIR), a state-funded initiative, Peter J. O'Donnell Jr. Brain Institute at The University of Texas Southwestern Medical Center	This prospective registry was funded by a grant from the Texas Institute for Brain Injury and Repair (TIBIR), a state-funded initiative as part of the Peter J. O'Donnell Jr. Brain Institute at The University of Texas Southwestern Medical Center.	Amick R. Z., 2015, ATHL TRAIN SPORT HLT, V7, P89, DOI DOI 10.3928/19425864-20150422-04; Amoo-Achampong K, 2017, PHYSICIAN SPORTSMED, V45, P239, DOI 10.1080/00913847.2017.1327304; Bramley H, 2017, CLIN PEDIATR, V56, P1280, DOI 10.1177/0009922816681603; Broglio SP, 2017, SPORTS MED, V47, P1437, DOI 10.1007/s40279-017-0707-1; Bunt S, 2019, CLIN J SPORT MED; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Chung JS, 2019, J CHILD NEUROL, V34, P639, DOI 10.1177/0883073819849741; Daneshvar DH, 2011, CLIN SPORT MED, V30, P1, DOI 10.1016/j.csm.2010.08.006; Demographics.texas.gov, 2019, POP PROJ TEX REP; DePadilla L, 2018, MMWR-MORBID MORTAL W, V67, P682, DOI 10.15585/mmwr.mm6724a3; Echemendia RJ, 2017, BRIT J SPORT MED, V51, P895, DOI 10.1136/bjsports-2016-097466; Galetta KM, 2011, J NEUROL SCI, V309, P34, DOI 10.1016/j.jns.2011.07.039; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Gioia GA, 2008, J HEAD TRAUMA REHAB, V23, P230, DOI 10.1097/01.HTR.0000327255.38881.ca; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Heitger MH, 2008, 30 ANN INT C IEEE EN; Henry LC, 2016, NEUROSURGERY, V78, P232, DOI 10.1227/NEU.0000000000001041; Iverson G.L, 2007, BRAIN INJURY MED PRI, P373; Iverson GL, 2013, BRAIN INJURY, V27, P596, DOI 10.3109/02699052.2013.772237; Kerr ZY, 2018, J ATHL TRAINING, V53, P729, DOI 10.4085/1062-6050-143-17; Kroenke K, 2002, PSYCHIAT ANN, V32, P509, DOI 10.3928/0048-5713-20020901-06; Lincoln AE, 2011, AM J SPORT MED, V39, P958, DOI 10.1177/0363546510392326; Lowe B, 2008, MED CARE, V46, P266, DOI 10.1097/MLR.0b013e318160d093; Lovell M, 2000, IMPACT IMMEDIATE POS; Marshall Stephen W, 2015, Inj Epidemiol, V2, P13; McCrory P, 2016, BRIT J SPORT MED, V2017, P838, DOI DOI 10.1136/BJSP0RTS-2017-097699; Patterson JA, 2014, INT J SPORTS PHYS TH, V9, P135; Pfister T, 2016, BRIT J SPORT MED, V50, P292, DOI 10.1136/bjsports-2015-094978; Smith BW, 2008, INT J BEHAV MED, V15, P194, DOI 10.1080/10705500802222972; Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092; Teel EF, 2017, J ATHL TRAINING, V52, P288, DOI 10.4085/1062-6050-52.1.12; Wallace J, 2017, J ATHL TRAINING, V52, P682, DOI 10.4085/1062-6050-52.3.06; Windle G, 2011, HEALTH QUAL LIFE OUT, V9, DOI 10.1186/1477-7525-9-8	34	7	7	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	2044-6055			BMJ OPEN	BMJ Open	JAN	2020	10	1							e032345	10.1136/bmjopen-2019-032345			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	KT9BD	WOS:000519306600142	31900269	Green Published, gold			2022-02-06	
J	Denby, E; Murphy, D; Busuttil, W; Sakel, M; Wilkinson, D				Denby, Emma; Murphy, Dominic; Busuttil, Walter; Sakel, Mohamed; Wilkinson, David			Neuropsychiatric Outcomes in UK Military Veterans With Mild Traumatic Brain Injury and Vestibular Dysfunction	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						balance; blast; blunt; mTBI; veterans	MEMORY COMPLAINTS INVENTORY; BLAST EXPOSURE; VALIDITY; SYMPTOMS; AFGHANISTAN; PERFORMANCE; PERSONNEL; ANXIETY; UTILITY; TBI	Objective: To estimate the frequency of vestibular dysfunction following blunt, blast, and combined blunt and blast mild traumatic brain injury (mTBI) and thereon assess the long-term impact of vestibular dysfunction on neurobehavioral function and disability independently of comorbid psychiatric symptoms. Setting: Combat Stress residential and Veterans' Outreach drop-in centers for psychological support. Participants: One hundred sixty-two help-seeking UK military veterans. Main Measures: Self-reported frequency and severity of mTBI (using the Ohio State TBI Identification Method), Vertigo Symptom Scale, PTSD Checklist for DSM-5, Kessler Psychological Distress Scale (K10), Neurobehavioral Symptom Inventory, Headache Impact Test (HIT6), Memory Complaints Inventory, World Health Organization Disability Assessment Schedule II short version (WHODAS 2.0). Results: Seventy-two percent of the sample reported 1 or more mTBIs over their lifetime. Chi-square analyses indicated that vestibular disturbance, which affected 69% of participants, was equally prevalent following blunt (59%) or blast (47%) injury and most prevalent following blunt and blast combined (83%). Mediation analysis indicated that when posttraumatic stress disorder, depression, and anxiety were taken into account, vestibular dysfunction in participants with mTBI was directly and independently associated with increased postconcussive symptoms and functional disability. Conclusion: Vestibular dysfunction is common after combined blunt and blast mTBI and singularly predictive of poor long-term mental health. From a treatment perspective, vestibular rehabilitation may provide relief from postconcussive symptoms other than dizziness and imbalance.	[Denby, Emma; Wilkinson, David] Univ Kent, Sch Psychol, Canterbury CT2 7NP, Kent, England; [Murphy, Dominic; Busuttil, Walter] Combat Stress, Tyrwhitt House, Leatherhead, Surrey, England; [Murphy, Dominic] Kings Coll London, Kings Ctr Mil Hlth Res, London, England; [Sakel, Mohamed] NHS Fdn Trust, East Kent Hosp Univ, East Kent Neurorehabil Serv, Canterbury, Kent, England		Wilkinson, D (corresponding author), Univ Kent, Sch Psychol, Canterbury CT2 7NP, Kent, England.	dtw@kent.ac.uk			KentHealth, University of Kent	E.D. was supported by an internal PhD studentship from KentHealth, University of Kent.	Alhilali LM, 2014, RADIOLOGY, V272, P224, DOI 10.1148/radiol.14132670; Andrews G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008343; Armistead-Jehle P, 2017, APPL NEUROPSYCH-ADUL, V24, P190, DOI 10.1080/23279095.2015.1132219; Armistead-Jehle P, 2016, CLIN NEUROPSYCHOL, V30, P610, DOI 10.1080/13854046.2016.1177597; Armistead-Jehle P, 2012, ARCH CLIN NEUROPSYCH, V27, P725, DOI 10.1093/arclin/acs071; Balabann CD, 2011, EXPERT REV NEUROTHER, V11, P379, DOI [10.1586/ern.11.19, 10.1586/ERN.11.19]; Bigelow RT, 2016, J NEUROL NEUROSUR PS, V87, P367, DOI 10.1136/jnnp-2015-310319; Carrick FR, 2015, FRONT PUBLIC HEALTH, V3, DOI 10.3389/fpubh.2015.00015; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Chamelian L, 2004, ARCH PHYS MED REHAB, V85, P1662, DOI 10.1016/j.apmr.2004.02.012; Cicerone K, 1994, ARCH PHYS MED REHAB, V75, P723; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P318, DOI 10.1097/01.HTR.0000300227.67748.77; Department of Health, 2016, UK CHIEF MED OFF ALC; Fausti SA, 2009, J REHABIL RES DEV, V46, P797, DOI 10.1682/JRRD.2008.09.0118; Fortier CB, 2014, J HEAD TRAUMA REHAB, V29, P89, DOI 10.1097/HTR.0b013e3182865859; Furman JM, 2000, PHYS THER, V80, P179, DOI 10.1093/ptj/80.2.179; Gervais RO, 2008, CLIN NEUROPSYCHOL, V22, P1061, DOI 10.1080/13854040701756930; Green P, 2001, BRAIN INJURY, V15, P1045, DOI 10.1080/02699050110088254; Green P., 2004, MEMORY COMPLAINTS IN; GRIMM RJ, 1989, ACTA OTO-LARYNGOL, P1, DOI 10.3109/00016488909138632; Haber YO, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168803; Hawley CA, 2015, J HEAD TRAUMA REHAB, V30, pE47, DOI 10.1097/HTR.0000000000000023; Hayes AF, 2017, INTRO MEDIATION MODE, V12, P2013; Hayes AF, 2009, COMMUN MONOGR, V76, P408, DOI 10.1080/03637750903310360; Hebert JR, 2018, J HEAD TRAUMA REHAB, V33, P403, DOI 10.1097/HTR.0000000000000385; Hoffer ME, 2010, OTOL NEUROTOL, V31, P232, DOI 10.1097/MAO.0b013e3181c993c3; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Jones N, 2014, BRAIN INJURY, V28, P896, DOI 10.3109/02699052.2014.888479; Kessler R., 1994, UPDATE DEV MENTAL HL; Kleffelgaard I, 2016, PHYS THER, V96, P839, DOI 10.2522/ptj.20150095; Kosinski M, 2003, QUAL LIFE RES, V12, P963, DOI 10.1023/A:1026119331193; Lew HL, 2007, J REHABIL RES DEV, V44, P921, DOI 10.1682/JRRD.2007.09.0140; Lippa SM, 2015, J TRAUMA STRESS, V28, P25, DOI 10.1002/jts.21979; MacGregor AJ, 2010, J HEAD TRAUMA REHAB, V25, P1, DOI 10.1097/HTR.0b013e3181c2993d; Management of Concussion/mTBI Working Group, 2009, J Rehabil Res Dev, V46, pCP1; McGlinchey RE, 2017, INT J METH PSYCH RES, V26, DOI 10.1002/mpr.1556; Pan T, 2015, GAIT POSTURE, V42, P550, DOI 10.1016/j.gaitpost.2015.08.012; Porter KE, 2018, J PSYCHIATR RES, V102, P8, DOI 10.1016/j.jpsychires.2018.03.004; Robinson ME, 2015, HUM BRAIN MAPP, V36, P911, DOI 10.1002/hbm.22675; Rona RJ, 2012, J HEAD TRAUMA REHAB, V27, P33, DOI 10.1097/HTR.0b013e318212f814; Smith L, J NEUROPSYCHOL, DOI DOI 10.1111/JNP12157; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; ustun K, 2010, MEASURING HLTH DISAB; Weathers F.W., 2013, PTSD CHECKLIST DSM 5; YARDLEY L, 1992, J PSYCHOSOM RES, V36, P731, DOI 10.1016/0022-3999(92)90131-K	46	7	7	0	7	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JAN-FEB	2020	35	1			SI		57	65		10.1097/HTR.0000000000000468			9	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	KL0UE	WOS:000513147300012	30829817	Green Accepted			2022-02-06	
J	Evran, S; Calis, F; Akkaya, E; Baran, O; Cevik, S; Katar, S; Gurevin, EG; Hanimoglu, H; Hatiboglu, MA; Armutak, EI; Karatas, E; Kocyigit, A; Kaynar, MY				Evran, Sevket; Calis, Fatih; Akkaya, Enes; Baran, Oguz; Cevik, Serdar; Katar, Salim; Gurevin, Ebru Gurel; Hanimoglu, Hakan; Hatiboglu, Mustafa Aziz; Armutak, Elif Ilkay; Karatas, Ersin; Kocyigit, Abdurrahim; Kaynar, Mehmet Yasar			The effect of high mobility group box-1 protein on cerebral edema, blood-brain barrier, oxidative stress and apoptosis in an experimental traumatic brain injury model	BRAIN RESEARCH BULLETIN			English	Article						HMGB-1; Ocdudin; Traumatic brain injury; Bax; bcl-2; Brain edema	ISCHEMIA-REPERFUSION INJURY; TIGHT JUNCTION PROTEINS; ETHYL PYRUVATE; CYTOCHROME-C; HMGB1; RAGE; ACTIVATION; EXPRESSION; THERAPY; RELEASE	Traumatic brain injury (TBI) is one of the important reason of morbidity and mortality. While the primary injury due to mechanical impact is unavoidable, the secondary injury which is formed as a result of primary injury and thought to occur due to neurointlammation in the forefront can be prevented and by this way mortality and morbidity can be reduced. High mobility group box-1 (HMGB1) is a protein that triggers the neuroinflammatory process by being released from the nucleus of necrotic tissues after primary injury. The aim of this study is to investigate the effects of HMGB1 on its receptors TLR4 and RAGE, cerebral edema, blood-brain barrier, oxidative stress and apoptosis causing secondary damage in an experimental traumatic brain injury model. Weighing between 280-320 g, 10 to 12 weeks-old, a total of 30 adult male Sprague-Dawley rats were used for the experiments. The rats were randomly assigned to 3 groups: 1) Control, 2) TBI and 3) TBI + ethyl pyruvate group (n = 10 per group). Right parietal cortical contusion was made by using a weight-dropping TBI method. Brain samples were harvested from pericontusional area at 24 h after TBI. HMGB1, TLR4, RAGE, occludin, claudin-5, ZO-1 levels are investigated by western blot analyses and immunohistochemistry examinations. HMGB-1, TLR4 and RAGE expressions increased after TBI. Major tight junction proteins in the blood-brain barrier: occludin, claudin-5 and ZO-1 expressions decreased after TBI. Brain edema increased after TBI. Also, proapoptotic bax and active caspase 3 expressions increased, antiapoptotic bcl-2 levels decreased after TBI. Total oxidant status and oxidative stress increased, total antioxidant status decreased after TBI. HMGB-1 protein plays a key role in the pathophysiology of traumatic brain injury.	[Evran, Sevket; Baran, Oguz] Hlth Sci Univ, Haseki Res & Training Hosp, Med Fac, Dept Neurosurg, Istanbul, Turkey; [Calis, Fatih] Istanbul Medeniyet Univ, Goztepe Res & Training Hosp, Dept Neurosurg, Istanbul, Turkey; [Akkaya, Enes] Hlth Sci Univ, Sisli Hamidiye Etfal Res & Training Hosp, Med Fac, Dept Neurosurg, Istanbul, Turkey; [Cevik, Serdar; Hanimoglu, Hakan; Kaynar, Mehmet Yasar] Koc Univ, Med Fac, Dept Neurosurg, Istanbul, Turkey; [Katar, Salim] Diyarbakir State Hosp, Neurosurg Clin, Diyarbakir, Turkey; [Gurevin, Ebru Gurel] Istanbul Univ, Fac Sci, Dept Biol, Istanbul, Turkey; [Hatiboglu, Mustafa Aziz] Bezmialem Vakif Univ, Med Fac, Dept Neurosurg, Istanbul, Turkey; [Armutak, Elif Ilkay] Istanbul Univ, Fac Vet Med, Dept Histol & Embriol, Istanbul, Turkey; [Karatas, Ersin; Kocyigit, Abdurrahim] Bezmialem Vakif Univ, Med Fac, Dept Biochem, Istanbul, Turkey		Evran, S (corresponding author), Hlth Sci Univ, Haseki Res & Training Hosp, Med Fac, Dept Neurosurg, Istanbul, Turkey.	sevketevran@hotmail.com	Cevik, Serdar/G-7161-2018; EVRAN, Sevket/AAG-3284-2019; BARAN, Oguz/AAG-3278-2019; KARATAS, Ersin/G-1852-2016; Armutak, Elif/D-2901-2019	KARATAS, Ersin/0000-0001-6848-7618; Armutak, Elif/0000-0002-7359-6568; Baran, Oguz/0000-0002-2345-4318			Acosta SA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090953; Adams JM, 2001, TRENDS BIOCHEM SCI, V26, P61, DOI 10.1016/S0968-0004(00)01740-0; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Andersson U, 2000, J EXP MED, V192, P565, DOI 10.1084/jem.192.4.565; Angeloni C, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/370312; Au AK, 2012, J NEUROTRAUM, V29, P2013, DOI 10.1089/neu.2011.2171; Bolton SJ, 1998, NEUROSCIENCE, V86, P1245, DOI 10.1016/S0306-4522(98)00058-X; Chen Y, 2014, CURR MED CHEM, V21, P2146, DOI 10.2174/0929867321666131228203906; Chesnut R M, 1995, New Horiz, V3, P366; Curtin JF, 2003, CELL SIGNAL, V15, P983, DOI 10.1016/S0898-6568(03)00093-7; Erel O, 2004, CLIN BIOCHEM, V37, P277, DOI 10.1016/j.clinbiochem.2003.11.015; Erel O, 2005, CLIN BIOCHEM, V38, P1103, DOI 10.1016/j.clinbiochem.2005.08.008; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; Gao HM, 2011, J NEUROSCI, V31, P1081, DOI 10.1523/JNEUROSCI.3732-10.2011; Goldmann T, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/208093; Gong G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089450; Ha YM, 2012, APOPTOSIS, V17, P463, DOI 10.1007/s10495-011-0688-8; Hernandez-Ontiveros DG, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00030; Kang R, 2014, MOL ASPECTS MED, V40, P1, DOI 10.1016/j.mam.2014.05.001; Kawabata H, 2010, SPINE, V35, P1109, DOI 10.1097/BRS.0b013e3181bd14b6; Kinoshita K, 2002, NEUROSURGERY, V51, P195, DOI 10.1097/00006123-200207000-00027; Laird MD, 2014, GLIA, V62, P26, DOI 10.1002/glia.22581; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lewen A, 2001, J CEREBR BLOOD F MET, V21, P914, DOI 10.1097/00004647-200108000-00003; Li JF, 1998, J BIOL CHEM, V273, P30870, DOI 10.1074/jbc.273.47.30870; Luan ZG, 2010, IMMUNOBIOLOGY, V215, P956, DOI 10.1016/j.imbio.2009.11.001; Mankertz J, 2000, J CELL SCI, V113, P2085; Mojtahedzadeh M, 2014, J RES MED SCI, V19, P867; Muhammad S, 2008, J NEUROSCI, V28, P12023, DOI 10.1523/JNEUROSCI.2435-08.2008; Niyonkuru C, 2013, J NEUROTRAUM, V30, P938, DOI 10.1089/neu.2012.2578; Norden DM, 2015, NEUROPHARMACOLOGY, V96, P29, DOI 10.1016/j.neuropharm.2014.10.028; Ohnishi M, 2014, NEUROCHEM INT, V75, P32, DOI 10.1016/j.neuint.2014.05.007; Okuma Y, 2014, NEUROPHARMACOLOGY, V85, P18, DOI 10.1016/j.neuropharm.2014.05.007; Okuma Y, 2012, ANN NEUROL, V72, P373, DOI 10.1002/ana.23602; Qiu JH, 2010, STROKE, V41, P2077, DOI 10.1161/STROKEAHA.110.590463; Rachmany L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079837; Ren D, 2006, INFLAMM RES, V55, P207, DOI 10.1007/s00011-006-0072-2; Rodriguez-Rodriguez A, 2014, CURR MED CHEM, V21, P1201, DOI 10.2174/0929867321666131217153310; Scaffidi P, 2002, NATURE, V418, P191, DOI 10.1038/nature00858; Shang GH, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-91; Shlosberg D, 2010, NAT REV NEUROL, V6, P393, DOI 10.1038/nrneurol.2010.74; Sims CA, 2001, CRIT CARE MED, V29, P1513, DOI 10.1097/00003246-200108000-00003; Spierings DC, 2004, J HISTOCHEM CYTOCHEM, V52, P821, DOI 10.1369/jhc.3A6112.2004; Stanisavljevic S, 2015, BIOMED PHARMACOTHER, V72, P11, DOI 10.1016/j.biopha.2015.03.006; Su XF, 2011, MEDIAT INFLAMM, V2011, DOI 10.1155/2011/807142; Sun Q, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-106; Szmydynger-Chodobska J, 2010, J NEUROTRAUM, V27, P1449, DOI 10.1089/neu.2010.1331; Szmydynger-Chodobska J, 2009, J CEREBR BLOOD F MET, V29, P1503, DOI 10.1038/jcbfm.2009.71; Taguchi A, 2000, NATURE, V405, P354, DOI 10.1038/35012626; Tajiri N, 2014, J NEUROSCI, V34, P313, DOI 10.1523/JNEUROSCI.2425-13.2014; Ulloa L, 2002, P NATL ACAD SCI USA, V99, P12351, DOI 10.1073/pnas.192222999; Vaccari JPD, 2014, J CEREBR BLOOD F MET, V34, P369, DOI 10.1038/jcbfm.2013.227; Walleck C A, 1992, AACN Clin Issues Crit Care Nurs, V3, P19; Wang Q, 2009, ANESTHESIOLOGY, V110, P1279, DOI 10.1097/ALN.0b013e3181a160d6; Weiss N, 2009, BBA-BIOMEMBRANES, V1788, P842, DOI 10.1016/j.bbamem.2008.10.022; Woo YJ, 2004, J THORAC CARDIOV SUR, V127, P1262, DOI 10.1016/j.jtcvs.2003.11.032; Yang LY, 2015, EXP NEUROL, V269, P56, DOI 10.1016/j.expneurol.2015.03.015; Yang Y, 2007, J CEREBR BLOOD F MET, V27, P697, DOI 10.1038/sj.jcbfm.9600375; Yang ZY, 2008, WORLD J GASTROENTERO, V14, P4546, DOI 10.3748/wjg.14.4546; Ye L, 2013, J NEUROCHEM, V125, P897, DOI 10.1111/jnc.12263; Yu M, 2006, SHOCK, V26, P174, DOI 10.1097/01.shk.0000225404.51320.82; Yu SJ, 2009, BRAIN RES, V1287, P157, DOI 10.1016/j.brainres.2009.06.067; Yu YM, 2005, STROKE, V36, P2238, DOI 10.1161/01.STR.0000181779.83472.35; Zhai CL, 2012, ACTA PHARMACOL SIN, V33, P1477, DOI 10.1038/aps.2012.112; Zhang JC, 2014, BRAIN RES, V1582, P176, DOI 10.1016/j.brainres.2014.07.002; Zhang JY, 2011, STROKE, V42, P1420, DOI 10.1161/STROKEAHA.110.598334	66	7	8	2	7	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0361-9230	1873-2747		BRAIN RES BULL	Brain Res. Bull.	JAN	2020	154						68	80		10.1016/j.brainresbull.2019.10.013			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	KE7SC	WOS:000508750400008	31715313				2022-02-06	
J	Furay, EJ; Daley, MJ; Satarasinghe, P; Lara, S; Aydelotte, JD; Teixeira, PG; Coopwood, TB; Ali, S; Brown, CVR				Furay, Elisa J.; Daley, Mitch J.; Satarasinghe, Praveen; Lara, Sabino; Aydelotte, Jayson D.; Teixeira, Pedro G.; Coopwood, Thomas B.; Ali, Sadia; Brown, Carlos V. R.			Desmopressin is a transfusion sparing option to reverse platelet dysfunction in patients with severe traumatic brain injury	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article; Proceedings Paper	77th Annual Meeting of the American-Association-for-the-Surgery-of-Trauma (AAST) / Clinical Congress of Acute Care Surgery / 4th World Trauma Congress	SEP 24-29, 2018	San Diego, CA	Amer Assoc Surg Trauma		Platelet dysfunction; TBI; DDAVP; TEG; platelet transfusion	ADENOSINE-DIPHOSPHATE; UNITED-STATES; HEAD TRAUMA; COAGULOPATHY; COAGULATION; SECONDARY; HYPONATREMIA; HEMORRHAGE; DISORDERS; ENURESIS	BACKGROUND Platelet dysfunction (PD) is an independent predictor of mortality in patients with severe traumatic brain injury (sTBI). Platelet transfusions (PLTs) have been shown to be an effective treatment strategy to reverse platelet inhibition. Their use is contingent on availability and may be associated with increased cost and transfusion-related complications, making desmopressin (DDAVP) attractive. We hypothesized that DDAVP would correct PD similarly to PLTs in patients with sTBI. METHODS This retrospective study evaluated all blunt trauma patients admitted to an urban, level 1 trauma center from July 2015 to October 2016 with sTBI (defined as head abbreviated injury scale [AIS] >= 3) and PD (defined as adenosine diphosphate [ADP] inhibition >= 60% on thromboelastography) and subsequently received treatment. Per our institutional practice, patients with sTBI and PD are transfused one unit of apheresis platelets to reverse inhibition. During a platelet shortage, we interchanged DDAVP for the initial treatment. Patients were classified as receiving DDAVP or PLT based on the initial treatment. RESULTS A total of 57 patients were included (DDAVP, n = 23; PLT, n = 34). Patients who received DDAVP were more severely injured (injury severity score, 29 vs. 23; p = 0.045), but there was no difference in head AIS (4 vs. 4, p = 0.16). There was no difference between the two groups in admission platelet count (244 +/- 68 x 10(3)/mu L vs. 265 +/- 66 x 10(3)/mu L, p = 0.24) or other coagulation parameters such as prothrombin time, partial thromboplastin time, or international normalized ratio. Before treatment, both groups had similar ADP inhibition as measured by thromboelastography (ADP, 86% vs. 89%, p = 0.34). After treatment, both the DDAVP and PLT groups had similar correction of platelet ADP inhibition (p = 0.28). CONCLUSION In patients with severe traumatic brain injury and PD, DDAVP may be an alternative to PLTs to correct PD.	[Furay, Elisa J.; Daley, Mitch J.; Satarasinghe, Praveen; Lara, Sabino; Aydelotte, Jayson D.; Teixeira, Pedro G.; Coopwood, Thomas B.; Ali, Sadia; Brown, Carlos V. R.] Univ Texas Austin, Dell Seton Med Ctr, Dept Surg & Perioperat Care, Austin, TX 78701 USA		Furay, EJ (corresponding author), Univ Texas Austin, Dell Seton Med Ctr, 1500 Red River St, Austin, TX 78701 USA.	Efuray@ascension.org					Alloussi SH, 2011, J PEDIATR UROL, V7, P10, DOI 10.1016/j.jpurol.2010.04.014; [Anonymous], 2013, DESM; Beshay JE, 2010, J NEUROSURG, V112, P307, DOI 10.3171/2009.7.JNS0982; Carless P.A., 2004, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD001884.PUB2; Castellino FJ, 2014, J TRAUMA ACUTE CARE, V76, P1169, DOI 10.1097/TA.0000000000000216; CATTANEO M, 1993, ARTERIOSCLER THROMB, V13, P393, DOI 10.1161/01.ATV.13.3.393; Collyer TC, 2009, BRIT J ANAESTH, V102, P492, DOI 10.1093/bja/aep039; Crescenzi G, 2008, ANESTHESIOLOGY, V109, P1063, DOI 10.1097/ALN.0b013e31818db18b; Daley MJ, 2017, EUR J TRAUMA EMERG S, V43, P105, DOI 10.1007/s00068-016-0643-z; Daurat A, 2016, TRANSFUSION, V56, P1295, DOI 10.1111/trf.13475; Manoel ALD, 2015, NEUROCRIT CARE, V22, P34, DOI 10.1007/s12028-014-0026-4; Edelstein LC, 2013, NAT MED, V19, P1609, DOI 10.1038/nm.3385; Epstein DS, 2015, BRIT J NEUROSURG, V29, P118, DOI 10.3109/02688697.2014.950632; Franchini M, 2007, AM J HEMATOL, V82, P731, DOI 10.1002/ajh.20940; Furay E, 2018, J TRAUMA ACUTE CARE, V85, P881, DOI 10.1097/TA.0000000000002047; Halpern CH, 2008, J NEUROTRAUM, V25, P997, DOI 10.1089/neu.2008.0548; Harhangi BS, 2008, ACTA NEUROCHIR, V150, P165, DOI 10.1007/s00701-007-1475-8; Holzmacher JL, 2018, BRAIN INJURY, V32, P325, DOI 10.1080/02699052.2018.1425804; Jacoby RC, 2001, J TRAUMA, V51, P639, DOI 10.1097/00005373-200110000-00003; Kapapa T, 2014, NEUROL RES INT, V2014, DOI 10.1155/2014/298767; Koscielny J, 2004, CLIN APPL THROMB-HEM, V10, P155, DOI 10.1177/107602960401000206; Laroche M, 2012, NEUROSURGERY, V70, P1334, DOI 10.1227/NEU.0b013e31824d179b; Lethagen S, 1998, AM J HEMATOL, V57, P153, DOI 10.1002/(SICI)1096-8652(199802)57:2<153::AID-AJH11>3.0.CO;2-D; Levine M, 2013, J MED TOXICOL, V9, P139, DOI 10.1007/s13181-012-0275-6; Lucchini B, 2013, J PEDIATR UROL, V9, P1049, DOI 10.1016/j.jpurol.2013.02.012; Maegele M, 2017, LANCET NEUROL, V16, P630, DOI 10.1016/S1474-4422(17)30197-7; MANNUCCI PM, 1986, BLOOD, V67, P1148; MANNUCCI PM, 1983, NEW ENGL J MED, V308, P8, DOI 10.1056/NEJM198301063080102; Miesbach W, 2010, HAMOSTASEOLOGIE, V30, pS172, DOI 10.1055/s-0037-1619106; Naidech AM, 2014, STROKE, V45, P2451, DOI 10.1161/STROKEAHA.114.006061; Nekludov M, 2007, J NEUROTRAUM, V24, P1699, DOI 10.1089/neu.2007.0322; Oertel M, 2002, J NEUROSURG, V96, P109, DOI 10.3171/jns.2002.96.1.0109; Palta S, 2014, INDIAN J ANAESTH, V58, P515, DOI 10.4103/0019-5049.144643; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Schwab M, 1996, EUR J PEDIATR, V155, P46; Shan Yuan Md, 2018, CLIN LAB ASPECTS PLA; Stanworth SJ, 2016, BRIT J SURG, V103, P357, DOI 10.1002/bjs.10052; Stein SC, 2004, NEUROCRIT CARE, V1, P479, DOI 10.1385/NCC:1:4:479; STEIN SC, 1992, NEUROSURGERY, V30, P160, DOI 10.1227/00006123-199202000-00002; Stein SC, 2002, J NEUROSURG, V97, P1373, DOI 10.3171/jns.2002.97.6.1373; Stettler GR, 2017, SURGERY, V162, P1286, DOI 10.1016/j.surg.2017.07.022; Stoof SCM, 2016, HAEMOPHILIA, V22, P39, DOI 10.1111/hae.12732; Suddock JT, 2018, STATPEARLS; Svensson PJ, 2014, BLOOD REV, V28, P95, DOI 10.1016/j.blre.2014.03.001; Talving P, 2009, J TRAUMA, V66, P55, DOI 10.1097/TA.0b013e318190c3c0; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Thiagarajan P, 2013, HEMATOL ONCOL CLIN N, V27, P629, DOI 10.1016/j.hoc.2013.03.004; Toner RW, 2011, APPL HEALTH ECON HEA, V9, P29, DOI 10.2165/11530740-000000000-00000; Van Hoeven LR, 2015, COLLECTION TESTING U; Wafaisade A, 2010, NEUROCRIT CARE, V12, P211, DOI 10.1007/s12028-009-9281-1; WFH, DESM DDAVP TREATM BL; Whitaker B, 2015, 2013 AABB BLOOD COLL; Yuan Q, 2016, J NEUROTRAUM, V33, P1279, DOI 10.1089/neu.2015.4205	53	7	7	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	JAN	2020	88	1					80	86		10.1097/TA.0000000000002521			7	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine; Surgery	KB7JL	WOS:000506666700013	31688782				2022-02-06	
J	Huang, MX; Huang, CW; Harrington, DL; Nichols, S; Robb-Swan, A; Angeles-Quinto, A; Le, L; Rimmele, C; Drake, A; Song, T; Huang, JW; Clifford, R; Ji, ZW; Cheng, CK; Lerman, I; Yurgil, KA; Lee, RR; Baker, DG				Huang, Ming-Xiong; Huang, Charles W.; Harrington, Deborah L.; Nichols, Sharon; Robb-Swan, Ashley; Angeles-Quinto, Annemarie; Le, Lu; Rimmele, Carl; Drake, Angela; Song, Tao; Huang, Jeffrey W.; Clifford, Royce; Ji, Zhengwei; Cheng, Chung-Kuan; Lerman, Imanuel; Yurgil, Kate A.; Lee, Roland R.; Baker, Dewleen G.			Marked Increases in Resting-State MEG Gamma-Band Activity in Combat-Related Mild Traumatic Brain Injury	CEREBRAL CORTEX			English	Article						cognition; frontoparietal network; gamma activity; magnetoencephalography; mild traumatic brain injury	PERSISTENT POSTCONCUSSIVE SYMPTOMS; ANTERIOR CINGULATE CORTEX; SIGNAL SPACE SEPARATION; SOURCE IMAGING APPROACH; FUNCTIONAL CONNECTIVITY; PARIETAL CORTEX; SERVICE MEMBERS; MECHANISMS; INTERNEURONS; MAGNETOENCEPHALOGRAPHY	Combat-related mild traumatic brain injury (mTBI) is a leading cause of sustained impairments in military service members and veterans. Recent animal studies show that GABA-ergic parvalbumin-positive interneurons are susceptible to brain injury, with damage causing abnormal increases in spontaneous gamma-band (30-80 Hz) activity. We investigated spontaneous gamma activity in individuals with mTBI using high-resolution resting-state magnetoencephalography source imaging. Participants included 25 symptomatic individuals with chronic combat-related blast mTBI and 35 healthy controls with similar combat experiences. Compared with controls, gamma activity was markedly elevated in mTBI participants throughout frontal, parietal, temporal, and occipital cortices, whereas gamma activity was reduced in ventromedial prefrontal cortex. Across groups, greater gamma activity correlated with poorer performances on tests of executive functioning and visuospatial processing. Many neurocognitive associations, however, were partly driven by the higher incidence of mTBI participants with both higher gamma activity and poorer cognition, suggesting that expansive upregulation of gamma has negative repercussions for cognition particularly in mTBI. This is the first human study to demonstrate abnormal resting-state gamma activity in mTBI. These novel findings suggest the possibility that abnormal gamma activities may be a proxy for GABA-ergic interneuron dysfunction and a promising neuroimaging marker of insidious mild head injuries.	[Huang, Ming-Xiong; Harrington, Deborah L.; Robb-Swan, Ashley; Angeles-Quinto, Annemarie; Clifford, Royce; Lerman, Imanuel; Yurgil, Kate A.; Lee, Roland R.; Baker, Dewleen G.] VA San Diego Healthcare Syst, Radiol Serv, San Diego, CA 92161 USA; [Huang, Ming-Xiong; Harrington, Deborah L.; Robb-Swan, Ashley; Angeles-Quinto, Annemarie; Clifford, Royce; Lerman, Imanuel; Yurgil, Kate A.; Lee, Roland R.; Baker, Dewleen G.] VA San Diego Healthcare Syst, Res Serv, San Diego, CA 92161 USA; [Huang, Ming-Xiong; Harrington, Deborah L.; Robb-Swan, Ashley; Angeles-Quinto, Annemarie; Clifford, Royce; Lerman, Imanuel; Yurgil, Kate A.; Lee, Roland R.; Baker, Dewleen G.] VA San Diego Healthcare Syst, Psychiat Serv, San Diego, CA 92161 USA; [Huang, Ming-Xiong; Harrington, Deborah L.; Robb-Swan, Ashley; Angeles-Quinto, Annemarie; Song, Tao; Ji, Zhengwei; Lee, Roland R.] Univ Calif San Diego, Dept Radiol, San Diego, CA 92093 USA; [Huang, Charles W.] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Nichols, Sharon] Univ Calif San Diego, Dept Neurosci, San Diego, CA 92093 USA; [Le, Lu; Rimmele, Carl] ASPIRE Ctr, VASDHS Residential Rehabil Treatment Program, San Diego, CA 92110 USA; [Drake, Angela] Cedar Sinai Med Grp Chron Pain Program, Beverly Hills, CA 90211 USA; [Huang, Jeffrey W.] Columbia Univ, Dept Comp Sci, New York, NY 10027 USA; [Clifford, Royce; Baker, Dewleen G.] Univ Calif San Diego, Dept Psychiat, San Diego, CA 92093 USA; [Clifford, Royce; Yurgil, Kate A.; Baker, Dewleen G.] VA Ctr Excellence Stress & Mental Hlth, San Diego, CA 92093 USA; [Cheng, Chung-Kuan] Univ Calif San Diego, Dept Comp Sci & Engn, San Diego, CA 92093 USA; [Yurgil, Kate A.] Loyola Univ, Dept Psychol Sci, New Orleans, LA 70118 USA		Huang, MX (corresponding author), Univ Calif San Diego, Radiol Imaging Lab, 3510 Dunhill St, San Diego, CA 92121 USA.	mxhuang@ucsd.edu	Baker, Dewleen/O-4957-2019	Baker, Dewleen/0000-0002-1736-9838; Clifford, Royce/0000-0002-5515-4336; Cheng, Chung-Kuan/0000-0002-9865-8390	Merit Review Grants from the Department of Veterans AffairsUS Department of Veterans Affairs [I01-CX000499, MHBA-010-14F, I01-RX001988, B1988-I, NURC-022-10F, NEUC-044-06S, I01-CX000146]; Naval Medical Research Center's Advanced Medical Development Program (Naval Medical Logistics Command) [N62645-11-C-4037]	This work was supported in part by Merit Review Grants from theDepartment of Veterans Affairs (grants I01-CX000499, MHBA-010-14F, I01-RX001988, B1988-I, NURC-022-10F, NEUC-044-06S to M.-X.H., grant I01-CX000146 to D.L.H.); Naval Medical Research Center's Advanced Medical Development Program (Naval Medical Logistics Command Contract #N62645-11-C-4037), for MRS-II (D.G. Baker, M.A. Geyer, M.X. Huang, V.B. Risbrough).	Asken BM, 2018, BRAIN IMAGING BEHAV, V12, P585, DOI 10.1007/s11682-017-9708-9; Bailey NW, 2017, BRAIN INJURY, V31, P379, DOI 10.1080/02699052.2016.1239273; Bartos M, 2007, NAT REV NEUROSCI, V8, P45, DOI 10.1038/nrn2044; Bigler ED, 2004, STUD NEUROPSYCHOL DE, P71; Bigler ED, 2008, J INT NEUROPSYCH SOC, V14, P1, DOI 10.1017/S135561770808017X; Bludau S, 2014, NEUROIMAGE, V93, P260, DOI 10.1016/j.neuroimage.2013.05.052; Botvinick MM, 2004, TRENDS COGN SCI, V8, P539, DOI 10.1016/j.tics.2004.10.003; Buzhdygan T, 2016, J NEUROIMMUNE PHARM, V11, P279, DOI 10.1007/s11481-016-9652-2; Buzsaki G, 2012, ANNU REV NEUROSCI, V35, P203, DOI 10.1146/annurev-neuro-062111-150444; Cabeza R, 2008, NAT REV NEUROSCI, V9, P613, DOI 10.1038/nrn2459; Cardin JA, 2009, NATURE, V459, P663, DOI 10.1038/nature08002; Carlen M, 2012, MOL PSYCHIATR, V17, P537, DOI 10.1038/mp.2011.31; Carter CS, 2007, COGN AFFECT BEHAV NE, V7, P367, DOI 10.3758/CABN.7.4.367; Cazalis F, 2006, BRAIN INJURY, V20, P1019, DOI 10.1080/02699050600664384; Cazalis Fabienne, 2011, Front Neurol, V1, P158, DOI 10.3389/fneur.2010.00158; Chen YC, 2017, FRONT HUM NEUROSCI, V11, DOI 10.3389/fnhum.2017.00022; Cho KKA, 2015, NEURON, V85, P1332, DOI 10.1016/j.neuron.2015.02.019; Cohen D, 2002, P 13 INT C BIOM, P919; Cooper DB, 2015, BRAIN IMAGING BEHAV, V9, P403, DOI 10.1007/s11682-015-9440-2; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; del Pino I, 2013, NEURON, V79, P1152, DOI 10.1016/j.neuron.2013.07.010; Delis DC., 2001, DELIS KAPLAN EXECUTI; DePalma RG, 2018, BEHAV BRAIN RES, V340, P102, DOI 10.1016/j.bbr.2016.08.036; Diwakar M, 2015, NEUROIMAGE-CLIN, V8, P210, DOI 10.1016/j.nicl.2015.04.011; Douglas David B, 2015, Top Magn Reson Imaging, V24, P241, DOI 10.1097/RMR.0000000000000062; Duncan J, 2010, TRENDS COGN SCI, V14, P172, DOI 10.1016/j.tics.2010.01.004; Elsinger CL, 2006, NEUROIMAGE, V31, P1177, DOI 10.1016/j.neuroimage.2006.01.041; Fan J, 2002, J COGNITIVE NEUROSCI, V14, P340, DOI 10.1162/089892902317361886; Fischer BL, 2014, J NEUROTRAUM, V31, P169, DOI 10.1089/neu.2013.2877; Fries P, 2009, ANNU REV NEUROSCI, V32, P209, DOI 10.1146/annurev.neuro.051508.135603; Gallivan Jason P, 2018, Handb Clin Neurol, V151, P449, DOI 10.1016/B978-0-444-63622-5.00023-1; Grabner G, 2006, LECT NOTES COMPUT SC, V4191, P58; HAMALAINEN M, 1993, REV MOD PHYS, V65, P413, DOI 10.1103/RevModPhys.65.413; Hannawi Y, 2016, CURR NEUROL NEUROSCI, V16, DOI 10.1007/s11910-016-0642-9; Harrington DL, 2010, CEREB CORTEX, V20, P1274, DOI 10.1093/cercor/bhp194; Hiser J, 2018, BIOL PSYCHIAT, V83, P638, DOI 10.1016/j.biopsych.2017.10.030; Hsieh TH, 2017, CEREB CORTEX, V27, P5509, DOI 10.1093/cercor/bhw318; Huang CW, 2016, CLIN NEUROPHYSIOL, V127, P2308, DOI 10.1016/j.clinph.2016.02.007; Huang M-X, CEREB CORTEX; Huang MX, 2007, NEUROIMAGE, V37, P731, DOI 10.1016/j.neuroimage.2007.06.002; Huang MX, 2017, J NEUROTRAUM, V34, P1412, DOI 10.1089/neu.2016.4581; Huang MX, 2014, NEUROIMAGE-CLIN, V5, P408, DOI 10.1016/j.nicl.2014.08.004; Huang MX, 2014, NEUROIMAGE-CLIN, V5, P109, DOI 10.1016/j.nicl.2014.06.004; Huang MX, 2014, NEUROIMAGE, V84, P585, DOI 10.1016/j.neuroimage.2013.09.022; Huang MX, 2012, NEUROIMAGE, V61, P1067, DOI 10.1016/j.neuroimage.2012.04.029; Hughes KC, 2011, EXPERT REV NEUROTHER, V11, P275, DOI [10.1586/ern.10.198, 10.1586/ERN.10.198]; Humphreys GF, 2015, CEREB CORTEX, V25, P3547, DOI 10.1093/cercor/bhu198; Hyafil A, 2009, J NEUROSCI, V29, P5135, DOI 10.1523/JNEUROSCI.2828-08.2009; Hyvarinen A, 1999, IEEE T NEURAL NETWOR, V10, P626, DOI 10.1109/72.761722; Hyvarinen A, 2000, NEURAL NETWORKS, V13, P411, DOI 10.1016/S0893-6080(00)00026-5; Johnston KM, 2001, CLIN J SPORT MED, V11, P166, DOI 10.1097/00042752-200107000-00007; JONES RSG, 1993, NEUROSCI LETT, V149, P35, DOI 10.1016/0304-3940(93)90341-H; Jovicich J, 2006, NEUROIMAGE, V30, P436, DOI 10.1016/j.neuroimage.2005.09.046; Kalemaki K, 2018, FRONT NEURAL CIRCUIT, V12, DOI 10.3389/fncir.2018.00096; Kerns JG, 2004, SCIENCE, V303, P1023, DOI 10.1126/science.1089910; Kim C, 2011, J NEUROSCI, V31, P4771, DOI 10.1523/JNEUROSCI.5923-10.2011; King Andrew J, 2018, F1000Res, V7, DOI 10.12688/f1000research.15580.1; Kirkwood MW, 2006, PEDIATRICS, V117, P1359, DOI 10.1542/peds.2005-0994; Koechlin E, 2011, TRENDS COGN SCI, V15, P241, DOI 10.1016/j.tics.2011.04.005; Korotkova T, 2010, NEURON, V68, P557, DOI 10.1016/j.neuron.2010.09.017; Kwon JS, 1999, ARCH GEN PSYCHIAT, V56, P1001, DOI 10.1001/archpsyc.56.11.1001; Leahy RM, 1998, ELECTROEN CLIN NEURO, V107, P159, DOI 10.1016/S0013-4694(98)00057-1; MacGregor AJ, 2011, J HEAD TRAUMA REHAB, V26, P312, DOI 10.1097/HTR.0b013e3181e94404; Management of Concussion/mTBI Working Group, 2009, J Rehabil Res Dev, V46, pCP1; McInnes K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174847; MCLEAN A, 1984, NEUROSURGERY, V14, P393, DOI 10.1227/00006123-198404000-00001; Morein-Zamir S, 2015, BRAIN RES, V1628, P117, DOI 10.1016/j.brainres.2014.09.012; Morillon B, 2015, ANN NY ACAD SCI, V1337, P26, DOI 10.1111/nyas.12629; Morissette SB, 2011, REHABIL PSYCHOL, V56, P340, DOI 10.1037/a0025462; Mosher JC, 1999, IEEE T BIO-MED ENG, V46, P245, DOI 10.1109/10.748978; Nathan DE, 2015, BRAIN CONNECT, V5, P102, DOI 10.1089/brain.2014.0273; Nourski KV, 2017, LARYNGOSCOPE INVEST, V2, P147, DOI 10.1002/lio2.73; Oken BS, 2006, CLIN NEUROPHYSIOL, V117, P1885, DOI 10.1016/j.clinph.2006.01.017; Owen AM, 2005, HUM BRAIN MAPP, V25, P46, DOI 10.1002/hbm.20131; Popov T, 2011, NEUROIMAGE, V56, P307, DOI 10.1016/j.neuroimage.2011.02.016; Raible DJ, 2015, EXP NEUROL, V271, P445, DOI 10.1016/j.expneurol.2015.07.001; Rao SM, 2001, NAT NEUROSCI, V4, P317, DOI 10.1038/85191; Rauch SL, 2006, BIOL PSYCHIAT, V60, P376, DOI 10.1016/j.biopsych.2006.06.004; Rauch SL., 1998, CNS SPECTRUMS, V3, P30, DOI [10. 1017/S1092852900007306, DOI 10.1017/S1092852900007306, 10.1017/S1092852900007306]; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Slewa-Younan S, 2002, CLIN NEUROPHYSIOL, V113, P1640, DOI 10.1016/S1388-2457(02)00239-0; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Sohal VS, 2009, NATURE, V459, P698, DOI 10.1038/nature07991; Song T, 2008, MED BIOL ENG COMPUT, V46, P923, DOI 10.1007/s11517-007-0290-y; Spooner RK, 2018, NEUROIMAGE-CLIN, V20, P85, DOI 10.1016/j.nicl.2018.07.009; Swan AR, 2015, J NEUROTRAUM, V32, P1510, DOI 10.1089/neu.2014.3654; Taulu S, 2004, BRAIN TOPOGR, V16, P269, DOI 10.1023/b:brat.0000032864.93890.f9; Taulu S, 2004, Neurol Clin Neurophysiol, V2004, P35; TEASDALE G, 1974, LANCET, V2, P81; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Traub RD, 1996, NATURE, V383, P621, DOI 10.1038/383621a0; Ullsperger M, 2004, CORTEX, V40, P593, DOI 10.1016/S0010-9452(08)70155-2; Vascak M, 2018, CEREB CORTEX, V28, P1625, DOI 10.1093/cercor/bhx058; Wechsler D., 2008, WAIS 4 WECHSLER ADUL; Wechsler D, 1997, WAIS 3 WECHSLER ADUL; Whitney C, 2012, J COGNITIVE NEUROSCI, V24, P133, DOI 10.1162/jocn_a_00123; Woolrich MW, 2009, NEUROIMAGE, V45, pS173, DOI 10.1016/j.neuroimage.2008.10.055; Young L, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00089; Young LA, 2015, SEMIN NEUROL, V35, P5, DOI 10.1055/s-0035-1544242; Zevin J., 2009, ENCY NEUROSCIENCE, P517, DOI [10.1016/B978-008045046-9.01881-7, DOI 10.1016/B978-008045046-9.01881-7]	100	7	7	0	6	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	1047-3211	1460-2199		CEREB CORTEX	Cereb. Cortex	JAN	2020	30	1					283	295		10.1093/cercor/bhz087			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	KN8NH	WOS:000515101400021	31041986	Bronze			2022-02-06	
J	Mao, WF; Yi, X; Qin, JB; Tian, ML; Jin, GH				Mao, Weifeng; Yi, Xin; Qin, Jianbing; Tian, Meiling; Jin, Guohua			CXCL12 promotes proliferation of radial glia like cells after traumatic brain injury in rats	CYTOKINE			English	Article						CXCL12; Radial glia cells; CXCR4; Traumatic brain injury	NEURAL STEM-CELLS; PROGENITOR; DIFFERENTIATION; MIGRATION; NEURONS; CORTEX; NEUROGENESIS; EXPRESSION; INCREASES; SYSTEM	To investigate the effect of CXCL12 on regeneration of radial glia like cells after traumatic brain injury (TBI). We randomly divided 48 rats into 4 groups: (1) the sham group, rats were performed craniotomy only, (2) the control group, saline were injected into the ipsilateral cortex after TBI, (3) the CXCL12 group, CXCL12 were injected, and (4) the CXCL12 + AMD3100 group, a mixture of CXCL12 and AMD3100 were injected. Seven days after TBI, the brain tissues were subjected to immunofluorescence double-labeled staining of BrdU/Nestin, BLBP/Nestin, BLBP/Vimentin, BLBP/SOX2, BLBP/CXCR4, BLBP/DCX. Western Blot assay was used to measure the levels of Nestin, BLBP, and Vimentin. Compared with the control group, CXCL12 treatment significantly increased the number of cells stained with BrdU/Nestin, BLBP/Nestin, and BLBP/Vimentin around the injured cortex and corpus callosum areas. CXCL12 + AMD3100 treatment significantly decreased the number of these cells compared with the CXCL12 treatment and control group. The protein levels of Nestin, BLBP, and Vimentin had the same change trends as those of the immunofluorescence staining. The BLBP/Vimentin positive cells presented with the astrocyte pattern around the injured cortex area but with the RGCs pattern around the injured corpus callosum area. The BLBP positive cells also expressed CXCR4 and SOX2. Altogether, CXCL12 promotes the proliferation of neural precursor cells after TBI by combing to its receptor, CXCR4. The proliferating neural precursor cells presents radial glial cell like cells. The RGCs-like cells can differentiate into immature neurons and promote the migration of immature neurons.	[Mao, Weifeng; Yi, Xin; Qin, Jianbing; Tian, Meiling; Jin, Guohua] Nantong Univ, Med Sch, Dept Anat, Nantong 226001, Jiangsu, Peoples R China		Jin, GH (corresponding author), Nantong Univ, 19 Qixiu Rd, Nantong 226001, Jiangsu, Peoples R China.	jguohua@163.com					Aertker BM, 2016, EXP NEUROL, V275, P411, DOI 10.1016/j.expneurol.2015.01.008; Ahmed AI, 2016, J ROY ARMY MED CORPS, V162, P98, DOI 10.1136/jramc-2015-000475; Bond AM, 2015, CELL STEM CELL, V17, P385, DOI 10.1016/j.stem.2015.09.003; Borrell V, 2014, CURR OPIN NEUROBIOL, V27, P39, DOI 10.1016/j.conb.2014.02.007; Buffo A, 2008, P NATL ACAD SCI USA, V105, P3581, DOI 10.1073/pnas.0709002105; Burda JE, 2016, EXP NEUROL, V275, P305, DOI 10.1016/j.expneurol.2015.03.020; Deierborg T, 2010, NEUROSCIENCE, V171, P1386, DOI 10.1016/j.neuroscience.2010.09.045; Dekmak A, 2018, BEHAV BRAIN RES, V340, P49, DOI 10.1016/j.bbr.2016.12.039; Dixon KJ, 2015, J NEUROTRAUM, V32, P753, DOI 10.1089/neu.2014.3390; Encinas JM, 2011, CELL STEM CELL, V8, P566, DOI 10.1016/j.stem.2011.03.010; Farkas LM, 2008, CURR OPIN CELL BIOL, V20, P707, DOI 10.1016/j.ceb.2008.09.008; FENG L, 1994, NEURON, V12, P895, DOI 10.1016/0896-6273(94)90341-7; FENG L, 1995, DEVELOPMENT, V121, P1719; Filippo TRM, 2013, STEM CELL RES, V11, P913, DOI 10.1016/j.scr.2013.06.003; Gong XM, 2006, CELL BIOL INT, V30, P466, DOI 10.1016/j.cellbi.2006.01.007; Grade S, 2017, NPJ REGEN MED, V2, DOI 10.1038/s41536-017-0033-0; Ibrahim S, 2016, SCI REP-UK, V6, DOI 10.1038/srep21793; Itoh T, 2009, NEUROL RES, V31, P90, DOI 10.1179/174313208X332995; Merino JJ, 2015, J CELL PHYSIOL, V230, P27, DOI 10.1002/jcp.24695; Kaneko N, 2011, GENES-BASEL, V2, P107, DOI 10.3390/genes2010107; Li HM, 2011, HISTOCHEM CELL BIOL, V136, P515, DOI 10.1007/s00418-011-0864-5; Li HM, 2011, NEUROSCI LETT, V490, P209, DOI 10.1016/j.neulet.2010.12.054; Li MZ, 2008, PROG NEUROBIOL, V84, P116, DOI 10.1016/j.pneurobio.2007.11.003; Liu Y, 2014, MOL MED REP, V9, P333, DOI 10.3892/mmr.2013.1803; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; McAllister Thomas W, 2011, Dialogues Clin Neurosci, V13, P287; Nacher J, 2001, EUR J NEUROSCI, V14, P629, DOI 10.1046/j.0953-816x.2001.01683.x; Osman AM, 2011, STROKE, V42, P3559, DOI 10.1161/STROKEAHA.111.627802; Picard-Riera N, 2004, J NEUROSCI RES, V76, P223, DOI 10.1002/jnr.20040; Sailor KA, 2017, CURR OPIN NEUROBIOL, V42, P111, DOI 10.1016/j.conb.2016.12.001; Sanai N, 2011, NATURE, V478, P382, DOI 10.1038/nature10487; Sharifi K, 2011, HISTOCHEM CELL BIOL, V136, P501, DOI 10.1007/s00418-011-0865-4; Sild M, 2011, NEUROSCIENTIST, V17, P288, DOI 10.1177/1073858410385870; Sun D, 2016, EXP NEUROL, V275, P405, DOI 10.1016/j.expneurol.2015.04.017; Tajiri N, 2014, FRONT SYST NEUROSCI, V8, DOI 10.3389/fnsys.2014.00116; Takase H, 2018, BEHAV BRAIN RES, V340, P205, DOI 10.1016/j.bbr.2016.10.042; Willaime-Morawek S, 2008, EUR J NEUROSCI, V27, P2354, DOI 10.1111/j.1460-9568.2008.06206.x; Wu YM, 2009, J NEUROCHEM, V109, P1157, DOI 10.1111/j.1471-4159.2009.06043.x; Yi X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070306; Zhu C, 2017, BRAIN RES, V1657, P223, DOI 10.1016/j.brainres.2016.06.011; Zibara K, 2019, NEUROPHARMACOLOGY, V145, P177, DOI 10.1016/j.neuropharm.2018.09.032	41	7	7	0	6	ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD	LONDON	24-28 OVAL RD, LONDON NW1 7DX, ENGLAND	1043-4666	1096-0023		CYTOKINE	Cytokine	JAN	2020	125								154771	10.1016/j.cyto.2019.154771			9	Biochemistry & Molecular Biology; Cell Biology; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Immunology	JU0TJ	WOS:000501391800005	31400639				2022-02-06	
J	Nelson, NW; Disner, SG; Anderson, CR; Doane, BM; McGuire, K; Lamberty, GJ; Hoelzle, J; Sponheim, SR				Nelson, Nathaniel W.; Disner, Seth G.; Anderson, Carolyn R.; Doane, Bridget M.; McGuire, Kathryn; Lamberty, Gregory J.; Hoelzle, James; Sponheim, Scott R.			Blast Concussion and Posttraumatic Stress as Predictors of Postcombat Neuropsychological Functioning in OEF/OIF/OND Veterans	NEUROPSYCHOLOGY			English	Article						blast concussion; Operation Iraqi Freedom; Operation Enduring Freedom; neuropsychological outcomes; posttraumatic stress disorder	TRAUMATIC BRAIN-INJURY; TEST-PERFORMANCE; POSTCONCUSSIVE SYMPTOMS; MILITARY PERSONNEL; DISORDER; EXPOSURE; OUTCOMES; HISTORY; MEMORY; PTSD	Objectives: Many combat veterans exhibit cognitive limitations of uncertain origin. In this study, we examined factors that predict cognitive functioning by considering effects of blast-related concussion (BRC), non-blast-related concussion (NBRC), and posttraumatic stress disorder (PTSD) symptoms. Analyses specifically tested whether (a) BRC and NBRC were distinct in their prediction of cognitive performance; (b) a dose-response relationship existed between recurrent concussion (BRC and NBRC) and cognitive impairment; and (c) PTSD symptoms mediated the relationship between BRC and cognitive performance. Method: Two hundred eighty veterans with combat zone deployment histories completed semistructured clinical interviews to define BRC and NBRC histories, current and past mental health disorders, and dimensional ratings of PTSD symptomatology. Participants were also administered a number of neuropsychological measures to appraise cognitive functioning. Results: A structural equation model (SEM) suggested that BRC and NBRC were not distinct in their prediction of cognitive performance, and there was no evidence that recurrent concussion (blast or nonblast) was directly associated with cognitive performance. BRC was significantly associated with PTSD symptoms (r = .24), PTSD symptoms were significantly associated with cognitive performance in the SEM (r = -.27), and PTSD symptoms significantly mediated the link between BRC and cognitive performance (p = .03). Conclusions: These results suggest that concussion history fails to directly contribute to cognitive performance, regardless of mechanism (blast or nonblast) and recurrence. BRC is nonetheless unique in its contribution to PTSD and PTSD-related cognitive deficits. Results support interventions specific to PTSD management in the interest of promoting neuropsychological functioning among war veterans.	[Nelson, Nathaniel W.] Univ St Thomas, Grad Sch Profess Psychol, 2115 Summit Ave, St Paul, MN 55105 USA; [Disner, Seth G.; Anderson, Carolyn R.; Doane, Bridget M.; McGuire, Kathryn; Sponheim, Scott R.] Minneapolis VA Med Ctr, Minneapolis, MN USA; [Lamberty, Gregory J.] Minneapolis VA Med Ctr, Mental Hlth Serv Line, Minneapolis, MN USA; [Lamberty, Gregory J.; Sponheim, Scott R.] Univ Minnesota, Dept Psychiat, Minneapolis, MN 55455 USA; [Hoelzle, James] Marquette Univ, Dept Psychol, Milwaukee, WI 53233 USA		Nelson, NW (corresponding author), Univ St Thomas, Grad Sch Profess Psychol, 2115 Summit Ave, St Paul, MN 55105 USA.	nels0600@stthomas.edu			Congressionally Directed Medical Research Programs (CDMRP)United States Department of Defense [W81XWH-08-2-0038]; VA Rehabilitation Research and Development Service (RRD) [1IK1RX002325, 1IK2RX002922, I01RX000622]; Minnesota Veterans Research Institute (MVRI)	This study was supported by grants funded in part by the Congressionally Directed Medical Research Programs (CDMRP, W81XWH-08-2-0038) to Scott R. Sponheim; by the VA Rehabilitation Research and Development Service (RR&D) to Seth Disner (1IK1RX002325; 1IK2RX002922) and Scott Sponheim (I01RX000622); and by the Minnesota Veterans Research Institute (MVRI) to Nathaniel W. Nelson. We thank Daniel Goldman, Craig Marquardt, and Mark Kramer for their contributions to the current DSM-IV consensus process.	Alosco ML, 2016, J HEAD TRAUMA REHAB, V31, P360, DOI 10.1097/HTR.0000000000000201; Ashendorf L, 2017, CLIN NEUROPSYCHOL, V31, P857, DOI 10.1080/13854046.2017.1285961; Babikian T, 2006, CLIN NEUROPSYCHOL, V20, P145, DOI 10.1080/13854040590947362; Belanger HG, 2010, J INT NEUROPSYCH SOC, V16, P262, DOI 10.1017/S1355617709991287; Belanger HG, 2009, J INT NEUROPSYCH SOC, V15, P1, DOI 10.1017/S1355617708090036; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P345, DOI 10.1017/S1355617705050411; BLAKE DD, 1995, J TRAUMA STRESS, V8, P75, DOI 10.1007/BF02105408; Byrne B.M., 2011, STRUCTURAL EQUATION, P432, DOI [DOI 10.4324/9780203807644, 10.4324/9780203807644]; Cernak I, 2001, BRAIN INJURY, V15, P593, DOI 10.1080/02699050010009559; Clark AL, 2014, CLIN NEUROPSYCHOL, V28, P802, DOI 10.1080/13854046.2014.904928; Combs HL, 2015, J NEUROTRAUM, V32, P956, DOI 10.1089/neu.2014.3585; Delis D.C., 2000, CALIFORNIA VERBAL LE; DePalma RG, 2005, NEW ENGL J MED, V352, P1335, DOI 10.1056/NEJMra042083; Disner SG, 2017, CLIN PSYCHOL SCI, V5, P650, DOI 10.1177/2167702617703436; Donnelly K, 2018, CLIN NEUROPSYCHOL, V32, P436, DOI 10.1080/13854046.2017.1390163; First M. B., 2007, 12007 SCIDINP BIOM R; Frencham KAR, 2005, J CLIN EXP NEUROPSYC, V27, P334, DOI 10.1080/13803390490520328; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Hayes AF, 2009, COMMUN MONOGR, V76, P408, DOI 10.1080/03637750903310360; Heaton R. K., 2004, REVISED COMPREHENSIV; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Howe LLS, 2009, CLIN NEUROPSYCHOL, V23, P1315, DOI 10.1080/13854040903266928; Iverson GL, 2005, CURR OPIN PSYCHIATR, V18, P301, DOI 10.1097/01.yco.0000165601.29047.ae; Iverson GL, 2002, CLIN NEUROPSYCHOL, V16, P398, DOI 10.1076/clin.16.3.398.13861; Jak AJ, 2015, J CLIN EXP NEUROPSYC, V37, P379, DOI 10.1080/13803395.2015.1020769; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P74, DOI [DOI 10.1097/00001199-199309000-00009, 10.1097/00001199-199309000-00009]; Kontos AP, 2013, J NEUROTRAUM, V30, P680, DOI 10.1089/neu.2012.2506; Lange RT, 2012, J INT NEUROPSYCH SOC, V18, P595, DOI 10.1017/S1355617712000239; Lippa SM, 2010, J INT NEUROPSYCH SOC, V16, P856, DOI 10.1017/S1355617710000743; Luethcke CA, 2011, J INT NEUROPSYCH SOC, V17, P36, DOI 10.1017/S1355617710001207; Mac Donald CL, 2017, JAMA NEUROL, V74, P821, DOI 10.1001/jamaneurol.2017.0143; MacGregor AJ, 2011, J HEAD TRAUMA REHAB, V26, P312, DOI 10.1097/HTR.0b013e3181e94404; Mattson EK, 2019, NEUROPSYCHOLOGY, V33, P913, DOI 10.1037/neu0000560; Mayorga MA, 1997, TOXICOLOGY, V121, P17, DOI 10.1016/S0300-483X(97)03652-4; McCormick CL, 2013, ARCH CLIN NEUROPSYCH, V28, P808, DOI 10.1093/arclin/act050; McCrea M, 2013, J INT NEUROPSYCH SOC, V19, P22, DOI 10.1017/S1355617712000872; McKee AC, 2014, ALZHEIMERS DEMENT, V10, pS242, DOI 10.1016/j.jalz.2014.04.003; Merz ZC, 2017, ARCH CLIN NEUROPSYCH, V32, P155, DOI 10.1093/arclin/acw092; Moore BA, 2004, BRAIN INJURY, V18, P975, DOI 10.1080/02699050410001672350; Nelson N.W., 2015, BRAIN NEUROTRAUMA MO, P451; Nelson NW, 2015, BRIT J PSYCHIAT, V206, P237, DOI 10.1192/bjp.bp.114.149096; Nelson NW, 2012, J INT NEUROPSYCH SOC, V18, P845, DOI 10.1017/S1355617712000616; Nelson NW, 2011, BRAIN INJURY, V25, P511, DOI 10.3109/02699052.2011.558040; Nelson NW, 2010, ARCH CLIN NEUROPSYCH, V25, P713, DOI 10.1093/arclin/acq075; Newsome MR, 2016, J INT NEUROPSYCH SOC, V22, P631, DOI 10.1017/S1355617716000448; Nordstrom A, 2018, PLOS MED, V15, DOI 10.1371/journal.pmed.1002496; Pagulayan KF, 2018, J INT NEUROPSYCH SOC, V24, P324, DOI 10.1017/S1355617717001217; Panayiotou A, 2010, J CLIN EXP NEUROPSYC, V32, P463, DOI 10.1080/13803390903164371; Polusny MA, 2011, ARCH GEN PSYCHIAT, V68, P79, DOI 10.1001/archgenpsychiatry.2010.172; Rau HK, 2018, CLIN NEUROPSYCHOL, V32, P1319, DOI 10.1080/13854046.2017.1381277; Reid MW, 2018, J NEUROTRAUM, V35, P1146, DOI 10.1089/neu.2017.5424; Ruff RM, 1999, STUD NEUROPSYCHOL DE, P315; Russo AC, 2017, ARCH CLIN NEUROPSYCH, V32, P184, DOI 10.1093/arclin/acw093; Scheibel RS, 2012, J INT NEUROPSYCH SOC, V18, P89, DOI 10.1017/S1355617711001433; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Schretlen DJ, 2003, INT REV PSYCHIATR, V15, P341, DOI 10.1080/09540260310001606728; Scott JC, 2015, PSYCHOL BULL, V141, P105, DOI 10.1037/a0038039; Slick DJ, 1996, J CLIN EXP NEUROPSYC, V18, P911, DOI 10.1080/01688639608408313; Stewart-Willis JJ, 2018, ARCH CLIN NEUROPSYCH, V33, P206, DOI 10.1093/arclin/acx053; Storzbach D, 2015, J INT NEUROPSYCH SOC, V21, P353, DOI 10.1017/S1355617715000326; Sullivan DR, 2018, J INT NEUROPSYCH SOC, V24, P662, DOI 10.1017/S1355617718000279; Taber KH, 2006, J NEUROPSYCH CLIN N, V18, P141, DOI 10.1176/appi.neuropsych.18.2.141; The Psychological Corporation, 2001, WECHSLER TEST ADULT; Troyanskaya M, 2015, MIL MED, V180, P285, DOI 10.7205/MILMED-D-14-00256; Van Dyke SA, 2010, MIL MED, V175, P947, DOI 10.7205/MILMED-D-10-00337; Verfaellie M, 2016, J HEAD TRAUMA REHAB, V31, P309, DOI 10.1097/HTR.0000000000000197; Verfaellie M, 2014, NEUROPSYCHOLOGY, V28, P337, DOI 10.1037/neu0000027; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird; Whiteneck G. G., 2015, VA TRAUMATIC BRAIN I; Wolfson, 1993, HALSTEAD REITAN NEUR; Xydakis MS, 2007, NEW ENGL J MED, V357, P830, DOI 10.1056/NEJMc076071	71	7	7	0	10	AMER PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA	0894-4105	1931-1559		NEUROPSYCHOLOGY	Neuropsychology	JAN	2020	34	1					116	126		10.1037/neu0000594			11	Psychology, Clinical; Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	JZ5TF	WOS:000505164800012	31545626	Green Accepted			2022-02-06	
S	Patterson, TT; Grandhi, R		Chen, P		Patterson, T. Tyler; Grandhi, Ramesh			Gut Microbiota and Neurologic Diseases and Injuries	GUT MICROBIOTA AND PATHOGENESIS OF ORGAN INJURY	Advances in Experimental Medicine and Biology		English	Article; Book Chapter						Gut microbiota; Autism; Parkinson's disease; Alzheimer's disease; Multiple sclerosis; Anxiety; Depression; Traumatic brain injury; Stroke	TRAUMATIC BRAIN-INJURY; AUTISM SPECTRUM DISORDERS; PARKINSONS-DISEASE; ENVIRONMENTAL-FACTORS; PSYCHOLOGICAL STRESS; ADHESION MOLECULE-1; KAPPA-B; AXIS; DEPRESSION; CHILDREN	The brain-gut axis is a bidirectional communication pathway connecting the central nervous system (CNS) and the gastrointestinal tract via nerve transmission, hormone, immune system, and other molecular signals. The bacterial flora of the human gut contributes direct and indirect signals to the CNS along the brain-gut axis. Alterations in gut flora, a state known as dysbiosis, has been tied to systemic inflammation, increased bacterial translocation, and increased absorbance of microbial by-products. An increase in recent literature has highlighted the role of the gut-brain axis in CNS pathology. This chapter reviews the association between gut flora dysbiosis and disorders of the central nervous system including autoimmune disease, developmental disorders, physiologic response to traumatic injury, and neurodegenerative disease.	[Patterson, T. Tyler] Univ Texas Hlth Sci Ctr San Antonio, Sch Med, Dept Neurosurg, San Antonio, TX 78229 USA; [Grandhi, Ramesh] Univ Utah, Sch Med, Dept Neurosurg, Salt Lake City, UT 84112 USA		Grandhi, R (corresponding author), Univ Utah, Sch Med, Dept Neurosurg, Salt Lake City, UT 84112 USA.	ramesh.grandhi@hsc.utah.edu					Abbott RD, 2007, MOVEMENT DISORD, V22, P1581, DOI 10.1002/mds.21560; Adams GC, 2016, J AFFECT DISORDERS, V206, P48, DOI 10.1016/j.jad.2016.07.031; Adler CH, 2016, MOVEMENT DISORD, V31, P1114, DOI 10.1002/mds.26605; Ait-Belgnaoui A, 2012, PSYCHONEUROENDOCRINO, V37, P1885, DOI 10.1016/j.psyneuen.2012.03.024; Ascherio A, 2008, SEMIN NEUROL, V28, P17, DOI 10.1055/s-2007-1019126; Baxter AJ, 2015, PSYCHOL MED, V45, P601, DOI 10.1017/S003329171400172X; Benakis C, 2016, NAT MED, V22, P516, DOI 10.1038/nm.4068; Berer K, 2011, NATURE, V479, P538, DOI 10.1038/nature10554; BOARD F, 1956, PSYCHOSOM MED, V18, P324, DOI 10.1097/00006842-195607000-00006; Braak H, 2003, NEUROBIOL AGING, V24, P197, DOI 10.1016/S0197-4580(02)00065-9; Bravo JA, 2011, P NATL ACAD SCI USA, V108, P16050, DOI 10.1073/pnas.1102999108; Chen G, 2008, ANN CLIN LAB SCI, V38, P65; Constantinescu CS, 2011, BRIT J PHARMACOL, V164, P1079, DOI 10.1111/j.1476-5381.2011.01302.x; Cummings JL, 1998, NEUROLOGY, V51, pS2, DOI 10.1212/WNL.51.1_Suppl_1.S2; Dauer W, 2003, NEURON, V39, P889, DOI 10.1016/S0896-6273(03)00568-3; de Magistris L, 2010, J PEDIATR GASTR NUTR, V51, P418, DOI 10.1097/MPG.0b013e3181dcc4a5; Dendrou CA, 2015, NAT REV IMMUNOL, V15, P545, DOI 10.1038/nri3871; Desbonnet L, 2010, NEUROSCIENCE, V170, P1179, DOI 10.1016/j.neuroscience.2010.08.005; Devos D, 2013, NEUROBIOL DIS, V50, P42, DOI 10.1016/j.nbd.2012.09.007; Emanuele E, 2010, NEUROSCI LETT, V471, P162, DOI 10.1016/j.neulet.2010.01.033; Faul M, 2010, TRAUMATIC BRAIN INJU; Fiorentino M, 2016, MOL AUTISM, V7, DOI 10.1186/s13229-016-0110-z; Flowers SA, 2015, PHARMACOTHERAPY, V35, P910, DOI 10.1002/phar.1640; Forsyth CB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028032; Ghaisas S, 2016, PHARMACOL THERAPEUT, V158, P52, DOI 10.1016/j.pharmthera.2015.11.012; Grabrucker Andreas M, 2012, Front Psychiatry, V3, P118, DOI 10.3389/fpsyt.2012.00118; Grenham S, 2011, FRONT PHYSIOL, V2, DOI 10.3389/fphys.2011.00094; Hallmayer J, 2011, ARCH GEN PSYCHIAT, V68, P1095, DOI 10.1001/archgenpsychiatry.2011.76; Hang CH, 2005, WORLD J GASTROENTERO, V11, P1149, DOI 10.3748/wjg.v11.i8.1149; Heijtza RD, 2011, P NATL ACAD SCI USA, V108, P3047, DOI 10.1073/pnas.1010529108; Hill-Burns EM, 2017, MOVEMENT DISORD, V32, P739, DOI 10.1002/mds.26942; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Jangi S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12015; Jhangi S, 2014, NEUROLOGY, V82; Kharrazian D, 2015, ALTERN THER HEALTH M, V21, P28; Kigerl KA, 2016, J EXP MED, V213, P2603, DOI 10.1084/jem.20151345; Klingelhoefer L, 2015, NAT REV NEUROL, V11, P625, DOI 10.1038/nrneurol.2015.197; Kremlev SG, 2005, J NEUROIMMUNOL, V162, P71, DOI 10.1016/j.jneuroim.2005.01.010; Lebouvier T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012728; Lee YK, 2011, P NATL ACAD SCI USA, V108, P4615, DOI 10.1073/pnas.1000082107; Li QR, 2017, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00120; MacFabe Derrick F., 2012, Microbial Ecology in Health and Disease, V23, P19260, DOI 10.3402/mehd.v23i0.19260; MacFabe DF, 2011, BEHAV BRAIN RES, V217, P47, DOI 10.1016/j.bbr.2010.10.005; Mayey EA, 2001, J CLIN PSYCHIAT, V62, P28; McDermott AJ, 2014, IMMUNOLOGY, V142, P24, DOI 10.1111/imm.12231; Mielcarz DW, 2015, CURR TREAT OPTION NE, V17, DOI 10.1007/s11940-015-0344-7; Minter MR, 2016, SCI REP-UK, V6, DOI 10.1038/srep30028; Miyake S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137429; Moreira PI, 2010, BBA-MOL BASIS DIS, V1802, P2, DOI 10.1016/j.bbadis.2009.10.006; Mulle JG, 2013, CURR PSYCHIAT REP, V15, DOI 10.1007/s11920-012-0337-0; Neufeld Karen-Anne M, 2011, Commun Integr Biol, V4, P492, DOI 10.4161/cib.4.4.15702; Nishio J, 2012, CELL MOL LIFE SCI, V69, P3635, DOI 10.1007/s00018-012-0993-6; Ochoa-Reparaz J, 2009, J IMMUNOL, V183, P6041, DOI 10.4049/jimmunol.0900747; Onore CE, 2012, BIOL PSYCHIAT, V72, P1020, DOI 10.1016/j.biopsych.2012.05.004; Ovbiagele B, 2011, NEUROTHERAPEUTICS, V8, P319, DOI 10.1007/s13311-011-0053-1; Park AJ, 2013, NEUROGASTROENT MOTIL, V25, P733, DOI 10.1111/nmo.12153; Parracho HMRT, 2005, J MED MICROBIOL, V54, P987, DOI 10.1099/jmm.0.46101-0; Ressler KJ, 2000, DEPRESS ANXIETY, V12, P2, DOI 10.1002/1520-6394(2000)12:1+<2::AID-DA2>3.0.CO;2-4; Rhee SH, 2009, NAT REV GASTRO HEPAT, V6, P306, DOI 10.1038/nrgastro.2009.35; Round JL, 2009, NAT REV IMMUNOL, V9, P313, DOI 10.1038/nri2515; Sampson TR, 2016, CELL, V167, P1469, DOI 10.1016/j.cell.2016.11.018; Scheperjans F, 2015, MOVEMENT DISORD, V30, P350, DOI 10.1002/mds.26069; Sharon G, 2016, CELL, V167, P915, DOI 10.1016/j.cell.2016.10.027; Singh V, 2016, J NEUROSCI, V36, P7428, DOI 10.1523/JNEUROSCI.1114-16.2016; Smith Sean M, 2006, Dialogues Clin Neurosci, V8, P383; Song YL, 2004, APPL ENVIRON MICROB, V70, P6459, DOI 10.1128/AEM.70.11.6459-6465.2004; Sudo N, 2004, J PHYSIOL-LONDON, V558, P263, DOI 10.1113/jphysiol.2004.063388; Sun GD, 2018, J EXP MED, V215, P521, DOI 10.1084/jem.20170686; Sundman MH, 2017, BRAIN BEHAV IMMUN, V66, P31, DOI 10.1016/j.bbi.2017.05.009; Toklu HZ, 2017, METHODS MOL BIOL, V1598, P313, DOI 10.1007/978-1-4939-6952-4_16; Unger MM, 2016, PARKINSONISM RELAT D, V32, P66, DOI 10.1016/j.parkreldis.2016.08.019; Vogt NM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13601-y; Vuong HE, 2017, BIOL PSYCHIAT, V81, P411, DOI 10.1016/j.biopsych.2016.08.024; Wang LW, 2011, J DEV BEHAV PEDIATR, V32, P351, DOI 10.1097/DBP.0b013e31821bd06a; Wang L, 2012, DIGEST DIS SCI, V57, P2096, DOI 10.1007/s10620-012-2167-7; Wang Y, 2014, BRAIN BEHAV IMMUN, V38, P1, DOI 10.1016/j.bbi.2013.12.015; Wen L, 2018, J NEUROTRAUM, V35, P2330, DOI 10.1089/neu.2017.5540	77	7	7	7	21	SPRINGER-VERLAG SINGAPORE PTE LTD	SINGAPORE	152 BEACH ROAD, #21-01/04 GATEWAY EAST, SINGAPORE, 189721, SINGAPORE	0065-2598	2214-8019	978-981-15-2385-4; 978-981-15-2384-7	ADV EXP MED BIOL	Adv.Exp.Med.Biol.		2020	1238						73	91		10.1007/978-981-15-2385-4_6	10.1007/978-981-15-2385-4		19	Gastroenterology & Hepatology; Medicine, Research & Experimental; Microbiology	Book Citation Index – Science (BKCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Gastroenterology & Hepatology; Research & Experimental Medicine; Microbiology	BP1EQ	WOS:000539027400006	32323181				2022-02-06	
J	Pietzka, S; Kaemmerer, PW; Pietzka, S; Schramm, A; Lampl, L; Lefering, R; Bieler, D; Kulla, M				Pietzka, Sebastian; Kaemmerer, Peer W.; Pietzka, Silke; Schramm, Alexander; Lampl, Lorenz; Lefering, Rolf; Bieler, Dan; Kulla, Martin			Maxillofacial injuries in severely injured patients after road traffic accidents-a retrospective evaluation of the TraumaRegister DGU (R) 1993-2014	CLINICAL ORAL INVESTIGATIONS			English	Article						Maxillofacial injury; Trauma; Epidemiology; Road traffic accident	TRAUMA; FRACTURES; EPIDEMIOLOGY; MANAGEMENT; IMPLEMENTATION; POLYTRAUMA; SEVERITY; PATTERNS; SOCIETY; GERMANY	Objectives It was the aim of the study to analyse the prevalence of maxillofacial trauma (MFT) in severely injured patients after road traffic accidence (RTA) and to investigate associated factors. Materials and methods In a retrospective study, data from patients after RTA by the TraumaRegister DGU (R) from 1993 to 2014 were evaluated for demographical and injury characteristics. The predictor variable was mechanism of injury and the outcome variables were type of injury, severity and hospital resources utilization. Results During the investigation period, n = 62,196 patients were enclosed with a prevalence of maxillofacial injuries of 20.3% (MFT positive). The injury severity score of MFT-positive patients was higher than in the MTF-negative subgroup (27 +/- 12.8 vs. 23.0 +/- 12.7). If MFT positive, 39.8% show minor, 37.1% moderate, 21.5% serious and 1.6% severe maxillofacial injuries. Injuries of the midface occurred in 60.3% of MTF-positive patients. A relevant blood loss (> 20% of total blood volume) occurred in 1.9%. MFT-positive patients had a higher coincidence with cervical spine fractures (11.3% vs. 7.8%) and traumatic brain injuries (62.6% vs. 34.8%) than MFT-negative patients. There was a noticeable decrease in the incidence of facial injuries in car/truck drivers during the study period. Conclusions Every 5th patient after RTA shows a MFT and the whole trauma team must be aware that this indicates a high prevalence of traumatic brain and cervical spine injuries.	[Pietzka, Sebastian; Schramm, Alexander] German Armed Forces Hosp Ulm, Dept Craniomaxillo Facial Surg, Ulm, Germany; [Pietzka, Sebastian; Kaemmerer, Peer W.; Schramm, Alexander] Univ Hosp Ulm, Dept Craniomaxillo Facial Surg, Ulm, Germany; [Pietzka, Silke] German Armed Forces Hosp Ulm, Dept Dent Care, Ulm, Germany; [Pietzka, Silke] German Armed Forces Hosp Ulm, Ctr Dent Specialties, Ulm, Germany; [Lampl, Lorenz] German Armed Forces Hosp Ulm, Dept Anaesthesiol & Intens Care Med, Ulm, Germany; [Lefering, Rolf] Witten Herdecke Univ, Inst Res Operat Med IFOM, Witten, Germany; [Bieler, Dan] German Armed Forces Cent Hosp Koblenz, Dept Trauma Surg & Orthopaed Reconstruct Surg Han, Ruebenacher Str 170, D-56072 Koblenz, Germany; [Kulla, Martin] German Aimed Forces Hosp Ulm, Dept Anaesthesiol & Intens Care Med, Emergency Med Sect, HEMS Christoph 22,Oberer Eselsberg 40, D-89081 Ulm, Germany		Kulla, M (corresponding author), German Aimed Forces Hosp Ulm, Dept Anaesthesiol & Intens Care Med, Emergency Med Sect, HEMS Christoph 22,Oberer Eselsberg 40, D-89081 Ulm, Germany.	Dr.Pietzka@gmx.net; drkaemmerer@icloud.com; silkepietzka@gmx.de; alexander.schramm@uni-ulm.de; dr.lorenz.lampl@t-online.de; Rolf.Lefering@uni-wh.de; danbieler@bundeswehr.org; martin.kulla@uni-ulm.de	Kulla, Martin/AAA-7718-2020; Kammerer, Peer W./H-7196-2019	Kulla, Martin/0000-0001-7454-0876; Kammerer, Peer W./0000-0002-1671-3764			Al-Khateeb T, 2007, J ORAL MAXIL SURG, V65, P1094, DOI 10.1016/j.joms.2006.09.013; Aladelusi T, 2014, CRANIOMAX TRAUM REC, V7, P284, DOI 10.1055/s-0034-1378183; Caldas IM, 2008, DENT TRAUMATOL, V24, P410, DOI 10.1111/j.1600-9657.2008.00584.x; Christie B, 2018, J PLAST RECONSTR AES, V71, P155, DOI 10.1016/j.bjps.2017.10.025; Corazza M, 2004, AM J CLIN DERMATOL, V5, P295, DOI 10.2165/00128071-200405050-00002; Debus F, 2015, DTSCH ARZTEBL INT, V112, P823, DOI 10.3238/arztebl.2015.0823; Dempf R, 2000, UNFALLCHIRURG, V103, P301, DOI 10.1007/s001130050540; Einy S, 2016, J CRANIOFAC SURG, V27, P857, DOI 10.1097/SCS.0000000000002555; Esmer E, 2016, NOTFALL RETTUNGSMED, V19, P92, DOI 10.1007/s10049-015-0101-1; HAUG HZ, 1992, J ORAL MAXIL SURG, V50, P218, DOI 10.1016/0278-2391(92)90315-Q; Hogg NJV, 2000, J TRAUMA, V49, P425, DOI 10.1097/00005373-200009000-00007; Huber C D, 2005, Traffic Inj Prev, V6, P170, DOI 10.1080/15389580590931644; Huber-Wagner S, 2009, LANCET, V373, P1455, DOI 10.1016/S0140-6736(09)60232-4; Jamal BT, 2009, J ORAL MAXIL SURG, V67, P559, DOI 10.1016/j.joms.2008.07.010; Jin ZL, 2014, DENT TRAUMATOL, V30, P147, DOI 10.1111/edt.12044; Joos U, 2001, Mund Kiefer Gesichtschir, V5, P86, DOI 10.1007/s100060000283; Kuhne CA, 2007, ORAL MAXILLOFAC SURG, V11, P201, DOI 10.1007/s10006-007-0063-7; Lefering R, 2014, CRIT CARE, V18, DOI 10.1186/s13054-014-0476-2; LEWIS VL, 1985, J TRAUMA, V25, P90, DOI 10.1097/00005373-198501000-00014; Manan MMA, 2012, IATSS RES, V36, P30, DOI 10.1016/j.iatssr.2012.02.005; Moafian G, 2013, CHIN J TRAUMATOL, V16, P140, DOI 10.3760/cma.j.issn.1008-1275.2013.03.003; Mulligan RP, 2010, PLAST RECONSTR SURG, V126, P1648, DOI 10.1097/PRS.0b013e3181ef90e4; Nobrega LM, 2014, AM J EMERG MED, V32, P1382, DOI 10.1016/j.ajem.2014.08.054; O'Connor RC, 2015, BRIT J ORAL MAX SURG, V53, P913, DOI 10.1016/j.bjoms.2015.08.261; Palm HG, 2018, EUR J TRAUMA EMERG S, V44, P759, DOI 10.1007/s00068-017-0870-y; Pehle B, 2006, UNFALLCHIRURG, V109, P964, DOI 10.1007/s00113-006-1161-y; Ramli R, 2014, J FORENSIC LEG MED, V26, P39, DOI 10.1016/j.jflm.2014.06.007; Rashid A, 2013, BRIT J ORAL MAX SURG, V51, P794, DOI 10.1016/j.bjoms.2013.04.007; Reich W, 2016, J CRANIO MAXILL SURG, V44, P1469, DOI 10.1016/j.jcms.2016.06.017; Ringdal KG, 2013, INJURY, V44, P691, DOI 10.1016/j.injury.2012.06.032; Rothweiler R, 2018, J CRANIO MAXILL SURG, V46, P283, DOI 10.1016/j.jcms.2017.11.027; Ruchholtz S, 2014, J TRAUMA ACUTE CARE, V76, P1456, DOI 10.1097/TA.0000000000000245; Sargent L A, 1999, J Craniomaxillofac Trauma, V5, P19; Schneider D, 2015, J CRANIO MAXILL SURG, V43, P1948, DOI 10.1016/j.jcms.2015.06.028; Scholz R, 1991, Fortschr Kiefer Gesichtschir, V36, P79; Siniscalchi EN, 2016, CASE REP MED, V2016, DOI 10.1155/2016/9168429; Surgeons ACo, 2012, AM COLL SURG COMM TR; Tsang KKT, 2012, BRIT J ORAL MAX SURG, V50, P298, DOI 10.1016/j.bjoms.2011.03.004; van Hout WMMT, 2013, BRIT J ORAL MAX SURG, V51, P416, DOI 10.1016/j.bjoms.2012.11.002; VONELM E, 2007, LANCET, V370, P1453, DOI DOI 10.1016/S0140-6736(07)61602-X; Walker TWM, 2012, BRIT J ORAL MAX SURG, V50, pE99, DOI 10.1016/j.bjoms.2011.09.026; Wirtz M, 2004, Rehabilitation (Stuttg), V43, P109; Yokoyama T, 2006, J ORAL MAXIL SURG, V64, P1731, DOI 10.1016/j.joms.2005.11.104	43	7	8	0	2	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1432-6981	1436-3771		CLIN ORAL INVEST	Clin. Oral Investig.	JAN	2020	24	1					503	513		10.1007/s00784-019-03024-6			11	Dentistry, Oral Surgery & Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Dentistry, Oral Surgery & Medicine	KL2DI	WOS:000513239100051	31377860	Bronze, Green Published			2022-02-06	
J	Poritz, JMP; Sherer, M; Kisala, PA; Tulsky, D; Leon-Novelo, L; Ngan, E				Poritz, Julia M. P.; Sherer, Mark; Kisala, Pamela A.; Tulsky, David; Leon-Novelo, Luis; Ngan, Esther			Responsiveness of the Traumatic Brain Injury-Quality of Life (TBI-QOL) Measurement System	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Health-related quality of life; Patient-reported outcome measure; Traumatic brain injury	OF-LIFE; PARTICIPATION ASSESSMENT; RHEUMATOID-ARTHRITIS; SHORT FORMS; VALIDATION; SF-36	Objective: To assess the responsiveness of the Traumatic Brain Injury-Quality of Life (TBI-QOL) measurement system. Design: Participants completed the 20 TBI-QOL item banks and the Participation Assessment with Recombined Tools-Objective (PART-O) Productivity Subscale at baseline and 6-month follow-up assessments. Participants were categorized into 4 groups (increased productivity, unchanged productivity, and decreased productivity) based on PART-O Productivity scores. Paired sample t tests were used to compare TBI-QOL scores at baseline and 6 months, and standardized response means and Cohen's d were computed to estimate effect sizes. Setting: Three traumatic brain injury (TBI) Model Systems rehabilitation centers in the United States. Participants: Two hundred one community-dwelling adults with TBI. Interventions: Not applicable. Main Outcome Measures: 20 TBI-QOL item banks. Results: As expected, given that there was no intervention, group mean TBI-QOL subdomain scores for the entire sample showed no change or small improvement over the 6-month study period. At the follow-up assessment, 72 participants reported increased productivity, 71 reported decreased productivity, and 58 reported the same level of productivity as they had 6 months prior. When compared with participants who reported unchanged or decreased productivity, participants who reported increased productivity on the PART-O subscale had clinically meaningful (d >= 0.30) improvements on 7 TBI-QOL measures. The largest improvement was in the Independence subdomain (mean change, 7.06; df=0.84), with differences also observed in the Mobility, Positive Affect and Well-Being, Resilience, Grief/Loss, Ability to Participate, and Satisfaction with Participation subdomains. Conclusions: The 20 TBI-QOL item banks demonstrate responsiveness to change and measurement stability in a community-dwelling sample. Researchers may use the TBI-QOL to detect changes in HRQOL after a clinical intervention and clinicians may use it in their daily practices to monitor patient recovery. (C) 2018 by the American Congress of Rehabilitation Medicine	[Poritz, Julia M. P.; Sherer, Mark] TIRR Mem Hermann, Brain Injury Res Ctr, Houston, TX USA; [Sherer, Mark] Baylor Coll Med, Dept Phys Med & Rehabil, Houston, TX 77030 USA; [Kisala, Pamela A.; Tulsky, David] Univ Delaware, Ctr Hlth Assessment Res & Translat, Newark, DE USA; [Leon-Novelo, Luis; Ngan, Esther] Univ Texas Hlth Sci Ctr Houston, Dept Biostat, Sch Publ Hlth, Houston, TX 77030 USA		Poritz, JMP (corresponding author), TIRR Mem Hermann, 1333 Moursund St, Houston, TX 77030 USA.	Julia.Poritz@memorialhermann.org	Poritz, Julia/N-9831-2018	Tulsky, David/0000-0002-4335-4509	National Institute on Disability, Independent Living, and Rehabilitation Research ([NIDILRR])United States Department of Health & Human Services [90RT5007, 90DP0028]	Developed under grants from the National Institute on Disability, Independent Living, and Rehabilitation Research ([NIDILRR] grant numbers 90RT5007, 90DP0028). NIDILRR is a Center within the Administration for Community Living (ACL), Department of Health and Human Services (HHS). The contents of this article do not necessarily represent the policies of NIDILRR, ACL, HHS, and endorsement by the federal government should not be assumed.	Aletaha D, 2005, ARTHRITIS RES THER, V7, pR796, DOI 10.1186/ar1740; Bogner JA, 2011, ARCH PHYS MED REHAB, V92, P552, DOI 10.1016/j.apmr.2010.11.014; Carlozzi NE, 2011, ARCH PHYS MED REHAB, V92, pS52, DOI 10.1016/j.apmr.2010.12.046; Cella D, 2007, MED CARE, V45, pS3, DOI 10.1097/01.mlr.0000258615.42478.55; Cella D, 2011, ARCH PHYS MED REHAB, V92, pS28, DOI 10.1016/j.apmr.2011.01.025; CELLA DF, 1995, SEMIN ONCOL, V22, P73; Hahn EA, 2016, J CLIN EPIDEMIOL, V73, P135, DOI 10.1016/j.jclinepi.2015.08.034; Hays R D, 1992, Qual Life Res, V1, P73, DOI 10.1007/BF00435438; Hays RD, 2015, ANN RHEUM DIS, V74, P104, DOI 10.1136/annrheumdis-2013-204053; Jensen RE, 2017, CANCER-AM CANCER SOC, V123, P327, DOI 10.1002/cncr.30354; Kean J, 2016, MED CARE, V54, P414, DOI 10.1097/MLR.0000000000000497; Keith R A, 1987, Adv Clin Rehabil, V1, P6; Miller DM, 2016, MULT SCLER J, V22, P830, DOI 10.1177/1352458515599450; Nowinski CJ, 2016, MOVEMENT DISORD, V31, P725, DOI 10.1002/mds.26546; Polinder S, 2015, POPUL HEALTH METR, V13, DOI 10.1186/s12963-015-0037-1; Salsman JM, 2013, QUAL LIFE RES, V22, P2569, DOI 10.1007/s11136-013-0382-0; Sherer M, 2020, ARCH PHYS MED REHAB, V101, P62, DOI 10.1016/j.apmr.2017.04.016; Sherer M, 2017, J HEAD TRAUMA REHAB, V32, P125, DOI 10.1097/HTR.0000000000000207; Sherer M, 2015, REHABIL PSYCHOL, V60, P138, DOI 10.1037/rep0000030; Stratford Paul W, 2005, Health Qual Life Outcomes, V3, P23, DOI 10.1186/1477-7525-3-23; Tulsky DS, 2016, J HEAD TRAUMA REHAB, V31, P40, DOI 10.1097/HTR.0000000000000131; Wahl E, 2017, ARTHRIT CARE RES, V69, P338, DOI 10.1002/acr.22956; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Whiteneck GG, 2011, ARCH PHYS MED REHAB, V92, P542, DOI 10.1016/j.apmr.2010.08.002	24	7	7	0	3	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	JAN	2020	101	1					54	61		10.1016/j.apmr.2017.11.018			8	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	KA2PR	WOS:000505640300006	29407517				2022-02-06	
J	Sydnor, VJ; Bouix, S; Pasternak, O; Hartl, E; Levin-Gleba, L; Reid, B; Tripodis, Y; Guenette, JP; Kaufmann, D; Makris, N; Fortier, C; Salat, DH; Rathi, Y; Milberg, WP; McGlinchey, RE; Shenton, ME; Koerte, IK				Sydnor, Valerie J.; Bouix, Sylvain; Pasternak, Ofer; Hartl, Elisabeth; Levin-Gleba, Laura; Reid, Benjamin; Tripodis, Yorghos; Guenette, Jeffrey P.; Kaufmann, David; Makris, Nikos; Fortier, Catherine; Salat, David H.; Rathi, Yogesh; Milberg, William P.; McGlinchey, Regina E.; Shenton, Martha E.; Koerte, Inga K.			Mild traumatic brain injury impacts associations between limbic system microstructure and post-traumatic stress disorder symptomatology	NEUROIMAGE-CLINICAL			English	Article						Post-traumatic stress disorder; Mild traumatic brain injury; Diffusion MRI; Microstructure; Limbic	TRANSCRANIAL MAGNETIC STIMULATION; SMALLER HIPPOCAMPAL VOLUME; WHITE-MATTER INTEGRITY; GRAY-MATTER; CORTICAL THICKNESS; PREFRONTAL CORTEX; NUCLEUS-ACCUMBENS; FUNCTIONAL CONNECTIVITY; RADIAL ORGANIZATION; APICAL DENDRITES	Background: Post-traumatic stress disorder (PTSD) is a psychiatric disorder that afflicts many individuals, yet the neuropathological mechanisms that contribute to this disorder remain to be fully determined. Moreover, it is unclear how exposure to mild traumatic brain injury (mTBI), a condition that is often comorbid with PTSD, particularly among military personnel, affects the clinical and neurological presentation of PTSD. To address these issues, the present study explores relationships between PTSD symptom severity and the microstructure of limbic and paralimbic gray matter brain regions, as well as the impact of mTBI comorbidity on these relationships. Methods: Structural and diffusion MRI data were acquired from 102 male veterans who were diagnosed with current PTSD. Diffusion data were analyzed with free-water imaging to quantify average CSF-corrected fractional anisotropy (FA) and mean diffusivity (MD) in 18 limbic and paralimbic gray matter regions. Associations between PTSD symptom severity and regional average dMRI measures were examined with repeated measures linear mixed models. Associations were studied separately in veterans with PTSD only, and in veterans with PTSD and a history of military mTBI. Results: Analyses revealed that in the PTSD only cohort, more severe symptoms were associated with higher FA in the right amygdala-hippocampus complex, lower FA in the right cingulate cortex, and lower MD in the left medial orbitofrontal cortex. In the PTSD and mTBI cohort, more severe PTSD symptoms were associated with higher FA bilaterally in the amygdala-hippocampus complex, with higher FA bilaterally in the nucleus accumbens, with lower FA bilaterally in the cingulate cortex, and with higher MD in the right amygdala-hippocampus complex. Conclusions: These findings suggest that the microstructure of limbic and paralimbic brain regions may influence PTSD symptomatology. Further, given the additional associations observed between microstructure and symptom severity in veterans with head trauma, we speculate that mTBI may exacerbate the impact of brain microstructure on PTSD symptoms, especially within regions of the brain known to be vulnerable to chronic stress. A heightened sensitivity to the microstructural environment of the brain could partially explain why individuals with PTSD and mTBI comorbidity experience more severe symptoms and poorer illness prognoses than those without a history of brain injury. The relevance of these microstructural findings to the conceptualization of PTSD as being a disorder of stress-induced neuronal connectivity loss is discussed.	[Sydnor, Valerie J.; Bouix, Sylvain; Pasternak, Ofer; Hartl, Elisabeth; Levin-Gleba, Laura; Reid, Benjamin; Guenette, Jeffrey P.; Kaufmann, David; Makris, Nikos; Rathi, Yogesh; Shenton, Martha E.; Koerte, Inga K.] Harvard Med Sch, Brigham & Womens Hosp, Dept Psychiat, Psychiat Neuroimaging Lab, Boston, MA 02115 USA; [Hartl, Elisabeth] Ludwig Maximilians Univ Munchen, Dept Neurol, Univ Hosp, Munich, Germany; [Levin-Gleba, Laura; Fortier, Catherine; Salat, David H.; Milberg, William P.; McGlinchey, Regina E.] VA Boston Healthcare Syst, Translat Res Ctr TBI & Stress Disorders TRACTS, Boston, MA USA; [Tripodis, Yorghos] Boston Univ, Sch Publ Hlth, Boston, MA USA; [Guenette, Jeffrey P.; Shenton, Martha E.] Harvard Med Sch, Brigham & Womens Hosp, Dept Radiol, Boston, MA 02115 USA; [Kaufmann, David; Koerte, Inga K.] Ludwig Maximilians Univ Munchen, Dept Child & Adolescent Psychiat Psychosomat & Ps, Munich, Germany; [Makris, Nikos] Harvard Med Sch, Ctr Morphometr Anal, Massachusetts Gen Hosp, Dept Psychiat & Neurol, Boston, MA 02115 USA; [Fortier, Catherine; Milberg, William P.; McGlinchey, Regina E.] Harvard Med Sch, Dept Psychiat, Boston, MA 02115 USA; [Salat, David H.] VA Boston Healthcare Syst, Neuroimaging Res Vet NeRVe Ctr, Boston, MA USA; [Milberg, William P.; McGlinchey, Regina E.] VA Boston Healthcare Syst, Geriatr Res Educ & Clin Ctr GRECC, Boston, MA USA; [Shenton, Martha E.] VA Boston Healthcare Syst, Brockton Div, Brockton, MA USA		Koerte, IK (corresponding author), Psychiat Neuroimaging Lab, 1249 Boylston St, Boston, MA 02215 USA.	ikoerte@bwh.harvard.edu	Fortier, Catherine/AAS-2163-2021; Koerte, Inga Katharina/AAW-3031-2021	Fortier, Catherine/0000-0002-8953-9904; Bouix, Sylvain/0000-0003-1326-6054	TRANSLATIONAL RESEARCH CENTER FOR TBI AND STRESS DISORDERS (TRACTS) via a VA Rehabilitation Research and Development National Network Research Center for Traumatic Brain Injury Grant [B9254-C]; TRANSLATIONAL RESEARCH CENTER FOR TBI AND STRESS DISORDERS (TRACTS) via VA Merit Award [I01RX000928-01A2]; NATIONAL INSTITUTES OF HEALTH NEUROIMAGE ANALYSIS CENTERUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NIH P41EB015902]	This research was supported by the TRANSLATIONAL RESEARCH CENTER FOR TBI AND STRESS DISORDERS (TRACTS) via a VA Rehabilitation Research and Development National Network Research Center for Traumatic Brain Injury Grant (B9254-C) to Regina McGlinchey, a VA Merit Award I01RX000928-01A2 to Martha E. Shenton (supporting MES, VJS, SB, YR), and a NATIONAL INSTITUTES OF HEALTH NEUROIMAGE ANALYSIS CENTER grant NIH P41EB015902 (OP).	Abdallah CG, 2017, NEUROPSYCHOPHARMACOL, V42, P1739, DOI 10.1038/npp.2017.49; Admon R, 2013, HUM BRAIN MAPP, V34, P2808, DOI 10.1002/hbm.22100; Admon R, 2013, TRENDS COGN SCI, V17, P337, DOI 10.1016/j.tics.2013.05.005; Alexander DC, 2019, NMR BIOMED, V32, DOI 10.1002/nbm.3841; Averill LA, 2017, NEUROSCI LETT, V649, P147, DOI 10.1016/j.neulet.2016.11.064; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BESSA JM, 2013, TRANSL PSYCHIAT, V3, DOI DOI 10.1038/TP.2013.39.E266; BLAKE DD, 1995, J TRAUMA STRESS, V8, P75, DOI 10.1007/BF02105408; Bock AS, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00149; Boggio PS, 2010, J CLIN PSYCHIAT, V71, P992, DOI 10.4088/JCP.08m04638blu; Bouix S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066205; Bozzali M, 2002, AM J NEURORADIOL, V23, P985; Bremner JD, 2007, NEUROIMAG CLIN N AM, V17, P523, DOI 10.1016/j.nic.2007.07.003; Broman-Fulks JJ, 2006, BEHAV THER, V37, P364, DOI 10.1016/j.beth.2006.02.006; Budde MD, 2011, BRAIN, V134, P2248, DOI 10.1093/brain/awr161; Bush G, 2000, TRENDS COGN SCI, V4, P215, DOI 10.1016/S1364-6613(00)01483-2; Carrion VG, 2007, PEDIATRICS, V119, P509, DOI 10.1542/peds.2006-2028; Chao L, 2013, PSYCHIAT RES-NEUROIM, V213, P193, DOI 10.1016/j.pscychresns.2013.03.002; Chemtob CM, 1998, J NERV MENT DIS, V186, P701, DOI 10.1097/00005053-199811000-00007; Chen YH, 2017, NEUROSCIENCE, V348, P180, DOI 10.1016/j.neuroscience.2017.02.001; Chen YC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048298; Cohen BE, 2013, J CLIN PSYCHIAT, V74, P1063, DOI 10.4088/JCP.12m08291; Cohen H, 2004, AM J PSYCHIAT, V161, P515, DOI 10.1176/appi.ajp.161.3.515; Crowson JJ, 1998, J ANXIETY DISORD, V12, P605, DOI 10.1016/S0887-6185(98)00037-1; Dean JM, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3004669; Edwards LJ, 2018, NEUROIMAGE, V182, P184, DOI 10.1016/j.neuroimage.2018.02.055; Eldridge LL, 2000, NAT NEUROSCI, V3, P1149, DOI 10.1038/80671; Elman I, 2009, BIOL PSYCHIAT, V66, P1083, DOI 10.1016/j.biopsych.2009.06.006; Etkin A, 2011, TRENDS COGN SCI, V15, P85, DOI 10.1016/j.tics.2010.11.004; Fani N, 2016, DEPRESS ANXIETY, V33, P300, DOI 10.1002/da.22483; Fani N, 2012, NEUROPSYCHOPHARMACOL, V37, P2740, DOI 10.1038/npp.2012.146; Feder A, 2014, JAMA PSYCHIAT, V71, P681, DOI 10.1001/jamapsychiatry.2014.62; Felmingham KL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103653; First M., 1995, STRUCTURED CLIN INTE, V9, P92; Foa EB, 2000, J TRAUMA STRESS, V13, P181, DOI 10.1023/A:1007781909213; Forbes D, 2005, J TRAUMA STRESS, V18, P647, DOI 10.1002/jts.20073; Fortier CB, 2014, J HEAD TRAUMA REHAB, V29, P89, DOI 10.1097/HTR.0b013e3182865859; Fulton JJ, 2015, J ANXIETY DISORD, V31, P98, DOI 10.1016/j.janxdis.2015.02.003; Gilbertson MW, 2002, NAT NEUROSCI, V5, P1242, DOI 10.1038/nn958; Greve DN, 2009, NEUROIMAGE, V48, P63, DOI 10.1016/j.neuroimage.2009.06.060; Grubaugh AL, 2005, J NERV MENT DIS, V193, P658, DOI 10.1097/01.nmd.0000180740.02644.ab; Guenette JP, 2018, NEUROIMAGE-CLIN, V18, P888, DOI 10.1016/j.nicl.2018.03.026; Gulban OF, 2018, NEUROIMAGE, V178, P104, DOI 10.1016/j.neuroimage.2018.05.010; Han F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069340; Hellstrom T, 2017, BRAIN INJURY, V31, P674, DOI 10.1080/02699052.2017.1283537; Helpman L, 2017, CURR PSYCHIAT REP, V19, DOI 10.1007/s11920-017-0854-y; Herringa R, 2012, PSYCHIAT RES-NEUROIM, V203, P139, DOI 10.1016/j.pscychresns.2012.02.005; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoge CW, 2007, AM J PSYCHIAT, V164, P150, DOI 10.1176/appi.ajp.164.1.150; Hull AM, 2002, BRIT J PSYCHIAT, V181, P102; Insel T, 2010, AM J PSYCHIAT, V167, P748, DOI 10.1176/appi.ajp.2010.09091379; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jonkman LE, 2016, MULT SCLER J, V22, P1804, DOI 10.1177/1352458516635290; Kansagara D., 2013, COMPLICATIONS MILD T; Karl A, 2006, NEUROSCI BIOBEHAV R, V30, P1004, DOI 10.1016/j.neubiorev.2006.03.004; Kasai K, 2008, BIOL PSYCHIAT, V63, P550, DOI 10.1016/j.biopsych.2007.06.022; Kim SJ, 2006, NEUROPSYCHOBIOLOGY, V54, P120, DOI 10.1159/000098262; Kitayama N, 2005, J AFFECT DISORDERS, V88, P79, DOI 10.1016/j.jad.2005.05.014; Krystal JH, 2017, CURR PSYCHIAT REP, V19, DOI 10.1007/s11920-017-0829-z; Kuhn S, 2013, BIOL PSYCHIAT, V73, P70, DOI 10.1016/j.biopsych.2012.06.029; Laitinen T, 2015, FRONT NEUROSCI-SWITZ, V9, DOI [10.3389/fnins.7015.00128, 10.3389/fnins.2015.00128]; Leech R, 2014, BRAIN, V137, P12, DOI 10.1093/brain/awt162; Lei D, 2015, SCI REP-UK, V5, DOI 10.1038/srep08933; Leigland LA, 2013, NEUROIMAGE, V83, P1081, DOI 10.1016/j.neuroimage.2013.07.068; Leigland LA, 2011, NEUROMETHODS, V50, P329, DOI 10.1007/978-1-60761-883-6_13; Leuze CWU, 2014, CEREB CORTEX, V24, P328, DOI 10.1093/cercor/bhs311; Li NX, 2011, BIOL PSYCHIAT, V69, P754, DOI 10.1016/j.biopsych.2010.12.015; Li NX, 2010, SCIENCE, V329, P959, DOI 10.1126/science.1190287; Lindemer ER, 2013, NEUROIMAGE-CLIN, V2, P601, DOI 10.1016/j.nicl.2013.04.009; Lindquist LK, 2017, J NEUROPSYCH CLIN N, V29, P254, DOI 10.1176/appi.neuropsych.16050100; Lippa SM, 2015, J TRAUMA STRESS, V28, P25, DOI 10.1002/jts.21979; Lobo I, 2015, J AFFECT DISORDERS, V183, P210, DOI 10.1016/j.jad.2015.05.015; Logue MW, 2018, BIOL PSYCHIAT, V83, P244, DOI 10.1016/j.biopsych.2017.09.006; Lovibond S.H., 1996, MANUAL DEPRESSION AN, V2nd ed.; MacDonald C, 1999, J TRAUMA STRESS, V12, P701, DOI 10.1023/A:1024729520686; MAGARINOS AM, 1995, NEUROSCIENCE, V69, P89, DOI 10.1016/0306-4522(95)00259-L; McGlinchey RE, 2017, INT J METH PSYCH RES, V26, DOI 10.1002/mpr.1556; McKinstry RC, 2002, CEREB CORTEX, V12, P1237, DOI 10.1093/cercor/12.12.1237; McKittrick CR, 2000, SYNAPSE, V36, P85, DOI 10.1002/(SICI)1098-2396(200005)36:2<85::AID-SYN1>3.0.CO;2-Y; McNab JA, 2013, NEUROIMAGE, V69, P87, DOI 10.1016/j.neuroimage.2012.11.065; Meng LH, 2016, SCI REP-UK, V6, DOI 10.1038/srep33748; Meng YJ, 2014, BEHAV BRAIN RES, V270, P307, DOI 10.1016/j.bbr.2014.05.021; Metzger LJ, 2008, J REHABIL RES DEV, V45, P437, DOI 10.1682/JRRD.2007.07.0100; Molet J, 2016, HIPPOCAMPUS, V26, P1618, DOI 10.1002/hipo.22661; Morey RA, 2012, ARCH GEN PSYCHIAT, V69, P1169, DOI 10.1001/archgenpsychiatry.2012.50; Nardo D, 2010, J PSYCHIATR RES, V44, P477, DOI 10.1016/j.jpsychires.2009.10.014; Nelson MD, 2017, CNS SPECTRUMS, V22, P363, DOI 10.1017/S1092852916000833; O'Doherty DCM, 2017, PSYCHIAT RES-NEUROIM, V266, P1, DOI 10.1016/j.pscychresns.2017.05.008; O'Doherty DCM, 2015, PSYCHIAT RES-NEUROIM, V232, P1, DOI 10.1016/j.pscychresns.2015.01.002; Oathes DJ, 2018, BIORXIV, DOI [10. 1101/503441, DOI 10.1101/503441]; Ohman A, 2005, PSYCHONEUROENDOCRINO, V30, P953, DOI 10.1016/j.psyneuen.2005.03.019; Pacella ML, 2013, J ANXIETY DISORD, V27, P33, DOI 10.1016/j.janxdis.2012.08.004; Palm KM, 2009, J ANXIETY DISORD, V23, P27, DOI 10.1016/j.janxdis.2008.03.012; Panchal H, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00616; Pasternak O, 2018, NEUROIMAGE, V182, P259, DOI 10.1016/j.neuroimage.2018.04.051; Pasternak O, 2009, MAGN RESON MED, V62, P717, DOI 10.1002/mrm.22055; Quadrelli S, 2018, PSYCHIAT RES-NEUROIM, V282, P110, DOI 10.1016/j.pscychresns.2018.07.001; Rathi Y, 2014, HUM BRAIN MAPP, V35, P3841, DOI 10.1002/hbm.22441; Robinson ME, 2017, J NEUROTRAUM, V34, pS53, DOI 10.1089/neu.2016.4709; Robinson ME, 2015, HUM BRAIN MAPP, V36, P911, DOI 10.1002/hbm.22675; Rogers MA, 2009, PSYCHIAT RES-NEUROIM, V174, P210, DOI 10.1016/j.pscychresns.2009.06.001; Ruscio AM, 2002, J ABNORM PSYCHOL, V111, P290, DOI 10.1037//0021-843X.111.2.290; Sailer U, 2008, NEUROPSYCHOLOGIA, V46, P2836, DOI 10.1016/j.neuropsychologia.2008.05.022; Sanacora G, 2013, BIOL PSYCHIAT, V73, P1172, DOI 10.1016/j.biopsych.2013.03.032; Sanjuan PM, 2013, PSYCHIAT RES-NEUROIM, V214, P260, DOI 10.1016/j.pscychresns.2013.09.002; SATTERTHWAITE FE, 1946, BIOMETRICS BULL, V2, P110, DOI 10.2307/3002019; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Schutzwohl M, 1999, J TRAUMA STRESS, V12, P155, DOI 10.1023/A:1024706702133; Seehaus A, 2015, FRONT NEUROANAT, V9, DOI 10.3389/fnana.2015.00098; Seitz J, 2018, BRAIN IMAGING BEHAV, V12, P54, DOI 10.1007/s11682-016-9666-7; Sekiguchi A, 2013, MOL PSYCHIATR, V18, P618, DOI 10.1038/mp.2012.51; Shah S, 2012, BRAIN INJURY, V26, P201, DOI 10.3109/02699052.2012.654591; Sizonenko SPV, 2007, CEREB CORTEX, V17, P2609, DOI 10.1093/cercor/bhl168; SKINNER HA, 1982, J STUD ALCOHOL, V43, P1157, DOI 10.15288/jsa.1982.43.1157; Smith ME, 2005, HIPPOCAMPUS, V15, P798, DOI 10.1002/hipo.20102; Snell FI, 2010, J PSYCHOSOC NURS MEN, V48, P22, DOI [10.3928/02793695-20100107-01, 10.3928/02793695-20100108-02]; Sollmann N, 2018, NEUROIMAGE-CLIN, V17, P642, DOI 10.1016/j.nicl.2017.11.020; Spadoni AD, 2018, CURR TOP BEHAV NEURO, V38, P163, DOI 10.1007/7854_2017_35; Spielberg JM, 2015, BIOL PSYCHIAT, V78, P210, DOI 10.1016/j.biopsych.2015.02.013; Stein MB, 1997, AM J PSYCHIAT, V154, P1114; Stein MB, 2009, AM J PSYCHIAT, V166, P768, DOI 10.1176/appi.ajp.2009.08101604; Stolp HB, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22295-9; Taber KH, 2015, J HEAD TRAUMA REHAB, V30, pE15, DOI 10.1097/HTR.0000000000000030; Tanev KS, 2014, BRAIN INJURY, V28, P261, DOI 10.3109/02699052.2013.873821; Taubitz LE, 2015, PERS INDIV DIFFER, V80, P107, DOI 10.1016/j.paid.2015.02.029; Trotter BB, 2015, BRAIN, V138, P2278, DOI 10.1093/brain/awv139; Twamley EW, 2009, J INT NEUROPSYCH SOC, V15, P879, DOI 10.1017/S135561770999049X; Vanderploeg RD, 2009, ARCH PHYS MED REHAB, V90, P1084, DOI 10.1016/j.apmr.2009.01.023; Vasterling JJ, 2009, CLIN PSYCHOL REV, V29, P674, DOI 10.1016/j.cpr.2009.08.004; Waltzman D, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170564; Wang Z, 2010, ARCH GEN PSYCHIAT, V67, P296, DOI 10.1001/archgenpsychiatry.2009.205; WATANABE Y, 1992, BRAIN RES, V588, P341, DOI 10.1016/0006-8993(92)91597-8; Watts BV, 2012, BRAIN STIMUL, V5, P38, DOI 10.1016/j.brs.2011.02.002; Weathers FW, 1999, PSYCHOL ASSESSMENT, V11, P124, DOI 10.1037/1040-3590.11.2.124; Weston PSJ, 2015, ALZHEIMERS RES THER, V7, DOI 10.1186/s13195-015-0132-3; Wiltgen BJ, 2010, CURR BIOL, V20, P1336, DOI 10.1016/j.cub.2010.06.068; WOOLLEY CS, 1990, BRAIN RES, V531, P225, DOI 10.1016/0006-8993(90)90778-A; Woon FL, 2010, PROG NEURO-PSYCHOPH, V34, P1181, DOI 10.1016/j.pnpbp.2010.06.016; Wrocklage KM, 2017, EUR NEUROPSYCHOPHARM, V27, P515, DOI 10.1016/j.euroneuro.2017.02.010; Xie B., 2015, DIGIT MED, V1, P23, DOI [10.4103/2226-8561.166367., DOI 10.4103/2226-8561.166367]; Xie B, 2013, BRAIN RES, V1490, P225, DOI 10.1016/j.brainres.2012.10.048; Yu QW, 2016, CEREB CORTEX, V26, P4381, DOI 10.1093/cercor/bhv201; Yurgil KA, 2014, JAMA PSYCHIAT, V71, P149, DOI 10.1001/jamapsychiatry.2013.3080	143	7	7	2	11	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	2213-1582			NEUROIMAGE-CLIN	NeuroImage-Clin.		2020	26								102190	10.1016/j.nicl.2020.102190			12	Neuroimaging	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	LN7YO	WOS:000533149400014	32070813	Green Published, gold			2022-02-06	
J	Wang, DM; Luo, MM; Huang, BS; Gao, W; Jiang, Y; Li, Q; Nan, KH; Lin, S				Wang, Dongmei; Luo, Mengmeng; Huang, Baoshan; Gao, Wa; Jiang, Yan; Li, Qing; Nan, Kaihui; Lin, Sen			Localized co-delivery of CNTF and FK506 using a thermosensitive hydrogel for retina ganglion cells protection after traumatic optic nerve injury	DRUG DELIVERY			English	Article						Thermo-sensitive hydrogel; ciliary neurotrophic factor; FK506 micelle; retina ganglion cells; traumatic optic nerve injury	RETROGRADE AXONAL-TRANSPORT; SCAR FORMATION; BDNF; NANOPARTICLES; REGENERATION; PROMOTES; EXPRESSION; MICROGLIA; RAT	Following the traumatic axonal injury in the optic nerve, the failure of retrograde axonal transport to continuously supply neurotrophins from the brain to retina results in deprivation of neurotrophins in retinal ganglion cells (RGCs), which in turn can modulate the fate of RGCs toward apoptosis and thereby impede axon regeneration. In this study, a ciliary neurotrophic factor (CNTF) loaded thermo-sensitive hydrogel was designed and developed as a localized drug depot to restore neurotrophins supply following axon injury. Besides, following traumatic axon injury, overactive immune responses cause neurotoxicity and induce scar formation which together constitutes the major hindrances for axon regeneration. Thus, the FK506, a hydrophobic macrolide immunosuppressant, was co-loaded into the hydrogel after encapsulating it into a polymeric micelle. The materials can undergo sol-to-gel transition within minutes under a physiological pH of 37 degrees C. The release of drugs from the hydrogel exhibited a sustainable profile in vitro. The optic nerve was exposed by surgical procedure and the animal model was prepared by crushing the nerve with a reverse clamp. For the localized delivery to the optic nerve, a pre-hydrogel liquid containing chitosan, FK506 (in micelle), CNTF, and the gelling agent was directly smeared on the injured site, which gelled under physiological condition. This co-delivery system exhibited in vivo RGCs protective effect against the adverse effects caused by traumatic optic nerve injury, indicating the potential of this drug delivery system for effective optic nerve repair and this strategy may provide promising platforms for localized drug delivery in various other therapies.	[Wang, Dongmei; Luo, Mengmeng; Huang, Baoshan; Gao, Wa; Jiang, Yan; Li, Qing; Nan, Kaihui; Lin, Sen] Wenzhou Med Univ, Sch Ophthalmol & Optometry, Wenzhou 325027, Peoples R China; [Wang, Dongmei; Luo, Mengmeng; Huang, Baoshan; Gao, Wa; Jiang, Yan; Li, Qing; Nan, Kaihui; Lin, Sen] Wenzhou Med Univ, Hosp Eye, Wenzhou 325027, Peoples R China; [Li, Qing; Nan, Kaihui; Lin, Sen] Wenzhou Med Univ, State Key Lab Ophthalmol Optometry & Visual Sci, Wenzhou, Peoples R China; [Luo, Mengmeng; Huang, Baoshan; Nan, Kaihui; Lin, Sen] Univ Chinese Acad Sci, Wenzhou Inst, Wenzhou, Peoples R China		Nan, KH; Lin, S (corresponding author), Wenzhou Med Univ, Sch Ophthalmol & Optometry, Wenzhou 325027, Peoples R China.; Nan, KH; Lin, S (corresponding author), Wenzhou Med Univ, Hosp Eye, Wenzhou 325027, Peoples R China.	nankh@163.com; youhulinsen@hotmail.com	Nan, Kaihui/F-7235-2011	Nan, Kaihui/0000-0002-6592-1682; Lin, Sen/0000-0001-8284-9988	National Key Research and Development Plan Project [2016YFC1101201]; National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [31901735, 31600807]; Provincial Natural Science Foundation of Zhejiang, ChinaNatural Science Foundation of Zhejiang Province [LY19H120002]; Project of State Key Laboratory of Ophthalmology, Optometry and Visual Science, Wenzhou Medical University [K171204]	This work was financially supported by the National Key Research and Development Plan Project [2016YFC1101201], the National Natural Science Foundation of China [31901735 and 31600807], the Provincial Natural Science Foundation of Zhejiang, China [LY19H120002], and the Project of State Key Laboratory of Ophthalmology, Optometry and Visual Science, Wenzhou Medical University [K171204].	Almasieh M, 2012, PROG RETIN EYE RES, V31, P152, DOI 10.1016/j.preteyeres.2011.11.002; Bei FF, 2016, CELL, V164, P219, DOI 10.1016/j.cell.2015.11.036; Berry M, 2019, PROG RETIN EYE RES, V71, P57, DOI 10.1016/j.preteyeres.2018.11.006; Bhattarai N, 2010, ADV DRUG DELIVER REV, V62, P83, DOI 10.1016/j.addr.2009.07.019; Block ML, 2007, NAT REV NEUROSCI, V8, P57, DOI 10.1038/nrn2038; Bringmann A, 2009, ENCY NEUROSCIENCE, P1083; Colafrancesco V, 2011, J GLAUCOMA, V20, P100, DOI 10.1097/IJG.0b013e3181d787e5; Deng AP, 2017, MAT SCI ENG C-MATER, V78, P1147, DOI 10.1016/j.msec.2017.04.109; Dudhani AR, 2010, CARBOHYD POLYM, V81, P243, DOI 10.1016/j.carbpol.2010.02.026; Fatteh N, 2011, INVES OPHTH VIS SCI, V52, P1859; Feng L, 2017, ENEURO, V4, DOI 10.1523/ENEURO.0331-16.2016; Fischer D, 2012, PROG RETIN EYE RES, V31, P688, DOI 10.1016/j.preteyeres.2012.06.005; Hellstrom M, 2011, J NEUROTRAUM, V28, P2475, DOI 10.1089/neu.2011.1928; Jin XM, 2016, J BIOCHEM, V159, P491, DOI 10.1093/jb/mvw009; Jongen JLM, 2005, EXP NEUROL, V194, P255, DOI 10.1016/j.expneurol.2005.02.019; Kean T, 2010, ADV DRUG DELIVER REV, V62, P3, DOI 10.1016/j.addr.2009.09.004; Kong XY, 2018, EXP THER MED, V15, P1442, DOI 10.3892/etm.2017.5586; Laughter MR, 2018, ACS BIOMATER SCI ENG, V4, P3374, DOI 10.1021/acsbiomaterials.8b00803; Lin S, 2019, ACS APPL MATER INTER, V11, P39603, DOI 10.1021/acsami.9b13851; Lin S, 2018, NANO RES, V11, P3619, DOI 10.1007/s12274-017-1928-1; Lin S, 2015, J MATER CHEM B, V3, P6001, DOI 10.1039/c5tb00736d; Luo MM, 2018, J MATER SCI-MATER M, V29, DOI 10.1007/s10856-018-6149-y; Muller A, 2009, MOL CELL NEUROSCI, V41, P233, DOI 10.1016/j.mcn.2009.03.002; Ostolska I, 2014, COLLOID POLYM SCI, V292, P2453, DOI 10.1007/s00396-014-3276-y; Que J, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.56; Que J, 2012, NEURAL REGEN RES, V7, P2500, DOI 10.3969/j.issn.1673-5374.2012.32.003; Quigley HA, 2000, INVEST OPHTH VIS SCI, V41, P3460; Reynolds AJ, 2000, BRAIN RES REV, V33, P169, DOI 10.1016/S0165-0173(00)00028-X; Shum JWH, 2016, NEURAL REGEN RES, V11, P32, DOI 10.4103/1673-5374.175038; Subhramanyam CS, 2019, SEMIN CELL DEV BIOL, V94, P112, DOI 10.1016/j.semcdb.2019.05.004; Tronci E, 2017, EXP NEUROL, V297, P73, DOI 10.1016/j.expneurol.2017.07.017; Wang L, 2018, ACS APPL MATER INTER, V10, P36721, DOI 10.1021/acsami.8b13077; Weber AJ, 2013, INVEST OPHTH VIS SCI, V54, P6594, DOI 10.1167/iovs.13-12683; Wolinsky JB, 2012, J CONTROL RELEASE, V159, P14, DOI 10.1016/j.jconrel.2011.11.031; Yang GQ, 2017, ACTA BIOMATER, V60, P232, DOI 10.1016/j.actbio.2017.05.003; Yuan Y, 2015, ACS NANO, V9, P5117, DOI 10.1021/acsnano.5b00287; Zawadzka M, 2012, J MOL MED, V90, P1459, DOI 10.1007/s00109-012-0925-9; Zhao J, 2014, J NEUROL SCI, V344, P20, DOI 10.1016/j.jns.2014.06.005; Zhou HY, 2015, CARBOHYD POLYM, V117, P524, DOI 10.1016/j.carbpol.2014.09.094	39	7	7	9	15	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	1071-7544	1521-0464		DRUG DELIV	Drug Deliv.	JAN 1	2020	27	1					556	564		10.1080/10717544.2020.1748759			9	Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	LK6VW	WOS:000531002800001	32351142	Green Published, gold			2022-02-06	
J	Sahbaie, P; Irvine, KA; Liang, DY; Shi, XY; Clark, JD				Sahbaie, Peyman; Irvine, Karen-Amanda; Liang, De-Yong; Shi, Xiaoyou; Clark, J. David			Mild Traumatic Brain Injury Causes Nociceptive Sensitization through Spinal Chemokine Upregulation	SCIENTIFIC REPORTS			English	Article							ROSTRAL VENTROMEDIAL MEDULLA; 5-HT3 RECEPTOR; NEUROPATHIC PAIN; DESCENDING PAIN; NERVE INJURY; CORD; STEM; MODULATION; ALLODYNIA; NEURONS	High rates of acute and chronic pain are associated with traumatic brain injury (TBI), but mechanisms responsible for the association remain elusive. Recent data suggest dysregulated descending pain modulation circuitry could be involved. Based on these and other observations, we hypothesized that serotonin (5-HT)-dependent activation of spinal CXC Motif Chemokine Receptor 2 (CXCR2) may support TBI-related nociceptive sensitization in a mouse model of mild TBI (mTBI). We observed that systemic 5-HT depletion with p-chlorophenylalanine attenuated mechanical hypersensitivity seen after mTBI. Likewise, selective spinal 5-HT fiber depletion with 5,7-dihydroxytryptamine (5,7-DHT) reduced hypersensitivity after mTBI. Consistent with a role for spinal 5-HT3 serotonin receptors, intrathecal ondansetron administration after TBI dose-dependently attenuated nociceptive sensitization. Also, selective CXCR2 antagonist SCH527123 treatment attenuated mechanical hypersensitivity after mTBI. Furthermore, spinal CXCL1 and CXCL2 mRNA and protein levels were increased after mTBI as were GFAP and IBA-1 markers. Spinal 5,7-DHT application reduced both chemokine expression and glial activation. Our results suggest dual pathways for nociceptive sensitization after mTBI, direct 5-HT effect through 5-HT3 receptors and indirectly through upregulation of chemokine signaling. Designing novel clinical interventions against either the 5-HT3 mediated component or chemokine pathway may be beneficial in treating pain frequently seen in patients after mTBI.	[Sahbaie, Peyman; Irvine, Karen-Amanda; Liang, De-Yong; Shi, Xiaoyou; Clark, J. David] Stanford Univ, Sch Med, Dept Anesthesia Perioperat & Pain Med, Stanford, CA 94305 USA; [Sahbaie, Peyman; Irvine, Karen-Amanda; Liang, De-Yong; Shi, Xiaoyou; Clark, J. David] Vet Affairs Palo Alto Hlth Care Syst, Anesthesiol Serv, 3801 Miranda Ave,112-A, Palo Alto, CA 94304 USA		Sahbaie, P (corresponding author), Stanford Univ, Sch Med, Dept Anesthesia Perioperat & Pain Med, Stanford, CA 94305 USA.; Sahbaie, P (corresponding author), Vet Affairs Palo Alto Hlth Care Syst, Anesthesiol Serv, 3801 Miranda Ave,112-A, Palo Alto, CA 94304 USA.	psahbaie@stanford.edu			VA Merit Review awardUS Department of Veterans Affairs [1I01RX001776]; Department of DefenseUnited States Department of Defense [MR130295]	This work was supported by the VA Merit Review award 1I01RX001776 and Department of Defense award MR130295 to J.D.C.	Abe K, 2016, NEUROL RES, V38, P358, DOI 10.1080/01616412.2015.1110402; Bobinski F, 2015, PAIN, V156, P2595, DOI 10.1097/j.pain.0000000000000372; Carlson JD, 2007, J NEUROSCI, V27, P13222, DOI 10.1523/JNEUROSCI.3715-07.2007; CHAPLAN SR, 1994, J NEUROSCI METH, V53, P55, DOI 10.1016/0165-0270(94)90144-9; Chen YH, 2009, J NEUROSCI RES, V87, P418, DOI 10.1002/jnr.21860; Defrin R, 2015, J NEUROTRAUM, V32, P28, DOI 10.1089/neu.2014.3359; Feliciano DP, 2014, NEUROSCI LETT, V583, P55, DOI 10.1016/j.neulet.2014.09.030; Gencer A, 2015, DRUG RES, V65, P645, DOI 10.1055/s-0034-1398550; Gironda RJ, 2009, REHABIL PSYCHOL, V54, P247, DOI 10.1037/a0016906; Guo W, 2014, MOL PAIN, V10, DOI 10.1186/1744-8069-10-35; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Irvine KA, 2018, J NEUROTRAUM, V35, P1495, DOI 10.1089/neu.2017.5411; Irvine KA, 2019, EXP NEUROL, V320, DOI 10.1016/j.expneurol.2019.112976; Irvine KA, 2018, PAIN MED, V19, P1315, DOI 10.1093/pm/pnx153; Jang SH, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000004017; Kennedy DL, 2016, PAIN, V157, P2410, DOI 10.1097/j.pain.0000000000000689; Kornum BR, 2006, NEUROSCI LETT, V392, P129, DOI 10.1016/j.neulet.2005.09.013; Liang DY, 2017, IBRO REP, V2, P14, DOI 10.1016/j.ibror.2016.12.001; Liang DY, 2017, MOL PAIN, V13, DOI 10.1177/1744806917730212; Liang DY, 2011, ANESTHESIOLOGY, V114, P1180, DOI 10.1097/ALN.0b013e31820efb19; Lucas S, 2015, CURR PAIN HEADACHE R, V19, DOI 10.1007/s11916-015-0520-1; Luo J, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00012; Macolino CM, 2014, J NEUROSCI METH, V226, P139, DOI 10.1016/j.jneumeth.2014.01.008; Marion DW, 2011, J NEUROTRAUM, V28, P517, DOI 10.1089/neu.2010.1638; Marshall TM, 2012, PAIN, V153, P86, DOI 10.1016/j.pain.2011.09.021; Meidahl AC, 2018, HEADACHE, V58, P545, DOI 10.1111/head.13248; Nampiaparampil DE, 2008, JAMA-J AM MED ASSOC, V300, P711, DOI 10.1001/jama.300.6.711; Nguyen R, 2016, CAN J NEUROL SCI, V43, P774, DOI 10.1017/cjn.2016.290; Oatway MA, 2004, PAIN, V110, P259, DOI 10.1016/j.pain.2004.03.040; Ofek H, 2007, PAIN, V131, P330, DOI 10.1016/j.pain.2007.06.015; Ossipov MH, 2014, CURR OPIN SUPPORT PA, V8, P143, DOI 10.1097/SPC.0000000000000055; Ossipov MH, 2010, J CLIN INVEST, V120, P3779, DOI 10.1172/JCI43766; Otto VI, 2001, NEUROREPORT, V12, P2059, DOI 10.1097/00001756-200107030-00053; Poree LR, 1998, ANESTH ANALG, V87, P941, DOI 10.1097/00000539-199810000-00037; Rahman W, 2004, NEUROSCI LETT, V361, P229, DOI 10.1016/j.neulet.2003.12.069; Roberts J, 2009, EUR J NEUROSCI, V30, P229, DOI 10.1111/j.1460-9568.2009.06813.x; Sagalajev B, 2015, BEHAV BRAIN RES, V282, P14, DOI 10.1016/j.bbr.2014.12.052; Sahbaie P, 2018, J PAIN, V19, P1392, DOI 10.1016/j.jpain.2018.06.004; Sahbaie P, 2014, ANESTH ANALG, V118, P1336, DOI 10.1213/ANE.0000000000000189; SAWYNOK J, 1994, EUR J PHARMACOL, V264, P249, DOI 10.1016/0014-2999(94)00465-X; Stroman PW, 2016, J NEUROTRAUM, V33, P1450, DOI 10.1089/neu.2015.4257; Studlack PE, 2018, BRAIN INJURY, V32, P1866, DOI 10.1080/02699052.2018.1536282; Sun Y, 2014, J PAIN, V15, P856, DOI 10.1016/j.jpain.2014.05.003; Sun Y, 2013, ANESTHESIOLOGY, V119, P1198, DOI 10.1097/ALN.0b013e31829ce340; Suzuki R, 2004, BRAIN RES, V1019, P68, DOI 10.1016/j.brainres.2004.05.108; Tajerian M, 2015, NEUROBIOL LEARN MEM, V123, P100, DOI 10.1016/j.nlm.2015.06.004; Valko PO, 2016, SLEEP, V39, P1249, DOI 10.5665/sleep.5844; Zhang XD, 2016, ADV MATER, V28, P6872, DOI 10.1002/adma.201600706; Zhang ZJ, 2013, PAIN, V154, P2185, DOI 10.1016/j.pain.2013.07.002	49	7	7	1	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	DEC 20	2019	9								19500	10.1038/s41598-019-55739-x			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KE9KJ	WOS:000508868500025	31863005	Green Published, gold			2022-02-06	
J	Pomytkin, I; Krasil'nikova, I; Bakaeva, Z; Surin, A; Pinelis, V				Pomytkin, Igor; Krasil'nikova, Irina; Bakaeva, Zanda; Surin, Alexander; Pinelis, Vsevolod			Excitotoxic glutamate causes neuronal insulin resistance by inhibiting insulin receptor/Akt/mTOR pathway	MOLECULAR BRAIN			English	Article						Insulin; Glutamate excitotoxicity; Central insulin resistance	PROTEIN-KINASE B	Aim: An impaired biological response to insulin in the brain, known as central insulin resistance, was identified during stroke and traumatic brain injury, for which glutamate excitotoxicity is a common pathogenic factor. The exact molecular link between excitotoxicity and central insulin resistance remains unclear. To explore this issue, the present study aimed to investigate the effects of glutamate-evoked increases in intracellular free Ca2+ concentrations [Ca2+]i and mitochondrial depolarisations, two key factors associated with excitotoxicity, on the insulin-induced activation of the insulin receptor (IR) and components of the Akt/mammalian target of rapamycin (mTOR) pathway in primary cultures of rat cortical neurons. Methods: Changes in [Ca2+](i) and mitochondrial inner membrane potentials (Delta psi(m)) were monitored in rat cultured cortical neurons, using the fluorescent indicators Fura-FF and Rhodamine 123, respectively. The levels of active, phosphorylated signalling molecules associated with the IR/Akt/mTOR pathway were measured with the multiplex fluorescent immunoassay. Results: When significant mitochondrial depolarisations occurred due to glutamate-evoked massive influxes of Ca2+ into the cells, insulin induced 48% less activation of the IR (assessed by IR tyrosine phosphorylation, pY(1150/1151)), 72% less activation of Akt (assessed by Akt serine phosphorylation, pS473), 44% less activation of mTOR (assessed by mTOR pS(2448)), and 38% less inhibition of glycogen synthase kinase beta (GSK3 beta) (assessed by GSK3 beta pS(9)) compared with respective controls. These results suggested that excitotoxic glutamate inhibits signalling via the IR/Akt/mTOR pathway at multiple levels, including the IR, resulting in the development of acute neuronal insulin resistance within minutes, as an early pathological event associated with excitotoxicity.	[Pomytkin, Igor] IM Sechenov First Moscow State Med Univ, Inst Regenerat Med, Trubetskaya St 8, Moscow 119991, Russia; [Pomytkin, Igor] Fed Med & Biol Agcy, Sci Ctr Biomed Technol, Svetlye Gory 143442, Moscow Region, Russia; [Krasil'nikova, Irina; Bakaeva, Zanda; Surin, Alexander; Pinelis, Vsevolod] Russian Minist Hlth, Natl Med Res Ctr Childrens Hlth, Lomonosovs Prospect 2, Moscow 119991, Russia; [Surin, Alexander] Inst Gen Pathol & Pathophysiol, Baltiyskaya St 8, Moscow 125315, Russia		Pomytkin, I (corresponding author), IM Sechenov First Moscow State Med Univ, Inst Regenerat Med, Trubetskaya St 8, Moscow 119991, Russia.; Pomytkin, I (corresponding author), Fed Med & Biol Agcy, Sci Ctr Biomed Technol, Svetlye Gory 143442, Moscow Region, Russia.	ipomytkin@mail.ru	Bakaeva, Zanda/AAO-5674-2020; Krasilnikova, Irina/ABD-3784-2020; Krasilnikova, Irina/AAO-3767-2020; Pinelis, Vsevood/K-5564-2017	Bakaeva, Zanda/0000-0002-2797-3270; Krasilnikova, Irina/0000-0001-9453-3040; Pomytkin, Igor/0000-0002-8426-3371; Pinelis, Vsevood/0000-0001-8579-605X	Russian Ministry of Health [AAAA-A19-119012590191-3]	This work was supported by Russian Ministry of Health, the project N. AAAA-A19-119012590191-3.	Abramov AY, 2008, BBA-BIOENERGETICS, V1777, P953, DOI 10.1016/j.bbabio.2008.04.017; Alessi DR, 1996, EMBO J, V15, P6541, DOI 10.1002/j.1460-2075.1996.tb01045.x; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Duchen MR, 2003, METHOD ENZYMOL, V361, P353; Guerriero RM, 2015, CURR NEUROL NEUROSCI, V15, DOI 10.1007/s11910-015-0545-1; Karelina K, 2016, EUR J NEUROSCI, V43, P1034, DOI 10.1111/ejn.13194; Krasil'nikova I, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.01027; Lai TW, 2014, PROG NEUROBIOL, V115, P157, DOI 10.1016/j.pneurobio.2013.11.006; Nave BT, 1999, BIOCHEM J, V344, P427, DOI 10.1042/0264-6021:3440427; Nicholls DG, 2004, CURR MOL MED, V4, P149, DOI 10.2174/1566524043479239; Persiyantseva Nadezhda A, 2013, J Mol Signal, V8, P11, DOI 10.1186/1750-2187-8-11; Storozhevykh TP, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-84; WHITE MF, 1994, J BIOL CHEM, V269, P1; Zhao WQ, 2008, FASEB J, V22, P246, DOI 10.1096/fj.06-7703com; Zhao WQ, 1999, J BIOL CHEM, V274, P34893, DOI 10.1074/jbc.274.49.34893	15	7	8	1	1	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1756-6606		MOL BRAIN	Mol. Brain	DEC 19	2019	12	1							112	10.1186/s13041-019-0533-5			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	KH8DG	WOS:000510878600001	31856878	gold, Green Published			2022-02-06	
J	Li, N; Wang, P; Liu, XL; Han, C; Ren, W; Li, T; Li, X; Tao, FY; Zhao, ZW				Li, Na; Wang, Peng; Liu, Xiaolong; Han, Chao; Ren, Wei; Li, Tuo; Li, Xing; Tao, Fengyun; Zhao, Zhenwen			Developing IR-780 as a Novel Matrix for Enhanced MALDI MS Imaging of Endogenous High-Molecular-Weight Lipids in Brain Tissues	ANALYTICAL CHEMISTRY			English	Article							DESORPTION/IONIZATION MASS-SPECTROMETRY; NEGATIVE-ION MATRIX; POSITIONAL ISOMERS; IONIZATION; MOBILITY; ACID; PHOSPHOLIPIDS; CARDIOLIPINS; ADVANCEMENTS; BIOMARKERS	The matrix plays a prominent role in expanding the ability of matrix assisted laser desorption/ionization mass spectrometry (MALDI MS). However, on account of the unclarity of necessary properties of the matrix in MALDI MS, development of a new matrix is still in the exploratory stage and lacks systematic theoretical guidance. Meanwhile, most of the existing matrices are unable to simultaneously detect various high-molecular-weight (high-MW) lipids including (poly-)phosphoinositides, cardiolipins, and gangliosides. In this study, we have successfully screened and optimized the application of commercially available IR-780 as a novel matrix for simultaneously profiling and imaging high-MW lipids in brain tissues by MALDI MS for the first time. The properties of IR-780 related to the matrix of MALDI MS, mainly including the optical properties (UV absorption, fluorescence emission, and photothermal efficiency), proton affinity, collision cross-sections (CCSs), salt-tolerance ability, and homogeneity, were comprehensively characterized, which demonstrated that high photothermal ability and large CCSs might guarantee the superior performance of IR-780 as matrix for the analysis of high-MW lipids in biological samples. This work provided some references for the development of a novel matrix, and especially, the concept of CCS was first introduced as a parameter for the development of a matrix. In addition, the simultaneous identification and imaging of endogenous high-MW lipids in rat brain tissues subjected to traumatic brain injury were successfully performed.	[Li, Na; Liu, Xiaolong; Han, Chao; Ren, Wei; Li, Tuo; Li, Xing; Zhao, Zhenwen] Chinese Acad Sci, Inst Chem,Key Lab Mol Nanostruct & Nanotechnol, Beijing Mass Spectrum Ctr,Key Lab Analyt Chem Liv, CAS Res Educ Ctr Excellence Mol Sci,Beijing Natl, Beijing 100190, Peoples R China; [Wang, Peng; Tao, Fengyun] Beijing Union Univ, Coll Biochem Engn, Beijing 100023, Peoples R China; [Li, Na; Han, Chao; Ren, Wei; Li, Tuo; Li, Xing; Zhao, Zhenwen] Univ Chinese Acad Sci, Grad Sch, Beijing 100049, Peoples R China		Zhao, ZW (corresponding author), Chinese Acad Sci, Inst Chem,Key Lab Mol Nanostruct & Nanotechnol, Beijing Mass Spectrum Ctr,Key Lab Analyt Chem Liv, CAS Res Educ Ctr Excellence Mol Sci,Beijing Natl, Beijing 100190, Peoples R China.; Zhao, ZW (corresponding author), Univ Chinese Acad Sci, Grad Sch, Beijing 100049, Peoples R China.	zhenwenzhao@iccas.ac.cn	Wei, Ren/J-7185-2019	Wei, Ren/0000-0002-5245-451X	National Key R&D Program of China [2018YFA0506900]; National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [21575146, 21635008, 21621062]	This work was supported by the National Key R&D Program of China (Grant Nos. 2018YFA0506900), and National Natural Science Foundation of China (21575146, 21635008, and 21621062). We are grateful to Prof. Jiang Zhou (Peking University, Beijing, People's Republic of China) for his technical assistance in the detection of CCS.	Amoscato AA, 2014, ANAL CHEM, V86, P6587, DOI 10.1021/ac5011876; Angelini R, 2015, J LIPID RES, V56, P1787, DOI 10.1194/jlr.D059824; Bae YJ, 2015, ANNU REV ANAL CHEM, V8, P41, DOI 10.1146/annurev-anchem-081413-024102; Baker TC, 2017, CURR OPIN BIOTECH, V43, P62, DOI 10.1016/j.copbio.2016.09.003; Bakker B, 2017, ANAL CHEM, V89, P9438, DOI 10.1021/acs.analchem.7b02265; Bijlsma L, 2017, ANAL CHEM, V89, P6583, DOI 10.1021/acs.analchem.7b00741; Bird SS, 2011, ANAL CHEM, V83, P940, DOI 10.1021/ac102598u; Brazil DP, 2002, CELL, V111, P293, DOI 10.1016/S0092-8674(02)01083-8; Buchberger AR, 2018, ANAL CHEM, V90, P240, DOI 10.1021/acs.analchem.7b04733; Bush MF, 2012, ANAL CHEM, V84, P7124, DOI 10.1021/ac3014498; Byeon SK, 2012, J CHROMATOGR A, V1270, P246, DOI 10.1016/j.chroma.2012.11.012; Chen R, 2012, ANAL CHEM, V84, P465, DOI 10.1021/ac202438a; Cuyckens F, 2011, RAPID COMMUN MASS SP, V25, P3497, DOI 10.1002/rcm.5258; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; Di Paolo G, 2011, NAT REV NEUROSCI, V12, P284, DOI 10.1038/nrn3012; Ledesma MD, 2012, PROG LIPID RES, V51, P23, DOI 10.1016/j.plipres.2011.11.004; Dreisewerd K, 2003, CHEM REV, V103, P395, DOI 10.1021/cr010375i; Frisch M.J., 2016, GAUSSIAN 16 REVISION; Fulop A, 2013, ANAL CHEM, V85, P9156, DOI 10.1021/ac4018154; Giampa M, 2016, CHEM COMMUN, V52, P9801, DOI 10.1039/c6cc02387h; Giles K, 2011, RAPID COMMUN MASS SP, V25, P1559, DOI 10.1002/rcm.5013; Gode D, 2013, ANALYST, V138, P1289, DOI 10.1039/c2an36337b; Guan M, 2018, TALANTA, V179, P624, DOI 10.1016/j.talanta.2017.11.067; Hadjiconstantinou M, 1998, J NEUROCHEM, V70, P1335; He HX, 2019, ANAL CHEM, V91, P2634, DOI 10.1021/acs.analchem.8b03522; Horneffer V, 1999, INT J MASS SPECTROM, V185, P859, DOI 10.1016/S1387-3806(98)14218-5; Iadecola C, 2011, NAT NEUROSCI, V14, P1363, DOI 10.1038/nn.2953; Ibrahim H, 2017, ANAL CHEM, V89, P12828, DOI 10.1021/acs.analchem.7b03284; JONAS V, 1994, J AM CHEM SOC, V116, P8741, DOI 10.1021/ja00098a037; Kameoka S, 2018, TRENDS CELL BIOL, V28, P67, DOI 10.1016/j.tcb.2017.08.011; Ketel K, 2016, NATURE, V529, P408, DOI 10.1038/nature16516; Kimura T, 2016, PROG LIPID RES, V62, P75, DOI 10.1016/j.plipres.2016.02.001; Kirmess KM, 2016, J MASS SPECTROM, V51, P79, DOI 10.1002/jms.3725; Knochenmuss R, 2003, CHEM REV, V103, P441, DOI 10.1021/cr0103773; Knochenmuss R, 2000, J MASS SPECTROM, V35, P1237, DOI 10.1002/1096-9888(200011)35:11<1237::AID-JMS74>3.0.CO;2-O; Knochenmuss R, 2014, ANALYST, V139, P147, DOI 10.1039/c3an01446k; Leopold J, 2018, BIOMOLECULES, V8, DOI 10.3390/biom8040173; Li B, 2019, ANAL CHEM, V91, P8221, DOI 10.1021/acs.analchem.9b00803; Li ST, 2016, SCI REP-UK, V6, DOI 10.1038/srep32588; Liu HH, 2018, ANAL CHEM, V90, P729, DOI 10.1021/acs.analchem.7b02710; Martensson CU, 2017, BBA-MOL CELL BIOL L, V1862, P102, DOI 10.1016/j.bbalip.2016.06.015; McDonnell LA, 2007, MASS SPECTROM REV, V26, P606, DOI 10.1002/mas.20124; Mirabelli MF, 2017, J AM SOC MASS SPECTR, V28, P1676, DOI 10.1007/s13361-017-1677-0; Ng KM, 2015, J PHYS CHEM C, V119, P23708, DOI 10.1021/acs.jpcc.5b05957; O'Rourke MB, 2018, MASS SPECTROM REV, V37, P217, DOI 10.1002/mas.21515; Romine J, 2014, VISUALIZED EXP; Rustam YH, 2018, ANAL CHEM, V90, P374, DOI 10.1021/acs.analchem.7b04836; Schiller J, 2002, ANAL BIOCHEM, V309, P311, DOI 10.1016/S0003-2697(02)00308-1; Shevchenko A, 2010, NAT REV MOL CELL BIO, V11, P593, DOI 10.1038/nrm2934; Soltwisch J, 2015, SCIENCE, V348, P211, DOI 10.1126/science.aaa1051; Sparvero LJ, 2016, J NEUROCHEM, V139, P659, DOI 10.1111/jnc.13840; Sparvero LJ, 2010, J NEUROCHEM, V115, P1322, DOI 10.1111/j.1471-4159.2010.07055.x; Tatsuta T, 2017, BBA-MOL CELL BIOL L, V1862, P81, DOI 10.1016/j.bbalip.2016.08.006; Tian H, 2017, ANAL CHEM, V89, P4611, DOI 10.1021/acs.analchem.7b00164; Tyurina YY, 2014, NAT CHEM, V6, P542, DOI [10.1038/nchem.1924, 10.1038/NCHEM.1924]; Woods AS, 2013, ACS CHEM NEUROSCI, V4, P594, DOI 10.1021/cn300216h; Zenobi R, 1998, MASS SPECTROM REV, V17, P337, DOI 10.1002/(SICI)1098-2787(1998)17:5<337::AID-MAS2>3.0.CO;2-S; Zhang JL, 2016, CANCER RES, V76, P6588, DOI 10.1158/0008-5472.CAN-16-1545; Zhang YY, 2016, SCI REP-UK, V6, DOI 10.1038/srep25289; Zhang YY, 2016, TALANTA, V150, P88, DOI 10.1016/j.talanta.2015.12.021; Zhao ZW, 2010, J LIPID RES, V51, P652, DOI 10.1194/jlr.D001503	61	7	7	8	69	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	0003-2700	1520-6882		ANAL CHEM	Anal. Chem.	DEC 17	2019	91	24					15873	15882		10.1021/acs.analchem.9b04315			10	Chemistry, Analytical	Science Citation Index Expanded (SCI-EXPANDED)	Chemistry	JX7KW	WOS:000503910600073	31718156				2022-02-06	
J	Newell, EA; Todd, BP; Luo, ZL; Evans, LP; Ferguson, PJ; Bassuk, AG				Newell, Elizabeth A.; Todd, Brittany P.; Luo, Zili; Evans, Lucy P.; Ferguson, Polly J.; Bassuk, Alexander G.			A Mouse Model for Juvenile, Lateral Fluid Percussion Brain Injury Reveals Sex-Dependent Differences in Neuroinflammation and Functional Recovery	JOURNAL OF NEUROTRAUMA			English	Article						age-dependent; FPI; function; neuroinflammation; sex	CEREBROSPINAL-FLUID; MICE; RAT; VULNERABILITY; PREDICTORS; PLASTICITY; MORPHOLOGY; MORTALITY; RESPONSES; INFANTS	Traumatic brain injury (TBI) is a leading cause of death and disability that lacks targeted therapies. Successful translation of promising neuroprotective therapies will likely require more precise identification of target populations through greater study of crucial biological factors like age and sex. A growing body of work supports the impact of these factors on response to and recovery from TBI. However, age and sex are understudied in TBI animal models. The first aim of this study was to demonstrate the feasibility of lateral fluid percussion injury (FPI) in juvenile mice as a model of pediatric TBI. Subsequently, we were interested in examining the impact of young age and sex on TBI outcome. After adapting the lateral FPI model to 21-day-old male and female mice, we characterized the molecular, histological, and functional outcomes. Whereas similar tissue injury was observed in male and female juvenile mice exposed to TBI, we observed differences in neuroinflammation and neurobehavioral function. Overall, our findings revealed less acute inflammatory cytokine expression, greater subacute microglial/macrophage accumulation, and greater neurological recovery in juvenile male mice after TBI. Given that ongoing brain development may affect progression of and recovery from TBI, juvenile models are of critical importance. The sex-dependent differences we discovered after FPI support the necessity of also including this biological variable in future TBI studies. Understanding the mechanisms underlying age- and sex-dependent differences may result in the discovery of novel therapeutic targets for TBI.	[Newell, Elizabeth A.; Todd, Brittany P.; Luo, Zili; Evans, Lucy P.; Ferguson, Polly J.; Bassuk, Alexander G.] Univ Iowa, Dept Pediat, Iowa City, IA 52242 USA; [Evans, Lucy P.; Bassuk, Alexander G.] Univ Iowa, Med Scientist Training Program, Iowa City, IA USA		Bassuk, AG (corresponding author), Univ Iowa Hosp & Clin, Dept Pediat, 200 Hawkins Dr, Iowa City, IA 52242 USA.	alexander-bassuk@uiowa.edu		Bassuk, Alexander/0000-0002-4067-2157; Newell, Elizabeth/0000-0002-1476-033X	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [K12 HD027748, K08NS110829, R01NS098590]	This work was supported by NIH grants K12 HD027748 (to E.A.N.), K08NS110829 (to E.A.N.), R01NS098590 (to A.G.B., P.J.F.), and R01NS098590 (to P.J.F.).	Anderson V, 2005, PEDIATRICS, V116, P1374, DOI 10.1542/peds.2004-1728; Anderson V, 2012, J NEUROTRAUM, V29, P143, DOI 10.1089/neu.2011.2012; Arambula SE, 2019, EXP NEUROL, V317, P168, DOI 10.1016/j.expneurol.2019.02.016; Badaut J, 2020, J NEUROSCI RES, V98, P129, DOI 10.1002/jnr.24415; Brickler TR, 2018, J NEUROSCI, V38, P9618, DOI 10.1523/JNEUROSCI.0914-18.2018; Fenn AM, 2015, J NEUROTRAUM, V32, P127, DOI 10.1089/neu.2014.3514; Friess SH, 2015, J NEUROTRAUM, V32, P791, DOI 10.1089/neu.2014.3564; Iverson GL, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097729; Jullienne A, 2018, J NEUROTRAUM, V35, P1646, DOI 10.1089/neu.2017.5547; Kochanek PM, 2020, J NEUROTRAUM, V37, P2353, DOI 10.1089/neu.2018.6203; LEVIN HS, 1992, NEUROSURGERY, V31, P435, DOI 10.1227/00006123-199209000-00008; Maria NSS, 2019, EXP NEUROL, V318, P78, DOI 10.1016/j.expneurol.2019.04.016; Meconi A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197187; MICHAUD LJ, 1992, NEUROSURGERY, V31, P254, DOI 10.1227/00006123-199208000-00010; Morrison Wynne E, 2004, Pediatr Crit Care Med, V5, P145, DOI 10.1097/01.PCC.0000112373.71645.2A; Mouzon B, 2019, J NEUROTRAUM, V36, P576, DOI 10.1089/neu.2018.5720; Mychasiuk R, 2014, BEHAV BRAIN RES, V259, P284, DOI 10.1016/j.bbr.2013.10.048; Nasr IW, 2019, EXP NEUROL, V320, DOI 10.1016/j.expneurol.2019.112957; Newell E, 2015, PEDIATR CRIT CARE ME, V16, P549, DOI 10.1097/PCC.0000000000000400; Newell EA, 2018, ENEURO, V5, DOI 10.1523/ENEURO.0385-17.2018; Prins ML, 1996, DEV BRAIN RES, V95, P272, DOI 10.1016/S0165-3806(96)00098-3; Sarnaik A, 2018, NEUROCRIT CARE, V28, P302, DOI 10.1007/s12028-017-0480-x; Satchell MA, 2005, J CEREBR BLOOD F MET, V25, P919, DOI 10.1038/sj.jcbfm.9600088; Schurman LD, 2017, NEUROSCI LETT, V653, P31, DOI 10.1016/j.neulet.2017.05.032; Schwarz JM, 2012, J NEUROCHEM, V120, P948, DOI 10.1111/j.1471-4159.2011.07630.x; Semple BD, 2017, BEHAV BRAIN RES, V319, P48, DOI 10.1016/j.bbr.2016.10.045; Semple BD, 2013, PROG NEUROBIOL, V106, P1, DOI 10.1016/j.pneurobio.2013.04.001; Spani CB, 2018, FRONT NEUROENDOCRIN, V50, P52, DOI 10.1016/j.yfrne.2018.03.006; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Thompson HJ, 2005, J NEUROTRAUM, V22, P42, DOI 10.1089/neu.2005.22.42; Velosky AG, 2017, BEHAV BRAIN RES, V324, P115, DOI 10.1016/j.bbr.2017.02.017; Villapol S, 2017, GLIA, V65, P1423, DOI 10.1002/glia.23171; Wagner AK, 2004, BRAIN RES, V998, P113, DOI 10.1016/j.brainres.2003.11.027; Wallisch JS, 2017, NEUROCRIT CARE, V27, P44, DOI 10.1007/s12028-017-0378-7; Webster KM, 2019, J COMP NEUROL, V527, P1102, DOI 10.1002/cne.24589; White ER, 2017, J NEUROTRAUM, V34, P1111, DOI 10.1089/neu.2016.4638; Yamakawa GR, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187218; Zhao S, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25475-9; Zhou J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057503	39	7	7	0	1	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	FEB 15	2020	37	4					635	646		10.1089/neu.2019.6675		DEC 2019	12	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	KI3UL	WOS:000504861700001	31621484	Green Published, hybrid			2022-02-06	
J	Becker, S; Berger, J; Backfisch, M; Ludwig, O; Kelm, J; Frohlich, M				Becker, Stephan; Berger, Joshua; Backfisch, Marco; Ludwig, Oliver; Kelm, Jens; Froehlich, Michael			Effects of a 6-Week Strength Training of the Neck Flexors and Extensors on the Head Acceleration during Headers in Soccer	JOURNAL OF SPORTS SCIENCE AND MEDICINE			English	Article						Heading; kinetics; head-neck-torso-alignment; neck musculature; repetitive head impacts; concussion	IMPACT FORCE; FOOTBALL; PERFORMANCE; CONCUSSION	The importance of well trained and stable neck flexors and extensors as well as trunk muscles for intentional headers in soccer is increasingly discussed. The neck flexors and extensors should ensure a coupling of trunk and head at the time of ball contact to increase the physical mass hitting the ball and reduce head acceleration. The aim of the study was to analyze the influence of a 6-week strength training program (neck flexors, neck extensors) on the acceleration of the head during standing, jumping and running headers as well as after fatigue of the trunk muscles on a pendulum header. A total of 33 active male soccer players (20.3 +/- 3.6 years, 1.81 +/- 0.07 m, 75.5 +/- 8.3 kg) participated and formed two training intervention groups (IG1: independent adult team, IG2: independent youth team) and one control group (CG: players from different teams). The training intervention consisted of three exercises for the neck flexors and extensors. The training effects were verified by means of the isometric maximum voluntary contraction (IMVC) measured by a telemetric Noraxon DTS force sensor. The head acceleration during ball contact was determined using a telemetric Noraxon DTS 3D accelerometer. There was no significant change of the IMVC over time between the groups (F=2.265, p=.121). Head acceleration was not reduced significantly for standing (IG1 0.4 +/- 2.0, IG2 0.1 +/- 1.4, CG -0.4 +/- 1.2; F = 0.796, p = 0.460), jumping (IG1 -0.7 +/- 1.4, IG2 -0.2 +/- 0.9, CG 0.1 +/- 1.2; F = 1.272, p = 0.295) and running (IG1 -1.0 +/- 1.9, IG2 -0.2 +/- 1.4, CG -0.1 +/- 1.6; F = 1.050, p = 0.362) headers as well as after fatigue of the trunk musculature for post-jumping (IG1 -0.2 +/- 2.1, IG2 -0.6 +/- 1.4; CG -0.6 +/- 1.3; F = 0.184, p = 0.833) and post-running (IG1 -0.3 +/- 1.6, IG2 -0.7 +/- 1.2, CG 0.0 +/- 1.4; F = 0.695, p = 0.507) headers over time between IG1, IG2 and CG. A 6-week strength training of the neck flexors and neck extensors could not show the presumed preventive benefit. Both the effects of a training intervention and the consequences of an effective intervention for the acceleration of the head while heading seem to be more complex than previously assumed and presumably only come into effect in case of strong impacts.	[Becker, Stephan; Berger, Joshua; Backfisch, Marco; Ludwig, Oliver; Froehlich, Michael] Tech Univ Kaiserslautern, Dept Sport Sci, D-67663 Kaiserslautern, Germany; [Kelm, Jens] Saarland Univ, Med Fac, Homburg Saar, Germany		Becker, S (corresponding author), Tech Univ Kaiserslautern, Dept Sport Sci, D-67663 Kaiserslautern, Germany.	stephan.becker@sowi.uni-kl.de; joshua.berger@sowi.uni-kl.de; marco.backfisch@sowi.uni-kl.de; oliver.ludwig@sowi.uni-kl.de; jens.kelm@chirurie-illinen.de; michael.froehlich@sowi.uni-kl.de		Becker, Stephan/0000-0002-0115-7064; Frohlich, Michael/0000-0003-1982-6374			Babbs C F, 2001, ScientificWorldJournal, V1, P281; Bauer JA, 2001, J SPORT SCI, V19, P171, DOI 10.1080/026404101750095312; Beaudouin F., 2017, BRIT J SPORT MED, V51, pA65; Becker S., 2013, BRIT J SPORT MED, V47, P39; Becker S., 2019, J FUNCTIONAL MORPHOL, V4, P1; Becker S, 2018, SPORTS, V6, DOI 10.3390/sports6020033; Becker S, 2017, SPORTS, V5, DOI 10.3390/sports5010010; Borg G., 1998, BORGS PERCEIVED EXER; Bretzin AC, 2017, SPORTS HEALTH, V9, P168, DOI 10.1177/1941738116678615; Broglio S.P., 2015, CONCUSSION, V1, P201; Busch D., 2016, LEISTUNGSSPORT, V46, P30; Caccese JB, 2018, NEUROLOGY, V91, pS26; Caccese JB, 2018, SPORT BIOMECH, V17, P462, DOI 10.1080/14763141.2017.1360385; Caccese JB, 2016, SPORTS MED, V46, P1591, DOI 10.1007/s40279-016-0544-7; Cusimano MD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058868; Dezman ZDW, 2013, SPORTS HEALTH, V5, P320, DOI 10.1177/1941738113480935; Gutierrez GM, 2014, PEDIATR EXERC SCI, V26, P33, DOI 10.1123/pes.2013-0102; Hanlon EM, 2012, MED SCI SPORT EXER, V44, P1102, DOI 10.1249/MSS.0b013e3182444d7d; Hohmann A., 2010, EINFUHRUNG TRAININGS; Kirkendall D.T., 2011, SOCCER ANATOMY YOUR; Kruyning E., 2014, MMA ESSENTIALS MIXED; Lamond LC, 2018, J ATHL TRAINING, V53, P115, DOI 10.4085/1062-6050-90-17; Lipton ML, 2013, RADIOLOGY, V268, P850, DOI 10.1148/radiol.13130545; Lisman P., 2012, INT J SPORTS SCI ENG, V6, P131; LUO ZP, 1991, J BIOMECH, V24, P499, DOI 10.1016/0021-9290(91)90284-T; Mansell J, 2005, J ATHL TRAINING, V40, P310; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Naunheim RS, 2003, MED SCI SPORT EXER, V35, P1406, DOI 10.1249/01.MSS.0000078933.84527.AE; O'Kane JW, 2016, PHYSICIAN SPORTSMED, V44, P190, DOI 10.1080/00913847.2016.1149423; Press JN, 2017, CLIN J SPORT MED, V27, P104, DOI 10.1097/JSM.0000000000000313; Queen RM, 2003, MED SCI SPORT EXER, V35, P2069, DOI 10.1249/01.MSS.0000099081.20125.A5; Sarmento H, 2018, SPORTS MED, V48, P799, DOI 10.1007/s40279-017-0836-6; SCHNEIDER K, 1988, INT J SPORT BIOMECH, V4, P358, DOI 10.1123/ijsb.4.4.358; Schubert M, 2008, EUR J NEUROSCI, V27, P2007, DOI 10.1111/j.1460-9568.2008.06186.x; Shewchenko N, 2005, BRIT J SPORT MED, V39, pI10, DOI 10.1136/bjsm.2005.019034; Shewchenko N, 2005, BRIT J SPORT MED, V39, pI26, DOI 10.1136/bjsm.2005.019042; Stewart WF, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00240; Sunami S, 2008, FOOTBALL SCI, V5, P7; Tarnutzer AA, 2017, BRIT J SPORT MED, V51, P1592, DOI 10.1136/bjsports-2016-096593; Teymouri M, 2012, ARCH TRAUMA RES, V1, P44, DOI [10.5812/atr.5399, 10.5812/atr.5307]; Tierney R.T., 2008, J ATHL TRAINING, V43, P163; Tschopp M., 2001, SWISS J SPORTS MED S, V49, P67; Willardson JM, 2007, J STRENGTH COND RES, V21, P979; Winchester JB, 2008, J STRENGTH COND RES, V22, P1728, DOI 10.1519/JSC.0b013e3181821abb; World Med Assoc, 2013, JAMA-J AM MED ASSOC, V310, P2191, DOI 10.1001/jama.2013.281053; Yang YT, 2016, JAMA PEDIATR, V170, P413, DOI 10.1001/jamapediatrics.2016.0338	46	7	7	0	9	JOURNAL SPORTS SCIENCE & MEDICINE	BURSA	MEDICAL FACULTY ULUDAG UNIV, DEPT SPORTS MEDICINE, BURSA, 16059, TURKEY	1303-2968			J SPORT SCI MED	J. Sport. Sci. Med.	DEC	2019	18	4					729	737					9	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	JP0HA	WOS:000497951600017	31827358				2022-02-06	
J	Breedlove, KM; Ortega, JD; Kaminski, TW; Harmon, KG; Schmidt, JD; Kontos, AP; Clugston, JR; Chrisman, SPD; McCrea, MA; McAllister, TW; Broglio, SP; Buckley, TA				Breedlove, Katherine M.; Ortega, Justus D.; Kaminski, Thomas W.; Harmon, Kimberly G.; Schmidt, Julianne D.; Kontos, Anthony P.; Clugston, James R.; Chrisman, Sara P. D.; McCrea, Michael A.; McAllister, Thomas W.; Broglio, Steven P.; Buckley, Thomas A.			King-Devick Test Reliability in National Collegiate Athletic Association Athletes: A National Collegiate Athletic Association-Department of Defense Concussion Assessment, Research and Education Report	JOURNAL OF ATHLETIC TRAINING			English	Article						mild traumatic brain injury; vision; oculomotor; baseline testing; psychometric properties	SPORTS-RELATED CONCUSSION; TRAINERS; VISION; COMMON	Context: The King-Devick (KD) test has received considerable attention in the literature as an emerging concussion assessment. However, important test psychometric properties remain to be addressed in large-scale independent studies. Objective: To assess (1) test-retest reliability between trials, (2) test-retest reliability between years 1 and 2, and (3) reliability of the 2 administration modes. Design: Cross-sectional study. Setting: Collegiate athletic training facilities. Patients or Other Participants: A total of 3248 intercollegiate student-athletes participated in year 1 (male = 55.3%, age = 20.2 +/- 2.3 years, height = 1.78 +/- 0.11 m, weight = 80.7 +/- 21.0 kg) and 833 participated in both years. Main Outcome Measure(s): Time, in seconds, to complete the KD error free. The KD test reliability was assessed between trials and between annual tests over 2 years and stratified by test modality (spiral-bound cards [n = 566] and tablet [n = 264]). Results: The KD test was reliable between trials (trial 1 = 43.2 +/- 8.3 seconds, trial 2 = 40.8 +/- 7.8 seconds; intraclass correlation coefficient [ICC] (2,1) = 0.888, P < .001), between years (year 1 = 40.8 +/- 7.4 seconds, year 2 = 38.7 +/- 7.7 seconds; ICC [2,1] = 0.827, P < .001), and for both spiral-bound cards (ICC [2,1]= 0.834, P < .001) and tablets (ICC [2,1]=0.827, P < .001). The mean change between trials for a single test was -2.4 +/- 3.8 seconds. Although most athletes improved from year 1 to year 2, 27.1% (226 of 883) of participants demonstrated worse (slower) KD times (3.2 +/- 3.9 seconds) in year 2. Conclusions: The KD test was reliable between trials and years and when stratified by modality. A small improvement of 2 seconds was identified with annual retesting, likely due to a practice effect; however, 27% of athletes displayed slowed performance from year 1 to year 2. These results suggest that the KD assessment was a reliable test with modest learning effects over time and that the assessment modality did not adversely affect baseline reliability.	[Breedlove, Katherine M.] Harvard Med Sch, Brigham & Womens Hosp, Ctr Clin Spect, Boston, MA 02115 USA; [Breedlove, Katherine M.] Harvard Med Sch, Dept Radiol, Boston, MA 02115 USA; [Ortega, Justus D.] Humboldt State Univ, Dept Kinesiol & Recreat Adm, Arcata, CA 95521 USA; [Kaminski, Thomas W.; Buckley, Thomas A.] Univ Delaware, Dept Kinesiol & Appl Physiol, 349 Tower & STAR Campus,100 Discovery Blvd, Newark, DE 19716 USA; [Harmon, Kimberly G.] Univ Washington, Dept Family Med, Seattle, WA 98195 USA; [Schmidt, Julianne D.] Univ Georgia, Dept Kinesiol, Athens, GA 30602 USA; [Kontos, Anthony P.] Univ Pittsburgh, Dept Orthopaed Surg, Pittsburgh, PA 15260 USA; [Clugston, James R.] Univ Florida, Dept Neurol, Dept Community Hlth & Family Med, Gainesville, FL USA; [Clugston, James R.] Univ Florida, Univ Athlet Assoc, Div Sports Hlth, Gainesville, FL USA; [Chrisman, Sara P. D.] Univ Washington, Seattle Childrens Res Inst, Seattle, WA 98195 USA; [Chrisman, Sara P. D.] Univ Washington, Dept Pediat, Seattle, WA 98195 USA; [McCrea, Michael A.] Med Coll Wisconsin, Dept Neurosurg, Milwaukee, WI 53226 USA; [McAllister, Thomas W.] Indiana Univ, Dept Psychiat, Indianapolis, IN USA; [Broglio, Steven P.] Univ Michigan, Sch Kinesiol, Ann Arbor, MI 48109 USA		Buckley, TA (corresponding author), Univ Delaware, Dept Kinesiol & Appl Physiol, 349 Tower & STAR Campus,100 Discovery Blvd, Newark, DE 19716 USA.	TBuckley@UDel.edu	Buckley, Thomas A/B-7525-2016	Buckley, Thomas A/0000-0002-0515-0150; Ortega, Justus/0000-0002-9931-5605; Chrisman, Sara/0000-0001-5373-7223; Clugston, James/0000-0002-2103-1039	Grand Alliance CARE Consortium - NCAA; DoDUnited States Department of Defense; Office of the Assistant Secretary of Defense for Health Affairs through the Psychological Health and Traumatic Brain Injury Program [W81XWH-14-2-0151]	We acknowledge the research team members and clinical athletic trainers who assisted in the data collection for this project. This publication was made possible, in part, by support from the Grand Alliance CARE Consortium, funded by the NCAA and the DoD. The US Army Medical Research Acquisition Activity, 820 Chandler Street, Fort Detrick, MD 21702-5014 is the awarding and administering acquisition office. This work was supported by the Office of the Assistant Secretary of Defense for Health Affairs through the Psychological Health and Traumatic Brain Injury Program under award W81XWH-14-2-0151. Opinions, interpretations, conclusions, and recommendations are those of the authors and are not necessarily endorsed by the DoD (Defense Health Program funds). King-Devick Technologies, Inc, provided iPad tablets to test sites free of charge as part of the overall study.	Alsalaheen B, 2016, SCAND J MED SCI SPOR, V26, P235, DOI 10.1111/sms.12628; Broglio SP, 2018, SPORTS MED, V48, P1255, DOI 10.1007/s40279-017-0813-0; Broglio SP, 2017, SPORTS MED, V47, P1437, DOI 10.1007/s40279-017-0707-1; Buckley TA, 2017, ORTHOP J SPORTS MED, V5, DOI 10.1177/2325967117702606; Buckley TA, 2015, J ATHL TRAINING, V50, P879, DOI 10.4085/1062-6050-50.7.04; Burk JM, 2013, CLIN J SPORT MED, V23, P312, DOI 10.1097/JSM.0b013e318285633f; Chrisman SPD, 2019, ANN BIOMED ENG, V47, P2122, DOI 10.1007/s10439-018-02150-8; Clugston JR, 2020, CLIN J SPORT MED, V30, pE139, DOI 10.1097/JSM.0000000000000691; Coronado VG, 2015, J HEAD TRAUMA REHAB, V30, P185, DOI 10.1097/HTR.0000000000000156; Erdal K, 2012, ARCH CLIN NEUROPSYCH, V27, P473, DOI 10.1093/arclin/acs050; Galetta K., 2015, CONCUSSION, V1; Galetta KM, 2011, NEUROLOGY, V76, P1456, DOI 10.1212/WNL.0b013e31821184c9; Galetta KM, 2015, J NEURO-OPHTHALMOL, V35, P235, DOI 10.1097/WNO.0000000000000226; Galetta KM, 2011, J NEUROL SCI, V309, P34, DOI 10.1016/j.jns.2011.07.039; Galetta MS, 2013, J NEUROL SCI, V328, P28, DOI 10.1016/j.jns.2013.02.008; Garcia GGP, 2019, J NEUROTRAUM, V36, P1571, DOI 10.1089/neu.2018.6098; Garcia GGP, 2018, SPORTS MED, V48, P1739, DOI 10.1007/s40279-018-0880-x; Heick JD, 2016, ATHLETIC TRAINING SP, V8, P222, DOI DOI 10.3928/19425864-20160509-01; Heitger MH, 2008, IEEE ENG MED BIO, P3570, DOI 10.1109/IEMBS.2008.4649977; Katz BP, 2018, SPORTS MED, V48, P1971, DOI 10.1007/s40279-018-0875-7; Kelly KC, 2014, J ATHL TRAINING, V49, P665, DOI 10.4085/1062-6050-49.3.25; King AT., 1976, PROPOSED KING DEVICK; Leong Danielle F, 2015, J Optom, V8, P131, DOI 10.1016/j.optom.2014.12.005; Marinides Z, 2015, NEUROL CLIN PRACT, V5, P25, DOI DOI 10.1212/CPJ.000000000; Master CL, 2016, CLIN PEDIATR, V55, P260, DOI 10.1177/0009922815594367; McCrea M, 2002, NEUROSURGERY, V50, P1032, DOI 10.1097/00006123-200205000-00017; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Molloy JH, 2017, J SCI MED SPORT, V20, P708, DOI 10.1016/j.jsams.2017.02.002; Oberlander TJ, 2017, J ATHL TRAINING, V52, P439, DOI 10.4085/1062-6050-52.2.12; Raynowska J., 2015, ANN SPORTS MED RES, V2, P1051; Smolyansky  V., 2016, OPTOM VIS PERFORM, V4, P147; Ventura RE, 2014, LANCET NEUROL, V13, P1006, DOI 10.1016/S1474-4422(14)70111-5; Watkins MP., 2015, FDN CLIN RES APPL PR, V3rd; Yorke AM, 2017, SPORTS HEALTH, V9, P174, DOI 10.1177/1941738116678411	34	7	7	0	4	NATL ATHLETIC TRAINERS ASSOC INC	DALLAS	2952 STEMMONS FREEWAY, DALLAS, TX 75247 USA	1062-6050	1938-162X		J ATHL TRAINING	J. Athl. Train.	DEC	2019	54	12					1241	1246		10.4085/1062-6050-219-18			6	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	JW6PV	WOS:000503172400003	31618072	gold, Green Published			2022-02-06	
J	Cocca, AT; Privette, A; Leon, SM; Crookes, BA; Hall, G; Lena, J; Eriksson, EA				Cocca, Alexandra T.; Privette, Alicia; Leon, Stuart M.; Crookes, Bruce A.; Hall, Gregory; Lena, Jonathan; Eriksson, Evert A.			DELAYED INTRACRANIAL HEMORRHAGE IN ANTICOAGULATED GERIATRIC PATIENTS AFTER GROUND LEVEL FALLS	JOURNAL OF EMERGENCY MEDICINE			English	Article						NOAC; apixaban; dabigatran; rivaroxaban; warfarin; traumatic brain injury; intracranial hemorrhage; geriatric	TRAUMATIC BRAIN-INJURY; ATRIAL-FIBRILLATION; HEAD TRAUMA; WARFARIN	Background: The reported risk of delayed intracranial hemorrhage (ICH) in a trauma patient on warfarin is estimated to be between 0.6% and 6%. The risk of delayed ICH in trauma patients taking novel oral anticoagulants (NOACs) is not well-defined. Objective: We hypothesized that there was a significant number of delayed presentations of ICH in patients on NOACs. Methods: A retrospective review of our trauma registry was performed on geriatric patients (age older than 64 years) who were initially evaluated at our level I trauma center, had fall from standing height or less, and were anticoagulated (warfarin or NOACs), from April 2017 to March 2018. Results: Seventy-seven patients met inclusion criteria. The mean age was 80 +/- 7.7 years and 46% of patients were male. The admission head computed tomography scan was positive in 20.8% of patients. Positive scans were more common in patients on warfarin vs. NOACs (30% vs. 14%; p = 0.074) and had a significantly higher Injury Severity Score (median [interquartile range]: 9 [3-15] vs. 5 [1-9]; p = 0.030) and Abbreviated Injury Scale-Head score (median [interquartile range]: 1 [0-3] vs. 1 [0-2]; p = 0.035). The agreement between loss of consciousness (LOC) and ICH was 72% (kappa = -0.064; p = 0.263). Fifty-one percent of patients had a repeat head CT. New ICH was diagnosed in 9.6% of patients. All of these patients were on NOACs. Conclusions: A fall from standing or less in anticoagulated geriatric patients is a significant mechanism of injury resulting in ICH. The absence of LOC does not eliminate the possibility of ICH. There is a significant risk of delayed ICH for patients on NOACs and repeat evaluations should be performed. A prospective multicenter evaluation of this finding is warranted. (C) 2019 Elsevier Inc. All rights reserved.	[Cocca, Alexandra T.; Privette, Alicia; Leon, Stuart M.; Crookes, Bruce A.; Eriksson, Evert A.] Med Univ South Carolina, Dept Surg, Div Trauma & Crit Care, Charleston, SC 29425 USA; [Hall, Gregory] Med Univ South Carolina, Dept Emergency Med, Charleston, SC 29425 USA; [Lena, Jonathan] Med Univ South Carolina, Dept Neurosurg, Charleston, SC 29425 USA		Eriksson, EA (corresponding author), Med Univ South Carolina, Dept Surg, 96 Jonathan Lucas St,CSB 420, Charleston, SC 29425 USA.						Beynon C, 2015, CLIN NEUROL NEUROSUR, V136, P73, DOI 10.1016/j.clineuro.2015.05.035; Centers for Disease Control and Prevention, TRAUM BRAIN INJ CONC; Chauny JM, 2016, J EMERG MED, V51, P519, DOI 10.1016/j.jemermed.2016.05.045; Chenoweth JA, 2017, WEST J EMERG MED, V18, P794, DOI 10.5811/westjem.2017.5.33092; Davis T, 2015, ARCH DIS CHILDHOOD-E, V100, P97, DOI 10.1136/archdischild-2014-306797; Hart RG, 2012, STROKE, V43, P1511, DOI 10.1161/STROKEAHA.112.650614; Miller J, 2015, J TRAUMA ACUTE CARE, V79, P310, DOI 10.1097/TA.0000000000000725; Nishijima DK, 2012, ANN EMERG MED, V59, P460, DOI 10.1016/j.annemergmed.2012.04.007; Ott MM, 2010, J TRAUMA, V68, P560, DOI 10.1097/TA.0b013e3181ad6600; Prexl O, 2018, SCAND J TRAUMA RESUS, V26, DOI 10.1186/s13049-018-0487-0; Smith AT, 2017, AM J EMERG MED, V35, P377, DOI DOI 10.1016/j.ajem.2016.08.024; Smith MN, 2019, J THROMB THROMBOLYS, V48, P250, DOI 10.1007/s11239-019-01846-5; Zhu JY, 2018, PHARMACOTHERAPY, V38, P907, DOI 10.1002/phar.2158	13	7	7	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0736-4679	1090-1280		J EMERG MED	J. Emerg. Med.	DEC	2019	57	6					812	816		10.1016/j.jemermed.2019.09.011			5	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	JX8WZ	WOS:000504010500019	31735656				2022-02-06	
J	Liu, N; Jiang, YH; Chung, JY; Li, YD; Yu, ZY; Kim, JW; Lok, JM; Whalen, MJ; Wang, XY				Liu, Ning; Jiang, Yinghua; Chung, Joon Yong; Li, Yadan; Yu, Zhanyang; Kim, Jeong Woo; Lok, Josephine M.; Whalen, Michael J.; Wang, Xiaoying			Annexin A2 Deficiency Exacerbates Neuroinflammation and Long-Term Neurological Deficits after Traumatic Brain Injury in Mice	INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES			English	Article						traumatic brain injury; Annexin A2; knockout mice; leukocytes infiltration; neuroinflammation; neurological function	CONTROLLED CORTICAL IMPACT; SPINAL-CORD-INJURY; UP-REGULATION; OUTCOMES; INFLAMMATION; ACTIVATION; EXPRESSION; RESPONSES; SURFACE; GROWTH	Our laboratory and others previously showed that Annexin A2 knockout (A2KO) mice had impaired blood-brain barrier (BBB) development and elevated pro-inflammatory response in macrophages, implying that Annexin A2 (AnxA2) might be one of the key endogenous factors for maintaining homeostasis of the neurovascular unit in the brain. Traumatic brain injury (TBI) is an important cause of disability and mortality worldwide, and neurovascular inflammation plays an important role in the TBI pathophysiology. In the present study, we aimed to test the hypothesis that A2KO promotes pro-inflammatory response in the brain and worsens neurobehavioral outcomes after TBI. TBI was conducted by a controlled cortical impact (CCI) device in mice. Our experimental results showed AnxA2 expression was significantly up-regulated in response to TBI at day three post-TBI. We also found more production of pro-inflammatory cytokines in the A2KO mouse brain, while there was a significant increase of inflammatory adhesion molecules mRNA expression in isolated cerebral micro-vessels of A2KO mice compared with wild-type (WT) mice. Consistently, the A2KO mice brains had a significant increase in leukocyte brain infiltration at two days after TBI. Importantly, A2KO mice had significantly worse sensorimotor and cognitive function deficits up to 28 days after TBI and significantly larger brain tissue loss. Therefore, these results suggested that AnxA2 deficiency results in exacerbated early neurovascular pro-inflammation, which leads to a worse long-term neurologic outcome after TBI.	[Liu, Ning; Jiang, Yinghua; Li, Yadan; Wang, Xiaoying] Tulane Univ, Sch Med, Dept Neurosurg, Clin Neurosci Res Ctr, New Orleans, LA 70112 USA; [Chung, Joon Yong; Whalen, Michael J.] Harvard Med Sch, Massachusetts Gen Hosp, Neurosci Ctr, Charlestown, MA 02129 USA; [Yu, Zhanyang; Kim, Jeong Woo; Lok, Josephine M.] Harvard Med Sch, Massachusetts Gen Hosp, Neuroprotect Res Lab, Charlestown, MA 02129 USA		Wang, XY (corresponding author), Tulane Univ, Sch Med, Dept Neurosurg, Clin Neurosci Res Ctr, New Orleans, LA 70112 USA.	nliu3@tulane.edu; yjiang11@tulane.edu; JYCHUNG@PARTNERS.ORG; yli72@tulane.edu; yu.zhanyang@mgh.harvard.edu; jeong_woo_kim@brown.edu; JLOK1@mgh.harvard.edu; MWHALEN@mgh.harvard.edu; xwang51@tulane.edu		Liu, Ning/0000-0002-5632-0359; Chung, Joon Yong/0000-0002-3980-2065	National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [RO1 NS092085]	This work was supported in part by National Institutes of Health (NIH) grants (RO1 NS092085 to X.W.).	Babiychuk EB, 2000, J CELL BIOL, V150, P1113, DOI 10.1083/jcb.150.5.1113; Chen JJ, 2017, NEUROPEPTIDES, V61, P67, DOI 10.1016/j.npep.2016.10.007; Chen S, 2003, EXP NEUROL, V182, P87, DOI 10.1016/S0014-4886(03)00002-5; Cheng CJ, 2017, INT J MED SCI, V14, P927, DOI 10.7150/ijms.18812; Chiu CC, 2016, J NEUROSCI METH, V272, P38, DOI 10.1016/j.jneumeth.2016.06.018; Choi YK, 2016, NAT MED, V22, P1335, DOI 10.1038/nm.4188; Chung JY, 2019, J NEUROTRAUM, V36, P370, DOI 10.1089/neu.2018.5659; Dai HB, 2013, THROMB HAEMOSTASIS, V109, P1070, DOI 10.1160/TH12-12-0944; Dassah M, 2014, J CELL SCI, V127, P828, DOI 10.1242/jcs.137802; Defour A, 2017, HUM MOL GENET, V26, P1979, DOI 10.1093/hmg/ddx065; Doran SJ, 2019, J NEUROTRAUM, V36, P1040, DOI 10.1089/neu.2018.6019; EBERHARD DA, 1994, AM J PATHOL, V145, P640; Guo SZ, 2016, J NEUROTRAUM, V33, P1303, DOI 10.1089/neu.2015.4101; HAMRE KM, 1995, J COMP NEUROL, V352, P421, DOI 10.1002/cne.903520308; He S, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005743; Jiang YH, 2018, STROKE, V49, P3039, DOI 10.1161/STROKEAHA.118.022119; Jin XM, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0041892, 10.1371/journal.pone.0040637]; Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156; Li RP, 2015, J IMMUNOL, V195, P3901, DOI 10.4049/jimmunol.1500967; Li WL, 2019, J CEREBR BLOOD F MET, V39, P2048, DOI 10.1177/0271678X18777916; Ling Q, 2004, J CLIN INVEST, V113, P38, DOI 10.1172/JCI200419684; Liu N, 2004, J NEUROSCI RES, V77, P391, DOI 10.1002/jnr.20167; Liu N, 2018, J ALZHEIMERS DIS, V64, P1163, DOI 10.3233/JAD-180163; Luo M, 2017, J EXP MED, V214, P2535, DOI 10.1084/jem.20160652; Ma JX, 2000, J BIOL CHEM, V275, P12806, DOI 10.1074/jbc.275.17.12806; Michinaga S, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20030571; Morel E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001118; SARAFIAN T, 1991, J CELL BIOL, V114, P1135, DOI 10.1083/jcb.114.6.1135; Scharf B, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1754; Sharma MR, 2006, EXP MOL PATHOL, V81, P136, DOI 10.1016/j.yexmp.2006.03.002; Siao CJ, 2002, J NEUROSCI, V22, P3352; Wang QZ, 2018, MOL NEUROBIOL, V55, P4702, DOI 10.1007/s12035-017-0663-7; Wang XY, 2000, J NEUROSCI, V20, P7037, DOI 10.1523/JNEUROSCI.20-18-07037.2000; Xia YG, 2018, P NATL ACAD SCI USA, V115, pE9230, DOI 10.1073/pnas.1810693115; Yu ZY, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-1007-x; Zhang S, 2015, SCI REP-UK, V5, DOI 10.1038/srep15859; Zhao BQ, 2006, NAT MED, V12, P441, DOI 10.1038/nm1387; Zhao S, 2017, NEUROSCI LETT, V643, P125, DOI 10.1016/j.neulet.2016.12.006; Zhao WQ, 2007, J NEUROCHEM, V100, P1211, DOI 10.1111/j.1471-4159.2006.04311.x	39	7	7	1	1	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		1422-0067		INT J MOL SCI	Int. J. Mol. Sci.	DEC	2019	20	24							6125	10.3390/ijms20246125			14	Biochemistry & Molecular Biology; Chemistry, Multidisciplinary	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Chemistry	KB9XE	WOS:000506840100020	31817350	gold, Green Published			2022-02-06	
J	Lutz, K; Kamenova, M; Schaedelin, S; Guzman, R; Mariani, L; Fandino, J; Soleman, J				Lutz, Katharina; Kamenova, Maria; Schaedelin, Sabine; Guzman, Raphael; Mariani, Luigi; Fandino, Javier; Soleman, Jehuda			Time to and Possible Risk Factors for Recurrence after Burr-hole Drainage of Chronic Subdural Hematoma: A Subanalysis of the cSDH-Drain Randomized Controlled Trial	WORLD NEUROSURGERY			English	Article						Chronic subdural hematoma; Subperiosteal drain; Subdural drain; Risk factors; Recurrence; Time to recurrence; Traumatic brain injury	PREDICTORS; EVACUATION; MANAGEMENT; RESUMPTION	OBJECTIVE: The randomized controlled Chronic Subdural Hematoma (cSDH)-Drain-Trial showed comparable recurrence rates after placing a subperiosteal drain (SPD) or a subdural drain (SDD) for surgically drained cSDH, although SDD was associated with higher rates of infection and iatrogenic brain injury. This subanalysis examines the time to recurrence and possible risk factors for recurrence after burr-hole drainage of cSDH and placement of a SPD compared with a SDD. METHODS: We included 220 patients from the preceding cSDH-Drain-Trial. Time to recurrence was compared within the 2 groups using a univariate Cox proportional hazards model. Apart from intraoperative brain expansion (iBE), defined by residual hematoma-cavity on computer tomography 24 hours after surgery, other possible pre-, intra- and postoperative risk factors for recurrence were assessed through univariate and multivariate analysis. RESULTS: Median time to recurrence was 22.5 days (interquartile range: 9.25-52 days, range: 0-81) showing no difference between the 2 groups. Less iBE (P = 0.019), lower Glasgow Outcome Scale score at discharge (P = 0.007), and lower Glasgow Coma Scale score at 24 hours (P = 0.037) were strongly associated with recurrence on univariate analysis. After multivariate logistic analysis, less iBE (odds ratio: 1.10, 95% CI: 1.01; 1.21; P = 0.03) remained the only significant risk factor associated with recurrence. When comparing the risk factors within the 2 groups, less iBE and lower Glasgow Outcome Scale score at release were associated with recurrence only in the SDD group. CONCLUSIONS: The inserted drain type after burr-hole drainage of cSDH does not seem to influence time to recurrence. SPD may be warranted in routine clinical practice, independent of individual patient, surgical, or hematoma characteristics.	[Lutz, Katharina; Guzman, Raphael; Mariani, Luigi; Soleman, Jehuda] Univ Basel, Fac Med, Basel, Switzerland; [Kamenova, Maria; Guzman, Raphael; Mariani, Luigi; Soleman, Jehuda] Univ Hosp Basel, Dept Neurosurg, Basel, Switzerland; [Lutz, Katharina] Inselspital Bern, Dept Neurosurg, Bern, Switzerland; [Schaedelin, Sabine] Univ Hosp Basel, Clin Trial Unit, Basel, Switzerland; [Fandino, Javier] Kantonsspital Aarau, Dept Neurosurg, Aarau, Switzerland		Soleman, J (corresponding author), Univ Basel, Fac Med, Basel, Switzerland.; Soleman, J (corresponding author), Univ Hosp Basel, Dept Neurosurg, Basel, Switzerland.	jehuda.soleman@gmail.com	Soleman, Jehuda/D-8083-2017	Soleman, Jehuda/0000-0003-1900-9286; Lutz, Katharina/0000-0002-4938-6974; Guzman, Raphael/0000-0001-9620-0581	Research Foundation Kantonsspital Aarau	The cSDH-Drain-Trial and the present subanalysis were funded by the Research Foundation Kantonsspital Aarau.	Almenawer SA, 2014, ANN SURG, V259, P449, DOI 10.1097/SLA.0000000000000255; Altaf I, 2018, PAK J MED SCI, V34, P194, DOI 10.12669/pjms.341.13735; Amirjamshidi A, 2007, BRIT J NEUROSURG, V21, P272, DOI 10.1080/02688690701272232; Bartek J, 2017, WORLD NEUROSURG, V106, P609, DOI 10.1016/j.wneu.2017.07.044; Brennan PM, 2017, J NEUROSURG, V127, P732, DOI 10.3171/2016.8.JNS16134; Guha D, 2016, J NEUROSURG, V124, P750, DOI 10.3171/2015.2.JNS141889; Hammer A, 2017, TURK NEUROSURG, V27, P756, DOI 10.5137/1019-5149.JTN.17347-16.1; Kamenova M, 2017, WORLD NEUROSURG, V100, P594, DOI 10.1016/j.wneu.2017.01.065; Kamenova M, 2016, NEUROSURGERY, V79, P715, DOI 10.1227/NEU.0000000000001393; Kawabata S, 2018, NEUROL MED-CHIR, V58, P247, DOI 10.2176/nmc.oa.2018-0019; Kim SU, 2017, J KOREAN NEUROSURG S, V60, P701, DOI 10.3340/jkns.2016.1010.003; Kolias AG, 2014, NAT REV NEUROL, V10, P570, DOI 10.1038/nrneurol.2014.163; Miki K, 2019, J NEUROSURG, V4, P1; Nathan S, 2017, NEUROLOGY, V88, P1889, DOI 10.1212/WNL.0000000000003918; Ohba S, 2013, NEUROSURG REV, V36, P145, DOI 10.1007/s10143-012-0396-z; Oishi M, 2001, NEUROL MED-CHIR, V41, P382, DOI 10.2176/nmc.41.382; Poon MTC, 2018, NEUROSURG REV, V41, P439, DOI 10.1007/s10143-017-0860-x; Santarius T, 2009, LANCET, V374, P1067, DOI 10.1016/S0140-6736(09)61115-6; Schwarz F, 2015, CLIN NEUROL NEUROSUR, V138, P66, DOI 10.1016/j.clineuro.2015.08.002; Soleman J, 2019, NEUROSURGERY; Soleman J, 2017, SWISS MED WKLY, V147, DOI 10.4414/smw.2017.14398; Soleman J, 2016, JMIR RES PROTOC, V5, DOI 10.2196/resprot.5339; Stanisic M, 2013, ACTA NEUROCHIR, V155, P323, DOI 10.1007/s00701-012-1565-0; Torihashi K, 2008, NEUROSURGERY, V63, P1125, DOI 10.1227/01.NEU.0000335782.60059.17	24	7	7	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	DEC	2019	132						E283	E289		10.1016/j.wneu.2019.08.175			7	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	JN5VR	WOS:000496966300034	31479790				2022-02-06	
J	Poon, W; Matula, C; Vos, PE; Muresanu, DF; von Steinbuchel, N; von Wild, K; Homberg, V; Wang, E; Lee, TMC; Strilciuc, S; Vester, JC				Poon, W.; Matula, C.; Vos, P. E.; Muresanu, D. F.; von Steinbuechel, N.; von Wild, K.; Hoemberg, V.; Wang, E.; Lee, T. M. C.; Strilciuc, S.; Vester, J. C.			Safety and efficacy of Cerebrolysin in acute brain injury and neurorecovery: CAPTAIN I-a randomized, placebo-controlled, double-blind, Asian-Pacific trial	NEUROLOGICAL SCIENCES			English	Article						Traumatic brain injury; Cerebrolysin; Multidimensional approach; Wei-Lachin pooling	QUALITY-OF-LIFE; GLASGOW COMA SCALE; SEVERE HEAD-INJURY; CLINICAL-TRIALS; NONPARAMETRIC METHODS; HOSPITAL ANXIETY; RECOVERY; OUTCOMES; PLASTICITY; QOLIBRI	Objective To evaluate the safety and efficacy of Cerebrolysin as an add-on therapy to local standard treatment protocol in patients after moderate-to-severe traumatic brain injury. Methods The patients received the study medication in addition to standard care (50 mL of Cerebrolysin or physiological saline solution daily for 10 days, followed by two additional treatment cycles with 10 mL daily for 10 days) in a prospective, randomized, double-blind, placebo-controlled, parallel-group, multi-centre phase IIIb/IV trial. The primary endpoint was a multidimensional ensemble of 14 outcome scales pooled to be analyzed by means of the multivariate, correlation-sensitive Wei-Lachin procedure. Results In 46 enrolled TBI patients (Cerebrolysin 22, placebo 24), three single outcomes showed stand-alone statistically significant superiority of Cerebrolysin [Stroop Word/Dots Interference (p = 0.0415, Mann-Whitney(MW) = 0.6816, 95% CI 0.51-0.86); Color Trails Tests 1 and 2 (p = 0.0223/0.0170, MW = 0.72/0.73, 95% CI 0.53-0.90/0.54-0.91), both effect sizes lying above the benchmark for "large" superiority (MW > 0.71)]. While for the primary multivariate ensemble, statistical significance was just missed in the intention-to-treat population (p(Wei-Lachin) < 0.1, MWcombined = 0.63, 95% CI 0.48-0.77, derived standardized mean difference (SMD) 0.45, 95% CI -0.07 to 1.04, derived OR 2.1, 95% CI 0.89-5.95), the per-protocol analysis showed a statistical significant superiority of Cerebrolysin (p(Wei-Lachin) = 0.0240, MWcombined = 0.69, 95% CI 0.53 to 0.85, derived SMD 0.69, 95% CI 0.09 to 1.47, derived OR 3.2, 95% CI 1.16 to 12.8), with effect sizes of six single outcomes lying above the benchmark for "large" superiority. Safety aspects were comparable to placebo. Conclusion Our trial suggests beneficial effects of Cerebrolysin on outcome after TBI. Results should be confirmed by a larger RCT with a comparable multidimensional approach.	[Poon, W.] Chinese Univ Hong Kong, Div Neurosurg, Prince Wales Hosp, Shatin, Hong Kong, Peoples R China; [Matula, C.] Med Univ Vienna, Dept Neurosurg, Vienna, Austria; [Vos, P. E.] Slingeland Hosp, Dept Neurol, Doetinchem, Netherlands; [Muresanu, D. F.; Strilciuc, S.] Iuliu Hatieganu Univ Med & Pharm, Dept Clin Neurosci, Cluj Napoca, Romania; [Muresanu, D. F.; Strilciuc, S.] RoNeuro Inst Neurol Res & Diagnost, 37 Mircea Eliade St, Cluj Napoca 400364, Romania; [von Steinbuechel, N.] Univ Med Ctr Gottingen, Inst Med Psychol & Med Sociol, Gottingen, Germany; [von Wild, K.] Westphalia Wilhelms Univ, Fac Med, Munster, Germany; [Hoemberg, V.] SRH Gesundheitszentrum Bad Wimpfen GmbH, Dept Neurol, Bad Wimpfen, Germany; [Wang, E.] Natl Neurosci Inst, Dept Neurosurg, Singapore, Singapore; [Lee, T. M. C.] Univ Hong Kong, State Key Lab Brain & Cognit Sci, Pokfulam, Hong Kong, Peoples R China; [Lee, T. M. C.] Univ Hong Kong, Neuropsychol Lab, Pokfulam, Hong Kong, Peoples R China; [Vester, J. C.] Idv Data Anal & Study Planning, Dept Biometry & Clin Res, Krailling, Germany		Muresanu, DF (corresponding author), Iuliu Hatieganu Univ Med & Pharm, Dept Clin Neurosci, Cluj Napoca, Romania.; Muresanu, DF (corresponding author), RoNeuro Inst Neurol Res & Diagnost, 37 Mircea Eliade St, Cluj Napoca 400364, Romania.	dafinm@ssnn.ro	Strilciuc, Stefan/AAC-6253-2019; Muresanu, Fior-Dafin/AAI-8120-2021	Strilciuc, Stefan/0000-0001-6112-0223; 	Ever Neuro Pharma GmbH	This study was funded by Ever Neuro Pharma GmbH.	AKAI F, 1992, HISTOL HISTOPATHOL, V7, P213; [Anonymous], 1998, ICH BIOSTATISTICS GU; Bagiella E, 2010, J HEAD TRAUMA REHAB, V25, P375, DOI 10.1097/HTR.0b013e3181d27fe3; Bagiella E, 2009, ARCH PHYS MED REHAB, V90, pS17, DOI 10.1016/j.apmr.2009.08.133; BARRETT GL, 1994, P NATL ACAD SCI USA, V91, P6501, DOI 10.1073/pnas.91.14.6501; Bauer P, 1999, STAT MED, V18, P1833, DOI 10.1002/(SICI)1097-0258(19990730)18:14<1833::AID-SIM221>3.3.CO;2-V; BAUER P, 1994, BIOMETRICS, V50, P1029, DOI 10.2307/2533441; Bjelland I, 2002, J PSYCHOSOM RES, V52, P69, DOI 10.1016/S0022-3999(01)00296-3; Bretz F, 2009, STAT MED, V28, P1181, DOI 10.1002/sim.3538; Chen CC, 2013, BRIT J NEUROSURG, V27, P803, DOI 10.3109/02688697.2013.793287; Cohen J, 1998, STAT POWER ANAL BEHA; Colditz G A, 1988, Int J Technol Assess Health Care, V4, P637; D'Agostino RB, 2006, STAT MED, V25, P541, DOI 10.1002/sim.2508; Diaz-Arrastia R, 2006, J HEAD TRAUMA REHAB, V21, P361, DOI 10.1097/00001199-200607000-00007; Dimitrenko A, 2010, MULTIPLE TESTING PRO; Donders J, 1997, CHILD NEUROPSYCHOL, V3, P71, DOI 10.1080/09297049708401369; Duffau H, 2006, J CLIN NEUROSCI, V13, P885, DOI 10.1016/j.jocn.2005.11.045; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Ghaffarpasand F, 2019, NEUROPSYCH DIS TREAT, V15, P127, DOI 10.2147/NDT.S186865; Gill MR, 2004, ANN EMERG MED, V43, P215, DOI 10.1016/S0196-0644(03)00814-X; Giza CC, 2006, DEV NEUROSCI-BASEL, V28, P364, DOI 10.1159/000094163; Griesbach GS, 2009, BRAIN RES, V1288, P105, DOI 10.1016/j.brainres.2009.06.045; Hawkins KA, 1998, CLIN NEUROPSYCHOL, V12, P535, DOI 10.1076/clin.12.4.535.7236; Hicks AJ, 2019, J NEUROTRAUM, V36, P3191, DOI 10.1089/neu.2018.6346; Hoffman JM, 2010, PM&R, V2, P911, DOI 10.1016/j.pmrj.2010.06.008; Huang CH, 2018, BMC NEUROL, V18, DOI 10.1186/s12883-018-1187-0; Huang P, 2008, STAT MED, V27, P3084, DOI 10.1002/sim.3182; Hukkelhoven CWPM, 2005, J NEUROTRAUM, V22, P1025, DOI 10.1089/neu.2005.22.1025; James SL, 2019, LANCET NEUROL, V18, P56, DOI 10.1016/S1474-4422(18)30415-0; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; Johnson SC, 2000, BARROW Q; Jordan BD, 2007, NEUROCHEM RES, V32, P905, DOI 10.1007/s11064-006-9251-3; Kim DH, 2005, NEUROCRIT CARE, V3, P71, DOI 10.1385/NCC:3:1:071; LACHIN JM, 1992, STAT MED, V11, P1151, DOI 10.1002/sim.4780110903; Lachin JM, 2015, CLIN TRIALS, V12, P627, DOI 10.1177/1740774515601027; LaVange LM, 2005, STAT METHODS MED RES, V14, P281, DOI 10.1191/0962280205sm397oa; Lee TMC, 2000, J CLIN EXP NEUROPSYC, V22, P465, DOI 10.1076/1380-3395(200008)22:4;1-0;FT465; Li YJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169650; Lombardi VRM, 1999, METHOD FIND EXP CLIN, V21, P331, DOI 10.1358/mf.1999.21.5.541910; Lu M, 2001, STAT MED, V20, P1891, DOI 10.1002/sim.841.abs; Maas AIR, 2010, NEUROTHERAPEUTICS, V7, P127, DOI 10.1016/j.nurt.2009.10.020; Maas AIR, 2010, NEUROTHERAPEUTICS, V7, P115, DOI 10.1016/j.nurt.2009.10.022; Mahmood A, 2002, J NEUROTRAUM, V19, P1609, DOI 10.1089/089771502762300265; MAHONEY F I, 1965, Md State Med J, V14, P61; Margulies S, 2009, J NEUROTRAUM, V26, P925, DOI [10.1089/neu.2008.0794, 10.1089/neu.2008-0794]; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; Martin TA, 2000, REHABIL PSYCHOL, V45, P402, DOI 10.1037/0090-5550.45.4.402; Masliah E, 1999, PHARMACOL BIOCHEM BE, V62, P239, DOI 10.1016/S0091-3057(98)00144-0; Mitrushina MN, 1999, HDB NORMATIVE DATA N; Morganti-Kossmann Maria Cristina, 2002, Curr Opin Crit Care, V8, P101; Muresanu D, 2003, NEUROTROPHIC FACTORS; Muresanu DF, 2016, STROKE, V47, P151, DOI 10.1161/STROKEAHA.115.009416; Nudo RJ, 2001, MUSCLE NERVE, V24, P1000, DOI 10.1002/mus.1104; O'Brien PC, 2005, STAT MED, V24, P341, DOI 10.1002/sim.1963; OBRIEN PC, 1984, BIOMETRICS, V40, P1079, DOI 10.2307/2531158; Olesen J, 2012, EUR J NEUROL, V19, P155, DOI 10.1111/j.1468-1331.2011.03590.x; Onose G, 2009, J Med Life, V2, P350; Poon W, 2015, J NEUROTRAUM, V32, P571, DOI 10.1089/neu.2014.3558; Rahlfs V, 2019, BIOMETRICAL J, V61, P973, DOI 10.1002/bimj.201800107; Rickels E, 2010, BRAIN INJURY, V24, P1491, DOI 10.3109/02699052.2010.498006; Riley C, 2006, J NEURAL TRANSM, V113, P103, DOI 10.1007/s00702-005-0302-8; Rockenstein E, 2006, J NEUROSCI RES, V83, P1252, DOI 10.1002/jnr.20818; Satou T, 2000, J NEURAL TRANSM, V107, P1253, DOI 10.1007/s007020070015; Scholten AC, 2016, J NEUROTRAUM, V33, P1969, DOI 10.1089/neu.2015.4252; Schwartz JM, 2005, PHILOS T R SOC B, V360, P1309, DOI 10.1098/rstb.2004.1598; Sharma HS, 2014, J NANOSCI NANOTECHNO, V14, P577, DOI 10.1166/jnn.2014.9213; Sharma HS, 2010, ANN NY ACAD SCI, V1199, P125, DOI 10.1111/j.1749-6632.2009.05329.x; Sugita Y, 1993, No To Shinkei, V45, P325; Tatebayashi Y, 2003, ACTA NEUROPATHOL, V105, P225, DOI 10.1007/s00401-002-0636-3; Temkin NR, 2007, LANCET NEUROL, V6, P29, DOI 10.1016/S1474-4422(06)70630-5; Thompson HJ, 2006, J AM GERIATR SOC, V54, P1590, DOI 10.1111/j.1532-5415.2006.00894.x; Truelle JL, 2010, BRAIN INJURY, V24, P1272, DOI 10.3109/02699052.2010.506865; von Steinbuchel N, 2010, J NEUROTRAUM, V27, P1167, DOI 10.1089/neu.2009.1076; von Steinbuchel N, 2010, J NEUROTRAUM, V27, P1157, DOI 10.1089/neu.2009.1077; Wechsler DW, ADULT INTELLIGENCE S; WEI LJ, 1984, J AM STAT ASSOC, V79, P653, DOI 10.2307/2288413; White T., 1996, COLOR TRAILS TEST PR; Whiteneck GG, 2004, J HEAD TRAUMA REHAB, V19, P191, DOI 10.1097/00001199-200405000-00001; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Wolfson, 1993, HALSTEAD REITAN NEUR; Wong GKC, 2005, ACTA NEUROCHIR SUPPL, V95, P59; Wronski R, 2000, J NEURAL TRANSM-SUPP, P263; Zafonte R, 2009, J NEUROTRAUM, V26, P2207, DOI 10.1089/neu.2009.1015; Zhang YL, 2018, J NEUROSURG, V129, P1295, DOI 10.3171/2017.6.JNS171007; Zhang YL, 2019, NEUROREHAB NEURAL RE, V33, P15, DOI 10.1177/1545968318809916; Zhang YL, 2015, J NEUROSURG, V122, P843, DOI 10.3171/2014.11.JNS14271; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x; Zuercher M, 2009, BRAIN INJURY, V23, P371, DOI 10.1080/02699050902926267	88	7	8	0	2	SPRINGER-VERLAG ITALIA SRL	MILAN	VIA DECEMBRIO, 28, MILAN, 20137, ITALY	1590-1874	1590-3478		NEUROL SCI	Neurol. Sci.	FEB	2020	41	2					281	293		10.1007/s10072-019-04053-5		DEC 2019	13	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	KR8RR	WOS:000499860400001	31494820				2022-02-06	
J	Wettervik, TS; Howells, T; Ronne-Engstrom, E; Hillered, L; Lewen, A; Enblad, P; Rostami, E				Wettervik, Teodor Svedung; Howells, Timothy; Ronne-Engstrom, Elisabeth; Hillered, Lars; Lewen, Anders; Enblad, Per; Rostami, Elham			High Arterial Glucose is Associated with Poor Pressure Autoregulation, High Cerebral Lactate/Pyruvate Ratio and Poor Outcome Following Traumatic Brain Injury	NEUROCRITICAL CARE			English	Article						Traumatic brain injury; Glucose; Autoregulation; Cerebral energy metabolism	INTENSIVE INSULIN THERAPY; INTRACEREBRAL MICRODIALYSIS; NEUROINTENSIVE CARE; PERFUSION-PRESSURE; REACTIVITY; HYPERGLYCEMIA; METABOLISM; LACTATE; STRESS; IMPACT	Background Arterial hyperglycemia is associated with poor outcome in traumatic brain injury (TBI), but the pathophysiology is not completely understood. Previous preclinical and clinical studies have indicated that arterial glucose worsens pressure autoregulation. The aim of this study was to evaluate the relationship of arterial glucose to both pressure reactivity and cerebral energy metabolism. Method This retrospective study was based on 120 patients with severe TBI treated at the Uppsala University hospital, Sweden, 2008-2018. Data from cerebral microdialysis (glucose, pyruvate, and lactate), arterial glucose, and pressure reactivity index (PRx55-15) were analyzed the first 3 days post-injury. Results High arterial glucose was associated with poor outcome/Glasgow Outcome Scale-Extended at 6-month follow-up (r = - 0.201, p value = 0.004) and showed a positive correlation with both PRx55-15 (r = 0.308, p = 0.001) and cerebral lactate/pyruvate ratio (LPR) days 1-3 (r = 0. 244, p = 0.014). Cerebral lactate-to-pyruvate ratio and PRx55-15 had a positive association day 2 (r = 0.219, p = 0.048). Multivariate linear regression analysis showed that high arterial glucose predicted poor pressure autoregulation on days 1 and 2. Conclusions High arterial glucose was associated with poor outcome, poor pressure autoregulation, and cerebral energy metabolic disturbances. The latter two suggest a pathophysiological mechanism for the negative effect of arterial hyperglycemia, although further studies are needed to elucidate if the correlations are causal or confounded by other factors.	[Wettervik, Teodor Svedung; Howells, Timothy; Ronne-Engstrom, Elisabeth; Hillered, Lars; Lewen, Anders; Enblad, Per; Rostami, Elham] Uppsala Univ, Dept Neurosci, Sect Neurosurg, S-75185 Uppsala, Sweden		Wettervik, TS (corresponding author), Uppsala Univ, Dept Neurosci, Sect Neurosurg, S-75185 Uppsala, Sweden.	teodor.svedung-wettervik@neuro.uu.se	Wettervik, Teodor Mikael Svedung/S-5356-2017				Adams H, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002353; Bilotta F, 2008, NEUROCRIT CARE, V9, P159, DOI 10.1007/s12028-008-9084-9; Bosarge PL, 2015, J TRAUMA ACUTE CARE, V79, P289, DOI 10.1097/TA.0000000000000716; Coester A, 2010, J TRAUMA, V68, P904, DOI 10.1097/TA.0b013e3181c9afc2; Czosnyka M, 1997, NEUROSURGERY, V41, P11, DOI 10.1097/00006123-199707000-00005; Diaz-Parejo P, 2003, INTENS CARE MED, V29, P544, DOI 10.1007/s00134-003-1669-3; Donnelly J, 2015, NEUROCRIT CARE, V22, P20, DOI 10.1007/s12028-014-0042-4; DUCKROW RB, 1985, ANN NEUROL, V17, P267, DOI 10.1002/ana.410170308; Elf K, 2005, NEUROSURGERY, V56, P962, DOI 10.1227/01.NEU.0000158317.00603.40; Howells T, 2005, J NEUROSURG, V102, P311, DOI 10.3171/jns.2005.102.2.0311; Howells T, 2015, J CLIN MONIT COMPUT, V29, P97, DOI 10.1007/s10877-014-9573-7; Hutchinson PJ, 2015, INTENS CARE MED, V41, P1517, DOI 10.1007/s00134-015-3930-y; Jeremitsky E, 2005, J TRAUMA, V58, P47, DOI 10.1097/01.TA.0000135158.42242.B1; Lott MEJ, 2007, AM J PHYSIOL-HEART C, V292, pH304, DOI 10.1152/ajpheart.00940.2005; Magnoni S, 2012, CRIT CARE MED, V40, P1785, DOI 10.1097/CCM.0b013e318246bd45; Marcoux J, 2008, CRIT CARE MED, V36, P2871, DOI 10.1097/CCM.0b013e318186a4a0; Martin NA, 1997, J NEUROSURG, V87, P9, DOI 10.3171/jns.1997.87.1.0009; Meier R, 2008, CRIT CARE, V12, DOI 10.1186/cc6974; Nyholm L, 2013, UPSALA J MED SCI, V118, P169, DOI 10.3109/03009734.2013.806616; Oddo M, 2008, CRIT CARE MED, V36, P3233, DOI 10.1097/CCM.0b013e31818f4026; Peeters W, 2015, ACTA NEUROCHIR, V157, P1683, DOI 10.1007/s00701-015-2512-7; Peterson EC, 2011, INT J VASC MED, V2011, DOI 10.1155/2011/823525; Reinstrup P, 2000, NEUROSURGERY, V47, P701, DOI 10.1097/00006123-200009000-00035; Ronne-Engstrom E, 2001, J NEUROSURG, V94, P397, DOI 10.3171/jns.2001.94.3.0397; ROSNER MJ, 1984, J NEUROSURG, V61, P76, DOI 10.3171/jns.1984.61.1.0076; Rostami E, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00091; Rostami Elham, 2011, J Diabetes Sci Technol, V5, P596; Russell JW, 2002, FASEB J, V16, P1738, DOI 10.1096/fj.01-1027com; Schulz MK, 2000, J NEUROSURG, V93, P808, DOI 10.3171/jns.2000.93.5.0808; Sorrentino E, 2012, NEUROCRIT CARE, V16, P258, DOI 10.1007/s12028-011-9630-8; Teasdale GM, 1998, J NEUROTRAUM, V15, P587, DOI 10.1089/neu.1998.15.587; Timofeev I, 2011, BRAIN, V134, P484, DOI 10.1093/brain/awq353; Title LM, 2000, J AM COLL CARDIOL, V36, P2185, DOI 10.1016/S0735-1097(00)00980-3; Vespa P, 2006, CRIT CARE MED, V34, P850, DOI 10.1097/01.CCM.0000201875.12245.6F; Vespa PM, 2003, J CEREBR BLOOD F MET, V23, P865, DOI 10.1097/01.WCB.0000076701.45782.EF; Ward ME, 2002, ANESTHESIOLOGY, V97, P471, DOI 10.1097/00000542-200208000-00026; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; WOOLF PD, 1987, J NEUROSURG, V66, P875, DOI 10.3171/jns.1987.66.6.0875; Young AMH, 2017, FRONT PEDIATR, V5, DOI 10.3389/fped.2017.00205; YOUNG B, 1989, ANN SURG, V210, P466, DOI 10.1097/00000658-198910000-00007	40	7	8	0	0	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	DEC	2019	31	3					526	533		10.1007/s12028-019-00743-2			8	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	JU5FK	WOS:000501700900011	31123993	Green Published, hybrid			2022-02-06	
J	Zhang, LM; Li, R; Sun, WB; Wang, XP; Qi, MM; Bai, Y; Bai, J; Zheng, WC				Zhang, Li-Min; Li, Rui; Sun, Wen-Bo; Wang, Xu-Peng; Qi, Man-Man; Bai, Yang; Bai, Jing; Zheng, Wei-Chao			Low-Dose, Early Fresh Frozen Plasma Transfusion Therapy After Severe Trauma Brain Injury: A Clinical, Prospective, Randomized, Controlled Study	WORLD NEUROSURGERY			English	Article						Delayed traumatic intracranial hematoma; Fresh frozen plasma; Glasgow Outcome Scale; Traumatic brain injury	LARGE ANIMAL-MODEL; CRITICALLY-ILL; NORMAL SALINE; SINGLE-CENTER; COAGULOPATHY; RESUSCITATION; PLATELET; CARE	BACKGROUND: To investigate role of Low-dose, Early Fresh frozen plasma Transfusion (LEFT) therapy in preventing perioperative coagulopathy and improving long-term outcome after severe traumatic brain injury (TBI). METHODS: A prospective, single-center, parallel-group, randomized trial was designed. Patients with severe TBI were eligible. We used a computer-generated randomization list and closed opaque envelops to randomly allocate patients to treatment with fresh frozen plasma (5 mL/kg body weight; LEFT group) or normal saline (5 mL/kg body weight; NO LEFT group) after admission in the operating room. RESULTS: Between January 1, 2018, and November 31, 2018, 63 patients were included and randomly allocated to LEFT (n = 28) and NO LEFT (n = 35) groups. The final interim analysis included 20 patients in the LEFT group and 32 patients in the NO LEFT group. The study was terminated early for futility and safety reasons because a high proportion of patients (7 of 20; 35.0%) in the LEFT group developed new delayed traumatic intracranial hematoma after surgery compared with the NO LEFT group (3 of 32; 9.4%) (relative risk, 5.205; 95% confidence interval, 1.159-23.384; P = 0.023). Demographic characteristics and indexes of severity of brain injury were similar at baseline. CONCLUSIONS: LEFT therapy was associated with a higher incidence of delayed traumatic intracranial hematoma than normal fresh frozen plasma transfusion in patients with severe TBI. A restricted fresh frozen plasma transfusion protocol, in the right clinical setting, may be more appropriate in patients with TBIs.	[Zhang, Li-Min; Li, Rui; Sun, Wen-Bo; Wang, Xu-Peng; Qi, Man-Man; Bai, Yang; Bai, Jing; Zheng, Wei-Chao] Cangzhou Cent Hosp, Dept Anesthesiol, Cangzhou, Peoples R China		Zhang, LM (corresponding author), Cangzhou Cent Hosp, Dept Anesthesiol, Cangzhou, Peoples R China.	azai2010@126.com			Bureau of Science and Technology of Hebei Province [172777117]	This study was supported by the Bureau of Science and Technology of Hebei Province (Grant No. 172777117 [to Dr. Li-Min Zhang]).	Abdel-Wahab OI, 2006, TRANSFUSION, V46, P1279, DOI 10.1111/j.1537-2995.2006.00891.x; Anglin CO, 2013, J NEUROSURG, V118, P676, DOI 10.3171/2012.11.JNS12622; Bianchi P, 2017, BRIT J ANAESTH, V118, P788, DOI 10.1093/bja/aex069; Brazinova A, 2021, J NEUROTRAUM, V38, P1411, DOI 10.1089/neu.2015.4126; Chambers LA, 2011, AM J CLIN PATHOL, V136, P364, DOI 10.1309/AJCPH16YXJEFSHEO; Etemadrezaie H, 2007, CLIN NEUROL NEUROSUR, V109, P166, DOI 10.1016/j.clineuro.2006.09.001; Halaweish I, 2015, J AM COLL SURGEONS, V220, P809, DOI 10.1016/j.jamcollsurg.2015.01.057; Imam A, 2015, J NEUROTRAUM, V32, P307, DOI 10.1089/neu.2014.3535; Innerhofer P, 2017, LANCET HAEMATOL, V4, pE258, DOI 10.1016/S2352-3026(17)30077-7; Jiang JY, 2019, LANCET NEUROL, V18, P286, DOI 10.1016/S1474-4422(18)30469-1; Kor DJ, 2010, CURR OPIN CRIT CARE, V16, P309, DOI 10.1097/MCC.0b013e32833bc4a4; Kumar MA, 2013, CURR NEUROL NEUROSCI, V13, DOI 10.1007/s11910-013-0391-y; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Marshall A, 2015, J THROMB, V14, P324; May AK, 1997, AM SURGEON, V63, P233; Nilsson CU, 2016, PERIOPER MED-LONDON, V5, DOI 10.1186/s13741-016-0046-z; Rourke C, 2012, J THROMB HAEMOST, V10, P1342, DOI 10.1111/j.1538-7836.2012.04752.x; Sandsmark DK, 2016, CURR NEUROL NEUROSCI, V16, DOI 10.1007/s11910-016-0654-5; Sezik S, 2014, J EMERG MED, V47, P596, DOI 10.1016/j.jemermed.2014.04.042; Sillesen M, 2014, J TRAUMA ACUTE CARE, V76, P998, DOI 10.1097/TA.0000000000000193; Stanworth SJ, 2011, CRIT CARE, V15, DOI 10.1186/cc10129; Talving P, 2009, J TRAUMA, V66, P55, DOI 10.1097/TA.0b013e318190c3c0; Vlaar APJ, 2009, TRANSFUSION MED, V19, P207, DOI 10.1111/j.1365-3148.2009.00928.x; Warner MA, 2017, ANESTH ANALG, V124, P1636, DOI 10.1213/ANE.0000000000001730; Zhang LM, 2017, WORLD NEUROSURG, V104, P381, DOI 10.1016/j.wneu.2017.04.140	25	7	7	1	5	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	DEC	2019	132						E21	E27		10.1016/j.wneu.2019.09.024			7	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	JN5VR	WOS:000496966300005	31521754				2022-02-06	
J	Yang, BC; Xu, JY; Li, Y; Dong, Y; Li, YY; Tucker, L; Yang, LD; Zong, XM; Wu, CY; Xu, T; Hu, SQ; Zhang, QG; Yan, XL				Yang, Baocheng; Xu, Juanyong; Li, Yong; Dong, Yan; Li, Yuyu; Tucker, Lorelei; Yang, Luodan; Zong, Xuemei; Wu, Chongyun; Xu, Tie; Hu, Shuqun; Zhang, Quanguang; Yan, Xianliang			Photobiomodulation therapy for repeated closed head injury in rats	JOURNAL OF BIOPHOTONICS			English	Article						gliosis; neuronal death; photobiomodulation; repeated closed head injury	TRAUMATIC BRAIN-INJURY; LEVEL LASER THERAPY; ANIMAL-MODELS; Y MAZE; INFLAMMATION; NEUROINFLAMMATION; NEUROPROTECTION; POLARIZATION; DEGENERATION; CONCUSSION	Repeated traumatic brain injury, leads to cumulative neuronal injury and neurological impairments. There are currently no effective treatments to prevent these consequences. Growing interest is building in the use of transcranial photobiomodulation (PBM) therapy to treat traumatic brain injury. Here, we examined PBM in a repeated closed head injury (rCHI) rat model. Rats were administered a total of three closed head injuries, with each injury separated by 5 days. PBM treatment was initiated 2 hours after the first injury and administered daily for a total of 15 days. We found that PBM-treated rCHI rats had a significant reduction in motor ability, anxiety and cognitive deficits compared to CHI group. PBM group showed an increase of synaptic proteins and surviving neurons, along with a reduction in reactive gliosis and neuronal injury. These findings highlight the complexity of gliosis and neuronal injury following rCHI and suggest that PBM may be a viable treatment option to mitigate these effects and their detrimental consequences.	[Yang, Baocheng; Li, Yuyu; Zong, Xuemei; Xu, Tie; Hu, Shuqun; Yan, Xianliang] Xuzhou Med Univ, Jiangsu Prov Inst Hlth Emergency, 99 Huaihai West Rd, Xuzhou 221002, Jiangsu, Peoples R China; [Yang, Baocheng; Li, Yuyu; Zong, Xuemei; Xu, Tie; Hu, Shuqun; Yan, Xianliang] Xuzhou Med Univ, Affiliated Hosp, Emergency Ctr, Xuzhou, Jiangsu, Peoples R China; [Xu, Juanyong] Nanjing Med Univ, Jiangsu Key Lab Oral Dis, Nanjing, Jiangsu, Peoples R China; [Xu, Juanyong] Nanjing Med Univ, Affiliated Hosp Stomatol, Dept Oral Med, Nanjing, Jiangsu, Peoples R China; [Li, Yong; Dong, Yan; Tucker, Lorelei; Yang, Luodan; Wu, Chongyun; Zhang, Quanguang] Augusta Univ, Med Coll Georgia, Dept Neurosci & Regenerat Med, 1120,15th St,CA3050, Augusta, GA 30912 USA; [Xu, Tie] Nanjing Jiangning Hosp, Dept Emergency, Nanjing, Jiangsu, Peoples R China		Hu, SQ; Yan, XL (corresponding author), Xuzhou Med Univ, Jiangsu Prov Inst Hlth Emergency, 99 Huaihai West Rd, Xuzhou 221002, Jiangsu, Peoples R China.; Zhang, QG (corresponding author), Augusta Univ, Med Coll Georgia, Dept Neurosci & Regenerat Med, 1120,15th St,CA3050, Augusta, GA 30912 USA.	hushuqun88@126.com; qzhang@augusta.edu; docyxl@163.com	Yang, Luodan/AAB-8891-2022		American Heart AssociationAmerican Heart Association [18IPA34170148]; Jiangsu Social Development and Natural Science Foundation [BE2016645, BK20161153, BE2017641]; Xuzhou National Clinical Key Specialty Cultivation Project [2018ZK004]; Qing Lan ProjectJiangsu Polytech Institute	American Heart Association, Grant/Award Number: 18IPA34170148; Jiangsu Social Development and Natural Science Foundation, Grant/Award Numbers: BE2016645, BK20161153, BE2017641; Xuzhou National Clinical Key Specialty Cultivation Project, Grant/Award Number: 2018ZK004; Qing Lan Project	Albensi BC, 2001, J NEUROSCI RES, V65, P279, DOI 10.1002/jnr.1151; Bak J, 2017, BEHAV BRAIN RES, V320, P219, DOI 10.1016/j.bbr.2016.12.011; BeitYannai E, 1996, BRAIN RES, V717, P22, DOI 10.1016/0006-8993(95)01492-6; Beni-Adani L, 2001, J PHARMACOL EXP THER, V296, P57; Bullock MR, 1999, NEUROSURGERY, V45, P207, DOI 10.1097/00006123-199908000-00001; Campos AC, 2013, REV BRAS PSIQUIATR, V35, pS101, DOI 10.1590/1516-4446-2013-1139; Carias E, 2019, BEHAV BRAIN RES, V356, P189, DOI 10.1016/j.bbr.2018.08.014; Chen JL, 2001, STROKE, V32, P1005, DOI 10.1161/01.STR.32.4.1005; Choe MC, 2012, CURR OPIN PEDIATR, V24, P689, DOI 10.1097/MOP.0b013e32835a1a44; Chung H, 2012, ANN BIOMED ENG, V40, P516, DOI 10.1007/s10439-011-0454-7; Colton CA, 2009, J NEUROIMMUNE PHARM, V4, P399, DOI 10.1007/s11481-009-9164-4; Conrad CD, 1996, BEHAV NEUROSCI, V110, P1321, DOI 10.1037/0735-7044.110.6.1321; Coughlin JM, 2015, NEUROBIOL DIS, V74, P58, DOI 10.1016/j.nbd.2014.10.019; Curzon P, 2009, FRONT NEUROSCI, P19; David S, 2011, NAT REV NEUROSCI, V12, P388, DOI 10.1038/nrn3053; Dewan MC, 2019, J NEUROSURG, V130, P1080, DOI 10.3171/2017.10.JNS17352; Donnelly DJ, 2008, EXP NEUROL, V209, P378, DOI 10.1016/j.expneurol.2007.06.009; Durafourt BA, 2012, GLIA, V60, P717, DOI 10.1002/glia.22298; Eissa M, 2017, LASER MED SCI, V32, P1261, DOI 10.1007/s10103-017-2230-x; Faden AI, 2016, BRIT J PHARMACOL, V173, P681, DOI 10.1111/bph.13179; Flierl MA, 2009, NAT PROTOC, V4, P1328, DOI 10.1038/nprot.2009.148; Goddeyne C, 2015, J NEUROPHYSIOL, V113, P3268, DOI 10.1152/jn.00970.2014; Goerdt S, 1999, PATHOBIOLOGY, V67, P222, DOI 10.1159/000028096; Gold EM, 2018, ASN NEURO, V10, DOI 10.1177/1759091418781921; Greenberg DA, 2005, NATURE, V438, P954, DOI 10.1038/nature04481; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Hacke W, 2014, STROKE, V45, P3187, DOI 10.1161/STROKEAHA.114.005795; Hamblin MR, 2018, J NEUROSCI RES, V96, P731, DOI 10.1002/jnr.24190; Hamblin MR, 2016, BBA CLIN, V6, P113, DOI 10.1016/j.bbacli.2016.09.002; Hellewell SC, 2010, J NEUROTRAUM, V27, P1997, DOI 10.1089/neu.2009.1245; Hennessy M, 2017, J OPTICS-UK, V19, DOI 10.1088/2040-8986/19/1/013003; Hinman JD, 2014, CURR OPIN NEUROL, V27, P615, DOI 10.1097/WCO.0000000000000149; Ippolito Dominic M, 2010, J Vis Exp, DOI 10.3791/2270; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; Kinoshita K, 2002, NEUROSURGERY, V51, P195, DOI 10.1097/00006123-200207000-00027; Kirkley KS, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0871-0; KITAGAWA K, 1989, NEUROSCIENCE, V31, P401, DOI 10.1016/0306-4522(89)90383-7; Kobeissy F., 2015, BRAIN NEUROTRAUMA MO; KOSTRON H, 1984, Neurological Research, V6, P29; Kovacech B, 2010, CURR ALZHEIMER RES, V7, P708, DOI 10.2174/156720510793611556; Langham J, 2003, COCHRANE DB SYST REV, V4, DOI [10.1002/14651858.CD000565, DOI 10.1002/14651858.CD000565]; Lapchak PA, 2008, STROKE, V39, P3073, DOI 10.1161/STROKEAHA.108.516393; Laurer HL, 2001, J NEUROSURG, V95, P859, DOI 10.3171/jns.2001.95.5.0859; Lu YJ, 2017, J ALZHEIMERS DIS, V56, P1469, DOI 10.3233/JAD-160869; Lu YJ, 2017, NEUROBIOL AGING, V49, P165, DOI 10.1016/j.neurobiolaging.2016.10.003; MacFarlane MP, 2015, BRAIN INJURY, V29, P139, DOI 10.3109/02699052.2014.965208; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Morgado P, 2018, FRONT BEHAV NEUROSCI, V12, DOI 10.3389/fnbeh.2018.00326; Mouzon B, 2012, J NEUROTRAUM, V29, P2761, DOI 10.1089/neu.2012.2498; Oron A, 2007, J NEUROTRAUM, V24, P651, DOI 10.1089/neu.2006.0198; Ott C, 2015, MOL MED, V21, P803, DOI 10.2119/molmed.2015.00192; Pekny M, 2016, BBA-MOL BASIS DIS, V1862, P483, DOI 10.1016/j.bbadis.2015.11.014; Perry VH, 2013, SEMIN IMMUNOPATHOL, V35, P601, DOI 10.1007/s00281-013-0382-8; Regen F, 2017, CURR ALZHEIMER RES, V14, P1140, DOI 10.2174/1567205014666170203141717; Roth TL, 2014, NATURE, V505, P223, DOI 10.1038/nature12808; Rubiano AM, 2015, NATURE, V527, pS193, DOI 10.1038/nature16035; Sawyer E, 2008, ANN PHARMACOTHER, V42, P247, DOI 10.1345/aph.1K284; Shankar GM, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-48; Shultz SR, 2012, J NEUROTRAUM, V29, P281, DOI 10.1089/neu.2011.2123; Shum D, 2011, NEUROPSYCHOLOGIA, V49, P2156, DOI 10.1016/j.neuropsychologia.2011.02.006; Small D H, 1999, J Alzheimers Dis, V1, P275; Steuer I, 2013, CURR PHARM DESIGN, V19, P4423, DOI 10.2174/1381612811319240009; Tatem KS, 2014, JOVE-J VIS EXP, DOI 10.3791/51785; Thornton E, 2006, BRAIN RES, V1094, P38, DOI 10.1016/j.brainres.2006.03.107; Tucker LD, 2018, J MOL NEUROSCI, V65, P514, DOI 10.1007/s12031-018-1121-3; Vink R, 2018, J NEUROSCI RES, V96, P527, DOI 10.1002/jnr.24079; Wang RM, 2019, MOL NEUROBIOL, V56, P1852, DOI 10.1007/s12035-018-1191-9; Webster KM, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0457-7; Wu CY, 2018, MED SCI SPORT EXER, V50, P945, DOI 10.1249/MSS.0000000000001519; Wu QH, 2012, LASER SURG MED, V44, P218, DOI 10.1002/lsm.22003; Xu X, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0934-2; Yang LD, 2018, EXP NEUROL, V299, P86, DOI 10.1016/j.expneurol.2017.10.013; Zhang QG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034504; Zhang QG, 2009, J NEUROSCI, V29, P13823, DOI 10.1523/JNEUROSCI.3574-09.2009; Zhao H, 2015, TRANSL STROKE RES, V6, P407, DOI 10.1007/s12975-015-0428-4	75	7	7	0	7	WILEY-V C H VERLAG GMBH	WEINHEIM	POSTFACH 101161, 69451 WEINHEIM, GERMANY	1864-063X	1864-0648		J BIOPHOTONICS	J. Biophotonics	FEB	2020	13	2							e201960117	10.1002/jbio.201960117		NOV 2019	18	Biochemical Research Methods; Biophysics; Optics	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biophysics; Optics	KM1BB	WOS:000498400800001	31657525				2022-02-06	
J	Andreasen, SH; Andersen, KW; Conde, V; Dyrby, TB; Puonti, O; Kammersgaard, LP; Madsen, CG; Madsen, KH; Poulsen, I; Siebner, HR				Andreasen, Sara H.; Andersen, Kasper W.; Conde, Virginia; Dyrby, Tim B.; Puonti, Oula; Kammersgaard, Lars Peter; Madsen, Camilla G.; Madsen, Kristoffer H.; Poulsen, Ingrid; Siebner, Hartwig R.			Limited Colocalization of Microbleeds and Microstructural Changes after Severe Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						diffusion tensor imaging; microbleeds; susceptibility-weighted imaging; traumatic axonal injury; traumatic brain injury	DIFFUSE AXONAL INJURY; MAGNETIC-RESONANCE; HEAD-INJURY; LESIONS; STEM; MODERATE; CONSCIOUSNESS; DEFINITION; DISORDERS; THALAMUS	Severe traumatic brain injury (TBI) produces shearing forces on long-range axons and brain vessels, causing axonal and vascular injury. To examine whether microbleeds and axonal injury colocalize after TBI, we performed whole-brain susceptibility-weighted imaging (SWI) and diffusion tensor imaging (DTI) in 14 patients during the subacute phase after severe TBI. SWI was used to determine the number and volumes of microbleeds in five brain regions: the frontotemporal lobe; parieto-occipital lobe; midsagittal region (cingular cortex, parasagittal white matter, and corpus callosum); deep nuclei (basal ganglia and thalamus); and brainstem. Averaged fractional anisotropy (FA) and mean diffusivity (MD) were measured to assess microstructural changes in the normal appearing white matter attributed to axonal injury in the same five regions. Regional expressions of microbleeds and microstructure were used in a partial least-squares model to predict the impairment of consciousness in the subacute stage after TBI as measured with the Coma Recovery Scale-Revised (CRS-R). Only in the midsagittal region, the expression of microbleeds was correlated with regional changes in microstructure as revealed by DTI. Microbleeds and microstructural DTI-based metrics of deep, but not superficial, brain regions were able to predict individual CRS-R. Our results suggest that microbleeds are not strictly related to axonal pathology in other than the midsagittal region. While each measure alone was predictive, the combination of both metrics scaled best with individual CRS-R. Structural alterations in deep brain structures are relevant in terms of determining the severity of impaired consciousness in the acute stage after TBI.	[Andreasen, Sara H.; Andersen, Kasper W.; Conde, Virginia; Dyrby, Tim B.; Puonti, Oula; Madsen, Camilla G.; Madsen, Kristoffer H.; Siebner, Hartwig R.] Copenhagen Univ Hosp Hvidovre, Danish Res Ctr Magnet Resonance, Ctr Funct & Diagnost Imaging Res, Kettegaard Alle 30, DK-2650 Hvidovre, Denmark; [Andreasen, Sara H.; Kammersgaard, Lars Peter; Poulsen, Ingrid] Copenhagen Univ Hosp, Rigshosp, Res Unit Brain Injury Rehabil Copenhagen, Dept Neurorehabil,Traumat Brain Injury, Copenhagen, Denmark; [Andreasen, Sara H.; Siebner, Hartwig R.] Univ Copenhagen, Inst Clin Med, Fac Hlth & Med Sci, Copenhagen, Denmark; [Conde, Virginia] Norwegian Univ Sci & Technol, Inst Psychol, Clin Neurosci Lab, Trondheim, Norway; [Dyrby, Tim B.; Puonti, Oula; Madsen, Kristoffer H.] Tech Univ Denmark, Dept Appl Math & Comp Sci, Lyngby, Denmark; [Kammersgaard, Lars Peter] Copenhagen Univ Hosp, Rigshosp, Dept Neurol, Copenhagen, Denmark; [Poulsen, Ingrid] Aarhus Univ, Fac Hlth, Dept Nursing Sci, Aarhus, Denmark; [Siebner, Hartwig R.] Copenhagen Univ Hosp Bispebjerg, Dept Neurol, Copenhagen, Denmark; [Madsen, Camilla G.] Copenhagen Univ Hosp Hvidovre, Dept Radiol, Hvidovre, Denmark		Siebner, HR (corresponding author), Copenhagen Univ Hosp Hvidovre, Danish Res Ctr Magnet Resonance, Ctr Funct & Diagnost Imaging Res, Kettegaard Alle 30, DK-2650 Hvidovre, Denmark.	Hartwig.roman.siebner@regionh.dk	Madsen, Kristoffer Hougaard/M-9547-2014; Poulsen, ingrid/AAH-2052-2019; Dyrby, Tim Bjorn/M-4823-2015	Madsen, Kristoffer Hougaard/0000-0001-8606-7641; Poulsen, ingrid/0000-0002-0342-017X; Puonti, Oula/0000-0003-3186-244X; Conde, Virginia/0000-0002-0309-0393; Dyrby, Tim Bjorn/0000-0003-3361-9734	Capital Region of Denmark (Region H) [R135-A4841]; Lundbeck FoundationLundbeckfonden [R186-2015-2138, R126-2012-12422]; Danish Council for Independent Research, Section of Medical Sciences (DFF-FSS) [DFF1331-00172]	The study was funded by the Capital Region of Denmark (Region H; grant no.: R135-A4841), the Lundbeck Foundation (grant no.: R126-2012-12422), and the Danish Council for Independent Research, Section of Medical Sciences (DFF-FSS; grant no.: DFF1331-00172). Hartwig R. Siebner holds a 5-year professorship in precision medicine at the Faculty of Health Sciences and Medicine, University of Copenhagen, which is sponsored by the Lundbeck Foundation (grant no.: R186-2015-2138).	Abu Hamdeh S, 2017, J NEUROTRAUM, V34, P341, DOI 10.1089/neu.2016.4426; ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; Akiyama Y, 2009, NEUROL MED-CHIR, V49, P97, DOI 10.2176/nmc.49.97; Andersson JLR, 2003, NEUROIMAGE, V20, P870, DOI 10.1016/S1053-8119(03)00336-7; Asano Y, 2012, NEUROL MED-CHIR, V52, P31, DOI 10.2176/nmc.52.31; Ashley M., 2009, EARLY VS LATE TREATM, pVA; Bernat JL, 2006, LANCET, V367, P1181, DOI 10.1016/S0140-6736(06)68508-5; Brown AW, 2005, J NEUROTRAUM, V22, P1040, DOI 10.1089/neu.2005.22.1040; Carpentier A, 2006, J NEUROTRAUM, V23, P674, DOI 10.1089/neu.2006.23.674; Chastain CA, 2009, J NEUROTRAUM, V26, P1183, DOI 10.1089/neu.2008.0650; Cicuendez M, 2019, J NEURORADIOLOGY, V46, P299, DOI 10.1016/j.neurad.2018.08.001; Conde V, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-016286; Cullen N, 2007, BRAIN INJURY, V21, P113, DOI 10.1080/02699050701201540; Debette S, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c3666; Dewan MC, 2019, J NEUROSURG, V130, P1080, DOI 10.3171/2017.10.JNS17352; Fuller P, 2011, J COMP NEUROL, V519, P933, DOI 10.1002/cne.22559; Gennarelli, 1998, Semin Clin Neuropsychiatry, V3, P160; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; Giacino JT, 2014, NAT REV NEUROL, V10, P99, DOI 10.1038/nrneurol.2013.279; Giacino JT, 2004, ARCH PHYS MED REHAB, V85, P2020, DOI 10.1016/j.apmr.2004.02.033; Giacino JT, 2002, NEUROLOGY, V58, P349, DOI 10.1212/WNL.58.3.349; Greenberg SM, 2009, LANCET NEUROL, V8, P165, DOI 10.1016/S1474-4422(09)70013-4; Haacke E.M., 2011, SUSCEPTIBILITY WEIGH; Hulkower MB, 2013, AM J NEURORADIOL, V34, P2064, DOI 10.3174/ajnr.A3395; Ivanidze J, 2016, AM J NEURORADIOL, V37, P1599, DOI 10.3174/ajnr.A4784; Kellner E, 2016, MAGN RESON MED, V76, P1574, DOI 10.1002/mrm.26054; Kou Z., 2009, P 17 ANN M ISMRM APR; Kumar R, 2009, J NEUROTRAUM, V26, P481, DOI 10.1089/neu.2008.0461; Laureys S, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-68; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Maas AIR, 2011, J NEUROTRAUM, V28, P177, DOI 10.1089/neu.2010.1617; Meythaler JM, 2001, ARCH PHYS MED REHAB, V82, P1461, DOI 10.1053/apmr.2001.25137; Moe HK, 2018, J NEUROTRAUM, V35, P975, DOI 10.1089/neu.2017.5252; Moen KG, 2014, J NEUROTRAUM, V31, P1486, DOI 10.1089/neu.2013.3258; Moen KG, 2016, J NEUROSCI RES, V94, P623, DOI 10.1002/jnr.23728; Moen KG, 2012, J NEUROL NEUROSUR PS, V83, P1193, DOI 10.1136/jnnp-2012-302644; Nielsen JS, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19475-y; Nilsson M, 2018, NEUROIMAGE, V182, P232, DOI 10.1016/j.neuroimage.2018.04.075; OMMAYA AK, 1995, J NEUROTRAUM, V12, P527, DOI 10.1089/neu.1995.12.527; Ponsford JL, 2016, J NEUROTRAUM, V33, P997, DOI 10.1089/neu.2015.4025; Scheid R, 2003, AM J NEURORADIOL, V24, P1049; Schiff ND, 2010, TRENDS NEUROSCI, V33, P1, DOI 10.1016/j.tins.2009.11.002; Schnakers C, 2009, BMC NEUROL, V9, DOI 10.1186/1471-2377-9-35; Shibata Y, 2000, CLIN NEUROL NEUROSUR, V102, P124, DOI 10.1016/S0303-8467(00)00095-0; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2007, NAT PROTOC, V2, P499, DOI 10.1038/nprot.2007.45; Spitz G, 2013, J NEUROTRAUM, V30, P2038, DOI 10.1089/neu.2013.3021; Tong K., 2011, SUSCEPTIBILITY WEIGH; Tong KA, 2004, ANN NEUROL, V56, P36, DOI 10.1002/ana.20123; Toth A, 2018, BEHAV BRAIN RES, V340, P106, DOI 10.1016/j.bbr.2017.02.039; Toth A, 2016, NEUROSCI LETT, V617, P207, DOI 10.1016/j.neulet.2016.02.028; Wardlaw JM, 2015, J AM HEART ASSOC, V4, DOI 10.1161/JAHA.114.001140; Wellman GC, 2013, ACTA NEUROCHIR SUPPL, V115, P173, DOI 10.1007/978-3-7091-1192-5_33; Whyte J, 2010, ARCH PHYS MED REHAB, V91, P1692, DOI 10.1016/j.apmr.2010.06.031; Zasler N., 2007, BRAIN INJURY MED PRI	56	7	7	0	5	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	FEB 15	2020	37	4					581	592		10.1089/neu.2019.6608		NOV 2019	12	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	KI3UL	WOS:000497527800001	31588844	Green Submitted			2022-02-06	
J	Ashendorf, L				Ashendorf, Lee			Rey Auditory Verbal Learning Test and Rey?Osterrieth Complex Figure Test performance validity indices in a VA Polytrauma sample	CLINICAL NEUROPSYCHOLOGIST			English	Article						Validity; effort; memory; veterans	RECOGNITION TRIAL; DIGIT SPAN; NEUROPSYCHOLOGISTS; REEXAMINATION; SENSITIVITY; VALIDATION; RATES	Objective: Performance validity assessment is a crucial component of any neuropsychological evaluation, particularly in settings where potential exaggeration of complaints and deficits is heightened. Standalone performance validity measures can be time-consuming, so many investigations have explored embedded indices within existing measures. The Rey Auditory Verbal Learning Test (RAVLT) and the Rey?Osterrieth Complex Figure Test (ROCF) each have a number of available embedded performance validity tests (PVTs). This investigation sought to evaluate several of these indices and to identify the most effective within a VA mild traumatic brain injury (mTBI)/Polytrauma sample. Method: A sample of 100?U.S. military veterans underwent clinical neuropsychological evaluation. There were 37 individuals whose test results were considered invalid based on failure of 2 or more independent PVTs, 47 whose results were valid, and 16 whose results were equivocal (failure on one PVT). The classification accuracies of published PVTs from the RAVLT and ROCF were evaluated. Results: Several indices had sensitivity values above 50% and strong positive predictive power with specificity held over 90%. Conclusions: The results demonstrated that there are multiple effective RAVLT & ROCF PVTs available for use in mTBI evaluations with veterans.	[Ashendorf, Lee] Univ Massachusetts, Sch Med, Dept Psychiat, Worcester, MA 01655 USA; [Ashendorf, Lee] VA Cent Western Massachusetts, Worcester, MA USA		Ashendorf, L (corresponding author), Worcester Lake Ave VA Clin, Ctr Ambulatory Care, 7th Floor,55 North Lake Ave, Worcester, MA 01655 USA.	Lee.Ashendorf@va.gov					Armistead-Jehle P, 2018, J CLIN EXP NEUROPSYC, V40, P213, DOI 10.1080/13803395.2017.1329406; Armistead-Jehle P, 2012, ARCH CLIN NEUROPSYCH, V27, P828, DOI 10.1093/arclin/acs086; Ashendorf L, 2017, CLIN NEUROPSYCHOL, V31, P857, DOI 10.1080/13854046.2017.1285961; Ashendorf L, 2016, CLIN NEUROPSYCHOL, V30, P599, DOI 10.1080/13854046.2016.1172668; Assistant Secretary of Defense, 2015, TRAUM BRAIN INJ UPD; Axelrod BN, 2006, CLIN NEUROPSYCHOL, V20, P513, DOI 10.1080/13854040590967117; Barrash J, 2004, J CLIN EXP NEUROPSYC, V26, P125, DOI 10.1076/jcen.26.1.125.23928; Beck A., 1996, BECK DEPRESSION INVE, V78, P490; BERNARD LC, 1993, J CLIN PSYCHOL, V49, P45, DOI 10.1002/1097-4679(199301)49:1<45::AID-JCLP2270490107>3.0.CO;2-7; Berthelson L, 2013, BRAIN INJURY, V27, P909, DOI 10.3109/02699052.2013.793400; Binder LM, 2003, J CLIN EXP NEUROPSYC, V25, P420, DOI 10.1076/jcen.25.3.420.13806; Blevins CA, 2015, J TRAUMA STRESS, V28, P489, DOI 10.1002/jts.22059; Boone K., 2002, DOT COUNTING TEST; Boone K.B., 2007, ASSESSMENT FEIGNED C; Boone KB, 2005, ARCH CLIN NEUROPSYCH, V20, P301, DOI 10.1016/j.acn.2004.08.001; Boone KB, 2002, J CLIN EXP NEUROPSYC, V24, P561, DOI 10.1076/jcen.24.5.561.1004; Bush, 2012, MILD TRAUMATIC BRAIN; Chouinard M J, 1997, J Int Neuropsychol Soc, V3, P545; Davis JJ, 2014, CLIN NEUROPSYCHOL, V28, P199, DOI 10.1080/13854046.2014.884633; Davis JJ, 2012, CLIN NEUROPSYCHOL, V26, P1397, DOI 10.1080/13854046.2012.728627; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Greiffenstein MF., 1994, PSYCHOL ASSESS, V6, P218, DOI [10.1037/1040-3590.6.3.218, DOI 10.1037/1040-3590.6.3.218]; Hosmer DW, 2000, WILEY PS TX, V2nd, P147; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; Knight J., 2003, REY OSTERRIETH COMPL; Larrabee G.J., 2007, ASSESSMENT MALINGERE; Larrabee GJ, 2003, CLIN NEUROPSYCHOL, V17, P410, DOI 10.1076/clin.17.3.410.18089; Larrabee GJ, 2008, CLIN NEUROPSYCHOL, V22, P666, DOI 10.1080/13854040701494987; Larrabee GJ, 2014, ARCH CLIN NEUROPSYCH, V29, P364, DOI 10.1093/arclin/acu019; Lezak MD, 2012, NEUROPSYCHOLOGICAL A; Lu PH, 2003, CLIN NEUROPSYCHOL, V17, P426, DOI 10.1076/clin.17.3.426.18083; Martin PK, 2015, CLIN NEUROPSYCHOL, V29, P741, DOI 10.1080/13854046.2015.1087597; Meyers J E, 2001, Appl Neuropsychol, V8, P234, DOI 10.1207/09084280152829084; Meyers J. E., 1995, CLIN NEUROPSYCHOL, V9, P63, DOI [10.1080/13854049508402059, DOI 10.1080/13854049508402059]; Meyers JE., 1995, REY COMPLEX FIGURE T; Meyers JE, 1998, APPL NEUROPSYCHOL, V5, P120, DOI 10.1207/s15324826an0503_2; Mitrushina M., 2005, HDB NORMATIVE DATA N, V2nd; Poreh A, 2016, APPL NEUROPSYCH-ADUL, V23, P155, DOI 10.1080/23279095.2015.1027343; Proto DA, 2014, ARCH CLIN NEUROPSYCH, V29, P614, DOI 10.1093/arclin/acu044; Rabin LA, 2016, ARCH CLIN NEUROPSYCH, V31, P206, DOI 10.1093/arclin/acw007; Reedy SD, 2013, ARCH CLIN NEUROPSYCH, V28, P30, DOI 10.1093/arclin/acs106; Schmidt M., 1996, REY AUDITORY VERBAL; Schroeder RW, 2019, CLIN NEUROPSYCHOL, V33, P466, DOI 10.1080/13854046.2018.1484517; Sherman DS, 2002, CLIN NEUROPSYCHOL, V16, P242, DOI 10.1076/clin.16.3.242.13860; Silk-Eglit GM, 2015, APPL NEUROPSYCH-ADUL, V22, P335, DOI 10.1080/23279095.2014.938809; Slick DJ, 1999, CLIN NEUROPSYCHOL, V13, P545, DOI 10.1076/1385-4046(199911)13:04;1-Y;FT545; Sugarman MA, 2016, APPL NEUROPSYCH-ADUL, V23, P105, DOI 10.1080/23279095.2015.1014557; Suhr JA, 2000, ARCH CLIN NEUROPSYCH, V15, P415, DOI 10.1016/S0887-6177(99)00033-5; Tombaugh T.N., 1996, TEST MEMORY MALINGER; Victor T, 2009, CLIN NEUROPSYCHOL, V23, P297, DOI 10.1080/13854040802232682; WechslerD, 2001, WECHSLER TEST ADULT; Young JC, 2012, CLIN NEUROPSYCHOL, V26, P147, DOI 10.1080/13854046.2011.647083	52	7	7	0	2	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1385-4046	1744-4144		CLIN NEUROPSYCHOL	Clin. Neuropsychol.	NOV 17	2019	33	8			SI		1388	1402		10.1080/13854046.2018.1543454			15	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	JH1IM	WOS:000492525700004	30638130				2022-02-06	
J	Baecker, J; Wartchow, K; Sehm, T; Ghoochani, A; Buchfelder, M; Kleindienst, A				Baecker, Justus; Wartchow, Krista; Sehm, Tina; Ghoochani, Ali; Buchfelder, Michael; Kleindienst, Andrea			Treatment with the Neurotrophic Protein S100 Calcium-Binding Protein B Increases Synaptogenesis after Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						neurogenesis; neuroplasticity; S100B; synaptogenesis; TBI	AMYLOID PRECURSOR PROTEIN; FOCAL CEREBRAL-ISCHEMIA; DENTATE GYRUS; AXONAL INJURY; HIPPOCAMPAL NEUROGENESIS; ACTIVATED MICROGLIA; CEREBROSPINAL-FLUID; ADULT NEUROGENESIS; COGNITIVE RECOVERY; BETA	Release of neurotrophic and growth factors such as S100 calcium-binding protein B (S100B) yields an endogenous repair mechanism following traumatic brain injury (TBI). Although nanomolar S100B concentrations enhance hippocampal progenitor cell proliferation, neuronal differentiation, and cognitive recovery, micromolar concentrations may foster inflammatory effects counteracting neuroplasticity. The purpose of the present study was to investigate the effect of S100B on synaptogenesis and microglial activation following experimental TBI. Male Sprague-Dawley rats (n = 40) were subjected to lateral fluid percussion or sham injury, and S100B (50 ng/h) or phosphate buffered saline (PBS) was infused into the lateral ventricle for 7 days using osmotic micropumps. The animals were euthanized on day 5 or, 5 weeks post-injury, and 5 mu m sections, 100 mu m apart (bregma -3.3 to -5.6mm) were analyzed histologically. Cell proliferation was assessed injecting the mitotic marker Bromodeoxyuridine (BrdU) on day 2. S100B enhanced significantly the synaptophysin (SYN) expression and microglial activation (ectodysplasin [ED1]) in the hippocampus in TBI and uninjured sham animals. The glial activation (glial fibrillary acidic protein [GFAP], S100B immunoreactive cells), axonal injury (APP) and cell death (terminal deoxynucleotidyl transferase dUTP nick end labeling [TUNEL]) were not altered. Triple-labelling with BrdU, NeuN, and SYN confirmed a significant participation of S100B in hippocampal synaptogenesis in TBI and uninjured sham animals. Our results demonstrate that S100B augments hippocampal neuro- and synaptogenesis in TBI and uninjured sham animals, thereby improving cognitive function as demonstrated earlier. The S100B-induced microglial activation does not counteract this effect within the first 5weeks. Further studies are required to elucidate respective cellular signaling mechanisms and possible long-term effects.	[Baecker, Justus; Sehm, Tina; Buchfelder, Michael; Kleindienst, Andrea] Friedrich Alexander Univ, Dept Neurosurg, Erlangen, Germany; [Wartchow, Krista] Univ Fed Rio Grande do Sul, Dept Biochem, Porto Alegre, RS, Brazil; [Ghoochani, Ali] Stanford Univ, Sch Med, Dept Radiol, Canary Ctr, Palo Alto, CA 94304 USA; [Kleindienst, Andrea] Klinikum Rummelsberg, Dept Spine Surg, Schwarzenbruck, Germany		Kleindienst, A (corresponding author), Univ Erlangen Nurnberg, Dept Neurosurg, Schwabachanlage 6, D-91054 Erlangen, Germany.	andrea.kleindienst@uk-erlangen.de					Adami C, 2004, BBA-MOL CELL RES, V1742, P169, DOI 10.1016/j.bbamcr.2004.09.008; ADAMS JH, 1982, ANN NEUROL, V12, P557, DOI 10.1002/ana.410120610; Ahlemeyer B, 2000, BRAIN RES, V858, P121, DOI 10.1016/S0006-8993(99)02438-5; Aimone JB, 2010, TRENDS COGN SCI, V14, P325, DOI 10.1016/j.tics.2010.04.003; Barger SW, 1997, NATURE, V388, P878, DOI 10.1038/42257; BARGER SW, 1995, BRAIN RES, V677, P167, DOI 10.1016/0006-8993(95)00160-R; Bergmann M, 1997, EXP BRAIN RES, V117, P80, DOI 10.1007/s002210050201; BERGMANN M, 1993, DEV BRAIN RES, V74, P235, DOI 10.1016/0165-3806(93)90009-Y; Bramlett HM, 1999, J NEUROSURG, V91, P653, DOI 10.3171/jns.1999.91.4.0653; Briones TL, 2006, BEHAV BRAIN RES, V171, P17, DOI 10.1016/j.bbr.2006.03.011; Clark RSB, 1997, J NEUROSCI, V17, P9172; CORTEZ SC, 1989, BRAIN RES, V482, P271, DOI 10.1016/0006-8993(89)91190-6; Cristovao JS, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aaq1702; Dash PK, 2001, J NEUROSCI RES, V63, P313, DOI 10.1002/1097-4547(20010215)63:4<313::AID-JNR1025>3.0.CO;2-4; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; Donato R, 2013, CURR MOL MED, V13, P24, DOI 10.2174/156652413804486214; Ekdahl CT, 2009, NEUROSCIENCE, V158, P1021, DOI 10.1016/j.neuroscience.2008.06.052; Emery DL, 2000, J COMP NEUROL, V424, P521; Emery DL, 2005, J NEUROTRAUM, V22, P978, DOI 10.1089/neu.2005.22.978; Faden AI, 2015, NEUROTHERAPEUTICS, V12, P143, DOI 10.1007/s13311-014-0319-5; GENTLEMAN SM, 1993, NEUROSCI LETT, V160, P139, DOI 10.1016/0304-3940(93)90398-5; Goncalves DS, 2000, NEUROREPORT, V11, P807, DOI 10.1097/00001756-200003200-00030; GRABS D, 1994, EUR J NEUROSCI, V6, P1765, DOI 10.1111/j.1460-9568.1994.tb00569.x; Green AJE, 1997, NEUROSCI LETT, V235, P5, DOI 10.1016/S0304-3940(97)00701-5; Guillery RW, 1997, J COMP NEUROL, V386, P2, DOI 10.1002/(SICI)1096-9861(19970915)386:1<2::AID-CNE2>3.0.CO;2-6; HATTEN ME, 1985, J CELL BIOL, V100, P384, DOI 10.1083/jcb.100.2.384; Heizmann CW, 2002, FRONT BIOSCI-LANDMRK, V7, pD1356, DOI 10.2741/heizmann; Hill SJ, 1996, J NEUROPATH EXP NEUR, V55, P1221, DOI 10.1097/00005072-199612000-00005; Hoehn BD, 2005, STROKE, V36, P2718, DOI 10.1161/01.STR.0000190020.30282.cc; Hu JR, 1997, J NEUROCHEM, V69, P2294; Huttunen HJ, 2000, J BIOL CHEM, V275, P40096, DOI 10.1074/jbc.M006993200; Iosif RE, 2006, J NEUROSCI, V26, P9703, DOI 10.1523/JNEUROSCI.2723-06.2006; JIANG H, 1993, J BIOL CHEM, V268, P20502; Jin KL, 2001, P NATL ACAD SCI USA, V98, P4710, DOI 10.1073/pnas.081011098; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; Kabadi SV, 2015, J CEREBR BLOOD F MET, V35, P2010, DOI 10.1038/jcbfm.2015.165; Kettenmann H, 2011, PHYSIOL REV, V91, P461, DOI 10.1152/physrev.00011.2010; Kirkham M, 2011, NEUROSCI LETT, V497, P11, DOI 10.1016/j.neulet.2011.04.007; Kleindienst A, 2005, J NEUROTRAUM, V22, P645, DOI 10.1089/neu.2005.22.645; Kleindienst A, 2004, J NEUROTRAUM, V21, P541, DOI 10.1089/089771504774129874; Kleindienst A, 2013, ACTA NEUROCHIR, V155, P1351, DOI 10.1007/s00701-013-1720-2; Kyritsis N, 2012, SCIENCE, V338, P1353, DOI 10.1126/science.1228773; Li YK, 1998, J NEUROCHEM, V71, P1421; Markakis EA, 1999, J COMP NEUROL, V406, P449; MARSHAK DR, 1990, PROG BRAIN RES, V86, P169; MASLIAH E, 1991, EXP NEUROL, V113, P131, DOI 10.1016/0014-4886(91)90169-D; Mattson MP, 1997, PHYSIOL REV, V77, P1081, DOI 10.1152/physrev.1997.77.4.1081; McAdory BS, 1998, BRAIN RES, V813, P211, DOI 10.1016/S0006-8993(98)01014-2; Nikolakopoulou AM, 2013, P NATL ACAD SCI USA, V110, P8714, DOI 10.1073/pnas.1218856110; ODowd BS, 1997, NEUROBIOL LEARN MEM, V67, P197, DOI 10.1006/nlme.1997.3766; Osier ND, 2015, J NEUROTRAUM, V32, P1861, DOI 10.1089/neu.2014.3680; Osman AM, 2011, STROKE, V42, P3559, DOI 10.1161/STROKEAHA.111.627802; Peskind ER, 2001, NEUROCHEM INT, V39, P409, DOI 10.1016/S0197-0186(01)00048-1; Pleines UE, 2001, J NEUROTRAUM, V18, P491, DOI 10.1089/089771501300227297; REEVES RH, 1994, P NATL ACAD SCI USA, V91, P5359, DOI 10.1073/pnas.91.12.5359; Rice AC, 2003, EXP NEUROL, V183, P406, DOI 10.1016/S0014-4886(03)00241-3; Ridet JL, 1997, TRENDS NEUROSCI, V20, P570, DOI 10.1016/S0166-2236(97)01139-9; Rohl C, 2007, BRAIN RES, V1129, P43, DOI 10.1016/j.brainres.2006.10.057; Roque P. J, 2014, CURR PROTOC TOXICOL, V60, P11; Scholzen T, 2000, J CELL PHYSIOL, V182, P311, DOI 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9; SHERRIFF FE, 1994, ACTA NEUROPATHOL, V88, P433; Soares HD, 1995, J NEUROSCI, V15, P8223; Souza TME, 2000, PHYSIOL BEHAV, V71, P29, DOI 10.1016/S0031-9384(00)00299-7; Stead LG, 2013, INT J EMERG MED, V6, DOI 10.1186/1865-1380-6-5; Sun D, 2007, EXP NEUROL, V204, P264, DOI 10.1016/j.expneurol.2006.11.005; Thelin EP, 2017, ACTA NEUROCHIR, V159, P209, DOI 10.1007/s00701-016-3046-3; TOULMOND S, 1993, BRAIN RES, V620, P24, DOI 10.1016/0006-8993(93)90266-P; Van Eldik LJ, 2003, RESTOR NEUROL NEUROS, V21, P97; Vilar M, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00026; WHITAKERAZMITIA PM, 1990, BRAIN RES, V528, P155, DOI 10.1016/0006-8993(90)90210-3; Xiong ZG, 2000, EXP CELL RES, V257, P281, DOI 10.1006/excr.2000.4902; Ziebell JM, 2010, NEUROTHERAPEUTICS, V7, P22, DOI 10.1016/j.nurt.2009.10.016	72	7	7	0	3	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	APR 15	2020	37	8					1097	1107		10.1089/neu.2019.6475		NOV 2019	11	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	LC5EK	WOS:000496153200001	31597524				2022-02-06	
J	Lippa, SM; French, LM; Bell, RS; Brickell, TA; Lange, RT				Lippa, Sara. M.; French, Louis M.; Bell, Randy S.; Brickell, Tracey A.; Lange, Rael T.			United States Military Service Members Demonstrate Substantial and Heterogeneous Long-Term Neuropsychological Dysfunction after Moderate, Severe, and Penetrating Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						closed brain injury; long-term outcome; military; neuropsychological performance; penetrating brain injury; traumatic brain injury	PERSONALITY-ASSESSMENT INVENTORY; COGNITIVE DECLINE; WORKING-MEMORY; HEAD-INJURY; INDIVIDUALS; PERFORMANCE; DEPRESSION; DEMENTIA; VALIDITY; TRIAL	The objective of the study was to examine long-term neuropsychological outcome after moderate, severe, and penetrating traumatic brain injury (TBI) in U.S. military service members and veterans (SMVs). Eighty-five SMVs with a history of moderate (n = 18), severe (n = 17), or penetrating (n = 26) TBI, or an injury without TBI (i.e., trauma control [TC], n = 24) were assessed five or more years (mean = 69.4 months; standard deviation = 35.6) post-injury. All passed performance validity tests. Participants completed a battery of neurocognitive tests and a personality inventory. Five cognitive domain composites, each composed of four test scores, and an overall test battery mean (OTBM) were computed. The penetrating TBI group performed worse than the TC group and/or the moderate TBI group on most cognitive domains and the OTBM. The severe TBI group also performed worse than the TC group and moderate TBI group on processing speed and the OTBM, and worse than the TC group on attention/working memory. Just more than half of participants with severe (56%) or penetrating (64%) TBI met criteria for mild neurocognitive disorder, with processing speed the most commonly impaired domain. In addition, 80% of TBI participants had one or more clinically elevated scales on the Minnesota Multiphasic Personality Inventory-2-Restructured Form (MMPI-2-RF), with somatic complaints the most common elevation. In conclusion, there was significantly reduced cognitive and psychological functioning many years after severe and penetrating TBI in SMVs. Cognitive and psychological dysfunction, however, were highly variable, with a substantial minority of SMVs having good outcome. Long-term individualized support is necessary for individuals after moderate, severe, and penetrating TBI.	[Lippa, Sara. M.; French, Louis M.; Brickell, Tracey A.; Lange, Rael T.] Walter Reed Natl Mil Med Ctr, Def & Vet Brain Injury Ctr, Room 6003,Bldg 19,8901 Wisconsin Ave, Bethesda, MD 20814 USA; [Lippa, Sara. M.; Lange, Rael T.] Walter Reed Natl Mil Med Ctr, Natl Intrepid Ctr Excellence, Bethesda, MD USA; [Bell, Randy S.] Walter Reed Natl Mil Med Ctr, Dept Neurol Surg, Bethesda, MD USA; [French, Louis M.; Bell, Randy S.; Brickell, Tracey A.] Uniformed Serv Univ Hlth Sci, Bethesda, MD 20814 USA; [Lange, Rael T.] Univ British Columbia, Vancouver, BC, Canada		Lippa, SM (corresponding author), Walter Reed Natl Mil Med Ctr, Def & Vet Brain Injury Ctr, Room 6003,Bldg 19,8901 Wisconsin Ave, Bethesda, MD 20814 USA.	sara.m.lippa.ctr@mail.mil	french, louis/AAB-2083-2020	french, louis/0000-0002-9451-0604			[Anonymous], 2015, C TRAUM BRAIN INJ US; APA, 2013, DIAGNOSTIC STAT MANU, DOI DOI 10.1176/APPI.BOOKS.9780890425596; Ben-Porath Y. S., 2011, MMPI 2 RF MINNESOTA; Carlozzi NE, 2013, J CLIN EXP NEUROPSYC, V35, P906, DOI 10.1080/13803395.2013.833178; Conners K., 2002, CONNERS CONTINUOUS P; CORKIN S, 1989, J NEUROSCI, V9, P3876; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P318, DOI 10.1097/01.HTR.0000300227.67748.77; Dean AC, 2009, CLIN NEUROPSYCHOL, V23, P133, DOI 10.1080/13854040701819050; Defense and Veterans Brain Injury Center D., 2018, DOD NUMB TRAUM BRAIN; Delis D.C., 2000, CALIFORNIA VERBAL LE; Delis DC., 2001, DELIS KAPLAN EXECUTI; Demakis GJ, 2007, ARCH CLIN NEUROPSYCH, V22, P123, DOI 10.1016/j.acn.2006.09.004; Denning JH, 2012, ARCH CLIN NEUROPSYCH, V27, P417, DOI 10.1093/arclin/acs044; DIKMEN SS, 1995, NEUROPSYCHOLOGY, V9, P80, DOI 10.1037/0894-4105.9.1.80; Dikmen SS, 2009, J HEAD TRAUMA REHAB, V24, P430, DOI 10.1097/HTR.0b013e3181c133e9; Draper K, 2008, NEUROPSYCHOLOGY, V22, P618, DOI 10.1037/0894-4105.22.5.618; Draper K, 2007, J HEAD TRAUMA REHAB, V22, P278, DOI 10.1097/01.HTR.0000290972.63753.a7; Dunning DL, 2016, NEUROPSYCHOLOGY, V30, P811, DOI 10.1037/neu0000285; Fann JR, 2018, LANCET PSYCHIAT, V5, P424, DOI 10.1016/S2215-0366(18)30065-8; Fraser EE, 2019, J NEUROTRAUM, V36, P2753, DOI 10.1089/neu.2019.6430; French LM, 2014, J REHABIL RES DEV, V51, P933, DOI 10.1682/JRRD.2013.10.0226; Gardner RC, 2014, JAMA NEUROL, V71, P1490, DOI 10.1001/jamaneurol.2014.2668; GHENT L, 1962, J COMP PHYSIOL PSYCH, V55, P705, DOI 10.1037/h0047520; Golden Z, 2003, INT J NEUROSCI, V113, P733, DOI 10.1080/00207450390200044; GRAFMAN J, 1990, PERCEPT MOTOR SKILL, V71, P1120, DOI 10.2466/PMS.71.7.1120-1122; GRAFMAN J, 1988, BRAIN, V111, P169, DOI 10.1093/brain/111.1.169; Grafman J., 1987, NEUROBEHAVIORAL RECO, P43; Grauwmeijer E, 2018, J NEUROTRAUM, V35, P1543, DOI 10.1089/neu.2017.5404; Green P, 2004, GREENS MED SYMPTOM V; Heaton R. K., 2004, REVISED COMPREHENSIV; Hibbard MR, 1998, J HEAD TRAUMA REHAB, V13, P24, DOI 10.1097/00001199-199808000-00003; Hibbard MR, 2004, ARCH PHYS MED REHAB, V85, pS43, DOI 10.1016/j.apmr.2003.08.116; Hoofien D, 2001, BRAIN INJURY, V15, P189; Iverson GL, 2011, LITTLE BLACK BOOK OF NEUROPSYCHOLOGY: A SYNDROME-BASED APPROACH, P663, DOI 10.1007/978-0-387-76978-3_21; Jourdan C, 2016, ANN PHYS REHABIL MED, V59, P100, DOI 10.1016/j.rehab.2015.10.009; Kennedy JE, 2015, ARCH CLIN NEUROPSYCH, V30, P236, DOI 10.1093/arclin/acv014; Larrabee GJ, 2003, CLIN NEUROPSYCHOL, V17, P54, DOI 10.1076/clin.17.1.54.15627; LEVIN JR, 1994, PSYCHOL BULL, V115, P153, DOI 10.1037/0033-2909.115.1.153; Lippa SM, 2018, CLIN NEUROPSYCHOL, V32, P391, DOI 10.1080/13854046.2017.1406146; Marsh NV, 2016, NEUROREHABILITATION, V38, P71, DOI 10.3233/NRE-151297; Millis SR, 2001, J HEAD TRAUMA REHAB, V16, P343, DOI 10.1097/00001199-200108000-00005; Mittenberg W, 2002, J CLIN EXP NEUROPSYC, V24, P1094, DOI 10.1076/jcen.24.8.1094.8379; Nordstrom A, 2018, PLOS MED, V15, DOI 10.1371/journal.pmed.1002496; Ponsford JL, 2014, J NEUROTRAUM, V31, P64, DOI 10.1089/neu.2013.2997; Prigatano G., 2008, TXB CLIN NEUROPSYCHO, P985; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; RUSSELL WR, 1951, J NEUROL NEUROSUR PS, V14, P35, DOI 10.1136/jnnp.14.1.35; Ruttan L, 2008, ARCH PHYS MED REHAB, V89, pS69, DOI 10.1016/j.apmr.2008.07.007; SALAZAR AM, 1986, NEUROLOGY, V36, P459, DOI 10.1212/WNL.36.4.459; Schretlen DJ, 2003, INT REV PSYCHIATR, V15, P341, DOI 10.1080/09540260310001606728; Schwartz ES, 2016, J INT NEUROPSYCH SOC, V22, P851, DOI 10.1017/S1355617716000746; Stern RA, 2003, NEUROPSYCHOLOGICAL A; SWANSON SJ, 1995, BRAIN, V118, P91, DOI 10.1093/brain/118.1.91; TATE RL, 1991, J NERV MENT DIS, V179, P117, DOI 10.1097/00005053-199103000-00001; Teuber H.-L., 1960, VISUAL FIELD DEFECTS; Till C, 2008, ARCH PHYS MED REHAB, V89, pS25, DOI 10.1016/j.apmr.2008.07.004; Tombaugh T.N., 1996, TOMM TEST MEMORY MAL; Vallat-Azouvi C, 2007, J INT NEUROPSYCH SOC, V13, P770, DOI 10.1017/S1355617707070993; Vanderploeg RD, 2007, J REHABIL RES DEV, V44, P937, DOI 10.1682/JRRD.2006.12.0163; Verploeg R.D., 2018, TXB CLIN NEUROPSYCHO, V2nd ed., P411; Walker WC, 2015, J HEAD TRAUMA REHAB, V30, P231, DOI 10.1097/HTR.0000000000000127; Warriner EM, 2003, J CLIN EXP NEUROPSYC, V25, P904, DOI 10.1076/jcen.25.7.904.16494; Wechsler D., 2009, ADV CLIN SOLUTIONS U; Wechsler D., 2009, WECHSLER MEMORY SCAL; Wechsler D., 2008, WECHSLER ADULT INTEL; WEINSTEIN S, 1957, J COMP PHYSIOL PSYCH, V50, P535, DOI 10.1037/h0047738; WEINSTEIN S, 1956, J PSYCHOL, V42, P249, DOI 10.1080/00223980.1956.9713038; WEINSTEIN S, 1957, SCIENCE, V125, P1036, DOI 10.1126/science.125.3256.1036; Wood RL, 2007, J INT NEUROPSYCH SOC, V13, P90, DOI 10.1017/S1355617707070129	69	7	7	1	3	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	FEB 15	2020	37	4					608	617		10.1089/neu.2019.6696		NOV 2019	10	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	KI3UL	WOS:000496152200001	31559904				2022-02-06	
J	Wade, SL; Narad, ME; Moscato, EL; LeBlond, EI; King, JA; Raj, SP; Platt, A; Thompson, AN; Baum, KT; Salloum, R				Wade, Shari L.; Narad, Megan E.; Moscato, Emily L.; LeBlond, Elizabeth I.; King, Jessica A.; Raj, Stacey P.; Platt, Amber; Thompson, Aimee N.; Baum, Katherine T.; Salloum, Ralph			A Survivor's Journey: Preliminary efficacy of an online problem-solving therapy for survivors of pediatric brain tumor	PEDIATRIC BLOOD & CANCER			English	Article						adolescent; CNS tumors; long-term survival; problem-solving; psychology; young adult	YOUNG-ADULT SURVIVORS; CHILDHOOD-CANCER; BEHAVIOR PROBLEMS; CHILDREN; ADOLESCENT; INJURY; INTERVENTION; OUTCOMES; TRIAL	Background Although pediatric brain tumor survivors are at high risk for a variety of psychosocial and neurocognitive late effects, there are few evidence-based interventions to address their needs. The purpose of this study was to test the efficacy of an online problem-solving intervention on improving the quality of life and executive dysfunction among adolescent and young adult brain tumor survivors. Procedure A Survivor's Journey was adapted from a similar intervention for survivors of traumatic brain injuries, and involved self-guided web modules providing training in problem-solving as a tool for coping with everyday challenges, as well as weekly teleconferences with a trained therapist. Survivors (n = 19) between the ages of 13 and 25, and their caregivers, completed standardized measures of their emotional and behavioral functioning, executive functioning, and quality of life before and after the 12- to 16-week intervention. Results Participation in the intervention led to significant improvements in self-reported overall (M-pre = 62.03, SDpre = 17.67, M-post = 71.97, SDpost = 16.75; d = 0.58, P = 0.01) and physical quality of life (M-pre = 63.13, SDpre = 21.88, M-post( )= 75.00, SDpost = 21.33; d = 0.55, P < 0.01) as well as parent-reported emotional quality of life (M-pre = 65.00, SDpre = 28.72, M-post = 76.15, SDpost = 23.47; d = 0.43, P = 0.03). Greater improvement was noted in those who were diagnosed before the age of seven and those with average or above average estimated IQs. Current age did not moderate outcomes. Conclusions Online problem-solving therapy may be efficacious in improving pediatric brain tumor survivors' quality of life; however, further research with a comparison group is needed. Online interventions such as Survivor's Journey may decrease barriers to evidence-based psychosocial care for brain tumor survivors.	[Wade, Shari L.; Moscato, Emily L.; LeBlond, Elizabeth I.] Cincinnati Childrens Hosp Med Ctr, Div Pediat Rehabil Med, 3333 Burnet Ave, Cincinnati, OH 45229 USA; [Wade, Shari L.; Narad, Megan E.; Salloum, Ralph] Univ Cincinnati, Dept Pediat, Cincinnati, OH USA; [Narad, Megan E.; King, Jessica A.] Cincinnati Childrens Hosp Med Ctr, Div Behav Med & Clin Psychol, Cincinnati, OH 45229 USA; [Moscato, Emily L.; LeBlond, Elizabeth I.] Univ Cincinnati, Dept Psychol, Cincinnati, OH 45221 USA; [Raj, Stacey P.] Xavier Univ, Sch Psychol, Cincinnati, OH 45207 USA; [Platt, Amber; Thompson, Aimee N.; Salloum, Ralph] Cincinnati Childrens Hosp Med Ctr, Canc & Blood Dis Inst, Cincinnati, OH 45229 USA; [Thompson, Aimee N.] PsychBc, Blue Ash, OH USA; [Baum, Katherine T.] Childrens Hosp Philadelphia, Dept Child & Adolescent Psychiat & Behav Sci, Philadelphia, PA 19104 USA		Wade, SL (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Pediat Rehabil Med, 3333 Burnet Ave, Cincinnati, OH 45229 USA.	shari.wade@cchmc.org		Moscato, Emily/0000-0002-0207-0251	Research Innovation Program at Cincinnati Children's HospitalMedical Center	We would like to thank our funding source, the Research Innovation Program at Cincinnati Children's HospitalMedical Center.	Baldwin RT, 2004, TOXICOL APPL PHARM, V199, P118, DOI 10.1016/j.taap.2003.12.029; Barrera M, 2005, CANCER-AM CANCER SOC, V104, P1751, DOI 10.1002/cncr.21390; Beauchamp M, 2011, DEV NEUROPSYCHOL, V36, P578, DOI 10.1080/87565641.2011.555572; Beck J.S., 1995, COGNITIVE THERAPY BA; Bonner MJ, 2008, J PEDIATR PSYCHOL, V33, P1142, DOI 10.1093/jpepsy/jsn035; Brier MJ, 2015, HEALTH PSYCHOL, V34, P130, DOI 10.1037/hea0000119; Conklin HM, 2017, J PEDIATR PSYCHOL, V42, P220, DOI 10.1093/jpepsy/jsw057; Cuijpers P, 2018, EUR PSYCHIAT, V48, P27, DOI 10.1016/j.eurpsy.2017.11.006; D'Zurilla T J, 2010, PROBLEM SOLVING THER; Foley B, 2010, CHILDRENS HLTH CARE, V29, P209; Ganesalingam K, 2007, J NEUROPSYCHOL, V1, P149, DOI 10.1348/174866407X185300; Gioia GA, 2000, CHILD NEUROPSYCHOL, V6, P235, DOI 10.1076/chin.6.3.235.3152; Glaser NJ, 2017, J FORMATIVE DES LEAR, V1, P126, DOI 10.1007/s41686-017-0011-3; Goodman R, 2001, J AM ACAD CHILD PSY, V40, P1337, DOI 10.1097/00004583-200111000-00015; Hardy KK, 2013, PSYCHO-ONCOLOGY, V22, P1856, DOI 10.1002/pon.3222; Hocking MC, 2019, J PEDIATR PSYCHOL, V44, P669, DOI 10.1093/jpepsy/jsz015; Karch D, 2013, DTSCH ARZTEBL INT, V110, P643, DOI 10.3238/arztebl.2013.0643; Kazak AE, 1998, J AM ACAD CHILD PSY, V37, P823, DOI 10.1097/00004583-199808000-00012; Klassen AF, 2011, SUPPORT CARE CANCER, V19, P1275, DOI 10.1007/s00520-011-1193-x; Kunin-Batson A, 2011, PEDIATR BLOOD CANCER, V57, P1197, DOI 10.1002/pbc.22982; Moscato EL, 2019, CLIN PRACT PEDIAT PS, V7, P68, DOI 10.1037/cpp0000265; Mulhern RK, 2004, LANCET ONCOL, V5, P399, DOI 10.1016/S1470-2045(04)01507-4; Narad ME, 2019, ARCH PHYS MED REHAB, V100, P811, DOI 10.1016/j.apmr.2019.01.010; Nezu AM, 2006, PROBLEM SOLVING THER; Patel SK, 2009, J PEDIAT HEMATOL ONC, V31, P670, DOI 10.1097/MPH.0b013e3181b25a1d; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Raj SP, 2018, J ADOLESC YOUNG ADUL, V7, P187, DOI 10.1089/jayao.2017.0084; Ribi K, 2005, NEUROPEDIATRICS, V36, P357, DOI 10.1055/s-2005-872880; Ries LAG HD, 2005, SEER CANC STAT REV; Riggs L, 2017, NEURO-ONCOLOGY, V19, P440, DOI 10.1093/neuonc/now177; Santacroce SJ, 2010, J PEDIATR ONCOL NURS, V27, P10, DOI 10.1177/1043454209340325; Sesma HW, 2008, PEDIATRICS, V121, pE1686, DOI 10.1542/peds.2007-2461; Varni James W, 2004, Health Qual Life Outcomes, V2, P55, DOI 10.1186/1477-7525-2-55; Wade SL, 2017, J AM ACAD CHILD PSY, V56, P930, DOI 10.1016/j.jaac.2017.09.413; Wade SL, 2017, ARCH PHYS MED REHAB, V98, P1614, DOI 10.1016/j.apmr.2017.03.006; Wade SL, 2014, REHABIL PSYCHOL, V59, P1, DOI 10.1037/a0034911; Wade SL, 2012, HEALTH PSYCHOL, V31, P767, DOI 10.1037/a0028440; Wade SL, 2011, PEDIATRICS, V128, pE947, DOI 10.1542/peds.2010-3721; Wechsler D., 1999, MANUAL WECHSLER ABBR; Zhang NH, 2019, J NEUROTRAUM, V36, P1147, DOI 10.1089/neu.2018.5885	40	7	7	0	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1545-5009	1545-5017		PEDIATR BLOOD CANCER	Pediatr. Blood Cancer	FEB	2020	67	2							e28043	10.1002/pbc.28043		NOV 2019	8	Oncology; Hematology; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Oncology; Hematology; Pediatrics	QB4CF	WOS:000496169400001	31724307				2022-02-06	
J	Adame, BJ; Corman, SR				Adame, Bradley J.; Corman, Steven R.			Vested Interests and Perceived Risk of Concussion Consequences among Power-5 College Athletes	HEALTH COMMUNICATION			English	Article							SPORT; EDUCATION; MODEL; EPIDEMIOLOGY; PREPAREDNESS; BEHAVIORS; SYMPTOMS	Concussion injuries among young athletes are a growing public health concern; concussion injuries pose threats to both short-term and long-term brain health. Significant, multidisciplinary efforts are underway to improve detection, diagnosis and treatment. Concussion symptoms are ambiguous and not outwardly visible; successful detection and diagnosis efforts depend on veridical athlete communication with health practitioners. To date, education programs to enhance reporting behaviors have not been successful. This research reports findings from the first phase of a project designed to understand athlete?s perceived risk of concussion consequences with the goal of informing theory-based motivational and educational interventions. Using a novel theoretical approach, this research examines the vested interests of 435 collegiate athletes from 12 universities, participating in six Division I level, high concussion-risk sports, sanctioned by a Power-5 conference. Our findings confirm that the vestedness model predicts a consequential amount of variance in perceived concussion risk, perceived levels of concussion education, and recalled head impacts. The model identifies several opportunities to craft theory-based messages that can motivate reporting behaviors. This research contributes to the literature on concussion safety by offering a unique theoretical framework that accounts for factors influencing risk perception and takes a step in a call for deliberate, theory-based optimization and translation of concussion education for high-risk athletes.	[Adame, Bradley J.; Corman, Steven R.] Arizona State Univ, Hugh Downs Sch Human Commun, POB 871205, Tempe, AZ 85287 USA		Adame, BJ (corresponding author), Arizona State Univ, Hugh Downs Sch Human Commun, POB 871205, Tempe, AZ 85287 USA.	badame@asu.edu		Adame, Bradley/0000-0002-9825-7300	National Collegiate Athletic Association under the Mind Matters Challenge grant program	This work was supported by the National Collegiate Athletic Association under the Mind Matters Challenge grant program.	Adame B. J., 2018, NATURAL DISASTERS RI, P49; Adame B, 2016, DISASTER PREV MANAG, V25, P282, DOI 10.1108/DPM-08-2015-0196; Adame BJ, 2015, HEALTH COMMUN, V30, P271, DOI 10.1080/10410236.2013.842527; Asken BM, 2017, ARCH CLIN NEUROPSYCH, V32, P963, DOI 10.1093/arclin/acx018; BANDURA A, 1982, AM PSYCHOL, V37, P122, DOI 10.1037/0003-066X.37.2.122; Bell JM, 2017, J SAFETY RES, V62, P253, DOI 10.1016/j.jsr.2017.04.002; Bishop G., 2012, NY TIMES; Branch J, 2016, NY TIMES; Brewer NT, 2007, HEALTH PSYCHOL, V26, P136, DOI 10.1037/0278-6133.26.2.136; Broglio Steven P, 2016, Concussion, V1, pCNC23, DOI 10.2217/cnc-2016-0007; Cohen J., 1983, APPL MULTIPLE REGRES; Crano WD, 2006, ANNU REV PSYCHOL, V57, P345, DOI 10.1146/annurev.psych.57.102904.190034; Daneshvar DH, 2011, CLIN SPORT MED, V30, P1, DOI 10.1016/j.csm.2010.08.006; De Dominicis S, 2014, J APPL SOC PSYCHOL, V44, P364, DOI 10.1111/jasp.12229; Elbin RJ, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2016-0910; Gilbert FC, 2016, SPORTS HEALTH, V8, P661, DOI 10.1177/1941738116666509; Hawkins RP, 2008, HEALTH EDUC RES, V23, P454, DOI 10.1093/her/cyn004; Johnson C., 2017, NEUROLOGY S, V88, P2055, DOI 10.1212/WNL.0000000000003693; Kerr ZY, 2014, BRAIN INJURY, V28, P1009, DOI 10.3109/02699052.2014.904049; Kroshus E, 2015, SOC SCI MED, V134, P66, DOI 10.1016/j.socscimed.2015.04.011; Kroshus E, 2014, J ADOLESCENT HEALTH, V54, P269, DOI 10.1016/j.jadohealth.2013.11.011; Kroshus E, 2014, BRIT J SPORT MED, V48, P135, DOI 10.1136/bjsports-2013-092498; Luca NR, 2013, J HEALTH COMMUN, V18, P20, DOI 10.1080/10810730.2012.688243; Lynall RC, 2015, MED SCI SPORT EXER, V47, P2487, DOI 10.1249/MSS.0000000000000716; Martini DN, 2018, INT J PSYCHOPHYSIOL, V132, P25, DOI 10.1016/j.ijpsycho.2017.09.019; McCrory P, 2013, J ATHL TRAINING, V48, P554, DOI 10.4085/1062-6050-48.4.05; Meier TB, 2015, J SCI MED SPORT, V18, P507, DOI 10.1016/j.jsams.2014.07.008; Mez J, 2017, JAMA-J AM MED ASSOC, V318, P360, DOI 10.1001/jama.2017.8334; Miller CH, 2013, DISASTERS, V37, P1, DOI 10.1111/j.1467-7717.2012.01290.x; Mrazik M, 2015, BRIT J SPORT MED, V49, DOI 10.1136/bjsports-2015-094848; National Collegiate Athletic Association, 2017, DIV 1 MAN; Omalu B, 2014, PROG NEUROL SURG, V28, P38, DOI 10.1159/000358761; Register-Mihalik J, 2017, J ATHL TRAINING, V52, P195, DOI 10.4085/1062-6050-51.12.02; Register-Mihalik JK, 2013, J ATHL TRAINING, V48, P645, DOI 10.4085/1062-6050-48.3.20; Register-Mihalik JK, 2013, BRAIN INJURY, V27, P878, DOI 10.3109/02699052.2013.775508; Roberto AJ, 2009, J HEALTH COMMUN, V14, P400, DOI 10.1080/10810730902873935; Ryan LM, 2003, INT REV PSYCHIATR, V15, P310, DOI 10.1080/09540260310001606692; Sallis J.F., 2002, HLTH BEHAV HLTH ED T; Schwartz A., 2007, NY TIMES; Sheeran P, 2014, PSYCHOL BULL, V140, P511, DOI 10.1037/a0033065; Sitkin SB, 1995, ACAD MANAGE J, V38, P1573, DOI 10.2307/256844; Sjoberg L, 2000, RISK ANAL, V20, P1, DOI 10.1111/0272-4332.00001; Slovic P., 2000, PERCEPTION RISK; Turner MM, 2012, COMMUN Q, V60, P545, DOI 10.1080/01463373.2012.705780; McLeod TCV, 2008, CLIN J SPORT MED, V18, P235, DOI 10.1097/JSM.0b013e3181705756; Witte K, 2001, EFFECTIVE HLTH RISK; Zuckerman SL, 2015, AM J SPORT MED, V43, P2654, DOI 10.1177/0363546515599634	47	7	7	0	8	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	1041-0236	1532-7027		HEALTH COMMUN	Health Commun.	NOV 10	2019	34	13					1673	1682		10.1080/10410236.2018.1517707			10	Communication; Health Policy & Services	Social Science Citation Index (SSCI)	Communication; Health Care Sciences & Services	JF4NW	WOS:000491365600015	30216096				2022-02-06	
J	Alois, J; Bellamkonda, S; Campolettano, ET; Gellner, RA; Genemaras, A; Beckwith, JG; Greenwald, RM; Smith, E; Rowson, S; Duma, SM; Crisco, JJ				Alois, Jaclyn; Bellamkonda, Srinidhi; Campolettano, Eamon T.; Gellner, Ryan A.; Genemaras, Amaris; Beckwith, Jonathan G.; Greenwald, Richard M.; Smith, Eric; Rowson, Steven; Duma, Stefan M.; Crisco, Joseph J.			Do American Youth Football Players Intentionally Use Their Heads for High-Magnitude Impacts?	AMERICAN JOURNAL OF SPORTS MEDICINE			English	Article						head; impact; mechanism; intentional; football; youth players	TRAUMATIC BRAIN-INJURY; HIGH-SCHOOL FOOTBALL; UNITED-STATES; EXPOSURE; CONCUSSION; ACCELERATION; EPIDEMIOLOGY; SYSTEM; KINEMATICS; FREQUENCY	Background: Concern for head injuries is widespread and has been reported by the media to be the number one cause of decreased participation in football among the American youth population. Identifying player mechanisms associated with intentional, or purposeful, head impacts should provide critical data for rule modifications, educational programs, and equipment design. Purpose: To investigate the frequency of intentional and unintentional head impacts and to examine the player mechanisms associated with intentional high-magnitude head impacts by comparing the impact mechanism distributions among session type, player position, and ball possession. Study Design: Cross-sectional study; Level of evidence, 3. Methods: Head impact sensors and video footage of 68 players were used to analyze and classify 1319 high-magnitude impacts recorded over 1 season of youth football. Results: In total, 80% of the high-magnitude head impacts were classified as being caused by intentional use of the head. Head-to-head impact was the primary impact mechanism (n = 868; 82.7%) within the 1050 intentional high-magnitude impacts, with classifiable mechanisms, followed by head-to-body (n = 139; 13.2%), head-to-ground (n = 34; 3.2%), and head-to-equipment (n = 9; 0.9%). Head-to-head impacts also accounted for a greater proportion of impacts during practices (n = 625; 88.9%) than games, for linemen (n = 585; 90.3%) than perimeters and backs, and for ball carriers (n = 72; 79.1%) than tacklers. Conclusion: Overall, the majority of high-magnitude head impacts were intentional and resulted from head-to-head contact. The proportion of head-to-head contact was significantly higher for practices than games, linemen than backs and perimeter players, and ball carriers than tacklers.	Brown Univ, Providence, RI 02912 USA; Virginia Tech Univ, Blacksburg, VA USA; [Alois, Jaclyn; Bellamkonda, Srinidhi; Crisco, Joseph J.] Brown Univ, Warren Alpert Med Sch, Dept Orthopaed, Bioengn Lab, CORO West,Suite 404,1 Hoppin St, Providence, RI 02903 USA; [Alois, Jaclyn; Bellamkonda, Srinidhi; Crisco, Joseph J.] Rhode Isl Hosp, CORO West,Suite 404,1 Hoppin St, Providence, RI 02903 USA; [Campolettano, Eamon T.; Gellner, Ryan A.; Rowson, Steven; Duma, Stefan M.] Virginia Tech, Dept Biomed Engn & Mech, Blacksburg, VA USA; [Genemaras, Amaris; Beckwith, Jonathan G.; Greenwald, Richard M.] Simbex, Lebanon, NH USA; [Smith, Eric] Virginia Tech, Dept Stat, Blacksburg, VA USA		Crisco, JJ (corresponding author), Brown Univ, Warren Alpert Med Sch, Dept Orthopaed, Bioengn Lab, CORO West,Suite 404,1 Hoppin St, Providence, RI 02903 USA.; Crisco, JJ (corresponding author), Rhode Isl Hosp, CORO West,Suite 404,1 Hoppin St, Providence, RI 02903 USA.	joseph_crisco@brown.edu	Rowson, Steven/B-1270-2012	Rowson, Steven/0000-0002-3227-0596; Crisco, Joseph/0000-0002-8786-0905	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NIH R01NS094410]; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R44HD40743]; Riddell Inc (Elyria, OH); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS094410] Funding Source: NIH RePORTER	Research reported in this publication was supported by the National Institutes of Health under award number NIH R01NS094410. HIT System technology was developed in part under NIH R44HD40743 and research and development support from Riddell Inc (Elyria, OH). J.G.B., R.M.G., and J.J.C. have a financial interest in the instruments (HIT System, Sideline Response System; Riddell Inc) that were used to collect the biomechanical data reported in this study. AOSSM checks author disclosures against the Open Payments Database (OPD). AOSSM has not conducted an independent investigation on the OPD and disclaims any liability or responsibility relating thereto.	ALLEN ME, 1994, SPINE, V19, P1285, DOI 10.1097/00007632-199405310-00017; Andersen TE, 2004, BRIT J SPORT MED, V38, P690, DOI 10.1136/bjsm.2003.009357; Bahrami N, 2016, RADIOLOGY, V281, P919, DOI 10.1148/radiol.2016160564; Beckwith JG, 2007, J APPL BIOMECH, V23, P238, DOI 10.1123/jab.23.3.238; Beckwith JG, 2012, ANN BIOMED ENG, V40, P237, DOI 10.1007/s10439-011-0422-2; Broglio SP, 2010, MED SCI SPORT EXER, V42, P2064, DOI 10.1249/MSS.0b013e3181dd9156; Broglio SP, 2009, J ATHL TRAINING, V44, P342, DOI 10.4085/1062-6050-44.4.342; Campolettano ET, 2017, J NEUROSURG-PEDIATR, V20, P604, DOI 10.3171/2017.5.PEDS17185; Campolettano ET, 2016, J NEUROSURG-PEDIATR, V18, P536, DOI 10.3171/2016.5.PEDS1696; Cobb Bryan R, 2014, Biomed Sci Instrum, V50, P285; Cobb BR, 2013, ANN BIOMED ENG, V41, P2463, DOI 10.1007/s10439-013-0867-6; Collins M, 2006, NEUROSURGERY, V58, P275, DOI 10.1227/01.NEU.0000200441.92742.46; Crisco JJ, 2011, J BIOMECH, V44, P2673, DOI 10.1016/j.jbiomech.2011.08.003; Crisco JJ, 2011, CURR SPORT MED REP, V10, P7, DOI 10.1249/JSR.0b013e318205e063; Crisco JJ, 2010, J ATHL TRAINING, V45, P549, DOI 10.4085/1062-6050-45.6.549; Cross MJ, 2019, BRIT J SPORT MED, V53, P1021, DOI 10.1136/bjsports-2017-097912; Daneshvar DH, 2011, CLIN SPORT MED, V30, P1, DOI 10.1016/j.csm.2010.08.006; Daniel RW, 2012, ANN BIOMED ENG, V40, P976, DOI 10.1007/s10439-012-0530-7; Davenport EM, 2014, J NEUROTRAUM, V31, P1617, DOI 10.1089/neu.2013.3233; Dick R, 2007, J ATHL TRAINING, V42, P221; Dompier TP, 2015, JAMA PEDIATR, V169, P659, DOI 10.1001/jamapediatrics.2015.0210; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Guskiewicz KM, 2007, NEUROSURGERY, V61, P1244, DOI 10.1227/01.neu.0000306103.68635.1a; Kavanagh JJ, 2004, GAIT POSTURE, V20, P291, DOI 10.1016/j.gaitpost.2003.10.004; Kelley ME, 2017, J NEUROSURG-PEDIATR, V20, P489, DOI 10.3171/2017.5.PEDS16627; Kerr ZY, 2018, HEALTH PROMOT PRACT, V19, P184, DOI 10.1177/1524839917700398; Kerr ZY, 2015, ORTHOP J SPORTS MED, V3, DOI 10.1177/2325967115610545; Kindschi Kari, 2017, BMJ Open Sport Exerc Med, V3, pe000165, DOI 10.1136/bmjsem-2016-000165; Kontos AP, 2013, J PEDIATR-US, V163, P717, DOI 10.1016/j.jpeds.2013.04.011; Kroshus E, 2015, SOC SCI MED, V134, P66, DOI 10.1016/j.socscimed.2015.04.011; McAllister TW, 2014, NEUROLOGY, V82, P63, DOI 10.1212/01.wnl.0000438220.16190.42; Mercer JA, 2003, J SPORT SCI, V21, P911, DOI 10.1080/0264041031000140383; Mihalik JP, 2010, PEDIATRICS, V125, pE1394, DOI 10.1542/peds.2009-2849; Newman JA, 2005, J BIOMECH, V38, P1469, DOI 10.1016/j.jbiomech.2004.06.025; Pellman EJ, 2003, NEUROSURGERY, V53, P799, DOI 10.1093/neurosurgery/53.3.799; Reynolds BB, 2016, J NEUROSURG, V124, P501, DOI 10.3171/2015.5.JNS15573; Rowson S, 2014, J NEUROSURG, V120, P919, DOI 10.3171/2014.1.JNS13916; Rowson S, 2013, ANN BIOMED ENG, V41, P873, DOI 10.1007/s10439-012-0731-0; Rowson S, 2012, ANN BIOMED ENG, V40, P2512, DOI 10.1007/s10439-012-0660-y; Rowson S, 2012, ANN BIOMED ENG, V40, P1, DOI 10.1007/s10439-011-0392-4; Rowson S, 2011, ANN BIOMED ENG, V39, P2130, DOI 10.1007/s10439-011-0322-5; Rowson S, 2011, J APPL BIOMECH, V27, P8, DOI 10.1123/jab.27.1.8; Schnebel B, 2007, NEUROSURGERY, V60, P490, DOI 10.1227/01.NEU.0000249286.92255.7F; Talavage TM, 2014, J NEUROTRAUM, V31, P327, DOI 10.1089/neu.2010.1512; Thurman DJ, 1998, J HEAD TRAUMA REHAB, V13, P1, DOI 10.1097/00001199-199804000-00003; Viano DC, 2012, ANN BIOMED ENG, V40, P160, DOI 10.1007/s10439-011-0384-4; Wilcox BJ, 2014, J BIOMECH, V47, P109, DOI 10.1016/j.jbiomech.2013.10.004; Wong RH, 2014, CLIN NEUROL NEUROSUR, V118, P1, DOI 10.1016/j.clineuro.2013.11.036; Xiong KL, 2014, BRAIN IMAGING BEHAV, V8, P487, DOI 10.1007/s11682-013-9288-2	49	7	7	1	4	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0363-5465	1552-3365		AM J SPORT MED	Am. J. Sports Med.	DEC	2019	47	14					3498	3504	0363546519882034	10.1177/0363546519882034		NOV 2019	7	Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Sport Sciences	JT2LZ	WOS:000497094400001	31697564	Green Accepted			2022-02-06	
J	Anderson, GR; Melugin, HP; Stuart, MJ				Anderson, Gregory R.; Melugin, Heath P.; Stuart, Michael J.			Epidemiology of Injuries in Ice Hockey	SPORTS HEALTH-A MULTIDISCIPLINARY APPROACH			English	Article						hockey; injuries; prevention; treatment	EMERGENCY-DEPARTMENTS; CONCUSSION; MENS; HEAD; PLAYERS; SUMMIT; 7-YEAR; RISK; NECK	Context: Hockey is a skillful contact sport with an elevated injury risk at higher levels of play. An understanding of injury incidence, type, mechanism, and severity at various levels of competition aids the clinician treating these athletes. The purpose of this clinical review is to discuss the epidemiology of hockey injuries at various levels of participation, including youth, high school, junior, college, and professional. Evidence Acquisition: A literature search was performed by a review of PubMed, Embase, and Cochrane databases and included articles published from 1988 to 2017. Studies were included in this review if determined to be of high quality and containing injury data relevant to the levels of competition. Pertinent data regarding ice hockey injury epidemiology and prevention at various levels of competition were analyzed. Study Design: Clinical review. Results: Youth, high school, junior, college, and professional hockey players have unique injury patterns. Injuries occur much more often in a game compared with a practice, and injury risk increases with each level of competition. Preventative measures, such as mandatory facial protection and delayed body checking in games until age 13 years, are proven strategies to reduce the risk of facial injury and concussion. Conclusion: An understanding of common injury types and mechanisms according to age and level of play aids the clinician in diagnosis and management. This information can also guide preventative strategies in the areas of education, coaching, rule enforcement, rule modifications, equipment improvement, and sportsmanship.	[Anderson, Gregory R.; Melugin, Heath P.; Stuart, Michael J.] Mayo Clin, Dept Orthoped Surg, 200 First St SW, Rochester, MN 55905 USA		Stuart, MJ (corresponding author), Mayo Clin, Dept Orthoped Surg, 200 First St SW, Rochester, MN 55905 USA.	stuart.michael@mayo.edu					Agel J, 2007, J ATHL TRAINING, V42, P241; Agel J, 2010, CAN J SURG, V53, P319; Benson BW, 1999, JAMA-J AM MED ASSOC, V282, P2328, DOI 10.1001/jama.282.24.2328; Brenner JS, 2014, PEDIATRICS, V133, P1151, DOI 10.1542/peds.2014-0692; Decloe MD, 2014, BRIT J SPORT MED, V48, P51, DOI 10.1136/bjsports-2012-091653; Deits J, 2010, J ATHL TRAINING, V45, P467, DOI 10.4085/1062-6050-45.5.467; Emery C, 2011, CAN MED ASSOC J, V183, P1249, DOI 10.1503/cmaj.101540; Emery CA, 2010, JAMA-J AM MED ASSOC, V303, P2265, DOI 10.1001/jama.2010.755; Engebretsen L, 2010, BRIT J SPORT MED, V44, P772, DOI 10.1136/bjsm.2010.076992; Flik K, 2005, AM J SPORT MED, V33, P183, DOI 10.1177/0363546504267349; LaPrade RF, 2009, BRIT J SPORT MED, V43, P1000, DOI 10.1136/bjsm.2009.067884; LORENTZON R, 1988, AM J SPORT MED, V16, P392, DOI 10.1177/036354658801600415; Molsa J, 2000, AM J SPORT MED, V28, P322; Molsa J, 1997, AM J SPORT MED, V25, P495, DOI 10.1177/036354659702500412; Polites SF, 2014, PEDIATRICS, V133, pE1601, DOI 10.1542/peds.2013-3628; Rowson B, 2015, ANN BIOMED ENG, V43, P2429, DOI 10.1007/s10439-015-1278-7; Saw R, 2018, SPORTS HEALTH, V10, P208, DOI 10.1177/1941738117726070; Sikka R, 2016, AM J SPORT MED, V44, P378, DOI 10.1177/0363546515616802; Smith Arfon M., 2016, PEERJ COMPUT SCI, V2, pe86; Smith AM, 2017, CLIN J SPORT MED, V27, P503, DOI 10.1097/JSM.0000000000000412; Smith AM, 2015, CLIN J SPORT MED, V25, P78, DOI 10.1097/JSM.0000000000000195; Smith AM, 2013, CURR SPORT MED REP, V12, P356, DOI 10.1249/JSR.0000000000000004; Smith AM, 2011, CLIN J SPORT MED, V21, P281, DOI 10.1097/JSM.0b013e318225bc15; STUART MJ, 1995, MAYO CLIN PROC, V70, P350, DOI 10.4065/70.4.350; STUART MJ, 1995, AM J SPORT MED, V23, P458, DOI 10.1177/036354659502300415; Stuart MJ, 2002, AM J SPORT MED, V30, P39, DOI 10.1177/03635465020300012001; Tuominen M, 2017, BRIT J SPORT MED, V51, P36, DOI 10.1136/bjsports-2016-095992; Tuominen M, 2016, BRIT J SPORT MED, V50, P1406, DOI 10.1136/bjsports-2015-094647; Tuominen M, 2015, BRIT J SPORT MED, V49, P30, DOI 10.1136/bjsports-2014-093688; USA Hockey, HLTH SAF MEN; Wennberg RA, 2008, CAN J NEUROL SCI, V35, P647, DOI 10.1017/S031716710000946X; Yard EE, 2006, J ATHL TRAINING, V41, P441	32	7	8	1	13	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1941-7381	1941-0921		SPORTS HEALTH	Sports Health	NOV	2019	11	6					514	519		10.1177/1941738119849105			6	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	JI0QB	WOS:000493171100007	31158326	Green Published			2022-02-06	
J	Elliott, TR; Hsiao, YY; Kimbrel, NA; DeBeer, BB; Gulliver, SB; Kwok, OM; Morissette, SB; Meyer, EC				Elliott, Timothy R.; Hsiao, Yu-Yu; Kimbrel, Nathan A.; DeBeer, Bryann B.; Gulliver, Suzy Bird; Kwok, Oi-Man; Morissette, Sandra B.; Meyer, Eric C.			Resilience Facilitates Adjustment Through Greater Psychological Flexibility Among Iraq/Afghanistan War Veterans With and Without Mild Traumatic Brain Injury	REHABILITATION PSYCHOLOGY			English	Article							POSTTRAUMATIC-STRESS-DISORDER; POST-CONCUSSIVE SYMPTOMS; QUALITY-OF-LIFE; PSYCHOMETRIC PROPERTIES; PERSONALITY PROTOTYPES; ACCEPTANCE; TRAJECTORIES; DISABILITY; POLYTRAUMA; PTSD	Objectives: Although many Iraq/Afghanistan warzone veterans report few problems with adjustment, a substantial proportion report debilitating mental health symptoms and functional impairment, suggesting the influence of personal factors that may promote adjustment. A significant minority also incur warzone-related traumatic brain injury (TBI), the majority of which are of mild severity (mTBI). We tested direct and indirect pathways through which a resilient personality prototype predicts adjustment of warzone veterans with and without mTBI over time. Method: A sample of 264 war veterans (181 men) completed measures of lifetime and warzone-related TBIs, personality traits, psychological adjustment, quality of life, and functional impairment. Social support, coping, and psychological flexibility were examined as mediators of the resilience-adjustment relationship. Instruments were administered at baseline, 4-, 8-, and 12-month assessments. Structural equation models accounted for combat exposure and response style. Results: Compared with a nonresilient personality prototype, a resilient prototype was directly associated with lower PTSD, depression, and functional disability, and higher quality of life at all time-points. Warzone mTBIs frequency was associated with higher scores on a measure of functional disability. Indirect effects via psychological flexibility were observed from personality to all outcomes, and from warzone-related mTBIs to PTSD, depression, and functional disability, at each time-point. Conclusions: Several characteristics differentiate veterans who are resilient from those who are less so. These findings reveal several factors through which a resilient personality prototype and the number of mTBIs may be associated with veteran adjustment. Psychological flexibility appears to be a critical modifiable factor in veteran adjustment. Impact and Implications The present study indicates that the beneficial effects of a resilient personality prototype occur among warzone veterans with and without mTBI. Several of the characteristics associated with a resilient personality prototype can be addressed in psychological interventions to facilitate psychological adjustment of veterans who are experiencing difficulties with depression, posttraumatic stress symptoms, and quality of life. Of these characteristics, psychological flexibility appears to be a particularly important mechanism through which resilience promotes adjustment, and psychological flexibility is a central element of acceptance and commitment therapy.	[Elliott, Timothy R.; Kwok, Oi-Man] Texas A&M Univ, Dept Educ Psychol, College Stn, TX 77843 USA; [Hsiao, Yu-Yu] Univ New Mexico, Dept Individual Family & Community Educ, Albuquerque, NM 87131 USA; [Kimbrel, Nathan A.] Durham Vet Affairs Med Ctr, VA Mid Atlantic Mental Illness Res Educ & Clin Ct, Durham, NC USA; [Kimbrel, Nathan A.] Duke Univ, Med Ctr, Dept Psychiat & Behav Sci, Durham, NC 27706 USA; [DeBeer, Bryann B.; Meyer, Eric C.] Cent Texas Vet Healthcare Syst, Vet Affairs VISN Ctr Excellence Res Returning War, Waco, TX USA; [DeBeer, Bryann B.] Texas A&M Univ, Hlth Sci Ctr, College Stn, TX 77843 USA; [Gulliver, Suzy Bird] Baylor Scott & White Hlth, Warriors Res Inst, Waco, TX USA; [Gulliver, Suzy Bird; Meyer, Eric C.] Texas A&M Univ, Hlth Sci Ctr, Dept Psychiat, College Stn, TX 77843 USA; [Morissette, Sandra B.] Univ Texas San Antonio, Dept Psychol, San Antonio, TX USA		Elliott, TR (corresponding author), Texas A&M Univ, Dept Educ Psychol, College Stn, TX 77843 USA.	telliott@tamu.edu; Sandra.Morissette@utsa.edu; Eric.Meyer2@va.gov	Elliott, Timothy R./I-5301-2012	Elliott, Timothy R./0000-0002-6608-7714; Kwok, Oiman/0000-0002-4617-4562	Rehabilitation Research and Development (RD) Service [I01RX000304-01, I01RX000304-04]; Veterans AffairsUS Department of Veterans Affairs [I01RX000304] Funding Source: NIH RePORTER	This research was supported by Merit Award I01RX000304-01 to Sandra B. Morissette and I01RX000304-04 to Eric C. Meyer and Sandra B. Morissette from the Rehabilitation Research and Development (R&D) Service. The views expressed in this article are those of the authors and do not necessarily reflect the position or policy of the Department of Veterans Affairs or the United States government. The present study is one in a series from the Project SERVE FX collaboration. An earlier version of this work was presented by Timothy R. Elliott at the 19th annual Rehabilitation Psychology Conference conducted in Albuquerque, NM, in February, 2017. A complete list of all papers and presentations from the Project SERVE FX collaboration is available from Sandra B. Morissette atSandra.Morissette@utsa.edu or from Eric C. Meyer at Eric.Meyer2@va.gov.	Alessandri G, 2014, J PERS, V82, P340, DOI 10.1111/jopy.12065; Alosco ML, 2016, J HEAD TRAUMA REHAB, V31, P360, DOI 10.1097/HTR.0000000000000201; Asendorpf JB, 2001, EUR J PERSONALITY, V15, P169, DOI 10.1002/per.408.abs; Bailie JM, 2016, J HEAD TRAUMA REHAB, V31, P2, DOI 10.1097/HTR.0000000000000142; Beck A., 1996, BECK DEPRESSION INVE, V78, P490; Berry JW, 2007, J PERS ASSESS, V89, P292, DOI 10.1080/00223890701629813; Blanchard EB, 1996, BEHAV RES THER, V34, P669, DOI 10.1016/0005-7967(96)00033-2; Block J., 1993, STUDYING LIVES TIME, P9, DOI DOI 10.1037/10127-018; Block J. H., 1980, DEV COGNITION AFFECT, V13, P39; Bonanno GA, 2012, BRIT J PSYCHIAT, V200, P317, DOI 10.1192/bjp.bp.111.096552; Bond FW, 2011, BEHAV THER, V42, P676, DOI 10.1016/j.beth.2011.03.007; Bovin M. J., 2019, USING WHO DISA UNPUB; Brenner LA, 2009, REHABIL PSYCHOL, V54, P239, DOI 10.1037/a0016908; Brickell TA, 2014, MIL MED, V179, P827, DOI 10.7205/MILMED-D-13-00506; Broshek DK, 2015, BRAIN INJURY, V29, P228, DOI 10.3109/02699052.2014.974674; Brown M.W., 1993, SOCIOL METHOD RES, P136; Burckhardt Carol S, 2003, Health Qual Life Outcomes, V1, P60, DOI 10.1186/1477-7525-1-60; BURCKHARDT CS, 1989, RES NURS HEALTH, V12, P347, DOI 10.1002/nur.4770120604; Carroll Linda J, 2014, Arch Phys Med Rehabil, V95, pS152, DOI 10.1016/j.apmr.2013.08.300; Carver CS, 1997, INT J BEHAV MED, V4, P92, DOI 10.1207/s15327558ijbm0401_6; Caspi A, 2000, J PERS SOC PSYCHOL, V78, P158, DOI 10.1037/0022-3514.78.1.158; Cifu DX, 2013, J REHABIL RES DEV, V50, P1169, DOI 10.1682/JRRD.2013.01.0006; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Cook AJ, 2015, BEHAV RES THER, V73, P25, DOI 10.1016/j.brat.2015.07.003; Costa P. T., 1992, REVISED NEO PERSONAL; Davydov DM, 2010, CLIN PSYCHOL REV, V30, P479, DOI 10.1016/j.cpr.2010.03.003; Defense and Veterans Brain Injury Center, 2019, DOD WORLDW NUMB TBI; Denissen JJA, 2008, J PERS, V76, P67, DOI 10.1111/j.1467-6494.2007.00480.x; DeYoung CG, 2006, J PERS SOC PSYCHOL, V91, P1138, DOI 10.1037/0022-3514.91.6.1138; Diener E, 2017, CAN PSYCHOL, V58, P87, DOI 10.1037/cap0000063; Donnellan MB, 2010, SOC PERSONAL PSYCHOL, V4, P1070, DOI 10.1111/j.1751-9004.2010.00313.x; Dretsch MN, 2015, J NEUROTRAUM, V32, P1301, DOI 10.1089/neu.2014.3810; Elliott T., 2019, UNDERSTANDING EXPERI, P137; Elliott TR, 2015, REHABIL PSYCHOL, V60, P263, DOI 10.1037/rep0000050; Farkas D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120883; Forbes D, 2001, BEHAV RES THER, V39, P977, DOI 10.1016/S0005-7967(00)00084-X; Fulton JJ, 2015, J ANXIETY DISORD, V31, P98, DOI 10.1016/j.janxdis.2015.02.003; Gramzow RH, 2004, EUR J PERSONALITY, V18, P367, DOI 10.1002/per.513; Grosso JA, 2014, J TRAUMA STRESS, V27, P478, DOI 10.1002/jts.21943; Hayes SC, 2006, BEHAV RES THER, V44, P1, DOI 10.1016/j.brat.2005.06.006; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Isaacs K, 2017, J PSYCHIATR RES, V84, P301, DOI 10.1016/j.jpsychires.2016.10.017; Jones A, 2012, CLIN NEUROPSYCHOL, V26, P790, DOI 10.1080/13854046.2012.693202; Jurick SM, 2019, ARCH CLIN NEUROPSYCH, V34, P366, DOI 10.1093/arclin/acy048; Kashdan TB, 2010, CLIN PSYCHOL REV, V30, P865, DOI 10.1016/j.cpr.2010.03.001; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; Kennedy JE, 2015, ARCH CLIN NEUROPSYCH, V30, P236, DOI 10.1093/arclin/acv014; King LA, 2006, MIL PSYCHOL, V18, P89, DOI 10.1207/s15327876mp1802_1; Kok B. E., 2014, INTERVENTIONS POLICI, VVI, P277; Konecky B, 2014, AM J PSYCHIAT, V171, P818, DOI 10.1176/appi.ajp.2014.14050587; Laird V, 2019, J HAPPINESS STUD, V20, P1419, DOI 10.1007/s10902-018-0004-1; Lambert CE, 2016, J RES PERS, V61, P80, DOI 10.1016/j.jrp.2016.02.004; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lange RT, 2014, ARCH CLIN NEUROPSYCH, V29, P329, DOI 10.1093/arclin/acu013; Losoi H, 2015, J NEUROTRAUM, V32, P942, DOI 10.1089/neu.2014.3799; Meyer EC, 2019, PSYCHOL TRAUMA-US, V11, P383, DOI 10.1037/tra0000358; Muthen L.K., 2012, MPLUS USERS GUIDE, V7; Ong AD, 2010, PSYCHOL AGING, V25, P516, DOI 10.1037/a0019384; Ong AD, 2009, J PERS, V77, P1777, DOI 10.1111/j.1467-6494.2009.00600.x; Panayiotou A, 2010, J CLIN EXP NEUROPSYC, V32, P463, DOI 10.1080/13803390903164371; Preacher KJ, 2008, BEHAV RES METHODS, V40, P879, DOI 10.3758/BRM.40.3.879; Rohling M. L., 2017, HDB FORENSIC NEUROPS, P147, DOI [10.1037/0000032-007, DOI 10.1037/0000032-007]; Seal KH, 2007, ARCH INTERN MED, V167, P476, DOI 10.1001/archinte.167.5.476; Shadel W. G., 2010, SOCIAL FDN CLIN PSYC, P329; Smith BW, 2008, INT J BEHAV MED, V15, P194, DOI 10.1080/10705500802222972; Spira JL, 2014, J NEUROTRAUM, V31, P1823, DOI 10.1089/neu.2014.3363; STRAHAN R, 1972, J CLIN PSYCHOL, V28, P191, DOI 10.1002/1097-4679(197204)28:2<191::AID-JCLP2270280220>3.0.CO;2-G; Sullivan KA, 2015, REHABIL PSYCHOL, V60, P147, DOI 10.1037/rep0000037; Tsai J, 2016, PSYCHIAT RES, V240, P157, DOI 10.1016/j.psychres.2016.04.036; Ustun TB, 2010, B WORLD HEALTH ORGAN, V88, P815, DOI 10.2471/BLT.09.067231; Ustun T, 2010, MEASURING HLTH DISAB; Vanderploeg RD, 2019, REHABIL PSYCHOL, V64, P1, DOI 10.1037/rep0000255; Vogt DS, 2008, ASSESSMENT, V15, P381, DOI 10.1177/1073191108316030; Walsh MV, 2016, ARCH PHYS MED REHAB, V97, P781, DOI 10.1016/j.apmr.2016.01.016; Weathers F. W., 1993, 9 ANN M INT SOC TRAU; Whiting DL, 2017, NEUROPSYCHOL REHABIL, V27, P263, DOI 10.1080/09602011.2015.1062115; Windle G, 2011, HEALTH QUAL LIFE OUT, V9, DOI 10.1186/1477-7525-9-8; Winer ES, 2016, J CLIN PSYCHOL, V72, P947, DOI 10.1002/jclp.22298; Yu CY, 2002, EVALUATING CUTOFF CR	80	7	7	1	10	EDUCATIONAL PUBLISHING FOUNDATION-AMERICAN PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST, NE, WASHINGTON, DC 20002-4242 USA	0090-5550	1939-1544		REHABIL PSYCHOL	Rehabil. Psychol.	NOV	2019	64	4					383	397		10.1037/rep0000282			15	Psychology, Clinical; Rehabilitation	Social Science Citation Index (SSCI)	Psychology; Rehabilitation	JF3KC	WOS:000491284200001	31246043				2022-02-06	
J	Hart, T; Ketchum, JM; O'Neil-Pirozzi, TM; Novack, TA; Johnson-Greene, D; Dams-O'Connor, K				Hart, Tessa; Ketchum, Jessica M.; O'Neil-Pirozzi, Therese M.; Novack, Thomas A.; Johnson-Greene, Doug; Dams-O'Connor, Kristen			Neurocognitive Status and Return to Work After Moderate to Severe Traumatic Brain Injury	REHABILITATION PSYCHOLOGY			English	Article						traumatic brain injuries; vocational outcomes; vocational rehabilitation; telephone assessment	JOB STABILITY; EMPLOYMENT; REHABILITATION; COGNITION; ORIENTATION; PREDICTORS	Purpose/Objective: To examine the relationship of cognitive status to employment outcomes at 1-year post moderate-severe traumatic brain injury (TBI), using a brief telephone-administered instrument. Research Method/Design: Prospective longitudinal study in which 320 people with moderate-severe TBI, all employed at injury, were enrolled during inpatient rehabilitation and evaluated at 1-year postinjury. Follow-up measures included whether and when participants had returned to work (RTW), and cognitive status assessed with the Brief Test of Adult Cognition by Telephone (BTACT). Multivariable logistic regression and survival analyses were used to assess the contribution of BTACT (overall and subscale scores) to employment outcomes, controlling for covariates with known associations to those outcomes, including demographic variables, injury severity, and driving status. Results: Fewer than 40% of participants (n = 124) were employed at 1-year follow-up. BTACT scores were strongly associated with RTW even after controlling for known covariates. Females had faster and higher rates of RTW compared to males. Resumption of driving and injury severity were also related to RTW. Conclusions/Implications: Neurocognitive status is a potentially modifiable factor with an important relationship to RTW following TBI. Vocational rehabilitation efforts should provide cognitive remediation or compensation as well as addressing transportation barriers. As a brief telephone-based assessment, the BTACT offers a new and efficient tool for evaluation of episodic memory and executive function. Impact and Implications It is important to assess modifiable factors for their relationship to return to work (RTW) following moderate to severe traumatic brain injury (TBI). Cognitive impairments are potentially modifiable and strongly related to RTW; thus, vocational rehabilitation should incorporate evidence-based cognitive remediation or compensation as well as addressing other modifiable obstacles such as transportation limitations. A brief, telephone-based assessment of episodic memory and executive function has the potential to add significantly to the evaluation of readiness to return to work at 1 year following moderate to severe TBI.	[Hart, Tessa] Moss Rehabil Res Inst, 50 Township Line, Elkins Pk, PA 19027 USA; [Ketchum, Jessica M.] Craig Hosp, Res Dept, Englewood, CO USA; [O'Neil-Pirozzi, Therese M.] Spaulding Rehabil Hosp, Boston, MA USA; [O'Neil-Pirozzi, Therese M.] Northeastern Univ, Dept Commun Sci & Disorders, Boston, MA 02115 USA; [Novack, Thomas A.] Univ Alabama Birmingham, Dept Phys Med & Rehabil, Birmingham, AL USA; [Johnson-Greene, Doug] Univ Miami, Miller Sch Med, Dept Phys Med & Rehabil, Coral Gables, FL 33124 USA; [Dams-O'Connor, Kristen] Icahn Sch Med Mt Sinai, Dept Rehabil Med, New York, NY 10029 USA; [Dams-O'Connor, Kristen] Icahn Sch Med Mt Sinai, Dept Neurol, New York, NY 10029 USA		Hart, T (corresponding author), Moss Rehabil Res Inst, 50 Township Line, Elkins Pk, PA 19027 USA.	thart@einstein.edu	Ketchum, Jessica/AAE-8200-2020		National Institute of Disability, Independent Living, and Rehabilitation Research (NIDILRR) [90DPTB0004, 90DPTB0011, 90DPTB0009, 90DP0084]	The contents of this manuscript were developed under grants from the National Institute of Disability, Independent Living, and Rehabilitation Research (NIDILRR Grants 90DPTB0004, 90DPTB0011, 90DPTB0009, and 90DP0084). NIDILRR is a Center within the Administration for Community Living (ACL), Department of Health and Human Services (HHS). The contents of this publication do not necessarily represent the policy of NIDILRR, ACL, or HHS, and you should not assume endorsement by the Federal Government. The authors thank Mitch Sevigny for expert assistance with data analysis and creation of figures.	Bogner JA, 2001, ARCH PHYS MED REHAB, V82, P571, DOI 10.1053/apmr.2001.22340; Centers for Disease Control and Prevention, 1998, BEH RISK FACT SURV S; Chien DK, 2017, ACCIDENT ANAL PREV, V98, P101, DOI 10.1016/j.aap.2016.09.025; Cicerone KD, 2019, ARCH PHYS MED REHAB, V100, P1515, DOI 10.1016/j.apmr.2019.02.011; Corrigan JD, 2003, ARCH PHYS MED REHAB, V84, P153, DOI 10.1053/apmr.2003.50093; Corrigan JD, 2001, J HEAD TRAUMA REHAB, V16, P543, DOI 10.1097/00001199-200112000-00003; Corrigan JD, 2004, J HEAD TRAUMA REHAB, V19, P205, DOI 10.1097/00001199-200405000-00002; Corrigan JD, 2007, ARCH PHYS MED REHAB, V88, P1400, DOI 10.1016/j.apmr.2007.08.006; Cuthbert JP, 2015, ARCH PHYS MED REHAB, V96, P2128, DOI 10.1016/j.apmr.2015.07.020; Dams-O'Connor K, 2018, J NEUROTRAUM, V35, P1138, DOI 10.1089/neu.2017.5347; Doctor JN, 2005, J INT NEUROPSYCH SOC, V11, P747, DOI 10.1017/S1355617705050836; Forslund MV, 2013, J REHABIL MED, V45, P801, DOI 10.2340/16501977-1168; Gordon W, 1993, J HEAD TRAUMA REHAB, V8, P26; Hanks RA, 2008, ARCH PHYS MED REHAB, V89, P950, DOI 10.1016/j.apmr.2008.01.011; Jackson WT, 1998, ARCH PHYS MED REHAB, V79, P718, DOI 10.1016/S0003-9993(98)90051-X; Kalechstein AD, 2003, J CLIN EXP NEUROPSYC, V25, P1186, DOI 10.1076/jcen.25.8.1186.16723; Kennedy MRT, 2008, NEUROPSYCHOL REHABIL, V18, P257, DOI 10.1080/09602010701748644; Kreutzer JS, 2003, J HEAD TRAUMA REHAB, V18, P128, DOI 10.1097/00001199-200303000-00004; Lachman ME, 2014, ASSESSMENT, V21, P404, DOI 10.1177/1073191113508807; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; Machamer J, 2005, J INT NEUROPSYCH SOC, V11, P807, DOI 10.1017/S135561770505099X; Mani K, 2017, WORK, V58, P51, DOI 10.3233/WOR-172597; Meulenbroek P, 2016, DISABIL REHABIL, V38, P452, DOI 10.3109/09638288.2015.1044621; Nakase-Richardson R, 2011, J NEUROL NEUROSUR PS, V82, P494, DOI 10.1136/jnnp.2010.222489; Ponsford JL, 2015, J HEAD TRAUMA REHAB, V30, pE1, DOI 10.1097/HTR.0000000000000033; Scaratti C, 2017, DISABIL REHABIL, V39, P847, DOI 10.3109/09638288.2016.1162854; Schiehser DM, 2011, J CLIN EXP NEUROPSYC, V33, P704, DOI 10.1080/13803395.2011.553587; Schonberger M, 2011, J NEUROL NEUROSUR PS, V82, P936, DOI 10.1136/jnnp.2010.210021; *SUBST AB MENT HLT, 1998, NAT HOUS SURV DRUG A; Trexler LE, 2018, J VOCAT REHABIL, V49, P195, DOI 10.3233/JVR-180965; van der Horn HJ, 2013, ARCH PHYS MED REHAB, V94, P867, DOI 10.1016/j.apmr.2012.11.039; van Velzen JM, 2009, BRAIN INJURY, V23, P473, DOI 10.1080/02699050902970737; van Velzen JM, 2009, BRAIN INJURY, V23, P385, DOI 10.1080/02699050902838165; Weber E, 2018, REHABIL PSYCHOL, V63, P383, DOI 10.1037/rep0000208; Wehman P, 2005, J HEAD TRAUMA REHAB, V20, P115, DOI 10.1097/00001199-200503000-00001; Yeates G, 2016, NEUROREHABILITATION, V38, P299, DOI 10.3233/NRE-161321	36	7	7	0	8	EDUCATIONAL PUBLISHING FOUNDATION-AMERICAN PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST, NE, WASHINGTON, DC 20002-4242 USA	0090-5550	1939-1544		REHABIL PSYCHOL	Rehabil. Psychol.	NOV	2019	64	4					435	444		10.1037/rep0000290			10	Psychology, Clinical; Rehabilitation	Social Science Citation Index (SSCI)	Psychology; Rehabilitation	JF3KC	WOS:000491284200005	31424238				2022-02-06	
J	Mikati, AG; Flahive, J; Khan, MW; Vedantam, A; Gopinath, S; Nordness, MF; Robertson, C; Patel, MB; Sheth, KN; Muehlschlegel, S				Mikati, Abdul Ghani; Flahive, Julie; Khan, Muhammad W.; Vedantam, Aditya; Gopinath, Shankar; Nordness, Mina F.; Robertson, Claudia; Patel, Mayur B.; Sheth, Kevin N.; Muehlschlegel, Susanne			Multicenter Validation of the Survival After Acute Civilian Penetrating Brain Injuries (SPIN) Score	NEUROSURGERY			English	Article						Penetrating brain injury; Gunshot wound; Outcome prediction; Prediction model; Traumatic brain injury	GUNSHOT WOUNDS; PROGNOSTIC MODELS; WITHDRAWAL; PREDICTORS; MORTALITY	BACKGROUND: Civilian penetrating traumatic brain injury (pTBI) is a serious public health problem in the United States, but predictors of outcome remain largely understudied. We previously developed the Survival After Acute Civilian Penetrating Brain Injuries (SPIN) score, a logistic, regression-based risk stratification scale for estimating in-hospital and 6-mo survival after civilian pTBI with excellent discrimination (area under the receiver operating curve [AUC-ROC = 0.96]) and calibration, but it has not been validated. OBJECTIVE: To validate the SPIN score in a multicenter cohort. METHODS: We identified pTBI patients from 3 United States level-1 trauma centers. The SPIN score variables (motor Glasgow Coma Scale [mGCS], sex, admission pupillary reactivity, self-inflicted pTBI, transfer status, injury severity score, and admission international normalized ratio [INR]) were retrospectively collected from local trauma registries and chart review. Using the original SPIN score multivariable logistic regression model, AUC-ROC analysis and Hosmer-Lemeshow goodness of fit testing were performed to determine discrimination and calibration. RESULTS: Of 362 pTBI patients available for analysis, 105 patients were lacking INR, leaving 257 patients for the full SPIN model validation. Discrimination (AUC-ROC = 0.88) and calibration (Hosmer-Lemeshow goodness of fit, P value = .58) were excellent. In a post hoc sensitivity analysis, we removed INR from the SPIN model to include all 362 patients (SPINNo-INR), still resulting in very good discrimination (AUC-ROC = 0.82), but reduced calibration (Hosmer-Lemeshow goodness of fit, P value = .04). CONCLUSION: This multicenter pTBI study confirmed that the full SPIN score predicts survival after civilian pTBI with excellent discrimination and calibration. Admission INR significantly adds to the prediction model discrimination and should be routinely measured in pTBI patients.	[Mikati, Abdul Ghani; Khan, Muhammad W.; Muehlschlegel, Susanne] Univ Massachusetts, Dept Neurol, Med Sch, Worcester, MA 01655 USA; [Flahive, Julie] Univ Massachusetts, Dept Populat & Quantitat Hlth Sci, Med Sch, Worcester, MA 01655 USA; [Vedantam, Aditya; Gopinath, Shankar; Robertson, Claudia] Baylor Coll Med, Dept Neurosurg, Houston, TX 77030 USA; [Nordness, Mina F.; Patel, Mayur B.] Vanderbilt Univ, Med Ctr, Ctr Trauma Burn & Emergency Surg, Nashville, TN USA; [Nordness, Mina F.; Patel, Mayur B.] Vanderbilt Univ, Dept Neurol Surg, Med Ctr, Nashville, TN USA; [Nordness, Mina F.; Patel, Mayur B.] Vanderbilt Univ, Dept Hearing & Speech Sci, Med Ctr, Nashville, TN USA; [Nordness, Mina F.; Patel, Mayur B.] Crit Illness Brain Dysfunct & Survivorship CIBS C, Nashville, TN USA; [Nordness, Mina F.; Patel, Mayur B.] Vanderbilt Univ, Med Ctr, Nashville, TN USA; [Sheth, Kevin N.] Yale Univ, Dept Neurol, Neurocrit Care & Emergency Neurol Div, New Haven, CT USA; [Sheth, Kevin N.] Yale Univ, Dept Neurosurg, New Haven, CT USA; [Muehlschlegel, Susanne] Univ Massachusetts, Dept Anesthesia Crit Care & Surg, Med Sch, Worcester, MA 01655 USA		Mikati, AG (corresponding author), Univ Massachusetts, Med Sch, 55 Lake Ave North,S-5, Worcester, MA 01655 USA.	abdul.mikati@umassmemorial.org		Flahive, Julie/0000-0002-2786-7144	National Center for Advancing Translational Sciences/National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1 TR000445]; National Institutes of Health/National Institute of General Medical SciencesUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R01GM120484, R01HL111111]; National Institutes of Health/National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [K23HD080971]; U Mass Memorial Medical Group "Prize for Academic Collaboration and Excellence (PACE)" Prize; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [U24NS107215, U24NS107136, U01NS106513, RO1NR018335]; AHA grant [17CSA33550004]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K23HD080971] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR001863] Funding Source: NIH RePORTER	The authors have no personal, financial, or institutional interest in any of the drugs, materials, or devices described in this article. This project was in part supported using REDCap (UL1 TR000445 from National Center for Advancing Translational Sciences/National Institutes of Health). Mayur B. Patel is supported by National Institutes of Health/National Institute of General Medical Sciences grant R01GM120484 and R01HL111111. Susanne Muehlschlegel is funded by the National Institutes of Health/National Institute of Neurological Disorders and Stroke grant K23HD080971 and the U Mass Memorial Medical Group "Prize for Academic Collaboration and Excellence (PACE)" Prize. Kevin Sheth is supported by the National Institutes of Health grants U24NS107215, U24NS107136, U01NS106513, and RO1NR018335 and the AHA grant 17CSA33550004.	Aarabi B, 2014, J NEUROSURG, V120, P1138, DOI 10.3171/2014.1.JNS131869; ALDRICH EF, 1992, SURG NEUROL, V38, P418, DOI 10.1016/0090-3019(92)90109-Z; [Anonymous], 2001, J TRAUMA, V51, pS7; [Anonymous], 2001, J Trauma, V51, pS3; [Anonymous], 2001, J TRAUMA, V51, pS16; Bratton SL, 2007, J NEUROTRAUMA S1, V24, pS45, DOI DOI 10.1089/NEU.2007.9989; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; CDC, 2015, CDCP NONF INJ REP; CDC, 2016, CDCP FAT INJ REP; Cook NR, 2007, CIRCULATION, V115, P928, DOI 10.1161/CIRCULATIONAHA.106.672402; Hemphill JC, 2009, EMERG MED CLIN N AM, V27, P27, DOI 10.1016/j.emc.2008.08.009; Izzy S, 2013, NEUROCRIT CARE, V19, P347, DOI 10.1007/s12028-013-9925-z; Martins RS, 2003, SURG NEUROL, V60, P98, DOI 10.1016/S0090-3019(03)00302-1; Muehlschlegel S, 2016, NEUROLOGY, V87, P2244, DOI 10.1212/WNL.0000000000003355; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Povlishock JT, 1995, GUIDELINES MANAGEMEN; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Sun H, 2016, J NEUROTRAUM, V33, P1535, DOI 10.1089/neu.2015.4164; Turgeon AF, 2011, CAN MED ASSOC J, V183, P1581, DOI 10.1503/cmaj.101786	20	7	7	0	0	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0148-396X	1524-4040		NEUROSURGERY	Neurosurgery	NOV	2019	85	5					E872	E879		10.1093/neuros/nyz127			8	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	JI6HX	WOS:000493569500020	31065707	Green Published			2022-02-06	
J	Minaee, S; Wang, Y; Aygar, A; Chung, S; Wang, XY; Lui, YW; Fieremans, E; Flanagan, S; Rath, J				Minaee, Shervin; Wang, Yao; Aygar, Alp; Chung, Sohae; Wang, Xiuyuan; Lui, Yvonne W.; Fieremans, Els; Flanagan, Steven; Rath, Joseph			MTBI Identification From Diffusion MR Images Using Bag of Adversarial Visual Features	IEEE TRANSACTIONS ON MEDICAL IMAGING			English	Article						Feature extraction; Magnetic resonance imaging; White matter; Machine learning; Measurement; Visualization; MTBI identification; diffusion MRI; deep learning; machine learning	TRAUMATIC BRAIN-INJURY; KURTOSIS; INTEGRITY; SELECTION	In this paper, we propose bag of adversarial features (BAFs) for identifying mild traumatic brain injury (MTBI) patients from their diffusion magnetic resonance images (MRIs) (obtained within one month of injury) by incorporating unsupervised feature learning techniques. MTBI is a growing public health problem with an estimated incidence of over 1.7 million people annually in USA. Diagnosis is based on clinical history and symptoms, and accurate, concrete measures of injury are lacking. Unlike most of the previous works, which use hand-crafted features extracted from different parts of brain for MTBI classification, we employ feature learning algorithms to learn more discriminative representation for this task. A major challenge in this field thus far is the relatively small number of subjects available for training. This makes it difficult to use an end-to-end convolutional neural network to directly classify a subject from MRIs. To overcome this challenge, we first apply an adversarial auto-encoder (with convolutional structure) to learn patch-level features, from overlapping image patches extracted from different brain regions. We then aggregate these features through a bag-of-words approach. We perform an extensive experimental study on a dataset of 227 subjects (including 109 MTBI patients, and 118 age and sex-matched healthy controls) and compare the bag-of-deep-features with several previous approaches. Our experimental results show that the BAF significantly outperforms earlier works relying on the mean values of MR metrics in selected brain regions.	[Minaee, Shervin; Wang, Yao; Aygar, Alp] NYU, Elect & Comp Engn Dept, New York, NY 10003 USA; [Chung, Sohae; Wang, Xiuyuan; Lui, Yvonne W.; Fieremans, Els] NYU, Dept Radiol, New York, NY 10003 USA; [Flanagan, Steven; Rath, Joseph] NYU, Dept Rehabil Med, New York, NY 10003 USA		Minaee, S (corresponding author), NYU, Elect & Comp Engn Dept, New York, NY 10003 USA.	shervin.minaee@nyu.edu	Rath, Joseph F./C-4823-2008	Rath, Joseph F./0000-0003-2933-6299; Aygar, Alp/0000-0003-1208-5438; Chung, Sohae/0000-0002-1132-900X; Flanagan, Steven/0000-0001-9005-5897; Wang, Yao/0000-0003-3199-3802; Fieremans, Els/0000-0002-1384-8591	National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01 NS039135-11, R21 NS090349]; National Institute for Neurological Disorders and Stroke (NINDS)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS); Center for Advanced Imaging Innovation and Research (CAI2R); NIBIB Biomedical Technology Resource Center [NIH P41 EB017183]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB) [P41EB017183] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R21NS090349, R01NS039135] Funding Source: NIH RePORTER	This work was supported in part by the National Institutes of Health (NIH) under Grants R01 NS039135-11 and R21 NS090349, in part by the National Institute for Neurological Disorders and Stroke (NINDS), in part by the Center for Advanced Imaging Innovation and Research (CAI2R), and in part by the NIBIB Biomedical Technology Resource Center under Grant NIH P41 EB017183.	BASSER PJ, 1994, BIOPHYS J, V66, P259, DOI 10.1016/S0006-3495(94)80775-1; Bay H, 2006, LECT NOTES COMPUT SC, V3951, P404, DOI 10.1007/11744023_32; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Chandrashekar G, 2014, COMPUT ELECTR ENG, V40, P16, DOI 10.1016/j.compeleceng.2013.11.024; Chung S, 2018, J NEUROTRAUM, V35, P1015, DOI 10.1089/neu.2017.5320; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1007/BF00994018; Dalal N., 2021, 2005 IEEE COMPUTER S, V1, P886, DOI DOI 10.1109/CVPR.2005.177; Douglas David B, 2015, Top Magn Reson Imaging, V24, P241, DOI 10.1097/RMR.0000000000000062; Faul M, 2010, TRAUMATIC BRAIN INJU; Fieremans E, 2011, NEUROIMAGE, V58, P177, DOI 10.1016/j.neuroimage.2011.06.006; GIRSHICK R, 2014, PROC CVPR IEEE, P580, DOI DOI 10.1109/CVPR.2014.81; Grossman EJ, 2013, AM J NEURORADIOL, V34, P951, DOI 10.3174/ajnr.A3358; Grossman EJ, 2016, J NEUROTRAUM, V33, P163, DOI 10.1089/neu.2015.3965; Grossman EJ, 2012, J NEUROTRAUM, V29, P2318, DOI 10.1089/neu.2011.1763; Grossman Elan J, 2010, Top Magn Reson Imaging, V21, P379, DOI 10.1097/RMR.0b013e31823e65b8; Guo ZH, 2010, IEEE T IMAGE PROCESS, V19, P1657, DOI 10.1109/TIP.2010.2044957; Guyon I., 2003, J MACH LEARN RES, V3, P1157, DOI DOI 10.1162/153244303322753616; Inglese M, 2005, J NEUROSURG, V103, P298, DOI 10.3171/jns.2005.103.2.0298; Jensen JH, 2010, NMR BIOMED, V23, P698, DOI 10.1002/nbm.1518; Kaiming He, 2016, 2016 IEEE Conference on Computer Vision and Pattern Recognition (CVPR), P770, DOI 10.1109/CVPR.2016.90; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Leng B, 2015, SIGNAL PROCESS, V112, P119, DOI 10.1016/j.sigpro.2014.09.005; Lowe DG, 2004, INT J COMPUT VISION, V60, P91, DOI 10.1023/B:VISI.0000029664.99615.94; Lui YW, 2014, NEUROLOGY, V83, P1235, DOI 10.1212/WNL.0000000000000834; Makhzani A, 2015, ADVERSARIAL AUTOENCO; Masci J, 2011, LECT NOTES COMPUT SC, V6791, P52, DOI 10.1007/978-3-642-21735-7_7; Mayer AR, 2010, NEUROLOGY, V74, P643, DOI 10.1212/WNL.0b013e3181d0ccdd; Mayer AR, 2015, HUM BRAIN MAPP, V36, P4394, DOI 10.1002/hbm.22930; Minaee S., 2017, SIGN PROC MED BIOL S, P1; Minaee S., 2013, SIGN PROC MED BIO S, P1; Minaee S., 2017, P 12 ANN M AM SOC FU; Minaee Shervin, 2018, Annu Int Conf IEEE Eng Med Biol Soc, V2018, P1267, DOI 10.1109/EMBC.2018.8512556; Mitra J, 2016, NEUROIMAGE, V129, P247, DOI 10.1016/j.neuroimage.2016.01.056; Naess-Schmidt ET, 2017, BRAIN INJURY, V31, P230, DOI 10.1080/02699052.2016.1229034; Peng HC, 2005, IEEE T PATTERN ANAL, V27, P1226, DOI 10.1109/TPAMI.2005.159; Peng XJ, 2016, COMPUT VIS IMAGE UND, V150, P109, DOI 10.1016/j.cviu.2016.03.013; Roe C, 2009, DISABIL REHABIL, V31, P1235, DOI 10.1080/09638280802532720; Ronneberger O, 2015, LECT NOTES COMPUT SC, V9351, P234, DOI 10.1007/978-3-319-24574-4_28; Shaker M, 2017, MED IMAGE ANAL, V37, P56, DOI 10.1016/j.media.2017.01.005; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Stokum JA, 2015, BRAIN INJURY, V29, P47, DOI 10.3109/02699052.2014.947628; Treble A, 2013, J NEUROTRAUM, V30, P1609, DOI 10.1089/neu.2013.2934; Vergara VM, 2017, J NEUROTRAUM, V34, P1045, DOI 10.1089/neu.2016.4526; Voormolen DC, 2018, J NEUROTRAUM, V35, P1233, DOI 10.1089/neu.2017.5257; Wu X, 2016, RADIOLOGY, V279, P693, DOI 10.1148/radiol.16142535; Yang J, 2007, LECT NOTES COMPUT SC, V4663, P197; Yang Y., 2010, P 18 SIGSPATIAL INT, P270, DOI DOI 10.1145/1869790.1869829; You QZ, 2016, PROC CVPR IEEE, P4651, DOI 10.1109/CVPR.2016.503	48	7	7	0	10	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0278-0062	1558-254X		IEEE T MED IMAGING	IEEE Trans. Med. Imaging	NOV	2019	38	11					2545	2555		10.1109/TMI.2019.2905917			11	Computer Science, Interdisciplinary Applications; Engineering, Biomedical; Engineering, Electrical & Electronic; Imaging Science & Photographic Technology; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Computer Science; Engineering; Imaging Science & Photographic Technology; Radiology, Nuclear Medicine & Medical Imaging	JJ8WT	WOS:000494433300006	30892204	Green Submitted, Green Accepted			2022-02-06	
J	Mucha, A; Trbovich, A				Mucha, Anne; Trbovich, Alicia			Considerations for Diagnosis and Management of Concussion	JOURNAL OF ORTHOPAEDIC & SPORTS PHYSICAL THERAPY			English	Article						assessment; concussion; diagnosis; heterogeneity	TRAUMATIC BRAIN-INJURY; SPORT-RELATED CONCUSSION; MOTOR SCREENING VOMS; KING-DEVICK TEST; HIGH-SCHOOL; NEUROCOGNITIVE PERFORMANCE; POSTURAL STABILITY; WHIPLASH INJURY; POSTTRAUMATIC MIGRAINE; RISK-FACTORS	SYNOPSIS: Concussion is an ongoing concern for health care providers. The incidence rates continue to be high and the rate of recovery is variable due to potential risk factors. With no valid biomarkers, diagnosis and assessment of concussion remain a clinical challenge. The heterogeneity in presentation following injury provides an additional level of complexity, requiring the screening and evaluation of diverse body systems, including oculomotor, vestibular, autonomic, psychiatric, cervical, and cognitive symptoms. While a few tools, such as the Vestibular/Ocular Motor Screening and Balance Error Scoring System, have been developed specifically for concussion, the vast majority of tests are adapted from other conditions. Further complicating the process is the overlapping and interactive nature of the multiple domains of postconcussion presentation. This commentary illustrates how clinicians can conceptualize the multiple profiles that present following concussion and describes tools that are available to assist with screening and evaluation of each area. The multifaceted nature of concussion warrants broad clinical screening skills and an interdisciplinary approach to management.	[Mucha, Anne] UPMC Ctr Rehab Serv, Pittsburgh, PA USA; [Trbovich, Alicia] UPMC Sports Med Concuss Program, Pittsburgh, PA USA; [Trbovich, Alicia] Univ Pittsburgh, Dept Orthopaed Surg, Pittsburgh, PA USA		Mucha, A (corresponding author), 3200 South Water St, Pittsburgh, PA 15203 USA.	muchaa@upmc.edu					Alsalaheen B, 2016, SCAND J MED SCI SPOR, V26, P235, DOI 10.1111/sms.12628; Anderson HD, 2017, BRAIN INJURY, V31, P1813, DOI 10.1080/02699052.2017.1346283; Anzalone AJ, 2017, AM J SPORT MED, V45, P474, DOI 10.1177/0363546516668624; BALKE B, 1959, U S Armed Forces Med J, V10, P675; Barkhoudarian G, 2016, PHYS MED REH CLIN N, V27, P373, DOI 10.1016/j.pmr.2016.01.003; Barlow KM, 2010, PEDIATRICS, V126, pE374, DOI 10.1542/peds.2009-0925; Barr WB, 2001, J INT NEUROPSYCH SOC, V7, P693, DOI 10.1017/S1355617701766052; Barth JT, 1989, MILD HEAD INJURY, P257; Bartsch T, 2005, PAIN, V117, P30, DOI 10.1016/j.pain.2005.05.015; Bes A, 2013, CEPHALALGIA, V33, P629, DOI 10.1177/0333102413485658; Bhattacharyya N, 2017, OTOLARYNG HEAD NECK, V156, P403, DOI 10.1177/0194599816689660; Biaggioni I, 1998, J VESTIBUL RES-EQUIL, V8, P35; Bianco A, 2014, ACTA OTO-LARYNGOL, V134, P947, DOI 10.3109/00016489.2014.906749; Bin Zahid A, 2018, APPL NEUROPSYCH-ADUL, V25, P110, DOI 10.1080/23279095.2016.1248765; Boake C, 2005, NEUROSURGERY, V56, P994, DOI 10.1227/01.NEU.0000158319.38230.C3; Bree D, 2018, CEPHALALGIA, V38, P246, DOI 10.1177/0333102416681571; Broglio SP, 2007, J ATHL TRAINING, V42, P504; Broglio SP, 2015, CLIN SPORT MED, V34, P213, DOI 10.1016/j.csm.2014.12.005; Buckley TA, 2018, CLIN J SPORT MED, V28, P174, DOI 10.1097/JSM.0000000000000426; Cambron M, 2014, HEADACHE, V54, P655, DOI 10.1111/head.12139; Cancelliere C, 2017, J HEAD TRAUMA REHAB, V32, pE37, DOI 10.1097/HTR.0000000000000260; Capo-Aponte JE, 2012, MIL MED, V177, P804, DOI 10.7205/MILMED-D-12-00061; Cassidy J David, 2014, Arch Phys Med Rehabil, V95, pS278, DOI 10.1016/j.apmr.2013.08.295; Catena RD, 2011, J NEUROENG REHABIL, V8, DOI 10.1186/1743-0003-8-8; Cavanaugh JT, 2005, SPORTS MED, V35, P935, DOI 10.2165/00007256-200535110-00002; Chin EY, 2016, AM J SPORT MED, V44, P2276, DOI 10.1177/0363546516648141; Coldren RL, 2010, MIL MED, V175, P477, DOI 10.7205/MILMED-D-09-00258; Collins MW, 2016, NEUROSURGERY, V79, P912, DOI 10.1227/NEU.0000000000001447; CONVERTINO VA, 1990, J APPL PHYSIOL, V68, P1458, DOI 10.1152/jappl.1990.68.4.1458; Coronado VG, 2012, J SAFETY RES, V43, P299, DOI 10.1016/j.jsr.2012.08.011; Corwin DJ, 2014, J PEDIATR-US, V165, P1207, DOI 10.1016/j.jpeds.2014.08.034; Costello DM, 2018, J CLIN NEUROSCI, V56, P1, DOI 10.1016/j.jocn.2018.07.002; Coupe M, 2009, RESP PHYSIOL NEUROBI, V169, pS10, DOI 10.1016/j.resp.2009.04.009; Covassin T, 2010, PHYSICIAN SPORTSMED, V38, P87, DOI 10.3810/psm.2010.12.1830; Craton N, 2017, BRAIN SCI, V7, DOI 10.3390/brainsci7090119; de Vries J, 2015, MANUAL THER, V20, P736, DOI 10.1016/j.math.2015.04.015; Dematteo C, 2015, MED SCI SPORT EXER, V47, P2283, DOI 10.1249/MSS.0000000000000682; Dobson JL, 2017, AM J PHYSIOL-REG I, V312, pR575, DOI 10.1152/ajpregu.00499.2016; Downey RI, 2018, BRAIN INJURY, V32, P1345, DOI 10.1080/02699052.2018.1484166; DuPrey KM, 2017, AM J SPORT MED, V45, P2388, DOI 10.1177/0363546517705640; Eddy R, 2020, CLIN J SPORT MED, V30, P239, DOI 10.1097/JSM.0000000000000586; Ellemberg D, 2009, J NEUROTRAUM, V26, P2365, DOI 10.1089/neu.2009.0906; Ellis MJ, 2015, J NEUROSURG-PEDIATR, V16, P709, DOI 10.3171/2015.5.PEDS15220; Ellis MJ, 2015, J NEUROSURG-PEDIATR, V16, P248, DOI 10.3171/2015.1.PEDS14524; Ellis MJ, 2015, BRAIN INJURY, V29, P238, DOI 10.3109/02699052.2014.965207; ELSON LM, 1994, SEMIN NEUROL, V14, P8, DOI 10.1055/s-2008-1041053; Esterov D, 2017, BRAIN SCI, V7, DOI 10.3390/brainsci7080100; Fait P, 2013, J HEAD TRAUMA REHAB, V28, P293, DOI 10.1097/HTR.0b013e3182407ace; Fazio VC, 2007, NEUROREHABILITATION, V22, P207; French L., 2008, J SPECIAL OPERATIONS, V8, P68; Fuller GW, 2019, BRIT J SPORT MED, V53, P1526, DOI 10.1136/bjsports-2017-098560; Furman J. M., 2010, VESTIBULAR DISORDERS; Gordon KE, 2014, BRAIN INJURY, V28, P311, DOI 10.3109/02699052.2013.862740; Griffith B, 2013, AM J NEURORADIOL, V34, P899, DOI 10.3174/ajnr.A3306; Guskiewicz KM, 2001, J ATHL TRAINING, V36, P263; Hain TC, 2015, CURR OPIN NEUROL, V28, P69, DOI 10.1097/WCO.0000000000000161; Hall T, 2004, MANUAL THER, V9, P197, DOI 10.1016/j.math.2004.04.004; HALMAGYI GM, 1988, ARCH NEUROL-CHICAGO, V45, P737, DOI 10.1001/archneur.1988.00520310043015; Harvey SA, 1997, AM J OTOL, V18, P207; Haydel MJ, 2000, NEW ENGL J MED, V343, P100, DOI 10.1056/NEJM200007133430204; Heyer GL, 2016, J PEDIATR-US, V174, P33, DOI 10.1016/j.jpeds.2016.03.014; Heyer GL, 2016, CEPHALALGIA, V36, P309, DOI 10.1177/0333102415590240; Heyer GL, 2016, CLIN J SPORT MED, V26, P40, DOI 10.1097/JSM.0000000000000183; Hides JA, 2017, MUSCULOSKEL SCI PRAC, V29, P7, DOI 10.1016/j.msksp.2017.02.003; Hinton-Bayre AD, 1999, J CLIN EXP NEUROPSYC, V21, P70, DOI 10.1076/jcen.21.1.70.945; Howell DR, 2018, J CHILD NEUROL, V33, P794, DOI 10.1177/0883073818789320; Iverson GL, 2015, JAMA PEDIATR, V169, P1132, DOI 10.1001/jamapediatrics.2015.2374; Jull G, 2007, CEPHALALGIA, V27, P793, DOI 10.1111/j.1468-2982.2007.01345.x; Kacperski J, 2016, HEADACHE, V56, P36, DOI 10.1111/head.12737; Kongsted A, 2008, CLIN REHABIL, V22, P469, DOI 10.1177/0269215507082141; Kontos AP, 2019, CURR SPORT MED REP, V18, P82, DOI 10.1249/JSR.0000000000000573; Kontos AP, 2016, AM J SPORT MED, V44, P1400, DOI 10.1177/0363546516632754; Kontos AP, 2016, CURR PAIN HEADACHE R, V20, DOI 10.1007/s11916-016-0571-y; Kontos AP, 2014, J INT NEUROPSYCH SOC, V20, P324, DOI 10.1017/S1355617713001471; Kontos AP, 2013, AM J SPORT MED, V41, P1497, DOI 10.1177/0363546513488751; Kontos AP, 2012, AM J SPORT MED, V40, P2375, DOI 10.1177/0363546512455400; Kontos AP, 2012, ARCH PHYS MED REHAB, V93, P1751, DOI 10.1016/j.apmr.2012.03.032; Kosinski M, 2003, QUAL LIFE RES, V12, P963, DOI 10.1023/A:1026119331193; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; L'Heureux-Lebeau B, 2014, OTOL NEUROTOL, V35, P1858, DOI 10.1097/MAO.0000000000000506; La Fountaine MF, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00013; Lau BC, 2011, AM J SPORT MED, V39, P2311, DOI 10.1177/0363546511410655; Leddy JJ, 2013, CURR SPORT MED REP, V12, P370, DOI 10.1249/JSR.0000000000000008; Leddy JJ, 2011, CLIN J SPORT MED, V21, P89, DOI 10.1097/JSM.0b013e3181fdc721; Lee JD, 2017, INT J PEDIATR OTORHI, V94, P36, DOI 10.1016/j.ijporl.2017.01.012; Lempert T, 2009, J NEUROL, V256, P333, DOI 10.1007/s00415-009-0149-2; Levin HS, 2015, LANCET NEUROL, V14, P506, DOI 10.1016/S1474-4422(15)00002-2; LEVIN HS, 1987, J NEUROSURG, V66, P234, DOI 10.3171/jns.1987.66.2.0234; LONGRIDGE NS, 1987, ACTA OTO-LARYNGOL, V103, P273, DOI 10.3109/00016488709107794; Lucas S, 2014, CEPHALALGIA, V34, P93, DOI 10.1177/0333102413499645; Manley G, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097791; Marcus DA, 2004, HEADACHE, V44, P328, DOI 10.1111/j.1526-4610.2004.04076.x; Master CL, 2016, CLIN PEDIATR, V55, P260, DOI 10.1177/0009922815594367; McCrea M, 2005, J INT NEUROPSYCH SOC, V11, P58, DOI 10.1017/S1355617705050083; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrea M, 1998, J HEAD TRAUMA REHAB, V13, P27, DOI 10.1097/00001199-199804000-00005; McCrea M, 2014, MIL MED, V179, P990, DOI 10.7205/MILMED-D-13-00349; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCrory Paul, 2005, Clin J Sport Med, V15, P48; McMahon P, 2014, J NEUROTRAUM, V31, P26, DOI 10.1089/neu.2013.2984; Meehan WP, 2013, CLIN J SPORT MED, V23, P339, DOI 10.1097/JSM.0b013e318291d3b3; Mihalik JP, 2013, AM J SPORT MED, V41, P1490, DOI 10.1177/0363546513487982; Molloy JH, 2017, J SCI MED SPORT, V20, P708, DOI 10.1016/j.jsams.2017.02.002; Moran R, 2017, J NEUROL SCI, V383, P101, DOI 10.1016/j.jns.2017.10.039; Moran RN, 2018, SCAND J MED SCI SPOR, V28, P2686, DOI 10.1111/sms.13286; Moran RN, 2018, AM J SPORT MED, V46, P1475, DOI 10.1177/0363546518756979; Morgan CD, 2015, J NEUROSURG-PEDIATR, V15, P589, DOI 10.3171/2014.10.PEDS14356; Mucha A, 2014, AM J SPORT MED, V42, P2479, DOI 10.1177/0363546514543775; Muller M, 2005, STROKE, V36, P1886, DOI 10.1161/01.STR.0000177886.94134.92; Murray N, 2014, J ATHL TRAINING, V49, P540, DOI 10.4085/1062-6050-49.3.32; Nacci A, 2011, ACTA OTORHINOLARYNGO, V31, P378; Naidu D, 2018, J NEUROTRAUM, V35, P2283, DOI 10.1089/neu.2017.5490; Oberlander TJ, 2017, J ATHL TRAINING, V52, P439, DOI 10.4085/1062-6050-52.2.12; ORIDE MKH, 1986, AM J OPTOM PHYS OPT, V63, P419; Parker TM, 2008, MED ENG PHYS, V30, P959, DOI 10.1016/j.medengphy.2007.12.006; Pearce KL, 2015, AM J SPORT MED, V43, P3055, DOI 10.1177/0363546515606430; Pertab JL, 2018, NEUROREHABILITATION, V42, P397, DOI 10.3233/NRE-172298; Powell JM, 2008, ARCH PHYS MED REHAB, V89, P1550, DOI 10.1016/j.apmr.2007.12.035; Rajagopalan Archana, 2017, J Nat Sci Biol Med, V8, P11, DOI 10.4103/0976-9668.198350; Reiley Alexander S, 2017, Arch Physiother, V7, P12, DOI 10.1186/s40945-017-0040-x; REVEL M, 1991, ARCH PHYS MED REHAB, V72, P288; Riemann BL, 2000, J ATHL TRAINING, V35, P19; Sandel N, 2017, SPORT EXERC PERFORM, V6, P304, DOI 10.1037/spy0000098; Sandel NK, 2017, AM J SPORT MED, V45, P937, DOI 10.1177/0363546516677246; Savola O, 2003, EUR J NEUROL, V10, P175, DOI 10.1046/j.1468-1331.2003.00552.x; Schatz P, 2013, AM J SPORT MED, V41, P321, DOI 10.1177/0363546512466038; Shechter A, 2002, NEUROLOGY, V58, P422, DOI 10.1212/WNL.58.3.422; Shekhar Chandra, 2015, J Emerg Trauma Shock, V8, P131, DOI 10.4103/0974-2700.160700; Slobounov S, 2012, BRAIN IMAGING BEHAV, V6, P224, DOI 10.1007/s11682-012-9167-2; Sterling M, 2003, PAIN, V104, P509, DOI 10.1016/S0304-3959(03)00078-2; Stewart WF, 1999, CEPHALALGIA, V19, P107, DOI 10.1046/j.1468-2982.1999.019002107.x; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X; Stiell IG, 2001, JAMA-J AM MED ASSOC, V286, P1841, DOI 10.1001/jama.286.15.1841; Stone AM, 2013, MANUAL THER, V18, P111, DOI 10.1016/j.math.2012.07.009; Sufrinko A, 2018, J HEAD TRAUMA REHAB, V33, P7, DOI 10.1097/HTR.0000000000000315; Tator CH, 2019, NEUROTRAUMA COMPREHE, P157; Tjell C, 1998, AM J OTOL, V19, P76; Treleaven J, 2003, J REHABIL MED, V35, P36, DOI 10.1080/16501970306109; Treleaven J, 2008, MANUAL THER, V13, P2, DOI 10.1016/j.math.2007.06.003; Treleaven J, 2017, J ORTHOP SPORT PHYS, V47, P492, DOI 10.2519/jospt.2017.7052; van der Naalt J, 2017, LANCET NEUROL, V16, P532, DOI 10.1016/S1474-4422(17)30117-5; Van Kampen DA, 2006, AM J SPORT MED, V34, P1630, DOI 10.1177/0363546506288677; Wallace J, 2017, J ATHL TRAINING, V52, P228, DOI 10.4085/1062-6050-52.1.07; Wang X, 2017, J NEUROTRAUM, V34, P273, DOI 10.1089/neu.2015.4392; Worts PR, 2018, AM J SPORT MED, V46, P2004, DOI 10.1177/0363546518768750; Wozniak JR, 2007, ARCH CLIN NEUROPSYCH, V22, P555, DOI 10.1016/j.acn.2007.03.004; Yorke AM, 2017, SPORTS HEALTH, V9, P174, DOI 10.1177/1941738116678411; Yorke AM, 2016, PHYS THER, V96, P1018, DOI 10.2522/ptj.20140598; Zemek R, 2016, JAMA-J AM MED ASSOC, V315, P1014, DOI 10.1001/jama.2016.1203; Zemek RL, 2017, JAMA-J AM MED ASSOC, V317, P1375, DOI 10.1001/jama.2017.1327; Zemek RL, 2017, J PEDIATR-US, V181, P222, DOI 10.1016/j.jpeds.2016.10.067; Zito G, 2006, MANUAL THER, V11, P118, DOI 10.1016/j.math.2005.04.007; Zogg CK, 2018, EPIDEMIOLOGY, V29, P885, DOI [10.1097/EDE.0000000000000900, 10.1097/ede.0000000000000900]; Zwart JA, 1997, HEADACHE, V37, P6, DOI 10.1046/j.1526-4610.1997.3701006.x	154	7	7	0	5	J O S P T	ALEXANDRIA	1111 NORTH FAIRFAX ST, STE 100, ALEXANDRIA, VA 22314-1436 USA	0190-6011	1938-1344		J ORTHOP SPORT PHYS	J. Orthop. Sports Phys. Ther.	NOV	2019	49	11					787	798		10.2519/jospt.2019.8855			12	Orthopedics; Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Orthopedics; Rehabilitation; Sport Sciences	JJ1VP	WOS:000493950100004	31597546				2022-02-06	
J	Perera, NKP; Akerlund, I; Hagglund, M				Perera, Nirmala Kanthi Panagodage; Akerlund, Ida; Hagglund, Martin			Motivation for sports participation, injury prevention expectations, injury risk perceptions and health problems in youth floorball players	KNEE SURGERY SPORTS TRAUMATOLOGY ARTHROSCOPY			English	Article						Youth sports; Sports injuries; Sports participation; Injury prevention; Floorball; Youth athletes	POSTTRAUMATIC OSTEOARTHRITIS; EPIDEMIOLOGY; BURDEN	Purpose Describe the motivation for floorball participation, injury prevention expectations, injury risk perceptions and prevalence of health problems in youth floorball players at the start of the season. Methods This cross-sectional survey is part of a larger Sport Without Injury ProgrammE (SWIPE) project and provides baseline data before a cluster randomised controlled trial of an injury prevention program (Knee Control). A baseline survey (online and paper based) was collected from 47 teams with 471 youth floorball players from two provinces of Sweden before the start of the 2017 season. Results The mean age for 140 females and 331 males was 13.7 (+/- 1.5) and 13.3 (+/- 1.0) years, respectively. The two most significant motivators for floorball participation were being part of the team (82% females, 75% males) and friends (65% females, 70% males). Fractures (84% females, 90% males), eye injuries (90% females, 83% males) and concussion (82% females, 83% males) were perceived as the most severe injuries. 93% of players believed that sports injuries can be prevented, while 74% believed it is unlikely that they will sustain an injury. Existing health problems at the beginning of the season were prevalent in 33% of players, with 65% being injuries and 35% illnesses. 17% of existing injuries at the start of the season caused time-loss from play and 17% required medical attention. Conclusion Social aspects were the greatest motivators for floorball participation in youths, suggesting that these factors are important to retain sports participants. The high number of health problems in youth is a concern; as such more effort, resources and priority should be given to sports safety programs. Many players believed that sports injuries can be prevented, possibly providing a fertile ground for implementation of such programs.	[Perera, Nirmala Kanthi Panagodage; Akerlund, Ida; Hagglund, Martin] Linkoping Univ, Dept Med & Hlth Sci, Div Physiotherapy, Linkoping, Sweden		Hagglund, M (corresponding author), Linkoping Univ, Dept Med & Hlth Sci, Div Physiotherapy, Linkoping, Sweden.	martin.hagglund@liu.se	Perera, Nirmala/AAB-7821-2020	Perera, Nirmala/0000-0001-6110-8945; Hagglund, Martin/0000-0002-6883-1471	Swedish Research CouncilSwedish Research CouncilEuropean Commission [2015-02414]; Swedish Research Council for Sport Science [P2018-0167]; Australia Awards-Endeavour Fellowship from the Department of Education and Training, Australia	The Sport Without Injury ProgrammE is funded by the Swedish Research Council (2015-02414) and the Swedish Research Council for Sport Science (P2018-0167). Nirmala Kanthi Panagodage Perera was supported by Australia Awards-Endeavour Fellowship from the Department of Education and Training, Australia.	Bowling A, 2005, J EPIDEMIOL COMMUN H, V59, P342, DOI 10.1136/jech.2004.021204; Bro T, 2017, SCAND J MED SCI SPOR, V27, P430, DOI 10.1111/sms.12653; Cameron KL, 2017, SPORTS MED ARTHROSC, V25, P144, DOI 10.1097/JSA.0000000000000155; Cao B, 2018, LANCET GLOB HEALTH, V6, pE1288, DOI 10.1016/s2214-109x(18)30411-x; Carbone A, 2017, J ORTHOP RES, V35, P397, DOI 10.1002/jor.23341; Clarsen B, 2014, BRIT J SPORT MED, V48, P754, DOI 10.1136/bjsports-2012-092087; Clarsen B, 2013, BRIT J SPORT MED, V47, P495, DOI 10.1136/bjsports-2012-091524; DiFiori JP, 2014, BRIT J SPORT MED, V48, DOI 10.1136/bjsports-2013-093299; Ding D, 2016, LANCET, V388, P1311, DOI 10.1016/S0140-6736(16)30383-X; Hartwig TB, 2019, SCAND J MED SCI SPOR, V29, P1305, DOI 10.1111/sms.13438; International Floorball Federation, 2018, MEMB ASS 2018; Kondric M, 2013, J SPORT SCI MED, V12, P10; Lehnert M., 2017, OPEN SPORTS SCI J, V10, P27, DOI [10.2174/1875399X01710010027, DOI 10.2174/1875399X01710010027]; Lehnert M, 2014, J HUM KINET, V42, P175, DOI 10.2478/hukin-2014-0072; Manley G, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097791; McKay CD, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13070657; Moseid CH, 2018, SCAND J MED SCI SPOR, V28, P1412, DOI 10.1111/sms.13047; Pasanen K, 2017, BMJ OPEN SPORT EXERC, V1, DOI 10.1136/bmjsem-2016-000217; Pasanen K, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a295; Riksidrottsforbundet, 2018, VERKS 2018 2019; Thomson A, 2015, BRIT J SPORT MED, V49, DOI 10.1136/bjsports-2014-094478; Tranaeus U, 2016, SPORTS HEALTH, V8, P224, DOI 10.1177/1941738116628472; Ullrich-French S, 2009, PSYCHOL SPORT EXERC, V10, P87, DOI 10.1016/j.psychsport.2008.06.007; von Rosen P, 2017, SCAND J MED SCI SPOR, V27, P1364, DOI 10.1111/sms.12735; von Rosen P, 2018, J ATHL TRAINING, V53, P262, DOI 10.4085/1062-6050-251-16; Watson A, 2017, ORTHOP J SPORTS MED, V5, DOI 10.1177/2325967117726976; Whittaker JL, 2015, OSTEOARTHR CARTILAGE, V23, P1122, DOI 10.1016/j.joca.2015.02.021; Whittaker JL, 2019, MED SCI SPORT EXER, V51, P255, DOI 10.1249/MSS.0000000000001787	28	7	8	4	21	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0942-2056	1433-7347		KNEE SURG SPORT TR A	Knee Surg. Sports Traumatol. Arthrosc.	NOV	2019	27	11					3722	3732		10.1007/s00167-019-05501-7			11	Orthopedics; Sport Sciences; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Sport Sciences; Surgery	JF7EC	WOS:000491548100041	30982108	hybrid, Green Published			2022-02-06	
J	Singh, R; Choudhri, K; Sinha, S; Mason, S; Lecky, F; Dawson, J				Singh, Rajiv; Choudhri, Kishor; Sinha, Saurabh; Mason, Suzanne; Lecky, Fiona; Dawson, Jeremy			Global outcome after traumatic brain injury in a prospective cohort	CLINICAL NEUROLOGY AND NEUROSURGERY			English	Article						TBI; Outcome; GOSE; Follow-up; Prognosis; Employment; Cohort; ICF; Participation restriction	QUALITY-OF-LIFE; HEAD-INJURY; YOUNG-PEOPLE; FOLLOW-UP; DEPRESSION SCALE; HOSPITAL ANXIETY; REHABILITATION; MODERATE; DISABILITY; CARE	Objectives: Traumatic Brain Injury(TBI) is one of the most common neurosurgical emergencies but the long-term outcome remains unclear. This study investigated the global outcome and return to work after TBI and tried to identify any relationships that exist with injury and demographic features. Patients & methods: 1322 consecutive TBI admissions over 4 years, assessed at a specialist neurorehabilitation clinic at 10weeks and 1 yr. The outcomes were Extended Glasgow Outcome Scale(GOSE), return to work, Rivermead Head Injury Follow-up Questionnaire, Rivermead Post-Concussion Symptoms and the Hospital Anxiety and Depression Score. Results: 1 year follow-up was achieved in 1207(91.3%). Mean age was 46.9(SD17.3) and 49.2% had mild TBI. The proportion attaining Good Recovery increased from 25.1% to 42.9% by 1 year. However 11.4% deteriorated in GOSE. Only 28.1% of individuals returned to the same pre-morbid level of work by 10 weeks, improving to 45.9% at 1 year. Over a quarter (25.6%) at 1 year were unable to make any return to work or study. Several demographic and injury variables were associated with these outcomes including TBI severity, social class, past psychiatric history and alcohol intoxication. These may allow targeting of vulnerable individuals. Conclusions: In a largely representative TBI population including predominantly mild injury, there is still considerable functional disability at 1 year and many individuals are unable to make any return to pre-morbid vocation.	[Singh, Rajiv; Mason, Suzanne; Lecky, Fiona] Univ Sheffield, Fac Med Dent & Hlth, Hlth Serv Res, Sch Hlth & Related Res ScHARR, Sheffield S1 4DA, S Yorkshire, England; [Singh, Rajiv] Sheffield Teaching Hosp, Osborn Neurorehabil Unit, Dept Rehabil Med, Sheffield S5 7AU, S Yorkshire, England; [Choudhri, Kishor; Sinha, Saurabh] Sheffield Teaching Hosp, Dept Neurosurg, Glossop Rd, Sheffield S10 2JF, S Yorkshire, England; [Dawson, Jeremy] Univ Sheffield, Inst Work Psychol, Sch Management, Conduit Rd, Sheffield S10 1FL, S Yorkshire, England		Singh, R (corresponding author), Univ Sheffield, Fac Med Dent & Hlth, Hlth Serv Res, Sch Hlth & Related Res ScHARR, Sheffield S1 4DA, S Yorkshire, England.	rajiv.singh@sth.nhs.uk		Sinha, Saurabh/0000-0001-7453-9576			Andelic N, 2012, J NEUROTRAUM, V29, P66, DOI 10.1089/neu.2011.1811; Andelic N, 2010, DISABIL REHABIL, V32, P1122, DOI 10.3109/09638280903410722; [Anonymous], 2014, HEAD INJURY TRIAGE A; Asikainen I, 1998, BRAIN INJURY, V12, P95, DOI 10.1080/026990598122737; BROOKS N, 1986, J NEUROL NEUROSUR PS, V49, P764, DOI 10.1136/jnnp.49.7.764; Chandola T, 2000, J PUBLIC HEALTH MED, V22, P182, DOI 10.1093/pubmed/22.2.182; COPE DN, 1982, ARCH PHYS MED REHAB, V63, P433; Corrigan JD, 1997, ARCH PHYS MED REHAB, V78, P132, DOI 10.1016/S0003-9993(97)90253-7; Corrigan JD, 2001, J HEAD TRAUMA REHAB, V16, P543, DOI 10.1097/00001199-200112000-00003; Corrigan JD, 2014, J HEAD TRAUMA REHAB, V29, pE1, DOI 10.1097/HTR.0000000000000020; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; Crawford S, 1996, J NEUROL NEUROSUR PS, V60, P510, DOI 10.1136/jnnp.60.5.510; Cuthbert JP, 2015, J HEAD TRAUMA REHAB, V30, P160, DOI 10.1097/HTR.0000000000000090; Dahm J, 2013, J AFFECT DISORDERS, V151, P392, DOI 10.1016/j.jad.2013.06.011; Dawkins N, 2006, BRAIN INJURY, V20, P1235, DOI 10.1080/02699050601076414; de Koning ME, 2015, BRAIN INJURY, V29, P423, DOI 10.3109/02699052.2014.982188; Dikmen SS, 2003, ARCH PHYS MED REHAB, V84, P1449, DOI 10.1016/S0003-9993(03)00287-9; Draper K, 2007, J HEAD TRAUMA REHAB, V22, P278, DOI 10.1097/01.HTR.0000290972.63753.a7; Engberg AW, 2006, ACTA NEUROL SCAND, V113, P178, DOI 10.1111/j.1600-0404.2005.00570.x; Farace E, 2000, J NEUROSURG, V93, P539, DOI 10.3171/jns.2000.93.4.0539; Forslund MV, 2013, J REHABIL MED, V45, P801, DOI 10.2340/16501977-1168; Godbolt AK, 2015, J HEAD TRAUMA REHAB, V30, pE41, DOI 10.1097/HTR.0000000000000050; Hawley CA, 2008, BRAIN INJURY, V22, P427, DOI 10.1080/02699050802064607; Huang DB, 2005, BRAIN INJURY, V19, P903, DOI 10.1080/02699050400004773; Jacobsson LJ, 2010, BRAIN INJURY, V24, P1075, DOI 10.3109/02699052.2010.494590; JAFFE KM, 1995, ARCH PHYS MED REHAB, V76, P17, DOI 10.1016/S0003-9993(95)80037-9; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; Jourdan C, 2013, BRAIN INJURY, V27, P1000, DOI 10.3109/02699052.2013.794971; Khan F, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006036.pub2; King NS, 1996, J NEUROL NEUROSUR PS, V61, P75, DOI 10.1136/jnnp.61.1.75; Kreutzer JS, 2003, J HEAD TRAUMA REHAB, V18, P128, DOI 10.1097/00001199-200303000-00004; Lecky F, 2000, LANCET, V355, P1771, DOI 10.1016/S0140-6736(00)02264-9; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; Maas AIR, 2013, LANCET NEUROL, V12, P1200, DOI 10.1016/S1474-4422(13)70234-5; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; Massagli TL, 1996, ARCH PHYS MED REHAB, V77, P125, DOI 10.1016/S0003-9993(96)90156-2; McMillan TM, 2012, J NEUROL NEUROSUR PS, V83, P1086, DOI 10.1136/jnnp-2012-302746; Mellick D, 2003, BRAIN INJURY, V17, P55, DOI 10.1080/0269905021000010159; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Olver JH, 1996, BRAIN INJURY, V10, P841, DOI 10.1080/026990596123945; Paniak C, 2000, BRAIN INJURY, V14, P219; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; PONSFORD JL, 1995, BRAIN INJURY, V9, P1, DOI 10.3109/02699059509004565; Pretz CR, 2013, ARCH PHYS MED REHAB, V94, P2486, DOI 10.1016/j.apmr.2013.06.021; Raj R, 2013, CRIT CARE, V17, DOI 10.1186/cc12856; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Rosenthal M, 1998, ARCH PHYS MED REHAB, V79, P90, DOI 10.1016/S0003-9993(98)90215-5; Ruff RM, 1996, BRAIN INJURY, V10, P551, DOI 10.1080/026990596124124; Ruttan L, 2008, ARCH PHYS MED REHAB, V89, pS69, DOI 10.1016/j.apmr.2008.07.007; Sandhaug M, 2015, BRAIN INJURY, V29, P1431, DOI 10.3109/02699052.2015.1063692; Scerrati A, 2018, J NEUROSURG SCI, V62, P574, DOI 10.23736/S0390-5616.18.04462-4; Seeley H, 2014, BRAIN INJURY, V28, P1559, DOI 10.3109/02699052.2014.939717; Sherer M, 1998, J HEAD TRAUMA REHAB, V13, P52, DOI 10.1097/00001199-199810000-00007; Sigurdardottir S, 2013, J REHABIL MED, V45, P808, DOI 10.2340/16501977-1156; Sigurdardottir S, 2009, BRAIN INJURY, V23, P489, DOI 10.1080/02699050902926309; Singh R, 2018, BRAIN INJURY, V32, P84, DOI 10.1080/02699052.2017.1376756; Singh R, 2013, ARCH TRAUMA RES, V2, P103, DOI 10.5812/atr.13665; Singh R, 2012, DISABIL REHABIL, V34, P439, DOI 10.3109/09638288.2011.608146; Siponkoski ST, 2013, J REHABIL MED, V45, P835, DOI 10.2340/16501977-1189; Soberg HL, 2013, J REHABIL MED, V45, P785, DOI 10.2340/16501977-1158; Son AHPWV, 2007, CLIN REHABIL, V21, P1024, DOI 10.1177/0269215507077603; Sorbo A, 2005, BRAIN INJURY, V19, P493, DOI 10.1080/02699050400013709; Stenberg M, 2017, BRAIN INJURY, V31, P351, DOI 10.1080/02699052.2016.1261303; Stenberg M, 2013, J REHABIL MED, V45, P792, DOI 10.2340/16501977-1200; Stucki G, 2002, DISABIL REHABIL, V24, P932, DOI 10.1080/09638280210148594; Thornhill S, 2000, BRIT MED J, V320, P1631, DOI 10.1136/bmj.320.7250.1631; Turner-Stokes L, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004170.pub2; Turner-Stokes L, 2008, J REHABIL MED, V40, P691, DOI 10.2340/16501977-0265; van der Naalt J, 1999, J NEUROL NEUROSUR PS, V66, P207, DOI 10.1136/jnnp.66.2.207; Walker WC, 2015, J HEAD TRAUMA REHAB, V30, P231, DOI 10.1097/HTR.0000000000000127; Wardlaw JM, 2002, J NEUROL NEUROSUR PS, V72, P188, DOI 10.1136/jnnp.72.2.188; Whitnall L, 2006, J NEUROL NEUROSUR PS, V77, P640, DOI 10.1136/jnnp.2005.078246; Wilde EA, 2010, ARCH PHYS MED REHAB, V91, P1650, DOI 10.1016/j.apmr.2010.06.033; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Wilson JTL, 2002, J NEUROTRAUM, V19, P999, DOI 10.1089/089771502760341910; Wood RL, 2006, J NEUROL NEUROSUR PS, V77, P71, DOI 10.1136/jnnp.2005.065540; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	77	7	8	1	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0303-8467	1872-6968		CLIN NEUROL NEUROSUR	Clin. Neurol. Neurosurg.	NOV	2019	186								105526	10.1016/j.clineuro.2019.105526			8	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Surgery	JN0OS	WOS:000496604500022	31585337	Green Accepted			2022-02-06	
J	Skarupa, D; Hanna, K; Zeeshan, M; Madbak, F; Hamidi, M; Haddadin, Z; Northcutt, A; Gries, L; Kulvatunyou, N; Joseph, B				Skarupa, David; Hanna, Kamil; Zeeshan, Muhammad; Madbak, Firas; Hamidi, Mohammad; Haddadin, Zaid; Northcutt, Ashley; Gries, Lynn; Kulvatunyou, Narong; Joseph, Bellal			Is early chemical thromboprophylaxis in patients with solid organ injury a solid decision?	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article; Proceedings Paper	49th Annual Meeting of the Western-Trauma-Association	MAR 03-09, 2019	Snowmass, CO	Western Trauma Assoc		Chemical thromboprophylaxis; blunt trauma; solid organs injury; TQIP	MOLECULAR-WEIGHT-HEPARIN; VENOUS THROMBOEMBOLISM PROPHYLAXIS; TRAUMATIC BRAIN-INJURY; DEEP-VEIN THROMBOSIS; NONOPERATIVE MANAGEMENT; BLUNT TRAUMA; AMERICAN-COLLEGE; PREVENTION; ENOXAPARIN; SAFE	BACKGROUND The optimal time to initiate chemical thromboprophylaxis (CTP) in patients who have undergone nonoperative management (NOM) of blunt solid organ injuries (SOI) remains controversial. The aim of our study was to assess the impact of early initiation of CTP in patients with blunt abdominal SOIs. METHODS We performed a 2-year (2013-2014) retrospective analysis of American College of Surgeons Trauma Quality Improvement Program. We included all adult trauma patients (age, >= 18 years) with blunt SOI who underwent NOM. Patients were stratified into three groups based on timing of CTP (early, <= 48 hours of injury; late, >48 hours of injury,; and no prophylaxis group). Our primary outcomes were rates of failure of NOM, pRBC transfusion, and mortality. Our secondary outcomes were the rate of venous thromboembolic (VTE) events (i.e., deep venous thrombosis [DVT] and/or pulmonary embolism [PE]) and length of stay. RESULTS A total of 36,187 patients met the inclusion criteria. Mean age was 49.5 +/- 19 years and 36% of patients received CTP (early, 37% (n = 4,819) versus late, 63% (n = 8,208)). After controlling for confounders, patients receiving early CTP had lower rates of DVT (p = 0.01) and PE (p = 0.01) compared with the no prophylaxis and late CTP groups. There was no difference between the three groups regarding the postprophylaxis pRBC transfusions, failure of NOM, and mortality. CONCLUSION Our results suggest that in patients undergoing NOM of blunt abdominal SOI, early initiation of CTP should be considered. It is associated with decreased rates of DVT and PE, with no significant difference in post prophylaxis pRBC transfusion, failure of nonoperative management, and mortality.	[Skarupa, David; Madbak, Firas] Univ Florida Hlth Jacksonville, Div Acute Care Surg, Dept Surg, Jacksonville, FL USA; [Hanna, Kamil; Zeeshan, Muhammad; Hamidi, Mohammad; Haddadin, Zaid; Northcutt, Ashley; Gries, Lynn; Kulvatunyou, Narong; Joseph, Bellal] Univ Arizona, Coll Med, Dept Surg, Div Trauma Crit Care Emergency Surg & Burns, Tucson, AZ USA		Skarupa, D (corresponding author), Univ Florida, Div Acute Care Surg, Dept Surg, 655 West 8th St, Jacksonville, FL 32209 USA.	David.Skarupa@jax.ufl.edu					Arnold JD, 2010, AM SURGEON, V76, P563; Barrera LM, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008303.pub2; Beere HM, 2000, NAT CELL BIOL, V2, P469, DOI 10.1038/35019501; Benjamin E, 2017, ANN SURG, V266, P463, DOI 10.1097/SLA.0000000000002359; Byrne JP, 2016, J AM COLL SURGEONS, V223, P621, DOI 10.1016/j.jamcollsurg.2016.06.382; Chapman BC, 2013, AM J SURG, V206, P917, DOI 10.1016/j.amjsurg.2013.07.024; Cimbanassi S, 2018, J TRAUMA ACUTE CARE, V84, P517, DOI 10.1097/TA.0000000000001774; Denson K, 2007, AM J SURG, V193, P380, DOI 10.1016/j.amjsurg.2006.12.004; Eberle BM, 2011, J TRAUMA, V70, P141, DOI 10.1097/TA.0b013e3182032f45; Feeney JM, 2016, J TRAUMA ACUTE CARE, V81, P843, DOI 10.1097/TA.0000000000001245; Ferguson C, 2018, EMERG MED J, V35, P127, DOI 10.1136/emermed-2017-207424.3; GEERTS WH, 1994, NEW ENGL J MED, V331, P1601, DOI 10.1056/NEJM199412153312401; Geerts WH, 1996, NEW ENGL J MED, V335, P701, DOI 10.1056/NEJM199609053351003; HILL SL, 1994, AM SURGEON, V60, P405; Jehan F, 2018, J TRAUMA ACUTE CARE, V85, P18, DOI 10.1097/TA.0000000000001938; Jehan F, 2017, J SURG RES, V219, P360, DOI 10.1016/j.jss.2017.06.049; Joseph B, 2015, AM J SURG, V209, P194, DOI 10.1016/j.amjsurg.2014.03.007; Kakkar V V, 1975, Adv Exp Med Biol, V52, P323; Kearon C, 2012, CHEST, V141, pE419S, DOI 10.1378/chest.11-2301; Khan M, 2018, J AM COLL SURGEONS, V226, P760, DOI 10.1016/j.jamcollsurg.2018.01.006; Khatsilouskaya T, 2017, WORLD J SURG, V41, P1193, DOI 10.1007/s00268-016-3820-7; Knudson MM, 2004, ANN SURG, V240, P490, DOI 10.1097/01.sla.0000137138.40116.6c; Kwok AM, 2016, AM J SURG, V212, P1231, DOI 10.1016/j.amjsurg.2016.09.026; Leppaniemi A, 2019, SCAND J SURG, V108, P95, DOI 10.1177/1457496919833220; Matsushima K, 2018, J TRAUMA ACUTE CARE, V84, P685, DOI 10.1097/TA.0000000000001803; Meyer D, 2014, J AM COLL SURGEONS, V219, pS69, DOI 10.1016/j.jamcollsurg.2014.07.160; Nathens AB, 2007, J TRAUMA, V62, P557, DOI 10.1097/TA.0b013e318031b5f5; Norwood SH, 2001, J AM COLL SURGEONS, V192, P161, DOI 10.1016/S1072-7515(00)00802-4; Olson EJ, 2015, J TRAUMA ACUTE CARE, V79, P961, DOI 10.1097/TA.0000000000000750; Paffrath T, 2010, INJURY, V41, P97, DOI 10.1016/j.injury.2009.06.010; Platzer P, 2006, ACTA ORTHOP, V77, P755, DOI 10.1080/17453670610012944; Reiff DA, 2009, J TRAUMA, V66, P1436, DOI 10.1097/TA.0b013e31817fdf1c; Rogers FB, 2002, J TRAUMA, V53, P142, DOI 10.1097/00005373-200207000-00032; Surgeons ACo, TRAUM QUAL IMPR PROG; Toker S, 2011, THROMBOSIS, V2011; Zeeshan M, 2018, J TRAUMA ACUTE CARE, V85, P387, DOI 10.1097/TA.0000000000001916	36	7	8	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	NOV	2019	87	5					1104	1111		10.1097/TA.0000000000002438			8	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine; Surgery	JZ1YN	WOS:000504900200022	31299694	Green Published			2022-02-06	
J	Stormann, P; Osinloye, W; Freiman, TM; Seifert, V; Marzi, I; Lustenberger, T				Stoermann, Philipp; Osinloye, William; Freiman, Thomas M.; Seifert, Volker; Marzi, Ingo; Lustenberger, Thomas			Early Chemical Thromboprophylaxis Does not Increase the Risk of Intracranial Hematoma Progression in Patients with Isolated Severe Traumatic Brain Injury	WORLD JOURNAL OF SURGERY			English	Article							MOLECULAR-WEIGHT-HEPARIN; VENOUS THROMBOEMBOLISM; ENOXAPARIN PROPHYLAXIS; PLATELET TRANSFUSION; HEMORRHAGE; SAFETY; CHEMOPROPHYLAXIS; ANTICOAGULATION; UTILITY	Background Venous thromboembolism (VTE) is recognized as a factor of morbidity and mortality in trauma patients suffering from severe blunt traumatic brain injury (TBI). The administration of pharmacological prophylaxis is broadly accepted as an effective therapy to prevent VTE events in trauma patients. Regardless of its ascertained efficacy, the risk of hematoma progression complicates the therapy in patients suffering from TBI: therefore, the optimal time to start prophylactic anticoagulation in these patients remains controversial. Methods All primary admissions to our level-1-trauma center between January 2012 and December 2016 were screened for severe blunt TBI with a head Abbreviated Injury Scale (AIS) >= 3. Patients who died within the first 24 h were excluded. Basic demographic results, thromboembolic events and progression of the intracranial hematoma were extracted from the patient's records. The patients were categorized into 4 groups according to start of VTE chemoprophylaxis: early ( < 24 h after hospitalization), intermediate (24-48 h), late ( > 48 h) and no therapy (no prophylactic anticoagulation within the first five days of hospitalization). A total of 292 patients with severe TBI were analyzed (early: n = 93, intermediate: n = 90, late: n = 74, no therapy: n = 35). The overall rate of intracranial bleeding progression was 13.6% after prophylactic anticoagulation was started. Results No statistically significant differences were found in the frequency of intracranial bleeding progression comparing the different time groups (early 12.9% vs. intermediate 11.1% vs. late 17.6%; adj. p = 0.13). In patients with VTE chemoprophylaxis, no thromboembolic events were recorded. Male gender, age, head AIS and subarachnoidal hemorrhage were identified as independent risk factors associated with intracranial hematoma progression. Conclusion The early administration of VTE chemoprophylaxis within 24 h after admission in patients with severe TBI did not increase the risk of intracranial bleeding progression.	[Stoermann, Philipp; Osinloye, William; Marzi, Ingo; Lustenberger, Thomas] Univ Frankfurt Main, Hosp Johann Wolfgang Goethe, Dept Trauma Hand & Reconstruct Surg, Theodor Stern Kai 7, D-60590 Frankfurt, Germany; [Freiman, Thomas M.; Seifert, Volker] Univ Frankfurt Main, Hosp Johann Wolfgang Goethe, Dept Neurosurg, Schleusenweg 2, D-60528 Frankfurt, Germany		Stormann, P (corresponding author), Univ Frankfurt Main, Hosp Johann Wolfgang Goethe, Dept Trauma Hand & Reconstruct Surg, Theodor Stern Kai 7, D-60590 Frankfurt, Germany.	philipp.stoermann@kgu.de; william-osinloye@hotmail.de; Thomas.Freiman@kgu.de; Volker.Seifert@kgu.de; marzi@trauma.uni-frankfurt.de; tom.lustenberg@gmail.com	Freiman, Thomas/AAV-8494-2021	Freiman, Thomas/0000-0002-2591-2829			Benjamin E, 2017, ANN SURG, V266, P463, DOI 10.1097/SLA.0000000000002359; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Byrne JP, 2016, J AM COLL SURGEONS, V223, P621, DOI 10.1016/j.jamcollsurg.2016.06.382; Denson K, 2007, AM J SURG, V193, P380, DOI 10.1016/j.amjsurg.2006.12.004; Dudley RR, 2010, J NEUROTRAUM, V27, P2165, DOI 10.1089/neu.2010.1366; Frisoli FA, 2017, NEUROSURGERY, V81, P1016, DOI 10.1093/neuros/nyx164; GEERTS WH, 1994, NEW ENGL J MED, V331, P1601, DOI 10.1056/NEJM199412153312401; Hachem LD, 2018, CLIN NEUROL NEUROSUR, V175, P68, DOI 10.1016/j.clineuro.2018.09.032; Holzmacher JL, 2018, BRAIN INJURY, V32, P325, DOI 10.1080/02699052.2018.1425804; Jamjoom AAB, 2016, BRIT J NEUROSURG, V30, P240, DOI 10.3109/02688697.2016.1161170; Kleindienst A, 2003, ACTA NEUROCHIR, V145, P1085, DOI 10.1007/s00701-003-0142-y; Knudson MM, 2004, ANN SURG, V240, P490, DOI 10.1097/01.sla.0000137138.40116.6c; KNUDSON MM, 1992, J TRAUMA, V32, P729, DOI 10.1097/00005373-199206000-00009; Lustenberger T, 2010, INJURY, V41, P924, DOI 10.1016/j.injury.2010.04.019; Margolick J, 2018, CAN J NEUROL SCI, V45, P432, DOI 10.1017/cjn.2017.275; Nickele CM, 2013, NEUROCRIT CARE, V18, P184, DOI 10.1007/s12028-012-9786-x; Nishijima DK, 2012, J TRAUMA ACUTE CARE, V72, P1658, DOI 10.1097/TA.0b013e318256dfc5; Norwood SH, 2002, ARCH SURG-CHICAGO, V137, P696, DOI 10.1001/archsurg.137.6.696; Pastorek RA, 2014, J NEUROTRAUM, V31, P1737, DOI 10.1089/neu.2014.3366; Phelan HA, 2012, J TRAUMA ACUTE CARE, V73, P1434, DOI 10.1097/TA.0b013e31825ac49e; Reiff DA, 2009, J TRAUMA, V66, P1436, DOI 10.1097/TA.0b013e31817fdf1c; Saadeh Y, 2012, J TRAUMA ACUTE CARE, V73, P426, DOI 10.1097/TA.0b013e31825a758b; Scudday T, 2011, J AM COLL SURGEONS, V213, P148, DOI 10.1016/j.jamcollsurg.2011.02.027; Skrifvars MB, 2017, INTENS CARE MED, V43, P419, DOI 10.1007/s00134-016-4655-2; Tong WS, 2012, BRAIN INJURY, V26, P1136, DOI 10.3109/02699052.2012.666437; Yumoto T, 2017, ACUTE MED SURG, V4, P394, DOI 10.1002/ams2.290	26	7	7	1	3	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0364-2313	1432-2323		WORLD J SURG	World J.Surg.	NOV	2019	43	11					2804	2811		10.1007/s00268-019-05072-1			8	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	JB8SX	WOS:000488847800021	31267142				2022-02-06	
J	Yi, NX; Zhou, LY; Wang, XY; Song, YJ; Han, HH; Zhang, TS; Wang, YJ; Shi, Q; Xu, H; Liang, QQ; Zhang, T				Yi, Nan-Xing; Zhou, Long-Yun; Wang, Xiao-Yun; Song, Yong-Jia; Han, Hai-Hui; Zhang, Tian-Song; Wang, Yong-Jun; Shi, Qi; Xu, Hao; Liang, Qian-Qian; Zhang, Ting			MK-801 attenuates lesion expansion following acute brain injury in rats: a meta-analysis	NEURAL REGENERATION RESEARCH			English	Article						nerve regeneration; acute brain injury; neurological function; spatial cognition; water maze test; lesion volume; brain edema; rat; systematic review; meta-analysis; neural regeneration	FOCAL CEREBRAL-ISCHEMIA; RECEPTOR ANTAGONIST MK-801; FIBRILLARY ACIDIC PROTEIN; ACUTE SUBDURAL-HEMATOMA; ARTERY OCCLUSION MODEL; D-ASPARTATE RECEPTORS; INFARCT VOLUME; NEUROTROPHIC FACTOR; COMBINATION THERAPY; DIZOCILPINE MK-801	OBJECTIVE: To evaluate the efficacy and safety of MK-801 and its effect on lesion volume in rat models of acute brain injury. DATA SOURCES: Key terms were "stroke", "brain diseases", "brain injuries", "brain hemorrhage, traumatic", "acute brain injury", "dizocilpine maleate", "dizocilpine", "MK-801", "MK801", "rat", "rats", "rattus" and "murine". PubMed, Cochrane library, EMBASE, the China National Knowledge Infrastructure, WanFang database, the VIP Journal Integration Platform (VJIP) and SinoMed databases were searched from their inception dates to March 2018. DATA SELECTION: Studies were selected if they reported the effects of MK-801 in experimental acute brain injury. Two investigators independently conducted literature screening, data extraction, and methodological quality assessments. OUTCOME MEASURES: The primary outcomes included lesion volume and brain edema. The secondary outcomes included behavioral assessments with the Bederson neurological grading system and the water maze test 24 hours after brain injury. RESULTS: A total of 52 studies with 2530 samples were included in the systematic review. Seventeen of these studies had a high methodological quality. Overall, the lesion volume (34 studies, n = 966, MD = -58.31, 95% CI: -66.55 to -50.07; P < 0.00001) and degree of cerebral edema (5 studies, n = 75, MD = -1.21, 95% CI: 1.50 to 0.91; P < 0.00001) were significantly decreased in the MK-801 group compared with the control group. MK-801 improved spatial cognition assessed with the water maze test (2 studies, n = 60, MD = -10.88, 95% CI: -20.75 to -1.00; P = 0.03) and neurological function 24 hours after brain injury (11 studies, n = 335, MD = -1.04, 95% CI: -1.47 to 0.60; P < 0.00001). Subgroup analysis suggested an association of reduction in lesion volume with various injury models (34 studies, n = 966, MD = -58.31, 95% CI: -66.55 to -50.07; P = 0.004). Further network analysis showed that 0-1 mg/kg MK-801 may be the optimal dose for treatment in the middle cerebral artery occlusion animal model. CONCLUSION: MK-801 effectively reduces brain lesion volume and the degree of cerebral edema in rat models of experimental acute brain injury, providing a good neuroprotective effect. Additionally, MK-801 has a good safety profile, and its mechanism of action is well known. Thus, MK-801 may be suitable for future clinical trials and applications.	[Yi, Nan-Xing; Wang, Xiao-Yun; Song, Yong-Jia; Shi, Qi; Xu, Hao; Liang, Qian-Qian; Zhang, Ting] Shanghai Univ Tradit Chinese Med, Longhua Hosp, Shanghai, Peoples R China; [Yi, Nan-Xing; Zhou, Long-Yun; Song, Yong-Jia; Han, Hai-Hui; Wang, Yong-Jun; Shi, Qi; Xu, Hao; Liang, Qian-Qian; Zhang, Ting] Shanghai Univ Tradit Chinese Med, Inst Spine, Shanghai, Peoples R China; [Yi, Nan-Xing; Zhou, Long-Yun; Song, Yong-Jia; Wang, Yong-Jun; Shi, Qi; Xu, Hao; Liang, Qian-Qian] Minist Educ, Key Lab Theory & Therapy Muscles & Bones, Shanghai, Peoples R China; [Zhou, Long-Yun] Shanghai Univ Tradit Chinese Med, Sch Rehabil Med, Shanghai, Peoples R China; [Han, Hai-Hui; Shi, Qi] Shanghai Univ Tradit Chinese Med, Guanghua Hosp, Shanghai, Peoples R China; [Zhang, Tian-Song] Fudan Univ, Jingan Dist Ctr Hosp, Shanghai, Peoples R China		Xu, H; Liang, QQ; Zhang, T (corresponding author), Shanghai Univ Tradit Chinese Med, Longhua Hosp, Shanghai, Peoples R China.; Xu, H; Liang, QQ; Zhang, T (corresponding author), Shanghai Univ Tradit Chinese Med, Inst Spine, Shanghai, Peoples R China.; Xu, H; Liang, QQ (corresponding author), Minist Educ, Key Lab Theory & Therapy Muscles & Bones, Shanghai, Peoples R China.	HOXU@163.com; liangqianqiantcm@126.com; ztingdd@hotmail.com		Han, Haihui/0000-0002-9074-7380	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81822050, 81873321, 81673990, 81330085, 81730107]; Shanghai Municipal Health and Family Planning Commission TCM Research Project of China [2018JP014]; Three-Year Action Plan to Promote Clinical Skills and Clinical Innovation in Municipal Hospitals of China [16CR1017A]; Shanghai Traditional Chinese Medicine Chronic Disease [Malignant Tumor, Bone Degenerative Disease] Clinical Medical Center of China [2017ZZ01010]; National Ministry of Education Innovation Team of China [IRT1270]; Innovation Team of Key Fields of the Ministry of Science and Technology of China [2015RA4002]; Outstanding Principle Investigator Project of Guanghua Hospital, Changning District, Shanghai, China [2016-01, 2016-06]	This work was supported by the National Natural Science Foundation of China, No. 81822050 (to QQL), 81873321 (to HX), 81673990 (to QQL), 81330085 (to QS), 81730107 (to YJW); the Shanghai Municipal Health and Family Planning Commission TCM Research Project of China, No. 2018JP014 (to HX); the Three-Year Action Plan to Promote Clinical Skills and Clinical Innovation in Municipal Hospitals of China, No. 16CR1017A (to YJW); the Shanghai Traditional Chinese Medicine Chronic Disease [Malignant Tumor, Bone Degenerative Disease] Clinical Medical Center of China, No. 2017ZZ01010 (to YJW); the National Ministry of Education Innovation Team of China, No. IRT1270 (to YJW); the Innovation Team of Key Fields of the Ministry of Science and Technology of China, No. 2015RA4002 (to YJW); the Outstanding Principle Investigator Project of Guanghua Hospital, Changning District, Shanghai, China, No. 2016-01 (to QS), 2016-06 (to YJW).	Al-Amin H, 2011, EXP NEUROL, V228, P30, DOI 10.1016/j.expneurol.2010.11.005; Allahtavakoli M, 2007, BASIC CLIN PHARMACOL, V101, P309, DOI 10.1111/j.1742-7843.2007.00127.x; Ao KH, 2017, SLEEP MED, V37, P187, DOI 10.1016/j.sleep.2017.02.010; Ashioti M, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-82; Bakiri Y, 2008, GLIA, V56, P233, DOI 10.1002/glia.20608; Balabanski AH, 2018, INT J STROKE, V13, P811, DOI 10.1177/1747493018778113; BEDERSON JB, 1986, STROKE, V17, P472, DOI 10.1161/01.STR.17.3.472; Bertorelli R, 1998, NEUROSCI LETT, V246, P41, DOI 10.1016/S0304-3940(98)00221-3; BIELENBERG GW, 1991, BRAIN RES, V552, P338, DOI 10.1016/0006-8993(91)90101-Z; BUCHAN AM, 1992, BRAIN RES, V574, P171, DOI 10.1016/0006-8993(92)90814-P; Cam E, 2008, J NEUROPSYCH CLIN N, V20, P367, DOI 10.1176/appi.neuropsych.20.3.367; Chen HSV, 1998, NEUROSCIENCE, V86, P1121, DOI 10.1016/S0306-4522(98)00163-8; Chen S, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0963-x; Chien L, 2018, BBA-MOL BASIS DIS, V1864, P3001, DOI 10.1016/j.bbadis.2018.06.012; DAWSON DA, 1994, BRIT J PHARMACOL, V113, P247, DOI 10.1111/j.1476-5381.1994.tb16201.x; Dietrich WD, 2000, J CEREBR BLOOD F MET, V20, P103, DOI 10.1097/00004647-200001000-00014; Ding YP, 2019, NEUROSCI RES, V142, P58, DOI 10.1016/j.neures.2018.05.002; DIRNAGL U, 1990, BRAIN RES, V527, P62, DOI 10.1016/0006-8993(90)91060-T; Dong YL, 2017, J NEUROIMMUNOL, V307, P7, DOI 10.1016/j.jneuroim.2017.03.005; Duris K, 2018, CURR NEUROPHARMACOL, V16, P1365, DOI 10.2174/1570159X16666180222155833; Ebrahimi F, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-89; Felderhoff-Mueser U, 2002, NEUROBIOL DIS, V11, P231, DOI 10.1006/nbdi.2002.0521; Fisher M, 2009, STROKE, V40, P2244, DOI 10.1161/STROKEAHA.108.541128; Foster KA, 2009, NEUROSCI RES, V63, P10, DOI 10.1016/j.neures.2008.09.007; FRAZZINI VI, 1994, NEUROSURGERY, V34, P1040, DOI 10.1227/00006123-199406000-00013; Garraway SM, 2016, NEURAL PLAST, V2016, P1; GILL R, 1991, BRIT J PHARMACOL, V103, P2030, DOI 10.1111/j.1476-5381.1991.tb12371.x; Gill R, 2016, J CEREB BLOOD FLOW M, V12, P371; Gorgulu A, 2000, ACTA NEUROCHIR, V142, P1287, DOI 10.1007/s007010070027; GREEN EJ, 1995, BRAIN RES, V702, P145, DOI 10.1016/0006-8993(95)01034-1; Tran HQ, 2017, TOXICOL APPL PHARM, V334, P158, DOI 10.1016/j.taap.2017.09.010; HAMM RJ, 1993, COGNITIVE BRAIN RES, V1, P223, DOI 10.1016/0926-6410(93)90006-Q; Han RZ, 2009, NEUROSCI BULL, V25, P367, DOI 10.1007/s12264-009-0608-x; Hanon E, 2001, SEIZURE-EUR J EPILEP, V10, P287, DOI 10.1053/seiz.2000.0511; Herz RCG, 1998, EUR J PHARMACOL, V346, P159, DOI 10.1016/S0014-2999(98)00051-X; Hu ZC, 2015, INT J NEUROSCI, V125, P298, DOI 10.3109/00207454.2014.931387; HUGHES P, 1993, NEUROSCIENCE, V57, P319, DOI 10.1016/0306-4522(93)90065-N; Iijima T, 2016, J CEREB BLOOD FLOW M, V12, P727; Jha MK, 2019, NEUROSCIENTIST, V25, P227, DOI 10.1177/1073858418783959; Jolliffe L, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-018791; Kaindl AM, 2012, ANN NEUROL, V72, P536, DOI 10.1002/ana.23626; Katsuta K, 2016, J CEREB BLOOD FLOW M, V15, P345; Kawai N, 2000, ACT NEUR S, V76, P529; Kawamoto EM, 2012, J NEUROSCI RES, V90, P213, DOI 10.1002/jnr.22745; Kuhlmann CRW, 2009, NEUROSCI LETT, V449, P168, DOI 10.1016/j.neulet.2008.10.096; Kunz WG, 2018, RADIOLOGY, V288, P518, DOI 10.1148/radiol.2018172886; Li L, 2017, NEUROL RES, V39, P271, DOI 10.1080/01616412.2017.1281198; Lima LD, 2013, NEUROPHARMACOLOGY, V73, P327, DOI 10.1016/j.neuropharm.2013.06.006; Liu X. G., 1995, Yaoxue Xuebao, V30, P896; Liu ZY, 2017, J CARDIOVASC PHARM, V70, P329, DOI 10.1097/FJC.0000000000000527; Lo EH, 2016, J CEREB BLOOD FLOW M, V14, P597; LYDEN PD, 1994, STROKE, V25, P189, DOI 10.1161/01.STR.25.1.189; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Mackensen GB, 2000, BRAIN RES, V853, P15, DOI 10.1016/S0006-8993(99)02212-X; Margaill I, 2016, J CEREB BLOOD FLOW M, V16, P107; Massari CM, 2016, TOXICOL IN VITRO, V37, P162, DOI 10.1016/j.tiv.2016.09.015; Matute C, 2007, NEURON GLIA BIOL, V3, P281, DOI 10.1017/S1740925X08000033; MEMEZAWA H, 1995, BRAIN RES, V670, P48, DOI 10.1016/0006-8993(94)01251-C; Milton M, 2018, FRONT CELL NEUROSCI, V12, DOI [10.3389/fncei.2018.00036, 10.3389/fncel.2018.00036]; Morkuniene R, 2015, J NEUROSCI RES, V93, P475, DOI 10.1002/jnr.23510; Moyanova S, 2007, INT J NEUROSCI, V117, P1361, DOI 10.1080/00207450600938847; Moyanova SG, 2007, BRAIN RES, V1153, P58, DOI 10.1016/j.brainres.2007.03.070; Nagalakshmi B, 2018, PROG MOL BIOL TRANSL, V157, P263, DOI 10.1016/bs.pmbts.2017.12.013; Nategh M, 2010, BASIC CLIN PHARMACOL, V107, P724, DOI 10.1111/j.1742-7843.2010.00570.x; OH SM, 1991, STROKE, V22, P915, DOI 10.1161/01.STR.22.7.915; Olmos G, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/861231; Onal MZ, 1997, STROKE, V28, P1060, DOI 10.1161/01.STR.28.5.1060; Pan DQ, 2003, ZHONGGUO LINCHUANG K, V5, P842; PARK CK, 1988, ANN NEUROL, V24, P543, DOI 10.1002/ana.410240411; Pascotini ET, 2018, J STROKE CEREBROVASC, V27, P3020, DOI 10.1016/j.jstrokecerebrovasdis.2018.06.032; PSCHORN U, 1993, MAGNET RESON MED, V30, P174, DOI 10.1002/mrm.1910300205; Qian YS, 2016, MOLECULES, V21, DOI 10.3390/molecules21081093; Regan Hillary K., 2007, Journal of Pharmacological and Toxicological Methods, V56, P339, DOI 10.1016/j.vascn.2007.05.005; Relton JK, 1996, EXP NEUROL, V138, P206, DOI 10.1006/exnr.1996.0059; ROUSSEL S, 1992, HYPERTENSION, V19, P40, DOI 10.1161/01.HYP.19.1.40; Sanchez AB, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0724-2; Sarraf-Yazdi S, 1998, ANESTH ANALG, V87, P72, DOI 10.1097/00000539-199807000-00016; Sarraf-Yazdi S, 1999, BRAIN RES, V826, P172, DOI 10.1016/S0006-8993(99)01233-0; SHAPIRA Y, 1993, ANESTH ANALG, V77, P141; [沈思钰 Shen Siyu], 2003, [中国行为医学科学, Chinese Journal of Behavioral Medical Science], V12, P489; Shirasaki Y, 2004, BRAIN RES, V1021, P159, DOI 10.1016/j.brainres.2004.06.012; Sommer JB, 2017, EUR J NEUROSCI, V45, P238, DOI 10.1111/ejn.13483; Song XQ, 2018, NATURE, V556, P515, DOI 10.1038/s41586-018-0039-9; Sonmez A, 2015, NEUROSCI LETT, V597, P137, DOI 10.1016/j.neulet.2015.05.001; Sriram K, 2004, J BIOL CHEM, V279, P19936, DOI 10.1074/jbc.M309304200; STREIT WJ, 1992, NEUROREPORT, V3, P146, DOI 10.1097/00001756-199202000-00006; Sutton G, 2002, J NEUROCHEM, V82, P1097, DOI 10.1046/j.1471-4159.2002.01031.x; Takamatsu H, 1998, EUR J PHARMACOL, V362, P137, DOI 10.1016/S0014-2999(98)00773-0; Uchida K, 2001, EUR J ANAESTH, V18, P295, DOI 10.1046/j.0265-0215.2000.00825.x; Wang J, 2017, MOL PAIN, V13, DOI 10.1177/1744806917746564; Wang W, 2011, BRAIN BEHAV IMMUN, V25, P1355, DOI 10.1016/j.bbi.2011.04.002; Wang WZ, 2017, CIRCULATION, V135, P759, DOI 10.1161/CIRCULATIONAHA.116.025250; Wenbin A, 2000, SHIYONG YIXUE JINXIU, V2, P93; Wexler EJ, 2002, J NEUROSCI METH, V113, P51, DOI 10.1016/S0165-0270(01)00476-9; Xue D, 2016, J CEREB BLOOD FLOW M, V14, P251; Ye L, 2013, J NEUROCHEM, V125, P897, DOI 10.1111/jnc.12263; You MM, 2019, FRONT AGING NEUROSCI, V10, DOI 10.3389/fnagi.2018.00428; Zhao HL, 2017, BRAIN RES, V1665, P1, DOI 10.1016/j.brainres.2017.03.029; Zhu XJ, 2015, BRAIN RES BULL, V114, P70, DOI 10.1016/j.brainresbull.2015.04.002; Zieminska E, 2017, NEUROCHEM RES, V42, P777, DOI 10.1007/s11064-016-2075-x	100	7	7	2	21	WOLTERS KLUWER MEDKNOW PUBLICATIONS	MUMBAI	WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2 VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA	1673-5374	1876-7958		NEURAL REGEN RES	Neural Regen. Res.	NOV	2019	14	11					1919	1931	PMID 31290450	10.4103/1673-5374.259619			13	Cell Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Neurosciences & Neurology	II0HY	WOS:000474887200018	31290450	Green Published, gold			2022-02-06	
J	Smith, KM; Blessing, MM; Parisi, JE; Britton, JW; Mandrekar, J; Cascino, GD				Smith, Kelsey M.; Blessing, Melissa M.; Parisi, Joseph E.; Britton, Jeffrey W.; Mandrekar, Jay; Cascino, Gregory D.			Tau deposition in young adults with drug-resistant focal epilepsy	EPILEPSIA			English	Article						chronic traumatic encephalopathy; epilepsy surgery; neuropathology	CHRONIC TRAUMATIC ENCEPHALOPATHY; HIPPOCAMPAL SCLEROSIS; BRAIN; DISEASE	Objective To evaluate the presence of tau deposition and pathologic features of chronic traumatic encephalopathy (CTE) in young adult patients treated with focal cortical resections for drug-resistant epilepsy. Methods Sixty consecutive patients who had undergone surgical treatment for drug-resistant focal epilepsy between 18 and 45 years of age were identified (2010-2017). Medical records were reviewed to determine clinical factors, including history of head trauma, age at seizure onset, age at surgical resection, seizure type(s) and frequency, imaging findings, and surgical outcome. All formalin-fixed, paraffin-embedded blocks from the surgical specimens from each subject were sectioned and stained with hematoxylin and eosin and antibodies to tau (Thermo Fisher Scientific Clone AT8), and examined blindly for tau pathology, including lesions characteristic of CTE. Results The median age at resection was 29.5 years (range = 19-45). A history of head trauma was reported in 19 patients. Although none of the patients had pathological findings characteristic of CTE, 23 patients (38%) demonstrated tau-immunoreactive lesions, including neurites, neurofibrillary pretangles, neurofibrillary tangles, subpial tau, and/or glial tau. In 4 of the 23 patients (7% of the cohort; 17% of those with tau pathology), substantial tau burden was identified. Three of these 4 patients had no significant history of head trauma; 1 patient had multiple sports-related concussions. No specific clinical factors correlated with the presence of tau pathology. Significance Tau-immunoreactive lesions were found in 38% of 60 patients who underwent a focal cortical resection for drug-resistant focal epilepsy. Diagnostic features of CTE were not detected in any patient; however, the pathological evaluation for CTE was limited to a surgical specimen. The prominent and excessive tau deposition in 23 patients (38%) is abnormal in this age group and warrants further investigation.	[Smith, Kelsey M.; Parisi, Joseph E.; Britton, Jeffrey W.; Cascino, Gregory D.] Mayo Clin, Dept Neurol, Rochester, MN 55905 USA; [Blessing, Melissa M.] Mayo Clin, Dept Pathol, Rochester, MN 55905 USA; [Parisi, Joseph E.] Mayo Clin, Dept Lab Med & Pathol, Rochester, MN 55905 USA; [Mandrekar, Jay] Mayo Clin, Div Biomed Stat & Informat, Rochester, MN USA		Cascino, GD (corresponding author), Mayo Clin, 200 First St SW, Rochester, MN 55905 USA.	gcascino@mayo.edu	Blessing, Melissa/AAZ-1340-2020	Blessing, Melissa/0000-0002-4014-4426; Smith, Kelsey/0000-0001-8659-3801	Mayo Foundation for Medical Education and Research	Mayo Foundation for Medical Education and Research	Amatniek JC, 2006, EPILEPSIA, V47, P867, DOI 10.1111/j.1528-1167.2006.00554.x; Braak H, 2011, J NEUROPATH EXP NEUR, V70, P960, DOI 10.1097/NEN.0b013e318232a379; Braak H, 2011, ACTA NEUROPATHOL, V121, P171, DOI 10.1007/s00401-010-0789-4; Engel Jr J, 1993, SURG TREATMENT EPILE, V2nd; Holth JK, 2013, J NEUROSCI, V33, P1651, DOI 10.1523/JNEUROSCI.3191-12.2013; Jones AL, 2018, NEUROLOGY, V90, pE474, DOI 10.1212/WNL.0000000000004927; Korczyn AD, 2013, EPILEPSY BEHAV, V28, P283, DOI 10.1016/j.yebeh.2013.03.012; Kwan P, 2011, NEW ENGL J MED, V365, P919, DOI 10.1056/NEJMra1004418; Lin JJ, 2012, LANCET, V380, P1180, DOI 10.1016/S0140-6736(12)61455-X; McKee AC, 2016, ACTA NEUROPATHOL, V131, P75, DOI 10.1007/s00401-015-1515-z; Miller LA, 2016, EPILEPSY BEHAV, V56, P113, DOI 10.1016/j.yebeh.2016.01.011; Montine TJ, 2012, ACTA NEUROPATHOL, V123, P1, DOI 10.1007/s00401-011-0910-3; Perrine K, 2017, WORLD NEUROSURG, V102, P533, DOI 10.1016/j.wneu.2017.02.084; Puvenna V, 2016, BRAIN RES, V1630, P225, DOI 10.1016/j.brainres.2015.11.007; Schmidt D, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g254; Simic G, 2016, BIOMOLECULES, V6, DOI 10.3390/biom6010006; Tai XY, 2018, NEUROPATH APPL NEURO, V44, P70, DOI 10.1111/nan.12458; Tai XY, 2016, BRAIN, V139, P2441, DOI 10.1093/brain/aww187; Thom M, 2011, BRAIN, V134, P2969, DOI 10.1093/brain/awr209; Xi ZQ, 2011, MED HYPOTHESES, V76, P897, DOI 10.1016/j.mehy.2011.03.003	20	7	7	1	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0013-9580	1528-1167		EPILEPSIA	Epilepsia	DEC	2019	60	12					2398	2403		10.1111/epi.16375		OCT 2019	6	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	MG3ZV	WOS:000493046800001	31663115	hybrid, Green Published			2022-02-06	
J	Kneavel, M; Ernst, W; Brandsma, L				Kneavel, Meredith; Ernst, William; Brandsma, Lynn			Collegiate athletes' perceptions of the culture of concussion reporting	JOURNAL OF AMERICAN COLLEGE HEALTH			English	Article						Mild traumatic brain injury; concussion; focus group; barriers to reporting; student-athletes; return to play	SPORT-RELATED CONCUSSION; POSITION STATEMENT; KNOWLEDGE; EDUCATION; EPIDEMIOLOGY; MANAGEMENT; PLAYERS; HOCKEY; INJURY; COACHES	Objective: The current study was designed to understand the culture of concussion among college student-athletes. Participants: Eight men's lacrosse and seven women's soccer players. Methods: A focus group was conducted to understand thoughts, barriers, team culture, and what was needed to feel safe reporting symptoms. Thematic analysis was conducted to identify key themes. Results: Themes included concerns about being taken out, pushing through, wanting to play, severity influencing reporting, changes about concussion reporting, uncertainty about symptoms, concussion have changed the game, reporting a teammate, wanting someone else to make the call, desire to raise awareness, deception, wanting professors to have more understanding, circumstances influencing reporting, helmets specific for concussion, malingering, and the return to play protocol being too long. Conclusion: Factors ranging from intrinsic to more distal cultural and environmental factors appear to influence reporting concussions. Student-athletes identified factors unique to the college athlete environment.	[Kneavel, Meredith; Brandsma, Lynn] Chestnut Hill Coll, Dept Psychol, Philadelphia, PA 19118 USA; [Ernst, William] Chestnut Hill Coll, Dept Profess Psychol, Philadelphia, PA USA; [Kneavel, Meredith] La Salle Univ, Dept Urban Publ Hlth & Nutr, Sch Nursing & Hlth Sci, Philadelphia, PA 19141 USA; [Brandsma, Lynn] Univ New England, Coll Med, Biddeford, ME USA		Kneavel, M (corresponding author), Chestnut Hill Coll, Dept Psychol, Philadelphia, PA 19118 USA.	kneavel@lasalle.edu	Kneavel, Meredith/ABG-5233-2021	Kneavel, Meredith/0000-0002-9820-6909; Ernst, William/0000-0002-6774-4528			Bagley AF, 2012, CLIN J SPORT MED, V22, P385, DOI 10.1097/JSM.0b013e3182639bb4; Baugh CM, 2015, AM J SPORT MED, V43, P47, DOI 10.1177/0363546514553090; Baugh CM, 2014, J LAW MED ETHICS, V42, P297, DOI 10.1111/jlme.12147; Bigler ED, 2008, J INT NEUROPSYCH SOC, V14, P1, DOI 10.1017/S135561770808017X; Bramley H, 2012, CLIN PEDIATR, V51, P283, DOI 10.1177/0009922811422434; Broglio SP, 2014, J ATHL TRAINING, V49, P245, DOI 10.4085/1062-6050-49.1.07; Centers for Disease Control and Prevention, HEADS 10 YEARS ANN V; Centers for Disease Control and Prevention. National Center for Injury Prevention and Control, 2008, HEADS CONC YOUTH SPO; Chrisman SP, 2013, J ADOLESCENT HEALTH, V52, P330, DOI 10.1016/j.jadohealth.2012.10.271; Cournoyer J, 2014, J ATHL TRAINING, V49, P654, DOI 10.4085/1062-6050-49.3.34; Covassin T, 2016, J ATHL TRAINING, V51, P189, DOI 10.4085/1062-6050-51.3.05; Creswell J.W., 2018, QUALITATIVE INQUIRY; Cusimano MD, 2014, BRIT J SPORT MED, V48, P141, DOI 10.1136/bjsports-2012-091660; Guerriero RM, 2012, CURR OPIN PEDIATR, V24, P696, DOI 10.1097/MOP.0b013e3283595175; Harmon KG, 2019, BRIT J SPORT MED, V53, P213, DOI 10.1136/bjsports-2018-100338; Hootman JM, 2007, J ATHL TRAINING, V42, P311; Hyde A, 2005, SOC SCI MED, V61, P2588, DOI 10.1016/j.socscimed.2005.04.040; Institute of Medicine, 2013, SPORTS RELATED CONCU; Kerr ZY, 2016, AM J SPORT MED, V44, P220, DOI 10.1177/0363546515612082; Khurana VG, 2012, J CLIN NEUROSCI, V19, P1, DOI 10.1016/j.jocn.2011.08.002; Kroshus E, 2016, HEALTH EDUC BEHAV, V43, P182, DOI 10.1177/1090198115599380; Kroshus E, 2015, SOC SCI MED, V134, P66, DOI 10.1016/j.socscimed.2015.04.011; Kroshus E, 2014, J ADOLESCENT HEALTH, V54, P269, DOI 10.1016/j.jadohealth.2013.11.011; Kroshus E, 2014, BRIT J SPORT MED, V48, P135, DOI 10.1136/bjsports-2013-092498; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lincoln AE, 2011, AM J SPORT MED, V39, P958, DOI 10.1177/0363546510392326; Lincoln Y.S., 2000, HDB QUALITATIVE RE E, P163; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; Morgan DL., 2019, BASIC ADV FOCUS GROU; Moustakas C.E., 1994, PHENOMENOLOGICAL RES; National Collegiate Athletic Association, 2013, DIV 1 HDB 2 8 1 PRIN; National Collegiate Athletic Association, 2015, MIND MATT CHALL; National Collegiate Athletic Association, 2017, CONC GUID DIAGN MAN; National Collegiate Athletic Association. NCAA About Us, 2018, NCAA US; Provvidenza C, 2013, BRIT J SPORT MED, V47, P332, DOI 10.1136/bjsports-2012-092099; Register-Mihalik JK, 2013, J ATHL TRAINING, V48, P645, DOI 10.4085/1062-6050-48.3.20; Register-Mihalik JK, 2013, BRAIN INJURY, V27, P878, DOI 10.3109/02699052.2013.775508; Sanderson J, 2017, COMMUN SPORT, V5, P267, DOI 10.1177/2167479515623455; Torres Daniel M, 2013, Neurol Clin Pract, V3, P279	39	7	7	0	2	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0744-8481	1940-3208		J AM COLL HEALTH	J. Am. Coll. Health	JUN 8	2021	69	4					435	443		10.1080/07448481.2019.1679816		OCT 2019	9	Education & Educational Research; Public, Environmental & Occupational Health	Social Science Citation Index (SSCI)	Education & Educational Research; Public, Environmental & Occupational Health	SN7YL	WOS:000493150600001	31662115				2022-02-06	
J	Plass, AM; Van Praag, D; Covic, A; Gorbunova, A; Real, R; von Steinbuechel, N				Plass, Anne Marie; Van Praag, Dominique; Covic, Amra; Gorbunova, Anastasia; Real, Ruben; von Steinbuechel, Nicole		Dutch Flemish Ctr TBI Investigat	The psychometric validation of the Dutch version of the Rivermead Post-Concussion Symptoms Questionnaire (RPQ) after traumatic brain injury (TBI)	PLOS ONE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; COVARIANCE STRUCTURE-ANALYSIS; QUALITY-OF-LIFE; CONSTRUCT-VALIDITY; EARLY PREDICTION; HEAD-INJURY; MILD; MODERATE; SCALE; RELIABILITY	Background Traumatic brain injury (TBI) is one of the most common neurological conditions. It can have wide-ranging physical, cognitive and psychosocial effects. Most people recover within weeks to months after the injury, but a substantial proportion are at risk of developing lasting post-concussion symptoms. The Rivermead Post-Concussion Syndrome Questionnaire (RPQ) is a short validated 16-items self-report instrument to evaluate post-concussive symptoms. The aim of this study was to test psychometrics characteristics of the current Dutch translation of the RPQ. Methods To determine the psychometric characteristics of the Dutch RPQ, 472 consecutive patients six months after they presented with a traumatic brain injury in seven medical centers in the Netherlands (N = 397), and in two in Belgium (Flanders) (N = 75) took part in the study which is part of the large prospective longitudinal observational CENTER-TBI-EU-study. Psychometric properties at six months post TBI, were assessed using exploratory and confirmatory factor analyses. Sensitivity was analyzed by comparing RPQ scores and self-reported recovery status of patients with mild vs. moderate and severe TBI. Findings The Dutch version of RPQ proved good, showing excellent psychometric characteristics: high internal consistency (Cronbach's alpha .93), and good construct validity, being sensitive to self-reported recovery status at six months post TBI. Moreover, data showed a good fit to the three dimensional structure of separate cognitive, emotional and somatic factors (Chi(2) = 119; df = 117; p = .4; CFI = .99; RMSEA = .006), reported earlier in the literature. Discussion Psychometric characteristics of the Dutch version of RPQ proved excellent to good, and can the instrument therefore be applied for research purposes and in daily clinical practice.	[Plass, Anne Marie; Covic, Amra; Gorbunova, Anastasia; Real, Ruben; von Steinbuechel, Nicole] Georg August Univ, Inst Med Psychol & Med Sociol, Univ Med Ctr Gottingen UMG, Gottingen, Germany; [Van Praag, Dominique] Antwerp Univ Hosp, Dept Neurosurg, Edegem, Belgium; [Van Praag, Dominique] Univ Antwerp, Edegem, Belgium		Plass, AM (corresponding author), Georg August Univ, Inst Med Psychol & Med Sociol, Univ Med Ctr Gottingen UMG, Gottingen, Germany.	annemarie.plass@med.uni-goettingen.de		Plass, Anne Marie/0000-0002-7801-9655; Van Praag, Dominique/0000-0002-4279-6532	EUEuropean Commission [602150]; Hannelore Kohl Stiftung	The funding parties (EU 7th Framework Programme FP7 (602150), and the Hannelore Kohl Stiftung) had had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajzen I, 2001, ANNU REV PSYCHOL, V52, P27, DOI 10.1146/annurev.psych.52.1.27; [Anonymous], 2015, FACTSHEET NONCONGENI; Brown T.A, 2014, CONFIRMATORY FACTOR; Casteno-Leon AM, 2017, EVALA HLTH PROF; Chalmers RP, 2012, J STAT SOFTW, V48, P1; Cnossen MC, 2017, J NEUROPSYCH CLIN N, V29, P206, DOI 10.1176/appi.neuropsych.16090165; Cnossen MC, 2017, J NEUROTRAUMA; Eyres S, 2005, CLIN REHABIL, V19, P878, DOI 10.1191/0269215505cr905oa; GUILLEMIN F, 1993, J CLIN EPIDEMIOL, V46, P1417, DOI 10.1016/0895-4356(93)90142-N; Haagsma JA, 2015, J NEUROTRAUM, V32, P853, DOI 10.1089/neu.2013.3283; Hendriks AAJ, 2017, INT J GERIATR PSYCH, V32, P734, DOI 10.1002/gps.4515; Herrmann N, 2009, J NEUROPSYCH CLIN N, V21, P181, DOI 10.1176/appi.neuropsych.21.2.181; Hersenstichting, HERS CIJF PAT; Hou RH, 2012, J NEUROL NEUROSUR PS, V83, P217, DOI 10.1136/jnnp-2011-300767; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; HU LT, 1992, PSYCHOL BULL, V112, P351, DOI 10.1037//0033-2909.112.2.351; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; King NS, 1996, J NEUROL NEUROSUR PS, V61, P75, DOI 10.1136/jnnp.61.1.75; King NS, 1999, BRIT J CLIN PSYCHOL, V38, P15, DOI 10.1348/014466599162638; Lannsjo M, 2011, J REHABIL MED, V43, P997, DOI 10.2340/16501977-0875; Maas AIR, 2015, NEUROSURGERY, V76, P67, DOI 10.1227/NEU.0000000000000575; Majdan M, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002331; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Nijman S, 2013, TRAUMATIC BRAIN INJU; Peters G.-J. Y., 2016, EUR HEAL PSYCHOL, V18, P235; Plass AMC, 2005, MED CAR SEEK SELF CA; Potter S, 2006, J NEUROL, V253, P1603, DOI 10.1007/s00415-006-0275-z; Smith-Seemiller L, 2003, BRAIN INJURY, V17, P199, DOI 10.1080/0269905021000030823; Stulemeijer M, 2008, J NEUROL NEUROSUR PS, V79, P936, DOI 10.1136/jnnp.2007.131250; TEASDALE G, 1974, LANCET, V2, P81; Teasdale G, 2014, LANCET NEUROL, V13, P844, DOI 10.1016/S1474-4422(14)70120-6; van den Dungen Catharina, 2008, Eur J Gen Pract, V14 Suppl 1, P53, DOI 10.1080/13814780802436218; van der Naalt J, 2017, LANCET NEUROL, V16, P532, DOI 10.1016/S1474-4422(17)30117-5; van Kessel P, 2017, BMC HEALTH SERV RES, V17, DOI 10.1186/s12913-017-2452-4; von Steinbuchel N, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176668; von Steinbuchel N, 2010, J NEUROTRAUM, V27, P1157, DOI 10.1089/neu.2009.1077; Wijers IGM, 2018, GERONTOLOGIST, V58, pE302, DOI 10.1093/geront/gnx061; Willis Gordon B, 2013, J Grad Med Educ, V5, P353, DOI 10.4300/JGME-D-13-00154.1; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Yuh Esther L, 2014, Neurosurgery, V75 Suppl 4, pS50, DOI 10.1227/NEU.0000000000000491; Yuh EL, 2013, ANN NEUROL, V73, P224, DOI 10.1002/ana.23783; Zadok J, 2015, NUMBERS CAUSES CONSE	42	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2019	14	10							e0210138	10.1371/journal.pone.0210138			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LN0JK	WOS:000532631800001	31647814	gold, Green Published, Green Submitted			2022-02-06	
J	Ghirardi, L; Chen, Q; Chang, Z; Kuja-Halkola, R; Skoglund, C; Quinn, PD; D'Onofrio, BM; Larsson, H				Ghirardi, Laura; Chen, Qi; Chang, Zheng; Kuja-Halkola, Ralf; Skoglund, Charlotte; Quinn, Patrick D.; D'Onofrio, Brian M.; Larsson, Henrik			Use of medication for attention-deficit/hyperactivity disorder and risk of unintentional injuries in children and adolescents with co-occurring neurodevelopmental disorders	JOURNAL OF CHILD PSYCHOLOGY AND PSYCHIATRY			English	Article						ADHD medication; injuries; neurodevelopmental disorders	DEFICIT-HYPERACTIVITY DISORDER; ADHD MEDICATION; YOUNG-PEOPLE; METHYLPHENIDATE; METAANALYSIS; ATOMOXETINE; POPULATION; PREVALENCE; SYMPTOMS; REGISTER	Background Attention-deficit/hyperactivity disorder (ADHD) is often associated with other neurodevelopmental disorders (NDs) and with risky behaviors and adverse health outcomes, including injuries. Treatment with ADHD medication has been associated with reduced risk of injuries. However, it is unknown whether the association is present in individuals with co-occurring NDs. The aim of the present study was to estimate the association between ADHD medication use and unintentional injuries in Sweden in children and adolescents with ADHD, including those with co-occurring NDs. Methods Using a linkage of several national registers via the unique personal identification number, we identified individuals with a diagnosis of ADHD and of other NDs, including autism spectrum disorder, intellectual disability, communication disorders, learning disorders and motor disorders. The primary outcome was unintentional injuries. Secondary outcome was traumatic brain injury (TBI). Individuals were followed from January 1st 2006 or their 5th birthday or the date of the first unintentional injury, whichever came last, to December 31st 2013 or their 18th birthday or death, whichever came first. We compared the rate of injuries during periods on-treatment with the rate of injuries during periods off-treatment within the same individual using stratified Cox regression to calculate hazard ratio (HR) with 95% confidence intervals (CIs). Results For children and adolescents with ADHD (N = 9,421) the rate of any unintentional injuries (HR = 0.85; 95% CI = 0.78-0.92) and TBIs (HR = 0.27; 95% CIs = 0.20-0.38) during medicated periods was lower than during non-medicated periods. Similar results were found among individuals with co-occurring NDs (N = 2,986), for unintentional injuries (HR = 0.88; 95% CI = 0.77-1.01) and for TBIs (HR = 0.27; 95% CI = 0.16-0.44). Conclusions Beneficial effects of ADHD medication may extend beyond reduction of ADHD core symptoms to prevention of unintentional injuries in children and adolescents, including individuals with co-occurring NDs.	[Ghirardi, Laura; Chen, Qi; Chang, Zheng; Kuja-Halkola, Ralf; D'Onofrio, Brian M.; Larsson, Henrik] Karolinska Inst, Dept Med Epidemiol & Biostat, Nobels Vag 12A, S-17177 Stockholm, Sweden; [Skoglund, Charlotte] Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden; [Quinn, Patrick D.] Indiana Univ, Dept Appl Hlth Sci, Sch Publ Hlth, Bloomington, IN 47405 USA; [D'Onofrio, Brian M.] Indiana Univ, Dept Psychol & Brain Sci, Bloomington, IN USA; [Larsson, Henrik] Orebro Univ, Sch Med Sci, Orebro, Sweden		Ghirardi, L (corresponding author), Karolinska Inst, Dept Med Epidemiol & Biostat, Nobels Vag 12A, S-17177 Stockholm, Sweden.	laura.ghirardi@ki.se	Kuja-Halkola, Ralf/ABA-5061-2020	Kuja-Halkola, Ralf/0000-0002-3765-2067; Quinn, Patrick/0000-0002-6770-8762; Skoglund, Charlotte/0000-0002-6893-2862	Swedish Research CouncilSwedish Research CouncilEuropean Commission [201802213, 2014-3831, 2013-2280]; Swedish Initiative for Research on Microdata in the Social And Medical Sciences (SIMSAM) [340-2013-5867]; European UnionEuropean Commission [643051]; National Institute on Drug Abuse of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA) [R00DA040727]; National Institute of Mental Health of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R01MH102221]	The authors acknowledge financial support from the Swedish Research Council (2014-3831; 2013-2280). The project has also received funding from Swedish Initiative for Research on Microdata in the Social And Medical Sciences (SIMSAM) framework Grant no. 340-2013-5867. L.G. is supported from the European Union's Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie grant agreement no. 643051. This report reflects only the authors' views and the European Union is not responsible for any use that may be made of the information it contains. Z.C. was supported by the Swedish Research Council (201802213). P.D.Q. was supported by the National Institute on Drug Abuse of the National Institutes of Health under Award Number R00DA040727. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. B.M.D. was supported by the National Institute of Mental Health of the National Institutes of Health under Award Number R01MH102221.	Allison PD, 1996, SOCIOL METHOD RES, V25, P207, DOI 10.1177/0049124196025002003; Allison PD., 2009, FIXED EFFECTS REGRES; Aman MG, 2003, J CHILD ADOL PSYCHOP, V13, P29, DOI 10.1089/104454603321666171; Balazs J, 2017, WORLD J PSYCHIATR, V7, P44, DOI 10.5498/wjp.v7.i1.44; Brikell I, 2019, EPILEPSIA, V60, P284, DOI 10.1111/epi.14640; Chang Z, 2017, JAMA PSYCHIAT, V74, P597, DOI 10.1001/jamapsychiatry.2017.0659; Chang Z, 2014, J CHILD PSYCHOL PSYC, V55, P878, DOI 10.1111/jcpp.12164; Chang Z, 2014, JAMA PSYCHIAT, V71, P319, DOI 10.1001/jamapsychiatry.2013.4174; Chen Q, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g3769; Chen VCH, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173762; Cortese S, 2018, LANCET PSYCHIAT, V5, P727, DOI 10.1016/S2215-0366(18)30269-4; Dalsgaard S, 2015, LANCET PSYCHIAT, V2, P702, DOI 10.1016/S2215-0366(15)00271-0; Erskine HE, 2016, J AM ACAD CHILD PSY, V55, P841, DOI 10.1016/j.jaac.2016.06.016; Faraone SV, 2017, J AM ACAD CHILD PSY, V56, P167, DOI 10.1016/j.jaac.2016.11.011; Ghirardi L, 2018, MOL PSYCHIATR, V23, P257, DOI 10.1038/mp.2017.17; Ghirardi L., 2019, J AM ACAD CHILD ADOL, DOI 10.1016/j.jaac.2019.06.010; Giacobini M, 2018, J ATTEN DISORD, V22, P3, DOI 10.1177/1087054714554617; Grzadzinski R, 2016, MOL AUTISM, V7, DOI 10.1186/s13229-016-0072-1; Haagsma JA, 2016, INJURY PREV, V22, P3, DOI 10.1136/injuryprev-2015-041616; Harfterkamp M, 2013, J CHILD ADOL PSYCHOP, V23, P194, DOI 10.1089/cap.2012.0012; Harfterkamp M, 2012, J AM ACAD CHILD PSY, V51, P733, DOI 10.1016/j.jaac.2012.04.011; Hodgkins P, 2011, CURR MED RES OPIN, V27, P53, DOI 10.1185/03007995.2011.623158; Koolwijk I, 2014, J DEV BEHAV PEDIATR, V35, P591, DOI 10.1097/DBP.0000000000000109; Korrel H, 2017, J CHILD PSYCHOL PSYC, V58, P640, DOI 10.1111/jcpp.12688; Larson K, 2011, PEDIATRICS, V127, P462, DOI 10.1542/peds.2010-0165; Lichtenstein P, 2012, NEW ENGL J MED, V367, P2006, DOI 10.1056/NEJMoa1203241; Ludvigsson JF, 2016, EUR J EPIDEMIOL, V31, P125, DOI 10.1007/s10654-016-0117-y; Ludvigsson JF, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-450; Ludvigsson JF, 2009, EUR J EPIDEMIOL, V24, P659, DOI 10.1007/s10654-009-9350-y; Man KKC, 2015, PEDIATRICS, V135, P40, DOI 10.1542/peds.2014-1738; Merrill RM, 2009, ADV MED SCI-POLAND, V54, P20, DOI 10.2478/v10039-009-0022-7; Mikolajczyk R, 2015, JAMA PEDIATR, V169, P391, DOI 10.1001/jamapediatrics.2014.3275; Mohr-Jensen C, 2016, CLIN PSYCHOL REV, V48, P32, DOI 10.1016/j.cpr.2016.05.002; Nigg JT, 2013, CLIN PSYCHOL REV, V33, P215, DOI 10.1016/j.cpr.2012.11.005; Osland ST, 2018, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007990.pub3; Peng XL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079476; Prasad V, 2018, CHILD CARE HLTH DEV, V44, P871, DOI 10.1111/cch.12591; Quinn PD, 2017, AM J PSYCHIAT, V174, P877, DOI 10.1176/appi.ajp.2017.16060686; Raman SR, 2013, INJURY PREV, V19, P164, DOI 10.1136/injuryprev-2012-040483; Ruiz-Goikoetxea M, 2018, NEUROSCI BIOBEHAV R, V84, P63, DOI 10.1016/j.neubiorev.2017.11.007; Sariaslan A, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002103; Sayal K, 2018, LANCET PSYCHIAT, V5, P175, DOI 10.1016/S2215-0366(17)30167-0; Simonoff E, 2013, J CHILD PSYCHOL PSYC, V54, P527, DOI 10.1111/j.1469-7610.2012.02569.x; StataCorp, 2017, STATA STAT SOFTWARE; Sturman N, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD011144.pub2; Tai YM, 2013, RES DEV DISABIL, V34, P1100, DOI 10.1016/j.ridd.2012.11.027; Thapar A, 2017, LANCET PSYCHIAT, V4, P339, DOI 10.1016/S2215-0366(16)30376-5; Wettermark B, 2007, PHARMACOEPIDEM DR S, V16, P726, DOI 10.1002/pds.1294; World Health Organization, 2014, INJ EUR CALL PUBL HL; Zablotsky B, 2020, J ATTEN DISORD, V24, P94, DOI 10.1177/1087054717713638	50	7	7	1	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0021-9630	1469-7610		J CHILD PSYCHOL PSYC	J. Child Psychol. Psychiatry	FEB	2020	61	2					140	147		10.1111/jcpp.13136		OCT 2019	8	Psychology, Developmental; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Psychiatry	KC5YV	WOS:000490960300001	31625605	Green Accepted			2022-02-06	
J	Blaker, AL; Moore, ER; Yamamoto, BK				Blaker, Amanda L.; Moore, Elizabeth R.; Yamamoto, Bryan K.			Serial exposure to ethanol drinking and methamphetamine enhances glutamate excitotoxicity	JOURNAL OF NEUROCHEMISTRY			English	Article						alcohol; dopamine; excitotoxicity; GLAST; glutamate; methamphetamine	BASAL EXTRACELLULAR GLUTAMATE; NATIONAL EPIDEMIOLOGIC SURVEY; TRAUMATIC BRAIN-INJURY; ALPHA-II-SPECTRIN; DSM-IV ALCOHOL; STRIATAL GLUTAMATE; NUCLEUS-ACCUMBENS; UNITED-STATES; CELL-DEATH; KINASE-II	A significant comorbidity exists between alcohol and methamphetamine (Meth) abuse but the neurochemical consequences of this co-abuse are unknown. Alcohol and Meth independently and differentially affect glutamatergic transmission but the unique effects of their serial exposure on glutamate signaling in mediating damage to dopamine neurons are unknown. Sprague-Dawley rats had intermittent voluntary access to 10% ethanol (EtOH) every other day and water over 28 days and were then administered a binge injection regimen of Meth or saline. EtOH drinking decreased the glutamate aspartate transporter and increased basal extracellular concentrations of glutamate within the striatum when measured after the last day of drinking. Ceftriaxone is known to increase the expression and/or activity of glutamate transporters in the brain and prevented both the decreases in glutamate aspartate transporter and the increases in basal extracellular glutamate when administered during EtOH drinking. EtOH drinking also exacerbated the acute increases in extracellular glutamate observed upon Meth exposure, the subsequent increases in spectrin proteolysis, and the long-term decreases in dopamine content in the striatum, all of which were attenuated by ceftriaxone administration during EtOH drinking only. These results implicate EtOH-induced increases in extracellular glutamate and corresponding decreases in glutamate uptake as mechanisms that contribute to the vulnerability produced by EtOH drinking and the unique neurotoxicity observed after serial exposure to Meth that is not observed with either drug alone.	[Blaker, Amanda L.] Univ Toledo, Coll Med, Dept Neurosci, 2801 W Bancroft St, Toledo, OH 43606 USA; [Moore, Elizabeth R.; Yamamoto, Bryan K.] Indiana Univ Sch Med, Dept Pharmacol & Toxicol, Indianapolis, IN 46202 USA		Yamamoto, BK (corresponding author), Dept Pharmacol & Toxicol, 635 Barnhill Dr,MS A418, Indianapolis, IN 46202 USA.	brkyama@iu.edu			National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [DA042737]; NATIONAL INSTITUTE ON DRUG ABUSEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission [R01DA042737] Funding Source: NIH RePORTER	The authors thank Dr. Reka Natarajan for her assistance in performing intracranial surgeries. This work was supported by the National Institutes of Health [DA042737]. Bryan K. Yamamoto is a handling editor for the Journal of Neurochemistry. The authors do not declare any other conflicts of interest.	Alhaddad H, 2014, PSYCHOPHARMACOLOGY, V231, P4049, DOI 10.1007/s00213-014-3545-y; Allan SM, 2000, P NATL ACAD SCI USA, V97, P5580, DOI 10.1073/pnas.090464197; Barr JL, 2015, BRIT J PHARMACOL, V172, P5414, DOI 10.1111/bph.13330; Battaglia G, 2002, J NEUROSCI, V22, P2135, DOI 10.1523/JNEUROSCI.22-06-02135.2002; Bishehsari F, 2017, ALCOHOL RES-CURR REV, V38, P163; Blaker AL, 2018, J NEUROIMMUNE PHARM, V13, P53, DOI 10.1007/s11481-017-9764-3; Bujarski S, 2014, DRUG ALCOHOL DEPEN, V142, P127, DOI 10.1016/j.drugalcdep.2014.06.004; Callaghan RC, 2012, DRUG ALCOHOL DEPEN, V120, P35, DOI 10.1016/j.drugalcdep.2011.06.013; Chawla AR, 2017, J NEUROCHEM, V140, P421, DOI 10.1111/jnc.13913; Chen WZ, 2004, J NEUROSCI, V24, P1136, DOI 10.1523/JNEUROSCI.1586-03.2004; Chen XF, 2016, J APPL TOXICOL, V36, P1460, DOI 10.1002/jat.3301; Cui CM, 2014, NEUROL SCI, V35, P695, DOI 10.1007/s10072-013-1585-4; Das SC, 2015, NEUROPHARMACOLOGY, V97, P67, DOI 10.1016/j.neuropharm.2015.05.009; Devaud LL, 2001, ALCOHOL CLIN EXP RES, V25, P606, DOI 10.1111/j.1530-0277.2001.tb02257.x; Ding ZM, 2013, ADDICT BIOL, V18, P297, DOI 10.1111/adb.12018; DONZANTI BA, 1988, PHARMACOL BIOCHEM BE, V30, P795, DOI 10.1016/0091-3057(88)90102-5; Dumont AO, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097649; Easton AC, 2013, NEUROPSYCHOPHARMACOL, V38, P1636, DOI 10.1038/npp.2013.60; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Flatscher-Bader T, 2008, ALCOHOL CLIN EXP RES, V32, P1849, DOI 10.1111/j.1530-0277.2008.00754.x; Fultz EK, 2017, DRUG ALCOHOL DEPEN, V177, P178, DOI 10.1016/j.drugalcdep.2017.03.026; GOODMAN SR, 1995, BRAIN RES BULL, V36, P593, DOI 10.1016/0361-9230(94)00264-2; Goodrich GS, 2013, J NEUROTRAUM, V30, P1434, DOI 10.1089/neu.2012.2712; Goodwin JS, 2009, J BIOL CHEM, V284, P2978, DOI 10.1074/jbc.M805298200; Grant BF, 2017, JAMA PSYCHIAT, V74, P911, DOI 10.1001/jamapsychiatry.2017.2161; Grant RJ, 2009, NEUROSCIENCE, V158, P558, DOI 10.1016/j.neuroscience.2008.10.023; Griffin WC, 2015, FRONT PHARMACOL, V6, DOI 10.3389/fphar.2015.00027; Halpin LE, 2014, NEUROPSYCHOPHARMACOL, V39, P1031, DOI 10.1038/npp.2013.306; Hameed MQ, 2019, CEREB CORTEX, V29, P4506, DOI 10.1093/cercor/bhy328; Hu YY, 2015, J NEUROCHEM, V132, P194, DOI 10.1111/jnc.12958; Jagadapillai R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100230; KITAMURA Y, 1993, J NEUROCHEM, V61, P100, DOI 10.1111/j.1471-4159.1993.tb03542.x; Kryger R, 2010, NEUROSCIENCE, V167, P361, DOI 10.1016/j.neuroscience.2010.01.061; Lawrence CB, 1998, EUR J NEUROSCI, V10, P1188, DOI 10.1046/j.1460-9568.1998.00136.x; Leclercq S, 2017, TRANSL PSYCHIAT, V7, DOI 10.1038/tp.2017.15; Lee SG, 2008, J BIOL CHEM, V283, P13116, DOI 10.1074/jbc.M707697200; Leslie EM, 2017, ADDICT BEHAV, V70, P27, DOI 10.1016/j.addbeh.2017.01.036; Leung TCH, 2012, ACS CHEM NEUROSCI, V3, P22, DOI 10.1021/cn200072h; Lewerenz J, 2013, ANTIOXID REDOX SIGN, V18, P522, DOI 10.1089/ars.2011.4391; Lipski J, 2007, NEUROSCIENCE, V146, P617, DOI 10.1016/j.neuroscience.2007.02.003; Mandolesi G, 2013, J NEUROSCI, V33, P12105, DOI 10.1523/JNEUROSCI.5369-12.2013; Mark KA, 2004, J NEUROSCI, V24, P11449, DOI 10.1523/JNEUROSCI.3597-04.2004; Mark KA, 2007, J NEUROSCI, V27, P6823, DOI 10.1523/JNEUROSCI.0013-07.2007; Massey VL, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00193; McCann UD, 1998, J NEUROSCI, V18, P8417; MCGLADEMCCULLOH E, 1993, NATURE, V362, P640, DOI 10.1038/362640a0; Melendez RI, 2005, ALCOHOL CLIN EXP RES, V29, P326, DOI 10.1097/01.ALC.0000156086.65665.4D; NASH JF, 1992, BRAIN RES, V581, P237, DOI 10.1016/0006-8993(92)90713-J; Orser BA, 1997, ANESTHESIOLOGY, V86, P903, DOI 10.1097/00000542-199704000-00021; Ottestad-Hansen S, 2018, GLIA, V66, P951, DOI 10.1002/glia.23294; Pati D, 2016, EUR J NEUROSCI, V44, P1896, DOI 10.1111/ejn.13284; Pike BR, 2001, J NEUROCHEM, V78, P1297, DOI 10.1046/j.1471-4159.2001.00510.x; Pow DV, 2001, GLIA, V34, P27, DOI 10.1002/glia.1037; Rao PSS, 2012, CURR MED CHEM, V19, P5148, DOI 10.2174/092986712803530511; RIEDERER BM, 1986, J CELL BIOL, V102, P2088, DOI 10.1083/jcb.102.6.2088; Roberts RC, 2014, NEUROSCIENCE, V277, P522, DOI 10.1016/j.neuroscience.2014.07.019; Rothstein JD, 2005, NATURE, V433, P73, DOI 10.1038/nature03180; SIMAN R, 1988, NEURON, V1, P279, DOI 10.1016/0896-6273(88)90076-1; Staszewski RD, 2006, J NEUROCHEM, V96, P1267, DOI 10.1111/j.1471-4159.2005.03618.x; STEPHANS SE, 1994, SYNAPSE, V17, P203, DOI 10.1002/syn.890170310; Stinson FS, 2005, DRUG ALCOHOL DEPEN, V80, P105, DOI 10.1016/j.drugalcdep.2005.03.009; Stroemer RP, 1998, J CEREBR BLOOD F MET, V18, P833, DOI 10.1097/00004647-199808000-00003; Tata DA, 2007, ADDICTION, V102, P49, DOI 10.1111/j.1360-0443.2007.01770.x; Thomas DM, 2005, J PHARMACOL EXP THER, V313, P870, DOI 10.1124/jpet.104.080242; Valles SL, 2004, BRAIN PATHOL, V14, P365; Volkow ND, 2001, AM J PSYCHIAT, V158, P377, DOI 10.1176/appi.ajp.158.3.377; Wang HJ, 2010, WORLD J GASTROENTERO, V16, P1304, DOI 10.3748/wjg.v16.i11.1304; Wang KKW, 1998, J BIOL CHEM, V273, P22490, DOI 10.1074/jbc.273.35.22490; Warren MW, 2007, ACTA NEUROPATHOL, V114, P277, DOI 10.1007/s00401-007-0259-9; Warren MW, 2005, LIFE SCI, V78, P301, DOI 10.1016/j.lfs.2005.04.058; Wei J, 2012, J TRAUMA ACUTE CARE, V73, P654, DOI 10.1097/TA.0b013e31825133c0; YAMAMOTO BK, 1990, BRAIN RES, V506, P236, DOI 10.1016/0006-8993(90)91256-G; Ye L, 2013, J NEUROCHEM, V125, P897, DOI 10.1111/jnc.12263	73	7	7	0	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-3042	1471-4159		J NEUROCHEM	J. Neurochem.	DEC	2019	151	6					749	763		10.1111/jnc.14861		OCT 2019	15	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	OA2FZ	WOS:000489968500001	31478210	Green Published, Green Accepted, Bronze			2022-02-06	
J	Titus, DJ; Johnstone, T; Johnson, NH; London, SH; Chapalamadugu, M; Hogenkamp, D; Gee, KW; Atkins, CM				Titus, David J.; Johnstone, Timothy; Johnson, Nathan H.; London, Sidney H.; Chapalamadugu, Meghana; Hogenkamp, Derk; Gee, Kelvin W.; Atkins, Coleen M.			Positive allosteric modulation of the alpha 7 nicotinic acetylcholine receptor as a treatment for cognitive deficits after traumatic brain injury	PLOS ONE			English	Article							LONG-TERM POTENTIATION; SUBUNIT MESSENGER-RNAS; NERVE GROWTH-FACTOR; CHOLINERGIC DYSFUNCTION; RAT MODEL; IN-VIVO; CHOLINESTERASE INHIBITOR; MICROGLIAL ACTIVATION; DEPENDENT ALTERATIONS; TARGET LOCALIZATION	Cognitive impairments are a common consequence of traumatic brain injury (TBI). The hippocampus is a subcortical structure that plays a key role in the formation of declarative memories and is highly vulnerable to TBI. The alpha 7 nicotinic acetylcholine receptor (nAChR) is highly expressed in the hippocampus and reduced expression and function of this receptor are linked with cognitive impairments in Alzheimer's disease and schizophrenia. Positive allosteric modulation of alpha 7 nAChRs with AVL-3288 enhances receptor currents and improves cognitive functioning in nave animals and healthy human subjects. Therefore, we hypothesized that targeting the alpha 7 nAChR with the positive allosteric modulator AVL-3288 would enhance cognitive functioning in the chronic recovery period of TBI. To test this hypothesis, adult male Sprague Dawley rats received moderate parasagittal fluid-percussion brain injury or sham surgery. At 3 months after recovery, animals were treated with vehicle or AVL-3288 at 30 min prior to cue and contextual fear conditioning and the water maze task. Treatment of TBI animals with AVL-3288 rescued learning and memory deficits in water maze retention and working memory. AVL-3288 treatment also improved cue and contextual fear memory when tested at 24 hr and 1 month after training, when TBI animals were treated acutely just during fear conditioning at 3 months post-TBI. Hippocampal atrophy but not cortical atrophy was reduced with AVL-3288 treatment in the chronic recovery phase of TBI. AVL-3288 application to acute hippocampal slices from animals at 3 months after TBI rescued basal synaptic transmission deficits and long-term potentiation (LTP) in area CA1. Our results demonstrate that AVL-3288 improves hippocampal synaptic plasticity, and learning and memory performance after TBI in the chronic recovery period. Enhancing cholinergic transmission through positive allosteric modulation of the alpha 7 nAChR may be a novel therapeutic to improve cognition after TBI.	[Titus, David J.; Johnson, Nathan H.; London, Sidney H.; Chapalamadugu, Meghana; Atkins, Coleen M.] Univ Miami, Miller Sch Med, Dept Neurol Surg, Miami Project Cure Paralysis, Miami, FL 33136 USA; [Johnstone, Timothy; Hogenkamp, Derk; Gee, Kelvin W.] Univ Calif Irvine, Sch Med, Dept Pharmacol, Irvine, CA 92717 USA		Atkins, CM (corresponding author), Univ Miami, Miller Sch Med, Dept Neurol Surg, Miami Project Cure Paralysis, Miami, FL 33136 USA.	catkins@miami.edu		Johnson, Nathan/0000-0002-4857-2273	NIH/NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS069721]; Miami Project to Cure Paralysis; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS069721] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [S10OD023579] Funding Source: NIH RePORTER	This work was supported by a grant awarded to C.M.A. by the NIH/NINDS NS069721 and the Miami Project to Cure Paralysis.	Almeida-Suhett CP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102627; Arciniegas DB, 2011, J HEAD TRAUMA REHAB, V26, P319, DOI 10.1097/HTR.0b013e31821ebfb3; Arciniegas DB, 2011, J HEAD TRAUMA REHAB, V26, P98, DOI 10.1097/HTR.0b013e31820516cb; Atkins CM, 2009, NEUROSCI LETT, V459, P52, DOI 10.1016/j.neulet.2009.04.064; Baki SGA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012490; Ballesteros J, 2008, J HEAD TRAUMA REHAB, V23, P171, DOI 10.1097/01.HTR.0000319935.99837.96; Barnes CA, 2000, NEUROSCIENCE, V99, P17, DOI 10.1016/S0306-4522(00)00180-9; Bigler ED, 2002, AM J NEURORADIOL, V23, P255; Bitner RS, 2007, J NEUROSCI, V27, P10578, DOI 10.1523/JNEUROSCI.2444-07.2007; Bramlett HM, 2002, ACTA NEUROPATHOL, V103, P607, DOI 10.1007/s00401-001-0510-8; Breese CR, 1997, J COMP NEUROL, V387, P385, DOI 10.1002/(SICI)1096-9861(19971027)387:3<385::AID-CNE5>3.0.CO;2-X; Christensen DZ, 2010, J NEUROCHEM, V114, P1205, DOI 10.1111/j.1471-4159.2010.06845.x; Dash PK, 2016, J NEUROSCI, V36, P2809, DOI 10.1523/JNEUROSCI.3197-15.2016; de la Tremblaye PB, 2017, J NEUROTRAUM, V34, P1610, DOI 10.1089/neu.2016.4790; DIXON CE, 1994, NEUROSCI LETT, V180, P127, DOI 10.1016/0304-3940(94)90503-7; Dixon CE, 1997, EXP NEUROL, V146, P479, DOI 10.1006/exnr.1997.6557; Dixon CE, 1997, J NEUROTRAUM, V14, P161, DOI 10.1089/neu.1997.14.161; Donat CK, 2008, BRAIN RES, V1246, P167, DOI 10.1016/j.brainres.2008.09.059; Drever BD, 2011, BEHAV BRAIN RES, V221, P505, DOI 10.1016/j.bbr.2010.11.037; Fabian-Fine R, 2001, J NEUROSCI, V21; Frieden T.R., 2015, REPORT C TRAUMATIC B; Fujiki M, 2008, J CLIN NEUROSCI, V15, P791, DOI 10.1016/j.jocn.2007.07.002; Gatson JW, 2015, BRAIN RES BULL, V112, P35, DOI 10.1016/j.brainresbull.2015.01.008; Gee KW, 2017, J PSYCHOPHARMACOL, V31, P434, DOI 10.1177/0269881117691590; Giniatullin R, 2005, TRENDS NEUROSCI, V28, P371, DOI 10.1016/j.tins.2005.04.009; Guseva MV, 2006, PHARMACOL BIOCHEM BE, V84, P26, DOI 10.1016/j.pbb.2006.04.002; Guseva MV, 2008, J NEUROTRAUM, V25, P975, DOI 10.1089/neu.2008.0516; Haber M, 2013, EXP NEUROL, V249, P169, DOI 10.1016/j.expneurol.2013.09.002; Han ZY, 2000, EUR J NEUROSCI, V12, P3664, DOI 10.1046/j.1460-9568.2000.00262.x; Hernandez CM, 2006, J PHARMACOL EXP THER, V316, P679, DOI 10.1124/jpet.105.093047; Hoffmeister PG, 2011, NEUROMOL MED, V13, P44, DOI 10.1007/s12017-010-8136-4; Hogenkamp DJ, 2013, J MED CHEM, V56, P8352, DOI 10.1021/jm400704g; Hurst RS, 2005, J NEUROSCI, V25, P4396, DOI 10.1523/JNEUROSCI.5269-04.2005; Ji D, 2001, NEURON, V31, P131, DOI 10.1016/S0896-6273(01)00332-4; Johnstone TB, 2011, J PHARMACOL EXP THER, V336, P908, DOI 10.1124/jpet.110.176255; Kelso ML, 2012, CURR DRUG TARGETS, V13, P631, DOI 10.2174/138945012800398964; Kelso ML, 2006, BRAIN RES, V1083, P204, DOI 10.1016/j.brainres.2006.01.127; Kim SY, 2014, DEMENT GERIATR COGN, V37, P232, DOI 10.1159/000355373; Klann E, 1998, J BIOL CHEM, V273, P4516, DOI 10.1074/jbc.273.8.4516; Koola MM, 2019, ASIAN J PSYCHIATR, V42, P115, DOI 10.1016/j.ajp.2017.11.008; Koola MM, 2019, ASIAN J PSYCHIATR, V40, P100, DOI 10.1016/j.ajp.2019.02.007; Koola MM, 2018, PRIM CARE COMPANION, V20, DOI [10.1002/hipo.20902, DOI 10.1002/HIPO.20902]; Lagostena L, 2008, NEUROPHARMACOLOGY, V54, P676, DOI 10.1016/j.neuropharm.2007.11.016; Lewis AS, 2017, PROG NEURO-PSYCHOPH, V75, P45, DOI 10.1016/j.pnpbp.2017.01.001; Lombardo S, 2015, NEUROPHARMACOLOGY, V96, P255, DOI 10.1016/j.neuropharm.2014.11.018; Ma LY, 2014, NEUROSCI LETT, V570, P97, DOI 10.1016/j.neulet.2014.04.018; Maier DL, 2011, NEUROPHARMACOLOGY, V61, P161, DOI 10.1016/j.neuropharm.2011.03.024; Massey KA, 2006, MOL CELL NEUROSCI, V33, P381, DOI 10.1016/j.mcn.2006.08.011; Matsuzono K, 2015, J ALZHEIMERS DIS, V45, P771, DOI 10.3233/JAD-143084; McAllister TW, 2016, NEUROPSYCHOPHARMACOL, V41, P1191, DOI 10.1038/npp.2015.282; McQuiston A Rory, 2014, Front Synaptic Neurosci, V6, P20, DOI 10.3389/fnsyn.2014.00020; Mihalak KB, 2006, MOL PHARMACOL, V70, P801, DOI 10.1124/mol.106.025130; Munro G, 2012, BRIT J PHARMACOL, V167, P421, DOI 10.1111/j.1476-5381.2012.02003.x; Nakauchi S, 2012, EUR J NEUROSCI, V35, P1381, DOI 10.1111/j.1460-9568.2012.08056.x; Navakkode S, 2012, HIPPOCAMPUS, V22, P335, DOI 10.1002/hipo.20902; Ng HJ, 2007, P NATL ACAD SCI USA, V104, P8059, DOI 10.1073/pnas.0701321104; Nirogi R, 2012, J PHARMACOL TOX MET, V66, P22, DOI 10.1016/j.vascn.2012.05.003; Njoku I, 2019, EXP NEUROL, V315, P32, DOI 10.1016/j.expneurol.2019.01.019; Noble JM, 2007, NEUROLOGY, V68, P1749, DOI 10.1212/01.wnl.0000266745.86958.ce; Norris CM, 2009, J NEUROTRAUM, V26, P2269, DOI 10.1089/neu.2009.1029; OrrUrtreger A, 1997, J NEUROSCI, V17, P9165; Ostberg A, 2011, NEUROLOGY, V76, P1046, DOI 10.1212/WNL.0b013e318211c1c4; Palmer CP, 2016, EXP NEUROL, V277, P215, DOI 10.1016/j.expneurol.2016.01.004; Pavlov VA, 2009, BRAIN BEHAV IMMUN, V23, P41, DOI 10.1016/j.bbi.2008.06.011; Pike BR, 1997, J NEUROTRAUM, V14, P897, DOI 10.1089/neu.1997.14.897; Radcliffe KA, 1998, J NEUROSCI, V18, P7075; Ramlackhansingh AF, 2011, ANN NEUROL, V70, P374, DOI 10.1002/ana.22455; Reid RT, 2003, J ALZHEIMERS DIS, V5, P429, DOI 10.3233/JAD-2003-5602; ROBINSON SE, 1989, BRAIN RES, V503, P32, DOI 10.1016/0006-8993(89)91699-5; Rutten K, 2008, EUR J NEUROSCI, V28, P625, DOI 10.1111/j.1460-9568.2008.06349.x; Salmond CH, 2005, BRAIN, V128, P189, DOI 10.1093/brain/awh352; SCHMIDT RH, 1995, J NEUROSURG, V83, P496, DOI 10.3171/jns.1995.83.3.0496; Schneider LS, 2014, J INTERN MED, V275, P251, DOI 10.1111/joim.12191; Scremin OU, 2012, J NEUROTRAUM, V29, P2457, DOI 10.1089/neu.2012.2465; SEGUELA P, 1993, J NEUROSCI, V13, P596; Shao ZQ, 2015, INT J CLIN EXP MED, V8, P2944; Shaw KE, 2013, J NEUROTRAUM, V30, P557, DOI 10.1089/neu.2012.2782; Shin SS, 2015, J NEUROTRAUM, V32, P1429, DOI 10.1089/neu.2014.3445; Shytle RD, 2004, J NEUROCHEM, V89, P337, DOI 10.1046/j.1471-4159.2004.02347.x; Sigurdardottir S, 2009, BRAIN INJURY, V23, P489, DOI 10.1080/02699050902926309; Smith RC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0143490; Targowska-Duda KM, 2016, BEHAV BRAIN RES, V302, P142, DOI 10.1016/j.bbr.2016.01.002; Tate DF, 2000, LEARN MEMORY, V7, P442, DOI 10.1101/lm.33000; Tenovuo O, 2005, PROG NEURO-PSYCHOPH, V29, P61, DOI 10.1016/j.pnpbp.2004.10.006; Tenovuo O, 2009, BRAIN INJURY, V23, P548, DOI 10.1080/02699050902926275; Thomsen MS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027014; Timmermann DB, 2007, J PHARMACOL EXP THER, V323, P294, DOI 10.1124/jpet.107.120436; Titus DJ, 2013, NEUROSCIENCE, V231, P182, DOI 10.1016/j.neuroscience.2012.12.002; Titus DJ, 2018, NEUROBIOL LEARN MEM, V148, P38, DOI 10.1016/j.nlm.2017.12.008; Titus DJ, 2016, J NEUROSCI, V36, P7095, DOI 10.1523/JNEUROSCI.3212-15.2016; Titus DJ, 2013, J NEUROSCI, V33, P5216, DOI 10.1523/JNEUROSCI.5133-12.2013; Tsoi KKF, 2016, J AM MED DIR ASSOC, V17, P1063, DOI 10.1016/j.jamda.2016.08.010; Valiyaveettil M, 2012, NEUROSCI LETT, V506, P141, DOI 10.1016/j.neulet.2011.10.067; Verbois SL, 2002, J NEUROTRAUM, V19, P1569, DOI 10.1089/089771502762300238; Verbois SL, 2003, NEUROSCIENCE, V119, P1199, DOI 10.1016/S0306-4522(03)00206-9; Verbois SL, 2003, NEUROPHARMACOLOGY, V44, P224, DOI 10.1016/S0028-3908(02)00366-0; WADA E, 1989, J COMP NEUROL, V284, P314, DOI 10.1002/cne.902840212; Walker W, 2004, BRAIN INJURY, V18, P739, DOI 10.1080/02699050310001646224; Werkheiser JL, 2011, NEUROSCIENCE, V186, P76, DOI 10.1016/j.neuroscience.2011.04.033; Wheaton P, 2011, J CLIN PSYCHOPHARM, V31, P745, DOI 10.1097/JCP.0b013e318235f4ac; Yu TS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118793; Zaloshnja E, 2008, J HEAD TRAUMA REHAB, V23, P394, DOI 10.1097/01.HTR.0000341435.52004.ac; Zhang L, 2004, ARCH PHYS MED REHAB, V85, P1050, DOI 10.1016/j.apmr.2003.10.014; Zhang L, 2013, J NEUROSCI RES, V91, P1581, DOI 10.1002/jnr.23263; Zhao J, 2018, J NEUROTRAUM, V35, P362, DOI 10.1089/neu.2017.5102	105	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2019	14	10							e0223180	10.1371/journal.pone.0223180			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LM6ZN	WOS:000532398600039	31581202	gold, Green Published			2022-02-06	
J	Brooks, BL; Sherman, EMS				Brooks, Brian L.; Sherman, Elisabeth M. S.			Using the Memory Validity Profile (MVP) to detect invalid performance in youth with mild traumatic brain injury	APPLIED NEUROPSYCHOLOGY-CHILD			English	Article						Adolescents; children; effort; malingering; memory	DIGIT SPAN; CHILDREN; INDICATORS; UTILITY; TOMM; BIAS	Performance validity tests (PVT) should be used when assessing youth with mild traumatic brain injury (MTBI). The goal of this study was to derive a new cutscore for determining invalid performance on the Memory Validity Profile (MVP) in youth with MTBI. Children and adolescents (N?=?92; mean age =14.8?years, SD?=?2.3, range =8?18) on average six months (SD?=?3.6) post-MTBI were administered the MVP as part of their assessment. Two validated PVTs [Test of Memory Malingering (TOMM) and Medical Symptom Validity Test (MSVT)] were administered and used to group the sample into valid (n?=?73, neither TOMM/MSVT failed) and invalid (n?=?19, both TOMM/MSVT failed). New cutscores for the MVP to determine invalid performance in this sample were established using failure on both TOMM/MSVT as the criterion. MVP performance correlated significantly with failure on TOMM/MSVT. Youth with invalid performance had significantly lower MVP total scores and area under the curve was .80, suggesting good separation of groups. A cutscore of 31 or less on the MVP provided sensitivity of 63% for detecting invalid performance with 93% specificity. This study yields a promising new cutscore for the MVP that has good sensitivity and strong specificity for detecting invalid performance in youth with MTBI.	[Brooks, Brian L.] Univ Calgary, Neuropsychol Serv, Alberta Childrens Hosp, Res Inst,Dept Paediat, Calgary, AB, Canada; [Brooks, Brian L.] Univ Calgary, Dept Clin Neurosci, Alberta Childrens Hosp, Res Inst, Calgary, AB, Canada; [Brooks, Brian L.] Univ Calgary, Dept Psychol, Alberta Childrens Hosp, Res Inst, Calgary, AB, Canada; [Sherman, Elisabeth M. S.] Copeman Healthcare Ctr, Calgary, AB, Canada		Brooks, BL (corresponding author), Alberta Childrens Prov Gen Hosp, Neurosci Program, 2888 Shaganappi Trail NW, Calgary, AB T3B 6A8, Canada.	brian.brooks@ahs.ca			Kinsmen Chair of Pediatric Neurosciences; ACHRI Neurotrauma Fund; ACH Neurosciences Program; Canadian Institutes of Health Research (CIHR) Embedded Clinician Researcher Salary AwardCanadian Institutes of Health Research (CIHR)	The BrainChild database was supported by funding from the Kinsmen Chair of Pediatric Neurosciences, the ACHRI Neurotrauma Fund, and the ACH Neurosciences Program (Conny Betuzzi). Brian Brooks acknowledges salary funding from the Canadian Institutes of Health Research (CIHR) Embedded Clinician Researcher Salary Award.	Baker DA, 2014, CLIN NEUROPSYCHOL, V28, P116, DOI 10.1080/13854046.2013.858184; Boone KB, 2009, CLIN NEUROPSYCHOL, V23, P729, DOI 10.1080/13854040802427803; Brooks B. L, 2016, VALIDITY TESTING CHI; Brooks BL, 2015, ARCH CLIN NEUROPSYCH, V30, P200, DOI 10.1093/arclin/acv017; Brooks BL, 2012, ARCH CLIN NEUROPSYCH, V27, P23, DOI 10.1093/arclin/acr086; Bush SS, 2005, ARCH CLIN NEUROPSYCH, V20, P419, DOI 10.1016/j.acn.2005.02.002; Centers for Disease Control and Prevention, 2003, REP C MILD TRAUM BRA; Green P, 2004, MANUAL GREENS MEDICA; Heilbronner RL, 2009, CLIN NEUROPSYCHOL, V23, P1093, DOI 10.1080/13854040903155063; IBM Corp, 2016, IBM SPSS STAT WIND V; Kirk JW, 2011, CHILD NEUROPSYCHOL, V17, P242, DOI 10.1080/09297049.2010.533166; Kirkwood M. W, 2016, VALIDITY TESTING CHI; Kirkwood M. W, 2012, PEDIAT FORENSIC NEUR, P136; Kirkwood MW, 2014, PEDIATRICS, V133, P643, DOI 10.1542/peds.2013-3195; Kirkwood MW, 2014, CHILD NEUROPSYCHOL, V20, P245, DOI 10.1080/09297049.2012.759553; Kirkwood MW, 2011, ARCH CLIN NEUROPSYCH, V26, P377, DOI 10.1093/arclin/acr040; Kirkwood MW, 2010, CLIN NEUROPSYCHOL, V24, P860, DOI 10.1080/13854040903527287; Larrabee GJ, 2003, CLIN NEUROPSYCHOL, V17, P410, DOI 10.1076/clin.17.3.410.18089; Larrabee GJ, 2008, CLIN NEUROPSYCHOL, V22, P666, DOI 10.1080/13854040701494987; Loughan AR, 2012, ARCH CLIN NEUROPSYCH, V27, P716, DOI 10.1093/arclin/acs072; MacAllister W. S., 2016, VALIDITY TESTING CHI; Perna R, 2014, APPL NEUROPSYCH-CHIL, V3, P45, DOI 10.1080/21622965.2012.691067; Perna RB, 2013, CHILD NEUROPSYCHOL, V19, P438, DOI 10.1080/09297049.2012.731500; Shay N, 2017, ARCH CLIN NEUROPSYCH, V32, P664, DOI 10.1093/arclin/acx075.19; Sherman E.M.S., 2015, CHILD ADOLESCENT MEM; Sherman EMS, 2015, MEMORY VALIDITY PROF; Slick D. J., 2012, PEDIAT FORENSIC NEUR, P113; Sussman ZW, 2019, APPL NEUROPSYCH-CHIL, V8, P70, DOI 10.1080/21622965.2017.1382359; Tombaugh T.N., 1996, TEST MEMORY MALINGER; Victor T, 2009, CLIN NEUROPSYCHOL, V23, P297, DOI 10.1080/13854040802232682; Welsh AJ, 2012, ARCH CLIN NEUROPSYCH, V27, P735, DOI 10.1093/arclin/acs063	31	7	7	0	1	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	2162-2965	2162-2973		APPL NEUROPSYCH-CHIL	Appl. Neuropsychol.-Child	OCT 2	2019	8	4					319	325		10.1080/21622965.2018.1476865			7	Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	JB9EN	WOS:000488884300003	29963927				2022-02-06	
J	O'Connor, S; Geaney, D; Beidler, E				O'Connor, Siobhan; Geaney, Deirdre; Beidler, Erica			Non-disclosure in Irish collegiate student-athletes: do concussion history, knowledge, pressure to play and gender impact concussion reporting?	PHYSICIAN AND SPORTSMEDICINE			English	Article						College athletes; sports related concussion; reporting; mild traumatic brain injury	SPORTS-RELATED CONCUSSION; HIGH-SCHOOL; FOOTBALL PLAYERS; ICE HOCKEY; INJURY; ATTITUDES; EPIDEMIOLOGY; BEHAVIORS	Objectives: Non-disclosure of concussions by collegiate student-athletes is documented internationally. This study aims to examine, for the first time, concussion non-disclosure frequency in Irish collegiate student-athletes and ascertain whether concussion history, knowledge, pressure to play and gender impacts this behavior. Methods: A cross-sectional study was implemented. A convenience sample of 268 Irish collegiate student-athletes from high-risk sports completed an anonymous survey developed from previous reliable, validated instruments. Results: One in four Irish collegiate student-athletes reported concussion non-disclosure. While a significant statistical model was generated to predict concussion non-disclosure (?(2)= 13.07 p = 0.004) with high specificity (99.5%), the sensitivity was non-existent (0.0%) and explained just 4.8?7.0% of the variance in non-disclosure. Just previous history of a concussion diagnosis contributed significantly to the model (OR = 2.6, 95% CI: 1.46?4.6). Gaps in concussion knowledge were evident and some participants previously felt pressure to return to play after sustaining a blow to the head by coaches (50.0%), teammates (45.5%) and fans (38.0%). Conclusion: Non-disclosure of concussions is common in this population. While gender, concussion knowledge and pressure to play do not seem to impact non-disclosure, a previous history of concussion increases the odds of concussion non-disclosure by 2.6 times. Thus, creating a positive concussion reporting culture in high-risk Irish collegiate sports is critical, particularly for those with a previous medically diagnosed concussion. Multifaceted strategies that incorporate the complexity of why athletes choose to not report a concussion targeted to the specific issues identified in this population and to all key stakeholders involved in collegiate sport are needed.	[O'Connor, Siobhan; Geaney, Deirdre] Dublin City Univ, Sch Hlth & Human Performance, H270A, Dublin 9, Ireland; [Beidler, Erica] Duquesne Univ, Dept Athlet Training, Pittsburgh, PA 15219 USA		O'Connor, S (corresponding author), Dublin City Univ, Sch Hlth & Human Performance, H270A, Dublin 9, Ireland.	siobhan.oconnor@dcu.ie	O'Connor, Siobhan/Q-8568-2018	O'Connor, Siobhan/0000-0002-2001-0746			Asken BM, 2016, J ATHL TRAINING, V51, P329, DOI 10.4085/1062-6050-51.5.02; Baker JF, 2013, IRISH J MED SCI, V182, P121, DOI 10.1007/s11845-012-0846-1; Beidler E, 2018, J ATHL TRAINING, V53, P866, DOI 10.4085/1062-6050-266-17; Bloodgood B, 2013, J ADOLESCENT HEALTH, V53, P34, DOI 10.1016/j.jadohealth.2013.01.022; Chinn NR., 2016, BMJ OPEN SPORT EXERC, V2; Chrisman SP, 2013, J ADOLESCENT HEALTH, V52, P330, DOI 10.1016/j.jadohealth.2012.10.271; Cohen J., 2013, STAT POWER ANAL BEHA; Fedor A, 2015, APPL NEUROPSYCH-ADUL, V22, P108, DOI 10.1080/23279095.2013.860604; Grady MF, 2010, CURR PROB PEDIATR AD, V40, P154, DOI 10.1016/j.cppeds.2010.06.002; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Kaut KP, 2003, CLIN J SPORT MED, V13, P213, DOI 10.1097/00042752-200307000-00004; Kerr ZY, 2016, AM J SPORT MED, V44, P220, DOI 10.1177/0363546515612082; Kroshus E, 2016, HEALTH EDUC BEHAV, V43, P442, DOI 10.1177/1090198115602676; Kroshus E, 2015, J ATHL TRAINING, V50, P944, DOI 10.4085/1062-6050-50.6.03; Kroshus E, 2015, SOC SCI MED, V134, P66, DOI 10.1016/j.socscimed.2015.04.011; Kroshus E, 2015, ANN BEHAV MED, V49, P95, DOI 10.1007/s12160-014-9636-5; Kroshus E, 2014, J ADOLESCENT HEALTH, V54, P269, DOI 10.1016/j.jadohealth.2013.11.011; Kroshus E, 2014, BRIT J SPORT MED, V48, P135, DOI 10.1136/bjsports-2013-092498; Kurowski B, 2014, J TRAUMA ACUTE CARE, V77, pS12, DOI 10.1097/TA.0000000000000316; Leahy R, 2019, PHYS THER SPORT; Littleton A, 2013, J SPORT HEALTH SCI, V2, P227, DOI 10.1016/j.jshs.2013.04.003; Llewellyn T, 2014, CLIN J SPORT MED, V24, P76, DOI 10.1097/01.jsm.0000432853.77520.3d; Manoj PDS, 2015, IEEE T COMPUT, V64, P3022, DOI 10.1109/TC.2015.2389827; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrea M, 2013, J INT NEUROPSYCH SOC, V19, P22, DOI 10.1017/S1355617712000872; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Nordstrom A, 2014, BRIT J SPORT MED, V48, P1447, DOI 10.1136/bjsports-2013-093406; O?Connor S, 2018, IR MED J, V111; O'Connell E, 2016, IRISH J MED SCI, V185, P521, DOI 10.1007/s11845-015-1313-6; O'Connor S, 2018, J ATHL TRAINING, V53, P950, DOI 10.4085/1062-6050-339-17; O' Connor S, 2016, J SCI MED SPORT, V19, P384, DOI 10.1016/j.jsams.2015.06.002; O'Connor S, 2018, CURR TOPICS LIBRARY, P1, DOI 10.1515/9783110535372-001; Register-Mihalik JK, 2013, J ATHL TRAINING, V48, P645, DOI 10.4085/1062-6050-48.3.20; Sullivan L, 2018, HEALTH EDUC RES, V33, P492, DOI 10.1093/her/cyy034; Sullivan L, 2017, INT J ADOLESC MED HL, V29; Torres Daniel M, 2013, Neurol Clin Pract, V3, P279; Wallace J, 2019, HEALTH EDUC J, V78, P315, DOI 10.1177/0017896918806935; Wallace J, 2017, J ATHL TRAINING, V52, P228, DOI 10.4085/1062-6050-52.1.07; Wasserman EB, 2016, AM J PUBLIC HEALTH, V106, P1247, DOI 10.2105/AJPH.2016.303154; Zuckerman SL, 2015, AM J SPORT MED, V43, P2654, DOI 10.1177/0363546515599634	40	7	7	0	2	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0091-3847	2326-3660		PHYSICIAN SPORTSMED	Physician Sportsmed.	APR 2	2020	48	2					186	193		10.1080/00913847.2019.1671141		OCT 2019	8	Primary Health Care; Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Orthopedics; Sport Sciences	LM9OZ	WOS:000488386800001	31538833				2022-02-06	
J	Day, GS; Cruchaga, C; Wingo, T; Schindler, SE; Coble, D; Morris, JC				Day, Gregory S.; Cruchaga, Carlos; Wingo, Thomas; Schindler, Suzanne E.; Coble, Dean; Morris, John C.			Association of Acquired and Heritable Factors With Intergenerational Differences in Age at Symptomatic Onset of Alzheimer Disease Between Offspring and Parents With Dementia	JAMA NETWORK OPEN			English	Article							LOW BLOOD-PRESSURE; FAMILY-HISTORY; NATIONAL INSTITUTE; RISK; EDUCATION; DIAGNOSIS; HYPERTENSION; ARCHITECTURE; VARIABILITY; GENOTYPE	IMPORTANCE Acquired and heritable traits are associated with dementia risk; however, how these traits are associated with age at symptomatic onset (AAO) of Alzheimer disease (AD) is unknown. Identifying the associations of acquired and heritable factors with variability in intergenerational AAO of AD could facilitate diagnosis, assessment, and counseling of the offspring of parents with AD. OBJECTIVE To quantify the associations of acquired and heritable factors with intergenerational differences in AAO of AD. DESIGN, SETTING, AND PARTICIPANTS This nested cohort study used data from the Knight Alzheimer Disease Research Center that included community-dwelling participants with symptomatic AD, parental history of dementia, and available DNA data who were enrolled in prospective studies of memory and aging from September 1, 2005, to August 31, 2016. Clinical, biomarker, and genetic data were extracted on January 17, 2017, and data analyses were conducted from July 1, 2017, to August 20, 2019. MAIN OUTCOMES AND MEASURES The associations of acquired (ie, years of education; body mass index; history of cardiovascular disease, hypertension, hypercholesterolemia, diabetes, active depression within 2 years, traumatic brain injury, tobacco use, and unhealthy alcohol use; and retrospective determination of AAO) and heritable factors (ie, ethnicity/race, paternal or maternal inheritance, parental history of early-onset dementia, APOE epsilon 4 allele status, and AD polygenic risk scores) to intergenerational difference in AAO of AD were quantified using stepwise forward multivariable regression. Missense or frameshift variants within genes associated with AD pathogenesis were screened using whole-exome sequencing. RESULTS There were 164 participants with symptomatic AD, known parental history of dementia, and available DNA data (mean [SD] age, 70.9 [8.3] years; 90 [54.9%] women) included in this study. Offspringwere diagnosed with symptomatic AD a mean (SD) 6.1 (10.7) years earlier than their parents (P < .001). The adjusted R-2 for measured acquired and heritable factors for intergenerational difference in AAO of AD was 0.29 (F-8,F-155 = 9.13; P < .001). Paternal (beta = -9.52 [95% CI, -13.79 to -5.25]) and maternal (beta = -6.68 [95% CI, -11.61 to -1.75]) history of dementia, more years of education (beta = -0.58 [95% CI -1.08 to -0.09]), and retrospective determination of AAO (beta = -3.46 [95% CI, -6.40 to -0.52]) were associated with earlier-than-expected intergenerational difference in AAO of AD. Parental history of early-onset dementia (beta = 21.30 [95% CI, 15.01 to 27.59]), presence of 1 APOE epsilon 4 allele (beta = 5.00 [95% CI, 2.11 to 7.88]), and history of hypertension (beta = 3.81 [95% CI, 0.88 to 6.74]) were associated with later-than-expected intergenerational difference in AAO of AD. Missense or frameshift variants within genes associated with AD pathogenesis were more common in participants with the greatest unexplained variability in intergenerational AAO of AD (19 of 48 participants [39.6%] vs 26 of 116 participants [22.4%]; P = .03). CONCLUSIONS AND RELEVANCE Acquired and heritable factors were associated with a substantial proportion of variability in intergenerational AAO of AD. Variants in genes associated with AD pathogenesis may contribute to unexplained variability, justifying further study.	[Day, Gregory S.; Cruchaga, Carlos; Schindler, Suzanne E.; Coble, Dean; Morris, John C.] Washington Univ, Charles F & Joanne Knight Alzheimer Dis Res Ctr, Sch Med St Louis, 4488 Forest Pk Ave,Ste 160, St Louis, MO 63108 USA; [Day, Gregory S.; Schindler, Suzanne E.; Morris, John C.] Washington Univ, Dept Neurol, Sch Med St Louis, St Louis, MO 63108 USA; [Cruchaga, Carlos] Washington Univ, Dept Psychiat, Sch Med St Louis, St Louis, MO 63108 USA; [Wingo, Thomas] Emory Univ, Dept Neurol, Atlanta, GA 30322 USA; [Wingo, Thomas] Emory Univ, Dept Human Genet, Atlanta, GA 30322 USA; [Coble, Dean] Washington Univ, Dept Biostat, Sch Med St Louis, St Louis, MO 63108 USA		Day, GS (corresponding author), Washington Univ, Charles F & Joanne Knight Alzheimer Dis Res Ctr, Sch Med St Louis, 4488 Forest Pk Ave,Ste 160, St Louis, MO 63108 USA.	gday@wustl.edu	Cruchaga, Carlos/ABF-4065-2020; Day, Gregory/I-3439-2019	Cruchaga, Carlos/0000-0002-0276-2899; Day, Gregory/0000-0001-5133-5538; Morris, John/0000-0001-9820-5618; Coble, Dean/0000-0001-7551-3132; Schindler, Suzanne/0000-0002-1680-1465	Knight ADRC [P50 AG05681]; NIAUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA); NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [P01AG003991, P01AG026276]; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [K23AG053426] Funding Source: NIH RePORTER	Study funding was provided through a grant paid to Knight ADRC (P50 AG05681) from NIA with additional support from grants from NIH (P01AG003991 and P01AG026276).	Beach TG, 2012, J NEUROPATH EXP NEUR, V71, P266, DOI 10.1097/NEN.0b013e31824b211b; Brickell KL, 2006, ARCH NEUROL-CHICAGO, V63, P1307, DOI 10.1001/archneur.63.9.1307; Cruchaga C, 2018, ALZHEIMERS DEMENT, V14, P205, DOI 10.1016/j.jalz.2017.08.013; Cruts M, 2012, HUM MUTAT, V33, P1340, DOI 10.1002/humu.22117; Day GS, 2017, NEUROLOGY, V88, P1273, DOI 10.1212/WNL.0000000000003770; Del Ser T, 1999, BRAIN, V122, P2309, DOI 10.1093/brain/122.12.2309; Del-Aguila JL, 2018, J ALZHEIMERS DIS, V62, P745, DOI 10.3233/JAD-170834; Del-Aguila JL, 2015, CURR OPIN GENET DEV, V33, P49, DOI 10.1016/j.gde.2015.07.008; Farrer LA, 1997, JAMA-J AM MED ASSOC, V278, P1349, DOI 10.1001/jama.278.16.1349; Gomez-Tortosa E, 2007, ARCH NEUROL-CHICAGO, V64, P1743, DOI 10.1001/archneur.64.12.1743; Green RC, 2002, JAMA-J AM MED ASSOC, V287, P329, DOI 10.1001/jama.287.3.329; Honea RA, 2012, J ALZHEIMERS DIS, V31, P659, DOI 10.3233/JAD-2012-120676; Hsu S, 2018, ALZHEIMERS RES THER, V10, DOI 10.1186/s13195-018-0392-9; HUTTON JT, 1993, NEUROLOGY, V43, P613, DOI 10.1212/WNL.43.3_Part_1.613; Ibanez L, 2017, BMC NEUROL, V17, DOI 10.1186/s12883-017-0978-z; Jack CR, 2018, ALZHEIMERS DEMENT, V14, P535, DOI 10.1016/j.jalz.2018.02.018; Jayadev S, 2008, ARCH NEUROL-CHICAGO, V65, P373, DOI 10.1001/archneurol.2007.61; Khachaturian AS, 2004, ARCH GEN PSYCHIAT, V61, P518, DOI 10.1001/archpsyc.61.5.518; Lee MH, 2018, NATURE, V563, P639, DOI 10.1038/s41586-018-0718-6; Livingston G, 2017, LANCET, V390, P2673, DOI 10.1016/S0140-6736(17)31363-6; McDowell I, 2007, J CLIN EXP NEUROPSYC, V29, P127, DOI 10.1080/13803390600582420; McKhann GM, 2011, ALZHEIMERS DEMENT, V7, P263, DOI 10.1016/j.jalz.2011.03.005; McMurtray AM, 2006, INT J GERIATR PSYCH, V21, P597, DOI 10.1002/gps.1540; Meyer MR, 1998, NAT GENET, V19, P321, DOI 10.1038/1206; Mishra S, 2017, NEUROIMAGE, V161, P171, DOI 10.1016/j.neuroimage.2017.07.050; Morris JC, 2006, ALZ DIS ASSOC DIS, V20, P210, DOI 10.1097/01.wad.0000213865.09806.92; Mosconi L, 2010, P NATL ACAD SCI USA, V107, P5949, DOI 10.1073/pnas.0914141107; Ngandu T, 2015, LANCET, V385, P2255, DOI 10.1016/S0140-6736(15)60461-5; Nicolas G, 2018, ALZHEIMERS DEMENT, V14, P1632, DOI 10.1016/j.jalz.2018.06.3056; Paterson AD, 1996, AM J HUM GENET, V59, P264; Posner HB, 2002, NEUROLOGY, V58, P1175, DOI 10.1212/WNL.58.8.1175; Qiu CX, 2003, ARCH NEUROL-CHICAGO, V60, P223, DOI 10.1001/archneur.60.2.223; Ryman Davis C, 2014, Neurology, V83, P253, DOI 10.1212/WNL.0000000000000596; Scarabino D, 2016, AM J MED GENET B, V171, P250, DOI 10.1002/ajmg.b.32399; Schindler SE, 2018, ALZHEIMERS DEMENT, V14, P1460, DOI 10.1016/j.jalz.2018.01.013; Silverman JM, 2005, ARCH GEN PSYCHIAT, V62, P565, DOI 10.1001/archpsyc.62.5.565; STERN Y, 1994, JAMA-J AM MED ASSOC, V271, P1004, DOI 10.1001/jama.271.13.1004; Stern Y, 2012, LANCET NEUROL, V11, P1006, DOI 10.1016/S1474-4422(12)70191-6; van den Dungen P, 2014, INT PSYCHOGERIATR, V26, P1603, DOI 10.1017/S1041610214000969; Verghese J, 2003, NEUROLOGY, V61, P1667, DOI 10.1212/01.WNL.0000098934.18300.BE; Vlassenko AG, 2016, ANN NEUROL, V80, P379, DOI 10.1002/ana.24719; Weintraub S, 2018, ALZ DIS ASSOC DIS, V32, P10, DOI 10.1097/WAD.0000000000000223; Whelton PK, 2018, HYPERTENSION, V71, pE13, DOI [10.1161/HYP.0000000000000065, 10.1161/HYP.0000000000000066]; Xu W, 2016, MOL NEUROBIOL, V53, P3113, DOI 10.1007/s12035-015-9211-5; Yang YH, 2011, AM J ALZHEIMERS DIS, V26, P457, DOI 10.1177/1533317511421779	45	7	7	2	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	2574-3805			JAMA NETW OPEN	JAMA Netw. Open	OCT	2019	2	10							e1913491	10.1001/jamanetworkopen.2019.13491			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JP0XK	WOS:000497997100055	31617930	gold, Green Published			2022-02-06	
J	Demir, D; Bektasoglu, PK; Koyuncuoglu, T; Kandemir, C; Akakin, D; Yuksel, M; Celikoglu, E; Yegen, BC; Gurer, B				Demir, Dilan; Bektasoglu, Pinar Kuru; Koyuncuoglu, Turkan; Kandemir, Cansu; Akakin, Dilek; Yuksel, Meral; Celikoglu, Erhan; Yegen, Berrak C.; Gurer, Bora			Neuroprotective effects of mildronate in a rat model of traumatic brain injury	INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED			English	Article						Antiapoptotic effect; Diffuse brain injury; Mildronate; Neuroprotection	CEREBRAL-BLOOD-FLOW; ISCHEMIA-REPERFUSION INJURY; ACID OXIDATION INHIBITORS; SPINAL-CORD ISCHEMIA; GAMMA-BUTYROBETAINE; ISCHEMIA/REPERFUSION INJURY; CARNITINE BIOSYNTHESIS; SUPEROXIDE-DISMUTASE; PROTEIN EXPRESSION; DARBEPOETIN-ALPHA	Objective: Traumatic brain injury (TBI) is one of the most common preventable causes of mortality and morbidity. Inflammation, apoptosis, oxidative stress, and ischemia are some of the important pathophysiological mechanisms underlying neuronal loss after TBI. Mildronate is demonstrated to be beneficial in various experimental models of ischemic diseases via anti-inflammatory, antioxidant, and neuroprotective mechanisms. This study aimed to investigate possible antioxidant, anti-inflammatory, antiapoptotic, and neuroprotective effects of mildronate in a rat model of TBI. Methods: A total of 46 male rats were divided into three groups of control, saline-treated TBI, and mildronate-treated TBI. Both TBI groups were subjected to closed-head contusive weight-drop injuries followed by treatment with saline or mildronate (100 mg/kg) administered intraperitoneally. The forebrain was removed 24h after trauma induction, the activities of myeloperoxidase (MPO) and caspase-3, levels of superoxide dismutase (SOD), luminol- and lucigenin-enhanced chemiluminescence were measured, and histomorphological evaluation of cerebral tissues was performed. Results: Increased MPO and caspase-3 activities in the vehicle-treated TBI group (p < 0.001) were suppressed in the mildronate-treated TBI group (p < 0.001). Similarly, increase in luminol and lucigenin levels (p < 0.001 and p < 0.01, respectively) in the vehicle-treated TBI group were decreased in the mildronatetreated TBI group (p < 0.001). Concomitantly, in the vehicle-treated TBI group, TBI-induced decrease in SOD activity (p < 0.01) was reversed with mildronate treatment (p < 0.05). On histopathological examination, TBI-induced damage in the cerebral cortex was lesser in the mildronate-treated TBI group than that in other groups. Conclusion: This study revealed for the first time that mildronate, exhibits neuroprotective effects against TBI because of its anti-inflammatory, antiapoptotic, and antioxidant activities. (C) 2019 Elsevier Ltd. All rights reserved.	[Demir, Dilan] Univ Hlth Sci, Dept Neurosurg, Istanbul Dr Lutfi Kirdar Kartal Educ & Res Hosp, Istanbul, Turkey; [Bektasoglu, Pinar Kuru; Celikoglu, Erhan; Gurer, Bora] Univ Hlth Sci, Fatih Sultan Mehmet Educ & Res Hosp, Dept Neurosurg, Istanbul, Turkey; [Bektasoglu, Pinar Kuru; Koyuncuoglu, Turkan; Yegen, Berrak C.] Marmara Univ, Dept Physiol, Sch Med, Istanbul, Turkey; [Kandemir, Cansu; Akakin, Dilek] Marmara Univ, Dept Histol, Sch Med, Istanbul, Turkey; [Yuksel, Meral] Marmara Univ, Dept Med Lab, Vocat Sch Hlth Related Serv, Istanbul, Turkey		Bektasoglu, PK (corresponding author), Univ Hlth Sci, Fatih Sultan Mehmet Educ & Res Hosp, Dept Neurosurg, Turkish Minist Hlth, Istanbul, Turkey.	pnr.kuru@gmail.com	Bektasoglu, Pinar Kuru/K-8612-2013; Yegen, Berrak/ABA-3274-2020; Koyuncuoglu, Turkan/AAD-3962-2021; Koyuncuoglu, Turkan/AAD-3448-2022; Yegen, Berrak C./ABA-1986-2020; Yegen, Berrak/O-6652-2017; Gurer, Bora/K-1177-2012	Bektasoglu, Pinar Kuru/0000-0001-9889-9955; Koyuncuoglu, Turkan/0000-0003-4749-9470; Koyuncuoglu, Turkan/0000-0003-4749-9470; Yegen, Berrak C./0000-0003-0791-0165; Yegen, Berrak/0000-0003-0791-0165; Gurer, Bora/0000-0003-1500-6184	Turkish Neurosurgical Society	Preparation for publication of this article is partly supported by Turkish Neurosurgical Society. The authors would like to thank Enago (www.enago.com) fort he English language review.	Acosta SA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053376; Armin SS, 2008, ACTA NEUROCHIR SUPPL, V104, P421; BOUMA GJ, 1992, J NEUROSURG, V77, P360, DOI 10.3171/jns.1992.77.3.0360; BOUMA GJ, 1991, J NEUROSURG, V75, P685, DOI 10.3171/jns.1991.75.5.0685; BRADLEY PP, 1982, J INVEST DERMATOL, V78, P206, DOI 10.1111/1523-1747.ep12506462; Dambrova M, 2002, TRENDS CARDIOVAS MED, V12, P275, DOI 10.1016/S1050-1738(02)00175-5; Deshpande SS, 2001, CRIT REV FOOD SCI, V41, P155, DOI 10.1080/20014091091797; DZINTARE M, 2002, PHARM REV COMMUN, V12, P163; EVANS PH, 1993, BRIT MED BULL, V49, P577, DOI 10.1093/oxfordjournals.bmb.a072632; Gokce EC, 2015, INJURY, V46, P2146, DOI 10.1016/j.injury.2015.08.017; Gurer B, 2015, INJURY, V46, P240, DOI 10.1016/j.injury.2014.11.002; Hall ED, 2010, NEUROTHERAPEUTICS, V7, P51, DOI 10.1016/j.nurt.2009.10.021; Inoue Y, 2005, J NEUROTRAUM, V22, P1411, DOI 10.1089/neu.2005.22.1411; Isajevs S, 2011, MEDICINA-LITHUANIA, V47, P552; Keane RW, 2001, J NEUROPATH EXP NEUR, V60, P422, DOI 10.1093/jnen/60.5.422; Kertmen H, 2015, ARCH MED SCI, V11, P1119, DOI 10.5114/aoms.2015.54869; Kertmen H, 2013, EUR J PHARMACOL, V714, P148, DOI 10.1016/j.ejphar.2013.05.012; Klusa V, 2013, MEDICINA-LITHUANIA, V49, P301; Klusa V, 2013, PHARMACOL BIOCHEM BE, V106, P68, DOI 10.1016/j.pbb.2013.03.012; Klusa VZ, 2010, INT J MOL SCI, V11, P4465, DOI 10.3390/ijms11114465; KROL W, 1990, BIOCHEM INT, V21, P593; Liepinsh E, 2006, J CARDIOVASC PHARM, V48, P314, DOI 10.1097/01.fjc.0000250077.07702.23; Liepinsh E, 2011, J PHARM PHARMACOL, V63, P1195, DOI 10.1111/j.2042-7158.2011.01325.x; Liou AKF, 2003, PROG NEUROBIOL, V69, P103, DOI 10.1016/S0301-0082(03)00005-4; Lozano D, 2015, NEUROPSYCH DIS TREAT, V11, P97, DOI 10.2147/NDT.S65815; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Makrecka M, 2014, EUR J PHARMACOL, V723, P55, DOI 10.1016/j.ejphar.2013.12.006; Marik PE, 2002, CHEST, V122, P699, DOI 10.1378/chest.122.2.699; Marklund N, 2011, BRIT J PHARMACOL, V164, P1207, DOI 10.1111/j.1476-5381.2010.01163.x; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; MATSUOKA M, 1992, BRAIN RES, V590, P334, DOI 10.1016/0006-8993(92)91117-W; MYLROIE AA, 1986, TOXICOL APPL PHARM, V82, P512, DOI 10.1016/0041-008X(86)90286-3; Ostergaard L, 2014, J CEREBR BLOOD F MET, V34, P1585, DOI 10.1038/jcbfm.2014.131; Ozay R, 2017, WORLD NEUROSURG, V104, P634, DOI 10.1016/j.wneu.2017.04.136; Ozay R, 2017, WORLD NEUROSURG, V97, P407, DOI 10.1016/j.wneu.2016.09.115; Ozdemir D, 2005, PHYSIOL RES, V54, P631; Pop V, 2011, TRANSL STROKE RES, V2, P533, DOI 10.1007/s12975-011-0126-9; Pupure J, 2010, NEUROSCI LETT, V470, P100, DOI 10.1016/j.neulet.2009.12.055; Rodriguez C, 2004, J PINEAL RES, V36, P1, DOI 10.1046/j.1600-079X.2003.00092.x; Rumaks J, 2012, MED LITH, V48, P525; Rupp H, 2002, HERZ, V27, P621, DOI 10.1007/s00059-002-2428-x; Sakurai M, 2003, J THORAC CARDIOV SUR, V125, P370, DOI 10.1067/mtc.2003.112; Salehi A, 2017, J CEREBR BLOOD F MET, V37, P2320, DOI 10.1177/0271678X17701460; Sesti C, 2006, J CARDIOVASC PHARM, V47, P493; Shutenko Zh. V., 1995, Khimiko-Farmatsevticheskii Zhurnal, V29, P13; Siedler DG, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00429; SIMKHOVICH BZ, 1988, BIOCHEM PHARMACOL, V37, P195, DOI 10.1016/0006-2952(88)90717-4; Sjakste N, 2005, CNS DRUG REV, V11, P151; Sjakste N, 2004, EUR J PHARMACOL, V495, P67, DOI 10.1016/j.ejphar.2004.05.006; Sjakste N, 2004, BASIC CLIN PHARMACOL, V94, P46; Sorby-Adams AJ, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18081788; Soustiel JF, 2005, J NEUROTRAUM, V22, P955, DOI 10.1089/neu.2005.22.955; Stanley WC, 2002, EXPERT OPIN INV DRUG, V11, P615, DOI 10.1517/13543784.11.5.615; Svalbe B, 2011, BEHAV BRAIN RES, V222, P26, DOI 10.1016/j.bbr.2011.03.027; Taoka Y, 1997, NEUROSCIENCE, V79, P1177, DOI 10.1016/S0306-4522(97)00011-0; Tugtepe H, 2007, REGUL PEPTIDES, V140, P101, DOI 10.1016/j.regpep.2006.11.026; Ucar T, 2006, J TRAUMA, V60, P558, DOI 10.1097/01.ta.0000209172.75637.db; Ustun ME, 2001, J TRAUMA, V51, P22, DOI 10.1097/00005373-200107000-00004; Vaz FM, 2002, BIOCHEM J, V361, P417, DOI 10.1042/0264-6021:3610417; Vilskersts R, 2013, CLIN EXP PHARMACOL P, V40, P518, DOI 10.1111/1440-1681.12127; Vilskersts R, 2009, CARDIOVASC DRUG THER, V23, P281, DOI 10.1007/s10557-009-6179-2; VINICHUK SM, 1991, VRACHEBNOE DELO, V7, P77; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Yilmaz ER, 2013, ACTA NEUROCHIR, V155, P141, DOI 10.1007/s00701-012-1501-3; Yilmaz ER, 2012, ACTA NEUROCHIR, V154, P1037, DOI 10.1007/s00701-012-1298-0; Zauner A, 2002, NEUROSURGERY, V51, P289, DOI 10.1097/00006123-200208000-00003; Zhang XP, 2002, J NEUROCHEM, V82, P181, DOI 10.1046/j.1471-4159.2002.00975.x; Zhu Y, 2013, CLIN DRUG INVEST, V33, P755, DOI 10.1007/s40261-013-0121-x; Zvejniece L, 2010, BEHAV PHARMACOL, V21, P548, DOI 10.1097/FBP.0b013e32833d5a59; Zwienenberg M, 2001, NEUROL RES, V23, P167, DOI 10.1179/016164101101198505	70	7	7	0	2	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0020-1383	1879-0267		INJURY	Injury-Int. J. Care Inj.	OCT	2019	50	10					1586	1592		10.1016/j.injury.2019.08.036			7	Critical Care Medicine; Emergency Medicine; Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Emergency Medicine; Orthopedics; Surgery	JJ2FC	WOS:000493975800002	31481152				2022-02-06	
J	Halstead, MR; Geocadin, RG				Halstead, Michael R.; Geocadin, Romergryko G.			The Medical Management of Cerebral Edema: Past, Present, and Future Therapies	NEUROTHERAPEUTICS			English	Article						Cerebral edema; cytotoxic edema; vasogenic edema; hyperosmolar therapy; elevated ICP	TRAUMATIC BRAIN-INJURY; ENDOTHELIAL GROWTH-FACTOR; ARTERY OCCLUSION MODEL; INTRACRANIAL-PRESSURE; INTRACEREBRAL HEMORRHAGE; BARRIER DISRUPTION; HYPERTONIC SALINE; SUBSTANCE-P; PPAR-GAMMA; MOLECULAR PATHOPHYSIOLOGY	Cerebral edema is commonly associated with cerebral pathology, and the clinical manifestation is largely related to the underlying lesioned tissue. Brain edema usually amplifies the dysfunction of the lesioned tissue and the burden of cerebral edema correlates with increased morbidity and mortality across diseases. Our modern-day approach to the medical management of cerebral edema has largely revolved around, an increasingly artificial distinction between cytotoxic and vasogenic cerebral edema. These nontargeted interventions such as hyperosmolar agents and sedation have been the mainstay in clinical practice and offer noneloquent solutions to a dire problem. Our current understanding of the underlying molecular mechanisms driving cerebral edema is becoming much more advanced, with differences being identified across diseases and populations. As our understanding of the underlying molecular mechanisms in neuronal injury continues to expand, so too is the list of targeted therapies in the pipeline. Here we present a brief review of the molecular mechanisms driving cerebral edema and a current overview of our understanding of the molecular targets being investigated.	[Halstead, Michael R.; Geocadin, Romergryko G.] Johns Hopkins Univ, Dept Neurol, Neurosci Crit Care Div, Sch Med, Baltimore, MD 21287 USA; [Halstead, Michael R.; Geocadin, Romergryko G.] Johns Hopkins Univ, Dept Anesthesiol Crit Care Med, Neurosci Crit Care Div, Sch Med, Baltimore, MD 21287 USA; [Halstead, Michael R.; Geocadin, Romergryko G.] Johns Hopkins Univ, Dept Neurosurg, Neurosci Crit Care Div, Sch Med, Baltimore, MD 21287 USA		Halstead, MR (corresponding author), Johns Hopkins Univ, Dept Neurol, Neurosci Crit Care Div, Sch Med, Baltimore, MD 21287 USA.; Halstead, MR (corresponding author), Johns Hopkins Univ, Dept Anesthesiol Crit Care Med, Neurosci Crit Care Div, Sch Med, Baltimore, MD 21287 USA.; Halstead, MR (corresponding author), Johns Hopkins Univ, Dept Neurosurg, Neurosci Crit Care Div, Sch Med, Baltimore, MD 21287 USA.	mhalste3@jhmi.edu					Allen CJ, 2018, AM SURGEON, V84, P43; Alnemari AM, 2017, WORLD NEUROSURG, V106, P509, DOI 10.1016/j.wneu.2017.07.009; Andrews PJD, 2015, NEW ENGL J MED, V373, P2403, DOI 10.1056/NEJMoa1507581; ANSARI S, 2018, NEUROLOGY S15, V90; Aoki K, 2003, ACTA NEUROPATHOL, V106, P121, DOI 10.1007/s00401-003-0709-y; Aronowski J, 2011, STROKE, V42, P1781, DOI 10.1161/STROKEAHA.110.596718; Askenase MH, 2016, SEMIN NEUROL, V36, P288, DOI 10.1055/s-0036-1582132; Aucott H, 2018, J INNATE IMMUN, V10, P215, DOI 10.1159/000487056; Badaut J, BRAIN ED; BAKER AJ, 1991, STROKE, V22, P666, DOI 10.1161/01.STR.22.5.666; Barnes PJ, 2005, IMMUNOL ALLERGY CLIN, V25, P451, DOI 10.1016/j.iac.2005.05.003; Bassin SL, 2008, CRIT CARE, V12, DOI 10.1186/cc7020; Battey TWK, 2014, STROKE, V45, P3643, DOI 10.1161/STROKEAHA.114.006884; Besson VC, 2005, NEUROSCI LETT, V388, P7, DOI 10.1016/j.neulet.2005.06.019; Bhardwaj, 1999, Curr Treat Options Neurol, V1, P179, DOI 10.1007/s11940-999-0002-z; Bleck TP, 2009, CRIT CARE CLIN, V25, P153, DOI 10.1016/j.ccc.2008.12.004; Boone Myles Dustin, 2015, Surg Neurol Int, V6, P177, DOI 10.4103/2152-7806.170248; Bruno G, 2003, INT J IMMUNOPATH PH, V16, P67, DOI 10.1177/039463200301600110; BUIJS RM, 1980, J HISTOCHEM CYTOCHEM, V28, P357, DOI 10.1177/28.4.6989899; Carmeliet P, 2011, NATURE, V473, P298, DOI 10.1038/nature10144; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Chavez A, 2011, INT REV CEL MOL BIO, V290, P205, DOI 10.1016/B978-0-12-386037-8.00001-6; Chehaibi K, 2017, TRANSL RES, V182, P27, DOI 10.1016/j.trsl.2016.10.004; Chen MK, 2001, J NEUROSCI, V21, P6512, DOI 10.1523/JNEUROSCI.21-17-06512.2001; Chesler M, 2003, PHYSIOL REV, V83, P1183, DOI 10.1152/physrev.00010.2003; Chodobski A, 2003, NEUROSCIENCE, V122, P853, DOI 10.1016/j.neuroscience.2003.08.055; Choi HA, 2012, NAT REV NEUROL, V8, P214, DOI 10.1038/nrneurol.2012.21; CLASEN RA, 1965, ARCH NEUROL-CHICAGO, V12, P424, DOI 10.1001/archneur.1965.00460280094009; Cui JK, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-21; Dardiotis E, 2014, J NEUROTRAUM, V31, P1920, DOI 10.1089/neu.2014.3347; Dietrich Jorg, 2011, Expert Rev Clin Pharmacol, V4, P233, DOI 10.1586/ecp.11.1; Ding ZY, 2013, CELL BIOCHEM BIOPHYS, V67, P615, DOI 10.1007/s12013-013-9549-0; Diringer MN, 2013, CURR OPIN CRIT CARE, V19, P77, DOI 10.1097/MCC.0b013e32835eba30; Donkin JJ, 2007, PROG BRAIN RES, V161, P97, DOI 10.1016/S0079-6123(06)61007-8; Donkin JJ, 2010, CURR OPIN NEUROL, V23, P293, DOI 10.1097/WCO.0b013e328337f451; Donkin JJ, 2009, J CEREBR BLOOD F MET, V29, P1388, DOI 10.1038/jcbfm.2009.63; Dore-Duffy P, 2007, NEUROL RES, V29, P395, DOI 10.1179/016164107X204729; Duan XC, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/1203285; DURWARD QJ, 1983, J NEUROSURG, V59, P803, DOI 10.3171/jns.1983.59.5.0803; Fandino W, 2017, J NEUROANAESTH CRIT, V4, P138; Farr GW, 2019, NEUROSCIENCE, V404, P484, DOI 10.1016/j.neuroscience.2019.01.034; Feigin VL, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004583.pub2; Feiler S, 2011, CEREBROVASC DIS, V32, P289, DOI 10.1159/000328248; Filippidis AS, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18010055; Fischer S, 2002, MICROVASC RES, V63, P70, DOI 10.1006/mvre.2001.2367; FISHER B, 1992, J NEUROSURG ANESTH, V4, P4, DOI 10.1097/00008506-199201000-00002; Fong JJ, 2008, CRIT CARE MED, V36, P2281, DOI 10.1097/CCM.0b013e318180c1eb; Fukuda S, 2004, STROKE, V35, P998, DOI 10.1161/01.STR.0000119383.76447.05; Gabrielian Levon, 2013, Acta Neurochir Suppl, V118, P201, DOI 10.1007/978-3-7091-1434-6_37; GARCIA JGN, 1986, J CELL PHYSIOL, V128, P96, DOI 10.1002/jcp.1041280115; Gautier S, 2015, PPAR RES, V2015, DOI 10.1155/2015/246329; Geiseler SJ, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19051362; Gu ZZ, 2005, J NEUROSCI, V25, P6401, DOI 10.1523/JNEUROSCI.1563-05.2005; Guyot LL, 2001, NEUROSCI LETT, V299, P37, DOI 10.1016/S0304-3940(01)01510-5; Hadass O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076904; Haj-Yasein NN, 2011, P NATL ACAD SCI USA, V108, P17815, DOI 10.1073/pnas.1110655108; Halperin JL, 2016, CIRCULATION, V133, P1426, DOI 10.1161/CIR.0000000000000312; Haruma J, 2016, SCI REP-UK, V6, DOI 10.1038/srep37755; Higashida T, 2011, J NEUROSURG, V114, P92, DOI 10.3171/2010.6.JNS10207; Hubbard JA, 2018, BRAIN RES BULL, V136, P118, DOI 10.1016/j.brainresbull.2017.02.011; Hyong A, 2008, ROSIGLITAZONE PPAR G, V1215; Illarionova NB, 2010, NEUROSCIENCE, V168, P915, DOI 10.1016/j.neuroscience.2009.11.062; Ito H, 2006, J NEUROCHEM, V99, P107, DOI 10.1111/j.1471-4159.2006.04036.x; Izumi Y, 1999, GLIA, V25, P379; JAVID M, 1956, JAMA-J AM MED ASSOC, V160, P943, DOI 10.1001/jama.1956.02960460021006; JAVID M, 1957, Surg Forum, V7, P528; Jayakumar AR, 2010, METAB BRAIN DIS, V25, P31, DOI 10.1007/s11011-010-9180-3; Jayakumar AR, 2008, J BIOL CHEM, V283, P33874, DOI 10.1074/jbc.M804016200; Jha RM, 2018, J NEUROTRAUM, V35, P2125, DOI 10.1089/neu.2016.4696; Jha RM, 2018, CURR NEUROL NEUROSCI, V18, DOI 10.1007/s11910-018-0912-9; Jha RM, 2019, NEUROPHARMACOLOGY, V145, P230, DOI 10.1016/j.neuropharm.2018.08.004; Jha S K, 2003, Med J Armed Forces India, V59, P326, DOI 10.1016/S0377-1237(03)80147-8; Jia F, 2014, J NEUROTRAUM, V31, P1225, DOI 10.1089/neu.2013.3230; KARIBE H, 1994, J CEREBR BLOOD F MET, V14, P620, DOI 10.1038/jcbfm.1994.77; Khalili H, 2017, WORLD NEUROSURG, V101, P130, DOI 10.1016/j.wneu.2017.01.103; Kiening KL, 2002, NEUROSCI LETT, V324, P105, DOI 10.1016/S0304-3940(02)00180-5; Kim WY, 2009, FEBS J, V276, P4653, DOI 10.1111/j.1742-4658.2009.07177.x; Kimberly WT, 2018, NEUROLOGY, V91, pE2163, DOI 10.1212/WNL.0000000000006618; Kleindienst A, 2006, ACTA NEUROCHIR SUPPL, V96, P303; Kleindienst A, 2013, ACTA NEUROCHIR, V155, P151, DOI 10.1007/s00701-012-1558-z; Klinger NV, 2016, OXID MED CELL LONGEV, V2016, P14; Koenig MA, 2008, NEUROLOGY, V70, P1023, DOI 10.1212/01.wnl.0000304042.05557.60; Koenig Matthew A, 2018, Continuum (Minneap Minn), V24, P1588, DOI 10.1212/CON.0000000000000665; Kok B, 2017, SEMIN RESP CRIT CARE, V38, P821, DOI 10.1055/s-0037-1608772; Korbakis G, 2014, CRIT CARE CLIN, V30, P657, DOI 10.1016/j.ccc.2014.06.001; Koyama Junji, 2007, Kobe J Med Sci, V53, P199; Krajcova A, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-1112-5; Krieg SM, 2017, J NEUROTRAUM, V34, P1329, DOI 10.1089/neu.2016.4514; Laird MD, 2014, GLIA, V62, P26, DOI 10.1002/glia.22581; Laird MD, 2010, J NEUROCHEM, V113, P637, DOI 10.1111/j.1471-4159.2010.06630.x; Lam TI, 2009, AM J PHYSIOL-CELL PH, V297, pC278, DOI 10.1152/ajpcell.00093.2009; Lam TL, 2005, DIABETES, V54, P510, DOI 10.2337/diabetes.54.2.510; Lazaridis C, 2016, CURR NEUROL NEUROSCI, V16, DOI 10.1007/s11910-016-0681-2; Lee SR, 2009, BIOCHEM BIOPH RES CO, V380, P17, DOI 10.1016/j.bbrc.2008.12.181; Leonard Anna V, 2013, Acta Neurochir Suppl, V118, P303, DOI 10.1007/978-3-7091-1434-6_59; Li H, 2019, FASEB J; Li W, 2017, MOL MED REP, V16, P4710, DOI 10.3892/mmr.2017.7205; Licht T, 2013, CELL MOL LIFE SCI, V70, P1727, DOI 10.1007/s00018-013-1280-x; Lok J, 2015, CNS NEUROSCI THER, V21, P304, DOI 10.1111/cns.12359; Lorente L, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-0911-z; Lu KT, 2007, NEUROL RES, V29, P404, DOI 10.1179/016164107X204738; Lu KT, 2017, J NEUROCHEM, V140, P718, DOI 10.1111/jnc.13920; Lu L, 2014, BRAIN RES, V1555, P89, DOI 10.1016/j.brainres.2014.01.048; Luh C, 2010, J NEUROCHEM, V112, P1015, DOI 10.1111/j.1471-4159.2009.06514.x; Mader S, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8020090; Maki T, 2013, CNS NEUROL DISORD-DR, V12, P302, DOI 10.2174/1871527311312030004; Manaenko A, 2011, ACTA NEUROCHIR SUPPL, V111, P191, DOI 10.1007/978-3-7091-0693-8_32; Mandrekar-Colucci S, 2013, ASN NEURO, V5, DOI 10.1042/AN20130030; Manley GT, 2000, NAT MED, V6, P159, DOI 10.1038/72256; Marcolini EG, 2018, CRIT CARE MED, V46, P307, DOI 10.1097/CCM.0000000000002876; Mehta RI, 2015, J NEUROPATH EXP NEUR, V74, P835, DOI 10.1097/NEN.0000000000000223; Moreno S, 2004, NEUROSCIENCE, V123, P131, DOI 10.1016/j.neuroscience.2003.08.064; MUIZELAAR JP, 1983, J NEUROSURG, V59, P822, DOI 10.3171/jns.1983.59.5.0822; Murayi R, 2016, CHILD NERV SYST, V32, P2293, DOI 10.1007/s00381-016-3240-x; Musumeci D, 2014, PHARMACOL THERAPEUT, V141, P347, DOI 10.1016/j.pharmthera.2013.11.001; NEWBOLD P, 1995, BRIT J PHARMACOL, V114, P570, DOI 10.1111/j.1476-5381.1995.tb17177.x; Newton R, 2014, EUR J PHARMACOL, V724, P231, DOI 10.1016/j.ejphar.2013.05.035; Nguyen JH, 2006, J HEPATOL, V44, P1105, DOI 10.1016/j.jhep.2005.09.019; Nielsen S, 1997, J NEUROSCI, V17, P171; NORENBERG MD, 1994, J NEUROPATH EXP NEUR, V53, P213, DOI 10.1097/00005072-199405000-00001; O'Donnell ME, 2013, J CEREBR BLOOD F MET, V33, P225, DOI 10.1038/jcbfm.2012.160; O'Donnell ME, 2004, J CEREBR BLOOD F MET, V24, P1046, DOI 10.1097/01.WCB.0000130867.32663.90; Obrenovitch TP, 1997, J NEUROTRAUM, V14, P677, DOI 10.1089/neu.1997.14.677; Otvos B, 2014, NEUROSURG FOCUS, V36, DOI 10.3171/2014.1.FOCUS13558; Palma L, 2006, J Neurosurg Sci, V50, P63; Papadopoulos MC, 2013, NAT REV NEUROSCI, V14, P265, DOI 10.1038/nrn3468; Papadopoulos MC, 2004, FASEB J, V18, P1291, DOI 10.1096/fj.04-1723fje; Papadopoulos MC, 2005, J BIOL CHEM, V280, P13906, DOI 10.1074/jbc.M413627200; Patel AD, 2010, J NEUROPATH EXP NEUR, V69, P1177, DOI 10.1097/NEN.0b013e3181fbf6d6; Pfortmueller CA, 2017, J CRIT CARE, V42, P168, DOI 10.1016/j.jcrc.2017.06.019; Pignataro G, 2015, ACS CHEM NEUROSCI, V6, P1517, DOI 10.1021/acschemneuro.5b00175; Pilipovic K, 2015, PROG NEURO-PSYCHOPH, V59, P8, DOI 10.1016/j.pnpbp.2015.01.003; POUNGVARIN N, 1987, NEW ENGL J MED, V316, P1229, DOI 10.1056/NEJM198705143162001; Qureshi AI, 1998, CRIT CARE MED, V26, P440, DOI 10.1097/00003246-199803000-00011; Qureshi AI, 2000, CRIT CARE MED, V28, P3301, DOI 10.1097/00003246-200009000-00032; Raslan Ahmed, 2007, Neurosurg Focus, V22, pE12; Ren ZG, 2013, J CEREBR BLOOD F MET, V33, P834, DOI 10.1038/jcbfm.2013.30; Robbins N, 2012, CARDIOVASC TOXICOL, V12, P1, DOI 10.1007/s12012-011-9145-8; Roberts I, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000033.pub2; ROSENBERG GA, 1995, J NEUROTRAUM, V12, P833, DOI 10.1089/neu.1995.12.833; Rosenstein JM, 2010, ORGANOGENESIS, V6, P107, DOI 10.4161/org.6.2.11687; Rossi JL, 2013, J NEUROTRAUM, V30, P1672, DOI 10.1089/neu.2013.2898; Rungta RL, 2015, CELL, V161, P610, DOI 10.1016/j.cell.2015.03.029; Saadoun S, 2005, J CELL SCI, V118, P5691, DOI 10.1242/jcs.02680; Saadoun S, 2002, J NEUROL NEUROSUR PS, V72, P262, DOI 10.1136/jnnp.72.2.262; Sandercock PAG, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000064.pub2; Scallan J, 2010, CAPILLARY FLUID EXCH; SCHNEIDER GH, 1992, CAN J PHYSIOL PHARM, V70, pS334, DOI 10.1139/y92-280; Schrier RW, 2007, CURR OPIN INVEST DR, V8, P304; Shah S, 2016, SEMIN NEUROL, V36, P502, DOI 10.1055/s-0036-1592109; Sheth KN, 2016, NEUROCRIT CARE, V24, P132, DOI 10.1007/s12028-015-0189-7; Shigemori Y, 2006, ACTA NEUROCHIR SUPPL, V96, P130; Shima K, BRAIN ED; Shore PM, 2004, NEUROSURGERY, V54, P605, DOI 10.1227/01.NEU.0000108642.88724.DB; Simard JM, 2007, LANCET NEUROL, V6, P258, DOI 10.1016/S1474-4422(07)70055-8; Simard JM, 2012, J CEREBR BLOOD F MET, V32, P1699, DOI 10.1038/jcbfm.2012.91; Simard JM, 2009, J NEUROTRAUM, V26, P2257, DOI 10.1089/neu.2009.1021; Simard JM, 2006, NAT MED, V12, P433, DOI 10.1038/nm1390; Sobrado M, 2009, J NEUROSCI, V29, P3875, DOI 10.1523/JNEUROSCI.5529-08.2009; SOLTOFF SP, 1983, SCIENCE, V220, P957, DOI 10.1126/science.6302840; Sorani MD, 2008, J NEUROSURG, V108, P80, DOI 10.3171/JNS/2008/108/01/0080; Stevens RD, 2012, NEUROCRIT CARE, V17, P60, DOI 10.1007/s12028-012-9754-5; Stockhammer G, 2000, ACTA NEUROPATHOL, V100, P101, DOI 10.1007/s004010051199; Stokum JA, 2018, GLIA, V66, P108, DOI 10.1002/glia.23231; Stokum JA, 2016, J CEREBR BLOOD F MET, V36, P513, DOI 10.1177/0271678X15617172; Sun N, 2016, STROKE, V47, P1899, DOI 10.1161/STROKEAHA.115.012236; Suzuki Y, 2002, BRAIN RES, V945, P242, DOI 10.1016/S0006-8993(02)02806-8; Taya K, 2010, J NEUROTRAUM, V27, P229, DOI 10.1089/neu.2009.0933; Thal SC, 2014, ARCH MED RES, V45, P698, DOI 10.1016/j.arcmed.2014.11.006; Todd MM, 2006, ANESTHESIOLOGY, V105, P1176, DOI 10.1097/00000542-200612000-00017; Trabold R, 2008, J NEUROTRAUM, V25, P1459, DOI 10.1089/neu.2008.0597; Tucker B, 2017, J EMERG MED, V53, P18, DOI 10.1016/j.jemermed.2017.02.010; Turner Renee, 2007, Timely Top Med Cardiovasc Dis, V11, pE24; Turner RJ, 2016, FRONT CELL NEUROSCI, V10, DOI 10.3389/fncel.2016.00056; Unterberg AW, 2004, NEUROSCIENCE, V129, P1021, DOI 10.1016/j.neuroscience.2004.06.046; Urday S, 2016, CRIT CARE MED, V44, P790, DOI 10.1097/CCM.0000000000001553; Urday S, 2015, NAT REV NEUROL, V11, P111, DOI 10.1038/nrneurol.2014.264; Vakili A, 2005, J CEREBR BLOOD F MET, V25, P1012, DOI 10.1038/sj.jcbfm.9600097; van Bruggen N, 1999, J CLIN INVEST, V104, P1613, DOI 10.1172/JCI8218; van der Worp HB, 2007, BRAIN, V130, P3063, DOI 10.1093/brain/awm083; Vaz R, 1998, ACTA NEUROCHIR, V140, P371, DOI 10.1007/s007010050111; Vink R, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00304; VORBRODT AW, 1985, ACTA NEUROPATHOL, V66, P265, DOI 10.1007/BF00690958; Vredenburgh JJ, 2007, CLIN CANCER RES, V13, P1253, DOI 10.1158/1078-0432.CCR-06-2309; Walcott BP, 2012, NEUROTHERAPEUTICS, V9, P65, DOI 10.1007/s13311-011-0087-4; Wallace BK, 2011, AM J PHYSIOL-CELL PH, V301, pC316, DOI 10.1152/ajpcell.00517.2010; Wallisch JS, 2019, PEDIATR RES, V85, P511, DOI 10.1038/s41390-018-0215-5; Wang BF, 2015, ACTA PHARMACOL SIN, V36, P939, DOI 10.1038/aps.2015.47; Wang DL, 2017, SCI REP-UK, V7, DOI 10.1038/srep46243; Warth A, 2004, ACTA NEUROPATHOL, V107, P311, DOI 10.1007/s00401-003-0812-0; Wilkinson CM, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0210660; Winkler EA, 2016, NEUROSURG CLIN N AM, V27, P473, DOI 10.1016/j.nec.2016.05.008; WISE B L, 1961, Surg Forum, V12, P398; Witek E, 2019, FRONT AGING NEUROSCI, V10, DOI 10.3389/fnagi.2018.00432; Xing CH, 2012, NEUROL RES, V34, P325, DOI 10.1179/1743132812Y.0000000019; Xiong XX, 2014, NEUROCHEM RES, V39, P216, DOI 10.1007/s11064-013-1212-z; Yancy CW, 2013, J AM COLL CARDIOL, V62, pE147, DOI 10.1016/j.jacc.2013.05.019; Yang LJ, 2018, CELL PHYSIOL BIOCHEM, V46, P2532, DOI 10.1159/000489659; Yao XM, 2015, J NEUROTRAUM, V32, P1458, DOI 10.1089/neu.2014.3675; Yi J, 2008, PPARGAMMA AGONIST RO, V1244; Yu LS, 2016, EXP THER MED, V11, P709, DOI 10.3892/etm.2016.3022; Yu ZF, 1997, NEUROREPORT, V8, P2117, DOI 10.1097/00001756-199707070-00006; Zafardoost P, 2016, TRAUMA MON, V21, DOI 10.5812/traumamon.25113; Zeynalov E, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183985; Zhang J, 2017, NEUROCHEM INT, V111, P23, DOI 10.1016/j.neuint.2017.05.020; Zhang ZG, 2000, J CLIN INVEST, V106, P829, DOI 10.1172/JCI9369; Zhao XR, 2015, CNS NEUROSCI THER, V21, P357, DOI 10.1111/cns.12350; Zhao XR, 2007, ANN NEUROL, V61, P352, DOI 10.1002/ana.21097; Zheng HP, 2016, CEREBROVASC DIS, V42, P155, DOI 10.1159/000445170; Zheng YY, 2008, ANESTH ANALG, V107, P2009, DOI 10.1213/ane.0b013e318187c313; Zweckberger K, 2014, NEUROSCIENCE, V272, P199, DOI 10.1016/j.neuroscience.2014.04.040	211	7	8	0	2	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	1933-7213	1878-7479		NEUROTHERAPEUTICS	Neurotherapeutics	OCT	2019	16	4			SI		1133	1148		10.1007/s13311-019-00779-4			16	Clinical Neurology; Neurosciences; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pharmacology & Pharmacy	KJ4RT	WOS:000512046900015	31512062	Bronze, Green Published			2022-02-06	
J	Kim, H; Kim, YT; Song, ES; Yoon, BC; Choi, YH; Kim, K; Kim, DJ				Kim, Hakseung; Kim, Young-Tak; Song, Eun-Suk; Yoon, Byung C.; Choi, Young Hun; Kim, Keewon; Kim, Dong-Joo			Changes in the gray and white matter of patients with ischemic-edematous insults after traumatic brain injury	JOURNAL OF NEUROSURGERY			English	Article						traumatic brain injury; computed tomography; densitometry; gray matter; white matter	COMPUTED-TOMOGRAPHY; CARDIAC-ARREST; COMATOSE PATIENTS; CT; DENSITY; FLUID; BIRTH; RATIO	OBJECTIVE Gray matter (GM) and white matter (WM) are vulnerable to ischemic-edematous insults after traumatic brain injury (TBI). The extent of secondary insult after brain injury is quantifiable using quantitative CT analysis. One conventional quantitative CT measure, the gray-white matter ratio (GWR), and a more recently proposed densitometric analysis are used to assess the extent of these insults. However, the prognostic capacity of the GWR in patients with TBI has not yet been validated. This study aims to test the prognostic value of the GWR and evaluate the alternative parameters derived from the densitometric analysis acquired during the acute phase of TBI. In addition, the prognostic ability of the conventional TBI prognostic models (i.e., IMPACT [International Mission for Prognosis and Analysis of Clinical Trials in TBI] and CRASH [Corticosteroid Randomisation After Significant Head Injury] models) were compared to that of the quantitative CT measures. METHODS Three hundred patients with TBI of varying ages (92 pediatric, 94 adult, and 114 geriatric patients) and admitted between 2008 and 2013 were included in this retrospective cohort study. The normality of the density of the deep GM and whole WM was evaluated as the proportion of CT pixels with Hounsfield unit values of 31-35 for GM and 26-30 for WM on CT images of the entire supratentorial brain. The outcome was evaluated using the Glasgow Outcome Scale (GOS) at discharge (GOS score <= 3, n = 100). RESULTS Lower proportions of normal densities in the deep GM and whole WM indicated worse outcomes. The proportion of normal WM exhibited a significant prognostic capacity (area under the curve [AUC] = 0.844). The association between the outcome and the normality of the WM density was significant in adult (AUC = 0.792), pediatric (AUC = 0.814), and geriatric (AUC = 0.885) patients. In pediatric patients, the normality of the overall density and the density of the GM were indicative of the outcome (AUC = 0.751). The average GWR was not associated with the outcome (AUC = 0.511). IMPACT and CRASH models showed adequate and reliable performance in the pediatric and geriatric groups but not in the adult group. The highest overall predictive performance was achieved by the densitometry-augmented IMPACT model (AUC = 0.881). CONCLUSIONS Both deep GM and WM are susceptible to ischemic-edematous insults during the early phase of TBI. The extent of the secondary injury was better evaluated by analyzing the normality of the deep GM and WM rather than by calculating the GWR.	[Kim, Hakseung; Kim, Young-Tak; Song, Eun-Suk; Kim, Dong-Joo] Korea Univ, Dept Brain & Cognit Engn, Seoul, South Korea; [Yoon, Byung C.] Stanford Univ, Sch Med, Dept Radiol, Stanford, CA 94305 USA; [Choi, Young Hun] Seoul Natl Univ Hosp, Coll Med, Dept Radiol, Seoul, South Korea; [Kim, Keewon] Seoul Natl Univ Hosp, Coll Med, Dept Rehabil, Seoul, South Korea; [Yoon, Byung C.] Massachusetts Gen Hosp, Dept Radiol, Boston, MA USA		Kim, DJ (corresponding author), Korea Univ, Seoul, South Korea.	dongjookim@korea.ac.kr	Kim, Hakseung/AAZ-8626-2021	Kim, Hakseung/0000-0001-5407-293X	Korea Health Technology R&D Project through the Korea Health Industry Development Institute - Ministry of Health & Welfare, Republic of Korea [HI17C1790]; Ministry of Science and ICT, Korea, under the Information Technology Research Center support program [IITP-2017-2016-0-00464]; Korea University grant	This research was supported by a grant from the Korea Health Technology R&D Project through the Korea Health Industry Development Institute, funded by the Ministry of Health & Welfare, Republic of Korea (grant no. HI17C1790) and by the Ministry of Science and ICT, Korea, under the Information Technology Research Center support program (IITP-2017-2016-0-00464) supervised by the Institute for Information & Communications Technology Promotion and supported by a Korea University grant.	Brunker C, 2015, INTENS CRIT CARE NUR, V31, P69, DOI 10.1016/j.iccn.2014.11.003; CALA LA, 1981, AM J NEURORADIOL, V2, P41; Choi SP, 2008, EMERG MED J, V25, P666, DOI 10.1136/emj.2007.053306; Donkin JJ, 2010, CURR OPIN NEUROL, V23, P293, DOI 10.1097/WCO.0b013e328337f451; Gentsch A, 2015, CLIN NEURORADIOL, V25, P49, DOI 10.1007/s00062-013-0281-3; Gold G, 2005, STROKE, V36, P1184, DOI 10.1161/01.STR.0000166052.89772.b5; Gruen P, 1994, NEUROSURGERY, V34, P938; Heinz Ute E, 2015, BMC Res Notes, V8, P243, DOI 10.1186/s13104-015-1175-z; Huang BY, 2008, RADIOGRAPHICS, V28, P417, DOI 10.1148/rg.282075066; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Kim H, 2018, NEUROSURGERY, V83, P226, DOI 10.1093/neuros/nyx379; Kim H, 2014, BMC MED, V12, DOI 10.1186/s12916-014-0186-2; Kim JJ, 2011, NEUROTHERAPEUTICS, V8, P39, DOI 10.1007/s13311-010-0003-3; Kim SH, 2013, SCAND J TRAUMA RESUS, V21, DOI 10.1186/1757-7241-21-57; Knickmeyer RC, 2008, J NEUROSCI, V28, P12176, DOI 10.1523/JNEUROSCI.3479-08.2008; Lee Bruce, 2005, NeuroRx, V2, P372; Lee BK, 2015, RESUSCITATION, V96, P46, DOI 10.1016/j.resuscitation.2015.07.027; Lee BK, 2013, RESUSCITATION, V84, P1387, DOI 10.1016/j.resuscitation.2013.05.026; Lu H, 2014, NEURAL REGEN RES, V9, P973, DOI 10.4103/1673-5374.133150; Lucking S. E., 2012, PEDIAT CRITICAL CARE, V12th; Metter RB, 2011, RESUSCITATION, V82, P1180, DOI 10.1016/j.resuscitation.2011.04.001; Naidich T.P., 2012, IMAGING BRAIN EXPERT, Vfirst; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Powers WJ, 2010, STROKE, V41, pS107, DOI 10.1161/STROKEAHA.110.595058; Reithmeier T, 2005, CHILD NERV SYST, V21, P249, DOI 10.1007/s00381-004-1044-x; Rusnak M, 2013, NAT REV NEUROL, V9, P186, DOI 10.1038/nrneurol.2013.38; Scheel M, 2013, SCAND J TRAUMA RESUS, V21, DOI 10.1186/1757-7241-21-23; Schneider W, 2000, PHYS MED BIOL, V45, P459, DOI 10.1088/0031-9155/45/2/314; Shekhar Chandra, 2015, J Emerg Trauma Shock, V8, P131, DOI 10.4103/0974-2700.160700; Shen XX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039256; Simard JM, 2007, LANCET NEUROL, V6, P258, DOI 10.1016/S1474-4422(07)70055-8; Sowell ER, 2003, NAT NEUROSCI, V6, P309, DOI 10.1038/nn1008; Starling RM, 2015, PEDIATR CRIT CARE ME, V16, P542, DOI 10.1097/PCC.0000000000000404; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Stoel BC, 2015, J MED IMAGING, V2, DOI 10.1117/1.JMI.2.1.014004; TODD NV, 1986, STROKE, V17, P466, DOI 10.1161/01.STR.17.3.466; Torbey MT, 2000, STROKE, V31, P2163, DOI 10.1161/01.STR.31.9.2163; Voller B, 2001, BRAIN INJURY, V15, P107, DOI 10.1080/026990501458344; Wendt R, 2010, J NUCL MED, V51, P1987, DOI [10.2967/jnumed.110.082529, DOI 10.2967/JNUMED.110.082529]; Wu O, 2011, STROKE, V42, P985, DOI 10.1161/STROKEAHA.110.594879; Yamamura H, 2016, SCAND J TRAUMA RESUS, V24, DOI 10.1186/s13049-016-0271-y; Zasler N, 2012, BRAIN INJURY MED; Zech WD, 2014, INT J LEGAL MED, V128, P795, DOI 10.1007/s00414-014-1030-0; Zhang CC, 2015, MOL MED REP, V12, P7351, DOI 10.3892/mmr.2015.4372	44	7	7	0	1	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	OCT	2019	131	4					1243	1253		10.3171/2018.5.JNS172711			11	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	JD8RN	WOS:000490249600030	30485242	Bronze			2022-02-06	
J	Minnema, AJ; Mehta, A; Boling, WW; Schwab, J; Simard, JM; Farhadi, HF				Minnema, Amy Janelle; Mehta, A.; Boling, Warren W.; Schwab, Jan; Simard, J. Marc; Farhadi, H. Francis			SCING-Spinal Cord Injury Neuroprotection with Glyburide: a pilot, open-label, multicentre, prospective evaluation of oral glyburide in patients with acute traumatic spinal cord injury in the USA	BMJ OPEN			English	Article							NONSELECTIVE CATION CHANNEL; CLINICAL-TRIALS NETWORK; SULFONYLUREA RECEPTOR 1; RAT MODEL; INTRAVENOUS GLYBURIDE; REACTIVE ASTROCYTES; LESION EXPANSION; EXCEPTION; GLIBENCLAMIDE; BRAIN	Introduction Acute traumatic spinal cord injury (tSCI) is a devastating neurological disorder with no pharmacological neuroprotective strategy proven effective to date. Progressive haemorrhagic necrosis (PHN) represents an increasingly well-characterised mechanism of secondary injury after tSCI that negatively impacts neurological outcomes following acute tSCI. Preclinical studies evaluating the use of the Food and Drug Administration-approved sulfonylurea receptor 1-transient receptor potential melastatin 4 channel blocker glyburide in rodent models have shown reduced secondary microhaemorrhage formation and the absence of capillary fragmentation, the pathological hallmark of PHN. Methods and analysis In this initial phase multicentre open-label pilot study, we propose to enrol 10 patients with acute cervical tSCI to primarily assess the feasibility, and safety of receiving oral glyburide within 8 hours of injury. Secondary objectives include pharmacokinetics and preliminary evaluations on neurological recovery as well as blood and MRI-based injury biomarkers. Analysis will be performed using the descriptive and non-parametric statistics. Ethics and dissemination Glyburide has been shown as an effective neuroprotective agent in preclinical tSCI models and in the treatment of ischaemic stroke with the additional risk of a hypoglycaemic response. Given the ongoing secondary injury and the traumatic hyperglycaemic stress response seen in patients with tSCI, glyburide; thus, offers an appealing neuroprotective strategy to supplement standard of care treatment. The study protocol was approved by the Ohio State University Biomedical Institutional Review Board. The protocol was amended in February 2017 with changes related to study feasibility and patient recruitment. Specifically, the route of administration was changed to the oral form to allow for streamlined and rapid drug administration, and the injury-to-drug time window was extended to 8 hours in an effort to further enhance enrolment. Participants or legally authorised representatives are informed about the trial and its anticipated risks orally and in written form using an approved informed consent form prior to inclusion. The findings of this study will be disseminated to the participants and to academic peers through scientific conferences and peer-reviewed journal publications.	[Minnema, Amy Janelle; Farhadi, H. Francis] Ohio State Univ, Dept Neurol Surg, Wexner Med Ctr, Columbus, OH 43210 USA; [Mehta, A.] Univ Illinois, Dept Neurosurg, Chicago, IL USA; [Boling, Warren W.] Loma Linda Univ, Dept Neurol Surg, Loma Linda, CA 92350 USA; [Schwab, Jan] Ohio State Univ, Dept Neurol, Wexner Med Ctr, Columbus, OH 43210 USA; [Simard, J. Marc] Univ Maryland, Sch Med, Dept Neurol Surg, Baltimore, MD 21201 USA		Farhadi, HF (corresponding author), Ohio State Univ, Dept Neurol Surg, Wexner Med Ctr, Columbus, OH 43210 USA.	francis.farhadi@osumc.edu		Farhadi, H Francis/0000-0002-4668-8512; Schwab, Jan/0000-0001-6784-4919	Department of Neuological Surgery at The Ohio State University Wexner Medical Center	Internal funding support is provided by the Department of Neuological Surgery at The Ohio State University Wexner Medical Center.	Aarabi B, 2012, J NEUROSURG-SPINE, V17, P243, DOI 10.3171/2012.6.SPINE12122; Ahuja CS, 2016, STEM CELL TRANSL MED, V5, P914, DOI 10.5966/sctm.2015-0381; BALENTINE JD, 1978, LAB INVEST, V39, P236; Bateman BT, 2003, STROKE, V34, P1317, DOI 10.1161/01.STR.0000065230.00053.B4; Bilgen M, 2001, MAGNET RESON MED, V45, P614, DOI 10.1002/mrm.1083; Blight AR, 2019, SPINAL CORD, V57, P348, DOI 10.1038/s41393-019-0276-2; Catz A, 2007, J REHABIL RES DEV, V44, P65, DOI 10.1682/JRRD.2005.07.0123; Chen MK, 2003, J NEUROSCI, V23, P8568; Chen MK, 2001, J NEUROSCI, V21, P6512, DOI 10.1523/JNEUROSCI.21-17-06512.2001; Evaniew N, 2015, J NEUROTRAUM, V32, P1674, DOI 10.1089/neu.2015.3963; Farhadi HF, 2018, J NEUROTRAUM, V35, P1398, DOI 10.1089/neu.2017.5510; Fehlings MG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032037; Galer BS, 1997, NEUROLOGY, V48, P332, DOI 10.1212/WNL.48.2.332; Gerzanich V, 2009, NAT MED, V15, P185, DOI 10.1038/nm.1899; Grossman RG, 2014, J NEUROTRAUM, V31, P239, DOI 10.1089/neu.2013.2969; Grossman RG, 2012, J NEUROSURG-SPINE, V17, P6, DOI 10.3171/2012.4.AOSPINE1294; Grossman RG, 2012, J NEUROSURG-SPINE, V17, P119, DOI 10.3171/2012.5.AOSPINE12127; Hosier H, 2015, J NEUROTRAUM, V32, P1633, DOI 10.1089/neu.2015.3892; Juneja R, 2009, CRIT CARE, V13, DOI 10.1186/cc8129; Kleindorfer D, 2011, CEREBROVASC DIS, V32, P321, DOI 10.1159/000328815; Kobayakawa K, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009430; Kopp MA, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010651; Kuhle J, 2015, J NEUROL NEUROSUR PS, V86, P273, DOI 10.1136/jnnp-2013-307454; Kwon BK, 2011, CLIN CHEM LAB MED, V49, P425, DOI 10.1515/CCLM.2011.068; Lammertse D, 2007, SPINAL CORD, V45, P232, DOI 10.1038/sj.sc.3102010; Pallan Tony V, 2014, J Vasc Interv Neurol, V7, P23; Popovich PG, 2012, EXP NEUROL, V233, P615, DOI 10.1016/j.expneurol.2010.11.016; Research USDoHaHSCfDEa, 2013, GUID I REV BOARDS CL; Ripley E, 2012, PREHOSP EMERG CARE, V16, P425, DOI 10.3109/10903127.2012.702189; Rose David Z, 2011, Front Neurol, V2, P65, DOI 10.3389/fneur.2011.00065; RYDBERG T, 1995, J CLIN PHARM THER, V20, P283, DOI 10.1111/j.1365-2710.1995.tb00664.x; sanofi-aventis US LLC, 2009, DIABETA PACK INS; Sheth KN, 2016, LANCET NEUROL, V15, P1160, DOI 10.1016/S1474-4422(16)30196-X; Sheth KN, 2014, STROKE, V45, P281, DOI 10.1161/STROKEAHA.113.003352; Silbergleit R, 2012, ACAD EMERG MED, V19, P448, DOI 10.1111/j.1553-2712.2012.01328.x; Simard JM, 2013, SPINAL CORD, V51, P823, DOI 10.1038/sc.2013.99; Simard JM, 2007, J CLIN INVEST, V117, P2105, DOI 10.1172/JCI32041; Simard JM, 2007, LANCET NEUROL, V6, P258, DOI 10.1016/S1474-4422(07)70055-8; Simard JM, 2014, NEUROCRIT CARE, V20, P319, DOI 10.1007/s12028-013-9923-1; Simard JM, 2012, J CEREBR BLOOD F MET, V32, P1699, DOI 10.1038/jcbfm.2012.91; Simard JM, 2012, EXP NEUROL, V233, P829, DOI 10.1016/j.expneurol.2011.11.048; Simard JM, 2012, EXP NEUROL, V233, P566, DOI 10.1016/j.expneurol.2011.11.044; Simard JM, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000522; Simard JM, 2006, NAT MED, V12, P433, DOI 10.1038/nm1390; Talbott JF, 2015, J NEUROSURG-SPINE, V23, P495, DOI 10.3171/2015.1.SPINE141033; Walters BC, 2013, NEUROSURGERY, V60, P82, DOI 10.1227/01.neu.0000430319.32247.7f; Widerstrom-Noga E, 2016, SPINAL CORD, V54, P1036, DOI 10.1038/sc.2016.51; Wilson JR, 2013, SPINE, V38, P97, DOI 10.1097/BRS.0b013e31826e2b91; Woo SK, 2013, J BIOL CHEM, V288, P3655, DOI 10.1074/jbc.M112.428219; Yokobori S, 2015, WORLD NEUROSURG, V83, P867, DOI 10.1016/j.wneu.2013.03.012	50	7	7	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	2044-6055			BMJ OPEN	BMJ Open	OCT	2019	9	10							e031329	10.1136/bmjopen-2019-031329			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KK6XG	WOS:000512882200200	31601596	Green Published, gold			2022-02-06	
J	Moisenovich, MM; Plotnikov, EY; Moysenovich, AM; Silachev, DN; Danilina, TI; Savchenko, ES; Bobrova, MM; Safonova, LA; Tatarskiy, VV; Kotliarova, MS; Agapov, II; Zorov, DB				Moisenovich, M. M.; Plotnikov, E. Y.; Moysenovich, A. M.; Silachev, D. N.; Danilina, T., I; Savchenko, E. S.; Bobrova, M. M.; Safonova, L. A.; Tatarskiy, V. V.; Kotliarova, M. S.; Agapov, I. I.; Zorov, D. B.			Effect of Silk Fibroin on Neuroregeneration After Traumatic Brain Injury	NEUROCHEMICAL RESEARCH			English	Article						Scaffold; Neurons; Astrocytes; Neuroprotection; Fibroin; Ischemia	FOCAL CEREBRAL-ISCHEMIA; NEURAL STEM-CELLS; MOLECULAR-MECHANISMS; IN-VIVO; STROKE; HYDROGELS; REPAIR; REGENERATION; TRANSPLANTATION; BIOMATERIALS	Traumatic brain injury is one of the leading causes of disability among the working-age population worldwide. Despite attempts to develop neuroprotective therapeutic approaches, including pharmacological or cellular technologies, significant advances in brain regeneration have not yet been achieved. Development of silk fibroin-based biomaterials represents a new frontier in neuroregenerative therapies after brain injury. In this study, we estimated the short and long-term effects of silk fibroin scaffold transplantation on traumatic brain injury and biocompatibility of this biomaterial within rat neuro-vascular cells. Silk fibroin microparticles were injected into a brain damage area 1 day after the injury. Silk fibroin affords neuroprotection as judged by diminished brain damage and recovery of long-term neurological functions. We did not detect considerable toxicity to neuro-vascular cells cultured on fibroin/fibroin-gelatin microparticles in vitro. Cultivation of primary cell cultures of neurons and astrocytes on silk fibroin matrices demonstrated their higher viability under oxygen-glucose deprivation compared to 2D conditions on plastic plates. Thus, we conclude that scaffolds based on silk fibroin can become the basis for the creation of constructs aimed to treat brain regeneration after injury.	[Moisenovich, M. M.; Moysenovich, A. M.; Bobrova, M. M.; Safonova, L. A.; Kotliarova, M. S.; Agapov, I. I.] Lomonosov Moscow State Univ, Biol Fac, Moscow, Russia; [Plotnikov, E. Y.; Silachev, D. N.; Zorov, D. B.] Lomonosov Moscow State Univ, AN Belozersky Inst Phys Chem Biol, Moscow, Russia; [Danilina, T., I; Savchenko, E. S.] Lomonosov Moscow State Univ, Fac Bioengn & Bioinformat, Moscow, Russia; [Bobrova, M. M.; Safonova, L. A.; Agapov, I. I.] VI Shumakov Natl Med Res Ctr Transplantol & Artif, Bionanotechnol Lab, Moscow, Russia; [Tatarskiy, V. V.] NN Blokhin Russian Canc Res Ctr, Moscow, Russia		Zorov, DB (corresponding author), Lomonosov Moscow State Univ, AN Belozersky Inst Phys Chem Biol, Moscow, Russia.	zorov@belozersky.msu.ru	Zorov, Dmitry B./AAB-1738-2019; Silachev, Denis N/C-9464-2012; Tatarskiy, Victor V/K-1224-2017; Plotnikov, Egor Y/F-8592-2019; Silachev, Denis/ABE-8515-2020; Moisenovich, Anastasia/P-6042-2017	Zorov, Dmitry B./0000-0003-0863-8490; Tatarskiy, Victor V/0000-0002-9080-5683; Plotnikov, Egor Y/0000-0003-2838-3704; Silachev, Denis/0000-0003-0581-9755	RFBRRussian Foundation for Basic Research (RFBR) [17-00-00359]; Russian Science FoundationRussian Science Foundation (RSF) [14-24-00107-model]	The reported study was funded by RFBR according to the research project no. 17-00-00359 and Russian Science Foundation (14-24-00107-model of the brain trauma used for animals, and OGD model used for cells).	An B, 2015, BIOMATERIALS, V48, P137, DOI 10.1016/j.biomaterials.2015.01.044; Arkhipova AY, 2016, BIOCHEMISTRY-MOSCOW+, V81, P1251, DOI 10.1134/S0006297916110031; Aykac A, 2018, GENE, V641, P287, DOI 10.1016/j.gene.2017.10.036; Bagrov D. V., 2017, Biofizika, V62, P23; Benfenati V, 2010, BIOMATERIALS, V31, P7883, DOI 10.1016/j.biomaterials.2010.07.013; Bible E, 2012, BIOMATERIALS, V33, P7435, DOI 10.1016/j.biomaterials.2012.06.085; Bikbaev A, 2015, SCI REP-UK, V5, DOI 10.1038/srep14527; BREWER GJ, 1995, J NEUROSCI RES, V42, P674, DOI 10.1002/jnr.490420510; Burdick JA, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3003997; Carmichael ST, 2006, ANN NEUROL, V59, P735, DOI 10.1002/ana.20845; Chen MQ, 2011, BIOMATERIALS, V32, P7532, DOI 10.1016/j.biomaterials.2011.06.054; Chomchalao P, 2013, BIOMED ENG ONLINE, V12, DOI 10.1186/1475-925X-12-28; Das S, 2015, BIOMATERIALS, V62, P66, DOI 10.1016/j.biomaterials.2015.04.047; Davies SJA, 1997, NATURE, V390, P680, DOI 10.1038/37776; DAVIS JQ, 1994, J BIOL CHEM, V269, P27163; Dirnagl U, 1999, TRENDS NEUROSCI, V22, P391, DOI 10.1016/S0166-2236(99)01401-0; Emerich DF, 2010, CELL TRANSPLANT, V19, P1063, DOI 10.3727/096368910X498278; FAWCETT JW, 1995, EXP BRAIN RES, V106, P275; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; Fernandez-Garcia L, 2016, ACTA BIOMATER, V45, P262, DOI 10.1016/j.actbio.2016.09.003; Fitch MT, 1999, J NEUROSCI, V19, P8182; Gast D, 2008, EXP CELL RES, V314, P2411, DOI 10.1016/j.yexcr.2008.04.004; Go AS, 2014, CIRCULATION, V129, pE28, DOI 10.1161/01.cir.0000441139.02102.80; Gogolla N, 2009, SCIENCE, V325, P1258, DOI 10.1126/science.1174146; Happel MFK, 2014, P NATL ACAD SCI USA, V111, P2800, DOI 10.1073/pnas.1310272111; Hopkins AM, 2013, ADV FUNCT MATER, V23, P5140, DOI 10.1002/adfm.201300435; Huang LJ, 2014, INT J MED SCI, V11, P344, DOI 10.7150/ijms.8140; Imparato G, 2013, BIOMATERIALS, V34, P7851, DOI 10.1016/j.biomaterials.2013.06.062; Isaev NK, 2012, BIOCHEMISTRY-MOSCOW+, V77, P996, DOI 10.1134/S0006297912090052; Jin KL, 2010, J CEREBR BLOOD F MET, V30, P534, DOI 10.1038/jcbfm.2009.219; Jolkkonen J, 2000, EUR J PHARMACOL, V400, P211, DOI 10.1016/S0014-2999(00)00409-X; Kim CE, 2017, SCI REP-UK, V7, DOI 10.1038/srep44364; Lao LL, 2011, INT J PHARMACEUT, V418, P28, DOI 10.1016/j.ijpharm.2010.12.020; Leung BM, 2007, ANN BIOMED ENG, V35, P2039, DOI 10.1007/s10439-007-9380-0; Ma J, 2007, BIOMED MATER, V2, P233, DOI 10.1088/1748-6041/2/4/005; Man AJ, 2011, TISSUE ENG PT A, V17, P2931, DOI 10.1089/ten.tea.2011.0030; MCCARTHY KD, 1980, J CELL BIOL, V85, P890, DOI 10.1083/jcb.85.3.890; Nichol JW, 2009, SOFT MATTER, V5, P1312, DOI 10.1039/b814285h; Nih LR, 2016, CURR OPIN BIOTECH, V40, P155, DOI 10.1016/j.copbio.2016.04.021; Orive G, 2009, NAT REV NEUROSCI, V10, P682, DOI 10.1038/nrn2685; Orlova AA, 2014, B EXP BIOL MED+, V158, P88, DOI 10.1007/s10517-014-2699-2; Pizzorusso T, 2002, SCIENCE, V298, P1248, DOI 10.1126/science.1072699; Qi Y, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18030237; Rodriguez-Nogales A, 2016, INT J NANOMED, V11, P5945, DOI 10.2147/IJN.S116479; Schallert T, 2000, NEUROPHARMACOLOGY, V39, P777, DOI 10.1016/S0028-3908(00)00005-8; Seo JH, 2012, CURR PHARM DESIGN, V18, P3645; Silachev DN, 2009, B EXP BIOL MED+, V147, P269, DOI 10.1007/s10517-009-0489-z; Silachev DN, 2014, BBA-GEN SUBJECTS, V1840, P3434, DOI 10.1016/j.bbagen.2014.09.002; Silver J, 2004, NAT REV NEUROSCI, V5, P146, DOI 10.1038/nrn1326; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Szybala C, 2009, EXP NEUROL, V219, P126, DOI 10.1016/j.expneurol.2009.05.018; Tang X, 2009, J BIOMED MATER RES A, V91A, P166, DOI 10.1002/jbm.a.32212; Tang-Schomer MD, 2014, ADV FUNCT MATER, V24, P1938, DOI 10.1002/adfm.201303196; Tedesco MT, 2018, BIOMATERIALS, V156, P159, DOI 10.1016/j.biomaterials.2017.11.043; Wevers NR, 2016, SCI REP-UK, V6, DOI 10.1038/srep38856; Yang YM, 2011, TISSUE ENG PT A, V17, P2231, DOI [10.1089/ten.tea.2010.0633, 10.1089/ten.TEA.2010.0633]; Yu HW, 2010, ANAT REC, V293, P911, DOI 10.1002/ar.20941	57	7	7	1	6	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0364-3190	1573-6903		NEUROCHEM RES	Neurochem. Res.	OCT	2019	44	10			SI		2261	2272		10.1007/s11064-018-2691-8			12	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	JD7HB	WOS:000490150700003	30519983				2022-02-06	
J	Tong, JF; Kedar, S; Ghate, D; Gu, LX				Tong, Junfei; Kedar, Sachin; Ghate, Deepta; Gu, Linxia			Indirect Traumatic Optic Neuropathy Induced by Primary Blast: A Fluid-Structure Interaction Study	JOURNAL OF BIOMECHANICAL ENGINEERING-TRANSACTIONS OF THE ASME			English	Article						primary blast; indirect traumatic optic neuropathy; intraocular pressure; cerebrospinal fluid pressure; strain rate; fluid-structure interaction	HUMAN EYE; INJURY; BRAIN; MODEL; PRESSURE; RESPONSES; PROTEINS; RISK; RAT	Current knowledge of traumatic ocular injury is still limited as most studies have focused on the ocular injuries that happened at the anterior part of the eye, whereas the damage to the optic nerve known as traumatic optic neuropathy (TON) is poorly understood. The goal of this study is to understand the mechanism of the TON following the primary blast through a fluid-structure interaction model. An axisymmetric three-dimensional (3D) eye model with detailed orbital components was developed to capture the dynamics of the eye under the blast wave. Our numerical results demonstrated a transient pressure elevation in both vitreous and cerebrospinal fluid (CSF). A high strain rate over 100 s(-1) was observed throughout the optic nerve during the blast with the most vulnerable part located at the intracanalicular region. The optic nerve deforming at such a high strain rate may account for the axonal damage and vision loss in patients subjected to the primary blast. The results from this work would enhance the understanding of indirect TON and provide guidance in the design of protective eyewear against such injury.	[Tong, Junfei; Gu, Linxia] Univ Nebraska, Dept Mech & Mat Engn, Lincoln, NE 68588 USA; [Kedar, Sachin; Ghate, Deepta] Univ Nebraska Med Ctr, Stanley Truhlsen Eye Inst, Omaha, NE 68105 USA; [Kedar, Sachin] Univ Nebraska Med Ctr, Dept Neurol Sci, Omaha, NE 68198 USA		Tong, JF (corresponding author), Univ Nebraska, Dept Mech & Mat Engn, Lincoln, NE 68588 USA.	junfei.tong@huskers.unl.edu	Tong, Junfei/AAD-4156-2022		Clinical Translational Research Mentored Scholar Pilot Grant [10.13039/100006518]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [U54GM115458] Funding Source: NIH RePORTER	The Clinical Translational Research Mentored Scholar Pilot Grant (Funder ID: 10.13039/100006518).	Ahmadzadeh H, 2014, BIOPHYS J, V106, P1123, DOI 10.1016/j.bpj.2014.01.024; Alphonse V. D., 2015, THESIS; Ari Adrienne B, 2006, Optometry, V77, P329, DOI 10.1016/j.optm.2006.03.015; Bailoor S, 2015, BIOMECH MODEL MECHAN, V14, P1227, DOI 10.1007/s10237-015-0667-z; Bain AC, 2000, J BIOMECH ENG-T ASME, V122, P615, DOI 10.1115/1.1324667; Balaratnasingam C, 2009, EXP EYE RES, V89, P618, DOI 10.1016/j.exer.2009.06.002; Bhardwaj R, 2014, BIOMECH MODEL MECHAN, V13, P123, DOI 10.1007/s10237-013-0490-3; Blanch RJ, 2011, EYE, V25, P218, DOI 10.1038/eye.2010.190; Bloomfield IG, 1998, PEDIATR NEUROSURG, V28, P246, DOI 10.1159/000028659; Bricker-Anthony C, 2014, INVEST OPHTH VIS SCI, V55, P4853, DOI 10.1167/iovs.14-14353; CROMPTON M R, 1970, Brain Behavior and Evolution, V93, P785, DOI 10.1093/brain/93.4.785; Duke-Elder S., 1961, SYSTEM OPHTHALMOLOGY, P556; Duma SM, 2012, CURR EYE RES, V37, P43, DOI 10.3109/02713683.2011.601841; Esposito L, 2015, COMPUT METHOD BIOMEC, V18, P107, DOI 10.1080/10255842.2013.779684; Feng K, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00179; Garimella HT, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190881; Geng XQ, 2018, TRANSL VIS SCI TECHN, V7, DOI 10.1167/tvst.7.3.16; Girard MJA, 2011, INVEST OPHTH VIS SCI, V52, P9684, DOI 10.1167/iovs.11-7894; Gorig C, 2006, AM J VET RES, V67, P288, DOI 10.2460/ajvr.67.2.288; Guley NH, 2016, J NEUROTRAUM, V33, P403, DOI 10.1089/neu.2015.3886; HABAL MB, 1977, J SURG RES, V22, P527, DOI 10.1016/0022-4804(77)90036-1; Harris J, 2017, CONSTANTINOPLE: CAPITAL OF BYZANTIUM, SECOND EDITION, P113; Hua Y, 2018, INVEST OPHTH VIS SCI, V59, P154, DOI 10.1167/iovs.17-22488; Hua Y, 2017, BIOMED ENG LETT, V7, P253, DOI 10.1007/s13534-017-0027-2; Hua Y, 2017, J BIOMECH ENG-T ASME, V139, DOI 10.1115/1.4035406; Hua Y, 2014, J COMPUT NONLIN DYN, V9, DOI 10.1115/1.4026156; Hwang SH, 2013, CLIN EXP OTORHINOLAR, V6, P23, DOI 10.3342/ceo.2013.6.1.23; Itoh S., 2002, 12 INT DET S, P281, DOI [10.1080/07370652.2020.1822461., DOI 10.1080/07370652.2020.1822461]; Jazi MS, 2016, COMPUT METHOD BIOMEC, V19, P1019, DOI 10.1080/10255842.2015.1088525; JONAS JB, 1991, INVEST OPHTH VIS SCI, V32, P401; Jonas JB, 2011, AM J OPHTHALMOL, V152, P1021, DOI 10.1016/j.ajo.2011.05.006; JONES IL, 1992, EYE, V6, P556, DOI 10.1038/eye.1992.121; Karimi A, 2016, INJURY, V47, P1042, DOI 10.1016/j.injury.2016.01.030; Kennedy Eric A, 2004, Annu Proc Assoc Adv Automot Med, V48, P165; KLINE LB, 1984, NEUROSURGERY, V14, P756, DOI 10.1227/00006123-198406000-00021; Lang J., 2012, CLIN ANATOMY HEAD NE; Leonardi AD, 2011, J NEUROTRAUM, V28, P85, DOI 10.1089/neu.2010.1324; Levin LA, 1999, OPHTHALMOLOGY, V106, P1268, DOI 10.1016/S0161-6420(99)00707-1; Liu MB, 2002, SHOCK WAVES, V12, P181, DOI 10.1007/s00193-002-0163-0; Liu XY, 2015, COMPUT METHOD BIOMEC, V18, P1024, DOI 10.1080/10255842.2013.869317; Midgett DE, 2017, ACTA BIOMATER, V53, P123, DOI 10.1016/j.actbio.2016.12.054; Norman RE, 2010, EXP EYE RES, V90, P277, DOI 10.1016/j.exer.2009.11.001; Notghi B, 2017, J BIOMECH ENG-T ASME, V139, DOI 10.1115/1.4037072; Olsen TW, 1998, AM J OPHTHALMOL, V125, P237, DOI 10.1016/S0002-9394(99)80096-8; PATIN DJ, 1993, ANESTH ANALG, V76, P535; Qiu G, 2011, COMPUT GEOTECH, V38, P30, DOI 10.1016/j.compgeo.2010.09.002; Rajiniganth MG, 2003, ARCH OTOLARYNGOL, V129, P1203, DOI 10.1001/archotol.129.11.1203; Rossi T, 2012, INVEST OPHTH VIS SCI, V53, P8057, DOI 10.1167/iovs.12-10591; Sahoo D, 2016, ACCIDENT ANAL PREV, V92, P53, DOI 10.1016/j.aap.2016.03.013; Schultz DS, 2008, INVEST OPHTH VIS SCI, V49, P4232, DOI 10.1167/iovs.08-1970; Scott RAH, 2015, TRAUMA, V17, P83, DOI 10.1177/1460408614539621; Shroff A., 2011, EYE NUMBERS READY RE; Sigal IA, 2004, INVEST OPHTH VIS SCI, V45, P4378, DOI 10.1167/iovs.04-0133; Singh A, 2009, J NEUROTRAUM, V26, P627, DOI 10.1089/neu.2008.0621; STEINSAPIR KD, 1994, SURV OPHTHALMOL, V38, P487, DOI 10.1016/0039-6257(94)90145-7; Stitzel J. D., 2002, 2002220005 SAE; Sundaramurthy A, 2012, J NEUROTRAUM, V29, P2352, DOI 10.1089/neu.2012.2413; Suri S., 2006, TRENDS BIOMATER ARTI, V20, P72; Tao WS, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12225-6; Tasman W, 1972, Trans Am Ophthalmol Soc, V70, P190; Wang F, 2007, CURR EYE RES, V32, P133, DOI 10.1080/02713680601139325; Wang X., 2018, J GLAUCOMA; Watson R, 2015, TRANSL VIS SCI TECHN, V4, DOI 10.1167/tvst.4.4.8; Weaver AA, 2017, BIOMECH MODEL MECHAN, V16, P463, DOI 10.1007/s10237-016-0830-1; Weichel ED, 2008, OPHTHALMOLOGY, V115, P2235, DOI 10.1016/j.ophtha.2008.08.033; Wright RM, 2012, BIOMECH MODEL MECHAN, V11, P245, DOI 10.1007/s10237-011-0307-1; Xie X., 2013, CRITICAL CARE, V17, P1; Yuen TJ, 2009, J NEUROSCI RES, V87, P3620, DOI 10.1002/jnr.22161; Zhang L, 2015, INVEST OPHTH VIS SCI, V56, P2031, DOI 10.1167/iovs.14-15734; Zhang LY, 2001, J NEUROTRAUM, V18, P21, DOI 10.1089/089771501750055749	70	7	7	0	6	ASME	NEW YORK	TWO PARK AVE, NEW YORK, NY 10016-5990 USA	0148-0731	1528-8951		J BIOMECH ENG-T ASME	J. Biomech. Eng.-Trans. ASME	OCT	2019	141	10							101011	10.1115/1.4043668			7	Biophysics; Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Biophysics; Engineering	JA3HA	WOS:000487709700011	31053852				2022-02-06	
J	Zahniser, E; Temkin, NR; Machamer, J; Barber, J; Manley, GT; Markowitz, AJ; Dikmen, SS; Adeoye, O; Badjatia, N; Boase, K; Bodien, Y; Bullock, MR; Chesnut, R; Corrigan, JD; Crawford, K; Diaz-Arrastia, R; Duhaime, AC; Ellenbogen, R; Feeser, VR; Ferguson, A; Foreman, B; Gardner, R; Gaudette, E; Giacino, J; Goldman, D; Gonzalez, L; Gopinath, S; Gullapalli, R; Hemphill, JC; Hotz, G; Jain, S; Korley, F; Kramer, J; Kreitzer, N; Levin, H; Lindsell, C; Madden, C; Martin, A; McAllister, T; McCrea, M; Merchant, R; Mukherjee, P; Nelson, L; Noel, F; Okonkwo, D; Palacios, E; Perl, D; Puccio, A; Rabinowitz, M; Robertson, C; Rosand, J; Sander, A; Schnyer, D; Seabury, S; Sherer, M; Stein, M; Taylor, S; Toga, A; Valadka, A; Vassar, M; Vespa, P; Wang, K; Yue, J; Yuh, E; Zafonte, R				Zahniser, Evan; Temkin, Nancy R.; Machamer, Joan; Barber, Jason; Manley, Geoffrey T.; Markowitz, Amy J.; Dikmen, Sureyya S.; Adeoye, Opeolu; Badjatia, Neeraj; Boase, Kim; Bodien, Yelena; Bullock, M. Ross; Chesnut, Randall; Corrigan, John D.; Crawford, Karen; Diaz-Arrastia, Ramon; Duhaime, Ann-Christine; Ellenbogen, Richard; Feeser, V. Ramana; Ferguson, Adam; Foreman, Brandon; Gardner, Raquel; Gaudette, Etienne; Giacino, Joseph; Goldman, Dana; Gonzalez, Luis; Gopinath, Shankar; Gullapalli, Rao; Hemphill, J. Claude; Hotz, Gillian; Jain, Sonia; Korley, Frederick; Kramer, Joel; Kreitzer, Natalie; Levin, Harvey; Lindsell, Chris; Madden, Christopher; Martin, Alastair; McAllister, Thomas; McCrea, Michael; Merchant, Randall; Mukherjee, Pratik; Nelson, Lindsay; Noel, Florence; Okonkwo, David; Palacios, Eva; Perl, Daniel; Puccio, Ava; Rabinowitz, Miri; Robertson, Claudia; Rosand, Jonathan; Sander, Angelle; Schnyer, David; Seabury, Seth; Sherer, Mark; Stein, Murray; Taylor, Sabrina; Toga, Arthur; Valadka, Alex; Vassar, Mary; Vespa, Paul; Wang, Kevin; Yue, John; Yuh, Esther; Zafonte, Ross		TRACK-TBI Investigators	The Functional Status Examination in Mild Traumatic Brain Injury: A TRACK-TBI Sub-Study	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article						Brain injuries; Traumatic; Brain concussion; Patient outcome assessment; Neuropsychology; Mental health; Glasgow Coma Scale	CONCUSSION SYMPTOMS QUESTIONNAIRE; GLASGOW OUTCOME SCALE; QUALITY-OF-LIFE; DEPRESSIVE SYMPTOMS; HEAD-INJURY; RECOVERY; VALIDITY; MODERATE; IMPACT	Objective: The Functional Status Examination (FSE) is a comprehensive measure of functional status post-traumatic brain injury (TBI) that has primarily been used in studies of moderate-to-severe TBI. The present observational study examines functional status using the FSE among patients who sustained mild TBIs (mTBIs; defined as Glasgow Coma Scale [GCS] = 13-15 at admission) seen in a Level 1 trauma center. Study aims included examining the course of functional status following mTBI, as well as exploring relationships of the FSE and other relevant constructs among those with GCS = 13-15. Method: Participants were assessed at 2 weeks (n = 112), 3 months (n = 113), 6 months (n = 106), and 12 months (n = 88) post-injury for changes in functional status resulting both (a) from all injuries and (b) from TBI only. Results: Among seven domains of day-to-day functioning, participants generally experienced the greatest disruption in their primary activity (work or school) and in leisure and recreation. Subjects' overall functional status tended to improve over time, with sharpest increases in functionality occurring in the first 3 months post-injury. However, some subjects continued to report functional limitations even at 12 months post-injury. Functional status was largely unrelated to neurocognitive functioning, but related strongly to post-traumatic symptoms, life satisfaction, and emotional well-being, particularly at 3 months post-injury and beyond. Conclusion: Findings indicate that functional impairments related to mTBI may be more likely to persist than widely believed, with those who experience lingering functional deficits at particular risk for emotional health difficulties.	[Zahniser, Evan; Temkin, Nancy R.; Barber, Jason] Univ Washington, Dept Neurol Surg, Seattle, WA 98104 USA; [Temkin, Nancy R.] Univ Washington, Dept Biostat, Seattle, WA 98104 USA; [Machamer, Joan; Dikmen, Sureyya S.] Univ Washington, Dept Rehabil Med, 325 Ninth Ave,Box 359612, Seattle, WA 98104 USA; [Manley, Geoffrey T.; Markowitz, Amy J.] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA 94122 USA; [Adeoye, Opeolu; Foreman, Brandon; Kreitzer, Natalie] Univ Cincinnati, Cincinnati, OH 45221 USA; [Badjatia, Neeraj; Gullapalli, Rao] Univ Maryland, Baltimore, MD 21201 USA; [Boase, Kim; Chesnut, Randall; Ellenbogen, Richard] Univ Washington, Seattle, WA 98195 USA; [Bodien, Yelena; Rosand, Jonathan] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Bullock, M. Ross; Hotz, Gillian] Univ Miami, Coral Gables, FL 33124 USA; [Corrigan, John D.] Ohio State Univ, Columbus, OH 43210 USA; [Crawford, Karen; Gaudette, Etienne; Goldman, Dana; Seabury, Seth; Toga, Arthur] Univ Southern Calif, Los Angeles, CA 90007 USA; [Diaz-Arrastia, Ramon] Univ Penn, Philadelphia, PA 19104 USA; [Duhaime, Ann-Christine] Mass Gen Hosp Children, Boston, MA USA; [Feeser, V. Ramana; Merchant, Randall; Valadka, Alex] Virginia Commonwealth Univ, Richmond, VA 23284 USA; [Ferguson, Adam; Gardner, Raquel; Hemphill, J. Claude; Kramer, Joel; Martin, Alastair; Mukherjee, Pratik; Palacios, Eva; Taylor, Sabrina; Vassar, Mary; Yue, John; Yuh, Esther] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Giacino, Joseph] Spaulding Rehabil Hosp, Boston, MA USA; [Gonzalez, Luis; Sherer, Mark] TIRR Mem Hermann, Houston, TX USA; [Gopinath, Shankar; Levin, Harvey; Noel, Florence; Robertson, Claudia; Sander, Angelle] Baylor Coll Med, Houston, TX 77030 USA; [Jain, Sonia; Stein, Murray] Univ Calif San Diego, San Diego, CA 92103 USA; [Korley, Frederick] Univ Michigan, Ann Arbor, MI 48109 USA; [Lindsell, Chris] Vanderbilt Univ, 221 Kirkland Hall, Nashville, TN 37235 USA; [Madden, Christopher] UT Southwestern, Dallas, TX USA; [McAllister, Thomas] Indiana Univ, Bloomington, IN 47405 USA; [McCrea, Michael; Nelson, Lindsay] Med Coll Wisconsin, Milwaukee, WI 53226 USA; [Okonkwo, David; Puccio, Ava; Rabinowitz, Miri] Univ Pittsburgh, Pittsburgh, PA 15260 USA; [Perl, Daniel] Uniformed Serv Univ Hlth Sci, Bethesda, MD USA; [Schnyer, David] UT Austin, Austin, TX USA; [Vespa, Paul] Univ Calif Los Angeles, Los Angeles, CA USA; [Wang, Kevin] Univ Florida, Gainesville, FL 32611 USA; [Zafonte, Ross] Harvard Med Sch, Boston, MA 02115 USA		Dikmen, SS (corresponding author), Univ Washington, Dept Rehabil Med, 325 Ninth Ave,Box 359612, Seattle, WA 98104 USA.	dikmen@uw.edu	Goldman, Dana P/E-7667-2013; Badjatia, Neeraj/AAS-4855-2021; Hemphill, Claude/AAY-5630-2021; Giacino, Joseph/AAF-1952-2021; Schnyer, David/ABD-6372-2021	Goldman, Dana P/0000-0001-8498-6396; Hemphill, Claude/0000-0003-4019-7525; Giacino, Joseph/0000-0002-7916-9698; Schnyer, David/0000-0002-7472-2853; Zahniser, Evan/0000-0002-2505-1336; Markowitz, Amy/0000-0001-9314-2814	Department of DefenseUnited States Department of Defense [W81XWH-14-2-0176]; National Institutes of Health/National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [1U01NS086090]	This work was supported by the Department of Defense [U.S. Army grant number W81XWH-14-2-0176] and the National Institutes of Health/National Institute of Neurological Disorders and Stroke [grant number 1U01NS086090].	BERGNER M, 1976, MED CARE, V14, P57, DOI 10.1097/00005650-197601000-00006; Blevins CA, 2015, J TRAUMA STRESS, V28, P489, DOI 10.1002/jts.22059; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Chaytor N, 2007, J INT NEUROPSYCH SOC, V13, P377, DOI 10.1017/S1355617707070592; Cohen J., 2013, STAT POWER ANAL BEHA; Derogatis L.R., 2000, BRIEF SYMPTOM INVENT; DEROGATIS LR, 1983, PSYCHOL MED, V13, P595, DOI 10.1017/S0033291700048017; DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13; Diener E., 2008, J POSIT PSYCHOL, V3, P137, DOI [10.1080/17439760701756946, DOI 10.1080/17439760701756946]; Dijkers M, 1997, J HEAD TRAUMA REHAB, V12, P74, DOI 10.1097/00001199-199712000-00007; Dikmen S, 2001, J NEUROTRAUM, V18, P127, DOI 10.1089/08977150150502578; Dikmen SS, 2003, ARCH PHYS MED REHAB, V84, P1449, DOI 10.1016/S0003-9993(03)00287-9; Dikmen S, 2017, J NEUROTRAUM, V34, P1524, DOI 10.1089/neu.2016.4618; Granger C. V., 1986, TOP GERIATR REHABIL, V1, P59, DOI DOI 10.1097/00013614-198604000-00007; Granger CV, 1998, ARCH PHYS MED REHAB, V79, P52, DOI 10.1016/S0003-9993(98)90208-8; Hall KM, 1996, J HEAD TRAUMA REHAB, V11, P27, DOI 10.1097/00001199-199610000-00004; Hiploylee C, 2017, J NEUROTRAUM, V34, P1511, DOI 10.1089/neu.2016.4677; Hudak AM, 2012, J HEAD TRAUMA REHAB, V27, P87, DOI 10.1097/HTR.0b013e3182114efd; Hudak AM, 2005, J NEUROTRAUM, V22, P1319, DOI 10.1089/neu.2005.22.1319; JENNETT B, 1975, LANCET, V1, P480; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Korley FK, 2017, J NEUROTRAUM, V34, P1531, DOI 10.1089/neu.2016.4723; Kreutzer J., 1993, J HEAD TRAUMA REHAB, V8, P75, DOI [10.1097/00001199-199308020-00009, DOI 10.1097/00001199-199308020-00009]; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Machamer J, 2013, J NEUROTRAUM, V30, P1845, DOI 10.1089/neu.2013.2920; McCrea M, 2005, J INT NEUROPSYCH SOC, V11, P58, DOI 10.1017/S1355617705050083; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; Menon DK, 2015, NAT REV NEUROL, V11, P71, DOI 10.1038/nrneurol.2014.261; Nichol AD, 2011, INJURY, V42, P281, DOI 10.1016/j.injury.2010.11.047; Pagulayan KF, 2008, ARCH PHYS MED REHAB, V89, P1887, DOI 10.1016/j.apmr.2008.03.019; Pagulayan KF, 2006, ARCH PHYS MED REHAB, V87, P611, DOI 10.1016/j.apmr.2006.01.018; Potter S, 2006, J NEUROL, V253, P1603, DOI 10.1007/s00415-006-0275-z; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Recklitis CJ, 2006, PSYCHOL ASSESSMENT, V18, P22, DOI 10.1037/1040-3590.18.1.22; Schonberger M, 2011, J INT NEUROPSYCH SOC, V17, P781, DOI 10.1017/S1355617711000701; Sherer M, 2015, CLIN NEUROPSYCHOL, V29, P522, DOI 10.1080/13854046.2015.1052763; Shukla D, 2011, CLIN NEUROL NEUROSUR, V113, P435, DOI 10.1016/j.clineuro.2011.02.013; Silverberg ND, 2015, J NEUROTRAUM, V32, P517, DOI 10.1089/neu.2014.3600; Strauss E., 2006, COMPENDIUM NEUROPSYC, V3rd; Temkin NR, 2003, J NEUROTRAUM, V20, P229, DOI 10.1089/089771503321532815; Wechsler D., 2008, WECHSLER ADULT INTEL; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Wise EK, 2010, ARCH PHYS MED REHAB, V91, P1357, DOI 10.1016/j.apmr.2010.06.009	43	7	7	1	2	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0887-6177	1873-5843		ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	OCT	2019	34	7					1165	1174		10.1093/arclin/acy103			10	Psychology, Clinical; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	KF8XL	WOS:000509519900007	30608522	Bronze			2022-02-06	
J	Papinutto, N; Asteggiano, C; Bischof, A; Gundel, TJ; Caverzasi, E; Stern, WA; Bastianello, S; Hauser, SL; Henry, RG				Papinutto, Nico; Asteggiano, Carlo; Bischof, Antje; Gundel, Tristan J.; Caverzasi, Eduardo; Stern, William A.; Bastianello, Stefano; Hauser, Stephen L.; Henry, Roland G.			Intersubject Variability and Normalization Strategies for Spinal Cord Total Cross-Sectional and Gray Matter Areas	JOURNAL OF NEUROIMAGING			English	Article						Intersubject variability; magnetic resonance imaging; morphometry; normalization strategies; spinal cord	REMITTING MULTIPLE-SCLEROSIS; GREY-MATTER; IN-VIVO; PHYSICAL-DISABILITY; ATROPHY; BRAIN; SEGMENTATION; MRI; ROBUST; ACCURATE	BACKGROUND AND PURPOSE The quantification of spinal cord (SC) atrophy by MRI has assumed an important role in assessment of neuroinflammatory/neurodegenerative diseases and traumatic SC injury. Recent technical advances make possible the quantification of gray matter (GM) and white matter tissues in clinical settings. However, the goal of a reliable diagnostic, prognostic or predictive marker is still elusive, in part due to large intersubject variability of SC areas. Here, we investigated the sources of this variability and explored effective strategies to reduce it. METHODS One hundred twenty-nine healthy subjects (mean age: 41.0 +/- 15.9) underwent MRI on a Siemens 3T Skyra scanner. Two-dimensional PSIR at the C2-C3 vertebral level and a sagittal 1 mm(3) 3D T1-weighted brain acquisition extended to the upper cervical cord were acquired. Total cross-sectional area and GM area were measured at C2-C3, as well as measures of the vertebra, spinal canal and the skull. Correlations between the different metrics were explored using Pearson product-moment coefficients. The most promising metrics were used to normalize cord areas using multiple regression analyses. RESULTS The most effective normalization metrics were the V-scale (from SienaX) and the product of the C2-C3 spinal canal diameters. Normalization methods based on these metrics reduced the intersubject variability of cord areas of up to 17.74%. The measured cord areas had a statistically significant sex difference, while the effect of age was moderate. CONCLUSIONS The present work explored in a large cohort of healthy subjects the source of intersubject variability of SC areas and proposes effective normalization methods for its reduction.	[Papinutto, Nico; Asteggiano, Carlo; Bischof, Antje; Gundel, Tristan J.; Caverzasi, Eduardo; Stern, William A.; Hauser, Stephen L.; Henry, Roland G.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; [Asteggiano, Carlo; Caverzasi, Eduardo; Bastianello, Stefano] Univ Pavia, Dept Brain & Behav Sci, Pavia, Italy		Papinutto, N (corresponding author), Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA.	nico.papinutto@ucsf.edu	Caverzasi, Eduardo/P-1707-2019	Bastianello, Stefano/0000-0002-8414-9077; Caverzasi, Eduardo/0000-0002-0350-0460	NIH/NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R35NS111644]; NMSSNational Multiple Sclerosis Society [RR 2005-A-3]	Support for this study was provided by NIH/NINDS: R35NS111644 and NMSS: RR 2005-A-3.	Bakshi R, 2005, J NEUROIMAGING, V15, p30S, DOI 10.1177/1051228405283901; Carbonell-Caballero J, 2006, MAGN RESON MATER PHY, V19, P237, DOI 10.1007/s10334-006-0052-0; Casserly C, 2018, J NEUROIMAGING, V28, P556, DOI 10.1111/jon.12553; Castellano A, 2016, BRAIN, V139, P1735, DOI 10.1093/brain/aww068; Chen M, 2013, NEUROIMAGE, V83, P1051, DOI 10.1016/j.neuroimage.2013.07.060; Cohen AB, 2012, J NEUROIMAGING, V22, P122, DOI 10.1111/j.1552-6569.2011.00589.x; De Leener B, 2016, MAGN RESON MATER PHY, V29, P125, DOI 10.1007/s10334-015-0507-2; De Leener B, 2015, IEEE T MED IMAGING, V34, P1705, DOI 10.1109/TMI.2015.2437192; De Stefano N, J NEUROIMAGING S1, V17, p10s; El Mendili MM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095516; Engl C, 2013, NEURORADIOLOGY, V55, P963, DOI 10.1007/s00234-013-1204-3; Evangelou N, 2005, BRAIN, V128, P29, DOI 10.1093/brain/awh323; Fradet L, 2014, SPINE, V39, pE262, DOI 10.1097/BRS.0000000000000125; Furby J, 2008, MULT SCLER J, V14, P1068, DOI 10.1177/1352458508093617; Gros C, 2019, NEUROIMAGE, V184, P901, DOI 10.1016/j.neuroimage.2018.09.081; Healy BC, 2012, J NEUROIMAGING, V22, pE12, DOI 10.1111/j.1552-6569.2011.00629.x; Ishikawa M, 2003, SPINAL CORD, V41, P159, DOI 10.1038/sj.sc.3101375; Israel H, 2005, ARCH NEUROL-CHICAGO, V62, P1157, DOI 10.1001/archneur.62.7.1157; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; Kato F, 2012, EUR SPINE J, V21, P1499, DOI 10.1007/s00586-012-2176-4; Kearney H, 2015, J NEUROL NEUROSUR PS, V86, P608, DOI 10.1136/jnnp-2014-308241; Kearney H, 2013, MULT SCLER RELAT DIS, V2, P103, DOI 10.1016/j.msard.2012.09.005; Kearney H, 2014, MULT SCLER J, V20, P72, DOI 10.1177/1352458513492245; Kearney H, 2014, J MAGN RESON IMAGING, V39, P617, DOI 10.1002/jmri.24194; Klein JP, 2011, AM J NEURORADIOL, V32, P1138, DOI 10.3174/ajnr.A2459; Koh J, 2010, IEEE ENG MED BIO, P3117, DOI 10.1109/IEMBS.2010.5626097; Koo TK, 2016, J CHIROPR MED, V15, P155, DOI 10.1016/j.jcm.2016.02.012; Lundell H, 2017, ACTA NEUROL SCAND, V136, P330, DOI 10.1111/ane.12729; Mann RS, 2007, J MAGN RESON IMAGING, V26, P61, DOI 10.1002/jmri.20959; Oh J, 2014, J NEUROIMAGING, V24, P577, DOI 10.1111/jon.12097; Olney NT, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0208255; Papinutto N, 2019, J MAGN RESON IMAGING, V49, P1078, DOI 10.1002/jmri.26269; Papinutto N, 2015, J MAGN RESON IMAGING, V42, P698, DOI 10.1002/jmri.24819; Papinutto N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118576; Powers JM, 2000, J NEUROPATH EXP NEUR, V59, P89, DOI 10.1093/jnen/59.2.89; Prados F, 2017, NEUROIMAGE, V152, P312, DOI 10.1016/j.neuroimage.2017.03.010; Rashid W, 2006, J MAGN RESON IMAGING, V23, P473, DOI 10.1002/jmri.20545; Rocca MA, 2011, NEUROLOGY, V76, P2096, DOI 10.1212/WNL.0b013e31821f46b8; Rocca MA, 2013, J NEUROL NEUROSUR PS, V84, P35, DOI 10.1136/jnnp-2012-303821; Sanfilipo MP, 2004, NEUROIMAGE, V22, P1732, DOI 10.1016/j.neuroimage.2004.03.037; SCHLAEGER R, 2017, NEUROLOGY S, V88, pS2; Schlaeger R, 2015, JAMA NEUROL, V72, P897, DOI 10.1001/jamaneurol.2015.0993; Schlaeger R, 2014, ANN NEUROL, V76, P568, DOI 10.1002/ana.24241; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2002, NEUROIMAGE, V17, P479, DOI 10.1006/nimg.2002.1040; Smith SM, 2001, J COMPUT ASSIST TOMO, V25, P466, DOI 10.1097/00004728-200105000-00022; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Song F, 2008, J NEUROIMAGING, V18, P320, DOI 10.1111/j.1552-6569.2007.00222.x; Tang LH, 2013, MAGN RESON IMAGING, V31, P1507, DOI 10.1016/j.mri.2013.07.003; Taso M, 2014, MAGN RESON MATER PHY, V27, P257, DOI 10.1007/s10334-013-0403-6; Valsasina P, 2015, J NEUROL, V262, P1622, DOI 10.1007/s00415-015-7754-z; Yanase M, 2006, J SPINAL DISORD TECH, V19, P125, DOI 10.1097/01.bsd.0000181294.67212.79; Yiannakas MC, 2012, NEUROIMAGE, V63, P1054, DOI 10.1016/j.neuroimage.2012.07.048; Yiannakas MC, 2019, J NEUROIMAGING, V29, P410, DOI 10.1111/jon.12591; Yiannakas MC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105544; Zeydan B, 2018, NEUROL-NEUROIMMUNOL, V5, DOI 10.1212/NXI.0000000000000435; Ziegler G, 2018, NEUROLOGY, V90, pE1257, DOI 10.1212/WNL.0000000000005258; Zivadinov R, 2008, AM J NEURORADIOL, V29, P319, DOI 10.3174/ajnr.A0813	59	7	7	1	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1051-2284	1552-6569		J NEUROIMAGING	J. Neuroimaging	JAN	2020	30	1					110	118		10.1111/jon.12666		SEP 2019	9	Clinical Neurology; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	KB5LD	WOS:000488275400001	31571307	Green Accepted			2022-02-06	
J	Pugh, MJ; Swan, AA; Amuan, ME; Eapen, BC; Jaramillo, CA; Delgado, R; Tate, DF; Yaffe, K; Wang, CP				Pugh, Mary Jo; Swan, Alicia A.; Amuan, Megan E.; Eapen, Blessen C.; Jaramillo, Carlos A.; Delgado, Roxana; Tate, David F.; Yaffe, Kristine; Wang, Chen-Pin			Deployment, suicide, and overdose among comorbidity phenotypes following mild traumatic brain injury: A retrospective cohort study from the Chronic Effects of Neurotrauma Consortium	PLOS ONE			English	Article							POLYTRAUMA-CLINICAL-TRIAD; MISERABLE MINORITY; RISK-FACTORS; CHRONIC PAIN; VETERANS; AFGHANISTAN; IRAQ; ASSOCIATION; DISABILITY; SEVERITY	Mild traumatic brain injury in the Veteran population is frequently comorbid with pain, posttraumatic stress disorder, and/or depression. However, not everyone exposed to mild traumatic brain injury experiences these comorbidities and it is unclear what factors contribute to this variability. The objective of this study was to identify comorbidity phenotypes among Post-9/11 deployed Veterans with no or mild traumatic brain injury and examine the association of comorbidity phenotypes with adverse outcomes. We found that Veterans with mild traumatic brain injury (n = 93,003) and no brain injury (n = 434,378) were mean age of 32.0 (SD 9.21) on entering Department of Veterans Health Administration care, were predominantly Caucasian non-Hispanic (64.69%), and served in the Army (61.31%). Latent class analysis revealed five phenotypes in each subcohort; Moderately Healthy and Mental Health phenotypes were common to both. The Healthy phenotype was found only in no brain injury. Unique phenotypes in mild traumatic brain injury included Moderately Healthy+Decline, Polytrauma, and Polytrauma+Improvement. There was substantial variation in adverse outcomes. The Polytrauma+Improvement phenotype had the lowest likelihood of adverse outcomes. There were no differences between Moderately Healthy+Decline and Polytrauma phenotypes. Phenotypes of comorbidity vary significantly by traumatic brain injury status including divergence in phenotypes (and outcomes) over time in the mild traumatic brain injury subcohort. Understanding risk factors for the divergence between Polytrauma vs. Polytrauma+Improvement and Moderately Healthy vs. Moderately Healthy+Decline, will improve our ability to proactively mitigate risk, better understand the early patterns of comorbidity that are associated with neurodegenerative sequelae following mild traumatic brain injury, and plan more patient-centered care.	[Pugh, Mary Jo; Amuan, Megan E.] VA Salt Lake City Hlth Care Syst, Informat Decis Enhancement & Analyt Sci Ctr, Salt Lake City, UT 84148 USA; [Pugh, Mary Jo] Univ Utah, Sch Med, Dept Internal Med, Salt Lake City, UT 84132 USA; [Swan, Alicia A.] Univ Texas San Antonio, Dept Psychol, San Antonio, TX USA; [Eapen, Blessen C.] VA Greater Los Angeles Hlth Care Syst, Dept Phys Med & Rehabil, Los Angeles, CA USA; [Eapen, Blessen C.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90095 USA; [Jaramillo, Carlos A.; Delgado, Roxana] South Texas Vet Hlth Care Syst, Polytrauma Rehabil Ctr, San Antonio, TX USA; [Tate, David F.] Univ Missouri, Missouri Inst Mental Hlth, St Louis, MO 63121 USA; [Yaffe, Kristine] Univ Calif San Francisco, Dept Psychiat Neurol & Epidemiol, San Francisco, CA 94143 USA; [Wang, Chen-Pin] Univ Texas Hlth Sci Ctr San Antonio, Dept Epidemiol & Biostat, San Antonio, TX 78229 USA		Pugh, MJ (corresponding author), VA Salt Lake City Hlth Care Syst, Informat Decis Enhancement & Analyt Sci Ctr, Salt Lake City, UT 84148 USA.; Pugh, MJ (corresponding author), Univ Utah, Sch Med, Dept Internal Med, Salt Lake City, UT 84132 USA.	MaryJo.Pugh@hsc.utah.edu	Swan, Alicia A/O-3536-2018; Tate, David/G-5166-2011	Swan, Alicia A/0000-0003-2412-0499; Pugh, Mary Jo/0000-0003-4196-7763; Tate, David/0000-0003-0213-1920	U.S. Department of Veterans Affairs funds [I01CX001246]; U.S. Department of DefenseUnited States Department of Defense [W81XWH-13-2-0095-04]; Veterans AffairsUS Department of Veterans Affairs [I01CX001135] Funding Source: NIH RePORTER	This study was supported by U.S. Department of Veterans Affairs funds, I01CX001246, https://www.research.va.gov, to MJP; and U.S. Department of Defense W81XWH-13-2-0095-04, http://cdmrp.army.mil, to KY. The sponsors played no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	Amick MM, 2018, J HEAD TRAUMA REHAB, V33, pE30, DOI 10.1097/HTR.0000000000000308; Bosco MA, 2013, HEADACHE J HEAD FACE; Brickell TA, 2014, MIL MED, V179, P827, DOI 10.7205/MILMED-D-13-00506; Collett Garen A, 2016, Drugs Real World Outcomes, V3, P45; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Edens EL, 2011, AM J ADDICTION, V20, P412, DOI 10.1111/j.1521-0391.2011.00166.x; Helmick KM, 2015, BRAIN IMAGING BEHAV, V9, P358, DOI 10.1007/s11682-015-9399-z; Jaramillo CA, 2015, BRAIN IMAGING BEHAV, V9, P445, DOI 10.1007/s11682-015-9402-8; Johnson DC, 2014, AM J PSYCHIAT, V171, P844, DOI 10.1176/appi.ajp.2014.13040502; Lew HL, 2009, J REHABIL RES DEV, V46, P697, DOI 10.1682/JRRD.2009.01.0006; Lippa SM, 2015, J TRAUMA STRESS, V28, P25, DOI 10.1002/jts.21979; Military Health System, 2016, SURV CAS DEF 13 0 NE; North CS, 2004, AM J PUBLIC HEALTH, V94, P103, DOI 10.2105/AJPH.94.1.103; Peixoto C, 2018, J PAIN RES, V11, P1927, DOI 10.2147/JPR.S165077; Peterson R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132664; Pugh MJ, 2018, ARCH PHYS MED REHAB, V99, pS40, DOI 10.1016/j.apmr.2017.05.021; Pugh MJ, 2016, BRAIN INJURY, V30, P1481, DOI 10.1080/02699052.2016.1219055; Pugh MJV, 2014, MED CARE, V52, P172, DOI 10.1097/MLR.0000000000000059; Rohling ML, 2012, CLIN NEUROPSYCHOL, V26, P197, DOI 10.1080/13854046.2011.647085; Ruff RM, 1996, BRAIN INJURY, V10, P551, DOI 10.1080/026990596124124; Seal KH, 2009, AM J PUBLIC HEALTH, V99, P1651, DOI 10.2105/AJPH.2008.150284; Swan AA, 2018, BRAIN INJURY, V32, P1197, DOI 10.1080/02699052.2018.1495340; Tanielian T., 2017, IMPROVING SUPPORT AM, DOI 10.7249/RB9950; The Management of Concussion-mild Traumatic Brain Injury Working Group, VA DOD CLIN PRACT GU; Wang C-P, 2012, RESIDUAL DIAGNOSTICS; Wood RL, 2004, BRAIN INJURY, V18, P1135, DOI 10.1080/02699050410001675906	26	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2019	14	9							e0222674	10.1371/journal.pone.0222674			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LM5OJ	WOS:000532297900025	31539410	Green Submitted, gold, Green Published			2022-02-06	
J	Klein, SP; De Sloovere, V; Meyfroidt, G; Depreitere, B				Klein, S. P.; De Sloovere, V.; Meyfroidt, G.; Depreitere, B.			Autoregulation assessment by direct visualisation of pial arterial blood flow in the piglet brain	SCIENTIFIC REPORTS			English	Article							LASER-DOPPLER; ANIMAL-MODELS; PRESSURE; MECHANISMS; VELOCITY; INJURY; CELLS; LIMIT; PIGS	Impairment of cerebrovascular autoregulation (CAR) is common after brain injury, although the pathophysiology remains elusive. The mechanisms of vascular dysregulation, their impact on brain function, and potential therapeutic implications are still incompletely understood. Clinical assessment of CAR remains challenging. Observational studies suggest that CAR impairment is associated with worse outcomes, and that optimization of cerebral blood flow (CBF) by individual arterial blood pressure (ABP) targets could potentially improve outcome. We present a porcine closed cranial window model that measures the hemodynamic response of pial arterioles, the main site of CBF control, based on changes in their diameter and red blood cell velocity. This quantitative direct CAR assessment is compared to laser Doppler flow (LDF). CAR breakpoints are determined by segmented regression analysis and validated using LDF and brain tissue oxygen pressure. Using a standardized cortical impact, CAR impairment in traumatic brain injury can be studied using our method of combining pial arteriolar diameter and RBC velocity to quantify RBC flux in a large animal model. The model has numerous potential applications to investigate CAR physiology and pathophysiology of CAR impairment after brain injury, the impact of therapeutic interventions, drugs, and other confounders, or to develop personalized ABP management strategies.	[Klein, S. P.; Depreitere, B.] Univ Hosp Leuven, Dept Neurosurg, Leuven, Belgium; [De Sloovere, V.] Univ Hosp Leuven, Dept Anesthesiol, Leuven, Belgium; [Meyfroidt, G.] Univ Hosp Leuven, Dept Intens Care Med, Leuven, Belgium		Klein, SP (corresponding author), Univ Hosp Leuven, Dept Neurosurg, Leuven, Belgium.	sam.klein@kuleuven.be	Depreitere, Bart/AAA-9846-2020; Klein, Samuel/AAB-3327-2020	Depreitere, Bart/0000-0002-7458-0648; Klein, Samuel/0000-0001-5595-4440	Johnson & Johnson Research Chair in Profound analysis of cerebrovascular pressure autoregulation	This work was supported in part by a Johnson & Johnson Research Chair in Profound analysis of cerebrovascular pressure autoregulation and associated physiological variables in severe traumatic brain injury at KU Leuven University.	Armstead WM, 2017, J NEUROTRAUM, V34, P1666, DOI 10.1089/neu.2016.4770; Barfod C, 1997, ACTA PHYSIOL SCAND, V160, P123, DOI 10.1046/j.1365-201X.1997.00130.x; Bishai JM, 2003, J PHYSIOL-LONDON, V546, P869, DOI 10.1113/jphysiol.2002.025270; BUCKLEY NM, 1986, COMP BIOCHEM PHYS A, V83, P1, DOI 10.1016/0300-9629(86)90080-0; BUSIJA DW, 1985, PEDIATR RES, V19, P1210, DOI 10.1203/00006450-198511000-00020; Croce AC, 2014, EUR J HISTOCHEM, V58, P320, DOI 10.4081/ejh.2014.2461; Daley ML, 2004, STROKE, V35, P1952, DOI 10.1161/01.STR.0000133690.94288.c9; DALEY ML, 1995, IEEE T BIO-MED ENG, V42, P420, DOI 10.1109/10.376137; Duhaime AC, 2006, DEV NEUROSCI-BASEL, V28, P380, DOI 10.1159/000094164; EYRE JA, 1988, CLIN PHYS PHYSIOL M, V9, P65, DOI 10.1088/0143-0815/9/1/006; Giarratana MC, 2005, NAT BIOTECHNOL, V23, P69, DOI 10.1038/nbt1047; HABERL RL, 1989, AM J PHYSIOL, V256, pH1247, DOI 10.1152/ajpheart.1989.256.4.H1247; Hamner JW, 2014, STROKE, V45, P1771, DOI 10.1161/STROKEAHA.114.005293; Iadecola C, 2004, NAT REV NEUROSCI, V5, P347, DOI 10.1038/nrn1387; Kassab GS, 1997, ANN BIOMED ENG, V25, P204, DOI 10.1007/BF02738551; Kinder HA, 2019, NEURAL REGEN RES, V14, P413, DOI 10.4103/1673-5374.245334; Kisler K, 2017, NAT REV NEUROSCI, V18, P419, DOI 10.1038/nrn.2017.48; KONTOS HA, 1989, STROKE, V20, P1; Lassen N, 1959, PHYSL REV, V39; LEVASSEUR JE, 1975, STROKE, V6, P308, DOI 10.1161/01.STR.6.3.308; Manley GT, 2006, J NEUROTRAUM, V23, P128, DOI 10.1089/neu.2006.23.128; Needham E, 2017, J NEUROTRAUM, V34, P963, DOI 10.1089/neu.2016.4450; Ngai AC, 1996, AM J PHYSIOL-HEART C, V270, pH1712, DOI 10.1152/ajpheart.1996.270.5.H1712; Panerai RB, 2008, CARDIOVASC ENG, V8, P42, DOI 10.1007/s10558-007-9044-6; Pastor P, 2019, BRAIN RES, V1711, P1, DOI 10.1016/j.brainres.2019.01.008; Pesek M, 2014, NEUROSURGERY, V75, P163, DOI 10.1227/NEU.0000000000000367; ROVAINEN CM, 1993, J CEREBR BLOOD F MET, V13, P359, DOI 10.1038/jcbfm.1993.49; Shih AY, 2012, J CEREBR BLOOD F MET, V32, P1277, DOI 10.1038/jcbfm.2011.196; Shih AY, 2009, J CEREBR BLOOD F MET, V29, P738, DOI 10.1038/jcbfm.2008.166; Steiner LA, 2002, CRIT CARE MED, V30, P733, DOI 10.1097/00003246-200204000-00002; TALBOT RB, 1970, AM J PHYSIOL, V218, P1141, DOI 10.1152/ajplegacy.1970.218.4.1141; Tan CO, 2014, EXP PHYSIOL, V99, P3, DOI 10.1113/expphysiol.2013.072355; Tonnesen J, 2005, EXP PHYSIOL, V90, P349, DOI 10.1113/expphysiol.2004.029512; Willie CK, 2014, J PHYSIOL-LONDON, V592, P841, DOI 10.1113/jphysiol.2013.268953; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Zeiler F. A, 2018, J NEUROTRAUMA NEU, V2017, P5604	36	7	7	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	SEP 16	2019	9								13333	10.1038/s41598-019-50046-x			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IX7KF	WOS:000485861500058	31527671	gold, Green Published			2022-02-06	
J	Dinsdale, RJ; Hazeldine, J; Al Tarrah, K; Hampson, P; Devi, A; Ermogenous, C; Bamford, AL; Bishop, J; Watts, S; Kirkman, E; Lucca, JJD; Midwinter, M; Woolley, T; Foster, M; Lord, JM; Moiemen, N; Harrison, P				Dinsdale, R. J.; Hazeldine, J.; Al Tarrah, K.; Hampson, P.; Devi, A.; Ermogenous, C.; Bamford, A. L.; Bishop, J.; Watts, S.; Kirkman, E.; Lucca, J. J. Dalle; Midwinter, M.; Woolley, T.; Foster, M.; Lord, J. M.; Moiemen, N.; Harrison, P.			Dysregulation of the actin scavenging system and inhibition of DNase activity following severe thermal injury	BRITISH JOURNAL OF SURGERY			English	Article							FRESH-FROZEN PLASMA; NEUTROPHIL EXTRACELLULAR TRAPS; TRAUMATIC BRAIN-INJURY; LARGE ANIMAL-MODEL; GELSOLIN LEVELS; GC-GLOBULIN; LYOPHILIZED PLASMA; BURN; SEPSIS; DYSFUNCTION	Background Circulating cell-free DNA (cfDNA) is not found in healthy subjects, but is readily detected after thermal injury and may contribute to the risk of multiple organ failure. The hypothesis was that a postburn reduction in DNase protein/enzyme activity could contribute to the increase in cfDNA following thermal injury. Methods Patients with severe burns covering at least 15 per cent of total body surface area were recruited to a prospective cohort study within 24 h of injury. Blood samples were collected from the day of injury for 12 months. Results Analysis of blood samples from 64 patients revealed a significant reduction in DNase activity on days 1-28 after injury, compared with healthy controls. DNase protein levels were not affected, suggesting the presence of an enzyme inhibitor. Further analysis revealed that actin (an inhibitor of DNase) was present in serum samples from patients but not those from controls, and concentrations of the actin scavenging proteins gelsolin and vitamin D-binding protein were significantly reduced after burn injury. In a pilot study of ten military patients with polytrauma, administration of blood products resulted in an increase in DNase activity and gelsolin levels. Conclusion The results of this study suggest a novel biological mechanism for the accumulation of cfDNA following thermal injury by which high levels of actin released by damaged tissue cause a reduction in DNase activity. Restoration of the actin scavenging system could therefore restore DNase activity, and reduce the risk of cfDNA-induced host tissue damage and thrombosis.	[Dinsdale, R. J.; Al Tarrah, K.; Hampson, P.; Devi, A.; Bamford, A. L.; Lord, J. M.; Moiemen, N.; Harrison, P.] Univ Hosp Birmingham NHS Fdn Trust, Birmingham Ctr Burns Res, Scar Free Fdn, Birmingham, W Midlands, England; [Hazeldine, J.; Bishop, J.; Foster, M.; Lord, J. M.] Univ Hosp Birmingham NHS Fdn Trust, Natl Inst Hlth Res Surg Reconstruct & Microbiol, Res Ctr, Birmingham, W Midlands, England; [Dinsdale, R. J.; Hazeldine, J.; Al Tarrah, K.; Hampson, P.; Devi, A.; Ermogenous, C.; Foster, M.; Lord, J. M.; Moiemen, N.; Harrison, P.] Univ Birmingham, Inst Inflammat & Ageing, Birmingham B15 2TT, W Midlands, England; [Woolley, T.] Birmingham Res Pk, ICT Ctr, Birmingham, W Midlands, England; [Watts, S.; Kirkman, E.; Woolley, T.] Def Sci & Technol Lab, Chem Biol & Radiol CBR Div, Salisbury, Wilts, England; [Lucca, J. J. Dalle] Def Threat Reduct Agcy, Dept Chem & Biol Technol, Translat Med Div, Ft Belvoir, VA USA; [Midwinter, M.] Univ Queensland, Sch Biomed Sci, Brisbane, Qld, Australia		Harrison, P (corresponding author), Univ Birmingham, Inst Inflammat & Ageing, Birmingham B15 2TT, W Midlands, England.	p.harrison.1@bham.ac.uk	Woolley, Tom/D-8110-2012; Harrison, Paul/AAN-1916-2021; Foster, Mark Anthony/AAS-9284-2020	Woolley, Tom/0000-0001-9957-6453; Harrison, Paul/0000-0003-4610-8909; Bishop, Jonathan/0000-0003-1789-5886; Lord, Janet/0000-0003-1030-6786	Scar Free Foundation; NIHR-SRMRC	The authors thank the nursing team at the Birmingham Burns Centre for their assistance with sample collection. They acknowledge the Scar Free Foundation and the National Institute for Health Research Surgical Reconstruction and Microbiology Research Centre (NIHR-SRMRC), a partnership between University Hospitals Birmingham NHS Foundation Trust, the University of Birmingham and the Royal Centre for Defence Medicine. This work was funded by the Scar Free Foundation and NIHR-SRMRC.	Al-Mayouf SM, 2011, NAT GENET, V43, P1186, DOI 10.1038/ng.975; Ananthakrishnan R, 2007, INT J BIOL SCI, V3, P303; Bhagirath VC, 2015, SHOCK, V44, P265, DOI 10.1097/SHK.0000000000000397; Boneschansker L, 2016, INTEGR BIOL-UK, V8, P149, DOI 10.1039/c5ib00265f; Chhabra D, 2005, PROTEOMICS, V5, P3131, DOI 10.1002/pmic.200401127; Clark SR, 2007, NAT MED, V13, P463, DOI 10.1038/nm1565; Cohen J, 2015, LANCET INFECT DIS, V15, P581, DOI 10.1016/S1473-3099(15)70112-X; Dahl B, 1999, INJURY, V30, P275, DOI 10.1016/S0020-1383(99)00080-7; Dahl B, 2003, CRIT CARE MED, V31, P152, DOI 10.1097/00003246-200301000-00024; Dahl B, 2001, INTENS CARE MED, V27, P394, DOI 10.1007/s001340000837; Dahl P, 1998, CRIT CARE MED, V26, P285, DOI 10.1097/00003246-199802000-00027; DiNubile MJ, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2547; Dwivedi DJ, 2012, CRIT CARE, V16, DOI 10.1186/cc11466; Engelmann B, 2013, NAT REV IMMUNOL, V13, P34, DOI 10.1038/nri3345; Fuchs TA, 2012, ARTERIOSCL THROM VAS, V32, P1777, DOI 10.1161/ATVBAHA.111.242859; Fuchs TA, 2010, P NATL ACAD SCI USA, V107, P15880, DOI 10.1073/pnas.1005743107; Georgoff PE, 2017, J NEUROTRAUM, V34, P2167, DOI 10.1089/neu.2016.4859; Greenhalgh DG, 2007, J BURN CARE RES, V28, P776, DOI 10.1097/BCR.0b013e3181599bc9; Gupta AK, 2010, FEBS LETT, V584, P3193, DOI 10.1016/j.febslet.2010.06.006; Hagiwara A, 2016, SHOCK, V45, P495, DOI 10.1097/SHK.0000000000000536; Hakkim A, 2010, P NATL ACAD SCI USA, V107, P9813, DOI 10.1073/pnas.0909927107; Halaweish I, 2016, J TRAUMA ACUTE CARE, V81, P1080, DOI 10.1097/TA.0000000000001204; Hampson P, 2017, ANN SURG, V265, P1241, DOI 10.1097/SLA.0000000000001807; Hu YL, 2013, LUPUS, V22, P1455, DOI 10.1177/0961203313507985; Huang LF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025748; Imam AM, 2013, J TRAUMA ACUTE CARE, V75, P976, DOI 10.1097/TA.0b013e31829e2186; ITO H, 1992, GASTROENTEROLOGY, V102, P1686, DOI 10.1016/0016-5085(92)91731-I; Jackson PC, 2014, ANN SURG, V259, P979, DOI 10.1097/SLA.0b013e31829160ca; Jimenez-Alcazar M, 2015, J THROMB HAEMOST, V13, P732, DOI 10.1111/jth.12796; Kaplan MJ, 2012, J IMMUNOL, V189, P2689, DOI 10.4049/jimmunol.1201719; KWIATKOWSKI DJ, 1989, J CELL BIOL, V108, P1717, DOI 10.1083/jcb.108.5.1717; LAZARIDES E, 1974, P NATL ACAD SCI USA, V71, P4742, DOI 10.1073/pnas.71.12.4742; Lee PS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003712; LEE WM, 1992, NEW ENGL J MED, V326, P1335; LIND SE, 1988, AM REV RESPIR DIS, V138, P429, DOI 10.1164/ajrccm/138.2.429; Lo YMD, 2000, CLIN CHEM, V46, P319; Mann EA, 2012, SHOCK, V37, P4, DOI 10.1097/SHK.0b013e318237d6bf; Meng W, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/149560; Mesar T, 2017, JAMA SURG, V152, P574, DOI 10.1001/jamasurg.2017.0098; Mitra B, 2010, INJURY, V41, P35, DOI 10.1016/j.injury.2009.09.029; Mogilner A, 1996, BIOPHYS J, V71, P3030, DOI 10.1016/S0006-3495(96)79496-1; Mounzer KC, 1999, AM J RESP CRIT CARE, V160, P1673, DOI 10.1164/ajrccm.160.5.9807137; Napirei M, 2005, BIOCHEM J, V389, P355, DOI 10.1042/BJ20042124; Napirei M, 2009, FEBS J, V276, P1059, DOI 10.1111/j.1742-4658.2008.06849.x; Naumann DN, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0189870; Osborn TM, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2520; Osler T, 2010, J TRAUMA, V68, P690, DOI 10.1097/TA.0b013e3181c453b3; Otawara M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-34952-0; Rhodes A, 2006, CRIT CARE, V10, DOI 10.1186/cc4894; Rothenbach PA, 2004, J APPL PHYSIOL, V96, P25, DOI 10.1152/japplphysiol.01074.2002; Saukkonen K, 2008, CLIN CHEM, V54, P1000, DOI 10.1373/clinchem.2007.101030; Shoham Y, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/306580; Sillesen M, 2014, J TRAUMA ACUTE CARE, V76, P998, DOI 10.1097/TA.0000000000000193; Srinivasan N, 2016, ELIFE, V5, DOI 10.7554/eLife.19662; Suhler E, 1997, CRIT CARE MED, V25, P594, DOI 10.1097/00003246-199704000-00007; Thierry AR, 2016, CANCER METAST REV, V35, P347, DOI 10.1007/s10555-016-9629-x; TOBIASEN J, 1982, ANN EMERG MED, V11, P260, DOI 10.1016/S0196-0644(82)80096-6; Watts S, 2015, SHOCK, V44, P138, DOI 10.1097/SHK.0000000000000409; Xiao WZ, 2011, J EXP MED, V208, P2581, DOI 10.1084/jem.20111354; YIN HL, 1988, J CELL BIOL, V106, P805, DOI 10.1083/jcb.106.3.805; Zhang LM, 2017, WORLD NEUROSURG, V104, P381, DOI 10.1016/j.wneu.2017.04.140	61	7	8	1	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0007-1323	1365-2168		BRIT J SURG	Br. J. Surg.	MAR	2020	107	4					391	401		10.1002/bjs.11310		SEP 2019	11	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	KR8AP	WOS:000485937600001	31502663	Green Published, hybrid			2022-02-06	
J	Motes, MA; Spence, JS; Yeatman, K; Jones, PM; Lutrell, M; O'Hair, R; Shakal, S; DeLaRosa, BL; To, W; Vanneste, S; Kraut, MA; Hart, J				Motes, Michael A.; Spence, Jeffrey S.; Yeatman, Kylee; Jones, Penelope M.; Lutrell, Morgan; O'Hair, Rachel; Shakal, Scott; DeLaRosa, Bambi L.; To, Wing; Vanneste, Sven; Kraut, Michael A.; Hart, John, Jr.			High-Definition Transcranial Direct Current Stimulation to Improve Verbal Retrieval Deficits in Chronic Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						learning and memory; neuroplasticity; rehabilitation; traumatic brain injury	WORD; TDCS; HEALTHY; MEMORY; METAANALYSIS; ACTIVATION; FACILITATION; MODULATION; DEPRESSION; CORTEX	Chronic verbal retrieval deficits have been noted in traumatic brain injury (TBI), but no U.S. Food and Drug Administration-approved interventions are available. The present study investigated whether 10 sessions of 20 min of 1 mA anodal high-definition transcranial direct current stimulation (HD-tDCS) targeting pre-supplementary motor area/dorsal anterior cingulate cortex (preSMA/dACC) compared with sham HD-tDCS would improve verbal retrieval deficits in TBI patients. Improvements in verbal retrieval processes were observed up to 8 weeks post-treatment. Thus, potential dysfunction to verbal retrieval circuitry in TBI appears amenable to remediation through electromodulation with HD tDCS to the preSMA/dACC. Although further studies clarifying mechanisms by which tDCS brought about these improvements will likely inform refinements in the application of this therapeutic technique, the findings suggest the efficacy of using HD-tDCS to target other systems vulnerable to TBI to improve functioning.	[Motes, Michael A.; Yeatman, Kylee; Lutrell, Morgan; O'Hair, Rachel; Shakal, Scott; DeLaRosa, Bambi L.; To, Wing; Vanneste, Sven; Hart, John, Jr.] Univ Texas Dallas, Callier Ctr Dallas, Room A115,1966 Inwood Rd, Dallas, TX 75235 USA; [Spence, Jeffrey S.] Univ Texas Dallas, Ctr Brain Hlth, Dallas, TX USA; [Jones, Penelope M.] US DOE, Washington, DC 20585 USA; [Kraut, Michael A.] Johns Hopkins Univ, Dept Radiol, Baltimore, MD USA; [Hart, John, Jr.] Univ Texas Southwestern Med Ctr Dallas, Dept Neurol & Neurotherapeut & Psychiat, Dallas, TX 75390 USA		Hart, J (corresponding author), Univ Texas Dallas, Callier Ctr Dallas, Room A115,1966 Inwood Rd, Dallas, TX 75235 USA.	jhart@utdallas.edu		Vanneste, Sven/0000-0003-1513-5752	Boot Campaign	The authors wish to thank the Veterans who participated in the study, and they also wish to thank the Boot Campaign for financial support and for referring participants to the study. The views expressed here do not necessarily reflect those of the United States Department of Energy or the United States government.	Alharbi MF, 2017, BEHAV BRAIN RES, V332, P7, DOI 10.1016/j.bbr.2017.05.050; Beck AT, 1996, J PERS ASSESS, V67, P588, DOI 10.1207/s15327752jpa6703_13; Bikson M, 2004, J PHYSIOL-LONDON, V557, P175, DOI 10.1113/jphysiol.2003.055772; Bikson M, 2013, FRONT NEUROSCI, P55; Bolzoni F, 2013, J PHYSIOL-LONDON, V591, P3381, DOI 10.1113/jphysiol.2012.244764; Bonnelle V, 2012, P NATL ACAD SCI USA, V109, P4690, DOI 10.1073/pnas.1113455109; Carreiras M, 2006, HUM BRAIN MAPP, V27, P963, DOI 10.1002/hbm.20236; Chao HHA, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-75; Chee MWL, 1999, HUM BRAIN MAPP, V7, P15, DOI 10.1002/(SICI)1097-0193(1999)7:1<15::AID-HBM2>3.0.CO;2-6; Cirillo G, 2017, BRAIN STIMUL, V10, P1, DOI 10.1016/j.brs.2016.11.009; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P318, DOI 10.1097/01.HTR.0000300227.67748.77; Crosson B, 2003, J INT NEUROPSYCH SOC, V9, P1061, DOI 10.1017/S135561770397010X; Crosson B, 2001, J COGNITIVE NEUROSCI, V13, P272, DOI 10.1162/089892901564225; Dedoncker J, 2016, BRAIN STIMUL, V9, P501, DOI 10.1016/j.brs.2016.04.006; Delis DC., 2001, DELIS KAPLAN EXECUTI; Dhaliwal SK, 2015, FRONT PSYCHIATRY, V6, DOI 10.3389/fpsyt.2015.00119; Diaz-Arrastia R, 2014, J NEUROTRAUM, V31, P135, DOI 10.1089/neu.2013.3019; Edwards D, 2013, NEUROIMAGE, V74, P266, DOI 10.1016/j.neuroimage.2013.01.042; Fertonani A, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00131; Fertonani A, 2010, BEHAV BRAIN RES, V208, P311, DOI 10.1016/j.bbr.2009.10.030; Hamsher K., 1994, MULTILINGUAL APHASIA; Hart J, 2013, BRAIN LANG, V126, P89, DOI 10.1016/j.bandl.2012.08.002; Henry JD, 2004, NEUROPSYCHOLOGY, V18, P621, DOI 10.1037/0894-4105.18.4.621; Hertrich I, 2016, NEUROSCI BIOBEHAV R, V68, P602, DOI 10.1016/j.neubiorev.2016.06.030; Hill AT, 2016, BRAIN STIMUL, V9, P197, DOI 10.1016/j.brs.2015.10.006; Jackson MP, 2016, CLIN NEUROPHYSIOL, V127, P3425, DOI 10.1016/j.clinph.2016.08.016; Jones EG, 2001, TRENDS NEUROSCI, V24, P595, DOI 10.1016/S0166-2236(00)01922-6; Kaplan E, 1983, BOSTON NAMING TEST; King KA, 2006, BRAIN INJURY, V20, P725, DOI 10.1080/02699050600743824; Konrad C, 2011, PSYCHOL MED, V41, P1197, DOI 10.1017/S0033291710001728; Kraut MA, 2002, J COGNITIVE NEUROSCI, V14, P24, DOI 10.1162/089892902317205294; Kraut MA, 2003, J INT NEUROPSYCH SOC, V9, P1031, DOI 10.1017/S135561770397007X; Kwon YH, 2013, NEURAL REGEN RES, V8, P1048, DOI 10.3969/j.issn.1673-5374.2013.11.011; Leroi I, 2013, J NEUROPSYCHOL, V7, P306, DOI 10.1111/jnp.12026; Lesniak M, 2014, J HEAD TRAUMA REHAB, V29, pE20, DOI 10.1097/HTR.0b013e318292a4c2; Li SS, 2015, NEUROPSYCH DIS TREAT, V11, P1573, DOI 10.2147/NDT.S65816; Llinas R, 1998, PHILOS T ROY SOC B, V353, P1841, DOI 10.1098/rstb.1998.0336; Miller J, 2015, NEUROSCI LETT, V588, P114, DOI 10.1016/j.neulet.2015.01.014; Monti A, 2008, J NEUROL NEUROSUR PS, V79, P451, DOI 10.1136/jnnp.2007.135277; Nikolin S, 2015, NEUROIMAGE, V117, P11, DOI 10.1016/j.neuroimage.2015.05.019; PELLETIER SJ, 2015, INT J NEUROPSYCHOPH, V18, P1; Pellicciari MC, 2013, NEUROIMAGE, V83, P569, DOI 10.1016/j.neuroimage.2013.06.076; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; Rey A, 1941, ARCH PSYCHOLOGIE, V28, P286; Sharp DJ, 2010, P NATL ACAD SCI USA, V107, P6106, DOI 10.1073/pnas.1000175107; Silver JM, 2009, AM J PSYCHIAT, V166, P653, DOI 10.1176/appi.ajp.2009.08111676; Talsma LJ, 2017, J COGNITIVE NEUROSCI, V29, P755, DOI 10.1162/jocn_a_01077; Ulam F, 2015, CLIN NEUROPHYSIOL, V126, P486, DOI 10.1016/j.clinph.2014.05.015; Ulrich M, 2013, J COGNITIVE NEUROSCI, V25, P2216, DOI 10.1162/jocn_a_00449; Usrey WM, 1999, ANNU REV PHYSIOL, V61, P435, DOI 10.1146/annurev.physiol.61.1.435; VAKIL E, 1993, J CLIN PSYCHOL, V49, P883, DOI 10.1002/1097-4679(199311)49:6<883::AID-JCLP2270490616>3.0.CO;2-6; Vannorsdall Tracy D, 2012, Front Psychiatry, V3, P73, DOI 10.3389/fpsyt.2012.00073; Weathers F.W., 2013, PTSD CHECKLIST DSM 5; Wechsler D., 2008, WECHSLER ADULT INTEL; Westwood SJ, 2017, NEUROPSYCHOLOGIA, V104, P234, DOI 10.1016/j.neuropsychologia.2017.07.031; Westwood SJ, 2017, CORTEX, V86, P64, DOI 10.1016/j.cortex.2016.10.016; Wood, 1997, EVALUATING STRESS BO, P23, DOI DOI 10.1007/978-0-387-79948-3_1972	57	7	8	2	3	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN 1	2020	37	1					170	177		10.1089/neu.2018.6331		SEP 2019	8	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	KA2YK	WOS:000485104900001	31354040				2022-02-06	
J	Bodanapally, UK; Shanmuganathan, K; Ramaswamy, M; Tsymbalyuk, S; Aarabi, B; Parikh, GY; Schwartzbauer, G; Dreizin, D; Simard, M; Ptak, T; Li, G; Liang, YY; Fleiter, TR				Bodanapally, Uttam K.; Shanmuganathan, Kathirkamanathan; Ramaswamy, Meghna; Tsymbalyuk, Solomiya; Aarabi, Bizhan; Parikh, Gunjan Y.; Schwartzbauer, Gary; Dreizin, David; Simard, Marc; Ptak, Thomas; Li, Guang; Liang, Yuanyuan; Fleiter, Thorsten R.			Iodine-based Dual-Energy CT of Traumatic Hemorrhagic Contusions: Relationship to In-Hospital Mortality and Short-term Outcome	RADIOLOGY			English	Article							SEVERE HEAD-INJURY; BRAIN-INJURY; UNITED-STATES; CLASSIFICATION; PROGRESSION; PREDICTION; DIAGNOSIS; SCALE; COMA	Background: Traumatic hemorrhagic contusions are associated with iodine leak; however, quantification of leakage and its importance to outcome is unclear. Purpose: To identify iodine-based dual-energy CT variables that correlate with in-hospital mortality and short-term outcomes for contusions at hospital discharge. Materials and Methods: In this retrospective study, consecutive patients with contusions from May 2016 through January 2017 were analyzed. Two radiologists evaluated CT variables from unenhanced admission head CT and follow-up head dual-energy CT scans obtained after contrast material-enhanced whole-body CT. The outcomes evaluated were in-hospital mortality, Rancho Los Amigos scale (RLAS) score, and disability rating scale (DRS) score. Logistic regression and linear regression were used to develop prediction models for categorical and continuous outcomes, respectively. Results: The study included 65 patients (median age, 48 years; interquartile range, 25-65.5 years); 50 were men. Dual-energy CT variables that correlated with mortality, RLAS score, and DRS score were iodine concentration, pseudohematoma volume, iodine quantity in pseudohematoma, and iodine quantity in contusion. The single-energy CT variable that correlated with mortality, RLAS score, and DRS score was hematoma volume at follow-up CT. Multiple logistic regression analysis after inclusion of clinical variables identified two predictors that enabled determination of mortality: postresuscitation Glasgow coma scale (P-GCS) (adjustedodds ratio, 0.42; 95% confidence interval [CI]: 0.2, 0.86; P = 0.01) and iodine quantity in pseudohematoma (adjusted odds ratio, 1.4 per milligram; 95% CI: 1.02 per milligram, 1.9 per milligram; P = 0.03), with a mean area under the receiver operating characteristic curve of 0.96 +/- 0.05 (standard error). For RLAS, the predictors were P-GCS (mean coefficient, 0.32 +/- 0.06; P < .001) and iodine quantity in contusion (mean coefficient, -0.04 per milligram +/- 0.02; P = 0.01). Predictors for DRS were P-GCS (mean coefficient, -1.15 +/- 0.27; P < .001), age (mean coefficient, 0.13 per year +/- 0.04; P = .002), and iodine quantity in contusion(mean coefficient, 0.19 per milligram +/- 0.07; P = .02). Conclusion: Iodine-based dual-energy CT variables correlate with in-hospital mortality and short-term outcomes for contusions at hospital discharge. (C) RSNA, 2019	[Bodanapally, Uttam K.; Shanmuganathan, Kathirkamanathan; Dreizin, David; Ptak, Thomas; Li, Guang; Fleiter, Thorsten R.] Univ Maryland, Sch Med, Dept Diagnost Radiol & Nucl Med, 22 S Greene St, Baltimore, MD 21201 USA; [Aarabi, Bizhan; Schwartzbauer, Gary; Simard, Marc] Univ Maryland, Sch Med, Dept Neurosurg, 22 S Greene St, Baltimore, MD 21201 USA; [Parikh, Gunjan Y.] Univ Maryland, Sch Med, R Adams Cowley Shock Trauma Ctr, Dept Neurol, 22 S Greene St, Baltimore, MD 21201 USA; [Liang, Yuanyuan] Univ Maryland, Sch Med, Dept Epidemiol & Publ Hlth, 22 S Greene St, Baltimore, MD 21201 USA; [Ramaswamy, Meghna; Tsymbalyuk, Solomiya] Univ Maryland, Sch Med, Baltimore, MD 21201 USA		Bodanapally, UK (corresponding author), Univ Maryland, Sch Med, Dept Diagnost Radiol & Nucl Med, 22 S Greene St, Baltimore, MD 21201 USA.	ubodanapally@umm.edu	Parikh, Gunjan/AAS-1375-2020	Parikh, Gunjan/0000-0002-8447-1349	NHLBI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [R01 HL082517] Funding Source: Medline		Bodanapally UK, 2018, AM J NEURORADIOL, V39, P658, DOI 10.3174/ajnr.A5558; Bodanapally UK, 2017, AM J NEURORADIOL, V38, P1946, DOI 10.3174/ajnr.A5318; Bonatti M, 2018, AM J NEURORADIOL, V39, P441, DOI 10.3174/ajnr.A5513; GENNARELLI TA, 1982, J NEUROSURG, V56, P26, DOI 10.3171/jns.1982.56.1.0026; Huang APH, 2011, J TRAUMA, V71, P1593, DOI 10.1097/TA.0b013e31822c8865; Huber-Wagner S, 2009, LANCET, V373, P1455, DOI 10.1016/S0140-6736(09)60232-4; Kurland D, 2012, J NEUROTRAUM, V29, P19, DOI 10.1089/neu.2011.2122; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Letourneau-Guillon L, 2013, AM J NEURORADIOL, V34, P773, DOI 10.3174/ajnr.A3309; Lingsma HF, 2010, LANCET NEUROL, V9, P543, DOI 10.1016/S1474-4422(10)70065-X; Lobato RD, 1997, ACTA NEUROCHIR, V139, P385, DOI 10.1007/BF01808871; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; Meredith W, 1998, J TRAUMA, V44, P839, DOI 10.1097/00005373-199805000-00016; Murray GD, 2007, J NEUROTRAUM, V24, P329, DOI 10.1089/neu.2006.0035; Mushkudiani NA, 2007, J NEUROTRAUM, V24, P259, DOI 10.1089/neu.2006.0028; Nelson DW, 2010, J NEUROTRAUM, V27, P51, DOI 10.1089/neu.2009.0986; Orito K, 2018, J NEUROTRAUM, V35, P760, DOI 10.1089/neu.2017.5247; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Rosa M, 2016, J NEUROTRAUM, V33, P1015, DOI 10.1089/neu.2015.4062; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Selassie AW, 2008, J HEAD TRAUMA REHAB, V23, P123, DOI 10.1097/01.HTR.0000314531.30401.39; Simard JM, 2006, NAT MED, V12, P433, DOI 10.1038/nm1390; Skandsen T, 2010, J NEUROSURG, V113, P556, DOI 10.3171/2009.9.JNS09626; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Tan CO, 2019, RADIOLOGY, V290, P179, DOI 10.1148/radiol.2018180322; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Tokutomi T, 2008, J NEUROTRAUM, V25, P1407, DOI 10.1089/neu.2008.0577; Wintermark M, 2015, AJNR Am J Neuroradiol, V36, pE1, DOI 10.3174/ajnr.A4181; Wright J, 2000, DISABILITY RATING SC	30	7	7	1	1	RADIOLOGICAL SOC NORTH AMERICA (RSNA)	OAK BROOK	820 JORIE BLVD, SUITE 200, OAK BROOK, ILLINOIS, UNITED STATES	0033-8419			RADIOLOGY	Radiology	SEP	2019	292	3					730	738		10.1148/radiol.2019190078			9	Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Radiology, Nuclear Medicine & Medical Imaging	IS5TQ	WOS:000482215800036	31361206	Bronze, Green Accepted			2022-02-06	
J	Cicuendez, M; Castano-Leon, A; Ramos, A; Hilario, A; Gomez, PA; Lagares, A				Cicuendez, Marta; Castano-Leon, Ana; Ramos, Ana; Hilario, Amaya; Gomez, Pedro A.; Lagares, Alfonso			The added prognostic value of magnetic resonance imaging in traumatic brain injury: The importance of traumatic axonal injury when performing ordinal logistic regression	JOURNAL OF NEURORADIOLOGY			English	Article						Traumatic axonal injury; Traumatic brain injury; Severe head trauma; Magnetic resonance imaging; Prognostic model	MODELS; STEM; MRI; CLASSIFICATION; PREDICTION; OUTCOMES	Background and purpose. - This study was performed to investigate the prognostic value of traumatic axonal injury (TAI) in severe head trauma. Methods. - We attempted to determine whether any MR imaging findings of TAI could be related to prognosis in 264 patients with severe head trauma. We performed an ordinal logistic regression, adjusted for the prognostic factors according to the IMPACT studies, adding each MR feature related to prognosis one at a time. A new prognostic model was described by adding these MR features to the classic prognostic factors. The model was externally validated in a prospective series. Harrel's c-statistic and ordinal c-index (ORC) were calculated to measure its predictive accuracy. Results. - We found 178 patients with TAI lesions. Lesions in the basal ganglia/thalamus, corpus callosum (CC) and brain stem were associated with poor outcome (P< 0.01). The highest OR was for TAI lesions in the splenium (OR: 2.6) and brain stem dorsal lesions (OR: 3.1). We only found significant differences in outcome between haemorrhagic and non-haemorrhagic TAI lesions in the subgroup of patients with white matter and basal ganglia/thalamus lesions (P= 0.01). We obtained a superior discriminatory capacity by adding these MR findings to the previous prognostic model (Harrel's c-statistic 0.72 and ORC 0.7) in a prospective series of 93 patients. Conclusions. - The prognostic model including MR findings maintained a superior discriminatory capacity than that obtained for the model with the classic prognostic factors alone. (C) 2018 Elsevier Masson SAS. All rights reserved.	[Cicuendez, Marta] Vall dHebron Univ Hosp, Dept Neurosurg, Res Inst VHIR, Barcelona, Spain; [Castano-Leon, Ana; Gomez, Pedro A.; Lagares, Alfonso] Univ Complutense Madrid, Dept Neurosurg, Inst Invest I 12, 12 Octubre Univ Hosp, Madrid, Spain; [Ramos, Ana; Hilario, Amaya] Univ Complutense Madrid, Dept Neuroradiol, 12 Octubre Univ Hosp, Madrid, Spain		Cicuendez, M (corresponding author), Vall dHebron Univ Hosp, Dept Neurosurg, Paseo Vall dHebron 119-129, Barcelona 08035, Spain.	marta.cicuendez@gmail.com	Gomez, Pedro/N-5051-2019; Castano-Leon, Ana M/ABF-6322-2020; Lagares, Alfonso/B-2969-2011	Gomez, Pedro/0000-0002-4185-5238; Castano-Leon, Ana M/0000-0002-7918-5049; Lagares, Alfonso/0000-0003-3996-0554; Hilario, Amaya/0000-0001-5143-603X	ISCIIIInstituto de Salud Carlos III; FEDER European institutions; FIS project [PI14/0157]	This research was jointly funded by the ISCIII and FEDER European institutions; with FIS project number PI14/0157. The sponsor had no role in the design or conduct of this research.	Abu Hamdeh S, 2017, J NEUROTRAUM, V34, P341, DOI 10.1089/neu.2016.4426; Bender R, 1997, J ROY COLL PHYS LOND, V31, P546; BRANT R, 1990, BIOMETRICS, V46, P1171, DOI 10.2307/2532457; Brown M, 2018, J NEURORADIOLOGY, V45, P123, DOI 10.1016/j.neurad.2017.09.004; Chastain CA, 2009, J NEUROTRAUM, V26, P1183, DOI 10.1089/neu.2008.0650; Chew BG, 2012, J NEUROSURG, V117, P722, DOI 10.3171/2012.6.JNS111736; Cicuendez M, 2016, ACTA NEUROCHIR WIEN, V59, P25; de Leeuw FE, 2001, J NEUROL NEUROSUR PS, V70, P9, DOI 10.1136/jnnp.70.1.9; Firsching R, 2001, ACTA NEUROCHIR, V143, P263; GENTRY LR, 1988, AM J ROENTGENOL, V150, P663, DOI 10.2214/ajr.150.3.663; Gomez PA, 2014, NEUROCIRUGIA, V25, P199, DOI 10.1016/j.neucir.2014.05.001; Hilario A, 2012, AM J NEURORADIOL, V33, P1925, DOI 10.3174/ajnr.A3092; Laouchedi M, 2015, J NEURORADIOLOGY, V42, P202, DOI 10.1016/j.neurad.2014.03.001; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; Moen KG, 2014, J NEUROTRAUM, V31, P1486, DOI 10.1089/neu.2013.3258; Moen KG, 2012, J NEUROL NEUROSUR PS, V83, P1193, DOI 10.1136/jnnp-2012-302644; Newson RB, 2010, STATA J, V10, P339, DOI 10.1177/1536867X1001000303; OMMAYA AK, 1974, BRAIN, V97, P633, DOI 10.1093/brain/97.1.633; Panczykowski DM, 2012, J NEUROTRAUM, V29, P47, DOI 10.1089/neu.2010.1482; PETERSON B, 1990, AM J EPIDEMIOL, V131, P745, DOI 10.1093/oxfordjournals.aje.a115562; Pierallini A, 2000, NEURORADIOLOGY, V42, P860, DOI 10.1007/s002340000447; Risselada R, 2010, BMC MED RES METHODOL, V10, DOI 10.1186/1471-2288-10-86; Roozenbeek B, 2011, CRIT CARE, V15, DOI 10.1186/cc10240; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Toth A, 2016, NEUROSCI LETT, V617, P207, DOI 10.1016/j.neulet.2016.02.028; Van Calster B, 2012, BIOMETRICAL J, V54, P674, DOI 10.1002/bimj.201200026; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Zheng WB, 2007, NEURORADIOLOGY, V49, P271, DOI 10.1007/s00234-006-0187-8	28	7	8	0	5	MASSON EDITEUR	MOULINEAUX CEDEX 9	21 STREET CAMILLE DESMOULINS, ISSY, 92789 MOULINEAUX CEDEX 9, FRANCE	0150-9861	1773-0406		J NEURORADIOLOGY	J. Neuroradiol.	SEP	2019	46	5					299	306		10.1016/j.neurad.2018.08.001			8	Clinical Neurology; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	IW0KE	WOS:000484650000005	30179689				2022-02-06	
J	Habets, EJJ; Hendriks, EJ; Taphoorn, MJB; Douw, L; Zwinderman, AH; Vandertop, WP; Barkhof, F; Hamer, PCD; Klein, M				Habets, Esther J. J.; Hendriks, Eef J.; Taphoorn, Martin J. B.; Douw, Linda; Zwinderman, Aeilko H.; Vandertop, W. Peter; Barkhof, Frederik; Hamer, Philip C. De Witt; Klein, Martin			Association between tumor location and neurocognitive functioning using tumor localization maps	JOURNAL OF NEURO-ONCOLOGY			English	Article						Glioma; Neurocognitive functioning; MRI; Functional mapping	LOW-GRADE GLIOMAS; TRAUMATIC BRAIN-INJURY; WORKING-MEMORY; ATTENTION SYSTEM; NETWORKS; ANATOMY; SURGERY; DEFICITS; OUTCOMES; IMPACT	Introduction Patients with diffuse glioma often experience neurocognitive impairment already prior to surgery. Pertinent information on whether damage to a specific brain region due to tumor activity results in neurocognitive impairment or not, is relevant in clinical decision-making, and at the same time renders unique information on brain lesion location and functioning relationships. To examine the impact of tumor location on preoperative neurocognitive functioning (NCF), we performed MRI based lesion-symptom mapping. Methods Seventy-two patients (mean age 40 years) with a radiologically suspected glioma were recruited preoperatively. For each of the six cognitive domains tested, we used tumor localization maps and voxel-based lesion-symptom mapping analyses to identify cortical and subcortical regions associated with NCF impairment. Results Compared to healthy controls, preoperative NCF was significantly impaired in all cognitive domains. Most frequently affected were attention (30% of patients) and working memory (20% of patients). Deficits in attention were significantly associated with regions in the left frontal and parietal cortex, including the precentral and parietal-opercular cortex, and in left-sided subcortical fiber tracts, including the arcuate fasciculus and corticospinal tract. Surprisingly, no regions could be related to working memory capacity. For the other neurocognitive domains, impairments were mainly associated with regions in the left hemisphere. Conclusions Prior to treatment, patients with diffuse glioma in the left hemisphere run the highest risk to have NCF deficits. Identification of a left frontoparietal network involved in NCF not only may optimize surgical procedures but may also be integrated in counseling and cognitive rehabilitation for these patients.	[Habets, Esther J. J.; Taphoorn, Martin J. B.] Haaglanden Med Ctr, Dept Neurol, Lijnbaan 32,POB 432, NL-2501 CK The Hague, Netherlands; [Hendriks, Eef J.; Barkhof, Frederik] Univ Amsterdam, Med Ctr, Locat VUmc, Dept Radiol & Nucl Med, Boelelaan 1117, NL-1081 HV Amsterdam, Netherlands; [Taphoorn, Martin J. B.] Leiden Univ, Med Ctr, Dept Neurol, POB 9600, NL-2300 RC Leiden, Netherlands; [Douw, Linda] Univ Amsterdam, Med Ctr, Dept Anat & Neurosci, Locat VUmc, Boelelaan 1118, NL-1081 HZ Amsterdam, Netherlands; [Douw, Linda] Massachusetts Gen Hosp, Athinoula Martinos Ctr Biomed Imaging, Dept Radiol, 149 Thirteenth St, Charlestown, MA USA; [Zwinderman, Aeilko H.] Univ Amsterdam, Med Ctr, Locat AMC, Dept Clin Epidemiol & Biostat, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands; [Vandertop, W. Peter; Hamer, Philip C. De Witt] Univ Amsterdam, Med Ctr, Brain Tumor Ctr Amsterdam, Neurosurg Ctr Amsterdam,Locat VUmc, Boelelaan 1117, NL-1081 HV Amsterdam, Netherlands; [Barkhof, Frederik] UCL, Inst Neurol & Healthcare Engn, Gower St, London WC1E 6BT, England; [Klein, Martin] Univ Amsterdam, Med Ctr, Dept Med Psychol, Locat VUmc, Boelelaan 1118, NL-1081 HZ Amsterdam, Netherlands; [Klein, Martin] Univ Amsterdam, Med Ctr, Brain Tumor Ctr, Locat VUmc, Boelelaan 1118, NL-1081 HZ Amsterdam, Netherlands		Habets, EJJ (corresponding author), Haaglanden Med Ctr, Dept Neurol, Lijnbaan 32,POB 432, NL-2501 CK The Hague, Netherlands.	e.habets@haaglandenmc.nl	Barkhof, Frederik/AAJ-6226-2020	Barkhof, Frederik/0000-0003-3543-3706; Klein, Martin/0000-0001-5553-7911; Habets, Esther/0000-0001-5938-9792; Douw, Linda/0000-0001-7058-4062; Vandertop, William/0000-0001-5417-0265	program Innovative Medical Devices Initiative - Netherlands Organization for Scientific Research (NWO)Netherlands Organization for Scientific Research (NWO) [10-10400-96-14003]; Dutch Cancer SocietyKWF Kankerbestrijding [VU2014-7113]	This study is part of the program Innovative Medical Devices Initiative with project number 10-10400-96-14003, which is financed by the Netherlands Organization for Scientific Research (NWO). This research is also supported by a research grant from the Dutch Cancer Society (Grant No. VU2014-7113).	Avants BB, 2008, MED IMAGE ANAL, V12, P26, DOI 10.1016/j.media.2007.06.004; Barbey AK, 2012, BRAIN, V135, P1154, DOI 10.1093/brain/aws021; Bates E, 2003, NAT NEUROSCI, V6, P448, DOI 10.1038/nn1050; Biesbroek JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060541; Campanella F, 2014, BRAIN, V137, P2532, DOI 10.1093/brain/awu183; Campanella F, 2010, NEUROPSYCHOLOGIA, V48, P1583, DOI 10.1016/j.neuropsychologia.2010.02.002; Catani M, 2008, CORTEX, V44, P1105, DOI 10.1016/j.cortex.2008.05.004; Charras P, 2015, CORTEX, V63, P27, DOI 10.1016/j.cortex.2014.08.010; Chiang HL, 2016, PSYCHOL MED, V46, P1225, DOI 10.1017/S0033291715002767; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Corbetta M, 2015, NEURON, V85, P927, DOI 10.1016/j.neuron.2015.02.027; De Bie SE, 1987, PROPOSAL UNIFORMISAT; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Dick AS, 2012, BRAIN, V135, P3529, DOI 10.1093/brain/aws222; Douw L, 2009, LANCET NEUROL, V8, P810, DOI 10.1016/S1474-4422(09)70204-2; Duffau H, 2003, J NEUROL NEUROSUR PS, V74, P901, DOI 10.1136/jnnp.74.7.901; Duffau H, 2014, BRAIN LANG, V131, P1, DOI 10.1016/j.bandl.2013.05.011; Duffau H, 2011, CORTEX, V47, P1016, DOI 10.1016/j.cortex.2010.11.010; Fonov V., 2009, NEUROIMAGE, V47, pS102; Gleichgerrcht E, 2015, NEUROLOGY, V85, P284, DOI 10.1212/WNL.0000000000001765; Hamer PCD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073353; Ivanova MV, 2018, NEUROPSYCHOLOGIA, V115, P25, DOI 10.1016/j.neuropsychologia.2018.03.003; Jolles J, 1998, Tijdschr Gerontol Geriatr, V29, P120; Karnath HO, 2011, CORTEX, V47, P1004, DOI 10.1016/j.cortex.2010.08.006; Kesler SR, 2017, J NEURO-ONCOL, V131, P565, DOI 10.1007/s11060-016-2328-1; Klein M, 2001, J CLIN ONCOL, V19, P4037, DOI 10.1200/JCO.2001.19.20.4037; Klein M, 2003, ANN NEUROL, V54, P514, DOI 10.1002/ana.10712; Lezak M. D., 2004, NEUROPSYCHOLOGICAL A; Mandonnet E, 2015, NEUROSURGERY, V76, P382, DOI 10.1227/NEU.0000000000000644; Merkley TL, 2013, J INT NEUROPSYCH SOC, V19, P899, DOI 10.1017/S135561771300074X; Meyers CA, 2003, NEURO S B C, P159; Murakami T, 2014, BRAIN RES, V1544, P25, DOI 10.1016/j.brainres.2013.11.029; Nichols T, 2003, STAT METHODS MED RES, V12, P419, DOI 10.1191/0962280203sm341ra; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; Noll KR, 2015, NEURO-ONCOLOGY, V17, P580, DOI 10.1093/neuonc/nou233; Owen AM, 2005, HUM BRAIN MAPP, V25, P46, DOI 10.1002/hbm.20131; Palacios EM, 2012, NEUROLOGY, V78, P852, DOI 10.1212/WNL.0b013e31824c465a; Papagno C, 2012, J NEURO-ONCOL, V108, P269, DOI 10.1007/s11060-012-0824-5; Perlbarg V, 2009, HUM BRAIN MAPP, V30, P3924, DOI 10.1002/hbm.20817; Petersen SE, 2012, ANNU REV NEUROSCI, V35, P73, DOI 10.1146/annurev-neuro-062111-150525; POSNER MI, 1990, ANNU REV NEUROSCI, V13, P25, DOI 10.1146/annurev.ne.13.030190.000325; Posner MI, 2006, NEURAL NETWORKS, V19, P1422, DOI 10.1016/j.neunet.2006.08.004; Raz Amir, 2004, Anatomical Record Part B:The New Anatomist, V281, P21, DOI 10.1002/ar.b.20035; Rinne P, 2013, NEUROLOGY, V81, P812, DOI 10.1212/WNL.0b013e3182a2ca34; Rorden C, 2007, J COGNITIVE NEUROSCI, V19, P1081, DOI 10.1162/jocn.2007.19.7.1081; Satoer D, 2012, J NEUROSURG, V117, P831, DOI 10.3171/2012.7.JNS12263; Schwartzman A, 2009, NEUROIMAGE, V44, P71, DOI 10.1016/j.neuroimage.2008.04.182; Shallice T, 2010, CORTEX, V46, P1178, DOI 10.1016/j.cortex.2010.04.005; Talacchi A, 2011, J NEURO-ONCOL, V103, P541, DOI 10.1007/s11060-010-0417-0; Taphoorn MJB, 2004, LANCET NEUROL, V3, P159, DOI 10.1016/S1474-4422(04)00680-5; Team R.C., 2013, R LANG ENV STAT COMP; Teixidor P, 2007, J NEURO-ONCOL, V81, P305, DOI 10.1007/s11060-006-9233-y; van Coevorden-van Loon EMP, 2017, J NEURO-ONCOL, V133, P237, DOI 10.1007/s11060-017-2454-4; Visser M, 2019, NEUROIMAGE-CLIN, V22, DOI 10.1016/j.nicl.2019.101727	54	7	7	0	2	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0167-594X	1573-7373		J NEURO-ONCOL	J. Neuro-Oncol.	SEP	2019	144	3					573	582		10.1007/s11060-019-03259-z			10	Oncology; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Oncology; Neurosciences & Neurology	JA5RG	WOS:000487899900016	31410731	Green Submitted			2022-02-06	
J	Iverson, GL; Terry, DP; Luz, M; Zafonte, R; McCrory, P; Solomon, GS; Gardner, AJ				Iverson, Grant L.; Terry, Douglas P.; Luz, Matthew; Zafonte, Ross; McCrory, Paul; Solomon, Gary S.; Gardner, Andrew J.			Anger and Depression in Middle-Aged Men: Implications for a Clinical Diagnosis of Chronic Traumatic Encephalopathy	JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES			English	Article							STRESSFUL LIFE EVENTS; NATIONAL EPIDEMIOLOGIC SURVEY; FOOTBALL LEAGUE PLAYERS; ANXIETY DISORDERS; UNITED-STATES; CHRONIC PAIN; BRAIN-INJURY; SYMPTOMS; PREVALENCE; DISEASE	Objective: In recent years, it has been proposed that problems with anger control and depression define clinical features of chronic traumatic encephalopathy (CTE). The authors examined anger problems and depression in middle-aged men from the general population and related those findings to the proposed clinical criteria for CTE. Methods: A sample of 166 community-dwelling men ages 40-60 was extracted from the normative database of the National Institutes of Health Toolbox. All participants denied prior head injury or traumatic brain injury (TBI). Participants completed scales assessing anger, hostility, aggression, anxiety, and depression. Results: In response to the item "I felt angry," 21.1% of men reported "sometimes," and 4.8% reported "often." When asked "If I am provoked enough I may hit another person," 11.4% endorsed the statement as true. There were moderate correlations between anger and anxiety (Spearman's rho=0.61) and between depression and affective anger (rho=0.51), hostility (rho=0.56), and perceived hostility (rho=0.35). Participants were dichotomized into a possible depression group (N=49) and a no-depression group (N=117) on the basis of the question "I feel depressed," specific to the past 7 days. The possible depression group reported higher anxiety (p<0.001, Cohen's d=1.51), anger (p<0.001, Cohen's d=0.96), and hostility (p<0.001, Cohen's d=0.95). Conclusions: Some degree of anger and aggression are reported by a sizable minority of middle-aged men in the general population with no known history of TBI. Anger and hostility are correlated with depression and anxiety, indicating that all tend to co-occur. The base rates and comorbidity of affective dysregulation in men in the general population is important to consider when conceptualizing CTE phenotypes.	[Iverson, Grant L.; Terry, Douglas P.; Luz, Matthew; Zafonte, Ross] Harvard Med Sch, Spaulding Rehabil Hosp, Dept Phys Med & Rehabil, Boston, MA 02115 USA; [Iverson, Grant L.; Terry, Douglas P.; Luz, Matthew; Zafonte, Ross] Harvard Med Sch, Spaulding Res Inst, Boston, MA 02115 USA; [Iverson, Grant L.; Terry, Douglas P.; Zafonte, Ross] Massachusetts Gen Hosp, Children Sports Concuss Program, Boston, MA 02114 USA; [Iverson, Grant L.; Terry, Douglas P.; Zafonte, Ross] Red Sox Fdn, Home Base, Boston, MA 02215 USA; [Iverson, Grant L.; Terry, Douglas P.; Zafonte, Ross] Massachusetts Gen Hosp Program, Boston, MA 02114 USA; [Zafonte, Ross] Harvard Med Sch, Brigham & Womens Hosp, Massachusetts Gen Hosp, Dept Phys Med & Rehabil,Spaulding Rehabil Hosp, Boston, MA 02115 USA; [McCrory, Paul] Melbourne Brain Ctr, Florey Inst Neurosci & Mental Hlth, Heidelberg, Vic, Australia; [Solomon, Gary S.] Vanderbilt Univ, Sch Med, Dept Neurol Surg, Nashville, TN 37212 USA; [Solomon, Gary S.] Vanderbilt Univ, Sch Med, Dept Orthopaed Surg & Rehabil, Nashville, TN 37212 USA; [Solomon, Gary S.] Vanderbilt Univ, Sch Med, Dept Psychiat & Behav Sci, Nashville, TN 37212 USA; [Solomon, Gary S.] Vanderbilt Univ, Sch Med, Vanderbilt Sports Concuss Ctr, Nashville, TN 37212 USA; [Gardner, Andrew J.] Univ Newcastle, Sch Med & Publ Hlth, Hunter New England Local Hlth Dist Sports Concuss, Newcastle, NSW, Australia; [Gardner, Andrew J.] Univ Newcastle, Sch Med & Publ Hlth, Ctr Stroke & Brain Injury, Newcastle, NSW, Australia		Iverson, GL (corresponding author), Harvard Med Sch, Spaulding Rehabil Hosp, Dept Phys Med & Rehabil, Boston, MA 02115 USA.; Iverson, GL (corresponding author), Harvard Med Sch, Spaulding Res Inst, Boston, MA 02115 USA.; Iverson, GL (corresponding author), Massachusetts Gen Hosp, Children Sports Concuss Program, Boston, MA 02114 USA.; Iverson, GL (corresponding author), Red Sox Fdn, Home Base, Boston, MA 02215 USA.; Iverson, GL (corresponding author), Massachusetts Gen Hosp Program, Boston, MA 02114 USA.	giverson@mgh.harvard.edu		Gardner, Andrew/0000-0001-5031-5586; McCrory, Paul/0000-0003-4850-0568	NIDILRRUnited States Department of Health & Human Services [90DP0039-03-00, 90SI5007-02-04,90 D P0060]; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [4 U01NS086090-04, 5R24HD082302-02, 5U01NS091951-03]; USARMC [W81XWH-112-0210]; CNS Vital Signs, ImPACT Applications Systems; NFL; Harvard Integrated Program; Heinz Family Foundation; ImPACT Applications; Mooney-Reed Charitable Foundation; Spaulding Research Institute [T-32]; Football Players Health Study at Harvard University - NFL Players Association; NFL Players Association - National Health & Medical Research Council of Australia; CogStateCogState Limited; University of Tennessee, Tennessee Tech University; Vanderbilt University; Brain Foundation (Australia); Hunter Medical Research Institute; (Jennie Thomas and Anne Greaves); NSW Sporting Injuries Committee; Hunter New England Local Health District; Research, Innovation and Partnerships Health Research & Translation Centre and Clinical Research Fellowship Scheme; University of Newcastle's Priority Research Centre for Stroke	Supported in part by NIDILRR (grants, 90DP0039-03-00, 90SI5007-02-04,90 D P0060), NIH (grants, 4 U01NS086090-04; 5R24HD082302-02; 5U01NS091951-03), and USARMC (grant, W81XWH-112-0210) to Dr. Zafonte.; Dr. Iverson has received reimbursement from the federal government, professional scientific bodies, and commercial organizations for discussing or presenting research relating to mild traumatic brain injury (mTBI) and sport-related concussion at meetings, scientific conferences, and symposiums; he is a co-investigator, collaborator, or consultant on grants relating to mTBI funded by the federal government and other organizations; he has received research support from CNS Vital Signs, ImPACT Applications Systems, and Psychological Assessment Resources; he has received grant support from the NFL and salary support from the Harvard Integrated Program to Protect and Improve the Health of NFLPA Members; he serves as a scientific advisor to BioDirection, Highmark, and SWAY Operations; and he has received unrestricted philanthropic support from the Heinz Family Foundation, ImPACT Applications, the Mooney-Reed Charitable Foundation, and the Spaulding Research Institute. Dr. Zafonte serves on the scientific advisory boards of BioDirection, ElMINDA, Myomo, and Oxeia Biopharma; he serves as co-principal investigator on a T-32 and receives funding from the Football Players Health Study at Harvard University, which is funded by the NFL Players Association; he has received royalties from Demos Publishing and Oakstone; and he evaluates patients in the MGH Brain and Body-TRUST Program funded by the NFL Players Association. Dr. McCrory is a co-investigator on competitive grants relating to mTBI funded by several governmental and other organizations; he receives funding under a fellowship awarded by the National Health & Medical Research Council of Australia and is employed at the Florey Institute of Neuroscience and Mental Health; he has received reimbursement by the federal government, professional scientific bodies, and commercial organizations for discussing or presenting research relating to mTBI and sport-related concussion at meetings, scientific conferences, and symposiums; he has received travel reimbursements from the AFL, FIFA, and NFL; he has received unrestricted philanthropic support from CogState; and he is chairperson of the Scientific Committees of the International Concussion and Head Injury Research Foundation in London and the Sports Surgery Clinic in Dublin. Dr. Solomon has received honoraria and expense reimbursements from the federal government and professional and scientific organizations for presenting research relating to sport-related concussion at meetings, scientific conferences, and symposiums; he is employed by Vanderbilt University Medical Center; he serves as the consulting neuropsychologist for the Nashville Predators, Tennessee Titans, and the athletic departments of the University of Tennessee, Tennessee Tech University, and Vanderbilt University; and he is Senior Medical Advisor for the National Football League Department of Health and Safety. Dr.; Gardner serves as a contracted concussion consultant to Rugby Australia; he has received travel funding from the Australian Football League at the Concussion in Football Conference; he has received grant support from the Brain Foundation (Australia), the Hunter Medical Research Institute (supported by Jennie Thomas and Anne Greaves), and the NSW Sporting Injuries Committee; he receives research funding via an NHMRC Early Career Fellowship, Hunter New England Local Health District, the Research, Innovation and Partnerships Health Research & Translation Centre and Clinical Research Fellowship Scheme, and the University of Newcastle's Priority Research Centre for Stroke and Brain Injury. All other authors report no financial relationships with commercial interests.	American Psychology Association, 2015, STRESS AM PAYING OUR; Anderson RJ, 2001, DIABETES CARE, V24, P1069, DOI 10.2337/diacare.24.6.1069; Ayerbe L, 2013, BRIT J PSYCHIAT, V202, P14, DOI 10.1192/bjp.bp.111.107664; Bandelow B, 2015, DIALOGUES CLIN NEURO, V17, P327; Barnes DE, 2006, ARCH GEN PSYCHIAT, V63, P273, DOI 10.1001/archpsyc.63.3.273; Baugh CM, 2012, BRAIN IMAGING BEHAV, V6, P244, DOI 10.1007/s11682-012-9164-5; Breslau N, 2003, NEUROLOGY, V60, P1308, DOI 10.1212/01.WNL.0000058907.41080.54; Brown JC, 2017, INT J SPORTS MED, V38, P582, DOI 10.1055/s-0043-103959; Brown SL, 2012, J GERONTOL B-PSYCHOL, V67, P731, DOI 10.1093/geronb/gbs089; Campbell LC, 2003, BIOL PSYCHIAT, V54, P399, DOI 10.1016/S0006-3223(03)00545-6; Carter RM, 2001, DEPRESS ANXIETY, V13, P78, DOI 10.1002/da.1020; Chappell MH, 2006, J MAGN RESON IMAGING, V24, P537, DOI 10.1002/jmri.20656; CORSELLIS JA, 1973, PSYCHOL MED, V3, P270, DOI 10.1017/S0033291700049588; Cottler LB, 2011, DRUG ALCOHOL DEPEN, V116, P188, DOI 10.1016/j.drugalcdep.2010.12.003; CRITCHLEY M, 1957, BMJ-BRIT MED J, V1, P357, DOI 10.1136/bmj.1.5015.357; Djamshidian A, 2014, CURR TREAT OPTION NE, V16, DOI 10.1007/s11940-014-0285-6; Dunne EM, CLIN J SPORT MED; Fanning JR, 2016, COMPR PSYCHIAT, V70, P125, DOI 10.1016/j.comppsych.2016.05.018; Fournier CN, 2015, NEUROLOGY, V84, P1788, DOI 10.1212/WNL.0000000000001522; Friis RH, 2002, EUR PSYCHIAT, V17, P241, DOI 10.1016/S0924-9338(02)00682-X; Garbarino S, BEHAV SLEEP MED; Gardner Raquel C, 2015, Neurol Clin Pract, V5, P285; Gatt JM, 2009, MOL PSYCHIATR, V14, P681, DOI 10.1038/mp.2008.143; Gavett BE, 2011, CLIN SPORT MED, V30, P179, DOI 10.1016/j.csm.2010.09.007; Gershon RC, 2013, NEUROLOGY, V80, pS2, DOI 10.1212/WNL.0b013e3182872e5f; Gershon RC, 2010, LANCET NEUROL, V9, P138, DOI 10.1016/S1474-4422(09)70335-7; Goldstein RB, 2016, SOC PSYCH PSYCH EPID, V51, P1137, DOI 10.1007/s00127-016-1208-5; Gonzalez HM, 2010, J PSYCHIATR RES, V44, P1043, DOI 10.1016/j.jpsychires.2010.03.017; Gothe F, 2012, PANMINERVA MED, V54, P161; Gouttebarge V, 2015, OCCUP MED-OXFORD, V65, P190, DOI 10.1093/occmed/kqu202; Grant BF, 2016, JAMA PSYCHIAT, V73, P39, DOI 10.1001/jamapsychiatry.2015.2132; Hampshire A, 2013, SCI REP-UK, V3, DOI 10.1038/srep02972; Hart J, 2013, JAMA NEUROL, V70, P326, DOI 10.1001/2013.jamaneurol.340; Hazrati LN, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00222; Heim C, 2008, PSYCHONEUROENDOCRINO, V33, P693, DOI 10.1016/j.psyneuen.2008.03.008; Hung CI, 2006, CEPHALALGIA, V26, P26, DOI 10.1111/j.1468-2982.2005.00985.x; Iverson GL, 2016, J NEUROPSYCH CLIN N, V28, P9, DOI 10.1176/appi.neuropsych.15070172; Iverson GL, 2014, BRIT J SPORT MED, V48, P162, DOI 10.1136/bjsports-2013-092935; Johannes CB, 2010, J PAIN, V11, P1230, DOI 10.1016/j.jpain.2010.07.002; Jordan BD, 2013, NAT REV NEUROL, V9, P222, DOI 10.1038/nrneurol.2013.33; JORDAN BD, 1992, RADIOLOGY, V185, P509, DOI 10.1148/radiology.185.2.1410364; Jordan BD, 2000, SEMIN NEUROL, V20, P179, DOI 10.1055/s-2000-9826; Judd LL, 1998, ACTA PSYCHIAT SCAND, V98, P6, DOI 10.1111/j.1600-0447.1998.tb05960.x; Kendler KS, 2001, AM J PSYCHIAT, V158, P582, DOI 10.1176/appi.ajp.158.4.582; Kendler KS, 1999, AM J PSYCHIAT, V156, P837, DOI 10.1176/ajp.156.6.837; Kessler RC, 2013, ANNU REV PUBL HEALTH, V34, P119, DOI 10.1146/annurev-publhealth-031912-114409; Koga S, 2016, J NEUROPATH EXP NEUR, V75, P963, DOI 10.1093/jnen/nlw073; Lehman EJ, 2016, AM J SPORT MED, V44, P2486, DOI 10.1177/0363546516645093; Ling HL, 2017, ACTA NEUROPATHOL, V133, P337, DOI 10.1007/s00401-017-1680-3; Ling HL, 2015, ACTA NEUROPATHOL, V130, P891, DOI 10.1007/s00401-015-1496-y; Ling H, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/2051-5960-2-24; Luppino FS, 2010, ARCH GEN PSYCHIAT, V67, P220, DOI 10.1001/archgenpsychiatry.2010.2; Maroon JC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117338; Martin LA, 2013, JAMA PSYCHIAT, V70, P1100, DOI 10.1001/jamapsychiatry.2013.1985; Martland HS, 1928, J AMER MED ASSOC, V91, P1103, DOI 10.1001/jama.1928.02700150029009; MAWDSLEY C, 1963, LANCET, V2, P795; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; McKee AC, 2010, J NEUROPATH EXP NEUR, V69, P918, DOI 10.1097/NEN.0b013e3181ee7d85; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; McWilliams LA, 2003, PAIN, V106, P127, DOI 10.1016/S0304-3959(03)00301-4; Medici M, 2014, J CLIN ENDOCR METAB, V99, P1213, DOI 10.1210/jc.2013-3589; MENDEZ MF, 1995, INT J PSYCHIAT MED, V25, P249, DOI 10.2190/CUMK-THT1-X98M-WB4C; Meng L, 2012, J HYPERTENS, V30, P842, DOI 10.1097/HJH.0b013e32835080b7; Mez J, 2017, JAMA-J AM MED ASSOC, V318, P360, DOI 10.1001/jama.2017.8334; Mez J, 2016, JAMA NEUROL, V73, P353, DOI 10.1001/jamaneurol.2015.3998; Monroe SM, 2005, PSYCHOL REV, V112, P417, DOI 10.1037/0033-295X.112.2.417; Montenigro PH, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/s13195-014-0068-z; NEUBUERGER KT, 1959, ARCH NEURO PSYCHIATR, V81, P403, DOI 10.1001/archneurpsyc.1959.02340160001001; Noy S, 2016, J NEUROPATH EXP NEUR, V75, P1145, DOI 10.1093/jnen/nlw092; Ohayon MM, 2004, ENCEPHALE, V30, P222; Ohayon MM, 2002, SLEEP MED REV, V6, P97, DOI 10.1053/smrv.2002.0186; Okuda MY, 2015, CNS SPECTRUMS, V20, P130, DOI 10.1017/S1092852914000182; Omalu B, 2014, PROG NEUROL SURG, V28, P38, DOI 10.1159/000358761; Omalu B, 2011, NEUROSURGERY, V69, P173, DOI 10.1227/NEU.0b013e318212bc7b; Omalu BI, 2006, NEUROSURGERY, V59, P1086, DOI 10.1227/01.NEU.0000245601.69451.27; Omalu Bennet I, 2010, J Forensic Nurs, V6, P40, DOI 10.1111/j.1939-3938.2009.01064.x; Omalu BI, 2010, AM J FOREN MED PATH, V31, P130, DOI 10.1097/PAF.0b013e3181ca7f35; Orrison WW, 2009, J NEUROTRAUM, V26, P689, DOI 10.1089/neu.2008.0636; PAYNE EE, 1968, NEUROCHIRURGIA, V11, P173; Puvenna V, 2016, BRAIN RES, V1630, P225, DOI 10.1016/j.brainres.2015.11.007; Raskind MA, 2008, AM J MED, V121, P28, DOI 10.1016/j.amjmed.2008.09.011; Ravven S, 2013, HARVARD REV PSYCHIAT, V21, P59, DOI 10.1097/HRP.0b013e31828a3612; Reams N, 2016, JAMA NEUROL, V73, P743, DOI 10.1001/jamaneurol.2015.5015; Roberts AH, 1969, BRAIN DAMAGE BOXERS; Sanders G, 2017, EUR J SPORT SCI, V17, P1311, DOI 10.1080/17461391.2017.1371795; Schwenk TL, 2007, MED SCI SPORT EXER, V39, P599, DOI 10.1249/mss.0b013e31802fa679; Smitherman TA, 2013, HEADACHE, V53, P427, DOI 10.1111/head.12074; Spielberger CD., 1999, STAXI 2 STATE TRAIT; Stern RA, 2013, NEUROLOGY, V81, P1122, DOI 10.1212/WNL.0b013e3182a55f7f; Stern RA, 2011, PM&R, V3, pS460, DOI 10.1016/j.pmrj.2011.08.008; Strain J, 2013, NEUROLOGY, V81, P25, DOI 10.1212/WNL.0b013e318299ccf8; Sullivan PF, 2000, AM J PSYCHIAT, V157, P1552, DOI 10.1176/appi.ajp.157.10.1552; Victoroff J, 2013, NEUROREHABILITATION, V32, P211, DOI 10.3233/NRE-130839; Wang XL, 2005, PSYCHOSOM MED, V67, P16, DOI 10.1097/01.psy.0000146331.10104.d4; Webner D, 2016, BRAIN INJURY, V30, P1718, DOI 10.1080/02699052.2016.1202451; Weir DR., 2009, NATL FOOTBALL LEAGUE; Wortzel HS, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/424280; Yavuz S, 2014, J CANCER RES THER, V10, P324, DOI 10.4103/0973-1482.136619; Zarrour FA, 2009, J PSYCHIATR PRACT, V15, P289, DOI 10.1097/01.pra.0000358315.88931.fc	99	7	8	1	10	AMER PSYCHIATRIC PUBLISHING, INC	WASHINGTON	800 MAINE AVE SW, SUITE 900, WASHINGTON, DC 20024 USA	0895-0172	1545-7222		J NEUROPSYCH CLIN N	J. Neuropsychiatr. Clin. Neurosci.	FAL	2019	31	4					328	336		10.1176/appi.neuropsych.18110280			9	Clinical Neurology; Neurosciences; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry	JD7SI	WOS:000490181300006	31018811	Bronze			2022-02-06	
J	Kim, E; Seo, HG; Lee, HH; Lee, SH; Choi, SH; Yoo, RE; Cho, WS; Wagner, AK; Oh, BM				Kim, Eunkyung; Seo, Han Gil; Lee, Hyun Haeng; Lee, Seung Hak; Choi, Seung Hong; Yoo, Roh-Eul; Cho, Won-Sang; Wagner, Amy K.; Oh, Byung-Mo			Altered White Matter Integrity after Mild to Moderate Traumatic Brain Injury	JOURNAL OF CLINICAL MEDICINE			English	Article						traumatic brain injury; diffusion tensor imaging; postural balance; memory deficit	DIFFUSE AXONAL INJURY; MINOR HEAD-INJURY; CEREBELLAR PEDUNCLE; CORTICOSPINAL TRACT; RADIAL DIFFUSIVITY; EPIDEMIOLOGY; DAMAGE; MRI	(1) Background: White matter changes among individuals with mild-to-moderate traumatic brain injury (TBI) may be sensitive imaging markers reflecting functional impairment, particularly in the context of post-concussion syndrome. The objective of this study was to examine the altered white matter integrity in mild-to-moderate TBI patients compared with age-matched normal controls. (2) Methods: Diffusion tensor imaging data from 15 individuals with TBI and 15 control subjects were retrospectively obtained. We investigated and compared white matter integrity in both groups, with regard to fractional anisotropy (FA), radial diffusivity (RD), and axial diffusivity (AD) and examined the relationship with cognitive dysfunction and impaired balance in patients. (3) Results: In comparison with controls, the TBI patients had significantly decreased FA as well as increased RD, in the right corticospinal tract. Decreased RD was observed in the left cerebellar area near the middle cerebellar peduncle. Decreased AD was observed in the left inferior cerebellar peduncle, showing positive correlation with poor balance control. We observed decreased FA and increased AD in the left superior longitudinal fasciculus showing positive and negative correlation, respectively, with cognitive function in the TBI group. (4) Conclusions: Altered white matter integrity in mild-to-moderate TBI cases may be indicative of cognitive dysfunction and impaired balance.	[Kim, Eunkyung; Seo, Han Gil; Lee, Hyun Haeng; Lee, Seung Hak; Oh, Byung-Mo] Seoul Natl Univ Hosp, Dept Rehabil Med, Seoul 03080, South Korea; [Lee, Hyun Haeng] Konkuk Univ, Dept Rehabil Med, Sch Med, Seoul 03080, South Korea; [Lee, Hyun Haeng] Konkuk Univ, Med Ctr, Seoul 03080, South Korea; [Lee, Seung Hak] Univ Ulsan, Asan Med Ctr, Dept Rehabil Med, Coll Med, Seoul 03080, South Korea; [Choi, Seung Hong; Yoo, Roh-Eul] Seoul Natl Univ, Dept Radiol, Coll Med, Seoul 03080, South Korea; [Choi, Seung Hong; Yoo, Roh-Eul] Seoul Natl Univ Hosp, Dept Radiol, Seoul 03080, South Korea; [Cho, Won-Sang] Seoul Natl Univ Hosp, Dept Neurosurg, Seoul 03080, South Korea; [Wagner, Amy K.] Univ Pittsburgh, Dept Phys Med & Rehabil, Pittsburgh, PA 15260 USA		Oh, BM (corresponding author), Seoul Natl Univ Hosp, Dept Rehabil Med, Seoul 03080, South Korea.	keepwiz@gmail.com		Kim, Eunkyung/0000-0001-6264-722X	National Research Foundation of Korea (NRF) - Korea government [NRF-2017R1A2B3005912, NRF-2018R1C1B6002554]	This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (Grant number NRF-2017R1A2B3005912 and NRF-2018R1C1B6002554).	Alexander AL, 2007, NEUROTHERAPEUTICS, V4, P316, DOI 10.1016/j.nurt.2007.05.011; American Psychiatric Association, 2013, DIAGN STAT MAN MENT; Bazarian JJ, 2007, J NEUROTRAUM, V24, P1447, DOI 10.1089/neu.2007.0241; Bazarian JJ, 1999, BRAIN INJURY, V13, P173, DOI 10.1080/026990599121692; Bazarian JJ, 2006, ACAD EMERG MED, V13, P31, DOI 10.1197/j.aem.2005.07.038; Behrens TEJ, 2003, MAGN RESON MED, V50, P1077, DOI 10.1002/mrm.10609; Belanger HG, 2007, J NEUROPSYCH CLIN N, V19, P5, DOI 10.1176/appi.neuropsych.19.1.5; Bigler ED, 2010, BRAIN IMAGING BEHAV, V4, P270, DOI 10.1007/s11682-010-9105-0; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Caeyenberghs K, 2010, HUM BRAIN MAPP, V31, P992, DOI 10.1002/hbm.20911; Delouche A, 2016, EUR J RADIOL, V85, P25, DOI 10.1016/j.ejrad.2015.11.004; Drijkoningen D, 2015, NEUROIMAGE-CLIN, V7, P240, DOI 10.1016/j.nicl.2014.12.006; Eierud C, 2014, NEUROIMAGE-CLIN, V4, P283, DOI 10.1016/j.nicl.2013.12.009; Glickstein M, 1992, Curr Opin Neurobiol, V2, P802, DOI 10.1016/0959-4388(92)90137-A; Hong JH, 2009, BRAIN RES BULL, V80, P30, DOI 10.1016/j.brainresbull.2009.05.021; Ilvesmaki T, 2014, BRAIN, V137, P1876, DOI 10.1093/brain/awu095; Inglese M, 2005, J NEUROSURG, V103, P298, DOI 10.3171/jns.2005.103.2.0298; Jacobowitz DM, 2012, BRAIN RES, V1465, P80, DOI 10.1016/j.brainres.2012.05.008; Jang SH, 2016, BRAIN INJURY, V30, P1271, DOI 10.1080/02699052.2016.1178805; Jang SH, 2014, J REHABIL MED, V46, P193, DOI 10.2340/16501977-1782; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Karlsgodt KH, 2008, BIOL PSYCHIAT, V63, P512, DOI 10.1016/j.biopsych.2007.06.017; KOHENRAZ R, 1991, PERCEPT MOTOR SKILL, V73, P635, DOI 10.2466/PMS.73.5.635-656; Kumar R, 2012, J NEUROSCI RES, V90, P346, DOI 10.1002/jnr.22757; Kumar R, 2010, J NEUROSCI RES, V88, P2146, DOI 10.1002/jnr.22385; Kwon HG, 2012, NEURAL REGEN RES, V7, P475, DOI 10.3969/j.issn.1673-5374.2012.06.012; LEVIN HS, 1987, J NEUROSURG, V66, P234, DOI 10.3171/jns.1987.66.2.0234; Lipton ML, 2009, RADIOLOGY, V252, P816, DOI 10.1148/radiol.2523081584; Mac Donald CL, 2007, EXP NEUROL, V205, P116, DOI 10.1016/j.expneurol.2007.01.035; Marsden J, 2011, CLIN REHABIL, V25, P195, DOI 10.1177/0269215510382495; Maskell F, 2006, BRAIN INJURY, V20, P293, DOI 10.1080/02699050500488041; Niogi SN, 2010, J HEAD TRAUMA REHAB, V25, P241, DOI 10.1097/HTR.0b013e3181e52c2a; Qin W, 2009, MAGN RESON MED, V61, P755, DOI 10.1002/mrm.21920; Rabinowitz AR, 2014, PSYCHIAT CLIN N AM, V37, P1, DOI 10.1016/j.psc.2013.11.004; Schmahmann JD, 2008, ANN NY ACAD SCI, V1142, P266, DOI 10.1196/annals.1444.017; Silverberg ND, 2015, J NEUROTRAUM, V32, P517, DOI 10.1089/neu.2014.3600; Smith DH, 2000, J NEUROSURG, V93, P315, DOI 10.3171/jns.2000.93.2.0315; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Smith SM, 2009, NEUROIMAGE, V44, P83, DOI 10.1016/j.neuroimage.2008.03.061; Song SK, 2002, NEUROIMAGE, V17, P1429, DOI 10.1006/nimg.2002.1267; Song SK, 2005, NEUROIMAGE, V26, P132, DOI 10.1016/j.neuroimage.2005.01.028	42	7	7	0	1	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2077-0383		J CLIN MED	J. Clin. Med.	SEP	2019	8	9							1318	10.3390/jcm8091318			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JC3NA	WOS:000489184200052	31461987	gold, Green Published			2022-02-06	
